,Gene_set,Term,Overlap,P-value,Adjusted P-value,Old P-value,Old Adjusted P-value,Odds Ratio,Combined Score,Genes
0,KEGG_2019_Human,Acute myeloid leukemia,1/66,0.003299948626608,0.012399870620181,0,0,19934.0,113899.85357353876,CEBPA
1,KEGG_2019_Human,Non-alcoholic fatty liver disease (NAFLD),1/149,0.0074499147221605,0.012399870620181,0,0,19851.0,97261.02051561224,CEBPA
2,KEGG_2019_Human,Transcriptional misregulation in cancer,1/186,0.0092999029651357,0.012399870620181,0,0,19814.0,92684.96451050608,CEBPA
3,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,CEBPA
4,KEGG_2019_Human,Basal transcription factors,1/45,0.0022499601197094,0.0035249384088572,0,0,19955.0,121662.49782449217,CCNH
5,KEGG_2019_Human,Nucleotide excision repair,1/47,0.0023499589392381,0.0035249384088572,0,0,19953.0,120782.64067395544,CCNH
6,KEGG_2019_Human,Cell cycle,1/124,0.0061999236097501,0.0061999236097501,0,0,19876.0,101034.04709010696,CCNH
7,KEGG_2019_Human,Cell cycle,1/124,0.0061999236097501,0.0061999236097501,0,0,19876.0,101034.04709010696,RAD21
8,KEGG_2019_Human,Lysine degradation,1/59,0.0029499522555206,0.0029499522555206,0,0,19941.0,116175.59385530632,SETD2
9,KEGG_2019_Human,Cysteine and methionine metabolism,1/47,0.0023499589392381,0.0046999178784763,0,0,19953.0,120782.64067395544,DNMT3A
10,KEGG_2019_Human,MicroRNAs in cancer,1/299,0.0149498740670514,0.0149498740670514,0,0,19701.0,82804.33538735632,DNMT3A
11,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR8H2
12,KEGG_2019_Human,Hepatocellular carcinoma,1/168,0.0083999085011095,0.0115498903940656,0,0,19832.0,94787.72752807094,ARID1A
13,KEGG_2019_Human,Thermogenesis,1/231,0.0115498903940656,0.0115498903940656,0,0,19769.0,88191.07730937863,ARID1A
14,KEGG_2019_Human,Lysosome,1/123,0.0061499239842961,0.0105998955026255,0,0,19877.0,101200.07933676826,AP1M1
15,KEGG_2019_Human,Human immunodeficiency virus 1 infection,1/212,0.0105998955026255,0.0105998955026255,0,0,19788.0,89974.27756224656,AP1M1
16,KEGG_2019_Human,Renin secretion,1/69,0.003449947123837,0.0149997992131669,0,0,19931.0,112996.7391397682,PTGER2
17,KEGG_2019_Human,Inflammatory mediator regulation of TRP channels,1/100,0.0049999330710556,0.0149997992131669,0,0,19900.0,105436.78197328727,PTGER2
18,KEGG_2019_Human,cAMP signaling pathway,1/212,0.0105998955026255,0.0168748379685508,0,0,19788.0,89974.27756224656,PTGER2
19,KEGG_2019_Human,Human cytomegalovirus infection,1/225,0.0112498919790339,0.0168748379685508,0,0,19775.0,88738.27077557483,PTGER2
20,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0202798389918715,0,0,19662.0,80229.79996326564,PTGER2
21,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,PTGER2
22,KEGG_2019_Human,Acute myeloid leukemia,1/66,0.003299948626608,0.0106998604053851,0,0,19934.0,113899.85357353876,RUNX1
23,KEGG_2019_Human,Chronic myeloid leukemia,1/76,0.0037999437281752,0.0106998604053851,0,0,19924.0,111031.8499691117,RUNX1
24,KEGG_2019_Human,Th17 cell differentiation,1/107,0.0053499302026925,0.0106998604053851,0,0,19893.0,104053.753408911,RUNX1
25,KEGG_2019_Human,Tight junction,1/170,0.0084999078692823,0.0111598835581629,0,0,19830.0,94543.49009679438,RUNX1
26,KEGG_2019_Human,Transcriptional misregulation in cancer,1/186,0.0092999029651357,0.0111598835581629,0,0,19814.0,92684.96451050608,RUNX1
27,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,RUNX1
28,KEGG_2019_Human,Bacterial invasion of epithelial cells,1/74,0.0036999446830449,0.0109598702076242,0,0,19926.0,111574.38983110404,CBL
29,KEGG_2019_Human,Chronic myeloid leukemia,1/76,0.0037999437281752,0.0109598702076242,0,0,19924.0,111031.8499691117,CBL
30,KEGG_2019_Human,ErbB signaling pathway,1/85,0.004249939567045,0.0109598702076242,0,0,19915.0,108752.83801948265,CBL
31,KEGG_2019_Human,Ubiquitin mediated proteolysis,1/137,0.0068499188797651,0.0109598702076242,0,0,19863.0,98987.62735269018,CBL
32,KEGG_2019_Human,Insulin signaling pathway,1/137,0.0068499188797651,0.0109598702076242,0,0,19863.0,98987.62735269018,CBL
33,KEGG_2019_Human,Proteoglycans in cancer,1/201,0.0100498985877989,0.0133998647837319,0,0,19799.0,91079.21596609056,CBL
34,KEGG_2019_Human,Endocytosis,1/244,0.0121998870519305,0.0139427280593492,0,0,19756.0,87051.4275316661,CBL
35,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,CBL
36,KEGG_2019_Human,Transcriptional misregulation in cancer,1/186,0.0092999029651357,0.0092999029651357,0,0,19814.0,92684.96451050608,WT1
37,KEGG_2019_Human,p53 signaling pathway,1/72,0.0035999456502131,0.0139362282047116,0,0,19928.0,112131.59838572376,CCND3
38,KEGG_2019_Human,Cell cycle,1/124,0.0061999236097501,0.0139362282047116,0,0,19876.0,101034.04709010696,CCND3
39,KEGG_2019_Human,Measles,1/138,0.0068999185254481,0.0139362282047116,0,0,19862.0,98838.19160389496,CCND3
40,KEGG_2019_Human,Wnt signaling pathway,1/158,0.0078999117225733,0.0139362282047116,0,0,19842.0,96053.2110949472,CCND3
41,KEGG_2019_Human,Cellular senescence,1/160,0.0079999110688441,0.0139362282047116,0,0,19840.0,95793.96509856998,CCND3
42,KEGG_2019_Human,Hippo signaling pathway,1/160,0.0079999110688441,0.0139362282047116,0,0,19840.0,95793.96509856998,CCND3
43,KEGG_2019_Human,JAK-STAT signaling pathway,1/162,0.0080999104202618,0.0139362282047116,0,0,19838.0,95537.86936302872,CCND3
44,KEGG_2019_Human,Focal adhesion,1/199,0.0099498991610159,0.0139362282047116,0,0,19801.0,91286.4288690606,CCND3
45,KEGG_2019_Human,Viral carcinogenesis,1/201,0.0100498985877989,0.0139362282047116,0,0,19799.0,91079.21596609056,CCND3
46,KEGG_2019_Human,Epstein-Barr virus infection,1/201,0.0100498985877989,0.0139362282047116,0,0,19799.0,91079.21596609056,CCND3
47,KEGG_2019_Human,Human T-cell leukemia virus 1 infection,1/219,0.0109498935894162,0.0139362282047116,0,0,19781.0,89299.85161916987,CCND3
48,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0190613905368566,0,0,19670.0,80733.60565076157,CCND3
49,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0190613905368566,0,0,19646.0,79255.8617626126,CCND3
50,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,CCND3
51,KEGG_2019_Human,Huntington disease,1/193,0.0096499008972596,0.0096499008972596,0,0,19807.0,91920.47679471428,DNAH10
52,KEGG_2019_Human,Transcriptional misregulation in cancer,1/186,0.0092999029651357,0.0092999029651357,0,0,19814.0,92684.96451050608,ETV6
53,KEGG_2019_Human,Cell cycle,1/124,0.0061999236097501,0.0061999236097501,0,0,19876.0,101034.04709010696,STAG2
54,KEGG_2019_Human,Spliceosome,1/134,0.0066999199497742,0.0066999199497742,0,0,19866.0,99442.43560916925,U2AF2
55,KEGG_2019_Human,Central carbon metabolism in cancer,1/65,0.003249949134407,0.0129331582145885,0,0,19935.0,114209.92613860144,FLT3
56,KEGG_2019_Human,Acute myeloid leukemia,1/66,0.003299948626608,0.0129331582145885,0,0,19934.0,113899.85357353876,FLT3
57,KEGG_2019_Human,Hematopoietic cell lineage,1/97,0.0048499343304706,0.0129331582145885,0,0,19903.0,106058.9096435903,FLT3
58,KEGG_2019_Human,Transcriptional misregulation in cancer,1/186,0.0092999029651357,0.0185598242159366,0,0,19814.0,92684.96451050608,FLT3
59,KEGG_2019_Human,Ras signaling pathway,1/232,0.0115998901349604,0.0185598242159366,0,0,19768.0,88101.22480150245,FLT3
60,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0196664999382009,0,0,19705.0,83086.53988020132,FLT3
61,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0202284144472764,0,0,19646.0,79255.8617626126,FLT3
62,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,FLT3
63,KEGG_2019_Human,Pyrimidine metabolism,1/57,0.002849953326298,0.005699906652596,0,0,19943.0,116875.00742975442,AK9
64,KEGG_2019_Human,Purine metabolism,1/129,0.006449921761047,0.006449921761047,0,0,19871.0,100223.109907462,AK9
65,KEGG_2019_Human,Protein processing in endoplasmic reticulum,1/165,0.0082499094553477,0.0164998189106955,0,0,19835.0,95159.46482222488,BCAP31
66,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0164998674589645,0,0,19670.0,80733.60565076157,BCAP31
67,KEGG_2019_Human,Lysine degradation,1/59,0.0029499522555206,0.0029499522555206,0,0,19941.0,116175.59385530632,NSD1
68,KEGG_2019_Human,Endocytosis,1/244,0.0121998870519305,0.0121998870519305,0,0,19756.0,87051.4275316661,SNX32
69,KEGG_2019_Human,Hippo signaling pathway,1/160,0.0079999110688441,0.0084999078692823,0,0,19840.0,95793.96509856998,AMOT
70,KEGG_2019_Human,Tight junction,1/170,0.0084999078692823,0.0084999078692823,0,0,19830.0,94543.49009679438,AMOT
71,KEGG_2019_Human,Spliceosome,1/134,0.0066999199497742,0.0133998398995484,0,0,19866.0,99442.43560916925,SRSF2
72,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,SRSF2
73,KEGG_2019_Human,Intestinal immune network for IgA production,1/48,0.0023999583567988,0.0102665548346894,0,0,19952.0,120356.5272753826,TGFB1
74,KEGG_2019_Human,Malaria,1/49,0.0024499577795033,0.0102665548346894,0,0,19951.0,119939.1172087114,TGFB1
75,KEGG_2019_Human,Inflammatory bowel disease (IBD),1/65,0.003249949134407,0.0102665548346894,0,0,19935.0,114209.92613860144,TGFB1
76,KEGG_2019_Human,Renal cell carcinoma,1/69,0.003449947123837,0.0102665548346894,0,0,19931.0,112996.7391397682,TGFB1
77,KEGG_2019_Human,Leishmaniasis,1/74,0.0036999446830449,0.0102665548346894,0,0,19926.0,111574.38983110404,TGFB1
78,KEGG_2019_Human,Pancreatic cancer,1/75,0.0037499442041125,0.0102665548346894,0,0,19925.0,111301.33528642564,TGFB1
79,KEGG_2019_Human,Chronic myeloid leukemia,1/76,0.0037999437281752,0.0102665548346894,0,0,19924.0,111031.8499691117,TGFB1
80,KEGG_2019_Human,Hypertrophic cardiomyopathy (HCM),1/85,0.004249939567045,0.0102665548346894,0,0,19915.0,108752.83801948265,TGFB1
81,KEGG_2019_Human,Colorectal cancer,1/86,0.0042999391173866,0.0102665548346894,0,0,19914.0,108514.46102290176,TGFB1
82,KEGG_2019_Human,TGF-beta signaling pathway,1/90,0.0044999373439762,0.0102665548346894,0,0,19910.0,107587.50385474482,TGFB1
83,KEGG_2019_Human,Dilated cardiomyopathy (DCM),1/91,0.0045499369072032,0.0102665548346894,0,0,19909.0,107362.10783923086,TGFB1
84,KEGG_2019_Human,Rheumatoid arthritis,1/91,0.0045499369072032,0.0102665548346894,0,0,19909.0,107362.10783923086,TGFB1
85,KEGG_2019_Human,Amoebiasis,1/96,0.0047999347538706,0.0102665548346894,0,0,19904.0,106270.50039849174,TGFB1
86,KEGG_2019_Human,AGE-RAGE signaling pathway in diabetic complications,1/100,0.0049999330710556,0.0102665548346894,0,0,19900.0,105436.78197328727,TGFB1
87,KEGG_2019_Human,Chagas disease (American trypanosomiasis),1/103,0.0051499318302617,0.0102665548346894,0,0,19897.0,104832.7525292024,TGFB1
88,KEGG_2019_Human,Th17 cell differentiation,1/107,0.0053499302026925,0.0102665548346894,0,0,19893.0,104053.753408911,TGFB1
89,KEGG_2019_Human,Toxoplasmosis,1/113,0.0056499278191151,0.0102665548346894,0,0,19887.0,102937.34947211576,TGFB1
90,KEGG_2019_Human,Cell cycle,1/124,0.0061999236097501,0.0102665548346894,0,0,19876.0,101034.04709010696,TGFB1
91,KEGG_2019_Human,Osteoclast differentiation,1/127,0.0063499224962247,0.0102665548346894,0,0,19873.0,100543.72072014232,TGFB1
92,KEGG_2019_Human,Relaxin signaling pathway,1/130,0.0064999213952527,0.0102665548346894,0,0,19870.0,100064.62842845908,TGFB1
93,KEGG_2019_Human,FoxO signaling pathway,1/132,0.0065999206698993,0.0102665548346894,0,0,19868.0,99751.22090491928,TGFB1
94,KEGG_2019_Human,Gastric cancer,1/149,0.0074499147221605,0.0102665548346894,0,0,19851.0,97261.02051561224,TGFB1
95,KEGG_2019_Human,Non-alcoholic fatty liver disease (NAFLD),1/149,0.0074499147221605,0.0102665548346894,0,0,19851.0,97261.02051561224,TGFB1
96,KEGG_2019_Human,Cellular senescence,1/160,0.0079999110688441,0.0102665548346894,0,0,19840.0,95793.96509856998,TGFB1
97,KEGG_2019_Human,Hippo signaling pathway,1/160,0.0079999110688441,0.0102665548346894,0,0,19840.0,95793.96509856998,TGFB1
98,KEGG_2019_Human,Hepatitis B,1/163,0.0081499100978668,0.0102665548346894,0,0,19837.0,95410.9786681514,TGFB1
99,KEGG_2019_Human,Hepatocellular carcinoma,1/168,0.0083999085011095,0.0102665548346894,0,0,19832.0,94787.72752807094,TGFB1
100,KEGG_2019_Human,Tuberculosis,1/179,0.0089499050800561,0.0105481024157804,0,0,19821.0,93478.0629355712,TGFB1
101,KEGG_2019_Human,Proteoglycans in cancer,1/201,0.0100498985877989,0.0114360914964609,0,0,19799.0,91079.21596609056,TGFB1
102,KEGG_2019_Human,Human T-cell leukemia virus 1 infection,1/219,0.0109498935894162,0.0120448829483578,0,0,19781.0,89299.85161916987,TGFB1
103,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0152108085459522,0,0,19706.0,83157.67014793828,TGFB1
104,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0152108085459522,0,0,19705.0,83086.53988020132,TGFB1
105,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,TGFB1
106,KEGG_2019_Human,Central carbon metabolism in cancer,1/65,0.003249949134407,0.0135665109458835,0,0,19935.0,114209.92613860144,KIT
107,KEGG_2019_Human,Acute myeloid leukemia,1/66,0.003299948626608,0.0135665109458835,0,0,19934.0,113899.85357353876,KIT
108,KEGG_2019_Human,Hematopoietic cell lineage,1/97,0.0048499343304706,0.0135665109458835,0,0,19903.0,106058.9096435903,KIT
109,KEGG_2019_Human,Melanogenesis,1/101,0.0050499326546803,0.0135665109458835,0,0,19899.0,105233.48101229242,KIT
110,KEGG_2019_Human,Breast cancer,1/147,0.0073499154017982,0.0135665109458835,0,0,19853.0,97539.10874372096,KIT
111,KEGG_2019_Human,Phospholipase D signaling pathway,1/148,0.007399915061391,0.0135665109458835,0,0,19852.0,97399.60470052566,KIT
112,KEGG_2019_Human,Rap1 signaling pathway,1/206,0.010299897173561,0.0159498489355705,0,0,19794.0,90569.849337325,KIT
113,KEGG_2019_Human,Ras signaling pathway,1/232,0.0115998901349604,0.0159498489355705,0,0,19768.0,88101.22480150245,KIT
114,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0180276249433508,0,0,19705.0,83086.53988020132,KIT
115,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0194698489055035,0,0,19646.0,79255.8617626126,KIT
116,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,KIT
117,KEGG_2019_Human,Axon guidance,1/181,0.0090499044707863,0.0090499044707863,0,0,19819.0,93248.41634586031,PLXNC1
118,KEGG_2019_Human,Homologous recombination,1/41,0.0020499625466866,0.0040999250933733,0,0,19959.0,123544.88783416104,BRCC3
119,KEGG_2019_Human,NOD-like receptor signaling pathway,1/178,0.0088999053857096,0.0088999053857096,0,0,19822.0,93593.82745769851,BRCC3
120,KEGG_2019_Human,Primary bile acid biosynthesis,1/17,0.0008499797390404818,0.0026999437884725,0,0,19983.0,141285.76583697114,SCP2
121,KEGG_2019_Human,Biosynthesis of unsaturated fatty acids,1/27,0.0013499718942362,0.0026999437884725,0,0,19973.0,131975.02298599784,SCP2
122,KEGG_2019_Human,PPAR signaling pathway,1/74,0.0036999446830449,0.0041499404726918,0,0,19926.0,111574.38983110404,SCP2
123,KEGG_2019_Human,Peroxisome,1/83,0.0041499404726918,0.0041499404726918,0,0,19917.0,109237.99888847338,SCP2
124,KEGG_2019_Human,Hepatocellular carcinoma,1/168,0.0083999085011095,0.0083999085011095,0,0,19832.0,94787.72752807094,ARID2
125,KEGG_2019_Human,Drug metabolism,1/108,0.0053999298011749,0.0053999298011749,0,0,19892.0,103863.47861844616,FMO3
126,KEGG_2019_Human,Fatty acid biosynthesis,1/13,0.0006499833083207112,0.0019499499249621,0,0,19987.0,146675.87616784443,FASN
127,KEGG_2019_Human,AMPK signaling pathway,1/120,0.0059999251180858,0.0068499188797651,0,0,19880.0,101706.2448082016,FASN
128,KEGG_2019_Human,Insulin signaling pathway,1/137,0.0068499188797651,0.0068499188797651,0,0,19863.0,98987.62735269018,FASN
129,KEGG_2019_Human,Thyroid cancer,1/37,0.0018499650702878,0.0120748684703449,0,0,19963.0,125618.9446446357,TP53
130,KEGG_2019_Human,Ferroptosis,1/40,0.0019999631680592,0.0120748684703449,0,0,19960.0,124043.94523066044,TP53
131,KEGG_2019_Human,Bladder cancer,1/41,0.0020499625466866,0.0120748684703449,0,0,19959.0,123544.88783416104,TP53
132,KEGG_2019_Human,Amyotrophic lateral sclerosis (ALS),1/51,0.0025499566390179,0.0120748684703449,0,0,19949.0,119129.0228601236,TP53
133,KEGG_2019_Human,Endometrial cancer,1/58,0.0028999527887707,0.0120748684703449,0,0,19942.0,116522.31890946148,TP53
134,KEGG_2019_Human,Basal cell carcinoma,1/63,0.0031499501598827,0.0120748684703449,0,0,19937.0,114844.46974572667,TP53
135,KEGG_2019_Human,Mitophagy,1/65,0.003249949134407,0.0120748684703449,0,0,19935.0,114209.92613860144,TP53
136,KEGG_2019_Human,Central carbon metabolism in cancer,1/65,0.003249949134407,0.0120748684703449,0,0,19935.0,114209.92613860144,TP53
137,KEGG_2019_Human,Non-small cell lung cancer,1/66,0.003299948626608,0.0120748684703449,0,0,19934.0,113899.85357353876,TP53
138,KEGG_2019_Human,Melanoma,1/72,0.0035999456502131,0.0120748684703449,0,0,19928.0,112131.59838572376,TP53
139,KEGG_2019_Human,p53 signaling pathway,1/72,0.0035999456502131,0.0120748684703449,0,0,19928.0,112131.59838572376,TP53
140,KEGG_2019_Human,Pancreatic cancer,1/75,0.0037499442041125,0.0120748684703449,0,0,19925.0,111301.33528642564,TP53
141,KEGG_2019_Human,Glioma,1/75,0.0037499442041125,0.0120748684703449,0,0,19925.0,111301.33528642564,TP53
142,KEGG_2019_Human,Chronic myeloid leukemia,1/76,0.0037999437281752,0.0120748684703449,0,0,19924.0,111031.8499691117,TP53
143,KEGG_2019_Human,Colorectal cancer,1/86,0.0042999391173866,0.0120748684703449,0,0,19914.0,108514.46102290176,TP53
144,KEGG_2019_Human,Small cell lung cancer,1/93,0.0046499360391879,0.0120748684703449,0,0,19907.0,106918.54242106884,TP53
145,KEGG_2019_Human,Prostate cancer,1/97,0.0048499343304706,0.0120748684703449,0,0,19903.0,106058.9096435903,TP53
146,KEGG_2019_Human,Longevity regulating pathway,1/102,0.0050999322416682,0.0120748684703449,0,0,19898.0,105032.15064717118,TP53
147,KEGG_2019_Human,Thyroid hormone signaling pathway,1/116,0.0057999266512085,0.0120748684703449,0,0,19884.0,102400.8105961506,TP53
148,KEGG_2019_Human,Sphingolipid signaling pathway,1/119,0.0059499254985137,0.0120748684703449,0,0,19881.0,101877.73080211312,TP53
149,KEGG_2019_Human,Neurotrophin signaling pathway,1/119,0.0059499254985137,0.0120748684703449,0,0,19881.0,101877.73080211312,TP53
150,KEGG_2019_Human,Cell cycle,1/124,0.0061999236097501,0.0120748684703449,0,0,19876.0,101034.04709010696,TP53
151,KEGG_2019_Human,Measles,1/138,0.0068999185254481,0.0120748684703449,0,0,19862.0,98838.19160389496,TP53
152,KEGG_2019_Human,Fluid shear stress and atherosclerosis,1/139,0.006949918172816,0.0120748684703449,0,0,19861.0,98689.81333375497,TP53
153,KEGG_2019_Human,Apoptosis,1/143,0.0071499167770442,0.0120748684703449,0,0,19857.0,98106.57763600958,TP53
154,KEGG_2019_Human,Breast cancer,1/147,0.0073499154017982,0.0120748684703449,0,0,19853.0,97539.10874372096,TP53
155,KEGG_2019_Human,Gastric cancer,1/149,0.0074499147221605,0.0120748684703449,0,0,19851.0,97261.02051561224,TP53
156,KEGG_2019_Human,Hepatitis C,1/155,0.0077499127120574,0.0120748684703449,0,0,19845.0,96448.16254952336,TP53
157,KEGG_2019_Human,Wnt signaling pathway,1/158,0.0078999117225733,0.0120748684703449,0,0,19842.0,96053.2110949472,TP53
158,KEGG_2019_Human,Cellular senescence,1/160,0.0079999110688441,0.0120748684703449,0,0,19840.0,95793.96509856998,TP53
159,KEGG_2019_Human,Hepatitis B,1/163,0.0081499100978668,0.0120748684703449,0,0,19837.0,95410.9786681514,TP53
160,KEGG_2019_Human,Hepatocellular carcinoma,1/168,0.0083999085011095,0.0120748684703449,0,0,19832.0,94787.72752807094,TP53
161,KEGG_2019_Human,Kaposi sarcoma-associated herpesvirus infection,1/186,0.0092999029651357,0.0121656667115461,0,0,19814.0,92684.96451050608,TP53
162,KEGG_2019_Human,Transcriptional misregulation in cancer,1/186,0.0092999029651357,0.0121656667115461,0,0,19814.0,92684.96451050608,TP53
163,KEGG_2019_Human,Huntington disease,1/193,0.0096499008972596,0.0121656667115461,0,0,19807.0,91920.47679471428,TP53
164,KEGG_2019_Human,Epstein-Barr virus infection,1/201,0.0100498985877989,0.0121656667115461,0,0,19799.0,91079.21596609056,TP53
165,KEGG_2019_Human,Proteoglycans in cancer,1/201,0.0100498985877989,0.0121656667115461,0,0,19799.0,91079.21596609056,TP53
166,KEGG_2019_Human,Viral carcinogenesis,1/201,0.0100498985877989,0.0121656667115461,0,0,19799.0,91079.21596609056,TP53
167,KEGG_2019_Human,Human T-cell leukemia virus 1 infection,1/219,0.0109498935894162,0.0129152591054653,0,0,19781.0,89299.85161916987,TP53
168,KEGG_2019_Human,Human cytomegalovirus infection,1/225,0.0112498919790339,0.012937375775889,0,0,19775.0,88738.27077557483,TP53
169,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0163736715972468,0,0,19705.0,83086.53988020132,TP53
170,KEGG_2019_Human,MicroRNAs in cancer,1/299,0.0149498740670514,0.0163736715972468,0,0,19701.0,82804.33538735632,TP53
171,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0176510210026132,0,0,19670.0,80733.60565076157,TP53
172,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0185044018523381,0,0,19646.0,79255.8617626126,TP53
173,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0251465020680608,0,0,19508.0,72277.44006442746,TP53
174,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,TP53
175,KEGG_2019_Human,Shigellosis,1/65,0.003249949134407,0.0073998893660899,0,0,19935.0,114209.92613860144,DOCK1
176,KEGG_2019_Human,Bacterial invasion of epithelial cells,1/74,0.0036999446830449,0.0073998893660899,0,0,19926.0,111574.38983110404,DOCK1
177,KEGG_2019_Human,Focal adhesion,1/199,0.0099498991610159,0.0106998949514067,0,0,19801.0,91286.4288690606,DOCK1
178,KEGG_2019_Human,Regulation of actin cytoskeleton,1/214,0.0106998949514067,0.0106998949514067,0,0,19786.0,89779.39753374986,DOCK1
179,KEGG_2019_Human,Thyroid hormone signaling pathway,1/116,0.0057999266512085,0.0057999266512085,0,0,19884.0,102400.8105961506,MED12
180,KEGG_2019_Human,Non-homologous end-joining,1/13,0.0006499833083207112,0.0006499833083207112,0,0,19987.0,146675.87616784443,XRCC6
181,KEGG_2019_Human,TGF-beta signaling pathway,1/90,0.0044999373439762,0.0108598853649436,0,0,19910.0,107587.50385474482,BMPR1B
182,KEGG_2019_Human,Fluid shear stress and atherosclerosis,1/139,0.006949918172816,0.0108598853649436,0,0,19861.0,98689.81333375497,BMPR1B
183,KEGG_2019_Human,Signaling pathways regulating pluripotency of stem cells,1/139,0.006949918172816,0.0108598853649436,0,0,19861.0,98689.81333375497,BMPR1B
184,KEGG_2019_Human,Hippo signaling pathway,1/160,0.0079999110688441,0.0108598853649436,0,0,19840.0,95793.96509856998,BMPR1B
185,KEGG_2019_Human,Axon guidance,1/181,0.0090499044707863,0.0108598853649436,0,0,19819.0,93248.41634586031,BMPR1B
186,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0146998751759735,0,0,19706.0,83157.67014793828,BMPR1B
187,KEGG_2019_Human,Transcriptional misregulation in cancer,1/186,0.0092999029651357,0.0092999029651357,0,0,19814.0,92684.96451050608,KDM6A
188,KEGG_2019_Human,Lysine degradation,1/59,0.0029499522555206,0.0029499522555206,0,0,19941.0,116175.59385530632,KMT2C
189,KEGG_2019_Human,RNA polymerase,1/31,0.0015499690656704,0.0030999381313408,0,0,19969.0,129189.85098816035,POLR2B
190,KEGG_2019_Human,Huntington disease,1/193,0.0096499008972596,0.0096499008972596,0,0,19807.0,91920.47679471428,POLR2B
191,KEGG_2019_Human,Cortisol synthesis and secretion,1/65,0.003249949134407,0.0092999029651357,0,0,19935.0,114209.92613860144,PBX1
192,KEGG_2019_Human,Cushing syndrome,1/155,0.0077499127120574,0.0092999029651357,0,0,19845.0,96448.16254952336,PBX1
193,KEGG_2019_Human,Transcriptional misregulation in cancer,1/186,0.0092999029651357,0.0092999029651357,0,0,19814.0,92684.96451050608,PBX1
194,KEGG_2019_Human,Lysine degradation,1/59,0.0029499522555206,0.0058999045110413,0,0,19941.0,116175.59385530632,EZH2
195,KEGG_2019_Human,MicroRNAs in cancer,1/299,0.0149498740670514,0.0149498740670514,0,0,19701.0,82804.33538735632,EZH2
196,KEGG_2019_Human,RNA degradation,1/79,0.0039499423167337,0.0039499423167337,0,0,19921.0,110243.89578070649,DDX6
197,KEGG_2019_Human,Amino sugar and nucleotide sugar metabolism,1/48,0.0023999583567988,0.0023999583567988,0,0,19952.0,120356.5272753826,CHIT1
198,KEGG_2019_Human,Steroid biosynthesis,1/19,0.00094997806231055,0.0028499341869316,0,0,19981.0,139049.2109571672,CYP27B1
199,KEGG_2019_Human,"Parathyroid hormone synthesis, secretion and action",1/106,0.0052999306076525,0.0079498959114788,0,0,19894.0,104245.78450366124,CYP27B1
200,KEGG_2019_Human,Tuberculosis,1/179,0.0089499050800561,0.0089499050800561,0,0,19821.0,93478.0629355712,CYP27B1
201,KEGG_2019_Human,Protein digestion and absorption,1/90,0.0044999373439762,0.0044999373439762,0,0,19910.0,107587.50385474482,COL22A1
202,KEGG_2019_Human,Lysine degradation,1/59,0.0029499522555206,0.0058999045110413,0,0,19941.0,116175.59385530632,DOT1L
203,KEGG_2019_Human,Transcriptional misregulation in cancer,1/186,0.0092999029651357,0.0092999029651357,0,0,19814.0,92684.96451050608,DOT1L
204,KEGG_2019_Human,Taurine and hypotaurine metabolism,1/11,0.0005499852259717758,0.0016499556779153,0,0,19989.0,150029.8210287992,GGT1
205,KEGG_2019_Human,Glutathione metabolism,1/56,0.0027999538675741,0.0031499501598827,0,0,19944.0,117233.87022514464,GGT1
206,KEGG_2019_Human,Arachidonic acid metabolism,1/63,0.0031499501598827,0.0031499501598827,0,0,19937.0,114844.46974572667,GGT1
207,KEGG_2019_Human,Adherens junction,1/72,0.0035999456502131,0.0068499188797651,0,0,19928.0,112131.59838572376,PTPN1
208,KEGG_2019_Human,Insulin resistance,1/108,0.0053999298011749,0.0068499188797651,0,0,19892.0,103863.47861844616,PTPN1
209,KEGG_2019_Human,Insulin signaling pathway,1/137,0.0068499188797651,0.0068499188797651,0,0,19863.0,98987.62735269018,PTPN1
210,KEGG_2019_Human,Inositol phosphate metabolism,1/74,0.0036999446830449,0.0098998669768137,0,0,19926.0,111574.38983110404,PIKFYVE
211,KEGG_2019_Human,Phosphatidylinositol signaling system,1/99,0.0049499334884068,0.0098998669768137,0,0,19901.0,105642.09305076736,PIKFYVE
212,KEGG_2019_Human,Phagosome,1/152,0.0075999137114971,0.0101332182819961,0,0,19848.0,96850.665715497,PIKFYVE
213,KEGG_2019_Human,Regulation of actin cytoskeleton,1/214,0.0106998949514067,0.0106998949514067,0,0,19786.0,89779.39753374986,PIKFYVE
214,KEGG_2019_Human,Mismatch repair,1/23,0.0011499748819949,0.0023499589392381,0,0,19977.0,135204.63922267244,RFC1
215,KEGG_2019_Human,DNA replication,1/36,0.0017999657178272,0.0023499589392381,0,0,19964.0,126172.23364250171,RFC1
216,KEGG_2019_Human,Nucleotide excision repair,1/47,0.0023499589392381,0.0023499589392381,0,0,19953.0,120782.64067395544,RFC1
217,KEGG_2019_Human,Wnt signaling pathway,1/158,0.0078999117225733,0.0078999117225733,0,0,19842.0,96053.2110949472,TBL1XR1
218,KEGG_2019_Human,Basal transcription factors,1/45,0.0022499601197094,0.0044999202394188,0,0,19955.0,121662.49782449217,GTF2I
219,KEGG_2019_Human,cGMP-PKG signaling pathway,1/166,0.0082999091363732,0.0082999091363732,0,0,19834.0,95034.82345515196,GTF2I
220,KEGG_2019_Human,Fanconi anemia pathway,1/54,0.0026999549628563,0.0026999549628563,0,0,19946.0,117971.01964061816,REV3L
221,KEGG_2019_Human,Lysine degradation,1/59,0.0029499522555206,0.0058999045110413,0,0,19941.0,116175.59385530632,KMT2D
222,KEGG_2019_Human,Cushing syndrome,1/155,0.0077499127120574,0.0077499127120574,0,0,19845.0,96448.16254952336,KMT2D
223,KEGG_2019_Human,Cell cycle,1/124,0.0061999236097501,0.0062499232373748,0,0,19876.0,101034.04709010696,SMC1A
224,KEGG_2019_Human,Oocyte meiosis,1/125,0.0062499232373748,0.0062499232373748,0,0,19875.0,100869.32368441945,SMC1A
225,KEGG_2019_Human,TGF-beta signaling pathway,1/90,0.0044999373439762,0.0090499044707863,0,0,19910.0,107587.50385474482,NEO1
226,KEGG_2019_Human,Cell adhesion molecules (CAMs),1/145,0.0072499160871101,0.0090499044707863,0,0,19855.0,97820.92670675044,NEO1
227,KEGG_2019_Human,Axon guidance,1/181,0.0090499044707863,0.0090499044707863,0,0,19819.0,93248.41634586031,NEO1
228,KEGG_2019_Human,Axon guidance,1/181,0.0090499044707863,0.0090499044707863,0,0,19819.0,93248.41634586031,UNC5B
229,KEGG_2019_Human,Aminoacyl-tRNA biosynthesis,1/66,0.003299948626608,0.003299948626608,0,0,19934.0,113899.85357353876,FARSA
230,KEGG_2019_Human,Pancreatic secretion,1/98,0.0048999339081079,0.009399902370135,0,0,19902.0,105849.45495286948,ATP2A1
231,KEGG_2019_Human,cGMP-PKG signaling pathway,1/166,0.0082999091363732,0.009399902370135,0,0,19834.0,95034.82345515196,ATP2A1
232,KEGG_2019_Human,Alzheimer disease,1/171,0.0085499075557634,0.009399902370135,0,0,19829.0,94422.42241345016,ATP2A1
233,KEGG_2019_Human,Calcium signaling pathway,1/188,0.009399902370135,0.009399902370135,0,0,19812.0,92463.712994847,ATP2A1
234,KEGG_2019_Human,Protein processing in endoplasmic reticulum,1/165,0.0082499094553477,0.0082499094553477,0,0,19835.0,95159.46482222488,EDEM1
235,KEGG_2019_Human,RNA transport,1/165,0.0082499094553477,0.0082499094553477,0,0,19835.0,95159.46482222488,NUP214
236,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR7C1
237,KEGG_2019_Human,RNA degradation,1/79,0.0039499423167337,0.0039499423167337,0,0,19921.0,110243.89578070649,CNOT1
238,KEGG_2019_Human,Proximal tubule bicarbonate reclamation,1/23,0.0011499748819949,0.0062999150247102,0,0,19977.0,135204.63922267244,ATP1A1
239,KEGG_2019_Human,Aldosterone-regulated sodium reabsorption,1/37,0.0018499650702878,0.0062999150247102,0,0,19963.0,125618.9446446357,ATP1A1
240,KEGG_2019_Human,Carbohydrate digestion and absorption,1/44,0.0021999607179423,0.0062999150247102,0,0,19956.0,122117.06559109331,ATP1A1
241,KEGG_2019_Human,Endocrine and other factor-regulated calcium reabsorption,1/48,0.0023999583567988,0.0062999150247102,0,0,19952.0,120356.5272753826,ATP1A1
242,KEGG_2019_Human,Mineral absorption,1/51,0.0025499566390179,0.0062999150247102,0,0,19949.0,119129.0228601236,ATP1A1
243,KEGG_2019_Human,Bile secretion,1/72,0.0035999456502131,0.0062999150247102,0,0,19928.0,112131.59838572376,ATP1A1
244,KEGG_2019_Human,Thyroid hormone synthesis,1/74,0.0036999446830449,0.0062999150247102,0,0,19926.0,111574.38983110404,ATP1A1
245,KEGG_2019_Human,Gastric acid secretion,1/75,0.0037499442041125,0.0062999150247102,0,0,19925.0,111301.33528642564,ATP1A1
246,KEGG_2019_Human,Cardiac muscle contraction,1/78,0.0038999427840466,0.0062999150247102,0,0,19922.0,110503.2180492851,ATP1A1
247,KEGG_2019_Human,Insulin secretion,1/86,0.0042999391173866,0.0062999150247102,0,0,19914.0,108514.46102290176,ATP1A1
248,KEGG_2019_Human,Salivary secretion,1/90,0.0044999373439762,0.0062999150247102,0,0,19910.0,107587.50385474482,ATP1A1
249,KEGG_2019_Human,Protein digestion and absorption,1/90,0.0044999373439762,0.0062999150247102,0,0,19910.0,107587.50385474482,ATP1A1
250,KEGG_2019_Human,Pancreatic secretion,1/98,0.0048999339081079,0.0062999150247102,0,0,19902.0,105849.45495286948,ATP1A1
251,KEGG_2019_Human,Aldosterone synthesis and secretion,1/98,0.0048999339081079,0.0062999150247102,0,0,19902.0,105849.45495286948,ATP1A1
252,KEGG_2019_Human,Thyroid hormone signaling pathway,1/116,0.0057999266512085,0.0069599119814502,0,0,19884.0,102400.8105961506,ATP1A1
253,KEGG_2019_Human,Adrenergic signaling in cardiomyocytes,1/145,0.0072499160871101,0.0081561555979989,0,0,19855.0,97820.92670675044,ATP1A1
254,KEGG_2019_Human,cGMP-PKG signaling pathway,1/166,0.0082999091363732,0.0087881390855717,0,0,19834.0,95034.82345515196,ATP1A1
255,KEGG_2019_Human,cAMP signaling pathway,1/212,0.0105998955026255,0.0105998955026255,0,0,19788.0,89974.27756224656,ATP1A1
256,KEGG_2019_Human,Mismatch repair,1/23,0.0011499748819949,0.0023499589392381,0,0,19977.0,135204.63922267244,POLD3
257,KEGG_2019_Human,Base excision repair,1/33,0.0016499677032113,0.0023499589392381,0,0,19967.0,127928.56031580272,POLD3
258,KEGG_2019_Human,DNA replication,1/36,0.0017999657178272,0.0023499589392381,0,0,19964.0,126172.23364250171,POLD3
259,KEGG_2019_Human,Homologous recombination,1/41,0.0020499625466866,0.0023499589392381,0,0,19959.0,123544.88783416104,POLD3
260,KEGG_2019_Human,Nucleotide excision repair,1/47,0.0023499589392381,0.0023499589392381,0,0,19953.0,120782.64067395544,POLD3
261,KEGG_2019_Human,Hippo signaling pathway,1/160,0.0079999110688441,0.0079999110688441,0,0,19840.0,95793.96509856998,FAT4
262,KEGG_2019_Human,Ether lipid metabolism,1/47,0.0023499589392381,0.0046999178784763,0,0,19953.0,120782.64067395544,PLD4
263,KEGG_2019_Human,Glycerophospholipid metabolism,1/97,0.0048499343304706,0.0048499343304706,0,0,19903.0,106058.9096435903,PLD4
264,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF614
265,KEGG_2019_Human,Central carbon metabolism in cancer,1/65,0.003249949134407,0.0167748446964045,0,0,19935.0,114209.92613860144,FGFR2
266,KEGG_2019_Human,Prostate cancer,1/97,0.0048499343304706,0.0167748446964045,0,0,19903.0,106058.9096435903,FGFR2
267,KEGG_2019_Human,Signaling pathways regulating pluripotency of stem cells,1/139,0.006949918172816,0.0167748446964045,0,0,19861.0,98689.81333375497,FGFR2
268,KEGG_2019_Human,Gastric cancer,1/149,0.0074499147221605,0.0167748446964045,0,0,19851.0,97261.02051561224,FGFR2
269,KEGG_2019_Human,Rap1 signaling pathway,1/206,0.010299897173561,0.0167748446964045,0,0,19794.0,90569.849337325,FGFR2
270,KEGG_2019_Human,Regulation of actin cytoskeleton,1/214,0.0106998949514067,0.0167748446964045,0,0,19786.0,89779.39753374986,FGFR2
271,KEGG_2019_Human,Ras signaling pathway,1/232,0.0115998901349604,0.0167748446964045,0,0,19768.0,88101.22480150245,FGFR2
272,KEGG_2019_Human,Endocytosis,1/244,0.0121998870519305,0.0167748446964045,0,0,19756.0,87051.4275316661,FGFR2
273,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0180276249433508,0,0,19705.0,83086.53988020132,FGFR2
274,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0194698489055035,0,0,19646.0,79255.8617626126,FGFR2
275,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,FGFR2
276,KEGG_2019_Human,Renal cell carcinoma,1/69,0.003449947123837,0.0074998996065834,0,0,19931.0,112996.7391397682,EGLN1
277,KEGG_2019_Human,HIF-1 signaling pathway,1/100,0.0049999330710556,0.0074998996065834,0,0,19900.0,105436.78197328727,EGLN1
278,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,EGLN1
279,KEGG_2019_Human,Protein digestion and absorption,1/90,0.0044999373439762,0.0044999373439762,0,0,19910.0,107587.50385474482,COL14A1
280,KEGG_2019_Human,"Glycine, serine and threonine metabolism",1/40,0.0019999631680592,0.0036749366692549,0,0,19960.0,124043.94523066044,DAO
281,KEGG_2019_Human,Arginine and proline metabolism,1/49,0.0024499577795033,0.0036749366692549,0,0,19951.0,119939.1172087114,DAO
282,KEGG_2019_Human,Peroxisome,1/83,0.0041499404726918,0.0041499404726918,0,0,19917.0,109237.99888847338,DAO
283,KEGG_2019_Human,ECM-receptor interaction,1/82,0.004099940929819,0.0099998661421113,0,0,19918.0,109484.9180722932,COL4A2
284,KEGG_2019_Human,Protein digestion and absorption,1/90,0.0044999373439762,0.0099998661421113,0,0,19910.0,107587.50385474482,COL4A2
285,KEGG_2019_Human,Small cell lung cancer,1/93,0.0046499360391879,0.0099998661421113,0,0,19907.0,106918.54242106884,COL4A2
286,KEGG_2019_Human,Amoebiasis,1/96,0.0047999347538706,0.0099998661421113,0,0,19904.0,106270.50039849174,COL4A2
287,KEGG_2019_Human,AGE-RAGE signaling pathway in diabetic complications,1/100,0.0049999330710556,0.0099998661421113,0,0,19900.0,105436.78197328727,COL4A2
288,KEGG_2019_Human,Relaxin signaling pathway,1/130,0.0064999213952527,0.0108332023254213,0,0,19870.0,100064.62842845908,COL4A2
289,KEGG_2019_Human,Focal adhesion,1/199,0.0099498991610159,0.0142141416585942,0,0,19801.0,91286.4288690606,COL4A2
290,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0196665140459632,0,0,19670.0,80733.60565076157,COL4A2
291,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0196665140459632,0,0,19646.0,79255.8617626126,COL4A2
292,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,COL4A2
293,KEGG_2019_Human,Maturity onset diabetes of the young,1/26,0.0012999726251831,0.0025999452503662,0,0,19974.0,132735.46073187632,PAX6
294,KEGG_2019_Human,Signaling pathways regulating pluripotency of stem cells,1/139,0.006949918172816,0.006949918172816,0,0,19861.0,98689.81333375497,PAX6
295,KEGG_2019_Human,Hippo signaling pathway,1/160,0.0079999110688441,0.0127498618039235,0,0,19840.0,95793.96509856998,DLG2
296,KEGG_2019_Human,Tight junction,1/170,0.0084999078692823,0.0127498618039235,0,0,19830.0,94543.49009679438,DLG2
297,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0164998674589645,0,0,19670.0,80733.60565076157,DLG2
298,KEGG_2019_Human,Transcriptional misregulation in cancer,1/186,0.0092999029651357,0.0092999029651357,0,0,19814.0,92684.96451050608,LDB1
299,KEGG_2019_Human,Transcriptional misregulation in cancer,1/186,0.0092999029651357,0.0092999029651357,0,0,19814.0,92684.96451050608,TSPAN7
300,KEGG_2019_Human,Signaling pathways regulating pluripotency of stem cells,1/139,0.006949918172816,0.006949918172816,0,0,19861.0,98689.81333375497,SMARCAD1
301,KEGG_2019_Human,Notch signaling pathway,1/48,0.0023999583567988,0.0124430608970639,0,0,19952.0,120356.5272753826,CREBBP
302,KEGG_2019_Human,Long-term potentiation,1/67,0.0033499481224912,0.0124430608970639,0,0,19933.0,113594.38808369274,CREBBP
303,KEGG_2019_Human,Renal cell carcinoma,1/69,0.003449947123837,0.0124430608970639,0,0,19931.0,112996.7391397682,CREBBP
304,KEGG_2019_Human,Adherens junction,1/72,0.0035999456502131,0.0124430608970639,0,0,19928.0,112131.59838572376,CREBBP
305,KEGG_2019_Human,TGF-beta signaling pathway,1/90,0.0044999373439762,0.0124430608970639,0,0,19910.0,107587.50385474482,CREBBP
306,KEGG_2019_Human,Prostate cancer,1/97,0.0048499343304706,0.0124430608970639,0,0,19903.0,106058.9096435903,CREBBP
307,KEGG_2019_Human,HIF-1 signaling pathway,1/100,0.0049999330710556,0.0124430608970639,0,0,19900.0,105436.78197328727,CREBBP
308,KEGG_2019_Human,Melanogenesis,1/101,0.0050499326546803,0.0124430608970639,0,0,19899.0,105233.48101229242,CREBBP
309,KEGG_2019_Human,Glucagon signaling pathway,1/103,0.0051499318302617,0.0124430608970639,0,0,19897.0,104832.7525292024,CREBBP
310,KEGG_2019_Human,Thyroid hormone signaling pathway,1/116,0.0057999266512085,0.0124430608970639,0,0,19884.0,102400.8105961506,CREBBP
311,KEGG_2019_Human,Cell cycle,1/124,0.0061999236097501,0.0124430608970639,0,0,19876.0,101034.04709010696,CREBBP
312,KEGG_2019_Human,FoxO signaling pathway,1/132,0.0065999206698993,0.0124430608970639,0,0,19868.0,99751.22090491928,CREBBP
313,KEGG_2019_Human,Wnt signaling pathway,1/158,0.0078999117225733,0.0124430608970639,0,0,19842.0,96053.2110949472,CREBBP
314,KEGG_2019_Human,JAK-STAT signaling pathway,1/162,0.0080999104202618,0.0124430608970639,0,0,19838.0,95537.86936302872,CREBBP
315,KEGG_2019_Human,Hepatitis B,1/163,0.0081499100978668,0.0124430608970639,0,0,19837.0,95410.9786681514,CREBBP
316,KEGG_2019_Human,Influenza A,1/171,0.0085499075557634,0.0124430608970639,0,0,19829.0,94422.42241345016,CREBBP
317,KEGG_2019_Human,Tuberculosis,1/179,0.0089499050800561,0.0124430608970639,0,0,19821.0,93478.0629355712,CREBBP
318,KEGG_2019_Human,Kaposi sarcoma-associated herpesvirus infection,1/186,0.0092999029651357,0.0124430608970639,0,0,19814.0,92684.96451050608,CREBBP
319,KEGG_2019_Human,Huntington disease,1/193,0.0096499008972596,0.0124430608970639,0,0,19807.0,91920.47679471428,CREBBP
320,KEGG_2019_Human,Viral carcinogenesis,1/201,0.0100498985877989,0.0124430608970639,0,0,19799.0,91079.21596609056,CREBBP
321,KEGG_2019_Human,cAMP signaling pathway,1/212,0.0105998955026255,0.0124430608970639,0,0,19788.0,89974.27756224656,CREBBP
322,KEGG_2019_Human,Human T-cell leukemia virus 1 infection,1/219,0.0109498935894162,0.0124430608970639,0,0,19781.0,89299.85161916987,CREBBP
323,KEGG_2019_Human,MicroRNAs in cancer,1/299,0.0149498740670514,0.0162498631163602,0,0,19701.0,82804.33538735632,CREBBP
324,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0171873619364213,0,0,19670.0,80733.60565076157,CREBBP
325,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,CREBBP
326,KEGG_2019_Human,Pantothenate and CoA biosynthesis,1/19,0.00094997806231055,0.0030999381313408,0,0,19981.0,139049.2109571672,UPB1
327,KEGG_2019_Human,beta-Alanine metabolism,1/31,0.0015499690656704,0.0030999381313408,0,0,19969.0,129189.85098816035,UPB1
328,KEGG_2019_Human,Pyrimidine metabolism,1/57,0.002849953326298,0.0037999377683973,0,0,19943.0,116875.00742975442,UPB1
329,KEGG_2019_Human,Drug metabolism,1/108,0.0053999298011749,0.0053999298011749,0,0,19892.0,103863.47861844616,UPB1
330,KEGG_2019_Human,Oxidative phosphorylation,1/133,0.0066499203093911,0.0112582177134695,0,0,19867.0,99596.2591544721,NDUFS8
331,KEGG_2019_Human,Parkinson disease,1/142,0.0070999171242726,0.0112582177134695,0,0,19858.0,98250.87390500787,NDUFS8
332,KEGG_2019_Human,Retrograde endocannabinoid signaling,1/148,0.007399915061391,0.0112582177134695,0,0,19852.0,97399.60470052566,NDUFS8
333,KEGG_2019_Human,Non-alcoholic fatty liver disease (NAFLD),1/149,0.0074499147221605,0.0112582177134695,0,0,19851.0,97261.02051561224,NDUFS8
334,KEGG_2019_Human,Alzheimer disease,1/171,0.0085499075557634,0.0112582177134695,0,0,19829.0,94422.42241345016,NDUFS8
335,KEGG_2019_Human,Huntington disease,1/193,0.0096499008972596,0.0112582177134695,0,0,19807.0,91920.47679471428,NDUFS8
336,KEGG_2019_Human,Thermogenesis,1/231,0.0115498903940656,0.0115498903940656,0,0,19769.0,88191.07730937863,NDUFS8
337,KEGG_2019_Human,Glycosphingolipid biosynthesis,1/45,0.0022499601197094,0.0022499601197094,0,0,19955.0,121662.49782449217,ST6GALNAC6
338,KEGG_2019_Human,Prion diseases,1/35,0.0017499663721595,0.0034999327443191,0,0,19965.0,126740.98858805298,NCAM2
339,KEGG_2019_Human,Cell adhesion molecules (CAMs),1/145,0.0072499160871101,0.0072499160871101,0,0,19855.0,97820.92670675044,NCAM2
340,KEGG_2019_Human,Cell cycle,1/124,0.0061999236097501,0.0093748848560622,0,0,19876.0,101034.04709010696,ESPL1
341,KEGG_2019_Human,Oocyte meiosis,1/125,0.0062499232373748,0.0093748848560622,0,0,19875.0,100869.32368441945,ESPL1
342,KEGG_2019_Human,Human T-cell leukemia virus 1 infection,1/219,0.0109498935894162,0.0109498935894162,0,0,19781.0,89299.85161916987,ESPL1
343,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF729
344,KEGG_2019_Human,Wnt signaling pathway,1/158,0.0078999117225733,0.0078999117225733,0,0,19842.0,96053.2110949472,VANGL2
345,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF85
346,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZIK1
347,KEGG_2019_Human,Complement and coagulation cascades,1/79,0.0039499423167337,0.0039499423167337,0,0,19921.0,110243.89578070649,SERPINC1
348,KEGG_2019_Human,Metabolism of xenobiotics by cytochrome P450,1/74,0.0036999446830449,0.0036999446830449,0,0,19926.0,111574.38983110404,AKR7A2
349,KEGG_2019_Human,Axon guidance,1/181,0.0090499044707863,0.0090499044707863,0,0,19819.0,93248.41634586031,EPHB1
350,KEGG_2019_Human,C-type lectin receptor signaling pathway,1/104,0.0051999314202997,0.0125623732347487,0,0,19896.0,104635.24941415618,STAT2
351,KEGG_2019_Human,Osteoclast differentiation,1/127,0.0063499224962247,0.0125623732347487,0,0,19873.0,100543.72072014232,STAT2
352,KEGG_2019_Human,Measles,1/138,0.0068999185254481,0.0125623732347487,0,0,19862.0,98838.19160389496,STAT2
353,KEGG_2019_Human,Hepatitis C,1/155,0.0077499127120574,0.0125623732347487,0,0,19845.0,96448.16254952336,STAT2
354,KEGG_2019_Human,Necroptosis,1/162,0.0080999104202618,0.0125623732347487,0,0,19838.0,95537.86936302872,STAT2
355,KEGG_2019_Human,JAK-STAT signaling pathway,1/162,0.0080999104202618,0.0125623732347487,0,0,19838.0,95537.86936302872,STAT2
356,KEGG_2019_Human,Hepatitis B,1/163,0.0081499100978668,0.0125623732347487,0,0,19837.0,95410.9786681514,STAT2
357,KEGG_2019_Human,Influenza A,1/171,0.0085499075557634,0.0125623732347487,0,0,19829.0,94422.42241345016,STAT2
358,KEGG_2019_Human,NOD-like receptor signaling pathway,1/178,0.0088999053857096,0.0125623732347487,0,0,19822.0,93593.82745769851,STAT2
359,KEGG_2019_Human,Kaposi sarcoma-associated herpesvirus infection,1/186,0.0092999029651357,0.0125623732347487,0,0,19814.0,92684.96451050608,STAT2
360,KEGG_2019_Human,Chemokine signaling pathway,1/190,0.0094999017791995,0.0125623732347487,0,0,19810.0,92244.74636351672,STAT2
361,KEGG_2019_Human,Epstein-Barr virus infection,1/201,0.0100498985877989,0.0125623732347487,0,0,19799.0,91079.21596609056,STAT2
362,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0190383086064975,0,0,19670.0,80733.60565076157,STAT2
363,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0263569703353121,0,0,19508.0,72277.44006442746,STAT2
364,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,STAT2
365,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF429
366,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF749
367,KEGG_2019_Human,Cell adhesion molecules (CAMs),1/145,0.0072499160871101,0.0072499160871101,0,0,19855.0,97820.92670675044,NRXN1
368,KEGG_2019_Human,Porphyrin and chlorophyll metabolism,1/42,0.0020999619311272,0.0025499566390179,0,0,19958.0,123057.75613441122,HEPH
369,KEGG_2019_Human,Mineral absorption,1/51,0.0025499566390179,0.0025499566390179,0,0,19949.0,119129.0228601236,HEPH
370,KEGG_2019_Human,Autophagy,1/128,0.0063999221281459,0.0068499188797651,0,0,19872.0,100382.8010329652,PIK3R4
371,KEGG_2019_Human,Apelin signaling pathway,1/137,0.0068499188797651,0.0068499188797651,0,0,19863.0,98987.62735269018,PIK3R4
372,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF234
373,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0147498749536506,0,0,19705.0,83086.53988020132,PTPRR
374,KEGG_2019_Human,Phagosome,1/152,0.0075999137114971,0.0089499050800561,0,0,19848.0,96850.665715497,MRC2
375,KEGG_2019_Human,Tuberculosis,1/179,0.0089499050800561,0.0089499050800561,0,0,19821.0,93478.0629355712,MRC2
376,KEGG_2019_Human,Notch signaling pathway,1/48,0.0023999583567988,0.0023999583567988,0,0,19952.0,120356.5272753826,DTX3
377,KEGG_2019_Human,Ubiquitin mediated proteolysis,1/137,0.0068499188797651,0.0068499188797651,0,0,19863.0,98987.62735269018,UBOX5
378,KEGG_2019_Human,RIG-I-like receptor signaling pathway,1/70,0.0034999466296654,0.0080999104202618,0,0,19930.0,112704.30065625212,CYLD
379,KEGG_2019_Human,C-type lectin receptor signaling pathway,1/104,0.0051999314202997,0.0080999104202618,0,0,19896.0,104635.24941415618,CYLD
380,KEGG_2019_Human,Osteoclast differentiation,1/127,0.0063499224962247,0.0080999104202618,0,0,19873.0,100543.72072014232,CYLD
381,KEGG_2019_Human,Necroptosis,1/162,0.0080999104202618,0.0080999104202618,0,0,19838.0,95537.86936302872,CYLD
382,KEGG_2019_Human,AMPK signaling pathway,1/120,0.0059999251180858,0.0076499133771537,0,0,19880.0,101706.2448082016,EEF2K
383,KEGG_2019_Human,Oxytocin signaling pathway,1/153,0.0076499133771537,0.0076499133771537,0,0,19847.0,96715.6407630817,EEF2K
384,KEGG_2019_Human,Shigellosis,1/65,0.003249949134407,0.0096998686609413,0,0,19935.0,114209.92613860144,CD44
385,KEGG_2019_Human,ECM-receptor interaction,1/82,0.004099940929819,0.0096998686609413,0,0,19918.0,109484.9180722932,CD44
386,KEGG_2019_Human,Hematopoietic cell lineage,1/97,0.0048499343304706,0.0096998686609413,0,0,19903.0,106058.9096435903,CD44
387,KEGG_2019_Human,Epstein-Barr virus infection,1/201,0.0100498985877989,0.0120598783053587,0,0,19799.0,91079.21596609056,CD44
388,KEGG_2019_Human,Proteoglycans in cancer,1/201,0.0100498985877989,0.0120598783053587,0,0,19799.0,91079.21596609056,CD44
389,KEGG_2019_Human,MicroRNAs in cancer,1/299,0.0149498740670514,0.0149498740670514,0,0,19701.0,82804.33538735632,CD44
390,KEGG_2019_Human,Tryptophan metabolism,1/42,0.0020999619311272,0.0049199291157828,0,0,19958.0,123057.75613441122,CYP1B1
391,KEGG_2019_Human,Ovarian steroidogenesis,1/49,0.0024499577795033,0.0049199291157828,0,0,19951.0,119939.1172087114,CYP1B1
392,KEGG_2019_Human,Steroid hormone biosynthesis,1/60,0.002999951725986,0.0049199291157828,0,0,19940.0,115834.63209072244,CYP1B1
393,KEGG_2019_Human,Metabolism of xenobiotics by cytochrome P450,1/74,0.0036999446830449,0.0049199291157828,0,0,19926.0,111574.38983110404,CYP1B1
394,KEGG_2019_Human,Chemical carcinogenesis,1/82,0.004099940929819,0.0049199291157828,0,0,19918.0,109484.9180722932,CYP1B1
395,KEGG_2019_Human,MicroRNAs in cancer,1/299,0.0149498740670514,0.0149498740670514,0,0,19701.0,82804.33538735632,CYP1B1
396,KEGG_2019_Human,Arginine and proline metabolism,1/49,0.0024499577795033,0.0024499577795033,0,0,19951.0,119939.1172087114,PYCR1
397,KEGG_2019_Human,Arrhythmogenic right ventricular cardiomyopathy (ARVC),1/72,0.0035999456502131,0.0079623895876056,0,0,19928.0,112131.59838572376,CACNA2D4
398,KEGG_2019_Human,Cardiac muscle contraction,1/78,0.0038999427840466,0.0079623895876056,0,0,19922.0,110503.2180492851,CACNA2D4
399,KEGG_2019_Human,Hypertrophic cardiomyopathy (HCM),1/85,0.004249939567045,0.0079623895876056,0,0,19915.0,108752.83801948265,CACNA2D4
400,KEGG_2019_Human,Dilated cardiomyopathy (DCM),1/91,0.0045499369072032,0.0079623895876056,0,0,19909.0,107362.10783923086,CACNA2D4
401,KEGG_2019_Human,Adrenergic signaling in cardiomyocytes,1/145,0.0072499160871101,0.0089248989400127,0,0,19855.0,97820.92670675044,CACNA2D4
402,KEGG_2019_Human,Oxytocin signaling pathway,1/153,0.0076499133771537,0.0089248989400127,0,0,19847.0,96715.6407630817,CACNA2D4
403,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0147498749536506,0,0,19705.0,83086.53988020132,CACNA2D4
404,KEGG_2019_Human,Thyroid hormone signaling pathway,1/116,0.0057999266512085,0.0057999266512085,0,0,19884.0,102400.8105961506,MED13L
405,KEGG_2019_Human,Oxidative phosphorylation,1/133,0.0066499203093911,0.0112582177134695,0,0,19867.0,99596.2591544721,NDUFS4
406,KEGG_2019_Human,Parkinson disease,1/142,0.0070999171242726,0.0112582177134695,0,0,19858.0,98250.87390500787,NDUFS4
407,KEGG_2019_Human,Retrograde endocannabinoid signaling,1/148,0.007399915061391,0.0112582177134695,0,0,19852.0,97399.60470052566,NDUFS4
408,KEGG_2019_Human,Non-alcoholic fatty liver disease (NAFLD),1/149,0.0074499147221605,0.0112582177134695,0,0,19851.0,97261.02051561224,NDUFS4
409,KEGG_2019_Human,Alzheimer disease,1/171,0.0085499075557634,0.0112582177134695,0,0,19829.0,94422.42241345016,NDUFS4
410,KEGG_2019_Human,Huntington disease,1/193,0.0096499008972596,0.0112582177134695,0,0,19807.0,91920.47679471428,NDUFS4
411,KEGG_2019_Human,Thermogenesis,1/231,0.0115498903940656,0.0115498903940656,0,0,19769.0,88191.07730937863,NDUFS4
412,KEGG_2019_Human,Antigen processing and presentation,1/77,0.0038499432547502,0.0038499432547502,0,0,19923.0,110765.8407373636,KIR3DL3
413,KEGG_2019_Human,Hypertrophic cardiomyopathy (HCM),1/85,0.004249939567045,0.0045499369072032,0,0,19915.0,108752.83801948265,TTN
414,KEGG_2019_Human,Dilated cardiomyopathy (DCM),1/91,0.0045499369072032,0.0045499369072032,0,0,19909.0,107362.10783923086,TTN
415,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF599
416,KEGG_2019_Human,Central carbon metabolism in cancer,1/65,0.003249949134407,0.0148498004652205,0,0,19935.0,114209.92613860144,PDGFRB
417,KEGG_2019_Human,Melanoma,1/72,0.0035999456502131,0.0148498004652205,0,0,19928.0,112131.59838572376,PDGFRB
418,KEGG_2019_Human,Glioma,1/75,0.0037499442041125,0.0148498004652205,0,0,19925.0,111301.33528642564,PDGFRB
419,KEGG_2019_Human,Gap junction,1/88,0.0043999382262822,0.0148498004652205,0,0,19912.0,108045.79305232369,PDGFRB
420,KEGG_2019_Human,Prostate cancer,1/97,0.0048499343304706,0.0148498004652205,0,0,19903.0,106058.9096435903,PDGFRB
421,KEGG_2019_Human,Choline metabolism in cancer,1/99,0.0049499334884068,0.0148498004652205,0,0,19901.0,105642.09305076736,PDGFRB
422,KEGG_2019_Human,Phospholipase D signaling pathway,1/148,0.007399915061391,0.0160498424271101,0,0,19852.0,97399.60470052566,PDGFRB
423,KEGG_2019_Human,JAK-STAT signaling pathway,1/162,0.0080999104202618,0.0160498424271101,0,0,19838.0,95537.86936302872,PDGFRB
424,KEGG_2019_Human,Calcium signaling pathway,1/188,0.009399902370135,0.0160498424271101,0,0,19812.0,92463.712994847,PDGFRB
425,KEGG_2019_Human,Focal adhesion,1/199,0.0099498991610159,0.0160498424271101,0,0,19801.0,91286.4288690606,PDGFRB
426,KEGG_2019_Human,Rap1 signaling pathway,1/206,0.010299897173561,0.0160498424271101,0,0,19794.0,90569.849337325,PDGFRB
427,KEGG_2019_Human,Regulation of actin cytoskeleton,1/214,0.0106998949514067,0.0160498424271101,0,0,19786.0,89779.39753374986,PDGFRB
428,KEGG_2019_Human,Ras signaling pathway,1/232,0.0115998901349604,0.0160613863407144,0,0,19768.0,88101.22480150245,PDGFRB
429,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0179398488804617,0,0,19705.0,83086.53988020132,PDGFRB
430,KEGG_2019_Human,MicroRNAs in cancer,1/299,0.0149498740670514,0.0179398488804617,0,0,19701.0,82804.33538735632,PDGFRB
431,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.018562350891335,0,0,19670.0,80733.60565076157,PDGFRB
432,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0187410310320355,0,0,19646.0,79255.8617626126,PDGFRB
433,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,PDGFRB
434,KEGG_2019_Human,Mitophagy,1/65,0.003249949134407,0.0075999137114971,0,0,19935.0,114209.92613860144,ULK1
435,KEGG_2019_Human,Longevity regulating pathway,1/102,0.0050999322416682,0.0075999137114971,0,0,19898.0,105032.15064717118,ULK1
436,KEGG_2019_Human,AMPK signaling pathway,1/120,0.0059999251180858,0.0075999137114971,0,0,19880.0,101706.2448082016,ULK1
437,KEGG_2019_Human,Autophagy,1/128,0.0063999221281459,0.0075999137114971,0,0,19872.0,100382.8010329652,ULK1
438,KEGG_2019_Human,mTOR signaling pathway,1/152,0.0075999137114971,0.0075999137114971,0,0,19848.0,96850.665715497,ULK1
439,KEGG_2019_Human,Ubiquitin mediated proteolysis,1/137,0.0068499188797651,0.0068499188797651,0,0,19863.0,98987.62735269018,UBR5
440,KEGG_2019_Human,Complement and coagulation cascades,1/79,0.0039499423167337,0.0039499423167337,0,0,19921.0,110243.89578070649,A2M
441,KEGG_2019_Human,TGF-beta signaling pathway,1/90,0.0044999373439762,0.0092999029651357,0,0,19910.0,107587.50385474482,SMAD1
442,KEGG_2019_Human,Signaling pathways regulating pluripotency of stem cells,1/139,0.006949918172816,0.0092999029651357,0,0,19861.0,98689.81333375497,SMAD1
443,KEGG_2019_Human,Hippo signaling pathway,1/160,0.0079999110688441,0.0092999029651357,0,0,19840.0,95793.96509856998,SMAD1
444,KEGG_2019_Human,Transcriptional misregulation in cancer,1/186,0.0092999029651357,0.0092999029651357,0,0,19814.0,92684.96451050608,SMAD1
445,KEGG_2019_Human,Staphylococcus aureus infection,1/68,0.0033999476216189,0.0059249134751006,0,0,19932.0,113293.39338050144,FGG
446,KEGG_2019_Human,Complement and coagulation cascades,1/79,0.0039499423167337,0.0059249134751006,0,0,19921.0,110243.89578070649,FGG
447,KEGG_2019_Human,Platelet activation,1/124,0.0061999236097501,0.0061999236097501,0,0,19876.0,101034.04709010696,FGG
448,KEGG_2019_Human,Wnt signaling pathway,1/158,0.0078999117225733,0.0078999117225733,0,0,19842.0,96053.2110949472,LGR5
449,KEGG_2019_Human,Nicotine addiction,1/40,0.0019999631680592,0.0108798323891805,0,0,19960.0,124043.94523066044,GRIN2A
450,KEGG_2019_Human,Cocaine addiction,1/49,0.0024499577795033,0.0108798323891805,0,0,19951.0,119939.1172087114,GRIN2A
451,KEGG_2019_Human,Amyotrophic lateral sclerosis (ALS),1/51,0.0025499566390179,0.0108798323891805,0,0,19949.0,119129.0228601236,GRIN2A
452,KEGG_2019_Human,Long-term potentiation,1/67,0.0033499481224912,0.0108798323891805,0,0,19933.0,113594.38808369274,GRIN2A
453,KEGG_2019_Human,Amphetamine addiction,1/68,0.0033999476216189,0.0108798323891805,0,0,19932.0,113293.39338050144,GRIN2A
454,KEGG_2019_Human,Circadian entrainment,1/97,0.0048499343304706,0.0118220805500286,0,0,19903.0,106058.9096435903,GRIN2A
455,KEGG_2019_Human,Glutamatergic synapse,1/114,0.005699927427839,0.0118220805500286,0,0,19886.0,102756.96431429044,GRIN2A
456,KEGG_2019_Human,Dopaminergic synapse,1/131,0.0065499210316603,0.0118220805500286,0,0,19869.0,99907.33811343512,GRIN2A
457,KEGG_2019_Human,Systemic lupus erythematosus,1/133,0.0066499203093911,0.0118220805500286,0,0,19867.0,99596.2591544721,GRIN2A
458,KEGG_2019_Human,Alzheimer disease,1/171,0.0085499075557634,0.0121141662887149,0,0,19829.0,94422.42241345016,GRIN2A
459,KEGG_2019_Human,Alcoholism,1/180,0.0089999047745351,0.0121141662887149,0,0,19820.0,93362.92821536642,GRIN2A
460,KEGG_2019_Human,Calcium signaling pathway,1/188,0.009399902370135,0.0121141662887149,0,0,19812.0,92463.712994847,GRIN2A
461,KEGG_2019_Human,Rap1 signaling pathway,1/206,0.010299897173561,0.0121141662887149,0,0,19794.0,90569.849337325,GRIN2A
462,KEGG_2019_Human,cAMP signaling pathway,1/212,0.0105998955026255,0.0121141662887149,0,0,19788.0,89974.27756224656,GRIN2A
463,KEGG_2019_Human,Ras signaling pathway,1/232,0.0115998901349604,0.0123732161439577,0,0,19768.0,88101.22480150245,GRIN2A
464,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,GRIN2A
465,KEGG_2019_Human,Ribosome biogenesis in eukaryotes,1/101,0.0050499326546803,0.0050499326546803,0,0,19899.0,105233.48101229242,WDR36
466,KEGG_2019_Human,Serotonergic synapse,1/113,0.0056499278191151,0.0141331940035007,0,0,19887.0,102937.34947211576,HTR4
467,KEGG_2019_Human,Calcium signaling pathway,1/188,0.009399902370135,0.0141331940035007,0,0,19812.0,92463.712994847,HTR4
468,KEGG_2019_Human,cAMP signaling pathway,1/212,0.0105998955026255,0.0141331940035007,0,0,19788.0,89974.27756224656,HTR4
469,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,HTR4
470,KEGG_2019_Human,Glycerolipid metabolism,1/61,0.0030499512001654,0.0061874168605085,0,0,19939.0,115499.24335773686,DGKI
471,KEGG_2019_Human,Glycerophospholipid metabolism,1/97,0.0048499343304706,0.0061874168605085,0,0,19903.0,106058.9096435903,DGKI
472,KEGG_2019_Human,Phosphatidylinositol signaling system,1/99,0.0049499334884068,0.0061874168605085,0,0,19901.0,105642.09305076736,DGKI
473,KEGG_2019_Human,Choline metabolism in cancer,1/99,0.0049499334884068,0.0061874168605085,0,0,19901.0,105642.09305076736,DGKI
474,KEGG_2019_Human,Phospholipase D signaling pathway,1/148,0.007399915061391,0.007399915061391,0,0,19852.0,97399.60470052566,DGKI
475,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR5D13
476,KEGG_2019_Human,Lysine degradation,1/59,0.0029499522555206,0.0029499522555206,0,0,19941.0,116175.59385530632,KMT2E
477,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF563
478,KEGG_2019_Human,Viral carcinogenesis,1/201,0.0100498985877989,0.0147498749536506,0,0,19799.0,91079.21596609056,RASA2
479,KEGG_2019_Human,Ras signaling pathway,1/232,0.0115998901349604,0.0147498749536506,0,0,19768.0,88101.22480150245,RASA2
480,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0147498749536506,0,0,19705.0,83086.53988020132,RASA2
481,KEGG_2019_Human,Protein digestion and absorption,1/90,0.0044999373439762,0.0044999373439762,0,0,19910.0,107587.50385474482,SLC7A7
482,KEGG_2019_Human,Cell cycle,1/124,0.0061999236097501,0.0114098741370135,0,0,19876.0,101034.04709010696,YWHAB
483,KEGG_2019_Human,Oocyte meiosis,1/125,0.0062499232373748,0.0114098741370135,0,0,19875.0,100869.32368441945,YWHAB
484,KEGG_2019_Human,Hepatitis C,1/155,0.0077499127120574,0.0114098741370135,0,0,19845.0,96448.16254952336,YWHAB
485,KEGG_2019_Human,Hippo signaling pathway,1/160,0.0079999110688441,0.0114098741370135,0,0,19840.0,95793.96509856998,YWHAB
486,KEGG_2019_Human,Hepatitis B,1/163,0.0081499100978668,0.0114098741370135,0,0,19837.0,95410.9786681514,YWHAB
487,KEGG_2019_Human,Viral carcinogenesis,1/201,0.0100498985877989,0.0117248816857654,0,0,19799.0,91079.21596609056,YWHAB
488,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0176998626413668,0,0,19646.0,79255.8617626126,YWHAB
489,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF285
490,KEGG_2019_Human,Shigellosis,1/65,0.003249949134407,0.0036999446830449,0,0,19935.0,114209.92613860144,ELMO2
491,KEGG_2019_Human,Bacterial invasion of epithelial cells,1/74,0.0036999446830449,0.0036999446830449,0,0,19926.0,111574.38983110404,ELMO2
492,KEGG_2019_Human,Thyroid cancer,1/37,0.0018499650702878,0.0122180487288865,0,0,19963.0,125618.9446446357,MYC
493,KEGG_2019_Human,Bladder cancer,1/41,0.0020499625466866,0.0122180487288865,0,0,19959.0,123544.88783416104,MYC
494,KEGG_2019_Human,Endometrial cancer,1/58,0.0028999527887707,0.0122180487288865,0,0,19942.0,116522.31890946148,MYC
495,KEGG_2019_Human,Central carbon metabolism in cancer,1/65,0.003249949134407,0.0122180487288865,0,0,19935.0,114209.92613860144,MYC
496,KEGG_2019_Human,Acute myeloid leukemia,1/66,0.003299948626608,0.0122180487288865,0,0,19934.0,113899.85357353876,MYC
497,KEGG_2019_Human,Chronic myeloid leukemia,1/76,0.0037999437281752,0.0122180487288865,0,0,19924.0,111031.8499691117,MYC
498,KEGG_2019_Human,ErbB signaling pathway,1/85,0.004249939567045,0.0122180487288865,0,0,19915.0,108752.83801948265,MYC
499,KEGG_2019_Human,Colorectal cancer,1/86,0.0042999391173866,0.0122180487288865,0,0,19914.0,108514.46102290176,MYC
500,KEGG_2019_Human,TGF-beta signaling pathway,1/90,0.0044999373439762,0.0122180487288865,0,0,19910.0,107587.50385474482,MYC
501,KEGG_2019_Human,Small cell lung cancer,1/93,0.0046499360391879,0.0122180487288865,0,0,19907.0,106918.54242106884,MYC
502,KEGG_2019_Human,Thyroid hormone signaling pathway,1/116,0.0057999266512085,0.0122180487288865,0,0,19884.0,102400.8105961506,MYC
503,KEGG_2019_Human,Cell cycle,1/124,0.0061999236097501,0.0122180487288865,0,0,19876.0,101034.04709010696,MYC
504,KEGG_2019_Human,Signaling pathways regulating pluripotency of stem cells,1/139,0.006949918172816,0.0122180487288865,0,0,19861.0,98689.81333375497,MYC
505,KEGG_2019_Human,Breast cancer,1/147,0.0073499154017982,0.0122180487288865,0,0,19853.0,97539.10874372096,MYC
506,KEGG_2019_Human,Gastric cancer,1/149,0.0074499147221605,0.0122180487288865,0,0,19851.0,97261.02051561224,MYC
507,KEGG_2019_Human,Hepatitis C,1/155,0.0077499127120574,0.0122180487288865,0,0,19845.0,96448.16254952336,MYC
508,KEGG_2019_Human,Wnt signaling pathway,1/158,0.0078999117225733,0.0122180487288865,0,0,19842.0,96053.2110949472,MYC
509,KEGG_2019_Human,Cellular senescence,1/160,0.0079999110688441,0.0122180487288865,0,0,19840.0,95793.96509856998,MYC
510,KEGG_2019_Human,Hippo signaling pathway,1/160,0.0079999110688441,0.0122180487288865,0,0,19840.0,95793.96509856998,MYC
511,KEGG_2019_Human,JAK-STAT signaling pathway,1/162,0.0080999104202618,0.0122180487288865,0,0,19838.0,95537.86936302872,MYC
512,KEGG_2019_Human,Hepatitis B,1/163,0.0081499100978668,0.0122180487288865,0,0,19837.0,95410.9786681514,MYC
513,KEGG_2019_Human,Hepatocellular carcinoma,1/168,0.0083999085011095,0.0122180487288865,0,0,19832.0,94787.72752807094,MYC
514,KEGG_2019_Human,Kaposi sarcoma-associated herpesvirus infection,1/186,0.0092999029651357,0.0123691059542141,0,0,19814.0,92684.96451050608,MYC
515,KEGG_2019_Human,Transcriptional misregulation in cancer,1/186,0.0092999029651357,0.0123691059542141,0,0,19814.0,92684.96451050608,MYC
516,KEGG_2019_Human,Epstein-Barr virus infection,1/201,0.0100498985877989,0.0123691059542141,0,0,19799.0,91079.21596609056,MYC
517,KEGG_2019_Human,Proteoglycans in cancer,1/201,0.0100498985877989,0.0123691059542141,0,0,19799.0,91079.21596609056,MYC
518,KEGG_2019_Human,Human T-cell leukemia virus 1 infection,1/219,0.0109498935894162,0.0128570194046101,0,0,19781.0,89299.85161916987,MYC
519,KEGG_2019_Human,Human cytomegalovirus infection,1/225,0.0112498919790339,0.0128570194046101,0,0,19775.0,88738.27077557483,MYC
520,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0159465323381882,0,0,19705.0,83086.53988020132,MYC
521,KEGG_2019_Human,MicroRNAs in cancer,1/299,0.0149498740670514,0.0159465323381882,0,0,19701.0,82804.33538735632,MYC
522,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0182708259523787,0,0,19646.0,79255.8617626126,MYC
523,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,MYC
524,KEGG_2019_Human,Oxytocin signaling pathway,1/153,0.0076499133771537,0.0088999053857096,0,0,19847.0,96715.6407630817,TRPM2
525,KEGG_2019_Human,NOD-like receptor signaling pathway,1/178,0.0088999053857096,0.0088999053857096,0,0,19822.0,93593.82745769851,TRPM2
526,KEGG_2019_Human,Focal adhesion,1/199,0.0099498991610159,0.0147498749536506,0,0,19801.0,91286.4288690606,RASGRF1
527,KEGG_2019_Human,Ras signaling pathway,1/232,0.0115998901349604,0.0147498749536506,0,0,19768.0,88101.22480150245,RASGRF1
528,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0147498749536506,0,0,19705.0,83086.53988020132,RASGRF1
529,KEGG_2019_Human,Legionellosis,1/55,0.0027499544131125,0.0122346591503639,0,0,19945.0,117599.1294878737,CASP8
530,KEGG_2019_Human,Viral myocarditis,1/59,0.0029499522555206,0.0122346591503639,0,0,19941.0,116175.59385530632,CASP8
531,KEGG_2019_Human,RIG-I-like receptor signaling pathway,1/70,0.0034999466296654,0.0122346591503639,0,0,19930.0,112704.30065625212,CASP8
532,KEGG_2019_Human,p53 signaling pathway,1/72,0.0035999456502131,0.0122346591503639,0,0,19928.0,112131.59838572376,CASP8
533,KEGG_2019_Human,IL-17 signaling pathway,1/93,0.0046499360391879,0.0122346591503639,0,0,19907.0,106918.54242106884,CASP8
534,KEGG_2019_Human,Chagas disease (American trypanosomiasis),1/103,0.0051499318302617,0.0122346591503639,0,0,19897.0,104832.7525292024,CASP8
535,KEGG_2019_Human,Toll-like receptor signaling pathway,1/104,0.0051999314202997,0.0122346591503639,0,0,19896.0,104635.24941415618,CASP8
536,KEGG_2019_Human,C-type lectin receptor signaling pathway,1/104,0.0051999314202997,0.0122346591503639,0,0,19896.0,104635.24941415618,CASP8
537,KEGG_2019_Human,TNF signaling pathway,1/110,0.0054999290027479,0.0122346591503639,0,0,19890.0,103488.06969787036,CASP8
538,KEGG_2019_Human,Toxoplasmosis,1/113,0.0056499278191151,0.0122346591503639,0,0,19887.0,102937.34947211576,CASP8
539,KEGG_2019_Human,Measles,1/138,0.0068999185254481,0.0122346591503639,0,0,19862.0,98838.19160389496,CASP8
540,KEGG_2019_Human,Apoptosis,1/143,0.0071499167770442,0.0122346591503639,0,0,19857.0,98106.57763600958,CASP8
541,KEGG_2019_Human,Non-alcoholic fatty liver disease (NAFLD),1/149,0.0074499147221605,0.0122346591503639,0,0,19851.0,97261.02051561224,CASP8
542,KEGG_2019_Human,Hepatitis C,1/155,0.0077499127120574,0.0122346591503639,0,0,19845.0,96448.16254952336,CASP8
543,KEGG_2019_Human,Necroptosis,1/162,0.0080999104202618,0.0122346591503639,0,0,19838.0,95537.86936302872,CASP8
544,KEGG_2019_Human,Hepatitis B,1/163,0.0081499100978668,0.0122346591503639,0,0,19837.0,95410.9786681514,CASP8
545,KEGG_2019_Human,Alzheimer disease,1/171,0.0085499075557634,0.0122346591503639,0,0,19829.0,94422.42241345016,CASP8
546,KEGG_2019_Human,NOD-like receptor signaling pathway,1/178,0.0088999053857096,0.0122346591503639,0,0,19822.0,93593.82745769851,CASP8
547,KEGG_2019_Human,Tuberculosis,1/179,0.0089499050800561,0.0122346591503639,0,0,19821.0,93478.0629355712,CASP8
548,KEGG_2019_Human,Kaposi sarcoma-associated herpesvirus infection,1/186,0.0092999029651357,0.0122346591503639,0,0,19814.0,92684.96451050608,CASP8
549,KEGG_2019_Human,Huntington disease,1/193,0.0096499008972596,0.0122346591503639,0,0,19807.0,91920.47679471428,CASP8
550,KEGG_2019_Human,Epstein-Barr virus infection,1/201,0.0100498985877989,0.0122346591503639,0,0,19799.0,91079.21596609056,CASP8
551,KEGG_2019_Human,Viral carcinogenesis,1/201,0.0100498985877989,0.0122346591503639,0,0,19799.0,91079.21596609056,CASP8
552,KEGG_2019_Human,Human immunodeficiency virus 1 infection,1/212,0.0105998955026255,0.0123665447530631,0,0,19788.0,89974.27756224656,CASP8
553,KEGG_2019_Human,Human cytomegalovirus infection,1/225,0.0112498919790339,0.0125998790165179,0,0,19775.0,88738.27077557483,CASP8
554,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.017769088032731,0,0,19670.0,80733.60565076157,CASP8
555,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0255109441270182,0,0,19508.0,72277.44006442746,CASP8
556,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,CASP8
557,KEGG_2019_Human,Nicotine addiction,1/40,0.0019999631680592,0.0101998428648568,0,0,19960.0,124043.94523066044,GRIN1
558,KEGG_2019_Human,Cocaine addiction,1/49,0.0024499577795033,0.0101998428648568,0,0,19951.0,119939.1172087114,GRIN1
559,KEGG_2019_Human,Amyotrophic lateral sclerosis (ALS),1/51,0.0025499566390179,0.0101998428648568,0,0,19949.0,119129.0228601236,GRIN1
560,KEGG_2019_Human,Long-term potentiation,1/67,0.0033499481224912,0.0101998428648568,0,0,19933.0,113594.38808369274,GRIN1
561,KEGG_2019_Human,Amphetamine addiction,1/68,0.0033999476216189,0.0101998428648568,0,0,19932.0,113293.39338050144,GRIN1
562,KEGG_2019_Human,Circadian entrainment,1/97,0.0048499343304706,0.0121248358261767,0,0,19903.0,106058.9096435903,GRIN1
563,KEGG_2019_Human,Glutamatergic synapse,1/114,0.005699927427839,0.0122141302025121,0,0,19886.0,102756.96431429044,GRIN1
564,KEGG_2019_Human,Alzheimer disease,1/171,0.0085499075557634,0.0122306486568756,0,0,19829.0,94422.42241345016,GRIN1
565,KEGG_2019_Human,Alcoholism,1/180,0.0089999047745351,0.0122306486568756,0,0,19820.0,93362.92821536642,GRIN1
566,KEGG_2019_Human,Calcium signaling pathway,1/188,0.009399902370135,0.0122306486568756,0,0,19812.0,92463.712994847,GRIN1
567,KEGG_2019_Human,Huntington disease,1/193,0.0096499008972596,0.0122306486568756,0,0,19807.0,91920.47679471428,GRIN1
568,KEGG_2019_Human,Rap1 signaling pathway,1/206,0.010299897173561,0.0122306486568756,0,0,19794.0,90569.849337325,GRIN1
569,KEGG_2019_Human,cAMP signaling pathway,1/212,0.0105998955026255,0.0122306486568756,0,0,19788.0,89974.27756224656,GRIN1
570,KEGG_2019_Human,Ras signaling pathway,1/232,0.0115998901349604,0.012428453716029,0,0,19768.0,88101.22480150245,GRIN1
571,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,GRIN1
572,KEGG_2019_Human,Signaling pathways regulating pluripotency of stem cells,1/139,0.006949918172816,0.006949918172816,0,0,19861.0,98689.81333375497,TBX3
573,KEGG_2019_Human,Cholesterol metabolism,1/50,0.0024999572069037,0.0047999275336174,0,0,19950.0,119530.05920663515,NCEH1
574,KEGG_2019_Human,Cortisol synthesis and secretion,1/65,0.003249949134407,0.0047999275336174,0,0,19935.0,114209.92613860144,NCEH1
575,KEGG_2019_Human,Bile secretion,1/72,0.0035999456502131,0.0047999275336174,0,0,19928.0,112131.59838572376,NCEH1
576,KEGG_2019_Human,Cushing syndrome,1/155,0.0077499127120574,0.0077499127120574,0,0,19845.0,96448.16254952336,NCEH1
577,KEGG_2019_Human,Axon guidance,1/181,0.0090499044707863,0.0090499044707863,0,0,19819.0,93248.41634586031,EFNB1
578,KEGG_2019_Human,Amoebiasis,1/96,0.0047999347538706,0.0047999347538706,0,0,19904.0,106270.50039849174,SERPINB13
579,KEGG_2019_Human,Cell cycle,1/124,0.0061999236097501,0.0061999236097501,0,0,19876.0,101034.04709010696,CDC14A
580,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF716
581,KEGG_2019_Human,Arrhythmogenic right ventricular cardiomyopathy (ARVC),1/72,0.0035999456502131,0.0083998866996136,0,0,19928.0,112131.59838572376,RYR2
582,KEGG_2019_Human,Cardiac muscle contraction,1/78,0.0038999427840466,0.0083998866996136,0,0,19922.0,110503.2180492851,RYR2
583,KEGG_2019_Human,Hypertrophic cardiomyopathy (HCM),1/85,0.004249939567045,0.0083998866996136,0,0,19915.0,108752.83801948265,RYR2
584,KEGG_2019_Human,Insulin secretion,1/86,0.0042999391173866,0.0083998866996136,0,0,19914.0,108514.46102290176,RYR2
585,KEGG_2019_Human,Dilated cardiomyopathy (DCM),1/91,0.0045499369072032,0.0083998866996136,0,0,19909.0,107362.10783923086,RYR2
586,KEGG_2019_Human,Circadian entrainment,1/97,0.0048499343304706,0.0083998866996136,0,0,19903.0,106058.9096435903,RYR2
587,KEGG_2019_Human,Pancreatic secretion,1/98,0.0048999339081079,0.0083998866996136,0,0,19902.0,105849.45495286948,RYR2
588,KEGG_2019_Human,Apelin signaling pathway,1/137,0.0068499188797651,0.0091798960525845,0,0,19863.0,98987.62735269018,RYR2
589,KEGG_2019_Human,Adrenergic signaling in cardiomyocytes,1/145,0.0072499160871101,0.0091798960525845,0,0,19855.0,97820.92670675044,RYR2
590,KEGG_2019_Human,Oxytocin signaling pathway,1/153,0.0076499133771537,0.0091798960525845,0,0,19847.0,96715.6407630817,RYR2
591,KEGG_2019_Human,Calcium signaling pathway,1/188,0.009399902370135,0.0102544389492382,0,0,19812.0,92463.712994847,RYR2
592,KEGG_2019_Human,cAMP signaling pathway,1/212,0.0105998955026255,0.0105998955026255,0,0,19788.0,89974.27756224656,RYR2
593,KEGG_2019_Human,RNA degradation,1/79,0.0039499423167337,0.0039499423167337,0,0,19921.0,110243.89578070649,EXOSC9
594,KEGG_2019_Human,Phototransduction,1/28,0.0013999711732997,0.0027999423465995,0,0,19972.0,131242.0761597353,PDE6A
595,KEGG_2019_Human,Purine metabolism,1/129,0.006449921761047,0.006449921761047,0,0,19871.0,100223.109907462,PDE6A
596,KEGG_2019_Human,Basal transcription factors,1/45,0.0022499601197094,0.0022499601197094,0,0,19955.0,121662.49782449217,TAF8
597,KEGG_2019_Human,Protein digestion and absorption,1/90,0.0044999373439762,0.0044999373439762,0,0,19910.0,107587.50385474482,DPP4
598,KEGG_2019_Human,Primary bile acid biosynthesis,1/17,0.0008499797390404818,0.0020249578413544,0,0,19983.0,141285.76583697114,HSD17B4
599,KEGG_2019_Human,Biosynthesis of unsaturated fatty acids,1/27,0.0013499718942362,0.0020249578413544,0,0,19973.0,131975.02298599784,HSD17B4
600,KEGG_2019_Human,Peroxisome,1/83,0.0041499404726918,0.0041499404726918,0,0,19917.0,109237.99888847338,HSD17B4
601,KEGG_2019_Human,Primary immunodeficiency,1/37,0.0018499650702878,0.0063124158183504,0,0,19963.0,125618.9446446357,CD8A
602,KEGG_2019_Human,Antigen processing and presentation,1/77,0.0038499432547502,0.0063124158183504,0,0,19923.0,110765.8407373636,CD8A
603,KEGG_2019_Human,Hematopoietic cell lineage,1/97,0.0048499343304706,0.0063124158183504,0,0,19903.0,106058.9096435903,CD8A
604,KEGG_2019_Human,T cell receptor signaling pathway,1/101,0.0050499326546803,0.0063124158183504,0,0,19899.0,105233.48101229242,CD8A
605,KEGG_2019_Human,Cell adhesion molecules (CAMs),1/145,0.0072499160871101,0.0072499160871101,0,0,19855.0,97820.92670675044,CD8A
606,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF254
607,KEGG_2019_Human,Amyotrophic lateral sclerosis (ALS),1/51,0.0025499566390179,0.0109665527651575,0,0,19949.0,119129.0228601236,PPP3R1
608,KEGG_2019_Human,VEGF signaling pathway,1/59,0.0029499522555206,0.0109665527651575,0,0,19941.0,116175.59385530632,PPP3R1
609,KEGG_2019_Human,Long-term potentiation,1/67,0.0033499481224912,0.0109665527651575,0,0,19933.0,113594.38808369274,PPP3R1
610,KEGG_2019_Human,Amphetamine addiction,1/68,0.0033999476216189,0.0109665527651575,0,0,19932.0,113293.39338050144,PPP3R1
611,KEGG_2019_Human,Renin secretion,1/69,0.003449947123837,0.0109665527651575,0,0,19931.0,112996.7391397682,PPP3R1
612,KEGG_2019_Human,B cell receptor signaling pathway,1/71,0.0035499461386618,0.0109665527651575,0,0,19929.0,112415.9585341616,PPP3R1
613,KEGG_2019_Human,Th1 and Th2 cell differentiation,1/92,0.0045999364719865,0.0109665527651575,0,0,19908.0,107139.13814408927,PPP3R1
614,KEGG_2019_Human,T cell receptor signaling pathway,1/101,0.0050499326546803,0.0109665527651575,0,0,19899.0,105233.48101229242,PPP3R1
615,KEGG_2019_Human,Glucagon signaling pathway,1/103,0.0051499318302617,0.0109665527651575,0,0,19897.0,104832.7525292024,PPP3R1
616,KEGG_2019_Human,C-type lectin receptor signaling pathway,1/104,0.0051999314202997,0.0109665527651575,0,0,19896.0,104635.24941415618,PPP3R1
617,KEGG_2019_Human,Th17 cell differentiation,1/107,0.0053499302026925,0.0109665527651575,0,0,19893.0,104053.753408911,PPP3R1
618,KEGG_2019_Human,Glutamatergic synapse,1/114,0.005699927427839,0.0109665527651575,0,0,19886.0,102756.96431429044,PPP3R1
619,KEGG_2019_Human,Oocyte meiosis,1/125,0.0062499232373748,0.0109665527651575,0,0,19875.0,100869.32368441945,PPP3R1
620,KEGG_2019_Human,Osteoclast differentiation,1/127,0.0063499224962247,0.0109665527651575,0,0,19873.0,100543.72072014232,PPP3R1
621,KEGG_2019_Human,Natural killer cell mediated cytotoxicity,1/131,0.0065499210316603,0.0109665527651575,0,0,19869.0,99907.33811343512,PPP3R1
622,KEGG_2019_Human,Oxytocin signaling pathway,1/153,0.0076499133771537,0.0109665527651575,0,0,19847.0,96715.6407630817,PPP3R1
623,KEGG_2019_Human,Wnt signaling pathway,1/158,0.0078999117225733,0.0109665527651575,0,0,19842.0,96053.2110949472,PPP3R1
624,KEGG_2019_Human,Cellular senescence,1/160,0.0079999110688441,0.0109665527651575,0,0,19840.0,95793.96509856998,PPP3R1
625,KEGG_2019_Human,cGMP-PKG signaling pathway,1/166,0.0082999091363732,0.0109665527651575,0,0,19834.0,95034.82345515196,PPP3R1
626,KEGG_2019_Human,Alzheimer disease,1/171,0.0085499075557634,0.0109665527651575,0,0,19829.0,94422.42241345016,PPP3R1
627,KEGG_2019_Human,Tuberculosis,1/179,0.0089499050800561,0.0109665527651575,0,0,19821.0,93478.0629355712,PPP3R1
628,KEGG_2019_Human,Axon guidance,1/181,0.0090499044707863,0.0109665527651575,0,0,19819.0,93248.41634586031,PPP3R1
629,KEGG_2019_Human,Kaposi sarcoma-associated herpesvirus infection,1/186,0.0092999029651357,0.0109665527651575,0,0,19814.0,92684.96451050608,PPP3R1
630,KEGG_2019_Human,Calcium signaling pathway,1/188,0.009399902370135,0.0109665527651575,0,0,19812.0,92463.712994847,PPP3R1
631,KEGG_2019_Human,Human immunodeficiency virus 1 infection,1/212,0.0105998955026255,0.011666554644924,0,0,19788.0,89974.27756224656,PPP3R1
632,KEGG_2019_Human,Human T-cell leukemia virus 1 infection,1/219,0.0109498935894162,0.011666554644924,0,0,19781.0,89299.85161916987,PPP3R1
633,KEGG_2019_Human,Human cytomegalovirus infection,1/225,0.0112498919790339,0.011666554644924,0,0,19775.0,88738.27077557483,PPP3R1
634,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0147498749536506,0,0,19705.0,83086.53988020132,PPP3R1
635,KEGG_2019_Human,mTOR signaling pathway,1/152,0.0075999137114971,0.0082499094553477,0,0,19848.0,96850.665715497,SEH1L
636,KEGG_2019_Human,RNA transport,1/165,0.0082499094553477,0.0082499094553477,0,0,19835.0,95159.46482222488,SEH1L
637,KEGG_2019_Human,Type II diabetes mellitus,1/46,0.0022999595269283,0.0091332251730202,0,0,19954.0,121217.8313311442,PRKCE
638,KEGG_2019_Human,Fc gamma R-mediated phagocytosis,1/91,0.0045499369072032,0.0091332251730202,0,0,19909.0,107362.10783923086,PRKCE
639,KEGG_2019_Human,Aldosterone synthesis and secretion,1/98,0.0048999339081079,0.0091332251730202,0,0,19902.0,105849.45495286948,PRKCE
640,KEGG_2019_Human,AGE-RAGE signaling pathway in diabetic complications,1/100,0.0049999330710556,0.0091332251730202,0,0,19900.0,105436.78197328727,PRKCE
641,KEGG_2019_Human,Inflammatory mediator regulation of TRP channels,1/100,0.0049999330710556,0.0091332251730202,0,0,19900.0,105436.78197328727,PRKCE
642,KEGG_2019_Human,Insulin resistance,1/108,0.0053999298011749,0.0091332251730202,0,0,19892.0,103863.47861844616,PRKCE
643,KEGG_2019_Human,Sphingolipid signaling pathway,1/119,0.0059499254985137,0.0091332251730202,0,0,19881.0,101877.73080211312,PRKCE
644,KEGG_2019_Human,Vascular smooth muscle contraction,1/132,0.0065999206698993,0.0091332251730202,0,0,19868.0,99751.22090491928,PRKCE
645,KEGG_2019_Human,Apelin signaling pathway,1/137,0.0068499188797651,0.0091332251730202,0,0,19863.0,98987.62735269018,PRKCE
646,KEGG_2019_Human,cGMP-PKG signaling pathway,1/166,0.0082999091363732,0.0092726267664898,0,0,19834.0,95034.82345515196,PRKCE
647,KEGG_2019_Human,Tight junction,1/170,0.0084999078692823,0.0092726267664898,0,0,19830.0,94543.49009679438,PRKCE
648,KEGG_2019_Human,MicroRNAs in cancer,1/299,0.0149498740670514,0.0149498740670514,0,0,19701.0,82804.33538735632,PRKCE
649,KEGG_2019_Human,Axon guidance,1/181,0.0090499044707863,0.0090499044707863,0,0,19819.0,93248.41634586031,PLXNB3
650,KEGG_2019_Human,ABC transporters,1/45,0.0022499601197094,0.0044999202394188,0,0,19955.0,121662.49782449217,ABCB9
651,KEGG_2019_Human,Lysosome,1/123,0.0061499239842961,0.0061499239842961,0,0,19877.0,101200.07933676826,ABCB9
652,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF107
653,KEGG_2019_Human,Galactose metabolism,1/31,0.0015499690656704,0.0021999607179423,0,0,19969.0,129189.85098816035,MGAM2
654,KEGG_2019_Human,Starch and sucrose metabolism,1/36,0.0017999657178272,0.0021999607179423,0,0,19964.0,126172.23364250171,MGAM2
655,KEGG_2019_Human,Carbohydrate digestion and absorption,1/44,0.0021999607179423,0.0021999607179423,0,0,19956.0,122117.06559109331,MGAM2
656,KEGG_2019_Human,"Parathyroid hormone synthesis, secretion and action",1/106,0.0052999306076525,0.0097998932512944,0,0,19894.0,104245.78450366124,LRP6
657,KEGG_2019_Human,Breast cancer,1/147,0.0073499154017982,0.0097998932512944,0,0,19853.0,97539.10874372096,LRP6
658,KEGG_2019_Human,Gastric cancer,1/149,0.0074499147221605,0.0097998932512944,0,0,19851.0,97261.02051561224,LRP6
659,KEGG_2019_Human,mTOR signaling pathway,1/152,0.0075999137114971,0.0097998932512944,0,0,19848.0,96850.665715497,LRP6
660,KEGG_2019_Human,Wnt signaling pathway,1/158,0.0078999117225733,0.0097998932512944,0,0,19842.0,96053.2110949472,LRP6
661,KEGG_2019_Human,Hepatocellular carcinoma,1/168,0.0083999085011095,0.0097998932512944,0,0,19832.0,94787.72752807094,LRP6
662,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,LRP6
663,KEGG_2019_Human,Vitamin digestion and absorption,1/24,0.0011999741185782,0.0024999572069037,0,0,19976.0,134347.69487847842,APOA4
664,KEGG_2019_Human,Fat digestion and absorption,1/41,0.0020499625466866,0.0024999572069037,0,0,19959.0,123544.88783416104,APOA4
665,KEGG_2019_Human,Cholesterol metabolism,1/50,0.0024999572069037,0.0024999572069037,0,0,19950.0,119530.05920663515,APOA4
666,KEGG_2019_Human,Ribosome biogenesis in eukaryotes,1/101,0.0050499326546803,0.0050499326546803,0,0,19899.0,105233.48101229242,NAT10
667,KEGG_2019_Human,Cell adhesion molecules (CAMs),1/145,0.0072499160871101,0.0072499160871101,0,0,19855.0,97820.92670675044,CNTNAP1
668,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR5A2
669,KEGG_2019_Human,Prion diseases,1/35,0.0017499663721595,0.0059249134751006,0,0,19965.0,126740.98858805298,C1QC
670,KEGG_2019_Human,Staphylococcus aureus infection,1/68,0.0033999476216189,0.0059249134751006,0,0,19932.0,113293.39338050144,C1QC
671,KEGG_2019_Human,Pertussis,1/76,0.0037999437281752,0.0059249134751006,0,0,19924.0,111031.8499691117,C1QC
672,KEGG_2019_Human,Complement and coagulation cascades,1/79,0.0039499423167337,0.0059249134751006,0,0,19921.0,110243.89578070649,C1QC
673,KEGG_2019_Human,Chagas disease (American trypanosomiasis),1/103,0.0051499318302617,0.006179918196314,0,0,19897.0,104832.7525292024,C1QC
674,KEGG_2019_Human,Systemic lupus erythematosus,1/133,0.0066499203093911,0.0066499203093911,0,0,19867.0,99596.2591544721,C1QC
675,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF282
676,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF761
677,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,TAAR9
678,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF587
679,KEGG_2019_Human,Tight junction,1/170,0.0084999078692823,0.0084999078692823,0,0,19830.0,94543.49009679438,ACTR3B
680,KEGG_2019_Human,Choline metabolism in cancer,1/99,0.0049499334884068,0.0049499334884068,0,0,19901.0,105642.09305076736,SLC22A5
681,KEGG_2019_Human,ABC transporters,1/45,0.0022499601197094,0.0022499601197094,0,0,19955.0,121662.49782449217,ABCA8
682,KEGG_2019_Human,Retinol metabolism,1/67,0.0033499481224912,0.0036999446830449,0,0,19933.0,113594.38808369274,CYP2S1
683,KEGG_2019_Human,Metabolism of xenobiotics by cytochrome P450,1/74,0.0036999446830449,0.0036999446830449,0,0,19926.0,111574.38983110404,CYP2S1
684,KEGG_2019_Human,Purine metabolism,1/129,0.006449921761047,0.006449921761047,0,0,19871.0,100223.109907462,PFAS
685,KEGG_2019_Human,Cell adhesion molecules (CAMs),1/145,0.0072499160871101,0.0072499160871101,0,0,19855.0,97820.92670675044,SIGLEC1
686,KEGG_2019_Human,Cocaine addiction,1/49,0.0024499577795033,0.0097998311180133,0,0,19951.0,119939.1172087114,GRM2
687,KEGG_2019_Human,Glutamatergic synapse,1/114,0.005699927427839,0.009866553415188,0,0,19886.0,102756.96431429044,GRM2
688,KEGG_2019_Human,Phospholipase D signaling pathway,1/148,0.007399915061391,0.009866553415188,0,0,19852.0,97399.60470052566,GRM2
689,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,GRM2
690,KEGG_2019_Human,Bile secretion,1/72,0.0035999456502131,0.0048999339081079,0,0,19928.0,112131.59838572376,SLC4A2
691,KEGG_2019_Human,Gastric acid secretion,1/75,0.0037499442041125,0.0048999339081079,0,0,19925.0,111301.33528642564,SLC4A2
692,KEGG_2019_Human,Salivary secretion,1/90,0.0044999373439762,0.0048999339081079,0,0,19910.0,107587.50385474482,SLC4A2
693,KEGG_2019_Human,Pancreatic secretion,1/98,0.0048999339081079,0.0048999339081079,0,0,19902.0,105849.45495286948,SLC4A2
694,KEGG_2019_Human,mRNA surveillance pathway,1/91,0.0045499369072032,0.0096665547828135,0,0,19909.0,107362.10783923086,PPP2R5B
695,KEGG_2019_Human,Sphingolipid signaling pathway,1/119,0.0059499254985137,0.0096665547828135,0,0,19881.0,101877.73080211312,PPP2R5B
696,KEGG_2019_Human,AMPK signaling pathway,1/120,0.0059999251180858,0.0096665547828135,0,0,19880.0,101706.2448082016,PPP2R5B
697,KEGG_2019_Human,Oocyte meiosis,1/125,0.0062499232373748,0.0096665547828135,0,0,19875.0,100869.32368441945,PPP2R5B
698,KEGG_2019_Human,Dopaminergic synapse,1/131,0.0065499210316603,0.0096665547828135,0,0,19869.0,99907.33811343512,PPP2R5B
699,KEGG_2019_Human,Adrenergic signaling in cardiomyocytes,1/145,0.0072499160871101,0.0096665547828135,0,0,19855.0,97820.92670675044,PPP2R5B
700,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0176998626413668,0,0,19670.0,80733.60565076157,PPP2R5B
701,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0176998626413668,0,0,19646.0,79255.8617626126,PPP2R5B
702,KEGG_2019_Human,Aldosterone synthesis and secretion,1/98,0.0048999339081079,0.0097998678162159,0,0,19902.0,105849.45495286948,PRKD1
703,KEGG_2019_Human,Rap1 signaling pathway,1/206,0.010299897173561,0.010299897173561,0,0,19794.0,90569.849337325,PRKD1
704,KEGG_2019_Human,Huntington disease,1/193,0.0096499008972596,0.0096499008972596,0,0,19807.0,91920.47679471428,DNAH17
705,KEGG_2019_Human,Ribosome biogenesis in eukaryotes,1/101,0.0050499326546803,0.0050499326546803,0,0,19899.0,105233.48101229242,HEATR1
706,KEGG_2019_Human,Autophagy,1/128,0.0063999221281459,0.0063999221281459,0,0,19872.0,100382.8010329652,ATG2B
707,KEGG_2019_Human,"Parathyroid hormone synthesis, secretion and action",1/106,0.0052999306076525,0.0082999091363732,0,0,19894.0,104245.78450366124,MEF2A
708,KEGG_2019_Human,Apelin signaling pathway,1/137,0.0068499188797651,0.0082999091363732,0,0,19863.0,98987.62735269018,MEF2A
709,KEGG_2019_Human,Fluid shear stress and atherosclerosis,1/139,0.006949918172816,0.0082999091363732,0,0,19861.0,98689.81333375497,MEF2A
710,KEGG_2019_Human,cGMP-PKG signaling pathway,1/166,0.0082999091363732,0.0082999091363732,0,0,19834.0,95034.82345515196,MEF2A
711,KEGG_2019_Human,Thermogenesis,1/231,0.0115498903940656,0.0115498903940656,0,0,19769.0,88191.07730937863,KDM3B
712,KEGG_2019_Human,Pathogenic Escherichia coli infection,1/55,0.0027499544131125,0.0093498670474992,0,0,19945.0,117599.1294878737,ABL1
713,KEGG_2019_Human,Viral myocarditis,1/59,0.0029499522555206,0.0093498670474992,0,0,19941.0,116175.59385530632,ABL1
714,KEGG_2019_Human,Shigellosis,1/65,0.003249949134407,0.0093498670474992,0,0,19935.0,114209.92613860144,ABL1
715,KEGG_2019_Human,Chronic myeloid leukemia,1/76,0.0037999437281752,0.0093498670474992,0,0,19924.0,111031.8499691117,ABL1
716,KEGG_2019_Human,ErbB signaling pathway,1/85,0.004249939567045,0.0093498670474992,0,0,19915.0,108752.83801948265,ABL1
717,KEGG_2019_Human,Neurotrophin signaling pathway,1/119,0.0059499254985137,0.0097427371010359,0,0,19881.0,101877.73080211312,ABL1
718,KEGG_2019_Human,Cell cycle,1/124,0.0061999236097501,0.0097427371010359,0,0,19876.0,101034.04709010696,ABL1
719,KEGG_2019_Human,Axon guidance,1/181,0.0090499044707863,0.0124436186473312,0,0,19819.0,93248.41634586031,ABL1
720,KEGG_2019_Human,Ras signaling pathway,1/232,0.0115998901349604,0.0141776434982849,0,0,19768.0,88101.22480150245,ABL1
721,KEGG_2019_Human,MicroRNAs in cancer,1/299,0.0149498740670514,0.0164448614737565,0,0,19701.0,82804.33538735632,ABL1
722,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,ABL1
723,KEGG_2019_Human,Tight junction,1/170,0.0084999078692823,0.0084999078692823,0,0,19830.0,94543.49009679438,MYH13
724,KEGG_2019_Human,Homologous recombination,1/41,0.0020499625466866,0.0020499625466866,0,0,19959.0,123544.88783416104,XRCC3
725,KEGG_2019_Human,Ribosome,1/153,0.0076499133771537,0.0076499133771537,0,0,19847.0,96715.6407630817,RPL4
726,KEGG_2019_Human,ABC transporters,1/45,0.0022499601197094,0.0041499404726918,0,0,19955.0,121662.49782449217,ABCD1
727,KEGG_2019_Human,Peroxisome,1/83,0.0041499404726918,0.0041499404726918,0,0,19917.0,109237.99888847338,ABCD1
728,KEGG_2019_Human,Steroid hormone biosynthesis,1/60,0.002999951725986,0.0064998982688141,0,0,19940.0,115834.63209072244,CYP21A2
729,KEGG_2019_Human,Cortisol synthesis and secretion,1/65,0.003249949134407,0.0064998982688141,0,0,19935.0,114209.92613860144,CYP21A2
730,KEGG_2019_Human,Aldosterone synthesis and secretion,1/98,0.0048999339081079,0.0065332452108106,0,0,19902.0,105849.45495286948,CYP21A2
731,KEGG_2019_Human,Cushing syndrome,1/155,0.0077499127120574,0.0077499127120574,0,0,19845.0,96448.16254952336,CYP21A2
732,KEGG_2019_Human,Epithelial cell signaling in Helicobacter pylori infection,1/68,0.0033999476216189,0.0084999078692823,0,0,19932.0,113293.39338050144,F11R
733,KEGG_2019_Human,Leukocyte transendothelial migration,1/112,0.0055999282120529,0.0084999078692823,0,0,19888.0,103119.30984392198,F11R
734,KEGG_2019_Human,Cell adhesion molecules (CAMs),1/145,0.0072499160871101,0.0084999078692823,0,0,19855.0,97820.92670675044,F11R
735,KEGG_2019_Human,Tight junction,1/170,0.0084999078692823,0.0084999078692823,0,0,19830.0,94543.49009679438,F11R
736,KEGG_2019_Human,Aminoacyl-tRNA biosynthesis,1/66,0.003299948626608,0.003299948626608,0,0,19934.0,113899.85357353876,CARS2
737,KEGG_2019_Human,ABC transporters,1/45,0.0022499601197094,0.007499888408225,0,0,19955.0,121662.49782449217,CFTR
738,KEGG_2019_Human,Vibrio cholerae infection,1/50,0.0024999572069037,0.007499888408225,0,0,19950.0,119530.05920663515,CFTR
739,KEGG_2019_Human,Bile secretion,1/72,0.0035999456502131,0.007499888408225,0,0,19928.0,112131.59838572376,CFTR
740,KEGG_2019_Human,Gastric acid secretion,1/75,0.0037499442041125,0.007499888408225,0,0,19925.0,111301.33528642564,CFTR
741,KEGG_2019_Human,Pancreatic secretion,1/98,0.0048999339081079,0.0078398942529727,0,0,19902.0,105849.45495286948,CFTR
742,KEGG_2019_Human,AMPK signaling pathway,1/120,0.0059999251180858,0.0079999001574478,0,0,19880.0,101706.2448082016,CFTR
743,KEGG_2019_Human,Tight junction,1/170,0.0084999078692823,0.0097141804220369,0,0,19830.0,94543.49009679438,CFTR
744,KEGG_2019_Human,cAMP signaling pathway,1/212,0.0105998955026255,0.0105998955026255,0,0,19788.0,89974.27756224656,CFTR
745,KEGG_2019_Human,African trypanosomiasis,1/37,0.0018499650702878,0.0095533816179956,0,0,19963.0,125618.9446446357,PLCB2
746,KEGG_2019_Human,Carbohydrate digestion and absorption,1/44,0.0021999607179423,0.0095533816179956,0,0,19956.0,122117.06559109331,PLCB2
747,KEGG_2019_Human,Endocrine and other factor-regulated calcium reabsorption,1/48,0.0023999583567988,0.0095533816179956,0,0,19952.0,120356.5272753826,PLCB2
748,KEGG_2019_Human,Long-term depression,1/60,0.002999951725986,0.0095533816179956,0,0,19940.0,115834.63209072244,PLCB2
749,KEGG_2019_Human,Cortisol synthesis and secretion,1/65,0.003249949134407,0.0095533816179956,0,0,19935.0,114209.92613860144,PLCB2
750,KEGG_2019_Human,Long-term potentiation,1/67,0.0033499481224912,0.0095533816179956,0,0,19933.0,113594.38808369274,PLCB2
751,KEGG_2019_Human,Renin secretion,1/69,0.003449947123837,0.0095533816179956,0,0,19931.0,112996.7391397682,PLCB2
752,KEGG_2019_Human,Inositol phosphate metabolism,1/74,0.0036999446830449,0.0095533816179956,0,0,19926.0,111574.38983110404,PLCB2
753,KEGG_2019_Human,Thyroid hormone synthesis,1/74,0.0036999446830449,0.0095533816179956,0,0,19926.0,111574.38983110404,PLCB2
754,KEGG_2019_Human,Gastric acid secretion,1/75,0.0037499442041125,0.0095533816179956,0,0,19925.0,111301.33528642564,PLCB2
755,KEGG_2019_Human,Taste transduction,1/83,0.0041499404726918,0.0095533816179956,0,0,19917.0,109237.99888847338,PLCB2
756,KEGG_2019_Human,Insulin secretion,1/86,0.0042999391173866,0.0095533816179956,0,0,19914.0,108514.46102290176,PLCB2
757,KEGG_2019_Human,Gap junction,1/88,0.0043999382262822,0.0095533816179956,0,0,19912.0,108045.79305232369,PLCB2
758,KEGG_2019_Human,Salivary secretion,1/90,0.0044999373439762,0.0095533816179956,0,0,19910.0,107587.50385474482,PLCB2
759,KEGG_2019_Human,GnRH signaling pathway,1/93,0.0046499360391879,0.0095533816179956,0,0,19907.0,106918.54242106884,PLCB2
760,KEGG_2019_Human,Amoebiasis,1/96,0.0047999347538706,0.0095533816179956,0,0,19904.0,106270.50039849174,PLCB2
761,KEGG_2019_Human,Circadian entrainment,1/97,0.0048499343304706,0.0095533816179956,0,0,19903.0,106058.9096435903,PLCB2
762,KEGG_2019_Human,Aldosterone synthesis and secretion,1/98,0.0048999339081079,0.0095533816179956,0,0,19902.0,105849.45495286948,PLCB2
763,KEGG_2019_Human,Pancreatic secretion,1/98,0.0048999339081079,0.0095533816179956,0,0,19902.0,105849.45495286948,PLCB2
764,KEGG_2019_Human,Phosphatidylinositol signaling system,1/99,0.0049499334884068,0.0095533816179956,0,0,19901.0,105642.09305076736,PLCB2
765,KEGG_2019_Human,AGE-RAGE signaling pathway in diabetic complications,1/100,0.0049999330710556,0.0095533816179956,0,0,19900.0,105436.78197328727,PLCB2
766,KEGG_2019_Human,Inflammatory mediator regulation of TRP channels,1/100,0.0049999330710556,0.0095533816179956,0,0,19900.0,105436.78197328727,PLCB2
767,KEGG_2019_Human,Melanogenesis,1/101,0.0050499326546803,0.0095533816179956,0,0,19899.0,105233.48101229242,PLCB2
768,KEGG_2019_Human,Chagas disease (American trypanosomiasis),1/103,0.0051499318302617,0.0095533816179956,0,0,19897.0,104832.7525292024,PLCB2
769,KEGG_2019_Human,Glucagon signaling pathway,1/103,0.0051499318302617,0.0095533816179956,0,0,19897.0,104832.7525292024,PLCB2
770,KEGG_2019_Human,"Parathyroid hormone synthesis, secretion and action",1/106,0.0052999306076525,0.0095533816179956,0,0,19894.0,104245.78450366124,PLCB2
771,KEGG_2019_Human,Cholinergic synapse,1/112,0.0055999282120529,0.0095533816179956,0,0,19888.0,103119.30984392198,PLCB2
772,KEGG_2019_Human,Serotonergic synapse,1/113,0.0056499278191151,0.0095533816179956,0,0,19887.0,102937.34947211576,PLCB2
773,KEGG_2019_Human,Glutamatergic synapse,1/114,0.005699927427839,0.0095533816179956,0,0,19886.0,102756.96431429044,PLCB2
774,KEGG_2019_Human,Thyroid hormone signaling pathway,1/116,0.0057999266512085,0.0095533816179956,0,0,19884.0,102400.8105961506,PLCB2
775,KEGG_2019_Human,Sphingolipid signaling pathway,1/119,0.0059499254985137,0.0095533816179956,0,0,19881.0,101877.73080211312,PLCB2
776,KEGG_2019_Human,Platelet activation,1/124,0.0061999236097501,0.0095533816179956,0,0,19876.0,101034.04709010696,PLCB2
777,KEGG_2019_Human,Relaxin signaling pathway,1/130,0.0064999213952527,0.0095533816179956,0,0,19870.0,100064.62842845908,PLCB2
778,KEGG_2019_Human,Dopaminergic synapse,1/131,0.0065499210316603,0.0095533816179956,0,0,19869.0,99907.33811343512,PLCB2
779,KEGG_2019_Human,Vascular smooth muscle contraction,1/132,0.0065999206698993,0.0095533816179956,0,0,19868.0,99751.22090491928,PLCB2
780,KEGG_2019_Human,Apelin signaling pathway,1/137,0.0068499188797651,0.0095533816179956,0,0,19863.0,98987.62735269018,PLCB2
781,KEGG_2019_Human,Estrogen signaling pathway,1/137,0.0068499188797651,0.0095533816179956,0,0,19863.0,98987.62735269018,PLCB2
782,KEGG_2019_Human,Adrenergic signaling in cardiomyocytes,1/145,0.0072499160871101,0.0095533816179956,0,0,19855.0,97820.92670675044,PLCB2
783,KEGG_2019_Human,Phospholipase D signaling pathway,1/148,0.007399915061391,0.0095533816179956,0,0,19852.0,97399.60470052566,PLCB2
784,KEGG_2019_Human,Retrograde endocannabinoid signaling,1/148,0.007399915061391,0.0095533816179956,0,0,19852.0,97399.60470052566,PLCB2
785,KEGG_2019_Human,Oxytocin signaling pathway,1/153,0.0076499133771537,0.0095533816179956,0,0,19847.0,96715.6407630817,PLCB2
786,KEGG_2019_Human,Cushing syndrome,1/155,0.0077499127120574,0.0095533816179956,0,0,19845.0,96448.16254952336,PLCB2
787,KEGG_2019_Human,Wnt signaling pathway,1/158,0.0078999117225733,0.0095533816179956,0,0,19842.0,96053.2110949472,PLCB2
788,KEGG_2019_Human,cGMP-PKG signaling pathway,1/166,0.0082999091363732,0.0098089835248047,0,0,19834.0,95034.82345515196,PLCB2
789,KEGG_2019_Human,Alzheimer disease,1/171,0.0085499075557634,0.0098798931755488,0,0,19829.0,94422.42241345016,PLCB2
790,KEGG_2019_Human,NOD-like receptor signaling pathway,1/178,0.0088999053857096,0.0100607626099326,0,0,19822.0,93593.82745769851,PLCB2
791,KEGG_2019_Human,Calcium signaling pathway,1/188,0.009399902370135,0.0102407111562755,0,0,19812.0,92463.712994847,PLCB2
792,KEGG_2019_Human,Chemokine signaling pathway,1/190,0.0094999017791995,0.0102407111562755,0,0,19810.0,92244.74636351672,PLCB2
793,KEGG_2019_Human,Huntington disease,1/193,0.0096499008972596,0.0102407111562755,0,0,19807.0,91920.47679471428,PLCB2
794,KEGG_2019_Human,Rap1 signaling pathway,1/206,0.010299897173561,0.0107118930605034,0,0,19794.0,90569.849337325,PLCB2
795,KEGG_2019_Human,Human cytomegalovirus infection,1/225,0.0112498919790339,0.0114704780962698,0,0,19775.0,88738.27077557483,PLCB2
796,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,PLCB2
797,KEGG_2019_Human,Choline metabolism in cancer,1/99,0.0049499334884068,0.0049499334884068,0,0,19901.0,105642.09305076736,SLC22A3
798,KEGG_2019_Human,Steroid biosynthesis,1/19,0.00094997806231055,0.00094997806231055,0,0,19981.0,139049.2109571672,LSS
799,KEGG_2019_Human,Ras signaling pathway,1/232,0.0115998901349604,0.0115998901349604,0,0,19768.0,88101.22480150245,RASAL2
800,KEGG_2019_Human,Steroid biosynthesis,1/19,0.00094997806231055,0.00094997806231055,0,0,19981.0,139049.2109571672,SQLE
801,KEGG_2019_Human,Epithelial cell signaling in Helicobacter pylori infection,1/68,0.0033999476216189,0.0109165350527672,0,0,19932.0,113293.39338050144,PTPN11
802,KEGG_2019_Human,Adipocytokine signaling pathway,1/69,0.003449947123837,0.0109165350527672,0,0,19931.0,112996.7391397682,PTPN11
803,KEGG_2019_Human,Renal cell carcinoma,1/69,0.003449947123837,0.0109165350527672,0,0,19931.0,112996.7391397682,PTPN11
804,KEGG_2019_Human,Chronic myeloid leukemia,1/76,0.0037999437281752,0.0109165350527672,0,0,19924.0,111031.8499691117,PTPN11
805,KEGG_2019_Human,C-type lectin receptor signaling pathway,1/104,0.0051999314202997,0.0109165350527672,0,0,19896.0,104635.24941415618,PTPN11
806,KEGG_2019_Human,Insulin resistance,1/108,0.0053999298011749,0.0109165350527672,0,0,19892.0,103863.47861844616,PTPN11
807,KEGG_2019_Human,Leukocyte transendothelial migration,1/112,0.0055999282120529,0.0109165350527672,0,0,19888.0,103119.30984392198,PTPN11
808,KEGG_2019_Human,Neurotrophin signaling pathway,1/119,0.0059499254985137,0.0109165350527672,0,0,19881.0,101877.73080211312,PTPN11
809,KEGG_2019_Human,Natural killer cell mediated cytotoxicity,1/131,0.0065499210316603,0.0109165350527672,0,0,19869.0,99907.33811343512,PTPN11
810,KEGG_2019_Human,Phospholipase D signaling pathway,1/148,0.007399915061391,0.0110453323912661,0,0,19852.0,97399.60470052566,PTPN11
811,KEGG_2019_Human,JAK-STAT signaling pathway,1/162,0.0080999104202618,0.0110453323912661,0,0,19838.0,95537.86936302872,PTPN11
812,KEGG_2019_Human,Axon guidance,1/181,0.0090499044707863,0.0113123805884829,0,0,19819.0,93248.41634586031,PTPN11
813,KEGG_2019_Human,Proteoglycans in cancer,1/201,0.0100498985877989,0.0115960368320757,0,0,19799.0,91079.21596609056,PTPN11
814,KEGG_2019_Human,Ras signaling pathway,1/232,0.0115998901349604,0.012428453716029,0,0,19768.0,88101.22480150245,PTPN11
815,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,PTPN11
816,KEGG_2019_Human,Cardiac muscle contraction,1/78,0.0038999427840466,0.0112582177134695,0,0,19922.0,110503.2180492851,UQCRB
817,KEGG_2019_Human,Oxidative phosphorylation,1/133,0.0066499203093911,0.0112582177134695,0,0,19867.0,99596.2591544721,UQCRB
818,KEGG_2019_Human,Parkinson disease,1/142,0.0070999171242726,0.0112582177134695,0,0,19858.0,98250.87390500787,UQCRB
819,KEGG_2019_Human,Non-alcoholic fatty liver disease (NAFLD),1/149,0.0074499147221605,0.0112582177134695,0,0,19851.0,97261.02051561224,UQCRB
820,KEGG_2019_Human,Alzheimer disease,1/171,0.0085499075557634,0.0112582177134695,0,0,19829.0,94422.42241345016,UQCRB
821,KEGG_2019_Human,Huntington disease,1/193,0.0096499008972596,0.0112582177134695,0,0,19807.0,91920.47679471428,UQCRB
822,KEGG_2019_Human,Thermogenesis,1/231,0.0115498903940656,0.0115498903940656,0,0,19769.0,88191.07730937863,UQCRB
823,KEGG_2019_Human,Starch and sucrose metabolism,1/36,0.0017999657178272,0.0017999657178272,0,0,19964.0,126172.23364250171,GBA3
824,KEGG_2019_Human,Synthesis and degradation of ketone bodies,1/10,0.0004999862257578379,0.0026399541924786,0,0,19990.0,151942.5908680334,ACAT2
825,KEGG_2019_Human,Terpenoid backbone biosynthesis,1/22,0.0010999756574123,0.0026399541924786,0,0,19978.0,136099.47030191717,ACAT2
826,KEGG_2019_Human,Butanoate metabolism,1/28,0.0013999711732997,0.0026399541924786,0,0,19972.0,131242.0761597353,ACAT2
827,KEGG_2019_Human,Glyoxylate and dicarboxylate metabolism,1/30,0.0014999697593334,0.0026399541924786,0,0,19970.0,129851.13732048514,ACAT2
828,KEGG_2019_Human,Propanoate metabolism,1/32,0.0015999683804467,0.0026399541924786,0,0,19968.0,128549.41955786056,ACAT2
829,KEGG_2019_Human,Pyruvate metabolism,1/39,0.0019499637955508,0.0026399541924786,0,0,19961.0,124555.53162481484,ACAT2
830,KEGG_2019_Human,Fat digestion and absorption,1/41,0.0020499625466866,0.0026399541924786,0,0,19959.0,123544.88783416104,ACAT2
831,KEGG_2019_Human,Tryptophan metabolism,1/42,0.0020999619311272,0.0026399541924786,0,0,19958.0,123057.75613441122,ACAT2
832,KEGG_2019_Human,Fatty acid degradation,1/44,0.0021999607179423,0.0026399541924786,0,0,19956.0,122117.06559109331,ACAT2
833,KEGG_2019_Human,"Valine, leucine and isoleucine degradation",1/48,0.0023999583567988,0.0026399541924786,0,0,19952.0,120356.5272753826,ACAT2
834,KEGG_2019_Human,Lysine degradation,1/59,0.0029499522555206,0.0029499522555206,0,0,19941.0,116175.59385530632,ACAT2
835,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF155
836,KEGG_2019_Human,Huntington disease,1/193,0.0096499008972596,0.0096499008972596,0,0,19807.0,91920.47679471428,DNAH11
837,KEGG_2019_Human,B cell receptor signaling pathway,1/71,0.0035499461386618,0.0063499224962247,0,0,19929.0,112415.9585341616,LILRB3
838,KEGG_2019_Human,Osteoclast differentiation,1/127,0.0063499224962247,0.0063499224962247,0,0,19873.0,100543.72072014232,LILRB3
839,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF546
840,KEGG_2019_Human,Non-homologous end-joining,1/13,0.0006499833083207112,0.0019499499249621,0,0,19987.0,146675.87616784443,MRE11
841,KEGG_2019_Human,Homologous recombination,1/41,0.0020499625466866,0.0030749438200299,0,0,19959.0,123544.88783416104,MRE11
842,KEGG_2019_Human,Cellular senescence,1/160,0.0079999110688441,0.0079999110688441,0,0,19840.0,95793.96509856998,MRE11
843,KEGG_2019_Human,Glycerolipid metabolism,1/61,0.0030499512001654,0.007274901495706,0,0,19939.0,115499.24335773686,AGPAT5
844,KEGG_2019_Human,Glycerophospholipid metabolism,1/97,0.0048499343304706,0.007274901495706,0,0,19903.0,106058.9096435903,AGPAT5
845,KEGG_2019_Human,Phospholipase D signaling pathway,1/148,0.007399915061391,0.007399915061391,0,0,19852.0,97399.60470052566,AGPAT5
846,KEGG_2019_Human,alpha-Linolenic acid metabolism,1/25,0.0012499733663791,0.0052874076132858,0,0,19975.0,133525.54486996148,PLA2G5
847,KEGG_2019_Human,Linoleic acid metabolism,1/29,0.001449970461791,0.0052874076132858,0,0,19971.0,130534.69172799008,PLA2G5
848,KEGG_2019_Human,Fat digestion and absorption,1/41,0.0020499625466866,0.0052874076132858,0,0,19959.0,123544.88783416104,PLA2G5
849,KEGG_2019_Human,Ether lipid metabolism,1/47,0.0023499589392381,0.0052874076132858,0,0,19953.0,120782.64067395544,PLA2G5
850,KEGG_2019_Human,Arachidonic acid metabolism,1/63,0.0031499501598827,0.005669910287789,0,0,19937.0,114844.46974572667,PLA2G5
851,KEGG_2019_Human,Glycerophospholipid metabolism,1/97,0.0048499343304706,0.0062999150247102,0,0,19903.0,106058.9096435903,PLA2G5
852,KEGG_2019_Human,Pancreatic secretion,1/98,0.0048999339081079,0.0062999150247102,0,0,19902.0,105849.45495286948,PLA2G5
853,KEGG_2019_Human,Vascular smooth muscle contraction,1/132,0.0065999206698993,0.0074249107536368,0,0,19868.0,99751.22090491928,PLA2G5
854,KEGG_2019_Human,Ras signaling pathway,1/232,0.0115998901349604,0.0115998901349604,0,0,19768.0,88101.22480150245,PLA2G5
855,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR2Z1
856,KEGG_2019_Human,Ubiquitin mediated proteolysis,1/137,0.0068499188797651,0.0068499188797651,0,0,19863.0,98987.62735269018,UBE4A
857,KEGG_2019_Human,Tyrosine metabolism,1/36,0.0017999657178272,0.0035999314356544,0,0,19964.0,126172.23364250171,TYR
858,KEGG_2019_Human,Melanogenesis,1/101,0.0050499326546803,0.0050499326546803,0,0,19899.0,105233.48101229242,TYR
859,KEGG_2019_Human,Cortisol synthesis and secretion,1/65,0.003249949134407,0.009899892959305,0,0,19935.0,114209.92613860144,CACNA1F
860,KEGG_2019_Human,Renin secretion,1/69,0.003449947123837,0.009899892959305,0,0,19931.0,112996.7391397682,CACNA1F
861,KEGG_2019_Human,Arrhythmogenic right ventricular cardiomyopathy (ARVC),1/72,0.0035999456502131,0.009899892959305,0,0,19928.0,112131.59838572376,CACNA1F
862,KEGG_2019_Human,Cardiac muscle contraction,1/78,0.0038999427840466,0.009899892959305,0,0,19922.0,110503.2180492851,CACNA1F
863,KEGG_2019_Human,Hypertrophic cardiomyopathy (HCM),1/85,0.004249939567045,0.009899892959305,0,0,19915.0,108752.83801948265,CACNA1F
864,KEGG_2019_Human,Insulin secretion,1/86,0.0042999391173866,0.009899892959305,0,0,19914.0,108514.46102290176,CACNA1F
865,KEGG_2019_Human,GABAergic synapse,1/89,0.0044499377838098,0.009899892959305,0,0,19911.0,107815.380281759,CACNA1F
866,KEGG_2019_Human,Dilated cardiomyopathy (DCM),1/91,0.0045499369072032,0.009899892959305,0,0,19909.0,107362.10783923086,CACNA1F
867,KEGG_2019_Human,GnRH signaling pathway,1/93,0.0046499360391879,0.009899892959305,0,0,19907.0,106918.54242106884,CACNA1F
868,KEGG_2019_Human,Aldosterone synthesis and secretion,1/98,0.0048999339081079,0.009899892959305,0,0,19902.0,105849.45495286948,CACNA1F
869,KEGG_2019_Human,Cholinergic synapse,1/112,0.0055999282120529,0.009899892959305,0,0,19888.0,103119.30984392198,CACNA1F
870,KEGG_2019_Human,Serotonergic synapse,1/113,0.0056499278191151,0.009899892959305,0,0,19887.0,102937.34947211576,CACNA1F
871,KEGG_2019_Human,Vascular smooth muscle contraction,1/132,0.0065999206698993,0.009899892959305,0,0,19868.0,99751.22090491928,CACNA1F
872,KEGG_2019_Human,Adrenergic signaling in cardiomyocytes,1/145,0.0072499160871101,0.009899892959305,0,0,19855.0,97820.92670675044,CACNA1F
873,KEGG_2019_Human,Retrograde endocannabinoid signaling,1/148,0.007399915061391,0.009899892959305,0,0,19852.0,97399.60470052566,CACNA1F
874,KEGG_2019_Human,Oxytocin signaling pathway,1/153,0.0076499133771537,0.009899892959305,0,0,19847.0,96715.6407630817,CACNA1F
875,KEGG_2019_Human,Cushing syndrome,1/155,0.0077499127120574,0.009899892959305,0,0,19845.0,96448.16254952336,CACNA1F
876,KEGG_2019_Human,cGMP-PKG signaling pathway,1/166,0.0082999091363732,0.009899892959305,0,0,19834.0,95034.82345515196,CACNA1F
877,KEGG_2019_Human,Alzheimer disease,1/171,0.0085499075557634,0.009899892959305,0,0,19829.0,94422.42241345016,CACNA1F
878,KEGG_2019_Human,Calcium signaling pathway,1/188,0.009399902370135,0.0103398926071485,0,0,19812.0,92463.712994847,CACNA1F
879,KEGG_2019_Human,cAMP signaling pathway,1/212,0.0105998955026255,0.011104652431322,0,0,19788.0,89974.27756224656,CACNA1F
880,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0147498749536506,0,0,19705.0,83086.53988020132,CACNA1F
881,KEGG_2019_Human,Staphylococcus aureus infection,1/68,0.0033999476216189,0.0039499423167337,0,0,19932.0,113293.39338050144,CFH
882,KEGG_2019_Human,Complement and coagulation cascades,1/79,0.0039499423167337,0.0039499423167337,0,0,19921.0,110243.89578070649,CFH
883,KEGG_2019_Human,Sphingolipid metabolism,1/47,0.0023499589392381,0.0046999178784763,0,0,19953.0,120782.64067395544,CERS3
884,KEGG_2019_Human,Sphingolipid signaling pathway,1/119,0.0059499254985137,0.0059499254985137,0,0,19881.0,101877.73080211312,CERS3
885,KEGG_2019_Human,GABAergic synapse,1/89,0.0044499377838098,0.0044499377838098,0,0,19911.0,107815.380281759,SLC12A5
886,KEGG_2019_Human,Regulation of actin cytoskeleton,1/214,0.0106998949514067,0.0106998949514067,0,0,19786.0,89779.39753374986,BRK1
887,KEGG_2019_Human,Regulation of actin cytoskeleton,1/214,0.0106998949514067,0.0106998949514067,0,0,19786.0,89779.39753374986,IQGAP2
888,KEGG_2019_Human,Hematopoietic cell lineage,1/97,0.0048499343304706,0.0202497760506546,0,0,19903.0,106058.9096435903,CSF3R
889,KEGG_2019_Human,JAK-STAT signaling pathway,1/162,0.0080999104202618,0.0202497760506546,0,0,19838.0,95537.86936302872,CSF3R
890,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0221248283017086,0,0,19706.0,83157.67014793828,CSF3R
891,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0221248283017086,0,0,19646.0,79255.8617626126,CSF3R
892,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,CSF3R
893,KEGG_2019_Human,Ascorbate and aldarate metabolism,1/27,0.0013499718942362,0.004685646776936,0,0,19973.0,131975.02298599784,UGT1A6
894,KEGG_2019_Human,Pentose and glucuronate interconversions,1/34,0.0016999670339032,0.004685646776936,0,0,19966.0,127326.1054203148,UGT1A6
895,KEGG_2019_Human,Porphyrin and chlorophyll metabolism,1/42,0.0020999619311272,0.004685646776936,0,0,19958.0,123057.75613441122,UGT1A6
896,KEGG_2019_Human,Steroid hormone biosynthesis,1/60,0.002999951725986,0.004685646776936,0,0,19940.0,115834.63209072244,UGT1A6
897,KEGG_2019_Human,Retinol metabolism,1/67,0.0033499481224912,0.004685646776936,0,0,19933.0,113594.38808369274,UGT1A6
898,KEGG_2019_Human,Metabolism of xenobiotics by cytochrome P450,1/74,0.0036999446830449,0.004685646776936,0,0,19926.0,111574.38983110404,UGT1A6
899,KEGG_2019_Human,Chemical carcinogenesis,1/82,0.004099940929819,0.004685646776936,0,0,19918.0,109484.9180722932,UGT1A6
900,KEGG_2019_Human,Drug metabolism,1/108,0.0053999298011749,0.0053999298011749,0,0,19892.0,103863.47861844616,UGT1A6
901,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF736
902,KEGG_2019_Human,Ether lipid metabolism,1/47,0.0023499589392381,0.0046999178784763,0,0,19953.0,120782.64067395544,PLD3
903,KEGG_2019_Human,Glycerophospholipid metabolism,1/97,0.0048499343304706,0.0048499343304706,0,0,19903.0,106058.9096435903,PLD3
904,KEGG_2019_Human,Spliceosome,1/134,0.0066999199497742,0.0066999199497742,0,0,19866.0,99442.43560916925,CDC5L
905,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR14K1
906,KEGG_2019_Human,Ovarian steroidogenesis,1/49,0.0024499577795033,0.0069998932593308,0,0,19951.0,119939.1172087114,LHCGR
907,KEGG_2019_Human,Prolactin signaling pathway,1/70,0.0034999466296654,0.0069998932593308,0,0,19930.0,112704.30065625212,LHCGR
908,KEGG_2019_Human,Calcium signaling pathway,1/188,0.009399902370135,0.01253320316018,0,0,19812.0,92463.712994847,LHCGR
909,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,LHCGR
910,KEGG_2019_Human,Breast cancer,1/147,0.0073499154017982,0.0220497462053947,0,0,19853.0,97539.10874372096,HEYL
911,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0247498011884467,0,0,19670.0,80733.60565076157,HEYL
912,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,HEYL
913,KEGG_2019_Human,Collecting duct acid secretion,1/27,0.0013499718942362,0.0013499718942362,0,0,19973.0,131975.02298599784,SLC12A7
914,KEGG_2019_Human,Longevity regulating pathway,1/102,0.0050999322416682,0.0063999221281459,0,0,19898.0,105032.15064717118,ATG13
915,KEGG_2019_Human,Autophagy,1/128,0.0063999221281459,0.0063999221281459,0,0,19872.0,100382.8010329652,ATG13
916,KEGG_2019_Human,Thyroid hormone synthesis,1/74,0.0036999446830449,0.0096248581368756,0,0,19926.0,111574.38983110404,CANX
917,KEGG_2019_Human,Antigen processing and presentation,1/77,0.0038499432547502,0.0096248581368756,0,0,19923.0,110765.8407373636,CANX
918,KEGG_2019_Human,Phagosome,1/152,0.0075999137114971,0.0103123868191847,0,0,19848.0,96850.665715497,CANX
919,KEGG_2019_Human,Protein processing in endoplasmic reticulum,1/165,0.0082499094553477,0.0103123868191847,0,0,19835.0,95159.46482222488,CANX
920,KEGG_2019_Human,Human T-cell leukemia virus 1 infection,1/219,0.0109498935894162,0.0109498935894162,0,0,19781.0,89299.85161916987,CANX
921,KEGG_2019_Human,Cushing syndrome,1/155,0.0077499127120574,0.0154998254241149,0,0,19845.0,96448.16254952336,CRHR2
922,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,CRHR2
923,KEGG_2019_Human,RNA degradation,1/79,0.0039499423167337,0.0039499423167337,0,0,19921.0,110243.89578070649,PAN3
924,KEGG_2019_Human,Fanconi anemia pathway,1/54,0.0026999549628563,0.0026999549628563,0,0,19946.0,117971.01964061816,POLI
925,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0176998626413668,0,0,19646.0,79255.8617626126,MYB
926,KEGG_2019_Human,Long-term depression,1/60,0.002999951725986,0.0102498845546566,0,0,19940.0,115834.63209072244,ITPR1
927,KEGG_2019_Human,Cortisol synthesis and secretion,1/65,0.003249949134407,0.0102498845546566,0,0,19935.0,114209.92613860144,ITPR1
928,KEGG_2019_Human,Long-term potentiation,1/67,0.0033499481224912,0.0102498845546566,0,0,19933.0,113594.38808369274,ITPR1
929,KEGG_2019_Human,Renin secretion,1/69,0.003449947123837,0.0102498845546566,0,0,19931.0,112996.7391397682,ITPR1
930,KEGG_2019_Human,Thyroid hormone synthesis,1/74,0.0036999446830449,0.0102498845546566,0,0,19926.0,111574.38983110404,ITPR1
931,KEGG_2019_Human,Gastric acid secretion,1/75,0.0037499442041125,0.0102498845546566,0,0,19925.0,111301.33528642564,ITPR1
932,KEGG_2019_Human,Gap junction,1/88,0.0043999382262822,0.0102498845546566,0,0,19912.0,108045.79305232369,ITPR1
933,KEGG_2019_Human,Salivary secretion,1/90,0.0044999373439762,0.0102498845546566,0,0,19910.0,107587.50385474482,ITPR1
934,KEGG_2019_Human,GnRH signaling pathway,1/93,0.0046499360391879,0.0102498845546566,0,0,19907.0,106918.54242106884,ITPR1
935,KEGG_2019_Human,Circadian entrainment,1/97,0.0048499343304706,0.0102498845546566,0,0,19903.0,106058.9096435903,ITPR1
936,KEGG_2019_Human,Pancreatic secretion,1/98,0.0048999339081079,0.0102498845546566,0,0,19902.0,105849.45495286948,ITPR1
937,KEGG_2019_Human,Aldosterone synthesis and secretion,1/98,0.0048999339081079,0.0102498845546566,0,0,19902.0,105849.45495286948,ITPR1
938,KEGG_2019_Human,Phosphatidylinositol signaling system,1/99,0.0049499334884068,0.0102498845546566,0,0,19901.0,105642.09305076736,ITPR1
939,KEGG_2019_Human,Inflammatory mediator regulation of TRP channels,1/100,0.0049999330710556,0.0102498845546566,0,0,19900.0,105436.78197328727,ITPR1
940,KEGG_2019_Human,Glucagon signaling pathway,1/103,0.0051499318302617,0.0102498845546566,0,0,19897.0,104832.7525292024,ITPR1
941,KEGG_2019_Human,C-type lectin receptor signaling pathway,1/104,0.0051999314202997,0.0102498845546566,0,0,19896.0,104635.24941415618,ITPR1
942,KEGG_2019_Human,"Parathyroid hormone synthesis, secretion and action",1/106,0.0052999306076525,0.0102498845546566,0,0,19894.0,104245.78450366124,ITPR1
943,KEGG_2019_Human,Cholinergic synapse,1/112,0.0055999282120529,0.0102498845546566,0,0,19888.0,103119.30984392198,ITPR1
944,KEGG_2019_Human,Serotonergic synapse,1/113,0.0056499278191151,0.0102498845546566,0,0,19887.0,102937.34947211576,ITPR1
945,KEGG_2019_Human,Glutamatergic synapse,1/114,0.005699927427839,0.0102498845546566,0,0,19886.0,102756.96431429044,ITPR1
946,KEGG_2019_Human,Platelet activation,1/124,0.0061999236097501,0.0102498845546566,0,0,19876.0,101034.04709010696,ITPR1
947,KEGG_2019_Human,Oocyte meiosis,1/125,0.0062499232373748,0.0102498845546566,0,0,19875.0,100869.32368441945,ITPR1
948,KEGG_2019_Human,Autophagy,1/128,0.0063999221281459,0.0102498845546566,0,0,19872.0,100382.8010329652,ITPR1
949,KEGG_2019_Human,Dopaminergic synapse,1/131,0.0065499210316603,0.0102498845546566,0,0,19869.0,99907.33811343512,ITPR1
950,KEGG_2019_Human,Vascular smooth muscle contraction,1/132,0.0065999206698993,0.0102498845546566,0,0,19868.0,99751.22090491928,ITPR1
951,KEGG_2019_Human,Estrogen signaling pathway,1/137,0.0068499188797651,0.0102498845546566,0,0,19863.0,98987.62735269018,ITPR1
952,KEGG_2019_Human,Apelin signaling pathway,1/137,0.0068499188797651,0.0102498845546566,0,0,19863.0,98987.62735269018,ITPR1
953,KEGG_2019_Human,Apoptosis,1/143,0.0071499167770442,0.0102498845546566,0,0,19857.0,98106.57763600958,ITPR1
954,KEGG_2019_Human,Retrograde endocannabinoid signaling,1/148,0.007399915061391,0.0102498845546566,0,0,19852.0,97399.60470052566,ITPR1
955,KEGG_2019_Human,Oxytocin signaling pathway,1/153,0.0076499133771537,0.0102498845546566,0,0,19847.0,96715.6407630817,ITPR1
956,KEGG_2019_Human,Cushing syndrome,1/155,0.0077499127120574,0.0102498845546566,0,0,19845.0,96448.16254952336,ITPR1
957,KEGG_2019_Human,Cellular senescence,1/160,0.0079999110688441,0.0102498860569565,0,0,19840.0,95793.96509856998,ITPR1
958,KEGG_2019_Human,cGMP-PKG signaling pathway,1/166,0.0082999091363732,0.0103101826407735,0,0,19834.0,95034.82345515196,ITPR1
959,KEGG_2019_Human,Alzheimer disease,1/171,0.0085499075557634,0.0103101826407735,0,0,19829.0,94422.42241345016,ITPR1
960,KEGG_2019_Human,NOD-like receptor signaling pathway,1/178,0.0088999053857096,0.0104117351786222,0,0,19822.0,93593.82745769851,ITPR1
961,KEGG_2019_Human,Kaposi sarcoma-associated herpesvirus infection,1/186,0.0092999029651357,0.0104117351786222,0,0,19814.0,92684.96451050608,ITPR1
962,KEGG_2019_Human,Calcium signaling pathway,1/188,0.009399902370135,0.0104117351786222,0,0,19812.0,92463.712994847,ITPR1
963,KEGG_2019_Human,Huntington disease,1/193,0.0096499008972596,0.0104117351786222,0,0,19807.0,91920.47679471428,ITPR1
964,KEGG_2019_Human,Proteoglycans in cancer,1/201,0.0100498985877989,0.0105652780025579,0,0,19799.0,91079.21596609056,ITPR1
965,KEGG_2019_Human,Human immunodeficiency virus 1 infection,1/212,0.0105998955026255,0.0108648928901912,0,0,19788.0,89974.27756224656,ITPR1
966,KEGG_2019_Human,Human cytomegalovirus infection,1/225,0.0112498919790339,0.0112498919790339,0,0,19775.0,88738.27077557483,ITPR1
967,KEGG_2019_Human,Inflammatory mediator regulation of TRP channels,1/100,0.0049999330710556,0.0088999053857096,0,0,19900.0,105436.78197328727,TRPV2
968,KEGG_2019_Human,NOD-like receptor signaling pathway,1/178,0.0088999053857096,0.0088999053857096,0,0,19822.0,93593.82745769851,TRPV2
969,KEGG_2019_Human,p53 signaling pathway,1/72,0.0035999456502131,0.0068499188797651,0,0,19928.0,112131.59838572376,COP1
970,KEGG_2019_Human,Ubiquitin mediated proteolysis,1/137,0.0068499188797651,0.0068499188797651,0,0,19863.0,98987.62735269018,COP1
971,KEGG_2019_Human,Mucin type O-glycan biosynthesis,1/31,0.0015499690656704,0.0015499690656704,0,0,19969.0,129189.85098816035,GALNT5
972,KEGG_2019_Human,Vascular smooth muscle contraction,1/132,0.0065999206698993,0.0084999078692823,0,0,19868.0,99751.22090491928,MYH11
973,KEGG_2019_Human,Tight junction,1/170,0.0084999078692823,0.0084999078692823,0,0,19830.0,94543.49009679438,MYH11
974,KEGG_2019_Human,RNA degradation,1/79,0.0039499423167337,0.0039499423167337,0,0,19921.0,110243.89578070649,CNOT2
975,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF717
976,KEGG_2019_Human,Aminoacyl-tRNA biosynthesis,1/66,0.003299948626608,0.003299948626608,0,0,19934.0,113899.85357353876,VARS2
977,KEGG_2019_Human,Ras signaling pathway,1/232,0.0115998901349604,0.0147498749536506,0,0,19768.0,88101.22480150245,NF1
978,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0147498749536506,0,0,19705.0,83086.53988020132,NF1
979,KEGG_2019_Human,Endometrial cancer,1/58,0.0028999527887707,0.0120398688515903,0,0,19942.0,116522.31890946148,SOS1
980,KEGG_2019_Human,Acute myeloid leukemia,1/66,0.003299948626608,0.0120398688515903,0,0,19934.0,113899.85357353876,SOS1
981,KEGG_2019_Human,Non-small cell lung cancer,1/66,0.003299948626608,0.0120398688515903,0,0,19934.0,113899.85357353876,SOS1
982,KEGG_2019_Human,Fc epsilon RI signaling pathway,1/68,0.0033999476216189,0.0120398688515903,0,0,19932.0,113293.39338050144,SOS1
983,KEGG_2019_Human,Renal cell carcinoma,1/69,0.003449947123837,0.0120398688515903,0,0,19931.0,112996.7391397682,SOS1
984,KEGG_2019_Human,Prolactin signaling pathway,1/70,0.0034999466296654,0.0120398688515903,0,0,19930.0,112704.30065625212,SOS1
985,KEGG_2019_Human,B cell receptor signaling pathway,1/71,0.0035499461386618,0.0120398688515903,0,0,19929.0,112415.9585341616,SOS1
986,KEGG_2019_Human,Glioma,1/75,0.0037499442041125,0.0120398688515903,0,0,19925.0,111301.33528642564,SOS1
987,KEGG_2019_Human,Chronic myeloid leukemia,1/76,0.0037999437281752,0.0120398688515903,0,0,19924.0,111031.8499691117,SOS1
988,KEGG_2019_Human,ErbB signaling pathway,1/85,0.004249939567045,0.0120398688515903,0,0,19915.0,108752.83801948265,SOS1
989,KEGG_2019_Human,Colorectal cancer,1/86,0.0042999391173866,0.0120398688515903,0,0,19914.0,108514.46102290176,SOS1
990,KEGG_2019_Human,Gap junction,1/88,0.0043999382262822,0.0120398688515903,0,0,19912.0,108045.79305232369,SOS1
991,KEGG_2019_Human,GnRH signaling pathway,1/93,0.0046499360391879,0.0120398688515903,0,0,19907.0,106918.54242106884,SOS1
992,KEGG_2019_Human,Prostate cancer,1/97,0.0048499343304706,0.0120398688515903,0,0,19903.0,106058.9096435903,SOS1
993,KEGG_2019_Human,Choline metabolism in cancer,1/99,0.0049499334884068,0.0120398688515903,0,0,19901.0,105642.09305076736,SOS1
994,KEGG_2019_Human,T cell receptor signaling pathway,1/101,0.0050499326546803,0.0120398688515903,0,0,19899.0,105233.48101229242,SOS1
995,KEGG_2019_Human,Neurotrophin signaling pathway,1/119,0.0059499254985137,0.0120398688515903,0,0,19881.0,101877.73080211312,SOS1
996,KEGG_2019_Human,Relaxin signaling pathway,1/130,0.0064999213952527,0.0120398688515903,0,0,19870.0,100064.62842845908,SOS1
997,KEGG_2019_Human,Natural killer cell mediated cytotoxicity,1/131,0.0065499210316603,0.0120398688515903,0,0,19869.0,99907.33811343512,SOS1
998,KEGG_2019_Human,FoxO signaling pathway,1/132,0.0065999206698993,0.0120398688515903,0,0,19868.0,99751.22090491928,SOS1
999,KEGG_2019_Human,Insulin signaling pathway,1/137,0.0068499188797651,0.0120398688515903,0,0,19863.0,98987.62735269018,SOS1
1000,KEGG_2019_Human,Estrogen signaling pathway,1/137,0.0068499188797651,0.0120398688515903,0,0,19863.0,98987.62735269018,SOS1
1001,KEGG_2019_Human,Breast cancer,1/147,0.0073499154017982,0.0120398688515903,0,0,19853.0,97539.10874372096,SOS1
1002,KEGG_2019_Human,Phospholipase D signaling pathway,1/148,0.007399915061391,0.0120398688515903,0,0,19852.0,97399.60470052566,SOS1
1003,KEGG_2019_Human,Gastric cancer,1/149,0.0074499147221605,0.0120398688515903,0,0,19851.0,97261.02051561224,SOS1
1004,KEGG_2019_Human,mTOR signaling pathway,1/152,0.0075999137114971,0.0120398688515903,0,0,19848.0,96850.665715497,SOS1
1005,KEGG_2019_Human,Hepatitis C,1/155,0.0077499127120574,0.0120398688515903,0,0,19845.0,96448.16254952336,SOS1
1006,KEGG_2019_Human,JAK-STAT signaling pathway,1/162,0.0080999104202618,0.0120398688515903,0,0,19838.0,95537.86936302872,SOS1
1007,KEGG_2019_Human,Hepatitis B,1/163,0.0081499100978668,0.0120398688515903,0,0,19837.0,95410.9786681514,SOS1
1008,KEGG_2019_Human,Hepatocellular carcinoma,1/168,0.0083999085011095,0.0120398688515903,0,0,19832.0,94787.72752807094,SOS1
1009,KEGG_2019_Human,Alcoholism,1/180,0.0089999047745351,0.0124837388808067,0,0,19820.0,93362.92821536642,SOS1
1010,KEGG_2019_Human,Chemokine signaling pathway,1/190,0.0094999017791995,0.0127101658610399,0,0,19810.0,92244.74636351672,SOS1
1011,KEGG_2019_Human,Focal adhesion,1/199,0.0099498991610159,0.0127101658610399,0,0,19801.0,91286.4288690606,SOS1
1012,KEGG_2019_Human,Proteoglycans in cancer,1/201,0.0100498985877989,0.0127101658610399,0,0,19799.0,91079.21596609056,SOS1
1013,KEGG_2019_Human,Regulation of actin cytoskeleton,1/214,0.0106998949514067,0.0131261914685078,0,0,19786.0,89779.39753374986,SOS1
1014,KEGG_2019_Human,Human cytomegalovirus infection,1/225,0.0112498919790339,0.0131261914685078,0,0,19775.0,88738.27077557483,SOS1
1015,KEGG_2019_Human,Thermogenesis,1/231,0.0115498903940656,0.0131261914685078,0,0,19769.0,88191.07730937863,SOS1
1016,KEGG_2019_Human,Ras signaling pathway,1/232,0.0115998901349604,0.0131261914685078,0,0,19768.0,88101.22480150245,SOS1
1017,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0160711146220803,0,0,19705.0,83086.53988020132,SOS1
1018,KEGG_2019_Human,MicroRNAs in cancer,1/299,0.0149498740670514,0.0160711146220803,0,0,19701.0,82804.33538735632,SOS1
1019,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0173047390423286,0,0,19670.0,80733.60565076157,SOS1
1020,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0181212879423518,0,0,19646.0,79255.8617626126,SOS1
1021,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,SOS1
1022,KEGG_2019_Human,Pertussis,1/76,0.0037999437281752,0.0111598835581629,0,0,19924.0,111031.8499691117,TICAM1
1023,KEGG_2019_Human,NF-kappa B signaling pathway,1/95,0.0047499351803394,0.0111598835581629,0,0,19905.0,106484.27183626965,TICAM1
1024,KEGG_2019_Human,Chagas disease (American trypanosomiasis),1/103,0.0051499318302617,0.0111598835581629,0,0,19897.0,104832.7525292024,TICAM1
1025,KEGG_2019_Human,Toll-like receptor signaling pathway,1/104,0.0051999314202997,0.0111598835581629,0,0,19896.0,104635.24941415618,TICAM1
1026,KEGG_2019_Human,Hepatitis C,1/155,0.0077499127120574,0.0111598835581629,0,0,19845.0,96448.16254952336,TICAM1
1027,KEGG_2019_Human,Necroptosis,1/162,0.0080999104202618,0.0111598835581629,0,0,19838.0,95537.86936302872,TICAM1
1028,KEGG_2019_Human,Hepatitis B,1/163,0.0081499100978668,0.0111598835581629,0,0,19837.0,95410.9786681514,TICAM1
1029,KEGG_2019_Human,Influenza A,1/171,0.0085499075557634,0.0111598835581629,0,0,19829.0,94422.42241345016,TICAM1
1030,KEGG_2019_Human,NOD-like receptor signaling pathway,1/178,0.0088999053857096,0.0111598835581629,0,0,19822.0,93593.82745769851,TICAM1
1031,KEGG_2019_Human,Kaposi sarcoma-associated herpesvirus infection,1/186,0.0092999029651357,0.0111598835581629,0,0,19814.0,92684.96451050608,TICAM1
1032,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0179998554097794,0,0,19670.0,80733.60565076157,TICAM1
1033,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,TICAM1
1034,KEGG_2019_Human,FoxO signaling pathway,1/132,0.0065999206698993,0.0092999029651357,0,0,19868.0,99751.22090491928,BCL6
1035,KEGG_2019_Human,Transcriptional misregulation in cancer,1/186,0.0092999029651357,0.0092999029651357,0,0,19814.0,92684.96451050608,BCL6
1036,KEGG_2019_Human,Cell adhesion molecules (CAMs),1/145,0.0072499160871101,0.0072499160871101,0,0,19855.0,97820.92670675044,PVR
1037,KEGG_2019_Human,Inflammatory bowel disease (IBD),1/65,0.003249949134407,0.0053499302026925,0,0,19935.0,114209.92613860144,FOXP3
1038,KEGG_2019_Human,Th17 cell differentiation,1/107,0.0053499302026925,0.0053499302026925,0,0,19893.0,104053.753408911,FOXP3
1039,KEGG_2019_Human,Tyrosine metabolism,1/36,0.0017999657178272,0.0047832644181221,0,0,19964.0,126172.23364250171,ADH1B
1040,KEGG_2019_Human,Fatty acid degradation,1/44,0.0021999607179423,0.0047832644181221,0,0,19956.0,122117.06559109331,ADH1B
1041,KEGG_2019_Human,Retinol metabolism,1/67,0.0033499481224912,0.0047832644181221,0,0,19933.0,113594.38808369274,ADH1B
1042,KEGG_2019_Human,Glycolysis / Gluconeogenesis,1/68,0.0033999476216189,0.0047832644181221,0,0,19932.0,113293.39338050144,ADH1B
1043,KEGG_2019_Human,Metabolism of xenobiotics by cytochrome P450,1/74,0.0036999446830449,0.0047832644181221,0,0,19926.0,111574.38983110404,ADH1B
1044,KEGG_2019_Human,Chemical carcinogenesis,1/82,0.004099940929819,0.0047832644181221,0,0,19918.0,109484.9180722932,ADH1B
1045,KEGG_2019_Human,Drug metabolism,1/108,0.0053999298011749,0.0053999298011749,0,0,19892.0,103863.47861844616,ADH1B
1046,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF169
1047,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR6C2
1048,KEGG_2019_Human,Autophagy,1/128,0.0063999221281459,0.0063999221281459,0,0,19872.0,100382.8010329652,ATG2A
1049,KEGG_2019_Human,N-Glycan biosynthesis,1/50,0.0024999572069037,0.0024999572069037,0,0,19950.0,119530.05920663515,MGAT2
1050,KEGG_2019_Human,Ubiquitin mediated proteolysis,1/137,0.0068499188797651,0.0121998870519305,0,0,19863.0,98987.62735269018,WWP1
1051,KEGG_2019_Human,Endocytosis,1/244,0.0121998870519305,0.0121998870519305,0,0,19756.0,87051.4275316661,WWP1
1052,KEGG_2019_Human,RNA degradation,1/79,0.0039499423167337,0.0050499326546803,0,0,19921.0,110243.89578070649,XRN1
1053,KEGG_2019_Human,Ribosome biogenesis in eukaryotes,1/101,0.0050499326546803,0.0050499326546803,0,0,19899.0,105233.48101229242,XRN1
1054,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF671
1055,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR52N1
1056,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF114
1057,KEGG_2019_Human,Axon guidance,1/181,0.0090499044707863,0.0090499044707863,0,0,19819.0,93248.41634586031,SEMA4G
1058,KEGG_2019_Human,Tight junction,1/170,0.0084999078692823,0.0084999078692823,0,0,19830.0,94543.49009679438,CGNL1
1059,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,SRPK1
1060,KEGG_2019_Human,Cholinergic synapse,1/112,0.0055999282120529,0.0160498424271101,0,0,19888.0,103119.30984392198,CHRM1
1061,KEGG_2019_Human,Calcium signaling pathway,1/188,0.009399902370135,0.0160498424271101,0,0,19812.0,92463.712994847,CHRM1
1062,KEGG_2019_Human,cAMP signaling pathway,1/212,0.0105998955026255,0.0160498424271101,0,0,19788.0,89974.27756224656,CHRM1
1063,KEGG_2019_Human,Regulation of actin cytoskeleton,1/214,0.0106998949514067,0.0160498424271101,0,0,19786.0,89779.39753374986,CHRM1
1064,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0176998626413668,0,0,19662.0,80229.79996326564,CHRM1
1065,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0176998626413668,0,0,19646.0,79255.8617626126,CHRM1
1066,KEGG_2019_Human,Salivary secretion,1/90,0.0044999373439762,0.009399902370135,0,0,19910.0,107587.50385474482,RYR3
1067,KEGG_2019_Human,Circadian entrainment,1/97,0.0048499343304706,0.009399902370135,0,0,19903.0,106058.9096435903,RYR3
1068,KEGG_2019_Human,Apelin signaling pathway,1/137,0.0068499188797651,0.009399902370135,0,0,19863.0,98987.62735269018,RYR3
1069,KEGG_2019_Human,Oxytocin signaling pathway,1/153,0.0076499133771537,0.009399902370135,0,0,19847.0,96715.6407630817,RYR3
1070,KEGG_2019_Human,Alzheimer disease,1/171,0.0085499075557634,0.009399902370135,0,0,19829.0,94422.42241345016,RYR3
1071,KEGG_2019_Human,Calcium signaling pathway,1/188,0.009399902370135,0.009399902370135,0,0,19812.0,92463.712994847,RYR3
1072,KEGG_2019_Human,Hippo signaling pathway,1/160,0.0079999110688441,0.0146398644623166,0,0,19840.0,95793.96509856998,PARD6B
1073,KEGG_2019_Human,Tight junction,1/170,0.0084999078692823,0.0146398644623166,0,0,19830.0,94543.49009679438,PARD6B
1074,KEGG_2019_Human,Axon guidance,1/181,0.0090499044707863,0.0146398644623166,0,0,19819.0,93248.41634586031,PARD6B
1075,KEGG_2019_Human,Rap1 signaling pathway,1/206,0.010299897173561,0.0146398644623166,0,0,19794.0,90569.849337325,PARD6B
1076,KEGG_2019_Human,Endocytosis,1/244,0.0121998870519305,0.0146398644623166,0,0,19756.0,87051.4275316661,PARD6B
1077,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0164998674589645,0,0,19670.0,80733.60565076157,PARD6B
1078,KEGG_2019_Human,alpha-Linolenic acid metabolism,1/25,0.0012499733663791,0.0064284853770715,0,0,19975.0,133525.54486996148,PLA2G6
1079,KEGG_2019_Human,Linoleic acid metabolism,1/29,0.001449970461791,0.0064284853770715,0,0,19971.0,130534.69172799008,PLA2G6
1080,KEGG_2019_Human,Ether lipid metabolism,1/47,0.0023499589392381,0.0064284853770715,0,0,19953.0,120782.64067395544,PLA2G6
1081,KEGG_2019_Human,Arachidonic acid metabolism,1/63,0.0031499501598827,0.0064284853770715,0,0,19937.0,114844.46974572667,PLA2G6
1082,KEGG_2019_Human,Fc gamma R-mediated phagocytosis,1/91,0.0045499369072032,0.0064284853770715,0,0,19909.0,107362.10783923086,PLA2G6
1083,KEGG_2019_Human,Glycerophospholipid metabolism,1/97,0.0048499343304706,0.0064284853770715,0,0,19903.0,106058.9096435903,PLA2G6
1084,KEGG_2019_Human,Inflammatory mediator regulation of TRP channels,1/100,0.0049999330710556,0.0064284853770715,0,0,19900.0,105436.78197328727,PLA2G6
1085,KEGG_2019_Human,Vascular smooth muscle contraction,1/132,0.0065999206698993,0.0074249107536368,0,0,19868.0,99751.22090491928,PLA2G6
1086,KEGG_2019_Human,Ras signaling pathway,1/232,0.0115998901349604,0.0115998901349604,0,0,19768.0,88101.22480150245,PLA2G6
1087,KEGG_2019_Human,Hippo signaling pathway,1/160,0.0079999110688441,0.0147498749536506,0,0,19840.0,95793.96509856998,STK3
1088,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0147498749536506,0,0,19705.0,83086.53988020132,STK3
1089,KEGG_2019_Human,Bacterial invasion of epithelial cells,1/74,0.0036999446830449,0.0036999446830449,0,0,19926.0,111574.38983110404,ARHGAP10
1090,KEGG_2019_Human,Galactose metabolism,1/31,0.0015499690656704,0.0021999607179423,0,0,19969.0,129189.85098816035,SI
1091,KEGG_2019_Human,Starch and sucrose metabolism,1/36,0.0017999657178272,0.0021999607179423,0,0,19964.0,126172.23364250171,SI
1092,KEGG_2019_Human,Carbohydrate digestion and absorption,1/44,0.0021999607179423,0.0021999607179423,0,0,19956.0,122117.06559109331,SI
1093,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR6M1
1094,KEGG_2019_Human,Thyroid hormone signaling pathway,1/116,0.0057999266512085,0.0115998533024171,0,0,19884.0,102400.8105961506,THRB
1095,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,THRB
1096,KEGG_2019_Human,Spliceosome,1/134,0.0066999199497742,0.0066999199497742,0,0,19866.0,99442.43560916925,USP39
1097,KEGG_2019_Human,Vitamin digestion and absorption,1/24,0.0011999741185782,0.0024999572069037,0,0,19976.0,134347.69487847842,APOB
1098,KEGG_2019_Human,Fat digestion and absorption,1/41,0.0020499625466866,0.0024999572069037,0,0,19959.0,123544.88783416104,APOB
1099,KEGG_2019_Human,Cholesterol metabolism,1/50,0.0024999572069037,0.0024999572069037,0,0,19950.0,119530.05920663515,APOB
1100,KEGG_2019_Human,Transcriptional misregulation in cancer,1/186,0.0092999029651357,0.0092999029651357,0,0,19814.0,92684.96451050608,HOXA10
1101,KEGG_2019_Human,Hepatocellular carcinoma,1/168,0.0083999085011095,0.0115498903940656,0,0,19832.0,94787.72752807094,DPF3
1102,KEGG_2019_Human,Thermogenesis,1/231,0.0115498903940656,0.0115498903940656,0,0,19769.0,88191.07730937863,DPF3
1103,KEGG_2019_Human,Staphylococcus aureus infection,1/68,0.0033999476216189,0.0065832371945562,0,0,19932.0,113293.39338050144,C1R
1104,KEGG_2019_Human,Pertussis,1/76,0.0037999437281752,0.0065832371945562,0,0,19924.0,111031.8499691117,C1R
1105,KEGG_2019_Human,Complement and coagulation cascades,1/79,0.0039499423167337,0.0065832371945562,0,0,19921.0,110243.89578070649,C1R
1106,KEGG_2019_Human,Systemic lupus erythematosus,1/133,0.0066499203093911,0.0075999137114971,0,0,19867.0,99596.2591544721,C1R
1107,KEGG_2019_Human,Phagosome,1/152,0.0075999137114971,0.0075999137114971,0,0,19848.0,96850.665715497,C1R
1108,KEGG_2019_Human,Glycosphingolipid biosynthesis,1/45,0.0022499601197094,0.0022499601197094,0,0,19955.0,121662.49782449217,B3GALT1
1109,KEGG_2019_Human,"Glycine, serine and threonine metabolism",1/40,0.0019999631680592,0.0019999631680592,0,0,19960.0,124043.94523066044,GCAT
1110,KEGG_2019_Human,Citrate cycle (TCA cycle),1/30,0.0014999697593334,0.0029499522555206,0,0,19970.0,129851.13732048514,DLST
1111,KEGG_2019_Human,Tryptophan metabolism,1/42,0.0020999619311272,0.0029499522555206,0,0,19958.0,123057.75613441122,DLST
1112,KEGG_2019_Human,Lysine degradation,1/59,0.0029499522555206,0.0029499522555206,0,0,19941.0,116175.59385530632,DLST
1113,KEGG_2019_Human,VEGF signaling pathway,1/59,0.0029499522555206,0.0111598835581629,0,0,19941.0,116175.59385530632,NFATC2
1114,KEGG_2019_Human,B cell receptor signaling pathway,1/71,0.0035499461386618,0.0111598835581629,0,0,19929.0,112415.9585341616,NFATC2
1115,KEGG_2019_Human,Th1 and Th2 cell differentiation,1/92,0.0045999364719865,0.0111598835581629,0,0,19908.0,107139.13814408927,NFATC2
1116,KEGG_2019_Human,T cell receptor signaling pathway,1/101,0.0050499326546803,0.0111598835581629,0,0,19899.0,105233.48101229242,NFATC2
1117,KEGG_2019_Human,C-type lectin receptor signaling pathway,1/104,0.0051999314202997,0.0111598835581629,0,0,19896.0,104635.24941415618,NFATC2
1118,KEGG_2019_Human,Th17 cell differentiation,1/107,0.0053499302026925,0.0111598835581629,0,0,19893.0,104053.753408911,NFATC2
1119,KEGG_2019_Human,Osteoclast differentiation,1/127,0.0063499224962247,0.0111598835581629,0,0,19873.0,100543.72072014232,NFATC2
1120,KEGG_2019_Human,Natural killer cell mediated cytotoxicity,1/131,0.0065499210316603,0.0111598835581629,0,0,19869.0,99907.33811343512,NFATC2
1121,KEGG_2019_Human,Oxytocin signaling pathway,1/153,0.0076499133771537,0.0111598835581629,0,0,19847.0,96715.6407630817,NFATC2
1122,KEGG_2019_Human,Wnt signaling pathway,1/158,0.0078999117225733,0.0111598835581629,0,0,19842.0,96053.2110949472,NFATC2
1123,KEGG_2019_Human,Cellular senescence,1/160,0.0079999110688441,0.0111598835581629,0,0,19840.0,95793.96509856998,NFATC2
1124,KEGG_2019_Human,Hepatitis B,1/163,0.0081499100978668,0.0111598835581629,0,0,19837.0,95410.9786681514,NFATC2
1125,KEGG_2019_Human,cGMP-PKG signaling pathway,1/166,0.0082999091363732,0.0111598835581629,0,0,19834.0,95034.82345515196,NFATC2
1126,KEGG_2019_Human,Axon guidance,1/181,0.0090499044707863,0.0111598835581629,0,0,19819.0,93248.41634586031,NFATC2
1127,KEGG_2019_Human,Kaposi sarcoma-associated herpesvirus infection,1/186,0.0092999029651357,0.0111598835581629,0,0,19814.0,92684.96451050608,NFATC2
1128,KEGG_2019_Human,Human immunodeficiency virus 1 infection,1/212,0.0105998955026255,0.0112498919790339,0,0,19788.0,89974.27756224656,NFATC2
1129,KEGG_2019_Human,Human T-cell leukemia virus 1 infection,1/219,0.0109498935894162,0.0112498919790339,0,0,19781.0,89299.85161916987,NFATC2
1130,KEGG_2019_Human,Human cytomegalovirus infection,1/225,0.0112498919790339,0.0112498919790339,0,0,19775.0,88738.27077557483,NFATC2
1131,KEGG_2019_Human,Mucin type O-glycan biosynthesis,1/31,0.0015499690656704,0.0015499690656704,0,0,19969.0,129189.85098816035,GALNT6
1132,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR10K1
1133,KEGG_2019_Human,Ras signaling pathway,1/232,0.0115998901349604,0.0115998901349604,0,0,19768.0,88101.22480150245,KSR2
1134,KEGG_2019_Human,RNA degradation,1/79,0.0039499423167337,0.0039499423167337,0,0,19921.0,110243.89578070649,EDC4
1135,KEGG_2019_Human,Pathogenic Escherichia coli infection,1/55,0.0027499544131125,0.0124832107766412,0,0,19945.0,117599.1294878737,EZR
1136,KEGG_2019_Human,Gastric acid secretion,1/75,0.0037499442041125,0.0124832107766412,0,0,19925.0,111301.33528642564,EZR
1137,KEGG_2019_Human,Leukocyte transendothelial migration,1/112,0.0055999282120529,0.0124832107766412,0,0,19888.0,103119.30984392198,EZR
1138,KEGG_2019_Human,Tight junction,1/170,0.0084999078692823,0.0124832107766412,0,0,19830.0,94543.49009679438,EZR
1139,KEGG_2019_Human,Proteoglycans in cancer,1/201,0.0100498985877989,0.0124832107766412,0,0,19799.0,91079.21596609056,EZR
1140,KEGG_2019_Human,Regulation of actin cytoskeleton,1/214,0.0106998949514067,0.0124832107766412,0,0,19786.0,89779.39753374986,EZR
1141,KEGG_2019_Human,MicroRNAs in cancer,1/299,0.0149498740670514,0.0149498740670514,0,0,19701.0,82804.33538735632,EZR
1142,KEGG_2019_Human,Pentose phosphate pathway,1/30,0.0014999697593334,0.0014999697593334,0,0,19970.0,129851.13732048514,DERA
1143,KEGG_2019_Human,Glycerophospholipid metabolism,1/97,0.0048499343304706,0.0048499343304706,0,0,19903.0,106058.9096435903,TAZ
1144,KEGG_2019_Human,Regulation of lipolysis in adipocytes,1/55,0.0027499544131125,0.0073998893660899,0,0,19945.0,117599.1294878737,PLIN1
1145,KEGG_2019_Human,PPAR signaling pathway,1/74,0.0036999446830449,0.0073998893660899,0,0,19926.0,111574.38983110404,PLIN1
1146,KEGG_2019_Human,Apelin signaling pathway,1/137,0.0068499188797651,0.0091332251730202,0,0,19863.0,98987.62735269018,PLIN1
1147,KEGG_2019_Human,Thermogenesis,1/231,0.0115498903940656,0.0115498903940656,0,0,19769.0,88191.07730937863,PLIN1
1148,KEGG_2019_Human,p53 signaling pathway,1/72,0.0035999456502131,0.0035999456502131,0,0,19928.0,112131.59838572376,ADGRB1
1149,KEGG_2019_Human,Inositol phosphate metabolism,1/74,0.0036999446830449,0.0036999446830449,0,0,19926.0,111574.38983110404,PLCH1
1150,KEGG_2019_Human,Renin-angiotensin system,1/23,0.0011499748819949,0.0022999497639899,0,0,19977.0,135204.63922267244,KLK2
1151,KEGG_2019_Human,Endocrine and other factor-regulated calcium reabsorption,1/48,0.0023999583567988,0.0023999583567988,0,0,19952.0,120356.5272753826,KLK2
1152,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR9K2
1153,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,POU2F1
1154,KEGG_2019_Human,Tight junction,1/170,0.0084999078692823,0.0084999078692823,0,0,19830.0,94543.49009679438,MYH4
1155,KEGG_2019_Human,Protein digestion and absorption,1/90,0.0044999373439762,0.0044999373439762,0,0,19910.0,107587.50385474482,COL12A1
1156,KEGG_2019_Human,TGF-beta signaling pathway,1/90,0.0044999373439762,0.010424877259224,0,0,19910.0,107587.50385474482,NODAL
1157,KEGG_2019_Human,Signaling pathways regulating pluripotency of stem cells,1/139,0.006949918172816,0.010424877259224,0,0,19861.0,98689.81333375497,NODAL
1158,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0146998751759735,0,0,19706.0,83157.67014793828,NODAL
1159,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,LTB4R
1160,KEGG_2019_Human,Phototransduction,1/28,0.0013999711732997,0.0013999711732997,0,0,19972.0,131242.0761597353,RCVRN
1161,KEGG_2019_Human,Vasopressin-regulated water reabsorption,1/44,0.0021999607179423,0.0093396383965821,0,0,19956.0,122117.06559109331,ADCY6
1162,KEGG_2019_Human,Endocrine and other factor-regulated calcium reabsorption,1/48,0.0023999583567988,0.0093396383965821,0,0,19952.0,120356.5272753826,ADCY6
1163,KEGG_2019_Human,Ovarian steroidogenesis,1/49,0.0024499577795033,0.0093396383965821,0,0,19951.0,119939.1172087114,ADCY6
1164,KEGG_2019_Human,Regulation of lipolysis in adipocytes,1/55,0.0027499544131125,0.0093396383965821,0,0,19945.0,117599.1294878737,ADCY6
1165,KEGG_2019_Human,Cortisol synthesis and secretion,1/65,0.003249949134407,0.0093396383965821,0,0,19935.0,114209.92613860144,ADCY6
1166,KEGG_2019_Human,Renin secretion,1/69,0.003449947123837,0.0093396383965821,0,0,19931.0,112996.7391397682,ADCY6
1167,KEGG_2019_Human,Bile secretion,1/72,0.0035999456502131,0.0093396383965821,0,0,19928.0,112131.59838572376,ADCY6
1168,KEGG_2019_Human,Thyroid hormone synthesis,1/74,0.0036999446830449,0.0093396383965821,0,0,19926.0,111574.38983110404,ADCY6
1169,KEGG_2019_Human,Gastric acid secretion,1/75,0.0037499442041125,0.0093396383965821,0,0,19925.0,111301.33528642564,ADCY6
1170,KEGG_2019_Human,Taste transduction,1/83,0.0041499404726918,0.0093396383965821,0,0,19917.0,109237.99888847338,ADCY6
1171,KEGG_2019_Human,Insulin secretion,1/86,0.0042999391173866,0.0093396383965821,0,0,19914.0,108514.46102290176,ADCY6
1172,KEGG_2019_Human,Gap junction,1/88,0.0043999382262822,0.0093396383965821,0,0,19912.0,108045.79305232369,ADCY6
1173,KEGG_2019_Human,GABAergic synapse,1/89,0.0044499377838098,0.0093396383965821,0,0,19911.0,107815.380281759,ADCY6
1174,KEGG_2019_Human,Salivary secretion,1/90,0.0044999373439762,0.0093396383965821,0,0,19910.0,107587.50385474482,ADCY6
1175,KEGG_2019_Human,Dilated cardiomyopathy (DCM),1/91,0.0045499369072032,0.0093396383965821,0,0,19909.0,107362.10783923086,ADCY6
1176,KEGG_2019_Human,Morphine addiction,1/91,0.0045499369072032,0.0093396383965821,0,0,19909.0,107362.10783923086,ADCY6
1177,KEGG_2019_Human,GnRH signaling pathway,1/93,0.0046499360391879,0.0093396383965821,0,0,19907.0,106918.54242106884,ADCY6
1178,KEGG_2019_Human,Circadian entrainment,1/97,0.0048499343304706,0.0093396383965821,0,0,19903.0,106058.9096435903,ADCY6
1179,KEGG_2019_Human,Pancreatic secretion,1/98,0.0048999339081079,0.0093396383965821,0,0,19902.0,105849.45495286948,ADCY6
1180,KEGG_2019_Human,Aldosterone synthesis and secretion,1/98,0.0048999339081079,0.0093396383965821,0,0,19902.0,105849.45495286948,ADCY6
1181,KEGG_2019_Human,Progesterone-mediated oocyte maturation,1/99,0.0049499334884068,0.0093396383965821,0,0,19901.0,105642.09305076736,ADCY6
1182,KEGG_2019_Human,Inflammatory mediator regulation of TRP channels,1/100,0.0049999330710556,0.0093396383965821,0,0,19900.0,105436.78197328727,ADCY6
1183,KEGG_2019_Human,Melanogenesis,1/101,0.0050499326546803,0.0093396383965821,0,0,19899.0,105233.48101229242,ADCY6
1184,KEGG_2019_Human,Longevity regulating pathway,1/102,0.0050999322416682,0.0093396383965821,0,0,19898.0,105032.15064717118,ADCY6
1185,KEGG_2019_Human,"Parathyroid hormone synthesis, secretion and action",1/106,0.0052999306076525,0.0093396383965821,0,0,19894.0,104245.78450366124,ADCY6
1186,KEGG_2019_Human,Cholinergic synapse,1/112,0.0055999282120529,0.0093396383965821,0,0,19888.0,103119.30984392198,ADCY6
1187,KEGG_2019_Human,Glutamatergic synapse,1/114,0.005699927427839,0.0093396383965821,0,0,19886.0,102756.96431429044,ADCY6
1188,KEGG_2019_Human,Platelet activation,1/124,0.0061999236097501,0.0093396383965821,0,0,19876.0,101034.04709010696,ADCY6
1189,KEGG_2019_Human,Oocyte meiosis,1/125,0.0062499232373748,0.0093396383965821,0,0,19875.0,100869.32368441945,ADCY6
1190,KEGG_2019_Human,Purine metabolism,1/129,0.006449921761047,0.0093396383965821,0,0,19871.0,100223.109907462,ADCY6
1191,KEGG_2019_Human,Relaxin signaling pathway,1/130,0.0064999213952527,0.0093396383965821,0,0,19870.0,100064.62842845908,ADCY6
1192,KEGG_2019_Human,Vascular smooth muscle contraction,1/132,0.0065999206698993,0.0093396383965821,0,0,19868.0,99751.22090491928,ADCY6
1193,KEGG_2019_Human,Estrogen signaling pathway,1/137,0.0068499188797651,0.0093396383965821,0,0,19863.0,98987.62735269018,ADCY6
1194,KEGG_2019_Human,Apelin signaling pathway,1/137,0.0068499188797651,0.0093396383965821,0,0,19863.0,98987.62735269018,ADCY6
1195,KEGG_2019_Human,Adrenergic signaling in cardiomyocytes,1/145,0.0072499160871101,0.0093396383965821,0,0,19855.0,97820.92670675044,ADCY6
1196,KEGG_2019_Human,Phospholipase D signaling pathway,1/148,0.007399915061391,0.0093396383965821,0,0,19852.0,97399.60470052566,ADCY6
1197,KEGG_2019_Human,Retrograde endocannabinoid signaling,1/148,0.007399915061391,0.0093396383965821,0,0,19852.0,97399.60470052566,ADCY6
1198,KEGG_2019_Human,Oxytocin signaling pathway,1/153,0.0076499133771537,0.0093396383965821,0,0,19847.0,96715.6407630817,ADCY6
1199,KEGG_2019_Human,Cushing syndrome,1/155,0.0077499127120574,0.0093396383965821,0,0,19845.0,96448.16254952336,ADCY6
1200,KEGG_2019_Human,cGMP-PKG signaling pathway,1/166,0.0082999091363732,0.0097523932352386,0,0,19834.0,95034.82345515196,ADCY6
1201,KEGG_2019_Human,Chemokine signaling pathway,1/190,0.0094999017791995,0.0108901313078629,0,0,19810.0,92244.74636351672,ADCY6
1202,KEGG_2019_Human,Rap1 signaling pathway,1/206,0.010299897173561,0.0115260754085087,0,0,19794.0,90569.849337325,ADCY6
1203,KEGG_2019_Human,cAMP signaling pathway,1/212,0.0105998955026255,0.0115859322935675,0,0,19788.0,89974.27756224656,ADCY6
1204,KEGG_2019_Human,Human T-cell leukemia virus 1 infection,1/219,0.0109498935894162,0.0116964772432401,0,0,19781.0,89299.85161916987,ADCY6
1205,KEGG_2019_Human,Human cytomegalovirus infection,1/225,0.0112498919790339,0.011749887178102,0,0,19775.0,88738.27077557483,ADCY6
1206,KEGG_2019_Human,Thermogenesis,1/231,0.0115498903940656,0.0118009749678496,0,0,19769.0,88191.07730937863,ADCY6
1207,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,ADCY6
1208,KEGG_2019_Human,p53 signaling pathway,1/72,0.0035999456502131,0.0092999029651357,0,0,19928.0,112131.59838572376,IGFBP3
1209,KEGG_2019_Human,Cellular senescence,1/160,0.0079999110688441,0.0092999029651357,0,0,19840.0,95793.96509856998,IGFBP3
1210,KEGG_2019_Human,Transcriptional misregulation in cancer,1/186,0.0092999029651357,0.0092999029651357,0,0,19814.0,92684.96451050608,IGFBP3
1211,KEGG_2019_Human,mRNA surveillance pathway,1/91,0.0045499369072032,0.0082499094553477,0,0,19909.0,107362.10783923086,UPF3B
1212,KEGG_2019_Human,RNA transport,1/165,0.0082499094553477,0.0082499094553477,0,0,19835.0,95159.46482222488,UPF3B
1213,KEGG_2019_Human,Other types of O-glycan biosynthesis,1/22,0.0010999756574123,0.003299926972237,0,0,19978.0,136099.47030191717,LFNG
1214,KEGG_2019_Human,Notch signaling pathway,1/48,0.0023999583567988,0.0035999375351982,0,0,19952.0,120356.5272753826,LFNG
1215,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0164998674589645,0,0,19670.0,80733.60565076157,LFNG
1216,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0146998751759735,0,0,19706.0,83157.67014793828,ACVRL1
1217,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR52E2
1218,KEGG_2019_Human,Lysine degradation,1/59,0.0029499522555206,0.0029499522555206,0,0,19941.0,116175.59385530632,KMT5B
1219,KEGG_2019_Human,Hippo signaling pathway,1/160,0.0079999110688441,0.0127498618039235,0,0,19840.0,95793.96509856998,MPP5
1220,KEGG_2019_Human,Tight junction,1/170,0.0084999078692823,0.0127498618039235,0,0,19830.0,94543.49009679438,MPP5
1221,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0164998674589645,0,0,19670.0,80733.60565076157,MPP5
1222,KEGG_2019_Human,Carbohydrate digestion and absorption,1/44,0.0021999607179423,0.0107174211792485,0,0,19956.0,122117.06559109331,AKT2
1223,KEGG_2019_Human,Regulation of lipolysis in adipocytes,1/55,0.0027499544131125,0.0107174211792485,0,0,19945.0,117599.1294878737,AKT2
1224,KEGG_2019_Human,Endometrial cancer,1/58,0.0028999527887707,0.0107174211792485,0,0,19942.0,116522.31890946148,AKT2
1225,KEGG_2019_Human,VEGF signaling pathway,1/59,0.0029499522555206,0.0107174211792485,0,0,19941.0,116175.59385530632,AKT2
1226,KEGG_2019_Human,Central carbon metabolism in cancer,1/65,0.003249949134407,0.0107174211792485,0,0,19935.0,114209.92613860144,AKT2
1227,KEGG_2019_Human,Acute myeloid leukemia,1/66,0.003299948626608,0.0107174211792485,0,0,19934.0,113899.85357353876,AKT2
1228,KEGG_2019_Human,Non-small cell lung cancer,1/66,0.003299948626608,0.0107174211792485,0,0,19934.0,113899.85357353876,AKT2
1229,KEGG_2019_Human,Fc epsilon RI signaling pathway,1/68,0.0033999476216189,0.0107174211792485,0,0,19932.0,113293.39338050144,AKT2
1230,KEGG_2019_Human,Adipocytokine signaling pathway,1/69,0.003449947123837,0.0107174211792485,0,0,19931.0,112996.7391397682,AKT2
1231,KEGG_2019_Human,Renal cell carcinoma,1/69,0.003449947123837,0.0107174211792485,0,0,19931.0,112996.7391397682,AKT2
1232,KEGG_2019_Human,Prolactin signaling pathway,1/70,0.0034999466296654,0.0107174211792485,0,0,19930.0,112704.30065625212,AKT2
1233,KEGG_2019_Human,B cell receptor signaling pathway,1/71,0.0035499461386618,0.0107174211792485,0,0,19929.0,112415.9585341616,AKT2
1234,KEGG_2019_Human,Melanoma,1/72,0.0035999456502131,0.0107174211792485,0,0,19928.0,112131.59838572376,AKT2
1235,KEGG_2019_Human,Pancreatic cancer,1/75,0.0037499442041125,0.0107174211792485,0,0,19925.0,111301.33528642564,AKT2
1236,KEGG_2019_Human,Glioma,1/75,0.0037499442041125,0.0107174211792485,0,0,19925.0,111301.33528642564,AKT2
1237,KEGG_2019_Human,Chronic myeloid leukemia,1/76,0.0037999437281752,0.0107174211792485,0,0,19924.0,111031.8499691117,AKT2
1238,KEGG_2019_Human,ErbB signaling pathway,1/85,0.004249939567045,0.0107174211792485,0,0,19915.0,108752.83801948265,AKT2
1239,KEGG_2019_Human,Colorectal cancer,1/86,0.0042999391173866,0.0107174211792485,0,0,19914.0,108514.46102290176,AKT2
1240,KEGG_2019_Human,Fc gamma R-mediated phagocytosis,1/91,0.0045499369072032,0.0107174211792485,0,0,19909.0,107362.10783923086,AKT2
1241,KEGG_2019_Human,Small cell lung cancer,1/93,0.0046499360391879,0.0107174211792485,0,0,19907.0,106918.54242106884,AKT2
1242,KEGG_2019_Human,Prostate cancer,1/97,0.0048499343304706,0.0107174211792485,0,0,19903.0,106058.9096435903,AKT2
1243,KEGG_2019_Human,Choline metabolism in cancer,1/99,0.0049499334884068,0.0107174211792485,0,0,19901.0,105642.09305076736,AKT2
1244,KEGG_2019_Human,Progesterone-mediated oocyte maturation,1/99,0.0049499334884068,0.0107174211792485,0,0,19901.0,105642.09305076736,AKT2
1245,KEGG_2019_Human,AGE-RAGE signaling pathway in diabetic complications,1/100,0.0049999330710556,0.0107174211792485,0,0,19900.0,105436.78197328727,AKT2
1246,KEGG_2019_Human,HIF-1 signaling pathway,1/100,0.0049999330710556,0.0107174211792485,0,0,19900.0,105436.78197328727,AKT2
1247,KEGG_2019_Human,T cell receptor signaling pathway,1/101,0.0050499326546803,0.0107174211792485,0,0,19899.0,105233.48101229242,AKT2
1248,KEGG_2019_Human,Longevity regulating pathway,1/102,0.0050999322416682,0.0107174211792485,0,0,19898.0,105032.15064717118,AKT2
1249,KEGG_2019_Human,Chagas disease (American trypanosomiasis),1/103,0.0051499318302617,0.0107174211792485,0,0,19897.0,104832.7525292024,AKT2
1250,KEGG_2019_Human,Glucagon signaling pathway,1/103,0.0051499318302617,0.0107174211792485,0,0,19897.0,104832.7525292024,AKT2
1251,KEGG_2019_Human,Toll-like receptor signaling pathway,1/104,0.0051999314202997,0.0107174211792485,0,0,19896.0,104635.24941415618,AKT2
1252,KEGG_2019_Human,C-type lectin receptor signaling pathway,1/104,0.0051999314202997,0.0107174211792485,0,0,19896.0,104635.24941415618,AKT2
1253,KEGG_2019_Human,Insulin resistance,1/108,0.0053999298011749,0.0107174211792485,0,0,19892.0,103863.47861844616,AKT2
1254,KEGG_2019_Human,TNF signaling pathway,1/110,0.0054999290027479,0.0107174211792485,0,0,19890.0,103488.06969787036,AKT2
1255,KEGG_2019_Human,Cholinergic synapse,1/112,0.0055999282120529,0.0107174211792485,0,0,19888.0,103119.30984392198,AKT2
1256,KEGG_2019_Human,Toxoplasmosis,1/113,0.0056499278191151,0.0107174211792485,0,0,19887.0,102937.34947211576,AKT2
1257,KEGG_2019_Human,Thyroid hormone signaling pathway,1/116,0.0057999266512085,0.0107174211792485,0,0,19884.0,102400.8105961506,AKT2
1258,KEGG_2019_Human,Sphingolipid signaling pathway,1/119,0.0059499254985137,0.0107174211792485,0,0,19881.0,101877.73080211312,AKT2
1259,KEGG_2019_Human,Neurotrophin signaling pathway,1/119,0.0059499254985137,0.0107174211792485,0,0,19881.0,101877.73080211312,AKT2
1260,KEGG_2019_Human,AMPK signaling pathway,1/120,0.0059999251180858,0.0107174211792485,0,0,19880.0,101706.2448082016,AKT2
1261,KEGG_2019_Human,Platelet activation,1/124,0.0061999236097501,0.0107174211792485,0,0,19876.0,101034.04709010696,AKT2
1262,KEGG_2019_Human,Osteoclast differentiation,1/127,0.0063499224962247,0.0107174211792485,0,0,19873.0,100543.72072014232,AKT2
1263,KEGG_2019_Human,Autophagy,1/128,0.0063999221281459,0.0107174211792485,0,0,19872.0,100382.8010329652,AKT2
1264,KEGG_2019_Human,Relaxin signaling pathway,1/130,0.0064999213952527,0.0107174211792485,0,0,19870.0,100064.62842845908,AKT2
1265,KEGG_2019_Human,Dopaminergic synapse,1/131,0.0065499210316603,0.0107174211792485,0,0,19869.0,99907.33811343512,AKT2
1266,KEGG_2019_Human,FoxO signaling pathway,1/132,0.0065999206698993,0.0107174211792485,0,0,19868.0,99751.22090491928,AKT2
1267,KEGG_2019_Human,Insulin signaling pathway,1/137,0.0068499188797651,0.0107174211792485,0,0,19863.0,98987.62735269018,AKT2
1268,KEGG_2019_Human,Apelin signaling pathway,1/137,0.0068499188797651,0.0107174211792485,0,0,19863.0,98987.62735269018,AKT2
1269,KEGG_2019_Human,Estrogen signaling pathway,1/137,0.0068499188797651,0.0107174211792485,0,0,19863.0,98987.62735269018,AKT2
1270,KEGG_2019_Human,Measles,1/138,0.0068999185254481,0.0107174211792485,0,0,19862.0,98838.19160389496,AKT2
1271,KEGG_2019_Human,Fluid shear stress and atherosclerosis,1/139,0.006949918172816,0.0107174211792485,0,0,19861.0,98689.81333375497,AKT2
1272,KEGG_2019_Human,Signaling pathways regulating pluripotency of stem cells,1/139,0.006949918172816,0.0107174211792485,0,0,19861.0,98689.81333375497,AKT2
1273,KEGG_2019_Human,Apoptosis,1/143,0.0071499167770442,0.0107174211792485,0,0,19857.0,98106.57763600958,AKT2
1274,KEGG_2019_Human,Adrenergic signaling in cardiomyocytes,1/145,0.0072499160871101,0.0107174211792485,0,0,19855.0,97820.92670675044,AKT2
1275,KEGG_2019_Human,Breast cancer,1/147,0.0073499154017982,0.0107174211792485,0,0,19853.0,97539.10874372096,AKT2
1276,KEGG_2019_Human,Phospholipase D signaling pathway,1/148,0.007399915061391,0.0107174211792485,0,0,19852.0,97399.60470052566,AKT2
1277,KEGG_2019_Human,Non-alcoholic fatty liver disease (NAFLD),1/149,0.0074499147221605,0.0107174211792485,0,0,19851.0,97261.02051561224,AKT2
1278,KEGG_2019_Human,Gastric cancer,1/149,0.0074499147221605,0.0107174211792485,0,0,19851.0,97261.02051561224,AKT2
1279,KEGG_2019_Human,mTOR signaling pathway,1/152,0.0075999137114971,0.0107447055921166,0,0,19848.0,96850.665715497,AKT2
1280,KEGG_2019_Human,Hepatitis C,1/155,0.0077499127120574,0.0107623827670465,0,0,19845.0,96448.16254952336,AKT2
1281,KEGG_2019_Human,Cellular senescence,1/160,0.0079999110688441,0.0107623827670465,0,0,19840.0,95793.96509856998,AKT2
1282,KEGG_2019_Human,JAK-STAT signaling pathway,1/162,0.0080999104202618,0.0107623827670465,0,0,19838.0,95537.86936302872,AKT2
1283,KEGG_2019_Human,Hepatitis B,1/163,0.0081499100978668,0.0107623827670465,0,0,19837.0,95410.9786681514,AKT2
1284,KEGG_2019_Human,cGMP-PKG signaling pathway,1/166,0.0082999091363732,0.0107623827670465,0,0,19834.0,95034.82345515196,AKT2
1285,KEGG_2019_Human,Hepatocellular carcinoma,1/168,0.0083999085011095,0.0107623827670465,0,0,19832.0,94787.72752807094,AKT2
1286,KEGG_2019_Human,Influenza A,1/171,0.0085499075557634,0.0107860372241938,0,0,19829.0,94422.42241345016,AKT2
1287,KEGG_2019_Human,Tuberculosis,1/179,0.0089499050800561,0.0111195790388576,0,0,19821.0,93478.0629355712,AKT2
1288,KEGG_2019_Human,Kaposi sarcoma-associated herpesvirus infection,1/186,0.0092999029651357,0.0113819707931512,0,0,19814.0,92684.96451050608,AKT2
1289,KEGG_2019_Human,Chemokine signaling pathway,1/190,0.0094999017791995,0.0114557639102112,0,0,19810.0,92244.74636351672,AKT2
1290,KEGG_2019_Human,Focal adhesion,1/199,0.0099498991610159,0.0116069251295706,0,0,19801.0,91286.4288690606,AKT2
1291,KEGG_2019_Human,Epstein-Barr virus infection,1/201,0.0100498985877989,0.0116069251295706,0,0,19799.0,91079.21596609056,AKT2
1292,KEGG_2019_Human,Proteoglycans in cancer,1/201,0.0100498985877989,0.0116069251295706,0,0,19799.0,91079.21596609056,AKT2
1293,KEGG_2019_Human,Rap1 signaling pathway,1/206,0.010299897173561,0.0117304384476667,0,0,19794.0,90569.849337325,AKT2
1294,KEGG_2019_Human,Human immunodeficiency virus 1 infection,1/212,0.0105998955026255,0.011745830151558,0,0,19788.0,89974.27756224656,AKT2
1295,KEGG_2019_Human,cAMP signaling pathway,1/212,0.0105998955026255,0.011745830151558,0,0,19788.0,89974.27756224656,AKT2
1296,KEGG_2019_Human,Human T-cell leukemia virus 1 infection,1/219,0.0109498935894162,0.0119718836577617,0,0,19781.0,89299.85161916987,AKT2
1297,KEGG_2019_Human,Human cytomegalovirus infection,1/225,0.0112498919790339,0.0121380413457997,0,0,19775.0,88738.27077557483,AKT2
1298,KEGG_2019_Human,Ras signaling pathway,1/232,0.0115998901349604,0.0123531297541136,0,0,19768.0,88101.22480150245,AKT2
1299,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0155062787974276,0,0,19705.0,83086.53988020132,AKT2
1300,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0171264447042416,0,0,19670.0,80733.60565076157,AKT2
1301,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.018142359207401,0,0,19646.0,79255.8617626126,AKT2
1302,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0249035406954225,0,0,19508.0,72277.44006442746,AKT2
1303,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,AKT2
1304,KEGG_2019_Human,Insulin secretion,1/86,0.0042999391173866,0.0082999091363732,0,0,19914.0,108514.46102290176,KCNMB3
1305,KEGG_2019_Human,Vascular smooth muscle contraction,1/132,0.0065999206698993,0.0082999091363732,0,0,19868.0,99751.22090491928,KCNMB3
1306,KEGG_2019_Human,cGMP-PKG signaling pathway,1/166,0.0082999091363732,0.0082999091363732,0,0,19834.0,95034.82345515196,KCNMB3
1307,KEGG_2019_Human,Pentose phosphate pathway,1/30,0.0014999697593334,0.0014999697593334,0,0,19970.0,129851.13732048514,RBKS
1308,KEGG_2019_Human,Long-term potentiation,1/67,0.0033499481224912,0.0112348896989771,0,0,19933.0,113594.38808369274,PPP1CA
1309,KEGG_2019_Human,Amphetamine addiction,1/68,0.0033999476216189,0.0112348896989771,0,0,19932.0,113293.39338050144,PPP1CA
1310,KEGG_2019_Human,mRNA surveillance pathway,1/91,0.0045499369072032,0.0112348896989771,0,0,19909.0,107362.10783923086,PPP1CA
1311,KEGG_2019_Human,Inflammatory mediator regulation of TRP channels,1/100,0.0049999330710556,0.0112348896989771,0,0,19900.0,105436.78197328727,PPP1CA
1312,KEGG_2019_Human,Insulin resistance,1/108,0.0053999298011749,0.0112348896989771,0,0,19892.0,103863.47861844616,PPP1CA
1313,KEGG_2019_Human,Platelet activation,1/124,0.0061999236097501,0.0112348896989771,0,0,19876.0,101034.04709010696,PPP1CA
1314,KEGG_2019_Human,Oocyte meiosis,1/125,0.0062499232373748,0.0112348896989771,0,0,19875.0,100869.32368441945,PPP1CA
1315,KEGG_2019_Human,Dopaminergic synapse,1/131,0.0065499210316603,0.0112348896989771,0,0,19869.0,99907.33811343512,PPP1CA
1316,KEGG_2019_Human,Vascular smooth muscle contraction,1/132,0.0065999206698993,0.0112348896989771,0,0,19868.0,99751.22090491928,PPP1CA
1317,KEGG_2019_Human,Insulin signaling pathway,1/137,0.0068499188797651,0.0112348896989771,0,0,19863.0,98987.62735269018,PPP1CA
1318,KEGG_2019_Human,Adrenergic signaling in cardiomyocytes,1/145,0.0072499160871101,0.0112348896989771,0,0,19855.0,97820.92670675044,PPP1CA
1319,KEGG_2019_Human,Oxytocin signaling pathway,1/153,0.0076499133771537,0.0112348896989771,0,0,19847.0,96715.6407630817,PPP1CA
1320,KEGG_2019_Human,Cellular senescence,1/160,0.0079999110688441,0.0112348896989771,0,0,19840.0,95793.96509856998,PPP1CA
1321,KEGG_2019_Human,Hippo signaling pathway,1/160,0.0079999110688441,0.0112348896989771,0,0,19840.0,95793.96509856998,PPP1CA
1322,KEGG_2019_Human,cGMP-PKG signaling pathway,1/166,0.0082999091363732,0.0112348896989771,0,0,19834.0,95034.82345515196,PPP1CA
1323,KEGG_2019_Human,Alcoholism,1/180,0.0089999047745351,0.0112348896989771,0,0,19820.0,93362.92821536642,PPP1CA
1324,KEGG_2019_Human,Focal adhesion,1/199,0.0099498991610159,0.0112348896989771,0,0,19801.0,91286.4288690606,PPP1CA
1325,KEGG_2019_Human,Proteoglycans in cancer,1/201,0.0100498985877989,0.0112348896989771,0,0,19799.0,91079.21596609056,PPP1CA
1326,KEGG_2019_Human,cAMP signaling pathway,1/212,0.0105998955026255,0.0112348896989771,0,0,19788.0,89974.27756224656,PPP1CA
1327,KEGG_2019_Human,Regulation of actin cytoskeleton,1/214,0.0106998949514067,0.0112348896989771,0,0,19786.0,89779.39753374986,PPP1CA
1328,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,PPP1CA
1329,KEGG_2019_Human,Hippo signaling pathway,1/160,0.0079999110688441,0.0079999110688441,0,0,19840.0,95793.96509856998,CRB2
1330,KEGG_2019_Human,Hippo signaling pathway,1/160,0.0079999110688441,0.0079999110688441,0,0,19840.0,95793.96509856998,MOB1B
1331,KEGG_2019_Human,Non-small cell lung cancer,1/66,0.003299948626608,0.006599897253216,0,0,19934.0,113899.85357353876,ALK
1332,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,ALK
1333,KEGG_2019_Human,N-Glycan biosynthesis,1/50,0.0024999572069037,0.0024999572069037,0,0,19950.0,119530.05920663515,MGAT3
1334,KEGG_2019_Human,Insulin resistance,1/108,0.0053999298011749,0.0053999298011749,0,0,19892.0,103863.47861844616,OGA
1335,KEGG_2019_Human,Cellular senescence,1/160,0.0079999110688441,0.0079999110688441,0,0,19840.0,95793.96509856998,ZFP36L1
1336,KEGG_2019_Human,Neurotrophin signaling pathway,1/119,0.0059499254985137,0.0068499188797651,0,0,19881.0,101877.73080211312,SH2B2
1337,KEGG_2019_Human,Insulin signaling pathway,1/137,0.0068499188797651,0.0068499188797651,0,0,19863.0,98987.62735269018,SH2B2
1338,KEGG_2019_Human,Retinol metabolism,1/67,0.0033499481224912,0.0033499481224912,0,0,19933.0,113594.38808369274,RDH8
1339,KEGG_2019_Human,Malaria,1/49,0.0024499577795033,0.0095998695077413,0,0,19951.0,119939.1172087114,ITGB2
1340,KEGG_2019_Human,Legionellosis,1/55,0.0027499544131125,0.0095998695077413,0,0,19945.0,117599.1294878737,ITGB2
1341,KEGG_2019_Human,Viral myocarditis,1/59,0.0029499522555206,0.0095998695077413,0,0,19941.0,116175.59385530632,ITGB2
1342,KEGG_2019_Human,Staphylococcus aureus infection,1/68,0.0033999476216189,0.0095998695077413,0,0,19932.0,113293.39338050144,ITGB2
1343,KEGG_2019_Human,Leishmaniasis,1/74,0.0036999446830449,0.0095998695077413,0,0,19926.0,111574.38983110404,ITGB2
1344,KEGG_2019_Human,Pertussis,1/76,0.0037999437281752,0.0095998695077413,0,0,19924.0,111031.8499691117,ITGB2
1345,KEGG_2019_Human,Complement and coagulation cascades,1/79,0.0039499423167337,0.0095998695077413,0,0,19921.0,110243.89578070649,ITGB2
1346,KEGG_2019_Human,Rheumatoid arthritis,1/91,0.0045499369072032,0.0095998695077413,0,0,19909.0,107362.10783923086,ITGB2
1347,KEGG_2019_Human,Amoebiasis,1/96,0.0047999347538706,0.0095998695077413,0,0,19904.0,106270.50039849174,ITGB2
1348,KEGG_2019_Human,Leukocyte transendothelial migration,1/112,0.0055999282120529,0.0100798707816953,0,0,19888.0,103119.30984392198,ITGB2
1349,KEGG_2019_Human,Natural killer cell mediated cytotoxicity,1/131,0.0065499210316603,0.0102855999456567,0,0,19869.0,99907.33811343512,ITGB2
1350,KEGG_2019_Human,Cell adhesion molecules (CAMs),1/145,0.0072499160871101,0.0102855999456567,0,0,19855.0,97820.92670675044,ITGB2
1351,KEGG_2019_Human,Phagosome,1/152,0.0075999137114971,0.0102855999456567,0,0,19848.0,96850.665715497,ITGB2
1352,KEGG_2019_Human,Hippo signaling pathway,1/160,0.0079999110688441,0.0102855999456567,0,0,19840.0,95793.96509856998,ITGB2
1353,KEGG_2019_Human,Tuberculosis,1/179,0.0089499050800561,0.0107398860960673,0,0,19821.0,93478.0629355712,ITGB2
1354,KEGG_2019_Human,Rap1 signaling pathway,1/206,0.010299897173561,0.0109498935894162,0,0,19794.0,90569.849337325,ITGB2
1355,KEGG_2019_Human,Regulation of actin cytoskeleton,1/214,0.0106998949514067,0.0109498935894162,0,0,19786.0,89779.39753374986,ITGB2
1356,KEGG_2019_Human,Human T-cell leukemia virus 1 infection,1/219,0.0109498935894162,0.0109498935894162,0,0,19781.0,89299.85161916987,ITGB2
1357,KEGG_2019_Human,B cell receptor signaling pathway,1/71,0.0035499461386618,0.0070998922773237,0,0,19929.0,112415.9585341616,PIK3AP1
1358,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0176998626413668,0,0,19646.0,79255.8617626126,PIK3AP1
1359,KEGG_2019_Human,Amino sugar and nucleotide sugar metabolism,1/48,0.0023999583567988,0.0023999583567988,0,0,19952.0,120356.5272753826,UXS1
1360,KEGG_2019_Human,Fanconi anemia pathway,1/54,0.0026999549628563,0.0026999549628563,0,0,19946.0,117971.01964061816,REV1
1361,KEGG_2019_Human,Notch signaling pathway,1/48,0.0023999583567988,0.0095998334271952,0,0,19952.0,120356.5272753826,SNW1
1362,KEGG_2019_Human,Spliceosome,1/134,0.0066999199497742,0.0100498985877989,0,0,19866.0,99442.43560916925,SNW1
1363,KEGG_2019_Human,Epstein-Barr virus infection,1/201,0.0100498985877989,0.0100498985877989,0,0,19799.0,91079.21596609056,SNW1
1364,KEGG_2019_Human,Viral carcinogenesis,1/201,0.0100498985877989,0.0100498985877989,0,0,19799.0,91079.21596609056,SNW1
1365,KEGG_2019_Human,Phagosome,1/152,0.0075999137114971,0.0075999137114971,0,0,19848.0,96850.665715497,MSR1
1366,KEGG_2019_Human,Inositol phosphate metabolism,1/74,0.0036999446830449,0.0049499334884068,0,0,19926.0,111574.38983110404,SYNJ2
1367,KEGG_2019_Human,Phosphatidylinositol signaling system,1/99,0.0049499334884068,0.0049499334884068,0,0,19901.0,105642.09305076736,SYNJ2
1368,KEGG_2019_Human,GABAergic synapse,1/89,0.0044499377838098,0.0137748695352654,0,0,19911.0,107815.380281759,GNG7
1369,KEGG_2019_Human,Morphine addiction,1/91,0.0045499369072032,0.0137748695352654,0,0,19909.0,107362.10783923086,GNG7
1370,KEGG_2019_Human,Circadian entrainment,1/97,0.0048499343304706,0.0137748695352654,0,0,19903.0,106058.9096435903,GNG7
1371,KEGG_2019_Human,Cholinergic synapse,1/112,0.0055999282120529,0.0137748695352654,0,0,19888.0,103119.30984392198,GNG7
1372,KEGG_2019_Human,Serotonergic synapse,1/113,0.0056499278191151,0.0137748695352654,0,0,19887.0,102937.34947211576,GNG7
1373,KEGG_2019_Human,Glutamatergic synapse,1/114,0.005699927427839,0.0137748695352654,0,0,19886.0,102756.96431429044,GNG7
1374,KEGG_2019_Human,Relaxin signaling pathway,1/130,0.0064999213952527,0.0137748695352654,0,0,19870.0,100064.62842845908,GNG7
1375,KEGG_2019_Human,Dopaminergic synapse,1/131,0.0065499210316603,0.0137748695352654,0,0,19869.0,99907.33811343512,GNG7
1376,KEGG_2019_Human,Apelin signaling pathway,1/137,0.0068499188797651,0.0137748695352654,0,0,19863.0,98987.62735269018,GNG7
1377,KEGG_2019_Human,Retrograde endocannabinoid signaling,1/148,0.007399915061391,0.0137748695352654,0,0,19852.0,97399.60470052566,GNG7
1378,KEGG_2019_Human,Alcoholism,1/180,0.0089999047745351,0.0137748695352654,0,0,19820.0,93362.92821536642,GNG7
1379,KEGG_2019_Human,Kaposi sarcoma-associated herpesvirus infection,1/186,0.0092999029651357,0.0137748695352654,0,0,19814.0,92684.96451050608,GNG7
1380,KEGG_2019_Human,Chemokine signaling pathway,1/190,0.0094999017791995,0.0137748695352654,0,0,19810.0,92244.74636351672,GNG7
1381,KEGG_2019_Human,Human immunodeficiency virus 1 infection,1/212,0.0105998955026255,0.0137748695352654,0,0,19788.0,89974.27756224656,GNG7
1382,KEGG_2019_Human,Human cytomegalovirus infection,1/225,0.0112498919790339,0.0137748695352654,0,0,19775.0,88738.27077557483,GNG7
1383,KEGG_2019_Human,Ras signaling pathway,1/232,0.0115998901349604,0.0137748695352654,0,0,19768.0,88101.22480150245,GNG7
1384,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0197821994227041,0,0,19646.0,79255.8617626126,GNG7
1385,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0234331713317091,0,0,19556.0,74462.79263140135,GNG7
1386,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,GNG7
1387,KEGG_2019_Human,Pyrimidine metabolism,1/57,0.002849953326298,0.0053999298011749,0,0,19943.0,116875.00742975442,TK1
1388,KEGG_2019_Human,Drug metabolism,1/108,0.0053999298011749,0.0053999298011749,0,0,19892.0,103863.47861844616,TK1
1389,KEGG_2019_Human,Cholesterol metabolism,1/50,0.0024999572069037,0.0030499512001654,0,0,19950.0,119530.05920663515,LIPC
1390,KEGG_2019_Human,Glycerolipid metabolism,1/61,0.0030499512001654,0.0030499512001654,0,0,19939.0,115499.24335773686,LIPC
1391,KEGG_2019_Human,Ubiquitin mediated proteolysis,1/137,0.0068499188797651,0.0068499188797651,0,0,19863.0,98987.62735269018,KLHL13
1392,KEGG_2019_Human,Epithelial cell signaling in Helicobacter pylori infection,1/68,0.0033999476216189,0.0115831969546933,0,0,19932.0,113293.39338050144,MAP2K4
1393,KEGG_2019_Human,Fc epsilon RI signaling pathway,1/68,0.0033999476216189,0.0115831969546933,0,0,19932.0,113293.39338050144,MAP2K4
1394,KEGG_2019_Human,ErbB signaling pathway,1/85,0.004249939567045,0.0115831969546933,0,0,19915.0,108752.83801948265,MAP2K4
1395,KEGG_2019_Human,GnRH signaling pathway,1/93,0.0046499360391879,0.0115831969546933,0,0,19907.0,106918.54242106884,MAP2K4
1396,KEGG_2019_Human,Chagas disease (American trypanosomiasis),1/103,0.0051499318302617,0.0115831969546933,0,0,19897.0,104832.7525292024,MAP2K4
1397,KEGG_2019_Human,Toll-like receptor signaling pathway,1/104,0.0051999314202997,0.0115831969546933,0,0,19896.0,104635.24941415618,MAP2K4
1398,KEGG_2019_Human,TNF signaling pathway,1/110,0.0054999290027479,0.0115831969546933,0,0,19890.0,103488.06969787036,MAP2K4
1399,KEGG_2019_Human,Relaxin signaling pathway,1/130,0.0064999213952527,0.0115831969546933,0,0,19870.0,100064.62842845908,MAP2K4
1400,KEGG_2019_Human,Fluid shear stress and atherosclerosis,1/139,0.006949918172816,0.0115831969546933,0,0,19861.0,98689.81333375497,MAP2K4
1401,KEGG_2019_Human,Hepatitis B,1/163,0.0081499100978668,0.0115960368320757,0,0,19837.0,95410.9786681514,MAP2K4
1402,KEGG_2019_Human,Influenza A,1/171,0.0085499075557634,0.0115960368320757,0,0,19829.0,94422.42241345016,MAP2K4
1403,KEGG_2019_Human,Kaposi sarcoma-associated herpesvirus infection,1/186,0.0092999029651357,0.0115960368320757,0,0,19814.0,92684.96451050608,MAP2K4
1404,KEGG_2019_Human,Epstein-Barr virus infection,1/201,0.0100498985877989,0.0115960368320757,0,0,19799.0,91079.21596609056,MAP2K4
1405,KEGG_2019_Human,Human T-cell leukemia virus 1 infection,1/219,0.0109498935894162,0.0117320288458031,0,0,19781.0,89299.85161916987,MAP2K4
1406,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0147498749536506,0,0,19705.0,83086.53988020132,MAP2K4
1407,KEGG_2019_Human,Protein processing in endoplasmic reticulum,1/165,0.0082499094553477,0.0082499094553477,0,0,19835.0,95159.46482222488,UGGT2
1408,KEGG_2019_Human,Basal cell carcinoma,1/63,0.0031499501598827,0.0109198810514423,0,0,19937.0,114844.46974572667,FZD5
1409,KEGG_2019_Human,Melanogenesis,1/101,0.0050499326546803,0.0109198810514423,0,0,19899.0,105233.48101229242,FZD5
1410,KEGG_2019_Human,Signaling pathways regulating pluripotency of stem cells,1/139,0.006949918172816,0.0109198810514423,0,0,19861.0,98689.81333375497,FZD5
1411,KEGG_2019_Human,Breast cancer,1/147,0.0073499154017982,0.0109198810514423,0,0,19853.0,97539.10874372096,FZD5
1412,KEGG_2019_Human,Gastric cancer,1/149,0.0074499147221605,0.0109198810514423,0,0,19851.0,97261.02051561224,FZD5
1413,KEGG_2019_Human,mTOR signaling pathway,1/152,0.0075999137114971,0.0109198810514423,0,0,19848.0,96850.665715497,FZD5
1414,KEGG_2019_Human,Cushing syndrome,1/155,0.0077499127120574,0.0109198810514423,0,0,19845.0,96448.16254952336,FZD5
1415,KEGG_2019_Human,Wnt signaling pathway,1/158,0.0078999117225733,0.0109198810514423,0,0,19842.0,96053.2110949472,FZD5
1416,KEGG_2019_Human,Hippo signaling pathway,1/160,0.0079999110688441,0.0109198810514423,0,0,19840.0,95793.96509856998,FZD5
1417,KEGG_2019_Human,Hepatocellular carcinoma,1/168,0.0083999085011095,0.0109198810514423,0,0,19832.0,94787.72752807094,FZD5
1418,KEGG_2019_Human,Proteoglycans in cancer,1/201,0.0100498985877989,0.0118771528764897,0,0,19799.0,91079.21596609056,FZD5
1419,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0178748564138782,0,0,19670.0,80733.60565076157,FZD5
1420,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,FZD5
1421,KEGG_2019_Human,Mucin type O-glycan biosynthesis,1/31,0.0015499690656704,0.0015499690656704,0,0,19969.0,129189.85098816035,GALNT9
1422,KEGG_2019_Human,Maturity onset diabetes of the young,1/26,0.0012999726251831,0.0062998949133314,0,0,19974.0,132735.46073187632,HES1
1423,KEGG_2019_Human,Notch signaling pathway,1/48,0.0023999583567988,0.0062998949133314,0,0,19952.0,120356.5272753826,HES1
1424,KEGG_2019_Human,Fanconi anemia pathway,1/54,0.0026999549628563,0.0062998949133314,0,0,19946.0,117971.01964061816,HES1
1425,KEGG_2019_Human,Breast cancer,1/147,0.0073499154017982,0.0128623519531469,0,0,19853.0,97539.10874372096,HES1
1426,KEGG_2019_Human,Epstein-Barr virus infection,1/201,0.0100498985877989,0.0140698580229185,0,0,19799.0,91079.21596609056,HES1
1427,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0192498453687919,0,0,19670.0,80733.60565076157,HES1
1428,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,HES1
1429,KEGG_2019_Human,Tight junction,1/170,0.0084999078692823,0.0084999078692823,0,0,19830.0,94543.49009679438,MYH8
1430,KEGG_2019_Human,Vitamin B6 metabolism,1/6,0.0002999905873105514,0.0002999905873105514,0,0,19994.0,162186.51863187927,PNPO
1431,KEGG_2019_Human,Synaptic vesicle cycle,1/78,0.0038999427840466,0.0038999427840466,0,0,19922.0,110503.2180492851,UNC13C
1432,KEGG_2019_Human,Glycerolipid metabolism,1/61,0.0030499512001654,0.0061874168605085,0,0,19939.0,115499.24335773686,DGKB
1433,KEGG_2019_Human,Glycerophospholipid metabolism,1/97,0.0048499343304706,0.0061874168605085,0,0,19903.0,106058.9096435903,DGKB
1434,KEGG_2019_Human,Phosphatidylinositol signaling system,1/99,0.0049499334884068,0.0061874168605085,0,0,19901.0,105642.09305076736,DGKB
1435,KEGG_2019_Human,Choline metabolism in cancer,1/99,0.0049499334884068,0.0061874168605085,0,0,19901.0,105642.09305076736,DGKB
1436,KEGG_2019_Human,Phospholipase D signaling pathway,1/148,0.007399915061391,0.007399915061391,0,0,19852.0,97399.60470052566,DGKB
1437,KEGG_2019_Human,Axon guidance,1/181,0.0090499044707863,0.0090499044707863,0,0,19819.0,93248.41634586031,PLXNA2
1438,KEGG_2019_Human,Basal transcription factors,1/45,0.0022499601197094,0.0022499601197094,0,0,19955.0,121662.49782449217,TAF6L
1439,KEGG_2019_Human,Fanconi anemia pathway,1/54,0.0026999549628563,0.0026999549628563,0,0,19946.0,117971.01964061816,POLN
1440,KEGG_2019_Human,p53 signaling pathway,1/72,0.0035999456502131,0.0035999456502131,0,0,19928.0,112131.59838572376,CD82
1441,KEGG_2019_Human,Mismatch repair,1/23,0.0011499748819949,0.0023499589392381,0,0,19977.0,135204.63922267244,POLD2
1442,KEGG_2019_Human,Base excision repair,1/33,0.0016499677032113,0.0023499589392381,0,0,19967.0,127928.56031580272,POLD2
1443,KEGG_2019_Human,DNA replication,1/36,0.0017999657178272,0.0023499589392381,0,0,19964.0,126172.23364250171,POLD2
1444,KEGG_2019_Human,Homologous recombination,1/41,0.0020499625466866,0.0023499589392381,0,0,19959.0,123544.88783416104,POLD2
1445,KEGG_2019_Human,Nucleotide excision repair,1/47,0.0023499589392381,0.0023499589392381,0,0,19953.0,120782.64067395544,POLD2
1446,KEGG_2019_Human,Endocytosis,1/244,0.0121998870519305,0.0121998870519305,0,0,19756.0,87051.4275316661,RAB11FIP5
1447,KEGG_2019_Human,Nicotine addiction,1/40,0.0019999631680592,0.0079332111171108,0,0,19960.0,124043.94523066044,GRIN3B
1448,KEGG_2019_Human,Cocaine addiction,1/49,0.0024499577795033,0.0079332111171108,0,0,19951.0,119939.1172087114,GRIN3B
1449,KEGG_2019_Human,Amphetamine addiction,1/68,0.0033999476216189,0.0079332111171108,0,0,19932.0,113293.39338050144,GRIN3B
1450,KEGG_2019_Human,Glutamatergic synapse,1/114,0.005699927427839,0.0099748729987182,0,0,19886.0,102756.96431429044,GRIN3B
1451,KEGG_2019_Human,Alcoholism,1/180,0.0089999047745351,0.0123665447530631,0,0,19820.0,93362.92821536642,GRIN3B
1452,KEGG_2019_Human,cAMP signaling pathway,1/212,0.0105998955026255,0.0123665447530631,0,0,19788.0,89974.27756224656,GRIN3B
1453,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,GRIN3B
1454,KEGG_2019_Human,alpha-Linolenic acid metabolism,1/25,0.0012499733663791,0.0020249578413544,0,0,19975.0,133525.54486996148,FADS2
1455,KEGG_2019_Human,Biosynthesis of unsaturated fatty acids,1/27,0.0013499718942362,0.0020249578413544,0,0,19973.0,131975.02298599784,FADS2
1456,KEGG_2019_Human,PPAR signaling pathway,1/74,0.0036999446830449,0.0036999446830449,0,0,19926.0,111574.38983110404,FADS2
1457,KEGG_2019_Human,Phototransduction,1/28,0.0013999711732997,0.0027999423465995,0,0,19972.0,131242.0761597353,GUCY2F
1458,KEGG_2019_Human,Purine metabolism,1/129,0.006449921761047,0.006449921761047,0,0,19871.0,100223.109907462,GUCY2F
1459,KEGG_2019_Human,Sphingolipid metabolism,1/47,0.0023499589392381,0.0023499589392381,0,0,19953.0,120782.64067395544,UGCG
1460,KEGG_2019_Human,Autoimmune thyroid disease,1/53,0.0026499555173137,0.0145586837375733,0,0,19947.0,118349.78824235698,IFNA5
1461,KEGG_2019_Human,Cytosolic DNA-sensing pathway,1/63,0.0031499501598827,0.0145586837375733,0,0,19937.0,114844.46974572667,IFNA5
1462,KEGG_2019_Human,RIG-I-like receptor signaling pathway,1/70,0.0034999466296654,0.0145586837375733,0,0,19930.0,112704.30065625212,IFNA5
1463,KEGG_2019_Human,Toll-like receptor signaling pathway,1/104,0.0051999314202997,0.0145586837375733,0,0,19896.0,104635.24941415618,IFNA5
1464,KEGG_2019_Human,Natural killer cell mediated cytotoxicity,1/131,0.0065499210316603,0.0145586837375733,0,0,19869.0,99907.33811343512,IFNA5
1465,KEGG_2019_Human,Measles,1/138,0.0068999185254481,0.0145586837375733,0,0,19862.0,98838.19160389496,IFNA5
1466,KEGG_2019_Human,Hepatitis C,1/155,0.0077499127120574,0.0145586837375733,0,0,19845.0,96448.16254952336,IFNA5
1467,KEGG_2019_Human,Necroptosis,1/162,0.0080999104202618,0.0145586837375733,0,0,19838.0,95537.86936302872,IFNA5
1468,KEGG_2019_Human,JAK-STAT signaling pathway,1/162,0.0080999104202618,0.0145586837375733,0,0,19838.0,95537.86936302872,IFNA5
1469,KEGG_2019_Human,Hepatitis B,1/163,0.0081499100978668,0.0145586837375733,0,0,19837.0,95410.9786681514,IFNA5
1470,KEGG_2019_Human,Influenza A,1/171,0.0085499075557634,0.0145586837375733,0,0,19829.0,94422.42241345016,IFNA5
1471,KEGG_2019_Human,NOD-like receptor signaling pathway,1/178,0.0088999053857096,0.0145586837375733,0,0,19822.0,93593.82745769851,IFNA5
1472,KEGG_2019_Human,Tuberculosis,1/179,0.0089499050800561,0.0145586837375733,0,0,19821.0,93478.0629355712,IFNA5
1473,KEGG_2019_Human,Kaposi sarcoma-associated herpesvirus infection,1/186,0.0092999029651357,0.0145586837375733,0,0,19814.0,92684.96451050608,IFNA5
1474,KEGG_2019_Human,Epstein-Barr virus infection,1/201,0.0100498985877989,0.0145586837375733,0,0,19799.0,91079.21596609056,IFNA5
1475,KEGG_2019_Human,Human immunodeficiency virus 1 infection,1/212,0.0105998955026255,0.0145586837375733,0,0,19788.0,89974.27756224656,IFNA5
1476,KEGG_2019_Human,Human cytomegalovirus infection,1/225,0.0112498919790339,0.0145586837375733,0,0,19775.0,88738.27077557483,IFNA5
1477,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0179665141039676,0,0,19706.0,83157.67014793828,IFNA5
1478,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0191051096893273,0,0,19670.0,80733.60565076157,IFNA5
1479,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0194698489055035,0,0,19646.0,79255.8617626126,IFNA5
1480,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0257712598834163,0,0,19508.0,72277.44006442746,IFNA5
1481,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,IFNA5
1482,KEGG_2019_Human,Ubiquitin mediated proteolysis,1/137,0.0068499188797651,0.0068499188797651,0,0,19863.0,98987.62735269018,HERC1
1483,KEGG_2019_Human,RNA degradation,1/79,0.0039499423167337,0.0039499423167337,0,0,19921.0,110243.89578070649,TTC37
1484,KEGG_2019_Human,Autophagy,1/128,0.0063999221281459,0.0063999221281459,0,0,19872.0,100382.8010329652,SUPT20H
1485,KEGG_2019_Human,Renin-angiotensin system,1/23,0.0011499748819949,0.0011499748819949,0,0,19977.0,135204.63922267244,PREP
1486,KEGG_2019_Human,Pentose phosphate pathway,1/30,0.0014999697593334,0.0014999697593334,0,0,19970.0,129851.13732048514,TKT
1487,KEGG_2019_Human,Axon guidance,1/181,0.0090499044707863,0.0090499044707863,0,0,19819.0,93248.41634586031,EPHB2
1488,KEGG_2019_Human,Fat digestion and absorption,1/41,0.0020499625466866,0.0030499512001654,0,0,19959.0,123544.88783416104,MOGAT2
1489,KEGG_2019_Human,Glycerolipid metabolism,1/61,0.0030499512001654,0.0030499512001654,0,0,19939.0,115499.24335773686,MOGAT2
1490,KEGG_2019_Human,Progesterone-mediated oocyte maturation,1/99,0.0049499334884068,0.0085623985997064,0,0,19901.0,105642.09305076736,ANAPC1
1491,KEGG_2019_Human,Cell cycle,1/124,0.0061999236097501,0.0085623985997064,0,0,19876.0,101034.04709010696,ANAPC1
1492,KEGG_2019_Human,Oocyte meiosis,1/125,0.0062499232373748,0.0085623985997064,0,0,19875.0,100869.32368441945,ANAPC1
1493,KEGG_2019_Human,Ubiquitin mediated proteolysis,1/137,0.0068499188797651,0.0085623985997064,0,0,19863.0,98987.62735269018,ANAPC1
1494,KEGG_2019_Human,Human T-cell leukemia virus 1 infection,1/219,0.0109498935894162,0.0109498935894162,0,0,19781.0,89299.85161916987,ANAPC1
1495,KEGG_2019_Human,Lysosome,1/123,0.0061499239842961,0.0121998870519305,0,0,19877.0,101200.07933676826,IGF2R
1496,KEGG_2019_Human,Endocytosis,1/244,0.0121998870519305,0.0121998870519305,0,0,19756.0,87051.4275316661,IGF2R
1497,KEGG_2019_Human,Cortisol synthesis and secretion,1/65,0.003249949134407,0.0097998678162159,0,0,19935.0,114209.92613860144,CACNA1H
1498,KEGG_2019_Human,Circadian entrainment,1/97,0.0048499343304706,0.0097998678162159,0,0,19903.0,106058.9096435903,CACNA1H
1499,KEGG_2019_Human,Aldosterone synthesis and secretion,1/98,0.0048999339081079,0.0097998678162159,0,0,19902.0,105849.45495286948,CACNA1H
1500,KEGG_2019_Human,Cushing syndrome,1/155,0.0077499127120574,0.011279882844162,0,0,19845.0,96448.16254952336,CACNA1H
1501,KEGG_2019_Human,Calcium signaling pathway,1/188,0.009399902370135,0.011279882844162,0,0,19812.0,92463.712994847,CACNA1H
1502,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0147498749536506,0,0,19705.0,83086.53988020132,CACNA1H
1503,KEGG_2019_Human,Lysine degradation,1/59,0.0029499522555206,0.0029499522555206,0,0,19941.0,116175.59385530632,KMT2B
1504,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF157
1505,KEGG_2019_Human,Spliceosome,1/134,0.0066999199497742,0.0066999199497742,0,0,19866.0,99442.43560916925,DHX38
1506,KEGG_2019_Human,Arrhythmogenic right ventricular cardiomyopathy (ARVC),1/72,0.0035999456502131,0.0035999456502131,0,0,19928.0,112131.59838572376,ACTN3
1507,KEGG_2019_Human,Glutathione metabolism,1/56,0.0027999538675741,0.0027999538675741,0,0,19944.0,117233.87022514464,OPLAH
1508,KEGG_2019_Human,ECM-receptor interaction,1/82,0.004099940929819,0.016399763719276,0,0,19918.0,109484.9180722932,RELN
1509,KEGG_2019_Human,Focal adhesion,1/199,0.0099498991610159,0.0176998626413668,0,0,19801.0,91286.4288690606,RELN
1510,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0176998626413668,0,0,19670.0,80733.60565076157,RELN
1511,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0176998626413668,0,0,19646.0,79255.8617626126,RELN
1512,KEGG_2019_Human,Salivary secretion,1/90,0.0044999373439762,0.0109665527651575,0,0,19910.0,107587.50385474482,ADRA1A
1513,KEGG_2019_Human,AMPK signaling pathway,1/120,0.0059999251180858,0.0109665527651575,0,0,19880.0,101706.2448082016,ADRA1A
1514,KEGG_2019_Human,Vascular smooth muscle contraction,1/132,0.0065999206698993,0.0109665527651575,0,0,19868.0,99751.22090491928,ADRA1A
1515,KEGG_2019_Human,Adrenergic signaling in cardiomyocytes,1/145,0.0072499160871101,0.0109665527651575,0,0,19855.0,97820.92670675044,ADRA1A
1516,KEGG_2019_Human,cGMP-PKG signaling pathway,1/166,0.0082999091363732,0.0109665527651575,0,0,19834.0,95034.82345515196,ADRA1A
1517,KEGG_2019_Human,Calcium signaling pathway,1/188,0.009399902370135,0.0109665527651575,0,0,19812.0,92463.712994847,ADRA1A
1518,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,ADRA1A
1519,KEGG_2019_Human,Insulin secretion,1/86,0.0042999391173866,0.0085998782347732,0,0,19914.0,108514.46102290176,GPR119
1520,KEGG_2019_Human,cAMP signaling pathway,1/212,0.0105998955026255,0.0105998955026255,0,0,19788.0,89974.27756224656,GPR119
1521,KEGG_2019_Human,Spliceosome,1/134,0.0066999199497742,0.0066999199497742,0,0,19866.0,99442.43560916925,PLRG1
1522,KEGG_2019_Human,Inositol phosphate metabolism,1/74,0.0036999446830449,0.0049499334884068,0,0,19926.0,111574.38983110404,CDIPT
1523,KEGG_2019_Human,Glycerophospholipid metabolism,1/97,0.0048499343304706,0.0049499334884068,0,0,19903.0,106058.9096435903,CDIPT
1524,KEGG_2019_Human,Phosphatidylinositol signaling system,1/99,0.0049499334884068,0.0049499334884068,0,0,19901.0,105642.09305076736,CDIPT
1525,KEGG_2019_Human,Tight junction,1/170,0.0084999078692823,0.0084999078692823,0,0,19830.0,94543.49009679438,ARHGEF18
1526,KEGG_2019_Human,Glycosaminoglycan degradation,1/19,0.00094997806231055,0.00094997806231055,0,0,19981.0,139049.2109571672,HYAL3
1527,KEGG_2019_Human,Regulation of actin cytoskeleton,1/214,0.0106998949514067,0.0106998949514067,0,0,19786.0,89779.39753374986,ITGAD
1528,KEGG_2019_Human,Endocrine and other factor-regulated calcium reabsorption,1/48,0.0023999583567988,0.0071998750703964,0,0,19952.0,120356.5272753826,PTH1R
1529,KEGG_2019_Human,"Parathyroid hormone synthesis, secretion and action",1/106,0.0052999306076525,0.0079498959114788,0,0,19894.0,104245.78450366124,PTH1R
1530,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,PTH1R
1531,KEGG_2019_Human,Glucagon signaling pathway,1/103,0.0051499318302617,0.0102998636605234,0,0,19897.0,104832.7525292024,GCGR
1532,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,GCGR
1533,KEGG_2019_Human,Adipocytokine signaling pathway,1/69,0.003449947123837,0.0074499147221605,0,0,19931.0,112996.7391397682,ADIPOR1
1534,KEGG_2019_Human,Longevity regulating pathway,1/102,0.0050999322416682,0.0074499147221605,0,0,19898.0,105032.15064717118,ADIPOR1
1535,KEGG_2019_Human,AMPK signaling pathway,1/120,0.0059999251180858,0.0074499147221605,0,0,19880.0,101706.2448082016,ADIPOR1
1536,KEGG_2019_Human,Non-alcoholic fatty liver disease (NAFLD),1/149,0.0074499147221605,0.0074499147221605,0,0,19851.0,97261.02051561224,ADIPOR1
1537,KEGG_2019_Human,Oxytocin signaling pathway,1/153,0.0076499133771537,0.0141331940035007,0,0,19847.0,96715.6407630817,OXTR
1538,KEGG_2019_Human,Calcium signaling pathway,1/188,0.009399902370135,0.0141331940035007,0,0,19812.0,92463.712994847,OXTR
1539,KEGG_2019_Human,cAMP signaling pathway,1/212,0.0105998955026255,0.0141331940035007,0,0,19788.0,89974.27756224656,OXTR
1540,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,OXTR
1541,KEGG_2019_Human,Hepatocellular carcinoma,1/168,0.0083999085011095,0.0083999085011095,0,0,19832.0,94787.72752807094,BRD7
1542,KEGG_2019_Human,Oxidative phosphorylation,1/133,0.0066499203093911,0.0112582177134695,0,0,19867.0,99596.2591544721,NDUFB4
1543,KEGG_2019_Human,Parkinson disease,1/142,0.0070999171242726,0.0112582177134695,0,0,19858.0,98250.87390500787,NDUFB4
1544,KEGG_2019_Human,Retrograde endocannabinoid signaling,1/148,0.007399915061391,0.0112582177134695,0,0,19852.0,97399.60470052566,NDUFB4
1545,KEGG_2019_Human,Non-alcoholic fatty liver disease (NAFLD),1/149,0.0074499147221605,0.0112582177134695,0,0,19851.0,97261.02051561224,NDUFB4
1546,KEGG_2019_Human,Alzheimer disease,1/171,0.0085499075557634,0.0112582177134695,0,0,19829.0,94422.42241345016,NDUFB4
1547,KEGG_2019_Human,Huntington disease,1/193,0.0096499008972596,0.0112582177134695,0,0,19807.0,91920.47679471428,NDUFB4
1548,KEGG_2019_Human,Thermogenesis,1/231,0.0115498903940656,0.0115498903940656,0,0,19769.0,88191.07730937863,NDUFB4
1549,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0147498749536506,0,0,19705.0,83086.53988020132,PPP5D1
1550,KEGG_2019_Human,Thyroid cancer,1/37,0.0018499650702878,0.0095198963012574,0,0,19963.0,125618.9446446357,TCF7
1551,KEGG_2019_Human,Endometrial cancer,1/58,0.0028999527887707,0.0095198963012574,0,0,19942.0,116522.31890946148,TCF7
1552,KEGG_2019_Human,Basal cell carcinoma,1/63,0.0031499501598827,0.0095198963012574,0,0,19937.0,114844.46974572667,TCF7
1553,KEGG_2019_Human,Acute myeloid leukemia,1/66,0.003299948626608,0.0095198963012574,0,0,19934.0,113899.85357353876,TCF7
1554,KEGG_2019_Human,Adherens junction,1/72,0.0035999456502131,0.0095198963012574,0,0,19928.0,112131.59838572376,TCF7
1555,KEGG_2019_Human,Arrhythmogenic right ventricular cardiomyopathy (ARVC),1/72,0.0035999456502131,0.0095198963012574,0,0,19928.0,112131.59838572376,TCF7
1556,KEGG_2019_Human,Colorectal cancer,1/86,0.0042999391173866,0.0095198963012574,0,0,19914.0,108514.46102290176,TCF7
1557,KEGG_2019_Human,Prostate cancer,1/97,0.0048499343304706,0.0095198963012574,0,0,19903.0,106058.9096435903,TCF7
1558,KEGG_2019_Human,Melanogenesis,1/101,0.0050499326546803,0.0095198963012574,0,0,19899.0,105233.48101229242,TCF7
1559,KEGG_2019_Human,Breast cancer,1/147,0.0073499154017982,0.0095198963012574,0,0,19853.0,97539.10874372096,TCF7
1560,KEGG_2019_Human,Gastric cancer,1/149,0.0074499147221605,0.0095198963012574,0,0,19851.0,97261.02051561224,TCF7
1561,KEGG_2019_Human,Cushing syndrome,1/155,0.0077499127120574,0.0095198963012574,0,0,19845.0,96448.16254952336,TCF7
1562,KEGG_2019_Human,Wnt signaling pathway,1/158,0.0078999117225733,0.0095198963012574,0,0,19842.0,96053.2110949472,TCF7
1563,KEGG_2019_Human,Hippo signaling pathway,1/160,0.0079999110688441,0.0095198963012574,0,0,19840.0,95793.96509856998,TCF7
1564,KEGG_2019_Human,Hepatocellular carcinoma,1/168,0.0083999085011095,0.0095198963012574,0,0,19832.0,94787.72752807094,TCF7
1565,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0175311091751498,0,0,19670.0,80733.60565076157,TCF7
1566,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,TCF7
1567,KEGG_2019_Human,Glyoxylate and dicarboxylate metabolism,1/30,0.0014999697593334,0.0014999697593334,0,0,19970.0,129851.13732048514,CS
1568,KEGG_2019_Human,Citrate cycle (TCA cycle),1/30,0.0014999697593334,0.0014999697593334,0,0,19970.0,129851.13732048514,CS
1569,KEGG_2019_Human,Calcium signaling pathway,1/188,0.009399902370135,0.0168998658265596,0,0,19812.0,92463.712994847,GRPR
1570,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,GRPR
1571,KEGG_2019_Human,Cholesterol metabolism,1/50,0.0024999572069037,0.0024999572069037,0,0,19950.0,119530.05920663515,LPA
1572,KEGG_2019_Human,Inositol phosphate metabolism,1/74,0.0036999446830449,0.0049499334884068,0,0,19926.0,111574.38983110404,PI4KA
1573,KEGG_2019_Human,Phosphatidylinositol signaling system,1/99,0.0049499334884068,0.0049499334884068,0,0,19901.0,105642.09305076736,PI4KA
1574,KEGG_2019_Human,mRNA surveillance pathway,1/91,0.0045499369072032,0.0045499369072032,0,0,19909.0,107362.10783923086,SSU72
1575,KEGG_2019_Human,Synthesis and degradation of ketone bodies,1/10,0.0004999862257578379,0.0019999449030313,0,0,19990.0,151942.5908680334,HMGCLL1
1576,KEGG_2019_Human,Butanoate metabolism,1/28,0.0013999711732997,0.0027999423465995,0,0,19972.0,131242.0761597353,HMGCLL1
1577,KEGG_2019_Human,"Valine, leucine and isoleucine degradation",1/48,0.0023999583567988,0.0031999444757317,0,0,19952.0,120356.5272753826,HMGCLL1
1578,KEGG_2019_Human,Peroxisome,1/83,0.0041499404726918,0.0041499404726918,0,0,19917.0,109237.99888847338,HMGCLL1
1579,KEGG_2019_Human,Endocytosis,1/244,0.0121998870519305,0.0121998870519305,0,0,19756.0,87051.4275316661,PSD4
1580,KEGG_2019_Human,Base excision repair,1/33,0.0016499677032113,0.0049499031096341,0,0,19967.0,127928.56031580272,PARP3
1581,KEGG_2019_Human,Apoptosis,1/143,0.0071499167770442,0.0080999104202618,0,0,19857.0,98106.57763600958,PARP3
1582,KEGG_2019_Human,Necroptosis,1/162,0.0080999104202618,0.0080999104202618,0,0,19838.0,95537.86936302872,PARP3
1583,KEGG_2019_Human,"Phenylalanine, tyrosine and tryptophan biosynthesis",1/5,0.0002499917995416556,0.0017499425967915,0,0,19995.0,165840.17843725558,GOT1
1584,KEGG_2019_Human,Phenylalanine metabolism,1/17,0.0008499797390404818,0.0024499450395929,0,0,19983.0,141285.76583697114,GOT1
1585,KEGG_2019_Human,Arginine biosynthesis,1/21,0.0010499764455398,0.0024499450395929,0,0,19979.0,137035.71221916509,GOT1
1586,KEGG_2019_Human,"Alanine, aspartate and glutamate metabolism",1/35,0.0017499663721595,0.0024499577795033,0,0,19965.0,126740.98858805298,GOT1
1587,KEGG_2019_Human,Tyrosine metabolism,1/36,0.0017999657178272,0.0024499577795033,0,0,19964.0,126172.23364250171,GOT1
1588,KEGG_2019_Human,Cysteine and methionine metabolism,1/47,0.0023499589392381,0.0024499577795033,0,0,19953.0,120782.64067395544,GOT1
1589,KEGG_2019_Human,Arginine and proline metabolism,1/49,0.0024499577795033,0.0024499577795033,0,0,19951.0,119939.1172087114,GOT1
1590,KEGG_2019_Human,Estrogen signaling pathway,1/137,0.0068499188797651,0.0068499188797651,0,0,19863.0,98987.62735269018,KRT40
1591,KEGG_2019_Human,Long-term depression,1/60,0.002999951725986,0.0099295756623236,0,0,19940.0,115834.63209072244,ITPR3
1592,KEGG_2019_Human,Cortisol synthesis and secretion,1/65,0.003249949134407,0.0099295756623236,0,0,19935.0,114209.92613860144,ITPR3
1593,KEGG_2019_Human,Long-term potentiation,1/67,0.0033499481224912,0.0099295756623236,0,0,19933.0,113594.38808369274,ITPR3
1594,KEGG_2019_Human,Renin secretion,1/69,0.003449947123837,0.0099295756623236,0,0,19931.0,112996.7391397682,ITPR3
1595,KEGG_2019_Human,Thyroid hormone synthesis,1/74,0.0036999446830449,0.0099295756623236,0,0,19926.0,111574.38983110404,ITPR3
1596,KEGG_2019_Human,Gastric acid secretion,1/75,0.0037499442041125,0.0099295756623236,0,0,19925.0,111301.33528642564,ITPR3
1597,KEGG_2019_Human,Taste transduction,1/83,0.0041499404726918,0.0099295756623236,0,0,19917.0,109237.99888847338,ITPR3
1598,KEGG_2019_Human,Insulin secretion,1/86,0.0042999391173866,0.0099295756623236,0,0,19914.0,108514.46102290176,ITPR3
1599,KEGG_2019_Human,Gap junction,1/88,0.0043999382262822,0.0099295756623236,0,0,19912.0,108045.79305232369,ITPR3
1600,KEGG_2019_Human,Salivary secretion,1/90,0.0044999373439762,0.0099295756623236,0,0,19910.0,107587.50385474482,ITPR3
1601,KEGG_2019_Human,GnRH signaling pathway,1/93,0.0046499360391879,0.0099295756623236,0,0,19907.0,106918.54242106884,ITPR3
1602,KEGG_2019_Human,Circadian entrainment,1/97,0.0048499343304706,0.0099295756623236,0,0,19903.0,106058.9096435903,ITPR3
1603,KEGG_2019_Human,Pancreatic secretion,1/98,0.0048999339081079,0.0099295756623236,0,0,19902.0,105849.45495286948,ITPR3
1604,KEGG_2019_Human,Aldosterone synthesis and secretion,1/98,0.0048999339081079,0.0099295756623236,0,0,19902.0,105849.45495286948,ITPR3
1605,KEGG_2019_Human,Phosphatidylinositol signaling system,1/99,0.0049499334884068,0.0099295756623236,0,0,19901.0,105642.09305076736,ITPR3
1606,KEGG_2019_Human,Inflammatory mediator regulation of TRP channels,1/100,0.0049999330710556,0.0099295756623236,0,0,19900.0,105436.78197328727,ITPR3
1607,KEGG_2019_Human,Glucagon signaling pathway,1/103,0.0051499318302617,0.0099295756623236,0,0,19897.0,104832.7525292024,ITPR3
1608,KEGG_2019_Human,C-type lectin receptor signaling pathway,1/104,0.0051999314202997,0.0099295756623236,0,0,19896.0,104635.24941415618,ITPR3
1609,KEGG_2019_Human,"Parathyroid hormone synthesis, secretion and action",1/106,0.0052999306076525,0.0099295756623236,0,0,19894.0,104245.78450366124,ITPR3
1610,KEGG_2019_Human,Cholinergic synapse,1/112,0.0055999282120529,0.0099295756623236,0,0,19888.0,103119.30984392198,ITPR3
1611,KEGG_2019_Human,Serotonergic synapse,1/113,0.0056499278191151,0.0099295756623236,0,0,19887.0,102937.34947211576,ITPR3
1612,KEGG_2019_Human,Glutamatergic synapse,1/114,0.005699927427839,0.0099295756623236,0,0,19886.0,102756.96431429044,ITPR3
1613,KEGG_2019_Human,Platelet activation,1/124,0.0061999236097501,0.0099295756623236,0,0,19876.0,101034.04709010696,ITPR3
1614,KEGG_2019_Human,Oocyte meiosis,1/125,0.0062499232373748,0.0099295756623236,0,0,19875.0,100869.32368441945,ITPR3
1615,KEGG_2019_Human,Dopaminergic synapse,1/131,0.0065499210316603,0.0099295756623236,0,0,19869.0,99907.33811343512,ITPR3
1616,KEGG_2019_Human,Vascular smooth muscle contraction,1/132,0.0065999206698993,0.0099295756623236,0,0,19868.0,99751.22090491928,ITPR3
1617,KEGG_2019_Human,Estrogen signaling pathway,1/137,0.0068499188797651,0.0099295756623236,0,0,19863.0,98987.62735269018,ITPR3
1618,KEGG_2019_Human,Apelin signaling pathway,1/137,0.0068499188797651,0.0099295756623236,0,0,19863.0,98987.62735269018,ITPR3
1619,KEGG_2019_Human,Apoptosis,1/143,0.0071499167770442,0.0099295756623236,0,0,19857.0,98106.57763600958,ITPR3
1620,KEGG_2019_Human,Retrograde endocannabinoid signaling,1/148,0.007399915061391,0.0099295756623236,0,0,19852.0,97399.60470052566,ITPR3
1621,KEGG_2019_Human,Oxytocin signaling pathway,1/153,0.0076499133771537,0.0099295756623236,0,0,19847.0,96715.6407630817,ITPR3
1622,KEGG_2019_Human,Cushing syndrome,1/155,0.0077499127120574,0.0099295756623236,0,0,19845.0,96448.16254952336,ITPR3
1623,KEGG_2019_Human,Cellular senescence,1/160,0.0079999110688441,0.00993928344917,0,0,19840.0,95793.96509856998,ITPR3
1624,KEGG_2019_Human,cGMP-PKG signaling pathway,1/166,0.0082999091363732,0.0100087139585677,0,0,19834.0,95034.82345515196,ITPR3
1625,KEGG_2019_Human,Alzheimer disease,1/171,0.0085499075557634,0.0100156059938943,0,0,19829.0,94422.42241345016,ITPR3
1626,KEGG_2019_Human,NOD-like receptor signaling pathway,1/178,0.0088999053857096,0.0101360033559471,0,0,19822.0,93593.82745769851,ITPR3
1627,KEGG_2019_Human,Kaposi sarcoma-associated herpesvirus infection,1/186,0.0092999029651357,0.010141999925672,0,0,19814.0,92684.96451050608,ITPR3
1628,KEGG_2019_Human,Calcium signaling pathway,1/188,0.009399902370135,0.010141999925672,0,0,19812.0,92463.712994847,ITPR3
1629,KEGG_2019_Human,Proteoglycans in cancer,1/201,0.0100498985877989,0.0105652780025579,0,0,19799.0,91079.21596609056,ITPR3
1630,KEGG_2019_Human,Human immunodeficiency virus 1 infection,1/212,0.0105998955026255,0.0108648928901912,0,0,19788.0,89974.27756224656,ITPR3
1631,KEGG_2019_Human,Human cytomegalovirus infection,1/225,0.0112498919790339,0.0112498919790339,0,0,19775.0,88738.27077557483,ITPR3
1632,KEGG_2019_Human,Retrograde endocannabinoid signaling,1/148,0.007399915061391,0.0153998538587541,0,0,19852.0,97399.60470052566,CNR1
1633,KEGG_2019_Human,Rap1 signaling pathway,1/206,0.010299897173561,0.0153998538587541,0,0,19794.0,90569.849337325,CNR1
1634,KEGG_2019_Human,Thermogenesis,1/231,0.0115498903940656,0.0153998538587541,0,0,19769.0,88191.07730937863,CNR1
1635,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,CNR1
1636,KEGG_2019_Human,Huntington disease,1/193,0.0096499008972596,0.0096499008972596,0,0,19807.0,91920.47679471428,DNAH1
1637,KEGG_2019_Human,Tight junction,1/170,0.0084999078692823,0.0084999078692823,0,0,19830.0,94543.49009679438,MYH3
1638,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,GLP2R
1639,KEGG_2019_Human,Acute myeloid leukemia,1/66,0.003299948626608,0.0184373436920633,0,0,19934.0,113899.85357353876,CSF1R
1640,KEGG_2019_Human,Hematopoietic cell lineage,1/97,0.0048499343304706,0.0184373436920633,0,0,19903.0,106058.9096435903,CSF1R
1641,KEGG_2019_Human,Osteoclast differentiation,1/127,0.0063499224962247,0.0184373436920633,0,0,19873.0,100543.72072014232,CSF1R
1642,KEGG_2019_Human,Transcriptional misregulation in cancer,1/186,0.0092999029651357,0.0184373436920633,0,0,19814.0,92684.96451050608,CSF1R
1643,KEGG_2019_Human,Rap1 signaling pathway,1/206,0.010299897173561,0.0184373436920633,0,0,19794.0,90569.849337325,CSF1R
1644,KEGG_2019_Human,Ras signaling pathway,1/232,0.0115998901349604,0.0184373436920633,0,0,19768.0,88101.22480150245,CSF1R
1645,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0184373436920633,0,0,19706.0,83157.67014793828,CSF1R
1646,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0184373436920633,0,0,19705.0,83086.53988020132,CSF1R
1647,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0196665140459632,0,0,19646.0,79255.8617626126,CSF1R
1648,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,CSF1R
1649,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF184
1650,KEGG_2019_Human,RNA transport,1/165,0.0082499094553477,0.0085499075557634,0,0,19835.0,95159.46482222488,NUP98
1651,KEGG_2019_Human,Influenza A,1/171,0.0085499075557634,0.0085499075557634,0,0,19829.0,94422.42241345016,NUP98
1652,KEGG_2019_Human,Drug metabolism,1/108,0.0053999298011749,0.0053999298011749,0,0,19892.0,103863.47861844616,CES2
1653,KEGG_2019_Human,Type II diabetes mellitus,1/46,0.0022999595269283,0.0068998785807849,0,0,19954.0,121217.8313311442,CACNA1E
1654,KEGG_2019_Human,Calcium signaling pathway,1/188,0.009399902370135,0.0140998535552025,0,0,19812.0,92463.712994847,CACNA1E
1655,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0147498749536506,0,0,19705.0,83086.53988020132,CACNA1E
1656,KEGG_2019_Human,Aminoacyl-tRNA biosynthesis,1/66,0.003299948626608,0.003299948626608,0,0,19934.0,113899.85357353876,AARS2
1657,KEGG_2019_Human,Non-small cell lung cancer,1/66,0.003299948626608,0.006599897253216,0,0,19934.0,113899.85357353876,EML4
1658,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,EML4
1659,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0147498749536506,0,0,19705.0,83086.53988020132,MAP4K4
1660,KEGG_2019_Human,Ribosome biogenesis in eukaryotes,1/101,0.0050499326546803,0.0082499094553477,0,0,19899.0,105233.48101229242,RPP40
1661,KEGG_2019_Human,RNA transport,1/165,0.0082499094553477,0.0082499094553477,0,0,19835.0,95159.46482222488,RPP40
1662,KEGG_2019_Human,RNA transport,1/165,0.0082499094553477,0.0082499094553477,0,0,19835.0,95159.46482222488,NUP188
1663,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0147498749536506,0,0,19705.0,83086.53988020132,MAP3K20
1664,KEGG_2019_Human,Calcium signaling pathway,1/188,0.009399902370135,0.009399902370135,0,0,19812.0,92463.712994847,STIM2
1665,KEGG_2019_Human,Long-term depression,1/60,0.002999951725986,0.0101332206872026,0,0,19940.0,115834.63209072244,ITPR2
1666,KEGG_2019_Human,Cortisol synthesis and secretion,1/65,0.003249949134407,0.0101332206872026,0,0,19935.0,114209.92613860144,ITPR2
1667,KEGG_2019_Human,Long-term potentiation,1/67,0.0033499481224912,0.0101332206872026,0,0,19933.0,113594.38808369274,ITPR2
1668,KEGG_2019_Human,Renin secretion,1/69,0.003449947123837,0.0101332206872026,0,0,19931.0,112996.7391397682,ITPR2
1669,KEGG_2019_Human,Thyroid hormone synthesis,1/74,0.0036999446830449,0.0101332206872026,0,0,19926.0,111574.38983110404,ITPR2
1670,KEGG_2019_Human,Gastric acid secretion,1/75,0.0037499442041125,0.0101332206872026,0,0,19925.0,111301.33528642564,ITPR2
1671,KEGG_2019_Human,Gap junction,1/88,0.0043999382262822,0.0101332206872026,0,0,19912.0,108045.79305232369,ITPR2
1672,KEGG_2019_Human,Salivary secretion,1/90,0.0044999373439762,0.0101332206872026,0,0,19910.0,107587.50385474482,ITPR2
1673,KEGG_2019_Human,GnRH signaling pathway,1/93,0.0046499360391879,0.0101332206872026,0,0,19907.0,106918.54242106884,ITPR2
1674,KEGG_2019_Human,Pancreatic secretion,1/98,0.0048999339081079,0.0101332206872026,0,0,19902.0,105849.45495286948,ITPR2
1675,KEGG_2019_Human,Aldosterone synthesis and secretion,1/98,0.0048999339081079,0.0101332206872026,0,0,19902.0,105849.45495286948,ITPR2
1676,KEGG_2019_Human,Phosphatidylinositol signaling system,1/99,0.0049499334884068,0.0101332206872026,0,0,19901.0,105642.09305076736,ITPR2
1677,KEGG_2019_Human,Inflammatory mediator regulation of TRP channels,1/100,0.0049999330710556,0.0101332206872026,0,0,19900.0,105436.78197328727,ITPR2
1678,KEGG_2019_Human,Glucagon signaling pathway,1/103,0.0051499318302617,0.0101332206872026,0,0,19897.0,104832.7525292024,ITPR2
1679,KEGG_2019_Human,C-type lectin receptor signaling pathway,1/104,0.0051999314202997,0.0101332206872026,0,0,19896.0,104635.24941415618,ITPR2
1680,KEGG_2019_Human,"Parathyroid hormone synthesis, secretion and action",1/106,0.0052999306076525,0.0101332206872026,0,0,19894.0,104245.78450366124,ITPR2
1681,KEGG_2019_Human,Cholinergic synapse,1/112,0.0055999282120529,0.0101332206872026,0,0,19888.0,103119.30984392198,ITPR2
1682,KEGG_2019_Human,Serotonergic synapse,1/113,0.0056499278191151,0.0101332206872026,0,0,19887.0,102937.34947211576,ITPR2
1683,KEGG_2019_Human,Glutamatergic synapse,1/114,0.005699927427839,0.0101332206872026,0,0,19886.0,102756.96431429044,ITPR2
1684,KEGG_2019_Human,Platelet activation,1/124,0.0061999236097501,0.0101332206872026,0,0,19876.0,101034.04709010696,ITPR2
1685,KEGG_2019_Human,Oocyte meiosis,1/125,0.0062499232373748,0.0101332206872026,0,0,19875.0,100869.32368441945,ITPR2
1686,KEGG_2019_Human,Dopaminergic synapse,1/131,0.0065499210316603,0.0101332206872026,0,0,19869.0,99907.33811343512,ITPR2
1687,KEGG_2019_Human,Vascular smooth muscle contraction,1/132,0.0065999206698993,0.0101332206872026,0,0,19868.0,99751.22090491928,ITPR2
1688,KEGG_2019_Human,Estrogen signaling pathway,1/137,0.0068499188797651,0.0101332206872026,0,0,19863.0,98987.62735269018,ITPR2
1689,KEGG_2019_Human,Apelin signaling pathway,1/137,0.0068499188797651,0.0101332206872026,0,0,19863.0,98987.62735269018,ITPR2
1690,KEGG_2019_Human,Apoptosis,1/143,0.0071499167770442,0.0101332206872026,0,0,19857.0,98106.57763600958,ITPR2
1691,KEGG_2019_Human,Retrograde endocannabinoid signaling,1/148,0.007399915061391,0.0101332206872026,0,0,19852.0,97399.60470052566,ITPR2
1692,KEGG_2019_Human,Oxytocin signaling pathway,1/153,0.0076499133771537,0.0101332206872026,0,0,19847.0,96715.6407630817,ITPR2
1693,KEGG_2019_Human,Cushing syndrome,1/155,0.0077499127120574,0.0101332206872026,0,0,19845.0,96448.16254952336,ITPR2
1694,KEGG_2019_Human,Cellular senescence,1/160,0.0079999110688441,0.0101332206872026,0,0,19840.0,95793.96509856998,ITPR2
1695,KEGG_2019_Human,cGMP-PKG signaling pathway,1/166,0.0082999091363732,0.010153015222469,0,0,19834.0,95034.82345515196,ITPR2
1696,KEGG_2019_Human,Alzheimer disease,1/171,0.0085499075557634,0.010153015222469,0,0,19829.0,94422.42241345016,ITPR2
1697,KEGG_2019_Human,NOD-like receptor signaling pathway,1/178,0.0088999053857096,0.0102056082875752,0,0,19822.0,93593.82745769851,ITPR2
1698,KEGG_2019_Human,Kaposi sarcoma-associated herpesvirus infection,1/186,0.0092999029651357,0.0102056082875752,0,0,19814.0,92684.96451050608,ITPR2
1699,KEGG_2019_Human,Calcium signaling pathway,1/188,0.009399902370135,0.0102056082875752,0,0,19812.0,92463.712994847,ITPR2
1700,KEGG_2019_Human,Proteoglycans in cancer,1/201,0.0100498985877989,0.0106082262871211,0,0,19799.0,91079.21596609056,ITPR2
1701,KEGG_2019_Human,Human immunodeficiency virus 1 infection,1/212,0.0105998955026255,0.0108863791648587,0,0,19788.0,89974.27756224656,ITPR2
1702,KEGG_2019_Human,Human cytomegalovirus infection,1/225,0.0112498919790339,0.0112498919790339,0,0,19775.0,88738.27077557483,ITPR2
1703,KEGG_2019_Human,Arginine biosynthesis,1/21,0.0010499764455398,0.0082498672464617,0,0,19979.0,137035.71221916509,NOS1
1704,KEGG_2019_Human,Arginine and proline metabolism,1/49,0.0024499577795033,0.0082498672464617,0,0,19951.0,119939.1172087114,NOS1
1705,KEGG_2019_Human,Amyotrophic lateral sclerosis (ALS),1/51,0.0025499566390179,0.0082498672464617,0,0,19949.0,119129.0228601236,NOS1
1706,KEGG_2019_Human,Long-term depression,1/60,0.002999951725986,0.0082498672464617,0,0,19940.0,115834.63209072244,NOS1
1707,KEGG_2019_Human,Salivary secretion,1/90,0.0044999373439762,0.0088915462725296,0,0,19910.0,107587.50385474482,NOS1
1708,KEGG_2019_Human,Circadian entrainment,1/97,0.0048499343304706,0.0088915462725296,0,0,19903.0,106058.9096435903,NOS1
1709,KEGG_2019_Human,Relaxin signaling pathway,1/130,0.0064999213952527,0.0092887834251631,0,0,19870.0,100064.62842845908,NOS1
1710,KEGG_2019_Human,Apelin signaling pathway,1/137,0.0068499188797651,0.0092887834251631,0,0,19863.0,98987.62735269018,NOS1
1711,KEGG_2019_Human,Phagosome,1/152,0.0075999137114971,0.0092887834251631,0,0,19848.0,96850.665715497,NOS1
1712,KEGG_2019_Human,Alzheimer disease,1/171,0.0085499075557634,0.009399902370135,0,0,19829.0,94422.42241345016,NOS1
1713,KEGG_2019_Human,Calcium signaling pathway,1/188,0.009399902370135,0.009399902370135,0,0,19812.0,92463.712994847,NOS1
1714,KEGG_2019_Human,Protein digestion and absorption,1/90,0.0044999373439762,0.0044999373439762,0,0,19910.0,107587.50385474482,COL5A3
1715,KEGG_2019_Human,mTOR signaling pathway,1/152,0.0075999137114971,0.0075999137114971,0,0,19848.0,96850.665715497,MAPKAP1
1716,KEGG_2019_Human,Mitophagy,1/65,0.003249949134407,0.0063999221281459,0,0,19935.0,114209.92613860144,ATG9B
1717,KEGG_2019_Human,Autophagy,1/128,0.0063999221281459,0.0063999221281459,0,0,19872.0,100382.8010329652,ATG9B
1718,KEGG_2019_Human,Renin-angiotensin system,1/23,0.0011499748819949,0.0011499748819949,0,0,19977.0,135204.63922267244,MRGPRD
1719,KEGG_2019_Human,Hedgehog signaling pathway,1/47,0.0023499589392381,0.0046999178784763,0,0,19953.0,120782.64067395544,BOC
1720,KEGG_2019_Human,Axon guidance,1/181,0.0090499044707863,0.0090499044707863,0,0,19819.0,93248.41634586031,BOC
1721,KEGG_2019_Human,Tight junction,1/170,0.0084999078692823,0.0084999078692823,0,0,19830.0,94543.49009679438,RAP2C
1722,KEGG_2019_Human,Vitamin digestion and absorption,1/24,0.0011999741185782,0.0011999741185782,0,0,19976.0,134347.69487847842,SLC23A1
1723,KEGG_2019_Human,mRNA surveillance pathway,1/91,0.0045499369072032,0.0082499094553477,0,0,19909.0,107362.10783923086,CASC3
1724,KEGG_2019_Human,RNA transport,1/165,0.0082499094553477,0.0082499094553477,0,0,19835.0,95159.46482222488,CASC3
1725,KEGG_2019_Human,Leukocyte transendothelial migration,1/112,0.0055999282120529,0.0106998949514067,0,0,19888.0,103119.30984392198,MYL10
1726,KEGG_2019_Human,Focal adhesion,1/199,0.0099498991610159,0.0106998949514067,0,0,19801.0,91286.4288690606,MYL10
1727,KEGG_2019_Human,Regulation of actin cytoskeleton,1/214,0.0106998949514067,0.0106998949514067,0,0,19786.0,89779.39753374986,MYL10
1728,KEGG_2019_Human,p53 signaling pathway,1/72,0.0035999456502131,0.0065999206698993,0,0,19928.0,112131.59838572376,CCNG2
1729,KEGG_2019_Human,FoxO signaling pathway,1/132,0.0065999206698993,0.0065999206698993,0,0,19868.0,99751.22090491928,CCNG2
1730,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0147498749536506,0,0,19705.0,83086.53988020132,MAP3K6
1731,KEGG_2019_Human,Ribosome biogenesis in eukaryotes,1/101,0.0050499326546803,0.0050499326546803,0,0,19899.0,105233.48101229242,EFL1
1732,KEGG_2019_Human,Non-small cell lung cancer,1/66,0.003299948626608,0.0130057511136222,0,0,19934.0,113899.85357353876,CDK6
1733,KEGG_2019_Human,p53 signaling pathway,1/72,0.0035999456502131,0.0130057511136222,0,0,19928.0,112131.59838572376,CDK6
1734,KEGG_2019_Human,Melanoma,1/72,0.0035999456502131,0.0130057511136222,0,0,19928.0,112131.59838572376,CDK6
1735,KEGG_2019_Human,Pancreatic cancer,1/75,0.0037499442041125,0.0130057511136222,0,0,19925.0,111301.33528642564,CDK6
1736,KEGG_2019_Human,Glioma,1/75,0.0037499442041125,0.0130057511136222,0,0,19925.0,111301.33528642564,CDK6
1737,KEGG_2019_Human,Chronic myeloid leukemia,1/76,0.0037999437281752,0.0130057511136222,0,0,19924.0,111031.8499691117,CDK6
1738,KEGG_2019_Human,Small cell lung cancer,1/93,0.0046499360391879,0.0130057511136222,0,0,19907.0,106918.54242106884,CDK6
1739,KEGG_2019_Human,Cell cycle,1/124,0.0061999236097501,0.0130057511136222,0,0,19876.0,101034.04709010696,CDK6
1740,KEGG_2019_Human,Measles,1/138,0.0068999185254481,0.0130057511136222,0,0,19862.0,98838.19160389496,CDK6
1741,KEGG_2019_Human,Breast cancer,1/147,0.0073499154017982,0.0130057511136222,0,0,19853.0,97539.10874372096,CDK6
1742,KEGG_2019_Human,Cushing syndrome,1/155,0.0077499127120574,0.0130057511136222,0,0,19845.0,96448.16254952336,CDK6
1743,KEGG_2019_Human,Hepatitis C,1/155,0.0077499127120574,0.0130057511136222,0,0,19845.0,96448.16254952336,CDK6
1744,KEGG_2019_Human,Cellular senescence,1/160,0.0079999110688441,0.0130057511136222,0,0,19840.0,95793.96509856998,CDK6
1745,KEGG_2019_Human,Hepatocellular carcinoma,1/168,0.0083999085011095,0.0130057511136222,0,0,19832.0,94787.72752807094,CDK6
1746,KEGG_2019_Human,Kaposi sarcoma-associated herpesvirus infection,1/186,0.0092999029651357,0.0130057511136222,0,0,19814.0,92684.96451050608,CDK6
1747,KEGG_2019_Human,Viral carcinogenesis,1/201,0.0100498985877989,0.0130057511136222,0,0,19799.0,91079.21596609056,CDK6
1748,KEGG_2019_Human,Epstein-Barr virus infection,1/201,0.0100498985877989,0.0130057511136222,0,0,19799.0,91079.21596609056,CDK6
1749,KEGG_2019_Human,Human cytomegalovirus infection,1/225,0.0112498919790339,0.0137498679743747,0,0,19775.0,88738.27077557483,CDK6
1750,KEGG_2019_Human,MicroRNAs in cancer,1/299,0.0149498740670514,0.0173103804986911,0,0,19701.0,82804.33538735632,CDK6
1751,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0181498542048609,0,0,19670.0,80733.60565076157,CDK6
1752,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0185427132433367,0,0,19646.0,79255.8617626126,CDK6
1753,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,CDK6
1754,KEGG_2019_Human,FoxO signaling pathway,1/132,0.0065999206698993,0.0100498985877989,0,0,19868.0,99751.22090491928,USP7
1755,KEGG_2019_Human,Epstein-Barr virus infection,1/201,0.0100498985877989,0.0100498985877989,0,0,19799.0,91079.21596609056,USP7
1756,KEGG_2019_Human,Viral carcinogenesis,1/201,0.0100498985877989,0.0100498985877989,0,0,19799.0,91079.21596609056,USP7
1757,KEGG_2019_Human,Gastric cancer,1/149,0.0074499147221605,0.0182498226490271,0,0,19851.0,97261.02051561224,TERT
1758,KEGG_2019_Human,Hepatocellular carcinoma,1/168,0.0083999085011095,0.0182498226490271,0,0,19832.0,94787.72752807094,TERT
1759,KEGG_2019_Human,Human T-cell leukemia virus 1 infection,1/219,0.0109498935894162,0.0182498226490271,0,0,19781.0,89299.85161916987,TERT
1760,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0206248343237056,0,0,19670.0,80733.60565076157,TERT
1761,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,TERT
1762,KEGG_2019_Human,Thyroid cancer,1/37,0.0018499650702878,0.0073998602811514,0,0,19963.0,125618.9446446357,PAX8
1763,KEGG_2019_Human,Thyroid hormone synthesis,1/74,0.0036999446830449,0.0073998893660899,0,0,19926.0,111574.38983110404,PAX8
1764,KEGG_2019_Human,Transcriptional misregulation in cancer,1/186,0.0092999029651357,0.012399870620181,0,0,19814.0,92684.96451050608,PAX8
1765,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,PAX8
1766,KEGG_2019_Human,Toxoplasmosis,1/113,0.0056499278191151,0.0140623649737923,0,0,19887.0,102937.34947211576,IL10RA
1767,KEGG_2019_Human,JAK-STAT signaling pathway,1/162,0.0080999104202618,0.0140623649737923,0,0,19838.0,95537.86936302872,IL10RA
1768,KEGG_2019_Human,Tuberculosis,1/179,0.0089499050800561,0.0140623649737923,0,0,19821.0,93478.0629355712,IL10RA
1769,KEGG_2019_Human,Human cytomegalovirus infection,1/225,0.0112498919790339,0.0140623649737923,0,0,19775.0,88738.27077557483,IL10RA
1770,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0146998751759735,0,0,19706.0,83157.67014793828,IL10RA
1771,KEGG_2019_Human,Phospholipase D signaling pathway,1/148,0.007399915061391,0.0178331582523446,0,0,19852.0,97399.60470052566,LPAR5
1772,KEGG_2019_Human,Rap1 signaling pathway,1/206,0.010299897173561,0.0178331582523446,0,0,19794.0,90569.849337325,LPAR5
1773,KEGG_2019_Human,Regulation of actin cytoskeleton,1/214,0.0106998949514067,0.0178331582523446,0,0,19786.0,89779.39753374986,LPAR5
1774,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0221248283017086,0,0,19646.0,79255.8617626126,LPAR5
1775,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,LPAR5
1776,KEGG_2019_Human,Protein export,1/23,0.0011499748819949,0.0011499748819949,0,0,19977.0,135204.63922267244,SRP14
1777,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0147498749536506,0,0,19705.0,83086.53988020132,DUSP3
1778,KEGG_2019_Human,Apoptosis,1/143,0.0071499167770442,0.0071499167770442,0,0,19857.0,98106.57763600958,CASP6
1779,KEGG_2019_Human,Fatty acid degradation,1/44,0.0021999607179423,0.0055499170245674,0,0,19956.0,122117.06559109331,CYP4A11
1780,KEGG_2019_Human,Arachidonic acid metabolism,1/63,0.0031499501598827,0.0055499170245674,0,0,19937.0,114844.46974572667,CYP4A11
1781,KEGG_2019_Human,Retinol metabolism,1/67,0.0033499481224912,0.0055499170245674,0,0,19933.0,113594.38808369274,CYP4A11
1782,KEGG_2019_Human,PPAR signaling pathway,1/74,0.0036999446830449,0.0055499170245674,0,0,19926.0,111574.38983110404,CYP4A11
1783,KEGG_2019_Human,Inflammatory mediator regulation of TRP channels,1/100,0.0049999330710556,0.0059999196852667,0,0,19900.0,105436.78197328727,CYP4A11
1784,KEGG_2019_Human,Vascular smooth muscle contraction,1/132,0.0065999206698993,0.0065999206698993,0,0,19868.0,99751.22090491928,CYP4A11
1785,KEGG_2019_Human,Serotonergic synapse,1/113,0.0056499278191151,0.0056499278191151,0,0,19887.0,102937.34947211576,KCND2
1786,KEGG_2019_Human,Cholesterol metabolism,1/50,0.0024999572069037,0.0024999572069037,0,0,19950.0,119530.05920663515,OSBPL5
1787,KEGG_2019_Human,Cell adhesion molecules (CAMs),1/145,0.0072499160871101,0.0072499160871101,0,0,19855.0,97820.92670675044,NFASC
1788,KEGG_2019_Human,Lysosome,1/123,0.0061499239842961,0.0061499239842961,0,0,19877.0,101200.07933676826,DNASE2
1789,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF816
1790,KEGG_2019_Human,Necroptosis,1/162,0.0080999104202618,0.0088999053857096,0,0,19838.0,95537.86936302872,RNF31
1791,KEGG_2019_Human,NOD-like receptor signaling pathway,1/178,0.0088999053857096,0.0088999053857096,0,0,19822.0,93593.82745769851,RNF31
1792,KEGG_2019_Human,Cell adhesion molecules (CAMs),1/145,0.0072499160871101,0.0090499044707863,0,0,19855.0,97820.92670675044,NTNG2
1793,KEGG_2019_Human,Axon guidance,1/181,0.0090499044707863,0.0090499044707863,0,0,19819.0,93248.41634586031,NTNG2
1794,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,SLC24A4
1795,KEGG_2019_Human,Phagosome,1/152,0.0075999137114971,0.0121998870519305,0,0,19848.0,96850.665715497,EEA1
1796,KEGG_2019_Human,Tuberculosis,1/179,0.0089499050800561,0.0121998870519305,0,0,19821.0,93478.0629355712,EEA1
1797,KEGG_2019_Human,Endocytosis,1/244,0.0121998870519305,0.0121998870519305,0,0,19756.0,87051.4275316661,EEA1
1798,KEGG_2019_Human,Protein processing in endoplasmic reticulum,1/165,0.0082499094553477,0.0082499094553477,0,0,19835.0,95159.46482222488,NGLY1
1799,KEGG_2019_Human,Glyoxylate and dicarboxylate metabolism,1/30,0.0014999697593334,0.0025999517274011,0,0,19970.0,129851.13732048514,ACSS1
1800,KEGG_2019_Human,Propanoate metabolism,1/32,0.0015999683804467,0.0025999517274011,0,0,19968.0,128549.41955786056,ACSS1
1801,KEGG_2019_Human,Pyruvate metabolism,1/39,0.0019499637955508,0.0025999517274011,0,0,19961.0,124555.53162481484,ACSS1
1802,KEGG_2019_Human,Glycolysis / Gluconeogenesis,1/68,0.0033999476216189,0.0033999476216189,0,0,19932.0,113293.39338050144,ACSS1
1803,KEGG_2019_Human,Pertussis,1/76,0.0037999437281752,0.0106998949514067,0,0,19924.0,111031.8499691117,CFL2
1804,KEGG_2019_Human,Fc gamma R-mediated phagocytosis,1/91,0.0045499369072032,0.0106998949514067,0,0,19909.0,107362.10783923086,CFL2
1805,KEGG_2019_Human,Axon guidance,1/181,0.0090499044707863,0.0106998949514067,0,0,19819.0,93248.41634586031,CFL2
1806,KEGG_2019_Human,Human immunodeficiency virus 1 infection,1/212,0.0105998955026255,0.0106998949514067,0,0,19788.0,89974.27756224656,CFL2
1807,KEGG_2019_Human,Regulation of actin cytoskeleton,1/214,0.0106998949514067,0.0106998949514067,0,0,19786.0,89779.39753374986,CFL2
1808,KEGG_2019_Human,African trypanosomiasis,1/37,0.0018499650702878,0.0107348628563188,0,0,19963.0,125618.9446446357,MYD88
1809,KEGG_2019_Human,Malaria,1/49,0.0024499577795033,0.0107348628563188,0,0,19951.0,119939.1172087114,MYD88
1810,KEGG_2019_Human,Legionellosis,1/55,0.0027499544131125,0.0107348628563188,0,0,19945.0,117599.1294878737,MYD88
1811,KEGG_2019_Human,Leishmaniasis,1/74,0.0036999446830449,0.0107348628563188,0,0,19926.0,111574.38983110404,MYD88
1812,KEGG_2019_Human,Pertussis,1/76,0.0037999437281752,0.0107348628563188,0,0,19924.0,111031.8499691117,MYD88
1813,KEGG_2019_Human,Salmonella infection,1/86,0.0042999391173866,0.0107348628563188,0,0,19914.0,108514.46102290176,MYD88
1814,KEGG_2019_Human,NF-kappa B signaling pathway,1/95,0.0047499351803394,0.0107348628563188,0,0,19905.0,106484.27183626965,MYD88
1815,KEGG_2019_Human,Chagas disease (American trypanosomiasis),1/103,0.0051499318302617,0.0107348628563188,0,0,19897.0,104832.7525292024,MYD88
1816,KEGG_2019_Human,Toll-like receptor signaling pathway,1/104,0.0051999314202997,0.0107348628563188,0,0,19896.0,104635.24941415618,MYD88
1817,KEGG_2019_Human,Toxoplasmosis,1/113,0.0056499278191151,0.0107348628563188,0,0,19887.0,102937.34947211576,MYD88
1818,KEGG_2019_Human,Measles,1/138,0.0068999185254481,0.0113365464347377,0,0,19862.0,98838.19160389496,MYD88
1819,KEGG_2019_Human,Hepatitis B,1/163,0.0081499100978668,0.0113365464347377,0,0,19837.0,95410.9786681514,MYD88
1820,KEGG_2019_Human,Influenza A,1/171,0.0085499075557634,0.0113365464347377,0,0,19829.0,94422.42241345016,MYD88
1821,KEGG_2019_Human,NOD-like receptor signaling pathway,1/178,0.0088999053857096,0.0113365464347377,0,0,19822.0,93593.82745769851,MYD88
1822,KEGG_2019_Human,Tuberculosis,1/179,0.0089499050800561,0.0113365464347377,0,0,19821.0,93478.0629355712,MYD88
1823,KEGG_2019_Human,Epstein-Barr virus infection,1/201,0.0100498985877989,0.0118469420323462,0,0,19799.0,91079.21596609056,MYD88
1824,KEGG_2019_Human,Human immunodeficiency virus 1 infection,1/212,0.0105998955026255,0.0118469420323462,0,0,19788.0,89974.27756224656,MYD88
1825,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0155693124510757,0,0,19705.0,83086.53988020132,MYD88
1826,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,MYD88
1827,KEGG_2019_Human,Inflammatory bowel disease (IBD),1/65,0.003249949134407,0.0106998604053851,0,0,19935.0,114209.92613860144,IL4R
1828,KEGG_2019_Human,Th1 and Th2 cell differentiation,1/92,0.0045999364719865,0.0106998604053851,0,0,19908.0,107139.13814408927,IL4R
1829,KEGG_2019_Human,Hematopoietic cell lineage,1/97,0.0048499343304706,0.0106998604053851,0,0,19903.0,106058.9096435903,IL4R
1830,KEGG_2019_Human,Th17 cell differentiation,1/107,0.0053499302026925,0.0106998604053851,0,0,19893.0,104053.753408911,IL4R
1831,KEGG_2019_Human,JAK-STAT signaling pathway,1/162,0.0080999104202618,0.0129598566724189,0,0,19838.0,95537.86936302872,IL4R
1832,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0195998335679646,0,0,19706.0,83157.67014793828,IL4R
1833,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0202284144472764,0,0,19646.0,79255.8617626126,IL4R
1834,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,IL4R
1835,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF124
1836,KEGG_2019_Human,Arrhythmogenic right ventricular cardiomyopathy (ARVC),1/72,0.0035999456502131,0.0035999456502131,0,0,19928.0,112131.59838572376,ACTN2
1837,KEGG_2019_Human,Ribosome,1/153,0.0076499133771537,0.0076499133771537,0,0,19847.0,96715.6407630817,RPL12
1838,KEGG_2019_Human,Folate biosynthesis,1/26,0.0012999726251831,0.0031499428966909,0,0,19974.0,132735.46073187632,TPH2
1839,KEGG_2019_Human,Tryptophan metabolism,1/42,0.0020999619311272,0.0031499428966909,0,0,19958.0,123057.75613441122,TPH2
1840,KEGG_2019_Human,Serotonergic synapse,1/113,0.0056499278191151,0.0056499278191151,0,0,19887.0,102937.34947211576,TPH2
1841,KEGG_2019_Human,Nicotinate and nicotinamide metabolism,1/30,0.0014999697593334,0.0014999697593334,0,0,19970.0,129851.13732048514,NNT
1842,KEGG_2019_Human,Cell adhesion molecules (CAMs),1/145,0.0072499160871101,0.0072499160871101,0,0,19855.0,97820.92670675044,CDH3
1843,KEGG_2019_Human,Renin secretion,1/69,0.003449947123837,0.0149997992131669,0,0,19931.0,112996.7391397682,PTGER4
1844,KEGG_2019_Human,Inflammatory mediator regulation of TRP channels,1/100,0.0049999330710556,0.0149997992131669,0,0,19900.0,105436.78197328727,PTGER4
1845,KEGG_2019_Human,Human cytomegalovirus infection,1/225,0.0112498919790339,0.0202798389918715,0,0,19775.0,88738.27077557483,PTGER4
1846,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0202798389918715,0,0,19670.0,80733.60565076157,PTGER4
1847,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0202798389918715,0,0,19662.0,80229.79996326564,PTGER4
1848,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,PTGER4
1849,KEGG_2019_Human,Endocytosis,1/244,0.0121998870519305,0.0121998870519305,0,0,19756.0,87051.4275316661,SH3KBP1
1850,KEGG_2019_Human,Wnt signaling pathway,1/158,0.0078999117225733,0.0078999117225733,0,0,19842.0,96053.2110949472,VANGL1
1851,KEGG_2019_Human,Endocytosis,1/244,0.0121998870519305,0.0121998870519305,0,0,19756.0,87051.4275316661,DNAJC6
1852,KEGG_2019_Human,Folate biosynthesis,1/26,0.0012999726251831,0.0012999726251831,0,0,19974.0,132735.46073187632,MOCOS
1853,KEGG_2019_Human,Tight junction,1/170,0.0084999078692823,0.0084999078692823,0,0,19830.0,94543.49009679438,CGN
1854,KEGG_2019_Human,Thyroid hormone synthesis,1/74,0.0036999446830449,0.0036999446830449,0,0,19926.0,111574.38983110404,SLC5A5
1855,KEGG_2019_Human,Ascorbate and aldarate metabolism,1/27,0.0013499718942362,0.004685646776936,0,0,19973.0,131975.02298599784,UGT1A9
1856,KEGG_2019_Human,Pentose and glucuronate interconversions,1/34,0.0016999670339032,0.004685646776936,0,0,19966.0,127326.1054203148,UGT1A9
1857,KEGG_2019_Human,Porphyrin and chlorophyll metabolism,1/42,0.0020999619311272,0.004685646776936,0,0,19958.0,123057.75613441122,UGT1A9
1858,KEGG_2019_Human,Steroid hormone biosynthesis,1/60,0.002999951725986,0.004685646776936,0,0,19940.0,115834.63209072244,UGT1A9
1859,KEGG_2019_Human,Retinol metabolism,1/67,0.0033499481224912,0.004685646776936,0,0,19933.0,113594.38808369274,UGT1A9
1860,KEGG_2019_Human,Metabolism of xenobiotics by cytochrome P450,1/74,0.0036999446830449,0.004685646776936,0,0,19926.0,111574.38983110404,UGT1A9
1861,KEGG_2019_Human,Chemical carcinogenesis,1/82,0.004099940929819,0.004685646776936,0,0,19918.0,109484.9180722932,UGT1A9
1862,KEGG_2019_Human,Drug metabolism,1/108,0.0053999298011749,0.0053999298011749,0,0,19892.0,103863.47861844616,UGT1A9
1863,KEGG_2019_Human,Thyroid hormone signaling pathway,1/116,0.0057999266512085,0.0057999266512085,0,0,19884.0,102400.8105961506,MED24
1864,KEGG_2019_Human,Osteoclast differentiation,1/127,0.0063499224962247,0.0063499224962247,0,0,19873.0,100543.72072014232,LILRB4
1865,KEGG_2019_Human,Protein processing in endoplasmic reticulum,1/165,0.0082499094553477,0.0082499094553477,0,0,19835.0,95159.46482222488,HERPUD1
1866,KEGG_2019_Human,Circadian rhythm,1/31,0.0015499690656704,0.0015499690656704,0,0,19969.0,129189.85098816035,CRY1
1867,KEGG_2019_Human,Bile secretion,1/72,0.0035999456502131,0.0035999456502131,0,0,19928.0,112131.59838572376,SLC51A
1868,KEGG_2019_Human,TNF signaling pathway,1/110,0.0054999290027479,0.0071499167770442,0,0,19890.0,103488.06969787036,DAB2IP
1869,KEGG_2019_Human,Apoptosis,1/143,0.0071499167770442,0.0071499167770442,0,0,19857.0,98106.57763600958,DAB2IP
1870,KEGG_2019_Human,Choline metabolism in cancer,1/99,0.0049499334884068,0.0055999282120529,0,0,19901.0,105642.09305076736,SLC5A7
1871,KEGG_2019_Human,Cholinergic synapse,1/112,0.0055999282120529,0.0055999282120529,0,0,19888.0,103119.30984392198,SLC5A7
1872,KEGG_2019_Human,Autoimmune thyroid disease,1/53,0.0026499555173137,0.0061665744717416,0,0,19947.0,118349.78824235698,TSHR
1873,KEGG_2019_Human,Regulation of lipolysis in adipocytes,1/55,0.0027499544131125,0.0061665744717416,0,0,19945.0,117599.1294878737,TSHR
1874,KEGG_2019_Human,Thyroid hormone synthesis,1/74,0.0036999446830449,0.0061665744717416,0,0,19926.0,111574.38983110404,TSHR
1875,KEGG_2019_Human,cAMP signaling pathway,1/212,0.0105998955026255,0.0132498693782819,0,0,19788.0,89974.27756224656,TSHR
1876,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,TSHR
1877,KEGG_2019_Human,Type II diabetes mellitus,1/46,0.0022999595269283,0.0085748843391889,0,0,19954.0,121217.8313311442,CACNA1G
1878,KEGG_2019_Human,Cortisol synthesis and secretion,1/65,0.003249949134407,0.0085748843391889,0,0,19935.0,114209.92613860144,CACNA1G
1879,KEGG_2019_Human,Circadian entrainment,1/97,0.0048499343304706,0.0085748843391889,0,0,19903.0,106058.9096435903,CACNA1G
1880,KEGG_2019_Human,Aldosterone synthesis and secretion,1/98,0.0048999339081079,0.0085748843391889,0,0,19902.0,105849.45495286948,CACNA1G
1881,KEGG_2019_Human,Cushing syndrome,1/155,0.0077499127120574,0.0108498777968804,0,0,19845.0,96448.16254952336,CACNA1G
1882,KEGG_2019_Human,Calcium signaling pathway,1/188,0.009399902370135,0.0109665527651575,0,0,19812.0,92463.712994847,CACNA1G
1883,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0147498749536506,0,0,19705.0,83086.53988020132,CACNA1G
1884,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0146998751759735,0,0,19706.0,83157.67014793828,TNFRSF12A
1885,KEGG_2019_Human,Glycerolipid metabolism,1/61,0.0030499512001654,0.0061874168605085,0,0,19939.0,115499.24335773686,DGKK
1886,KEGG_2019_Human,Glycerophospholipid metabolism,1/97,0.0048499343304706,0.0061874168605085,0,0,19903.0,106058.9096435903,DGKK
1887,KEGG_2019_Human,Phosphatidylinositol signaling system,1/99,0.0049499334884068,0.0061874168605085,0,0,19901.0,105642.09305076736,DGKK
1888,KEGG_2019_Human,Choline metabolism in cancer,1/99,0.0049499334884068,0.0061874168605085,0,0,19901.0,105642.09305076736,DGKK
1889,KEGG_2019_Human,Phospholipase D signaling pathway,1/148,0.007399915061391,0.007399915061391,0,0,19852.0,97399.60470052566,DGKK
1890,KEGG_2019_Human,FoxO signaling pathway,1/132,0.0065999206698993,0.0115998901349604,0,0,19868.0,99751.22090491928,FOXO4
1891,KEGG_2019_Human,Ras signaling pathway,1/232,0.0115998901349604,0.0115998901349604,0,0,19768.0,88101.22480150245,FOXO4
1892,KEGG_2019_Human,Ovarian steroidogenesis,1/49,0.0024499577795033,0.0056499278191151,0,0,19951.0,119939.1172087114,ALOX5
1893,KEGG_2019_Human,Arachidonic acid metabolism,1/63,0.0031499501598827,0.0056499278191151,0,0,19937.0,114844.46974572667,ALOX5
1894,KEGG_2019_Human,Fc epsilon RI signaling pathway,1/68,0.0033999476216189,0.0056499278191151,0,0,19932.0,113293.39338050144,ALOX5
1895,KEGG_2019_Human,Toxoplasmosis,1/113,0.0056499278191151,0.0056499278191151,0,0,19887.0,102937.34947211576,ALOX5
1896,KEGG_2019_Human,Serotonergic synapse,1/113,0.0056499278191151,0.0056499278191151,0,0,19887.0,102937.34947211576,ALOX5
1897,KEGG_2019_Human,Cholinergic synapse,1/112,0.0055999282120529,0.0160498424271101,0,0,19888.0,103119.30984392198,CHRM4
1898,KEGG_2019_Human,Regulation of actin cytoskeleton,1/214,0.0106998949514067,0.0160498424271101,0,0,19786.0,89779.39753374986,CHRM4
1899,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,CHRM4
1900,KEGG_2019_Human,p53 signaling pathway,1/72,0.0035999456502131,0.0119998666032662,0,0,19928.0,112131.59838572376,TSC2
1901,KEGG_2019_Human,Choline metabolism in cancer,1/99,0.0049499334884068,0.0119998666032662,0,0,19901.0,105642.09305076736,TSC2
1902,KEGG_2019_Human,Longevity regulating pathway,1/102,0.0050999322416682,0.0119998666032662,0,0,19898.0,105032.15064717118,TSC2
1903,KEGG_2019_Human,Thyroid hormone signaling pathway,1/116,0.0057999266512085,0.0119998666032662,0,0,19884.0,102400.8105961506,TSC2
1904,KEGG_2019_Human,AMPK signaling pathway,1/120,0.0059999251180858,0.0119998666032662,0,0,19880.0,101706.2448082016,TSC2
1905,KEGG_2019_Human,Autophagy,1/128,0.0063999221281459,0.0119998666032662,0,0,19872.0,100382.8010329652,TSC2
1906,KEGG_2019_Human,Insulin signaling pathway,1/137,0.0068499188797651,0.0119998666032662,0,0,19863.0,98987.62735269018,TSC2
1907,KEGG_2019_Human,Phospholipase D signaling pathway,1/148,0.007399915061391,0.0119998666032662,0,0,19852.0,97399.60470052566,TSC2
1908,KEGG_2019_Human,mTOR signaling pathway,1/152,0.0075999137114971,0.0119998666032662,0,0,19848.0,96850.665715497,TSC2
1909,KEGG_2019_Human,Cellular senescence,1/160,0.0079999110688441,0.0119998666032662,0,0,19840.0,95793.96509856998,TSC2
1910,KEGG_2019_Human,Human cytomegalovirus infection,1/225,0.0112498919790339,0.014437362992582,0,0,19775.0,88738.27077557483,TSC2
1911,KEGG_2019_Human,Thermogenesis,1/231,0.0115498903940656,0.014437362992582,0,0,19769.0,88191.07730937863,TSC2
1912,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0189641385443216,0,0,19670.0,80733.60565076157,TSC2
1913,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0189641385443216,0,0,19646.0,79255.8617626126,TSC2
1914,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,TSC2
1915,KEGG_2019_Human,RNA transport,1/165,0.0082499094553477,0.0082499094553477,0,0,19835.0,95159.46482222488,EIF3G
1916,KEGG_2019_Human,Axon guidance,1/181,0.0090499044707863,0.0090499044707863,0,0,19819.0,93248.41634586031,PLXNA1
1917,KEGG_2019_Human,Spliceosome,1/134,0.0066999199497742,0.0082499094553477,0,0,19866.0,99442.43560916925,THOC2
1918,KEGG_2019_Human,RNA transport,1/165,0.0082499094553477,0.0082499094553477,0,0,19835.0,95159.46482222488,THOC2
1919,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR1G1
1920,KEGG_2019_Human,Insulin resistance,1/108,0.0053999298011749,0.0053999298011749,0,0,19892.0,103863.47861844616,SLC27A3
1921,KEGG_2019_Human,Protein processing in endoplasmic reticulum,1/165,0.0082499094553477,0.0082499094553477,0,0,19835.0,95159.46482222488,SELENOS
1922,KEGG_2019_Human,Transcriptional misregulation in cancer,1/186,0.0092999029651357,0.0092999029651357,0,0,19814.0,92684.96451050608,BAIAP3
1923,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0146998751759735,0,0,19706.0,83157.67014793828,INHA
1924,KEGG_2019_Human,C-type lectin receptor signaling pathway,1/104,0.0051999314202997,0.0126561284764131,0,0,19896.0,104635.24941415618,ARHGEF12
1925,KEGG_2019_Human,Platelet activation,1/124,0.0061999236097501,0.0126561284764131,0,0,19876.0,101034.04709010696,ARHGEF12
1926,KEGG_2019_Human,Vascular smooth muscle contraction,1/132,0.0065999206698993,0.0126561284764131,0,0,19868.0,99751.22090491928,ARHGEF12
1927,KEGG_2019_Human,Tuberculosis,1/179,0.0089499050800561,0.0126561284764131,0,0,19821.0,93478.0629355712,ARHGEF12
1928,KEGG_2019_Human,Axon guidance,1/181,0.0090499044707863,0.0126561284764131,0,0,19819.0,93248.41634586031,ARHGEF12
1929,KEGG_2019_Human,Proteoglycans in cancer,1/201,0.0100498985877989,0.0126561284764131,0,0,19799.0,91079.21596609056,ARHGEF12
1930,KEGG_2019_Human,Regulation of actin cytoskeleton,1/214,0.0106998949514067,0.0126561284764131,0,0,19786.0,89779.39753374986,ARHGEF12
1931,KEGG_2019_Human,Human cytomegalovirus infection,1/225,0.0112498919790339,0.0126561284764131,0,0,19775.0,88738.27077557483,ARHGEF12
1932,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,ARHGEF12
1933,KEGG_2019_Human,Protein processing in endoplasmic reticulum,1/165,0.0082499094553477,0.0082499094553477,0,0,19835.0,95159.46482222488,AMFR
1934,KEGG_2019_Human,Circadian rhythm,1/31,0.0015499690656704,0.0089248989400127,0,0,19969.0,129189.85098816035,PRKAG3
1935,KEGG_2019_Human,Adipocytokine signaling pathway,1/69,0.003449947123837,0.0089248989400127,0,0,19931.0,112996.7391397682,PRKAG3
1936,KEGG_2019_Human,Hypertrophic cardiomyopathy (HCM),1/85,0.004249939567045,0.0089248989400127,0,0,19915.0,108752.83801948265,PRKAG3
1937,KEGG_2019_Human,Longevity regulating pathway,1/102,0.0050999322416682,0.0089248989400127,0,0,19898.0,105032.15064717118,PRKAG3
1938,KEGG_2019_Human,Glucagon signaling pathway,1/103,0.0051499318302617,0.0089248989400127,0,0,19897.0,104832.7525292024,PRKAG3
1939,KEGG_2019_Human,Insulin resistance,1/108,0.0053999298011749,0.0089248989400127,0,0,19892.0,103863.47861844616,PRKAG3
1940,KEGG_2019_Human,AMPK signaling pathway,1/120,0.0059999251180858,0.0089248989400127,0,0,19880.0,101706.2448082016,PRKAG3
1941,KEGG_2019_Human,FoxO signaling pathway,1/132,0.0065999206698993,0.0089248989400127,0,0,19868.0,99751.22090491928,PRKAG3
1942,KEGG_2019_Human,Insulin signaling pathway,1/137,0.0068499188797651,0.0089248989400127,0,0,19863.0,98987.62735269018,PRKAG3
1943,KEGG_2019_Human,Apelin signaling pathway,1/137,0.0068499188797651,0.0089248989400127,0,0,19863.0,98987.62735269018,PRKAG3
1944,KEGG_2019_Human,Non-alcoholic fatty liver disease (NAFLD),1/149,0.0074499147221605,0.0089248989400127,0,0,19851.0,97261.02051561224,PRKAG3
1945,KEGG_2019_Human,Oxytocin signaling pathway,1/153,0.0076499133771537,0.0089248989400127,0,0,19847.0,96715.6407630817,PRKAG3
1946,KEGG_2019_Human,Tight junction,1/170,0.0084999078692823,0.0091537469361502,0,0,19830.0,94543.49009679438,PRKAG3
1947,KEGG_2019_Human,Thermogenesis,1/231,0.0115498903940656,0.0115498903940656,0,0,19769.0,88191.07730937863,PRKAG3
1948,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR10Q1
1949,KEGG_2019_Human,"Valine, leucine and isoleucine degradation",1/48,0.0023999583567988,0.0023999583567988,0,0,19952.0,120356.5272753826,ACAD8
1950,KEGG_2019_Human,Axon guidance,1/181,0.0090499044707863,0.0090499044707863,0,0,19819.0,93248.41634586031,SEMA4B
1951,KEGG_2019_Human,Prion diseases,1/35,0.0017499663721595,0.0095998334271952,0,0,19965.0,126740.98858805298,NOTCH1
1952,KEGG_2019_Human,Notch signaling pathway,1/48,0.0023999583567988,0.0095998334271952,0,0,19952.0,120356.5272753826,NOTCH1
1953,KEGG_2019_Human,Th1 and Th2 cell differentiation,1/92,0.0045999364719865,0.0115998533024171,0,0,19908.0,107139.13814408927,NOTCH1
1954,KEGG_2019_Human,Thyroid hormone signaling pathway,1/116,0.0057999266512085,0.0115998533024171,0,0,19884.0,102400.8105961506,NOTCH1
1955,KEGG_2019_Human,Breast cancer,1/147,0.0073499154017982,0.0117598646428772,0,0,19853.0,97539.10874372096,NOTCH1
1956,KEGG_2019_Human,MicroRNAs in cancer,1/299,0.0149498740670514,0.0188569913816737,0,0,19701.0,82804.33538735632,NOTCH1
1957,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0188569913816737,0,0,19670.0,80733.60565076157,NOTCH1
1958,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,NOTCH1
1959,KEGG_2019_Human,Thiamine metabolism,1/15,0.0007499814841592997,0.0012999726251831,0,0,19985.0,143801.30885993244,ALPG
1960,KEGG_2019_Human,Folate biosynthesis,1/26,0.0012999726251831,0.0012999726251831,0,0,19974.0,132735.46073187632,ALPG
1961,KEGG_2019_Human,One carbon pool by folate,1/20,0.0009999772468562472,0.0019999544937124,0,0,19980.0,138017.40508704726,TYMS
1962,KEGG_2019_Human,Pyrimidine metabolism,1/57,0.002849953326298,0.002849953326298,0,0,19943.0,116875.00742975442,TYMS
1963,KEGG_2019_Human,Signaling pathways regulating pluripotency of stem cells,1/139,0.006949918172816,0.006949918172816,0,0,19861.0,98689.81333375497,ZFHX3
1964,KEGG_2019_Human,Renin-angiotensin system,1/23,0.0011499748819949,0.0011499748819949,0,0,19977.0,135204.63922267244,ATP6AP2
1965,KEGG_2019_Human,Regulation of lipolysis in adipocytes,1/55,0.0027499544131125,0.0090998738144064,0,0,19945.0,117599.1294878737,ADRB1
1966,KEGG_2019_Human,Renin secretion,1/69,0.003449947123837,0.0090998738144064,0,0,19931.0,112996.7391397682,ADRB1
1967,KEGG_2019_Human,Gap junction,1/88,0.0043999382262822,0.0090998738144064,0,0,19912.0,108045.79305232369,ADRB1
1968,KEGG_2019_Human,Salivary secretion,1/90,0.0044999373439762,0.0090998738144064,0,0,19910.0,107587.50385474482,ADRB1
1969,KEGG_2019_Human,Dilated cardiomyopathy (DCM),1/91,0.0045499369072032,0.0090998738144064,0,0,19909.0,107362.10783923086,ADRB1
1970,KEGG_2019_Human,Adrenergic signaling in cardiomyocytes,1/145,0.0072499160871101,0.0117498779626688,0,0,19855.0,97820.92670675044,ADRB1
1971,KEGG_2019_Human,cGMP-PKG signaling pathway,1/166,0.0082999091363732,0.0117498779626688,0,0,19834.0,95034.82345515196,ADRB1
1972,KEGG_2019_Human,Calcium signaling pathway,1/188,0.009399902370135,0.0117498779626688,0,0,19812.0,92463.712994847,ADRB1
1973,KEGG_2019_Human,cAMP signaling pathway,1/212,0.0105998955026255,0.0117776616695839,0,0,19788.0,89974.27756224656,ADRB1
1974,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,ADRB1
1975,KEGG_2019_Human,Tryptophan metabolism,1/42,0.0020999619311272,0.0020999619311272,0,0,19958.0,123057.75613441122,ACMSD
1976,KEGG_2019_Human,Renal cell carcinoma,1/69,0.003449947123837,0.0115998901349604,0,0,19931.0,112996.7391397682,PAK5
1977,KEGG_2019_Human,ErbB signaling pathway,1/85,0.004249939567045,0.0115998901349604,0,0,19915.0,108752.83801948265,PAK5
1978,KEGG_2019_Human,T cell receptor signaling pathway,1/101,0.0050499326546803,0.0115998901349604,0,0,19899.0,105233.48101229242,PAK5
1979,KEGG_2019_Human,Axon guidance,1/181,0.0090499044707863,0.0115998901349604,0,0,19819.0,93248.41634586031,PAK5
1980,KEGG_2019_Human,Focal adhesion,1/199,0.0099498991610159,0.0115998901349604,0,0,19801.0,91286.4288690606,PAK5
1981,KEGG_2019_Human,Human immunodeficiency virus 1 infection,1/212,0.0105998955026255,0.0115998901349604,0,0,19788.0,89974.27756224656,PAK5
1982,KEGG_2019_Human,Regulation of actin cytoskeleton,1/214,0.0106998949514067,0.0115998901349604,0,0,19786.0,89779.39753374986,PAK5
1983,KEGG_2019_Human,Ras signaling pathway,1/232,0.0115998901349604,0.0115998901349604,0,0,19768.0,88101.22480150245,PAK5
1984,KEGG_2019_Human,Ribosome,1/153,0.0076499133771537,0.0076499133771537,0,0,19847.0,96715.6407630817,MRPL14
1985,KEGG_2019_Human,Synaptic vesicle cycle,1/78,0.0038999427840466,0.007399915061391,0,0,19922.0,110503.2180492851,RIMS1
1986,KEGG_2019_Human,Retrograde endocannabinoid signaling,1/148,0.007399915061391,0.007399915061391,0,0,19852.0,97399.60470052566,RIMS1
1987,KEGG_2019_Human,Notch signaling pathway,1/48,0.0023999583567988,0.0095998334271952,0,0,19952.0,120356.5272753826,KAT2B
1988,KEGG_2019_Human,Thyroid hormone signaling pathway,1/116,0.0057999266512085,0.0109498935894162,0,0,19884.0,102400.8105961506,KAT2B
1989,KEGG_2019_Human,Viral carcinogenesis,1/201,0.0100498985877989,0.0109498935894162,0,0,19799.0,91079.21596609056,KAT2B
1990,KEGG_2019_Human,Human T-cell leukemia virus 1 infection,1/219,0.0109498935894162,0.0109498935894162,0,0,19781.0,89299.85161916987,KAT2B
1991,KEGG_2019_Human,Long-term depression,1/60,0.002999951725986,0.009807586003018,0,0,19940.0,115834.63209072244,PPP2CB
1992,KEGG_2019_Human,TGF-beta signaling pathway,1/90,0.0044999373439762,0.009807586003018,0,0,19910.0,107587.50385474482,PPP2CB
1993,KEGG_2019_Human,mRNA surveillance pathway,1/91,0.0045499369072032,0.009807586003018,0,0,19909.0,107362.10783923086,PPP2CB
1994,KEGG_2019_Human,Chagas disease (American trypanosomiasis),1/103,0.0051499318302617,0.009807586003018,0,0,19897.0,104832.7525292024,PPP2CB
1995,KEGG_2019_Human,Sphingolipid signaling pathway,1/119,0.0059499254985137,0.009807586003018,0,0,19881.0,101877.73080211312,PPP2CB
1996,KEGG_2019_Human,AMPK signaling pathway,1/120,0.0059999251180858,0.009807586003018,0,0,19880.0,101706.2448082016,PPP2CB
1997,KEGG_2019_Human,Oocyte meiosis,1/125,0.0062499232373748,0.009807586003018,0,0,19875.0,100869.32368441945,PPP2CB
1998,KEGG_2019_Human,Autophagy,1/128,0.0063999221281459,0.009807586003018,0,0,19872.0,100382.8010329652,PPP2CB
1999,KEGG_2019_Human,Dopaminergic synapse,1/131,0.0065499210316603,0.009807586003018,0,0,19869.0,99907.33811343512,PPP2CB
2000,KEGG_2019_Human,Adrenergic signaling in cardiomyocytes,1/145,0.0072499160871101,0.009807586003018,0,0,19855.0,97820.92670675044,PPP2CB
2001,KEGG_2019_Human,Hepatitis C,1/155,0.0077499127120574,0.009807586003018,0,0,19845.0,96448.16254952336,PPP2CB
2002,KEGG_2019_Human,Hippo signaling pathway,1/160,0.0079999110688441,0.009807586003018,0,0,19840.0,95793.96509856998,PPP2CB
2003,KEGG_2019_Human,Tight junction,1/170,0.0084999078692823,0.009807586003018,0,0,19830.0,94543.49009679438,PPP2CB
2004,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0176784294203191,0,0,19670.0,80733.60565076157,PPP2CB
2005,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0176998626413668,0,0,19646.0,79255.8617626126,PPP2CB
2006,KEGG_2019_Human,RNA transport,1/165,0.0082499094553477,0.0164998189106955,0,0,19835.0,95159.46482222488,EIF2B5
2007,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,EIF2B5
2008,KEGG_2019_Human,Alzheimer disease,1/171,0.0085499075557634,0.0085499075557634,0,0,19829.0,94422.42241345016,APBB1
2009,KEGG_2019_Human,Nitrogen metabolism,1/17,0.0008499797390404818,0.0008499797390404818,0,0,19983.0,141285.76583697114,CA14
2010,KEGG_2019_Human,"Parathyroid hormone synthesis, secretion and action",1/106,0.0052999306076525,0.0105998612153051,0,0,19894.0,104245.78450366124,AKAP13
2011,KEGG_2019_Human,Human cytomegalovirus infection,1/225,0.0112498919790339,0.0112498919790339,0,0,19775.0,88738.27077557483,AKAP13
2012,KEGG_2019_Human,VEGF signaling pathway,1/59,0.0029499522555206,0.0058999045110413,0,0,19941.0,116175.59385530632,MAPKAPK3
2013,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0147498749536506,0,0,19705.0,83086.53988020132,MAPKAPK3
2014,KEGG_2019_Human,Axon guidance,1/181,0.0090499044707863,0.0090499044707863,0,0,19819.0,93248.41634586031,SLIT1
2015,KEGG_2019_Human,Phagosome,1/152,0.0075999137114971,0.0089499050800561,0,0,19848.0,96850.665715497,MRC1
2016,KEGG_2019_Human,Tuberculosis,1/179,0.0089499050800561,0.0089499050800561,0,0,19821.0,93478.0629355712,MRC1
2017,KEGG_2019_Human,Glycerophospholipid metabolism,1/97,0.0048499343304706,0.0048499343304706,0,0,19903.0,106058.9096435903,PTDSS1
2018,KEGG_2019_Human,ECM-receptor interaction,1/82,0.004099940929819,0.0176998626413668,0,0,19918.0,109484.9180722932,TNR
2019,KEGG_2019_Human,Focal adhesion,1/199,0.0099498991610159,0.0176998626413668,0,0,19801.0,91286.4288690606,TNR
2020,KEGG_2019_Human,MicroRNAs in cancer,1/299,0.0149498740670514,0.0176998626413668,0,0,19701.0,82804.33538735632,TNR
2021,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0176998626413668,0,0,19670.0,80733.60565076157,TNR
2022,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0176998626413668,0,0,19646.0,79255.8617626126,TNR
2023,KEGG_2019_Human,Pathogenic Escherichia coli infection,1/55,0.0027499544131125,0.0111598464940509,0,0,19945.0,117599.1294878737,ITGB1
2024,KEGG_2019_Human,Shigellosis,1/65,0.003249949134407,0.0111598464940509,0,0,19935.0,114209.92613860144,ITGB1
2025,KEGG_2019_Human,Arrhythmogenic right ventricular cardiomyopathy (ARVC),1/72,0.0035999456502131,0.0111598464940509,0,0,19928.0,112131.59838572376,ITGB1
2026,KEGG_2019_Human,Bacterial invasion of epithelial cells,1/74,0.0036999446830449,0.0111598464940509,0,0,19926.0,111574.38983110404,ITGB1
2027,KEGG_2019_Human,Leishmaniasis,1/74,0.0036999446830449,0.0111598464940509,0,0,19926.0,111574.38983110404,ITGB1
2028,KEGG_2019_Human,Pertussis,1/76,0.0037999437281752,0.0111598464940509,0,0,19924.0,111031.8499691117,ITGB1
2029,KEGG_2019_Human,ECM-receptor interaction,1/82,0.004099940929819,0.0111598464940509,0,0,19918.0,109484.9180722932,ITGB1
2030,KEGG_2019_Human,Hypertrophic cardiomyopathy (HCM),1/85,0.004249939567045,0.0111598464940509,0,0,19915.0,108752.83801948265,ITGB1
2031,KEGG_2019_Human,Dilated cardiomyopathy (DCM),1/91,0.0045499369072032,0.0111598464940509,0,0,19909.0,107362.10783923086,ITGB1
2032,KEGG_2019_Human,Small cell lung cancer,1/93,0.0046499360391879,0.0111598464940509,0,0,19907.0,106918.54242106884,ITGB1
2033,KEGG_2019_Human,Leukocyte transendothelial migration,1/112,0.0055999282120529,0.0112998556382303,0,0,19888.0,103119.30984392198,ITGB1
2034,KEGG_2019_Human,Toxoplasmosis,1/113,0.0056499278191151,0.0112998556382303,0,0,19887.0,102937.34947211576,ITGB1
2035,KEGG_2019_Human,Platelet activation,1/124,0.0061999236097501,0.0114460128180002,0,0,19876.0,101034.04709010696,ITGB1
2036,KEGG_2019_Human,Cell adhesion molecules (CAMs),1/145,0.0072499160871101,0.0121598619383953,0,0,19855.0,97820.92670675044,ITGB1
2037,KEGG_2019_Human,Phagosome,1/152,0.0075999137114971,0.0121598619383953,0,0,19848.0,96850.665715497,ITGB1
2038,KEGG_2019_Human,Tight junction,1/170,0.0084999078692823,0.0122284513730363,0,0,19830.0,94543.49009679438,ITGB1
2039,KEGG_2019_Human,Axon guidance,1/181,0.0090499044707863,0.0122284513730363,0,0,19819.0,93248.41634586031,ITGB1
2040,KEGG_2019_Human,Focal adhesion,1/199,0.0099498991610159,0.0122284513730363,0,0,19801.0,91286.4288690606,ITGB1
2041,KEGG_2019_Human,Proteoglycans in cancer,1/201,0.0100498985877989,0.0122284513730363,0,0,19799.0,91079.21596609056,ITGB1
2042,KEGG_2019_Human,Rap1 signaling pathway,1/206,0.010299897173561,0.0122284513730363,0,0,19794.0,90569.849337325,ITGB1
2043,KEGG_2019_Human,Regulation of actin cytoskeleton,1/214,0.0106998949514067,0.0122284513730363,0,0,19786.0,89779.39753374986,ITGB1
2044,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0179998554097794,0,0,19670.0,80733.60565076157,ITGB1
2045,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0184694218866437,0,0,19646.0,79255.8617626126,ITGB1
2046,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,ITGB1
2047,KEGG_2019_Human,Phagosome,1/152,0.0075999137114971,0.0121998870519305,0,0,19848.0,96850.665715497,HGS
2048,KEGG_2019_Human,Endocytosis,1/244,0.0121998870519305,0.0121998870519305,0,0,19756.0,87051.4275316661,HGS
2049,KEGG_2019_Human,Cardiac muscle contraction,1/78,0.0038999427840466,0.0072499160871101,0,0,19922.0,110503.2180492851,MYL3
2050,KEGG_2019_Human,Hypertrophic cardiomyopathy (HCM),1/85,0.004249939567045,0.0072499160871101,0,0,19915.0,108752.83801948265,MYL3
2051,KEGG_2019_Human,Dilated cardiomyopathy (DCM),1/91,0.0045499369072032,0.0072499160871101,0,0,19909.0,107362.10783923086,MYL3
2052,KEGG_2019_Human,Apelin signaling pathway,1/137,0.0068499188797651,0.0072499160871101,0,0,19863.0,98987.62735269018,MYL3
2053,KEGG_2019_Human,Adrenergic signaling in cardiomyocytes,1/145,0.0072499160871101,0.0072499160871101,0,0,19855.0,97820.92670675044,MYL3
2054,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF786
2055,KEGG_2019_Human,Salmonella infection,1/86,0.0042999391173866,0.0133998647837319,0,0,19914.0,108514.46102290176,FLNB
2056,KEGG_2019_Human,Focal adhesion,1/199,0.0099498991610159,0.0133998647837319,0,0,19801.0,91286.4288690606,FLNB
2057,KEGG_2019_Human,Proteoglycans in cancer,1/201,0.0100498985877989,0.0133998647837319,0,0,19799.0,91079.21596609056,FLNB
2058,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0147498749536506,0,0,19705.0,83086.53988020132,FLNB
2059,KEGG_2019_Human,Tight junction,1/170,0.0084999078692823,0.0084999078692823,0,0,19830.0,94543.49009679438,TJP3
2060,KEGG_2019_Human,Homologous recombination,1/41,0.0020499625466866,0.0062499070068542,0,0,19959.0,123544.88783416104,BRCA2
2061,KEGG_2019_Human,Fanconi anemia pathway,1/54,0.0026999549628563,0.0062499070068542,0,0,19946.0,117971.01964061816,BRCA2
2062,KEGG_2019_Human,Pancreatic cancer,1/75,0.0037499442041125,0.0062499070068542,0,0,19925.0,111301.33528642564,BRCA2
2063,KEGG_2019_Human,Breast cancer,1/147,0.0073499154017982,0.0091873942522478,0,0,19853.0,97539.10874372096,BRCA2
2064,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,BRCA2
2065,KEGG_2019_Human,Basal cell carcinoma,1/63,0.0031499501598827,0.0115180602355462,0,0,19937.0,114844.46974572667,WNT5A
2066,KEGG_2019_Human,Melanogenesis,1/101,0.0050499326546803,0.0115180602355462,0,0,19899.0,105233.48101229242,WNT5A
2067,KEGG_2019_Human,Signaling pathways regulating pluripotency of stem cells,1/139,0.006949918172816,0.0115180602355462,0,0,19861.0,98689.81333375497,WNT5A
2068,KEGG_2019_Human,Breast cancer,1/147,0.0073499154017982,0.0115180602355462,0,0,19853.0,97539.10874372096,WNT5A
2069,KEGG_2019_Human,Gastric cancer,1/149,0.0074499147221605,0.0115180602355462,0,0,19851.0,97261.02051561224,WNT5A
2070,KEGG_2019_Human,mTOR signaling pathway,1/152,0.0075999137114971,0.0115180602355462,0,0,19848.0,96850.665715497,WNT5A
2071,KEGG_2019_Human,Cushing syndrome,1/155,0.0077499127120574,0.0115180602355462,0,0,19845.0,96448.16254952336,WNT5A
2072,KEGG_2019_Human,Wnt signaling pathway,1/158,0.0078999117225733,0.0115180602355462,0,0,19842.0,96053.2110949472,WNT5A
2073,KEGG_2019_Human,Hippo signaling pathway,1/160,0.0079999110688441,0.0115180602355462,0,0,19840.0,95793.96509856998,WNT5A
2074,KEGG_2019_Human,Hepatocellular carcinoma,1/168,0.0083999085011095,0.0115180602355462,0,0,19832.0,94787.72752807094,WNT5A
2075,KEGG_2019_Human,Axon guidance,1/181,0.0090499044707863,0.0115180602355462,0,0,19819.0,93248.41634586031,WNT5A
2076,KEGG_2019_Human,Proteoglycans in cancer,1/201,0.0100498985877989,0.0117248816857654,0,0,19799.0,91079.21596609056,WNT5A
2077,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.017769088032731,0,0,19670.0,80733.60565076157,WNT5A
2078,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,WNT5A
2079,KEGG_2019_Human,Glycosphingolipid biosynthesis,1/45,0.0022499601197094,0.0022499601197094,0,0,19955.0,121662.49782449217,GCNT2
2080,KEGG_2019_Human,Prolactin signaling pathway,1/70,0.0034999466296654,0.007916558633899,0,0,19930.0,112704.30065625212,TNFRSF11A
2081,KEGG_2019_Human,Rheumatoid arthritis,1/91,0.0045499369072032,0.007916558633899,0,0,19909.0,107362.10783923086,TNFRSF11A
2082,KEGG_2019_Human,NF-kappa B signaling pathway,1/95,0.0047499351803394,0.007916558633899,0,0,19905.0,106484.27183626965,TNFRSF11A
2083,KEGG_2019_Human,Osteoclast differentiation,1/127,0.0063499224962247,0.0079374031202809,0,0,19873.0,100543.72072014232,TNFRSF11A
2084,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0146998751759735,0,0,19706.0,83157.67014793828,TNFRSF11A
2085,KEGG_2019_Human,Glucagon signaling pathway,1/103,0.0051499318302617,0.0051499318302617,0,0,19897.0,104832.7525292024,SIK2
2086,KEGG_2019_Human,Protein processing in endoplasmic reticulum,1/165,0.0082499094553477,0.0082499094553477,0,0,19835.0,95159.46482222488,MBTPS1
2087,KEGG_2019_Human,Legionellosis,1/55,0.0027499544131125,0.0104498870125997,0,0,19945.0,117599.1294878737,HSPA1B
2088,KEGG_2019_Human,Antigen processing and presentation,1/77,0.0038499432547502,0.0104498870125997,0,0,19923.0,110765.8407373636,HSPA1B
2089,KEGG_2019_Human,Longevity regulating pathway,1/102,0.0050999322416682,0.0104498870125997,0,0,19898.0,105032.15064717118,HSPA1B
2090,KEGG_2019_Human,Toxoplasmosis,1/113,0.0056499278191151,0.0104498870125997,0,0,19887.0,102937.34947211576,HSPA1B
2091,KEGG_2019_Human,Spliceosome,1/134,0.0066999199497742,0.0104498870125997,0,0,19866.0,99442.43560916925,HSPA1B
2092,KEGG_2019_Human,Estrogen signaling pathway,1/137,0.0068499188797651,0.0104498870125997,0,0,19863.0,98987.62735269018,HSPA1B
2093,KEGG_2019_Human,Measles,1/138,0.0068999185254481,0.0104498870125997,0,0,19862.0,98838.19160389496,HSPA1B
2094,KEGG_2019_Human,Protein processing in endoplasmic reticulum,1/165,0.0082499094553477,0.0104498870125997,0,0,19835.0,95159.46482222488,HSPA1B
2095,KEGG_2019_Human,Influenza A,1/171,0.0085499075557634,0.0104498870125997,0,0,19829.0,94422.42241345016,HSPA1B
2096,KEGG_2019_Human,Endocytosis,1/244,0.0121998870519305,0.0134198757571236,0,0,19756.0,87051.4275316661,HSPA1B
2097,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0147498749536506,0,0,19705.0,83086.53988020132,HSPA1B
2098,KEGG_2019_Human,Mineral absorption,1/51,0.0025499566390179,0.0044999373439762,0,0,19949.0,119129.0228601236,TRPV6
2099,KEGG_2019_Human,Salivary secretion,1/90,0.0044999373439762,0.0044999373439762,0,0,19910.0,107587.50385474482,TRPV6
2100,KEGG_2019_Human,Taste transduction,1/83,0.0041499404726918,0.0041499404726918,0,0,19917.0,109237.99888847338,SCN9A
2101,KEGG_2019_Human,Hedgehog signaling pathway,1/47,0.0023499589392381,0.0023499589392381,0,0,19953.0,120782.64067395544,DHH
2102,KEGG_2019_Human,Primary bile acid biosynthesis,1/17,0.0008499797390404818,0.0008499797390404818,0,0,19983.0,141285.76583697114,CYP46A1
2103,KEGG_2019_Human,p53 signaling pathway,1/72,0.0035999456502131,0.0106665480917922,0,0,19928.0,112131.59838572376,CHEK2
2104,KEGG_2019_Human,Cell cycle,1/124,0.0061999236097501,0.0106665480917922,0,0,19876.0,101034.04709010696,CHEK2
2105,KEGG_2019_Human,Cellular senescence,1/160,0.0079999110688441,0.0106665480917922,0,0,19840.0,95793.96509856998,CHEK2
2106,KEGG_2019_Human,Human T-cell leukemia virus 1 infection,1/219,0.0109498935894162,0.0109498935894162,0,0,19781.0,89299.85161916987,CHEK2
2107,KEGG_2019_Human,Estrogen signaling pathway,1/137,0.0068499188797651,0.0068499188797651,0,0,19863.0,98987.62735269018,GPER1
2108,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF461
2109,KEGG_2019_Human,Endocytosis,1/244,0.0121998870519305,0.0121998870519305,0,0,19756.0,87051.4275316661,ZFYVE27
2110,KEGG_2019_Human,Protein digestion and absorption,1/90,0.0044999373439762,0.0044999373439762,0,0,19910.0,107587.50385474482,COL7A1
2111,KEGG_2019_Human,Glycerophospholipid metabolism,1/97,0.0048499343304706,0.0048499343304706,0,0,19903.0,106058.9096435903,GPD1
2112,KEGG_2019_Human,Protein processing in endoplasmic reticulum,1/165,0.0082499094553477,0.0082499094553477,0,0,19835.0,95159.46482222488,DNAJB2
2113,KEGG_2019_Human,Axon guidance,1/181,0.0090499044707863,0.0090499044707863,0,0,19819.0,93248.41634586031,PLXNA4
2114,KEGG_2019_Human,Glyoxylate and dicarboxylate metabolism,1/30,0.0014999697593334,0.00239995257067,0,0,19970.0,129851.13732048514,PCCB
2115,KEGG_2019_Human,Propanoate metabolism,1/32,0.0015999683804467,0.00239995257067,0,0,19968.0,128549.41955786056,PCCB
2116,KEGG_2019_Human,"Valine, leucine and isoleucine degradation",1/48,0.0023999583567988,0.0023999583567988,0,0,19952.0,120356.5272753826,PCCB
2117,KEGG_2019_Human,Ubiquitin mediated proteolysis,1/137,0.0068499188797651,0.0068499188797651,0,0,19863.0,98987.62735269018,HUWE1
2118,KEGG_2019_Human,RNA degradation,1/79,0.0039499423167337,0.0039499423167337,0,0,19921.0,110243.89578070649,BTG4
2119,KEGG_2019_Human,Parkinson disease,1/142,0.0070999171242726,0.0109498935894162,0,0,19858.0,98250.87390500787,SLC25A31
2120,KEGG_2019_Human,Cellular senescence,1/160,0.0079999110688441,0.0109498935894162,0,0,19840.0,95793.96509856998,SLC25A31
2121,KEGG_2019_Human,Necroptosis,1/162,0.0080999104202618,0.0109498935894162,0,0,19838.0,95537.86936302872,SLC25A31
2122,KEGG_2019_Human,cGMP-PKG signaling pathway,1/166,0.0082999091363732,0.0109498935894162,0,0,19834.0,95034.82345515196,SLC25A31
2123,KEGG_2019_Human,Calcium signaling pathway,1/188,0.009399902370135,0.0109498935894162,0,0,19812.0,92463.712994847,SLC25A31
2124,KEGG_2019_Human,Huntington disease,1/193,0.0096499008972596,0.0109498935894162,0,0,19807.0,91920.47679471428,SLC25A31
2125,KEGG_2019_Human,Human T-cell leukemia virus 1 infection,1/219,0.0109498935894162,0.0109498935894162,0,0,19781.0,89299.85161916987,SLC25A31
2126,KEGG_2019_Human,RNA transport,1/165,0.0082499094553477,0.0082499094553477,0,0,19835.0,95159.46482222488,GEMIN4
2127,KEGG_2019_Human,Estrogen signaling pathway,1/137,0.0068499188797651,0.0068499188797651,0,0,19863.0,98987.62735269018,KRT38
2128,KEGG_2019_Human,Osteoclast differentiation,1/127,0.0063499224962247,0.0063499224962247,0,0,19873.0,100543.72072014232,FOSL2
2129,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR5AC2
2130,KEGG_2019_Human,Hedgehog signaling pathway,1/47,0.0023499589392381,0.0036999446830449,0,0,19953.0,120782.64067395544,LRP2
2131,KEGG_2019_Human,Cholesterol metabolism,1/50,0.0024999572069037,0.0036999446830449,0,0,19950.0,119530.05920663515,LRP2
2132,KEGG_2019_Human,Thyroid hormone synthesis,1/74,0.0036999446830449,0.0036999446830449,0,0,19926.0,111574.38983110404,LRP2
2133,KEGG_2019_Human,Rap1 signaling pathway,1/206,0.010299897173561,0.010299897173561,0,0,19794.0,90569.849337325,DOCK4
2134,KEGG_2019_Human,Basal cell carcinoma,1/63,0.0031499501598827,0.0113123805884829,0,0,19937.0,114844.46974572667,WNT4
2135,KEGG_2019_Human,Melanogenesis,1/101,0.0050499326546803,0.0113123805884829,0,0,19899.0,105233.48101229242,WNT4
2136,KEGG_2019_Human,Thyroid hormone signaling pathway,1/116,0.0057999266512085,0.0113123805884829,0,0,19884.0,102400.8105961506,WNT4
2137,KEGG_2019_Human,Signaling pathways regulating pluripotency of stem cells,1/139,0.006949918172816,0.0113123805884829,0,0,19861.0,98689.81333375497,WNT4
2138,KEGG_2019_Human,Breast cancer,1/147,0.0073499154017982,0.0113123805884829,0,0,19853.0,97539.10874372096,WNT4
2139,KEGG_2019_Human,Gastric cancer,1/149,0.0074499147221605,0.0113123805884829,0,0,19851.0,97261.02051561224,WNT4
2140,KEGG_2019_Human,mTOR signaling pathway,1/152,0.0075999137114971,0.0113123805884829,0,0,19848.0,96850.665715497,WNT4
2141,KEGG_2019_Human,Cushing syndrome,1/155,0.0077499127120574,0.0113123805884829,0,0,19845.0,96448.16254952336,WNT4
2142,KEGG_2019_Human,Wnt signaling pathway,1/158,0.0078999117225733,0.0113123805884829,0,0,19842.0,96053.2110949472,WNT4
2143,KEGG_2019_Human,Hippo signaling pathway,1/160,0.0079999110688441,0.0113123805884829,0,0,19840.0,95793.96509856998,WNT4
2144,KEGG_2019_Human,Hepatocellular carcinoma,1/168,0.0083999085011095,0.0113123805884829,0,0,19832.0,94787.72752807094,WNT4
2145,KEGG_2019_Human,Axon guidance,1/181,0.0090499044707863,0.0113123805884829,0,0,19819.0,93248.41634586031,WNT4
2146,KEGG_2019_Human,Proteoglycans in cancer,1/201,0.0100498985877989,0.0115960368320757,0,0,19799.0,91079.21596609056,WNT4
2147,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0176784294203191,0,0,19670.0,80733.60565076157,WNT4
2148,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,WNT4
2149,KEGG_2019_Human,Protein processing in endoplasmic reticulum,1/165,0.0082499094553477,0.0082499094553477,0,0,19835.0,95159.46482222488,CKAP4
2150,KEGG_2019_Human,Neurotrophin signaling pathway,1/119,0.0059499254985137,0.0059499254985137,0,0,19881.0,101877.73080211312,MAGED1
2151,KEGG_2019_Human,Ferroptosis,1/40,0.0019999631680592,0.0038249349585269,0,0,19960.0,124043.94523066044,TF
2152,KEGG_2019_Human,Mineral absorption,1/51,0.0025499566390179,0.0038249349585269,0,0,19949.0,119129.0228601236,TF
2153,KEGG_2019_Human,HIF-1 signaling pathway,1/100,0.0049999330710556,0.0049999330710556,0,0,19900.0,105436.78197328727,TF
2154,KEGG_2019_Human,Pentose phosphate pathway,1/30,0.0014999697593334,0.0014999697593334,0,0,19970.0,129851.13732048514,TKTL1
2155,KEGG_2019_Human,Chemokine signaling pathway,1/190,0.0094999017791995,0.0146998751759735,0,0,19810.0,92244.74636351672,CCL16
2156,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0146998751759735,0,0,19706.0,83157.67014793828,CCL16
2157,KEGG_2019_Human,Staphylococcus aureus infection,1/68,0.0033999476216189,0.0039499423167337,0,0,19932.0,113293.39338050144,MASP1
2158,KEGG_2019_Human,Complement and coagulation cascades,1/79,0.0039499423167337,0.0039499423167337,0,0,19921.0,110243.89578070649,MASP1
2159,KEGG_2019_Human,Hippo signaling pathway,1/160,0.0079999110688441,0.0079999110688441,0,0,19840.0,95793.96509856998,DCHS2
2160,KEGG_2019_Human,Ribosome biogenesis in eukaryotes,1/101,0.0050499326546803,0.0050499326546803,0,0,19899.0,105233.48101229242,FBL
2161,KEGG_2019_Human,Spliceosome,1/134,0.0066999199497742,0.0066999199497742,0,0,19866.0,99442.43560916925,RBMXL3
2162,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR4F5
2163,KEGG_2019_Human,Taste transduction,1/83,0.0041499404726918,0.0056499278191151,0,0,19917.0,109237.99888847338,HTR3D
2164,KEGG_2019_Human,Serotonergic synapse,1/113,0.0056499278191151,0.0056499278191151,0,0,19887.0,102937.34947211576,HTR3D
2165,KEGG_2019_Human,Tight junction,1/170,0.0084999078692823,0.0084999078692823,0,0,19830.0,94543.49009679438,MYH7B
2166,KEGG_2019_Human,African trypanosomiasis,1/37,0.0018499650702878,0.0097639803052533,0,0,19963.0,125618.9446446357,PRKCA
2167,KEGG_2019_Human,Aldosterone-regulated sodium reabsorption,1/37,0.0018499650702878,0.0097639803052533,0,0,19963.0,125618.9446446357,PRKCA
2168,KEGG_2019_Human,Endocrine and other factor-regulated calcium reabsorption,1/48,0.0023999583567988,0.0097639803052533,0,0,19952.0,120356.5272753826,PRKCA
2169,KEGG_2019_Human,Vibrio cholerae infection,1/50,0.0024999572069037,0.0097639803052533,0,0,19950.0,119530.05920663515,PRKCA
2170,KEGG_2019_Human,Pathogenic Escherichia coli infection,1/55,0.0027499544131125,0.0097639803052533,0,0,19945.0,117599.1294878737,PRKCA
2171,KEGG_2019_Human,VEGF signaling pathway,1/59,0.0029499522555206,0.0097639803052533,0,0,19941.0,116175.59385530632,PRKCA
2172,KEGG_2019_Human,Long-term depression,1/60,0.002999951725986,0.0097639803052533,0,0,19940.0,115834.63209072244,PRKCA
2173,KEGG_2019_Human,Non-small cell lung cancer,1/66,0.003299948626608,0.0097639803052533,0,0,19934.0,113899.85357353876,PRKCA
2174,KEGG_2019_Human,Long-term potentiation,1/67,0.0033499481224912,0.0097639803052533,0,0,19933.0,113594.38808369274,PRKCA
2175,KEGG_2019_Human,Amphetamine addiction,1/68,0.0033999476216189,0.0097639803052533,0,0,19932.0,113293.39338050144,PRKCA
2176,KEGG_2019_Human,Fc epsilon RI signaling pathway,1/68,0.0033999476216189,0.0097639803052533,0,0,19932.0,113293.39338050144,PRKCA
2177,KEGG_2019_Human,Thyroid hormone synthesis,1/74,0.0036999446830449,0.0097639803052533,0,0,19926.0,111574.38983110404,PRKCA
2178,KEGG_2019_Human,Gastric acid secretion,1/75,0.0037499442041125,0.0097639803052533,0,0,19925.0,111301.33528642564,PRKCA
2179,KEGG_2019_Human,Glioma,1/75,0.0037499442041125,0.0097639803052533,0,0,19925.0,111301.33528642564,PRKCA
2180,KEGG_2019_Human,ErbB signaling pathway,1/85,0.004249939567045,0.0097639803052533,0,0,19915.0,108752.83801948265,PRKCA
2181,KEGG_2019_Human,Insulin secretion,1/86,0.0042999391173866,0.0097639803052533,0,0,19914.0,108514.46102290176,PRKCA
2182,KEGG_2019_Human,Gap junction,1/88,0.0043999382262822,0.0097639803052533,0,0,19912.0,108045.79305232369,PRKCA
2183,KEGG_2019_Human,GABAergic synapse,1/89,0.0044499377838098,0.0097639803052533,0,0,19911.0,107815.380281759,PRKCA
2184,KEGG_2019_Human,Salivary secretion,1/90,0.0044999373439762,0.0097639803052533,0,0,19910.0,107587.50385474482,PRKCA
2185,KEGG_2019_Human,Morphine addiction,1/91,0.0045499369072032,0.0097639803052533,0,0,19909.0,107362.10783923086,PRKCA
2186,KEGG_2019_Human,Fc gamma R-mediated phagocytosis,1/91,0.0045499369072032,0.0097639803052533,0,0,19909.0,107362.10783923086,PRKCA
2187,KEGG_2019_Human,GnRH signaling pathway,1/93,0.0046499360391879,0.0097639803052533,0,0,19907.0,106918.54242106884,PRKCA
2188,KEGG_2019_Human,Amoebiasis,1/96,0.0047999347538706,0.0097639803052533,0,0,19904.0,106270.50039849174,PRKCA
2189,KEGG_2019_Human,Circadian entrainment,1/97,0.0048499343304706,0.0097639803052533,0,0,19903.0,106058.9096435903,PRKCA
2190,KEGG_2019_Human,Aldosterone synthesis and secretion,1/98,0.0048999339081079,0.0097639803052533,0,0,19902.0,105849.45495286948,PRKCA
2191,KEGG_2019_Human,Pancreatic secretion,1/98,0.0048999339081079,0.0097639803052533,0,0,19902.0,105849.45495286948,PRKCA
2192,KEGG_2019_Human,Choline metabolism in cancer,1/99,0.0049499334884068,0.0097639803052533,0,0,19901.0,105642.09305076736,PRKCA
2193,KEGG_2019_Human,Phosphatidylinositol signaling system,1/99,0.0049499334884068,0.0097639803052533,0,0,19901.0,105642.09305076736,PRKCA
2194,KEGG_2019_Human,AGE-RAGE signaling pathway in diabetic complications,1/100,0.0049999330710556,0.0097639803052533,0,0,19900.0,105436.78197328727,PRKCA
2195,KEGG_2019_Human,Inflammatory mediator regulation of TRP channels,1/100,0.0049999330710556,0.0097639803052533,0,0,19900.0,105436.78197328727,PRKCA
2196,KEGG_2019_Human,HIF-1 signaling pathway,1/100,0.0049999330710556,0.0097639803052533,0,0,19900.0,105436.78197328727,PRKCA
2197,KEGG_2019_Human,Melanogenesis,1/101,0.0050499326546803,0.0097639803052533,0,0,19899.0,105233.48101229242,PRKCA
2198,KEGG_2019_Human,"Parathyroid hormone synthesis, secretion and action",1/106,0.0052999306076525,0.0097639803052533,0,0,19894.0,104245.78450366124,PRKCA
2199,KEGG_2019_Human,Leukocyte transendothelial migration,1/112,0.0055999282120529,0.0097639803052533,0,0,19888.0,103119.30984392198,PRKCA
2200,KEGG_2019_Human,Cholinergic synapse,1/112,0.0055999282120529,0.0097639803052533,0,0,19888.0,103119.30984392198,PRKCA
2201,KEGG_2019_Human,Serotonergic synapse,1/113,0.0056499278191151,0.0097639803052533,0,0,19887.0,102937.34947211576,PRKCA
2202,KEGG_2019_Human,Glutamatergic synapse,1/114,0.005699927427839,0.0097639803052533,0,0,19886.0,102756.96431429044,PRKCA
2203,KEGG_2019_Human,Thyroid hormone signaling pathway,1/116,0.0057999266512085,0.0097639803052533,0,0,19884.0,102400.8105961506,PRKCA
2204,KEGG_2019_Human,Sphingolipid signaling pathway,1/119,0.0059499254985137,0.0097639803052533,0,0,19881.0,101877.73080211312,PRKCA
2205,KEGG_2019_Human,Relaxin signaling pathway,1/130,0.0064999213952527,0.0098231377412455,0,0,19870.0,100064.62842845908,PRKCA
2206,KEGG_2019_Human,Natural killer cell mediated cytotoxicity,1/131,0.0065499210316603,0.0098231377412455,0,0,19869.0,99907.33811343512,PRKCA
2207,KEGG_2019_Human,Dopaminergic synapse,1/131,0.0065499210316603,0.0098231377412455,0,0,19869.0,99907.33811343512,PRKCA
2208,KEGG_2019_Human,Vascular smooth muscle contraction,1/132,0.0065999206698993,0.0098231377412455,0,0,19868.0,99751.22090491928,PRKCA
2209,KEGG_2019_Human,Adrenergic signaling in cardiomyocytes,1/145,0.0072499160871101,0.0101998845028717,0,0,19855.0,97820.92670675044,PRKCA
2210,KEGG_2019_Human,Phospholipase D signaling pathway,1/148,0.007399915061391,0.0101998845028717,0,0,19852.0,97399.60470052566,PRKCA
2211,KEGG_2019_Human,Retrograde endocannabinoid signaling,1/148,0.007399915061391,0.0101998845028717,0,0,19852.0,97399.60470052566,PRKCA
2212,KEGG_2019_Human,mTOR signaling pathway,1/152,0.0075999137114971,0.0101998845028717,0,0,19848.0,96850.665715497,PRKCA
2213,KEGG_2019_Human,Oxytocin signaling pathway,1/153,0.0076499133771537,0.0101998845028717,0,0,19847.0,96715.6407630817,PRKCA
2214,KEGG_2019_Human,Wnt signaling pathway,1/158,0.0078999117225733,0.01031825204581,0,0,19842.0,96053.2110949472,PRKCA
2215,KEGG_2019_Human,Hepatitis B,1/163,0.0081499100978668,0.0104318849252695,0,0,19837.0,95410.9786681514,PRKCA
2216,KEGG_2019_Human,Hepatocellular carcinoma,1/168,0.0083999085011095,0.0105229631455549,0,0,19832.0,94787.72752807094,PRKCA
2217,KEGG_2019_Human,Influenza A,1/171,0.0085499075557634,0.0105229631455549,0,0,19829.0,94422.42241345016,PRKCA
2218,KEGG_2019_Human,Axon guidance,1/181,0.0090499044707863,0.0109281865307608,0,0,19819.0,93248.41634586031,PRKCA
2219,KEGG_2019_Human,Calcium signaling pathway,1/188,0.009399902370135,0.0111406250312711,0,0,19812.0,92463.712994847,PRKCA
2220,KEGG_2019_Human,Focal adhesion,1/199,0.0099498991610159,0.0114855983860559,0,0,19801.0,91286.4288690606,PRKCA
2221,KEGG_2019_Human,Proteoglycans in cancer,1/201,0.0100498985877989,0.0114855983860559,0,0,19799.0,91079.21596609056,PRKCA
2222,KEGG_2019_Human,Rap1 signaling pathway,1/206,0.010299897173561,0.0115647968264545,0,0,19794.0,90569.849337325,PRKCA
2223,KEGG_2019_Human,Human immunodeficiency virus 1 infection,1/212,0.0105998955026255,0.0116964364166903,0,0,19788.0,89974.27756224656,PRKCA
2224,KEGG_2019_Human,Human cytomegalovirus infection,1/225,0.0112498919790339,0.0122032726552232,0,0,19775.0,88738.27077557483,PRKCA
2225,KEGG_2019_Human,Ras signaling pathway,1/232,0.0115998901349604,0.0123732161439577,0,0,19768.0,88101.22480150245,PRKCA
2226,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0154321280692143,0,0,19705.0,83086.53988020132,PRKCA
2227,KEGG_2019_Human,MicroRNAs in cancer,1/299,0.0149498740670514,0.0154321280692143,0,0,19701.0,82804.33538735632,PRKCA
2228,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0179808128420234,0,0,19646.0,79255.8617626126,PRKCA
2229,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,PRKCA
2230,KEGG_2019_Human,Circadian rhythm,1/31,0.0015499690656704,0.0089248989400127,0,0,19969.0,129189.85098816035,PRKAG1
2231,KEGG_2019_Human,Adipocytokine signaling pathway,1/69,0.003449947123837,0.0089248989400127,0,0,19931.0,112996.7391397682,PRKAG1
2232,KEGG_2019_Human,Hypertrophic cardiomyopathy (HCM),1/85,0.004249939567045,0.0089248989400127,0,0,19915.0,108752.83801948265,PRKAG1
2233,KEGG_2019_Human,Longevity regulating pathway,1/102,0.0050999322416682,0.0089248989400127,0,0,19898.0,105032.15064717118,PRKAG1
2234,KEGG_2019_Human,Glucagon signaling pathway,1/103,0.0051499318302617,0.0089248989400127,0,0,19897.0,104832.7525292024,PRKAG1
2235,KEGG_2019_Human,Insulin resistance,1/108,0.0053999298011749,0.0089248989400127,0,0,19892.0,103863.47861844616,PRKAG1
2236,KEGG_2019_Human,AMPK signaling pathway,1/120,0.0059999251180858,0.0089248989400127,0,0,19880.0,101706.2448082016,PRKAG1
2237,KEGG_2019_Human,FoxO signaling pathway,1/132,0.0065999206698993,0.0089248989400127,0,0,19868.0,99751.22090491928,PRKAG1
2238,KEGG_2019_Human,Insulin signaling pathway,1/137,0.0068499188797651,0.0089248989400127,0,0,19863.0,98987.62735269018,PRKAG1
2239,KEGG_2019_Human,Apelin signaling pathway,1/137,0.0068499188797651,0.0089248989400127,0,0,19863.0,98987.62735269018,PRKAG1
2240,KEGG_2019_Human,Non-alcoholic fatty liver disease (NAFLD),1/149,0.0074499147221605,0.0089248989400127,0,0,19851.0,97261.02051561224,PRKAG1
2241,KEGG_2019_Human,Oxytocin signaling pathway,1/153,0.0076499133771537,0.0089248989400127,0,0,19847.0,96715.6407630817,PRKAG1
2242,KEGG_2019_Human,Tight junction,1/170,0.0084999078692823,0.0091537469361502,0,0,19830.0,94543.49009679438,PRKAG1
2243,KEGG_2019_Human,Thermogenesis,1/231,0.0115498903940656,0.0115498903940656,0,0,19769.0,88191.07730937863,PRKAG1
2244,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF780B
2245,KEGG_2019_Human,Wnt signaling pathway,1/158,0.0078999117225733,0.0078999117225733,0,0,19842.0,96053.2110949472,DAAM2
2246,KEGG_2019_Human,Glycerolipid metabolism,1/61,0.0030499512001654,0.0061874168605085,0,0,19939.0,115499.24335773686,DGKH
2247,KEGG_2019_Human,Glycerophospholipid metabolism,1/97,0.0048499343304706,0.0061874168605085,0,0,19903.0,106058.9096435903,DGKH
2248,KEGG_2019_Human,Phosphatidylinositol signaling system,1/99,0.0049499334884068,0.0061874168605085,0,0,19901.0,105642.09305076736,DGKH
2249,KEGG_2019_Human,Choline metabolism in cancer,1/99,0.0049499334884068,0.0061874168605085,0,0,19901.0,105642.09305076736,DGKH
2250,KEGG_2019_Human,Phospholipase D signaling pathway,1/148,0.007399915061391,0.007399915061391,0,0,19852.0,97399.60470052566,DGKH
2251,KEGG_2019_Human,Pyrimidine metabolism,1/57,0.002849953326298,0.0053999298011749,0,0,19943.0,116875.00742975442,UCK1
2252,KEGG_2019_Human,Drug metabolism,1/108,0.0053999298011749,0.0053999298011749,0,0,19892.0,103863.47861844616,UCK1
2253,KEGG_2019_Human,ECM-receptor interaction,1/82,0.004099940929819,0.0112998556382303,0,0,19918.0,109484.9180722932,LAMB2
2254,KEGG_2019_Human,Small cell lung cancer,1/93,0.0046499360391879,0.0112998556382303,0,0,19907.0,106918.54242106884,LAMB2
2255,KEGG_2019_Human,Amoebiasis,1/96,0.0047999347538706,0.0112998556382303,0,0,19904.0,106270.50039849174,LAMB2
2256,KEGG_2019_Human,Toxoplasmosis,1/113,0.0056499278191151,0.0112998556382303,0,0,19887.0,102937.34947211576,LAMB2
2257,KEGG_2019_Human,Focal adhesion,1/199,0.0099498991610159,0.0159198386576255,0,0,19801.0,91286.4288690606,LAMB2
2258,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0202284144472764,0,0,19670.0,80733.60565076157,LAMB2
2259,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0202284144472764,0,0,19646.0,79255.8617626126,LAMB2
2260,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,LAMB2
2261,KEGG_2019_Human,Renal cell carcinoma,1/69,0.003449947123837,0.0148152391634863,0,0,19931.0,112996.7391397682,PDGFB
2262,KEGG_2019_Human,Melanoma,1/72,0.0035999456502131,0.0148152391634863,0,0,19928.0,112131.59838572376,PDGFB
2263,KEGG_2019_Human,Glioma,1/75,0.0037499442041125,0.0148152391634863,0,0,19925.0,111301.33528642564,PDGFB
2264,KEGG_2019_Human,Gap junction,1/88,0.0043999382262822,0.0148152391634863,0,0,19912.0,108045.79305232369,PDGFB
2265,KEGG_2019_Human,Prostate cancer,1/97,0.0048499343304706,0.0148152391634863,0,0,19903.0,106058.9096435903,PDGFB
2266,KEGG_2019_Human,Choline metabolism in cancer,1/99,0.0049499334884068,0.0148152391634863,0,0,19901.0,105642.09305076736,PDGFB
2267,KEGG_2019_Human,Fluid shear stress and atherosclerosis,1/139,0.006949918172816,0.0148152391634863,0,0,19861.0,98689.81333375497,PDGFB
2268,KEGG_2019_Human,Phospholipase D signaling pathway,1/148,0.007399915061391,0.0148152391634863,0,0,19852.0,97399.60470052566,PDGFB
2269,KEGG_2019_Human,JAK-STAT signaling pathway,1/162,0.0080999104202618,0.0148152391634863,0,0,19838.0,95537.86936302872,PDGFB
2270,KEGG_2019_Human,Kaposi sarcoma-associated herpesvirus infection,1/186,0.0092999029651357,0.0148152391634863,0,0,19814.0,92684.96451050608,PDGFB
2271,KEGG_2019_Human,Focal adhesion,1/199,0.0099498991610159,0.0148152391634863,0,0,19801.0,91286.4288690606,PDGFB
2272,KEGG_2019_Human,Rap1 signaling pathway,1/206,0.010299897173561,0.0148152391634863,0,0,19794.0,90569.849337325,PDGFB
2273,KEGG_2019_Human,Regulation of actin cytoskeleton,1/214,0.0106998949514067,0.0148152391634863,0,0,19786.0,89779.39753374986,PDGFB
2274,KEGG_2019_Human,Ras signaling pathway,1/232,0.0115998901349604,0.0149141444592348,0,0,19768.0,88101.22480150245,PDGFB
2275,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0168186083254328,0,0,19705.0,83086.53988020132,PDGFB
2276,KEGG_2019_Human,MicroRNAs in cancer,1/299,0.0149498740670514,0.0168186083254328,0,0,19701.0,82804.33538735632,PDGFB
2277,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0187410310320355,0,0,19646.0,79255.8617626126,PDGFB
2278,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,PDGFB
2279,KEGG_2019_Human,Viral myocarditis,1/59,0.0029499522555206,0.0058999045110413,0,0,19941.0,116175.59385530632,EIF4G3
2280,KEGG_2019_Human,RNA transport,1/165,0.0082499094553477,0.0082499094553477,0,0,19835.0,95159.46482222488,EIF4G3
2281,KEGG_2019_Human,mRNA surveillance pathway,1/91,0.0045499369072032,0.0103887762846784,0,0,19909.0,107362.10783923086,PPP2R2B
2282,KEGG_2019_Human,Chagas disease (American trypanosomiasis),1/103,0.0051499318302617,0.0103887762846784,0,0,19897.0,104832.7525292024,PPP2R2B
2283,KEGG_2019_Human,Sphingolipid signaling pathway,1/119,0.0059499254985137,0.0103887762846784,0,0,19881.0,101877.73080211312,PPP2R2B
2284,KEGG_2019_Human,AMPK signaling pathway,1/120,0.0059999251180858,0.0103887762846784,0,0,19880.0,101706.2448082016,PPP2R2B
2285,KEGG_2019_Human,Dopaminergic synapse,1/131,0.0065499210316603,0.0103887762846784,0,0,19869.0,99907.33811343512,PPP2R2B
2286,KEGG_2019_Human,Adrenergic signaling in cardiomyocytes,1/145,0.0072499160871101,0.0103887762846784,0,0,19855.0,97820.92670675044,PPP2R2B
2287,KEGG_2019_Human,Hepatitis C,1/155,0.0077499127120574,0.0103887762846784,0,0,19845.0,96448.16254952336,PPP2R2B
2288,KEGG_2019_Human,Hippo signaling pathway,1/160,0.0079999110688441,0.0103887762846784,0,0,19840.0,95793.96509856998,PPP2R2B
2289,KEGG_2019_Human,Tight junction,1/170,0.0084999078692823,0.0103887762846784,0,0,19830.0,94543.49009679438,PPP2R2B
2290,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0176998626413668,0,0,19670.0,80733.60565076157,PPP2R2B
2291,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0176998626413668,0,0,19646.0,79255.8617626126,PPP2R2B
2292,KEGG_2019_Human,Arrhythmogenic right ventricular cardiomyopathy (ARVC),1/72,0.0035999456502131,0.011374842268008,0,0,19928.0,112131.59838572376,ITGB5
2293,KEGG_2019_Human,ECM-receptor interaction,1/82,0.004099940929819,0.011374842268008,0,0,19918.0,109484.9180722932,ITGB5
2294,KEGG_2019_Human,Hypertrophic cardiomyopathy (HCM),1/85,0.004249939567045,0.011374842268008,0,0,19915.0,108752.83801948265,ITGB5
2295,KEGG_2019_Human,Dilated cardiomyopathy (DCM),1/91,0.0045499369072032,0.011374842268008,0,0,19909.0,107362.10783923086,ITGB5
2296,KEGG_2019_Human,Phagosome,1/152,0.0075999137114971,0.0133748686892584,0,0,19848.0,96850.665715497,ITGB5
2297,KEGG_2019_Human,Focal adhesion,1/199,0.0099498991610159,0.0133748686892584,0,0,19801.0,91286.4288690606,ITGB5
2298,KEGG_2019_Human,Proteoglycans in cancer,1/201,0.0100498985877989,0.0133748686892584,0,0,19799.0,91079.21596609056,ITGB5
2299,KEGG_2019_Human,Regulation of actin cytoskeleton,1/214,0.0106998949514067,0.0133748686892584,0,0,19786.0,89779.39753374986,ITGB5
2300,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0176998626413668,0,0,19670.0,80733.60565076157,ITGB5
2301,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0176998626413668,0,0,19646.0,79255.8617626126,ITGB5
2302,KEGG_2019_Human,Phosphatidylinositol signaling system,1/99,0.0049499334884068,0.0049499334884068,0,0,19901.0,105642.09305076736,IP6K3
2303,KEGG_2019_Human,Progesterone-mediated oocyte maturation,1/99,0.0049499334884068,0.0085623985997064,0,0,19901.0,105642.09305076736,ANAPC2
2304,KEGG_2019_Human,Cell cycle,1/124,0.0061999236097501,0.0085623985997064,0,0,19876.0,101034.04709010696,ANAPC2
2305,KEGG_2019_Human,Oocyte meiosis,1/125,0.0062499232373748,0.0085623985997064,0,0,19875.0,100869.32368441945,ANAPC2
2306,KEGG_2019_Human,Ubiquitin mediated proteolysis,1/137,0.0068499188797651,0.0085623985997064,0,0,19863.0,98987.62735269018,ANAPC2
2307,KEGG_2019_Human,Human T-cell leukemia virus 1 infection,1/219,0.0109498935894162,0.0109498935894162,0,0,19781.0,89299.85161916987,ANAPC2
2308,KEGG_2019_Human,Notch signaling pathway,1/48,0.0023999583567988,0.0091998729439731,0,0,19952.0,120356.5272753826,JAG2
2309,KEGG_2019_Human,Th1 and Th2 cell differentiation,1/92,0.0045999364719865,0.0091998729439731,0,0,19908.0,107139.13814408927,JAG2
2310,KEGG_2019_Human,Breast cancer,1/147,0.0073499154017982,0.0097998872023976,0,0,19853.0,97539.10874372096,JAG2
2311,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,JAG2
2312,KEGG_2019_Human,"Parathyroid hormone synthesis, secretion and action",1/106,0.0052999306076525,0.0108498867926584,0,0,19894.0,104245.78450366124,MEF2C
2313,KEGG_2019_Human,Apelin signaling pathway,1/137,0.0068499188797651,0.0108498867926584,0,0,19863.0,98987.62735269018,MEF2C
2314,KEGG_2019_Human,Fluid shear stress and atherosclerosis,1/139,0.006949918172816,0.0108498867926584,0,0,19861.0,98689.81333375497,MEF2C
2315,KEGG_2019_Human,Oxytocin signaling pathway,1/153,0.0076499133771537,0.0108498867926584,0,0,19847.0,96715.6407630817,MEF2C
2316,KEGG_2019_Human,cGMP-PKG signaling pathway,1/166,0.0082999091363732,0.0108498867926584,0,0,19834.0,95034.82345515196,MEF2C
2317,KEGG_2019_Human,Transcriptional misregulation in cancer,1/186,0.0092999029651357,0.0108498867926584,0,0,19814.0,92684.96451050608,MEF2C
2318,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0147498749536506,0,0,19705.0,83086.53988020132,MEF2C
2319,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,ANO2
2320,KEGG_2019_Human,Circadian rhythm,1/31,0.0015499690656704,0.0015499690656704,0,0,19969.0,129189.85098816035,RORB
2321,KEGG_2019_Human,Regulation of lipolysis in adipocytes,1/55,0.0027499544131125,0.0085623985997064,0,0,19945.0,117599.1294878737,PDE3B
2322,KEGG_2019_Human,Renin secretion,1/69,0.003449947123837,0.0085623985997064,0,0,19931.0,112996.7391397682,PDE3B
2323,KEGG_2019_Human,Morphine addiction,1/91,0.0045499369072032,0.0085623985997064,0,0,19909.0,107362.10783923086,PDE3B
2324,KEGG_2019_Human,Progesterone-mediated oocyte maturation,1/99,0.0049499334884068,0.0085623985997064,0,0,19901.0,105642.09305076736,PDE3B
2325,KEGG_2019_Human,Glucagon signaling pathway,1/103,0.0051499318302617,0.0085623985997064,0,0,19897.0,104832.7525292024,PDE3B
2326,KEGG_2019_Human,Purine metabolism,1/129,0.006449921761047,0.0085623985997064,0,0,19871.0,100223.109907462,PDE3B
2327,KEGG_2019_Human,Apelin signaling pathway,1/137,0.0068499188797651,0.0085623985997064,0,0,19863.0,98987.62735269018,PDE3B
2328,KEGG_2019_Human,Insulin signaling pathway,1/137,0.0068499188797651,0.0085623985997064,0,0,19863.0,98987.62735269018,PDE3B
2329,KEGG_2019_Human,cGMP-PKG signaling pathway,1/166,0.0082999091363732,0.0092221212626369,0,0,19834.0,95034.82345515196,PDE3B
2330,KEGG_2019_Human,cAMP signaling pathway,1/212,0.0105998955026255,0.0105998955026255,0,0,19788.0,89974.27756224656,PDE3B
2331,KEGG_2019_Human,Endocytosis,1/244,0.0121998870519305,0.0121998870519305,0,0,19756.0,87051.4275316661,WASHC2C
2332,KEGG_2019_Human,FoxO signaling pathway,1/132,0.0065999206698993,0.0065999206698993,0,0,19868.0,99751.22090491928,FOXO6
2333,KEGG_2019_Human,Oxidative phosphorylation,1/133,0.0066499203093911,0.0112582177134695,0,0,19867.0,99596.2591544721,NDUFB9
2334,KEGG_2019_Human,Parkinson disease,1/142,0.0070999171242726,0.0112582177134695,0,0,19858.0,98250.87390500787,NDUFB9
2335,KEGG_2019_Human,Retrograde endocannabinoid signaling,1/148,0.007399915061391,0.0112582177134695,0,0,19852.0,97399.60470052566,NDUFB9
2336,KEGG_2019_Human,Non-alcoholic fatty liver disease (NAFLD),1/149,0.0074499147221605,0.0112582177134695,0,0,19851.0,97261.02051561224,NDUFB9
2337,KEGG_2019_Human,Alzheimer disease,1/171,0.0085499075557634,0.0112582177134695,0,0,19829.0,94422.42241345016,NDUFB9
2338,KEGG_2019_Human,Huntington disease,1/193,0.0096499008972596,0.0112582177134695,0,0,19807.0,91920.47679471428,NDUFB9
2339,KEGG_2019_Human,Thermogenesis,1/231,0.0115498903940656,0.0115498903940656,0,0,19769.0,88191.07730937863,NDUFB9
2340,KEGG_2019_Human,RNA transport,1/165,0.0082499094553477,0.0082499094553477,0,0,19835.0,95159.46482222488,POM121
2341,KEGG_2019_Human,Ferroptosis,1/40,0.0019999631680592,0.0019999631680592,0,0,19960.0,124043.94523066044,PCBP2
2342,KEGG_2019_Human,Biosynthesis of unsaturated fatty acids,1/27,0.0013499718942362,0.0013499718942362,0,0,19973.0,131975.02298599784,FADS1
2343,KEGG_2019_Human,Thyroid cancer,1/37,0.0018499650702878,0.0036999301405757,0,0,19963.0,125618.9446446357,CCDC6
2344,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,CCDC6
2345,KEGG_2019_Human,Ribosome biogenesis in eukaryotes,1/101,0.0050499326546803,0.0050499326546803,0,0,19899.0,105233.48101229242,UTP14C
2346,KEGG_2019_Human,Inflammatory bowel disease (IBD),1/65,0.003249949134407,0.0114998411799664,0,0,19935.0,114209.92613860144,IL12RB2
2347,KEGG_2019_Human,Th1 and Th2 cell differentiation,1/92,0.0045999364719865,0.0114998411799664,0,0,19908.0,107139.13814408927,IL12RB2
2348,KEGG_2019_Human,JAK-STAT signaling pathway,1/162,0.0080999104202618,0.0134998507004364,0,0,19838.0,95537.86936302872,IL12RB2
2349,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0183748439699668,0,0,19706.0,83157.67014793828,IL12RB2
2350,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,IL12RB2
2351,KEGG_2019_Human,Other types of O-glycan biosynthesis,1/22,0.0010999756574123,0.0021999513148247,0,0,19978.0,136099.47030191717,OGT
2352,KEGG_2019_Human,Insulin resistance,1/108,0.0053999298011749,0.0053999298011749,0,0,19892.0,103863.47861844616,OGT
2353,KEGG_2019_Human,Protein processing in endoplasmic reticulum,1/165,0.0082499094553477,0.0082499094553477,0,0,19835.0,95159.46482222488,UBXN6
2354,KEGG_2019_Human,Fat digestion and absorption,1/41,0.0020499625466866,0.0020499625466866,0,0,19959.0,123544.88783416104,NPC1L1
2355,KEGG_2019_Human,Maturity onset diabetes of the young,1/26,0.0012999726251831,0.0025999452503662,0,0,19974.0,132735.46073187632,ONECUT1
2356,KEGG_2019_Human,Signaling pathways regulating pluripotency of stem cells,1/139,0.006949918172816,0.006949918172816,0,0,19861.0,98689.81333375497,ONECUT1
2357,KEGG_2019_Human,Protein processing in endoplasmic reticulum,1/165,0.0082499094553477,0.0082499094553477,0,0,19835.0,95159.46482222488,EDEM2
2358,KEGG_2019_Human,Renin-angiotensin system,1/23,0.0011499748819949,0.0011499748819949,0,0,19977.0,135204.63922267244,NLN
2359,KEGG_2019_Human,Arginine and proline metabolism,1/49,0.0024499577795033,0.0024499577795033,0,0,19951.0,119939.1172087114,AGMAT
2360,KEGG_2019_Human,Hedgehog signaling pathway,1/47,0.0023499589392381,0.0047249252398241,0,0,19953.0,120782.64067395544,SUFU
2361,KEGG_2019_Human,Basal cell carcinoma,1/63,0.0031499501598827,0.0047249252398241,0,0,19937.0,114844.46974572667,SUFU
2362,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,SUFU
2363,KEGG_2019_Human,Platelet activation,1/124,0.0061999236097501,0.0140998535552025,0,0,19876.0,101034.04709010696,TBXA2R
2364,KEGG_2019_Human,Calcium signaling pathway,1/188,0.009399902370135,0.0140998535552025,0,0,19812.0,92463.712994847,TBXA2R
2365,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,TBXA2R
2366,KEGG_2019_Human,GABAergic synapse,1/89,0.0044499377838098,0.0076499133771537,0,0,19911.0,107815.380281759,KCNJ6
2367,KEGG_2019_Human,Morphine addiction,1/91,0.0045499369072032,0.0076499133771537,0,0,19909.0,107362.10783923086,KCNJ6
2368,KEGG_2019_Human,Circadian entrainment,1/97,0.0048499343304706,0.0076499133771537,0,0,19903.0,106058.9096435903,KCNJ6
2369,KEGG_2019_Human,Cholinergic synapse,1/112,0.0055999282120529,0.0076499133771537,0,0,19888.0,103119.30984392198,KCNJ6
2370,KEGG_2019_Human,Serotonergic synapse,1/113,0.0056499278191151,0.0076499133771537,0,0,19887.0,102937.34947211576,KCNJ6
2371,KEGG_2019_Human,Dopaminergic synapse,1/131,0.0065499210316603,0.0076499133771537,0,0,19869.0,99907.33811343512,KCNJ6
2372,KEGG_2019_Human,Estrogen signaling pathway,1/137,0.0068499188797651,0.0076499133771537,0,0,19863.0,98987.62735269018,KCNJ6
2373,KEGG_2019_Human,Retrograde endocannabinoid signaling,1/148,0.007399915061391,0.0076499133771537,0,0,19852.0,97399.60470052566,KCNJ6
2374,KEGG_2019_Human,Oxytocin signaling pathway,1/153,0.0076499133771537,0.0076499133771537,0,0,19847.0,96715.6407630817,KCNJ6
2375,KEGG_2019_Human,Regulation of lipolysis in adipocytes,1/55,0.0027499544131125,0.0104998538026112,0,0,19945.0,117599.1294878737,ADRB3
2376,KEGG_2019_Human,Renin secretion,1/69,0.003449947123837,0.0104998538026112,0,0,19931.0,112996.7391397682,ADRB3
2377,KEGG_2019_Human,Salivary secretion,1/90,0.0044999373439762,0.0104998538026112,0,0,19910.0,107587.50385474482,ADRB3
2378,KEGG_2019_Human,cGMP-PKG signaling pathway,1/166,0.0082999091363732,0.013159863318189,0,0,19834.0,95034.82345515196,ADRB3
2379,KEGG_2019_Human,Calcium signaling pathway,1/188,0.009399902370135,0.013159863318189,0,0,19812.0,92463.712994847,ADRB3
2380,KEGG_2019_Human,Thermogenesis,1/231,0.0115498903940656,0.0134748721264098,0,0,19769.0,88191.07730937863,ADRB3
2381,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,ADRB3
2382,KEGG_2019_Human,Glycerolipid metabolism,1/61,0.0030499512001654,0.007274901495706,0,0,19939.0,115499.24335773686,LPIN1
2383,KEGG_2019_Human,Glycerophospholipid metabolism,1/97,0.0048499343304706,0.007274901495706,0,0,19903.0,106058.9096435903,LPIN1
2384,KEGG_2019_Human,mTOR signaling pathway,1/152,0.0075999137114971,0.0075999137114971,0,0,19848.0,96850.665715497,LPIN1
2385,KEGG_2019_Human,Spliceosome,1/134,0.0066999199497742,0.0066999199497742,0,0,19866.0,99442.43560916925,RBM17
2386,KEGG_2019_Human,Autoimmune thyroid disease,1/53,0.0026499555173137,0.0036999446830449,0,0,19947.0,118349.78824235698,TG
2387,KEGG_2019_Human,Thyroid hormone synthesis,1/74,0.0036999446830449,0.0036999446830449,0,0,19926.0,111574.38983110404,TG
2388,KEGG_2019_Human,AGE-RAGE signaling pathway in diabetic complications,1/100,0.0049999330710556,0.0173998352024406,0,0,19900.0,105436.78197328727,VEGFC
2389,KEGG_2019_Human,TNF signaling pathway,1/110,0.0054999290027479,0.0173998352024406,0,0,19890.0,103488.06969787036,VEGFC
2390,KEGG_2019_Human,Relaxin signaling pathway,1/130,0.0064999213952527,0.0173998352024406,0,0,19870.0,100064.62842845908,VEGFC
2391,KEGG_2019_Human,Focal adhesion,1/199,0.0099498991610159,0.0173998352024406,0,0,19801.0,91286.4288690606,VEGFC
2392,KEGG_2019_Human,Rap1 signaling pathway,1/206,0.010299897173561,0.0173998352024406,0,0,19794.0,90569.849337325,VEGFC
2393,KEGG_2019_Human,Ras signaling pathway,1/232,0.0115998901349604,0.0173998352024406,0,0,19768.0,88101.22480150245,VEGFC
2394,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.018964124940408,0,0,19705.0,83086.53988020132,VEGFC
2395,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0199123454715377,0,0,19646.0,79255.8617626126,VEGFC
2396,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,VEGFC
2397,KEGG_2019_Human,Renin secretion,1/69,0.003449947123837,0.0131998413397987,0,0,19931.0,112996.7391397682,EDN3
2398,KEGG_2019_Human,Vascular smooth muscle contraction,1/132,0.0065999206698993,0.0131998413397987,0,0,19868.0,99751.22090491928,EDN3
2399,KEGG_2019_Human,cAMP signaling pathway,1/212,0.0105998955026255,0.0141331940035007,0,0,19788.0,89974.27756224656,EDN3
2400,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,EDN3
2401,KEGG_2019_Human,Glycosaminoglycan biosynthesis,1/53,0.0026499555173137,0.0026499555173137,0,0,19947.0,118349.78824235698,XYLT1
2402,KEGG_2019_Human,Cytosolic DNA-sensing pathway,1/63,0.0031499501598827,0.0085499075557634,0,0,19937.0,114844.46974572667,ADAR
2403,KEGG_2019_Human,Measles,1/138,0.0068999185254481,0.0085499075557634,0,0,19862.0,98838.19160389496,ADAR
2404,KEGG_2019_Human,Influenza A,1/171,0.0085499075557634,0.0085499075557634,0,0,19829.0,94422.42241345016,ADAR
2405,KEGG_2019_Human,Ubiquitin mediated proteolysis,1/137,0.0068499188797651,0.0080999104202618,0,0,19863.0,98987.62735269018,PIAS3
2406,KEGG_2019_Human,JAK-STAT signaling pathway,1/162,0.0080999104202618,0.0080999104202618,0,0,19838.0,95537.86936302872,PIAS3
2407,KEGG_2019_Human,Autoimmune thyroid disease,1/53,0.0026499555173137,0.0145586837375733,0,0,19947.0,118349.78824235698,IFNA10
2408,KEGG_2019_Human,Cytosolic DNA-sensing pathway,1/63,0.0031499501598827,0.0145586837375733,0,0,19937.0,114844.46974572667,IFNA10
2409,KEGG_2019_Human,RIG-I-like receptor signaling pathway,1/70,0.0034999466296654,0.0145586837375733,0,0,19930.0,112704.30065625212,IFNA10
2410,KEGG_2019_Human,Toll-like receptor signaling pathway,1/104,0.0051999314202997,0.0145586837375733,0,0,19896.0,104635.24941415618,IFNA10
2411,KEGG_2019_Human,Natural killer cell mediated cytotoxicity,1/131,0.0065499210316603,0.0145586837375733,0,0,19869.0,99907.33811343512,IFNA10
2412,KEGG_2019_Human,Measles,1/138,0.0068999185254481,0.0145586837375733,0,0,19862.0,98838.19160389496,IFNA10
2413,KEGG_2019_Human,Hepatitis C,1/155,0.0077499127120574,0.0145586837375733,0,0,19845.0,96448.16254952336,IFNA10
2414,KEGG_2019_Human,Necroptosis,1/162,0.0080999104202618,0.0145586837375733,0,0,19838.0,95537.86936302872,IFNA10
2415,KEGG_2019_Human,JAK-STAT signaling pathway,1/162,0.0080999104202618,0.0145586837375733,0,0,19838.0,95537.86936302872,IFNA10
2416,KEGG_2019_Human,Hepatitis B,1/163,0.0081499100978668,0.0145586837375733,0,0,19837.0,95410.9786681514,IFNA10
2417,KEGG_2019_Human,Influenza A,1/171,0.0085499075557634,0.0145586837375733,0,0,19829.0,94422.42241345016,IFNA10
2418,KEGG_2019_Human,NOD-like receptor signaling pathway,1/178,0.0088999053857096,0.0145586837375733,0,0,19822.0,93593.82745769851,IFNA10
2419,KEGG_2019_Human,Tuberculosis,1/179,0.0089499050800561,0.0145586837375733,0,0,19821.0,93478.0629355712,IFNA10
2420,KEGG_2019_Human,Kaposi sarcoma-associated herpesvirus infection,1/186,0.0092999029651357,0.0145586837375733,0,0,19814.0,92684.96451050608,IFNA10
2421,KEGG_2019_Human,Epstein-Barr virus infection,1/201,0.0100498985877989,0.0145586837375733,0,0,19799.0,91079.21596609056,IFNA10
2422,KEGG_2019_Human,Human immunodeficiency virus 1 infection,1/212,0.0105998955026255,0.0145586837375733,0,0,19788.0,89974.27756224656,IFNA10
2423,KEGG_2019_Human,Human cytomegalovirus infection,1/225,0.0112498919790339,0.0145586837375733,0,0,19775.0,88738.27077557483,IFNA10
2424,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0179665141039676,0,0,19706.0,83157.67014793828,IFNA10
2425,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0191051096893273,0,0,19670.0,80733.60565076157,IFNA10
2426,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0194698489055035,0,0,19646.0,79255.8617626126,IFNA10
2427,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0257712598834163,0,0,19508.0,72277.44006442746,IFNA10
2428,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,IFNA10
2429,KEGG_2019_Human,Glycerophospholipid metabolism,1/97,0.0048499343304706,0.0048499343304706,0,0,19903.0,106058.9096435903,PGS1
2430,KEGG_2019_Human,Viral myocarditis,1/59,0.0029499522555206,0.0063749093505676,0,0,19941.0,116175.59385530632,ABL2
2431,KEGG_2019_Human,ErbB signaling pathway,1/85,0.004249939567045,0.0063749093505676,0,0,19915.0,108752.83801948265,ABL2
2432,KEGG_2019_Human,Ras signaling pathway,1/232,0.0115998901349604,0.0115998901349604,0,0,19768.0,88101.22480150245,ABL2
2433,KEGG_2019_Human,MicroRNAs in cancer,1/299,0.0149498740670514,0.0149498740670514,0,0,19701.0,82804.33538735632,SPRY2
2434,KEGG_2019_Human,Ribosome biogenesis in eukaryotes,1/101,0.0050499326546803,0.0050499326546803,0,0,19899.0,105233.48101229242,UTP6
2435,KEGG_2019_Human,Vasopressin-regulated water reabsorption,1/44,0.0021999607179423,0.0115367054817097,0,0,19956.0,122117.06559109331,CREB3L2
2436,KEGG_2019_Human,Cocaine addiction,1/49,0.0024499577795033,0.0115367054817097,0,0,19951.0,119939.1172087114,CREB3L2
2437,KEGG_2019_Human,Cortisol synthesis and secretion,1/65,0.003249949134407,0.0115367054817097,0,0,19935.0,114209.92613860144,CREB3L2
2438,KEGG_2019_Human,Amphetamine addiction,1/68,0.0033999476216189,0.0115367054817097,0,0,19932.0,113293.39338050144,CREB3L2
2439,KEGG_2019_Human,Thyroid hormone synthesis,1/74,0.0036999446830449,0.0115367054817097,0,0,19926.0,111574.38983110404,CREB3L2
2440,KEGG_2019_Human,Insulin secretion,1/86,0.0042999391173866,0.0115367054817097,0,0,19914.0,108514.46102290176,CREB3L2
2441,KEGG_2019_Human,Prostate cancer,1/97,0.0048499343304706,0.0115367054817097,0,0,19903.0,106058.9096435903,CREB3L2
2442,KEGG_2019_Human,Aldosterone synthesis and secretion,1/98,0.0048999339081079,0.0115367054817097,0,0,19902.0,105849.45495286948,CREB3L2
2443,KEGG_2019_Human,Melanogenesis,1/101,0.0050499326546803,0.0115367054817097,0,0,19899.0,105233.48101229242,CREB3L2
2444,KEGG_2019_Human,Longevity regulating pathway,1/102,0.0050999322416682,0.0115367054817097,0,0,19898.0,105032.15064717118,CREB3L2
2445,KEGG_2019_Human,Glucagon signaling pathway,1/103,0.0051499318302617,0.0115367054817097,0,0,19897.0,104832.7525292024,CREB3L2
2446,KEGG_2019_Human,"Parathyroid hormone synthesis, secretion and action",1/106,0.0052999306076525,0.0115367054817097,0,0,19894.0,104245.78450366124,CREB3L2
2447,KEGG_2019_Human,Insulin resistance,1/108,0.0053999298011749,0.0115367054817097,0,0,19892.0,103863.47861844616,CREB3L2
2448,KEGG_2019_Human,TNF signaling pathway,1/110,0.0054999290027479,0.0115367054817097,0,0,19890.0,103488.06969787036,CREB3L2
2449,KEGG_2019_Human,Cholinergic synapse,1/112,0.0055999282120529,0.0115367054817097,0,0,19888.0,103119.30984392198,CREB3L2
2450,KEGG_2019_Human,AMPK signaling pathway,1/120,0.0059999251180858,0.0115367054817097,0,0,19880.0,101706.2448082016,CREB3L2
2451,KEGG_2019_Human,Relaxin signaling pathway,1/130,0.0064999213952527,0.0115367054817097,0,0,19870.0,100064.62842845908,CREB3L2
2452,KEGG_2019_Human,Dopaminergic synapse,1/131,0.0065499210316603,0.0115367054817097,0,0,19869.0,99907.33811343512,CREB3L2
2453,KEGG_2019_Human,Estrogen signaling pathway,1/137,0.0068499188797651,0.0115367054817097,0,0,19863.0,98987.62735269018,CREB3L2
2454,KEGG_2019_Human,Adrenergic signaling in cardiomyocytes,1/145,0.0072499160871101,0.0115476996679976,0,0,19855.0,97820.92670675044,CREB3L2
2455,KEGG_2019_Human,Cushing syndrome,1/155,0.0077499127120574,0.0115476996679976,0,0,19845.0,96448.16254952336,CREB3L2
2456,KEGG_2019_Human,Hepatitis B,1/163,0.0081499100978668,0.0115476996679976,0,0,19837.0,95410.9786681514,CREB3L2
2457,KEGG_2019_Human,cGMP-PKG signaling pathway,1/166,0.0082999091363732,0.0115476996679976,0,0,19834.0,95034.82345515196,CREB3L2
2458,KEGG_2019_Human,Alcoholism,1/180,0.0089999047745351,0.0119998730327134,0,0,19820.0,93362.92821536642,CREB3L2
2459,KEGG_2019_Human,Huntington disease,1/193,0.0096499008972596,0.0123198830870033,0,0,19807.0,91920.47679471428,CREB3L2
2460,KEGG_2019_Human,Viral carcinogenesis,1/201,0.0100498985877989,0.0123198830870033,0,0,19799.0,91079.21596609056,CREB3L2
2461,KEGG_2019_Human,cAMP signaling pathway,1/212,0.0105998955026255,0.0123198830870033,0,0,19788.0,89974.27756224656,CREB3L2
2462,KEGG_2019_Human,Human T-cell leukemia virus 1 infection,1/219,0.0109498935894162,0.0123198830870033,0,0,19781.0,89299.85161916987,CREB3L2
2463,KEGG_2019_Human,Human cytomegalovirus infection,1/225,0.0112498919790339,0.0123198830870033,0,0,19775.0,88738.27077557483,CREB3L2
2464,KEGG_2019_Human,Thermogenesis,1/231,0.0115498903940656,0.0123198830870033,0,0,19769.0,88191.07730937863,CREB3L2
2465,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0170321212479633,0,0,19670.0,80733.60565076157,CREB3L2
2466,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0176998626413668,0,0,19646.0,79255.8617626126,CREB3L2
2467,KEGG_2019_Human,RNA transport,1/165,0.0082499094553477,0.0106998949514067,0,0,19835.0,95159.46482222488,CYFIP1
2468,KEGG_2019_Human,Regulation of actin cytoskeleton,1/214,0.0106998949514067,0.0106998949514067,0,0,19786.0,89779.39753374986,CYFIP1
2469,KEGG_2019_Human,Nucleotide excision repair,1/47,0.0023499589392381,0.0105998955026255,0,0,19953.0,120782.64067395544,DDB1
2470,KEGG_2019_Human,Ubiquitin mediated proteolysis,1/137,0.0068499188797651,0.0105998955026255,0,0,19863.0,98987.62735269018,DDB1
2471,KEGG_2019_Human,Hepatitis B,1/163,0.0081499100978668,0.0105998955026255,0,0,19837.0,95410.9786681514,DDB1
2472,KEGG_2019_Human,Viral carcinogenesis,1/201,0.0100498985877989,0.0105998955026255,0,0,19799.0,91079.21596609056,DDB1
2473,KEGG_2019_Human,Human immunodeficiency virus 1 infection,1/212,0.0105998955026255,0.0105998955026255,0,0,19788.0,89974.27756224656,DDB1
2474,KEGG_2019_Human,Type II diabetes mellitus,1/46,0.0022999595269283,0.0118748772239994,0,0,19954.0,121217.8313311442,PRKCZ
2475,KEGG_2019_Human,AGE-RAGE signaling pathway in diabetic complications,1/100,0.0049999330710556,0.0118748772239994,0,0,19900.0,105436.78197328727,PRKCZ
2476,KEGG_2019_Human,Insulin resistance,1/108,0.0053999298011749,0.0118748772239994,0,0,19892.0,103863.47861844616,PRKCZ
2477,KEGG_2019_Human,Sphingolipid signaling pathway,1/119,0.0059499254985137,0.0118748772239994,0,0,19881.0,101877.73080211312,PRKCZ
2478,KEGG_2019_Human,Platelet activation,1/124,0.0061999236097501,0.0118748772239994,0,0,19876.0,101034.04709010696,PRKCZ
2479,KEGG_2019_Human,Relaxin signaling pathway,1/130,0.0064999213952527,0.0118748772239994,0,0,19870.0,100064.62842845908,PRKCZ
2480,KEGG_2019_Human,Insulin signaling pathway,1/137,0.0068499188797651,0.0118748772239994,0,0,19863.0,98987.62735269018,PRKCZ
2481,KEGG_2019_Human,Fluid shear stress and atherosclerosis,1/139,0.006949918172816,0.0118748772239994,0,0,19861.0,98689.81333375497,PRKCZ
2482,KEGG_2019_Human,Hippo signaling pathway,1/160,0.0079999110688441,0.0118748772239994,0,0,19840.0,95793.96509856998,PRKCZ
2483,KEGG_2019_Human,Tight junction,1/170,0.0084999078692823,0.0118748772239994,0,0,19830.0,94543.49009679438,PRKCZ
2484,KEGG_2019_Human,Axon guidance,1/181,0.0090499044707863,0.0118748772239994,0,0,19819.0,93248.41634586031,PRKCZ
2485,KEGG_2019_Human,Chemokine signaling pathway,1/190,0.0094999017791995,0.0118748772239994,0,0,19810.0,92244.74636351672,PRKCZ
2486,KEGG_2019_Human,Rap1 signaling pathway,1/206,0.010299897173561,0.0118844967387242,0,0,19794.0,90569.849337325,PRKCZ
2487,KEGG_2019_Human,Endocytosis,1/244,0.0121998870519305,0.0130713075556398,0,0,19756.0,87051.4275316661,PRKCZ
2488,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0164998674589645,0,0,19670.0,80733.60565076157,PRKCZ
2489,KEGG_2019_Human,Apoptosis,1/143,0.0071499167770442,0.0085499075557634,0,0,19857.0,98106.57763600958,CAPN1
2490,KEGG_2019_Human,Cellular senescence,1/160,0.0079999110688441,0.0085499075557634,0,0,19840.0,95793.96509856998,CAPN1
2491,KEGG_2019_Human,Necroptosis,1/162,0.0080999104202618,0.0085499075557634,0,0,19838.0,95537.86936302872,CAPN1
2492,KEGG_2019_Human,Protein processing in endoplasmic reticulum,1/165,0.0082499094553477,0.0085499075557634,0,0,19835.0,95159.46482222488,CAPN1
2493,KEGG_2019_Human,Alzheimer disease,1/171,0.0085499075557634,0.0085499075557634,0,0,19829.0,94422.42241345016,CAPN1
2494,KEGG_2019_Human,ECM-receptor interaction,1/82,0.004099940929819,0.0100498985877989,0,0,19918.0,109484.9180722932,HSPG2
2495,KEGG_2019_Human,Hepatitis B,1/163,0.0081499100978668,0.0100498985877989,0,0,19837.0,95410.9786681514,HSPG2
2496,KEGG_2019_Human,Proteoglycans in cancer,1/201,0.0100498985877989,0.0100498985877989,0,0,19799.0,91079.21596609056,HSPG2
2497,KEGG_2019_Human,Signaling pathways regulating pluripotency of stem cells,1/139,0.006949918172816,0.006949918172816,0,0,19861.0,98689.81333375497,OTX1
2498,KEGG_2019_Human,Cell adhesion molecules (CAMs),1/145,0.0072499160871101,0.0072499160871101,0,0,19855.0,97820.92670675044,NRXN3
2499,KEGG_2019_Human,Wnt signaling pathway,1/158,0.0078999117225733,0.0078999117225733,0,0,19842.0,96053.2110949472,TBL1Y
2500,KEGG_2019_Human,ABC transporters,1/45,0.0022499601197094,0.0022499601197094,0,0,19955.0,121662.49782449217,ABCC11
2501,KEGG_2019_Human,Fatty acid degradation,1/44,0.0021999607179423,0.0069999126377668,0,0,19956.0,122117.06559109331,CPT1B
2502,KEGG_2019_Human,Adipocytokine signaling pathway,1/69,0.003449947123837,0.0069999126377668,0,0,19931.0,112996.7391397682,CPT1B
2503,KEGG_2019_Human,PPAR signaling pathway,1/74,0.0036999446830449,0.0069999126377668,0,0,19926.0,111574.38983110404,CPT1B
2504,KEGG_2019_Human,Glucagon signaling pathway,1/103,0.0051499318302617,0.0069999126377668,0,0,19897.0,104832.7525292024,CPT1B
2505,KEGG_2019_Human,Insulin resistance,1/108,0.0053999298011749,0.0069999126377668,0,0,19892.0,103863.47861844616,CPT1B
2506,KEGG_2019_Human,AMPK signaling pathway,1/120,0.0059999251180858,0.0069999126377668,0,0,19880.0,101706.2448082016,CPT1B
2507,KEGG_2019_Human,Thermogenesis,1/231,0.0115498903940656,0.0115498903940656,0,0,19769.0,88191.07730937863,CPT1B
2508,KEGG_2019_Human,Proteoglycans in cancer,1/201,0.0100498985877989,0.0100498985877989,0,0,19799.0,91079.21596609056,TFAP4
2509,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR4B1
2510,KEGG_2019_Human,Estrogen signaling pathway,1/137,0.0068499188797651,0.0068499188797651,0,0,19863.0,98987.62735269018,KRT39
2511,KEGG_2019_Human,Fatty acid biosynthesis,1/13,0.0006499833083207112,0.0051998664665656,0,0,19987.0,146675.87616784443,ACACB
2512,KEGG_2019_Human,Propanoate metabolism,1/32,0.0015999683804467,0.0051999034548022,0,0,19968.0,128549.41955786056,ACACB
2513,KEGG_2019_Human,Pyruvate metabolism,1/39,0.0019499637955508,0.0051999034548022,0,0,19961.0,124555.53162481484,ACACB
2514,KEGG_2019_Human,Adipocytokine signaling pathway,1/69,0.003449947123837,0.0068499188797651,0,0,19931.0,112996.7391397682,ACACB
2515,KEGG_2019_Human,Glucagon signaling pathway,1/103,0.0051499318302617,0.0068499188797651,0,0,19897.0,104832.7525292024,ACACB
2516,KEGG_2019_Human,Insulin resistance,1/108,0.0053999298011749,0.0068499188797651,0,0,19892.0,103863.47861844616,ACACB
2517,KEGG_2019_Human,AMPK signaling pathway,1/120,0.0059999251180858,0.0068499188797651,0,0,19880.0,101706.2448082016,ACACB
2518,KEGG_2019_Human,Insulin signaling pathway,1/137,0.0068499188797651,0.0068499188797651,0,0,19863.0,98987.62735269018,ACACB
2519,KEGG_2019_Human,Alcoholism,1/180,0.0089999047745351,0.0100498985877989,0,0,19820.0,93362.92821536642,HDAC8
2520,KEGG_2019_Human,Viral carcinogenesis,1/201,0.0100498985877989,0.0100498985877989,0,0,19799.0,91079.21596609056,HDAC8
2521,KEGG_2019_Human,Viral carcinogenesis,1/201,0.0100498985877989,0.0100498985877989,0,0,19799.0,91079.21596609056,SND1
2522,KEGG_2019_Human,Inositol phosphate metabolism,1/74,0.0036999446830449,0.0049499334884068,0,0,19926.0,111574.38983110404,INPP5F
2523,KEGG_2019_Human,Phosphatidylinositol signaling system,1/99,0.0049499334884068,0.0049499334884068,0,0,19901.0,105642.09305076736,INPP5F
2524,KEGG_2019_Human,Ribosome biogenesis in eukaryotes,1/101,0.0050499326546803,0.0050499326546803,0,0,19899.0,105233.48101229242,REXO2
2525,KEGG_2019_Human,Melanoma,1/72,0.0035999456502131,0.0173998352024406,0,0,19928.0,112131.59838572376,FGF9
2526,KEGG_2019_Human,Breast cancer,1/147,0.0073499154017982,0.0173998352024406,0,0,19853.0,97539.10874372096,FGF9
2527,KEGG_2019_Human,Gastric cancer,1/149,0.0074499147221605,0.0173998352024406,0,0,19851.0,97261.02051561224,FGF9
2528,KEGG_2019_Human,Rap1 signaling pathway,1/206,0.010299897173561,0.0173998352024406,0,0,19794.0,90569.849337325,FGF9
2529,KEGG_2019_Human,Regulation of actin cytoskeleton,1/214,0.0106998949514067,0.0173998352024406,0,0,19786.0,89779.39753374986,FGF9
2530,KEGG_2019_Human,Ras signaling pathway,1/232,0.0115998901349604,0.0173998352024406,0,0,19768.0,88101.22480150245,FGF9
2531,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.018964124940408,0,0,19705.0,83086.53988020132,FGF9
2532,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0199123454715377,0,0,19646.0,79255.8617626126,FGF9
2533,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,FGF9
2534,KEGG_2019_Human,Legionellosis,1/55,0.0027499544131125,0.0054999088262251,0,0,19945.0,117599.1294878737,EEF1A2
2535,KEGG_2019_Human,RNA transport,1/165,0.0082499094553477,0.0082499094553477,0,0,19835.0,95159.46482222488,EEF1A2
2536,KEGG_2019_Human,cGMP-PKG signaling pathway,1/166,0.0082999091363732,0.0090499044707863,0,0,19834.0,95034.82345515196,TRPC6
2537,KEGG_2019_Human,Axon guidance,1/181,0.0090499044707863,0.0090499044707863,0,0,19819.0,93248.41634586031,TRPC6
2538,KEGG_2019_Human,Viral carcinogenesis,1/201,0.0100498985877989,0.0164998674589645,0,0,19799.0,91079.21596609056,UBR4
2539,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0164998674589645,0,0,19670.0,80733.60565076157,UBR4
2540,KEGG_2019_Human,Endocrine and other factor-regulated calcium reabsorption,1/48,0.0023999583567988,0.0077998855680932,0,0,19952.0,120356.5272753826,CLTC
2541,KEGG_2019_Human,Bacterial invasion of epithelial cells,1/74,0.0036999446830449,0.0077998855680932,0,0,19926.0,111574.38983110404,CLTC
2542,KEGG_2019_Human,Synaptic vesicle cycle,1/78,0.0038999427840466,0.0077998855680932,0,0,19922.0,110503.2180492851,CLTC
2543,KEGG_2019_Human,Lysosome,1/123,0.0061499239842961,0.0092248859764442,0,0,19877.0,101200.07933676826,CLTC
2544,KEGG_2019_Human,Huntington disease,1/193,0.0096499008972596,0.0115798810767115,0,0,19807.0,91920.47679471428,CLTC
2545,KEGG_2019_Human,Endocytosis,1/244,0.0121998870519305,0.0121998870519305,0,0,19756.0,87051.4275316661,CLTC
2546,KEGG_2019_Human,Malaria,1/49,0.0024499577795033,0.012299822789457,0,0,19951.0,119939.1172087114,THBS2
2547,KEGG_2019_Human,ECM-receptor interaction,1/82,0.004099940929819,0.012299822789457,0,0,19918.0,109484.9180722932,THBS2
2548,KEGG_2019_Human,Phagosome,1/152,0.0075999137114971,0.0149248487415239,0,0,19848.0,96850.665715497,THBS2
2549,KEGG_2019_Human,Focal adhesion,1/199,0.0099498991610159,0.0149248487415239,0,0,19801.0,91286.4288690606,THBS2
2550,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0176998626413668,0,0,19670.0,80733.60565076157,THBS2
2551,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0176998626413668,0,0,19646.0,79255.8617626126,THBS2
2552,KEGG_2019_Human,Antigen processing and presentation,1/77,0.0038499432547502,0.0076998865095004,0,0,19923.0,110765.8407373636,HSPA4
2553,KEGG_2019_Human,Tight junction,1/170,0.0084999078692823,0.0084999078692823,0,0,19830.0,94543.49009679438,HSPA4
2554,KEGG_2019_Human,Signaling pathways regulating pluripotency of stem cells,1/139,0.006949918172816,0.006949918172816,0,0,19861.0,98689.81333375497,JARID2
2555,KEGG_2019_Human,Fanconi anemia pathway,1/54,0.0026999549628563,0.0026999549628563,0,0,19946.0,117971.01964061816,RMI1
2556,KEGG_2019_Human,Ribosome,1/153,0.0076499133771537,0.0076499133771537,0,0,19847.0,96715.6407630817,RPL7
2557,KEGG_2019_Human,Ribosome biogenesis in eukaryotes,1/101,0.0050499326546803,0.0050499326546803,0,0,19899.0,105233.48101229242,IMP3
2558,KEGG_2019_Human,Proteasome,1/45,0.0022499601197094,0.0022499601197094,0,0,19955.0,121662.49782449217,PSME4
2559,KEGG_2019_Human,Antigen processing and presentation,1/77,0.0038499432547502,0.0106798864628515,0,0,19923.0,110765.8407373636,HSP90AB1
2560,KEGG_2019_Human,IL-17 signaling pathway,1/93,0.0046499360391879,0.0106798864628515,0,0,19907.0,106918.54242106884,HSP90AB1
2561,KEGG_2019_Human,Prostate cancer,1/97,0.0048499343304706,0.0106798864628515,0,0,19903.0,106058.9096435903,HSP90AB1
2562,KEGG_2019_Human,Progesterone-mediated oocyte maturation,1/99,0.0049499334884068,0.0106798864628515,0,0,19901.0,105642.09305076736,HSP90AB1
2563,KEGG_2019_Human,Th17 cell differentiation,1/107,0.0053499302026925,0.0106798864628515,0,0,19893.0,104053.753408911,HSP90AB1
2564,KEGG_2019_Human,Estrogen signaling pathway,1/137,0.0068499188797651,0.0106798864628515,0,0,19863.0,98987.62735269018,HSP90AB1
2565,KEGG_2019_Human,Fluid shear stress and atherosclerosis,1/139,0.006949918172816,0.0106798864628515,0,0,19861.0,98689.81333375497,HSP90AB1
2566,KEGG_2019_Human,Necroptosis,1/162,0.0080999104202618,0.0106798864628515,0,0,19838.0,95537.86936302872,HSP90AB1
2567,KEGG_2019_Human,Protein processing in endoplasmic reticulum,1/165,0.0082499094553477,0.0106798864628515,0,0,19835.0,95159.46482222488,HSP90AB1
2568,KEGG_2019_Human,NOD-like receptor signaling pathway,1/178,0.0088999053857096,0.0106798864628515,0,0,19822.0,93593.82745769851,HSP90AB1
2569,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0193089410633093,0,0,19646.0,79255.8617626126,HSP90AB1
2570,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,HSP90AB1
2571,KEGG_2019_Human,Axon guidance,1/181,0.0090499044707863,0.0090499044707863,0,0,19819.0,93248.41634586031,RGS3
2572,KEGG_2019_Human,Acute myeloid leukemia,1/66,0.003299948626608,0.0162748301889875,0,0,19934.0,113899.85357353876,PML
2573,KEGG_2019_Human,Ubiquitin mediated proteolysis,1/137,0.0068499188797651,0.0162748301889875,0,0,19863.0,98987.62735269018,PML
2574,KEGG_2019_Human,Influenza A,1/171,0.0085499075557634,0.0162748301889875,0,0,19829.0,94422.42241345016,PML
2575,KEGG_2019_Human,Transcriptional misregulation in cancer,1/186,0.0092999029651357,0.0162748301889875,0,0,19814.0,92684.96451050608,PML
2576,KEGG_2019_Human,Endocytosis,1/244,0.0121998870519305,0.0170798418727027,0,0,19756.0,87051.4275316661,PML
2577,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0264998334376226,0,0,19508.0,72277.44006442746,PML
2578,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,PML
2579,KEGG_2019_Human,Adipocytokine signaling pathway,1/69,0.003449947123837,0.006941579748266,0,0,19931.0,112996.7391397682,NFKBIE
2580,KEGG_2019_Human,B cell receptor signaling pathway,1/71,0.0035499461386618,0.006941579748266,0,0,19929.0,112415.9585341616,NFKBIE
2581,KEGG_2019_Human,Th1 and Th2 cell differentiation,1/92,0.0045999364719865,0.006941579748266,0,0,19908.0,107139.13814408927,NFKBIE
2582,KEGG_2019_Human,T cell receptor signaling pathway,1/101,0.0050499326546803,0.006941579748266,0,0,19899.0,105233.48101229242,NFKBIE
2583,KEGG_2019_Human,Th17 cell differentiation,1/107,0.0053499302026925,0.006941579748266,0,0,19893.0,104053.753408911,NFKBIE
2584,KEGG_2019_Human,Neurotrophin signaling pathway,1/119,0.0059499254985137,0.006941579748266,0,0,19881.0,101877.73080211312,NFKBIE
2585,KEGG_2019_Human,Epstein-Barr virus infection,1/201,0.0100498985877989,0.0100498985877989,0,0,19799.0,91079.21596609056,NFKBIE
2586,KEGG_2019_Human,Circadian entrainment,1/97,0.0048499343304706,0.0048499343304706,0,0,19903.0,106058.9096435903,NOS1AP
2587,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF823
2588,KEGG_2019_Human,Taste transduction,1/83,0.0041499404726918,0.0041499404726918,0,0,19917.0,109237.99888847338,TAS2R38
2589,KEGG_2019_Human,Leukocyte transendothelial migration,1/112,0.0055999282120529,0.0084999078692823,0,0,19888.0,103119.30984392198,CLDN5
2590,KEGG_2019_Human,Cell adhesion molecules (CAMs),1/145,0.0072499160871101,0.0084999078692823,0,0,19855.0,97820.92670675044,CLDN5
2591,KEGG_2019_Human,Hepatitis C,1/155,0.0077499127120574,0.0084999078692823,0,0,19845.0,96448.16254952336,CLDN5
2592,KEGG_2019_Human,Tight junction,1/170,0.0084999078692823,0.0084999078692823,0,0,19830.0,94543.49009679438,CLDN5
2593,KEGG_2019_Human,Oxidative phosphorylation,1/133,0.0066499203093911,0.0112582177134695,0,0,19867.0,99596.2591544721,NDUFA5
2594,KEGG_2019_Human,Parkinson disease,1/142,0.0070999171242726,0.0112582177134695,0,0,19858.0,98250.87390500787,NDUFA5
2595,KEGG_2019_Human,Retrograde endocannabinoid signaling,1/148,0.007399915061391,0.0112582177134695,0,0,19852.0,97399.60470052566,NDUFA5
2596,KEGG_2019_Human,Non-alcoholic fatty liver disease (NAFLD),1/149,0.0074499147221605,0.0112582177134695,0,0,19851.0,97261.02051561224,NDUFA5
2597,KEGG_2019_Human,Alzheimer disease,1/171,0.0085499075557634,0.0112582177134695,0,0,19829.0,94422.42241345016,NDUFA5
2598,KEGG_2019_Human,Huntington disease,1/193,0.0096499008972596,0.0112582177134695,0,0,19807.0,91920.47679471428,NDUFA5
2599,KEGG_2019_Human,Thermogenesis,1/231,0.0115498903940656,0.0115498903940656,0,0,19769.0,88191.07730937863,NDUFA5
2600,KEGG_2019_Human,Endocrine and other factor-regulated calcium reabsorption,1/48,0.0023999583567988,0.0118998509970274,0,0,19952.0,120356.5272753826,BDKRB2
2601,KEGG_2019_Human,Complement and coagulation cascades,1/79,0.0039499423167337,0.0118998509970274,0,0,19921.0,110243.89578070649,BDKRB2
2602,KEGG_2019_Human,Inflammatory mediator regulation of TRP channels,1/100,0.0049999330710556,0.0118998509970274,0,0,19900.0,105436.78197328727,BDKRB2
2603,KEGG_2019_Human,Chagas disease (American trypanosomiasis),1/103,0.0051499318302617,0.0118998509970274,0,0,19897.0,104832.7525292024,BDKRB2
2604,KEGG_2019_Human,Sphingolipid signaling pathway,1/119,0.0059499254985137,0.0118998509970274,0,0,19881.0,101877.73080211312,BDKRB2
2605,KEGG_2019_Human,cGMP-PKG signaling pathway,1/166,0.0082999091363732,0.0133748686892584,0,0,19834.0,95034.82345515196,BDKRB2
2606,KEGG_2019_Human,Calcium signaling pathway,1/188,0.009399902370135,0.0133748686892584,0,0,19812.0,92463.712994847,BDKRB2
2607,KEGG_2019_Human,Regulation of actin cytoskeleton,1/214,0.0106998949514067,0.0133748686892584,0,0,19786.0,89779.39753374986,BDKRB2
2608,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0187776286961773,0,0,19662.0,80229.79996326564,BDKRB2
2609,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,BDKRB2
2610,KEGG_2019_Human,mRNA surveillance pathway,1/91,0.0045499369072032,0.0045499369072032,0,0,19909.0,107362.10783923086,CSTF2
2611,KEGG_2019_Human,Protein digestion and absorption,1/90,0.0044999373439762,0.0044999373439762,0,0,19910.0,107587.50385474482,COL11A1
2612,KEGG_2019_Human,RNA transport,1/165,0.0082499094553477,0.0082499094553477,0,0,19835.0,95159.46482222488,EIF3A
2613,KEGG_2019_Human,NF-kappa B signaling pathway,1/95,0.0047499351803394,0.0109212999858537,0,0,19905.0,106484.27183626965,IL1R1
2614,KEGG_2019_Human,Amoebiasis,1/96,0.0047999347538706,0.0109212999858537,0,0,19904.0,106270.50039849174,IL1R1
2615,KEGG_2019_Human,Hematopoietic cell lineage,1/97,0.0048499343304706,0.0109212999858537,0,0,19903.0,106058.9096435903,IL1R1
2616,KEGG_2019_Human,Inflammatory mediator regulation of TRP channels,1/100,0.0049999330710556,0.0109212999858537,0,0,19900.0,105436.78197328727,IL1R1
2617,KEGG_2019_Human,Th17 cell differentiation,1/107,0.0053499302026925,0.0109212999858537,0,0,19893.0,104053.753408911,IL1R1
2618,KEGG_2019_Human,Osteoclast differentiation,1/127,0.0063499224962247,0.0109212999858537,0,0,19873.0,100543.72072014232,IL1R1
2619,KEGG_2019_Human,Fluid shear stress and atherosclerosis,1/139,0.006949918172816,0.0109212999858537,0,0,19861.0,98689.81333375497,IL1R1
2620,KEGG_2019_Human,Human T-cell leukemia virus 1 infection,1/219,0.0109498935894162,0.0137498679743747,0,0,19781.0,89299.85161916987,IL1R1
2621,KEGG_2019_Human,Human cytomegalovirus infection,1/225,0.0112498919790339,0.0137498679743747,0,0,19775.0,88738.27077557483,IL1R1
2622,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0147498749536506,0,0,19706.0,83157.67014793828,IL1R1
2623,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0147498749536506,0,0,19705.0,83086.53988020132,IL1R1
2624,KEGG_2019_Human,Hedgehog signaling pathway,1/47,0.0023499589392381,0.0023499589392381,0,0,19953.0,120782.64067395544,EVC2
2625,KEGG_2019_Human,Spliceosome,1/134,0.0066999199497742,0.0066999199497742,0,0,19866.0,99442.43560916925,PPIE
2626,KEGG_2019_Human,Prolactin signaling pathway,1/70,0.0034999466296654,0.0174997331483271,0,0,19930.0,112704.30065625212,PRLR
2627,KEGG_2019_Human,JAK-STAT signaling pathway,1/162,0.0080999104202618,0.0176998626413668,0,0,19838.0,95537.86936302872,PRLR
2628,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0176998626413668,0,0,19706.0,83157.67014793828,PRLR
2629,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0176998626413668,0,0,19662.0,80229.79996326564,PRLR
2630,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0176998626413668,0,0,19646.0,79255.8617626126,PRLR
2631,KEGG_2019_Human,Collecting duct acid secretion,1/27,0.0013499718942362,0.0081898864329657,0,0,19973.0,131975.02298599784,ATP6V1B1
2632,KEGG_2019_Human,Vibrio cholerae infection,1/50,0.0024999572069037,0.0081898864329657,0,0,19950.0,119530.05920663515,ATP6V1B1
2633,KEGG_2019_Human,Epithelial cell signaling in Helicobacter pylori infection,1/68,0.0033999476216189,0.0081898864329657,0,0,19932.0,113293.39338050144,ATP6V1B1
2634,KEGG_2019_Human,Synaptic vesicle cycle,1/78,0.0038999427840466,0.0081898864329657,0,0,19922.0,110503.2180492851,ATP6V1B1
2635,KEGG_2019_Human,Rheumatoid arthritis,1/91,0.0045499369072032,0.0081898864329657,0,0,19909.0,107362.10783923086,ATP6V1B1
2636,KEGG_2019_Human,Oxidative phosphorylation,1/133,0.0066499203093911,0.0085499029254342,0,0,19867.0,99596.2591544721,ATP6V1B1
2637,KEGG_2019_Human,mTOR signaling pathway,1/152,0.0075999137114971,0.0085499029254342,0,0,19848.0,96850.665715497,ATP6V1B1
2638,KEGG_2019_Human,Phagosome,1/152,0.0075999137114971,0.0085499029254342,0,0,19848.0,96850.665715497,ATP6V1B1
2639,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0164998674589645,0,0,19670.0,80733.60565076157,ATP6V1B1
2640,KEGG_2019_Human,Tuberculosis,1/179,0.0089499050800561,0.0089499050800561,0,0,19821.0,93478.0629355712,CEBPG
2641,KEGG_2019_Human,Hematopoietic cell lineage,1/97,0.0048499343304706,0.0084999078692823,0,0,19903.0,106058.9096435903,CD1E
2642,KEGG_2019_Human,Tight junction,1/170,0.0084999078692823,0.0084999078692823,0,0,19830.0,94543.49009679438,CD1E
2643,KEGG_2019_Human,Adherens junction,1/72,0.0035999456502131,0.0106998949514067,0,0,19928.0,112131.59838572376,IQGAP1
2644,KEGG_2019_Human,Proteoglycans in cancer,1/201,0.0100498985877989,0.0106998949514067,0,0,19799.0,91079.21596609056,IQGAP1
2645,KEGG_2019_Human,Regulation of actin cytoskeleton,1/214,0.0106998949514067,0.0106998949514067,0,0,19786.0,89779.39753374986,IQGAP1
2646,KEGG_2019_Human,Pentose phosphate pathway,1/30,0.0014999697593334,0.0029999395186669,0,0,19970.0,129851.13732048514,PRPS2
2647,KEGG_2019_Human,Purine metabolism,1/129,0.006449921761047,0.006449921761047,0,0,19871.0,100223.109907462,PRPS2
2648,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR2AP1
2649,KEGG_2019_Human,RNA degradation,1/79,0.0039499423167337,0.0039499423167337,0,0,19921.0,110243.89578070649,MTREX
2650,KEGG_2019_Human,Viral myocarditis,1/59,0.0029499522555206,0.0045499369072032,0,0,19941.0,116175.59385530632,DAG1
2651,KEGG_2019_Human,Arrhythmogenic right ventricular cardiomyopathy (ARVC),1/72,0.0035999456502131,0.0045499369072032,0,0,19928.0,112131.59838572376,DAG1
2652,KEGG_2019_Human,ECM-receptor interaction,1/82,0.004099940929819,0.0045499369072032,0,0,19918.0,109484.9180722932,DAG1
2653,KEGG_2019_Human,Hypertrophic cardiomyopathy (HCM),1/85,0.004249939567045,0.0045499369072032,0,0,19915.0,108752.83801948265,DAG1
2654,KEGG_2019_Human,Dilated cardiomyopathy (DCM),1/91,0.0045499369072032,0.0045499369072032,0,0,19909.0,107362.10783923086,DAG1
2655,KEGG_2019_Human,Synaptic vesicle cycle,1/78,0.0038999427840466,0.0055999282120529,0,0,19922.0,110503.2180492851,SLC18A3
2656,KEGG_2019_Human,Cholinergic synapse,1/112,0.0055999282120529,0.0055999282120529,0,0,19888.0,103119.30984392198,SLC18A3
2657,KEGG_2019_Human,mRNA surveillance pathway,1/91,0.0045499369072032,0.0082499094553477,0,0,19909.0,107362.10783923086,PYM1
2658,KEGG_2019_Human,RNA transport,1/165,0.0082499094553477,0.0082499094553477,0,0,19835.0,95159.46482222488,PYM1
2659,KEGG_2019_Human,Notch signaling pathway,1/48,0.0023999583567988,0.0099271645922203,0,0,19952.0,120356.5272753826,DVL3
2660,KEGG_2019_Human,Basal cell carcinoma,1/63,0.0031499501598827,0.0099271645922203,0,0,19937.0,114844.46974572667,DVL3
2661,KEGG_2019_Human,Melanogenesis,1/101,0.0050499326546803,0.0099271645922203,0,0,19899.0,105233.48101229242,DVL3
2662,KEGG_2019_Human,Signaling pathways regulating pluripotency of stem cells,1/139,0.006949918172816,0.0099271645922203,0,0,19861.0,98689.81333375497,DVL3
2663,KEGG_2019_Human,Breast cancer,1/147,0.0073499154017982,0.0099271645922203,0,0,19853.0,97539.10874372096,DVL3
2664,KEGG_2019_Human,Gastric cancer,1/149,0.0074499147221605,0.0099271645922203,0,0,19851.0,97261.02051561224,DVL3
2665,KEGG_2019_Human,mTOR signaling pathway,1/152,0.0075999137114971,0.0099271645922203,0,0,19848.0,96850.665715497,DVL3
2666,KEGG_2019_Human,Cushing syndrome,1/155,0.0077499127120574,0.0099271645922203,0,0,19845.0,96448.16254952336,DVL3
2667,KEGG_2019_Human,Wnt signaling pathway,1/158,0.0078999117225733,0.0099271645922203,0,0,19842.0,96053.2110949472,DVL3
2668,KEGG_2019_Human,Hippo signaling pathway,1/160,0.0079999110688441,0.0099271645922203,0,0,19840.0,95793.96509856998,DVL3
2669,KEGG_2019_Human,Hepatocellular carcinoma,1/168,0.0083999085011095,0.0099271645922203,0,0,19832.0,94787.72752807094,DVL3
2670,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0178748564138782,0,0,19670.0,80733.60565076157,DVL3
2671,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,DVL3
2672,KEGG_2019_Human,Adherens junction,1/72,0.0035999456502131,0.0115998901349604,0,0,19928.0,112131.59838572376,AFDN
2673,KEGG_2019_Human,Leukocyte transendothelial migration,1/112,0.0055999282120529,0.0115998901349604,0,0,19888.0,103119.30984392198,AFDN
2674,KEGG_2019_Human,Tight junction,1/170,0.0084999078692823,0.0115998901349604,0,0,19830.0,94543.49009679438,AFDN
2675,KEGG_2019_Human,Rap1 signaling pathway,1/206,0.010299897173561,0.0115998901349604,0,0,19794.0,90569.849337325,AFDN
2676,KEGG_2019_Human,cAMP signaling pathway,1/212,0.0105998955026255,0.0115998901349604,0,0,19788.0,89974.27756224656,AFDN
2677,KEGG_2019_Human,Ras signaling pathway,1/232,0.0115998901349604,0.0115998901349604,0,0,19768.0,88101.22480150245,AFDN
2678,KEGG_2019_Human,Citrate cycle (TCA cycle),1/30,0.0014999697593334,0.0014999697593334,0,0,19970.0,129851.13732048514,OGDHL
2679,KEGG_2019_Human,ECM-receptor interaction,1/82,0.004099940929819,0.004099940929819,0,0,19918.0,109484.9180722932,AGRN
2680,KEGG_2019_Human,Vasopressin-regulated water reabsorption,1/44,0.0021999607179423,0.0064499086760799,0,0,19956.0,122117.06559109331,DYNC1H1
2681,KEGG_2019_Human,Salmonella infection,1/86,0.0042999391173866,0.0064499086760799,0,0,19914.0,108514.46102290176,DYNC1H1
2682,KEGG_2019_Human,Phagosome,1/152,0.0075999137114971,0.0075999137114971,0,0,19848.0,96850.665715497,DYNC1H1
2683,KEGG_2019_Human,Protein digestion and absorption,1/90,0.0044999373439762,0.0044999373439762,0,0,19910.0,107587.50385474482,COL13A1
2684,KEGG_2019_Human,Folate biosynthesis,1/26,0.0012999726251831,0.0031499501598827,0,0,19974.0,132735.46073187632,AKR1C3
2685,KEGG_2019_Human,Ovarian steroidogenesis,1/49,0.0024499577795033,0.0031499501598827,0,0,19951.0,119939.1172087114,AKR1C3
2686,KEGG_2019_Human,Steroid hormone biosynthesis,1/60,0.002999951725986,0.0031499501598827,0,0,19940.0,115834.63209072244,AKR1C3
2687,KEGG_2019_Human,Arachidonic acid metabolism,1/63,0.0031499501598827,0.0031499501598827,0,0,19937.0,114844.46974572667,AKR1C3
2688,KEGG_2019_Human,Drug metabolism,1/108,0.0053999298011749,0.0053999298011749,0,0,19892.0,103863.47861844616,FMO1
2689,KEGG_2019_Human,Taste transduction,1/83,0.0041499404726918,0.009866553415188,0,0,19917.0,109237.99888847338,GRM4
2690,KEGG_2019_Human,Glutamatergic synapse,1/114,0.005699927427839,0.009866553415188,0,0,19886.0,102756.96431429044,GRM4
2691,KEGG_2019_Human,Phospholipase D signaling pathway,1/148,0.007399915061391,0.009866553415188,0,0,19852.0,97399.60470052566,GRM4
2692,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,GRM4
2693,KEGG_2019_Human,Endocytosis,1/244,0.0121998870519305,0.0121998870519305,0,0,19756.0,87051.4275316661,VPS28
2694,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR10X1
2695,KEGG_2019_Human,Central carbon metabolism in cancer,1/65,0.003249949134407,0.0087998929262006,0,0,19935.0,114209.92613860144,HIF1A
2696,KEGG_2019_Human,Mitophagy,1/65,0.003249949134407,0.0087998929262006,0,0,19935.0,114209.92613860144,HIF1A
2697,KEGG_2019_Human,Renal cell carcinoma,1/69,0.003449947123837,0.0087998929262006,0,0,19931.0,112996.7391397682,HIF1A
2698,KEGG_2019_Human,Choline metabolism in cancer,1/99,0.0049499334884068,0.0087998929262006,0,0,19901.0,105642.09305076736,HIF1A
2699,KEGG_2019_Human,HIF-1 signaling pathway,1/100,0.0049999330710556,0.0087998929262006,0,0,19900.0,105436.78197328727,HIF1A
2700,KEGG_2019_Human,Th17 cell differentiation,1/107,0.0053499302026925,0.0087998929262006,0,0,19893.0,104053.753408911,HIF1A
2701,KEGG_2019_Human,Thyroid hormone signaling pathway,1/116,0.0057999266512085,0.0087998929262006,0,0,19884.0,102400.8105961506,HIF1A
2702,KEGG_2019_Human,Autophagy,1/128,0.0063999221281459,0.0087998929262006,0,0,19872.0,100382.8010329652,HIF1A
2703,KEGG_2019_Human,Kaposi sarcoma-associated herpesvirus infection,1/186,0.0092999029651357,0.0110548884465788,0,0,19814.0,92684.96451050608,HIF1A
2704,KEGG_2019_Human,Proteoglycans in cancer,1/201,0.0100498985877989,0.0110548884465788,0,0,19799.0,91079.21596609056,HIF1A
2705,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,HIF1A
2706,KEGG_2019_Human,Transcriptional misregulation in cancer,1/186,0.0092999029651357,0.0092999029651357,0,0,19814.0,92684.96451050608,NR4A3
2707,KEGG_2019_Human,Nicotinate and nicotinamide metabolism,1/30,0.0014999697593334,0.0014999697593334,0,0,19970.0,129851.13732048514,NMNAT2
2708,KEGG_2019_Human,Lysine degradation,1/59,0.0029499522555206,0.0029499522555206,0,0,19941.0,116175.59385530632,SETD1A
2709,KEGG_2019_Human,Axon guidance,1/181,0.0090499044707863,0.0090499044707863,0,0,19819.0,93248.41634586031,NTN3
2710,KEGG_2019_Human,RNA polymerase,1/31,0.0015499690656704,0.0030999381313408,0,0,19969.0,129189.85098816035,POLR3B
2711,KEGG_2019_Human,Cytosolic DNA-sensing pathway,1/63,0.0031499501598827,0.0031499501598827,0,0,19937.0,114844.46974572667,POLR3B
2712,KEGG_2019_Human,Arrhythmogenic right ventricular cardiomyopathy (ARVC),1/72,0.0035999456502131,0.0088915462725296,0,0,19928.0,112131.59838572376,ITGA3
2713,KEGG_2019_Human,ECM-receptor interaction,1/82,0.004099940929819,0.0088915462725296,0,0,19918.0,109484.9180722932,ITGA3
2714,KEGG_2019_Human,Hypertrophic cardiomyopathy (HCM),1/85,0.004249939567045,0.0088915462725296,0,0,19915.0,108752.83801948265,ITGA3
2715,KEGG_2019_Human,Dilated cardiomyopathy (DCM),1/91,0.0045499369072032,0.0088915462725296,0,0,19909.0,107362.10783923086,ITGA3
2716,KEGG_2019_Human,Small cell lung cancer,1/93,0.0046499360391879,0.0088915462725296,0,0,19907.0,106918.54242106884,ITGA3
2717,KEGG_2019_Human,Hematopoietic cell lineage,1/97,0.0048499343304706,0.0088915462725296,0,0,19903.0,106058.9096435903,ITGA3
2718,KEGG_2019_Human,Focal adhesion,1/199,0.0099498991610159,0.0147123555581843,0,0,19801.0,91286.4288690606,ITGA3
2719,KEGG_2019_Human,Regulation of actin cytoskeleton,1/214,0.0106998949514067,0.0147123555581843,0,0,19786.0,89779.39753374986,ITGA3
2720,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0194698489055035,0,0,19670.0,80733.60565076157,ITGA3
2721,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0194698489055035,0,0,19646.0,79255.8617626126,ITGA3
2722,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,ITGA3
2723,KEGG_2019_Human,Protein digestion and absorption,1/90,0.0044999373439762,0.0044999373439762,0,0,19910.0,107587.50385474482,XPNPEP2
2724,KEGG_2019_Human,Protein processing in endoplasmic reticulum,1/165,0.0082499094553477,0.0085499075557634,0,0,19835.0,95159.46482222488,DNAJB1
2725,KEGG_2019_Human,Influenza A,1/171,0.0085499075557634,0.0085499075557634,0,0,19829.0,94422.42241345016,DNAJB1
2726,KEGG_2019_Human,ECM-receptor interaction,1/82,0.004099940929819,0.0176998626413668,0,0,19918.0,109484.9180722932,TNXB
2727,KEGG_2019_Human,Focal adhesion,1/199,0.0099498991610159,0.0176998626413668,0,0,19801.0,91286.4288690606,TNXB
2728,KEGG_2019_Human,MicroRNAs in cancer,1/299,0.0149498740670514,0.0176998626413668,0,0,19701.0,82804.33538735632,TNXB
2729,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0176998626413668,0,0,19670.0,80733.60565076157,TNXB
2730,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0176998626413668,0,0,19646.0,79255.8617626126,TNXB
2731,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR2G6
2732,KEGG_2019_Human,Adherens junction,1/72,0.0035999456502131,0.0035999456502131,0,0,19928.0,112131.59838572376,LMO7
2733,KEGG_2019_Human,Inositol phosphate metabolism,1/74,0.0036999446830449,0.0049499334884068,0,0,19926.0,111574.38983110404,INPP5J
2734,KEGG_2019_Human,Phosphatidylinositol signaling system,1/99,0.0049499334884068,0.0049499334884068,0,0,19901.0,105642.09305076736,INPP5J
2735,KEGG_2019_Human,RNA transport,1/165,0.0082499094553477,0.0082499094553477,0,0,19835.0,95159.46482222488,NUP205
2736,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,GPR156
2737,KEGG_2019_Human,Fanconi anemia pathway,1/54,0.0026999549628563,0.0026999549628563,0,0,19946.0,117971.01964061816,FAAP100
2738,KEGG_2019_Human,Tyrosine metabolism,1/36,0.0017999657178272,0.0047832644181221,0,0,19964.0,126172.23364250171,ADH5
2739,KEGG_2019_Human,Fatty acid degradation,1/44,0.0021999607179423,0.0047832644181221,0,0,19956.0,122117.06559109331,ADH5
2740,KEGG_2019_Human,Retinol metabolism,1/67,0.0033499481224912,0.0047832644181221,0,0,19933.0,113594.38808369274,ADH5
2741,KEGG_2019_Human,Glycolysis / Gluconeogenesis,1/68,0.0033999476216189,0.0047832644181221,0,0,19932.0,113293.39338050144,ADH5
2742,KEGG_2019_Human,Metabolism of xenobiotics by cytochrome P450,1/74,0.0036999446830449,0.0047832644181221,0,0,19926.0,111574.38983110404,ADH5
2743,KEGG_2019_Human,Chemical carcinogenesis,1/82,0.004099940929819,0.0047832644181221,0,0,19918.0,109484.9180722932,ADH5
2744,KEGG_2019_Human,Drug metabolism,1/108,0.0053999298011749,0.0053999298011749,0,0,19892.0,103863.47861844616,ADH5
2745,KEGG_2019_Human,Platelet activation,1/124,0.0061999236097501,0.0109498935894162,0,0,19876.0,101034.04709010696,TLN1
2746,KEGG_2019_Human,Focal adhesion,1/199,0.0099498991610159,0.0109498935894162,0,0,19801.0,91286.4288690606,TLN1
2747,KEGG_2019_Human,Rap1 signaling pathway,1/206,0.010299897173561,0.0109498935894162,0,0,19794.0,90569.849337325,TLN1
2748,KEGG_2019_Human,Human T-cell leukemia virus 1 infection,1/219,0.0109498935894162,0.0109498935894162,0,0,19781.0,89299.85161916987,TLN1
2749,KEGG_2019_Human,Type II diabetes mellitus,1/46,0.0022999595269283,0.007199910141703,0,0,19954.0,121217.8313311442,ADIPOQ
2750,KEGG_2019_Human,Adipocytokine signaling pathway,1/69,0.003449947123837,0.007199910141703,0,0,19931.0,112996.7391397682,ADIPOQ
2751,KEGG_2019_Human,PPAR signaling pathway,1/74,0.0036999446830449,0.007199910141703,0,0,19926.0,111574.38983110404,ADIPOQ
2752,KEGG_2019_Human,Longevity regulating pathway,1/102,0.0050999322416682,0.007199910141703,0,0,19898.0,105032.15064717118,ADIPOQ
2753,KEGG_2019_Human,AMPK signaling pathway,1/120,0.0059999251180858,0.007199910141703,0,0,19880.0,101706.2448082016,ADIPOQ
2754,KEGG_2019_Human,Non-alcoholic fatty liver disease (NAFLD),1/149,0.0074499147221605,0.0074499147221605,0,0,19851.0,97261.02051561224,ADIPOQ
2755,KEGG_2019_Human,Regulation of actin cytoskeleton,1/214,0.0106998949514067,0.0106998949514067,0,0,19786.0,89779.39753374986,IQGAP3
2756,KEGG_2019_Human,TGF-beta signaling pathway,1/90,0.0044999373439762,0.0044999373439762,0,0,19910.0,107587.50385474482,CHRD
2757,KEGG_2019_Human,Arrhythmogenic right ventricular cardiomyopathy (ARVC),1/72,0.0035999456502131,0.0090998738144064,0,0,19928.0,112131.59838572376,ITGB4
2758,KEGG_2019_Human,ECM-receptor interaction,1/82,0.004099940929819,0.0090998738144064,0,0,19918.0,109484.9180722932,ITGB4
2759,KEGG_2019_Human,Hypertrophic cardiomyopathy (HCM),1/85,0.004249939567045,0.0090998738144064,0,0,19915.0,108752.83801948265,ITGB4
2760,KEGG_2019_Human,Dilated cardiomyopathy (DCM),1/91,0.0045499369072032,0.0090998738144064,0,0,19909.0,107362.10783923086,ITGB4
2761,KEGG_2019_Human,Focal adhesion,1/199,0.0099498991610159,0.0142665266018757,0,0,19801.0,91286.4288690606,ITGB4
2762,KEGG_2019_Human,Regulation of actin cytoskeleton,1/214,0.0106998949514067,0.0142665266018757,0,0,19786.0,89779.39753374986,ITGB4
2763,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0176998626413668,0,0,19670.0,80733.60565076157,ITGB4
2764,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0176998626413668,0,0,19646.0,79255.8617626126,ITGB4
2765,KEGG_2019_Human,Pancreatic cancer,1/75,0.0037499442041125,0.0115498448062826,0,0,19925.0,111301.33528642564,RALGDS
2766,KEGG_2019_Human,Colorectal cancer,1/86,0.0042999391173866,0.0115498448062826,0,0,19914.0,108514.46102290176,RALGDS
2767,KEGG_2019_Human,Choline metabolism in cancer,1/99,0.0049499334884068,0.0115498448062826,0,0,19901.0,105642.09305076736,RALGDS
2768,KEGG_2019_Human,Phospholipase D signaling pathway,1/148,0.007399915061391,0.0129498513574342,0,0,19852.0,97399.60470052566,RALGDS
2769,KEGG_2019_Human,Rap1 signaling pathway,1/206,0.010299897173561,0.0135332051574538,0,0,19794.0,90569.849337325,RALGDS
2770,KEGG_2019_Human,Ras signaling pathway,1/232,0.0115998901349604,0.0135332051574538,0,0,19768.0,88101.22480150245,RALGDS
2771,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,RALGDS
2772,KEGG_2019_Human,RNA transport,1/165,0.0082499094553477,0.0082499094553477,0,0,19835.0,95159.46482222488,THOC5
2773,KEGG_2019_Human,RNA degradation,1/79,0.0039499423167337,0.0039499423167337,0,0,19921.0,110243.89578070649,CNOT6L
2774,KEGG_2019_Human,Selenocompound metabolism,1/17,0.0008499797390404818,0.0016999594780809,0,0,19983.0,141285.76583697114,MARS2
2775,KEGG_2019_Human,Aminoacyl-tRNA biosynthesis,1/66,0.003299948626608,0.003299948626608,0,0,19934.0,113899.85357353876,MARS2
2776,KEGG_2019_Human,Long-term potentiation,1/67,0.0033499481224912,0.0106771546448906,0,0,19933.0,113594.38808369274,CAMK2A
2777,KEGG_2019_Human,Amphetamine addiction,1/68,0.0033999476216189,0.0106771546448906,0,0,19932.0,113293.39338050144,CAMK2A
2778,KEGG_2019_Human,Gastric acid secretion,1/75,0.0037499442041125,0.0106771546448906,0,0,19925.0,111301.33528642564,CAMK2A
2779,KEGG_2019_Human,Glioma,1/75,0.0037499442041125,0.0106771546448906,0,0,19925.0,111301.33528642564,CAMK2A
2780,KEGG_2019_Human,ErbB signaling pathway,1/85,0.004249939567045,0.0106771546448906,0,0,19915.0,108752.83801948265,CAMK2A
2781,KEGG_2019_Human,Insulin secretion,1/86,0.0042999391173866,0.0106771546448906,0,0,19914.0,108514.46102290176,CAMK2A
2782,KEGG_2019_Human,GnRH signaling pathway,1/93,0.0046499360391879,0.0106771546448906,0,0,19907.0,106918.54242106884,CAMK2A
2783,KEGG_2019_Human,Circadian entrainment,1/97,0.0048499343304706,0.0106771546448906,0,0,19903.0,106058.9096435903,CAMK2A
2784,KEGG_2019_Human,Aldosterone synthesis and secretion,1/98,0.0048999339081079,0.0106771546448906,0,0,19902.0,105849.45495286948,CAMK2A
2785,KEGG_2019_Human,Inflammatory mediator regulation of TRP channels,1/100,0.0049999330710556,0.0106771546448906,0,0,19900.0,105436.78197328727,CAMK2A
2786,KEGG_2019_Human,HIF-1 signaling pathway,1/100,0.0049999330710556,0.0106771546448906,0,0,19900.0,105436.78197328727,CAMK2A
2787,KEGG_2019_Human,Melanogenesis,1/101,0.0050499326546803,0.0106771546448906,0,0,19899.0,105233.48101229242,CAMK2A
2788,KEGG_2019_Human,Glucagon signaling pathway,1/103,0.0051499318302617,0.0106771546448906,0,0,19897.0,104832.7525292024,CAMK2A
2789,KEGG_2019_Human,Cholinergic synapse,1/112,0.0055999282120529,0.0106771546448906,0,0,19888.0,103119.30984392198,CAMK2A
2790,KEGG_2019_Human,Neurotrophin signaling pathway,1/119,0.0059499254985137,0.0106771546448906,0,0,19881.0,101877.73080211312,CAMK2A
2791,KEGG_2019_Human,Oocyte meiosis,1/125,0.0062499232373748,0.0106771546448906,0,0,19875.0,100869.32368441945,CAMK2A
2792,KEGG_2019_Human,Dopaminergic synapse,1/131,0.0065499210316603,0.0106771546448906,0,0,19869.0,99907.33811343512,CAMK2A
2793,KEGG_2019_Human,Adrenergic signaling in cardiomyocytes,1/145,0.0072499160871101,0.0106771546448906,0,0,19855.0,97820.92670675044,CAMK2A
2794,KEGG_2019_Human,Oxytocin signaling pathway,1/153,0.0076499133771537,0.0106771546448906,0,0,19847.0,96715.6407630817,CAMK2A
2795,KEGG_2019_Human,Cushing syndrome,1/155,0.0077499127120574,0.0106771546448906,0,0,19845.0,96448.16254952336,CAMK2A
2796,KEGG_2019_Human,Wnt signaling pathway,1/158,0.0078999117225733,0.0106771546448906,0,0,19842.0,96053.2110949472,CAMK2A
2797,KEGG_2019_Human,Necroptosis,1/162,0.0080999104202618,0.0106771546448906,0,0,19838.0,95537.86936302872,CAMK2A
2798,KEGG_2019_Human,Tuberculosis,1/179,0.0089499050800561,0.0109038867493566,0,0,19821.0,93478.0629355712,CAMK2A
2799,KEGG_2019_Human,Axon guidance,1/181,0.0090499044707863,0.0109038867493566,0,0,19819.0,93248.41634586031,CAMK2A
2800,KEGG_2019_Human,Calcium signaling pathway,1/188,0.009399902370135,0.0109038867493566,0,0,19812.0,92463.712994847,CAMK2A
2801,KEGG_2019_Human,Proteoglycans in cancer,1/201,0.0100498985877989,0.0112095022710065,0,0,19799.0,91079.21596609056,CAMK2A
2802,KEGG_2019_Human,cAMP signaling pathway,1/212,0.0105998955026255,0.0113850729472645,0,0,19788.0,89974.27756224656,CAMK2A
2803,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0229926981863763,0,0,19556.0,74462.79263140135,CAMK2A
2804,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,CAMK2A
2805,KEGG_2019_Human,D-Glutamine and D-glutamate metabolism,1/5,0.0002499917995416556,0.0019999343963332,0,0,19995.0,165840.17843725558,GLS
2806,KEGG_2019_Human,Arginine biosynthesis,1/21,0.0010499764455398,0.0030665996853199,0,0,19979.0,137035.71221916509,GLS
2807,KEGG_2019_Human,Proximal tubule bicarbonate reclamation,1/23,0.0011499748819949,0.0030665996853199,0,0,19977.0,135204.63922267244,GLS
2808,KEGG_2019_Human,"Alanine, aspartate and glutamate metabolism",1/35,0.0017499663721595,0.0034999327443191,0,0,19965.0,126740.98858805298,GLS
2809,KEGG_2019_Human,Central carbon metabolism in cancer,1/65,0.003249949134407,0.0051999186150512,0,0,19935.0,114209.92613860144,GLS
2810,KEGG_2019_Human,GABAergic synapse,1/89,0.0044499377838098,0.0059332503784131,0,0,19911.0,107815.380281759,GLS
2811,KEGG_2019_Human,Glutamatergic synapse,1/114,0.005699927427839,0.0065142027746731,0,0,19886.0,102756.96431429044,GLS
2812,KEGG_2019_Human,MicroRNAs in cancer,1/299,0.0149498740670514,0.0149498740670514,0,0,19701.0,82804.33538735632,GLS
2813,KEGG_2019_Human,Inositol phosphate metabolism,1/74,0.0036999446830449,0.0049499334884068,0,0,19926.0,111574.38983110404,MTMR8
2814,KEGG_2019_Human,Phosphatidylinositol signaling system,1/99,0.0049499334884068,0.0049499334884068,0,0,19901.0,105642.09305076736,MTMR8
2815,KEGG_2019_Human,Bladder cancer,1/41,0.0020499625466866,0.0105554142611174,0,0,19959.0,123544.88783416104,ERBB2
2816,KEGG_2019_Human,Endometrial cancer,1/58,0.0028999527887707,0.0105554142611174,0,0,19942.0,116522.31890946148,ERBB2
2817,KEGG_2019_Human,Central carbon metabolism in cancer,1/65,0.003249949134407,0.0105554142611174,0,0,19935.0,114209.92613860144,ERBB2
2818,KEGG_2019_Human,Non-small cell lung cancer,1/66,0.003299948626608,0.0105554142611174,0,0,19934.0,113899.85357353876,ERBB2
2819,KEGG_2019_Human,Adherens junction,1/72,0.0035999456502131,0.0105554142611174,0,0,19928.0,112131.59838572376,ERBB2
2820,KEGG_2019_Human,Pancreatic cancer,1/75,0.0037499442041125,0.0105554142611174,0,0,19925.0,111301.33528642564,ERBB2
2821,KEGG_2019_Human,ErbB signaling pathway,1/85,0.004249939567045,0.0105554142611174,0,0,19915.0,108752.83801948265,ERBB2
2822,KEGG_2019_Human,Prostate cancer,1/97,0.0048499343304706,0.0105554142611174,0,0,19903.0,106058.9096435903,ERBB2
2823,KEGG_2019_Human,HIF-1 signaling pathway,1/100,0.0049999330710556,0.0105554142611174,0,0,19900.0,105436.78197328727,ERBB2
2824,KEGG_2019_Human,Breast cancer,1/147,0.0073499154017982,0.0127298715445453,0,0,19853.0,97539.10874372096,ERBB2
2825,KEGG_2019_Human,Gastric cancer,1/149,0.0074499147221605,0.0127298715445453,0,0,19851.0,97261.02051561224,ERBB2
2826,KEGG_2019_Human,Tight junction,1/170,0.0084999078692823,0.0127298715445453,0,0,19830.0,94543.49009679438,ERBB2
2827,KEGG_2019_Human,Calcium signaling pathway,1/188,0.009399902370135,0.0127298715445453,0,0,19812.0,92463.712994847,ERBB2
2828,KEGG_2019_Human,Focal adhesion,1/199,0.0099498991610159,0.0127298715445453,0,0,19801.0,91286.4288690606,ERBB2
2829,KEGG_2019_Human,Proteoglycans in cancer,1/201,0.0100498985877989,0.0127298715445453,0,0,19799.0,91079.21596609056,ERBB2
2830,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0167086827808222,0,0,19705.0,83086.53988020132,ERBB2
2831,KEGG_2019_Human,MicroRNAs in cancer,1/299,0.0149498740670514,0.0167086827808222,0,0,19701.0,82804.33538735632,ERBB2
2832,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.018683188343665,0,0,19646.0,79255.8617626126,ERBB2
2833,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,ERBB2
2834,KEGG_2019_Human,Fatty acid biosynthesis,1/13,0.0006499833083207112,0.0045498831582449,0,0,19987.0,146675.87616784443,ACSL1
2835,KEGG_2019_Human,Ferroptosis,1/40,0.0019999631680592,0.0048415972181405,0,0,19960.0,124043.94523066044,ACSL1
2836,KEGG_2019_Human,Fatty acid degradation,1/44,0.0021999607179423,0.0048415972181405,0,0,19956.0,122117.06559109331,ACSL1
2837,KEGG_2019_Human,Adipocytokine signaling pathway,1/69,0.003449947123837,0.0048415972181405,0,0,19931.0,112996.7391397682,ACSL1
2838,KEGG_2019_Human,PPAR signaling pathway,1/74,0.0036999446830449,0.0048415972181405,0,0,19926.0,111574.38983110404,ACSL1
2839,KEGG_2019_Human,Peroxisome,1/83,0.0041499404726918,0.0048415972181405,0,0,19917.0,109237.99888847338,ACSL1
2840,KEGG_2019_Human,Thermogenesis,1/231,0.0115498903940656,0.0115498903940656,0,0,19769.0,88191.07730937863,ACSL1
2841,KEGG_2019_Human,Vibrio cholerae infection,1/50,0.0024999572069037,0.0098248815474905,0,0,19950.0,119530.05920663515,PLCG2
2842,KEGG_2019_Human,VEGF signaling pathway,1/59,0.0029499522555206,0.0098248815474905,0,0,19941.0,116175.59385530632,PLCG2
2843,KEGG_2019_Human,Non-small cell lung cancer,1/66,0.003299948626608,0.0098248815474905,0,0,19934.0,113899.85357353876,PLCG2
2844,KEGG_2019_Human,Epithelial cell signaling in Helicobacter pylori infection,1/68,0.0033999476216189,0.0098248815474905,0,0,19932.0,113293.39338050144,PLCG2
2845,KEGG_2019_Human,Fc epsilon RI signaling pathway,1/68,0.0033999476216189,0.0098248815474905,0,0,19932.0,113293.39338050144,PLCG2
2846,KEGG_2019_Human,B cell receptor signaling pathway,1/71,0.0035499461386618,0.0098248815474905,0,0,19929.0,112415.9585341616,PLCG2
2847,KEGG_2019_Human,Inositol phosphate metabolism,1/74,0.0036999446830449,0.0098248815474905,0,0,19926.0,111574.38983110404,PLCG2
2848,KEGG_2019_Human,Glioma,1/75,0.0037499442041125,0.0098248815474905,0,0,19925.0,111301.33528642564,PLCG2
2849,KEGG_2019_Human,ErbB signaling pathway,1/85,0.004249939567045,0.0098248815474905,0,0,19915.0,108752.83801948265,PLCG2
2850,KEGG_2019_Human,Fc gamma R-mediated phagocytosis,1/91,0.0045499369072032,0.0098248815474905,0,0,19909.0,107362.10783923086,PLCG2
2851,KEGG_2019_Human,NF-kappa B signaling pathway,1/95,0.0047499351803394,0.0098248815474905,0,0,19905.0,106484.27183626965,PLCG2
2852,KEGG_2019_Human,Phosphatidylinositol signaling system,1/99,0.0049499334884068,0.0098248815474905,0,0,19901.0,105642.09305076736,PLCG2
2853,KEGG_2019_Human,AGE-RAGE signaling pathway in diabetic complications,1/100,0.0049999330710556,0.0098248815474905,0,0,19900.0,105436.78197328727,PLCG2
2854,KEGG_2019_Human,Inflammatory mediator regulation of TRP channels,1/100,0.0049999330710556,0.0098248815474905,0,0,19900.0,105436.78197328727,PLCG2
2855,KEGG_2019_Human,HIF-1 signaling pathway,1/100,0.0049999330710556,0.0098248815474905,0,0,19900.0,105436.78197328727,PLCG2
2856,KEGG_2019_Human,C-type lectin receptor signaling pathway,1/104,0.0051999314202997,0.0098248815474905,0,0,19896.0,104635.24941415618,PLCG2
2857,KEGG_2019_Human,Leukocyte transendothelial migration,1/112,0.0055999282120529,0.0098248815474905,0,0,19888.0,103119.30984392198,PLCG2
2858,KEGG_2019_Human,Thyroid hormone signaling pathway,1/116,0.0057999266512085,0.0098248815474905,0,0,19884.0,102400.8105961506,PLCG2
2859,KEGG_2019_Human,Neurotrophin signaling pathway,1/119,0.0059499254985137,0.0098248815474905,0,0,19881.0,101877.73080211312,PLCG2
2860,KEGG_2019_Human,Platelet activation,1/124,0.0061999236097501,0.0098248815474905,0,0,19876.0,101034.04709010696,PLCG2
2861,KEGG_2019_Human,Osteoclast differentiation,1/127,0.0063499224962247,0.0098248815474905,0,0,19873.0,100543.72072014232,PLCG2
2862,KEGG_2019_Human,Natural killer cell mediated cytotoxicity,1/131,0.0065499210316603,0.0098248815474905,0,0,19869.0,99907.33811343512,PLCG2
2863,KEGG_2019_Human,Phospholipase D signaling pathway,1/148,0.007399915061391,0.0106172694359088,0,0,19852.0,97399.60470052566,PLCG2
2864,KEGG_2019_Human,Hepatocellular carcinoma,1/168,0.0083999085011095,0.0114360914964609,0,0,19832.0,94787.72752807094,PLCG2
2865,KEGG_2019_Human,Axon guidance,1/181,0.0090499044707863,0.0114360914964609,0,0,19819.0,93248.41634586031,PLCG2
2866,KEGG_2019_Human,Kaposi sarcoma-associated herpesvirus infection,1/186,0.0092999029651357,0.0114360914964609,0,0,19814.0,92684.96451050608,PLCG2
2867,KEGG_2019_Human,Calcium signaling pathway,1/188,0.009399902370135,0.0114360914964609,0,0,19812.0,92463.712994847,PLCG2
2868,KEGG_2019_Human,Epstein-Barr virus infection,1/201,0.0100498985877989,0.0114360914964609,0,0,19799.0,91079.21596609056,PLCG2
2869,KEGG_2019_Human,Proteoglycans in cancer,1/201,0.0100498985877989,0.0114360914964609,0,0,19799.0,91079.21596609056,PLCG2
2870,KEGG_2019_Human,Human immunodeficiency virus 1 infection,1/212,0.0105998955026255,0.0116598850528881,0,0,19788.0,89974.27756224656,PLCG2
2871,KEGG_2019_Human,Ras signaling pathway,1/232,0.0115998901349604,0.0123482701436675,0,0,19768.0,88101.22480150245,PLCG2
2872,KEGG_2019_Human,MicroRNAs in cancer,1/299,0.0149498740670514,0.0154170576316468,0,0,19701.0,82804.33538735632,PLCG2
2873,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,PLCG2
2874,KEGG_2019_Human,Pyruvate metabolism,1/39,0.0019499637955508,0.0019499637955508,0,0,19961.0,124555.53162481484,ACYP2
2875,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR8K5
2876,KEGG_2019_Human,Fc epsilon RI signaling pathway,1/68,0.0033999476216189,0.0106998949514067,0,0,19932.0,113293.39338050144,VAV3
2877,KEGG_2019_Human,B cell receptor signaling pathway,1/71,0.0035499461386618,0.0106998949514067,0,0,19929.0,112415.9585341616,VAV3
2878,KEGG_2019_Human,Fc gamma R-mediated phagocytosis,1/91,0.0045499369072032,0.0106998949514067,0,0,19909.0,107362.10783923086,VAV3
2879,KEGG_2019_Human,T cell receptor signaling pathway,1/101,0.0050499326546803,0.0106998949514067,0,0,19899.0,105233.48101229242,VAV3
2880,KEGG_2019_Human,Leukocyte transendothelial migration,1/112,0.0055999282120529,0.0106998949514067,0,0,19888.0,103119.30984392198,VAV3
2881,KEGG_2019_Human,Natural killer cell mediated cytotoxicity,1/131,0.0065499210316603,0.0106998949514067,0,0,19869.0,99907.33811343512,VAV3
2882,KEGG_2019_Human,Chemokine signaling pathway,1/190,0.0094999017791995,0.0106998949514067,0,0,19810.0,92244.74636351672,VAV3
2883,KEGG_2019_Human,Focal adhesion,1/199,0.0099498991610159,0.0106998949514067,0,0,19801.0,91286.4288690606,VAV3
2884,KEGG_2019_Human,cAMP signaling pathway,1/212,0.0105998955026255,0.0106998949514067,0,0,19788.0,89974.27756224656,VAV3
2885,KEGG_2019_Human,Regulation of actin cytoskeleton,1/214,0.0106998949514067,0.0106998949514067,0,0,19786.0,89779.39753374986,VAV3
2886,KEGG_2019_Human,TNF signaling pathway,1/110,0.0054999290027479,0.0088999053857096,0,0,19890.0,103488.06969787036,DNM1L
2887,KEGG_2019_Human,Necroptosis,1/162,0.0080999104202618,0.0088999053857096,0,0,19838.0,95537.86936302872,DNM1L
2888,KEGG_2019_Human,NOD-like receptor signaling pathway,1/178,0.0088999053857096,0.0088999053857096,0,0,19822.0,93593.82745769851,DNM1L
2889,KEGG_2019_Human,Human T-cell leukemia virus 1 infection,1/219,0.0109498935894162,0.0109498935894162,0,0,19781.0,89299.85161916987,TRRAP
2890,KEGG_2019_Human,Endocytosis,1/244,0.0121998870519305,0.0121998870519305,0,0,19756.0,87051.4275316661,EHD1
2891,KEGG_2019_Human,RNA transport,1/165,0.0082499094553477,0.0082499094553477,0,0,19835.0,95159.46482222488,ELAC1
2892,KEGG_2019_Human,Glycosylphosphatidylinositol (GPI)-anchor biosynthesis,1/25,0.0012499733663791,0.0012499733663791,0,0,19975.0,133525.54486996148,PIGQ
2893,KEGG_2019_Human,Homologous recombination,1/41,0.0020499625466866,0.008099864888569,0,0,19959.0,123544.88783416104,BRCA1
2894,KEGG_2019_Human,Fanconi anemia pathway,1/54,0.0026999549628563,0.008099864888569,0,0,19946.0,117971.01964061816,BRCA1
2895,KEGG_2019_Human,Ubiquitin mediated proteolysis,1/137,0.0068499188797651,0.0110248731026973,0,0,19863.0,98987.62735269018,BRCA1
2896,KEGG_2019_Human,Breast cancer,1/147,0.0073499154017982,0.0110248731026973,0,0,19853.0,97539.10874372096,BRCA1
2897,KEGG_2019_Human,MicroRNAs in cancer,1/299,0.0149498740670514,0.0176998626413668,0,0,19701.0,82804.33538735632,BRCA1
2898,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0176998626413668,0,0,19646.0,79255.8617626126,BRCA1
2899,KEGG_2019_Human,Axon guidance,1/181,0.0090499044707863,0.0090499044707863,0,0,19819.0,93248.41634586031,SRGAP2
2900,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,P2RY8
2901,KEGG_2019_Human,Synthesis and degradation of ketone bodies,1/10,0.0004999862257578379,0.0018666282310663,0,0,19990.0,151942.5908680334,HMGCS1
2902,KEGG_2019_Human,Terpenoid backbone biosynthesis,1/22,0.0010999756574123,0.0018666282310663,0,0,19978.0,136099.47030191717,HMGCS1
2903,KEGG_2019_Human,Butanoate metabolism,1/28,0.0013999711732997,0.0018666282310663,0,0,19972.0,131242.0761597353,HMGCS1
2904,KEGG_2019_Human,"Valine, leucine and isoleucine degradation",1/48,0.0023999583567988,0.0023999583567988,0,0,19952.0,120356.5272753826,HMGCS1
2905,KEGG_2019_Human,Cardiac muscle contraction,1/78,0.0038999427840466,0.0112582177134695,0,0,19922.0,110503.2180492851,COX6A2
2906,KEGG_2019_Human,Oxidative phosphorylation,1/133,0.0066499203093911,0.0112582177134695,0,0,19867.0,99596.2591544721,COX6A2
2907,KEGG_2019_Human,Parkinson disease,1/142,0.0070999171242726,0.0112582177134695,0,0,19858.0,98250.87390500787,COX6A2
2908,KEGG_2019_Human,Non-alcoholic fatty liver disease (NAFLD),1/149,0.0074499147221605,0.0112582177134695,0,0,19851.0,97261.02051561224,COX6A2
2909,KEGG_2019_Human,Alzheimer disease,1/171,0.0085499075557634,0.0112582177134695,0,0,19829.0,94422.42241345016,COX6A2
2910,KEGG_2019_Human,Huntington disease,1/193,0.0096499008972596,0.0112582177134695,0,0,19807.0,91920.47679471428,COX6A2
2911,KEGG_2019_Human,Thermogenesis,1/231,0.0115498903940656,0.0115498903940656,0,0,19769.0,88191.07730937863,COX6A2
2912,KEGG_2019_Human,Basal cell carcinoma,1/63,0.0031499501598827,0.0109198810514423,0,0,19937.0,114844.46974572667,FZD10
2913,KEGG_2019_Human,Melanogenesis,1/101,0.0050499326546803,0.0109198810514423,0,0,19899.0,105233.48101229242,FZD10
2914,KEGG_2019_Human,Signaling pathways regulating pluripotency of stem cells,1/139,0.006949918172816,0.0109198810514423,0,0,19861.0,98689.81333375497,FZD10
2915,KEGG_2019_Human,Breast cancer,1/147,0.0073499154017982,0.0109198810514423,0,0,19853.0,97539.10874372096,FZD10
2916,KEGG_2019_Human,Gastric cancer,1/149,0.0074499147221605,0.0109198810514423,0,0,19851.0,97261.02051561224,FZD10
2917,KEGG_2019_Human,mTOR signaling pathway,1/152,0.0075999137114971,0.0109198810514423,0,0,19848.0,96850.665715497,FZD10
2918,KEGG_2019_Human,Cushing syndrome,1/155,0.0077499127120574,0.0109198810514423,0,0,19845.0,96448.16254952336,FZD10
2919,KEGG_2019_Human,Wnt signaling pathway,1/158,0.0078999117225733,0.0109198810514423,0,0,19842.0,96053.2110949472,FZD10
2920,KEGG_2019_Human,Hippo signaling pathway,1/160,0.0079999110688441,0.0109198810514423,0,0,19840.0,95793.96509856998,FZD10
2921,KEGG_2019_Human,Hepatocellular carcinoma,1/168,0.0083999085011095,0.0109198810514423,0,0,19832.0,94787.72752807094,FZD10
2922,KEGG_2019_Human,Proteoglycans in cancer,1/201,0.0100498985877989,0.0118771528764897,0,0,19799.0,91079.21596609056,FZD10
2923,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0178748564138782,0,0,19670.0,80733.60565076157,FZD10
2924,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,FZD10
2925,KEGG_2019_Human,Hippo signaling pathway,1/160,0.0079999110688441,0.0079999110688441,0,0,19840.0,95793.96509856998,WWC1
2926,KEGG_2019_Human,Glycosphingolipid biosynthesis,1/45,0.0022499601197094,0.0022499601197094,0,0,19955.0,121662.49782449217,ST8SIA5
2927,KEGG_2019_Human,Progesterone-mediated oocyte maturation,1/99,0.0049499334884068,0.0062499232373748,0,0,19901.0,105642.09305076736,CPEB1
2928,KEGG_2019_Human,Oocyte meiosis,1/125,0.0062499232373748,0.0062499232373748,0,0,19875.0,100869.32368441945,CPEB1
2929,KEGG_2019_Human,Cholesterol metabolism,1/50,0.0024999572069037,0.0024999572069037,0,0,19950.0,119530.05920663515,PCSK9
2930,KEGG_2019_Human,Taste transduction,1/83,0.0041499404726918,0.0041499404726918,0,0,19917.0,109237.99888847338,PKD1L3
2931,KEGG_2019_Human,Prion diseases,1/35,0.0017499663721595,0.0101698700744073,0,0,19965.0,126740.98858805298,LAMC1
2932,KEGG_2019_Human,ECM-receptor interaction,1/82,0.004099940929819,0.0101698700744073,0,0,19918.0,109484.9180722932,LAMC1
2933,KEGG_2019_Human,Small cell lung cancer,1/93,0.0046499360391879,0.0101698700744073,0,0,19907.0,106918.54242106884,LAMC1
2934,KEGG_2019_Human,Amoebiasis,1/96,0.0047999347538706,0.0101698700744073,0,0,19904.0,106270.50039849174,LAMC1
2935,KEGG_2019_Human,Toxoplasmosis,1/113,0.0056499278191151,0.0101698700744073,0,0,19887.0,102937.34947211576,LAMC1
2936,KEGG_2019_Human,Focal adhesion,1/199,0.0099498991610159,0.0149248487415239,0,0,19801.0,91286.4288690606,LAMC1
2937,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0199123454715377,0,0,19670.0,80733.60565076157,LAMC1
2938,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0199123454715377,0,0,19646.0,79255.8617626126,LAMC1
2939,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,LAMC1
2940,KEGG_2019_Human,Pentose phosphate pathway,1/30,0.0014999697593334,0.0014999697593334,0,0,19970.0,129851.13732048514,TKTL2
2941,KEGG_2019_Human,ECM-receptor interaction,1/82,0.004099940929819,0.0112998556382303,0,0,19918.0,109484.9180722932,LAMC2
2942,KEGG_2019_Human,Small cell lung cancer,1/93,0.0046499360391879,0.0112998556382303,0,0,19907.0,106918.54242106884,LAMC2
2943,KEGG_2019_Human,Amoebiasis,1/96,0.0047999347538706,0.0112998556382303,0,0,19904.0,106270.50039849174,LAMC2
2944,KEGG_2019_Human,Toxoplasmosis,1/113,0.0056499278191151,0.0112998556382303,0,0,19887.0,102937.34947211576,LAMC2
2945,KEGG_2019_Human,Focal adhesion,1/199,0.0099498991610159,0.0159198386576255,0,0,19801.0,91286.4288690606,LAMC2
2946,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0202284144472764,0,0,19670.0,80733.60565076157,LAMC2
2947,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0202284144472764,0,0,19646.0,79255.8617626126,LAMC2
2948,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,LAMC2
2949,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF354C
2950,KEGG_2019_Human,NF-kappa B signaling pathway,1/95,0.0047499351803394,0.0047499351803394,0,0,19905.0,106484.27183626965,CARD10
2951,KEGG_2019_Human,ABC transporters,1/45,0.0022499601197094,0.0044999202394188,0,0,19955.0,121662.49782449217,ABCA2
2952,KEGG_2019_Human,Lysosome,1/123,0.0061499239842961,0.0061499239842961,0,0,19877.0,101200.07933676826,ABCA2
2953,KEGG_2019_Human,Galactose metabolism,1/31,0.0015499690656704,0.0021999607179423,0,0,19969.0,129189.85098816035,LCT
2954,KEGG_2019_Human,Carbohydrate digestion and absorption,1/44,0.0021999607179423,0.0021999607179423,0,0,19956.0,122117.06559109331,LCT
2955,KEGG_2019_Human,Histidine metabolism,1/23,0.0011499748819949,0.0023249535985056,0,0,19977.0,135204.63922267244,CARNS1
2956,KEGG_2019_Human,beta-Alanine metabolism,1/31,0.0015499690656704,0.0023249535985056,0,0,19969.0,129189.85098816035,CARNS1
2957,KEGG_2019_Human,Arginine and proline metabolism,1/49,0.0024499577795033,0.0024499577795033,0,0,19951.0,119939.1172087114,CARNS1
2958,KEGG_2019_Human,Pancreatic secretion,1/98,0.0048999339081079,0.009399902370135,0,0,19902.0,105849.45495286948,ATP2A3
2959,KEGG_2019_Human,cGMP-PKG signaling pathway,1/166,0.0082999091363732,0.009399902370135,0,0,19834.0,95034.82345515196,ATP2A3
2960,KEGG_2019_Human,Alzheimer disease,1/171,0.0085499075557634,0.009399902370135,0,0,19829.0,94422.42241345016,ATP2A3
2961,KEGG_2019_Human,Calcium signaling pathway,1/188,0.009399902370135,0.009399902370135,0,0,19812.0,92463.712994847,ATP2A3
2962,KEGG_2019_Human,Small cell lung cancer,1/93,0.0046499360391879,0.0121665484326847,0,0,19907.0,106918.54242106884,XIAP
2963,KEGG_2019_Human,NF-kappa B signaling pathway,1/95,0.0047499351803394,0.0121665484326847,0,0,19905.0,106484.27183626965,XIAP
2964,KEGG_2019_Human,Toxoplasmosis,1/113,0.0056499278191151,0.0121665484326847,0,0,19887.0,102937.34947211576,XIAP
2965,KEGG_2019_Human,Ubiquitin mediated proteolysis,1/137,0.0068499188797651,0.0121665484326847,0,0,19863.0,98987.62735269018,XIAP
2966,KEGG_2019_Human,Apoptosis,1/143,0.0071499167770442,0.0121665484326847,0,0,19857.0,98106.57763600958,XIAP
2967,KEGG_2019_Human,Necroptosis,1/162,0.0080999104202618,0.0121665484326847,0,0,19838.0,95537.86936302872,XIAP
2968,KEGG_2019_Human,NOD-like receptor signaling pathway,1/178,0.0088999053857096,0.0121665484326847,0,0,19822.0,93593.82745769851,XIAP
2969,KEGG_2019_Human,Focal adhesion,1/199,0.0099498991610159,0.0121665484326847,0,0,19801.0,91286.4288690606,XIAP
2970,KEGG_2019_Human,Human T-cell leukemia virus 1 infection,1/219,0.0109498935894162,0.0121665484326847,0,0,19781.0,89299.85161916987,XIAP
2971,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,XIAP
2972,KEGG_2019_Human,Axon guidance,1/181,0.0090499044707863,0.0090499044707863,0,0,19819.0,93248.41634586031,RHOD
2973,KEGG_2019_Human,Ether lipid metabolism,1/47,0.0023499589392381,0.0092554396643547,0,0,19953.0,120782.64067395544,PLD1
2974,KEGG_2019_Human,Pancreatic cancer,1/75,0.0037499442041125,0.0092554396643547,0,0,19925.0,111301.33528642564,PLD1
2975,KEGG_2019_Human,Fc gamma R-mediated phagocytosis,1/91,0.0045499369072032,0.0092554396643547,0,0,19909.0,107362.10783923086,PLD1
2976,KEGG_2019_Human,GnRH signaling pathway,1/93,0.0046499360391879,0.0092554396643547,0,0,19907.0,106918.54242106884,PLD1
2977,KEGG_2019_Human,Glycerophospholipid metabolism,1/97,0.0048499343304706,0.0092554396643547,0,0,19903.0,106058.9096435903,PLD1
2978,KEGG_2019_Human,Choline metabolism in cancer,1/99,0.0049499334884068,0.0092554396643547,0,0,19901.0,105642.09305076736,PLD1
2979,KEGG_2019_Human,"Parathyroid hormone synthesis, secretion and action",1/106,0.0052999306076525,0.0092554396643547,0,0,19894.0,104245.78450366124,PLD1
2980,KEGG_2019_Human,Glutamatergic synapse,1/114,0.005699927427839,0.0092554396643547,0,0,19886.0,102756.96431429044,PLD1
2981,KEGG_2019_Human,Sphingolipid signaling pathway,1/119,0.0059499254985137,0.0092554396643547,0,0,19881.0,101877.73080211312,PLD1
2982,KEGG_2019_Human,Phospholipase D signaling pathway,1/148,0.007399915061391,0.0103598810859474,0,0,19852.0,97399.60470052566,PLD1
2983,KEGG_2019_Human,cAMP signaling pathway,1/212,0.0105998955026255,0.013138339902079,0,0,19788.0,89974.27756224656,PLD1
2984,KEGG_2019_Human,Ras signaling pathway,1/232,0.0115998901349604,0.013138339902079,0,0,19768.0,88101.22480150245,PLD1
2985,KEGG_2019_Human,Endocytosis,1/244,0.0121998870519305,0.013138339902079,0,0,19756.0,87051.4275316661,PLD1
2986,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,PLD1
2987,KEGG_2019_Human,ABC transporters,1/45,0.0022499601197094,0.0022499601197094,0,0,19955.0,121662.49782449217,ABCC10
2988,KEGG_2019_Human,Endocrine and other factor-regulated calcium reabsorption,1/48,0.0023999583567988,0.0068249053608048,0,0,19952.0,120356.5272753826,DNM2
2989,KEGG_2019_Human,Bacterial invasion of epithelial cells,1/74,0.0036999446830449,0.0068249053608048,0,0,19926.0,111574.38983110404,DNM2
2990,KEGG_2019_Human,Synaptic vesicle cycle,1/78,0.0038999427840466,0.0068249053608048,0,0,19922.0,110503.2180492851,DNM2
2991,KEGG_2019_Human,Fc gamma R-mediated phagocytosis,1/91,0.0045499369072032,0.0068249053608048,0,0,19909.0,107362.10783923086,DNM2
2992,KEGG_2019_Human,Phospholipase D signaling pathway,1/148,0.007399915061391,0.0088798980736692,0,0,19852.0,97399.60470052566,DNM2
2993,KEGG_2019_Human,Endocytosis,1/244,0.0121998870519305,0.0121998870519305,0,0,19756.0,87051.4275316661,DNM2
2994,KEGG_2019_Human,p53 signaling pathway,1/72,0.0035999456502131,0.0079999110688441,0,0,19928.0,112131.59838572376,TP73
2995,KEGG_2019_Human,Neurotrophin signaling pathway,1/119,0.0059499254985137,0.0079999110688441,0,0,19881.0,101877.73080211312,TP73
2996,KEGG_2019_Human,Measles,1/138,0.0068999185254481,0.0079999110688441,0,0,19862.0,98838.19160389496,TP73
2997,KEGG_2019_Human,Hippo signaling pathway,1/160,0.0079999110688441,0.0079999110688441,0,0,19840.0,95793.96509856998,TP73
2998,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF248
2999,KEGG_2019_Human,Protein export,1/23,0.0011499748819949,0.0011499748819949,0,0,19977.0,135204.63922267244,IMMP2L
3000,KEGG_2019_Human,Lysine degradation,1/59,0.0029499522555206,0.008849856766562,0,0,19941.0,116175.59385530632,KMT2A
3001,KEGG_2019_Human,Cushing syndrome,1/155,0.0077499127120574,0.0092999029651357,0,0,19845.0,96448.16254952336,KMT2A
3002,KEGG_2019_Human,Transcriptional misregulation in cancer,1/186,0.0092999029651357,0.0092999029651357,0,0,19814.0,92684.96451050608,KMT2A
3003,KEGG_2019_Human,ECM-receptor interaction,1/82,0.004099940929819,0.0112998556382303,0,0,19918.0,109484.9180722932,LAMA5
3004,KEGG_2019_Human,Small cell lung cancer,1/93,0.0046499360391879,0.0112998556382303,0,0,19907.0,106918.54242106884,LAMA5
3005,KEGG_2019_Human,Amoebiasis,1/96,0.0047999347538706,0.0112998556382303,0,0,19904.0,106270.50039849174,LAMA5
3006,KEGG_2019_Human,Toxoplasmosis,1/113,0.0056499278191151,0.0112998556382303,0,0,19887.0,102937.34947211576,LAMA5
3007,KEGG_2019_Human,Focal adhesion,1/199,0.0099498991610159,0.0159198386576255,0,0,19801.0,91286.4288690606,LAMA5
3008,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0202284144472764,0,0,19670.0,80733.60565076157,LAMA5
3009,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0202284144472764,0,0,19646.0,79255.8617626126,LAMA5
3010,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,LAMA5
3011,KEGG_2019_Human,Cysteine and methionine metabolism,1/47,0.0023499589392381,0.0023499589392381,0,0,19953.0,120782.64067395544,MAT1A
3012,KEGG_2019_Human,Axon guidance,1/181,0.0090499044707863,0.0090499044707863,0,0,19819.0,93248.41634586031,EPHA5
3013,KEGG_2019_Human,Ubiquitin mediated proteolysis,1/137,0.0068499188797651,0.0068499188797651,0,0,19863.0,98987.62735269018,PPIL2
3014,KEGG_2019_Human,ECM-receptor interaction,1/82,0.004099940929819,0.0112498433599406,0,0,19918.0,109484.9180722932,COL6A3
3015,KEGG_2019_Human,Protein digestion and absorption,1/90,0.0044999373439762,0.0112498433599406,0,0,19910.0,107587.50385474482,COL6A3
3016,KEGG_2019_Human,Focal adhesion,1/199,0.0099498991610159,0.0165831652683599,0,0,19801.0,91286.4288690606,COL6A3
3017,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0176998626413668,0,0,19670.0,80733.60565076157,COL6A3
3018,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0176998626413668,0,0,19646.0,79255.8617626126,COL6A3
3019,KEGG_2019_Human,Salivary secretion,1/90,0.0044999373439762,0.0044999373439762,0,0,19910.0,107587.50385474482,AQP5
3020,KEGG_2019_Human,Vasopressin-regulated water reabsorption,1/44,0.0021999607179423,0.0021999607179423,0,0,19956.0,122117.06559109331,AQP2
3021,KEGG_2019_Human,Lysosome,1/123,0.0061499239842961,0.0061499239842961,0,0,19877.0,101200.07933676826,LITAF
3022,KEGG_2019_Human,ECM-receptor interaction,1/82,0.004099940929819,0.0097498820928791,0,0,19918.0,109484.9180722932,COL1A1
3023,KEGG_2019_Human,Protein digestion and absorption,1/90,0.0044999373439762,0.0097498820928791,0,0,19910.0,107587.50385474482,COL1A1
3024,KEGG_2019_Human,Amoebiasis,1/96,0.0047999347538706,0.0097498820928791,0,0,19904.0,106270.50039849174,COL1A1
3025,KEGG_2019_Human,AGE-RAGE signaling pathway in diabetic complications,1/100,0.0049999330710556,0.0097498820928791,0,0,19900.0,105436.78197328727,COL1A1
3026,KEGG_2019_Human,Platelet activation,1/124,0.0061999236097501,0.0097498820928791,0,0,19876.0,101034.04709010696,COL1A1
3027,KEGG_2019_Human,Relaxin signaling pathway,1/130,0.0064999213952527,0.0097498820928791,0,0,19870.0,100064.62842845908,COL1A1
3028,KEGG_2019_Human,Focal adhesion,1/199,0.0099498991610159,0.0127927274927348,0,0,19801.0,91286.4288690606,COL1A1
3029,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0176998626413668,0,0,19670.0,80733.60565076157,COL1A1
3030,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0176998626413668,0,0,19646.0,79255.8617626126,COL1A1
3031,KEGG_2019_Human,Nicotine addiction,1/40,0.0019999631680592,0.0108798323891805,0,0,19960.0,124043.94523066044,GRIN2B
3032,KEGG_2019_Human,Cocaine addiction,1/49,0.0024499577795033,0.0108798323891805,0,0,19951.0,119939.1172087114,GRIN2B
3033,KEGG_2019_Human,Amyotrophic lateral sclerosis (ALS),1/51,0.0025499566390179,0.0108798323891805,0,0,19949.0,119129.0228601236,GRIN2B
3034,KEGG_2019_Human,Long-term potentiation,1/67,0.0033499481224912,0.0108798323891805,0,0,19933.0,113594.38808369274,GRIN2B
3035,KEGG_2019_Human,Amphetamine addiction,1/68,0.0033999476216189,0.0108798323891805,0,0,19932.0,113293.39338050144,GRIN2B
3036,KEGG_2019_Human,Circadian entrainment,1/97,0.0048499343304706,0.0118220805500286,0,0,19903.0,106058.9096435903,GRIN2B
3037,KEGG_2019_Human,Glutamatergic synapse,1/114,0.005699927427839,0.0118220805500286,0,0,19886.0,102756.96431429044,GRIN2B
3038,KEGG_2019_Human,Dopaminergic synapse,1/131,0.0065499210316603,0.0118220805500286,0,0,19869.0,99907.33811343512,GRIN2B
3039,KEGG_2019_Human,Systemic lupus erythematosus,1/133,0.0066499203093911,0.0118220805500286,0,0,19867.0,99596.2591544721,GRIN2B
3040,KEGG_2019_Human,Alzheimer disease,1/171,0.0085499075557634,0.0121141662887149,0,0,19829.0,94422.42241345016,GRIN2B
3041,KEGG_2019_Human,Alcoholism,1/180,0.0089999047745351,0.0121141662887149,0,0,19820.0,93362.92821536642,GRIN2B
3042,KEGG_2019_Human,Huntington disease,1/193,0.0096499008972596,0.0121141662887149,0,0,19807.0,91920.47679471428,GRIN2B
3043,KEGG_2019_Human,Rap1 signaling pathway,1/206,0.010299897173561,0.0121141662887149,0,0,19794.0,90569.849337325,GRIN2B
3044,KEGG_2019_Human,cAMP signaling pathway,1/212,0.0105998955026255,0.0121141662887149,0,0,19788.0,89974.27756224656,GRIN2B
3045,KEGG_2019_Human,Ras signaling pathway,1/232,0.0115998901349604,0.0123732161439577,0,0,19768.0,88101.22480150245,GRIN2B
3046,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,GRIN2B
3047,KEGG_2019_Human,Nicotine addiction,1/40,0.0019999631680592,0.007583228178672,0,0,19960.0,124043.94523066044,GABRE
3048,KEGG_2019_Human,GABAergic synapse,1/89,0.0044499377838098,0.007583228178672,0,0,19911.0,107815.380281759,GABRE
3049,KEGG_2019_Human,Morphine addiction,1/91,0.0045499369072032,0.007583228178672,0,0,19909.0,107362.10783923086,GABRE
3050,KEGG_2019_Human,Retrograde endocannabinoid signaling,1/148,0.007399915061391,0.0092498938267387,0,0,19852.0,97399.60470052566,GABRE
3051,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,GABRE
3052,KEGG_2019_Human,"Parathyroid hormone synthesis, secretion and action",1/106,0.0052999306076525,0.0052999306076525,0,0,19894.0,104245.78450366124,SLC34A1
3053,KEGG_2019_Human,Sphingolipid metabolism,1/47,0.0023499589392381,0.0023499589392381,0,0,19953.0,120782.64067395544,ENPP7
3054,KEGG_2019_Human,Staphylococcus aureus infection,1/68,0.0033999476216189,0.0078998846334674,0,0,19932.0,113293.39338050144,PLG
3055,KEGG_2019_Human,Complement and coagulation cascades,1/79,0.0039499423167337,0.0078998846334674,0,0,19921.0,110243.89578070649,PLG
3056,KEGG_2019_Human,Influenza A,1/171,0.0085499075557634,0.0113998767410179,0,0,19829.0,94422.42241345016,PLG
3057,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,PLG
3058,KEGG_2019_Human,Huntington disease,1/193,0.0096499008972596,0.0096499008972596,0,0,19807.0,91920.47679471428,DNAH9
3059,KEGG_2019_Human,alpha-Linolenic acid metabolism,1/25,0.0012499733663791,0.0052874076132858,0,0,19975.0,133525.54486996148,PLA2G2E
3060,KEGG_2019_Human,Linoleic acid metabolism,1/29,0.001449970461791,0.0052874076132858,0,0,19971.0,130534.69172799008,PLA2G2E
3061,KEGG_2019_Human,Fat digestion and absorption,1/41,0.0020499625466866,0.0052874076132858,0,0,19959.0,123544.88783416104,PLA2G2E
3062,KEGG_2019_Human,Ether lipid metabolism,1/47,0.0023499589392381,0.0052874076132858,0,0,19953.0,120782.64067395544,PLA2G2E
3063,KEGG_2019_Human,Arachidonic acid metabolism,1/63,0.0031499501598827,0.005669910287789,0,0,19937.0,114844.46974572667,PLA2G2E
3064,KEGG_2019_Human,Glycerophospholipid metabolism,1/97,0.0048499343304706,0.0062999150247102,0,0,19903.0,106058.9096435903,PLA2G2E
3065,KEGG_2019_Human,Pancreatic secretion,1/98,0.0048999339081079,0.0062999150247102,0,0,19902.0,105849.45495286948,PLA2G2E
3066,KEGG_2019_Human,Vascular smooth muscle contraction,1/132,0.0065999206698993,0.0074249107536368,0,0,19868.0,99751.22090491928,PLA2G2E
3067,KEGG_2019_Human,Ras signaling pathway,1/232,0.0115998901349604,0.0115998901349604,0,0,19768.0,88101.22480150245,PLA2G2E
3068,KEGG_2019_Human,Type II diabetes mellitus,1/46,0.0022999595269283,0.0115074461482065,0,0,19954.0,121217.8313311442,IKBKB
3069,KEGG_2019_Human,Cytosolic DNA-sensing pathway,1/63,0.0031499501598827,0.0115074461482065,0,0,19937.0,114844.46974572667,IKBKB
3070,KEGG_2019_Human,Shigellosis,1/65,0.003249949134407,0.0115074461482065,0,0,19935.0,114209.92613860144,IKBKB
3071,KEGG_2019_Human,Acute myeloid leukemia,1/66,0.003299948626608,0.0115074461482065,0,0,19934.0,113899.85357353876,IKBKB
3072,KEGG_2019_Human,Epithelial cell signaling in Helicobacter pylori infection,1/68,0.0033999476216189,0.0115074461482065,0,0,19932.0,113293.39338050144,IKBKB
3073,KEGG_2019_Human,Adipocytokine signaling pathway,1/69,0.003449947123837,0.0115074461482065,0,0,19931.0,112996.7391397682,IKBKB
3074,KEGG_2019_Human,RIG-I-like receptor signaling pathway,1/70,0.0034999466296654,0.0115074461482065,0,0,19930.0,112704.30065625212,IKBKB
3075,KEGG_2019_Human,B cell receptor signaling pathway,1/71,0.0035499461386618,0.0115074461482065,0,0,19929.0,112415.9585341616,IKBKB
3076,KEGG_2019_Human,Pancreatic cancer,1/75,0.0037499442041125,0.0115074461482065,0,0,19925.0,111301.33528642564,IKBKB
3077,KEGG_2019_Human,Chronic myeloid leukemia,1/76,0.0037999437281752,0.0115074461482065,0,0,19924.0,111031.8499691117,IKBKB
3078,KEGG_2019_Human,Th1 and Th2 cell differentiation,1/92,0.0045999364719865,0.0115074461482065,0,0,19908.0,107139.13814408927,IKBKB
3079,KEGG_2019_Human,IL-17 signaling pathway,1/93,0.0046499360391879,0.0115074461482065,0,0,19907.0,106918.54242106884,IKBKB
3080,KEGG_2019_Human,Small cell lung cancer,1/93,0.0046499360391879,0.0115074461482065,0,0,19907.0,106918.54242106884,IKBKB
3081,KEGG_2019_Human,NF-kappa B signaling pathway,1/95,0.0047499351803394,0.0115074461482065,0,0,19905.0,106484.27183626965,IKBKB
3082,KEGG_2019_Human,Prostate cancer,1/97,0.0048499343304706,0.0115074461482065,0,0,19903.0,106058.9096435903,IKBKB
3083,KEGG_2019_Human,T cell receptor signaling pathway,1/101,0.0050499326546803,0.0115074461482065,0,0,19899.0,105233.48101229242,IKBKB
3084,KEGG_2019_Human,Chagas disease (American trypanosomiasis),1/103,0.0051499318302617,0.0115074461482065,0,0,19897.0,104832.7525292024,IKBKB
3085,KEGG_2019_Human,Toll-like receptor signaling pathway,1/104,0.0051999314202997,0.0115074461482065,0,0,19896.0,104635.24941415618,IKBKB
3086,KEGG_2019_Human,C-type lectin receptor signaling pathway,1/104,0.0051999314202997,0.0115074461482065,0,0,19896.0,104635.24941415618,IKBKB
3087,KEGG_2019_Human,Th17 cell differentiation,1/107,0.0053499302026925,0.0115074461482065,0,0,19893.0,104053.753408911,IKBKB
3088,KEGG_2019_Human,Insulin resistance,1/108,0.0053999298011749,0.0115074461482065,0,0,19892.0,103863.47861844616,IKBKB
3089,KEGG_2019_Human,TNF signaling pathway,1/110,0.0054999290027479,0.0115074461482065,0,0,19890.0,103488.06969787036,IKBKB
3090,KEGG_2019_Human,Toxoplasmosis,1/113,0.0056499278191151,0.0115074461482065,0,0,19887.0,102937.34947211576,IKBKB
3091,KEGG_2019_Human,Neurotrophin signaling pathway,1/119,0.0059499254985137,0.0115074461482065,0,0,19881.0,101877.73080211312,IKBKB
3092,KEGG_2019_Human,Osteoclast differentiation,1/127,0.0063499224962247,0.0115074461482065,0,0,19873.0,100543.72072014232,IKBKB
3093,KEGG_2019_Human,FoxO signaling pathway,1/132,0.0065999206698993,0.0115074461482065,0,0,19868.0,99751.22090491928,IKBKB
3094,KEGG_2019_Human,Insulin signaling pathway,1/137,0.0068499188797651,0.0115074461482065,0,0,19863.0,98987.62735269018,IKBKB
3095,KEGG_2019_Human,Measles,1/138,0.0068999185254481,0.0115074461482065,0,0,19862.0,98838.19160389496,IKBKB
3096,KEGG_2019_Human,Fluid shear stress and atherosclerosis,1/139,0.006949918172816,0.0115074461482065,0,0,19861.0,98689.81333375497,IKBKB
3097,KEGG_2019_Human,Apoptosis,1/143,0.0071499167770442,0.0115074461482065,0,0,19857.0,98106.57763600958,IKBKB
3098,KEGG_2019_Human,Non-alcoholic fatty liver disease (NAFLD),1/149,0.0074499147221605,0.0115074461482065,0,0,19851.0,97261.02051561224,IKBKB
3099,KEGG_2019_Human,mTOR signaling pathway,1/152,0.0075999137114971,0.0115074461482065,0,0,19848.0,96850.665715497,IKBKB
3100,KEGG_2019_Human,Hepatitis C,1/155,0.0077499127120574,0.0115074461482065,0,0,19845.0,96448.16254952336,IKBKB
3101,KEGG_2019_Human,Hepatitis B,1/163,0.0081499100978668,0.0117454586704551,0,0,19837.0,95410.9786681514,IKBKB
3102,KEGG_2019_Human,Influenza A,1/171,0.0085499075557634,0.0119698705780688,0,0,19829.0,94422.42241345016,IKBKB
3103,KEGG_2019_Human,NOD-like receptor signaling pathway,1/178,0.0088999053857096,0.012113760108327,0,0,19822.0,93593.82745769851,IKBKB
3104,KEGG_2019_Human,Kaposi sarcoma-associated herpesvirus infection,1/186,0.0092999029651357,0.0122498733468626,0,0,19814.0,92684.96451050608,IKBKB
3105,KEGG_2019_Human,Chemokine signaling pathway,1/190,0.0094999017791995,0.0122498733468626,0,0,19810.0,92244.74636351672,IKBKB
3106,KEGG_2019_Human,Epstein-Barr virus infection,1/201,0.0100498985877989,0.0126267956615936,0,0,19799.0,91079.21596609056,IKBKB
3107,KEGG_2019_Human,Human immunodeficiency virus 1 infection,1/212,0.0105998955026255,0.0129848719907163,0,0,19788.0,89974.27756224656,IKBKB
3108,KEGG_2019_Human,Human T-cell leukemia virus 1 infection,1/219,0.0109498935894162,0.0130864581922291,0,0,19781.0,89299.85161916987,IKBKB
3109,KEGG_2019_Human,Human cytomegalovirus infection,1/225,0.0112498919790339,0.0131248739755395,0,0,19775.0,88738.27077557483,IKBKB
3110,KEGG_2019_Human,Ras signaling pathway,1/232,0.0115998901349604,0.0132184794561176,0,0,19768.0,88101.22480150245,IKBKB
3111,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0162787517619004,0,0,19705.0,83086.53988020132,IKBKB
3112,KEGG_2019_Human,MicroRNAs in cancer,1/299,0.0149498740670514,0.0162787517619004,0,0,19701.0,82804.33538735632,IKBKB
3113,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0175759457715056,0,0,19670.0,80733.60565076157,IKBKB
3114,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0184530482856803,0,0,19646.0,79255.8617626126,IKBKB
3115,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0251123356250335,0,0,19508.0,72277.44006442746,IKBKB
3116,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,IKBKB
3117,KEGG_2019_Human,Estrogen signaling pathway,1/137,0.0068499188797651,0.0068499188797651,0,0,19863.0,98987.62735269018,KRT27
3118,KEGG_2019_Human,Prion diseases,1/35,0.0017499663721595,0.0098943272707719,0,0,19965.0,126740.98858805298,PRKACB
3119,KEGG_2019_Human,Vasopressin-regulated water reabsorption,1/44,0.0021999607179423,0.0098943272707719,0,0,19956.0,122117.06559109331,PRKACB
3120,KEGG_2019_Human,Hedgehog signaling pathway,1/47,0.0023499589392381,0.0098943272707719,0,0,19953.0,120782.64067395544,PRKACB
3121,KEGG_2019_Human,Endocrine and other factor-regulated calcium reabsorption,1/48,0.0023999583567988,0.0098943272707719,0,0,19952.0,120356.5272753826,PRKACB
3122,KEGG_2019_Human,Cocaine addiction,1/49,0.0024499577795033,0.0098943272707719,0,0,19951.0,119939.1172087114,PRKACB
3123,KEGG_2019_Human,Ovarian steroidogenesis,1/49,0.0024499577795033,0.0098943272707719,0,0,19951.0,119939.1172087114,PRKACB
3124,KEGG_2019_Human,Vibrio cholerae infection,1/50,0.0024999572069037,0.0098943272707719,0,0,19950.0,119530.05920663515,PRKACB
3125,KEGG_2019_Human,Regulation of lipolysis in adipocytes,1/55,0.0027499544131125,0.0098943272707719,0,0,19945.0,117599.1294878737,PRKACB
3126,KEGG_2019_Human,Cortisol synthesis and secretion,1/65,0.003249949134407,0.0098943272707719,0,0,19935.0,114209.92613860144,PRKACB
3127,KEGG_2019_Human,Long-term potentiation,1/67,0.0033499481224912,0.0098943272707719,0,0,19933.0,113594.38808369274,PRKACB
3128,KEGG_2019_Human,Amphetamine addiction,1/68,0.0033999476216189,0.0098943272707719,0,0,19932.0,113293.39338050144,PRKACB
3129,KEGG_2019_Human,Renin secretion,1/69,0.003449947123837,0.0098943272707719,0,0,19931.0,112996.7391397682,PRKACB
3130,KEGG_2019_Human,Bile secretion,1/72,0.0035999456502131,0.0098943272707719,0,0,19928.0,112131.59838572376,PRKACB
3131,KEGG_2019_Human,Thyroid hormone synthesis,1/74,0.0036999446830449,0.0098943272707719,0,0,19926.0,111574.38983110404,PRKACB
3132,KEGG_2019_Human,Gastric acid secretion,1/75,0.0037499442041125,0.0098943272707719,0,0,19925.0,111301.33528642564,PRKACB
3133,KEGG_2019_Human,Taste transduction,1/83,0.0041499404726918,0.0098943272707719,0,0,19917.0,109237.99888847338,PRKACB
3134,KEGG_2019_Human,Insulin secretion,1/86,0.0042999391173866,0.0098943272707719,0,0,19914.0,108514.46102290176,PRKACB
3135,KEGG_2019_Human,Gap junction,1/88,0.0043999382262822,0.0098943272707719,0,0,19912.0,108045.79305232369,PRKACB
3136,KEGG_2019_Human,GABAergic synapse,1/89,0.0044499377838098,0.0098943272707719,0,0,19911.0,107815.380281759,PRKACB
3137,KEGG_2019_Human,Salivary secretion,1/90,0.0044999373439762,0.0098943272707719,0,0,19910.0,107587.50385474482,PRKACB
3138,KEGG_2019_Human,Morphine addiction,1/91,0.0045499369072032,0.0098943272707719,0,0,19909.0,107362.10783923086,PRKACB
3139,KEGG_2019_Human,Dilated cardiomyopathy (DCM),1/91,0.0045499369072032,0.0098943272707719,0,0,19909.0,107362.10783923086,PRKACB
3140,KEGG_2019_Human,GnRH signaling pathway,1/93,0.0046499360391879,0.0098943272707719,0,0,19907.0,106918.54242106884,PRKACB
3141,KEGG_2019_Human,Amoebiasis,1/96,0.0047999347538706,0.0098943272707719,0,0,19904.0,106270.50039849174,PRKACB
3142,KEGG_2019_Human,Circadian entrainment,1/97,0.0048499343304706,0.0098943272707719,0,0,19903.0,106058.9096435903,PRKACB
3143,KEGG_2019_Human,Aldosterone synthesis and secretion,1/98,0.0048999339081079,0.0098943272707719,0,0,19902.0,105849.45495286948,PRKACB
3144,KEGG_2019_Human,Progesterone-mediated oocyte maturation,1/99,0.0049499334884068,0.0098943272707719,0,0,19901.0,105642.09305076736,PRKACB
3145,KEGG_2019_Human,Inflammatory mediator regulation of TRP channels,1/100,0.0049999330710556,0.0098943272707719,0,0,19900.0,105436.78197328727,PRKACB
3146,KEGG_2019_Human,Melanogenesis,1/101,0.0050499326546803,0.0098943272707719,0,0,19899.0,105233.48101229242,PRKACB
3147,KEGG_2019_Human,Longevity regulating pathway,1/102,0.0050999322416682,0.0098943272707719,0,0,19898.0,105032.15064717118,PRKACB
3148,KEGG_2019_Human,Glucagon signaling pathway,1/103,0.0051499318302617,0.0098943272707719,0,0,19897.0,104832.7525292024,PRKACB
3149,KEGG_2019_Human,"Parathyroid hormone synthesis, secretion and action",1/106,0.0052999306076525,0.0098943272707719,0,0,19894.0,104245.78450366124,PRKACB
3150,KEGG_2019_Human,Cholinergic synapse,1/112,0.0055999282120529,0.0098943272707719,0,0,19888.0,103119.30984392198,PRKACB
3151,KEGG_2019_Human,Serotonergic synapse,1/113,0.0056499278191151,0.0098943272707719,0,0,19887.0,102937.34947211576,PRKACB
3152,KEGG_2019_Human,Glutamatergic synapse,1/114,0.005699927427839,0.0098943272707719,0,0,19886.0,102756.96431429044,PRKACB
3153,KEGG_2019_Human,Thyroid hormone signaling pathway,1/116,0.0057999266512085,0.0098943272707719,0,0,19884.0,102400.8105961506,PRKACB
3154,KEGG_2019_Human,Platelet activation,1/124,0.0061999236097501,0.0098943272707719,0,0,19876.0,101034.04709010696,PRKACB
3155,KEGG_2019_Human,Oocyte meiosis,1/125,0.0062499232373748,0.0098943272707719,0,0,19875.0,100869.32368441945,PRKACB
3156,KEGG_2019_Human,Autophagy,1/128,0.0063999221281459,0.0098943272707719,0,0,19872.0,100382.8010329652,PRKACB
3157,KEGG_2019_Human,Relaxin signaling pathway,1/130,0.0064999213952527,0.0098943272707719,0,0,19870.0,100064.62842845908,PRKACB
3158,KEGG_2019_Human,Dopaminergic synapse,1/131,0.0065499210316603,0.0098943272707719,0,0,19869.0,99907.33811343512,PRKACB
3159,KEGG_2019_Human,Vascular smooth muscle contraction,1/132,0.0065999206698993,0.0098943272707719,0,0,19868.0,99751.22090491928,PRKACB
3160,KEGG_2019_Human,Insulin signaling pathway,1/137,0.0068499188797651,0.0098943272707719,0,0,19863.0,98987.62735269018,PRKACB
3161,KEGG_2019_Human,Apelin signaling pathway,1/137,0.0068499188797651,0.0098943272707719,0,0,19863.0,98987.62735269018,PRKACB
3162,KEGG_2019_Human,Estrogen signaling pathway,1/137,0.0068499188797651,0.0098943272707719,0,0,19863.0,98987.62735269018,PRKACB
3163,KEGG_2019_Human,Parkinson disease,1/142,0.0070999171242726,0.0100207183123003,0,0,19858.0,98250.87390500787,PRKACB
3164,KEGG_2019_Human,Adrenergic signaling in cardiomyocytes,1/145,0.0072499160871101,0.0100207183123003,0,0,19855.0,97820.92670675044,PRKACB
3165,KEGG_2019_Human,Retrograde endocannabinoid signaling,1/148,0.007399915061391,0.0100207183123003,0,0,19852.0,97399.60470052566,PRKACB
3166,KEGG_2019_Human,Oxytocin signaling pathway,1/153,0.0076499133771537,0.0100685149405346,0,0,19847.0,96715.6407630817,PRKACB
3167,KEGG_2019_Human,Cushing syndrome,1/155,0.0077499127120574,0.0100685149405346,0,0,19845.0,96448.16254952336,PRKACB
3168,KEGG_2019_Human,Wnt signaling pathway,1/158,0.0078999117225733,0.0100685149405346,0,0,19842.0,96053.2110949472,PRKACB
3169,KEGG_2019_Human,Tight junction,1/170,0.0084999078692823,0.0106248848366029,0,0,19830.0,94543.49009679438,PRKACB
3170,KEGG_2019_Human,Calcium signaling pathway,1/188,0.009399902370135,0.0114350669564439,0,0,19812.0,92463.712994847,PRKACB
3171,KEGG_2019_Human,Chemokine signaling pathway,1/190,0.0094999017791995,0.0114350669564439,0,0,19810.0,92244.74636351672,PRKACB
3172,KEGG_2019_Human,Viral carcinogenesis,1/201,0.0100498985877989,0.0116650608608381,0,0,19799.0,91079.21596609056,PRKACB
3173,KEGG_2019_Human,Proteoglycans in cancer,1/201,0.0100498985877989,0.0116650608608381,0,0,19799.0,91079.21596609056,PRKACB
3174,KEGG_2019_Human,cAMP signaling pathway,1/212,0.0105998955026255,0.012087600134573,0,0,19788.0,89974.27756224656,PRKACB
3175,KEGG_2019_Human,Human T-cell leukemia virus 1 infection,1/219,0.0109498935894162,0.0122714324708975,0,0,19781.0,89299.85161916987,PRKACB
3176,KEGG_2019_Human,Human cytomegalovirus infection,1/225,0.0112498919790339,0.0123605386684004,0,0,19775.0,88738.27077557483,PRKACB
3177,KEGG_2019_Human,Thermogenesis,1/231,0.0115498903940656,0.0123605386684004,0,0,19769.0,88191.07730937863,PRKACB
3178,KEGG_2019_Human,Ras signaling pathway,1/232,0.0115998901349604,0.0123605386684004,0,0,19768.0,88101.22480150245,PRKACB
3179,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0154635785804402,0,0,19705.0,83086.53988020132,PRKACB
3180,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0170236727751221,0,0,19670.0,80733.60565076157,PRKACB
3181,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0225467191267267,0,0,19556.0,74462.79263140135,PRKACB
3182,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,PRKACB
3183,KEGG_2019_Human,Renin-angiotensin system,1/23,0.0011499748819949,0.0011499748819949,0,0,19977.0,135204.63922267244,LNPEP
3184,KEGG_2019_Human,Axon guidance,1/181,0.0090499044707863,0.0090499044707863,0,0,19819.0,93248.41634586031,EPHA1
3185,KEGG_2019_Human,Huntington disease,1/193,0.0096499008972596,0.0096499008972596,0,0,19807.0,91920.47679471428,DNAH2
3186,KEGG_2019_Human,Pertussis,1/76,0.0037999437281752,0.0039499423167337,0,0,19924.0,111031.8499691117,C4BPB
3187,KEGG_2019_Human,Complement and coagulation cascades,1/79,0.0039499423167337,0.0039499423167337,0,0,19921.0,110243.89578070649,C4BPB
3188,KEGG_2019_Human,B cell receptor signaling pathway,1/71,0.0035499461386618,0.0050499326546803,0,0,19929.0,112415.9585341616,CARD11
3189,KEGG_2019_Human,NF-kappa B signaling pathway,1/95,0.0047499351803394,0.0050499326546803,0,0,19905.0,106484.27183626965,CARD11
3190,KEGG_2019_Human,T cell receptor signaling pathway,1/101,0.0050499326546803,0.0050499326546803,0,0,19899.0,105233.48101229242,CARD11
3191,KEGG_2019_Human,Prostate cancer,1/97,0.0048499343304706,0.0093748848560622,0,0,19903.0,106058.9096435903,AR
3192,KEGG_2019_Human,Oocyte meiosis,1/125,0.0062499232373748,0.0093748848560622,0,0,19875.0,100869.32368441945,AR
3193,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,AR
3194,KEGG_2019_Human,Autophagy,1/128,0.0063999221281459,0.0063999221281459,0,0,19872.0,100382.8010329652,ATG4C
3195,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF350
3196,KEGG_2019_Human,Carbohydrate digestion and absorption,1/44,0.0021999607179423,0.0041499404726918,0,0,19956.0,122117.06559109331,TAS1R3
3197,KEGG_2019_Human,Taste transduction,1/83,0.0041499404726918,0.0041499404726918,0,0,19917.0,109237.99888847338,TAS1R3
3198,KEGG_2019_Human,Long-term depression,1/60,0.002999951725986,0.009399902370135,0,0,19940.0,115834.63209072244,RYR1
3199,KEGG_2019_Human,Circadian entrainment,1/97,0.0048499343304706,0.009399902370135,0,0,19903.0,106058.9096435903,RYR1
3200,KEGG_2019_Human,Apelin signaling pathway,1/137,0.0068499188797651,0.009399902370135,0,0,19863.0,98987.62735269018,RYR1
3201,KEGG_2019_Human,Oxytocin signaling pathway,1/153,0.0076499133771537,0.009399902370135,0,0,19847.0,96715.6407630817,RYR1
3202,KEGG_2019_Human,Calcium signaling pathway,1/188,0.009399902370135,0.009399902370135,0,0,19812.0,92463.712994847,RYR1
3203,KEGG_2019_Human,Endocytosis,1/244,0.0121998870519305,0.0121998870519305,0,0,19756.0,87051.4275316661,IZUMO1R
3204,KEGG_2019_Human,mRNA surveillance pathway,1/91,0.0045499369072032,0.0101498825219542,0,0,19909.0,107362.10783923086,PPP2R3A
3205,KEGG_2019_Human,Sphingolipid signaling pathway,1/119,0.0059499254985137,0.0101498825219542,0,0,19881.0,101877.73080211312,PPP2R3A
3206,KEGG_2019_Human,AMPK signaling pathway,1/120,0.0059999251180858,0.0101498825219542,0,0,19880.0,101706.2448082016,PPP2R3A
3207,KEGG_2019_Human,Dopaminergic synapse,1/131,0.0065499210316603,0.0101498825219542,0,0,19869.0,99907.33811343512,PPP2R3A
3208,KEGG_2019_Human,Adrenergic signaling in cardiomyocytes,1/145,0.0072499160871101,0.0101498825219542,0,0,19855.0,97820.92670675044,PPP2R3A
3209,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0176998626413668,0,0,19670.0,80733.60565076157,PPP2R3A
3210,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0176998626413668,0,0,19646.0,79255.8617626126,PPP2R3A
3211,KEGG_2019_Human,Serotonergic synapse,1/113,0.0056499278191151,0.0085499075557634,0,0,19887.0,102937.34947211576,APP
3212,KEGG_2019_Human,Alzheimer disease,1/171,0.0085499075557634,0.0085499075557634,0,0,19829.0,94422.42241345016,APP
3213,KEGG_2019_Human,Intestinal immune network for IgA production,1/48,0.0023999583567988,0.0071998750703964,0,0,19952.0,120356.5272753826,CCR9
3214,KEGG_2019_Human,Chemokine signaling pathway,1/190,0.0094999017791995,0.0142498526687993,0,0,19810.0,92244.74636351672,CCR9
3215,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0146998751759735,0,0,19706.0,83157.67014793828,CCR9
3216,KEGG_2019_Human,Other glycan degradation,1/18,0.0008999788927950273,0.0008999788927950273,0,0,19982.0,140136.54844084635,MAN2C1
3217,KEGG_2019_Human,Arrhythmogenic right ventricular cardiomyopathy (ARVC),1/72,0.0035999456502131,0.0102373580412072,0,0,19928.0,112131.59838572376,ITGA8
3218,KEGG_2019_Human,ECM-receptor interaction,1/82,0.004099940929819,0.0102373580412072,0,0,19918.0,109484.9180722932,ITGA8
3219,KEGG_2019_Human,Hypertrophic cardiomyopathy (HCM),1/85,0.004249939567045,0.0102373580412072,0,0,19915.0,108752.83801948265,ITGA8
3220,KEGG_2019_Human,Dilated cardiomyopathy (DCM),1/91,0.0045499369072032,0.0102373580412072,0,0,19909.0,107362.10783923086,ITGA8
3221,KEGG_2019_Human,Cell adhesion molecules (CAMs),1/145,0.0072499160871101,0.0130498489567983,0,0,19855.0,97820.92670675044,ITGA8
3222,KEGG_2019_Human,Focal adhesion,1/199,0.0099498991610159,0.0137570077946658,0,0,19801.0,91286.4288690606,ITGA8
3223,KEGG_2019_Human,Regulation of actin cytoskeleton,1/214,0.0106998949514067,0.0137570077946658,0,0,19786.0,89779.39753374986,ITGA8
3224,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0176998626413668,0,0,19670.0,80733.60565076157,ITGA8
3225,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0176998626413668,0,0,19646.0,79255.8617626126,ITGA8
3226,KEGG_2019_Human,Thiamine metabolism,1/15,0.0007499814841592997,0.0014999629683185,0,0,19985.0,143801.30885993244,AK2
3227,KEGG_2019_Human,Purine metabolism,1/129,0.006449921761047,0.006449921761047,0,0,19871.0,100223.109907462,AK2
3228,KEGG_2019_Human,Glycosylphosphatidylinositol (GPI)-anchor biosynthesis,1/25,0.0012499733663791,0.0012499733663791,0,0,19975.0,133525.54486996148,PIGT
3229,KEGG_2019_Human,Glycerophospholipid metabolism,1/97,0.0048499343304706,0.0048499343304706,0,0,19903.0,106058.9096435903,PNPLA7
3230,KEGG_2019_Human,Neurotrophin signaling pathway,1/119,0.0059499254985137,0.0059499254985137,0,0,19881.0,101877.73080211312,SH2B1
3231,KEGG_2019_Human,Protein processing in endoplasmic reticulum,1/165,0.0082499094553477,0.0082499094553477,0,0,19835.0,95159.46482222488,LMAN1
3232,KEGG_2019_Human,Necroptosis,1/162,0.0080999104202618,0.0088999053857096,0,0,19838.0,95537.86936302872,RBCK1
3233,KEGG_2019_Human,NOD-like receptor signaling pathway,1/178,0.0088999053857096,0.0088999053857096,0,0,19822.0,93593.82745769851,RBCK1
3234,KEGG_2019_Human,Steroid hormone biosynthesis,1/60,0.002999951725986,0.002999951725986,0,0,19940.0,115834.63209072244,HSD17B3
3235,KEGG_2019_Human,Axon guidance,1/181,0.0090499044707863,0.0090499044707863,0,0,19819.0,93248.41634586031,SLIT2
3236,KEGG_2019_Human,Arrhythmogenic right ventricular cardiomyopathy (ARVC),1/72,0.0035999456502131,0.0035999456502131,0,0,19928.0,112131.59838572376,DSP
3237,KEGG_2019_Human,Proteoglycans in cancer,1/201,0.0100498985877989,0.0100498985877989,0,0,19799.0,91079.21596609056,ANK1
3238,KEGG_2019_Human,Hematopoietic cell lineage,1/97,0.0048499343304706,0.0202497760506546,0,0,19903.0,106058.9096435903,EPOR
3239,KEGG_2019_Human,JAK-STAT signaling pathway,1/162,0.0080999104202618,0.0202497760506546,0,0,19838.0,95537.86936302872,EPOR
3240,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0221248283017086,0,0,19706.0,83157.67014793828,EPOR
3241,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0221248283017086,0,0,19646.0,79255.8617626126,EPOR
3242,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,EPOR
3243,KEGG_2019_Human,Ribosome,1/153,0.0076499133771537,0.0076499133771537,0,0,19847.0,96715.6407630817,MRPL24
3244,KEGG_2019_Human,Leukocyte transendothelial migration,1/112,0.0055999282120529,0.0084999078692823,0,0,19888.0,103119.30984392198,CLDN6
3245,KEGG_2019_Human,Cell adhesion molecules (CAMs),1/145,0.0072499160871101,0.0084999078692823,0,0,19855.0,97820.92670675044,CLDN6
3246,KEGG_2019_Human,Hepatitis C,1/155,0.0077499127120574,0.0084999078692823,0,0,19845.0,96448.16254952336,CLDN6
3247,KEGG_2019_Human,Tight junction,1/170,0.0084999078692823,0.0084999078692823,0,0,19830.0,94543.49009679438,CLDN6
3248,KEGG_2019_Human,RNA polymerase,1/31,0.0015499690656704,0.0015499690656704,0,0,19969.0,129189.85098816035,POLR1A
3249,KEGG_2019_Human,Nicotine addiction,1/40,0.0019999631680592,0.0088784580014667,0,0,19960.0,124043.94523066044,CACNA1B
3250,KEGG_2019_Human,Type II diabetes mellitus,1/46,0.0022999595269283,0.0088784580014667,0,0,19954.0,121217.8313311442,CACNA1B
3251,KEGG_2019_Human,Synaptic vesicle cycle,1/78,0.0038999427840466,0.0088784580014667,0,0,19922.0,110503.2180492851,CACNA1B
3252,KEGG_2019_Human,GABAergic synapse,1/89,0.0044499377838098,0.0088784580014667,0,0,19911.0,107815.380281759,CACNA1B
3253,KEGG_2019_Human,Morphine addiction,1/91,0.0045499369072032,0.0088784580014667,0,0,19909.0,107362.10783923086,CACNA1B
3254,KEGG_2019_Human,Cholinergic synapse,1/112,0.0055999282120529,0.0088784580014667,0,0,19888.0,103119.30984392198,CACNA1B
3255,KEGG_2019_Human,Serotonergic synapse,1/113,0.0056499278191151,0.0088784580014667,0,0,19887.0,102937.34947211576,CACNA1B
3256,KEGG_2019_Human,Dopaminergic synapse,1/131,0.0065499210316603,0.0090061414185329,0,0,19869.0,99907.33811343512,CACNA1B
3257,KEGG_2019_Human,Retrograde endocannabinoid signaling,1/148,0.007399915061391,0.009044340630589,0,0,19852.0,97399.60470052566,CACNA1B
3258,KEGG_2019_Human,Calcium signaling pathway,1/188,0.009399902370135,0.0103398926071485,0,0,19812.0,92463.712994847,CACNA1B
3259,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0147498749536506,0,0,19705.0,83086.53988020132,CACNA1B
3260,KEGG_2019_Human,Glyoxylate and dicarboxylate metabolism,1/30,0.0014999697593334,0.0019999631680592,0,0,19970.0,129851.13732048514,GLDC
3261,KEGG_2019_Human,"Glycine, serine and threonine metabolism",1/40,0.0019999631680592,0.0019999631680592,0,0,19960.0,124043.94523066044,GLDC
3262,KEGG_2019_Human,Bile secretion,1/72,0.0035999456502131,0.0073499008621619,0,0,19928.0,112131.59838572376,SCTR
3263,KEGG_2019_Human,Pancreatic secretion,1/98,0.0048999339081079,0.0073499008621619,0,0,19902.0,105849.45495286948,SCTR
3264,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,SCTR
3265,KEGG_2019_Human,Peroxisome,1/83,0.0041499404726918,0.0041499404726918,0,0,19917.0,109237.99888847338,PEX14
3266,KEGG_2019_Human,RIG-I-like receptor signaling pathway,1/70,0.0034999466296654,0.0088999053857096,0,0,19930.0,112704.30065625212,NLRX1
3267,KEGG_2019_Human,Influenza A,1/171,0.0085499075557634,0.0088999053857096,0,0,19829.0,94422.42241345016,NLRX1
3268,KEGG_2019_Human,NOD-like receptor signaling pathway,1/178,0.0088999053857096,0.0088999053857096,0,0,19822.0,93593.82745769851,NLRX1
3269,KEGG_2019_Human,Protein processing in endoplasmic reticulum,1/165,0.0082499094553477,0.0082499094553477,0,0,19835.0,95159.46482222488,TXNDC5
3270,KEGG_2019_Human,Thyroid hormone signaling pathway,1/116,0.0057999266512085,0.0057999266512085,0,0,19884.0,102400.8105961506,SLCO1C1
3271,KEGG_2019_Human,C-type lectin receptor signaling pathway,1/104,0.0051999314202997,0.0054999290027479,0,0,19896.0,104635.24941415618,BCL3
3272,KEGG_2019_Human,TNF signaling pathway,1/110,0.0054999290027479,0.0054999290027479,0,0,19890.0,103488.06969787036,BCL3
3273,KEGG_2019_Human,Salmonella infection,1/86,0.0042999391173866,0.0106998949514067,0,0,19914.0,108514.46102290176,MYH10
3274,KEGG_2019_Human,Tight junction,1/170,0.0084999078692823,0.0106998949514067,0,0,19830.0,94543.49009679438,MYH10
3275,KEGG_2019_Human,Regulation of actin cytoskeleton,1/214,0.0106998949514067,0.0106998949514067,0,0,19786.0,89779.39753374986,MYH10
3276,KEGG_2019_Human,Oxidative phosphorylation,1/133,0.0066499203093911,0.0066499203093911,0,0,19867.0,99596.2591544721,LHPP
3277,KEGG_2019_Human,Systemic lupus erythematosus,1/133,0.0066499203093911,0.0066999199497742,0,0,19867.0,99596.2591544721,SNRPB
3278,KEGG_2019_Human,Spliceosome,1/134,0.0066999199497742,0.0066999199497742,0,0,19866.0,99442.43560916925,SNRPB
3279,KEGG_2019_Human,NOD-like receptor signaling pathway,1/178,0.0088999053857096,0.0088999053857096,0,0,19822.0,93593.82745769851,SUGT1
3280,KEGG_2019_Human,Bladder cancer,1/41,0.0020499625466866,0.0108331883206205,0,0,19959.0,123544.88783416104,EGF
3281,KEGG_2019_Human,Endometrial cancer,1/58,0.0028999527887707,0.0108331883206205,0,0,19942.0,116522.31890946148,EGF
3282,KEGG_2019_Human,Non-small cell lung cancer,1/66,0.003299948626608,0.0108331883206205,0,0,19934.0,113899.85357353876,EGF
3283,KEGG_2019_Human,Melanoma,1/72,0.0035999456502131,0.0108331883206205,0,0,19928.0,112131.59838572376,EGF
3284,KEGG_2019_Human,Pancreatic cancer,1/75,0.0037499442041125,0.0108331883206205,0,0,19925.0,111301.33528642564,EGF
3285,KEGG_2019_Human,Glioma,1/75,0.0037499442041125,0.0108331883206205,0,0,19925.0,111301.33528642564,EGF
3286,KEGG_2019_Human,ErbB signaling pathway,1/85,0.004249939567045,0.0108331883206205,0,0,19915.0,108752.83801948265,EGF
3287,KEGG_2019_Human,Colorectal cancer,1/86,0.0042999391173866,0.0108331883206205,0,0,19914.0,108514.46102290176,EGF
3288,KEGG_2019_Human,Gap junction,1/88,0.0043999382262822,0.0108331883206205,0,0,19912.0,108045.79305232369,EGF
3289,KEGG_2019_Human,Prostate cancer,1/97,0.0048499343304706,0.0108331883206205,0,0,19903.0,106058.9096435903,EGF
3290,KEGG_2019_Human,Choline metabolism in cancer,1/99,0.0049499334884068,0.0108331883206205,0,0,19901.0,105642.09305076736,EGF
3291,KEGG_2019_Human,HIF-1 signaling pathway,1/100,0.0049999330710556,0.0108331883206205,0,0,19900.0,105436.78197328727,EGF
3292,KEGG_2019_Human,FoxO signaling pathway,1/132,0.0065999206698993,0.0116998706070448,0,0,19868.0,99751.22090491928,EGF
3293,KEGG_2019_Human,Breast cancer,1/147,0.0073499154017982,0.0116998706070448,0,0,19853.0,97539.10874372096,EGF
3294,KEGG_2019_Human,Phospholipase D signaling pathway,1/148,0.007399915061391,0.0116998706070448,0,0,19852.0,97399.60470052566,EGF
3295,KEGG_2019_Human,Gastric cancer,1/149,0.0074499147221605,0.0116998706070448,0,0,19851.0,97261.02051561224,EGF
3296,KEGG_2019_Human,Hepatitis C,1/155,0.0077499127120574,0.0116998706070448,0,0,19845.0,96448.16254952336,EGF
3297,KEGG_2019_Human,JAK-STAT signaling pathway,1/162,0.0080999104202618,0.0116998706070448,0,0,19838.0,95537.86936302872,EGF
3298,KEGG_2019_Human,Focal adhesion,1/199,0.0099498991610159,0.013247488987456,0,0,19801.0,91286.4288690606,EGF
3299,KEGG_2019_Human,Rap1 signaling pathway,1/206,0.010299897173561,0.013247488987456,0,0,19794.0,90569.849337325,EGF
3300,KEGG_2019_Human,Regulation of actin cytoskeleton,1/214,0.0106998949514067,0.013247488987456,0,0,19786.0,89779.39753374986,EGF
3301,KEGG_2019_Human,Ras signaling pathway,1/232,0.0115998901349604,0.0137089610685895,0,0,19768.0,88101.22480150245,EGF
3302,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0166737716867355,0,0,19705.0,83086.53988020132,EGF
3303,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0178748564138782,0,0,19670.0,80733.60565076157,EGF
3304,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0184078571470215,0,0,19646.0,79255.8617626126,EGF
3305,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,EGF
3306,KEGG_2019_Human,Hippo signaling pathway,1/160,0.0079999110688441,0.0146398644623166,0,0,19840.0,95793.96509856998,PARD6G
3307,KEGG_2019_Human,Tight junction,1/170,0.0084999078692823,0.0146398644623166,0,0,19830.0,94543.49009679438,PARD6G
3308,KEGG_2019_Human,Axon guidance,1/181,0.0090499044707863,0.0146398644623166,0,0,19819.0,93248.41634586031,PARD6G
3309,KEGG_2019_Human,Rap1 signaling pathway,1/206,0.010299897173561,0.0146398644623166,0,0,19794.0,90569.849337325,PARD6G
3310,KEGG_2019_Human,Endocytosis,1/244,0.0121998870519305,0.0146398644623166,0,0,19756.0,87051.4275316661,PARD6G
3311,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0164998674589645,0,0,19670.0,80733.60565076157,PARD6G
3312,KEGG_2019_Human,Pantothenate and CoA biosynthesis,1/19,0.00094997806231055,0.00094997806231055,0,0,19981.0,139049.2109571672,COASY
3313,KEGG_2019_Human,Bladder cancer,1/41,0.0020499625466866,0.0061498876400599,0,0,19959.0,123544.88783416104,DAPK1
3314,KEGG_2019_Human,Autophagy,1/128,0.0063999221281459,0.0095998831922188,0,0,19872.0,100382.8010329652,DAPK1
3315,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,DAPK1
3316,KEGG_2019_Human,NOD-like receptor signaling pathway,1/178,0.0088999053857096,0.0088999053857096,0,0,19822.0,93593.82745769851,ERBIN
3317,KEGG_2019_Human,Axon guidance,1/181,0.0090499044707863,0.0090499044707863,0,0,19819.0,93248.41634586031,ABLIM2
3318,KEGG_2019_Human,Thiamine metabolism,1/15,0.0007499814841592997,0.0014999629683185,0,0,19985.0,143801.30885993244,AK7
3319,KEGG_2019_Human,Purine metabolism,1/129,0.006449921761047,0.006449921761047,0,0,19871.0,100223.109907462,AK7
3320,KEGG_2019_Human,Autophagy,1/128,0.0063999221281459,0.0063999221281459,0,0,19872.0,100382.8010329652,RAB33B
3321,KEGG_2019_Human,NOD-like receptor signaling pathway,1/178,0.0088999053857096,0.0088999053857096,0,0,19822.0,93593.82745769851,NLRP12
3322,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR4X1
3323,KEGG_2019_Human,mTOR signaling pathway,1/152,0.0075999137114971,0.0075999137114971,0,0,19848.0,96850.665715497,FNIP2
3324,KEGG_2019_Human,Autophagy,1/128,0.0063999221281459,0.0063999221281459,0,0,19872.0,100382.8010329652,WIPI1
3325,KEGG_2019_Human,Aldosterone-regulated sodium reabsorption,1/37,0.0018499650702878,0.0073998602811514,0,0,19963.0,125618.9446446357,NEDD4L
3326,KEGG_2019_Human,Ubiquitin mediated proteolysis,1/137,0.0068499188797651,0.0113332104923764,0,0,19863.0,98987.62735269018,NEDD4L
3327,KEGG_2019_Human,Tight junction,1/170,0.0084999078692823,0.0113332104923764,0,0,19830.0,94543.49009679438,NEDD4L
3328,KEGG_2019_Human,Endocytosis,1/244,0.0121998870519305,0.0121998870519305,0,0,19756.0,87051.4275316661,NEDD4L
3329,KEGG_2019_Human,Cell adhesion molecules (CAMs),1/145,0.0072499160871101,0.0072499160871101,0,0,19855.0,97820.92670675044,SELL
3330,KEGG_2019_Human,Basal cell carcinoma,1/63,0.0031499501598827,0.0117598719015533,0,0,19937.0,114844.46974572667,WNT3
3331,KEGG_2019_Human,Melanogenesis,1/101,0.0050499326546803,0.0117598719015533,0,0,19899.0,105233.48101229242,WNT3
3332,KEGG_2019_Human,Signaling pathways regulating pluripotency of stem cells,1/139,0.006949918172816,0.0117598719015533,0,0,19861.0,98689.81333375497,WNT3
3333,KEGG_2019_Human,Breast cancer,1/147,0.0073499154017982,0.0117598719015533,0,0,19853.0,97539.10874372096,WNT3
3334,KEGG_2019_Human,Gastric cancer,1/149,0.0074499147221605,0.0117598719015533,0,0,19851.0,97261.02051561224,WNT3
3335,KEGG_2019_Human,mTOR signaling pathway,1/152,0.0075999137114971,0.0117598719015533,0,0,19848.0,96850.665715497,WNT3
3336,KEGG_2019_Human,Cushing syndrome,1/155,0.0077499127120574,0.0117598719015533,0,0,19845.0,96448.16254952336,WNT3
3337,KEGG_2019_Human,Wnt signaling pathway,1/158,0.0078999117225733,0.0117598719015533,0,0,19842.0,96053.2110949472,WNT3
3338,KEGG_2019_Human,Hippo signaling pathway,1/160,0.0079999110688441,0.0117598719015533,0,0,19840.0,95793.96509856998,WNT3
3339,KEGG_2019_Human,Hepatocellular carcinoma,1/168,0.0083999085011095,0.0117598719015533,0,0,19832.0,94787.72752807094,WNT3
3340,KEGG_2019_Human,Proteoglycans in cancer,1/201,0.0100498985877989,0.012790780020835,0,0,19799.0,91079.21596609056,WNT3
3341,KEGG_2019_Human,MicroRNAs in cancer,1/299,0.0149498740670514,0.0174415197448933,0,0,19701.0,82804.33538735632,WNT3
3342,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.017769088032731,0,0,19670.0,80733.60565076157,WNT3
3343,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,WNT3
3344,KEGG_2019_Human,Tight junction,1/170,0.0084999078692823,0.0084999078692823,0,0,19830.0,94543.49009679438,MICALL2
3345,KEGG_2019_Human,Synaptic vesicle cycle,1/78,0.0038999427840466,0.005699927427839,0,0,19922.0,110503.2180492851,SLC1A7
3346,KEGG_2019_Human,Glutamatergic synapse,1/114,0.005699927427839,0.005699927427839,0,0,19886.0,102756.96431429044,SLC1A7
3347,KEGG_2019_Human,Apoptosis,1/143,0.0071499167770442,0.0071499167770442,0,0,19857.0,98106.57763600958,DFFA
3348,KEGG_2019_Human,Salmonella infection,1/86,0.0042999391173866,0.0042999391173866,0,0,19914.0,108514.46102290176,KLC1
3349,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR6B3
3350,KEGG_2019_Human,Fc gamma R-mediated phagocytosis,1/91,0.0045499369072032,0.0094999017791995,0,0,19909.0,107362.10783923086,HCK
3351,KEGG_2019_Human,Kaposi sarcoma-associated herpesvirus infection,1/186,0.0092999029651357,0.0094999017791995,0,0,19814.0,92684.96451050608,HCK
3352,KEGG_2019_Human,Chemokine signaling pathway,1/190,0.0094999017791995,0.0094999017791995,0,0,19810.0,92244.74636351672,HCK
3353,KEGG_2019_Human,Nicotinate and nicotinamide metabolism,1/30,0.0014999697593334,0.0014999697593334,0,0,19970.0,129851.13732048514,QPRT
3354,KEGG_2019_Human,Salivary secretion,1/90,0.0044999373439762,0.0046499360391879,0,0,19910.0,107587.50385474482,MUC5B
3355,KEGG_2019_Human,IL-17 signaling pathway,1/93,0.0046499360391879,0.0046499360391879,0,0,19907.0,106918.54242106884,MUC5B
3356,KEGG_2019_Human,Pyrimidine metabolism,1/57,0.002849953326298,0.002849953326298,0,0,19943.0,116875.00742975442,CTPS2
3357,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF8
3358,KEGG_2019_Human,Salivary secretion,1/90,0.0044999373439762,0.0105998955026255,0,0,19910.0,107587.50385474482,ATP2B2
3359,KEGG_2019_Human,Pancreatic secretion,1/98,0.0048999339081079,0.0105998955026255,0,0,19902.0,105849.45495286948,ATP2B2
3360,KEGG_2019_Human,Aldosterone synthesis and secretion,1/98,0.0048999339081079,0.0105998955026255,0,0,19902.0,105849.45495286948,ATP2B2
3361,KEGG_2019_Human,Adrenergic signaling in cardiomyocytes,1/145,0.0072499160871101,0.0105998955026255,0,0,19855.0,97820.92670675044,ATP2B2
3362,KEGG_2019_Human,cGMP-PKG signaling pathway,1/166,0.0082999091363732,0.0105998955026255,0,0,19834.0,95034.82345515196,ATP2B2
3363,KEGG_2019_Human,Calcium signaling pathway,1/188,0.009399902370135,0.0105998955026255,0,0,19812.0,92463.712994847,ATP2B2
3364,KEGG_2019_Human,cAMP signaling pathway,1/212,0.0105998955026255,0.0105998955026255,0,0,19788.0,89974.27756224656,ATP2B2
3365,KEGG_2019_Human,Bile secretion,1/72,0.0035999456502131,0.004099940929819,0,0,19928.0,112131.59838572376,EPHX1
3366,KEGG_2019_Human,Metabolism of xenobiotics by cytochrome P450,1/74,0.0036999446830449,0.004099940929819,0,0,19926.0,111574.38983110404,EPHX1
3367,KEGG_2019_Human,Chemical carcinogenesis,1/82,0.004099940929819,0.004099940929819,0,0,19918.0,109484.9180722932,EPHX1
3368,KEGG_2019_Human,Glycerolipid metabolism,1/61,0.0030499512001654,0.0061874168605085,0,0,19939.0,115499.24335773686,DGKZ
3369,KEGG_2019_Human,Glycerophospholipid metabolism,1/97,0.0048499343304706,0.0061874168605085,0,0,19903.0,106058.9096435903,DGKZ
3370,KEGG_2019_Human,Phosphatidylinositol signaling system,1/99,0.0049499334884068,0.0061874168605085,0,0,19901.0,105642.09305076736,DGKZ
3371,KEGG_2019_Human,Choline metabolism in cancer,1/99,0.0049499334884068,0.0061874168605085,0,0,19901.0,105642.09305076736,DGKZ
3372,KEGG_2019_Human,Phospholipase D signaling pathway,1/148,0.007399915061391,0.007399915061391,0,0,19852.0,97399.60470052566,DGKZ
3373,KEGG_2019_Human,Ribosome,1/153,0.0076499133771537,0.0076499133771537,0,0,19847.0,96715.6407630817,RPL10
3374,KEGG_2019_Human,Glutamatergic synapse,1/114,0.005699927427839,0.005699927427839,0,0,19886.0,102756.96431429044,SHANK2
3375,KEGG_2019_Human,Mucin type O-glycan biosynthesis,1/31,0.0015499690656704,0.0015499690656704,0,0,19969.0,129189.85098816035,B3GNT6
3376,KEGG_2019_Human,Autophagy,1/128,0.0063999221281459,0.0092999029651357,0,0,19872.0,100382.8010329652,ATG14
3377,KEGG_2019_Human,Kaposi sarcoma-associated herpesvirus infection,1/186,0.0092999029651357,0.0092999029651357,0,0,19814.0,92684.96451050608,ATG14
3378,KEGG_2019_Human,Inositol phosphate metabolism,1/74,0.0036999446830449,0.0049499334884068,0,0,19926.0,111574.38983110404,MTMR7
3379,KEGG_2019_Human,Phosphatidylinositol signaling system,1/99,0.0049499334884068,0.0049499334884068,0,0,19901.0,105642.09305076736,MTMR7
3380,KEGG_2019_Human,Huntington disease,1/193,0.0096499008972596,0.0096499008972596,0,0,19807.0,91920.47679471428,DNAH5
3381,KEGG_2019_Human,Protein digestion and absorption,1/90,0.0044999373439762,0.0064999213952527,0,0,19910.0,107587.50385474482,COL3A1
3382,KEGG_2019_Human,Amoebiasis,1/96,0.0047999347538706,0.0064999213952527,0,0,19904.0,106270.50039849174,COL3A1
3383,KEGG_2019_Human,AGE-RAGE signaling pathway in diabetic complications,1/100,0.0049999330710556,0.0064999213952527,0,0,19900.0,105436.78197328727,COL3A1
3384,KEGG_2019_Human,Platelet activation,1/124,0.0061999236097501,0.0064999213952527,0,0,19876.0,101034.04709010696,COL3A1
3385,KEGG_2019_Human,Relaxin signaling pathway,1/130,0.0064999213952527,0.0064999213952527,0,0,19870.0,100064.62842845908,COL3A1
3386,KEGG_2019_Human,Thyroid hormone signaling pathway,1/116,0.0057999266512085,0.0068499188797651,0,0,19884.0,102400.8105961506,NCOA2
3387,KEGG_2019_Human,Estrogen signaling pathway,1/137,0.0068499188797651,0.0068499188797651,0,0,19863.0,98987.62735269018,NCOA2
3388,KEGG_2019_Human,Base excision repair,1/33,0.0016499677032113,0.0023499589392381,0,0,19967.0,127928.56031580272,POLE
3389,KEGG_2019_Human,DNA replication,1/36,0.0017999657178272,0.0023499589392381,0,0,19964.0,126172.23364250171,POLE
3390,KEGG_2019_Human,Nucleotide excision repair,1/47,0.0023499589392381,0.0023499589392381,0,0,19953.0,120782.64067395544,POLE
3391,KEGG_2019_Human,Measles,1/138,0.0068999185254481,0.0106873844447042,0,0,19862.0,98838.19160389496,EIF2AK1
3392,KEGG_2019_Human,Hepatitis C,1/155,0.0077499127120574,0.0106873844447042,0,0,19845.0,96448.16254952336,EIF2AK1
3393,KEGG_2019_Human,Protein processing in endoplasmic reticulum,1/165,0.0082499094553477,0.0106873844447042,0,0,19835.0,95159.46482222488,EIF2AK1
3394,KEGG_2019_Human,Influenza A,1/171,0.0085499075557634,0.0106873844447042,0,0,19829.0,94422.42241345016,EIF2AK1
3395,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,EIF2AK1
3396,KEGG_2019_Human,Spliceosome,1/134,0.0066999199497742,0.0066999199497742,0,0,19866.0,99442.43560916925,EFTUD2
3397,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0164998674589645,0,0,19670.0,80733.60565076157,TADA3
3398,KEGG_2019_Human,RNA transport,1/165,0.0082499094553477,0.0164998189106955,0,0,19835.0,95159.46482222488,EIF2B4
3399,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,EIF2B4
3400,KEGG_2019_Human,Lysine degradation,1/59,0.0029499522555206,0.0029499522555206,0,0,19941.0,116175.59385530632,PLOD1
3401,KEGG_2019_Human,Phenylalanine metabolism,1/17,0.0008499797390404818,0.0035999314356544,0,0,19983.0,141285.76583697114,ALDH3A1
3402,KEGG_2019_Human,Histidine metabolism,1/23,0.0011499748819949,0.0035999314356544,0,0,19977.0,135204.63922267244,ALDH3A1
3403,KEGG_2019_Human,beta-Alanine metabolism,1/31,0.0015499690656704,0.0035999314356544,0,0,19969.0,129189.85098816035,ALDH3A1
3404,KEGG_2019_Human,Tyrosine metabolism,1/36,0.0017999657178272,0.0035999314356544,0,0,19964.0,126172.23364250171,ALDH3A1
3405,KEGG_2019_Human,Glycolysis / Gluconeogenesis,1/68,0.0033999476216189,0.004685646776936,0,0,19932.0,113293.39338050144,ALDH3A1
3406,KEGG_2019_Human,Metabolism of xenobiotics by cytochrome P450,1/74,0.0036999446830449,0.004685646776936,0,0,19926.0,111574.38983110404,ALDH3A1
3407,KEGG_2019_Human,Chemical carcinogenesis,1/82,0.004099940929819,0.004685646776936,0,0,19918.0,109484.9180722932,ALDH3A1
3408,KEGG_2019_Human,Drug metabolism,1/108,0.0053999298011749,0.0053999298011749,0,0,19892.0,103863.47861844616,ALDH3A1
3409,KEGG_2019_Human,Selenocompound metabolism,1/17,0.0008499797390404818,0.0025499392171214,0,0,19983.0,141285.76583697114,TXNRD2
3410,KEGG_2019_Human,Hepatocellular carcinoma,1/168,0.0083999085011095,0.0125998627516642,0,0,19832.0,94787.72752807094,TXNRD2
3411,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,TXNRD2
3412,KEGG_2019_Human,Bladder cancer,1/41,0.0020499625466866,0.0178747202392388,0,0,19959.0,123544.88783416104,FGFR3
3413,KEGG_2019_Human,Central carbon metabolism in cancer,1/65,0.003249949134407,0.0178747202392388,0,0,19935.0,114209.92613860144,FGFR3
3414,KEGG_2019_Human,Signaling pathways regulating pluripotency of stem cells,1/139,0.006949918172816,0.0182720683041739,0,0,19861.0,98689.81333375497,FGFR3
3415,KEGG_2019_Human,Rap1 signaling pathway,1/206,0.010299897173561,0.0182720683041739,0,0,19794.0,90569.849337325,FGFR3
3416,KEGG_2019_Human,Regulation of actin cytoskeleton,1/214,0.0106998949514067,0.0182720683041739,0,0,19786.0,89779.39753374986,FGFR3
3417,KEGG_2019_Human,Ras signaling pathway,1/232,0.0115998901349604,0.0182720683041739,0,0,19768.0,88101.22480150245,FGFR3
3418,KEGG_2019_Human,Endocytosis,1/244,0.0121998870519305,0.0182720683041739,0,0,19756.0,87051.4275316661,FGFR3
3419,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0182720683041739,0,0,19705.0,83086.53988020132,FGFR3
3420,KEGG_2019_Human,MicroRNAs in cancer,1/299,0.0149498740670514,0.0182720683041739,0,0,19701.0,82804.33538735632,FGFR3
3421,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0194698489055035,0,0,19646.0,79255.8617626126,FGFR3
3422,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,FGFR3
3423,KEGG_2019_Human,Prion diseases,1/35,0.0017499663721595,0.0059249134751006,0,0,19965.0,126740.98858805298,C1QA
3424,KEGG_2019_Human,Staphylococcus aureus infection,1/68,0.0033999476216189,0.0059249134751006,0,0,19932.0,113293.39338050144,C1QA
3425,KEGG_2019_Human,Pertussis,1/76,0.0037999437281752,0.0059249134751006,0,0,19924.0,111031.8499691117,C1QA
3426,KEGG_2019_Human,Complement and coagulation cascades,1/79,0.0039499423167337,0.0059249134751006,0,0,19921.0,110243.89578070649,C1QA
3427,KEGG_2019_Human,Chagas disease (American trypanosomiasis),1/103,0.0051499318302617,0.006179918196314,0,0,19897.0,104832.7525292024,C1QA
3428,KEGG_2019_Human,Systemic lupus erythematosus,1/133,0.0066499203093911,0.0066499203093911,0,0,19867.0,99596.2591544721,C1QA
3429,KEGG_2019_Human,Arginine and proline metabolism,1/49,0.0024499577795033,0.0024499577795033,0,0,19951.0,119939.1172087114,CKM
3430,KEGG_2019_Human,Cholesterol metabolism,1/50,0.0024999572069037,0.0024999572069037,0,0,19950.0,119530.05920663515,LRPAP1
3431,KEGG_2019_Human,Axon guidance,1/181,0.0090499044707863,0.0176998626413668,0,0,19819.0,93248.41634586031,EPHA2
3432,KEGG_2019_Human,Rap1 signaling pathway,1/206,0.010299897173561,0.0176998626413668,0,0,19794.0,90569.849337325,EPHA2
3433,KEGG_2019_Human,Ras signaling pathway,1/232,0.0115998901349604,0.0176998626413668,0,0,19768.0,88101.22480150245,EPHA2
3434,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0176998626413668,0,0,19705.0,83086.53988020132,EPHA2
3435,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0176998626413668,0,0,19646.0,79255.8617626126,EPHA2
3436,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,GLRB
3437,KEGG_2019_Human,Inositol phosphate metabolism,1/74,0.0036999446830449,0.0068499188797651,0,0,19926.0,111574.38983110404,INPP5K
3438,KEGG_2019_Human,Phosphatidylinositol signaling system,1/99,0.0049499334884068,0.0068499188797651,0,0,19901.0,105642.09305076736,INPP5K
3439,KEGG_2019_Human,Insulin signaling pathway,1/137,0.0068499188797651,0.0068499188797651,0,0,19863.0,98987.62735269018,INPP5K
3440,KEGG_2019_Human,Vascular smooth muscle contraction,1/132,0.0065999206698993,0.0123665447530631,0,0,19868.0,99751.22090491928,ADORA2A
3441,KEGG_2019_Human,Parkinson disease,1/142,0.0070999171242726,0.0123665447530631,0,0,19858.0,98250.87390500787,ADORA2A
3442,KEGG_2019_Human,Alcoholism,1/180,0.0089999047745351,0.0123665447530631,0,0,19820.0,93362.92821536642,ADORA2A
3443,KEGG_2019_Human,Calcium signaling pathway,1/188,0.009399902370135,0.0123665447530631,0,0,19812.0,92463.712994847,ADORA2A
3444,KEGG_2019_Human,Rap1 signaling pathway,1/206,0.010299897173561,0.0123665447530631,0,0,19794.0,90569.849337325,ADORA2A
3445,KEGG_2019_Human,cAMP signaling pathway,1/212,0.0105998955026255,0.0123665447530631,0,0,19788.0,89974.27756224656,ADORA2A
3446,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,ADORA2A
3447,KEGG_2019_Human,Axon guidance,1/181,0.0090499044707863,0.0090499044707863,0,0,19819.0,93248.41634586031,ROBO2
3448,KEGG_2019_Human,Arrhythmogenic right ventricular cardiomyopathy (ARVC),1/72,0.0035999456502131,0.0035999456502131,0,0,19928.0,112131.59838572376,PKP2
3449,KEGG_2019_Human,Axon guidance,1/181,0.0090499044707863,0.0090499044707863,0,0,19819.0,93248.41634586031,NGEF
3450,KEGG_2019_Human,Pertussis,1/76,0.0037999437281752,0.0037999437281752,0,0,19924.0,111031.8499691117,IRF8
3451,KEGG_2019_Human,Complement and coagulation cascades,1/79,0.0039499423167337,0.0039499423167337,0,0,19921.0,110243.89578070649,TFPI
3452,KEGG_2019_Human,Wnt signaling pathway,1/158,0.0078999117225733,0.0078999117225733,0,0,19842.0,96053.2110949472,SOX17
3453,KEGG_2019_Human,C-type lectin receptor signaling pathway,1/104,0.0051999314202997,0.0115998901349604,0,0,19896.0,104635.24941415618,KSR1
3454,KEGG_2019_Human,Tuberculosis,1/179,0.0089499050800561,0.0115998901349604,0,0,19821.0,93478.0629355712,KSR1
3455,KEGG_2019_Human,Ras signaling pathway,1/232,0.0115998901349604,0.0115998901349604,0,0,19768.0,88101.22480150245,KSR1
3456,KEGG_2019_Human,Malaria,1/49,0.0024499577795033,0.0024499577795033,0,0,19951.0,119939.1172087114,GYPC
3457,KEGG_2019_Human,Complement and coagulation cascades,1/79,0.0039499423167337,0.0039499423167337,0,0,19921.0,110243.89578070649,PROC
3458,KEGG_2019_Human,Proteoglycans in cancer,1/201,0.0100498985877989,0.0100498985877989,0,0,19799.0,91079.21596609056,ANK2
3459,KEGG_2019_Human,Nicotinate and nicotinamide metabolism,1/30,0.0014999697593334,0.004274929989447,0,0,19970.0,129851.13732048514,NT5C1A
3460,KEGG_2019_Human,Pyrimidine metabolism,1/57,0.002849953326298,0.004274929989447,0,0,19943.0,116875.00742975442,NT5C1A
3461,KEGG_2019_Human,Purine metabolism,1/129,0.006449921761047,0.006449921761047,0,0,19871.0,100223.109907462,NT5C1A
3462,KEGG_2019_Human,Protein digestion and absorption,1/90,0.0044999373439762,0.0117498779626688,0,0,19910.0,107587.50385474482,SLC8A2
3463,KEGG_2019_Human,Apelin signaling pathway,1/137,0.0068499188797651,0.0117498779626688,0,0,19863.0,98987.62735269018,SLC8A2
3464,KEGG_2019_Human,cGMP-PKG signaling pathway,1/166,0.0082999091363732,0.0117498779626688,0,0,19834.0,95034.82345515196,SLC8A2
3465,KEGG_2019_Human,Calcium signaling pathway,1/188,0.009399902370135,0.0117498779626688,0,0,19812.0,92463.712994847,SLC8A2
3466,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,SLC8A2
3467,KEGG_2019_Human,Basal cell carcinoma,1/63,0.0031499501598827,0.0117598719015533,0,0,19937.0,114844.46974572667,WNT3A
3468,KEGG_2019_Human,Melanogenesis,1/101,0.0050499326546803,0.0117598719015533,0,0,19899.0,105233.48101229242,WNT3A
3469,KEGG_2019_Human,Signaling pathways regulating pluripotency of stem cells,1/139,0.006949918172816,0.0117598719015533,0,0,19861.0,98689.81333375497,WNT3A
3470,KEGG_2019_Human,Breast cancer,1/147,0.0073499154017982,0.0117598719015533,0,0,19853.0,97539.10874372096,WNT3A
3471,KEGG_2019_Human,Gastric cancer,1/149,0.0074499147221605,0.0117598719015533,0,0,19851.0,97261.02051561224,WNT3A
3472,KEGG_2019_Human,mTOR signaling pathway,1/152,0.0075999137114971,0.0117598719015533,0,0,19848.0,96850.665715497,WNT3A
3473,KEGG_2019_Human,Cushing syndrome,1/155,0.0077499127120574,0.0117598719015533,0,0,19845.0,96448.16254952336,WNT3A
3474,KEGG_2019_Human,Wnt signaling pathway,1/158,0.0078999117225733,0.0117598719015533,0,0,19842.0,96053.2110949472,WNT3A
3475,KEGG_2019_Human,Hippo signaling pathway,1/160,0.0079999110688441,0.0117598719015533,0,0,19840.0,95793.96509856998,WNT3A
3476,KEGG_2019_Human,Hepatocellular carcinoma,1/168,0.0083999085011095,0.0117598719015533,0,0,19832.0,94787.72752807094,WNT3A
3477,KEGG_2019_Human,Proteoglycans in cancer,1/201,0.0100498985877989,0.012790780020835,0,0,19799.0,91079.21596609056,WNT3A
3478,KEGG_2019_Human,MicroRNAs in cancer,1/299,0.0149498740670514,0.0174415197448933,0,0,19701.0,82804.33538735632,WNT3A
3479,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.017769088032731,0,0,19670.0,80733.60565076157,WNT3A
3480,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,WNT3A
3481,KEGG_2019_Human,Estrogen signaling pathway,1/137,0.0068499188797651,0.0068499188797651,0,0,19863.0,98987.62735269018,KRT24
3482,KEGG_2019_Human,Glycosylphosphatidylinositol (GPI)-anchor biosynthesis,1/25,0.0012499733663791,0.0012499733663791,0,0,19975.0,133525.54486996148,PIGO
3483,KEGG_2019_Human,Ribosome biogenesis in eukaryotes,1/101,0.0050499326546803,0.0066999199497742,0,0,19899.0,105233.48101229242,SNU13
3484,KEGG_2019_Human,Spliceosome,1/134,0.0066999199497742,0.0066999199497742,0,0,19866.0,99442.43560916925,SNU13
3485,KEGG_2019_Human,Serotonergic synapse,1/113,0.0056499278191151,0.0154665201799472,0,0,19887.0,102937.34947211576,HTR7
3486,KEGG_2019_Human,Calcium signaling pathway,1/188,0.009399902370135,0.0154665201799472,0,0,19812.0,92463.712994847,HTR7
3487,KEGG_2019_Human,Ras signaling pathway,1/232,0.0115998901349604,0.0154665201799472,0,0,19768.0,88101.22480150245,HTR7
3488,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,HTR7
3489,KEGG_2019_Human,Starch and sucrose metabolism,1/36,0.0017999657178272,0.0080999104202618,0,0,19964.0,126172.23364250171,PYGB
3490,KEGG_2019_Human,Glucagon signaling pathway,1/103,0.0051499318302617,0.0080999104202618,0,0,19897.0,104832.7525292024,PYGB
3491,KEGG_2019_Human,Insulin resistance,1/108,0.0053999298011749,0.0080999104202618,0,0,19892.0,103863.47861844616,PYGB
3492,KEGG_2019_Human,Insulin signaling pathway,1/137,0.0068499188797651,0.0080999104202618,0,0,19863.0,98987.62735269018,PYGB
3493,KEGG_2019_Human,Necroptosis,1/162,0.0080999104202618,0.0080999104202618,0,0,19838.0,95537.86936302872,PYGB
3494,KEGG_2019_Human,Bile secretion,1/72,0.0035999456502131,0.0035999456502131,0,0,19928.0,112131.59838572376,SLCO1B3
3495,KEGG_2019_Human,ABC transporters,1/45,0.0022499601197094,0.0022499601197094,0,0,19955.0,121662.49782449217,ABCC9
3496,KEGG_2019_Human,Leukocyte transendothelial migration,1/112,0.0055999282120529,0.0084999078692823,0,0,19888.0,103119.30984392198,CLDN17
3497,KEGG_2019_Human,Cell adhesion molecules (CAMs),1/145,0.0072499160871101,0.0084999078692823,0,0,19855.0,97820.92670675044,CLDN17
3498,KEGG_2019_Human,Hepatitis C,1/155,0.0077499127120574,0.0084999078692823,0,0,19845.0,96448.16254952336,CLDN17
3499,KEGG_2019_Human,Tight junction,1/170,0.0084999078692823,0.0084999078692823,0,0,19830.0,94543.49009679438,CLDN17
3500,KEGG_2019_Human,Relaxin signaling pathway,1/130,0.0064999213952527,0.0129998427905055,0,0,19870.0,100064.62842845908,RLN3
3501,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,RLN3
3502,KEGG_2019_Human,Nicotine addiction,1/40,0.0019999631680592,0.0084748917286727,0,0,19960.0,124043.94523066044,GABRB3
3503,KEGG_2019_Human,GABAergic synapse,1/89,0.0044499377838098,0.0084748917286727,0,0,19911.0,107815.380281759,GABRB3
3504,KEGG_2019_Human,Morphine addiction,1/91,0.0045499369072032,0.0084748917286727,0,0,19909.0,107362.10783923086,GABRB3
3505,KEGG_2019_Human,Serotonergic synapse,1/113,0.0056499278191151,0.0084748917286727,0,0,19887.0,102937.34947211576,GABRB3
3506,KEGG_2019_Human,Retrograde endocannabinoid signaling,1/148,0.007399915061391,0.0088798980736692,0,0,19852.0,97399.60470052566,GABRB3
3507,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,GABRB3
3508,KEGG_2019_Human,Signaling pathways regulating pluripotency of stem cells,1/139,0.006949918172816,0.006949918172816,0,0,19861.0,98689.81333375497,ZIC3
3509,KEGG_2019_Human,Adherens junction,1/72,0.0035999456502131,0.0035999456502131,0,0,19928.0,112131.59838572376,FER
3510,KEGG_2019_Human,Rap1 signaling pathway,1/206,0.010299897173561,0.010299897173561,0,0,19794.0,90569.849337325,SIPA1L3
3511,KEGG_2019_Human,Glycosylphosphatidylinositol (GPI)-anchor biosynthesis,1/25,0.0012499733663791,0.0012499733663791,0,0,19975.0,133525.54486996148,PIGG
3512,KEGG_2019_Human,Amyotrophic lateral sclerosis (ALS),1/51,0.0025499566390179,0.0101998265560719,0,0,19949.0,119129.0228601236,DAXX
3513,KEGG_2019_Human,Apoptosis,1/143,0.0071499167770442,0.0142998335540884,0,0,19857.0,98106.57763600958,DAXX
3514,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0196664999382009,0,0,19705.0,83086.53988020132,DAXX
3515,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,DAXX
3516,KEGG_2019_Human,Estrogen signaling pathway,1/137,0.0068499188797651,0.0068499188797651,0,0,19863.0,98987.62735269018,KRT26
3517,KEGG_2019_Human,Intestinal immune network for IgA production,1/48,0.0023999583567988,0.010009861195847,0,0,19952.0,120356.5272753826,ITGB7
3518,KEGG_2019_Human,Arrhythmogenic right ventricular cardiomyopathy (ARVC),1/72,0.0035999456502131,0.010009861195847,0,0,19928.0,112131.59838572376,ITGB7
3519,KEGG_2019_Human,ECM-receptor interaction,1/82,0.004099940929819,0.010009861195847,0,0,19918.0,109484.9180722932,ITGB7
3520,KEGG_2019_Human,Hypertrophic cardiomyopathy (HCM),1/85,0.004249939567045,0.010009861195847,0,0,19915.0,108752.83801948265,ITGB7
3521,KEGG_2019_Human,Dilated cardiomyopathy (DCM),1/91,0.0045499369072032,0.010009861195847,0,0,19909.0,107362.10783923086,ITGB7
3522,KEGG_2019_Human,Cell adhesion molecules (CAMs),1/145,0.0072499160871101,0.0130776493850527,0,0,19855.0,97820.92670675044,ITGB7
3523,KEGG_2019_Human,Transcriptional misregulation in cancer,1/186,0.0092999029651357,0.0130776493850527,0,0,19814.0,92684.96451050608,ITGB7
3524,KEGG_2019_Human,Focal adhesion,1/199,0.0099498991610159,0.0130776493850527,0,0,19801.0,91286.4288690606,ITGB7
3525,KEGG_2019_Human,Regulation of actin cytoskeleton,1/214,0.0106998949514067,0.0130776493850527,0,0,19786.0,89779.39753374986,ITGB7
3526,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0176998626413668,0,0,19670.0,80733.60565076157,ITGB7
3527,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0176998626413668,0,0,19646.0,79255.8617626126,ITGB7
3528,KEGG_2019_Human,Glycosphingolipid biosynthesis,1/45,0.0022499601197094,0.0022499601197094,0,0,19955.0,121662.49782449217,B3GNT4
3529,KEGG_2019_Human,Salivary secretion,1/90,0.0044999373439762,0.0044999373439762,0,0,19910.0,107587.50385474482,DMBT1
3530,KEGG_2019_Human,Glucagon signaling pathway,1/103,0.0051499318302617,0.0099998751968097,0,0,19897.0,104832.7525292024,CRTC2
3531,KEGG_2019_Human,Insulin resistance,1/108,0.0053999298011749,0.0099998751968097,0,0,19892.0,103863.47861844616,CRTC2
3532,KEGG_2019_Human,AMPK signaling pathway,1/120,0.0059999251180858,0.0099998751968097,0,0,19880.0,101706.2448082016,CRTC2
3533,KEGG_2019_Human,Human T-cell leukemia virus 1 infection,1/219,0.0109498935894162,0.0136873669867703,0,0,19781.0,89299.85161916987,CRTC2
3534,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0176998626413668,0,0,19646.0,79255.8617626126,CRTC2
3535,KEGG_2019_Human,DNA replication,1/36,0.0017999657178272,0.0035999314356544,0,0,19964.0,126172.23364250171,MCM7
3536,KEGG_2019_Human,Cell cycle,1/124,0.0061999236097501,0.0061999236097501,0,0,19876.0,101034.04709010696,MCM7
3537,KEGG_2019_Human,mRNA surveillance pathway,1/91,0.0045499369072032,0.0096665547828135,0,0,19909.0,107362.10783923086,PPP2R5C
3538,KEGG_2019_Human,Sphingolipid signaling pathway,1/119,0.0059499254985137,0.0096665547828135,0,0,19881.0,101877.73080211312,PPP2R5C
3539,KEGG_2019_Human,AMPK signaling pathway,1/120,0.0059999251180858,0.0096665547828135,0,0,19880.0,101706.2448082016,PPP2R5C
3540,KEGG_2019_Human,Oocyte meiosis,1/125,0.0062499232373748,0.0096665547828135,0,0,19875.0,100869.32368441945,PPP2R5C
3541,KEGG_2019_Human,Dopaminergic synapse,1/131,0.0065499210316603,0.0096665547828135,0,0,19869.0,99907.33811343512,PPP2R5C
3542,KEGG_2019_Human,Adrenergic signaling in cardiomyocytes,1/145,0.0072499160871101,0.0096665547828135,0,0,19855.0,97820.92670675044,PPP2R5C
3543,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0176998626413668,0,0,19670.0,80733.60565076157,PPP2R5C
3544,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0176998626413668,0,0,19646.0,79255.8617626126,PPP2R5C
3545,KEGG_2019_Human,Legionellosis,1/55,0.0027499544131125,0.0027499544131125,0,0,19945.0,117599.1294878737,CLK1
3546,KEGG_2019_Human,mRNA surveillance pathway,1/91,0.0045499369072032,0.010999879273797,0,0,19909.0,107362.10783923086,ALYREF
3547,KEGG_2019_Human,Spliceosome,1/134,0.0066999199497742,0.010999879273797,0,0,19866.0,99442.43560916925,ALYREF
3548,KEGG_2019_Human,RNA transport,1/165,0.0082499094553477,0.010999879273797,0,0,19835.0,95159.46482222488,ALYREF
3549,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ALYREF
3550,KEGG_2019_Human,Axon guidance,1/181,0.0090499044707863,0.0090499044707863,0,0,19819.0,93248.41634586031,TRPC4
3551,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZSCAN32
3552,KEGG_2019_Human,MicroRNAs in cancer,1/299,0.0149498740670514,0.0149498740670514,0,0,19701.0,82804.33538735632,FOXP1
3553,KEGG_2019_Human,Basal cell carcinoma,1/63,0.0031499501598827,0.0109198810514423,0,0,19937.0,114844.46974572667,WNT7B
3554,KEGG_2019_Human,Melanogenesis,1/101,0.0050499326546803,0.0109198810514423,0,0,19899.0,105233.48101229242,WNT7B
3555,KEGG_2019_Human,Signaling pathways regulating pluripotency of stem cells,1/139,0.006949918172816,0.0109198810514423,0,0,19861.0,98689.81333375497,WNT7B
3556,KEGG_2019_Human,Breast cancer,1/147,0.0073499154017982,0.0109198810514423,0,0,19853.0,97539.10874372096,WNT7B
3557,KEGG_2019_Human,Gastric cancer,1/149,0.0074499147221605,0.0109198810514423,0,0,19851.0,97261.02051561224,WNT7B
3558,KEGG_2019_Human,mTOR signaling pathway,1/152,0.0075999137114971,0.0109198810514423,0,0,19848.0,96850.665715497,WNT7B
3559,KEGG_2019_Human,Cushing syndrome,1/155,0.0077499127120574,0.0109198810514423,0,0,19845.0,96448.16254952336,WNT7B
3560,KEGG_2019_Human,Wnt signaling pathway,1/158,0.0078999117225733,0.0109198810514423,0,0,19842.0,96053.2110949472,WNT7B
3561,KEGG_2019_Human,Hippo signaling pathway,1/160,0.0079999110688441,0.0109198810514423,0,0,19840.0,95793.96509856998,WNT7B
3562,KEGG_2019_Human,Hepatocellular carcinoma,1/168,0.0083999085011095,0.0109198810514423,0,0,19832.0,94787.72752807094,WNT7B
3563,KEGG_2019_Human,Proteoglycans in cancer,1/201,0.0100498985877989,0.0118771528764897,0,0,19799.0,91079.21596609056,WNT7B
3564,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0178748564138782,0,0,19670.0,80733.60565076157,WNT7B
3565,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,WNT7B
3566,KEGG_2019_Human,NOD-like receptor signaling pathway,1/178,0.0088999053857096,0.0088999053857096,0,0,19822.0,93593.82745769851,GPRC6A
3567,KEGG_2019_Human,Acute myeloid leukemia,1/66,0.003299948626608,0.0089998641255328,0,0,19934.0,113899.85357353876,JUP
3568,KEGG_2019_Human,Arrhythmogenic right ventricular cardiomyopathy (ARVC),1/72,0.0035999456502131,0.0089998641255328,0,0,19928.0,112131.59838572376,JUP
3569,KEGG_2019_Human,Gastric cancer,1/149,0.0074499147221605,0.0116248787064197,0,0,19851.0,97261.02051561224,JUP
3570,KEGG_2019_Human,Transcriptional misregulation in cancer,1/186,0.0092999029651357,0.0116248787064197,0,0,19814.0,92684.96451050608,JUP
3571,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,JUP
3572,KEGG_2019_Human,N-Glycan biosynthesis,1/50,0.0024999572069037,0.0049999144138074,0,0,19950.0,119530.05920663515,GANAB
3573,KEGG_2019_Human,Protein processing in endoplasmic reticulum,1/165,0.0082499094553477,0.0082499094553477,0,0,19835.0,95159.46482222488,GANAB
3574,KEGG_2019_Human,Citrate cycle (TCA cycle),1/30,0.0014999697593334,0.0014999697593334,0,0,19970.0,129851.13732048514,ACLY
3575,KEGG_2019_Human,Regulation of actin cytoskeleton,1/214,0.0106998949514067,0.0106998949514067,0,0,19786.0,89779.39753374986,FGD3
3576,KEGG_2019_Human,TGF-beta signaling pathway,1/90,0.0044999373439762,0.0044999373439762,0,0,19910.0,107587.50385474482,FMOD
3577,KEGG_2019_Human,Adherens junction,1/72,0.0035999456502131,0.0083998923180794,0,0,19928.0,112131.59838572376,CTNND1
3578,KEGG_2019_Human,Leukocyte transendothelial migration,1/112,0.0055999282120529,0.0083998923180794,0,0,19888.0,103119.30984392198,CTNND1
3579,KEGG_2019_Human,Rap1 signaling pathway,1/206,0.010299897173561,0.010299897173561,0,0,19794.0,90569.849337325,CTNND1
3580,KEGG_2019_Human,Viral myocarditis,1/59,0.0029499522555206,0.0068249053608048,0,0,19941.0,116175.59385530632,MYH7
3581,KEGG_2019_Human,Cardiac muscle contraction,1/78,0.0038999427840466,0.0068249053608048,0,0,19922.0,110503.2180492851,MYH7
3582,KEGG_2019_Human,Hypertrophic cardiomyopathy (HCM),1/85,0.004249939567045,0.0068249053608048,0,0,19915.0,108752.83801948265,MYH7
3583,KEGG_2019_Human,Dilated cardiomyopathy (DCM),1/91,0.0045499369072032,0.0068249053608048,0,0,19909.0,107362.10783923086,MYH7
3584,KEGG_2019_Human,Adrenergic signaling in cardiomyocytes,1/145,0.0072499160871101,0.0082999091363732,0,0,19855.0,97820.92670675044,MYH7
3585,KEGG_2019_Human,cGMP-PKG signaling pathway,1/166,0.0082999091363732,0.0082999091363732,0,0,19834.0,95034.82345515196,MYH7
3586,KEGG_2019_Human,Glutathione metabolism,1/56,0.0027999538675741,0.0036999446830449,0,0,19944.0,117233.87022514464,GPX6
3587,KEGG_2019_Human,Arachidonic acid metabolism,1/63,0.0031499501598827,0.0036999446830449,0,0,19937.0,114844.46974572667,GPX6
3588,KEGG_2019_Human,Thyroid hormone synthesis,1/74,0.0036999446830449,0.0036999446830449,0,0,19926.0,111574.38983110404,GPX6
3589,KEGG_2019_Human,Circadian rhythm,1/31,0.0015499690656704,0.0030999381313408,0,0,19969.0,129189.85098816035,ARNTL
3590,KEGG_2019_Human,Dopaminergic synapse,1/131,0.0065499210316603,0.0065499210316603,0,0,19869.0,99907.33811343512,ARNTL
3591,KEGG_2019_Human,Thermogenesis,1/231,0.0115498903940656,0.0115498903940656,0,0,19769.0,88191.07730937863,KDM1A
3592,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF790
3593,KEGG_2019_Human,Adherens junction,1/72,0.0035999456502131,0.0035999456502131,0,0,19928.0,112131.59838572376,NECTIN4
3594,KEGG_2019_Human,Ovarian steroidogenesis,1/49,0.0024499577795033,0.0043749332870817,0,0,19951.0,119939.1172087114,CYP17A1
3595,KEGG_2019_Human,Steroid hormone biosynthesis,1/60,0.002999951725986,0.0043749332870817,0,0,19940.0,115834.63209072244,CYP17A1
3596,KEGG_2019_Human,Cortisol synthesis and secretion,1/65,0.003249949134407,0.0043749332870817,0,0,19935.0,114209.92613860144,CYP17A1
3597,KEGG_2019_Human,Prolactin signaling pathway,1/70,0.0034999466296654,0.0043749332870817,0,0,19930.0,112704.30065625212,CYP17A1
3598,KEGG_2019_Human,Cushing syndrome,1/155,0.0077499127120574,0.0077499127120574,0,0,19845.0,96448.16254952336,CYP17A1
3599,KEGG_2019_Human,Cocaine addiction,1/49,0.0024499577795033,0.0097998311180133,0,0,19951.0,119939.1172087114,GRM3
3600,KEGG_2019_Human,Glutamatergic synapse,1/114,0.005699927427839,0.009866553415188,0,0,19886.0,102756.96431429044,GRM3
3601,KEGG_2019_Human,Phospholipase D signaling pathway,1/148,0.007399915061391,0.009866553415188,0,0,19852.0,97399.60470052566,GRM3
3602,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,GRM3
3603,KEGG_2019_Human,Aminoacyl-tRNA biosynthesis,1/66,0.003299948626608,0.003299948626608,0,0,19934.0,113899.85357353876,TARS2
3604,KEGG_2019_Human,Nicotine addiction,1/40,0.0019999631680592,0.007583228178672,0,0,19960.0,124043.94523066044,GABRQ
3605,KEGG_2019_Human,GABAergic synapse,1/89,0.0044499377838098,0.007583228178672,0,0,19911.0,107815.380281759,GABRQ
3606,KEGG_2019_Human,Morphine addiction,1/91,0.0045499369072032,0.007583228178672,0,0,19909.0,107362.10783923086,GABRQ
3607,KEGG_2019_Human,Retrograde endocannabinoid signaling,1/148,0.007399915061391,0.0092498938267387,0,0,19852.0,97399.60470052566,GABRQ
3608,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,GABRQ
3609,KEGG_2019_Human,Axon guidance,1/181,0.0090499044707863,0.0090499044707863,0,0,19819.0,93248.41634586031,EPHA7
3610,KEGG_2019_Human,Aminoacyl-tRNA biosynthesis,1/66,0.003299948626608,0.003299948626608,0,0,19934.0,113899.85357353876,RARS2
3611,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR10C1
3612,KEGG_2019_Human,Axon guidance,1/181,0.0090499044707863,0.0090499044707863,0,0,19819.0,93248.41634586031,SEMA5A
3613,KEGG_2019_Human,Insulin secretion,1/86,0.0042999391173866,0.0082999091363732,0,0,19914.0,108514.46102290176,KCNU1
3614,KEGG_2019_Human,Vascular smooth muscle contraction,1/132,0.0065999206698993,0.0082999091363732,0,0,19868.0,99751.22090491928,KCNU1
3615,KEGG_2019_Human,cGMP-PKG signaling pathway,1/166,0.0082999091363732,0.0082999091363732,0,0,19834.0,95034.82345515196,KCNU1
3616,KEGG_2019_Human,Adherens junction,1/72,0.0035999456502131,0.0035999456502131,0,0,19928.0,112131.59838572376,PTPRJ
3617,KEGG_2019_Human,Axon guidance,1/181,0.0090499044707863,0.0090499044707863,0,0,19819.0,93248.41634586031,ROBO1
3618,KEGG_2019_Human,Primary immunodeficiency,1/37,0.0018499650702878,0.0125623732347487,0,0,19963.0,125618.9446446357,JAK3
3619,KEGG_2019_Human,Non-small cell lung cancer,1/66,0.003299948626608,0.0125623732347487,0,0,19934.0,113899.85357353876,JAK3
3620,KEGG_2019_Human,Th1 and Th2 cell differentiation,1/92,0.0045999364719865,0.0125623732347487,0,0,19908.0,107139.13814408927,JAK3
3621,KEGG_2019_Human,Th17 cell differentiation,1/107,0.0053499302026925,0.0125623732347487,0,0,19893.0,104053.753408911,JAK3
3622,KEGG_2019_Human,Measles,1/138,0.0068999185254481,0.0125623732347487,0,0,19862.0,98838.19160389496,JAK3
3623,KEGG_2019_Human,Signaling pathways regulating pluripotency of stem cells,1/139,0.006949918172816,0.0125623732347487,0,0,19861.0,98689.81333375497,JAK3
3624,KEGG_2019_Human,Necroptosis,1/162,0.0080999104202618,0.0125623732347487,0,0,19838.0,95537.86936302872,JAK3
3625,KEGG_2019_Human,JAK-STAT signaling pathway,1/162,0.0080999104202618,0.0125623732347487,0,0,19838.0,95537.86936302872,JAK3
3626,KEGG_2019_Human,Hepatitis B,1/163,0.0081499100978668,0.0125623732347487,0,0,19837.0,95410.9786681514,JAK3
3627,KEGG_2019_Human,Chemokine signaling pathway,1/190,0.0094999017791995,0.0125623732347487,0,0,19810.0,92244.74636351672,JAK3
3628,KEGG_2019_Human,Viral carcinogenesis,1/201,0.0100498985877989,0.0125623732347487,0,0,19799.0,91079.21596609056,JAK3
3629,KEGG_2019_Human,Epstein-Barr virus infection,1/201,0.0100498985877989,0.0125623732347487,0,0,19799.0,91079.21596609056,JAK3
3630,KEGG_2019_Human,Human T-cell leukemia virus 1 infection,1/219,0.0109498935894162,0.0126344926031726,0,0,19781.0,89299.85161916987,JAK3
3631,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0189641385443216,0,0,19646.0,79255.8617626126,JAK3
3632,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,JAK3
3633,KEGG_2019_Human,Citrate cycle (TCA cycle),1/30,0.0014999697593334,0.0019499637955508,0,0,19970.0,129851.13732048514,PC
3634,KEGG_2019_Human,Pyruvate metabolism,1/39,0.0019499637955508,0.0019499637955508,0,0,19961.0,124555.53162481484,PC
3635,KEGG_2019_Human,Regulation of lipolysis in adipocytes,1/55,0.0027499544131125,0.0027499544131125,0,0,19945.0,117599.1294878737,ABHD5
3636,KEGG_2019_Human,Nicotine addiction,1/40,0.0019999631680592,0.009866553415188,0,0,19960.0,124043.94523066044,GRIA4
3637,KEGG_2019_Human,Amphetamine addiction,1/68,0.0033999476216189,0.009866553415188,0,0,19932.0,113293.39338050144,GRIA4
3638,KEGG_2019_Human,Circadian entrainment,1/97,0.0048499343304706,0.009866553415188,0,0,19903.0,106058.9096435903,GRIA4
3639,KEGG_2019_Human,Glutamatergic synapse,1/114,0.005699927427839,0.009866553415188,0,0,19886.0,102756.96431429044,GRIA4
3640,KEGG_2019_Human,Dopaminergic synapse,1/131,0.0065499210316603,0.009866553415188,0,0,19869.0,99907.33811343512,GRIA4
3641,KEGG_2019_Human,Retrograde endocannabinoid signaling,1/148,0.007399915061391,0.009866553415188,0,0,19852.0,97399.60470052566,GRIA4
3642,KEGG_2019_Human,cAMP signaling pathway,1/212,0.0105998955026255,0.0121141662887149,0,0,19788.0,89974.27756224656,GRIA4
3643,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,GRIA4
3644,KEGG_2019_Human,Estrogen signaling pathway,1/137,0.0068499188797651,0.0068499188797651,0,0,19863.0,98987.62735269018,KRT33B
3645,KEGG_2019_Human,Ribosome biogenesis in eukaryotes,1/101,0.0050499326546803,0.0050499326546803,0,0,19899.0,105233.48101229242,RIOK2
3646,KEGG_2019_Human,Progesterone-mediated oocyte maturation,1/99,0.0049499334884068,0.0099998888360552,0,0,19901.0,105642.09305076736,CCNB3
3647,KEGG_2019_Human,Cell cycle,1/124,0.0061999236097501,0.0099998888360552,0,0,19876.0,101034.04709010696,CCNB3
3648,KEGG_2019_Human,FoxO signaling pathway,1/132,0.0065999206698993,0.0099998888360552,0,0,19868.0,99751.22090491928,CCNB3
3649,KEGG_2019_Human,Cellular senescence,1/160,0.0079999110688441,0.0099998888360552,0,0,19840.0,95793.96509856998,CCNB3
3650,KEGG_2019_Human,Human immunodeficiency virus 1 infection,1/212,0.0105998955026255,0.0105998955026255,0,0,19788.0,89974.27756224656,CCNB3
3651,KEGG_2019_Human,Mitophagy,1/65,0.003249949134407,0.0075748989820205,0,0,19935.0,114209.92613860144,CSNK2A2
3652,KEGG_2019_Human,Adherens junction,1/72,0.0035999456502131,0.0075748989820205,0,0,19928.0,112131.59838572376,CSNK2A2
3653,KEGG_2019_Human,NF-kappa B signaling pathway,1/95,0.0047499351803394,0.0075748989820205,0,0,19905.0,106484.27183626965,CSNK2A2
3654,KEGG_2019_Human,Ribosome biogenesis in eukaryotes,1/101,0.0050499326546803,0.0075748989820205,0,0,19899.0,105233.48101229242,CSNK2A2
3655,KEGG_2019_Human,Measles,1/138,0.0068999185254481,0.0078999117225733,0,0,19862.0,98838.19160389496,CSNK2A2
3656,KEGG_2019_Human,Wnt signaling pathway,1/158,0.0078999117225733,0.0078999117225733,0,0,19842.0,96053.2110949472,CSNK2A2
3657,KEGG_2019_Human,Bacterial invasion of epithelial cells,1/74,0.0036999446830449,0.0112498919790339,0,0,19926.0,111574.38983110404,BCAR1
3658,KEGG_2019_Human,Leukocyte transendothelial migration,1/112,0.0055999282120529,0.0112498919790339,0,0,19888.0,103119.30984392198,BCAR1
3659,KEGG_2019_Human,Chemokine signaling pathway,1/190,0.0094999017791995,0.0112498919790339,0,0,19810.0,92244.74636351672,BCAR1
3660,KEGG_2019_Human,Focal adhesion,1/199,0.0099498991610159,0.0112498919790339,0,0,19801.0,91286.4288690606,BCAR1
3661,KEGG_2019_Human,Rap1 signaling pathway,1/206,0.010299897173561,0.0112498919790339,0,0,19794.0,90569.849337325,BCAR1
3662,KEGG_2019_Human,Regulation of actin cytoskeleton,1/214,0.0106998949514067,0.0112498919790339,0,0,19786.0,89779.39753374986,BCAR1
3663,KEGG_2019_Human,Human cytomegalovirus infection,1/225,0.0112498919790339,0.0112498919790339,0,0,19775.0,88738.27077557483,BCAR1
3664,KEGG_2019_Human,Proteasome,1/45,0.0022499601197094,0.0044999202394188,0,0,19955.0,121662.49782449217,ADRM1
3665,KEGG_2019_Human,Epstein-Barr virus infection,1/201,0.0100498985877989,0.0100498985877989,0,0,19799.0,91079.21596609056,ADRM1
3666,KEGG_2019_Human,Dopaminergic synapse,1/131,0.0065499210316603,0.0130998420633206,0,0,19869.0,99907.33811343512,DRD4
3667,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,DRD4
3668,KEGG_2019_Human,Complement and coagulation cascades,1/79,0.0039499423167337,0.0039499423167337,0,0,19921.0,110243.89578070649,F12
3669,KEGG_2019_Human,RNA transport,1/165,0.0082499094553477,0.0082499094553477,0,0,19835.0,95159.46482222488,NUP107
3670,KEGG_2019_Human,Endocytosis,1/244,0.0121998870519305,0.0121998870519305,0,0,19756.0,87051.4275316661,ARFGAP2
3671,KEGG_2019_Human,NF-kappa B signaling pathway,1/95,0.0047499351803394,0.0047499351803394,0,0,19905.0,106484.27183626965,CARD14
3672,KEGG_2019_Human,ECM-receptor interaction,1/82,0.004099940929819,0.0112498433599406,0,0,19918.0,109484.9180722932,COL6A5
3673,KEGG_2019_Human,Protein digestion and absorption,1/90,0.0044999373439762,0.0112498433599406,0,0,19910.0,107587.50385474482,COL6A5
3674,KEGG_2019_Human,Focal adhesion,1/199,0.0099498991610159,0.0165831652683599,0,0,19801.0,91286.4288690606,COL6A5
3675,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0176998626413668,0,0,19670.0,80733.60565076157,COL6A5
3676,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0176998626413668,0,0,19646.0,79255.8617626126,COL6A5
3677,KEGG_2019_Human,Complement and coagulation cascades,1/79,0.0039499423167337,0.0039499423167337,0,0,19921.0,110243.89578070649,F11
3678,KEGG_2019_Human,Leukocyte transendothelial migration,1/112,0.0055999282120529,0.0084999078692823,0,0,19888.0,103119.30984392198,CLDN20
3679,KEGG_2019_Human,Cell adhesion molecules (CAMs),1/145,0.0072499160871101,0.0084999078692823,0,0,19855.0,97820.92670675044,CLDN20
3680,KEGG_2019_Human,Hepatitis C,1/155,0.0077499127120574,0.0084999078692823,0,0,19845.0,96448.16254952336,CLDN20
3681,KEGG_2019_Human,Tight junction,1/170,0.0084999078692823,0.0084999078692823,0,0,19830.0,94543.49009679438,CLDN20
3682,KEGG_2019_Human,Central carbon metabolism in cancer,1/65,0.003249949134407,0.0044999373439762,0,0,19935.0,114209.92613860144,SLC1A5
3683,KEGG_2019_Human,Protein digestion and absorption,1/90,0.0044999373439762,0.0044999373439762,0,0,19910.0,107587.50385474482,SLC1A5
3684,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,CFP
3685,KEGG_2019_Human,Gastric acid secretion,1/75,0.0037499442041125,0.0106998949514067,0,0,19925.0,111301.33528642564,MYLK
3686,KEGG_2019_Human,Platelet activation,1/124,0.0061999236097501,0.0106998949514067,0,0,19876.0,101034.04709010696,MYLK
3687,KEGG_2019_Human,Vascular smooth muscle contraction,1/132,0.0065999206698993,0.0106998949514067,0,0,19868.0,99751.22090491928,MYLK
3688,KEGG_2019_Human,Apelin signaling pathway,1/137,0.0068499188797651,0.0106998949514067,0,0,19863.0,98987.62735269018,MYLK
3689,KEGG_2019_Human,Oxytocin signaling pathway,1/153,0.0076499133771537,0.0106998949514067,0,0,19847.0,96715.6407630817,MYLK
3690,KEGG_2019_Human,cGMP-PKG signaling pathway,1/166,0.0082999091363732,0.0106998949514067,0,0,19834.0,95034.82345515196,MYLK
3691,KEGG_2019_Human,Calcium signaling pathway,1/188,0.009399902370135,0.0106998949514067,0,0,19812.0,92463.712994847,MYLK
3692,KEGG_2019_Human,Focal adhesion,1/199,0.0099498991610159,0.0106998949514067,0,0,19801.0,91286.4288690606,MYLK
3693,KEGG_2019_Human,Regulation of actin cytoskeleton,1/214,0.0106998949514067,0.0106998949514067,0,0,19786.0,89779.39753374986,MYLK
3694,KEGG_2019_Human,Measles,1/138,0.0068999185254481,0.0120598783053587,0,0,19862.0,98838.19160389496,OAS3
3695,KEGG_2019_Human,Hepatitis C,1/155,0.0077499127120574,0.0120598783053587,0,0,19845.0,96448.16254952336,OAS3
3696,KEGG_2019_Human,Influenza A,1/171,0.0085499075557634,0.0120598783053587,0,0,19829.0,94422.42241345016,OAS3
3697,KEGG_2019_Human,NOD-like receptor signaling pathway,1/178,0.0088999053857096,0.0120598783053587,0,0,19822.0,93593.82745769851,OAS3
3698,KEGG_2019_Human,Epstein-Barr virus infection,1/201,0.0100498985877989,0.0120598783053587,0,0,19799.0,91079.21596609056,OAS3
3699,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,OAS3
3700,KEGG_2019_Human,Hippo signaling pathway,1/160,0.0079999110688441,0.0079999110688441,0,0,19840.0,95793.96509856998,DCHS1
3701,KEGG_2019_Human,Bladder cancer,1/41,0.0020499625466866,0.0122210161997829,0,0,19959.0,123544.88783416104,EGFR
3702,KEGG_2019_Human,Endometrial cancer,1/58,0.0028999527887707,0.0122210161997829,0,0,19942.0,116522.31890946148,EGFR
3703,KEGG_2019_Human,Central carbon metabolism in cancer,1/65,0.003249949134407,0.0122210161997829,0,0,19935.0,114209.92613860144,EGFR
3704,KEGG_2019_Human,Non-small cell lung cancer,1/66,0.003299948626608,0.0122210161997829,0,0,19934.0,113899.85357353876,EGFR
3705,KEGG_2019_Human,Epithelial cell signaling in Helicobacter pylori infection,1/68,0.0033999476216189,0.0122210161997829,0,0,19932.0,113293.39338050144,EGFR
3706,KEGG_2019_Human,Adherens junction,1/72,0.0035999456502131,0.0122210161997829,0,0,19928.0,112131.59838572376,EGFR
3707,KEGG_2019_Human,Melanoma,1/72,0.0035999456502131,0.0122210161997829,0,0,19928.0,112131.59838572376,EGFR
3708,KEGG_2019_Human,Pancreatic cancer,1/75,0.0037499442041125,0.0122210161997829,0,0,19925.0,111301.33528642564,EGFR
3709,KEGG_2019_Human,Glioma,1/75,0.0037499442041125,0.0122210161997829,0,0,19925.0,111301.33528642564,EGFR
3710,KEGG_2019_Human,ErbB signaling pathway,1/85,0.004249939567045,0.0122210161997829,0,0,19915.0,108752.83801948265,EGFR
3711,KEGG_2019_Human,Colorectal cancer,1/86,0.0042999391173866,0.0122210161997829,0,0,19914.0,108514.46102290176,EGFR
3712,KEGG_2019_Human,Gap junction,1/88,0.0043999382262822,0.0122210161997829,0,0,19912.0,108045.79305232369,EGFR
3713,KEGG_2019_Human,GnRH signaling pathway,1/93,0.0046499360391879,0.0122210161997829,0,0,19907.0,106918.54242106884,EGFR
3714,KEGG_2019_Human,Prostate cancer,1/97,0.0048499343304706,0.0122210161997829,0,0,19903.0,106058.9096435903,EGFR
3715,KEGG_2019_Human,Choline metabolism in cancer,1/99,0.0049499334884068,0.0122210161997829,0,0,19901.0,105642.09305076736,EGFR
3716,KEGG_2019_Human,HIF-1 signaling pathway,1/100,0.0049999330710556,0.0122210161997829,0,0,19900.0,105436.78197328727,EGFR
3717,KEGG_2019_Human,"Parathyroid hormone synthesis, secretion and action",1/106,0.0052999306076525,0.0122210161997829,0,0,19894.0,104245.78450366124,EGFR
3718,KEGG_2019_Human,Relaxin signaling pathway,1/130,0.0064999213952527,0.0122210161997829,0,0,19870.0,100064.62842845908,EGFR
3719,KEGG_2019_Human,FoxO signaling pathway,1/132,0.0065999206698993,0.0122210161997829,0,0,19868.0,99751.22090491928,EGFR
3720,KEGG_2019_Human,Estrogen signaling pathway,1/137,0.0068499188797651,0.0122210161997829,0,0,19863.0,98987.62735269018,EGFR
3721,KEGG_2019_Human,Breast cancer,1/147,0.0073499154017982,0.0122210161997829,0,0,19853.0,97539.10874372096,EGFR
3722,KEGG_2019_Human,Phospholipase D signaling pathway,1/148,0.007399915061391,0.0122210161997829,0,0,19852.0,97399.60470052566,EGFR
3723,KEGG_2019_Human,Gastric cancer,1/149,0.0074499147221605,0.0122210161997829,0,0,19851.0,97261.02051561224,EGFR
3724,KEGG_2019_Human,Oxytocin signaling pathway,1/153,0.0076499133771537,0.0122210161997829,0,0,19847.0,96715.6407630817,EGFR
3725,KEGG_2019_Human,Cushing syndrome,1/155,0.0077499127120574,0.0122210161997829,0,0,19845.0,96448.16254952336,EGFR
3726,KEGG_2019_Human,Hepatitis C,1/155,0.0077499127120574,0.0122210161997829,0,0,19845.0,96448.16254952336,EGFR
3727,KEGG_2019_Human,JAK-STAT signaling pathway,1/162,0.0080999104202618,0.0122998639715087,0,0,19838.0,95537.86936302872,EGFR
3728,KEGG_2019_Human,Hepatocellular carcinoma,1/168,0.0083999085011095,0.0122998660194818,0,0,19832.0,94787.72752807094,EGFR
3729,KEGG_2019_Human,Calcium signaling pathway,1/188,0.009399902370135,0.013196743253625,0,0,19812.0,92463.712994847,EGFR
3730,KEGG_2019_Human,Focal adhesion,1/199,0.0099498991610159,0.013196743253625,0,0,19801.0,91286.4288690606,EGFR
3731,KEGG_2019_Human,Proteoglycans in cancer,1/201,0.0100498985877989,0.013196743253625,0,0,19799.0,91079.21596609056,EGFR
3732,KEGG_2019_Human,Rap1 signaling pathway,1/206,0.010299897173561,0.013196743253625,0,0,19794.0,90569.849337325,EGFR
3733,KEGG_2019_Human,Regulation of actin cytoskeleton,1/214,0.0106998949514067,0.0132938088790205,0,0,19786.0,89779.39753374986,EGFR
3734,KEGG_2019_Human,Human cytomegalovirus infection,1/225,0.0112498919790339,0.0135660462100114,0,0,19775.0,88738.27077557483,EGFR
3735,KEGG_2019_Human,Ras signaling pathway,1/232,0.0115998901349604,0.013588442729525,0,0,19768.0,88101.22480150245,EGFR
3736,KEGG_2019_Human,Endocytosis,1/244,0.0121998870519305,0.0138943158091431,0,0,19756.0,87051.4275316661,EGFR
3737,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0161301272828712,0,0,19705.0,83086.53988020132,EGFR
3738,KEGG_2019_Human,MicroRNAs in cancer,1/299,0.0149498740670514,0.0161301272828712,0,0,19701.0,82804.33538735632,EGFR
3739,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0173460145081421,0,0,19670.0,80733.60565076157,EGFR
3740,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.018142359207401,0,0,19646.0,79255.8617626126,EGFR
3741,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,EGFR
3742,KEGG_2019_Human,Human T-cell leukemia virus 1 infection,1/219,0.0109498935894162,0.0109498935894162,0,0,19781.0,89299.85161916987,CRTC1
3743,KEGG_2019_Human,Axon guidance,1/181,0.0090499044707863,0.0090499044707863,0,0,19819.0,93248.41634586031,SRGAP3
3744,KEGG_2019_Human,Fc gamma R-mediated phagocytosis,1/91,0.0045499369072032,0.0090998738144064,0,0,19909.0,107362.10783923086,ASAP1
3745,KEGG_2019_Human,Endocytosis,1/244,0.0121998870519305,0.0121998870519305,0,0,19756.0,87051.4275316661,ASAP1
3746,KEGG_2019_Human,Salmonella infection,1/86,0.0042999391173866,0.0106998949514067,0,0,19914.0,108514.46102290176,MYH14
3747,KEGG_2019_Human,Tight junction,1/170,0.0084999078692823,0.0106998949514067,0,0,19830.0,94543.49009679438,MYH14
3748,KEGG_2019_Human,Regulation of actin cytoskeleton,1/214,0.0106998949514067,0.0106998949514067,0,0,19786.0,89779.39753374986,MYH14
3749,KEGG_2019_Human,Pathogenic Escherichia coli infection,1/55,0.0027499544131125,0.0063699116700844,0,0,19945.0,117599.1294878737,ARPC4
3750,KEGG_2019_Human,Shigellosis,1/65,0.003249949134407,0.0063699116700844,0,0,19935.0,114209.92613860144,ARPC4
3751,KEGG_2019_Human,Bacterial invasion of epithelial cells,1/74,0.0036999446830449,0.0063699116700844,0,0,19926.0,111574.38983110404,ARPC4
3752,KEGG_2019_Human,Salmonella infection,1/86,0.0042999391173866,0.0063699116700844,0,0,19914.0,108514.46102290176,ARPC4
3753,KEGG_2019_Human,Fc gamma R-mediated phagocytosis,1/91,0.0045499369072032,0.0063699116700844,0,0,19909.0,107362.10783923086,ARPC4
3754,KEGG_2019_Human,Regulation of actin cytoskeleton,1/214,0.0106998949514067,0.0121998870519305,0,0,19786.0,89779.39753374986,ARPC4
3755,KEGG_2019_Human,Endocytosis,1/244,0.0121998870519305,0.0121998870519305,0,0,19756.0,87051.4275316661,ARPC4
3756,KEGG_2019_Human,Amyotrophic lateral sclerosis (ALS),1/51,0.0025499566390179,0.0025499566390179,0,0,19949.0,119129.0228601236,TOMM40
3757,KEGG_2019_Human,Cell cycle,1/124,0.0061999236097501,0.0061999236097501,0,0,19876.0,101034.04709010696,CDC14B
3758,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,UCN
3759,KEGG_2019_Human,Biosynthesis of unsaturated fatty acids,1/27,0.0013499718942362,0.0040499156827088,0,0,19973.0,131975.02298599784,SCD5
3760,KEGG_2019_Human,PPAR signaling pathway,1/74,0.0036999446830449,0.0055499170245674,0,0,19926.0,111574.38983110404,SCD5
3761,KEGG_2019_Human,AMPK signaling pathway,1/120,0.0059999251180858,0.0059999251180858,0,0,19880.0,101706.2448082016,SCD5
3762,KEGG_2019_Human,Hedgehog signaling pathway,1/47,0.0023499589392381,0.0094498504796483,0,0,19953.0,120782.64067395544,SHH
3763,KEGG_2019_Human,Basal cell carcinoma,1/63,0.0031499501598827,0.0094498504796483,0,0,19937.0,114844.46974572667,SHH
3764,KEGG_2019_Human,Gastric cancer,1/149,0.0074499147221605,0.0120598783053587,0,0,19851.0,97261.02051561224,SHH
3765,KEGG_2019_Human,Axon guidance,1/181,0.0090499044707863,0.0120598783053587,0,0,19819.0,93248.41634586031,SHH
3766,KEGG_2019_Human,Proteoglycans in cancer,1/201,0.0100498985877989,0.0120598783053587,0,0,19799.0,91079.21596609056,SHH
3767,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,SHH
3768,KEGG_2019_Human,Tyrosine metabolism,1/36,0.0017999657178272,0.0017999657178272,0,0,19964.0,126172.23364250171,GSTZ1
3769,KEGG_2019_Human,Vitamin digestion and absorption,1/24,0.0011999741185782,0.0011999741185782,0,0,19976.0,134347.69487847842,SLC19A1
3770,KEGG_2019_Human,Cysteine and methionine metabolism,1/47,0.0023499589392381,0.0046999178784763,0,0,19953.0,120782.64067395544,DNMT1
3771,KEGG_2019_Human,MicroRNAs in cancer,1/299,0.0149498740670514,0.0149498740670514,0,0,19701.0,82804.33538735632,DNMT1
3772,KEGG_2019_Human,Cell adhesion molecules (CAMs),1/145,0.0072499160871101,0.0072499160871101,0,0,19855.0,97820.92670675044,GLG1
3773,KEGG_2019_Human,Fatty acid degradation,1/44,0.0021999607179423,0.0069999126377668,0,0,19956.0,122117.06559109331,CPT1A
3774,KEGG_2019_Human,Adipocytokine signaling pathway,1/69,0.003449947123837,0.0069999126377668,0,0,19931.0,112996.7391397682,CPT1A
3775,KEGG_2019_Human,PPAR signaling pathway,1/74,0.0036999446830449,0.0069999126377668,0,0,19926.0,111574.38983110404,CPT1A
3776,KEGG_2019_Human,Glucagon signaling pathway,1/103,0.0051499318302617,0.0069999126377668,0,0,19897.0,104832.7525292024,CPT1A
3777,KEGG_2019_Human,Insulin resistance,1/108,0.0053999298011749,0.0069999126377668,0,0,19892.0,103863.47861844616,CPT1A
3778,KEGG_2019_Human,AMPK signaling pathway,1/120,0.0059999251180858,0.0069999126377668,0,0,19880.0,101706.2448082016,CPT1A
3779,KEGG_2019_Human,Thermogenesis,1/231,0.0115498903940656,0.0115498903940656,0,0,19769.0,88191.07730937863,CPT1A
3780,KEGG_2019_Human,Homologous recombination,1/41,0.0020499625466866,0.0040999250933733,0,0,19959.0,123544.88783416104,NBN
3781,KEGG_2019_Human,Cellular senescence,1/160,0.0079999110688441,0.0079999110688441,0,0,19840.0,95793.96509856998,NBN
3782,KEGG_2019_Human,Sphingolipid metabolism,1/47,0.0023499589392381,0.0046999178784763,0,0,19953.0,120782.64067395544,SGPP1
3783,KEGG_2019_Human,Sphingolipid signaling pathway,1/119,0.0059499254985137,0.0059499254985137,0,0,19881.0,101877.73080211312,SGPP1
3784,KEGG_2019_Human,Melanoma,1/72,0.0035999456502131,0.0173998352024406,0,0,19928.0,112131.59838572376,FGF8
3785,KEGG_2019_Human,Breast cancer,1/147,0.0073499154017982,0.0173998352024406,0,0,19853.0,97539.10874372096,FGF8
3786,KEGG_2019_Human,Gastric cancer,1/149,0.0074499147221605,0.0173998352024406,0,0,19851.0,97261.02051561224,FGF8
3787,KEGG_2019_Human,Rap1 signaling pathway,1/206,0.010299897173561,0.0173998352024406,0,0,19794.0,90569.849337325,FGF8
3788,KEGG_2019_Human,Regulation of actin cytoskeleton,1/214,0.0106998949514067,0.0173998352024406,0,0,19786.0,89779.39753374986,FGF8
3789,KEGG_2019_Human,Ras signaling pathway,1/232,0.0115998901349604,0.0173998352024406,0,0,19768.0,88101.22480150245,FGF8
3790,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.018964124940408,0,0,19705.0,83086.53988020132,FGF8
3791,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0199123454715377,0,0,19646.0,79255.8617626126,FGF8
3792,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,FGF8
3793,KEGG_2019_Human,Ribosome biogenesis in eukaryotes,1/101,0.0050499326546803,0.0050499326546803,0,0,19899.0,105233.48101229242,DKC1
3794,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR2C1
3795,KEGG_2019_Human,Ubiquitin mediated proteolysis,1/137,0.0068499188797651,0.0105998955026255,0,0,19863.0,98987.62735269018,CUL5
3796,KEGG_2019_Human,Human immunodeficiency virus 1 infection,1/212,0.0105998955026255,0.0105998955026255,0,0,19788.0,89974.27756224656,CUL5
3797,KEGG_2019_Human,Regulation of actin cytoskeleton,1/214,0.0106998949514067,0.0106998949514067,0,0,19786.0,89779.39753374986,SPATA13
3798,KEGG_2019_Human,Gastric acid secretion,1/75,0.0037499442041125,0.0037499442041125,0,0,19925.0,111301.33528642564,KCNJ15
3799,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR4K15
3800,KEGG_2019_Human,Endometrial cancer,1/58,0.0028999527887707,0.0117598719015533,0,0,19942.0,116522.31890946148,APC2
3801,KEGG_2019_Human,Basal cell carcinoma,1/63,0.0031499501598827,0.0117598719015533,0,0,19937.0,114844.46974572667,APC2
3802,KEGG_2019_Human,Colorectal cancer,1/86,0.0042999391173866,0.0117598719015533,0,0,19914.0,108514.46102290176,APC2
3803,KEGG_2019_Human,Signaling pathways regulating pluripotency of stem cells,1/139,0.006949918172816,0.0117598719015533,0,0,19861.0,98689.81333375497,APC2
3804,KEGG_2019_Human,Breast cancer,1/147,0.0073499154017982,0.0117598719015533,0,0,19853.0,97539.10874372096,APC2
3805,KEGG_2019_Human,Gastric cancer,1/149,0.0074499147221605,0.0117598719015533,0,0,19851.0,97261.02051561224,APC2
3806,KEGG_2019_Human,Cushing syndrome,1/155,0.0077499127120574,0.0117598719015533,0,0,19845.0,96448.16254952336,APC2
3807,KEGG_2019_Human,Wnt signaling pathway,1/158,0.0078999117225733,0.0117598719015533,0,0,19842.0,96053.2110949472,APC2
3808,KEGG_2019_Human,Hippo signaling pathway,1/160,0.0079999110688441,0.0117598719015533,0,0,19840.0,95793.96509856998,APC2
3809,KEGG_2019_Human,Hepatocellular carcinoma,1/168,0.0083999085011095,0.0117598719015533,0,0,19832.0,94787.72752807094,APC2
3810,KEGG_2019_Human,Regulation of actin cytoskeleton,1/214,0.0106998949514067,0.0136180481199722,0,0,19786.0,89779.39753374986,APC2
3811,KEGG_2019_Human,MicroRNAs in cancer,1/299,0.0149498740670514,0.0174415197448933,0,0,19701.0,82804.33538735632,APC2
3812,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.017769088032731,0,0,19670.0,80733.60565076157,APC2
3813,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,APC2
3814,KEGG_2019_Human,Protein export,1/23,0.0011499748819949,0.0011499748819949,0,0,19977.0,135204.63922267244,SRP19
3815,KEGG_2019_Human,Mismatch repair,1/23,0.0011499748819949,0.0022999497639899,0,0,19977.0,135204.63922267244,PMS2
3816,KEGG_2019_Human,Fanconi anemia pathway,1/54,0.0026999549628563,0.0026999549628563,0,0,19946.0,117971.01964061816,PMS2
3817,KEGG_2019_Human,Spliceosome,1/134,0.0066999199497742,0.0066999199497742,0,0,19866.0,99442.43560916925,PUF60
3818,KEGG_2019_Human,JAK-STAT signaling pathway,1/162,0.0080999104202618,0.0121998870519305,0,0,19838.0,95537.86936302872,STAM
3819,KEGG_2019_Human,Endocytosis,1/244,0.0121998870519305,0.0121998870519305,0,0,19756.0,87051.4275316661,STAM
3820,KEGG_2019_Human,Endocytosis,1/244,0.0121998870519305,0.0121998870519305,0,0,19756.0,87051.4275316661,IQSEC3
3821,KEGG_2019_Human,Hedgehog signaling pathway,1/47,0.0023499589392381,0.0089998746879525,0,0,19953.0,120782.64067395544,SMURF2
3822,KEGG_2019_Human,TGF-beta signaling pathway,1/90,0.0044999373439762,0.0089998746879525,0,0,19910.0,107587.50385474482,SMURF2
3823,KEGG_2019_Human,Ubiquitin mediated proteolysis,1/137,0.0068499188797651,0.0091332251730202,0,0,19863.0,98987.62735269018,SMURF2
3824,KEGG_2019_Human,Endocytosis,1/244,0.0121998870519305,0.0121998870519305,0,0,19756.0,87051.4275316661,SMURF2
3825,KEGG_2019_Human,Ferroptosis,1/40,0.0019999631680592,0.0107221121080662,0,0,19960.0,124043.94523066044,VDAC2
3826,KEGG_2019_Human,Cholesterol metabolism,1/50,0.0024999572069037,0.0107221121080662,0,0,19950.0,119530.05920663515,VDAC2
3827,KEGG_2019_Human,Parkinson disease,1/142,0.0070999171242726,0.0107221121080662,0,0,19858.0,98250.87390500787,VDAC2
3828,KEGG_2019_Human,Cellular senescence,1/160,0.0079999110688441,0.0107221121080662,0,0,19840.0,95793.96509856998,VDAC2
3829,KEGG_2019_Human,Necroptosis,1/162,0.0080999104202618,0.0107221121080662,0,0,19838.0,95537.86936302872,VDAC2
3830,KEGG_2019_Human,cGMP-PKG signaling pathway,1/166,0.0082999091363732,0.0107221121080662,0,0,19834.0,95034.82345515196,VDAC2
3831,KEGG_2019_Human,NOD-like receptor signaling pathway,1/178,0.0088999053857096,0.0107221121080662,0,0,19822.0,93593.82745769851,VDAC2
3832,KEGG_2019_Human,Calcium signaling pathway,1/188,0.009399902370135,0.0107221121080662,0,0,19812.0,92463.712994847,VDAC2
3833,KEGG_2019_Human,Huntington disease,1/193,0.0096499008972596,0.0107221121080662,0,0,19807.0,91920.47679471428,VDAC2
3834,KEGG_2019_Human,Human T-cell leukemia virus 1 infection,1/219,0.0109498935894162,0.0109498935894162,0,0,19781.0,89299.85161916987,VDAC2
3835,KEGG_2019_Human,Transcriptional misregulation in cancer,1/186,0.0092999029651357,0.0092999029651357,0,0,19814.0,92684.96451050608,ASPSCR1
3836,KEGG_2019_Human,Osteoclast differentiation,1/127,0.0063499224962247,0.0063499224962247,0,0,19873.0,100543.72072014232,TREM2
3837,KEGG_2019_Human,Cortisol synthesis and secretion,1/65,0.003249949134407,0.003249949134407,0,0,19935.0,114209.92613860144,NR0B1
3838,KEGG_2019_Human,Thyroid hormone signaling pathway,1/116,0.0057999266512085,0.0057999266512085,0,0,19884.0,102400.8105961506,MED13
3839,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0147498749536506,0,0,19705.0,83086.53988020132,TAOK3
3840,KEGG_2019_Human,Glutamatergic synapse,1/114,0.005699927427839,0.011399854855678,0,0,19886.0,102756.96431429044,GRIK4
3841,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,GRIK4
3842,KEGG_2019_Human,Endocrine and other factor-regulated calcium reabsorption,1/48,0.0023999583567988,0.0064999046400777,0,0,19952.0,120356.5272753826,DNM3
3843,KEGG_2019_Human,Bacterial invasion of epithelial cells,1/74,0.0036999446830449,0.0064999046400777,0,0,19926.0,111574.38983110404,DNM3
3844,KEGG_2019_Human,Synaptic vesicle cycle,1/78,0.0038999427840466,0.0064999046400777,0,0,19922.0,110503.2180492851,DNM3
3845,KEGG_2019_Human,Phospholipase D signaling pathway,1/148,0.007399915061391,0.0092498938267387,0,0,19852.0,97399.60470052566,DNM3
3846,KEGG_2019_Human,Endocytosis,1/244,0.0121998870519305,0.0121998870519305,0,0,19756.0,87051.4275316661,DNM3
3847,KEGG_2019_Human,Inflammatory bowel disease (IBD),1/65,0.003249949134407,0.0106998604053851,0,0,19935.0,114209.92613860144,IL12RB1
3848,KEGG_2019_Human,Th1 and Th2 cell differentiation,1/92,0.0045999364719865,0.0106998604053851,0,0,19908.0,107139.13814408927,IL12RB1
3849,KEGG_2019_Human,Th17 cell differentiation,1/107,0.0053499302026925,0.0106998604053851,0,0,19893.0,104053.753408911,IL12RB1
3850,KEGG_2019_Human,JAK-STAT signaling pathway,1/162,0.0080999104202618,0.0121498656303927,0,0,19838.0,95537.86936302872,IL12RB1
3851,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0176398502111682,0,0,19706.0,83157.67014793828,IL12RB1
3852,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,IL12RB1
3853,KEGG_2019_Human,Lysine degradation,1/59,0.0029499522555206,0.0029499522555206,0,0,19941.0,116175.59385530632,PHYKPL
3854,KEGG_2019_Human,Arachidonic acid metabolism,1/63,0.0031499501598827,0.0031499501598827,0,0,19937.0,114844.46974572667,PTGIS
3855,KEGG_2019_Human,Tight junction,1/170,0.0084999078692823,0.0084999078692823,0,0,19830.0,94543.49009679438,MYH2
3856,KEGG_2019_Human,Epithelial cell signaling in Helicobacter pylori infection,1/68,0.0033999476216189,0.0067998952432378,0,0,19932.0,113293.39338050144,IGSF5
3857,KEGG_2019_Human,Tight junction,1/170,0.0084999078692823,0.0084999078692823,0,0,19830.0,94543.49009679438,IGSF5
3858,KEGG_2019_Human,Histidine metabolism,1/23,0.0011499748819949,0.0024499577795033,0,0,19977.0,135204.63922267244,AOC1
3859,KEGG_2019_Human,Tryptophan metabolism,1/42,0.0020999619311272,0.0024499577795033,0,0,19958.0,123057.75613441122,AOC1
3860,KEGG_2019_Human,Arginine and proline metabolism,1/49,0.0024499577795033,0.0024499577795033,0,0,19951.0,119939.1172087114,AOC1
3861,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR51V1
3862,KEGG_2019_Human,Regulation of lipolysis in adipocytes,1/55,0.0027499544131125,0.010412369622399,0,0,19945.0,117599.1294878737,ADORA1
3863,KEGG_2019_Human,Renin secretion,1/69,0.003449947123837,0.010412369622399,0,0,19931.0,112996.7391397682,ADORA1
3864,KEGG_2019_Human,Morphine addiction,1/91,0.0045499369072032,0.010412369622399,0,0,19909.0,107362.10783923086,ADORA1
3865,KEGG_2019_Human,Sphingolipid signaling pathway,1/119,0.0059499254985137,0.010412369622399,0,0,19881.0,101877.73080211312,ADORA1
3866,KEGG_2019_Human,cGMP-PKG signaling pathway,1/166,0.0082999091363732,0.0116198727909225,0,0,19834.0,95034.82345515196,ADORA1
3867,KEGG_2019_Human,cAMP signaling pathway,1/212,0.0105998955026255,0.0123665447530631,0,0,19788.0,89974.27756224656,ADORA1
3868,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,ADORA1
3869,KEGG_2019_Human,Axon guidance,1/181,0.0090499044707863,0.0090499044707863,0,0,19819.0,93248.41634586031,PLXNA3
3870,KEGG_2019_Human,Melanoma,1/72,0.0035999456502131,0.016571271621372,0,0,19928.0,112131.59838572376,FGF23
3871,KEGG_2019_Human,"Parathyroid hormone synthesis, secretion and action",1/106,0.0052999306076525,0.016571271621372,0,0,19894.0,104245.78450366124,FGF23
3872,KEGG_2019_Human,Breast cancer,1/147,0.0073499154017982,0.016571271621372,0,0,19853.0,97539.10874372096,FGF23
3873,KEGG_2019_Human,Gastric cancer,1/149,0.0074499147221605,0.016571271621372,0,0,19851.0,97261.02051561224,FGF23
3874,KEGG_2019_Human,Rap1 signaling pathway,1/206,0.010299897173561,0.016571271621372,0,0,19794.0,90569.849337325,FGF23
3875,KEGG_2019_Human,Regulation of actin cytoskeleton,1/214,0.0106998949514067,0.016571271621372,0,0,19786.0,89779.39753374986,FGF23
3876,KEGG_2019_Human,Ras signaling pathway,1/232,0.0115998901349604,0.016571271621372,0,0,19768.0,88101.22480150245,FGF23
3877,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0184373436920633,0,0,19705.0,83086.53988020132,FGF23
3878,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0196665140459632,0,0,19646.0,79255.8617626126,FGF23
3879,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,FGF23
3880,KEGG_2019_Human,Thyroid hormone signaling pathway,1/116,0.0057999266512085,0.0057999266512085,0,0,19884.0,102400.8105961506,MED16
3881,KEGG_2019_Human,ECM-receptor interaction,1/82,0.004099940929819,0.0112498433599406,0,0,19918.0,109484.9180722932,COL6A6
3882,KEGG_2019_Human,Protein digestion and absorption,1/90,0.0044999373439762,0.0112498433599406,0,0,19910.0,107587.50385474482,COL6A6
3883,KEGG_2019_Human,Focal adhesion,1/199,0.0099498991610159,0.0165831652683599,0,0,19801.0,91286.4288690606,COL6A6
3884,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0176998626413668,0,0,19670.0,80733.60565076157,COL6A6
3885,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0176998626413668,0,0,19646.0,79255.8617626126,COL6A6
3886,KEGG_2019_Human,Lysosome,1/123,0.0061499239842961,0.0061499239842961,0,0,19877.0,101200.07933676826,PSAP
3887,KEGG_2019_Human,SNARE interactions in vesicular transport,1/34,0.0016999670339032,0.0016999670339032,0,0,19966.0,127326.1054203148,VTI1A
3888,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR5D18
3889,KEGG_2019_Human,Complement and coagulation cascades,1/79,0.0039499423167337,0.0039499423167337,0,0,19921.0,110243.89578070649,F13B
3890,KEGG_2019_Human,Long-term depression,1/60,0.002999951725986,0.0082499008373742,0,0,19940.0,115834.63209072244,GUCY1A1
3891,KEGG_2019_Human,Renin secretion,1/69,0.003449947123837,0.0082499008373742,0,0,19931.0,112996.7391397682,GUCY1A1
3892,KEGG_2019_Human,Gap junction,1/88,0.0043999382262822,0.0082499008373742,0,0,19912.0,108045.79305232369,GUCY1A1
3893,KEGG_2019_Human,Salivary secretion,1/90,0.0044999373439762,0.0082499008373742,0,0,19910.0,107587.50385474482,GUCY1A1
3894,KEGG_2019_Human,Circadian entrainment,1/97,0.0048499343304706,0.0082499008373742,0,0,19903.0,106058.9096435903,GUCY1A1
3895,KEGG_2019_Human,Platelet activation,1/124,0.0061999236097501,0.0082499008373742,0,0,19876.0,101034.04709010696,GUCY1A1
3896,KEGG_2019_Human,Purine metabolism,1/129,0.006449921761047,0.0082499008373742,0,0,19871.0,100223.109907462,GUCY1A1
3897,KEGG_2019_Human,Vascular smooth muscle contraction,1/132,0.0065999206698993,0.0082499008373742,0,0,19868.0,99751.22090491928,GUCY1A1
3898,KEGG_2019_Human,Oxytocin signaling pathway,1/153,0.0076499133771537,0.0082999091363732,0,0,19847.0,96715.6407630817,GUCY1A1
3899,KEGG_2019_Human,cGMP-PKG signaling pathway,1/166,0.0082999091363732,0.0082999091363732,0,0,19834.0,95034.82345515196,GUCY1A1
3900,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR9G1
3901,KEGG_2019_Human,Transcriptional misregulation in cancer,1/186,0.0092999029651357,0.0092999029651357,0,0,19814.0,92684.96451050608,FLI1
3902,KEGG_2019_Human,NOD-like receptor signaling pathway,1/178,0.0088999053857096,0.0088999053857096,0,0,19822.0,93593.82745769851,NLRP1
3903,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR8K3
3904,KEGG_2019_Human,Amyotrophic lateral sclerosis (ALS),1/51,0.0025499566390179,0.0101089718877324,0,0,19949.0,119129.0228601236,MAPK13
3905,KEGG_2019_Human,VEGF signaling pathway,1/59,0.0029499522555206,0.0101089718877324,0,0,19941.0,116175.59385530632,MAPK13
3906,KEGG_2019_Human,Shigellosis,1/65,0.003249949134407,0.0101089718877324,0,0,19935.0,114209.92613860144,MAPK13
3907,KEGG_2019_Human,Epithelial cell signaling in Helicobacter pylori infection,1/68,0.0033999476216189,0.0101089718877324,0,0,19932.0,113293.39338050144,MAPK13
3908,KEGG_2019_Human,Fc epsilon RI signaling pathway,1/68,0.0033999476216189,0.0101089718877324,0,0,19932.0,113293.39338050144,MAPK13
3909,KEGG_2019_Human,Prolactin signaling pathway,1/70,0.0034999466296654,0.0101089718877324,0,0,19930.0,112704.30065625212,MAPK13
3910,KEGG_2019_Human,RIG-I-like receptor signaling pathway,1/70,0.0034999466296654,0.0101089718877324,0,0,19930.0,112704.30065625212,MAPK13
3911,KEGG_2019_Human,Leishmaniasis,1/74,0.0036999446830449,0.0101089718877324,0,0,19926.0,111574.38983110404,MAPK13
3912,KEGG_2019_Human,Pertussis,1/76,0.0037999437281752,0.0101089718877324,0,0,19924.0,111031.8499691117,MAPK13
3913,KEGG_2019_Human,Salmonella infection,1/86,0.0042999391173866,0.0101089718877324,0,0,19914.0,108514.46102290176,MAPK13
3914,KEGG_2019_Human,Th1 and Th2 cell differentiation,1/92,0.0045999364719865,0.0101089718877324,0,0,19908.0,107139.13814408927,MAPK13
3915,KEGG_2019_Human,IL-17 signaling pathway,1/93,0.0046499360391879,0.0101089718877324,0,0,19907.0,106918.54242106884,MAPK13
3916,KEGG_2019_Human,GnRH signaling pathway,1/93,0.0046499360391879,0.0101089718877324,0,0,19907.0,106918.54242106884,MAPK13
3917,KEGG_2019_Human,Progesterone-mediated oocyte maturation,1/99,0.0049499334884068,0.0101089718877324,0,0,19901.0,105642.09305076736,MAPK13
3918,KEGG_2019_Human,AGE-RAGE signaling pathway in diabetic complications,1/100,0.0049999330710556,0.0101089718877324,0,0,19900.0,105436.78197328727,MAPK13
3919,KEGG_2019_Human,Inflammatory mediator regulation of TRP channels,1/100,0.0049999330710556,0.0101089718877324,0,0,19900.0,105436.78197328727,MAPK13
3920,KEGG_2019_Human,T cell receptor signaling pathway,1/101,0.0050499326546803,0.0101089718877324,0,0,19899.0,105233.48101229242,MAPK13
3921,KEGG_2019_Human,Chagas disease (American trypanosomiasis),1/103,0.0051499318302617,0.0101089718877324,0,0,19897.0,104832.7525292024,MAPK13
3922,KEGG_2019_Human,Toll-like receptor signaling pathway,1/104,0.0051999314202997,0.0101089718877324,0,0,19896.0,104635.24941415618,MAPK13
3923,KEGG_2019_Human,C-type lectin receptor signaling pathway,1/104,0.0051999314202997,0.0101089718877324,0,0,19896.0,104635.24941415618,MAPK13
3924,KEGG_2019_Human,Th17 cell differentiation,1/107,0.0053499302026925,0.0101089718877324,0,0,19893.0,104053.753408911,MAPK13
3925,KEGG_2019_Human,TNF signaling pathway,1/110,0.0054999290027479,0.0101089718877324,0,0,19890.0,103488.06969787036,MAPK13
3926,KEGG_2019_Human,Leukocyte transendothelial migration,1/112,0.0055999282120529,0.0101089718877324,0,0,19888.0,103119.30984392198,MAPK13
3927,KEGG_2019_Human,Toxoplasmosis,1/113,0.0056499278191151,0.0101089718877324,0,0,19887.0,102937.34947211576,MAPK13
3928,KEGG_2019_Human,Sphingolipid signaling pathway,1/119,0.0059499254985137,0.0101089718877324,0,0,19881.0,101877.73080211312,MAPK13
3929,KEGG_2019_Human,Neurotrophin signaling pathway,1/119,0.0059499254985137,0.0101089718877324,0,0,19881.0,101877.73080211312,MAPK13
3930,KEGG_2019_Human,Platelet activation,1/124,0.0061999236097501,0.0101089718877324,0,0,19876.0,101034.04709010696,MAPK13
3931,KEGG_2019_Human,Osteoclast differentiation,1/127,0.0063499224962247,0.0101089718877324,0,0,19873.0,100543.72072014232,MAPK13
3932,KEGG_2019_Human,Relaxin signaling pathway,1/130,0.0064999213952527,0.0101089718877324,0,0,19870.0,100064.62842845908,MAPK13
3933,KEGG_2019_Human,Dopaminergic synapse,1/131,0.0065499210316603,0.0101089718877324,0,0,19869.0,99907.33811343512,MAPK13
3934,KEGG_2019_Human,FoxO signaling pathway,1/132,0.0065999206698993,0.0101089718877324,0,0,19868.0,99751.22090491928,MAPK13
3935,KEGG_2019_Human,Fluid shear stress and atherosclerosis,1/139,0.006949918172816,0.0101089718877324,0,0,19861.0,98689.81333375497,MAPK13
3936,KEGG_2019_Human,Signaling pathways regulating pluripotency of stem cells,1/139,0.006949918172816,0.0101089718877324,0,0,19861.0,98689.81333375497,MAPK13
3937,KEGG_2019_Human,Adrenergic signaling in cardiomyocytes,1/145,0.0072499160871101,0.0101484549413362,0,0,19855.0,97820.92670675044,MAPK13
3938,KEGG_2019_Human,Retrograde endocannabinoid signaling,1/148,0.007399915061391,0.0101484549413362,0,0,19852.0,97399.60470052566,MAPK13
3939,KEGG_2019_Human,Cellular senescence,1/160,0.0079999110688441,0.0105728563431785,0,0,19840.0,95793.96509856998,MAPK13
3940,KEGG_2019_Human,Hepatitis B,1/163,0.0081499100978668,0.0105728563431785,0,0,19837.0,95410.9786681514,MAPK13
3941,KEGG_2019_Human,Influenza A,1/171,0.0085499075557634,0.0107398860960673,0,0,19829.0,94422.42241345016,MAPK13
3942,KEGG_2019_Human,NOD-like receptor signaling pathway,1/178,0.0088999053857096,0.0107398860960673,0,0,19822.0,93593.82745769851,MAPK13
3943,KEGG_2019_Human,Tuberculosis,1/179,0.0089499050800561,0.0107398860960673,0,0,19821.0,93478.0629355712,MAPK13
3944,KEGG_2019_Human,Kaposi sarcoma-associated herpesvirus infection,1/186,0.0092999029651357,0.0108876912762565,0,0,19814.0,92684.96451050608,MAPK13
3945,KEGG_2019_Human,Epstein-Barr virus infection,1/201,0.0100498985877989,0.0112184914468453,0,0,19799.0,91079.21596609056,MAPK13
3946,KEGG_2019_Human,Proteoglycans in cancer,1/201,0.0100498985877989,0.0112184914468453,0,0,19799.0,91079.21596609056,MAPK13
3947,KEGG_2019_Human,Rap1 signaling pathway,1/206,0.010299897173561,0.0112362514620665,0,0,19794.0,90569.849337325,MAPK13
3948,KEGG_2019_Human,Human immunodeficiency virus 1 infection,1/212,0.0105998955026255,0.0113065552028006,0,0,19788.0,89974.27756224656,MAPK13
3949,KEGG_2019_Human,Human cytomegalovirus infection,1/225,0.0112498919790339,0.0117390177172527,0,0,19775.0,88738.27077557483,MAPK13
3950,KEGG_2019_Human,Thermogenesis,1/231,0.0115498903940656,0.0117956327428755,0,0,19769.0,88191.07730937863,MAPK13
3951,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0147498749536506,0,0,19705.0,83086.53988020132,MAPK13
3952,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR52H1
3953,KEGG_2019_Human,Estrogen signaling pathway,1/137,0.0068499188797651,0.0068499188797651,0,0,19863.0,98987.62735269018,KRT14
3954,KEGG_2019_Human,MicroRNAs in cancer,1/299,0.0149498740670514,0.0149498740670514,0,0,19701.0,82804.33538735632,ST14
3955,KEGG_2019_Human,Leukocyte transendothelial migration,1/112,0.0055999282120529,0.0106998949514067,0,0,19888.0,103119.30984392198,MYL5
3956,KEGG_2019_Human,Axon guidance,1/181,0.0090499044707863,0.0106998949514067,0,0,19819.0,93248.41634586031,MYL5
3957,KEGG_2019_Human,Focal adhesion,1/199,0.0099498991610159,0.0106998949514067,0,0,19801.0,91286.4288690606,MYL5
3958,KEGG_2019_Human,Regulation of actin cytoskeleton,1/214,0.0106998949514067,0.0106998949514067,0,0,19786.0,89779.39753374986,MYL5
3959,KEGG_2019_Human,Endocytosis,1/244,0.0121998870519305,0.0121998870519305,0,0,19756.0,87051.4275316661,SH3GL3
3960,KEGG_2019_Human,Alzheimer disease,1/171,0.0085499075557634,0.0147498749536506,0,0,19829.0,94422.42241345016,MAPT
3961,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0147498749536506,0,0,19705.0,83086.53988020132,MAPT
3962,KEGG_2019_Human,Ribosome biogenesis in eukaryotes,1/101,0.0050499326546803,0.0050499326546803,0,0,19899.0,105233.48101229242,GNL3L
3963,KEGG_2019_Human,Arrhythmogenic right ventricular cardiomyopathy (ARVC),1/72,0.0035999456502131,0.0090998738144064,0,0,19928.0,112131.59838572376,ITGB6
3964,KEGG_2019_Human,ECM-receptor interaction,1/82,0.004099940929819,0.0090998738144064,0,0,19918.0,109484.9180722932,ITGB6
3965,KEGG_2019_Human,Hypertrophic cardiomyopathy (HCM),1/85,0.004249939567045,0.0090998738144064,0,0,19915.0,108752.83801948265,ITGB6
3966,KEGG_2019_Human,Dilated cardiomyopathy (DCM),1/91,0.0045499369072032,0.0090998738144064,0,0,19909.0,107362.10783923086,ITGB6
3967,KEGG_2019_Human,Focal adhesion,1/199,0.0099498991610159,0.0142665266018757,0,0,19801.0,91286.4288690606,ITGB6
3968,KEGG_2019_Human,Regulation of actin cytoskeleton,1/214,0.0106998949514067,0.0142665266018757,0,0,19786.0,89779.39753374986,ITGB6
3969,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0176998626413668,0,0,19670.0,80733.60565076157,ITGB6
3970,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0176998626413668,0,0,19646.0,79255.8617626126,ITGB6
3971,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR7G1
3972,KEGG_2019_Human,ABC transporters,1/45,0.0022499601197094,0.0022499601197094,0,0,19955.0,121662.49782449217,ABCA7
3973,KEGG_2019_Human,Estrogen signaling pathway,1/137,0.0068499188797651,0.0068499188797651,0,0,19863.0,98987.62735269018,KRT37
3974,KEGG_2019_Human,Spliceosome,1/134,0.0066999199497742,0.0066999199497742,0,0,19866.0,99442.43560916925,PRPF8
3975,KEGG_2019_Human,Osteoclast differentiation,1/127,0.0063499224962247,0.0063499224962247,0,0,19873.0,100543.72072014232,LILRB2
3976,KEGG_2019_Human,Necroptosis,1/162,0.0080999104202618,0.0121998870519305,0,0,19838.0,95537.86936302872,CHMP1A
3977,KEGG_2019_Human,Endocytosis,1/244,0.0121998870519305,0.0121998870519305,0,0,19756.0,87051.4275316661,CHMP1A
3978,KEGG_2019_Human,Taste transduction,1/83,0.0041499404726918,0.0056499278191151,0,0,19917.0,109237.99888847338,HTR3C
3979,KEGG_2019_Human,Serotonergic synapse,1/113,0.0056499278191151,0.0056499278191151,0,0,19887.0,102937.34947211576,HTR3C
3980,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR2AG1
3981,KEGG_2019_Human,Transcriptional misregulation in cancer,1/186,0.0092999029651357,0.0092999029651357,0,0,19814.0,92684.96451050608,BMP2K
3982,KEGG_2019_Human,Phagosome,1/152,0.0075999137114971,0.0075999137114971,0,0,19848.0,96850.665715497,COLEC12
3983,KEGG_2019_Human,Bile secretion,1/72,0.0035999456502131,0.0035999456502131,0,0,19928.0,112131.59838572376,NR1H4
3984,KEGG_2019_Human,RNA transport,1/165,0.0082499094553477,0.0082499094553477,0,0,19835.0,95159.46482222488,EIF3D
3985,KEGG_2019_Human,Basal transcription factors,1/45,0.0022499601197094,0.0022499601197094,0,0,19955.0,121662.49782449217,TAF1L
3986,KEGG_2019_Human,Glycosaminoglycan biosynthesis,1/53,0.0026499555173137,0.0026499555173137,0,0,19947.0,118349.78824235698,CHST4
3987,KEGG_2019_Human,Viral carcinogenesis,1/201,0.0100498985877989,0.0164998674589645,0,0,19799.0,91079.21596609056,CHD4
3988,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0164998674589645,0,0,19670.0,80733.60565076157,CHD4
3989,KEGG_2019_Human,mRNA surveillance pathway,1/91,0.0045499369072032,0.0045499369072032,0,0,19909.0,107362.10783923086,WDR33
3990,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR14J1
3991,KEGG_2019_Human,Regulation of lipolysis in adipocytes,1/55,0.0027499544131125,0.0036999446830449,0,0,19945.0,117599.1294878737,AQP7
3992,KEGG_2019_Human,PPAR signaling pathway,1/74,0.0036999446830449,0.0036999446830449,0,0,19926.0,111574.38983110404,AQP7
3993,KEGG_2019_Human,Inositol phosphate metabolism,1/74,0.0036999446830449,0.0049499334884068,0,0,19926.0,111574.38983110404,IMPA2
3994,KEGG_2019_Human,Phosphatidylinositol signaling system,1/99,0.0049499334884068,0.0049499334884068,0,0,19901.0,105642.09305076736,IMPA2
3995,KEGG_2019_Human,Thyroid cancer,1/37,0.0018499650702878,0.0125548273058073,0,0,19963.0,125618.9446446357,BAK1
3996,KEGG_2019_Human,Endometrial cancer,1/58,0.0028999527887707,0.0125548273058073,0,0,19942.0,116522.31890946148,BAK1
3997,KEGG_2019_Human,Basal cell carcinoma,1/63,0.0031499501598827,0.0125548273058073,0,0,19937.0,114844.46974572667,BAK1
3998,KEGG_2019_Human,Non-small cell lung cancer,1/66,0.003299948626608,0.0125548273058073,0,0,19934.0,113899.85357353876,BAK1
3999,KEGG_2019_Human,Melanoma,1/72,0.0035999456502131,0.0125548273058073,0,0,19928.0,112131.59838572376,BAK1
4000,KEGG_2019_Human,Pancreatic cancer,1/75,0.0037499442041125,0.0125548273058073,0,0,19925.0,111301.33528642564,BAK1
4001,KEGG_2019_Human,Glioma,1/75,0.0037499442041125,0.0125548273058073,0,0,19925.0,111301.33528642564,BAK1
4002,KEGG_2019_Human,Chronic myeloid leukemia,1/76,0.0037999437281752,0.0125548273058073,0,0,19924.0,111031.8499691117,BAK1
4003,KEGG_2019_Human,Colorectal cancer,1/86,0.0042999391173866,0.0125548273058073,0,0,19914.0,108514.46102290176,BAK1
4004,KEGG_2019_Human,Small cell lung cancer,1/93,0.0046499360391879,0.0125548273058073,0,0,19907.0,106918.54242106884,BAK1
4005,KEGG_2019_Human,Measles,1/138,0.0068999185254481,0.0129212981843129,0,0,19862.0,98838.19160389496,BAK1
4006,KEGG_2019_Human,Apoptosis,1/143,0.0071499167770442,0.0129212981843129,0,0,19857.0,98106.57763600958,BAK1
4007,KEGG_2019_Human,Breast cancer,1/147,0.0073499154017982,0.0129212981843129,0,0,19853.0,97539.10874372096,BAK1
4008,KEGG_2019_Human,Gastric cancer,1/149,0.0074499147221605,0.0129212981843129,0,0,19851.0,97261.02051561224,BAK1
4009,KEGG_2019_Human,Hepatitis C,1/155,0.0077499127120574,0.0129212981843129,0,0,19845.0,96448.16254952336,BAK1
4010,KEGG_2019_Human,Protein processing in endoplasmic reticulum,1/165,0.0082499094553477,0.0129212981843129,0,0,19835.0,95159.46482222488,BAK1
4011,KEGG_2019_Human,Hepatocellular carcinoma,1/168,0.0083999085011095,0.0129212981843129,0,0,19832.0,94787.72752807094,BAK1
4012,KEGG_2019_Human,Kaposi sarcoma-associated herpesvirus infection,1/186,0.0092999029651357,0.0129212981843129,0,0,19814.0,92684.96451050608,BAK1
4013,KEGG_2019_Human,Transcriptional misregulation in cancer,1/186,0.0092999029651357,0.0129212981843129,0,0,19814.0,92684.96451050608,BAK1
4014,KEGG_2019_Human,Epstein-Barr virus infection,1/201,0.0100498985877989,0.0129212981843129,0,0,19799.0,91079.21596609056,BAK1
4015,KEGG_2019_Human,Viral carcinogenesis,1/201,0.0100498985877989,0.0129212981843129,0,0,19799.0,91079.21596609056,BAK1
4016,KEGG_2019_Human,Human immunodeficiency virus 1 infection,1/212,0.0105998955026255,0.0130089626623132,0,0,19788.0,89974.27756224656,BAK1
4017,KEGG_2019_Human,Human cytomegalovirus infection,1/225,0.0112498919790339,0.0132063949319093,0,0,19775.0,88738.27077557483,BAK1
4018,KEGG_2019_Human,MicroRNAs in cancer,1/299,0.0149498740670514,0.0168186083254328,0,0,19701.0,82804.33538735632,BAK1
4019,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0178198568556816,0,0,19670.0,80733.60565076157,BAK1
4020,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0255459866326871,0,0,19508.0,72277.44006442746,BAK1
4021,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,BAK1
4022,KEGG_2019_Human,Insulin secretion,1/86,0.0042999391173866,0.0128998173521599,0,0,19914.0,108514.46102290176,GLP1R
4023,KEGG_2019_Human,cAMP signaling pathway,1/212,0.0105998955026255,0.0158998432539383,0,0,19788.0,89974.27756224656,GLP1R
4024,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,GLP1R
4025,KEGG_2019_Human,Carbohydrate digestion and absorption,1/44,0.0021999607179423,0.0041499404726918,0,0,19956.0,122117.06559109331,TAS1R2
4026,KEGG_2019_Human,Taste transduction,1/83,0.0041499404726918,0.0041499404726918,0,0,19917.0,109237.99888847338,TAS1R2
4027,KEGG_2019_Human,Axon guidance,1/181,0.0090499044707863,0.0090499044707863,0,0,19819.0,93248.41634586031,SEMA5B
4028,KEGG_2019_Human,Insulin secretion,1/86,0.0042999391173866,0.0082999091363732,0,0,19914.0,108514.46102290176,KCNMB4
4029,KEGG_2019_Human,Vascular smooth muscle contraction,1/132,0.0065999206698993,0.0082999091363732,0,0,19868.0,99751.22090491928,KCNMB4
4030,KEGG_2019_Human,cGMP-PKG signaling pathway,1/166,0.0082999091363732,0.0082999091363732,0,0,19834.0,95034.82345515196,KCNMB4
4031,KEGG_2019_Human,Arrhythmogenic right ventricular cardiomyopathy (ARVC),1/72,0.0035999456502131,0.0079623895876056,0,0,19928.0,112131.59838572376,CACNA2D3
4032,KEGG_2019_Human,Cardiac muscle contraction,1/78,0.0038999427840466,0.0079623895876056,0,0,19922.0,110503.2180492851,CACNA2D3
4033,KEGG_2019_Human,Hypertrophic cardiomyopathy (HCM),1/85,0.004249939567045,0.0079623895876056,0,0,19915.0,108752.83801948265,CACNA2D3
4034,KEGG_2019_Human,Dilated cardiomyopathy (DCM),1/91,0.0045499369072032,0.0079623895876056,0,0,19909.0,107362.10783923086,CACNA2D3
4035,KEGG_2019_Human,Adrenergic signaling in cardiomyocytes,1/145,0.0072499160871101,0.0089248989400127,0,0,19855.0,97820.92670675044,CACNA2D3
4036,KEGG_2019_Human,Oxytocin signaling pathway,1/153,0.0076499133771537,0.0089248989400127,0,0,19847.0,96715.6407630817,CACNA2D3
4037,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0147498749536506,0,0,19705.0,83086.53988020132,CACNA2D3
4038,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF317
4039,KEGG_2019_Human,PPAR signaling pathway,1/74,0.0036999446830449,0.0053999298011749,0,0,19926.0,111574.38983110404,SLC27A1
4040,KEGG_2019_Human,Insulin resistance,1/108,0.0053999298011749,0.0053999298011749,0,0,19892.0,103863.47861844616,SLC27A1
4041,KEGG_2019_Human,Amoebiasis,1/96,0.0047999347538706,0.0113165134377649,0,0,19904.0,106270.50039849174,IL1R2
4042,KEGG_2019_Human,Hematopoietic cell lineage,1/97,0.0048499343304706,0.0113165134377649,0,0,19903.0,106058.9096435903,IL1R2
4043,KEGG_2019_Human,Prostate cancer,1/97,0.0048499343304706,0.0113165134377649,0,0,19903.0,106058.9096435903,IL1R2
4044,KEGG_2019_Human,Fluid shear stress and atherosclerosis,1/139,0.006949918172816,0.012162356802428,0,0,19861.0,98689.81333375497,IL1R2
4045,KEGG_2019_Human,Transcriptional misregulation in cancer,1/186,0.0092999029651357,0.0127748758543189,0,0,19814.0,92684.96451050608,IL1R2
4046,KEGG_2019_Human,Human T-cell leukemia virus 1 infection,1/219,0.0109498935894162,0.0127748758543189,0,0,19781.0,89299.85161916987,IL1R2
4047,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0146998751759735,0,0,19706.0,83157.67014793828,IL1R2
4048,KEGG_2019_Human,Glycosphingolipid biosynthesis,1/45,0.0022499601197094,0.0022499601197094,0,0,19955.0,121662.49782449217,B4GALNT1
4049,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR4D5
4050,KEGG_2019_Human,Cell adhesion molecules (CAMs),1/145,0.0072499160871101,0.0072499160871101,0,0,19855.0,97820.92670675044,CNTNAP2
4051,KEGG_2019_Human,Toll-like receptor signaling pathway,1/104,0.0051999314202997,0.0085499075557634,0,0,19896.0,104635.24941415618,TLR7
4052,KEGG_2019_Human,Measles,1/138,0.0068999185254481,0.0085499075557634,0,0,19862.0,98838.19160389496,TLR7
4053,KEGG_2019_Human,Influenza A,1/171,0.0085499075557634,0.0085499075557634,0,0,19829.0,94422.42241345016,TLR7
4054,KEGG_2019_Human,Homologous recombination,1/41,0.0020499625466866,0.0131398723072995,0,0,19959.0,123544.88783416104,ATM
4055,KEGG_2019_Human,p53 signaling pathway,1/72,0.0035999456502131,0.0131398723072995,0,0,19928.0,112131.59838572376,ATM
4056,KEGG_2019_Human,NF-kappa B signaling pathway,1/95,0.0047499351803394,0.0131398723072995,0,0,19905.0,106484.27183626965,ATM
4057,KEGG_2019_Human,Cell cycle,1/124,0.0061999236097501,0.0131398723072995,0,0,19876.0,101034.04709010696,ATM
4058,KEGG_2019_Human,FoxO signaling pathway,1/132,0.0065999206698993,0.0131398723072995,0,0,19868.0,99751.22090491928,ATM
4059,KEGG_2019_Human,Apoptosis,1/143,0.0071499167770442,0.0131398723072995,0,0,19857.0,98106.57763600958,ATM
4060,KEGG_2019_Human,Cellular senescence,1/160,0.0079999110688441,0.0131398723072995,0,0,19840.0,95793.96509856998,ATM
4061,KEGG_2019_Human,Transcriptional misregulation in cancer,1/186,0.0092999029651357,0.0131398723072995,0,0,19814.0,92684.96451050608,ATM
4062,KEGG_2019_Human,Human immunodeficiency virus 1 infection,1/212,0.0105998955026255,0.0131398723072995,0,0,19788.0,89974.27756224656,ATM
4063,KEGG_2019_Human,Human T-cell leukemia virus 1 infection,1/219,0.0109498935894162,0.0131398723072995,0,0,19781.0,89299.85161916987,ATM
4064,KEGG_2019_Human,MicroRNAs in cancer,1/299,0.0149498740670514,0.0163089535276924,0,0,19701.0,82804.33538735632,ATM
4065,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0164998674589645,0,0,19670.0,80733.60565076157,ATM
4066,KEGG_2019_Human,Viral myocarditis,1/59,0.0029499522555206,0.0045499369072032,0,0,19941.0,116175.59385530632,SGCA
4067,KEGG_2019_Human,Arrhythmogenic right ventricular cardiomyopathy (ARVC),1/72,0.0035999456502131,0.0045499369072032,0,0,19928.0,112131.59838572376,SGCA
4068,KEGG_2019_Human,Hypertrophic cardiomyopathy (HCM),1/85,0.004249939567045,0.0045499369072032,0,0,19915.0,108752.83801948265,SGCA
4069,KEGG_2019_Human,Dilated cardiomyopathy (DCM),1/91,0.0045499369072032,0.0045499369072032,0,0,19909.0,107362.10783923086,SGCA
4070,KEGG_2019_Human,Spliceosome,1/134,0.0066999199497742,0.0066999199497742,0,0,19866.0,99442.43560916925,SF3B1
4071,KEGG_2019_Human,ECM-receptor interaction,1/82,0.004099940929819,0.0112498433599406,0,0,19918.0,109484.9180722932,COL9A1
4072,KEGG_2019_Human,Protein digestion and absorption,1/90,0.0044999373439762,0.0112498433599406,0,0,19910.0,107587.50385474482,COL9A1
4073,KEGG_2019_Human,Focal adhesion,1/199,0.0099498991610159,0.0165831652683599,0,0,19801.0,91286.4288690606,COL9A1
4074,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0176998626413668,0,0,19670.0,80733.60565076157,COL9A1
4075,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0176998626413668,0,0,19646.0,79255.8617626126,COL9A1
4076,KEGG_2019_Human,Transcriptional misregulation in cancer,1/186,0.0092999029651357,0.0092999029651357,0,0,19814.0,92684.96451050608,MYCN
4077,KEGG_2019_Human,Relaxin signaling pathway,1/130,0.0064999213952527,0.0129998427905055,0,0,19870.0,100064.62842845908,RXFP3
4078,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,RXFP3
4079,KEGG_2019_Human,Linoleic acid metabolism,1/29,0.001449970461791,0.0049999079201481,0,0,19971.0,130534.69172799008,ALOX15
4080,KEGG_2019_Human,Ferroptosis,1/40,0.0019999631680592,0.0049999079201481,0,0,19960.0,124043.94523066044,ALOX15
4081,KEGG_2019_Human,Arachidonic acid metabolism,1/63,0.0031499501598827,0.0052499169331379,0,0,19937.0,114844.46974572667,ALOX15
4082,KEGG_2019_Human,Serotonergic synapse,1/113,0.0056499278191151,0.0070624097738939,0,0,19887.0,102937.34947211576,ALOX15
4083,KEGG_2019_Human,Necroptosis,1/162,0.0080999104202618,0.0080999104202618,0,0,19838.0,95537.86936302872,ALOX15
4084,KEGG_2019_Human,Axon guidance,1/181,0.0090499044707863,0.0090499044707863,0,0,19819.0,93248.41634586031,EPHA3
4085,KEGG_2019_Human,Inflammatory mediator regulation of TRP channels,1/100,0.0049999330710556,0.0168569999470293,0,0,19900.0,105436.78197328727,NGF
4086,KEGG_2019_Human,Neurotrophin signaling pathway,1/119,0.0059499254985137,0.0168569999470293,0,0,19881.0,101877.73080211312,NGF
4087,KEGG_2019_Human,Apoptosis,1/143,0.0071499167770442,0.0168569999470293,0,0,19857.0,98106.57763600958,NGF
4088,KEGG_2019_Human,Rap1 signaling pathway,1/206,0.010299897173561,0.0168569999470293,0,0,19794.0,90569.849337325,NGF
4089,KEGG_2019_Human,Ras signaling pathway,1/232,0.0115998901349604,0.0168569999470293,0,0,19768.0,88101.22480150245,NGF
4090,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0168569999470293,0,0,19706.0,83157.67014793828,NGF
4091,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0168569999470293,0,0,19705.0,83086.53988020132,NGF
4092,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0176998626413668,0,0,19646.0,79255.8617626126,NGF
4093,KEGG_2019_Human,Phototransduction,1/28,0.0013999711732997,0.0134543910207109,0,0,19972.0,131242.0761597353,GNB1
4094,KEGG_2019_Human,GABAergic synapse,1/89,0.0044499377838098,0.0134543910207109,0,0,19911.0,107815.380281759,GNB1
4095,KEGG_2019_Human,Morphine addiction,1/91,0.0045499369072032,0.0134543910207109,0,0,19909.0,107362.10783923086,GNB1
4096,KEGG_2019_Human,Circadian entrainment,1/97,0.0048499343304706,0.0134543910207109,0,0,19903.0,106058.9096435903,GNB1
4097,KEGG_2019_Human,Cholinergic synapse,1/112,0.0055999282120529,0.0134543910207109,0,0,19888.0,103119.30984392198,GNB1
4098,KEGG_2019_Human,Serotonergic synapse,1/113,0.0056499278191151,0.0134543910207109,0,0,19887.0,102937.34947211576,GNB1
4099,KEGG_2019_Human,Glutamatergic synapse,1/114,0.005699927427839,0.0134543910207109,0,0,19886.0,102756.96431429044,GNB1
4100,KEGG_2019_Human,Relaxin signaling pathway,1/130,0.0064999213952527,0.0134543910207109,0,0,19870.0,100064.62842845908,GNB1
4101,KEGG_2019_Human,Dopaminergic synapse,1/131,0.0065499210316603,0.0134543910207109,0,0,19869.0,99907.33811343512,GNB1
4102,KEGG_2019_Human,Apelin signaling pathway,1/137,0.0068499188797651,0.0134543910207109,0,0,19863.0,98987.62735269018,GNB1
4103,KEGG_2019_Human,Retrograde endocannabinoid signaling,1/148,0.007399915061391,0.0134543910207109,0,0,19852.0,97399.60470052566,GNB1
4104,KEGG_2019_Human,Alcoholism,1/180,0.0089999047745351,0.0135712882559994,0,0,19820.0,93362.92821536642,GNB1
4105,KEGG_2019_Human,Kaposi sarcoma-associated herpesvirus infection,1/186,0.0092999029651357,0.0135712882559994,0,0,19814.0,92684.96451050608,GNB1
4106,KEGG_2019_Human,Chemokine signaling pathway,1/190,0.0094999017791995,0.0135712882559994,0,0,19810.0,92244.74636351672,GNB1
4107,KEGG_2019_Human,Human immunodeficiency virus 1 infection,1/212,0.0105998955026255,0.0136469295705416,0,0,19788.0,89974.27756224656,GNB1
4108,KEGG_2019_Human,Human cytomegalovirus infection,1/225,0.0112498919790339,0.0136469295705416,0,0,19775.0,88738.27077557483,GNB1
4109,KEGG_2019_Human,Ras signaling pathway,1/232,0.0115998901349604,0.0136469295705416,0,0,19768.0,88101.22480150245,GNB1
4110,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0196665140459632,0,0,19646.0,79255.8617626126,GNB1
4111,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0233682594997654,0,0,19556.0,74462.79263140135,GNB1
4112,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,GNB1
4113,KEGG_2019_Human,Adrenergic signaling in cardiomyocytes,1/145,0.0072499160871101,0.0072499160871101,0,0,19855.0,97820.92670675044,SCN5A
4114,KEGG_2019_Human,Citrate cycle (TCA cycle),1/30,0.0014999697593334,0.0041499404726918,0,0,19970.0,129851.13732048514,IDH2
4115,KEGG_2019_Human,Glutathione metabolism,1/56,0.0027999538675741,0.0041499404726918,0,0,19944.0,117233.87022514464,IDH2
4116,KEGG_2019_Human,Peroxisome,1/83,0.0041499404726918,0.0041499404726918,0,0,19917.0,109237.99888847338,IDH2
4117,KEGG_2019_Human,Steroid biosynthesis,1/19,0.00094997806231055,0.0037999122492422,0,0,19981.0,139049.2109571672,CEL
4118,KEGG_2019_Human,Fat digestion and absorption,1/41,0.0020499625466866,0.0040666016002205,0,0,19959.0,123544.88783416104,CEL
4119,KEGG_2019_Human,Glycerolipid metabolism,1/61,0.0030499512001654,0.0040666016002205,0,0,19939.0,115499.24335773686,CEL
4120,KEGG_2019_Human,Pancreatic secretion,1/98,0.0048999339081079,0.0048999339081079,0,0,19902.0,105849.45495286948,CEL
4121,KEGG_2019_Human,Citrate cycle (TCA cycle),1/30,0.0014999697593334,0.0041499404726918,0,0,19970.0,129851.13732048514,IDH1
4122,KEGG_2019_Human,Glutathione metabolism,1/56,0.0027999538675741,0.0041499404726918,0,0,19944.0,117233.87022514464,IDH1
4123,KEGG_2019_Human,Central carbon metabolism in cancer,1/65,0.003249949134407,0.0041499404726918,0,0,19935.0,114209.92613860144,IDH1
4124,KEGG_2019_Human,Peroxisome,1/83,0.0041499404726918,0.0041499404726918,0,0,19917.0,109237.99888847338,IDH1
4125,KEGG_2019_Human,JAK-STAT signaling pathway,1/162,0.0080999104202618,0.0176998626413668,0,0,19838.0,95537.86936302872,GHR
4126,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0176998626413668,0,0,19706.0,83157.67014793828,GHR
4127,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0176998626413668,0,0,19662.0,80229.79996326564,GHR
4128,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0176998626413668,0,0,19646.0,79255.8617626126,GHR
4129,KEGG_2019_Human,Thyroid cancer,1/37,0.0018499650702878,0.0111404995235826,0,0,19963.0,125618.9446446357,NRAS
4130,KEGG_2019_Human,Bladder cancer,1/41,0.0020499625466866,0.0111404995235826,0,0,19959.0,123544.88783416104,NRAS
4131,KEGG_2019_Human,Endometrial cancer,1/58,0.0028999527887707,0.0111404995235826,0,0,19942.0,116522.31890946148,NRAS
4132,KEGG_2019_Human,VEGF signaling pathway,1/59,0.0029499522555206,0.0111404995235826,0,0,19941.0,116175.59385530632,NRAS
4133,KEGG_2019_Human,Long-term depression,1/60,0.002999951725986,0.0111404995235826,0,0,19940.0,115834.63209072244,NRAS
4134,KEGG_2019_Human,Mitophagy,1/65,0.003249949134407,0.0111404995235826,0,0,19935.0,114209.92613860144,NRAS
4135,KEGG_2019_Human,Central carbon metabolism in cancer,1/65,0.003249949134407,0.0111404995235826,0,0,19935.0,114209.92613860144,NRAS
4136,KEGG_2019_Human,Acute myeloid leukemia,1/66,0.003299948626608,0.0111404995235826,0,0,19934.0,113899.85357353876,NRAS
4137,KEGG_2019_Human,Non-small cell lung cancer,1/66,0.003299948626608,0.0111404995235826,0,0,19934.0,113899.85357353876,NRAS
4138,KEGG_2019_Human,Long-term potentiation,1/67,0.0033499481224912,0.0111404995235826,0,0,19933.0,113594.38808369274,NRAS
4139,KEGG_2019_Human,Fc epsilon RI signaling pathway,1/68,0.0033999476216189,0.0111404995235826,0,0,19932.0,113293.39338050144,NRAS
4140,KEGG_2019_Human,Renal cell carcinoma,1/69,0.003449947123837,0.0111404995235826,0,0,19931.0,112996.7391397682,NRAS
4141,KEGG_2019_Human,Prolactin signaling pathway,1/70,0.0034999466296654,0.0111404995235826,0,0,19930.0,112704.30065625212,NRAS
4142,KEGG_2019_Human,B cell receptor signaling pathway,1/71,0.0035499461386618,0.0111404995235826,0,0,19929.0,112415.9585341616,NRAS
4143,KEGG_2019_Human,Melanoma,1/72,0.0035999456502131,0.0111404995235826,0,0,19928.0,112131.59838572376,NRAS
4144,KEGG_2019_Human,Glioma,1/75,0.0037499442041125,0.0111404995235826,0,0,19925.0,111301.33528642564,NRAS
4145,KEGG_2019_Human,Chronic myeloid leukemia,1/76,0.0037999437281752,0.0111404995235826,0,0,19924.0,111031.8499691117,NRAS
4146,KEGG_2019_Human,ErbB signaling pathway,1/85,0.004249939567045,0.0111404995235826,0,0,19915.0,108752.83801948265,NRAS
4147,KEGG_2019_Human,Colorectal cancer,1/86,0.0042999391173866,0.0111404995235826,0,0,19914.0,108514.46102290176,NRAS
4148,KEGG_2019_Human,Gap junction,1/88,0.0043999382262822,0.0111404995235826,0,0,19912.0,108045.79305232369,NRAS
4149,KEGG_2019_Human,GnRH signaling pathway,1/93,0.0046499360391879,0.0111404995235826,0,0,19907.0,106918.54242106884,NRAS
4150,KEGG_2019_Human,Prostate cancer,1/97,0.0048499343304706,0.0111404995235826,0,0,19903.0,106058.9096435903,NRAS
4151,KEGG_2019_Human,Choline metabolism in cancer,1/99,0.0049499334884068,0.0111404995235826,0,0,19901.0,105642.09305076736,NRAS
4152,KEGG_2019_Human,AGE-RAGE signaling pathway in diabetic complications,1/100,0.0049999330710556,0.0111404995235826,0,0,19900.0,105436.78197328727,NRAS
4153,KEGG_2019_Human,T cell receptor signaling pathway,1/101,0.0050499326546803,0.0111404995235826,0,0,19899.0,105233.48101229242,NRAS
4154,KEGG_2019_Human,Melanogenesis,1/101,0.0050499326546803,0.0111404995235826,0,0,19899.0,105233.48101229242,NRAS
4155,KEGG_2019_Human,Longevity regulating pathway,1/102,0.0050999322416682,0.0111404995235826,0,0,19898.0,105032.15064717118,NRAS
4156,KEGG_2019_Human,C-type lectin receptor signaling pathway,1/104,0.0051999314202997,0.0111404995235826,0,0,19896.0,104635.24941415618,NRAS
4157,KEGG_2019_Human,Cholinergic synapse,1/112,0.0055999282120529,0.0111404995235826,0,0,19888.0,103119.30984392198,NRAS
4158,KEGG_2019_Human,Serotonergic synapse,1/113,0.0056499278191151,0.0111404995235826,0,0,19887.0,102937.34947211576,NRAS
4159,KEGG_2019_Human,Thyroid hormone signaling pathway,1/116,0.0057999266512085,0.0111404995235826,0,0,19884.0,102400.8105961506,NRAS
4160,KEGG_2019_Human,Sphingolipid signaling pathway,1/119,0.0059499254985137,0.0111404995235826,0,0,19881.0,101877.73080211312,NRAS
4161,KEGG_2019_Human,Neurotrophin signaling pathway,1/119,0.0059499254985137,0.0111404995235826,0,0,19881.0,101877.73080211312,NRAS
4162,KEGG_2019_Human,Autophagy,1/128,0.0063999221281459,0.0111404995235826,0,0,19872.0,100382.8010329652,NRAS
4163,KEGG_2019_Human,Relaxin signaling pathway,1/130,0.0064999213952527,0.0111404995235826,0,0,19870.0,100064.62842845908,NRAS
4164,KEGG_2019_Human,Natural killer cell mediated cytotoxicity,1/131,0.0065499210316603,0.0111404995235826,0,0,19869.0,99907.33811343512,NRAS
4165,KEGG_2019_Human,FoxO signaling pathway,1/132,0.0065999206698993,0.0111404995235826,0,0,19868.0,99751.22090491928,NRAS
4166,KEGG_2019_Human,Insulin signaling pathway,1/137,0.0068499188797651,0.0111404995235826,0,0,19863.0,98987.62735269018,NRAS
4167,KEGG_2019_Human,Apelin signaling pathway,1/137,0.0068499188797651,0.0111404995235826,0,0,19863.0,98987.62735269018,NRAS
4168,KEGG_2019_Human,Estrogen signaling pathway,1/137,0.0068499188797651,0.0111404995235826,0,0,19863.0,98987.62735269018,NRAS
4169,KEGG_2019_Human,Signaling pathways regulating pluripotency of stem cells,1/139,0.006949918172816,0.0111404995235826,0,0,19861.0,98689.81333375497,NRAS
4170,KEGG_2019_Human,Apoptosis,1/143,0.0071499167770442,0.0111404995235826,0,0,19857.0,98106.57763600958,NRAS
4171,KEGG_2019_Human,Breast cancer,1/147,0.0073499154017982,0.0111404995235826,0,0,19853.0,97539.10874372096,NRAS
4172,KEGG_2019_Human,Phospholipase D signaling pathway,1/148,0.007399915061391,0.0111404995235826,0,0,19852.0,97399.60470052566,NRAS
4173,KEGG_2019_Human,Gastric cancer,1/149,0.0074499147221605,0.0111404995235826,0,0,19851.0,97261.02051561224,NRAS
4174,KEGG_2019_Human,mTOR signaling pathway,1/152,0.0075999137114971,0.0111404995235826,0,0,19848.0,96850.665715497,NRAS
4175,KEGG_2019_Human,Oxytocin signaling pathway,1/153,0.0076499133771537,0.0111404995235826,0,0,19847.0,96715.6407630817,NRAS
4176,KEGG_2019_Human,Hepatitis C,1/155,0.0077499127120574,0.0111404995235826,0,0,19845.0,96448.16254952336,NRAS
4177,KEGG_2019_Human,Cellular senescence,1/160,0.0079999110688441,0.0112468759350562,0,0,19840.0,95793.96509856998,NRAS
4178,KEGG_2019_Human,Hepatitis B,1/163,0.0081499100978668,0.0112468759350562,0,0,19837.0,95410.9786681514,NRAS
4179,KEGG_2019_Human,Hepatocellular carcinoma,1/168,0.0083999085011095,0.0113645820897364,0,0,19832.0,94787.72752807094,NRAS
4180,KEGG_2019_Human,Alcoholism,1/180,0.0089999047745351,0.0117819511034765,0,0,19820.0,93362.92821536642,NRAS
4181,KEGG_2019_Human,Axon guidance,1/181,0.0090499044707863,0.0117819511034765,0,0,19819.0,93248.41634586031,NRAS
4182,KEGG_2019_Human,Kaposi sarcoma-associated herpesvirus infection,1/186,0.0092999029651357,0.0118832093443401,0,0,19814.0,92684.96451050608,NRAS
4183,KEGG_2019_Human,Chemokine signaling pathway,1/190,0.0094999017791995,0.0119180585957231,0,0,19810.0,92244.74636351672,NRAS
4184,KEGG_2019_Human,Viral carcinogenesis,1/201,0.0100498985877989,0.0121656667115461,0,0,19799.0,91079.21596609056,NRAS
4185,KEGG_2019_Human,Proteoglycans in cancer,1/201,0.0100498985877989,0.0121656667115461,0,0,19799.0,91079.21596609056,NRAS
4186,KEGG_2019_Human,Rap1 signaling pathway,1/206,0.010299897173561,0.0122533259478571,0,0,19794.0,90569.849337325,NRAS
4187,KEGG_2019_Human,Human immunodeficiency virus 1 infection,1/212,0.0105998955026255,0.0123048791941177,0,0,19788.0,89974.27756224656,NRAS
4188,KEGG_2019_Human,Regulation of actin cytoskeleton,1/214,0.0106998949514067,0.0123048791941177,0,0,19786.0,89779.39753374986,NRAS
4189,KEGG_2019_Human,Human T-cell leukemia virus 1 infection,1/219,0.0109498935894162,0.0123859452077003,0,0,19781.0,89299.85161916987,NRAS
4190,KEGG_2019_Human,Human cytomegalovirus infection,1/225,0.0112498919790339,0.0125061315517541,0,0,19775.0,88738.27077557483,NRAS
4191,KEGG_2019_Human,Thermogenesis,1/231,0.0115498903940656,0.0125061315517541,0,0,19769.0,88191.07730937863,NRAS
4192,KEGG_2019_Human,Ras signaling pathway,1/232,0.0115998901349604,0.0125061315517541,0,0,19768.0,88101.22480150245,NRAS
4193,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0156294137973719,0,0,19705.0,83086.53988020132,NRAS
4194,KEGG_2019_Human,MicroRNAs in cancer,1/299,0.0149498740670514,0.0156294137973719,0,0,19701.0,82804.33538735632,NRAS
4195,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0169924008159485,0,0,19670.0,80733.60565076157,NRAS
4196,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.017960154739034,0,0,19646.0,79255.8617626126,NRAS
4197,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,NRAS
4198,KEGG_2019_Human,Aldosterone-regulated sodium reabsorption,1/37,0.0018499650702878,0.0109410532405517,0,0,19963.0,125618.9446446357,KRAS
4199,KEGG_2019_Human,Thyroid cancer,1/37,0.0018499650702878,0.0109410532405517,0,0,19963.0,125618.9446446357,KRAS
4200,KEGG_2019_Human,Bladder cancer,1/41,0.0020499625466866,0.0109410532405517,0,0,19959.0,123544.88783416104,KRAS
4201,KEGG_2019_Human,Endometrial cancer,1/58,0.0028999527887707,0.0109410532405517,0,0,19942.0,116522.31890946148,KRAS
4202,KEGG_2019_Human,VEGF signaling pathway,1/59,0.0029499522555206,0.0109410532405517,0,0,19941.0,116175.59385530632,KRAS
4203,KEGG_2019_Human,Long-term depression,1/60,0.002999951725986,0.0109410532405517,0,0,19940.0,115834.63209072244,KRAS
4204,KEGG_2019_Human,Mitophagy,1/65,0.003249949134407,0.0109410532405517,0,0,19935.0,114209.92613860144,KRAS
4205,KEGG_2019_Human,Central carbon metabolism in cancer,1/65,0.003249949134407,0.0109410532405517,0,0,19935.0,114209.92613860144,KRAS
4206,KEGG_2019_Human,Acute myeloid leukemia,1/66,0.003299948626608,0.0109410532405517,0,0,19934.0,113899.85357353876,KRAS
4207,KEGG_2019_Human,Non-small cell lung cancer,1/66,0.003299948626608,0.0109410532405517,0,0,19934.0,113899.85357353876,KRAS
4208,KEGG_2019_Human,Long-term potentiation,1/67,0.0033499481224912,0.0109410532405517,0,0,19933.0,113594.38808369274,KRAS
4209,KEGG_2019_Human,Fc epsilon RI signaling pathway,1/68,0.0033999476216189,0.0109410532405517,0,0,19932.0,113293.39338050144,KRAS
4210,KEGG_2019_Human,Renal cell carcinoma,1/69,0.003449947123837,0.0109410532405517,0,0,19931.0,112996.7391397682,KRAS
4211,KEGG_2019_Human,Prolactin signaling pathway,1/70,0.0034999466296654,0.0109410532405517,0,0,19930.0,112704.30065625212,KRAS
4212,KEGG_2019_Human,B cell receptor signaling pathway,1/71,0.0035499461386618,0.0109410532405517,0,0,19929.0,112415.9585341616,KRAS
4213,KEGG_2019_Human,Melanoma,1/72,0.0035999456502131,0.0109410532405517,0,0,19928.0,112131.59838572376,KRAS
4214,KEGG_2019_Human,Pancreatic cancer,1/75,0.0037499442041125,0.0109410532405517,0,0,19925.0,111301.33528642564,KRAS
4215,KEGG_2019_Human,Glioma,1/75,0.0037499442041125,0.0109410532405517,0,0,19925.0,111301.33528642564,KRAS
4216,KEGG_2019_Human,Chronic myeloid leukemia,1/76,0.0037999437281752,0.0109410532405517,0,0,19924.0,111031.8499691117,KRAS
4217,KEGG_2019_Human,ErbB signaling pathway,1/85,0.004249939567045,0.0109410532405517,0,0,19915.0,108752.83801948265,KRAS
4218,KEGG_2019_Human,Colorectal cancer,1/86,0.0042999391173866,0.0109410532405517,0,0,19914.0,108514.46102290176,KRAS
4219,KEGG_2019_Human,Gap junction,1/88,0.0043999382262822,0.0109410532405517,0,0,19912.0,108045.79305232369,KRAS
4220,KEGG_2019_Human,GnRH signaling pathway,1/93,0.0046499360391879,0.0109410532405517,0,0,19907.0,106918.54242106884,KRAS
4221,KEGG_2019_Human,Prostate cancer,1/97,0.0048499343304706,0.0109410532405517,0,0,19903.0,106058.9096435903,KRAS
4222,KEGG_2019_Human,Choline metabolism in cancer,1/99,0.0049499334884068,0.0109410532405517,0,0,19901.0,105642.09305076736,KRAS
4223,KEGG_2019_Human,Progesterone-mediated oocyte maturation,1/99,0.0049499334884068,0.0109410532405517,0,0,19901.0,105642.09305076736,KRAS
4224,KEGG_2019_Human,AGE-RAGE signaling pathway in diabetic complications,1/100,0.0049999330710556,0.0109410532405517,0,0,19900.0,105436.78197328727,KRAS
4225,KEGG_2019_Human,T cell receptor signaling pathway,1/101,0.0050499326546803,0.0109410532405517,0,0,19899.0,105233.48101229242,KRAS
4226,KEGG_2019_Human,Melanogenesis,1/101,0.0050499326546803,0.0109410532405517,0,0,19899.0,105233.48101229242,KRAS
4227,KEGG_2019_Human,Longevity regulating pathway,1/102,0.0050999322416682,0.0109410532405517,0,0,19898.0,105032.15064717118,KRAS
4228,KEGG_2019_Human,C-type lectin receptor signaling pathway,1/104,0.0051999314202997,0.0109410532405517,0,0,19896.0,104635.24941415618,KRAS
4229,KEGG_2019_Human,Cholinergic synapse,1/112,0.0055999282120529,0.0109410532405517,0,0,19888.0,103119.30984392198,KRAS
4230,KEGG_2019_Human,Serotonergic synapse,1/113,0.0056499278191151,0.0109410532405517,0,0,19887.0,102937.34947211576,KRAS
4231,KEGG_2019_Human,Thyroid hormone signaling pathway,1/116,0.0057999266512085,0.0109410532405517,0,0,19884.0,102400.8105961506,KRAS
4232,KEGG_2019_Human,Sphingolipid signaling pathway,1/119,0.0059499254985137,0.0109410532405517,0,0,19881.0,101877.73080211312,KRAS
4233,KEGG_2019_Human,Neurotrophin signaling pathway,1/119,0.0059499254985137,0.0109410532405517,0,0,19881.0,101877.73080211312,KRAS
4234,KEGG_2019_Human,Autophagy,1/128,0.0063999221281459,0.0109410532405517,0,0,19872.0,100382.8010329652,KRAS
4235,KEGG_2019_Human,Relaxin signaling pathway,1/130,0.0064999213952527,0.0109410532405517,0,0,19870.0,100064.62842845908,KRAS
4236,KEGG_2019_Human,Natural killer cell mediated cytotoxicity,1/131,0.0065499210316603,0.0109410532405517,0,0,19869.0,99907.33811343512,KRAS
4237,KEGG_2019_Human,FoxO signaling pathway,1/132,0.0065999206698993,0.0109410532405517,0,0,19868.0,99751.22090491928,KRAS
4238,KEGG_2019_Human,Insulin signaling pathway,1/137,0.0068499188797651,0.0109410532405517,0,0,19863.0,98987.62735269018,KRAS
4239,KEGG_2019_Human,Apelin signaling pathway,1/137,0.0068499188797651,0.0109410532405517,0,0,19863.0,98987.62735269018,KRAS
4240,KEGG_2019_Human,Estrogen signaling pathway,1/137,0.0068499188797651,0.0109410532405517,0,0,19863.0,98987.62735269018,KRAS
4241,KEGG_2019_Human,Signaling pathways regulating pluripotency of stem cells,1/139,0.006949918172816,0.0109410532405517,0,0,19861.0,98689.81333375497,KRAS
4242,KEGG_2019_Human,Apoptosis,1/143,0.0071499167770442,0.0109410532405517,0,0,19857.0,98106.57763600958,KRAS
4243,KEGG_2019_Human,Breast cancer,1/147,0.0073499154017982,0.0109410532405517,0,0,19853.0,97539.10874372096,KRAS
4244,KEGG_2019_Human,Phospholipase D signaling pathway,1/148,0.007399915061391,0.0109410532405517,0,0,19852.0,97399.60470052566,KRAS
4245,KEGG_2019_Human,Gastric cancer,1/149,0.0074499147221605,0.0109410532405517,0,0,19851.0,97261.02051561224,KRAS
4246,KEGG_2019_Human,mTOR signaling pathway,1/152,0.0075999137114971,0.0109410532405517,0,0,19848.0,96850.665715497,KRAS
4247,KEGG_2019_Human,Oxytocin signaling pathway,1/153,0.0076499133771537,0.0109410532405517,0,0,19847.0,96715.6407630817,KRAS
4248,KEGG_2019_Human,Hepatitis C,1/155,0.0077499127120574,0.0109410532405517,0,0,19845.0,96448.16254952336,KRAS
4249,KEGG_2019_Human,Cellular senescence,1/160,0.0079999110688441,0.0110715759820077,0,0,19840.0,95793.96509856998,KRAS
4250,KEGG_2019_Human,Hepatitis B,1/163,0.0081499100978668,0.0110715759820077,0,0,19837.0,95410.9786681514,KRAS
4251,KEGG_2019_Human,Hepatocellular carcinoma,1/168,0.0083999085011095,0.0111998780014793,0,0,19832.0,94787.72752807094,KRAS
4252,KEGG_2019_Human,Alcoholism,1/180,0.0089999047745351,0.0116355914624396,0,0,19820.0,93362.92821536642,KRAS
4253,KEGG_2019_Human,Axon guidance,1/181,0.0090499044707863,0.0116355914624396,0,0,19819.0,93248.41634586031,KRAS
4254,KEGG_2019_Human,Kaposi sarcoma-associated herpesvirus infection,1/186,0.0092999029651357,0.0117472458506978,0,0,19814.0,92684.96451050608,KRAS
4255,KEGG_2019_Human,Chemokine signaling pathway,1/190,0.0094999017791995,0.0117929815190063,0,0,19810.0,92244.74636351672,KRAS
4256,KEGG_2019_Human,Viral carcinogenesis,1/201,0.0100498985877989,0.0120598783053587,0,0,19799.0,91079.21596609056,KRAS
4257,KEGG_2019_Human,Proteoglycans in cancer,1/201,0.0100498985877989,0.0120598783053587,0,0,19799.0,91079.21596609056,KRAS
4258,KEGG_2019_Human,Rap1 signaling pathway,1/206,0.010299897173561,0.0121572556802687,0,0,19794.0,90569.849337325,KRAS
4259,KEGG_2019_Human,Human immunodeficiency virus 1 infection,1/212,0.0105998955026255,0.0122284513730363,0,0,19788.0,89974.27756224656,KRAS
4260,KEGG_2019_Human,Regulation of actin cytoskeleton,1/214,0.0106998949514067,0.0122284513730363,0,0,19786.0,89779.39753374986,KRAS
4261,KEGG_2019_Human,Human T-cell leukemia virus 1 infection,1/219,0.0109498935894162,0.0123186302880933,0,0,19781.0,89299.85161916987,KRAS
4262,KEGG_2019_Human,Human cytomegalovirus infection,1/225,0.0112498919790339,0.0124614188075452,0,0,19775.0,88738.27077557483,KRAS
4263,KEGG_2019_Human,Thermogenesis,1/231,0.0115498903940656,0.0124655535778679,0,0,19769.0,88191.07730937863,KRAS
4264,KEGG_2019_Human,Ras signaling pathway,1/232,0.0115998901349604,0.0124655535778679,0,0,19768.0,88101.22480150245,KRAS
4265,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0155998685917058,0,0,19705.0,83086.53988020132,KRAS
4266,KEGG_2019_Human,MicroRNAs in cancer,1/299,0.0149498740670514,0.0155998685917058,0,0,19701.0,82804.33538735632,KRAS
4267,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0169712922435063,0,0,19670.0,80733.60565076157,KRAS
4268,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0179491564813861,0,0,19646.0,79255.8617626126,KRAS
4269,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,KRAS
4270,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,NPFFR2
4271,KEGG_2019_Human,Hedgehog signaling pathway,1/47,0.0023499589392381,0.0023499589392381,0,0,19953.0,120782.64067395544,CDON
4272,KEGG_2019_Human,Morphine addiction,1/91,0.0045499369072032,0.0103748864204666,0,0,19909.0,107362.10783923086,PDE2A
4273,KEGG_2019_Human,Aldosterone synthesis and secretion,1/98,0.0048999339081079,0.0103748864204666,0,0,19902.0,105849.45495286948,PDE2A
4274,KEGG_2019_Human,Purine metabolism,1/129,0.006449921761047,0.0103748864204666,0,0,19871.0,100223.109907462,PDE2A
4275,KEGG_2019_Human,cGMP-PKG signaling pathway,1/166,0.0082999091363732,0.0103748864204666,0,0,19834.0,95034.82345515196,PDE2A
4276,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,PDE2A
4277,KEGG_2019_Human,Synaptic vesicle cycle,1/78,0.0038999427840466,0.0038999427840466,0,0,19922.0,110503.2180492851,SLC6A9
4278,KEGG_2019_Human,RNA transport,1/165,0.0082499094553477,0.0082499094553477,0,0,19835.0,95159.46482222488,KPNB1
4279,KEGG_2019_Human,Starch and sucrose metabolism,1/36,0.0017999657178272,0.0080999104202618,0,0,19964.0,126172.23364250171,PYGM
4280,KEGG_2019_Human,Glucagon signaling pathway,1/103,0.0051499318302617,0.0080999104202618,0,0,19897.0,104832.7525292024,PYGM
4281,KEGG_2019_Human,Insulin resistance,1/108,0.0053999298011749,0.0080999104202618,0,0,19892.0,103863.47861844616,PYGM
4282,KEGG_2019_Human,Insulin signaling pathway,1/137,0.0068499188797651,0.0080999104202618,0,0,19863.0,98987.62735269018,PYGM
4283,KEGG_2019_Human,Necroptosis,1/162,0.0080999104202618,0.0080999104202618,0,0,19838.0,95537.86936302872,PYGM
4284,KEGG_2019_Human,Glutathione metabolism,1/56,0.0027999538675741,0.0094498771520562,0,0,19944.0,117233.87022514464,GSTA4
4285,KEGG_2019_Human,Metabolism of xenobiotics by cytochrome P450,1/74,0.0036999446830449,0.0094498771520562,0,0,19926.0,111574.38983110404,GSTA4
4286,KEGG_2019_Human,Chemical carcinogenesis,1/82,0.004099940929819,0.0094498771520562,0,0,19918.0,109484.9180722932,GSTA4
4287,KEGG_2019_Human,Drug metabolism,1/108,0.0053999298011749,0.0094498771520562,0,0,19892.0,103863.47861844616,GSTA4
4288,KEGG_2019_Human,Fluid shear stress and atherosclerosis,1/139,0.006949918172816,0.0097298854419424,0,0,19861.0,98689.81333375497,GSTA4
4289,KEGG_2019_Human,Hepatocellular carcinoma,1/168,0.0083999085011095,0.0097998932512944,0,0,19832.0,94787.72752807094,GSTA4
4290,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,GSTA4
4291,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR56A4
4292,KEGG_2019_Human,Ras signaling pathway,1/232,0.0115998901349604,0.0115998901349604,0,0,19768.0,88101.22480150245,RASA4B
4293,KEGG_2019_Human,Peroxisome,1/83,0.0041499404726918,0.0041499404726918,0,0,19917.0,109237.99888847338,PEX11B
4294,KEGG_2019_Human,HIF-1 signaling pathway,1/100,0.0049999330710556,0.012239861403446,0,0,19900.0,105436.78197328727,RPS6
4295,KEGG_2019_Human,Apelin signaling pathway,1/137,0.0068499188797651,0.012239861403446,0,0,19863.0,98987.62735269018,RPS6
4296,KEGG_2019_Human,Insulin signaling pathway,1/137,0.0068499188797651,0.012239861403446,0,0,19863.0,98987.62735269018,RPS6
4297,KEGG_2019_Human,mTOR signaling pathway,1/152,0.0075999137114971,0.012239861403446,0,0,19848.0,96850.665715497,RPS6
4298,KEGG_2019_Human,Ribosome,1/153,0.0076499133771537,0.012239861403446,0,0,19847.0,96715.6407630817,RPS6
4299,KEGG_2019_Human,Proteoglycans in cancer,1/201,0.0100498985877989,0.0131998747360749,0,0,19799.0,91079.21596609056,RPS6
4300,KEGG_2019_Human,Thermogenesis,1/231,0.0115498903940656,0.0131998747360749,0,0,19769.0,88191.07730937863,RPS6
4301,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0176998626413668,0,0,19646.0,79255.8617626126,RPS6
4302,KEGG_2019_Human,Estrogen signaling pathway,1/137,0.0068499188797651,0.0068499188797651,0,0,19863.0,98987.62735269018,EBAG9
4303,KEGG_2019_Human,Long-term potentiation,1/67,0.0033499481224912,0.0110284581682967,0,0,19933.0,113594.38808369274,GRM5
4304,KEGG_2019_Human,Gap junction,1/88,0.0043999382262822,0.0110284581682967,0,0,19912.0,108045.79305232369,GRM5
4305,KEGG_2019_Human,Glutamatergic synapse,1/114,0.005699927427839,0.0110284581682967,0,0,19886.0,102756.96431429044,GRM5
4306,KEGG_2019_Human,Phospholipase D signaling pathway,1/148,0.007399915061391,0.0110284581682967,0,0,19852.0,97399.60470052566,GRM5
4307,KEGG_2019_Human,Retrograde endocannabinoid signaling,1/148,0.007399915061391,0.0110284581682967,0,0,19852.0,97399.60470052566,GRM5
4308,KEGG_2019_Human,Calcium signaling pathway,1/188,0.009399902370135,0.0110284581682967,0,0,19812.0,92463.712994847,GRM5
4309,KEGG_2019_Human,Huntington disease,1/193,0.0096499008972596,0.0110284581682967,0,0,19807.0,91920.47679471428,GRM5
4310,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,GRM5
4311,KEGG_2019_Human,Pentose phosphate pathway,1/30,0.0014999697593334,0.0035999314356544,0,0,19970.0,129851.13732048514,PGM2
4312,KEGG_2019_Human,Galactose metabolism,1/31,0.0015499690656704,0.0035999314356544,0,0,19969.0,129189.85098816035,PGM2
4313,KEGG_2019_Human,Starch and sucrose metabolism,1/36,0.0017999657178272,0.0035999314356544,0,0,19964.0,126172.23364250171,PGM2
4314,KEGG_2019_Human,Amino sugar and nucleotide sugar metabolism,1/48,0.0023999583567988,0.0035999375351982,0,0,19952.0,120356.5272753826,PGM2
4315,KEGG_2019_Human,Glycolysis / Gluconeogenesis,1/68,0.0033999476216189,0.0040799371459427,0,0,19932.0,113293.39338050144,PGM2
4316,KEGG_2019_Human,Purine metabolism,1/129,0.006449921761047,0.006449921761047,0,0,19871.0,100223.109907462,PGM2
4317,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0146998751759735,0,0,19706.0,83157.67014793828,GDF10
4318,KEGG_2019_Human,mTOR signaling pathway,1/152,0.0075999137114971,0.0082499094553477,0,0,19848.0,96850.665715497,SEC13
4319,KEGG_2019_Human,Protein processing in endoplasmic reticulum,1/165,0.0082499094553477,0.0082499094553477,0,0,19835.0,95159.46482222488,SEC13
4320,KEGG_2019_Human,RNA transport,1/165,0.0082499094553477,0.0082499094553477,0,0,19835.0,95159.46482222488,SEC13
4321,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF300
4322,KEGG_2019_Human,Thyroid hormone synthesis,1/74,0.0036999446830449,0.0036999446830449,0,0,19926.0,111574.38983110404,DUOX2
4323,KEGG_2019_Human,ErbB signaling pathway,1/85,0.004249939567045,0.0080499049463562,0,0,19915.0,108752.83801948265,CBLB
4324,KEGG_2019_Human,T cell receptor signaling pathway,1/101,0.0050499326546803,0.0080499049463562,0,0,19899.0,105233.48101229242,CBLB
4325,KEGG_2019_Human,C-type lectin receptor signaling pathway,1/104,0.0051999314202997,0.0080499049463562,0,0,19896.0,104635.24941415618,CBLB
4326,KEGG_2019_Human,Ubiquitin mediated proteolysis,1/137,0.0068499188797651,0.0080499049463562,0,0,19863.0,98987.62735269018,CBLB
4327,KEGG_2019_Human,Insulin signaling pathway,1/137,0.0068499188797651,0.0080499049463562,0,0,19863.0,98987.62735269018,CBLB
4328,KEGG_2019_Human,Measles,1/138,0.0068999185254481,0.0080499049463562,0,0,19862.0,98838.19160389496,CBLB
4329,KEGG_2019_Human,Endocytosis,1/244,0.0121998870519305,0.0121998870519305,0,0,19756.0,87051.4275316661,CBLB
4330,KEGG_2019_Human,Phototransduction,1/28,0.0013999711732997,0.0041999135198993,0,0,19972.0,131242.0761597353,CNGA1
4331,KEGG_2019_Human,cGMP-PKG signaling pathway,1/166,0.0082999091363732,0.0105998955026255,0,0,19834.0,95034.82345515196,CNGA1
4332,KEGG_2019_Human,cAMP signaling pathway,1/212,0.0105998955026255,0.0105998955026255,0,0,19788.0,89974.27756224656,CNGA1
4333,KEGG_2019_Human,Linoleic acid metabolism,1/29,0.001449970461791,0.0056499278191151,0,0,19971.0,130534.69172799008,CYP2C9
4334,KEGG_2019_Human,Arachidonic acid metabolism,1/63,0.0031499501598827,0.0056499278191151,0,0,19937.0,114844.46974572667,CYP2C9
4335,KEGG_2019_Human,Retinol metabolism,1/67,0.0033499481224912,0.0056499278191151,0,0,19933.0,113594.38808369274,CYP2C9
4336,KEGG_2019_Human,Metabolism of xenobiotics by cytochrome P450,1/74,0.0036999446830449,0.0056499278191151,0,0,19926.0,111574.38983110404,CYP2C9
4337,KEGG_2019_Human,Chemical carcinogenesis,1/82,0.004099940929819,0.0056499278191151,0,0,19918.0,109484.9180722932,CYP2C9
4338,KEGG_2019_Human,Drug metabolism,1/108,0.0053999298011749,0.0056499278191151,0,0,19892.0,103863.47861844616,CYP2C9
4339,KEGG_2019_Human,Serotonergic synapse,1/113,0.0056499278191151,0.0056499278191151,0,0,19887.0,102937.34947211576,CYP2C9
4340,KEGG_2019_Human,Tight junction,1/170,0.0084999078692823,0.0115998901349604,0,0,19830.0,94543.49009679438,TIAM1
4341,KEGG_2019_Human,Chemokine signaling pathway,1/190,0.0094999017791995,0.0115998901349604,0,0,19810.0,92244.74636351672,TIAM1
4342,KEGG_2019_Human,Proteoglycans in cancer,1/201,0.0100498985877989,0.0115998901349604,0,0,19799.0,91079.21596609056,TIAM1
4343,KEGG_2019_Human,Rap1 signaling pathway,1/206,0.010299897173561,0.0115998901349604,0,0,19794.0,90569.849337325,TIAM1
4344,KEGG_2019_Human,cAMP signaling pathway,1/212,0.0105998955026255,0.0115998901349604,0,0,19788.0,89974.27756224656,TIAM1
4345,KEGG_2019_Human,Regulation of actin cytoskeleton,1/214,0.0106998949514067,0.0115998901349604,0,0,19786.0,89779.39753374986,TIAM1
4346,KEGG_2019_Human,Ras signaling pathway,1/232,0.0115998901349604,0.0115998901349604,0,0,19768.0,88101.22480150245,TIAM1
4347,KEGG_2019_Human,Ribosome biogenesis in eukaryotes,1/101,0.0050499326546803,0.0050499326546803,0,0,19899.0,105233.48101229242,REXO1
4348,KEGG_2019_Human,Insulin secretion,1/86,0.0042999391173866,0.0042999391173866,0,0,19914.0,108514.46102290176,PCLO
4349,KEGG_2019_Human,Cholinergic synapse,1/112,0.0055999282120529,0.0076499133771537,0,0,19888.0,103119.30984392198,KCNJ12
4350,KEGG_2019_Human,Oxytocin signaling pathway,1/153,0.0076499133771537,0.0076499133771537,0,0,19847.0,96715.6407630817,KCNJ12
4351,KEGG_2019_Human,Vasopressin-regulated water reabsorption,1/44,0.0021999607179423,0.006599882153827,0,0,19956.0,122117.06559109331,RAB11B
4352,KEGG_2019_Human,AMPK signaling pathway,1/120,0.0059999251180858,0.0089998876771287,0,0,19880.0,101706.2448082016,RAB11B
4353,KEGG_2019_Human,Endocytosis,1/244,0.0121998870519305,0.0121998870519305,0,0,19756.0,87051.4275316661,RAB11B
4354,KEGG_2019_Human,Prion diseases,1/35,0.0017499663721595,0.0034999327443191,0,0,19965.0,126740.98858805298,NCAM1
4355,KEGG_2019_Human,Cell adhesion molecules (CAMs),1/145,0.0072499160871101,0.0072499160871101,0,0,19855.0,97820.92670675044,NCAM1
4356,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZFP90
4357,KEGG_2019_Human,Arginine and proline metabolism,1/49,0.0024499577795033,0.0024499577795033,0,0,19951.0,119939.1172087114,P4HA1
4358,KEGG_2019_Human,TNF signaling pathway,1/110,0.0054999290027479,0.0080999104202618,0,0,19890.0,103488.06969787036,MLKL
4359,KEGG_2019_Human,Necroptosis,1/162,0.0080999104202618,0.0080999104202618,0,0,19838.0,95537.86936302872,MLKL
4360,KEGG_2019_Human,Parkinson disease,1/142,0.0070999171242726,0.0070999171242726,0,0,19858.0,98250.87390500787,UCHL1
4361,KEGG_2019_Human,Ascorbate and aldarate metabolism,1/27,0.0013499718942362,0.004685646776936,0,0,19973.0,131975.02298599784,UGT2B7
4362,KEGG_2019_Human,Pentose and glucuronate interconversions,1/34,0.0016999670339032,0.004685646776936,0,0,19966.0,127326.1054203148,UGT2B7
4363,KEGG_2019_Human,Porphyrin and chlorophyll metabolism,1/42,0.0020999619311272,0.004685646776936,0,0,19958.0,123057.75613441122,UGT2B7
4364,KEGG_2019_Human,Steroid hormone biosynthesis,1/60,0.002999951725986,0.004685646776936,0,0,19940.0,115834.63209072244,UGT2B7
4365,KEGG_2019_Human,Retinol metabolism,1/67,0.0033499481224912,0.004685646776936,0,0,19933.0,113594.38808369274,UGT2B7
4366,KEGG_2019_Human,Metabolism of xenobiotics by cytochrome P450,1/74,0.0036999446830449,0.004685646776936,0,0,19926.0,111574.38983110404,UGT2B7
4367,KEGG_2019_Human,Chemical carcinogenesis,1/82,0.004099940929819,0.004685646776936,0,0,19918.0,109484.9180722932,UGT2B7
4368,KEGG_2019_Human,Drug metabolism,1/108,0.0053999298011749,0.0053999298011749,0,0,19892.0,103863.47861844616,UGT2B7
4369,KEGG_2019_Human,Intestinal immune network for IgA production,1/48,0.0023999583567988,0.0099998661421113,0,0,19952.0,120356.5272753826,LTBR
4370,KEGG_2019_Human,NF-kappa B signaling pathway,1/95,0.0047499351803394,0.0099998661421113,0,0,19905.0,106484.27183626965,LTBR
4371,KEGG_2019_Human,HIF-1 signaling pathway,1/100,0.0049999330710556,0.0099998661421113,0,0,19900.0,105436.78197328727,LTBR
4372,KEGG_2019_Human,Viral carcinogenesis,1/201,0.0100498985877989,0.0131398723072995,0,0,19799.0,91079.21596609056,LTBR
4373,KEGG_2019_Human,Human T-cell leukemia virus 1 infection,1/219,0.0109498935894162,0.0131398723072995,0,0,19781.0,89299.85161916987,LTBR
4374,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0146998751759735,0,0,19706.0,83157.67014793828,LTBR
4375,KEGG_2019_Human,Platelet activation,1/124,0.0061999236097501,0.0106998949514067,0,0,19876.0,101034.04709010696,PPP1R12A
4376,KEGG_2019_Human,Vascular smooth muscle contraction,1/132,0.0065999206698993,0.0106998949514067,0,0,19868.0,99751.22090491928,PPP1R12A
4377,KEGG_2019_Human,Oxytocin signaling pathway,1/153,0.0076499133771537,0.0106998949514067,0,0,19847.0,96715.6407630817,PPP1R12A
4378,KEGG_2019_Human,cGMP-PKG signaling pathway,1/166,0.0082999091363732,0.0106998949514067,0,0,19834.0,95034.82345515196,PPP1R12A
4379,KEGG_2019_Human,Focal adhesion,1/199,0.0099498991610159,0.0106998949514067,0,0,19801.0,91286.4288690606,PPP1R12A
4380,KEGG_2019_Human,Proteoglycans in cancer,1/201,0.0100498985877989,0.0106998949514067,0,0,19799.0,91079.21596609056,PPP1R12A
4381,KEGG_2019_Human,cAMP signaling pathway,1/212,0.0105998955026255,0.0106998949514067,0,0,19788.0,89974.27756224656,PPP1R12A
4382,KEGG_2019_Human,Regulation of actin cytoskeleton,1/214,0.0106998949514067,0.0106998949514067,0,0,19786.0,89779.39753374986,PPP1R12A
4383,KEGG_2019_Human,Fc gamma R-mediated phagocytosis,1/91,0.0045499369072032,0.0045499369072032,0,0,19909.0,107362.10783923086,MYO10
4384,KEGG_2019_Human,Glycosaminoglycan biosynthesis,1/53,0.0026499555173137,0.0026499555173137,0,0,19947.0,118349.78824235698,NDST4
4385,KEGG_2019_Human,Signaling pathways regulating pluripotency of stem cells,1/139,0.006949918172816,0.0092999029651357,0,0,19861.0,98689.81333375497,MEIS1
4386,KEGG_2019_Human,Transcriptional misregulation in cancer,1/186,0.0092999029651357,0.0092999029651357,0,0,19814.0,92684.96451050608,MEIS1
4387,KEGG_2019_Human,Cholinergic synapse,1/112,0.0055999282120529,0.0055999282120529,0,0,19888.0,103119.30984392198,KCNQ2
4388,KEGG_2019_Human,Notch signaling pathway,1/48,0.0023999583567988,0.0117598646428772,0,0,19952.0,120356.5272753826,NOTCH3
4389,KEGG_2019_Human,Th1 and Th2 cell differentiation,1/92,0.0045999364719865,0.0117598646428772,0,0,19908.0,107139.13814408927,NOTCH3
4390,KEGG_2019_Human,Thyroid hormone signaling pathway,1/116,0.0057999266512085,0.0117598646428772,0,0,19884.0,102400.8105961506,NOTCH3
4391,KEGG_2019_Human,Apelin signaling pathway,1/137,0.0068499188797651,0.0117598646428772,0,0,19863.0,98987.62735269018,NOTCH3
4392,KEGG_2019_Human,Breast cancer,1/147,0.0073499154017982,0.0117598646428772,0,0,19853.0,97539.10874372096,NOTCH3
4393,KEGG_2019_Human,MicroRNAs in cancer,1/299,0.0149498740670514,0.0188569913816737,0,0,19701.0,82804.33538735632,NOTCH3
4394,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0188569913816737,0,0,19670.0,80733.60565076157,NOTCH3
4395,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,NOTCH3
4396,KEGG_2019_Human,mRNA surveillance pathway,1/91,0.0045499369072032,0.0082499094553477,0,0,19909.0,107362.10783923086,ACIN1
4397,KEGG_2019_Human,Spliceosome,1/134,0.0066999199497742,0.0082499094553477,0,0,19866.0,99442.43560916925,ACIN1
4398,KEGG_2019_Human,RNA transport,1/165,0.0082499094553477,0.0082499094553477,0,0,19835.0,95159.46482222488,ACIN1
4399,KEGG_2019_Human,RIG-I-like receptor signaling pathway,1/70,0.0034999466296654,0.0113332104923764,0,0,19930.0,112704.30065625212,MAP3K1
4400,KEGG_2019_Human,GnRH signaling pathway,1/93,0.0046499360391879,0.0113332104923764,0,0,19907.0,106918.54242106884,MAP3K1
4401,KEGG_2019_Human,Neurotrophin signaling pathway,1/119,0.0059499254985137,0.0113332104923764,0,0,19881.0,101877.73080211312,MAP3K1
4402,KEGG_2019_Human,Ubiquitin mediated proteolysis,1/137,0.0068499188797651,0.0113332104923764,0,0,19863.0,98987.62735269018,MAP3K1
4403,KEGG_2019_Human,Hepatitis B,1/163,0.0081499100978668,0.0113332104923764,0,0,19837.0,95410.9786681514,MAP3K1
4404,KEGG_2019_Human,Tight junction,1/170,0.0084999078692823,0.0113332104923764,0,0,19830.0,94543.49009679438,MAP3K1
4405,KEGG_2019_Human,Human T-cell leukemia virus 1 infection,1/219,0.0109498935894162,0.01251416410219,0,0,19781.0,89299.85161916987,MAP3K1
4406,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0147498749536506,0,0,19705.0,83086.53988020132,MAP3K1
4407,KEGG_2019_Human,Collecting duct acid secretion,1/27,0.0013499718942362,0.0090998738144064,0,0,19973.0,131975.02298599784,TCIRG1
4408,KEGG_2019_Human,Vibrio cholerae infection,1/50,0.0024999572069037,0.0090998738144064,0,0,19950.0,119530.05920663515,TCIRG1
4409,KEGG_2019_Human,Epithelial cell signaling in Helicobacter pylori infection,1/68,0.0033999476216189,0.0090998738144064,0,0,19932.0,113293.39338050144,TCIRG1
4410,KEGG_2019_Human,Synaptic vesicle cycle,1/78,0.0038999427840466,0.0090998738144064,0,0,19922.0,110503.2180492851,TCIRG1
4411,KEGG_2019_Human,Rheumatoid arthritis,1/91,0.0045499369072032,0.0090998738144064,0,0,19909.0,107362.10783923086,TCIRG1
4412,KEGG_2019_Human,Lysosome,1/123,0.0061499239842961,0.009499886156273,0,0,19877.0,101200.07933676826,TCIRG1
4413,KEGG_2019_Human,Oxidative phosphorylation,1/133,0.0066499203093911,0.009499886156273,0,0,19867.0,99596.2591544721,TCIRG1
4414,KEGG_2019_Human,Phagosome,1/152,0.0075999137114971,0.0094998921393714,0,0,19848.0,96850.665715497,TCIRG1
4415,KEGG_2019_Human,Tuberculosis,1/179,0.0089499050800561,0.0099443389778401,0,0,19821.0,93478.0629355712,TCIRG1
4416,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0164998674589645,0,0,19670.0,80733.60565076157,TCIRG1
4417,KEGG_2019_Human,p53 signaling pathway,1/72,0.0035999456502131,0.0068999185254481,0,0,19928.0,112131.59838572376,RCHY1
4418,KEGG_2019_Human,Ubiquitin mediated proteolysis,1/137,0.0068499188797651,0.0068999185254481,0,0,19863.0,98987.62735269018,RCHY1
4419,KEGG_2019_Human,Measles,1/138,0.0068999185254481,0.0068999185254481,0,0,19862.0,98838.19160389496,RCHY1
4420,KEGG_2019_Human,IL-17 signaling pathway,1/93,0.0046499360391879,0.0046499360391879,0,0,19907.0,106918.54242106884,MAPK4
4421,KEGG_2019_Human,Necroptosis,1/162,0.0080999104202618,0.0080999104202618,0,0,19838.0,95537.86936302872,FAF1
4422,KEGG_2019_Human,mRNA surveillance pathway,1/91,0.0045499369072032,0.0045499369072032,0,0,19909.0,107362.10783923086,GSPT2
4423,KEGG_2019_Human,Bacterial invasion of epithelial cells,1/74,0.0036999446830449,0.0109998527563224,0,0,19926.0,111574.38983110404,FN1
4424,KEGG_2019_Human,ECM-receptor interaction,1/82,0.004099940929819,0.0109998527563224,0,0,19918.0,109484.9180722932,FN1
4425,KEGG_2019_Human,Small cell lung cancer,1/93,0.0046499360391879,0.0109998527563224,0,0,19907.0,106918.54242106884,FN1
4426,KEGG_2019_Human,Amoebiasis,1/96,0.0047999347538706,0.0109998527563224,0,0,19904.0,106270.50039849174,FN1
4427,KEGG_2019_Human,AGE-RAGE signaling pathway in diabetic complications,1/100,0.0049999330710556,0.0109998527563224,0,0,19900.0,105436.78197328727,FN1
4428,KEGG_2019_Human,Focal adhesion,1/199,0.0099498991610159,0.0147123555581843,0,0,19801.0,91286.4288690606,FN1
4429,KEGG_2019_Human,Proteoglycans in cancer,1/201,0.0100498985877989,0.0147123555581843,0,0,19799.0,91079.21596609056,FN1
4430,KEGG_2019_Human,Regulation of actin cytoskeleton,1/214,0.0106998949514067,0.0147123555581843,0,0,19786.0,89779.39753374986,FN1
4431,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0194698489055035,0,0,19670.0,80733.60565076157,FN1
4432,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0194698489055035,0,0,19646.0,79255.8617626126,FN1
4433,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,FN1
4434,KEGG_2019_Human,Cocaine addiction,1/49,0.0024499577795033,0.0100748865256747,0,0,19951.0,119939.1172087114,GNAI2
4435,KEGG_2019_Human,Regulation of lipolysis in adipocytes,1/55,0.0027499544131125,0.0100748865256747,0,0,19945.0,117599.1294878737,GNAI2
4436,KEGG_2019_Human,Long-term depression,1/60,0.002999951725986,0.0100748865256747,0,0,19940.0,115834.63209072244,GNAI2
4437,KEGG_2019_Human,Renin secretion,1/69,0.003449947123837,0.0100748865256747,0,0,19931.0,112996.7391397682,GNAI2
4438,KEGG_2019_Human,Gastric acid secretion,1/75,0.0037499442041125,0.0100748865256747,0,0,19925.0,111301.33528642564,GNAI2
4439,KEGG_2019_Human,Pertussis,1/76,0.0037999437281752,0.0100748865256747,0,0,19924.0,111031.8499691117,GNAI2
4440,KEGG_2019_Human,Gap junction,1/88,0.0043999382262822,0.0100748865256747,0,0,19912.0,108045.79305232369,GNAI2
4441,KEGG_2019_Human,GABAergic synapse,1/89,0.0044499377838098,0.0100748865256747,0,0,19911.0,107815.380281759,GNAI2
4442,KEGG_2019_Human,Morphine addiction,1/91,0.0045499369072032,0.0100748865256747,0,0,19909.0,107362.10783923086,GNAI2
4443,KEGG_2019_Human,Circadian entrainment,1/97,0.0048499343304706,0.0100748865256747,0,0,19903.0,106058.9096435903,GNAI2
4444,KEGG_2019_Human,Progesterone-mediated oocyte maturation,1/99,0.0049499334884068,0.0100748865256747,0,0,19901.0,105642.09305076736,GNAI2
4445,KEGG_2019_Human,Melanogenesis,1/101,0.0050499326546803,0.0100748865256747,0,0,19899.0,105233.48101229242,GNAI2
4446,KEGG_2019_Human,Chagas disease (American trypanosomiasis),1/103,0.0051499318302617,0.0100748865256747,0,0,19897.0,104832.7525292024,GNAI2
4447,KEGG_2019_Human,"Parathyroid hormone synthesis, secretion and action",1/106,0.0052999306076525,0.0100748865256747,0,0,19894.0,104245.78450366124,GNAI2
4448,KEGG_2019_Human,Leukocyte transendothelial migration,1/112,0.0055999282120529,0.0100748865256747,0,0,19888.0,103119.30984392198,GNAI2
4449,KEGG_2019_Human,Cholinergic synapse,1/112,0.0055999282120529,0.0100748865256747,0,0,19888.0,103119.30984392198,GNAI2
4450,KEGG_2019_Human,Toxoplasmosis,1/113,0.0056499278191151,0.0100748865256747,0,0,19887.0,102937.34947211576,GNAI2
4451,KEGG_2019_Human,Serotonergic synapse,1/113,0.0056499278191151,0.0100748865256747,0,0,19887.0,102937.34947211576,GNAI2
4452,KEGG_2019_Human,Glutamatergic synapse,1/114,0.005699927427839,0.0100748865256747,0,0,19886.0,102756.96431429044,GNAI2
4453,KEGG_2019_Human,Sphingolipid signaling pathway,1/119,0.0059499254985137,0.0100748865256747,0,0,19881.0,101877.73080211312,GNAI2
4454,KEGG_2019_Human,Platelet activation,1/124,0.0061999236097501,0.0100748865256747,0,0,19876.0,101034.04709010696,GNAI2
4455,KEGG_2019_Human,Relaxin signaling pathway,1/130,0.0064999213952527,0.0100748865256747,0,0,19870.0,100064.62842845908,GNAI2
4456,KEGG_2019_Human,Dopaminergic synapse,1/131,0.0065499210316603,0.0100748865256747,0,0,19869.0,99907.33811343512,GNAI2
4457,KEGG_2019_Human,Estrogen signaling pathway,1/137,0.0068499188797651,0.0100748865256747,0,0,19863.0,98987.62735269018,GNAI2
4458,KEGG_2019_Human,Apelin signaling pathway,1/137,0.0068499188797651,0.0100748865256747,0,0,19863.0,98987.62735269018,GNAI2
4459,KEGG_2019_Human,Parkinson disease,1/142,0.0070999171242726,0.0100748865256747,0,0,19858.0,98250.87390500787,GNAI2
4460,KEGG_2019_Human,Adrenergic signaling in cardiomyocytes,1/145,0.0072499160871101,0.0100748865256747,0,0,19855.0,97820.92670675044,GNAI2
4461,KEGG_2019_Human,Retrograde endocannabinoid signaling,1/148,0.007399915061391,0.0100748865256747,0,0,19852.0,97399.60470052566,GNAI2
4462,KEGG_2019_Human,Oxytocin signaling pathway,1/153,0.0076499133771537,0.0100748865256747,0,0,19847.0,96715.6407630817,GNAI2
4463,KEGG_2019_Human,Cushing syndrome,1/155,0.0077499127120574,0.0100748865256747,0,0,19845.0,96448.16254952336,GNAI2
4464,KEGG_2019_Human,cGMP-PKG signaling pathway,1/166,0.0082999091363732,0.0104418211715663,0,0,19834.0,95034.82345515196,GNAI2
4465,KEGG_2019_Human,Alcoholism,1/180,0.0089999047745351,0.0106953416472929,0,0,19820.0,93362.92821536642,GNAI2
4466,KEGG_2019_Human,Axon guidance,1/181,0.0090499044707863,0.0106953416472929,0,0,19819.0,93248.41634586031,GNAI2
4467,KEGG_2019_Human,Chemokine signaling pathway,1/190,0.0094999017791995,0.0108969461584936,0,0,19810.0,92244.74636351672,GNAI2
4468,KEGG_2019_Human,Rap1 signaling pathway,1/206,0.010299897173561,0.0111728628270918,0,0,19794.0,90569.849337325,GNAI2
4469,KEGG_2019_Human,Human immunodeficiency virus 1 infection,1/212,0.0105998955026255,0.0111728628270918,0,0,19788.0,89974.27756224656,GNAI2
4470,KEGG_2019_Human,cAMP signaling pathway,1/212,0.0105998955026255,0.0111728628270918,0,0,19788.0,89974.27756224656,GNAI2
4471,KEGG_2019_Human,Human cytomegalovirus infection,1/225,0.0112498919790339,0.0115459417679558,0,0,19775.0,88738.27077557483,GNAI2
4472,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,GNAI2
4473,KEGG_2019_Human,Glycosaminoglycan biosynthesis,1/53,0.0026499555173137,0.0026499555173137,0,0,19947.0,118349.78824235698,CHST2
4474,KEGG_2019_Human,IL-17 signaling pathway,1/93,0.0046499360391879,0.0073332386703305,0,0,19907.0,106918.54242106884,TAB3
4475,KEGG_2019_Human,NF-kappa B signaling pathway,1/95,0.0047499351803394,0.0073332386703305,0,0,19905.0,106484.27183626965,TAB3
4476,KEGG_2019_Human,TNF signaling pathway,1/110,0.0054999290027479,0.0073332386703305,0,0,19890.0,103488.06969787036,TAB3
4477,KEGG_2019_Human,NOD-like receptor signaling pathway,1/178,0.0088999053857096,0.0088999053857096,0,0,19822.0,93593.82745769851,TAB3
4478,KEGG_2019_Human,PPAR signaling pathway,1/74,0.0036999446830449,0.0036999446830449,0,0,19926.0,111574.38983110404,APOA5
4479,KEGG_2019_Human,Glycosaminoglycan biosynthesis,1/53,0.0026499555173137,0.0026499555173137,0,0,19947.0,118349.78824235698,HS3ST5
4480,KEGG_2019_Human,RNA transport,1/165,0.0082499094553477,0.0082499094553477,0,0,19835.0,95159.46482222488,EIF4A1
4481,KEGG_2019_Human,Notch signaling pathway,1/48,0.0023999583567988,0.0095998334271952,0,0,19952.0,120356.5272753826,KAT2A
4482,KEGG_2019_Human,Thyroid hormone signaling pathway,1/116,0.0057999266512085,0.0109498935894162,0,0,19884.0,102400.8105961506,KAT2A
4483,KEGG_2019_Human,Viral carcinogenesis,1/201,0.0100498985877989,0.0109498935894162,0,0,19799.0,91079.21596609056,KAT2A
4484,KEGG_2019_Human,Human T-cell leukemia virus 1 infection,1/219,0.0109498935894162,0.0109498935894162,0,0,19781.0,89299.85161916987,KAT2A
4485,KEGG_2019_Human,"Alanine, aspartate and glutamate metabolism",1/35,0.0017499663721595,0.002849953326298,0,0,19965.0,126740.98858805298,CAD
4486,KEGG_2019_Human,Pyrimidine metabolism,1/57,0.002849953326298,0.002849953326298,0,0,19943.0,116875.00742975442,CAD
4487,KEGG_2019_Human,alpha-Linolenic acid metabolism,1/25,0.0012499733663791,0.0052874076132858,0,0,19975.0,133525.54486996148,PLA2G3
4488,KEGG_2019_Human,Linoleic acid metabolism,1/29,0.001449970461791,0.0052874076132858,0,0,19971.0,130534.69172799008,PLA2G3
4489,KEGG_2019_Human,Fat digestion and absorption,1/41,0.0020499625466866,0.0052874076132858,0,0,19959.0,123544.88783416104,PLA2G3
4490,KEGG_2019_Human,Ether lipid metabolism,1/47,0.0023499589392381,0.0052874076132858,0,0,19953.0,120782.64067395544,PLA2G3
4491,KEGG_2019_Human,Arachidonic acid metabolism,1/63,0.0031499501598827,0.005669910287789,0,0,19937.0,114844.46974572667,PLA2G3
4492,KEGG_2019_Human,Glycerophospholipid metabolism,1/97,0.0048499343304706,0.0062999150247102,0,0,19903.0,106058.9096435903,PLA2G3
4493,KEGG_2019_Human,Pancreatic secretion,1/98,0.0048999339081079,0.0062999150247102,0,0,19902.0,105849.45495286948,PLA2G3
4494,KEGG_2019_Human,Vascular smooth muscle contraction,1/132,0.0065999206698993,0.0074249107536368,0,0,19868.0,99751.22090491928,PLA2G3
4495,KEGG_2019_Human,Ras signaling pathway,1/232,0.0115998901349604,0.0115998901349604,0,0,19768.0,88101.22480150245,PLA2G3
4496,KEGG_2019_Human,Salivary secretion,1/90,0.0044999373439762,0.0044999373439762,0,0,19910.0,107587.50385474482,PRB1
4497,KEGG_2019_Human,Arrhythmogenic right ventricular cardiomyopathy (ARVC),1/72,0.0035999456502131,0.0090998738144064,0,0,19928.0,112131.59838572376,ITGA7
4498,KEGG_2019_Human,ECM-receptor interaction,1/82,0.004099940929819,0.0090998738144064,0,0,19918.0,109484.9180722932,ITGA7
4499,KEGG_2019_Human,Hypertrophic cardiomyopathy (HCM),1/85,0.004249939567045,0.0090998738144064,0,0,19915.0,108752.83801948265,ITGA7
4500,KEGG_2019_Human,Dilated cardiomyopathy (DCM),1/91,0.0045499369072032,0.0090998738144064,0,0,19909.0,107362.10783923086,ITGA7
4501,KEGG_2019_Human,Focal adhesion,1/199,0.0099498991610159,0.0142665266018757,0,0,19801.0,91286.4288690606,ITGA7
4502,KEGG_2019_Human,Regulation of actin cytoskeleton,1/214,0.0106998949514067,0.0142665266018757,0,0,19786.0,89779.39753374986,ITGA7
4503,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0176998626413668,0,0,19670.0,80733.60565076157,ITGA7
4504,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0176998626413668,0,0,19646.0,79255.8617626126,ITGA7
4505,KEGG_2019_Human,Hepatocellular carcinoma,1/168,0.0083999085011095,0.0083999085011095,0,0,19832.0,94787.72752807094,PBRM1
4506,KEGG_2019_Human,Complement and coagulation cascades,1/79,0.0039499423167337,0.012299822789457,0,0,19921.0,110243.89578070649,VWF
4507,KEGG_2019_Human,ECM-receptor interaction,1/82,0.004099940929819,0.012299822789457,0,0,19918.0,109484.9180722932,VWF
4508,KEGG_2019_Human,Platelet activation,1/124,0.0061999236097501,0.0123998472195002,0,0,19876.0,101034.04709010696,VWF
4509,KEGG_2019_Human,Focal adhesion,1/199,0.0099498991610159,0.0149248487415239,0,0,19801.0,91286.4288690606,VWF
4510,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0176998626413668,0,0,19670.0,80733.60565076157,VWF
4511,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0176998626413668,0,0,19646.0,79255.8617626126,VWF
4512,KEGG_2019_Human,Tight junction,1/170,0.0084999078692823,0.0084999078692823,0,0,19830.0,94543.49009679438,AMOTL2
4513,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF764
4514,KEGG_2019_Human,Antigen processing and presentation,1/77,0.0038499432547502,0.0126561284764131,0,0,19923.0,110765.8407373636,CALR
4515,KEGG_2019_Human,Chagas disease (American trypanosomiasis),1/103,0.0051499318302617,0.0126561284764131,0,0,19897.0,104832.7525292024,CALR
4516,KEGG_2019_Human,Phagosome,1/152,0.0075999137114971,0.0126561284764131,0,0,19848.0,96850.665715497,CALR
4517,KEGG_2019_Human,Protein processing in endoplasmic reticulum,1/165,0.0082499094553477,0.0126561284764131,0,0,19835.0,95159.46482222488,CALR
4518,KEGG_2019_Human,Epstein-Barr virus infection,1/201,0.0100498985877989,0.0126561284764131,0,0,19799.0,91079.21596609056,CALR
4519,KEGG_2019_Human,Human immunodeficiency virus 1 infection,1/212,0.0105998955026255,0.0126561284764131,0,0,19788.0,89974.27756224656,CALR
4520,KEGG_2019_Human,Human T-cell leukemia virus 1 infection,1/219,0.0109498935894162,0.0126561284764131,0,0,19781.0,89299.85161916987,CALR
4521,KEGG_2019_Human,Human cytomegalovirus infection,1/225,0.0112498919790339,0.0126561284764131,0,0,19775.0,88738.27077557483,CALR
4522,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,CALR
4523,KEGG_2019_Human,Complement and coagulation cascades,1/79,0.0039499423167337,0.0039499423167337,0,0,19921.0,110243.89578070649,F5
4524,KEGG_2019_Human,Adherens junction,1/72,0.0035999456502131,0.0035999456502131,0,0,19928.0,112131.59838572376,PTPRB
4525,KEGG_2019_Human,Endocytosis,1/244,0.0121998870519305,0.0121998870519305,0,0,19756.0,87051.4275316661,GIT2
4526,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF284
4527,KEGG_2019_Human,Renin secretion,1/69,0.003449947123837,0.0090998738144064,0,0,19931.0,112996.7391397682,PDE1A
4528,KEGG_2019_Human,Taste transduction,1/83,0.0041499404726918,0.0090998738144064,0,0,19917.0,109237.99888847338,PDE1A
4529,KEGG_2019_Human,Morphine addiction,1/91,0.0045499369072032,0.0090998738144064,0,0,19909.0,107362.10783923086,PDE1A
4530,KEGG_2019_Human,Purine metabolism,1/129,0.006449921761047,0.0096748826415705,0,0,19871.0,100223.109907462,PDE1A
4531,KEGG_2019_Human,Calcium signaling pathway,1/188,0.009399902370135,0.011279882844162,0,0,19812.0,92463.712994847,PDE1A
4532,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,PDE1A
4533,KEGG_2019_Human,Ribosome biogenesis in eukaryotes,1/101,0.0050499326546803,0.0050499326546803,0,0,19899.0,105233.48101229242,GAR1
4534,KEGG_2019_Human,ECM-receptor interaction,1/82,0.004099940929819,0.0176998626413668,0,0,19918.0,109484.9180722932,TNN
4535,KEGG_2019_Human,Focal adhesion,1/199,0.0099498991610159,0.0176998626413668,0,0,19801.0,91286.4288690606,TNN
4536,KEGG_2019_Human,MicroRNAs in cancer,1/299,0.0149498740670514,0.0176998626413668,0,0,19701.0,82804.33538735632,TNN
4537,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0176998626413668,0,0,19670.0,80733.60565076157,TNN
4538,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0176998626413668,0,0,19646.0,79255.8617626126,TNN
4539,KEGG_2019_Human,mRNA surveillance pathway,1/91,0.0045499369072032,0.0045499369072032,0,0,19909.0,107362.10783923086,SMG7
4540,KEGG_2019_Human,Inflammatory mediator regulation of TRP channels,1/100,0.0049999330710556,0.0099998661421113,0,0,19900.0,105436.78197328727,P2RY2
4541,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,P2RY2
4542,KEGG_2019_Human,Cell cycle,1/124,0.0061999236097501,0.0062499232373748,0,0,19876.0,101034.04709010696,SMC3
4543,KEGG_2019_Human,Oocyte meiosis,1/125,0.0062499232373748,0.0062499232373748,0,0,19875.0,100869.32368441945,SMC3
4544,KEGG_2019_Human,Pyruvate metabolism,1/39,0.0019499637955508,0.0036999446830449,0,0,19961.0,124555.53162481484,ME1
4545,KEGG_2019_Human,PPAR signaling pathway,1/74,0.0036999446830449,0.0036999446830449,0,0,19926.0,111574.38983110404,ME1
4546,KEGG_2019_Human,Vascular smooth muscle contraction,1/132,0.0065999206698993,0.0106998949514067,0,0,19868.0,99751.22090491928,PPP1R12B
4547,KEGG_2019_Human,Oxytocin signaling pathway,1/153,0.0076499133771537,0.0106998949514067,0,0,19847.0,96715.6407630817,PPP1R12B
4548,KEGG_2019_Human,Focal adhesion,1/199,0.0099498991610159,0.0106998949514067,0,0,19801.0,91286.4288690606,PPP1R12B
4549,KEGG_2019_Human,Proteoglycans in cancer,1/201,0.0100498985877989,0.0106998949514067,0,0,19799.0,91079.21596609056,PPP1R12B
4550,KEGG_2019_Human,Regulation of actin cytoskeleton,1/214,0.0106998949514067,0.0106998949514067,0,0,19786.0,89779.39753374986,PPP1R12B
4551,KEGG_2019_Human,Synaptic vesicle cycle,1/78,0.0038999427840466,0.0038999427840466,0,0,19922.0,110503.2180492851,SLC6A2
4552,KEGG_2019_Human,Ubiquitin mediated proteolysis,1/137,0.0068499188797651,0.0068499188797651,0,0,19863.0,98987.62735269018,RHOBTB1
4553,KEGG_2019_Human,Citrate cycle (TCA cycle),1/30,0.0014999697593334,0.0104997883153344,0,0,19970.0,129851.13732048514,SDHA
4554,KEGG_2019_Human,Oxidative phosphorylation,1/133,0.0066499203093911,0.0112582177134695,0,0,19867.0,99596.2591544721,SDHA
4555,KEGG_2019_Human,Parkinson disease,1/142,0.0070999171242726,0.0112582177134695,0,0,19858.0,98250.87390500787,SDHA
4556,KEGG_2019_Human,Non-alcoholic fatty liver disease (NAFLD),1/149,0.0074499147221605,0.0112582177134695,0,0,19851.0,97261.02051561224,SDHA
4557,KEGG_2019_Human,Alzheimer disease,1/171,0.0085499075557634,0.0112582177134695,0,0,19829.0,94422.42241345016,SDHA
4558,KEGG_2019_Human,Huntington disease,1/193,0.0096499008972596,0.0112582177134695,0,0,19807.0,91920.47679471428,SDHA
4559,KEGG_2019_Human,Thermogenesis,1/231,0.0115498903940656,0.0115498903940656,0,0,19769.0,88191.07730937863,SDHA
4560,KEGG_2019_Human,Viral myocarditis,1/59,0.0029499522555206,0.0068249053608048,0,0,19941.0,116175.59385530632,MYH6
4561,KEGG_2019_Human,Cardiac muscle contraction,1/78,0.0038999427840466,0.0068249053608048,0,0,19922.0,110503.2180492851,MYH6
4562,KEGG_2019_Human,Hypertrophic cardiomyopathy (HCM),1/85,0.004249939567045,0.0068249053608048,0,0,19915.0,108752.83801948265,MYH6
4563,KEGG_2019_Human,Dilated cardiomyopathy (DCM),1/91,0.0045499369072032,0.0068249053608048,0,0,19909.0,107362.10783923086,MYH6
4564,KEGG_2019_Human,Thyroid hormone signaling pathway,1/116,0.0057999266512085,0.0069599119814502,0,0,19884.0,102400.8105961506,MYH6
4565,KEGG_2019_Human,Adrenergic signaling in cardiomyocytes,1/145,0.0072499160871101,0.0072499160871101,0,0,19855.0,97820.92670675044,MYH6
4566,KEGG_2019_Human,mRNA surveillance pathway,1/91,0.0045499369072032,0.0045499369072032,0,0,19909.0,107362.10783923086,NUDT21
4567,KEGG_2019_Human,Cell adhesion molecules (CAMs),1/145,0.0072499160871101,0.0072499160871101,0,0,19855.0,97820.92670675044,NLGN3
4568,KEGG_2019_Human,Cholinergic synapse,1/112,0.0055999282120529,0.0076499133771537,0,0,19888.0,103119.30984392198,KCNJ14
4569,KEGG_2019_Human,Oxytocin signaling pathway,1/153,0.0076499133771537,0.0076499133771537,0,0,19847.0,96715.6407630817,KCNJ14
4570,KEGG_2019_Human,RNA transport,1/165,0.0082499094553477,0.0082499094553477,0,0,19835.0,95159.46482222488,NUP58
4571,KEGG_2019_Human,Spliceosome,1/134,0.0066999199497742,0.0066999199497742,0,0,19866.0,99442.43560916925,SF3A2
4572,KEGG_2019_Human,Leukocyte transendothelial migration,1/112,0.0055999282120529,0.0084999078692823,0,0,19888.0,103119.30984392198,CLDN10
4573,KEGG_2019_Human,Cell adhesion molecules (CAMs),1/145,0.0072499160871101,0.0084999078692823,0,0,19855.0,97820.92670675044,CLDN10
4574,KEGG_2019_Human,Hepatitis C,1/155,0.0077499127120574,0.0084999078692823,0,0,19845.0,96448.16254952336,CLDN10
4575,KEGG_2019_Human,Tight junction,1/170,0.0084999078692823,0.0084999078692823,0,0,19830.0,94543.49009679438,CLDN10
4576,KEGG_2019_Human,Regulation of actin cytoskeleton,1/214,0.0106998949514067,0.0106998949514067,0,0,19786.0,89779.39753374986,NCKAP1
4577,KEGG_2019_Human,Breast cancer,1/147,0.0073499154017982,0.0202998077361807,0,0,19853.0,97539.10874372096,FLT4
4578,KEGG_2019_Human,Focal adhesion,1/199,0.0099498991610159,0.0202998077361807,0,0,19801.0,91286.4288690606,FLT4
4579,KEGG_2019_Human,Rap1 signaling pathway,1/206,0.010299897173561,0.0202998077361807,0,0,19794.0,90569.849337325,FLT4
4580,KEGG_2019_Human,Ras signaling pathway,1/232,0.0115998901349604,0.0202998077361807,0,0,19768.0,88101.22480150245,FLT4
4581,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0206498249351109,0,0,19705.0,83086.53988020132,FLT4
4582,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0206498397482613,0,0,19646.0,79255.8617626126,FLT4
4583,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,FLT4
4584,KEGG_2019_Human,Central carbon metabolism in cancer,1/65,0.003249949134407,0.0059499254985137,0,0,19935.0,114209.92613860144,NTRK3
4585,KEGG_2019_Human,Neurotrophin signaling pathway,1/119,0.0059499254985137,0.0059499254985137,0,0,19881.0,101877.73080211312,NTRK3
4586,KEGG_2019_Human,Protein processing in endoplasmic reticulum,1/165,0.0082499094553477,0.0082499094553477,0,0,19835.0,95159.46482222488,RRBP1
4587,KEGG_2019_Human,SNARE interactions in vesicular transport,1/34,0.0016999670339032,0.0016999670339032,0,0,19966.0,127326.1054203148,YKT6
4588,KEGG_2019_Human,Endocrine and other factor-regulated calcium reabsorption,1/48,0.0023999583567988,0.0047999167135976,0,0,19952.0,120356.5272753826,TRPV5
4589,KEGG_2019_Human,"Parathyroid hormone synthesis, secretion and action",1/106,0.0052999306076525,0.0052999306076525,0,0,19894.0,104245.78450366124,TRPV5
4590,KEGG_2019_Human,Renin-angiotensin system,1/23,0.0011499748819949,0.0022999497639899,0,0,19977.0,135204.63922267244,MAS1
4591,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,MAS1
4592,KEGG_2019_Human,Ubiquitin mediated proteolysis,1/137,0.0068499188797651,0.0068499188797651,0,0,19863.0,98987.62735269018,HERC2
4593,KEGG_2019_Human,ECM-receptor interaction,1/82,0.004099940929819,0.0112998556382303,0,0,19918.0,109484.9180722932,LAMB1
4594,KEGG_2019_Human,Small cell lung cancer,1/93,0.0046499360391879,0.0112998556382303,0,0,19907.0,106918.54242106884,LAMB1
4595,KEGG_2019_Human,Amoebiasis,1/96,0.0047999347538706,0.0112998556382303,0,0,19904.0,106270.50039849174,LAMB1
4596,KEGG_2019_Human,Toxoplasmosis,1/113,0.0056499278191151,0.0112998556382303,0,0,19887.0,102937.34947211576,LAMB1
4597,KEGG_2019_Human,Focal adhesion,1/199,0.0099498991610159,0.0159198386576255,0,0,19801.0,91286.4288690606,LAMB1
4598,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0202284144472764,0,0,19670.0,80733.60565076157,LAMB1
4599,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0202284144472764,0,0,19646.0,79255.8617626126,LAMB1
4600,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,LAMB1
4601,KEGG_2019_Human,NOD-like receptor signaling pathway,1/178,0.0088999053857096,0.0088999053857096,0,0,19822.0,93593.82745769851,DHX33
4602,KEGG_2019_Human,cGMP-PKG signaling pathway,1/166,0.0082999091363732,0.0165998182727465,0,0,19834.0,95034.82345515196,ADRA2C
4603,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,ADRA2C
4604,KEGG_2019_Human,Renal cell carcinoma,1/69,0.003449947123837,0.0103498413715111,0,0,19931.0,112996.7391397682,ARNT2
4605,KEGG_2019_Human,Transcriptional misregulation in cancer,1/186,0.0092999029651357,0.0139498544477036,0,0,19814.0,92684.96451050608,ARNT2
4606,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,ARNT2
4607,KEGG_2019_Human,Endocytosis,1/244,0.0121998870519305,0.0121998870519305,0,0,19756.0,87051.4275316661,RAB11FIP4
4608,KEGG_2019_Human,Bile secretion,1/72,0.0035999456502131,0.0035999456502131,0,0,19928.0,112131.59838572376,SLC22A8
4609,KEGG_2019_Human,RNA transport,1/165,0.0082499094553477,0.0082499094553477,0,0,19835.0,95159.46482222488,DDX20
4610,KEGG_2019_Human,VEGF signaling pathway,1/59,0.0029499522555206,0.0126085762336526,0,0,19941.0,116175.59385530632,RAC2
4611,KEGG_2019_Human,Viral myocarditis,1/59,0.0029499522555206,0.0126085762336526,0,0,19941.0,116175.59385530632,RAC2
4612,KEGG_2019_Human,Fc epsilon RI signaling pathway,1/68,0.0033999476216189,0.0126085762336526,0,0,19932.0,113293.39338050144,RAC2
4613,KEGG_2019_Human,B cell receptor signaling pathway,1/71,0.0035499461386618,0.0126085762336526,0,0,19929.0,112415.9585341616,RAC2
4614,KEGG_2019_Human,Adherens junction,1/72,0.0035999456502131,0.0126085762336526,0,0,19928.0,112131.59838572376,RAC2
4615,KEGG_2019_Human,Pancreatic cancer,1/75,0.0037499442041125,0.0126085762336526,0,0,19925.0,111301.33528642564,RAC2
4616,KEGG_2019_Human,Colorectal cancer,1/86,0.0042999391173866,0.0126085762336526,0,0,19914.0,108514.46102290176,RAC2
4617,KEGG_2019_Human,Fc gamma R-mediated phagocytosis,1/91,0.0045499369072032,0.0126085762336526,0,0,19909.0,107362.10783923086,RAC2
4618,KEGG_2019_Human,Choline metabolism in cancer,1/99,0.0049499334884068,0.0126085762336526,0,0,19901.0,105642.09305076736,RAC2
4619,KEGG_2019_Human,Leukocyte transendothelial migration,1/112,0.0055999282120529,0.0126085762336526,0,0,19888.0,103119.30984392198,RAC2
4620,KEGG_2019_Human,Sphingolipid signaling pathway,1/119,0.0059499254985137,0.0126085762336526,0,0,19881.0,101877.73080211312,RAC2
4621,KEGG_2019_Human,Natural killer cell mediated cytotoxicity,1/131,0.0065499210316603,0.0126085762336526,0,0,19869.0,99907.33811343512,RAC2
4622,KEGG_2019_Human,Fluid shear stress and atherosclerosis,1/139,0.006949918172816,0.0126085762336526,0,0,19861.0,98689.81333375497,RAC2
4623,KEGG_2019_Human,Wnt signaling pathway,1/158,0.0078999117225733,0.0126085762336526,0,0,19842.0,96053.2110949472,RAC2
4624,KEGG_2019_Human,Axon guidance,1/181,0.0090499044707863,0.0126085762336526,0,0,19819.0,93248.41634586031,RAC2
4625,KEGG_2019_Human,Chemokine signaling pathway,1/190,0.0094999017791995,0.0126085762336526,0,0,19810.0,92244.74636351672,RAC2
4626,KEGG_2019_Human,Focal adhesion,1/199,0.0099498991610159,0.0126085762336526,0,0,19801.0,91286.4288690606,RAC2
4627,KEGG_2019_Human,Rap1 signaling pathway,1/206,0.010299897173561,0.0126085762336526,0,0,19794.0,90569.849337325,RAC2
4628,KEGG_2019_Human,Human immunodeficiency virus 1 infection,1/212,0.0105998955026255,0.0126085762336526,0,0,19788.0,89974.27756224656,RAC2
4629,KEGG_2019_Human,cAMP signaling pathway,1/212,0.0105998955026255,0.0126085762336526,0,0,19788.0,89974.27756224656,RAC2
4630,KEGG_2019_Human,Regulation of actin cytoskeleton,1/214,0.0106998949514067,0.0126085762336526,0,0,19786.0,89779.39753374986,RAC2
4631,KEGG_2019_Human,Human cytomegalovirus infection,1/225,0.0112498919790339,0.0126085762336526,0,0,19775.0,88738.27077557483,RAC2
4632,KEGG_2019_Human,Ras signaling pathway,1/232,0.0115998901349604,0.0126085762336526,0,0,19768.0,88101.22480150245,RAC2
4633,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0153644530767194,0,0,19705.0,83086.53988020132,RAC2
4634,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,RAC2
4635,KEGG_2019_Human,Glycosaminoglycan biosynthesis,1/53,0.0026499555173137,0.0026499555173137,0,0,19947.0,118349.78824235698,EXTL3
4636,KEGG_2019_Human,Cytosolic DNA-sensing pathway,1/63,0.0031499501598827,0.0112498919790339,0,0,19937.0,114844.46974572667,RIPK1
4637,KEGG_2019_Human,RIG-I-like receptor signaling pathway,1/70,0.0034999466296654,0.0112498919790339,0,0,19930.0,112704.30065625212,RIPK1
4638,KEGG_2019_Human,NF-kappa B signaling pathway,1/95,0.0047499351803394,0.0112498919790339,0,0,19905.0,106484.27183626965,RIPK1
4639,KEGG_2019_Human,Toll-like receptor signaling pathway,1/104,0.0051999314202997,0.0112498919790339,0,0,19896.0,104635.24941415618,RIPK1
4640,KEGG_2019_Human,TNF signaling pathway,1/110,0.0054999290027479,0.0112498919790339,0,0,19890.0,103488.06969787036,RIPK1
4641,KEGG_2019_Human,Apoptosis,1/143,0.0071499167770442,0.0112498919790339,0,0,19857.0,98106.57763600958,RIPK1
4642,KEGG_2019_Human,Hepatitis C,1/155,0.0077499127120574,0.0112498919790339,0,0,19845.0,96448.16254952336,RIPK1
4643,KEGG_2019_Human,Necroptosis,1/162,0.0080999104202618,0.0112498919790339,0,0,19838.0,95537.86936302872,RIPK1
4644,KEGG_2019_Human,NOD-like receptor signaling pathway,1/178,0.0088999053857096,0.0112498919790339,0,0,19822.0,93593.82745769851,RIPK1
4645,KEGG_2019_Human,Epstein-Barr virus infection,1/201,0.0100498985877989,0.0112498919790339,0,0,19799.0,91079.21596609056,RIPK1
4646,KEGG_2019_Human,Human immunodeficiency virus 1 infection,1/212,0.0105998955026255,0.0112498919790339,0,0,19788.0,89974.27756224656,RIPK1
4647,KEGG_2019_Human,Human cytomegalovirus infection,1/225,0.0112498919790339,0.0112498919790339,0,0,19775.0,88738.27077557483,RIPK1
4648,KEGG_2019_Human,Glycerophospholipid metabolism,1/97,0.0048499343304706,0.0055999282120529,0,0,19903.0,106058.9096435903,CHAT
4649,KEGG_2019_Human,Cholinergic synapse,1/112,0.0055999282120529,0.0055999282120529,0,0,19888.0,103119.30984392198,CHAT
4650,KEGG_2019_Human,Inositol phosphate metabolism,1/74,0.0036999446830449,0.0049499334884068,0,0,19926.0,111574.38983110404,INPP4A
4651,KEGG_2019_Human,Phosphatidylinositol signaling system,1/99,0.0049499334884068,0.0049499334884068,0,0,19901.0,105642.09305076736,INPP4A
4652,KEGG_2019_Human,Maturity onset diabetes of the young,1/26,0.0012999726251831,0.0012999726251831,0,0,19974.0,132735.46073187632,MNX1
4653,KEGG_2019_Human,Tyrosine metabolism,1/36,0.0017999657178272,0.0047832644181221,0,0,19964.0,126172.23364250171,ADH1A
4654,KEGG_2019_Human,Fatty acid degradation,1/44,0.0021999607179423,0.0047832644181221,0,0,19956.0,122117.06559109331,ADH1A
4655,KEGG_2019_Human,Retinol metabolism,1/67,0.0033499481224912,0.0047832644181221,0,0,19933.0,113594.38808369274,ADH1A
4656,KEGG_2019_Human,Glycolysis / Gluconeogenesis,1/68,0.0033999476216189,0.0047832644181221,0,0,19932.0,113293.39338050144,ADH1A
4657,KEGG_2019_Human,Metabolism of xenobiotics by cytochrome P450,1/74,0.0036999446830449,0.0047832644181221,0,0,19926.0,111574.38983110404,ADH1A
4658,KEGG_2019_Human,Chemical carcinogenesis,1/82,0.004099940929819,0.0047832644181221,0,0,19918.0,109484.9180722932,ADH1A
4659,KEGG_2019_Human,Drug metabolism,1/108,0.0053999298011749,0.0053999298011749,0,0,19892.0,103863.47861844616,ADH1A
4660,KEGG_2019_Human,Endocrine and other factor-regulated calcium reabsorption,1/48,0.0023999583567988,0.0077998855680932,0,0,19952.0,120356.5272753826,CLTCL1
4661,KEGG_2019_Human,Bacterial invasion of epithelial cells,1/74,0.0036999446830449,0.0077998855680932,0,0,19926.0,111574.38983110404,CLTCL1
4662,KEGG_2019_Human,Synaptic vesicle cycle,1/78,0.0038999427840466,0.0077998855680932,0,0,19922.0,110503.2180492851,CLTCL1
4663,KEGG_2019_Human,Lysosome,1/123,0.0061499239842961,0.0092248859764442,0,0,19877.0,101200.07933676826,CLTCL1
4664,KEGG_2019_Human,Huntington disease,1/193,0.0096499008972596,0.0115798810767115,0,0,19807.0,91920.47679471428,CLTCL1
4665,KEGG_2019_Human,Endocytosis,1/244,0.0121998870519305,0.0121998870519305,0,0,19756.0,87051.4275316661,CLTCL1
4666,KEGG_2019_Human,Retinol metabolism,1/67,0.0033499481224912,0.0033499481224912,0,0,19933.0,113594.38808369274,RDH10
4667,KEGG_2019_Human,Amphetamine addiction,1/68,0.0033999476216189,0.0092398889378591,0,0,19932.0,113293.39338050144,SIRT1
4668,KEGG_2019_Human,Longevity regulating pathway,1/102,0.0050999322416682,0.0092398889378591,0,0,19898.0,105032.15064717118,SIRT1
4669,KEGG_2019_Human,Glucagon signaling pathway,1/103,0.0051499318302617,0.0092398889378591,0,0,19897.0,104832.7525292024,SIRT1
4670,KEGG_2019_Human,AMPK signaling pathway,1/120,0.0059999251180858,0.0092398889378591,0,0,19880.0,101706.2448082016,SIRT1
4671,KEGG_2019_Human,FoxO signaling pathway,1/132,0.0065999206698993,0.0092398889378591,0,0,19868.0,99751.22090491928,SIRT1
4672,KEGG_2019_Human,Cellular senescence,1/160,0.0079999110688441,0.0093332295803181,0,0,19840.0,95793.96509856998,SIRT1
4673,KEGG_2019_Human,MicroRNAs in cancer,1/299,0.0149498740670514,0.0149498740670514,0,0,19701.0,82804.33538735632,SIRT1
4674,KEGG_2019_Human,Inositol phosphate metabolism,1/74,0.0036999446830449,0.0063999221281459,0,0,19926.0,111574.38983110404,MTMR3
4675,KEGG_2019_Human,Phosphatidylinositol signaling system,1/99,0.0049499334884068,0.0063999221281459,0,0,19901.0,105642.09305076736,MTMR3
4676,KEGG_2019_Human,Autophagy,1/128,0.0063999221281459,0.0063999221281459,0,0,19872.0,100382.8010329652,MTMR3
4677,KEGG_2019_Human,Thiamine metabolism,1/15,0.0007499814841592997,0.0012999726251831,0,0,19985.0,143801.30885993244,ALPL
4678,KEGG_2019_Human,Folate biosynthesis,1/26,0.0012999726251831,0.0012999726251831,0,0,19974.0,132735.46073187632,ALPL
4679,KEGG_2019_Human,Dopaminergic synapse,1/131,0.0065499210316603,0.0065499210316603,0,0,19869.0,99907.33811343512,SCN1A
4680,KEGG_2019_Human,Ovarian steroidogenesis,1/49,0.0024499577795033,0.0096350266149903,0,0,19951.0,119939.1172087114,ADCY8
4681,KEGG_2019_Human,Regulation of lipolysis in adipocytes,1/55,0.0027499544131125,0.0096350266149903,0,0,19945.0,117599.1294878737,ADCY8
4682,KEGG_2019_Human,Cortisol synthesis and secretion,1/65,0.003249949134407,0.0096350266149903,0,0,19935.0,114209.92613860144,ADCY8
4683,KEGG_2019_Human,Long-term potentiation,1/67,0.0033499481224912,0.0096350266149903,0,0,19933.0,113594.38808369274,ADCY8
4684,KEGG_2019_Human,Bile secretion,1/72,0.0035999456502131,0.0096350266149903,0,0,19928.0,112131.59838572376,ADCY8
4685,KEGG_2019_Human,Thyroid hormone synthesis,1/74,0.0036999446830449,0.0096350266149903,0,0,19926.0,111574.38983110404,ADCY8
4686,KEGG_2019_Human,Gastric acid secretion,1/75,0.0037499442041125,0.0096350266149903,0,0,19925.0,111301.33528642564,ADCY8
4687,KEGG_2019_Human,Taste transduction,1/83,0.0041499404726918,0.0096350266149903,0,0,19917.0,109237.99888847338,ADCY8
4688,KEGG_2019_Human,Insulin secretion,1/86,0.0042999391173866,0.0096350266149903,0,0,19914.0,108514.46102290176,ADCY8
4689,KEGG_2019_Human,Gap junction,1/88,0.0043999382262822,0.0096350266149903,0,0,19912.0,108045.79305232369,ADCY8
4690,KEGG_2019_Human,GABAergic synapse,1/89,0.0044499377838098,0.0096350266149903,0,0,19911.0,107815.380281759,ADCY8
4691,KEGG_2019_Human,Salivary secretion,1/90,0.0044999373439762,0.0096350266149903,0,0,19910.0,107587.50385474482,ADCY8
4692,KEGG_2019_Human,Dilated cardiomyopathy (DCM),1/91,0.0045499369072032,0.0096350266149903,0,0,19909.0,107362.10783923086,ADCY8
4693,KEGG_2019_Human,Morphine addiction,1/91,0.0045499369072032,0.0096350266149903,0,0,19909.0,107362.10783923086,ADCY8
4694,KEGG_2019_Human,GnRH signaling pathway,1/93,0.0046499360391879,0.0096350266149903,0,0,19907.0,106918.54242106884,ADCY8
4695,KEGG_2019_Human,Circadian entrainment,1/97,0.0048499343304706,0.0096350266149903,0,0,19903.0,106058.9096435903,ADCY8
4696,KEGG_2019_Human,Pancreatic secretion,1/98,0.0048999339081079,0.0096350266149903,0,0,19902.0,105849.45495286948,ADCY8
4697,KEGG_2019_Human,Aldosterone synthesis and secretion,1/98,0.0048999339081079,0.0096350266149903,0,0,19902.0,105849.45495286948,ADCY8
4698,KEGG_2019_Human,Progesterone-mediated oocyte maturation,1/99,0.0049499334884068,0.0096350266149903,0,0,19901.0,105642.09305076736,ADCY8
4699,KEGG_2019_Human,Inflammatory mediator regulation of TRP channels,1/100,0.0049999330710556,0.0096350266149903,0,0,19900.0,105436.78197328727,ADCY8
4700,KEGG_2019_Human,Melanogenesis,1/101,0.0050499326546803,0.0096350266149903,0,0,19899.0,105233.48101229242,ADCY8
4701,KEGG_2019_Human,Longevity regulating pathway,1/102,0.0050999322416682,0.0096350266149903,0,0,19898.0,105032.15064717118,ADCY8
4702,KEGG_2019_Human,"Parathyroid hormone synthesis, secretion and action",1/106,0.0052999306076525,0.0096350266149903,0,0,19894.0,104245.78450366124,ADCY8
4703,KEGG_2019_Human,Cholinergic synapse,1/112,0.0055999282120529,0.0096350266149903,0,0,19888.0,103119.30984392198,ADCY8
4704,KEGG_2019_Human,Glutamatergic synapse,1/114,0.005699927427839,0.0096350266149903,0,0,19886.0,102756.96431429044,ADCY8
4705,KEGG_2019_Human,Platelet activation,1/124,0.0061999236097501,0.0096350266149903,0,0,19876.0,101034.04709010696,ADCY8
4706,KEGG_2019_Human,Oocyte meiosis,1/125,0.0062499232373748,0.0096350266149903,0,0,19875.0,100869.32368441945,ADCY8
4707,KEGG_2019_Human,Purine metabolism,1/129,0.006449921761047,0.0096350266149903,0,0,19871.0,100223.109907462,ADCY8
4708,KEGG_2019_Human,Relaxin signaling pathway,1/130,0.0064999213952527,0.0096350266149903,0,0,19870.0,100064.62842845908,ADCY8
4709,KEGG_2019_Human,Vascular smooth muscle contraction,1/132,0.0065999206698993,0.0096350266149903,0,0,19868.0,99751.22090491928,ADCY8
4710,KEGG_2019_Human,Estrogen signaling pathway,1/137,0.0068499188797651,0.0096350266149903,0,0,19863.0,98987.62735269018,ADCY8
4711,KEGG_2019_Human,Apelin signaling pathway,1/137,0.0068499188797651,0.0096350266149903,0,0,19863.0,98987.62735269018,ADCY8
4712,KEGG_2019_Human,Adrenergic signaling in cardiomyocytes,1/145,0.0072499160871101,0.0096350266149903,0,0,19855.0,97820.92670675044,ADCY8
4713,KEGG_2019_Human,Phospholipase D signaling pathway,1/148,0.007399915061391,0.0096350266149903,0,0,19852.0,97399.60470052566,ADCY8
4714,KEGG_2019_Human,Retrograde endocannabinoid signaling,1/148,0.007399915061391,0.0096350266149903,0,0,19852.0,97399.60470052566,ADCY8
4715,KEGG_2019_Human,Oxytocin signaling pathway,1/153,0.0076499133771537,0.0096350266149903,0,0,19847.0,96715.6407630817,ADCY8
4716,KEGG_2019_Human,Cushing syndrome,1/155,0.0077499127120574,0.0096350266149903,0,0,19845.0,96448.16254952336,ADCY8
4717,KEGG_2019_Human,cGMP-PKG signaling pathway,1/166,0.0082999091363732,0.0100472584282413,0,0,19834.0,95034.82345515196,ADCY8
4718,KEGG_2019_Human,Calcium signaling pathway,1/188,0.009399902370135,0.0109248870460795,0,0,19812.0,92463.712994847,ADCY8
4719,KEGG_2019_Human,Chemokine signaling pathway,1/190,0.0094999017791995,0.0109248870460795,0,0,19810.0,92244.74636351672,ADCY8
4720,KEGG_2019_Human,Rap1 signaling pathway,1/206,0.010299897173561,0.011555982194727,0,0,19794.0,90569.849337325,ADCY8
4721,KEGG_2019_Human,cAMP signaling pathway,1/212,0.0105998955026255,0.0116094093600185,0,0,19788.0,89974.27756224656,ADCY8
4722,KEGG_2019_Human,Human T-cell leukemia virus 1 infection,1/219,0.0109498935894162,0.0117138396537941,0,0,19781.0,89299.85161916987,ADCY8
4723,KEGG_2019_Human,Human cytomegalovirus infection,1/225,0.0112498919790339,0.0117612507053536,0,0,19775.0,88738.27077557483,ADCY8
4724,KEGG_2019_Human,Thermogenesis,1/231,0.0115498903940656,0.0118065546250448,0,0,19769.0,88191.07730937863,ADCY8
4725,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,ADCY8
4726,KEGG_2019_Human,Gastric acid secretion,1/75,0.0037499442041125,0.0037499442041125,0,0,19925.0,111301.33528642564,SLC26A7
4727,KEGG_2019_Human,Basal transcription factors,1/45,0.0022499601197094,0.0044999202394188,0,0,19955.0,121662.49782449217,TAF4
4728,KEGG_2019_Human,Huntington disease,1/193,0.0096499008972596,0.0096499008972596,0,0,19807.0,91920.47679471428,TAF4
4729,KEGG_2019_Human,Toll-like receptor signaling pathway,1/104,0.0051999314202997,0.012399870620181,0,0,19896.0,104635.24941415618,TLR3
4730,KEGG_2019_Human,Hepatitis C,1/155,0.0077499127120574,0.012399870620181,0,0,19845.0,96448.16254952336,TLR3
4731,KEGG_2019_Human,Necroptosis,1/162,0.0080999104202618,0.012399870620181,0,0,19838.0,95537.86936302872,TLR3
4732,KEGG_2019_Human,Hepatitis B,1/163,0.0081499100978668,0.012399870620181,0,0,19837.0,95410.9786681514,TLR3
4733,KEGG_2019_Human,Influenza A,1/171,0.0085499075557634,0.012399870620181,0,0,19829.0,94422.42241345016,TLR3
4734,KEGG_2019_Human,Kaposi sarcoma-associated herpesvirus infection,1/186,0.0092999029651357,0.012399870620181,0,0,19814.0,92684.96451050608,TLR3
4735,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0188569913816737,0,0,19670.0,80733.60565076157,TLR3
4736,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,TLR3
4737,KEGG_2019_Human,Peroxisome,1/83,0.0041499404726918,0.0041499404726918,0,0,19917.0,109237.99888847338,PEX5L
4738,KEGG_2019_Human,ECM-receptor interaction,1/82,0.004099940929819,0.0112998556382303,0,0,19918.0,109484.9180722932,LAMA1
4739,KEGG_2019_Human,Small cell lung cancer,1/93,0.0046499360391879,0.0112998556382303,0,0,19907.0,106918.54242106884,LAMA1
4740,KEGG_2019_Human,Amoebiasis,1/96,0.0047999347538706,0.0112998556382303,0,0,19904.0,106270.50039849174,LAMA1
4741,KEGG_2019_Human,Toxoplasmosis,1/113,0.0056499278191151,0.0112998556382303,0,0,19887.0,102937.34947211576,LAMA1
4742,KEGG_2019_Human,Focal adhesion,1/199,0.0099498991610159,0.0159198386576255,0,0,19801.0,91286.4288690606,LAMA1
4743,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0202284144472764,0,0,19670.0,80733.60565076157,LAMA1
4744,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0202284144472764,0,0,19646.0,79255.8617626126,LAMA1
4745,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,LAMA1
4746,KEGG_2019_Human,Nicotine addiction,1/40,0.0019999631680592,0.0084748917286727,0,0,19960.0,124043.94523066044,GABRB2
4747,KEGG_2019_Human,GABAergic synapse,1/89,0.0044499377838098,0.0084748917286727,0,0,19911.0,107815.380281759,GABRB2
4748,KEGG_2019_Human,Morphine addiction,1/91,0.0045499369072032,0.0084748917286727,0,0,19909.0,107362.10783923086,GABRB2
4749,KEGG_2019_Human,Serotonergic synapse,1/113,0.0056499278191151,0.0084748917286727,0,0,19887.0,102937.34947211576,GABRB2
4750,KEGG_2019_Human,Retrograde endocannabinoid signaling,1/148,0.007399915061391,0.0088798980736692,0,0,19852.0,97399.60470052566,GABRB2
4751,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,GABRB2
4752,KEGG_2019_Human,Insulin secretion,1/86,0.0042999391173866,0.0042999391173866,0,0,19914.0,108514.46102290176,TRPM4
4753,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0146998751759735,0,0,19706.0,83157.67014793828,BMP3
4754,KEGG_2019_Human,Glutamatergic synapse,1/114,0.005699927427839,0.011399854855678,0,0,19886.0,102756.96431429044,GRIK2
4755,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,GRIK2
4756,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF83
4757,KEGG_2019_Human,Oxidative phosphorylation,1/133,0.0066499203093911,0.0112582177134695,0,0,19867.0,99596.2591544721,NDUFB10
4758,KEGG_2019_Human,Parkinson disease,1/142,0.0070999171242726,0.0112582177134695,0,0,19858.0,98250.87390500787,NDUFB10
4759,KEGG_2019_Human,Retrograde endocannabinoid signaling,1/148,0.007399915061391,0.0112582177134695,0,0,19852.0,97399.60470052566,NDUFB10
4760,KEGG_2019_Human,Non-alcoholic fatty liver disease (NAFLD),1/149,0.0074499147221605,0.0112582177134695,0,0,19851.0,97261.02051561224,NDUFB10
4761,KEGG_2019_Human,Alzheimer disease,1/171,0.0085499075557634,0.0112582177134695,0,0,19829.0,94422.42241345016,NDUFB10
4762,KEGG_2019_Human,Huntington disease,1/193,0.0096499008972596,0.0112582177134695,0,0,19807.0,91920.47679471428,NDUFB10
4763,KEGG_2019_Human,Thermogenesis,1/231,0.0115498903940656,0.0115498903940656,0,0,19769.0,88191.07730937863,NDUFB10
4764,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF331
4765,KEGG_2019_Human,Phenylalanine metabolism,1/17,0.0008499797390404818,0.0035999314356544,0,0,19983.0,141285.76583697114,ALDH3B2
4766,KEGG_2019_Human,Histidine metabolism,1/23,0.0011499748819949,0.0035999314356544,0,0,19977.0,135204.63922267244,ALDH3B2
4767,KEGG_2019_Human,beta-Alanine metabolism,1/31,0.0015499690656704,0.0035999314356544,0,0,19969.0,129189.85098816035,ALDH3B2
4768,KEGG_2019_Human,Tyrosine metabolism,1/36,0.0017999657178272,0.0035999314356544,0,0,19964.0,126172.23364250171,ALDH3B2
4769,KEGG_2019_Human,Glycolysis / Gluconeogenesis,1/68,0.0033999476216189,0.004685646776936,0,0,19932.0,113293.39338050144,ALDH3B2
4770,KEGG_2019_Human,Metabolism of xenobiotics by cytochrome P450,1/74,0.0036999446830449,0.004685646776936,0,0,19926.0,111574.38983110404,ALDH3B2
4771,KEGG_2019_Human,Chemical carcinogenesis,1/82,0.004099940929819,0.004685646776936,0,0,19918.0,109484.9180722932,ALDH3B2
4772,KEGG_2019_Human,Drug metabolism,1/108,0.0053999298011749,0.0053999298011749,0,0,19892.0,103863.47861844616,ALDH3B2
4773,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR11G2
4774,KEGG_2019_Human,Ubiquitin mediated proteolysis,1/137,0.0068499188797651,0.0068499188797651,0,0,19863.0,98987.62735269018,TRIM32
4775,KEGG_2019_Human,Base excision repair,1/33,0.0016499677032113,0.0016499677032113,0,0,19967.0,127928.56031580272,OGG1
4776,KEGG_2019_Human,Natural killer cell mediated cytotoxicity,1/131,0.0065499210316603,0.0065499210316603,0,0,19869.0,99907.33811343512,SH2D1A
4777,KEGG_2019_Human,Malaria,1/49,0.0024499577795033,0.0100427069968364,0,0,19951.0,119939.1172087114,MET
4778,KEGG_2019_Human,Central carbon metabolism in cancer,1/65,0.003249949134407,0.0100427069968364,0,0,19935.0,114209.92613860144,MET
4779,KEGG_2019_Human,Epithelial cell signaling in Helicobacter pylori infection,1/68,0.0033999476216189,0.0100427069968364,0,0,19932.0,113293.39338050144,MET
4780,KEGG_2019_Human,Renal cell carcinoma,1/69,0.003449947123837,0.0100427069968364,0,0,19931.0,112996.7391397682,MET
4781,KEGG_2019_Human,Adherens junction,1/72,0.0035999456502131,0.0100427069968364,0,0,19928.0,112131.59838572376,MET
4782,KEGG_2019_Human,Melanoma,1/72,0.0035999456502131,0.0100427069968364,0,0,19928.0,112131.59838572376,MET
4783,KEGG_2019_Human,Bacterial invasion of epithelial cells,1/74,0.0036999446830449,0.0100427069968364,0,0,19926.0,111574.38983110404,MET
4784,KEGG_2019_Human,Gastric cancer,1/149,0.0074499147221605,0.0139784318784042,0,0,19851.0,97261.02051561224,MET
4785,KEGG_2019_Human,Hepatocellular carcinoma,1/168,0.0083999085011095,0.0139784318784042,0,0,19832.0,94787.72752807094,MET
4786,KEGG_2019_Human,Axon guidance,1/181,0.0090499044707863,0.0139784318784042,0,0,19819.0,93248.41634586031,MET
4787,KEGG_2019_Human,Transcriptional misregulation in cancer,1/186,0.0092999029651357,0.0139784318784042,0,0,19814.0,92684.96451050608,MET
4788,KEGG_2019_Human,Focal adhesion,1/199,0.0099498991610159,0.0139784318784042,0,0,19801.0,91286.4288690606,MET
4789,KEGG_2019_Human,Proteoglycans in cancer,1/201,0.0100498985877989,0.0139784318784042,0,0,19799.0,91079.21596609056,MET
4790,KEGG_2019_Human,Rap1 signaling pathway,1/206,0.010299897173561,0.0139784318784042,0,0,19794.0,90569.849337325,MET
4791,KEGG_2019_Human,Ras signaling pathway,1/232,0.0115998901349604,0.0146931941709498,0,0,19768.0,88101.22480150245,MET
4792,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0167086827808222,0,0,19705.0,83086.53988020132,MET
4793,KEGG_2019_Human,MicroRNAs in cancer,1/299,0.0149498740670514,0.0167086827808222,0,0,19701.0,82804.33538735632,MET
4794,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.018683188343665,0,0,19646.0,79255.8617626126,MET
4795,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,MET
4796,KEGG_2019_Human,Axon guidance,1/181,0.0090499044707863,0.0090499044707863,0,0,19819.0,93248.41634586031,ABLIM1
4797,KEGG_2019_Human,Other types of O-glycan biosynthesis,1/22,0.0010999756574123,0.0010999756574123,0,0,19978.0,136099.47030191717,B3GLCT
4798,KEGG_2019_Human,Phospholipase D signaling pathway,1/148,0.007399915061391,0.0121998870519305,0,0,19852.0,97399.60470052566,CYTH1
4799,KEGG_2019_Human,Endocytosis,1/244,0.0121998870519305,0.0121998870519305,0,0,19756.0,87051.4275316661,CYTH1
4800,KEGG_2019_Human,Inositol phosphate metabolism,1/74,0.0036999446830449,0.0115998901349604,0,0,19926.0,111574.38983110404,PLCE1
4801,KEGG_2019_Human,Phosphatidylinositol signaling system,1/99,0.0049499334884068,0.0115998901349604,0,0,19901.0,105642.09305076736,PLCE1
4802,KEGG_2019_Human,AGE-RAGE signaling pathway in diabetic complications,1/100,0.0049999330710556,0.0115998901349604,0,0,19900.0,105436.78197328727,PLCE1
4803,KEGG_2019_Human,Thyroid hormone signaling pathway,1/116,0.0057999266512085,0.0115998901349604,0,0,19884.0,102400.8105961506,PLCE1
4804,KEGG_2019_Human,Calcium signaling pathway,1/188,0.009399902370135,0.0115998901349604,0,0,19812.0,92463.712994847,PLCE1
4805,KEGG_2019_Human,Proteoglycans in cancer,1/201,0.0100498985877989,0.0115998901349604,0,0,19799.0,91079.21596609056,PLCE1
4806,KEGG_2019_Human,Rap1 signaling pathway,1/206,0.010299897173561,0.0115998901349604,0,0,19794.0,90569.849337325,PLCE1
4807,KEGG_2019_Human,cAMP signaling pathway,1/212,0.0105998955026255,0.0115998901349604,0,0,19788.0,89974.27756224656,PLCE1
4808,KEGG_2019_Human,Ras signaling pathway,1/232,0.0115998901349604,0.0115998901349604,0,0,19768.0,88101.22480150245,PLCE1
4809,KEGG_2019_Human,Cortisol synthesis and secretion,1/65,0.003249949134407,0.0064998982688141,0,0,19935.0,114209.92613860144,NR5A1
4810,KEGG_2019_Human,Cushing syndrome,1/155,0.0077499127120574,0.0077499127120574,0,0,19845.0,96448.16254952336,NR5A1
4811,KEGG_2019_Human,Lysosome,1/123,0.0061499239842961,0.0071499167770442,0,0,19877.0,101200.07933676826,CTSF
4812,KEGG_2019_Human,Apoptosis,1/143,0.0071499167770442,0.0071499167770442,0,0,19857.0,98106.57763600958,CTSF
4813,KEGG_2019_Human,Arginine biosynthesis,1/21,0.0010499764455398,0.0010499764455398,0,0,19979.0,137035.71221916509,ACY1
4814,KEGG_2019_Human,Malaria,1/49,0.0024499577795033,0.0024499577795033,0,0,19951.0,119939.1172087114,ACKR1
4815,KEGG_2019_Human,Signaling pathways regulating pluripotency of stem cells,1/139,0.006949918172816,0.006949918172816,0,0,19861.0,98689.81333375497,KAT6A
4816,KEGG_2019_Human,Morphine addiction,1/91,0.0045499369072032,0.0096748826415705,0,0,19909.0,107362.10783923086,PDE10A
4817,KEGG_2019_Human,Purine metabolism,1/129,0.006449921761047,0.0096748826415705,0,0,19871.0,100223.109907462,PDE10A
4818,KEGG_2019_Human,cAMP signaling pathway,1/212,0.0105998955026255,0.0105998955026255,0,0,19788.0,89974.27756224656,PDE10A
4819,KEGG_2019_Human,Type II diabetes mellitus,1/46,0.0022999595269283,0.0069998932593308,0,0,19954.0,121217.8313311442,SOCS4
4820,KEGG_2019_Human,Prolactin signaling pathway,1/70,0.0034999466296654,0.0069998932593308,0,0,19930.0,112704.30065625212,SOCS4
4821,KEGG_2019_Human,Insulin signaling pathway,1/137,0.0068499188797651,0.0080999104202618,0,0,19863.0,98987.62735269018,SOCS4
4822,KEGG_2019_Human,JAK-STAT signaling pathway,1/162,0.0080999104202618,0.0080999104202618,0,0,19838.0,95537.86936302872,SOCS4
4823,KEGG_2019_Human,Thyroid hormone signaling pathway,1/116,0.0057999266512085,0.0057999266512085,0,0,19884.0,102400.8105961506,DIO2
4824,KEGG_2019_Human,Fc gamma R-mediated phagocytosis,1/91,0.0045499369072032,0.0090998738144064,0,0,19909.0,107362.10783923086,AMPH
4825,KEGG_2019_Human,Endocytosis,1/244,0.0121998870519305,0.0121998870519305,0,0,19756.0,87051.4275316661,AMPH
4826,KEGG_2019_Human,Hepatocellular carcinoma,1/168,0.0083999085011095,0.0115498903940656,0,0,19832.0,94787.72752807094,ACTL6B
4827,KEGG_2019_Human,Thermogenesis,1/231,0.0115498903940656,0.0115498903940656,0,0,19769.0,88191.07730937863,ACTL6B
4828,KEGG_2019_Human,"Parathyroid hormone synthesis, secretion and action",1/106,0.0052999306076525,0.0052999306076525,0,0,19894.0,104245.78450366124,MAFB
4829,KEGG_2019_Human,Aldosterone-regulated sodium reabsorption,1/37,0.0018499650702878,0.0036999301405757,0,0,19963.0,125618.9446446357,SCNN1A
4830,KEGG_2019_Human,Taste transduction,1/83,0.0041499404726918,0.0041499404726918,0,0,19917.0,109237.99888847338,SCNN1A
4831,KEGG_2019_Human,Arrhythmogenic right ventricular cardiomyopathy (ARVC),1/72,0.0035999456502131,0.0103398926071485,0,0,19928.0,112131.59838572376,ATP2A2
4832,KEGG_2019_Human,Cardiac muscle contraction,1/78,0.0038999427840466,0.0103398926071485,0,0,19922.0,110503.2180492851,ATP2A2
4833,KEGG_2019_Human,Hypertrophic cardiomyopathy (HCM),1/85,0.004249939567045,0.0103398926071485,0,0,19915.0,108752.83801948265,ATP2A2
4834,KEGG_2019_Human,Dilated cardiomyopathy (DCM),1/91,0.0045499369072032,0.0103398926071485,0,0,19909.0,107362.10783923086,ATP2A2
4835,KEGG_2019_Human,Pancreatic secretion,1/98,0.0048999339081079,0.0103398926071485,0,0,19902.0,105849.45495286948,ATP2A2
4836,KEGG_2019_Human,Thyroid hormone signaling pathway,1/116,0.0057999266512085,0.0103398926071485,0,0,19884.0,102400.8105961506,ATP2A2
4837,KEGG_2019_Human,Adrenergic signaling in cardiomyocytes,1/145,0.0072499160871101,0.0103398926071485,0,0,19855.0,97820.92670675044,ATP2A2
4838,KEGG_2019_Human,cGMP-PKG signaling pathway,1/166,0.0082999091363732,0.0103398926071485,0,0,19834.0,95034.82345515196,ATP2A2
4839,KEGG_2019_Human,Alzheimer disease,1/171,0.0085499075557634,0.0103398926071485,0,0,19829.0,94422.42241345016,ATP2A2
4840,KEGG_2019_Human,Calcium signaling pathway,1/188,0.009399902370135,0.0103398926071485,0,0,19812.0,92463.712994847,ATP2A2
4841,KEGG_2019_Human,cAMP signaling pathway,1/212,0.0105998955026255,0.0105998955026255,0,0,19788.0,89974.27756224656,ATP2A2
4842,KEGG_2019_Human,cGMP-PKG signaling pathway,1/166,0.0082999091363732,0.0165998182727465,0,0,19834.0,95034.82345515196,ADRA2B
4843,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,ADRA2B
4844,KEGG_2019_Human,Protein processing in endoplasmic reticulum,1/165,0.0082499094553477,0.0082499094553477,0,0,19835.0,95159.46482222488,SEL1L2
4845,KEGG_2019_Human,Endocytosis,1/244,0.0121998870519305,0.0121998870519305,0,0,19756.0,87051.4275316661,RAB11FIP1
4846,KEGG_2019_Human,Amyotrophic lateral sclerosis (ALS),1/51,0.0025499566390179,0.0025499566390179,0,0,19949.0,119129.0228601236,PRPH
4847,KEGG_2019_Human,Cell adhesion molecules (CAMs),1/145,0.0072499160871101,0.0072499160871101,0,0,19855.0,97820.92670675044,CDH4
4848,KEGG_2019_Human,Glutamatergic synapse,1/114,0.005699927427839,0.005699927427839,0,0,19886.0,102756.96431429044,SHANK1
4849,KEGG_2019_Human,ABC transporters,1/45,0.0022499601197094,0.0022499601197094,0,0,19955.0,121662.49782449217,ABCA4
4850,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF99
4851,KEGG_2019_Human,Mucin type O-glycan biosynthesis,1/31,0.0015499690656704,0.0015499690656704,0,0,19969.0,129189.85098816035,GALNT2
4852,KEGG_2019_Human,Hippo signaling pathway,1/160,0.0079999110688441,0.0127498618039235,0,0,19840.0,95793.96509856998,DLG3
4853,KEGG_2019_Human,Tight junction,1/170,0.0084999078692823,0.0127498618039235,0,0,19830.0,94543.49009679438,DLG3
4854,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0164998674589645,0,0,19670.0,80733.60565076157,DLG3
4855,KEGG_2019_Human,Signaling pathways regulating pluripotency of stem cells,1/139,0.006949918172816,0.0195198192830889,0,0,19861.0,98689.81333375497,FGFR4
4856,KEGG_2019_Human,Rap1 signaling pathway,1/206,0.010299897173561,0.0195198192830889,0,0,19794.0,90569.849337325,FGFR4
4857,KEGG_2019_Human,Regulation of actin cytoskeleton,1/214,0.0106998949514067,0.0195198192830889,0,0,19786.0,89779.39753374986,FGFR4
4858,KEGG_2019_Human,Ras signaling pathway,1/232,0.0115998901349604,0.0195198192830889,0,0,19768.0,88101.22480150245,FGFR4
4859,KEGG_2019_Human,Endocytosis,1/244,0.0121998870519305,0.0195198192830889,0,0,19756.0,87051.4275316661,FGFR4
4860,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0196664999382009,0,0,19705.0,83086.53988020132,FGFR4
4861,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0202284144472764,0,0,19646.0,79255.8617626126,FGFR4
4862,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,FGFR4
4863,KEGG_2019_Human,Cardiac muscle contraction,1/78,0.0038999427840466,0.0112582177134695,0,0,19922.0,110503.2180492851,UQCRFS1
4864,KEGG_2019_Human,Oxidative phosphorylation,1/133,0.0066499203093911,0.0112582177134695,0,0,19867.0,99596.2591544721,UQCRFS1
4865,KEGG_2019_Human,Parkinson disease,1/142,0.0070999171242726,0.0112582177134695,0,0,19858.0,98250.87390500787,UQCRFS1
4866,KEGG_2019_Human,Non-alcoholic fatty liver disease (NAFLD),1/149,0.0074499147221605,0.0112582177134695,0,0,19851.0,97261.02051561224,UQCRFS1
4867,KEGG_2019_Human,Alzheimer disease,1/171,0.0085499075557634,0.0112582177134695,0,0,19829.0,94422.42241345016,UQCRFS1
4868,KEGG_2019_Human,Huntington disease,1/193,0.0096499008972596,0.0112582177134695,0,0,19807.0,91920.47679471428,UQCRFS1
4869,KEGG_2019_Human,Thermogenesis,1/231,0.0115498903940656,0.0115498903940656,0,0,19769.0,88191.07730937863,UQCRFS1
4870,KEGG_2019_Human,Tight junction,1/170,0.0084999078692823,0.0084999078692823,0,0,19830.0,94543.49009679438,MYH1
4871,KEGG_2019_Human,Nicotine addiction,1/40,0.0019999631680592,0.0079332111171108,0,0,19960.0,124043.94523066044,GRIN3A
4872,KEGG_2019_Human,Cocaine addiction,1/49,0.0024499577795033,0.0079332111171108,0,0,19951.0,119939.1172087114,GRIN3A
4873,KEGG_2019_Human,Amphetamine addiction,1/68,0.0033999476216189,0.0079332111171108,0,0,19932.0,113293.39338050144,GRIN3A
4874,KEGG_2019_Human,Glutamatergic synapse,1/114,0.005699927427839,0.0099748729987182,0,0,19886.0,102756.96431429044,GRIN3A
4875,KEGG_2019_Human,Alcoholism,1/180,0.0089999047745351,0.0123665447530631,0,0,19820.0,93362.92821536642,GRIN3A
4876,KEGG_2019_Human,cAMP signaling pathway,1/212,0.0105998955026255,0.0123665447530631,0,0,19788.0,89974.27756224656,GRIN3A
4877,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,GRIN3A
4878,KEGG_2019_Human,Primary immunodeficiency,1/37,0.0018499650702878,0.0107862258364926,0,0,19963.0,125618.9446446357,IKBKG
4879,KEGG_2019_Human,Cytosolic DNA-sensing pathway,1/63,0.0031499501598827,0.0107862258364926,0,0,19937.0,114844.46974572667,IKBKG
4880,KEGG_2019_Human,Shigellosis,1/65,0.003249949134407,0.0107862258364926,0,0,19935.0,114209.92613860144,IKBKG
4881,KEGG_2019_Human,Acute myeloid leukemia,1/66,0.003299948626608,0.0107862258364926,0,0,19934.0,113899.85357353876,IKBKG
4882,KEGG_2019_Human,Epithelial cell signaling in Helicobacter pylori infection,1/68,0.0033999476216189,0.0107862258364926,0,0,19932.0,113293.39338050144,IKBKG
4883,KEGG_2019_Human,Adipocytokine signaling pathway,1/69,0.003449947123837,0.0107862258364926,0,0,19931.0,112996.7391397682,IKBKG
4884,KEGG_2019_Human,RIG-I-like receptor signaling pathway,1/70,0.0034999466296654,0.0107862258364926,0,0,19930.0,112704.30065625212,IKBKG
4885,KEGG_2019_Human,B cell receptor signaling pathway,1/71,0.0035499461386618,0.0107862258364926,0,0,19929.0,112415.9585341616,IKBKG
4886,KEGG_2019_Human,Pancreatic cancer,1/75,0.0037499442041125,0.0107862258364926,0,0,19925.0,111301.33528642564,IKBKG
4887,KEGG_2019_Human,Chronic myeloid leukemia,1/76,0.0037999437281752,0.0107862258364926,0,0,19924.0,111031.8499691117,IKBKG
4888,KEGG_2019_Human,Th1 and Th2 cell differentiation,1/92,0.0045999364719865,0.0107862258364926,0,0,19908.0,107139.13814408927,IKBKG
4889,KEGG_2019_Human,IL-17 signaling pathway,1/93,0.0046499360391879,0.0107862258364926,0,0,19907.0,106918.54242106884,IKBKG
4890,KEGG_2019_Human,Small cell lung cancer,1/93,0.0046499360391879,0.0107862258364926,0,0,19907.0,106918.54242106884,IKBKG
4891,KEGG_2019_Human,NF-kappa B signaling pathway,1/95,0.0047499351803394,0.0107862258364926,0,0,19905.0,106484.27183626965,IKBKG
4892,KEGG_2019_Human,Prostate cancer,1/97,0.0048499343304706,0.0107862258364926,0,0,19903.0,106058.9096435903,IKBKG
4893,KEGG_2019_Human,T cell receptor signaling pathway,1/101,0.0050499326546803,0.0107862258364926,0,0,19899.0,105233.48101229242,IKBKG
4894,KEGG_2019_Human,Chagas disease (American trypanosomiasis),1/103,0.0051499318302617,0.0107862258364926,0,0,19897.0,104832.7525292024,IKBKG
4895,KEGG_2019_Human,Toll-like receptor signaling pathway,1/104,0.0051999314202997,0.0107862258364926,0,0,19896.0,104635.24941415618,IKBKG
4896,KEGG_2019_Human,C-type lectin receptor signaling pathway,1/104,0.0051999314202997,0.0107862258364926,0,0,19896.0,104635.24941415618,IKBKG
4897,KEGG_2019_Human,Th17 cell differentiation,1/107,0.0053499302026925,0.0107862258364926,0,0,19893.0,104053.753408911,IKBKG
4898,KEGG_2019_Human,TNF signaling pathway,1/110,0.0054999290027479,0.0107862258364926,0,0,19890.0,103488.06969787036,IKBKG
4899,KEGG_2019_Human,Toxoplasmosis,1/113,0.0056499278191151,0.0107862258364926,0,0,19887.0,102937.34947211576,IKBKG
4900,KEGG_2019_Human,Osteoclast differentiation,1/127,0.0063499224962247,0.0115498655629176,0,0,19873.0,100543.72072014232,IKBKG
4901,KEGG_2019_Human,Measles,1/138,0.0068999185254481,0.0115498655629176,0,0,19862.0,98838.19160389496,IKBKG
4902,KEGG_2019_Human,Fluid shear stress and atherosclerosis,1/139,0.006949918172816,0.0115498655629176,0,0,19861.0,98689.81333375497,IKBKG
4903,KEGG_2019_Human,Apoptosis,1/143,0.0071499167770442,0.0115498655629176,0,0,19857.0,98106.57763600958,IKBKG
4904,KEGG_2019_Human,Hepatitis C,1/155,0.0077499127120574,0.0120554197743116,0,0,19845.0,96448.16254952336,IKBKG
4905,KEGG_2019_Human,Hepatitis B,1/163,0.0081499100978668,0.0122248651468002,0,0,19837.0,95410.9786681514,IKBKG
4906,KEGG_2019_Human,NOD-like receptor signaling pathway,1/178,0.0088999053857096,0.012790780020835,0,0,19822.0,93593.82745769851,IKBKG
4907,KEGG_2019_Human,Kaposi sarcoma-associated herpesvirus infection,1/186,0.0092999029651357,0.012790780020835,0,0,19814.0,92684.96451050608,IKBKG
4908,KEGG_2019_Human,Chemokine signaling pathway,1/190,0.0094999017791995,0.012790780020835,0,0,19810.0,92244.74636351672,IKBKG
4909,KEGG_2019_Human,Epstein-Barr virus infection,1/201,0.0100498985877989,0.012790780020835,0,0,19799.0,91079.21596609056,IKBKG
4910,KEGG_2019_Human,Viral carcinogenesis,1/201,0.0100498985877989,0.012790780020835,0,0,19799.0,91079.21596609056,IKBKG
4911,KEGG_2019_Human,Human immunodeficiency virus 1 infection,1/212,0.0105998955026255,0.0130939885620669,0,0,19788.0,89974.27756224656,IKBKG
4912,KEGG_2019_Human,Human T-cell leukemia virus 1 infection,1/219,0.0109498935894162,0.0131248739755395,0,0,19781.0,89299.85161916987,IKBKG
4913,KEGG_2019_Human,Human cytomegalovirus infection,1/225,0.0112498919790339,0.0131248739755395,0,0,19775.0,88738.27077557483,IKBKG
4914,KEGG_2019_Human,Ras signaling pathway,1/232,0.0115998901349604,0.013167442855901,0,0,19768.0,88101.22480150245,IKBKG
4915,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0163024933698244,0,0,19705.0,83086.53988020132,IKBKG
4916,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.017769088032731,0,0,19670.0,80733.60565076157,IKBKG
4917,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0185848557734352,0,0,19646.0,79255.8617626126,IKBKG
4918,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0251998350522984,0,0,19508.0,72277.44006442746,IKBKG
4919,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,IKBKG
4920,KEGG_2019_Human,Fat digestion and absorption,1/41,0.0020499625466866,0.0033332762758716,0,0,19959.0,123544.88783416104,ABCG8
4921,KEGG_2019_Human,ABC transporters,1/45,0.0022499601197094,0.0033332762758716,0,0,19955.0,121662.49782449217,ABCG8
4922,KEGG_2019_Human,Cholesterol metabolism,1/50,0.0024999572069037,0.0033332762758716,0,0,19950.0,119530.05920663515,ABCG8
4923,KEGG_2019_Human,Bile secretion,1/72,0.0035999456502131,0.0035999456502131,0,0,19928.0,112131.59838572376,ABCG8
4924,KEGG_2019_Human,Malaria,1/49,0.0024499577795033,0.012299822789457,0,0,19951.0,119939.1172087114,THBS4
4925,KEGG_2019_Human,ECM-receptor interaction,1/82,0.004099940929819,0.012299822789457,0,0,19918.0,109484.9180722932,THBS4
4926,KEGG_2019_Human,Phagosome,1/152,0.0075999137114971,0.0149248487415239,0,0,19848.0,96850.665715497,THBS4
4927,KEGG_2019_Human,Focal adhesion,1/199,0.0099498991610159,0.0149248487415239,0,0,19801.0,91286.4288690606,THBS4
4928,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0176998626413668,0,0,19670.0,80733.60565076157,THBS4
4929,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0176998626413668,0,0,19646.0,79255.8617626126,THBS4
4930,KEGG_2019_Human,Malaria,1/49,0.0024499577795033,0.0037499358103555,0,0,19951.0,119939.1172087114,LRP1
4931,KEGG_2019_Human,Cholesterol metabolism,1/50,0.0024999572069037,0.0037499358103555,0,0,19950.0,119530.05920663515,LRP1
4932,KEGG_2019_Human,Alzheimer disease,1/171,0.0085499075557634,0.0085499075557634,0,0,19829.0,94422.42241345016,LRP1
4933,KEGG_2019_Human,Amino sugar and nucleotide sugar metabolism,1/48,0.0023999583567988,0.0023999583567988,0,0,19952.0,120356.5272753826,CHIA
4934,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR4F15
4935,KEGG_2019_Human,Adherens junction,1/72,0.0035999456502131,0.0107998369506393,0,0,19928.0,112131.59838572376,NECTIN1
4936,KEGG_2019_Human,Cell adhesion molecules (CAMs),1/145,0.0072499160871101,0.0108748741306652,0,0,19855.0,97820.92670675044,NECTIN1
4937,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,NECTIN1
4938,KEGG_2019_Human,ECM-receptor interaction,1/82,0.004099940929819,0.0112498433599406,0,0,19918.0,109484.9180722932,COL2A1
4939,KEGG_2019_Human,Protein digestion and absorption,1/90,0.0044999373439762,0.0112498433599406,0,0,19910.0,107587.50385474482,COL2A1
4940,KEGG_2019_Human,Focal adhesion,1/199,0.0099498991610159,0.0165831652683599,0,0,19801.0,91286.4288690606,COL2A1
4941,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0176998626413668,0,0,19670.0,80733.60565076157,COL2A1
4942,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0176998626413668,0,0,19646.0,79255.8617626126,COL2A1
4943,KEGG_2019_Human,Protein digestion and absorption,1/90,0.0044999373439762,0.0044999373439762,0,0,19910.0,107587.50385474482,COL17A1
4944,KEGG_2019_Human,Ferroptosis,1/40,0.0019999631680592,0.0019999631680592,0,0,19960.0,124043.94523066044,SLC39A14
4945,KEGG_2019_Human,Estrogen signaling pathway,1/137,0.0068499188797651,0.0068499188797651,0,0,19863.0,98987.62735269018,KRT34
4946,KEGG_2019_Human,Metabolism of xenobiotics by cytochrome P450,1/74,0.0036999446830449,0.0056499278191151,0,0,19926.0,111574.38983110404,CYP2D6
4947,KEGG_2019_Human,Drug metabolism,1/108,0.0053999298011749,0.0056499278191151,0,0,19892.0,103863.47861844616,CYP2D6
4948,KEGG_2019_Human,Serotonergic synapse,1/113,0.0056499278191151,0.0056499278191151,0,0,19887.0,102937.34947211576,CYP2D6
4949,KEGG_2019_Human,JAK-STAT signaling pathway,1/162,0.0080999104202618,0.0146998751759735,0,0,19838.0,95537.86936302872,IFNLR1
4950,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0146998751759735,0,0,19706.0,83157.67014793828,IFNLR1
4951,KEGG_2019_Human,T cell receptor signaling pathway,1/101,0.0050499326546803,0.0154998090243753,0,0,19899.0,105233.48101229242,RASGRP1
4952,KEGG_2019_Human,Platelet activation,1/124,0.0061999236097501,0.0154998090243753,0,0,19876.0,101034.04709010696,RASGRP1
4953,KEGG_2019_Human,Ras signaling pathway,1/232,0.0115998901349604,0.0184373436920633,0,0,19768.0,88101.22480150245,RASGRP1
4954,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0184373436920633,0,0,19705.0,83086.53988020132,RASGRP1
4955,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,RASGRP1
4956,KEGG_2019_Human,Axon guidance,1/181,0.0090499044707863,0.0090499044707863,0,0,19819.0,93248.41634586031,SEMA3A
4957,KEGG_2019_Human,Fanconi anemia pathway,1/54,0.0026999549628563,0.0026999549628563,0,0,19946.0,117971.01964061816,FAN1
4958,KEGG_2019_Human,Regulation of actin cytoskeleton,1/214,0.0106998949514067,0.0106998949514067,0,0,19786.0,89779.39753374986,NCKAP1L
4959,KEGG_2019_Human,Collecting duct acid secretion,1/27,0.0013499718942362,0.0013499718942362,0,0,19973.0,131975.02298599784,SLC4A1
4960,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF778
4961,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR5M8
4962,KEGG_2019_Human,Vasopressin-regulated water reabsorption,1/44,0.0021999607179423,0.0095854183543869,0,0,19956.0,122117.06559109331,ADCY9
4963,KEGG_2019_Human,Endocrine and other factor-regulated calcium reabsorption,1/48,0.0023999583567988,0.0095854183543869,0,0,19952.0,120356.5272753826,ADCY9
4964,KEGG_2019_Human,Ovarian steroidogenesis,1/49,0.0024499577795033,0.0095854183543869,0,0,19951.0,119939.1172087114,ADCY9
4965,KEGG_2019_Human,Vibrio cholerae infection,1/50,0.0024999572069037,0.0095854183543869,0,0,19950.0,119530.05920663515,ADCY9
4966,KEGG_2019_Human,Regulation of lipolysis in adipocytes,1/55,0.0027499544131125,0.0095854183543869,0,0,19945.0,117599.1294878737,ADCY9
4967,KEGG_2019_Human,Cortisol synthesis and secretion,1/65,0.003249949134407,0.0095854183543869,0,0,19935.0,114209.92613860144,ADCY9
4968,KEGG_2019_Human,Bile secretion,1/72,0.0035999456502131,0.0095854183543869,0,0,19928.0,112131.59838572376,ADCY9
4969,KEGG_2019_Human,Thyroid hormone synthesis,1/74,0.0036999446830449,0.0095854183543869,0,0,19926.0,111574.38983110404,ADCY9
4970,KEGG_2019_Human,Gastric acid secretion,1/75,0.0037499442041125,0.0095854183543869,0,0,19925.0,111301.33528642564,ADCY9
4971,KEGG_2019_Human,Insulin secretion,1/86,0.0042999391173866,0.0095854183543869,0,0,19914.0,108514.46102290176,ADCY9
4972,KEGG_2019_Human,Gap junction,1/88,0.0043999382262822,0.0095854183543869,0,0,19912.0,108045.79305232369,ADCY9
4973,KEGG_2019_Human,GABAergic synapse,1/89,0.0044499377838098,0.0095854183543869,0,0,19911.0,107815.380281759,ADCY9
4974,KEGG_2019_Human,Salivary secretion,1/90,0.0044999373439762,0.0095854183543869,0,0,19910.0,107587.50385474482,ADCY9
4975,KEGG_2019_Human,Dilated cardiomyopathy (DCM),1/91,0.0045499369072032,0.0095854183543869,0,0,19909.0,107362.10783923086,ADCY9
4976,KEGG_2019_Human,Morphine addiction,1/91,0.0045499369072032,0.0095854183543869,0,0,19909.0,107362.10783923086,ADCY9
4977,KEGG_2019_Human,GnRH signaling pathway,1/93,0.0046499360391879,0.0095854183543869,0,0,19907.0,106918.54242106884,ADCY9
4978,KEGG_2019_Human,Circadian entrainment,1/97,0.0048499343304706,0.0095854183543869,0,0,19903.0,106058.9096435903,ADCY9
4979,KEGG_2019_Human,Pancreatic secretion,1/98,0.0048999339081079,0.0095854183543869,0,0,19902.0,105849.45495286948,ADCY9
4980,KEGG_2019_Human,Aldosterone synthesis and secretion,1/98,0.0048999339081079,0.0095854183543869,0,0,19902.0,105849.45495286948,ADCY9
4981,KEGG_2019_Human,Progesterone-mediated oocyte maturation,1/99,0.0049499334884068,0.0095854183543869,0,0,19901.0,105642.09305076736,ADCY9
4982,KEGG_2019_Human,Inflammatory mediator regulation of TRP channels,1/100,0.0049999330710556,0.0095854183543869,0,0,19900.0,105436.78197328727,ADCY9
4983,KEGG_2019_Human,Melanogenesis,1/101,0.0050499326546803,0.0095854183543869,0,0,19899.0,105233.48101229242,ADCY9
4984,KEGG_2019_Human,Longevity regulating pathway,1/102,0.0050999322416682,0.0095854183543869,0,0,19898.0,105032.15064717118,ADCY9
4985,KEGG_2019_Human,"Parathyroid hormone synthesis, secretion and action",1/106,0.0052999306076525,0.0095854183543869,0,0,19894.0,104245.78450366124,ADCY9
4986,KEGG_2019_Human,Cholinergic synapse,1/112,0.0055999282120529,0.0095854183543869,0,0,19888.0,103119.30984392198,ADCY9
4987,KEGG_2019_Human,Glutamatergic synapse,1/114,0.005699927427839,0.0095854183543869,0,0,19886.0,102756.96431429044,ADCY9
4988,KEGG_2019_Human,Platelet activation,1/124,0.0061999236097501,0.0095854183543869,0,0,19876.0,101034.04709010696,ADCY9
4989,KEGG_2019_Human,Oocyte meiosis,1/125,0.0062499232373748,0.0095854183543869,0,0,19875.0,100869.32368441945,ADCY9
4990,KEGG_2019_Human,Purine metabolism,1/129,0.006449921761047,0.0095854183543869,0,0,19871.0,100223.109907462,ADCY9
4991,KEGG_2019_Human,Relaxin signaling pathway,1/130,0.0064999213952527,0.0095854183543869,0,0,19870.0,100064.62842845908,ADCY9
4992,KEGG_2019_Human,Vascular smooth muscle contraction,1/132,0.0065999206698993,0.0095854183543869,0,0,19868.0,99751.22090491928,ADCY9
4993,KEGG_2019_Human,Estrogen signaling pathway,1/137,0.0068499188797651,0.0095854183543869,0,0,19863.0,98987.62735269018,ADCY9
4994,KEGG_2019_Human,Apelin signaling pathway,1/137,0.0068499188797651,0.0095854183543869,0,0,19863.0,98987.62735269018,ADCY9
4995,KEGG_2019_Human,Adrenergic signaling in cardiomyocytes,1/145,0.0072499160871101,0.0095854183543869,0,0,19855.0,97820.92670675044,ADCY9
4996,KEGG_2019_Human,Phospholipase D signaling pathway,1/148,0.007399915061391,0.0095854183543869,0,0,19852.0,97399.60470052566,ADCY9
4997,KEGG_2019_Human,Retrograde endocannabinoid signaling,1/148,0.007399915061391,0.0095854183543869,0,0,19852.0,97399.60470052566,ADCY9
4998,KEGG_2019_Human,Oxytocin signaling pathway,1/153,0.0076499133771537,0.0095854183543869,0,0,19847.0,96715.6407630817,ADCY9
4999,KEGG_2019_Human,Cushing syndrome,1/155,0.0077499127120574,0.0095854183543869,0,0,19845.0,96448.16254952336,ADCY9
5000,KEGG_2019_Human,cGMP-PKG signaling pathway,1/166,0.0082999091363732,0.0100024546002447,0,0,19834.0,95034.82345515196,ADCY9
5001,KEGG_2019_Human,Calcium signaling pathway,1/188,0.009399902370135,0.0108901313078629,0,0,19812.0,92463.712994847,ADCY9
5002,KEGG_2019_Human,Chemokine signaling pathway,1/190,0.0094999017791995,0.0108901313078629,0,0,19810.0,92244.74636351672,ADCY9
5003,KEGG_2019_Human,Rap1 signaling pathway,1/206,0.010299897173561,0.0115260754085087,0,0,19794.0,90569.849337325,ADCY9
5004,KEGG_2019_Human,cAMP signaling pathway,1/212,0.0105998955026255,0.0115859322935675,0,0,19788.0,89974.27756224656,ADCY9
5005,KEGG_2019_Human,Human T-cell leukemia virus 1 infection,1/219,0.0109498935894162,0.0116964772432401,0,0,19781.0,89299.85161916987,ADCY9
5006,KEGG_2019_Human,Human cytomegalovirus infection,1/225,0.0112498919790339,0.011749887178102,0,0,19775.0,88738.27077557483,ADCY9
5007,KEGG_2019_Human,Thermogenesis,1/231,0.0115498903940656,0.0118009749678496,0,0,19769.0,88191.07730937863,ADCY9
5008,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,ADCY9
5009,KEGG_2019_Human,Spliceosome,1/134,0.0066999199497742,0.0066999199497742,0,0,19866.0,99442.43560916925,SLU7
5010,KEGG_2019_Human,Ovarian steroidogenesis,1/49,0.0024499577795033,0.002999951725986,0,0,19951.0,119939.1172087114,HSD17B2
5011,KEGG_2019_Human,Steroid hormone biosynthesis,1/60,0.002999951725986,0.002999951725986,0,0,19940.0,115834.63209072244,HSD17B2
5012,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,HCRTR2
5013,KEGG_2019_Human,Lysine degradation,1/59,0.0029499522555206,0.0050999322416682,0,0,19941.0,116175.59385530632,EHMT1
5014,KEGG_2019_Human,Longevity regulating pathway,1/102,0.0050999322416682,0.0050999322416682,0,0,19898.0,105032.15064717118,EHMT1
5015,KEGG_2019_Human,Hedgehog signaling pathway,1/47,0.0023499589392381,0.0047249252398241,0,0,19953.0,120782.64067395544,KIF7
5016,KEGG_2019_Human,Basal cell carcinoma,1/63,0.0031499501598827,0.0047249252398241,0,0,19937.0,114844.46974572667,KIF7
5017,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,KIF7
5018,KEGG_2019_Human,Oxidative phosphorylation,1/133,0.0066499203093911,0.0112582177134695,0,0,19867.0,99596.2591544721,NDUFS7
5019,KEGG_2019_Human,Parkinson disease,1/142,0.0070999171242726,0.0112582177134695,0,0,19858.0,98250.87390500787,NDUFS7
5020,KEGG_2019_Human,Retrograde endocannabinoid signaling,1/148,0.007399915061391,0.0112582177134695,0,0,19852.0,97399.60470052566,NDUFS7
5021,KEGG_2019_Human,Non-alcoholic fatty liver disease (NAFLD),1/149,0.0074499147221605,0.0112582177134695,0,0,19851.0,97261.02051561224,NDUFS7
5022,KEGG_2019_Human,Alzheimer disease,1/171,0.0085499075557634,0.0112582177134695,0,0,19829.0,94422.42241345016,NDUFS7
5023,KEGG_2019_Human,Huntington disease,1/193,0.0096499008972596,0.0112582177134695,0,0,19807.0,91920.47679471428,NDUFS7
5024,KEGG_2019_Human,Thermogenesis,1/231,0.0115498903940656,0.0115498903940656,0,0,19769.0,88191.07730937863,NDUFS7
5025,KEGG_2019_Human,Notch signaling pathway,1/48,0.0023999583567988,0.0047999167135976,0,0,19952.0,120356.5272753826,PTCRA
5026,KEGG_2019_Human,Transcriptional misregulation in cancer,1/186,0.0092999029651357,0.0092999029651357,0,0,19814.0,92684.96451050608,PTCRA
5027,KEGG_2019_Human,Endocrine and other factor-regulated calcium reabsorption,1/48,0.0023999583567988,0.0077998855680932,0,0,19952.0,120356.5272753826,AP2A2
5028,KEGG_2019_Human,Synaptic vesicle cycle,1/78,0.0038999427840466,0.0077998855680932,0,0,19922.0,110503.2180492851,AP2A2
5029,KEGG_2019_Human,Huntington disease,1/193,0.0096499008972596,0.0121998870519305,0,0,19807.0,91920.47679471428,AP2A2
5030,KEGG_2019_Human,Endocytosis,1/244,0.0121998870519305,0.0121998870519305,0,0,19756.0,87051.4275316661,AP2A2
5031,KEGG_2019_Human,Axon guidance,1/181,0.0090499044707863,0.0090499044707863,0,0,19819.0,93248.41634586031,SEMA3F
5032,KEGG_2019_Human,Ribosome biogenesis in eukaryotes,1/101,0.0050499326546803,0.0050499326546803,0,0,19899.0,105233.48101229242,TBL3
5033,KEGG_2019_Human,TGF-beta signaling pathway,1/90,0.0044999373439762,0.0089998746879525,0,0,19910.0,107587.50385474482,AMHR2
5034,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0146998751759735,0,0,19706.0,83157.67014793828,AMHR2
5035,KEGG_2019_Human,Ferroptosis,1/40,0.0019999631680592,0.0035999456502131,0,0,19960.0,124043.94523066044,STEAP3
5036,KEGG_2019_Human,p53 signaling pathway,1/72,0.0035999456502131,0.0035999456502131,0,0,19928.0,112131.59838572376,STEAP3
5037,KEGG_2019_Human,Mannose type O-glycan biosynthesis,1/23,0.0011499748819949,0.0011499748819949,0,0,19977.0,135204.63922267244,LARGE1
5038,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR3A2
5039,KEGG_2019_Human,Aldosterone synthesis and secretion,1/98,0.0048999339081079,0.007399915061391,0,0,19902.0,105849.45495286948,DAGLA
5040,KEGG_2019_Human,Retrograde endocannabinoid signaling,1/148,0.007399915061391,0.007399915061391,0,0,19852.0,97399.60470052566,DAGLA
5041,KEGG_2019_Human,Ascorbate and aldarate metabolism,1/27,0.0013499718942362,0.0046124335460463,0,0,19973.0,131975.02298599784,UGT2B4
5042,KEGG_2019_Human,Pentose and glucuronate interconversions,1/34,0.0016999670339032,0.0046124335460463,0,0,19966.0,127326.1054203148,UGT2B4
5043,KEGG_2019_Human,Porphyrin and chlorophyll metabolism,1/42,0.0020999619311272,0.0046124335460463,0,0,19958.0,123057.75613441122,UGT2B4
5044,KEGG_2019_Human,Steroid hormone biosynthesis,1/60,0.002999951725986,0.0046124335460463,0,0,19940.0,115834.63209072244,UGT2B4
5045,KEGG_2019_Human,Retinol metabolism,1/67,0.0033499481224912,0.0046124335460463,0,0,19933.0,113594.38808369274,UGT2B4
5046,KEGG_2019_Human,Bile secretion,1/72,0.0035999456502131,0.0046124335460463,0,0,19928.0,112131.59838572376,UGT2B4
5047,KEGG_2019_Human,Metabolism of xenobiotics by cytochrome P450,1/74,0.0036999446830449,0.0046124335460463,0,0,19926.0,111574.38983110404,UGT2B4
5048,KEGG_2019_Human,Chemical carcinogenesis,1/82,0.004099940929819,0.0046124335460463,0,0,19918.0,109484.9180722932,UGT2B4
5049,KEGG_2019_Human,Drug metabolism,1/108,0.0053999298011749,0.0053999298011749,0,0,19892.0,103863.47861844616,UGT2B4
5050,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR6B2
5051,KEGG_2019_Human,MicroRNAs in cancer,1/299,0.0149498740670514,0.0149498740670514,0,0,19701.0,82804.33538735632,MIR520A
5052,KEGG_2019_Human,"Glycine, serine and threonine metabolism",1/40,0.0019999631680592,0.0023499589392381,0,0,19960.0,124043.94523066044,BHMT
5053,KEGG_2019_Human,Cysteine and methionine metabolism,1/47,0.0023499589392381,0.0023499589392381,0,0,19953.0,120782.64067395544,BHMT
5054,KEGG_2019_Human,Maturity onset diabetes of the young,1/26,0.0012999726251831,0.0025999452503662,0,0,19974.0,132735.46073187632,HNF4A
5055,KEGG_2019_Human,AMPK signaling pathway,1/120,0.0059999251180858,0.0059999251180858,0,0,19880.0,101706.2448082016,HNF4A
5056,KEGG_2019_Human,Calcium signaling pathway,1/188,0.009399902370135,0.009399902370135,0,0,19812.0,92463.712994847,TPCN1
5057,KEGG_2019_Human,Leukocyte transendothelial migration,1/112,0.0055999282120529,0.0084999078692823,0,0,19888.0,103119.30984392198,CLDN8
5058,KEGG_2019_Human,Cell adhesion molecules (CAMs),1/145,0.0072499160871101,0.0084999078692823,0,0,19855.0,97820.92670675044,CLDN8
5059,KEGG_2019_Human,Hepatitis C,1/155,0.0077499127120574,0.0084999078692823,0,0,19845.0,96448.16254952336,CLDN8
5060,KEGG_2019_Human,Tight junction,1/170,0.0084999078692823,0.0084999078692823,0,0,19830.0,94543.49009679438,CLDN8
5061,KEGG_2019_Human,Ribosome,1/153,0.0076499133771537,0.0076499133771537,0,0,19847.0,96715.6407630817,RPL9
5062,KEGG_2019_Human,Inositol phosphate metabolism,1/74,0.0036999446830449,0.0086623836047119,0,0,19926.0,111574.38983110404,PIP5K1B
5063,KEGG_2019_Human,Fc gamma R-mediated phagocytosis,1/91,0.0045499369072032,0.0086623836047119,0,0,19909.0,107362.10783923086,PIP5K1B
5064,KEGG_2019_Human,Phosphatidylinositol signaling system,1/99,0.0049499334884068,0.0086623836047119,0,0,19901.0,105642.09305076736,PIP5K1B
5065,KEGG_2019_Human,Choline metabolism in cancer,1/99,0.0049499334884068,0.0086623836047119,0,0,19901.0,105642.09305076736,PIP5K1B
5066,KEGG_2019_Human,Phospholipase D signaling pathway,1/148,0.007399915061391,0.0103598810859474,0,0,19852.0,97399.60470052566,PIP5K1B
5067,KEGG_2019_Human,Regulation of actin cytoskeleton,1/214,0.0106998949514067,0.0121998870519305,0,0,19786.0,89779.39753374986,PIP5K1B
5068,KEGG_2019_Human,Endocytosis,1/244,0.0121998870519305,0.0121998870519305,0,0,19756.0,87051.4275316661,PIP5K1B
5069,KEGG_2019_Human,Circadian rhythm,1/31,0.0015499690656704,0.0089998999524496,0,0,19969.0,129189.85098816035,FBXW11
5070,KEGG_2019_Human,Hedgehog signaling pathway,1/47,0.0023499589392381,0.0089998999524496,0,0,19953.0,120782.64067395544,FBXW11
5071,KEGG_2019_Human,Shigellosis,1/65,0.003249949134407,0.0089998999524496,0,0,19935.0,114209.92613860144,FBXW11
5072,KEGG_2019_Human,Oocyte meiosis,1/125,0.0062499232373748,0.0089998999524496,0,0,19875.0,100869.32368441945,FBXW11
5073,KEGG_2019_Human,Ubiquitin mediated proteolysis,1/137,0.0068499188797651,0.0089998999524496,0,0,19863.0,98987.62735269018,FBXW11
5074,KEGG_2019_Human,Wnt signaling pathway,1/158,0.0078999117225733,0.0089998999524496,0,0,19842.0,96053.2110949472,FBXW11
5075,KEGG_2019_Human,Cellular senescence,1/160,0.0079999110688441,0.0089998999524496,0,0,19840.0,95793.96509856998,FBXW11
5076,KEGG_2019_Human,Hippo signaling pathway,1/160,0.0079999110688441,0.0089998999524496,0,0,19840.0,95793.96509856998,FBXW11
5077,KEGG_2019_Human,Human immunodeficiency virus 1 infection,1/212,0.0105998955026255,0.0105998955026255,0,0,19788.0,89974.27756224656,FBXW11
5078,KEGG_2019_Human,Hypertrophic cardiomyopathy (HCM),1/85,0.004249939567045,0.0045499369072032,0,0,19915.0,108752.83801948265,MYBPC3
5079,KEGG_2019_Human,Dilated cardiomyopathy (DCM),1/91,0.0045499369072032,0.0045499369072032,0,0,19909.0,107362.10783923086,MYBPC3
5080,KEGG_2019_Human,Aldosterone-regulated sodium reabsorption,1/37,0.0018499650702878,0.0093537399526118,0,0,19963.0,125618.9446446357,IRS1
5081,KEGG_2019_Human,Type II diabetes mellitus,1/46,0.0022999595269283,0.0093537399526118,0,0,19954.0,121217.8313311442,IRS1
5082,KEGG_2019_Human,Regulation of lipolysis in adipocytes,1/55,0.0027499544131125,0.0093537399526118,0,0,19945.0,117599.1294878737,IRS1
5083,KEGG_2019_Human,Adipocytokine signaling pathway,1/69,0.003449947123837,0.0093537399526118,0,0,19931.0,112996.7391397682,IRS1
5084,KEGG_2019_Human,Longevity regulating pathway,1/102,0.0050999322416682,0.0093537399526118,0,0,19898.0,105032.15064717118,IRS1
5085,KEGG_2019_Human,Insulin resistance,1/108,0.0053999298011749,0.0093537399526118,0,0,19892.0,103863.47861844616,IRS1
5086,KEGG_2019_Human,Neurotrophin signaling pathway,1/119,0.0059499254985137,0.0093537399526118,0,0,19881.0,101877.73080211312,IRS1
5087,KEGG_2019_Human,AMPK signaling pathway,1/120,0.0059999251180858,0.0093537399526118,0,0,19880.0,101706.2448082016,IRS1
5088,KEGG_2019_Human,Autophagy,1/128,0.0063999221281459,0.0093537399526118,0,0,19872.0,100382.8010329652,IRS1
5089,KEGG_2019_Human,FoxO signaling pathway,1/132,0.0065999206698993,0.0093537399526118,0,0,19868.0,99751.22090491928,IRS1
5090,KEGG_2019_Human,Insulin signaling pathway,1/137,0.0068499188797651,0.0093537399526118,0,0,19863.0,98987.62735269018,IRS1
5091,KEGG_2019_Human,Non-alcoholic fatty liver disease (NAFLD),1/149,0.0074499147221605,0.0093537399526118,0,0,19851.0,97261.02051561224,IRS1
5092,KEGG_2019_Human,mTOR signaling pathway,1/152,0.0075999137114971,0.0093537399526118,0,0,19848.0,96850.665715497,IRS1
5093,KEGG_2019_Human,cGMP-PKG signaling pathway,1/166,0.0082999091363732,0.0094856104415694,0,0,19834.0,95034.82345515196,IRS1
5094,KEGG_2019_Human,MicroRNAs in cancer,1/299,0.0149498740670514,0.0159465323381882,0,0,19701.0,82804.33538735632,IRS1
5095,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0176998626413668,0,0,19646.0,79255.8617626126,IRS1
5096,KEGG_2019_Human,Thermogenesis,1/231,0.0115498903940656,0.0115498903940656,0,0,19769.0,88191.07730937863,NDUFAF7
5097,KEGG_2019_Human,TGF-beta signaling pathway,1/90,0.0044999373439762,0.0044999373439762,0,0,19910.0,107587.50385474482,LTBP1
5098,KEGG_2019_Human,SNARE interactions in vesicular transport,1/34,0.0016999670339032,0.0044999373439762,0,0,19966.0,127326.1054203148,VAMP2
5099,KEGG_2019_Human,Vasopressin-regulated water reabsorption,1/44,0.0021999607179423,0.0044999373439762,0,0,19956.0,122117.06559109331,VAMP2
5100,KEGG_2019_Human,Synaptic vesicle cycle,1/78,0.0038999427840466,0.0044999373439762,0,0,19922.0,110503.2180492851,VAMP2
5101,KEGG_2019_Human,Insulin secretion,1/86,0.0042999391173866,0.0044999373439762,0,0,19914.0,108514.46102290176,VAMP2
5102,KEGG_2019_Human,Salivary secretion,1/90,0.0044999373439762,0.0044999373439762,0,0,19910.0,107587.50385474482,VAMP2
5103,KEGG_2019_Human,Cell adhesion molecules (CAMs),1/145,0.0072499160871101,0.0072499160871101,0,0,19855.0,97820.92670675044,CADM1
5104,KEGG_2019_Human,N-Glycan biosynthesis,1/50,0.0024999572069037,0.0024999572069037,0,0,19950.0,119530.05920663515,MAN2A2
5105,KEGG_2019_Human,Endocytosis,1/244,0.0121998870519305,0.0121998870519305,0,0,19756.0,87051.4275316661,IST1
5106,KEGG_2019_Human,Collecting duct acid secretion,1/27,0.0013499718942362,0.0090998738144064,0,0,19973.0,131975.02298599784,ATP6V0A4
5107,KEGG_2019_Human,Vibrio cholerae infection,1/50,0.0024999572069037,0.0090998738144064,0,0,19950.0,119530.05920663515,ATP6V0A4
5108,KEGG_2019_Human,Epithelial cell signaling in Helicobacter pylori infection,1/68,0.0033999476216189,0.0090998738144064,0,0,19932.0,113293.39338050144,ATP6V0A4
5109,KEGG_2019_Human,Synaptic vesicle cycle,1/78,0.0038999427840466,0.0090998738144064,0,0,19922.0,110503.2180492851,ATP6V0A4
5110,KEGG_2019_Human,Rheumatoid arthritis,1/91,0.0045499369072032,0.0090998738144064,0,0,19909.0,107362.10783923086,ATP6V0A4
5111,KEGG_2019_Human,Lysosome,1/123,0.0061499239842961,0.009499886156273,0,0,19877.0,101200.07933676826,ATP6V0A4
5112,KEGG_2019_Human,Oxidative phosphorylation,1/133,0.0066499203093911,0.009499886156273,0,0,19867.0,99596.2591544721,ATP6V0A4
5113,KEGG_2019_Human,Phagosome,1/152,0.0075999137114971,0.0094998921393714,0,0,19848.0,96850.665715497,ATP6V0A4
5114,KEGG_2019_Human,Tuberculosis,1/179,0.0089499050800561,0.0099443389778401,0,0,19821.0,93478.0629355712,ATP6V0A4
5115,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0164998674589645,0,0,19670.0,80733.60565076157,ATP6V0A4
5116,KEGG_2019_Human,ECM-receptor interaction,1/82,0.004099940929819,0.0112998556382303,0,0,19918.0,109484.9180722932,LAMC3
5117,KEGG_2019_Human,Small cell lung cancer,1/93,0.0046499360391879,0.0112998556382303,0,0,19907.0,106918.54242106884,LAMC3
5118,KEGG_2019_Human,Amoebiasis,1/96,0.0047999347538706,0.0112998556382303,0,0,19904.0,106270.50039849174,LAMC3
5119,KEGG_2019_Human,Toxoplasmosis,1/113,0.0056499278191151,0.0112998556382303,0,0,19887.0,102937.34947211576,LAMC3
5120,KEGG_2019_Human,Focal adhesion,1/199,0.0099498991610159,0.0159198386576255,0,0,19801.0,91286.4288690606,LAMC3
5121,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0202284144472764,0,0,19670.0,80733.60565076157,LAMC3
5122,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0202284144472764,0,0,19646.0,79255.8617626126,LAMC3
5123,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,LAMC3
5124,KEGG_2019_Human,Phospholipase D signaling pathway,1/148,0.007399915061391,0.0221248283017086,0,0,19852.0,97399.60470052566,LPAR3
5125,KEGG_2019_Human,Rap1 signaling pathway,1/206,0.010299897173561,0.0221248283017086,0,0,19794.0,90569.849337325,LPAR3
5126,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0221248283017086,0,0,19662.0,80229.79996326564,LPAR3
5127,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0221248283017086,0,0,19646.0,79255.8617626126,LPAR3
5128,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,LPAR3
5129,KEGG_2019_Human,Insulin secretion,1/86,0.0042999391173866,0.0082999091363732,0,0,19914.0,108514.46102290176,KCNMB2
5130,KEGG_2019_Human,Vascular smooth muscle contraction,1/132,0.0065999206698993,0.0082999091363732,0,0,19868.0,99751.22090491928,KCNMB2
5131,KEGG_2019_Human,cGMP-PKG signaling pathway,1/166,0.0082999091363732,0.0082999091363732,0,0,19834.0,95034.82345515196,KCNMB2
5132,KEGG_2019_Human,Pentose phosphate pathway,1/30,0.0014999697593334,0.0014999697593334,0,0,19970.0,129851.13732048514,TALDO1
5133,KEGG_2019_Human,Apelin signaling pathway,1/137,0.0068499188797651,0.0133998647837319,0,0,19863.0,98987.62735269018,HDAC4
5134,KEGG_2019_Human,Alcoholism,1/180,0.0089999047745351,0.0133998647837319,0,0,19820.0,93362.92821536642,HDAC4
5135,KEGG_2019_Human,Viral carcinogenesis,1/201,0.0100498985877989,0.0133998647837319,0,0,19799.0,91079.21596609056,HDAC4
5136,KEGG_2019_Human,MicroRNAs in cancer,1/299,0.0149498740670514,0.0149498740670514,0,0,19701.0,82804.33538735632,HDAC4
5137,KEGG_2019_Human,Amoebiasis,1/96,0.0047999347538706,0.0074499147221605,0,0,19904.0,106270.50039849174,MUC2
5138,KEGG_2019_Human,Gastric cancer,1/149,0.0074499147221605,0.0074499147221605,0,0,19851.0,97261.02051561224,MUC2
5139,KEGG_2019_Human,Type II diabetes mellitus,1/46,0.0022999595269283,0.0091332251730202,0,0,19954.0,121217.8313311442,SOCS1
5140,KEGG_2019_Human,Prolactin signaling pathway,1/70,0.0034999466296654,0.0091332251730202,0,0,19930.0,112704.30065625212,SOCS1
5141,KEGG_2019_Human,Toxoplasmosis,1/113,0.0056499278191151,0.0091332251730202,0,0,19887.0,102937.34947211576,SOCS1
5142,KEGG_2019_Human,Osteoclast differentiation,1/127,0.0063499224962247,0.0091332251730202,0,0,19873.0,100543.72072014232,SOCS1
5143,KEGG_2019_Human,Ubiquitin mediated proteolysis,1/137,0.0068499188797651,0.0091332251730202,0,0,19863.0,98987.62735269018,SOCS1
5144,KEGG_2019_Human,Insulin signaling pathway,1/137,0.0068499188797651,0.0091332251730202,0,0,19863.0,98987.62735269018,SOCS1
5145,KEGG_2019_Human,JAK-STAT signaling pathway,1/162,0.0080999104202618,0.0092570404802992,0,0,19838.0,95537.86936302872,SOCS1
5146,KEGG_2019_Human,MicroRNAs in cancer,1/299,0.0149498740670514,0.0149498740670514,0,0,19701.0,82804.33538735632,SOCS1
5147,KEGG_2019_Human,Glycosylphosphatidylinositol (GPI)-anchor biosynthesis,1/25,0.0012499733663791,0.0012499733663791,0,0,19975.0,133525.54486996148,PGAP1
5148,KEGG_2019_Human,Tyrosine metabolism,1/36,0.0017999657178272,0.0017999657178272,0,0,19964.0,126172.23364250171,FAHD1
5149,KEGG_2019_Human,Adherens junction,1/72,0.0035999456502131,0.0154498457603415,0,0,19928.0,112131.59838572376,PARD3
5150,KEGG_2019_Human,Hippo signaling pathway,1/160,0.0079999110688441,0.0154498457603415,0,0,19840.0,95793.96509856998,PARD3
5151,KEGG_2019_Human,Tight junction,1/170,0.0084999078692823,0.0154498457603415,0,0,19830.0,94543.49009679438,PARD3
5152,KEGG_2019_Human,Axon guidance,1/181,0.0090499044707863,0.0154498457603415,0,0,19819.0,93248.41634586031,PARD3
5153,KEGG_2019_Human,Chemokine signaling pathway,1/190,0.0094999017791995,0.0154498457603415,0,0,19810.0,92244.74636351672,PARD3
5154,KEGG_2019_Human,Rap1 signaling pathway,1/206,0.010299897173561,0.0154498457603415,0,0,19794.0,90569.849337325,PARD3
5155,KEGG_2019_Human,Endocytosis,1/244,0.0121998870519305,0.0156855690667678,0,0,19756.0,87051.4275316661,PARD3
5156,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0168998658265596,0,0,19670.0,80733.60565076157,PARD3
5157,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,PARD3
5158,KEGG_2019_Human,ErbB signaling pathway,1/85,0.004249939567045,0.0167498309796649,0,0,19915.0,108752.83801948265,ERBB4
5159,KEGG_2019_Human,Calcium signaling pathway,1/188,0.009399902370135,0.0167498309796649,0,0,19812.0,92463.712994847,ERBB4
5160,KEGG_2019_Human,Proteoglycans in cancer,1/201,0.0100498985877989,0.0167498309796649,0,0,19799.0,91079.21596609056,ERBB4
5161,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0176998626413668,0,0,19705.0,83086.53988020132,ERBB4
5162,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0176998626413668,0,0,19646.0,79255.8617626126,ERBB4
5163,KEGG_2019_Human,Cell adhesion molecules (CAMs),1/145,0.0072499160871101,0.0072499160871101,0,0,19855.0,97820.92670675044,CDH15
5164,KEGG_2019_Human,Apelin signaling pathway,1/137,0.0068499188797651,0.0096499008972596,0,0,19863.0,98987.62735269018,TFAM
5165,KEGG_2019_Human,Huntington disease,1/193,0.0096499008972596,0.0096499008972596,0,0,19807.0,91920.47679471428,TFAM
5166,KEGG_2019_Human,Aldosterone-regulated sodium reabsorption,1/37,0.0018499650702878,0.0103141686084603,0,0,19963.0,125618.9446446357,INSR
5167,KEGG_2019_Human,Type II diabetes mellitus,1/46,0.0022999595269283,0.0103141686084603,0,0,19954.0,121217.8313311442,INSR
5168,KEGG_2019_Human,Ovarian steroidogenesis,1/49,0.0024499577795033,0.0103141686084603,0,0,19951.0,119939.1172087114,INSR
5169,KEGG_2019_Human,Regulation of lipolysis in adipocytes,1/55,0.0027499544131125,0.0103141686084603,0,0,19945.0,117599.1294878737,INSR
5170,KEGG_2019_Human,Adherens junction,1/72,0.0035999456502131,0.0103141686084603,0,0,19928.0,112131.59838572376,INSR
5171,KEGG_2019_Human,HIF-1 signaling pathway,1/100,0.0049999330710556,0.0103141686084603,0,0,19900.0,105436.78197328727,INSR
5172,KEGG_2019_Human,Longevity regulating pathway,1/102,0.0050999322416682,0.0103141686084603,0,0,19898.0,105032.15064717118,INSR
5173,KEGG_2019_Human,Insulin resistance,1/108,0.0053999298011749,0.0103141686084603,0,0,19892.0,103863.47861844616,INSR
5174,KEGG_2019_Human,AMPK signaling pathway,1/120,0.0059999251180858,0.0103141686084603,0,0,19880.0,101706.2448082016,INSR
5175,KEGG_2019_Human,FoxO signaling pathway,1/132,0.0065999206698993,0.0103141686084603,0,0,19868.0,99751.22090491928,INSR
5176,KEGG_2019_Human,Insulin signaling pathway,1/137,0.0068499188797651,0.0103141686084603,0,0,19863.0,98987.62735269018,INSR
5177,KEGG_2019_Human,Phospholipase D signaling pathway,1/148,0.007399915061391,0.0103141686084603,0,0,19852.0,97399.60470052566,INSR
5178,KEGG_2019_Human,Non-alcoholic fatty liver disease (NAFLD),1/149,0.0074499147221605,0.0103141686084603,0,0,19851.0,97261.02051561224,INSR
5179,KEGG_2019_Human,mTOR signaling pathway,1/152,0.0075999137114971,0.0103141686084603,0,0,19848.0,96850.665715497,INSR
5180,KEGG_2019_Human,cGMP-PKG signaling pathway,1/166,0.0082999091363732,0.0105132182394061,0,0,19834.0,95034.82345515196,INSR
5181,KEGG_2019_Human,Rap1 signaling pathway,1/206,0.010299897173561,0.0122311278936037,0,0,19794.0,90569.849337325,INSR
5182,KEGG_2019_Human,Ras signaling pathway,1/232,0.0115998901349604,0.0129645830920145,0,0,19768.0,88101.22480150245,INSR
5183,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0155693124510757,0,0,19705.0,83086.53988020132,INSR
5184,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0176998626413668,0,0,19646.0,79255.8617626126,INSR
5185,KEGG_2019_Human,Thermogenesis,1/231,0.0115498903940656,0.0115498903940656,0,0,19769.0,88191.07730937863,COX18
5186,KEGG_2019_Human,Axon guidance,1/181,0.0090499044707863,0.0090499044707863,0,0,19819.0,93248.41634586031,PLXNB1
5187,KEGG_2019_Human,Nicotine addiction,1/40,0.0019999631680592,0.007583228178672,0,0,19960.0,124043.94523066044,GABRG2
5188,KEGG_2019_Human,GABAergic synapse,1/89,0.0044499377838098,0.007583228178672,0,0,19911.0,107815.380281759,GABRG2
5189,KEGG_2019_Human,Morphine addiction,1/91,0.0045499369072032,0.007583228178672,0,0,19909.0,107362.10783923086,GABRG2
5190,KEGG_2019_Human,Retrograde endocannabinoid signaling,1/148,0.007399915061391,0.0092498938267387,0,0,19852.0,97399.60470052566,GABRG2
5191,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,GABRG2
5192,KEGG_2019_Human,Lysine degradation,1/59,0.0029499522555206,0.0029499522555206,0,0,19941.0,116175.59385530632,KMT5C
5193,KEGG_2019_Human,Collecting duct acid secretion,1/27,0.0013499718942362,0.0081898864329657,0,0,19973.0,131975.02298599784,ATP6V1B2
5194,KEGG_2019_Human,Vibrio cholerae infection,1/50,0.0024999572069037,0.0081898864329657,0,0,19950.0,119530.05920663515,ATP6V1B2
5195,KEGG_2019_Human,Epithelial cell signaling in Helicobacter pylori infection,1/68,0.0033999476216189,0.0081898864329657,0,0,19932.0,113293.39338050144,ATP6V1B2
5196,KEGG_2019_Human,Synaptic vesicle cycle,1/78,0.0038999427840466,0.0081898864329657,0,0,19922.0,110503.2180492851,ATP6V1B2
5197,KEGG_2019_Human,Rheumatoid arthritis,1/91,0.0045499369072032,0.0081898864329657,0,0,19909.0,107362.10783923086,ATP6V1B2
5198,KEGG_2019_Human,Oxidative phosphorylation,1/133,0.0066499203093911,0.0085499029254342,0,0,19867.0,99596.2591544721,ATP6V1B2
5199,KEGG_2019_Human,mTOR signaling pathway,1/152,0.0075999137114971,0.0085499029254342,0,0,19848.0,96850.665715497,ATP6V1B2
5200,KEGG_2019_Human,Phagosome,1/152,0.0075999137114971,0.0085499029254342,0,0,19848.0,96850.665715497,ATP6V1B2
5201,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0164998674589645,0,0,19670.0,80733.60565076157,ATP6V1B2
5202,KEGG_2019_Human,Inflammatory bowel disease (IBD),1/65,0.003249949134407,0.0097798921174401,0,0,19935.0,114209.92613860144,STAT4
5203,KEGG_2019_Human,Th1 and Th2 cell differentiation,1/92,0.0045999364719865,0.0097798921174401,0,0,19908.0,107139.13814408927,STAT4
5204,KEGG_2019_Human,Necroptosis,1/162,0.0080999104202618,0.0097798921174401,0,0,19838.0,95537.86936302872,STAT4
5205,KEGG_2019_Human,JAK-STAT signaling pathway,1/162,0.0080999104202618,0.0097798921174401,0,0,19838.0,95537.86936302872,STAT4
5206,KEGG_2019_Human,Hepatitis B,1/163,0.0081499100978668,0.0097798921174401,0,0,19837.0,95410.9786681514,STAT4
5207,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,STAT4
5208,KEGG_2019_Human,Lysine degradation,1/59,0.0029499522555206,0.0029499522555206,0,0,19941.0,116175.59385530632,PLOD2
5209,KEGG_2019_Human,cAMP signaling pathway,1/212,0.0105998955026255,0.0168998658265596,0,0,19788.0,89974.27756224656,SSTR5
5210,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,SSTR5
5211,KEGG_2019_Human,African trypanosomiasis,1/37,0.0018499650702878,0.0101698700744073,0,0,19963.0,125618.9446446357,LAMA4
5212,KEGG_2019_Human,ECM-receptor interaction,1/82,0.004099940929819,0.0101698700744073,0,0,19918.0,109484.9180722932,LAMA4
5213,KEGG_2019_Human,Small cell lung cancer,1/93,0.0046499360391879,0.0101698700744073,0,0,19907.0,106918.54242106884,LAMA4
5214,KEGG_2019_Human,Amoebiasis,1/96,0.0047999347538706,0.0101698700744073,0,0,19904.0,106270.50039849174,LAMA4
5215,KEGG_2019_Human,Toxoplasmosis,1/113,0.0056499278191151,0.0101698700744073,0,0,19887.0,102937.34947211576,LAMA4
5216,KEGG_2019_Human,Focal adhesion,1/199,0.0099498991610159,0.0149248487415239,0,0,19801.0,91286.4288690606,LAMA4
5217,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0199123454715377,0,0,19670.0,80733.60565076157,LAMA4
5218,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0199123454715377,0,0,19646.0,79255.8617626126,LAMA4
5219,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,LAMA4
5220,KEGG_2019_Human,Cell adhesion molecules (CAMs),1/145,0.0072499160871101,0.0090499044707863,0,0,19855.0,97820.92670675044,L1CAM
5221,KEGG_2019_Human,Axon guidance,1/181,0.0090499044707863,0.0090499044707863,0,0,19819.0,93248.41634586031,L1CAM
5222,KEGG_2019_Human,C-type lectin receptor signaling pathway,1/104,0.0051999314202997,0.0109498935894162,0,0,19896.0,104635.24941415618,EGR2
5223,KEGG_2019_Human,Hepatitis B,1/163,0.0081499100978668,0.0109498935894162,0,0,19837.0,95410.9786681514,EGR2
5224,KEGG_2019_Human,Viral carcinogenesis,1/201,0.0100498985877989,0.0109498935894162,0,0,19799.0,91079.21596609056,EGR2
5225,KEGG_2019_Human,Human T-cell leukemia virus 1 infection,1/219,0.0109498935894162,0.0109498935894162,0,0,19781.0,89299.85161916987,EGR2
5226,KEGG_2019_Human,Nicotine addiction,1/40,0.0019999631680592,0.0093332136867549,0,0,19960.0,124043.94523066044,CHRNA7
5227,KEGG_2019_Human,Chemical carcinogenesis,1/82,0.004099940929819,0.0093332136867549,0,0,19918.0,109484.9180722932,CHRNA7
5228,KEGG_2019_Human,Cholinergic synapse,1/112,0.0055999282120529,0.0093332136867549,0,0,19888.0,103119.30984392198,CHRNA7
5229,KEGG_2019_Human,Calcium signaling pathway,1/188,0.009399902370135,0.0117498779626688,0,0,19812.0,92463.712994847,CHRNA7
5230,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,CHRNA7
5231,KEGG_2019_Human,Progesterone-mediated oocyte maturation,1/99,0.0049499334884068,0.010416538728958,0,0,19901.0,105642.09305076736,MAD1L1
5232,KEGG_2019_Human,Cell cycle,1/124,0.0061999236097501,0.010416538728958,0,0,19876.0,101034.04709010696,MAD1L1
5233,KEGG_2019_Human,Oocyte meiosis,1/125,0.0062499232373748,0.010416538728958,0,0,19875.0,100869.32368441945,MAD1L1
5234,KEGG_2019_Human,Viral carcinogenesis,1/201,0.0100498985877989,0.0109498935894162,0,0,19799.0,91079.21596609056,MAD1L1
5235,KEGG_2019_Human,Human T-cell leukemia virus 1 infection,1/219,0.0109498935894162,0.0109498935894162,0,0,19781.0,89299.85161916987,MAD1L1
5236,KEGG_2019_Human,Galactose metabolism,1/31,0.0015499690656704,0.0017999657178272,0,0,19969.0,129189.85098816035,GANC
5237,KEGG_2019_Human,Starch and sucrose metabolism,1/36,0.0017999657178272,0.0017999657178272,0,0,19964.0,126172.23364250171,GANC
5238,KEGG_2019_Human,Fc epsilon RI signaling pathway,1/68,0.0033999476216189,0.0049499334884068,0,0,19932.0,113293.39338050144,INPP5D
5239,KEGG_2019_Human,B cell receptor signaling pathway,1/71,0.0035499461386618,0.0049499334884068,0,0,19929.0,112415.9585341616,INPP5D
5240,KEGG_2019_Human,Inositol phosphate metabolism,1/74,0.0036999446830449,0.0049499334884068,0,0,19926.0,111574.38983110404,INPP5D
5241,KEGG_2019_Human,Fc gamma R-mediated phagocytosis,1/91,0.0045499369072032,0.0049499334884068,0,0,19909.0,107362.10783923086,INPP5D
5242,KEGG_2019_Human,Phosphatidylinositol signaling system,1/99,0.0049499334884068,0.0049499334884068,0,0,19901.0,105642.09305076736,INPP5D
5243,KEGG_2019_Human,Glioma,1/75,0.0037499442041125,0.009399902370135,0,0,19925.0,111301.33528642564,CAMK1G
5244,KEGG_2019_Human,Aldosterone synthesis and secretion,1/98,0.0048999339081079,0.009399902370135,0,0,19902.0,105849.45495286948,CAMK1G
5245,KEGG_2019_Human,Oxytocin signaling pathway,1/153,0.0076499133771537,0.009399902370135,0,0,19847.0,96715.6407630817,CAMK1G
5246,KEGG_2019_Human,Calcium signaling pathway,1/188,0.009399902370135,0.009399902370135,0,0,19812.0,92463.712994847,CAMK1G
5247,KEGG_2019_Human,Mineral absorption,1/51,0.0025499566390179,0.0025499566390179,0,0,19949.0,119129.0228601236,SLC26A6
5248,KEGG_2019_Human,Hepatocellular carcinoma,1/168,0.0083999085011095,0.0115498903940656,0,0,19832.0,94787.72752807094,ARID1B
5249,KEGG_2019_Human,Thermogenesis,1/231,0.0115498903940656,0.0115498903940656,0,0,19769.0,88191.07730937863,ARID1B
5250,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,PILRA
5251,KEGG_2019_Human,Cushing syndrome,1/155,0.0077499127120574,0.0077499127120574,0,0,19845.0,96448.16254952336,RBBP5
5252,KEGG_2019_Human,Protein processing in endoplasmic reticulum,1/165,0.0082499094553477,0.0082499094553477,0,0,19835.0,95159.46482222488,PRKCSH
5253,KEGG_2019_Human,Glucagon signaling pathway,1/103,0.0051499318302617,0.0051499318302617,0,0,19897.0,104832.7525292024,PPP4C
5254,KEGG_2019_Human,Notch signaling pathway,1/48,0.0023999583567988,0.0124430608970639,0,0,19952.0,120356.5272753826,EP300
5255,KEGG_2019_Human,Long-term potentiation,1/67,0.0033499481224912,0.0124430608970639,0,0,19933.0,113594.38808369274,EP300
5256,KEGG_2019_Human,Renal cell carcinoma,1/69,0.003449947123837,0.0124430608970639,0,0,19931.0,112996.7391397682,EP300
5257,KEGG_2019_Human,Adherens junction,1/72,0.0035999456502131,0.0124430608970639,0,0,19928.0,112131.59838572376,EP300
5258,KEGG_2019_Human,TGF-beta signaling pathway,1/90,0.0044999373439762,0.0124430608970639,0,0,19910.0,107587.50385474482,EP300
5259,KEGG_2019_Human,Prostate cancer,1/97,0.0048499343304706,0.0124430608970639,0,0,19903.0,106058.9096435903,EP300
5260,KEGG_2019_Human,HIF-1 signaling pathway,1/100,0.0049999330710556,0.0124430608970639,0,0,19900.0,105436.78197328727,EP300
5261,KEGG_2019_Human,Melanogenesis,1/101,0.0050499326546803,0.0124430608970639,0,0,19899.0,105233.48101229242,EP300
5262,KEGG_2019_Human,Glucagon signaling pathway,1/103,0.0051499318302617,0.0124430608970639,0,0,19897.0,104832.7525292024,EP300
5263,KEGG_2019_Human,Thyroid hormone signaling pathway,1/116,0.0057999266512085,0.0124430608970639,0,0,19884.0,102400.8105961506,EP300
5264,KEGG_2019_Human,Cell cycle,1/124,0.0061999236097501,0.0124430608970639,0,0,19876.0,101034.04709010696,EP300
5265,KEGG_2019_Human,FoxO signaling pathway,1/132,0.0065999206698993,0.0124430608970639,0,0,19868.0,99751.22090491928,EP300
5266,KEGG_2019_Human,Wnt signaling pathway,1/158,0.0078999117225733,0.0124430608970639,0,0,19842.0,96053.2110949472,EP300
5267,KEGG_2019_Human,JAK-STAT signaling pathway,1/162,0.0080999104202618,0.0124430608970639,0,0,19838.0,95537.86936302872,EP300
5268,KEGG_2019_Human,Hepatitis B,1/163,0.0081499100978668,0.0124430608970639,0,0,19837.0,95410.9786681514,EP300
5269,KEGG_2019_Human,Influenza A,1/171,0.0085499075557634,0.0124430608970639,0,0,19829.0,94422.42241345016,EP300
5270,KEGG_2019_Human,Tuberculosis,1/179,0.0089499050800561,0.0124430608970639,0,0,19821.0,93478.0629355712,EP300
5271,KEGG_2019_Human,Kaposi sarcoma-associated herpesvirus infection,1/186,0.0092999029651357,0.0124430608970639,0,0,19814.0,92684.96451050608,EP300
5272,KEGG_2019_Human,Huntington disease,1/193,0.0096499008972596,0.0124430608970639,0,0,19807.0,91920.47679471428,EP300
5273,KEGG_2019_Human,Viral carcinogenesis,1/201,0.0100498985877989,0.0124430608970639,0,0,19799.0,91079.21596609056,EP300
5274,KEGG_2019_Human,cAMP signaling pathway,1/212,0.0105998955026255,0.0124430608970639,0,0,19788.0,89974.27756224656,EP300
5275,KEGG_2019_Human,Human T-cell leukemia virus 1 infection,1/219,0.0109498935894162,0.0124430608970639,0,0,19781.0,89299.85161916987,EP300
5276,KEGG_2019_Human,MicroRNAs in cancer,1/299,0.0149498740670514,0.0162498631163602,0,0,19701.0,82804.33538735632,EP300
5277,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0171873619364213,0,0,19670.0,80733.60565076157,EP300
5278,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,EP300
5279,KEGG_2019_Human,Carbohydrate digestion and absorption,1/44,0.0021999607179423,0.0094998972841815,0,0,19956.0,122117.06559109331,CACNA1D
5280,KEGG_2019_Human,Type II diabetes mellitus,1/46,0.0022999595269283,0.0094998972841815,0,0,19954.0,121217.8313311442,CACNA1D
5281,KEGG_2019_Human,Cortisol synthesis and secretion,1/65,0.003249949134407,0.0094998972841815,0,0,19935.0,114209.92613860144,CACNA1D
5282,KEGG_2019_Human,Amphetamine addiction,1/68,0.0033999476216189,0.0094998972841815,0,0,19932.0,113293.39338050144,CACNA1D
5283,KEGG_2019_Human,Renin secretion,1/69,0.003449947123837,0.0094998972841815,0,0,19931.0,112996.7391397682,CACNA1D
5284,KEGG_2019_Human,Arrhythmogenic right ventricular cardiomyopathy (ARVC),1/72,0.0035999456502131,0.0094998972841815,0,0,19928.0,112131.59838572376,CACNA1D
5285,KEGG_2019_Human,Cardiac muscle contraction,1/78,0.0038999427840466,0.0094998972841815,0,0,19922.0,110503.2180492851,CACNA1D
5286,KEGG_2019_Human,Hypertrophic cardiomyopathy (HCM),1/85,0.004249939567045,0.0094998972841815,0,0,19915.0,108752.83801948265,CACNA1D
5287,KEGG_2019_Human,Insulin secretion,1/86,0.0042999391173866,0.0094998972841815,0,0,19914.0,108514.46102290176,CACNA1D
5288,KEGG_2019_Human,GABAergic synapse,1/89,0.0044499377838098,0.0094998972841815,0,0,19911.0,107815.380281759,CACNA1D
5289,KEGG_2019_Human,Dilated cardiomyopathy (DCM),1/91,0.0045499369072032,0.0094998972841815,0,0,19909.0,107362.10783923086,CACNA1D
5290,KEGG_2019_Human,GnRH signaling pathway,1/93,0.0046499360391879,0.0094998972841815,0,0,19907.0,106918.54242106884,CACNA1D
5291,KEGG_2019_Human,Circadian entrainment,1/97,0.0048499343304706,0.0094998972841815,0,0,19903.0,106058.9096435903,CACNA1D
5292,KEGG_2019_Human,Aldosterone synthesis and secretion,1/98,0.0048999339081079,0.0094998972841815,0,0,19902.0,105849.45495286948,CACNA1D
5293,KEGG_2019_Human,Cholinergic synapse,1/112,0.0055999282120529,0.0094998972841815,0,0,19888.0,103119.30984392198,CACNA1D
5294,KEGG_2019_Human,Serotonergic synapse,1/113,0.0056499278191151,0.0094998972841815,0,0,19887.0,102937.34947211576,CACNA1D
5295,KEGG_2019_Human,Glutamatergic synapse,1/114,0.005699927427839,0.0094998972841815,0,0,19886.0,102756.96431429044,CACNA1D
5296,KEGG_2019_Human,Dopaminergic synapse,1/131,0.0065499210316603,0.0094998972841815,0,0,19869.0,99907.33811343512,CACNA1D
5297,KEGG_2019_Human,Vascular smooth muscle contraction,1/132,0.0065999206698993,0.0094998972841815,0,0,19868.0,99751.22090491928,CACNA1D
5298,KEGG_2019_Human,Adrenergic signaling in cardiomyocytes,1/145,0.0072499160871101,0.0094998972841815,0,0,19855.0,97820.92670675044,CACNA1D
5299,KEGG_2019_Human,Retrograde endocannabinoid signaling,1/148,0.007399915061391,0.0094998972841815,0,0,19852.0,97399.60470052566,CACNA1D
5300,KEGG_2019_Human,Oxytocin signaling pathway,1/153,0.0076499133771537,0.0094998972841815,0,0,19847.0,96715.6407630817,CACNA1D
5301,KEGG_2019_Human,Cushing syndrome,1/155,0.0077499127120574,0.0094998972841815,0,0,19845.0,96448.16254952336,CACNA1D
5302,KEGG_2019_Human,Cellular senescence,1/160,0.0079999110688441,0.0094998972841815,0,0,19840.0,95793.96509856998,CACNA1D
5303,KEGG_2019_Human,cGMP-PKG signaling pathway,1/166,0.0082999091363732,0.0094998972841815,0,0,19834.0,95034.82345515196,CACNA1D
5304,KEGG_2019_Human,Tight junction,1/170,0.0084999078692823,0.0094998972841815,0,0,19830.0,94543.49009679438,CACNA1D
5305,KEGG_2019_Human,Alzheimer disease,1/171,0.0085499075557634,0.0094998972841815,0,0,19829.0,94422.42241345016,CACNA1D
5306,KEGG_2019_Human,Calcium signaling pathway,1/188,0.009399902370135,0.0100713239680018,0,0,19812.0,92463.712994847,CACNA1D
5307,KEGG_2019_Human,cAMP signaling pathway,1/212,0.0105998955026255,0.0109654091406471,0,0,19788.0,89974.27756224656,CACNA1D
5308,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0147498749536506,0,0,19705.0,83086.53988020132,CACNA1D
5309,KEGG_2019_Human,Long-term potentiation,1/67,0.0033499481224912,0.0099998771797997,0,0,19933.0,113594.38808369274,RPS6KA2
5310,KEGG_2019_Human,Progesterone-mediated oocyte maturation,1/99,0.0049499334884068,0.0099998771797997,0,0,19901.0,105642.09305076736,RPS6KA2
5311,KEGG_2019_Human,Insulin resistance,1/108,0.0053999298011749,0.0099998771797997,0,0,19892.0,103863.47861844616,RPS6KA2
5312,KEGG_2019_Human,Neurotrophin signaling pathway,1/119,0.0059499254985137,0.0099998771797997,0,0,19881.0,101877.73080211312,RPS6KA2
5313,KEGG_2019_Human,Oocyte meiosis,1/125,0.0062499232373748,0.0099998771797997,0,0,19875.0,100869.32368441945,RPS6KA2
5314,KEGG_2019_Human,mTOR signaling pathway,1/152,0.0075999137114971,0.0101332182819961,0,0,19848.0,96850.665715497,RPS6KA2
5315,KEGG_2019_Human,Thermogenesis,1/231,0.0115498903940656,0.0131998747360749,0,0,19769.0,88191.07730937863,RPS6KA2
5316,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0147498749536506,0,0,19705.0,83086.53988020132,RPS6KA2
5317,KEGG_2019_Human,Insulin signaling pathway,1/137,0.0068499188797651,0.0068499188797651,0,0,19863.0,98987.62735269018,PRKAR2B
5318,KEGG_2019_Human,Aldosterone-regulated sodium reabsorption,1/37,0.0018499650702878,0.0106782111017634,0,0,19963.0,125618.9446446357,PIK3CA
5319,KEGG_2019_Human,Carbohydrate digestion and absorption,1/44,0.0021999607179423,0.0106782111017634,0,0,19956.0,122117.06559109331,PIK3CA
5320,KEGG_2019_Human,Type II diabetes mellitus,1/46,0.0022999595269283,0.0106782111017634,0,0,19954.0,121217.8313311442,PIK3CA
5321,KEGG_2019_Human,Regulation of lipolysis in adipocytes,1/55,0.0027499544131125,0.0106782111017634,0,0,19945.0,117599.1294878737,PIK3CA
5322,KEGG_2019_Human,Endometrial cancer,1/58,0.0028999527887707,0.0106782111017634,0,0,19942.0,116522.31890946148,PIK3CA
5323,KEGG_2019_Human,VEGF signaling pathway,1/59,0.0029499522555206,0.0106782111017634,0,0,19941.0,116175.59385530632,PIK3CA
5324,KEGG_2019_Human,Central carbon metabolism in cancer,1/65,0.003249949134407,0.0106782111017634,0,0,19935.0,114209.92613860144,PIK3CA
5325,KEGG_2019_Human,Acute myeloid leukemia,1/66,0.003299948626608,0.0106782111017634,0,0,19934.0,113899.85357353876,PIK3CA
5326,KEGG_2019_Human,Non-small cell lung cancer,1/66,0.003299948626608,0.0106782111017634,0,0,19934.0,113899.85357353876,PIK3CA
5327,KEGG_2019_Human,Fc epsilon RI signaling pathway,1/68,0.0033999476216189,0.0106782111017634,0,0,19932.0,113293.39338050144,PIK3CA
5328,KEGG_2019_Human,Renal cell carcinoma,1/69,0.003449947123837,0.0106782111017634,0,0,19931.0,112996.7391397682,PIK3CA
5329,KEGG_2019_Human,Prolactin signaling pathway,1/70,0.0034999466296654,0.0106782111017634,0,0,19930.0,112704.30065625212,PIK3CA
5330,KEGG_2019_Human,B cell receptor signaling pathway,1/71,0.0035499461386618,0.0106782111017634,0,0,19929.0,112415.9585341616,PIK3CA
5331,KEGG_2019_Human,Melanoma,1/72,0.0035999456502131,0.0106782111017634,0,0,19928.0,112131.59838572376,PIK3CA
5332,KEGG_2019_Human,Inositol phosphate metabolism,1/74,0.0036999446830449,0.0106782111017634,0,0,19926.0,111574.38983110404,PIK3CA
5333,KEGG_2019_Human,Bacterial invasion of epithelial cells,1/74,0.0036999446830449,0.0106782111017634,0,0,19926.0,111574.38983110404,PIK3CA
5334,KEGG_2019_Human,Pancreatic cancer,1/75,0.0037499442041125,0.0106782111017634,0,0,19925.0,111301.33528642564,PIK3CA
5335,KEGG_2019_Human,Glioma,1/75,0.0037499442041125,0.0106782111017634,0,0,19925.0,111301.33528642564,PIK3CA
5336,KEGG_2019_Human,Chronic myeloid leukemia,1/76,0.0037999437281752,0.0106782111017634,0,0,19924.0,111031.8499691117,PIK3CA
5337,KEGG_2019_Human,ErbB signaling pathway,1/85,0.004249939567045,0.0106782111017634,0,0,19915.0,108752.83801948265,PIK3CA
5338,KEGG_2019_Human,Colorectal cancer,1/86,0.0042999391173866,0.0106782111017634,0,0,19914.0,108514.46102290176,PIK3CA
5339,KEGG_2019_Human,Fc gamma R-mediated phagocytosis,1/91,0.0045499369072032,0.0106782111017634,0,0,19909.0,107362.10783923086,PIK3CA
5340,KEGG_2019_Human,Small cell lung cancer,1/93,0.0046499360391879,0.0106782111017634,0,0,19907.0,106918.54242106884,PIK3CA
5341,KEGG_2019_Human,Amoebiasis,1/96,0.0047999347538706,0.0106782111017634,0,0,19904.0,106270.50039849174,PIK3CA
5342,KEGG_2019_Human,Prostate cancer,1/97,0.0048499343304706,0.0106782111017634,0,0,19903.0,106058.9096435903,PIK3CA
5343,KEGG_2019_Human,Choline metabolism in cancer,1/99,0.0049499334884068,0.0106782111017634,0,0,19901.0,105642.09305076736,PIK3CA
5344,KEGG_2019_Human,Phosphatidylinositol signaling system,1/99,0.0049499334884068,0.0106782111017634,0,0,19901.0,105642.09305076736,PIK3CA
5345,KEGG_2019_Human,Progesterone-mediated oocyte maturation,1/99,0.0049499334884068,0.0106782111017634,0,0,19901.0,105642.09305076736,PIK3CA
5346,KEGG_2019_Human,AGE-RAGE signaling pathway in diabetic complications,1/100,0.0049999330710556,0.0106782111017634,0,0,19900.0,105436.78197328727,PIK3CA
5347,KEGG_2019_Human,Inflammatory mediator regulation of TRP channels,1/100,0.0049999330710556,0.0106782111017634,0,0,19900.0,105436.78197328727,PIK3CA
5348,KEGG_2019_Human,HIF-1 signaling pathway,1/100,0.0049999330710556,0.0106782111017634,0,0,19900.0,105436.78197328727,PIK3CA
5349,KEGG_2019_Human,T cell receptor signaling pathway,1/101,0.0050499326546803,0.0106782111017634,0,0,19899.0,105233.48101229242,PIK3CA
5350,KEGG_2019_Human,Longevity regulating pathway,1/102,0.0050999322416682,0.0106782111017634,0,0,19898.0,105032.15064717118,PIK3CA
5351,KEGG_2019_Human,Chagas disease (American trypanosomiasis),1/103,0.0051499318302617,0.0106782111017634,0,0,19897.0,104832.7525292024,PIK3CA
5352,KEGG_2019_Human,Toll-like receptor signaling pathway,1/104,0.0051999314202997,0.0106782111017634,0,0,19896.0,104635.24941415618,PIK3CA
5353,KEGG_2019_Human,C-type lectin receptor signaling pathway,1/104,0.0051999314202997,0.0106782111017634,0,0,19896.0,104635.24941415618,PIK3CA
5354,KEGG_2019_Human,Insulin resistance,1/108,0.0053999298011749,0.0106782111017634,0,0,19892.0,103863.47861844616,PIK3CA
5355,KEGG_2019_Human,TNF signaling pathway,1/110,0.0054999290027479,0.0106782111017634,0,0,19890.0,103488.06969787036,PIK3CA
5356,KEGG_2019_Human,Leukocyte transendothelial migration,1/112,0.0055999282120529,0.0106782111017634,0,0,19888.0,103119.30984392198,PIK3CA
5357,KEGG_2019_Human,Cholinergic synapse,1/112,0.0055999282120529,0.0106782111017634,0,0,19888.0,103119.30984392198,PIK3CA
5358,KEGG_2019_Human,Thyroid hormone signaling pathway,1/116,0.0057999266512085,0.0106782111017634,0,0,19884.0,102400.8105961506,PIK3CA
5359,KEGG_2019_Human,Sphingolipid signaling pathway,1/119,0.0059499254985137,0.0106782111017634,0,0,19881.0,101877.73080211312,PIK3CA
5360,KEGG_2019_Human,Neurotrophin signaling pathway,1/119,0.0059499254985137,0.0106782111017634,0,0,19881.0,101877.73080211312,PIK3CA
5361,KEGG_2019_Human,AMPK signaling pathway,1/120,0.0059999251180858,0.0106782111017634,0,0,19880.0,101706.2448082016,PIK3CA
5362,KEGG_2019_Human,Platelet activation,1/124,0.0061999236097501,0.0106782111017634,0,0,19876.0,101034.04709010696,PIK3CA
5363,KEGG_2019_Human,Osteoclast differentiation,1/127,0.0063499224962247,0.0106782111017634,0,0,19873.0,100543.72072014232,PIK3CA
5364,KEGG_2019_Human,Autophagy,1/128,0.0063999221281459,0.0106782111017634,0,0,19872.0,100382.8010329652,PIK3CA
5365,KEGG_2019_Human,Relaxin signaling pathway,1/130,0.0064999213952527,0.0106782111017634,0,0,19870.0,100064.62842845908,PIK3CA
5366,KEGG_2019_Human,Natural killer cell mediated cytotoxicity,1/131,0.0065499210316603,0.0106782111017634,0,0,19869.0,99907.33811343512,PIK3CA
5367,KEGG_2019_Human,FoxO signaling pathway,1/132,0.0065999206698993,0.0106782111017634,0,0,19868.0,99751.22090491928,PIK3CA
5368,KEGG_2019_Human,Insulin signaling pathway,1/137,0.0068499188797651,0.0106782111017634,0,0,19863.0,98987.62735269018,PIK3CA
5369,KEGG_2019_Human,Estrogen signaling pathway,1/137,0.0068499188797651,0.0106782111017634,0,0,19863.0,98987.62735269018,PIK3CA
5370,KEGG_2019_Human,Measles,1/138,0.0068999185254481,0.0106782111017634,0,0,19862.0,98838.19160389496,PIK3CA
5371,KEGG_2019_Human,Fluid shear stress and atherosclerosis,1/139,0.006949918172816,0.0106782111017634,0,0,19861.0,98689.81333375497,PIK3CA
5372,KEGG_2019_Human,Signaling pathways regulating pluripotency of stem cells,1/139,0.006949918172816,0.0106782111017634,0,0,19861.0,98689.81333375497,PIK3CA
5373,KEGG_2019_Human,Apoptosis,1/143,0.0071499167770442,0.0106782111017634,0,0,19857.0,98106.57763600958,PIK3CA
5374,KEGG_2019_Human,Breast cancer,1/147,0.0073499154017982,0.0106782111017634,0,0,19853.0,97539.10874372096,PIK3CA
5375,KEGG_2019_Human,Phospholipase D signaling pathway,1/148,0.007399915061391,0.0106782111017634,0,0,19852.0,97399.60470052566,PIK3CA
5376,KEGG_2019_Human,Non-alcoholic fatty liver disease (NAFLD),1/149,0.0074499147221605,0.0106782111017634,0,0,19851.0,97261.02051561224,PIK3CA
5377,KEGG_2019_Human,Gastric cancer,1/149,0.0074499147221605,0.0106782111017634,0,0,19851.0,97261.02051561224,PIK3CA
5378,KEGG_2019_Human,mTOR signaling pathway,1/152,0.0075999137114971,0.0107146324457172,0,0,19848.0,96850.665715497,PIK3CA
5379,KEGG_2019_Human,Hepatitis C,1/155,0.0077499127120574,0.0107498789231765,0,0,19845.0,96448.16254952336,PIK3CA
5380,KEGG_2019_Human,Cellular senescence,1/160,0.0079999110688441,0.0107829579756391,0,0,19840.0,95793.96509856998,PIK3CA
5381,KEGG_2019_Human,JAK-STAT signaling pathway,1/162,0.0080999104202618,0.0107829579756391,0,0,19838.0,95537.86936302872,PIK3CA
5382,KEGG_2019_Human,Hepatitis B,1/163,0.0081499100978668,0.0107829579756391,0,0,19837.0,95410.9786681514,PIK3CA
5383,KEGG_2019_Human,Hepatocellular carcinoma,1/168,0.0083999085011095,0.0109453353196275,0,0,19832.0,94787.72752807094,PIK3CA
5384,KEGG_2019_Human,Influenza A,1/171,0.0085499075557634,0.0109745082059053,0,0,19829.0,94422.42241345016,PIK3CA
5385,KEGG_2019_Human,Axon guidance,1/181,0.0090499044707863,0.0114454674189356,0,0,19819.0,93248.41634586031,PIK3CA
5386,KEGG_2019_Human,Kaposi sarcoma-associated herpesvirus infection,1/186,0.0092999029651357,0.0115911834058213,0,0,19814.0,92684.96451050608,PIK3CA
5387,KEGG_2019_Human,Chemokine signaling pathway,1/190,0.0094999017791995,0.0116713079001594,0,0,19810.0,92244.74636351672,PIK3CA
5388,KEGG_2019_Human,Focal adhesion,1/199,0.0099498991610159,0.0116796118723069,0,0,19801.0,91286.4288690606,PIK3CA
5389,KEGG_2019_Human,Viral carcinogenesis,1/201,0.0100498985877989,0.0116796118723069,0,0,19799.0,91079.21596609056,PIK3CA
5390,KEGG_2019_Human,Epstein-Barr virus infection,1/201,0.0100498985877989,0.0116796118723069,0,0,19799.0,91079.21596609056,PIK3CA
5391,KEGG_2019_Human,Proteoglycans in cancer,1/201,0.0100498985877989,0.0116796118723069,0,0,19799.0,91079.21596609056,PIK3CA
5392,KEGG_2019_Human,Rap1 signaling pathway,1/206,0.010299897173561,0.0117973200746279,0,0,19794.0,90569.849337325,PIK3CA
5393,KEGG_2019_Human,Human immunodeficiency virus 1 infection,1/212,0.0105998955026255,0.0117973200746279,0,0,19788.0,89974.27756224656,PIK3CA
5394,KEGG_2019_Human,cAMP signaling pathway,1/212,0.0105998955026255,0.0117973200746279,0,0,19788.0,89974.27756224656,PIK3CA
5395,KEGG_2019_Human,Regulation of actin cytoskeleton,1/214,0.0106998949514067,0.0117973200746279,0,0,19786.0,89779.39753374986,PIK3CA
5396,KEGG_2019_Human,Human T-cell leukemia virus 1 infection,1/219,0.0109498935894162,0.0119201373251873,0,0,19781.0,89299.85161916987,PIK3CA
5397,KEGG_2019_Human,Human cytomegalovirus infection,1/225,0.0112498919790339,0.0120936338774614,0,0,19775.0,88738.27077557483,PIK3CA
5398,KEGG_2019_Human,Ras signaling pathway,1/232,0.0115998901349604,0.0123159327358838,0,0,19768.0,88101.22480150245,PIK3CA
5399,KEGG_2019_Human,MicroRNAs in cancer,1/299,0.0149498740670514,0.0156791362166637,0,0,19701.0,82804.33538735632,PIK3CA
5400,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0170962482104933,0,0,19670.0,80733.60565076157,PIK3CA
5401,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0181212879423518,0,0,19646.0,79255.8617626126,PIK3CA
5402,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0248892488499732,0,0,19508.0,72277.44006442746,PIK3CA
5403,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,PIK3CA
5404,KEGG_2019_Human,Alzheimer disease,1/171,0.0085499075557634,0.0085499075557634,0,0,19829.0,94422.42241345016,BACE1
5405,KEGG_2019_Human,Mismatch repair,1/23,0.0011499748819949,0.0023499589392381,0,0,19977.0,135204.63922267244,RFC4
5406,KEGG_2019_Human,DNA replication,1/36,0.0017999657178272,0.0023499589392381,0,0,19964.0,126172.23364250171,RFC4
5407,KEGG_2019_Human,Nucleotide excision repair,1/47,0.0023499589392381,0.0023499589392381,0,0,19953.0,120782.64067395544,RFC4
5408,KEGG_2019_Human,Aldosterone-regulated sodium reabsorption,1/37,0.0018499650702878,0.0036999301405757,0,0,19963.0,125618.9446446357,SCNN1B
5409,KEGG_2019_Human,Taste transduction,1/83,0.0041499404726918,0.0041499404726918,0,0,19917.0,109237.99888847338,SCNN1B
5410,KEGG_2019_Human,Mannose type O-glycan biosynthesis,1/23,0.0011499748819949,0.0022999497639899,0,0,19977.0,135204.63922267244,MGAT5B
5411,KEGG_2019_Human,N-Glycan biosynthesis,1/50,0.0024999572069037,0.0024999572069037,0,0,19950.0,119530.05920663515,MGAT5B
5412,KEGG_2019_Human,Endometrial cancer,1/58,0.0028999527887707,0.0117598719015533,0,0,19942.0,116522.31890946148,APC
5413,KEGG_2019_Human,Basal cell carcinoma,1/63,0.0031499501598827,0.0117598719015533,0,0,19937.0,114844.46974572667,APC
5414,KEGG_2019_Human,Colorectal cancer,1/86,0.0042999391173866,0.0117598719015533,0,0,19914.0,108514.46102290176,APC
5415,KEGG_2019_Human,Signaling pathways regulating pluripotency of stem cells,1/139,0.006949918172816,0.0117598719015533,0,0,19861.0,98689.81333375497,APC
5416,KEGG_2019_Human,Breast cancer,1/147,0.0073499154017982,0.0117598719015533,0,0,19853.0,97539.10874372096,APC
5417,KEGG_2019_Human,Gastric cancer,1/149,0.0074499147221605,0.0117598719015533,0,0,19851.0,97261.02051561224,APC
5418,KEGG_2019_Human,Cushing syndrome,1/155,0.0077499127120574,0.0117598719015533,0,0,19845.0,96448.16254952336,APC
5419,KEGG_2019_Human,Wnt signaling pathway,1/158,0.0078999117225733,0.0117598719015533,0,0,19842.0,96053.2110949472,APC
5420,KEGG_2019_Human,Hippo signaling pathway,1/160,0.0079999110688441,0.0117598719015533,0,0,19840.0,95793.96509856998,APC
5421,KEGG_2019_Human,Hepatocellular carcinoma,1/168,0.0083999085011095,0.0117598719015533,0,0,19832.0,94787.72752807094,APC
5422,KEGG_2019_Human,Regulation of actin cytoskeleton,1/214,0.0106998949514067,0.0136180481199722,0,0,19786.0,89779.39753374986,APC
5423,KEGG_2019_Human,MicroRNAs in cancer,1/299,0.0149498740670514,0.0174415197448933,0,0,19701.0,82804.33538735632,APC
5424,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.017769088032731,0,0,19670.0,80733.60565076157,APC
5425,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,APC
5426,KEGG_2019_Human,NOD-like receptor signaling pathway,1/178,0.0088999053857096,0.0088999053857096,0,0,19822.0,93593.82745769851,GBP5
5427,KEGG_2019_Human,Phagosome,1/152,0.0075999137114971,0.0075999137114971,0,0,19848.0,96850.665715497,MARCO
5428,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF398
5429,KEGG_2019_Human,Thyroid cancer,1/37,0.0018499650702878,0.0048749237016105,0,0,19963.0,125618.9446446357,RET
5430,KEGG_2019_Human,Central carbon metabolism in cancer,1/65,0.003249949134407,0.0048749237016105,0,0,19935.0,114209.92613860144,RET
5431,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,RET
5432,KEGG_2019_Human,Longevity regulating pathway,1/102,0.0050999322416682,0.0121598619383953,0,0,19898.0,105032.15064717118,RPTOR
5433,KEGG_2019_Human,AMPK signaling pathway,1/120,0.0059999251180858,0.0121598619383953,0,0,19880.0,101706.2448082016,RPTOR
5434,KEGG_2019_Human,Autophagy,1/128,0.0063999221281459,0.0121598619383953,0,0,19872.0,100382.8010329652,RPTOR
5435,KEGG_2019_Human,Insulin signaling pathway,1/137,0.0068499188797651,0.0121598619383953,0,0,19863.0,98987.62735269018,RPTOR
5436,KEGG_2019_Human,mTOR signaling pathway,1/152,0.0075999137114971,0.0121598619383953,0,0,19848.0,96850.665715497,RPTOR
5437,KEGG_2019_Human,Thermogenesis,1/231,0.0115498903940656,0.0153998538587541,0,0,19769.0,88191.07730937863,RPTOR
5438,KEGG_2019_Human,MicroRNAs in cancer,1/299,0.0149498740670514,0.0170855703623445,0,0,19701.0,82804.33538735632,RPTOR
5439,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0176998626413668,0,0,19646.0,79255.8617626126,RPTOR
5440,KEGG_2019_Human,Purine metabolism,1/129,0.006449921761047,0.0082999091363732,0,0,19871.0,100223.109907462,NPR2
5441,KEGG_2019_Human,Vascular smooth muscle contraction,1/132,0.0065999206698993,0.0082999091363732,0,0,19868.0,99751.22090491928,NPR2
5442,KEGG_2019_Human,Oxytocin signaling pathway,1/153,0.0076499133771537,0.0082999091363732,0,0,19847.0,96715.6407630817,NPR2
5443,KEGG_2019_Human,cGMP-PKG signaling pathway,1/166,0.0082999091363732,0.0082999091363732,0,0,19834.0,95034.82345515196,NPR2
5444,KEGG_2019_Human,Thyroid hormone signaling pathway,1/116,0.0057999266512085,0.0057999266512085,0,0,19884.0,102400.8105961506,MED14
5445,KEGG_2019_Human,Alcoholism,1/180,0.0089999047745351,0.0100498985877989,0,0,19820.0,93362.92821536642,HDAC6
5446,KEGG_2019_Human,Viral carcinogenesis,1/201,0.0100498985877989,0.0100498985877989,0,0,19799.0,91079.21596609056,HDAC6
5447,KEGG_2019_Human,Vasopressin-regulated water reabsorption,1/44,0.0021999607179423,0.0116953265103441,0,0,19956.0,122117.06559109331,CREB5
5448,KEGG_2019_Human,Cocaine addiction,1/49,0.0024499577795033,0.0116953265103441,0,0,19951.0,119939.1172087114,CREB5
5449,KEGG_2019_Human,Cortisol synthesis and secretion,1/65,0.003249949134407,0.0116953265103441,0,0,19935.0,114209.92613860144,CREB5
5450,KEGG_2019_Human,Amphetamine addiction,1/68,0.0033999476216189,0.0116953265103441,0,0,19932.0,113293.39338050144,CREB5
5451,KEGG_2019_Human,Thyroid hormone synthesis,1/74,0.0036999446830449,0.0116953265103441,0,0,19926.0,111574.38983110404,CREB5
5452,KEGG_2019_Human,Insulin secretion,1/86,0.0042999391173866,0.0116953265103441,0,0,19914.0,108514.46102290176,CREB5
5453,KEGG_2019_Human,Prostate cancer,1/97,0.0048499343304706,0.0116953265103441,0,0,19903.0,106058.9096435903,CREB5
5454,KEGG_2019_Human,Aldosterone synthesis and secretion,1/98,0.0048999339081079,0.0116953265103441,0,0,19902.0,105849.45495286948,CREB5
5455,KEGG_2019_Human,Longevity regulating pathway,1/102,0.0050999322416682,0.0116953265103441,0,0,19898.0,105032.15064717118,CREB5
5456,KEGG_2019_Human,Glucagon signaling pathway,1/103,0.0051499318302617,0.0116953265103441,0,0,19897.0,104832.7525292024,CREB5
5457,KEGG_2019_Human,"Parathyroid hormone synthesis, secretion and action",1/106,0.0052999306076525,0.0116953265103441,0,0,19894.0,104245.78450366124,CREB5
5458,KEGG_2019_Human,Insulin resistance,1/108,0.0053999298011749,0.0116953265103441,0,0,19892.0,103863.47861844616,CREB5
5459,KEGG_2019_Human,TNF signaling pathway,1/110,0.0054999290027479,0.0116953265103441,0,0,19890.0,103488.06969787036,CREB5
5460,KEGG_2019_Human,Cholinergic synapse,1/112,0.0055999282120529,0.0116953265103441,0,0,19888.0,103119.30984392198,CREB5
5461,KEGG_2019_Human,AMPK signaling pathway,1/120,0.0059999251180858,0.0116953265103441,0,0,19880.0,101706.2448082016,CREB5
5462,KEGG_2019_Human,Relaxin signaling pathway,1/130,0.0064999213952527,0.0116953265103441,0,0,19870.0,100064.62842845908,CREB5
5463,KEGG_2019_Human,Dopaminergic synapse,1/131,0.0065499210316603,0.0116953265103441,0,0,19869.0,99907.33811343512,CREB5
5464,KEGG_2019_Human,Estrogen signaling pathway,1/137,0.0068499188797651,0.0116953265103441,0,0,19863.0,98987.62735269018,CREB5
5465,KEGG_2019_Human,Adrenergic signaling in cardiomyocytes,1/145,0.0072499160871101,0.0116953265103441,0,0,19855.0,97820.92670675044,CREB5
5466,KEGG_2019_Human,Cushing syndrome,1/155,0.0077499127120574,0.0116953265103441,0,0,19845.0,96448.16254952336,CREB5
5467,KEGG_2019_Human,Hepatitis B,1/163,0.0081499100978668,0.0116953265103441,0,0,19837.0,95410.9786681514,CREB5
5468,KEGG_2019_Human,cGMP-PKG signaling pathway,1/166,0.0082999091363732,0.0116953265103441,0,0,19834.0,95034.82345515196,CREB5
5469,KEGG_2019_Human,Alcoholism,1/180,0.0089999047745351,0.0121303064352429,0,0,19820.0,93362.92821536642,CREB5
5470,KEGG_2019_Human,Huntington disease,1/193,0.0096499008972596,0.0123464345591735,0,0,19807.0,91920.47679471428,CREB5
5471,KEGG_2019_Human,Viral carcinogenesis,1/201,0.0100498985877989,0.0123464345591735,0,0,19799.0,91079.21596609056,CREB5
5472,KEGG_2019_Human,cAMP signaling pathway,1/212,0.0105998955026255,0.0123464345591735,0,0,19788.0,89974.27756224656,CREB5
5473,KEGG_2019_Human,Human T-cell leukemia virus 1 infection,1/219,0.0109498935894162,0.0123464345591735,0,0,19781.0,89299.85161916987,CREB5
5474,KEGG_2019_Human,Human cytomegalovirus infection,1/225,0.0112498919790339,0.0123464345591735,0,0,19775.0,88738.27077557483,CREB5
5475,KEGG_2019_Human,Thermogenesis,1/231,0.0115498903940656,0.0123464345591735,0,0,19769.0,88191.07730937863,CREB5
5476,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.01704986304093,0,0,19670.0,80733.60565076157,CREB5
5477,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0176998626413668,0,0,19646.0,79255.8617626126,CREB5
5478,KEGG_2019_Human,Epithelial cell signaling in Helicobacter pylori infection,1/68,0.0033999476216189,0.0033999476216189,0,0,19932.0,113293.39338050144,PTPRZ1
5479,KEGG_2019_Human,Signaling pathways regulating pluripotency of stem cells,1/139,0.006949918172816,0.006949918172816,0,0,19861.0,98689.81333375497,POU5F1B
5480,KEGG_2019_Human,Thyroid hormone signaling pathway,1/116,0.0057999266512085,0.0092999029651357,0,0,19884.0,102400.8105961506,NCOR1
5481,KEGG_2019_Human,Transcriptional misregulation in cancer,1/186,0.0092999029651357,0.0092999029651357,0,0,19814.0,92684.96451050608,NCOR1
5482,KEGG_2019_Human,Natural killer cell mediated cytotoxicity,1/131,0.0065499210316603,0.0065499210316603,0,0,19869.0,99907.33811343512,NCR3
5483,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,NMUR2
5484,KEGG_2019_Human,Transcriptional misregulation in cancer,1/186,0.0092999029651357,0.0092999029651357,0,0,19814.0,92684.96451050608,BCL11B
5485,KEGG_2019_Human,Phosphonate and phosphinate metabolism,1/6,0.0002999905873105514,0.0008999717619316542,0,0,19994.0,162186.51863187927,PCYT1A
5486,KEGG_2019_Human,Glycerophospholipid metabolism,1/97,0.0048499343304706,0.0049499334884068,0,0,19903.0,106058.9096435903,PCYT1A
5487,KEGG_2019_Human,Choline metabolism in cancer,1/99,0.0049499334884068,0.0049499334884068,0,0,19901.0,105642.09305076736,PCYT1A
5488,KEGG_2019_Human,Galactose metabolism,1/31,0.0015499690656704,0.0023999583567988,0,0,19969.0,129189.85098816035,GALE
5489,KEGG_2019_Human,Amino sugar and nucleotide sugar metabolism,1/48,0.0023999583567988,0.0023999583567988,0,0,19952.0,120356.5272753826,GALE
5490,KEGG_2019_Human,Malaria,1/49,0.0024499577795033,0.0112998556382303,0,0,19951.0,119939.1172087114,TLR2
5491,KEGG_2019_Human,Legionellosis,1/55,0.0027499544131125,0.0112998556382303,0,0,19945.0,117599.1294878737,TLR2
5492,KEGG_2019_Human,Inflammatory bowel disease (IBD),1/65,0.003249949134407,0.0112998556382303,0,0,19935.0,114209.92613860144,TLR2
5493,KEGG_2019_Human,Leishmaniasis,1/74,0.0036999446830449,0.0112998556382303,0,0,19926.0,111574.38983110404,TLR2
5494,KEGG_2019_Human,Rheumatoid arthritis,1/91,0.0045499369072032,0.0112998556382303,0,0,19909.0,107362.10783923086,TLR2
5495,KEGG_2019_Human,Amoebiasis,1/96,0.0047999347538706,0.0112998556382303,0,0,19904.0,106270.50039849174,TLR2
5496,KEGG_2019_Human,Chagas disease (American trypanosomiasis),1/103,0.0051499318302617,0.0112998556382303,0,0,19897.0,104832.7525292024,TLR2
5497,KEGG_2019_Human,Toll-like receptor signaling pathway,1/104,0.0051999314202997,0.0112998556382303,0,0,19896.0,104635.24941415618,TLR2
5498,KEGG_2019_Human,Toxoplasmosis,1/113,0.0056499278191151,0.0112998556382303,0,0,19887.0,102937.34947211576,TLR2
5499,KEGG_2019_Human,Measles,1/138,0.0068999185254481,0.0119248824404537,0,0,19862.0,98838.19160389496,TLR2
5500,KEGG_2019_Human,Phagosome,1/152,0.0075999137114971,0.0119248824404537,0,0,19848.0,96850.665715497,TLR2
5501,KEGG_2019_Human,Hepatitis B,1/163,0.0081499100978668,0.0119248824404537,0,0,19837.0,95410.9786681514,TLR2
5502,KEGG_2019_Human,Tuberculosis,1/179,0.0089499050800561,0.0119248824404537,0,0,19821.0,93478.0629355712,TLR2
5503,KEGG_2019_Human,Proteoglycans in cancer,1/201,0.0100498985877989,0.0119248824404537,0,0,19799.0,91079.21596609056,TLR2
5504,KEGG_2019_Human,Epstein-Barr virus infection,1/201,0.0100498985877989,0.0119248824404537,0,0,19799.0,91079.21596609056,TLR2
5505,KEGG_2019_Human,Human immunodeficiency virus 1 infection,1/212,0.0105998955026255,0.0119248824404537,0,0,19788.0,89974.27756224656,TLR2
5506,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0187410310320355,0,0,19646.0,79255.8617626126,TLR2
5507,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,TLR2
5508,KEGG_2019_Human,cAMP signaling pathway,1/212,0.0105998955026255,0.0211997910052511,0,0,19788.0,89974.27756224656,CNGA3
5509,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,CNGA3
5510,KEGG_2019_Human,Ubiquitin mediated proteolysis,1/137,0.0068499188797651,0.0068499188797651,0,0,19863.0,98987.62735269018,RHOBTB2
5511,KEGG_2019_Human,Long-term depression,1/60,0.002999951725986,0.0089998551779582,0,0,19940.0,115834.63209072244,CRHR1
5512,KEGG_2019_Human,Cushing syndrome,1/155,0.0077499127120574,0.0116248690680862,0,0,19845.0,96448.16254952336,CRHR1
5513,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,CRHR1
5514,KEGG_2019_Human,JAK-STAT signaling pathway,1/162,0.0080999104202618,0.0121998870519305,0,0,19838.0,95537.86936302872,STAM2
5515,KEGG_2019_Human,Endocytosis,1/244,0.0121998870519305,0.0121998870519305,0,0,19756.0,87051.4275316661,STAM2
5516,KEGG_2019_Human,Acute myeloid leukemia,1/66,0.003299948626608,0.0092999029651357,0,0,19934.0,113899.85357353876,MPO
5517,KEGG_2019_Human,Drug metabolism,1/108,0.0053999298011749,0.0092999029651357,0,0,19892.0,103863.47861844616,MPO
5518,KEGG_2019_Human,Phagosome,1/152,0.0075999137114971,0.0092999029651357,0,0,19848.0,96850.665715497,MPO
5519,KEGG_2019_Human,Transcriptional misregulation in cancer,1/186,0.0092999029651357,0.0092999029651357,0,0,19814.0,92684.96451050608,MPO
5520,KEGG_2019_Human,Porphyrin and chlorophyll metabolism,1/42,0.0020999619311272,0.0062998857933818,0,0,19958.0,123057.75613441122,COX15
5521,KEGG_2019_Human,Oxidative phosphorylation,1/133,0.0066499203093911,0.0099748804640867,0,0,19867.0,99596.2591544721,COX15
5522,KEGG_2019_Human,Thermogenesis,1/231,0.0115498903940656,0.0115498903940656,0,0,19769.0,88191.07730937863,COX15
5523,KEGG_2019_Human,Mucin type O-glycan biosynthesis,1/31,0.0015499690656704,0.0015499690656704,0,0,19969.0,129189.85098816035,ST6GALNAC1
5524,KEGG_2019_Human,Graft-versus-host disease,1/41,0.0020499625466866,0.0076998865095004,0,0,19959.0,123544.88783416104,KIR2DL3
5525,KEGG_2019_Human,Antigen processing and presentation,1/77,0.0038499432547502,0.0076998865095004,0,0,19923.0,110765.8407373636,KIR2DL3
5526,KEGG_2019_Human,Natural killer cell mediated cytotoxicity,1/131,0.0065499210316603,0.0079999110688441,0,0,19869.0,99907.33811343512,KIR2DL3
5527,KEGG_2019_Human,Cellular senescence,1/160,0.0079999110688441,0.0079999110688441,0,0,19840.0,95793.96509856998,KIR2DL3
5528,KEGG_2019_Human,Lysosome,1/123,0.0061499239842961,0.0061499239842961,0,0,19877.0,101200.07933676826,AP3S1
5529,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR52R1
5530,KEGG_2019_Human,Thermogenesis,1/231,0.0115498903940656,0.0115498903940656,0,0,19769.0,88191.07730937863,ZNF516
5531,KEGG_2019_Human,Phototransduction,1/28,0.0013999711732997,0.0041999135198993,0,0,19972.0,131242.0761597353,GRK1
5532,KEGG_2019_Human,Chemokine signaling pathway,1/190,0.0094999017791995,0.0121998870519305,0,0,19810.0,92244.74636351672,GRK1
5533,KEGG_2019_Human,Endocytosis,1/244,0.0121998870519305,0.0121998870519305,0,0,19756.0,87051.4275316661,GRK1
5534,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0164998674589645,0,0,19670.0,80733.60565076157,HES6
5535,KEGG_2019_Human,Mitophagy,1/65,0.003249949134407,0.003249949134407,0,0,19935.0,114209.92613860144,USP30
5536,KEGG_2019_Human,Proximal tubule bicarbonate reclamation,1/23,0.0011499748819949,0.0044999373439762,0,0,19977.0,135204.63922267244,SLC9A3
5537,KEGG_2019_Human,Mineral absorption,1/51,0.0025499566390179,0.0044999373439762,0,0,19949.0,119129.0228601236,SLC9A3
5538,KEGG_2019_Human,Bile secretion,1/72,0.0035999456502131,0.0044999373439762,0,0,19928.0,112131.59838572376,SLC9A3
5539,KEGG_2019_Human,Protein digestion and absorption,1/90,0.0044999373439762,0.0044999373439762,0,0,19910.0,107587.50385474482,SLC9A3
5540,KEGG_2019_Human,Prostate cancer,1/97,0.0048499343304706,0.0096998686609413,0,0,19903.0,106058.9096435903,INSRR
5541,KEGG_2019_Human,Regulation of actin cytoskeleton,1/214,0.0106998949514067,0.0106998949514067,0,0,19786.0,89779.39753374986,INSRR
5542,KEGG_2019_Human,RNA transport,1/165,0.0082499094553477,0.0082499094553477,0,0,19835.0,95159.46482222488,GEMIN8
5543,KEGG_2019_Human,Basal cell carcinoma,1/63,0.0031499501598827,0.0106665480917922,0,0,19937.0,114844.46974572667,BMP4
5544,KEGG_2019_Human,TGF-beta signaling pathway,1/90,0.0044999373439762,0.0106665480917922,0,0,19910.0,107587.50385474482,BMP4
5545,KEGG_2019_Human,Thyroid hormone signaling pathway,1/116,0.0057999266512085,0.0106665480917922,0,0,19884.0,102400.8105961506,BMP4
5546,KEGG_2019_Human,Fluid shear stress and atherosclerosis,1/139,0.006949918172816,0.0106665480917922,0,0,19861.0,98689.81333375497,BMP4
5547,KEGG_2019_Human,Signaling pathways regulating pluripotency of stem cells,1/139,0.006949918172816,0.0106665480917922,0,0,19861.0,98689.81333375497,BMP4
5548,KEGG_2019_Human,Hippo signaling pathway,1/160,0.0079999110688441,0.0106665480917922,0,0,19840.0,95793.96509856998,BMP4
5549,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0167998573439697,0,0,19706.0,83157.67014793828,BMP4
5550,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,BMP4
5551,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF595
5552,KEGG_2019_Human,Antigen processing and presentation,1/77,0.0038499432547502,0.0134998703748406,0,0,19923.0,110765.8407373636,PDIA3
5553,KEGG_2019_Human,Protein processing in endoplasmic reticulum,1/165,0.0082499094553477,0.0134998703748406,0,0,19835.0,95159.46482222488,PDIA3
5554,KEGG_2019_Human,Epstein-Barr virus infection,1/201,0.0100498985877989,0.0134998703748406,0,0,19799.0,91079.21596609056,PDIA3
5555,KEGG_2019_Human,Human immunodeficiency virus 1 infection,1/212,0.0105998955026255,0.0134998703748406,0,0,19788.0,89974.27756224656,PDIA3
5556,KEGG_2019_Human,Human cytomegalovirus infection,1/225,0.0112498919790339,0.0134998703748406,0,0,19775.0,88738.27077557483,PDIA3
5557,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,PDIA3
5558,KEGG_2019_Human,Renin secretion,1/69,0.003449947123837,0.0073499008621619,0,0,19931.0,112996.7391397682,KCNMA1
5559,KEGG_2019_Human,Insulin secretion,1/86,0.0042999391173866,0.0073499008621619,0,0,19914.0,108514.46102290176,KCNMA1
5560,KEGG_2019_Human,Salivary secretion,1/90,0.0044999373439762,0.0073499008621619,0,0,19910.0,107587.50385474482,KCNMA1
5561,KEGG_2019_Human,Pancreatic secretion,1/98,0.0048999339081079,0.0073499008621619,0,0,19902.0,105849.45495286948,KCNMA1
5562,KEGG_2019_Human,Vascular smooth muscle contraction,1/132,0.0065999206698993,0.0079199048038792,0,0,19868.0,99751.22090491928,KCNMA1
5563,KEGG_2019_Human,cGMP-PKG signaling pathway,1/166,0.0082999091363732,0.0082999091363732,0,0,19834.0,95034.82345515196,KCNMA1
5564,KEGG_2019_Human,cAMP signaling pathway,1/212,0.0105998955026255,0.0168998658265596,0,0,19788.0,89974.27756224656,VIPR2
5565,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,VIPR2
5566,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0147498749536506,0,0,19705.0,83086.53988020132,PTPN5
5567,KEGG_2019_Human,"Glycine, serine and threonine metabolism",1/40,0.0019999631680592,0.0045332634954919,0,0,19960.0,124043.94523066044,PGAM4
5568,KEGG_2019_Human,Central carbon metabolism in cancer,1/65,0.003249949134407,0.0045332634954919,0,0,19935.0,114209.92613860144,PGAM4
5569,KEGG_2019_Human,Glycolysis / Gluconeogenesis,1/68,0.0033999476216189,0.0045332634954919,0,0,19932.0,113293.39338050144,PGAM4
5570,KEGG_2019_Human,Glucagon signaling pathway,1/103,0.0051499318302617,0.0051499318302617,0,0,19897.0,104832.7525292024,PGAM4
5571,KEGG_2019_Human,Pertussis,1/76,0.0037999437281752,0.0088999053857096,0,0,19924.0,111031.8499691117,NLRP3
5572,KEGG_2019_Human,C-type lectin receptor signaling pathway,1/104,0.0051999314202997,0.0088999053857096,0,0,19896.0,104635.24941415618,NLRP3
5573,KEGG_2019_Human,Necroptosis,1/162,0.0080999104202618,0.0088999053857096,0,0,19838.0,95537.86936302872,NLRP3
5574,KEGG_2019_Human,Influenza A,1/171,0.0085499075557634,0.0088999053857096,0,0,19829.0,94422.42241345016,NLRP3
5575,KEGG_2019_Human,NOD-like receptor signaling pathway,1/178,0.0088999053857096,0.0088999053857096,0,0,19822.0,93593.82745769851,NLRP3
5576,KEGG_2019_Human,Glutathione metabolism,1/56,0.0027999538675741,0.005699906652596,0,0,19944.0,117233.87022514464,RRM1
5577,KEGG_2019_Human,Pyrimidine metabolism,1/57,0.002849953326298,0.005699906652596,0,0,19943.0,116875.00742975442,RRM1
5578,KEGG_2019_Human,Drug metabolism,1/108,0.0053999298011749,0.006449921761047,0,0,19892.0,103863.47861844616,RRM1
5579,KEGG_2019_Human,Purine metabolism,1/129,0.006449921761047,0.006449921761047,0,0,19871.0,100223.109907462,RRM1
5580,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR12D3
5581,KEGG_2019_Human,Gastric acid secretion,1/75,0.0037499442041125,0.0037499442041125,0,0,19925.0,111301.33528642564,KCNE2
5582,KEGG_2019_Human,Regulation of actin cytoskeleton,1/214,0.0106998949514067,0.0106998949514067,0,0,19786.0,89779.39753374986,DIAPH2
5583,KEGG_2019_Human,TGF-beta signaling pathway,1/90,0.0044999373439762,0.0119998666032662,0,0,19910.0,107587.50385474482,GDF5
5584,KEGG_2019_Human,Hippo signaling pathway,1/160,0.0079999110688441,0.0119998666032662,0,0,19840.0,95793.96509856998,GDF5
5585,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0146998751759735,0,0,19706.0,83157.67014793828,GDF5
5586,KEGG_2019_Human,Aldosterone synthesis and secretion,1/98,0.0048999339081079,0.0048999339081079,0,0,19902.0,105849.45495286948,KCNK9
5587,KEGG_2019_Human,Wnt signaling pathway,1/158,0.0078999117225733,0.0078999117225733,0,0,19842.0,96053.2110949472,ROR1
5588,KEGG_2019_Human,Protein processing in endoplasmic reticulum,1/165,0.0082499094553477,0.0082499094553477,0,0,19835.0,95159.46482222488,WFS1
5589,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF846
5590,KEGG_2019_Human,Inflammatory mediator regulation of TRP channels,1/100,0.0049999330710556,0.0099998661421113,0,0,19900.0,105436.78197328727,TRPV1
5591,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,TRPV1
5592,KEGG_2019_Human,Epithelial cell signaling in Helicobacter pylori infection,1/68,0.0033999476216189,0.0084999078692823,0,0,19932.0,113293.39338050144,JAM2
5593,KEGG_2019_Human,Leukocyte transendothelial migration,1/112,0.0055999282120529,0.0084999078692823,0,0,19888.0,103119.30984392198,JAM2
5594,KEGG_2019_Human,Cell adhesion molecules (CAMs),1/145,0.0072499160871101,0.0084999078692823,0,0,19855.0,97820.92670675044,JAM2
5595,KEGG_2019_Human,Tight junction,1/170,0.0084999078692823,0.0084999078692823,0,0,19830.0,94543.49009679438,JAM2
5596,KEGG_2019_Human,Pathogenic Escherichia coli infection,1/55,0.0027499544131125,0.0084999078692823,0,0,19945.0,117599.1294878737,TUBA3C
5597,KEGG_2019_Human,Gap junction,1/88,0.0043999382262822,0.0084999078692823,0,0,19912.0,108045.79305232369,TUBA3C
5598,KEGG_2019_Human,Apoptosis,1/143,0.0071499167770442,0.0084999078692823,0,0,19857.0,98106.57763600958,TUBA3C
5599,KEGG_2019_Human,Phagosome,1/152,0.0075999137114971,0.0084999078692823,0,0,19848.0,96850.665715497,TUBA3C
5600,KEGG_2019_Human,Tight junction,1/170,0.0084999078692823,0.0084999078692823,0,0,19830.0,94543.49009679438,TUBA3C
5601,KEGG_2019_Human,Bladder cancer,1/41,0.0020499625466866,0.011293617030826,0,0,19959.0,123544.88783416104,MMP9
5602,KEGG_2019_Human,IL-17 signaling pathway,1/93,0.0046499360391879,0.011293617030826,0,0,19907.0,106918.54242106884,MMP9
5603,KEGG_2019_Human,Prostate cancer,1/97,0.0048499343304706,0.011293617030826,0,0,19903.0,106058.9096435903,MMP9
5604,KEGG_2019_Human,TNF signaling pathway,1/110,0.0054999290027479,0.011293617030826,0,0,19890.0,103488.06969787036,MMP9
5605,KEGG_2019_Human,Leukocyte transendothelial migration,1/112,0.0055999282120529,0.011293617030826,0,0,19888.0,103119.30984392198,MMP9
5606,KEGG_2019_Human,Relaxin signaling pathway,1/130,0.0064999213952527,0.011293617030826,0,0,19870.0,100064.62842845908,MMP9
5607,KEGG_2019_Human,Estrogen signaling pathway,1/137,0.0068499188797651,0.011293617030826,0,0,19863.0,98987.62735269018,MMP9
5608,KEGG_2019_Human,Fluid shear stress and atherosclerosis,1/139,0.006949918172816,0.011293617030826,0,0,19861.0,98689.81333375497,MMP9
5609,KEGG_2019_Human,Hepatitis B,1/163,0.0081499100978668,0.0117720923635854,0,0,19837.0,95410.9786681514,MMP9
5610,KEGG_2019_Human,Transcriptional misregulation in cancer,1/186,0.0092999029651357,0.0118771528764897,0,0,19814.0,92684.96451050608,MMP9
5611,KEGG_2019_Human,Proteoglycans in cancer,1/201,0.0100498985877989,0.0118771528764897,0,0,19799.0,91079.21596609056,MMP9
5612,KEGG_2019_Human,MicroRNAs in cancer,1/299,0.0149498740670514,0.0161956969059724,0,0,19701.0,82804.33538735632,MMP9
5613,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,MMP9
5614,KEGG_2019_Human,Cocaine addiction,1/49,0.0024499577795033,0.0067998952432378,0,0,19951.0,119939.1172087114,PDYN
5615,KEGG_2019_Human,Amphetamine addiction,1/68,0.0033999476216189,0.0067998952432378,0,0,19932.0,113293.39338050144,PDYN
5616,KEGG_2019_Human,Alcoholism,1/180,0.0089999047745351,0.0119998730327134,0,0,19820.0,93362.92821536642,PDYN
5617,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,PDYN
5618,KEGG_2019_Human,Histidine metabolism,1/23,0.0011499748819949,0.0023249535985056,0,0,19977.0,135204.63922267244,CNDP1
5619,KEGG_2019_Human,beta-Alanine metabolism,1/31,0.0015499690656704,0.0023249535985056,0,0,19969.0,129189.85098816035,CNDP1
5620,KEGG_2019_Human,Arginine and proline metabolism,1/49,0.0024499577795033,0.0024499577795033,0,0,19951.0,119939.1172087114,CNDP1
5621,KEGG_2019_Human,Shigellosis,1/65,0.003249949134407,0.005066591637567,0,0,19935.0,114209.92613860144,NOD1
5622,KEGG_2019_Human,Epithelial cell signaling in Helicobacter pylori infection,1/68,0.0033999476216189,0.005066591637567,0,0,19932.0,113293.39338050144,NOD1
5623,KEGG_2019_Human,Pertussis,1/76,0.0037999437281752,0.005066591637567,0,0,19924.0,111031.8499691117,NOD1
5624,KEGG_2019_Human,NOD-like receptor signaling pathway,1/178,0.0088999053857096,0.0088999053857096,0,0,19822.0,93593.82745769851,NOD1
5625,KEGG_2019_Human,Glycosphingolipid biosynthesis,1/45,0.0022499601197094,0.0022499601197094,0,0,19955.0,121662.49782449217,FUT2
5626,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0146998751759735,0,0,19706.0,83157.67014793828,TNFRSF9
5627,KEGG_2019_Human,Inositol phosphate metabolism,1/74,0.0036999446830449,0.0049499334884068,0,0,19926.0,111574.38983110404,PIK3C2B
5628,KEGG_2019_Human,Phosphatidylinositol signaling system,1/99,0.0049499334884068,0.0049499334884068,0,0,19901.0,105642.09305076736,PIK3C2B
5629,KEGG_2019_Human,Wnt signaling pathway,1/158,0.0078999117225733,0.0078999117225733,0,0,19842.0,96053.2110949472,LGR6
5630,KEGG_2019_Human,Mannose type O-glycan biosynthesis,1/23,0.0011499748819949,0.0011499748819949,0,0,19977.0,135204.63922267244,B3GAT1
5631,KEGG_2019_Human,Butanoate metabolism,1/28,0.0013999711732997,0.0013999711732997,0,0,19972.0,131242.0761597353,ACSM2A
5632,KEGG_2019_Human,JAK-STAT signaling pathway,1/162,0.0080999104202618,0.0146998751759735,0,0,19838.0,95537.86936302872,MPL
5633,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0146998751759735,0,0,19706.0,83157.67014793828,MPL
5634,KEGG_2019_Human,Long-term depression,1/60,0.002999951725986,0.009044340630589,0,0,19940.0,115834.63209072244,GRM1
5635,KEGG_2019_Human,Long-term potentiation,1/67,0.0033499481224912,0.009044340630589,0,0,19933.0,113594.38808369274,GRM1
5636,KEGG_2019_Human,Taste transduction,1/83,0.0041499404726918,0.009044340630589,0,0,19917.0,109237.99888847338,GRM1
5637,KEGG_2019_Human,Gap junction,1/88,0.0043999382262822,0.009044340630589,0,0,19912.0,108045.79305232369,GRM1
5638,KEGG_2019_Human,Glutamatergic synapse,1/114,0.005699927427839,0.009044340630589,0,0,19886.0,102756.96431429044,GRM1
5639,KEGG_2019_Human,FoxO signaling pathway,1/132,0.0065999206698993,0.009044340630589,0,0,19868.0,99751.22090491928,GRM1
5640,KEGG_2019_Human,Estrogen signaling pathway,1/137,0.0068499188797651,0.009044340630589,0,0,19863.0,98987.62735269018,GRM1
5641,KEGG_2019_Human,Phospholipase D signaling pathway,1/148,0.007399915061391,0.009044340630589,0,0,19852.0,97399.60470052566,GRM1
5642,KEGG_2019_Human,Retrograde endocannabinoid signaling,1/148,0.007399915061391,0.009044340630589,0,0,19852.0,97399.60470052566,GRM1
5643,KEGG_2019_Human,Calcium signaling pathway,1/188,0.009399902370135,0.0103398926071485,0,0,19812.0,92463.712994847,GRM1
5644,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,GRM1
5645,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR1N2
5646,KEGG_2019_Human,Glycosphingolipid biosynthesis,1/45,0.0022499601197094,0.0022499601197094,0,0,19955.0,121662.49782449217,A4GALT
5647,KEGG_2019_Human,Vitamin digestion and absorption,1/24,0.0011999741185782,0.0011999741185782,0,0,19976.0,134347.69487847842,CUBN
5648,KEGG_2019_Human,Prion diseases,1/35,0.0017499663721595,0.0052498991164787,0,0,19965.0,126740.98858805298,C6
5649,KEGG_2019_Human,Complement and coagulation cascades,1/79,0.0039499423167337,0.0059249134751006,0,0,19921.0,110243.89578070649,C6
5650,KEGG_2019_Human,Systemic lupus erythematosus,1/133,0.0066499203093911,0.0066499203093911,0,0,19867.0,99596.2591544721,C6
5651,KEGG_2019_Human,Glycerolipid metabolism,1/61,0.0030499512001654,0.0048499343304706,0,0,19939.0,115499.24335773686,LPIN2
5652,KEGG_2019_Human,Glycerophospholipid metabolism,1/97,0.0048499343304706,0.0048499343304706,0,0,19903.0,106058.9096435903,LPIN2
5653,KEGG_2019_Human,Cortisol synthesis and secretion,1/65,0.003249949134407,0.0056249163061687,0,0,19935.0,114209.92613860144,KCNK2
5654,KEGG_2019_Human,Gastric acid secretion,1/75,0.0037499442041125,0.0056249163061687,0,0,19925.0,111301.33528642564,KCNK2
5655,KEGG_2019_Human,Cushing syndrome,1/155,0.0077499127120574,0.0077499127120574,0,0,19845.0,96448.16254952336,KCNK2
5656,KEGG_2019_Human,"Neomycin, kanamycin and gentamicin biosynthesis",1/5,0.0002499917995416556,0.0027499097949582,0,0,19995.0,165840.17843725558,HK3
5657,KEGG_2019_Human,Galactose metabolism,1/31,0.0015499690656704,0.0037713631321124,0,0,19969.0,129189.85098816035,HK3
5658,KEGG_2019_Human,Fructose and mannose metabolism,1/33,0.0016499677032113,0.0037713631321124,0,0,19967.0,127928.56031580272,HK3
5659,KEGG_2019_Human,Starch and sucrose metabolism,1/36,0.0017999657178272,0.0037713631321124,0,0,19964.0,126172.23364250171,HK3
5660,KEGG_2019_Human,Carbohydrate digestion and absorption,1/44,0.0021999607179423,0.0037713631321124,0,0,19956.0,122117.06559109331,HK3
5661,KEGG_2019_Human,Type II diabetes mellitus,1/46,0.0022999595269283,0.0037713631321124,0,0,19954.0,121217.8313311442,HK3
5662,KEGG_2019_Human,Amino sugar and nucleotide sugar metabolism,1/48,0.0023999583567988,0.0037713631321124,0,0,19952.0,120356.5272753826,HK3
5663,KEGG_2019_Human,Central carbon metabolism in cancer,1/65,0.003249949134407,0.0041554915375342,0,0,19935.0,114209.92613860144,HK3
5664,KEGG_2019_Human,Glycolysis / Gluconeogenesis,1/68,0.0033999476216189,0.0041554915375342,0,0,19932.0,113293.39338050144,HK3
5665,KEGG_2019_Human,HIF-1 signaling pathway,1/100,0.0049999330710556,0.0054999263781612,0,0,19900.0,105436.78197328727,HK3
5666,KEGG_2019_Human,Insulin signaling pathway,1/137,0.0068499188797651,0.0068499188797651,0,0,19863.0,98987.62735269018,HK3
5667,KEGG_2019_Human,Cell adhesion molecules (CAMs),1/145,0.0072499160871101,0.0072499160871101,0,0,19855.0,97820.92670675044,NRXN2
5668,KEGG_2019_Human,Maturity onset diabetes of the young,1/26,0.0012999726251831,0.0012999726251831,0,0,19974.0,132735.46073187632,HNF4G
5669,KEGG_2019_Human,Glycosphingolipid biosynthesis,1/45,0.0022499601197094,0.0022499601197094,0,0,19955.0,121662.49782449217,ST6GALNAC5
5670,KEGG_2019_Human,ABC transporters,1/45,0.0022499601197094,0.0034499392903924,0,0,19955.0,121662.49782449217,ABCC8
5671,KEGG_2019_Human,Type II diabetes mellitus,1/46,0.0022999595269283,0.0034499392903924,0,0,19954.0,121217.8313311442,ABCC8
5672,KEGG_2019_Human,Insulin secretion,1/86,0.0042999391173866,0.0042999391173866,0,0,19914.0,108514.46102290176,ABCC8
5673,KEGG_2019_Human,Melanogenesis,1/101,0.0050499326546803,0.0100998653093607,0,0,19899.0,105233.48101229242,MC1R
5674,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,MC1R
5675,KEGG_2019_Human,cAMP signaling pathway,1/212,0.0105998955026255,0.0168998658265596,0,0,19788.0,89974.27756224656,VIP
5676,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,VIP
5677,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF275
5678,KEGG_2019_Human,Fc epsilon RI signaling pathway,1/68,0.0033999476216189,0.0109927382859815,0,0,19932.0,113293.39338050144,MAP2K7
5679,KEGG_2019_Human,ErbB signaling pathway,1/85,0.004249939567045,0.0109927382859815,0,0,19915.0,108752.83801948265,MAP2K7
5680,KEGG_2019_Human,GnRH signaling pathway,1/93,0.0046499360391879,0.0109927382859815,0,0,19907.0,106918.54242106884,MAP2K7
5681,KEGG_2019_Human,T cell receptor signaling pathway,1/101,0.0050499326546803,0.0109927382859815,0,0,19899.0,105233.48101229242,MAP2K7
5682,KEGG_2019_Human,Toll-like receptor signaling pathway,1/104,0.0051999314202997,0.0109927382859815,0,0,19896.0,104635.24941415618,MAP2K7
5683,KEGG_2019_Human,TNF signaling pathway,1/110,0.0054999290027479,0.0109927382859815,0,0,19890.0,103488.06969787036,MAP2K7
5684,KEGG_2019_Human,Neurotrophin signaling pathway,1/119,0.0059499254985137,0.0109927382859815,0,0,19881.0,101877.73080211312,MAP2K7
5685,KEGG_2019_Human,Osteoclast differentiation,1/127,0.0063499224962247,0.0109927382859815,0,0,19873.0,100543.72072014232,MAP2K7
5686,KEGG_2019_Human,Relaxin signaling pathway,1/130,0.0064999213952527,0.0109927382859815,0,0,19870.0,100064.62842845908,MAP2K7
5687,KEGG_2019_Human,Fluid shear stress and atherosclerosis,1/139,0.006949918172816,0.0109927382859815,0,0,19861.0,98689.81333375497,MAP2K7
5688,KEGG_2019_Human,Hepatitis B,1/163,0.0081499100978668,0.0109927382859815,0,0,19837.0,95410.9786681514,MAP2K7
5689,KEGG_2019_Human,Protein processing in endoplasmic reticulum,1/165,0.0082499094553477,0.0109927382859815,0,0,19835.0,95159.46482222488,MAP2K7
5690,KEGG_2019_Human,Tight junction,1/170,0.0084999078692823,0.0109927382859815,0,0,19830.0,94543.49009679438,MAP2K7
5691,KEGG_2019_Human,Influenza A,1/171,0.0085499075557634,0.0109927382859815,0,0,19829.0,94422.42241345016,MAP2K7
5692,KEGG_2019_Human,Kaposi sarcoma-associated herpesvirus infection,1/186,0.0092999029651357,0.0111598835581629,0,0,19814.0,92684.96451050608,MAP2K7
5693,KEGG_2019_Human,Epstein-Barr virus infection,1/201,0.0100498985877989,0.0112234187674859,0,0,19799.0,91079.21596609056,MAP2K7
5694,KEGG_2019_Human,Human immunodeficiency virus 1 infection,1/212,0.0105998955026255,0.0112234187674859,0,0,19788.0,89974.27756224656,MAP2K7
5695,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0147498749536506,0,0,19705.0,83086.53988020132,MAP2K7
5696,KEGG_2019_Human,Nitrogen metabolism,1/17,0.0008499797390404818,0.0008499797390404818,0,0,19983.0,141285.76583697114,CA12
5697,KEGG_2019_Human,B cell receptor signaling pathway,1/71,0.0035499461386618,0.0061874168605085,0,0,19929.0,112415.9585341616,INPPL1
5698,KEGG_2019_Human,Inositol phosphate metabolism,1/74,0.0036999446830449,0.0061874168605085,0,0,19926.0,111574.38983110404,INPPL1
5699,KEGG_2019_Human,Fc gamma R-mediated phagocytosis,1/91,0.0045499369072032,0.0061874168605085,0,0,19909.0,107362.10783923086,INPPL1
5700,KEGG_2019_Human,Phosphatidylinositol signaling system,1/99,0.0049499334884068,0.0061874168605085,0,0,19901.0,105642.09305076736,INPPL1
5701,KEGG_2019_Human,Insulin signaling pathway,1/137,0.0068499188797651,0.0068499188797651,0,0,19863.0,98987.62735269018,INPPL1
5702,KEGG_2019_Human,TNF signaling pathway,1/110,0.0054999290027479,0.0109998580054958,0,0,19890.0,103488.06969787036,RPS6KA4
5703,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0147498749536506,0,0,19705.0,83086.53988020132,RPS6KA4
5704,KEGG_2019_Human,Renin-angiotensin system,1/23,0.0011499748819949,0.0034499246459849,0,0,19977.0,135204.63922267244,CPA3
5705,KEGG_2019_Human,Protein digestion and absorption,1/90,0.0044999373439762,0.0048999339081079,0,0,19910.0,107587.50385474482,CPA3
5706,KEGG_2019_Human,Pancreatic secretion,1/98,0.0048999339081079,0.0048999339081079,0,0,19902.0,105849.45495286948,CPA3
5707,KEGG_2019_Human,RNA transport,1/165,0.0082499094553477,0.0082499094553477,0,0,19835.0,95159.46482222488,EIF1AX
5708,KEGG_2019_Human,Glutamatergic synapse,1/114,0.005699927427839,0.0065999206698993,0,0,19886.0,102756.96431429044,HOMER3
5709,KEGG_2019_Human,FoxO signaling pathway,1/132,0.0065999206698993,0.0065999206698993,0,0,19868.0,99751.22090491928,HOMER3
5710,KEGG_2019_Human,Glycerolipid metabolism,1/61,0.0030499512001654,0.0048499343304706,0,0,19939.0,115499.24335773686,LPIN3
5711,KEGG_2019_Human,Glycerophospholipid metabolism,1/97,0.0048499343304706,0.0048499343304706,0,0,19903.0,106058.9096435903,LPIN3
5712,KEGG_2019_Human,Bladder cancer,1/41,0.0020499625466866,0.0100103039197409,0,0,19959.0,123544.88783416104,ARAF
5713,KEGG_2019_Human,Endometrial cancer,1/58,0.0028999527887707,0.0100103039197409,0,0,19942.0,116522.31890946148,ARAF
5714,KEGG_2019_Human,Long-term depression,1/60,0.002999951725986,0.0100103039197409,0,0,19940.0,115834.63209072244,ARAF
5715,KEGG_2019_Human,Acute myeloid leukemia,1/66,0.003299948626608,0.0100103039197409,0,0,19934.0,113899.85357353876,ARAF
5716,KEGG_2019_Human,Non-small cell lung cancer,1/66,0.003299948626608,0.0100103039197409,0,0,19934.0,113899.85357353876,ARAF
5717,KEGG_2019_Human,Long-term potentiation,1/67,0.0033499481224912,0.0100103039197409,0,0,19933.0,113594.38808369274,ARAF
5718,KEGG_2019_Human,Renal cell carcinoma,1/69,0.003449947123837,0.0100103039197409,0,0,19931.0,112996.7391397682,ARAF
5719,KEGG_2019_Human,Melanoma,1/72,0.0035999456502131,0.0100103039197409,0,0,19928.0,112131.59838572376,ARAF
5720,KEGG_2019_Human,Pancreatic cancer,1/75,0.0037499442041125,0.0100103039197409,0,0,19925.0,111301.33528642564,ARAF
5721,KEGG_2019_Human,Glioma,1/75,0.0037499442041125,0.0100103039197409,0,0,19925.0,111301.33528642564,ARAF
5722,KEGG_2019_Human,Chronic myeloid leukemia,1/76,0.0037999437281752,0.0100103039197409,0,0,19924.0,111031.8499691117,ARAF
5723,KEGG_2019_Human,ErbB signaling pathway,1/85,0.004249939567045,0.0100103039197409,0,0,19915.0,108752.83801948265,ARAF
5724,KEGG_2019_Human,Colorectal cancer,1/86,0.0042999391173866,0.0100103039197409,0,0,19914.0,108514.46102290176,ARAF
5725,KEGG_2019_Human,Prostate cancer,1/97,0.0048499343304706,0.0100103039197409,0,0,19903.0,106058.9096435903,ARAF
5726,KEGG_2019_Human,Progesterone-mediated oocyte maturation,1/99,0.0049499334884068,0.0100103039197409,0,0,19901.0,105642.09305076736,ARAF
5727,KEGG_2019_Human,"Parathyroid hormone synthesis, secretion and action",1/106,0.0052999306076525,0.0100103039197409,0,0,19894.0,104245.78450366124,ARAF
5728,KEGG_2019_Human,Serotonergic synapse,1/113,0.0056499278191151,0.0100103039197409,0,0,19887.0,102937.34947211576,ARAF
5729,KEGG_2019_Human,Natural killer cell mediated cytotoxicity,1/131,0.0065499210316603,0.0100103039197409,0,0,19869.0,99907.33811343512,ARAF
5730,KEGG_2019_Human,FoxO signaling pathway,1/132,0.0065999206698993,0.0100103039197409,0,0,19868.0,99751.22090491928,ARAF
5731,KEGG_2019_Human,Vascular smooth muscle contraction,1/132,0.0065999206698993,0.0100103039197409,0,0,19868.0,99751.22090491928,ARAF
5732,KEGG_2019_Human,Insulin signaling pathway,1/137,0.0068499188797651,0.0100103039197409,0,0,19863.0,98987.62735269018,ARAF
5733,KEGG_2019_Human,Breast cancer,1/147,0.0073499154017982,0.0100103039197409,0,0,19853.0,97539.10874372096,ARAF
5734,KEGG_2019_Human,Gastric cancer,1/149,0.0074499147221605,0.0100103039197409,0,0,19851.0,97261.02051561224,ARAF
5735,KEGG_2019_Human,Hepatitis C,1/155,0.0077499127120574,0.0100103039197409,0,0,19845.0,96448.16254952336,ARAF
5736,KEGG_2019_Human,Hepatitis B,1/163,0.0081499100978668,0.0100152755205536,0,0,19837.0,95410.9786681514,ARAF
5737,KEGG_2019_Human,Hepatocellular carcinoma,1/168,0.0083999085011095,0.0100152755205536,0,0,19832.0,94787.72752807094,ARAF
5738,KEGG_2019_Human,Alcoholism,1/180,0.0089999047745351,0.0103332240003921,0,0,19820.0,93362.92821536642,ARAF
5739,KEGG_2019_Human,Proteoglycans in cancer,1/201,0.0100498985877989,0.0111266734364917,0,0,19799.0,91079.21596609056,ARAF
5740,KEGG_2019_Human,Regulation of actin cytoskeleton,1/214,0.0106998949514067,0.0114378187411589,0,0,19786.0,89779.39753374986,ARAF
5741,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0152415374521057,0,0,19705.0,83086.53988020132,ARAF
5742,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,ARAF
5743,KEGG_2019_Human,Huntington disease,1/193,0.0096499008972596,0.0096499008972596,0,0,19807.0,91920.47679471428,DNAH8
5744,KEGG_2019_Human,Ribosome,1/153,0.0076499133771537,0.0076499133771537,0,0,19847.0,96715.6407630817,FAU
5745,KEGG_2019_Human,Signaling pathways regulating pluripotency of stem cells,1/139,0.006949918172816,0.006949918172816,0,0,19861.0,98689.81333375497,POU5F1
5746,KEGG_2019_Human,Nicotine addiction,1/40,0.0019999631680592,0.0074798847675616,0,0,19960.0,124043.94523066044,GRIA1
5747,KEGG_2019_Human,Amyotrophic lateral sclerosis (ALS),1/51,0.0025499566390179,0.0074798847675616,0,0,19949.0,119129.0228601236,GRIA1
5748,KEGG_2019_Human,Long-term depression,1/60,0.002999951725986,0.0074798847675616,0,0,19940.0,115834.63209072244,GRIA1
5749,KEGG_2019_Human,Long-term potentiation,1/67,0.0033499481224912,0.0074798847675616,0,0,19933.0,113594.38808369274,GRIA1
5750,KEGG_2019_Human,Amphetamine addiction,1/68,0.0033999476216189,0.0074798847675616,0,0,19932.0,113293.39338050144,GRIA1
5751,KEGG_2019_Human,Circadian entrainment,1/97,0.0048499343304706,0.0088915462725296,0,0,19903.0,106058.9096435903,GRIA1
5752,KEGG_2019_Human,Glutamatergic synapse,1/114,0.005699927427839,0.0089570288151755,0,0,19886.0,102756.96431429044,GRIA1
5753,KEGG_2019_Human,Dopaminergic synapse,1/131,0.0065499210316603,0.0090061414185329,0,0,19869.0,99907.33811343512,GRIA1
5754,KEGG_2019_Human,Retrograde endocannabinoid signaling,1/148,0.007399915061391,0.009044340630589,0,0,19852.0,97399.60470052566,GRIA1
5755,KEGG_2019_Human,cAMP signaling pathway,1/212,0.0105998955026255,0.0116598850528881,0,0,19788.0,89974.27756224656,GRIA1
5756,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,GRIA1
5757,KEGG_2019_Human,Nicotine addiction,1/40,0.0019999631680592,0.0059998895041777,0,0,19960.0,124043.94523066044,CHRNB2
5758,KEGG_2019_Human,Cholinergic synapse,1/112,0.0055999282120529,0.0083998923180794,0,0,19888.0,103119.30984392198,CHRNB2
5759,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,CHRNB2
5760,KEGG_2019_Human,Adherens junction,1/72,0.0035999456502131,0.0115498741890255,0,0,19928.0,112131.59838572376,TGFBR2
5761,KEGG_2019_Human,Pancreatic cancer,1/75,0.0037499442041125,0.0115498741890255,0,0,19925.0,111301.33528642564,TGFBR2
5762,KEGG_2019_Human,Chronic myeloid leukemia,1/76,0.0037999437281752,0.0115498741890255,0,0,19924.0,111031.8499691117,TGFBR2
5763,KEGG_2019_Human,Colorectal cancer,1/86,0.0042999391173866,0.0115498741890255,0,0,19914.0,108514.46102290176,TGFBR2
5764,KEGG_2019_Human,TGF-beta signaling pathway,1/90,0.0044999373439762,0.0115498741890255,0,0,19910.0,107587.50385474482,TGFBR2
5765,KEGG_2019_Human,AGE-RAGE signaling pathway in diabetic complications,1/100,0.0049999330710556,0.0115498741890255,0,0,19900.0,105436.78197328727,TGFBR2
5766,KEGG_2019_Human,Chagas disease (American trypanosomiasis),1/103,0.0051499318302617,0.0115498741890255,0,0,19897.0,104832.7525292024,TGFBR2
5767,KEGG_2019_Human,Th17 cell differentiation,1/107,0.0053499302026925,0.0115498741890255,0,0,19893.0,104053.753408911,TGFBR2
5768,KEGG_2019_Human,Osteoclast differentiation,1/127,0.0063499224962247,0.0115498741890255,0,0,19873.0,100543.72072014232,TGFBR2
5769,KEGG_2019_Human,Relaxin signaling pathway,1/130,0.0064999213952527,0.0115498741890255,0,0,19870.0,100064.62842845908,TGFBR2
5770,KEGG_2019_Human,FoxO signaling pathway,1/132,0.0065999206698993,0.0115498741890255,0,0,19868.0,99751.22090491928,TGFBR2
5771,KEGG_2019_Human,Gastric cancer,1/149,0.0074499147221605,0.0115498741890255,0,0,19851.0,97261.02051561224,TGFBR2
5772,KEGG_2019_Human,Cellular senescence,1/160,0.0079999110688441,0.0115498741890255,0,0,19840.0,95793.96509856998,TGFBR2
5773,KEGG_2019_Human,Hippo signaling pathway,1/160,0.0079999110688441,0.0115498741890255,0,0,19840.0,95793.96509856998,TGFBR2
5774,KEGG_2019_Human,Hepatitis B,1/163,0.0081499100978668,0.0115498741890255,0,0,19837.0,95410.9786681514,TGFBR2
5775,KEGG_2019_Human,Hepatocellular carcinoma,1/168,0.0083999085011095,0.0115498741890255,0,0,19832.0,94787.72752807094,TGFBR2
5776,KEGG_2019_Human,Transcriptional misregulation in cancer,1/186,0.0092999029651357,0.0120351685431168,0,0,19814.0,92684.96451050608,TGFBR2
5777,KEGG_2019_Human,Human T-cell leukemia virus 1 infection,1/219,0.0109498935894162,0.0133832032759532,0,0,19781.0,89299.85161916987,TGFBR2
5778,KEGG_2019_Human,Endocytosis,1/244,0.0121998870519305,0.0141261850074985,0,0,19756.0,87051.4275316661,TGFBR2
5779,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0154522499514435,0,0,19706.0,83157.67014793828,TGFBR2
5780,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0154522499514435,0,0,19705.0,83086.53988020132,TGFBR2
5781,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,TGFBR2
5782,KEGG_2019_Human,Inflammatory mediator regulation of TRP channels,1/100,0.0049999330710556,0.0049999330710556,0,0,19900.0,105436.78197328727,TRPM8
5783,KEGG_2019_Human,JAK-STAT signaling pathway,1/162,0.0080999104202618,0.0146998751759735,0,0,19838.0,95537.86936302872,IL20RA
5784,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0146998751759735,0,0,19706.0,83157.67014793828,IL20RA
5785,KEGG_2019_Human,Metabolism of xenobiotics by cytochrome P450,1/74,0.0036999446830449,0.004099940929819,0,0,19926.0,111574.38983110404,CYP2A13
5786,KEGG_2019_Human,Chemical carcinogenesis,1/82,0.004099940929819,0.004099940929819,0,0,19918.0,109484.9180722932,CYP2A13
5787,KEGG_2019_Human,Aldosterone-regulated sodium reabsorption,1/37,0.0018499650702878,0.0036999301405757,0,0,19963.0,125618.9446446357,SCNN1G
5788,KEGG_2019_Human,Taste transduction,1/83,0.0041499404726918,0.0041499404726918,0,0,19917.0,109237.99888847338,SCNN1G
5789,KEGG_2019_Human,Hedgehog signaling pathway,1/47,0.0023499589392381,0.011399854855678,0,0,19953.0,120782.64067395544,GRK2
5790,KEGG_2019_Human,Morphine addiction,1/91,0.0045499369072032,0.011399854855678,0,0,19909.0,107362.10783923086,GRK2
5791,KEGG_2019_Human,Glutamatergic synapse,1/114,0.005699927427839,0.011399854855678,0,0,19886.0,102756.96431429044,GRK2
5792,KEGG_2019_Human,Chemokine signaling pathway,1/190,0.0094999017791995,0.0142498526687993,0,0,19810.0,92244.74636351672,GRK2
5793,KEGG_2019_Human,Endocytosis,1/244,0.0121998870519305,0.0146398644623166,0,0,19756.0,87051.4275316661,GRK2
5794,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,GRK2
5795,KEGG_2019_Human,Ubiquitin mediated proteolysis,1/137,0.0068499188797651,0.0080999104202618,0,0,19863.0,98987.62735269018,PIAS2
5796,KEGG_2019_Human,JAK-STAT signaling pathway,1/162,0.0080999104202618,0.0080999104202618,0,0,19838.0,95537.86936302872,PIAS2
5797,KEGG_2019_Human,Mucin type O-glycan biosynthesis,1/31,0.0015499690656704,0.0015499690656704,0,0,19969.0,129189.85098816035,GALNT11
5798,KEGG_2019_Human,Breast cancer,1/147,0.0073499154017982,0.0220497462053947,0,0,19853.0,97539.10874372096,HEY1
5799,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0247498011884467,0,0,19670.0,80733.60565076157,HEY1
5800,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,HEY1
5801,KEGG_2019_Human,TGF-beta signaling pathway,1/90,0.0044999373439762,0.0120665392943818,0,0,19910.0,107587.50385474482,BMP7
5802,KEGG_2019_Human,Hippo signaling pathway,1/160,0.0079999110688441,0.0120665392943818,0,0,19840.0,95793.96509856998,BMP7
5803,KEGG_2019_Human,Axon guidance,1/181,0.0090499044707863,0.0120665392943818,0,0,19819.0,93248.41634586031,BMP7
5804,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0146998751759735,0,0,19706.0,83157.67014793828,BMP7
5805,KEGG_2019_Human,Transcriptional misregulation in cancer,1/186,0.0092999029651357,0.0092999029651357,0,0,19814.0,92684.96451050608,PAX3
5806,KEGG_2019_Human,Vasopressin-regulated water reabsorption,1/44,0.0021999607179423,0.0088963120914168,0,0,19956.0,122117.06559109331,GNAS
5807,KEGG_2019_Human,Endocrine and other factor-regulated calcium reabsorption,1/48,0.0023999583567988,0.0088963120914168,0,0,19952.0,120356.5272753826,GNAS
5808,KEGG_2019_Human,Cocaine addiction,1/49,0.0024499577795033,0.0088963120914168,0,0,19951.0,119939.1172087114,GNAS
5809,KEGG_2019_Human,Ovarian steroidogenesis,1/49,0.0024499577795033,0.0088963120914168,0,0,19951.0,119939.1172087114,GNAS
5810,KEGG_2019_Human,Vibrio cholerae infection,1/50,0.0024999572069037,0.0088963120914168,0,0,19950.0,119530.05920663515,GNAS
5811,KEGG_2019_Human,Regulation of lipolysis in adipocytes,1/55,0.0027499544131125,0.0088963120914168,0,0,19945.0,117599.1294878737,GNAS
5812,KEGG_2019_Human,Long-term depression,1/60,0.002999951725986,0.0088963120914168,0,0,19940.0,115834.63209072244,GNAS
5813,KEGG_2019_Human,Cortisol synthesis and secretion,1/65,0.003249949134407,0.0088963120914168,0,0,19935.0,114209.92613860144,GNAS
5814,KEGG_2019_Human,Amphetamine addiction,1/68,0.0033999476216189,0.0088963120914168,0,0,19932.0,113293.39338050144,GNAS
5815,KEGG_2019_Human,Renin secretion,1/69,0.003449947123837,0.0088963120914168,0,0,19931.0,112996.7391397682,GNAS
5816,KEGG_2019_Human,Bile secretion,1/72,0.0035999456502131,0.0088963120914168,0,0,19928.0,112131.59838572376,GNAS
5817,KEGG_2019_Human,Thyroid hormone synthesis,1/74,0.0036999446830449,0.0088963120914168,0,0,19926.0,111574.38983110404,GNAS
5818,KEGG_2019_Human,Gastric acid secretion,1/75,0.0037499442041125,0.0088963120914168,0,0,19925.0,111301.33528642564,GNAS
5819,KEGG_2019_Human,Insulin secretion,1/86,0.0042999391173866,0.0088963120914168,0,0,19914.0,108514.46102290176,GNAS
5820,KEGG_2019_Human,Gap junction,1/88,0.0043999382262822,0.0088963120914168,0,0,19912.0,108045.79305232369,GNAS
5821,KEGG_2019_Human,Salivary secretion,1/90,0.0044999373439762,0.0088963120914168,0,0,19910.0,107587.50385474482,GNAS
5822,KEGG_2019_Human,Dilated cardiomyopathy (DCM),1/91,0.0045499369072032,0.0088963120914168,0,0,19909.0,107362.10783923086,GNAS
5823,KEGG_2019_Human,Morphine addiction,1/91,0.0045499369072032,0.0088963120914168,0,0,19909.0,107362.10783923086,GNAS
5824,KEGG_2019_Human,GnRH signaling pathway,1/93,0.0046499360391879,0.0088963120914168,0,0,19907.0,106918.54242106884,GNAS
5825,KEGG_2019_Human,Amoebiasis,1/96,0.0047999347538706,0.0088963120914168,0,0,19904.0,106270.50039849174,GNAS
5826,KEGG_2019_Human,Circadian entrainment,1/97,0.0048499343304706,0.0088963120914168,0,0,19903.0,106058.9096435903,GNAS
5827,KEGG_2019_Human,Pancreatic secretion,1/98,0.0048999339081079,0.0088963120914168,0,0,19902.0,105849.45495286948,GNAS
5828,KEGG_2019_Human,Aldosterone synthesis and secretion,1/98,0.0048999339081079,0.0088963120914168,0,0,19902.0,105849.45495286948,GNAS
5829,KEGG_2019_Human,Inflammatory mediator regulation of TRP channels,1/100,0.0049999330710556,0.0088963120914168,0,0,19900.0,105436.78197328727,GNAS
5830,KEGG_2019_Human,Melanogenesis,1/101,0.0050499326546803,0.0088963120914168,0,0,19899.0,105233.48101229242,GNAS
5831,KEGG_2019_Human,Glucagon signaling pathway,1/103,0.0051499318302617,0.0088963120914168,0,0,19897.0,104832.7525292024,GNAS
5832,KEGG_2019_Human,Chagas disease (American trypanosomiasis),1/103,0.0051499318302617,0.0088963120914168,0,0,19897.0,104832.7525292024,GNAS
5833,KEGG_2019_Human,"Parathyroid hormone synthesis, secretion and action",1/106,0.0052999306076525,0.0088963120914168,0,0,19894.0,104245.78450366124,GNAS
5834,KEGG_2019_Human,Serotonergic synapse,1/113,0.0056499278191151,0.0089298863036144,0,0,19887.0,102937.34947211576,GNAS
5835,KEGG_2019_Human,Glutamatergic synapse,1/114,0.005699927427839,0.0089298863036144,0,0,19886.0,102756.96431429044,GNAS
5836,KEGG_2019_Human,Platelet activation,1/124,0.0061999236097501,0.0091234197495667,0,0,19876.0,101034.04709010696,GNAS
5837,KEGG_2019_Human,Relaxin signaling pathway,1/130,0.0064999213952527,0.0091234197495667,0,0,19870.0,100064.62842845908,GNAS
5838,KEGG_2019_Human,Dopaminergic synapse,1/131,0.0065499210316603,0.0091234197495667,0,0,19869.0,99907.33811343512,GNAS
5839,KEGG_2019_Human,Vascular smooth muscle contraction,1/132,0.0065999206698993,0.0091234197495667,0,0,19868.0,99751.22090491928,GNAS
5840,KEGG_2019_Human,Estrogen signaling pathway,1/137,0.0068499188797651,0.0091984624956846,0,0,19863.0,98987.62735269018,GNAS
5841,KEGG_2019_Human,Adrenergic signaling in cardiomyocytes,1/145,0.0072499160871101,0.0093396383965821,0,0,19855.0,97820.92670675044,GNAS
5842,KEGG_2019_Human,Phospholipase D signaling pathway,1/148,0.007399915061391,0.0093396383965821,0,0,19852.0,97399.60470052566,GNAS
5843,KEGG_2019_Human,Oxytocin signaling pathway,1/153,0.0076499133771537,0.0093396383965821,0,0,19847.0,96715.6407630817,GNAS
5844,KEGG_2019_Human,Cushing syndrome,1/155,0.0077499127120574,0.0093396383965821,0,0,19845.0,96448.16254952336,GNAS
5845,KEGG_2019_Human,Alcoholism,1/180,0.0089999047745351,0.0105748881100787,0,0,19820.0,93362.92821536642,GNAS
5846,KEGG_2019_Human,Calcium signaling pathway,1/188,0.009399902370135,0.0107754978389353,0,0,19812.0,92463.712994847,GNAS
5847,KEGG_2019_Human,Rap1 signaling pathway,1/206,0.010299897173561,0.0115260754085087,0,0,19794.0,90569.849337325,GNAS
5848,KEGG_2019_Human,cAMP signaling pathway,1/212,0.0105998955026255,0.0115859322935675,0,0,19788.0,89974.27756224656,GNAS
5849,KEGG_2019_Human,Human cytomegalovirus infection,1/225,0.0112498919790339,0.0120169300685134,0,0,19775.0,88738.27077557483,GNAS
5850,KEGG_2019_Human,Thermogenesis,1/231,0.0115498903940656,0.012063218856024,0,0,19769.0,88191.07730937863,GNAS
5851,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0168585602298115,0,0,19670.0,80733.60565076157,GNAS
5852,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,GNAS
5853,KEGG_2019_Human,Bladder cancer,1/41,0.0020499625466866,0.010799849625543,0,0,19959.0,123544.88783416104,THBS1
5854,KEGG_2019_Human,Malaria,1/49,0.0024499577795033,0.010799849625543,0,0,19951.0,119939.1172087114,THBS1
5855,KEGG_2019_Human,p53 signaling pathway,1/72,0.0035999456502131,0.010799849625543,0,0,19928.0,112131.59838572376,THBS1
5856,KEGG_2019_Human,ECM-receptor interaction,1/82,0.004099940929819,0.010799849625543,0,0,19918.0,109484.9180722932,THBS1
5857,KEGG_2019_Human,TGF-beta signaling pathway,1/90,0.0044999373439762,0.010799849625543,0,0,19910.0,107587.50385474482,THBS1
5858,KEGG_2019_Human,Phagosome,1/152,0.0075999137114971,0.0137331962314147,0,0,19848.0,96850.665715497,THBS1
5859,KEGG_2019_Human,Focal adhesion,1/199,0.0099498991610159,0.0137331962314147,0,0,19801.0,91286.4288690606,THBS1
5860,KEGG_2019_Human,Proteoglycans in cancer,1/201,0.0100498985877989,0.0137331962314147,0,0,19799.0,91079.21596609056,THBS1
5861,KEGG_2019_Human,Rap1 signaling pathway,1/206,0.010299897173561,0.0137331962314147,0,0,19794.0,90569.849337325,THBS1
5862,KEGG_2019_Human,MicroRNAs in cancer,1/299,0.0149498740670514,0.0176998626413668,0,0,19701.0,82804.33538735632,THBS1
5863,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0176998626413668,0,0,19670.0,80733.60565076157,THBS1
5864,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0176998626413668,0,0,19646.0,79255.8617626126,THBS1
5865,KEGG_2019_Human,Arrhythmogenic right ventricular cardiomyopathy (ARVC),1/72,0.0035999456502131,0.0079623895876056,0,0,19928.0,112131.59838572376,CACNG3
5866,KEGG_2019_Human,Cardiac muscle contraction,1/78,0.0038999427840466,0.0079623895876056,0,0,19922.0,110503.2180492851,CACNG3
5867,KEGG_2019_Human,Hypertrophic cardiomyopathy (HCM),1/85,0.004249939567045,0.0079623895876056,0,0,19915.0,108752.83801948265,CACNG3
5868,KEGG_2019_Human,Dilated cardiomyopathy (DCM),1/91,0.0045499369072032,0.0079623895876056,0,0,19909.0,107362.10783923086,CACNG3
5869,KEGG_2019_Human,Adrenergic signaling in cardiomyocytes,1/145,0.0072499160871101,0.0089248989400127,0,0,19855.0,97820.92670675044,CACNG3
5870,KEGG_2019_Human,Oxytocin signaling pathway,1/153,0.0076499133771537,0.0089248989400127,0,0,19847.0,96715.6407630817,CACNG3
5871,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0147498749536506,0,0,19705.0,83086.53988020132,CACNG3
5872,KEGG_2019_Human,Spliceosome,1/134,0.0066999199497742,0.0066999199497742,0,0,19866.0,99442.43560916925,DHX15
5873,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR4K13
5874,KEGG_2019_Human,Pyrimidine metabolism,1/57,0.002849953326298,0.0085498599788941,0,0,19943.0,116875.00742975442,ENTPD1
5875,KEGG_2019_Human,Purine metabolism,1/129,0.006449921761047,0.0096748826415705,0,0,19871.0,100223.109907462,ENTPD1
5876,KEGG_2019_Human,Epstein-Barr virus infection,1/201,0.0100498985877989,0.0100498985877989,0,0,19799.0,91079.21596609056,ENTPD1
5877,KEGG_2019_Human,Adipocytokine signaling pathway,1/69,0.003449947123837,0.0112811333627995,0,0,19931.0,112996.7391397682,JAK2
5878,KEGG_2019_Human,Prolactin signaling pathway,1/70,0.0034999466296654,0.0112811333627995,0,0,19930.0,112704.30065625212,JAK2
5879,KEGG_2019_Human,Leishmaniasis,1/74,0.0036999446830449,0.0112811333627995,0,0,19926.0,111574.38983110404,JAK2
5880,KEGG_2019_Human,Th1 and Th2 cell differentiation,1/92,0.0045999364719865,0.0112811333627995,0,0,19908.0,107139.13814408927,JAK2
5881,KEGG_2019_Human,AGE-RAGE signaling pathway in diabetic complications,1/100,0.0049999330710556,0.0112811333627995,0,0,19900.0,105436.78197328727,JAK2
5882,KEGG_2019_Human,Th17 cell differentiation,1/107,0.0053499302026925,0.0112811333627995,0,0,19893.0,104053.753408911,JAK2
5883,KEGG_2019_Human,Cholinergic synapse,1/112,0.0055999282120529,0.0112811333627995,0,0,19888.0,103119.30984392198,JAK2
5884,KEGG_2019_Human,Toxoplasmosis,1/113,0.0056499278191151,0.0112811333627995,0,0,19887.0,102937.34947211576,JAK2
5885,KEGG_2019_Human,Signaling pathways regulating pluripotency of stem cells,1/139,0.006949918172816,0.0112811333627995,0,0,19861.0,98689.81333375497,JAK2
5886,KEGG_2019_Human,Necroptosis,1/162,0.0080999104202618,0.0112811333627995,0,0,19838.0,95537.86936302872,JAK2
5887,KEGG_2019_Human,JAK-STAT signaling pathway,1/162,0.0080999104202618,0.0112811333627995,0,0,19838.0,95537.86936302872,JAK2
5888,KEGG_2019_Human,Hepatitis B,1/163,0.0081499100978668,0.0112811333627995,0,0,19837.0,95410.9786681514,JAK2
5889,KEGG_2019_Human,Influenza A,1/171,0.0085499075557634,0.0112811333627995,0,0,19829.0,94422.42241345016,JAK2
5890,KEGG_2019_Human,Tuberculosis,1/179,0.0089499050800561,0.0112811333627995,0,0,19821.0,93478.0629355712,JAK2
5891,KEGG_2019_Human,Kaposi sarcoma-associated herpesvirus infection,1/186,0.0092999029651357,0.0112811333627995,0,0,19814.0,92684.96451050608,JAK2
5892,KEGG_2019_Human,Chemokine signaling pathway,1/190,0.0094999017791995,0.0112811333627995,0,0,19810.0,92244.74636351672,JAK2
5893,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0197821994227041,0,0,19646.0,79255.8617626126,JAK2
5894,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0259664967007149,0,0,19508.0,72277.44006442746,JAK2
5895,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,JAK2
5896,KEGG_2019_Human,Nitrogen metabolism,1/17,0.0008499797390404818,0.0015749646683097,0,0,19983.0,141285.76583697114,CPS1
5897,KEGG_2019_Human,Arginine biosynthesis,1/21,0.0010499764455398,0.0015749646683097,0,0,19979.0,137035.71221916509,CPS1
5898,KEGG_2019_Human,"Alanine, aspartate and glutamate metabolism",1/35,0.0017499663721595,0.0017499663721595,0,0,19965.0,126740.98858805298,CPS1
5899,KEGG_2019_Human,Apoptosis,1/143,0.0071499167770442,0.0071499167770442,0,0,19857.0,98106.57763600958,SPTA1
5900,KEGG_2019_Human,Bladder cancer,1/41,0.0020499625466866,0.0086855856644005,0,0,19959.0,123544.88783416104,CDKN2A
5901,KEGG_2019_Human,Non-small cell lung cancer,1/66,0.003299948626608,0.0086855856644005,0,0,19934.0,113899.85357353876,CDKN2A
5902,KEGG_2019_Human,p53 signaling pathway,1/72,0.0035999456502131,0.0086855856644005,0,0,19928.0,112131.59838572376,CDKN2A
5903,KEGG_2019_Human,Melanoma,1/72,0.0035999456502131,0.0086855856644005,0,0,19928.0,112131.59838572376,CDKN2A
5904,KEGG_2019_Human,Pancreatic cancer,1/75,0.0037499442041125,0.0086855856644005,0,0,19925.0,111301.33528642564,CDKN2A
5905,KEGG_2019_Human,Glioma,1/75,0.0037499442041125,0.0086855856644005,0,0,19925.0,111301.33528642564,CDKN2A
5906,KEGG_2019_Human,Chronic myeloid leukemia,1/76,0.0037999437281752,0.0086855856644005,0,0,19924.0,111031.8499691117,CDKN2A
5907,KEGG_2019_Human,Cell cycle,1/124,0.0061999236097501,0.0122180487288865,0,0,19876.0,101034.04709010696,CDKN2A
5908,KEGG_2019_Human,Cushing syndrome,1/155,0.0077499127120574,0.0122180487288865,0,0,19845.0,96448.16254952336,CDKN2A
5909,KEGG_2019_Human,Cellular senescence,1/160,0.0079999110688441,0.0122180487288865,0,0,19840.0,95793.96509856998,CDKN2A
5910,KEGG_2019_Human,Hepatocellular carcinoma,1/168,0.0083999085011095,0.0122180487288865,0,0,19832.0,94787.72752807094,CDKN2A
5911,KEGG_2019_Human,Viral carcinogenesis,1/201,0.0100498985877989,0.0128570194046101,0,0,19799.0,91079.21596609056,CDKN2A
5912,KEGG_2019_Human,Human T-cell leukemia virus 1 infection,1/219,0.0109498935894162,0.0128570194046101,0,0,19781.0,89299.85161916987,CDKN2A
5913,KEGG_2019_Human,Human cytomegalovirus infection,1/225,0.0112498919790339,0.0128570194046101,0,0,19775.0,88738.27077557483,CDKN2A
5914,KEGG_2019_Human,MicroRNAs in cancer,1/299,0.0149498740670514,0.0159465323381882,0,0,19701.0,82804.33538735632,CDKN2A
5915,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,CDKN2A
5916,KEGG_2019_Human,Toll-like receptor signaling pathway,1/104,0.0051999314202997,0.0142373563327152,0,0,19896.0,104635.24941415618,IFNAR1
5917,KEGG_2019_Human,Osteoclast differentiation,1/127,0.0063499224962247,0.0142373563327152,0,0,19873.0,100543.72072014232,IFNAR1
5918,KEGG_2019_Human,Natural killer cell mediated cytotoxicity,1/131,0.0065499210316603,0.0142373563327152,0,0,19869.0,99907.33811343512,IFNAR1
5919,KEGG_2019_Human,Measles,1/138,0.0068999185254481,0.0142373563327152,0,0,19862.0,98838.19160389496,IFNAR1
5920,KEGG_2019_Human,Hepatitis C,1/155,0.0077499127120574,0.0142373563327152,0,0,19845.0,96448.16254952336,IFNAR1
5921,KEGG_2019_Human,Necroptosis,1/162,0.0080999104202618,0.0142373563327152,0,0,19838.0,95537.86936302872,IFNAR1
5922,KEGG_2019_Human,JAK-STAT signaling pathway,1/162,0.0080999104202618,0.0142373563327152,0,0,19838.0,95537.86936302872,IFNAR1
5923,KEGG_2019_Human,Hepatitis B,1/163,0.0081499100978668,0.0142373563327152,0,0,19837.0,95410.9786681514,IFNAR1
5924,KEGG_2019_Human,Influenza A,1/171,0.0085499075557634,0.0142373563327152,0,0,19829.0,94422.42241345016,IFNAR1
5925,KEGG_2019_Human,NOD-like receptor signaling pathway,1/178,0.0088999053857096,0.0142373563327152,0,0,19822.0,93593.82745769851,IFNAR1
5926,KEGG_2019_Human,Kaposi sarcoma-associated herpesvirus infection,1/186,0.0092999029651357,0.0142373563327152,0,0,19814.0,92684.96451050608,IFNAR1
5927,KEGG_2019_Human,Epstein-Barr virus infection,1/201,0.0100498985877989,0.0142373563327152,0,0,19799.0,91079.21596609056,IFNAR1
5928,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0192229136916576,0,0,19706.0,83157.67014793828,IFNAR1
5929,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0200355533430283,0,0,19670.0,80733.60565076157,IFNAR1
5930,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0200598443268824,0,0,19646.0,79255.8617626126,IFNAR1
5931,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0261373289158512,0,0,19508.0,72277.44006442746,IFNAR1
5932,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,IFNAR1
5933,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF135
5934,KEGG_2019_Human,Cocaine addiction,1/49,0.0024499577795033,0.0121141662887149,0,0,19951.0,119939.1172087114,DRD2
5935,KEGG_2019_Human,Gap junction,1/88,0.0043999382262822,0.0121141662887149,0,0,19912.0,108045.79305232369,DRD2
5936,KEGG_2019_Human,Dopaminergic synapse,1/131,0.0065499210316603,0.0121141662887149,0,0,19869.0,99907.33811343512,DRD2
5937,KEGG_2019_Human,Parkinson disease,1/142,0.0070999171242726,0.0121141662887149,0,0,19858.0,98250.87390500787,DRD2
5938,KEGG_2019_Human,Alcoholism,1/180,0.0089999047745351,0.0121141662887149,0,0,19820.0,93362.92821536642,DRD2
5939,KEGG_2019_Human,Rap1 signaling pathway,1/206,0.010299897173561,0.0121141662887149,0,0,19794.0,90569.849337325,DRD2
5940,KEGG_2019_Human,cAMP signaling pathway,1/212,0.0105998955026255,0.0121141662887149,0,0,19788.0,89974.27756224656,DRD2
5941,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,DRD2
5942,KEGG_2019_Human,RNA degradation,1/79,0.0039499423167337,0.0068249053608048,0,0,19921.0,110243.89578070649,PABPC4
5943,KEGG_2019_Human,mRNA surveillance pathway,1/91,0.0045499369072032,0.0068249053608048,0,0,19909.0,107362.10783923086,PABPC4
5944,KEGG_2019_Human,RNA transport,1/165,0.0082499094553477,0.0082499094553477,0,0,19835.0,95159.46482222488,PABPC4
5945,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF490
5946,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR4A5
5947,KEGG_2019_Human,Folate biosynthesis,1/26,0.0012999726251831,0.0012999726251831,0,0,19974.0,132735.46073187632,SPR
5948,KEGG_2019_Human,Bile secretion,1/72,0.0035999456502131,0.0035999456502131,0,0,19928.0,112131.59838572376,AQP8
5949,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF416
5950,KEGG_2019_Human,Pentose and glucuronate interconversions,1/34,0.0016999670339032,0.0047999167135976,0,0,19966.0,127326.1054203148,KL
5951,KEGG_2019_Human,Endocrine and other factor-regulated calcium reabsorption,1/48,0.0023999583567988,0.0047999167135976,0,0,19952.0,120356.5272753826,KL
5952,KEGG_2019_Human,Longevity regulating pathway,1/102,0.0050999322416682,0.0052999306076525,0,0,19898.0,105032.15064717118,KL
5953,KEGG_2019_Human,"Parathyroid hormone synthesis, secretion and action",1/106,0.0052999306076525,0.0052999306076525,0,0,19894.0,104245.78450366124,KL
5954,KEGG_2019_Human,Tight junction,1/170,0.0084999078692823,0.0084999078692823,0,0,19830.0,94543.49009679438,ACTR3
5955,KEGG_2019_Human,Phagosome,1/152,0.0075999137114971,0.0089499050800561,0,0,19848.0,96850.665715497,PLA2R1
5956,KEGG_2019_Human,Tuberculosis,1/179,0.0089499050800561,0.0089499050800561,0,0,19821.0,93478.0629355712,PLA2R1
5957,KEGG_2019_Human,Ribosome,1/153,0.0076499133771537,0.0076499133771537,0,0,19847.0,96715.6407630817,RPL10A
5958,KEGG_2019_Human,Purine metabolism,1/129,0.006449921761047,0.0082999091363732,0,0,19871.0,100223.109907462,PDE5A
5959,KEGG_2019_Human,cGMP-PKG signaling pathway,1/166,0.0082999091363732,0.0082999091363732,0,0,19834.0,95034.82345515196,PDE5A
5960,KEGG_2019_Human,Viral myocarditis,1/59,0.0029499522555206,0.0110998340491349,0,0,19941.0,116175.59385530632,CAV1
5961,KEGG_2019_Human,Bacterial invasion of epithelial cells,1/74,0.0036999446830449,0.0110998340491349,0,0,19926.0,111574.38983110404,CAV1
5962,KEGG_2019_Human,Fluid shear stress and atherosclerosis,1/139,0.006949918172816,0.0120598783053587,0,0,19861.0,98689.81333375497,CAV1
5963,KEGG_2019_Human,Focal adhesion,1/199,0.0099498991610159,0.0120598783053587,0,0,19801.0,91286.4288690606,CAV1
5964,KEGG_2019_Human,Proteoglycans in cancer,1/201,0.0100498985877989,0.0120598783053587,0,0,19799.0,91079.21596609056,CAV1
5965,KEGG_2019_Human,Endocytosis,1/244,0.0121998870519305,0.0121998870519305,0,0,19756.0,87051.4275316661,CAV1
5966,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR4Q3
5967,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF560
5968,KEGG_2019_Human,Mineral absorption,1/51,0.0025499566390179,0.0025499566390179,0,0,19949.0,119129.0228601236,STEAP2
5969,KEGG_2019_Human,Ferroptosis,1/40,0.0019999631680592,0.0038249349585269,0,0,19960.0,124043.94523066044,SLC11A2
5970,KEGG_2019_Human,Mineral absorption,1/51,0.0025499566390179,0.0038249349585269,0,0,19949.0,119129.0228601236,SLC11A2
5971,KEGG_2019_Human,Lysosome,1/123,0.0061499239842961,0.0061499239842961,0,0,19877.0,101200.07933676826,SLC11A2
5972,KEGG_2019_Human,Kaposi sarcoma-associated herpesvirus infection,1/186,0.0092999029651357,0.0133998647837319,0,0,19814.0,92684.96451050608,CCR4
5973,KEGG_2019_Human,Chemokine signaling pathway,1/190,0.0094999017791995,0.0133998647837319,0,0,19810.0,92244.74636351672,CCR4
5974,KEGG_2019_Human,Viral carcinogenesis,1/201,0.0100498985877989,0.0133998647837319,0,0,19799.0,91079.21596609056,CCR4
5975,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0146998751759735,0,0,19706.0,83157.67014793828,CCR4
5976,KEGG_2019_Human,Protein processing in endoplasmic reticulum,1/165,0.0082499094553477,0.0082499094553477,0,0,19835.0,95159.46482222488,ERLEC1
5977,KEGG_2019_Human,DNA replication,1/36,0.0017999657178272,0.0035999314356544,0,0,19964.0,126172.23364250171,MCM4
5978,KEGG_2019_Human,Cell cycle,1/124,0.0061999236097501,0.0061999236097501,0,0,19876.0,101034.04709010696,MCM4
5979,KEGG_2019_Human,Salivary secretion,1/90,0.0044999373439762,0.011279882844162,0,0,19910.0,107587.50385474482,ADRA1D
5980,KEGG_2019_Human,Vascular smooth muscle contraction,1/132,0.0065999206698993,0.011279882844162,0,0,19868.0,99751.22090491928,ADRA1D
5981,KEGG_2019_Human,Adrenergic signaling in cardiomyocytes,1/145,0.0072499160871101,0.011279882844162,0,0,19855.0,97820.92670675044,ADRA1D
5982,KEGG_2019_Human,cGMP-PKG signaling pathway,1/166,0.0082999091363732,0.011279882844162,0,0,19834.0,95034.82345515196,ADRA1D
5983,KEGG_2019_Human,Calcium signaling pathway,1/188,0.009399902370135,0.011279882844162,0,0,19812.0,92463.712994847,ADRA1D
5984,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,ADRA1D
5985,KEGG_2019_Human,Citrate cycle (TCA cycle),1/30,0.0014999697593334,0.0104997883153344,0,0,19970.0,129851.13732048514,SDHD
5986,KEGG_2019_Human,Oxidative phosphorylation,1/133,0.0066499203093911,0.0112582177134695,0,0,19867.0,99596.2591544721,SDHD
5987,KEGG_2019_Human,Parkinson disease,1/142,0.0070999171242726,0.0112582177134695,0,0,19858.0,98250.87390500787,SDHD
5988,KEGG_2019_Human,Non-alcoholic fatty liver disease (NAFLD),1/149,0.0074499147221605,0.0112582177134695,0,0,19851.0,97261.02051561224,SDHD
5989,KEGG_2019_Human,Alzheimer disease,1/171,0.0085499075557634,0.0112582177134695,0,0,19829.0,94422.42241345016,SDHD
5990,KEGG_2019_Human,Huntington disease,1/193,0.0096499008972596,0.0112582177134695,0,0,19807.0,91920.47679471428,SDHD
5991,KEGG_2019_Human,Thermogenesis,1/231,0.0115498903940656,0.0115498903940656,0,0,19769.0,88191.07730937863,SDHD
5992,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR5D16
5993,KEGG_2019_Human,Human T-cell leukemia virus 1 infection,1/219,0.0109498935894162,0.0109498935894162,0,0,19781.0,89299.85161916987,RANBP3
5994,KEGG_2019_Human,Proximal tubule bicarbonate reclamation,1/23,0.0011499748819949,0.0062999150247102,0,0,19977.0,135204.63922267244,ATP1A2
5995,KEGG_2019_Human,Aldosterone-regulated sodium reabsorption,1/37,0.0018499650702878,0.0062999150247102,0,0,19963.0,125618.9446446357,ATP1A2
5996,KEGG_2019_Human,Carbohydrate digestion and absorption,1/44,0.0021999607179423,0.0062999150247102,0,0,19956.0,122117.06559109331,ATP1A2
5997,KEGG_2019_Human,Endocrine and other factor-regulated calcium reabsorption,1/48,0.0023999583567988,0.0062999150247102,0,0,19952.0,120356.5272753826,ATP1A2
5998,KEGG_2019_Human,Mineral absorption,1/51,0.0025499566390179,0.0062999150247102,0,0,19949.0,119129.0228601236,ATP1A2
5999,KEGG_2019_Human,Bile secretion,1/72,0.0035999456502131,0.0062999150247102,0,0,19928.0,112131.59838572376,ATP1A2
6000,KEGG_2019_Human,Thyroid hormone synthesis,1/74,0.0036999446830449,0.0062999150247102,0,0,19926.0,111574.38983110404,ATP1A2
6001,KEGG_2019_Human,Gastric acid secretion,1/75,0.0037499442041125,0.0062999150247102,0,0,19925.0,111301.33528642564,ATP1A2
6002,KEGG_2019_Human,Cardiac muscle contraction,1/78,0.0038999427840466,0.0062999150247102,0,0,19922.0,110503.2180492851,ATP1A2
6003,KEGG_2019_Human,Insulin secretion,1/86,0.0042999391173866,0.0062999150247102,0,0,19914.0,108514.46102290176,ATP1A2
6004,KEGG_2019_Human,Salivary secretion,1/90,0.0044999373439762,0.0062999150247102,0,0,19910.0,107587.50385474482,ATP1A2
6005,KEGG_2019_Human,Protein digestion and absorption,1/90,0.0044999373439762,0.0062999150247102,0,0,19910.0,107587.50385474482,ATP1A2
6006,KEGG_2019_Human,Pancreatic secretion,1/98,0.0048999339081079,0.0062999150247102,0,0,19902.0,105849.45495286948,ATP1A2
6007,KEGG_2019_Human,Aldosterone synthesis and secretion,1/98,0.0048999339081079,0.0062999150247102,0,0,19902.0,105849.45495286948,ATP1A2
6008,KEGG_2019_Human,Thyroid hormone signaling pathway,1/116,0.0057999266512085,0.0069599119814502,0,0,19884.0,102400.8105961506,ATP1A2
6009,KEGG_2019_Human,Adrenergic signaling in cardiomyocytes,1/145,0.0072499160871101,0.0081561555979989,0,0,19855.0,97820.92670675044,ATP1A2
6010,KEGG_2019_Human,cGMP-PKG signaling pathway,1/166,0.0082999091363732,0.0087881390855717,0,0,19834.0,95034.82345515196,ATP1A2
6011,KEGG_2019_Human,cAMP signaling pathway,1/212,0.0105998955026255,0.0105998955026255,0,0,19788.0,89974.27756224656,ATP1A2
6012,KEGG_2019_Human,Proximal tubule bicarbonate reclamation,1/23,0.0011499748819949,0.0073998893660899,0,0,19977.0,135204.63922267244,PCK1
6013,KEGG_2019_Human,Citrate cycle (TCA cycle),1/30,0.0014999697593334,0.0073998893660899,0,0,19970.0,129851.13732048514,PCK1
6014,KEGG_2019_Human,Pyruvate metabolism,1/39,0.0019499637955508,0.0073998893660899,0,0,19961.0,124555.53162481484,PCK1
6015,KEGG_2019_Human,Glycolysis / Gluconeogenesis,1/68,0.0033999476216189,0.0073998893660899,0,0,19932.0,113293.39338050144,PCK1
6016,KEGG_2019_Human,Adipocytokine signaling pathway,1/69,0.003449947123837,0.0073998893660899,0,0,19931.0,112996.7391397682,PCK1
6017,KEGG_2019_Human,PPAR signaling pathway,1/74,0.0036999446830449,0.0073998893660899,0,0,19926.0,111574.38983110404,PCK1
6018,KEGG_2019_Human,Glucagon signaling pathway,1/103,0.0051499318302617,0.0074726387779256,0,0,19897.0,104832.7525292024,PCK1
6019,KEGG_2019_Human,Insulin resistance,1/108,0.0053999298011749,0.0074726387779256,0,0,19892.0,103863.47861844616,PCK1
6020,KEGG_2019_Human,AMPK signaling pathway,1/120,0.0059999251180858,0.0074726387779256,0,0,19880.0,101706.2448082016,PCK1
6021,KEGG_2019_Human,FoxO signaling pathway,1/132,0.0065999206698993,0.0074726387779256,0,0,19868.0,99751.22090491928,PCK1
6022,KEGG_2019_Human,Insulin signaling pathway,1/137,0.0068499188797651,0.0074726387779256,0,0,19863.0,98987.62735269018,PCK1
6023,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0176998626413668,0,0,19646.0,79255.8617626126,PCK1
6024,KEGG_2019_Human,Mitophagy,1/65,0.003249949134407,0.0089373959713052,0,0,19935.0,114209.92613860144,BECN1
6025,KEGG_2019_Human,Autophagy,1/128,0.0063999221281459,0.0089373959713052,0,0,19872.0,100382.8010329652,BECN1
6026,KEGG_2019_Human,Apelin signaling pathway,1/137,0.0068499188797651,0.0089373959713052,0,0,19863.0,98987.62735269018,BECN1
6027,KEGG_2019_Human,Apoptosis,1/143,0.0071499167770442,0.0089373959713052,0,0,19857.0,98106.57763600958,BECN1
6028,KEGG_2019_Human,Kaposi sarcoma-associated herpesvirus infection,1/186,0.0092999029651357,0.0092999029651357,0,0,19814.0,92684.96451050608,BECN1
6029,KEGG_2019_Human,Glycosphingolipid biosynthesis,1/45,0.0022499601197094,0.0022499601197094,0,0,19955.0,121662.49782449217,FUT6
6030,KEGG_2019_Human,MicroRNAs in cancer,1/299,0.0149498740670514,0.0149498740670514,0,0,19701.0,82804.33538735632,DICER1
6031,KEGG_2019_Human,Hepatitis C,1/155,0.0077499127120574,0.0082499094553477,0,0,19845.0,96448.16254952336,EIF3E
6032,KEGG_2019_Human,RNA transport,1/165,0.0082499094553477,0.0082499094553477,0,0,19835.0,95159.46482222488,EIF3E
6033,KEGG_2019_Human,RNA degradation,1/79,0.0039499423167337,0.0068249053608048,0,0,19921.0,110243.89578070649,PABPC4L
6034,KEGG_2019_Human,mRNA surveillance pathway,1/91,0.0045499369072032,0.0068249053608048,0,0,19909.0,107362.10783923086,PABPC4L
6035,KEGG_2019_Human,RNA transport,1/165,0.0082499094553477,0.0082499094553477,0,0,19835.0,95159.46482222488,PABPC4L
6036,KEGG_2019_Human,Amyotrophic lateral sclerosis (ALS),1/51,0.0025499566390179,0.0127261830049226,0,0,19949.0,119129.0228601236,TNFRSF1A
6037,KEGG_2019_Human,Adipocytokine signaling pathway,1/69,0.003449947123837,0.0127261830049226,0,0,19931.0,112996.7391397682,TNFRSF1A
6038,KEGG_2019_Human,NF-kappa B signaling pathway,1/95,0.0047499351803394,0.0127261830049226,0,0,19905.0,106484.27183626965,TNFRSF1A
6039,KEGG_2019_Human,Chagas disease (American trypanosomiasis),1/103,0.0051499318302617,0.0127261830049226,0,0,19897.0,104832.7525292024,TNFRSF1A
6040,KEGG_2019_Human,Insulin resistance,1/108,0.0053999298011749,0.0127261830049226,0,0,19892.0,103863.47861844616,TNFRSF1A
6041,KEGG_2019_Human,TNF signaling pathway,1/110,0.0054999290027479,0.0127261830049226,0,0,19890.0,103488.06969787036,TNFRSF1A
6042,KEGG_2019_Human,Toxoplasmosis,1/113,0.0056499278191151,0.0127261830049226,0,0,19887.0,102937.34947211576,TNFRSF1A
6043,KEGG_2019_Human,Sphingolipid signaling pathway,1/119,0.0059499254985137,0.0127261830049226,0,0,19881.0,101877.73080211312,TNFRSF1A
6044,KEGG_2019_Human,Osteoclast differentiation,1/127,0.0063499224962247,0.0127261830049226,0,0,19873.0,100543.72072014232,TNFRSF1A
6045,KEGG_2019_Human,Fluid shear stress and atherosclerosis,1/139,0.006949918172816,0.0127261830049226,0,0,19861.0,98689.81333375497,TNFRSF1A
6046,KEGG_2019_Human,Apoptosis,1/143,0.0071499167770442,0.0127261830049226,0,0,19857.0,98106.57763600958,TNFRSF1A
6047,KEGG_2019_Human,Non-alcoholic fatty liver disease (NAFLD),1/149,0.0074499147221605,0.0127261830049226,0,0,19851.0,97261.02051561224,TNFRSF1A
6048,KEGG_2019_Human,mTOR signaling pathway,1/152,0.0075999137114971,0.0127261830049226,0,0,19848.0,96850.665715497,TNFRSF1A
6049,KEGG_2019_Human,Hepatitis C,1/155,0.0077499127120574,0.0127261830049226,0,0,19845.0,96448.16254952336,TNFRSF1A
6050,KEGG_2019_Human,Necroptosis,1/162,0.0080999104202618,0.0127261830049226,0,0,19838.0,95537.86936302872,TNFRSF1A
6051,KEGG_2019_Human,Influenza A,1/171,0.0085499075557634,0.0127261830049226,0,0,19829.0,94422.42241345016,TNFRSF1A
6052,KEGG_2019_Human,Alzheimer disease,1/171,0.0085499075557634,0.0127261830049226,0,0,19829.0,94422.42241345016,TNFRSF1A
6053,KEGG_2019_Human,Tuberculosis,1/179,0.0089499050800561,0.0127261830049226,0,0,19821.0,93478.0629355712,TNFRSF1A
6054,KEGG_2019_Human,Kaposi sarcoma-associated herpesvirus infection,1/186,0.0092999029651357,0.0127261830049226,0,0,19814.0,92684.96451050608,TNFRSF1A
6055,KEGG_2019_Human,Human immunodeficiency virus 1 infection,1/212,0.0105998955026255,0.0132953268843128,0,0,19788.0,89974.27756224656,TNFRSF1A
6056,KEGG_2019_Human,Human T-cell leukemia virus 1 infection,1/219,0.0109498935894162,0.0132953268843128,0,0,19781.0,89299.85161916987,TNFRSF1A
6057,KEGG_2019_Human,Human cytomegalovirus infection,1/225,0.0112498919790339,0.0132953268843128,0,0,19775.0,88738.27077557483,TNFRSF1A
6058,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0159790311997882,0,0,19706.0,83157.67014793828,TNFRSF1A
6059,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0159790311997882,0,0,19705.0,83086.53988020132,TNFRSF1A
6060,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0171598621573231,0,0,19670.0,80733.60565076157,TNFRSF1A
6061,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,TNFRSF1A
6062,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0146998751759735,0,0,19706.0,83157.67014793828,EDAR
6063,KEGG_2019_Human,Sphingolipid metabolism,1/47,0.0023499589392381,0.0046999178784763,0,0,19953.0,120782.64067395544,SGMS2
6064,KEGG_2019_Human,Sphingolipid signaling pathway,1/119,0.0059499254985137,0.0059499254985137,0,0,19881.0,101877.73080211312,SGMS2
6065,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,TAAR8
6066,KEGG_2019_Human,Mineral absorption,1/51,0.0025499566390179,0.0025499566390179,0,0,19949.0,119129.0228601236,MT1A
6067,KEGG_2019_Human,Leishmaniasis,1/74,0.0036999446830449,0.0120748574195343,0,0,19926.0,111574.38983110404,TAB2
6068,KEGG_2019_Human,IL-17 signaling pathway,1/93,0.0046499360391879,0.0120748574195343,0,0,19907.0,106918.54242106884,TAB2
6069,KEGG_2019_Human,NF-kappa B signaling pathway,1/95,0.0047499351803394,0.0120748574195343,0,0,19905.0,106484.27183626965,TAB2
6070,KEGG_2019_Human,Toll-like receptor signaling pathway,1/104,0.0051999314202997,0.0120748574195343,0,0,19896.0,104635.24941415618,TAB2
6071,KEGG_2019_Human,TNF signaling pathway,1/110,0.0054999290027479,0.0120748574195343,0,0,19890.0,103488.06969787036,TAB2
6072,KEGG_2019_Human,Toxoplasmosis,1/113,0.0056499278191151,0.0120748574195343,0,0,19887.0,102937.34947211576,TAB2
6073,KEGG_2019_Human,Osteoclast differentiation,1/127,0.0063499224962247,0.0120748574195343,0,0,19873.0,100543.72072014232,TAB2
6074,KEGG_2019_Human,Measles,1/138,0.0068999185254481,0.0120748574195343,0,0,19862.0,98838.19160389496,TAB2
6075,KEGG_2019_Human,Hepatitis B,1/163,0.0081499100978668,0.0123665447530631,0,0,19837.0,95410.9786681514,TAB2
6076,KEGG_2019_Human,NOD-like receptor signaling pathway,1/178,0.0088999053857096,0.0123665447530631,0,0,19822.0,93593.82745769851,TAB2
6077,KEGG_2019_Human,Epstein-Barr virus infection,1/201,0.0100498985877989,0.0123665447530631,0,0,19799.0,91079.21596609056,TAB2
6078,KEGG_2019_Human,Human immunodeficiency virus 1 infection,1/212,0.0105998955026255,0.0123665447530631,0,0,19788.0,89974.27756224656,TAB2
6079,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0158844807193161,0,0,19705.0,83086.53988020132,TAB2
6080,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,TAB2
6081,KEGG_2019_Human,Mitophagy,1/65,0.003249949134407,0.003249949134407,0,0,19935.0,114209.92613860144,CALCOCO2
6082,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF484
6083,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF19
6084,KEGG_2019_Human,alpha-Linolenic acid metabolism,1/25,0.0012499733663791,0.0083598935608305,0,0,19975.0,133525.54486996148,PLA2G4E
6085,KEGG_2019_Human,Linoleic acid metabolism,1/29,0.001449970461791,0.0083598935608305,0,0,19971.0,130534.69172799008,PLA2G4E
6086,KEGG_2019_Human,Ether lipid metabolism,1/47,0.0023499589392381,0.0083598935608305,0,0,19953.0,120782.64067395544,PLA2G4E
6087,KEGG_2019_Human,Ovarian steroidogenesis,1/49,0.0024499577795033,0.0083598935608305,0,0,19951.0,119939.1172087114,PLA2G4E
6088,KEGG_2019_Human,VEGF signaling pathway,1/59,0.0029499522555206,0.0083598935608305,0,0,19941.0,116175.59385530632,PLA2G4E
6089,KEGG_2019_Human,Long-term depression,1/60,0.002999951725986,0.0083598935608305,0,0,19940.0,115834.63209072244,PLA2G4E
6090,KEGG_2019_Human,Arachidonic acid metabolism,1/63,0.0031499501598827,0.0083598935608305,0,0,19937.0,114844.46974572667,PLA2G4E
6091,KEGG_2019_Human,Fc epsilon RI signaling pathway,1/68,0.0033999476216189,0.0083598935608305,0,0,19932.0,113293.39338050144,PLA2G4E
6092,KEGG_2019_Human,Fc gamma R-mediated phagocytosis,1/91,0.0045499369072032,0.0083598935608305,0,0,19909.0,107362.10783923086,PLA2G4E
6093,KEGG_2019_Human,GnRH signaling pathway,1/93,0.0046499360391879,0.0083598935608305,0,0,19907.0,106918.54242106884,PLA2G4E
6094,KEGG_2019_Human,Glycerophospholipid metabolism,1/97,0.0048499343304706,0.0083598935608305,0,0,19903.0,106058.9096435903,PLA2G4E
6095,KEGG_2019_Human,Choline metabolism in cancer,1/99,0.0049499334884068,0.0083598935608305,0,0,19901.0,105642.09305076736,PLA2G4E
6096,KEGG_2019_Human,Inflammatory mediator regulation of TRP channels,1/100,0.0049999330710556,0.0083598935608305,0,0,19900.0,105436.78197328727,PLA2G4E
6097,KEGG_2019_Human,Serotonergic synapse,1/113,0.0056499278191151,0.0083598935608305,0,0,19887.0,102937.34947211576,PLA2G4E
6098,KEGG_2019_Human,Glutamatergic synapse,1/114,0.005699927427839,0.0083598935608305,0,0,19886.0,102756.96431429044,PLA2G4E
6099,KEGG_2019_Human,Platelet activation,1/124,0.0061999236097501,0.0085248949634064,0,0,19876.0,101034.04709010696,PLA2G4E
6100,KEGG_2019_Human,Vascular smooth muscle contraction,1/132,0.0065999206698993,0.008541073808105,0,0,19868.0,99751.22090491928,PLA2G4E
6101,KEGG_2019_Human,Phospholipase D signaling pathway,1/148,0.007399915061391,0.0088577944367043,0,0,19852.0,97399.60470052566,PLA2G4E
6102,KEGG_2019_Human,Oxytocin signaling pathway,1/153,0.0076499133771537,0.0088577944367043,0,0,19847.0,96715.6407630817,PLA2G4E
6103,KEGG_2019_Human,Necroptosis,1/162,0.0080999104202618,0.008909901462288,0,0,19838.0,95537.86936302872,PLA2G4E
6104,KEGG_2019_Human,Ras signaling pathway,1/232,0.0115998901349604,0.0121522658556728,0,0,19768.0,88101.22480150245,PLA2G4E
6105,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0147498749536506,0,0,19705.0,83086.53988020132,PLA2G4E
6106,KEGG_2019_Human,Ribosome,1/153,0.0076499133771537,0.0076499133771537,0,0,19847.0,96715.6407630817,MRPS10
6107,KEGG_2019_Human,Nicotine addiction,1/40,0.0019999631680592,0.007583228178672,0,0,19960.0,124043.94523066044,GABRG3
6108,KEGG_2019_Human,GABAergic synapse,1/89,0.0044499377838098,0.007583228178672,0,0,19911.0,107815.380281759,GABRG3
6109,KEGG_2019_Human,Morphine addiction,1/91,0.0045499369072032,0.007583228178672,0,0,19909.0,107362.10783923086,GABRG3
6110,KEGG_2019_Human,Retrograde endocannabinoid signaling,1/148,0.007399915061391,0.0092498938267387,0,0,19852.0,97399.60470052566,GABRG3
6111,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,GABRG3
6112,KEGG_2019_Human,Homologous recombination,1/41,0.0020499625466866,0.0026999549628563,0,0,19959.0,123544.88783416104,BLM
6113,KEGG_2019_Human,Fanconi anemia pathway,1/54,0.0026999549628563,0.0026999549628563,0,0,19946.0,117971.01964061816,BLM
6114,KEGG_2019_Human,cAMP signaling pathway,1/212,0.0105998955026255,0.0105998955026255,0,0,19788.0,89974.27756224656,CNGB3
6115,KEGG_2019_Human,Apoptosis,1/143,0.0071499167770442,0.0071499167770442,0,0,19857.0,98106.57763600958,DFFB
6116,KEGG_2019_Human,mRNA surveillance pathway,1/91,0.0045499369072032,0.0106873844447042,0,0,19909.0,107362.10783923086,NXF3
6117,KEGG_2019_Human,Ribosome biogenesis in eukaryotes,1/101,0.0050499326546803,0.0106873844447042,0,0,19899.0,105233.48101229242,NXF3
6118,KEGG_2019_Human,RNA transport,1/165,0.0082499094553477,0.0106873844447042,0,0,19835.0,95159.46482222488,NXF3
6119,KEGG_2019_Human,Influenza A,1/171,0.0085499075557634,0.0106873844447042,0,0,19829.0,94422.42241345016,NXF3
6120,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,NXF3
6121,KEGG_2019_Human,Glycerophospholipid metabolism,1/97,0.0048499343304706,0.0049499334884068,0,0,19903.0,106058.9096435903,CHKA
6122,KEGG_2019_Human,Choline metabolism in cancer,1/99,0.0049499334884068,0.0049499334884068,0,0,19901.0,105642.09305076736,CHKA
6123,KEGG_2019_Human,Central carbon metabolism in cancer,1/65,0.003249949134407,0.007088799240366,0,0,19935.0,114209.92613860144,SLC2A1
6124,KEGG_2019_Human,Adipocytokine signaling pathway,1/69,0.003449947123837,0.007088799240366,0,0,19931.0,112996.7391397682,SLC2A1
6125,KEGG_2019_Human,Renal cell carcinoma,1/69,0.003449947123837,0.007088799240366,0,0,19931.0,112996.7391397682,SLC2A1
6126,KEGG_2019_Human,Bile secretion,1/72,0.0035999456502131,0.007088799240366,0,0,19928.0,112131.59838572376,SLC2A1
6127,KEGG_2019_Human,Insulin secretion,1/86,0.0042999391173866,0.007088799240366,0,0,19914.0,108514.46102290176,SLC2A1
6128,KEGG_2019_Human,HIF-1 signaling pathway,1/100,0.0049999330710556,0.007088799240366,0,0,19900.0,105436.78197328727,SLC2A1
6129,KEGG_2019_Human,Glucagon signaling pathway,1/103,0.0051499318302617,0.007088799240366,0,0,19897.0,104832.7525292024,SLC2A1
6130,KEGG_2019_Human,Insulin resistance,1/108,0.0053999298011749,0.007088799240366,0,0,19892.0,103863.47861844616,SLC2A1
6131,KEGG_2019_Human,Thyroid hormone signaling pathway,1/116,0.0057999266512085,0.007088799240366,0,0,19884.0,102400.8105961506,SLC2A1
6132,KEGG_2019_Human,Human T-cell leukemia virus 1 infection,1/219,0.0109498935894162,0.0120448829483578,0,0,19781.0,89299.85161916987,SLC2A1
6133,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,SLC2A1
6134,KEGG_2019_Human,Spliceosome,1/134,0.0066999199497742,0.0066999199497742,0,0,19866.0,99442.43560916925,RP9
6135,KEGG_2019_Human,Hedgehog signaling pathway,1/47,0.0023499589392381,0.0100798902013314,0,0,19953.0,120782.64067395544,CSNK1A1
6136,KEGG_2019_Human,Breast cancer,1/147,0.0073499154017982,0.0100798902013314,0,0,19853.0,97539.10874372096,CSNK1A1
6137,KEGG_2019_Human,Gastric cancer,1/149,0.0074499147221605,0.0100798902013314,0,0,19851.0,97261.02051561224,CSNK1A1
6138,KEGG_2019_Human,Wnt signaling pathway,1/158,0.0078999117225733,0.0100798902013314,0,0,19842.0,96053.2110949472,CSNK1A1
6139,KEGG_2019_Human,Hepatocellular carcinoma,1/168,0.0083999085011095,0.0100798902013314,0,0,19832.0,94787.72752807094,CSNK1A1
6140,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0164998674589645,0,0,19670.0,80733.60565076157,CSNK1A1
6141,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR52K2
6142,KEGG_2019_Human,Amyotrophic lateral sclerosis (ALS),1/51,0.0025499566390179,0.0025499566390179,0,0,19949.0,119129.0228601236,NEFL
6143,KEGG_2019_Human,Thermogenesis,1/231,0.0115498903940656,0.0115498903940656,0,0,19769.0,88191.07730937863,SLC25A20
6144,KEGG_2019_Human,ABC transporters,1/45,0.0022499601197094,0.0035999456502131,0,0,19955.0,121662.49782449217,ABCC3
6145,KEGG_2019_Human,Bile secretion,1/72,0.0035999456502131,0.0035999456502131,0,0,19928.0,112131.59838572376,ABCC3
6146,KEGG_2019_Human,Non-homologous end-joining,1/13,0.0006499833083207112,0.0012999666166414,0,0,19987.0,146675.87616784443,POLL
6147,KEGG_2019_Human,Base excision repair,1/33,0.0016499677032113,0.0016499677032113,0,0,19967.0,127928.56031580272,POLL
6148,KEGG_2019_Human,Fluid shear stress and atherosclerosis,1/139,0.006949918172816,0.0082499094553477,0,0,19861.0,98689.81333375497,SUMO2
6149,KEGG_2019_Human,RNA transport,1/165,0.0082499094553477,0.0082499094553477,0,0,19835.0,95159.46482222488,SUMO2
6150,KEGG_2019_Human,RNA degradation,1/79,0.0039499423167337,0.0039499423167337,0,0,19921.0,110243.89578070649,CNOT6
6151,KEGG_2019_Human,Long-term depression,1/60,0.002999951725986,0.0059999034519721,0,0,19940.0,115834.63209072244,GRID2
6152,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,GRID2
6153,KEGG_2019_Human,Arginine and proline metabolism,1/49,0.0024499577795033,0.0027999538675741,0,0,19951.0,119939.1172087114,ODC1
6154,KEGG_2019_Human,Glutathione metabolism,1/56,0.0027999538675741,0.0027999538675741,0,0,19944.0,117233.87022514464,ODC1
6155,KEGG_2019_Human,Hepatocellular carcinoma,1/168,0.0083999085011095,0.0083999085011095,0,0,19832.0,94787.72752807094,PHF10
6156,KEGG_2019_Human,JAK-STAT signaling pathway,1/162,0.0080999104202618,0.0080999104202618,0,0,19838.0,95537.86936302872,FHL1
6157,KEGG_2019_Human,Thyroid hormone signaling pathway,1/116,0.0057999266512085,0.0097998872023976,0,0,19884.0,102400.8105961506,NCOA3
6158,KEGG_2019_Human,Estrogen signaling pathway,1/137,0.0068499188797651,0.0097998872023976,0,0,19863.0,98987.62735269018,NCOA3
6159,KEGG_2019_Human,Breast cancer,1/147,0.0073499154017982,0.0097998872023976,0,0,19853.0,97539.10874372096,NCOA3
6160,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,NCOA3
6161,KEGG_2019_Human,Nicotine addiction,1/40,0.0019999631680592,0.0068249053608048,0,0,19960.0,124043.94523066044,GABRA6
6162,KEGG_2019_Human,Taste transduction,1/83,0.0041499404726918,0.0068249053608048,0,0,19917.0,109237.99888847338,GABRA6
6163,KEGG_2019_Human,GABAergic synapse,1/89,0.0044499377838098,0.0068249053608048,0,0,19911.0,107815.380281759,GABRA6
6164,KEGG_2019_Human,Morphine addiction,1/91,0.0045499369072032,0.0068249053608048,0,0,19909.0,107362.10783923086,GABRA6
6165,KEGG_2019_Human,Retrograde endocannabinoid signaling,1/148,0.007399915061391,0.0088798980736692,0,0,19852.0,97399.60470052566,GABRA6
6166,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,GABRA6
6167,KEGG_2019_Human,Notch signaling pathway,1/48,0.0023999583567988,0.0068999047079798,0,0,19952.0,120356.5272753826,MAML2
6168,KEGG_2019_Human,Th1 and Th2 cell differentiation,1/92,0.0045999364719865,0.0068999047079798,0,0,19908.0,107139.13814408927,MAML2
6169,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0164998674589645,0,0,19670.0,80733.60565076157,MAML2
6170,KEGG_2019_Human,Acute myeloid leukemia,1/66,0.003299948626608,0.0124998326776391,0,0,19934.0,113899.85357353876,PIM1
6171,KEGG_2019_Human,AGE-RAGE signaling pathway in diabetic complications,1/100,0.0049999330710556,0.0124998326776391,0,0,19900.0,105436.78197328727,PIM1
6172,KEGG_2019_Human,JAK-STAT signaling pathway,1/162,0.0080999104202618,0.0134998507004364,0,0,19838.0,95537.86936302872,PIM1
6173,KEGG_2019_Human,MicroRNAs in cancer,1/299,0.0149498740670514,0.0186873425838143,0,0,19701.0,82804.33538735632,PIM1
6174,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,PIM1
6175,KEGG_2019_Human,Sulfur metabolism,1/9,0.0004499872571388355,0.0012749696085607,0,0,19991.0,154056.46923976458,PAPSS2
6176,KEGG_2019_Human,Selenocompound metabolism,1/17,0.0008499797390404818,0.0012749696085607,0,0,19983.0,141285.76583697114,PAPSS2
6177,KEGG_2019_Human,Purine metabolism,1/129,0.006449921761047,0.006449921761047,0,0,19871.0,100223.109907462,PAPSS2
6178,KEGG_2019_Human,Mineral absorption,1/51,0.0025499566390179,0.0025499566390179,0,0,19949.0,119129.0228601236,ATP7A
6179,KEGG_2019_Human,Renin-angiotensin system,1/23,0.0011499748819949,0.0011499748819949,0,0,19977.0,135204.63922267244,ENPEP
6180,KEGG_2019_Human,Pantothenate and CoA biosynthesis,1/19,0.00094997806231055,0.00094997806231055,0,0,19981.0,139049.2109571672,PANK3
6181,KEGG_2019_Human,RNA degradation,1/79,0.0039499423167337,0.0039499423167337,0,0,19921.0,110243.89578070649,DCP2
6182,KEGG_2019_Human,RNA transport,1/165,0.0082499094553477,0.0082499094553477,0,0,19835.0,95159.46482222488,NUP153
6183,KEGG_2019_Human,One carbon pool by folate,1/20,0.0009999772468562472,0.0011499748819949,0,0,19980.0,138017.40508704726,FTCD
6184,KEGG_2019_Human,Histidine metabolism,1/23,0.0011499748819949,0.0011499748819949,0,0,19977.0,135204.63922267244,FTCD
6185,KEGG_2019_Human,Ubiquitin mediated proteolysis,1/137,0.0068499188797651,0.0068499188797651,0,0,19863.0,98987.62735269018,TRIP12
6186,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF721
6187,KEGG_2019_Human,Biosynthesis of unsaturated fatty acids,1/27,0.0013499718942362,0.0013499718942362,0,0,19973.0,131975.02298599784,HACD1
6188,KEGG_2019_Human,Fatty acid elongation,1/27,0.0013499718942362,0.0013499718942362,0,0,19973.0,131975.02298599784,HACD1
6189,KEGG_2019_Human,Ribosome,1/153,0.0076499133771537,0.0076499133771537,0,0,19847.0,96715.6407630817,RPL26
6190,KEGG_2019_Human,p53 signaling pathway,1/72,0.0035999456502131,0.0035999456502131,0,0,19928.0,112131.59838572376,PPM1D
6191,KEGG_2019_Human,Signaling pathways regulating pluripotency of stem cells,1/139,0.006949918172816,0.006949918172816,0,0,19861.0,98689.81333375497,RIF1
6192,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0146998751759735,0,0,19706.0,83157.67014793828,GDF9
6193,KEGG_2019_Human,Ribosome,1/153,0.0076499133771537,0.0076499133771537,0,0,19847.0,96715.6407630817,RPS16
6194,KEGG_2019_Human,Ubiquinone and other terpenoid-quinone biosynthesis,1/11,0.0005499852259717758,0.0005499852259717758,0,0,19989.0,150029.8210287992,GGCX
6195,KEGG_2019_Human,Hippo signaling pathway,1/160,0.0079999110688441,0.0079999110688441,0,0,19840.0,95793.96509856998,TEAD3
6196,KEGG_2019_Human,Protein processing in endoplasmic reticulum,1/165,0.0082499094553477,0.0082499094553477,0,0,19835.0,95159.46482222488,HSPA4L
6197,KEGG_2019_Human,Glycosylphosphatidylinositol (GPI)-anchor biosynthesis,1/25,0.0012499733663791,0.0012499733663791,0,0,19975.0,133525.54486996148,PIGS
6198,KEGG_2019_Human,p53 signaling pathway,1/72,0.0035999456502131,0.0102598890669161,0,0,19928.0,112131.59838572376,TNFRSF10B
6199,KEGG_2019_Human,Natural killer cell mediated cytotoxicity,1/131,0.0065499210316603,0.0102598890669161,0,0,19869.0,99907.33811343512,TNFRSF10B
6200,KEGG_2019_Human,Apoptosis,1/143,0.0071499167770442,0.0102598890669161,0,0,19857.0,98106.57763600958,TNFRSF10B
6201,KEGG_2019_Human,Necroptosis,1/162,0.0080999104202618,0.0102598890669161,0,0,19838.0,95537.86936302872,TNFRSF10B
6202,KEGG_2019_Human,Influenza A,1/171,0.0085499075557634,0.0102598890669161,0,0,19829.0,94422.42241345016,TNFRSF10B
6203,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0146998751759735,0,0,19706.0,83157.67014793828,TNFRSF10B
6204,KEGG_2019_Human,Transcriptional misregulation in cancer,1/186,0.0092999029651357,0.0092999029651357,0,0,19814.0,92684.96451050608,MLLT1
6205,KEGG_2019_Human,Progesterone-mediated oocyte maturation,1/99,0.0049499334884068,0.0062499232373748,0,0,19901.0,105642.09305076736,CPEB3
6206,KEGG_2019_Human,Oocyte meiosis,1/125,0.0062499232373748,0.0062499232373748,0,0,19875.0,100869.32368441945,CPEB3
6207,KEGG_2019_Human,MicroRNAs in cancer,1/299,0.0149498740670514,0.0149498740670514,0,0,19701.0,82804.33538735632,ZEB2
6208,KEGG_2019_Human,Autoimmune thyroid disease,1/53,0.0026499555173137,0.0145586837375733,0,0,19947.0,118349.78824235698,IFNA6
6209,KEGG_2019_Human,Cytosolic DNA-sensing pathway,1/63,0.0031499501598827,0.0145586837375733,0,0,19937.0,114844.46974572667,IFNA6
6210,KEGG_2019_Human,RIG-I-like receptor signaling pathway,1/70,0.0034999466296654,0.0145586837375733,0,0,19930.0,112704.30065625212,IFNA6
6211,KEGG_2019_Human,Toll-like receptor signaling pathway,1/104,0.0051999314202997,0.0145586837375733,0,0,19896.0,104635.24941415618,IFNA6
6212,KEGG_2019_Human,Natural killer cell mediated cytotoxicity,1/131,0.0065499210316603,0.0145586837375733,0,0,19869.0,99907.33811343512,IFNA6
6213,KEGG_2019_Human,Measles,1/138,0.0068999185254481,0.0145586837375733,0,0,19862.0,98838.19160389496,IFNA6
6214,KEGG_2019_Human,Hepatitis C,1/155,0.0077499127120574,0.0145586837375733,0,0,19845.0,96448.16254952336,IFNA6
6215,KEGG_2019_Human,Necroptosis,1/162,0.0080999104202618,0.0145586837375733,0,0,19838.0,95537.86936302872,IFNA6
6216,KEGG_2019_Human,JAK-STAT signaling pathway,1/162,0.0080999104202618,0.0145586837375733,0,0,19838.0,95537.86936302872,IFNA6
6217,KEGG_2019_Human,Hepatitis B,1/163,0.0081499100978668,0.0145586837375733,0,0,19837.0,95410.9786681514,IFNA6
6218,KEGG_2019_Human,Influenza A,1/171,0.0085499075557634,0.0145586837375733,0,0,19829.0,94422.42241345016,IFNA6
6219,KEGG_2019_Human,NOD-like receptor signaling pathway,1/178,0.0088999053857096,0.0145586837375733,0,0,19822.0,93593.82745769851,IFNA6
6220,KEGG_2019_Human,Tuberculosis,1/179,0.0089499050800561,0.0145586837375733,0,0,19821.0,93478.0629355712,IFNA6
6221,KEGG_2019_Human,Kaposi sarcoma-associated herpesvirus infection,1/186,0.0092999029651357,0.0145586837375733,0,0,19814.0,92684.96451050608,IFNA6
6222,KEGG_2019_Human,Epstein-Barr virus infection,1/201,0.0100498985877989,0.0145586837375733,0,0,19799.0,91079.21596609056,IFNA6
6223,KEGG_2019_Human,Human immunodeficiency virus 1 infection,1/212,0.0105998955026255,0.0145586837375733,0,0,19788.0,89974.27756224656,IFNA6
6224,KEGG_2019_Human,Human cytomegalovirus infection,1/225,0.0112498919790339,0.0145586837375733,0,0,19775.0,88738.27077557483,IFNA6
6225,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0179665141039676,0,0,19706.0,83157.67014793828,IFNA6
6226,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0191051096893273,0,0,19670.0,80733.60565076157,IFNA6
6227,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0194698489055035,0,0,19646.0,79255.8617626126,IFNA6
6228,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0257712598834163,0,0,19508.0,72277.44006442746,IFNA6
6229,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,IFNA6
6230,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF630
6231,KEGG_2019_Human,mTOR signaling pathway,1/152,0.0075999137114971,0.0075999137114971,0,0,19848.0,96850.665715497,DEPDC5
6232,KEGG_2019_Human,Regulation of actin cytoskeleton,1/214,0.0106998949514067,0.0106998949514067,0,0,19786.0,89779.39753374986,ITGAE
6233,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF33B
6234,KEGG_2019_Human,Ribosome,1/153,0.0076499133771537,0.0076499133771537,0,0,19847.0,96715.6407630817,RPS15A
6235,KEGG_2019_Human,Huntington disease,1/193,0.0096499008972596,0.0096499008972596,0,0,19807.0,91920.47679471428,DNAH3
6236,KEGG_2019_Human,Amyotrophic lateral sclerosis (ALS),1/51,0.0025499566390179,0.0086248678095925,0,0,19949.0,119129.0228601236,TNFRSF1B
6237,KEGG_2019_Human,Adipocytokine signaling pathway,1/69,0.003449947123837,0.0086248678095925,0,0,19931.0,112996.7391397682,TNFRSF1B
6238,KEGG_2019_Human,TNF signaling pathway,1/110,0.0054999290027479,0.0091665483379131,0,0,19890.0,103488.06969787036,TNFRSF1B
6239,KEGG_2019_Human,Human immunodeficiency virus 1 infection,1/212,0.0105998955026255,0.0132498693782819,0,0,19788.0,89974.27756224656,TNFRSF1B
6240,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0146998751759735,0,0,19706.0,83157.67014793828,TNFRSF1B
6241,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF7
6242,KEGG_2019_Human,Synaptic vesicle cycle,1/78,0.0038999427840466,0.0038999427840466,0,0,19922.0,110503.2180492851,SLC6A7
6243,KEGG_2019_Human,Adipocytokine signaling pathway,1/69,0.003449947123837,0.0097141804220369,0,0,19931.0,112996.7391397682,STK11
6244,KEGG_2019_Human,Longevity regulating pathway,1/102,0.0050999322416682,0.0097141804220369,0,0,19898.0,105032.15064717118,STK11
6245,KEGG_2019_Human,AMPK signaling pathway,1/120,0.0059999251180858,0.0097141804220369,0,0,19880.0,101706.2448082016,STK11
6246,KEGG_2019_Human,Autophagy,1/128,0.0063999221281459,0.0097141804220369,0,0,19872.0,100382.8010329652,STK11
6247,KEGG_2019_Human,FoxO signaling pathway,1/132,0.0065999206698993,0.0097141804220369,0,0,19868.0,99751.22090491928,STK11
6248,KEGG_2019_Human,mTOR signaling pathway,1/152,0.0075999137114971,0.0097141804220369,0,0,19848.0,96850.665715497,STK11
6249,KEGG_2019_Human,Tight junction,1/170,0.0084999078692823,0.0097141804220369,0,0,19830.0,94543.49009679438,STK11
6250,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0176998626413668,0,0,19646.0,79255.8617626126,STK11
6251,KEGG_2019_Human,African trypanosomiasis,1/37,0.0018499650702878,0.0095734215854827,0,0,19963.0,125618.9446446357,GNAQ
6252,KEGG_2019_Human,Endocrine and other factor-regulated calcium reabsorption,1/48,0.0023999583567988,0.0095734215854827,0,0,19952.0,120356.5272753826,GNAQ
6253,KEGG_2019_Human,Long-term depression,1/60,0.002999951725986,0.0095734215854827,0,0,19940.0,115834.63209072244,GNAQ
6254,KEGG_2019_Human,Cortisol synthesis and secretion,1/65,0.003249949134407,0.0095734215854827,0,0,19935.0,114209.92613860144,GNAQ
6255,KEGG_2019_Human,Long-term potentiation,1/67,0.0033499481224912,0.0095734215854827,0,0,19933.0,113594.38808369274,GNAQ
6256,KEGG_2019_Human,Renin secretion,1/69,0.003449947123837,0.0095734215854827,0,0,19931.0,112996.7391397682,GNAQ
6257,KEGG_2019_Human,Thyroid hormone synthesis,1/74,0.0036999446830449,0.0095734215854827,0,0,19926.0,111574.38983110404,GNAQ
6258,KEGG_2019_Human,Gastric acid secretion,1/75,0.0037499442041125,0.0095734215854827,0,0,19925.0,111301.33528642564,GNAQ
6259,KEGG_2019_Human,Insulin secretion,1/86,0.0042999391173866,0.0095734215854827,0,0,19914.0,108514.46102290176,GNAQ
6260,KEGG_2019_Human,Gap junction,1/88,0.0043999382262822,0.0095734215854827,0,0,19912.0,108045.79305232369,GNAQ
6261,KEGG_2019_Human,Salivary secretion,1/90,0.0044999373439762,0.0095734215854827,0,0,19910.0,107587.50385474482,GNAQ
6262,KEGG_2019_Human,GnRH signaling pathway,1/93,0.0046499360391879,0.0095734215854827,0,0,19907.0,106918.54242106884,GNAQ
6263,KEGG_2019_Human,Amoebiasis,1/96,0.0047999347538706,0.0095734215854827,0,0,19904.0,106270.50039849174,GNAQ
6264,KEGG_2019_Human,Circadian entrainment,1/97,0.0048499343304706,0.0095734215854827,0,0,19903.0,106058.9096435903,GNAQ
6265,KEGG_2019_Human,Pancreatic secretion,1/98,0.0048999339081079,0.0095734215854827,0,0,19902.0,105849.45495286948,GNAQ
6266,KEGG_2019_Human,Aldosterone synthesis and secretion,1/98,0.0048999339081079,0.0095734215854827,0,0,19902.0,105849.45495286948,GNAQ
6267,KEGG_2019_Human,Inflammatory mediator regulation of TRP channels,1/100,0.0049999330710556,0.0095734215854827,0,0,19900.0,105436.78197328727,GNAQ
6268,KEGG_2019_Human,Melanogenesis,1/101,0.0050499326546803,0.0095734215854827,0,0,19899.0,105233.48101229242,GNAQ
6269,KEGG_2019_Human,Glucagon signaling pathway,1/103,0.0051499318302617,0.0095734215854827,0,0,19897.0,104832.7525292024,GNAQ
6270,KEGG_2019_Human,Chagas disease (American trypanosomiasis),1/103,0.0051499318302617,0.0095734215854827,0,0,19897.0,104832.7525292024,GNAQ
6271,KEGG_2019_Human,"Parathyroid hormone synthesis, secretion and action",1/106,0.0052999306076525,0.0095734215854827,0,0,19894.0,104245.78450366124,GNAQ
6272,KEGG_2019_Human,Cholinergic synapse,1/112,0.0055999282120529,0.0095734215854827,0,0,19888.0,103119.30984392198,GNAQ
6273,KEGG_2019_Human,Serotonergic synapse,1/113,0.0056499278191151,0.0095734215854827,0,0,19887.0,102937.34947211576,GNAQ
6274,KEGG_2019_Human,Glutamatergic synapse,1/114,0.005699927427839,0.0095734215854827,0,0,19886.0,102756.96431429044,GNAQ
6275,KEGG_2019_Human,Sphingolipid signaling pathway,1/119,0.0059499254985137,0.0095734215854827,0,0,19881.0,101877.73080211312,GNAQ
6276,KEGG_2019_Human,Platelet activation,1/124,0.0061999236097501,0.0095734215854827,0,0,19876.0,101034.04709010696,GNAQ
6277,KEGG_2019_Human,Dopaminergic synapse,1/131,0.0065499210316603,0.0095734215854827,0,0,19869.0,99907.33811343512,GNAQ
6278,KEGG_2019_Human,Vascular smooth muscle contraction,1/132,0.0065999206698993,0.0095734215854827,0,0,19868.0,99751.22090491928,GNAQ
6279,KEGG_2019_Human,Estrogen signaling pathway,1/137,0.0068499188797651,0.0095734215854827,0,0,19863.0,98987.62735269018,GNAQ
6280,KEGG_2019_Human,Apelin signaling pathway,1/137,0.0068499188797651,0.0095734215854827,0,0,19863.0,98987.62735269018,GNAQ
6281,KEGG_2019_Human,Adrenergic signaling in cardiomyocytes,1/145,0.0072499160871101,0.0095734215854827,0,0,19855.0,97820.92670675044,GNAQ
6282,KEGG_2019_Human,Retrograde endocannabinoid signaling,1/148,0.007399915061391,0.0095734215854827,0,0,19852.0,97399.60470052566,GNAQ
6283,KEGG_2019_Human,Oxytocin signaling pathway,1/153,0.0076499133771537,0.0095734215854827,0,0,19847.0,96715.6407630817,GNAQ
6284,KEGG_2019_Human,Cushing syndrome,1/155,0.0077499127120574,0.0095734215854827,0,0,19845.0,96448.16254952336,GNAQ
6285,KEGG_2019_Human,cGMP-PKG signaling pathway,1/166,0.0082999091363732,0.0099598909636479,0,0,19834.0,95034.82345515196,GNAQ
6286,KEGG_2019_Human,Alzheimer disease,1/171,0.0085499075557634,0.0099748921483906,0,0,19829.0,94422.42241345016,GNAQ
6287,KEGG_2019_Human,Calcium signaling pathway,1/188,0.009399902370135,0.0106656799390764,0,0,19812.0,92463.712994847,GNAQ
6288,KEGG_2019_Human,Huntington disease,1/193,0.0096499008972596,0.0106656799390764,0,0,19807.0,91920.47679471428,GNAQ
6289,KEGG_2019_Human,Rap1 signaling pathway,1/206,0.010299897173561,0.0110921969561426,0,0,19794.0,90569.849337325,GNAQ
6290,KEGG_2019_Human,Human immunodeficiency virus 1 infection,1/212,0.0105998955026255,0.0111298902777568,0,0,19788.0,89974.27756224656,GNAQ
6291,KEGG_2019_Human,Human cytomegalovirus infection,1/225,0.0112498919790339,0.0115242795882786,0,0,19775.0,88738.27077557483,GNAQ
6292,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,GNAQ
6293,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR5D14
6294,KEGG_2019_Human,Acute myeloid leukemia,1/66,0.003299948626608,0.0106998604053851,0,0,19934.0,113899.85357353876,STAT5B
6295,KEGG_2019_Human,Non-small cell lung cancer,1/66,0.003299948626608,0.0106998604053851,0,0,19934.0,113899.85357353876,STAT5B
6296,KEGG_2019_Human,Prolactin signaling pathway,1/70,0.0034999466296654,0.0106998604053851,0,0,19930.0,112704.30065625212,STAT5B
6297,KEGG_2019_Human,Chronic myeloid leukemia,1/76,0.0037999437281752,0.0106998604053851,0,0,19924.0,111031.8499691117,STAT5B
6298,KEGG_2019_Human,ErbB signaling pathway,1/85,0.004249939567045,0.0106998604053851,0,0,19915.0,108752.83801948265,STAT5B
6299,KEGG_2019_Human,Th1 and Th2 cell differentiation,1/92,0.0045999364719865,0.0106998604053851,0,0,19908.0,107139.13814408927,STAT5B
6300,KEGG_2019_Human,AGE-RAGE signaling pathway in diabetic complications,1/100,0.0049999330710556,0.0106998604053851,0,0,19900.0,105436.78197328727,STAT5B
6301,KEGG_2019_Human,Th17 cell differentiation,1/107,0.0053499302026925,0.0106998604053851,0,0,19893.0,104053.753408911,STAT5B
6302,KEGG_2019_Human,Measles,1/138,0.0068999185254481,0.0108665467971557,0,0,19862.0,98838.19160389496,STAT5B
6303,KEGG_2019_Human,Necroptosis,1/162,0.0080999104202618,0.0108665467971557,0,0,19838.0,95537.86936302872,STAT5B
6304,KEGG_2019_Human,JAK-STAT signaling pathway,1/162,0.0080999104202618,0.0108665467971557,0,0,19838.0,95537.86936302872,STAT5B
6305,KEGG_2019_Human,Hepatitis B,1/163,0.0081499100978668,0.0108665467971557,0,0,19837.0,95410.9786681514,STAT5B
6306,KEGG_2019_Human,Chemokine signaling pathway,1/190,0.0094999017791995,0.0114855983860559,0,0,19810.0,92244.74636351672,STAT5B
6307,KEGG_2019_Human,Viral carcinogenesis,1/201,0.0100498985877989,0.0114855983860559,0,0,19799.0,91079.21596609056,STAT5B
6308,KEGG_2019_Human,Human T-cell leukemia virus 1 infection,1/219,0.0109498935894162,0.0116798864953773,0,0,19781.0,89299.85161916987,STAT5B
6309,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,STAT5B
6310,KEGG_2019_Human,Spliceosome,1/134,0.0066999199497742,0.0066999199497742,0,0,19866.0,99442.43560916925,SART1
6311,KEGG_2019_Human,Shigellosis,1/65,0.003249949134407,0.0064998982688141,0,0,19935.0,114209.92613860144,U2AF1
6312,KEGG_2019_Human,Spliceosome,1/134,0.0066999199497742,0.0066999199497742,0,0,19866.0,99442.43560916925,U2AF1
6313,KEGG_2019_Human,Cholesterol metabolism,1/50,0.0024999572069037,0.0024999572069037,0,0,19950.0,119530.05920663515,VAPB
6314,KEGG_2019_Human,Pertussis,1/76,0.0037999437281752,0.0075998874563505,0,0,19924.0,111031.8499691117,SFTPA2
6315,KEGG_2019_Human,Phagosome,1/152,0.0075999137114971,0.0075999137114971,0,0,19848.0,96850.665715497,SFTPA2
6316,KEGG_2019_Human,Notch signaling pathway,1/48,0.0023999583567988,0.0099271645922203,0,0,19952.0,120356.5272753826,DVL1
6317,KEGG_2019_Human,Basal cell carcinoma,1/63,0.0031499501598827,0.0099271645922203,0,0,19937.0,114844.46974572667,DVL1
6318,KEGG_2019_Human,Melanogenesis,1/101,0.0050499326546803,0.0099271645922203,0,0,19899.0,105233.48101229242,DVL1
6319,KEGG_2019_Human,Signaling pathways regulating pluripotency of stem cells,1/139,0.006949918172816,0.0099271645922203,0,0,19861.0,98689.81333375497,DVL1
6320,KEGG_2019_Human,Breast cancer,1/147,0.0073499154017982,0.0099271645922203,0,0,19853.0,97539.10874372096,DVL1
6321,KEGG_2019_Human,Gastric cancer,1/149,0.0074499147221605,0.0099271645922203,0,0,19851.0,97261.02051561224,DVL1
6322,KEGG_2019_Human,mTOR signaling pathway,1/152,0.0075999137114971,0.0099271645922203,0,0,19848.0,96850.665715497,DVL1
6323,KEGG_2019_Human,Cushing syndrome,1/155,0.0077499127120574,0.0099271645922203,0,0,19845.0,96448.16254952336,DVL1
6324,KEGG_2019_Human,Wnt signaling pathway,1/158,0.0078999117225733,0.0099271645922203,0,0,19842.0,96053.2110949472,DVL1
6325,KEGG_2019_Human,Hippo signaling pathway,1/160,0.0079999110688441,0.0099271645922203,0,0,19840.0,95793.96509856998,DVL1
6326,KEGG_2019_Human,Hepatocellular carcinoma,1/168,0.0083999085011095,0.0099271645922203,0,0,19832.0,94787.72752807094,DVL1
6327,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0178748564138782,0,0,19670.0,80733.60565076157,DVL1
6328,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,DVL1
6329,KEGG_2019_Human,RNA degradation,1/79,0.0039499423167337,0.0068249053608048,0,0,19921.0,110243.89578070649,PABPC1L
6330,KEGG_2019_Human,mRNA surveillance pathway,1/91,0.0045499369072032,0.0068249053608048,0,0,19909.0,107362.10783923086,PABPC1L
6331,KEGG_2019_Human,RNA transport,1/165,0.0082499094553477,0.0082499094553477,0,0,19835.0,95159.46482222488,PABPC1L
6332,KEGG_2019_Human,Thyroid hormone signaling pathway,1/116,0.0057999266512085,0.0115998533024171,0,0,19884.0,102400.8105961506,THRA
6333,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,THRA
6334,KEGG_2019_Human,Protein digestion and absorption,1/90,0.0044999373439762,0.0097998678162159,0,0,19910.0,107587.50385474482,PRSS1
6335,KEGG_2019_Human,Pancreatic secretion,1/98,0.0048999339081079,0.0097998678162159,0,0,19902.0,105849.45495286948,PRSS1
6336,KEGG_2019_Human,Influenza A,1/171,0.0085499075557634,0.0113998767410179,0,0,19829.0,94422.42241345016,PRSS1
6337,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,PRSS1
6338,KEGG_2019_Human,Ribosome,1/153,0.0076499133771537,0.0076499133771537,0,0,19847.0,96715.6407630817,RPLP2
6339,KEGG_2019_Human,Amino sugar and nucleotide sugar metabolism,1/48,0.0023999583567988,0.0023999583567988,0,0,19952.0,120356.5272753826,NANS
6340,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,TAC4
6341,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0147498749536506,0,0,19705.0,83086.53988020132,TAOK2
6342,KEGG_2019_Human,Retrograde endocannabinoid signaling,1/148,0.007399915061391,0.007399915061391,0,0,19852.0,97399.60470052566,NAPEPLD
6343,KEGG_2019_Human,Prolactin signaling pathway,1/70,0.0034999466296654,0.0174997331483271,0,0,19930.0,112704.30065625212,PRL
6344,KEGG_2019_Human,JAK-STAT signaling pathway,1/162,0.0080999104202618,0.0176998626413668,0,0,19838.0,95537.86936302872,PRL
6345,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0176998626413668,0,0,19706.0,83157.67014793828,PRL
6346,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0176998626413668,0,0,19662.0,80229.79996326564,PRL
6347,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0176998626413668,0,0,19646.0,79255.8617626126,PRL
6348,KEGG_2019_Human,Asthma,1/31,0.0015499690656704,0.0015499690656704,0,0,19969.0,129189.85098816035,EPX
6349,KEGG_2019_Human,Mineral absorption,1/51,0.0025499566390179,0.0050999132780359,0,0,19949.0,119129.0228601236,SLC34A2
6350,KEGG_2019_Human,"Parathyroid hormone synthesis, secretion and action",1/106,0.0052999306076525,0.0052999306076525,0,0,19894.0,104245.78450366124,SLC34A2
6351,KEGG_2019_Human,Vitamin B6 metabolism,1/6,0.0002999905873105514,0.0023999246984844,0,0,19994.0,162186.51863187927,AOX1
6352,KEGG_2019_Human,Nicotinate and nicotinamide metabolism,1/30,0.0014999697593334,0.0038399333708781,0,0,19970.0,129851.13732048514,AOX1
6353,KEGG_2019_Human,Tyrosine metabolism,1/36,0.0017999657178272,0.0038399333708781,0,0,19964.0,126172.23364250171,AOX1
6354,KEGG_2019_Human,Tryptophan metabolism,1/42,0.0020999619311272,0.0038399333708781,0,0,19958.0,123057.75613441122,AOX1
6355,KEGG_2019_Human,"Valine, leucine and isoleucine degradation",1/48,0.0023999583567988,0.0038399333708781,0,0,19952.0,120356.5272753826,AOX1
6356,KEGG_2019_Human,Retinol metabolism,1/67,0.0033499481224912,0.0044665974966549,0,0,19933.0,113594.38808369274,AOX1
6357,KEGG_2019_Human,Drug metabolism,1/108,0.0053999298011749,0.0061713483441999,0,0,19892.0,103863.47861844616,AOX1
6358,KEGG_2019_Human,JAK-STAT signaling pathway,1/162,0.0080999104202618,0.0080999104202618,0,0,19838.0,95537.86936302872,AOX1
6359,KEGG_2019_Human,Cell cycle,1/124,0.0061999236097501,0.0150748478816984,0,0,19876.0,101034.04709010696,RBL2
6360,KEGG_2019_Human,FoxO signaling pathway,1/132,0.0065999206698993,0.0150748478816984,0,0,19868.0,99751.22090491928,RBL2
6361,KEGG_2019_Human,Cellular senescence,1/160,0.0079999110688441,0.0150748478816984,0,0,19840.0,95793.96509856998,RBL2
6362,KEGG_2019_Human,Viral carcinogenesis,1/201,0.0100498985877989,0.0150748478816984,0,0,19799.0,91079.21596609056,RBL2
6363,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0176998626413668,0,0,19670.0,80733.60565076157,RBL2
6364,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0176998626413668,0,0,19646.0,79255.8617626126,RBL2
6365,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,HCFC2
6366,KEGG_2019_Human,Ubiquitin mediated proteolysis,1/137,0.0068499188797651,0.0111998780014793,0,0,19863.0,98987.62735269018,KEAP1
6367,KEGG_2019_Human,Fluid shear stress and atherosclerosis,1/139,0.006949918172816,0.0111998780014793,0,0,19861.0,98689.81333375497,KEAP1
6368,KEGG_2019_Human,Hepatocellular carcinoma,1/168,0.0083999085011095,0.0111998780014793,0,0,19832.0,94787.72752807094,KEAP1
6369,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,KEAP1
6370,KEGG_2019_Human,Cytosolic DNA-sensing pathway,1/63,0.0031499501598827,0.0113998767410179,0,0,19937.0,114844.46974572667,IL33
6371,KEGG_2019_Human,Necroptosis,1/162,0.0080999104202618,0.0113998767410179,0,0,19838.0,95537.86936302872,IL33
6372,KEGG_2019_Human,Influenza A,1/171,0.0085499075557634,0.0113998767410179,0,0,19829.0,94422.42241345016,IL33
6373,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0146998751759735,0,0,19706.0,83157.67014793828,IL33
6374,KEGG_2019_Human,Notch signaling pathway,1/48,0.0023999583567988,0.0091998729439731,0,0,19952.0,120356.5272753826,DLL3
6375,KEGG_2019_Human,Th1 and Th2 cell differentiation,1/92,0.0045999364719865,0.0091998729439731,0,0,19908.0,107139.13814408927,DLL3
6376,KEGG_2019_Human,Breast cancer,1/147,0.0073499154017982,0.0097998872023976,0,0,19853.0,97539.10874372096,DLL3
6377,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,DLL3
6378,KEGG_2019_Human,Regulation of lipolysis in adipocytes,1/55,0.0027499544131125,0.0082498632393376,0,0,19945.0,117599.1294878737,NPY1R
6379,KEGG_2019_Human,cAMP signaling pathway,1/212,0.0105998955026255,0.0158998432539383,0,0,19788.0,89974.27756224656,NPY1R
6380,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,NPY1R
6381,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR10R2
6382,KEGG_2019_Human,Hedgehog signaling pathway,1/47,0.0023499589392381,0.011399854855678,0,0,19953.0,120782.64067395544,GRK3
6383,KEGG_2019_Human,Morphine addiction,1/91,0.0045499369072032,0.011399854855678,0,0,19909.0,107362.10783923086,GRK3
6384,KEGG_2019_Human,Glutamatergic synapse,1/114,0.005699927427839,0.011399854855678,0,0,19886.0,102756.96431429044,GRK3
6385,KEGG_2019_Human,Chemokine signaling pathway,1/190,0.0094999017791995,0.0142498526687993,0,0,19810.0,92244.74636351672,GRK3
6386,KEGG_2019_Human,Endocytosis,1/244,0.0121998870519305,0.0146398644623166,0,0,19756.0,87051.4275316661,GRK3
6387,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,GRK3
6388,KEGG_2019_Human,N-Glycan biosynthesis,1/50,0.0024999572069037,0.0024999572069037,0,0,19950.0,119530.05920663515,ALG6
6389,KEGG_2019_Human,RNA degradation,1/79,0.0039499423167337,0.0039499423167337,0,0,19921.0,110243.89578070649,DIS3L
6390,KEGG_2019_Human,Ras signaling pathway,1/232,0.0115998901349604,0.0115998901349604,0,0,19768.0,88101.22480150245,RASAL1
6391,KEGG_2019_Human,Notch signaling pathway,1/48,0.0023999583567988,0.0091998729439731,0,0,19952.0,120356.5272753826,DLL1
6392,KEGG_2019_Human,Th1 and Th2 cell differentiation,1/92,0.0045999364719865,0.0091998729439731,0,0,19908.0,107139.13814408927,DLL1
6393,KEGG_2019_Human,Breast cancer,1/147,0.0073499154017982,0.0097998872023976,0,0,19853.0,97539.10874372096,DLL1
6394,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,DLL1
6395,KEGG_2019_Human,Bladder cancer,1/41,0.0020499625466866,0.0089356090793349,0,0,19959.0,123544.88783416104,MMP2
6396,KEGG_2019_Human,GnRH signaling pathway,1/93,0.0046499360391879,0.0089356090793349,0,0,19907.0,106918.54242106884,MMP2
6397,KEGG_2019_Human,AGE-RAGE signaling pathway in diabetic complications,1/100,0.0049999330710556,0.0089356090793349,0,0,19900.0,105436.78197328727,MMP2
6398,KEGG_2019_Human,Leukocyte transendothelial migration,1/112,0.0055999282120529,0.0089356090793349,0,0,19888.0,103119.30984392198,MMP2
6399,KEGG_2019_Human,Relaxin signaling pathway,1/130,0.0064999213952527,0.0089356090793349,0,0,19870.0,100064.62842845908,MMP2
6400,KEGG_2019_Human,Estrogen signaling pathway,1/137,0.0068499188797651,0.0089356090793349,0,0,19863.0,98987.62735269018,MMP2
6401,KEGG_2019_Human,Fluid shear stress and atherosclerosis,1/139,0.006949918172816,0.0089356090793349,0,0,19861.0,98689.81333375497,MMP2
6402,KEGG_2019_Human,Proteoglycans in cancer,1/201,0.0100498985877989,0.0113061359112738,0,0,19799.0,91079.21596609056,MMP2
6403,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,MMP2
6404,KEGG_2019_Human,Pyrimidine metabolism,1/57,0.002849953326298,0.002849953326298,0,0,19943.0,116875.00742975442,CMPK2
6405,KEGG_2019_Human,Taste transduction,1/83,0.0041499404726918,0.0041499404726918,0,0,19917.0,109237.99888847338,TAS2R42
6406,KEGG_2019_Human,RIG-I-like receptor signaling pathway,1/70,0.0034999466296654,0.0123691059542141,0,0,19930.0,112704.30065625212,TRAF3
6407,KEGG_2019_Human,IL-17 signaling pathway,1/93,0.0046499360391879,0.0123691059542141,0,0,19907.0,106918.54242106884,TRAF3
6408,KEGG_2019_Human,Small cell lung cancer,1/93,0.0046499360391879,0.0123691059542141,0,0,19907.0,106918.54242106884,TRAF3
6409,KEGG_2019_Human,NF-kappa B signaling pathway,1/95,0.0047499351803394,0.0123691059542141,0,0,19905.0,106484.27183626965,TRAF3
6410,KEGG_2019_Human,Toll-like receptor signaling pathway,1/104,0.0051999314202997,0.0123691059542141,0,0,19896.0,104635.24941415618,TRAF3
6411,KEGG_2019_Human,TNF signaling pathway,1/110,0.0054999290027479,0.0123691059542141,0,0,19890.0,103488.06969787036,TRAF3
6412,KEGG_2019_Human,Measles,1/138,0.0068999185254481,0.0123691059542141,0,0,19862.0,98838.19160389496,TRAF3
6413,KEGG_2019_Human,Hepatitis C,1/155,0.0077499127120574,0.0123691059542141,0,0,19845.0,96448.16254952336,TRAF3
6414,KEGG_2019_Human,Hepatitis B,1/163,0.0081499100978668,0.0123691059542141,0,0,19837.0,95410.9786681514,TRAF3
6415,KEGG_2019_Human,NOD-like receptor signaling pathway,1/178,0.0088999053857096,0.0123691059542141,0,0,19822.0,93593.82745769851,TRAF3
6416,KEGG_2019_Human,Kaposi sarcoma-associated herpesvirus infection,1/186,0.0092999029651357,0.0123691059542141,0,0,19814.0,92684.96451050608,TRAF3
6417,KEGG_2019_Human,Viral carcinogenesis,1/201,0.0100498985877989,0.0123691059542141,0,0,19799.0,91079.21596609056,TRAF3
6418,KEGG_2019_Human,Epstein-Barr virus infection,1/201,0.0100498985877989,0.0123691059542141,0,0,19799.0,91079.21596609056,TRAF3
6419,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0188569913816737,0,0,19670.0,80733.60565076157,TRAF3
6420,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.026239828244933,0,0,19508.0,72277.44006442746,TRAF3
6421,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,TRAF3
6422,KEGG_2019_Human,Axon guidance,1/181,0.0090499044707863,0.0090499044707863,0,0,19819.0,93248.41634586031,EPHA8
6423,KEGG_2019_Human,Base excision repair,1/33,0.0016499677032113,0.0049499031096341,0,0,19967.0,127928.56031580272,PARP2
6424,KEGG_2019_Human,Apoptosis,1/143,0.0071499167770442,0.0080999104202618,0,0,19857.0,98106.57763600958,PARP2
6425,KEGG_2019_Human,Necroptosis,1/162,0.0080999104202618,0.0080999104202618,0,0,19838.0,95537.86936302872,PARP2
6426,KEGG_2019_Human,Salmonella infection,1/86,0.0042999391173866,0.0133998647837319,0,0,19914.0,108514.46102290176,FLNC
6427,KEGG_2019_Human,Focal adhesion,1/199,0.0099498991610159,0.0133998647837319,0,0,19801.0,91286.4288690606,FLNC
6428,KEGG_2019_Human,Proteoglycans in cancer,1/201,0.0100498985877989,0.0133998647837319,0,0,19799.0,91079.21596609056,FLNC
6429,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0147498749536506,0,0,19705.0,83086.53988020132,FLNC
6430,KEGG_2019_Human,Transcriptional misregulation in cancer,1/186,0.0092999029651357,0.0092999029651357,0,0,19814.0,92684.96451050608,PAX5
6431,KEGG_2019_Human,RNA polymerase,1/31,0.0015499690656704,0.0030999381313408,0,0,19969.0,129189.85098816035,POLR3C
6432,KEGG_2019_Human,Cytosolic DNA-sensing pathway,1/63,0.0031499501598827,0.0031499501598827,0,0,19937.0,114844.46974572667,POLR3C
6433,KEGG_2019_Human,Platelet activation,1/124,0.0061999236097501,0.0061999236097501,0,0,19876.0,101034.04709010696,FERMT3
6434,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZFP69
6435,KEGG_2019_Human,Thyroid hormone synthesis,1/74,0.0036999446830449,0.0036999446830449,0,0,19926.0,111574.38983110404,ASGR2
6436,KEGG_2019_Human,Sphingolipid metabolism,1/47,0.0023499589392381,0.0023499589392381,0,0,19953.0,120782.64067395544,SMPD3
6437,KEGG_2019_Human,Ras signaling pathway,1/232,0.0115998901349604,0.0115998901349604,0,0,19768.0,88101.22480150245,EXOC2
6438,KEGG_2019_Human,Antigen processing and presentation,1/77,0.0038499432547502,0.0134998703748406,0,0,19923.0,110765.8407373636,B2M
6439,KEGG_2019_Human,Epstein-Barr virus infection,1/201,0.0100498985877989,0.0134998703748406,0,0,19799.0,91079.21596609056,B2M
6440,KEGG_2019_Human,Human immunodeficiency virus 1 infection,1/212,0.0105998955026255,0.0134998703748406,0,0,19788.0,89974.27756224656,B2M
6441,KEGG_2019_Human,Human T-cell leukemia virus 1 infection,1/219,0.0109498935894162,0.0134998703748406,0,0,19781.0,89299.85161916987,B2M
6442,KEGG_2019_Human,Human cytomegalovirus infection,1/225,0.0112498919790339,0.0134998703748406,0,0,19775.0,88738.27077557483,B2M
6443,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,B2M
6444,KEGG_2019_Human,Steroid biosynthesis,1/19,0.00094997806231055,0.0018999561246211,0,0,19981.0,139049.2109571672,SOAT2
6445,KEGG_2019_Human,Cholesterol metabolism,1/50,0.0024999572069037,0.0024999572069037,0,0,19950.0,119530.05920663515,SOAT2
6446,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR13C9
6447,KEGG_2019_Human,Antigen processing and presentation,1/77,0.0038499432547502,0.0076998865095004,0,0,19923.0,110765.8407373636,NFYC
6448,KEGG_2019_Human,Tuberculosis,1/179,0.0089499050800561,0.0089499050800561,0,0,19821.0,93478.0629355712,NFYC
6449,KEGG_2019_Human,Choline metabolism in cancer,1/99,0.0049499334884068,0.0049499334884068,0,0,19901.0,105642.09305076736,SLC44A2
6450,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR5H6
6451,KEGG_2019_Human,Glutamatergic synapse,1/114,0.005699927427839,0.005699927427839,0,0,19886.0,102756.96431429044,SHANK3
6452,KEGG_2019_Human,RNA degradation,1/79,0.0039499423167337,0.0039499423167337,0,0,19921.0,110243.89578070649,TENT4B
6453,KEGG_2019_Human,Inflammatory bowel disease (IBD),1/65,0.003249949134407,0.0108677418829253,0,0,19935.0,114209.92613860144,IFNGR2
6454,KEGG_2019_Human,Leishmaniasis,1/74,0.0036999446830449,0.0108677418829253,0,0,19926.0,111574.38983110404,IFNGR2
6455,KEGG_2019_Human,Salmonella infection,1/86,0.0042999391173866,0.0108677418829253,0,0,19914.0,108514.46102290176,IFNGR2
6456,KEGG_2019_Human,Th1 and Th2 cell differentiation,1/92,0.0045999364719865,0.0108677418829253,0,0,19908.0,107139.13814408927,IFNGR2
6457,KEGG_2019_Human,HIF-1 signaling pathway,1/100,0.0049999330710556,0.0108677418829253,0,0,19900.0,105436.78197328727,IFNGR2
6458,KEGG_2019_Human,Chagas disease (American trypanosomiasis),1/103,0.0051499318302617,0.0108677418829253,0,0,19897.0,104832.7525292024,IFNGR2
6459,KEGG_2019_Human,Th17 cell differentiation,1/107,0.0053499302026925,0.0108677418829253,0,0,19893.0,104053.753408911,IFNGR2
6460,KEGG_2019_Human,Toxoplasmosis,1/113,0.0056499278191151,0.0108677418829253,0,0,19887.0,102937.34947211576,IFNGR2
6461,KEGG_2019_Human,Osteoclast differentiation,1/127,0.0063499224962247,0.0108677418829253,0,0,19873.0,100543.72072014232,IFNGR2
6462,KEGG_2019_Human,Natural killer cell mediated cytotoxicity,1/131,0.0065499210316603,0.0108677418829253,0,0,19869.0,99907.33811343512,IFNGR2
6463,KEGG_2019_Human,Necroptosis,1/162,0.0080999104202618,0.0108677418829253,0,0,19838.0,95537.86936302872,IFNGR2
6464,KEGG_2019_Human,JAK-STAT signaling pathway,1/162,0.0080999104202618,0.0108677418829253,0,0,19838.0,95537.86936302872,IFNGR2
6465,KEGG_2019_Human,Influenza A,1/171,0.0085499075557634,0.0108677418829253,0,0,19829.0,94422.42241345016,IFNGR2
6466,KEGG_2019_Human,Tuberculosis,1/179,0.0089499050800561,0.0108677418829253,0,0,19821.0,93478.0629355712,IFNGR2
6467,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0166598585327699,0,0,19706.0,83157.67014793828,IFNGR2
6468,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0261373289158512,0,0,19508.0,72277.44006442746,IFNGR2
6469,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,IFNGR2
6470,KEGG_2019_Human,Circadian rhythm,1/31,0.0015499690656704,0.0015499690656704,0,0,19969.0,129189.85098816035,BHLHE41
6471,KEGG_2019_Human,SNARE interactions in vesicular transport,1/34,0.0016999670339032,0.0016999670339032,0,0,19966.0,127326.1054203148,USE1
6472,KEGG_2019_Human,RNA degradation,1/79,0.0039499423167337,0.0039499423167337,0,0,19921.0,110243.89578070649,TENT4A
6473,KEGG_2019_Human,Nicotine addiction,1/40,0.0019999631680592,0.0067998952432378,0,0,19960.0,124043.94523066044,GRIA2
6474,KEGG_2019_Human,Cocaine addiction,1/49,0.0024499577795033,0.0067998952432378,0,0,19951.0,119939.1172087114,GRIA2
6475,KEGG_2019_Human,Amyotrophic lateral sclerosis (ALS),1/51,0.0025499566390179,0.0067998952432378,0,0,19949.0,119129.0228601236,GRIA2
6476,KEGG_2019_Human,Long-term depression,1/60,0.002999951725986,0.0067998952432378,0,0,19940.0,115834.63209072244,GRIA2
6477,KEGG_2019_Human,Long-term potentiation,1/67,0.0033499481224912,0.0067998952432378,0,0,19933.0,113594.38808369274,GRIA2
6478,KEGG_2019_Human,Amphetamine addiction,1/68,0.0033999476216189,0.0067998952432378,0,0,19932.0,113293.39338050144,GRIA2
6479,KEGG_2019_Human,Circadian entrainment,1/97,0.0048499343304706,0.0083141731379497,0,0,19903.0,106058.9096435903,GRIA2
6480,KEGG_2019_Human,Glutamatergic synapse,1/114,0.005699927427839,0.0085498911417585,0,0,19886.0,102756.96431429044,GRIA2
6481,KEGG_2019_Human,Dopaminergic synapse,1/131,0.0065499210316603,0.0087332280422137,0,0,19869.0,99907.33811343512,GRIA2
6482,KEGG_2019_Human,Retrograde endocannabinoid signaling,1/148,0.007399915061391,0.0088798980736692,0,0,19852.0,97399.60470052566,GRIA2
6483,KEGG_2019_Human,cAMP signaling pathway,1/212,0.0105998955026255,0.0115635223665006,0,0,19788.0,89974.27756224656,GRIA2
6484,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,GRIA2
6485,KEGG_2019_Human,Thyroid cancer,1/37,0.0018499650702878,0.0107945212775086,0,0,19963.0,125618.9446446357,BRAF
6486,KEGG_2019_Human,Bladder cancer,1/41,0.0020499625466866,0.0107945212775086,0,0,19959.0,123544.88783416104,BRAF
6487,KEGG_2019_Human,Endometrial cancer,1/58,0.0028999527887707,0.0107945212775086,0,0,19942.0,116522.31890946148,BRAF
6488,KEGG_2019_Human,Long-term depression,1/60,0.002999951725986,0.0107945212775086,0,0,19940.0,115834.63209072244,BRAF
6489,KEGG_2019_Human,Acute myeloid leukemia,1/66,0.003299948626608,0.0107945212775086,0,0,19934.0,113899.85357353876,BRAF
6490,KEGG_2019_Human,Non-small cell lung cancer,1/66,0.003299948626608,0.0107945212775086,0,0,19934.0,113899.85357353876,BRAF
6491,KEGG_2019_Human,Long-term potentiation,1/67,0.0033499481224912,0.0107945212775086,0,0,19933.0,113594.38808369274,BRAF
6492,KEGG_2019_Human,Renal cell carcinoma,1/69,0.003449947123837,0.0107945212775086,0,0,19931.0,112996.7391397682,BRAF
6493,KEGG_2019_Human,Melanoma,1/72,0.0035999456502131,0.0107945212775086,0,0,19928.0,112131.59838572376,BRAF
6494,KEGG_2019_Human,Pancreatic cancer,1/75,0.0037499442041125,0.0107945212775086,0,0,19925.0,111301.33528642564,BRAF
6495,KEGG_2019_Human,Glioma,1/75,0.0037499442041125,0.0107945212775086,0,0,19925.0,111301.33528642564,BRAF
6496,KEGG_2019_Human,Chronic myeloid leukemia,1/76,0.0037999437281752,0.0107945212775086,0,0,19924.0,111031.8499691117,BRAF
6497,KEGG_2019_Human,ErbB signaling pathway,1/85,0.004249939567045,0.0107945212775086,0,0,19915.0,108752.83801948265,BRAF
6498,KEGG_2019_Human,Colorectal cancer,1/86,0.0042999391173866,0.0107945212775086,0,0,19914.0,108514.46102290176,BRAF
6499,KEGG_2019_Human,Prostate cancer,1/97,0.0048499343304706,0.0107945212775086,0,0,19903.0,106058.9096435903,BRAF
6500,KEGG_2019_Human,Progesterone-mediated oocyte maturation,1/99,0.0049499334884068,0.0107945212775086,0,0,19901.0,105642.09305076736,BRAF
6501,KEGG_2019_Human,"Parathyroid hormone synthesis, secretion and action",1/106,0.0052999306076525,0.0107945212775086,0,0,19894.0,104245.78450366124,BRAF
6502,KEGG_2019_Human,Serotonergic synapse,1/113,0.0056499278191151,0.0107945212775086,0,0,19887.0,102937.34947211576,BRAF
6503,KEGG_2019_Human,Neurotrophin signaling pathway,1/119,0.0059499254985137,0.0107945212775086,0,0,19881.0,101877.73080211312,BRAF
6504,KEGG_2019_Human,Natural killer cell mediated cytotoxicity,1/131,0.0065499210316603,0.0107945212775086,0,0,19869.0,99907.33811343512,BRAF
6505,KEGG_2019_Human,FoxO signaling pathway,1/132,0.0065999206698993,0.0107945212775086,0,0,19868.0,99751.22090491928,BRAF
6506,KEGG_2019_Human,Vascular smooth muscle contraction,1/132,0.0065999206698993,0.0107945212775086,0,0,19868.0,99751.22090491928,BRAF
6507,KEGG_2019_Human,Insulin signaling pathway,1/137,0.0068499188797651,0.0107945212775086,0,0,19863.0,98987.62735269018,BRAF
6508,KEGG_2019_Human,Breast cancer,1/147,0.0073499154017982,0.0107945212775086,0,0,19853.0,97539.10874372096,BRAF
6509,KEGG_2019_Human,Gastric cancer,1/149,0.0074499147221605,0.0107945212775086,0,0,19851.0,97261.02051561224,BRAF
6510,KEGG_2019_Human,mTOR signaling pathway,1/152,0.0075999137114971,0.0107945212775086,0,0,19848.0,96850.665715497,BRAF
6511,KEGG_2019_Human,Cushing syndrome,1/155,0.0077499127120574,0.0107945212775086,0,0,19845.0,96448.16254952336,BRAF
6512,KEGG_2019_Human,Hepatitis C,1/155,0.0077499127120574,0.0107945212775086,0,0,19845.0,96448.16254952336,BRAF
6513,KEGG_2019_Human,Hepatitis B,1/163,0.0081499100978668,0.0109198810514423,0,0,19837.0,95410.9786681514,BRAF
6514,KEGG_2019_Human,Hepatocellular carcinoma,1/168,0.0083999085011095,0.0109198810514423,0,0,19832.0,94787.72752807094,BRAF
6515,KEGG_2019_Human,Alcoholism,1/180,0.0089999047745351,0.0112782676514828,0,0,19820.0,93362.92821536642,BRAF
6516,KEGG_2019_Human,Chemokine signaling pathway,1/190,0.0094999017791995,0.0112782676514828,0,0,19810.0,92244.74636351672,BRAF
6517,KEGG_2019_Human,Focal adhesion,1/199,0.0099498991610159,0.0112782676514828,0,0,19801.0,91286.4288690606,BRAF
6518,KEGG_2019_Human,Proteoglycans in cancer,1/201,0.0100498985877989,0.0112782676514828,0,0,19799.0,91079.21596609056,BRAF
6519,KEGG_2019_Human,Rap1 signaling pathway,1/206,0.010299897173561,0.0112782676514828,0,0,19794.0,90569.849337325,BRAF
6520,KEGG_2019_Human,cAMP signaling pathway,1/212,0.0105998955026255,0.0112782676514828,0,0,19788.0,89974.27756224656,BRAF
6521,KEGG_2019_Human,Regulation of actin cytoskeleton,1/214,0.0106998949514067,0.0112782676514828,0,0,19786.0,89779.39753374986,BRAF
6522,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0151380295576941,0,0,19705.0,83086.53988020132,BRAF
6523,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,BRAF
6524,KEGG_2019_Human,mRNA surveillance pathway,1/91,0.0045499369072032,0.0082499094553477,0,0,19909.0,107362.10783923086,SRRM1
6525,KEGG_2019_Human,RNA transport,1/165,0.0082499094553477,0.0082499094553477,0,0,19835.0,95159.46482222488,SRRM1
6526,KEGG_2019_Human,Regulation of lipolysis in adipocytes,1/55,0.0027499544131125,0.0086248678095925,0,0,19945.0,117599.1294878737,NPY
6527,KEGG_2019_Human,Adipocytokine signaling pathway,1/69,0.003449947123837,0.0086248678095925,0,0,19931.0,112996.7391397682,NPY
6528,KEGG_2019_Human,Alcoholism,1/180,0.0089999047745351,0.0132498693782819,0,0,19820.0,93362.92821536642,NPY
6529,KEGG_2019_Human,cAMP signaling pathway,1/212,0.0105998955026255,0.0132498693782819,0,0,19788.0,89974.27756224656,NPY
6530,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,NPY
6531,KEGG_2019_Human,"Glycine, serine and threonine metabolism",1/40,0.0019999631680592,0.0019999631680592,0,0,19960.0,124043.94523066044,SARDH
6532,KEGG_2019_Human,Ovarian steroidogenesis,1/49,0.0024499577795033,0.0095854183543869,0,0,19951.0,119939.1172087114,ADCY1
6533,KEGG_2019_Human,Regulation of lipolysis in adipocytes,1/55,0.0027499544131125,0.0095854183543869,0,0,19945.0,117599.1294878737,ADCY1
6534,KEGG_2019_Human,Cortisol synthesis and secretion,1/65,0.003249949134407,0.0095854183543869,0,0,19935.0,114209.92613860144,ADCY1
6535,KEGG_2019_Human,Long-term potentiation,1/67,0.0033499481224912,0.0095854183543869,0,0,19933.0,113594.38808369274,ADCY1
6536,KEGG_2019_Human,Bile secretion,1/72,0.0035999456502131,0.0095854183543869,0,0,19928.0,112131.59838572376,ADCY1
6537,KEGG_2019_Human,Thyroid hormone synthesis,1/74,0.0036999446830449,0.0095854183543869,0,0,19926.0,111574.38983110404,ADCY1
6538,KEGG_2019_Human,Gastric acid secretion,1/75,0.0037499442041125,0.0095854183543869,0,0,19925.0,111301.33528642564,ADCY1
6539,KEGG_2019_Human,Insulin secretion,1/86,0.0042999391173866,0.0095854183543869,0,0,19914.0,108514.46102290176,ADCY1
6540,KEGG_2019_Human,Gap junction,1/88,0.0043999382262822,0.0095854183543869,0,0,19912.0,108045.79305232369,ADCY1
6541,KEGG_2019_Human,GABAergic synapse,1/89,0.0044499377838098,0.0095854183543869,0,0,19911.0,107815.380281759,ADCY1
6542,KEGG_2019_Human,Salivary secretion,1/90,0.0044999373439762,0.0095854183543869,0,0,19910.0,107587.50385474482,ADCY1
6543,KEGG_2019_Human,Dilated cardiomyopathy (DCM),1/91,0.0045499369072032,0.0095854183543869,0,0,19909.0,107362.10783923086,ADCY1
6544,KEGG_2019_Human,Morphine addiction,1/91,0.0045499369072032,0.0095854183543869,0,0,19909.0,107362.10783923086,ADCY1
6545,KEGG_2019_Human,GnRH signaling pathway,1/93,0.0046499360391879,0.0095854183543869,0,0,19907.0,106918.54242106884,ADCY1
6546,KEGG_2019_Human,Amoebiasis,1/96,0.0047999347538706,0.0095854183543869,0,0,19904.0,106270.50039849174,ADCY1
6547,KEGG_2019_Human,Circadian entrainment,1/97,0.0048499343304706,0.0095854183543869,0,0,19903.0,106058.9096435903,ADCY1
6548,KEGG_2019_Human,Pancreatic secretion,1/98,0.0048999339081079,0.0095854183543869,0,0,19902.0,105849.45495286948,ADCY1
6549,KEGG_2019_Human,Aldosterone synthesis and secretion,1/98,0.0048999339081079,0.0095854183543869,0,0,19902.0,105849.45495286948,ADCY1
6550,KEGG_2019_Human,Progesterone-mediated oocyte maturation,1/99,0.0049499334884068,0.0095854183543869,0,0,19901.0,105642.09305076736,ADCY1
6551,KEGG_2019_Human,Inflammatory mediator regulation of TRP channels,1/100,0.0049999330710556,0.0095854183543869,0,0,19900.0,105436.78197328727,ADCY1
6552,KEGG_2019_Human,Melanogenesis,1/101,0.0050499326546803,0.0095854183543869,0,0,19899.0,105233.48101229242,ADCY1
6553,KEGG_2019_Human,Longevity regulating pathway,1/102,0.0050999322416682,0.0095854183543869,0,0,19898.0,105032.15064717118,ADCY1
6554,KEGG_2019_Human,Chagas disease (American trypanosomiasis),1/103,0.0051499318302617,0.0095854183543869,0,0,19897.0,104832.7525292024,ADCY1
6555,KEGG_2019_Human,"Parathyroid hormone synthesis, secretion and action",1/106,0.0052999306076525,0.0095854183543869,0,0,19894.0,104245.78450366124,ADCY1
6556,KEGG_2019_Human,Cholinergic synapse,1/112,0.0055999282120529,0.0095854183543869,0,0,19888.0,103119.30984392198,ADCY1
6557,KEGG_2019_Human,Glutamatergic synapse,1/114,0.005699927427839,0.0095854183543869,0,0,19886.0,102756.96431429044,ADCY1
6558,KEGG_2019_Human,Platelet activation,1/124,0.0061999236097501,0.0095854183543869,0,0,19876.0,101034.04709010696,ADCY1
6559,KEGG_2019_Human,Oocyte meiosis,1/125,0.0062499232373748,0.0095854183543869,0,0,19875.0,100869.32368441945,ADCY1
6560,KEGG_2019_Human,Purine metabolism,1/129,0.006449921761047,0.0095854183543869,0,0,19871.0,100223.109907462,ADCY1
6561,KEGG_2019_Human,Relaxin signaling pathway,1/130,0.0064999213952527,0.0095854183543869,0,0,19870.0,100064.62842845908,ADCY1
6562,KEGG_2019_Human,Vascular smooth muscle contraction,1/132,0.0065999206698993,0.0095854183543869,0,0,19868.0,99751.22090491928,ADCY1
6563,KEGG_2019_Human,Estrogen signaling pathway,1/137,0.0068499188797651,0.0095854183543869,0,0,19863.0,98987.62735269018,ADCY1
6564,KEGG_2019_Human,Apelin signaling pathway,1/137,0.0068499188797651,0.0095854183543869,0,0,19863.0,98987.62735269018,ADCY1
6565,KEGG_2019_Human,Adrenergic signaling in cardiomyocytes,1/145,0.0072499160871101,0.0095854183543869,0,0,19855.0,97820.92670675044,ADCY1
6566,KEGG_2019_Human,Phospholipase D signaling pathway,1/148,0.007399915061391,0.0095854183543869,0,0,19852.0,97399.60470052566,ADCY1
6567,KEGG_2019_Human,Retrograde endocannabinoid signaling,1/148,0.007399915061391,0.0095854183543869,0,0,19852.0,97399.60470052566,ADCY1
6568,KEGG_2019_Human,Oxytocin signaling pathway,1/153,0.0076499133771537,0.0095854183543869,0,0,19847.0,96715.6407630817,ADCY1
6569,KEGG_2019_Human,Cushing syndrome,1/155,0.0077499127120574,0.0095854183543869,0,0,19845.0,96448.16254952336,ADCY1
6570,KEGG_2019_Human,cGMP-PKG signaling pathway,1/166,0.0082999091363732,0.0100024546002447,0,0,19834.0,95034.82345515196,ADCY1
6571,KEGG_2019_Human,Calcium signaling pathway,1/188,0.009399902370135,0.0108901313078629,0,0,19812.0,92463.712994847,ADCY1
6572,KEGG_2019_Human,Chemokine signaling pathway,1/190,0.0094999017791995,0.0108901313078629,0,0,19810.0,92244.74636351672,ADCY1
6573,KEGG_2019_Human,Rap1 signaling pathway,1/206,0.010299897173561,0.0115260754085087,0,0,19794.0,90569.849337325,ADCY1
6574,KEGG_2019_Human,cAMP signaling pathway,1/212,0.0105998955026255,0.0115859322935675,0,0,19788.0,89974.27756224656,ADCY1
6575,KEGG_2019_Human,Human T-cell leukemia virus 1 infection,1/219,0.0109498935894162,0.0116964772432401,0,0,19781.0,89299.85161916987,ADCY1
6576,KEGG_2019_Human,Human cytomegalovirus infection,1/225,0.0112498919790339,0.011749887178102,0,0,19775.0,88738.27077557483,ADCY1
6577,KEGG_2019_Human,Thermogenesis,1/231,0.0115498903940656,0.0118009749678496,0,0,19769.0,88191.07730937863,ADCY1
6578,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,ADCY1
6579,KEGG_2019_Human,Terpenoid backbone biosynthesis,1/22,0.0010999756574123,0.0010999756574123,0,0,19978.0,136099.47030191717,PCYOX1
6580,KEGG_2019_Human,FoxO signaling pathway,1/132,0.0065999206698993,0.0065999206698993,0,0,19868.0,99751.22090491928,FOXG1
6581,KEGG_2019_Human,Amphetamine addiction,1/68,0.0033999476216189,0.0095276681134421,0,0,19932.0,113293.39338050144,FOS
6582,KEGG_2019_Human,Prolactin signaling pathway,1/70,0.0034999466296654,0.0095276681134421,0,0,19930.0,112704.30065625212,FOS
6583,KEGG_2019_Human,B cell receptor signaling pathway,1/71,0.0035499461386618,0.0095276681134421,0,0,19929.0,112415.9585341616,FOS
6584,KEGG_2019_Human,Leishmaniasis,1/74,0.0036999446830449,0.0095276681134421,0,0,19926.0,111574.38983110404,FOS
6585,KEGG_2019_Human,Pertussis,1/76,0.0037999437281752,0.0095276681134421,0,0,19924.0,111031.8499691117,FOS
6586,KEGG_2019_Human,Salmonella infection,1/86,0.0042999391173866,0.0095276681134421,0,0,19914.0,108514.46102290176,FOS
6587,KEGG_2019_Human,Colorectal cancer,1/86,0.0042999391173866,0.0095276681134421,0,0,19914.0,108514.46102290176,FOS
6588,KEGG_2019_Human,Rheumatoid arthritis,1/91,0.0045499369072032,0.0095276681134421,0,0,19909.0,107362.10783923086,FOS
6589,KEGG_2019_Human,Th1 and Th2 cell differentiation,1/92,0.0045999364719865,0.0095276681134421,0,0,19908.0,107139.13814408927,FOS
6590,KEGG_2019_Human,IL-17 signaling pathway,1/93,0.0046499360391879,0.0095276681134421,0,0,19907.0,106918.54242106884,FOS
6591,KEGG_2019_Human,Circadian entrainment,1/97,0.0048499343304706,0.0095276681134421,0,0,19903.0,106058.9096435903,FOS
6592,KEGG_2019_Human,Choline metabolism in cancer,1/99,0.0049499334884068,0.0095276681134421,0,0,19901.0,105642.09305076736,FOS
6593,KEGG_2019_Human,T cell receptor signaling pathway,1/101,0.0050499326546803,0.0095276681134421,0,0,19899.0,105233.48101229242,FOS
6594,KEGG_2019_Human,Chagas disease (American trypanosomiasis),1/103,0.0051499318302617,0.0095276681134421,0,0,19897.0,104832.7525292024,FOS
6595,KEGG_2019_Human,Toll-like receptor signaling pathway,1/104,0.0051999314202997,0.0095276681134421,0,0,19896.0,104635.24941415618,FOS
6596,KEGG_2019_Human,"Parathyroid hormone synthesis, secretion and action",1/106,0.0052999306076525,0.0095276681134421,0,0,19894.0,104245.78450366124,FOS
6597,KEGG_2019_Human,Th17 cell differentiation,1/107,0.0053499302026925,0.0095276681134421,0,0,19893.0,104053.753408911,FOS
6598,KEGG_2019_Human,TNF signaling pathway,1/110,0.0054999290027479,0.0095276681134421,0,0,19890.0,103488.06969787036,FOS
6599,KEGG_2019_Human,Cholinergic synapse,1/112,0.0055999282120529,0.0095276681134421,0,0,19888.0,103119.30984392198,FOS
6600,KEGG_2019_Human,Osteoclast differentiation,1/127,0.0063499224962247,0.0095276681134421,0,0,19873.0,100543.72072014232,FOS
6601,KEGG_2019_Human,Relaxin signaling pathway,1/130,0.0064999213952527,0.0095276681134421,0,0,19870.0,100064.62842845908,FOS
6602,KEGG_2019_Human,Dopaminergic synapse,1/131,0.0065499210316603,0.0095276681134421,0,0,19869.0,99907.33811343512,FOS
6603,KEGG_2019_Human,Estrogen signaling pathway,1/137,0.0068499188797651,0.0095276681134421,0,0,19863.0,98987.62735269018,FOS
6604,KEGG_2019_Human,Measles,1/138,0.0068999185254481,0.0095276681134421,0,0,19862.0,98838.19160389496,FOS
6605,KEGG_2019_Human,Fluid shear stress and atherosclerosis,1/139,0.006949918172816,0.0095276681134421,0,0,19861.0,98689.81333375497,FOS
6606,KEGG_2019_Human,Apoptosis,1/143,0.0071499167770442,0.0095276681134421,0,0,19857.0,98106.57763600958,FOS
6607,KEGG_2019_Human,Breast cancer,1/147,0.0073499154017982,0.0095276681134421,0,0,19853.0,97539.10874372096,FOS
6608,KEGG_2019_Human,Oxytocin signaling pathway,1/153,0.0076499133771537,0.0095623917214422,0,0,19847.0,96715.6407630817,FOS
6609,KEGG_2019_Human,Hepatitis B,1/163,0.0081499100978668,0.0098360983939772,0,0,19837.0,95410.9786681514,FOS
6610,KEGG_2019_Human,Kaposi sarcoma-associated herpesvirus infection,1/186,0.0092999029651357,0.0108498867926584,0,0,19814.0,92684.96451050608,FOS
6611,KEGG_2019_Human,Human immunodeficiency virus 1 infection,1/212,0.0105998955026255,0.0115936357059967,0,0,19788.0,89974.27756224656,FOS
6612,KEGG_2019_Human,cAMP signaling pathway,1/212,0.0105998955026255,0.0115936357059967,0,0,19788.0,89974.27756224656,FOS
6613,KEGG_2019_Human,Human T-cell leukemia virus 1 infection,1/219,0.0109498935894162,0.0116135235039263,0,0,19781.0,89299.85161916987,FOS
6614,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0151836948052286,0,0,19705.0,83086.53988020132,FOS
6615,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,FOS
6616,KEGG_2019_Human,RNA transport,1/165,0.0082499094553477,0.0082499094553477,0,0,19835.0,95159.46482222488,NUP210L
6617,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR13C3
6618,KEGG_2019_Human,Taste transduction,1/83,0.0041499404726918,0.0056499278191151,0,0,19917.0,109237.99888847338,HTR3A
6619,KEGG_2019_Human,Serotonergic synapse,1/113,0.0056499278191151,0.0056499278191151,0,0,19887.0,102937.34947211576,HTR3A
6620,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR2T3
6621,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR2AT4
6622,KEGG_2019_Human,TGF-beta signaling pathway,1/90,0.0044999373439762,0.010424877259224,0,0,19910.0,107587.50385474482,ACVR1B
6623,KEGG_2019_Human,Signaling pathways regulating pluripotency of stem cells,1/139,0.006949918172816,0.010424877259224,0,0,19861.0,98689.81333375497,ACVR1B
6624,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0146998751759735,0,0,19706.0,83157.67014793828,ACVR1B
6625,KEGG_2019_Human,Neurotrophin signaling pathway,1/119,0.0059499254985137,0.0176998626413668,0,0,19881.0,101877.73080211312,NTRK2
6626,KEGG_2019_Human,Alcoholism,1/180,0.0089999047745351,0.0176998626413668,0,0,19820.0,93362.92821536642,NTRK2
6627,KEGG_2019_Human,Ras signaling pathway,1/232,0.0115998901349604,0.0176998626413668,0,0,19768.0,88101.22480150245,NTRK2
6628,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0176998626413668,0,0,19705.0,83086.53988020132,NTRK2
6629,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0176998626413668,0,0,19646.0,79255.8617626126,NTRK2
6630,KEGG_2019_Human,Primary immunodeficiency,1/37,0.0018499650702878,0.0018499650702878,0,0,19963.0,125618.9446446357,IGLL1
6631,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR11H1
6632,KEGG_2019_Human,Wnt signaling pathway,1/158,0.0078999117225733,0.0078999117225733,0,0,19842.0,96053.2110949472,CHD8
6633,KEGG_2019_Human,Leukocyte transendothelial migration,1/112,0.0055999282120529,0.0084999078692823,0,0,19888.0,103119.30984392198,CLDN18
6634,KEGG_2019_Human,Cell adhesion molecules (CAMs),1/145,0.0072499160871101,0.0084999078692823,0,0,19855.0,97820.92670675044,CLDN18
6635,KEGG_2019_Human,Hepatitis C,1/155,0.0077499127120574,0.0084999078692823,0,0,19845.0,96448.16254952336,CLDN18
6636,KEGG_2019_Human,Tight junction,1/170,0.0084999078692823,0.0084999078692823,0,0,19830.0,94543.49009679438,CLDN18
6637,KEGG_2019_Human,beta-Alanine metabolism,1/31,0.0015499690656704,0.0027999538675741,0,0,19969.0,129189.85098816035,SMS
6638,KEGG_2019_Human,Cysteine and methionine metabolism,1/47,0.0023499589392381,0.0027999538675741,0,0,19953.0,120782.64067395544,SMS
6639,KEGG_2019_Human,Arginine and proline metabolism,1/49,0.0024499577795033,0.0027999538675741,0,0,19951.0,119939.1172087114,SMS
6640,KEGG_2019_Human,Glutathione metabolism,1/56,0.0027999538675741,0.0027999538675741,0,0,19944.0,117233.87022514464,SMS
6641,KEGG_2019_Human,Axon guidance,1/181,0.0090499044707863,0.0090499044707863,0,0,19819.0,93248.41634586031,UNC5C
6642,KEGG_2019_Human,Staphylococcus aureus infection,1/68,0.0033999476216189,0.0033999476216189,0,0,19932.0,113293.39338050144,DSG1
6643,KEGG_2019_Human,Basal cell carcinoma,1/63,0.0031499501598827,0.0117248816857654,0,0,19937.0,114844.46974572667,WNT16
6644,KEGG_2019_Human,Melanogenesis,1/101,0.0050499326546803,0.0117248816857654,0,0,19899.0,105233.48101229242,WNT16
6645,KEGG_2019_Human,Signaling pathways regulating pluripotency of stem cells,1/139,0.006949918172816,0.0117248816857654,0,0,19861.0,98689.81333375497,WNT16
6646,KEGG_2019_Human,Breast cancer,1/147,0.0073499154017982,0.0117248816857654,0,0,19853.0,97539.10874372096,WNT16
6647,KEGG_2019_Human,Gastric cancer,1/149,0.0074499147221605,0.0117248816857654,0,0,19851.0,97261.02051561224,WNT16
6648,KEGG_2019_Human,mTOR signaling pathway,1/152,0.0075999137114971,0.0117248816857654,0,0,19848.0,96850.665715497,WNT16
6649,KEGG_2019_Human,Cushing syndrome,1/155,0.0077499127120574,0.0117248816857654,0,0,19845.0,96448.16254952336,WNT16
6650,KEGG_2019_Human,Wnt signaling pathway,1/158,0.0078999117225733,0.0117248816857654,0,0,19842.0,96053.2110949472,WNT16
6651,KEGG_2019_Human,Hippo signaling pathway,1/160,0.0079999110688441,0.0117248816857654,0,0,19840.0,95793.96509856998,WNT16
6652,KEGG_2019_Human,Hepatocellular carcinoma,1/168,0.0083999085011095,0.0117248816857654,0,0,19832.0,94787.72752807094,WNT16
6653,KEGG_2019_Human,Transcriptional misregulation in cancer,1/186,0.0092999029651357,0.0117248816857654,0,0,19814.0,92684.96451050608,WNT16
6654,KEGG_2019_Human,Proteoglycans in cancer,1/201,0.0100498985877989,0.0117248816857654,0,0,19799.0,91079.21596609056,WNT16
6655,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.017769088032731,0,0,19670.0,80733.60565076157,WNT16
6656,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,WNT16
6657,KEGG_2019_Human,Lysine degradation,1/59,0.0029499522555206,0.0029499522555206,0,0,19941.0,116175.59385530632,EZH1
6658,KEGG_2019_Human,Pantothenate and CoA biosynthesis,1/19,0.00094997806231055,0.0023999583567988,0,0,19981.0,139049.2109571672,BCAT1
6659,KEGG_2019_Human,Cysteine and methionine metabolism,1/47,0.0023499589392381,0.0023999583567988,0,0,19953.0,120782.64067395544,BCAT1
6660,KEGG_2019_Human,"Valine, leucine and isoleucine degradation",1/48,0.0023999583567988,0.0023999583567988,0,0,19952.0,120356.5272753826,BCAT1
6661,KEGG_2019_Human,beta-Alanine metabolism,1/31,0.0015499690656704,0.0029999479459985,0,0,19969.0,129189.85098816035,ACADM
6662,KEGG_2019_Human,Propanoate metabolism,1/32,0.0015999683804467,0.0029999479459985,0,0,19968.0,128549.41955786056,ACADM
6663,KEGG_2019_Human,Fatty acid degradation,1/44,0.0021999607179423,0.0029999479459985,0,0,19956.0,122117.06559109331,ACADM
6664,KEGG_2019_Human,"Valine, leucine and isoleucine degradation",1/48,0.0023999583567988,0.0029999479459985,0,0,19952.0,120356.5272753826,ACADM
6665,KEGG_2019_Human,PPAR signaling pathway,1/74,0.0036999446830449,0.0036999446830449,0,0,19926.0,111574.38983110404,ACADM
6666,KEGG_2019_Human,Spliceosome,1/134,0.0066999199497742,0.0066999199497742,0,0,19866.0,99442.43560916925,PRPF38B
6667,KEGG_2019_Human,Hippo signaling pathway,1/160,0.0079999110688441,0.0084999078692823,0,0,19840.0,95793.96509856998,NF2
6668,KEGG_2019_Human,Tight junction,1/170,0.0084999078692823,0.0084999078692823,0,0,19830.0,94543.49009679438,NF2
6669,KEGG_2019_Human,Fat digestion and absorption,1/41,0.0020499625466866,0.0045749268002481,0,0,19959.0,123544.88783416104,PNLIPRP2
6670,KEGG_2019_Human,Glycerolipid metabolism,1/61,0.0030499512001654,0.0045749268002481,0,0,19939.0,115499.24335773686,PNLIPRP2
6671,KEGG_2019_Human,Pancreatic secretion,1/98,0.0048999339081079,0.0048999339081079,0,0,19902.0,105849.45495286948,PNLIPRP2
6672,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0147498749536506,0,0,19705.0,83086.53988020132,DUSP7
6673,KEGG_2019_Human,Glycosaminoglycan degradation,1/19,0.00094997806231055,0.00094997806231055,0,0,19981.0,139049.2109571672,HYAL4
6674,KEGG_2019_Human,Primary bile acid biosynthesis,1/17,0.0008499797390404818,0.0016999594780809,0,0,19983.0,141285.76583697114,CYP7B1
6675,KEGG_2019_Human,Steroid hormone biosynthesis,1/60,0.002999951725986,0.002999951725986,0,0,19940.0,115834.63209072244,CYP7B1
6676,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,TAAR5
6677,KEGG_2019_Human,Hematopoietic cell lineage,1/97,0.0048499343304706,0.0121498656303927,0,0,19903.0,106058.9096435903,THPO
6678,KEGG_2019_Human,JAK-STAT signaling pathway,1/162,0.0080999104202618,0.0121498656303927,0,0,19838.0,95537.86936302872,THPO
6679,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0146998751759735,0,0,19706.0,83157.67014793828,THPO
6680,KEGG_2019_Human,Caffeine metabolism,1/5,0.0002499917995416556,0.0009999671981666225,0,0,19995.0,165840.17843725558,XDH
6681,KEGG_2019_Human,Peroxisome,1/83,0.0041499404726918,0.006449921761047,0,0,19917.0,109237.99888847338,XDH
6682,KEGG_2019_Human,Drug metabolism,1/108,0.0053999298011749,0.006449921761047,0,0,19892.0,103863.47861844616,XDH
6683,KEGG_2019_Human,Purine metabolism,1/129,0.006449921761047,0.006449921761047,0,0,19871.0,100223.109907462,XDH
6684,KEGG_2019_Human,mRNA surveillance pathway,1/91,0.0045499369072032,0.0106873844447042,0,0,19909.0,107362.10783923086,NXF5
6685,KEGG_2019_Human,Ribosome biogenesis in eukaryotes,1/101,0.0050499326546803,0.0106873844447042,0,0,19899.0,105233.48101229242,NXF5
6686,KEGG_2019_Human,RNA transport,1/165,0.0082499094553477,0.0106873844447042,0,0,19835.0,95159.46482222488,NXF5
6687,KEGG_2019_Human,Influenza A,1/171,0.0085499075557634,0.0106873844447042,0,0,19829.0,94422.42241345016,NXF5
6688,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,NXF5
6689,KEGG_2019_Human,Adrenergic signaling in cardiomyocytes,1/145,0.0072499160871101,0.0072499160871101,0,0,19855.0,97820.92670675044,SCN4B
6690,KEGG_2019_Human,Ribosome,1/153,0.0076499133771537,0.0076499133771537,0,0,19847.0,96715.6407630817,RPS29
6691,KEGG_2019_Human,Pyrimidine metabolism,1/57,0.002849953326298,0.0053999298011749,0,0,19943.0,116875.00742975442,UMPS
6692,KEGG_2019_Human,Drug metabolism,1/108,0.0053999298011749,0.0053999298011749,0,0,19892.0,103863.47861844616,UMPS
6693,KEGG_2019_Human,Notch signaling pathway,1/48,0.0023999583567988,0.0091998729439731,0,0,19952.0,120356.5272753826,DLL4
6694,KEGG_2019_Human,Th1 and Th2 cell differentiation,1/92,0.0045999364719865,0.0091998729439731,0,0,19908.0,107139.13814408927,DLL4
6695,KEGG_2019_Human,Breast cancer,1/147,0.0073499154017982,0.0097998872023976,0,0,19853.0,97539.10874372096,DLL4
6696,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,DLL4
6697,KEGG_2019_Human,IL-17 signaling pathway,1/93,0.0046499360391879,0.0064999213952527,0,0,19907.0,106918.54242106884,MMP13
6698,KEGG_2019_Human,"Parathyroid hormone synthesis, secretion and action",1/106,0.0052999306076525,0.0064999213952527,0,0,19894.0,104245.78450366124,MMP13
6699,KEGG_2019_Human,Relaxin signaling pathway,1/130,0.0064999213952527,0.0064999213952527,0,0,19870.0,100064.62842845908,MMP13
6700,KEGG_2019_Human,SNARE interactions in vesicular transport,1/34,0.0016999670339032,0.0016999670339032,0,0,19966.0,127326.1054203148,VAMP7
6701,KEGG_2019_Human,Complement and coagulation cascades,1/79,0.0039499423167337,0.0039499423167337,0,0,19921.0,110243.89578070649,PROS1
6702,KEGG_2019_Human,Melanogenesis,1/101,0.0050499326546803,0.0140998535552025,0,0,19899.0,105233.48101229242,EDNRB
6703,KEGG_2019_Human,Relaxin signaling pathway,1/130,0.0064999213952527,0.0140998535552025,0,0,19870.0,100064.62842845908,EDNRB
6704,KEGG_2019_Human,cGMP-PKG signaling pathway,1/166,0.0082999091363732,0.0140998535552025,0,0,19834.0,95034.82345515196,EDNRB
6705,KEGG_2019_Human,Calcium signaling pathway,1/188,0.009399902370135,0.0140998535552025,0,0,19812.0,92463.712994847,EDNRB
6706,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0202798389918715,0,0,19662.0,80229.79996326564,EDNRB
6707,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,EDNRB
6708,KEGG_2019_Human,Fanconi anemia pathway,1/54,0.0026999549628563,0.0026999549628563,0,0,19946.0,117971.01964061816,FANCD2
6709,KEGG_2019_Human,Complement and coagulation cascades,1/79,0.0039499423167337,0.0068999185254481,0,0,19921.0,110243.89578070649,CD46
6710,KEGG_2019_Human,Measles,1/138,0.0068999185254481,0.0068999185254481,0,0,19862.0,98838.19160389496,CD46
6711,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF454
6712,KEGG_2019_Human,Arachidonic acid metabolism,1/63,0.0031499501598827,0.0031499501598827,0,0,19937.0,114844.46974572667,LTA4H
6713,KEGG_2019_Human,Circadian rhythm,1/31,0.0015499690656704,0.0091798960525845,0,0,19969.0,129189.85098816035,PRKAA2
6714,KEGG_2019_Human,Adipocytokine signaling pathway,1/69,0.003449947123837,0.0091798960525845,0,0,19931.0,112996.7391397682,PRKAA2
6715,KEGG_2019_Human,Hypertrophic cardiomyopathy (HCM),1/85,0.004249939567045,0.0091798960525845,0,0,19915.0,108752.83801948265,PRKAA2
6716,KEGG_2019_Human,Longevity regulating pathway,1/102,0.0050999322416682,0.0091798960525845,0,0,19898.0,105032.15064717118,PRKAA2
6717,KEGG_2019_Human,Glucagon signaling pathway,1/103,0.0051499318302617,0.0091798960525845,0,0,19897.0,104832.7525292024,PRKAA2
6718,KEGG_2019_Human,Insulin resistance,1/108,0.0053999298011749,0.0091798960525845,0,0,19892.0,103863.47861844616,PRKAA2
6719,KEGG_2019_Human,AMPK signaling pathway,1/120,0.0059999251180858,0.0091798960525845,0,0,19880.0,101706.2448082016,PRKAA2
6720,KEGG_2019_Human,Autophagy,1/128,0.0063999221281459,0.0091798960525845,0,0,19872.0,100382.8010329652,PRKAA2
6721,KEGG_2019_Human,FoxO signaling pathway,1/132,0.0065999206698993,0.0091798960525845,0,0,19868.0,99751.22090491928,PRKAA2
6722,KEGG_2019_Human,Insulin signaling pathway,1/137,0.0068499188797651,0.0091798960525845,0,0,19863.0,98987.62735269018,PRKAA2
6723,KEGG_2019_Human,Apelin signaling pathway,1/137,0.0068499188797651,0.0091798960525845,0,0,19863.0,98987.62735269018,PRKAA2
6724,KEGG_2019_Human,Fluid shear stress and atherosclerosis,1/139,0.006949918172816,0.0091798960525845,0,0,19861.0,98689.81333375497,PRKAA2
6725,KEGG_2019_Human,Non-alcoholic fatty liver disease (NAFLD),1/149,0.0074499147221605,0.0091798960525845,0,0,19851.0,97261.02051561224,PRKAA2
6726,KEGG_2019_Human,mTOR signaling pathway,1/152,0.0075999137114971,0.0091798960525845,0,0,19848.0,96850.665715497,PRKAA2
6727,KEGG_2019_Human,Oxytocin signaling pathway,1/153,0.0076499133771537,0.0091798960525845,0,0,19847.0,96715.6407630817,PRKAA2
6728,KEGG_2019_Human,Tight junction,1/170,0.0084999078692823,0.0095623963529426,0,0,19830.0,94543.49009679438,PRKAA2
6729,KEGG_2019_Human,Thermogenesis,1/231,0.0115498903940656,0.0122292957113635,0,0,19769.0,88191.07730937863,PRKAA2
6730,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0176998626413668,0,0,19646.0,79255.8617626126,PRKAA2
6731,KEGG_2019_Human,Glutamatergic synapse,1/114,0.005699927427839,0.0110998725920865,0,0,19886.0,102756.96431429044,GRM7
6732,KEGG_2019_Human,Phospholipase D signaling pathway,1/148,0.007399915061391,0.0110998725920865,0,0,19852.0,97399.60470052566,GRM7
6733,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,GRM7
6734,KEGG_2019_Human,Ovarian steroidogenesis,1/49,0.0024499577795033,0.0054165818906784,0,0,19951.0,119939.1172087114,HSD3B2
6735,KEGG_2019_Human,Steroid hormone biosynthesis,1/60,0.002999951725986,0.0054165818906784,0,0,19940.0,115834.63209072244,HSD3B2
6736,KEGG_2019_Human,Cortisol synthesis and secretion,1/65,0.003249949134407,0.0054165818906784,0,0,19935.0,114209.92613860144,HSD3B2
6737,KEGG_2019_Human,Aldosterone synthesis and secretion,1/98,0.0048999339081079,0.0061249173851349,0,0,19902.0,105849.45495286948,HSD3B2
6738,KEGG_2019_Human,Cushing syndrome,1/155,0.0077499127120574,0.0077499127120574,0,0,19845.0,96448.16254952336,HSD3B2
6739,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0147498749536506,0,0,19705.0,83086.53988020132,MAP3K13
6740,KEGG_2019_Human,Fatty acid biosynthesis,1/13,0.0006499833083207112,0.0045498831582449,0,0,19987.0,146675.87616784443,ACSL5
6741,KEGG_2019_Human,Ferroptosis,1/40,0.0019999631680592,0.0048415972181405,0,0,19960.0,124043.94523066044,ACSL5
6742,KEGG_2019_Human,Fatty acid degradation,1/44,0.0021999607179423,0.0048415972181405,0,0,19956.0,122117.06559109331,ACSL5
6743,KEGG_2019_Human,Adipocytokine signaling pathway,1/69,0.003449947123837,0.0048415972181405,0,0,19931.0,112996.7391397682,ACSL5
6744,KEGG_2019_Human,PPAR signaling pathway,1/74,0.0036999446830449,0.0048415972181405,0,0,19926.0,111574.38983110404,ACSL5
6745,KEGG_2019_Human,Peroxisome,1/83,0.0041499404726918,0.0048415972181405,0,0,19917.0,109237.99888847338,ACSL5
6746,KEGG_2019_Human,Thermogenesis,1/231,0.0115498903940656,0.0115498903940656,0,0,19769.0,88191.07730937863,ACSL5
6747,KEGG_2019_Human,Amyotrophic lateral sclerosis (ALS),1/51,0.0025499566390179,0.005699927427839,0,0,19949.0,119129.0228601236,SLC1A2
6748,KEGG_2019_Human,Synaptic vesicle cycle,1/78,0.0038999427840466,0.005699927427839,0,0,19922.0,110503.2180492851,SLC1A2
6749,KEGG_2019_Human,Glutamatergic synapse,1/114,0.005699927427839,0.005699927427839,0,0,19886.0,102756.96431429044,SLC1A2
6750,KEGG_2019_Human,Prion diseases,1/35,0.0017499663721595,0.0052498991164787,0,0,19965.0,126740.98858805298,C7
6751,KEGG_2019_Human,Complement and coagulation cascades,1/79,0.0039499423167337,0.0059249134751006,0,0,19921.0,110243.89578070649,C7
6752,KEGG_2019_Human,Systemic lupus erythematosus,1/133,0.0066499203093911,0.0066499203093911,0,0,19867.0,99596.2591544721,C7
6753,KEGG_2019_Human,mRNA surveillance pathway,1/91,0.0045499369072032,0.0045499369072032,0,0,19909.0,107362.10783923086,PAPOLA
6754,KEGG_2019_Human,Other glycan degradation,1/18,0.0008999788927950273,0.0023749451557763,0,0,19982.0,140136.54844084635,HEXB
6755,KEGG_2019_Human,Glycosaminoglycan degradation,1/19,0.00094997806231055,0.0023749451557763,0,0,19981.0,139049.2109571672,HEXB
6756,KEGG_2019_Human,Glycosphingolipid biosynthesis,1/45,0.0022499601197094,0.0029999479459985,0,0,19955.0,121662.49782449217,HEXB
6757,KEGG_2019_Human,Amino sugar and nucleotide sugar metabolism,1/48,0.0023999583567988,0.0029999479459985,0,0,19952.0,120356.5272753826,HEXB
6758,KEGG_2019_Human,Lysosome,1/123,0.0061499239842961,0.0061499239842961,0,0,19877.0,101200.07933676826,HEXB
6759,KEGG_2019_Human,"Neomycin, kanamycin and gentamicin biosynthesis",1/5,0.0002499917995416556,0.0027499097949582,0,0,19995.0,165840.17843725558,HK1
6760,KEGG_2019_Human,Galactose metabolism,1/31,0.0015499690656704,0.0037713631321124,0,0,19969.0,129189.85098816035,HK1
6761,KEGG_2019_Human,Fructose and mannose metabolism,1/33,0.0016499677032113,0.0037713631321124,0,0,19967.0,127928.56031580272,HK1
6762,KEGG_2019_Human,Starch and sucrose metabolism,1/36,0.0017999657178272,0.0037713631321124,0,0,19964.0,126172.23364250171,HK1
6763,KEGG_2019_Human,Carbohydrate digestion and absorption,1/44,0.0021999607179423,0.0037713631321124,0,0,19956.0,122117.06559109331,HK1
6764,KEGG_2019_Human,Type II diabetes mellitus,1/46,0.0022999595269283,0.0037713631321124,0,0,19954.0,121217.8313311442,HK1
6765,KEGG_2019_Human,Amino sugar and nucleotide sugar metabolism,1/48,0.0023999583567988,0.0037713631321124,0,0,19952.0,120356.5272753826,HK1
6766,KEGG_2019_Human,Central carbon metabolism in cancer,1/65,0.003249949134407,0.0041554915375342,0,0,19935.0,114209.92613860144,HK1
6767,KEGG_2019_Human,Glycolysis / Gluconeogenesis,1/68,0.0033999476216189,0.0041554915375342,0,0,19932.0,113293.39338050144,HK1
6768,KEGG_2019_Human,HIF-1 signaling pathway,1/100,0.0049999330710556,0.0054999263781612,0,0,19900.0,105436.78197328727,HK1
6769,KEGG_2019_Human,Insulin signaling pathway,1/137,0.0068499188797651,0.0068499188797651,0,0,19863.0,98987.62735269018,HK1
6770,KEGG_2019_Human,Arrhythmogenic right ventricular cardiomyopathy (ARVC),1/72,0.0035999456502131,0.0104927230926424,0,0,19928.0,112131.59838572376,ITGA6
6771,KEGG_2019_Human,ECM-receptor interaction,1/82,0.004099940929819,0.0104927230926424,0,0,19918.0,109484.9180722932,ITGA6
6772,KEGG_2019_Human,Hypertrophic cardiomyopathy (HCM),1/85,0.004249939567045,0.0104927230926424,0,0,19915.0,108752.83801948265,ITGA6
6773,KEGG_2019_Human,Dilated cardiomyopathy (DCM),1/91,0.0045499369072032,0.0104927230926424,0,0,19909.0,107362.10783923086,ITGA6
6774,KEGG_2019_Human,Small cell lung cancer,1/93,0.0046499360391879,0.0104927230926424,0,0,19907.0,106918.54242106884,ITGA6
6775,KEGG_2019_Human,Hematopoietic cell lineage,1/97,0.0048499343304706,0.0104927230926424,0,0,19903.0,106058.9096435903,ITGA6
6776,KEGG_2019_Human,Toxoplasmosis,1/113,0.0056499278191151,0.0104927230926424,0,0,19887.0,102937.34947211576,ITGA6
6777,KEGG_2019_Human,Cell adhesion molecules (CAMs),1/145,0.0072499160871101,0.011781113641554,0,0,19855.0,97820.92670675044,ITGA6
6778,KEGG_2019_Human,Focal adhesion,1/199,0.0099498991610159,0.0139098634368288,0,0,19801.0,91286.4288690606,ITGA6
6779,KEGG_2019_Human,Regulation of actin cytoskeleton,1/214,0.0106998949514067,0.0139098634368288,0,0,19786.0,89779.39753374986,ITGA6
6780,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0191748511948141,0,0,19670.0,80733.60565076157,ITGA6
6781,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0191748511948141,0,0,19646.0,79255.8617626126,ITGA6
6782,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,ITGA6
6783,KEGG_2019_Human,Glycerolipid metabolism,1/61,0.0030499512001654,0.0061874168605085,0,0,19939.0,115499.24335773686,DGKD
6784,KEGG_2019_Human,Glycerophospholipid metabolism,1/97,0.0048499343304706,0.0061874168605085,0,0,19903.0,106058.9096435903,DGKD
6785,KEGG_2019_Human,Phosphatidylinositol signaling system,1/99,0.0049499334884068,0.0061874168605085,0,0,19901.0,105642.09305076736,DGKD
6786,KEGG_2019_Human,Choline metabolism in cancer,1/99,0.0049499334884068,0.0061874168605085,0,0,19901.0,105642.09305076736,DGKD
6787,KEGG_2019_Human,Phospholipase D signaling pathway,1/148,0.007399915061391,0.007399915061391,0,0,19852.0,97399.60470052566,DGKD
6788,KEGG_2019_Human,Hematopoietic cell lineage,1/97,0.0048499343304706,0.0161998208405236,0,0,19903.0,106058.9096435903,CSF2RA
6789,KEGG_2019_Human,JAK-STAT signaling pathway,1/162,0.0080999104202618,0.0161998208405236,0,0,19838.0,95537.86936302872,CSF2RA
6790,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0195998335679646,0,0,19706.0,83157.67014793828,CSF2RA
6791,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,CSF2RA
6792,KEGG_2019_Human,African trypanosomiasis,1/37,0.0018499650702878,0.0089898863093732,0,0,19963.0,125618.9446446357,PRKCB
6793,KEGG_2019_Human,Aldosterone-regulated sodium reabsorption,1/37,0.0018499650702878,0.0089898863093732,0,0,19963.0,125618.9446446357,PRKCB
6794,KEGG_2019_Human,Carbohydrate digestion and absorption,1/44,0.0021999607179423,0.0089898863093732,0,0,19956.0,122117.06559109331,PRKCB
6795,KEGG_2019_Human,Endocrine and other factor-regulated calcium reabsorption,1/48,0.0023999583567988,0.0089898863093732,0,0,19952.0,120356.5272753826,PRKCB
6796,KEGG_2019_Human,VEGF signaling pathway,1/59,0.0029499522555206,0.0089898863093732,0,0,19941.0,116175.59385530632,PRKCB
6797,KEGG_2019_Human,Long-term depression,1/60,0.002999951725986,0.0089898863093732,0,0,19940.0,115834.63209072244,PRKCB
6798,KEGG_2019_Human,Non-small cell lung cancer,1/66,0.003299948626608,0.0089898863093732,0,0,19934.0,113899.85357353876,PRKCB
6799,KEGG_2019_Human,Long-term potentiation,1/67,0.0033499481224912,0.0089898863093732,0,0,19933.0,113594.38808369274,PRKCB
6800,KEGG_2019_Human,Amphetamine addiction,1/68,0.0033999476216189,0.0089898863093732,0,0,19932.0,113293.39338050144,PRKCB
6801,KEGG_2019_Human,B cell receptor signaling pathway,1/71,0.0035499461386618,0.0089898863093732,0,0,19929.0,112415.9585341616,PRKCB
6802,KEGG_2019_Human,Leishmaniasis,1/74,0.0036999446830449,0.0089898863093732,0,0,19926.0,111574.38983110404,PRKCB
6803,KEGG_2019_Human,Thyroid hormone synthesis,1/74,0.0036999446830449,0.0089898863093732,0,0,19926.0,111574.38983110404,PRKCB
6804,KEGG_2019_Human,Gastric acid secretion,1/75,0.0037499442041125,0.0089898863093732,0,0,19925.0,111301.33528642564,PRKCB
6805,KEGG_2019_Human,Glioma,1/75,0.0037499442041125,0.0089898863093732,0,0,19925.0,111301.33528642564,PRKCB
6806,KEGG_2019_Human,ErbB signaling pathway,1/85,0.004249939567045,0.0089898863093732,0,0,19915.0,108752.83801948265,PRKCB
6807,KEGG_2019_Human,Insulin secretion,1/86,0.0042999391173866,0.0089898863093732,0,0,19914.0,108514.46102290176,PRKCB
6808,KEGG_2019_Human,Gap junction,1/88,0.0043999382262822,0.0089898863093732,0,0,19912.0,108045.79305232369,PRKCB
6809,KEGG_2019_Human,GABAergic synapse,1/89,0.0044499377838098,0.0089898863093732,0,0,19911.0,107815.380281759,PRKCB
6810,KEGG_2019_Human,Salivary secretion,1/90,0.0044999373439762,0.0089898863093732,0,0,19910.0,107587.50385474482,PRKCB
6811,KEGG_2019_Human,Morphine addiction,1/91,0.0045499369072032,0.0089898863093732,0,0,19909.0,107362.10783923086,PRKCB
6812,KEGG_2019_Human,Fc gamma R-mediated phagocytosis,1/91,0.0045499369072032,0.0089898863093732,0,0,19909.0,107362.10783923086,PRKCB
6813,KEGG_2019_Human,GnRH signaling pathway,1/93,0.0046499360391879,0.0089898863093732,0,0,19907.0,106918.54242106884,PRKCB
6814,KEGG_2019_Human,NF-kappa B signaling pathway,1/95,0.0047499351803394,0.0089898863093732,0,0,19905.0,106484.27183626965,PRKCB
6815,KEGG_2019_Human,Amoebiasis,1/96,0.0047999347538706,0.0089898863093732,0,0,19904.0,106270.50039849174,PRKCB
6816,KEGG_2019_Human,Circadian entrainment,1/97,0.0048499343304706,0.0089898863093732,0,0,19903.0,106058.9096435903,PRKCB
6817,KEGG_2019_Human,Aldosterone synthesis and secretion,1/98,0.0048999339081079,0.0089898863093732,0,0,19902.0,105849.45495286948,PRKCB
6818,KEGG_2019_Human,Pancreatic secretion,1/98,0.0048999339081079,0.0089898863093732,0,0,19902.0,105849.45495286948,PRKCB
6819,KEGG_2019_Human,Choline metabolism in cancer,1/99,0.0049499334884068,0.0089898863093732,0,0,19901.0,105642.09305076736,PRKCB
6820,KEGG_2019_Human,Phosphatidylinositol signaling system,1/99,0.0049499334884068,0.0089898863093732,0,0,19901.0,105642.09305076736,PRKCB
6821,KEGG_2019_Human,AGE-RAGE signaling pathway in diabetic complications,1/100,0.0049999330710556,0.0089898863093732,0,0,19900.0,105436.78197328727,PRKCB
6822,KEGG_2019_Human,Inflammatory mediator regulation of TRP channels,1/100,0.0049999330710556,0.0089898863093732,0,0,19900.0,105436.78197328727,PRKCB
6823,KEGG_2019_Human,HIF-1 signaling pathway,1/100,0.0049999330710556,0.0089898863093732,0,0,19900.0,105436.78197328727,PRKCB
6824,KEGG_2019_Human,Melanogenesis,1/101,0.0050499326546803,0.0089898863093732,0,0,19899.0,105233.48101229242,PRKCB
6825,KEGG_2019_Human,"Parathyroid hormone synthesis, secretion and action",1/106,0.0052999306076525,0.0089898863093732,0,0,19894.0,104245.78450366124,PRKCB
6826,KEGG_2019_Human,Insulin resistance,1/108,0.0053999298011749,0.0089898863093732,0,0,19892.0,103863.47861844616,PRKCB
6827,KEGG_2019_Human,Leukocyte transendothelial migration,1/112,0.0055999282120529,0.0089898863093732,0,0,19888.0,103119.30984392198,PRKCB
6828,KEGG_2019_Human,Cholinergic synapse,1/112,0.0055999282120529,0.0089898863093732,0,0,19888.0,103119.30984392198,PRKCB
6829,KEGG_2019_Human,Serotonergic synapse,1/113,0.0056499278191151,0.0089898863093732,0,0,19887.0,102937.34947211576,PRKCB
6830,KEGG_2019_Human,Glutamatergic synapse,1/114,0.005699927427839,0.0089898863093732,0,0,19886.0,102756.96431429044,PRKCB
6831,KEGG_2019_Human,Thyroid hormone signaling pathway,1/116,0.0057999266512085,0.0089898863093732,0,0,19884.0,102400.8105961506,PRKCB
6832,KEGG_2019_Human,Sphingolipid signaling pathway,1/119,0.0059499254985137,0.0089974483148256,0,0,19881.0,101877.73080211312,PRKCB
6833,KEGG_2019_Human,Natural killer cell mediated cytotoxicity,1/131,0.0065499210316603,0.0092998882166764,0,0,19869.0,99907.33811343512,PRKCB
6834,KEGG_2019_Human,Dopaminergic synapse,1/131,0.0065499210316603,0.0092998882166764,0,0,19869.0,99907.33811343512,PRKCB
6835,KEGG_2019_Human,Vascular smooth muscle contraction,1/132,0.0065999206698993,0.0092998882166764,0,0,19868.0,99751.22090491928,PRKCB
6836,KEGG_2019_Human,Retrograde endocannabinoid signaling,1/148,0.007399915061391,0.0100913750932667,0,0,19852.0,97399.60470052566,PRKCB
6837,KEGG_2019_Human,mTOR signaling pathway,1/152,0.0075999137114971,0.0100913750932667,0,0,19848.0,96850.665715497,PRKCB
6838,KEGG_2019_Human,Oxytocin signaling pathway,1/153,0.0076499133771537,0.0100913750932667,0,0,19847.0,96715.6407630817,PRKCB
6839,KEGG_2019_Human,Wnt signaling pathway,1/158,0.0078999117225733,0.0102040526416572,0,0,19842.0,96053.2110949472,PRKCB
6840,KEGG_2019_Human,Hepatitis B,1/163,0.0081499100978668,0.0103121311442396,0,0,19837.0,95410.9786681514,PRKCB
6841,KEGG_2019_Human,Hepatocellular carcinoma,1/168,0.0083999085011095,0.0103940052638692,0,0,19832.0,94787.72752807094,PRKCB
6842,KEGG_2019_Human,Influenza A,1/171,0.0085499075557634,0.0103940052638692,0,0,19829.0,94422.42241345016,PRKCB
6843,KEGG_2019_Human,Calcium signaling pathway,1/188,0.009399902370135,0.0111130926473655,0,0,19812.0,92463.712994847,PRKCB
6844,KEGG_2019_Human,Chemokine signaling pathway,1/190,0.0094999017791995,0.0111130926473655,0,0,19810.0,92244.74636351672,PRKCB
6845,KEGG_2019_Human,Focal adhesion,1/199,0.0099498991610159,0.0113289765898825,0,0,19801.0,91286.4288690606,PRKCB
6846,KEGG_2019_Human,Proteoglycans in cancer,1/201,0.0100498985877989,0.0113289765898825,0,0,19799.0,91079.21596609056,PRKCB
6847,KEGG_2019_Human,Rap1 signaling pathway,1/206,0.010299897173561,0.011403457585014,0,0,19794.0,90569.849337325,PRKCB
6848,KEGG_2019_Human,Human immunodeficiency virus 1 infection,1/212,0.0105998955026255,0.0115297108975927,0,0,19788.0,89974.27756224656,PRKCB
6849,KEGG_2019_Human,Human cytomegalovirus infection,1/225,0.0112498919790339,0.0120257465982776,0,0,19775.0,88738.27077557483,PRKCB
6850,KEGG_2019_Human,Ras signaling pathway,1/232,0.0115998901349604,0.012189715057077,0,0,19768.0,88101.22480150245,PRKCB
6851,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0151949539697899,0,0,19705.0,83086.53988020132,PRKCB
6852,KEGG_2019_Human,MicroRNAs in cancer,1/299,0.0149498740670514,0.0151949539697899,0,0,19701.0,82804.33538735632,PRKCB
6853,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,PRKCB
6854,KEGG_2019_Human,Vascular smooth muscle contraction,1/132,0.0065999206698993,0.0065999206698993,0,0,19868.0,99751.22090491928,ACTG2
6855,KEGG_2019_Human,Amino sugar and nucleotide sugar metabolism,1/48,0.0023999583567988,0.0023999583567988,0,0,19952.0,120356.5272753826,CYB5RL
6856,KEGG_2019_Human,NOD-like receptor signaling pathway,1/178,0.0088999053857096,0.0088999053857096,0,0,19822.0,93593.82745769851,PSTPIP1
6857,KEGG_2019_Human,beta-Alanine metabolism,1/31,0.0015499690656704,0.0024499577795033,0,0,19969.0,129189.85098816035,SMOX
6858,KEGG_2019_Human,Arginine and proline metabolism,1/49,0.0024499577795033,0.0024499577795033,0,0,19951.0,119939.1172087114,SMOX
6859,KEGG_2019_Human,FoxO signaling pathway,1/132,0.0065999206698993,0.0131998413397987,0,0,19868.0,99751.22090491928,C8ORF44-SGK3
6860,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0176998626413668,0,0,19646.0,79255.8617626126,C8ORF44-SGK3
6861,KEGG_2019_Human,Platelet activation,1/124,0.0061999236097501,0.0173998352024406,0,0,19876.0,101034.04709010696,RASGRP2
6862,KEGG_2019_Human,Chemokine signaling pathway,1/190,0.0094999017791995,0.0173998352024406,0,0,19810.0,92244.74636351672,RASGRP2
6863,KEGG_2019_Human,Rap1 signaling pathway,1/206,0.010299897173561,0.0173998352024406,0,0,19794.0,90569.849337325,RASGRP2
6864,KEGG_2019_Human,Ras signaling pathway,1/232,0.0115998901349604,0.0173998352024406,0,0,19768.0,88101.22480150245,RASGRP2
6865,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0176998499443808,0,0,19705.0,83086.53988020132,RASGRP2
6866,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,RASGRP2
6867,KEGG_2019_Human,Fructose and mannose metabolism,1/33,0.0016499677032113,0.0023999583567988,0,0,19967.0,127928.56031580272,PMM2
6868,KEGG_2019_Human,Amino sugar and nucleotide sugar metabolism,1/48,0.0023999583567988,0.0023999583567988,0,0,19952.0,120356.5272753826,PMM2
6869,KEGG_2019_Human,mTOR signaling pathway,1/152,0.0075999137114971,0.0075999137114971,0,0,19848.0,96850.665715497,LAMTOR4
6870,KEGG_2019_Human,Ribosome,1/153,0.0076499133771537,0.0076499133771537,0,0,19847.0,96715.6407630817,RPL23
6871,KEGG_2019_Human,Osteoclast differentiation,1/127,0.0063499224962247,0.0065499210316603,0,0,19873.0,100543.72072014232,TYROBP
6872,KEGG_2019_Human,Natural killer cell mediated cytotoxicity,1/131,0.0065499210316603,0.0065499210316603,0,0,19869.0,99907.33811343512,TYROBP
6873,KEGG_2019_Human,Folate biosynthesis,1/26,0.0012999726251831,0.0025999452503662,0,0,19974.0,132735.46073187632,GPHN
6874,KEGG_2019_Human,GABAergic synapse,1/89,0.0044499377838098,0.0044499377838098,0,0,19911.0,107815.380281759,GPHN
6875,KEGG_2019_Human,Arachidonic acid metabolism,1/63,0.0031499501598827,0.0061999236097501,0,0,19937.0,114844.46974572667,TBXAS1
6876,KEGG_2019_Human,Platelet activation,1/124,0.0061999236097501,0.0061999236097501,0,0,19876.0,101034.04709010696,TBXAS1
6877,KEGG_2019_Human,Sulfur relay system,1/8,0.0003999883241497325,0.0007499814841592997,0,0,19992.0,156418.91141655247,NFS1
6878,KEGG_2019_Human,Thiamine metabolism,1/15,0.0007499814841592997,0.0007499814841592997,0,0,19985.0,143801.30885993244,NFS1
6879,KEGG_2019_Human,Pathogenic Escherichia coli infection,1/55,0.0027499544131125,0.012371753537564,0,0,19945.0,117599.1294878737,RHOA
6880,KEGG_2019_Human,Adherens junction,1/72,0.0035999456502131,0.012371753537564,0,0,19928.0,112131.59838572376,RHOA
6881,KEGG_2019_Human,Bacterial invasion of epithelial cells,1/74,0.0036999446830449,0.012371753537564,0,0,19926.0,111574.38983110404,RHOA
6882,KEGG_2019_Human,Pertussis,1/76,0.0037999437281752,0.012371753537564,0,0,19924.0,111031.8499691117,RHOA
6883,KEGG_2019_Human,Colorectal cancer,1/86,0.0042999391173866,0.012371753537564,0,0,19914.0,108514.46102290176,RHOA
6884,KEGG_2019_Human,TGF-beta signaling pathway,1/90,0.0044999373439762,0.012371753537564,0,0,19910.0,107587.50385474482,RHOA
6885,KEGG_2019_Human,Pancreatic secretion,1/98,0.0048999339081079,0.012371753537564,0,0,19902.0,105849.45495286948,RHOA
6886,KEGG_2019_Human,T cell receptor signaling pathway,1/101,0.0050499326546803,0.012371753537564,0,0,19899.0,105233.48101229242,RHOA
6887,KEGG_2019_Human,C-type lectin receptor signaling pathway,1/104,0.0051999314202997,0.012371753537564,0,0,19896.0,104635.24941415618,RHOA
6888,KEGG_2019_Human,"Parathyroid hormone synthesis, secretion and action",1/106,0.0052999306076525,0.012371753537564,0,0,19894.0,104245.78450366124,RHOA
6889,KEGG_2019_Human,Leukocyte transendothelial migration,1/112,0.0055999282120529,0.012371753537564,0,0,19888.0,103119.30984392198,RHOA
6890,KEGG_2019_Human,Sphingolipid signaling pathway,1/119,0.0059499254985137,0.012371753537564,0,0,19881.0,101877.73080211312,RHOA
6891,KEGG_2019_Human,Neurotrophin signaling pathway,1/119,0.0059499254985137,0.012371753537564,0,0,19881.0,101877.73080211312,RHOA
6892,KEGG_2019_Human,Platelet activation,1/124,0.0061999236097501,0.012371753537564,0,0,19876.0,101034.04709010696,RHOA
6893,KEGG_2019_Human,Vascular smooth muscle contraction,1/132,0.0065999206698993,0.012371753537564,0,0,19868.0,99751.22090491928,RHOA
6894,KEGG_2019_Human,Fluid shear stress and atherosclerosis,1/139,0.006949918172816,0.012371753537564,0,0,19861.0,98689.81333375497,RHOA
6895,KEGG_2019_Human,Phospholipase D signaling pathway,1/148,0.007399915061391,0.012371753537564,0,0,19852.0,97399.60470052566,RHOA
6896,KEGG_2019_Human,mTOR signaling pathway,1/152,0.0075999137114971,0.012371753537564,0,0,19848.0,96850.665715497,RHOA
6897,KEGG_2019_Human,Oxytocin signaling pathway,1/153,0.0076499133771537,0.012371753537564,0,0,19847.0,96715.6407630817,RHOA
6898,KEGG_2019_Human,Wnt signaling pathway,1/158,0.0078999117225733,0.012371753537564,0,0,19842.0,96053.2110949472,RHOA
6899,KEGG_2019_Human,cGMP-PKG signaling pathway,1/166,0.0082999091363732,0.012371753537564,0,0,19834.0,95034.82345515196,RHOA
6900,KEGG_2019_Human,Tight junction,1/170,0.0084999078692823,0.012371753537564,0,0,19830.0,94543.49009679438,RHOA
6901,KEGG_2019_Human,NOD-like receptor signaling pathway,1/178,0.0088999053857096,0.012371753537564,0,0,19822.0,93593.82745769851,RHOA
6902,KEGG_2019_Human,Tuberculosis,1/179,0.0089499050800561,0.012371753537564,0,0,19821.0,93478.0629355712,RHOA
6903,KEGG_2019_Human,Axon guidance,1/181,0.0090499044707863,0.012371753537564,0,0,19819.0,93248.41634586031,RHOA
6904,KEGG_2019_Human,Chemokine signaling pathway,1/190,0.0094999017791995,0.012371753537564,0,0,19810.0,92244.74636351672,RHOA
6905,KEGG_2019_Human,Focal adhesion,1/199,0.0099498991610159,0.012371753537564,0,0,19801.0,91286.4288690606,RHOA
6906,KEGG_2019_Human,Proteoglycans in cancer,1/201,0.0100498985877989,0.012371753537564,0,0,19799.0,91079.21596609056,RHOA
6907,KEGG_2019_Human,Viral carcinogenesis,1/201,0.0100498985877989,0.012371753537564,0,0,19799.0,91079.21596609056,RHOA
6908,KEGG_2019_Human,Rap1 signaling pathway,1/206,0.010299897173561,0.012371753537564,0,0,19794.0,90569.849337325,RHOA
6909,KEGG_2019_Human,cAMP signaling pathway,1/212,0.0105998955026255,0.012371753537564,0,0,19788.0,89974.27756224656,RHOA
6910,KEGG_2019_Human,Regulation of actin cytoskeleton,1/214,0.0106998949514067,0.012371753537564,0,0,19786.0,89779.39753374986,RHOA
6911,KEGG_2019_Human,Human cytomegalovirus infection,1/225,0.0112498919790339,0.0126135152492198,0,0,19775.0,88738.27077557483,RHOA
6912,KEGG_2019_Human,Ras signaling pathway,1/232,0.0115998901349604,0.012623409852751,0,0,19768.0,88101.22480150245,RHOA
6913,KEGG_2019_Human,Endocytosis,1/244,0.0121998870519305,0.012897023454898,0,0,19756.0,87051.4275316661,RHOA
6914,KEGG_2019_Human,MicroRNAs in cancer,1/299,0.0149498740670514,0.0153651483466917,0,0,19701.0,82804.33538735632,RHOA
6915,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,RHOA
6916,KEGG_2019_Human,Th1 and Th2 cell differentiation,1/92,0.0045999364719865,0.0115960368320757,0,0,19908.0,107139.13814408927,TYK2
6917,KEGG_2019_Human,Th17 cell differentiation,1/107,0.0053499302026925,0.0115960368320757,0,0,19893.0,104053.753408911,TYK2
6918,KEGG_2019_Human,Toxoplasmosis,1/113,0.0056499278191151,0.0115960368320757,0,0,19887.0,102937.34947211576,TYK2
6919,KEGG_2019_Human,Osteoclast differentiation,1/127,0.0063499224962247,0.0115960368320757,0,0,19873.0,100543.72072014232,TYK2
6920,KEGG_2019_Human,Measles,1/138,0.0068999185254481,0.0115960368320757,0,0,19862.0,98838.19160389496,TYK2
6921,KEGG_2019_Human,Hepatitis C,1/155,0.0077499127120574,0.0115960368320757,0,0,19845.0,96448.16254952336,TYK2
6922,KEGG_2019_Human,Necroptosis,1/162,0.0080999104202618,0.0115960368320757,0,0,19838.0,95537.86936302872,TYK2
6923,KEGG_2019_Human,JAK-STAT signaling pathway,1/162,0.0080999104202618,0.0115960368320757,0,0,19838.0,95537.86936302872,TYK2
6924,KEGG_2019_Human,Hepatitis B,1/163,0.0081499100978668,0.0115960368320757,0,0,19837.0,95410.9786681514,TYK2
6925,KEGG_2019_Human,Influenza A,1/171,0.0085499075557634,0.0115960368320757,0,0,19829.0,94422.42241345016,TYK2
6926,KEGG_2019_Human,NOD-like receptor signaling pathway,1/178,0.0088999053857096,0.0115960368320757,0,0,19822.0,93593.82745769851,TYK2
6927,KEGG_2019_Human,Kaposi sarcoma-associated herpesvirus infection,1/186,0.0092999029651357,0.0115960368320757,0,0,19814.0,92684.96451050608,TYK2
6928,KEGG_2019_Human,Epstein-Barr virus infection,1/201,0.0100498985877989,0.0115960368320757,0,0,19799.0,91079.21596609056,TYK2
6929,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0176784294203191,0,0,19670.0,80733.60565076157,TYK2
6930,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,TYK2
6931,KEGG_2019_Human,RNA degradation,1/79,0.0039499423167337,0.0078998846334674,0,0,19921.0,110243.89578070649,HSPA9
6932,KEGG_2019_Human,Tuberculosis,1/179,0.0089499050800561,0.0089499050800561,0,0,19821.0,93478.0629355712,HSPA9
6933,KEGG_2019_Human,B cell receptor signaling pathway,1/71,0.0035499461386618,0.0119998847776361,0,0,19929.0,112415.9585341616,NFATC3
6934,KEGG_2019_Human,Th1 and Th2 cell differentiation,1/92,0.0045999364719865,0.0119998847776361,0,0,19908.0,107139.13814408927,NFATC3
6935,KEGG_2019_Human,T cell receptor signaling pathway,1/101,0.0050499326546803,0.0119998847776361,0,0,19899.0,105233.48101229242,NFATC3
6936,KEGG_2019_Human,C-type lectin receptor signaling pathway,1/104,0.0051999314202997,0.0119998847776361,0,0,19896.0,104635.24941415618,NFATC3
6937,KEGG_2019_Human,Th17 cell differentiation,1/107,0.0053499302026925,0.0119998847776361,0,0,19893.0,104053.753408911,NFATC3
6938,KEGG_2019_Human,Oxytocin signaling pathway,1/153,0.0076499133771537,0.0119998847776361,0,0,19847.0,96715.6407630817,NFATC3
6939,KEGG_2019_Human,Wnt signaling pathway,1/158,0.0078999117225733,0.0119998847776361,0,0,19842.0,96053.2110949472,NFATC3
6940,KEGG_2019_Human,Cellular senescence,1/160,0.0079999110688441,0.0119998847776361,0,0,19840.0,95793.96509856998,NFATC3
6941,KEGG_2019_Human,Hepatitis B,1/163,0.0081499100978668,0.0119998847776361,0,0,19837.0,95410.9786681514,NFATC3
6942,KEGG_2019_Human,cGMP-PKG signaling pathway,1/166,0.0082999091363732,0.0119998847776361,0,0,19834.0,95034.82345515196,NFATC3
6943,KEGG_2019_Human,Axon guidance,1/181,0.0090499044707863,0.0119998847776361,0,0,19819.0,93248.41634586031,NFATC3
6944,KEGG_2019_Human,Kaposi sarcoma-associated herpesvirus infection,1/186,0.0092999029651357,0.0119998847776361,0,0,19814.0,92684.96451050608,NFATC3
6945,KEGG_2019_Human,Human immunodeficiency virus 1 infection,1/212,0.0105998955026255,0.0119998847776361,0,0,19788.0,89974.27756224656,NFATC3
6946,KEGG_2019_Human,Human T-cell leukemia virus 1 infection,1/219,0.0109498935894162,0.0119998847776361,0,0,19781.0,89299.85161916987,NFATC3
6947,KEGG_2019_Human,Human cytomegalovirus infection,1/225,0.0112498919790339,0.0119998847776361,0,0,19775.0,88738.27077557483,NFATC3
6948,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0147498749536506,0,0,19705.0,83086.53988020132,NFATC3
6949,KEGG_2019_Human,Graft-versus-host disease,1/41,0.0020499625466866,0.0057749148821253,0,0,19959.0,123544.88783416104,KLRD1
6950,KEGG_2019_Human,Antigen processing and presentation,1/77,0.0038499432547502,0.0057749148821253,0,0,19923.0,110765.8407373636,KLRD1
6951,KEGG_2019_Human,Natural killer cell mediated cytotoxicity,1/131,0.0065499210316603,0.0065499210316603,0,0,19869.0,99907.33811343512,KLRD1
6952,KEGG_2019_Human,Phagosome,1/152,0.0075999137114971,0.0075999137114971,0,0,19848.0,96850.665715497,COLEC11
6953,KEGG_2019_Human,Inflammatory bowel disease (IBD),1/65,0.003249949134407,0.0082498935041218,0,0,19935.0,114209.92613860144,IL18R1
6954,KEGG_2019_Human,TNF signaling pathway,1/110,0.0054999290027479,0.0082498935041218,0,0,19890.0,103488.06969787036,IL18R1
6955,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0146998751759735,0,0,19706.0,83157.67014793828,IL18R1
6956,KEGG_2019_Human,Mucin type O-glycan biosynthesis,1/31,0.0015499690656704,0.0015499690656704,0,0,19969.0,129189.85098816035,GALNT13
6957,KEGG_2019_Human,Nicotine addiction,1/40,0.0019999631680592,0.0068249053608048,0,0,19960.0,124043.94523066044,GABRA1
6958,KEGG_2019_Human,Taste transduction,1/83,0.0041499404726918,0.0068249053608048,0,0,19917.0,109237.99888847338,GABRA1
6959,KEGG_2019_Human,GABAergic synapse,1/89,0.0044499377838098,0.0068249053608048,0,0,19911.0,107815.380281759,GABRA1
6960,KEGG_2019_Human,Morphine addiction,1/91,0.0045499369072032,0.0068249053608048,0,0,19909.0,107362.10783923086,GABRA1
6961,KEGG_2019_Human,Retrograde endocannabinoid signaling,1/148,0.007399915061391,0.0088798980736692,0,0,19852.0,97399.60470052566,GABRA1
6962,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,GABRA1
6963,KEGG_2019_Human,Ubiquitin mediated proteolysis,1/137,0.0068499188797651,0.0071499167770442,0,0,19863.0,98987.62735269018,BIRC6
6964,KEGG_2019_Human,Apoptosis,1/143,0.0071499167770442,0.0071499167770442,0,0,19857.0,98106.57763600958,BIRC6
6965,KEGG_2019_Human,Adherens junction,1/72,0.0035999456502131,0.0055499170245674,0,0,19928.0,112131.59838572376,SORBS1
6966,KEGG_2019_Human,PPAR signaling pathway,1/74,0.0036999446830449,0.0055499170245674,0,0,19926.0,111574.38983110404,SORBS1
6967,KEGG_2019_Human,Insulin signaling pathway,1/137,0.0068499188797651,0.0068499188797651,0,0,19863.0,98987.62735269018,SORBS1
6968,KEGG_2019_Human,N-Glycan biosynthesis,1/50,0.0024999572069037,0.0039749332759706,0,0,19950.0,119530.05920663515,FUT8
6969,KEGG_2019_Human,Glycosaminoglycan biosynthesis,1/53,0.0026499555173137,0.0039749332759706,0,0,19947.0,118349.78824235698,FUT8
6970,KEGG_2019_Human,Transcriptional misregulation in cancer,1/186,0.0092999029651357,0.0092999029651357,0,0,19814.0,92684.96451050608,FUT8
6971,KEGG_2019_Human,Pyruvate metabolism,1/39,0.0019499637955508,0.0019499637955508,0,0,19961.0,124555.53162481484,ME2
6972,KEGG_2019_Human,cAMP signaling pathway,1/212,0.0105998955026255,0.0168998658265596,0,0,19788.0,89974.27756224656,GHRL
6973,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,GHRL
6974,KEGG_2019_Human,Endocytosis,1/244,0.0121998870519305,0.0121998870519305,0,0,19756.0,87051.4275316661,RAB4A
6975,KEGG_2019_Human,Regulation of lipolysis in adipocytes,1/55,0.0027499544131125,0.0094284580998562,0,0,19945.0,117599.1294878737,PRKG1
6976,KEGG_2019_Human,Long-term depression,1/60,0.002999951725986,0.0094284580998562,0,0,19940.0,115834.63209072244,PRKG1
6977,KEGG_2019_Human,Gap junction,1/88,0.0043999382262822,0.0094284580998562,0,0,19912.0,108045.79305232369,PRKG1
6978,KEGG_2019_Human,Salivary secretion,1/90,0.0044999373439762,0.0094284580998562,0,0,19910.0,107587.50385474482,PRKG1
6979,KEGG_2019_Human,Circadian entrainment,1/97,0.0048499343304706,0.0094284580998562,0,0,19903.0,106058.9096435903,PRKG1
6980,KEGG_2019_Human,Platelet activation,1/124,0.0061999236097501,0.0094284580998562,0,0,19876.0,101034.04709010696,PRKG1
6981,KEGG_2019_Human,Vascular smooth muscle contraction,1/132,0.0065999206698993,0.0094284580998562,0,0,19868.0,99751.22090491928,PRKG1
6982,KEGG_2019_Human,cGMP-PKG signaling pathway,1/166,0.0082999091363732,0.0103748864204666,0,0,19834.0,95034.82345515196,PRKG1
6983,KEGG_2019_Human,Thermogenesis,1/231,0.0115498903940656,0.0128332115489617,0,0,19769.0,88191.07730937863,PRKG1
6984,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,PRKG1
6985,KEGG_2019_Human,Amyotrophic lateral sclerosis (ALS),1/51,0.0025499566390179,0.0119116503307417,0,0,19949.0,119129.0228601236,MAP2K6
6986,KEGG_2019_Human,Fc epsilon RI signaling pathway,1/68,0.0033999476216189,0.0119116503307417,0,0,19932.0,113293.39338050144,MAP2K6
6987,KEGG_2019_Human,GnRH signaling pathway,1/93,0.0046499360391879,0.0119116503307417,0,0,19907.0,106918.54242106884,MAP2K6
6988,KEGG_2019_Human,Inflammatory mediator regulation of TRP channels,1/100,0.0049999330710556,0.0119116503307417,0,0,19900.0,105436.78197328727,MAP2K6
6989,KEGG_2019_Human,Toll-like receptor signaling pathway,1/104,0.0051999314202997,0.0119116503307417,0,0,19896.0,104635.24941415618,MAP2K6
6990,KEGG_2019_Human,TNF signaling pathway,1/110,0.0054999290027479,0.0119116503307417,0,0,19890.0,103488.06969787036,MAP2K6
6991,KEGG_2019_Human,Toxoplasmosis,1/113,0.0056499278191151,0.0119116503307417,0,0,19887.0,102937.34947211576,MAP2K6
6992,KEGG_2019_Human,Osteoclast differentiation,1/127,0.0063499224962247,0.0119116503307417,0,0,19873.0,100543.72072014232,MAP2K6
6993,KEGG_2019_Human,Fluid shear stress and atherosclerosis,1/139,0.006949918172816,0.0119116503307417,0,0,19861.0,98689.81333375497,MAP2K6
6994,KEGG_2019_Human,Cellular senescence,1/160,0.0079999110688441,0.0119116503307417,0,0,19840.0,95793.96509856998,MAP2K6
6995,KEGG_2019_Human,Hepatitis B,1/163,0.0081499100978668,0.0119116503307417,0,0,19837.0,95410.9786681514,MAP2K6
6996,KEGG_2019_Human,Influenza A,1/171,0.0085499075557634,0.0119116503307417,0,0,19829.0,94422.42241345016,MAP2K6
6997,KEGG_2019_Human,Kaposi sarcoma-associated herpesvirus infection,1/186,0.0092999029651357,0.0119116503307417,0,0,19814.0,92684.96451050608,MAP2K6
6998,KEGG_2019_Human,Epstein-Barr virus infection,1/201,0.0100498985877989,0.0119116503307417,0,0,19799.0,91079.21596609056,MAP2K6
6999,KEGG_2019_Human,Rap1 signaling pathway,1/206,0.010299897173561,0.0119116503307417,0,0,19794.0,90569.849337325,MAP2K6
7000,KEGG_2019_Human,Human immunodeficiency virus 1 infection,1/212,0.0105998955026255,0.0119116503307417,0,0,19788.0,89974.27756224656,MAP2K6
7001,KEGG_2019_Human,Human cytomegalovirus infection,1/225,0.0112498919790339,0.0119116503307417,0,0,19775.0,88738.27077557483,MAP2K6
7002,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0147498749536506,0,0,19705.0,83086.53988020132,MAP2K6
7003,KEGG_2019_Human,Signaling pathways regulating pluripotency of stem cells,1/139,0.006949918172816,0.006949918172816,0,0,19861.0,98689.81333375497,DLX5
7004,KEGG_2019_Human,Pyrimidine metabolism,1/57,0.002849953326298,0.0053999298011749,0,0,19943.0,116875.00742975442,DUT
7005,KEGG_2019_Human,Drug metabolism,1/108,0.0053999298011749,0.0053999298011749,0,0,19892.0,103863.47861844616,DUT
7006,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR5H15
7007,KEGG_2019_Human,Huntington disease,1/193,0.0096499008972596,0.0096499008972596,0,0,19807.0,91920.47679471428,DNAH14
7008,KEGG_2019_Human,Nitrogen metabolism,1/17,0.0008499797390404818,0.0008499797390404818,0,0,19983.0,141285.76583697114,CA1
7009,KEGG_2019_Human,Neurotrophin signaling pathway,1/119,0.0059499254985137,0.0168569999470293,0,0,19881.0,101877.73080211312,NGFR
7010,KEGG_2019_Human,Apoptosis,1/143,0.0071499167770442,0.0168569999470293,0,0,19857.0,98106.57763600958,NGFR
7011,KEGG_2019_Human,Transcriptional misregulation in cancer,1/186,0.0092999029651357,0.0168569999470293,0,0,19814.0,92684.96451050608,NGFR
7012,KEGG_2019_Human,Rap1 signaling pathway,1/206,0.010299897173561,0.0168569999470293,0,0,19794.0,90569.849337325,NGFR
7013,KEGG_2019_Human,Ras signaling pathway,1/232,0.0115998901349604,0.0168569999470293,0,0,19768.0,88101.22480150245,NGFR
7014,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0168569999470293,0,0,19706.0,83157.67014793828,NGFR
7015,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0168569999470293,0,0,19705.0,83086.53988020132,NGFR
7016,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0176998626413668,0,0,19646.0,79255.8617626126,NGFR
7017,KEGG_2019_Human,Colorectal cancer,1/86,0.0042999391173866,0.0128998173521599,0,0,19914.0,108514.46102290176,DCC
7018,KEGG_2019_Human,Axon guidance,1/181,0.0090499044707863,0.0135748567061795,0,0,19819.0,93248.41634586031,DCC
7019,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,DCC
7020,KEGG_2019_Human,Hedgehog signaling pathway,1/47,0.0023499589392381,0.0023499589392381,0,0,19953.0,120782.64067395544,EVC
7021,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR6Y1
7022,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF879
7023,KEGG_2019_Human,Pancreatic secretion,1/98,0.0048999339081079,0.009399902370135,0,0,19902.0,105849.45495286948,TPCN2
7024,KEGG_2019_Human,Calcium signaling pathway,1/188,0.009399902370135,0.009399902370135,0,0,19812.0,92463.712994847,TPCN2
7025,KEGG_2019_Human,HIF-1 signaling pathway,1/100,0.0049999330710556,0.0098998913464173,0,0,19900.0,105436.78197328727,EIF4E1B
7026,KEGG_2019_Human,Longevity regulating pathway,1/102,0.0050999322416682,0.0098998913464173,0,0,19898.0,105032.15064717118,EIF4E1B
7027,KEGG_2019_Human,Insulin signaling pathway,1/137,0.0068499188797651,0.0098998913464173,0,0,19863.0,98987.62735269018,EIF4E1B
7028,KEGG_2019_Human,mTOR signaling pathway,1/152,0.0075999137114971,0.0098998913464173,0,0,19848.0,96850.665715497,EIF4E1B
7029,KEGG_2019_Human,RNA transport,1/165,0.0082499094553477,0.0098998913464173,0,0,19835.0,95159.46482222488,EIF4E1B
7030,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0176998626413668,0,0,19646.0,79255.8617626126,EIF4E1B
7031,KEGG_2019_Human,Estrogen signaling pathway,1/137,0.0068499188797651,0.0068499188797651,0,0,19863.0,98987.62735269018,KRT9
7032,KEGG_2019_Human,Renal cell carcinoma,1/69,0.003449947123837,0.0130498764018304,0,0,19931.0,112996.7391397682,PAK4
7033,KEGG_2019_Human,ErbB signaling pathway,1/85,0.004249939567045,0.0130498764018304,0,0,19915.0,108752.83801948265,PAK4
7034,KEGG_2019_Human,T cell receptor signaling pathway,1/101,0.0050499326546803,0.0130498764018304,0,0,19899.0,105233.48101229242,PAK4
7035,KEGG_2019_Human,Axon guidance,1/181,0.0090499044707863,0.0130498764018304,0,0,19819.0,93248.41634586031,PAK4
7036,KEGG_2019_Human,Focal adhesion,1/199,0.0099498991610159,0.0130498764018304,0,0,19801.0,91286.4288690606,PAK4
7037,KEGG_2019_Human,Human immunodeficiency virus 1 infection,1/212,0.0105998955026255,0.0130498764018304,0,0,19788.0,89974.27756224656,PAK4
7038,KEGG_2019_Human,Regulation of actin cytoskeleton,1/214,0.0106998949514067,0.0130498764018304,0,0,19786.0,89779.39753374986,PAK4
7039,KEGG_2019_Human,Ras signaling pathway,1/232,0.0115998901349604,0.0130498764018304,0,0,19768.0,88101.22480150245,PAK4
7040,KEGG_2019_Human,MicroRNAs in cancer,1/299,0.0149498740670514,0.0149498740670514,0,0,19701.0,82804.33538735632,PAK4
7041,KEGG_2019_Human,VEGF signaling pathway,1/59,0.0029499522555206,0.0123748811769373,0,0,19941.0,116175.59385530632,PXN
7042,KEGG_2019_Human,Bacterial invasion of epithelial cells,1/74,0.0036999446830449,0.0123748811769373,0,0,19926.0,111574.38983110404,PXN
7043,KEGG_2019_Human,Leukocyte transendothelial migration,1/112,0.0055999282120529,0.0123748811769373,0,0,19888.0,103119.30984392198,PXN
7044,KEGG_2019_Human,Chemokine signaling pathway,1/190,0.0094999017791995,0.0123748811769373,0,0,19810.0,92244.74636351672,PXN
7045,KEGG_2019_Human,Focal adhesion,1/199,0.0099498991610159,0.0123748811769373,0,0,19801.0,91286.4288690606,PXN
7046,KEGG_2019_Human,Proteoglycans in cancer,1/201,0.0100498985877989,0.0123748811769373,0,0,19799.0,91079.21596609056,PXN
7047,KEGG_2019_Human,Viral carcinogenesis,1/201,0.0100498985877989,0.0123748811769373,0,0,19799.0,91079.21596609056,PXN
7048,KEGG_2019_Human,Human immunodeficiency virus 1 infection,1/212,0.0105998955026255,0.0123748811769373,0,0,19788.0,89974.27756224656,PXN
7049,KEGG_2019_Human,Regulation of actin cytoskeleton,1/214,0.0106998949514067,0.0123748811769373,0,0,19786.0,89779.39753374986,PXN
7050,KEGG_2019_Human,Human cytomegalovirus infection,1/225,0.0112498919790339,0.0123748811769373,0,0,19775.0,88738.27077557483,PXN
7051,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0164998674589645,0,0,19670.0,80733.60565076157,PXN
7052,KEGG_2019_Human,Spliceosome,1/134,0.0066999199497742,0.0066999199497742,0,0,19866.0,99442.43560916925,RBMXL2
7053,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF208
7054,KEGG_2019_Human,Protein processing in endoplasmic reticulum,1/165,0.0082499094553477,0.0082499094553477,0,0,19835.0,95159.46482222488,MBTPS2
7055,KEGG_2019_Human,ECM-receptor interaction,1/82,0.004099940929819,0.0097498820928791,0,0,19918.0,109484.9180722932,COL1A2
7056,KEGG_2019_Human,Protein digestion and absorption,1/90,0.0044999373439762,0.0097498820928791,0,0,19910.0,107587.50385474482,COL1A2
7057,KEGG_2019_Human,Amoebiasis,1/96,0.0047999347538706,0.0097498820928791,0,0,19904.0,106270.50039849174,COL1A2
7058,KEGG_2019_Human,AGE-RAGE signaling pathway in diabetic complications,1/100,0.0049999330710556,0.0097498820928791,0,0,19900.0,105436.78197328727,COL1A2
7059,KEGG_2019_Human,Platelet activation,1/124,0.0061999236097501,0.0097498820928791,0,0,19876.0,101034.04709010696,COL1A2
7060,KEGG_2019_Human,Relaxin signaling pathway,1/130,0.0064999213952527,0.0097498820928791,0,0,19870.0,100064.62842845908,COL1A2
7061,KEGG_2019_Human,Focal adhesion,1/199,0.0099498991610159,0.0127927274927348,0,0,19801.0,91286.4288690606,COL1A2
7062,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0176998626413668,0,0,19670.0,80733.60565076157,COL1A2
7063,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0176998626413668,0,0,19646.0,79255.8617626126,COL1A2
7064,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0149498740670514,0,0,19705.0,83086.53988020132,STMN1
7065,KEGG_2019_Human,MicroRNAs in cancer,1/299,0.0149498740670514,0.0149498740670514,0,0,19701.0,82804.33538735632,STMN1
7066,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR6B1
7067,KEGG_2019_Human,Inflammatory bowel disease (IBD),1/65,0.003249949134407,0.0106998604053851,0,0,19935.0,114209.92613860144,IL21R
7068,KEGG_2019_Human,Th17 cell differentiation,1/107,0.0053499302026925,0.0106998604053851,0,0,19893.0,104053.753408911,IL21R
7069,KEGG_2019_Human,JAK-STAT signaling pathway,1/162,0.0080999104202618,0.0107998805603491,0,0,19838.0,95537.86936302872,IL21R
7070,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0146998751759735,0,0,19706.0,83157.67014793828,IL21R
7071,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR6A2
7072,KEGG_2019_Human,Cardiac muscle contraction,1/78,0.0038999427840466,0.0060665825429376,0,0,19922.0,110503.2180492851,ACTC1
7073,KEGG_2019_Human,Hypertrophic cardiomyopathy (HCM),1/85,0.004249939567045,0.0060665825429376,0,0,19915.0,108752.83801948265,ACTC1
7074,KEGG_2019_Human,Dilated cardiomyopathy (DCM),1/91,0.0045499369072032,0.0060665825429376,0,0,19909.0,107362.10783923086,ACTC1
7075,KEGG_2019_Human,Adrenergic signaling in cardiomyocytes,1/145,0.0072499160871101,0.0072499160871101,0,0,19855.0,97820.92670675044,ACTC1
7076,KEGG_2019_Human,Ribosome biogenesis in eukaryotes,1/101,0.0050499326546803,0.0050499326546803,0,0,19899.0,105233.48101229242,BMS1
7077,KEGG_2019_Human,Pantothenate and CoA biosynthesis,1/19,0.00094997806231055,0.00094997806231055,0,0,19981.0,139049.2109571672,PANK1
7078,KEGG_2019_Human,RNA degradation,1/79,0.0039499423167337,0.0039499423167337,0,0,19921.0,110243.89578070649,TOB1
7079,KEGG_2019_Human,Inositol phosphate metabolism,1/74,0.0036999446830449,0.0086623836047119,0,0,19926.0,111574.38983110404,PIP5K1A
7080,KEGG_2019_Human,Fc gamma R-mediated phagocytosis,1/91,0.0045499369072032,0.0086623836047119,0,0,19909.0,107362.10783923086,PIP5K1A
7081,KEGG_2019_Human,Phosphatidylinositol signaling system,1/99,0.0049499334884068,0.0086623836047119,0,0,19901.0,105642.09305076736,PIP5K1A
7082,KEGG_2019_Human,Choline metabolism in cancer,1/99,0.0049499334884068,0.0086623836047119,0,0,19901.0,105642.09305076736,PIP5K1A
7083,KEGG_2019_Human,Phospholipase D signaling pathway,1/148,0.007399915061391,0.0103598810859474,0,0,19852.0,97399.60470052566,PIP5K1A
7084,KEGG_2019_Human,Regulation of actin cytoskeleton,1/214,0.0106998949514067,0.0121998870519305,0,0,19786.0,89779.39753374986,PIP5K1A
7085,KEGG_2019_Human,Endocytosis,1/244,0.0121998870519305,0.0121998870519305,0,0,19756.0,87051.4275316661,PIP5K1A
7086,KEGG_2019_Human,"Parathyroid hormone synthesis, secretion and action",1/106,0.0052999306076525,0.0105998612153051,0,0,19894.0,104245.78450366124,MMP16
7087,KEGG_2019_Human,MicroRNAs in cancer,1/299,0.0149498740670514,0.0149498740670514,0,0,19701.0,82804.33538735632,MMP16
7088,KEGG_2019_Human,RNA transport,1/165,0.0082499094553477,0.0082499094553477,0,0,19835.0,95159.46482222488,RANBP2
7089,KEGG_2019_Human,Ovarian steroidogenesis,1/49,0.0024499577795033,0.0073498733385099,0,0,19951.0,119939.1172087114,FSHR
7090,KEGG_2019_Human,cAMP signaling pathway,1/212,0.0105998955026255,0.0158998432539383,0,0,19788.0,89974.27756224656,FSHR
7091,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,FSHR
7092,KEGG_2019_Human,Asthma,1/31,0.0015499690656704,0.0061998762626816,0,0,19969.0,129189.85098816035,MS4A2
7093,KEGG_2019_Human,Fc epsilon RI signaling pathway,1/68,0.0033999476216189,0.0067998952432378,0,0,19932.0,113293.39338050144,MS4A2
7094,KEGG_2019_Human,Sphingolipid signaling pathway,1/119,0.0059499254985137,0.007399915061391,0,0,19881.0,101877.73080211312,MS4A2
7095,KEGG_2019_Human,Phospholipase D signaling pathway,1/148,0.007399915061391,0.007399915061391,0,0,19852.0,97399.60470052566,MS4A2
7096,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF570
7097,KEGG_2019_Human,Ras signaling pathway,1/232,0.0115998901349604,0.0115998901349604,0,0,19768.0,88101.22480150245,BRAP
7098,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR5AP2
7099,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF235
7100,KEGG_2019_Human,Apelin signaling pathway,1/137,0.0068499188797651,0.0136998377595303,0,0,19863.0,98987.62735269018,APLNR
7101,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,APLNR
7102,KEGG_2019_Human,Collecting duct acid secretion,1/27,0.0013499718942362,0.0040499156827088,0,0,19973.0,131975.02298599784,ATP4B
7103,KEGG_2019_Human,Gastric acid secretion,1/75,0.0037499442041125,0.0056249163061687,0,0,19925.0,111301.33528642564,ATP4B
7104,KEGG_2019_Human,Oxidative phosphorylation,1/133,0.0066499203093911,0.0066499203093911,0,0,19867.0,99596.2591544721,ATP4B
7105,KEGG_2019_Human,One carbon pool by folate,1/20,0.0009999772468562472,0.0019999544937124,0,0,19980.0,138017.40508704726,ATIC
7106,KEGG_2019_Human,Purine metabolism,1/129,0.006449921761047,0.006449921761047,0,0,19871.0,100223.109907462,ATIC
7107,KEGG_2019_Human,Complement and coagulation cascades,1/79,0.0039499423167337,0.0061999236097501,0,0,19921.0,110243.89578070649,FGB
7108,KEGG_2019_Human,Platelet activation,1/124,0.0061999236097501,0.0061999236097501,0,0,19876.0,101034.04709010696,FGB
7109,KEGG_2019_Human,Autophagy,1/128,0.0063999221281459,0.0075999137114971,0,0,19872.0,100382.8010329652,RRAGB
7110,KEGG_2019_Human,mTOR signaling pathway,1/152,0.0075999137114971,0.0075999137114971,0,0,19848.0,96850.665715497,RRAGB
7111,KEGG_2019_Human,Nicotine addiction,1/40,0.0019999631680592,0.007583228178672,0,0,19960.0,124043.94523066044,GABRG1
7112,KEGG_2019_Human,GABAergic synapse,1/89,0.0044499377838098,0.007583228178672,0,0,19911.0,107815.380281759,GABRG1
7113,KEGG_2019_Human,Morphine addiction,1/91,0.0045499369072032,0.007583228178672,0,0,19909.0,107362.10783923086,GABRG1
7114,KEGG_2019_Human,Retrograde endocannabinoid signaling,1/148,0.007399915061391,0.0092498938267387,0,0,19852.0,97399.60470052566,GABRG1
7115,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,GABRG1
7116,KEGG_2019_Human,Central carbon metabolism in cancer,1/65,0.003249949134407,0.0074998996065834,0,0,19935.0,114209.92613860144,PDK1
7117,KEGG_2019_Human,HIF-1 signaling pathway,1/100,0.0049999330710556,0.0074998996065834,0,0,19900.0,105436.78197328727,PDK1
7118,KEGG_2019_Human,Axon guidance,1/181,0.0090499044707863,0.0090499044707863,0,0,19819.0,93248.41634586031,PDK1
7119,KEGG_2019_Human,Notch signaling pathway,1/48,0.0023999583567988,0.0120598783053587,0,0,19952.0,120356.5272753826,HDAC2
7120,KEGG_2019_Human,Chronic myeloid leukemia,1/76,0.0037999437281752,0.0120598783053587,0,0,19924.0,111031.8499691117,HDAC2
7121,KEGG_2019_Human,Longevity regulating pathway,1/102,0.0050999322416682,0.0120598783053587,0,0,19898.0,105032.15064717118,HDAC2
7122,KEGG_2019_Human,Thyroid hormone signaling pathway,1/116,0.0057999266512085,0.0120598783053587,0,0,19884.0,102400.8105961506,HDAC2
7123,KEGG_2019_Human,Cell cycle,1/124,0.0061999236097501,0.0120598783053587,0,0,19876.0,101034.04709010696,HDAC2
7124,KEGG_2019_Human,Alcoholism,1/180,0.0089999047745351,0.0120598783053587,0,0,19820.0,93362.92821536642,HDAC2
7125,KEGG_2019_Human,Transcriptional misregulation in cancer,1/186,0.0092999029651357,0.0120598783053587,0,0,19814.0,92684.96451050608,HDAC2
7126,KEGG_2019_Human,Huntington disease,1/193,0.0096499008972596,0.0120598783053587,0,0,19807.0,91920.47679471428,HDAC2
7127,KEGG_2019_Human,Epstein-Barr virus infection,1/201,0.0100498985877989,0.0120598783053587,0,0,19799.0,91079.21596609056,HDAC2
7128,KEGG_2019_Human,Viral carcinogenesis,1/201,0.0100498985877989,0.0120598783053587,0,0,19799.0,91079.21596609056,HDAC2
7129,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0179998554097794,0,0,19670.0,80733.60565076157,HDAC2
7130,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,HDAC2
7131,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR1C1
7132,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,TAC3
7133,KEGG_2019_Human,Endocytosis,1/244,0.0121998870519305,0.0121998870519305,0,0,19756.0,87051.4275316661,ACAP2
7134,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR2T27
7135,KEGG_2019_Human,NOD-like receptor signaling pathway,1/178,0.0088999053857096,0.0088999053857096,0,0,19822.0,93593.82745769851,GBP4
7136,KEGG_2019_Human,Transcriptional misregulation in cancer,1/186,0.0092999029651357,0.0092999029651357,0,0,19814.0,92684.96451050608,MLLT3
7137,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF677
7138,KEGG_2019_Human,Selenocompound metabolism,1/17,0.0008499797390404818,0.0014999658702843,0,0,19983.0,141285.76583697114,MTR
7139,KEGG_2019_Human,One carbon pool by folate,1/20,0.0009999772468562472,0.0014999658702843,0,0,19980.0,138017.40508704726,MTR
7140,KEGG_2019_Human,Cysteine and methionine metabolism,1/47,0.0023499589392381,0.0023499589392381,0,0,19953.0,120782.64067395544,MTR
7141,KEGG_2019_Human,Ovarian steroidogenesis,1/49,0.0024499577795033,0.0096873908900718,0,0,19951.0,119939.1172087114,ADCY2
7142,KEGG_2019_Human,Regulation of lipolysis in adipocytes,1/55,0.0027499544131125,0.0096873908900718,0,0,19945.0,117599.1294878737,ADCY2
7143,KEGG_2019_Human,Cortisol synthesis and secretion,1/65,0.003249949134407,0.0096873908900718,0,0,19935.0,114209.92613860144,ADCY2
7144,KEGG_2019_Human,Bile secretion,1/72,0.0035999456502131,0.0096873908900718,0,0,19928.0,112131.59838572376,ADCY2
7145,KEGG_2019_Human,Thyroid hormone synthesis,1/74,0.0036999446830449,0.0096873908900718,0,0,19926.0,111574.38983110404,ADCY2
7146,KEGG_2019_Human,Gastric acid secretion,1/75,0.0037499442041125,0.0096873908900718,0,0,19925.0,111301.33528642564,ADCY2
7147,KEGG_2019_Human,Insulin secretion,1/86,0.0042999391173866,0.0096873908900718,0,0,19914.0,108514.46102290176,ADCY2
7148,KEGG_2019_Human,Gap junction,1/88,0.0043999382262822,0.0096873908900718,0,0,19912.0,108045.79305232369,ADCY2
7149,KEGG_2019_Human,GABAergic synapse,1/89,0.0044499377838098,0.0096873908900718,0,0,19911.0,107815.380281759,ADCY2
7150,KEGG_2019_Human,Salivary secretion,1/90,0.0044999373439762,0.0096873908900718,0,0,19910.0,107587.50385474482,ADCY2
7151,KEGG_2019_Human,Dilated cardiomyopathy (DCM),1/91,0.0045499369072032,0.0096873908900718,0,0,19909.0,107362.10783923086,ADCY2
7152,KEGG_2019_Human,Morphine addiction,1/91,0.0045499369072032,0.0096873908900718,0,0,19909.0,107362.10783923086,ADCY2
7153,KEGG_2019_Human,GnRH signaling pathway,1/93,0.0046499360391879,0.0096873908900718,0,0,19907.0,106918.54242106884,ADCY2
7154,KEGG_2019_Human,Circadian entrainment,1/97,0.0048499343304706,0.0096873908900718,0,0,19903.0,106058.9096435903,ADCY2
7155,KEGG_2019_Human,Pancreatic secretion,1/98,0.0048999339081079,0.0096873908900718,0,0,19902.0,105849.45495286948,ADCY2
7156,KEGG_2019_Human,Aldosterone synthesis and secretion,1/98,0.0048999339081079,0.0096873908900718,0,0,19902.0,105849.45495286948,ADCY2
7157,KEGG_2019_Human,Progesterone-mediated oocyte maturation,1/99,0.0049499334884068,0.0096873908900718,0,0,19901.0,105642.09305076736,ADCY2
7158,KEGG_2019_Human,Inflammatory mediator regulation of TRP channels,1/100,0.0049999330710556,0.0096873908900718,0,0,19900.0,105436.78197328727,ADCY2
7159,KEGG_2019_Human,Melanogenesis,1/101,0.0050499326546803,0.0096873908900718,0,0,19899.0,105233.48101229242,ADCY2
7160,KEGG_2019_Human,Longevity regulating pathway,1/102,0.0050999322416682,0.0096873908900718,0,0,19898.0,105032.15064717118,ADCY2
7161,KEGG_2019_Human,Glucagon signaling pathway,1/103,0.0051499318302617,0.0096873908900718,0,0,19897.0,104832.7525292024,ADCY2
7162,KEGG_2019_Human,"Parathyroid hormone synthesis, secretion and action",1/106,0.0052999306076525,0.0096873908900718,0,0,19894.0,104245.78450366124,ADCY2
7163,KEGG_2019_Human,Cholinergic synapse,1/112,0.0055999282120529,0.0096873908900718,0,0,19888.0,103119.30984392198,ADCY2
7164,KEGG_2019_Human,Glutamatergic synapse,1/114,0.005699927427839,0.0096873908900718,0,0,19886.0,102756.96431429044,ADCY2
7165,KEGG_2019_Human,Platelet activation,1/124,0.0061999236097501,0.0096873908900718,0,0,19876.0,101034.04709010696,ADCY2
7166,KEGG_2019_Human,Oocyte meiosis,1/125,0.0062499232373748,0.0096873908900718,0,0,19875.0,100869.32368441945,ADCY2
7167,KEGG_2019_Human,Purine metabolism,1/129,0.006449921761047,0.0096873908900718,0,0,19871.0,100223.109907462,ADCY2
7168,KEGG_2019_Human,Relaxin signaling pathway,1/130,0.0064999213952527,0.0096873908900718,0,0,19870.0,100064.62842845908,ADCY2
7169,KEGG_2019_Human,Vascular smooth muscle contraction,1/132,0.0065999206698993,0.0096873908900718,0,0,19868.0,99751.22090491928,ADCY2
7170,KEGG_2019_Human,Estrogen signaling pathway,1/137,0.0068499188797651,0.0096873908900718,0,0,19863.0,98987.62735269018,ADCY2
7171,KEGG_2019_Human,Apelin signaling pathway,1/137,0.0068499188797651,0.0096873908900718,0,0,19863.0,98987.62735269018,ADCY2
7172,KEGG_2019_Human,Adrenergic signaling in cardiomyocytes,1/145,0.0072499160871101,0.0096873908900718,0,0,19855.0,97820.92670675044,ADCY2
7173,KEGG_2019_Human,Phospholipase D signaling pathway,1/148,0.007399915061391,0.0096873908900718,0,0,19852.0,97399.60470052566,ADCY2
7174,KEGG_2019_Human,Retrograde endocannabinoid signaling,1/148,0.007399915061391,0.0096873908900718,0,0,19852.0,97399.60470052566,ADCY2
7175,KEGG_2019_Human,Oxytocin signaling pathway,1/153,0.0076499133771537,0.0096873908900718,0,0,19847.0,96715.6407630817,ADCY2
7176,KEGG_2019_Human,Cushing syndrome,1/155,0.0077499127120574,0.0096873908900718,0,0,19845.0,96448.16254952336,ADCY2
7177,KEGG_2019_Human,cGMP-PKG signaling pathway,1/166,0.0082999091363732,0.0100944840847783,0,0,19834.0,95034.82345515196,ADCY2
7178,KEGG_2019_Human,Calcium signaling pathway,1/188,0.009399902370135,0.0109614251298456,0,0,19812.0,92463.712994847,ADCY2
7179,KEGG_2019_Human,Chemokine signaling pathway,1/190,0.0094999017791995,0.0109614251298456,0,0,19810.0,92244.74636351672,ADCY2
7180,KEGG_2019_Human,Rap1 signaling pathway,1/206,0.010299897173561,0.0115873843202561,0,0,19794.0,90569.849337325,ADCY2
7181,KEGG_2019_Human,cAMP signaling pathway,1/212,0.0105998955026255,0.0116340316492232,0,0,19788.0,89974.27756224656,ADCY2
7182,KEGG_2019_Human,Human T-cell leukemia virus 1 infection,1/219,0.0109498935894162,0.0117320288458031,0,0,19781.0,89299.85161916987,ADCY2
7183,KEGG_2019_Human,Human cytomegalovirus infection,1/225,0.0112498919790339,0.0117731427687564,0,0,19775.0,88738.27077557483,ADCY2
7184,KEGG_2019_Human,Thermogenesis,1/231,0.0115498903940656,0.0118123879030216,0,0,19769.0,88191.07730937863,ADCY2
7185,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,ADCY2
7186,KEGG_2019_Human,Protein processing in endoplasmic reticulum,1/165,0.0082499094553477,0.0082499094553477,0,0,19835.0,95159.46482222488,SEC31B
7187,KEGG_2019_Human,Synaptic vesicle cycle,1/78,0.0038999427840466,0.0044499377838098,0,0,19922.0,110503.2180492851,SLC6A13
7188,KEGG_2019_Human,GABAergic synapse,1/89,0.0044499377838098,0.0044499377838098,0,0,19911.0,107815.380281759,SLC6A13
7189,KEGG_2019_Human,Long-term depression,1/60,0.002999951725986,0.0082499008373742,0,0,19940.0,115834.63209072244,GUCY1A2
7190,KEGG_2019_Human,Renin secretion,1/69,0.003449947123837,0.0082499008373742,0,0,19931.0,112996.7391397682,GUCY1A2
7191,KEGG_2019_Human,Gap junction,1/88,0.0043999382262822,0.0082499008373742,0,0,19912.0,108045.79305232369,GUCY1A2
7192,KEGG_2019_Human,Salivary secretion,1/90,0.0044999373439762,0.0082499008373742,0,0,19910.0,107587.50385474482,GUCY1A2
7193,KEGG_2019_Human,Circadian entrainment,1/97,0.0048499343304706,0.0082499008373742,0,0,19903.0,106058.9096435903,GUCY1A2
7194,KEGG_2019_Human,Platelet activation,1/124,0.0061999236097501,0.0082499008373742,0,0,19876.0,101034.04709010696,GUCY1A2
7195,KEGG_2019_Human,Purine metabolism,1/129,0.006449921761047,0.0082499008373742,0,0,19871.0,100223.109907462,GUCY1A2
7196,KEGG_2019_Human,Vascular smooth muscle contraction,1/132,0.0065999206698993,0.0082499008373742,0,0,19868.0,99751.22090491928,GUCY1A2
7197,KEGG_2019_Human,Oxytocin signaling pathway,1/153,0.0076499133771537,0.0082999091363732,0,0,19847.0,96715.6407630817,GUCY1A2
7198,KEGG_2019_Human,cGMP-PKG signaling pathway,1/166,0.0082999091363732,0.0082999091363732,0,0,19834.0,95034.82345515196,GUCY1A2
7199,KEGG_2019_Human,Spliceosome,1/134,0.0066999199497742,0.0066999199497742,0,0,19866.0,99442.43560916925,SNRNP70
7200,KEGG_2019_Human,Kaposi sarcoma-associated herpesvirus infection,1/186,0.0092999029651357,0.0092999029651357,0,0,19814.0,92684.96451050608,CD200R1
7201,KEGG_2019_Human,Thyroid hormone synthesis,1/74,0.0036999446830449,0.0036999446830449,0,0,19926.0,111574.38983110404,DUOXA2
7202,KEGG_2019_Human,Tight junction,1/170,0.0084999078692823,0.0084999078692823,0,0,19830.0,94543.49009679438,MPP4
7203,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR8B2
7204,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF607
7205,KEGG_2019_Human,Spliceosome,1/134,0.0066999199497742,0.0066999199497742,0,0,19866.0,99442.43560916925,SF3B2
7206,KEGG_2019_Human,Signaling pathways regulating pluripotency of stem cells,1/139,0.006949918172816,0.0096499008972596,0,0,19861.0,98689.81333375497,REST
7207,KEGG_2019_Human,Huntington disease,1/193,0.0096499008972596,0.0096499008972596,0,0,19807.0,91920.47679471428,REST
7208,KEGG_2019_Human,Insulin secretion,1/86,0.0042999391173866,0.0042999391173866,0,0,19914.0,108514.46102290176,RIMS2
7209,KEGG_2019_Human,Arrhythmogenic right ventricular cardiomyopathy (ARVC),1/72,0.0035999456502131,0.0102373580412072,0,0,19928.0,112131.59838572376,ITGB8
7210,KEGG_2019_Human,ECM-receptor interaction,1/82,0.004099940929819,0.0102373580412072,0,0,19918.0,109484.9180722932,ITGB8
7211,KEGG_2019_Human,Hypertrophic cardiomyopathy (HCM),1/85,0.004249939567045,0.0102373580412072,0,0,19915.0,108752.83801948265,ITGB8
7212,KEGG_2019_Human,Dilated cardiomyopathy (DCM),1/91,0.0045499369072032,0.0102373580412072,0,0,19909.0,107362.10783923086,ITGB8
7213,KEGG_2019_Human,Cell adhesion molecules (CAMs),1/145,0.0072499160871101,0.0130498489567983,0,0,19855.0,97820.92670675044,ITGB8
7214,KEGG_2019_Human,Focal adhesion,1/199,0.0099498991610159,0.0137570077946658,0,0,19801.0,91286.4288690606,ITGB8
7215,KEGG_2019_Human,Regulation of actin cytoskeleton,1/214,0.0106998949514067,0.0137570077946658,0,0,19786.0,89779.39753374986,ITGB8
7216,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0176998626413668,0,0,19670.0,80733.60565076157,ITGB8
7217,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0176998626413668,0,0,19646.0,79255.8617626126,ITGB8
7218,KEGG_2019_Human,DNA replication,1/36,0.0017999657178272,0.0035999314356544,0,0,19964.0,126172.23364250171,MCM2
7219,KEGG_2019_Human,Cell cycle,1/124,0.0061999236097501,0.0061999236097501,0,0,19876.0,101034.04709010696,MCM2
7220,KEGG_2019_Human,Nicotine addiction,1/40,0.0019999631680592,0.0068249053608048,0,0,19960.0,124043.94523066044,GABRA3
7221,KEGG_2019_Human,Taste transduction,1/83,0.0041499404726918,0.0068249053608048,0,0,19917.0,109237.99888847338,GABRA3
7222,KEGG_2019_Human,GABAergic synapse,1/89,0.0044499377838098,0.0068249053608048,0,0,19911.0,107815.380281759,GABRA3
7223,KEGG_2019_Human,Morphine addiction,1/91,0.0045499369072032,0.0068249053608048,0,0,19909.0,107362.10783923086,GABRA3
7224,KEGG_2019_Human,Retrograde endocannabinoid signaling,1/148,0.007399915061391,0.0088798980736692,0,0,19852.0,97399.60470052566,GABRA3
7225,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,GABRA3
7226,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,GRP
7227,KEGG_2019_Human,MicroRNAs in cancer,1/299,0.0149498740670514,0.0149498740670514,0,0,19701.0,82804.33538735632,KIF23
7228,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR2H1
7229,KEGG_2019_Human,Signaling pathways regulating pluripotency of stem cells,1/139,0.006949918172816,0.006949918172816,0,0,19861.0,98689.81333375497,LHX5
7230,KEGG_2019_Human,Endocytosis,1/244,0.0121998870519305,0.0121998870519305,0,0,19756.0,87051.4275316661,DAB2
7231,KEGG_2019_Human,Cell adhesion molecules (CAMs),1/145,0.0072499160871101,0.0072499160871101,0,0,19855.0,97820.92670675044,VCAN
7232,KEGG_2019_Human,Riboflavin metabolism,1/8,0.0003999883241497325,0.0023999299448983,0,0,19992.0,156418.91141655247,ENPP3
7233,KEGG_2019_Human,Pantothenate and CoA biosynthesis,1/19,0.00094997806231055,0.0026999485767408,0,0,19981.0,139049.2109571672,ENPP3
7234,KEGG_2019_Human,Nicotinate and nicotinamide metabolism,1/30,0.0014999697593334,0.0026999485767408,0,0,19970.0,129851.13732048514,ENPP3
7235,KEGG_2019_Human,Starch and sucrose metabolism,1/36,0.0017999657178272,0.0026999485767408,0,0,19964.0,126172.23364250171,ENPP3
7236,KEGG_2019_Human,Pyrimidine metabolism,1/57,0.002849953326298,0.0034199439915576,0,0,19943.0,116875.00742975442,ENPP3
7237,KEGG_2019_Human,Purine metabolism,1/129,0.006449921761047,0.006449921761047,0,0,19871.0,100223.109907462,ENPP3
7238,KEGG_2019_Human,Circadian entrainment,1/97,0.0048499343304706,0.0114165314662752,0,0,19903.0,106058.9096435903,ADCY10
7239,KEGG_2019_Human,Purine metabolism,1/129,0.006449921761047,0.0114165314662752,0,0,19871.0,100223.109907462,ADCY10
7240,KEGG_2019_Human,Apelin signaling pathway,1/137,0.0068499188797651,0.0114165314662752,0,0,19863.0,98987.62735269018,ADCY10
7241,KEGG_2019_Human,cAMP signaling pathway,1/212,0.0105998955026255,0.0115498903940656,0,0,19788.0,89974.27756224656,ADCY10
7242,KEGG_2019_Human,Thermogenesis,1/231,0.0115498903940656,0.0115498903940656,0,0,19769.0,88191.07730937863,ADCY10
7243,KEGG_2019_Human,Primary immunodeficiency,1/37,0.0018499650702878,0.0067332435395738,0,0,19963.0,125618.9446446357,PTPRC
7244,KEGG_2019_Human,Fc gamma R-mediated phagocytosis,1/91,0.0045499369072032,0.0067332435395738,0,0,19909.0,107362.10783923086,PTPRC
7245,KEGG_2019_Human,T cell receptor signaling pathway,1/101,0.0050499326546803,0.0067332435395738,0,0,19899.0,105233.48101229242,PTPRC
7246,KEGG_2019_Human,Cell adhesion molecules (CAMs),1/145,0.0072499160871101,0.0072499160871101,0,0,19855.0,97820.92670675044,PTPRC
7247,KEGG_2019_Human,African trypanosomiasis,1/37,0.0018499650702878,0.0055498952108636,0,0,19963.0,125618.9446446357,F2RL1
7248,KEGG_2019_Human,Inflammatory mediator regulation of TRP channels,1/100,0.0049999330710556,0.0074998996065834,0,0,19900.0,105436.78197328727,F2RL1
7249,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,F2RL1
7250,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR2AK2
7251,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR5H1
7252,KEGG_2019_Human,Autophagy,1/128,0.0063999221281459,0.0088999053857096,0,0,19872.0,100382.8010329652,ATG16L1
7253,KEGG_2019_Human,NOD-like receptor signaling pathway,1/178,0.0088999053857096,0.0088999053857096,0,0,19822.0,93593.82745769851,ATG16L1
7254,KEGG_2019_Human,Other types of O-glycan biosynthesis,1/22,0.0010999756574123,0.0021999513148247,0,0,19978.0,136099.47030191717,ST6GAL1
7255,KEGG_2019_Human,N-Glycan biosynthesis,1/50,0.0024999572069037,0.0024999572069037,0,0,19950.0,119530.05920663515,ST6GAL1
7256,KEGG_2019_Human,Cysteine and methionine metabolism,1/47,0.0023499589392381,0.0023499589392381,0,0,19953.0,120782.64067395544,MTAP
7257,KEGG_2019_Human,Thiamine metabolism,1/15,0.0007499814841592997,0.0007499814841592997,0,0,19985.0,143801.30885993244,TPK1
7258,KEGG_2019_Human,Mismatch repair,1/23,0.0011499748819949,0.0011499748819949,0,0,19977.0,135204.63922267244,EXO1
7259,KEGG_2019_Human,Aminoacyl-tRNA biosynthesis,1/66,0.003299948626608,0.003299948626608,0,0,19934.0,113899.85357353876,NARS2
7260,KEGG_2019_Human,Protein digestion and absorption,1/90,0.0044999373439762,0.0044999373439762,0,0,19910.0,107587.50385474482,COL18A1
7261,KEGG_2019_Human,Ether lipid metabolism,1/47,0.0023499589392381,0.0023499589392381,0,0,19953.0,120782.64067395544,PLA2G7
7262,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR8J3
7263,KEGG_2019_Human,RNA transport,1/165,0.0082499094553477,0.0082499094553477,0,0,19835.0,95159.46482222488,XPOT
7264,KEGG_2019_Human,Autoimmune thyroid disease,1/53,0.0026499555173137,0.0145586837375733,0,0,19947.0,118349.78824235698,IFNA8
7265,KEGG_2019_Human,Cytosolic DNA-sensing pathway,1/63,0.0031499501598827,0.0145586837375733,0,0,19937.0,114844.46974572667,IFNA8
7266,KEGG_2019_Human,RIG-I-like receptor signaling pathway,1/70,0.0034999466296654,0.0145586837375733,0,0,19930.0,112704.30065625212,IFNA8
7267,KEGG_2019_Human,Toll-like receptor signaling pathway,1/104,0.0051999314202997,0.0145586837375733,0,0,19896.0,104635.24941415618,IFNA8
7268,KEGG_2019_Human,Natural killer cell mediated cytotoxicity,1/131,0.0065499210316603,0.0145586837375733,0,0,19869.0,99907.33811343512,IFNA8
7269,KEGG_2019_Human,Measles,1/138,0.0068999185254481,0.0145586837375733,0,0,19862.0,98838.19160389496,IFNA8
7270,KEGG_2019_Human,Hepatitis C,1/155,0.0077499127120574,0.0145586837375733,0,0,19845.0,96448.16254952336,IFNA8
7271,KEGG_2019_Human,Necroptosis,1/162,0.0080999104202618,0.0145586837375733,0,0,19838.0,95537.86936302872,IFNA8
7272,KEGG_2019_Human,JAK-STAT signaling pathway,1/162,0.0080999104202618,0.0145586837375733,0,0,19838.0,95537.86936302872,IFNA8
7273,KEGG_2019_Human,Hepatitis B,1/163,0.0081499100978668,0.0145586837375733,0,0,19837.0,95410.9786681514,IFNA8
7274,KEGG_2019_Human,Influenza A,1/171,0.0085499075557634,0.0145586837375733,0,0,19829.0,94422.42241345016,IFNA8
7275,KEGG_2019_Human,NOD-like receptor signaling pathway,1/178,0.0088999053857096,0.0145586837375733,0,0,19822.0,93593.82745769851,IFNA8
7276,KEGG_2019_Human,Tuberculosis,1/179,0.0089499050800561,0.0145586837375733,0,0,19821.0,93478.0629355712,IFNA8
7277,KEGG_2019_Human,Kaposi sarcoma-associated herpesvirus infection,1/186,0.0092999029651357,0.0145586837375733,0,0,19814.0,92684.96451050608,IFNA8
7278,KEGG_2019_Human,Epstein-Barr virus infection,1/201,0.0100498985877989,0.0145586837375733,0,0,19799.0,91079.21596609056,IFNA8
7279,KEGG_2019_Human,Human immunodeficiency virus 1 infection,1/212,0.0105998955026255,0.0145586837375733,0,0,19788.0,89974.27756224656,IFNA8
7280,KEGG_2019_Human,Human cytomegalovirus infection,1/225,0.0112498919790339,0.0145586837375733,0,0,19775.0,88738.27077557483,IFNA8
7281,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0179665141039676,0,0,19706.0,83157.67014793828,IFNA8
7282,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0191051096893273,0,0,19670.0,80733.60565076157,IFNA8
7283,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0194698489055035,0,0,19646.0,79255.8617626126,IFNA8
7284,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0257712598834163,0,0,19508.0,72277.44006442746,IFNA8
7285,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,IFNA8
7286,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF534
7287,KEGG_2019_Human,Base excision repair,1/33,0.0016499677032113,0.0016499677032113,0,0,19967.0,127928.56031580272,LIG3
7288,KEGG_2019_Human,Epithelial cell signaling in Helicobacter pylori infection,1/68,0.0033999476216189,0.0101998428648568,0,0,19932.0,113293.39338050144,GIT1
7289,KEGG_2019_Human,Regulation of actin cytoskeleton,1/214,0.0106998949514067,0.0121998870519305,0,0,19786.0,89779.39753374986,GIT1
7290,KEGG_2019_Human,Endocytosis,1/244,0.0121998870519305,0.0121998870519305,0,0,19756.0,87051.4275316661,GIT1
7291,KEGG_2019_Human,Propanoate metabolism,1/32,0.0015999683804467,0.0047599266702665,0,0,19968.0,128549.41955786056,LDHA
7292,KEGG_2019_Human,Pyruvate metabolism,1/39,0.0019499637955508,0.0047599266702665,0,0,19961.0,124555.53162481484,LDHA
7293,KEGG_2019_Human,Cysteine and methionine metabolism,1/47,0.0023499589392381,0.0047599266702665,0,0,19953.0,120782.64067395544,LDHA
7294,KEGG_2019_Human,Central carbon metabolism in cancer,1/65,0.003249949134407,0.0047599266702665,0,0,19935.0,114209.92613860144,LDHA
7295,KEGG_2019_Human,Glycolysis / Gluconeogenesis,1/68,0.0033999476216189,0.0047599266702665,0,0,19932.0,113293.39338050144,LDHA
7296,KEGG_2019_Human,HIF-1 signaling pathway,1/100,0.0049999330710556,0.0051499318302617,0,0,19900.0,105436.78197328727,LDHA
7297,KEGG_2019_Human,Glucagon signaling pathway,1/103,0.0051499318302617,0.0051499318302617,0,0,19897.0,104832.7525292024,LDHA
7298,KEGG_2019_Human,Ribosome,1/153,0.0076499133771537,0.0076499133771537,0,0,19847.0,96715.6407630817,RPS3
7299,KEGG_2019_Human,One carbon pool by folate,1/20,0.0009999772468562472,0.0009999772468562472,0,0,19980.0,138017.40508704726,ALDH1L1
7300,KEGG_2019_Human,Vascular smooth muscle contraction,1/132,0.0065999206698993,0.0065999206698993,0,0,19868.0,99751.22090491928,RAMP2
7301,KEGG_2019_Human,Fatty acid degradation,1/44,0.0021999607179423,0.0021999607179423,0,0,19956.0,122117.06559109331,ECI1
7302,KEGG_2019_Human,NOD-like receptor signaling pathway,1/178,0.0088999053857096,0.0088999053857096,0,0,19822.0,93593.82745769851,GSDMD
7303,KEGG_2019_Human,Cardiac muscle contraction,1/78,0.0038999427840466,0.0112582177134695,0,0,19922.0,110503.2180492851,UQCRC2
7304,KEGG_2019_Human,Oxidative phosphorylation,1/133,0.0066499203093911,0.0112582177134695,0,0,19867.0,99596.2591544721,UQCRC2
7305,KEGG_2019_Human,Parkinson disease,1/142,0.0070999171242726,0.0112582177134695,0,0,19858.0,98250.87390500787,UQCRC2
7306,KEGG_2019_Human,Non-alcoholic fatty liver disease (NAFLD),1/149,0.0074499147221605,0.0112582177134695,0,0,19851.0,97261.02051561224,UQCRC2
7307,KEGG_2019_Human,Alzheimer disease,1/171,0.0085499075557634,0.0112582177134695,0,0,19829.0,94422.42241345016,UQCRC2
7308,KEGG_2019_Human,Huntington disease,1/193,0.0096499008972596,0.0112582177134695,0,0,19807.0,91920.47679471428,UQCRC2
7309,KEGG_2019_Human,Thermogenesis,1/231,0.0115498903940656,0.0115498903940656,0,0,19769.0,88191.07730937863,UQCRC2
7310,KEGG_2019_Human,Protein digestion and absorption,1/90,0.0044999373439762,0.0048999339081079,0,0,19910.0,107587.50385474482,CELA3B
7311,KEGG_2019_Human,Pancreatic secretion,1/98,0.0048999339081079,0.0048999339081079,0,0,19902.0,105849.45495286948,CELA3B
7312,KEGG_2019_Human,ABC transporters,1/45,0.0022499601197094,0.0022499601197094,0,0,19955.0,121662.49782449217,ABCB5
7313,KEGG_2019_Human,Osteoclast differentiation,1/127,0.0063499224962247,0.0063499224962247,0,0,19873.0,100543.72072014232,LILRA1
7314,KEGG_2019_Human,Biosynthesis of unsaturated fatty acids,1/27,0.0013499718942362,0.0013499718942362,0,0,19973.0,131975.02298599784,TECR
7315,KEGG_2019_Human,Fatty acid elongation,1/27,0.0013499718942362,0.0013499718942362,0,0,19973.0,131975.02298599784,TECR
7316,KEGG_2019_Human,Fc epsilon RI signaling pathway,1/68,0.0033999476216189,0.0106998949514067,0,0,19932.0,113293.39338050144,VAV1
7317,KEGG_2019_Human,B cell receptor signaling pathway,1/71,0.0035499461386618,0.0106998949514067,0,0,19929.0,112415.9585341616,VAV1
7318,KEGG_2019_Human,Fc gamma R-mediated phagocytosis,1/91,0.0045499369072032,0.0106998949514067,0,0,19909.0,107362.10783923086,VAV1
7319,KEGG_2019_Human,T cell receptor signaling pathway,1/101,0.0050499326546803,0.0106998949514067,0,0,19899.0,105233.48101229242,VAV1
7320,KEGG_2019_Human,Leukocyte transendothelial migration,1/112,0.0055999282120529,0.0106998949514067,0,0,19888.0,103119.30984392198,VAV1
7321,KEGG_2019_Human,Natural killer cell mediated cytotoxicity,1/131,0.0065499210316603,0.0106998949514067,0,0,19869.0,99907.33811343512,VAV1
7322,KEGG_2019_Human,Chemokine signaling pathway,1/190,0.0094999017791995,0.0106998949514067,0,0,19810.0,92244.74636351672,VAV1
7323,KEGG_2019_Human,Focal adhesion,1/199,0.0099498991610159,0.0106998949514067,0,0,19801.0,91286.4288690606,VAV1
7324,KEGG_2019_Human,cAMP signaling pathway,1/212,0.0105998955026255,0.0106998949514067,0,0,19788.0,89974.27756224656,VAV1
7325,KEGG_2019_Human,Regulation of actin cytoskeleton,1/214,0.0106998949514067,0.0106998949514067,0,0,19786.0,89779.39753374986,VAV1
7326,KEGG_2019_Human,Viral myocarditis,1/59,0.0029499522555206,0.008228459578064,0,0,19941.0,116175.59385530632,LAMA2
7327,KEGG_2019_Human,Arrhythmogenic right ventricular cardiomyopathy (ARVC),1/72,0.0035999456502131,0.008228459578064,0,0,19928.0,112131.59838572376,LAMA2
7328,KEGG_2019_Human,ECM-receptor interaction,1/82,0.004099940929819,0.008228459578064,0,0,19918.0,109484.9180722932,LAMA2
7329,KEGG_2019_Human,Hypertrophic cardiomyopathy (HCM),1/85,0.004249939567045,0.008228459578064,0,0,19915.0,108752.83801948265,LAMA2
7330,KEGG_2019_Human,Dilated cardiomyopathy (DCM),1/91,0.0045499369072032,0.008228459578064,0,0,19909.0,107362.10783923086,LAMA2
7331,KEGG_2019_Human,Small cell lung cancer,1/93,0.0046499360391879,0.008228459578064,0,0,19907.0,106918.54242106884,LAMA2
7332,KEGG_2019_Human,Amoebiasis,1/96,0.0047999347538706,0.008228459578064,0,0,19904.0,106270.50039849174,LAMA2
7333,KEGG_2019_Human,Toxoplasmosis,1/113,0.0056499278191151,0.0084748917286727,0,0,19887.0,102937.34947211576,LAMA2
7334,KEGG_2019_Human,Focal adhesion,1/199,0.0099498991610159,0.0132665322146879,0,0,19801.0,91286.4288690606,LAMA2
7335,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0193089410633093,0,0,19670.0,80733.60565076157,LAMA2
7336,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0193089410633093,0,0,19646.0,79255.8617626126,LAMA2
7337,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,LAMA2
7338,KEGG_2019_Human,Ribosome,1/153,0.0076499133771537,0.0076499133771537,0,0,19847.0,96715.6407630817,RPL3L
7339,KEGG_2019_Human,Intestinal immune network for IgA production,1/48,0.0023999583567988,0.0090070208994455,0,0,19952.0,120356.5272753826,ITGA4
7340,KEGG_2019_Human,Arrhythmogenic right ventricular cardiomyopathy (ARVC),1/72,0.0035999456502131,0.0090070208994455,0,0,19928.0,112131.59838572376,ITGA4
7341,KEGG_2019_Human,Leishmaniasis,1/74,0.0036999446830449,0.0090070208994455,0,0,19926.0,111574.38983110404,ITGA4
7342,KEGG_2019_Human,ECM-receptor interaction,1/82,0.004099940929819,0.0090070208994455,0,0,19918.0,109484.9180722932,ITGA4
7343,KEGG_2019_Human,Hypertrophic cardiomyopathy (HCM),1/85,0.004249939567045,0.0090070208994455,0,0,19915.0,108752.83801948265,ITGA4
7344,KEGG_2019_Human,Dilated cardiomyopathy (DCM),1/91,0.0045499369072032,0.0090070208994455,0,0,19909.0,107362.10783923086,ITGA4
7345,KEGG_2019_Human,Hematopoietic cell lineage,1/97,0.0048499343304706,0.0090070208994455,0,0,19903.0,106058.9096435903,ITGA4
7346,KEGG_2019_Human,Leukocyte transendothelial migration,1/112,0.0055999282120529,0.009099883344586,0,0,19888.0,103119.30984392198,ITGA4
7347,KEGG_2019_Human,Cell adhesion molecules (CAMs),1/145,0.0072499160871101,0.0104721010147147,0,0,19855.0,97820.92670675044,ITGA4
7348,KEGG_2019_Human,Focal adhesion,1/199,0.0099498991610159,0.0126453303971171,0,0,19801.0,91286.4288690606,ITGA4
7349,KEGG_2019_Human,Regulation of actin cytoskeleton,1/214,0.0106998949514067,0.0126453303971171,0,0,19786.0,89779.39753374986,ITGA4
7350,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0176998626413668,0,0,19670.0,80733.60565076157,ITGA4
7351,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0176998626413668,0,0,19646.0,79255.8617626126,ITGA4
7352,KEGG_2019_Human,Galactose metabolism,1/31,0.0015499690656704,0.0021999607179423,0,0,19969.0,129189.85098816035,MGAM
7353,KEGG_2019_Human,Starch and sucrose metabolism,1/36,0.0017999657178272,0.0021999607179423,0,0,19964.0,126172.23364250171,MGAM
7354,KEGG_2019_Human,Carbohydrate digestion and absorption,1/44,0.0021999607179423,0.0021999607179423,0,0,19956.0,122117.06559109331,MGAM
7355,KEGG_2019_Human,Cell adhesion molecules (CAMs),1/145,0.0072499160871101,0.0090499044707863,0,0,19855.0,97820.92670675044,NTNG1
7356,KEGG_2019_Human,Axon guidance,1/181,0.0090499044707863,0.0090499044707863,0,0,19819.0,93248.41634586031,NTNG1
7357,KEGG_2019_Human,Natural killer cell mediated cytotoxicity,1/131,0.0065499210316603,0.0065499210316603,0,0,19869.0,99907.33811343512,NCR1
7358,KEGG_2019_Human,Rap1 signaling pathway,1/206,0.010299897173561,0.010299897173561,0,0,19794.0,90569.849337325,SIPA1L1
7359,KEGG_2019_Human,Viral carcinogenesis,1/201,0.0100498985877989,0.0100498985877989,0,0,19799.0,91079.21596609056,DNAJA3
7360,KEGG_2019_Human,Axon guidance,1/181,0.0090499044707863,0.0090499044707863,0,0,19819.0,93248.41634586031,SLIT3
7361,KEGG_2019_Human,Oocyte meiosis,1/125,0.0062499232373748,0.0062499232373748,0,0,19875.0,100869.32368441945,SGO1
7362,KEGG_2019_Human,Nicotine addiction,1/40,0.0019999631680592,0.0068249053608048,0,0,19960.0,124043.94523066044,GABRA2
7363,KEGG_2019_Human,Taste transduction,1/83,0.0041499404726918,0.0068249053608048,0,0,19917.0,109237.99888847338,GABRA2
7364,KEGG_2019_Human,GABAergic synapse,1/89,0.0044499377838098,0.0068249053608048,0,0,19911.0,107815.380281759,GABRA2
7365,KEGG_2019_Human,Morphine addiction,1/91,0.0045499369072032,0.0068249053608048,0,0,19909.0,107362.10783923086,GABRA2
7366,KEGG_2019_Human,Retrograde endocannabinoid signaling,1/148,0.007399915061391,0.0088798980736692,0,0,19852.0,97399.60470052566,GABRA2
7367,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,GABRA2
7368,KEGG_2019_Human,Nucleotide excision repair,1/47,0.0023499589392381,0.0026999549628563,0,0,19953.0,120782.64067395544,ERCC4
7369,KEGG_2019_Human,Fanconi anemia pathway,1/54,0.0026999549628563,0.0026999549628563,0,0,19946.0,117971.01964061816,ERCC4
7370,KEGG_2019_Human,Endocytosis,1/244,0.0121998870519305,0.0121998870519305,0,0,19756.0,87051.4275316661,VPS37A
7371,KEGG_2019_Human,Pentose phosphate pathway,1/30,0.0014999697593334,0.0014999697593334,0,0,19970.0,129851.13732048514,RPIA
7372,KEGG_2019_Human,Serotonergic synapse,1/113,0.0056499278191151,0.0056499278191151,0,0,19887.0,102937.34947211576,CYP4X1
7373,KEGG_2019_Human,Purine metabolism,1/129,0.006449921761047,0.006449921761047,0,0,19871.0,100223.109907462,AMPD2
7374,KEGG_2019_Human,Notch signaling pathway,1/48,0.0023999583567988,0.0106873844447042,0,0,19952.0,120356.5272753826,PSEN1
7375,KEGG_2019_Human,Neurotrophin signaling pathway,1/119,0.0059499254985137,0.0106873844447042,0,0,19881.0,101877.73080211312,PSEN1
7376,KEGG_2019_Human,Wnt signaling pathway,1/158,0.0078999117225733,0.0106873844447042,0,0,19842.0,96053.2110949472,PSEN1
7377,KEGG_2019_Human,Alzheimer disease,1/171,0.0085499075557634,0.0106873844447042,0,0,19829.0,94422.42241345016,PSEN1
7378,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0164998674589645,0,0,19670.0,80733.60565076157,PSEN1
7379,KEGG_2019_Human,Renin-angiotensin system,1/23,0.0011499748819949,0.0011499748819949,0,0,19977.0,135204.63922267244,CMA1
7380,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR2M7
7381,KEGG_2019_Human,Bladder cancer,1/41,0.0020499625466866,0.0136998377595303,0,0,19959.0,123544.88783416104,MDM2
7382,KEGG_2019_Human,p53 signaling pathway,1/72,0.0035999456502131,0.0136998377595303,0,0,19928.0,112131.59838572376,MDM2
7383,KEGG_2019_Human,Melanoma,1/72,0.0035999456502131,0.0136998377595303,0,0,19928.0,112131.59838572376,MDM2
7384,KEGG_2019_Human,Glioma,1/75,0.0037499442041125,0.0136998377595303,0,0,19925.0,111301.33528642564,MDM2
7385,KEGG_2019_Human,Chronic myeloid leukemia,1/76,0.0037999437281752,0.0136998377595303,0,0,19924.0,111031.8499691117,MDM2
7386,KEGG_2019_Human,Prostate cancer,1/97,0.0048499343304706,0.0136998377595303,0,0,19903.0,106058.9096435903,MDM2
7387,KEGG_2019_Human,C-type lectin receptor signaling pathway,1/104,0.0051999314202997,0.0136998377595303,0,0,19896.0,104635.24941415618,MDM2
7388,KEGG_2019_Human,Thyroid hormone signaling pathway,1/116,0.0057999266512085,0.0136998377595303,0,0,19884.0,102400.8105961506,MDM2
7389,KEGG_2019_Human,Cell cycle,1/124,0.0061999236097501,0.0136998377595303,0,0,19876.0,101034.04709010696,MDM2
7390,KEGG_2019_Human,FoxO signaling pathway,1/132,0.0065999206698993,0.0136998377595303,0,0,19868.0,99751.22090491928,MDM2
7391,KEGG_2019_Human,Ubiquitin mediated proteolysis,1/137,0.0068499188797651,0.0136998377595303,0,0,19863.0,98987.62735269018,MDM2
7392,KEGG_2019_Human,Cellular senescence,1/160,0.0079999110688441,0.0138186105582236,0,0,19840.0,95793.96509856998,MDM2
7393,KEGG_2019_Human,Transcriptional misregulation in cancer,1/186,0.0092999029651357,0.0138186105582236,0,0,19814.0,92684.96451050608,MDM2
7394,KEGG_2019_Human,Proteoglycans in cancer,1/201,0.0100498985877989,0.0138186105582236,0,0,19799.0,91079.21596609056,MDM2
7395,KEGG_2019_Human,Viral carcinogenesis,1/201,0.0100498985877989,0.0138186105582236,0,0,19799.0,91079.21596609056,MDM2
7396,KEGG_2019_Human,Epstein-Barr virus infection,1/201,0.0100498985877989,0.0138186105582236,0,0,19799.0,91079.21596609056,MDM2
7397,KEGG_2019_Human,Human cytomegalovirus infection,1/225,0.0112498919790339,0.0145586837375733,0,0,19775.0,88738.27077557483,MDM2
7398,KEGG_2019_Human,Endocytosis,1/244,0.0121998870519305,0.0149109730634706,0,0,19756.0,87051.4275316661,MDM2
7399,KEGG_2019_Human,MicroRNAs in cancer,1/299,0.0149498740670514,0.0173103804986911,0,0,19701.0,82804.33538735632,MDM2
7400,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0181498542048609,0,0,19670.0,80733.60565076157,MDM2
7401,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0185427132433367,0,0,19646.0,79255.8617626126,MDM2
7402,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,MDM2
7403,KEGG_2019_Human,Rheumatoid arthritis,1/91,0.0045499369072032,0.0154665201799472,0,0,19909.0,107362.10783923086,FLT1
7404,KEGG_2019_Human,HIF-1 signaling pathway,1/100,0.0049999330710556,0.0154665201799472,0,0,19900.0,105436.78197328727,FLT1
7405,KEGG_2019_Human,Transcriptional misregulation in cancer,1/186,0.0092999029651357,0.0154665201799472,0,0,19814.0,92684.96451050608,FLT1
7406,KEGG_2019_Human,Focal adhesion,1/199,0.0099498991610159,0.0154665201799472,0,0,19801.0,91286.4288690606,FLT1
7407,KEGG_2019_Human,Rap1 signaling pathway,1/206,0.010299897173561,0.0154665201799472,0,0,19794.0,90569.849337325,FLT1
7408,KEGG_2019_Human,Ras signaling pathway,1/232,0.0115998901349604,0.0154665201799472,0,0,19768.0,88101.22480150245,FLT1
7409,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0168569999470293,0,0,19705.0,83086.53988020132,FLT1
7410,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0176998626413668,0,0,19646.0,79255.8617626126,FLT1
7411,KEGG_2019_Human,Nicotinate and nicotinamide metabolism,1/30,0.0014999697593334,0.0014999697593334,0,0,19970.0,129851.13732048514,NMNAT1
7412,KEGG_2019_Human,Mucin type O-glycan biosynthesis,1/31,0.0015499690656704,0.0026499555173137,0,0,19969.0,129189.85098816035,ST3GAL2
7413,KEGG_2019_Human,Glycosphingolipid biosynthesis,1/45,0.0022499601197094,0.0026499555173137,0,0,19955.0,121662.49782449217,ST3GAL2
7414,KEGG_2019_Human,Glycosaminoglycan biosynthesis,1/53,0.0026499555173137,0.0026499555173137,0,0,19947.0,118349.78824235698,ST3GAL2
7415,KEGG_2019_Human,"Parathyroid hormone synthesis, secretion and action",1/106,0.0052999306076525,0.0052999306076525,0,0,19894.0,104245.78450366124,GCM1
7416,KEGG_2019_Human,Malaria,1/49,0.0024499577795033,0.0058199211965648,0,0,19951.0,119939.1172087114,CR1
7417,KEGG_2019_Human,Legionellosis,1/55,0.0027499544131125,0.0058199211965648,0,0,19945.0,117599.1294878737,CR1
7418,KEGG_2019_Human,Leishmaniasis,1/74,0.0036999446830449,0.0058199211965648,0,0,19926.0,111574.38983110404,CR1
7419,KEGG_2019_Human,Complement and coagulation cascades,1/79,0.0039499423167337,0.0058199211965648,0,0,19921.0,110243.89578070649,CR1
7420,KEGG_2019_Human,Hematopoietic cell lineage,1/97,0.0048499343304706,0.0058199211965648,0,0,19903.0,106058.9096435903,CR1
7421,KEGG_2019_Human,Tuberculosis,1/179,0.0089499050800561,0.0089499050800561,0,0,19821.0,93478.0629355712,CR1
7422,KEGG_2019_Human,ECM-receptor interaction,1/82,0.004099940929819,0.004099940929819,0,0,19918.0,109484.9180722932,HMMR
7423,KEGG_2019_Human,Osteoclast differentiation,1/127,0.0063499224962247,0.0063499224962247,0,0,19873.0,100543.72072014232,LILRA4
7424,KEGG_2019_Human,Steroid hormone biosynthesis,1/60,0.002999951725986,0.0048749237016105,0,0,19940.0,115834.63209072244,CYP11B1
7425,KEGG_2019_Human,Cortisol synthesis and secretion,1/65,0.003249949134407,0.0048749237016105,0,0,19935.0,114209.92613860144,CYP11B1
7426,KEGG_2019_Human,Cushing syndrome,1/155,0.0077499127120574,0.0077499127120574,0,0,19845.0,96448.16254952336,CYP11B1
7427,KEGG_2019_Human,Arrhythmogenic right ventricular cardiomyopathy (ARVC),1/72,0.0035999456502131,0.0113165134377649,0,0,19928.0,112131.59838572376,ITGA2B
7428,KEGG_2019_Human,ECM-receptor interaction,1/82,0.004099940929819,0.0113165134377649,0,0,19918.0,109484.9180722932,ITGA2B
7429,KEGG_2019_Human,Hypertrophic cardiomyopathy (HCM),1/85,0.004249939567045,0.0113165134377649,0,0,19915.0,108752.83801948265,ITGA2B
7430,KEGG_2019_Human,Dilated cardiomyopathy (DCM),1/91,0.0045499369072032,0.0113165134377649,0,0,19909.0,107362.10783923086,ITGA2B
7431,KEGG_2019_Human,Small cell lung cancer,1/93,0.0046499360391879,0.0113165134377649,0,0,19907.0,106918.54242106884,ITGA2B
7432,KEGG_2019_Human,Hematopoietic cell lineage,1/97,0.0048499343304706,0.0113165134377649,0,0,19903.0,106058.9096435903,ITGA2B
7433,KEGG_2019_Human,Platelet activation,1/124,0.0061999236097501,0.012162356802428,0,0,19876.0,101034.04709010696,ITGA2B
7434,KEGG_2019_Human,Fluid shear stress and atherosclerosis,1/139,0.006949918172816,0.012162356802428,0,0,19861.0,98689.81333375497,ITGA2B
7435,KEGG_2019_Human,Focal adhesion,1/199,0.0099498991610159,0.0136180481199722,0,0,19801.0,91286.4288690606,ITGA2B
7436,KEGG_2019_Human,Rap1 signaling pathway,1/206,0.010299897173561,0.0136180481199722,0,0,19794.0,90569.849337325,ITGA2B
7437,KEGG_2019_Human,Regulation of actin cytoskeleton,1/214,0.0106998949514067,0.0136180481199722,0,0,19786.0,89779.39753374986,ITGA2B
7438,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0190613905368566,0,0,19670.0,80733.60565076157,ITGA2B
7439,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0190613905368566,0,0,19646.0,79255.8617626126,ITGA2B
7440,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,ITGA2B
7441,KEGG_2019_Human,RNA degradation,1/79,0.0039499423167337,0.0039499423167337,0,0,19921.0,110243.89578070649,EXOSC4
7442,KEGG_2019_Human,Graft-versus-host disease,1/41,0.0020499625466866,0.0076998865095004,0,0,19959.0,123544.88783416104,KIR2DL1
7443,KEGG_2019_Human,Antigen processing and presentation,1/77,0.0038499432547502,0.0076998865095004,0,0,19923.0,110765.8407373636,KIR2DL1
7444,KEGG_2019_Human,Natural killer cell mediated cytotoxicity,1/131,0.0065499210316603,0.0079999110688441,0,0,19869.0,99907.33811343512,KIR2DL1
7445,KEGG_2019_Human,Cellular senescence,1/160,0.0079999110688441,0.0079999110688441,0,0,19840.0,95793.96509856998,KIR2DL1
7446,KEGG_2019_Human,ECM-receptor interaction,1/82,0.004099940929819,0.0112498433599406,0,0,19918.0,109484.9180722932,COL9A3
7447,KEGG_2019_Human,Protein digestion and absorption,1/90,0.0044999373439762,0.0112498433599406,0,0,19910.0,107587.50385474482,COL9A3
7448,KEGG_2019_Human,Focal adhesion,1/199,0.0099498991610159,0.0165831652683599,0,0,19801.0,91286.4288690606,COL9A3
7449,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0176998626413668,0,0,19670.0,80733.60565076157,COL9A3
7450,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0176998626413668,0,0,19646.0,79255.8617626126,COL9A3
7451,KEGG_2019_Human,Renin-angiotensin system,1/23,0.0011499748819949,0.0045998995279799,0,0,19977.0,135204.63922267244,MME
7452,KEGG_2019_Human,Protein digestion and absorption,1/90,0.0044999373439762,0.0064665791072942,0,0,19910.0,107587.50385474482,MME
7453,KEGG_2019_Human,Hematopoietic cell lineage,1/97,0.0048499343304706,0.0064665791072942,0,0,19903.0,106058.9096435903,MME
7454,KEGG_2019_Human,Alzheimer disease,1/171,0.0085499075557634,0.0085499075557634,0,0,19829.0,94422.42241345016,MME
7455,KEGG_2019_Human,Antigen processing and presentation,1/77,0.0038499432547502,0.0065499210316603,0,0,19923.0,110765.8407373636,KLRC3
7456,KEGG_2019_Human,Natural killer cell mediated cytotoxicity,1/131,0.0065499210316603,0.0065499210316603,0,0,19869.0,99907.33811343512,KLRC3
7457,KEGG_2019_Human,Hedgehog signaling pathway,1/47,0.0023499589392381,0.0023499589392381,0,0,19953.0,120782.64067395544,SPOPL
7458,KEGG_2019_Human,Glycosphingolipid biosynthesis,1/45,0.0022499601197094,0.0022499601197094,0,0,19955.0,121662.49782449217,FUT5
7459,KEGG_2019_Human,cAMP signaling pathway,1/212,0.0105998955026255,0.0168998658265596,0,0,19788.0,89974.27756224656,GHSR
7460,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,GHSR
7461,KEGG_2019_Human,Cell cycle,1/124,0.0061999236097501,0.0061999236097501,0,0,19876.0,101034.04709010696,ORC4
7462,KEGG_2019_Human,N-Glycan biosynthesis,1/50,0.0024999572069037,0.0049999144138074,0,0,19950.0,119530.05920663515,MAN1C1
7463,KEGG_2019_Human,Protein processing in endoplasmic reticulum,1/165,0.0082499094553477,0.0082499094553477,0,0,19835.0,95159.46482222488,MAN1C1
7464,KEGG_2019_Human,p53 signaling pathway,1/72,0.0035999456502131,0.0071998913004262,0,0,19928.0,112131.59838572376,MDM4
7465,KEGG_2019_Human,MicroRNAs in cancer,1/299,0.0149498740670514,0.0149498740670514,0,0,19701.0,82804.33538735632,MDM4
7466,KEGG_2019_Human,Folate biosynthesis,1/26,0.0012999726251831,0.0012999726251831,0,0,19974.0,132735.46073187632,PTS
7467,KEGG_2019_Human,Glycerolipid metabolism,1/61,0.0030499512001654,0.0036999446830449,0,0,19939.0,115499.24335773686,GK2
7468,KEGG_2019_Human,PPAR signaling pathway,1/74,0.0036999446830449,0.0036999446830449,0,0,19926.0,111574.38983110404,GK2
7469,KEGG_2019_Human,Progesterone-mediated oocyte maturation,1/99,0.0049499334884068,0.0062499232373748,0,0,19901.0,105642.09305076736,SPDYE5
7470,KEGG_2019_Human,Oocyte meiosis,1/125,0.0062499232373748,0.0062499232373748,0,0,19875.0,100869.32368441945,SPDYE5
7471,KEGG_2019_Human,Hedgehog signaling pathway,1/47,0.0023499589392381,0.0023499589392381,0,0,19953.0,120782.64067395544,GPR161
7472,KEGG_2019_Human,Prion diseases,1/35,0.0017499663721595,0.0019999631680592,0,0,19965.0,126740.98858805298,PRNP
7473,KEGG_2019_Human,Ferroptosis,1/40,0.0019999631680592,0.0019999631680592,0,0,19960.0,124043.94523066044,PRNP
7474,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR4N2
7475,KEGG_2019_Human,C-type lectin receptor signaling pathway,1/104,0.0051999314202997,0.0089499050800561,0,0,19896.0,104635.24941415618,LSP1
7476,KEGG_2019_Human,Tuberculosis,1/179,0.0089499050800561,0.0089499050800561,0,0,19821.0,93478.0629355712,LSP1
7477,KEGG_2019_Human,SNARE interactions in vesicular transport,1/34,0.0016999670339032,0.0016999670339032,0,0,19966.0,127326.1054203148,STX11
7478,KEGG_2019_Human,Basal transcription factors,1/45,0.0022499601197094,0.0044999202394188,0,0,19955.0,121662.49782449217,TAF4B
7479,KEGG_2019_Human,Huntington disease,1/193,0.0096499008972596,0.0096499008972596,0,0,19807.0,91920.47679471428,TAF4B
7480,KEGG_2019_Human,Ras signaling pathway,1/232,0.0115998901349604,0.0147498749536506,0,0,19768.0,88101.22480150245,RASGRF2
7481,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0147498749536506,0,0,19705.0,83086.53988020132,RASGRF2
7482,KEGG_2019_Human,Ras signaling pathway,1/232,0.0115998901349604,0.0115998901349604,0,0,19768.0,88101.22480150245,RASA3
7483,KEGG_2019_Human,Aminoacyl-tRNA biosynthesis,1/66,0.003299948626608,0.003299948626608,0,0,19934.0,113899.85357353876,IARS2
7484,KEGG_2019_Human,Arrhythmogenic right ventricular cardiomyopathy (ARVC),1/72,0.0035999456502131,0.0043999382262822,0,0,19928.0,112131.59838572376,GJA1
7485,KEGG_2019_Human,Gap junction,1/88,0.0043999382262822,0.0043999382262822,0,0,19912.0,108045.79305232369,GJA1
7486,KEGG_2019_Human,Mitophagy,1/65,0.003249949134407,0.0104415559267321,0,0,19935.0,114209.92613860144,RAB7A
7487,KEGG_2019_Human,Salmonella infection,1/86,0.0042999391173866,0.0104415559267321,0,0,19914.0,108514.46102290176,RAB7A
7488,KEGG_2019_Human,Amoebiasis,1/96,0.0047999347538706,0.0104415559267321,0,0,19904.0,106270.50039849174,RAB7A
7489,KEGG_2019_Human,Autophagy,1/128,0.0063999221281459,0.0104415559267321,0,0,19872.0,100382.8010329652,RAB7A
7490,KEGG_2019_Human,Phagosome,1/152,0.0075999137114971,0.0104415559267321,0,0,19848.0,96850.665715497,RAB7A
7491,KEGG_2019_Human,Tuberculosis,1/179,0.0089499050800561,0.0104415559267321,0,0,19821.0,93478.0629355712,RAB7A
7492,KEGG_2019_Human,Endocytosis,1/244,0.0121998870519305,0.0121998870519305,0,0,19756.0,87051.4275316661,RAB7A
7493,KEGG_2019_Human,Endocrine and other factor-regulated calcium reabsorption,1/48,0.0023999583567988,0.0023999583567988,0,0,19952.0,120356.5272753826,CALB1
7494,KEGG_2019_Human,Type II diabetes mellitus,1/46,0.0022999595269283,0.0077061587397358,0,0,19954.0,121217.8313311442,IRS4
7495,KEGG_2019_Human,Regulation of lipolysis in adipocytes,1/55,0.0027499544131125,0.0077061587397358,0,0,19945.0,117599.1294878737,IRS4
7496,KEGG_2019_Human,Adipocytokine signaling pathway,1/69,0.003449947123837,0.0077061587397358,0,0,19931.0,112996.7391397682,IRS4
7497,KEGG_2019_Human,Longevity regulating pathway,1/102,0.0050999322416682,0.0077061587397358,0,0,19898.0,105032.15064717118,IRS4
7498,KEGG_2019_Human,AMPK signaling pathway,1/120,0.0059999251180858,0.0077061587397358,0,0,19880.0,101706.2448082016,IRS4
7499,KEGG_2019_Human,Autophagy,1/128,0.0063999221281459,0.0077061587397358,0,0,19872.0,100382.8010329652,IRS4
7500,KEGG_2019_Human,FoxO signaling pathway,1/132,0.0065999206698993,0.0077061587397358,0,0,19868.0,99751.22090491928,IRS4
7501,KEGG_2019_Human,Insulin signaling pathway,1/137,0.0068499188797651,0.0077061587397358,0,0,19863.0,98987.62735269018,IRS4
7502,KEGG_2019_Human,cGMP-PKG signaling pathway,1/166,0.0082999091363732,0.0082999091363732,0,0,19834.0,95034.82345515196,IRS4
7503,KEGG_2019_Human,Viral myocarditis,1/59,0.0029499522555206,0.0045499369072032,0,0,19941.0,116175.59385530632,DMD
7504,KEGG_2019_Human,Arrhythmogenic right ventricular cardiomyopathy (ARVC),1/72,0.0035999456502131,0.0045499369072032,0,0,19928.0,112131.59838572376,DMD
7505,KEGG_2019_Human,Hypertrophic cardiomyopathy (HCM),1/85,0.004249939567045,0.0045499369072032,0,0,19915.0,108752.83801948265,DMD
7506,KEGG_2019_Human,Dilated cardiomyopathy (DCM),1/91,0.0045499369072032,0.0045499369072032,0,0,19909.0,107362.10783923086,DMD
7507,KEGG_2019_Human,Endocytosis,1/244,0.0121998870519305,0.0121998870519305,0,0,19756.0,87051.4275316661,VPS45
7508,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF606
7509,KEGG_2019_Human,Glucagon signaling pathway,1/103,0.0051499318302617,0.0065999206698993,0,0,19897.0,104832.7525292024,PRMT1
7510,KEGG_2019_Human,FoxO signaling pathway,1/132,0.0065999206698993,0.0065999206698993,0,0,19868.0,99751.22090491928,PRMT1
7511,KEGG_2019_Human,TGF-beta signaling pathway,1/90,0.0044999373439762,0.0092665575637547,0,0,19910.0,107587.50385474482,ACVR2A
7512,KEGG_2019_Human,Fluid shear stress and atherosclerosis,1/139,0.006949918172816,0.0092665575637547,0,0,19861.0,98689.81333375497,ACVR2A
7513,KEGG_2019_Human,Signaling pathways regulating pluripotency of stem cells,1/139,0.006949918172816,0.0092665575637547,0,0,19861.0,98689.81333375497,ACVR2A
7514,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0146998751759735,0,0,19706.0,83157.67014793828,ACVR2A
7515,KEGG_2019_Human,Hepatocellular carcinoma,1/168,0.0083999085011095,0.0115498903940656,0,0,19832.0,94787.72752807094,SMARCA4
7516,KEGG_2019_Human,Thermogenesis,1/231,0.0115498903940656,0.0115498903940656,0,0,19769.0,88191.07730937863,SMARCA4
7517,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR4C16
7518,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR8J1
7519,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,NMU
7520,KEGG_2019_Human,Maturity onset diabetes of the young,1/26,0.0012999726251831,0.0053999298011749,0,0,19974.0,132735.46073187632,SLC2A2
7521,KEGG_2019_Human,Carbohydrate digestion and absorption,1/44,0.0021999607179423,0.0053999298011749,0,0,19956.0,122117.06559109331,SLC2A2
7522,KEGG_2019_Human,Type II diabetes mellitus,1/46,0.0022999595269283,0.0053999298011749,0,0,19954.0,121217.8313311442,SLC2A2
7523,KEGG_2019_Human,Central carbon metabolism in cancer,1/65,0.003249949134407,0.0053999298011749,0,0,19935.0,114209.92613860144,SLC2A2
7524,KEGG_2019_Human,Prolactin signaling pathway,1/70,0.0034999466296654,0.0053999298011749,0,0,19930.0,112704.30065625212,SLC2A2
7525,KEGG_2019_Human,Insulin secretion,1/86,0.0042999391173866,0.0053999298011749,0,0,19914.0,108514.46102290176,SLC2A2
7526,KEGG_2019_Human,Glucagon signaling pathway,1/103,0.0051499318302617,0.0053999298011749,0,0,19897.0,104832.7525292024,SLC2A2
7527,KEGG_2019_Human,Insulin resistance,1/108,0.0053999298011749,0.0053999298011749,0,0,19892.0,103863.47861844616,SLC2A2
7528,KEGG_2019_Human,Hippo signaling pathway,1/160,0.0079999110688441,0.0079999110688441,0,0,19840.0,95793.96509856998,CRB1
7529,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR5W2
7530,KEGG_2019_Human,Necroptosis,1/162,0.0080999104202618,0.0121998870519305,0,0,19838.0,95537.86936302872,CHMP4C
7531,KEGG_2019_Human,Endocytosis,1/244,0.0121998870519305,0.0121998870519305,0,0,19756.0,87051.4275316661,CHMP4C
7532,KEGG_2019_Human,Mucin type O-glycan biosynthesis,1/31,0.0015499690656704,0.0015499690656704,0,0,19969.0,129189.85098816035,GALNT16
7533,KEGG_2019_Human,Endocytosis,1/244,0.0121998870519305,0.0121998870519305,0,0,19756.0,87051.4275316661,GBF1
7534,KEGG_2019_Human,Human immunodeficiency virus 1 infection,1/212,0.0105998955026255,0.0105998955026255,0,0,19788.0,89974.27756224656,APOBEC3H
7535,KEGG_2019_Human,Tight junction,1/170,0.0084999078692823,0.0084999078692823,0,0,19830.0,94543.49009679438,WHAMM
7536,KEGG_2019_Human,Phenylalanine metabolism,1/17,0.0008499797390404818,0.0035999314356544,0,0,19983.0,141285.76583697114,ALDH1A3
7537,KEGG_2019_Human,Histidine metabolism,1/23,0.0011499748819949,0.0035999314356544,0,0,19977.0,135204.63922267244,ALDH1A3
7538,KEGG_2019_Human,beta-Alanine metabolism,1/31,0.0015499690656704,0.0035999314356544,0,0,19969.0,129189.85098816035,ALDH1A3
7539,KEGG_2019_Human,Tyrosine metabolism,1/36,0.0017999657178272,0.0035999314356544,0,0,19964.0,126172.23364250171,ALDH1A3
7540,KEGG_2019_Human,Glycolysis / Gluconeogenesis,1/68,0.0033999476216189,0.004685646776936,0,0,19932.0,113293.39338050144,ALDH1A3
7541,KEGG_2019_Human,Metabolism of xenobiotics by cytochrome P450,1/74,0.0036999446830449,0.004685646776936,0,0,19926.0,111574.38983110404,ALDH1A3
7542,KEGG_2019_Human,Chemical carcinogenesis,1/82,0.004099940929819,0.004685646776936,0,0,19918.0,109484.9180722932,ALDH1A3
7543,KEGG_2019_Human,Drug metabolism,1/108,0.0053999298011749,0.0053999298011749,0,0,19892.0,103863.47861844616,ALDH1A3
7544,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR51T1
7545,KEGG_2019_Human,ErbB signaling pathway,1/85,0.004249939567045,0.004249939567045,0,0,19915.0,108752.83801948265,NRG1
7546,KEGG_2019_Human,Tight junction,1/170,0.0084999078692823,0.0142665266018757,0,0,19830.0,94543.49009679438,RDX
7547,KEGG_2019_Human,Proteoglycans in cancer,1/201,0.0100498985877989,0.0142665266018757,0,0,19799.0,91079.21596609056,RDX
7548,KEGG_2019_Human,Regulation of actin cytoskeleton,1/214,0.0106998949514067,0.0142665266018757,0,0,19786.0,89779.39753374986,RDX
7549,KEGG_2019_Human,MicroRNAs in cancer,1/299,0.0149498740670514,0.0149498740670514,0,0,19701.0,82804.33538735632,RDX
7550,KEGG_2019_Human,Signaling pathways regulating pluripotency of stem cells,1/139,0.006949918172816,0.0079999110688441,0,0,19861.0,98689.81333375497,SOX2
7551,KEGG_2019_Human,Hippo signaling pathway,1/160,0.0079999110688441,0.0079999110688441,0,0,19840.0,95793.96509856998,SOX2
7552,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,P2RY14
7553,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF665
7554,KEGG_2019_Human,Bile secretion,1/72,0.0035999456502131,0.0035999456502131,0,0,19928.0,112131.59838572376,AQP9
7555,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR5J2
7556,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF10
7557,KEGG_2019_Human,Gastric acid secretion,1/75,0.0037499442041125,0.0112498326123375,0,0,19925.0,111301.33528642564,SST
7558,KEGG_2019_Human,cAMP signaling pathway,1/212,0.0105998955026255,0.0158998432539383,0,0,19788.0,89974.27756224656,SST
7559,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,SST
7560,KEGG_2019_Human,Gastric acid secretion,1/75,0.0037499442041125,0.0037499442041125,0,0,19925.0,111301.33528642564,KCNJ16
7561,KEGG_2019_Human,Axon guidance,1/181,0.0090499044707863,0.0090499044707863,0,0,19819.0,93248.41634586031,EPHB3
7562,KEGG_2019_Human,Taste transduction,1/83,0.0041499404726918,0.0041499404726918,0,0,19917.0,109237.99888847338,TAS2R60
7563,KEGG_2019_Human,IL-17 signaling pathway,1/93,0.0046499360391879,0.0046499360391879,0,0,19907.0,106918.54242106884,MUC5AC
7564,KEGG_2019_Human,Retinol metabolism,1/67,0.0033499481224912,0.0033499481224912,0,0,19933.0,113594.38808369274,CYP27C1
7565,KEGG_2019_Human,Ubiquitin mediated proteolysis,1/137,0.0068499188797651,0.0068499188797651,0,0,19863.0,98987.62735269018,WWP2
7566,KEGG_2019_Human,Adherens junction,1/72,0.0035999456502131,0.0072499160871101,0,0,19928.0,112131.59838572376,PTPRF
7567,KEGG_2019_Human,Insulin resistance,1/108,0.0053999298011749,0.0072499160871101,0,0,19892.0,103863.47861844616,PTPRF
7568,KEGG_2019_Human,Insulin signaling pathway,1/137,0.0068499188797651,0.0072499160871101,0,0,19863.0,98987.62735269018,PTPRF
7569,KEGG_2019_Human,Cell adhesion molecules (CAMs),1/145,0.0072499160871101,0.0072499160871101,0,0,19855.0,97820.92670675044,PTPRF
7570,KEGG_2019_Human,Basal cell carcinoma,1/63,0.0031499501598827,0.0112498433599406,0,0,19937.0,114844.46974572667,BMP2
7571,KEGG_2019_Human,TGF-beta signaling pathway,1/90,0.0044999373439762,0.0112498433599406,0,0,19910.0,107587.50385474482,BMP2
7572,KEGG_2019_Human,Hippo signaling pathway,1/160,0.0079999110688441,0.0133331851147402,0,0,19840.0,95793.96509856998,BMP2
7573,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0183748439699668,0,0,19706.0,83157.67014793828,BMP2
7574,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,BMP2
7575,KEGG_2019_Human,ABC transporters,1/45,0.0022499601197094,0.0022499601197094,0,0,19955.0,121662.49782449217,ABCA12
7576,KEGG_2019_Human,Fat digestion and absorption,1/41,0.0020499625466866,0.0024999572069037,0,0,19959.0,123544.88783416104,ABCA1
7577,KEGG_2019_Human,ABC transporters,1/45,0.0022499601197094,0.0024999572069037,0,0,19955.0,121662.49782449217,ABCA1
7578,KEGG_2019_Human,Cholesterol metabolism,1/50,0.0024999572069037,0.0024999572069037,0,0,19950.0,119530.05920663515,ABCA1
7579,KEGG_2019_Human,Protein processing in endoplasmic reticulum,1/165,0.0082499094553477,0.0082499094553477,0,0,19835.0,95159.46482222488,SEC31A
7580,KEGG_2019_Human,Renal cell carcinoma,1/69,0.003449947123837,0.0115998901349604,0,0,19931.0,112996.7391397682,PAK3
7581,KEGG_2019_Human,ErbB signaling pathway,1/85,0.004249939567045,0.0115998901349604,0,0,19915.0,108752.83801948265,PAK3
7582,KEGG_2019_Human,T cell receptor signaling pathway,1/101,0.0050499326546803,0.0115998901349604,0,0,19899.0,105233.48101229242,PAK3
7583,KEGG_2019_Human,Axon guidance,1/181,0.0090499044707863,0.0115998901349604,0,0,19819.0,93248.41634586031,PAK3
7584,KEGG_2019_Human,Focal adhesion,1/199,0.0099498991610159,0.0115998901349604,0,0,19801.0,91286.4288690606,PAK3
7585,KEGG_2019_Human,Human immunodeficiency virus 1 infection,1/212,0.0105998955026255,0.0115998901349604,0,0,19788.0,89974.27756224656,PAK3
7586,KEGG_2019_Human,Regulation of actin cytoskeleton,1/214,0.0106998949514067,0.0115998901349604,0,0,19786.0,89779.39753374986,PAK3
7587,KEGG_2019_Human,Ras signaling pathway,1/232,0.0115998901349604,0.0115998901349604,0,0,19768.0,88101.22480150245,PAK3
7588,KEGG_2019_Human,Ras signaling pathway,1/232,0.0115998901349604,0.0115998901349604,0,0,19768.0,88101.22480150245,SHOC2
7589,KEGG_2019_Human,Insulin resistance,1/108,0.0053999298011749,0.0068499188797651,0,0,19892.0,103863.47861844616,PPP1R3A
7590,KEGG_2019_Human,Insulin signaling pathway,1/137,0.0068499188797651,0.0068499188797651,0,0,19863.0,98987.62735269018,PPP1R3A
7591,KEGG_2019_Human,Ras signaling pathway,1/232,0.0115998901349604,0.0115998901349604,0,0,19768.0,88101.22480150245,RGL1
7592,KEGG_2019_Human,Circadian rhythm,1/31,0.0015499690656704,0.0111063878362936,0,0,19969.0,129189.85098816035,CREB1
7593,KEGG_2019_Human,Vasopressin-regulated water reabsorption,1/44,0.0021999607179423,0.0111063878362936,0,0,19956.0,122117.06559109331,CREB1
7594,KEGG_2019_Human,Cocaine addiction,1/49,0.0024499577795033,0.0111063878362936,0,0,19951.0,119939.1172087114,CREB1
7595,KEGG_2019_Human,Cortisol synthesis and secretion,1/65,0.003249949134407,0.0111063878362936,0,0,19935.0,114209.92613860144,CREB1
7596,KEGG_2019_Human,Amphetamine addiction,1/68,0.0033999476216189,0.0111063878362936,0,0,19932.0,113293.39338050144,CREB1
7597,KEGG_2019_Human,Renin secretion,1/69,0.003449947123837,0.0111063878362936,0,0,19931.0,112996.7391397682,CREB1
7598,KEGG_2019_Human,Thyroid hormone synthesis,1/74,0.0036999446830449,0.0111063878362936,0,0,19926.0,111574.38983110404,CREB1
7599,KEGG_2019_Human,Antigen processing and presentation,1/77,0.0038499432547502,0.0111063878362936,0,0,19923.0,110765.8407373636,CREB1
7600,KEGG_2019_Human,Insulin secretion,1/86,0.0042999391173866,0.0111063878362936,0,0,19914.0,108514.46102290176,CREB1
7601,KEGG_2019_Human,Prostate cancer,1/97,0.0048499343304706,0.0111063878362936,0,0,19903.0,106058.9096435903,CREB1
7602,KEGG_2019_Human,Circadian entrainment,1/97,0.0048499343304706,0.0111063878362936,0,0,19903.0,106058.9096435903,CREB1
7603,KEGG_2019_Human,Aldosterone synthesis and secretion,1/98,0.0048999339081079,0.0111063878362936,0,0,19902.0,105849.45495286948,CREB1
7604,KEGG_2019_Human,Melanogenesis,1/101,0.0050499326546803,0.0111063878362936,0,0,19899.0,105233.48101229242,CREB1
7605,KEGG_2019_Human,Longevity regulating pathway,1/102,0.0050999322416682,0.0111063878362936,0,0,19898.0,105032.15064717118,CREB1
7606,KEGG_2019_Human,Glucagon signaling pathway,1/103,0.0051499318302617,0.0111063878362936,0,0,19897.0,104832.7525292024,CREB1
7607,KEGG_2019_Human,"Parathyroid hormone synthesis, secretion and action",1/106,0.0052999306076525,0.0111063878362936,0,0,19894.0,104245.78450366124,CREB1
7608,KEGG_2019_Human,Insulin resistance,1/108,0.0053999298011749,0.0111063878362936,0,0,19892.0,103863.47861844616,CREB1
7609,KEGG_2019_Human,TNF signaling pathway,1/110,0.0054999290027479,0.0111063878362936,0,0,19890.0,103488.06969787036,CREB1
7610,KEGG_2019_Human,Cholinergic synapse,1/112,0.0055999282120529,0.0111063878362936,0,0,19888.0,103119.30984392198,CREB1
7611,KEGG_2019_Human,AMPK signaling pathway,1/120,0.0059999251180858,0.0111063878362936,0,0,19880.0,101706.2448082016,CREB1
7612,KEGG_2019_Human,Osteoclast differentiation,1/127,0.0063499224962247,0.0111063878362936,0,0,19873.0,100543.72072014232,CREB1
7613,KEGG_2019_Human,Relaxin signaling pathway,1/130,0.0064999213952527,0.0111063878362936,0,0,19870.0,100064.62842845908,CREB1
7614,KEGG_2019_Human,Dopaminergic synapse,1/131,0.0065499210316603,0.0111063878362936,0,0,19869.0,99907.33811343512,CREB1
7615,KEGG_2019_Human,Estrogen signaling pathway,1/137,0.0068499188797651,0.0111311181796183,0,0,19863.0,98987.62735269018,CREB1
7616,KEGG_2019_Human,Adrenergic signaling in cardiomyocytes,1/145,0.0072499160871101,0.0113098690958918,0,0,19855.0,97820.92670675044,CREB1
7617,KEGG_2019_Human,Cushing syndrome,1/155,0.0077499127120574,0.0115605877256627,0,0,19845.0,96448.16254952336,CREB1
7618,KEGG_2019_Human,Hepatitis B,1/163,0.0081499100978668,0.0115605877256627,0,0,19837.0,95410.9786681514,CREB1
7619,KEGG_2019_Human,cGMP-PKG signaling pathway,1/166,0.0082999091363732,0.0115605877256627,0,0,19834.0,95034.82345515196,CREB1
7620,KEGG_2019_Human,Tuberculosis,1/179,0.0089499050800561,0.0116998762068956,0,0,19821.0,93478.0629355712,CREB1
7621,KEGG_2019_Human,Alcoholism,1/180,0.0089999047745351,0.0116998762068956,0,0,19820.0,93362.92821536642,CREB1
7622,KEGG_2019_Human,Kaposi sarcoma-associated herpesvirus infection,1/186,0.0092999029651357,0.0116998779238804,0,0,19814.0,92684.96451050608,CREB1
7623,KEGG_2019_Human,Huntington disease,1/193,0.0096499008972596,0.0117608167185351,0,0,19807.0,91920.47679471428,CREB1
7624,KEGG_2019_Human,Viral carcinogenesis,1/201,0.0100498985877989,0.0118771528764897,0,0,19799.0,91079.21596609056,CREB1
7625,KEGG_2019_Human,cAMP signaling pathway,1/212,0.0105998955026255,0.0121587036647764,0,0,19788.0,89974.27756224656,CREB1
7626,KEGG_2019_Human,Human T-cell leukemia virus 1 infection,1/219,0.0109498935894162,0.0121742087937448,0,0,19781.0,89299.85161916987,CREB1
7627,KEGG_2019_Human,Human cytomegalovirus infection,1/225,0.0112498919790339,0.0121742087937448,0,0,19775.0,88738.27077557483,CREB1
7628,KEGG_2019_Human,Thermogenesis,1/231,0.0115498903940656,0.0121742087937448,0,0,19769.0,88191.07730937863,CREB1
7629,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0169340744973583,0,0,19670.0,80733.60565076157,CREB1
7630,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0176998626413668,0,0,19646.0,79255.8617626126,CREB1
7631,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR11L1
7632,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR10J3
7633,KEGG_2019_Human,Ribosome biogenesis in eukaryotes,1/101,0.0050499326546803,0.0082499094553477,0,0,19899.0,105233.48101229242,NMD3
7634,KEGG_2019_Human,RNA transport,1/165,0.0082499094553477,0.0082499094553477,0,0,19835.0,95159.46482222488,NMD3
7635,KEGG_2019_Human,"Parathyroid hormone synthesis, secretion and action",1/106,0.0052999306076525,0.0052999306076525,0,0,19894.0,104245.78450366124,MMP15
7636,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0147498749536506,0,0,19705.0,83086.53988020132,MAPK8IP3
7637,KEGG_2019_Human,Synaptic vesicle cycle,1/78,0.0038999427840466,0.0038999427840466,0,0,19922.0,110503.2180492851,UNC13A
7638,KEGG_2019_Human,ECM-receptor interaction,1/82,0.004099940929819,0.0099998661421113,0,0,19918.0,109484.9180722932,COL4A5
7639,KEGG_2019_Human,Protein digestion and absorption,1/90,0.0044999373439762,0.0099998661421113,0,0,19910.0,107587.50385474482,COL4A5
7640,KEGG_2019_Human,Small cell lung cancer,1/93,0.0046499360391879,0.0099998661421113,0,0,19907.0,106918.54242106884,COL4A5
7641,KEGG_2019_Human,Amoebiasis,1/96,0.0047999347538706,0.0099998661421113,0,0,19904.0,106270.50039849174,COL4A5
7642,KEGG_2019_Human,AGE-RAGE signaling pathway in diabetic complications,1/100,0.0049999330710556,0.0099998661421113,0,0,19900.0,105436.78197328727,COL4A5
7643,KEGG_2019_Human,Relaxin signaling pathway,1/130,0.0064999213952527,0.0108332023254213,0,0,19870.0,100064.62842845908,COL4A5
7644,KEGG_2019_Human,Focal adhesion,1/199,0.0099498991610159,0.0142141416585942,0,0,19801.0,91286.4288690606,COL4A5
7645,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0196665140459632,0,0,19670.0,80733.60565076157,COL4A5
7646,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0196665140459632,0,0,19646.0,79255.8617626126,COL4A5
7647,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,COL4A5
7648,KEGG_2019_Human,ABC transporters,1/45,0.0022499601197094,0.0022499601197094,0,0,19955.0,121662.49782449217,ABCG4
7649,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR4L1
7650,KEGG_2019_Human,Apoptosis,1/143,0.0071499167770442,0.0071499167770442,0,0,19857.0,98106.57763600958,PTPN13
7651,KEGG_2019_Human,Transcriptional misregulation in cancer,1/186,0.0092999029651357,0.0092999029651357,0,0,19814.0,92684.96451050608,AFF1
7652,KEGG_2019_Human,VEGF signaling pathway,1/59,0.0029499522555206,0.0154665201799472,0,0,19941.0,116175.59385530632,KDR
7653,KEGG_2019_Human,Fluid shear stress and atherosclerosis,1/139,0.006949918172816,0.0154665201799472,0,0,19861.0,98689.81333375497,KDR
7654,KEGG_2019_Human,Focal adhesion,1/199,0.0099498991610159,0.0154665201799472,0,0,19801.0,91286.4288690606,KDR
7655,KEGG_2019_Human,Proteoglycans in cancer,1/201,0.0100498985877989,0.0154665201799472,0,0,19799.0,91079.21596609056,KDR
7656,KEGG_2019_Human,Rap1 signaling pathway,1/206,0.010299897173561,0.0154665201799472,0,0,19794.0,90569.849337325,KDR
7657,KEGG_2019_Human,Ras signaling pathway,1/232,0.0115998901349604,0.0154665201799472,0,0,19768.0,88101.22480150245,KDR
7658,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0168569999470293,0,0,19705.0,83086.53988020132,KDR
7659,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0176998626413668,0,0,19646.0,79255.8617626126,KDR
7660,KEGG_2019_Human,JAK-STAT signaling pathway,1/162,0.0080999104202618,0.0176998626413668,0,0,19838.0,95537.86936302872,OSMR
7661,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0176998626413668,0,0,19706.0,83157.67014793828,OSMR
7662,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0176998626413668,0,0,19646.0,79255.8617626126,OSMR
7663,KEGG_2019_Human,Taurine and hypotaurine metabolism,1/11,0.0005499852259717758,0.0025799535860348,0,0,19989.0,150029.8210287992,GAD2
7664,KEGG_2019_Human,Butanoate metabolism,1/28,0.0013999711732997,0.0025799535860348,0,0,19972.0,131242.0761597353,GAD2
7665,KEGG_2019_Human,beta-Alanine metabolism,1/31,0.0015499690656704,0.0025799535860348,0,0,19969.0,129189.85098816035,GAD2
7666,KEGG_2019_Human,"Alanine, aspartate and glutamate metabolism",1/35,0.0017499663721595,0.0025799535860348,0,0,19965.0,126740.98858805298,GAD2
7667,KEGG_2019_Human,Type I diabetes mellitus,1/43,0.0021499613216957,0.0025799535860348,0,0,19957.0,122581.98940490963,GAD2
7668,KEGG_2019_Human,GABAergic synapse,1/89,0.0044499377838098,0.0044499377838098,0,0,19911.0,107815.380281759,GAD2
7669,KEGG_2019_Human,Staphylococcus aureus infection,1/68,0.0033999476216189,0.0101998428648568,0,0,19932.0,113293.39338050144,FPR1
7670,KEGG_2019_Human,Rap1 signaling pathway,1/206,0.010299897173561,0.0154498457603415,0,0,19794.0,90569.849337325,FPR1
7671,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,FPR1
7672,KEGG_2019_Human,Chemical carcinogenesis,1/82,0.004099940929819,0.004099940929819,0,0,19918.0,109484.9180722932,CYP3A43
7673,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,CHRNA1
7674,KEGG_2019_Human,Vasopressin-regulated water reabsorption,1/44,0.0021999607179423,0.0021999607179423,0,0,19956.0,122117.06559109331,DYNC2LI1
7675,KEGG_2019_Human,Sphingolipid metabolism,1/47,0.0023499589392381,0.0046999178784763,0,0,19953.0,120782.64067395544,CERS4
7676,KEGG_2019_Human,Sphingolipid signaling pathway,1/119,0.0059499254985137,0.0059499254985137,0,0,19881.0,101877.73080211312,CERS4
7677,KEGG_2019_Human,Taste transduction,1/83,0.0041499404726918,0.0041499404726918,0,0,19917.0,109237.99888847338,TAS2R41
7678,KEGG_2019_Human,Sulfur metabolism,1/9,0.0004499872571388355,0.0012749696085607,0,0,19991.0,154056.46923976458,PAPSS1
7679,KEGG_2019_Human,Selenocompound metabolism,1/17,0.0008499797390404818,0.0012749696085607,0,0,19983.0,141285.76583697114,PAPSS1
7680,KEGG_2019_Human,Purine metabolism,1/129,0.006449921761047,0.006449921761047,0,0,19871.0,100223.109907462,PAPSS1
7681,KEGG_2019_Human,Wnt signaling pathway,1/158,0.0078999117225733,0.0078999117225733,0,0,19842.0,96053.2110949472,PRICKLE1
7682,KEGG_2019_Human,AMPK signaling pathway,1/120,0.0059999251180858,0.0059999251180858,0,0,19880.0,101706.2448082016,TBC1D1
7683,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF517
7684,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR1J2
7685,KEGG_2019_Human,Vascular smooth muscle contraction,1/132,0.0065999206698993,0.01253320316018,0,0,19868.0,99751.22090491928,AVPR1A
7686,KEGG_2019_Human,Phospholipase D signaling pathway,1/148,0.007399915061391,0.01253320316018,0,0,19852.0,97399.60470052566,AVPR1A
7687,KEGG_2019_Human,Calcium signaling pathway,1/188,0.009399902370135,0.01253320316018,0,0,19812.0,92463.712994847,AVPR1A
7688,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,AVPR1A
7689,KEGG_2019_Human,Signaling pathways regulating pluripotency of stem cells,1/139,0.006949918172816,0.006949918172816,0,0,19861.0,98689.81333375497,MYF5
7690,KEGG_2019_Human,Ribosome biogenesis in eukaryotes,1/101,0.0050499326546803,0.0050499326546803,0,0,19899.0,105233.48101229242,WDR75
7691,KEGG_2019_Human,Cell adhesion molecules (CAMs),1/145,0.0072499160871101,0.0072499160871101,0,0,19855.0,97820.92670675044,NRCAM
7692,KEGG_2019_Human,MicroRNAs in cancer,1/299,0.0149498740670514,0.0149498740670514,0,0,19701.0,82804.33538735632,ZFPM2
7693,KEGG_2019_Human,Axon guidance,1/181,0.0090499044707863,0.0090499044707863,0,0,19819.0,93248.41634586031,SEMA4F
7694,KEGG_2019_Human,Protein processing in endoplasmic reticulum,1/165,0.0082499094553477,0.0082499094553477,0,0,19835.0,95159.46482222488,DNAJC1
7695,KEGG_2019_Human,ABC transporters,1/45,0.0022499601197094,0.0035999456502131,0,0,19955.0,121662.49782449217,ABCG2
7696,KEGG_2019_Human,Bile secretion,1/72,0.0035999456502131,0.0035999456502131,0,0,19928.0,112131.59838572376,ABCG2
7697,KEGG_2019_Human,Lysine degradation,1/59,0.0029499522555206,0.0029499522555206,0,0,19941.0,116175.59385530632,PRDM9
7698,KEGG_2019_Human,Fc epsilon RI signaling pathway,1/68,0.0033999476216189,0.0033999476216189,0,0,19932.0,113293.39338050144,ALOX5AP
7699,KEGG_2019_Human,Inositol phosphate metabolism,1/74,0.0036999446830449,0.0049499334884068,0,0,19926.0,111574.38983110404,PIK3C2G
7700,KEGG_2019_Human,Phosphatidylinositol signaling system,1/99,0.0049499334884068,0.0049499334884068,0,0,19901.0,105642.09305076736,PIK3C2G
7701,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR2D2
7702,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR8I2
7703,KEGG_2019_Human,Starch and sucrose metabolism,1/36,0.0017999657178272,0.0080999104202618,0,0,19964.0,126172.23364250171,PYGL
7704,KEGG_2019_Human,Glucagon signaling pathway,1/103,0.0051499318302617,0.0080999104202618,0,0,19897.0,104832.7525292024,PYGL
7705,KEGG_2019_Human,Insulin resistance,1/108,0.0053999298011749,0.0080999104202618,0,0,19892.0,103863.47861844616,PYGL
7706,KEGG_2019_Human,Insulin signaling pathway,1/137,0.0068499188797651,0.0080999104202618,0,0,19863.0,98987.62735269018,PYGL
7707,KEGG_2019_Human,Necroptosis,1/162,0.0080999104202618,0.0080999104202618,0,0,19838.0,95537.86936302872,PYGL
7708,KEGG_2019_Human,Axon guidance,1/181,0.0090499044707863,0.0090499044707863,0,0,19819.0,93248.41634586031,SEMA6A
7709,KEGG_2019_Human,Progesterone-mediated oocyte maturation,1/99,0.0049499334884068,0.0065999206698993,0,0,19901.0,105642.09305076736,PLK1
7710,KEGG_2019_Human,Cell cycle,1/124,0.0061999236097501,0.0065999206698993,0,0,19876.0,101034.04709010696,PLK1
7711,KEGG_2019_Human,Oocyte meiosis,1/125,0.0062499232373748,0.0065999206698993,0,0,19875.0,100869.32368441945,PLK1
7712,KEGG_2019_Human,FoxO signaling pathway,1/132,0.0065999206698993,0.0065999206698993,0,0,19868.0,99751.22090491928,PLK1
7713,KEGG_2019_Human,Protein digestion and absorption,1/90,0.0044999373439762,0.0117498779626688,0,0,19910.0,107587.50385474482,SLC8A3
7714,KEGG_2019_Human,Apelin signaling pathway,1/137,0.0068499188797651,0.0117498779626688,0,0,19863.0,98987.62735269018,SLC8A3
7715,KEGG_2019_Human,cGMP-PKG signaling pathway,1/166,0.0082999091363732,0.0117498779626688,0,0,19834.0,95034.82345515196,SLC8A3
7716,KEGG_2019_Human,Calcium signaling pathway,1/188,0.009399902370135,0.0117498779626688,0,0,19812.0,92463.712994847,SLC8A3
7717,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,SLC8A3
7718,KEGG_2019_Human,AGE-RAGE signaling pathway in diabetic complications,1/100,0.0049999330710556,0.0049999330710556,0,0,19900.0,105436.78197328727,NOX4
7719,KEGG_2019_Human,Taste transduction,1/83,0.0041499404726918,0.0112998556382303,0,0,19917.0,109237.99888847338,HTR1A
7720,KEGG_2019_Human,Serotonergic synapse,1/113,0.0056499278191151,0.0112998556382303,0,0,19887.0,102937.34947211576,HTR1A
7721,KEGG_2019_Human,cAMP signaling pathway,1/212,0.0105998955026255,0.0141331940035007,0,0,19788.0,89974.27756224656,HTR1A
7722,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,HTR1A
7723,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,MCHR2
7724,KEGG_2019_Human,ECM-receptor interaction,1/82,0.004099940929819,0.0112498433599406,0,0,19918.0,109484.9180722932,COL9A2
7725,KEGG_2019_Human,Protein digestion and absorption,1/90,0.0044999373439762,0.0112498433599406,0,0,19910.0,107587.50385474482,COL9A2
7726,KEGG_2019_Human,Focal adhesion,1/199,0.0099498991610159,0.0165831652683599,0,0,19801.0,91286.4288690606,COL9A2
7727,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0176998626413668,0,0,19670.0,80733.60565076157,COL9A2
7728,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0176998626413668,0,0,19646.0,79255.8617626126,COL9A2
7729,KEGG_2019_Human,Mismatch repair,1/23,0.0011499748819949,0.0034499246459849,0,0,19977.0,135204.63922267244,MSH2
7730,KEGG_2019_Human,Colorectal cancer,1/86,0.0042999391173866,0.0064499086760799,0,0,19914.0,108514.46102290176,MSH2
7731,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,MSH2
7732,KEGG_2019_Human,Thyroid cancer,1/37,0.0018499650702878,0.0092887513355395,0,0,19963.0,125618.9446446357,GADD45A
7733,KEGG_2019_Human,Endometrial cancer,1/58,0.0028999527887707,0.0092887513355395,0,0,19942.0,116522.31890946148,GADD45A
7734,KEGG_2019_Human,Basal cell carcinoma,1/63,0.0031499501598827,0.0092887513355395,0,0,19937.0,114844.46974572667,GADD45A
7735,KEGG_2019_Human,Non-small cell lung cancer,1/66,0.003299948626608,0.0092887513355395,0,0,19934.0,113899.85357353876,GADD45A
7736,KEGG_2019_Human,p53 signaling pathway,1/72,0.0035999456502131,0.0092887513355395,0,0,19928.0,112131.59838572376,GADD45A
7737,KEGG_2019_Human,Melanoma,1/72,0.0035999456502131,0.0092887513355395,0,0,19928.0,112131.59838572376,GADD45A
7738,KEGG_2019_Human,Pancreatic cancer,1/75,0.0037499442041125,0.0092887513355395,0,0,19925.0,111301.33528642564,GADD45A
7739,KEGG_2019_Human,Glioma,1/75,0.0037499442041125,0.0092887513355395,0,0,19925.0,111301.33528642564,GADD45A
7740,KEGG_2019_Human,Chronic myeloid leukemia,1/76,0.0037999437281752,0.0092887513355395,0,0,19924.0,111031.8499691117,GADD45A
7741,KEGG_2019_Human,Colorectal cancer,1/86,0.0042999391173866,0.0092998720783758,0,0,19914.0,108514.46102290176,GADD45A
7742,KEGG_2019_Human,Small cell lung cancer,1/93,0.0046499360391879,0.0092998720783758,0,0,19907.0,106918.54242106884,GADD45A
7743,KEGG_2019_Human,Cell cycle,1/124,0.0061999236097501,0.0102436327429707,0,0,19876.0,101034.04709010696,GADD45A
7744,KEGG_2019_Human,FoxO signaling pathway,1/132,0.0065999206698993,0.0102436327429707,0,0,19868.0,99751.22090491928,GADD45A
7745,KEGG_2019_Human,Apoptosis,1/143,0.0071499167770442,0.0102436327429707,0,0,19857.0,98106.57763600958,GADD45A
7746,KEGG_2019_Human,Breast cancer,1/147,0.0073499154017982,0.0102436327429707,0,0,19853.0,97539.10874372096,GADD45A
7747,KEGG_2019_Human,Gastric cancer,1/149,0.0074499147221605,0.0102436327429707,0,0,19851.0,97261.02051561224,GADD45A
7748,KEGG_2019_Human,Cellular senescence,1/160,0.0079999110688441,0.0102665548346894,0,0,19840.0,95793.96509856998,GADD45A
7749,KEGG_2019_Human,Hepatocellular carcinoma,1/168,0.0083999085011095,0.0102665548346894,0,0,19832.0,94787.72752807094,GADD45A
7750,KEGG_2019_Human,Transcriptional misregulation in cancer,1/186,0.0092999029651357,0.0107683086964729,0,0,19814.0,92684.96451050608,GADD45A
7751,KEGG_2019_Human,Epstein-Barr virus infection,1/201,0.0100498985877989,0.0110548884465788,0,0,19799.0,91079.21596609056,GADD45A
7752,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0154522499514435,0,0,19705.0,83086.53988020132,GADD45A
7753,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,GADD45A
7754,KEGG_2019_Human,Notch signaling pathway,1/48,0.0023999583567988,0.0143997501407928,0,0,19952.0,120356.5272753826,NOTCH4
7755,KEGG_2019_Human,Thyroid hormone signaling pathway,1/116,0.0057999266512085,0.0146998308035964,0,0,19884.0,102400.8105961506,NOTCH4
7756,KEGG_2019_Human,Breast cancer,1/147,0.0073499154017982,0.0146998308035964,0,0,19853.0,97539.10874372096,NOTCH4
7757,KEGG_2019_Human,MicroRNAs in cancer,1/299,0.0149498740670514,0.0197998409507574,0,0,19701.0,82804.33538735632,NOTCH4
7758,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0197998409507574,0,0,19670.0,80733.60565076157,NOTCH4
7759,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,NOTCH4
7760,KEGG_2019_Human,Small cell lung cancer,1/93,0.0046499360391879,0.0118665405142795,0,0,19907.0,106918.54242106884,BIRC2
7761,KEGG_2019_Human,NF-kappa B signaling pathway,1/95,0.0047499351803394,0.0118665405142795,0,0,19905.0,106484.27183626965,BIRC2
7762,KEGG_2019_Human,TNF signaling pathway,1/110,0.0054999290027479,0.0118665405142795,0,0,19890.0,103488.06969787036,BIRC2
7763,KEGG_2019_Human,Toxoplasmosis,1/113,0.0056499278191151,0.0118665405142795,0,0,19887.0,102937.34947211576,BIRC2
7764,KEGG_2019_Human,Ubiquitin mediated proteolysis,1/137,0.0068499188797651,0.0118665405142795,0,0,19863.0,98987.62735269018,BIRC2
7765,KEGG_2019_Human,Apoptosis,1/143,0.0071499167770442,0.0118665405142795,0,0,19857.0,98106.57763600958,BIRC2
7766,KEGG_2019_Human,Hippo signaling pathway,1/160,0.0079999110688441,0.0118665405142795,0,0,19840.0,95793.96509856998,BIRC2
7767,KEGG_2019_Human,Necroptosis,1/162,0.0080999104202618,0.0118665405142795,0,0,19838.0,95537.86936302872,BIRC2
7768,KEGG_2019_Human,NOD-like receptor signaling pathway,1/178,0.0088999053857096,0.0118665405142795,0,0,19822.0,93593.82745769851,BIRC2
7769,KEGG_2019_Human,Focal adhesion,1/199,0.0099498991610159,0.0119398789932191,0,0,19801.0,91286.4288690606,BIRC2
7770,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0264998334376226,0,0,19508.0,72277.44006442746,BIRC2
7771,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,BIRC2
7772,KEGG_2019_Human,Leukocyte transendothelial migration,1/112,0.0055999282120529,0.0084999078692823,0,0,19888.0,103119.30984392198,CLDN25
7773,KEGG_2019_Human,Cell adhesion molecules (CAMs),1/145,0.0072499160871101,0.0084999078692823,0,0,19855.0,97820.92670675044,CLDN25
7774,KEGG_2019_Human,Hepatitis C,1/155,0.0077499127120574,0.0084999078692823,0,0,19845.0,96448.16254952336,CLDN25
7775,KEGG_2019_Human,Tight junction,1/170,0.0084999078692823,0.0084999078692823,0,0,19830.0,94543.49009679438,CLDN25
7776,KEGG_2019_Human,Amino sugar and nucleotide sugar metabolism,1/48,0.0023999583567988,0.0023999583567988,0,0,19952.0,120356.5272753826,CYB5R4
7777,KEGG_2019_Human,Endometrial cancer,1/58,0.0028999527887707,0.0113645820897364,0,0,19942.0,116522.31890946148,PTEN
7778,KEGG_2019_Human,Central carbon metabolism in cancer,1/65,0.003249949134407,0.0113645820897364,0,0,19935.0,114209.92613860144,PTEN
7779,KEGG_2019_Human,p53 signaling pathway,1/72,0.0035999456502131,0.0113645820897364,0,0,19928.0,112131.59838572376,PTEN
7780,KEGG_2019_Human,Melanoma,1/72,0.0035999456502131,0.0113645820897364,0,0,19928.0,112131.59838572376,PTEN
7781,KEGG_2019_Human,Inositol phosphate metabolism,1/74,0.0036999446830449,0.0113645820897364,0,0,19926.0,111574.38983110404,PTEN
7782,KEGG_2019_Human,Glioma,1/75,0.0037499442041125,0.0113645820897364,0,0,19925.0,111301.33528642564,PTEN
7783,KEGG_2019_Human,Small cell lung cancer,1/93,0.0046499360391879,0.0113645820897364,0,0,19907.0,106918.54242106884,PTEN
7784,KEGG_2019_Human,Prostate cancer,1/97,0.0048499343304706,0.0113645820897364,0,0,19903.0,106058.9096435903,PTEN
7785,KEGG_2019_Human,Phosphatidylinositol signaling system,1/99,0.0049499334884068,0.0113645820897364,0,0,19901.0,105642.09305076736,PTEN
7786,KEGG_2019_Human,Insulin resistance,1/108,0.0053999298011749,0.0113645820897364,0,0,19892.0,103863.47861844616,PTEN
7787,KEGG_2019_Human,Sphingolipid signaling pathway,1/119,0.0059499254985137,0.0113645820897364,0,0,19881.0,101877.73080211312,PTEN
7788,KEGG_2019_Human,Autophagy,1/128,0.0063999221281459,0.0113645820897364,0,0,19872.0,100382.8010329652,PTEN
7789,KEGG_2019_Human,FoxO signaling pathway,1/132,0.0065999206698993,0.0113645820897364,0,0,19868.0,99751.22090491928,PTEN
7790,KEGG_2019_Human,Breast cancer,1/147,0.0073499154017982,0.0113645820897364,0,0,19853.0,97539.10874372096,PTEN
7791,KEGG_2019_Human,mTOR signaling pathway,1/152,0.0075999137114971,0.0113645820897364,0,0,19848.0,96850.665715497,PTEN
7792,KEGG_2019_Human,Cellular senescence,1/160,0.0079999110688441,0.0113645820897364,0,0,19840.0,95793.96509856998,PTEN
7793,KEGG_2019_Human,Hepatocellular carcinoma,1/168,0.0083999085011095,0.0113645820897364,0,0,19832.0,94787.72752807094,PTEN
7794,KEGG_2019_Human,Focal adhesion,1/199,0.0099498991610159,0.0127137600390759,0,0,19801.0,91286.4288690606,PTEN
7795,KEGG_2019_Human,Human T-cell leukemia virus 1 infection,1/219,0.0109498935894162,0.0132551343450828,0,0,19781.0,89299.85161916987,PTEN
7796,KEGG_2019_Human,MicroRNAs in cancer,1/299,0.0149498740670514,0.0171923551771091,0,0,19701.0,82804.33538735632,PTEN
7797,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0180712834074373,0,0,19670.0,80733.60565076157,PTEN
7798,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0185044018523381,0,0,19646.0,79255.8617626126,PTEN
7799,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,PTEN
7800,KEGG_2019_Human,Protein processing in endoplasmic reticulum,1/165,0.0082499094553477,0.0082499094553477,0,0,19835.0,95159.46482222488,UGGT1
7801,KEGG_2019_Human,Phospholipase D signaling pathway,1/148,0.007399915061391,0.0121998870519305,0,0,19852.0,97399.60470052566,CYTH2
7802,KEGG_2019_Human,Endocytosis,1/244,0.0121998870519305,0.0121998870519305,0,0,19756.0,87051.4275316661,CYTH2
7803,KEGG_2019_Human,Staphylococcus aureus infection,1/68,0.0033999476216189,0.0052665897556449,0,0,19932.0,113293.39338050144,C4B
7804,KEGG_2019_Human,Pertussis,1/76,0.0037999437281752,0.0052665897556449,0,0,19924.0,111031.8499691117,C4B
7805,KEGG_2019_Human,Complement and coagulation cascades,1/79,0.0039499423167337,0.0052665897556449,0,0,19921.0,110243.89578070649,C4B
7806,KEGG_2019_Human,Systemic lupus erythematosus,1/133,0.0066499203093911,0.0066499203093911,0,0,19867.0,99596.2591544721,C4B
7807,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF571
7808,KEGG_2019_Human,Primary bile acid biosynthesis,1/17,0.0008499797390404818,0.0036999446830449,0,0,19983.0,141285.76583697114,CYP7A1
7809,KEGG_2019_Human,Cholesterol metabolism,1/50,0.0024999572069037,0.0036999446830449,0,0,19950.0,119530.05920663515,CYP7A1
7810,KEGG_2019_Human,Steroid hormone biosynthesis,1/60,0.002999951725986,0.0036999446830449,0,0,19940.0,115834.63209072244,CYP7A1
7811,KEGG_2019_Human,Bile secretion,1/72,0.0035999456502131,0.0036999446830449,0,0,19928.0,112131.59838572376,CYP7A1
7812,KEGG_2019_Human,PPAR signaling pathway,1/74,0.0036999446830449,0.0036999446830449,0,0,19926.0,111574.38983110404,CYP7A1
7813,KEGG_2019_Human,Ribosome biogenesis in eukaryotes,1/101,0.0050499326546803,0.0050499326546803,0,0,19899.0,105233.48101229242,SPATA5
7814,KEGG_2019_Human,Cell adhesion molecules (CAMs),1/145,0.0072499160871101,0.0072499160871101,0,0,19855.0,97820.92670675044,CNTN1
7815,KEGG_2019_Human,Selenocompound metabolism,1/17,0.0008499797390404818,0.0016999594780809,0,0,19983.0,141285.76583697114,INMT
7816,KEGG_2019_Human,Tryptophan metabolism,1/42,0.0020999619311272,0.0020999619311272,0,0,19958.0,123057.75613441122,INMT
7817,KEGG_2019_Human,Staphylococcus aureus infection,1/68,0.0033999476216189,0.0092999029651357,0,0,19932.0,113293.39338050144,DEFA3
7818,KEGG_2019_Human,NOD-like receptor signaling pathway,1/178,0.0088999053857096,0.0092999029651357,0,0,19822.0,93593.82745769851,DEFA3
7819,KEGG_2019_Human,Transcriptional misregulation in cancer,1/186,0.0092999029651357,0.0092999029651357,0,0,19814.0,92684.96451050608,DEFA3
7820,KEGG_2019_Human,Inositol phosphate metabolism,1/74,0.0036999446830449,0.0072499083140107,0,0,19926.0,111574.38983110404,PLCD4
7821,KEGG_2019_Human,Phosphatidylinositol signaling system,1/99,0.0049499334884068,0.0072499083140107,0,0,19901.0,105642.09305076736,PLCD4
7822,KEGG_2019_Human,AGE-RAGE signaling pathway in diabetic complications,1/100,0.0049999330710556,0.0072499083140107,0,0,19900.0,105436.78197328727,PLCD4
7823,KEGG_2019_Human,Thyroid hormone signaling pathway,1/116,0.0057999266512085,0.0072499083140107,0,0,19884.0,102400.8105961506,PLCD4
7824,KEGG_2019_Human,Calcium signaling pathway,1/188,0.009399902370135,0.009399902370135,0,0,19812.0,92463.712994847,PLCD4
7825,KEGG_2019_Human,TGF-beta signaling pathway,1/90,0.0044999373439762,0.010424877259224,0,0,19910.0,107587.50385474482,INHBE
7826,KEGG_2019_Human,Signaling pathways regulating pluripotency of stem cells,1/139,0.006949918172816,0.010424877259224,0,0,19861.0,98689.81333375497,INHBE
7827,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0146998751759735,0,0,19706.0,83157.67014793828,INHBE
7828,KEGG_2019_Human,Hippo signaling pathway,1/160,0.0079999110688441,0.0079999110688441,0,0,19840.0,95793.96509856998,TEAD1
7829,KEGG_2019_Human,Histidine metabolism,1/23,0.0011499748819949,0.0011499748819949,0,0,19977.0,135204.63922267244,HDC
7830,KEGG_2019_Human,Vitamin digestion and absorption,1/24,0.0011999741185782,0.0011999741185782,0,0,19976.0,134347.69487847842,SLC19A3
7831,KEGG_2019_Human,Renin secretion,1/69,0.003449947123837,0.0048999339081079,0,0,19931.0,112996.7391397682,CLCA1
7832,KEGG_2019_Human,Pancreatic secretion,1/98,0.0048999339081079,0.0048999339081079,0,0,19902.0,105849.45495286948,CLCA1
7833,KEGG_2019_Human,Lysine degradation,1/59,0.0029499522555206,0.0029499522555206,0,0,19941.0,116175.59385530632,BBOX1
7834,KEGG_2019_Human,Proteoglycans in cancer,1/201,0.0100498985877989,0.0100498985877989,0,0,19799.0,91079.21596609056,GPC3
7835,KEGG_2019_Human,Base excision repair,1/33,0.0016499677032113,0.0049499031096341,0,0,19967.0,127928.56031580272,POLB
7836,KEGG_2019_Human,Viral carcinogenesis,1/201,0.0100498985877989,0.0109498935894162,0,0,19799.0,91079.21596609056,POLB
7837,KEGG_2019_Human,Human T-cell leukemia virus 1 infection,1/219,0.0109498935894162,0.0109498935894162,0,0,19781.0,89299.85161916987,POLB
7838,KEGG_2019_Human,Synaptic vesicle cycle,1/78,0.0038999427840466,0.0038999427840466,0,0,19922.0,110503.2180492851,SYT1
7839,KEGG_2019_Human,Ascorbate and aldarate metabolism,1/27,0.0013499718942362,0.004685646776936,0,0,19973.0,131975.02298599784,UGT2B17
7840,KEGG_2019_Human,Pentose and glucuronate interconversions,1/34,0.0016999670339032,0.004685646776936,0,0,19966.0,127326.1054203148,UGT2B17
7841,KEGG_2019_Human,Porphyrin and chlorophyll metabolism,1/42,0.0020999619311272,0.004685646776936,0,0,19958.0,123057.75613441122,UGT2B17
7842,KEGG_2019_Human,Steroid hormone biosynthesis,1/60,0.002999951725986,0.004685646776936,0,0,19940.0,115834.63209072244,UGT2B17
7843,KEGG_2019_Human,Retinol metabolism,1/67,0.0033499481224912,0.004685646776936,0,0,19933.0,113594.38808369274,UGT2B17
7844,KEGG_2019_Human,Metabolism of xenobiotics by cytochrome P450,1/74,0.0036999446830449,0.004685646776936,0,0,19926.0,111574.38983110404,UGT2B17
7845,KEGG_2019_Human,Chemical carcinogenesis,1/82,0.004099940929819,0.004685646776936,0,0,19918.0,109484.9180722932,UGT2B17
7846,KEGG_2019_Human,Drug metabolism,1/108,0.0053999298011749,0.0053999298011749,0,0,19892.0,103863.47861844616,UGT2B17
7847,KEGG_2019_Human,Cholinergic synapse,1/112,0.0055999282120529,0.0055999282120529,0,0,19888.0,103119.30984392198,KCNQ5
7848,KEGG_2019_Human,Huntington disease,1/193,0.0096499008972596,0.0096499008972596,0,0,19807.0,91920.47679471428,DNAI2
7849,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR2L5
7850,KEGG_2019_Human,Primary immunodeficiency,1/37,0.0018499650702878,0.012949755492015,0,0,19963.0,125618.9446446357,IL7R
7851,KEGG_2019_Human,Hematopoietic cell lineage,1/97,0.0048499343304706,0.0141748432354582,0,0,19903.0,106058.9096435903,IL7R
7852,KEGG_2019_Human,FoxO signaling pathway,1/132,0.0065999206698993,0.0141748432354582,0,0,19868.0,99751.22090491928,IL7R
7853,KEGG_2019_Human,JAK-STAT signaling pathway,1/162,0.0080999104202618,0.0141748432354582,0,0,19838.0,95537.86936302872,IL7R
7854,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0205798252463629,0,0,19706.0,83157.67014793828,IL7R
7855,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0206498397482613,0,0,19646.0,79255.8617626126,IL7R
7856,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,IL7R
7857,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR5B12
7858,KEGG_2019_Human,Apoptosis,1/143,0.0071499167770442,0.0071499167770442,0,0,19857.0,98106.57763600958,SPTAN1
7859,KEGG_2019_Human,ABC transporters,1/45,0.0022499601197094,0.0022499601197094,0,0,19955.0,121662.49782449217,ABCA3
7860,KEGG_2019_Human,GABAergic synapse,1/89,0.0044499377838098,0.0044499377838098,0,0,19911.0,107815.380281759,PLCL1
7861,KEGG_2019_Human,Renin secretion,1/69,0.003449947123837,0.0080832238841178,0,0,19931.0,112996.7391397682,ADCYAP1
7862,KEGG_2019_Human,Insulin secretion,1/86,0.0042999391173866,0.0080832238841178,0,0,19914.0,108514.46102290176,ADCYAP1
7863,KEGG_2019_Human,Circadian entrainment,1/97,0.0048499343304706,0.0080832238841178,0,0,19903.0,106058.9096435903,ADCYAP1
7864,KEGG_2019_Human,cAMP signaling pathway,1/212,0.0105998955026255,0.0132498693782819,0,0,19788.0,89974.27756224656,ADCYAP1
7865,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,ADCYAP1
7866,KEGG_2019_Human,Axon guidance,1/181,0.0090499044707863,0.0090499044707863,0,0,19819.0,93248.41634586031,SEMA6D
7867,KEGG_2019_Human,Pancreatic secretion,1/98,0.0048999339081079,0.0075999032371186,0,0,19902.0,105849.45495286948,TRPC1
7868,KEGG_2019_Human,Serotonergic synapse,1/113,0.0056499278191151,0.0075999032371186,0,0,19887.0,102937.34947211576,TRPC1
7869,KEGG_2019_Human,Glutamatergic synapse,1/114,0.005699927427839,0.0075999032371186,0,0,19886.0,102756.96431429044,TRPC1
7870,KEGG_2019_Human,Axon guidance,1/181,0.0090499044707863,0.0090499044707863,0,0,19819.0,93248.41634586031,TRPC1
7871,KEGG_2019_Human,Platelet activation,1/124,0.0061999236097501,0.0142332015605856,0,0,19876.0,101034.04709010696,PRKCI
7872,KEGG_2019_Human,Insulin signaling pathway,1/137,0.0068499188797651,0.0142332015605856,0,0,19863.0,98987.62735269018,PRKCI
7873,KEGG_2019_Human,Hippo signaling pathway,1/160,0.0079999110688441,0.0142332015605856,0,0,19840.0,95793.96509856998,PRKCI
7874,KEGG_2019_Human,Tight junction,1/170,0.0084999078692823,0.0142332015605856,0,0,19830.0,94543.49009679438,PRKCI
7875,KEGG_2019_Human,Rap1 signaling pathway,1/206,0.010299897173561,0.0142332015605856,0,0,19794.0,90569.849337325,PRKCI
7876,KEGG_2019_Human,Endocytosis,1/244,0.0121998870519305,0.0142332015605856,0,0,19756.0,87051.4275316661,PRKCI
7877,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0164998674589645,0,0,19670.0,80733.60565076157,PRKCI
7878,KEGG_2019_Human,Intestinal immune network for IgA production,1/48,0.0023999583567988,0.0063332469071192,0,0,19952.0,120356.5272753826,TNFSF13B
7879,KEGG_2019_Human,Rheumatoid arthritis,1/91,0.0045499369072032,0.0063332469071192,0,0,19909.0,107362.10783923086,TNFSF13B
7880,KEGG_2019_Human,NF-kappa B signaling pathway,1/95,0.0047499351803394,0.0063332469071192,0,0,19905.0,106484.27183626965,TNFSF13B
7881,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0146998751759735,0,0,19706.0,83157.67014793828,TNFSF13B
7882,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR6C75
7883,KEGG_2019_Human,Glucagon signaling pathway,1/103,0.0051499318302617,0.009399902370135,0,0,19897.0,104832.7525292024,PHKA1
7884,KEGG_2019_Human,Insulin signaling pathway,1/137,0.0068499188797651,0.009399902370135,0,0,19863.0,98987.62735269018,PHKA1
7885,KEGG_2019_Human,Calcium signaling pathway,1/188,0.009399902370135,0.009399902370135,0,0,19812.0,92463.712994847,PHKA1
7886,KEGG_2019_Human,Proteasome,1/45,0.0022499601197094,0.0044999202394188,0,0,19955.0,121662.49782449217,PSMD7
7887,KEGG_2019_Human,Epstein-Barr virus infection,1/201,0.0100498985877989,0.0100498985877989,0,0,19799.0,91079.21596609056,PSMD7
7888,KEGG_2019_Human,Melanoma,1/72,0.0035999456502131,0.0173998352024406,0,0,19928.0,112131.59838572376,FGF18
7889,KEGG_2019_Human,Breast cancer,1/147,0.0073499154017982,0.0173998352024406,0,0,19853.0,97539.10874372096,FGF18
7890,KEGG_2019_Human,Gastric cancer,1/149,0.0074499147221605,0.0173998352024406,0,0,19851.0,97261.02051561224,FGF18
7891,KEGG_2019_Human,Rap1 signaling pathway,1/206,0.010299897173561,0.0173998352024406,0,0,19794.0,90569.849337325,FGF18
7892,KEGG_2019_Human,Regulation of actin cytoskeleton,1/214,0.0106998949514067,0.0173998352024406,0,0,19786.0,89779.39753374986,FGF18
7893,KEGG_2019_Human,Ras signaling pathway,1/232,0.0115998901349604,0.0173998352024406,0,0,19768.0,88101.22480150245,FGF18
7894,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.018964124940408,0,0,19705.0,83086.53988020132,FGF18
7895,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0199123454715377,0,0,19646.0,79255.8617626126,FGF18
7896,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,FGF18
7897,KEGG_2019_Human,Synaptic vesicle cycle,1/78,0.0038999427840466,0.0044499377838098,0,0,19922.0,110503.2180492851,SLC6A1
7898,KEGG_2019_Human,GABAergic synapse,1/89,0.0044499377838098,0.0044499377838098,0,0,19911.0,107815.380281759,SLC6A1
7899,KEGG_2019_Human,Primary immunodeficiency,1/37,0.0018499650702878,0.0074856240361832,0,0,19963.0,125618.9446446357,LCK
7900,KEGG_2019_Human,Th1 and Th2 cell differentiation,1/92,0.0045999364719865,0.0074856240361832,0,0,19908.0,107139.13814408927,LCK
7901,KEGG_2019_Human,NF-kappa B signaling pathway,1/95,0.0047499351803394,0.0074856240361832,0,0,19905.0,106484.27183626965,LCK
7902,KEGG_2019_Human,T cell receptor signaling pathway,1/101,0.0050499326546803,0.0074856240361832,0,0,19899.0,105233.48101229242,LCK
7903,KEGG_2019_Human,Th17 cell differentiation,1/107,0.0053499302026925,0.0074856240361832,0,0,19893.0,104053.753408911,LCK
7904,KEGG_2019_Human,Osteoclast differentiation,1/127,0.0063499224962247,0.0074856240361832,0,0,19873.0,100543.72072014232,LCK
7905,KEGG_2019_Human,Natural killer cell mediated cytotoxicity,1/131,0.0065499210316603,0.0074856240361832,0,0,19869.0,99907.33811343512,LCK
7906,KEGG_2019_Human,Human T-cell leukemia virus 1 infection,1/219,0.0109498935894162,0.0109498935894162,0,0,19781.0,89299.85161916987,LCK
7907,KEGG_2019_Human,Basal transcription factors,1/45,0.0022499601197094,0.0022499601197094,0,0,19955.0,121662.49782449217,TAF3
7908,KEGG_2019_Human,Glycerophospholipid metabolism,1/97,0.0048499343304706,0.0049499334884068,0,0,19903.0,106058.9096435903,CHKB
7909,KEGG_2019_Human,Choline metabolism in cancer,1/99,0.0049499334884068,0.0049499334884068,0,0,19901.0,105642.09305076736,CHKB
7910,KEGG_2019_Human,Wnt signaling pathway,1/158,0.0078999117225733,0.0078999117225733,0,0,19842.0,96053.2110949472,SFRP2
7911,KEGG_2019_Human,Huntington disease,1/193,0.0096499008972596,0.0096499008972596,0,0,19807.0,91920.47679471428,HTT
7912,KEGG_2019_Human,Spliceosome,1/134,0.0066999199497742,0.0066999199497742,0,0,19866.0,99442.43560916925,TRA2B
7913,KEGG_2019_Human,SNARE interactions in vesicular transport,1/34,0.0016999670339032,0.0016999670339032,0,0,19966.0,127326.1054203148,STX6
7914,KEGG_2019_Human,Sphingolipid metabolism,1/47,0.0023499589392381,0.0023499589392381,0,0,19953.0,120782.64067395544,UGT8
7915,KEGG_2019_Human,Ether lipid metabolism,1/47,0.0023499589392381,0.0023499589392381,0,0,19953.0,120782.64067395544,UGT8
7916,KEGG_2019_Human,ABC transporters,1/45,0.0022499601197094,0.0035999456502131,0,0,19955.0,121662.49782449217,ABCB4
7917,KEGG_2019_Human,Bile secretion,1/72,0.0035999456502131,0.0035999456502131,0,0,19928.0,112131.59838572376,ABCB4
7918,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF267
7919,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR7G2
7920,KEGG_2019_Human,ECM-receptor interaction,1/82,0.004099940929819,0.0099998661421113,0,0,19918.0,109484.9180722932,COL4A6
7921,KEGG_2019_Human,Protein digestion and absorption,1/90,0.0044999373439762,0.0099998661421113,0,0,19910.0,107587.50385474482,COL4A6
7922,KEGG_2019_Human,Small cell lung cancer,1/93,0.0046499360391879,0.0099998661421113,0,0,19907.0,106918.54242106884,COL4A6
7923,KEGG_2019_Human,Amoebiasis,1/96,0.0047999347538706,0.0099998661421113,0,0,19904.0,106270.50039849174,COL4A6
7924,KEGG_2019_Human,AGE-RAGE signaling pathway in diabetic complications,1/100,0.0049999330710556,0.0099998661421113,0,0,19900.0,105436.78197328727,COL4A6
7925,KEGG_2019_Human,Relaxin signaling pathway,1/130,0.0064999213952527,0.0108332023254213,0,0,19870.0,100064.62842845908,COL4A6
7926,KEGG_2019_Human,Focal adhesion,1/199,0.0099498991610159,0.0142141416585942,0,0,19801.0,91286.4288690606,COL4A6
7927,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0196665140459632,0,0,19670.0,80733.60565076157,COL4A6
7928,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0196665140459632,0,0,19646.0,79255.8617626126,COL4A6
7929,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,COL4A6
7930,KEGG_2019_Human,Taste transduction,1/83,0.0041499404726918,0.0041499404726918,0,0,19917.0,109237.99888847338,TAS2R5
7931,KEGG_2019_Human,Colorectal cancer,1/86,0.0042999391173866,0.0076498983625023,0,0,19914.0,108514.46102290176,APPL1
7932,KEGG_2019_Human,Longevity regulating pathway,1/102,0.0050999322416682,0.0076498983625023,0,0,19898.0,105032.15064717118,APPL1
7933,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,APPL1
7934,KEGG_2019_Human,RNA polymerase,1/31,0.0015499690656704,0.0030999381313408,0,0,19969.0,129189.85098816035,POLR3A
7935,KEGG_2019_Human,Cytosolic DNA-sensing pathway,1/63,0.0031499501598827,0.0031499501598827,0,0,19937.0,114844.46974572667,POLR3A
7936,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR1S1
7937,KEGG_2019_Human,Cortisol synthesis and secretion,1/65,0.003249949134407,0.0115798810767115,0,0,19935.0,114209.92613860144,SP1
7938,KEGG_2019_Human,Mitophagy,1/65,0.003249949134407,0.0115798810767115,0,0,19935.0,114209.92613860144,SP1
7939,KEGG_2019_Human,TGF-beta signaling pathway,1/90,0.0044999373439762,0.0115798810767115,0,0,19910.0,107587.50385474482,SP1
7940,KEGG_2019_Human,Choline metabolism in cancer,1/99,0.0049499334884068,0.0115798810767115,0,0,19901.0,105642.09305076736,SP1
7941,KEGG_2019_Human,"Parathyroid hormone synthesis, secretion and action",1/106,0.0052999306076525,0.0115798810767115,0,0,19894.0,104245.78450366124,SP1
7942,KEGG_2019_Human,Estrogen signaling pathway,1/137,0.0068499188797651,0.0115798810767115,0,0,19863.0,98987.62735269018,SP1
7943,KEGG_2019_Human,Breast cancer,1/147,0.0073499154017982,0.0115798810767115,0,0,19853.0,97539.10874372096,SP1
7944,KEGG_2019_Human,Cushing syndrome,1/155,0.0077499127120574,0.0115798810767115,0,0,19845.0,96448.16254952336,SP1
7945,KEGG_2019_Human,Transcriptional misregulation in cancer,1/186,0.0092999029651357,0.0115798810767115,0,0,19814.0,92684.96451050608,SP1
7946,KEGG_2019_Human,Huntington disease,1/193,0.0096499008972596,0.0115798810767115,0,0,19807.0,91920.47679471428,SP1
7947,KEGG_2019_Human,Human cytomegalovirus infection,1/225,0.0112498919790339,0.0122726094316733,0,0,19775.0,88738.27077557483,SP1
7948,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,SP1
7949,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR5B17
7950,KEGG_2019_Human,Gastric acid secretion,1/75,0.0037499442041125,0.0112498326123375,0,0,19925.0,111301.33528642564,HRH2
7951,KEGG_2019_Human,Calcium signaling pathway,1/188,0.009399902370135,0.0140998535552025,0,0,19812.0,92463.712994847,HRH2
7952,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,HRH2
7953,KEGG_2019_Human,ABC transporters,1/45,0.0022499601197094,0.0071998913004262,0,0,19955.0,121662.49782449217,ABCB1
7954,KEGG_2019_Human,Bile secretion,1/72,0.0035999456502131,0.0071998913004262,0,0,19928.0,112131.59838572376,ABCB1
7955,KEGG_2019_Human,Gastric cancer,1/149,0.0074499147221605,0.0099332196295474,0,0,19851.0,97261.02051561224,ABCB1
7956,KEGG_2019_Human,MicroRNAs in cancer,1/299,0.0149498740670514,0.0149498740670514,0,0,19701.0,82804.33538735632,ABCB1
7957,KEGG_2019_Human,Lysine degradation,1/59,0.0029499522555206,0.0029499522555206,0,0,19941.0,116175.59385530632,SETD1B
7958,KEGG_2019_Human,Ubiquinone and other terpenoid-quinone biosynthesis,1/11,0.0005499852259717758,0.0012749696085607,0,0,19989.0,150029.8210287992,HPD
7959,KEGG_2019_Human,Phenylalanine metabolism,1/17,0.0008499797390404818,0.0012749696085607,0,0,19983.0,141285.76583697114,HPD
7960,KEGG_2019_Human,Tyrosine metabolism,1/36,0.0017999657178272,0.0017999657178272,0,0,19964.0,126172.23364250171,HPD
7961,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR6F1
7962,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF189
7963,KEGG_2019_Human,Nicotine addiction,1/40,0.0019999631680592,0.0059998895041777,0,0,19960.0,124043.94523066044,CHRNA4
7964,KEGG_2019_Human,Cholinergic synapse,1/112,0.0055999282120529,0.0083998923180794,0,0,19888.0,103119.30984392198,CHRNA4
7965,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,CHRNA4
7966,KEGG_2019_Human,Prion diseases,1/35,0.0017499663721595,0.0017499663721595,0,0,19965.0,126740.98858805298,STIP1
7967,KEGG_2019_Human,Adrenergic signaling in cardiomyocytes,1/145,0.0072499160871101,0.0072499160871101,0,0,19855.0,97820.92670675044,SCN7A
7968,KEGG_2019_Human,Starch and sucrose metabolism,1/36,0.0017999657178272,0.0082199026557181,0,0,19964.0,126172.23364250171,GYS2
7969,KEGG_2019_Human,Glucagon signaling pathway,1/103,0.0051499318302617,0.0082199026557181,0,0,19897.0,104832.7525292024,GYS2
7970,KEGG_2019_Human,Insulin resistance,1/108,0.0053999298011749,0.0082199026557181,0,0,19892.0,103863.47861844616,GYS2
7971,KEGG_2019_Human,AMPK signaling pathway,1/120,0.0059999251180858,0.0082199026557181,0,0,19880.0,101706.2448082016,GYS2
7972,KEGG_2019_Human,Insulin signaling pathway,1/137,0.0068499188797651,0.0082199026557181,0,0,19863.0,98987.62735269018,GYS2
7973,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0176998626413668,0,0,19646.0,79255.8617626126,GYS2
7974,KEGG_2019_Human,Butanoate metabolism,1/28,0.0013999711732997,0.0035999375351982,0,0,19972.0,131242.0761597353,EHHADH
7975,KEGG_2019_Human,beta-Alanine metabolism,1/31,0.0015499690656704,0.0035999375351982,0,0,19969.0,129189.85098816035,EHHADH
7976,KEGG_2019_Human,Propanoate metabolism,1/32,0.0015999683804467,0.0035999375351982,0,0,19968.0,128549.41955786056,EHHADH
7977,KEGG_2019_Human,Tryptophan metabolism,1/42,0.0020999619311272,0.0035999375351982,0,0,19958.0,123057.75613441122,EHHADH
7978,KEGG_2019_Human,Fatty acid degradation,1/44,0.0021999607179423,0.0035999375351982,0,0,19956.0,122117.06559109331,EHHADH
7979,KEGG_2019_Human,"Valine, leucine and isoleucine degradation",1/48,0.0023999583567988,0.0035999375351982,0,0,19952.0,120356.5272753826,EHHADH
7980,KEGG_2019_Human,Lysine degradation,1/59,0.0029499522555206,0.003792795757098,0,0,19941.0,116175.59385530632,EHHADH
7981,KEGG_2019_Human,PPAR signaling pathway,1/74,0.0036999446830449,0.0041499404726918,0,0,19926.0,111574.38983110404,EHHADH
7982,KEGG_2019_Human,Peroxisome,1/83,0.0041499404726918,0.0041499404726918,0,0,19917.0,109237.99888847338,EHHADH
7983,KEGG_2019_Human,Antigen processing and presentation,1/77,0.0038499432547502,0.0038499432547502,0,0,19923.0,110765.8407373636,IFI30
7984,KEGG_2019_Human,Rheumatoid arthritis,1/91,0.0045499369072032,0.0068749112534348,0,0,19909.0,107362.10783923086,MMP3
7985,KEGG_2019_Human,IL-17 signaling pathway,1/93,0.0046499360391879,0.0068749112534348,0,0,19907.0,106918.54242106884,MMP3
7986,KEGG_2019_Human,Prostate cancer,1/97,0.0048499343304706,0.0068749112534348,0,0,19903.0,106058.9096435903,MMP3
7987,KEGG_2019_Human,TNF signaling pathway,1/110,0.0054999290027479,0.0068749112534348,0,0,19890.0,103488.06969787036,MMP3
7988,KEGG_2019_Human,Transcriptional misregulation in cancer,1/186,0.0092999029651357,0.0092999029651357,0,0,19814.0,92684.96451050608,MMP3
7989,KEGG_2019_Human,Th1 and Th2 cell differentiation,1/92,0.0045999364719865,0.0096298743648466,0,0,19908.0,107139.13814408927,CD3G
7990,KEGG_2019_Human,Hematopoietic cell lineage,1/97,0.0048499343304706,0.0096298743648466,0,0,19903.0,106058.9096435903,CD3G
7991,KEGG_2019_Human,T cell receptor signaling pathway,1/101,0.0050499326546803,0.0096298743648466,0,0,19899.0,105233.48101229242,CD3G
7992,KEGG_2019_Human,Chagas disease (American trypanosomiasis),1/103,0.0051499318302617,0.0096298743648466,0,0,19897.0,104832.7525292024,CD3G
7993,KEGG_2019_Human,Th17 cell differentiation,1/107,0.0053499302026925,0.0096298743648466,0,0,19893.0,104053.753408911,CD3G
7994,KEGG_2019_Human,Measles,1/138,0.0068999185254481,0.0103498777881722,0,0,19862.0,98838.19160389496,CD3G
7995,KEGG_2019_Human,Epstein-Barr virus infection,1/201,0.0100498985877989,0.0109498935894162,0,0,19799.0,91079.21596609056,CD3G
7996,KEGG_2019_Human,Human immunodeficiency virus 1 infection,1/212,0.0105998955026255,0.0109498935894162,0,0,19788.0,89974.27756224656,CD3G
7997,KEGG_2019_Human,Human T-cell leukemia virus 1 infection,1/219,0.0109498935894162,0.0109498935894162,0,0,19781.0,89299.85161916987,CD3G
7998,KEGG_2019_Human,Lysine degradation,1/59,0.0029499522555206,0.0029499522555206,0,0,19941.0,116175.59385530632,SETDB2
7999,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR2M2
8000,KEGG_2019_Human,Salivary secretion,1/90,0.0044999373439762,0.0105998955026255,0,0,19910.0,107587.50385474482,ATP2B3
8001,KEGG_2019_Human,Pancreatic secretion,1/98,0.0048999339081079,0.0105998955026255,0,0,19902.0,105849.45495286948,ATP2B3
8002,KEGG_2019_Human,Aldosterone synthesis and secretion,1/98,0.0048999339081079,0.0105998955026255,0,0,19902.0,105849.45495286948,ATP2B3
8003,KEGG_2019_Human,Adrenergic signaling in cardiomyocytes,1/145,0.0072499160871101,0.0105998955026255,0,0,19855.0,97820.92670675044,ATP2B3
8004,KEGG_2019_Human,cGMP-PKG signaling pathway,1/166,0.0082999091363732,0.0105998955026255,0,0,19834.0,95034.82345515196,ATP2B3
8005,KEGG_2019_Human,Calcium signaling pathway,1/188,0.009399902370135,0.0105998955026255,0,0,19812.0,92463.712994847,ATP2B3
8006,KEGG_2019_Human,cAMP signaling pathway,1/212,0.0105998955026255,0.0105998955026255,0,0,19788.0,89974.27756224656,ATP2B3
8007,KEGG_2019_Human,Parkinson disease,1/142,0.0070999171242726,0.0070999171242726,0,0,19858.0,98250.87390500787,LRRK2
8008,KEGG_2019_Human,Cortisol synthesis and secretion,1/65,0.003249949134407,0.009899892959305,0,0,19935.0,114209.92613860144,CACNA1S
8009,KEGG_2019_Human,Renin secretion,1/69,0.003449947123837,0.009899892959305,0,0,19931.0,112996.7391397682,CACNA1S
8010,KEGG_2019_Human,Arrhythmogenic right ventricular cardiomyopathy (ARVC),1/72,0.0035999456502131,0.009899892959305,0,0,19928.0,112131.59838572376,CACNA1S
8011,KEGG_2019_Human,Cardiac muscle contraction,1/78,0.0038999427840466,0.009899892959305,0,0,19922.0,110503.2180492851,CACNA1S
8012,KEGG_2019_Human,Hypertrophic cardiomyopathy (HCM),1/85,0.004249939567045,0.009899892959305,0,0,19915.0,108752.83801948265,CACNA1S
8013,KEGG_2019_Human,Insulin secretion,1/86,0.0042999391173866,0.009899892959305,0,0,19914.0,108514.46102290176,CACNA1S
8014,KEGG_2019_Human,GABAergic synapse,1/89,0.0044499377838098,0.009899892959305,0,0,19911.0,107815.380281759,CACNA1S
8015,KEGG_2019_Human,Dilated cardiomyopathy (DCM),1/91,0.0045499369072032,0.009899892959305,0,0,19909.0,107362.10783923086,CACNA1S
8016,KEGG_2019_Human,GnRH signaling pathway,1/93,0.0046499360391879,0.009899892959305,0,0,19907.0,106918.54242106884,CACNA1S
8017,KEGG_2019_Human,Aldosterone synthesis and secretion,1/98,0.0048999339081079,0.009899892959305,0,0,19902.0,105849.45495286948,CACNA1S
8018,KEGG_2019_Human,Cholinergic synapse,1/112,0.0055999282120529,0.009899892959305,0,0,19888.0,103119.30984392198,CACNA1S
8019,KEGG_2019_Human,Serotonergic synapse,1/113,0.0056499278191151,0.009899892959305,0,0,19887.0,102937.34947211576,CACNA1S
8020,KEGG_2019_Human,Vascular smooth muscle contraction,1/132,0.0065999206698993,0.009899892959305,0,0,19868.0,99751.22090491928,CACNA1S
8021,KEGG_2019_Human,Adrenergic signaling in cardiomyocytes,1/145,0.0072499160871101,0.009899892959305,0,0,19855.0,97820.92670675044,CACNA1S
8022,KEGG_2019_Human,Retrograde endocannabinoid signaling,1/148,0.007399915061391,0.009899892959305,0,0,19852.0,97399.60470052566,CACNA1S
8023,KEGG_2019_Human,Oxytocin signaling pathway,1/153,0.0076499133771537,0.009899892959305,0,0,19847.0,96715.6407630817,CACNA1S
8024,KEGG_2019_Human,Cushing syndrome,1/155,0.0077499127120574,0.009899892959305,0,0,19845.0,96448.16254952336,CACNA1S
8025,KEGG_2019_Human,cGMP-PKG signaling pathway,1/166,0.0082999091363732,0.009899892959305,0,0,19834.0,95034.82345515196,CACNA1S
8026,KEGG_2019_Human,Alzheimer disease,1/171,0.0085499075557634,0.009899892959305,0,0,19829.0,94422.42241345016,CACNA1S
8027,KEGG_2019_Human,Calcium signaling pathway,1/188,0.009399902370135,0.0103398926071485,0,0,19812.0,92463.712994847,CACNA1S
8028,KEGG_2019_Human,cAMP signaling pathway,1/212,0.0105998955026255,0.011104652431322,0,0,19788.0,89974.27756224656,CACNA1S
8029,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0147498749536506,0,0,19705.0,83086.53988020132,CACNA1S
8030,KEGG_2019_Human,Basal transcription factors,1/45,0.0022499601197094,0.0023499589392381,0,0,19955.0,121662.49782449217,MNAT1
8031,KEGG_2019_Human,Nucleotide excision repair,1/47,0.0023499589392381,0.0023499589392381,0,0,19953.0,120782.64067395544,MNAT1
8032,KEGG_2019_Human,Adipocytokine signaling pathway,1/69,0.003449947123837,0.008807038559698,0,0,19931.0,112996.7391397682,PPARGC1A
8033,KEGG_2019_Human,Longevity regulating pathway,1/102,0.0050999322416682,0.008807038559698,0,0,19898.0,105032.15064717118,PPARGC1A
8034,KEGG_2019_Human,Glucagon signaling pathway,1/103,0.0051499318302617,0.008807038559698,0,0,19897.0,104832.7525292024,PPARGC1A
8035,KEGG_2019_Human,Insulin resistance,1/108,0.0053999298011749,0.008807038559698,0,0,19892.0,103863.47861844616,PPARGC1A
8036,KEGG_2019_Human,AMPK signaling pathway,1/120,0.0059999251180858,0.008807038559698,0,0,19880.0,101706.2448082016,PPARGC1A
8037,KEGG_2019_Human,Apelin signaling pathway,1/137,0.0068499188797651,0.008807038559698,0,0,19863.0,98987.62735269018,PPARGC1A
8038,KEGG_2019_Human,Insulin signaling pathway,1/137,0.0068499188797651,0.008807038559698,0,0,19863.0,98987.62735269018,PPARGC1A
8039,KEGG_2019_Human,Huntington disease,1/193,0.0096499008972596,0.010856138509417,0,0,19807.0,91920.47679471428,PPARGC1A
8040,KEGG_2019_Human,Thermogenesis,1/231,0.0115498903940656,0.0115498903940656,0,0,19769.0,88191.07730937863,PPARGC1A
8041,KEGG_2019_Human,Protein processing in endoplasmic reticulum,1/165,0.0082499094553477,0.0082499094553477,0,0,19835.0,95159.46482222488,OS9
8042,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR4C13
8043,KEGG_2019_Human,Fatty acid biosynthesis,1/13,0.0006499833083207112,0.0038998998499242,0,0,19987.0,146675.87616784443,ACACA
8044,KEGG_2019_Human,Propanoate metabolism,1/32,0.0015999683804467,0.0038999275911016,0,0,19968.0,128549.41955786056,ACACA
8045,KEGG_2019_Human,Pyruvate metabolism,1/39,0.0019499637955508,0.0038999275911016,0,0,19961.0,124555.53162481484,ACACA
8046,KEGG_2019_Human,Glucagon signaling pathway,1/103,0.0051499318302617,0.0068499188797651,0,0,19897.0,104832.7525292024,ACACA
8047,KEGG_2019_Human,AMPK signaling pathway,1/120,0.0059999251180858,0.0068499188797651,0,0,19880.0,101706.2448082016,ACACA
8048,KEGG_2019_Human,Insulin signaling pathway,1/137,0.0068499188797651,0.0068499188797651,0,0,19863.0,98987.62735269018,ACACA
8049,KEGG_2019_Human,Asthma,1/31,0.0015499690656704,0.0054784827602526,0,0,19969.0,129189.85098816035,CD40LG
8050,KEGG_2019_Human,Primary immunodeficiency,1/37,0.0018499650702878,0.0054784827602526,0,0,19963.0,125618.9446446357,CD40LG
8051,KEGG_2019_Human,Allograft rejection,1/38,0.001899964429635,0.0054784827602526,0,0,19962.0,125080.29732025368,CD40LG
8052,KEGG_2019_Human,Intestinal immune network for IgA production,1/48,0.0023999583567988,0.0054784827602526,0,0,19952.0,120356.5272753826,CD40LG
8053,KEGG_2019_Human,Malaria,1/49,0.0024499577795033,0.0054784827602526,0,0,19951.0,119939.1172087114,CD40LG
8054,KEGG_2019_Human,Autoimmune thyroid disease,1/53,0.0026499555173137,0.0054784827602526,0,0,19947.0,118349.78824235698,CD40LG
8055,KEGG_2019_Human,Viral myocarditis,1/59,0.0029499522555206,0.0054784827602526,0,0,19941.0,116175.59385530632,CD40LG
8056,KEGG_2019_Human,NF-kappa B signaling pathway,1/95,0.0047499351803394,0.0072943471678716,0,0,19905.0,106484.27183626965,CD40LG
8057,KEGG_2019_Human,T cell receptor signaling pathway,1/101,0.0050499326546803,0.0072943471678716,0,0,19899.0,105233.48101229242,CD40LG
8058,KEGG_2019_Human,Toxoplasmosis,1/113,0.0056499278191151,0.0073449061648497,0,0,19887.0,102937.34947211576,CD40LG
8059,KEGG_2019_Human,Systemic lupus erythematosus,1/133,0.0066499203093911,0.007854075761036,0,0,19867.0,99596.2591544721,CD40LG
8060,KEGG_2019_Human,Cell adhesion molecules (CAMs),1/145,0.0072499160871101,0.007854075761036,0,0,19855.0,97820.92670675044,CD40LG
8061,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0146998751759735,0,0,19706.0,83157.67014793828,CD40LG
8062,KEGG_2019_Human,Bladder cancer,1/41,0.0020499625466866,0.0116732167967025,0,0,19959.0,123544.88783416104,SRC
8063,KEGG_2019_Human,VEGF signaling pathway,1/59,0.0029499522555206,0.0116732167967025,0,0,19941.0,116175.59385530632,SRC
8064,KEGG_2019_Human,Mitophagy,1/65,0.003249949134407,0.0116732167967025,0,0,19935.0,114209.92613860144,SRC
8065,KEGG_2019_Human,Shigellosis,1/65,0.003249949134407,0.0116732167967025,0,0,19935.0,114209.92613860144,SRC
8066,KEGG_2019_Human,Epithelial cell signaling in Helicobacter pylori infection,1/68,0.0033999476216189,0.0116732167967025,0,0,19932.0,113293.39338050144,SRC
8067,KEGG_2019_Human,Prolactin signaling pathway,1/70,0.0034999466296654,0.0116732167967025,0,0,19930.0,112704.30065625212,SRC
8068,KEGG_2019_Human,Adherens junction,1/72,0.0035999456502131,0.0116732167967025,0,0,19928.0,112131.59838572376,SRC
8069,KEGG_2019_Human,Bacterial invasion of epithelial cells,1/74,0.0036999446830449,0.0116732167967025,0,0,19926.0,111574.38983110404,SRC
8070,KEGG_2019_Human,ErbB signaling pathway,1/85,0.004249939567045,0.0116732167967025,0,0,19915.0,108752.83801948265,SRC
8071,KEGG_2019_Human,Gap junction,1/88,0.0043999382262822,0.0116732167967025,0,0,19912.0,108045.79305232369,SRC
8072,KEGG_2019_Human,GABAergic synapse,1/89,0.0044499377838098,0.0116732167967025,0,0,19911.0,107815.380281759,SRC
8073,KEGG_2019_Human,GnRH signaling pathway,1/93,0.0046499360391879,0.0116732167967025,0,0,19907.0,106918.54242106884,SRC
8074,KEGG_2019_Human,Inflammatory mediator regulation of TRP channels,1/100,0.0049999330710556,0.0116732167967025,0,0,19900.0,105436.78197328727,SRC
8075,KEGG_2019_Human,C-type lectin receptor signaling pathway,1/104,0.0051999314202997,0.0116732167967025,0,0,19896.0,104635.24941415618,SRC
8076,KEGG_2019_Human,Thyroid hormone signaling pathway,1/116,0.0057999266512085,0.0116732167967025,0,0,19884.0,102400.8105961506,SRC
8077,KEGG_2019_Human,Platelet activation,1/124,0.0061999236097501,0.0116732167967025,0,0,19876.0,101034.04709010696,SRC
8078,KEGG_2019_Human,Relaxin signaling pathway,1/130,0.0064999213952527,0.0116732167967025,0,0,19870.0,100064.62842845908,SRC
8079,KEGG_2019_Human,Estrogen signaling pathway,1/137,0.0068499188797651,0.0116732167967025,0,0,19863.0,98987.62735269018,SRC
8080,KEGG_2019_Human,Fluid shear stress and atherosclerosis,1/139,0.006949918172816,0.0116732167967025,0,0,19861.0,98689.81333375497,SRC
8081,KEGG_2019_Human,Oxytocin signaling pathway,1/153,0.0076499133771537,0.0116732167967025,0,0,19847.0,96715.6407630817,SRC
8082,KEGG_2019_Human,Hepatitis B,1/163,0.0081499100978668,0.0116732167967025,0,0,19837.0,95410.9786681514,SRC
8083,KEGG_2019_Human,Tight junction,1/170,0.0084999078692823,0.0116732167967025,0,0,19830.0,94543.49009679438,SRC
8084,KEGG_2019_Human,Tuberculosis,1/179,0.0089499050800561,0.0116732167967025,0,0,19821.0,93478.0629355712,SRC
8085,KEGG_2019_Human,Axon guidance,1/181,0.0090499044707863,0.0116732167967025,0,0,19819.0,93248.41634586031,SRC
8086,KEGG_2019_Human,Kaposi sarcoma-associated herpesvirus infection,1/186,0.0092999029651357,0.0116732167967025,0,0,19814.0,92684.96451050608,SRC
8087,KEGG_2019_Human,Chemokine signaling pathway,1/190,0.0094999017791995,0.0116732167967025,0,0,19810.0,92244.74636351672,SRC
8088,KEGG_2019_Human,Focal adhesion,1/199,0.0099498991610159,0.0116732167967025,0,0,19801.0,91286.4288690606,SRC
8089,KEGG_2019_Human,Proteoglycans in cancer,1/201,0.0100498985877989,0.0116732167967025,0,0,19799.0,91079.21596609056,SRC
8090,KEGG_2019_Human,Viral carcinogenesis,1/201,0.0100498985877989,0.0116732167967025,0,0,19799.0,91079.21596609056,SRC
8091,KEGG_2019_Human,Rap1 signaling pathway,1/206,0.010299897173561,0.0116732167967025,0,0,19794.0,90569.849337325,SRC
8092,KEGG_2019_Human,Regulation of actin cytoskeleton,1/214,0.0106998949514067,0.0117353686563816,0,0,19786.0,89779.39753374986,SRC
8093,KEGG_2019_Human,Human cytomegalovirus infection,1/225,0.0112498919790339,0.0119530102277235,0,0,19775.0,88738.27077557483,SRC
8094,KEGG_2019_Human,Endocytosis,1/244,0.0121998870519305,0.0125695805989587,0,0,19756.0,87051.4275316661,SRC
8095,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,SRC
8096,KEGG_2019_Human,Renal cell carcinoma,1/69,0.003449947123837,0.006899894247674,0,0,19931.0,112996.7391397682,PRCC
8097,KEGG_2019_Human,Transcriptional misregulation in cancer,1/186,0.0092999029651357,0.0092999029651357,0,0,19814.0,92684.96451050608,PRCC
8098,KEGG_2019_Human,AMPK signaling pathway,1/120,0.0059999251180858,0.0075999137114971,0,0,19880.0,101706.2448082016,CAB39L
8099,KEGG_2019_Human,mTOR signaling pathway,1/152,0.0075999137114971,0.0075999137114971,0,0,19848.0,96850.665715497,CAB39L
8100,KEGG_2019_Human,Carbohydrate digestion and absorption,1/44,0.0021999607179423,0.0021999607179423,0,0,19956.0,122117.06559109331,SLC2A5
8101,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF334
8102,KEGG_2019_Human,Glutamatergic synapse,1/114,0.005699927427839,0.0110998725920865,0,0,19886.0,102756.96431429044,GRM8
8103,KEGG_2019_Human,Phospholipase D signaling pathway,1/148,0.007399915061391,0.0110998725920865,0,0,19852.0,97399.60470052566,GRM8
8104,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,GRM8
8105,KEGG_2019_Human,Primary immunodeficiency,1/37,0.0018499650702878,0.0036999301405757,0,0,19963.0,125618.9446446357,RAG1
8106,KEGG_2019_Human,FoxO signaling pathway,1/132,0.0065999206698993,0.0065999206698993,0,0,19868.0,99751.22090491928,RAG1
8107,KEGG_2019_Human,Thyroid hormone signaling pathway,1/116,0.0057999266512085,0.0057999266512085,0,0,19884.0,102400.8105961506,SLC16A2
8108,KEGG_2019_Human,Ether lipid metabolism,1/47,0.0023499589392381,0.0089248882477706,0,0,19953.0,120782.64067395544,PLD2
8109,KEGG_2019_Human,Fc gamma R-mediated phagocytosis,1/91,0.0045499369072032,0.0089248882477706,0,0,19909.0,107362.10783923086,PLD2
8110,KEGG_2019_Human,GnRH signaling pathway,1/93,0.0046499360391879,0.0089248882477706,0,0,19907.0,106918.54242106884,PLD2
8111,KEGG_2019_Human,Glycerophospholipid metabolism,1/97,0.0048499343304706,0.0089248882477706,0,0,19903.0,106058.9096435903,PLD2
8112,KEGG_2019_Human,Choline metabolism in cancer,1/99,0.0049499334884068,0.0089248882477706,0,0,19901.0,105642.09305076736,PLD2
8113,KEGG_2019_Human,"Parathyroid hormone synthesis, secretion and action",1/106,0.0052999306076525,0.0089248882477706,0,0,19894.0,104245.78450366124,PLD2
8114,KEGG_2019_Human,Glutamatergic synapse,1/114,0.005699927427839,0.0089248882477706,0,0,19886.0,102756.96431429044,PLD2
8115,KEGG_2019_Human,Sphingolipid signaling pathway,1/119,0.0059499254985137,0.0089248882477706,0,0,19881.0,101877.73080211312,PLD2
8116,KEGG_2019_Human,Phospholipase D signaling pathway,1/148,0.007399915061391,0.009866553415188,0,0,19852.0,97399.60470052566,PLD2
8117,KEGG_2019_Human,cAMP signaling pathway,1/212,0.0105998955026255,0.0121998870519305,0,0,19788.0,89974.27756224656,PLD2
8118,KEGG_2019_Human,Ras signaling pathway,1/232,0.0115998901349604,0.0121998870519305,0,0,19768.0,88101.22480150245,PLD2
8119,KEGG_2019_Human,Endocytosis,1/244,0.0121998870519305,0.0121998870519305,0,0,19756.0,87051.4275316661,PLD2
8120,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF273
8121,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR5M1
8122,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF676
8123,KEGG_2019_Human,Neurotrophin signaling pathway,1/119,0.0059499254985137,0.0059499254985137,0,0,19881.0,101877.73080211312,MATK
8124,KEGG_2019_Human,Retinol metabolism,1/67,0.0033499481224912,0.0033499481224912,0,0,19933.0,113594.38808369274,ALDH1A2
8125,KEGG_2019_Human,Asthma,1/31,0.0015499690656704,0.0061998762626816,0,0,19969.0,129189.85098816035,FCER1A
8126,KEGG_2019_Human,Fc epsilon RI signaling pathway,1/68,0.0033999476216189,0.0067998952432378,0,0,19932.0,113293.39338050144,FCER1A
8127,KEGG_2019_Human,Sphingolipid signaling pathway,1/119,0.0059499254985137,0.007399915061391,0,0,19881.0,101877.73080211312,FCER1A
8128,KEGG_2019_Human,Phospholipase D signaling pathway,1/148,0.007399915061391,0.007399915061391,0,0,19852.0,97399.60470052566,FCER1A
8129,KEGG_2019_Human,Pancreatic cancer,1/75,0.0037499442041125,0.0128998173521599,0,0,19925.0,111301.33528642564,RALA
8130,KEGG_2019_Human,Colorectal cancer,1/86,0.0042999391173866,0.0128998173521599,0,0,19914.0,108514.46102290176,RALA
8131,KEGG_2019_Human,Phospholipase D signaling pathway,1/148,0.007399915061391,0.0139198681619524,0,0,19852.0,97399.60470052566,RALA
8132,KEGG_2019_Human,Rap1 signaling pathway,1/206,0.010299897173561,0.0139198681619524,0,0,19794.0,90569.849337325,RALA
8133,KEGG_2019_Human,Ras signaling pathway,1/232,0.0115998901349604,0.0139198681619524,0,0,19768.0,88101.22480150245,RALA
8134,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,RALA
8135,KEGG_2019_Human,Peroxisome,1/83,0.0041499404726918,0.0041499404726918,0,0,19917.0,109237.99888847338,PAOX
8136,KEGG_2019_Human,Malaria,1/49,0.0024499577795033,0.0095998733913226,0,0,19951.0,119939.1172087114,TLR4
8137,KEGG_2019_Human,Pathogenic Escherichia coli infection,1/55,0.0027499544131125,0.0095998733913226,0,0,19945.0,117599.1294878737,TLR4
8138,KEGG_2019_Human,Legionellosis,1/55,0.0027499544131125,0.0095998733913226,0,0,19945.0,117599.1294878737,TLR4
8139,KEGG_2019_Human,Inflammatory bowel disease (IBD),1/65,0.003249949134407,0.0095998733913226,0,0,19935.0,114209.92613860144,TLR4
8140,KEGG_2019_Human,Leishmaniasis,1/74,0.0036999446830449,0.0095998733913226,0,0,19926.0,111574.38983110404,TLR4
8141,KEGG_2019_Human,Pertussis,1/76,0.0037999437281752,0.0095998733913226,0,0,19924.0,111031.8499691117,TLR4
8142,KEGG_2019_Human,Salmonella infection,1/86,0.0042999391173866,0.0095998733913226,0,0,19914.0,108514.46102290176,TLR4
8143,KEGG_2019_Human,Rheumatoid arthritis,1/91,0.0045499369072032,0.0095998733913226,0,0,19909.0,107362.10783923086,TLR4
8144,KEGG_2019_Human,NF-kappa B signaling pathway,1/95,0.0047499351803394,0.0095998733913226,0,0,19905.0,106484.27183626965,TLR4
8145,KEGG_2019_Human,Amoebiasis,1/96,0.0047999347538706,0.0095998733913226,0,0,19904.0,106270.50039849174,TLR4
8146,KEGG_2019_Human,HIF-1 signaling pathway,1/100,0.0049999330710556,0.0095998733913226,0,0,19900.0,105436.78197328727,TLR4
8147,KEGG_2019_Human,Chagas disease (American trypanosomiasis),1/103,0.0051499318302617,0.0095998733913226,0,0,19897.0,104832.7525292024,TLR4
8148,KEGG_2019_Human,Toll-like receptor signaling pathway,1/104,0.0051999314202997,0.0095998733913226,0,0,19896.0,104635.24941415618,TLR4
8149,KEGG_2019_Human,Toxoplasmosis,1/113,0.0056499278191151,0.0096855905470545,0,0,19887.0,102937.34947211576,TLR4
8150,KEGG_2019_Human,Measles,1/138,0.0068999185254481,0.0102284629486356,0,0,19862.0,98838.19160389496,TLR4
8151,KEGG_2019_Human,Phagosome,1/152,0.0075999137114971,0.0102284629486356,0,0,19848.0,96850.665715497,TLR4
8152,KEGG_2019_Human,Necroptosis,1/162,0.0080999104202618,0.0102284629486356,0,0,19838.0,95537.86936302872,TLR4
8153,KEGG_2019_Human,Hepatitis B,1/163,0.0081499100978668,0.0102284629486356,0,0,19837.0,95410.9786681514,TLR4
8154,KEGG_2019_Human,Influenza A,1/171,0.0085499075557634,0.0102284629486356,0,0,19829.0,94422.42241345016,TLR4
8155,KEGG_2019_Human,NOD-like receptor signaling pathway,1/178,0.0088999053857096,0.0102284629486356,0,0,19822.0,93593.82745769851,TLR4
8156,KEGG_2019_Human,Tuberculosis,1/179,0.0089499050800561,0.0102284629486356,0,0,19821.0,93478.0629355712,TLR4
8157,KEGG_2019_Human,Proteoglycans in cancer,1/201,0.0100498985877989,0.0109635257321443,0,0,19799.0,91079.21596609056,TLR4
8158,KEGG_2019_Human,Human immunodeficiency virus 1 infection,1/212,0.0105998955026255,0.0110607605244788,0,0,19788.0,89974.27756224656,TLR4
8159,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0176998626413668,0,0,19646.0,79255.8617626126,TLR4
8160,KEGG_2019_Human,Morphine addiction,1/91,0.0045499369072032,0.008599895681396,0,0,19909.0,107362.10783923086,PDE4B
8161,KEGG_2019_Human,"Parathyroid hormone synthesis, secretion and action",1/106,0.0052999306076525,0.008599895681396,0,0,19894.0,104245.78450366124,PDE4B
8162,KEGG_2019_Human,Purine metabolism,1/129,0.006449921761047,0.008599895681396,0,0,19871.0,100223.109907462,PDE4B
8163,KEGG_2019_Human,cAMP signaling pathway,1/212,0.0105998955026255,0.0105998955026255,0,0,19788.0,89974.27756224656,PDE4B
8164,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF439
8165,KEGG_2019_Human,Thiamine metabolism,1/15,0.0007499814841592997,0.0014999629683185,0,0,19985.0,143801.30885993244,AK8
8166,KEGG_2019_Human,Purine metabolism,1/129,0.006449921761047,0.006449921761047,0,0,19871.0,100223.109907462,AK8
8167,KEGG_2019_Human,Allograft rejection,1/38,0.001899964429635,0.0054082458017879,0,0,19962.0,125080.29732025368,CD28
8168,KEGG_2019_Human,Graft-versus-host disease,1/41,0.0020499625466866,0.0054082458017879,0,0,19959.0,123544.88783416104,CD28
8169,KEGG_2019_Human,Type I diabetes mellitus,1/43,0.0021499613216957,0.0054082458017879,0,0,19957.0,122581.98940490963,CD28
8170,KEGG_2019_Human,Intestinal immune network for IgA production,1/48,0.0023999583567988,0.0054082458017879,0,0,19952.0,120356.5272753826,CD28
8171,KEGG_2019_Human,Autoimmune thyroid disease,1/53,0.0026499555173137,0.0054082458017879,0,0,19947.0,118349.78824235698,CD28
8172,KEGG_2019_Human,Viral myocarditis,1/59,0.0029499522555206,0.0054082458017879,0,0,19941.0,116175.59385530632,CD28
8173,KEGG_2019_Human,Rheumatoid arthritis,1/91,0.0045499369072032,0.0069436574001854,0,0,19909.0,107362.10783923086,CD28
8174,KEGG_2019_Human,T cell receptor signaling pathway,1/101,0.0050499326546803,0.0069436574001854,0,0,19899.0,105233.48101229242,CD28
8175,KEGG_2019_Human,Systemic lupus erythematosus,1/133,0.0066499203093911,0.0072499160871101,0,0,19867.0,99596.2591544721,CD28
8176,KEGG_2019_Human,Measles,1/138,0.0068999185254481,0.0072499160871101,0,0,19862.0,98838.19160389496,CD28
8177,KEGG_2019_Human,Cell adhesion molecules (CAMs),1/145,0.0072499160871101,0.0072499160871101,0,0,19855.0,97820.92670675044,CD28
8178,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR2L8
8179,KEGG_2019_Human,Salivary secretion,1/90,0.0044999373439762,0.0044999373439762,0,0,19910.0,107587.50385474482,LPO
8180,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF530
8181,KEGG_2019_Human,ABC transporters,1/45,0.0022499601197094,0.0022499601197094,0,0,19955.0,121662.49782449217,ABCA13
8182,KEGG_2019_Human,Vasopressin-regulated water reabsorption,1/44,0.0021999607179423,0.0064499086760799,0,0,19956.0,122117.06559109331,DYNC2H1
8183,KEGG_2019_Human,Salmonella infection,1/86,0.0042999391173866,0.0064499086760799,0,0,19914.0,108514.46102290176,DYNC2H1
8184,KEGG_2019_Human,Phagosome,1/152,0.0075999137114971,0.0075999137114971,0,0,19848.0,96850.665715497,DYNC2H1
8185,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR13C2
8186,KEGG_2019_Human,African trypanosomiasis,1/37,0.0018499650702878,0.009634038686065,0,0,19963.0,125618.9446446357,PLCB3
8187,KEGG_2019_Human,Endocrine and other factor-regulated calcium reabsorption,1/48,0.0023999583567988,0.009634038686065,0,0,19952.0,120356.5272753826,PLCB3
8188,KEGG_2019_Human,Long-term depression,1/60,0.002999951725986,0.009634038686065,0,0,19940.0,115834.63209072244,PLCB3
8189,KEGG_2019_Human,Cortisol synthesis and secretion,1/65,0.003249949134407,0.009634038686065,0,0,19935.0,114209.92613860144,PLCB3
8190,KEGG_2019_Human,Long-term potentiation,1/67,0.0033499481224912,0.009634038686065,0,0,19933.0,113594.38808369274,PLCB3
8191,KEGG_2019_Human,Renin secretion,1/69,0.003449947123837,0.009634038686065,0,0,19931.0,112996.7391397682,PLCB3
8192,KEGG_2019_Human,Inositol phosphate metabolism,1/74,0.0036999446830449,0.009634038686065,0,0,19926.0,111574.38983110404,PLCB3
8193,KEGG_2019_Human,Thyroid hormone synthesis,1/74,0.0036999446830449,0.009634038686065,0,0,19926.0,111574.38983110404,PLCB3
8194,KEGG_2019_Human,Gastric acid secretion,1/75,0.0037499442041125,0.009634038686065,0,0,19925.0,111301.33528642564,PLCB3
8195,KEGG_2019_Human,Insulin secretion,1/86,0.0042999391173866,0.009634038686065,0,0,19914.0,108514.46102290176,PLCB3
8196,KEGG_2019_Human,Gap junction,1/88,0.0043999382262822,0.009634038686065,0,0,19912.0,108045.79305232369,PLCB3
8197,KEGG_2019_Human,Salivary secretion,1/90,0.0044999373439762,0.009634038686065,0,0,19910.0,107587.50385474482,PLCB3
8198,KEGG_2019_Human,GnRH signaling pathway,1/93,0.0046499360391879,0.009634038686065,0,0,19907.0,106918.54242106884,PLCB3
8199,KEGG_2019_Human,Amoebiasis,1/96,0.0047999347538706,0.009634038686065,0,0,19904.0,106270.50039849174,PLCB3
8200,KEGG_2019_Human,Circadian entrainment,1/97,0.0048499343304706,0.009634038686065,0,0,19903.0,106058.9096435903,PLCB3
8201,KEGG_2019_Human,Aldosterone synthesis and secretion,1/98,0.0048999339081079,0.009634038686065,0,0,19902.0,105849.45495286948,PLCB3
8202,KEGG_2019_Human,Pancreatic secretion,1/98,0.0048999339081079,0.009634038686065,0,0,19902.0,105849.45495286948,PLCB3
8203,KEGG_2019_Human,Phosphatidylinositol signaling system,1/99,0.0049499334884068,0.009634038686065,0,0,19901.0,105642.09305076736,PLCB3
8204,KEGG_2019_Human,AGE-RAGE signaling pathway in diabetic complications,1/100,0.0049999330710556,0.009634038686065,0,0,19900.0,105436.78197328727,PLCB3
8205,KEGG_2019_Human,Inflammatory mediator regulation of TRP channels,1/100,0.0049999330710556,0.009634038686065,0,0,19900.0,105436.78197328727,PLCB3
8206,KEGG_2019_Human,Melanogenesis,1/101,0.0050499326546803,0.009634038686065,0,0,19899.0,105233.48101229242,PLCB3
8207,KEGG_2019_Human,Chagas disease (American trypanosomiasis),1/103,0.0051499318302617,0.009634038686065,0,0,19897.0,104832.7525292024,PLCB3
8208,KEGG_2019_Human,Glucagon signaling pathway,1/103,0.0051499318302617,0.009634038686065,0,0,19897.0,104832.7525292024,PLCB3
8209,KEGG_2019_Human,"Parathyroid hormone synthesis, secretion and action",1/106,0.0052999306076525,0.009634038686065,0,0,19894.0,104245.78450366124,PLCB3
8210,KEGG_2019_Human,Cholinergic synapse,1/112,0.0055999282120529,0.009634038686065,0,0,19888.0,103119.30984392198,PLCB3
8211,KEGG_2019_Human,Serotonergic synapse,1/113,0.0056499278191151,0.009634038686065,0,0,19887.0,102937.34947211576,PLCB3
8212,KEGG_2019_Human,Glutamatergic synapse,1/114,0.005699927427839,0.009634038686065,0,0,19886.0,102756.96431429044,PLCB3
8213,KEGG_2019_Human,Thyroid hormone signaling pathway,1/116,0.0057999266512085,0.009634038686065,0,0,19884.0,102400.8105961506,PLCB3
8214,KEGG_2019_Human,Sphingolipid signaling pathway,1/119,0.0059499254985137,0.009634038686065,0,0,19881.0,101877.73080211312,PLCB3
8215,KEGG_2019_Human,Platelet activation,1/124,0.0061999236097501,0.009634038686065,0,0,19876.0,101034.04709010696,PLCB3
8216,KEGG_2019_Human,Relaxin signaling pathway,1/130,0.0064999213952527,0.009634038686065,0,0,19870.0,100064.62842845908,PLCB3
8217,KEGG_2019_Human,Dopaminergic synapse,1/131,0.0065499210316603,0.009634038686065,0,0,19869.0,99907.33811343512,PLCB3
8218,KEGG_2019_Human,Vascular smooth muscle contraction,1/132,0.0065999206698993,0.009634038686065,0,0,19868.0,99751.22090491928,PLCB3
8219,KEGG_2019_Human,Apelin signaling pathway,1/137,0.0068499188797651,0.009634038686065,0,0,19863.0,98987.62735269018,PLCB3
8220,KEGG_2019_Human,Estrogen signaling pathway,1/137,0.0068499188797651,0.009634038686065,0,0,19863.0,98987.62735269018,PLCB3
8221,KEGG_2019_Human,Adrenergic signaling in cardiomyocytes,1/145,0.0072499160871101,0.009634038686065,0,0,19855.0,97820.92670675044,PLCB3
8222,KEGG_2019_Human,Phospholipase D signaling pathway,1/148,0.007399915061391,0.009634038686065,0,0,19852.0,97399.60470052566,PLCB3
8223,KEGG_2019_Human,Retrograde endocannabinoid signaling,1/148,0.007399915061391,0.009634038686065,0,0,19852.0,97399.60470052566,PLCB3
8224,KEGG_2019_Human,Oxytocin signaling pathway,1/153,0.0076499133771537,0.009634038686065,0,0,19847.0,96715.6407630817,PLCB3
8225,KEGG_2019_Human,Cushing syndrome,1/155,0.0077499127120574,0.009634038686065,0,0,19845.0,96448.16254952336,PLCB3
8226,KEGG_2019_Human,Wnt signaling pathway,1/158,0.0078999117225733,0.009634038686065,0,0,19842.0,96053.2110949472,PLCB3
8227,KEGG_2019_Human,cGMP-PKG signaling pathway,1/166,0.0082999091363732,0.0098808442099681,0,0,19834.0,95034.82345515196,PLCB3
8228,KEGG_2019_Human,Alzheimer disease,1/171,0.0085499075557634,0.0099417529718179,0,0,19829.0,94422.42241345016,PLCB3
8229,KEGG_2019_Human,NOD-like receptor signaling pathway,1/178,0.0088999053857096,0.0101135288473973,0,0,19822.0,93593.82745769851,PLCB3
8230,KEGG_2019_Human,Calcium signaling pathway,1/188,0.009399902370135,0.0102658520183613,0,0,19812.0,92463.712994847,PLCB3
8231,KEGG_2019_Human,Chemokine signaling pathway,1/190,0.0094999017791995,0.0102658520183613,0,0,19810.0,92244.74636351672,PLCB3
8232,KEGG_2019_Human,Huntington disease,1/193,0.0096499008972596,0.0102658520183613,0,0,19807.0,91920.47679471428,PLCB3
8233,KEGG_2019_Human,Rap1 signaling pathway,1/206,0.010299897173561,0.0107290595557927,0,0,19794.0,90569.849337325,PLCB3
8234,KEGG_2019_Human,Human cytomegalovirus infection,1/225,0.0112498919790339,0.011479481611259,0,0,19775.0,88738.27077557483,PLCB3
8235,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,PLCB3
8236,KEGG_2019_Human,Lysosome,1/123,0.0061499239842961,0.0061499239842961,0,0,19877.0,101200.07933676826,AP4E1
8237,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF420
8238,KEGG_2019_Human,Nicotine addiction,1/40,0.0019999631680592,0.007399915061391,0,0,19960.0,124043.94523066044,SLC17A8
8239,KEGG_2019_Human,Synaptic vesicle cycle,1/78,0.0038999427840466,0.007399915061391,0,0,19922.0,110503.2180492851,SLC17A8
8240,KEGG_2019_Human,Glutamatergic synapse,1/114,0.005699927427839,0.007399915061391,0,0,19886.0,102756.96431429044,SLC17A8
8241,KEGG_2019_Human,Retrograde endocannabinoid signaling,1/148,0.007399915061391,0.007399915061391,0,0,19852.0,97399.60470052566,SLC17A8
8242,KEGG_2019_Human,Glycosaminoglycan biosynthesis,1/53,0.0026499555173137,0.0026499555173137,0,0,19947.0,118349.78824235698,HS3ST2
8243,KEGG_2019_Human,"Parathyroid hormone synthesis, secretion and action",1/106,0.0052999306076525,0.0088999053857096,0,0,19894.0,104245.78450366124,CASR
8244,KEGG_2019_Human,NOD-like receptor signaling pathway,1/178,0.0088999053857096,0.0088999053857096,0,0,19822.0,93593.82745769851,CASR
8245,KEGG_2019_Human,Tight junction,1/170,0.0084999078692823,0.0176998626413668,0,0,19830.0,94543.49009679438,MAGI1
8246,KEGG_2019_Human,Rap1 signaling pathway,1/206,0.010299897173561,0.0176998626413668,0,0,19794.0,90569.849337325,MAGI1
8247,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0176998626413668,0,0,19670.0,80733.60565076157,MAGI1
8248,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0176998626413668,0,0,19646.0,79255.8617626126,MAGI1
8249,KEGG_2019_Human,Glycosaminoglycan biosynthesis,1/53,0.0026499555173137,0.0026499555173137,0,0,19947.0,118349.78824235698,B3GALT6
8250,KEGG_2019_Human,Glycerophospholipid metabolism,1/97,0.0048499343304706,0.0048499343304706,0,0,19903.0,106058.9096435903,GPD2
8251,KEGG_2019_Human,Kaposi sarcoma-associated herpesvirus infection,1/186,0.0092999029651357,0.0094999017791995,0,0,19814.0,92684.96451050608,PREX1
8252,KEGG_2019_Human,Chemokine signaling pathway,1/190,0.0094999017791995,0.0094999017791995,0,0,19810.0,92244.74636351672,PREX1
8253,KEGG_2019_Human,Nicotinate and nicotinamide metabolism,1/30,0.0014999697593334,0.004274929989447,0,0,19970.0,129851.13732048514,PNP
8254,KEGG_2019_Human,Pyrimidine metabolism,1/57,0.002849953326298,0.004274929989447,0,0,19943.0,116875.00742975442,PNP
8255,KEGG_2019_Human,Purine metabolism,1/129,0.006449921761047,0.006449921761047,0,0,19871.0,100223.109907462,PNP
8256,KEGG_2019_Human,Arrhythmogenic right ventricular cardiomyopathy (ARVC),1/72,0.0035999456502131,0.0079623895876056,0,0,19928.0,112131.59838572376,CACNG7
8257,KEGG_2019_Human,Cardiac muscle contraction,1/78,0.0038999427840466,0.0079623895876056,0,0,19922.0,110503.2180492851,CACNG7
8258,KEGG_2019_Human,Hypertrophic cardiomyopathy (HCM),1/85,0.004249939567045,0.0079623895876056,0,0,19915.0,108752.83801948265,CACNG7
8259,KEGG_2019_Human,Dilated cardiomyopathy (DCM),1/91,0.0045499369072032,0.0079623895876056,0,0,19909.0,107362.10783923086,CACNG7
8260,KEGG_2019_Human,Adrenergic signaling in cardiomyocytes,1/145,0.0072499160871101,0.0089248989400127,0,0,19855.0,97820.92670675044,CACNG7
8261,KEGG_2019_Human,Oxytocin signaling pathway,1/153,0.0076499133771537,0.0089248989400127,0,0,19847.0,96715.6407630817,CACNG7
8262,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0147498749536506,0,0,19705.0,83086.53988020132,CACNG7
8263,KEGG_2019_Human,Proteasome,1/45,0.0022499601197094,0.0044999202394188,0,0,19955.0,121662.49782449217,PSMC6
8264,KEGG_2019_Human,Epstein-Barr virus infection,1/201,0.0100498985877989,0.0100498985877989,0,0,19799.0,91079.21596609056,PSMC6
8265,KEGG_2019_Human,Mismatch repair,1/23,0.0011499748819949,0.0026999549628563,0,0,19977.0,135204.63922267244,RPA1
8266,KEGG_2019_Human,DNA replication,1/36,0.0017999657178272,0.0026999549628563,0,0,19964.0,126172.23364250171,RPA1
8267,KEGG_2019_Human,Homologous recombination,1/41,0.0020499625466866,0.0026999549628563,0,0,19959.0,123544.88783416104,RPA1
8268,KEGG_2019_Human,Nucleotide excision repair,1/47,0.0023499589392381,0.0026999549628563,0,0,19953.0,120782.64067395544,RPA1
8269,KEGG_2019_Human,Fanconi anemia pathway,1/54,0.0026999549628563,0.0026999549628563,0,0,19946.0,117971.01964061816,RPA1
8270,KEGG_2019_Human,IL-17 signaling pathway,1/93,0.0046499360391879,0.0046499360391879,0,0,19907.0,106918.54242106884,USP25
8271,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF383
8272,KEGG_2019_Human,MicroRNAs in cancer,1/299,0.0149498740670514,0.0149498740670514,0,0,19701.0,82804.33538735632,TRIM71
8273,KEGG_2019_Human,Synaptic vesicle cycle,1/78,0.0038999427840466,0.0044499377838098,0,0,19922.0,110503.2180492851,SLC6A11
8274,KEGG_2019_Human,GABAergic synapse,1/89,0.0044499377838098,0.0044499377838098,0,0,19911.0,107815.380281759,SLC6A11
8275,KEGG_2019_Human,Longevity regulating pathway,1/102,0.0050999322416682,0.0063999221281459,0,0,19898.0,105032.15064717118,RB1CC1
8276,KEGG_2019_Human,Autophagy,1/128,0.0063999221281459,0.0063999221281459,0,0,19872.0,100382.8010329652,RB1CC1
8277,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF93
8278,KEGG_2019_Human,Inositol phosphate metabolism,1/74,0.0036999446830449,0.0063999221281459,0,0,19926.0,111574.38983110404,MTMR14
8279,KEGG_2019_Human,Phosphatidylinositol signaling system,1/99,0.0049499334884068,0.0063999221281459,0,0,19901.0,105642.09305076736,MTMR14
8280,KEGG_2019_Human,Autophagy,1/128,0.0063999221281459,0.0063999221281459,0,0,19872.0,100382.8010329652,MTMR14
8281,KEGG_2019_Human,RNA polymerase,1/31,0.0015499690656704,0.0030999381313408,0,0,19969.0,129189.85098816035,POLR3D
8282,KEGG_2019_Human,Cytosolic DNA-sensing pathway,1/63,0.0031499501598827,0.0031499501598827,0,0,19937.0,114844.46974572667,POLR3D
8283,KEGG_2019_Human,Protein processing in endoplasmic reticulum,1/165,0.0082499094553477,0.0082499094553477,0,0,19835.0,95159.46482222488,SEC24A
8284,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,GPR35
8285,KEGG_2019_Human,Inositol phosphate metabolism,1/74,0.0036999446830449,0.0049499334884068,0,0,19926.0,111574.38983110404,IPPK
8286,KEGG_2019_Human,Phosphatidylinositol signaling system,1/99,0.0049499334884068,0.0049499334884068,0,0,19901.0,105642.09305076736,IPPK
8287,KEGG_2019_Human,Phototransduction,1/28,0.0013999711732997,0.0055998846931991,0,0,19972.0,131242.0761597353,CNGB1
8288,KEGG_2019_Human,cGMP-PKG signaling pathway,1/166,0.0082999091363732,0.0141331940035007,0,0,19834.0,95034.82345515196,CNGB1
8289,KEGG_2019_Human,cAMP signaling pathway,1/212,0.0105998955026255,0.0141331940035007,0,0,19788.0,89974.27756224656,CNGB1
8290,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,CNGB1
8291,KEGG_2019_Human,Pentose phosphate pathway,1/30,0.0014999697593334,0.0027999538675741,0,0,19970.0,129851.13732048514,PGD
8292,KEGG_2019_Human,Glutathione metabolism,1/56,0.0027999538675741,0.0027999538675741,0,0,19944.0,117233.87022514464,PGD
8293,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR5T1
8294,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR2T10
8295,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF2
8296,KEGG_2019_Human,Cell adhesion molecules (CAMs),1/145,0.0072499160871101,0.0072499160871101,0,0,19855.0,97820.92670675044,NLGN4Y
8297,KEGG_2019_Human,Cholinergic synapse,1/112,0.0055999282120529,0.0076499133771537,0,0,19888.0,103119.30984392198,KCNJ4
8298,KEGG_2019_Human,Oxytocin signaling pathway,1/153,0.0076499133771537,0.0076499133771537,0,0,19847.0,96715.6407630817,KCNJ4
8299,KEGG_2019_Human,Inflammatory mediator regulation of TRP channels,1/100,0.0049999330710556,0.0140998535552025,0,0,19900.0,105436.78197328727,HRH1
8300,KEGG_2019_Human,Calcium signaling pathway,1/188,0.009399902370135,0.0140998535552025,0,0,19812.0,92463.712994847,HRH1
8301,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,HRH1
8302,KEGG_2019_Human,Protein digestion and absorption,1/90,0.0044999373439762,0.0044999373439762,0,0,19910.0,107587.50385474482,KCNJ13
8303,KEGG_2019_Human,ABC transporters,1/45,0.0022499601197094,0.0022499601197094,0,0,19955.0,121662.49782449217,ABCA5
8304,KEGG_2019_Human,Thyroid hormone signaling pathway,1/116,0.0057999266512085,0.0057999266512085,0,0,19884.0,102400.8105961506,MED30
8305,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR13C4
8306,KEGG_2019_Human,ABC transporters,1/45,0.0022499601197094,0.0022499601197094,0,0,19955.0,121662.49782449217,ABCA9
8307,KEGG_2019_Human,Synthesis and degradation of ketone bodies,1/10,0.0004999862257578379,0.0014999586772735,0,0,19990.0,151942.5908680334,OXCT1
8308,KEGG_2019_Human,Butanoate metabolism,1/28,0.0013999711732997,0.0020999567599496,0,0,19972.0,131242.0761597353,OXCT1
8309,KEGG_2019_Human,"Valine, leucine and isoleucine degradation",1/48,0.0023999583567988,0.0023999583567988,0,0,19952.0,120356.5272753826,OXCT1
8310,KEGG_2019_Human,Osteoclast differentiation,1/127,0.0063499224962247,0.0063499224962247,0,0,19873.0,100543.72072014232,FHL2
8311,KEGG_2019_Human,Leukocyte transendothelial migration,1/112,0.0055999282120529,0.0106998949514067,0,0,19888.0,103119.30984392198,MYL7
8312,KEGG_2019_Human,Focal adhesion,1/199,0.0099498991610159,0.0106998949514067,0,0,19801.0,91286.4288690606,MYL7
8313,KEGG_2019_Human,Regulation of actin cytoskeleton,1/214,0.0106998949514067,0.0106998949514067,0,0,19786.0,89779.39753374986,MYL7
8314,KEGG_2019_Human,Staphylococcus aureus infection,1/68,0.0033999476216189,0.0059249134751006,0,0,19932.0,113293.39338050144,MBL2
8315,KEGG_2019_Human,Complement and coagulation cascades,1/79,0.0039499423167337,0.0059249134751006,0,0,19921.0,110243.89578070649,MBL2
8316,KEGG_2019_Human,Phagosome,1/152,0.0075999137114971,0.0075999137114971,0,0,19848.0,96850.665715497,MBL2
8317,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR13D1
8318,KEGG_2019_Human,Pentose phosphate pathway,1/30,0.0014999697593334,0.0038499246408265,0,0,19970.0,129851.13732048514,PFKM
8319,KEGG_2019_Human,Galactose metabolism,1/31,0.0015499690656704,0.0038499246408265,0,0,19969.0,129189.85098816035,PFKM
8320,KEGG_2019_Human,Fructose and mannose metabolism,1/33,0.0016499677032113,0.0038499246408265,0,0,19967.0,127928.56031580272,PFKM
8321,KEGG_2019_Human,Central carbon metabolism in cancer,1/65,0.003249949134407,0.0046082660361893,0,0,19935.0,114209.92613860144,PFKM
8322,KEGG_2019_Human,Glycolysis / Gluconeogenesis,1/68,0.0033999476216189,0.0046082660361893,0,0,19932.0,113293.39338050144,PFKM
8323,KEGG_2019_Human,RNA degradation,1/79,0.0039499423167337,0.0046082660361893,0,0,19921.0,110243.89578070649,PFKM
8324,KEGG_2019_Human,AMPK signaling pathway,1/120,0.0059999251180858,0.0059999251180858,0,0,19880.0,101706.2448082016,PFKM
8325,KEGG_2019_Human,Ovarian steroidogenesis,1/49,0.0024499577795033,0.0080998777129795,0,0,19951.0,119939.1172087114,LDLR
8326,KEGG_2019_Human,Cholesterol metabolism,1/50,0.0024999572069037,0.0080998777129795,0,0,19950.0,119530.05920663515,LDLR
8327,KEGG_2019_Human,Cortisol synthesis and secretion,1/65,0.003249949134407,0.0080998777129795,0,0,19935.0,114209.92613860144,LDLR
8328,KEGG_2019_Human,Bile secretion,1/72,0.0035999456502131,0.0080998777129795,0,0,19928.0,112131.59838572376,LDLR
8329,KEGG_2019_Human,Aldosterone synthesis and secretion,1/98,0.0048999339081079,0.0084748917286727,0,0,19902.0,105849.45495286948,LDLR
8330,KEGG_2019_Human,Toxoplasmosis,1/113,0.0056499278191151,0.0084748917286727,0,0,19887.0,102937.34947211576,LDLR
8331,KEGG_2019_Human,Cushing syndrome,1/155,0.0077499127120574,0.0087186518010646,0,0,19845.0,96448.16254952336,LDLR
8332,KEGG_2019_Human,Hepatitis C,1/155,0.0077499127120574,0.0087186518010646,0,0,19845.0,96448.16254952336,LDLR
8333,KEGG_2019_Human,Endocytosis,1/244,0.0121998870519305,0.0121998870519305,0,0,19756.0,87051.4275316661,LDLR
8334,KEGG_2019_Human,Glucagon signaling pathway,1/103,0.0051499318302617,0.009399902370135,0,0,19897.0,104832.7525292024,PHKB
8335,KEGG_2019_Human,Insulin signaling pathway,1/137,0.0068499188797651,0.009399902370135,0,0,19863.0,98987.62735269018,PHKB
8336,KEGG_2019_Human,Calcium signaling pathway,1/188,0.009399902370135,0.009399902370135,0,0,19812.0,92463.712994847,PHKB
8337,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0146998751759735,0,0,19706.0,83157.67014793828,TNFRSF21
8338,KEGG_2019_Human,N-Glycan biosynthesis,1/50,0.0024999572069037,0.0049999144138074,0,0,19950.0,119530.05920663515,MAN1A2
8339,KEGG_2019_Human,Protein processing in endoplasmic reticulum,1/165,0.0082499094553477,0.0082499094553477,0,0,19835.0,95159.46482222488,MAN1A2
8340,KEGG_2019_Human,RNA transport,1/165,0.0082499094553477,0.0082499094553477,0,0,19835.0,95159.46482222488,EIF1B
8341,KEGG_2019_Human,African trypanosomiasis,1/37,0.0018499650702878,0.009634038686065,0,0,19963.0,125618.9446446357,PLCB1
8342,KEGG_2019_Human,Endocrine and other factor-regulated calcium reabsorption,1/48,0.0023999583567988,0.009634038686065,0,0,19952.0,120356.5272753826,PLCB1
8343,KEGG_2019_Human,Long-term depression,1/60,0.002999951725986,0.009634038686065,0,0,19940.0,115834.63209072244,PLCB1
8344,KEGG_2019_Human,Cortisol synthesis and secretion,1/65,0.003249949134407,0.009634038686065,0,0,19935.0,114209.92613860144,PLCB1
8345,KEGG_2019_Human,Long-term potentiation,1/67,0.0033499481224912,0.009634038686065,0,0,19933.0,113594.38808369274,PLCB1
8346,KEGG_2019_Human,Renin secretion,1/69,0.003449947123837,0.009634038686065,0,0,19931.0,112996.7391397682,PLCB1
8347,KEGG_2019_Human,Inositol phosphate metabolism,1/74,0.0036999446830449,0.009634038686065,0,0,19926.0,111574.38983110404,PLCB1
8348,KEGG_2019_Human,Thyroid hormone synthesis,1/74,0.0036999446830449,0.009634038686065,0,0,19926.0,111574.38983110404,PLCB1
8349,KEGG_2019_Human,Gastric acid secretion,1/75,0.0037499442041125,0.009634038686065,0,0,19925.0,111301.33528642564,PLCB1
8350,KEGG_2019_Human,Insulin secretion,1/86,0.0042999391173866,0.009634038686065,0,0,19914.0,108514.46102290176,PLCB1
8351,KEGG_2019_Human,Gap junction,1/88,0.0043999382262822,0.009634038686065,0,0,19912.0,108045.79305232369,PLCB1
8352,KEGG_2019_Human,Salivary secretion,1/90,0.0044999373439762,0.009634038686065,0,0,19910.0,107587.50385474482,PLCB1
8353,KEGG_2019_Human,GnRH signaling pathway,1/93,0.0046499360391879,0.009634038686065,0,0,19907.0,106918.54242106884,PLCB1
8354,KEGG_2019_Human,Amoebiasis,1/96,0.0047999347538706,0.009634038686065,0,0,19904.0,106270.50039849174,PLCB1
8355,KEGG_2019_Human,Circadian entrainment,1/97,0.0048499343304706,0.009634038686065,0,0,19903.0,106058.9096435903,PLCB1
8356,KEGG_2019_Human,Aldosterone synthesis and secretion,1/98,0.0048999339081079,0.009634038686065,0,0,19902.0,105849.45495286948,PLCB1
8357,KEGG_2019_Human,Pancreatic secretion,1/98,0.0048999339081079,0.009634038686065,0,0,19902.0,105849.45495286948,PLCB1
8358,KEGG_2019_Human,Phosphatidylinositol signaling system,1/99,0.0049499334884068,0.009634038686065,0,0,19901.0,105642.09305076736,PLCB1
8359,KEGG_2019_Human,AGE-RAGE signaling pathway in diabetic complications,1/100,0.0049999330710556,0.009634038686065,0,0,19900.0,105436.78197328727,PLCB1
8360,KEGG_2019_Human,Inflammatory mediator regulation of TRP channels,1/100,0.0049999330710556,0.009634038686065,0,0,19900.0,105436.78197328727,PLCB1
8361,KEGG_2019_Human,Melanogenesis,1/101,0.0050499326546803,0.009634038686065,0,0,19899.0,105233.48101229242,PLCB1
8362,KEGG_2019_Human,Chagas disease (American trypanosomiasis),1/103,0.0051499318302617,0.009634038686065,0,0,19897.0,104832.7525292024,PLCB1
8363,KEGG_2019_Human,Glucagon signaling pathway,1/103,0.0051499318302617,0.009634038686065,0,0,19897.0,104832.7525292024,PLCB1
8364,KEGG_2019_Human,"Parathyroid hormone synthesis, secretion and action",1/106,0.0052999306076525,0.009634038686065,0,0,19894.0,104245.78450366124,PLCB1
8365,KEGG_2019_Human,Cholinergic synapse,1/112,0.0055999282120529,0.009634038686065,0,0,19888.0,103119.30984392198,PLCB1
8366,KEGG_2019_Human,Serotonergic synapse,1/113,0.0056499278191151,0.009634038686065,0,0,19887.0,102937.34947211576,PLCB1
8367,KEGG_2019_Human,Glutamatergic synapse,1/114,0.005699927427839,0.009634038686065,0,0,19886.0,102756.96431429044,PLCB1
8368,KEGG_2019_Human,Thyroid hormone signaling pathway,1/116,0.0057999266512085,0.009634038686065,0,0,19884.0,102400.8105961506,PLCB1
8369,KEGG_2019_Human,Sphingolipid signaling pathway,1/119,0.0059499254985137,0.009634038686065,0,0,19881.0,101877.73080211312,PLCB1
8370,KEGG_2019_Human,Platelet activation,1/124,0.0061999236097501,0.009634038686065,0,0,19876.0,101034.04709010696,PLCB1
8371,KEGG_2019_Human,Relaxin signaling pathway,1/130,0.0064999213952527,0.009634038686065,0,0,19870.0,100064.62842845908,PLCB1
8372,KEGG_2019_Human,Dopaminergic synapse,1/131,0.0065499210316603,0.009634038686065,0,0,19869.0,99907.33811343512,PLCB1
8373,KEGG_2019_Human,Vascular smooth muscle contraction,1/132,0.0065999206698993,0.009634038686065,0,0,19868.0,99751.22090491928,PLCB1
8374,KEGG_2019_Human,Apelin signaling pathway,1/137,0.0068499188797651,0.009634038686065,0,0,19863.0,98987.62735269018,PLCB1
8375,KEGG_2019_Human,Estrogen signaling pathway,1/137,0.0068499188797651,0.009634038686065,0,0,19863.0,98987.62735269018,PLCB1
8376,KEGG_2019_Human,Adrenergic signaling in cardiomyocytes,1/145,0.0072499160871101,0.009634038686065,0,0,19855.0,97820.92670675044,PLCB1
8377,KEGG_2019_Human,Phospholipase D signaling pathway,1/148,0.007399915061391,0.009634038686065,0,0,19852.0,97399.60470052566,PLCB1
8378,KEGG_2019_Human,Retrograde endocannabinoid signaling,1/148,0.007399915061391,0.009634038686065,0,0,19852.0,97399.60470052566,PLCB1
8379,KEGG_2019_Human,Oxytocin signaling pathway,1/153,0.0076499133771537,0.009634038686065,0,0,19847.0,96715.6407630817,PLCB1
8380,KEGG_2019_Human,Cushing syndrome,1/155,0.0077499127120574,0.009634038686065,0,0,19845.0,96448.16254952336,PLCB1
8381,KEGG_2019_Human,Wnt signaling pathway,1/158,0.0078999117225733,0.009634038686065,0,0,19842.0,96053.2110949472,PLCB1
8382,KEGG_2019_Human,cGMP-PKG signaling pathway,1/166,0.0082999091363732,0.0098808442099681,0,0,19834.0,95034.82345515196,PLCB1
8383,KEGG_2019_Human,Alzheimer disease,1/171,0.0085499075557634,0.0099417529718179,0,0,19829.0,94422.42241345016,PLCB1
8384,KEGG_2019_Human,NOD-like receptor signaling pathway,1/178,0.0088999053857096,0.0101135288473973,0,0,19822.0,93593.82745769851,PLCB1
8385,KEGG_2019_Human,Calcium signaling pathway,1/188,0.009399902370135,0.0102658520183613,0,0,19812.0,92463.712994847,PLCB1
8386,KEGG_2019_Human,Chemokine signaling pathway,1/190,0.0094999017791995,0.0102658520183613,0,0,19810.0,92244.74636351672,PLCB1
8387,KEGG_2019_Human,Huntington disease,1/193,0.0096499008972596,0.0102658520183613,0,0,19807.0,91920.47679471428,PLCB1
8388,KEGG_2019_Human,Rap1 signaling pathway,1/206,0.010299897173561,0.0107290595557927,0,0,19794.0,90569.849337325,PLCB1
8389,KEGG_2019_Human,Human cytomegalovirus infection,1/225,0.0112498919790339,0.011479481611259,0,0,19775.0,88738.27077557483,PLCB1
8390,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,PLCB1
8391,KEGG_2019_Human,Thiamine metabolism,1/15,0.0007499814841592997,0.0012999726251831,0,0,19985.0,143801.30885993244,ALPI
8392,KEGG_2019_Human,Folate biosynthesis,1/26,0.0012999726251831,0.0012999726251831,0,0,19974.0,132735.46073187632,ALPI
8393,KEGG_2019_Human,Arginine biosynthesis,1/21,0.0010499764455398,0.0026249495582393,0,0,19979.0,137035.71221916509,ASS1
8394,KEGG_2019_Human,"Alanine, aspartate and glutamate metabolism",1/35,0.0017499663721595,0.0026249495582393,0,0,19965.0,126740.98858805298,ASS1
8395,KEGG_2019_Human,Fluid shear stress and atherosclerosis,1/139,0.006949918172816,0.006949918172816,0,0,19861.0,98689.81333375497,ASS1
8396,KEGG_2019_Human,Renin secretion,1/69,0.003449947123837,0.0048999339081079,0,0,19931.0,112996.7391397682,CLCA4
8397,KEGG_2019_Human,Pancreatic secretion,1/98,0.0048999339081079,0.0048999339081079,0,0,19902.0,105849.45495286948,CLCA4
8398,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR1K1
8399,KEGG_2019_Human,Autoimmune thyroid disease,1/53,0.0026499555173137,0.0145586837375733,0,0,19947.0,118349.78824235698,IFNA17
8400,KEGG_2019_Human,Cytosolic DNA-sensing pathway,1/63,0.0031499501598827,0.0145586837375733,0,0,19937.0,114844.46974572667,IFNA17
8401,KEGG_2019_Human,RIG-I-like receptor signaling pathway,1/70,0.0034999466296654,0.0145586837375733,0,0,19930.0,112704.30065625212,IFNA17
8402,KEGG_2019_Human,Toll-like receptor signaling pathway,1/104,0.0051999314202997,0.0145586837375733,0,0,19896.0,104635.24941415618,IFNA17
8403,KEGG_2019_Human,Natural killer cell mediated cytotoxicity,1/131,0.0065499210316603,0.0145586837375733,0,0,19869.0,99907.33811343512,IFNA17
8404,KEGG_2019_Human,Measles,1/138,0.0068999185254481,0.0145586837375733,0,0,19862.0,98838.19160389496,IFNA17
8405,KEGG_2019_Human,Hepatitis C,1/155,0.0077499127120574,0.0145586837375733,0,0,19845.0,96448.16254952336,IFNA17
8406,KEGG_2019_Human,Necroptosis,1/162,0.0080999104202618,0.0145586837375733,0,0,19838.0,95537.86936302872,IFNA17
8407,KEGG_2019_Human,JAK-STAT signaling pathway,1/162,0.0080999104202618,0.0145586837375733,0,0,19838.0,95537.86936302872,IFNA17
8408,KEGG_2019_Human,Hepatitis B,1/163,0.0081499100978668,0.0145586837375733,0,0,19837.0,95410.9786681514,IFNA17
8409,KEGG_2019_Human,Influenza A,1/171,0.0085499075557634,0.0145586837375733,0,0,19829.0,94422.42241345016,IFNA17
8410,KEGG_2019_Human,NOD-like receptor signaling pathway,1/178,0.0088999053857096,0.0145586837375733,0,0,19822.0,93593.82745769851,IFNA17
8411,KEGG_2019_Human,Tuberculosis,1/179,0.0089499050800561,0.0145586837375733,0,0,19821.0,93478.0629355712,IFNA17
8412,KEGG_2019_Human,Kaposi sarcoma-associated herpesvirus infection,1/186,0.0092999029651357,0.0145586837375733,0,0,19814.0,92684.96451050608,IFNA17
8413,KEGG_2019_Human,Epstein-Barr virus infection,1/201,0.0100498985877989,0.0145586837375733,0,0,19799.0,91079.21596609056,IFNA17
8414,KEGG_2019_Human,Human immunodeficiency virus 1 infection,1/212,0.0105998955026255,0.0145586837375733,0,0,19788.0,89974.27756224656,IFNA17
8415,KEGG_2019_Human,Human cytomegalovirus infection,1/225,0.0112498919790339,0.0145586837375733,0,0,19775.0,88738.27077557483,IFNA17
8416,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0179665141039676,0,0,19706.0,83157.67014793828,IFNA17
8417,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0191051096893273,0,0,19670.0,80733.60565076157,IFNA17
8418,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0194698489055035,0,0,19646.0,79255.8617626126,IFNA17
8419,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0257712598834163,0,0,19508.0,72277.44006442746,IFNA17
8420,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,IFNA17
8421,KEGG_2019_Human,Peroxisome,1/83,0.0041499404726918,0.0087998942265325,0,0,19917.0,109237.99888847338,SOD2
8422,KEGG_2019_Human,Longevity regulating pathway,1/102,0.0050999322416682,0.0087998942265325,0,0,19898.0,105032.15064717118,SOD2
8423,KEGG_2019_Human,FoxO signaling pathway,1/132,0.0065999206698993,0.0087998942265325,0,0,19868.0,99751.22090491928,SOD2
8424,KEGG_2019_Human,Huntington disease,1/193,0.0096499008972596,0.0096499008972596,0,0,19807.0,91920.47679471428,SOD2
8425,KEGG_2019_Human,Tight junction,1/170,0.0084999078692823,0.0084999078692823,0,0,19830.0,94543.49009679438,MARVELD2
8426,KEGG_2019_Human,Spliceosome,1/134,0.0066999199497742,0.0066999199497742,0,0,19866.0,99442.43560916925,CHERP
8427,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF37A
8428,KEGG_2019_Human,Steroid hormone biosynthesis,1/60,0.002999951725986,0.002999951725986,0,0,19940.0,115834.63209072244,SRD5A1
8429,KEGG_2019_Human,N-Glycan biosynthesis,1/50,0.0024999572069037,0.0024999572069037,0,0,19950.0,119530.05920663515,MGAT4C
8430,KEGG_2019_Human,Hematopoietic cell lineage,1/97,0.0048499343304706,0.0084999078692823,0,0,19903.0,106058.9096435903,CD1B
8431,KEGG_2019_Human,Tight junction,1/170,0.0084999078692823,0.0084999078692823,0,0,19830.0,94543.49009679438,CD1B
8432,KEGG_2019_Human,Protein processing in endoplasmic reticulum,1/165,0.0082499094553477,0.0085499075557634,0,0,19835.0,95159.46482222488,DNAJC3
8433,KEGG_2019_Human,Influenza A,1/171,0.0085499075557634,0.0085499075557634,0,0,19829.0,94422.42241345016,DNAJC3
8434,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,P2RY10
8435,KEGG_2019_Human,Purine metabolism,1/129,0.006449921761047,0.006449921761047,0,0,19871.0,100223.109907462,PDE6H
8436,KEGG_2019_Human,Amyotrophic lateral sclerosis (ALS),1/51,0.0025499566390179,0.0025499566390179,0,0,19949.0,119129.0228601236,ALS2
8437,KEGG_2019_Human,NOD-like receptor signaling pathway,1/178,0.0088999053857096,0.0088999053857096,0,0,19822.0,93593.82745769851,CARD17
8438,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR2W5
8439,KEGG_2019_Human,MicroRNAs in cancer,1/299,0.0149498740670514,0.0149498740670514,0,0,19701.0,82804.33538735632,MIR520C
8440,KEGG_2019_Human,MicroRNAs in cancer,1/299,0.0149498740670514,0.0149498740670514,0,0,19701.0,82804.33538735632,MIRLET7A2
8441,KEGG_2019_Human,Vibrio cholerae infection,1/50,0.0024999572069037,0.0024999572069037,0,0,19950.0,119530.05920663515,KDELR1
8442,KEGG_2019_Human,N-Glycan biosynthesis,1/50,0.0024999572069037,0.0024999572069037,0,0,19950.0,119530.05920663515,ALG11
8443,KEGG_2019_Human,Renin-angiotensin system,1/23,0.0011499748819949,0.0022999497639899,0,0,19977.0,135204.63922267244,REN
8444,KEGG_2019_Human,Renin secretion,1/69,0.003449947123837,0.003449947123837,0,0,19931.0,112996.7391397682,REN
8445,KEGG_2019_Human,Nitrogen metabolism,1/17,0.0008499797390404818,0.0030624411512792,0,0,19983.0,141285.76583697114,GLUL
8446,KEGG_2019_Human,Arginine biosynthesis,1/21,0.0010499764455398,0.0030624411512792,0,0,19979.0,137035.71221916509,GLUL
8447,KEGG_2019_Human,Glyoxylate and dicarboxylate metabolism,1/30,0.0014999697593334,0.0030624411512792,0,0,19970.0,129851.13732048514,GLUL
8448,KEGG_2019_Human,"Alanine, aspartate and glutamate metabolism",1/35,0.0017499663721595,0.0030624411512792,0,0,19965.0,126740.98858805298,GLUL
8449,KEGG_2019_Human,GABAergic synapse,1/89,0.0044499377838098,0.0062299128973337,0,0,19911.0,107815.380281759,GLUL
8450,KEGG_2019_Human,Glutamatergic synapse,1/114,0.005699927427839,0.0066499153324788,0,0,19886.0,102756.96431429044,GLUL
8451,KEGG_2019_Human,Necroptosis,1/162,0.0080999104202618,0.0080999104202618,0,0,19838.0,95537.86936302872,GLUL
8452,KEGG_2019_Human,Progesterone-mediated oocyte maturation,1/99,0.0049499334884068,0.0049499334884068,0,0,19901.0,105642.09305076736,STK10
8453,KEGG_2019_Human,Axon guidance,1/181,0.0090499044707863,0.0090499044707863,0,0,19819.0,93248.41634586031,SEMA6B
8454,KEGG_2019_Human,RNA transport,1/165,0.0082499094553477,0.0082499094553477,0,0,19835.0,95159.46482222488,XPO5
8455,KEGG_2019_Human,Melanoma,1/72,0.0035999456502131,0.0173998352024406,0,0,19928.0,112131.59838572376,FGF6
8456,KEGG_2019_Human,Breast cancer,1/147,0.0073499154017982,0.0173998352024406,0,0,19853.0,97539.10874372096,FGF6
8457,KEGG_2019_Human,Gastric cancer,1/149,0.0074499147221605,0.0173998352024406,0,0,19851.0,97261.02051561224,FGF6
8458,KEGG_2019_Human,Rap1 signaling pathway,1/206,0.010299897173561,0.0173998352024406,0,0,19794.0,90569.849337325,FGF6
8459,KEGG_2019_Human,Regulation of actin cytoskeleton,1/214,0.0106998949514067,0.0173998352024406,0,0,19786.0,89779.39753374986,FGF6
8460,KEGG_2019_Human,Ras signaling pathway,1/232,0.0115998901349604,0.0173998352024406,0,0,19768.0,88101.22480150245,FGF6
8461,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.018964124940408,0,0,19705.0,83086.53988020132,FGF6
8462,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0199123454715377,0,0,19646.0,79255.8617626126,FGF6
8463,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,FGF6
8464,KEGG_2019_Human,Amino sugar and nucleotide sugar metabolism,1/48,0.0023999583567988,0.0023999583567988,0,0,19952.0,120356.5272753826,AMDHD2
8465,KEGG_2019_Human,Inositol phosphate metabolism,1/74,0.0036999446830449,0.0049499334884068,0,0,19926.0,111574.38983110404,ITPK1
8466,KEGG_2019_Human,Phosphatidylinositol signaling system,1/99,0.0049499334884068,0.0049499334884068,0,0,19901.0,105642.09305076736,ITPK1
8467,KEGG_2019_Human,Folate biosynthesis,1/26,0.0012999726251831,0.0012999726251831,0,0,19974.0,132735.46073187632,PCBD1
8468,KEGG_2019_Human,Natural killer cell mediated cytotoxicity,1/131,0.0065499210316603,0.0065499210316603,0,0,19869.0,99907.33811343512,SH3BP2
8469,KEGG_2019_Human,N-Glycan biosynthesis,1/50,0.0024999572069037,0.0024999572069037,0,0,19950.0,119530.05920663515,ALG2
8470,KEGG_2019_Human,Inflammatory bowel disease (IBD),1/65,0.003249949134407,0.0068999047079798,0,0,19935.0,114209.92613860144,MAF
8471,KEGG_2019_Human,Th1 and Th2 cell differentiation,1/92,0.0045999364719865,0.0068999047079798,0,0,19908.0,107139.13814408927,MAF
8472,KEGG_2019_Human,Transcriptional misregulation in cancer,1/186,0.0092999029651357,0.0092999029651357,0,0,19814.0,92684.96451050608,MAF
8473,KEGG_2019_Human,Wnt signaling pathway,1/158,0.0078999117225733,0.0078999117225733,0,0,19842.0,96053.2110949472,NKD2
8474,KEGG_2019_Human,Peroxisome,1/83,0.0041499404726918,0.0041499404726918,0,0,19917.0,109237.99888847338,PEX19
8475,KEGG_2019_Human,Fructose and mannose metabolism,1/33,0.0016499677032113,0.0036999446830449,0,0,19967.0,127928.56031580272,TPI1
8476,KEGG_2019_Human,Glycolysis / Gluconeogenesis,1/68,0.0033999476216189,0.0036999446830449,0,0,19932.0,113293.39338050144,TPI1
8477,KEGG_2019_Human,Inositol phosphate metabolism,1/74,0.0036999446830449,0.0036999446830449,0,0,19926.0,111574.38983110404,TPI1
8478,KEGG_2019_Human,Human T-cell leukemia virus 1 infection,1/219,0.0109498935894162,0.0109498935894162,0,0,19781.0,89299.85161916987,MSX1
8479,KEGG_2019_Human,Other glycan degradation,1/18,0.0008999788927950273,0.00179995778559,0,0,19982.0,140136.54844084635,MANBA
8480,KEGG_2019_Human,Lysosome,1/123,0.0061499239842961,0.0061499239842961,0,0,19877.0,101200.07933676826,MANBA
8481,KEGG_2019_Human,Transcriptional misregulation in cancer,1/186,0.0092999029651357,0.0092999029651357,0,0,19814.0,92684.96451050608,HOXA11
8482,KEGG_2019_Human,Glycosaminoglycan biosynthesis,1/53,0.0026499555173137,0.0026499555173137,0,0,19947.0,118349.78824235698,XYLT2
8483,KEGG_2019_Human,Lysosome,1/123,0.0061499239842961,0.0105998955026255,0,0,19877.0,101200.07933676826,AP1G2
8484,KEGG_2019_Human,Human immunodeficiency virus 1 infection,1/212,0.0105998955026255,0.0105998955026255,0,0,19788.0,89974.27756224656,AP1G2
8485,KEGG_2019_Human,Signaling pathways regulating pluripotency of stem cells,1/139,0.006949918172816,0.006949918172816,0,0,19861.0,98689.81333375497,HESX1
8486,KEGG_2019_Human,Pyrimidine metabolism,1/57,0.002849953326298,0.0053999298011749,0,0,19943.0,116875.00742975442,UCK2
8487,KEGG_2019_Human,Drug metabolism,1/108,0.0053999298011749,0.0053999298011749,0,0,19892.0,103863.47861844616,UCK2
8488,KEGG_2019_Human,Ribosome,1/153,0.0076499133771537,0.0076499133771537,0,0,19847.0,96715.6407630817,RPL3
8489,KEGG_2019_Human,Amoebiasis,1/96,0.0047999347538706,0.0047999347538706,0,0,19904.0,106270.50039849174,SERPINB10
8490,KEGG_2019_Human,Proteasome,1/45,0.0022499601197094,0.0057749148821253,0,0,19955.0,121662.49782449217,PSME3
8491,KEGG_2019_Human,Antigen processing and presentation,1/77,0.0038499432547502,0.0057749148821253,0,0,19923.0,110765.8407373636,PSME3
8492,KEGG_2019_Human,Hepatitis C,1/155,0.0077499127120574,0.0077499127120574,0,0,19845.0,96448.16254952336,PSME3
8493,KEGG_2019_Human,Prostate cancer,1/97,0.0048499343304706,0.0092999029651357,0,0,19903.0,106058.9096435903,ETV5
8494,KEGG_2019_Human,Transcriptional misregulation in cancer,1/186,0.0092999029651357,0.0092999029651357,0,0,19814.0,92684.96451050608,ETV5
8495,KEGG_2019_Human,Arrhythmogenic right ventricular cardiomyopathy (ARVC),1/72,0.0035999456502131,0.0045499369072032,0,0,19928.0,112131.59838572376,DES
8496,KEGG_2019_Human,Hypertrophic cardiomyopathy (HCM),1/85,0.004249939567045,0.0045499369072032,0,0,19915.0,108752.83801948265,DES
8497,KEGG_2019_Human,Dilated cardiomyopathy (DCM),1/91,0.0045499369072032,0.0045499369072032,0,0,19909.0,107362.10783923086,DES
8498,KEGG_2019_Human,Endocytosis,1/244,0.0121998870519305,0.0121998870519305,0,0,19756.0,87051.4275316661,PSD3
8499,KEGG_2019_Human,Inflammatory mediator regulation of TRP channels,1/100,0.0049999330710556,0.0049999330710556,0,0,19900.0,105436.78197328727,TRPA1
8500,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF667
8501,KEGG_2019_Human,Complement and coagulation cascades,1/79,0.0039499423167337,0.0039499423167337,0,0,19921.0,110243.89578070649,F13A1
8502,KEGG_2019_Human,Arrhythmogenic right ventricular cardiomyopathy (ARVC),1/72,0.0035999456502131,0.0079623895876056,0,0,19928.0,112131.59838572376,CACNB1
8503,KEGG_2019_Human,Cardiac muscle contraction,1/78,0.0038999427840466,0.0079623895876056,0,0,19922.0,110503.2180492851,CACNB1
8504,KEGG_2019_Human,Hypertrophic cardiomyopathy (HCM),1/85,0.004249939567045,0.0079623895876056,0,0,19915.0,108752.83801948265,CACNB1
8505,KEGG_2019_Human,Dilated cardiomyopathy (DCM),1/91,0.0045499369072032,0.0079623895876056,0,0,19909.0,107362.10783923086,CACNB1
8506,KEGG_2019_Human,Adrenergic signaling in cardiomyocytes,1/145,0.0072499160871101,0.0089248989400127,0,0,19855.0,97820.92670675044,CACNB1
8507,KEGG_2019_Human,Oxytocin signaling pathway,1/153,0.0076499133771537,0.0089248989400127,0,0,19847.0,96715.6407630817,CACNB1
8508,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0147498749536506,0,0,19705.0,83086.53988020132,CACNB1
8509,KEGG_2019_Human,Prostate cancer,1/97,0.0048499343304706,0.0096998686609413,0,0,19903.0,106058.9096435903,KLK3
8510,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,KLK3
8511,KEGG_2019_Human,mTOR signaling pathway,1/152,0.0075999137114971,0.0075999137114971,0,0,19848.0,96850.665715497,RICTOR
8512,KEGG_2019_Human,Lysosome,1/123,0.0061499239842961,0.0071499167770442,0,0,19877.0,101200.07933676826,CTSC
8513,KEGG_2019_Human,Apoptosis,1/143,0.0071499167770442,0.0071499167770442,0,0,19857.0,98106.57763600958,CTSC
8514,KEGG_2019_Human,Riboflavin metabolism,1/8,0.0003999883241497325,0.0011249722262389,0,0,19992.0,156418.91141655247,ACP1
8515,KEGG_2019_Human,Thiamine metabolism,1/15,0.0007499814841592997,0.0011249722262389,0,0,19985.0,143801.30885993244,ACP1
8516,KEGG_2019_Human,Adherens junction,1/72,0.0035999456502131,0.0035999456502131,0,0,19928.0,112131.59838572376,ACP1
8517,KEGG_2019_Human,RNA transport,1/165,0.0082499094553477,0.0082499094553477,0,0,19835.0,95159.46482222488,FMR1
8518,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR8A1
8519,KEGG_2019_Human,Shigellosis,1/65,0.003249949134407,0.0128914879037424,0,0,19935.0,114209.92613860144,CRK
8520,KEGG_2019_Human,Renal cell carcinoma,1/69,0.003449947123837,0.0128914879037424,0,0,19931.0,112996.7391397682,CRK
8521,KEGG_2019_Human,Bacterial invasion of epithelial cells,1/74,0.0036999446830449,0.0128914879037424,0,0,19926.0,111574.38983110404,CRK
8522,KEGG_2019_Human,Chronic myeloid leukemia,1/76,0.0037999437281752,0.0128914879037424,0,0,19924.0,111031.8499691117,CRK
8523,KEGG_2019_Human,ErbB signaling pathway,1/85,0.004249939567045,0.0128914879037424,0,0,19915.0,108752.83801948265,CRK
8524,KEGG_2019_Human,Fc gamma R-mediated phagocytosis,1/91,0.0045499369072032,0.0128914879037424,0,0,19909.0,107362.10783923086,CRK
8525,KEGG_2019_Human,Neurotrophin signaling pathway,1/119,0.0059499254985137,0.0136605831173983,0,0,19881.0,101877.73080211312,CRK
8526,KEGG_2019_Human,Insulin signaling pathway,1/137,0.0068499188797651,0.0136605831173983,0,0,19863.0,98987.62735269018,CRK
8527,KEGG_2019_Human,Chemokine signaling pathway,1/190,0.0094999017791995,0.0136605831173983,0,0,19810.0,92244.74636351672,CRK
8528,KEGG_2019_Human,Focal adhesion,1/199,0.0099498991610159,0.0136605831173983,0,0,19801.0,91286.4288690606,CRK
8529,KEGG_2019_Human,Rap1 signaling pathway,1/206,0.010299897173561,0.0136605831173983,0,0,19794.0,90569.849337325,CRK
8530,KEGG_2019_Human,Human immunodeficiency virus 1 infection,1/212,0.0105998955026255,0.0136605831173983,0,0,19788.0,89974.27756224656,CRK
8531,KEGG_2019_Human,Regulation of actin cytoskeleton,1/214,0.0106998949514067,0.0136605831173983,0,0,19786.0,89779.39753374986,CRK
8532,KEGG_2019_Human,Human cytomegalovirus infection,1/225,0.0112498919790339,0.0136605831173983,0,0,19775.0,88738.27077557483,CRK
8533,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0158842411962421,0,0,19705.0,83086.53988020132,CRK
8534,KEGG_2019_Human,MicroRNAs in cancer,1/299,0.0149498740670514,0.0158842411962421,0,0,19701.0,82804.33538735632,CRK
8535,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,CRK
8536,KEGG_2019_Human,Insulin secretion,1/86,0.0042999391173866,0.0042999391173866,0,0,19914.0,108514.46102290176,KCNN1
8537,KEGG_2019_Human,Cholesterol metabolism,1/50,0.0024999572069037,0.0061499239842961,0,0,19950.0,119530.05920663515,SORT1
8538,KEGG_2019_Human,Neurotrophin signaling pathway,1/119,0.0059499254985137,0.0061499239842961,0,0,19881.0,101877.73080211312,SORT1
8539,KEGG_2019_Human,Lysosome,1/123,0.0061499239842961,0.0061499239842961,0,0,19877.0,101200.07933676826,SORT1
8540,KEGG_2019_Human,Endocytosis,1/244,0.0121998870519305,0.0121998870519305,0,0,19756.0,87051.4275316661,SNX5
8541,KEGG_2019_Human,Serotonergic synapse,1/113,0.0056499278191151,0.0140998535552025,0,0,19887.0,102937.34947211576,HTR5A
8542,KEGG_2019_Human,Calcium signaling pathway,1/188,0.009399902370135,0.0140998535552025,0,0,19812.0,92463.712994847,HTR5A
8543,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,HTR5A
8544,KEGG_2019_Human,"Parathyroid hormone synthesis, secretion and action",1/106,0.0052999306076525,0.0052999306076525,0,0,19894.0,104245.78450366124,PTHLH
8545,KEGG_2019_Human,Glycerophospholipid metabolism,1/97,0.0048499343304706,0.0048499343304706,0,0,19903.0,106058.9096435903,ETNK1
8546,KEGG_2019_Human,Arrhythmogenic right ventricular cardiomyopathy (ARVC),1/72,0.0035999456502131,0.0113165134377649,0,0,19928.0,112131.59838572376,ITGA2
8547,KEGG_2019_Human,ECM-receptor interaction,1/82,0.004099940929819,0.0113165134377649,0,0,19918.0,109484.9180722932,ITGA2
8548,KEGG_2019_Human,Hypertrophic cardiomyopathy (HCM),1/85,0.004249939567045,0.0113165134377649,0,0,19915.0,108752.83801948265,ITGA2
8549,KEGG_2019_Human,Dilated cardiomyopathy (DCM),1/91,0.0045499369072032,0.0113165134377649,0,0,19909.0,107362.10783923086,ITGA2
8550,KEGG_2019_Human,Small cell lung cancer,1/93,0.0046499360391879,0.0113165134377649,0,0,19907.0,106918.54242106884,ITGA2
8551,KEGG_2019_Human,Hematopoietic cell lineage,1/97,0.0048499343304706,0.0113165134377649,0,0,19903.0,106058.9096435903,ITGA2
8552,KEGG_2019_Human,Platelet activation,1/124,0.0061999236097501,0.0123998472195002,0,0,19876.0,101034.04709010696,ITGA2
8553,KEGG_2019_Human,Phagosome,1/152,0.0075999137114971,0.0132998489951199,0,0,19848.0,96850.665715497,ITGA2
8554,KEGG_2019_Human,Focal adhesion,1/199,0.0099498991610159,0.0136180481199722,0,0,19801.0,91286.4288690606,ITGA2
8555,KEGG_2019_Human,Proteoglycans in cancer,1/201,0.0100498985877989,0.0136180481199722,0,0,19799.0,91079.21596609056,ITGA2
8556,KEGG_2019_Human,Regulation of actin cytoskeleton,1/214,0.0106998949514067,0.0136180481199722,0,0,19786.0,89779.39753374986,ITGA2
8557,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0190613905368566,0,0,19670.0,80733.60565076157,ITGA2
8558,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0190613905368566,0,0,19646.0,79255.8617626126,ITGA2
8559,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,ITGA2
8560,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0146998751759735,0,0,19706.0,83157.67014793828,IL16
8561,KEGG_2019_Human,African trypanosomiasis,1/37,0.0018499650702878,0.0137797686900317,0,0,19963.0,125618.9446446357,FASLG
8562,KEGG_2019_Human,Allograft rejection,1/38,0.001899964429635,0.0137797686900317,0,0,19962.0,125080.29732025368,FASLG
8563,KEGG_2019_Human,Graft-versus-host disease,1/41,0.0020499625466866,0.0137797686900317,0,0,19959.0,123544.88783416104,FASLG
8564,KEGG_2019_Human,Type I diabetes mellitus,1/43,0.0021499613216957,0.0137797686900317,0,0,19957.0,122581.98940490963,FASLG
8565,KEGG_2019_Human,Autoimmune thyroid disease,1/53,0.0026499555173137,0.0137797686900317,0,0,19947.0,118349.78824235698,FASLG
8566,KEGG_2019_Human,Chagas disease (American trypanosomiasis),1/103,0.0051499318302617,0.0138935997781155,0,0,19897.0,104832.7525292024,FASLG
8567,KEGG_2019_Human,Neurotrophin signaling pathway,1/119,0.0059499254985137,0.0138935997781155,0,0,19881.0,101877.73080211312,FASLG
8568,KEGG_2019_Human,Natural killer cell mediated cytotoxicity,1/131,0.0065499210316603,0.0138935997781155,0,0,19869.0,99907.33811343512,FASLG
8569,KEGG_2019_Human,FoxO signaling pathway,1/132,0.0065999206698993,0.0138935997781155,0,0,19868.0,99751.22090491928,FASLG
8570,KEGG_2019_Human,Measles,1/138,0.0068999185254481,0.0138935997781155,0,0,19862.0,98838.19160389496,FASLG
8571,KEGG_2019_Human,Apoptosis,1/143,0.0071499167770442,0.0138935997781155,0,0,19857.0,98106.57763600958,FASLG
8572,KEGG_2019_Human,Non-alcoholic fatty liver disease (NAFLD),1/149,0.0074499147221605,0.0138935997781155,0,0,19851.0,97261.02051561224,FASLG
8573,KEGG_2019_Human,Hepatitis C,1/155,0.0077499127120574,0.0138935997781155,0,0,19845.0,96448.16254952336,FASLG
8574,KEGG_2019_Human,Necroptosis,1/162,0.0080999104202618,0.0138935997781155,0,0,19838.0,95537.86936302872,FASLG
8575,KEGG_2019_Human,Hepatitis B,1/163,0.0081499100978668,0.0138935997781155,0,0,19837.0,95410.9786681514,FASLG
8576,KEGG_2019_Human,Influenza A,1/171,0.0085499075557634,0.0138935997781155,0,0,19829.0,94422.42241345016,FASLG
8577,KEGG_2019_Human,Proteoglycans in cancer,1/201,0.0100498985877989,0.0150798571754485,0,0,19799.0,91079.21596609056,FASLG
8578,KEGG_2019_Human,Human immunodeficiency virus 1 infection,1/212,0.0105998955026255,0.0150798571754485,0,0,19788.0,89974.27756224656,FASLG
8579,KEGG_2019_Human,Human cytomegalovirus infection,1/225,0.0112498919790339,0.0150798571754485,0,0,19775.0,88738.27077557483,FASLG
8580,KEGG_2019_Human,Ras signaling pathway,1/232,0.0115998901349604,0.0150798571754485,0,0,19768.0,88101.22480150245,FASLG
8581,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.017431670399769,0,0,19706.0,83157.67014793828,FASLG
8582,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.017431670399769,0,0,19705.0,83086.53988020132,FASLG
8583,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0186520240840468,0,0,19670.0,80733.60565076157,FASLG
8584,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0191748511948141,0,0,19646.0,79255.8617626126,FASLG
8585,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0255838325388096,0,0,19508.0,72277.44006442746,FASLG
8586,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,FASLG
8587,KEGG_2019_Human,Galactose metabolism,1/31,0.0015499690656704,0.0075349107677416,0,0,19969.0,129189.85098816035,G6PC3
8588,KEGG_2019_Human,Starch and sucrose metabolism,1/36,0.0017999657178272,0.0075349107677416,0,0,19964.0,126172.23364250171,G6PC3
8589,KEGG_2019_Human,Carbohydrate digestion and absorption,1/44,0.0021999607179423,0.0075349107677416,0,0,19956.0,122117.06559109331,G6PC3
8590,KEGG_2019_Human,Glycolysis / Gluconeogenesis,1/68,0.0033999476216189,0.0075349107677416,0,0,19932.0,113293.39338050144,G6PC3
8591,KEGG_2019_Human,Adipocytokine signaling pathway,1/69,0.003449947123837,0.0075349107677416,0,0,19931.0,112996.7391397682,G6PC3
8592,KEGG_2019_Human,Glucagon signaling pathway,1/103,0.0051499318302617,0.0075349107677416,0,0,19897.0,104832.7525292024,G6PC3
8593,KEGG_2019_Human,Insulin resistance,1/108,0.0053999298011749,0.0075349107677416,0,0,19892.0,103863.47861844616,G6PC3
8594,KEGG_2019_Human,AMPK signaling pathway,1/120,0.0059999251180858,0.0075349107677416,0,0,19880.0,101706.2448082016,G6PC3
8595,KEGG_2019_Human,FoxO signaling pathway,1/132,0.0065999206698993,0.0075349107677416,0,0,19868.0,99751.22090491928,G6PC3
8596,KEGG_2019_Human,Insulin signaling pathway,1/137,0.0068499188797651,0.0075349107677416,0,0,19863.0,98987.62735269018,G6PC3
8597,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0176998626413668,0,0,19646.0,79255.8617626126,G6PC3
8598,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF41
8599,KEGG_2019_Human,Proximal tubule bicarbonate reclamation,1/23,0.0011499748819949,0.0062999150247102,0,0,19977.0,135204.63922267244,ATP1A3
8600,KEGG_2019_Human,Aldosterone-regulated sodium reabsorption,1/37,0.0018499650702878,0.0062999150247102,0,0,19963.0,125618.9446446357,ATP1A3
8601,KEGG_2019_Human,Carbohydrate digestion and absorption,1/44,0.0021999607179423,0.0062999150247102,0,0,19956.0,122117.06559109331,ATP1A3
8602,KEGG_2019_Human,Endocrine and other factor-regulated calcium reabsorption,1/48,0.0023999583567988,0.0062999150247102,0,0,19952.0,120356.5272753826,ATP1A3
8603,KEGG_2019_Human,Mineral absorption,1/51,0.0025499566390179,0.0062999150247102,0,0,19949.0,119129.0228601236,ATP1A3
8604,KEGG_2019_Human,Bile secretion,1/72,0.0035999456502131,0.0062999150247102,0,0,19928.0,112131.59838572376,ATP1A3
8605,KEGG_2019_Human,Thyroid hormone synthesis,1/74,0.0036999446830449,0.0062999150247102,0,0,19926.0,111574.38983110404,ATP1A3
8606,KEGG_2019_Human,Gastric acid secretion,1/75,0.0037499442041125,0.0062999150247102,0,0,19925.0,111301.33528642564,ATP1A3
8607,KEGG_2019_Human,Cardiac muscle contraction,1/78,0.0038999427840466,0.0062999150247102,0,0,19922.0,110503.2180492851,ATP1A3
8608,KEGG_2019_Human,Insulin secretion,1/86,0.0042999391173866,0.0062999150247102,0,0,19914.0,108514.46102290176,ATP1A3
8609,KEGG_2019_Human,Salivary secretion,1/90,0.0044999373439762,0.0062999150247102,0,0,19910.0,107587.50385474482,ATP1A3
8610,KEGG_2019_Human,Protein digestion and absorption,1/90,0.0044999373439762,0.0062999150247102,0,0,19910.0,107587.50385474482,ATP1A3
8611,KEGG_2019_Human,Pancreatic secretion,1/98,0.0048999339081079,0.0062999150247102,0,0,19902.0,105849.45495286948,ATP1A3
8612,KEGG_2019_Human,Aldosterone synthesis and secretion,1/98,0.0048999339081079,0.0062999150247102,0,0,19902.0,105849.45495286948,ATP1A3
8613,KEGG_2019_Human,Thyroid hormone signaling pathway,1/116,0.0057999266512085,0.0069599119814502,0,0,19884.0,102400.8105961506,ATP1A3
8614,KEGG_2019_Human,Adrenergic signaling in cardiomyocytes,1/145,0.0072499160871101,0.0081561555979989,0,0,19855.0,97820.92670675044,ATP1A3
8615,KEGG_2019_Human,cGMP-PKG signaling pathway,1/166,0.0082999091363732,0.0087881390855717,0,0,19834.0,95034.82345515196,ATP1A3
8616,KEGG_2019_Human,cAMP signaling pathway,1/212,0.0105998955026255,0.0105998955026255,0,0,19788.0,89974.27756224656,ATP1A3
8617,KEGG_2019_Human,Pertussis,1/76,0.0037999437281752,0.0086665523671662,0,0,19924.0,111031.8499691117,TIRAP
8618,KEGG_2019_Human,NF-kappa B signaling pathway,1/95,0.0047499351803394,0.0086665523671662,0,0,19905.0,106484.27183626965,TIRAP
8619,KEGG_2019_Human,Toll-like receptor signaling pathway,1/104,0.0051999314202997,0.0086665523671662,0,0,19896.0,104635.24941415618,TIRAP
8620,KEGG_2019_Human,Hepatitis B,1/163,0.0081499100978668,0.0089499050800561,0,0,19837.0,95410.9786681514,TIRAP
8621,KEGG_2019_Human,Tuberculosis,1/179,0.0089499050800561,0.0089499050800561,0,0,19821.0,93478.0629355712,TIRAP
8622,KEGG_2019_Human,Mitophagy,1/65,0.003249949134407,0.0095248837443371,0,0,19935.0,114209.92613860144,MITF
8623,KEGG_2019_Human,Melanoma,1/72,0.0035999456502131,0.0095248837443371,0,0,19928.0,112131.59838572376,MITF
8624,KEGG_2019_Human,Melanogenesis,1/101,0.0050499326546803,0.0095248837443371,0,0,19899.0,105233.48101229242,MITF
8625,KEGG_2019_Human,Osteoclast differentiation,1/127,0.0063499224962247,0.0095248837443371,0,0,19873.0,100543.72072014232,MITF
8626,KEGG_2019_Human,Transcriptional misregulation in cancer,1/186,0.0092999029651357,0.0111598835581629,0,0,19814.0,92684.96451050608,MITF
8627,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,MITF
8628,KEGG_2019_Human,Transcriptional misregulation in cancer,1/186,0.0092999029651357,0.0092999029651357,0,0,19814.0,92684.96451050608,LMO2
8629,KEGG_2019_Human,Inositol phosphate metabolism,1/74,0.0036999446830449,0.0036999446830449,0,0,19926.0,111574.38983110404,PLCH2
8630,KEGG_2019_Human,Vasopressin-regulated water reabsorption,1/44,0.0021999607179423,0.0043999214358846,0,0,19956.0,122117.06559109331,DCTN4
8631,KEGG_2019_Human,Huntington disease,1/193,0.0096499008972596,0.0096499008972596,0,0,19807.0,91920.47679471428,DCTN4
8632,KEGG_2019_Human,Other glycan degradation,1/18,0.0008999788927950273,0.00179995778559,0,0,19982.0,140136.54844084635,NEU4
8633,KEGG_2019_Human,Sphingolipid metabolism,1/47,0.0023499589392381,0.0023499589392381,0,0,19953.0,120782.64067395544,NEU4
8634,KEGG_2019_Human,Endocytosis,1/244,0.0121998870519305,0.0121998870519305,0,0,19756.0,87051.4275316661,VPS35
8635,KEGG_2019_Human,Fanconi anemia pathway,1/54,0.0026999549628563,0.0026999549628563,0,0,19946.0,117971.01964061816,FANCM
8636,KEGG_2019_Human,SNARE interactions in vesicular transport,1/34,0.0016999670339032,0.0021999607179423,0,0,19966.0,127326.1054203148,STX4
8637,KEGG_2019_Human,Vasopressin-regulated water reabsorption,1/44,0.0021999607179423,0.0021999607179423,0,0,19956.0,122117.06559109331,STX4
8638,KEGG_2019_Human,TGF-beta signaling pathway,1/90,0.0044999373439762,0.006949918172816,0,0,19910.0,107587.50385474482,LEFTY2
8639,KEGG_2019_Human,Signaling pathways regulating pluripotency of stem cells,1/139,0.006949918172816,0.006949918172816,0,0,19861.0,98689.81333375497,LEFTY2
8640,KEGG_2019_Human,Glycerophospholipid metabolism,1/97,0.0048499343304706,0.0061499239842961,0,0,19903.0,106058.9096435903,PLA2G15
8641,KEGG_2019_Human,Lysosome,1/123,0.0061499239842961,0.0061499239842961,0,0,19877.0,101200.07933676826,PLA2G15
8642,KEGG_2019_Human,Glycosphingolipid biosynthesis,1/45,0.0022499601197094,0.0022499601197094,0,0,19955.0,121662.49782449217,ST3GAL5
8643,KEGG_2019_Human,Vibrio cholerae infection,1/50,0.0024999572069037,0.0104930683638914,0,0,19950.0,119530.05920663515,ACTB
8644,KEGG_2019_Human,Pathogenic Escherichia coli infection,1/55,0.0027499544131125,0.0104930683638914,0,0,19945.0,117599.1294878737,ACTB
8645,KEGG_2019_Human,Viral myocarditis,1/59,0.0029499522555206,0.0104930683638914,0,0,19941.0,116175.59385530632,ACTB
8646,KEGG_2019_Human,Shigellosis,1/65,0.003249949134407,0.0104930683638914,0,0,19935.0,114209.92613860144,ACTB
8647,KEGG_2019_Human,Adherens junction,1/72,0.0035999456502131,0.0104930683638914,0,0,19928.0,112131.59838572376,ACTB
8648,KEGG_2019_Human,Arrhythmogenic right ventricular cardiomyopathy (ARVC),1/72,0.0035999456502131,0.0104930683638914,0,0,19928.0,112131.59838572376,ACTB
8649,KEGG_2019_Human,Bacterial invasion of epithelial cells,1/74,0.0036999446830449,0.0104930683638914,0,0,19926.0,111574.38983110404,ACTB
8650,KEGG_2019_Human,Gastric acid secretion,1/75,0.0037499442041125,0.0104930683638914,0,0,19925.0,111301.33528642564,ACTB
8651,KEGG_2019_Human,Hypertrophic cardiomyopathy (HCM),1/85,0.004249939567045,0.0104930683638914,0,0,19915.0,108752.83801948265,ACTB
8652,KEGG_2019_Human,Salmonella infection,1/86,0.0042999391173866,0.0104930683638914,0,0,19914.0,108514.46102290176,ACTB
8653,KEGG_2019_Human,Dilated cardiomyopathy (DCM),1/91,0.0045499369072032,0.0104930683638914,0,0,19909.0,107362.10783923086,ACTB
8654,KEGG_2019_Human,Leukocyte transendothelial migration,1/112,0.0055999282120529,0.0104930683638914,0,0,19888.0,103119.30984392198,ACTB
8655,KEGG_2019_Human,Thyroid hormone signaling pathway,1/116,0.0057999266512085,0.0104930683638914,0,0,19884.0,102400.8105961506,ACTB
8656,KEGG_2019_Human,Platelet activation,1/124,0.0061999236097501,0.0104930683638914,0,0,19876.0,101034.04709010696,ACTB
8657,KEGG_2019_Human,Fluid shear stress and atherosclerosis,1/139,0.006949918172816,0.0104930683638914,0,0,19861.0,98689.81333375497,ACTB
8658,KEGG_2019_Human,Apoptosis,1/143,0.0071499167770442,0.0104930683638914,0,0,19857.0,98106.57763600958,ACTB
8659,KEGG_2019_Human,Phagosome,1/152,0.0075999137114971,0.0104930683638914,0,0,19848.0,96850.665715497,ACTB
8660,KEGG_2019_Human,Oxytocin signaling pathway,1/153,0.0076499133771537,0.0104930683638914,0,0,19847.0,96715.6407630817,ACTB
8661,KEGG_2019_Human,Hippo signaling pathway,1/160,0.0079999110688441,0.0104930683638914,0,0,19840.0,95793.96509856998,ACTB
8662,KEGG_2019_Human,Hepatocellular carcinoma,1/168,0.0083999085011095,0.0104930683638914,0,0,19832.0,94787.72752807094,ACTB
8663,KEGG_2019_Human,Tight junction,1/170,0.0084999078692823,0.0104930683638914,0,0,19830.0,94543.49009679438,ACTB
8664,KEGG_2019_Human,Influenza A,1/171,0.0085499075557634,0.0104930683638914,0,0,19829.0,94422.42241345016,ACTB
8665,KEGG_2019_Human,Focal adhesion,1/199,0.0099498991610159,0.0111114293726147,0,0,19801.0,91286.4288690606,ACTB
8666,KEGG_2019_Human,Proteoglycans in cancer,1/201,0.0100498985877989,0.0111114293726147,0,0,19799.0,91079.21596609056,ACTB
8667,KEGG_2019_Human,Rap1 signaling pathway,1/206,0.010299897173561,0.0111114293726147,0,0,19794.0,90569.849337325,ACTB
8668,KEGG_2019_Human,Regulation of actin cytoskeleton,1/214,0.0106998949514067,0.0111114293726147,0,0,19786.0,89779.39753374986,ACTB
8669,KEGG_2019_Human,Thermogenesis,1/231,0.0115498903940656,0.0115498903940656,0,0,19769.0,88191.07730937863,ACTB
8670,KEGG_2019_Human,Wnt signaling pathway,1/158,0.0078999117225733,0.0078999117225733,0,0,19842.0,96053.2110949472,NOTUM
8671,KEGG_2019_Human,Alzheimer disease,1/171,0.0085499075557634,0.0085499075557634,0,0,19829.0,94422.42241345016,RTN4
8672,KEGG_2019_Human,Human immunodeficiency virus 1 infection,1/212,0.0105998955026255,0.0105998955026255,0,0,19788.0,89974.27756224656,TRIM5
8673,KEGG_2019_Human,Morphine addiction,1/91,0.0045499369072032,0.0076499133771537,0,0,19909.0,107362.10783923086,KCNJ5
8674,KEGG_2019_Human,Circadian entrainment,1/97,0.0048499343304706,0.0076499133771537,0,0,19903.0,106058.9096435903,KCNJ5
8675,KEGG_2019_Human,Aldosterone synthesis and secretion,1/98,0.0048999339081079,0.0076499133771537,0,0,19902.0,105849.45495286948,KCNJ5
8676,KEGG_2019_Human,Serotonergic synapse,1/113,0.0056499278191151,0.0076499133771537,0,0,19887.0,102937.34947211576,KCNJ5
8677,KEGG_2019_Human,Dopaminergic synapse,1/131,0.0065499210316603,0.0076499133771537,0,0,19869.0,99907.33811343512,KCNJ5
8678,KEGG_2019_Human,Estrogen signaling pathway,1/137,0.0068499188797651,0.0076499133771537,0,0,19863.0,98987.62735269018,KCNJ5
8679,KEGG_2019_Human,Retrograde endocannabinoid signaling,1/148,0.007399915061391,0.0076499133771537,0,0,19852.0,97399.60470052566,KCNJ5
8680,KEGG_2019_Human,Oxytocin signaling pathway,1/153,0.0076499133771537,0.0076499133771537,0,0,19847.0,96715.6407630817,KCNJ5
8681,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF418
8682,KEGG_2019_Human,Endocytosis,1/244,0.0121998870519305,0.0121998870519305,0,0,19756.0,87051.4275316661,AGAP1
8683,KEGG_2019_Human,ECM-receptor interaction,1/82,0.004099940929819,0.0112498433599406,0,0,19918.0,109484.9180722932,COL6A2
8684,KEGG_2019_Human,Protein digestion and absorption,1/90,0.0044999373439762,0.0112498433599406,0,0,19910.0,107587.50385474482,COL6A2
8685,KEGG_2019_Human,Focal adhesion,1/199,0.0099498991610159,0.0165831652683599,0,0,19801.0,91286.4288690606,COL6A2
8686,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0176998626413668,0,0,19670.0,80733.60565076157,COL6A2
8687,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0176998626413668,0,0,19646.0,79255.8617626126,COL6A2
8688,KEGG_2019_Human,Porphyrin and chlorophyll metabolism,1/42,0.0020999619311272,0.0020999619311272,0,0,19958.0,123057.75613441122,UROS
8689,KEGG_2019_Human,Cortisol synthesis and secretion,1/65,0.003249949134407,0.0097998678162159,0,0,19935.0,114209.92613860144,CACNA1I
8690,KEGG_2019_Human,Circadian entrainment,1/97,0.0048499343304706,0.0097998678162159,0,0,19903.0,106058.9096435903,CACNA1I
8691,KEGG_2019_Human,Aldosterone synthesis and secretion,1/98,0.0048999339081079,0.0097998678162159,0,0,19902.0,105849.45495286948,CACNA1I
8692,KEGG_2019_Human,Cushing syndrome,1/155,0.0077499127120574,0.011279882844162,0,0,19845.0,96448.16254952336,CACNA1I
8693,KEGG_2019_Human,Calcium signaling pathway,1/188,0.009399902370135,0.011279882844162,0,0,19812.0,92463.712994847,CACNA1I
8694,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0147498749536506,0,0,19705.0,83086.53988020132,CACNA1I
8695,KEGG_2019_Human,Inositol phosphate metabolism,1/74,0.0036999446830449,0.0072499083140107,0,0,19926.0,111574.38983110404,PLCD1
8696,KEGG_2019_Human,Phosphatidylinositol signaling system,1/99,0.0049499334884068,0.0072499083140107,0,0,19901.0,105642.09305076736,PLCD1
8697,KEGG_2019_Human,AGE-RAGE signaling pathway in diabetic complications,1/100,0.0049999330710556,0.0072499083140107,0,0,19900.0,105436.78197328727,PLCD1
8698,KEGG_2019_Human,Thyroid hormone signaling pathway,1/116,0.0057999266512085,0.0072499083140107,0,0,19884.0,102400.8105961506,PLCD1
8699,KEGG_2019_Human,Calcium signaling pathway,1/188,0.009399902370135,0.009399902370135,0,0,19812.0,92463.712994847,PLCD1
8700,KEGG_2019_Human,Epithelial cell signaling in Helicobacter pylori infection,1/68,0.0033999476216189,0.0067998952432378,0,0,19932.0,113293.39338050144,ADAM10
8701,KEGG_2019_Human,Alzheimer disease,1/171,0.0085499075557634,0.0085499075557634,0,0,19829.0,94422.42241345016,ADAM10
8702,KEGG_2019_Human,Maturity onset diabetes of the young,1/26,0.0012999726251831,0.0025999452503662,0,0,19974.0,132735.46073187632,HNF1A
8703,KEGG_2019_Human,Signaling pathways regulating pluripotency of stem cells,1/139,0.006949918172816,0.006949918172816,0,0,19861.0,98689.81333375497,HNF1A
8704,KEGG_2019_Human,"Parathyroid hormone synthesis, secretion and action",1/106,0.0052999306076525,0.0052999306076525,0,0,19894.0,104245.78450366124,NACA
8705,KEGG_2019_Human,Oxidative phosphorylation,1/133,0.0066499203093911,0.0112582177134695,0,0,19867.0,99596.2591544721,NDUFS1
8706,KEGG_2019_Human,Parkinson disease,1/142,0.0070999171242726,0.0112582177134695,0,0,19858.0,98250.87390500787,NDUFS1
8707,KEGG_2019_Human,Retrograde endocannabinoid signaling,1/148,0.007399915061391,0.0112582177134695,0,0,19852.0,97399.60470052566,NDUFS1
8708,KEGG_2019_Human,Non-alcoholic fatty liver disease (NAFLD),1/149,0.0074499147221605,0.0112582177134695,0,0,19851.0,97261.02051561224,NDUFS1
8709,KEGG_2019_Human,Alzheimer disease,1/171,0.0085499075557634,0.0112582177134695,0,0,19829.0,94422.42241345016,NDUFS1
8710,KEGG_2019_Human,Huntington disease,1/193,0.0096499008972596,0.0112582177134695,0,0,19807.0,91920.47679471428,NDUFS1
8711,KEGG_2019_Human,Thermogenesis,1/231,0.0115498903940656,0.0115498903940656,0,0,19769.0,88191.07730937863,NDUFS1
8712,KEGG_2019_Human,Melanoma,1/72,0.0035999456502131,0.0136123170931188,0,0,19928.0,112131.59838572376,PDGFD
8713,KEGG_2019_Human,Gap junction,1/88,0.0043999382262822,0.0136123170931188,0,0,19912.0,108045.79305232369,PDGFD
8714,KEGG_2019_Human,Prostate cancer,1/97,0.0048499343304706,0.0136123170931188,0,0,19903.0,106058.9096435903,PDGFD
8715,KEGG_2019_Human,Choline metabolism in cancer,1/99,0.0049499334884068,0.0136123170931188,0,0,19901.0,105642.09305076736,PDGFD
8716,KEGG_2019_Human,Phospholipase D signaling pathway,1/148,0.007399915061391,0.0141776434982849,0,0,19852.0,97399.60470052566,PDGFD
8717,KEGG_2019_Human,Focal adhesion,1/199,0.0099498991610159,0.0141776434982849,0,0,19801.0,91286.4288690606,PDGFD
8718,KEGG_2019_Human,Rap1 signaling pathway,1/206,0.010299897173561,0.0141776434982849,0,0,19794.0,90569.849337325,PDGFD
8719,KEGG_2019_Human,Regulation of actin cytoskeleton,1/214,0.0106998949514067,0.0141776434982849,0,0,19786.0,89779.39753374986,PDGFD
8720,KEGG_2019_Human,Ras signaling pathway,1/232,0.0115998901349604,0.0141776434982849,0,0,19768.0,88101.22480150245,PDGFD
8721,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0162248624490157,0,0,19705.0,83086.53988020132,PDGFD
8722,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0176998626413668,0,0,19646.0,79255.8617626126,PDGFD
8723,KEGG_2019_Human,Arginine biosynthesis,1/21,0.0010499764455398,0.0092665575637547,0,0,19979.0,137035.71221916509,NOS3
8724,KEGG_2019_Human,Arginine and proline metabolism,1/49,0.0024499577795033,0.0092665575637547,0,0,19951.0,119939.1172087114,NOS3
8725,KEGG_2019_Human,VEGF signaling pathway,1/59,0.0029499522555206,0.0092665575637547,0,0,19941.0,116175.59385530632,NOS3
8726,KEGG_2019_Human,AGE-RAGE signaling pathway in diabetic complications,1/100,0.0049999330710556,0.0092665575637547,0,0,19900.0,105436.78197328727,NOS3
8727,KEGG_2019_Human,HIF-1 signaling pathway,1/100,0.0049999330710556,0.0092665575637547,0,0,19900.0,105436.78197328727,NOS3
8728,KEGG_2019_Human,Insulin resistance,1/108,0.0053999298011749,0.0092665575637547,0,0,19892.0,103863.47861844616,NOS3
8729,KEGG_2019_Human,Sphingolipid signaling pathway,1/119,0.0059499254985137,0.0092665575637547,0,0,19881.0,101877.73080211312,NOS3
8730,KEGG_2019_Human,Platelet activation,1/124,0.0061999236097501,0.0092665575637547,0,0,19876.0,101034.04709010696,NOS3
8731,KEGG_2019_Human,Relaxin signaling pathway,1/130,0.0064999213952527,0.0092665575637547,0,0,19870.0,100064.62842845908,NOS3
8732,KEGG_2019_Human,Estrogen signaling pathway,1/137,0.0068499188797651,0.0092665575637547,0,0,19863.0,98987.62735269018,NOS3
8733,KEGG_2019_Human,Apelin signaling pathway,1/137,0.0068499188797651,0.0092665575637547,0,0,19863.0,98987.62735269018,NOS3
8734,KEGG_2019_Human,Fluid shear stress and atherosclerosis,1/139,0.006949918172816,0.0092665575637547,0,0,19861.0,98689.81333375497,NOS3
8735,KEGG_2019_Human,Oxytocin signaling pathway,1/153,0.0076499133771537,0.0094152780026508,0,0,19847.0,96715.6407630817,NOS3
8736,KEGG_2019_Human,cGMP-PKG signaling pathway,1/166,0.0082999091363732,0.0094856104415694,0,0,19834.0,95034.82345515196,NOS3
8737,KEGG_2019_Human,Calcium signaling pathway,1/188,0.009399902370135,0.010026562528144,0,0,19812.0,92463.712994847,NOS3
8738,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0176998626413668,0,0,19646.0,79255.8617626126,NOS3
8739,KEGG_2019_Human,Primary immunodeficiency,1/37,0.0018499650702878,0.0074899022837696,0,0,19963.0,125618.9446446357,ZAP70
8740,KEGG_2019_Human,Th1 and Th2 cell differentiation,1/92,0.0045999364719865,0.0074899022837696,0,0,19908.0,107139.13814408927,ZAP70
8741,KEGG_2019_Human,NF-kappa B signaling pathway,1/95,0.0047499351803394,0.0074899022837696,0,0,19905.0,106484.27183626965,ZAP70
8742,KEGG_2019_Human,T cell receptor signaling pathway,1/101,0.0050499326546803,0.0074899022837696,0,0,19899.0,105233.48101229242,ZAP70
8743,KEGG_2019_Human,Th17 cell differentiation,1/107,0.0053499302026925,0.0074899022837696,0,0,19893.0,104053.753408911,ZAP70
8744,KEGG_2019_Human,Natural killer cell mediated cytotoxicity,1/131,0.0065499210316603,0.007641574536937,0,0,19869.0,99907.33811343512,ZAP70
8745,KEGG_2019_Human,Ras signaling pathway,1/232,0.0115998901349604,0.0115998901349604,0,0,19768.0,88101.22480150245,ZAP70
8746,KEGG_2019_Human,Fanconi anemia pathway,1/54,0.0026999549628563,0.0026999549628563,0,0,19946.0,117971.01964061816,EME2
8747,KEGG_2019_Human,RNA polymerase,1/31,0.0015499690656704,0.0046499071970112,0,0,19969.0,129189.85098816035,POLR2F
8748,KEGG_2019_Human,Cytosolic DNA-sensing pathway,1/63,0.0031499501598827,0.0047249252398241,0,0,19937.0,114844.46974572667,POLR2F
8749,KEGG_2019_Human,Huntington disease,1/193,0.0096499008972596,0.0096499008972596,0,0,19807.0,91920.47679471428,POLR2F
8750,KEGG_2019_Human,Apoptosis,1/143,0.0071499167770442,0.0071499167770442,0,0,19857.0,98106.57763600958,DIABLO
8751,KEGG_2019_Human,Mitophagy,1/65,0.003249949134407,0.0082499094553477,0,0,19935.0,114209.92613860144,PRKN
8752,KEGG_2019_Human,Ubiquitin mediated proteolysis,1/137,0.0068499188797651,0.0082499094553477,0,0,19863.0,98987.62735269018,PRKN
8753,KEGG_2019_Human,Parkinson disease,1/142,0.0070999171242726,0.0082499094553477,0,0,19858.0,98250.87390500787,PRKN
8754,KEGG_2019_Human,Protein processing in endoplasmic reticulum,1/165,0.0082499094553477,0.0082499094553477,0,0,19835.0,95159.46482222488,PRKN
8755,KEGG_2019_Human,Acute myeloid leukemia,1/66,0.003299948626608,0.0098998458798241,0,0,19934.0,113899.85357353876,RUNX1T1
8756,KEGG_2019_Human,Transcriptional misregulation in cancer,1/186,0.0092999029651357,0.0139498544477036,0,0,19814.0,92684.96451050608,RUNX1T1
8757,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,RUNX1T1
8758,KEGG_2019_Human,Bladder cancer,1/41,0.0020499625466866,0.0061498876400599,0,0,19959.0,123544.88783416104,DAPK3
8759,KEGG_2019_Human,Autophagy,1/128,0.0063999221281459,0.0095998831922188,0,0,19872.0,100382.8010329652,DAPK3
8760,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,DAPK3
8761,KEGG_2019_Human,Fluid shear stress and atherosclerosis,1/139,0.006949918172816,0.0100498985877989,0,0,19861.0,98689.81333375497,GPC1
8762,KEGG_2019_Human,Proteoglycans in cancer,1/201,0.0100498985877989,0.0100498985877989,0,0,19799.0,91079.21596609056,GPC1
8763,KEGG_2019_Human,Oxidative phosphorylation,1/133,0.0066499203093911,0.0112582177134695,0,0,19867.0,99596.2591544721,NDUFS3
8764,KEGG_2019_Human,Parkinson disease,1/142,0.0070999171242726,0.0112582177134695,0,0,19858.0,98250.87390500787,NDUFS3
8765,KEGG_2019_Human,Retrograde endocannabinoid signaling,1/148,0.007399915061391,0.0112582177134695,0,0,19852.0,97399.60470052566,NDUFS3
8766,KEGG_2019_Human,Non-alcoholic fatty liver disease (NAFLD),1/149,0.0074499147221605,0.0112582177134695,0,0,19851.0,97261.02051561224,NDUFS3
8767,KEGG_2019_Human,Alzheimer disease,1/171,0.0085499075557634,0.0112582177134695,0,0,19829.0,94422.42241345016,NDUFS3
8768,KEGG_2019_Human,Huntington disease,1/193,0.0096499008972596,0.0112582177134695,0,0,19807.0,91920.47679471428,NDUFS3
8769,KEGG_2019_Human,Thermogenesis,1/231,0.0115498903940656,0.0115498903940656,0,0,19769.0,88191.07730937863,NDUFS3
8770,KEGG_2019_Human,DNA replication,1/36,0.0017999657178272,0.0017999657178272,0,0,19964.0,126172.23364250171,POLA1
8771,KEGG_2019_Human,Mismatch repair,1/23,0.0011499748819949,0.0023499589392381,0,0,19977.0,135204.63922267244,LIG1
8772,KEGG_2019_Human,Base excision repair,1/33,0.0016499677032113,0.0023499589392381,0,0,19967.0,127928.56031580272,LIG1
8773,KEGG_2019_Human,DNA replication,1/36,0.0017999657178272,0.0023499589392381,0,0,19964.0,126172.23364250171,LIG1
8774,KEGG_2019_Human,Nucleotide excision repair,1/47,0.0023499589392381,0.0023499589392381,0,0,19953.0,120782.64067395544,LIG1
8775,KEGG_2019_Human,ECM-receptor interaction,1/82,0.004099940929819,0.0099998661421113,0,0,19918.0,109484.9180722932,COL4A1
8776,KEGG_2019_Human,Protein digestion and absorption,1/90,0.0044999373439762,0.0099998661421113,0,0,19910.0,107587.50385474482,COL4A1
8777,KEGG_2019_Human,Small cell lung cancer,1/93,0.0046499360391879,0.0099998661421113,0,0,19907.0,106918.54242106884,COL4A1
8778,KEGG_2019_Human,Amoebiasis,1/96,0.0047999347538706,0.0099998661421113,0,0,19904.0,106270.50039849174,COL4A1
8779,KEGG_2019_Human,AGE-RAGE signaling pathway in diabetic complications,1/100,0.0049999330710556,0.0099998661421113,0,0,19900.0,105436.78197328727,COL4A1
8780,KEGG_2019_Human,Relaxin signaling pathway,1/130,0.0064999213952527,0.0108332023254213,0,0,19870.0,100064.62842845908,COL4A1
8781,KEGG_2019_Human,Focal adhesion,1/199,0.0099498991610159,0.0142141416585942,0,0,19801.0,91286.4288690606,COL4A1
8782,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0196665140459632,0,0,19670.0,80733.60565076157,COL4A1
8783,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0196665140459632,0,0,19646.0,79255.8617626126,COL4A1
8784,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,COL4A1
8785,KEGG_2019_Human,Dopaminergic synapse,1/131,0.0065499210316603,0.0065499210316603,0,0,19869.0,99907.33811343512,CALY
8786,KEGG_2019_Human,Circadian rhythm,1/31,0.0015499690656704,0.0089248989400127,0,0,19969.0,129189.85098816035,PRKAG2
8787,KEGG_2019_Human,Adipocytokine signaling pathway,1/69,0.003449947123837,0.0089248989400127,0,0,19931.0,112996.7391397682,PRKAG2
8788,KEGG_2019_Human,Hypertrophic cardiomyopathy (HCM),1/85,0.004249939567045,0.0089248989400127,0,0,19915.0,108752.83801948265,PRKAG2
8789,KEGG_2019_Human,Longevity regulating pathway,1/102,0.0050999322416682,0.0089248989400127,0,0,19898.0,105032.15064717118,PRKAG2
8790,KEGG_2019_Human,Glucagon signaling pathway,1/103,0.0051499318302617,0.0089248989400127,0,0,19897.0,104832.7525292024,PRKAG2
8791,KEGG_2019_Human,Insulin resistance,1/108,0.0053999298011749,0.0089248989400127,0,0,19892.0,103863.47861844616,PRKAG2
8792,KEGG_2019_Human,AMPK signaling pathway,1/120,0.0059999251180858,0.0089248989400127,0,0,19880.0,101706.2448082016,PRKAG2
8793,KEGG_2019_Human,FoxO signaling pathway,1/132,0.0065999206698993,0.0089248989400127,0,0,19868.0,99751.22090491928,PRKAG2
8794,KEGG_2019_Human,Insulin signaling pathway,1/137,0.0068499188797651,0.0089248989400127,0,0,19863.0,98987.62735269018,PRKAG2
8795,KEGG_2019_Human,Apelin signaling pathway,1/137,0.0068499188797651,0.0089248989400127,0,0,19863.0,98987.62735269018,PRKAG2
8796,KEGG_2019_Human,Non-alcoholic fatty liver disease (NAFLD),1/149,0.0074499147221605,0.0089248989400127,0,0,19851.0,97261.02051561224,PRKAG2
8797,KEGG_2019_Human,Oxytocin signaling pathway,1/153,0.0076499133771537,0.0089248989400127,0,0,19847.0,96715.6407630817,PRKAG2
8798,KEGG_2019_Human,Tight junction,1/170,0.0084999078692823,0.0091537469361502,0,0,19830.0,94543.49009679438,PRKAG2
8799,KEGG_2019_Human,Thermogenesis,1/231,0.0115498903940656,0.0115498903940656,0,0,19769.0,88191.07730937863,PRKAG2
8800,KEGG_2019_Human,Protein digestion and absorption,1/90,0.0044999373439762,0.0044999373439762,0,0,19910.0,107587.50385474482,COL5A2
8801,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF772
8802,KEGG_2019_Human,Primary immunodeficiency,1/37,0.0018499650702878,0.0089998404788377,0,0,19963.0,125618.9446446357,TAP2
8803,KEGG_2019_Human,ABC transporters,1/45,0.0022499601197094,0.0089998404788377,0,0,19955.0,121662.49782449217,TAP2
8804,KEGG_2019_Human,Antigen processing and presentation,1/77,0.0038499432547502,0.0102665153460006,0,0,19923.0,110765.8407373636,TAP2
8805,KEGG_2019_Human,Phagosome,1/152,0.0075999137114971,0.0128570194046101,0,0,19848.0,96850.665715497,TAP2
8806,KEGG_2019_Human,Epstein-Barr virus infection,1/201,0.0100498985877989,0.0128570194046101,0,0,19799.0,91079.21596609056,TAP2
8807,KEGG_2019_Human,Human immunodeficiency virus 1 infection,1/212,0.0105998955026255,0.0128570194046101,0,0,19788.0,89974.27756224656,TAP2
8808,KEGG_2019_Human,Human cytomegalovirus infection,1/225,0.0112498919790339,0.0128570194046101,0,0,19775.0,88738.27077557483,TAP2
8809,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,TAP2
8810,KEGG_2019_Human,Ribosome,1/153,0.0076499133771537,0.0076499133771537,0,0,19847.0,96715.6407630817,RPS13
8811,KEGG_2019_Human,Ribosome,1/153,0.0076499133771537,0.0076499133771537,0,0,19847.0,96715.6407630817,RPL22L1
8812,KEGG_2019_Human,Protein processing in endoplasmic reticulum,1/165,0.0082499094553477,0.0082499094553477,0,0,19835.0,95159.46482222488,BAG1
8813,KEGG_2019_Human,ECM-receptor interaction,1/82,0.004099940929819,0.0112998556382303,0,0,19918.0,109484.9180722932,LAMB4
8814,KEGG_2019_Human,Small cell lung cancer,1/93,0.0046499360391879,0.0112998556382303,0,0,19907.0,106918.54242106884,LAMB4
8815,KEGG_2019_Human,Amoebiasis,1/96,0.0047999347538706,0.0112998556382303,0,0,19904.0,106270.50039849174,LAMB4
8816,KEGG_2019_Human,Toxoplasmosis,1/113,0.0056499278191151,0.0112998556382303,0,0,19887.0,102937.34947211576,LAMB4
8817,KEGG_2019_Human,Focal adhesion,1/199,0.0099498991610159,0.0159198386576255,0,0,19801.0,91286.4288690606,LAMB4
8818,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0202284144472764,0,0,19670.0,80733.60565076157,LAMB4
8819,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0202284144472764,0,0,19646.0,79255.8617626126,LAMB4
8820,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,LAMB4
8821,KEGG_2019_Human,Endocytosis,1/244,0.0121998870519305,0.0121998870519305,0,0,19756.0,87051.4275316661,RAB11FIP2
8822,KEGG_2019_Human,Sphingolipid metabolism,1/47,0.0023499589392381,0.0061499239842961,0,0,19953.0,120782.64067395544,ASAH1
8823,KEGG_2019_Human,Sphingolipid signaling pathway,1/119,0.0059499254985137,0.0061499239842961,0,0,19881.0,101877.73080211312,ASAH1
8824,KEGG_2019_Human,Lysosome,1/123,0.0061499239842961,0.0061499239842961,0,0,19877.0,101200.07933676826,ASAH1
8825,KEGG_2019_Human,Glyoxylate and dicarboxylate metabolism,1/30,0.0014999697593334,0.0030856607444556,0,0,19970.0,129851.13732048514,DLD
8826,KEGG_2019_Human,Citrate cycle (TCA cycle),1/30,0.0014999697593334,0.0030856607444556,0,0,19970.0,129851.13732048514,DLD
8827,KEGG_2019_Human,Propanoate metabolism,1/32,0.0015999683804467,0.0030856607444556,0,0,19968.0,128549.41955786056,DLD
8828,KEGG_2019_Human,Pyruvate metabolism,1/39,0.0019499637955508,0.0030856607444556,0,0,19961.0,124555.53162481484,DLD
8829,KEGG_2019_Human,"Glycine, serine and threonine metabolism",1/40,0.0019999631680592,0.0030856607444556,0,0,19960.0,124043.94523066044,DLD
8830,KEGG_2019_Human,Tryptophan metabolism,1/42,0.0020999619311272,0.0030856607444556,0,0,19958.0,123057.75613441122,DLD
8831,KEGG_2019_Human,"Valine, leucine and isoleucine degradation",1/48,0.0023999583567988,0.0030856607444556,0,0,19952.0,120356.5272753826,DLD
8832,KEGG_2019_Human,Lysine degradation,1/59,0.0029499522555206,0.0033186962874607,0,0,19941.0,116175.59385530632,DLD
8833,KEGG_2019_Human,Glycolysis / Gluconeogenesis,1/68,0.0033999476216189,0.0033999476216189,0,0,19932.0,113293.39338050144,DLD
8834,KEGG_2019_Human,Nicotine addiction,1/40,0.0019999631680592,0.007399915061391,0,0,19960.0,124043.94523066044,SLC17A7
8835,KEGG_2019_Human,Synaptic vesicle cycle,1/78,0.0038999427840466,0.007399915061391,0,0,19922.0,110503.2180492851,SLC17A7
8836,KEGG_2019_Human,Glutamatergic synapse,1/114,0.005699927427839,0.007399915061391,0,0,19886.0,102756.96431429044,SLC17A7
8837,KEGG_2019_Human,Retrograde endocannabinoid signaling,1/148,0.007399915061391,0.007399915061391,0,0,19852.0,97399.60470052566,SLC17A7
8838,KEGG_2019_Human,Notch signaling pathway,1/48,0.0023999583567988,0.0075998874563505,0,0,19952.0,120356.5272753826,CTBP1
8839,KEGG_2019_Human,Chronic myeloid leukemia,1/76,0.0037999437281752,0.0075998874563505,0,0,19924.0,111031.8499691117,CTBP1
8840,KEGG_2019_Human,Wnt signaling pathway,1/158,0.0078999117225733,0.0105332156300977,0,0,19842.0,96053.2110949472,CTBP1
8841,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,CTBP1
8842,KEGG_2019_Human,Terpenoid backbone biosynthesis,1/22,0.0010999756574123,0.0010999756574123,0,0,19978.0,136099.47030191717,PDSS2
8843,KEGG_2019_Human,Insulin resistance,1/108,0.0053999298011749,0.0074499147221605,0,0,19892.0,103863.47861844616,MLXIP
8844,KEGG_2019_Human,Non-alcoholic fatty liver disease (NAFLD),1/149,0.0074499147221605,0.0074499147221605,0,0,19851.0,97261.02051561224,MLXIP
8845,KEGG_2019_Human,Folate biosynthesis,1/26,0.0012999726251831,0.0055999146074646,0,0,19974.0,132735.46073187632,TH
8846,KEGG_2019_Human,Tyrosine metabolism,1/36,0.0017999657178272,0.0055999146074646,0,0,19964.0,126172.23364250171,TH
8847,KEGG_2019_Human,Cocaine addiction,1/49,0.0024499577795033,0.0055999146074646,0,0,19951.0,119939.1172087114,TH
8848,KEGG_2019_Human,Amphetamine addiction,1/68,0.0033999476216189,0.0055999146074646,0,0,19932.0,113293.39338050144,TH
8849,KEGG_2019_Human,Prolactin signaling pathway,1/70,0.0034999466296654,0.0055999146074646,0,0,19930.0,112704.30065625212,TH
8850,KEGG_2019_Human,Dopaminergic synapse,1/131,0.0065499210316603,0.0081141909991687,0,0,19869.0,99907.33811343512,TH
8851,KEGG_2019_Human,Parkinson disease,1/142,0.0070999171242726,0.0081141909991687,0,0,19858.0,98250.87390500787,TH
8852,KEGG_2019_Human,Alcoholism,1/180,0.0089999047745351,0.0089999047745351,0,0,19820.0,93362.92821536642,TH
8853,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF140
8854,KEGG_2019_Human,GABAergic synapse,1/89,0.0044499377838098,0.005699927427839,0,0,19911.0,107815.380281759,SLC38A2
8855,KEGG_2019_Human,Protein digestion and absorption,1/90,0.0044999373439762,0.005699927427839,0,0,19910.0,107587.50385474482,SLC38A2
8856,KEGG_2019_Human,Glutamatergic synapse,1/114,0.005699927427839,0.005699927427839,0,0,19886.0,102756.96431429044,SLC38A2
8857,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF528
8858,KEGG_2019_Human,Insulin resistance,1/108,0.0053999298011749,0.0053999298011749,0,0,19892.0,103863.47861844616,PPARGC1B
8859,KEGG_2019_Human,Legionellosis,1/55,0.0027499544131125,0.0102698500235077,0,0,19945.0,117599.1294878737,C3
8860,KEGG_2019_Human,Staphylococcus aureus infection,1/68,0.0033999476216189,0.0102698500235077,0,0,19932.0,113293.39338050144,C3
8861,KEGG_2019_Human,Leishmaniasis,1/74,0.0036999446830449,0.0102698500235077,0,0,19926.0,111574.38983110404,C3
8862,KEGG_2019_Human,Pertussis,1/76,0.0037999437281752,0.0102698500235077,0,0,19924.0,111031.8499691117,C3
8863,KEGG_2019_Human,Complement and coagulation cascades,1/79,0.0039499423167337,0.0102698500235077,0,0,19921.0,110243.89578070649,C3
8864,KEGG_2019_Human,Chagas disease (American trypanosomiasis),1/103,0.0051499318302617,0.0111581856322336,0,0,19897.0,104832.7525292024,C3
8865,KEGG_2019_Human,Systemic lupus erythematosus,1/133,0.0066499203093911,0.0118771528764897,0,0,19867.0,99596.2591544721,C3
8866,KEGG_2019_Human,Phagosome,1/152,0.0075999137114971,0.0118771528764897,0,0,19848.0,96850.665715497,C3
8867,KEGG_2019_Human,Tuberculosis,1/179,0.0089499050800561,0.0118771528764897,0,0,19821.0,93478.0629355712,C3
8868,KEGG_2019_Human,Kaposi sarcoma-associated herpesvirus infection,1/186,0.0092999029651357,0.0118771528764897,0,0,19814.0,92684.96451050608,C3
8869,KEGG_2019_Human,Viral carcinogenesis,1/201,0.0100498985877989,0.0118771528764897,0,0,19799.0,91079.21596609056,C3
8870,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0183081879787729,0,0,19662.0,80229.79996326564,C3
8871,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,C3
8872,KEGG_2019_Human,Endocytosis,1/244,0.0121998870519305,0.0121998870519305,0,0,19756.0,87051.4275316661,RNF41
8873,KEGG_2019_Human,ABC transporters,1/45,0.0022499601197094,0.0022499601197094,0,0,19955.0,121662.49782449217,ABCB8
8874,KEGG_2019_Human,Ribosome,1/153,0.0076499133771537,0.0076499133771537,0,0,19847.0,96715.6407630817,RPL28
8875,KEGG_2019_Human,Transcriptional misregulation in cancer,1/186,0.0092999029651357,0.0149498740670514,0,0,19814.0,92684.96451050608,HMGA2
8876,KEGG_2019_Human,MicroRNAs in cancer,1/299,0.0149498740670514,0.0149498740670514,0,0,19701.0,82804.33538735632,HMGA2
8877,KEGG_2019_Human,Type II diabetes mellitus,1/46,0.0022999595269283,0.0105389037533003,0,0,19954.0,121217.8313311442,MAPK9
8878,KEGG_2019_Human,Mitophagy,1/65,0.003249949134407,0.0105389037533003,0,0,19935.0,114209.92613860144,MAPK9
8879,KEGG_2019_Human,Shigellosis,1/65,0.003249949134407,0.0105389037533003,0,0,19935.0,114209.92613860144,MAPK9
8880,KEGG_2019_Human,Epithelial cell signaling in Helicobacter pylori infection,1/68,0.0033999476216189,0.0105389037533003,0,0,19932.0,113293.39338050144,MAPK9
8881,KEGG_2019_Human,Fc epsilon RI signaling pathway,1/68,0.0033999476216189,0.0105389037533003,0,0,19932.0,113293.39338050144,MAPK9
8882,KEGG_2019_Human,Adipocytokine signaling pathway,1/69,0.003449947123837,0.0105389037533003,0,0,19931.0,112996.7391397682,MAPK9
8883,KEGG_2019_Human,Prolactin signaling pathway,1/70,0.0034999466296654,0.0105389037533003,0,0,19930.0,112704.30065625212,MAPK9
8884,KEGG_2019_Human,RIG-I-like receptor signaling pathway,1/70,0.0034999466296654,0.0105389037533003,0,0,19930.0,112704.30065625212,MAPK9
8885,KEGG_2019_Human,Pancreatic cancer,1/75,0.0037499442041125,0.0105389037533003,0,0,19925.0,111301.33528642564,MAPK9
8886,KEGG_2019_Human,Pertussis,1/76,0.0037999437281752,0.0105389037533003,0,0,19924.0,111031.8499691117,MAPK9
8887,KEGG_2019_Human,ErbB signaling pathway,1/85,0.004249939567045,0.0105389037533003,0,0,19915.0,108752.83801948265,MAPK9
8888,KEGG_2019_Human,Colorectal cancer,1/86,0.0042999391173866,0.0105389037533003,0,0,19914.0,108514.46102290176,MAPK9
8889,KEGG_2019_Human,Salmonella infection,1/86,0.0042999391173866,0.0105389037533003,0,0,19914.0,108514.46102290176,MAPK9
8890,KEGG_2019_Human,Th1 and Th2 cell differentiation,1/92,0.0045999364719865,0.0105389037533003,0,0,19908.0,107139.13814408927,MAPK9
8891,KEGG_2019_Human,IL-17 signaling pathway,1/93,0.0046499360391879,0.0105389037533003,0,0,19907.0,106918.54242106884,MAPK9
8892,KEGG_2019_Human,GnRH signaling pathway,1/93,0.0046499360391879,0.0105389037533003,0,0,19907.0,106918.54242106884,MAPK9
8893,KEGG_2019_Human,Choline metabolism in cancer,1/99,0.0049499334884068,0.0105389037533003,0,0,19901.0,105642.09305076736,MAPK9
8894,KEGG_2019_Human,Progesterone-mediated oocyte maturation,1/99,0.0049499334884068,0.0105389037533003,0,0,19901.0,105642.09305076736,MAPK9
8895,KEGG_2019_Human,AGE-RAGE signaling pathway in diabetic complications,1/100,0.0049999330710556,0.0105389037533003,0,0,19900.0,105436.78197328727,MAPK9
8896,KEGG_2019_Human,Inflammatory mediator regulation of TRP channels,1/100,0.0049999330710556,0.0105389037533003,0,0,19900.0,105436.78197328727,MAPK9
8897,KEGG_2019_Human,T cell receptor signaling pathway,1/101,0.0050499326546803,0.0105389037533003,0,0,19899.0,105233.48101229242,MAPK9
8898,KEGG_2019_Human,Chagas disease (American trypanosomiasis),1/103,0.0051499318302617,0.0105389037533003,0,0,19897.0,104832.7525292024,MAPK9
8899,KEGG_2019_Human,Toll-like receptor signaling pathway,1/104,0.0051999314202997,0.0105389037533003,0,0,19896.0,104635.24941415618,MAPK9
8900,KEGG_2019_Human,C-type lectin receptor signaling pathway,1/104,0.0051999314202997,0.0105389037533003,0,0,19896.0,104635.24941415618,MAPK9
8901,KEGG_2019_Human,Th17 cell differentiation,1/107,0.0053499302026925,0.0105389037533003,0,0,19893.0,104053.753408911,MAPK9
8902,KEGG_2019_Human,Insulin resistance,1/108,0.0053999298011749,0.0105389037533003,0,0,19892.0,103863.47861844616,MAPK9
8903,KEGG_2019_Human,TNF signaling pathway,1/110,0.0054999290027479,0.0105389037533003,0,0,19890.0,103488.06969787036,MAPK9
8904,KEGG_2019_Human,Toxoplasmosis,1/113,0.0056499278191151,0.0105389037533003,0,0,19887.0,102937.34947211576,MAPK9
8905,KEGG_2019_Human,Sphingolipid signaling pathway,1/119,0.0059499254985137,0.0105389037533003,0,0,19881.0,101877.73080211312,MAPK9
8906,KEGG_2019_Human,Neurotrophin signaling pathway,1/119,0.0059499254985137,0.0105389037533003,0,0,19881.0,101877.73080211312,MAPK9
8907,KEGG_2019_Human,Osteoclast differentiation,1/127,0.0063499224962247,0.0105389037533003,0,0,19873.0,100543.72072014232,MAPK9
8908,KEGG_2019_Human,Autophagy,1/128,0.0063999221281459,0.0105389037533003,0,0,19872.0,100382.8010329652,MAPK9
8909,KEGG_2019_Human,Relaxin signaling pathway,1/130,0.0064999213952527,0.0105389037533003,0,0,19870.0,100064.62842845908,MAPK9
8910,KEGG_2019_Human,Dopaminergic synapse,1/131,0.0065499210316603,0.0105389037533003,0,0,19869.0,99907.33811343512,MAPK9
8911,KEGG_2019_Human,FoxO signaling pathway,1/132,0.0065999206698993,0.0105389037533003,0,0,19868.0,99751.22090491928,MAPK9
8912,KEGG_2019_Human,Insulin signaling pathway,1/137,0.0068499188797651,0.0105389037533003,0,0,19863.0,98987.62735269018,MAPK9
8913,KEGG_2019_Human,Measles,1/138,0.0068999185254481,0.0105389037533003,0,0,19862.0,98838.19160389496,MAPK9
8914,KEGG_2019_Human,Fluid shear stress and atherosclerosis,1/139,0.006949918172816,0.0105389037533003,0,0,19861.0,98689.81333375497,MAPK9
8915,KEGG_2019_Human,Apoptosis,1/143,0.0071499167770442,0.0105389037533003,0,0,19857.0,98106.57763600958,MAPK9
8916,KEGG_2019_Human,Retrograde endocannabinoid signaling,1/148,0.007399915061391,0.0105389037533003,0,0,19852.0,97399.60470052566,MAPK9
8917,KEGG_2019_Human,Non-alcoholic fatty liver disease (NAFLD),1/149,0.0074499147221605,0.0105389037533003,0,0,19851.0,97261.02051561224,MAPK9
8918,KEGG_2019_Human,Wnt signaling pathway,1/158,0.0078999117225733,0.0105509497496655,0,0,19842.0,96053.2110949472,MAPK9
8919,KEGG_2019_Human,Necroptosis,1/162,0.0080999104202618,0.0105509497496655,0,0,19838.0,95537.86936302872,MAPK9
8920,KEGG_2019_Human,Hepatitis B,1/163,0.0081499100978668,0.0105509497496655,0,0,19837.0,95410.9786681514,MAPK9
8921,KEGG_2019_Human,Protein processing in endoplasmic reticulum,1/165,0.0082499094553477,0.0105509497496655,0,0,19835.0,95159.46482222488,MAPK9
8922,KEGG_2019_Human,Tight junction,1/170,0.0084999078692823,0.0105509497496655,0,0,19830.0,94543.49009679438,MAPK9
8923,KEGG_2019_Human,Influenza A,1/171,0.0085499075557634,0.0105509497496655,0,0,19829.0,94422.42241345016,MAPK9
8924,KEGG_2019_Human,NOD-like receptor signaling pathway,1/178,0.0088999053857096,0.0105937651968011,0,0,19822.0,93593.82745769851,MAPK9
8925,KEGG_2019_Human,Tuberculosis,1/179,0.0089499050800561,0.0105937651968011,0,0,19821.0,93478.0629355712,MAPK9
8926,KEGG_2019_Human,Kaposi sarcoma-associated herpesvirus infection,1/186,0.0092999029651357,0.0107878874395574,0,0,19814.0,92684.96451050608,MAPK9
8927,KEGG_2019_Human,Focal adhesion,1/199,0.0099498991610159,0.0112095022710065,0,0,19801.0,91286.4288690606,MAPK9
8928,KEGG_2019_Human,Epstein-Barr virus infection,1/201,0.0100498985877989,0.0112095022710065,0,0,19799.0,91079.21596609056,MAPK9
8929,KEGG_2019_Human,Human immunodeficiency virus 1 infection,1/212,0.0105998955026255,0.0113850729472645,0,0,19788.0,89974.27756224656,MAPK9
8930,KEGG_2019_Human,cAMP signaling pathway,1/212,0.0105998955026255,0.0113850729472645,0,0,19788.0,89974.27756224656,MAPK9
8931,KEGG_2019_Human,Human T-cell leukemia virus 1 infection,1/219,0.0109498935894162,0.0115471605124753,0,0,19781.0,89299.85161916987,MAPK9
8932,KEGG_2019_Human,Ras signaling pathway,1/232,0.0115998901349604,0.0120141719254947,0,0,19768.0,88101.22480150245,MAPK9
8933,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0150086446896796,0,0,19705.0,83086.53988020132,MAPK9
8934,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,MAPK9
8935,KEGG_2019_Human,Inositol phosphate metabolism,1/74,0.0036999446830449,0.0049499334884068,0,0,19926.0,111574.38983110404,INPP4B
8936,KEGG_2019_Human,Phosphatidylinositol signaling system,1/99,0.0049499334884068,0.0049499334884068,0,0,19901.0,105642.09305076736,INPP4B
8937,KEGG_2019_Human,T cell receptor signaling pathway,1/101,0.0050499326546803,0.0083998923180794,0,0,19899.0,105233.48101229242,ITK
8938,KEGG_2019_Human,Leukocyte transendothelial migration,1/112,0.0055999282120529,0.0083998923180794,0,0,19888.0,103119.30984392198,ITK
8939,KEGG_2019_Human,Chemokine signaling pathway,1/190,0.0094999017791995,0.0094999017791995,0,0,19810.0,92244.74636351672,ITK
8940,KEGG_2019_Human,mRNA surveillance pathway,1/91,0.0045499369072032,0.0103887762846784,0,0,19909.0,107362.10783923086,PPP2R2C
8941,KEGG_2019_Human,Chagas disease (American trypanosomiasis),1/103,0.0051499318302617,0.0103887762846784,0,0,19897.0,104832.7525292024,PPP2R2C
8942,KEGG_2019_Human,Sphingolipid signaling pathway,1/119,0.0059499254985137,0.0103887762846784,0,0,19881.0,101877.73080211312,PPP2R2C
8943,KEGG_2019_Human,AMPK signaling pathway,1/120,0.0059999251180858,0.0103887762846784,0,0,19880.0,101706.2448082016,PPP2R2C
8944,KEGG_2019_Human,Dopaminergic synapse,1/131,0.0065499210316603,0.0103887762846784,0,0,19869.0,99907.33811343512,PPP2R2C
8945,KEGG_2019_Human,Adrenergic signaling in cardiomyocytes,1/145,0.0072499160871101,0.0103887762846784,0,0,19855.0,97820.92670675044,PPP2R2C
8946,KEGG_2019_Human,Hepatitis C,1/155,0.0077499127120574,0.0103887762846784,0,0,19845.0,96448.16254952336,PPP2R2C
8947,KEGG_2019_Human,Hippo signaling pathway,1/160,0.0079999110688441,0.0103887762846784,0,0,19840.0,95793.96509856998,PPP2R2C
8948,KEGG_2019_Human,Tight junction,1/170,0.0084999078692823,0.0103887762846784,0,0,19830.0,94543.49009679438,PPP2R2C
8949,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0176998626413668,0,0,19670.0,80733.60565076157,PPP2R2C
8950,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0176998626413668,0,0,19646.0,79255.8617626126,PPP2R2C
8951,KEGG_2019_Human,Protein export,1/23,0.0011499748819949,0.0011499748819949,0,0,19977.0,135204.63922267244,SRP9
8952,KEGG_2019_Human,mRNA surveillance pathway,1/91,0.0045499369072032,0.0045499369072032,0,0,19909.0,107362.10783923086,GSPT1
8953,KEGG_2019_Human,Glyoxylate and dicarboxylate metabolism,1/30,0.0014999697593334,0.0050999132780359,0,0,19970.0,129851.13732048514,CAT
8954,KEGG_2019_Human,Tryptophan metabolism,1/42,0.0020999619311272,0.0050999132780359,0,0,19958.0,123057.75613441122,CAT
8955,KEGG_2019_Human,Amyotrophic lateral sclerosis (ALS),1/51,0.0025499566390179,0.0050999132780359,0,0,19949.0,119129.0228601236,CAT
8956,KEGG_2019_Human,Peroxisome,1/83,0.0041499404726918,0.0061199186900018,0,0,19917.0,109237.99888847338,CAT
8957,KEGG_2019_Human,Longevity regulating pathway,1/102,0.0050999322416682,0.0061199186900018,0,0,19898.0,105032.15064717118,CAT
8958,KEGG_2019_Human,FoxO signaling pathway,1/132,0.0065999206698993,0.0065999206698993,0,0,19868.0,99751.22090491928,CAT
8959,KEGG_2019_Human,Lysosome,1/123,0.0061499239842961,0.0061499239842961,0,0,19877.0,101200.07933676826,CLN3
8960,KEGG_2019_Human,Fatty acid degradation,1/44,0.0021999607179423,0.0041499404726918,0,0,19956.0,122117.06559109331,ECI2
8961,KEGG_2019_Human,Peroxisome,1/83,0.0041499404726918,0.0041499404726918,0,0,19917.0,109237.99888847338,ECI2
8962,KEGG_2019_Human,Oxidative phosphorylation,1/133,0.0066499203093911,0.0112582177134695,0,0,19867.0,99596.2591544721,NDUFA10
8963,KEGG_2019_Human,Parkinson disease,1/142,0.0070999171242726,0.0112582177134695,0,0,19858.0,98250.87390500787,NDUFA10
8964,KEGG_2019_Human,Retrograde endocannabinoid signaling,1/148,0.007399915061391,0.0112582177134695,0,0,19852.0,97399.60470052566,NDUFA10
8965,KEGG_2019_Human,Non-alcoholic fatty liver disease (NAFLD),1/149,0.0074499147221605,0.0112582177134695,0,0,19851.0,97261.02051561224,NDUFA10
8966,KEGG_2019_Human,Alzheimer disease,1/171,0.0085499075557634,0.0112582177134695,0,0,19829.0,94422.42241345016,NDUFA10
8967,KEGG_2019_Human,Huntington disease,1/193,0.0096499008972596,0.0112582177134695,0,0,19807.0,91920.47679471428,NDUFA10
8968,KEGG_2019_Human,Thermogenesis,1/231,0.0115498903940656,0.0115498903940656,0,0,19769.0,88191.07730937863,NDUFA10
8969,KEGG_2019_Human,Glucagon signaling pathway,1/103,0.0051499318302617,0.009399902370135,0,0,19897.0,104832.7525292024,PHKG1
8970,KEGG_2019_Human,Insulin signaling pathway,1/137,0.0068499188797651,0.009399902370135,0,0,19863.0,98987.62735269018,PHKG1
8971,KEGG_2019_Human,Calcium signaling pathway,1/188,0.009399902370135,0.009399902370135,0,0,19812.0,92463.712994847,PHKG1
8972,KEGG_2019_Human,Lysosome,1/123,0.0061499239842961,0.0061499239842961,0,0,19877.0,101200.07933676826,AP4S1
8973,KEGG_2019_Human,Pantothenate and CoA biosynthesis,1/19,0.00094997806231055,0.0030999381313408,0,0,19981.0,139049.2109571672,DPYS
8974,KEGG_2019_Human,beta-Alanine metabolism,1/31,0.0015499690656704,0.0030999381313408,0,0,19969.0,129189.85098816035,DPYS
8975,KEGG_2019_Human,Pyrimidine metabolism,1/57,0.002849953326298,0.0037999377683973,0,0,19943.0,116875.00742975442,DPYS
8976,KEGG_2019_Human,Drug metabolism,1/108,0.0053999298011749,0.0053999298011749,0,0,19892.0,103863.47861844616,DPYS
8977,KEGG_2019_Human,Starch and sucrose metabolism,1/36,0.0017999657178272,0.0017999657178272,0,0,19964.0,126172.23364250171,GBE1
8978,KEGG_2019_Human,Endocytosis,1/244,0.0121998870519305,0.0121998870519305,0,0,19756.0,87051.4275316661,SNX6
8979,KEGG_2019_Human,African trypanosomiasis,1/37,0.0018499650702878,0.0020999619311272,0,0,19963.0,125618.9446446357,IDO1
8980,KEGG_2019_Human,Tryptophan metabolism,1/42,0.0020999619311272,0.0020999619311272,0,0,19958.0,123057.75613441122,IDO1
8981,KEGG_2019_Human,Base excision repair,1/33,0.0016499677032113,0.0016499677032113,0,0,19967.0,127928.56031580272,MUTYH
8982,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0146998751759735,0,0,19706.0,83157.67014793828,TNFRSF4
8983,KEGG_2019_Human,Glycosaminoglycan degradation,1/19,0.00094997806231055,0.0018999561246211,0,0,19981.0,139049.2109571672,IDUA
8984,KEGG_2019_Human,Lysosome,1/123,0.0061499239842961,0.0061499239842961,0,0,19877.0,101200.07933676826,IDUA
8985,KEGG_2019_Human,Oxidative phosphorylation,1/133,0.0066499203093911,0.0115498903940656,0,0,19867.0,99596.2591544721,ATP5PO
8986,KEGG_2019_Human,Parkinson disease,1/142,0.0070999171242726,0.0115498903940656,0,0,19858.0,98250.87390500787,ATP5PO
8987,KEGG_2019_Human,Alzheimer disease,1/171,0.0085499075557634,0.0115498903940656,0,0,19829.0,94422.42241345016,ATP5PO
8988,KEGG_2019_Human,Huntington disease,1/193,0.0096499008972596,0.0115498903940656,0,0,19807.0,91920.47679471428,ATP5PO
8989,KEGG_2019_Human,Thermogenesis,1/231,0.0115498903940656,0.0115498903940656,0,0,19769.0,88191.07730937863,ATP5PO
8990,KEGG_2019_Human,Acute myeloid leukemia,1/66,0.003299948626608,0.0111763436933781,0,0,19934.0,113899.85357353876,RPS6KB2
8991,KEGG_2019_Human,Pancreatic cancer,1/75,0.0037499442041125,0.0111763436933781,0,0,19925.0,111301.33528642564,RPS6KB2
8992,KEGG_2019_Human,ErbB signaling pathway,1/85,0.004249939567045,0.0111763436933781,0,0,19915.0,108752.83801948265,RPS6KB2
8993,KEGG_2019_Human,Colorectal cancer,1/86,0.0042999391173866,0.0111763436933781,0,0,19914.0,108514.46102290176,RPS6KB2
8994,KEGG_2019_Human,TGF-beta signaling pathway,1/90,0.0044999373439762,0.0111763436933781,0,0,19910.0,107587.50385474482,RPS6KB2
8995,KEGG_2019_Human,Fc gamma R-mediated phagocytosis,1/91,0.0045499369072032,0.0111763436933781,0,0,19909.0,107362.10783923086,RPS6KB2
8996,KEGG_2019_Human,Choline metabolism in cancer,1/99,0.0049499334884068,0.0111763436933781,0,0,19901.0,105642.09305076736,RPS6KB2
8997,KEGG_2019_Human,HIF-1 signaling pathway,1/100,0.0049999330710556,0.0111763436933781,0,0,19900.0,105436.78197328727,RPS6KB2
8998,KEGG_2019_Human,Longevity regulating pathway,1/102,0.0050999322416682,0.0111763436933781,0,0,19898.0,105032.15064717118,RPS6KB2
8999,KEGG_2019_Human,Insulin resistance,1/108,0.0053999298011749,0.0111763436933781,0,0,19892.0,103863.47861844616,RPS6KB2
9000,KEGG_2019_Human,AMPK signaling pathway,1/120,0.0059999251180858,0.0111763436933781,0,0,19880.0,101706.2448082016,RPS6KB2
9001,KEGG_2019_Human,Autophagy,1/128,0.0063999221281459,0.0111763436933781,0,0,19872.0,100382.8010329652,RPS6KB2
9002,KEGG_2019_Human,Insulin signaling pathway,1/137,0.0068499188797651,0.0111763436933781,0,0,19863.0,98987.62735269018,RPS6KB2
9003,KEGG_2019_Human,Apelin signaling pathway,1/137,0.0068499188797651,0.0111763436933781,0,0,19863.0,98987.62735269018,RPS6KB2
9004,KEGG_2019_Human,Breast cancer,1/147,0.0073499154017982,0.0111763436933781,0,0,19853.0,97539.10874372096,RPS6KB2
9005,KEGG_2019_Human,Gastric cancer,1/149,0.0074499147221605,0.0111763436933781,0,0,19851.0,97261.02051561224,RPS6KB2
9006,KEGG_2019_Human,mTOR signaling pathway,1/152,0.0075999137114971,0.0111763436933781,0,0,19848.0,96850.665715497,RPS6KB2
9007,KEGG_2019_Human,Hepatocellular carcinoma,1/168,0.0083999085011095,0.0116665395848743,0,0,19832.0,94787.72752807094,RPS6KB2
9008,KEGG_2019_Human,Proteoglycans in cancer,1/201,0.0100498985877989,0.0131248754478018,0,0,19799.0,91079.21596609056,RPS6KB2
9009,KEGG_2019_Human,Human immunodeficiency virus 1 infection,1/212,0.0105998955026255,0.0131248754478018,0,0,19788.0,89974.27756224656,RPS6KB2
9010,KEGG_2019_Human,Human cytomegalovirus infection,1/225,0.0112498919790339,0.0131248754478018,0,0,19775.0,88738.27077557483,RPS6KB2
9011,KEGG_2019_Human,Thermogenesis,1/231,0.0115498903940656,0.0131248754478018,0,0,19769.0,88191.07730937863,RPS6KB2
9012,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0179346385423527,0,0,19670.0,80733.60565076157,RPS6KB2
9013,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0184373569180905,0,0,19646.0,79255.8617626126,RPS6KB2
9014,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,RPS6KB2
9015,KEGG_2019_Human,Vibrio cholerae infection,1/50,0.0024999572069037,0.0052799258715386,0,0,19950.0,119530.05920663515,TJP1
9016,KEGG_2019_Human,Epithelial cell signaling in Helicobacter pylori infection,1/68,0.0033999476216189,0.0052799258715386,0,0,19932.0,113293.39338050144,TJP1
9017,KEGG_2019_Human,Adherens junction,1/72,0.0035999456502131,0.0052799258715386,0,0,19928.0,112131.59838572376,TJP1
9018,KEGG_2019_Human,Salmonella infection,1/86,0.0042999391173866,0.0052799258715386,0,0,19914.0,108514.46102290176,TJP1
9019,KEGG_2019_Human,Gap junction,1/88,0.0043999382262822,0.0052799258715386,0,0,19912.0,108045.79305232369,TJP1
9020,KEGG_2019_Human,Tight junction,1/170,0.0084999078692823,0.0084999078692823,0,0,19830.0,94543.49009679438,TJP1
9021,KEGG_2019_Human,Regulation of actin cytoskeleton,1/214,0.0106998949514067,0.0106998949514067,0,0,19786.0,89779.39753374986,ARHGEF4
9022,KEGG_2019_Human,Notch signaling pathway,1/48,0.0023999583567988,0.0068999047079798,0,0,19952.0,120356.5272753826,MAML3
9023,KEGG_2019_Human,Th1 and Th2 cell differentiation,1/92,0.0045999364719865,0.0068999047079798,0,0,19908.0,107139.13814408927,MAML3
9024,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0164998674589645,0,0,19670.0,80733.60565076157,MAML3
9025,KEGG_2019_Human,"Alanine, aspartate and glutamate metabolism",1/35,0.0017499663721595,0.0017499663721595,0,0,19965.0,126740.98858805298,NIT2
9026,KEGG_2019_Human,Axon guidance,1/181,0.0090499044707863,0.0090499044707863,0,0,19819.0,93248.41634586031,SEMA4A
9027,KEGG_2019_Human,Cytosolic DNA-sensing pathway,1/63,0.0031499501598827,0.0062999003197655,0,0,19937.0,114844.46974572667,ZBP1
9028,KEGG_2019_Human,Necroptosis,1/162,0.0080999104202618,0.0080999104202618,0,0,19838.0,95537.86936302872,ZBP1
9029,KEGG_2019_Human,Synthesis and degradation of ketone bodies,1/10,0.0004999862257578379,0.0009999724515156758,0,0,19990.0,151942.5908680334,BDH1
9030,KEGG_2019_Human,Butanoate metabolism,1/28,0.0013999711732997,0.0013999711732997,0,0,19972.0,131242.0761597353,BDH1
9031,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF605
9032,KEGG_2019_Human,Lysosome,1/123,0.0061499239842961,0.0061499239842961,0,0,19877.0,101200.07933676826,AP3B2
9033,KEGG_2019_Human,Hematopoietic cell lineage,1/97,0.0048499343304706,0.0048499343304706,0,0,19903.0,106058.9096435903,CD33
9034,KEGG_2019_Human,ABC transporters,1/45,0.0022499601197094,0.0022499601197094,0,0,19955.0,121662.49782449217,ABCC6
9035,KEGG_2019_Human,NOD-like receptor signaling pathway,1/178,0.0088999053857096,0.0088999053857096,0,0,19822.0,93593.82745769851,ANTXR2
9036,KEGG_2019_Human,Fatty acid degradation,1/44,0.0021999607179423,0.0021999607179423,0,0,19956.0,122117.06559109331,ACADVL
9037,KEGG_2019_Human,Legionellosis,1/55,0.0027499544131125,0.0098998722049462,0,0,19945.0,117599.1294878737,CXCL2
9038,KEGG_2019_Human,Salmonella infection,1/86,0.0042999391173866,0.0098998722049462,0,0,19914.0,108514.46102290176,CXCL2
9039,KEGG_2019_Human,IL-17 signaling pathway,1/93,0.0046499360391879,0.0098998722049462,0,0,19907.0,106918.54242106884,CXCL2
9040,KEGG_2019_Human,NF-kappa B signaling pathway,1/95,0.0047499351803394,0.0098998722049462,0,0,19905.0,106484.27183626965,CXCL2
9041,KEGG_2019_Human,TNF signaling pathway,1/110,0.0054999290027479,0.0098998722049462,0,0,19890.0,103488.06969787036,CXCL2
9042,KEGG_2019_Human,NOD-like receptor signaling pathway,1/178,0.0088999053857096,0.0106873895015995,0,0,19822.0,93593.82745769851,CXCL2
9043,KEGG_2019_Human,Kaposi sarcoma-associated herpesvirus infection,1/186,0.0092999029651357,0.0106873895015995,0,0,19814.0,92684.96451050608,CXCL2
9044,KEGG_2019_Human,Chemokine signaling pathway,1/190,0.0094999017791995,0.0106873895015995,0,0,19810.0,92244.74636351672,CXCL2
9045,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0146998751759735,0,0,19706.0,83157.67014793828,CXCL2
9046,KEGG_2019_Human,Signaling pathways regulating pluripotency of stem cells,1/139,0.006949918172816,0.006949918172816,0,0,19861.0,98689.81333375497,HOXB1
9047,KEGG_2019_Human,Measles,1/138,0.0068999185254481,0.0068999185254481,0,0,19862.0,98838.19160389496,RACK1
9048,KEGG_2019_Human,Signaling pathways regulating pluripotency of stem cells,1/139,0.006949918172816,0.006949918172816,0,0,19861.0,98689.81333375497,PCGF3
9049,KEGG_2019_Human,Osteoclast differentiation,1/127,0.0063499224962247,0.0063499224962247,0,0,19873.0,100543.72072014232,LILRB5
9050,KEGG_2019_Human,Allograft rejection,1/38,0.001899964429635,0.0112098185709785,0,0,19962.0,125080.29732025368,HLA-E
9051,KEGG_2019_Human,Graft-versus-host disease,1/41,0.0020499625466866,0.0112098185709785,0,0,19959.0,123544.88783416104,HLA-E
9052,KEGG_2019_Human,Type I diabetes mellitus,1/43,0.0021499613216957,0.0112098185709785,0,0,19957.0,122581.98940490963,HLA-E
9053,KEGG_2019_Human,Autoimmune thyroid disease,1/53,0.0026499555173137,0.0112098185709785,0,0,19947.0,118349.78824235698,HLA-E
9054,KEGG_2019_Human,Viral myocarditis,1/59,0.0029499522555206,0.0112098185709785,0,0,19941.0,116175.59385530632,HLA-E
9055,KEGG_2019_Human,Antigen processing and presentation,1/77,0.0038499432547502,0.0121914869733757,0,0,19923.0,110765.8407373636,HLA-E
9056,KEGG_2019_Human,Natural killer cell mediated cytotoxicity,1/131,0.0065499210316603,0.0133592467251027,0,0,19869.0,99907.33811343512,HLA-E
9057,KEGG_2019_Human,Cell adhesion molecules (CAMs),1/145,0.0072499160871101,0.0133592467251027,0,0,19855.0,97820.92670675044,HLA-E
9058,KEGG_2019_Human,Phagosome,1/152,0.0075999137114971,0.0133592467251027,0,0,19848.0,96850.665715497,HLA-E
9059,KEGG_2019_Human,Cellular senescence,1/160,0.0079999110688441,0.0133592467251027,0,0,19840.0,95793.96509856998,HLA-E
9060,KEGG_2019_Human,Kaposi sarcoma-associated herpesvirus infection,1/186,0.0092999029651357,0.0133592467251027,0,0,19814.0,92684.96451050608,HLA-E
9061,KEGG_2019_Human,Viral carcinogenesis,1/201,0.0100498985877989,0.0133592467251027,0,0,19799.0,91079.21596609056,HLA-E
9062,KEGG_2019_Human,Epstein-Barr virus infection,1/201,0.0100498985877989,0.0133592467251027,0,0,19799.0,91079.21596609056,HLA-E
9063,KEGG_2019_Human,Human immunodeficiency virus 1 infection,1/212,0.0105998955026255,0.0133592467251027,0,0,19788.0,89974.27756224656,HLA-E
9064,KEGG_2019_Human,Human T-cell leukemia virus 1 infection,1/219,0.0109498935894162,0.0133592467251027,0,0,19781.0,89299.85161916987,HLA-E
9065,KEGG_2019_Human,Human cytomegalovirus infection,1/225,0.0112498919790339,0.0133592467251027,0,0,19775.0,88738.27077557483,HLA-E
9066,KEGG_2019_Human,Endocytosis,1/244,0.0121998870519305,0.0136351678815694,0,0,19756.0,87051.4275316661,HLA-E
9067,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0174165267622403,0,0,19670.0,80733.60565076157,HLA-E
9068,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,HLA-E
9069,KEGG_2019_Human,Selenocompound metabolism,1/17,0.0008499797390404818,0.0025499392171214,0,0,19983.0,141285.76583697114,TXNRD1
9070,KEGG_2019_Human,Hepatocellular carcinoma,1/168,0.0083999085011095,0.0125998627516642,0,0,19832.0,94787.72752807094,TXNRD1
9071,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,TXNRD1
9072,KEGG_2019_Human,Maturity onset diabetes of the young,1/26,0.0012999726251831,0.0012999726251831,0,0,19974.0,132735.46073187632,PAX4
9073,KEGG_2019_Human,Endocytosis,1/244,0.0121998870519305,0.0121998870519305,0,0,19756.0,87051.4275316661,ARAP1
9074,KEGG_2019_Human,Osteoclast differentiation,1/127,0.0063499224962247,0.0063499224962247,0,0,19873.0,100543.72072014232,LILRB1
9075,KEGG_2019_Human,Alzheimer disease,1/171,0.0085499075557634,0.0085499075557634,0,0,19829.0,94422.42241345016,BACE2
9076,KEGG_2019_Human,alpha-Linolenic acid metabolism,1/25,0.0012499733663791,0.0052874076132858,0,0,19975.0,133525.54486996148,PLA2G10
9077,KEGG_2019_Human,Linoleic acid metabolism,1/29,0.001449970461791,0.0052874076132858,0,0,19971.0,130534.69172799008,PLA2G10
9078,KEGG_2019_Human,Fat digestion and absorption,1/41,0.0020499625466866,0.0052874076132858,0,0,19959.0,123544.88783416104,PLA2G10
9079,KEGG_2019_Human,Ether lipid metabolism,1/47,0.0023499589392381,0.0052874076132858,0,0,19953.0,120782.64067395544,PLA2G10
9080,KEGG_2019_Human,Arachidonic acid metabolism,1/63,0.0031499501598827,0.005669910287789,0,0,19937.0,114844.46974572667,PLA2G10
9081,KEGG_2019_Human,Glycerophospholipid metabolism,1/97,0.0048499343304706,0.0062999150247102,0,0,19903.0,106058.9096435903,PLA2G10
9082,KEGG_2019_Human,Pancreatic secretion,1/98,0.0048999339081079,0.0062999150247102,0,0,19902.0,105849.45495286948,PLA2G10
9083,KEGG_2019_Human,Vascular smooth muscle contraction,1/132,0.0065999206698993,0.0074249107536368,0,0,19868.0,99751.22090491928,PLA2G10
9084,KEGG_2019_Human,Ras signaling pathway,1/232,0.0115998901349604,0.0115998901349604,0,0,19768.0,88101.22480150245,PLA2G10
9085,KEGG_2019_Human,Allograft rejection,1/38,0.001899964429635,0.0046374221552991,0,0,19962.0,125080.29732025368,GZMB
9086,KEGG_2019_Human,Graft-versus-host disease,1/41,0.0020499625466866,0.0046374221552991,0,0,19959.0,123544.88783416104,GZMB
9087,KEGG_2019_Human,Type I diabetes mellitus,1/43,0.0021499613216957,0.0046374221552991,0,0,19957.0,122581.98940490963,GZMB
9088,KEGG_2019_Human,Autoimmune thyroid disease,1/53,0.0026499555173137,0.0046374221552991,0,0,19947.0,118349.78824235698,GZMB
9089,KEGG_2019_Human,Natural killer cell mediated cytotoxicity,1/131,0.0065499210316603,0.0083415695732182,0,0,19869.0,99907.33811343512,GZMB
9090,KEGG_2019_Human,Apoptosis,1/143,0.0071499167770442,0.0083415695732182,0,0,19857.0,98106.57763600958,GZMB
9091,KEGG_2019_Human,Transcriptional misregulation in cancer,1/186,0.0092999029651357,0.0092999029651357,0,0,19814.0,92684.96451050608,GZMB
9092,KEGG_2019_Human,Primary immunodeficiency,1/37,0.0018499650702878,0.0089165503378209,0,0,19963.0,125618.9446446357,CD3E
9093,KEGG_2019_Human,Th1 and Th2 cell differentiation,1/92,0.0045999364719865,0.0089165503378209,0,0,19908.0,107139.13814408927,CD3E
9094,KEGG_2019_Human,Hematopoietic cell lineage,1/97,0.0048499343304706,0.0089165503378209,0,0,19903.0,106058.9096435903,CD3E
9095,KEGG_2019_Human,T cell receptor signaling pathway,1/101,0.0050499326546803,0.0089165503378209,0,0,19899.0,105233.48101229242,CD3E
9096,KEGG_2019_Human,Chagas disease (American trypanosomiasis),1/103,0.0051499318302617,0.0089165503378209,0,0,19897.0,104832.7525292024,CD3E
9097,KEGG_2019_Human,Th17 cell differentiation,1/107,0.0053499302026925,0.0089165503378209,0,0,19893.0,104053.753408911,CD3E
9098,KEGG_2019_Human,Measles,1/138,0.0068999185254481,0.0098570264649259,0,0,19862.0,98838.19160389496,CD3E
9099,KEGG_2019_Human,Epstein-Barr virus infection,1/201,0.0100498985877989,0.0109498935894162,0,0,19799.0,91079.21596609056,CD3E
9100,KEGG_2019_Human,Human immunodeficiency virus 1 infection,1/212,0.0105998955026255,0.0109498935894162,0,0,19788.0,89974.27756224656,CD3E
9101,KEGG_2019_Human,Human T-cell leukemia virus 1 infection,1/219,0.0109498935894162,0.0109498935894162,0,0,19781.0,89299.85161916987,CD3E
9102,KEGG_2019_Human,Purine metabolism,1/129,0.006449921761047,0.006449921761047,0,0,19871.0,100223.109907462,PDE6C
9103,KEGG_2019_Human,Pyruvate metabolism,1/39,0.0019499637955508,0.0067998952432378,0,0,19961.0,124555.53162481484,PKM
9104,KEGG_2019_Human,Type II diabetes mellitus,1/46,0.0022999595269283,0.0067998952432378,0,0,19954.0,121217.8313311442,PKM
9105,KEGG_2019_Human,Central carbon metabolism in cancer,1/65,0.003249949134407,0.0067998952432378,0,0,19935.0,114209.92613860144,PKM
9106,KEGG_2019_Human,Glycolysis / Gluconeogenesis,1/68,0.0033999476216189,0.0067998952432378,0,0,19932.0,113293.39338050144,PKM
9107,KEGG_2019_Human,Glucagon signaling pathway,1/103,0.0051499318302617,0.0082398909284187,0,0,19897.0,104832.7525292024,PKM
9108,KEGG_2019_Human,Purine metabolism,1/129,0.006449921761047,0.008599895681396,0,0,19871.0,100223.109907462,PKM
9109,KEGG_2019_Human,Viral carcinogenesis,1/201,0.0100498985877989,0.0114855983860559,0,0,19799.0,91079.21596609056,PKM
9110,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0164998674589645,0,0,19670.0,80733.60565076157,PKM
9111,KEGG_2019_Human,NOD-like receptor signaling pathway,1/178,0.0088999053857096,0.0088999053857096,0,0,19822.0,93593.82745769851,GBP2
9112,KEGG_2019_Human,Hedgehog signaling pathway,1/47,0.0023499589392381,0.0078748753997069,0,0,19953.0,120782.64067395544,SMO
9113,KEGG_2019_Human,Basal cell carcinoma,1/63,0.0031499501598827,0.0078748753997069,0,0,19937.0,114844.46974572667,SMO
9114,KEGG_2019_Human,Axon guidance,1/181,0.0090499044707863,0.0125623732347487,0,0,19819.0,93248.41634586031,SMO
9115,KEGG_2019_Human,Proteoglycans in cancer,1/201,0.0100498985877989,0.0125623732347487,0,0,19799.0,91079.21596609056,SMO
9116,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,SMO
9117,KEGG_2019_Human,RNA transport,1/165,0.0082499094553477,0.0082499094553477,0,0,19835.0,95159.46482222488,NUP210
9118,KEGG_2019_Human,Circadian rhythm,1/31,0.0015499690656704,0.0089998999524496,0,0,19969.0,129189.85098816035,BTRC
9119,KEGG_2019_Human,Hedgehog signaling pathway,1/47,0.0023499589392381,0.0089998999524496,0,0,19953.0,120782.64067395544,BTRC
9120,KEGG_2019_Human,Shigellosis,1/65,0.003249949134407,0.0089998999524496,0,0,19935.0,114209.92613860144,BTRC
9121,KEGG_2019_Human,Oocyte meiosis,1/125,0.0062499232373748,0.0089998999524496,0,0,19875.0,100869.32368441945,BTRC
9122,KEGG_2019_Human,Ubiquitin mediated proteolysis,1/137,0.0068499188797651,0.0089998999524496,0,0,19863.0,98987.62735269018,BTRC
9123,KEGG_2019_Human,Wnt signaling pathway,1/158,0.0078999117225733,0.0089998999524496,0,0,19842.0,96053.2110949472,BTRC
9124,KEGG_2019_Human,Cellular senescence,1/160,0.0079999110688441,0.0089998999524496,0,0,19840.0,95793.96509856998,BTRC
9125,KEGG_2019_Human,Hippo signaling pathway,1/160,0.0079999110688441,0.0089998999524496,0,0,19840.0,95793.96509856998,BTRC
9126,KEGG_2019_Human,Human immunodeficiency virus 1 infection,1/212,0.0105998955026255,0.0105998955026255,0,0,19788.0,89974.27756224656,BTRC
9127,KEGG_2019_Human,Phenylalanine metabolism,1/17,0.0008499797390404818,0.0041999276220057,0,0,19983.0,141285.76583697114,MAOA
9128,KEGG_2019_Human,Histidine metabolism,1/23,0.0011499748819949,0.0041999276220057,0,0,19977.0,135204.63922267244,MAOA
9129,KEGG_2019_Human,Tyrosine metabolism,1/36,0.0017999657178272,0.0041999276220057,0,0,19964.0,126172.23364250171,MAOA
9130,KEGG_2019_Human,"Glycine, serine and threonine metabolism",1/40,0.0019999631680592,0.0041999276220057,0,0,19960.0,124043.94523066044,MAOA
9131,KEGG_2019_Human,Tryptophan metabolism,1/42,0.0020999619311272,0.0041999276220057,0,0,19958.0,123057.75613441122,MAOA
9132,KEGG_2019_Human,Arginine and proline metabolism,1/49,0.0024499577795033,0.0041999276220057,0,0,19951.0,119939.1172087114,MAOA
9133,KEGG_2019_Human,Cocaine addiction,1/49,0.0024499577795033,0.0041999276220057,0,0,19951.0,119939.1172087114,MAOA
9134,KEGG_2019_Human,Amphetamine addiction,1/68,0.0033999476216189,0.0050999214324284,0,0,19932.0,113293.39338050144,MAOA
9135,KEGG_2019_Human,Drug metabolism,1/108,0.0053999298011749,0.0067799133829382,0,0,19892.0,103863.47861844616,MAOA
9136,KEGG_2019_Human,Serotonergic synapse,1/113,0.0056499278191151,0.0067799133829382,0,0,19887.0,102937.34947211576,MAOA
9137,KEGG_2019_Human,Dopaminergic synapse,1/131,0.0065499210316603,0.0071453683981749,0,0,19869.0,99907.33811343512,MAOA
9138,KEGG_2019_Human,Alcoholism,1/180,0.0089999047745351,0.0089999047745351,0,0,19820.0,93362.92821536642,MAOA
9139,KEGG_2019_Human,Ribosome biogenesis in eukaryotes,1/101,0.0050499326546803,0.0100498985877989,0,0,19899.0,105233.48101229242,DROSHA
9140,KEGG_2019_Human,Proteoglycans in cancer,1/201,0.0100498985877989,0.0100498985877989,0,0,19799.0,91079.21596609056,DROSHA
9141,KEGG_2019_Human,Cell adhesion molecules (CAMs),1/145,0.0072499160871101,0.0072499160871101,0,0,19855.0,97820.92670675044,NLGN1
9142,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR4D11
9143,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF569
9144,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR10A4
9145,KEGG_2019_Human,Taurine and hypotaurine metabolism,1/11,0.0005499852259717758,0.0010999704519435,0,0,19989.0,150029.8210287992,CDO1
9146,KEGG_2019_Human,Cysteine and methionine metabolism,1/47,0.0023499589392381,0.0023499589392381,0,0,19953.0,120782.64067395544,CDO1
9147,KEGG_2019_Human,Progesterone-mediated oocyte maturation,1/99,0.0049499334884068,0.0062499232373748,0,0,19901.0,105642.09305076736,SPDYE3
9148,KEGG_2019_Human,Oocyte meiosis,1/125,0.0062499232373748,0.0062499232373748,0,0,19875.0,100869.32368441945,SPDYE3
9149,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR5C1
9150,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF853
9151,KEGG_2019_Human,"Valine, leucine and isoleucine degradation",1/48,0.0023999583567988,0.0023999583567988,0,0,19952.0,120356.5272753826,ACSF3
9152,KEGG_2019_Human,Morphine addiction,1/91,0.0045499369072032,0.0102748783196477,0,0,19909.0,107362.10783923086,OPRM1
9153,KEGG_2019_Human,Estrogen signaling pathway,1/137,0.0068499188797651,0.0102748783196477,0,0,19863.0,98987.62735269018,OPRM1
9154,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,OPRM1
9155,KEGG_2019_Human,p53 signaling pathway,1/72,0.0035999456502131,0.0079999110688441,0,0,19928.0,112131.59838572376,SERPINE1
9156,KEGG_2019_Human,Complement and coagulation cascades,1/79,0.0039499423167337,0.0079999110688441,0,0,19921.0,110243.89578070649,SERPINE1
9157,KEGG_2019_Human,AGE-RAGE signaling pathway in diabetic complications,1/100,0.0049999330710556,0.0079999110688441,0,0,19900.0,105436.78197328727,SERPINE1
9158,KEGG_2019_Human,HIF-1 signaling pathway,1/100,0.0049999330710556,0.0079999110688441,0,0,19900.0,105436.78197328727,SERPINE1
9159,KEGG_2019_Human,Chagas disease (American trypanosomiasis),1/103,0.0051499318302617,0.0079999110688441,0,0,19897.0,104832.7525292024,SERPINE1
9160,KEGG_2019_Human,Apelin signaling pathway,1/137,0.0068499188797651,0.0079999110688441,0,0,19863.0,98987.62735269018,SERPINE1
9161,KEGG_2019_Human,Cellular senescence,1/160,0.0079999110688441,0.0079999110688441,0,0,19840.0,95793.96509856998,SERPINE1
9162,KEGG_2019_Human,Hippo signaling pathway,1/160,0.0079999110688441,0.0079999110688441,0,0,19840.0,95793.96509856998,SERPINE1
9163,KEGG_2019_Human,NF-kappa B signaling pathway,1/95,0.0047499351803394,0.0142498055410182,0,0,19905.0,106484.27183626965,CCL13
9164,KEGG_2019_Human,Chemokine signaling pathway,1/190,0.0094999017791995,0.0142498526687993,0,0,19810.0,92244.74636351672,CCL13
9165,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0146998751759735,0,0,19706.0,83157.67014793828,CCL13
9166,KEGG_2019_Human,TGF-beta signaling pathway,1/90,0.0044999373439762,0.010424877259224,0,0,19910.0,107587.50385474482,INHBA
9167,KEGG_2019_Human,Signaling pathways regulating pluripotency of stem cells,1/139,0.006949918172816,0.010424877259224,0,0,19861.0,98689.81333375497,INHBA
9168,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0146998751759735,0,0,19706.0,83157.67014793828,INHBA
9169,KEGG_2019_Human,GABAergic synapse,1/89,0.0044499377838098,0.0044499377838098,0,0,19911.0,107815.380281759,SLC38A5
9170,KEGG_2019_Human,Endometrial cancer,1/58,0.0028999527887707,0.0073998893660899,0,0,19942.0,116522.31890946148,CTNNA2
9171,KEGG_2019_Human,Adherens junction,1/72,0.0035999456502131,0.0073998893660899,0,0,19928.0,112131.59838572376,CTNNA2
9172,KEGG_2019_Human,Arrhythmogenic right ventricular cardiomyopathy (ARVC),1/72,0.0035999456502131,0.0073998893660899,0,0,19928.0,112131.59838572376,CTNNA2
9173,KEGG_2019_Human,Bacterial invasion of epithelial cells,1/74,0.0036999446830449,0.0073998893660899,0,0,19926.0,111574.38983110404,CTNNA2
9174,KEGG_2019_Human,Leukocyte transendothelial migration,1/112,0.0055999282120529,0.0089598851392847,0,0,19888.0,103119.30984392198,CTNNA2
9175,KEGG_2019_Human,Gastric cancer,1/149,0.0074499147221605,0.0091427555072504,0,0,19851.0,97261.02051561224,CTNNA2
9176,KEGG_2019_Human,Hippo signaling pathway,1/160,0.0079999110688441,0.0091427555072504,0,0,19840.0,95793.96509856998,CTNNA2
9177,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,CTNNA2
9178,KEGG_2019_Human,Homologous recombination,1/41,0.0020499625466866,0.0026999549628563,0,0,19959.0,123544.88783416104,PALB2
9179,KEGG_2019_Human,Fanconi anemia pathway,1/54,0.0026999549628563,0.0026999549628563,0,0,19946.0,117971.01964061816,PALB2
9180,KEGG_2019_Human,Protein processing in endoplasmic reticulum,1/165,0.0082499094553477,0.0082499094553477,0,0,19835.0,95159.46482222488,DNAJC10
9181,KEGG_2019_Human,Fc epsilon RI signaling pathway,1/68,0.0033999476216189,0.0106998949514067,0,0,19932.0,113293.39338050144,VAV2
9182,KEGG_2019_Human,B cell receptor signaling pathway,1/71,0.0035499461386618,0.0106998949514067,0,0,19929.0,112415.9585341616,VAV2
9183,KEGG_2019_Human,Fc gamma R-mediated phagocytosis,1/91,0.0045499369072032,0.0106998949514067,0,0,19909.0,107362.10783923086,VAV2
9184,KEGG_2019_Human,T cell receptor signaling pathway,1/101,0.0050499326546803,0.0106998949514067,0,0,19899.0,105233.48101229242,VAV2
9185,KEGG_2019_Human,Leukocyte transendothelial migration,1/112,0.0055999282120529,0.0106998949514067,0,0,19888.0,103119.30984392198,VAV2
9186,KEGG_2019_Human,Natural killer cell mediated cytotoxicity,1/131,0.0065499210316603,0.0106998949514067,0,0,19869.0,99907.33811343512,VAV2
9187,KEGG_2019_Human,Chemokine signaling pathway,1/190,0.0094999017791995,0.0106998949514067,0,0,19810.0,92244.74636351672,VAV2
9188,KEGG_2019_Human,Focal adhesion,1/199,0.0099498991610159,0.0106998949514067,0,0,19801.0,91286.4288690606,VAV2
9189,KEGG_2019_Human,Proteoglycans in cancer,1/201,0.0100498985877989,0.0106998949514067,0,0,19799.0,91079.21596609056,VAV2
9190,KEGG_2019_Human,Rap1 signaling pathway,1/206,0.010299897173561,0.0106998949514067,0,0,19794.0,90569.849337325,VAV2
9191,KEGG_2019_Human,cAMP signaling pathway,1/212,0.0105998955026255,0.0106998949514067,0,0,19788.0,89974.27756224656,VAV2
9192,KEGG_2019_Human,Regulation of actin cytoskeleton,1/214,0.0106998949514067,0.0106998949514067,0,0,19786.0,89779.39753374986,VAV2
9193,KEGG_2019_Human,Renal cell carcinoma,1/69,0.003449947123837,0.0091332251730202,0,0,19931.0,112996.7391397682,VHL
9194,KEGG_2019_Human,HIF-1 signaling pathway,1/100,0.0049999330710556,0.0091332251730202,0,0,19900.0,105436.78197328727,VHL
9195,KEGG_2019_Human,Ubiquitin mediated proteolysis,1/137,0.0068499188797651,0.0091332251730202,0,0,19863.0,98987.62735269018,VHL
9196,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,VHL
9197,KEGG_2019_Human,Homologous recombination,1/41,0.0020499625466866,0.0020499625466866,0,0,19959.0,123544.88783416104,TOPBP1
9198,KEGG_2019_Human,Primary immunodeficiency,1/37,0.0018499650702878,0.0089499050800561,0,0,19963.0,125618.9446446357,CIITA
9199,KEGG_2019_Human,Antigen processing and presentation,1/77,0.0038499432547502,0.0089499050800561,0,0,19923.0,110765.8407373636,CIITA
9200,KEGG_2019_Human,Toxoplasmosis,1/113,0.0056499278191151,0.0089499050800561,0,0,19887.0,102937.34947211576,CIITA
9201,KEGG_2019_Human,Influenza A,1/171,0.0085499075557634,0.0089499050800561,0,0,19829.0,94422.42241345016,CIITA
9202,KEGG_2019_Human,Tuberculosis,1/179,0.0089499050800561,0.0089499050800561,0,0,19821.0,93478.0629355712,CIITA
9203,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR2T1
9204,KEGG_2019_Human,Pathogenic Escherichia coli infection,1/55,0.0027499544131125,0.0084999078692823,0,0,19945.0,117599.1294878737,TUBA4A
9205,KEGG_2019_Human,Gap junction,1/88,0.0043999382262822,0.0084999078692823,0,0,19912.0,108045.79305232369,TUBA4A
9206,KEGG_2019_Human,Apoptosis,1/143,0.0071499167770442,0.0084999078692823,0,0,19857.0,98106.57763600958,TUBA4A
9207,KEGG_2019_Human,Phagosome,1/152,0.0075999137114971,0.0084999078692823,0,0,19848.0,96850.665715497,TUBA4A
9208,KEGG_2019_Human,Tight junction,1/170,0.0084999078692823,0.0084999078692823,0,0,19830.0,94543.49009679438,TUBA4A
9209,KEGG_2019_Human,Autophagy,1/128,0.0063999221281459,0.0063999221281459,0,0,19872.0,100382.8010329652,ATG16L2
9210,KEGG_2019_Human,Arrhythmogenic right ventricular cardiomyopathy (ARVC),1/72,0.0035999456502131,0.0079623895876056,0,0,19928.0,112131.59838572376,CACNA2D2
9211,KEGG_2019_Human,Cardiac muscle contraction,1/78,0.0038999427840466,0.0079623895876056,0,0,19922.0,110503.2180492851,CACNA2D2
9212,KEGG_2019_Human,Hypertrophic cardiomyopathy (HCM),1/85,0.004249939567045,0.0079623895876056,0,0,19915.0,108752.83801948265,CACNA2D2
9213,KEGG_2019_Human,Dilated cardiomyopathy (DCM),1/91,0.0045499369072032,0.0079623895876056,0,0,19909.0,107362.10783923086,CACNA2D2
9214,KEGG_2019_Human,Adrenergic signaling in cardiomyocytes,1/145,0.0072499160871101,0.0089248989400127,0,0,19855.0,97820.92670675044,CACNA2D2
9215,KEGG_2019_Human,Oxytocin signaling pathway,1/153,0.0076499133771537,0.0089248989400127,0,0,19847.0,96715.6407630817,CACNA2D2
9216,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0147498749536506,0,0,19705.0,83086.53988020132,CACNA2D2
9217,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR1M1
9218,KEGG_2019_Human,Circadian rhythm,1/31,0.0015499690656704,0.0058748973480953,0,0,19969.0,129189.85098816035,CSNK1E
9219,KEGG_2019_Human,Hedgehog signaling pathway,1/47,0.0023499589392381,0.0058748973480953,0,0,19953.0,120782.64067395544,CSNK1E
9220,KEGG_2019_Human,FoxO signaling pathway,1/132,0.0065999206698993,0.0079999110688441,0,0,19868.0,99751.22090491928,CSNK1E
9221,KEGG_2019_Human,Wnt signaling pathway,1/158,0.0078999117225733,0.0079999110688441,0,0,19842.0,96053.2110949472,CSNK1E
9222,KEGG_2019_Human,Hippo signaling pathway,1/160,0.0079999110688441,0.0079999110688441,0,0,19840.0,95793.96509856998,CSNK1E
9223,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR14A16
9224,KEGG_2019_Human,Mismatch repair,1/23,0.0011499748819949,0.0034499246459849,0,0,19977.0,135204.63922267244,MSH3
9225,KEGG_2019_Human,Colorectal cancer,1/86,0.0042999391173866,0.0064499086760799,0,0,19914.0,108514.46102290176,MSH3
9226,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,MSH3
9227,KEGG_2019_Human,mTOR signaling pathway,1/152,0.0075999137114971,0.0075999137114971,0,0,19848.0,96850.665715497,WDR24
9228,KEGG_2019_Human,Epithelial cell signaling in Helicobacter pylori infection,1/68,0.0033999476216189,0.0121265476115943,0,0,19932.0,113293.39338050144,PAK1
9229,KEGG_2019_Human,Renal cell carcinoma,1/69,0.003449947123837,0.0121265476115943,0,0,19931.0,112996.7391397682,PAK1
9230,KEGG_2019_Human,ErbB signaling pathway,1/85,0.004249939567045,0.0121265476115943,0,0,19915.0,108752.83801948265,PAK1
9231,KEGG_2019_Human,Fc gamma R-mediated phagocytosis,1/91,0.0045499369072032,0.0121265476115943,0,0,19909.0,107362.10783923086,PAK1
9232,KEGG_2019_Human,T cell receptor signaling pathway,1/101,0.0050499326546803,0.0121265476115943,0,0,19899.0,105233.48101229242,PAK1
9233,KEGG_2019_Human,C-type lectin receptor signaling pathway,1/104,0.0051999314202997,0.0121265476115943,0,0,19896.0,104635.24941415618,PAK1
9234,KEGG_2019_Human,Natural killer cell mediated cytotoxicity,1/131,0.0065499210316603,0.0121265476115943,0,0,19869.0,99907.33811343512,PAK1
9235,KEGG_2019_Human,Hippo signaling pathway,1/160,0.0079999110688441,0.0121265476115943,0,0,19840.0,95793.96509856998,PAK1
9236,KEGG_2019_Human,Axon guidance,1/181,0.0090499044707863,0.0121265476115943,0,0,19819.0,93248.41634586031,PAK1
9237,KEGG_2019_Human,Chemokine signaling pathway,1/190,0.0094999017791995,0.0121265476115943,0,0,19810.0,92244.74636351672,PAK1
9238,KEGG_2019_Human,Focal adhesion,1/199,0.0099498991610159,0.0121265476115943,0,0,19801.0,91286.4288690606,PAK1
9239,KEGG_2019_Human,Proteoglycans in cancer,1/201,0.0100498985877989,0.0121265476115943,0,0,19799.0,91079.21596609056,PAK1
9240,KEGG_2019_Human,Human immunodeficiency virus 1 infection,1/212,0.0105998955026255,0.0121265476115943,0,0,19788.0,89974.27756224656,PAK1
9241,KEGG_2019_Human,cAMP signaling pathway,1/212,0.0105998955026255,0.0121265476115943,0,0,19788.0,89974.27756224656,PAK1
9242,KEGG_2019_Human,Regulation of actin cytoskeleton,1/214,0.0106998949514067,0.0121265476115943,0,0,19786.0,89779.39753374986,PAK1
9243,KEGG_2019_Human,Ras signaling pathway,1/232,0.0115998901349604,0.0123248832683954,0,0,19768.0,88101.22480150245,PAK1
9244,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0147498749536506,0,0,19705.0,83086.53988020132,PAK1
9245,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR4C6
9246,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0164998674589645,0,0,19670.0,80733.60565076157,OASL
9247,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR6K6
9248,KEGG_2019_Human,Amyotrophic lateral sclerosis (ALS),1/51,0.0025499566390179,0.0077398904112959,0,0,19949.0,119129.0228601236,CASP1
9249,KEGG_2019_Human,Legionellosis,1/55,0.0027499544131125,0.0077398904112959,0,0,19945.0,117599.1294878737,CASP1
9250,KEGG_2019_Human,Cytosolic DNA-sensing pathway,1/63,0.0031499501598827,0.0077398904112959,0,0,19937.0,114844.46974572667,CASP1
9251,KEGG_2019_Human,Pertussis,1/76,0.0037999437281752,0.0077398904112959,0,0,19924.0,111031.8499691117,CASP1
9252,KEGG_2019_Human,Salmonella infection,1/86,0.0042999391173866,0.0077398904112959,0,0,19914.0,108514.46102290176,CASP1
9253,KEGG_2019_Human,C-type lectin receptor signaling pathway,1/104,0.0051999314202997,0.0077998971304496,0,0,19896.0,104635.24941415618,CASP1
9254,KEGG_2019_Human,Necroptosis,1/162,0.0080999104202618,0.0088999053857096,0,0,19838.0,95537.86936302872,CASP1
9255,KEGG_2019_Human,Influenza A,1/171,0.0085499075557634,0.0088999053857096,0,0,19829.0,94422.42241345016,CASP1
9256,KEGG_2019_Human,NOD-like receptor signaling pathway,1/178,0.0088999053857096,0.0088999053857096,0,0,19822.0,93593.82745769851,CASP1
9257,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF479
9258,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR4K17
9259,KEGG_2019_Human,Prion diseases,1/35,0.0017499663721595,0.0059249134751006,0,0,19965.0,126740.98858805298,C1QB
9260,KEGG_2019_Human,Staphylococcus aureus infection,1/68,0.0033999476216189,0.0059249134751006,0,0,19932.0,113293.39338050144,C1QB
9261,KEGG_2019_Human,Pertussis,1/76,0.0037999437281752,0.0059249134751006,0,0,19924.0,111031.8499691117,C1QB
9262,KEGG_2019_Human,Complement and coagulation cascades,1/79,0.0039499423167337,0.0059249134751006,0,0,19921.0,110243.89578070649,C1QB
9263,KEGG_2019_Human,Chagas disease (American trypanosomiasis),1/103,0.0051499318302617,0.006179918196314,0,0,19897.0,104832.7525292024,C1QB
9264,KEGG_2019_Human,Systemic lupus erythematosus,1/133,0.0066499203093911,0.0066499203093911,0,0,19867.0,99596.2591544721,C1QB
9265,KEGG_2019_Human,Phenylalanine metabolism,1/17,0.0008499797390404818,0.0019999631680592,0,0,19983.0,141285.76583697114,AOC3
9266,KEGG_2019_Human,beta-Alanine metabolism,1/31,0.0015499690656704,0.0019999631680592,0,0,19969.0,129189.85098816035,AOC3
9267,KEGG_2019_Human,Tyrosine metabolism,1/36,0.0017999657178272,0.0019999631680592,0,0,19964.0,126172.23364250171,AOC3
9268,KEGG_2019_Human,"Glycine, serine and threonine metabolism",1/40,0.0019999631680592,0.0019999631680592,0,0,19960.0,124043.94523066044,AOC3
9269,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR5AN1
9270,KEGG_2019_Human,Inositol phosphate metabolism,1/74,0.0036999446830449,0.0103635292136722,0,0,19926.0,111574.38983110404,PIK3CG
9271,KEGG_2019_Human,Cholinergic synapse,1/112,0.0055999282120529,0.0103635292136722,0,0,19888.0,103119.30984392198,PIK3CG
9272,KEGG_2019_Human,Toxoplasmosis,1/113,0.0056499278191151,0.0103635292136722,0,0,19887.0,102937.34947211576,PIK3CG
9273,KEGG_2019_Human,Platelet activation,1/124,0.0061999236097501,0.0103635292136722,0,0,19876.0,101034.04709010696,PIK3CG
9274,KEGG_2019_Human,Apelin signaling pathway,1/137,0.0068499188797651,0.0103635292136722,0,0,19863.0,98987.62735269018,PIK3CG
9275,KEGG_2019_Human,Adrenergic signaling in cardiomyocytes,1/145,0.0072499160871101,0.0103635292136722,0,0,19855.0,97820.92670675044,PIK3CG
9276,KEGG_2019_Human,Phospholipase D signaling pathway,1/148,0.007399915061391,0.0103635292136722,0,0,19852.0,97399.60470052566,PIK3CG
9277,KEGG_2019_Human,Oxytocin signaling pathway,1/153,0.0076499133771537,0.0103635292136722,0,0,19847.0,96715.6407630817,PIK3CG
9278,KEGG_2019_Human,cGMP-PKG signaling pathway,1/166,0.0082999091363732,0.0103635292136722,0,0,19834.0,95034.82345515196,PIK3CG
9279,KEGG_2019_Human,Kaposi sarcoma-associated herpesvirus infection,1/186,0.0092999029651357,0.0103635292136722,0,0,19814.0,92684.96451050608,PIK3CG
9280,KEGG_2019_Human,Chemokine signaling pathway,1/190,0.0094999017791995,0.0103635292136722,0,0,19810.0,92244.74636351672,PIK3CG
9281,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0176998626413668,0,0,19646.0,79255.8617626126,PIK3CG
9282,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR52K1
9283,KEGG_2019_Human,Adherens junction,1/72,0.0035999456502131,0.0035999456502131,0,0,19928.0,112131.59838572376,SNAI1
9284,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR51E1
9285,KEGG_2019_Human,Glutathione metabolism,1/56,0.0027999538675741,0.0036999446830449,0,0,19944.0,117233.87022514464,GSR
9286,KEGG_2019_Human,Thyroid hormone synthesis,1/74,0.0036999446830449,0.0036999446830449,0,0,19926.0,111574.38983110404,GSR
9287,KEGG_2019_Human,Axon guidance,1/181,0.0090499044707863,0.0090499044707863,0,0,19819.0,93248.41634586031,PLXNB2
9288,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF141
9289,KEGG_2019_Human,Cellular senescence,1/160,0.0079999110688441,0.0079999110688441,0,0,19840.0,95793.96509856998,HIPK2
9290,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR6K2
9291,KEGG_2019_Human,RNA polymerase,1/31,0.0015499690656704,0.0030999381313408,0,0,19969.0,129189.85098816035,POLR3E
9292,KEGG_2019_Human,Cytosolic DNA-sensing pathway,1/63,0.0031499501598827,0.0031499501598827,0,0,19937.0,114844.46974572667,POLR3E
9293,KEGG_2019_Human,Chagas disease (American trypanosomiasis),1/103,0.0051499318302617,0.0089499050800561,0,0,19897.0,104832.7525292024,TLR6
9294,KEGG_2019_Human,Toll-like receptor signaling pathway,1/104,0.0051999314202997,0.0089499050800561,0,0,19896.0,104635.24941415618,TLR6
9295,KEGG_2019_Human,Phagosome,1/152,0.0075999137114971,0.0089499050800561,0,0,19848.0,96850.665715497,TLR6
9296,KEGG_2019_Human,Tuberculosis,1/179,0.0089499050800561,0.0089499050800561,0,0,19821.0,93478.0629355712,TLR6
9297,KEGG_2019_Human,Ferroptosis,1/40,0.0019999631680592,0.0088999053857096,0,0,19960.0,124043.94523066044,CYBB
9298,KEGG_2019_Human,Leishmaniasis,1/74,0.0036999446830449,0.0088999053857096,0,0,19926.0,111574.38983110404,CYBB
9299,KEGG_2019_Human,AGE-RAGE signaling pathway in diabetic complications,1/100,0.0049999330710556,0.0088999053857096,0,0,19900.0,105436.78197328727,CYBB
9300,KEGG_2019_Human,HIF-1 signaling pathway,1/100,0.0049999330710556,0.0088999053857096,0,0,19900.0,105436.78197328727,CYBB
9301,KEGG_2019_Human,Leukocyte transendothelial migration,1/112,0.0055999282120529,0.0088999053857096,0,0,19888.0,103119.30984392198,CYBB
9302,KEGG_2019_Human,Phagosome,1/152,0.0075999137114971,0.0088999053857096,0,0,19848.0,96850.665715497,CYBB
9303,KEGG_2019_Human,Necroptosis,1/162,0.0080999104202618,0.0088999053857096,0,0,19838.0,95537.86936302872,CYBB
9304,KEGG_2019_Human,NOD-like receptor signaling pathway,1/178,0.0088999053857096,0.0088999053857096,0,0,19822.0,93593.82745769851,CYBB
9305,KEGG_2019_Human,Glutamatergic synapse,1/114,0.005699927427839,0.005699927427839,0,0,19886.0,102756.96431429044,DLGAP1
9306,KEGG_2019_Human,PPAR signaling pathway,1/74,0.0036999446830449,0.0036999446830449,0,0,19926.0,111574.38983110404,PLIN5
9307,KEGG_2019_Human,"Parathyroid hormone synthesis, secretion and action",1/106,0.0052999306076525,0.0097998932512944,0,0,19894.0,104245.78450366124,LRP5
9308,KEGG_2019_Human,Breast cancer,1/147,0.0073499154017982,0.0097998932512944,0,0,19853.0,97539.10874372096,LRP5
9309,KEGG_2019_Human,Gastric cancer,1/149,0.0074499147221605,0.0097998932512944,0,0,19851.0,97261.02051561224,LRP5
9310,KEGG_2019_Human,mTOR signaling pathway,1/152,0.0075999137114971,0.0097998932512944,0,0,19848.0,96850.665715497,LRP5
9311,KEGG_2019_Human,Wnt signaling pathway,1/158,0.0078999117225733,0.0097998932512944,0,0,19842.0,96053.2110949472,LRP5
9312,KEGG_2019_Human,Hepatocellular carcinoma,1/168,0.0083999085011095,0.0097998932512944,0,0,19832.0,94787.72752807094,LRP5
9313,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,LRP5
9314,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR10AG1
9315,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR7E24
9316,KEGG_2019_Human,ABC transporters,1/45,0.0022499601197094,0.0053999184753196,0,0,19955.0,121662.49782449217,ABCC4
9317,KEGG_2019_Human,Bile secretion,1/72,0.0035999456502131,0.0053999184753196,0,0,19928.0,112131.59838572376,ABCC4
9318,KEGG_2019_Human,cAMP signaling pathway,1/212,0.0105998955026255,0.0105998955026255,0,0,19788.0,89974.27756224656,ABCC4
9319,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR4D9
9320,KEGG_2019_Human,Regulation of lipolysis in adipocytes,1/55,0.0027499544131125,0.0106713117467656,0,0,19945.0,117599.1294878737,NPR1
9321,KEGG_2019_Human,Renin secretion,1/69,0.003449947123837,0.0106713117467656,0,0,19931.0,112996.7391397682,NPR1
9322,KEGG_2019_Human,Aldosterone synthesis and secretion,1/98,0.0048999339081079,0.0106713117467656,0,0,19902.0,105849.45495286948,NPR1
9323,KEGG_2019_Human,Purine metabolism,1/129,0.006449921761047,0.0106713117467656,0,0,19871.0,100223.109907462,NPR1
9324,KEGG_2019_Human,Vascular smooth muscle contraction,1/132,0.0065999206698993,0.0106713117467656,0,0,19868.0,99751.22090491928,NPR1
9325,KEGG_2019_Human,Oxytocin signaling pathway,1/153,0.0076499133771537,0.0106713117467656,0,0,19847.0,96715.6407630817,NPR1
9326,KEGG_2019_Human,cGMP-PKG signaling pathway,1/166,0.0082999091363732,0.0106713117467656,0,0,19834.0,95034.82345515196,NPR1
9327,KEGG_2019_Human,cAMP signaling pathway,1/212,0.0105998955026255,0.0115498903940656,0,0,19788.0,89974.27756224656,NPR1
9328,KEGG_2019_Human,Thermogenesis,1/231,0.0115498903940656,0.0115498903940656,0,0,19769.0,88191.07730937863,NPR1
9329,KEGG_2019_Human,Glycerolipid metabolism,1/61,0.0030499512001654,0.0036999446830449,0,0,19939.0,115499.24335773686,GK
9330,KEGG_2019_Human,PPAR signaling pathway,1/74,0.0036999446830449,0.0036999446830449,0,0,19926.0,111574.38983110404,GK
9331,KEGG_2019_Human,Ribosome,1/153,0.0076499133771537,0.0076499133771537,0,0,19847.0,96715.6407630817,RPL5
9332,KEGG_2019_Human,Asthma,1/31,0.0015499690656704,0.0015499690656704,0,0,19969.0,129189.85098816035,RNASE3
9333,KEGG_2019_Human,Glycerolipid metabolism,1/61,0.0030499512001654,0.0061874168605085,0,0,19939.0,115499.24335773686,DGKA
9334,KEGG_2019_Human,Glycerophospholipid metabolism,1/97,0.0048499343304706,0.0061874168605085,0,0,19903.0,106058.9096435903,DGKA
9335,KEGG_2019_Human,Phosphatidylinositol signaling system,1/99,0.0049499334884068,0.0061874168605085,0,0,19901.0,105642.09305076736,DGKA
9336,KEGG_2019_Human,Choline metabolism in cancer,1/99,0.0049499334884068,0.0061874168605085,0,0,19901.0,105642.09305076736,DGKA
9337,KEGG_2019_Human,Phospholipase D signaling pathway,1/148,0.007399915061391,0.007399915061391,0,0,19852.0,97399.60470052566,DGKA
9338,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR4F17
9339,KEGG_2019_Human,Notch signaling pathway,1/48,0.0023999583567988,0.0068999047079798,0,0,19952.0,120356.5272753826,MAML1
9340,KEGG_2019_Human,Th1 and Th2 cell differentiation,1/92,0.0045999364719865,0.0068999047079798,0,0,19908.0,107139.13814408927,MAML1
9341,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0164998674589645,0,0,19670.0,80733.60565076157,MAML1
9342,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR10S1
9343,KEGG_2019_Human,Axon guidance,1/181,0.0090499044707863,0.0090499044707863,0,0,19819.0,93248.41634586031,EFNB3
9344,KEGG_2019_Human,Spliceosome,1/134,0.0066999199497742,0.0066999199497742,0,0,19866.0,99442.43560916925,DDX42
9345,KEGG_2019_Human,Protein processing in endoplasmic reticulum,1/165,0.0082499094553477,0.0082499094553477,0,0,19835.0,95159.46482222488,UBQLN3
9346,KEGG_2019_Human,Riboflavin metabolism,1/8,0.0003999883241497325,0.0023999299448983,0,0,19992.0,156418.91141655247,ENPP1
9347,KEGG_2019_Human,Pantothenate and CoA biosynthesis,1/19,0.00094997806231055,0.0026999485767408,0,0,19981.0,139049.2109571672,ENPP1
9348,KEGG_2019_Human,Nicotinate and nicotinamide metabolism,1/30,0.0014999697593334,0.0026999485767408,0,0,19970.0,129851.13732048514,ENPP1
9349,KEGG_2019_Human,Starch and sucrose metabolism,1/36,0.0017999657178272,0.0026999485767408,0,0,19964.0,126172.23364250171,ENPP1
9350,KEGG_2019_Human,Pyrimidine metabolism,1/57,0.002849953326298,0.0034199439915576,0,0,19943.0,116875.00742975442,ENPP1
9351,KEGG_2019_Human,Purine metabolism,1/129,0.006449921761047,0.006449921761047,0,0,19871.0,100223.109907462,ENPP1
9352,KEGG_2019_Human,Complement and coagulation cascades,1/79,0.0039499423167337,0.0061999236097501,0,0,19921.0,110243.89578070649,FGA
9353,KEGG_2019_Human,Platelet activation,1/124,0.0061999236097501,0.0061999236097501,0,0,19876.0,101034.04709010696,FGA
9354,KEGG_2019_Human,NOD-like receptor signaling pathway,1/178,0.0088999053857096,0.0088999053857096,0,0,19822.0,93593.82745769851,PANX1
9355,KEGG_2019_Human,Gastric acid secretion,1/75,0.0037499442041125,0.0106998949514067,0,0,19925.0,111301.33528642564,MYLK2
9356,KEGG_2019_Human,Platelet activation,1/124,0.0061999236097501,0.0106998949514067,0,0,19876.0,101034.04709010696,MYLK2
9357,KEGG_2019_Human,Vascular smooth muscle contraction,1/132,0.0065999206698993,0.0106998949514067,0,0,19868.0,99751.22090491928,MYLK2
9358,KEGG_2019_Human,Apelin signaling pathway,1/137,0.0068499188797651,0.0106998949514067,0,0,19863.0,98987.62735269018,MYLK2
9359,KEGG_2019_Human,Oxytocin signaling pathway,1/153,0.0076499133771537,0.0106998949514067,0,0,19847.0,96715.6407630817,MYLK2
9360,KEGG_2019_Human,cGMP-PKG signaling pathway,1/166,0.0082999091363732,0.0106998949514067,0,0,19834.0,95034.82345515196,MYLK2
9361,KEGG_2019_Human,Calcium signaling pathway,1/188,0.009399902370135,0.0106998949514067,0,0,19812.0,92463.712994847,MYLK2
9362,KEGG_2019_Human,Focal adhesion,1/199,0.0099498991610159,0.0106998949514067,0,0,19801.0,91286.4288690606,MYLK2
9363,KEGG_2019_Human,Regulation of actin cytoskeleton,1/214,0.0106998949514067,0.0106998949514067,0,0,19786.0,89779.39753374986,MYLK2
9364,KEGG_2019_Human,Ovarian steroidogenesis,1/49,0.0024499577795033,0.0123498597811828,0,0,19951.0,119939.1172087114,IGF1R
9365,KEGG_2019_Human,Long-term depression,1/60,0.002999951725986,0.0123498597811828,0,0,19940.0,115834.63209072244,IGF1R
9366,KEGG_2019_Human,Adherens junction,1/72,0.0035999456502131,0.0123498597811828,0,0,19928.0,112131.59838572376,IGF1R
9367,KEGG_2019_Human,Melanoma,1/72,0.0035999456502131,0.0123498597811828,0,0,19928.0,112131.59838572376,IGF1R
9368,KEGG_2019_Human,Glioma,1/75,0.0037499442041125,0.0123498597811828,0,0,19925.0,111301.33528642564,IGF1R
9369,KEGG_2019_Human,Prostate cancer,1/97,0.0048499343304706,0.0123498597811828,0,0,19903.0,106058.9096435903,IGF1R
9370,KEGG_2019_Human,Progesterone-mediated oocyte maturation,1/99,0.0049499334884068,0.0123498597811828,0,0,19901.0,105642.09305076736,IGF1R
9371,KEGG_2019_Human,HIF-1 signaling pathway,1/100,0.0049999330710556,0.0123498597811828,0,0,19900.0,105436.78197328727,IGF1R
9372,KEGG_2019_Human,Longevity regulating pathway,1/102,0.0050999322416682,0.0123498597811828,0,0,19898.0,105032.15064717118,IGF1R
9373,KEGG_2019_Human,AMPK signaling pathway,1/120,0.0059999251180858,0.0123498597811828,0,0,19880.0,101706.2448082016,IGF1R
9374,KEGG_2019_Human,Oocyte meiosis,1/125,0.0062499232373748,0.0123498597811828,0,0,19875.0,100869.32368441945,IGF1R
9375,KEGG_2019_Human,Autophagy,1/128,0.0063999221281459,0.0123498597811828,0,0,19872.0,100382.8010329652,IGF1R
9376,KEGG_2019_Human,FoxO signaling pathway,1/132,0.0065999206698993,0.0123498597811828,0,0,19868.0,99751.22090491928,IGF1R
9377,KEGG_2019_Human,Signaling pathways regulating pluripotency of stem cells,1/139,0.006949918172816,0.0123498597811828,0,0,19861.0,98689.81333375497,IGF1R
9378,KEGG_2019_Human,Breast cancer,1/147,0.0073499154017982,0.0123498597811828,0,0,19853.0,97539.10874372096,IGF1R
9379,KEGG_2019_Human,mTOR signaling pathway,1/152,0.0075999137114971,0.0123498597811828,0,0,19848.0,96850.665715497,IGF1R
9380,KEGG_2019_Human,Hepatocellular carcinoma,1/168,0.0083999085011095,0.0127522536434565,0,0,19832.0,94787.72752807094,IGF1R
9381,KEGG_2019_Human,Transcriptional misregulation in cancer,1/186,0.0092999029651357,0.0127522536434565,0,0,19814.0,92684.96451050608,IGF1R
9382,KEGG_2019_Human,Focal adhesion,1/199,0.0099498991610159,0.0127522536434565,0,0,19801.0,91286.4288690606,IGF1R
9383,KEGG_2019_Human,Proteoglycans in cancer,1/201,0.0100498985877989,0.0127522536434565,0,0,19799.0,91079.21596609056,IGF1R
9384,KEGG_2019_Human,Rap1 signaling pathway,1/206,0.010299897173561,0.0127522536434565,0,0,19794.0,90569.849337325,IGF1R
9385,KEGG_2019_Human,Ras signaling pathway,1/232,0.0115998901349604,0.0137089610685895,0,0,19768.0,88101.22480150245,IGF1R
9386,KEGG_2019_Human,Endocytosis,1/244,0.0121998870519305,0.0137911766673997,0,0,19756.0,87051.4275316661,IGF1R
9387,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0159790311997882,0,0,19705.0,83086.53988020132,IGF1R
9388,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0184078571470215,0,0,19646.0,79255.8617626126,IGF1R
9389,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,IGF1R
9390,KEGG_2019_Human,Signaling pathways regulating pluripotency of stem cells,1/139,0.006949918172816,0.006949918172816,0,0,19861.0,98689.81333375497,NEUROG1
9391,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR5H14
9392,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR10H1
9393,KEGG_2019_Human,Cholinergic synapse,1/112,0.0055999282120529,0.0104498919571195,0,0,19888.0,103119.30984392198,PIK3R5
9394,KEGG_2019_Human,Toxoplasmosis,1/113,0.0056499278191151,0.0104498919571195,0,0,19887.0,102937.34947211576,PIK3R5
9395,KEGG_2019_Human,Platelet activation,1/124,0.0061999236097501,0.0104498919571195,0,0,19876.0,101034.04709010696,PIK3R5
9396,KEGG_2019_Human,Apelin signaling pathway,1/137,0.0068499188797651,0.0104498919571195,0,0,19863.0,98987.62735269018,PIK3R5
9397,KEGG_2019_Human,Adrenergic signaling in cardiomyocytes,1/145,0.0072499160871101,0.0104498919571195,0,0,19855.0,97820.92670675044,PIK3R5
9398,KEGG_2019_Human,Phospholipase D signaling pathway,1/148,0.007399915061391,0.0104498919571195,0,0,19852.0,97399.60470052566,PIK3R5
9399,KEGG_2019_Human,Oxytocin signaling pathway,1/153,0.0076499133771537,0.0104498919571195,0,0,19847.0,96715.6407630817,PIK3R5
9400,KEGG_2019_Human,cGMP-PKG signaling pathway,1/166,0.0082999091363732,0.0104498919571195,0,0,19834.0,95034.82345515196,PIK3R5
9401,KEGG_2019_Human,Kaposi sarcoma-associated herpesvirus infection,1/186,0.0092999029651357,0.0104498919571195,0,0,19814.0,92684.96451050608,PIK3R5
9402,KEGG_2019_Human,Chemokine signaling pathway,1/190,0.0094999017791995,0.0104498919571195,0,0,19810.0,92244.74636351672,PIK3R5
9403,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0176998626413668,0,0,19646.0,79255.8617626126,PIK3R5
9404,KEGG_2019_Human,AMPK signaling pathway,1/120,0.0059999251180858,0.0076499133771537,0,0,19880.0,101706.2448082016,EEF2
9405,KEGG_2019_Human,Oxytocin signaling pathway,1/153,0.0076499133771537,0.0076499133771537,0,0,19847.0,96715.6407630817,EEF2
9406,KEGG_2019_Human,Central carbon metabolism in cancer,1/65,0.003249949134407,0.003249949134407,0,0,19935.0,114209.92613860144,SLC16A3
9407,KEGG_2019_Human,Glycerolipid metabolism,1/61,0.0030499512001654,0.0048499343304706,0,0,19939.0,115499.24335773686,PLPP4
9408,KEGG_2019_Human,Glycerophospholipid metabolism,1/97,0.0048499343304706,0.0048499343304706,0,0,19903.0,106058.9096435903,PLPP4
9409,KEGG_2019_Human,Carbohydrate digestion and absorption,1/44,0.0021999607179423,0.0107174211792485,0,0,19956.0,122117.06559109331,AKT1
9410,KEGG_2019_Human,Regulation of lipolysis in adipocytes,1/55,0.0027499544131125,0.0107174211792485,0,0,19945.0,117599.1294878737,AKT1
9411,KEGG_2019_Human,Endometrial cancer,1/58,0.0028999527887707,0.0107174211792485,0,0,19942.0,116522.31890946148,AKT1
9412,KEGG_2019_Human,VEGF signaling pathway,1/59,0.0029499522555206,0.0107174211792485,0,0,19941.0,116175.59385530632,AKT1
9413,KEGG_2019_Human,Central carbon metabolism in cancer,1/65,0.003249949134407,0.0107174211792485,0,0,19935.0,114209.92613860144,AKT1
9414,KEGG_2019_Human,Acute myeloid leukemia,1/66,0.003299948626608,0.0107174211792485,0,0,19934.0,113899.85357353876,AKT1
9415,KEGG_2019_Human,Non-small cell lung cancer,1/66,0.003299948626608,0.0107174211792485,0,0,19934.0,113899.85357353876,AKT1
9416,KEGG_2019_Human,Fc epsilon RI signaling pathway,1/68,0.0033999476216189,0.0107174211792485,0,0,19932.0,113293.39338050144,AKT1
9417,KEGG_2019_Human,Adipocytokine signaling pathway,1/69,0.003449947123837,0.0107174211792485,0,0,19931.0,112996.7391397682,AKT1
9418,KEGG_2019_Human,Renal cell carcinoma,1/69,0.003449947123837,0.0107174211792485,0,0,19931.0,112996.7391397682,AKT1
9419,KEGG_2019_Human,Prolactin signaling pathway,1/70,0.0034999466296654,0.0107174211792485,0,0,19930.0,112704.30065625212,AKT1
9420,KEGG_2019_Human,B cell receptor signaling pathway,1/71,0.0035499461386618,0.0107174211792485,0,0,19929.0,112415.9585341616,AKT1
9421,KEGG_2019_Human,Melanoma,1/72,0.0035999456502131,0.0107174211792485,0,0,19928.0,112131.59838572376,AKT1
9422,KEGG_2019_Human,Pancreatic cancer,1/75,0.0037499442041125,0.0107174211792485,0,0,19925.0,111301.33528642564,AKT1
9423,KEGG_2019_Human,Glioma,1/75,0.0037499442041125,0.0107174211792485,0,0,19925.0,111301.33528642564,AKT1
9424,KEGG_2019_Human,Chronic myeloid leukemia,1/76,0.0037999437281752,0.0107174211792485,0,0,19924.0,111031.8499691117,AKT1
9425,KEGG_2019_Human,ErbB signaling pathway,1/85,0.004249939567045,0.0107174211792485,0,0,19915.0,108752.83801948265,AKT1
9426,KEGG_2019_Human,Colorectal cancer,1/86,0.0042999391173866,0.0107174211792485,0,0,19914.0,108514.46102290176,AKT1
9427,KEGG_2019_Human,Fc gamma R-mediated phagocytosis,1/91,0.0045499369072032,0.0107174211792485,0,0,19909.0,107362.10783923086,AKT1
9428,KEGG_2019_Human,Small cell lung cancer,1/93,0.0046499360391879,0.0107174211792485,0,0,19907.0,106918.54242106884,AKT1
9429,KEGG_2019_Human,Prostate cancer,1/97,0.0048499343304706,0.0107174211792485,0,0,19903.0,106058.9096435903,AKT1
9430,KEGG_2019_Human,Choline metabolism in cancer,1/99,0.0049499334884068,0.0107174211792485,0,0,19901.0,105642.09305076736,AKT1
9431,KEGG_2019_Human,Progesterone-mediated oocyte maturation,1/99,0.0049499334884068,0.0107174211792485,0,0,19901.0,105642.09305076736,AKT1
9432,KEGG_2019_Human,AGE-RAGE signaling pathway in diabetic complications,1/100,0.0049999330710556,0.0107174211792485,0,0,19900.0,105436.78197328727,AKT1
9433,KEGG_2019_Human,HIF-1 signaling pathway,1/100,0.0049999330710556,0.0107174211792485,0,0,19900.0,105436.78197328727,AKT1
9434,KEGG_2019_Human,T cell receptor signaling pathway,1/101,0.0050499326546803,0.0107174211792485,0,0,19899.0,105233.48101229242,AKT1
9435,KEGG_2019_Human,Longevity regulating pathway,1/102,0.0050999322416682,0.0107174211792485,0,0,19898.0,105032.15064717118,AKT1
9436,KEGG_2019_Human,Chagas disease (American trypanosomiasis),1/103,0.0051499318302617,0.0107174211792485,0,0,19897.0,104832.7525292024,AKT1
9437,KEGG_2019_Human,Glucagon signaling pathway,1/103,0.0051499318302617,0.0107174211792485,0,0,19897.0,104832.7525292024,AKT1
9438,KEGG_2019_Human,Toll-like receptor signaling pathway,1/104,0.0051999314202997,0.0107174211792485,0,0,19896.0,104635.24941415618,AKT1
9439,KEGG_2019_Human,C-type lectin receptor signaling pathway,1/104,0.0051999314202997,0.0107174211792485,0,0,19896.0,104635.24941415618,AKT1
9440,KEGG_2019_Human,Insulin resistance,1/108,0.0053999298011749,0.0107174211792485,0,0,19892.0,103863.47861844616,AKT1
9441,KEGG_2019_Human,TNF signaling pathway,1/110,0.0054999290027479,0.0107174211792485,0,0,19890.0,103488.06969787036,AKT1
9442,KEGG_2019_Human,Cholinergic synapse,1/112,0.0055999282120529,0.0107174211792485,0,0,19888.0,103119.30984392198,AKT1
9443,KEGG_2019_Human,Toxoplasmosis,1/113,0.0056499278191151,0.0107174211792485,0,0,19887.0,102937.34947211576,AKT1
9444,KEGG_2019_Human,Thyroid hormone signaling pathway,1/116,0.0057999266512085,0.0107174211792485,0,0,19884.0,102400.8105961506,AKT1
9445,KEGG_2019_Human,Sphingolipid signaling pathway,1/119,0.0059499254985137,0.0107174211792485,0,0,19881.0,101877.73080211312,AKT1
9446,KEGG_2019_Human,Neurotrophin signaling pathway,1/119,0.0059499254985137,0.0107174211792485,0,0,19881.0,101877.73080211312,AKT1
9447,KEGG_2019_Human,AMPK signaling pathway,1/120,0.0059999251180858,0.0107174211792485,0,0,19880.0,101706.2448082016,AKT1
9448,KEGG_2019_Human,Platelet activation,1/124,0.0061999236097501,0.0107174211792485,0,0,19876.0,101034.04709010696,AKT1
9449,KEGG_2019_Human,Osteoclast differentiation,1/127,0.0063499224962247,0.0107174211792485,0,0,19873.0,100543.72072014232,AKT1
9450,KEGG_2019_Human,Autophagy,1/128,0.0063999221281459,0.0107174211792485,0,0,19872.0,100382.8010329652,AKT1
9451,KEGG_2019_Human,Relaxin signaling pathway,1/130,0.0064999213952527,0.0107174211792485,0,0,19870.0,100064.62842845908,AKT1
9452,KEGG_2019_Human,Dopaminergic synapse,1/131,0.0065499210316603,0.0107174211792485,0,0,19869.0,99907.33811343512,AKT1
9453,KEGG_2019_Human,FoxO signaling pathway,1/132,0.0065999206698993,0.0107174211792485,0,0,19868.0,99751.22090491928,AKT1
9454,KEGG_2019_Human,Insulin signaling pathway,1/137,0.0068499188797651,0.0107174211792485,0,0,19863.0,98987.62735269018,AKT1
9455,KEGG_2019_Human,Apelin signaling pathway,1/137,0.0068499188797651,0.0107174211792485,0,0,19863.0,98987.62735269018,AKT1
9456,KEGG_2019_Human,Estrogen signaling pathway,1/137,0.0068499188797651,0.0107174211792485,0,0,19863.0,98987.62735269018,AKT1
9457,KEGG_2019_Human,Measles,1/138,0.0068999185254481,0.0107174211792485,0,0,19862.0,98838.19160389496,AKT1
9458,KEGG_2019_Human,Fluid shear stress and atherosclerosis,1/139,0.006949918172816,0.0107174211792485,0,0,19861.0,98689.81333375497,AKT1
9459,KEGG_2019_Human,Signaling pathways regulating pluripotency of stem cells,1/139,0.006949918172816,0.0107174211792485,0,0,19861.0,98689.81333375497,AKT1
9460,KEGG_2019_Human,Apoptosis,1/143,0.0071499167770442,0.0107174211792485,0,0,19857.0,98106.57763600958,AKT1
9461,KEGG_2019_Human,Adrenergic signaling in cardiomyocytes,1/145,0.0072499160871101,0.0107174211792485,0,0,19855.0,97820.92670675044,AKT1
9462,KEGG_2019_Human,Breast cancer,1/147,0.0073499154017982,0.0107174211792485,0,0,19853.0,97539.10874372096,AKT1
9463,KEGG_2019_Human,Phospholipase D signaling pathway,1/148,0.007399915061391,0.0107174211792485,0,0,19852.0,97399.60470052566,AKT1
9464,KEGG_2019_Human,Non-alcoholic fatty liver disease (NAFLD),1/149,0.0074499147221605,0.0107174211792485,0,0,19851.0,97261.02051561224,AKT1
9465,KEGG_2019_Human,Gastric cancer,1/149,0.0074499147221605,0.0107174211792485,0,0,19851.0,97261.02051561224,AKT1
9466,KEGG_2019_Human,mTOR signaling pathway,1/152,0.0075999137114971,0.0107447055921166,0,0,19848.0,96850.665715497,AKT1
9467,KEGG_2019_Human,Hepatitis C,1/155,0.0077499127120574,0.0107623827670465,0,0,19845.0,96448.16254952336,AKT1
9468,KEGG_2019_Human,Cellular senescence,1/160,0.0079999110688441,0.0107623827670465,0,0,19840.0,95793.96509856998,AKT1
9469,KEGG_2019_Human,JAK-STAT signaling pathway,1/162,0.0080999104202618,0.0107623827670465,0,0,19838.0,95537.86936302872,AKT1
9470,KEGG_2019_Human,Hepatitis B,1/163,0.0081499100978668,0.0107623827670465,0,0,19837.0,95410.9786681514,AKT1
9471,KEGG_2019_Human,cGMP-PKG signaling pathway,1/166,0.0082999091363732,0.0107623827670465,0,0,19834.0,95034.82345515196,AKT1
9472,KEGG_2019_Human,Hepatocellular carcinoma,1/168,0.0083999085011095,0.0107623827670465,0,0,19832.0,94787.72752807094,AKT1
9473,KEGG_2019_Human,Influenza A,1/171,0.0085499075557634,0.0107860372241938,0,0,19829.0,94422.42241345016,AKT1
9474,KEGG_2019_Human,Tuberculosis,1/179,0.0089499050800561,0.0111195790388576,0,0,19821.0,93478.0629355712,AKT1
9475,KEGG_2019_Human,Kaposi sarcoma-associated herpesvirus infection,1/186,0.0092999029651357,0.0113819707931512,0,0,19814.0,92684.96451050608,AKT1
9476,KEGG_2019_Human,Chemokine signaling pathway,1/190,0.0094999017791995,0.0114557639102112,0,0,19810.0,92244.74636351672,AKT1
9477,KEGG_2019_Human,Focal adhesion,1/199,0.0099498991610159,0.0116069251295706,0,0,19801.0,91286.4288690606,AKT1
9478,KEGG_2019_Human,Epstein-Barr virus infection,1/201,0.0100498985877989,0.0116069251295706,0,0,19799.0,91079.21596609056,AKT1
9479,KEGG_2019_Human,Proteoglycans in cancer,1/201,0.0100498985877989,0.0116069251295706,0,0,19799.0,91079.21596609056,AKT1
9480,KEGG_2019_Human,Rap1 signaling pathway,1/206,0.010299897173561,0.0117304384476667,0,0,19794.0,90569.849337325,AKT1
9481,KEGG_2019_Human,Human immunodeficiency virus 1 infection,1/212,0.0105998955026255,0.011745830151558,0,0,19788.0,89974.27756224656,AKT1
9482,KEGG_2019_Human,cAMP signaling pathway,1/212,0.0105998955026255,0.011745830151558,0,0,19788.0,89974.27756224656,AKT1
9483,KEGG_2019_Human,Human T-cell leukemia virus 1 infection,1/219,0.0109498935894162,0.0119718836577617,0,0,19781.0,89299.85161916987,AKT1
9484,KEGG_2019_Human,Human cytomegalovirus infection,1/225,0.0112498919790339,0.0121380413457997,0,0,19775.0,88738.27077557483,AKT1
9485,KEGG_2019_Human,Ras signaling pathway,1/232,0.0115998901349604,0.0123531297541136,0,0,19768.0,88101.22480150245,AKT1
9486,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0155062787974276,0,0,19705.0,83086.53988020132,AKT1
9487,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0171264447042416,0,0,19670.0,80733.60565076157,AKT1
9488,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.018142359207401,0,0,19646.0,79255.8617626126,AKT1
9489,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0249035406954225,0,0,19508.0,72277.44006442746,AKT1
9490,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,AKT1
9491,KEGG_2019_Human,Allograft rejection,1/38,0.001899964429635,0.0112098185709785,0,0,19962.0,125080.29732025368,HLA-G
9492,KEGG_2019_Human,Graft-versus-host disease,1/41,0.0020499625466866,0.0112098185709785,0,0,19959.0,123544.88783416104,HLA-G
9493,KEGG_2019_Human,Type I diabetes mellitus,1/43,0.0021499613216957,0.0112098185709785,0,0,19957.0,122581.98940490963,HLA-G
9494,KEGG_2019_Human,Autoimmune thyroid disease,1/53,0.0026499555173137,0.0112098185709785,0,0,19947.0,118349.78824235698,HLA-G
9495,KEGG_2019_Human,Viral myocarditis,1/59,0.0029499522555206,0.0112098185709785,0,0,19941.0,116175.59385530632,HLA-G
9496,KEGG_2019_Human,Antigen processing and presentation,1/77,0.0038499432547502,0.0121914869733757,0,0,19923.0,110765.8407373636,HLA-G
9497,KEGG_2019_Human,Natural killer cell mediated cytotoxicity,1/131,0.0065499210316603,0.0133592467251027,0,0,19869.0,99907.33811343512,HLA-G
9498,KEGG_2019_Human,Cell adhesion molecules (CAMs),1/145,0.0072499160871101,0.0133592467251027,0,0,19855.0,97820.92670675044,HLA-G
9499,KEGG_2019_Human,Phagosome,1/152,0.0075999137114971,0.0133592467251027,0,0,19848.0,96850.665715497,HLA-G
9500,KEGG_2019_Human,Cellular senescence,1/160,0.0079999110688441,0.0133592467251027,0,0,19840.0,95793.96509856998,HLA-G
9501,KEGG_2019_Human,Kaposi sarcoma-associated herpesvirus infection,1/186,0.0092999029651357,0.0133592467251027,0,0,19814.0,92684.96451050608,HLA-G
9502,KEGG_2019_Human,Viral carcinogenesis,1/201,0.0100498985877989,0.0133592467251027,0,0,19799.0,91079.21596609056,HLA-G
9503,KEGG_2019_Human,Epstein-Barr virus infection,1/201,0.0100498985877989,0.0133592467251027,0,0,19799.0,91079.21596609056,HLA-G
9504,KEGG_2019_Human,Human immunodeficiency virus 1 infection,1/212,0.0105998955026255,0.0133592467251027,0,0,19788.0,89974.27756224656,HLA-G
9505,KEGG_2019_Human,Human T-cell leukemia virus 1 infection,1/219,0.0109498935894162,0.0133592467251027,0,0,19781.0,89299.85161916987,HLA-G
9506,KEGG_2019_Human,Human cytomegalovirus infection,1/225,0.0112498919790339,0.0133592467251027,0,0,19775.0,88738.27077557483,HLA-G
9507,KEGG_2019_Human,Endocytosis,1/244,0.0121998870519305,0.0136351678815694,0,0,19756.0,87051.4275316661,HLA-G
9508,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0174165267622403,0,0,19670.0,80733.60565076157,HLA-G
9509,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,HLA-G
9510,KEGG_2019_Human,Small cell lung cancer,1/93,0.0046499360391879,0.0089373959713052,0,0,19907.0,106918.54242106884,BIRC7
9511,KEGG_2019_Human,Toxoplasmosis,1/113,0.0056499278191151,0.0089373959713052,0,0,19887.0,102937.34947211576,BIRC7
9512,KEGG_2019_Human,Ubiquitin mediated proteolysis,1/137,0.0068499188797651,0.0089373959713052,0,0,19863.0,98987.62735269018,BIRC7
9513,KEGG_2019_Human,Apoptosis,1/143,0.0071499167770442,0.0089373959713052,0,0,19857.0,98106.57763600958,BIRC7
9514,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,BIRC7
9515,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0176998626413668,0,0,19646.0,79255.8617626126,PHLPP2
9516,KEGG_2019_Human,Prion diseases,1/35,0.0017499663721595,0.0132570172970976,0,0,19965.0,126740.98858805298,ELK1
9517,KEGG_2019_Human,Endometrial cancer,1/58,0.0028999527887707,0.0132570172970976,0,0,19942.0,116522.31890946148,ELK1
9518,KEGG_2019_Human,Leishmaniasis,1/74,0.0036999446830449,0.0132570172970976,0,0,19926.0,111574.38983110404,ELK1
9519,KEGG_2019_Human,ErbB signaling pathway,1/85,0.004249939567045,0.0132570172970976,0,0,19915.0,108752.83801948265,ELK1
9520,KEGG_2019_Human,GnRH signaling pathway,1/93,0.0046499360391879,0.0132570172970976,0,0,19907.0,106918.54242106884,ELK1
9521,KEGG_2019_Human,Insulin signaling pathway,1/137,0.0068499188797651,0.0132570172970976,0,0,19863.0,98987.62735269018,ELK1
9522,KEGG_2019_Human,Oxytocin signaling pathway,1/153,0.0076499133771537,0.0132570172970976,0,0,19847.0,96715.6407630817,ELK1
9523,KEGG_2019_Human,Hepatitis B,1/163,0.0081499100978668,0.0132570172970976,0,0,19837.0,95410.9786681514,ELK1
9524,KEGG_2019_Human,Hepatocellular carcinoma,1/168,0.0083999085011095,0.0132570172970976,0,0,19832.0,94787.72752807094,ELK1
9525,KEGG_2019_Human,Focal adhesion,1/199,0.0099498991610159,0.0132570172970976,0,0,19801.0,91286.4288690606,ELK1
9526,KEGG_2019_Human,Proteoglycans in cancer,1/201,0.0100498985877989,0.0132570172970976,0,0,19799.0,91079.21596609056,ELK1
9527,KEGG_2019_Human,Human T-cell leukemia virus 1 infection,1/219,0.0109498935894162,0.0132570172970976,0,0,19781.0,89299.85161916987,ELK1
9528,KEGG_2019_Human,Human cytomegalovirus infection,1/225,0.0112498919790339,0.0132570172970976,0,0,19775.0,88738.27077557483,ELK1
9529,KEGG_2019_Human,Ras signaling pathway,1/232,0.0115998901349604,0.0132570172970976,0,0,19768.0,88101.22480150245,ELK1
9530,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0157331999505607,0,0,19705.0,83086.53988020132,ELK1
9531,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,ELK1
9532,KEGG_2019_Human,Protein processing in endoplasmic reticulum,1/165,0.0082499094553477,0.0082499094553477,0,0,19835.0,95159.46482222488,HSPBP1
9533,KEGG_2019_Human,Salmonella infection,1/86,0.0042999391173866,0.0133998647837319,0,0,19914.0,108514.46102290176,FLNA
9534,KEGG_2019_Human,Focal adhesion,1/199,0.0099498991610159,0.0133998647837319,0,0,19801.0,91286.4288690606,FLNA
9535,KEGG_2019_Human,Proteoglycans in cancer,1/201,0.0100498985877989,0.0133998647837319,0,0,19799.0,91079.21596609056,FLNA
9536,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0147498749536506,0,0,19705.0,83086.53988020132,FLNA
9537,KEGG_2019_Human,Bladder cancer,1/41,0.0020499625466866,0.0020499625466866,0,0,19959.0,123544.88783416104,UPK3A
9538,KEGG_2019_Human,Inflammatory bowel disease (IBD),1/65,0.003249949134407,0.0064998982688141,0,0,19935.0,114209.92613860144,IL18RAP
9539,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0146998751759735,0,0,19706.0,83157.67014793828,IL18RAP
9540,KEGG_2019_Human,Asthma,1/31,0.0015499690656704,0.0083141731379497,0,0,19969.0,129189.85098816035,HLA-DPA1
9541,KEGG_2019_Human,Allograft rejection,1/38,0.001899964429635,0.0083141731379497,0,0,19962.0,125080.29732025368,HLA-DPA1
9542,KEGG_2019_Human,Graft-versus-host disease,1/41,0.0020499625466866,0.0083141731379497,0,0,19959.0,123544.88783416104,HLA-DPA1
9543,KEGG_2019_Human,Type I diabetes mellitus,1/43,0.0021499613216957,0.0083141731379497,0,0,19957.0,122581.98940490963,HLA-DPA1
9544,KEGG_2019_Human,Intestinal immune network for IgA production,1/48,0.0023999583567988,0.0083141731379497,0,0,19952.0,120356.5272753826,HLA-DPA1
9545,KEGG_2019_Human,Autoimmune thyroid disease,1/53,0.0026499555173137,0.0083141731379497,0,0,19947.0,118349.78824235698,HLA-DPA1
9546,KEGG_2019_Human,Viral myocarditis,1/59,0.0029499522555206,0.0083141731379497,0,0,19941.0,116175.59385530632,HLA-DPA1
9547,KEGG_2019_Human,Inflammatory bowel disease (IBD),1/65,0.003249949134407,0.0083141731379497,0,0,19935.0,114209.92613860144,HLA-DPA1
9548,KEGG_2019_Human,Staphylococcus aureus infection,1/68,0.0033999476216189,0.0083141731379497,0,0,19932.0,113293.39338050144,HLA-DPA1
9549,KEGG_2019_Human,Leishmaniasis,1/74,0.0036999446830449,0.0083141731379497,0,0,19926.0,111574.38983110404,HLA-DPA1
9550,KEGG_2019_Human,Antigen processing and presentation,1/77,0.0038499432547502,0.0083141731379497,0,0,19923.0,110765.8407373636,HLA-DPA1
9551,KEGG_2019_Human,Rheumatoid arthritis,1/91,0.0045499369072032,0.0083141731379497,0,0,19909.0,107362.10783923086,HLA-DPA1
9552,KEGG_2019_Human,Th1 and Th2 cell differentiation,1/92,0.0045999364719865,0.0083141731379497,0,0,19908.0,107139.13814408927,HLA-DPA1
9553,KEGG_2019_Human,Hematopoietic cell lineage,1/97,0.0048499343304706,0.0083141731379497,0,0,19903.0,106058.9096435903,HLA-DPA1
9554,KEGG_2019_Human,Th17 cell differentiation,1/107,0.0053499302026925,0.0084748917286727,0,0,19893.0,104053.753408911,HLA-DPA1
9555,KEGG_2019_Human,Toxoplasmosis,1/113,0.0056499278191151,0.0084748917286727,0,0,19887.0,102937.34947211576,HLA-DPA1
9556,KEGG_2019_Human,Systemic lupus erythematosus,1/133,0.0066499203093911,0.0093881227897286,0,0,19867.0,99596.2591544721,HLA-DPA1
9557,KEGG_2019_Human,Cell adhesion molecules (CAMs),1/145,0.0072499160871101,0.0095998910039963,0,0,19855.0,97820.92670675044,HLA-DPA1
9558,KEGG_2019_Human,Phagosome,1/152,0.0075999137114971,0.0095998910039963,0,0,19848.0,96850.665715497,HLA-DPA1
9559,KEGG_2019_Human,Influenza A,1/171,0.0085499075557634,0.0102284629486356,0,0,19829.0,94422.42241345016,HLA-DPA1
9560,KEGG_2019_Human,Tuberculosis,1/179,0.0089499050800561,0.0102284629486356,0,0,19821.0,93478.0629355712,HLA-DPA1
9561,KEGG_2019_Human,Epstein-Barr virus infection,1/201,0.0100498985877989,0.0109635257321443,0,0,19799.0,91079.21596609056,HLA-DPA1
9562,KEGG_2019_Human,Human T-cell leukemia virus 1 infection,1/219,0.0109498935894162,0.0114259759193908,0,0,19781.0,89299.85161916987,HLA-DPA1
9563,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,HLA-DPA1
9564,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0146998751759735,0,0,19706.0,83157.67014793828,IL1RL1
9565,KEGG_2019_Human,"Neomycin, kanamycin and gentamicin biosynthesis",1/5,0.0002499917995416556,0.0027499097949582,0,0,19995.0,165840.17843725558,HK2
9566,KEGG_2019_Human,Galactose metabolism,1/31,0.0015499690656704,0.0037713631321124,0,0,19969.0,129189.85098816035,HK2
9567,KEGG_2019_Human,Fructose and mannose metabolism,1/33,0.0016499677032113,0.0037713631321124,0,0,19967.0,127928.56031580272,HK2
9568,KEGG_2019_Human,Starch and sucrose metabolism,1/36,0.0017999657178272,0.0037713631321124,0,0,19964.0,126172.23364250171,HK2
9569,KEGG_2019_Human,Carbohydrate digestion and absorption,1/44,0.0021999607179423,0.0037713631321124,0,0,19956.0,122117.06559109331,HK2
9570,KEGG_2019_Human,Type II diabetes mellitus,1/46,0.0022999595269283,0.0037713631321124,0,0,19954.0,121217.8313311442,HK2
9571,KEGG_2019_Human,Amino sugar and nucleotide sugar metabolism,1/48,0.0023999583567988,0.0037713631321124,0,0,19952.0,120356.5272753826,HK2
9572,KEGG_2019_Human,Central carbon metabolism in cancer,1/65,0.003249949134407,0.0041554915375342,0,0,19935.0,114209.92613860144,HK2
9573,KEGG_2019_Human,Glycolysis / Gluconeogenesis,1/68,0.0033999476216189,0.0041554915375342,0,0,19932.0,113293.39338050144,HK2
9574,KEGG_2019_Human,HIF-1 signaling pathway,1/100,0.0049999330710556,0.0054999263781612,0,0,19900.0,105436.78197328727,HK2
9575,KEGG_2019_Human,Insulin signaling pathway,1/137,0.0068499188797651,0.0068499188797651,0,0,19863.0,98987.62735269018,HK2
9576,KEGG_2019_Human,Glycosphingolipid biosynthesis,1/45,0.0022499601197094,0.0022499601197094,0,0,19955.0,121662.49782449217,GBGT1
9577,KEGG_2019_Human,Synaptic vesicle cycle,1/78,0.0038999427840466,0.005699927427839,0,0,19922.0,110503.2180492851,SLC1A3
9578,KEGG_2019_Human,Glutamatergic synapse,1/114,0.005699927427839,0.005699927427839,0,0,19886.0,102756.96431429044,SLC1A3
9579,KEGG_2019_Human,Wnt signaling pathway,1/158,0.0078999117225733,0.0078999117225733,0,0,19842.0,96053.2110949472,DKK2
9580,KEGG_2019_Human,Hedgehog signaling pathway,1/47,0.0023499589392381,0.0129998427905055,0,0,19953.0,120782.64067395544,ARRB1
9581,KEGG_2019_Human,Morphine addiction,1/91,0.0045499369072032,0.0129998427905055,0,0,19909.0,107362.10783923086,ARRB1
9582,KEGG_2019_Human,"Parathyroid hormone synthesis, secretion and action",1/106,0.0052999306076525,0.0129998427905055,0,0,19894.0,104245.78450366124,ARRB1
9583,KEGG_2019_Human,Relaxin signaling pathway,1/130,0.0064999213952527,0.0129998427905055,0,0,19870.0,100064.62842845908,ARRB1
9584,KEGG_2019_Human,Chemokine signaling pathway,1/190,0.0094999017791995,0.0151998428467193,0,0,19810.0,92244.74636351672,ARRB1
9585,KEGG_2019_Human,Endocytosis,1/244,0.0121998870519305,0.0162665160692407,0,0,19756.0,87051.4275316661,ARRB1
9586,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0168569999470293,0,0,19705.0,83086.53988020132,ARRB1
9587,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,ARRB1
9588,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF226
9589,KEGG_2019_Human,Other types of O-glycan biosynthesis,1/22,0.0010999756574123,0.0022999497639899,0,0,19978.0,136099.47030191717,ST3GAL3
9590,KEGG_2019_Human,Mannose type O-glycan biosynthesis,1/23,0.0011499748819949,0.0022999497639899,0,0,19977.0,135204.63922267244,ST3GAL3
9591,KEGG_2019_Human,Glycosphingolipid biosynthesis,1/45,0.0022499601197094,0.0026499555173137,0,0,19955.0,121662.49782449217,ST3GAL3
9592,KEGG_2019_Human,Glycosaminoglycan biosynthesis,1/53,0.0026499555173137,0.0026499555173137,0,0,19947.0,118349.78824235698,ST3GAL3
9593,KEGG_2019_Human,Steroid hormone biosynthesis,1/60,0.002999951725986,0.0048999339081079,0,0,19940.0,115834.63209072244,CYP11B2
9594,KEGG_2019_Human,Aldosterone synthesis and secretion,1/98,0.0048999339081079,0.0048999339081079,0,0,19902.0,105849.45495286948,CYP11B2
9595,KEGG_2019_Human,Notch signaling pathway,1/48,0.0023999583567988,0.0047999167135976,0,0,19952.0,120356.5272753826,NCOR2
9596,KEGG_2019_Human,Epstein-Barr virus infection,1/201,0.0100498985877989,0.0100498985877989,0,0,19799.0,91079.21596609056,NCOR2
9597,KEGG_2019_Human,Fanconi anemia pathway,1/54,0.0026999549628563,0.0026999549628563,0,0,19946.0,117971.01964061816,FANCE
9598,KEGG_2019_Human,Cholinergic synapse,1/112,0.0055999282120529,0.0160498424271101,0,0,19888.0,103119.30984392198,CHRM2
9599,KEGG_2019_Human,Calcium signaling pathway,1/188,0.009399902370135,0.0160498424271101,0,0,19812.0,92463.712994847,CHRM2
9600,KEGG_2019_Human,cAMP signaling pathway,1/212,0.0105998955026255,0.0160498424271101,0,0,19788.0,89974.27756224656,CHRM2
9601,KEGG_2019_Human,Regulation of actin cytoskeleton,1/214,0.0106998949514067,0.0160498424271101,0,0,19786.0,89779.39753374986,CHRM2
9602,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0176998626413668,0,0,19662.0,80229.79996326564,CHRM2
9603,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0176998626413668,0,0,19646.0,79255.8617626126,CHRM2
9604,KEGG_2019_Human,Butanoate metabolism,1/28,0.0013999711732997,0.0013999711732997,0,0,19972.0,131242.0761597353,ACSM1
9605,KEGG_2019_Human,IL-17 signaling pathway,1/93,0.0046499360391879,0.0046499360391879,0,0,19907.0,106918.54242106884,MAPK15
9606,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR7G3
9607,KEGG_2019_Human,Apoptosis,1/143,0.0071499167770442,0.0161998208405236,0,0,19857.0,98106.57763600958,CSF2RB
9608,KEGG_2019_Human,JAK-STAT signaling pathway,1/162,0.0080999104202618,0.0161998208405236,0,0,19838.0,95537.86936302872,CSF2RB
9609,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0195998335679646,0,0,19706.0,83157.67014793828,CSF2RB
9610,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,CSF2RB
9611,KEGG_2019_Human,Protein digestion and absorption,1/90,0.0044999373439762,0.0044999373439762,0,0,19910.0,107587.50385474482,COL15A1
9612,KEGG_2019_Human,Nicotine addiction,1/40,0.0019999631680592,0.0081598742918854,0,0,19960.0,124043.94523066044,GRIN2D
9613,KEGG_2019_Human,Cocaine addiction,1/49,0.0024499577795033,0.0081598742918854,0,0,19951.0,119939.1172087114,GRIN2D
9614,KEGG_2019_Human,Amyotrophic lateral sclerosis (ALS),1/51,0.0025499566390179,0.0081598742918854,0,0,19949.0,119129.0228601236,GRIN2D
9615,KEGG_2019_Human,Long-term potentiation,1/67,0.0033499481224912,0.0081598742918854,0,0,19933.0,113594.38808369274,GRIN2D
9616,KEGG_2019_Human,Amphetamine addiction,1/68,0.0033999476216189,0.0081598742918854,0,0,19932.0,113293.39338050144,GRIN2D
9617,KEGG_2019_Human,Circadian entrainment,1/97,0.0048499343304706,0.0096998686609413,0,0,19903.0,106058.9096435903,GRIN2D
9618,KEGG_2019_Human,Glutamatergic synapse,1/114,0.005699927427839,0.0097713041620097,0,0,19886.0,102756.96431429044,GRIN2D
9619,KEGG_2019_Human,Alzheimer disease,1/171,0.0085499075557634,0.011279882844162,0,0,19829.0,94422.42241345016,GRIN2D
9620,KEGG_2019_Human,Alcoholism,1/180,0.0089999047745351,0.011279882844162,0,0,19820.0,93362.92821536642,GRIN2D
9621,KEGG_2019_Human,Calcium signaling pathway,1/188,0.009399902370135,0.011279882844162,0,0,19812.0,92463.712994847,GRIN2D
9622,KEGG_2019_Human,cAMP signaling pathway,1/212,0.0105998955026255,0.0115635223665006,0,0,19788.0,89974.27756224656,GRIN2D
9623,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,GRIN2D
9624,KEGG_2019_Human,Leukocyte transendothelial migration,1/112,0.0055999282120529,0.0084999078692823,0,0,19888.0,103119.30984392198,CLDN3
9625,KEGG_2019_Human,Cell adhesion molecules (CAMs),1/145,0.0072499160871101,0.0084999078692823,0,0,19855.0,97820.92670675044,CLDN3
9626,KEGG_2019_Human,Hepatitis C,1/155,0.0077499127120574,0.0084999078692823,0,0,19845.0,96448.16254952336,CLDN3
9627,KEGG_2019_Human,Tight junction,1/170,0.0084999078692823,0.0084999078692823,0,0,19830.0,94543.49009679438,CLDN3
9628,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZFP28
9629,KEGG_2019_Human,ABC transporters,1/45,0.0022499601197094,0.0022499601197094,0,0,19955.0,121662.49782449217,ABCC5
9630,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0146998751759735,0,0,19706.0,83157.67014793828,TNFSF9
9631,KEGG_2019_Human,ECM-receptor interaction,1/82,0.004099940929819,0.0112998556382303,0,0,19918.0,109484.9180722932,LAMA3
9632,KEGG_2019_Human,Small cell lung cancer,1/93,0.0046499360391879,0.0112998556382303,0,0,19907.0,106918.54242106884,LAMA3
9633,KEGG_2019_Human,Amoebiasis,1/96,0.0047999347538706,0.0112998556382303,0,0,19904.0,106270.50039849174,LAMA3
9634,KEGG_2019_Human,Toxoplasmosis,1/113,0.0056499278191151,0.0112998556382303,0,0,19887.0,102937.34947211576,LAMA3
9635,KEGG_2019_Human,Focal adhesion,1/199,0.0099498991610159,0.0159198386576255,0,0,19801.0,91286.4288690606,LAMA3
9636,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0202284144472764,0,0,19670.0,80733.60565076157,LAMA3
9637,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0202284144472764,0,0,19646.0,79255.8617626126,LAMA3
9638,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,LAMA3
9639,KEGG_2019_Human,Cocaine addiction,1/49,0.0024499577795033,0.010799877708923,0,0,19951.0,119939.1172087114,JUN
9640,KEGG_2019_Human,Inflammatory bowel disease (IBD),1/65,0.003249949134407,0.010799877708923,0,0,19935.0,114209.92613860144,JUN
9641,KEGG_2019_Human,Mitophagy,1/65,0.003249949134407,0.010799877708923,0,0,19935.0,114209.92613860144,JUN
9642,KEGG_2019_Human,Epithelial cell signaling in Helicobacter pylori infection,1/68,0.0033999476216189,0.010799877708923,0,0,19932.0,113293.39338050144,JUN
9643,KEGG_2019_Human,Amphetamine addiction,1/68,0.0033999476216189,0.010799877708923,0,0,19932.0,113293.39338050144,JUN
9644,KEGG_2019_Human,Renal cell carcinoma,1/69,0.003449947123837,0.010799877708923,0,0,19931.0,112996.7391397682,JUN
9645,KEGG_2019_Human,B cell receptor signaling pathway,1/71,0.0035499461386618,0.010799877708923,0,0,19929.0,112415.9585341616,JUN
9646,KEGG_2019_Human,Leishmaniasis,1/74,0.0036999446830449,0.010799877708923,0,0,19926.0,111574.38983110404,JUN
9647,KEGG_2019_Human,Pertussis,1/76,0.0037999437281752,0.010799877708923,0,0,19924.0,111031.8499691117,JUN
9648,KEGG_2019_Human,ErbB signaling pathway,1/85,0.004249939567045,0.010799877708923,0,0,19915.0,108752.83801948265,JUN
9649,KEGG_2019_Human,Salmonella infection,1/86,0.0042999391173866,0.010799877708923,0,0,19914.0,108514.46102290176,JUN
9650,KEGG_2019_Human,Colorectal cancer,1/86,0.0042999391173866,0.010799877708923,0,0,19914.0,108514.46102290176,JUN
9651,KEGG_2019_Human,Rheumatoid arthritis,1/91,0.0045499369072032,0.010799877708923,0,0,19909.0,107362.10783923086,JUN
9652,KEGG_2019_Human,Th1 and Th2 cell differentiation,1/92,0.0045999364719865,0.010799877708923,0,0,19908.0,107139.13814408927,JUN
9653,KEGG_2019_Human,IL-17 signaling pathway,1/93,0.0046499360391879,0.010799877708923,0,0,19907.0,106918.54242106884,JUN
9654,KEGG_2019_Human,GnRH signaling pathway,1/93,0.0046499360391879,0.010799877708923,0,0,19907.0,106918.54242106884,JUN
9655,KEGG_2019_Human,Choline metabolism in cancer,1/99,0.0049499334884068,0.010799877708923,0,0,19901.0,105642.09305076736,JUN
9656,KEGG_2019_Human,AGE-RAGE signaling pathway in diabetic complications,1/100,0.0049999330710556,0.010799877708923,0,0,19900.0,105436.78197328727,JUN
9657,KEGG_2019_Human,T cell receptor signaling pathway,1/101,0.0050499326546803,0.010799877708923,0,0,19899.0,105233.48101229242,JUN
9658,KEGG_2019_Human,Chagas disease (American trypanosomiasis),1/103,0.0051499318302617,0.010799877708923,0,0,19897.0,104832.7525292024,JUN
9659,KEGG_2019_Human,Toll-like receptor signaling pathway,1/104,0.0051999314202997,0.010799877708923,0,0,19896.0,104635.24941415618,JUN
9660,KEGG_2019_Human,C-type lectin receptor signaling pathway,1/104,0.0051999314202997,0.010799877708923,0,0,19896.0,104635.24941415618,JUN
9661,KEGG_2019_Human,Th17 cell differentiation,1/107,0.0053499302026925,0.010799877708923,0,0,19893.0,104053.753408911,JUN
9662,KEGG_2019_Human,TNF signaling pathway,1/110,0.0054999290027479,0.010799877708923,0,0,19890.0,103488.06969787036,JUN
9663,KEGG_2019_Human,Neurotrophin signaling pathway,1/119,0.0059499254985137,0.010799877708923,0,0,19881.0,101877.73080211312,JUN
9664,KEGG_2019_Human,Osteoclast differentiation,1/127,0.0063499224962247,0.010799877708923,0,0,19873.0,100543.72072014232,JUN
9665,KEGG_2019_Human,Relaxin signaling pathway,1/130,0.0064999213952527,0.010799877708923,0,0,19870.0,100064.62842845908,JUN
9666,KEGG_2019_Human,Estrogen signaling pathway,1/137,0.0068499188797651,0.010799877708923,0,0,19863.0,98987.62735269018,JUN
9667,KEGG_2019_Human,Measles,1/138,0.0068999185254481,0.010799877708923,0,0,19862.0,98838.19160389496,JUN
9668,KEGG_2019_Human,Fluid shear stress and atherosclerosis,1/139,0.006949918172816,0.010799877708923,0,0,19861.0,98689.81333375497,JUN
9669,KEGG_2019_Human,Apoptosis,1/143,0.0071499167770442,0.010799877708923,0,0,19857.0,98106.57763600958,JUN
9670,KEGG_2019_Human,Breast cancer,1/147,0.0073499154017982,0.010799877708923,0,0,19853.0,97539.10874372096,JUN
9671,KEGG_2019_Human,Non-alcoholic fatty liver disease (NAFLD),1/149,0.0074499147221605,0.010799877708923,0,0,19851.0,97261.02051561224,JUN
9672,KEGG_2019_Human,Oxytocin signaling pathway,1/153,0.0076499133771537,0.010799877708923,0,0,19847.0,96715.6407630817,JUN
9673,KEGG_2019_Human,Wnt signaling pathway,1/158,0.0078999117225733,0.0107998832283327,0,0,19842.0,96053.2110949472,JUN
9674,KEGG_2019_Human,Hepatitis B,1/163,0.0081499100978668,0.0107998832283327,0,0,19837.0,95410.9786681514,JUN
9675,KEGG_2019_Human,Tight junction,1/170,0.0084999078692823,0.0107998832283327,0,0,19830.0,94543.49009679438,JUN
9676,KEGG_2019_Human,Influenza A,1/171,0.0085499075557634,0.0107998832283327,0,0,19829.0,94422.42241345016,JUN
9677,KEGG_2019_Human,NOD-like receptor signaling pathway,1/178,0.0088999053857096,0.0109537297054887,0,0,19822.0,93593.82745769851,JUN
9678,KEGG_2019_Human,Kaposi sarcoma-associated herpesvirus infection,1/186,0.0092999029651357,0.0111598835581629,0,0,19814.0,92684.96451050608,JUN
9679,KEGG_2019_Human,Focal adhesion,1/199,0.0099498991610159,0.0112184914468453,0,0,19801.0,91286.4288690606,JUN
9680,KEGG_2019_Human,Epstein-Barr virus infection,1/201,0.0100498985877989,0.0112184914468453,0,0,19799.0,91079.21596609056,JUN
9681,KEGG_2019_Human,Viral carcinogenesis,1/201,0.0100498985877989,0.0112184914468453,0,0,19799.0,91079.21596609056,JUN
9682,KEGG_2019_Human,Human immunodeficiency virus 1 infection,1/212,0.0105998955026255,0.0113065552028006,0,0,19788.0,89974.27756224656,JUN
9683,KEGG_2019_Human,cAMP signaling pathway,1/212,0.0105998955026255,0.0113065552028006,0,0,19788.0,89974.27756224656,JUN
9684,KEGG_2019_Human,Human T-cell leukemia virus 1 infection,1/219,0.0109498935894162,0.0114259759193908,0,0,19781.0,89299.85161916987,JUN
9685,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0150637020803241,0,0,19705.0,83086.53988020132,JUN
9686,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,JUN
9687,KEGG_2019_Human,Metabolism of xenobiotics by cytochrome P450,1/74,0.0036999446830449,0.0036999446830449,0,0,19926.0,111574.38983110404,CYP2F1
9688,KEGG_2019_Human,Thyroid cancer,1/37,0.0018499650702878,0.0111998754963818,0,0,19963.0,125618.9446446357,CTNNB1
9689,KEGG_2019_Human,Pathogenic Escherichia coli infection,1/55,0.0027499544131125,0.0111998754963818,0,0,19945.0,117599.1294878737,CTNNB1
9690,KEGG_2019_Human,Endometrial cancer,1/58,0.0028999527887707,0.0111998754963818,0,0,19942.0,116522.31890946148,CTNNB1
9691,KEGG_2019_Human,Basal cell carcinoma,1/63,0.0031499501598827,0.0111998754963818,0,0,19937.0,114844.46974572667,CTNNB1
9692,KEGG_2019_Human,Adherens junction,1/72,0.0035999456502131,0.0111998754963818,0,0,19928.0,112131.59838572376,CTNNB1
9693,KEGG_2019_Human,Arrhythmogenic right ventricular cardiomyopathy (ARVC),1/72,0.0035999456502131,0.0111998754963818,0,0,19928.0,112131.59838572376,CTNNB1
9694,KEGG_2019_Human,Bacterial invasion of epithelial cells,1/74,0.0036999446830449,0.0111998754963818,0,0,19926.0,111574.38983110404,CTNNB1
9695,KEGG_2019_Human,Colorectal cancer,1/86,0.0042999391173866,0.0111998754963818,0,0,19914.0,108514.46102290176,CTNNB1
9696,KEGG_2019_Human,Prostate cancer,1/97,0.0048499343304706,0.0111998754963818,0,0,19903.0,106058.9096435903,CTNNB1
9697,KEGG_2019_Human,Melanogenesis,1/101,0.0050499326546803,0.0111998754963818,0,0,19899.0,105233.48101229242,CTNNB1
9698,KEGG_2019_Human,Leukocyte transendothelial migration,1/112,0.0055999282120529,0.0111998754963818,0,0,19888.0,103119.30984392198,CTNNB1
9699,KEGG_2019_Human,Thyroid hormone signaling pathway,1/116,0.0057999266512085,0.0111998754963818,0,0,19884.0,102400.8105961506,CTNNB1
9700,KEGG_2019_Human,Fluid shear stress and atherosclerosis,1/139,0.006949918172816,0.0111998754963818,0,0,19861.0,98689.81333375497,CTNNB1
9701,KEGG_2019_Human,Signaling pathways regulating pluripotency of stem cells,1/139,0.006949918172816,0.0111998754963818,0,0,19861.0,98689.81333375497,CTNNB1
9702,KEGG_2019_Human,Breast cancer,1/147,0.0073499154017982,0.0111998754963818,0,0,19853.0,97539.10874372096,CTNNB1
9703,KEGG_2019_Human,Gastric cancer,1/149,0.0074499147221605,0.0111998754963818,0,0,19851.0,97261.02051561224,CTNNB1
9704,KEGG_2019_Human,Cushing syndrome,1/155,0.0077499127120574,0.0111998754963818,0,0,19845.0,96448.16254952336,CTNNB1
9705,KEGG_2019_Human,Hepatitis C,1/155,0.0077499127120574,0.0111998754963818,0,0,19845.0,96448.16254952336,CTNNB1
9706,KEGG_2019_Human,Wnt signaling pathway,1/158,0.0078999117225733,0.0111998754963818,0,0,19842.0,96053.2110949472,CTNNB1
9707,KEGG_2019_Human,Hippo signaling pathway,1/160,0.0079999110688441,0.0111998754963818,0,0,19840.0,95793.96509856998,CTNNB1
9708,KEGG_2019_Human,Hepatocellular carcinoma,1/168,0.0083999085011095,0.0111998780014793,0,0,19832.0,94787.72752807094,CTNNB1
9709,KEGG_2019_Human,Kaposi sarcoma-associated herpesvirus infection,1/186,0.0092999029651357,0.0115358848343883,0,0,19814.0,92684.96451050608,CTNNB1
9710,KEGG_2019_Human,Focal adhesion,1/199,0.0099498991610159,0.0115358848343883,0,0,19801.0,91286.4288690606,CTNNB1
9711,KEGG_2019_Human,Proteoglycans in cancer,1/201,0.0100498985877989,0.0115358848343883,0,0,19799.0,91079.21596609056,CTNNB1
9712,KEGG_2019_Human,Rap1 signaling pathway,1/206,0.010299897173561,0.0115358848343883,0,0,19794.0,90569.849337325,CTNNB1
9713,KEGG_2019_Human,Human cytomegalovirus infection,1/225,0.0112498919790339,0.0121152682851134,0,0,19775.0,88738.27077557483,CTNNB1
9714,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0171109736611483,0,0,19670.0,80733.60565076157,CTNNB1
9715,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,CTNNB1
9716,KEGG_2019_Human,Circadian rhythm,1/31,0.0015499690656704,0.0030999381313408,0,0,19969.0,129189.85098816035,PER1
9717,KEGG_2019_Human,Circadian entrainment,1/97,0.0048499343304706,0.0048499343304706,0,0,19903.0,106058.9096435903,PER1
9718,KEGG_2019_Human,Porphyrin and chlorophyll metabolism,1/42,0.0020999619311272,0.0020999619311272,0,0,19958.0,123057.75613441122,UROD
9719,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF783
9720,KEGG_2019_Human,Fanconi anemia pathway,1/54,0.0026999549628563,0.0026999549628563,0,0,19946.0,117971.01964061816,WDR48
9721,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR5M11
9722,KEGG_2019_Human,Renin secretion,1/69,0.003449947123837,0.0074665709494039,0,0,19931.0,112996.7391397682,KCNJ2
9723,KEGG_2019_Human,Gastric acid secretion,1/75,0.0037499442041125,0.0074665709494039,0,0,19925.0,111301.33528642564,KCNJ2
9724,KEGG_2019_Human,Cholinergic synapse,1/112,0.0055999282120529,0.0074665709494039,0,0,19888.0,103119.30984392198,KCNJ2
9725,KEGG_2019_Human,Oxytocin signaling pathway,1/153,0.0076499133771537,0.0076499133771537,0,0,19847.0,96715.6407630817,KCNJ2
9726,KEGG_2019_Human,Salmonella infection,1/86,0.0042999391173866,0.0042999391173866,0,0,19914.0,108514.46102290176,KLC3
9727,KEGG_2019_Human,Amyotrophic lateral sclerosis (ALS),1/51,0.0025499566390179,0.0115960368320757,0,0,19949.0,119129.0228601236,APAF1
9728,KEGG_2019_Human,Legionellosis,1/55,0.0027499544131125,0.0115960368320757,0,0,19945.0,117599.1294878737,APAF1
9729,KEGG_2019_Human,p53 signaling pathway,1/72,0.0035999456502131,0.0115960368320757,0,0,19928.0,112131.59838572376,APAF1
9730,KEGG_2019_Human,Small cell lung cancer,1/93,0.0046499360391879,0.0115960368320757,0,0,19907.0,106918.54242106884,APAF1
9731,KEGG_2019_Human,Measles,1/138,0.0068999185254481,0.0115960368320757,0,0,19862.0,98838.19160389496,APAF1
9732,KEGG_2019_Human,Parkinson disease,1/142,0.0070999171242726,0.0115960368320757,0,0,19858.0,98250.87390500787,APAF1
9733,KEGG_2019_Human,Apoptosis,1/143,0.0071499167770442,0.0115960368320757,0,0,19857.0,98106.57763600958,APAF1
9734,KEGG_2019_Human,Hepatitis C,1/155,0.0077499127120574,0.0115960368320757,0,0,19845.0,96448.16254952336,APAF1
9735,KEGG_2019_Human,Hepatitis B,1/163,0.0081499100978668,0.0115960368320757,0,0,19837.0,95410.9786681514,APAF1
9736,KEGG_2019_Human,Alzheimer disease,1/171,0.0085499075557634,0.0115960368320757,0,0,19829.0,94422.42241345016,APAF1
9737,KEGG_2019_Human,Tuberculosis,1/179,0.0089499050800561,0.0115960368320757,0,0,19821.0,93478.0629355712,APAF1
9738,KEGG_2019_Human,Huntington disease,1/193,0.0096499008972596,0.0115960368320757,0,0,19807.0,91920.47679471428,APAF1
9739,KEGG_2019_Human,Epstein-Barr virus infection,1/201,0.0100498985877989,0.0115960368320757,0,0,19799.0,91079.21596609056,APAF1
9740,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0263569703353121,0,0,19508.0,72277.44006442746,APAF1
9741,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,APAF1
9742,KEGG_2019_Human,Arrhythmogenic right ventricular cardiomyopathy (ARVC),1/72,0.0035999456502131,0.0079623895876056,0,0,19928.0,112131.59838572376,CACNG8
9743,KEGG_2019_Human,Cardiac muscle contraction,1/78,0.0038999427840466,0.0079623895876056,0,0,19922.0,110503.2180492851,CACNG8
9744,KEGG_2019_Human,Hypertrophic cardiomyopathy (HCM),1/85,0.004249939567045,0.0079623895876056,0,0,19915.0,108752.83801948265,CACNG8
9745,KEGG_2019_Human,Dilated cardiomyopathy (DCM),1/91,0.0045499369072032,0.0079623895876056,0,0,19909.0,107362.10783923086,CACNG8
9746,KEGG_2019_Human,Adrenergic signaling in cardiomyocytes,1/145,0.0072499160871101,0.0089248989400127,0,0,19855.0,97820.92670675044,CACNG8
9747,KEGG_2019_Human,Oxytocin signaling pathway,1/153,0.0076499133771537,0.0089248989400127,0,0,19847.0,96715.6407630817,CACNG8
9748,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0147498749536506,0,0,19705.0,83086.53988020132,CACNG8
9749,KEGG_2019_Human,Arginine biosynthesis,1/21,0.0010499764455398,0.0010499764455398,0,0,19979.0,137035.71221916509,ABHD14A-ACY1
9750,KEGG_2019_Human,Endocytosis,1/244,0.0121998870519305,0.0121998870519305,0,0,19756.0,87051.4275316661,SPG21
9751,KEGG_2019_Human,NOD-like receptor signaling pathway,1/178,0.0088999053857096,0.0088999053857096,0,0,19822.0,93593.82745769851,CARD8
9752,KEGG_2019_Human,Leukocyte transendothelial migration,1/112,0.0055999282120529,0.0084999078692823,0,0,19888.0,103119.30984392198,CLDN11
9753,KEGG_2019_Human,Cell adhesion molecules (CAMs),1/145,0.0072499160871101,0.0084999078692823,0,0,19855.0,97820.92670675044,CLDN11
9754,KEGG_2019_Human,Hepatitis C,1/155,0.0077499127120574,0.0084999078692823,0,0,19845.0,96448.16254952336,CLDN11
9755,KEGG_2019_Human,Tight junction,1/170,0.0084999078692823,0.0084999078692823,0,0,19830.0,94543.49009679438,CLDN11
9756,KEGG_2019_Human,Gastric acid secretion,1/75,0.0037499442041125,0.0037499442041125,0,0,19925.0,111301.33528642564,SLC9A4
9757,KEGG_2019_Human,Systemic lupus erythematosus,1/133,0.0066499203093911,0.0066499203093911,0,0,19867.0,99596.2591544721,RO60
9758,KEGG_2019_Human,Non-homologous end-joining,1/13,0.0006499833083207112,0.0012999666166414,0,0,19987.0,146675.87616784443,DNTT
9759,KEGG_2019_Human,Hematopoietic cell lineage,1/97,0.0048499343304706,0.0048499343304706,0,0,19903.0,106058.9096435903,DNTT
9760,KEGG_2019_Human,Porphyrin and chlorophyll metabolism,1/42,0.0020999619311272,0.0020999619311272,0,0,19958.0,123057.75613441122,ALAD
9761,KEGG_2019_Human,Estrogen signaling pathway,1/137,0.0068499188797651,0.0068499188797651,0,0,19863.0,98987.62735269018,KRT33A
9762,KEGG_2019_Human,African trypanosomiasis,1/37,0.0018499650702878,0.0024499577795033,0,0,19963.0,125618.9446446357,HBB
9763,KEGG_2019_Human,Malaria,1/49,0.0024499577795033,0.0024499577795033,0,0,19951.0,119939.1172087114,HBB
9764,KEGG_2019_Human,Thyroid cancer,1/37,0.0018499650702878,0.0142998335540884,0,0,19963.0,125618.9446446357,NTRK1
9765,KEGG_2019_Human,Central carbon metabolism in cancer,1/65,0.003249949134407,0.0142998335540884,0,0,19935.0,114209.92613860144,NTRK1
9766,KEGG_2019_Human,Inflammatory mediator regulation of TRP channels,1/100,0.0049999330710556,0.0142998335540884,0,0,19900.0,105436.78197328727,NTRK1
9767,KEGG_2019_Human,Neurotrophin signaling pathway,1/119,0.0059499254985137,0.0142998335540884,0,0,19881.0,101877.73080211312,NTRK1
9768,KEGG_2019_Human,Apoptosis,1/143,0.0071499167770442,0.0142998335540884,0,0,19857.0,98106.57763600958,NTRK1
9769,KEGG_2019_Human,Transcriptional misregulation in cancer,1/186,0.0092999029651357,0.0154998382752262,0,0,19814.0,92684.96451050608,NTRK1
9770,KEGG_2019_Human,Ras signaling pathway,1/232,0.0115998901349604,0.016571271621372,0,0,19768.0,88101.22480150245,NTRK1
9771,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0184373436920633,0,0,19705.0,83086.53988020132,NTRK1
9772,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0196665140459632,0,0,19646.0,79255.8617626126,NTRK1
9773,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,NTRK1
9774,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR4S2
9775,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR4C15
9776,KEGG_2019_Human,Gap junction,1/88,0.0043999382262822,0.0101998845028717,0,0,19912.0,108045.79305232369,MAPK7
9777,KEGG_2019_Human,GnRH signaling pathway,1/93,0.0046499360391879,0.0101998845028717,0,0,19907.0,106918.54242106884,MAPK7
9778,KEGG_2019_Human,IL-17 signaling pathway,1/93,0.0046499360391879,0.0101998845028717,0,0,19907.0,106918.54242106884,MAPK7
9779,KEGG_2019_Human,Neurotrophin signaling pathway,1/119,0.0059499254985137,0.0101998845028717,0,0,19881.0,101877.73080211312,MAPK7
9780,KEGG_2019_Human,Fluid shear stress and atherosclerosis,1/139,0.006949918172816,0.0101998845028717,0,0,19861.0,98689.81333375497,MAPK7
9781,KEGG_2019_Human,Oxytocin signaling pathway,1/153,0.0076499133771537,0.0101998845028717,0,0,19847.0,96715.6407630817,MAPK7
9782,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0149498740670514,0,0,19705.0,83086.53988020132,MAPK7
9783,KEGG_2019_Human,MicroRNAs in cancer,1/299,0.0149498740670514,0.0149498740670514,0,0,19701.0,82804.33538735632,MAPK7
9784,KEGG_2019_Human,Glycosphingolipid biosynthesis,1/45,0.0022499601197094,0.0022499601197094,0,0,19955.0,121662.49782449217,A3GALT2
9785,KEGG_2019_Human,SNARE interactions in vesicular transport,1/34,0.0016999670339032,0.0050999011017096,0,0,19966.0,127326.1054203148,VAMP8
9786,KEGG_2019_Human,Platelet activation,1/124,0.0061999236097501,0.0063999221281459,0,0,19876.0,101034.04709010696,VAMP8
9787,KEGG_2019_Human,Autophagy,1/128,0.0063999221281459,0.0063999221281459,0,0,19872.0,100382.8010329652,VAMP8
9788,KEGG_2019_Human,Taste transduction,1/83,0.0041499404726918,0.0049999330710556,0,0,19917.0,109237.99888847338,ASIC2
9789,KEGG_2019_Human,Inflammatory mediator regulation of TRP channels,1/100,0.0049999330710556,0.0049999330710556,0,0,19900.0,105436.78197328727,ASIC2
9790,KEGG_2019_Human,Pyrimidine metabolism,1/57,0.002849953326298,0.0053999298011749,0,0,19943.0,116875.00742975442,UPP2
9791,KEGG_2019_Human,Drug metabolism,1/108,0.0053999298011749,0.0053999298011749,0,0,19892.0,103863.47861844616,UPP2
9792,KEGG_2019_Human,RNA degradation,1/79,0.0039499423167337,0.0039499423167337,0,0,19921.0,110243.89578070649,PAN2
9793,KEGG_2019_Human,Other types of O-glycan biosynthesis,1/22,0.0010999756574123,0.0021999513148247,0,0,19978.0,136099.47030191717,PLOD3
9794,KEGG_2019_Human,Lysine degradation,1/59,0.0029499522555206,0.0029499522555206,0,0,19941.0,116175.59385530632,PLOD3
9795,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR10A6
9796,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR8H3
9797,KEGG_2019_Human,Proteasome,1/45,0.0022499601197094,0.0022499601197094,0,0,19955.0,121662.49782449217,PSMB3
9798,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR52D1
9799,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR10A5
9800,KEGG_2019_Human,Cellular senescence,1/160,0.0079999110688441,0.0079999110688441,0,0,19840.0,95793.96509856998,HUS1
9801,KEGG_2019_Human,Type II diabetes mellitus,1/46,0.0022999595269283,0.0116306425399978,0,0,19954.0,121217.8313311442,MTOR
9802,KEGG_2019_Human,Central carbon metabolism in cancer,1/65,0.003249949134407,0.0116306425399978,0,0,19935.0,114209.92613860144,MTOR
9803,KEGG_2019_Human,Acute myeloid leukemia,1/66,0.003299948626608,0.0116306425399978,0,0,19934.0,113899.85357353876,MTOR
9804,KEGG_2019_Human,Adipocytokine signaling pathway,1/69,0.003449947123837,0.0116306425399978,0,0,19931.0,112996.7391397682,MTOR
9805,KEGG_2019_Human,Pancreatic cancer,1/75,0.0037499442041125,0.0116306425399978,0,0,19925.0,111301.33528642564,MTOR
9806,KEGG_2019_Human,Glioma,1/75,0.0037499442041125,0.0116306425399978,0,0,19925.0,111301.33528642564,MTOR
9807,KEGG_2019_Human,ErbB signaling pathway,1/85,0.004249939567045,0.0116306425399978,0,0,19915.0,108752.83801948265,MTOR
9808,KEGG_2019_Human,Colorectal cancer,1/86,0.0042999391173866,0.0116306425399978,0,0,19914.0,108514.46102290176,MTOR
9809,KEGG_2019_Human,Prostate cancer,1/97,0.0048499343304706,0.0116306425399978,0,0,19903.0,106058.9096435903,MTOR
9810,KEGG_2019_Human,Choline metabolism in cancer,1/99,0.0049499334884068,0.0116306425399978,0,0,19901.0,105642.09305076736,MTOR
9811,KEGG_2019_Human,HIF-1 signaling pathway,1/100,0.0049999330710556,0.0116306425399978,0,0,19900.0,105436.78197328727,MTOR
9812,KEGG_2019_Human,Longevity regulating pathway,1/102,0.0050999322416682,0.0116306425399978,0,0,19898.0,105032.15064717118,MTOR
9813,KEGG_2019_Human,Th17 cell differentiation,1/107,0.0053499302026925,0.0116306425399978,0,0,19893.0,104053.753408911,MTOR
9814,KEGG_2019_Human,Insulin resistance,1/108,0.0053999298011749,0.0116306425399978,0,0,19892.0,103863.47861844616,MTOR
9815,KEGG_2019_Human,Thyroid hormone signaling pathway,1/116,0.0057999266512085,0.0116306425399978,0,0,19884.0,102400.8105961506,MTOR
9816,KEGG_2019_Human,AMPK signaling pathway,1/120,0.0059999251180858,0.0116306425399978,0,0,19880.0,101706.2448082016,MTOR
9817,KEGG_2019_Human,Autophagy,1/128,0.0063999221281459,0.0116306425399978,0,0,19872.0,100382.8010329652,MTOR
9818,KEGG_2019_Human,Insulin signaling pathway,1/137,0.0068499188797651,0.0116306425399978,0,0,19863.0,98987.62735269018,MTOR
9819,KEGG_2019_Human,Apelin signaling pathway,1/137,0.0068499188797651,0.0116306425399978,0,0,19863.0,98987.62735269018,MTOR
9820,KEGG_2019_Human,Breast cancer,1/147,0.0073499154017982,0.0116306425399978,0,0,19853.0,97539.10874372096,MTOR
9821,KEGG_2019_Human,Phospholipase D signaling pathway,1/148,0.007399915061391,0.0116306425399978,0,0,19852.0,97399.60470052566,MTOR
9822,KEGG_2019_Human,Gastric cancer,1/149,0.0074499147221605,0.0116306425399978,0,0,19851.0,97261.02051561224,MTOR
9823,KEGG_2019_Human,mTOR signaling pathway,1/152,0.0075999137114971,0.0116306425399978,0,0,19848.0,96850.665715497,MTOR
9824,KEGG_2019_Human,Cellular senescence,1/160,0.0079999110688441,0.0116306425399978,0,0,19840.0,95793.96509856998,MTOR
9825,KEGG_2019_Human,JAK-STAT signaling pathway,1/162,0.0080999104202618,0.0116306425399978,0,0,19838.0,95537.86936302872,MTOR
9826,KEGG_2019_Human,Hepatocellular carcinoma,1/168,0.0083999085011095,0.0116306425399978,0,0,19832.0,94787.72752807094,MTOR
9827,KEGG_2019_Human,Kaposi sarcoma-associated herpesvirus infection,1/186,0.0092999029651357,0.012399870620181,0,0,19814.0,92684.96451050608,MTOR
9828,KEGG_2019_Human,Proteoglycans in cancer,1/201,0.0100498985877989,0.0129212981843129,0,0,19799.0,91079.21596609056,MTOR
9829,KEGG_2019_Human,Human immunodeficiency virus 1 infection,1/212,0.0105998955026255,0.0131584909687765,0,0,19788.0,89974.27756224656,MTOR
9830,KEGG_2019_Human,Human cytomegalovirus infection,1/225,0.0112498919790339,0.0134127759414955,0,0,19775.0,88738.27077557483,MTOR
9831,KEGG_2019_Human,Thermogenesis,1/231,0.0115498903940656,0.0134127759414955,0,0,19769.0,88191.07730937863,MTOR
9832,KEGG_2019_Human,MicroRNAs in cancer,1/299,0.0149498740670514,0.0168186083254328,0,0,19701.0,82804.33538735632,MTOR
9833,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0179998554097794,0,0,19670.0,80733.60565076157,MTOR
9834,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0187410310320355,0,0,19646.0,79255.8617626126,MTOR
9835,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0253026915218996,0,0,19508.0,72277.44006442746,MTOR
9836,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,MTOR
9837,KEGG_2019_Human,Osteoclast differentiation,1/127,0.0063499224962247,0.0063499224962247,0,0,19873.0,100543.72072014232,LILRA2
9838,KEGG_2019_Human,Mismatch repair,1/23,0.0011499748819949,0.0023499589392381,0,0,19977.0,135204.63922267244,RFC2
9839,KEGG_2019_Human,DNA replication,1/36,0.0017999657178272,0.0023499589392381,0,0,19964.0,126172.23364250171,RFC2
9840,KEGG_2019_Human,Nucleotide excision repair,1/47,0.0023499589392381,0.0023499589392381,0,0,19953.0,120782.64067395544,RFC2
9841,KEGG_2019_Human,Proteasome,1/45,0.0022499601197094,0.0044999202394188,0,0,19955.0,121662.49782449217,PSMD12
9842,KEGG_2019_Human,Epstein-Barr virus infection,1/201,0.0100498985877989,0.0100498985877989,0,0,19799.0,91079.21596609056,PSMD12
9843,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0164998674589645,0,0,19670.0,80733.60565076157,HES7
9844,KEGG_2019_Human,Melanoma,1/72,0.0035999456502131,0.0173998352024406,0,0,19928.0,112131.59838572376,FGF3
9845,KEGG_2019_Human,Breast cancer,1/147,0.0073499154017982,0.0173998352024406,0,0,19853.0,97539.10874372096,FGF3
9846,KEGG_2019_Human,Gastric cancer,1/149,0.0074499147221605,0.0173998352024406,0,0,19851.0,97261.02051561224,FGF3
9847,KEGG_2019_Human,Rap1 signaling pathway,1/206,0.010299897173561,0.0173998352024406,0,0,19794.0,90569.849337325,FGF3
9848,KEGG_2019_Human,Regulation of actin cytoskeleton,1/214,0.0106998949514067,0.0173998352024406,0,0,19786.0,89779.39753374986,FGF3
9849,KEGG_2019_Human,Ras signaling pathway,1/232,0.0115998901349604,0.0173998352024406,0,0,19768.0,88101.22480150245,FGF3
9850,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.018964124940408,0,0,19705.0,83086.53988020132,FGF3
9851,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0199123454715377,0,0,19646.0,79255.8617626126,FGF3
9852,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,FGF3
9853,KEGG_2019_Human,Pathogenic Escherichia coli infection,1/55,0.0027499544131125,0.0065999073394233,0,0,19945.0,117599.1294878737,TUBB2B
9854,KEGG_2019_Human,Gap junction,1/88,0.0043999382262822,0.0065999073394233,0,0,19912.0,108045.79305232369,TUBB2B
9855,KEGG_2019_Human,Phagosome,1/152,0.0075999137114971,0.0075999137114971,0,0,19848.0,96850.665715497,TUBB2B
9856,KEGG_2019_Human,Nicotine addiction,1/40,0.0019999631680592,0.005687421134004,0,0,19960.0,124043.94523066044,SLC32A1
9857,KEGG_2019_Human,Synaptic vesicle cycle,1/78,0.0038999427840466,0.005687421134004,0,0,19922.0,110503.2180492851,SLC32A1
9858,KEGG_2019_Human,GABAergic synapse,1/89,0.0044499377838098,0.005687421134004,0,0,19911.0,107815.380281759,SLC32A1
9859,KEGG_2019_Human,Morphine addiction,1/91,0.0045499369072032,0.005687421134004,0,0,19909.0,107362.10783923086,SLC32A1
9860,KEGG_2019_Human,Retrograde endocannabinoid signaling,1/148,0.007399915061391,0.007399915061391,0,0,19852.0,97399.60470052566,SLC32A1
9861,KEGG_2019_Human,RNA transport,1/165,0.0082499094553477,0.0082499094553477,0,0,19835.0,95159.46482222488,POM121C
9862,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF585B
9863,KEGG_2019_Human,Cardiac muscle contraction,1/78,0.0038999427840466,0.0112582177134695,0,0,19922.0,110503.2180492851,COX7B2
9864,KEGG_2019_Human,Oxidative phosphorylation,1/133,0.0066499203093911,0.0112582177134695,0,0,19867.0,99596.2591544721,COX7B2
9865,KEGG_2019_Human,Parkinson disease,1/142,0.0070999171242726,0.0112582177134695,0,0,19858.0,98250.87390500787,COX7B2
9866,KEGG_2019_Human,Non-alcoholic fatty liver disease (NAFLD),1/149,0.0074499147221605,0.0112582177134695,0,0,19851.0,97261.02051561224,COX7B2
9867,KEGG_2019_Human,Alzheimer disease,1/171,0.0085499075557634,0.0112582177134695,0,0,19829.0,94422.42241345016,COX7B2
9868,KEGG_2019_Human,Huntington disease,1/193,0.0096499008972596,0.0112582177134695,0,0,19807.0,91920.47679471428,COX7B2
9869,KEGG_2019_Human,Thermogenesis,1/231,0.0115498903940656,0.0115498903940656,0,0,19769.0,88191.07730937863,COX7B2
9870,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0245998389796247,0,0,19706.0,83157.67014793828,TNFRSF14
9871,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,TNFRSF14
9872,KEGG_2019_Human,Adipocytokine signaling pathway,1/69,0.003449947123837,0.0121498656303927,0,0,19931.0,112996.7391397682,LEPR
9873,KEGG_2019_Human,AMPK signaling pathway,1/120,0.0059999251180858,0.0121498656303927,0,0,19880.0,101706.2448082016,LEPR
9874,KEGG_2019_Human,Non-alcoholic fatty liver disease (NAFLD),1/149,0.0074499147221605,0.0121498656303927,0,0,19851.0,97261.02051561224,LEPR
9875,KEGG_2019_Human,JAK-STAT signaling pathway,1/162,0.0080999104202618,0.0121498656303927,0,0,19838.0,95537.86936302872,LEPR
9876,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0168998658265596,0,0,19706.0,83157.67014793828,LEPR
9877,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,LEPR
9878,KEGG_2019_Human,Malaria,1/49,0.0024499577795033,0.0090623951088877,0,0,19951.0,119939.1172087114,SDC1
9879,KEGG_2019_Human,ECM-receptor interaction,1/82,0.004099940929819,0.0090623951088877,0,0,19918.0,109484.9180722932,SDC1
9880,KEGG_2019_Human,Fluid shear stress and atherosclerosis,1/139,0.006949918172816,0.0090623951088877,0,0,19861.0,98689.81333375497,SDC1
9881,KEGG_2019_Human,Cell adhesion molecules (CAMs),1/145,0.0072499160871101,0.0090623951088877,0,0,19855.0,97820.92670675044,SDC1
9882,KEGG_2019_Human,Proteoglycans in cancer,1/201,0.0100498985877989,0.0100498985877989,0,0,19799.0,91079.21596609056,SDC1
9883,KEGG_2019_Human,Biosynthesis of unsaturated fatty acids,1/27,0.0013499718942362,0.0013499718942362,0,0,19973.0,131975.02298599784,ELOVL4
9884,KEGG_2019_Human,Fatty acid elongation,1/27,0.0013499718942362,0.0013499718942362,0,0,19973.0,131975.02298599784,ELOVL4
9885,KEGG_2019_Human,Shigellosis,1/65,0.003249949134407,0.0078398994968741,0,0,19935.0,114209.92613860144,VCL
9886,KEGG_2019_Human,Adherens junction,1/72,0.0035999456502131,0.0078398994968741,0,0,19928.0,112131.59838572376,VCL
9887,KEGG_2019_Human,Bacterial invasion of epithelial cells,1/74,0.0036999446830449,0.0078398994968741,0,0,19926.0,111574.38983110404,VCL
9888,KEGG_2019_Human,Amoebiasis,1/96,0.0047999347538706,0.0078398994968741,0,0,19904.0,106270.50039849174,VCL
9889,KEGG_2019_Human,Leukocyte transendothelial migration,1/112,0.0055999282120529,0.0078398994968741,0,0,19888.0,103119.30984392198,VCL
9890,KEGG_2019_Human,Focal adhesion,1/199,0.0099498991610159,0.0106998949514067,0,0,19801.0,91286.4288690606,VCL
9891,KEGG_2019_Human,Regulation of actin cytoskeleton,1/214,0.0106998949514067,0.0106998949514067,0,0,19786.0,89779.39753374986,VCL
9892,KEGG_2019_Human,Collecting duct acid secretion,1/27,0.0013499718942362,0.0090998738144064,0,0,19973.0,131975.02298599784,ATP6V0A1
9893,KEGG_2019_Human,Vibrio cholerae infection,1/50,0.0024999572069037,0.0090998738144064,0,0,19950.0,119530.05920663515,ATP6V0A1
9894,KEGG_2019_Human,Epithelial cell signaling in Helicobacter pylori infection,1/68,0.0033999476216189,0.0090998738144064,0,0,19932.0,113293.39338050144,ATP6V0A1
9895,KEGG_2019_Human,Synaptic vesicle cycle,1/78,0.0038999427840466,0.0090998738144064,0,0,19922.0,110503.2180492851,ATP6V0A1
9896,KEGG_2019_Human,Rheumatoid arthritis,1/91,0.0045499369072032,0.0090998738144064,0,0,19909.0,107362.10783923086,ATP6V0A1
9897,KEGG_2019_Human,Lysosome,1/123,0.0061499239842961,0.009499886156273,0,0,19877.0,101200.07933676826,ATP6V0A1
9898,KEGG_2019_Human,Oxidative phosphorylation,1/133,0.0066499203093911,0.009499886156273,0,0,19867.0,99596.2591544721,ATP6V0A1
9899,KEGG_2019_Human,Phagosome,1/152,0.0075999137114971,0.0094998921393714,0,0,19848.0,96850.665715497,ATP6V0A1
9900,KEGG_2019_Human,Tuberculosis,1/179,0.0089499050800561,0.0099443389778401,0,0,19821.0,93478.0629355712,ATP6V0A1
9901,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0164998674589645,0,0,19670.0,80733.60565076157,ATP6V0A1
9902,KEGG_2019_Human,Nitrogen metabolism,1/17,0.0008499797390404818,0.0008499797390404818,0,0,19983.0,141285.76583697114,CA6
9903,KEGG_2019_Human,Vasopressin-regulated water reabsorption,1/44,0.0021999607179423,0.0043999214358846,0,0,19956.0,122117.06559109331,DCTN1
9904,KEGG_2019_Human,Huntington disease,1/193,0.0096499008972596,0.0096499008972596,0,0,19807.0,91920.47679471428,DCTN1
9905,KEGG_2019_Human,Ras signaling pathway,1/232,0.0115998901349604,0.0115998901349604,0,0,19768.0,88101.22480150245,RIN1
9906,KEGG_2019_Human,Glutamatergic synapse,1/114,0.005699927427839,0.0110998725920865,0,0,19886.0,102756.96431429044,GRM6
9907,KEGG_2019_Human,Phospholipase D signaling pathway,1/148,0.007399915061391,0.0110998725920865,0,0,19852.0,97399.60470052566,GRM6
9908,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,GRM6
9909,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF90
9910,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,TAAR2
9911,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF746
9912,KEGG_2019_Human,Fc gamma R-mediated phagocytosis,1/91,0.0045499369072032,0.0090998738144064,0,0,19909.0,107362.10783923086,DOCK2
9913,KEGG_2019_Human,Chemokine signaling pathway,1/190,0.0094999017791995,0.0094999017791995,0,0,19810.0,92244.74636351672,DOCK2
9914,KEGG_2019_Human,Fat digestion and absorption,1/41,0.0020499625466866,0.0066665834645398,0,0,19959.0,123544.88783416104,CD36
9915,KEGG_2019_Human,Malaria,1/49,0.0024499577795033,0.0066665834645398,0,0,19951.0,119939.1172087114,CD36
9916,KEGG_2019_Human,Cholesterol metabolism,1/50,0.0024999572069037,0.0066665834645398,0,0,19950.0,119530.05920663515,CD36
9917,KEGG_2019_Human,Adipocytokine signaling pathway,1/69,0.003449947123837,0.0066665834645398,0,0,19931.0,112996.7391397682,CD36
9918,KEGG_2019_Human,PPAR signaling pathway,1/74,0.0036999446830449,0.0066665834645398,0,0,19926.0,111574.38983110404,CD36
9919,KEGG_2019_Human,ECM-receptor interaction,1/82,0.004099940929819,0.0066665834645398,0,0,19918.0,109484.9180722932,CD36
9920,KEGG_2019_Human,Hematopoietic cell lineage,1/97,0.0048499343304706,0.0066665834645398,0,0,19903.0,106058.9096435903,CD36
9921,KEGG_2019_Human,Insulin resistance,1/108,0.0053999298011749,0.0066665834645398,0,0,19892.0,103863.47861844616,CD36
9922,KEGG_2019_Human,AMPK signaling pathway,1/120,0.0059999251180858,0.0066665834645398,0,0,19880.0,101706.2448082016,CD36
9923,KEGG_2019_Human,Phagosome,1/152,0.0075999137114971,0.0075999137114971,0,0,19848.0,96850.665715497,CD36
9924,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,SSTR4
9925,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,GRID1
9926,KEGG_2019_Human,IL-17 signaling pathway,1/93,0.0046499360391879,0.0100498985877989,0,0,19907.0,106918.54242106884,TNFAIP3
9927,KEGG_2019_Human,NF-kappa B signaling pathway,1/95,0.0047499351803394,0.0100498985877989,0,0,19905.0,106484.27183626965,TNFAIP3
9928,KEGG_2019_Human,TNF signaling pathway,1/110,0.0054999290027479,0.0100498985877989,0,0,19890.0,103488.06969787036,TNFAIP3
9929,KEGG_2019_Human,Measles,1/138,0.0068999185254481,0.0100498985877989,0,0,19862.0,98838.19160389496,TNFAIP3
9930,KEGG_2019_Human,Necroptosis,1/162,0.0080999104202618,0.0100498985877989,0,0,19838.0,95537.86936302872,TNFAIP3
9931,KEGG_2019_Human,NOD-like receptor signaling pathway,1/178,0.0088999053857096,0.0100498985877989,0,0,19822.0,93593.82745769851,TNFAIP3
9932,KEGG_2019_Human,Epstein-Barr virus infection,1/201,0.0100498985877989,0.0100498985877989,0,0,19799.0,91079.21596609056,TNFAIP3
9933,KEGG_2019_Human,Leukocyte transendothelial migration,1/112,0.0055999282120529,0.0072499160871101,0,0,19888.0,103119.30984392198,CD99
9934,KEGG_2019_Human,Cell adhesion molecules (CAMs),1/145,0.0072499160871101,0.0072499160871101,0,0,19855.0,97820.92670675044,CD99
9935,KEGG_2019_Human,PPAR signaling pathway,1/74,0.0036999446830449,0.0053999298011749,0,0,19926.0,111574.38983110404,SLC27A6
9936,KEGG_2019_Human,Insulin resistance,1/108,0.0053999298011749,0.0053999298011749,0,0,19892.0,103863.47861844616,SLC27A6
9937,KEGG_2019_Human,Glycosaminoglycan biosynthesis,1/53,0.0026499555173137,0.0026499555173137,0,0,19947.0,118349.78824235698,NDST3
9938,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0147498749536506,0,0,19705.0,83086.53988020132,MAP4K3
9939,KEGG_2019_Human,Galactose metabolism,1/31,0.0015499690656704,0.0026999485767408,0,0,19969.0,129189.85098816035,GAA
9940,KEGG_2019_Human,Starch and sucrose metabolism,1/36,0.0017999657178272,0.0026999485767408,0,0,19964.0,126172.23364250171,GAA
9941,KEGG_2019_Human,Lysosome,1/123,0.0061499239842961,0.0061499239842961,0,0,19877.0,101200.07933676826,GAA
9942,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR1D2
9943,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,MC5R
9944,KEGG_2019_Human,Axon guidance,1/181,0.0090499044707863,0.0090499044707863,0,0,19819.0,93248.41634586031,ABLIM3
9945,KEGG_2019_Human,Lysosome,1/123,0.0061499239842961,0.0061499239842961,0,0,19877.0,101200.07933676826,AP3S2
9946,KEGG_2019_Human,Endocytosis,1/244,0.0121998870519305,0.0121998870519305,0,0,19756.0,87051.4275316661,ACAP1
9947,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR2F1
9948,KEGG_2019_Human,Necroptosis,1/162,0.0080999104202618,0.0088999053857096,0,0,19838.0,95537.86936302872,SHARPIN
9949,KEGG_2019_Human,NOD-like receptor signaling pathway,1/178,0.0088999053857096,0.0088999053857096,0,0,19822.0,93593.82745769851,SHARPIN
9950,KEGG_2019_Human,PPAR signaling pathway,1/74,0.0036999446830449,0.0036999446830449,0,0,19926.0,111574.38983110404,UBC
9951,KEGG_2019_Human,Melanoma,1/72,0.0035999456502131,0.016571271621372,0,0,19928.0,112131.59838572376,FGF21
9952,KEGG_2019_Human,Breast cancer,1/147,0.0073499154017982,0.016571271621372,0,0,19853.0,97539.10874372096,FGF21
9953,KEGG_2019_Human,Gastric cancer,1/149,0.0074499147221605,0.016571271621372,0,0,19851.0,97261.02051561224,FGF21
9954,KEGG_2019_Human,Rap1 signaling pathway,1/206,0.010299897173561,0.016571271621372,0,0,19794.0,90569.849337325,FGF21
9955,KEGG_2019_Human,Regulation of actin cytoskeleton,1/214,0.0106998949514067,0.016571271621372,0,0,19786.0,89779.39753374986,FGF21
9956,KEGG_2019_Human,Thermogenesis,1/231,0.0115498903940656,0.016571271621372,0,0,19769.0,88191.07730937863,FGF21
9957,KEGG_2019_Human,Ras signaling pathway,1/232,0.0115998901349604,0.016571271621372,0,0,19768.0,88101.22480150245,FGF21
9958,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0184373436920633,0,0,19705.0,83086.53988020132,FGF21
9959,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0196665140459632,0,0,19646.0,79255.8617626126,FGF21
9960,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,FGF21
9961,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR4D10
9962,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR2T8
9963,KEGG_2019_Human,NOD-like receptor signaling pathway,1/178,0.0088999053857096,0.0088999053857096,0,0,19822.0,93593.82745769851,NLRP6
9964,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR6C1
9965,KEGG_2019_Human,Linoleic acid metabolism,1/29,0.001449970461791,0.0056499278191151,0,0,19971.0,130534.69172799008,CYP2C19
9966,KEGG_2019_Human,Arachidonic acid metabolism,1/63,0.0031499501598827,0.0056499278191151,0,0,19937.0,114844.46974572667,CYP2C19
9967,KEGG_2019_Human,Chemical carcinogenesis,1/82,0.004099940929819,0.0056499278191151,0,0,19918.0,109484.9180722932,CYP2C19
9968,KEGG_2019_Human,Drug metabolism,1/108,0.0053999298011749,0.0056499278191151,0,0,19892.0,103863.47861844616,CYP2C19
9969,KEGG_2019_Human,Serotonergic synapse,1/113,0.0056499278191151,0.0056499278191151,0,0,19887.0,102937.34947211576,CYP2C19
9970,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR6S1
9971,KEGG_2019_Human,Type II diabetes mellitus,1/46,0.0022999595269283,0.0091832164115184,0,0,19954.0,121217.8313311442,CACNA1C
9972,KEGG_2019_Human,Cortisol synthesis and secretion,1/65,0.003249949134407,0.0091832164115184,0,0,19935.0,114209.92613860144,CACNA1C
9973,KEGG_2019_Human,Long-term potentiation,1/67,0.0033499481224912,0.0091832164115184,0,0,19933.0,113594.38808369274,CACNA1C
9974,KEGG_2019_Human,Amphetamine addiction,1/68,0.0033999476216189,0.0091832164115184,0,0,19932.0,113293.39338050144,CACNA1C
9975,KEGG_2019_Human,Renin secretion,1/69,0.003449947123837,0.0091832164115184,0,0,19931.0,112996.7391397682,CACNA1C
9976,KEGG_2019_Human,Arrhythmogenic right ventricular cardiomyopathy (ARVC),1/72,0.0035999456502131,0.0091832164115184,0,0,19928.0,112131.59838572376,CACNA1C
9977,KEGG_2019_Human,Cardiac muscle contraction,1/78,0.0038999427840466,0.0091832164115184,0,0,19922.0,110503.2180492851,CACNA1C
9978,KEGG_2019_Human,Taste transduction,1/83,0.0041499404726918,0.0091832164115184,0,0,19917.0,109237.99888847338,CACNA1C
9979,KEGG_2019_Human,Hypertrophic cardiomyopathy (HCM),1/85,0.004249939567045,0.0091832164115184,0,0,19915.0,108752.83801948265,CACNA1C
9980,KEGG_2019_Human,Insulin secretion,1/86,0.0042999391173866,0.0091832164115184,0,0,19914.0,108514.46102290176,CACNA1C
9981,KEGG_2019_Human,GABAergic synapse,1/89,0.0044499377838098,0.0091832164115184,0,0,19911.0,107815.380281759,CACNA1C
9982,KEGG_2019_Human,Dilated cardiomyopathy (DCM),1/91,0.0045499369072032,0.0091832164115184,0,0,19909.0,107362.10783923086,CACNA1C
9983,KEGG_2019_Human,GnRH signaling pathway,1/93,0.0046499360391879,0.0091832164115184,0,0,19907.0,106918.54242106884,CACNA1C
9984,KEGG_2019_Human,Circadian entrainment,1/97,0.0048499343304706,0.0091832164115184,0,0,19903.0,106058.9096435903,CACNA1C
9985,KEGG_2019_Human,Aldosterone synthesis and secretion,1/98,0.0048999339081079,0.0091832164115184,0,0,19902.0,105849.45495286948,CACNA1C
9986,KEGG_2019_Human,Cholinergic synapse,1/112,0.0055999282120529,0.0091832164115184,0,0,19888.0,103119.30984392198,CACNA1C
9987,KEGG_2019_Human,Serotonergic synapse,1/113,0.0056499278191151,0.0091832164115184,0,0,19887.0,102937.34947211576,CACNA1C
9988,KEGG_2019_Human,Glutamatergic synapse,1/114,0.005699927427839,0.0091832164115184,0,0,19886.0,102756.96431429044,CACNA1C
9989,KEGG_2019_Human,Dopaminergic synapse,1/131,0.0065499210316603,0.0093644778604028,0,0,19869.0,99907.33811343512,CACNA1C
9990,KEGG_2019_Human,Vascular smooth muscle contraction,1/132,0.0065999206698993,0.0093644778604028,0,0,19868.0,99751.22090491928,CACNA1C
9991,KEGG_2019_Human,Adrenergic signaling in cardiomyocytes,1/145,0.0072499160871101,0.0093644778604028,0,0,19855.0,97820.92670675044,CACNA1C
9992,KEGG_2019_Human,Retrograde endocannabinoid signaling,1/148,0.007399915061391,0.0093644778604028,0,0,19852.0,97399.60470052566,CACNA1C
9993,KEGG_2019_Human,Oxytocin signaling pathway,1/153,0.0076499133771537,0.0093644778604028,0,0,19847.0,96715.6407630817,CACNA1C
9994,KEGG_2019_Human,Cushing syndrome,1/155,0.0077499127120574,0.0093644778604028,0,0,19845.0,96448.16254952336,CACNA1C
9995,KEGG_2019_Human,cGMP-PKG signaling pathway,1/166,0.0082999091363732,0.0095364353506592,0,0,19834.0,95034.82345515196,CACNA1C
9996,KEGG_2019_Human,Alzheimer disease,1/171,0.0085499075557634,0.0095364353506592,0,0,19829.0,94422.42241345016,CACNA1C
9997,KEGG_2019_Human,Calcium signaling pathway,1/188,0.009399902370135,0.0100961914345895,0,0,19812.0,92463.712994847,CACNA1C
9998,KEGG_2019_Human,cAMP signaling pathway,1/212,0.0105998955026255,0.0109784631991479,0,0,19788.0,89974.27756224656,CACNA1C
9999,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0147498749536506,0,0,19705.0,83086.53988020132,CACNA1C
10000,KEGG_2019_Human,Vasopressin-regulated water reabsorption,1/44,0.0021999607179423,0.0043999214358846,0,0,19956.0,122117.06559109331,ARHGDIA
10001,KEGG_2019_Human,Neurotrophin signaling pathway,1/119,0.0059499254985137,0.0059499254985137,0,0,19881.0,101877.73080211312,ARHGDIA
10002,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0147498749536506,0,0,19705.0,83086.53988020132,DUSP8
10003,KEGG_2019_Human,Synaptic vesicle cycle,1/78,0.0038999427840466,0.0038999427840466,0,0,19922.0,110503.2180492851,SLC6A5
10004,KEGG_2019_Human,Protein processing in endoplasmic reticulum,1/165,0.0082499094553477,0.0082499094553477,0,0,19835.0,95159.46482222488,P4HB
10005,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR10Z1
10006,KEGG_2019_Human,Fc gamma R-mediated phagocytosis,1/91,0.0045499369072032,0.0090998738144064,0,0,19909.0,107362.10783923086,MARCKS
10007,KEGG_2019_Human,MicroRNAs in cancer,1/299,0.0149498740670514,0.0149498740670514,0,0,19701.0,82804.33538735632,MARCKS
10008,KEGG_2019_Human,African trypanosomiasis,1/37,0.0018499650702878,0.0092748838653302,0,0,19963.0,125618.9446446357,PRKCG
10009,KEGG_2019_Human,Aldosterone-regulated sodium reabsorption,1/37,0.0018499650702878,0.0092748838653302,0,0,19963.0,125618.9446446357,PRKCG
10010,KEGG_2019_Human,Endocrine and other factor-regulated calcium reabsorption,1/48,0.0023999583567988,0.0092748838653302,0,0,19952.0,120356.5272753826,PRKCG
10011,KEGG_2019_Human,VEGF signaling pathway,1/59,0.0029499522555206,0.0092748838653302,0,0,19941.0,116175.59385530632,PRKCG
10012,KEGG_2019_Human,Long-term depression,1/60,0.002999951725986,0.0092748838653302,0,0,19940.0,115834.63209072244,PRKCG
10013,KEGG_2019_Human,Non-small cell lung cancer,1/66,0.003299948626608,0.0092748838653302,0,0,19934.0,113899.85357353876,PRKCG
10014,KEGG_2019_Human,Long-term potentiation,1/67,0.0033499481224912,0.0092748838653302,0,0,19933.0,113594.38808369274,PRKCG
10015,KEGG_2019_Human,Amphetamine addiction,1/68,0.0033999476216189,0.0092748838653302,0,0,19932.0,113293.39338050144,PRKCG
10016,KEGG_2019_Human,Thyroid hormone synthesis,1/74,0.0036999446830449,0.0092748838653302,0,0,19926.0,111574.38983110404,PRKCG
10017,KEGG_2019_Human,Gastric acid secretion,1/75,0.0037499442041125,0.0092748838653302,0,0,19925.0,111301.33528642564,PRKCG
10018,KEGG_2019_Human,Glioma,1/75,0.0037499442041125,0.0092748838653302,0,0,19925.0,111301.33528642564,PRKCG
10019,KEGG_2019_Human,ErbB signaling pathway,1/85,0.004249939567045,0.0092748838653302,0,0,19915.0,108752.83801948265,PRKCG
10020,KEGG_2019_Human,Insulin secretion,1/86,0.0042999391173866,0.0092748838653302,0,0,19914.0,108514.46102290176,PRKCG
10021,KEGG_2019_Human,Gap junction,1/88,0.0043999382262822,0.0092748838653302,0,0,19912.0,108045.79305232369,PRKCG
10022,KEGG_2019_Human,GABAergic synapse,1/89,0.0044499377838098,0.0092748838653302,0,0,19911.0,107815.380281759,PRKCG
10023,KEGG_2019_Human,Salivary secretion,1/90,0.0044999373439762,0.0092748838653302,0,0,19910.0,107587.50385474482,PRKCG
10024,KEGG_2019_Human,Morphine addiction,1/91,0.0045499369072032,0.0092748838653302,0,0,19909.0,107362.10783923086,PRKCG
10025,KEGG_2019_Human,Fc gamma R-mediated phagocytosis,1/91,0.0045499369072032,0.0092748838653302,0,0,19909.0,107362.10783923086,PRKCG
10026,KEGG_2019_Human,Amoebiasis,1/96,0.0047999347538706,0.0092748838653302,0,0,19904.0,106270.50039849174,PRKCG
10027,KEGG_2019_Human,Circadian entrainment,1/97,0.0048499343304706,0.0092748838653302,0,0,19903.0,106058.9096435903,PRKCG
10028,KEGG_2019_Human,Aldosterone synthesis and secretion,1/98,0.0048999339081079,0.0092748838653302,0,0,19902.0,105849.45495286948,PRKCG
10029,KEGG_2019_Human,Pancreatic secretion,1/98,0.0048999339081079,0.0092748838653302,0,0,19902.0,105849.45495286948,PRKCG
10030,KEGG_2019_Human,Choline metabolism in cancer,1/99,0.0049499334884068,0.0092748838653302,0,0,19901.0,105642.09305076736,PRKCG
10031,KEGG_2019_Human,Phosphatidylinositol signaling system,1/99,0.0049499334884068,0.0092748838653302,0,0,19901.0,105642.09305076736,PRKCG
10032,KEGG_2019_Human,Inflammatory mediator regulation of TRP channels,1/100,0.0049999330710556,0.0092748838653302,0,0,19900.0,105436.78197328727,PRKCG
10033,KEGG_2019_Human,HIF-1 signaling pathway,1/100,0.0049999330710556,0.0092748838653302,0,0,19900.0,105436.78197328727,PRKCG
10034,KEGG_2019_Human,Melanogenesis,1/101,0.0050499326546803,0.0092748838653302,0,0,19899.0,105233.48101229242,PRKCG
10035,KEGG_2019_Human,"Parathyroid hormone synthesis, secretion and action",1/106,0.0052999306076525,0.0092748838653302,0,0,19894.0,104245.78450366124,PRKCG
10036,KEGG_2019_Human,Leukocyte transendothelial migration,1/112,0.0055999282120529,0.0092748838653302,0,0,19888.0,103119.30984392198,PRKCG
10037,KEGG_2019_Human,Cholinergic synapse,1/112,0.0055999282120529,0.0092748838653302,0,0,19888.0,103119.30984392198,PRKCG
10038,KEGG_2019_Human,Serotonergic synapse,1/113,0.0056499278191151,0.0092748838653302,0,0,19887.0,102937.34947211576,PRKCG
10039,KEGG_2019_Human,Glutamatergic synapse,1/114,0.005699927427839,0.0092748838653302,0,0,19886.0,102756.96431429044,PRKCG
10040,KEGG_2019_Human,Thyroid hormone signaling pathway,1/116,0.0057999266512085,0.0092748838653302,0,0,19884.0,102400.8105961506,PRKCG
10041,KEGG_2019_Human,Sphingolipid signaling pathway,1/119,0.0059499254985137,0.0092748838653302,0,0,19881.0,101877.73080211312,PRKCG
10042,KEGG_2019_Human,Natural killer cell mediated cytotoxicity,1/131,0.0065499210316603,0.009453940419045,0,0,19869.0,99907.33811343512,PRKCG
10043,KEGG_2019_Human,Dopaminergic synapse,1/131,0.0065499210316603,0.009453940419045,0,0,19869.0,99907.33811343512,PRKCG
10044,KEGG_2019_Human,Vascular smooth muscle contraction,1/132,0.0065999206698993,0.009453940419045,0,0,19868.0,99751.22090491928,PRKCG
10045,KEGG_2019_Human,Retrograde endocannabinoid signaling,1/148,0.007399915061391,0.0101361352247287,0,0,19852.0,97399.60470052566,PRKCG
10046,KEGG_2019_Human,mTOR signaling pathway,1/152,0.0075999137114971,0.0101361352247287,0,0,19848.0,96850.665715497,PRKCG
10047,KEGG_2019_Human,Oxytocin signaling pathway,1/153,0.0076499133771537,0.0101361352247287,0,0,19847.0,96715.6407630817,PRKCG
10048,KEGG_2019_Human,Wnt signaling pathway,1/158,0.0078999117225733,0.0102120810072289,0,0,19842.0,96053.2110949472,PRKCG
10049,KEGG_2019_Human,Hepatitis B,1/163,0.0081499100978668,0.0102844103615938,0,0,19837.0,95410.9786681514,PRKCG
10050,KEGG_2019_Human,Hepatocellular carcinoma,1/168,0.0083999085011095,0.0103533755943908,0,0,19832.0,94787.72752807094,PRKCG
10051,KEGG_2019_Human,Calcium signaling pathway,1/188,0.009399902370135,0.0113226096731172,0,0,19812.0,92463.712994847,PRKCG
10052,KEGG_2019_Human,Focal adhesion,1/199,0.0099498991610159,0.0115792309815944,0,0,19801.0,91286.4288690606,PRKCG
10053,KEGG_2019_Human,Proteoglycans in cancer,1/201,0.0100498985877989,0.0115792309815944,0,0,19799.0,91079.21596609056,PRKCG
10054,KEGG_2019_Human,Rap1 signaling pathway,1/206,0.010299897173561,0.0116147776638028,0,0,19794.0,90569.849337325,PRKCG
10055,KEGG_2019_Human,Human immunodeficiency virus 1 infection,1/212,0.0105998955026255,0.011704051284149,0,0,19788.0,89974.27756224656,PRKCG
10056,KEGG_2019_Human,Human cytomegalovirus infection,1/225,0.0112498919790339,0.0121682505079346,0,0,19775.0,88738.27077557483,PRKCG
10057,KEGG_2019_Human,Ras signaling pathway,1/232,0.0115998901349604,0.012295883543058,0,0,19768.0,88101.22480150245,PRKCG
10058,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0152373716452639,0,0,19705.0,83086.53988020132,PRKCG
10059,KEGG_2019_Human,MicroRNAs in cancer,1/299,0.0149498740670514,0.0152373716452639,0,0,19701.0,82804.33538735632,PRKCG
10060,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,PRKCG
10061,KEGG_2019_Human,Nicotine addiction,1/40,0.0019999631680592,0.0068249053608048,0,0,19960.0,124043.94523066044,GABRA4
10062,KEGG_2019_Human,Taste transduction,1/83,0.0041499404726918,0.0068249053608048,0,0,19917.0,109237.99888847338,GABRA4
10063,KEGG_2019_Human,GABAergic synapse,1/89,0.0044499377838098,0.0068249053608048,0,0,19911.0,107815.380281759,GABRA4
10064,KEGG_2019_Human,Morphine addiction,1/91,0.0045499369072032,0.0068249053608048,0,0,19909.0,107362.10783923086,GABRA4
10065,KEGG_2019_Human,Retrograde endocannabinoid signaling,1/148,0.007399915061391,0.0088798980736692,0,0,19852.0,97399.60470052566,GABRA4
10066,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,GABRA4
10067,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR2T12
10068,KEGG_2019_Human,Dopaminergic synapse,1/131,0.0065499210316603,0.0141331940035007,0,0,19869.0,99907.33811343512,DRD5
10069,KEGG_2019_Human,Calcium signaling pathway,1/188,0.009399902370135,0.0141331940035007,0,0,19812.0,92463.712994847,DRD5
10070,KEGG_2019_Human,cAMP signaling pathway,1/212,0.0105998955026255,0.0141331940035007,0,0,19788.0,89974.27756224656,DRD5
10071,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,DRD5
10072,KEGG_2019_Human,Endocytosis,1/244,0.0121998870519305,0.0121998870519305,0,0,19756.0,87051.4275316661,PSD2
10073,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR2G2
10074,KEGG_2019_Human,Hematopoietic cell lineage,1/97,0.0048499343304706,0.0096998686609413,0,0,19903.0,106058.9096435903,FCER2
10075,KEGG_2019_Human,Epstein-Barr virus infection,1/201,0.0100498985877989,0.0100498985877989,0,0,19799.0,91079.21596609056,FCER2
10076,KEGG_2019_Human,Calcium signaling pathway,1/188,0.009399902370135,0.0168998658265596,0,0,19812.0,92463.712994847,NTSR1
10077,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,NTSR1
10078,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR5AS1
10079,KEGG_2019_Human,RNA transport,1/165,0.0082499094553477,0.0082499094553477,0,0,19835.0,95159.46482222488,NUP54
10080,KEGG_2019_Human,Graft-versus-host disease,1/41,0.0020499625466866,0.0057749148821253,0,0,19959.0,123544.88783416104,KLRC1
10081,KEGG_2019_Human,Antigen processing and presentation,1/77,0.0038499432547502,0.0057749148821253,0,0,19923.0,110765.8407373636,KLRC1
10082,KEGG_2019_Human,Natural killer cell mediated cytotoxicity,1/131,0.0065499210316603,0.0065499210316603,0,0,19869.0,99907.33811343512,KLRC1
10083,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,POU2F2
10084,KEGG_2019_Human,Pantothenate and CoA biosynthesis,1/19,0.00094997806231055,0.0030999381313408,0,0,19981.0,139049.2109571672,DPYD
10085,KEGG_2019_Human,beta-Alanine metabolism,1/31,0.0015499690656704,0.0030999381313408,0,0,19969.0,129189.85098816035,DPYD
10086,KEGG_2019_Human,Pyrimidine metabolism,1/57,0.002849953326298,0.0037999377683973,0,0,19943.0,116875.00742975442,DPYD
10087,KEGG_2019_Human,Drug metabolism,1/108,0.0053999298011749,0.0053999298011749,0,0,19892.0,103863.47861844616,DPYD
10088,KEGG_2019_Human,Complement and coagulation cascades,1/79,0.0039499423167337,0.0152855642162954,0,0,19921.0,110243.89578070649,F2R
10089,KEGG_2019_Human,Platelet activation,1/124,0.0061999236097501,0.0152855642162954,0,0,19876.0,101034.04709010696,F2R
10090,KEGG_2019_Human,Phospholipase D signaling pathway,1/148,0.007399915061391,0.0152855642162954,0,0,19852.0,97399.60470052566,F2R
10091,KEGG_2019_Human,Calcium signaling pathway,1/188,0.009399902370135,0.0152855642162954,0,0,19812.0,92463.712994847,F2R
10092,KEGG_2019_Human,Rap1 signaling pathway,1/206,0.010299897173561,0.0152855642162954,0,0,19794.0,90569.849337325,F2R
10093,KEGG_2019_Human,cAMP signaling pathway,1/212,0.0105998955026255,0.0152855642162954,0,0,19788.0,89974.27756224656,F2R
10094,KEGG_2019_Human,Regulation of actin cytoskeleton,1/214,0.0106998949514067,0.0152855642162954,0,0,19786.0,89779.39753374986,F2R
10095,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0196665140459632,0,0,19662.0,80229.79996326564,F2R
10096,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0196665140459632,0,0,19646.0,79255.8617626126,F2R
10097,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,F2R
10098,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,NPY4R
10099,KEGG_2019_Human,Bile secretion,1/72,0.0035999456502131,0.0099686346197764,0,0,19928.0,112131.59838572376,SLC9A1
10100,KEGG_2019_Human,Gastric acid secretion,1/75,0.0037499442041125,0.0099686346197764,0,0,19925.0,111301.33528642564,SLC9A1
10101,KEGG_2019_Human,Cardiac muscle contraction,1/78,0.0038999427840466,0.0099686346197764,0,0,19922.0,110503.2180492851,SLC9A1
10102,KEGG_2019_Human,Salivary secretion,1/90,0.0044999373439762,0.0099686346197764,0,0,19910.0,107587.50385474482,SLC9A1
10103,KEGG_2019_Human,Pancreatic secretion,1/98,0.0048999339081079,0.0099686346197764,0,0,19902.0,105849.45495286948,SLC9A1
10104,KEGG_2019_Human,Thyroid hormone signaling pathway,1/116,0.0057999266512085,0.0099686346197764,0,0,19884.0,102400.8105961506,SLC9A1
10105,KEGG_2019_Human,Apelin signaling pathway,1/137,0.0068499188797651,0.0099686346197764,0,0,19863.0,98987.62735269018,SLC9A1
10106,KEGG_2019_Human,Adrenergic signaling in cardiomyocytes,1/145,0.0072499160871101,0.0099686346197764,0,0,19855.0,97820.92670675044,SLC9A1
10107,KEGG_2019_Human,Proteoglycans in cancer,1/201,0.0100498985877989,0.0106998949514067,0,0,19799.0,91079.21596609056,SLC9A1
10108,KEGG_2019_Human,cAMP signaling pathway,1/212,0.0105998955026255,0.0106998949514067,0,0,19788.0,89974.27756224656,SLC9A1
10109,KEGG_2019_Human,Regulation of actin cytoskeleton,1/214,0.0106998949514067,0.0106998949514067,0,0,19786.0,89779.39753374986,SLC9A1
10110,KEGG_2019_Human,Taste transduction,1/83,0.0041499404726918,0.0124498214180756,0,0,19917.0,109237.99888847338,P2RX2
10111,KEGG_2019_Human,Calcium signaling pathway,1/188,0.009399902370135,0.0140998535552025,0,0,19812.0,92463.712994847,P2RX2
10112,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,P2RX2
10113,KEGG_2019_Human,Human immunodeficiency virus 1 infection,1/212,0.0105998955026255,0.0105998955026255,0,0,19788.0,89974.27756224656,DCAF1
10114,KEGG_2019_Human,Cell cycle,1/124,0.0061999236097501,0.0061999236097501,0,0,19876.0,101034.04709010696,TTK
10115,KEGG_2019_Human,Neurotrophin signaling pathway,1/119,0.0059499254985137,0.0176998626413668,0,0,19881.0,101877.73080211312,NTF3
10116,KEGG_2019_Human,Ras signaling pathway,1/232,0.0115998901349604,0.0176998626413668,0,0,19768.0,88101.22480150245,NTF3
10117,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0176998626413668,0,0,19705.0,83086.53988020132,NTF3
10118,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0176998626413668,0,0,19646.0,79255.8617626126,NTF3
10119,KEGG_2019_Human,Systemic lupus erythematosus,1/133,0.0066499203093911,0.0092999029651357,0,0,19867.0,99596.2591544721,ELANE
10120,KEGG_2019_Human,Transcriptional misregulation in cancer,1/186,0.0092999029651357,0.0092999029651357,0,0,19814.0,92684.96451050608,ELANE
10121,KEGG_2019_Human,Proximal tubule bicarbonate reclamation,1/23,0.0011499748819949,0.0062999150247102,0,0,19977.0,135204.63922267244,ATP1B1
10122,KEGG_2019_Human,Aldosterone-regulated sodium reabsorption,1/37,0.0018499650702878,0.0062999150247102,0,0,19963.0,125618.9446446357,ATP1B1
10123,KEGG_2019_Human,Carbohydrate digestion and absorption,1/44,0.0021999607179423,0.0062999150247102,0,0,19956.0,122117.06559109331,ATP1B1
10124,KEGG_2019_Human,Endocrine and other factor-regulated calcium reabsorption,1/48,0.0023999583567988,0.0062999150247102,0,0,19952.0,120356.5272753826,ATP1B1
10125,KEGG_2019_Human,Mineral absorption,1/51,0.0025499566390179,0.0062999150247102,0,0,19949.0,119129.0228601236,ATP1B1
10126,KEGG_2019_Human,Bile secretion,1/72,0.0035999456502131,0.0062999150247102,0,0,19928.0,112131.59838572376,ATP1B1
10127,KEGG_2019_Human,Thyroid hormone synthesis,1/74,0.0036999446830449,0.0062999150247102,0,0,19926.0,111574.38983110404,ATP1B1
10128,KEGG_2019_Human,Gastric acid secretion,1/75,0.0037499442041125,0.0062999150247102,0,0,19925.0,111301.33528642564,ATP1B1
10129,KEGG_2019_Human,Cardiac muscle contraction,1/78,0.0038999427840466,0.0062999150247102,0,0,19922.0,110503.2180492851,ATP1B1
10130,KEGG_2019_Human,Insulin secretion,1/86,0.0042999391173866,0.0062999150247102,0,0,19914.0,108514.46102290176,ATP1B1
10131,KEGG_2019_Human,Salivary secretion,1/90,0.0044999373439762,0.0062999150247102,0,0,19910.0,107587.50385474482,ATP1B1
10132,KEGG_2019_Human,Protein digestion and absorption,1/90,0.0044999373439762,0.0062999150247102,0,0,19910.0,107587.50385474482,ATP1B1
10133,KEGG_2019_Human,Pancreatic secretion,1/98,0.0048999339081079,0.0062999150247102,0,0,19902.0,105849.45495286948,ATP1B1
10134,KEGG_2019_Human,Aldosterone synthesis and secretion,1/98,0.0048999339081079,0.0062999150247102,0,0,19902.0,105849.45495286948,ATP1B1
10135,KEGG_2019_Human,Thyroid hormone signaling pathway,1/116,0.0057999266512085,0.0069599119814502,0,0,19884.0,102400.8105961506,ATP1B1
10136,KEGG_2019_Human,Adrenergic signaling in cardiomyocytes,1/145,0.0072499160871101,0.0081561555979989,0,0,19855.0,97820.92670675044,ATP1B1
10137,KEGG_2019_Human,cGMP-PKG signaling pathway,1/166,0.0082999091363732,0.0087881390855717,0,0,19834.0,95034.82345515196,ATP1B1
10138,KEGG_2019_Human,cAMP signaling pathway,1/212,0.0105998955026255,0.0105998955026255,0,0,19788.0,89974.27756224656,ATP1B1
10139,KEGG_2019_Human,Mucin type O-glycan biosynthesis,1/31,0.0015499690656704,0.0015499690656704,0,0,19969.0,129189.85098816035,GALNT8
10140,KEGG_2019_Human,Glycosaminoglycan degradation,1/19,0.00094997806231055,0.00094997806231055,0,0,19981.0,139049.2109571672,SPAM1
10141,KEGG_2019_Human,Sphingolipid metabolism,1/47,0.0023499589392381,0.0046999178784763,0,0,19953.0,120782.64067395544,SPTLC3
10142,KEGG_2019_Human,Sphingolipid signaling pathway,1/119,0.0059499254985137,0.0059499254985137,0,0,19881.0,101877.73080211312,SPTLC3
10143,KEGG_2019_Human,Starch and sucrose metabolism,1/36,0.0017999657178272,0.0032999410769135,0,0,19964.0,126172.23364250171,AMY2A
10144,KEGG_2019_Human,Carbohydrate digestion and absorption,1/44,0.0021999607179423,0.0032999410769135,0,0,19956.0,122117.06559109331,AMY2A
10145,KEGG_2019_Human,Pancreatic secretion,1/98,0.0048999339081079,0.0048999339081079,0,0,19902.0,105849.45495286948,AMY2A
10146,KEGG_2019_Human,Nicotine addiction,1/40,0.0019999631680592,0.0081598742918854,0,0,19960.0,124043.94523066044,GRIN2C
10147,KEGG_2019_Human,Cocaine addiction,1/49,0.0024499577795033,0.0081598742918854,0,0,19951.0,119939.1172087114,GRIN2C
10148,KEGG_2019_Human,Amyotrophic lateral sclerosis (ALS),1/51,0.0025499566390179,0.0081598742918854,0,0,19949.0,119129.0228601236,GRIN2C
10149,KEGG_2019_Human,Long-term potentiation,1/67,0.0033499481224912,0.0081598742918854,0,0,19933.0,113594.38808369274,GRIN2C
10150,KEGG_2019_Human,Amphetamine addiction,1/68,0.0033999476216189,0.0081598742918854,0,0,19932.0,113293.39338050144,GRIN2C
10151,KEGG_2019_Human,Circadian entrainment,1/97,0.0048499343304706,0.0096998686609413,0,0,19903.0,106058.9096435903,GRIN2C
10152,KEGG_2019_Human,Glutamatergic synapse,1/114,0.005699927427839,0.0097713041620097,0,0,19886.0,102756.96431429044,GRIN2C
10153,KEGG_2019_Human,Alzheimer disease,1/171,0.0085499075557634,0.011279882844162,0,0,19829.0,94422.42241345016,GRIN2C
10154,KEGG_2019_Human,Alcoholism,1/180,0.0089999047745351,0.011279882844162,0,0,19820.0,93362.92821536642,GRIN2C
10155,KEGG_2019_Human,Calcium signaling pathway,1/188,0.009399902370135,0.011279882844162,0,0,19812.0,92463.712994847,GRIN2C
10156,KEGG_2019_Human,cAMP signaling pathway,1/212,0.0105998955026255,0.0115635223665006,0,0,19788.0,89974.27756224656,GRIN2C
10157,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,GRIN2C
10158,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR4K14
10159,KEGG_2019_Human,Pyrimidine metabolism,1/57,0.002849953326298,0.002849953326298,0,0,19943.0,116875.00742975442,DTYMK
10160,KEGG_2019_Human,Steroid hormone biosynthesis,1/60,0.002999951725986,0.0051249261622737,0,0,19940.0,115834.63209072244,CYP3A5
10161,KEGG_2019_Human,Retinol metabolism,1/67,0.0033499481224912,0.0051249261622737,0,0,19933.0,113594.38808369274,CYP3A5
10162,KEGG_2019_Human,Metabolism of xenobiotics by cytochrome P450,1/74,0.0036999446830449,0.0051249261622737,0,0,19926.0,111574.38983110404,CYP3A5
10163,KEGG_2019_Human,Chemical carcinogenesis,1/82,0.004099940929819,0.0051249261622737,0,0,19918.0,109484.9180722932,CYP3A5
10164,KEGG_2019_Human,Drug metabolism,1/108,0.0053999298011749,0.0053999298011749,0,0,19892.0,103863.47861844616,CYP3A5
10165,KEGG_2019_Human,Th1 and Th2 cell differentiation,1/92,0.0045999364719865,0.0091998729439731,0,0,19908.0,107139.13814408927,RUNX3
10166,KEGG_2019_Human,Epstein-Barr virus infection,1/201,0.0100498985877989,0.0100498985877989,0,0,19799.0,91079.21596609056,RUNX3
10167,KEGG_2019_Human,Fructose and mannose metabolism,1/33,0.0016499677032113,0.0023999583567988,0,0,19967.0,127928.56031580272,GMPPA
10168,KEGG_2019_Human,Amino sugar and nucleotide sugar metabolism,1/48,0.0023999583567988,0.0023999583567988,0,0,19952.0,120356.5272753826,GMPPA
10169,KEGG_2019_Human,Maturity onset diabetes of the young,1/26,0.0012999726251831,0.0012999726251831,0,0,19974.0,132735.46073187632,RFX6
10170,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0147498749536506,0,0,19705.0,83086.53988020132,MAP4K1
10171,KEGG_2019_Human,Folate biosynthesis,1/26,0.0012999726251831,0.002124958792379,0,0,19974.0,132735.46073187632,AKR1B10
10172,KEGG_2019_Human,Galactose metabolism,1/31,0.0015499690656704,0.002124958792379,0,0,19969.0,129189.85098816035,AKR1B10
10173,KEGG_2019_Human,Fructose and mannose metabolism,1/33,0.0016499677032113,0.002124958792379,0,0,19967.0,127928.56031580272,AKR1B10
10174,KEGG_2019_Human,Pentose and glucuronate interconversions,1/34,0.0016999670339032,0.002124958792379,0,0,19966.0,127326.1054203148,AKR1B10
10175,KEGG_2019_Human,Glycerolipid metabolism,1/61,0.0030499512001654,0.0030499512001654,0,0,19939.0,115499.24335773686,AKR1B10
10176,KEGG_2019_Human,Protein processing in endoplasmic reticulum,1/165,0.0082499094553477,0.0082499094553477,0,0,19835.0,95159.46482222488,HYOU1
10177,KEGG_2019_Human,Thyroid hormone signaling pathway,1/116,0.0057999266512085,0.0097998872023976,0,0,19884.0,102400.8105961506,NCOA1
10178,KEGG_2019_Human,Estrogen signaling pathway,1/137,0.0068499188797651,0.0097998872023976,0,0,19863.0,98987.62735269018,NCOA1
10179,KEGG_2019_Human,Breast cancer,1/147,0.0073499154017982,0.0097998872023976,0,0,19853.0,97539.10874372096,NCOA1
10180,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,NCOA1
10181,KEGG_2019_Human,Ether lipid metabolism,1/47,0.0023499589392381,0.0046999178784763,0,0,19953.0,120782.64067395544,LPCAT1
10182,KEGG_2019_Human,Glycerophospholipid metabolism,1/97,0.0048499343304706,0.0048499343304706,0,0,19903.0,106058.9096435903,LPCAT1
10183,KEGG_2019_Human,Cortisol synthesis and secretion,1/65,0.003249949134407,0.0064998982688141,0,0,19935.0,114209.92613860144,MRAP
10184,KEGG_2019_Human,Cushing syndrome,1/155,0.0077499127120574,0.0077499127120574,0,0,19845.0,96448.16254952336,MRAP
10185,KEGG_2019_Human,Mitophagy,1/65,0.003249949134407,0.003249949134407,0,0,19935.0,114209.92613860144,RHOT1
10186,KEGG_2019_Human,Terpenoid backbone biosynthesis,1/22,0.0010999756574123,0.0010999756574123,0,0,19978.0,136099.47030191717,GGPS1
10187,KEGG_2019_Human,p53 signaling pathway,1/72,0.0035999456502131,0.0071998913004262,0,0,19928.0,112131.59838572376,SERPINB5
10188,KEGG_2019_Human,MicroRNAs in cancer,1/299,0.0149498740670514,0.0149498740670514,0,0,19701.0,82804.33538735632,SERPINB5
10189,KEGG_2019_Human,Malaria,1/49,0.0024499577795033,0.0143997826008524,0,0,19951.0,119939.1172087114,HGF
10190,KEGG_2019_Human,Renal cell carcinoma,1/69,0.003449947123837,0.0143997826008524,0,0,19931.0,112996.7391397682,HGF
10191,KEGG_2019_Human,Melanoma,1/72,0.0035999456502131,0.0143997826008524,0,0,19928.0,112131.59838572376,HGF
10192,KEGG_2019_Human,Gastric cancer,1/149,0.0074499147221605,0.0154498457603415,0,0,19851.0,97261.02051561224,HGF
10193,KEGG_2019_Human,Hepatocellular carcinoma,1/168,0.0083999085011095,0.0154498457603415,0,0,19832.0,94787.72752807094,HGF
10194,KEGG_2019_Human,Focal adhesion,1/199,0.0099498991610159,0.0154498457603415,0,0,19801.0,91286.4288690606,HGF
10195,KEGG_2019_Human,Proteoglycans in cancer,1/201,0.0100498985877989,0.0154498457603415,0,0,19799.0,91079.21596609056,HGF
10196,KEGG_2019_Human,Rap1 signaling pathway,1/206,0.010299897173561,0.0154498457603415,0,0,19794.0,90569.849337325,HGF
10197,KEGG_2019_Human,Ras signaling pathway,1/232,0.0115998901349604,0.0154665201799472,0,0,19768.0,88101.22480150245,HGF
10198,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0176998499443808,0,0,19705.0,83086.53988020132,HGF
10199,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0193089410633093,0,0,19646.0,79255.8617626126,HGF
10200,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,HGF
10201,KEGG_2019_Human,mTOR signaling pathway,1/152,0.0075999137114971,0.0075999137114971,0,0,19848.0,96850.665715497,NPRL3
10202,KEGG_2019_Human,Arginine biosynthesis,1/21,0.0010499764455398,0.0017499663721595,0,0,19979.0,137035.71221916509,GPT
10203,KEGG_2019_Human,"Alanine, aspartate and glutamate metabolism",1/35,0.0017499663721595,0.0017499663721595,0,0,19965.0,126740.98858805298,GPT
10204,KEGG_2019_Human,Purine metabolism,1/129,0.006449921761047,0.006449921761047,0,0,19871.0,100223.109907462,HDDC3
10205,KEGG_2019_Human,Nicotine addiction,1/40,0.0019999631680592,0.0105713072305585,0,0,19960.0,124043.94523066044,GRIA3
10206,KEGG_2019_Human,Long-term depression,1/60,0.002999951725986,0.0105713072305585,0,0,19940.0,115834.63209072244,GRIA3
10207,KEGG_2019_Human,Amphetamine addiction,1/68,0.0033999476216189,0.0105713072305585,0,0,19932.0,113293.39338050144,GRIA3
10208,KEGG_2019_Human,Circadian entrainment,1/97,0.0048499343304706,0.0105713072305585,0,0,19903.0,106058.9096435903,GRIA3
10209,KEGG_2019_Human,Glutamatergic synapse,1/114,0.005699927427839,0.0105713072305585,0,0,19886.0,102756.96431429044,GRIA3
10210,KEGG_2019_Human,Dopaminergic synapse,1/131,0.0065499210316603,0.0105713072305585,0,0,19869.0,99907.33811343512,GRIA3
10211,KEGG_2019_Human,Retrograde endocannabinoid signaling,1/148,0.007399915061391,0.0105713072305585,0,0,19852.0,97399.60470052566,GRIA3
10212,KEGG_2019_Human,Transcriptional misregulation in cancer,1/186,0.0092999029651357,0.0116248787064197,0,0,19814.0,92684.96451050608,GRIA3
10213,KEGG_2019_Human,cAMP signaling pathway,1/212,0.0105998955026255,0.0117776616695839,0,0,19788.0,89974.27756224656,GRIA3
10214,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,GRIA3
10215,KEGG_2019_Human,Homologous recombination,1/41,0.0020499625466866,0.0020499625466866,0,0,19959.0,123544.88783416104,BARD1
10216,KEGG_2019_Human,Oocyte meiosis,1/125,0.0062499232373748,0.0062499232373748,0,0,19875.0,100869.32368441945,STAG3
10217,KEGG_2019_Human,Ether lipid metabolism,1/47,0.0023499589392381,0.0023499589392381,0,0,19953.0,120782.64067395544,ENPP2
10218,KEGG_2019_Human,Arrhythmogenic right ventricular cardiomyopathy (ARVC),1/72,0.0035999456502131,0.0090998738144064,0,0,19928.0,112131.59838572376,ITGA10
10219,KEGG_2019_Human,ECM-receptor interaction,1/82,0.004099940929819,0.0090998738144064,0,0,19918.0,109484.9180722932,ITGA10
10220,KEGG_2019_Human,Hypertrophic cardiomyopathy (HCM),1/85,0.004249939567045,0.0090998738144064,0,0,19915.0,108752.83801948265,ITGA10
10221,KEGG_2019_Human,Dilated cardiomyopathy (DCM),1/91,0.0045499369072032,0.0090998738144064,0,0,19909.0,107362.10783923086,ITGA10
10222,KEGG_2019_Human,Focal adhesion,1/199,0.0099498991610159,0.0142665266018757,0,0,19801.0,91286.4288690606,ITGA10
10223,KEGG_2019_Human,Regulation of actin cytoskeleton,1/214,0.0106998949514067,0.0142665266018757,0,0,19786.0,89779.39753374986,ITGA10
10224,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0176998626413668,0,0,19670.0,80733.60565076157,ITGA10
10225,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0176998626413668,0,0,19646.0,79255.8617626126,ITGA10
10226,KEGG_2019_Human,Mismatch repair,1/23,0.0011499748819949,0.0026999549628563,0,0,19977.0,135204.63922267244,RPA4
10227,KEGG_2019_Human,DNA replication,1/36,0.0017999657178272,0.0026999549628563,0,0,19964.0,126172.23364250171,RPA4
10228,KEGG_2019_Human,Homologous recombination,1/41,0.0020499625466866,0.0026999549628563,0,0,19959.0,123544.88783416104,RPA4
10229,KEGG_2019_Human,Nucleotide excision repair,1/47,0.0023499589392381,0.0026999549628563,0,0,19953.0,120782.64067395544,RPA4
10230,KEGG_2019_Human,Fanconi anemia pathway,1/54,0.0026999549628563,0.0026999549628563,0,0,19946.0,117971.01964061816,RPA4
10231,KEGG_2019_Human,ABC transporters,1/45,0.0022499601197094,0.0035999456502131,0,0,19955.0,121662.49782449217,ABCB11
10232,KEGG_2019_Human,Cholesterol metabolism,1/50,0.0024999572069037,0.0035999456502131,0,0,19950.0,119530.05920663515,ABCB11
10233,KEGG_2019_Human,Bile secretion,1/72,0.0035999456502131,0.0035999456502131,0,0,19928.0,112131.59838572376,ABCB11
10234,KEGG_2019_Human,Arrhythmogenic right ventricular cardiomyopathy (ARVC),1/72,0.0035999456502131,0.0071998913004262,0,0,19928.0,112131.59838572376,CDH2
10235,KEGG_2019_Human,Cell adhesion molecules (CAMs),1/145,0.0072499160871101,0.0072499160871101,0,0,19855.0,97820.92670675044,CDH2
10236,KEGG_2019_Human,Retinol metabolism,1/67,0.0033499481224912,0.0033499481224912,0,0,19933.0,113594.38808369274,CYP26C1
10237,KEGG_2019_Human,Renin-angiotensin system,1/23,0.0011499748819949,0.0057498744099749,0,0,19977.0,135204.63922267244,CTSG
10238,KEGG_2019_Human,Amoebiasis,1/96,0.0047999347538706,0.0083124003867389,0,0,19904.0,106270.50039849174,CTSG
10239,KEGG_2019_Human,Lysosome,1/123,0.0061499239842961,0.0083124003867389,0,0,19877.0,101200.07933676826,CTSG
10240,KEGG_2019_Human,Systemic lupus erythematosus,1/133,0.0066499203093911,0.0083124003867389,0,0,19867.0,99596.2591544721,CTSG
10241,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,CTSG
10242,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF891
10243,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF233
10244,KEGG_2019_Human,Legionellosis,1/55,0.0027499544131125,0.0051999314202997,0,0,19945.0,117599.1294878737,TLR5
10245,KEGG_2019_Human,Pathogenic Escherichia coli infection,1/55,0.0027499544131125,0.0051999314202997,0,0,19945.0,117599.1294878737,TLR5
10246,KEGG_2019_Human,Inflammatory bowel disease (IBD),1/65,0.003249949134407,0.0051999314202997,0,0,19935.0,114209.92613860144,TLR5
10247,KEGG_2019_Human,Salmonella infection,1/86,0.0042999391173866,0.0051999314202997,0,0,19914.0,108514.46102290176,TLR5
10248,KEGG_2019_Human,Toll-like receptor signaling pathway,1/104,0.0051999314202997,0.0051999314202997,0,0,19896.0,104635.24941415618,TLR5
10249,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR52B2
10250,KEGG_2019_Human,Primary immunodeficiency,1/37,0.0018499650702878,0.0023999583567988,0,0,19963.0,125618.9446446357,AICDA
10251,KEGG_2019_Human,Intestinal immune network for IgA production,1/48,0.0023999583567988,0.0023999583567988,0,0,19952.0,120356.5272753826,AICDA
10252,KEGG_2019_Human,Histidine metabolism,1/23,0.0011499748819949,0.0011499748819949,0,0,19977.0,135204.63922267244,UROC1
10253,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF765
10254,KEGG_2019_Human,Mineral absorption,1/51,0.0025499566390179,0.0025499566390179,0,0,19949.0,119129.0228601236,TRPM6
10255,KEGG_2019_Human,Thyroid hormone signaling pathway,1/116,0.0057999266512085,0.0057999266512085,0,0,19884.0,102400.8105961506,DIO1
10256,KEGG_2019_Human,Lysosome,1/123,0.0061499239842961,0.0061499239842961,0,0,19877.0,101200.07933676826,GNPTG
10257,KEGG_2019_Human,Phototransduction,1/28,0.0013999711732997,0.0027999423465995,0,0,19972.0,131242.0761597353,PDE6B
10258,KEGG_2019_Human,Purine metabolism,1/129,0.006449921761047,0.006449921761047,0,0,19871.0,100223.109907462,PDE6B
10259,KEGG_2019_Human,Osteoclast differentiation,1/127,0.0063499224962247,0.0063499224962247,0,0,19873.0,100543.72072014232,LILRA6
10260,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR51M1
10261,KEGG_2019_Human,Complement and coagulation cascades,1/79,0.0039499423167337,0.0039499423167337,0,0,19921.0,110243.89578070649,F9
10262,KEGG_2019_Human,Salivary secretion,1/90,0.0044999373439762,0.0044999373439762,0,0,19910.0,107587.50385474482,BEST2
10263,KEGG_2019_Human,Vascular smooth muscle contraction,1/132,0.0065999206698993,0.0131998413397987,0,0,19868.0,99751.22090491928,CALCB
10264,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,CALCB
10265,KEGG_2019_Human,Pathogenic Escherichia coli infection,1/55,0.0027499544131125,0.0065999073394233,0,0,19945.0,117599.1294878737,TUBB1
10266,KEGG_2019_Human,Gap junction,1/88,0.0043999382262822,0.0065999073394233,0,0,19912.0,108045.79305232369,TUBB1
10267,KEGG_2019_Human,Phagosome,1/152,0.0075999137114971,0.0075999137114971,0,0,19848.0,96850.665715497,TUBB1
10268,KEGG_2019_Human,Glycerolipid metabolism,1/61,0.0030499512001654,0.0030499512001654,0,0,19939.0,115499.24335773686,PNPLA3
10269,KEGG_2019_Human,Retinol metabolism,1/67,0.0033499481224912,0.0033499481224912,0,0,19933.0,113594.38808369274,BCO1
10270,KEGG_2019_Human,Axon guidance,1/181,0.0090499044707863,0.0090499044707863,0,0,19819.0,93248.41634586031,SEMA3E
10271,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,OPRK1
10272,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR5L2
10273,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR14C36
10274,KEGG_2019_Human,RNA degradation,1/79,0.0039499423167337,0.0068249053608048,0,0,19921.0,110243.89578070649,PABPC5
10275,KEGG_2019_Human,mRNA surveillance pathway,1/91,0.0045499369072032,0.0068249053608048,0,0,19909.0,107362.10783923086,PABPC5
10276,KEGG_2019_Human,RNA transport,1/165,0.0082499094553477,0.0082499094553477,0,0,19835.0,95159.46482222488,PABPC5
10277,KEGG_2019_Human,Mucin type O-glycan biosynthesis,1/31,0.0015499690656704,0.0015499690656704,0,0,19969.0,129189.85098816035,GALNT17
10278,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR5M10
10279,KEGG_2019_Human,Inflammatory bowel disease (IBD),1/65,0.003249949134407,0.0053499302026925,0,0,19935.0,114209.92613860144,GATA3
10280,KEGG_2019_Human,Th1 and Th2 cell differentiation,1/92,0.0045999364719865,0.0053499302026925,0,0,19908.0,107139.13814408927,GATA3
10281,KEGG_2019_Human,"Parathyroid hormone synthesis, secretion and action",1/106,0.0052999306076525,0.0053499302026925,0,0,19894.0,104245.78450366124,GATA3
10282,KEGG_2019_Human,Th17 cell differentiation,1/107,0.0053499302026925,0.0053499302026925,0,0,19893.0,104053.753408911,GATA3
10283,KEGG_2019_Human,Mitophagy,1/65,0.003249949134407,0.003249949134407,0,0,19935.0,114209.92613860144,TBC1D17
10284,KEGG_2019_Human,Mineral absorption,1/51,0.0025499566390179,0.0025499566390179,0,0,19949.0,119129.0228601236,SLC39A4
10285,KEGG_2019_Human,Axon guidance,1/181,0.0090499044707863,0.0090499044707863,0,0,19819.0,93248.41634586031,ROBO3
10286,KEGG_2019_Human,Huntington disease,1/193,0.0096499008972596,0.0096499008972596,0,0,19807.0,91920.47679471428,HIP1
10287,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,CHRNA9
10288,KEGG_2019_Human,Taste transduction,1/83,0.0041499404726918,0.0041499404726918,0,0,19917.0,109237.99888847338,SCN2A
10289,KEGG_2019_Human,Selenocompound metabolism,1/17,0.0008499797390404818,0.0016999594780809,0,0,19983.0,141285.76583697114,PSTK
10290,KEGG_2019_Human,Aminoacyl-tRNA biosynthesis,1/66,0.003299948626608,0.003299948626608,0,0,19934.0,113899.85357353876,PSTK
10291,KEGG_2019_Human,Hepatocellular carcinoma,1/168,0.0083999085011095,0.0115498903940656,0,0,19832.0,94787.72752807094,SMARCA2
10292,KEGG_2019_Human,Thermogenesis,1/231,0.0115498903940656,0.0115498903940656,0,0,19769.0,88191.07730937863,SMARCA2
10293,KEGG_2019_Human,Mineral absorption,1/51,0.0025499566390179,0.0025499566390179,0,0,19949.0,119129.0228601236,CLCN2
10294,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR5A1
10295,KEGG_2019_Human,Wnt signaling pathway,1/158,0.0078999117225733,0.0078999117225733,0,0,19842.0,96053.2110949472,LGR4
10296,KEGG_2019_Human,N-Glycan biosynthesis,1/50,0.0024999572069037,0.0049999144138074,0,0,19950.0,119530.05920663515,DDOST
10297,KEGG_2019_Human,Protein processing in endoplasmic reticulum,1/165,0.0082499094553477,0.0082499094553477,0,0,19835.0,95159.46482222488,DDOST
10298,KEGG_2019_Human,Thyroid hormone signaling pathway,1/116,0.0057999266512085,0.0057999266512085,0,0,19884.0,102400.8105961506,MED12L
10299,KEGG_2019_Human,Relaxin signaling pathway,1/130,0.0064999213952527,0.0129998427905055,0,0,19870.0,100064.62842845908,RXFP4
10300,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,RXFP4
10301,KEGG_2019_Human,Rheumatoid arthritis,1/91,0.0045499369072032,0.0149997992131669,0,0,19909.0,107362.10783923086,TEK
10302,KEGG_2019_Human,HIF-1 signaling pathway,1/100,0.0049999330710556,0.0149997992131669,0,0,19900.0,105436.78197328727,TEK
10303,KEGG_2019_Human,Rap1 signaling pathway,1/206,0.010299897173561,0.0173998352024406,0,0,19794.0,90569.849337325,TEK
10304,KEGG_2019_Human,Ras signaling pathway,1/232,0.0115998901349604,0.0173998352024406,0,0,19768.0,88101.22480150245,TEK
10305,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0176998499443808,0,0,19705.0,83086.53988020132,TEK
10306,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0176998626413668,0,0,19646.0,79255.8617626126,TEK
10307,KEGG_2019_Human,Proteoglycans in cancer,1/201,0.0100498985877989,0.0149498740670514,0,0,19799.0,91079.21596609056,HOXD10
10308,KEGG_2019_Human,MicroRNAs in cancer,1/299,0.0149498740670514,0.0149498740670514,0,0,19701.0,82804.33538735632,HOXD10
10309,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF91
10310,KEGG_2019_Human,Taste transduction,1/83,0.0041499404726918,0.0041499404726918,0,0,19917.0,109237.99888847338,TAS2R16
10311,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR4K5
10312,KEGG_2019_Human,Cholesterol metabolism,1/50,0.0024999572069037,0.0036999446830449,0,0,19950.0,119530.05920663515,PLTP
10313,KEGG_2019_Human,PPAR signaling pathway,1/74,0.0036999446830449,0.0036999446830449,0,0,19926.0,111574.38983110404,PLTP
10314,KEGG_2019_Human,Glyoxylate and dicarboxylate metabolism,1/30,0.0014999697593334,0.0029999395186669,0,0,19970.0,129851.13732048514,HAO1
10315,KEGG_2019_Human,Peroxisome,1/83,0.0041499404726918,0.0041499404726918,0,0,19917.0,109237.99888847338,HAO1
10316,KEGG_2019_Human,Progesterone-mediated oocyte maturation,1/99,0.0049499334884068,0.0062499232373748,0,0,19901.0,105642.09305076736,SPDYE1
10317,KEGG_2019_Human,Oocyte meiosis,1/125,0.0062499232373748,0.0062499232373748,0,0,19875.0,100869.32368441945,SPDYE1
10318,KEGG_2019_Human,Viral myocarditis,1/59,0.0029499522555206,0.0045499369072032,0,0,19941.0,116175.59385530632,SGCD
10319,KEGG_2019_Human,Arrhythmogenic right ventricular cardiomyopathy (ARVC),1/72,0.0035999456502131,0.0045499369072032,0,0,19928.0,112131.59838572376,SGCD
10320,KEGG_2019_Human,Hypertrophic cardiomyopathy (HCM),1/85,0.004249939567045,0.0045499369072032,0,0,19915.0,108752.83801948265,SGCD
10321,KEGG_2019_Human,Dilated cardiomyopathy (DCM),1/91,0.0045499369072032,0.0045499369072032,0,0,19909.0,107362.10783923086,SGCD
10322,KEGG_2019_Human,Estrogen signaling pathway,1/137,0.0068499188797651,0.0068499188797651,0,0,19863.0,98987.62735269018,KRT15
10323,KEGG_2019_Human,Taste transduction,1/83,0.0041499404726918,0.0041499404726918,0,0,19917.0,109237.99888847338,TAS1R1
10324,KEGG_2019_Human,Renin-angiotensin system,1/23,0.0011499748819949,0.0045998995279799,0,0,19977.0,135204.63922267244,ACE
10325,KEGG_2019_Human,Renin secretion,1/69,0.003449947123837,0.0051499318302617,0,0,19931.0,112996.7391397682,ACE
10326,KEGG_2019_Human,Hypertrophic cardiomyopathy (HCM),1/85,0.004249939567045,0.0051499318302617,0,0,19915.0,108752.83801948265,ACE
10327,KEGG_2019_Human,Chagas disease (American trypanosomiasis),1/103,0.0051499318302617,0.0051499318302617,0,0,19897.0,104832.7525292024,ACE
10328,KEGG_2019_Human,Salivary secretion,1/90,0.0044999373439762,0.0044999373439762,0,0,19910.0,107587.50385474482,CST1
10329,KEGG_2019_Human,Morphine addiction,1/91,0.0045499369072032,0.008599895681396,0,0,19909.0,107362.10783923086,PDE4D
10330,KEGG_2019_Human,"Parathyroid hormone synthesis, secretion and action",1/106,0.0052999306076525,0.008599895681396,0,0,19894.0,104245.78450366124,PDE4D
10331,KEGG_2019_Human,Purine metabolism,1/129,0.006449921761047,0.008599895681396,0,0,19871.0,100223.109907462,PDE4D
10332,KEGG_2019_Human,cAMP signaling pathway,1/212,0.0105998955026255,0.0105998955026255,0,0,19788.0,89974.27756224656,PDE4D
10333,KEGG_2019_Human,Viral carcinogenesis,1/201,0.0100498985877989,0.0100498985877989,0,0,19799.0,91079.21596609056,MRPS18B
10334,KEGG_2019_Human,"Alanine, aspartate and glutamate metabolism",1/35,0.0017499663721595,0.0035999375351982,0,0,19965.0,126740.98858805298,GFPT1
10335,KEGG_2019_Human,Amino sugar and nucleotide sugar metabolism,1/48,0.0023999583567988,0.0035999375351982,0,0,19952.0,120356.5272753826,GFPT1
10336,KEGG_2019_Human,Insulin resistance,1/108,0.0053999298011749,0.0053999298011749,0,0,19892.0,103863.47861844616,GFPT1
10337,KEGG_2019_Human,Glycosaminoglycan degradation,1/19,0.00094997806231055,0.0018999561246211,0,0,19981.0,139049.2109571672,HPSE
10338,KEGG_2019_Human,Proteoglycans in cancer,1/201,0.0100498985877989,0.0100498985877989,0,0,19799.0,91079.21596609056,HPSE
10339,KEGG_2019_Human,Endocytosis,1/244,0.0121998870519305,0.0121998870519305,0,0,19756.0,87051.4275316661,SNX4
10340,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR13F1
10341,KEGG_2019_Human,Peroxisome,1/83,0.0041499404726918,0.0041499404726918,0,0,19917.0,109237.99888847338,PEX26
10342,KEGG_2019_Human,Non-alcoholic fatty liver disease (NAFLD),1/149,0.0074499147221605,0.0147498749536506,0,0,19851.0,97261.02051561224,MAP3K11
10343,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0147498749536506,0,0,19705.0,83086.53988020132,MAP3K11
10344,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR10G7
10345,KEGG_2019_Human,RNA transport,1/165,0.0082499094553477,0.0082499094553477,0,0,19835.0,95159.46482222488,EIF3I
10346,KEGG_2019_Human,Leukocyte transendothelial migration,1/112,0.0055999282120529,0.0072499160871101,0,0,19888.0,103119.30984392198,CDH5
10347,KEGG_2019_Human,Fluid shear stress and atherosclerosis,1/139,0.006949918172816,0.0072499160871101,0,0,19861.0,98689.81333375497,CDH5
10348,KEGG_2019_Human,Cell adhesion molecules (CAMs),1/145,0.0072499160871101,0.0072499160871101,0,0,19855.0,97820.92670675044,CDH5
10349,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR4K2
10350,KEGG_2019_Human,Taste transduction,1/83,0.0041499404726918,0.0112998556382303,0,0,19917.0,109237.99888847338,HTR1E
10351,KEGG_2019_Human,Serotonergic synapse,1/113,0.0056499278191151,0.0112998556382303,0,0,19887.0,102937.34947211576,HTR1E
10352,KEGG_2019_Human,cAMP signaling pathway,1/212,0.0105998955026255,0.0141331940035007,0,0,19788.0,89974.27756224656,HTR1E
10353,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,HTR1E
10354,KEGG_2019_Human,ECM-receptor interaction,1/82,0.004099940929819,0.0112998556382303,0,0,19918.0,109484.9180722932,LAMB3
10355,KEGG_2019_Human,Small cell lung cancer,1/93,0.0046499360391879,0.0112998556382303,0,0,19907.0,106918.54242106884,LAMB3
10356,KEGG_2019_Human,Amoebiasis,1/96,0.0047999347538706,0.0112998556382303,0,0,19904.0,106270.50039849174,LAMB3
10357,KEGG_2019_Human,Toxoplasmosis,1/113,0.0056499278191151,0.0112998556382303,0,0,19887.0,102937.34947211576,LAMB3
10358,KEGG_2019_Human,Focal adhesion,1/199,0.0099498991610159,0.0159198386576255,0,0,19801.0,91286.4288690606,LAMB3
10359,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0202284144472764,0,0,19670.0,80733.60565076157,LAMB3
10360,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0202284144472764,0,0,19646.0,79255.8617626126,LAMB3
10361,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,LAMB3
10362,KEGG_2019_Human,ABC transporters,1/45,0.0022499601197094,0.0041499404726918,0,0,19955.0,121662.49782449217,ABCD3
10363,KEGG_2019_Human,Peroxisome,1/83,0.0041499404726918,0.0041499404726918,0,0,19917.0,109237.99888847338,ABCD3
10364,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR2L2
10365,KEGG_2019_Human,Toll-like receptor signaling pathway,1/104,0.0051999314202997,0.0051999314202997,0,0,19896.0,104635.24941415618,TLR8
10366,KEGG_2019_Human,ABC transporters,1/45,0.0022499601197094,0.0022499601197094,0,0,19955.0,121662.49782449217,ABCA10
10367,KEGG_2019_Human,p53 signaling pathway,1/72,0.0035999456502131,0.0035999456502131,0,0,19928.0,112131.59838572376,SIVA1
10368,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,HRH3
10369,KEGG_2019_Human,Influenza A,1/171,0.0085499075557634,0.0085499075557634,0,0,19829.0,94422.42241345016,IVNS1ABP
10370,KEGG_2019_Human,Synaptic vesicle cycle,1/78,0.0038999427840466,0.0042999391173866,0,0,19922.0,110503.2180492851,SNAP25
10371,KEGG_2019_Human,Insulin secretion,1/86,0.0042999391173866,0.0042999391173866,0,0,19914.0,108514.46102290176,SNAP25
10372,KEGG_2019_Human,ECM-receptor interaction,1/82,0.004099940929819,0.0112498433599406,0,0,19918.0,109484.9180722932,COL6A1
10373,KEGG_2019_Human,Protein digestion and absorption,1/90,0.0044999373439762,0.0112498433599406,0,0,19910.0,107587.50385474482,COL6A1
10374,KEGG_2019_Human,Focal adhesion,1/199,0.0099498991610159,0.0165831652683599,0,0,19801.0,91286.4288690606,COL6A1
10375,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0176998626413668,0,0,19670.0,80733.60565076157,COL6A1
10376,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0176998626413668,0,0,19646.0,79255.8617626126,COL6A1
10377,KEGG_2019_Human,Cell adhesion molecules (CAMs),1/145,0.0072499160871101,0.0072499160871101,0,0,19855.0,97820.92670675044,NLGN4X
10378,KEGG_2019_Human,Glycosphingolipid biosynthesis,1/45,0.0022499601197094,0.0022499601197094,0,0,19955.0,121662.49782449217,ST8SIA1
10379,KEGG_2019_Human,Hedgehog signaling pathway,1/47,0.0023499589392381,0.0094498504796483,0,0,19953.0,120782.64067395544,PTCH1
10380,KEGG_2019_Human,Basal cell carcinoma,1/63,0.0031499501598827,0.0094498504796483,0,0,19937.0,114844.46974572667,PTCH1
10381,KEGG_2019_Human,Axon guidance,1/181,0.0090499044707863,0.0127198746031507,0,0,19819.0,93248.41634586031,PTCH1
10382,KEGG_2019_Human,Proteoglycans in cancer,1/201,0.0100498985877989,0.0127198746031507,0,0,19799.0,91079.21596609056,PTCH1
10383,KEGG_2019_Human,cAMP signaling pathway,1/212,0.0105998955026255,0.0127198746031507,0,0,19788.0,89974.27756224656,PTCH1
10384,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,PTCH1
10385,KEGG_2019_Human,Cellular senescence,1/160,0.0079999110688441,0.0079999110688441,0,0,19840.0,95793.96509856998,MYBL2
10386,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR6P1
10387,KEGG_2019_Human,Ferroptosis,1/40,0.0019999631680592,0.0067998843707146,0,0,19960.0,124043.94523066044,HMOX1
10388,KEGG_2019_Human,Porphyrin and chlorophyll metabolism,1/42,0.0020999619311272,0.0067998843707146,0,0,19958.0,123057.75613441122,HMOX1
10389,KEGG_2019_Human,Mineral absorption,1/51,0.0025499566390179,0.0067998843707146,0,0,19949.0,119129.0228601236,HMOX1
10390,KEGG_2019_Human,HIF-1 signaling pathway,1/100,0.0049999330710556,0.0099998661421113,0,0,19900.0,105436.78197328727,HMOX1
10391,KEGG_2019_Human,Fluid shear stress and atherosclerosis,1/139,0.006949918172816,0.0111198690765056,0,0,19861.0,98689.81333375497,HMOX1
10392,KEGG_2019_Human,Hepatocellular carcinoma,1/168,0.0083999085011095,0.0111998780014793,0,0,19832.0,94787.72752807094,HMOX1
10393,KEGG_2019_Human,MicroRNAs in cancer,1/299,0.0149498740670514,0.0170855703623445,0,0,19701.0,82804.33538735632,HMOX1
10394,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,HMOX1
10395,KEGG_2019_Human,Tight junction,1/170,0.0084999078692823,0.0084999078692823,0,0,19830.0,94543.49009679438,TJAP1
10396,KEGG_2019_Human,Renin-angiotensin system,1/23,0.0011499748819949,0.0105635207190205,0,0,19977.0,135204.63922267244,AGTR1
10397,KEGG_2019_Human,Cortisol synthesis and secretion,1/65,0.003249949134407,0.0105635207190205,0,0,19935.0,114209.92613860144,AGTR1
10398,KEGG_2019_Human,Renin secretion,1/69,0.003449947123837,0.0105635207190205,0,0,19931.0,112996.7391397682,AGTR1
10399,KEGG_2019_Human,Aldosterone synthesis and secretion,1/98,0.0048999339081079,0.0105635207190205,0,0,19902.0,105849.45495286948,AGTR1
10400,KEGG_2019_Human,AGE-RAGE signaling pathway in diabetic complications,1/100,0.0049999330710556,0.0105635207190205,0,0,19900.0,105436.78197328727,AGTR1
10401,KEGG_2019_Human,Vascular smooth muscle contraction,1/132,0.0065999206698993,0.0105635207190205,0,0,19868.0,99751.22090491928,AGTR1
10402,KEGG_2019_Human,Apelin signaling pathway,1/137,0.0068499188797651,0.0105635207190205,0,0,19863.0,98987.62735269018,AGTR1
10403,KEGG_2019_Human,Adrenergic signaling in cardiomyocytes,1/145,0.0072499160871101,0.0105635207190205,0,0,19855.0,97820.92670675044,AGTR1
10404,KEGG_2019_Human,Phospholipase D signaling pathway,1/148,0.007399915061391,0.0105635207190205,0,0,19852.0,97399.60470052566,AGTR1
10405,KEGG_2019_Human,Cushing syndrome,1/155,0.0077499127120574,0.0105635207190205,0,0,19845.0,96448.16254952336,AGTR1
10406,KEGG_2019_Human,cGMP-PKG signaling pathway,1/166,0.0082999091363732,0.0105635207190205,0,0,19834.0,95034.82345515196,AGTR1
10407,KEGG_2019_Human,Calcium signaling pathway,1/188,0.009399902370135,0.0109665527651575,0,0,19812.0,92463.712994847,AGTR1
10408,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0181998555055257,0,0,19662.0,80229.79996326564,AGTR1
10409,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,AGTR1
10410,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR5L1
10411,KEGG_2019_Human,"Parathyroid hormone synthesis, secretion and action",1/106,0.0052999306076525,0.0052999306076525,0,0,19894.0,104245.78450366124,SLC34A3
10412,KEGG_2019_Human,Thermogenesis,1/231,0.0115498903940656,0.0115498903940656,0,0,19769.0,88191.07730937863,KDM3A
10413,KEGG_2019_Human,Cholesterol metabolism,1/50,0.0024999572069037,0.0049999144138074,0,0,19950.0,119530.05920663515,APOE
10414,KEGG_2019_Human,Alzheimer disease,1/171,0.0085499075557634,0.0085499075557634,0,0,19829.0,94422.42241345016,APOE
10415,KEGG_2019_Human,Selenocompound metabolism,1/17,0.0008499797390404818,0.0008499797390404818,0,0,19983.0,141285.76583697114,SEPHS1
10416,KEGG_2019_Human,Ubiquitin mediated proteolysis,1/137,0.0068499188797651,0.0082499094553477,0,0,19863.0,98987.62735269018,STUB1
10417,KEGG_2019_Human,Protein processing in endoplasmic reticulum,1/165,0.0082499094553477,0.0082499094553477,0,0,19835.0,95159.46482222488,STUB1
10418,KEGG_2019_Human,Hepatocellular carcinoma,1/168,0.0083999085011095,0.0115498903940656,0,0,19832.0,94787.72752807094,SMARCB1
10419,KEGG_2019_Human,Thermogenesis,1/231,0.0115498903940656,0.0115498903940656,0,0,19769.0,88191.07730937863,SMARCB1
10420,KEGG_2019_Human,Glycosaminoglycan degradation,1/19,0.00094997806231055,0.0018999561246211,0,0,19981.0,139049.2109571672,NAGLU
10421,KEGG_2019_Human,Lysosome,1/123,0.0061499239842961,0.0061499239842961,0,0,19877.0,101200.07933676826,NAGLU
10422,KEGG_2019_Human,Staphylococcus aureus infection,1/68,0.0033999476216189,0.0052665897556449,0,0,19932.0,113293.39338050144,C4A
10423,KEGG_2019_Human,Pertussis,1/76,0.0037999437281752,0.0052665897556449,0,0,19924.0,111031.8499691117,C4A
10424,KEGG_2019_Human,Complement and coagulation cascades,1/79,0.0039499423167337,0.0052665897556449,0,0,19921.0,110243.89578070649,C4A
10425,KEGG_2019_Human,Systemic lupus erythematosus,1/133,0.0066499203093911,0.0066499203093911,0,0,19867.0,99596.2591544721,C4A
10426,KEGG_2019_Human,Butanoate metabolism,1/28,0.0013999711732997,0.0013999711732997,0,0,19972.0,131242.0761597353,L2HGDH
10427,KEGG_2019_Human,Renin-angiotensin system,1/23,0.0011499748819949,0.0022999497639899,0,0,19977.0,135204.63922267244,KLK1
10428,KEGG_2019_Human,Endocrine and other factor-regulated calcium reabsorption,1/48,0.0023999583567988,0.0023999583567988,0,0,19952.0,120356.5272753826,KLK1
10429,KEGG_2019_Human,Pentose phosphate pathway,1/30,0.0014999697593334,0.003249949134407,0,0,19970.0,129851.13732048514,G6PD
10430,KEGG_2019_Human,Glutathione metabolism,1/56,0.0027999538675741,0.003249949134407,0,0,19944.0,117233.87022514464,G6PD
10431,KEGG_2019_Human,Central carbon metabolism in cancer,1/65,0.003249949134407,0.003249949134407,0,0,19935.0,114209.92613860144,G6PD
10432,KEGG_2019_Human,B cell receptor signaling pathway,1/71,0.0035499461386618,0.0072499160871101,0,0,19929.0,112415.9585341616,CD22
10433,KEGG_2019_Human,Hematopoietic cell lineage,1/97,0.0048499343304706,0.0072499160871101,0,0,19903.0,106058.9096435903,CD22
10434,KEGG_2019_Human,Cell adhesion molecules (CAMs),1/145,0.0072499160871101,0.0072499160871101,0,0,19855.0,97820.92670675044,CD22
10435,KEGG_2019_Human,Cocaine addiction,1/49,0.0024499577795033,0.0084998690540473,0,0,19951.0,119939.1172087114,PPP1R1B
10436,KEGG_2019_Human,Amphetamine addiction,1/68,0.0033999476216189,0.0084998690540473,0,0,19932.0,113293.39338050144,PPP1R1B
10437,KEGG_2019_Human,Dopaminergic synapse,1/131,0.0065499210316603,0.0105998955026255,0,0,19869.0,99907.33811343512,PPP1R1B
10438,KEGG_2019_Human,Alcoholism,1/180,0.0089999047745351,0.0105998955026255,0,0,19820.0,93362.92821536642,PPP1R1B
10439,KEGG_2019_Human,cAMP signaling pathway,1/212,0.0105998955026255,0.0105998955026255,0,0,19788.0,89974.27756224656,PPP1R1B
10440,KEGG_2019_Human,Fatty acid biosynthesis,1/13,0.0006499833083207112,0.0045498831582449,0,0,19987.0,146675.87616784443,ACSL6
10441,KEGG_2019_Human,Ferroptosis,1/40,0.0019999631680592,0.0048415972181405,0,0,19960.0,124043.94523066044,ACSL6
10442,KEGG_2019_Human,Fatty acid degradation,1/44,0.0021999607179423,0.0048415972181405,0,0,19956.0,122117.06559109331,ACSL6
10443,KEGG_2019_Human,Adipocytokine signaling pathway,1/69,0.003449947123837,0.0048415972181405,0,0,19931.0,112996.7391397682,ACSL6
10444,KEGG_2019_Human,PPAR signaling pathway,1/74,0.0036999446830449,0.0048415972181405,0,0,19926.0,111574.38983110404,ACSL6
10445,KEGG_2019_Human,Peroxisome,1/83,0.0041499404726918,0.0048415972181405,0,0,19917.0,109237.99888847338,ACSL6
10446,KEGG_2019_Human,Thermogenesis,1/231,0.0115498903940656,0.0115498903940656,0,0,19769.0,88191.07730937863,ACSL6
10447,KEGG_2019_Human,Sphingolipid signaling pathway,1/119,0.0059499254985137,0.0118998509970274,0,0,19881.0,101877.73080211312,S1PR3
10448,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,S1PR3
10449,KEGG_2019_Human,Endocytosis,1/244,0.0121998870519305,0.0121998870519305,0,0,19756.0,87051.4275316661,WASHC2A
10450,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,CHRND
10451,KEGG_2019_Human,Rap1 signaling pathway,1/206,0.010299897173561,0.0115998901349604,0,0,19794.0,90569.849337325,RAPGEF5
10452,KEGG_2019_Human,Ras signaling pathway,1/232,0.0115998901349604,0.0115998901349604,0,0,19768.0,88101.22480150245,RAPGEF5
10453,KEGG_2019_Human,Autophagy,1/128,0.0063999221281459,0.0063999221281459,0,0,19872.0,100382.8010329652,ATG4B
10454,KEGG_2019_Human,Glycosphingolipid biosynthesis,1/45,0.0022499601197094,0.0022499601197094,0,0,19955.0,121662.49782449217,FUT7
10455,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR11H2
10456,KEGG_2019_Human,Natural killer cell mediated cytotoxicity,1/131,0.0065499210316603,0.0092999029651357,0,0,19869.0,99907.33811343512,MICA
10457,KEGG_2019_Human,Kaposi sarcoma-associated herpesvirus infection,1/186,0.0092999029651357,0.0092999029651357,0,0,19814.0,92684.96451050608,MICA
10458,KEGG_2019_Human,Ribosome biogenesis in eukaryotes,1/101,0.0050499326546803,0.0050499326546803,0,0,19899.0,105233.48101229242,LSG1
10459,KEGG_2019_Human,Lysosome,1/123,0.0061499239842961,0.0061499239842961,0,0,19877.0,101200.07933676826,AP3B1
10460,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF506
10461,KEGG_2019_Human,Mitophagy,1/65,0.003249949134407,0.003249949134407,0,0,19935.0,114209.92613860144,TOMM7
10462,KEGG_2019_Human,RNA transport,1/165,0.0082499094553477,0.0082499094553477,0,0,19835.0,95159.46482222488,EIF2S2
10463,KEGG_2019_Human,Mitophagy,1/65,0.003249949134407,0.0094998972841815,0,0,19935.0,114209.92613860144,EIF2AK3
10464,KEGG_2019_Human,Autophagy,1/128,0.0063999221281459,0.0094998972841815,0,0,19872.0,100382.8010329652,EIF2AK3
10465,KEGG_2019_Human,Measles,1/138,0.0068999185254481,0.0094998972841815,0,0,19862.0,98838.19160389496,EIF2AK3
10466,KEGG_2019_Human,Apoptosis,1/143,0.0071499167770442,0.0094998972841815,0,0,19857.0,98106.57763600958,EIF2AK3
10467,KEGG_2019_Human,Non-alcoholic fatty liver disease (NAFLD),1/149,0.0074499147221605,0.0094998972841815,0,0,19851.0,97261.02051561224,EIF2AK3
10468,KEGG_2019_Human,Hepatitis C,1/155,0.0077499127120574,0.0094998972841815,0,0,19845.0,96448.16254952336,EIF2AK3
10469,KEGG_2019_Human,Protein processing in endoplasmic reticulum,1/165,0.0082499094553477,0.0094998972841815,0,0,19835.0,95159.46482222488,EIF2AK3
10470,KEGG_2019_Human,Influenza A,1/171,0.0085499075557634,0.0094998972841815,0,0,19829.0,94422.42241345016,EIF2AK3
10471,KEGG_2019_Human,Alzheimer disease,1/171,0.0085499075557634,0.0094998972841815,0,0,19829.0,94422.42241345016,EIF2AK3
10472,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,EIF2AK3
10473,KEGG_2019_Human,Osteoclast differentiation,1/127,0.0063499224962247,0.0126998449924495,0,0,19873.0,100543.72072014232,CALCR
10474,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,CALCR
10475,KEGG_2019_Human,Ribosome biogenesis in eukaryotes,1/101,0.0050499326546803,0.0050499326546803,0,0,19899.0,105233.48101229242,MDN1
10476,KEGG_2019_Human,Thyroid hormone signaling pathway,1/116,0.0057999266512085,0.0057999266512085,0,0,19884.0,102400.8105961506,MED1
10477,KEGG_2019_Human,Choline metabolism in cancer,1/99,0.0049499334884068,0.0049499334884068,0,0,19901.0,105642.09305076736,SLC44A5
10478,KEGG_2019_Human,Glyoxylate and dicarboxylate metabolism,1/30,0.0014999697593334,0.00239995257067,0,0,19970.0,129851.13732048514,MMUT
10479,KEGG_2019_Human,Propanoate metabolism,1/32,0.0015999683804467,0.00239995257067,0,0,19968.0,128549.41955786056,MMUT
10480,KEGG_2019_Human,"Valine, leucine and isoleucine degradation",1/48,0.0023999583567988,0.0023999583567988,0,0,19952.0,120356.5272753826,MMUT
10481,KEGG_2019_Human,Staphylococcus aureus infection,1/68,0.0033999476216189,0.0086856156702824,0,0,19932.0,113293.39338050144,FCGR3A
10482,KEGG_2019_Human,Leishmaniasis,1/74,0.0036999446830449,0.0086856156702824,0,0,19926.0,111574.38983110404,FCGR3A
10483,KEGG_2019_Human,Fc gamma R-mediated phagocytosis,1/91,0.0045499369072032,0.0086856156702824,0,0,19909.0,107362.10783923086,FCGR3A
10484,KEGG_2019_Human,Osteoclast differentiation,1/127,0.0063499224962247,0.0086856156702824,0,0,19873.0,100543.72072014232,FCGR3A
10485,KEGG_2019_Human,Natural killer cell mediated cytotoxicity,1/131,0.0065499210316603,0.0086856156702824,0,0,19869.0,99907.33811343512,FCGR3A
10486,KEGG_2019_Human,Systemic lupus erythematosus,1/133,0.0066499203093911,0.0086856156702824,0,0,19867.0,99596.2591544721,FCGR3A
10487,KEGG_2019_Human,Phagosome,1/152,0.0075999137114971,0.0086856156702824,0,0,19848.0,96850.665715497,FCGR3A
10488,KEGG_2019_Human,Tuberculosis,1/179,0.0089499050800561,0.0089499050800561,0,0,19821.0,93478.0629355712,FCGR3A
10489,KEGG_2019_Human,Glutamatergic synapse,1/114,0.005699927427839,0.011399854855678,0,0,19886.0,102756.96431429044,GRIK5
10490,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,GRIK5
10491,KEGG_2019_Human,Protein digestion and absorption,1/90,0.0044999373439762,0.0044999373439762,0,0,19910.0,107587.50385474482,COL11A2
10492,KEGG_2019_Human,Inositol phosphate metabolism,1/74,0.0036999446830449,0.0049499334884068,0,0,19926.0,111574.38983110404,SYNJ1
10493,KEGG_2019_Human,Phosphatidylinositol signaling system,1/99,0.0049499334884068,0.0049499334884068,0,0,19901.0,105642.09305076736,SYNJ1
10494,KEGG_2019_Human,Hematopoietic cell lineage,1/97,0.0048499343304706,0.0161998208405236,0,0,19903.0,106058.9096435903,IL5RA
10495,KEGG_2019_Human,JAK-STAT signaling pathway,1/162,0.0080999104202618,0.0161998208405236,0,0,19838.0,95537.86936302872,IL5RA
10496,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0195998335679646,0,0,19706.0,83157.67014793828,IL5RA
10497,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,IL5RA
10498,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF182
10499,KEGG_2019_Human,Tyrosine metabolism,1/36,0.0017999657178272,0.0017999657178272,0,0,19964.0,126172.23364250171,HGD
10500,KEGG_2019_Human,Estrogen signaling pathway,1/137,0.0068499188797651,0.0068499188797651,0,0,19863.0,98987.62735269018,KRT25
10501,KEGG_2019_Human,Proteasome,1/45,0.0022499601197094,0.0022499601197094,0,0,19955.0,121662.49782449217,PSMB2
10502,KEGG_2019_Human,Retinol metabolism,1/67,0.0033499481224912,0.0033499481224912,0,0,19933.0,113594.38808369274,RPE65
10503,KEGG_2019_Human,Fanconi anemia pathway,1/54,0.0026999549628563,0.0125998097757459,0,0,19946.0,117971.01964061816,ATR
10504,KEGG_2019_Human,p53 signaling pathway,1/72,0.0035999456502131,0.0125998097757459,0,0,19928.0,112131.59838572376,ATR
10505,KEGG_2019_Human,Cell cycle,1/124,0.0061999236097501,0.0127748758543189,0,0,19876.0,101034.04709010696,ATR
10506,KEGG_2019_Human,Cellular senescence,1/160,0.0079999110688441,0.0127748758543189,0,0,19840.0,95793.96509856998,ATR
10507,KEGG_2019_Human,Human immunodeficiency virus 1 infection,1/212,0.0105998955026255,0.0127748758543189,0,0,19788.0,89974.27756224656,ATR
10508,KEGG_2019_Human,Human T-cell leukemia virus 1 infection,1/219,0.0109498935894162,0.0127748758543189,0,0,19781.0,89299.85161916987,ATR
10509,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0164998674589645,0,0,19670.0,80733.60565076157,ATR
10510,KEGG_2019_Human,Pentose phosphate pathway,1/30,0.0014999697593334,0.002474951554817,0,0,19970.0,129851.13732048514,ALDOB
10511,KEGG_2019_Human,Fructose and mannose metabolism,1/33,0.0016499677032113,0.002474951554817,0,0,19967.0,127928.56031580272,ALDOB
10512,KEGG_2019_Human,Glycolysis / Gluconeogenesis,1/68,0.0033999476216189,0.0033999476216189,0,0,19932.0,113293.39338050144,ALDOB
10513,KEGG_2019_Human,Legionellosis,1/55,0.0027499544131125,0.0105294109356237,0,0,19945.0,117599.1294878737,NFKBIA
10514,KEGG_2019_Human,Cytosolic DNA-sensing pathway,1/63,0.0031499501598827,0.0105294109356237,0,0,19937.0,114844.46974572667,NFKBIA
10515,KEGG_2019_Human,Shigellosis,1/65,0.003249949134407,0.0105294109356237,0,0,19935.0,114209.92613860144,NFKBIA
10516,KEGG_2019_Human,Epithelial cell signaling in Helicobacter pylori infection,1/68,0.0033999476216189,0.0105294109356237,0,0,19932.0,113293.39338050144,NFKBIA
10517,KEGG_2019_Human,Adipocytokine signaling pathway,1/69,0.003449947123837,0.0105294109356237,0,0,19931.0,112996.7391397682,NFKBIA
10518,KEGG_2019_Human,RIG-I-like receptor signaling pathway,1/70,0.0034999466296654,0.0105294109356237,0,0,19930.0,112704.30065625212,NFKBIA
10519,KEGG_2019_Human,B cell receptor signaling pathway,1/71,0.0035499461386618,0.0105294109356237,0,0,19929.0,112415.9585341616,NFKBIA
10520,KEGG_2019_Human,Leishmaniasis,1/74,0.0036999446830449,0.0105294109356237,0,0,19926.0,111574.38983110404,NFKBIA
10521,KEGG_2019_Human,Chronic myeloid leukemia,1/76,0.0037999437281752,0.0105294109356237,0,0,19924.0,111031.8499691117,NFKBIA
10522,KEGG_2019_Human,Th1 and Th2 cell differentiation,1/92,0.0045999364719865,0.0105294109356237,0,0,19908.0,107139.13814408927,NFKBIA
10523,KEGG_2019_Human,IL-17 signaling pathway,1/93,0.0046499360391879,0.0105294109356237,0,0,19907.0,106918.54242106884,NFKBIA
10524,KEGG_2019_Human,Small cell lung cancer,1/93,0.0046499360391879,0.0105294109356237,0,0,19907.0,106918.54242106884,NFKBIA
10525,KEGG_2019_Human,NF-kappa B signaling pathway,1/95,0.0047499351803394,0.0105294109356237,0,0,19905.0,106484.27183626965,NFKBIA
10526,KEGG_2019_Human,Prostate cancer,1/97,0.0048499343304706,0.0105294109356237,0,0,19903.0,106058.9096435903,NFKBIA
10527,KEGG_2019_Human,T cell receptor signaling pathway,1/101,0.0050499326546803,0.0105294109356237,0,0,19899.0,105233.48101229242,NFKBIA
10528,KEGG_2019_Human,Chagas disease (American trypanosomiasis),1/103,0.0051499318302617,0.0105294109356237,0,0,19897.0,104832.7525292024,NFKBIA
10529,KEGG_2019_Human,Toll-like receptor signaling pathway,1/104,0.0051999314202997,0.0105294109356237,0,0,19896.0,104635.24941415618,NFKBIA
10530,KEGG_2019_Human,C-type lectin receptor signaling pathway,1/104,0.0051999314202997,0.0105294109356237,0,0,19896.0,104635.24941415618,NFKBIA
10531,KEGG_2019_Human,Th17 cell differentiation,1/107,0.0053499302026925,0.0105294109356237,0,0,19893.0,104053.753408911,NFKBIA
10532,KEGG_2019_Human,Insulin resistance,1/108,0.0053999298011749,0.0105294109356237,0,0,19892.0,103863.47861844616,NFKBIA
10533,KEGG_2019_Human,TNF signaling pathway,1/110,0.0054999290027479,0.0105294109356237,0,0,19890.0,103488.06969787036,NFKBIA
10534,KEGG_2019_Human,Toxoplasmosis,1/113,0.0056499278191151,0.0105294109356237,0,0,19887.0,102937.34947211576,NFKBIA
10535,KEGG_2019_Human,Neurotrophin signaling pathway,1/119,0.0059499254985137,0.0106063889321331,0,0,19881.0,101877.73080211312,NFKBIA
10536,KEGG_2019_Human,Osteoclast differentiation,1/127,0.0063499224962247,0.0106598710882145,0,0,19873.0,100543.72072014232,NFKBIA
10537,KEGG_2019_Human,Relaxin signaling pathway,1/130,0.0064999213952527,0.0106598710882145,0,0,19870.0,100064.62842845908,NFKBIA
10538,KEGG_2019_Human,Measles,1/138,0.0068999185254481,0.0108572810318079,0,0,19862.0,98838.19160389496,NFKBIA
10539,KEGG_2019_Human,Apoptosis,1/143,0.0071499167770442,0.0108572810318079,0,0,19857.0,98106.57763600958,NFKBIA
10540,KEGG_2019_Human,Hepatitis C,1/155,0.0077499127120574,0.011348086471227,0,0,19845.0,96448.16254952336,NFKBIA
10541,KEGG_2019_Human,Hepatitis B,1/163,0.0081499100978668,0.0115222866900875,0,0,19837.0,95410.9786681514,NFKBIA
10542,KEGG_2019_Human,Influenza A,1/171,0.0085499075557634,0.0116848736595433,0,0,19829.0,94422.42241345016,NFKBIA
10543,KEGG_2019_Human,NOD-like receptor signaling pathway,1/178,0.0088999053857096,0.011745830151558,0,0,19822.0,93593.82745769851,NFKBIA
10544,KEGG_2019_Human,Kaposi sarcoma-associated herpesvirus infection,1/186,0.0092999029651357,0.011745830151558,0,0,19814.0,92684.96451050608,NFKBIA
10545,KEGG_2019_Human,Chemokine signaling pathway,1/190,0.0094999017791995,0.011745830151558,0,0,19810.0,92244.74636351672,NFKBIA
10546,KEGG_2019_Human,Epstein-Barr virus infection,1/201,0.0100498985877989,0.011745830151558,0,0,19799.0,91079.21596609056,NFKBIA
10547,KEGG_2019_Human,Viral carcinogenesis,1/201,0.0100498985877989,0.011745830151558,0,0,19799.0,91079.21596609056,NFKBIA
10548,KEGG_2019_Human,Human immunodeficiency virus 1 infection,1/212,0.0105998955026255,0.011745830151558,0,0,19788.0,89974.27756224656,NFKBIA
10549,KEGG_2019_Human,cAMP signaling pathway,1/212,0.0105998955026255,0.011745830151558,0,0,19788.0,89974.27756224656,NFKBIA
10550,KEGG_2019_Human,Human T-cell leukemia virus 1 infection,1/219,0.0109498935894162,0.0118143588727912,0,0,19781.0,89299.85161916987,NFKBIA
10551,KEGG_2019_Human,Human cytomegalovirus infection,1/225,0.0112498919790339,0.0118268095164202,0,0,19775.0,88738.27077557483,NFKBIA
10552,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0252148349541153,0,0,19508.0,72277.44006442746,NFKBIA
10553,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,NFKBIA
10554,KEGG_2019_Human,NOD-like receptor signaling pathway,1/178,0.0088999053857096,0.0088999053857096,0,0,19822.0,93593.82745769851,MEFV
10555,KEGG_2019_Human,Arachidonic acid metabolism,1/63,0.0031499501598827,0.0031499501598827,0,0,19937.0,114844.46974572667,CYP4F8
10556,KEGG_2019_Human,Progesterone-mediated oocyte maturation,1/99,0.0049499334884068,0.0073499154017982,0,0,19901.0,105642.09305076736,PGR
10557,KEGG_2019_Human,Oocyte meiosis,1/125,0.0062499232373748,0.0073499154017982,0,0,19875.0,100869.32368441945,PGR
10558,KEGG_2019_Human,Estrogen signaling pathway,1/137,0.0068499188797651,0.0073499154017982,0,0,19863.0,98987.62735269018,PGR
10559,KEGG_2019_Human,Breast cancer,1/147,0.0073499154017982,0.0073499154017982,0,0,19853.0,97539.10874372096,PGR
10560,KEGG_2019_Human,mTOR signaling pathway,1/152,0.0075999137114971,0.0075999137114971,0,0,19848.0,96850.665715497,PRR5
10561,KEGG_2019_Human,Phenylalanine metabolism,1/17,0.0008499797390404818,0.0048999155590066,0,0,19983.0,141285.76583697114,DDC
10562,KEGG_2019_Human,Tyrosine metabolism,1/36,0.0017999657178272,0.0048999155590066,0,0,19964.0,126172.23364250171,DDC
10563,KEGG_2019_Human,Tryptophan metabolism,1/42,0.0020999619311272,0.0048999155590066,0,0,19958.0,123057.75613441122,DDC
10564,KEGG_2019_Human,Cocaine addiction,1/49,0.0024499577795033,0.0048999155590066,0,0,19951.0,119939.1172087114,DDC
10565,KEGG_2019_Human,Amphetamine addiction,1/68,0.0033999476216189,0.0054399161945902,0,0,19932.0,113293.39338050144,DDC
10566,KEGG_2019_Human,Serotonergic synapse,1/113,0.0056499278191151,0.0074856240361832,0,0,19887.0,102937.34947211576,DDC
10567,KEGG_2019_Human,Dopaminergic synapse,1/131,0.0065499210316603,0.0074856240361832,0,0,19869.0,99907.33811343512,DDC
10568,KEGG_2019_Human,Alcoholism,1/180,0.0089999047745351,0.0089999047745351,0,0,19820.0,93362.92821536642,DDC
10569,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,PRLH
10570,KEGG_2019_Human,Oxidative phosphorylation,1/133,0.0066499203093911,0.0112582177134695,0,0,19867.0,99596.2591544721,NDUFA13
10571,KEGG_2019_Human,Parkinson disease,1/142,0.0070999171242726,0.0112582177134695,0,0,19858.0,98250.87390500787,NDUFA13
10572,KEGG_2019_Human,Retrograde endocannabinoid signaling,1/148,0.007399915061391,0.0112582177134695,0,0,19852.0,97399.60470052566,NDUFA13
10573,KEGG_2019_Human,Non-alcoholic fatty liver disease (NAFLD),1/149,0.0074499147221605,0.0112582177134695,0,0,19851.0,97261.02051561224,NDUFA13
10574,KEGG_2019_Human,Alzheimer disease,1/171,0.0085499075557634,0.0112582177134695,0,0,19829.0,94422.42241345016,NDUFA13
10575,KEGG_2019_Human,Huntington disease,1/193,0.0096499008972596,0.0112582177134695,0,0,19807.0,91920.47679471428,NDUFA13
10576,KEGG_2019_Human,Thermogenesis,1/231,0.0115498903940656,0.0115498903940656,0,0,19769.0,88191.07730937863,NDUFA13
10577,KEGG_2019_Human,Inflammatory bowel disease (IBD),1/65,0.003249949134407,0.0112271566481449,0,0,19935.0,114209.92613860144,STAT1
10578,KEGG_2019_Human,Prolactin signaling pathway,1/70,0.0034999466296654,0.0112271566481449,0,0,19930.0,112704.30065625212,STAT1
10579,KEGG_2019_Human,Leishmaniasis,1/74,0.0036999446830449,0.0112271566481449,0,0,19926.0,111574.38983110404,STAT1
10580,KEGG_2019_Human,Pancreatic cancer,1/75,0.0037499442041125,0.0112271566481449,0,0,19925.0,111301.33528642564,STAT1
10581,KEGG_2019_Human,Th1 and Th2 cell differentiation,1/92,0.0045999364719865,0.0112271566481449,0,0,19908.0,107139.13814408927,STAT1
10582,KEGG_2019_Human,AGE-RAGE signaling pathway in diabetic complications,1/100,0.0049999330710556,0.0112271566481449,0,0,19900.0,105436.78197328727,STAT1
10583,KEGG_2019_Human,Toll-like receptor signaling pathway,1/104,0.0051999314202997,0.0112271566481449,0,0,19896.0,104635.24941415618,STAT1
10584,KEGG_2019_Human,C-type lectin receptor signaling pathway,1/104,0.0051999314202997,0.0112271566481449,0,0,19896.0,104635.24941415618,STAT1
10585,KEGG_2019_Human,Th17 cell differentiation,1/107,0.0053499302026925,0.0112271566481449,0,0,19893.0,104053.753408911,STAT1
10586,KEGG_2019_Human,Toxoplasmosis,1/113,0.0056499278191151,0.0112271566481449,0,0,19887.0,102937.34947211576,STAT1
10587,KEGG_2019_Human,Thyroid hormone signaling pathway,1/116,0.0057999266512085,0.0112271566481449,0,0,19884.0,102400.8105961506,STAT1
10588,KEGG_2019_Human,Osteoclast differentiation,1/127,0.0063499224962247,0.0112271566481449,0,0,19873.0,100543.72072014232,STAT1
10589,KEGG_2019_Human,Measles,1/138,0.0068999185254481,0.0112271566481449,0,0,19862.0,98838.19160389496,STAT1
10590,KEGG_2019_Human,Hepatitis C,1/155,0.0077499127120574,0.0112271566481449,0,0,19845.0,96448.16254952336,STAT1
10591,KEGG_2019_Human,JAK-STAT signaling pathway,1/162,0.0080999104202618,0.0112271566481449,0,0,19838.0,95537.86936302872,STAT1
10592,KEGG_2019_Human,Necroptosis,1/162,0.0080999104202618,0.0112271566481449,0,0,19838.0,95537.86936302872,STAT1
10593,KEGG_2019_Human,Hepatitis B,1/163,0.0081499100978668,0.0112271566481449,0,0,19837.0,95410.9786681514,STAT1
10594,KEGG_2019_Human,Influenza A,1/171,0.0085499075557634,0.0112271566481449,0,0,19829.0,94422.42241345016,STAT1
10595,KEGG_2019_Human,NOD-like receptor signaling pathway,1/178,0.0088999053857096,0.0112271566481449,0,0,19822.0,93593.82745769851,STAT1
10596,KEGG_2019_Human,Tuberculosis,1/179,0.0089499050800561,0.0112271566481449,0,0,19821.0,93478.0629355712,STAT1
10597,KEGG_2019_Human,Kaposi sarcoma-associated herpesvirus infection,1/186,0.0092999029651357,0.0112271566481449,0,0,19814.0,92684.96451050608,STAT1
10598,KEGG_2019_Human,Chemokine signaling pathway,1/190,0.0094999017791995,0.0112271566481449,0,0,19810.0,92244.74636351672,STAT1
10599,KEGG_2019_Human,Epstein-Barr virus infection,1/201,0.0100498985877989,0.0113607549253379,0,0,19799.0,91079.21596609056,STAT1
10600,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0178748564138782,0,0,19670.0,80733.60565076157,STAT1
10601,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0255838325388096,0,0,19508.0,72277.44006442746,STAT1
10602,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,STAT1
10603,KEGG_2019_Human,Small cell lung cancer,1/93,0.0046499360391879,0.0123998472195002,0,0,19907.0,106918.54242106884,ZBTB17
10604,KEGG_2019_Human,Cell cycle,1/124,0.0061999236097501,0.0123998472195002,0,0,19876.0,101034.04709010696,ZBTB17
10605,KEGG_2019_Human,Transcriptional misregulation in cancer,1/186,0.0092999029651357,0.012399870620181,0,0,19814.0,92684.96451050608,ZBTB17
10606,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,ZBTB17
10607,KEGG_2019_Human,Arginine biosynthesis,1/21,0.0010499764455398,0.0031499293366194,0,0,19979.0,137035.71221916509,ARG2
10608,KEGG_2019_Human,Arginine and proline metabolism,1/49,0.0024499577795033,0.0036749366692549,0,0,19951.0,119939.1172087114,ARG2
10609,KEGG_2019_Human,Amoebiasis,1/96,0.0047999347538706,0.0047999347538706,0,0,19904.0,106270.50039849174,ARG2
10610,KEGG_2019_Human,Steroid hormone biosynthesis,1/60,0.002999951725986,0.004099940929819,0,0,19940.0,115834.63209072244,CYP3A7
10611,KEGG_2019_Human,Retinol metabolism,1/67,0.0033499481224912,0.004099940929819,0,0,19933.0,113594.38808369274,CYP3A7
10612,KEGG_2019_Human,Chemical carcinogenesis,1/82,0.004099940929819,0.004099940929819,0,0,19918.0,109484.9180722932,CYP3A7
10613,KEGG_2019_Human,Synthesis and degradation of ketone bodies,1/10,0.0004999862257578379,0.0026666203964431,0,0,19990.0,151942.5908680334,ACAT1
10614,KEGG_2019_Human,Terpenoid backbone biosynthesis,1/22,0.0010999756574123,0.0026666203964431,0,0,19978.0,136099.47030191717,ACAT1
10615,KEGG_2019_Human,Butanoate metabolism,1/28,0.0013999711732997,0.0026666203964431,0,0,19972.0,131242.0761597353,ACAT1
10616,KEGG_2019_Human,Glyoxylate and dicarboxylate metabolism,1/30,0.0014999697593334,0.0026666203964431,0,0,19970.0,129851.13732048514,ACAT1
10617,KEGG_2019_Human,Propanoate metabolism,1/32,0.0015999683804467,0.0026666203964431,0,0,19968.0,128549.41955786056,ACAT1
10618,KEGG_2019_Human,Pyruvate metabolism,1/39,0.0019499637955508,0.0026666203964431,0,0,19961.0,124555.53162481484,ACAT1
10619,KEGG_2019_Human,Tryptophan metabolism,1/42,0.0020999619311272,0.0026666203964431,0,0,19958.0,123057.75613441122,ACAT1
10620,KEGG_2019_Human,Fatty acid degradation,1/44,0.0021999607179423,0.0026666203964431,0,0,19956.0,122117.06559109331,ACAT1
10621,KEGG_2019_Human,"Valine, leucine and isoleucine degradation",1/48,0.0023999583567988,0.0026666203964431,0,0,19952.0,120356.5272753826,ACAT1
10622,KEGG_2019_Human,Lysine degradation,1/59,0.0029499522555206,0.0029499522555206,0,0,19941.0,116175.59385530632,ACAT1
10623,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,POU2F3
10624,KEGG_2019_Human,Arginine and proline metabolism,1/49,0.0024499577795033,0.0024499577795033,0,0,19951.0,119939.1172087114,AZIN2
10625,KEGG_2019_Human,Vitamin digestion and absorption,1/24,0.0011999741185782,0.0017499663721595,0,0,19976.0,134347.69487847842,FOLH1
10626,KEGG_2019_Human,"Alanine, aspartate and glutamate metabolism",1/35,0.0017499663721595,0.0017499663721595,0,0,19965.0,126740.98858805298,FOLH1
10627,KEGG_2019_Human,Synaptic vesicle cycle,1/78,0.0038999427840466,0.0038999427840466,0,0,19922.0,110503.2180492851,UNC13B
10628,KEGG_2019_Human,Endocytosis,1/244,0.0121998870519305,0.0121998870519305,0,0,19756.0,87051.4275316661,EPN1
10629,KEGG_2019_Human,Hepatocellular carcinoma,1/168,0.0083999085011095,0.0115498903940656,0,0,19832.0,94787.72752807094,DPF1
10630,KEGG_2019_Human,Thermogenesis,1/231,0.0115498903940656,0.0115498903940656,0,0,19769.0,88191.07730937863,DPF1
10631,KEGG_2019_Human,Inositol phosphate metabolism,1/74,0.0036999446830449,0.0049499334884068,0,0,19926.0,111574.38983110404,OCRL
10632,KEGG_2019_Human,Phosphatidylinositol signaling system,1/99,0.0049499334884068,0.0049499334884068,0,0,19901.0,105642.09305076736,OCRL
10633,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0146998751759735,0,0,19706.0,83157.67014793828,IL26
10634,KEGG_2019_Human,Proximal tubule bicarbonate reclamation,1/23,0.0011499748819949,0.0034499246459849,0,0,19977.0,135204.63922267244,SLC4A4
10635,KEGG_2019_Human,Bile secretion,1/72,0.0035999456502131,0.0048999339081079,0,0,19928.0,112131.59838572376,SLC4A4
10636,KEGG_2019_Human,Pancreatic secretion,1/98,0.0048999339081079,0.0048999339081079,0,0,19902.0,105849.45495286948,SLC4A4
10637,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0147498749536506,0,0,19705.0,83086.53988020132,DUSP4
10638,KEGG_2019_Human,Taste transduction,1/83,0.0041499404726918,0.0056499278191151,0,0,19917.0,109237.99888847338,HTR3E
10639,KEGG_2019_Human,Serotonergic synapse,1/113,0.0056499278191151,0.0056499278191151,0,0,19887.0,102937.34947211576,HTR3E
10640,KEGG_2019_Human,Pantothenate and CoA biosynthesis,1/19,0.00094997806231055,0.00094997806231055,0,0,19981.0,139049.2109571672,VNN1
10641,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR7A17
10642,KEGG_2019_Human,Mucin type O-glycan biosynthesis,1/31,0.0015499690656704,0.0015499690656704,0,0,19969.0,129189.85098816035,GALNTL6
10643,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR51B6
10644,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,NTSR2
10645,KEGG_2019_Human,MicroRNAs in cancer,1/299,0.0149498740670514,0.0149498740670514,0,0,19701.0,82804.33538735632,FSCN1
10646,KEGG_2019_Human,Mismatch repair,1/23,0.0011499748819949,0.0011499748819949,0,0,19977.0,135204.63922267244,MLH3
10647,KEGG_2019_Human,Ubiquitin mediated proteolysis,1/137,0.0068499188797651,0.0121998870519305,0,0,19863.0,98987.62735269018,NEDD4
10648,KEGG_2019_Human,Tight junction,1/170,0.0084999078692823,0.0121998870519305,0,0,19830.0,94543.49009679438,NEDD4
10649,KEGG_2019_Human,Epstein-Barr virus infection,1/201,0.0100498985877989,0.0121998870519305,0,0,19799.0,91079.21596609056,NEDD4
10650,KEGG_2019_Human,Endocytosis,1/244,0.0121998870519305,0.0121998870519305,0,0,19756.0,87051.4275316661,NEDD4
10651,KEGG_2019_Human,Axon guidance,1/181,0.0090499044707863,0.0090499044707863,0,0,19819.0,93248.41634586031,EPHB6
10652,KEGG_2019_Human,Primary bile acid biosynthesis,1/17,0.0008499797390404818,0.0016999594780809,0,0,19983.0,141285.76583697114,CYP8B1
10653,KEGG_2019_Human,PPAR signaling pathway,1/74,0.0036999446830449,0.0036999446830449,0,0,19926.0,111574.38983110404,CYP8B1
10654,KEGG_2019_Human,Autophagy,1/128,0.0063999221281459,0.0085499075557634,0,0,19872.0,100382.8010329652,ERN1
10655,KEGG_2019_Human,Apoptosis,1/143,0.0071499167770442,0.0085499075557634,0,0,19857.0,98106.57763600958,ERN1
10656,KEGG_2019_Human,Non-alcoholic fatty liver disease (NAFLD),1/149,0.0074499147221605,0.0085499075557634,0,0,19851.0,97261.02051561224,ERN1
10657,KEGG_2019_Human,Protein processing in endoplasmic reticulum,1/165,0.0082499094553477,0.0085499075557634,0,0,19835.0,95159.46482222488,ERN1
10658,KEGG_2019_Human,Alzheimer disease,1/171,0.0085499075557634,0.0085499075557634,0,0,19829.0,94422.42241345016,ERN1
10659,KEGG_2019_Human,Autoimmune thyroid disease,1/53,0.0026499555173137,0.0145586837375733,0,0,19947.0,118349.78824235698,IFNA2
10660,KEGG_2019_Human,Cytosolic DNA-sensing pathway,1/63,0.0031499501598827,0.0145586837375733,0,0,19937.0,114844.46974572667,IFNA2
10661,KEGG_2019_Human,RIG-I-like receptor signaling pathway,1/70,0.0034999466296654,0.0145586837375733,0,0,19930.0,112704.30065625212,IFNA2
10662,KEGG_2019_Human,Toll-like receptor signaling pathway,1/104,0.0051999314202997,0.0145586837375733,0,0,19896.0,104635.24941415618,IFNA2
10663,KEGG_2019_Human,Natural killer cell mediated cytotoxicity,1/131,0.0065499210316603,0.0145586837375733,0,0,19869.0,99907.33811343512,IFNA2
10664,KEGG_2019_Human,Measles,1/138,0.0068999185254481,0.0145586837375733,0,0,19862.0,98838.19160389496,IFNA2
10665,KEGG_2019_Human,Hepatitis C,1/155,0.0077499127120574,0.0145586837375733,0,0,19845.0,96448.16254952336,IFNA2
10666,KEGG_2019_Human,Necroptosis,1/162,0.0080999104202618,0.0145586837375733,0,0,19838.0,95537.86936302872,IFNA2
10667,KEGG_2019_Human,JAK-STAT signaling pathway,1/162,0.0080999104202618,0.0145586837375733,0,0,19838.0,95537.86936302872,IFNA2
10668,KEGG_2019_Human,Hepatitis B,1/163,0.0081499100978668,0.0145586837375733,0,0,19837.0,95410.9786681514,IFNA2
10669,KEGG_2019_Human,Influenza A,1/171,0.0085499075557634,0.0145586837375733,0,0,19829.0,94422.42241345016,IFNA2
10670,KEGG_2019_Human,NOD-like receptor signaling pathway,1/178,0.0088999053857096,0.0145586837375733,0,0,19822.0,93593.82745769851,IFNA2
10671,KEGG_2019_Human,Tuberculosis,1/179,0.0089499050800561,0.0145586837375733,0,0,19821.0,93478.0629355712,IFNA2
10672,KEGG_2019_Human,Kaposi sarcoma-associated herpesvirus infection,1/186,0.0092999029651357,0.0145586837375733,0,0,19814.0,92684.96451050608,IFNA2
10673,KEGG_2019_Human,Epstein-Barr virus infection,1/201,0.0100498985877989,0.0145586837375733,0,0,19799.0,91079.21596609056,IFNA2
10674,KEGG_2019_Human,Human immunodeficiency virus 1 infection,1/212,0.0105998955026255,0.0145586837375733,0,0,19788.0,89974.27756224656,IFNA2
10675,KEGG_2019_Human,Human cytomegalovirus infection,1/225,0.0112498919790339,0.0145586837375733,0,0,19775.0,88738.27077557483,IFNA2
10676,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0179665141039676,0,0,19706.0,83157.67014793828,IFNA2
10677,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0191051096893273,0,0,19670.0,80733.60565076157,IFNA2
10678,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0194698489055035,0,0,19646.0,79255.8617626126,IFNA2
10679,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0257712598834163,0,0,19508.0,72277.44006442746,IFNA2
10680,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,IFNA2
10681,KEGG_2019_Human,Circadian rhythm,1/31,0.0015499690656704,0.0061998762626816,0,0,19969.0,129189.85098816035,PER2
10682,KEGG_2019_Human,Acute myeloid leukemia,1/66,0.003299948626608,0.0064665791072942,0,0,19934.0,113899.85357353876,PER2
10683,KEGG_2019_Human,Circadian entrainment,1/97,0.0048499343304706,0.0064665791072942,0,0,19903.0,106058.9096435903,PER2
10684,KEGG_2019_Human,Transcriptional misregulation in cancer,1/186,0.0092999029651357,0.0092999029651357,0,0,19814.0,92684.96451050608,PER2
10685,KEGG_2019_Human,Bile secretion,1/72,0.0035999456502131,0.0035999456502131,0,0,19928.0,112131.59838572376,SLC10A2
10686,KEGG_2019_Human,Tryptophan metabolism,1/42,0.0020999619311272,0.004099940929819,0,0,19958.0,123057.75613441122,CYP1A1
10687,KEGG_2019_Human,Ovarian steroidogenesis,1/49,0.0024499577795033,0.004099940929819,0,0,19951.0,119939.1172087114,CYP1A1
10688,KEGG_2019_Human,Steroid hormone biosynthesis,1/60,0.002999951725986,0.004099940929819,0,0,19940.0,115834.63209072244,CYP1A1
10689,KEGG_2019_Human,Retinol metabolism,1/67,0.0033499481224912,0.004099940929819,0,0,19933.0,113594.38808369274,CYP1A1
10690,KEGG_2019_Human,Metabolism of xenobiotics by cytochrome P450,1/74,0.0036999446830449,0.004099940929819,0,0,19926.0,111574.38983110404,CYP1A1
10691,KEGG_2019_Human,Chemical carcinogenesis,1/82,0.004099940929819,0.004099940929819,0,0,19918.0,109484.9180722932,CYP1A1
10692,KEGG_2019_Human,Galactose metabolism,1/31,0.0015499690656704,0.0015499690656704,0,0,19969.0,129189.85098816035,LALBA
10693,KEGG_2019_Human,Primary immunodeficiency,1/37,0.0018499650702878,0.0036999301405757,0,0,19963.0,125618.9446446357,ADA
10694,KEGG_2019_Human,Purine metabolism,1/129,0.006449921761047,0.006449921761047,0,0,19871.0,100223.109907462,ADA
10695,KEGG_2019_Human,RIG-I-like receptor signaling pathway,1/70,0.0034999466296654,0.0069998932593308,0,0,19930.0,112704.30065625212,TANK
10696,KEGG_2019_Human,NOD-like receptor signaling pathway,1/178,0.0088999053857096,0.0088999053857096,0,0,19822.0,93593.82745769851,TANK
10697,KEGG_2019_Human,Basal transcription factors,1/45,0.0022499601197094,0.0022499601197094,0,0,19955.0,121662.49782449217,TAF2
10698,KEGG_2019_Human,Chemokine signaling pathway,1/190,0.0094999017791995,0.0146998751759735,0,0,19810.0,92244.74636351672,CXCR3
10699,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0146998751759735,0,0,19706.0,83157.67014793828,CXCR3
10700,KEGG_2019_Human,Signaling pathways regulating pluripotency of stem cells,1/139,0.006949918172816,0.006949918172816,0,0,19861.0,98689.81333375497,ESRRB
10701,KEGG_2019_Human,Endocytosis,1/244,0.0121998870519305,0.0121998870519305,0,0,19756.0,87051.4275316661,EPS15
10702,KEGG_2019_Human,Endometrial cancer,1/58,0.0028999527887707,0.0073998893660899,0,0,19942.0,116522.31890946148,CTNNA3
10703,KEGG_2019_Human,Adherens junction,1/72,0.0035999456502131,0.0073998893660899,0,0,19928.0,112131.59838572376,CTNNA3
10704,KEGG_2019_Human,Arrhythmogenic right ventricular cardiomyopathy (ARVC),1/72,0.0035999456502131,0.0073998893660899,0,0,19928.0,112131.59838572376,CTNNA3
10705,KEGG_2019_Human,Bacterial invasion of epithelial cells,1/74,0.0036999446830449,0.0073998893660899,0,0,19926.0,111574.38983110404,CTNNA3
10706,KEGG_2019_Human,Leukocyte transendothelial migration,1/112,0.0055999282120529,0.0089598851392847,0,0,19888.0,103119.30984392198,CTNNA3
10707,KEGG_2019_Human,Gastric cancer,1/149,0.0074499147221605,0.0091427555072504,0,0,19851.0,97261.02051561224,CTNNA3
10708,KEGG_2019_Human,Hippo signaling pathway,1/160,0.0079999110688441,0.0091427555072504,0,0,19840.0,95793.96509856998,CTNNA3
10709,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,CTNNA3
10710,KEGG_2019_Human,Sulfur relay system,1/8,0.0003999883241497325,0.0003999883241497325,0,0,19992.0,156418.91141655247,CTU1
10711,KEGG_2019_Human,Ribosome biogenesis in eukaryotes,1/101,0.0050499326546803,0.0050499326546803,0,0,19899.0,105233.48101229242,WDR43
10712,KEGG_2019_Human,Basal cell carcinoma,1/63,0.0031499501598827,0.0109198810514423,0,0,19937.0,114844.46974572667,FZD6
10713,KEGG_2019_Human,Melanogenesis,1/101,0.0050499326546803,0.0109198810514423,0,0,19899.0,105233.48101229242,FZD6
10714,KEGG_2019_Human,Signaling pathways regulating pluripotency of stem cells,1/139,0.006949918172816,0.0109198810514423,0,0,19861.0,98689.81333375497,FZD6
10715,KEGG_2019_Human,Breast cancer,1/147,0.0073499154017982,0.0109198810514423,0,0,19853.0,97539.10874372096,FZD6
10716,KEGG_2019_Human,Gastric cancer,1/149,0.0074499147221605,0.0109198810514423,0,0,19851.0,97261.02051561224,FZD6
10717,KEGG_2019_Human,mTOR signaling pathway,1/152,0.0075999137114971,0.0109198810514423,0,0,19848.0,96850.665715497,FZD6
10718,KEGG_2019_Human,Cushing syndrome,1/155,0.0077499127120574,0.0109198810514423,0,0,19845.0,96448.16254952336,FZD6
10719,KEGG_2019_Human,Wnt signaling pathway,1/158,0.0078999117225733,0.0109198810514423,0,0,19842.0,96053.2110949472,FZD6
10720,KEGG_2019_Human,Hippo signaling pathway,1/160,0.0079999110688441,0.0109198810514423,0,0,19840.0,95793.96509856998,FZD6
10721,KEGG_2019_Human,Hepatocellular carcinoma,1/168,0.0083999085011095,0.0109198810514423,0,0,19832.0,94787.72752807094,FZD6
10722,KEGG_2019_Human,Proteoglycans in cancer,1/201,0.0100498985877989,0.0118771528764897,0,0,19799.0,91079.21596609056,FZD6
10723,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0178748564138782,0,0,19670.0,80733.60565076157,FZD6
10724,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,FZD6
10725,KEGG_2019_Human,RNA transport,1/165,0.0082499094553477,0.0082499094553477,0,0,19835.0,95159.46482222488,NUP133
10726,KEGG_2019_Human,Cortisol synthesis and secretion,1/65,0.003249949134407,0.0064998982688141,0,0,19935.0,114209.92613860144,KCNA4
10727,KEGG_2019_Human,Cushing syndrome,1/155,0.0077499127120574,0.0077499127120574,0,0,19845.0,96448.16254952336,KCNA4
10728,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF229
10729,KEGG_2019_Human,Bile secretion,1/72,0.0035999456502131,0.0035999456502131,0,0,19928.0,112131.59838572376,SLCO1B1
10730,KEGG_2019_Human,Glycerophospholipid metabolism,1/97,0.0048499343304706,0.0048499343304706,0,0,19903.0,106058.9096435903,LYPLA2
10731,KEGG_2019_Human,Huntington disease,1/193,0.0096499008972596,0.0096499008972596,0,0,19807.0,91920.47679471428,DNAH7
10732,KEGG_2019_Human,Primary immunodeficiency,1/37,0.0018499650702878,0.0055498952108636,0,0,19963.0,125618.9446446357,RFXANK
10733,KEGG_2019_Human,Antigen processing and presentation,1/77,0.0038499432547502,0.0057749148821253,0,0,19923.0,110765.8407373636,RFXANK
10734,KEGG_2019_Human,Tuberculosis,1/179,0.0089499050800561,0.0089499050800561,0,0,19821.0,93478.0629355712,RFXANK
10735,KEGG_2019_Human,Cushing syndrome,1/155,0.0077499127120574,0.0077499127120574,0,0,19845.0,96448.16254952336,AIPL1
10736,KEGG_2019_Human,Cell adhesion molecules (CAMs),1/145,0.0072499160871101,0.0072499160871101,0,0,19855.0,97820.92670675044,CD274
10737,KEGG_2019_Human,Estrogen signaling pathway,1/137,0.0068499188797651,0.0068499188797651,0,0,19863.0,98987.62735269018,KRT13
10738,KEGG_2019_Human,Primary immunodeficiency,1/37,0.0018499650702878,0.0147123080574046,0,0,19963.0,125618.9446446357,IL2RG
10739,KEGG_2019_Human,Inflammatory bowel disease (IBD),1/65,0.003249949134407,0.0147123080574046,0,0,19935.0,114209.92613860144,IL2RG
10740,KEGG_2019_Human,Th1 and Th2 cell differentiation,1/92,0.0045999364719865,0.0147123080574046,0,0,19908.0,107139.13814408927,IL2RG
10741,KEGG_2019_Human,Th17 cell differentiation,1/107,0.0053499302026925,0.0147123080574046,0,0,19893.0,104053.753408911,IL2RG
10742,KEGG_2019_Human,Measles,1/138,0.0068999185254481,0.01484983577048,0,0,19862.0,98838.19160389496,IL2RG
10743,KEGG_2019_Human,JAK-STAT signaling pathway,1/162,0.0080999104202618,0.01484983577048,0,0,19838.0,95537.86936302872,IL2RG
10744,KEGG_2019_Human,Human T-cell leukemia virus 1 infection,1/219,0.0109498935894162,0.0167748446964045,0,0,19781.0,89299.85161916987,IL2RG
10745,KEGG_2019_Human,Endocytosis,1/244,0.0121998870519305,0.0167748446964045,0,0,19756.0,87051.4275316661,IL2RG
10746,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0179665141039676,0,0,19706.0,83157.67014793828,IL2RG
10747,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0194698489055035,0,0,19646.0,79255.8617626126,IL2RG
10748,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,IL2RG
10749,KEGG_2019_Human,Platelet activation,1/124,0.0061999236097501,0.009899881004849,0,0,19876.0,101034.04709010696,PTGIR
10750,KEGG_2019_Human,Vascular smooth muscle contraction,1/132,0.0065999206698993,0.009899881004849,0,0,19868.0,99751.22090491928,PTGIR
10751,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,PTGIR
10752,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF251
10753,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR51Q1
10754,KEGG_2019_Human,Central carbon metabolism in cancer,1/65,0.003249949134407,0.0154531902657787,0,0,19935.0,114209.92613860144,PDGFRA
10755,KEGG_2019_Human,Melanoma,1/72,0.0035999456502131,0.0154531902657787,0,0,19928.0,112131.59838572376,PDGFRA
10756,KEGG_2019_Human,Glioma,1/75,0.0037499442041125,0.0154531902657787,0,0,19925.0,111301.33528642564,PDGFRA
10757,KEGG_2019_Human,Gap junction,1/88,0.0043999382262822,0.0154531902657787,0,0,19912.0,108045.79305232369,PDGFRA
10758,KEGG_2019_Human,Prostate cancer,1/97,0.0048499343304706,0.0154531902657787,0,0,19903.0,106058.9096435903,PDGFRA
10759,KEGG_2019_Human,Choline metabolism in cancer,1/99,0.0049499334884068,0.0154531902657787,0,0,19901.0,105642.09305076736,PDGFRA
10760,KEGG_2019_Human,Phospholipase D signaling pathway,1/148,0.007399915061391,0.0154531902657787,0,0,19852.0,97399.60470052566,PDGFRA
10761,KEGG_2019_Human,JAK-STAT signaling pathway,1/162,0.0080999104202618,0.0154531902657787,0,0,19838.0,95537.86936302872,PDGFRA
10762,KEGG_2019_Human,Calcium signaling pathway,1/188,0.009399902370135,0.0154531902657787,0,0,19812.0,92463.712994847,PDGFRA
10763,KEGG_2019_Human,Focal adhesion,1/199,0.0099498991610159,0.0154531902657787,0,0,19801.0,91286.4288690606,PDGFRA
10764,KEGG_2019_Human,Rap1 signaling pathway,1/206,0.010299897173561,0.0154531902657787,0,0,19794.0,90569.849337325,PDGFRA
10765,KEGG_2019_Human,Regulation of actin cytoskeleton,1/214,0.0106998949514067,0.0154531902657787,0,0,19786.0,89779.39753374986,PDGFRA
10766,KEGG_2019_Human,Human cytomegalovirus infection,1/225,0.0112498919790339,0.0154531902657787,0,0,19775.0,88738.27077557483,PDGFRA
10767,KEGG_2019_Human,Ras signaling pathway,1/232,0.0115998901349604,0.0154531902657787,0,0,19768.0,88101.22480150245,PDGFRA
10768,KEGG_2019_Human,Endocytosis,1/244,0.0121998870519305,0.0154531902657787,0,0,19756.0,87051.4275316661,PDGFRA
10769,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0167086827808222,0,0,19705.0,83086.53988020132,PDGFRA
10770,KEGG_2019_Human,MicroRNAs in cancer,1/299,0.0149498740670514,0.0167086827808222,0,0,19701.0,82804.33538735632,PDGFRA
10771,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.018683188343665,0,0,19646.0,79255.8617626126,PDGFRA
10772,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,PDGFRA
10773,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR2T2
10774,KEGG_2019_Human,Mucin type O-glycan biosynthesis,1/31,0.0015499690656704,0.0015499690656704,0,0,19969.0,129189.85098816035,GCNT4
10775,KEGG_2019_Human,JAK-STAT signaling pathway,1/162,0.0080999104202618,0.0146998751759735,0,0,19838.0,95537.86936302872,IFNL2
10776,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0146998751759735,0,0,19706.0,83157.67014793828,IFNL2
10777,KEGG_2019_Human,Selenocompound metabolism,1/17,0.0008499797390404818,0.0008499797390404818,0,0,19983.0,141285.76583697114,SEPHS2
10778,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR6C3
10779,KEGG_2019_Human,Ribosome,1/153,0.0076499133771537,0.0076499133771537,0,0,19847.0,96715.6407630817,MRPS12
10780,KEGG_2019_Human,Cell cycle,1/124,0.0061999236097501,0.0061999236097501,0,0,19876.0,101034.04709010696,STAG1
10781,KEGG_2019_Human,Measles,1/138,0.0068999185254481,0.0113998767410179,0,0,19862.0,98838.19160389496,MX1
10782,KEGG_2019_Human,Hepatitis C,1/155,0.0077499127120574,0.0113998767410179,0,0,19845.0,96448.16254952336,MX1
10783,KEGG_2019_Human,Influenza A,1/171,0.0085499075557634,0.0113998767410179,0,0,19829.0,94422.42241345016,MX1
10784,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0164998674589645,0,0,19670.0,80733.60565076157,MX1
10785,KEGG_2019_Human,Prion diseases,1/35,0.0017499663721595,0.0104011986398666,0,0,19965.0,126740.98858805298,MAPK3
10786,KEGG_2019_Human,Aldosterone-regulated sodium reabsorption,1/37,0.0018499650702878,0.0104011986398666,0,0,19963.0,125618.9446446357,MAPK3
10787,KEGG_2019_Human,Thyroid cancer,1/37,0.0018499650702878,0.0104011986398666,0,0,19963.0,125618.9446446357,MAPK3
10788,KEGG_2019_Human,Bladder cancer,1/41,0.0020499625466866,0.0104011986398666,0,0,19959.0,123544.88783416104,MAPK3
10789,KEGG_2019_Human,Type II diabetes mellitus,1/46,0.0022999595269283,0.0104011986398666,0,0,19954.0,121217.8313311442,MAPK3
10790,KEGG_2019_Human,Endometrial cancer,1/58,0.0028999527887707,0.0104011986398666,0,0,19942.0,116522.31890946148,MAPK3
10791,KEGG_2019_Human,VEGF signaling pathway,1/59,0.0029499522555206,0.0104011986398666,0,0,19941.0,116175.59385530632,MAPK3
10792,KEGG_2019_Human,Long-term depression,1/60,0.002999951725986,0.0104011986398666,0,0,19940.0,115834.63209072244,MAPK3
10793,KEGG_2019_Human,Central carbon metabolism in cancer,1/65,0.003249949134407,0.0104011986398666,0,0,19935.0,114209.92613860144,MAPK3
10794,KEGG_2019_Human,Shigellosis,1/65,0.003249949134407,0.0104011986398666,0,0,19935.0,114209.92613860144,MAPK3
10795,KEGG_2019_Human,Acute myeloid leukemia,1/66,0.003299948626608,0.0104011986398666,0,0,19934.0,113899.85357353876,MAPK3
10796,KEGG_2019_Human,Non-small cell lung cancer,1/66,0.003299948626608,0.0104011986398666,0,0,19934.0,113899.85357353876,MAPK3
10797,KEGG_2019_Human,Long-term potentiation,1/67,0.0033499481224912,0.0104011986398666,0,0,19933.0,113594.38808369274,MAPK3
10798,KEGG_2019_Human,Fc epsilon RI signaling pathway,1/68,0.0033999476216189,0.0104011986398666,0,0,19932.0,113293.39338050144,MAPK3
10799,KEGG_2019_Human,Renal cell carcinoma,1/69,0.003449947123837,0.0104011986398666,0,0,19931.0,112996.7391397682,MAPK3
10800,KEGG_2019_Human,Prolactin signaling pathway,1/70,0.0034999466296654,0.0104011986398666,0,0,19930.0,112704.30065625212,MAPK3
10801,KEGG_2019_Human,B cell receptor signaling pathway,1/71,0.0035499461386618,0.0104011986398666,0,0,19929.0,112415.9585341616,MAPK3
10802,KEGG_2019_Human,Adherens junction,1/72,0.0035999456502131,0.0104011986398666,0,0,19928.0,112131.59838572376,MAPK3
10803,KEGG_2019_Human,Melanoma,1/72,0.0035999456502131,0.0104011986398666,0,0,19928.0,112131.59838572376,MAPK3
10804,KEGG_2019_Human,Leishmaniasis,1/74,0.0036999446830449,0.0104011986398666,0,0,19926.0,111574.38983110404,MAPK3
10805,KEGG_2019_Human,Glioma,1/75,0.0037499442041125,0.0104011986398666,0,0,19925.0,111301.33528642564,MAPK3
10806,KEGG_2019_Human,Pancreatic cancer,1/75,0.0037499442041125,0.0104011986398666,0,0,19925.0,111301.33528642564,MAPK3
10807,KEGG_2019_Human,Chronic myeloid leukemia,1/76,0.0037999437281752,0.0104011986398666,0,0,19924.0,111031.8499691117,MAPK3
10808,KEGG_2019_Human,Pertussis,1/76,0.0037999437281752,0.0104011986398666,0,0,19924.0,111031.8499691117,MAPK3
10809,KEGG_2019_Human,ErbB signaling pathway,1/85,0.004249939567045,0.0104011986398666,0,0,19915.0,108752.83801948265,MAPK3
10810,KEGG_2019_Human,Colorectal cancer,1/86,0.0042999391173866,0.0104011986398666,0,0,19914.0,108514.46102290176,MAPK3
10811,KEGG_2019_Human,Salmonella infection,1/86,0.0042999391173866,0.0104011986398666,0,0,19914.0,108514.46102290176,MAPK3
10812,KEGG_2019_Human,Gap junction,1/88,0.0043999382262822,0.0104011986398666,0,0,19912.0,108045.79305232369,MAPK3
10813,KEGG_2019_Human,TGF-beta signaling pathway,1/90,0.0044999373439762,0.0104011986398666,0,0,19910.0,107587.50385474482,MAPK3
10814,KEGG_2019_Human,Fc gamma R-mediated phagocytosis,1/91,0.0045499369072032,0.0104011986398666,0,0,19909.0,107362.10783923086,MAPK3
10815,KEGG_2019_Human,Th1 and Th2 cell differentiation,1/92,0.0045999364719865,0.0104011986398666,0,0,19908.0,107139.13814408927,MAPK3
10816,KEGG_2019_Human,GnRH signaling pathway,1/93,0.0046499360391879,0.0104011986398666,0,0,19907.0,106918.54242106884,MAPK3
10817,KEGG_2019_Human,IL-17 signaling pathway,1/93,0.0046499360391879,0.0104011986398666,0,0,19907.0,106918.54242106884,MAPK3
10818,KEGG_2019_Human,Circadian entrainment,1/97,0.0048499343304706,0.0104011986398666,0,0,19903.0,106058.9096435903,MAPK3
10819,KEGG_2019_Human,Prostate cancer,1/97,0.0048499343304706,0.0104011986398666,0,0,19903.0,106058.9096435903,MAPK3
10820,KEGG_2019_Human,Choline metabolism in cancer,1/99,0.0049499334884068,0.0104011986398666,0,0,19901.0,105642.09305076736,MAPK3
10821,KEGG_2019_Human,Progesterone-mediated oocyte maturation,1/99,0.0049499334884068,0.0104011986398666,0,0,19901.0,105642.09305076736,MAPK3
10822,KEGG_2019_Human,AGE-RAGE signaling pathway in diabetic complications,1/100,0.0049999330710556,0.0104011986398666,0,0,19900.0,105436.78197328727,MAPK3
10823,KEGG_2019_Human,HIF-1 signaling pathway,1/100,0.0049999330710556,0.0104011986398666,0,0,19900.0,105436.78197328727,MAPK3
10824,KEGG_2019_Human,T cell receptor signaling pathway,1/101,0.0050499326546803,0.0104011986398666,0,0,19899.0,105233.48101229242,MAPK3
10825,KEGG_2019_Human,Melanogenesis,1/101,0.0050499326546803,0.0104011986398666,0,0,19899.0,105233.48101229242,MAPK3
10826,KEGG_2019_Human,Chagas disease (American trypanosomiasis),1/103,0.0051499318302617,0.0104011986398666,0,0,19897.0,104832.7525292024,MAPK3
10827,KEGG_2019_Human,Toll-like receptor signaling pathway,1/104,0.0051999314202997,0.0104011986398666,0,0,19896.0,104635.24941415618,MAPK3
10828,KEGG_2019_Human,C-type lectin receptor signaling pathway,1/104,0.0051999314202997,0.0104011986398666,0,0,19896.0,104635.24941415618,MAPK3
10829,KEGG_2019_Human,"Parathyroid hormone synthesis, secretion and action",1/106,0.0052999306076525,0.0104011986398666,0,0,19894.0,104245.78450366124,MAPK3
10830,KEGG_2019_Human,Th17 cell differentiation,1/107,0.0053499302026925,0.0104011986398666,0,0,19893.0,104053.753408911,MAPK3
10831,KEGG_2019_Human,TNF signaling pathway,1/110,0.0054999290027479,0.0104011986398666,0,0,19890.0,103488.06969787036,MAPK3
10832,KEGG_2019_Human,Cholinergic synapse,1/112,0.0055999282120529,0.0104011986398666,0,0,19888.0,103119.30984392198,MAPK3
10833,KEGG_2019_Human,Toxoplasmosis,1/113,0.0056499278191151,0.0104011986398666,0,0,19887.0,102937.34947211576,MAPK3
10834,KEGG_2019_Human,Serotonergic synapse,1/113,0.0056499278191151,0.0104011986398666,0,0,19887.0,102937.34947211576,MAPK3
10835,KEGG_2019_Human,Glutamatergic synapse,1/114,0.005699927427839,0.0104011986398666,0,0,19886.0,102756.96431429044,MAPK3
10836,KEGG_2019_Human,Thyroid hormone signaling pathway,1/116,0.0057999266512085,0.0104011986398666,0,0,19884.0,102400.8105961506,MAPK3
10837,KEGG_2019_Human,Sphingolipid signaling pathway,1/119,0.0059499254985137,0.0104011986398666,0,0,19881.0,101877.73080211312,MAPK3
10838,KEGG_2019_Human,Neurotrophin signaling pathway,1/119,0.0059499254985137,0.0104011986398666,0,0,19881.0,101877.73080211312,MAPK3
10839,KEGG_2019_Human,Platelet activation,1/124,0.0061999236097501,0.0104011986398666,0,0,19876.0,101034.04709010696,MAPK3
10840,KEGG_2019_Human,Oocyte meiosis,1/125,0.0062499232373748,0.0104011986398666,0,0,19875.0,100869.32368441945,MAPK3
10841,KEGG_2019_Human,Osteoclast differentiation,1/127,0.0063499224962247,0.0104011986398666,0,0,19873.0,100543.72072014232,MAPK3
10842,KEGG_2019_Human,Autophagy,1/128,0.0063999221281459,0.0104011986398666,0,0,19872.0,100382.8010329652,MAPK3
10843,KEGG_2019_Human,Relaxin signaling pathway,1/130,0.0064999213952527,0.0104011986398666,0,0,19870.0,100064.62842845908,MAPK3
10844,KEGG_2019_Human,Natural killer cell mediated cytotoxicity,1/131,0.0065499210316603,0.0104011986398666,0,0,19869.0,99907.33811343512,MAPK3
10845,KEGG_2019_Human,Vascular smooth muscle contraction,1/132,0.0065999206698993,0.0104011986398666,0,0,19868.0,99751.22090491928,MAPK3
10846,KEGG_2019_Human,FoxO signaling pathway,1/132,0.0065999206698993,0.0104011986398666,0,0,19868.0,99751.22090491928,MAPK3
10847,KEGG_2019_Human,Apelin signaling pathway,1/137,0.0068499188797651,0.0104011986398666,0,0,19863.0,98987.62735269018,MAPK3
10848,KEGG_2019_Human,Estrogen signaling pathway,1/137,0.0068499188797651,0.0104011986398666,0,0,19863.0,98987.62735269018,MAPK3
10849,KEGG_2019_Human,Insulin signaling pathway,1/137,0.0068499188797651,0.0104011986398666,0,0,19863.0,98987.62735269018,MAPK3
10850,KEGG_2019_Human,Signaling pathways regulating pluripotency of stem cells,1/139,0.006949918172816,0.0104011986398666,0,0,19861.0,98689.81333375497,MAPK3
10851,KEGG_2019_Human,Apoptosis,1/143,0.0071499167770442,0.0104011986398666,0,0,19857.0,98106.57763600958,MAPK3
10852,KEGG_2019_Human,Adrenergic signaling in cardiomyocytes,1/145,0.0072499160871101,0.0104011986398666,0,0,19855.0,97820.92670675044,MAPK3
10853,KEGG_2019_Human,Breast cancer,1/147,0.0073499154017982,0.0104011986398666,0,0,19853.0,97539.10874372096,MAPK3
10854,KEGG_2019_Human,Phospholipase D signaling pathway,1/148,0.007399915061391,0.0104011986398666,0,0,19852.0,97399.60470052566,MAPK3
10855,KEGG_2019_Human,Retrograde endocannabinoid signaling,1/148,0.007399915061391,0.0104011986398666,0,0,19852.0,97399.60470052566,MAPK3
10856,KEGG_2019_Human,Gastric cancer,1/149,0.0074499147221605,0.0104011986398666,0,0,19851.0,97261.02051561224,MAPK3
10857,KEGG_2019_Human,mTOR signaling pathway,1/152,0.0075999137114971,0.0104011986398666,0,0,19848.0,96850.665715497,MAPK3
10858,KEGG_2019_Human,Oxytocin signaling pathway,1/153,0.0076499133771537,0.0104011986398666,0,0,19847.0,96715.6407630817,MAPK3
10859,KEGG_2019_Human,Cushing syndrome,1/155,0.0077499127120574,0.0104011986398666,0,0,19845.0,96448.16254952336,MAPK3
10860,KEGG_2019_Human,Hepatitis C,1/155,0.0077499127120574,0.0104011986398666,0,0,19845.0,96448.16254952336,MAPK3
10861,KEGG_2019_Human,Cellular senescence,1/160,0.0079999110688441,0.0105972847924948,0,0,19840.0,95793.96509856998,MAPK3
10862,KEGG_2019_Human,Hepatitis B,1/163,0.0081499100978668,0.0106352508620471,0,0,19837.0,95410.9786681514,MAPK3
10863,KEGG_2019_Human,cGMP-PKG signaling pathway,1/166,0.0082999091363732,0.0106352508620471,0,0,19834.0,95034.82345515196,MAPK3
10864,KEGG_2019_Human,Hepatocellular carcinoma,1/168,0.0083999085011095,0.0106352508620471,0,0,19832.0,94787.72752807094,MAPK3
10865,KEGG_2019_Human,Alzheimer disease,1/171,0.0085499075557634,0.0106352508620471,0,0,19829.0,94422.42241345016,MAPK3
10866,KEGG_2019_Human,Influenza A,1/171,0.0085499075557634,0.0106352508620471,0,0,19829.0,94422.42241345016,MAPK3
10867,KEGG_2019_Human,NOD-like receptor signaling pathway,1/178,0.0088999053857096,0.0107336076281419,0,0,19822.0,93593.82745769851,MAPK3
10868,KEGG_2019_Human,Tuberculosis,1/179,0.0089499050800561,0.0107336076281419,0,0,19821.0,93478.0629355712,MAPK3
10869,KEGG_2019_Human,Alcoholism,1/180,0.0089999047745351,0.0107336076281419,0,0,19820.0,93362.92821536642,MAPK3
10870,KEGG_2019_Human,Axon guidance,1/181,0.0090499044707863,0.0107336076281419,0,0,19819.0,93248.41634586031,MAPK3
10871,KEGG_2019_Human,Kaposi sarcoma-associated herpesvirus infection,1/186,0.0092999029651357,0.0109033345108488,0,0,19814.0,92684.96451050608,MAPK3
10872,KEGG_2019_Human,Chemokine signaling pathway,1/190,0.0094999017791995,0.0110112497895267,0,0,19810.0,92244.74636351672,MAPK3
10873,KEGG_2019_Human,Focal adhesion,1/199,0.0099498991610159,0.0112647214940164,0,0,19801.0,91286.4288690606,MAPK3
10874,KEGG_2019_Human,Viral carcinogenesis,1/201,0.0100498985877989,0.0112647214940164,0,0,19799.0,91079.21596609056,MAPK3
10875,KEGG_2019_Human,Proteoglycans in cancer,1/201,0.0100498985877989,0.0112647214940164,0,0,19799.0,91079.21596609056,MAPK3
10876,KEGG_2019_Human,Rap1 signaling pathway,1/206,0.010299897173561,0.0114194512141655,0,0,19794.0,90569.849337325,MAPK3
10877,KEGG_2019_Human,cAMP signaling pathway,1/212,0.0105998955026255,0.0114883082636157,0,0,19788.0,89974.27756224656,MAPK3
10878,KEGG_2019_Human,Human immunodeficiency virus 1 infection,1/212,0.0105998955026255,0.0114883082636157,0,0,19788.0,89974.27756224656,MAPK3
10879,KEGG_2019_Human,Regulation of actin cytoskeleton,1/214,0.0106998949514067,0.0114883082636157,0,0,19786.0,89779.39753374986,MAPK3
10880,KEGG_2019_Human,Human T-cell leukemia virus 1 infection,1/219,0.0109498935894162,0.0116342619387547,0,0,19781.0,89299.85161916987,MAPK3
10881,KEGG_2019_Human,Human cytomegalovirus infection,1/225,0.0112498919790339,0.0118297833181593,0,0,19775.0,88738.27077557483,MAPK3
10882,KEGG_2019_Human,Ras signaling pathway,1/232,0.0115998901349604,0.0120733550384281,0,0,19768.0,88101.22480150245,MAPK3
10883,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.015196840861337,0,0,19705.0,83086.53988020132,MAPK3
10884,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0168298648081438,0,0,19670.0,80733.60565076157,MAPK3
10885,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0178751088061328,0,0,19646.0,79255.8617626126,MAPK3
10886,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,MAPK3
10887,KEGG_2019_Human,Nicotinate and nicotinamide metabolism,1/30,0.0014999697593334,0.0029999395186669,0,0,19970.0,129851.13732048514,NUDT12
10888,KEGG_2019_Human,Peroxisome,1/83,0.0041499404726918,0.0041499404726918,0,0,19917.0,109237.99888847338,NUDT12
10889,KEGG_2019_Human,Melanoma,1/72,0.0035999456502131,0.0173998352024406,0,0,19928.0,112131.59838572376,FGF10
10890,KEGG_2019_Human,Breast cancer,1/147,0.0073499154017982,0.0173998352024406,0,0,19853.0,97539.10874372096,FGF10
10891,KEGG_2019_Human,Gastric cancer,1/149,0.0074499147221605,0.0173998352024406,0,0,19851.0,97261.02051561224,FGF10
10892,KEGG_2019_Human,Rap1 signaling pathway,1/206,0.010299897173561,0.0173998352024406,0,0,19794.0,90569.849337325,FGF10
10893,KEGG_2019_Human,Regulation of actin cytoskeleton,1/214,0.0106998949514067,0.0173998352024406,0,0,19786.0,89779.39753374986,FGF10
10894,KEGG_2019_Human,Ras signaling pathway,1/232,0.0115998901349604,0.0173998352024406,0,0,19768.0,88101.22480150245,FGF10
10895,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.018964124940408,0,0,19705.0,83086.53988020132,FGF10
10896,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0199123454715377,0,0,19646.0,79255.8617626126,FGF10
10897,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,FGF10
10898,KEGG_2019_Human,Autophagy,1/128,0.0063999221281459,0.0075999137114971,0,0,19872.0,100382.8010329652,ULK2
10899,KEGG_2019_Human,mTOR signaling pathway,1/152,0.0075999137114971,0.0075999137114971,0,0,19848.0,96850.665715497,ULK2
10900,KEGG_2019_Human,cAMP signaling pathway,1/212,0.0105998955026255,0.0168998658265596,0,0,19788.0,89974.27756224656,SSTR1
10901,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,SSTR1
10902,KEGG_2019_Human,RNA degradation,1/79,0.0039499423167337,0.0039499423167337,0,0,19921.0,110243.89578070649,DHX36
10903,KEGG_2019_Human,Nucleotide excision repair,1/47,0.0023499589392381,0.0023499589392381,0,0,19953.0,120782.64067395544,CETN2
10904,KEGG_2019_Human,Complement and coagulation cascades,1/79,0.0039499423167337,0.0149997992131669,0,0,19921.0,110243.89578070649,BDKRB1
10905,KEGG_2019_Human,Inflammatory mediator regulation of TRP channels,1/100,0.0049999330710556,0.0149997992131669,0,0,19900.0,105436.78197328727,BDKRB1
10906,KEGG_2019_Human,Calcium signaling pathway,1/188,0.009399902370135,0.0160498424271101,0,0,19812.0,92463.712994847,BDKRB1
10907,KEGG_2019_Human,Regulation of actin cytoskeleton,1/214,0.0106998949514067,0.0160498424271101,0,0,19786.0,89779.39753374986,BDKRB1
10908,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0202798389918715,0,0,19662.0,80229.79996326564,BDKRB1
10909,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,BDKRB1
10910,KEGG_2019_Human,Glycosphingolipid biosynthesis,1/45,0.0022499601197094,0.0022499601197094,0,0,19955.0,121662.49782449217,SLC33A1
10911,KEGG_2019_Human,RNA degradation,1/79,0.0039499423167337,0.0039499423167337,0,0,19921.0,110243.89578070649,DIS3
10912,KEGG_2019_Human,Gastric acid secretion,1/75,0.0037499442041125,0.0037499442041125,0,0,19925.0,111301.33528642564,KCNK10
10913,KEGG_2019_Human,Taste transduction,1/83,0.0041499404726918,0.0112998556382303,0,0,19917.0,109237.99888847338,HTR1F
10914,KEGG_2019_Human,Serotonergic synapse,1/113,0.0056499278191151,0.0112998556382303,0,0,19887.0,102937.34947211576,HTR1F
10915,KEGG_2019_Human,cAMP signaling pathway,1/212,0.0105998955026255,0.0141331940035007,0,0,19788.0,89974.27756224656,HTR1F
10916,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,HTR1F
10917,KEGG_2019_Human,SNARE interactions in vesicular transport,1/34,0.0016999670339032,0.0033999340678064,0,0,19966.0,127326.1054203148,STX1B
10918,KEGG_2019_Human,Synaptic vesicle cycle,1/78,0.0038999427840466,0.0038999427840466,0,0,19922.0,110503.2180492851,STX1B
10919,KEGG_2019_Human,Butanoate metabolism,1/28,0.0013999711732997,0.0013999711732997,0,0,19972.0,131242.0761597353,ACSM2B
10920,KEGG_2019_Human,Staphylococcus aureus infection,1/68,0.0033999476216189,0.0067998952432378,0,0,19932.0,113293.39338050144,DEFA5
10921,KEGG_2019_Human,NOD-like receptor signaling pathway,1/178,0.0088999053857096,0.0088999053857096,0,0,19822.0,93593.82745769851,DEFA5
10922,KEGG_2019_Human,Peroxisome,1/83,0.0041499404726918,0.0041499404726918,0,0,19917.0,109237.99888847338,PEX3
10923,KEGG_2019_Human,Morphine addiction,1/91,0.0045499369072032,0.0121998870519305,0,0,19909.0,107362.10783923086,GRK4
10924,KEGG_2019_Human,Chemokine signaling pathway,1/190,0.0094999017791995,0.0121998870519305,0,0,19810.0,92244.74636351672,GRK4
10925,KEGG_2019_Human,Endocytosis,1/244,0.0121998870519305,0.0121998870519305,0,0,19756.0,87051.4275316661,GRK4
10926,KEGG_2019_Human,mRNA surveillance pathway,1/91,0.0045499369072032,0.0084999078692823,0,0,19909.0,107362.10783923086,SYMPK
10927,KEGG_2019_Human,Tight junction,1/170,0.0084999078692823,0.0084999078692823,0,0,19830.0,94543.49009679438,SYMPK
10928,KEGG_2019_Human,Endocytosis,1/244,0.0121998870519305,0.0121998870519305,0,0,19756.0,87051.4275316661,IQSEC2
10929,KEGG_2019_Human,Arachidonic acid metabolism,1/63,0.0031499501598827,0.0031499501598827,0,0,19937.0,114844.46974572667,CYP4F3
10930,KEGG_2019_Human,Glycerolipid metabolism,1/61,0.0030499512001654,0.0048499343304706,0,0,19939.0,115499.24335773686,GPAT3
10931,KEGG_2019_Human,Glycerophospholipid metabolism,1/97,0.0048499343304706,0.0048499343304706,0,0,19903.0,106058.9096435903,GPAT3
10932,KEGG_2019_Human,Measles,1/138,0.0068999185254481,0.0082499094553477,0,0,19862.0,98838.19160389496,EIF3H
10933,KEGG_2019_Human,RNA transport,1/165,0.0082499094553477,0.0082499094553477,0,0,19835.0,95159.46482222488,EIF3H
10934,KEGG_2019_Human,mTOR signaling pathway,1/152,0.0075999137114971,0.0075999137114971,0,0,19848.0,96850.665715497,GRB10
10935,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR2A5
10936,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR2F2
10937,KEGG_2019_Human,Signaling pathways regulating pluripotency of stem cells,1/139,0.006949918172816,0.0100498985877989,0,0,19861.0,98689.81333375497,NANOG
10938,KEGG_2019_Human,Proteoglycans in cancer,1/201,0.0100498985877989,0.0100498985877989,0,0,19799.0,91079.21596609056,NANOG
10939,KEGG_2019_Human,Vascular smooth muscle contraction,1/132,0.0065999206698993,0.0131998413397987,0,0,19868.0,99751.22090491928,CALCRL
10940,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,CALCRL
10941,KEGG_2019_Human,Complement and coagulation cascades,1/79,0.0039499423167337,0.014799830122782,0,0,19921.0,110243.89578070649,F2
10942,KEGG_2019_Human,Platelet activation,1/124,0.0061999236097501,0.014799830122782,0,0,19876.0,101034.04709010696,F2
10943,KEGG_2019_Human,Phospholipase D signaling pathway,1/148,0.007399915061391,0.014799830122782,0,0,19852.0,97399.60470052566,F2
10944,KEGG_2019_Human,Regulation of actin cytoskeleton,1/214,0.0106998949514067,0.0160498424271101,0,0,19786.0,89779.39753374986,F2
10945,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0202798389918715,0,0,19662.0,80229.79996326564,F2
10946,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,F2
10947,KEGG_2019_Human,Progesterone-mediated oocyte maturation,1/99,0.0049499334884068,0.0062499232373748,0,0,19901.0,105642.09305076736,BUB1
10948,KEGG_2019_Human,Cell cycle,1/124,0.0061999236097501,0.0062499232373748,0,0,19876.0,101034.04709010696,BUB1
10949,KEGG_2019_Human,Oocyte meiosis,1/125,0.0062499232373748,0.0062499232373748,0,0,19875.0,100869.32368441945,BUB1
10950,KEGG_2019_Human,Nicotine addiction,1/40,0.0019999631680592,0.007583228178672,0,0,19960.0,124043.94523066044,GABRD
10951,KEGG_2019_Human,GABAergic synapse,1/89,0.0044499377838098,0.007583228178672,0,0,19911.0,107815.380281759,GABRD
10952,KEGG_2019_Human,Morphine addiction,1/91,0.0045499369072032,0.007583228178672,0,0,19909.0,107362.10783923086,GABRD
10953,KEGG_2019_Human,Retrograde endocannabinoid signaling,1/148,0.007399915061391,0.0092498938267387,0,0,19852.0,97399.60470052566,GABRD
10954,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,GABRD
10955,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF415
10956,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF256
10957,KEGG_2019_Human,Ribosome,1/153,0.0076499133771537,0.0076499133771537,0,0,19847.0,96715.6407630817,MRPL9
10958,KEGG_2019_Human,D-Glutamine and D-glutamate metabolism,1/5,0.0002499917995416556,0.0014999507972499,0,0,19995.0,165840.17843725558,GLUD2
10959,KEGG_2019_Human,Nitrogen metabolism,1/17,0.0008499797390404818,0.0017249623229924,0,0,19983.0,141285.76583697114,GLUD2
10960,KEGG_2019_Human,Arginine biosynthesis,1/21,0.0010499764455398,0.0017249623229924,0,0,19979.0,137035.71221916509,GLUD2
10961,KEGG_2019_Human,Proximal tubule bicarbonate reclamation,1/23,0.0011499748819949,0.0017249623229924,0,0,19977.0,135204.63922267244,GLUD2
10962,KEGG_2019_Human,"Alanine, aspartate and glutamate metabolism",1/35,0.0017499663721595,0.0020999596465915,0,0,19965.0,126740.98858805298,GLUD2
10963,KEGG_2019_Human,Necroptosis,1/162,0.0080999104202618,0.0080999104202618,0,0,19838.0,95537.86936302872,GLUD2
10964,KEGG_2019_Human,Spliceosome,1/134,0.0066999199497742,0.0082499094553477,0,0,19866.0,99442.43560916925,THOC1
10965,KEGG_2019_Human,RNA transport,1/165,0.0082499094553477,0.0082499094553477,0,0,19835.0,95159.46482222488,THOC1
10966,KEGG_2019_Human,Amino sugar and nucleotide sugar metabolism,1/48,0.0023999583567988,0.0023999583567988,0,0,19952.0,120356.5272753826,NAGK
10967,KEGG_2019_Human,p53 signaling pathway,1/72,0.0035999456502131,0.0050999322416682,0,0,19928.0,112131.59838572376,SESN1
10968,KEGG_2019_Human,Longevity regulating pathway,1/102,0.0050999322416682,0.0050999322416682,0,0,19898.0,105032.15064717118,SESN1
10969,KEGG_2019_Human,mRNA surveillance pathway,1/91,0.0045499369072032,0.0045499369072032,0,0,19909.0,107362.10783923086,SMG1
10970,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,SSTR3
10971,KEGG_2019_Human,Human immunodeficiency virus 1 infection,1/212,0.0105998955026255,0.0105998955026255,0,0,19788.0,89974.27756224656,APOBEC3C
10972,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF527
10973,KEGG_2019_Human,Proteasome,1/45,0.0022499601197094,0.0022499601197094,0,0,19955.0,121662.49782449217,PSMB9
10974,KEGG_2019_Human,Axon guidance,1/181,0.0090499044707863,0.0176998626413668,0,0,19819.0,93248.41634586031,EFNA3
10975,KEGG_2019_Human,Rap1 signaling pathway,1/206,0.010299897173561,0.0176998626413668,0,0,19794.0,90569.849337325,EFNA3
10976,KEGG_2019_Human,Ras signaling pathway,1/232,0.0115998901349604,0.0176998626413668,0,0,19768.0,88101.22480150245,EFNA3
10977,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0176998626413668,0,0,19705.0,83086.53988020132,EFNA3
10978,KEGG_2019_Human,MicroRNAs in cancer,1/299,0.0149498740670514,0.0176998626413668,0,0,19701.0,82804.33538735632,EFNA3
10979,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0176998626413668,0,0,19646.0,79255.8617626126,EFNA3
10980,KEGG_2019_Human,Circadian rhythm,1/31,0.0015499690656704,0.0030999381313408,0,0,19969.0,129189.85098816035,PER3
10981,KEGG_2019_Human,Circadian entrainment,1/97,0.0048499343304706,0.0048499343304706,0,0,19903.0,106058.9096435903,PER3
10982,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF473
10983,KEGG_2019_Human,Retinol metabolism,1/67,0.0033499481224912,0.0033499481224912,0,0,19933.0,113594.38808369274,DHRS3
10984,KEGG_2019_Human,Cholinergic synapse,1/112,0.0055999282120529,0.0055999282120529,0,0,19888.0,103119.30984392198,KCNQ4
10985,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR5T2
10986,KEGG_2019_Human,Maturity onset diabetes of the young,1/26,0.0012999726251831,0.0012999726251831,0,0,19974.0,132735.46073187632,BHLHA15
10987,KEGG_2019_Human,Tight junction,1/170,0.0084999078692823,0.0084999078692823,0,0,19830.0,94543.49009679438,MYH15
10988,KEGG_2019_Human,Endometrial cancer,1/58,0.0028999527887707,0.0061665744717416,0,0,19942.0,116522.31890946148,ILK
10989,KEGG_2019_Human,Bacterial invasion of epithelial cells,1/74,0.0036999446830449,0.0061665744717416,0,0,19926.0,111574.38983110404,ILK
10990,KEGG_2019_Human,PPAR signaling pathway,1/74,0.0036999446830449,0.0061665744717416,0,0,19926.0,111574.38983110404,ILK
10991,KEGG_2019_Human,Axon guidance,1/181,0.0090499044707863,0.0099498991610159,0,0,19819.0,93248.41634586031,ILK
10992,KEGG_2019_Human,Focal adhesion,1/199,0.0099498991610159,0.0099498991610159,0,0,19801.0,91286.4288690606,ILK
10993,KEGG_2019_Human,Leukocyte transendothelial migration,1/112,0.0055999282120529,0.0084999078692823,0,0,19888.0,103119.30984392198,CLDN4
10994,KEGG_2019_Human,Cell adhesion molecules (CAMs),1/145,0.0072499160871101,0.0084999078692823,0,0,19855.0,97820.92670675044,CLDN4
10995,KEGG_2019_Human,Hepatitis C,1/155,0.0077499127120574,0.0084999078692823,0,0,19845.0,96448.16254952336,CLDN4
10996,KEGG_2019_Human,Tight junction,1/170,0.0084999078692823,0.0084999078692823,0,0,19830.0,94543.49009679438,CLDN4
10997,KEGG_2019_Human,Inositol phosphate metabolism,1/74,0.0036999446830449,0.0098998669768137,0,0,19926.0,111574.38983110404,PIP5K1C
10998,KEGG_2019_Human,Fc gamma R-mediated phagocytosis,1/91,0.0045499369072032,0.0098998669768137,0,0,19909.0,107362.10783923086,PIP5K1C
10999,KEGG_2019_Human,Phosphatidylinositol signaling system,1/99,0.0049499334884068,0.0098998669768137,0,0,19901.0,105642.09305076736,PIP5K1C
11000,KEGG_2019_Human,Choline metabolism in cancer,1/99,0.0049499334884068,0.0098998669768137,0,0,19901.0,105642.09305076736,PIP5K1C
11001,KEGG_2019_Human,Phospholipase D signaling pathway,1/148,0.007399915061391,0.0118398640982256,0,0,19852.0,97399.60470052566,PIP5K1C
11002,KEGG_2019_Human,Focal adhesion,1/199,0.0099498991610159,0.0121998870519305,0,0,19801.0,91286.4288690606,PIP5K1C
11003,KEGG_2019_Human,Regulation of actin cytoskeleton,1/214,0.0106998949514067,0.0121998870519305,0,0,19786.0,89779.39753374986,PIP5K1C
11004,KEGG_2019_Human,Endocytosis,1/244,0.0121998870519305,0.0121998870519305,0,0,19756.0,87051.4275316661,PIP5K1C
11005,KEGG_2019_Human,TGF-beta signaling pathway,1/90,0.0044999373439762,0.010424877259224,0,0,19910.0,107587.50385474482,ACVR1C
11006,KEGG_2019_Human,Signaling pathways regulating pluripotency of stem cells,1/139,0.006949918172816,0.010424877259224,0,0,19861.0,98689.81333375497,ACVR1C
11007,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0146998751759735,0,0,19706.0,83157.67014793828,ACVR1C
11008,KEGG_2019_Human,Glycolysis / Gluconeogenesis,1/68,0.0033999476216189,0.0049999330710556,0,0,19932.0,113293.39338050144,ENO4
11009,KEGG_2019_Human,RNA degradation,1/79,0.0039499423167337,0.0049999330710556,0,0,19921.0,110243.89578070649,ENO4
11010,KEGG_2019_Human,HIF-1 signaling pathway,1/100,0.0049999330710556,0.0049999330710556,0,0,19900.0,105436.78197328727,ENO4
11011,KEGG_2019_Human,Mismatch repair,1/23,0.0011499748819949,0.0023499589392381,0,0,19977.0,135204.63922267244,POLD1
11012,KEGG_2019_Human,Base excision repair,1/33,0.0016499677032113,0.0023499589392381,0,0,19967.0,127928.56031580272,POLD1
11013,KEGG_2019_Human,DNA replication,1/36,0.0017999657178272,0.0023499589392381,0,0,19964.0,126172.23364250171,POLD1
11014,KEGG_2019_Human,Homologous recombination,1/41,0.0020499625466866,0.0023499589392381,0,0,19959.0,123544.88783416104,POLD1
11015,KEGG_2019_Human,Nucleotide excision repair,1/47,0.0023499589392381,0.0023499589392381,0,0,19953.0,120782.64067395544,POLD1
11016,KEGG_2019_Human,Purine metabolism,1/129,0.006449921761047,0.006449921761047,0,0,19871.0,100223.109907462,GUCY2C
11017,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR1Q1
11018,KEGG_2019_Human,ABC transporters,1/45,0.0022499601197094,0.0022499601197094,0,0,19955.0,121662.49782449217,ABCB6
11019,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF180
11020,KEGG_2019_Human,Renin secretion,1/69,0.003449947123837,0.0090998738144064,0,0,19931.0,112996.7391397682,PDE1B
11021,KEGG_2019_Human,Taste transduction,1/83,0.0041499404726918,0.0090998738144064,0,0,19917.0,109237.99888847338,PDE1B
11022,KEGG_2019_Human,Morphine addiction,1/91,0.0045499369072032,0.0090998738144064,0,0,19909.0,107362.10783923086,PDE1B
11023,KEGG_2019_Human,Purine metabolism,1/129,0.006449921761047,0.0096748826415705,0,0,19871.0,100223.109907462,PDE1B
11024,KEGG_2019_Human,Calcium signaling pathway,1/188,0.009399902370135,0.011279882844162,0,0,19812.0,92463.712994847,PDE1B
11025,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,PDE1B
11026,KEGG_2019_Human,Non-homologous end-joining,1/13,0.0006499833083207112,0.0006499833083207112,0,0,19987.0,146675.87616784443,LIG4
11027,KEGG_2019_Human,Sphingolipid metabolism,1/47,0.0023499589392381,0.0080999104202618,0,0,19953.0,120782.64067395544,SMPD1
11028,KEGG_2019_Human,Sphingolipid signaling pathway,1/119,0.0059499254985137,0.0080999104202618,0,0,19881.0,101877.73080211312,SMPD1
11029,KEGG_2019_Human,Lysosome,1/123,0.0061499239842961,0.0080999104202618,0,0,19877.0,101200.07933676826,SMPD1
11030,KEGG_2019_Human,Necroptosis,1/162,0.0080999104202618,0.0080999104202618,0,0,19838.0,95537.86936302872,SMPD1
11031,KEGG_2019_Human,Choline metabolism in cancer,1/99,0.0049499334884068,0.0049499334884068,0,0,19901.0,105642.09305076736,SLC22A2
11032,KEGG_2019_Human,Lysine degradation,1/59,0.0029499522555206,0.0058999045110413,0,0,19941.0,116175.59385530632,NSD2
11033,KEGG_2019_Human,Transcriptional misregulation in cancer,1/186,0.0092999029651357,0.0092999029651357,0,0,19814.0,92684.96451050608,NSD2
11034,KEGG_2019_Human,Vitamin digestion and absorption,1/24,0.0011999741185782,0.0044999202394188,0,0,19976.0,134347.69487847842,ABCC1
11035,KEGG_2019_Human,ABC transporters,1/45,0.0022499601197094,0.0044999202394188,0,0,19955.0,121662.49782449217,ABCC1
11036,KEGG_2019_Human,Sphingolipid signaling pathway,1/119,0.0059499254985137,0.0079332339980183,0,0,19881.0,101877.73080211312,ABCC1
11037,KEGG_2019_Human,MicroRNAs in cancer,1/299,0.0149498740670514,0.0149498740670514,0,0,19701.0,82804.33538735632,ABCC1
11038,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR11H7
11039,KEGG_2019_Human,Complement and coagulation cascades,1/79,0.0039499423167337,0.006949918172816,0,0,19921.0,110243.89578070649,THBD
11040,KEGG_2019_Human,AGE-RAGE signaling pathway in diabetic complications,1/100,0.0049999330710556,0.006949918172816,0,0,19900.0,105436.78197328727,THBD
11041,KEGG_2019_Human,Fluid shear stress and atherosclerosis,1/139,0.006949918172816,0.006949918172816,0,0,19861.0,98689.81333375497,THBD
11042,KEGG_2019_Human,VEGF signaling pathway,1/59,0.0029499522555206,0.0134998703748406,0,0,19941.0,116175.59385530632,PTK2
11043,KEGG_2019_Human,Bacterial invasion of epithelial cells,1/74,0.0036999446830449,0.0134998703748406,0,0,19926.0,111574.38983110404,PTK2
11044,KEGG_2019_Human,ErbB signaling pathway,1/85,0.004249939567045,0.0134998703748406,0,0,19915.0,108752.83801948265,PTK2
11045,KEGG_2019_Human,Small cell lung cancer,1/93,0.0046499360391879,0.0134998703748406,0,0,19907.0,106918.54242106884,PTK2
11046,KEGG_2019_Human,Amoebiasis,1/96,0.0047999347538706,0.0134998703748406,0,0,19904.0,106270.50039849174,PTK2
11047,KEGG_2019_Human,Leukocyte transendothelial migration,1/112,0.0055999282120529,0.0134998703748406,0,0,19888.0,103119.30984392198,PTK2
11048,KEGG_2019_Human,Fluid shear stress and atherosclerosis,1/139,0.006949918172816,0.0134998703748406,0,0,19861.0,98689.81333375497,PTK2
11049,KEGG_2019_Human,Axon guidance,1/181,0.0090499044707863,0.0134998703748406,0,0,19819.0,93248.41634586031,PTK2
11050,KEGG_2019_Human,Transcriptional misregulation in cancer,1/186,0.0092999029651357,0.0134998703748406,0,0,19814.0,92684.96451050608,PTK2
11051,KEGG_2019_Human,Chemokine signaling pathway,1/190,0.0094999017791995,0.0134998703748406,0,0,19810.0,92244.74636351672,PTK2
11052,KEGG_2019_Human,Focal adhesion,1/199,0.0099498991610159,0.0134998703748406,0,0,19801.0,91286.4288690606,PTK2
11053,KEGG_2019_Human,Proteoglycans in cancer,1/201,0.0100498985877989,0.0134998703748406,0,0,19799.0,91079.21596609056,PTK2
11054,KEGG_2019_Human,Human immunodeficiency virus 1 infection,1/212,0.0105998955026255,0.0134998703748406,0,0,19788.0,89974.27756224656,PTK2
11055,KEGG_2019_Human,Regulation of actin cytoskeleton,1/214,0.0106998949514067,0.0134998703748406,0,0,19786.0,89779.39753374986,PTK2
11056,KEGG_2019_Human,Human cytomegalovirus infection,1/225,0.0112498919790339,0.0134998703748406,0,0,19775.0,88738.27077557483,PTK2
11057,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.018562350891335,0,0,19670.0,80733.60565076157,PTK2
11058,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0187410310320355,0,0,19646.0,79255.8617626126,PTK2
11059,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,PTK2
11060,KEGG_2019_Human,Basal transcription factors,1/45,0.0022499601197094,0.0022499601197094,0,0,19955.0,121662.49782449217,GTF2F1
11061,KEGG_2019_Human,JAK-STAT signaling pathway,1/162,0.0080999104202618,0.0176998626413668,0,0,19838.0,95537.86936302872,GH2
11062,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0176998626413668,0,0,19706.0,83157.67014793828,GH2
11063,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0176998626413668,0,0,19662.0,80229.79996326564,GH2
11064,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0176998626413668,0,0,19646.0,79255.8617626126,GH2
11065,KEGG_2019_Human,Axon guidance,1/181,0.0090499044707863,0.0147498749536506,0,0,19819.0,93248.41634586031,RASA1
11066,KEGG_2019_Human,Ras signaling pathway,1/232,0.0115998901349604,0.0147498749536506,0,0,19768.0,88101.22480150245,RASA1
11067,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0147498749536506,0,0,19705.0,83086.53988020132,RASA1
11068,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF250
11069,KEGG_2019_Human,Cholinergic synapse,1/112,0.0055999282120529,0.0055999282120529,0,0,19888.0,103119.30984392198,KCNQ3
11070,KEGG_2019_Human,Phototransduction,1/28,0.0013999711732997,0.0041999135198993,0,0,19972.0,131242.0761597353,GRK7
11071,KEGG_2019_Human,Chemokine signaling pathway,1/190,0.0094999017791995,0.0121998870519305,0,0,19810.0,92244.74636351672,GRK7
11072,KEGG_2019_Human,Endocytosis,1/244,0.0121998870519305,0.0121998870519305,0,0,19756.0,87051.4275316661,GRK7
11073,KEGG_2019_Human,Terpenoid backbone biosynthesis,1/22,0.0010999756574123,0.0021999513148247,0,0,19978.0,136099.47030191717,PMVK
11074,KEGG_2019_Human,Peroxisome,1/83,0.0041499404726918,0.0041499404726918,0,0,19917.0,109237.99888847338,PMVK
11075,KEGG_2019_Human,ECM-receptor interaction,1/82,0.004099940929819,0.0061999236097501,0,0,19918.0,109484.9180722932,GP5
11076,KEGG_2019_Human,Hematopoietic cell lineage,1/97,0.0048499343304706,0.0061999236097501,0,0,19903.0,106058.9096435903,GP5
11077,KEGG_2019_Human,Platelet activation,1/124,0.0061999236097501,0.0061999236097501,0,0,19876.0,101034.04709010696,GP5
11078,KEGG_2019_Human,Collecting duct acid secretion,1/27,0.0013499718942362,0.0081898864329657,0,0,19973.0,131975.02298599784,ATP6V1G3
11079,KEGG_2019_Human,Vibrio cholerae infection,1/50,0.0024999572069037,0.0081898864329657,0,0,19950.0,119530.05920663515,ATP6V1G3
11080,KEGG_2019_Human,Epithelial cell signaling in Helicobacter pylori infection,1/68,0.0033999476216189,0.0081898864329657,0,0,19932.0,113293.39338050144,ATP6V1G3
11081,KEGG_2019_Human,Synaptic vesicle cycle,1/78,0.0038999427840466,0.0081898864329657,0,0,19922.0,110503.2180492851,ATP6V1G3
11082,KEGG_2019_Human,Rheumatoid arthritis,1/91,0.0045499369072032,0.0081898864329657,0,0,19909.0,107362.10783923086,ATP6V1G3
11083,KEGG_2019_Human,Oxidative phosphorylation,1/133,0.0066499203093911,0.0085499029254342,0,0,19867.0,99596.2591544721,ATP6V1G3
11084,KEGG_2019_Human,mTOR signaling pathway,1/152,0.0075999137114971,0.0085499029254342,0,0,19848.0,96850.665715497,ATP6V1G3
11085,KEGG_2019_Human,Phagosome,1/152,0.0075999137114971,0.0085499029254342,0,0,19848.0,96850.665715497,ATP6V1G3
11086,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0164998674589645,0,0,19670.0,80733.60565076157,ATP6V1G3
11087,KEGG_2019_Human,Thyroid cancer,1/37,0.0018499650702878,0.0096665444186809,0,0,19963.0,125618.9446446357,RXRA
11088,KEGG_2019_Human,Non-small cell lung cancer,1/66,0.003299948626608,0.0096665444186809,0,0,19934.0,113899.85357353876,RXRA
11089,KEGG_2019_Human,Adipocytokine signaling pathway,1/69,0.003449947123837,0.0096665444186809,0,0,19931.0,112996.7391397682,RXRA
11090,KEGG_2019_Human,Bile secretion,1/72,0.0035999456502131,0.0096665444186809,0,0,19928.0,112131.59838572376,RXRA
11091,KEGG_2019_Human,PPAR signaling pathway,1/74,0.0036999446830449,0.0096665444186809,0,0,19926.0,111574.38983110404,RXRA
11092,KEGG_2019_Human,Small cell lung cancer,1/93,0.0046499360391879,0.0096665444186809,0,0,19907.0,106918.54242106884,RXRA
11093,KEGG_2019_Human,"Parathyroid hormone synthesis, secretion and action",1/106,0.0052999306076525,0.0096665444186809,0,0,19894.0,104245.78450366124,RXRA
11094,KEGG_2019_Human,Th17 cell differentiation,1/107,0.0053499302026925,0.0096665444186809,0,0,19893.0,104053.753408911,RXRA
11095,KEGG_2019_Human,Thyroid hormone signaling pathway,1/116,0.0057999266512085,0.0096665444186809,0,0,19884.0,102400.8105961506,RXRA
11096,KEGG_2019_Human,Gastric cancer,1/149,0.0074499147221605,0.0096873908900718,0,0,19851.0,97261.02051561224,RXRA
11097,KEGG_2019_Human,Non-alcoholic fatty liver disease (NAFLD),1/149,0.0074499147221605,0.0096873908900718,0,0,19851.0,97261.02051561224,RXRA
11098,KEGG_2019_Human,Hepatitis C,1/155,0.0077499127120574,0.0096873908900718,0,0,19845.0,96448.16254952336,RXRA
11099,KEGG_2019_Human,Transcriptional misregulation in cancer,1/186,0.0092999029651357,0.0107306572674643,0,0,19814.0,92684.96451050608,RXRA
11100,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0189641385443216,0,0,19646.0,79255.8617626126,RXRA
11101,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,RXRA
11102,KEGG_2019_Human,Drug metabolism,1/108,0.0053999298011749,0.0053999298011749,0,0,19892.0,103863.47861844616,FMO2
11103,KEGG_2019_Human,Taurine and hypotaurine metabolism,1/11,0.0005499852259717758,0.0016499556779153,0,0,19989.0,150029.8210287992,GGT5
11104,KEGG_2019_Human,Glutathione metabolism,1/56,0.0027999538675741,0.0031499501598827,0,0,19944.0,117233.87022514464,GGT5
11105,KEGG_2019_Human,Arachidonic acid metabolism,1/63,0.0031499501598827,0.0031499501598827,0,0,19937.0,114844.46974572667,GGT5
11106,KEGG_2019_Human,Pathogenic Escherichia coli infection,1/55,0.0027499544131125,0.0108665467971557,0,0,19945.0,117599.1294878737,YWHAQ
11107,KEGG_2019_Human,Cell cycle,1/124,0.0061999236097501,0.0108665467971557,0,0,19876.0,101034.04709010696,YWHAQ
11108,KEGG_2019_Human,Oocyte meiosis,1/125,0.0062499232373748,0.0108665467971557,0,0,19875.0,100869.32368441945,YWHAQ
11109,KEGG_2019_Human,Hepatitis C,1/155,0.0077499127120574,0.0108665467971557,0,0,19845.0,96448.16254952336,YWHAQ
11110,KEGG_2019_Human,Hippo signaling pathway,1/160,0.0079999110688441,0.0108665467971557,0,0,19840.0,95793.96509856998,YWHAQ
11111,KEGG_2019_Human,Hepatitis B,1/163,0.0081499100978668,0.0108665467971557,0,0,19837.0,95410.9786681514,YWHAQ
11112,KEGG_2019_Human,Viral carcinogenesis,1/201,0.0100498985877989,0.0114855983860559,0,0,19799.0,91079.21596609056,YWHAQ
11113,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0176998626413668,0,0,19646.0,79255.8617626126,YWHAQ
11114,KEGG_2019_Human,Shigellosis,1/65,0.003249949134407,0.0055499170245674,0,0,19935.0,114209.92613860144,ELMO1
11115,KEGG_2019_Human,Bacterial invasion of epithelial cells,1/74,0.0036999446830449,0.0055499170245674,0,0,19926.0,111574.38983110404,ELMO1
11116,KEGG_2019_Human,Chemokine signaling pathway,1/190,0.0094999017791995,0.0094999017791995,0,0,19810.0,92244.74636351672,ELMO1
11117,KEGG_2019_Human,Mitophagy,1/65,0.003249949134407,0.0063999221281459,0,0,19935.0,114209.92613860144,ATG9A
11118,KEGG_2019_Human,Autophagy,1/128,0.0063999221281459,0.0063999221281459,0,0,19872.0,100382.8010329652,ATG9A
11119,KEGG_2019_Human,Pathogenic Escherichia coli infection,1/55,0.0027499544131125,0.0118748859778691,0,0,19945.0,117599.1294878737,ROCK2
11120,KEGG_2019_Human,Shigellosis,1/65,0.003249949134407,0.0118748859778691,0,0,19935.0,114209.92613860144,ROCK2
11121,KEGG_2019_Human,Salmonella infection,1/86,0.0042999391173866,0.0118748859778691,0,0,19914.0,108514.46102290176,ROCK2
11122,KEGG_2019_Human,Leukocyte transendothelial migration,1/112,0.0055999282120529,0.0118748859778691,0,0,19888.0,103119.30984392198,ROCK2
11123,KEGG_2019_Human,Sphingolipid signaling pathway,1/119,0.0059499254985137,0.0118748859778691,0,0,19881.0,101877.73080211312,ROCK2
11124,KEGG_2019_Human,Platelet activation,1/124,0.0061999236097501,0.0118748859778691,0,0,19876.0,101034.04709010696,ROCK2
11125,KEGG_2019_Human,Vascular smooth muscle contraction,1/132,0.0065999206698993,0.0118748859778691,0,0,19868.0,99751.22090491928,ROCK2
11126,KEGG_2019_Human,Oxytocin signaling pathway,1/153,0.0076499133771537,0.0118748859778691,0,0,19847.0,96715.6407630817,ROCK2
11127,KEGG_2019_Human,Wnt signaling pathway,1/158,0.0078999117225733,0.0118748859778691,0,0,19842.0,96053.2110949472,ROCK2
11128,KEGG_2019_Human,cGMP-PKG signaling pathway,1/166,0.0082999091363732,0.0118748859778691,0,0,19834.0,95034.82345515196,ROCK2
11129,KEGG_2019_Human,Tight junction,1/170,0.0084999078692823,0.0118748859778691,0,0,19830.0,94543.49009679438,ROCK2
11130,KEGG_2019_Human,Axon guidance,1/181,0.0090499044707863,0.0118748859778691,0,0,19819.0,93248.41634586031,ROCK2
11131,KEGG_2019_Human,Chemokine signaling pathway,1/190,0.0094999017791995,0.0118748859778691,0,0,19810.0,92244.74636351672,ROCK2
11132,KEGG_2019_Human,Focal adhesion,1/199,0.0099498991610159,0.0118748859778691,0,0,19801.0,91286.4288690606,ROCK2
11133,KEGG_2019_Human,Proteoglycans in cancer,1/201,0.0100498985877989,0.0118748859778691,0,0,19799.0,91079.21596609056,ROCK2
11134,KEGG_2019_Human,cAMP signaling pathway,1/212,0.0105998955026255,0.0118748859778691,0,0,19788.0,89974.27756224656,ROCK2
11135,KEGG_2019_Human,Regulation of actin cytoskeleton,1/214,0.0106998949514067,0.0118748859778691,0,0,19786.0,89779.39753374986,ROCK2
11136,KEGG_2019_Human,Human cytomegalovirus infection,1/225,0.0112498919790339,0.0118748859778691,0,0,19775.0,88738.27077557483,ROCK2
11137,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,ROCK2
11138,KEGG_2019_Human,Glycosaminoglycan degradation,1/19,0.00094997806231055,0.0018999561246211,0,0,19981.0,139049.2109571672,HPSE2
11139,KEGG_2019_Human,Proteoglycans in cancer,1/201,0.0100498985877989,0.0100498985877989,0,0,19799.0,91079.21596609056,HPSE2
11140,KEGG_2019_Human,Sphingolipid metabolism,1/47,0.0023499589392381,0.0023499589392381,0,0,19953.0,120782.64067395544,KDSR
11141,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF674
11142,KEGG_2019_Human,Legionellosis,1/55,0.0027499544131125,0.0027499544131125,0,0,19945.0,117599.1294878737,HSF1
11143,KEGG_2019_Human,Th17 cell differentiation,1/107,0.0053499302026925,0.0121498656303927,0,0,19893.0,104053.753408911,IL27RA
11144,KEGG_2019_Human,JAK-STAT signaling pathway,1/162,0.0080999104202618,0.0121498656303927,0,0,19838.0,95537.86936302872,IL27RA
11145,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0146998751759735,0,0,19706.0,83157.67014793828,IL27RA
11146,KEGG_2019_Human,Prostate cancer,1/97,0.0048499343304706,0.0092999029651357,0,0,19903.0,106058.9096435903,ERG
11147,KEGG_2019_Human,Transcriptional misregulation in cancer,1/186,0.0092999029651357,0.0092999029651357,0,0,19814.0,92684.96451050608,ERG
11148,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0146998751759735,0,0,19706.0,83157.67014793828,TNFRSF8
11149,KEGG_2019_Human,Glycosaminoglycan biosynthesis,1/53,0.0026499555173137,0.0026499555173137,0,0,19947.0,118349.78824235698,CHST15
11150,KEGG_2019_Human,VEGF signaling pathway,1/59,0.0029499522555206,0.0101105985515036,0,0,19941.0,116175.59385530632,SHC2
11151,KEGG_2019_Human,Prolactin signaling pathway,1/70,0.0034999466296654,0.0101105985515036,0,0,19930.0,112704.30065625212,SHC2
11152,KEGG_2019_Human,Bacterial invasion of epithelial cells,1/74,0.0036999446830449,0.0101105985515036,0,0,19926.0,111574.38983110404,SHC2
11153,KEGG_2019_Human,Glioma,1/75,0.0037499442041125,0.0101105985515036,0,0,19925.0,111301.33528642564,SHC2
11154,KEGG_2019_Human,Chronic myeloid leukemia,1/76,0.0037999437281752,0.0101105985515036,0,0,19924.0,111031.8499691117,SHC2
11155,KEGG_2019_Human,ErbB signaling pathway,1/85,0.004249939567045,0.0101105985515036,0,0,19915.0,108752.83801948265,SHC2
11156,KEGG_2019_Human,Neurotrophin signaling pathway,1/119,0.0059499254985137,0.0101105985515036,0,0,19881.0,101877.73080211312,SHC2
11157,KEGG_2019_Human,Relaxin signaling pathway,1/130,0.0064999213952527,0.0101105985515036,0,0,19870.0,100064.62842845908,SHC2
11158,KEGG_2019_Human,Natural killer cell mediated cytotoxicity,1/131,0.0065499210316603,0.0101105985515036,0,0,19869.0,99907.33811343512,SHC2
11159,KEGG_2019_Human,Insulin signaling pathway,1/137,0.0068499188797651,0.0101105985515036,0,0,19863.0,98987.62735269018,SHC2
11160,KEGG_2019_Human,Estrogen signaling pathway,1/137,0.0068499188797651,0.0101105985515036,0,0,19863.0,98987.62735269018,SHC2
11161,KEGG_2019_Human,Breast cancer,1/147,0.0073499154017982,0.0101105985515036,0,0,19853.0,97539.10874372096,SHC2
11162,KEGG_2019_Human,Phospholipase D signaling pathway,1/148,0.007399915061391,0.0101105985515036,0,0,19852.0,97399.60470052566,SHC2
11163,KEGG_2019_Human,Gastric cancer,1/149,0.0074499147221605,0.0101105985515036,0,0,19851.0,97261.02051561224,SHC2
11164,KEGG_2019_Human,Hepatocellular carcinoma,1/168,0.0083999085011095,0.0105026713366279,0,0,19832.0,94787.72752807094,SHC2
11165,KEGG_2019_Human,Alcoholism,1/180,0.0089999047745351,0.0105026713366279,0,0,19820.0,93362.92821536642,SHC2
11166,KEGG_2019_Human,Chemokine signaling pathway,1/190,0.0094999017791995,0.0105026713366279,0,0,19810.0,92244.74636351672,SHC2
11167,KEGG_2019_Human,Focal adhesion,1/199,0.0099498991610159,0.0105026713366279,0,0,19801.0,91286.4288690606,SHC2
11168,KEGG_2019_Human,Ras signaling pathway,1/232,0.0115998901349604,0.0115998901349604,0,0,19768.0,88101.22480150245,SHC2
11169,KEGG_2019_Human,Human T-cell leukemia virus 1 infection,1/219,0.0109498935894162,0.0109498935894162,0,0,19781.0,89299.85161916987,KAT5
11170,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR5F1
11171,KEGG_2019_Human,Inflammatory bowel disease (IBD),1/65,0.003249949134407,0.0106998604053851,0,0,19935.0,114209.92613860144,IL22
11172,KEGG_2019_Human,Th17 cell differentiation,1/107,0.0053499302026925,0.0106998604053851,0,0,19893.0,104053.753408911,IL22
11173,KEGG_2019_Human,JAK-STAT signaling pathway,1/162,0.0080999104202618,0.0107998805603491,0,0,19838.0,95537.86936302872,IL22
11174,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0146998751759735,0,0,19706.0,83157.67014793828,IL22
11175,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0146998751759735,0,0,19706.0,83157.67014793828,IL36G
11176,KEGG_2019_Human,Mineral absorption,1/51,0.0025499566390179,0.0044999373439762,0,0,19949.0,119129.0228601236,SLC6A19
11177,KEGG_2019_Human,Protein digestion and absorption,1/90,0.0044999373439762,0.0044999373439762,0,0,19910.0,107587.50385474482,SLC6A19
11178,KEGG_2019_Human,Lysine degradation,1/59,0.0029499522555206,0.0029499522555206,0,0,19941.0,116175.59385530632,ASH1L
11179,KEGG_2019_Human,Estrogen signaling pathway,1/137,0.0068499188797651,0.0068499188797651,0,0,19863.0,98987.62735269018,KRT16
11180,KEGG_2019_Human,Tryptophan metabolism,1/42,0.0020999619311272,0.0020999619311272,0,0,19958.0,123057.75613441122,ALDH8A1
11181,KEGG_2019_Human,Arachidonic acid metabolism,1/63,0.0031499501598827,0.0056499278191151,0,0,19937.0,114844.46974572667,ALOX15B
11182,KEGG_2019_Human,Serotonergic synapse,1/113,0.0056499278191151,0.0056499278191151,0,0,19887.0,102937.34947211576,ALOX15B
11183,KEGG_2019_Human,Thiamine metabolism,1/15,0.0007499814841592997,0.0014999629683185,0,0,19985.0,143801.30885993244,AK5
11184,KEGG_2019_Human,Purine metabolism,1/129,0.006449921761047,0.006449921761047,0,0,19871.0,100223.109907462,AK5
11185,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,GPR83
11186,KEGG_2019_Human,Phagosome,1/152,0.0075999137114971,0.0089499050800561,0,0,19848.0,96850.665715497,CORO1A
11187,KEGG_2019_Human,Tuberculosis,1/179,0.0089499050800561,0.0089499050800561,0,0,19821.0,93478.0629355712,CORO1A
11188,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,HCFC1
11189,KEGG_2019_Human,Non-homologous end-joining,1/13,0.0006499833083207112,0.0006499833083207112,0,0,19987.0,146675.87616784443,XRCC5
11190,KEGG_2019_Human,RNA degradation,1/79,0.0039499423167337,0.0039499423167337,0,0,19921.0,110243.89578070649,EDC3
11191,KEGG_2019_Human,Leishmaniasis,1/74,0.0036999446830449,0.0045499369072032,0,0,19926.0,111574.38983110404,MARCKSL1
11192,KEGG_2019_Human,Fc gamma R-mediated phagocytosis,1/91,0.0045499369072032,0.0045499369072032,0,0,19909.0,107362.10783923086,MARCKSL1
11193,KEGG_2019_Human,Tryptophan metabolism,1/42,0.0020999619311272,0.0029499522555206,0,0,19958.0,123057.75613441122,AADAT
11194,KEGG_2019_Human,Lysine degradation,1/59,0.0029499522555206,0.0029499522555206,0,0,19941.0,116175.59385530632,AADAT
11195,KEGG_2019_Human,Lysosome,1/123,0.0061499239842961,0.0061499239842961,0,0,19877.0,101200.07933676826,SLC11A1
11196,KEGG_2019_Human,Axon guidance,1/181,0.0090499044707863,0.0090499044707863,0,0,19819.0,93248.41634586031,SEMA3D
11197,KEGG_2019_Human,Glycosaminoglycan biosynthesis,1/53,0.0026499555173137,0.0026499555173137,0,0,19947.0,118349.78824235698,CHPF
11198,KEGG_2019_Human,Taste transduction,1/83,0.0041499404726918,0.0041499404726918,0,0,19917.0,109237.99888847338,SCN3A
11199,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR9Q1
11200,KEGG_2019_Human,Bacterial invasion of epithelial cells,1/74,0.0036999446830449,0.0121998870519305,0,0,19926.0,111574.38983110404,CAV3
11201,KEGG_2019_Human,Fluid shear stress and atherosclerosis,1/139,0.006949918172816,0.0121998870519305,0,0,19861.0,98689.81333375497,CAV3
11202,KEGG_2019_Human,Focal adhesion,1/199,0.0099498991610159,0.0121998870519305,0,0,19801.0,91286.4288690606,CAV3
11203,KEGG_2019_Human,Proteoglycans in cancer,1/201,0.0100498985877989,0.0121998870519305,0,0,19799.0,91079.21596609056,CAV3
11204,KEGG_2019_Human,Endocytosis,1/244,0.0121998870519305,0.0121998870519305,0,0,19756.0,87051.4275316661,CAV3
11205,KEGG_2019_Human,Hepatocellular carcinoma,1/168,0.0083999085011095,0.0115498903940656,0,0,19832.0,94787.72752807094,SMARCD1
11206,KEGG_2019_Human,Thermogenesis,1/231,0.0115498903940656,0.0115498903940656,0,0,19769.0,88191.07730937863,SMARCD1
11207,KEGG_2019_Human,Lysosome,1/123,0.0061499239842961,0.0061499239842961,0,0,19877.0,101200.07933676826,SUMF1
11208,KEGG_2019_Human,Phototransduction,1/28,0.0013999711732997,0.0113938210547091,0,0,19972.0,131242.0761597353,CALM3
11209,KEGG_2019_Human,Long-term potentiation,1/67,0.0033499481224912,0.0113938210547091,0,0,19933.0,113594.38808369274,CALM3
11210,KEGG_2019_Human,Amphetamine addiction,1/68,0.0033999476216189,0.0113938210547091,0,0,19932.0,113293.39338050144,CALM3
11211,KEGG_2019_Human,Renin secretion,1/69,0.003449947123837,0.0113938210547091,0,0,19931.0,112996.7391397682,CALM3
11212,KEGG_2019_Human,Gastric acid secretion,1/75,0.0037499442041125,0.0113938210547091,0,0,19925.0,111301.33528642564,CALM3
11213,KEGG_2019_Human,Glioma,1/75,0.0037499442041125,0.0113938210547091,0,0,19925.0,111301.33528642564,CALM3
11214,KEGG_2019_Human,Pertussis,1/76,0.0037999437281752,0.0113938210547091,0,0,19924.0,111031.8499691117,CALM3
11215,KEGG_2019_Human,Salivary secretion,1/90,0.0044999373439762,0.0113938210547091,0,0,19910.0,107587.50385474482,CALM3
11216,KEGG_2019_Human,GnRH signaling pathway,1/93,0.0046499360391879,0.0113938210547091,0,0,19907.0,106918.54242106884,CALM3
11217,KEGG_2019_Human,Circadian entrainment,1/97,0.0048499343304706,0.0113938210547091,0,0,19903.0,106058.9096435903,CALM3
11218,KEGG_2019_Human,Aldosterone synthesis and secretion,1/98,0.0048999339081079,0.0113938210547091,0,0,19902.0,105849.45495286948,CALM3
11219,KEGG_2019_Human,Phosphatidylinositol signaling system,1/99,0.0049499334884068,0.0113938210547091,0,0,19901.0,105642.09305076736,CALM3
11220,KEGG_2019_Human,Inflammatory mediator regulation of TRP channels,1/100,0.0049999330710556,0.0113938210547091,0,0,19900.0,105436.78197328727,CALM3
11221,KEGG_2019_Human,Melanogenesis,1/101,0.0050499326546803,0.0113938210547091,0,0,19899.0,105233.48101229242,CALM3
11222,KEGG_2019_Human,Glucagon signaling pathway,1/103,0.0051499318302617,0.0113938210547091,0,0,19897.0,104832.7525292024,CALM3
11223,KEGG_2019_Human,C-type lectin receptor signaling pathway,1/104,0.0051999314202997,0.0113938210547091,0,0,19896.0,104635.24941415618,CALM3
11224,KEGG_2019_Human,Neurotrophin signaling pathway,1/119,0.0059499254985137,0.0113938210547091,0,0,19881.0,101877.73080211312,CALM3
11225,KEGG_2019_Human,Oocyte meiosis,1/125,0.0062499232373748,0.0113938210547091,0,0,19875.0,100869.32368441945,CALM3
11226,KEGG_2019_Human,Dopaminergic synapse,1/131,0.0065499210316603,0.0113938210547091,0,0,19869.0,99907.33811343512,CALM3
11227,KEGG_2019_Human,Vascular smooth muscle contraction,1/132,0.0065999206698993,0.0113938210547091,0,0,19868.0,99751.22090491928,CALM3
11228,KEGG_2019_Human,Insulin signaling pathway,1/137,0.0068499188797651,0.0113938210547091,0,0,19863.0,98987.62735269018,CALM3
11229,KEGG_2019_Human,Estrogen signaling pathway,1/137,0.0068499188797651,0.0113938210547091,0,0,19863.0,98987.62735269018,CALM3
11230,KEGG_2019_Human,Apelin signaling pathway,1/137,0.0068499188797651,0.0113938210547091,0,0,19863.0,98987.62735269018,CALM3
11231,KEGG_2019_Human,Fluid shear stress and atherosclerosis,1/139,0.006949918172816,0.0113938210547091,0,0,19861.0,98689.81333375497,CALM3
11232,KEGG_2019_Human,Adrenergic signaling in cardiomyocytes,1/145,0.0072499160871101,0.0113938210547091,0,0,19855.0,97820.92670675044,CALM3
11233,KEGG_2019_Human,Oxytocin signaling pathway,1/153,0.0076499133771537,0.0113938210547091,0,0,19847.0,96715.6407630817,CALM3
11234,KEGG_2019_Human,Cellular senescence,1/160,0.0079999110688441,0.0113938210547091,0,0,19840.0,95793.96509856998,CALM3
11235,KEGG_2019_Human,cGMP-PKG signaling pathway,1/166,0.0082999091363732,0.0113938210547091,0,0,19834.0,95034.82345515196,CALM3
11236,KEGG_2019_Human,Alzheimer disease,1/171,0.0085499075557634,0.0113938210547091,0,0,19829.0,94422.42241345016,CALM3
11237,KEGG_2019_Human,Tuberculosis,1/179,0.0089499050800561,0.0113938210547091,0,0,19821.0,93478.0629355712,CALM3
11238,KEGG_2019_Human,Alcoholism,1/180,0.0089999047745351,0.0113938210547091,0,0,19820.0,93362.92821536642,CALM3
11239,KEGG_2019_Human,Kaposi sarcoma-associated herpesvirus infection,1/186,0.0092999029651357,0.0113938210547091,0,0,19814.0,92684.96451050608,CALM3
11240,KEGG_2019_Human,Calcium signaling pathway,1/188,0.009399902370135,0.0113938210547091,0,0,19812.0,92463.712994847,CALM3
11241,KEGG_2019_Human,Rap1 signaling pathway,1/206,0.010299897173561,0.0117776616695839,0,0,19794.0,90569.849337325,CALM3
11242,KEGG_2019_Human,Human immunodeficiency virus 1 infection,1/212,0.0105998955026255,0.0117776616695839,0,0,19788.0,89974.27756224656,CALM3
11243,KEGG_2019_Human,cAMP signaling pathway,1/212,0.0105998955026255,0.0117776616695839,0,0,19788.0,89974.27756224656,CALM3
11244,KEGG_2019_Human,Human cytomegalovirus infection,1/225,0.0112498919790339,0.0121620453827393,0,0,19775.0,88738.27077557483,CALM3
11245,KEGG_2019_Human,Ras signaling pathway,1/232,0.0115998901349604,0.0122104106683793,0,0,19768.0,88101.22480150245,CALM3
11246,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0227690733587457,0,0,19556.0,74462.79263140135,CALM3
11247,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,CALM3
11248,KEGG_2019_Human,RNA transport,1/165,0.0082499094553477,0.0082499094553477,0,0,19835.0,95159.46482222488,POM121L2
11249,KEGG_2019_Human,Asthma,1/31,0.0015499690656704,0.0084570457844468,0,0,19969.0,129189.85098816035,FCER1G
11250,KEGG_2019_Human,Fc epsilon RI signaling pathway,1/68,0.0033999476216189,0.0084570457844468,0,0,19932.0,113293.39338050144,FCER1G
11251,KEGG_2019_Human,C-type lectin receptor signaling pathway,1/104,0.0051999314202997,0.0084570457844468,0,0,19896.0,104635.24941415618,FCER1G
11252,KEGG_2019_Human,Sphingolipid signaling pathway,1/119,0.0059499254985137,0.0084570457844468,0,0,19881.0,101877.73080211312,FCER1G
11253,KEGG_2019_Human,Platelet activation,1/124,0.0061999236097501,0.0084570457844468,0,0,19876.0,101034.04709010696,FCER1G
11254,KEGG_2019_Human,Natural killer cell mediated cytotoxicity,1/131,0.0065499210316603,0.0084570457844468,0,0,19869.0,99907.33811343512,FCER1G
11255,KEGG_2019_Human,Phospholipase D signaling pathway,1/148,0.007399915061391,0.0084570457844468,0,0,19852.0,97399.60470052566,FCER1G
11256,KEGG_2019_Human,Tuberculosis,1/179,0.0089499050800561,0.0089499050800561,0,0,19821.0,93478.0629355712,FCER1G
11257,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF813
11258,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF45
11259,KEGG_2019_Human,Cell cycle,1/124,0.0061999236097501,0.0093748848560622,0,0,19876.0,101034.04709010696,PTTG2
11260,KEGG_2019_Human,Oocyte meiosis,1/125,0.0062499232373748,0.0093748848560622,0,0,19875.0,100869.32368441945,PTTG2
11261,KEGG_2019_Human,Human T-cell leukemia virus 1 infection,1/219,0.0109498935894162,0.0109498935894162,0,0,19781.0,89299.85161916987,PTTG2
11262,KEGG_2019_Human,Measles,1/138,0.0068999185254481,0.0120598783053587,0,0,19862.0,98838.19160389496,OAS2
11263,KEGG_2019_Human,Hepatitis C,1/155,0.0077499127120574,0.0120598783053587,0,0,19845.0,96448.16254952336,OAS2
11264,KEGG_2019_Human,Influenza A,1/171,0.0085499075557634,0.0120598783053587,0,0,19829.0,94422.42241345016,OAS2
11265,KEGG_2019_Human,NOD-like receptor signaling pathway,1/178,0.0088999053857096,0.0120598783053587,0,0,19822.0,93593.82745769851,OAS2
11266,KEGG_2019_Human,Epstein-Barr virus infection,1/201,0.0100498985877989,0.0120598783053587,0,0,19799.0,91079.21596609056,OAS2
11267,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,OAS2
11268,KEGG_2019_Human,Huntington disease,1/193,0.0096499008972596,0.0096499008972596,0,0,19807.0,91920.47679471428,DNAI1
11269,KEGG_2019_Human,Arrhythmogenic right ventricular cardiomyopathy (ARVC),1/72,0.0035999456502131,0.0090998738144064,0,0,19928.0,112131.59838572376,ITGA11
11270,KEGG_2019_Human,ECM-receptor interaction,1/82,0.004099940929819,0.0090998738144064,0,0,19918.0,109484.9180722932,ITGA11
11271,KEGG_2019_Human,Hypertrophic cardiomyopathy (HCM),1/85,0.004249939567045,0.0090998738144064,0,0,19915.0,108752.83801948265,ITGA11
11272,KEGG_2019_Human,Dilated cardiomyopathy (DCM),1/91,0.0045499369072032,0.0090998738144064,0,0,19909.0,107362.10783923086,ITGA11
11273,KEGG_2019_Human,Focal adhesion,1/199,0.0099498991610159,0.0142665266018757,0,0,19801.0,91286.4288690606,ITGA11
11274,KEGG_2019_Human,Regulation of actin cytoskeleton,1/214,0.0106998949514067,0.0142665266018757,0,0,19786.0,89779.39753374986,ITGA11
11275,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0176998626413668,0,0,19670.0,80733.60565076157,ITGA11
11276,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0176998626413668,0,0,19646.0,79255.8617626126,ITGA11
11277,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF582
11278,KEGG_2019_Human,Nucleotide excision repair,1/47,0.0023499589392381,0.0023499589392381,0,0,19953.0,120782.64067395544,BIVM-ERCC5
11279,KEGG_2019_Human,Vascular smooth muscle contraction,1/132,0.0065999206698993,0.0106998949514067,0,0,19868.0,99751.22090491928,PPP1R12C
11280,KEGG_2019_Human,Oxytocin signaling pathway,1/153,0.0076499133771537,0.0106998949514067,0,0,19847.0,96715.6407630817,PPP1R12C
11281,KEGG_2019_Human,Focal adhesion,1/199,0.0099498991610159,0.0106998949514067,0,0,19801.0,91286.4288690606,PPP1R12C
11282,KEGG_2019_Human,Proteoglycans in cancer,1/201,0.0100498985877989,0.0106998949514067,0,0,19799.0,91079.21596609056,PPP1R12C
11283,KEGG_2019_Human,Regulation of actin cytoskeleton,1/214,0.0106998949514067,0.0106998949514067,0,0,19786.0,89779.39753374986,PPP1R12C
11284,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0146998751759735,0,0,19706.0,83157.67014793828,CXCL17
11285,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF492
11286,KEGG_2019_Human,Glycolysis / Gluconeogenesis,1/68,0.0033999476216189,0.0033999476216189,0,0,19932.0,113293.39338050144,PGK2
11287,KEGG_2019_Human,Fluid shear stress and atherosclerosis,1/139,0.006949918172816,0.0111998780014793,0,0,19861.0,98689.81333375497,NFE2L2
11288,KEGG_2019_Human,Protein processing in endoplasmic reticulum,1/165,0.0082499094553477,0.0111998780014793,0,0,19835.0,95159.46482222488,NFE2L2
11289,KEGG_2019_Human,Hepatocellular carcinoma,1/168,0.0083999085011095,0.0111998780014793,0,0,19832.0,94787.72752807094,NFE2L2
11290,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,NFE2L2
11291,KEGG_2019_Human,Cholesterol metabolism,1/50,0.0024999572069037,0.0036999446830449,0,0,19950.0,119530.05920663515,ANGPTL4
11292,KEGG_2019_Human,PPAR signaling pathway,1/74,0.0036999446830449,0.0036999446830449,0,0,19926.0,111574.38983110404,ANGPTL4
11293,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR2T33
11294,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR2V2
11295,KEGG_2019_Human,Inositol phosphate metabolism,1/74,0.0036999446830449,0.0074249002326102,0,0,19926.0,111574.38983110404,ITPKB
11296,KEGG_2019_Human,Phosphatidylinositol signaling system,1/99,0.0049499334884068,0.0074249002326102,0,0,19901.0,105642.09305076736,ITPKB
11297,KEGG_2019_Human,Calcium signaling pathway,1/188,0.009399902370135,0.009399902370135,0,0,19812.0,92463.712994847,ITPKB
11298,KEGG_2019_Human,Other glycan degradation,1/18,0.0008999788927950273,0.002699936678385,0,0,19982.0,140136.54844084635,GBA
11299,KEGG_2019_Human,Sphingolipid metabolism,1/47,0.0023499589392381,0.0035249384088572,0,0,19953.0,120782.64067395544,GBA
11300,KEGG_2019_Human,Lysosome,1/123,0.0061499239842961,0.0061499239842961,0,0,19877.0,101200.07933676826,GBA
11301,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR52W1
11302,KEGG_2019_Human,ECM-receptor interaction,1/82,0.004099940929819,0.0099998661421113,0,0,19918.0,109484.9180722932,COL4A4
11303,KEGG_2019_Human,Protein digestion and absorption,1/90,0.0044999373439762,0.0099998661421113,0,0,19910.0,107587.50385474482,COL4A4
11304,KEGG_2019_Human,Small cell lung cancer,1/93,0.0046499360391879,0.0099998661421113,0,0,19907.0,106918.54242106884,COL4A4
11305,KEGG_2019_Human,Amoebiasis,1/96,0.0047999347538706,0.0099998661421113,0,0,19904.0,106270.50039849174,COL4A4
11306,KEGG_2019_Human,AGE-RAGE signaling pathway in diabetic complications,1/100,0.0049999330710556,0.0099998661421113,0,0,19900.0,105436.78197328727,COL4A4
11307,KEGG_2019_Human,Relaxin signaling pathway,1/130,0.0064999213952527,0.0108332023254213,0,0,19870.0,100064.62842845908,COL4A4
11308,KEGG_2019_Human,Focal adhesion,1/199,0.0099498991610159,0.0142141416585942,0,0,19801.0,91286.4288690606,COL4A4
11309,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0196665140459632,0,0,19670.0,80733.60565076157,COL4A4
11310,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0196665140459632,0,0,19646.0,79255.8617626126,COL4A4
11311,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,COL4A4
11312,KEGG_2019_Human,Renin secretion,1/69,0.003449947123837,0.0090998738144064,0,0,19931.0,112996.7391397682,PDE1C
11313,KEGG_2019_Human,Taste transduction,1/83,0.0041499404726918,0.0090998738144064,0,0,19917.0,109237.99888847338,PDE1C
11314,KEGG_2019_Human,Morphine addiction,1/91,0.0045499369072032,0.0090998738144064,0,0,19909.0,107362.10783923086,PDE1C
11315,KEGG_2019_Human,Purine metabolism,1/129,0.006449921761047,0.0096748826415705,0,0,19871.0,100223.109907462,PDE1C
11316,KEGG_2019_Human,Calcium signaling pathway,1/188,0.009399902370135,0.011279882844162,0,0,19812.0,92463.712994847,PDE1C
11317,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,PDE1C
11318,KEGG_2019_Human,Insulin resistance,1/108,0.0053999298011749,0.0057999266512085,0,0,19892.0,103863.47861844616,TBC1D4
11319,KEGG_2019_Human,Thyroid hormone signaling pathway,1/116,0.0057999266512085,0.0057999266512085,0,0,19884.0,102400.8105961506,TBC1D4
11320,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR3A3
11321,KEGG_2019_Human,Gastric acid secretion,1/75,0.0037499442041125,0.0106998949514067,0,0,19925.0,111301.33528642564,MYLK3
11322,KEGG_2019_Human,Platelet activation,1/124,0.0061999236097501,0.0106998949514067,0,0,19876.0,101034.04709010696,MYLK3
11323,KEGG_2019_Human,Vascular smooth muscle contraction,1/132,0.0065999206698993,0.0106998949514067,0,0,19868.0,99751.22090491928,MYLK3
11324,KEGG_2019_Human,Apelin signaling pathway,1/137,0.0068499188797651,0.0106998949514067,0,0,19863.0,98987.62735269018,MYLK3
11325,KEGG_2019_Human,Oxytocin signaling pathway,1/153,0.0076499133771537,0.0106998949514067,0,0,19847.0,96715.6407630817,MYLK3
11326,KEGG_2019_Human,cGMP-PKG signaling pathway,1/166,0.0082999091363732,0.0106998949514067,0,0,19834.0,95034.82345515196,MYLK3
11327,KEGG_2019_Human,Calcium signaling pathway,1/188,0.009399902370135,0.0106998949514067,0,0,19812.0,92463.712994847,MYLK3
11328,KEGG_2019_Human,Focal adhesion,1/199,0.0099498991610159,0.0106998949514067,0,0,19801.0,91286.4288690606,MYLK3
11329,KEGG_2019_Human,Regulation of actin cytoskeleton,1/214,0.0106998949514067,0.0106998949514067,0,0,19786.0,89779.39753374986,MYLK3
11330,KEGG_2019_Human,Maturity onset diabetes of the young,1/26,0.0012999726251831,0.0012999726251831,0,0,19974.0,132735.46073187632,NR5A2
11331,KEGG_2019_Human,Staphylococcus aureus infection,1/68,0.0033999476216189,0.0067998952432378,0,0,19932.0,113293.39338050144,DEFA6
11332,KEGG_2019_Human,NOD-like receptor signaling pathway,1/178,0.0088999053857096,0.0088999053857096,0,0,19822.0,93593.82745769851,DEFA6
11333,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR4N5
11334,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR9G4
11335,KEGG_2019_Human,GABAergic synapse,1/89,0.0044499377838098,0.0136469295705416,0,0,19911.0,107815.380281759,GNG12
11336,KEGG_2019_Human,Morphine addiction,1/91,0.0045499369072032,0.0136469295705416,0,0,19909.0,107362.10783923086,GNG12
11337,KEGG_2019_Human,Circadian entrainment,1/97,0.0048499343304706,0.0136469295705416,0,0,19903.0,106058.9096435903,GNG12
11338,KEGG_2019_Human,Cholinergic synapse,1/112,0.0055999282120529,0.0136469295705416,0,0,19888.0,103119.30984392198,GNG12
11339,KEGG_2019_Human,Serotonergic synapse,1/113,0.0056499278191151,0.0136469295705416,0,0,19887.0,102937.34947211576,GNG12
11340,KEGG_2019_Human,Glutamatergic synapse,1/114,0.005699927427839,0.0136469295705416,0,0,19886.0,102756.96431429044,GNG12
11341,KEGG_2019_Human,Relaxin signaling pathway,1/130,0.0064999213952527,0.0136469295705416,0,0,19870.0,100064.62842845908,GNG12
11342,KEGG_2019_Human,Dopaminergic synapse,1/131,0.0065499210316603,0.0136469295705416,0,0,19869.0,99907.33811343512,GNG12
11343,KEGG_2019_Human,Apelin signaling pathway,1/137,0.0068499188797651,0.0136469295705416,0,0,19863.0,98987.62735269018,GNG12
11344,KEGG_2019_Human,Retrograde endocannabinoid signaling,1/148,0.007399915061391,0.0136469295705416,0,0,19852.0,97399.60470052566,GNG12
11345,KEGG_2019_Human,Alcoholism,1/180,0.0089999047745351,0.0136469295705416,0,0,19820.0,93362.92821536642,GNG12
11346,KEGG_2019_Human,Kaposi sarcoma-associated herpesvirus infection,1/186,0.0092999029651357,0.0136469295705416,0,0,19814.0,92684.96451050608,GNG12
11347,KEGG_2019_Human,Chemokine signaling pathway,1/190,0.0094999017791995,0.0136469295705416,0,0,19810.0,92244.74636351672,GNG12
11348,KEGG_2019_Human,Human immunodeficiency virus 1 infection,1/212,0.0105998955026255,0.0136469295705416,0,0,19788.0,89974.27756224656,GNG12
11349,KEGG_2019_Human,Regulation of actin cytoskeleton,1/214,0.0106998949514067,0.0136469295705416,0,0,19786.0,89779.39753374986,GNG12
11350,KEGG_2019_Human,Human cytomegalovirus infection,1/225,0.0112498919790339,0.0136469295705416,0,0,19775.0,88738.27077557483,GNG12
11351,KEGG_2019_Human,Ras signaling pathway,1/232,0.0115998901349604,0.0136469295705416,0,0,19768.0,88101.22480150245,GNG12
11352,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0163887499485007,0,0,19705.0,83086.53988020132,GNG12
11353,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0186314343593335,0,0,19646.0,79255.8617626126,GNG12
11354,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,GNG12
11355,KEGG_2019_Human,Cocaine addiction,1/49,0.0024499577795033,0.0094511130634847,0,0,19951.0,119939.1172087114,ADCY5
11356,KEGG_2019_Human,Ovarian steroidogenesis,1/49,0.0024499577795033,0.0094511130634847,0,0,19951.0,119939.1172087114,ADCY5
11357,KEGG_2019_Human,Regulation of lipolysis in adipocytes,1/55,0.0027499544131125,0.0094511130634847,0,0,19945.0,117599.1294878737,ADCY5
11358,KEGG_2019_Human,Cortisol synthesis and secretion,1/65,0.003249949134407,0.0094511130634847,0,0,19935.0,114209.92613860144,ADCY5
11359,KEGG_2019_Human,Amphetamine addiction,1/68,0.0033999476216189,0.0094511130634847,0,0,19932.0,113293.39338050144,ADCY5
11360,KEGG_2019_Human,Renin secretion,1/69,0.003449947123837,0.0094511130634847,0,0,19931.0,112996.7391397682,ADCY5
11361,KEGG_2019_Human,Bile secretion,1/72,0.0035999456502131,0.0094511130634847,0,0,19928.0,112131.59838572376,ADCY5
11362,KEGG_2019_Human,Thyroid hormone synthesis,1/74,0.0036999446830449,0.0094511130634847,0,0,19926.0,111574.38983110404,ADCY5
11363,KEGG_2019_Human,Gastric acid secretion,1/75,0.0037499442041125,0.0094511130634847,0,0,19925.0,111301.33528642564,ADCY5
11364,KEGG_2019_Human,Insulin secretion,1/86,0.0042999391173866,0.0094511130634847,0,0,19914.0,108514.46102290176,ADCY5
11365,KEGG_2019_Human,Gap junction,1/88,0.0043999382262822,0.0094511130634847,0,0,19912.0,108045.79305232369,ADCY5
11366,KEGG_2019_Human,GABAergic synapse,1/89,0.0044499377838098,0.0094511130634847,0,0,19911.0,107815.380281759,ADCY5
11367,KEGG_2019_Human,Salivary secretion,1/90,0.0044999373439762,0.0094511130634847,0,0,19910.0,107587.50385474482,ADCY5
11368,KEGG_2019_Human,Morphine addiction,1/91,0.0045499369072032,0.0094511130634847,0,0,19909.0,107362.10783923086,ADCY5
11369,KEGG_2019_Human,Dilated cardiomyopathy (DCM),1/91,0.0045499369072032,0.0094511130634847,0,0,19909.0,107362.10783923086,ADCY5
11370,KEGG_2019_Human,GnRH signaling pathway,1/93,0.0046499360391879,0.0094511130634847,0,0,19907.0,106918.54242106884,ADCY5
11371,KEGG_2019_Human,Circadian entrainment,1/97,0.0048499343304706,0.0094511130634847,0,0,19903.0,106058.9096435903,ADCY5
11372,KEGG_2019_Human,Aldosterone synthesis and secretion,1/98,0.0048999339081079,0.0094511130634847,0,0,19902.0,105849.45495286948,ADCY5
11373,KEGG_2019_Human,Pancreatic secretion,1/98,0.0048999339081079,0.0094511130634847,0,0,19902.0,105849.45495286948,ADCY5
11374,KEGG_2019_Human,Progesterone-mediated oocyte maturation,1/99,0.0049499334884068,0.0094511130634847,0,0,19901.0,105642.09305076736,ADCY5
11375,KEGG_2019_Human,Inflammatory mediator regulation of TRP channels,1/100,0.0049999330710556,0.0094511130634847,0,0,19900.0,105436.78197328727,ADCY5
11376,KEGG_2019_Human,Melanogenesis,1/101,0.0050499326546803,0.0094511130634847,0,0,19899.0,105233.48101229242,ADCY5
11377,KEGG_2019_Human,Longevity regulating pathway,1/102,0.0050999322416682,0.0094511130634847,0,0,19898.0,105032.15064717118,ADCY5
11378,KEGG_2019_Human,"Parathyroid hormone synthesis, secretion and action",1/106,0.0052999306076525,0.0094511130634847,0,0,19894.0,104245.78450366124,ADCY5
11379,KEGG_2019_Human,Cholinergic synapse,1/112,0.0055999282120529,0.0094511130634847,0,0,19888.0,103119.30984392198,ADCY5
11380,KEGG_2019_Human,Serotonergic synapse,1/113,0.0056499278191151,0.0094511130634847,0,0,19887.0,102937.34947211576,ADCY5
11381,KEGG_2019_Human,Glutamatergic synapse,1/114,0.005699927427839,0.0094511130634847,0,0,19886.0,102756.96431429044,ADCY5
11382,KEGG_2019_Human,Platelet activation,1/124,0.0061999236097501,0.0094511130634847,0,0,19876.0,101034.04709010696,ADCY5
11383,KEGG_2019_Human,Oocyte meiosis,1/125,0.0062499232373748,0.0094511130634847,0,0,19875.0,100869.32368441945,ADCY5
11384,KEGG_2019_Human,Purine metabolism,1/129,0.006449921761047,0.0094511130634847,0,0,19871.0,100223.109907462,ADCY5
11385,KEGG_2019_Human,Relaxin signaling pathway,1/130,0.0064999213952527,0.0094511130634847,0,0,19870.0,100064.62842845908,ADCY5
11386,KEGG_2019_Human,Dopaminergic synapse,1/131,0.0065499210316603,0.0094511130634847,0,0,19869.0,99907.33811343512,ADCY5
11387,KEGG_2019_Human,Vascular smooth muscle contraction,1/132,0.0065999206698993,0.0094511130634847,0,0,19868.0,99751.22090491928,ADCY5
11388,KEGG_2019_Human,Apelin signaling pathway,1/137,0.0068499188797651,0.0094511130634847,0,0,19863.0,98987.62735269018,ADCY5
11389,KEGG_2019_Human,Estrogen signaling pathway,1/137,0.0068499188797651,0.0094511130634847,0,0,19863.0,98987.62735269018,ADCY5
11390,KEGG_2019_Human,Parkinson disease,1/142,0.0070999171242726,0.0094511130634847,0,0,19858.0,98250.87390500787,ADCY5
11391,KEGG_2019_Human,Adrenergic signaling in cardiomyocytes,1/145,0.0072499160871101,0.0094511130634847,0,0,19855.0,97820.92670675044,ADCY5
11392,KEGG_2019_Human,Phospholipase D signaling pathway,1/148,0.007399915061391,0.0094511130634847,0,0,19852.0,97399.60470052566,ADCY5
11393,KEGG_2019_Human,Retrograde endocannabinoid signaling,1/148,0.007399915061391,0.0094511130634847,0,0,19852.0,97399.60470052566,ADCY5
11394,KEGG_2019_Human,Oxytocin signaling pathway,1/153,0.0076499133771537,0.0094511130634847,0,0,19847.0,96715.6407630817,ADCY5
11395,KEGG_2019_Human,Cushing syndrome,1/155,0.0077499127120574,0.0094511130634847,0,0,19845.0,96448.16254952336,ADCY5
11396,KEGG_2019_Human,cGMP-PKG signaling pathway,1/166,0.0082999091363732,0.0098808442099681,0,0,19834.0,95034.82345515196,ADCY5
11397,KEGG_2019_Human,Alcoholism,1/180,0.0089999047745351,0.010465005551785,0,0,19820.0,93362.92821536642,ADCY5
11398,KEGG_2019_Human,Chemokine signaling pathway,1/190,0.0094999017791995,0.0107953429309086,0,0,19810.0,92244.74636351672,ADCY5
11399,KEGG_2019_Human,Rap1 signaling pathway,1/206,0.010299897173561,0.0114443301928456,0,0,19794.0,90569.849337325,ADCY5
11400,KEGG_2019_Human,cAMP signaling pathway,1/212,0.0105998955026255,0.0115216255463321,0,0,19788.0,89974.27756224656,ADCY5
11401,KEGG_2019_Human,Human T-cell leukemia virus 1 infection,1/219,0.0109498935894162,0.0116488229674641,0,0,19781.0,89299.85161916987,ADCY5
11402,KEGG_2019_Human,Human cytomegalovirus infection,1/225,0.0112498919790339,0.0117186374781603,0,0,19775.0,88738.27077557483,ADCY5
11403,KEGG_2019_Human,Thermogenesis,1/231,0.0115498903940656,0.011785602442924,0,0,19769.0,88191.07730937863,ADCY5
11404,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,ADCY5
11405,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0147498749536506,0,0,19705.0,83086.53988020132,MAPK8IP2
11406,KEGG_2019_Human,Morphine addiction,1/91,0.0045499369072032,0.0077499127120574,0,0,19909.0,107362.10783923086,PDE11A
11407,KEGG_2019_Human,Purine metabolism,1/129,0.006449921761047,0.0077499127120574,0,0,19871.0,100223.109907462,PDE11A
11408,KEGG_2019_Human,Cushing syndrome,1/155,0.0077499127120574,0.0077499127120574,0,0,19845.0,96448.16254952336,PDE11A
11409,KEGG_2019_Human,Hedgehog signaling pathway,1/47,0.0023499589392381,0.0062999003197655,0,0,19953.0,120782.64067395544,GLI2
11410,KEGG_2019_Human,Basal cell carcinoma,1/63,0.0031499501598827,0.0062999003197655,0,0,19937.0,114844.46974572667,GLI2
11411,KEGG_2019_Human,Hippo signaling pathway,1/160,0.0079999110688441,0.0106665480917922,0,0,19840.0,95793.96509856998,GLI2
11412,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,GLI2
11413,KEGG_2019_Human,RNA degradation,1/79,0.0039499423167337,0.0039499423167337,0,0,19921.0,110243.89578070649,DCP1B
11414,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR1L6
11415,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR2W3
11416,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZFP82
11417,KEGG_2019_Human,Mitophagy,1/65,0.003249949134407,0.0064998982688141,0,0,19935.0,114209.92613860144,MFN2
11418,KEGG_2019_Human,NOD-like receptor signaling pathway,1/178,0.0088999053857096,0.0088999053857096,0,0,19822.0,93593.82745769851,MFN2
11419,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF98
11420,KEGG_2019_Human,Steroid hormone biosynthesis,1/60,0.002999951725986,0.002999951725986,0,0,19940.0,115834.63209072244,SULT1E1
11421,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR4S1
11422,KEGG_2019_Human,Axon guidance,1/181,0.0090499044707863,0.0090499044707863,0,0,19819.0,93248.41634586031,EPHA6
11423,KEGG_2019_Human,Glycerophospholipid metabolism,1/97,0.0048499343304706,0.0048499343304706,0,0,19903.0,106058.9096435903,CRLS1
11424,KEGG_2019_Human,Viral myocarditis,1/59,0.0029499522555206,0.0058999045110413,0,0,19941.0,116175.59385530632,EIF4G2
11425,KEGG_2019_Human,RNA transport,1/165,0.0082499094553477,0.0082499094553477,0,0,19835.0,95159.46482222488,EIF4G2
11426,KEGG_2019_Human,ABC transporters,1/45,0.0022499601197094,0.0022499601197094,0,0,19955.0,121662.49782449217,ABCA6
11427,KEGG_2019_Human,Ribosome,1/153,0.0076499133771537,0.0076499133771537,0,0,19847.0,96715.6407630817,MRPL21
11428,KEGG_2019_Human,Proteasome,1/45,0.0022499601197094,0.0044999202394188,0,0,19955.0,121662.49782449217,PSMC3
11429,KEGG_2019_Human,Epstein-Barr virus infection,1/201,0.0100498985877989,0.0100498985877989,0,0,19799.0,91079.21596609056,PSMC3
11430,KEGG_2019_Human,Pentose phosphate pathway,1/30,0.0014999697593334,0.0016999670339032,0,0,19970.0,129851.13732048514,RPEL1
11431,KEGG_2019_Human,Pentose and glucuronate interconversions,1/34,0.0016999670339032,0.0016999670339032,0,0,19966.0,127326.1054203148,RPEL1
11432,KEGG_2019_Human,mRNA surveillance pathway,1/91,0.0045499369072032,0.0045499369072032,0,0,19909.0,107362.10783923086,RNGTT
11433,KEGG_2019_Human,Mitophagy,1/65,0.003249949134407,0.003249949134407,0,0,19935.0,114209.92613860144,BNIP3L
11434,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR2AJ1
11435,KEGG_2019_Human,mRNA surveillance pathway,1/91,0.0045499369072032,0.0045499369072032,0,0,19909.0,107362.10783923086,PAPOLB
11436,KEGG_2019_Human,Taurine and hypotaurine metabolism,1/11,0.0005499852259717758,0.0005499852259717758,0,0,19989.0,150029.8210287992,ADO
11437,KEGG_2019_Human,Glycosphingolipid biosynthesis,1/45,0.0022499601197094,0.0022499601197094,0,0,19955.0,121662.49782449217,B3GNT3
11438,KEGG_2019_Human,Lysine degradation,1/59,0.0029499522555206,0.0029499522555206,0,0,19941.0,116175.59385530632,AASS
11439,KEGG_2019_Human,Neurotrophin signaling pathway,1/119,0.0059499254985137,0.0059499254985137,0,0,19881.0,101877.73080211312,IRAK3
11440,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR2T6
11441,KEGG_2019_Human,Rap1 signaling pathway,1/206,0.010299897173561,0.010299897173561,0,0,19794.0,90569.849337325,FYB1
11442,KEGG_2019_Human,Thyroid cancer,1/37,0.0018499650702878,0.0055498952108636,0,0,19963.0,125618.9446446357,TPR
11443,KEGG_2019_Human,RNA transport,1/165,0.0082499094553477,0.0123748641830216,0,0,19835.0,95159.46482222488,TPR
11444,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,TPR
11445,KEGG_2019_Human,Other types of O-glycan biosynthesis,1/22,0.0010999756574123,0.0010999756574123,0,0,19978.0,136099.47030191717,GXYLT1
11446,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR8D2
11447,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF311
11448,KEGG_2019_Human,Calcium signaling pathway,1/188,0.009399902370135,0.0168998658265596,0,0,19812.0,92463.712994847,LTB4R2
11449,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,LTB4R2
11450,KEGG_2019_Human,Collecting duct acid secretion,1/27,0.0013499718942362,0.0040499156827088,0,0,19973.0,131975.02298599784,ATP4A
11451,KEGG_2019_Human,Gastric acid secretion,1/75,0.0037499442041125,0.0056249163061687,0,0,19925.0,111301.33528642564,ATP4A
11452,KEGG_2019_Human,Oxidative phosphorylation,1/133,0.0066499203093911,0.0066499203093911,0,0,19867.0,99596.2591544721,ATP4A
11453,KEGG_2019_Human,GABAergic synapse,1/89,0.0044499377838098,0.0130498764018304,0,0,19911.0,107815.380281759,GNB2
11454,KEGG_2019_Human,Morphine addiction,1/91,0.0045499369072032,0.0130498764018304,0,0,19909.0,107362.10783923086,GNB2
11455,KEGG_2019_Human,Circadian entrainment,1/97,0.0048499343304706,0.0130498764018304,0,0,19903.0,106058.9096435903,GNB2
11456,KEGG_2019_Human,Cholinergic synapse,1/112,0.0055999282120529,0.0130498764018304,0,0,19888.0,103119.30984392198,GNB2
11457,KEGG_2019_Human,Serotonergic synapse,1/113,0.0056499278191151,0.0130498764018304,0,0,19887.0,102937.34947211576,GNB2
11458,KEGG_2019_Human,Glutamatergic synapse,1/114,0.005699927427839,0.0130498764018304,0,0,19886.0,102756.96431429044,GNB2
11459,KEGG_2019_Human,Relaxin signaling pathway,1/130,0.0064999213952527,0.0130498764018304,0,0,19870.0,100064.62842845908,GNB2
11460,KEGG_2019_Human,Dopaminergic synapse,1/131,0.0065499210316603,0.0130498764018304,0,0,19869.0,99907.33811343512,GNB2
11461,KEGG_2019_Human,Apelin signaling pathway,1/137,0.0068499188797651,0.0130498764018304,0,0,19863.0,98987.62735269018,GNB2
11462,KEGG_2019_Human,Retrograde endocannabinoid signaling,1/148,0.007399915061391,0.0130498764018304,0,0,19852.0,97399.60470052566,GNB2
11463,KEGG_2019_Human,Alcoholism,1/180,0.0089999047745351,0.0130498764018304,0,0,19820.0,93362.92821536642,GNB2
11464,KEGG_2019_Human,Kaposi sarcoma-associated herpesvirus infection,1/186,0.0092999029651357,0.0130498764018304,0,0,19814.0,92684.96451050608,GNB2
11465,KEGG_2019_Human,Chemokine signaling pathway,1/190,0.0094999017791995,0.0130498764018304,0,0,19810.0,92244.74636351672,GNB2
11466,KEGG_2019_Human,Human immunodeficiency virus 1 infection,1/212,0.0105998955026255,0.0130498764018304,0,0,19788.0,89974.27756224656,GNB2
11467,KEGG_2019_Human,Human cytomegalovirus infection,1/225,0.0112498919790339,0.0130498764018304,0,0,19775.0,88738.27077557483,GNB2
11468,KEGG_2019_Human,Ras signaling pathway,1/232,0.0115998901349604,0.0130498764018304,0,0,19768.0,88101.22480150245,GNB2
11469,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0187410310320355,0,0,19646.0,79255.8617626126,GNB2
11470,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,GNB2
11471,KEGG_2019_Human,Regulation of actin cytoskeleton,1/214,0.0106998949514067,0.0106998949514067,0,0,19786.0,89779.39753374986,DIAPH3
11472,KEGG_2019_Human,T cell receptor signaling pathway,1/101,0.0050499326546803,0.0073332386703305,0,0,19899.0,105233.48101229242,MAP3K8
11473,KEGG_2019_Human,Toll-like receptor signaling pathway,1/104,0.0051999314202997,0.0073332386703305,0,0,19896.0,104635.24941415618,MAP3K8
11474,KEGG_2019_Human,TNF signaling pathway,1/110,0.0054999290027479,0.0073332386703305,0,0,19890.0,103488.06969787036,MAP3K8
11475,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0147498749536506,0,0,19705.0,83086.53988020132,MAP3K8
11476,KEGG_2019_Human,Cocaine addiction,1/49,0.0024499577795033,0.0082832366449848,0,0,19951.0,119939.1172087114,SLC18A2
11477,KEGG_2019_Human,Amphetamine addiction,1/68,0.0033999476216189,0.0082832366449848,0,0,19932.0,113293.39338050144,SLC18A2
11478,KEGG_2019_Human,Synaptic vesicle cycle,1/78,0.0038999427840466,0.0082832366449848,0,0,19922.0,110503.2180492851,SLC18A2
11479,KEGG_2019_Human,Serotonergic synapse,1/113,0.0056499278191151,0.0082832366449848,0,0,19887.0,102937.34947211576,SLC18A2
11480,KEGG_2019_Human,Dopaminergic synapse,1/131,0.0065499210316603,0.0082832366449848,0,0,19869.0,99907.33811343512,SLC18A2
11481,KEGG_2019_Human,Parkinson disease,1/142,0.0070999171242726,0.0082832366449848,0,0,19858.0,98250.87390500787,SLC18A2
11482,KEGG_2019_Human,Alcoholism,1/180,0.0089999047745351,0.0089999047745351,0,0,19820.0,93362.92821536642,SLC18A2
11483,KEGG_2019_Human,Salmonella infection,1/86,0.0042999391173866,0.006933241893733,0,0,19914.0,108514.46102290176,LBP
11484,KEGG_2019_Human,NF-kappa B signaling pathway,1/95,0.0047499351803394,0.006933241893733,0,0,19905.0,106484.27183626965,LBP
11485,KEGG_2019_Human,Toll-like receptor signaling pathway,1/104,0.0051999314202997,0.006933241893733,0,0,19896.0,104635.24941415618,LBP
11486,KEGG_2019_Human,Tuberculosis,1/179,0.0089499050800561,0.0089499050800561,0,0,19821.0,93478.0629355712,LBP
11487,KEGG_2019_Human,Axon guidance,1/181,0.0090499044707863,0.0090499044707863,0,0,19819.0,93248.41634586031,UNC5A
11488,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF480
11489,KEGG_2019_Human,Fructose and mannose metabolism,1/33,0.0016499677032113,0.0049499031096341,0,0,19967.0,127928.56031580272,PFKFB3
11490,KEGG_2019_Human,HIF-1 signaling pathway,1/100,0.0049999330710556,0.0059999251180858,0,0,19900.0,105436.78197328727,PFKFB3
11491,KEGG_2019_Human,AMPK signaling pathway,1/120,0.0059999251180858,0.0059999251180858,0,0,19880.0,101706.2448082016,PFKFB3
11492,KEGG_2019_Human,Hedgehog signaling pathway,1/47,0.0023499589392381,0.0023499589392381,0,0,19953.0,120782.64067395544,CSNK1G2
11493,KEGG_2019_Human,Arginine biosynthesis,1/21,0.0010499764455398,0.0082180768278038,0,0,19979.0,137035.71221916509,NOS2
11494,KEGG_2019_Human,Arginine and proline metabolism,1/49,0.0024499577795033,0.0082180768278038,0,0,19951.0,119939.1172087114,NOS2
11495,KEGG_2019_Human,Leishmaniasis,1/74,0.0036999446830449,0.0082180768278038,0,0,19926.0,111574.38983110404,NOS2
11496,KEGG_2019_Human,Pertussis,1/76,0.0037999437281752,0.0082180768278038,0,0,19924.0,111031.8499691117,NOS2
11497,KEGG_2019_Human,Peroxisome,1/83,0.0041499404726918,0.0082180768278038,0,0,19917.0,109237.99888847338,NOS2
11498,KEGG_2019_Human,Salmonella infection,1/86,0.0042999391173866,0.0082180768278038,0,0,19914.0,108514.46102290176,NOS2
11499,KEGG_2019_Human,Small cell lung cancer,1/93,0.0046499360391879,0.0082180768278038,0,0,19907.0,106918.54242106884,NOS2
11500,KEGG_2019_Human,Amoebiasis,1/96,0.0047999347538706,0.0082180768278038,0,0,19904.0,106270.50039849174,NOS2
11501,KEGG_2019_Human,HIF-1 signaling pathway,1/100,0.0049999330710556,0.0082180768278038,0,0,19900.0,105436.78197328727,NOS2
11502,KEGG_2019_Human,Chagas disease (American trypanosomiasis),1/103,0.0051499318302617,0.0082180768278038,0,0,19897.0,104832.7525292024,NOS2
11503,KEGG_2019_Human,Toxoplasmosis,1/113,0.0056499278191151,0.0082180768278038,0,0,19887.0,102937.34947211576,NOS2
11504,KEGG_2019_Human,Relaxin signaling pathway,1/130,0.0064999213952527,0.0084306693904802,0,0,19870.0,100064.62842845908,NOS2
11505,KEGG_2019_Human,Apelin signaling pathway,1/137,0.0068499188797651,0.0084306693904802,0,0,19863.0,98987.62735269018,NOS2
11506,KEGG_2019_Human,Tuberculosis,1/179,0.0089499050800561,0.010026562528144,0,0,19821.0,93478.0629355712,NOS2
11507,KEGG_2019_Human,Calcium signaling pathway,1/188,0.009399902370135,0.010026562528144,0,0,19812.0,92463.712994847,NOS2
11508,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,NOS2
11509,KEGG_2019_Human,Sphingolipid metabolism,1/47,0.0023499589392381,0.0046999178784763,0,0,19953.0,120782.64067395544,GALC
11510,KEGG_2019_Human,Lysosome,1/123,0.0061499239842961,0.0061499239842961,0,0,19877.0,101200.07933676826,GALC
11511,KEGG_2019_Human,Oocyte meiosis,1/125,0.0062499232373748,0.0062499232373748,0,0,19875.0,100869.32368441945,SLK
11512,KEGG_2019_Human,Pyruvate metabolism,1/39,0.0019499637955508,0.0019499637955508,0,0,19961.0,124555.53162481484,HAGH
11513,KEGG_2019_Human,Leishmaniasis,1/74,0.0036999446830449,0.0133998647837319,0,0,19926.0,111574.38983110404,JAK1
11514,KEGG_2019_Human,Pancreatic cancer,1/75,0.0037499442041125,0.0133998647837319,0,0,19925.0,111301.33528642564,JAK1
11515,KEGG_2019_Human,Th1 and Th2 cell differentiation,1/92,0.0045999364719865,0.0133998647837319,0,0,19908.0,107139.13814408927,JAK1
11516,KEGG_2019_Human,Th17 cell differentiation,1/107,0.0053499302026925,0.0133998647837319,0,0,19893.0,104053.753408911,JAK1
11517,KEGG_2019_Human,Toxoplasmosis,1/113,0.0056499278191151,0.0133998647837319,0,0,19887.0,102937.34947211576,JAK1
11518,KEGG_2019_Human,Osteoclast differentiation,1/127,0.0063499224962247,0.0133998647837319,0,0,19873.0,100543.72072014232,JAK1
11519,KEGG_2019_Human,Measles,1/138,0.0068999185254481,0.0133998647837319,0,0,19862.0,98838.19160389496,JAK1
11520,KEGG_2019_Human,Signaling pathways regulating pluripotency of stem cells,1/139,0.006949918172816,0.0133998647837319,0,0,19861.0,98689.81333375497,JAK1
11521,KEGG_2019_Human,Hepatitis C,1/155,0.0077499127120574,0.0133998647837319,0,0,19845.0,96448.16254952336,JAK1
11522,KEGG_2019_Human,Necroptosis,1/162,0.0080999104202618,0.0133998647837319,0,0,19838.0,95537.86936302872,JAK1
11523,KEGG_2019_Human,JAK-STAT signaling pathway,1/162,0.0080999104202618,0.0133998647837319,0,0,19838.0,95537.86936302872,JAK1
11524,KEGG_2019_Human,Hepatitis B,1/163,0.0081499100978668,0.0133998647837319,0,0,19837.0,95410.9786681514,JAK1
11525,KEGG_2019_Human,Influenza A,1/171,0.0085499075557634,0.0133998647837319,0,0,19829.0,94422.42241345016,JAK1
11526,KEGG_2019_Human,NOD-like receptor signaling pathway,1/178,0.0088999053857096,0.0133998647837319,0,0,19822.0,93593.82745769851,JAK1
11527,KEGG_2019_Human,Tuberculosis,1/179,0.0089499050800561,0.0133998647837319,0,0,19821.0,93478.0629355712,JAK1
11528,KEGG_2019_Human,Kaposi sarcoma-associated herpesvirus infection,1/186,0.0092999029651357,0.0133998647837319,0,0,19814.0,92684.96451050608,JAK1
11529,KEGG_2019_Human,Viral carcinogenesis,1/201,0.0100498985877989,0.0133998647837319,0,0,19799.0,91079.21596609056,JAK1
11530,KEGG_2019_Human,Epstein-Barr virus infection,1/201,0.0100498985877989,0.0133998647837319,0,0,19799.0,91079.21596609056,JAK1
11531,KEGG_2019_Human,Human T-cell leukemia virus 1 infection,1/219,0.0109498935894162,0.0134998703748406,0,0,19781.0,89299.85161916987,JAK1
11532,KEGG_2019_Human,Human cytomegalovirus infection,1/225,0.0112498919790339,0.0134998703748406,0,0,19775.0,88738.27077557483,JAK1
11533,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0188569913816737,0,0,19670.0,80733.60565076157,JAK1
11534,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0193089410633093,0,0,19646.0,79255.8617626126,JAK1
11535,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0256693971961301,0,0,19508.0,72277.44006442746,JAK1
11536,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,JAK1
11537,KEGG_2019_Human,Spliceosome,1/134,0.0066999199497742,0.0066999199497742,0,0,19866.0,99442.43560916925,DDX23
11538,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR5V1
11539,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF589
11540,KEGG_2019_Human,Signaling pathways regulating pluripotency of stem cells,1/139,0.006949918172816,0.006949918172816,0,0,19861.0,98689.81333375497,SKIL
11541,KEGG_2019_Human,Ubiquitin mediated proteolysis,1/137,0.0068499188797651,0.0070999171242726,0,0,19863.0,98987.62735269018,UBE2L3
11542,KEGG_2019_Human,Parkinson disease,1/142,0.0070999171242726,0.0070999171242726,0,0,19858.0,98250.87390500787,UBE2L3
11543,KEGG_2019_Human,Cell adhesion molecules (CAMs),1/145,0.0072499160871101,0.0072499160871101,0,0,19855.0,97820.92670675044,CD226
11544,KEGG_2019_Human,Legionellosis,1/55,0.0027499544131125,0.0136873669867703,0,0,19945.0,117599.1294878737,NFKB2
11545,KEGG_2019_Human,NF-kappa B signaling pathway,1/95,0.0047499351803394,0.0136873669867703,0,0,19905.0,106484.27183626965,NFKB2
11546,KEGG_2019_Human,C-type lectin receptor signaling pathway,1/104,0.0051999314202997,0.0136873669867703,0,0,19896.0,104635.24941415618,NFKB2
11547,KEGG_2019_Human,Osteoclast differentiation,1/127,0.0063499224962247,0.0136873669867703,0,0,19873.0,100543.72072014232,NFKB2
11548,KEGG_2019_Human,Breast cancer,1/147,0.0073499154017982,0.0136873669867703,0,0,19853.0,97539.10874372096,NFKB2
11549,KEGG_2019_Human,Epstein-Barr virus infection,1/201,0.0100498985877989,0.0136873669867703,0,0,19799.0,91079.21596609056,NFKB2
11550,KEGG_2019_Human,Viral carcinogenesis,1/201,0.0100498985877989,0.0136873669867703,0,0,19799.0,91079.21596609056,NFKB2
11551,KEGG_2019_Human,Human T-cell leukemia virus 1 infection,1/219,0.0109498935894162,0.0136873669867703,0,0,19781.0,89299.85161916987,NFKB2
11552,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0163887499485007,0,0,19705.0,83086.53988020132,NFKB2
11553,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,NFKB2
11554,KEGG_2019_Human,Steroid biosynthesis,1/19,0.00094997806231055,0.0028499341869316,0,0,19981.0,139049.2109571672,CYP24A1
11555,KEGG_2019_Human,"Parathyroid hormone synthesis, secretion and action",1/106,0.0052999306076525,0.0079498959114788,0,0,19894.0,104245.78450366124,CYP24A1
11556,KEGG_2019_Human,MicroRNAs in cancer,1/299,0.0149498740670514,0.0149498740670514,0,0,19701.0,82804.33538735632,CYP24A1
11557,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR51I1
11558,KEGG_2019_Human,Fanconi anemia pathway,1/54,0.0026999549628563,0.0026999549628563,0,0,19946.0,117971.01964061816,FANCA
11559,KEGG_2019_Human,Prolactin signaling pathway,1/70,0.0034999466296654,0.0108883369016192,0,0,19930.0,112704.30065625212,SHC4
11560,KEGG_2019_Human,Bacterial invasion of epithelial cells,1/74,0.0036999446830449,0.0108883369016192,0,0,19926.0,111574.38983110404,SHC4
11561,KEGG_2019_Human,Glioma,1/75,0.0037499442041125,0.0108883369016192,0,0,19925.0,111301.33528642564,SHC4
11562,KEGG_2019_Human,Chronic myeloid leukemia,1/76,0.0037999437281752,0.0108883369016192,0,0,19924.0,111031.8499691117,SHC4
11563,KEGG_2019_Human,ErbB signaling pathway,1/85,0.004249939567045,0.0108883369016192,0,0,19915.0,108752.83801948265,SHC4
11564,KEGG_2019_Human,Neurotrophin signaling pathway,1/119,0.0059499254985137,0.0108883369016192,0,0,19881.0,101877.73080211312,SHC4
11565,KEGG_2019_Human,Relaxin signaling pathway,1/130,0.0064999213952527,0.0108883369016192,0,0,19870.0,100064.62842845908,SHC4
11566,KEGG_2019_Human,Natural killer cell mediated cytotoxicity,1/131,0.0065499210316603,0.0108883369016192,0,0,19869.0,99907.33811343512,SHC4
11567,KEGG_2019_Human,Insulin signaling pathway,1/137,0.0068499188797651,0.0108883369016192,0,0,19863.0,98987.62735269018,SHC4
11568,KEGG_2019_Human,Estrogen signaling pathway,1/137,0.0068499188797651,0.0108883369016192,0,0,19863.0,98987.62735269018,SHC4
11569,KEGG_2019_Human,Breast cancer,1/147,0.0073499154017982,0.0108883369016192,0,0,19853.0,97539.10874372096,SHC4
11570,KEGG_2019_Human,Phospholipase D signaling pathway,1/148,0.007399915061391,0.0108883369016192,0,0,19852.0,97399.60470052566,SHC4
11571,KEGG_2019_Human,Gastric cancer,1/149,0.0074499147221605,0.0108883369016192,0,0,19851.0,97261.02051561224,SHC4
11572,KEGG_2019_Human,Hepatocellular carcinoma,1/168,0.0083999085011095,0.0111204755329001,0,0,19832.0,94787.72752807094,SHC4
11573,KEGG_2019_Human,Alcoholism,1/180,0.0089999047745351,0.0111204755329001,0,0,19820.0,93362.92821536642,SHC4
11574,KEGG_2019_Human,Chemokine signaling pathway,1/190,0.0094999017791995,0.0111204755329001,0,0,19810.0,92244.74636351672,SHC4
11575,KEGG_2019_Human,Focal adhesion,1/199,0.0099498991610159,0.0111204755329001,0,0,19801.0,91286.4288690606,SHC4
11576,KEGG_2019_Human,Ras signaling pathway,1/232,0.0115998901349604,0.0122443284757915,0,0,19768.0,88101.22480150245,SHC4
11577,KEGG_2019_Human,MicroRNAs in cancer,1/299,0.0149498740670514,0.0149498740670514,0,0,19701.0,82804.33538735632,SHC4
11578,KEGG_2019_Human,Ferroptosis,1/40,0.0019999631680592,0.0027999538675741,0,0,19960.0,124043.94523066044,GPX4
11579,KEGG_2019_Human,Glutathione metabolism,1/56,0.0027999538675741,0.0027999538675741,0,0,19944.0,117233.87022514464,GPX4
11580,KEGG_2019_Human,Nicotine addiction,1/40,0.0019999631680592,0.007399915061391,0,0,19960.0,124043.94523066044,SLC17A6
11581,KEGG_2019_Human,Synaptic vesicle cycle,1/78,0.0038999427840466,0.007399915061391,0,0,19922.0,110503.2180492851,SLC17A6
11582,KEGG_2019_Human,Glutamatergic synapse,1/114,0.005699927427839,0.007399915061391,0,0,19886.0,102756.96431429044,SLC17A6
11583,KEGG_2019_Human,Retrograde endocannabinoid signaling,1/148,0.007399915061391,0.007399915061391,0,0,19852.0,97399.60470052566,SLC17A6
11584,KEGG_2019_Human,Mineral absorption,1/51,0.0025499566390179,0.0025499566390179,0,0,19949.0,119129.0228601236,SLC30A1
11585,KEGG_2019_Human,N-Glycan biosynthesis,1/50,0.0024999572069037,0.0049999144138074,0,0,19950.0,119530.05920663515,RPN2
11586,KEGG_2019_Human,Protein processing in endoplasmic reticulum,1/165,0.0082499094553477,0.0082499094553477,0,0,19835.0,95159.46482222488,RPN2
11587,KEGG_2019_Human,Cardiac muscle contraction,1/78,0.0038999427840466,0.007583228178672,0,0,19922.0,110503.2180492851,TNNI3
11588,KEGG_2019_Human,Hypertrophic cardiomyopathy (HCM),1/85,0.004249939567045,0.007583228178672,0,0,19915.0,108752.83801948265,TNNI3
11589,KEGG_2019_Human,Dilated cardiomyopathy (DCM),1/91,0.0045499369072032,0.007583228178672,0,0,19909.0,107362.10783923086,TNNI3
11590,KEGG_2019_Human,Adrenergic signaling in cardiomyocytes,1/145,0.0072499160871101,0.0090623951088877,0,0,19855.0,97820.92670675044,TNNI3
11591,KEGG_2019_Human,cAMP signaling pathway,1/212,0.0105998955026255,0.0105998955026255,0,0,19788.0,89974.27756224656,TNNI3
11592,KEGG_2019_Human,Pathogenic Escherichia coli infection,1/55,0.0027499544131125,0.0084999078692823,0,0,19945.0,117599.1294878737,OCLN
11593,KEGG_2019_Human,Leukocyte transendothelial migration,1/112,0.0055999282120529,0.0084999078692823,0,0,19888.0,103119.30984392198,OCLN
11594,KEGG_2019_Human,Cell adhesion molecules (CAMs),1/145,0.0072499160871101,0.0084999078692823,0,0,19855.0,97820.92670675044,OCLN
11595,KEGG_2019_Human,Hepatitis C,1/155,0.0077499127120574,0.0084999078692823,0,0,19845.0,96448.16254952336,OCLN
11596,KEGG_2019_Human,Tight junction,1/170,0.0084999078692823,0.0084999078692823,0,0,19830.0,94543.49009679438,OCLN
11597,KEGG_2019_Human,Ribosome biogenesis in eukaryotes,1/101,0.0050499326546803,0.0050499326546803,0,0,19899.0,105233.48101229242,TCOF1
11598,KEGG_2019_Human,Hippo signaling pathway,1/160,0.0079999110688441,0.0127498618039235,0,0,19840.0,95793.96509856998,LLGL2
11599,KEGG_2019_Human,Tight junction,1/170,0.0084999078692823,0.0127498618039235,0,0,19830.0,94543.49009679438,LLGL2
11600,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0164998674589645,0,0,19670.0,80733.60565076157,LLGL2
11601,KEGG_2019_Human,Amyotrophic lateral sclerosis (ALS),1/51,0.0025499566390179,0.0109665527651575,0,0,19949.0,119129.0228601236,PPP3R2
11602,KEGG_2019_Human,VEGF signaling pathway,1/59,0.0029499522555206,0.0109665527651575,0,0,19941.0,116175.59385530632,PPP3R2
11603,KEGG_2019_Human,Long-term potentiation,1/67,0.0033499481224912,0.0109665527651575,0,0,19933.0,113594.38808369274,PPP3R2
11604,KEGG_2019_Human,Amphetamine addiction,1/68,0.0033999476216189,0.0109665527651575,0,0,19932.0,113293.39338050144,PPP3R2
11605,KEGG_2019_Human,Renin secretion,1/69,0.003449947123837,0.0109665527651575,0,0,19931.0,112996.7391397682,PPP3R2
11606,KEGG_2019_Human,B cell receptor signaling pathway,1/71,0.0035499461386618,0.0109665527651575,0,0,19929.0,112415.9585341616,PPP3R2
11607,KEGG_2019_Human,Th1 and Th2 cell differentiation,1/92,0.0045999364719865,0.0109665527651575,0,0,19908.0,107139.13814408927,PPP3R2
11608,KEGG_2019_Human,T cell receptor signaling pathway,1/101,0.0050499326546803,0.0109665527651575,0,0,19899.0,105233.48101229242,PPP3R2
11609,KEGG_2019_Human,Glucagon signaling pathway,1/103,0.0051499318302617,0.0109665527651575,0,0,19897.0,104832.7525292024,PPP3R2
11610,KEGG_2019_Human,C-type lectin receptor signaling pathway,1/104,0.0051999314202997,0.0109665527651575,0,0,19896.0,104635.24941415618,PPP3R2
11611,KEGG_2019_Human,Th17 cell differentiation,1/107,0.0053499302026925,0.0109665527651575,0,0,19893.0,104053.753408911,PPP3R2
11612,KEGG_2019_Human,Glutamatergic synapse,1/114,0.005699927427839,0.0109665527651575,0,0,19886.0,102756.96431429044,PPP3R2
11613,KEGG_2019_Human,Oocyte meiosis,1/125,0.0062499232373748,0.0109665527651575,0,0,19875.0,100869.32368441945,PPP3R2
11614,KEGG_2019_Human,Osteoclast differentiation,1/127,0.0063499224962247,0.0109665527651575,0,0,19873.0,100543.72072014232,PPP3R2
11615,KEGG_2019_Human,Natural killer cell mediated cytotoxicity,1/131,0.0065499210316603,0.0109665527651575,0,0,19869.0,99907.33811343512,PPP3R2
11616,KEGG_2019_Human,Oxytocin signaling pathway,1/153,0.0076499133771537,0.0109665527651575,0,0,19847.0,96715.6407630817,PPP3R2
11617,KEGG_2019_Human,Wnt signaling pathway,1/158,0.0078999117225733,0.0109665527651575,0,0,19842.0,96053.2110949472,PPP3R2
11618,KEGG_2019_Human,Cellular senescence,1/160,0.0079999110688441,0.0109665527651575,0,0,19840.0,95793.96509856998,PPP3R2
11619,KEGG_2019_Human,cGMP-PKG signaling pathway,1/166,0.0082999091363732,0.0109665527651575,0,0,19834.0,95034.82345515196,PPP3R2
11620,KEGG_2019_Human,Alzheimer disease,1/171,0.0085499075557634,0.0109665527651575,0,0,19829.0,94422.42241345016,PPP3R2
11621,KEGG_2019_Human,Tuberculosis,1/179,0.0089499050800561,0.0109665527651575,0,0,19821.0,93478.0629355712,PPP3R2
11622,KEGG_2019_Human,Axon guidance,1/181,0.0090499044707863,0.0109665527651575,0,0,19819.0,93248.41634586031,PPP3R2
11623,KEGG_2019_Human,Kaposi sarcoma-associated herpesvirus infection,1/186,0.0092999029651357,0.0109665527651575,0,0,19814.0,92684.96451050608,PPP3R2
11624,KEGG_2019_Human,Calcium signaling pathway,1/188,0.009399902370135,0.0109665527651575,0,0,19812.0,92463.712994847,PPP3R2
11625,KEGG_2019_Human,Human immunodeficiency virus 1 infection,1/212,0.0105998955026255,0.011666554644924,0,0,19788.0,89974.27756224656,PPP3R2
11626,KEGG_2019_Human,Human T-cell leukemia virus 1 infection,1/219,0.0109498935894162,0.011666554644924,0,0,19781.0,89299.85161916987,PPP3R2
11627,KEGG_2019_Human,Human cytomegalovirus infection,1/225,0.0112498919790339,0.011666554644924,0,0,19775.0,88738.27077557483,PPP3R2
11628,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0147498749536506,0,0,19705.0,83086.53988020132,PPP3R2
11629,KEGG_2019_Human,Basal cell carcinoma,1/63,0.0031499501598827,0.0109198810514423,0,0,19937.0,114844.46974572667,WNT9B
11630,KEGG_2019_Human,Melanogenesis,1/101,0.0050499326546803,0.0109198810514423,0,0,19899.0,105233.48101229242,WNT9B
11631,KEGG_2019_Human,Signaling pathways regulating pluripotency of stem cells,1/139,0.006949918172816,0.0109198810514423,0,0,19861.0,98689.81333375497,WNT9B
11632,KEGG_2019_Human,Breast cancer,1/147,0.0073499154017982,0.0109198810514423,0,0,19853.0,97539.10874372096,WNT9B
11633,KEGG_2019_Human,Gastric cancer,1/149,0.0074499147221605,0.0109198810514423,0,0,19851.0,97261.02051561224,WNT9B
11634,KEGG_2019_Human,mTOR signaling pathway,1/152,0.0075999137114971,0.0109198810514423,0,0,19848.0,96850.665715497,WNT9B
11635,KEGG_2019_Human,Cushing syndrome,1/155,0.0077499127120574,0.0109198810514423,0,0,19845.0,96448.16254952336,WNT9B
11636,KEGG_2019_Human,Wnt signaling pathway,1/158,0.0078999117225733,0.0109198810514423,0,0,19842.0,96053.2110949472,WNT9B
11637,KEGG_2019_Human,Hippo signaling pathway,1/160,0.0079999110688441,0.0109198810514423,0,0,19840.0,95793.96509856998,WNT9B
11638,KEGG_2019_Human,Hepatocellular carcinoma,1/168,0.0083999085011095,0.0109198810514423,0,0,19832.0,94787.72752807094,WNT9B
11639,KEGG_2019_Human,Proteoglycans in cancer,1/201,0.0100498985877989,0.0118771528764897,0,0,19799.0,91079.21596609056,WNT9B
11640,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0178748564138782,0,0,19670.0,80733.60565076157,WNT9B
11641,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,WNT9B
11642,KEGG_2019_Human,Long-term depression,1/60,0.002999951725986,0.0096898902777281,0,0,19940.0,115834.63209072244,GNAO1
11643,KEGG_2019_Human,GABAergic synapse,1/89,0.0044499377838098,0.0096898902777281,0,0,19911.0,107815.380281759,GNAO1
11644,KEGG_2019_Human,Morphine addiction,1/91,0.0045499369072032,0.0096898902777281,0,0,19909.0,107362.10783923086,GNAO1
11645,KEGG_2019_Human,Circadian entrainment,1/97,0.0048499343304706,0.0096898902777281,0,0,19903.0,106058.9096435903,GNAO1
11646,KEGG_2019_Human,Melanogenesis,1/101,0.0050499326546803,0.0096898902777281,0,0,19899.0,105233.48101229242,GNAO1
11647,KEGG_2019_Human,Chagas disease (American trypanosomiasis),1/103,0.0051499318302617,0.0096898902777281,0,0,19897.0,104832.7525292024,GNAO1
11648,KEGG_2019_Human,Cholinergic synapse,1/112,0.0055999282120529,0.0096898902777281,0,0,19888.0,103119.30984392198,GNAO1
11649,KEGG_2019_Human,Toxoplasmosis,1/113,0.0056499278191151,0.0096898902777281,0,0,19887.0,102937.34947211576,GNAO1
11650,KEGG_2019_Human,Serotonergic synapse,1/113,0.0056499278191151,0.0096898902777281,0,0,19887.0,102937.34947211576,GNAO1
11651,KEGG_2019_Human,Glutamatergic synapse,1/114,0.005699927427839,0.0096898902777281,0,0,19886.0,102756.96431429044,GNAO1
11652,KEGG_2019_Human,Relaxin signaling pathway,1/130,0.0064999213952527,0.0096898902777281,0,0,19870.0,100064.62842845908,GNAO1
11653,KEGG_2019_Human,Dopaminergic synapse,1/131,0.0065499210316603,0.0096898902777281,0,0,19869.0,99907.33811343512,GNAO1
11654,KEGG_2019_Human,Estrogen signaling pathway,1/137,0.0068499188797651,0.0096898902777281,0,0,19863.0,98987.62735269018,GNAO1
11655,KEGG_2019_Human,Retrograde endocannabinoid signaling,1/148,0.007399915061391,0.0096898902777281,0,0,19852.0,97399.60470052566,GNAO1
11656,KEGG_2019_Human,Oxytocin signaling pathway,1/153,0.0076499133771537,0.0096898902777281,0,0,19847.0,96715.6407630817,GNAO1
11657,KEGG_2019_Human,Alcoholism,1/180,0.0089999047745351,0.0106873869197604,0,0,19820.0,93362.92821536642,GNAO1
11658,KEGG_2019_Human,Rap1 signaling pathway,1/206,0.010299897173561,0.0111887785861047,0,0,19794.0,90569.849337325,GNAO1
11659,KEGG_2019_Human,Human immunodeficiency virus 1 infection,1/212,0.0105998955026255,0.0111887785861047,0,0,19788.0,89974.27756224656,GNAO1
11660,KEGG_2019_Human,Human cytomegalovirus infection,1/225,0.0112498919790339,0.0112498919790339,0,0,19775.0,88738.27077557483,GNAO1
11661,KEGG_2019_Human,ABC transporters,1/45,0.0022499601197094,0.0022499601197094,0,0,19955.0,121662.49782449217,ABCC12
11662,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,PYY
11663,KEGG_2019_Human,Arachidonic acid metabolism,1/63,0.0031499501598827,0.0049332595773933,0,0,19937.0,114844.46974572667,CYP2B6
11664,KEGG_2019_Human,Retinol metabolism,1/67,0.0033499481224912,0.0049332595773933,0,0,19933.0,113594.38808369274,CYP2B6
11665,KEGG_2019_Human,Metabolism of xenobiotics by cytochrome P450,1/74,0.0036999446830449,0.0049332595773933,0,0,19926.0,111574.38983110404,CYP2B6
11666,KEGG_2019_Human,Drug metabolism,1/108,0.0053999298011749,0.0053999298011749,0,0,19892.0,103863.47861844616,CYP2B6
11667,KEGG_2019_Human,Ubiquitin mediated proteolysis,1/137,0.0068499188797651,0.0068499188797651,0,0,19863.0,98987.62735269018,NHLRC1
11668,KEGG_2019_Human,Glycosaminoglycan biosynthesis,1/53,0.0026499555173137,0.0026499555173137,0,0,19947.0,118349.78824235698,HS3ST3A1
11669,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF627
11670,KEGG_2019_Human,Arrhythmogenic right ventricular cardiomyopathy (ARVC),1/72,0.0035999456502131,0.0035999456502131,0,0,19928.0,112131.59838572376,DSG2
11671,KEGG_2019_Human,Leukocyte transendothelial migration,1/112,0.0055999282120529,0.0099498991610159,0,0,19888.0,103119.30984392198,ARHGAP5
11672,KEGG_2019_Human,Focal adhesion,1/199,0.0099498991610159,0.0099498991610159,0,0,19801.0,91286.4288690606,ARHGAP5
11673,KEGG_2019_Human,Huntington disease,1/193,0.0096499008972596,0.0096499008972596,0,0,19807.0,91920.47679471428,DNAH12
11674,KEGG_2019_Human,Staphylococcus aureus infection,1/68,0.0033999476216189,0.0067998952432378,0,0,19932.0,113293.39338050144,KRT10
11675,KEGG_2019_Human,Estrogen signaling pathway,1/137,0.0068499188797651,0.0068499188797651,0,0,19863.0,98987.62735269018,KRT10
11676,KEGG_2019_Human,Homologous recombination,1/41,0.0020499625466866,0.0020499625466866,0,0,19959.0,123544.88783416104,RAD54L
11677,KEGG_2019_Human,Protein digestion and absorption,1/90,0.0044999373439762,0.0044999373439762,0,0,19910.0,107587.50385474482,SLC36A1
11678,KEGG_2019_Human,Thyroid cancer,1/37,0.0018499650702878,0.0089599024011834,0,0,19963.0,125618.9446446357,LEF1
11679,KEGG_2019_Human,Endometrial cancer,1/58,0.0028999527887707,0.0089599024011834,0,0,19942.0,116522.31890946148,LEF1
11680,KEGG_2019_Human,Basal cell carcinoma,1/63,0.0031499501598827,0.0089599024011834,0,0,19937.0,114844.46974572667,LEF1
11681,KEGG_2019_Human,Acute myeloid leukemia,1/66,0.003299948626608,0.0089599024011834,0,0,19934.0,113899.85357353876,LEF1
11682,KEGG_2019_Human,Adherens junction,1/72,0.0035999456502131,0.0089599024011834,0,0,19928.0,112131.59838572376,LEF1
11683,KEGG_2019_Human,Arrhythmogenic right ventricular cardiomyopathy (ARVC),1/72,0.0035999456502131,0.0089599024011834,0,0,19928.0,112131.59838572376,LEF1
11684,KEGG_2019_Human,Colorectal cancer,1/86,0.0042999391173866,0.0089599024011834,0,0,19914.0,108514.46102290176,LEF1
11685,KEGG_2019_Human,Prostate cancer,1/97,0.0048499343304706,0.0089599024011834,0,0,19903.0,106058.9096435903,LEF1
11686,KEGG_2019_Human,Melanogenesis,1/101,0.0050499326546803,0.0089599024011834,0,0,19899.0,105233.48101229242,LEF1
11687,KEGG_2019_Human,Breast cancer,1/147,0.0073499154017982,0.0089599024011834,0,0,19853.0,97539.10874372096,LEF1
11688,KEGG_2019_Human,Gastric cancer,1/149,0.0074499147221605,0.0089599024011834,0,0,19851.0,97261.02051561224,LEF1
11689,KEGG_2019_Human,Cushing syndrome,1/155,0.0077499127120574,0.0089599024011834,0,0,19845.0,96448.16254952336,LEF1
11690,KEGG_2019_Human,Wnt signaling pathway,1/158,0.0078999117225733,0.0089599024011834,0,0,19842.0,96053.2110949472,LEF1
11691,KEGG_2019_Human,Hippo signaling pathway,1/160,0.0079999110688441,0.0089599024011834,0,0,19840.0,95793.96509856998,LEF1
11692,KEGG_2019_Human,Hepatocellular carcinoma,1/168,0.0083999085011095,0.0089599024011834,0,0,19832.0,94787.72752807094,LEF1
11693,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,LEF1
11694,KEGG_2019_Human,Hedgehog signaling pathway,1/47,0.0023499589392381,0.0023499589392381,0,0,19953.0,120782.64067395544,SPOP
11695,KEGG_2019_Human,Inositol phosphate metabolism,1/74,0.0036999446830449,0.0049499334884068,0,0,19926.0,111574.38983110404,IMPA1
11696,KEGG_2019_Human,Phosphatidylinositol signaling system,1/99,0.0049499334884068,0.0049499334884068,0,0,19901.0,105642.09305076736,IMPA1
11697,KEGG_2019_Human,N-Glycan biosynthesis,1/50,0.0024999572069037,0.0024999572069037,0,0,19950.0,119530.05920663515,ALG3
11698,KEGG_2019_Human,Proteoglycans in cancer,1/201,0.0100498985877989,0.0100498985877989,0,0,19799.0,91079.21596609056,ANK3
11699,KEGG_2019_Human,Protein processing in endoplasmic reticulum,1/165,0.0082499094553477,0.0082499094553477,0,0,19835.0,95159.46482222488,HSPH1
11700,KEGG_2019_Human,Renal cell carcinoma,1/69,0.003449947123837,0.0130498764018304,0,0,19931.0,112996.7391397682,PAK2
11701,KEGG_2019_Human,ErbB signaling pathway,1/85,0.004249939567045,0.0130498764018304,0,0,19915.0,108752.83801948265,PAK2
11702,KEGG_2019_Human,T cell receptor signaling pathway,1/101,0.0050499326546803,0.0130498764018304,0,0,19899.0,105233.48101229242,PAK2
11703,KEGG_2019_Human,Axon guidance,1/181,0.0090499044707863,0.0130498764018304,0,0,19819.0,93248.41634586031,PAK2
11704,KEGG_2019_Human,Focal adhesion,1/199,0.0099498991610159,0.0130498764018304,0,0,19801.0,91286.4288690606,PAK2
11705,KEGG_2019_Human,Human immunodeficiency virus 1 infection,1/212,0.0105998955026255,0.0130498764018304,0,0,19788.0,89974.27756224656,PAK2
11706,KEGG_2019_Human,Regulation of actin cytoskeleton,1/214,0.0106998949514067,0.0130498764018304,0,0,19786.0,89779.39753374986,PAK2
11707,KEGG_2019_Human,Ras signaling pathway,1/232,0.0115998901349604,0.0130498764018304,0,0,19768.0,88101.22480150245,PAK2
11708,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0147498749536506,0,0,19705.0,83086.53988020132,PAK2
11709,KEGG_2019_Human,Nicotinate and nicotinamide metabolism,1/30,0.0014999697593334,0.0014999697593334,0,0,19970.0,129851.13732048514,NADK2
11710,KEGG_2019_Human,Hippo signaling pathway,1/160,0.0079999110688441,0.0079999110688441,0,0,19840.0,95793.96509856998,LATS1
11711,KEGG_2019_Human,Ribosome,1/153,0.0076499133771537,0.0076499133771537,0,0,19847.0,96715.6407630817,RPL26L1
11712,KEGG_2019_Human,Transcriptional misregulation in cancer,1/186,0.0092999029651357,0.0092999029651357,0,0,19814.0,92684.96451050608,CDK9
11713,KEGG_2019_Human,RNA transport,1/165,0.0082499094553477,0.0082499094553477,0,0,19835.0,95159.46482222488,NUP155
11714,KEGG_2019_Human,Transcriptional misregulation in cancer,1/186,0.0092999029651357,0.0092999029651357,0,0,19814.0,92684.96451050608,ETV4
11715,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF17
11716,KEGG_2019_Human,Endocytosis,1/244,0.0121998870519305,0.0121998870519305,0,0,19756.0,87051.4275316661,WIPF2
11717,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF417
11718,KEGG_2019_Human,RNA transport,1/165,0.0082499094553477,0.0082499094553477,0,0,19835.0,95159.46482222488,STRAP
11719,KEGG_2019_Human,RNA degradation,1/79,0.0039499423167337,0.0039499423167337,0,0,19921.0,110243.89578070649,WDR61
11720,KEGG_2019_Human,Cardiac muscle contraction,1/78,0.0038999427840466,0.007583228178672,0,0,19922.0,110503.2180492851,TNNC1
11721,KEGG_2019_Human,Hypertrophic cardiomyopathy (HCM),1/85,0.004249939567045,0.007583228178672,0,0,19915.0,108752.83801948265,TNNC1
11722,KEGG_2019_Human,Dilated cardiomyopathy (DCM),1/91,0.0045499369072032,0.007583228178672,0,0,19909.0,107362.10783923086,TNNC1
11723,KEGG_2019_Human,Adrenergic signaling in cardiomyocytes,1/145,0.0072499160871101,0.0090623951088877,0,0,19855.0,97820.92670675044,TNNC1
11724,KEGG_2019_Human,Calcium signaling pathway,1/188,0.009399902370135,0.009399902370135,0,0,19812.0,92463.712994847,TNNC1
11725,KEGG_2019_Human,Rheumatoid arthritis,1/91,0.0045499369072032,0.0149997992131669,0,0,19909.0,107362.10783923086,ANGPT1
11726,KEGG_2019_Human,HIF-1 signaling pathway,1/100,0.0049999330710556,0.0149997992131669,0,0,19900.0,105436.78197328727,ANGPT1
11727,KEGG_2019_Human,Rap1 signaling pathway,1/206,0.010299897173561,0.0173998352024406,0,0,19794.0,90569.849337325,ANGPT1
11728,KEGG_2019_Human,Ras signaling pathway,1/232,0.0115998901349604,0.0173998352024406,0,0,19768.0,88101.22480150245,ANGPT1
11729,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0176998499443808,0,0,19705.0,83086.53988020132,ANGPT1
11730,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0176998626413668,0,0,19646.0,79255.8617626126,ANGPT1
11731,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0176998626413668,0,0,19646.0,79255.8617626126,PHLPP1
11732,KEGG_2019_Human,RNA transport,1/165,0.0082499094553477,0.0082499094553477,0,0,19835.0,95159.46482222488,NDC1
11733,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZFP37
11734,KEGG_2019_Human,Hepatitis C,1/155,0.0077499127120574,0.0118665405142795,0,0,19845.0,96448.16254952336,RNASEL
11735,KEGG_2019_Human,Influenza A,1/171,0.0085499075557634,0.0118665405142795,0,0,19829.0,94422.42241345016,RNASEL
11736,KEGG_2019_Human,NOD-like receptor signaling pathway,1/178,0.0088999053857096,0.0118665405142795,0,0,19822.0,93593.82745769851,RNASEL
11737,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,RNASEL
11738,KEGG_2019_Human,Intestinal immune network for IgA production,1/48,0.0023999583567988,0.0023999583567988,0,0,19952.0,120356.5272753826,PIGR
11739,KEGG_2019_Human,Type II diabetes mellitus,1/46,0.0022999595269283,0.0089398976665926,0,0,19954.0,121217.8313311442,IRS2
11740,KEGG_2019_Human,Regulation of lipolysis in adipocytes,1/55,0.0027499544131125,0.0089398976665926,0,0,19945.0,117599.1294878737,IRS2
11741,KEGG_2019_Human,Adipocytokine signaling pathway,1/69,0.003449947123837,0.0089398976665926,0,0,19931.0,112996.7391397682,IRS2
11742,KEGG_2019_Human,Longevity regulating pathway,1/102,0.0050999322416682,0.0089398976665926,0,0,19898.0,105032.15064717118,IRS2
11743,KEGG_2019_Human,Insulin resistance,1/108,0.0053999298011749,0.0089398976665926,0,0,19892.0,103863.47861844616,IRS2
11744,KEGG_2019_Human,AMPK signaling pathway,1/120,0.0059999251180858,0.0089398976665926,0,0,19880.0,101706.2448082016,IRS2
11745,KEGG_2019_Human,Autophagy,1/128,0.0063999221281459,0.0089398976665926,0,0,19872.0,100382.8010329652,IRS2
11746,KEGG_2019_Human,FoxO signaling pathway,1/132,0.0065999206698993,0.0089398976665926,0,0,19868.0,99751.22090491928,IRS2
11747,KEGG_2019_Human,Insulin signaling pathway,1/137,0.0068499188797651,0.0089398976665926,0,0,19863.0,98987.62735269018,IRS2
11748,KEGG_2019_Human,Non-alcoholic fatty liver disease (NAFLD),1/149,0.0074499147221605,0.0089398976665926,0,0,19851.0,97261.02051561224,IRS2
11749,KEGG_2019_Human,cGMP-PKG signaling pathway,1/166,0.0082999091363732,0.009054446330589,0,0,19834.0,95034.82345515196,IRS2
11750,KEGG_2019_Human,MicroRNAs in cancer,1/299,0.0149498740670514,0.0149498740670514,0,0,19701.0,82804.33538735632,IRS2
11751,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR4A15
11752,KEGG_2019_Human,Protein processing in endoplasmic reticulum,1/165,0.0082499094553477,0.0085499075557634,0,0,19835.0,95159.46482222488,ATF6
11753,KEGG_2019_Human,Alzheimer disease,1/171,0.0085499075557634,0.0085499075557634,0,0,19829.0,94422.42241345016,ATF6
11754,KEGG_2019_Human,Axon guidance,1/181,0.0090499044707863,0.0090499044707863,0,0,19819.0,93248.41634586031,SEMA7A
11755,KEGG_2019_Human,Spliceosome,1/134,0.0066999199497742,0.0066999199497742,0,0,19866.0,99442.43560916925,TCERG1
11756,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZFP30
11757,KEGG_2019_Human,Spliceosome,1/134,0.0066999199497742,0.0100498985877989,0,0,19866.0,99442.43560916925,DDX5
11758,KEGG_2019_Human,Transcriptional misregulation in cancer,1/186,0.0092999029651357,0.0100498985877989,0,0,19814.0,92684.96451050608,DDX5
11759,KEGG_2019_Human,Proteoglycans in cancer,1/201,0.0100498985877989,0.0100498985877989,0,0,19799.0,91079.21596609056,DDX5
11760,KEGG_2019_Human,Circadian rhythm,1/31,0.0015499690656704,0.0015499690656704,0,0,19969.0,129189.85098816035,NPAS2
11761,KEGG_2019_Human,Dopaminergic synapse,1/131,0.0065499210316603,0.0121998870519305,0,0,19869.0,99907.33811343512,KIF5C
11762,KEGG_2019_Human,Endocytosis,1/244,0.0121998870519305,0.0121998870519305,0,0,19756.0,87051.4275316661,KIF5C
11763,KEGG_2019_Human,Basal transcription factors,1/45,0.0022499601197094,0.0044999202394188,0,0,19955.0,121662.49782449217,GTF2A1
11764,KEGG_2019_Human,Viral carcinogenesis,1/201,0.0100498985877989,0.0100498985877989,0,0,19799.0,91079.21596609056,GTF2A1
11765,KEGG_2019_Human,Inositol phosphate metabolism,1/74,0.0036999446830449,0.0074249002326102,0,0,19926.0,111574.38983110404,PIP4K2B
11766,KEGG_2019_Human,Phosphatidylinositol signaling system,1/99,0.0049499334884068,0.0074249002326102,0,0,19901.0,105642.09305076736,PIP4K2B
11767,KEGG_2019_Human,Regulation of actin cytoskeleton,1/214,0.0106998949514067,0.0106998949514067,0,0,19786.0,89779.39753374986,PIP4K2B
11768,KEGG_2019_Human,Glutathione metabolism,1/56,0.0027999538675741,0.0094498771520562,0,0,19944.0,117233.87022514464,GSTT2B
11769,KEGG_2019_Human,Metabolism of xenobiotics by cytochrome P450,1/74,0.0036999446830449,0.0094498771520562,0,0,19926.0,111574.38983110404,GSTT2B
11770,KEGG_2019_Human,Chemical carcinogenesis,1/82,0.004099940929819,0.0094498771520562,0,0,19918.0,109484.9180722932,GSTT2B
11771,KEGG_2019_Human,Drug metabolism,1/108,0.0053999298011749,0.0094498771520562,0,0,19892.0,103863.47861844616,GSTT2B
11772,KEGG_2019_Human,Fluid shear stress and atherosclerosis,1/139,0.006949918172816,0.0097298854419424,0,0,19861.0,98689.81333375497,GSTT2B
11773,KEGG_2019_Human,Hepatocellular carcinoma,1/168,0.0083999085011095,0.0097998932512944,0,0,19832.0,94787.72752807094,GSTT2B
11774,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,GSTT2B
11775,KEGG_2019_Human,Ascorbate and aldarate metabolism,1/27,0.0013499718942362,0.004685646776936,0,0,19973.0,131975.02298599784,UGT2B15
11776,KEGG_2019_Human,Pentose and glucuronate interconversions,1/34,0.0016999670339032,0.004685646776936,0,0,19966.0,127326.1054203148,UGT2B15
11777,KEGG_2019_Human,Porphyrin and chlorophyll metabolism,1/42,0.0020999619311272,0.004685646776936,0,0,19958.0,123057.75613441122,UGT2B15
11778,KEGG_2019_Human,Steroid hormone biosynthesis,1/60,0.002999951725986,0.004685646776936,0,0,19940.0,115834.63209072244,UGT2B15
11779,KEGG_2019_Human,Retinol metabolism,1/67,0.0033499481224912,0.004685646776936,0,0,19933.0,113594.38808369274,UGT2B15
11780,KEGG_2019_Human,Metabolism of xenobiotics by cytochrome P450,1/74,0.0036999446830449,0.004685646776936,0,0,19926.0,111574.38983110404,UGT2B15
11781,KEGG_2019_Human,Chemical carcinogenesis,1/82,0.004099940929819,0.004685646776936,0,0,19918.0,109484.9180722932,UGT2B15
11782,KEGG_2019_Human,Drug metabolism,1/108,0.0053999298011749,0.0053999298011749,0,0,19892.0,103863.47861844616,UGT2B15
11783,KEGG_2019_Human,Tyrosine metabolism,1/36,0.0017999657178272,0.0036999446830449,0,0,19964.0,126172.23364250171,TPO
11784,KEGG_2019_Human,Autoimmune thyroid disease,1/53,0.0026499555173137,0.0036999446830449,0,0,19947.0,118349.78824235698,TPO
11785,KEGG_2019_Human,Thyroid hormone synthesis,1/74,0.0036999446830449,0.0036999446830449,0,0,19926.0,111574.38983110404,TPO
11786,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR7C2
11787,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,NPY5R
11788,KEGG_2019_Human,Amyotrophic lateral sclerosis (ALS),1/51,0.0025499566390179,0.0103887762846784,0,0,19949.0,119129.0228601236,MAP3K5
11789,KEGG_2019_Human,TNF signaling pathway,1/110,0.0054999290027479,0.0103887762846784,0,0,19890.0,103488.06969787036,MAP3K5
11790,KEGG_2019_Human,Sphingolipid signaling pathway,1/119,0.0059499254985137,0.0103887762846784,0,0,19881.0,101877.73080211312,MAP3K5
11791,KEGG_2019_Human,Neurotrophin signaling pathway,1/119,0.0059499254985137,0.0103887762846784,0,0,19881.0,101877.73080211312,MAP3K5
11792,KEGG_2019_Human,Fluid shear stress and atherosclerosis,1/139,0.006949918172816,0.0103887762846784,0,0,19861.0,98689.81333375497,MAP3K5
11793,KEGG_2019_Human,Apoptosis,1/143,0.0071499167770442,0.0103887762846784,0,0,19857.0,98106.57763600958,MAP3K5
11794,KEGG_2019_Human,Non-alcoholic fatty liver disease (NAFLD),1/149,0.0074499147221605,0.0103887762846784,0,0,19851.0,97261.02051561224,MAP3K5
11795,KEGG_2019_Human,Protein processing in endoplasmic reticulum,1/165,0.0082499094553477,0.0103887762846784,0,0,19835.0,95159.46482222488,MAP3K5
11796,KEGG_2019_Human,Tight junction,1/170,0.0084999078692823,0.0103887762846784,0,0,19830.0,94543.49009679438,MAP3K5
11797,KEGG_2019_Human,Thermogenesis,1/231,0.0115498903940656,0.0127048794334721,0,0,19769.0,88191.07730937863,MAP3K5
11798,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0147498749536506,0,0,19705.0,83086.53988020132,MAP3K5
11799,KEGG_2019_Human,Hedgehog signaling pathway,1/47,0.0023499589392381,0.0047249252398241,0,0,19953.0,120782.64067395544,PTCH2
11800,KEGG_2019_Human,Basal cell carcinoma,1/63,0.0031499501598827,0.0047249252398241,0,0,19937.0,114844.46974572667,PTCH2
11801,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,PTCH2
11802,KEGG_2019_Human,Amyotrophic lateral sclerosis (ALS),1/51,0.0025499566390179,0.010016058543176,0,0,19949.0,119129.0228601236,MAPK12
11803,KEGG_2019_Human,VEGF signaling pathway,1/59,0.0029499522555206,0.010016058543176,0,0,19941.0,116175.59385530632,MAPK12
11804,KEGG_2019_Human,Shigellosis,1/65,0.003249949134407,0.010016058543176,0,0,19935.0,114209.92613860144,MAPK12
11805,KEGG_2019_Human,Epithelial cell signaling in Helicobacter pylori infection,1/68,0.0033999476216189,0.010016058543176,0,0,19932.0,113293.39338050144,MAPK12
11806,KEGG_2019_Human,Fc epsilon RI signaling pathway,1/68,0.0033999476216189,0.010016058543176,0,0,19932.0,113293.39338050144,MAPK12
11807,KEGG_2019_Human,Prolactin signaling pathway,1/70,0.0034999466296654,0.010016058543176,0,0,19930.0,112704.30065625212,MAPK12
11808,KEGG_2019_Human,RIG-I-like receptor signaling pathway,1/70,0.0034999466296654,0.010016058543176,0,0,19930.0,112704.30065625212,MAPK12
11809,KEGG_2019_Human,Leishmaniasis,1/74,0.0036999446830449,0.010016058543176,0,0,19926.0,111574.38983110404,MAPK12
11810,KEGG_2019_Human,Pertussis,1/76,0.0037999437281752,0.010016058543176,0,0,19924.0,111031.8499691117,MAPK12
11811,KEGG_2019_Human,Salmonella infection,1/86,0.0042999391173866,0.010016058543176,0,0,19914.0,108514.46102290176,MAPK12
11812,KEGG_2019_Human,Th1 and Th2 cell differentiation,1/92,0.0045999364719865,0.010016058543176,0,0,19908.0,107139.13814408927,MAPK12
11813,KEGG_2019_Human,IL-17 signaling pathway,1/93,0.0046499360391879,0.010016058543176,0,0,19907.0,106918.54242106884,MAPK12
11814,KEGG_2019_Human,GnRH signaling pathway,1/93,0.0046499360391879,0.010016058543176,0,0,19907.0,106918.54242106884,MAPK12
11815,KEGG_2019_Human,Progesterone-mediated oocyte maturation,1/99,0.0049499334884068,0.010016058543176,0,0,19901.0,105642.09305076736,MAPK12
11816,KEGG_2019_Human,AGE-RAGE signaling pathway in diabetic complications,1/100,0.0049999330710556,0.010016058543176,0,0,19900.0,105436.78197328727,MAPK12
11817,KEGG_2019_Human,Inflammatory mediator regulation of TRP channels,1/100,0.0049999330710556,0.010016058543176,0,0,19900.0,105436.78197328727,MAPK12
11818,KEGG_2019_Human,T cell receptor signaling pathway,1/101,0.0050499326546803,0.010016058543176,0,0,19899.0,105233.48101229242,MAPK12
11819,KEGG_2019_Human,Chagas disease (American trypanosomiasis),1/103,0.0051499318302617,0.010016058543176,0,0,19897.0,104832.7525292024,MAPK12
11820,KEGG_2019_Human,Toll-like receptor signaling pathway,1/104,0.0051999314202997,0.010016058543176,0,0,19896.0,104635.24941415618,MAPK12
11821,KEGG_2019_Human,C-type lectin receptor signaling pathway,1/104,0.0051999314202997,0.010016058543176,0,0,19896.0,104635.24941415618,MAPK12
11822,KEGG_2019_Human,Th17 cell differentiation,1/107,0.0053499302026925,0.010016058543176,0,0,19893.0,104053.753408911,MAPK12
11823,KEGG_2019_Human,TNF signaling pathway,1/110,0.0054999290027479,0.010016058543176,0,0,19890.0,103488.06969787036,MAPK12
11824,KEGG_2019_Human,Leukocyte transendothelial migration,1/112,0.0055999282120529,0.010016058543176,0,0,19888.0,103119.30984392198,MAPK12
11825,KEGG_2019_Human,Toxoplasmosis,1/113,0.0056499278191151,0.010016058543176,0,0,19887.0,102937.34947211576,MAPK12
11826,KEGG_2019_Human,Sphingolipid signaling pathway,1/119,0.0059499254985137,0.010016058543176,0,0,19881.0,101877.73080211312,MAPK12
11827,KEGG_2019_Human,Neurotrophin signaling pathway,1/119,0.0059499254985137,0.010016058543176,0,0,19881.0,101877.73080211312,MAPK12
11828,KEGG_2019_Human,Platelet activation,1/124,0.0061999236097501,0.010016058543176,0,0,19876.0,101034.04709010696,MAPK12
11829,KEGG_2019_Human,Oocyte meiosis,1/125,0.0062499232373748,0.010016058543176,0,0,19875.0,100869.32368441945,MAPK12
11830,KEGG_2019_Human,Osteoclast differentiation,1/127,0.0063499224962247,0.010016058543176,0,0,19873.0,100543.72072014232,MAPK12
11831,KEGG_2019_Human,Relaxin signaling pathway,1/130,0.0064999213952527,0.010016058543176,0,0,19870.0,100064.62842845908,MAPK12
11832,KEGG_2019_Human,Dopaminergic synapse,1/131,0.0065499210316603,0.010016058543176,0,0,19869.0,99907.33811343512,MAPK12
11833,KEGG_2019_Human,FoxO signaling pathway,1/132,0.0065999206698993,0.010016058543176,0,0,19868.0,99751.22090491928,MAPK12
11834,KEGG_2019_Human,Fluid shear stress and atherosclerosis,1/139,0.006949918172816,0.010016058543176,0,0,19861.0,98689.81333375497,MAPK12
11835,KEGG_2019_Human,Signaling pathways regulating pluripotency of stem cells,1/139,0.006949918172816,0.010016058543176,0,0,19861.0,98689.81333375497,MAPK12
11836,KEGG_2019_Human,Adrenergic signaling in cardiomyocytes,1/145,0.0072499160871101,0.0100721066113377,0,0,19855.0,97820.92670675044,MAPK12
11837,KEGG_2019_Human,Retrograde endocannabinoid signaling,1/148,0.007399915061391,0.0100721066113377,0,0,19852.0,97399.60470052566,MAPK12
11838,KEGG_2019_Human,Cellular senescence,1/160,0.0079999110688441,0.0105090945998809,0,0,19840.0,95793.96509856998,MAPK12
11839,KEGG_2019_Human,Hepatitis B,1/163,0.0081499100978668,0.0105090945998809,0,0,19837.0,95410.9786681514,MAPK12
11840,KEGG_2019_Human,Influenza A,1/171,0.0085499075557634,0.0106962280225061,0,0,19829.0,94422.42241345016,MAPK12
11841,KEGG_2019_Human,NOD-like receptor signaling pathway,1/178,0.0088999053857096,0.0106962280225061,0,0,19822.0,93593.82745769851,MAPK12
11842,KEGG_2019_Human,Tuberculosis,1/179,0.0089499050800561,0.0106962280225061,0,0,19821.0,93478.0629355712,MAPK12
11843,KEGG_2019_Human,Kaposi sarcoma-associated herpesvirus infection,1/186,0.0092999029651357,0.0108498867926584,0,0,19814.0,92684.96451050608,MAPK12
11844,KEGG_2019_Human,Epstein-Barr virus infection,1/201,0.0100498985877989,0.0111919325182306,0,0,19799.0,91079.21596609056,MAPK12
11845,KEGG_2019_Human,Proteoglycans in cancer,1/201,0.0100498985877989,0.0111919325182306,0,0,19799.0,91079.21596609056,MAPK12
11846,KEGG_2019_Human,Rap1 signaling pathway,1/206,0.010299897173561,0.0112154435889886,0,0,19794.0,90569.849337325,MAPK12
11847,KEGG_2019_Human,Human immunodeficiency virus 1 infection,1/212,0.0105998955026255,0.0112911930354055,0,0,19788.0,89974.27756224656,MAPK12
11848,KEGG_2019_Human,Human cytomegalovirus infection,1/225,0.0112498919790339,0.0117286107866523,0,0,19775.0,88738.27077557483,MAPK12
11849,KEGG_2019_Human,Thermogenesis,1/231,0.0115498903940656,0.0117905131106086,0,0,19769.0,88191.07730937863,MAPK12
11850,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0147498749536506,0,0,19705.0,83086.53988020132,MAPK12
11851,KEGG_2019_Human,Axon guidance,1/181,0.0090499044707863,0.0090499044707863,0,0,19819.0,93248.41634586031,SEMA4D
11852,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,KISS1
11853,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF669
11854,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,CNR2
11855,KEGG_2019_Human,Malaria,1/49,0.0024499577795033,0.0096998686609413,0,0,19951.0,119939.1172087114,CSF3
11856,KEGG_2019_Human,IL-17 signaling pathway,1/93,0.0046499360391879,0.0096998686609413,0,0,19907.0,106918.54242106884,CSF3
11857,KEGG_2019_Human,Hematopoietic cell lineage,1/97,0.0048499343304706,0.0096998686609413,0,0,19903.0,106058.9096435903,CSF3
11858,KEGG_2019_Human,JAK-STAT signaling pathway,1/162,0.0080999104202618,0.0121498656303927,0,0,19838.0,95537.86936302872,CSF3
11859,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0176398502111682,0,0,19706.0,83157.67014793828,CSF3
11860,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0176998626413668,0,0,19646.0,79255.8617626126,CSF3
11861,KEGG_2019_Human,Tight junction,1/170,0.0084999078692823,0.0084999078692823,0,0,19830.0,94543.49009679438,ARHGAP17
11862,KEGG_2019_Human,Glycosaminoglycan biosynthesis,1/53,0.0026499555173137,0.0026499555173137,0,0,19947.0,118349.78824235698,HS6ST2
11863,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR5I1
11864,KEGG_2019_Human,Fatty acid degradation,1/44,0.0021999607179423,0.0036999446830449,0,0,19956.0,122117.06559109331,ACADL
11865,KEGG_2019_Human,PPAR signaling pathway,1/74,0.0036999446830449,0.0036999446830449,0,0,19926.0,111574.38983110404,ACADL
11866,KEGG_2019_Human,Pathogenic Escherichia coli infection,1/55,0.0027499544131125,0.0084999078692823,0,0,19945.0,117599.1294878737,TUBA3E
11867,KEGG_2019_Human,Gap junction,1/88,0.0043999382262822,0.0084999078692823,0,0,19912.0,108045.79305232369,TUBA3E
11868,KEGG_2019_Human,Apoptosis,1/143,0.0071499167770442,0.0084999078692823,0,0,19857.0,98106.57763600958,TUBA3E
11869,KEGG_2019_Human,Phagosome,1/152,0.0075999137114971,0.0084999078692823,0,0,19848.0,96850.665715497,TUBA3E
11870,KEGG_2019_Human,Tight junction,1/170,0.0084999078692823,0.0084999078692823,0,0,19830.0,94543.49009679438,TUBA3E
11871,KEGG_2019_Human,Prion diseases,1/35,0.0017499663721595,0.0063999130051608,0,0,19965.0,126740.98858805298,C8A
11872,KEGG_2019_Human,Complement and coagulation cascades,1/79,0.0039499423167337,0.0063999130051608,0,0,19921.0,110243.89578070649,C8A
11873,KEGG_2019_Human,Amoebiasis,1/96,0.0047999347538706,0.0063999130051608,0,0,19904.0,106270.50039849174,C8A
11874,KEGG_2019_Human,Systemic lupus erythematosus,1/133,0.0066499203093911,0.0066499203093911,0,0,19867.0,99596.2591544721,C8A
11875,KEGG_2019_Human,Glutamatergic synapse,1/114,0.005699927427839,0.011399854855678,0,0,19886.0,102756.96431429044,GRIK1
11876,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,GRIK1
11877,KEGG_2019_Human,Endocytosis,1/244,0.0121998870519305,0.0121998870519305,0,0,19756.0,87051.4275316661,AGAP3
11878,KEGG_2019_Human,IL-17 signaling pathway,1/93,0.0046499360391879,0.0059999251180858,0,0,19907.0,106918.54242106884,ELAVL1
11879,KEGG_2019_Human,AMPK signaling pathway,1/120,0.0059999251180858,0.0059999251180858,0,0,19880.0,101706.2448082016,ELAVL1
11880,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZFP57
11881,KEGG_2019_Human,Inositol phosphate metabolism,1/74,0.0036999446830449,0.0074249002326102,0,0,19926.0,111574.38983110404,PIP4K2C
11882,KEGG_2019_Human,Phosphatidylinositol signaling system,1/99,0.0049499334884068,0.0074249002326102,0,0,19901.0,105642.09305076736,PIP4K2C
11883,KEGG_2019_Human,Regulation of actin cytoskeleton,1/214,0.0106998949514067,0.0106998949514067,0,0,19786.0,89779.39753374986,PIP4K2C
11884,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR51B2
11885,KEGG_2019_Human,Fat digestion and absorption,1/41,0.0020499625466866,0.0033499481224912,0,0,19959.0,123544.88783416104,DGAT1
11886,KEGG_2019_Human,Glycerolipid metabolism,1/61,0.0030499512001654,0.0033499481224912,0,0,19939.0,115499.24335773686,DGAT1
11887,KEGG_2019_Human,Retinol metabolism,1/67,0.0033499481224912,0.0033499481224912,0,0,19933.0,113594.38808369274,DGAT1
11888,KEGG_2019_Human,Non-homologous end-joining,1/13,0.0006499833083207112,0.0012999666166414,0,0,19987.0,146675.87616784443,PRKDC
11889,KEGG_2019_Human,Cell cycle,1/124,0.0061999236097501,0.0061999236097501,0,0,19876.0,101034.04709010696,PRKDC
11890,KEGG_2019_Human,Relaxin signaling pathway,1/130,0.0064999213952527,0.0129998427905055,0,0,19870.0,100064.62842845908,RXFP2
11891,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,RXFP2
11892,KEGG_2019_Human,Cholesterol metabolism,1/50,0.0024999572069037,0.0024999572069037,0,0,19950.0,119530.05920663515,CETP
11893,KEGG_2019_Human,Phosphatidylinositol signaling system,1/99,0.0049499334884068,0.0049499334884068,0,0,19901.0,105642.09305076736,PIP4P2
11894,KEGG_2019_Human,Tight junction,1/170,0.0084999078692823,0.0084999078692823,0,0,19830.0,94543.49009679438,BVES
11895,KEGG_2019_Human,Hippo signaling pathway,1/160,0.0079999110688441,0.0079999110688441,0,0,19840.0,95793.96509856998,TP53BP2
11896,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,PTH2
11897,KEGG_2019_Human,"Glycine, serine and threonine metabolism",1/40,0.0019999631680592,0.0020999619311272,0,0,19960.0,124043.94523066044,ALAS2
11898,KEGG_2019_Human,Porphyrin and chlorophyll metabolism,1/42,0.0020999619311272,0.0020999619311272,0,0,19958.0,123057.75613441122,ALAS2
11899,KEGG_2019_Human,Cushing syndrome,1/155,0.0077499127120574,0.0077499127120574,0,0,19845.0,96448.16254952336,WDR5B
11900,KEGG_2019_Human,Parkinson disease,1/142,0.0070999171242726,0.0070999171242726,0,0,19858.0,98250.87390500787,SNCAIP
11901,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF793
11902,KEGG_2019_Human,Ascorbate and aldarate metabolism,1/27,0.0013499718942362,0.004685646776936,0,0,19973.0,131975.02298599784,UGT2A3
11903,KEGG_2019_Human,Pentose and glucuronate interconversions,1/34,0.0016999670339032,0.004685646776936,0,0,19966.0,127326.1054203148,UGT2A3
11904,KEGG_2019_Human,Porphyrin and chlorophyll metabolism,1/42,0.0020999619311272,0.004685646776936,0,0,19958.0,123057.75613441122,UGT2A3
11905,KEGG_2019_Human,Steroid hormone biosynthesis,1/60,0.002999951725986,0.004685646776936,0,0,19940.0,115834.63209072244,UGT2A3
11906,KEGG_2019_Human,Retinol metabolism,1/67,0.0033499481224912,0.004685646776936,0,0,19933.0,113594.38808369274,UGT2A3
11907,KEGG_2019_Human,Metabolism of xenobiotics by cytochrome P450,1/74,0.0036999446830449,0.004685646776936,0,0,19926.0,111574.38983110404,UGT2A3
11908,KEGG_2019_Human,Chemical carcinogenesis,1/82,0.004099940929819,0.004685646776936,0,0,19918.0,109484.9180722932,UGT2A3
11909,KEGG_2019_Human,Drug metabolism,1/108,0.0053999298011749,0.0053999298011749,0,0,19892.0,103863.47861844616,UGT2A3
11910,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF43
11911,KEGG_2019_Human,Vitamin digestion and absorption,1/24,0.0011999741185782,0.0011999741185782,0,0,19976.0,134347.69487847842,LMBRD1
11912,KEGG_2019_Human,Histidine metabolism,1/23,0.0011499748819949,0.0011499748819949,0,0,19977.0,135204.63922267244,CARNMT1
11913,KEGG_2019_Human,Porphyrin and chlorophyll metabolism,1/42,0.0020999619311272,0.0020999619311272,0,0,19958.0,123057.75613441122,CPOX
11914,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,PLEKHG5
11915,KEGG_2019_Human,Mucin type O-glycan biosynthesis,1/31,0.0015499690656704,0.0015499690656704,0,0,19969.0,129189.85098816035,GALNT18
11916,KEGG_2019_Human,Cortisol synthesis and secretion,1/65,0.003249949134407,0.0077499127120574,0,0,19935.0,114209.92613860144,PDE8A
11917,KEGG_2019_Human,Morphine addiction,1/91,0.0045499369072032,0.0077499127120574,0,0,19909.0,107362.10783923086,PDE8A
11918,KEGG_2019_Human,Purine metabolism,1/129,0.006449921761047,0.0077499127120574,0,0,19871.0,100223.109907462,PDE8A
11919,KEGG_2019_Human,Cushing syndrome,1/155,0.0077499127120574,0.0077499127120574,0,0,19845.0,96448.16254952336,PDE8A
11920,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,NPY2R
11921,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF337
11922,KEGG_2019_Human,mTOR signaling pathway,1/152,0.0075999137114971,0.0133998647837319,0,0,19848.0,96850.665715497,EIF4B
11923,KEGG_2019_Human,RNA transport,1/165,0.0082499094553477,0.0133998647837319,0,0,19835.0,95159.46482222488,EIF4B
11924,KEGG_2019_Human,Proteoglycans in cancer,1/201,0.0100498985877989,0.0133998647837319,0,0,19799.0,91079.21596609056,EIF4B
11925,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0176998626413668,0,0,19646.0,79255.8617626126,EIF4B
11926,KEGG_2019_Human,Gap junction,1/88,0.0043999382262822,0.0095623917214422,0,0,19912.0,108045.79305232369,MAP2K5
11927,KEGG_2019_Human,Neurotrophin signaling pathway,1/119,0.0059499254985137,0.0095623917214422,0,0,19881.0,101877.73080211312,MAP2K5
11928,KEGG_2019_Human,Fluid shear stress and atherosclerosis,1/139,0.006949918172816,0.0095623917214422,0,0,19861.0,98689.81333375497,MAP2K5
11929,KEGG_2019_Human,Oxytocin signaling pathway,1/153,0.0076499133771537,0.0095623917214422,0,0,19847.0,96715.6407630817,MAP2K5
11930,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0147498749536506,0,0,19705.0,83086.53988020132,MAP2K5
11931,KEGG_2019_Human,Alcoholism,1/180,0.0089999047745351,0.0100498985877989,0,0,19820.0,93362.92821536642,HDAC11
11932,KEGG_2019_Human,Viral carcinogenesis,1/201,0.0100498985877989,0.0100498985877989,0,0,19799.0,91079.21596609056,HDAC11
11933,KEGG_2019_Human,Parkinson disease,1/142,0.0070999171242726,0.0070999171242726,0,0,19858.0,98250.87390500787,GPR37
11934,KEGG_2019_Human,Salivary secretion,1/90,0.0044999373439762,0.011279882844162,0,0,19910.0,107587.50385474482,ADRA1B
11935,KEGG_2019_Human,Vascular smooth muscle contraction,1/132,0.0065999206698993,0.011279882844162,0,0,19868.0,99751.22090491928,ADRA1B
11936,KEGG_2019_Human,Adrenergic signaling in cardiomyocytes,1/145,0.0072499160871101,0.011279882844162,0,0,19855.0,97820.92670675044,ADRA1B
11937,KEGG_2019_Human,cGMP-PKG signaling pathway,1/166,0.0082999091363732,0.011279882844162,0,0,19834.0,95034.82345515196,ADRA1B
11938,KEGG_2019_Human,Calcium signaling pathway,1/188,0.009399902370135,0.011279882844162,0,0,19812.0,92463.712994847,ADRA1B
11939,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,ADRA1B
11940,KEGG_2019_Human,Cholinergic synapse,1/112,0.0055999282120529,0.0104498919571195,0,0,19888.0,103119.30984392198,PIK3R6
11941,KEGG_2019_Human,Toxoplasmosis,1/113,0.0056499278191151,0.0104498919571195,0,0,19887.0,102937.34947211576,PIK3R6
11942,KEGG_2019_Human,Platelet activation,1/124,0.0061999236097501,0.0104498919571195,0,0,19876.0,101034.04709010696,PIK3R6
11943,KEGG_2019_Human,Apelin signaling pathway,1/137,0.0068499188797651,0.0104498919571195,0,0,19863.0,98987.62735269018,PIK3R6
11944,KEGG_2019_Human,Adrenergic signaling in cardiomyocytes,1/145,0.0072499160871101,0.0104498919571195,0,0,19855.0,97820.92670675044,PIK3R6
11945,KEGG_2019_Human,Phospholipase D signaling pathway,1/148,0.007399915061391,0.0104498919571195,0,0,19852.0,97399.60470052566,PIK3R6
11946,KEGG_2019_Human,Oxytocin signaling pathway,1/153,0.0076499133771537,0.0104498919571195,0,0,19847.0,96715.6407630817,PIK3R6
11947,KEGG_2019_Human,cGMP-PKG signaling pathway,1/166,0.0082999091363732,0.0104498919571195,0,0,19834.0,95034.82345515196,PIK3R6
11948,KEGG_2019_Human,Kaposi sarcoma-associated herpesvirus infection,1/186,0.0092999029651357,0.0104498919571195,0,0,19814.0,92684.96451050608,PIK3R6
11949,KEGG_2019_Human,Chemokine signaling pathway,1/190,0.0094999017791995,0.0104498919571195,0,0,19810.0,92244.74636351672,PIK3R6
11950,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0176998626413668,0,0,19646.0,79255.8617626126,PIK3R6
11951,KEGG_2019_Human,Axon guidance,1/181,0.0090499044707863,0.0090499044707863,0,0,19819.0,93248.41634586031,UNC5D
11952,KEGG_2019_Human,Longevity regulating pathway,1/102,0.0050999322416682,0.0063999221281459,0,0,19898.0,105032.15064717118,ATG101
11953,KEGG_2019_Human,Autophagy,1/128,0.0063999221281459,0.0063999221281459,0,0,19872.0,100382.8010329652,ATG101
11954,KEGG_2019_Human,Glycosphingolipid biosynthesis,1/45,0.0022499601197094,0.0044999202394188,0,0,19955.0,121662.49782449217,NAGA
11955,KEGG_2019_Human,Lysosome,1/123,0.0061499239842961,0.0061499239842961,0,0,19877.0,101200.07933676826,NAGA
11956,KEGG_2019_Human,Spliceosome,1/134,0.0066999199497742,0.0133998398995484,0,0,19866.0,99442.43560916925,SRSF9
11957,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,SRSF9
11958,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0164998674589645,0,0,19670.0,80733.60565076157,HES4
11959,KEGG_2019_Human,"Alanine, aspartate and glutamate metabolism",1/35,0.0017499663721595,0.0034999327443191,0,0,19965.0,126740.98858805298,PPAT
11960,KEGG_2019_Human,Purine metabolism,1/129,0.006449921761047,0.006449921761047,0,0,19871.0,100223.109907462,PPAT
11961,KEGG_2019_Human,Amyotrophic lateral sclerosis (ALS),1/51,0.0025499566390179,0.0121436274602571,0,0,19949.0,119129.0228601236,CASP9
11962,KEGG_2019_Human,Legionellosis,1/55,0.0027499544131125,0.0121436274602571,0,0,19945.0,117599.1294878737,CASP9
11963,KEGG_2019_Human,Endometrial cancer,1/58,0.0028999527887707,0.0121436274602571,0,0,19942.0,116522.31890946148,CASP9
11964,KEGG_2019_Human,VEGF signaling pathway,1/59,0.0029499522555206,0.0121436274602571,0,0,19941.0,116175.59385530632,CASP9
11965,KEGG_2019_Human,Viral myocarditis,1/59,0.0029499522555206,0.0121436274602571,0,0,19941.0,116175.59385530632,CASP9
11966,KEGG_2019_Human,Non-small cell lung cancer,1/66,0.003299948626608,0.0121436274602571,0,0,19934.0,113899.85357353876,CASP9
11967,KEGG_2019_Human,p53 signaling pathway,1/72,0.0035999456502131,0.0121436274602571,0,0,19928.0,112131.59838572376,CASP9
11968,KEGG_2019_Human,Pancreatic cancer,1/75,0.0037499442041125,0.0121436274602571,0,0,19925.0,111301.33528642564,CASP9
11969,KEGG_2019_Human,Colorectal cancer,1/86,0.0042999391173866,0.0121436274602571,0,0,19914.0,108514.46102290176,CASP9
11970,KEGG_2019_Human,Small cell lung cancer,1/93,0.0046499360391879,0.0121436274602571,0,0,19907.0,106918.54242106884,CASP9
11971,KEGG_2019_Human,Prostate cancer,1/97,0.0048499343304706,0.0121436274602571,0,0,19903.0,106058.9096435903,CASP9
11972,KEGG_2019_Human,Toxoplasmosis,1/113,0.0056499278191151,0.0121436274602571,0,0,19887.0,102937.34947211576,CASP9
11973,KEGG_2019_Human,Thyroid hormone signaling pathway,1/116,0.0057999266512085,0.0121436274602571,0,0,19884.0,102400.8105961506,CASP9
11974,KEGG_2019_Human,Measles,1/138,0.0068999185254481,0.0121436274602571,0,0,19862.0,98838.19160389496,CASP9
11975,KEGG_2019_Human,Parkinson disease,1/142,0.0070999171242726,0.0121436274602571,0,0,19858.0,98250.87390500787,CASP9
11976,KEGG_2019_Human,Apoptosis,1/143,0.0071499167770442,0.0121436274602571,0,0,19857.0,98106.57763600958,CASP9
11977,KEGG_2019_Human,Hepatitis C,1/155,0.0077499127120574,0.0121436274602571,0,0,19845.0,96448.16254952336,CASP9
11978,KEGG_2019_Human,Hepatitis B,1/163,0.0081499100978668,0.0121436274602571,0,0,19837.0,95410.9786681514,CASP9
11979,KEGG_2019_Human,Influenza A,1/171,0.0085499075557634,0.0121436274602571,0,0,19829.0,94422.42241345016,CASP9
11980,KEGG_2019_Human,Alzheimer disease,1/171,0.0085499075557634,0.0121436274602571,0,0,19829.0,94422.42241345016,CASP9
11981,KEGG_2019_Human,Tuberculosis,1/179,0.0089499050800561,0.0121436274602571,0,0,19821.0,93478.0629355712,CASP9
11982,KEGG_2019_Human,Kaposi sarcoma-associated herpesvirus infection,1/186,0.0092999029651357,0.0121436274602571,0,0,19814.0,92684.96451050608,CASP9
11983,KEGG_2019_Human,Huntington disease,1/193,0.0096499008972596,0.0121436274602571,0,0,19807.0,91920.47679471428,CASP9
11984,KEGG_2019_Human,Epstein-Barr virus infection,1/201,0.0100498985877989,0.0121436274602571,0,0,19799.0,91079.21596609056,CASP9
11985,KEGG_2019_Human,Human immunodeficiency virus 1 infection,1/212,0.0105998955026255,0.0122958787830456,0,0,19788.0,89974.27756224656,CASP9
11986,KEGG_2019_Human,Human cytomegalovirus infection,1/225,0.0112498919790339,0.0125479564381532,0,0,19775.0,88738.27077557483,CASP9
11987,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0190109635777644,0,0,19646.0,79255.8617626126,CASP9
11988,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0254784046574684,0,0,19508.0,72277.44006442746,CASP9
11989,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,CASP9
11990,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,NCALD
11991,KEGG_2019_Human,RIG-I-like receptor signaling pathway,1/70,0.0034999466296654,0.0106873844447042,0,0,19930.0,112704.30065625212,IFIH1
11992,KEGG_2019_Human,Measles,1/138,0.0068999185254481,0.0106873844447042,0,0,19862.0,98838.19160389496,IFIH1
11993,KEGG_2019_Human,Hepatitis B,1/163,0.0081499100978668,0.0106873844447042,0,0,19837.0,95410.9786681514,IFIH1
11994,KEGG_2019_Human,Influenza A,1/171,0.0085499075557634,0.0106873844447042,0,0,19829.0,94422.42241345016,IFIH1
11995,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,IFIH1
11996,KEGG_2019_Human,mRNA surveillance pathway,1/91,0.0045499369072032,0.0045499369072032,0,0,19909.0,107362.10783923086,CPSF7
11997,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF224
11998,KEGG_2019_Human,Legionellosis,1/55,0.0027499544131125,0.0054999088262251,0,0,19945.0,117599.1294878737,NAIP
11999,KEGG_2019_Human,NOD-like receptor signaling pathway,1/178,0.0088999053857096,0.0088999053857096,0,0,19822.0,93593.82745769851,NAIP
12000,KEGG_2019_Human,Spliceosome,1/134,0.0066999199497742,0.0066999199497742,0,0,19866.0,99442.43560916925,U2SURP
12001,KEGG_2019_Human,Aldosterone-regulated sodium reabsorption,1/37,0.0018499650702878,0.0107329279895533,0,0,19963.0,125618.9446446357,PIK3R2
12002,KEGG_2019_Human,Carbohydrate digestion and absorption,1/44,0.0021999607179423,0.0107329279895533,0,0,19956.0,122117.06559109331,PIK3R2
12003,KEGG_2019_Human,Type II diabetes mellitus,1/46,0.0022999595269283,0.0107329279895533,0,0,19954.0,121217.8313311442,PIK3R2
12004,KEGG_2019_Human,Regulation of lipolysis in adipocytes,1/55,0.0027499544131125,0.0107329279895533,0,0,19945.0,117599.1294878737,PIK3R2
12005,KEGG_2019_Human,Endometrial cancer,1/58,0.0028999527887707,0.0107329279895533,0,0,19942.0,116522.31890946148,PIK3R2
12006,KEGG_2019_Human,VEGF signaling pathway,1/59,0.0029499522555206,0.0107329279895533,0,0,19941.0,116175.59385530632,PIK3R2
12007,KEGG_2019_Human,Central carbon metabolism in cancer,1/65,0.003249949134407,0.0107329279895533,0,0,19935.0,114209.92613860144,PIK3R2
12008,KEGG_2019_Human,Acute myeloid leukemia,1/66,0.003299948626608,0.0107329279895533,0,0,19934.0,113899.85357353876,PIK3R2
12009,KEGG_2019_Human,Non-small cell lung cancer,1/66,0.003299948626608,0.0107329279895533,0,0,19934.0,113899.85357353876,PIK3R2
12010,KEGG_2019_Human,Fc epsilon RI signaling pathway,1/68,0.0033999476216189,0.0107329279895533,0,0,19932.0,113293.39338050144,PIK3R2
12011,KEGG_2019_Human,Renal cell carcinoma,1/69,0.003449947123837,0.0107329279895533,0,0,19931.0,112996.7391397682,PIK3R2
12012,KEGG_2019_Human,Prolactin signaling pathway,1/70,0.0034999466296654,0.0107329279895533,0,0,19930.0,112704.30065625212,PIK3R2
12013,KEGG_2019_Human,B cell receptor signaling pathway,1/71,0.0035499461386618,0.0107329279895533,0,0,19929.0,112415.9585341616,PIK3R2
12014,KEGG_2019_Human,Melanoma,1/72,0.0035999456502131,0.0107329279895533,0,0,19928.0,112131.59838572376,PIK3R2
12015,KEGG_2019_Human,Bacterial invasion of epithelial cells,1/74,0.0036999446830449,0.0107329279895533,0,0,19926.0,111574.38983110404,PIK3R2
12016,KEGG_2019_Human,Pancreatic cancer,1/75,0.0037499442041125,0.0107329279895533,0,0,19925.0,111301.33528642564,PIK3R2
12017,KEGG_2019_Human,Glioma,1/75,0.0037499442041125,0.0107329279895533,0,0,19925.0,111301.33528642564,PIK3R2
12018,KEGG_2019_Human,Chronic myeloid leukemia,1/76,0.0037999437281752,0.0107329279895533,0,0,19924.0,111031.8499691117,PIK3R2
12019,KEGG_2019_Human,ErbB signaling pathway,1/85,0.004249939567045,0.0107329279895533,0,0,19915.0,108752.83801948265,PIK3R2
12020,KEGG_2019_Human,Colorectal cancer,1/86,0.0042999391173866,0.0107329279895533,0,0,19914.0,108514.46102290176,PIK3R2
12021,KEGG_2019_Human,Fc gamma R-mediated phagocytosis,1/91,0.0045499369072032,0.0107329279895533,0,0,19909.0,107362.10783923086,PIK3R2
12022,KEGG_2019_Human,Small cell lung cancer,1/93,0.0046499360391879,0.0107329279895533,0,0,19907.0,106918.54242106884,PIK3R2
12023,KEGG_2019_Human,Amoebiasis,1/96,0.0047999347538706,0.0107329279895533,0,0,19904.0,106270.50039849174,PIK3R2
12024,KEGG_2019_Human,Prostate cancer,1/97,0.0048499343304706,0.0107329279895533,0,0,19903.0,106058.9096435903,PIK3R2
12025,KEGG_2019_Human,Choline metabolism in cancer,1/99,0.0049499334884068,0.0107329279895533,0,0,19901.0,105642.09305076736,PIK3R2
12026,KEGG_2019_Human,Phosphatidylinositol signaling system,1/99,0.0049499334884068,0.0107329279895533,0,0,19901.0,105642.09305076736,PIK3R2
12027,KEGG_2019_Human,Progesterone-mediated oocyte maturation,1/99,0.0049499334884068,0.0107329279895533,0,0,19901.0,105642.09305076736,PIK3R2
12028,KEGG_2019_Human,AGE-RAGE signaling pathway in diabetic complications,1/100,0.0049999330710556,0.0107329279895533,0,0,19900.0,105436.78197328727,PIK3R2
12029,KEGG_2019_Human,Inflammatory mediator regulation of TRP channels,1/100,0.0049999330710556,0.0107329279895533,0,0,19900.0,105436.78197328727,PIK3R2
12030,KEGG_2019_Human,HIF-1 signaling pathway,1/100,0.0049999330710556,0.0107329279895533,0,0,19900.0,105436.78197328727,PIK3R2
12031,KEGG_2019_Human,T cell receptor signaling pathway,1/101,0.0050499326546803,0.0107329279895533,0,0,19899.0,105233.48101229242,PIK3R2
12032,KEGG_2019_Human,Longevity regulating pathway,1/102,0.0050999322416682,0.0107329279895533,0,0,19898.0,105032.15064717118,PIK3R2
12033,KEGG_2019_Human,Chagas disease (American trypanosomiasis),1/103,0.0051499318302617,0.0107329279895533,0,0,19897.0,104832.7525292024,PIK3R2
12034,KEGG_2019_Human,Toll-like receptor signaling pathway,1/104,0.0051999314202997,0.0107329279895533,0,0,19896.0,104635.24941415618,PIK3R2
12035,KEGG_2019_Human,C-type lectin receptor signaling pathway,1/104,0.0051999314202997,0.0107329279895533,0,0,19896.0,104635.24941415618,PIK3R2
12036,KEGG_2019_Human,Insulin resistance,1/108,0.0053999298011749,0.0107329279895533,0,0,19892.0,103863.47861844616,PIK3R2
12037,KEGG_2019_Human,TNF signaling pathway,1/110,0.0054999290027479,0.0107329279895533,0,0,19890.0,103488.06969787036,PIK3R2
12038,KEGG_2019_Human,Leukocyte transendothelial migration,1/112,0.0055999282120529,0.0107329279895533,0,0,19888.0,103119.30984392198,PIK3R2
12039,KEGG_2019_Human,Cholinergic synapse,1/112,0.0055999282120529,0.0107329279895533,0,0,19888.0,103119.30984392198,PIK3R2
12040,KEGG_2019_Human,Thyroid hormone signaling pathway,1/116,0.0057999266512085,0.0107329279895533,0,0,19884.0,102400.8105961506,PIK3R2
12041,KEGG_2019_Human,Sphingolipid signaling pathway,1/119,0.0059499254985137,0.0107329279895533,0,0,19881.0,101877.73080211312,PIK3R2
12042,KEGG_2019_Human,Neurotrophin signaling pathway,1/119,0.0059499254985137,0.0107329279895533,0,0,19881.0,101877.73080211312,PIK3R2
12043,KEGG_2019_Human,AMPK signaling pathway,1/120,0.0059999251180858,0.0107329279895533,0,0,19880.0,101706.2448082016,PIK3R2
12044,KEGG_2019_Human,Platelet activation,1/124,0.0061999236097501,0.0107329279895533,0,0,19876.0,101034.04709010696,PIK3R2
12045,KEGG_2019_Human,Osteoclast differentiation,1/127,0.0063499224962247,0.0107329279895533,0,0,19873.0,100543.72072014232,PIK3R2
12046,KEGG_2019_Human,Autophagy,1/128,0.0063999221281459,0.0107329279895533,0,0,19872.0,100382.8010329652,PIK3R2
12047,KEGG_2019_Human,Relaxin signaling pathway,1/130,0.0064999213952527,0.0107329279895533,0,0,19870.0,100064.62842845908,PIK3R2
12048,KEGG_2019_Human,Natural killer cell mediated cytotoxicity,1/131,0.0065499210316603,0.0107329279895533,0,0,19869.0,99907.33811343512,PIK3R2
12049,KEGG_2019_Human,FoxO signaling pathway,1/132,0.0065999206698993,0.0107329279895533,0,0,19868.0,99751.22090491928,PIK3R2
12050,KEGG_2019_Human,Insulin signaling pathway,1/137,0.0068499188797651,0.0107329279895533,0,0,19863.0,98987.62735269018,PIK3R2
12051,KEGG_2019_Human,Estrogen signaling pathway,1/137,0.0068499188797651,0.0107329279895533,0,0,19863.0,98987.62735269018,PIK3R2
12052,KEGG_2019_Human,Measles,1/138,0.0068999185254481,0.0107329279895533,0,0,19862.0,98838.19160389496,PIK3R2
12053,KEGG_2019_Human,Fluid shear stress and atherosclerosis,1/139,0.006949918172816,0.0107329279895533,0,0,19861.0,98689.81333375497,PIK3R2
12054,KEGG_2019_Human,Signaling pathways regulating pluripotency of stem cells,1/139,0.006949918172816,0.0107329279895533,0,0,19861.0,98689.81333375497,PIK3R2
12055,KEGG_2019_Human,Apoptosis,1/143,0.0071499167770442,0.0107329279895533,0,0,19857.0,98106.57763600958,PIK3R2
12056,KEGG_2019_Human,Breast cancer,1/147,0.0073499154017982,0.0107329279895533,0,0,19853.0,97539.10874372096,PIK3R2
12057,KEGG_2019_Human,Phospholipase D signaling pathway,1/148,0.007399915061391,0.0107329279895533,0,0,19852.0,97399.60470052566,PIK3R2
12058,KEGG_2019_Human,Non-alcoholic fatty liver disease (NAFLD),1/149,0.0074499147221605,0.0107329279895533,0,0,19851.0,97261.02051561224,PIK3R2
12059,KEGG_2019_Human,Gastric cancer,1/149,0.0074499147221605,0.0107329279895533,0,0,19851.0,97261.02051561224,PIK3R2
12060,KEGG_2019_Human,mTOR signaling pathway,1/152,0.0075999137114971,0.0107665444246209,0,0,19848.0,96850.665715497,PIK3R2
12061,KEGG_2019_Human,Hepatitis C,1/155,0.0077499127120574,0.0107990586971292,0,0,19845.0,96448.16254952336,PIK3R2
12062,KEGG_2019_Human,Cellular senescence,1/160,0.0079999110688441,0.0108240993487293,0,0,19840.0,95793.96509856998,PIK3R2
12063,KEGG_2019_Human,JAK-STAT signaling pathway,1/162,0.0080999104202618,0.0108240993487293,0,0,19838.0,95537.86936302872,PIK3R2
12064,KEGG_2019_Human,Hepatitis B,1/163,0.0081499100978668,0.0108240993487293,0,0,19837.0,95410.9786681514,PIK3R2
12065,KEGG_2019_Human,Hepatocellular carcinoma,1/168,0.0083999085011095,0.0109844957322201,0,0,19832.0,94787.72752807094,PIK3R2
12066,KEGG_2019_Human,Influenza A,1/171,0.0085499075557634,0.0110112445793923,0,0,19829.0,94422.42241345016,PIK3R2
12067,KEGG_2019_Human,Axon guidance,1/181,0.0090499044707863,0.0114812220898035,0,0,19819.0,93248.41634586031,PIK3R2
12068,KEGG_2019_Human,Kaposi sarcoma-associated herpesvirus infection,1/186,0.0092999029651357,0.0116248787064197,0,0,19814.0,92684.96451050608,PIK3R2
12069,KEGG_2019_Human,Chemokine signaling pathway,1/190,0.0094999017791995,0.0117019367118207,0,0,19810.0,92244.74636351672,PIK3R2
12070,KEGG_2019_Human,Focal adhesion,1/199,0.0099498991610159,0.0117019367118207,0,0,19801.0,91286.4288690606,PIK3R2
12071,KEGG_2019_Human,Viral carcinogenesis,1/201,0.0100498985877989,0.0117019367118207,0,0,19799.0,91079.21596609056,PIK3R2
12072,KEGG_2019_Human,Epstein-Barr virus infection,1/201,0.0100498985877989,0.0117019367118207,0,0,19799.0,91079.21596609056,PIK3R2
12073,KEGG_2019_Human,Proteoglycans in cancer,1/201,0.0100498985877989,0.0117019367118207,0,0,19799.0,91079.21596609056,PIK3R2
12074,KEGG_2019_Human,Rap1 signaling pathway,1/206,0.010299897173561,0.0118115723489555,0,0,19794.0,90569.849337325,PIK3R2
12075,KEGG_2019_Human,Human immunodeficiency virus 1 infection,1/212,0.0105998955026255,0.0118115723489555,0,0,19788.0,89974.27756224656,PIK3R2
12076,KEGG_2019_Human,cAMP signaling pathway,1/212,0.0105998955026255,0.0118115723489555,0,0,19788.0,89974.27756224656,PIK3R2
12077,KEGG_2019_Human,Regulation of actin cytoskeleton,1/214,0.0106998949514067,0.0118115723489555,0,0,19786.0,89779.39753374986,PIK3R2
12078,KEGG_2019_Human,Human T-cell leukemia virus 1 infection,1/219,0.0109498935894162,0.0119325763474408,0,0,19781.0,89299.85161916987,PIK3R2
12079,KEGG_2019_Human,Human cytomegalovirus infection,1/225,0.0112498919790339,0.0121043141546567,0,0,19775.0,88738.27077557483,PIK3R2
12080,KEGG_2019_Human,Ras signaling pathway,1/232,0.0115998901349604,0.0123248832683954,0,0,19768.0,88101.22480150245,PIK3R2
12081,KEGG_2019_Human,MicroRNAs in cancer,1/299,0.0149498740670514,0.0156881394530786,0,0,19701.0,82804.33538735632,PIK3R2
12082,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0171035211464876,0,0,19670.0,80733.60565076157,PIK3R2
12083,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0181263653556166,0,0,19646.0,79255.8617626126,PIK3R2
12084,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0248926942055726,0,0,19508.0,72277.44006442746,PIK3R2
12085,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,PIK3R2
12086,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0147498749536506,0,0,19705.0,83086.53988020132,MAP4K2
12087,KEGG_2019_Human,Fatty acid degradation,1/44,0.0021999607179423,0.0055499170245674,0,0,19956.0,122117.06559109331,CYP4A22
12088,KEGG_2019_Human,Arachidonic acid metabolism,1/63,0.0031499501598827,0.0055499170245674,0,0,19937.0,114844.46974572667,CYP4A22
12089,KEGG_2019_Human,Retinol metabolism,1/67,0.0033499481224912,0.0055499170245674,0,0,19933.0,113594.38808369274,CYP4A22
12090,KEGG_2019_Human,PPAR signaling pathway,1/74,0.0036999446830449,0.0055499170245674,0,0,19926.0,111574.38983110404,CYP4A22
12091,KEGG_2019_Human,Inflammatory mediator regulation of TRP channels,1/100,0.0049999330710556,0.0059999196852667,0,0,19900.0,105436.78197328727,CYP4A22
12092,KEGG_2019_Human,Vascular smooth muscle contraction,1/132,0.0065999206698993,0.0065999206698993,0,0,19868.0,99751.22090491928,CYP4A22
12093,KEGG_2019_Human,Mismatch repair,1/23,0.0011499748819949,0.0057999055775414,0,0,19977.0,135204.63922267244,MLH1
12094,KEGG_2019_Human,Fanconi anemia pathway,1/54,0.0026999549628563,0.0057999055775414,0,0,19946.0,117971.01964061816,MLH1
12095,KEGG_2019_Human,Endometrial cancer,1/58,0.0028999527887707,0.0057999055775414,0,0,19942.0,116522.31890946148,MLH1
12096,KEGG_2019_Human,Colorectal cancer,1/86,0.0042999391173866,0.0064499086760799,0,0,19914.0,108514.46102290176,MLH1
12097,KEGG_2019_Human,Gastric cancer,1/149,0.0074499147221605,0.0089398976665926,0,0,19851.0,97261.02051561224,MLH1
12098,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,MLH1
12099,KEGG_2019_Human,Ubiquinone and other terpenoid-quinone biosynthesis,1/11,0.0005499852259717758,0.0005499852259717758,0,0,19989.0,150029.8210287992,COQ5
12100,KEGG_2019_Human,TGF-beta signaling pathway,1/90,0.0044999373439762,0.0044999373439762,0,0,19910.0,107587.50385474482,TGIF1
12101,KEGG_2019_Human,Steroid hormone biosynthesis,1/60,0.002999951725986,0.004099940929819,0,0,19940.0,115834.63209072244,HSD11B1
12102,KEGG_2019_Human,Metabolism of xenobiotics by cytochrome P450,1/74,0.0036999446830449,0.004099940929819,0,0,19926.0,111574.38983110404,HSD11B1
12103,KEGG_2019_Human,Chemical carcinogenesis,1/82,0.004099940929819,0.004099940929819,0,0,19918.0,109484.9180722932,HSD11B1
12104,KEGG_2019_Human,Transcriptional misregulation in cancer,1/186,0.0092999029651357,0.0092999029651357,0,0,19814.0,92684.96451050608,TLX3
12105,KEGG_2019_Human,Inositol phosphate metabolism,1/74,0.0036999446830449,0.0074249002326102,0,0,19926.0,111574.38983110404,PIP4K2A
12106,KEGG_2019_Human,Phosphatidylinositol signaling system,1/99,0.0049499334884068,0.0074249002326102,0,0,19901.0,105642.09305076736,PIP4K2A
12107,KEGG_2019_Human,Regulation of actin cytoskeleton,1/214,0.0106998949514067,0.0106998949514067,0,0,19786.0,89779.39753374986,PIP4K2A
12108,KEGG_2019_Human,Nicotinate and nicotinamide metabolism,1/30,0.0014999697593334,0.0029999395186669,0,0,19970.0,129851.13732048514,NAMPT
12109,KEGG_2019_Human,NOD-like receptor signaling pathway,1/178,0.0088999053857096,0.0088999053857096,0,0,19822.0,93593.82745769851,NAMPT
12110,KEGG_2019_Human,Arrhythmogenic right ventricular cardiomyopathy (ARVC),1/72,0.0035999456502131,0.0079623895876056,0,0,19928.0,112131.59838572376,CACNA2D1
12111,KEGG_2019_Human,Cardiac muscle contraction,1/78,0.0038999427840466,0.0079623895876056,0,0,19922.0,110503.2180492851,CACNA2D1
12112,KEGG_2019_Human,Hypertrophic cardiomyopathy (HCM),1/85,0.004249939567045,0.0079623895876056,0,0,19915.0,108752.83801948265,CACNA2D1
12113,KEGG_2019_Human,Dilated cardiomyopathy (DCM),1/91,0.0045499369072032,0.0079623895876056,0,0,19909.0,107362.10783923086,CACNA2D1
12114,KEGG_2019_Human,Adrenergic signaling in cardiomyocytes,1/145,0.0072499160871101,0.0089248989400127,0,0,19855.0,97820.92670675044,CACNA2D1
12115,KEGG_2019_Human,Oxytocin signaling pathway,1/153,0.0076499133771537,0.0089248989400127,0,0,19847.0,96715.6407630817,CACNA2D1
12116,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0147498749536506,0,0,19705.0,83086.53988020132,CACNA2D1
12117,KEGG_2019_Human,Glycosphingolipid biosynthesis,1/45,0.0022499601197094,0.0022499601197094,0,0,19955.0,121662.49782449217,B3GALT2
12118,KEGG_2019_Human,Terpenoid backbone biosynthesis,1/22,0.0010999756574123,0.0010999756574123,0,0,19978.0,136099.47030191717,FNTA
12119,KEGG_2019_Human,Histidine metabolism,1/23,0.0011499748819949,0.0033549463201819,0,0,19977.0,135204.63922267244,ALDH1B1
12120,KEGG_2019_Human,Ascorbate and aldarate metabolism,1/27,0.0013499718942362,0.0033549463201819,0,0,19973.0,131975.02298599784,ALDH1B1
12121,KEGG_2019_Human,beta-Alanine metabolism,1/31,0.0015499690656704,0.0033549463201819,0,0,19969.0,129189.85098816035,ALDH1B1
12122,KEGG_2019_Human,Pyruvate metabolism,1/39,0.0019499637955508,0.0033549463201819,0,0,19961.0,124555.53162481484,ALDH1B1
12123,KEGG_2019_Human,Tryptophan metabolism,1/42,0.0020999619311272,0.0033549463201819,0,0,19958.0,123057.75613441122,ALDH1B1
12124,KEGG_2019_Human,Fatty acid degradation,1/44,0.0021999607179423,0.0033549463201819,0,0,19956.0,122117.06559109331,ALDH1B1
12125,KEGG_2019_Human,"Valine, leucine and isoleucine degradation",1/48,0.0023999583567988,0.0033549463201819,0,0,19952.0,120356.5272753826,ALDH1B1
12126,KEGG_2019_Human,Arginine and proline metabolism,1/49,0.0024499577795033,0.0033549463201819,0,0,19951.0,119939.1172087114,ALDH1B1
12127,KEGG_2019_Human,Lysine degradation,1/59,0.0029499522555206,0.0033549463201819,0,0,19941.0,116175.59385530632,ALDH1B1
12128,KEGG_2019_Human,Glycerolipid metabolism,1/61,0.0030499512001654,0.0033549463201819,0,0,19939.0,115499.24335773686,ALDH1B1
12129,KEGG_2019_Human,Glycolysis / Gluconeogenesis,1/68,0.0033999476216189,0.0033999476216189,0,0,19932.0,113293.39338050144,ALDH1B1
12130,KEGG_2019_Human,Taste transduction,1/83,0.0041499404726918,0.0041499404726918,0,0,19917.0,109237.99888847338,TRPM5
12131,KEGG_2019_Human,Insulin secretion,1/86,0.0042999391173866,0.0042999391173866,0,0,19914.0,108514.46102290176,FFAR1
12132,KEGG_2019_Human,"Neomycin, kanamycin and gentamicin biosynthesis",1/5,0.0002499917995416556,0.0029999015944998,0,0,19995.0,165840.17843725558,GCK
12133,KEGG_2019_Human,Maturity onset diabetes of the young,1/26,0.0012999726251831,0.0046665955062205,0,0,19974.0,132735.46073187632,GCK
12134,KEGG_2019_Human,Galactose metabolism,1/31,0.0015499690656704,0.0046665955062205,0,0,19969.0,129189.85098816035,GCK
12135,KEGG_2019_Human,Starch and sucrose metabolism,1/36,0.0017999657178272,0.0046665955062205,0,0,19964.0,126172.23364250171,GCK
12136,KEGG_2019_Human,Type II diabetes mellitus,1/46,0.0022999595269283,0.0046665955062205,0,0,19954.0,121217.8313311442,GCK
12137,KEGG_2019_Human,Amino sugar and nucleotide sugar metabolism,1/48,0.0023999583567988,0.0046665955062205,0,0,19952.0,120356.5272753826,GCK
12138,KEGG_2019_Human,Central carbon metabolism in cancer,1/65,0.003249949134407,0.0046665955062205,0,0,19935.0,114209.92613860144,GCK
12139,KEGG_2019_Human,Glycolysis / Gluconeogenesis,1/68,0.0033999476216189,0.0046665955062205,0,0,19932.0,113293.39338050144,GCK
12140,KEGG_2019_Human,Prolactin signaling pathway,1/70,0.0034999466296654,0.0046665955062205,0,0,19930.0,112704.30065625212,GCK
12141,KEGG_2019_Human,Insulin secretion,1/86,0.0042999391173866,0.0051599269408639,0,0,19914.0,108514.46102290176,GCK
12142,KEGG_2019_Human,Glucagon signaling pathway,1/103,0.0051499318302617,0.0056181074511945,0,0,19897.0,104832.7525292024,GCK
12143,KEGG_2019_Human,Insulin signaling pathway,1/137,0.0068499188797651,0.0068499188797651,0,0,19863.0,98987.62735269018,GCK
12144,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR52E8
12145,KEGG_2019_Human,Thyroid hormone signaling pathway,1/116,0.0057999266512085,0.0084999078692823,0,0,19884.0,102400.8105961506,GATA4
12146,KEGG_2019_Human,Cellular senescence,1/160,0.0079999110688441,0.0084999078692823,0,0,19840.0,95793.96509856998,GATA4
12147,KEGG_2019_Human,cGMP-PKG signaling pathway,1/166,0.0082999091363732,0.0084999078692823,0,0,19834.0,95034.82345515196,GATA4
12148,KEGG_2019_Human,Tight junction,1/170,0.0084999078692823,0.0084999078692823,0,0,19830.0,94543.49009679438,GATA4
12149,KEGG_2019_Human,Glucagon signaling pathway,1/103,0.0051499318302617,0.0051499318302617,0,0,19897.0,104832.7525292024,PPP4R3A
12150,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR4K1
12151,KEGG_2019_Human,Pyrimidine metabolism,1/57,0.002849953326298,0.0053999298011749,0,0,19943.0,116875.00742975442,UCKL1
12152,KEGG_2019_Human,Drug metabolism,1/108,0.0053999298011749,0.0053999298011749,0,0,19892.0,103863.47861844616,UCKL1
12153,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR4F6
12154,KEGG_2019_Human,Other types of O-glycan biosynthesis,1/22,0.0010999756574123,0.0021999513148247,0,0,19978.0,136099.47030191717,COLGALT2
12155,KEGG_2019_Human,Lysine degradation,1/59,0.0029499522555206,0.0029499522555206,0,0,19941.0,116175.59385530632,COLGALT2
12156,KEGG_2019_Human,RNA polymerase,1/31,0.0015499690656704,0.0030999381313408,0,0,19969.0,129189.85098816035,POLR2I
12157,KEGG_2019_Human,Huntington disease,1/193,0.0096499008972596,0.0096499008972596,0,0,19807.0,91920.47679471428,POLR2I
12158,KEGG_2019_Human,Cocaine addiction,1/49,0.0024499577795033,0.0082832366449848,0,0,19951.0,119939.1172087114,SLC18A1
12159,KEGG_2019_Human,Amphetamine addiction,1/68,0.0033999476216189,0.0082832366449848,0,0,19932.0,113293.39338050144,SLC18A1
12160,KEGG_2019_Human,Synaptic vesicle cycle,1/78,0.0038999427840466,0.0082832366449848,0,0,19922.0,110503.2180492851,SLC18A1
12161,KEGG_2019_Human,Serotonergic synapse,1/113,0.0056499278191151,0.0082832366449848,0,0,19887.0,102937.34947211576,SLC18A1
12162,KEGG_2019_Human,Dopaminergic synapse,1/131,0.0065499210316603,0.0082832366449848,0,0,19869.0,99907.33811343512,SLC18A1
12163,KEGG_2019_Human,Parkinson disease,1/142,0.0070999171242726,0.0082832366449848,0,0,19858.0,98250.87390500787,SLC18A1
12164,KEGG_2019_Human,Alcoholism,1/180,0.0089999047745351,0.0089999047745351,0,0,19820.0,93362.92821536642,SLC18A1
12165,KEGG_2019_Human,Protein digestion and absorption,1/90,0.0044999373439762,0.0044999373439762,0,0,19910.0,107587.50385474482,SLC7A9
12166,KEGG_2019_Human,Gastric acid secretion,1/75,0.0037499442041125,0.0112498326123375,0,0,19925.0,111301.33528642564,SSTR2
12167,KEGG_2019_Human,cAMP signaling pathway,1/212,0.0105998955026255,0.0158998432539383,0,0,19788.0,89974.27756224656,SSTR2
12168,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,SSTR2
12169,KEGG_2019_Human,Thermogenesis,1/231,0.0115498903940656,0.0115498903940656,0,0,19769.0,88191.07730937863,COX20
12170,KEGG_2019_Human,Prion diseases,1/35,0.0017499663721595,0.0063999130051608,0,0,19965.0,126740.98858805298,C9
12171,KEGG_2019_Human,Complement and coagulation cascades,1/79,0.0039499423167337,0.0063999130051608,0,0,19921.0,110243.89578070649,C9
12172,KEGG_2019_Human,Amoebiasis,1/96,0.0047999347538706,0.0063999130051608,0,0,19904.0,106270.50039849174,C9
12173,KEGG_2019_Human,Systemic lupus erythematosus,1/133,0.0066499203093911,0.0066499203093911,0,0,19867.0,99596.2591544721,C9
12174,KEGG_2019_Human,Propanoate metabolism,1/32,0.0015999683804467,0.0023999583567988,0,0,19968.0,128549.41955786056,BCKDHB
12175,KEGG_2019_Human,"Valine, leucine and isoleucine degradation",1/48,0.0023999583567988,0.0023999583567988,0,0,19952.0,120356.5272753826,BCKDHB
12176,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR6Q1
12177,KEGG_2019_Human,Gap junction,1/88,0.0043999382262822,0.0043999382262822,0,0,19912.0,108045.79305232369,GJD2
12178,KEGG_2019_Human,Arginine and proline metabolism,1/49,0.0024499577795033,0.0024499577795033,0,0,19951.0,119939.1172087114,OAT
12179,KEGG_2019_Human,Cell adhesion molecules (CAMs),1/145,0.0072499160871101,0.0090499044707863,0,0,19855.0,97820.92670675044,LRRC4
12180,KEGG_2019_Human,Axon guidance,1/181,0.0090499044707863,0.0090499044707863,0,0,19819.0,93248.41634586031,LRRC4
12181,KEGG_2019_Human,Protein export,1/23,0.0011499748819949,0.0045998995279799,0,0,19977.0,135204.63922267244,SEC61G
12182,KEGG_2019_Human,Vibrio cholerae infection,1/50,0.0024999572069037,0.0049999144138074,0,0,19950.0,119530.05920663515,SEC61G
12183,KEGG_2019_Human,Phagosome,1/152,0.0075999137114971,0.0082499094553477,0,0,19848.0,96850.665715497,SEC61G
12184,KEGG_2019_Human,Protein processing in endoplasmic reticulum,1/165,0.0082499094553477,0.0082499094553477,0,0,19835.0,95159.46482222488,SEC61G
12185,KEGG_2019_Human,C-type lectin receptor signaling pathway,1/104,0.0051999314202997,0.0119332067734082,0,0,19896.0,104635.24941415618,CARD9
12186,KEGG_2019_Human,NOD-like receptor signaling pathway,1/178,0.0088999053857096,0.0119332067734082,0,0,19822.0,93593.82745769851,CARD9
12187,KEGG_2019_Human,Tuberculosis,1/179,0.0089499050800561,0.0119332067734082,0,0,19821.0,93478.0629355712,CARD9
12188,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,CARD9
12189,KEGG_2019_Human,Arrhythmogenic right ventricular cardiomyopathy (ARVC),1/72,0.0035999456502131,0.0079623895876056,0,0,19928.0,112131.59838572376,CACNG1
12190,KEGG_2019_Human,Cardiac muscle contraction,1/78,0.0038999427840466,0.0079623895876056,0,0,19922.0,110503.2180492851,CACNG1
12191,KEGG_2019_Human,Hypertrophic cardiomyopathy (HCM),1/85,0.004249939567045,0.0079623895876056,0,0,19915.0,108752.83801948265,CACNG1
12192,KEGG_2019_Human,Dilated cardiomyopathy (DCM),1/91,0.0045499369072032,0.0079623895876056,0,0,19909.0,107362.10783923086,CACNG1
12193,KEGG_2019_Human,Adrenergic signaling in cardiomyocytes,1/145,0.0072499160871101,0.0089248989400127,0,0,19855.0,97820.92670675044,CACNG1
12194,KEGG_2019_Human,Oxytocin signaling pathway,1/153,0.0076499133771537,0.0089248989400127,0,0,19847.0,96715.6407630817,CACNG1
12195,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0147498749536506,0,0,19705.0,83086.53988020132,CACNG1
12196,KEGG_2019_Human,Mitophagy,1/65,0.003249949134407,0.003249949134407,0,0,19935.0,114209.92613860144,USP15
12197,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR2L3
12198,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR6N1
12199,KEGG_2019_Human,Basal cell carcinoma,1/63,0.0031499501598827,0.0109198810514423,0,0,19937.0,114844.46974572667,FZD4
12200,KEGG_2019_Human,Melanogenesis,1/101,0.0050499326546803,0.0109198810514423,0,0,19899.0,105233.48101229242,FZD4
12201,KEGG_2019_Human,Signaling pathways regulating pluripotency of stem cells,1/139,0.006949918172816,0.0109198810514423,0,0,19861.0,98689.81333375497,FZD4
12202,KEGG_2019_Human,Breast cancer,1/147,0.0073499154017982,0.0109198810514423,0,0,19853.0,97539.10874372096,FZD4
12203,KEGG_2019_Human,Gastric cancer,1/149,0.0074499147221605,0.0109198810514423,0,0,19851.0,97261.02051561224,FZD4
12204,KEGG_2019_Human,mTOR signaling pathway,1/152,0.0075999137114971,0.0109198810514423,0,0,19848.0,96850.665715497,FZD4
12205,KEGG_2019_Human,Cushing syndrome,1/155,0.0077499127120574,0.0109198810514423,0,0,19845.0,96448.16254952336,FZD4
12206,KEGG_2019_Human,Wnt signaling pathway,1/158,0.0078999117225733,0.0109198810514423,0,0,19842.0,96053.2110949472,FZD4
12207,KEGG_2019_Human,Hippo signaling pathway,1/160,0.0079999110688441,0.0109198810514423,0,0,19840.0,95793.96509856998,FZD4
12208,KEGG_2019_Human,Hepatocellular carcinoma,1/168,0.0083999085011095,0.0109198810514423,0,0,19832.0,94787.72752807094,FZD4
12209,KEGG_2019_Human,Proteoglycans in cancer,1/201,0.0100498985877989,0.0118771528764897,0,0,19799.0,91079.21596609056,FZD4
12210,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0178748564138782,0,0,19670.0,80733.60565076157,FZD4
12211,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,FZD4
12212,KEGG_2019_Human,Systemic lupus erythematosus,1/133,0.0066499203093911,0.0066499203093911,0,0,19867.0,99596.2591544721,TRIM21
12213,KEGG_2019_Human,Porphyrin and chlorophyll metabolism,1/42,0.0020999619311272,0.003299948626608,0,0,19958.0,123057.75613441122,EARS2
12214,KEGG_2019_Human,Aminoacyl-tRNA biosynthesis,1/66,0.003299948626608,0.003299948626608,0,0,19934.0,113899.85357353876,EARS2
12215,KEGG_2019_Human,Hedgehog signaling pathway,1/47,0.0023499589392381,0.0023499589392381,0,0,19953.0,120782.64067395544,KIF3A
12216,KEGG_2019_Human,Endocytosis,1/244,0.0121998870519305,0.0121998870519305,0,0,19756.0,87051.4275316661,WASHC5
12217,KEGG_2019_Human,Transcriptional misregulation in cancer,1/186,0.0092999029651357,0.0092999029651357,0,0,19814.0,92684.96451050608,CDK14
12218,KEGG_2019_Human,NOD-like receptor signaling pathway,1/178,0.0088999053857096,0.0088999053857096,0,0,19822.0,93593.82745769851,CASP4
12219,KEGG_2019_Human,GABAergic synapse,1/89,0.0044499377838098,0.0044499377838098,0,0,19911.0,107815.380281759,TRAK2
12220,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,GHRHR
12221,KEGG_2019_Human,Shigellosis,1/65,0.003249949134407,0.0128914879037424,0,0,19935.0,114209.92613860144,CRKL
12222,KEGG_2019_Human,Renal cell carcinoma,1/69,0.003449947123837,0.0128914879037424,0,0,19931.0,112996.7391397682,CRKL
12223,KEGG_2019_Human,Bacterial invasion of epithelial cells,1/74,0.0036999446830449,0.0128914879037424,0,0,19926.0,111574.38983110404,CRKL
12224,KEGG_2019_Human,Chronic myeloid leukemia,1/76,0.0037999437281752,0.0128914879037424,0,0,19924.0,111031.8499691117,CRKL
12225,KEGG_2019_Human,ErbB signaling pathway,1/85,0.004249939567045,0.0128914879037424,0,0,19915.0,108752.83801948265,CRKL
12226,KEGG_2019_Human,Fc gamma R-mediated phagocytosis,1/91,0.0045499369072032,0.0128914879037424,0,0,19909.0,107362.10783923086,CRKL
12227,KEGG_2019_Human,Neurotrophin signaling pathway,1/119,0.0059499254985137,0.0136605831173983,0,0,19881.0,101877.73080211312,CRKL
12228,KEGG_2019_Human,Insulin signaling pathway,1/137,0.0068499188797651,0.0136605831173983,0,0,19863.0,98987.62735269018,CRKL
12229,KEGG_2019_Human,Chemokine signaling pathway,1/190,0.0094999017791995,0.0136605831173983,0,0,19810.0,92244.74636351672,CRKL
12230,KEGG_2019_Human,Focal adhesion,1/199,0.0099498991610159,0.0136605831173983,0,0,19801.0,91286.4288690606,CRKL
12231,KEGG_2019_Human,Rap1 signaling pathway,1/206,0.010299897173561,0.0136605831173983,0,0,19794.0,90569.849337325,CRKL
12232,KEGG_2019_Human,Human immunodeficiency virus 1 infection,1/212,0.0105998955026255,0.0136605831173983,0,0,19788.0,89974.27756224656,CRKL
12233,KEGG_2019_Human,Regulation of actin cytoskeleton,1/214,0.0106998949514067,0.0136605831173983,0,0,19786.0,89779.39753374986,CRKL
12234,KEGG_2019_Human,Human cytomegalovirus infection,1/225,0.0112498919790339,0.0136605831173983,0,0,19775.0,88738.27077557483,CRKL
12235,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0158842411962421,0,0,19705.0,83086.53988020132,CRKL
12236,KEGG_2019_Human,MicroRNAs in cancer,1/299,0.0149498740670514,0.0158842411962421,0,0,19701.0,82804.33538735632,CRKL
12237,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,CRKL
12238,KEGG_2019_Human,Oxidative phosphorylation,1/133,0.0066499203093911,0.0115498903940656,0,0,19867.0,99596.2591544721,ATP5F1A
12239,KEGG_2019_Human,Parkinson disease,1/142,0.0070999171242726,0.0115498903940656,0,0,19858.0,98250.87390500787,ATP5F1A
12240,KEGG_2019_Human,Alzheimer disease,1/171,0.0085499075557634,0.0115498903940656,0,0,19829.0,94422.42241345016,ATP5F1A
12241,KEGG_2019_Human,Huntington disease,1/193,0.0096499008972596,0.0115498903940656,0,0,19807.0,91920.47679471428,ATP5F1A
12242,KEGG_2019_Human,Thermogenesis,1/231,0.0115498903940656,0.0115498903940656,0,0,19769.0,88191.07730937863,ATP5F1A
12243,KEGG_2019_Human,Staphylococcus aureus infection,1/68,0.0033999476216189,0.0101998428648568,0,0,19932.0,113293.39338050144,PTAFR
12244,KEGG_2019_Human,Calcium signaling pathway,1/188,0.009399902370135,0.0140998535552025,0,0,19812.0,92463.712994847,PTAFR
12245,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,PTAFR
12246,KEGG_2019_Human,Morphine addiction,1/91,0.0045499369072032,0.006449921761047,0,0,19909.0,107362.10783923086,PDE7B
12247,KEGG_2019_Human,Purine metabolism,1/129,0.006449921761047,0.006449921761047,0,0,19871.0,100223.109907462,PDE7B
12248,KEGG_2019_Human,Amyotrophic lateral sclerosis (ALS),1/51,0.0025499566390179,0.0050999132780359,0,0,19949.0,119129.0228601236,DERL1
12249,KEGG_2019_Human,Protein processing in endoplasmic reticulum,1/165,0.0082499094553477,0.0082499094553477,0,0,19835.0,95159.46482222488,DERL1
12250,KEGG_2019_Human,Base excision repair,1/33,0.0016499677032113,0.0065998708128454,0,0,19967.0,127928.56031580272,PARP1
12251,KEGG_2019_Human,NF-kappa B signaling pathway,1/95,0.0047499351803394,0.0080999104202618,0,0,19905.0,106484.27183626965,PARP1
12252,KEGG_2019_Human,Apoptosis,1/143,0.0071499167770442,0.0080999104202618,0,0,19857.0,98106.57763600958,PARP1
12253,KEGG_2019_Human,Necroptosis,1/162,0.0080999104202618,0.0080999104202618,0,0,19838.0,95537.86936302872,PARP1
12254,KEGG_2019_Human,Apoptosis,1/143,0.0071499167770442,0.0071499167770442,0,0,19857.0,98106.57763600958,HRK
12255,KEGG_2019_Human,Arginine biosynthesis,1/21,0.0010499764455398,0.0017499663721595,0,0,19979.0,137035.71221916509,ASL
12256,KEGG_2019_Human,"Alanine, aspartate and glutamate metabolism",1/35,0.0017499663721595,0.0017499663721595,0,0,19965.0,126740.98858805298,ASL
12257,KEGG_2019_Human,Ubiquitin mediated proteolysis,1/137,0.0068499188797651,0.0068499188797651,0,0,19863.0,98987.62735269018,UBA6
12258,KEGG_2019_Human,Hematopoietic cell lineage,1/97,0.0048499343304706,0.0084999078692823,0,0,19903.0,106058.9096435903,CD1C
12259,KEGG_2019_Human,Tight junction,1/170,0.0084999078692823,0.0084999078692823,0,0,19830.0,94543.49009679438,CD1C
12260,KEGG_2019_Human,Phospholipase D signaling pathway,1/148,0.007399915061391,0.0121998870519305,0,0,19852.0,97399.60470052566,CYTH4
12261,KEGG_2019_Human,Endocytosis,1/244,0.0121998870519305,0.0121998870519305,0,0,19756.0,87051.4275316661,CYTH4
12262,KEGG_2019_Human,FoxO signaling pathway,1/132,0.0065999206698993,0.0131998413397987,0,0,19868.0,99751.22090491928,SGK2
12263,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0176998626413668,0,0,19646.0,79255.8617626126,SGK2
12264,KEGG_2019_Human,Cell adhesion molecules (CAMs),1/145,0.0072499160871101,0.0072499160871101,0,0,19855.0,97820.92670675044,NEGR1
12265,KEGG_2019_Human,Alzheimer disease,1/171,0.0085499075557634,0.0085499075557634,0,0,19829.0,94422.42241345016,RTN3
12266,KEGG_2019_Human,Toll-like receptor signaling pathway,1/104,0.0051999314202997,0.0051999314202997,0,0,19896.0,104635.24941415618,TOLLIP
12267,KEGG_2019_Human,Protein processing in endoplasmic reticulum,1/165,0.0082499094553477,0.0082499094553477,0,0,19835.0,95159.46482222488,TRAM1
12268,KEGG_2019_Human,Hippo signaling pathway,1/160,0.0079999110688441,0.0079999110688441,0,0,19840.0,95793.96509856998,FRMD1
12269,KEGG_2019_Human,Lysine degradation,1/59,0.0029499522555206,0.0050999322416682,0,0,19941.0,116175.59385530632,EHMT2
12270,KEGG_2019_Human,Longevity regulating pathway,1/102,0.0050999322416682,0.0050999322416682,0,0,19898.0,105032.15064717118,EHMT2
12271,KEGG_2019_Human,mRNA surveillance pathway,1/91,0.0045499369072032,0.0045499369072032,0,0,19909.0,107362.10783923086,CSTF2T
12272,KEGG_2019_Human,Thyroid hormone synthesis,1/74,0.0036999446830449,0.0036999446830449,0,0,19926.0,111574.38983110404,SERPINA7
12273,KEGG_2019_Human,Staphylococcus aureus infection,1/68,0.0033999476216189,0.0086856156702824,0,0,19932.0,113293.39338050144,FCGR2A
12274,KEGG_2019_Human,Leishmaniasis,1/74,0.0036999446830449,0.0086856156702824,0,0,19926.0,111574.38983110404,FCGR2A
12275,KEGG_2019_Human,Fc gamma R-mediated phagocytosis,1/91,0.0045499369072032,0.0086856156702824,0,0,19909.0,107362.10783923086,FCGR2A
12276,KEGG_2019_Human,Platelet activation,1/124,0.0061999236097501,0.0086856156702824,0,0,19876.0,101034.04709010696,FCGR2A
12277,KEGG_2019_Human,Osteoclast differentiation,1/127,0.0063499224962247,0.0086856156702824,0,0,19873.0,100543.72072014232,FCGR2A
12278,KEGG_2019_Human,Systemic lupus erythematosus,1/133,0.0066499203093911,0.0086856156702824,0,0,19867.0,99596.2591544721,FCGR2A
12279,KEGG_2019_Human,Phagosome,1/152,0.0075999137114971,0.0086856156702824,0,0,19848.0,96850.665715497,FCGR2A
12280,KEGG_2019_Human,Tuberculosis,1/179,0.0089499050800561,0.0089499050800561,0,0,19821.0,93478.0629355712,FCGR2A
12281,KEGG_2019_Human,cAMP signaling pathway,1/212,0.0105998955026255,0.0105998955026255,0,0,19788.0,89974.27756224656,HCN2
12282,KEGG_2019_Human,Ubiquinone and other terpenoid-quinone biosynthesis,1/11,0.0005499852259717758,0.0005499852259717758,0,0,19989.0,150029.8210287992,COQ3
12283,KEGG_2019_Human,Mitophagy,1/65,0.003249949134407,0.003249949134407,0,0,19935.0,114209.92613860144,TFEB
12284,KEGG_2019_Human,Protein digestion and absorption,1/90,0.0044999373439762,0.0044999373439762,0,0,19910.0,107587.50385474482,ELN
12285,KEGG_2019_Human,Axon guidance,1/181,0.0090499044707863,0.0090499044707863,0,0,19819.0,93248.41634586031,SRGAP1
12286,KEGG_2019_Human,Prion diseases,1/35,0.0017499663721595,0.0100465476903222,0,0,19965.0,126740.98858805298,PRKACA
12287,KEGG_2019_Human,Vasopressin-regulated water reabsorption,1/44,0.0021999607179423,0.0100465476903222,0,0,19956.0,122117.06559109331,PRKACA
12288,KEGG_2019_Human,Hedgehog signaling pathway,1/47,0.0023499589392381,0.0100465476903222,0,0,19953.0,120782.64067395544,PRKACA
12289,KEGG_2019_Human,Endocrine and other factor-regulated calcium reabsorption,1/48,0.0023999583567988,0.0100465476903222,0,0,19952.0,120356.5272753826,PRKACA
12290,KEGG_2019_Human,Cocaine addiction,1/49,0.0024499577795033,0.0100465476903222,0,0,19951.0,119939.1172087114,PRKACA
12291,KEGG_2019_Human,Ovarian steroidogenesis,1/49,0.0024499577795033,0.0100465476903222,0,0,19951.0,119939.1172087114,PRKACA
12292,KEGG_2019_Human,Vibrio cholerae infection,1/50,0.0024999572069037,0.0100465476903222,0,0,19950.0,119530.05920663515,PRKACA
12293,KEGG_2019_Human,Regulation of lipolysis in adipocytes,1/55,0.0027499544131125,0.0100465476903222,0,0,19945.0,117599.1294878737,PRKACA
12294,KEGG_2019_Human,Cortisol synthesis and secretion,1/65,0.003249949134407,0.0100465476903222,0,0,19935.0,114209.92613860144,PRKACA
12295,KEGG_2019_Human,Long-term potentiation,1/67,0.0033499481224912,0.0100465476903222,0,0,19933.0,113594.38808369274,PRKACA
12296,KEGG_2019_Human,Amphetamine addiction,1/68,0.0033999476216189,0.0100465476903222,0,0,19932.0,113293.39338050144,PRKACA
12297,KEGG_2019_Human,Renin secretion,1/69,0.003449947123837,0.0100465476903222,0,0,19931.0,112996.7391397682,PRKACA
12298,KEGG_2019_Human,Bile secretion,1/72,0.0035999456502131,0.0100465476903222,0,0,19928.0,112131.59838572376,PRKACA
12299,KEGG_2019_Human,Thyroid hormone synthesis,1/74,0.0036999446830449,0.0100465476903222,0,0,19926.0,111574.38983110404,PRKACA
12300,KEGG_2019_Human,Gastric acid secretion,1/75,0.0037499442041125,0.0100465476903222,0,0,19925.0,111301.33528642564,PRKACA
12301,KEGG_2019_Human,Taste transduction,1/83,0.0041499404726918,0.0100465476903222,0,0,19917.0,109237.99888847338,PRKACA
12302,KEGG_2019_Human,Insulin secretion,1/86,0.0042999391173866,0.0100465476903222,0,0,19914.0,108514.46102290176,PRKACA
12303,KEGG_2019_Human,Gap junction,1/88,0.0043999382262822,0.0100465476903222,0,0,19912.0,108045.79305232369,PRKACA
12304,KEGG_2019_Human,GABAergic synapse,1/89,0.0044499377838098,0.0100465476903222,0,0,19911.0,107815.380281759,PRKACA
12305,KEGG_2019_Human,Salivary secretion,1/90,0.0044999373439762,0.0100465476903222,0,0,19910.0,107587.50385474482,PRKACA
12306,KEGG_2019_Human,Morphine addiction,1/91,0.0045499369072032,0.0100465476903222,0,0,19909.0,107362.10783923086,PRKACA
12307,KEGG_2019_Human,Dilated cardiomyopathy (DCM),1/91,0.0045499369072032,0.0100465476903222,0,0,19909.0,107362.10783923086,PRKACA
12308,KEGG_2019_Human,GnRH signaling pathway,1/93,0.0046499360391879,0.0100465476903222,0,0,19907.0,106918.54242106884,PRKACA
12309,KEGG_2019_Human,Amoebiasis,1/96,0.0047999347538706,0.0100465476903222,0,0,19904.0,106270.50039849174,PRKACA
12310,KEGG_2019_Human,Circadian entrainment,1/97,0.0048499343304706,0.0100465476903222,0,0,19903.0,106058.9096435903,PRKACA
12311,KEGG_2019_Human,Aldosterone synthesis and secretion,1/98,0.0048999339081079,0.0100465476903222,0,0,19902.0,105849.45495286948,PRKACA
12312,KEGG_2019_Human,Progesterone-mediated oocyte maturation,1/99,0.0049499334884068,0.0100465476903222,0,0,19901.0,105642.09305076736,PRKACA
12313,KEGG_2019_Human,Inflammatory mediator regulation of TRP channels,1/100,0.0049999330710556,0.0100465476903222,0,0,19900.0,105436.78197328727,PRKACA
12314,KEGG_2019_Human,Melanogenesis,1/101,0.0050499326546803,0.0100465476903222,0,0,19899.0,105233.48101229242,PRKACA
12315,KEGG_2019_Human,Longevity regulating pathway,1/102,0.0050999322416682,0.0100465476903222,0,0,19898.0,105032.15064717118,PRKACA
12316,KEGG_2019_Human,Glucagon signaling pathway,1/103,0.0051499318302617,0.0100465476903222,0,0,19897.0,104832.7525292024,PRKACA
12317,KEGG_2019_Human,"Parathyroid hormone synthesis, secretion and action",1/106,0.0052999306076525,0.0100465476903222,0,0,19894.0,104245.78450366124,PRKACA
12318,KEGG_2019_Human,Cholinergic synapse,1/112,0.0055999282120529,0.0100465476903222,0,0,19888.0,103119.30984392198,PRKACA
12319,KEGG_2019_Human,Serotonergic synapse,1/113,0.0056499278191151,0.0100465476903222,0,0,19887.0,102937.34947211576,PRKACA
12320,KEGG_2019_Human,Glutamatergic synapse,1/114,0.005699927427839,0.0100465476903222,0,0,19886.0,102756.96431429044,PRKACA
12321,KEGG_2019_Human,Thyroid hormone signaling pathway,1/116,0.0057999266512085,0.0100465476903222,0,0,19884.0,102400.8105961506,PRKACA
12322,KEGG_2019_Human,Platelet activation,1/124,0.0061999236097501,0.0100465476903222,0,0,19876.0,101034.04709010696,PRKACA
12323,KEGG_2019_Human,Oocyte meiosis,1/125,0.0062499232373748,0.0100465476903222,0,0,19875.0,100869.32368441945,PRKACA
12324,KEGG_2019_Human,Autophagy,1/128,0.0063999221281459,0.0100465476903222,0,0,19872.0,100382.8010329652,PRKACA
12325,KEGG_2019_Human,Relaxin signaling pathway,1/130,0.0064999213952527,0.0100465476903222,0,0,19870.0,100064.62842845908,PRKACA
12326,KEGG_2019_Human,Dopaminergic synapse,1/131,0.0065499210316603,0.0100465476903222,0,0,19869.0,99907.33811343512,PRKACA
12327,KEGG_2019_Human,Vascular smooth muscle contraction,1/132,0.0065999206698993,0.0100465476903222,0,0,19868.0,99751.22090491928,PRKACA
12328,KEGG_2019_Human,Insulin signaling pathway,1/137,0.0068499188797651,0.0100465476903222,0,0,19863.0,98987.62735269018,PRKACA
12329,KEGG_2019_Human,Apelin signaling pathway,1/137,0.0068499188797651,0.0100465476903222,0,0,19863.0,98987.62735269018,PRKACA
12330,KEGG_2019_Human,Estrogen signaling pathway,1/137,0.0068499188797651,0.0100465476903222,0,0,19863.0,98987.62735269018,PRKACA
12331,KEGG_2019_Human,Parkinson disease,1/142,0.0070999171242726,0.0101748832094126,0,0,19858.0,98250.87390500787,PRKACA
12332,KEGG_2019_Human,Adrenergic signaling in cardiomyocytes,1/145,0.0072499160871101,0.0101748832094126,0,0,19855.0,97820.92670675044,PRKACA
12333,KEGG_2019_Human,Retrograde endocannabinoid signaling,1/148,0.007399915061391,0.0101748832094126,0,0,19852.0,97399.60470052566,PRKACA
12334,KEGG_2019_Human,Oxytocin signaling pathway,1/153,0.0076499133771537,0.010223415170389,0,0,19847.0,96715.6407630817,PRKACA
12335,KEGG_2019_Human,Cushing syndrome,1/155,0.0077499127120574,0.010223415170389,0,0,19845.0,96448.16254952336,PRKACA
12336,KEGG_2019_Human,Wnt signaling pathway,1/158,0.0078999117225733,0.010223415170389,0,0,19842.0,96053.2110949472,PRKACA
12337,KEGG_2019_Human,Tight junction,1/170,0.0084999078692823,0.0107883446033199,0,0,19830.0,94543.49009679438,PRKACA
12338,KEGG_2019_Human,Alcoholism,1/180,0.0089999047745351,0.0112074285871569,0,0,19820.0,93362.92821536642,PRKACA
12339,KEGG_2019_Human,Calcium signaling pathway,1/188,0.009399902370135,0.0113998821350394,0,0,19812.0,92463.712994847,PRKACA
12340,KEGG_2019_Human,Chemokine signaling pathway,1/190,0.0094999017791995,0.0113998821350394,0,0,19810.0,92244.74636351672,PRKACA
12341,KEGG_2019_Human,Viral carcinogenesis,1/201,0.0100498985877989,0.0116367246806093,0,0,19799.0,91079.21596609056,PRKACA
12342,KEGG_2019_Human,Proteoglycans in cancer,1/201,0.0100498985877989,0.0116367246806093,0,0,19799.0,91079.21596609056,PRKACA
12343,KEGG_2019_Human,cAMP signaling pathway,1/212,0.0105998955026255,0.0120619500547118,0,0,19788.0,89974.27756224656,PRKACA
12344,KEGG_2019_Human,Human T-cell leukemia virus 1 infection,1/219,0.0109498935894162,0.0122490335068046,0,0,19781.0,89299.85161916987,PRKACA
12345,KEGG_2019_Human,Human cytomegalovirus infection,1/225,0.0112498919790339,0.0123482701436675,0,0,19775.0,88738.27077557483,PRKACA
12346,KEGG_2019_Human,Thermogenesis,1/231,0.0115498903940656,0.0123482701436675,0,0,19769.0,88191.07730937863,PRKACA
12347,KEGG_2019_Human,Ras signaling pathway,1/232,0.0115998901349604,0.0123482701436675,0,0,19768.0,88101.22480150245,PRKACA
12348,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0154522499514435,0,0,19705.0,83086.53988020132,PRKACA
12349,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0170154883170571,0,0,19670.0,80733.60565076157,PRKACA
12350,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0225413826251583,0,0,19556.0,74462.79263140135,PRKACA
12351,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,PRKACA
12352,KEGG_2019_Human,Tyrosine metabolism,1/36,0.0017999657178272,0.0035999314356544,0,0,19964.0,126172.23364250171,TYRP1
12353,KEGG_2019_Human,Melanogenesis,1/101,0.0050499326546803,0.0050499326546803,0,0,19899.0,105233.48101229242,TYRP1
12354,KEGG_2019_Human,Mineral absorption,1/51,0.0025499566390179,0.0088999053857096,0,0,19949.0,119129.0228601236,TRPM7
12355,KEGG_2019_Human,Cellular senescence,1/160,0.0079999110688441,0.0088999053857096,0,0,19840.0,95793.96509856998,TRPM7
12356,KEGG_2019_Human,Necroptosis,1/162,0.0080999104202618,0.0088999053857096,0,0,19838.0,95537.86936302872,TRPM7
12357,KEGG_2019_Human,NOD-like receptor signaling pathway,1/178,0.0088999053857096,0.0088999053857096,0,0,19822.0,93593.82745769851,TRPM7
12358,KEGG_2019_Human,Spliceosome,1/134,0.0066999199497742,0.0066999199497742,0,0,19866.0,99442.43560916925,CRNKL1
12359,KEGG_2019_Human,Ribosome,1/153,0.0076499133771537,0.0076499133771537,0,0,19847.0,96715.6407630817,RPS15
12360,KEGG_2019_Human,Bacterial invasion of epithelial cells,1/74,0.0036999446830449,0.0036999446830449,0,0,19926.0,111574.38983110404,ARHGEF26
12361,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF77
12362,KEGG_2019_Human,Steroid biosynthesis,1/19,0.00094997806231055,0.00094997806231055,0,0,19981.0,139049.2109571672,DHCR7
12363,KEGG_2019_Human,Oxidative phosphorylation,1/133,0.0066499203093911,0.0112582177134695,0,0,19867.0,99596.2591544721,NDUFB8
12364,KEGG_2019_Human,Parkinson disease,1/142,0.0070999171242726,0.0112582177134695,0,0,19858.0,98250.87390500787,NDUFB8
12365,KEGG_2019_Human,Retrograde endocannabinoid signaling,1/148,0.007399915061391,0.0112582177134695,0,0,19852.0,97399.60470052566,NDUFB8
12366,KEGG_2019_Human,Non-alcoholic fatty liver disease (NAFLD),1/149,0.0074499147221605,0.0112582177134695,0,0,19851.0,97261.02051561224,NDUFB8
12367,KEGG_2019_Human,Alzheimer disease,1/171,0.0085499075557634,0.0112582177134695,0,0,19829.0,94422.42241345016,NDUFB8
12368,KEGG_2019_Human,Huntington disease,1/193,0.0096499008972596,0.0112582177134695,0,0,19807.0,91920.47679471428,NDUFB8
12369,KEGG_2019_Human,Thermogenesis,1/231,0.0115498903940656,0.0115498903940656,0,0,19769.0,88191.07730937863,NDUFB8
12370,KEGG_2019_Human,Circadian rhythm,1/31,0.0015499690656704,0.0015499690656704,0,0,19969.0,129189.85098816035,NR1D1
12371,KEGG_2019_Human,Hedgehog signaling pathway,1/47,0.0023499589392381,0.0046999178784763,0,0,19953.0,120782.64067395544,IHH
12372,KEGG_2019_Human,Proteoglycans in cancer,1/201,0.0100498985877989,0.0100498985877989,0,0,19799.0,91079.21596609056,IHH
12373,KEGG_2019_Human,FoxO signaling pathway,1/132,0.0065999206698993,0.0121998870519305,0,0,19868.0,99751.22090491928,AGAP2
12374,KEGG_2019_Human,Endocytosis,1/244,0.0121998870519305,0.0121998870519305,0,0,19756.0,87051.4275316661,AGAP2
12375,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0146998751759735,0,0,19706.0,83157.67014793828,IL1F10
12376,KEGG_2019_Human,Cell adhesion molecules (CAMs),1/145,0.0072499160871101,0.0072499160871101,0,0,19855.0,97820.92670675044,LRRC4B
12377,KEGG_2019_Human,Complement and coagulation cascades,1/79,0.0039499423167337,0.0106998949514067,0,0,19921.0,110243.89578070649,ITGAX
12378,KEGG_2019_Human,Tuberculosis,1/179,0.0089499050800561,0.0106998949514067,0,0,19821.0,93478.0629355712,ITGAX
12379,KEGG_2019_Human,Regulation of actin cytoskeleton,1/214,0.0106998949514067,0.0106998949514067,0,0,19786.0,89779.39753374986,ITGAX
12380,KEGG_2019_Human,Inositol phosphate metabolism,1/74,0.0036999446830449,0.0074249002326102,0,0,19926.0,111574.38983110404,ITPKC
12381,KEGG_2019_Human,Phosphatidylinositol signaling system,1/99,0.0049499334884068,0.0074249002326102,0,0,19901.0,105642.09305076736,ITPKC
12382,KEGG_2019_Human,Calcium signaling pathway,1/188,0.009399902370135,0.009399902370135,0,0,19812.0,92463.712994847,ITPKC
12383,KEGG_2019_Human,Kaposi sarcoma-associated herpesvirus infection,1/186,0.0092999029651357,0.0133998647837319,0,0,19814.0,92684.96451050608,CCR8
12384,KEGG_2019_Human,Chemokine signaling pathway,1/190,0.0094999017791995,0.0133998647837319,0,0,19810.0,92244.74636351672,CCR8
12385,KEGG_2019_Human,Viral carcinogenesis,1/201,0.0100498985877989,0.0133998647837319,0,0,19799.0,91079.21596609056,CCR8
12386,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0146998751759735,0,0,19706.0,83157.67014793828,CCR8
12387,KEGG_2019_Human,Maturity onset diabetes of the young,1/26,0.0012999726251831,0.0022999595269283,0,0,19974.0,132735.46073187632,MAFA
12388,KEGG_2019_Human,Type II diabetes mellitus,1/46,0.0022999595269283,0.0022999595269283,0,0,19954.0,121217.8313311442,MAFA
12389,KEGG_2019_Human,Glycosaminoglycan biosynthesis,1/53,0.0026499555173137,0.0026499555173137,0,0,19947.0,118349.78824235698,HS6ST3
12390,KEGG_2019_Human,Arginine and proline metabolism,1/49,0.0024499577795033,0.0024499577795033,0,0,19951.0,119939.1172087114,P4HA2
12391,KEGG_2019_Human,Hippo signaling pathway,1/160,0.0079999110688441,0.0079999110688441,0,0,19840.0,95793.96509856998,RASSF6
12392,KEGG_2019_Human,Cysteine and methionine metabolism,1/47,0.0023499589392381,0.0024499577795033,0,0,19953.0,120782.64067395544,AMD1
12393,KEGG_2019_Human,Arginine and proline metabolism,1/49,0.0024499577795033,0.0024499577795033,0,0,19951.0,119939.1172087114,AMD1
12394,KEGG_2019_Human,Long-term potentiation,1/67,0.0033499481224912,0.0106771546448906,0,0,19933.0,113594.38808369274,CAMK2G
12395,KEGG_2019_Human,Amphetamine addiction,1/68,0.0033999476216189,0.0106771546448906,0,0,19932.0,113293.39338050144,CAMK2G
12396,KEGG_2019_Human,Gastric acid secretion,1/75,0.0037499442041125,0.0106771546448906,0,0,19925.0,111301.33528642564,CAMK2G
12397,KEGG_2019_Human,Glioma,1/75,0.0037499442041125,0.0106771546448906,0,0,19925.0,111301.33528642564,CAMK2G
12398,KEGG_2019_Human,ErbB signaling pathway,1/85,0.004249939567045,0.0106771546448906,0,0,19915.0,108752.83801948265,CAMK2G
12399,KEGG_2019_Human,Insulin secretion,1/86,0.0042999391173866,0.0106771546448906,0,0,19914.0,108514.46102290176,CAMK2G
12400,KEGG_2019_Human,GnRH signaling pathway,1/93,0.0046499360391879,0.0106771546448906,0,0,19907.0,106918.54242106884,CAMK2G
12401,KEGG_2019_Human,Circadian entrainment,1/97,0.0048499343304706,0.0106771546448906,0,0,19903.0,106058.9096435903,CAMK2G
12402,KEGG_2019_Human,Aldosterone synthesis and secretion,1/98,0.0048999339081079,0.0106771546448906,0,0,19902.0,105849.45495286948,CAMK2G
12403,KEGG_2019_Human,Inflammatory mediator regulation of TRP channels,1/100,0.0049999330710556,0.0106771546448906,0,0,19900.0,105436.78197328727,CAMK2G
12404,KEGG_2019_Human,HIF-1 signaling pathway,1/100,0.0049999330710556,0.0106771546448906,0,0,19900.0,105436.78197328727,CAMK2G
12405,KEGG_2019_Human,Melanogenesis,1/101,0.0050499326546803,0.0106771546448906,0,0,19899.0,105233.48101229242,CAMK2G
12406,KEGG_2019_Human,Glucagon signaling pathway,1/103,0.0051499318302617,0.0106771546448906,0,0,19897.0,104832.7525292024,CAMK2G
12407,KEGG_2019_Human,Cholinergic synapse,1/112,0.0055999282120529,0.0106771546448906,0,0,19888.0,103119.30984392198,CAMK2G
12408,KEGG_2019_Human,Neurotrophin signaling pathway,1/119,0.0059499254985137,0.0106771546448906,0,0,19881.0,101877.73080211312,CAMK2G
12409,KEGG_2019_Human,Oocyte meiosis,1/125,0.0062499232373748,0.0106771546448906,0,0,19875.0,100869.32368441945,CAMK2G
12410,KEGG_2019_Human,Dopaminergic synapse,1/131,0.0065499210316603,0.0106771546448906,0,0,19869.0,99907.33811343512,CAMK2G
12411,KEGG_2019_Human,Adrenergic signaling in cardiomyocytes,1/145,0.0072499160871101,0.0106771546448906,0,0,19855.0,97820.92670675044,CAMK2G
12412,KEGG_2019_Human,Oxytocin signaling pathway,1/153,0.0076499133771537,0.0106771546448906,0,0,19847.0,96715.6407630817,CAMK2G
12413,KEGG_2019_Human,Cushing syndrome,1/155,0.0077499127120574,0.0106771546448906,0,0,19845.0,96448.16254952336,CAMK2G
12414,KEGG_2019_Human,Wnt signaling pathway,1/158,0.0078999117225733,0.0106771546448906,0,0,19842.0,96053.2110949472,CAMK2G
12415,KEGG_2019_Human,Necroptosis,1/162,0.0080999104202618,0.0106771546448906,0,0,19838.0,95537.86936302872,CAMK2G
12416,KEGG_2019_Human,Tuberculosis,1/179,0.0089499050800561,0.0109038867493566,0,0,19821.0,93478.0629355712,CAMK2G
12417,KEGG_2019_Human,Axon guidance,1/181,0.0090499044707863,0.0109038867493566,0,0,19819.0,93248.41634586031,CAMK2G
12418,KEGG_2019_Human,Calcium signaling pathway,1/188,0.009399902370135,0.0109038867493566,0,0,19812.0,92463.712994847,CAMK2G
12419,KEGG_2019_Human,Proteoglycans in cancer,1/201,0.0100498985877989,0.0112095022710065,0,0,19799.0,91079.21596609056,CAMK2G
12420,KEGG_2019_Human,cAMP signaling pathway,1/212,0.0105998955026255,0.0113850729472645,0,0,19788.0,89974.27756224656,CAMK2G
12421,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0229926981863763,0,0,19556.0,74462.79263140135,CAMK2G
12422,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,CAMK2G
12423,KEGG_2019_Human,Calcium signaling pathway,1/188,0.009399902370135,0.0168998658265596,0,0,19812.0,92463.712994847,P2RX5
12424,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,P2RX5
12425,KEGG_2019_Human,Homologous recombination,1/41,0.0020499625466866,0.0026999549628563,0,0,19959.0,123544.88783416104,BRIP1
12426,KEGG_2019_Human,Fanconi anemia pathway,1/54,0.0026999549628563,0.0026999549628563,0,0,19946.0,117971.01964061816,BRIP1
12427,KEGG_2019_Human,MicroRNAs in cancer,1/299,0.0149498740670514,0.0149498740670514,0,0,19701.0,82804.33538735632,RECK
12428,KEGG_2019_Human,Ovarian steroidogenesis,1/49,0.0024499577795033,0.0089998746879525,0,0,19951.0,119939.1172087114,BMP6
12429,KEGG_2019_Human,TGF-beta signaling pathway,1/90,0.0044999373439762,0.0089998746879525,0,0,19910.0,107587.50385474482,BMP6
12430,KEGG_2019_Human,Hippo signaling pathway,1/160,0.0079999110688441,0.0106665480917922,0,0,19840.0,95793.96509856998,BMP6
12431,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0146998751759735,0,0,19706.0,83157.67014793828,BMP6
12432,KEGG_2019_Human,Wnt signaling pathway,1/158,0.0078999117225733,0.0078999117225733,0,0,19842.0,96053.2110949472,DKK1
12433,KEGG_2019_Human,Homologous recombination,1/41,0.0020499625466866,0.0026999549628563,0,0,19959.0,123544.88783416104,TOP3B
12434,KEGG_2019_Human,Fanconi anemia pathway,1/54,0.0026999549628563,0.0026999549628563,0,0,19946.0,117971.01964061816,TOP3B
12435,KEGG_2019_Human,Pyrimidine metabolism,1/57,0.002849953326298,0.0085498599788941,0,0,19943.0,116875.00742975442,ENTPD8
12436,KEGG_2019_Human,Purine metabolism,1/129,0.006449921761047,0.0096748826415705,0,0,19871.0,100223.109907462,ENTPD8
12437,KEGG_2019_Human,Epstein-Barr virus infection,1/201,0.0100498985877989,0.0100498985877989,0,0,19799.0,91079.21596609056,ENTPD8
12438,KEGG_2019_Human,Cell cycle,1/124,0.0061999236097501,0.0093748848560622,0,0,19876.0,101034.04709010696,PTTG1
12439,KEGG_2019_Human,Oocyte meiosis,1/125,0.0062499232373748,0.0093748848560622,0,0,19875.0,100869.32368441945,PTTG1
12440,KEGG_2019_Human,Human T-cell leukemia virus 1 infection,1/219,0.0109498935894162,0.0109498935894162,0,0,19781.0,89299.85161916987,PTTG1
12441,KEGG_2019_Human,Sphingolipid metabolism,1/47,0.0023499589392381,0.0046999178784763,0,0,19953.0,120782.64067395544,SGMS1
12442,KEGG_2019_Human,Sphingolipid signaling pathway,1/119,0.0059499254985137,0.0059499254985137,0,0,19881.0,101877.73080211312,SGMS1
12443,KEGG_2019_Human,Vitamin digestion and absorption,1/24,0.0011999741185782,0.0040666016002205,0,0,19976.0,134347.69487847842,PNLIP
12444,KEGG_2019_Human,Fat digestion and absorption,1/41,0.0020499625466866,0.0040666016002205,0,0,19959.0,123544.88783416104,PNLIP
12445,KEGG_2019_Human,Glycerolipid metabolism,1/61,0.0030499512001654,0.0040666016002205,0,0,19939.0,115499.24335773686,PNLIP
12446,KEGG_2019_Human,Pancreatic secretion,1/98,0.0048999339081079,0.0048999339081079,0,0,19902.0,105849.45495286948,PNLIP
12447,KEGG_2019_Human,RNA transport,1/165,0.0082499094553477,0.0082499094553477,0,0,19835.0,95159.46482222488,GEMIN5
12448,KEGG_2019_Human,Non-homologous end-joining,1/13,0.0006499833083207112,0.0006499833083207112,0,0,19987.0,146675.87616784443,POLM
12449,KEGG_2019_Human,Transcriptional misregulation in cancer,1/186,0.0092999029651357,0.0149498740670514,0,0,19814.0,92684.96451050608,SLC45A3
12450,KEGG_2019_Human,MicroRNAs in cancer,1/299,0.0149498740670514,0.0149498740670514,0,0,19701.0,82804.33538735632,SLC45A3
12451,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR2AG2
12452,KEGG_2019_Human,NOD-like receptor signaling pathway,1/178,0.0088999053857096,0.0088999053857096,0,0,19822.0,93593.82745769851,CASP5
12453,KEGG_2019_Human,Inositol phosphate metabolism,1/74,0.0036999446830449,0.0049499334884068,0,0,19926.0,111574.38983110404,PI4K2A
12454,KEGG_2019_Human,Phosphatidylinositol signaling system,1/99,0.0049499334884068,0.0049499334884068,0,0,19901.0,105642.09305076736,PI4K2A
12455,KEGG_2019_Human,ABC transporters,1/45,0.0022499601197094,0.0041499404726918,0,0,19955.0,121662.49782449217,ABCD4
12456,KEGG_2019_Human,Peroxisome,1/83,0.0041499404726918,0.0041499404726918,0,0,19917.0,109237.99888847338,ABCD4
12457,KEGG_2019_Human,Nicotinate and nicotinamide metabolism,1/30,0.0014999697593334,0.004274929989447,0,0,19970.0,129851.13732048514,NT5C3A
12458,KEGG_2019_Human,Pyrimidine metabolism,1/57,0.002849953326298,0.004274929989447,0,0,19943.0,116875.00742975442,NT5C3A
12459,KEGG_2019_Human,Purine metabolism,1/129,0.006449921761047,0.006449921761047,0,0,19871.0,100223.109907462,NT5C3A
12460,KEGG_2019_Human,Hematopoietic cell lineage,1/97,0.0048499343304706,0.0145798387564713,0,0,19903.0,106058.9096435903,IL6R
12461,KEGG_2019_Human,HIF-1 signaling pathway,1/100,0.0049999330710556,0.0145798387564713,0,0,19900.0,105436.78197328727,IL6R
12462,KEGG_2019_Human,Th17 cell differentiation,1/107,0.0053499302026925,0.0145798387564713,0,0,19893.0,104053.753408911,IL6R
12463,KEGG_2019_Human,Non-alcoholic fatty liver disease (NAFLD),1/149,0.0074499147221605,0.0145798387564713,0,0,19851.0,97261.02051561224,IL6R
12464,KEGG_2019_Human,JAK-STAT signaling pathway,1/162,0.0080999104202618,0.0145798387564713,0,0,19838.0,95537.86936302872,IL6R
12465,KEGG_2019_Human,Human cytomegalovirus infection,1/225,0.0112498919790339,0.0168748379685508,0,0,19775.0,88738.27077557483,IL6R
12466,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0188998395119659,0,0,19706.0,83157.67014793828,IL6R
12467,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0199123454715377,0,0,19646.0,79255.8617626126,IL6R
12468,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,IL6R
12469,KEGG_2019_Human,Calcium signaling pathway,1/188,0.009399902370135,0.0168998658265596,0,0,19812.0,92463.712994847,CYSLTR2
12470,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,CYSLTR2
12471,KEGG_2019_Human,Tryptophan metabolism,1/42,0.0020999619311272,0.0029499522555206,0,0,19958.0,123057.75613441122,DHTKD1
12472,KEGG_2019_Human,Lysine degradation,1/59,0.0029499522555206,0.0029499522555206,0,0,19941.0,116175.59385530632,DHTKD1
12473,KEGG_2019_Human,JAK-STAT signaling pathway,1/162,0.0080999104202618,0.0146998751759735,0,0,19838.0,95537.86936302872,IL13RA2
12474,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0146998751759735,0,0,19706.0,83157.67014793828,IL13RA2
12475,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR6K3
12476,KEGG_2019_Human,TGF-beta signaling pathway,1/90,0.0044999373439762,0.0089998746879525,0,0,19910.0,107587.50385474482,ZFYVE9
12477,KEGG_2019_Human,Endocytosis,1/244,0.0121998870519305,0.0121998870519305,0,0,19756.0,87051.4275316661,ZFYVE9
12478,KEGG_2019_Human,ECM-receptor interaction,1/82,0.004099940929819,0.004099940929819,0,0,19918.0,109484.9180722932,CD47
12479,KEGG_2019_Human,Spliceosome,1/134,0.0066999199497742,0.0066999199497742,0,0,19866.0,99442.43560916925,SNRPC
12480,KEGG_2019_Human,Ether lipid metabolism,1/47,0.0023499589392381,0.0023499589392381,0,0,19953.0,120782.64067395544,PAFAH2
12481,KEGG_2019_Human,Arrhythmogenic right ventricular cardiomyopathy (ARVC),1/72,0.0035999456502131,0.0102373580412072,0,0,19928.0,112131.59838572376,ITGA9
12482,KEGG_2019_Human,ECM-receptor interaction,1/82,0.004099940929819,0.0102373580412072,0,0,19918.0,109484.9180722932,ITGA9
12483,KEGG_2019_Human,Hypertrophic cardiomyopathy (HCM),1/85,0.004249939567045,0.0102373580412072,0,0,19915.0,108752.83801948265,ITGA9
12484,KEGG_2019_Human,Dilated cardiomyopathy (DCM),1/91,0.0045499369072032,0.0102373580412072,0,0,19909.0,107362.10783923086,ITGA9
12485,KEGG_2019_Human,Cell adhesion molecules (CAMs),1/145,0.0072499160871101,0.0130498489567983,0,0,19855.0,97820.92670675044,ITGA9
12486,KEGG_2019_Human,Focal adhesion,1/199,0.0099498991610159,0.0137570077946658,0,0,19801.0,91286.4288690606,ITGA9
12487,KEGG_2019_Human,Regulation of actin cytoskeleton,1/214,0.0106998949514067,0.0137570077946658,0,0,19786.0,89779.39753374986,ITGA9
12488,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0176998626413668,0,0,19670.0,80733.60565076157,ITGA9
12489,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0176998626413668,0,0,19646.0,79255.8617626126,ITGA9
12490,KEGG_2019_Human,Retinol metabolism,1/67,0.0033499481224912,0.0033499481224912,0,0,19933.0,113594.38808369274,PNPLA4
12491,KEGG_2019_Human,Mucin type O-glycan biosynthesis,1/31,0.0015499690656704,0.0015499690656704,0,0,19969.0,129189.85098816035,GALNT10
12492,KEGG_2019_Human,Regulation of actin cytoskeleton,1/214,0.0106998949514067,0.0106998949514067,0,0,19786.0,89779.39753374986,ARHGEF7
12493,KEGG_2019_Human,Galactose metabolism,1/31,0.0015499690656704,0.0075349107677416,0,0,19969.0,129189.85098816035,G6PC2
12494,KEGG_2019_Human,Starch and sucrose metabolism,1/36,0.0017999657178272,0.0075349107677416,0,0,19964.0,126172.23364250171,G6PC2
12495,KEGG_2019_Human,Carbohydrate digestion and absorption,1/44,0.0021999607179423,0.0075349107677416,0,0,19956.0,122117.06559109331,G6PC2
12496,KEGG_2019_Human,Glycolysis / Gluconeogenesis,1/68,0.0033999476216189,0.0075349107677416,0,0,19932.0,113293.39338050144,G6PC2
12497,KEGG_2019_Human,Adipocytokine signaling pathway,1/69,0.003449947123837,0.0075349107677416,0,0,19931.0,112996.7391397682,G6PC2
12498,KEGG_2019_Human,Glucagon signaling pathway,1/103,0.0051499318302617,0.0075349107677416,0,0,19897.0,104832.7525292024,G6PC2
12499,KEGG_2019_Human,Insulin resistance,1/108,0.0053999298011749,0.0075349107677416,0,0,19892.0,103863.47861844616,G6PC2
12500,KEGG_2019_Human,AMPK signaling pathway,1/120,0.0059999251180858,0.0075349107677416,0,0,19880.0,101706.2448082016,G6PC2
12501,KEGG_2019_Human,FoxO signaling pathway,1/132,0.0065999206698993,0.0075349107677416,0,0,19868.0,99751.22090491928,G6PC2
12502,KEGG_2019_Human,Insulin signaling pathway,1/137,0.0068499188797651,0.0075349107677416,0,0,19863.0,98987.62735269018,G6PC2
12503,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0176998626413668,0,0,19646.0,79255.8617626126,G6PC2
12504,KEGG_2019_Human,Transcriptional misregulation in cancer,1/186,0.0092999029651357,0.0092999029651357,0,0,19814.0,92684.96451050608,JMJD1C
12505,KEGG_2019_Human,Rheumatoid arthritis,1/91,0.0045499369072032,0.0142873256165057,0,0,19909.0,107362.10783923086,CSF1
12506,KEGG_2019_Human,Hematopoietic cell lineage,1/97,0.0048499343304706,0.0142873256165057,0,0,19903.0,106058.9096435903,CSF1
12507,KEGG_2019_Human,TNF signaling pathway,1/110,0.0054999290027479,0.0142873256165057,0,0,19890.0,103488.06969787036,CSF1
12508,KEGG_2019_Human,Osteoclast differentiation,1/127,0.0063499224962247,0.0142873256165057,0,0,19873.0,100543.72072014232,CSF1
12509,KEGG_2019_Human,Rap1 signaling pathway,1/206,0.010299897173561,0.016593609322857,0,0,19794.0,90569.849337325,CSF1
12510,KEGG_2019_Human,Ras signaling pathway,1/232,0.0115998901349604,0.016593609322857,0,0,19768.0,88101.22480150245,CSF1
12511,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.016593609322857,0,0,19706.0,83157.67014793828,CSF1
12512,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.016593609322857,0,0,19705.0,83086.53988020132,CSF1
12513,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0176998626413668,0,0,19646.0,79255.8617626126,CSF1
12514,KEGG_2019_Human,Ascorbate and aldarate metabolism,1/27,0.0013499718942362,0.004685646776936,0,0,19973.0,131975.02298599784,UGT2A1
12515,KEGG_2019_Human,Pentose and glucuronate interconversions,1/34,0.0016999670339032,0.004685646776936,0,0,19966.0,127326.1054203148,UGT2A1
12516,KEGG_2019_Human,Porphyrin and chlorophyll metabolism,1/42,0.0020999619311272,0.004685646776936,0,0,19958.0,123057.75613441122,UGT2A1
12517,KEGG_2019_Human,Steroid hormone biosynthesis,1/60,0.002999951725986,0.004685646776936,0,0,19940.0,115834.63209072244,UGT2A1
12518,KEGG_2019_Human,Retinol metabolism,1/67,0.0033499481224912,0.004685646776936,0,0,19933.0,113594.38808369274,UGT2A1
12519,KEGG_2019_Human,Metabolism of xenobiotics by cytochrome P450,1/74,0.0036999446830449,0.004685646776936,0,0,19926.0,111574.38983110404,UGT2A1
12520,KEGG_2019_Human,Chemical carcinogenesis,1/82,0.004099940929819,0.004685646776936,0,0,19918.0,109484.9180722932,UGT2A1
12521,KEGG_2019_Human,Drug metabolism,1/108,0.0053999298011749,0.0053999298011749,0,0,19892.0,103863.47861844616,UGT2A1
12522,KEGG_2019_Human,Notch signaling pathway,1/48,0.0023999583567988,0.0128623519531469,0,0,19952.0,120356.5272753826,NOTCH2
12523,KEGG_2019_Human,Th1 and Th2 cell differentiation,1/92,0.0045999364719865,0.0128623519531469,0,0,19908.0,107139.13814408927,NOTCH2
12524,KEGG_2019_Human,Thyroid hormone signaling pathway,1/116,0.0057999266512085,0.0128623519531469,0,0,19884.0,102400.8105961506,NOTCH2
12525,KEGG_2019_Human,Breast cancer,1/147,0.0073499154017982,0.0128623519531469,0,0,19853.0,97539.10874372096,NOTCH2
12526,KEGG_2019_Human,MicroRNAs in cancer,1/299,0.0149498740670514,0.0192498453687919,0,0,19701.0,82804.33538735632,NOTCH2
12527,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0192498453687919,0,0,19670.0,80733.60565076157,NOTCH2
12528,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,NOTCH2
12529,KEGG_2019_Human,Glutathione metabolism,1/56,0.0027999538675741,0.0094498771520562,0,0,19944.0,117233.87022514464,GSTM1
12530,KEGG_2019_Human,Metabolism of xenobiotics by cytochrome P450,1/74,0.0036999446830449,0.0094498771520562,0,0,19926.0,111574.38983110404,GSTM1
12531,KEGG_2019_Human,Chemical carcinogenesis,1/82,0.004099940929819,0.0094498771520562,0,0,19918.0,109484.9180722932,GSTM1
12532,KEGG_2019_Human,Drug metabolism,1/108,0.0053999298011749,0.0094498771520562,0,0,19892.0,103863.47861844616,GSTM1
12533,KEGG_2019_Human,Fluid shear stress and atherosclerosis,1/139,0.006949918172816,0.0097298854419424,0,0,19861.0,98689.81333375497,GSTM1
12534,KEGG_2019_Human,Hepatocellular carcinoma,1/168,0.0083999085011095,0.0097998932512944,0,0,19832.0,94787.72752807094,GSTM1
12535,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,GSTM1
12536,KEGG_2019_Human,Regulation of lipolysis in adipocytes,1/55,0.0027499544131125,0.0080832238841178,0,0,19945.0,117599.1294878737,PRKG2
12537,KEGG_2019_Human,Long-term depression,1/60,0.002999951725986,0.0080832238841178,0,0,19940.0,115834.63209072244,PRKG2
12538,KEGG_2019_Human,Renin secretion,1/69,0.003449947123837,0.0080832238841178,0,0,19931.0,112996.7391397682,PRKG2
12539,KEGG_2019_Human,Gap junction,1/88,0.0043999382262822,0.0080832238841178,0,0,19912.0,108045.79305232369,PRKG2
12540,KEGG_2019_Human,Salivary secretion,1/90,0.0044999373439762,0.0080832238841178,0,0,19910.0,107587.50385474482,PRKG2
12541,KEGG_2019_Human,Circadian entrainment,1/97,0.0048499343304706,0.0080832238841178,0,0,19903.0,106058.9096435903,PRKG2
12542,KEGG_2019_Human,Platelet activation,1/124,0.0061999236097501,0.0088570337282144,0,0,19876.0,101034.04709010696,PRKG2
12543,KEGG_2019_Human,cGMP-PKG signaling pathway,1/166,0.0082999091363732,0.0103748864204666,0,0,19834.0,95034.82345515196,PRKG2
12544,KEGG_2019_Human,Thermogenesis,1/231,0.0115498903940656,0.0128332115489617,0,0,19769.0,88191.07730937863,PRKG2
12545,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,PRKG2
12546,KEGG_2019_Human,mRNA surveillance pathway,1/91,0.0045499369072032,0.0045499369072032,0,0,19909.0,107362.10783923086,MSI1
12547,KEGG_2019_Human,Legionellosis,1/55,0.0027499544131125,0.0090936268696325,0,0,19945.0,117599.1294878737,ITGAM
12548,KEGG_2019_Human,Acute myeloid leukemia,1/66,0.003299948626608,0.0090936268696325,0,0,19934.0,113899.85357353876,ITGAM
12549,KEGG_2019_Human,Staphylococcus aureus infection,1/68,0.0033999476216189,0.0090936268696325,0,0,19932.0,113293.39338050144,ITGAM
12550,KEGG_2019_Human,Leishmaniasis,1/74,0.0036999446830449,0.0090936268696325,0,0,19926.0,111574.38983110404,ITGAM
12551,KEGG_2019_Human,Pertussis,1/76,0.0037999437281752,0.0090936268696325,0,0,19924.0,111031.8499691117,ITGAM
12552,KEGG_2019_Human,Complement and coagulation cascades,1/79,0.0039499423167337,0.0090936268696325,0,0,19921.0,110243.89578070649,ITGAM
12553,KEGG_2019_Human,Amoebiasis,1/96,0.0047999347538706,0.0090936268696325,0,0,19904.0,106270.50039849174,ITGAM
12554,KEGG_2019_Human,Hematopoietic cell lineage,1/97,0.0048499343304706,0.0090936268696325,0,0,19903.0,106058.9096435903,ITGAM
12555,KEGG_2019_Human,Leukocyte transendothelial migration,1/112,0.0055999282120529,0.0093332136867549,0,0,19888.0,103119.30984392198,ITGAM
12556,KEGG_2019_Human,Cell adhesion molecules (CAMs),1/145,0.0072499160871101,0.010363518697496,0,0,19855.0,97820.92670675044,ITGAM
12557,KEGG_2019_Human,Phagosome,1/152,0.0075999137114971,0.010363518697496,0,0,19848.0,96850.665715497,ITGAM
12558,KEGG_2019_Human,Tuberculosis,1/179,0.0089499050800561,0.0106998949514067,0,0,19821.0,93478.0629355712,ITGAM
12559,KEGG_2019_Human,Transcriptional misregulation in cancer,1/186,0.0092999029651357,0.0106998949514067,0,0,19814.0,92684.96451050608,ITGAM
12560,KEGG_2019_Human,Rap1 signaling pathway,1/206,0.010299897173561,0.0106998949514067,0,0,19794.0,90569.849337325,ITGAM
12561,KEGG_2019_Human,Regulation of actin cytoskeleton,1/214,0.0106998949514067,0.0106998949514067,0,0,19786.0,89779.39753374986,ITGAM
12562,KEGG_2019_Human,"Phenylalanine, tyrosine and tryptophan biosynthesis",1/5,0.0002499917995416556,0.0007499753986249669,0,0,19995.0,165840.17843725558,PAH
12563,KEGG_2019_Human,Phenylalanine metabolism,1/17,0.0008499797390404818,0.0012749696085607,0,0,19983.0,141285.76583697114,PAH
12564,KEGG_2019_Human,Folate biosynthesis,1/26,0.0012999726251831,0.0012999726251831,0,0,19974.0,132735.46073187632,PAH
12565,KEGG_2019_Human,Fatty acid biosynthesis,1/13,0.0006499833083207112,0.0025999332332828,0,0,19987.0,146675.87616784443,ACSBG1
12566,KEGG_2019_Human,Fatty acid degradation,1/44,0.0021999607179423,0.0036999446830449,0,0,19956.0,122117.06559109331,ACSBG1
12567,KEGG_2019_Human,Adipocytokine signaling pathway,1/69,0.003449947123837,0.0036999446830449,0,0,19931.0,112996.7391397682,ACSBG1
12568,KEGG_2019_Human,PPAR signaling pathway,1/74,0.0036999446830449,0.0036999446830449,0,0,19926.0,111574.38983110404,ACSBG1
12569,KEGG_2019_Human,Central carbon metabolism in cancer,1/65,0.003249949134407,0.0064998982688141,0,0,19935.0,114209.92613860144,SLC7A5
12570,KEGG_2019_Human,mTOR signaling pathway,1/152,0.0075999137114971,0.0075999137114971,0,0,19848.0,96850.665715497,SLC7A5
12571,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR2M3
12572,KEGG_2019_Human,B cell receptor signaling pathway,1/71,0.0035499461386618,0.0035499461386618,0,0,19929.0,112415.9585341616,IFITM1
12573,KEGG_2019_Human,Purine metabolism,1/129,0.006449921761047,0.006449921761047,0,0,19871.0,100223.109907462,AMPD3
12574,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF200
12575,KEGG_2019_Human,Huntington disease,1/193,0.0096499008972596,0.0096499008972596,0,0,19807.0,91920.47679471428,TGM2
12576,KEGG_2019_Human,Base excision repair,1/33,0.0016499677032113,0.0016499677032113,0,0,19967.0,127928.56031580272,NEIL1
12577,KEGG_2019_Human,Cytosolic DNA-sensing pathway,1/63,0.0031499501598827,0.0062999003197655,0,0,19937.0,114844.46974572667,AIM2
12578,KEGG_2019_Human,NOD-like receptor signaling pathway,1/178,0.0088999053857096,0.0088999053857096,0,0,19822.0,93593.82745769851,AIM2
12579,KEGG_2019_Human,Transcriptional misregulation in cancer,1/186,0.0092999029651357,0.0092999029651357,0,0,19814.0,92684.96451050608,EYA1
12580,KEGG_2019_Human,Hippo signaling pathway,1/160,0.0079999110688441,0.0079999110688441,0,0,19840.0,95793.96509856998,TEAD4
12581,KEGG_2019_Human,Homologous recombination,1/41,0.0020499625466866,0.0020499625466866,0,0,19959.0,123544.88783416104,RAD54B
12582,KEGG_2019_Human,Rap1 signaling pathway,1/206,0.010299897173561,0.010299897173561,0,0,19794.0,90569.849337325,SIPA1L2
12583,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,PTH2R
12584,KEGG_2019_Human,Ferroptosis,1/40,0.0019999631680592,0.0020999619311272,0,0,19960.0,124043.94523066044,CP
12585,KEGG_2019_Human,Porphyrin and chlorophyll metabolism,1/42,0.0020999619311272,0.0020999619311272,0,0,19958.0,123057.75613441122,CP
12586,KEGG_2019_Human,Synthesis and degradation of ketone bodies,1/10,0.0004999862257578379,0.0014999586772735,0,0,19990.0,151942.5908680334,OXCT2
12587,KEGG_2019_Human,Butanoate metabolism,1/28,0.0013999711732997,0.0020999567599496,0,0,19972.0,131242.0761597353,OXCT2
12588,KEGG_2019_Human,"Valine, leucine and isoleucine degradation",1/48,0.0023999583567988,0.0023999583567988,0,0,19952.0,120356.5272753826,OXCT2
12589,KEGG_2019_Human,Transcriptional misregulation in cancer,1/186,0.0092999029651357,0.0092999029651357,0,0,19814.0,92684.96451050608,SIX4
12590,KEGG_2019_Human,Ribosome,1/153,0.0076499133771537,0.0076499133771537,0,0,19847.0,96715.6407630817,RPS4Y2
12591,KEGG_2019_Human,Vascular smooth muscle contraction,1/132,0.0065999206698993,0.0131998413397987,0,0,19868.0,99751.22090491928,CALCA
12592,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,CALCA
12593,KEGG_2019_Human,Salivary secretion,1/90,0.0044999373439762,0.0044999373439762,0,0,19910.0,107587.50385474482,CST2
12594,KEGG_2019_Human,Glycosaminoglycan biosynthesis,1/53,0.0026499555173137,0.0026499555173137,0,0,19947.0,118349.78824235698,CHST1
12595,KEGG_2019_Human,B cell receptor signaling pathway,1/71,0.0035499461386618,0.0064665791072942,0,0,19929.0,112415.9585341616,CR2
12596,KEGG_2019_Human,Complement and coagulation cascades,1/79,0.0039499423167337,0.0064665791072942,0,0,19921.0,110243.89578070649,CR2
12597,KEGG_2019_Human,Hematopoietic cell lineage,1/97,0.0048499343304706,0.0064665791072942,0,0,19903.0,106058.9096435903,CR2
12598,KEGG_2019_Human,Epstein-Barr virus infection,1/201,0.0100498985877989,0.0100498985877989,0,0,19799.0,91079.21596609056,CR2
12599,KEGG_2019_Human,Fatty acid elongation,1/27,0.0013499718942362,0.0027428095506272,0,0,19973.0,131975.02298599784,ECHS1
12600,KEGG_2019_Human,Butanoate metabolism,1/28,0.0013999711732997,0.0027428095506272,0,0,19972.0,131242.0761597353,ECHS1
12601,KEGG_2019_Human,beta-Alanine metabolism,1/31,0.0015499690656704,0.0027428095506272,0,0,19969.0,129189.85098816035,ECHS1
12602,KEGG_2019_Human,Propanoate metabolism,1/32,0.0015999683804467,0.0027428095506272,0,0,19968.0,128549.41955786056,ECHS1
12603,KEGG_2019_Human,Tryptophan metabolism,1/42,0.0020999619311272,0.0027428095506272,0,0,19958.0,123057.75613441122,ECHS1
12604,KEGG_2019_Human,Fatty acid degradation,1/44,0.0021999607179423,0.0027428095506272,0,0,19956.0,122117.06559109331,ECHS1
12605,KEGG_2019_Human,"Valine, leucine and isoleucine degradation",1/48,0.0023999583567988,0.0027428095506272,0,0,19952.0,120356.5272753826,ECHS1
12606,KEGG_2019_Human,Lysine degradation,1/59,0.0029499522555206,0.0029499522555206,0,0,19941.0,116175.59385530632,ECHS1
12607,KEGG_2019_Human,Hedgehog signaling pathway,1/47,0.0023499589392381,0.010829882903967,0,0,19953.0,120782.64067395544,GSK3B
12608,KEGG_2019_Human,Endometrial cancer,1/58,0.0028999527887707,0.010829882903967,0,0,19942.0,116522.31890946148,GSK3B
12609,KEGG_2019_Human,Basal cell carcinoma,1/63,0.0031499501598827,0.010829882903967,0,0,19937.0,114844.46974572667,GSK3B
12610,KEGG_2019_Human,Prolactin signaling pathway,1/70,0.0034999466296654,0.010829882903967,0,0,19930.0,112704.30065625212,GSK3B
12611,KEGG_2019_Human,B cell receptor signaling pathway,1/71,0.0035499461386618,0.010829882903967,0,0,19929.0,112415.9585341616,GSK3B
12612,KEGG_2019_Human,ErbB signaling pathway,1/85,0.004249939567045,0.010829882903967,0,0,19915.0,108752.83801948265,GSK3B
12613,KEGG_2019_Human,Colorectal cancer,1/86,0.0042999391173866,0.010829882903967,0,0,19914.0,108514.46102290176,GSK3B
12614,KEGG_2019_Human,IL-17 signaling pathway,1/93,0.0046499360391879,0.010829882903967,0,0,19907.0,106918.54242106884,GSK3B
12615,KEGG_2019_Human,Prostate cancer,1/97,0.0048499343304706,0.010829882903967,0,0,19903.0,106058.9096435903,GSK3B
12616,KEGG_2019_Human,T cell receptor signaling pathway,1/101,0.0050499326546803,0.010829882903967,0,0,19899.0,105233.48101229242,GSK3B
12617,KEGG_2019_Human,Melanogenesis,1/101,0.0050499326546803,0.010829882903967,0,0,19899.0,105233.48101229242,GSK3B
12618,KEGG_2019_Human,Insulin resistance,1/108,0.0053999298011749,0.010829882903967,0,0,19892.0,103863.47861844616,GSK3B
12619,KEGG_2019_Human,Thyroid hormone signaling pathway,1/116,0.0057999266512085,0.010829882903967,0,0,19884.0,102400.8105961506,GSK3B
12620,KEGG_2019_Human,Neurotrophin signaling pathway,1/119,0.0059499254985137,0.010829882903967,0,0,19881.0,101877.73080211312,GSK3B
12621,KEGG_2019_Human,Cell cycle,1/124,0.0061999236097501,0.010829882903967,0,0,19876.0,101034.04709010696,GSK3B
12622,KEGG_2019_Human,Dopaminergic synapse,1/131,0.0065499210316603,0.010829882903967,0,0,19869.0,99907.33811343512,GSK3B
12623,KEGG_2019_Human,Insulin signaling pathway,1/137,0.0068499188797651,0.010829882903967,0,0,19863.0,98987.62735269018,GSK3B
12624,KEGG_2019_Human,Measles,1/138,0.0068999185254481,0.010829882903967,0,0,19862.0,98838.19160389496,GSK3B
12625,KEGG_2019_Human,Signaling pathways regulating pluripotency of stem cells,1/139,0.006949918172816,0.010829882903967,0,0,19861.0,98689.81333375497,GSK3B
12626,KEGG_2019_Human,Breast cancer,1/147,0.0073499154017982,0.010829882903967,0,0,19853.0,97539.10874372096,GSK3B
12627,KEGG_2019_Human,Gastric cancer,1/149,0.0074499147221605,0.010829882903967,0,0,19851.0,97261.02051561224,GSK3B
12628,KEGG_2019_Human,Non-alcoholic fatty liver disease (NAFLD),1/149,0.0074499147221605,0.010829882903967,0,0,19851.0,97261.02051561224,GSK3B
12629,KEGG_2019_Human,mTOR signaling pathway,1/152,0.0075999137114971,0.010829882903967,0,0,19848.0,96850.665715497,GSK3B
12630,KEGG_2019_Human,Cushing syndrome,1/155,0.0077499127120574,0.010829882903967,0,0,19845.0,96448.16254952336,GSK3B
12631,KEGG_2019_Human,Hepatitis C,1/155,0.0077499127120574,0.010829882903967,0,0,19845.0,96448.16254952336,GSK3B
12632,KEGG_2019_Human,Wnt signaling pathway,1/158,0.0078999117225733,0.010829882903967,0,0,19842.0,96053.2110949472,GSK3B
12633,KEGG_2019_Human,Hippo signaling pathway,1/160,0.0079999110688441,0.010829882903967,0,0,19840.0,95793.96509856998,GSK3B
12634,KEGG_2019_Human,Hepatocellular carcinoma,1/168,0.0083999085011095,0.010829882903967,0,0,19832.0,94787.72752807094,GSK3B
12635,KEGG_2019_Human,Influenza A,1/171,0.0085499075557634,0.010829882903967,0,0,19829.0,94422.42241345016,GSK3B
12636,KEGG_2019_Human,Alzheimer disease,1/171,0.0085499075557634,0.010829882903967,0,0,19829.0,94422.42241345016,GSK3B
12637,KEGG_2019_Human,Axon guidance,1/181,0.0090499044707863,0.010939280836654,0,0,19819.0,93248.41634586031,GSK3B
12638,KEGG_2019_Human,Kaposi sarcoma-associated herpesvirus infection,1/186,0.0092999029651357,0.010939280836654,0,0,19814.0,92684.96451050608,GSK3B
12639,KEGG_2019_Human,Chemokine signaling pathway,1/190,0.0094999017791995,0.010939280836654,0,0,19810.0,92244.74636351672,GSK3B
12640,KEGG_2019_Human,Focal adhesion,1/199,0.0099498991610159,0.0111204755329001,0,0,19801.0,91286.4288690606,GSK3B
12641,KEGG_2019_Human,Human cytomegalovirus infection,1/225,0.0112498919790339,0.0122141684343796,0,0,19775.0,88738.27077557483,GSK3B
12642,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0174165267622403,0,0,19670.0,80733.60565076157,GSK3B
12643,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0181782373073497,0,0,19646.0,79255.8617626126,GSK3B
12644,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,GSK3B
12645,KEGG_2019_Human,Proximal tubule bicarbonate reclamation,1/23,0.0011499748819949,0.0062999150247102,0,0,19977.0,135204.63922267244,ATP1A4
12646,KEGG_2019_Human,Aldosterone-regulated sodium reabsorption,1/37,0.0018499650702878,0.0062999150247102,0,0,19963.0,125618.9446446357,ATP1A4
12647,KEGG_2019_Human,Carbohydrate digestion and absorption,1/44,0.0021999607179423,0.0062999150247102,0,0,19956.0,122117.06559109331,ATP1A4
12648,KEGG_2019_Human,Endocrine and other factor-regulated calcium reabsorption,1/48,0.0023999583567988,0.0062999150247102,0,0,19952.0,120356.5272753826,ATP1A4
12649,KEGG_2019_Human,Mineral absorption,1/51,0.0025499566390179,0.0062999150247102,0,0,19949.0,119129.0228601236,ATP1A4
12650,KEGG_2019_Human,Bile secretion,1/72,0.0035999456502131,0.0062999150247102,0,0,19928.0,112131.59838572376,ATP1A4
12651,KEGG_2019_Human,Thyroid hormone synthesis,1/74,0.0036999446830449,0.0062999150247102,0,0,19926.0,111574.38983110404,ATP1A4
12652,KEGG_2019_Human,Gastric acid secretion,1/75,0.0037499442041125,0.0062999150247102,0,0,19925.0,111301.33528642564,ATP1A4
12653,KEGG_2019_Human,Cardiac muscle contraction,1/78,0.0038999427840466,0.0062999150247102,0,0,19922.0,110503.2180492851,ATP1A4
12654,KEGG_2019_Human,Insulin secretion,1/86,0.0042999391173866,0.0062999150247102,0,0,19914.0,108514.46102290176,ATP1A4
12655,KEGG_2019_Human,Salivary secretion,1/90,0.0044999373439762,0.0062999150247102,0,0,19910.0,107587.50385474482,ATP1A4
12656,KEGG_2019_Human,Protein digestion and absorption,1/90,0.0044999373439762,0.0062999150247102,0,0,19910.0,107587.50385474482,ATP1A4
12657,KEGG_2019_Human,Pancreatic secretion,1/98,0.0048999339081079,0.0062999150247102,0,0,19902.0,105849.45495286948,ATP1A4
12658,KEGG_2019_Human,Aldosterone synthesis and secretion,1/98,0.0048999339081079,0.0062999150247102,0,0,19902.0,105849.45495286948,ATP1A4
12659,KEGG_2019_Human,Thyroid hormone signaling pathway,1/116,0.0057999266512085,0.0069599119814502,0,0,19884.0,102400.8105961506,ATP1A4
12660,KEGG_2019_Human,Adrenergic signaling in cardiomyocytes,1/145,0.0072499160871101,0.0081561555979989,0,0,19855.0,97820.92670675044,ATP1A4
12661,KEGG_2019_Human,cGMP-PKG signaling pathway,1/166,0.0082999091363732,0.0087881390855717,0,0,19834.0,95034.82345515196,ATP1A4
12662,KEGG_2019_Human,cAMP signaling pathway,1/212,0.0105998955026255,0.0105998955026255,0,0,19788.0,89974.27756224656,ATP1A4
12663,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR6C4
12664,KEGG_2019_Human,Cellular senescence,1/160,0.0079999110688441,0.0079999110688441,0,0,19840.0,95793.96509856998,LIN9
12665,KEGG_2019_Human,Taste transduction,1/83,0.0041499404726918,0.0041499404726918,0,0,19917.0,109237.99888847338,TAS2R14
12666,KEGG_2019_Human,Hippo signaling pathway,1/160,0.0079999110688441,0.0079999110688441,0,0,19840.0,95793.96509856998,AJUBA
12667,KEGG_2019_Human,Fanconi anemia pathway,1/54,0.0026999549628563,0.0026999549628563,0,0,19946.0,117971.01964061816,SLX4
12668,KEGG_2019_Human,Axon guidance,1/181,0.0090499044707863,0.0090499044707863,0,0,19819.0,93248.41634586031,DPYSL2
12669,KEGG_2019_Human,Homologous recombination,1/41,0.0020499625466866,0.0020499625466866,0,0,19959.0,123544.88783416104,ABRAXAS1
12670,KEGG_2019_Human,Vascular smooth muscle contraction,1/132,0.0065999206698993,0.01253320316018,0,0,19868.0,99751.22090491928,AVPR1B
12671,KEGG_2019_Human,Phospholipase D signaling pathway,1/148,0.007399915061391,0.01253320316018,0,0,19852.0,97399.60470052566,AVPR1B
12672,KEGG_2019_Human,Calcium signaling pathway,1/188,0.009399902370135,0.01253320316018,0,0,19812.0,92463.712994847,AVPR1B
12673,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,AVPR1B
12674,KEGG_2019_Human,Primary immunodeficiency,1/37,0.0018499650702878,0.005999895891997,0,0,19963.0,125618.9446446357,TNFRSF13C
12675,KEGG_2019_Human,Intestinal immune network for IgA production,1/48,0.0023999583567988,0.005999895891997,0,0,19952.0,120356.5272753826,TNFRSF13C
12676,KEGG_2019_Human,NF-kappa B signaling pathway,1/95,0.0047499351803394,0.007916558633899,0,0,19905.0,106484.27183626965,TNFRSF13C
12677,KEGG_2019_Human,Human T-cell leukemia virus 1 infection,1/219,0.0109498935894162,0.0136873669867703,0,0,19781.0,89299.85161916987,TNFRSF13C
12678,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0146998751759735,0,0,19706.0,83157.67014793828,TNFRSF13C
12679,KEGG_2019_Human,ECM-receptor interaction,1/82,0.004099940929819,0.004099940929819,0,0,19918.0,109484.9180722932,SV2A
12680,KEGG_2019_Human,Peroxisome,1/83,0.0041499404726918,0.0041499404726918,0,0,19917.0,109237.99888847338,PXMP2
12681,KEGG_2019_Human,Phototransduction,1/28,0.0013999711732997,0.0024499577795033,0,0,19972.0,131242.0761597353,RGS9
12682,KEGG_2019_Human,Cocaine addiction,1/49,0.0024499577795033,0.0024499577795033,0,0,19951.0,119939.1172087114,RGS9
12683,KEGG_2019_Human,Dopaminergic synapse,1/131,0.0065499210316603,0.0130998420633206,0,0,19869.0,99907.33811343512,DRD3
12684,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,DRD3
12685,KEGG_2019_Human,Other types of O-glycan biosynthesis,1/22,0.0010999756574123,0.0010999756574123,0,0,19978.0,136099.47030191717,GXYLT2
12686,KEGG_2019_Human,"Alanine, aspartate and glutamate metabolism",1/35,0.0017499663721595,0.0023999583567988,0,0,19965.0,126740.98858805298,AGXT2
12687,KEGG_2019_Human,"Glycine, serine and threonine metabolism",1/40,0.0019999631680592,0.0023999583567988,0,0,19960.0,124043.94523066044,AGXT2
12688,KEGG_2019_Human,Cysteine and methionine metabolism,1/47,0.0023499589392381,0.0023999583567988,0,0,19953.0,120782.64067395544,AGXT2
12689,KEGG_2019_Human,"Valine, leucine and isoleucine degradation",1/48,0.0023999583567988,0.0023999583567988,0,0,19952.0,120356.5272753826,AGXT2
12690,KEGG_2019_Human,Spliceosome,1/134,0.0066999199497742,0.0066999199497742,0,0,19866.0,99442.43560916925,XAB2
12691,KEGG_2019_Human,Focal adhesion,1/199,0.0099498991610159,0.0099498991610159,0,0,19801.0,91286.4288690606,PARVA
12692,KEGG_2019_Human,Glycosaminoglycan biosynthesis,1/53,0.0026499555173137,0.0026499555173137,0,0,19947.0,118349.78824235698,CHSY3
12693,KEGG_2019_Human,Malaria,1/49,0.0024499577795033,0.0024499577795033,0,0,19951.0,119939.1172087114,GYPB
12694,KEGG_2019_Human,Epstein-Barr virus infection,1/201,0.0100498985877989,0.0149498740670514,0,0,19799.0,91079.21596609056,VIM
12695,KEGG_2019_Human,MicroRNAs in cancer,1/299,0.0149498740670514,0.0149498740670514,0,0,19701.0,82804.33538735632,VIM
12696,KEGG_2019_Human,Focal adhesion,1/199,0.0099498991610159,0.0099498991610159,0,0,19801.0,91286.4288690606,ZYX
12697,KEGG_2019_Human,Glycosylphosphatidylinositol (GPI)-anchor biosynthesis,1/25,0.0012499733663791,0.0012499733663791,0,0,19975.0,133525.54486996148,PIGU
12698,KEGG_2019_Human,p53 signaling pathway,1/72,0.0035999456502131,0.0035999456502131,0,0,19928.0,112131.59838572376,RPRM
12699,KEGG_2019_Human,Adipocytokine signaling pathway,1/69,0.003449947123837,0.0133592467251027,0,0,19931.0,112996.7391397682,TRADD
12700,KEGG_2019_Human,RIG-I-like receptor signaling pathway,1/70,0.0034999466296654,0.0133592467251027,0,0,19930.0,112704.30065625212,TRADD
12701,KEGG_2019_Human,IL-17 signaling pathway,1/93,0.0046499360391879,0.0133592467251027,0,0,19907.0,106918.54242106884,TRADD
12702,KEGG_2019_Human,NF-kappa B signaling pathway,1/95,0.0047499351803394,0.0133592467251027,0,0,19905.0,106484.27183626965,TRADD
12703,KEGG_2019_Human,TNF signaling pathway,1/110,0.0054999290027479,0.0133592467251027,0,0,19890.0,103488.06969787036,TRADD
12704,KEGG_2019_Human,Sphingolipid signaling pathway,1/119,0.0059499254985137,0.0133592467251027,0,0,19881.0,101877.73080211312,TRADD
12705,KEGG_2019_Human,Measles,1/138,0.0068999185254481,0.0133592467251027,0,0,19862.0,98838.19160389496,TRADD
12706,KEGG_2019_Human,Apoptosis,1/143,0.0071499167770442,0.0133592467251027,0,0,19857.0,98106.57763600958,TRADD
12707,KEGG_2019_Human,Hepatitis C,1/155,0.0077499127120574,0.0133592467251027,0,0,19845.0,96448.16254952336,TRADD
12708,KEGG_2019_Human,Necroptosis,1/162,0.0080999104202618,0.0133592467251027,0,0,19838.0,95537.86936302872,TRADD
12709,KEGG_2019_Human,Tuberculosis,1/179,0.0089499050800561,0.0133592467251027,0,0,19821.0,93478.0629355712,TRADD
12710,KEGG_2019_Human,Kaposi sarcoma-associated herpesvirus infection,1/186,0.0092999029651357,0.0133592467251027,0,0,19814.0,92684.96451050608,TRADD
12711,KEGG_2019_Human,Viral carcinogenesis,1/201,0.0100498985877989,0.0133592467251027,0,0,19799.0,91079.21596609056,TRADD
12712,KEGG_2019_Human,Epstein-Barr virus infection,1/201,0.0100498985877989,0.0133592467251027,0,0,19799.0,91079.21596609056,TRADD
12713,KEGG_2019_Human,Human immunodeficiency virus 1 infection,1/212,0.0105998955026255,0.0133592467251027,0,0,19788.0,89974.27756224656,TRADD
12714,KEGG_2019_Human,Human cytomegalovirus infection,1/225,0.0112498919790339,0.0133592467251027,0,0,19775.0,88738.27077557483,TRADD
12715,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0164851543599625,0,0,19705.0,83086.53988020132,TRADD
12716,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0174165267622403,0,0,19670.0,80733.60565076157,TRADD
12717,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,TRADD
12718,KEGG_2019_Human,Porphyrin and chlorophyll metabolism,1/42,0.0020999619311272,0.0020999619311272,0,0,19958.0,123057.75613441122,FECH
12719,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR56B1
12720,KEGG_2019_Human,Progesterone-mediated oocyte maturation,1/99,0.0049499334884068,0.0085623985997064,0,0,19901.0,105642.09305076736,CDC23
12721,KEGG_2019_Human,Cell cycle,1/124,0.0061999236097501,0.0085623985997064,0,0,19876.0,101034.04709010696,CDC23
12722,KEGG_2019_Human,Oocyte meiosis,1/125,0.0062499232373748,0.0085623985997064,0,0,19875.0,100869.32368441945,CDC23
12723,KEGG_2019_Human,Ubiquitin mediated proteolysis,1/137,0.0068499188797651,0.0085623985997064,0,0,19863.0,98987.62735269018,CDC23
12724,KEGG_2019_Human,Human T-cell leukemia virus 1 infection,1/219,0.0109498935894162,0.0109498935894162,0,0,19781.0,89299.85161916987,CDC23
12725,KEGG_2019_Human,ErbB signaling pathway,1/85,0.004249939567045,0.004249939567045,0,0,19915.0,108752.83801948265,NRG3
12726,KEGG_2019_Human,"Valine, leucine and isoleucine degradation",1/48,0.0023999583567988,0.0023999583567988,0,0,19952.0,120356.5272753826,HIBADH
12727,KEGG_2019_Human,Vascular smooth muscle contraction,1/132,0.0065999206698993,0.0065999206698993,0,0,19868.0,99751.22090491928,RAMP3
12728,KEGG_2019_Human,Mitophagy,1/65,0.003249949134407,0.0063999221281459,0,0,19935.0,114209.92613860144,AMBRA1
12729,KEGG_2019_Human,Autophagy,1/128,0.0063999221281459,0.0063999221281459,0,0,19872.0,100382.8010329652,AMBRA1
12730,KEGG_2019_Human,Staphylococcus aureus infection,1/68,0.0033999476216189,0.0088665659967466,0,0,19932.0,113293.39338050144,FCGR2B
12731,KEGG_2019_Human,B cell receptor signaling pathway,1/71,0.0035499461386618,0.0088665659967466,0,0,19929.0,112415.9585341616,FCGR2B
12732,KEGG_2019_Human,Fc gamma R-mediated phagocytosis,1/91,0.0045499369072032,0.0088665659967466,0,0,19909.0,107362.10783923086,FCGR2B
12733,KEGG_2019_Human,Osteoclast differentiation,1/127,0.0063499224962247,0.0088665659967466,0,0,19873.0,100543.72072014232,FCGR2B
12734,KEGG_2019_Human,Measles,1/138,0.0068999185254481,0.0088665659967466,0,0,19862.0,98838.19160389496,FCGR2B
12735,KEGG_2019_Human,Phagosome,1/152,0.0075999137114971,0.0088665659967466,0,0,19848.0,96850.665715497,FCGR2B
12736,KEGG_2019_Human,Tuberculosis,1/179,0.0089499050800561,0.0089499050800561,0,0,19821.0,93478.0629355712,FCGR2B
12737,KEGG_2019_Human,"Parathyroid hormone synthesis, secretion and action",1/106,0.0052999306076525,0.0131998413397987,0,0,19894.0,104245.78450366124,ARHGEF11
12738,KEGG_2019_Human,Vascular smooth muscle contraction,1/132,0.0065999206698993,0.0131998413397987,0,0,19868.0,99751.22090491928,ARHGEF11
12739,KEGG_2019_Human,Human cytomegalovirus infection,1/225,0.0112498919790339,0.0149998559720452,0,0,19775.0,88738.27077557483,ARHGEF11
12740,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,ARHGEF11
12741,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF726
12742,KEGG_2019_Human,Estrogen signaling pathway,1/137,0.0068499188797651,0.0068499188797651,0,0,19863.0,98987.62735269018,KRT28
12743,KEGG_2019_Human,Base excision repair,1/33,0.0016499677032113,0.0049499031096341,0,0,19967.0,127928.56031580272,PARP4
12744,KEGG_2019_Human,Apoptosis,1/143,0.0071499167770442,0.0080999104202618,0,0,19857.0,98106.57763600958,PARP4
12745,KEGG_2019_Human,Necroptosis,1/162,0.0080999104202618,0.0080999104202618,0,0,19838.0,95537.86936302872,PARP4
12746,KEGG_2019_Human,Proteoglycans in cancer,1/201,0.0100498985877989,0.0100498985877989,0,0,19799.0,91079.21596609056,LUM
12747,KEGG_2019_Human,Amyotrophic lateral sclerosis (ALS),1/51,0.0025499566390179,0.0125734086824496,0,0,19949.0,119129.0228601236,BID
12748,KEGG_2019_Human,Viral myocarditis,1/59,0.0029499522555206,0.0125734086824496,0,0,19941.0,116175.59385530632,BID
12749,KEGG_2019_Human,p53 signaling pathway,1/72,0.0035999456502131,0.0125734086824496,0,0,19928.0,112131.59838572376,BID
12750,KEGG_2019_Human,Sphingolipid signaling pathway,1/119,0.0059499254985137,0.0125734086824496,0,0,19881.0,101877.73080211312,BID
12751,KEGG_2019_Human,Natural killer cell mediated cytotoxicity,1/131,0.0065499210316603,0.0125734086824496,0,0,19869.0,99907.33811343512,BID
12752,KEGG_2019_Human,Measles,1/138,0.0068999185254481,0.0125734086824496,0,0,19862.0,98838.19160389496,BID
12753,KEGG_2019_Human,Apoptosis,1/143,0.0071499167770442,0.0125734086824496,0,0,19857.0,98106.57763600958,BID
12754,KEGG_2019_Human,Non-alcoholic fatty liver disease (NAFLD),1/149,0.0074499147221605,0.0125734086824496,0,0,19851.0,97261.02051561224,BID
12755,KEGG_2019_Human,Hepatitis C,1/155,0.0077499127120574,0.0125734086824496,0,0,19845.0,96448.16254952336,BID
12756,KEGG_2019_Human,Necroptosis,1/162,0.0080999104202618,0.0125734086824496,0,0,19838.0,95537.86936302872,BID
12757,KEGG_2019_Human,Hepatitis B,1/163,0.0081499100978668,0.0125734086824496,0,0,19837.0,95410.9786681514,BID
12758,KEGG_2019_Human,Alzheimer disease,1/171,0.0085499075557634,0.0125734086824496,0,0,19829.0,94422.42241345016,BID
12759,KEGG_2019_Human,Tuberculosis,1/179,0.0089499050800561,0.0125734086824496,0,0,19821.0,93478.0629355712,BID
12760,KEGG_2019_Human,Kaposi sarcoma-associated herpesvirus infection,1/186,0.0092999029651357,0.0125734086824496,0,0,19814.0,92684.96451050608,BID
12761,KEGG_2019_Human,Epstein-Barr virus infection,1/201,0.0100498985877989,0.0125734086824496,0,0,19799.0,91079.21596609056,BID
12762,KEGG_2019_Human,Human immunodeficiency virus 1 infection,1/212,0.0105998955026255,0.0125734086824496,0,0,19788.0,89974.27756224656,BID
12763,KEGG_2019_Human,Human cytomegalovirus infection,1/225,0.0112498919790339,0.0125734086824496,0,0,19775.0,88738.27077557483,BID
12764,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0259664967007149,0,0,19508.0,72277.44006442746,BID
12765,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,BID
12766,KEGG_2019_Human,NF-kappa B signaling pathway,1/95,0.0047499351803394,0.0126998449924495,0,0,19905.0,106484.27183626965,RELB
12767,KEGG_2019_Human,C-type lectin receptor signaling pathway,1/104,0.0051999314202997,0.0126998449924495,0,0,19896.0,104635.24941415618,RELB
12768,KEGG_2019_Human,Osteoclast differentiation,1/127,0.0063499224962247,0.0126998449924495,0,0,19873.0,100543.72072014232,RELB
12769,KEGG_2019_Human,Epstein-Barr virus infection,1/201,0.0100498985877989,0.0131398723072995,0,0,19799.0,91079.21596609056,RELB
12770,KEGG_2019_Human,Human T-cell leukemia virus 1 infection,1/219,0.0109498935894162,0.0131398723072995,0,0,19781.0,89299.85161916987,RELB
12771,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0147498749536506,0,0,19705.0,83086.53988020132,RELB
12772,KEGG_2019_Human,Bladder cancer,1/41,0.0020499625466866,0.0120748684703449,0,0,19959.0,123544.88783416104,RB1
12773,KEGG_2019_Human,Non-small cell lung cancer,1/66,0.003299948626608,0.0120748684703449,0,0,19934.0,113899.85357353876,RB1
12774,KEGG_2019_Human,Melanoma,1/72,0.0035999456502131,0.0120748684703449,0,0,19928.0,112131.59838572376,RB1
12775,KEGG_2019_Human,Pancreatic cancer,1/75,0.0037499442041125,0.0120748684703449,0,0,19925.0,111301.33528642564,RB1
12776,KEGG_2019_Human,Glioma,1/75,0.0037499442041125,0.0120748684703449,0,0,19925.0,111301.33528642564,RB1
12777,KEGG_2019_Human,Chronic myeloid leukemia,1/76,0.0037999437281752,0.0120748684703449,0,0,19924.0,111031.8499691117,RB1
12778,KEGG_2019_Human,Small cell lung cancer,1/93,0.0046499360391879,0.0120748684703449,0,0,19907.0,106918.54242106884,RB1
12779,KEGG_2019_Human,Prostate cancer,1/97,0.0048499343304706,0.0120748684703449,0,0,19903.0,106058.9096435903,RB1
12780,KEGG_2019_Human,Cell cycle,1/124,0.0061999236097501,0.0120748684703449,0,0,19876.0,101034.04709010696,RB1
12781,KEGG_2019_Human,Breast cancer,1/147,0.0073499154017982,0.0120748684703449,0,0,19853.0,97539.10874372096,RB1
12782,KEGG_2019_Human,Gastric cancer,1/149,0.0074499147221605,0.0120748684703449,0,0,19851.0,97261.02051561224,RB1
12783,KEGG_2019_Human,Cushing syndrome,1/155,0.0077499127120574,0.0120748684703449,0,0,19845.0,96448.16254952336,RB1
12784,KEGG_2019_Human,Hepatitis C,1/155,0.0077499127120574,0.0120748684703449,0,0,19845.0,96448.16254952336,RB1
12785,KEGG_2019_Human,Cellular senescence,1/160,0.0079999110688441,0.0120748684703449,0,0,19840.0,95793.96509856998,RB1
12786,KEGG_2019_Human,Hepatitis B,1/163,0.0081499100978668,0.0120748684703449,0,0,19837.0,95410.9786681514,RB1
12787,KEGG_2019_Human,Hepatocellular carcinoma,1/168,0.0083999085011095,0.0120748684703449,0,0,19832.0,94787.72752807094,RB1
12788,KEGG_2019_Human,Kaposi sarcoma-associated herpesvirus infection,1/186,0.0092999029651357,0.0121656667115461,0,0,19814.0,92684.96451050608,RB1
12789,KEGG_2019_Human,Viral carcinogenesis,1/201,0.0100498985877989,0.0121656667115461,0,0,19799.0,91079.21596609056,RB1
12790,KEGG_2019_Human,Epstein-Barr virus infection,1/201,0.0100498985877989,0.0121656667115461,0,0,19799.0,91079.21596609056,RB1
12791,KEGG_2019_Human,Human T-cell leukemia virus 1 infection,1/219,0.0109498935894162,0.0123213102627514,0,0,19781.0,89299.85161916987,RB1
12792,KEGG_2019_Human,Human cytomegalovirus infection,1/225,0.0112498919790339,0.0123213102627514,0,0,19775.0,88738.27077557483,RB1
12793,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.017249861434372,0,0,19670.0,80733.60565076157,RB1
12794,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,RB1
12795,KEGG_2019_Human,Long-term potentiation,1/67,0.0033499481224912,0.0099998771797997,0,0,19933.0,113594.38808369274,RPS6KA6
12796,KEGG_2019_Human,Progesterone-mediated oocyte maturation,1/99,0.0049499334884068,0.0099998771797997,0,0,19901.0,105642.09305076736,RPS6KA6
12797,KEGG_2019_Human,Insulin resistance,1/108,0.0053999298011749,0.0099998771797997,0,0,19892.0,103863.47861844616,RPS6KA6
12798,KEGG_2019_Human,Neurotrophin signaling pathway,1/119,0.0059499254985137,0.0099998771797997,0,0,19881.0,101877.73080211312,RPS6KA6
12799,KEGG_2019_Human,Oocyte meiosis,1/125,0.0062499232373748,0.0099998771797997,0,0,19875.0,100869.32368441945,RPS6KA6
12800,KEGG_2019_Human,mTOR signaling pathway,1/152,0.0075999137114971,0.0101332182819961,0,0,19848.0,96850.665715497,RPS6KA6
12801,KEGG_2019_Human,Thermogenesis,1/231,0.0115498903940656,0.0131998747360749,0,0,19769.0,88191.07730937863,RPS6KA6
12802,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0147498749536506,0,0,19705.0,83086.53988020132,RPS6KA6
12803,KEGG_2019_Human,Primary immunodeficiency,1/37,0.0018499650702878,0.007916558633899,0,0,19963.0,125618.9446446357,BLNK
12804,KEGG_2019_Human,B cell receptor signaling pathway,1/71,0.0035499461386618,0.007916558633899,0,0,19929.0,112415.9585341616,BLNK
12805,KEGG_2019_Human,NF-kappa B signaling pathway,1/95,0.0047499351803394,0.007916558633899,0,0,19905.0,106484.27183626965,BLNK
12806,KEGG_2019_Human,Osteoclast differentiation,1/127,0.0063499224962247,0.0079374031202809,0,0,19873.0,100543.72072014232,BLNK
12807,KEGG_2019_Human,Epstein-Barr virus infection,1/201,0.0100498985877989,0.0100498985877989,0,0,19799.0,91079.21596609056,BLNK
12808,KEGG_2019_Human,Wnt signaling pathway,1/158,0.0078999117225733,0.0078999117225733,0,0,19842.0,96053.2110949472,DAAM1
12809,KEGG_2019_Human,Choline metabolism in cancer,1/99,0.0049499334884068,0.0124443061070909,0,0,19901.0,105642.09305076736,RHEB
12810,KEGG_2019_Human,Longevity regulating pathway,1/102,0.0050999322416682,0.0124443061070909,0,0,19898.0,105032.15064717118,RHEB
12811,KEGG_2019_Human,Thyroid hormone signaling pathway,1/116,0.0057999266512085,0.0124443061070909,0,0,19884.0,102400.8105961506,RHEB
12812,KEGG_2019_Human,AMPK signaling pathway,1/120,0.0059999251180858,0.0124443061070909,0,0,19880.0,101706.2448082016,RHEB
12813,KEGG_2019_Human,Autophagy,1/128,0.0063999221281459,0.0124443061070909,0,0,19872.0,100382.8010329652,RHEB
12814,KEGG_2019_Human,Insulin signaling pathway,1/137,0.0068499188797651,0.0124443061070909,0,0,19863.0,98987.62735269018,RHEB
12815,KEGG_2019_Human,Phospholipase D signaling pathway,1/148,0.007399915061391,0.0124443061070909,0,0,19852.0,97399.60470052566,RHEB
12816,KEGG_2019_Human,mTOR signaling pathway,1/152,0.0075999137114971,0.0124443061070909,0,0,19848.0,96850.665715497,RHEB
12817,KEGG_2019_Human,Cellular senescence,1/160,0.0079999110688441,0.0124443061070909,0,0,19840.0,95793.96509856998,RHEB
12818,KEGG_2019_Human,Human cytomegalovirus infection,1/225,0.0112498919790339,0.014699860501538,0,0,19775.0,88738.27077557483,RHEB
12819,KEGG_2019_Human,Thermogenesis,1/231,0.0115498903940656,0.014699860501538,0,0,19769.0,88191.07730937863,RHEB
12820,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0190613905368566,0,0,19670.0,80733.60565076157,RHEB
12821,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0190613905368566,0,0,19646.0,79255.8617626126,RHEB
12822,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,RHEB
12823,KEGG_2019_Human,Mitophagy,1/65,0.003249949134407,0.0051749206857555,0,0,19935.0,114209.92613860144,TFE3
12824,KEGG_2019_Human,Renal cell carcinoma,1/69,0.003449947123837,0.0051749206857555,0,0,19931.0,112996.7391397682,TFE3
12825,KEGG_2019_Human,Transcriptional misregulation in cancer,1/186,0.0092999029651357,0.0092999029651357,0,0,19814.0,92684.96451050608,TFE3
12826,KEGG_2019_Human,Nucleotide excision repair,1/47,0.0023499589392381,0.0070498768177144,0,0,19953.0,120782.64067395544,CUL4B
12827,KEGG_2019_Human,Ubiquitin mediated proteolysis,1/137,0.0068499188797651,0.0102748783196477,0,0,19863.0,98987.62735269018,CUL4B
12828,KEGG_2019_Human,Human immunodeficiency virus 1 infection,1/212,0.0105998955026255,0.0105998955026255,0,0,19788.0,89974.27756224656,CUL4B
12829,KEGG_2019_Human,Cytosolic DNA-sensing pathway,1/63,0.0031499501598827,0.0086544370887472,0,0,19937.0,114844.46974572667,NFKBIB
12830,KEGG_2019_Human,Shigellosis,1/65,0.003249949134407,0.0086544370887472,0,0,19935.0,114209.92613860144,NFKBIB
12831,KEGG_2019_Human,Adipocytokine signaling pathway,1/69,0.003449947123837,0.0086544370887472,0,0,19931.0,112996.7391397682,NFKBIB
12832,KEGG_2019_Human,RIG-I-like receptor signaling pathway,1/70,0.0034999466296654,0.0086544370887472,0,0,19930.0,112704.30065625212,NFKBIB
12833,KEGG_2019_Human,B cell receptor signaling pathway,1/71,0.0035499461386618,0.0086544370887472,0,0,19929.0,112415.9585341616,NFKBIB
12834,KEGG_2019_Human,Leishmaniasis,1/74,0.0036999446830449,0.0086544370887472,0,0,19926.0,111574.38983110404,NFKBIB
12835,KEGG_2019_Human,Th1 and Th2 cell differentiation,1/92,0.0045999364719865,0.0086544370887472,0,0,19908.0,107139.13814408927,NFKBIB
12836,KEGG_2019_Human,T cell receptor signaling pathway,1/101,0.0050499326546803,0.0086544370887472,0,0,19899.0,105233.48101229242,NFKBIB
12837,KEGG_2019_Human,Th17 cell differentiation,1/107,0.0053499302026925,0.0086544370887472,0,0,19893.0,104053.753408911,NFKBIB
12838,KEGG_2019_Human,Toxoplasmosis,1/113,0.0056499278191151,0.0086544370887472,0,0,19887.0,102937.34947211576,NFKBIB
12839,KEGG_2019_Human,Neurotrophin signaling pathway,1/119,0.0059499254985137,0.0086544370887472,0,0,19881.0,101877.73080211312,NFKBIB
12840,KEGG_2019_Human,Measles,1/138,0.0068999185254481,0.0091998913672642,0,0,19862.0,98838.19160389496,NFKBIB
12841,KEGG_2019_Human,Influenza A,1/171,0.0085499075557634,0.0100498985877989,0,0,19829.0,94422.42241345016,NFKBIB
12842,KEGG_2019_Human,NOD-like receptor signaling pathway,1/178,0.0088999053857096,0.0100498985877989,0,0,19822.0,93593.82745769851,NFKBIB
12843,KEGG_2019_Human,Chemokine signaling pathway,1/190,0.0094999017791995,0.0100498985877989,0,0,19810.0,92244.74636351672,NFKBIB
12844,KEGG_2019_Human,Epstein-Barr virus infection,1/201,0.0100498985877989,0.0100498985877989,0,0,19799.0,91079.21596609056,NFKBIB
12845,KEGG_2019_Human,Autophagy,1/128,0.0063999221281459,0.0063999221281459,0,0,19872.0,100382.8010329652,ATG10
12846,KEGG_2019_Human,Protein digestion and absorption,1/90,0.0044999373439762,0.0044999373439762,0,0,19910.0,107587.50385474482,COL24A1
12847,KEGG_2019_Human,Purine metabolism,1/129,0.006449921761047,0.006449921761047,0,0,19871.0,100223.109907462,PRUNE1
12848,KEGG_2019_Human,Ether lipid metabolism,1/47,0.0023499589392381,0.0041499404726918,0,0,19953.0,120782.64067395544,AGPS
12849,KEGG_2019_Human,Peroxisome,1/83,0.0041499404726918,0.0041499404726918,0,0,19917.0,109237.99888847338,AGPS
12850,KEGG_2019_Human,Melanoma,1/72,0.0035999456502131,0.0154665201799472,0,0,19928.0,112131.59838572376,FGF2
12851,KEGG_2019_Human,Signaling pathways regulating pluripotency of stem cells,1/139,0.006949918172816,0.0154665201799472,0,0,19861.0,98689.81333375497,FGF2
12852,KEGG_2019_Human,Breast cancer,1/147,0.0073499154017982,0.0154665201799472,0,0,19853.0,97539.10874372096,FGF2
12853,KEGG_2019_Human,Gastric cancer,1/149,0.0074499147221605,0.0154665201799472,0,0,19851.0,97261.02051561224,FGF2
12854,KEGG_2019_Human,Kaposi sarcoma-associated herpesvirus infection,1/186,0.0092999029651357,0.0154665201799472,0,0,19814.0,92684.96451050608,FGF2
12855,KEGG_2019_Human,Proteoglycans in cancer,1/201,0.0100498985877989,0.0154665201799472,0,0,19799.0,91079.21596609056,FGF2
12856,KEGG_2019_Human,Rap1 signaling pathway,1/206,0.010299897173561,0.0154665201799472,0,0,19794.0,90569.849337325,FGF2
12857,KEGG_2019_Human,Regulation of actin cytoskeleton,1/214,0.0106998949514067,0.0154665201799472,0,0,19786.0,89779.39753374986,FGF2
12858,KEGG_2019_Human,Ras signaling pathway,1/232,0.0115998901349604,0.0154665201799472,0,0,19768.0,88101.22480150245,FGF2
12859,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0176998499443808,0,0,19705.0,83086.53988020132,FGF2
12860,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0193089410633093,0,0,19646.0,79255.8617626126,FGF2
12861,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,FGF2
12862,KEGG_2019_Human,Terpenoid backbone biosynthesis,1/22,0.0010999756574123,0.0010999756574123,0,0,19978.0,136099.47030191717,MVD
12863,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR8U1
12864,KEGG_2019_Human,Prolactin signaling pathway,1/70,0.0034999466296654,0.0069998932593308,0,0,19930.0,112704.30065625212,SOCS7
12865,KEGG_2019_Human,JAK-STAT signaling pathway,1/162,0.0080999104202618,0.0080999104202618,0,0,19838.0,95537.86936302872,SOCS7
12866,KEGG_2019_Human,Sphingolipid metabolism,1/47,0.0023499589392381,0.0046999178784763,0,0,19953.0,120782.64067395544,SGPP2
12867,KEGG_2019_Human,Sphingolipid signaling pathway,1/119,0.0059499254985137,0.0059499254985137,0,0,19881.0,101877.73080211312,SGPP2
12868,KEGG_2019_Human,Peroxisome,1/83,0.0041499404726918,0.0041499404726918,0,0,19917.0,109237.99888847338,PEX1
12869,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR2B6
12870,KEGG_2019_Human,Citrate cycle (TCA cycle),1/30,0.0014999697593334,0.0015999683804467,0,0,19970.0,129851.13732048514,SUCLG2
12871,KEGG_2019_Human,Propanoate metabolism,1/32,0.0015999683804467,0.0015999683804467,0,0,19968.0,128549.41955786056,SUCLG2
12872,KEGG_2019_Human,Protein digestion and absorption,1/90,0.0044999373439762,0.0044999373439762,0,0,19910.0,107587.50385474482,PGA3
12873,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR51S1
12874,KEGG_2019_Human,Inflammatory mediator regulation of TRP channels,1/100,0.0049999330710556,0.0049999330710556,0,0,19900.0,105436.78197328727,ASIC4
12875,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR2A25
12876,KEGG_2019_Human,Taste transduction,1/83,0.0041499404726918,0.0112998556382303,0,0,19917.0,109237.99888847338,HTR1B
12877,KEGG_2019_Human,Serotonergic synapse,1/113,0.0056499278191151,0.0112998556382303,0,0,19887.0,102937.34947211576,HTR1B
12878,KEGG_2019_Human,cAMP signaling pathway,1/212,0.0105998955026255,0.0141331940035007,0,0,19788.0,89974.27756224656,HTR1B
12879,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,HTR1B
12880,KEGG_2019_Human,Circadian entrainment,1/97,0.0048499343304706,0.0077499127120574,0,0,19903.0,106058.9096435903,RASD1
12881,KEGG_2019_Human,Cushing syndrome,1/155,0.0077499127120574,0.0077499127120574,0,0,19845.0,96448.16254952336,RASD1
12882,KEGG_2019_Human,Gastric acid secretion,1/75,0.0037499442041125,0.0112498326123375,0,0,19925.0,111301.33528642564,CCKBR
12883,KEGG_2019_Human,Calcium signaling pathway,1/188,0.009399902370135,0.0140998535552025,0,0,19812.0,92463.712994847,CCKBR
12884,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,CCKBR
12885,KEGG_2019_Human,Proteasome,1/45,0.0022499601197094,0.0022499601197094,0,0,19955.0,121662.49782449217,PSMA5
12886,KEGG_2019_Human,Folate biosynthesis,1/26,0.0012999726251831,0.0012999726251831,0,0,19974.0,132735.46073187632,GCH1
12887,KEGG_2019_Human,Arrhythmogenic right ventricular cardiomyopathy (ARVC),1/72,0.0035999456502131,0.0035999456502131,0,0,19928.0,112131.59838572376,DSC2
12888,KEGG_2019_Human,Glycerolipid metabolism,1/61,0.0030499512001654,0.0061874168605085,0,0,19939.0,115499.24335773686,DGKG
12889,KEGG_2019_Human,Glycerophospholipid metabolism,1/97,0.0048499343304706,0.0061874168605085,0,0,19903.0,106058.9096435903,DGKG
12890,KEGG_2019_Human,Phosphatidylinositol signaling system,1/99,0.0049499334884068,0.0061874168605085,0,0,19901.0,105642.09305076736,DGKG
12891,KEGG_2019_Human,Choline metabolism in cancer,1/99,0.0049499334884068,0.0061874168605085,0,0,19901.0,105642.09305076736,DGKG
12892,KEGG_2019_Human,Phospholipase D signaling pathway,1/148,0.007399915061391,0.007399915061391,0,0,19852.0,97399.60470052566,DGKG
12893,KEGG_2019_Human,Proteasome,1/45,0.0022499601197094,0.0022499601197094,0,0,19955.0,121662.49782449217,PSMA2
12894,KEGG_2019_Human,Peroxisome,1/83,0.0041499404726918,0.0041499404726918,0,0,19917.0,109237.99888847338,CRAT
12895,KEGG_2019_Human,HIF-1 signaling pathway,1/100,0.0049999330710556,0.0176998626413668,0,0,19900.0,105436.78197328727,ANGPT4
12896,KEGG_2019_Human,Rap1 signaling pathway,1/206,0.010299897173561,0.0176998626413668,0,0,19794.0,90569.849337325,ANGPT4
12897,KEGG_2019_Human,Ras signaling pathway,1/232,0.0115998901349604,0.0176998626413668,0,0,19768.0,88101.22480150245,ANGPT4
12898,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0176998626413668,0,0,19705.0,83086.53988020132,ANGPT4
12899,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0176998626413668,0,0,19646.0,79255.8617626126,ANGPT4
12900,KEGG_2019_Human,Cell adhesion molecules (CAMs),1/145,0.0072499160871101,0.0072499160871101,0,0,19855.0,97820.92670675044,CADM3
12901,KEGG_2019_Human,Basal transcription factors,1/45,0.0022499601197094,0.0022499601197094,0,0,19955.0,121662.49782449217,TAF9B
12902,KEGG_2019_Human,Vasopressin-regulated water reabsorption,1/44,0.0021999607179423,0.0115367054817097,0,0,19956.0,122117.06559109331,CREB3L1
12903,KEGG_2019_Human,Cocaine addiction,1/49,0.0024499577795033,0.0115367054817097,0,0,19951.0,119939.1172087114,CREB3L1
12904,KEGG_2019_Human,Cortisol synthesis and secretion,1/65,0.003249949134407,0.0115367054817097,0,0,19935.0,114209.92613860144,CREB3L1
12905,KEGG_2019_Human,Amphetamine addiction,1/68,0.0033999476216189,0.0115367054817097,0,0,19932.0,113293.39338050144,CREB3L1
12906,KEGG_2019_Human,Thyroid hormone synthesis,1/74,0.0036999446830449,0.0115367054817097,0,0,19926.0,111574.38983110404,CREB3L1
12907,KEGG_2019_Human,Insulin secretion,1/86,0.0042999391173866,0.0115367054817097,0,0,19914.0,108514.46102290176,CREB3L1
12908,KEGG_2019_Human,Prostate cancer,1/97,0.0048499343304706,0.0115367054817097,0,0,19903.0,106058.9096435903,CREB3L1
12909,KEGG_2019_Human,Aldosterone synthesis and secretion,1/98,0.0048999339081079,0.0115367054817097,0,0,19902.0,105849.45495286948,CREB3L1
12910,KEGG_2019_Human,Melanogenesis,1/101,0.0050499326546803,0.0115367054817097,0,0,19899.0,105233.48101229242,CREB3L1
12911,KEGG_2019_Human,Longevity regulating pathway,1/102,0.0050999322416682,0.0115367054817097,0,0,19898.0,105032.15064717118,CREB3L1
12912,KEGG_2019_Human,Glucagon signaling pathway,1/103,0.0051499318302617,0.0115367054817097,0,0,19897.0,104832.7525292024,CREB3L1
12913,KEGG_2019_Human,"Parathyroid hormone synthesis, secretion and action",1/106,0.0052999306076525,0.0115367054817097,0,0,19894.0,104245.78450366124,CREB3L1
12914,KEGG_2019_Human,Insulin resistance,1/108,0.0053999298011749,0.0115367054817097,0,0,19892.0,103863.47861844616,CREB3L1
12915,KEGG_2019_Human,TNF signaling pathway,1/110,0.0054999290027479,0.0115367054817097,0,0,19890.0,103488.06969787036,CREB3L1
12916,KEGG_2019_Human,Cholinergic synapse,1/112,0.0055999282120529,0.0115367054817097,0,0,19888.0,103119.30984392198,CREB3L1
12917,KEGG_2019_Human,AMPK signaling pathway,1/120,0.0059999251180858,0.0115367054817097,0,0,19880.0,101706.2448082016,CREB3L1
12918,KEGG_2019_Human,Relaxin signaling pathway,1/130,0.0064999213952527,0.0115367054817097,0,0,19870.0,100064.62842845908,CREB3L1
12919,KEGG_2019_Human,Dopaminergic synapse,1/131,0.0065499210316603,0.0115367054817097,0,0,19869.0,99907.33811343512,CREB3L1
12920,KEGG_2019_Human,Estrogen signaling pathway,1/137,0.0068499188797651,0.0115367054817097,0,0,19863.0,98987.62735269018,CREB3L1
12921,KEGG_2019_Human,Adrenergic signaling in cardiomyocytes,1/145,0.0072499160871101,0.0115476996679976,0,0,19855.0,97820.92670675044,CREB3L1
12922,KEGG_2019_Human,Cushing syndrome,1/155,0.0077499127120574,0.0115476996679976,0,0,19845.0,96448.16254952336,CREB3L1
12923,KEGG_2019_Human,Hepatitis B,1/163,0.0081499100978668,0.0115476996679976,0,0,19837.0,95410.9786681514,CREB3L1
12924,KEGG_2019_Human,cGMP-PKG signaling pathway,1/166,0.0082999091363732,0.0115476996679976,0,0,19834.0,95034.82345515196,CREB3L1
12925,KEGG_2019_Human,Alcoholism,1/180,0.0089999047745351,0.0119998730327134,0,0,19820.0,93362.92821536642,CREB3L1
12926,KEGG_2019_Human,Huntington disease,1/193,0.0096499008972596,0.0123198830870033,0,0,19807.0,91920.47679471428,CREB3L1
12927,KEGG_2019_Human,Viral carcinogenesis,1/201,0.0100498985877989,0.0123198830870033,0,0,19799.0,91079.21596609056,CREB3L1
12928,KEGG_2019_Human,cAMP signaling pathway,1/212,0.0105998955026255,0.0123198830870033,0,0,19788.0,89974.27756224656,CREB3L1
12929,KEGG_2019_Human,Human T-cell leukemia virus 1 infection,1/219,0.0109498935894162,0.0123198830870033,0,0,19781.0,89299.85161916987,CREB3L1
12930,KEGG_2019_Human,Human cytomegalovirus infection,1/225,0.0112498919790339,0.0123198830870033,0,0,19775.0,88738.27077557483,CREB3L1
12931,KEGG_2019_Human,Thermogenesis,1/231,0.0115498903940656,0.0123198830870033,0,0,19769.0,88191.07730937863,CREB3L1
12932,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0170321212479633,0,0,19670.0,80733.60565076157,CREB3L1
12933,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0176998626413668,0,0,19646.0,79255.8617626126,CREB3L1
12934,KEGG_2019_Human,Selenocompound metabolism,1/17,0.0008499797390404818,0.0025499392171214,0,0,19983.0,141285.76583697114,TXNRD3
12935,KEGG_2019_Human,Hepatocellular carcinoma,1/168,0.0083999085011095,0.0125998627516642,0,0,19832.0,94787.72752807094,TXNRD3
12936,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,TXNRD3
12937,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR5B2
12938,KEGG_2019_Human,Glycosaminoglycan biosynthesis,1/53,0.0026499555173137,0.0026499555173137,0,0,19947.0,118349.78824235698,EXTL2
12939,KEGG_2019_Human,Phospholipase D signaling pathway,1/148,0.007399915061391,0.0140998535552025,0,0,19852.0,97399.60470052566,PTGFR
12940,KEGG_2019_Human,Calcium signaling pathway,1/188,0.009399902370135,0.0140998535552025,0,0,19812.0,92463.712994847,PTGFR
12941,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,PTGFR
12942,KEGG_2019_Human,Glycosaminoglycan biosynthesis,1/53,0.0026499555173137,0.0026499555173137,0,0,19947.0,118349.78824235698,CHST13
12943,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF845
12944,KEGG_2019_Human,Lysine degradation,1/59,0.0029499522555206,0.0029499522555206,0,0,19941.0,116175.59385530632,SETD3
12945,KEGG_2019_Human,Cell adhesion molecules (CAMs),1/145,0.0072499160871101,0.0072499160871101,0,0,19855.0,97820.92670675044,CNTN2
12946,KEGG_2019_Human,Ovarian steroidogenesis,1/49,0.0024499577795033,0.0048999155590066,0,0,19951.0,119939.1172087114,BMP15
12947,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0146998751759735,0,0,19706.0,83157.67014793828,BMP15
12948,KEGG_2019_Human,Pentose and glucuronate interconversions,1/34,0.0016999670339032,0.0016999670339032,0,0,19966.0,127326.1054203148,XYLB
12949,KEGG_2019_Human,Phospholipase D signaling pathway,1/148,0.007399915061391,0.0212398351696402,0,0,19852.0,97399.60470052566,LPAR2
12950,KEGG_2019_Human,Rap1 signaling pathway,1/206,0.010299897173561,0.0212398351696402,0,0,19794.0,90569.849337325,LPAR2
12951,KEGG_2019_Human,Regulation of actin cytoskeleton,1/214,0.0106998949514067,0.0212398351696402,0,0,19786.0,89779.39753374986,LPAR2
12952,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0212398351696402,0,0,19662.0,80229.79996326564,LPAR2
12953,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0212398351696402,0,0,19646.0,79255.8617626126,LPAR2
12954,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,LPAR2
12955,KEGG_2019_Human,Progesterone-mediated oocyte maturation,1/99,0.0049499334884068,0.0123186302880933,0,0,19901.0,105642.09305076736,CCNA2
12956,KEGG_2019_Human,AMPK signaling pathway,1/120,0.0059999251180858,0.0123186302880933,0,0,19880.0,101706.2448082016,CCNA2
12957,KEGG_2019_Human,Cell cycle,1/124,0.0061999236097501,0.0123186302880933,0,0,19876.0,101034.04709010696,CCNA2
12958,KEGG_2019_Human,Cellular senescence,1/160,0.0079999110688441,0.0123186302880933,0,0,19840.0,95793.96509856998,CCNA2
12959,KEGG_2019_Human,Hepatitis B,1/163,0.0081499100978668,0.0123186302880933,0,0,19837.0,95410.9786681514,CCNA2
12960,KEGG_2019_Human,Epstein-Barr virus infection,1/201,0.0100498985877989,0.0123186302880933,0,0,19799.0,91079.21596609056,CCNA2
12961,KEGG_2019_Human,Viral carcinogenesis,1/201,0.0100498985877989,0.0123186302880933,0,0,19799.0,91079.21596609056,CCNA2
12962,KEGG_2019_Human,Human T-cell leukemia virus 1 infection,1/219,0.0109498935894162,0.0123186302880933,0,0,19781.0,89299.85161916987,CCNA2
12963,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0164998674589645,0,0,19670.0,80733.60565076157,CCNA2
12964,KEGG_2019_Human,Glycosylphosphatidylinositol (GPI)-anchor biosynthesis,1/25,0.0012499733663791,0.0012499733663791,0,0,19975.0,133525.54486996148,PIGZ
12965,KEGG_2019_Human,Renal cell carcinoma,1/69,0.003449947123837,0.0091332251730202,0,0,19931.0,112996.7391397682,CUL2
12966,KEGG_2019_Human,HIF-1 signaling pathway,1/100,0.0049999330710556,0.0091332251730202,0,0,19900.0,105436.78197328727,CUL2
12967,KEGG_2019_Human,Ubiquitin mediated proteolysis,1/137,0.0068499188797651,0.0091332251730202,0,0,19863.0,98987.62735269018,CUL2
12968,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,CUL2
12969,KEGG_2019_Human,Citrate cycle (TCA cycle),1/30,0.0014999697593334,0.0014999697593334,0,0,19970.0,129851.13732048514,IDH3B
12970,KEGG_2019_Human,RIG-I-like receptor signaling pathway,1/70,0.0034999466296654,0.0034999466296654,0,0,19930.0,112704.30065625212,DHX58
12971,KEGG_2019_Human,Taste transduction,1/83,0.0041499404726918,0.0041499404726918,0,0,19917.0,109237.99888847338,TAS2R39
12972,KEGG_2019_Human,Rheumatoid arthritis,1/91,0.0045499369072032,0.0071249027705091,0,0,19909.0,107362.10783923086,LTB
12973,KEGG_2019_Human,NF-kappa B signaling pathway,1/95,0.0047499351803394,0.0071249027705091,0,0,19905.0,106484.27183626965,LTB
12974,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0146998751759735,0,0,19706.0,83157.67014793828,LTB
12975,KEGG_2019_Human,Cocaine addiction,1/49,0.0024499577795033,0.0024499577795033,0,0,19951.0,119939.1172087114,GPSM1
12976,KEGG_2019_Human,Axon guidance,1/181,0.0090499044707863,0.0090499044707863,0,0,19819.0,93248.41634586031,SEMA3C
12977,KEGG_2019_Human,Bile secretion,1/72,0.0035999456502131,0.0035999456502131,0,0,19928.0,112131.59838572376,SLCO1A2
12978,KEGG_2019_Human,Alcoholism,1/180,0.0089999047745351,0.0089999047745351,0,0,19820.0,93362.92821536642,PKIA
12979,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF675
12980,KEGG_2019_Human,Ubiquitin mediated proteolysis,1/137,0.0068499188797651,0.0070999171242726,0,0,19863.0,98987.62735269018,UBA1
12981,KEGG_2019_Human,Parkinson disease,1/142,0.0070999171242726,0.0070999171242726,0,0,19858.0,98250.87390500787,UBA1
12982,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR5P3
12983,KEGG_2019_Human,Protein digestion and absorption,1/90,0.0044999373439762,0.0044999373439762,0,0,19910.0,107587.50385474482,COL5A1
12984,KEGG_2019_Human,Type I diabetes mellitus,1/43,0.0021499613216957,0.0021499613216957,0,0,19957.0,122581.98940490963,PTPRN
12985,KEGG_2019_Human,Tight junction,1/170,0.0084999078692823,0.0084999078692823,0,0,19830.0,94543.49009679438,MPDZ
12986,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR5R1
12987,KEGG_2019_Human,Choline metabolism in cancer,1/99,0.0049499334884068,0.0049499334884068,0,0,19901.0,105642.09305076736,SLC44A4
12988,KEGG_2019_Human,Ovarian steroidogenesis,1/49,0.0024499577795033,0.0089457190469323,0,0,19951.0,119939.1172087114,PTGS2
12989,KEGG_2019_Human,Regulation of lipolysis in adipocytes,1/55,0.0027499544131125,0.0089457190469323,0,0,19945.0,117599.1294878737,PTGS2
12990,KEGG_2019_Human,VEGF signaling pathway,1/59,0.0029499522555206,0.0089457190469323,0,0,19941.0,116175.59385530632,PTGS2
12991,KEGG_2019_Human,Arachidonic acid metabolism,1/63,0.0031499501598827,0.0089457190469323,0,0,19937.0,114844.46974572667,PTGS2
12992,KEGG_2019_Human,Leishmaniasis,1/74,0.0036999446830449,0.0089457190469323,0,0,19926.0,111574.38983110404,PTGS2
12993,KEGG_2019_Human,Chemical carcinogenesis,1/82,0.004099940929819,0.0089457190469323,0,0,19918.0,109484.9180722932,PTGS2
12994,KEGG_2019_Human,IL-17 signaling pathway,1/93,0.0046499360391879,0.0089457190469323,0,0,19907.0,106918.54242106884,PTGS2
12995,KEGG_2019_Human,Small cell lung cancer,1/93,0.0046499360391879,0.0089457190469323,0,0,19907.0,106918.54242106884,PTGS2
12996,KEGG_2019_Human,NF-kappa B signaling pathway,1/95,0.0047499351803394,0.0089457190469323,0,0,19905.0,106484.27183626965,PTGS2
12997,KEGG_2019_Human,C-type lectin receptor signaling pathway,1/104,0.0051999314202997,0.0089457190469323,0,0,19896.0,104635.24941415618,PTGS2
12998,KEGG_2019_Human,TNF signaling pathway,1/110,0.0054999290027479,0.0089457190469323,0,0,19890.0,103488.06969787036,PTGS2
12999,KEGG_2019_Human,Serotonergic synapse,1/113,0.0056499278191151,0.0089457190469323,0,0,19887.0,102937.34947211576,PTGS2
13000,KEGG_2019_Human,Retrograde endocannabinoid signaling,1/148,0.007399915061391,0.0103820252975658,0,0,19852.0,97399.60470052566,PTGS2
13001,KEGG_2019_Human,Oxytocin signaling pathway,1/153,0.0076499133771537,0.0103820252975658,0,0,19847.0,96715.6407630817,PTGS2
13002,KEGG_2019_Human,Kaposi sarcoma-associated herpesvirus infection,1/186,0.0092999029651357,0.0117798770891719,0,0,19814.0,92684.96451050608,PTGS2
13003,KEGG_2019_Human,Human cytomegalovirus infection,1/225,0.0112498919790339,0.0133592467251027,0,0,19775.0,88738.27077557483,PTGS2
13004,KEGG_2019_Human,MicroRNAs in cancer,1/299,0.0149498740670514,0.0167086827808222,0,0,19701.0,82804.33538735632,PTGS2
13005,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0174165267622403,0,0,19670.0,80733.60565076157,PTGS2
13006,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,PTGS2
13007,KEGG_2019_Human,Legionellosis,1/55,0.0027499544131125,0.0064499086760799,0,0,19945.0,117599.1294878737,NLRC4
13008,KEGG_2019_Human,Salmonella infection,1/86,0.0042999391173866,0.0064499086760799,0,0,19914.0,108514.46102290176,NLRC4
13009,KEGG_2019_Human,NOD-like receptor signaling pathway,1/178,0.0088999053857096,0.0088999053857096,0,0,19822.0,93593.82745769851,NLRC4
13010,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF709
13011,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF699
13012,KEGG_2019_Human,Rap1 signaling pathway,1/206,0.010299897173561,0.0176998626413668,0,0,19794.0,90569.849337325,MAGI2
13013,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0176998626413668,0,0,19646.0,79255.8617626126,MAGI2
13014,KEGG_2019_Human,Other glycan degradation,1/18,0.0008999788927950273,0.00179995778559,0,0,19982.0,140136.54844084635,NEU3
13015,KEGG_2019_Human,Sphingolipid metabolism,1/47,0.0023499589392381,0.0023499589392381,0,0,19953.0,120782.64067395544,NEU3
13016,KEGG_2019_Human,Inflammatory bowel disease (IBD),1/65,0.003249949134407,0.0081248728360176,0,0,19935.0,114209.92613860144,NOD2
13017,KEGG_2019_Human,Shigellosis,1/65,0.003249949134407,0.0081248728360176,0,0,19935.0,114209.92613860144,NOD2
13018,KEGG_2019_Human,TNF signaling pathway,1/110,0.0054999290027479,0.0089499050800561,0,0,19890.0,103488.06969787036,NOD2
13019,KEGG_2019_Human,NOD-like receptor signaling pathway,1/178,0.0088999053857096,0.0089499050800561,0,0,19822.0,93593.82745769851,NOD2
13020,KEGG_2019_Human,Tuberculosis,1/179,0.0089499050800561,0.0089499050800561,0,0,19821.0,93478.0629355712,NOD2
13021,KEGG_2019_Human,Nitrogen metabolism,1/17,0.0008499797390404818,0.0026999437884725,0,0,19983.0,141285.76583697114,CA2
13022,KEGG_2019_Human,Proximal tubule bicarbonate reclamation,1/23,0.0011499748819949,0.0026999437884725,0,0,19977.0,135204.63922267244,CA2
13023,KEGG_2019_Human,Collecting duct acid secretion,1/27,0.0013499718942362,0.0026999437884725,0,0,19973.0,131975.02298599784,CA2
13024,KEGG_2019_Human,Bile secretion,1/72,0.0035999456502131,0.004499933044935,0,0,19928.0,112131.59838572376,CA2
13025,KEGG_2019_Human,Gastric acid secretion,1/75,0.0037499442041125,0.004499933044935,0,0,19925.0,111301.33528642564,CA2
13026,KEGG_2019_Human,Pancreatic secretion,1/98,0.0048999339081079,0.0048999339081079,0,0,19902.0,105849.45495286948,CA2
13027,KEGG_2019_Human,RNA degradation,1/79,0.0039499423167337,0.0039499423167337,0,0,19921.0,110243.89578070649,PNPT1
13028,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR2M5
13029,KEGG_2019_Human,Thyroid hormone signaling pathway,1/116,0.0057999266512085,0.0100498985877989,0,0,19884.0,102400.8105961506,SIN3A
13030,KEGG_2019_Human,Transcriptional misregulation in cancer,1/186,0.0092999029651357,0.0100498985877989,0,0,19814.0,92684.96451050608,SIN3A
13031,KEGG_2019_Human,Huntington disease,1/193,0.0096499008972596,0.0100498985877989,0,0,19807.0,91920.47679471428,SIN3A
13032,KEGG_2019_Human,Epstein-Barr virus infection,1/201,0.0100498985877989,0.0100498985877989,0,0,19799.0,91079.21596609056,SIN3A
13033,KEGG_2019_Human,Transcriptional misregulation in cancer,1/186,0.0092999029651357,0.0092999029651357,0,0,19814.0,92684.96451050608,SUPT3H
13034,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,GALR1
13035,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR2M4
13036,KEGG_2019_Human,Cellular senescence,1/160,0.0079999110688441,0.0079999110688441,0,0,19840.0,95793.96509856998,HIPK3
13037,KEGG_2019_Human,Pathogenic Escherichia coli infection,1/55,0.0027499544131125,0.0077784669103536,0,0,19945.0,117599.1294878737,WAS
13038,KEGG_2019_Human,Shigellosis,1/65,0.003249949134407,0.0077784669103536,0,0,19935.0,114209.92613860144,WAS
13039,KEGG_2019_Human,Adherens junction,1/72,0.0035999456502131,0.0077784669103536,0,0,19928.0,112131.59838572376,WAS
13040,KEGG_2019_Human,Bacterial invasion of epithelial cells,1/74,0.0036999446830449,0.0077784669103536,0,0,19926.0,111574.38983110404,WAS
13041,KEGG_2019_Human,Salmonella infection,1/86,0.0042999391173866,0.0077784669103536,0,0,19914.0,108514.46102290176,WAS
13042,KEGG_2019_Human,Fc gamma R-mediated phagocytosis,1/91,0.0045499369072032,0.0077784669103536,0,0,19909.0,107362.10783923086,WAS
13043,KEGG_2019_Human,Choline metabolism in cancer,1/99,0.0049499334884068,0.0077784669103536,0,0,19901.0,105642.09305076736,WAS
13044,KEGG_2019_Human,Tight junction,1/170,0.0084999078692823,0.0116109910634661,0,0,19830.0,94543.49009679438,WAS
13045,KEGG_2019_Human,Chemokine signaling pathway,1/190,0.0094999017791995,0.0116109910634661,0,0,19810.0,92244.74636351672,WAS
13046,KEGG_2019_Human,Regulation of actin cytoskeleton,1/214,0.0106998949514067,0.0117698844465474,0,0,19786.0,89779.39753374986,WAS
13047,KEGG_2019_Human,Endocytosis,1/244,0.0121998870519305,0.0121998870519305,0,0,19756.0,87051.4275316661,WAS
13048,KEGG_2019_Human,Endocytosis,1/244,0.0121998870519305,0.0121998870519305,0,0,19756.0,87051.4275316661,ARAP2
13049,KEGG_2019_Human,Spliceosome,1/134,0.0066999199497742,0.0066999199497742,0,0,19866.0,99442.43560916925,SNRNP200
13050,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF768
13051,KEGG_2019_Human,Thyroid cancer,1/37,0.0018499650702878,0.0079748991454117,0,0,19963.0,125618.9446446357,RXRB
13052,KEGG_2019_Human,Non-small cell lung cancer,1/66,0.003299948626608,0.0079748991454117,0,0,19934.0,113899.85357353876,RXRB
13053,KEGG_2019_Human,Adipocytokine signaling pathway,1/69,0.003449947123837,0.0079748991454117,0,0,19931.0,112996.7391397682,RXRB
13054,KEGG_2019_Human,PPAR signaling pathway,1/74,0.0036999446830449,0.0079748991454117,0,0,19926.0,111574.38983110404,RXRB
13055,KEGG_2019_Human,Small cell lung cancer,1/93,0.0046499360391879,0.0079748991454117,0,0,19907.0,106918.54242106884,RXRB
13056,KEGG_2019_Human,"Parathyroid hormone synthesis, secretion and action",1/106,0.0052999306076525,0.0079748991454117,0,0,19894.0,104245.78450366124,RXRB
13057,KEGG_2019_Human,Th17 cell differentiation,1/107,0.0053499302026925,0.0079748991454117,0,0,19893.0,104053.753408911,RXRB
13058,KEGG_2019_Human,Thyroid hormone signaling pathway,1/116,0.0057999266512085,0.0079748991454117,0,0,19884.0,102400.8105961506,RXRB
13059,KEGG_2019_Human,Gastric cancer,1/149,0.0074499147221605,0.0091054513270851,0,0,19851.0,97261.02051561224,RXRB
13060,KEGG_2019_Human,Transcriptional misregulation in cancer,1/186,0.0092999029651357,0.0102298932616493,0,0,19814.0,92684.96451050608,RXRB
13061,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,RXRB
13062,KEGG_2019_Human,Complement and coagulation cascades,1/79,0.0039499423167337,0.0039499423167337,0,0,19921.0,110243.89578070649,F7
13063,KEGG_2019_Human,Amyotrophic lateral sclerosis (ALS),1/51,0.0025499566390179,0.0125623732347487,0,0,19949.0,119129.0228601236,CASP3
13064,KEGG_2019_Human,Legionellosis,1/55,0.0027499544131125,0.0125623732347487,0,0,19945.0,117599.1294878737,CASP3
13065,KEGG_2019_Human,Viral myocarditis,1/59,0.0029499522555206,0.0125623732347487,0,0,19941.0,116175.59385530632,CASP3
13066,KEGG_2019_Human,Epithelial cell signaling in Helicobacter pylori infection,1/68,0.0033999476216189,0.0125623732347487,0,0,19932.0,113293.39338050144,CASP3
13067,KEGG_2019_Human,p53 signaling pathway,1/72,0.0035999456502131,0.0125623732347487,0,0,19928.0,112131.59838572376,CASP3
13068,KEGG_2019_Human,Pertussis,1/76,0.0037999437281752,0.0125623732347487,0,0,19924.0,111031.8499691117,CASP3
13069,KEGG_2019_Human,Colorectal cancer,1/86,0.0042999391173866,0.0125623732347487,0,0,19914.0,108514.46102290176,CASP3
13070,KEGG_2019_Human,IL-17 signaling pathway,1/93,0.0046499360391879,0.0125623732347487,0,0,19907.0,106918.54242106884,CASP3
13071,KEGG_2019_Human,Small cell lung cancer,1/93,0.0046499360391879,0.0125623732347487,0,0,19907.0,106918.54242106884,CASP3
13072,KEGG_2019_Human,Amoebiasis,1/96,0.0047999347538706,0.0125623732347487,0,0,19904.0,106270.50039849174,CASP3
13073,KEGG_2019_Human,AGE-RAGE signaling pathway in diabetic complications,1/100,0.0049999330710556,0.0125623732347487,0,0,19900.0,105436.78197328727,CASP3
13074,KEGG_2019_Human,TNF signaling pathway,1/110,0.0054999290027479,0.0125623732347487,0,0,19890.0,103488.06969787036,CASP3
13075,KEGG_2019_Human,Toxoplasmosis,1/113,0.0056499278191151,0.0125623732347487,0,0,19887.0,102937.34947211576,CASP3
13076,KEGG_2019_Human,Serotonergic synapse,1/113,0.0056499278191151,0.0125623732347487,0,0,19887.0,102937.34947211576,CASP3
13077,KEGG_2019_Human,Natural killer cell mediated cytotoxicity,1/131,0.0065499210316603,0.0125623732347487,0,0,19869.0,99907.33811343512,CASP3
13078,KEGG_2019_Human,Measles,1/138,0.0068999185254481,0.0125623732347487,0,0,19862.0,98838.19160389496,CASP3
13079,KEGG_2019_Human,Parkinson disease,1/142,0.0070999171242726,0.0125623732347487,0,0,19858.0,98250.87390500787,CASP3
13080,KEGG_2019_Human,Apoptosis,1/143,0.0071499167770442,0.0125623732347487,0,0,19857.0,98106.57763600958,CASP3
13081,KEGG_2019_Human,Non-alcoholic fatty liver disease (NAFLD),1/149,0.0074499147221605,0.0125623732347487,0,0,19851.0,97261.02051561224,CASP3
13082,KEGG_2019_Human,Hepatitis C,1/155,0.0077499127120574,0.0125623732347487,0,0,19845.0,96448.16254952336,CASP3
13083,KEGG_2019_Human,Hepatitis B,1/163,0.0081499100978668,0.0125623732347487,0,0,19837.0,95410.9786681514,CASP3
13084,KEGG_2019_Human,Alzheimer disease,1/171,0.0085499075557634,0.0125623732347487,0,0,19829.0,94422.42241345016,CASP3
13085,KEGG_2019_Human,Tuberculosis,1/179,0.0089499050800561,0.0125623732347487,0,0,19821.0,93478.0629355712,CASP3
13086,KEGG_2019_Human,Kaposi sarcoma-associated herpesvirus infection,1/186,0.0092999029651357,0.0125623732347487,0,0,19814.0,92684.96451050608,CASP3
13087,KEGG_2019_Human,Huntington disease,1/193,0.0096499008972596,0.0125623732347487,0,0,19807.0,91920.47679471428,CASP3
13088,KEGG_2019_Human,Epstein-Barr virus infection,1/201,0.0100498985877989,0.0125623732347487,0,0,19799.0,91079.21596609056,CASP3
13089,KEGG_2019_Human,Proteoglycans in cancer,1/201,0.0100498985877989,0.0125623732347487,0,0,19799.0,91079.21596609056,CASP3
13090,KEGG_2019_Human,Viral carcinogenesis,1/201,0.0100498985877989,0.0125623732347487,0,0,19799.0,91079.21596609056,CASP3
13091,KEGG_2019_Human,Human immunodeficiency virus 1 infection,1/212,0.0105998955026255,0.012792977330755,0,0,19788.0,89974.27756224656,CASP3
13092,KEGG_2019_Human,Human cytomegalovirus infection,1/225,0.0112498919790339,0.0131248739755395,0,0,19775.0,88738.27077557483,CASP3
13093,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0163514247608375,0,0,19705.0,83086.53988020132,CASP3
13094,KEGG_2019_Human,MicroRNAs in cancer,1/299,0.0149498740670514,0.0163514247608375,0,0,19701.0,82804.33538735632,CASP3
13095,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0174998594261744,0,0,19670.0,80733.60565076157,CASP3
13096,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.025323363655496,0,0,19508.0,72277.44006442746,CASP3
13097,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,CASP3
13098,KEGG_2019_Human,"Parathyroid hormone synthesis, secretion and action",1/106,0.0052999306076525,0.0078999117225733,0,0,19894.0,104245.78450366124,SOST
13099,KEGG_2019_Human,Wnt signaling pathway,1/158,0.0078999117225733,0.0078999117225733,0,0,19842.0,96053.2110949472,SOST
13100,KEGG_2019_Human,Inositol phosphate metabolism,1/74,0.0036999446830449,0.0036999446830449,0,0,19926.0,111574.38983110404,ISYNA1
13101,KEGG_2019_Human,Notch signaling pathway,1/48,0.0023999583567988,0.0023999583567988,0,0,19952.0,120356.5272753826,NUMBL
13102,KEGG_2019_Human,mRNA surveillance pathway,1/91,0.0045499369072032,0.0103887762846784,0,0,19909.0,107362.10783923086,PPP2R2A
13103,KEGG_2019_Human,Chagas disease (American trypanosomiasis),1/103,0.0051499318302617,0.0103887762846784,0,0,19897.0,104832.7525292024,PPP2R2A
13104,KEGG_2019_Human,Sphingolipid signaling pathway,1/119,0.0059499254985137,0.0103887762846784,0,0,19881.0,101877.73080211312,PPP2R2A
13105,KEGG_2019_Human,AMPK signaling pathway,1/120,0.0059999251180858,0.0103887762846784,0,0,19880.0,101706.2448082016,PPP2R2A
13106,KEGG_2019_Human,Dopaminergic synapse,1/131,0.0065499210316603,0.0103887762846784,0,0,19869.0,99907.33811343512,PPP2R2A
13107,KEGG_2019_Human,Adrenergic signaling in cardiomyocytes,1/145,0.0072499160871101,0.0103887762846784,0,0,19855.0,97820.92670675044,PPP2R2A
13108,KEGG_2019_Human,Hepatitis C,1/155,0.0077499127120574,0.0103887762846784,0,0,19845.0,96448.16254952336,PPP2R2A
13109,KEGG_2019_Human,Hippo signaling pathway,1/160,0.0079999110688441,0.0103887762846784,0,0,19840.0,95793.96509856998,PPP2R2A
13110,KEGG_2019_Human,Tight junction,1/170,0.0084999078692823,0.0103887762846784,0,0,19830.0,94543.49009679438,PPP2R2A
13111,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0176998626413668,0,0,19670.0,80733.60565076157,PPP2R2A
13112,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0176998626413668,0,0,19646.0,79255.8617626126,PPP2R2A
13113,KEGG_2019_Human,Cortisol synthesis and secretion,1/65,0.003249949134407,0.0077499127120574,0,0,19935.0,114209.92613860144,PDE8B
13114,KEGG_2019_Human,Morphine addiction,1/91,0.0045499369072032,0.0077499127120574,0,0,19909.0,107362.10783923086,PDE8B
13115,KEGG_2019_Human,Purine metabolism,1/129,0.006449921761047,0.0077499127120574,0,0,19871.0,100223.109907462,PDE8B
13116,KEGG_2019_Human,Cushing syndrome,1/155,0.0077499127120574,0.0077499127120574,0,0,19845.0,96448.16254952336,PDE8B
13117,KEGG_2019_Human,Sphingolipid metabolism,1/47,0.0023499589392381,0.0046999178784763,0,0,19953.0,120782.64067395544,SGPL1
13118,KEGG_2019_Human,Sphingolipid signaling pathway,1/119,0.0059499254985137,0.0059499254985137,0,0,19881.0,101877.73080211312,SGPL1
13119,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR11H6
13120,KEGG_2019_Human,Endocytosis,1/244,0.0121998870519305,0.0121998870519305,0,0,19756.0,87051.4275316661,IQSEC1
13121,KEGG_2019_Human,Homologous recombination,1/41,0.0020499625466866,0.0020499625466866,0,0,19959.0,123544.88783416104,RAD51D
13122,KEGG_2019_Human,Nucleotide excision repair,1/47,0.0023499589392381,0.0023499589392381,0,0,19953.0,120782.64067395544,ERCC6
13123,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0146998751759735,0,0,19706.0,83157.67014793828,IL36B
13124,KEGG_2019_Human,Vasopressin-regulated water reabsorption,1/44,0.0021999607179423,0.0115367054817097,0,0,19956.0,122117.06559109331,CREB3L3
13125,KEGG_2019_Human,Cocaine addiction,1/49,0.0024499577795033,0.0115367054817097,0,0,19951.0,119939.1172087114,CREB3L3
13126,KEGG_2019_Human,Cortisol synthesis and secretion,1/65,0.003249949134407,0.0115367054817097,0,0,19935.0,114209.92613860144,CREB3L3
13127,KEGG_2019_Human,Amphetamine addiction,1/68,0.0033999476216189,0.0115367054817097,0,0,19932.0,113293.39338050144,CREB3L3
13128,KEGG_2019_Human,Thyroid hormone synthesis,1/74,0.0036999446830449,0.0115367054817097,0,0,19926.0,111574.38983110404,CREB3L3
13129,KEGG_2019_Human,Insulin secretion,1/86,0.0042999391173866,0.0115367054817097,0,0,19914.0,108514.46102290176,CREB3L3
13130,KEGG_2019_Human,Prostate cancer,1/97,0.0048499343304706,0.0115367054817097,0,0,19903.0,106058.9096435903,CREB3L3
13131,KEGG_2019_Human,Aldosterone synthesis and secretion,1/98,0.0048999339081079,0.0115367054817097,0,0,19902.0,105849.45495286948,CREB3L3
13132,KEGG_2019_Human,Melanogenesis,1/101,0.0050499326546803,0.0115367054817097,0,0,19899.0,105233.48101229242,CREB3L3
13133,KEGG_2019_Human,Longevity regulating pathway,1/102,0.0050999322416682,0.0115367054817097,0,0,19898.0,105032.15064717118,CREB3L3
13134,KEGG_2019_Human,Glucagon signaling pathway,1/103,0.0051499318302617,0.0115367054817097,0,0,19897.0,104832.7525292024,CREB3L3
13135,KEGG_2019_Human,"Parathyroid hormone synthesis, secretion and action",1/106,0.0052999306076525,0.0115367054817097,0,0,19894.0,104245.78450366124,CREB3L3
13136,KEGG_2019_Human,Insulin resistance,1/108,0.0053999298011749,0.0115367054817097,0,0,19892.0,103863.47861844616,CREB3L3
13137,KEGG_2019_Human,TNF signaling pathway,1/110,0.0054999290027479,0.0115367054817097,0,0,19890.0,103488.06969787036,CREB3L3
13138,KEGG_2019_Human,Cholinergic synapse,1/112,0.0055999282120529,0.0115367054817097,0,0,19888.0,103119.30984392198,CREB3L3
13139,KEGG_2019_Human,AMPK signaling pathway,1/120,0.0059999251180858,0.0115367054817097,0,0,19880.0,101706.2448082016,CREB3L3
13140,KEGG_2019_Human,Relaxin signaling pathway,1/130,0.0064999213952527,0.0115367054817097,0,0,19870.0,100064.62842845908,CREB3L3
13141,KEGG_2019_Human,Dopaminergic synapse,1/131,0.0065499210316603,0.0115367054817097,0,0,19869.0,99907.33811343512,CREB3L3
13142,KEGG_2019_Human,Estrogen signaling pathway,1/137,0.0068499188797651,0.0115367054817097,0,0,19863.0,98987.62735269018,CREB3L3
13143,KEGG_2019_Human,Adrenergic signaling in cardiomyocytes,1/145,0.0072499160871101,0.0115476996679976,0,0,19855.0,97820.92670675044,CREB3L3
13144,KEGG_2019_Human,Cushing syndrome,1/155,0.0077499127120574,0.0115476996679976,0,0,19845.0,96448.16254952336,CREB3L3
13145,KEGG_2019_Human,Hepatitis B,1/163,0.0081499100978668,0.0115476996679976,0,0,19837.0,95410.9786681514,CREB3L3
13146,KEGG_2019_Human,cGMP-PKG signaling pathway,1/166,0.0082999091363732,0.0115476996679976,0,0,19834.0,95034.82345515196,CREB3L3
13147,KEGG_2019_Human,Alcoholism,1/180,0.0089999047745351,0.0119998730327134,0,0,19820.0,93362.92821536642,CREB3L3
13148,KEGG_2019_Human,Huntington disease,1/193,0.0096499008972596,0.0123198830870033,0,0,19807.0,91920.47679471428,CREB3L3
13149,KEGG_2019_Human,Viral carcinogenesis,1/201,0.0100498985877989,0.0123198830870033,0,0,19799.0,91079.21596609056,CREB3L3
13150,KEGG_2019_Human,cAMP signaling pathway,1/212,0.0105998955026255,0.0123198830870033,0,0,19788.0,89974.27756224656,CREB3L3
13151,KEGG_2019_Human,Human T-cell leukemia virus 1 infection,1/219,0.0109498935894162,0.0123198830870033,0,0,19781.0,89299.85161916987,CREB3L3
13152,KEGG_2019_Human,Human cytomegalovirus infection,1/225,0.0112498919790339,0.0123198830870033,0,0,19775.0,88738.27077557483,CREB3L3
13153,KEGG_2019_Human,Thermogenesis,1/231,0.0115498903940656,0.0123198830870033,0,0,19769.0,88191.07730937863,CREB3L3
13154,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0170321212479633,0,0,19670.0,80733.60565076157,CREB3L3
13155,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0176998626413668,0,0,19646.0,79255.8617626126,CREB3L3
13156,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR2A12
13157,KEGG_2019_Human,Cocaine addiction,1/49,0.0024499577795033,0.0100748865256747,0,0,19951.0,119939.1172087114,GNAI3
13158,KEGG_2019_Human,Regulation of lipolysis in adipocytes,1/55,0.0027499544131125,0.0100748865256747,0,0,19945.0,117599.1294878737,GNAI3
13159,KEGG_2019_Human,Long-term depression,1/60,0.002999951725986,0.0100748865256747,0,0,19940.0,115834.63209072244,GNAI3
13160,KEGG_2019_Human,Renin secretion,1/69,0.003449947123837,0.0100748865256747,0,0,19931.0,112996.7391397682,GNAI3
13161,KEGG_2019_Human,Gastric acid secretion,1/75,0.0037499442041125,0.0100748865256747,0,0,19925.0,111301.33528642564,GNAI3
13162,KEGG_2019_Human,Pertussis,1/76,0.0037999437281752,0.0100748865256747,0,0,19924.0,111031.8499691117,GNAI3
13163,KEGG_2019_Human,Gap junction,1/88,0.0043999382262822,0.0100748865256747,0,0,19912.0,108045.79305232369,GNAI3
13164,KEGG_2019_Human,GABAergic synapse,1/89,0.0044499377838098,0.0100748865256747,0,0,19911.0,107815.380281759,GNAI3
13165,KEGG_2019_Human,Morphine addiction,1/91,0.0045499369072032,0.0100748865256747,0,0,19909.0,107362.10783923086,GNAI3
13166,KEGG_2019_Human,Circadian entrainment,1/97,0.0048499343304706,0.0100748865256747,0,0,19903.0,106058.9096435903,GNAI3
13167,KEGG_2019_Human,Progesterone-mediated oocyte maturation,1/99,0.0049499334884068,0.0100748865256747,0,0,19901.0,105642.09305076736,GNAI3
13168,KEGG_2019_Human,Melanogenesis,1/101,0.0050499326546803,0.0100748865256747,0,0,19899.0,105233.48101229242,GNAI3
13169,KEGG_2019_Human,Chagas disease (American trypanosomiasis),1/103,0.0051499318302617,0.0100748865256747,0,0,19897.0,104832.7525292024,GNAI3
13170,KEGG_2019_Human,"Parathyroid hormone synthesis, secretion and action",1/106,0.0052999306076525,0.0100748865256747,0,0,19894.0,104245.78450366124,GNAI3
13171,KEGG_2019_Human,Leukocyte transendothelial migration,1/112,0.0055999282120529,0.0100748865256747,0,0,19888.0,103119.30984392198,GNAI3
13172,KEGG_2019_Human,Cholinergic synapse,1/112,0.0055999282120529,0.0100748865256747,0,0,19888.0,103119.30984392198,GNAI3
13173,KEGG_2019_Human,Toxoplasmosis,1/113,0.0056499278191151,0.0100748865256747,0,0,19887.0,102937.34947211576,GNAI3
13174,KEGG_2019_Human,Serotonergic synapse,1/113,0.0056499278191151,0.0100748865256747,0,0,19887.0,102937.34947211576,GNAI3
13175,KEGG_2019_Human,Glutamatergic synapse,1/114,0.005699927427839,0.0100748865256747,0,0,19886.0,102756.96431429044,GNAI3
13176,KEGG_2019_Human,Sphingolipid signaling pathway,1/119,0.0059499254985137,0.0100748865256747,0,0,19881.0,101877.73080211312,GNAI3
13177,KEGG_2019_Human,Platelet activation,1/124,0.0061999236097501,0.0100748865256747,0,0,19876.0,101034.04709010696,GNAI3
13178,KEGG_2019_Human,Relaxin signaling pathway,1/130,0.0064999213952527,0.0100748865256747,0,0,19870.0,100064.62842845908,GNAI3
13179,KEGG_2019_Human,Dopaminergic synapse,1/131,0.0065499210316603,0.0100748865256747,0,0,19869.0,99907.33811343512,GNAI3
13180,KEGG_2019_Human,Estrogen signaling pathway,1/137,0.0068499188797651,0.0100748865256747,0,0,19863.0,98987.62735269018,GNAI3
13181,KEGG_2019_Human,Apelin signaling pathway,1/137,0.0068499188797651,0.0100748865256747,0,0,19863.0,98987.62735269018,GNAI3
13182,KEGG_2019_Human,Parkinson disease,1/142,0.0070999171242726,0.0100748865256747,0,0,19858.0,98250.87390500787,GNAI3
13183,KEGG_2019_Human,Adrenergic signaling in cardiomyocytes,1/145,0.0072499160871101,0.0100748865256747,0,0,19855.0,97820.92670675044,GNAI3
13184,KEGG_2019_Human,Retrograde endocannabinoid signaling,1/148,0.007399915061391,0.0100748865256747,0,0,19852.0,97399.60470052566,GNAI3
13185,KEGG_2019_Human,Oxytocin signaling pathway,1/153,0.0076499133771537,0.0100748865256747,0,0,19847.0,96715.6407630817,GNAI3
13186,KEGG_2019_Human,Cushing syndrome,1/155,0.0077499127120574,0.0100748865256747,0,0,19845.0,96448.16254952336,GNAI3
13187,KEGG_2019_Human,cGMP-PKG signaling pathway,1/166,0.0082999091363732,0.0104418211715663,0,0,19834.0,95034.82345515196,GNAI3
13188,KEGG_2019_Human,Alcoholism,1/180,0.0089999047745351,0.0106953416472929,0,0,19820.0,93362.92821536642,GNAI3
13189,KEGG_2019_Human,Axon guidance,1/181,0.0090499044707863,0.0106953416472929,0,0,19819.0,93248.41634586031,GNAI3
13190,KEGG_2019_Human,Chemokine signaling pathway,1/190,0.0094999017791995,0.0108969461584936,0,0,19810.0,92244.74636351672,GNAI3
13191,KEGG_2019_Human,Rap1 signaling pathway,1/206,0.010299897173561,0.0111728628270918,0,0,19794.0,90569.849337325,GNAI3
13192,KEGG_2019_Human,Human immunodeficiency virus 1 infection,1/212,0.0105998955026255,0.0111728628270918,0,0,19788.0,89974.27756224656,GNAI3
13193,KEGG_2019_Human,cAMP signaling pathway,1/212,0.0105998955026255,0.0111728628270918,0,0,19788.0,89974.27756224656,GNAI3
13194,KEGG_2019_Human,Human cytomegalovirus infection,1/225,0.0112498919790339,0.0115459417679558,0,0,19775.0,88738.27077557483,GNAI3
13195,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,GNAI3
13196,KEGG_2019_Human,mRNA surveillance pathway,1/91,0.0045499369072032,0.0045499369072032,0,0,19909.0,107362.10783923086,FIP1L1
13197,KEGG_2019_Human,Insulin resistance,1/108,0.0053999298011749,0.0068499188797651,0,0,19892.0,103863.47861844616,PPP1R3C
13198,KEGG_2019_Human,Insulin signaling pathway,1/137,0.0068499188797651,0.0068499188797651,0,0,19863.0,98987.62735269018,PPP1R3C
13199,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,GLRA3
13200,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR8H1
13201,KEGG_2019_Human,Ubiquitin mediated proteolysis,1/137,0.0068499188797651,0.0068499188797651,0,0,19863.0,98987.62735269018,UBE2F
13202,KEGG_2019_Human,Circadian rhythm,1/31,0.0015499690656704,0.0046499071970112,0,0,19969.0,129189.85098816035,RORA
13203,KEGG_2019_Human,Inflammatory bowel disease (IBD),1/65,0.003249949134407,0.0048749237016105,0,0,19935.0,114209.92613860144,RORA
13204,KEGG_2019_Human,Th17 cell differentiation,1/107,0.0053499302026925,0.0053499302026925,0,0,19893.0,104053.753408911,RORA
13205,KEGG_2019_Human,Amyotrophic lateral sclerosis (ALS),1/51,0.0025499566390179,0.0121069881838182,0,0,19949.0,119129.0228601236,MAP2K3
13206,KEGG_2019_Human,Fc epsilon RI signaling pathway,1/68,0.0033999476216189,0.0121069881838182,0,0,19932.0,113293.39338050144,MAP2K3
13207,KEGG_2019_Human,GnRH signaling pathway,1/93,0.0046499360391879,0.0121069881838182,0,0,19907.0,106918.54242106884,MAP2K3
13208,KEGG_2019_Human,Inflammatory mediator regulation of TRP channels,1/100,0.0049999330710556,0.0121069881838182,0,0,19900.0,105436.78197328727,MAP2K3
13209,KEGG_2019_Human,Toll-like receptor signaling pathway,1/104,0.0051999314202997,0.0121069881838182,0,0,19896.0,104635.24941415618,MAP2K3
13210,KEGG_2019_Human,TNF signaling pathway,1/110,0.0054999290027479,0.0121069881838182,0,0,19890.0,103488.06969787036,MAP2K3
13211,KEGG_2019_Human,Toxoplasmosis,1/113,0.0056499278191151,0.0121069881838182,0,0,19887.0,102937.34947211576,MAP2K3
13212,KEGG_2019_Human,Cellular senescence,1/160,0.0079999110688441,0.0122306486568756,0,0,19840.0,95793.96509856998,MAP2K3
13213,KEGG_2019_Human,Hepatitis B,1/163,0.0081499100978668,0.0122306486568756,0,0,19837.0,95410.9786681514,MAP2K3
13214,KEGG_2019_Human,Influenza A,1/171,0.0085499075557634,0.0122306486568756,0,0,19829.0,94422.42241345016,MAP2K3
13215,KEGG_2019_Human,Epstein-Barr virus infection,1/201,0.0100498985877989,0.0122306486568756,0,0,19799.0,91079.21596609056,MAP2K3
13216,KEGG_2019_Human,Rap1 signaling pathway,1/206,0.010299897173561,0.0122306486568756,0,0,19794.0,90569.849337325,MAP2K3
13217,KEGG_2019_Human,Human immunodeficiency virus 1 infection,1/212,0.0105998955026255,0.0122306486568756,0,0,19788.0,89974.27756224656,MAP2K3
13218,KEGG_2019_Human,Thermogenesis,1/231,0.0115498903940656,0.0123748825650702,0,0,19769.0,88191.07730937863,MAP2K3
13219,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0147498749536506,0,0,19705.0,83086.53988020132,MAP2K3
13220,KEGG_2019_Human,RNA transport,1/165,0.0082499094553477,0.0082499094553477,0,0,19835.0,95159.46482222488,THOC6
13221,KEGG_2019_Human,Ribosome biogenesis in eukaryotes,1/101,0.0050499326546803,0.0050499326546803,0,0,19899.0,105233.48101229242,NOL6
13222,KEGG_2019_Human,Homologous recombination,1/41,0.0020499625466866,0.0020499625466866,0,0,19959.0,123544.88783416104,XRCC2
13223,KEGG_2019_Human,Hippo signaling pathway,1/160,0.0079999110688441,0.0079999110688441,0,0,19840.0,95793.96509856998,LATS2
13224,KEGG_2019_Human,Legionellosis,1/55,0.0027499544131125,0.0104498870125997,0,0,19945.0,117599.1294878737,HSPA1L
13225,KEGG_2019_Human,Antigen processing and presentation,1/77,0.0038499432547502,0.0104498870125997,0,0,19923.0,110765.8407373636,HSPA1L
13226,KEGG_2019_Human,Longevity regulating pathway,1/102,0.0050999322416682,0.0104498870125997,0,0,19898.0,105032.15064717118,HSPA1L
13227,KEGG_2019_Human,Toxoplasmosis,1/113,0.0056499278191151,0.0104498870125997,0,0,19887.0,102937.34947211576,HSPA1L
13228,KEGG_2019_Human,Spliceosome,1/134,0.0066999199497742,0.0104498870125997,0,0,19866.0,99442.43560916925,HSPA1L
13229,KEGG_2019_Human,Estrogen signaling pathway,1/137,0.0068499188797651,0.0104498870125997,0,0,19863.0,98987.62735269018,HSPA1L
13230,KEGG_2019_Human,Measles,1/138,0.0068999185254481,0.0104498870125997,0,0,19862.0,98838.19160389496,HSPA1L
13231,KEGG_2019_Human,Protein processing in endoplasmic reticulum,1/165,0.0082499094553477,0.0104498870125997,0,0,19835.0,95159.46482222488,HSPA1L
13232,KEGG_2019_Human,Influenza A,1/171,0.0085499075557634,0.0104498870125997,0,0,19829.0,94422.42241345016,HSPA1L
13233,KEGG_2019_Human,Endocytosis,1/244,0.0121998870519305,0.0134198757571236,0,0,19756.0,87051.4275316661,HSPA1L
13234,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0147498749536506,0,0,19705.0,83086.53988020132,HSPA1L
13235,KEGG_2019_Human,Taste transduction,1/83,0.0041499404726918,0.0082998809453837,0,0,19917.0,109237.99888847338,HCN4
13236,KEGG_2019_Human,cAMP signaling pathway,1/212,0.0105998955026255,0.0105998955026255,0,0,19788.0,89974.27756224656,HCN4
13237,KEGG_2019_Human,African trypanosomiasis,1/37,0.0018499650702878,0.0085748522282616,0,0,19963.0,125618.9446446357,TLR9
13238,KEGG_2019_Human,Malaria,1/49,0.0024499577795033,0.0085748522282616,0,0,19951.0,119939.1172087114,TLR9
13239,KEGG_2019_Human,Chagas disease (American trypanosomiasis),1/103,0.0051499318302617,0.0090998799855245,0,0,19897.0,104832.7525292024,TLR9
13240,KEGG_2019_Human,Toll-like receptor signaling pathway,1/104,0.0051999314202997,0.0090998799855245,0,0,19896.0,104635.24941415618,TLR9
13241,KEGG_2019_Human,Measles,1/138,0.0068999185254481,0.0096598859356274,0,0,19862.0,98838.19160389496,TLR9
13242,KEGG_2019_Human,Tuberculosis,1/179,0.0089499050800561,0.0104415559267321,0,0,19821.0,93478.0629355712,TLR9
13243,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,TLR9
13244,KEGG_2019_Human,Allograft rejection,1/38,0.001899964429635,0.0058999045110413,0,0,19962.0,125080.29732025368,CD86
13245,KEGG_2019_Human,Graft-versus-host disease,1/41,0.0020499625466866,0.0058999045110413,0,0,19959.0,123544.88783416104,CD86
13246,KEGG_2019_Human,Type I diabetes mellitus,1/43,0.0021499613216957,0.0058999045110413,0,0,19957.0,122581.98940490963,CD86
13247,KEGG_2019_Human,Intestinal immune network for IgA production,1/48,0.0023999583567988,0.0058999045110413,0,0,19952.0,120356.5272753826,CD86
13248,KEGG_2019_Human,Autoimmune thyroid disease,1/53,0.0026499555173137,0.0058999045110413,0,0,19947.0,118349.78824235698,CD86
13249,KEGG_2019_Human,Viral myocarditis,1/59,0.0029499522555206,0.0058999045110413,0,0,19941.0,116175.59385530632,CD86
13250,KEGG_2019_Human,Rheumatoid arthritis,1/91,0.0045499369072032,0.0077998918409197,0,0,19909.0,107362.10783923086,CD86
13251,KEGG_2019_Human,Toll-like receptor signaling pathway,1/104,0.0051999314202997,0.0077998971304496,0,0,19896.0,104635.24941415618,CD86
13252,KEGG_2019_Human,Systemic lupus erythematosus,1/133,0.0066499203093911,0.0086998993045322,0,0,19867.0,99596.2591544721,CD86
13253,KEGG_2019_Human,Cell adhesion molecules (CAMs),1/145,0.0072499160871101,0.0086998993045322,0,0,19855.0,97820.92670675044,CD86
13254,KEGG_2019_Human,Transcriptional misregulation in cancer,1/186,0.0092999029651357,0.0092999029651357,0,0,19814.0,92684.96451050608,CD86
13255,KEGG_2019_Human,Kaposi sarcoma-associated herpesvirus infection,1/186,0.0092999029651357,0.0092999029651357,0,0,19814.0,92684.96451050608,CD86
13256,KEGG_2019_Human,Basal transcription factors,1/45,0.0022499601197094,0.0112498005985471,0,0,19955.0,121662.49782449217,TBP
13257,KEGG_2019_Human,Huntington disease,1/193,0.0096499008972596,0.0136873669867703,0,0,19807.0,91920.47679471428,TBP
13258,KEGG_2019_Human,Viral carcinogenesis,1/201,0.0100498985877989,0.0136873669867703,0,0,19799.0,91079.21596609056,TBP
13259,KEGG_2019_Human,Human T-cell leukemia virus 1 infection,1/219,0.0109498935894162,0.0136873669867703,0,0,19781.0,89299.85161916987,TBP
13260,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0164998674589645,0,0,19670.0,80733.60565076157,TBP
13261,KEGG_2019_Human,Inositol phosphate metabolism,1/74,0.0036999446830449,0.0092999029651357,0,0,19926.0,111574.38983110404,PIK3C3
13262,KEGG_2019_Human,Phosphatidylinositol signaling system,1/99,0.0049499334884068,0.0092999029651357,0,0,19901.0,105642.09305076736,PIK3C3
13263,KEGG_2019_Human,Autophagy,1/128,0.0063999221281459,0.0092999029651357,0,0,19872.0,100382.8010329652,PIK3C3
13264,KEGG_2019_Human,Apelin signaling pathway,1/137,0.0068499188797651,0.0092999029651357,0,0,19863.0,98987.62735269018,PIK3C3
13265,KEGG_2019_Human,Phagosome,1/152,0.0075999137114971,0.0092999029651357,0,0,19848.0,96850.665715497,PIK3C3
13266,KEGG_2019_Human,Tuberculosis,1/179,0.0089499050800561,0.0092999029651357,0,0,19821.0,93478.0629355712,PIK3C3
13267,KEGG_2019_Human,Kaposi sarcoma-associated herpesvirus infection,1/186,0.0092999029651357,0.0092999029651357,0,0,19814.0,92684.96451050608,PIK3C3
13268,KEGG_2019_Human,Endocytosis,1/244,0.0121998870519305,0.0121998870519305,0,0,19756.0,87051.4275316661,WIPF1
13269,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF382
13270,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF565
13271,KEGG_2019_Human,Calcium signaling pathway,1/188,0.009399902370135,0.0168998658265596,0,0,19812.0,92463.712994847,TACR3
13272,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,TACR3
13273,KEGG_2019_Human,Glutamatergic synapse,1/114,0.005699927427839,0.011399854855678,0,0,19886.0,102756.96431429044,GRIK3
13274,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,GRIK3
13275,KEGG_2019_Human,Staphylococcus aureus infection,1/68,0.0033999476216189,0.0059249134751006,0,0,19932.0,113293.39338050144,C5AR1
13276,KEGG_2019_Human,Complement and coagulation cascades,1/79,0.0039499423167337,0.0059249134751006,0,0,19921.0,110243.89578070649,C5AR1
13277,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,C5AR1
13278,KEGG_2019_Human,NOD-like receptor signaling pathway,1/178,0.0088999053857096,0.0088999053857096,0,0,19822.0,93593.82745769851,NLRP7
13279,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR51D1
13280,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF670
13281,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR2L13
13282,KEGG_2019_Human,Acute myeloid leukemia,1/66,0.003299948626608,0.0111763436933781,0,0,19934.0,113899.85357353876,RPS6KB1
13283,KEGG_2019_Human,Pancreatic cancer,1/75,0.0037499442041125,0.0111763436933781,0,0,19925.0,111301.33528642564,RPS6KB1
13284,KEGG_2019_Human,ErbB signaling pathway,1/85,0.004249939567045,0.0111763436933781,0,0,19915.0,108752.83801948265,RPS6KB1
13285,KEGG_2019_Human,Colorectal cancer,1/86,0.0042999391173866,0.0111763436933781,0,0,19914.0,108514.46102290176,RPS6KB1
13286,KEGG_2019_Human,TGF-beta signaling pathway,1/90,0.0044999373439762,0.0111763436933781,0,0,19910.0,107587.50385474482,RPS6KB1
13287,KEGG_2019_Human,Fc gamma R-mediated phagocytosis,1/91,0.0045499369072032,0.0111763436933781,0,0,19909.0,107362.10783923086,RPS6KB1
13288,KEGG_2019_Human,Choline metabolism in cancer,1/99,0.0049499334884068,0.0111763436933781,0,0,19901.0,105642.09305076736,RPS6KB1
13289,KEGG_2019_Human,HIF-1 signaling pathway,1/100,0.0049999330710556,0.0111763436933781,0,0,19900.0,105436.78197328727,RPS6KB1
13290,KEGG_2019_Human,Longevity regulating pathway,1/102,0.0050999322416682,0.0111763436933781,0,0,19898.0,105032.15064717118,RPS6KB1
13291,KEGG_2019_Human,Insulin resistance,1/108,0.0053999298011749,0.0111763436933781,0,0,19892.0,103863.47861844616,RPS6KB1
13292,KEGG_2019_Human,AMPK signaling pathway,1/120,0.0059999251180858,0.0111763436933781,0,0,19880.0,101706.2448082016,RPS6KB1
13293,KEGG_2019_Human,Autophagy,1/128,0.0063999221281459,0.0111763436933781,0,0,19872.0,100382.8010329652,RPS6KB1
13294,KEGG_2019_Human,Insulin signaling pathway,1/137,0.0068499188797651,0.0111763436933781,0,0,19863.0,98987.62735269018,RPS6KB1
13295,KEGG_2019_Human,Apelin signaling pathway,1/137,0.0068499188797651,0.0111763436933781,0,0,19863.0,98987.62735269018,RPS6KB1
13296,KEGG_2019_Human,Breast cancer,1/147,0.0073499154017982,0.0111763436933781,0,0,19853.0,97539.10874372096,RPS6KB1
13297,KEGG_2019_Human,Gastric cancer,1/149,0.0074499147221605,0.0111763436933781,0,0,19851.0,97261.02051561224,RPS6KB1
13298,KEGG_2019_Human,mTOR signaling pathway,1/152,0.0075999137114971,0.0111763436933781,0,0,19848.0,96850.665715497,RPS6KB1
13299,KEGG_2019_Human,Hepatocellular carcinoma,1/168,0.0083999085011095,0.0116665395848743,0,0,19832.0,94787.72752807094,RPS6KB1
13300,KEGG_2019_Human,Proteoglycans in cancer,1/201,0.0100498985877989,0.0131248754478018,0,0,19799.0,91079.21596609056,RPS6KB1
13301,KEGG_2019_Human,Human immunodeficiency virus 1 infection,1/212,0.0105998955026255,0.0131248754478018,0,0,19788.0,89974.27756224656,RPS6KB1
13302,KEGG_2019_Human,Human cytomegalovirus infection,1/225,0.0112498919790339,0.0131248754478018,0,0,19775.0,88738.27077557483,RPS6KB1
13303,KEGG_2019_Human,Thermogenesis,1/231,0.0115498903940656,0.0131248754478018,0,0,19769.0,88191.07730937863,RPS6KB1
13304,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0179346385423527,0,0,19670.0,80733.60565076157,RPS6KB1
13305,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0184373569180905,0,0,19646.0,79255.8617626126,RPS6KB1
13306,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,RPS6KB1
13307,KEGG_2019_Human,Ubiquitin mediated proteolysis,1/137,0.0068499188797651,0.0068499188797651,0,0,19863.0,98987.62735269018,CUL7
13308,KEGG_2019_Human,Insulin signaling pathway,1/137,0.0068499188797651,0.0068499188797651,0,0,19863.0,98987.62735269018,PRKAR1B
13309,KEGG_2019_Human,Inositol phosphate metabolism,1/74,0.0036999446830449,0.0063999221281459,0,0,19926.0,111574.38983110404,MTMR4
13310,KEGG_2019_Human,Phosphatidylinositol signaling system,1/99,0.0049499334884068,0.0063999221281459,0,0,19901.0,105642.09305076736,MTMR4
13311,KEGG_2019_Human,Autophagy,1/128,0.0063999221281459,0.0063999221281459,0,0,19872.0,100382.8010329652,MTMR4
13312,KEGG_2019_Human,Axon guidance,1/181,0.0090499044707863,0.0090499044707863,0,0,19819.0,93248.41634586031,SEMA4C
13313,KEGG_2019_Human,Primary immunodeficiency,1/37,0.0018499650702878,0.0036999301405757,0,0,19963.0,125618.9446446357,RAG2
13314,KEGG_2019_Human,FoxO signaling pathway,1/132,0.0065999206698993,0.0065999206698993,0,0,19868.0,99751.22090491928,RAG2
13315,KEGG_2019_Human,Th1 and Th2 cell differentiation,1/92,0.0045999364719865,0.0174284100741865,0,0,19908.0,107139.13814408927,IL2RB
13316,KEGG_2019_Human,Th17 cell differentiation,1/107,0.0053499302026925,0.0174284100741865,0,0,19893.0,104053.753408911,IL2RB
13317,KEGG_2019_Human,Measles,1/138,0.0068999185254481,0.0174284100741865,0,0,19862.0,98838.19160389496,IL2RB
13318,KEGG_2019_Human,JAK-STAT signaling pathway,1/162,0.0080999104202618,0.0174284100741865,0,0,19838.0,95537.86936302872,IL2RB
13319,KEGG_2019_Human,Transcriptional misregulation in cancer,1/186,0.0092999029651357,0.0174284100741865,0,0,19814.0,92684.96451050608,IL2RB
13320,KEGG_2019_Human,Human T-cell leukemia virus 1 infection,1/219,0.0109498935894162,0.0174284100741865,0,0,19781.0,89299.85161916987,IL2RB
13321,KEGG_2019_Human,Endocytosis,1/244,0.0121998870519305,0.0174284100741865,0,0,19756.0,87051.4275316661,IL2RB
13322,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0183748439699668,0,0,19706.0,83157.67014793828,IL2RB
13323,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0196665140459632,0,0,19646.0,79255.8617626126,IL2RB
13324,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,IL2RB
13325,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF679
13326,KEGG_2019_Human,Renin secretion,1/69,0.003449947123837,0.0080832238841178,0,0,19931.0,112996.7391397682,ADCYAP1R1
13327,KEGG_2019_Human,Insulin secretion,1/86,0.0042999391173866,0.0080832238841178,0,0,19914.0,108514.46102290176,ADCYAP1R1
13328,KEGG_2019_Human,Circadian entrainment,1/97,0.0048499343304706,0.0080832238841178,0,0,19903.0,106058.9096435903,ADCYAP1R1
13329,KEGG_2019_Human,cAMP signaling pathway,1/212,0.0105998955026255,0.0132498693782819,0,0,19788.0,89974.27756224656,ADCYAP1R1
13330,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,ADCYAP1R1
13331,KEGG_2019_Human,Fat digestion and absorption,1/41,0.0020499625466866,0.0060999024003308,0,0,19959.0,123544.88783416104,AGPAT1
13332,KEGG_2019_Human,Glycerolipid metabolism,1/61,0.0030499512001654,0.0060999024003308,0,0,19939.0,115499.24335773686,AGPAT1
13333,KEGG_2019_Human,Glycerophospholipid metabolism,1/97,0.0048499343304706,0.0064665791072942,0,0,19903.0,106058.9096435903,AGPAT1
13334,KEGG_2019_Human,Phospholipase D signaling pathway,1/148,0.007399915061391,0.007399915061391,0,0,19852.0,97399.60470052566,AGPAT1
13335,KEGG_2019_Human,Ubiquitin mediated proteolysis,1/137,0.0068499188797651,0.0068499188797651,0,0,19863.0,98987.62735269018,UBE2Q1
13336,KEGG_2019_Human,Complement and coagulation cascades,1/79,0.0039499423167337,0.0039499423167337,0,0,19921.0,110243.89578070649,VSIG4
13337,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR2A1
13338,KEGG_2019_Human,JAK-STAT signaling pathway,1/162,0.0080999104202618,0.0080999104202618,0,0,19838.0,95537.86936302872,GFAP
13339,KEGG_2019_Human,cAMP signaling pathway,1/212,0.0105998955026255,0.0105998955026255,0,0,19788.0,89974.27756224656,HCAR1
13340,KEGG_2019_Human,Glyoxylate and dicarboxylate metabolism,1/30,0.0014999697593334,0.0014999697593334,0,0,19970.0,129851.13732048514,ACO1
13341,KEGG_2019_Human,Citrate cycle (TCA cycle),1/30,0.0014999697593334,0.0014999697593334,0,0,19970.0,129851.13732048514,ACO1
13342,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF597
13343,KEGG_2019_Human,Synaptic vesicle cycle,1/78,0.0038999427840466,0.0056499278191151,0,0,19922.0,110503.2180492851,SLC6A4
13344,KEGG_2019_Human,Serotonergic synapse,1/113,0.0056499278191151,0.0056499278191151,0,0,19887.0,102937.34947211576,SLC6A4
13345,KEGG_2019_Human,Taste transduction,1/83,0.0041499404726918,0.0082998809453837,0,0,19917.0,109237.99888847338,P2RY4
13346,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,P2RY4
13347,KEGG_2019_Human,Cocaine addiction,1/49,0.0024499577795033,0.0096499008972596,0,0,19951.0,119939.1172087114,DLG4
13348,KEGG_2019_Human,Glutamatergic synapse,1/114,0.005699927427839,0.0096499008972596,0,0,19886.0,102756.96431429044,DLG4
13349,KEGG_2019_Human,Hippo signaling pathway,1/160,0.0079999110688441,0.0096499008972596,0,0,19840.0,95793.96509856998,DLG4
13350,KEGG_2019_Human,Huntington disease,1/193,0.0096499008972596,0.0096499008972596,0,0,19807.0,91920.47679471428,DLG4
13351,KEGG_2019_Human,Pathogenic Escherichia coli infection,1/55,0.0027499544131125,0.0065999073394233,0,0,19945.0,117599.1294878737,TUBB4B
13352,KEGG_2019_Human,Gap junction,1/88,0.0043999382262822,0.0065999073394233,0,0,19912.0,108045.79305232369,TUBB4B
13353,KEGG_2019_Human,Phagosome,1/152,0.0075999137114971,0.0075999137114971,0,0,19848.0,96850.665715497,TUBB4B
13354,KEGG_2019_Human,Galactose metabolism,1/31,0.0015499690656704,0.0030999381313408,0,0,19969.0,129189.85098816035,GALM
13355,KEGG_2019_Human,Glycolysis / Gluconeogenesis,1/68,0.0033999476216189,0.0033999476216189,0,0,19932.0,113293.39338050144,GALM
13356,KEGG_2019_Human,Inositol phosphate metabolism,1/74,0.0036999446830449,0.0049499334884068,0,0,19926.0,111574.38983110404,INPP5B
13357,KEGG_2019_Human,Phosphatidylinositol signaling system,1/99,0.0049499334884068,0.0049499334884068,0,0,19901.0,105642.09305076736,INPP5B
13358,KEGG_2019_Human,Endocytosis,1/244,0.0121998870519305,0.0121998870519305,0,0,19756.0,87051.4275316661,SPART
13359,KEGG_2019_Human,Basal transcription factors,1/45,0.0022499601197094,0.0022499601197094,0,0,19955.0,121662.49782449217,TAF1
13360,KEGG_2019_Human,Complement and coagulation cascades,1/79,0.0039499423167337,0.0039499423167337,0,0,19921.0,110243.89578070649,F8
13361,KEGG_2019_Human,Protein digestion and absorption,1/90,0.0044999373439762,0.0089998746879525,0,0,19910.0,107587.50385474482,COL21A1
13362,KEGG_2019_Human,Proteoglycans in cancer,1/201,0.0100498985877989,0.0100498985877989,0,0,19799.0,91079.21596609056,COL21A1
13363,KEGG_2019_Human,Autoimmune thyroid disease,1/53,0.0026499555173137,0.0145586837375733,0,0,19947.0,118349.78824235698,IFNA16
13364,KEGG_2019_Human,Cytosolic DNA-sensing pathway,1/63,0.0031499501598827,0.0145586837375733,0,0,19937.0,114844.46974572667,IFNA16
13365,KEGG_2019_Human,RIG-I-like receptor signaling pathway,1/70,0.0034999466296654,0.0145586837375733,0,0,19930.0,112704.30065625212,IFNA16
13366,KEGG_2019_Human,Toll-like receptor signaling pathway,1/104,0.0051999314202997,0.0145586837375733,0,0,19896.0,104635.24941415618,IFNA16
13367,KEGG_2019_Human,Natural killer cell mediated cytotoxicity,1/131,0.0065499210316603,0.0145586837375733,0,0,19869.0,99907.33811343512,IFNA16
13368,KEGG_2019_Human,Measles,1/138,0.0068999185254481,0.0145586837375733,0,0,19862.0,98838.19160389496,IFNA16
13369,KEGG_2019_Human,Hepatitis C,1/155,0.0077499127120574,0.0145586837375733,0,0,19845.0,96448.16254952336,IFNA16
13370,KEGG_2019_Human,Necroptosis,1/162,0.0080999104202618,0.0145586837375733,0,0,19838.0,95537.86936302872,IFNA16
13371,KEGG_2019_Human,JAK-STAT signaling pathway,1/162,0.0080999104202618,0.0145586837375733,0,0,19838.0,95537.86936302872,IFNA16
13372,KEGG_2019_Human,Hepatitis B,1/163,0.0081499100978668,0.0145586837375733,0,0,19837.0,95410.9786681514,IFNA16
13373,KEGG_2019_Human,Influenza A,1/171,0.0085499075557634,0.0145586837375733,0,0,19829.0,94422.42241345016,IFNA16
13374,KEGG_2019_Human,NOD-like receptor signaling pathway,1/178,0.0088999053857096,0.0145586837375733,0,0,19822.0,93593.82745769851,IFNA16
13375,KEGG_2019_Human,Tuberculosis,1/179,0.0089499050800561,0.0145586837375733,0,0,19821.0,93478.0629355712,IFNA16
13376,KEGG_2019_Human,Kaposi sarcoma-associated herpesvirus infection,1/186,0.0092999029651357,0.0145586837375733,0,0,19814.0,92684.96451050608,IFNA16
13377,KEGG_2019_Human,Epstein-Barr virus infection,1/201,0.0100498985877989,0.0145586837375733,0,0,19799.0,91079.21596609056,IFNA16
13378,KEGG_2019_Human,Human immunodeficiency virus 1 infection,1/212,0.0105998955026255,0.0145586837375733,0,0,19788.0,89974.27756224656,IFNA16
13379,KEGG_2019_Human,Human cytomegalovirus infection,1/225,0.0112498919790339,0.0145586837375733,0,0,19775.0,88738.27077557483,IFNA16
13380,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0179665141039676,0,0,19706.0,83157.67014793828,IFNA16
13381,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0191051096893273,0,0,19670.0,80733.60565076157,IFNA16
13382,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0194698489055035,0,0,19646.0,79255.8617626126,IFNA16
13383,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0257712598834163,0,0,19508.0,72277.44006442746,IFNA16
13384,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,IFNA16
13385,KEGG_2019_Human,Non-homologous end-joining,1/13,0.0006499833083207112,0.0019499499249621,0,0,19987.0,146675.87616784443,RAD50
13386,KEGG_2019_Human,Homologous recombination,1/41,0.0020499625466866,0.0030749438200299,0,0,19959.0,123544.88783416104,RAD50
13387,KEGG_2019_Human,Cellular senescence,1/160,0.0079999110688441,0.0079999110688441,0,0,19840.0,95793.96509856998,RAD50
13388,KEGG_2019_Human,Ribosome,1/153,0.0076499133771537,0.0076499133771537,0,0,19847.0,96715.6407630817,RPL15
13389,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR51F1
13390,KEGG_2019_Human,Primary bile acid biosynthesis,1/17,0.0008499797390404818,0.0033999189561619,0,0,19983.0,141285.76583697114,SLC27A5
13391,KEGG_2019_Human,Bile secretion,1/72,0.0035999456502131,0.0049332595773933,0,0,19928.0,112131.59838572376,SLC27A5
13392,KEGG_2019_Human,PPAR signaling pathway,1/74,0.0036999446830449,0.0049332595773933,0,0,19926.0,111574.38983110404,SLC27A5
13393,KEGG_2019_Human,Insulin resistance,1/108,0.0053999298011749,0.0053999298011749,0,0,19892.0,103863.47861844616,SLC27A5
13394,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF44
13395,KEGG_2019_Human,Circadian rhythm,1/31,0.0015499690656704,0.0015499690656704,0,0,19969.0,129189.85098816035,BHLHE40
13396,KEGG_2019_Human,Propanoate metabolism,1/32,0.0015999683804467,0.0039165982320635,0,0,19968.0,128549.41955786056,LDHC
13397,KEGG_2019_Human,Pyruvate metabolism,1/39,0.0019499637955508,0.0039165982320635,0,0,19961.0,124555.53162481484,LDHC
13398,KEGG_2019_Human,Cysteine and methionine metabolism,1/47,0.0023499589392381,0.0039165982320635,0,0,19953.0,120782.64067395544,LDHC
13399,KEGG_2019_Human,Glycolysis / Gluconeogenesis,1/68,0.0033999476216189,0.0042499345270236,0,0,19932.0,113293.39338050144,LDHC
13400,KEGG_2019_Human,Glucagon signaling pathway,1/103,0.0051499318302617,0.0051499318302617,0,0,19897.0,104832.7525292024,LDHC
13401,KEGG_2019_Human,Protein digestion and absorption,1/90,0.0044999373439762,0.0044999373439762,0,0,19910.0,107587.50385474482,COL27A1
13402,KEGG_2019_Human,IL-17 signaling pathway,1/93,0.0046499360391879,0.0082199026557181,0,0,19907.0,106918.54242106884,ANAPC5
13403,KEGG_2019_Human,Progesterone-mediated oocyte maturation,1/99,0.0049499334884068,0.0082199026557181,0,0,19901.0,105642.09305076736,ANAPC5
13404,KEGG_2019_Human,Cell cycle,1/124,0.0061999236097501,0.0082199026557181,0,0,19876.0,101034.04709010696,ANAPC5
13405,KEGG_2019_Human,Oocyte meiosis,1/125,0.0062499232373748,0.0082199026557181,0,0,19875.0,100869.32368441945,ANAPC5
13406,KEGG_2019_Human,Ubiquitin mediated proteolysis,1/137,0.0068499188797651,0.0082199026557181,0,0,19863.0,98987.62735269018,ANAPC5
13407,KEGG_2019_Human,Human T-cell leukemia virus 1 infection,1/219,0.0109498935894162,0.0109498935894162,0,0,19781.0,89299.85161916987,ANAPC5
13408,KEGG_2019_Human,Starch and sucrose metabolism,1/36,0.0017999657178272,0.0017999657178272,0,0,19964.0,126172.23364250171,AGL
13409,KEGG_2019_Human,Complement and coagulation cascades,1/79,0.0039499423167337,0.0039499423167337,0,0,19921.0,110243.89578070649,F10
13410,KEGG_2019_Human,Citrate cycle (TCA cycle),1/30,0.0014999697593334,0.0050999214324284,0,0,19970.0,129851.13732048514,PDHA2
13411,KEGG_2019_Human,Pyruvate metabolism,1/39,0.0019499637955508,0.0050999214324284,0,0,19961.0,124555.53162481484,PDHA2
13412,KEGG_2019_Human,Central carbon metabolism in cancer,1/65,0.003249949134407,0.0050999214324284,0,0,19935.0,114209.92613860144,PDHA2
13413,KEGG_2019_Human,Glycolysis / Gluconeogenesis,1/68,0.0033999476216189,0.0050999214324284,0,0,19932.0,113293.39338050144,PDHA2
13414,KEGG_2019_Human,HIF-1 signaling pathway,1/100,0.0049999330710556,0.0051499318302617,0,0,19900.0,105436.78197328727,PDHA2
13415,KEGG_2019_Human,Glucagon signaling pathway,1/103,0.0051499318302617,0.0051499318302617,0,0,19897.0,104832.7525292024,PDHA2
13416,KEGG_2019_Human,Retinol metabolism,1/67,0.0033499481224912,0.0033499481224912,0,0,19933.0,113594.38808369274,RDH16
13417,KEGG_2019_Human,Type I diabetes mellitus,1/43,0.0021499613216957,0.0021499613216957,0,0,19957.0,122581.98940490963,PTPRN2
13418,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR10H4
13419,KEGG_2019_Human,Basal cell carcinoma,1/63,0.0031499501598827,0.0109198810514423,0,0,19937.0,114844.46974572667,WNT8A
13420,KEGG_2019_Human,Melanogenesis,1/101,0.0050499326546803,0.0109198810514423,0,0,19899.0,105233.48101229242,WNT8A
13421,KEGG_2019_Human,Signaling pathways regulating pluripotency of stem cells,1/139,0.006949918172816,0.0109198810514423,0,0,19861.0,98689.81333375497,WNT8A
13422,KEGG_2019_Human,Breast cancer,1/147,0.0073499154017982,0.0109198810514423,0,0,19853.0,97539.10874372096,WNT8A
13423,KEGG_2019_Human,Gastric cancer,1/149,0.0074499147221605,0.0109198810514423,0,0,19851.0,97261.02051561224,WNT8A
13424,KEGG_2019_Human,mTOR signaling pathway,1/152,0.0075999137114971,0.0109198810514423,0,0,19848.0,96850.665715497,WNT8A
13425,KEGG_2019_Human,Cushing syndrome,1/155,0.0077499127120574,0.0109198810514423,0,0,19845.0,96448.16254952336,WNT8A
13426,KEGG_2019_Human,Wnt signaling pathway,1/158,0.0078999117225733,0.0109198810514423,0,0,19842.0,96053.2110949472,WNT8A
13427,KEGG_2019_Human,Hippo signaling pathway,1/160,0.0079999110688441,0.0109198810514423,0,0,19840.0,95793.96509856998,WNT8A
13428,KEGG_2019_Human,Hepatocellular carcinoma,1/168,0.0083999085011095,0.0109198810514423,0,0,19832.0,94787.72752807094,WNT8A
13429,KEGG_2019_Human,Proteoglycans in cancer,1/201,0.0100498985877989,0.0118771528764897,0,0,19799.0,91079.21596609056,WNT8A
13430,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0178748564138782,0,0,19670.0,80733.60565076157,WNT8A
13431,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,WNT8A
13432,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,RBAK
13433,KEGG_2019_Human,"Glycine, serine and threonine metabolism",1/40,0.0019999631680592,0.0019999631680592,0,0,19960.0,124043.94523066044,DMGDH
13434,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR4E2
13435,KEGG_2019_Human,Alcoholism,1/180,0.0089999047745351,0.0100498985877989,0,0,19820.0,93362.92821536642,HDAC7
13436,KEGG_2019_Human,Viral carcinogenesis,1/201,0.0100498985877989,0.0100498985877989,0,0,19799.0,91079.21596609056,HDAC7
13437,KEGG_2019_Human,Ferroptosis,1/40,0.0019999631680592,0.0039999263361184,0,0,19960.0,124043.94523066044,PCBP1
13438,KEGG_2019_Human,Spliceosome,1/134,0.0066999199497742,0.0066999199497742,0,0,19866.0,99442.43560916925,PCBP1
13439,KEGG_2019_Human,MicroRNAs in cancer,1/299,0.0149498740670514,0.0149498740670514,0,0,19701.0,82804.33538735632,CDCA5
13440,KEGG_2019_Human,Longevity regulating pathway,1/102,0.0050999322416682,0.0050999322416682,0,0,19898.0,105032.15064717118,CLPB
13441,KEGG_2019_Human,Lysosome,1/123,0.0061499239842961,0.0061499239842961,0,0,19877.0,101200.07933676826,MFSD8
13442,KEGG_2019_Human,Cholesterol metabolism,1/50,0.0024999572069037,0.0024999572069037,0,0,19950.0,119530.05920663515,ANGPTL8
13443,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR9A4
13444,KEGG_2019_Human,Allograft rejection,1/38,0.001899964429635,0.0082680739496158,0,0,19962.0,125080.29732025368,IL2
13445,KEGG_2019_Human,Graft-versus-host disease,1/41,0.0020499625466866,0.0082680739496158,0,0,19959.0,123544.88783416104,IL2
13446,KEGG_2019_Human,Type I diabetes mellitus,1/43,0.0021499613216957,0.0082680739496158,0,0,19957.0,122581.98940490963,IL2
13447,KEGG_2019_Human,Intestinal immune network for IgA production,1/48,0.0023999583567988,0.0082680739496158,0,0,19952.0,120356.5272753826,IL2
13448,KEGG_2019_Human,Autoimmune thyroid disease,1/53,0.0026499555173137,0.0082680739496158,0,0,19947.0,118349.78824235698,IL2
13449,KEGG_2019_Human,Inflammatory bowel disease (IBD),1/65,0.003249949134407,0.0082680739496158,0,0,19935.0,114209.92613860144,IL2
13450,KEGG_2019_Human,Th1 and Th2 cell differentiation,1/92,0.0045999364719865,0.0082680739496158,0,0,19908.0,107139.13814408927,IL2
13451,KEGG_2019_Human,T cell receptor signaling pathway,1/101,0.0050499326546803,0.0082680739496158,0,0,19899.0,105233.48101229242,IL2
13452,KEGG_2019_Human,Chagas disease (American trypanosomiasis),1/103,0.0051499318302617,0.0082680739496158,0,0,19897.0,104832.7525292024,IL2
13453,KEGG_2019_Human,C-type lectin receptor signaling pathway,1/104,0.0051999314202997,0.0082680739496158,0,0,19896.0,104635.24941415618,IL2
13454,KEGG_2019_Human,Th17 cell differentiation,1/107,0.0053499302026925,0.0082680739496158,0,0,19893.0,104053.753408911,IL2
13455,KEGG_2019_Human,Measles,1/138,0.0068999185254481,0.0097748845777182,0,0,19862.0,98838.19160389496,IL2
13456,KEGG_2019_Human,JAK-STAT signaling pathway,1/162,0.0080999104202618,0.0105921905495731,0,0,19838.0,95537.86936302872,IL2
13457,KEGG_2019_Human,Human T-cell leukemia virus 1 infection,1/219,0.0109498935894162,0.0132962993585768,0,0,19781.0,89299.85161916987,IL2
13458,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0166598585327699,0,0,19706.0,83157.67014793828,IL2
13459,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0188061040564523,0,0,19646.0,79255.8617626126,IL2
13460,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,IL2
13461,KEGG_2019_Human,Necroptosis,1/162,0.0080999104202618,0.0121998870519305,0,0,19838.0,95537.86936302872,VPS4B
13462,KEGG_2019_Human,Endocytosis,1/244,0.0121998870519305,0.0121998870519305,0,0,19756.0,87051.4275316661,VPS4B
13463,KEGG_2019_Human,Autophagy,1/128,0.0063999221281459,0.0063999221281459,0,0,19872.0,100382.8010329652,RUBCN
13464,KEGG_2019_Human,Pathogenic Escherichia coli infection,1/55,0.0027499544131125,0.0061665744717416,0,0,19945.0,117599.1294878737,HCLS1
13465,KEGG_2019_Human,Shigellosis,1/65,0.003249949134407,0.0061665744717416,0,0,19935.0,114209.92613860144,HCLS1
13466,KEGG_2019_Human,Bacterial invasion of epithelial cells,1/74,0.0036999446830449,0.0061665744717416,0,0,19926.0,111574.38983110404,HCLS1
13467,KEGG_2019_Human,Tight junction,1/170,0.0084999078692823,0.0100498985877989,0,0,19830.0,94543.49009679438,HCLS1
13468,KEGG_2019_Human,Proteoglycans in cancer,1/201,0.0100498985877989,0.0100498985877989,0,0,19799.0,91079.21596609056,HCLS1
13469,KEGG_2019_Human,Acute myeloid leukemia,1/66,0.003299948626608,0.0131398723072995,0,0,19934.0,113899.85357353876,CCNA1
13470,KEGG_2019_Human,Progesterone-mediated oocyte maturation,1/99,0.0049499334884068,0.0131398723072995,0,0,19901.0,105642.09305076736,CCNA1
13471,KEGG_2019_Human,AMPK signaling pathway,1/120,0.0059999251180858,0.0131398723072995,0,0,19880.0,101706.2448082016,CCNA1
13472,KEGG_2019_Human,Cell cycle,1/124,0.0061999236097501,0.0131398723072995,0,0,19876.0,101034.04709010696,CCNA1
13473,KEGG_2019_Human,Cellular senescence,1/160,0.0079999110688441,0.0131398723072995,0,0,19840.0,95793.96509856998,CCNA1
13474,KEGG_2019_Human,Hepatitis B,1/163,0.0081499100978668,0.0131398723072995,0,0,19837.0,95410.9786681514,CCNA1
13475,KEGG_2019_Human,Transcriptional misregulation in cancer,1/186,0.0092999029651357,0.0131398723072995,0,0,19814.0,92684.96451050608,CCNA1
13476,KEGG_2019_Human,Epstein-Barr virus infection,1/201,0.0100498985877989,0.0131398723072995,0,0,19799.0,91079.21596609056,CCNA1
13477,KEGG_2019_Human,Viral carcinogenesis,1/201,0.0100498985877989,0.0131398723072995,0,0,19799.0,91079.21596609056,CCNA1
13478,KEGG_2019_Human,Human T-cell leukemia virus 1 infection,1/219,0.0109498935894162,0.0131398723072995,0,0,19781.0,89299.85161916987,CCNA1
13479,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0179998554097794,0,0,19670.0,80733.60565076157,CCNA1
13480,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,CCNA1
13481,KEGG_2019_Human,Malaria,1/49,0.0024499577795033,0.012299822789457,0,0,19951.0,119939.1172087114,THBS3
13482,KEGG_2019_Human,ECM-receptor interaction,1/82,0.004099940929819,0.012299822789457,0,0,19918.0,109484.9180722932,THBS3
13483,KEGG_2019_Human,Phagosome,1/152,0.0075999137114971,0.0149248487415239,0,0,19848.0,96850.665715497,THBS3
13484,KEGG_2019_Human,Focal adhesion,1/199,0.0099498991610159,0.0149248487415239,0,0,19801.0,91286.4288690606,THBS3
13485,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0176998626413668,0,0,19670.0,80733.60565076157,THBS3
13486,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0176998626413668,0,0,19646.0,79255.8617626126,THBS3
13487,KEGG_2019_Human,Axon guidance,1/181,0.0090499044707863,0.0090499044707863,0,0,19819.0,93248.41634586031,DPYSL5
13488,KEGG_2019_Human,IL-17 signaling pathway,1/93,0.0046499360391879,0.0084665633282996,0,0,19907.0,106918.54242106884,JUND
13489,KEGG_2019_Human,"Parathyroid hormone synthesis, secretion and action",1/106,0.0052999306076525,0.0084665633282996,0,0,19894.0,104245.78450366124,JUND
13490,KEGG_2019_Human,Osteoclast differentiation,1/127,0.0063499224962247,0.0084665633282996,0,0,19873.0,100543.72072014232,JUND
13491,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0147498749536506,0,0,19705.0,83086.53988020132,JUND
13492,KEGG_2019_Human,Hematopoietic cell lineage,1/97,0.0048499343304706,0.0121498656303927,0,0,19903.0,106058.9096435903,IL11RA
13493,KEGG_2019_Human,JAK-STAT signaling pathway,1/162,0.0080999104202618,0.0121498656303927,0,0,19838.0,95537.86936302872,IL11RA
13494,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0146998751759735,0,0,19706.0,83157.67014793828,IL11RA
13495,KEGG_2019_Human,Basal cell carcinoma,1/63,0.0031499501598827,0.0109198810514423,0,0,19937.0,114844.46974572667,FZD9
13496,KEGG_2019_Human,Melanogenesis,1/101,0.0050499326546803,0.0109198810514423,0,0,19899.0,105233.48101229242,FZD9
13497,KEGG_2019_Human,Signaling pathways regulating pluripotency of stem cells,1/139,0.006949918172816,0.0109198810514423,0,0,19861.0,98689.81333375497,FZD9
13498,KEGG_2019_Human,Breast cancer,1/147,0.0073499154017982,0.0109198810514423,0,0,19853.0,97539.10874372096,FZD9
13499,KEGG_2019_Human,Gastric cancer,1/149,0.0074499147221605,0.0109198810514423,0,0,19851.0,97261.02051561224,FZD9
13500,KEGG_2019_Human,mTOR signaling pathway,1/152,0.0075999137114971,0.0109198810514423,0,0,19848.0,96850.665715497,FZD9
13501,KEGG_2019_Human,Cushing syndrome,1/155,0.0077499127120574,0.0109198810514423,0,0,19845.0,96448.16254952336,FZD9
13502,KEGG_2019_Human,Wnt signaling pathway,1/158,0.0078999117225733,0.0109198810514423,0,0,19842.0,96053.2110949472,FZD9
13503,KEGG_2019_Human,Hippo signaling pathway,1/160,0.0079999110688441,0.0109198810514423,0,0,19840.0,95793.96509856998,FZD9
13504,KEGG_2019_Human,Hepatocellular carcinoma,1/168,0.0083999085011095,0.0109198810514423,0,0,19832.0,94787.72752807094,FZD9
13505,KEGG_2019_Human,Proteoglycans in cancer,1/201,0.0100498985877989,0.0118771528764897,0,0,19799.0,91079.21596609056,FZD9
13506,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0178748564138782,0,0,19670.0,80733.60565076157,FZD9
13507,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,FZD9
13508,KEGG_2019_Human,Porphyrin and chlorophyll metabolism,1/42,0.0020999619311272,0.0020999619311272,0,0,19958.0,123057.75613441122,MMAB
13509,KEGG_2019_Human,Butanoate metabolism,1/28,0.0013999711732997,0.0013999711732997,0,0,19972.0,131242.0761597353,ACSM5
13510,KEGG_2019_Human,Hedgehog signaling pathway,1/47,0.0023499589392381,0.0046999178784763,0,0,19953.0,120782.64067395544,CUL3
13511,KEGG_2019_Human,Ubiquitin mediated proteolysis,1/137,0.0068499188797651,0.0068499188797651,0,0,19863.0,98987.62735269018,CUL3
13512,KEGG_2019_Human,Mismatch repair,1/23,0.0011499748819949,0.0041124281436667,0,0,19977.0,135204.63922267244,PCNA
13513,KEGG_2019_Human,Base excision repair,1/33,0.0016499677032113,0.0041124281436667,0,0,19967.0,127928.56031580272,PCNA
13514,KEGG_2019_Human,DNA replication,1/36,0.0017999657178272,0.0041124281436667,0,0,19964.0,126172.23364250171,PCNA
13515,KEGG_2019_Human,Nucleotide excision repair,1/47,0.0023499589392381,0.0041124281436667,0,0,19953.0,120782.64067395544,PCNA
13516,KEGG_2019_Human,Cell cycle,1/124,0.0061999236097501,0.0084999078692823,0,0,19876.0,101034.04709010696,PCNA
13517,KEGG_2019_Human,Hepatitis B,1/163,0.0081499100978668,0.0084999078692823,0,0,19837.0,95410.9786681514,PCNA
13518,KEGG_2019_Human,Tight junction,1/170,0.0084999078692823,0.0084999078692823,0,0,19830.0,94543.49009679438,PCNA
13519,KEGG_2019_Human,Amyotrophic lateral sclerosis (ALS),1/51,0.0025499566390179,0.0025499566390179,0,0,19949.0,119129.0228601236,NEFM
13520,KEGG_2019_Human,Proteasome,1/45,0.0022499601197094,0.0022499601197094,0,0,19955.0,121662.49782449217,PSMA3
13521,KEGG_2019_Human,Salmonella infection,1/86,0.0042999391173866,0.0042999391173866,0,0,19914.0,108514.46102290176,KLC4
13522,KEGG_2019_Human,Type II diabetes mellitus,1/46,0.0022999595269283,0.0105944506669242,0,0,19954.0,121217.8313311442,MAPK10
13523,KEGG_2019_Human,Mitophagy,1/65,0.003249949134407,0.0105944506669242,0,0,19935.0,114209.92613860144,MAPK10
13524,KEGG_2019_Human,Shigellosis,1/65,0.003249949134407,0.0105944506669242,0,0,19935.0,114209.92613860144,MAPK10
13525,KEGG_2019_Human,Epithelial cell signaling in Helicobacter pylori infection,1/68,0.0033999476216189,0.0105944506669242,0,0,19932.0,113293.39338050144,MAPK10
13526,KEGG_2019_Human,Fc epsilon RI signaling pathway,1/68,0.0033999476216189,0.0105944506669242,0,0,19932.0,113293.39338050144,MAPK10
13527,KEGG_2019_Human,Adipocytokine signaling pathway,1/69,0.003449947123837,0.0105944506669242,0,0,19931.0,112996.7391397682,MAPK10
13528,KEGG_2019_Human,Prolactin signaling pathway,1/70,0.0034999466296654,0.0105944506669242,0,0,19930.0,112704.30065625212,MAPK10
13529,KEGG_2019_Human,RIG-I-like receptor signaling pathway,1/70,0.0034999466296654,0.0105944506669242,0,0,19930.0,112704.30065625212,MAPK10
13530,KEGG_2019_Human,Pancreatic cancer,1/75,0.0037499442041125,0.0105944506669242,0,0,19925.0,111301.33528642564,MAPK10
13531,KEGG_2019_Human,Pertussis,1/76,0.0037999437281752,0.0105944506669242,0,0,19924.0,111031.8499691117,MAPK10
13532,KEGG_2019_Human,ErbB signaling pathway,1/85,0.004249939567045,0.0105944506669242,0,0,19915.0,108752.83801948265,MAPK10
13533,KEGG_2019_Human,Colorectal cancer,1/86,0.0042999391173866,0.0105944506669242,0,0,19914.0,108514.46102290176,MAPK10
13534,KEGG_2019_Human,Salmonella infection,1/86,0.0042999391173866,0.0105944506669242,0,0,19914.0,108514.46102290176,MAPK10
13535,KEGG_2019_Human,Th1 and Th2 cell differentiation,1/92,0.0045999364719865,0.0105944506669242,0,0,19908.0,107139.13814408927,MAPK10
13536,KEGG_2019_Human,IL-17 signaling pathway,1/93,0.0046499360391879,0.0105944506669242,0,0,19907.0,106918.54242106884,MAPK10
13537,KEGG_2019_Human,GnRH signaling pathway,1/93,0.0046499360391879,0.0105944506669242,0,0,19907.0,106918.54242106884,MAPK10
13538,KEGG_2019_Human,Choline metabolism in cancer,1/99,0.0049499334884068,0.0105944506669242,0,0,19901.0,105642.09305076736,MAPK10
13539,KEGG_2019_Human,Progesterone-mediated oocyte maturation,1/99,0.0049499334884068,0.0105944506669242,0,0,19901.0,105642.09305076736,MAPK10
13540,KEGG_2019_Human,AGE-RAGE signaling pathway in diabetic complications,1/100,0.0049999330710556,0.0105944506669242,0,0,19900.0,105436.78197328727,MAPK10
13541,KEGG_2019_Human,Inflammatory mediator regulation of TRP channels,1/100,0.0049999330710556,0.0105944506669242,0,0,19900.0,105436.78197328727,MAPK10
13542,KEGG_2019_Human,Chagas disease (American trypanosomiasis),1/103,0.0051499318302617,0.0105944506669242,0,0,19897.0,104832.7525292024,MAPK10
13543,KEGG_2019_Human,Toll-like receptor signaling pathway,1/104,0.0051999314202997,0.0105944506669242,0,0,19896.0,104635.24941415618,MAPK10
13544,KEGG_2019_Human,C-type lectin receptor signaling pathway,1/104,0.0051999314202997,0.0105944506669242,0,0,19896.0,104635.24941415618,MAPK10
13545,KEGG_2019_Human,Th17 cell differentiation,1/107,0.0053499302026925,0.0105944506669242,0,0,19893.0,104053.753408911,MAPK10
13546,KEGG_2019_Human,Insulin resistance,1/108,0.0053999298011749,0.0105944506669242,0,0,19892.0,103863.47861844616,MAPK10
13547,KEGG_2019_Human,TNF signaling pathway,1/110,0.0054999290027479,0.0105944506669242,0,0,19890.0,103488.06969787036,MAPK10
13548,KEGG_2019_Human,Toxoplasmosis,1/113,0.0056499278191151,0.0105944506669242,0,0,19887.0,102937.34947211576,MAPK10
13549,KEGG_2019_Human,Sphingolipid signaling pathway,1/119,0.0059499254985137,0.0105944506669242,0,0,19881.0,101877.73080211312,MAPK10
13550,KEGG_2019_Human,Neurotrophin signaling pathway,1/119,0.0059499254985137,0.0105944506669242,0,0,19881.0,101877.73080211312,MAPK10
13551,KEGG_2019_Human,Osteoclast differentiation,1/127,0.0063499224962247,0.0105944506669242,0,0,19873.0,100543.72072014232,MAPK10
13552,KEGG_2019_Human,Autophagy,1/128,0.0063999221281459,0.0105944506669242,0,0,19872.0,100382.8010329652,MAPK10
13553,KEGG_2019_Human,Relaxin signaling pathway,1/130,0.0064999213952527,0.0105944506669242,0,0,19870.0,100064.62842845908,MAPK10
13554,KEGG_2019_Human,Dopaminergic synapse,1/131,0.0065499210316603,0.0105944506669242,0,0,19869.0,99907.33811343512,MAPK10
13555,KEGG_2019_Human,FoxO signaling pathway,1/132,0.0065999206698993,0.0105944506669242,0,0,19868.0,99751.22090491928,MAPK10
13556,KEGG_2019_Human,Insulin signaling pathway,1/137,0.0068499188797651,0.0105944506669242,0,0,19863.0,98987.62735269018,MAPK10
13557,KEGG_2019_Human,Measles,1/138,0.0068999185254481,0.0105944506669242,0,0,19862.0,98838.19160389496,MAPK10
13558,KEGG_2019_Human,Fluid shear stress and atherosclerosis,1/139,0.006949918172816,0.0105944506669242,0,0,19861.0,98689.81333375497,MAPK10
13559,KEGG_2019_Human,Apoptosis,1/143,0.0071499167770442,0.0105944506669242,0,0,19857.0,98106.57763600958,MAPK10
13560,KEGG_2019_Human,Retrograde endocannabinoid signaling,1/148,0.007399915061391,0.0105944506669242,0,0,19852.0,97399.60470052566,MAPK10
13561,KEGG_2019_Human,Non-alcoholic fatty liver disease (NAFLD),1/149,0.0074499147221605,0.0105944506669242,0,0,19851.0,97261.02051561224,MAPK10
13562,KEGG_2019_Human,Wnt signaling pathway,1/158,0.0078999117225733,0.0105944506669242,0,0,19842.0,96053.2110949472,MAPK10
13563,KEGG_2019_Human,Necroptosis,1/162,0.0080999104202618,0.0105944506669242,0,0,19838.0,95537.86936302872,MAPK10
13564,KEGG_2019_Human,Hepatitis B,1/163,0.0081499100978668,0.0105944506669242,0,0,19837.0,95410.9786681514,MAPK10
13565,KEGG_2019_Human,Protein processing in endoplasmic reticulum,1/165,0.0082499094553477,0.0105944506669242,0,0,19835.0,95159.46482222488,MAPK10
13566,KEGG_2019_Human,Tight junction,1/170,0.0084999078692823,0.0105944506669242,0,0,19830.0,94543.49009679438,MAPK10
13567,KEGG_2019_Human,Influenza A,1/171,0.0085499075557634,0.0105944506669242,0,0,19829.0,94422.42241345016,MAPK10
13568,KEGG_2019_Human,NOD-like receptor signaling pathway,1/178,0.0088999053857096,0.0106280122825666,0,0,19822.0,93593.82745769851,MAPK10
13569,KEGG_2019_Human,Tuberculosis,1/179,0.0089499050800561,0.0106280122825666,0,0,19821.0,93478.0629355712,MAPK10
13570,KEGG_2019_Human,Kaposi sarcoma-associated herpesvirus infection,1/186,0.0092999029651357,0.0108182544696477,0,0,19814.0,92684.96451050608,MAPK10
13571,KEGG_2019_Human,Focal adhesion,1/199,0.0099498991610159,0.0112322395981282,0,0,19801.0,91286.4288690606,MAPK10
13572,KEGG_2019_Human,Epstein-Barr virus infection,1/201,0.0100498985877989,0.0112322395981282,0,0,19799.0,91079.21596609056,MAPK10
13573,KEGG_2019_Human,Human immunodeficiency virus 1 infection,1/212,0.0105998955026255,0.0113998876160312,0,0,19788.0,89974.27756224656,MAPK10
13574,KEGG_2019_Human,cAMP signaling pathway,1/212,0.0105998955026255,0.0113998876160312,0,0,19788.0,89974.27756224656,MAPK10
13575,KEGG_2019_Human,Human T-cell leukemia virus 1 infection,1/219,0.0109498935894162,0.0115582210110505,0,0,19781.0,89299.85161916987,MAPK10
13576,KEGG_2019_Human,Ras signaling pathway,1/232,0.0115998901349604,0.0120217043216862,0,0,19768.0,88101.22480150245,MAPK10
13577,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.015013265577823,0,0,19705.0,83086.53988020132,MAPK10
13578,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,MAPK10
13579,KEGG_2019_Human,Small cell lung cancer,1/93,0.0046499360391879,0.0089373959713052,0,0,19907.0,106918.54242106884,BIRC8
13580,KEGG_2019_Human,Toxoplasmosis,1/113,0.0056499278191151,0.0089373959713052,0,0,19887.0,102937.34947211576,BIRC8
13581,KEGG_2019_Human,Ubiquitin mediated proteolysis,1/137,0.0068499188797651,0.0089373959713052,0,0,19863.0,98987.62735269018,BIRC8
13582,KEGG_2019_Human,Apoptosis,1/143,0.0071499167770442,0.0089373959713052,0,0,19857.0,98106.57763600958,BIRC8
13583,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,BIRC8
13584,KEGG_2019_Human,MicroRNAs in cancer,1/299,0.0149498740670514,0.0149498740670514,0,0,19701.0,82804.33538735632,MIR520E
13585,KEGG_2019_Human,Thermogenesis,1/231,0.0115498903940656,0.0115498903940656,0,0,19769.0,88191.07730937863,NDUFAF5
13586,KEGG_2019_Human,Choline metabolism in cancer,1/99,0.0049499334884068,0.0049499334884068,0,0,19901.0,105642.09305076736,SLC44A1
13587,KEGG_2019_Human,Cell cycle,1/124,0.0061999236097501,0.0061999236097501,0,0,19876.0,101034.04709010696,ORC6
13588,KEGG_2019_Human,Type I diabetes mellitus,1/43,0.0021499613216957,0.0109998580054958,0,0,19957.0,122581.98940490963,LTA
13589,KEGG_2019_Human,NF-kappa B signaling pathway,1/95,0.0047499351803394,0.0109998580054958,0,0,19905.0,106484.27183626965,LTA
13590,KEGG_2019_Human,TNF signaling pathway,1/110,0.0054999290027479,0.0109998580054958,0,0,19890.0,103488.06969787036,LTA
13591,KEGG_2019_Human,Human T-cell leukemia virus 1 infection,1/219,0.0109498935894162,0.0164248403841244,0,0,19781.0,89299.85161916987,LTA
13592,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0176398502111682,0,0,19706.0,83157.67014793828,LTA
13593,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,LTA
13594,KEGG_2019_Human,Amino sugar and nucleotide sugar metabolism,1/48,0.0023999583567988,0.0023999583567988,0,0,19952.0,120356.5272753826,NPL
13595,KEGG_2019_Human,Hippo signaling pathway,1/160,0.0079999110688441,0.0079999110688441,0,0,19840.0,95793.96509856998,AFP
13596,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF268
13597,KEGG_2019_Human,Endocytosis,1/244,0.0121998870519305,0.0121998870519305,0,0,19756.0,87051.4275316661,EPN3
13598,KEGG_2019_Human,Epstein-Barr virus infection,1/201,0.0100498985877989,0.0100498985877989,0,0,19799.0,91079.21596609056,SAP30
13599,KEGG_2019_Human,Wnt signaling pathway,1/158,0.0078999117225733,0.0078999117225733,0,0,19842.0,96053.2110949472,PORCN
13600,KEGG_2019_Human,RIG-I-like receptor signaling pathway,1/70,0.0034999466296654,0.0071249027705091,0,0,19930.0,112704.30065625212,TRIM25
13601,KEGG_2019_Human,NF-kappa B signaling pathway,1/95,0.0047499351803394,0.0071249027705091,0,0,19905.0,106484.27183626965,TRIM25
13602,KEGG_2019_Human,Influenza A,1/171,0.0085499075557634,0.0085499075557634,0,0,19829.0,94422.42241345016,TRIM25
13603,KEGG_2019_Human,Glycosaminoglycan biosynthesis,1/53,0.0026499555173137,0.0026499555173137,0,0,19947.0,118349.78824235698,CSGALNACT1
13604,KEGG_2019_Human,Autophagy,1/128,0.0063999221281459,0.0063999221281459,0,0,19872.0,100382.8010329652,VMP1
13605,KEGG_2019_Human,Pathogenic Escherichia coli infection,1/55,0.0027499544131125,0.0061665744717416,0,0,19945.0,117599.1294878737,CTTN
13606,KEGG_2019_Human,Shigellosis,1/65,0.003249949134407,0.0061665744717416,0,0,19935.0,114209.92613860144,CTTN
13607,KEGG_2019_Human,Bacterial invasion of epithelial cells,1/74,0.0036999446830449,0.0061665744717416,0,0,19926.0,111574.38983110404,CTTN
13608,KEGG_2019_Human,Tight junction,1/170,0.0084999078692823,0.0100498985877989,0,0,19830.0,94543.49009679438,CTTN
13609,KEGG_2019_Human,Proteoglycans in cancer,1/201,0.0100498985877989,0.0100498985877989,0,0,19799.0,91079.21596609056,CTTN
13610,KEGG_2019_Human,Starch and sucrose metabolism,1/36,0.0017999657178272,0.0082199026557181,0,0,19964.0,126172.23364250171,GYS1
13611,KEGG_2019_Human,Glucagon signaling pathway,1/103,0.0051499318302617,0.0082199026557181,0,0,19897.0,104832.7525292024,GYS1
13612,KEGG_2019_Human,Insulin resistance,1/108,0.0053999298011749,0.0082199026557181,0,0,19892.0,103863.47861844616,GYS1
13613,KEGG_2019_Human,AMPK signaling pathway,1/120,0.0059999251180858,0.0082199026557181,0,0,19880.0,101706.2448082016,GYS1
13614,KEGG_2019_Human,Insulin signaling pathway,1/137,0.0068499188797651,0.0082199026557181,0,0,19863.0,98987.62735269018,GYS1
13615,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0176998626413668,0,0,19646.0,79255.8617626126,GYS1
13616,KEGG_2019_Human,Insulin resistance,1/108,0.0053999298011749,0.0074499147221605,0,0,19892.0,103863.47861844616,MLX
13617,KEGG_2019_Human,Non-alcoholic fatty liver disease (NAFLD),1/149,0.0074499147221605,0.0074499147221605,0,0,19851.0,97261.02051561224,MLX
13618,KEGG_2019_Human,Fc gamma R-mediated phagocytosis,1/91,0.0045499369072032,0.0090998738144064,0,0,19909.0,107362.10783923086,BIN1
13619,KEGG_2019_Human,Endocytosis,1/244,0.0121998870519305,0.0121998870519305,0,0,19756.0,87051.4275316661,BIN1
13620,KEGG_2019_Human,Legionellosis,1/55,0.0027499544131125,0.0064998982688141,0,0,19945.0,117599.1294878737,BNIP3
13621,KEGG_2019_Human,Mitophagy,1/65,0.003249949134407,0.0064998982688141,0,0,19935.0,114209.92613860144,BNIP3
13622,KEGG_2019_Human,Autophagy,1/128,0.0063999221281459,0.0065999206698993,0,0,19872.0,100382.8010329652,BNIP3
13623,KEGG_2019_Human,FoxO signaling pathway,1/132,0.0065999206698993,0.0065999206698993,0,0,19868.0,99751.22090491928,BNIP3
13624,KEGG_2019_Human,Hedgehog signaling pathway,1/47,0.0023499589392381,0.0023499589392381,0,0,19953.0,120782.64067395544,GAS1
13625,KEGG_2019_Human,Acute myeloid leukemia,1/66,0.003299948626608,0.0114165314662752,0,0,19934.0,113899.85357353876,RARA
13626,KEGG_2019_Human,Th17 cell differentiation,1/107,0.0053499302026925,0.0114165314662752,0,0,19893.0,104053.753408911,RARA
13627,KEGG_2019_Human,Estrogen signaling pathway,1/137,0.0068499188797651,0.0114165314662752,0,0,19863.0,98987.62735269018,RARA
13628,KEGG_2019_Human,Transcriptional misregulation in cancer,1/186,0.0092999029651357,0.0116248787064197,0,0,19814.0,92684.96451050608,RARA
13629,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,RARA
13630,KEGG_2019_Human,Adipocytokine signaling pathway,1/69,0.003449947123837,0.0129554278365423,0,0,19931.0,112996.7391397682,TRAF2
13631,KEGG_2019_Human,RIG-I-like receptor signaling pathway,1/70,0.0034999466296654,0.0129554278365423,0,0,19930.0,112704.30065625212,TRAF2
13632,KEGG_2019_Human,IL-17 signaling pathway,1/93,0.0046499360391879,0.0129554278365423,0,0,19907.0,106918.54242106884,TRAF2
13633,KEGG_2019_Human,Small cell lung cancer,1/93,0.0046499360391879,0.0129554278365423,0,0,19907.0,106918.54242106884,TRAF2
13634,KEGG_2019_Human,NF-kappa B signaling pathway,1/95,0.0047499351803394,0.0129554278365423,0,0,19905.0,106484.27183626965,TRAF2
13635,KEGG_2019_Human,TNF signaling pathway,1/110,0.0054999290027479,0.0129554278365423,0,0,19890.0,103488.06969787036,TRAF2
13636,KEGG_2019_Human,Sphingolipid signaling pathway,1/119,0.0059499254985137,0.0129554278365423,0,0,19881.0,101877.73080211312,TRAF2
13637,KEGG_2019_Human,Osteoclast differentiation,1/127,0.0063499224962247,0.0129554278365423,0,0,19873.0,100543.72072014232,TRAF2
13638,KEGG_2019_Human,Apoptosis,1/143,0.0071499167770442,0.0129554278365423,0,0,19857.0,98106.57763600958,TRAF2
13639,KEGG_2019_Human,Non-alcoholic fatty liver disease (NAFLD),1/149,0.0074499147221605,0.0129554278365423,0,0,19851.0,97261.02051561224,TRAF2
13640,KEGG_2019_Human,Hepatitis C,1/155,0.0077499127120574,0.0129554278365423,0,0,19845.0,96448.16254952336,TRAF2
13641,KEGG_2019_Human,Necroptosis,1/162,0.0080999104202618,0.0129554278365423,0,0,19838.0,95537.86936302872,TRAF2
13642,KEGG_2019_Human,Protein processing in endoplasmic reticulum,1/165,0.0082499094553477,0.0129554278365423,0,0,19835.0,95159.46482222488,TRAF2
13643,KEGG_2019_Human,NOD-like receptor signaling pathway,1/178,0.0088999053857096,0.0129554278365423,0,0,19822.0,93593.82745769851,TRAF2
13644,KEGG_2019_Human,Kaposi sarcoma-associated herpesvirus infection,1/186,0.0092999029651357,0.0129554278365423,0,0,19814.0,92684.96451050608,TRAF2
13645,KEGG_2019_Human,Viral carcinogenesis,1/201,0.0100498985877989,0.0129554278365423,0,0,19799.0,91079.21596609056,TRAF2
13646,KEGG_2019_Human,Epstein-Barr virus infection,1/201,0.0100498985877989,0.0129554278365423,0,0,19799.0,91079.21596609056,TRAF2
13647,KEGG_2019_Human,Human immunodeficiency virus 1 infection,1/212,0.0105998955026255,0.0129554278365423,0,0,19788.0,89974.27756224656,TRAF2
13648,KEGG_2019_Human,Human cytomegalovirus infection,1/225,0.0112498919790339,0.0130261907125655,0,0,19775.0,88738.27077557483,TRAF2
13649,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0162248624490157,0,0,19705.0,83086.53988020132,TRAF2
13650,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0257712598834163,0,0,19508.0,72277.44006442746,TRAF2
13651,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,TRAF2
13652,KEGG_2019_Human,Sphingolipid signaling pathway,1/119,0.0059499254985137,0.009899881004849,0,0,19881.0,101877.73080211312,S1PR1
13653,KEGG_2019_Human,FoxO signaling pathway,1/132,0.0065999206698993,0.009899881004849,0,0,19868.0,99751.22090491928,S1PR1
13654,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,S1PR1
13655,KEGG_2019_Human,Leukocyte transendothelial migration,1/112,0.0055999282120529,0.0055999282120529,0,0,19888.0,103119.30984392198,THY1
13656,KEGG_2019_Human,ECM-receptor interaction,1/82,0.004099940929819,0.0061999236097501,0,0,19918.0,109484.9180722932,GP6
13657,KEGG_2019_Human,Platelet activation,1/124,0.0061999236097501,0.0061999236097501,0,0,19876.0,101034.04709010696,GP6
13658,KEGG_2019_Human,Cardiac muscle contraction,1/78,0.0038999427840466,0.0112582177134695,0,0,19922.0,110503.2180492851,UQCRC1
13659,KEGG_2019_Human,Oxidative phosphorylation,1/133,0.0066499203093911,0.0112582177134695,0,0,19867.0,99596.2591544721,UQCRC1
13660,KEGG_2019_Human,Parkinson disease,1/142,0.0070999171242726,0.0112582177134695,0,0,19858.0,98250.87390500787,UQCRC1
13661,KEGG_2019_Human,Non-alcoholic fatty liver disease (NAFLD),1/149,0.0074499147221605,0.0112582177134695,0,0,19851.0,97261.02051561224,UQCRC1
13662,KEGG_2019_Human,Alzheimer disease,1/171,0.0085499075557634,0.0112582177134695,0,0,19829.0,94422.42241345016,UQCRC1
13663,KEGG_2019_Human,Huntington disease,1/193,0.0096499008972596,0.0112582177134695,0,0,19807.0,91920.47679471428,UQCRC1
13664,KEGG_2019_Human,Thermogenesis,1/231,0.0115498903940656,0.0115498903940656,0,0,19769.0,88191.07730937863,UQCRC1
13665,KEGG_2019_Human,Folate biosynthesis,1/26,0.0012999726251831,0.0012999726251831,0,0,19974.0,132735.46073187632,MOCS1
13666,KEGG_2019_Human,Wnt signaling pathway,1/158,0.0078999117225733,0.0078999117225733,0,0,19842.0,96053.2110949472,TBL1X
13667,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF559-ZNF177
13668,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0146998751759735,0,0,19706.0,83157.67014793828,EDA2R
13669,KEGG_2019_Human,AMPK signaling pathway,1/120,0.0059999251180858,0.0059999251180858,0,0,19880.0,101706.2448082016,RAB2A
13670,KEGG_2019_Human,Leishmaniasis,1/74,0.0036999446830449,0.0075999137114971,0,0,19926.0,111574.38983110404,NCF2
13671,KEGG_2019_Human,Leukocyte transendothelial migration,1/112,0.0055999282120529,0.0075999137114971,0,0,19888.0,103119.30984392198,NCF2
13672,KEGG_2019_Human,Osteoclast differentiation,1/127,0.0063499224962247,0.0075999137114971,0,0,19873.0,100543.72072014232,NCF2
13673,KEGG_2019_Human,Fluid shear stress and atherosclerosis,1/139,0.006949918172816,0.0075999137114971,0,0,19861.0,98689.81333375497,NCF2
13674,KEGG_2019_Human,Phagosome,1/152,0.0075999137114971,0.0075999137114971,0,0,19848.0,96850.665715497,NCF2
13675,KEGG_2019_Human,DNA replication,1/36,0.0017999657178272,0.0017999657178272,0,0,19964.0,126172.23364250171,RNASEH2C
13676,KEGG_2019_Human,Vasopressin-regulated water reabsorption,1/44,0.0021999607179423,0.0121998870519305,0,0,19956.0,122117.06559109331,RAB5C
13677,KEGG_2019_Human,Amoebiasis,1/96,0.0047999347538706,0.0121998870519305,0,0,19904.0,106270.50039849174,RAB5C
13678,KEGG_2019_Human,Phagosome,1/152,0.0075999137114971,0.0121998870519305,0,0,19848.0,96850.665715497,RAB5C
13679,KEGG_2019_Human,Tuberculosis,1/179,0.0089499050800561,0.0121998870519305,0,0,19821.0,93478.0629355712,RAB5C
13680,KEGG_2019_Human,Ras signaling pathway,1/232,0.0115998901349604,0.0121998870519305,0,0,19768.0,88101.22480150245,RAB5C
13681,KEGG_2019_Human,Endocytosis,1/244,0.0121998870519305,0.0121998870519305,0,0,19756.0,87051.4275316661,RAB5C
13682,KEGG_2019_Human,Ferroptosis,1/40,0.0019999631680592,0.0019999631680592,0,0,19960.0,124043.94523066044,MAP1LC3A
13683,KEGG_2019_Human,Lysosome,1/123,0.0061499239842961,0.0061499239842961,0,0,19877.0,101200.07933676826,MCOLN1
13684,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,CHRNA10
13685,KEGG_2019_Human,Viral carcinogenesis,1/201,0.0100498985877989,0.0200997971755979,0,0,19799.0,91079.21596609056,SP100
13686,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,SP100
13687,KEGG_2019_Human,Basal transcription factors,1/45,0.0022499601197094,0.0044999202394188,0,0,19955.0,121662.49782449217,GTF2A1L
13688,KEGG_2019_Human,Viral carcinogenesis,1/201,0.0100498985877989,0.0100498985877989,0,0,19799.0,91079.21596609056,GTF2A1L
13689,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF12
13690,KEGG_2019_Human,Amoebiasis,1/96,0.0047999347538706,0.007274901495706,0,0,19904.0,106270.50039849174,CD1D
13691,KEGG_2019_Human,Hematopoietic cell lineage,1/97,0.0048499343304706,0.007274901495706,0,0,19903.0,106058.9096435903,CD1D
13692,KEGG_2019_Human,Tight junction,1/170,0.0084999078692823,0.0084999078692823,0,0,19830.0,94543.49009679438,CD1D
13693,KEGG_2019_Human,Base excision repair,1/33,0.0016499677032113,0.0016499677032113,0,0,19967.0,127928.56031580272,APEX2
13694,KEGG_2019_Human,Inflammatory bowel disease (IBD),1/65,0.003249949134407,0.0053499302026925,0,0,19935.0,114209.92613860144,TBX21
13695,KEGG_2019_Human,Th1 and Th2 cell differentiation,1/92,0.0045999364719865,0.0053499302026925,0,0,19908.0,107139.13814408927,TBX21
13696,KEGG_2019_Human,Th17 cell differentiation,1/107,0.0053499302026925,0.0053499302026925,0,0,19893.0,104053.753408911,TBX21
13697,KEGG_2019_Human,Ribosome,1/153,0.0076499133771537,0.0076499133771537,0,0,19847.0,96715.6407630817,RPS27
13698,KEGG_2019_Human,ECM-receptor interaction,1/82,0.004099940929819,0.0099998661421113,0,0,19918.0,109484.9180722932,COL4A3
13699,KEGG_2019_Human,Protein digestion and absorption,1/90,0.0044999373439762,0.0099998661421113,0,0,19910.0,107587.50385474482,COL4A3
13700,KEGG_2019_Human,Small cell lung cancer,1/93,0.0046499360391879,0.0099998661421113,0,0,19907.0,106918.54242106884,COL4A3
13701,KEGG_2019_Human,Amoebiasis,1/96,0.0047999347538706,0.0099998661421113,0,0,19904.0,106270.50039849174,COL4A3
13702,KEGG_2019_Human,AGE-RAGE signaling pathway in diabetic complications,1/100,0.0049999330710556,0.0099998661421113,0,0,19900.0,105436.78197328727,COL4A3
13703,KEGG_2019_Human,Relaxin signaling pathway,1/130,0.0064999213952527,0.0108332023254213,0,0,19870.0,100064.62842845908,COL4A3
13704,KEGG_2019_Human,Focal adhesion,1/199,0.0099498991610159,0.0142141416585942,0,0,19801.0,91286.4288690606,COL4A3
13705,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0196665140459632,0,0,19670.0,80733.60565076157,COL4A3
13706,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0196665140459632,0,0,19646.0,79255.8617626126,COL4A3
13707,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,COL4A3
13708,KEGG_2019_Human,GABAergic synapse,1/89,0.0044499377838098,0.0130498764018304,0,0,19911.0,107815.380281759,GNG2
13709,KEGG_2019_Human,Morphine addiction,1/91,0.0045499369072032,0.0130498764018304,0,0,19909.0,107362.10783923086,GNG2
13710,KEGG_2019_Human,Circadian entrainment,1/97,0.0048499343304706,0.0130498764018304,0,0,19903.0,106058.9096435903,GNG2
13711,KEGG_2019_Human,Cholinergic synapse,1/112,0.0055999282120529,0.0130498764018304,0,0,19888.0,103119.30984392198,GNG2
13712,KEGG_2019_Human,Serotonergic synapse,1/113,0.0056499278191151,0.0130498764018304,0,0,19887.0,102937.34947211576,GNG2
13713,KEGG_2019_Human,Glutamatergic synapse,1/114,0.005699927427839,0.0130498764018304,0,0,19886.0,102756.96431429044,GNG2
13714,KEGG_2019_Human,Relaxin signaling pathway,1/130,0.0064999213952527,0.0130498764018304,0,0,19870.0,100064.62842845908,GNG2
13715,KEGG_2019_Human,Dopaminergic synapse,1/131,0.0065499210316603,0.0130498764018304,0,0,19869.0,99907.33811343512,GNG2
13716,KEGG_2019_Human,Apelin signaling pathway,1/137,0.0068499188797651,0.0130498764018304,0,0,19863.0,98987.62735269018,GNG2
13717,KEGG_2019_Human,Retrograde endocannabinoid signaling,1/148,0.007399915061391,0.0130498764018304,0,0,19852.0,97399.60470052566,GNG2
13718,KEGG_2019_Human,Alcoholism,1/180,0.0089999047745351,0.0130498764018304,0,0,19820.0,93362.92821536642,GNG2
13719,KEGG_2019_Human,Kaposi sarcoma-associated herpesvirus infection,1/186,0.0092999029651357,0.0130498764018304,0,0,19814.0,92684.96451050608,GNG2
13720,KEGG_2019_Human,Chemokine signaling pathway,1/190,0.0094999017791995,0.0130498764018304,0,0,19810.0,92244.74636351672,GNG2
13721,KEGG_2019_Human,Human immunodeficiency virus 1 infection,1/212,0.0105998955026255,0.0130498764018304,0,0,19788.0,89974.27756224656,GNG2
13722,KEGG_2019_Human,Human cytomegalovirus infection,1/225,0.0112498919790339,0.0130498764018304,0,0,19775.0,88738.27077557483,GNG2
13723,KEGG_2019_Human,Ras signaling pathway,1/232,0.0115998901349604,0.0130498764018304,0,0,19768.0,88101.22480150245,GNG2
13724,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0187410310320355,0,0,19646.0,79255.8617626126,GNG2
13725,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,GNG2
13726,KEGG_2019_Human,Sphingolipid metabolism,1/47,0.0023499589392381,0.0046999178784763,0,0,19953.0,120782.64067395544,SPTLC2
13727,KEGG_2019_Human,Sphingolipid signaling pathway,1/119,0.0059499254985137,0.0059499254985137,0,0,19881.0,101877.73080211312,SPTLC2
13728,KEGG_2019_Human,TGF-beta signaling pathway,1/90,0.0044999373439762,0.0044999373439762,0,0,19910.0,107587.50385474482,RGMB
13729,KEGG_2019_Human,Glyoxylate and dicarboxylate metabolism,1/30,0.0014999697593334,0.00239995257067,0,0,19970.0,129851.13732048514,PCCA
13730,KEGG_2019_Human,Propanoate metabolism,1/32,0.0015999683804467,0.00239995257067,0,0,19968.0,128549.41955786056,PCCA
13731,KEGG_2019_Human,"Valine, leucine and isoleucine degradation",1/48,0.0023999583567988,0.0023999583567988,0,0,19952.0,120356.5272753826,PCCA
13732,KEGG_2019_Human,One carbon pool by folate,1/20,0.0009999772468562472,0.0009999772468562472,0,0,19980.0,138017.40508704726,ST20-MTHFS
13733,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF264
13734,KEGG_2019_Human,ECM-receptor interaction,1/82,0.004099940929819,0.0096665547828135,0,0,19918.0,109484.9180722932,SDC4
13735,KEGG_2019_Human,Fluid shear stress and atherosclerosis,1/139,0.006949918172816,0.0096665547828135,0,0,19861.0,98689.81333375497,SDC4
13736,KEGG_2019_Human,Cell adhesion molecules (CAMs),1/145,0.0072499160871101,0.0096665547828135,0,0,19855.0,97820.92670675044,SDC4
13737,KEGG_2019_Human,Proteoglycans in cancer,1/201,0.0100498985877989,0.0100498985877989,0,0,19799.0,91079.21596609056,SDC4
13738,KEGG_2019_Human,Histidine metabolism,1/23,0.0011499748819949,0.0033549463201819,0,0,19977.0,135204.63922267244,ALDH3A2
13739,KEGG_2019_Human,Ascorbate and aldarate metabolism,1/27,0.0013499718942362,0.0033549463201819,0,0,19973.0,131975.02298599784,ALDH3A2
13740,KEGG_2019_Human,beta-Alanine metabolism,1/31,0.0015499690656704,0.0033549463201819,0,0,19969.0,129189.85098816035,ALDH3A2
13741,KEGG_2019_Human,Pyruvate metabolism,1/39,0.0019499637955508,0.0033549463201819,0,0,19961.0,124555.53162481484,ALDH3A2
13742,KEGG_2019_Human,Tryptophan metabolism,1/42,0.0020999619311272,0.0033549463201819,0,0,19958.0,123057.75613441122,ALDH3A2
13743,KEGG_2019_Human,Fatty acid degradation,1/44,0.0021999607179423,0.0033549463201819,0,0,19956.0,122117.06559109331,ALDH3A2
13744,KEGG_2019_Human,"Valine, leucine and isoleucine degradation",1/48,0.0023999583567988,0.0033549463201819,0,0,19952.0,120356.5272753826,ALDH3A2
13745,KEGG_2019_Human,Arginine and proline metabolism,1/49,0.0024499577795033,0.0033549463201819,0,0,19951.0,119939.1172087114,ALDH3A2
13746,KEGG_2019_Human,Lysine degradation,1/59,0.0029499522555206,0.0033549463201819,0,0,19941.0,116175.59385530632,ALDH3A2
13747,KEGG_2019_Human,Glycerolipid metabolism,1/61,0.0030499512001654,0.0033549463201819,0,0,19939.0,115499.24335773686,ALDH3A2
13748,KEGG_2019_Human,Glycolysis / Gluconeogenesis,1/68,0.0033999476216189,0.0033999476216189,0,0,19932.0,113293.39338050144,ALDH3A2
13749,KEGG_2019_Human,Arrhythmogenic right ventricular cardiomyopathy (ARVC),1/72,0.0035999456502131,0.0079623895876056,0,0,19928.0,112131.59838572376,CACNB4
13750,KEGG_2019_Human,Cardiac muscle contraction,1/78,0.0038999427840466,0.0079623895876056,0,0,19922.0,110503.2180492851,CACNB4
13751,KEGG_2019_Human,Hypertrophic cardiomyopathy (HCM),1/85,0.004249939567045,0.0079623895876056,0,0,19915.0,108752.83801948265,CACNB4
13752,KEGG_2019_Human,Dilated cardiomyopathy (DCM),1/91,0.0045499369072032,0.0079623895876056,0,0,19909.0,107362.10783923086,CACNB4
13753,KEGG_2019_Human,Adrenergic signaling in cardiomyocytes,1/145,0.0072499160871101,0.0089248989400127,0,0,19855.0,97820.92670675044,CACNB4
13754,KEGG_2019_Human,Oxytocin signaling pathway,1/153,0.0076499133771537,0.0089248989400127,0,0,19847.0,96715.6407630817,CACNB4
13755,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0147498749536506,0,0,19705.0,83086.53988020132,CACNB4
13756,KEGG_2019_Human,Spliceosome,1/134,0.0066999199497742,0.0066999199497742,0,0,19866.0,99442.43560916925,HNRNPA3
13757,KEGG_2019_Human,Spliceosome,1/134,0.0066999199497742,0.0066999199497742,0,0,19866.0,99442.43560916925,PRPF3
13758,KEGG_2019_Human,TGF-beta signaling pathway,1/90,0.0044999373439762,0.0044999373439762,0,0,19910.0,107587.50385474482,SMAD6
13759,KEGG_2019_Human,Metabolism of xenobiotics by cytochrome P450,1/74,0.0036999446830449,0.0056499278191151,0,0,19926.0,111574.38983110404,CYP2D7
13760,KEGG_2019_Human,Drug metabolism,1/108,0.0053999298011749,0.0056499278191151,0,0,19892.0,103863.47861844616,CYP2D7
13761,KEGG_2019_Human,Serotonergic synapse,1/113,0.0056499278191151,0.0056499278191151,0,0,19887.0,102937.34947211576,CYP2D7
13762,KEGG_2019_Human,RIG-I-like receptor signaling pathway,1/70,0.0034999466296654,0.0034999466296654,0,0,19930.0,112704.30065625212,PIN1
13763,KEGG_2019_Human,Cell cycle,1/124,0.0061999236097501,0.0109498935894162,0,0,19876.0,101034.04709010696,BUB3
13764,KEGG_2019_Human,Human T-cell leukemia virus 1 infection,1/219,0.0109498935894162,0.0109498935894162,0,0,19781.0,89299.85161916987,BUB3
13765,KEGG_2019_Human,Fanconi anemia pathway,1/54,0.0026999549628563,0.0026999549628563,0,0,19946.0,117971.01964061816,SLX1B
13766,KEGG_2019_Human,Renin-angiotensin system,1/23,0.0011499748819949,0.0022999497639899,0,0,19977.0,135204.63922267244,CTSA
13767,KEGG_2019_Human,Lysosome,1/123,0.0061499239842961,0.0061499239842961,0,0,19877.0,101200.07933676826,CTSA
13768,KEGG_2019_Human,Wnt signaling pathway,1/158,0.0078999117225733,0.0079999110688441,0,0,19842.0,96053.2110949472,NKD1
13769,KEGG_2019_Human,Hippo signaling pathway,1/160,0.0079999110688441,0.0079999110688441,0,0,19840.0,95793.96509856998,NKD1
13770,KEGG_2019_Human,Ribosome biogenesis in eukaryotes,1/101,0.0050499326546803,0.0050499326546803,0,0,19899.0,105233.48101229242,NHP2
13771,KEGG_2019_Human,Fc epsilon RI signaling pathway,1/68,0.0033999476216189,0.0080248953040388,0,0,19932.0,113293.39338050144,LAT
13772,KEGG_2019_Human,Fc gamma R-mediated phagocytosis,1/91,0.0045499369072032,0.0080248953040388,0,0,19909.0,107362.10783923086,LAT
13773,KEGG_2019_Human,Th1 and Th2 cell differentiation,1/92,0.0045999364719865,0.0080248953040388,0,0,19908.0,107139.13814408927,LAT
13774,KEGG_2019_Human,NF-kappa B signaling pathway,1/95,0.0047499351803394,0.0080248953040388,0,0,19905.0,106484.27183626965,LAT
13775,KEGG_2019_Human,T cell receptor signaling pathway,1/101,0.0050499326546803,0.0080248953040388,0,0,19899.0,105233.48101229242,LAT
13776,KEGG_2019_Human,Th17 cell differentiation,1/107,0.0053499302026925,0.0080248953040388,0,0,19893.0,104053.753408911,LAT
13777,KEGG_2019_Human,Natural killer cell mediated cytotoxicity,1/131,0.0065499210316603,0.0084213270407061,0,0,19869.0,99907.33811343512,LAT
13778,KEGG_2019_Human,Rap1 signaling pathway,1/206,0.010299897173561,0.0115873843202561,0,0,19794.0,90569.849337325,LAT
13779,KEGG_2019_Human,Ras signaling pathway,1/232,0.0115998901349604,0.0115998901349604,0,0,19768.0,88101.22480150245,LAT
13780,KEGG_2019_Human,Mineral absorption,1/51,0.0025499566390179,0.0025499566390179,0,0,19949.0,119129.0228601236,MT1E
13781,KEGG_2019_Human,Axon guidance,1/181,0.0090499044707863,0.0109498935894162,0,0,19819.0,93248.41634586031,NRP1
13782,KEGG_2019_Human,Human T-cell leukemia virus 1 infection,1/219,0.0109498935894162,0.0109498935894162,0,0,19781.0,89299.85161916987,NRP1
13783,KEGG_2019_Human,Pentose phosphate pathway,1/30,0.0014999697593334,0.0014999697593334,0,0,19970.0,129851.13732048514,IDNK
13784,KEGG_2019_Human,N-Glycan biosynthesis,1/50,0.0024999572069037,0.0049999144138074,0,0,19950.0,119530.05920663515,TUSC3
13785,KEGG_2019_Human,Protein processing in endoplasmic reticulum,1/165,0.0082499094553477,0.0082499094553477,0,0,19835.0,95159.46482222488,TUSC3
13786,KEGG_2019_Human,Autophagy,1/128,0.0063999221281459,0.0063999221281459,0,0,19872.0,100382.8010329652,IGBP1
13787,KEGG_2019_Human,Fat digestion and absorption,1/41,0.0020499625466866,0.0030499512001654,0,0,19959.0,123544.88783416104,MOGAT3
13788,KEGG_2019_Human,Glycerolipid metabolism,1/61,0.0030499512001654,0.0030499512001654,0,0,19939.0,115499.24335773686,MOGAT3
13789,KEGG_2019_Human,Ribosome biogenesis in eukaryotes,1/101,0.0050499326546803,0.0050499326546803,0,0,19899.0,105233.48101229242,GNL2
13790,KEGG_2019_Human,Thyroid hormone signaling pathway,1/116,0.0057999266512085,0.0092999029651357,0,0,19884.0,102400.8105961506,RCAN1
13791,KEGG_2019_Human,Oxytocin signaling pathway,1/153,0.0076499133771537,0.0092999029651357,0,0,19847.0,96715.6407630817,RCAN1
13792,KEGG_2019_Human,Kaposi sarcoma-associated herpesvirus infection,1/186,0.0092999029651357,0.0092999029651357,0,0,19814.0,92684.96451050608,RCAN1
13793,KEGG_2019_Human,mRNA surveillance pathway,1/91,0.0045499369072032,0.0085499075557634,0,0,19909.0,107362.10783923086,CPSF4
13794,KEGG_2019_Human,Influenza A,1/171,0.0085499075557634,0.0085499075557634,0,0,19829.0,94422.42241345016,CPSF4
13795,KEGG_2019_Human,Cholesterol metabolism,1/50,0.0024999572069037,0.0024999572069037,0,0,19950.0,119530.05920663515,STARD3
13796,KEGG_2019_Human,Glycosaminoglycan degradation,1/19,0.00094997806231055,0.0018999561246211,0,0,19981.0,139049.2109571672,HGSNAT
13797,KEGG_2019_Human,Lysosome,1/123,0.0061499239842961,0.0061499239842961,0,0,19877.0,101200.07933676826,HGSNAT
13798,KEGG_2019_Human,Prion diseases,1/35,0.0017499663721595,0.0108518057438535,0,0,19965.0,126740.98858805298,MAP2K2
13799,KEGG_2019_Human,Thyroid cancer,1/37,0.0018499650702878,0.0108518057438535,0,0,19963.0,125618.9446446357,MAP2K2
13800,KEGG_2019_Human,Bladder cancer,1/41,0.0020499625466866,0.0108518057438535,0,0,19959.0,123544.88783416104,MAP2K2
13801,KEGG_2019_Human,Endometrial cancer,1/58,0.0028999527887707,0.0108518057438535,0,0,19942.0,116522.31890946148,MAP2K2
13802,KEGG_2019_Human,VEGF signaling pathway,1/59,0.0029499522555206,0.0108518057438535,0,0,19941.0,116175.59385530632,MAP2K2
13803,KEGG_2019_Human,Long-term depression,1/60,0.002999951725986,0.0108518057438535,0,0,19940.0,115834.63209072244,MAP2K2
13804,KEGG_2019_Human,Central carbon metabolism in cancer,1/65,0.003249949134407,0.0108518057438535,0,0,19935.0,114209.92613860144,MAP2K2
13805,KEGG_2019_Human,Acute myeloid leukemia,1/66,0.003299948626608,0.0108518057438535,0,0,19934.0,113899.85357353876,MAP2K2
13806,KEGG_2019_Human,Non-small cell lung cancer,1/66,0.003299948626608,0.0108518057438535,0,0,19934.0,113899.85357353876,MAP2K2
13807,KEGG_2019_Human,Long-term potentiation,1/67,0.0033499481224912,0.0108518057438535,0,0,19933.0,113594.38808369274,MAP2K2
13808,KEGG_2019_Human,Fc epsilon RI signaling pathway,1/68,0.0033999476216189,0.0108518057438535,0,0,19932.0,113293.39338050144,MAP2K2
13809,KEGG_2019_Human,Renal cell carcinoma,1/69,0.003449947123837,0.0108518057438535,0,0,19931.0,112996.7391397682,MAP2K2
13810,KEGG_2019_Human,Prolactin signaling pathway,1/70,0.0034999466296654,0.0108518057438535,0,0,19930.0,112704.30065625212,MAP2K2
13811,KEGG_2019_Human,B cell receptor signaling pathway,1/71,0.0035499461386618,0.0108518057438535,0,0,19929.0,112415.9585341616,MAP2K2
13812,KEGG_2019_Human,Melanoma,1/72,0.0035999456502131,0.0108518057438535,0,0,19928.0,112131.59838572376,MAP2K2
13813,KEGG_2019_Human,Glioma,1/75,0.0037499442041125,0.0108518057438535,0,0,19925.0,111301.33528642564,MAP2K2
13814,KEGG_2019_Human,Chronic myeloid leukemia,1/76,0.0037999437281752,0.0108518057438535,0,0,19924.0,111031.8499691117,MAP2K2
13815,KEGG_2019_Human,ErbB signaling pathway,1/85,0.004249939567045,0.0108518057438535,0,0,19915.0,108752.83801948265,MAP2K2
13816,KEGG_2019_Human,Colorectal cancer,1/86,0.0042999391173866,0.0108518057438535,0,0,19914.0,108514.46102290176,MAP2K2
13817,KEGG_2019_Human,Gap junction,1/88,0.0043999382262822,0.0108518057438535,0,0,19912.0,108045.79305232369,MAP2K2
13818,KEGG_2019_Human,GnRH signaling pathway,1/93,0.0046499360391879,0.0108518057438535,0,0,19907.0,106918.54242106884,MAP2K2
13819,KEGG_2019_Human,Prostate cancer,1/97,0.0048499343304706,0.0108518057438535,0,0,19903.0,106058.9096435903,MAP2K2
13820,KEGG_2019_Human,Choline metabolism in cancer,1/99,0.0049499334884068,0.0108518057438535,0,0,19901.0,105642.09305076736,MAP2K2
13821,KEGG_2019_Human,HIF-1 signaling pathway,1/100,0.0049999330710556,0.0108518057438535,0,0,19900.0,105436.78197328727,MAP2K2
13822,KEGG_2019_Human,T cell receptor signaling pathway,1/101,0.0050499326546803,0.0108518057438535,0,0,19899.0,105233.48101229242,MAP2K2
13823,KEGG_2019_Human,Melanogenesis,1/101,0.0050499326546803,0.0108518057438535,0,0,19899.0,105233.48101229242,MAP2K2
13824,KEGG_2019_Human,Toll-like receptor signaling pathway,1/104,0.0051999314202997,0.0108518057438535,0,0,19896.0,104635.24941415618,MAP2K2
13825,KEGG_2019_Human,Thyroid hormone signaling pathway,1/116,0.0057999266512085,0.0108518057438535,0,0,19884.0,102400.8105961506,MAP2K2
13826,KEGG_2019_Human,Sphingolipid signaling pathway,1/119,0.0059499254985137,0.0108518057438535,0,0,19881.0,101877.73080211312,MAP2K2
13827,KEGG_2019_Human,Neurotrophin signaling pathway,1/119,0.0059499254985137,0.0108518057438535,0,0,19881.0,101877.73080211312,MAP2K2
13828,KEGG_2019_Human,Autophagy,1/128,0.0063999221281459,0.0108518057438535,0,0,19872.0,100382.8010329652,MAP2K2
13829,KEGG_2019_Human,Relaxin signaling pathway,1/130,0.0064999213952527,0.0108518057438535,0,0,19870.0,100064.62842845908,MAP2K2
13830,KEGG_2019_Human,Natural killer cell mediated cytotoxicity,1/131,0.0065499210316603,0.0108518057438535,0,0,19869.0,99907.33811343512,MAP2K2
13831,KEGG_2019_Human,Vascular smooth muscle contraction,1/132,0.0065999206698993,0.0108518057438535,0,0,19868.0,99751.22090491928,MAP2K2
13832,KEGG_2019_Human,FoxO signaling pathway,1/132,0.0065999206698993,0.0108518057438535,0,0,19868.0,99751.22090491928,MAP2K2
13833,KEGG_2019_Human,Insulin signaling pathway,1/137,0.0068499188797651,0.0108518057438535,0,0,19863.0,98987.62735269018,MAP2K2
13834,KEGG_2019_Human,Apelin signaling pathway,1/137,0.0068499188797651,0.0108518057438535,0,0,19863.0,98987.62735269018,MAP2K2
13835,KEGG_2019_Human,Estrogen signaling pathway,1/137,0.0068499188797651,0.0108518057438535,0,0,19863.0,98987.62735269018,MAP2K2
13836,KEGG_2019_Human,Signaling pathways regulating pluripotency of stem cells,1/139,0.006949918172816,0.0108518057438535,0,0,19861.0,98689.81333375497,MAP2K2
13837,KEGG_2019_Human,Apoptosis,1/143,0.0071499167770442,0.0108518057438535,0,0,19857.0,98106.57763600958,MAP2K2
13838,KEGG_2019_Human,Breast cancer,1/147,0.0073499154017982,0.0108518057438535,0,0,19853.0,97539.10874372096,MAP2K2
13839,KEGG_2019_Human,Phospholipase D signaling pathway,1/148,0.007399915061391,0.0108518057438535,0,0,19852.0,97399.60470052566,MAP2K2
13840,KEGG_2019_Human,Gastric cancer,1/149,0.0074499147221605,0.0108518057438535,0,0,19851.0,97261.02051561224,MAP2K2
13841,KEGG_2019_Human,mTOR signaling pathway,1/152,0.0075999137114971,0.0108518057438535,0,0,19848.0,96850.665715497,MAP2K2
13842,KEGG_2019_Human,Oxytocin signaling pathway,1/153,0.0076499133771537,0.0108518057438535,0,0,19847.0,96715.6407630817,MAP2K2
13843,KEGG_2019_Human,Cushing syndrome,1/155,0.0077499127120574,0.0108518057438535,0,0,19845.0,96448.16254952336,MAP2K2
13844,KEGG_2019_Human,Hepatitis C,1/155,0.0077499127120574,0.0108518057438535,0,0,19845.0,96448.16254952336,MAP2K2
13845,KEGG_2019_Human,Cellular senescence,1/160,0.0079999110688441,0.0108518057438535,0,0,19840.0,95793.96509856998,MAP2K2
13846,KEGG_2019_Human,Hepatitis B,1/163,0.0081499100978668,0.0108518057438535,0,0,19837.0,95410.9786681514,MAP2K2
13847,KEGG_2019_Human,cGMP-PKG signaling pathway,1/166,0.0082999091363732,0.0108518057438535,0,0,19834.0,95034.82345515196,MAP2K2
13848,KEGG_2019_Human,Hepatocellular carcinoma,1/168,0.0083999085011095,0.0108518057438535,0,0,19832.0,94787.72752807094,MAP2K2
13849,KEGG_2019_Human,Influenza A,1/171,0.0085499075557634,0.0108518057438535,0,0,19829.0,94422.42241345016,MAP2K2
13850,KEGG_2019_Human,Kaposi sarcoma-associated herpesvirus infection,1/186,0.0092999029651357,0.011581011239603,0,0,19814.0,92684.96451050608,MAP2K2
13851,KEGG_2019_Human,Proteoglycans in cancer,1/201,0.0100498985877989,0.0121757425309111,0,0,19799.0,91079.21596609056,MAP2K2
13852,KEGG_2019_Human,Rap1 signaling pathway,1/206,0.010299897173561,0.0121757425309111,0,0,19794.0,90569.849337325,MAP2K2
13853,KEGG_2019_Human,Human immunodeficiency virus 1 infection,1/212,0.0105998955026255,0.0121757425309111,0,0,19788.0,89974.27756224656,MAP2K2
13854,KEGG_2019_Human,cAMP signaling pathway,1/212,0.0105998955026255,0.0121757425309111,0,0,19788.0,89974.27756224656,MAP2K2
13855,KEGG_2019_Human,Regulation of actin cytoskeleton,1/214,0.0106998949514067,0.0121757425309111,0,0,19786.0,89779.39753374986,MAP2K2
13856,KEGG_2019_Human,Human T-cell leukemia virus 1 infection,1/219,0.0109498935894162,0.0122490335068046,0,0,19781.0,89299.85161916987,MAP2K2
13857,KEGG_2019_Human,Human cytomegalovirus infection,1/225,0.0112498919790339,0.0123748811769373,0,0,19775.0,88738.27077557483,MAP2K2
13858,KEGG_2019_Human,Ras signaling pathway,1/232,0.0115998901349604,0.0125507008017604,0,0,19768.0,88101.22480150245,MAP2K2
13859,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0156617728321491,0,0,19705.0,83086.53988020132,MAP2K2
13860,KEGG_2019_Human,MicroRNAs in cancer,1/299,0.0149498740670514,0.0156617728321491,0,0,19701.0,82804.33538735632,MAP2K2
13861,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0170154883170571,0,0,19670.0,80733.60565076157,MAP2K2
13862,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0179721682204648,0,0,19646.0,79255.8617626126,MAP2K2
13863,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,MAP2K2
13864,KEGG_2019_Human,Measles,1/138,0.0068999185254481,0.0120598783053587,0,0,19862.0,98838.19160389496,OAS1
13865,KEGG_2019_Human,Hepatitis C,1/155,0.0077499127120574,0.0120598783053587,0,0,19845.0,96448.16254952336,OAS1
13866,KEGG_2019_Human,Influenza A,1/171,0.0085499075557634,0.0120598783053587,0,0,19829.0,94422.42241345016,OAS1
13867,KEGG_2019_Human,NOD-like receptor signaling pathway,1/178,0.0088999053857096,0.0120598783053587,0,0,19822.0,93593.82745769851,OAS1
13868,KEGG_2019_Human,Epstein-Barr virus infection,1/201,0.0100498985877989,0.0120598783053587,0,0,19799.0,91079.21596609056,OAS1
13869,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,OAS1
13870,KEGG_2019_Human,Staphylococcus aureus infection,1/68,0.0033999476216189,0.0039499423167337,0,0,19932.0,113293.39338050144,MASP2
13871,KEGG_2019_Human,Complement and coagulation cascades,1/79,0.0039499423167337,0.0039499423167337,0,0,19921.0,110243.89578070649,MASP2
13872,KEGG_2019_Human,"Valine, leucine and isoleucine degradation",1/48,0.0023999583567988,0.0023999583567988,0,0,19952.0,120356.5272753826,MCCC2
13873,KEGG_2019_Human,Arrhythmogenic right ventricular cardiomyopathy (ARVC),1/72,0.0035999456502131,0.0079623895876056,0,0,19928.0,112131.59838572376,CACNB2
13874,KEGG_2019_Human,Cardiac muscle contraction,1/78,0.0038999427840466,0.0079623895876056,0,0,19922.0,110503.2180492851,CACNB2
13875,KEGG_2019_Human,Hypertrophic cardiomyopathy (HCM),1/85,0.004249939567045,0.0079623895876056,0,0,19915.0,108752.83801948265,CACNB2
13876,KEGG_2019_Human,Dilated cardiomyopathy (DCM),1/91,0.0045499369072032,0.0079623895876056,0,0,19909.0,107362.10783923086,CACNB2
13877,KEGG_2019_Human,Adrenergic signaling in cardiomyocytes,1/145,0.0072499160871101,0.0089248989400127,0,0,19855.0,97820.92670675044,CACNB2
13878,KEGG_2019_Human,Oxytocin signaling pathway,1/153,0.0076499133771537,0.0089248989400127,0,0,19847.0,96715.6407630817,CACNB2
13879,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0147498749536506,0,0,19705.0,83086.53988020132,CACNB2
13880,KEGG_2019_Human,Peroxisome,1/83,0.0041499404726918,0.0041499404726918,0,0,19917.0,109237.99888847338,MPV17
13881,KEGG_2019_Human,Purine metabolism,1/129,0.006449921761047,0.006449921761047,0,0,19871.0,100223.109907462,ADK
13882,KEGG_2019_Human,Platelet activation,1/124,0.0061999236097501,0.0109498935894162,0,0,19876.0,101034.04709010696,TLN2
13883,KEGG_2019_Human,Focal adhesion,1/199,0.0099498991610159,0.0109498935894162,0,0,19801.0,91286.4288690606,TLN2
13884,KEGG_2019_Human,Rap1 signaling pathway,1/206,0.010299897173561,0.0109498935894162,0,0,19794.0,90569.849337325,TLN2
13885,KEGG_2019_Human,Human T-cell leukemia virus 1 infection,1/219,0.0109498935894162,0.0109498935894162,0,0,19781.0,89299.85161916987,TLN2
13886,KEGG_2019_Human,Cytosolic DNA-sensing pathway,1/63,0.0031499501598827,0.0090998799855245,0,0,19937.0,114844.46974572667,CCL4L2
13887,KEGG_2019_Human,Salmonella infection,1/86,0.0042999391173866,0.0090998799855245,0,0,19914.0,108514.46102290176,CCL4L2
13888,KEGG_2019_Human,NF-kappa B signaling pathway,1/95,0.0047499351803394,0.0090998799855245,0,0,19905.0,106484.27183626965,CCL4L2
13889,KEGG_2019_Human,Toll-like receptor signaling pathway,1/104,0.0051999314202997,0.0090998799855245,0,0,19896.0,104635.24941415618,CCL4L2
13890,KEGG_2019_Human,Chemokine signaling pathway,1/190,0.0094999017791995,0.0131248739755395,0,0,19810.0,92244.74636351672,CCL4L2
13891,KEGG_2019_Human,Human cytomegalovirus infection,1/225,0.0112498919790339,0.0131248739755395,0,0,19775.0,88738.27077557483,CCL4L2
13892,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0146998751759735,0,0,19706.0,83157.67014793828,CCL4L2
13893,KEGG_2019_Human,Shigellosis,1/65,0.003249949134407,0.0062499232373748,0,0,19935.0,114209.92613860144,MAD2L2
13894,KEGG_2019_Human,Bacterial invasion of epithelial cells,1/74,0.0036999446830449,0.0062499232373748,0,0,19926.0,111574.38983110404,MAD2L2
13895,KEGG_2019_Human,Progesterone-mediated oocyte maturation,1/99,0.0049499334884068,0.0062499232373748,0,0,19901.0,105642.09305076736,MAD2L2
13896,KEGG_2019_Human,Cell cycle,1/124,0.0061999236097501,0.0062499232373748,0,0,19876.0,101034.04709010696,MAD2L2
13897,KEGG_2019_Human,Oocyte meiosis,1/125,0.0062499232373748,0.0062499232373748,0,0,19875.0,100869.32368441945,MAD2L2
13898,KEGG_2019_Human,Vascular smooth muscle contraction,1/132,0.0065999206698993,0.0065999206698993,0,0,19868.0,99751.22090491928,PPP1R14A
13899,KEGG_2019_Human,Relaxin signaling pathway,1/130,0.0064999213952527,0.0129998427905055,0,0,19870.0,100064.62842845908,RLN2
13900,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,RLN2
13901,KEGG_2019_Human,TGF-beta signaling pathway,1/90,0.0044999373439762,0.011428444384063,0,0,19910.0,107587.50385474482,CDKN2B
13902,KEGG_2019_Human,Small cell lung cancer,1/93,0.0046499360391879,0.011428444384063,0,0,19907.0,106918.54242106884,CDKN2B
13903,KEGG_2019_Human,Cell cycle,1/124,0.0061999236097501,0.011428444384063,0,0,19876.0,101034.04709010696,CDKN2B
13904,KEGG_2019_Human,FoxO signaling pathway,1/132,0.0065999206698993,0.011428444384063,0,0,19868.0,99751.22090491928,CDKN2B
13905,KEGG_2019_Human,Gastric cancer,1/149,0.0074499147221605,0.011428444384063,0,0,19851.0,97261.02051561224,CDKN2B
13906,KEGG_2019_Human,Cushing syndrome,1/155,0.0077499127120574,0.011428444384063,0,0,19845.0,96448.16254952336,CDKN2B
13907,KEGG_2019_Human,Cellular senescence,1/160,0.0079999110688441,0.011428444384063,0,0,19840.0,95793.96509856998,CDKN2B
13908,KEGG_2019_Human,Viral carcinogenesis,1/201,0.0100498985877989,0.0121665484326847,0,0,19799.0,91079.21596609056,CDKN2B
13909,KEGG_2019_Human,Human T-cell leukemia virus 1 infection,1/219,0.0109498935894162,0.0121665484326847,0,0,19781.0,89299.85161916987,CDKN2B
13910,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,CDKN2B
13911,KEGG_2019_Human,Sphingolipid metabolism,1/47,0.0023499589392381,0.0046999178784763,0,0,19953.0,120782.64067395544,CERS5
13912,KEGG_2019_Human,Sphingolipid signaling pathway,1/119,0.0059499254985137,0.0059499254985137,0,0,19881.0,101877.73080211312,CERS5
13913,KEGG_2019_Human,Glycerolipid metabolism,1/61,0.0030499512001654,0.007274901495706,0,0,19939.0,115499.24335773686,AGPAT4
13914,KEGG_2019_Human,Glycerophospholipid metabolism,1/97,0.0048499343304706,0.007274901495706,0,0,19903.0,106058.9096435903,AGPAT4
13915,KEGG_2019_Human,Phospholipase D signaling pathway,1/148,0.007399915061391,0.007399915061391,0,0,19852.0,97399.60470052566,AGPAT4
13916,KEGG_2019_Human,Pentose phosphate pathway,1/30,0.0014999697593334,0.0032999354064227,0,0,19970.0,129851.13732048514,ALDOA
13917,KEGG_2019_Human,Fructose and mannose metabolism,1/33,0.0016499677032113,0.0032999354064227,0,0,19967.0,127928.56031580272,ALDOA
13918,KEGG_2019_Human,Glycolysis / Gluconeogenesis,1/68,0.0033999476216189,0.0045332634954919,0,0,19932.0,113293.39338050144,ALDOA
13919,KEGG_2019_Human,HIF-1 signaling pathway,1/100,0.0049999330710556,0.0049999330710556,0,0,19900.0,105436.78197328727,ALDOA
13920,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF419
13921,KEGG_2019_Human,Selenocompound metabolism,1/17,0.0008499797390404818,0.0008499797390404818,0,0,19983.0,141285.76583697114,SCLY
13922,KEGG_2019_Human,Dopaminergic synapse,1/131,0.0065499210316603,0.0121998870519305,0,0,19869.0,99907.33811343512,KIF5A
13923,KEGG_2019_Human,Endocytosis,1/244,0.0121998870519305,0.0121998870519305,0,0,19756.0,87051.4275316661,KIF5A
13924,KEGG_2019_Human,Cholesterol metabolism,1/50,0.0024999572069037,0.0036999446830449,0,0,19950.0,119530.05920663515,APOA2
13925,KEGG_2019_Human,PPAR signaling pathway,1/74,0.0036999446830449,0.0036999446830449,0,0,19926.0,111574.38983110404,APOA2
13926,KEGG_2019_Human,Cell cycle,1/124,0.0061999236097501,0.0061999236097501,0,0,19876.0,101034.04709010696,ORC5
13927,KEGG_2019_Human,Endocytosis,1/244,0.0121998870519305,0.0121998870519305,0,0,19756.0,87051.4275316661,ARFGAP1
13928,KEGG_2019_Human,C-type lectin receptor signaling pathway,1/104,0.0051999314202997,0.0100498985877989,0,0,19896.0,104635.24941415618,EGR3
13929,KEGG_2019_Human,Hepatitis B,1/163,0.0081499100978668,0.0100498985877989,0,0,19837.0,95410.9786681514,EGR3
13930,KEGG_2019_Human,Viral carcinogenesis,1/201,0.0100498985877989,0.0100498985877989,0,0,19799.0,91079.21596609056,EGR3
13931,KEGG_2019_Human,Arrhythmogenic right ventricular cardiomyopathy (ARVC),1/72,0.0035999456502131,0.0079623895876056,0,0,19928.0,112131.59838572376,CACNB3
13932,KEGG_2019_Human,Cardiac muscle contraction,1/78,0.0038999427840466,0.0079623895876056,0,0,19922.0,110503.2180492851,CACNB3
13933,KEGG_2019_Human,Hypertrophic cardiomyopathy (HCM),1/85,0.004249939567045,0.0079623895876056,0,0,19915.0,108752.83801948265,CACNB3
13934,KEGG_2019_Human,Dilated cardiomyopathy (DCM),1/91,0.0045499369072032,0.0079623895876056,0,0,19909.0,107362.10783923086,CACNB3
13935,KEGG_2019_Human,Adrenergic signaling in cardiomyocytes,1/145,0.0072499160871101,0.0089248989400127,0,0,19855.0,97820.92670675044,CACNB3
13936,KEGG_2019_Human,Oxytocin signaling pathway,1/153,0.0076499133771537,0.0089248989400127,0,0,19847.0,96715.6407630817,CACNB3
13937,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0147498749536506,0,0,19705.0,83086.53988020132,CACNB3
13938,KEGG_2019_Human,"Alanine, aspartate and glutamate metabolism",1/35,0.0017499663721595,0.0035999375351982,0,0,19965.0,126740.98858805298,GFPT2
13939,KEGG_2019_Human,Amino sugar and nucleotide sugar metabolism,1/48,0.0023999583567988,0.0035999375351982,0,0,19952.0,120356.5272753826,GFPT2
13940,KEGG_2019_Human,Insulin resistance,1/108,0.0053999298011749,0.0053999298011749,0,0,19892.0,103863.47861844616,GFPT2
13941,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,PENK
13942,KEGG_2019_Human,Aldosterone-regulated sodium reabsorption,1/37,0.0018499650702878,0.0087387871719429,0,0,19963.0,125618.9446446357,PDPK1
13943,KEGG_2019_Human,Endometrial cancer,1/58,0.0028999527887707,0.0087387871719429,0,0,19942.0,116522.31890946148,PDPK1
13944,KEGG_2019_Human,Non-small cell lung cancer,1/66,0.003299948626608,0.0087387871719429,0,0,19934.0,113899.85357353876,PDPK1
13945,KEGG_2019_Human,Fc epsilon RI signaling pathway,1/68,0.0033999476216189,0.0087387871719429,0,0,19932.0,113293.39338050144,PDPK1
13946,KEGG_2019_Human,PPAR signaling pathway,1/74,0.0036999446830449,0.0087387871719429,0,0,19926.0,111574.38983110404,PDPK1
13947,KEGG_2019_Human,Prostate cancer,1/97,0.0048499343304706,0.0087387871719429,0,0,19903.0,106058.9096435903,PDPK1
13948,KEGG_2019_Human,Choline metabolism in cancer,1/99,0.0049499334884068,0.0087387871719429,0,0,19901.0,105642.09305076736,PDPK1
13949,KEGG_2019_Human,T cell receptor signaling pathway,1/101,0.0050499326546803,0.0087387871719429,0,0,19899.0,105233.48101229242,PDPK1
13950,KEGG_2019_Human,Insulin resistance,1/108,0.0053999298011749,0.0087387871719429,0,0,19892.0,103863.47861844616,PDPK1
13951,KEGG_2019_Human,Toxoplasmosis,1/113,0.0056499278191151,0.0087387871719429,0,0,19887.0,102937.34947211576,PDPK1
13952,KEGG_2019_Human,Thyroid hormone signaling pathway,1/116,0.0057999266512085,0.0087387871719429,0,0,19884.0,102400.8105961506,PDPK1
13953,KEGG_2019_Human,Sphingolipid signaling pathway,1/119,0.0059499254985137,0.0087387871719429,0,0,19881.0,101877.73080211312,PDPK1
13954,KEGG_2019_Human,Neurotrophin signaling pathway,1/119,0.0059499254985137,0.0087387871719429,0,0,19881.0,101877.73080211312,PDPK1
13955,KEGG_2019_Human,AMPK signaling pathway,1/120,0.0059999251180858,0.0087387871719429,0,0,19880.0,101706.2448082016,PDPK1
13956,KEGG_2019_Human,Autophagy,1/128,0.0063999221281459,0.0087387871719429,0,0,19872.0,100382.8010329652,PDPK1
13957,KEGG_2019_Human,FoxO signaling pathway,1/132,0.0065999206698993,0.0087387871719429,0,0,19868.0,99751.22090491928,PDPK1
13958,KEGG_2019_Human,Insulin signaling pathway,1/137,0.0068499188797651,0.0087387871719429,0,0,19863.0,98987.62735269018,PDPK1
13959,KEGG_2019_Human,Apoptosis,1/143,0.0071499167770442,0.0087387871719429,0,0,19857.0,98106.57763600958,PDPK1
13960,KEGG_2019_Human,mTOR signaling pathway,1/152,0.0075999137114971,0.0087999000869966,0,0,19848.0,96850.665715497,PDPK1
13961,KEGG_2019_Human,Focal adhesion,1/199,0.0099498991610159,0.0105284651872179,0,0,19801.0,91286.4288690606,PDPK1
13962,KEGG_2019_Human,Proteoglycans in cancer,1/201,0.0100498985877989,0.0105284651872179,0,0,19799.0,91079.21596609056,PDPK1
13963,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0176998626413668,0,0,19646.0,79255.8617626126,PDPK1
13964,KEGG_2019_Human,Complement and coagulation cascades,1/79,0.0039499423167337,0.0048499343304706,0,0,19921.0,110243.89578070649,CD59
13965,KEGG_2019_Human,Hematopoietic cell lineage,1/97,0.0048499343304706,0.0048499343304706,0,0,19903.0,106058.9096435903,CD59
13966,KEGG_2019_Human,Bladder cancer,1/41,0.0020499625466866,0.0061498876400599,0,0,19959.0,123544.88783416104,DAPK2
13967,KEGG_2019_Human,Autophagy,1/128,0.0063999221281459,0.0095998831922188,0,0,19872.0,100382.8010329652,DAPK2
13968,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,DAPK2
13969,KEGG_2019_Human,African trypanosomiasis,1/37,0.0018499650702878,0.0107098658973247,0,0,19963.0,125618.9446446357,KNG1
13970,KEGG_2019_Human,Complement and coagulation cascades,1/79,0.0039499423167337,0.0107098658973247,0,0,19921.0,110243.89578070649,KNG1
13971,KEGG_2019_Human,Inflammatory mediator regulation of TRP channels,1/100,0.0049999330710556,0.0107098658973247,0,0,19900.0,105436.78197328727,KNG1
13972,KEGG_2019_Human,Chagas disease (American trypanosomiasis),1/103,0.0051499318302617,0.0107098658973247,0,0,19897.0,104832.7525292024,KNG1
13973,KEGG_2019_Human,Sphingolipid signaling pathway,1/119,0.0059499254985137,0.0107098658973247,0,0,19881.0,101877.73080211312,KNG1
13974,KEGG_2019_Human,cGMP-PKG signaling pathway,1/166,0.0082999091363732,0.0124498637045599,0,0,19834.0,95034.82345515196,KNG1
13975,KEGG_2019_Human,Regulation of actin cytoskeleton,1/214,0.0106998949514067,0.0137570077946658,0,0,19786.0,89779.39753374986,KNG1
13976,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0190123490548795,0,0,19662.0,80229.79996326564,KNG1
13977,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,KNG1
13978,KEGG_2019_Human,Nitrogen metabolism,1/17,0.0008499797390404818,0.0008499797390404818,0,0,19983.0,141285.76583697114,CA13
13979,KEGG_2019_Human,Thermogenesis,1/231,0.0115498903940656,0.0115498903940656,0,0,19769.0,88191.07730937863,NDUFAF3
13980,KEGG_2019_Human,Staphylococcus aureus infection,1/68,0.0033999476216189,0.0067998952432378,0,0,19932.0,113293.39338050144,FCAR
13981,KEGG_2019_Human,Phagosome,1/152,0.0075999137114971,0.0075999137114971,0,0,19848.0,96850.665715497,FCAR
13982,KEGG_2019_Human,Folate biosynthesis,1/26,0.0012999726251831,0.0031499428966909,0,0,19974.0,132735.46073187632,TPH1
13983,KEGG_2019_Human,Tryptophan metabolism,1/42,0.0020999619311272,0.0031499428966909,0,0,19958.0,123057.75613441122,TPH1
13984,KEGG_2019_Human,Serotonergic synapse,1/113,0.0056499278191151,0.0056499278191151,0,0,19887.0,102937.34947211576,TPH1
13985,KEGG_2019_Human,Cysteine and methionine metabolism,1/47,0.0023499589392381,0.0023499589392381,0,0,19953.0,120782.64067395544,ADI1
13986,KEGG_2019_Human,Long-term potentiation,1/67,0.0033499481224912,0.0099998771797997,0,0,19933.0,113594.38808369274,RPS6KA1
13987,KEGG_2019_Human,Progesterone-mediated oocyte maturation,1/99,0.0049499334884068,0.0099998771797997,0,0,19901.0,105642.09305076736,RPS6KA1
13988,KEGG_2019_Human,Insulin resistance,1/108,0.0053999298011749,0.0099998771797997,0,0,19892.0,103863.47861844616,RPS6KA1
13989,KEGG_2019_Human,Neurotrophin signaling pathway,1/119,0.0059499254985137,0.0099998771797997,0,0,19881.0,101877.73080211312,RPS6KA1
13990,KEGG_2019_Human,Oocyte meiosis,1/125,0.0062499232373748,0.0099998771797997,0,0,19875.0,100869.32368441945,RPS6KA1
13991,KEGG_2019_Human,mTOR signaling pathway,1/152,0.0075999137114971,0.0101332182819961,0,0,19848.0,96850.665715497,RPS6KA1
13992,KEGG_2019_Human,Thermogenesis,1/231,0.0115498903940656,0.0131998747360749,0,0,19769.0,88191.07730937863,RPS6KA1
13993,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0147498749536506,0,0,19705.0,83086.53988020132,RPS6KA1
13994,KEGG_2019_Human,Ribosome,1/153,0.0076499133771537,0.0076499133771537,0,0,19847.0,96715.6407630817,RPS12
13995,KEGG_2019_Human,Amyotrophic lateral sclerosis (ALS),1/51,0.0025499566390179,0.0123665447530631,0,0,19949.0,119129.0228601236,BAD
13996,KEGG_2019_Human,Endometrial cancer,1/58,0.0028999527887707,0.0123665447530631,0,0,19942.0,116522.31890946148,BAD
13997,KEGG_2019_Human,VEGF signaling pathway,1/59,0.0029499522555206,0.0123665447530631,0,0,19941.0,116175.59385530632,BAD
13998,KEGG_2019_Human,Acute myeloid leukemia,1/66,0.003299948626608,0.0123665447530631,0,0,19934.0,113899.85357353876,BAD
13999,KEGG_2019_Human,Non-small cell lung cancer,1/66,0.003299948626608,0.0123665447530631,0,0,19934.0,113899.85357353876,BAD
14000,KEGG_2019_Human,Renal cell carcinoma,1/69,0.003449947123837,0.0123665447530631,0,0,19931.0,112996.7391397682,BAD
14001,KEGG_2019_Human,Melanoma,1/72,0.0035999456502131,0.0123665447530631,0,0,19928.0,112131.59838572376,BAD
14002,KEGG_2019_Human,Pancreatic cancer,1/75,0.0037499442041125,0.0123665447530631,0,0,19925.0,111301.33528642564,BAD
14003,KEGG_2019_Human,Chronic myeloid leukemia,1/76,0.0037999437281752,0.0123665447530631,0,0,19924.0,111031.8499691117,BAD
14004,KEGG_2019_Human,ErbB signaling pathway,1/85,0.004249939567045,0.0123665447530631,0,0,19915.0,108752.83801948265,BAD
14005,KEGG_2019_Human,Colorectal cancer,1/86,0.0042999391173866,0.0123665447530631,0,0,19914.0,108514.46102290176,BAD
14006,KEGG_2019_Human,Prostate cancer,1/97,0.0048499343304706,0.0123665447530631,0,0,19903.0,106058.9096435903,BAD
14007,KEGG_2019_Human,Toxoplasmosis,1/113,0.0056499278191151,0.0123665447530631,0,0,19887.0,102937.34947211576,BAD
14008,KEGG_2019_Human,Thyroid hormone signaling pathway,1/116,0.0057999266512085,0.0123665447530631,0,0,19884.0,102400.8105961506,BAD
14009,KEGG_2019_Human,Neurotrophin signaling pathway,1/119,0.0059499254985137,0.0123665447530631,0,0,19881.0,101877.73080211312,BAD
14010,KEGG_2019_Human,Autophagy,1/128,0.0063999221281459,0.0123665447530631,0,0,19872.0,100382.8010329652,BAD
14011,KEGG_2019_Human,Insulin signaling pathway,1/137,0.0068499188797651,0.0123665447530631,0,0,19863.0,98987.62735269018,BAD
14012,KEGG_2019_Human,Measles,1/138,0.0068999185254481,0.0123665447530631,0,0,19862.0,98838.19160389496,BAD
14013,KEGG_2019_Human,Apoptosis,1/143,0.0071499167770442,0.0123665447530631,0,0,19857.0,98106.57763600958,BAD
14014,KEGG_2019_Human,Hepatitis C,1/155,0.0077499127120574,0.0123665447530631,0,0,19845.0,96448.16254952336,BAD
14015,KEGG_2019_Human,Hepatitis B,1/163,0.0081499100978668,0.0123665447530631,0,0,19837.0,95410.9786681514,BAD
14016,KEGG_2019_Human,cGMP-PKG signaling pathway,1/166,0.0082999091363732,0.0123665447530631,0,0,19834.0,95034.82345515196,BAD
14017,KEGG_2019_Human,Hepatocellular carcinoma,1/168,0.0083999085011095,0.0123665447530631,0,0,19832.0,94787.72752807094,BAD
14018,KEGG_2019_Human,Alzheimer disease,1/171,0.0085499075557634,0.0123665447530631,0,0,19829.0,94422.42241345016,BAD
14019,KEGG_2019_Human,Tuberculosis,1/179,0.0089499050800561,0.0123665447530631,0,0,19821.0,93478.0629355712,BAD
14020,KEGG_2019_Human,Chemokine signaling pathway,1/190,0.0094999017791995,0.0123665447530631,0,0,19810.0,92244.74636351672,BAD
14021,KEGG_2019_Human,Focal adhesion,1/199,0.0099498991610159,0.0123665447530631,0,0,19801.0,91286.4288690606,BAD
14022,KEGG_2019_Human,Viral carcinogenesis,1/201,0.0100498985877989,0.0123665447530631,0,0,19799.0,91079.21596609056,BAD
14023,KEGG_2019_Human,Human immunodeficiency virus 1 infection,1/212,0.0105998955026255,0.0123665447530631,0,0,19788.0,89974.27756224656,BAD
14024,KEGG_2019_Human,cAMP signaling pathway,1/212,0.0105998955026255,0.0123665447530631,0,0,19788.0,89974.27756224656,BAD
14025,KEGG_2019_Human,Ras signaling pathway,1/232,0.0115998901349604,0.0130966501523746,0,0,19768.0,88101.22480150245,BAD
14026,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0180467300332424,0,0,19670.0,80733.60565076157,BAD
14027,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0187725815893285,0,0,19646.0,79255.8617626126,BAD
14028,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.025323363655496,0,0,19508.0,72277.44006442746,BAD
14029,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,BAD
14030,KEGG_2019_Human,Ubiquitin mediated proteolysis,1/137,0.0068499188797651,0.0068499188797651,0,0,19863.0,98987.62735269018,UBE3B
14031,KEGG_2019_Human,Ribosome biogenesis in eukaryotes,1/101,0.0050499326546803,0.0082499094553477,0,0,19899.0,105233.48101229242,POP4
14032,KEGG_2019_Human,RNA transport,1/165,0.0082499094553477,0.0082499094553477,0,0,19835.0,95159.46482222488,POP4
14033,KEGG_2019_Human,Osteoclast differentiation,1/127,0.0063499224962247,0.0063499224962247,0,0,19873.0,100543.72072014232,SIRPB1
14034,KEGG_2019_Human,Sphingolipid metabolism,1/47,0.0023499589392381,0.009399902370135,0,0,19953.0,120782.64067395544,SPHK2
14035,KEGG_2019_Human,VEGF signaling pathway,1/59,0.0029499522555206,0.009399902370135,0,0,19941.0,116175.59385530632,SPHK2
14036,KEGG_2019_Human,Fc gamma R-mediated phagocytosis,1/91,0.0045499369072032,0.009399902370135,0,0,19909.0,107362.10783923086,SPHK2
14037,KEGG_2019_Human,Sphingolipid signaling pathway,1/119,0.0059499254985137,0.009399902370135,0,0,19881.0,101877.73080211312,SPHK2
14038,KEGG_2019_Human,Apelin signaling pathway,1/137,0.0068499188797651,0.009399902370135,0,0,19863.0,98987.62735269018,SPHK2
14039,KEGG_2019_Human,Phospholipase D signaling pathway,1/148,0.007399915061391,0.009399902370135,0,0,19852.0,97399.60470052566,SPHK2
14040,KEGG_2019_Human,Tuberculosis,1/179,0.0089499050800561,0.009399902370135,0,0,19821.0,93478.0629355712,SPHK2
14041,KEGG_2019_Human,Calcium signaling pathway,1/188,0.009399902370135,0.009399902370135,0,0,19812.0,92463.712994847,SPHK2
14042,KEGG_2019_Human,Inflammatory mediator regulation of TRP channels,1/100,0.0049999330710556,0.0049999330710556,0,0,19900.0,105436.78197328727,ASIC1
14043,KEGG_2019_Human,Lysosome,1/123,0.0061499239842961,0.0061499239842961,0,0,19877.0,101200.07933676826,TPP1
14044,KEGG_2019_Human,Glyoxylate and dicarboxylate metabolism,1/30,0.0014999697593334,0.0019999631680592,0,0,19970.0,129851.13732048514,GCSH
14045,KEGG_2019_Human,"Glycine, serine and threonine metabolism",1/40,0.0019999631680592,0.0019999631680592,0,0,19960.0,124043.94523066044,GCSH
14046,KEGG_2019_Human,Regulation of lipolysis in adipocytes,1/55,0.0027499544131125,0.0164997264786753,0,0,19945.0,117599.1294878737,PTGER3
14047,KEGG_2019_Human,Calcium signaling pathway,1/188,0.009399902370135,0.0168748379685508,0,0,19812.0,92463.712994847,PTGER3
14048,KEGG_2019_Human,cAMP signaling pathway,1/212,0.0105998955026255,0.0168748379685508,0,0,19788.0,89974.27756224656,PTGER3
14049,KEGG_2019_Human,Human cytomegalovirus infection,1/225,0.0112498919790339,0.0168748379685508,0,0,19775.0,88738.27077557483,PTGER3
14050,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0202798389918715,0,0,19662.0,80229.79996326564,PTGER3
14051,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,PTGER3
14052,KEGG_2019_Human,Amyotrophic lateral sclerosis (ALS),1/51,0.0025499566390179,0.0101089718877324,0,0,19949.0,119129.0228601236,MAPK11
14053,KEGG_2019_Human,VEGF signaling pathway,1/59,0.0029499522555206,0.0101089718877324,0,0,19941.0,116175.59385530632,MAPK11
14054,KEGG_2019_Human,Shigellosis,1/65,0.003249949134407,0.0101089718877324,0,0,19935.0,114209.92613860144,MAPK11
14055,KEGG_2019_Human,Epithelial cell signaling in Helicobacter pylori infection,1/68,0.0033999476216189,0.0101089718877324,0,0,19932.0,113293.39338050144,MAPK11
14056,KEGG_2019_Human,Fc epsilon RI signaling pathway,1/68,0.0033999476216189,0.0101089718877324,0,0,19932.0,113293.39338050144,MAPK11
14057,KEGG_2019_Human,Prolactin signaling pathway,1/70,0.0034999466296654,0.0101089718877324,0,0,19930.0,112704.30065625212,MAPK11
14058,KEGG_2019_Human,RIG-I-like receptor signaling pathway,1/70,0.0034999466296654,0.0101089718877324,0,0,19930.0,112704.30065625212,MAPK11
14059,KEGG_2019_Human,Leishmaniasis,1/74,0.0036999446830449,0.0101089718877324,0,0,19926.0,111574.38983110404,MAPK11
14060,KEGG_2019_Human,Pertussis,1/76,0.0037999437281752,0.0101089718877324,0,0,19924.0,111031.8499691117,MAPK11
14061,KEGG_2019_Human,Salmonella infection,1/86,0.0042999391173866,0.0101089718877324,0,0,19914.0,108514.46102290176,MAPK11
14062,KEGG_2019_Human,Th1 and Th2 cell differentiation,1/92,0.0045999364719865,0.0101089718877324,0,0,19908.0,107139.13814408927,MAPK11
14063,KEGG_2019_Human,IL-17 signaling pathway,1/93,0.0046499360391879,0.0101089718877324,0,0,19907.0,106918.54242106884,MAPK11
14064,KEGG_2019_Human,GnRH signaling pathway,1/93,0.0046499360391879,0.0101089718877324,0,0,19907.0,106918.54242106884,MAPK11
14065,KEGG_2019_Human,Progesterone-mediated oocyte maturation,1/99,0.0049499334884068,0.0101089718877324,0,0,19901.0,105642.09305076736,MAPK11
14066,KEGG_2019_Human,AGE-RAGE signaling pathway in diabetic complications,1/100,0.0049999330710556,0.0101089718877324,0,0,19900.0,105436.78197328727,MAPK11
14067,KEGG_2019_Human,Inflammatory mediator regulation of TRP channels,1/100,0.0049999330710556,0.0101089718877324,0,0,19900.0,105436.78197328727,MAPK11
14068,KEGG_2019_Human,T cell receptor signaling pathway,1/101,0.0050499326546803,0.0101089718877324,0,0,19899.0,105233.48101229242,MAPK11
14069,KEGG_2019_Human,Chagas disease (American trypanosomiasis),1/103,0.0051499318302617,0.0101089718877324,0,0,19897.0,104832.7525292024,MAPK11
14070,KEGG_2019_Human,Toll-like receptor signaling pathway,1/104,0.0051999314202997,0.0101089718877324,0,0,19896.0,104635.24941415618,MAPK11
14071,KEGG_2019_Human,C-type lectin receptor signaling pathway,1/104,0.0051999314202997,0.0101089718877324,0,0,19896.0,104635.24941415618,MAPK11
14072,KEGG_2019_Human,Th17 cell differentiation,1/107,0.0053499302026925,0.0101089718877324,0,0,19893.0,104053.753408911,MAPK11
14073,KEGG_2019_Human,TNF signaling pathway,1/110,0.0054999290027479,0.0101089718877324,0,0,19890.0,103488.06969787036,MAPK11
14074,KEGG_2019_Human,Leukocyte transendothelial migration,1/112,0.0055999282120529,0.0101089718877324,0,0,19888.0,103119.30984392198,MAPK11
14075,KEGG_2019_Human,Toxoplasmosis,1/113,0.0056499278191151,0.0101089718877324,0,0,19887.0,102937.34947211576,MAPK11
14076,KEGG_2019_Human,Sphingolipid signaling pathway,1/119,0.0059499254985137,0.0101089718877324,0,0,19881.0,101877.73080211312,MAPK11
14077,KEGG_2019_Human,Neurotrophin signaling pathway,1/119,0.0059499254985137,0.0101089718877324,0,0,19881.0,101877.73080211312,MAPK11
14078,KEGG_2019_Human,Platelet activation,1/124,0.0061999236097501,0.0101089718877324,0,0,19876.0,101034.04709010696,MAPK11
14079,KEGG_2019_Human,Osteoclast differentiation,1/127,0.0063499224962247,0.0101089718877324,0,0,19873.0,100543.72072014232,MAPK11
14080,KEGG_2019_Human,Relaxin signaling pathway,1/130,0.0064999213952527,0.0101089718877324,0,0,19870.0,100064.62842845908,MAPK11
14081,KEGG_2019_Human,Dopaminergic synapse,1/131,0.0065499210316603,0.0101089718877324,0,0,19869.0,99907.33811343512,MAPK11
14082,KEGG_2019_Human,FoxO signaling pathway,1/132,0.0065999206698993,0.0101089718877324,0,0,19868.0,99751.22090491928,MAPK11
14083,KEGG_2019_Human,Fluid shear stress and atherosclerosis,1/139,0.006949918172816,0.0101089718877324,0,0,19861.0,98689.81333375497,MAPK11
14084,KEGG_2019_Human,Signaling pathways regulating pluripotency of stem cells,1/139,0.006949918172816,0.0101089718877324,0,0,19861.0,98689.81333375497,MAPK11
14085,KEGG_2019_Human,Adrenergic signaling in cardiomyocytes,1/145,0.0072499160871101,0.0101484549413362,0,0,19855.0,97820.92670675044,MAPK11
14086,KEGG_2019_Human,Retrograde endocannabinoid signaling,1/148,0.007399915061391,0.0101484549413362,0,0,19852.0,97399.60470052566,MAPK11
14087,KEGG_2019_Human,Cellular senescence,1/160,0.0079999110688441,0.0105728563431785,0,0,19840.0,95793.96509856998,MAPK11
14088,KEGG_2019_Human,Hepatitis B,1/163,0.0081499100978668,0.0105728563431785,0,0,19837.0,95410.9786681514,MAPK11
14089,KEGG_2019_Human,Influenza A,1/171,0.0085499075557634,0.0107398860960673,0,0,19829.0,94422.42241345016,MAPK11
14090,KEGG_2019_Human,NOD-like receptor signaling pathway,1/178,0.0088999053857096,0.0107398860960673,0,0,19822.0,93593.82745769851,MAPK11
14091,KEGG_2019_Human,Tuberculosis,1/179,0.0089499050800561,0.0107398860960673,0,0,19821.0,93478.0629355712,MAPK11
14092,KEGG_2019_Human,Kaposi sarcoma-associated herpesvirus infection,1/186,0.0092999029651357,0.0108876912762565,0,0,19814.0,92684.96451050608,MAPK11
14093,KEGG_2019_Human,Epstein-Barr virus infection,1/201,0.0100498985877989,0.0112184914468453,0,0,19799.0,91079.21596609056,MAPK11
14094,KEGG_2019_Human,Proteoglycans in cancer,1/201,0.0100498985877989,0.0112184914468453,0,0,19799.0,91079.21596609056,MAPK11
14095,KEGG_2019_Human,Rap1 signaling pathway,1/206,0.010299897173561,0.0112362514620665,0,0,19794.0,90569.849337325,MAPK11
14096,KEGG_2019_Human,Human immunodeficiency virus 1 infection,1/212,0.0105998955026255,0.0113065552028006,0,0,19788.0,89974.27756224656,MAPK11
14097,KEGG_2019_Human,Human cytomegalovirus infection,1/225,0.0112498919790339,0.0117390177172527,0,0,19775.0,88738.27077557483,MAPK11
14098,KEGG_2019_Human,Thermogenesis,1/231,0.0115498903940656,0.0117956327428755,0,0,19769.0,88191.07730937863,MAPK11
14099,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0147498749536506,0,0,19705.0,83086.53988020132,MAPK11
14100,KEGG_2019_Human,Colorectal cancer,1/86,0.0042999391173866,0.0148998294443211,0,0,19914.0,108514.46102290176,BCL2L11
14101,KEGG_2019_Human,FoxO signaling pathway,1/132,0.0065999206698993,0.0148998294443211,0,0,19868.0,99751.22090491928,BCL2L11
14102,KEGG_2019_Human,Apoptosis,1/143,0.0071499167770442,0.0148998294443211,0,0,19857.0,98106.57763600958,BCL2L11
14103,KEGG_2019_Human,Non-alcoholic fatty liver disease (NAFLD),1/149,0.0074499147221605,0.0148998294443211,0,0,19851.0,97261.02051561224,BCL2L11
14104,KEGG_2019_Human,Epstein-Barr virus infection,1/201,0.0100498985877989,0.0160798377404783,0,0,19799.0,91079.21596609056,BCL2L11
14105,KEGG_2019_Human,MicroRNAs in cancer,1/299,0.0149498740670514,0.0199331654227352,0,0,19701.0,82804.33538735632,BCL2L11
14106,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0202284144472764,0,0,19646.0,79255.8617626126,BCL2L11
14107,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,BCL2L11
14108,KEGG_2019_Human,Ubiquitin mediated proteolysis,1/137,0.0068499188797651,0.0068499188797651,0,0,19863.0,98987.62735269018,UBE2O
14109,KEGG_2019_Human,Autoimmune thyroid disease,1/53,0.0026499555173137,0.0145586837375733,0,0,19947.0,118349.78824235698,IFNA21
14110,KEGG_2019_Human,Cytosolic DNA-sensing pathway,1/63,0.0031499501598827,0.0145586837375733,0,0,19937.0,114844.46974572667,IFNA21
14111,KEGG_2019_Human,RIG-I-like receptor signaling pathway,1/70,0.0034999466296654,0.0145586837375733,0,0,19930.0,112704.30065625212,IFNA21
14112,KEGG_2019_Human,Toll-like receptor signaling pathway,1/104,0.0051999314202997,0.0145586837375733,0,0,19896.0,104635.24941415618,IFNA21
14113,KEGG_2019_Human,Natural killer cell mediated cytotoxicity,1/131,0.0065499210316603,0.0145586837375733,0,0,19869.0,99907.33811343512,IFNA21
14114,KEGG_2019_Human,Measles,1/138,0.0068999185254481,0.0145586837375733,0,0,19862.0,98838.19160389496,IFNA21
14115,KEGG_2019_Human,Hepatitis C,1/155,0.0077499127120574,0.0145586837375733,0,0,19845.0,96448.16254952336,IFNA21
14116,KEGG_2019_Human,Necroptosis,1/162,0.0080999104202618,0.0145586837375733,0,0,19838.0,95537.86936302872,IFNA21
14117,KEGG_2019_Human,JAK-STAT signaling pathway,1/162,0.0080999104202618,0.0145586837375733,0,0,19838.0,95537.86936302872,IFNA21
14118,KEGG_2019_Human,Hepatitis B,1/163,0.0081499100978668,0.0145586837375733,0,0,19837.0,95410.9786681514,IFNA21
14119,KEGG_2019_Human,Influenza A,1/171,0.0085499075557634,0.0145586837375733,0,0,19829.0,94422.42241345016,IFNA21
14120,KEGG_2019_Human,NOD-like receptor signaling pathway,1/178,0.0088999053857096,0.0145586837375733,0,0,19822.0,93593.82745769851,IFNA21
14121,KEGG_2019_Human,Tuberculosis,1/179,0.0089499050800561,0.0145586837375733,0,0,19821.0,93478.0629355712,IFNA21
14122,KEGG_2019_Human,Kaposi sarcoma-associated herpesvirus infection,1/186,0.0092999029651357,0.0145586837375733,0,0,19814.0,92684.96451050608,IFNA21
14123,KEGG_2019_Human,Epstein-Barr virus infection,1/201,0.0100498985877989,0.0145586837375733,0,0,19799.0,91079.21596609056,IFNA21
14124,KEGG_2019_Human,Human immunodeficiency virus 1 infection,1/212,0.0105998955026255,0.0145586837375733,0,0,19788.0,89974.27756224656,IFNA21
14125,KEGG_2019_Human,Human cytomegalovirus infection,1/225,0.0112498919790339,0.0145586837375733,0,0,19775.0,88738.27077557483,IFNA21
14126,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0179665141039676,0,0,19706.0,83157.67014793828,IFNA21
14127,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0191051096893273,0,0,19670.0,80733.60565076157,IFNA21
14128,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0194698489055035,0,0,19646.0,79255.8617626126,IFNA21
14129,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0257712598834163,0,0,19508.0,72277.44006442746,IFNA21
14130,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,IFNA21
14131,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF568
14132,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR2D3
14133,KEGG_2019_Human,Gastric cancer,1/149,0.0074499147221605,0.0074499147221605,0,0,19851.0,97261.02051561224,CDH17
14134,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR56B4
14135,KEGG_2019_Human,Staphylococcus aureus infection,1/68,0.0033999476216189,0.0088665659967466,0,0,19932.0,113293.39338050144,FCGR3B
14136,KEGG_2019_Human,Leishmaniasis,1/74,0.0036999446830449,0.0088665659967466,0,0,19926.0,111574.38983110404,FCGR3B
14137,KEGG_2019_Human,Osteoclast differentiation,1/127,0.0063499224962247,0.0088665659967466,0,0,19873.0,100543.72072014232,FCGR3B
14138,KEGG_2019_Human,Natural killer cell mediated cytotoxicity,1/131,0.0065499210316603,0.0088665659967466,0,0,19869.0,99907.33811343512,FCGR3B
14139,KEGG_2019_Human,Systemic lupus erythematosus,1/133,0.0066499203093911,0.0088665659967466,0,0,19867.0,99596.2591544721,FCGR3B
14140,KEGG_2019_Human,Phagosome,1/152,0.0075999137114971,0.0088665659967466,0,0,19848.0,96850.665715497,FCGR3B
14141,KEGG_2019_Human,Tuberculosis,1/179,0.0089499050800561,0.0089499050800561,0,0,19821.0,93478.0629355712,FCGR3B
14142,KEGG_2019_Human,MicroRNAs in cancer,1/299,0.0149498740670514,0.0149498740670514,0,0,19701.0,82804.33538735632,TP63
14143,KEGG_2019_Human,Spliceosome,1/134,0.0066999199497742,0.0066999199497742,0,0,19866.0,99442.43560916925,PRPF40A
14144,KEGG_2019_Human,Basal cell carcinoma,1/63,0.0031499501598827,0.0109198810514423,0,0,19937.0,114844.46974572667,FZD8
14145,KEGG_2019_Human,Melanogenesis,1/101,0.0050499326546803,0.0109198810514423,0,0,19899.0,105233.48101229242,FZD8
14146,KEGG_2019_Human,Signaling pathways regulating pluripotency of stem cells,1/139,0.006949918172816,0.0109198810514423,0,0,19861.0,98689.81333375497,FZD8
14147,KEGG_2019_Human,Breast cancer,1/147,0.0073499154017982,0.0109198810514423,0,0,19853.0,97539.10874372096,FZD8
14148,KEGG_2019_Human,Gastric cancer,1/149,0.0074499147221605,0.0109198810514423,0,0,19851.0,97261.02051561224,FZD8
14149,KEGG_2019_Human,mTOR signaling pathway,1/152,0.0075999137114971,0.0109198810514423,0,0,19848.0,96850.665715497,FZD8
14150,KEGG_2019_Human,Cushing syndrome,1/155,0.0077499127120574,0.0109198810514423,0,0,19845.0,96448.16254952336,FZD8
14151,KEGG_2019_Human,Wnt signaling pathway,1/158,0.0078999117225733,0.0109198810514423,0,0,19842.0,96053.2110949472,FZD8
14152,KEGG_2019_Human,Hippo signaling pathway,1/160,0.0079999110688441,0.0109198810514423,0,0,19840.0,95793.96509856998,FZD8
14153,KEGG_2019_Human,Hepatocellular carcinoma,1/168,0.0083999085011095,0.0109198810514423,0,0,19832.0,94787.72752807094,FZD8
14154,KEGG_2019_Human,Proteoglycans in cancer,1/201,0.0100498985877989,0.0118771528764897,0,0,19799.0,91079.21596609056,FZD8
14155,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0178748564138782,0,0,19670.0,80733.60565076157,FZD8
14156,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,FZD8
14157,KEGG_2019_Human,Peroxisome,1/83,0.0041499404726918,0.0041499404726918,0,0,19917.0,109237.99888847338,SLC25A17
14158,KEGG_2019_Human,Maturity onset diabetes of the young,1/26,0.0012999726251831,0.0053665722294994,0,0,19974.0,132735.46073187632,PKLR
14159,KEGG_2019_Human,Pyruvate metabolism,1/39,0.0019499637955508,0.0053665722294994,0,0,19961.0,124555.53162481484,PKLR
14160,KEGG_2019_Human,Type II diabetes mellitus,1/46,0.0022999595269283,0.0053665722294994,0,0,19954.0,121217.8313311442,PKLR
14161,KEGG_2019_Human,Glycolysis / Gluconeogenesis,1/68,0.0033999476216189,0.0059499083378331,0,0,19932.0,113293.39338050144,PKLR
14162,KEGG_2019_Human,Purine metabolism,1/129,0.006449921761047,0.0074499147221605,0,0,19871.0,100223.109907462,PKLR
14163,KEGG_2019_Human,Insulin signaling pathway,1/137,0.0068499188797651,0.0074499147221605,0,0,19863.0,98987.62735269018,PKLR
14164,KEGG_2019_Human,Non-alcoholic fatty liver disease (NAFLD),1/149,0.0074499147221605,0.0074499147221605,0,0,19851.0,97261.02051561224,PKLR
14165,KEGG_2019_Human,Renal cell carcinoma,1/69,0.003449947123837,0.0144998626687005,0,0,19931.0,112996.7391397682,ETS1
14166,KEGG_2019_Human,Cellular senescence,1/160,0.0079999110688441,0.0144998626687005,0,0,19840.0,95793.96509856998,ETS1
14167,KEGG_2019_Human,Human T-cell leukemia virus 1 infection,1/219,0.0109498935894162,0.0144998626687005,0,0,19781.0,89299.85161916987,ETS1
14168,KEGG_2019_Human,Ras signaling pathway,1/232,0.0115998901349604,0.0144998626687005,0,0,19768.0,88101.22480150245,ETS1
14169,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,ETS1
14170,KEGG_2019_Human,Vasopressin-regulated water reabsorption,1/44,0.0021999607179423,0.0064499086760799,0,0,19956.0,122117.06559109331,DYNC1LI2
14171,KEGG_2019_Human,Salmonella infection,1/86,0.0042999391173866,0.0064499086760799,0,0,19914.0,108514.46102290176,DYNC1LI2
14172,KEGG_2019_Human,Phagosome,1/152,0.0075999137114971,0.0075999137114971,0,0,19848.0,96850.665715497,DYNC1LI2
14173,KEGG_2019_Human,Calcium signaling pathway,1/188,0.009399902370135,0.0168998658265596,0,0,19812.0,92463.712994847,P2RX6
14174,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,P2RX6
14175,KEGG_2019_Human,Adipocytokine signaling pathway,1/69,0.003449947123837,0.0089999047745351,0,0,19931.0,112996.7391397682,CAMKK2
14176,KEGG_2019_Human,Longevity regulating pathway,1/102,0.0050999322416682,0.0089999047745351,0,0,19898.0,105032.15064717118,CAMKK2
14177,KEGG_2019_Human,AMPK signaling pathway,1/120,0.0059999251180858,0.0089999047745351,0,0,19880.0,101706.2448082016,CAMKK2
14178,KEGG_2019_Human,Autophagy,1/128,0.0063999221281459,0.0089999047745351,0,0,19872.0,100382.8010329652,CAMKK2
14179,KEGG_2019_Human,Oxytocin signaling pathway,1/153,0.0076499133771537,0.0089999047745351,0,0,19847.0,96715.6407630817,CAMKK2
14180,KEGG_2019_Human,Alcoholism,1/180,0.0089999047745351,0.0089999047745351,0,0,19820.0,93362.92821536642,CAMKK2
14181,KEGG_2019_Human,Thyroid cancer,1/37,0.0018499650702878,0.0029999447520888,0,0,19963.0,125618.9446446357,NCOA4
14182,KEGG_2019_Human,Ferroptosis,1/40,0.0019999631680592,0.0029999447520888,0,0,19960.0,124043.94523066044,NCOA4
14183,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,NCOA4
14184,KEGG_2019_Human,Autophagy,1/128,0.0063999221281459,0.0063999221281459,0,0,19872.0,100382.8010329652,WIPI2
14185,KEGG_2019_Human,Other types of O-glycan biosynthesis,1/22,0.0010999756574123,0.0021999513148247,0,0,19978.0,136099.47030191717,COLGALT1
14186,KEGG_2019_Human,Lysine degradation,1/59,0.0029499522555206,0.0029499522555206,0,0,19941.0,116175.59385530632,COLGALT1
14187,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR52A5
14188,KEGG_2019_Human,Cortisol synthesis and secretion,1/65,0.003249949134407,0.0100998653093607,0,0,19935.0,114209.92613860144,POMC
14189,KEGG_2019_Human,Adipocytokine signaling pathway,1/69,0.003449947123837,0.0100998653093607,0,0,19931.0,112996.7391397682,POMC
14190,KEGG_2019_Human,Aldosterone synthesis and secretion,1/98,0.0048999339081079,0.0100998653093607,0,0,19902.0,105849.45495286948,POMC
14191,KEGG_2019_Human,Melanogenesis,1/101,0.0050499326546803,0.0100998653093607,0,0,19899.0,105233.48101229242,POMC
14192,KEGG_2019_Human,Estrogen signaling pathway,1/137,0.0068499188797651,0.0103332169494099,0,0,19863.0,98987.62735269018,POMC
14193,KEGG_2019_Human,Cushing syndrome,1/155,0.0077499127120574,0.0103332169494099,0,0,19845.0,96448.16254952336,POMC
14194,KEGG_2019_Human,cAMP signaling pathway,1/212,0.0105998955026255,0.0121141662887149,0,0,19788.0,89974.27756224656,POMC
14195,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,POMC
14196,KEGG_2019_Human,Legionellosis,1/55,0.0027499544131125,0.0104498870125997,0,0,19945.0,117599.1294878737,HSPA2
14197,KEGG_2019_Human,Antigen processing and presentation,1/77,0.0038499432547502,0.0104498870125997,0,0,19923.0,110765.8407373636,HSPA2
14198,KEGG_2019_Human,Longevity regulating pathway,1/102,0.0050999322416682,0.0104498870125997,0,0,19898.0,105032.15064717118,HSPA2
14199,KEGG_2019_Human,Toxoplasmosis,1/113,0.0056499278191151,0.0104498870125997,0,0,19887.0,102937.34947211576,HSPA2
14200,KEGG_2019_Human,Spliceosome,1/134,0.0066999199497742,0.0104498870125997,0,0,19866.0,99442.43560916925,HSPA2
14201,KEGG_2019_Human,Estrogen signaling pathway,1/137,0.0068499188797651,0.0104498870125997,0,0,19863.0,98987.62735269018,HSPA2
14202,KEGG_2019_Human,Measles,1/138,0.0068999185254481,0.0104498870125997,0,0,19862.0,98838.19160389496,HSPA2
14203,KEGG_2019_Human,Protein processing in endoplasmic reticulum,1/165,0.0082499094553477,0.0104498870125997,0,0,19835.0,95159.46482222488,HSPA2
14204,KEGG_2019_Human,Influenza A,1/171,0.0085499075557634,0.0104498870125997,0,0,19829.0,94422.42241345016,HSPA2
14205,KEGG_2019_Human,Endocytosis,1/244,0.0121998870519305,0.0134198757571236,0,0,19756.0,87051.4275316661,HSPA2
14206,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0147498749536506,0,0,19705.0,83086.53988020132,HSPA2
14207,KEGG_2019_Human,N-Glycan biosynthesis,1/50,0.0024999572069037,0.0024999572069037,0,0,19950.0,119530.05920663515,ALG10
14208,KEGG_2019_Human,Fluid shear stress and atherosclerosis,1/139,0.006949918172816,0.0082499094553477,0,0,19861.0,98689.81333375497,SUMO4
14209,KEGG_2019_Human,RNA transport,1/165,0.0082499094553477,0.0082499094553477,0,0,19835.0,95159.46482222488,SUMO4
14210,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR2B3
14211,KEGG_2019_Human,Shigellosis,1/65,0.003249949134407,0.0057749224031413,0,0,19935.0,114209.92613860144,WASF2
14212,KEGG_2019_Human,Adherens junction,1/72,0.0035999456502131,0.0057749224031413,0,0,19928.0,112131.59838572376,WASF2
14213,KEGG_2019_Human,Bacterial invasion of epithelial cells,1/74,0.0036999446830449,0.0057749224031413,0,0,19926.0,111574.38983110404,WASF2
14214,KEGG_2019_Human,Salmonella infection,1/86,0.0042999391173866,0.0057749224031413,0,0,19914.0,108514.46102290176,WASF2
14215,KEGG_2019_Human,Fc gamma R-mediated phagocytosis,1/91,0.0045499369072032,0.0057749224031413,0,0,19909.0,107362.10783923086,WASF2
14216,KEGG_2019_Human,Choline metabolism in cancer,1/99,0.0049499334884068,0.0057749224031413,0,0,19901.0,105642.09305076736,WASF2
14217,KEGG_2019_Human,Regulation of actin cytoskeleton,1/214,0.0106998949514067,0.0106998949514067,0,0,19786.0,89779.39753374986,WASF2
14218,KEGG_2019_Human,Nicotine addiction,1/40,0.0019999631680592,0.0068249053608048,0,0,19960.0,124043.94523066044,GABRA5
14219,KEGG_2019_Human,Taste transduction,1/83,0.0041499404726918,0.0068249053608048,0,0,19917.0,109237.99888847338,GABRA5
14220,KEGG_2019_Human,GABAergic synapse,1/89,0.0044499377838098,0.0068249053608048,0,0,19911.0,107815.380281759,GABRA5
14221,KEGG_2019_Human,Morphine addiction,1/91,0.0045499369072032,0.0068249053608048,0,0,19909.0,107362.10783923086,GABRA5
14222,KEGG_2019_Human,Retrograde endocannabinoid signaling,1/148,0.007399915061391,0.0088798980736692,0,0,19852.0,97399.60470052566,GABRA5
14223,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,GABRA5
14224,KEGG_2019_Human,Prion diseases,1/35,0.0017499663721595,0.006912399054284,0,0,19965.0,126740.98858805298,C5
14225,KEGG_2019_Human,Staphylococcus aureus infection,1/68,0.0033999476216189,0.006912399054284,0,0,19932.0,113293.39338050144,C5
14226,KEGG_2019_Human,Pertussis,1/76,0.0037999437281752,0.006912399054284,0,0,19924.0,111031.8499691117,C5
14227,KEGG_2019_Human,Complement and coagulation cascades,1/79,0.0039499423167337,0.006912399054284,0,0,19921.0,110243.89578070649,C5
14228,KEGG_2019_Human,Systemic lupus erythematosus,1/133,0.0066499203093911,0.0093098884331475,0,0,19867.0,99596.2591544721,C5
14229,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0197165101309862,0,0,19662.0,80229.79996326564,C5
14230,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,C5
14231,KEGG_2019_Human,Ras signaling pathway,1/232,0.0115998901349604,0.0115998901349604,0,0,19768.0,88101.22480150245,RASAL3
14232,KEGG_2019_Human,Type II diabetes mellitus,1/46,0.0022999595269283,0.0042999391173866,0,0,19954.0,121217.8313311442,KCNJ11
14233,KEGG_2019_Human,Insulin secretion,1/86,0.0042999391173866,0.0042999391173866,0,0,19914.0,108514.46102290176,KCNJ11
14234,KEGG_2019_Human,Cocaine addiction,1/49,0.0024499577795033,0.0077998855680932,0,0,19951.0,119939.1172087114,SLC6A3
14235,KEGG_2019_Human,Amphetamine addiction,1/68,0.0033999476216189,0.0077998855680932,0,0,19932.0,113293.39338050144,SLC6A3
14236,KEGG_2019_Human,Synaptic vesicle cycle,1/78,0.0038999427840466,0.0077998855680932,0,0,19922.0,110503.2180492851,SLC6A3
14237,KEGG_2019_Human,Dopaminergic synapse,1/131,0.0065499210316603,0.0085199005491272,0,0,19869.0,99907.33811343512,SLC6A3
14238,KEGG_2019_Human,Parkinson disease,1/142,0.0070999171242726,0.0085199005491272,0,0,19858.0,98250.87390500787,SLC6A3
14239,KEGG_2019_Human,Alcoholism,1/180,0.0089999047745351,0.0089999047745351,0,0,19820.0,93362.92821536642,SLC6A3
14240,KEGG_2019_Human,Wnt signaling pathway,1/158,0.0078999117225733,0.0078999117225733,0,0,19842.0,96053.2110949472,RUVBL1
14241,KEGG_2019_Human,Aldosterone synthesis and secretion,1/98,0.0048999339081079,0.007399915061391,0,0,19902.0,105849.45495286948,DAGLB
14242,KEGG_2019_Human,Retrograde endocannabinoid signaling,1/148,0.007399915061391,0.007399915061391,0,0,19852.0,97399.60470052566,DAGLB
14243,KEGG_2019_Human,Intestinal immune network for IgA production,1/48,0.0023999583567988,0.0098311355684358,0,0,19952.0,120356.5272753826,MAP3K14
14244,KEGG_2019_Human,Epithelial cell signaling in Helicobacter pylori infection,1/68,0.0033999476216189,0.0098311355684358,0,0,19932.0,113293.39338050144,MAP3K14
14245,KEGG_2019_Human,NF-kappa B signaling pathway,1/95,0.0047499351803394,0.0098311355684358,0,0,19905.0,106484.27183626965,MAP3K14
14246,KEGG_2019_Human,T cell receptor signaling pathway,1/101,0.0050499326546803,0.0098311355684358,0,0,19899.0,105233.48101229242,MAP3K14
14247,KEGG_2019_Human,C-type lectin receptor signaling pathway,1/104,0.0051999314202997,0.0098311355684358,0,0,19896.0,104635.24941415618,MAP3K14
14248,KEGG_2019_Human,TNF signaling pathway,1/110,0.0054999290027479,0.0098311355684358,0,0,19890.0,103488.06969787036,MAP3K14
14249,KEGG_2019_Human,Osteoclast differentiation,1/127,0.0063499224962247,0.0098311355684358,0,0,19873.0,100543.72072014232,MAP3K14
14250,KEGG_2019_Human,Apoptosis,1/143,0.0071499167770442,0.0098311355684358,0,0,19857.0,98106.57763600958,MAP3K14
14251,KEGG_2019_Human,Epstein-Barr virus infection,1/201,0.0100498985877989,0.0120448829483578,0,0,19799.0,91079.21596609056,MAP3K14
14252,KEGG_2019_Human,Human T-cell leukemia virus 1 infection,1/219,0.0109498935894162,0.0120448829483578,0,0,19781.0,89299.85161916987,MAP3K14
14253,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0147498749536506,0,0,19705.0,83086.53988020132,MAP3K14
14254,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0146998751759735,0,0,19706.0,83157.67014793828,ACKR3
14255,KEGG_2019_Human,Estrogen signaling pathway,1/137,0.0068499188797651,0.0068499188797651,0,0,19863.0,98987.62735269018,KRT32
14256,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR2C3
14257,KEGG_2019_Human,"Neomycin, kanamycin and gentamicin biosynthesis",1/5,0.0002499917995416556,0.0027499097949582,0,0,19995.0,165840.17843725558,HKDC1
14258,KEGG_2019_Human,Galactose metabolism,1/31,0.0015499690656704,0.0037713631321124,0,0,19969.0,129189.85098816035,HKDC1
14259,KEGG_2019_Human,Fructose and mannose metabolism,1/33,0.0016499677032113,0.0037713631321124,0,0,19967.0,127928.56031580272,HKDC1
14260,KEGG_2019_Human,Starch and sucrose metabolism,1/36,0.0017999657178272,0.0037713631321124,0,0,19964.0,126172.23364250171,HKDC1
14261,KEGG_2019_Human,Carbohydrate digestion and absorption,1/44,0.0021999607179423,0.0037713631321124,0,0,19956.0,122117.06559109331,HKDC1
14262,KEGG_2019_Human,Type II diabetes mellitus,1/46,0.0022999595269283,0.0037713631321124,0,0,19954.0,121217.8313311442,HKDC1
14263,KEGG_2019_Human,Amino sugar and nucleotide sugar metabolism,1/48,0.0023999583567988,0.0037713631321124,0,0,19952.0,120356.5272753826,HKDC1
14264,KEGG_2019_Human,Central carbon metabolism in cancer,1/65,0.003249949134407,0.0041554915375342,0,0,19935.0,114209.92613860144,HKDC1
14265,KEGG_2019_Human,Glycolysis / Gluconeogenesis,1/68,0.0033999476216189,0.0041554915375342,0,0,19932.0,113293.39338050144,HKDC1
14266,KEGG_2019_Human,HIF-1 signaling pathway,1/100,0.0049999330710556,0.0054999263781612,0,0,19900.0,105436.78197328727,HKDC1
14267,KEGG_2019_Human,Insulin signaling pathway,1/137,0.0068499188797651,0.0068499188797651,0,0,19863.0,98987.62735269018,HKDC1
14268,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR11A1
14269,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,NPBWR2
14270,KEGG_2019_Human,Lysine degradation,1/59,0.0029499522555206,0.0029499522555206,0,0,19941.0,116175.59385530632,PRDM7
14271,KEGG_2019_Human,Pathogenic Escherichia coli infection,1/55,0.0027499544131125,0.0084999078692823,0,0,19945.0,117599.1294878737,TUBAL3
14272,KEGG_2019_Human,Gap junction,1/88,0.0043999382262822,0.0084999078692823,0,0,19912.0,108045.79305232369,TUBAL3
14273,KEGG_2019_Human,Apoptosis,1/143,0.0071499167770442,0.0084999078692823,0,0,19857.0,98106.57763600958,TUBAL3
14274,KEGG_2019_Human,Phagosome,1/152,0.0075999137114971,0.0084999078692823,0,0,19848.0,96850.665715497,TUBAL3
14275,KEGG_2019_Human,Tight junction,1/170,0.0084999078692823,0.0084999078692823,0,0,19830.0,94543.49009679438,TUBAL3
14276,KEGG_2019_Human,Renin-angiotensin system,1/23,0.0011499748819949,0.0034499246459849,0,0,19977.0,135204.63922267244,ANPEP
14277,KEGG_2019_Human,Glutathione metabolism,1/56,0.0027999538675741,0.0041999308013612,0,0,19944.0,117233.87022514464,ANPEP
14278,KEGG_2019_Human,Hematopoietic cell lineage,1/97,0.0048499343304706,0.0048499343304706,0,0,19903.0,106058.9096435903,ANPEP
14279,KEGG_2019_Human,Spliceosome,1/134,0.0066999199497742,0.0066999199497742,0,0,19866.0,99442.43560916925,SF3B5
14280,KEGG_2019_Human,Thyroid hormone signaling pathway,1/116,0.0057999266512085,0.0100498985877989,0,0,19884.0,102400.8105961506,HDAC3
14281,KEGG_2019_Human,Alcoholism,1/180,0.0089999047745351,0.0100498985877989,0,0,19820.0,93362.92821536642,HDAC3
14282,KEGG_2019_Human,Viral carcinogenesis,1/201,0.0100498985877989,0.0100498985877989,0,0,19799.0,91079.21596609056,HDAC3
14283,KEGG_2019_Human,"Alanine, aspartate and glutamate metabolism",1/35,0.0017499663721595,0.0024499577795033,0,0,19965.0,126740.98858805298,ALDH4A1
14284,KEGG_2019_Human,Arginine and proline metabolism,1/49,0.0024499577795033,0.0024499577795033,0,0,19951.0,119939.1172087114,ALDH4A1
14285,KEGG_2019_Human,Hedgehog signaling pathway,1/47,0.0023499589392381,0.0062999003197655,0,0,19953.0,120782.64067395544,GLI1
14286,KEGG_2019_Human,Basal cell carcinoma,1/63,0.0031499501598827,0.0062999003197655,0,0,19937.0,114844.46974572667,GLI1
14287,KEGG_2019_Human,cAMP signaling pathway,1/212,0.0105998955026255,0.0141331940035007,0,0,19788.0,89974.27756224656,GLI1
14288,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,GLI1
14289,KEGG_2019_Human,Glyoxylate and dicarboxylate metabolism,1/30,0.0014999697593334,0.0023499589392381,0,0,19970.0,129851.13732048514,MDH2
14290,KEGG_2019_Human,Citrate cycle (TCA cycle),1/30,0.0014999697593334,0.0023499589392381,0,0,19970.0,129851.13732048514,MDH2
14291,KEGG_2019_Human,Pyruvate metabolism,1/39,0.0019499637955508,0.0023499589392381,0,0,19961.0,124555.53162481484,MDH2
14292,KEGG_2019_Human,Cysteine and methionine metabolism,1/47,0.0023499589392381,0.0023499589392381,0,0,19953.0,120782.64067395544,MDH2
14293,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF347
14294,KEGG_2019_Human,Other types of O-glycan biosynthesis,1/22,0.0010999756574123,0.0010999756574123,0,0,19978.0,136099.47030191717,POFUT1
14295,KEGG_2019_Human,Chemokine signaling pathway,1/190,0.0094999017791995,0.0146998751759735,0,0,19810.0,92244.74636351672,PF4V1
14296,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0146998751759735,0,0,19706.0,83157.67014793828,PF4V1
14297,KEGG_2019_Human,Cell cycle,1/124,0.0061999236097501,0.0061999236097501,0,0,19876.0,101034.04709010696,CDKN1C
14298,KEGG_2019_Human,Phototransduction,1/28,0.0013999711732997,0.0041999135198993,0,0,19972.0,131242.0761597353,GUCY2D
14299,KEGG_2019_Human,Purine metabolism,1/129,0.006449921761047,0.0096748826415705,0,0,19871.0,100223.109907462,GUCY2D
14300,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,GUCY2D
14301,KEGG_2019_Human,Glycerophospholipid metabolism,1/97,0.0048499343304706,0.0048499343304706,0,0,19903.0,106058.9096435903,MBOAT7
14302,KEGG_2019_Human,SNARE interactions in vesicular transport,1/34,0.0016999670339032,0.0016999670339032,0,0,19966.0,127326.1054203148,STX5
14303,KEGG_2019_Human,Protein processing in endoplasmic reticulum,1/165,0.0082499094553477,0.0082499094553477,0,0,19835.0,95159.46482222488,SSR1
14304,KEGG_2019_Human,Measles,1/138,0.0068999185254481,0.0125623732347487,0,0,19862.0,98838.19160389496,EIF2AK2
14305,KEGG_2019_Human,Hepatitis C,1/155,0.0077499127120574,0.0125623732347487,0,0,19845.0,96448.16254952336,EIF2AK2
14306,KEGG_2019_Human,Necroptosis,1/162,0.0080999104202618,0.0125623732347487,0,0,19838.0,95537.86936302872,EIF2AK2
14307,KEGG_2019_Human,Protein processing in endoplasmic reticulum,1/165,0.0082499094553477,0.0125623732347487,0,0,19835.0,95159.46482222488,EIF2AK2
14308,KEGG_2019_Human,Influenza A,1/171,0.0085499075557634,0.0125623732347487,0,0,19829.0,94422.42241345016,EIF2AK2
14309,KEGG_2019_Human,Kaposi sarcoma-associated herpesvirus infection,1/186,0.0092999029651357,0.0125623732347487,0,0,19814.0,92684.96451050608,EIF2AK2
14310,KEGG_2019_Human,Epstein-Barr virus infection,1/201,0.0100498985877989,0.0125623732347487,0,0,19799.0,91079.21596609056,EIF2AK2
14311,KEGG_2019_Human,Viral carcinogenesis,1/201,0.0100498985877989,0.0125623732347487,0,0,19799.0,91079.21596609056,EIF2AK2
14312,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0183331860655161,0,0,19670.0,80733.60565076157,EIF2AK2
14313,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,EIF2AK2
14314,KEGG_2019_Human,Cholinergic synapse,1/112,0.0055999282120529,0.0111998564241059,0,0,19888.0,103119.30984392198,CHRNA3
14315,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,CHRNA3
14316,KEGG_2019_Human,Circadian rhythm,1/31,0.0015499690656704,0.0046499071970112,0,0,19969.0,129189.85098816035,RORC
14317,KEGG_2019_Human,Inflammatory bowel disease (IBD),1/65,0.003249949134407,0.0048749237016105,0,0,19935.0,114209.92613860144,RORC
14318,KEGG_2019_Human,Th17 cell differentiation,1/107,0.0053499302026925,0.0053499302026925,0,0,19893.0,104053.753408911,RORC
14319,KEGG_2019_Human,Thyroid cancer,1/37,0.0018499650702878,0.0079748991454117,0,0,19963.0,125618.9446446357,RXRG
14320,KEGG_2019_Human,Non-small cell lung cancer,1/66,0.003299948626608,0.0079748991454117,0,0,19934.0,113899.85357353876,RXRG
14321,KEGG_2019_Human,Adipocytokine signaling pathway,1/69,0.003449947123837,0.0079748991454117,0,0,19931.0,112996.7391397682,RXRG
14322,KEGG_2019_Human,PPAR signaling pathway,1/74,0.0036999446830449,0.0079748991454117,0,0,19926.0,111574.38983110404,RXRG
14323,KEGG_2019_Human,Small cell lung cancer,1/93,0.0046499360391879,0.0079748991454117,0,0,19907.0,106918.54242106884,RXRG
14324,KEGG_2019_Human,"Parathyroid hormone synthesis, secretion and action",1/106,0.0052999306076525,0.0079748991454117,0,0,19894.0,104245.78450366124,RXRG
14325,KEGG_2019_Human,Th17 cell differentiation,1/107,0.0053499302026925,0.0079748991454117,0,0,19893.0,104053.753408911,RXRG
14326,KEGG_2019_Human,Thyroid hormone signaling pathway,1/116,0.0057999266512085,0.0079748991454117,0,0,19884.0,102400.8105961506,RXRG
14327,KEGG_2019_Human,Gastric cancer,1/149,0.0074499147221605,0.0091054513270851,0,0,19851.0,97261.02051561224,RXRG
14328,KEGG_2019_Human,Transcriptional misregulation in cancer,1/186,0.0092999029651357,0.0102298932616493,0,0,19814.0,92684.96451050608,RXRG
14329,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,RXRG
14330,KEGG_2019_Human,Ribosome,1/153,0.0076499133771537,0.0076499133771537,0,0,19847.0,96715.6407630817,RPL7A
14331,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR2B11
14332,KEGG_2019_Human,Nitrogen metabolism,1/17,0.0008499797390404818,0.0008499797390404818,0,0,19983.0,141285.76583697114,CA9
14333,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF829
14334,KEGG_2019_Human,TGF-beta signaling pathway,1/90,0.0044999373439762,0.0119998666032662,0,0,19910.0,107587.50385474482,BMP5
14335,KEGG_2019_Human,Hippo signaling pathway,1/160,0.0079999110688441,0.0119998666032662,0,0,19840.0,95793.96509856998,BMP5
14336,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0146998751759735,0,0,19706.0,83157.67014793828,BMP5
14337,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF624
14338,KEGG_2019_Human,PPAR signaling pathway,1/74,0.0036999446830449,0.0053999298011749,0,0,19926.0,111574.38983110404,SLC27A2
14339,KEGG_2019_Human,Peroxisome,1/83,0.0041499404726918,0.0053999298011749,0,0,19917.0,109237.99888847338,SLC27A2
14340,KEGG_2019_Human,Insulin resistance,1/108,0.0053999298011749,0.0053999298011749,0,0,19892.0,103863.47861844616,SLC27A2
14341,KEGG_2019_Human,p53 signaling pathway,1/72,0.0035999456502131,0.0071249027705091,0,0,19928.0,112131.59838572376,PIDD1
14342,KEGG_2019_Human,NF-kappa B signaling pathway,1/95,0.0047499351803394,0.0071249027705091,0,0,19905.0,106484.27183626965,PIDD1
14343,KEGG_2019_Human,Apoptosis,1/143,0.0071499167770442,0.0071499167770442,0,0,19857.0,98106.57763600958,PIDD1
14344,KEGG_2019_Human,Steroid biosynthesis,1/19,0.00094997806231055,0.0028499341869316,0,0,19981.0,139049.2109571672,HSD17B7
14345,KEGG_2019_Human,Ovarian steroidogenesis,1/49,0.0024499577795033,0.002999951725986,0,0,19951.0,119939.1172087114,HSD17B7
14346,KEGG_2019_Human,Steroid hormone biosynthesis,1/60,0.002999951725986,0.002999951725986,0,0,19940.0,115834.63209072244,HSD17B7
14347,KEGG_2019_Human,"Glycine, serine and threonine metabolism",1/40,0.0019999631680592,0.0045332634954919,0,0,19960.0,124043.94523066044,PGAM2
14348,KEGG_2019_Human,Central carbon metabolism in cancer,1/65,0.003249949134407,0.0045332634954919,0,0,19935.0,114209.92613860144,PGAM2
14349,KEGG_2019_Human,Glycolysis / Gluconeogenesis,1/68,0.0033999476216189,0.0045332634954919,0,0,19932.0,113293.39338050144,PGAM2
14350,KEGG_2019_Human,Glucagon signaling pathway,1/103,0.0051499318302617,0.0051499318302617,0,0,19897.0,104832.7525292024,PGAM2
14351,KEGG_2019_Human,Peroxisome,1/83,0.0041499404726918,0.0041499404726918,0,0,19917.0,109237.99888847338,PEX6
14352,KEGG_2019_Human,Progesterone-mediated oocyte maturation,1/99,0.0049499334884068,0.0062499232373748,0,0,19901.0,105642.09305076736,SPDYE6
14353,KEGG_2019_Human,Oocyte meiosis,1/125,0.0062499232373748,0.0062499232373748,0,0,19875.0,100869.32368441945,SPDYE6
14354,KEGG_2019_Human,Prolactin signaling pathway,1/70,0.0034999466296654,0.0069998932593308,0,0,19930.0,112704.30065625212,SOCS6
14355,KEGG_2019_Human,JAK-STAT signaling pathway,1/162,0.0080999104202618,0.0080999104202618,0,0,19838.0,95537.86936302872,SOCS6
14356,KEGG_2019_Human,Hematopoietic cell lineage,1/97,0.0048499343304706,0.0048499343304706,0,0,19903.0,106058.9096435903,CD37
14357,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,CHRNA5
14358,KEGG_2019_Human,African trypanosomiasis,1/37,0.0018499650702878,0.0072499160871101,0,0,19963.0,125618.9446446357,SELE
14359,KEGG_2019_Human,Malaria,1/49,0.0024499577795033,0.0072499160871101,0,0,19951.0,119939.1172087114,SELE
14360,KEGG_2019_Human,AGE-RAGE signaling pathway in diabetic complications,1/100,0.0049999330710556,0.0072499160871101,0,0,19900.0,105436.78197328727,SELE
14361,KEGG_2019_Human,TNF signaling pathway,1/110,0.0054999290027479,0.0072499160871101,0,0,19890.0,103488.06969787036,SELE
14362,KEGG_2019_Human,Fluid shear stress and atherosclerosis,1/139,0.006949918172816,0.0072499160871101,0,0,19861.0,98689.81333375497,SELE
14363,KEGG_2019_Human,Cell adhesion molecules (CAMs),1/145,0.0072499160871101,0.0072499160871101,0,0,19855.0,97820.92670675044,SELE
14364,KEGG_2019_Human,Calcium signaling pathway,1/188,0.009399902370135,0.009399902370135,0,0,19812.0,92463.712994847,ORAI2
14365,KEGG_2019_Human,Estrogen signaling pathway,1/137,0.0068499188797651,0.0068499188797651,0,0,19863.0,98987.62735269018,KRT19
14366,KEGG_2019_Human,Vitamin digestion and absorption,1/24,0.0011999741185782,0.0011999741185782,0,0,19976.0,134347.69487847842,CBLIF
14367,KEGG_2019_Human,Autophagy,1/128,0.0063999221281459,0.0075999137114971,0,0,19872.0,100382.8010329652,RRAGD
14368,KEGG_2019_Human,mTOR signaling pathway,1/152,0.0075999137114971,0.0075999137114971,0,0,19848.0,96850.665715497,RRAGD
14369,KEGG_2019_Human,Lysine degradation,1/59,0.0029499522555206,0.0029499522555206,0,0,19941.0,116175.59385530632,SETMAR
14370,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR8B12
14371,KEGG_2019_Human,Neurotrophin signaling pathway,1/119,0.0059499254985137,0.0059499254985137,0,0,19881.0,101877.73080211312,SH2B3
14372,KEGG_2019_Human,Malaria,1/49,0.0024499577795033,0.0050999214324284,0,0,19951.0,119939.1172087114,SELP
14373,KEGG_2019_Human,Staphylococcus aureus infection,1/68,0.0033999476216189,0.0050999214324284,0,0,19932.0,113293.39338050144,SELP
14374,KEGG_2019_Human,Cell adhesion molecules (CAMs),1/145,0.0072499160871101,0.0072499160871101,0,0,19855.0,97820.92670675044,SELP
14375,KEGG_2019_Human,Asthma,1/31,0.0015499690656704,0.0083141731379497,0,0,19969.0,129189.85098816035,HLA-DRA
14376,KEGG_2019_Human,Allograft rejection,1/38,0.001899964429635,0.0083141731379497,0,0,19962.0,125080.29732025368,HLA-DRA
14377,KEGG_2019_Human,Graft-versus-host disease,1/41,0.0020499625466866,0.0083141731379497,0,0,19959.0,123544.88783416104,HLA-DRA
14378,KEGG_2019_Human,Type I diabetes mellitus,1/43,0.0021499613216957,0.0083141731379497,0,0,19957.0,122581.98940490963,HLA-DRA
14379,KEGG_2019_Human,Intestinal immune network for IgA production,1/48,0.0023999583567988,0.0083141731379497,0,0,19952.0,120356.5272753826,HLA-DRA
14380,KEGG_2019_Human,Autoimmune thyroid disease,1/53,0.0026499555173137,0.0083141731379497,0,0,19947.0,118349.78824235698,HLA-DRA
14381,KEGG_2019_Human,Viral myocarditis,1/59,0.0029499522555206,0.0083141731379497,0,0,19941.0,116175.59385530632,HLA-DRA
14382,KEGG_2019_Human,Inflammatory bowel disease (IBD),1/65,0.003249949134407,0.0083141731379497,0,0,19935.0,114209.92613860144,HLA-DRA
14383,KEGG_2019_Human,Staphylococcus aureus infection,1/68,0.0033999476216189,0.0083141731379497,0,0,19932.0,113293.39338050144,HLA-DRA
14384,KEGG_2019_Human,Leishmaniasis,1/74,0.0036999446830449,0.0083141731379497,0,0,19926.0,111574.38983110404,HLA-DRA
14385,KEGG_2019_Human,Antigen processing and presentation,1/77,0.0038499432547502,0.0083141731379497,0,0,19923.0,110765.8407373636,HLA-DRA
14386,KEGG_2019_Human,Rheumatoid arthritis,1/91,0.0045499369072032,0.0083141731379497,0,0,19909.0,107362.10783923086,HLA-DRA
14387,KEGG_2019_Human,Th1 and Th2 cell differentiation,1/92,0.0045999364719865,0.0083141731379497,0,0,19908.0,107139.13814408927,HLA-DRA
14388,KEGG_2019_Human,Hematopoietic cell lineage,1/97,0.0048499343304706,0.0083141731379497,0,0,19903.0,106058.9096435903,HLA-DRA
14389,KEGG_2019_Human,Th17 cell differentiation,1/107,0.0053499302026925,0.0084748917286727,0,0,19893.0,104053.753408911,HLA-DRA
14390,KEGG_2019_Human,Toxoplasmosis,1/113,0.0056499278191151,0.0084748917286727,0,0,19887.0,102937.34947211576,HLA-DRA
14391,KEGG_2019_Human,Systemic lupus erythematosus,1/133,0.0066499203093911,0.0093881227897286,0,0,19867.0,99596.2591544721,HLA-DRA
14392,KEGG_2019_Human,Cell adhesion molecules (CAMs),1/145,0.0072499160871101,0.0095998910039963,0,0,19855.0,97820.92670675044,HLA-DRA
14393,KEGG_2019_Human,Phagosome,1/152,0.0075999137114971,0.0095998910039963,0,0,19848.0,96850.665715497,HLA-DRA
14394,KEGG_2019_Human,Influenza A,1/171,0.0085499075557634,0.0102284629486356,0,0,19829.0,94422.42241345016,HLA-DRA
14395,KEGG_2019_Human,Tuberculosis,1/179,0.0089499050800561,0.0102284629486356,0,0,19821.0,93478.0629355712,HLA-DRA
14396,KEGG_2019_Human,Epstein-Barr virus infection,1/201,0.0100498985877989,0.0109635257321443,0,0,19799.0,91079.21596609056,HLA-DRA
14397,KEGG_2019_Human,Human T-cell leukemia virus 1 infection,1/219,0.0109498935894162,0.0114259759193908,0,0,19781.0,89299.85161916987,HLA-DRA
14398,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,HLA-DRA
14399,KEGG_2019_Human,Amyotrophic lateral sclerosis (ALS),1/51,0.0025499566390179,0.0025499566390179,0,0,19949.0,119129.0228601236,NEFH
14400,KEGG_2019_Human,Intestinal immune network for IgA production,1/48,0.0023999583567988,0.011999791783994,0,0,19952.0,120356.5272753826,IL15RA
14401,KEGG_2019_Human,JAK-STAT signaling pathway,1/162,0.0080999104202618,0.0182498226490271,0,0,19838.0,95537.86936302872,IL15RA
14402,KEGG_2019_Human,Human T-cell leukemia virus 1 infection,1/219,0.0109498935894162,0.0182498226490271,0,0,19781.0,89299.85161916987,IL15RA
14403,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0183748439699668,0,0,19706.0,83157.67014793828,IL15RA
14404,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,IL15RA
14405,KEGG_2019_Human,Arachidonic acid metabolism,1/63,0.0031499501598827,0.0031499501598827,0,0,19937.0,114844.46974572667,CYP4F2
14406,KEGG_2019_Human,Vitamin digestion and absorption,1/24,0.0011999741185782,0.0031249465086296,0,0,19976.0,134347.69487847842,APOA1
14407,KEGG_2019_Human,African trypanosomiasis,1/37,0.0018499650702878,0.0031249465086296,0,0,19963.0,125618.9446446357,APOA1
14408,KEGG_2019_Human,Fat digestion and absorption,1/41,0.0020499625466866,0.0031249465086296,0,0,19959.0,123544.88783416104,APOA1
14409,KEGG_2019_Human,Cholesterol metabolism,1/50,0.0024999572069037,0.0031249465086296,0,0,19950.0,119530.05920663515,APOA1
14410,KEGG_2019_Human,PPAR signaling pathway,1/74,0.0036999446830449,0.0036999446830449,0,0,19926.0,111574.38983110404,APOA1
14411,KEGG_2019_Human,Protein processing in endoplasmic reticulum,1/165,0.0082499094553477,0.0082499094553477,0,0,19835.0,95159.46482222488,SSR3
14412,KEGG_2019_Human,Leukocyte transendothelial migration,1/112,0.0055999282120529,0.010299897173561,0,0,19888.0,103119.30984392198,SIPA1
14413,KEGG_2019_Human,Rap1 signaling pathway,1/206,0.010299897173561,0.010299897173561,0,0,19794.0,90569.849337325,SIPA1
14414,KEGG_2019_Human,Pertussis,1/76,0.0037999437281752,0.0106998949514067,0,0,19924.0,111031.8499691117,CFL1
14415,KEGG_2019_Human,Fc gamma R-mediated phagocytosis,1/91,0.0045499369072032,0.0106998949514067,0,0,19909.0,107362.10783923086,CFL1
14416,KEGG_2019_Human,Axon guidance,1/181,0.0090499044707863,0.0106998949514067,0,0,19819.0,93248.41634586031,CFL1
14417,KEGG_2019_Human,Human immunodeficiency virus 1 infection,1/212,0.0105998955026255,0.0106998949514067,0,0,19788.0,89974.27756224656,CFL1
14418,KEGG_2019_Human,Regulation of actin cytoskeleton,1/214,0.0106998949514067,0.0106998949514067,0,0,19786.0,89779.39753374986,CFL1
14419,KEGG_2019_Human,Lysosome,1/123,0.0061499239842961,0.0105998955026255,0,0,19877.0,101200.07933676826,AP1B1
14420,KEGG_2019_Human,Human immunodeficiency virus 1 infection,1/212,0.0105998955026255,0.0105998955026255,0,0,19788.0,89974.27756224656,AP1B1
14421,KEGG_2019_Human,Steroid biosynthesis,1/19,0.00094997806231055,0.00094997806231055,0,0,19981.0,139049.2109571672,CYP2R1
14422,KEGG_2019_Human,Synaptic vesicle cycle,1/78,0.0038999427840466,0.0042999391173866,0,0,19922.0,110503.2180492851,RAB3A
14423,KEGG_2019_Human,Insulin secretion,1/86,0.0042999391173866,0.0042999391173866,0,0,19914.0,108514.46102290176,RAB3A
14424,KEGG_2019_Human,Rap1 signaling pathway,1/206,0.010299897173561,0.0121998870519305,0,0,19794.0,90569.849337325,ARAP3
14425,KEGG_2019_Human,cAMP signaling pathway,1/212,0.0105998955026255,0.0121998870519305,0,0,19788.0,89974.27756224656,ARAP3
14426,KEGG_2019_Human,Endocytosis,1/244,0.0121998870519305,0.0121998870519305,0,0,19756.0,87051.4275316661,ARAP3
14427,KEGG_2019_Human,Necroptosis,1/162,0.0080999104202618,0.0080999104202618,0,0,19838.0,95537.86936302872,USP21
14428,KEGG_2019_Human,Ubiquitin mediated proteolysis,1/137,0.0068499188797651,0.0068499188797651,0,0,19863.0,98987.62735269018,UBE2Q2
14429,KEGG_2019_Human,Cell adhesion molecules (CAMs),1/145,0.0072499160871101,0.0072499160871101,0,0,19855.0,97820.92670675044,IGSF11
14430,KEGG_2019_Human,Arginine and proline metabolism,1/49,0.0024499577795033,0.0027999538675741,0,0,19951.0,119939.1172087114,LAP3
14431,KEGG_2019_Human,Glutathione metabolism,1/56,0.0027999538675741,0.0027999538675741,0,0,19944.0,117233.87022514464,LAP3
14432,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR8B8
14433,KEGG_2019_Human,Allograft rejection,1/38,0.001899964429635,0.0049165870925344,0,0,19962.0,125080.29732025368,CD80
14434,KEGG_2019_Human,Graft-versus-host disease,1/41,0.0020499625466866,0.0049165870925344,0,0,19959.0,123544.88783416104,CD80
14435,KEGG_2019_Human,Type I diabetes mellitus,1/43,0.0021499613216957,0.0049165870925344,0,0,19957.0,122581.98940490963,CD80
14436,KEGG_2019_Human,Intestinal immune network for IgA production,1/48,0.0023999583567988,0.0049165870925344,0,0,19952.0,120356.5272753826,CD80
14437,KEGG_2019_Human,Autoimmune thyroid disease,1/53,0.0026499555173137,0.0049165870925344,0,0,19947.0,118349.78824235698,CD80
14438,KEGG_2019_Human,Viral myocarditis,1/59,0.0029499522555206,0.0049165870925344,0,0,19941.0,116175.59385530632,CD80
14439,KEGG_2019_Human,Rheumatoid arthritis,1/91,0.0045499369072032,0.0064999098674331,0,0,19909.0,107362.10783923086,CD80
14440,KEGG_2019_Human,Toll-like receptor signaling pathway,1/104,0.0051999314202997,0.0064999142753747,0,0,19896.0,104635.24941415618,CD80
14441,KEGG_2019_Human,Systemic lupus erythematosus,1/133,0.0066499203093911,0.0072499160871101,0,0,19867.0,99596.2591544721,CD80
14442,KEGG_2019_Human,Cell adhesion molecules (CAMs),1/145,0.0072499160871101,0.0072499160871101,0,0,19855.0,97820.92670675044,CD80
14443,KEGG_2019_Human,Basal cell carcinoma,1/63,0.0031499501598827,0.0109198810514423,0,0,19937.0,114844.46974572667,FZD7
14444,KEGG_2019_Human,Melanogenesis,1/101,0.0050499326546803,0.0109198810514423,0,0,19899.0,105233.48101229242,FZD7
14445,KEGG_2019_Human,Signaling pathways regulating pluripotency of stem cells,1/139,0.006949918172816,0.0109198810514423,0,0,19861.0,98689.81333375497,FZD7
14446,KEGG_2019_Human,Breast cancer,1/147,0.0073499154017982,0.0109198810514423,0,0,19853.0,97539.10874372096,FZD7
14447,KEGG_2019_Human,Gastric cancer,1/149,0.0074499147221605,0.0109198810514423,0,0,19851.0,97261.02051561224,FZD7
14448,KEGG_2019_Human,mTOR signaling pathway,1/152,0.0075999137114971,0.0109198810514423,0,0,19848.0,96850.665715497,FZD7
14449,KEGG_2019_Human,Cushing syndrome,1/155,0.0077499127120574,0.0109198810514423,0,0,19845.0,96448.16254952336,FZD7
14450,KEGG_2019_Human,Wnt signaling pathway,1/158,0.0078999117225733,0.0109198810514423,0,0,19842.0,96053.2110949472,FZD7
14451,KEGG_2019_Human,Hippo signaling pathway,1/160,0.0079999110688441,0.0109198810514423,0,0,19840.0,95793.96509856998,FZD7
14452,KEGG_2019_Human,Hepatocellular carcinoma,1/168,0.0083999085011095,0.0109198810514423,0,0,19832.0,94787.72752807094,FZD7
14453,KEGG_2019_Human,Proteoglycans in cancer,1/201,0.0100498985877989,0.0118771528764897,0,0,19799.0,91079.21596609056,FZD7
14454,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0178748564138782,0,0,19670.0,80733.60565076157,FZD7
14455,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,FZD7
14456,KEGG_2019_Human,cAMP signaling pathway,1/212,0.0105998955026255,0.0211997910052511,0,0,19788.0,89974.27756224656,CNGA4
14457,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,CNGA4
14458,KEGG_2019_Human,Gastric acid secretion,1/75,0.0037499442041125,0.0083998923180794,0,0,19925.0,111301.33528642564,CHRM3
14459,KEGG_2019_Human,Taste transduction,1/83,0.0041499404726918,0.0083998923180794,0,0,19917.0,109237.99888847338,CHRM3
14460,KEGG_2019_Human,Insulin secretion,1/86,0.0042999391173866,0.0083998923180794,0,0,19914.0,108514.46102290176,CHRM3
14461,KEGG_2019_Human,Salivary secretion,1/90,0.0044999373439762,0.0083998923180794,0,0,19910.0,107587.50385474482,CHRM3
14462,KEGG_2019_Human,Pancreatic secretion,1/98,0.0048999339081079,0.0083998923180794,0,0,19902.0,105849.45495286948,CHRM3
14463,KEGG_2019_Human,Cholinergic synapse,1/112,0.0055999282120529,0.0083998923180794,0,0,19888.0,103119.30984392198,CHRM3
14464,KEGG_2019_Human,Calcium signaling pathway,1/188,0.009399902370135,0.0120373818203326,0,0,19812.0,92463.712994847,CHRM3
14465,KEGG_2019_Human,Regulation of actin cytoskeleton,1/214,0.0106998949514067,0.0120373818203326,0,0,19786.0,89779.39753374986,CHRM3
14466,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,CHRM3
14467,KEGG_2019_Human,Prion diseases,1/35,0.0017499663721595,0.0099443389778401,0,0,19965.0,126740.98858805298,IL1A
14468,KEGG_2019_Human,Graft-versus-host disease,1/41,0.0020499625466866,0.0099443389778401,0,0,19959.0,123544.88783416104,IL1A
14469,KEGG_2019_Human,Type I diabetes mellitus,1/43,0.0021499613216957,0.0099443389778401,0,0,19957.0,122581.98940490963,IL1A
14470,KEGG_2019_Human,Inflammatory bowel disease (IBD),1/65,0.003249949134407,0.0099443389778401,0,0,19935.0,114209.92613860144,IL1A
14471,KEGG_2019_Human,Leishmaniasis,1/74,0.0036999446830449,0.0099443389778401,0,0,19926.0,111574.38983110404,IL1A
14472,KEGG_2019_Human,Pertussis,1/76,0.0037999437281752,0.0099443389778401,0,0,19924.0,111031.8499691117,IL1A
14473,KEGG_2019_Human,Salmonella infection,1/86,0.0042999391173866,0.0099443389778401,0,0,19914.0,108514.46102290176,IL1A
14474,KEGG_2019_Human,Rheumatoid arthritis,1/91,0.0045499369072032,0.0099443389778401,0,0,19909.0,107362.10783923086,IL1A
14475,KEGG_2019_Human,Hematopoietic cell lineage,1/97,0.0048499343304706,0.0099443389778401,0,0,19903.0,106058.9096435903,IL1A
14476,KEGG_2019_Human,AGE-RAGE signaling pathway in diabetic complications,1/100,0.0049999330710556,0.0099443389778401,0,0,19900.0,105436.78197328727,IL1A
14477,KEGG_2019_Human,Osteoclast differentiation,1/127,0.0063499224962247,0.0099443389778401,0,0,19873.0,100543.72072014232,IL1A
14478,KEGG_2019_Human,Measles,1/138,0.0068999185254481,0.0099443389778401,0,0,19862.0,98838.19160389496,IL1A
14479,KEGG_2019_Human,Fluid shear stress and atherosclerosis,1/139,0.006949918172816,0.0099443389778401,0,0,19861.0,98689.81333375497,IL1A
14480,KEGG_2019_Human,Non-alcoholic fatty liver disease (NAFLD),1/149,0.0074499147221605,0.0099443389778401,0,0,19851.0,97261.02051561224,IL1A
14481,KEGG_2019_Human,Cellular senescence,1/160,0.0079999110688441,0.0099443389778401,0,0,19840.0,95793.96509856998,IL1A
14482,KEGG_2019_Human,Necroptosis,1/162,0.0080999104202618,0.0099443389778401,0,0,19838.0,95537.86936302872,IL1A
14483,KEGG_2019_Human,Influenza A,1/171,0.0085499075557634,0.0099443389778401,0,0,19829.0,94422.42241345016,IL1A
14484,KEGG_2019_Human,Tuberculosis,1/179,0.0089499050800561,0.0099443389778401,0,0,19821.0,93478.0629355712,IL1A
14485,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0147498749536506,0,0,19706.0,83157.67014793828,IL1A
14486,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0147498749536506,0,0,19705.0,83086.53988020132,IL1A
14487,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF160
14488,KEGG_2019_Human,Lysine degradation,1/59,0.0029499522555206,0.0029499522555206,0,0,19941.0,116175.59385530632,TMLHE
14489,KEGG_2019_Human,N-Glycan biosynthesis,1/50,0.0024999572069037,0.0049999144138074,0,0,19950.0,119530.05920663515,MAN1A1
14490,KEGG_2019_Human,Protein processing in endoplasmic reticulum,1/165,0.0082499094553477,0.0082499094553477,0,0,19835.0,95159.46482222488,MAN1A1
14491,KEGG_2019_Human,Hedgehog signaling pathway,1/47,0.0023499589392381,0.0062999003197655,0,0,19953.0,120782.64067395544,GLI3
14492,KEGG_2019_Human,Basal cell carcinoma,1/63,0.0031499501598827,0.0062999003197655,0,0,19937.0,114844.46974572667,GLI3
14493,KEGG_2019_Human,cAMP signaling pathway,1/212,0.0105998955026255,0.0141331940035007,0,0,19788.0,89974.27756224656,GLI3
14494,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,GLI3
14495,KEGG_2019_Human,Ovarian steroidogenesis,1/49,0.0024499577795033,0.002999951725986,0,0,19951.0,119939.1172087114,CYP19A1
14496,KEGG_2019_Human,Steroid hormone biosynthesis,1/60,0.002999951725986,0.002999951725986,0,0,19940.0,115834.63209072244,CYP19A1
14497,KEGG_2019_Human,IL-17 signaling pathway,1/93,0.0046499360391879,0.0092998720783758,0,0,19907.0,106918.54242106884,IL17RE
14498,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0146998751759735,0,0,19706.0,83157.67014793828,IL17RE
14499,KEGG_2019_Human,Glutathione metabolism,1/56,0.0027999538675741,0.0027999538675741,0,0,19944.0,117233.87022514464,NAT8
14500,KEGG_2019_Human,Gap junction,1/88,0.0043999382262822,0.0094165463651919,0,0,19912.0,108045.79305232369,HTR2A
14501,KEGG_2019_Human,Inflammatory mediator regulation of TRP channels,1/100,0.0049999330710556,0.0094165463651919,0,0,19900.0,105436.78197328727,HTR2A
14502,KEGG_2019_Human,Serotonergic synapse,1/113,0.0056499278191151,0.0094165463651919,0,0,19887.0,102937.34947211576,HTR2A
14503,KEGG_2019_Human,Calcium signaling pathway,1/188,0.009399902370135,0.0117498779626688,0,0,19812.0,92463.712994847,HTR2A
14504,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,HTR2A
14505,KEGG_2019_Human,Long-term depression,1/60,0.002999951725986,0.0087082144972889,0,0,19940.0,115834.63209072244,LYN
14506,KEGG_2019_Human,Fc epsilon RI signaling pathway,1/68,0.0033999476216189,0.0087082144972889,0,0,19932.0,113293.39338050144,LYN
14507,KEGG_2019_Human,Epithelial cell signaling in Helicobacter pylori infection,1/68,0.0033999476216189,0.0087082144972889,0,0,19932.0,113293.39338050144,LYN
14508,KEGG_2019_Human,B cell receptor signaling pathway,1/71,0.0035499461386618,0.0087082144972889,0,0,19929.0,112415.9585341616,LYN
14509,KEGG_2019_Human,Fc gamma R-mediated phagocytosis,1/91,0.0045499369072032,0.0087082144972889,0,0,19909.0,107362.10783923086,LYN
14510,KEGG_2019_Human,NF-kappa B signaling pathway,1/95,0.0047499351803394,0.0087082144972889,0,0,19905.0,106484.27183626965,LYN
14511,KEGG_2019_Human,Platelet activation,1/124,0.0061999236097501,0.0097427371010359,0,0,19876.0,101034.04709010696,LYN
14512,KEGG_2019_Human,Kaposi sarcoma-associated herpesvirus infection,1/186,0.0092999029651357,0.0100498985877989,0,0,19814.0,92684.96451050608,LYN
14513,KEGG_2019_Human,Chemokine signaling pathway,1/190,0.0094999017791995,0.0100498985877989,0,0,19810.0,92244.74636351672,LYN
14514,KEGG_2019_Human,Epstein-Barr virus infection,1/201,0.0100498985877989,0.0100498985877989,0,0,19799.0,91079.21596609056,LYN
14515,KEGG_2019_Human,Viral carcinogenesis,1/201,0.0100498985877989,0.0100498985877989,0,0,19799.0,91079.21596609056,LYN
14516,KEGG_2019_Human,Complement and coagulation cascades,1/79,0.0039499423167337,0.0078998846334674,0,0,19921.0,110243.89578070649,F2RL2
14517,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,F2RL2
14518,KEGG_2019_Human,Mitophagy,1/65,0.003249949134407,0.0092999029651357,0,0,19935.0,114209.92613860144,GABARAP
14519,KEGG_2019_Human,GABAergic synapse,1/89,0.0044499377838098,0.0092999029651357,0,0,19911.0,107815.380281759,GABARAP
14520,KEGG_2019_Human,Autophagy,1/128,0.0063999221281459,0.0092999029651357,0,0,19872.0,100382.8010329652,GABARAP
14521,KEGG_2019_Human,FoxO signaling pathway,1/132,0.0065999206698993,0.0092999029651357,0,0,19868.0,99751.22090491928,GABARAP
14522,KEGG_2019_Human,Apelin signaling pathway,1/137,0.0068499188797651,0.0092999029651357,0,0,19863.0,98987.62735269018,GABARAP
14523,KEGG_2019_Human,NOD-like receptor signaling pathway,1/178,0.0088999053857096,0.0092999029651357,0,0,19822.0,93593.82745769851,GABARAP
14524,KEGG_2019_Human,Kaposi sarcoma-associated herpesvirus infection,1/186,0.0092999029651357,0.0092999029651357,0,0,19814.0,92684.96451050608,GABARAP
14525,KEGG_2019_Human,T cell receptor signaling pathway,1/101,0.0050499326546803,0.0050499326546803,0,0,19899.0,105233.48101229242,GRAP2
14526,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR10G8
14527,KEGG_2019_Human,RNA degradation,1/79,0.0039499423167337,0.0039499423167337,0,0,19921.0,110243.89578070649,EXOSC1
14528,KEGG_2019_Human,C-type lectin receptor signaling pathway,1/104,0.0051999314202997,0.0112498919790339,0,0,19896.0,104635.24941415618,NFATC4
14529,KEGG_2019_Human,Oxytocin signaling pathway,1/153,0.0076499133771537,0.0112498919790339,0,0,19847.0,96715.6407630817,NFATC4
14530,KEGG_2019_Human,Wnt signaling pathway,1/158,0.0078999117225733,0.0112498919790339,0,0,19842.0,96053.2110949472,NFATC4
14531,KEGG_2019_Human,Cellular senescence,1/160,0.0079999110688441,0.0112498919790339,0,0,19840.0,95793.96509856998,NFATC4
14532,KEGG_2019_Human,Hepatitis B,1/163,0.0081499100978668,0.0112498919790339,0,0,19837.0,95410.9786681514,NFATC4
14533,KEGG_2019_Human,cGMP-PKG signaling pathway,1/166,0.0082999091363732,0.0112498919790339,0,0,19834.0,95034.82345515196,NFATC4
14534,KEGG_2019_Human,Axon guidance,1/181,0.0090499044707863,0.0112498919790339,0,0,19819.0,93248.41634586031,NFATC4
14535,KEGG_2019_Human,Kaposi sarcoma-associated herpesvirus infection,1/186,0.0092999029651357,0.0112498919790339,0,0,19814.0,92684.96451050608,NFATC4
14536,KEGG_2019_Human,Human immunodeficiency virus 1 infection,1/212,0.0105998955026255,0.0112498919790339,0,0,19788.0,89974.27756224656,NFATC4
14537,KEGG_2019_Human,Human T-cell leukemia virus 1 infection,1/219,0.0109498935894162,0.0112498919790339,0,0,19781.0,89299.85161916987,NFATC4
14538,KEGG_2019_Human,Human cytomegalovirus infection,1/225,0.0112498919790339,0.0112498919790339,0,0,19775.0,88738.27077557483,NFATC4
14539,KEGG_2019_Human,TGF-beta signaling pathway,1/90,0.0044999373439762,0.0089998746879525,0,0,19910.0,107587.50385474482,RGMA
14540,KEGG_2019_Human,Axon guidance,1/181,0.0090499044707863,0.0090499044707863,0,0,19819.0,93248.41634586031,RGMA
14541,KEGG_2019_Human,Influenza A,1/171,0.0085499075557634,0.0085499075557634,0,0,19829.0,94422.42241345016,HNRNPUL1
14542,KEGG_2019_Human,Synthesis and degradation of ketone bodies,1/10,0.0004999862257578379,0.0019999449030313,0,0,19990.0,151942.5908680334,HMGCL
14543,KEGG_2019_Human,Butanoate metabolism,1/28,0.0013999711732997,0.0027999423465995,0,0,19972.0,131242.0761597353,HMGCL
14544,KEGG_2019_Human,"Valine, leucine and isoleucine degradation",1/48,0.0023999583567988,0.0031999444757317,0,0,19952.0,120356.5272753826,HMGCL
14545,KEGG_2019_Human,Peroxisome,1/83,0.0041499404726918,0.0041499404726918,0,0,19917.0,109237.99888847338,HMGCL
14546,KEGG_2019_Human,Central carbon metabolism in cancer,1/65,0.003249949134407,0.0144998626687005,0,0,19935.0,114209.92613860144,FGFR1
14547,KEGG_2019_Human,Adherens junction,1/72,0.0035999456502131,0.0144998626687005,0,0,19928.0,112131.59838572376,FGFR1
14548,KEGG_2019_Human,Melanoma,1/72,0.0035999456502131,0.0144998626687005,0,0,19928.0,112131.59838572376,FGFR1
14549,KEGG_2019_Human,Prostate cancer,1/97,0.0048499343304706,0.0144998626687005,0,0,19903.0,106058.9096435903,FGFR1
14550,KEGG_2019_Human,"Parathyroid hormone synthesis, secretion and action",1/106,0.0052999306076525,0.0144998626687005,0,0,19894.0,104245.78450366124,FGFR1
14551,KEGG_2019_Human,Signaling pathways regulating pluripotency of stem cells,1/139,0.006949918172816,0.0144998626687005,0,0,19861.0,98689.81333375497,FGFR1
14552,KEGG_2019_Human,Breast cancer,1/147,0.0073499154017982,0.0144998626687005,0,0,19853.0,97539.10874372096,FGFR1
14553,KEGG_2019_Human,Proteoglycans in cancer,1/201,0.0100498985877989,0.0144998626687005,0,0,19799.0,91079.21596609056,FGFR1
14554,KEGG_2019_Human,Rap1 signaling pathway,1/206,0.010299897173561,0.0144998626687005,0,0,19794.0,90569.849337325,FGFR1
14555,KEGG_2019_Human,Regulation of actin cytoskeleton,1/214,0.0106998949514067,0.0144998626687005,0,0,19786.0,89779.39753374986,FGFR1
14556,KEGG_2019_Human,Thermogenesis,1/231,0.0115498903940656,0.0144998626687005,0,0,19769.0,88191.07730937863,FGFR1
14557,KEGG_2019_Human,Ras signaling pathway,1/232,0.0115998901349604,0.0144998626687005,0,0,19768.0,88101.22480150245,FGFR1
14558,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0170190864849815,0,0,19705.0,83086.53988020132,FGFR1
14559,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0189641385443216,0,0,19646.0,79255.8617626126,FGFR1
14560,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,FGFR1
14561,KEGG_2019_Human,Retrograde endocannabinoid signaling,1/148,0.007399915061391,0.007399915061391,0,0,19852.0,97399.60470052566,FAAH
14562,KEGG_2019_Human,Oxidative phosphorylation,1/133,0.0066499203093911,0.0112582177134695,0,0,19867.0,99596.2591544721,NDUFA9
14563,KEGG_2019_Human,Parkinson disease,1/142,0.0070999171242726,0.0112582177134695,0,0,19858.0,98250.87390500787,NDUFA9
14564,KEGG_2019_Human,Retrograde endocannabinoid signaling,1/148,0.007399915061391,0.0112582177134695,0,0,19852.0,97399.60470052566,NDUFA9
14565,KEGG_2019_Human,Non-alcoholic fatty liver disease (NAFLD),1/149,0.0074499147221605,0.0112582177134695,0,0,19851.0,97261.02051561224,NDUFA9
14566,KEGG_2019_Human,Alzheimer disease,1/171,0.0085499075557634,0.0112582177134695,0,0,19829.0,94422.42241345016,NDUFA9
14567,KEGG_2019_Human,Huntington disease,1/193,0.0096499008972596,0.0112582177134695,0,0,19807.0,91920.47679471428,NDUFA9
14568,KEGG_2019_Human,Thermogenesis,1/231,0.0115498903940656,0.0115498903940656,0,0,19769.0,88191.07730937863,NDUFA9
14569,KEGG_2019_Human,Chemokine signaling pathway,1/190,0.0094999017791995,0.0146998751759735,0,0,19810.0,92244.74636351672,CXCR6
14570,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0146998751759735,0,0,19706.0,83157.67014793828,CXCR6
14571,KEGG_2019_Human,Pantothenate and CoA biosynthesis,1/19,0.00094997806231055,0.00094997806231055,0,0,19981.0,139049.2109571672,VNN2
14572,KEGG_2019_Human,GnRH signaling pathway,1/93,0.0046499360391879,0.0118998509970274,0,0,19907.0,106918.54242106884,MAP3K3
14573,KEGG_2019_Human,Neurotrophin signaling pathway,1/119,0.0059499254985137,0.0118998509970274,0,0,19881.0,101877.73080211312,MAP3K3
14574,KEGG_2019_Human,Human T-cell leukemia virus 1 infection,1/219,0.0109498935894162,0.0145998581192216,0,0,19781.0,89299.85161916987,MAP3K3
14575,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0147498749536506,0,0,19705.0,83086.53988020132,MAP3K3
14576,KEGG_2019_Human,RNA transport,1/165,0.0082499094553477,0.0082499094553477,0,0,19835.0,95159.46482222488,FXR1
14577,KEGG_2019_Human,Hippo signaling pathway,1/160,0.0079999110688441,0.0127498618039235,0,0,19840.0,95793.96509856998,PATJ
14578,KEGG_2019_Human,Tight junction,1/170,0.0084999078692823,0.0127498618039235,0,0,19830.0,94543.49009679438,PATJ
14579,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0164998674589645,0,0,19670.0,80733.60565076157,PATJ
14580,KEGG_2019_Human,Chemokine signaling pathway,1/190,0.0094999017791995,0.0146998751759735,0,0,19810.0,92244.74636351672,XCR1
14581,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0146998751759735,0,0,19706.0,83157.67014793828,XCR1
14582,KEGG_2019_Human,Mucin type O-glycan biosynthesis,1/31,0.0015499690656704,0.0015499690656704,0,0,19969.0,129189.85098816035,GALNT15
14583,KEGG_2019_Human,Transcriptional misregulation in cancer,1/186,0.0092999029651357,0.0092999029651357,0,0,19814.0,92684.96451050608,PAX7
14584,KEGG_2019_Human,RNA transport,1/165,0.0082499094553477,0.0082499094553477,0,0,19835.0,95159.46482222488,NUP88
14585,KEGG_2019_Human,Glyoxylate and dicarboxylate metabolism,1/30,0.0014999697593334,0.0019999631680592,0,0,19970.0,129851.13732048514,GRHPR
14586,KEGG_2019_Human,Pyruvate metabolism,1/39,0.0019499637955508,0.0019999631680592,0,0,19961.0,124555.53162481484,GRHPR
14587,KEGG_2019_Human,"Glycine, serine and threonine metabolism",1/40,0.0019999631680592,0.0019999631680592,0,0,19960.0,124043.94523066044,GRHPR
14588,KEGG_2019_Human,Natural killer cell mediated cytotoxicity,1/131,0.0065499210316603,0.0065499210316603,0,0,19869.0,99907.33811343512,CD244
14589,KEGG_2019_Human,Purine metabolism,1/129,0.006449921761047,0.006449921761047,0,0,19871.0,100223.109907462,ALLC
14590,KEGG_2019_Human,Glycerophospholipid metabolism,1/97,0.0048499343304706,0.0049499334884068,0,0,19903.0,106058.9096435903,GPCPD1
14591,KEGG_2019_Human,Choline metabolism in cancer,1/99,0.0049499334884068,0.0049499334884068,0,0,19901.0,105642.09305076736,GPCPD1
14592,KEGG_2019_Human,Arachidonic acid metabolism,1/63,0.0031499501598827,0.0041499404726918,0,0,19937.0,114844.46974572667,EPHX2
14593,KEGG_2019_Human,Peroxisome,1/83,0.0041499404726918,0.0041499404726918,0,0,19917.0,109237.99888847338,EPHX2
14594,KEGG_2019_Human,Bile secretion,1/72,0.0035999456502131,0.0071998913004262,0,0,19928.0,112131.59838572376,SLC10A1
14595,KEGG_2019_Human,Hepatitis B,1/163,0.0081499100978668,0.0081499100978668,0,0,19837.0,95410.9786681514,SLC10A1
14596,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR14A2
14597,KEGG_2019_Human,Pathogenic Escherichia coli infection,1/55,0.0027499544131125,0.0067332435395738,0,0,19945.0,117599.1294878737,NCK2
14598,KEGG_2019_Human,ErbB signaling pathway,1/85,0.004249939567045,0.0067332435395738,0,0,19915.0,108752.83801948265,NCK2
14599,KEGG_2019_Human,T cell receptor signaling pathway,1/101,0.0050499326546803,0.0067332435395738,0,0,19899.0,105233.48101229242,NCK2
14600,KEGG_2019_Human,Axon guidance,1/181,0.0090499044707863,0.0090499044707863,0,0,19819.0,93248.41634586031,NCK2
14601,KEGG_2019_Human,Protein export,1/23,0.0011499748819949,0.0011499748819949,0,0,19977.0,135204.63922267244,SRP72
14602,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR4Q2
14603,KEGG_2019_Human,Insulin resistance,1/108,0.0053999298011749,0.0068499188797651,0,0,19892.0,103863.47861844616,PPP1R3B
14604,KEGG_2019_Human,Insulin signaling pathway,1/137,0.0068499188797651,0.0068499188797651,0,0,19863.0,98987.62735269018,PPP1R3B
14605,KEGG_2019_Human,Nitrogen metabolism,1/17,0.0008499797390404818,0.0011499748819949,0,0,19983.0,141285.76583697114,CA4
14606,KEGG_2019_Human,Proximal tubule bicarbonate reclamation,1/23,0.0011499748819949,0.0011499748819949,0,0,19977.0,135204.63922267244,CA4
14607,KEGG_2019_Human,Histidine metabolism,1/23,0.0011499748819949,0.0033549463201819,0,0,19977.0,135204.63922267244,ALDH2
14608,KEGG_2019_Human,Ascorbate and aldarate metabolism,1/27,0.0013499718942362,0.0033549463201819,0,0,19973.0,131975.02298599784,ALDH2
14609,KEGG_2019_Human,beta-Alanine metabolism,1/31,0.0015499690656704,0.0033549463201819,0,0,19969.0,129189.85098816035,ALDH2
14610,KEGG_2019_Human,Pyruvate metabolism,1/39,0.0019499637955508,0.0033549463201819,0,0,19961.0,124555.53162481484,ALDH2
14611,KEGG_2019_Human,Tryptophan metabolism,1/42,0.0020999619311272,0.0033549463201819,0,0,19958.0,123057.75613441122,ALDH2
14612,KEGG_2019_Human,Fatty acid degradation,1/44,0.0021999607179423,0.0033549463201819,0,0,19956.0,122117.06559109331,ALDH2
14613,KEGG_2019_Human,"Valine, leucine and isoleucine degradation",1/48,0.0023999583567988,0.0033549463201819,0,0,19952.0,120356.5272753826,ALDH2
14614,KEGG_2019_Human,Arginine and proline metabolism,1/49,0.0024499577795033,0.0033549463201819,0,0,19951.0,119939.1172087114,ALDH2
14615,KEGG_2019_Human,Lysine degradation,1/59,0.0029499522555206,0.0033549463201819,0,0,19941.0,116175.59385530632,ALDH2
14616,KEGG_2019_Human,Glycerolipid metabolism,1/61,0.0030499512001654,0.0033549463201819,0,0,19939.0,115499.24335773686,ALDH2
14617,KEGG_2019_Human,Glycolysis / Gluconeogenesis,1/68,0.0033999476216189,0.0033999476216189,0,0,19932.0,113293.39338050144,ALDH2
14618,KEGG_2019_Human,Leukocyte transendothelial migration,1/112,0.0055999282120529,0.0084999078692823,0,0,19888.0,103119.30984392198,CLDN22
14619,KEGG_2019_Human,Cell adhesion molecules (CAMs),1/145,0.0072499160871101,0.0084999078692823,0,0,19855.0,97820.92670675044,CLDN22
14620,KEGG_2019_Human,Hepatitis C,1/155,0.0077499127120574,0.0084999078692823,0,0,19845.0,96448.16254952336,CLDN22
14621,KEGG_2019_Human,Tight junction,1/170,0.0084999078692823,0.0084999078692823,0,0,19830.0,94543.49009679438,CLDN22
14622,KEGG_2019_Human,Sulfur relay system,1/8,0.0003999883241497325,0.0006749808857082532,0,0,19992.0,156418.91141655247,TST
14623,KEGG_2019_Human,Sulfur metabolism,1/9,0.0004499872571388355,0.0006749808857082532,0,0,19991.0,154056.46923976458,TST
14624,KEGG_2019_Human,Cysteine and methionine metabolism,1/47,0.0023499589392381,0.0023499589392381,0,0,19953.0,120782.64067395544,TST
14625,KEGG_2019_Human,Axon guidance,1/181,0.0090499044707863,0.0106998949514067,0,0,19819.0,93248.41634586031,ENAH
14626,KEGG_2019_Human,Regulation of actin cytoskeleton,1/214,0.0106998949514067,0.0106998949514067,0,0,19786.0,89779.39753374986,ENAH
14627,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR52N5
14628,KEGG_2019_Human,Protein processing in endoplasmic reticulum,1/165,0.0082499094553477,0.0082499094553477,0,0,19835.0,95159.46482222488,DNAJB11
14629,KEGG_2019_Human,Circadian rhythm,1/31,0.0015499690656704,0.0046999178784763,0,0,19969.0,129189.85098816035,CSNK1D
14630,KEGG_2019_Human,Hedgehog signaling pathway,1/47,0.0023499589392381,0.0046999178784763,0,0,19953.0,120782.64067395544,CSNK1D
14631,KEGG_2019_Human,Gap junction,1/88,0.0043999382262822,0.0058665843017096,0,0,19912.0,108045.79305232369,CSNK1D
14632,KEGG_2019_Human,Hippo signaling pathway,1/160,0.0079999110688441,0.0079999110688441,0,0,19840.0,95793.96509856998,CSNK1D
14633,KEGG_2019_Human,Th17 cell differentiation,1/107,0.0053499302026925,0.0077499127120574,0,0,19893.0,104053.753408911,AHR
14634,KEGG_2019_Human,Cushing syndrome,1/155,0.0077499127120574,0.0077499127120574,0,0,19845.0,96448.16254952336,AHR
14635,KEGG_2019_Human,Hippo signaling pathway,1/160,0.0079999110688441,0.0079999110688441,0,0,19840.0,95793.96509856998,LIMD1
14636,KEGG_2019_Human,Hepatocellular carcinoma,1/168,0.0083999085011095,0.0115498903940656,0,0,19832.0,94787.72752807094,SMARCC2
14637,KEGG_2019_Human,Thermogenesis,1/231,0.0115498903940656,0.0115498903940656,0,0,19769.0,88191.07730937863,SMARCC2
14638,KEGG_2019_Human,Vitamin digestion and absorption,1/24,0.0011999741185782,0.0028999409235821,0,0,19976.0,134347.69487847842,PLB1
14639,KEGG_2019_Human,alpha-Linolenic acid metabolism,1/25,0.0012499733663791,0.0028999409235821,0,0,19975.0,133525.54486996148,PLB1
14640,KEGG_2019_Human,Linoleic acid metabolism,1/29,0.001449970461791,0.0028999409235821,0,0,19971.0,130534.69172799008,PLB1
14641,KEGG_2019_Human,Ether lipid metabolism,1/47,0.0023499589392381,0.0035249384088572,0,0,19953.0,120782.64067395544,PLB1
14642,KEGG_2019_Human,Arachidonic acid metabolism,1/63,0.0031499501598827,0.0037799401918593,0,0,19937.0,114844.46974572667,PLB1
14643,KEGG_2019_Human,Glycerophospholipid metabolism,1/97,0.0048499343304706,0.0048499343304706,0,0,19903.0,106058.9096435903,PLB1
14644,KEGG_2019_Human,Transcriptional misregulation in cancer,1/186,0.0092999029651357,0.0092999029651357,0,0,19814.0,92684.96451050608,MLF1
14645,KEGG_2019_Human,Salmonella infection,1/86,0.0042999391173866,0.0106998949514067,0,0,19914.0,108514.46102290176,MYH9
14646,KEGG_2019_Human,Tight junction,1/170,0.0084999078692823,0.0106998949514067,0,0,19830.0,94543.49009679438,MYH9
14647,KEGG_2019_Human,Regulation of actin cytoskeleton,1/214,0.0106998949514067,0.0106998949514067,0,0,19786.0,89779.39753374986,MYH9
14648,KEGG_2019_Human,TGF-beta signaling pathway,1/90,0.0044999373439762,0.0044999373439762,0,0,19910.0,107587.50385474482,PITX2
14649,KEGG_2019_Human,Arginine and proline metabolism,1/49,0.0024499577795033,0.0024499577795033,0,0,19951.0,119939.1172087114,PRODH2
14650,KEGG_2019_Human,Wnt signaling pathway,1/158,0.0078999117225733,0.0078999117225733,0,0,19842.0,96053.2110949472,RSPO4
14651,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF562
14652,KEGG_2019_Human,Ribosome,1/153,0.0076499133771537,0.0076499133771537,0,0,19847.0,96715.6407630817,RPL10L
14653,KEGG_2019_Human,Lysosome,1/123,0.0061499239842961,0.0061499239842961,0,0,19877.0,101200.07933676826,AP4B1
14654,KEGG_2019_Human,cAMP signaling pathway,1/212,0.0105998955026255,0.0105998955026255,0,0,19788.0,89974.27756224656,SOX9
14655,KEGG_2019_Human,Long-term depression,1/60,0.002999951725986,0.002999951725986,0,0,19940.0,115834.63209072244,PPP1R17
14656,KEGG_2019_Human,mTOR signaling pathway,1/152,0.0075999137114971,0.0075999137114971,0,0,19848.0,96850.665715497,NPRL2
14657,KEGG_2019_Human,Basal cell carcinoma,1/63,0.0031499501598827,0.0109198810514423,0,0,19937.0,114844.46974572667,FZD1
14658,KEGG_2019_Human,Melanogenesis,1/101,0.0050499326546803,0.0109198810514423,0,0,19899.0,105233.48101229242,FZD1
14659,KEGG_2019_Human,Signaling pathways regulating pluripotency of stem cells,1/139,0.006949918172816,0.0109198810514423,0,0,19861.0,98689.81333375497,FZD1
14660,KEGG_2019_Human,Breast cancer,1/147,0.0073499154017982,0.0109198810514423,0,0,19853.0,97539.10874372096,FZD1
14661,KEGG_2019_Human,Gastric cancer,1/149,0.0074499147221605,0.0109198810514423,0,0,19851.0,97261.02051561224,FZD1
14662,KEGG_2019_Human,mTOR signaling pathway,1/152,0.0075999137114971,0.0109198810514423,0,0,19848.0,96850.665715497,FZD1
14663,KEGG_2019_Human,Cushing syndrome,1/155,0.0077499127120574,0.0109198810514423,0,0,19845.0,96448.16254952336,FZD1
14664,KEGG_2019_Human,Wnt signaling pathway,1/158,0.0078999117225733,0.0109198810514423,0,0,19842.0,96053.2110949472,FZD1
14665,KEGG_2019_Human,Hippo signaling pathway,1/160,0.0079999110688441,0.0109198810514423,0,0,19840.0,95793.96509856998,FZD1
14666,KEGG_2019_Human,Hepatocellular carcinoma,1/168,0.0083999085011095,0.0109198810514423,0,0,19832.0,94787.72752807094,FZD1
14667,KEGG_2019_Human,Proteoglycans in cancer,1/201,0.0100498985877989,0.0118771528764897,0,0,19799.0,91079.21596609056,FZD1
14668,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0178748564138782,0,0,19670.0,80733.60565076157,FZD1
14669,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,FZD1
14670,KEGG_2019_Human,Axon guidance,1/181,0.0090499044707863,0.0090499044707863,0,0,19819.0,93248.41634586031,TRPC3
14671,KEGG_2019_Human,Glycerophospholipid metabolism,1/97,0.0048499343304706,0.0048499343304706,0,0,19903.0,106058.9096435903,ETNPPL
14672,KEGG_2019_Human,Glycosylphosphatidylinositol (GPI)-anchor biosynthesis,1/25,0.0012499733663791,0.0012499733663791,0,0,19975.0,133525.54486996148,PIGC
14673,KEGG_2019_Human,Glycosphingolipid biosynthesis,1/45,0.0022499601197094,0.0022499601197094,0,0,19955.0,121662.49782449217,B3GALT5
14674,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF57
14675,KEGG_2019_Human,Ovarian steroidogenesis,1/49,0.0024499577795033,0.0097427474094437,0,0,19951.0,119939.1172087114,ADCY7
14676,KEGG_2019_Human,Regulation of lipolysis in adipocytes,1/55,0.0027499544131125,0.0097427474094437,0,0,19945.0,117599.1294878737,ADCY7
14677,KEGG_2019_Human,Cortisol synthesis and secretion,1/65,0.003249949134407,0.0097427474094437,0,0,19935.0,114209.92613860144,ADCY7
14678,KEGG_2019_Human,Bile secretion,1/72,0.0035999456502131,0.0097427474094437,0,0,19928.0,112131.59838572376,ADCY7
14679,KEGG_2019_Human,Thyroid hormone synthesis,1/74,0.0036999446830449,0.0097427474094437,0,0,19926.0,111574.38983110404,ADCY7
14680,KEGG_2019_Human,Gastric acid secretion,1/75,0.0037499442041125,0.0097427474094437,0,0,19925.0,111301.33528642564,ADCY7
14681,KEGG_2019_Human,Insulin secretion,1/86,0.0042999391173866,0.0097427474094437,0,0,19914.0,108514.46102290176,ADCY7
14682,KEGG_2019_Human,Gap junction,1/88,0.0043999382262822,0.0097427474094437,0,0,19912.0,108045.79305232369,ADCY7
14683,KEGG_2019_Human,GABAergic synapse,1/89,0.0044499377838098,0.0097427474094437,0,0,19911.0,107815.380281759,ADCY7
14684,KEGG_2019_Human,Salivary secretion,1/90,0.0044999373439762,0.0097427474094437,0,0,19910.0,107587.50385474482,ADCY7
14685,KEGG_2019_Human,Dilated cardiomyopathy (DCM),1/91,0.0045499369072032,0.0097427474094437,0,0,19909.0,107362.10783923086,ADCY7
14686,KEGG_2019_Human,Morphine addiction,1/91,0.0045499369072032,0.0097427474094437,0,0,19909.0,107362.10783923086,ADCY7
14687,KEGG_2019_Human,GnRH signaling pathway,1/93,0.0046499360391879,0.0097427474094437,0,0,19907.0,106918.54242106884,ADCY7
14688,KEGG_2019_Human,Circadian entrainment,1/97,0.0048499343304706,0.0097427474094437,0,0,19903.0,106058.9096435903,ADCY7
14689,KEGG_2019_Human,Pancreatic secretion,1/98,0.0048999339081079,0.0097427474094437,0,0,19902.0,105849.45495286948,ADCY7
14690,KEGG_2019_Human,Aldosterone synthesis and secretion,1/98,0.0048999339081079,0.0097427474094437,0,0,19902.0,105849.45495286948,ADCY7
14691,KEGG_2019_Human,Progesterone-mediated oocyte maturation,1/99,0.0049499334884068,0.0097427474094437,0,0,19901.0,105642.09305076736,ADCY7
14692,KEGG_2019_Human,Inflammatory mediator regulation of TRP channels,1/100,0.0049999330710556,0.0097427474094437,0,0,19900.0,105436.78197328727,ADCY7
14693,KEGG_2019_Human,Melanogenesis,1/101,0.0050499326546803,0.0097427474094437,0,0,19899.0,105233.48101229242,ADCY7
14694,KEGG_2019_Human,Longevity regulating pathway,1/102,0.0050999322416682,0.0097427474094437,0,0,19898.0,105032.15064717118,ADCY7
14695,KEGG_2019_Human,"Parathyroid hormone synthesis, secretion and action",1/106,0.0052999306076525,0.0097427474094437,0,0,19894.0,104245.78450366124,ADCY7
14696,KEGG_2019_Human,Cholinergic synapse,1/112,0.0055999282120529,0.0097427474094437,0,0,19888.0,103119.30984392198,ADCY7
14697,KEGG_2019_Human,Glutamatergic synapse,1/114,0.005699927427839,0.0097427474094437,0,0,19886.0,102756.96431429044,ADCY7
14698,KEGG_2019_Human,Platelet activation,1/124,0.0061999236097501,0.0097427474094437,0,0,19876.0,101034.04709010696,ADCY7
14699,KEGG_2019_Human,Oocyte meiosis,1/125,0.0062499232373748,0.0097427474094437,0,0,19875.0,100869.32368441945,ADCY7
14700,KEGG_2019_Human,Purine metabolism,1/129,0.006449921761047,0.0097427474094437,0,0,19871.0,100223.109907462,ADCY7
14701,KEGG_2019_Human,Relaxin signaling pathway,1/130,0.0064999213952527,0.0097427474094437,0,0,19870.0,100064.62842845908,ADCY7
14702,KEGG_2019_Human,Vascular smooth muscle contraction,1/132,0.0065999206698993,0.0097427474094437,0,0,19868.0,99751.22090491928,ADCY7
14703,KEGG_2019_Human,Estrogen signaling pathway,1/137,0.0068499188797651,0.0097427474094437,0,0,19863.0,98987.62735269018,ADCY7
14704,KEGG_2019_Human,Apelin signaling pathway,1/137,0.0068499188797651,0.0097427474094437,0,0,19863.0,98987.62735269018,ADCY7
14705,KEGG_2019_Human,Adrenergic signaling in cardiomyocytes,1/145,0.0072499160871101,0.0097427474094437,0,0,19855.0,97820.92670675044,ADCY7
14706,KEGG_2019_Human,Phospholipase D signaling pathway,1/148,0.007399915061391,0.0097427474094437,0,0,19852.0,97399.60470052566,ADCY7
14707,KEGG_2019_Human,Retrograde endocannabinoid signaling,1/148,0.007399915061391,0.0097427474094437,0,0,19852.0,97399.60470052566,ADCY7
14708,KEGG_2019_Human,Oxytocin signaling pathway,1/153,0.0076499133771537,0.0097427474094437,0,0,19847.0,96715.6407630817,ADCY7
14709,KEGG_2019_Human,Cushing syndrome,1/155,0.0077499127120574,0.0097427474094437,0,0,19845.0,96448.16254952336,ADCY7
14710,KEGG_2019_Human,cGMP-PKG signaling pathway,1/166,0.0082999091363732,0.0101443333889006,0,0,19834.0,95034.82345515196,ADCY7
14711,KEGG_2019_Human,Calcium signaling pathway,1/188,0.009399902370135,0.0109998862706521,0,0,19812.0,92463.712994847,ADCY7
14712,KEGG_2019_Human,Chemokine signaling pathway,1/190,0.0094999017791995,0.0109998862706521,0,0,19810.0,92244.74636351672,ADCY7
14713,KEGG_2019_Human,Rap1 signaling pathway,1/206,0.010299897173561,0.011620396811197,0,0,19794.0,90569.849337325,ADCY7
14714,KEGG_2019_Human,cAMP signaling pathway,1/212,0.0105998955026255,0.0116598850528881,0,0,19788.0,89974.27756224656,ADCY7
14715,KEGG_2019_Human,Human T-cell leukemia virus 1 infection,1/219,0.0109498935894162,0.0117511053154711,0,0,19781.0,89299.85161916987,ADCY7
14716,KEGG_2019_Human,Human cytomegalovirus infection,1/225,0.0112498919790339,0.0117856011208926,0,0,19775.0,88738.27077557483,ADCY7
14717,KEGG_2019_Human,Thermogenesis,1/231,0.0115498903940656,0.0118184924962531,0,0,19769.0,88191.07730937863,ADCY7
14718,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,ADCY7
14719,KEGG_2019_Human,Hippo signaling pathway,1/160,0.0079999110688441,0.0079999110688441,0,0,19840.0,95793.96509856998,WTIP
14720,KEGG_2019_Human,GnRH signaling pathway,1/93,0.0046499360391879,0.0112498919790339,0,0,19907.0,106918.54242106884,PTK2B
14721,KEGG_2019_Human,Leukocyte transendothelial migration,1/112,0.0055999282120529,0.0112498919790339,0,0,19888.0,103119.30984392198,PTK2B
14722,KEGG_2019_Human,Natural killer cell mediated cytotoxicity,1/131,0.0065499210316603,0.0112498919790339,0,0,19869.0,99907.33811343512,PTK2B
14723,KEGG_2019_Human,Phospholipase D signaling pathway,1/148,0.007399915061391,0.0112498919790339,0,0,19852.0,97399.60470052566,PTK2B
14724,KEGG_2019_Human,Hepatitis B,1/163,0.0081499100978668,0.0112498919790339,0,0,19837.0,95410.9786681514,PTK2B
14725,KEGG_2019_Human,Calcium signaling pathway,1/188,0.009399902370135,0.0112498919790339,0,0,19812.0,92463.712994847,PTK2B
14726,KEGG_2019_Human,Chemokine signaling pathway,1/190,0.0094999017791995,0.0112498919790339,0,0,19810.0,92244.74636351672,PTK2B
14727,KEGG_2019_Human,Human immunodeficiency virus 1 infection,1/212,0.0105998955026255,0.0112498919790339,0,0,19788.0,89974.27756224656,PTK2B
14728,KEGG_2019_Human,Human cytomegalovirus infection,1/225,0.0112498919790339,0.0112498919790339,0,0,19775.0,88738.27077557483,PTK2B
14729,KEGG_2019_Human,Tyrosine metabolism,1/36,0.0017999657178272,0.0047832644181221,0,0,19964.0,126172.23364250171,ADH6
14730,KEGG_2019_Human,Fatty acid degradation,1/44,0.0021999607179423,0.0047832644181221,0,0,19956.0,122117.06559109331,ADH6
14731,KEGG_2019_Human,Retinol metabolism,1/67,0.0033499481224912,0.0047832644181221,0,0,19933.0,113594.38808369274,ADH6
14732,KEGG_2019_Human,Glycolysis / Gluconeogenesis,1/68,0.0033999476216189,0.0047832644181221,0,0,19932.0,113293.39338050144,ADH6
14733,KEGG_2019_Human,Metabolism of xenobiotics by cytochrome P450,1/74,0.0036999446830449,0.0047832644181221,0,0,19926.0,111574.38983110404,ADH6
14734,KEGG_2019_Human,Chemical carcinogenesis,1/82,0.004099940929819,0.0047832644181221,0,0,19918.0,109484.9180722932,ADH6
14735,KEGG_2019_Human,Drug metabolism,1/108,0.0053999298011749,0.0053999298011749,0,0,19892.0,103863.47861844616,ADH6
14736,KEGG_2019_Human,Cushing syndrome,1/155,0.0077499127120574,0.0077499127120574,0,0,19845.0,96448.16254952336,ARMC5
14737,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,CHRNB3
14738,KEGG_2019_Human,Collecting duct acid secretion,1/27,0.0013499718942362,0.0090998738144064,0,0,19973.0,131975.02298599784,ATP6V0A2
14739,KEGG_2019_Human,Vibrio cholerae infection,1/50,0.0024999572069037,0.0090998738144064,0,0,19950.0,119530.05920663515,ATP6V0A2
14740,KEGG_2019_Human,Epithelial cell signaling in Helicobacter pylori infection,1/68,0.0033999476216189,0.0090998738144064,0,0,19932.0,113293.39338050144,ATP6V0A2
14741,KEGG_2019_Human,Synaptic vesicle cycle,1/78,0.0038999427840466,0.0090998738144064,0,0,19922.0,110503.2180492851,ATP6V0A2
14742,KEGG_2019_Human,Rheumatoid arthritis,1/91,0.0045499369072032,0.0090998738144064,0,0,19909.0,107362.10783923086,ATP6V0A2
14743,KEGG_2019_Human,Lysosome,1/123,0.0061499239842961,0.009499886156273,0,0,19877.0,101200.07933676826,ATP6V0A2
14744,KEGG_2019_Human,Oxidative phosphorylation,1/133,0.0066499203093911,0.009499886156273,0,0,19867.0,99596.2591544721,ATP6V0A2
14745,KEGG_2019_Human,Phagosome,1/152,0.0075999137114971,0.0094998921393714,0,0,19848.0,96850.665715497,ATP6V0A2
14746,KEGG_2019_Human,Tuberculosis,1/179,0.0089499050800561,0.0099443389778401,0,0,19821.0,93478.0629355712,ATP6V0A2
14747,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0164998674589645,0,0,19670.0,80733.60565076157,ATP6V0A2
14748,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF613
14749,KEGG_2019_Human,Endometrial cancer,1/58,0.0028999527887707,0.0120398688515903,0,0,19942.0,116522.31890946148,SOS2
14750,KEGG_2019_Human,Acute myeloid leukemia,1/66,0.003299948626608,0.0120398688515903,0,0,19934.0,113899.85357353876,SOS2
14751,KEGG_2019_Human,Non-small cell lung cancer,1/66,0.003299948626608,0.0120398688515903,0,0,19934.0,113899.85357353876,SOS2
14752,KEGG_2019_Human,Fc epsilon RI signaling pathway,1/68,0.0033999476216189,0.0120398688515903,0,0,19932.0,113293.39338050144,SOS2
14753,KEGG_2019_Human,Renal cell carcinoma,1/69,0.003449947123837,0.0120398688515903,0,0,19931.0,112996.7391397682,SOS2
14754,KEGG_2019_Human,Prolactin signaling pathway,1/70,0.0034999466296654,0.0120398688515903,0,0,19930.0,112704.30065625212,SOS2
14755,KEGG_2019_Human,B cell receptor signaling pathway,1/71,0.0035499461386618,0.0120398688515903,0,0,19929.0,112415.9585341616,SOS2
14756,KEGG_2019_Human,Glioma,1/75,0.0037499442041125,0.0120398688515903,0,0,19925.0,111301.33528642564,SOS2
14757,KEGG_2019_Human,Chronic myeloid leukemia,1/76,0.0037999437281752,0.0120398688515903,0,0,19924.0,111031.8499691117,SOS2
14758,KEGG_2019_Human,ErbB signaling pathway,1/85,0.004249939567045,0.0120398688515903,0,0,19915.0,108752.83801948265,SOS2
14759,KEGG_2019_Human,Colorectal cancer,1/86,0.0042999391173866,0.0120398688515903,0,0,19914.0,108514.46102290176,SOS2
14760,KEGG_2019_Human,Gap junction,1/88,0.0043999382262822,0.0120398688515903,0,0,19912.0,108045.79305232369,SOS2
14761,KEGG_2019_Human,GnRH signaling pathway,1/93,0.0046499360391879,0.0120398688515903,0,0,19907.0,106918.54242106884,SOS2
14762,KEGG_2019_Human,Prostate cancer,1/97,0.0048499343304706,0.0120398688515903,0,0,19903.0,106058.9096435903,SOS2
14763,KEGG_2019_Human,Choline metabolism in cancer,1/99,0.0049499334884068,0.0120398688515903,0,0,19901.0,105642.09305076736,SOS2
14764,KEGG_2019_Human,T cell receptor signaling pathway,1/101,0.0050499326546803,0.0120398688515903,0,0,19899.0,105233.48101229242,SOS2
14765,KEGG_2019_Human,Neurotrophin signaling pathway,1/119,0.0059499254985137,0.0120398688515903,0,0,19881.0,101877.73080211312,SOS2
14766,KEGG_2019_Human,Relaxin signaling pathway,1/130,0.0064999213952527,0.0120398688515903,0,0,19870.0,100064.62842845908,SOS2
14767,KEGG_2019_Human,Natural killer cell mediated cytotoxicity,1/131,0.0065499210316603,0.0120398688515903,0,0,19869.0,99907.33811343512,SOS2
14768,KEGG_2019_Human,FoxO signaling pathway,1/132,0.0065999206698993,0.0120398688515903,0,0,19868.0,99751.22090491928,SOS2
14769,KEGG_2019_Human,Insulin signaling pathway,1/137,0.0068499188797651,0.0120398688515903,0,0,19863.0,98987.62735269018,SOS2
14770,KEGG_2019_Human,Estrogen signaling pathway,1/137,0.0068499188797651,0.0120398688515903,0,0,19863.0,98987.62735269018,SOS2
14771,KEGG_2019_Human,Breast cancer,1/147,0.0073499154017982,0.0120398688515903,0,0,19853.0,97539.10874372096,SOS2
14772,KEGG_2019_Human,Phospholipase D signaling pathway,1/148,0.007399915061391,0.0120398688515903,0,0,19852.0,97399.60470052566,SOS2
14773,KEGG_2019_Human,Gastric cancer,1/149,0.0074499147221605,0.0120398688515903,0,0,19851.0,97261.02051561224,SOS2
14774,KEGG_2019_Human,mTOR signaling pathway,1/152,0.0075999137114971,0.0120398688515903,0,0,19848.0,96850.665715497,SOS2
14775,KEGG_2019_Human,Hepatitis C,1/155,0.0077499127120574,0.0120398688515903,0,0,19845.0,96448.16254952336,SOS2
14776,KEGG_2019_Human,JAK-STAT signaling pathway,1/162,0.0080999104202618,0.0120398688515903,0,0,19838.0,95537.86936302872,SOS2
14777,KEGG_2019_Human,Hepatitis B,1/163,0.0081499100978668,0.0120398688515903,0,0,19837.0,95410.9786681514,SOS2
14778,KEGG_2019_Human,Hepatocellular carcinoma,1/168,0.0083999085011095,0.0120398688515903,0,0,19832.0,94787.72752807094,SOS2
14779,KEGG_2019_Human,Alcoholism,1/180,0.0089999047745351,0.0124837388808067,0,0,19820.0,93362.92821536642,SOS2
14780,KEGG_2019_Human,Chemokine signaling pathway,1/190,0.0094999017791995,0.0127101658610399,0,0,19810.0,92244.74636351672,SOS2
14781,KEGG_2019_Human,Focal adhesion,1/199,0.0099498991610159,0.0127101658610399,0,0,19801.0,91286.4288690606,SOS2
14782,KEGG_2019_Human,Proteoglycans in cancer,1/201,0.0100498985877989,0.0127101658610399,0,0,19799.0,91079.21596609056,SOS2
14783,KEGG_2019_Human,Regulation of actin cytoskeleton,1/214,0.0106998949514067,0.0131261914685078,0,0,19786.0,89779.39753374986,SOS2
14784,KEGG_2019_Human,Human cytomegalovirus infection,1/225,0.0112498919790339,0.0131261914685078,0,0,19775.0,88738.27077557483,SOS2
14785,KEGG_2019_Human,Thermogenesis,1/231,0.0115498903940656,0.0131261914685078,0,0,19769.0,88191.07730937863,SOS2
14786,KEGG_2019_Human,Ras signaling pathway,1/232,0.0115998901349604,0.0131261914685078,0,0,19768.0,88101.22480150245,SOS2
14787,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0160711146220803,0,0,19705.0,83086.53988020132,SOS2
14788,KEGG_2019_Human,MicroRNAs in cancer,1/299,0.0149498740670514,0.0160711146220803,0,0,19701.0,82804.33538735632,SOS2
14789,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0173047390423286,0,0,19670.0,80733.60565076157,SOS2
14790,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0181212879423518,0,0,19646.0,79255.8617626126,SOS2
14791,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,SOS2
14792,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR9Q2
14793,KEGG_2019_Human,Nicotinate and nicotinamide metabolism,1/30,0.0014999697593334,0.0014999697593334,0,0,19970.0,129851.13732048514,NADK
14794,KEGG_2019_Human,Wnt signaling pathway,1/158,0.0078999117225733,0.0078999117225733,0,0,19842.0,96053.2110949472,ROR2
14795,KEGG_2019_Human,TGF-beta signaling pathway,1/90,0.0044999373439762,0.006949918172816,0,0,19910.0,107587.50385474482,SMAD9
14796,KEGG_2019_Human,Signaling pathways regulating pluripotency of stem cells,1/139,0.006949918172816,0.006949918172816,0,0,19861.0,98689.81333375497,SMAD9
14797,KEGG_2019_Human,Fat digestion and absorption,1/41,0.0020499625466866,0.0056570668438935,0,0,19959.0,123544.88783416104,PLPP3
14798,KEGG_2019_Human,Sphingolipid metabolism,1/47,0.0023499589392381,0.0056570668438935,0,0,19953.0,120782.64067395544,PLPP3
14799,KEGG_2019_Human,Ether lipid metabolism,1/47,0.0023499589392381,0.0056570668438935,0,0,19953.0,120782.64067395544,PLPP3
14800,KEGG_2019_Human,Glycerolipid metabolism,1/61,0.0030499512001654,0.0056570668438935,0,0,19939.0,115499.24335773686,PLPP3
14801,KEGG_2019_Human,Fc gamma R-mediated phagocytosis,1/91,0.0045499369072032,0.0056570668438935,0,0,19909.0,107362.10783923086,PLPP3
14802,KEGG_2019_Human,Glycerophospholipid metabolism,1/97,0.0048499343304706,0.0056570668438935,0,0,19903.0,106058.9096435903,PLPP3
14803,KEGG_2019_Human,Choline metabolism in cancer,1/99,0.0049499334884068,0.0056570668438935,0,0,19901.0,105642.09305076736,PLPP3
14804,KEGG_2019_Human,Phospholipase D signaling pathway,1/148,0.007399915061391,0.007399915061391,0,0,19852.0,97399.60470052566,PLPP3
14805,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF550
14806,KEGG_2019_Human,African trypanosomiasis,1/37,0.0018499650702878,0.009634038686065,0,0,19963.0,125618.9446446357,PLCB4
14807,KEGG_2019_Human,Endocrine and other factor-regulated calcium reabsorption,1/48,0.0023999583567988,0.009634038686065,0,0,19952.0,120356.5272753826,PLCB4
14808,KEGG_2019_Human,Long-term depression,1/60,0.002999951725986,0.009634038686065,0,0,19940.0,115834.63209072244,PLCB4
14809,KEGG_2019_Human,Cortisol synthesis and secretion,1/65,0.003249949134407,0.009634038686065,0,0,19935.0,114209.92613860144,PLCB4
14810,KEGG_2019_Human,Long-term potentiation,1/67,0.0033499481224912,0.009634038686065,0,0,19933.0,113594.38808369274,PLCB4
14811,KEGG_2019_Human,Renin secretion,1/69,0.003449947123837,0.009634038686065,0,0,19931.0,112996.7391397682,PLCB4
14812,KEGG_2019_Human,Inositol phosphate metabolism,1/74,0.0036999446830449,0.009634038686065,0,0,19926.0,111574.38983110404,PLCB4
14813,KEGG_2019_Human,Thyroid hormone synthesis,1/74,0.0036999446830449,0.009634038686065,0,0,19926.0,111574.38983110404,PLCB4
14814,KEGG_2019_Human,Gastric acid secretion,1/75,0.0037499442041125,0.009634038686065,0,0,19925.0,111301.33528642564,PLCB4
14815,KEGG_2019_Human,Insulin secretion,1/86,0.0042999391173866,0.009634038686065,0,0,19914.0,108514.46102290176,PLCB4
14816,KEGG_2019_Human,Gap junction,1/88,0.0043999382262822,0.009634038686065,0,0,19912.0,108045.79305232369,PLCB4
14817,KEGG_2019_Human,Salivary secretion,1/90,0.0044999373439762,0.009634038686065,0,0,19910.0,107587.50385474482,PLCB4
14818,KEGG_2019_Human,GnRH signaling pathway,1/93,0.0046499360391879,0.009634038686065,0,0,19907.0,106918.54242106884,PLCB4
14819,KEGG_2019_Human,Amoebiasis,1/96,0.0047999347538706,0.009634038686065,0,0,19904.0,106270.50039849174,PLCB4
14820,KEGG_2019_Human,Circadian entrainment,1/97,0.0048499343304706,0.009634038686065,0,0,19903.0,106058.9096435903,PLCB4
14821,KEGG_2019_Human,Aldosterone synthesis and secretion,1/98,0.0048999339081079,0.009634038686065,0,0,19902.0,105849.45495286948,PLCB4
14822,KEGG_2019_Human,Pancreatic secretion,1/98,0.0048999339081079,0.009634038686065,0,0,19902.0,105849.45495286948,PLCB4
14823,KEGG_2019_Human,Phosphatidylinositol signaling system,1/99,0.0049499334884068,0.009634038686065,0,0,19901.0,105642.09305076736,PLCB4
14824,KEGG_2019_Human,AGE-RAGE signaling pathway in diabetic complications,1/100,0.0049999330710556,0.009634038686065,0,0,19900.0,105436.78197328727,PLCB4
14825,KEGG_2019_Human,Inflammatory mediator regulation of TRP channels,1/100,0.0049999330710556,0.009634038686065,0,0,19900.0,105436.78197328727,PLCB4
14826,KEGG_2019_Human,Melanogenesis,1/101,0.0050499326546803,0.009634038686065,0,0,19899.0,105233.48101229242,PLCB4
14827,KEGG_2019_Human,Chagas disease (American trypanosomiasis),1/103,0.0051499318302617,0.009634038686065,0,0,19897.0,104832.7525292024,PLCB4
14828,KEGG_2019_Human,Glucagon signaling pathway,1/103,0.0051499318302617,0.009634038686065,0,0,19897.0,104832.7525292024,PLCB4
14829,KEGG_2019_Human,"Parathyroid hormone synthesis, secretion and action",1/106,0.0052999306076525,0.009634038686065,0,0,19894.0,104245.78450366124,PLCB4
14830,KEGG_2019_Human,Cholinergic synapse,1/112,0.0055999282120529,0.009634038686065,0,0,19888.0,103119.30984392198,PLCB4
14831,KEGG_2019_Human,Serotonergic synapse,1/113,0.0056499278191151,0.009634038686065,0,0,19887.0,102937.34947211576,PLCB4
14832,KEGG_2019_Human,Glutamatergic synapse,1/114,0.005699927427839,0.009634038686065,0,0,19886.0,102756.96431429044,PLCB4
14833,KEGG_2019_Human,Thyroid hormone signaling pathway,1/116,0.0057999266512085,0.009634038686065,0,0,19884.0,102400.8105961506,PLCB4
14834,KEGG_2019_Human,Sphingolipid signaling pathway,1/119,0.0059499254985137,0.009634038686065,0,0,19881.0,101877.73080211312,PLCB4
14835,KEGG_2019_Human,Platelet activation,1/124,0.0061999236097501,0.009634038686065,0,0,19876.0,101034.04709010696,PLCB4
14836,KEGG_2019_Human,Relaxin signaling pathway,1/130,0.0064999213952527,0.009634038686065,0,0,19870.0,100064.62842845908,PLCB4
14837,KEGG_2019_Human,Dopaminergic synapse,1/131,0.0065499210316603,0.009634038686065,0,0,19869.0,99907.33811343512,PLCB4
14838,KEGG_2019_Human,Vascular smooth muscle contraction,1/132,0.0065999206698993,0.009634038686065,0,0,19868.0,99751.22090491928,PLCB4
14839,KEGG_2019_Human,Apelin signaling pathway,1/137,0.0068499188797651,0.009634038686065,0,0,19863.0,98987.62735269018,PLCB4
14840,KEGG_2019_Human,Estrogen signaling pathway,1/137,0.0068499188797651,0.009634038686065,0,0,19863.0,98987.62735269018,PLCB4
14841,KEGG_2019_Human,Adrenergic signaling in cardiomyocytes,1/145,0.0072499160871101,0.009634038686065,0,0,19855.0,97820.92670675044,PLCB4
14842,KEGG_2019_Human,Phospholipase D signaling pathway,1/148,0.007399915061391,0.009634038686065,0,0,19852.0,97399.60470052566,PLCB4
14843,KEGG_2019_Human,Retrograde endocannabinoid signaling,1/148,0.007399915061391,0.009634038686065,0,0,19852.0,97399.60470052566,PLCB4
14844,KEGG_2019_Human,Oxytocin signaling pathway,1/153,0.0076499133771537,0.009634038686065,0,0,19847.0,96715.6407630817,PLCB4
14845,KEGG_2019_Human,Cushing syndrome,1/155,0.0077499127120574,0.009634038686065,0,0,19845.0,96448.16254952336,PLCB4
14846,KEGG_2019_Human,Wnt signaling pathway,1/158,0.0078999117225733,0.009634038686065,0,0,19842.0,96053.2110949472,PLCB4
14847,KEGG_2019_Human,cGMP-PKG signaling pathway,1/166,0.0082999091363732,0.0098808442099681,0,0,19834.0,95034.82345515196,PLCB4
14848,KEGG_2019_Human,Alzheimer disease,1/171,0.0085499075557634,0.0099417529718179,0,0,19829.0,94422.42241345016,PLCB4
14849,KEGG_2019_Human,NOD-like receptor signaling pathway,1/178,0.0088999053857096,0.0101135288473973,0,0,19822.0,93593.82745769851,PLCB4
14850,KEGG_2019_Human,Calcium signaling pathway,1/188,0.009399902370135,0.0102658520183613,0,0,19812.0,92463.712994847,PLCB4
14851,KEGG_2019_Human,Chemokine signaling pathway,1/190,0.0094999017791995,0.0102658520183613,0,0,19810.0,92244.74636351672,PLCB4
14852,KEGG_2019_Human,Huntington disease,1/193,0.0096499008972596,0.0102658520183613,0,0,19807.0,91920.47679471428,PLCB4
14853,KEGG_2019_Human,Rap1 signaling pathway,1/206,0.010299897173561,0.0107290595557927,0,0,19794.0,90569.849337325,PLCB4
14854,KEGG_2019_Human,Human cytomegalovirus infection,1/225,0.0112498919790339,0.011479481611259,0,0,19775.0,88738.27077557483,PLCB4
14855,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,PLCB4
14856,KEGG_2019_Human,Adherens junction,1/72,0.0035999456502131,0.0071998913004262,0,0,19928.0,112131.59838572376,FARP2
14857,KEGG_2019_Human,Rap1 signaling pathway,1/206,0.010299897173561,0.010299897173561,0,0,19794.0,90569.849337325,FARP2
14858,KEGG_2019_Human,ABC transporters,1/45,0.0022499601197094,0.0035999456502131,0,0,19955.0,121662.49782449217,ABCC2
14859,KEGG_2019_Human,Bile secretion,1/72,0.0035999456502131,0.0035999456502131,0,0,19928.0,112131.59838572376,ABCC2
14860,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR6T1
14861,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR56A5
14862,KEGG_2019_Human,Pentose phosphate pathway,1/30,0.0014999697593334,0.0029999395186669,0,0,19970.0,129851.13732048514,PRPS1L1
14863,KEGG_2019_Human,Purine metabolism,1/129,0.006449921761047,0.006449921761047,0,0,19871.0,100223.109907462,PRPS1L1
14864,KEGG_2019_Human,MicroRNAs in cancer,1/299,0.0149498740670514,0.0149498740670514,0,0,19701.0,82804.33538735632,MIR133A2
14865,KEGG_2019_Human,MicroRNAs in cancer,1/299,0.0149498740670514,0.0149498740670514,0,0,19701.0,82804.33538735632,MIR9-2
14866,KEGG_2019_Human,Adherens junction,1/72,0.0035999456502131,0.0071998913004262,0,0,19928.0,112131.59838572376,BAIAP2
14867,KEGG_2019_Human,Regulation of actin cytoskeleton,1/214,0.0106998949514067,0.0106998949514067,0,0,19786.0,89779.39753374986,BAIAP2
14868,KEGG_2019_Human,Pentose phosphate pathway,1/30,0.0014999697593334,0.0031999444757317,0,0,19970.0,129851.13732048514,GPI
14869,KEGG_2019_Human,Starch and sucrose metabolism,1/36,0.0017999657178272,0.0031999444757317,0,0,19964.0,126172.23364250171,GPI
14870,KEGG_2019_Human,Amino sugar and nucleotide sugar metabolism,1/48,0.0023999583567988,0.0031999444757317,0,0,19952.0,120356.5272753826,GPI
14871,KEGG_2019_Human,Glycolysis / Gluconeogenesis,1/68,0.0033999476216189,0.0033999476216189,0,0,19932.0,113293.39338050144,GPI
14872,KEGG_2019_Human,Oxidative phosphorylation,1/133,0.0066499203093911,0.0112582177134695,0,0,19867.0,99596.2591544721,NDUFA7
14873,KEGG_2019_Human,Parkinson disease,1/142,0.0070999171242726,0.0112582177134695,0,0,19858.0,98250.87390500787,NDUFA7
14874,KEGG_2019_Human,Retrograde endocannabinoid signaling,1/148,0.007399915061391,0.0112582177134695,0,0,19852.0,97399.60470052566,NDUFA7
14875,KEGG_2019_Human,Non-alcoholic fatty liver disease (NAFLD),1/149,0.0074499147221605,0.0112582177134695,0,0,19851.0,97261.02051561224,NDUFA7
14876,KEGG_2019_Human,Alzheimer disease,1/171,0.0085499075557634,0.0112582177134695,0,0,19829.0,94422.42241345016,NDUFA7
14877,KEGG_2019_Human,Huntington disease,1/193,0.0096499008972596,0.0112582177134695,0,0,19807.0,91920.47679471428,NDUFA7
14878,KEGG_2019_Human,Thermogenesis,1/231,0.0115498903940656,0.0115498903940656,0,0,19769.0,88191.07730937863,NDUFA7
14879,KEGG_2019_Human,Endocytosis,1/244,0.0121998870519305,0.0121998870519305,0,0,19756.0,87051.4275316661,ARFGAP3
14880,KEGG_2019_Human,Glutathione metabolism,1/56,0.0027999538675741,0.0086398876818799,0,0,19944.0,117233.87022514464,GSTP1
14881,KEGG_2019_Human,Metabolism of xenobiotics by cytochrome P450,1/74,0.0036999446830449,0.0086398876818799,0,0,19926.0,111574.38983110404,GSTP1
14882,KEGG_2019_Human,Chemical carcinogenesis,1/82,0.004099940929819,0.0086398876818799,0,0,19918.0,109484.9180722932,GSTP1
14883,KEGG_2019_Human,Prostate cancer,1/97,0.0048499343304706,0.0086398876818799,0,0,19903.0,106058.9096435903,GSTP1
14884,KEGG_2019_Human,Drug metabolism,1/108,0.0053999298011749,0.0086398876818799,0,0,19892.0,103863.47861844616,GSTP1
14885,KEGG_2019_Human,Fluid shear stress and atherosclerosis,1/139,0.006949918172816,0.0092665575637547,0,0,19861.0,98689.81333375497,GSTP1
14886,KEGG_2019_Human,Hepatocellular carcinoma,1/168,0.0083999085011095,0.0095998954298394,0,0,19832.0,94787.72752807094,GSTP1
14887,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,GSTP1
14888,KEGG_2019_Human,Oxidative phosphorylation,1/133,0.0066499203093911,0.0112582177134695,0,0,19867.0,99596.2591544721,NDUFA11
14889,KEGG_2019_Human,Parkinson disease,1/142,0.0070999171242726,0.0112582177134695,0,0,19858.0,98250.87390500787,NDUFA11
14890,KEGG_2019_Human,Retrograde endocannabinoid signaling,1/148,0.007399915061391,0.0112582177134695,0,0,19852.0,97399.60470052566,NDUFA11
14891,KEGG_2019_Human,Non-alcoholic fatty liver disease (NAFLD),1/149,0.0074499147221605,0.0112582177134695,0,0,19851.0,97261.02051561224,NDUFA11
14892,KEGG_2019_Human,Alzheimer disease,1/171,0.0085499075557634,0.0112582177134695,0,0,19829.0,94422.42241345016,NDUFA11
14893,KEGG_2019_Human,Huntington disease,1/193,0.0096499008972596,0.0112582177134695,0,0,19807.0,91920.47679471428,NDUFA11
14894,KEGG_2019_Human,Thermogenesis,1/231,0.0115498903940656,0.0115498903940656,0,0,19769.0,88191.07730937863,NDUFA11
14895,KEGG_2019_Human,Glycolysis / Gluconeogenesis,1/68,0.0033999476216189,0.0033999476216189,0,0,19932.0,113293.39338050144,ADPGK
14896,KEGG_2019_Human,Basal transcription factors,1/45,0.0022499601197094,0.0022499601197094,0,0,19955.0,121662.49782449217,TAF9
14897,KEGG_2019_Human,RNA degradation,1/79,0.0039499423167337,0.0039499423167337,0,0,19921.0,110243.89578070649,PARN
14898,KEGG_2019_Human,Protein export,1/23,0.0011499748819949,0.0022999497639899,0,0,19977.0,135204.63922267244,SEC62
14899,KEGG_2019_Human,Protein processing in endoplasmic reticulum,1/165,0.0082499094553477,0.0082499094553477,0,0,19835.0,95159.46482222488,SEC62
14900,KEGG_2019_Human,Transcriptional misregulation in cancer,1/186,0.0092999029651357,0.0092999029651357,0,0,19814.0,92684.96451050608,CCNT2
14901,KEGG_2019_Human,Hippo signaling pathway,1/160,0.0079999110688441,0.0079999110688441,0,0,19840.0,95793.96509856998,FRMD6
14902,KEGG_2019_Human,B cell receptor signaling pathway,1/71,0.0035499461386618,0.0086332042604383,0,0,19929.0,112415.9585341616,PTPN6
14903,KEGG_2019_Human,Adherens junction,1/72,0.0035999456502131,0.0086332042604383,0,0,19928.0,112131.59838572376,PTPN6
14904,KEGG_2019_Human,Leishmaniasis,1/74,0.0036999446830449,0.0086332042604383,0,0,19926.0,111574.38983110404,PTPN6
14905,KEGG_2019_Human,T cell receptor signaling pathway,1/101,0.0050499326546803,0.0088373821456906,0,0,19899.0,105233.48101229242,PTPN6
14906,KEGG_2019_Human,Natural killer cell mediated cytotoxicity,1/131,0.0065499210316603,0.0091698894443244,0,0,19869.0,99907.33811343512,PTPN6
14907,KEGG_2019_Human,JAK-STAT signaling pathway,1/162,0.0080999104202618,0.0094498954903054,0,0,19838.0,95537.86936302872,PTPN6
14908,KEGG_2019_Human,Proteoglycans in cancer,1/201,0.0100498985877989,0.0100498985877989,0,0,19799.0,91079.21596609056,PTPN6
14909,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,CHRNB1
14910,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF136
14911,KEGG_2019_Human,Sphingolipid metabolism,1/47,0.0023499589392381,0.0046999178784763,0,0,19953.0,120782.64067395544,CERS6
14912,KEGG_2019_Human,Sphingolipid signaling pathway,1/119,0.0059499254985137,0.0059499254985137,0,0,19881.0,101877.73080211312,CERS6
14913,KEGG_2019_Human,Collecting duct acid secretion,1/27,0.0013499718942362,0.0090998738144064,0,0,19973.0,131975.02298599784,ATP6V0C
14914,KEGG_2019_Human,Vibrio cholerae infection,1/50,0.0024999572069037,0.0090998738144064,0,0,19950.0,119530.05920663515,ATP6V0C
14915,KEGG_2019_Human,Epithelial cell signaling in Helicobacter pylori infection,1/68,0.0033999476216189,0.0090998738144064,0,0,19932.0,113293.39338050144,ATP6V0C
14916,KEGG_2019_Human,Synaptic vesicle cycle,1/78,0.0038999427840466,0.0090998738144064,0,0,19922.0,110503.2180492851,ATP6V0C
14917,KEGG_2019_Human,Rheumatoid arthritis,1/91,0.0045499369072032,0.0090998738144064,0,0,19909.0,107362.10783923086,ATP6V0C
14918,KEGG_2019_Human,Lysosome,1/123,0.0061499239842961,0.009499886156273,0,0,19877.0,101200.07933676826,ATP6V0C
14919,KEGG_2019_Human,Oxidative phosphorylation,1/133,0.0066499203093911,0.009499886156273,0,0,19867.0,99596.2591544721,ATP6V0C
14920,KEGG_2019_Human,Phagosome,1/152,0.0075999137114971,0.0094998921393714,0,0,19848.0,96850.665715497,ATP6V0C
14921,KEGG_2019_Human,Tuberculosis,1/179,0.0089499050800561,0.0099443389778401,0,0,19821.0,93478.0629355712,ATP6V0C
14922,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0164998674589645,0,0,19670.0,80733.60565076157,ATP6V0C
14923,KEGG_2019_Human,Aldosterone-regulated sodium reabsorption,1/37,0.0018499650702878,0.0105540458563941,0,0,19963.0,125618.9446446357,PIK3CD
14924,KEGG_2019_Human,Carbohydrate digestion and absorption,1/44,0.0021999607179423,0.0105540458563941,0,0,19956.0,122117.06559109331,PIK3CD
14925,KEGG_2019_Human,Type II diabetes mellitus,1/46,0.0022999595269283,0.0105540458563941,0,0,19954.0,121217.8313311442,PIK3CD
14926,KEGG_2019_Human,Regulation of lipolysis in adipocytes,1/55,0.0027499544131125,0.0105540458563941,0,0,19945.0,117599.1294878737,PIK3CD
14927,KEGG_2019_Human,Endometrial cancer,1/58,0.0028999527887707,0.0105540458563941,0,0,19942.0,116522.31890946148,PIK3CD
14928,KEGG_2019_Human,VEGF signaling pathway,1/59,0.0029499522555206,0.0105540458563941,0,0,19941.0,116175.59385530632,PIK3CD
14929,KEGG_2019_Human,Central carbon metabolism in cancer,1/65,0.003249949134407,0.0105540458563941,0,0,19935.0,114209.92613860144,PIK3CD
14930,KEGG_2019_Human,Acute myeloid leukemia,1/66,0.003299948626608,0.0105540458563941,0,0,19934.0,113899.85357353876,PIK3CD
14931,KEGG_2019_Human,Non-small cell lung cancer,1/66,0.003299948626608,0.0105540458563941,0,0,19934.0,113899.85357353876,PIK3CD
14932,KEGG_2019_Human,Fc epsilon RI signaling pathway,1/68,0.0033999476216189,0.0105540458563941,0,0,19932.0,113293.39338050144,PIK3CD
14933,KEGG_2019_Human,Renal cell carcinoma,1/69,0.003449947123837,0.0105540458563941,0,0,19931.0,112996.7391397682,PIK3CD
14934,KEGG_2019_Human,Prolactin signaling pathway,1/70,0.0034999466296654,0.0105540458563941,0,0,19930.0,112704.30065625212,PIK3CD
14935,KEGG_2019_Human,B cell receptor signaling pathway,1/71,0.0035499461386618,0.0105540458563941,0,0,19929.0,112415.9585341616,PIK3CD
14936,KEGG_2019_Human,Melanoma,1/72,0.0035999456502131,0.0105540458563941,0,0,19928.0,112131.59838572376,PIK3CD
14937,KEGG_2019_Human,Inositol phosphate metabolism,1/74,0.0036999446830449,0.0105540458563941,0,0,19926.0,111574.38983110404,PIK3CD
14938,KEGG_2019_Human,Bacterial invasion of epithelial cells,1/74,0.0036999446830449,0.0105540458563941,0,0,19926.0,111574.38983110404,PIK3CD
14939,KEGG_2019_Human,Pancreatic cancer,1/75,0.0037499442041125,0.0105540458563941,0,0,19925.0,111301.33528642564,PIK3CD
14940,KEGG_2019_Human,Glioma,1/75,0.0037499442041125,0.0105540458563941,0,0,19925.0,111301.33528642564,PIK3CD
14941,KEGG_2019_Human,Chronic myeloid leukemia,1/76,0.0037999437281752,0.0105540458563941,0,0,19924.0,111031.8499691117,PIK3CD
14942,KEGG_2019_Human,ErbB signaling pathway,1/85,0.004249939567045,0.0105540458563941,0,0,19915.0,108752.83801948265,PIK3CD
14943,KEGG_2019_Human,Colorectal cancer,1/86,0.0042999391173866,0.0105540458563941,0,0,19914.0,108514.46102290176,PIK3CD
14944,KEGG_2019_Human,Fc gamma R-mediated phagocytosis,1/91,0.0045499369072032,0.0105540458563941,0,0,19909.0,107362.10783923086,PIK3CD
14945,KEGG_2019_Human,Small cell lung cancer,1/93,0.0046499360391879,0.0105540458563941,0,0,19907.0,106918.54242106884,PIK3CD
14946,KEGG_2019_Human,Amoebiasis,1/96,0.0047999347538706,0.0105540458563941,0,0,19904.0,106270.50039849174,PIK3CD
14947,KEGG_2019_Human,Prostate cancer,1/97,0.0048499343304706,0.0105540458563941,0,0,19903.0,106058.9096435903,PIK3CD
14948,KEGG_2019_Human,Choline metabolism in cancer,1/99,0.0049499334884068,0.0105540458563941,0,0,19901.0,105642.09305076736,PIK3CD
14949,KEGG_2019_Human,Phosphatidylinositol signaling system,1/99,0.0049499334884068,0.0105540458563941,0,0,19901.0,105642.09305076736,PIK3CD
14950,KEGG_2019_Human,Progesterone-mediated oocyte maturation,1/99,0.0049499334884068,0.0105540458563941,0,0,19901.0,105642.09305076736,PIK3CD
14951,KEGG_2019_Human,AGE-RAGE signaling pathway in diabetic complications,1/100,0.0049999330710556,0.0105540458563941,0,0,19900.0,105436.78197328727,PIK3CD
14952,KEGG_2019_Human,Inflammatory mediator regulation of TRP channels,1/100,0.0049999330710556,0.0105540458563941,0,0,19900.0,105436.78197328727,PIK3CD
14953,KEGG_2019_Human,HIF-1 signaling pathway,1/100,0.0049999330710556,0.0105540458563941,0,0,19900.0,105436.78197328727,PIK3CD
14954,KEGG_2019_Human,T cell receptor signaling pathway,1/101,0.0050499326546803,0.0105540458563941,0,0,19899.0,105233.48101229242,PIK3CD
14955,KEGG_2019_Human,Longevity regulating pathway,1/102,0.0050999322416682,0.0105540458563941,0,0,19898.0,105032.15064717118,PIK3CD
14956,KEGG_2019_Human,Chagas disease (American trypanosomiasis),1/103,0.0051499318302617,0.0105540458563941,0,0,19897.0,104832.7525292024,PIK3CD
14957,KEGG_2019_Human,Toll-like receptor signaling pathway,1/104,0.0051999314202997,0.0105540458563941,0,0,19896.0,104635.24941415618,PIK3CD
14958,KEGG_2019_Human,C-type lectin receptor signaling pathway,1/104,0.0051999314202997,0.0105540458563941,0,0,19896.0,104635.24941415618,PIK3CD
14959,KEGG_2019_Human,Insulin resistance,1/108,0.0053999298011749,0.0105540458563941,0,0,19892.0,103863.47861844616,PIK3CD
14960,KEGG_2019_Human,TNF signaling pathway,1/110,0.0054999290027479,0.0105540458563941,0,0,19890.0,103488.06969787036,PIK3CD
14961,KEGG_2019_Human,Leukocyte transendothelial migration,1/112,0.0055999282120529,0.0105540458563941,0,0,19888.0,103119.30984392198,PIK3CD
14962,KEGG_2019_Human,Cholinergic synapse,1/112,0.0055999282120529,0.0105540458563941,0,0,19888.0,103119.30984392198,PIK3CD
14963,KEGG_2019_Human,Thyroid hormone signaling pathway,1/116,0.0057999266512085,0.0105540458563941,0,0,19884.0,102400.8105961506,PIK3CD
14964,KEGG_2019_Human,Sphingolipid signaling pathway,1/119,0.0059499254985137,0.0105540458563941,0,0,19881.0,101877.73080211312,PIK3CD
14965,KEGG_2019_Human,Neurotrophin signaling pathway,1/119,0.0059499254985137,0.0105540458563941,0,0,19881.0,101877.73080211312,PIK3CD
14966,KEGG_2019_Human,AMPK signaling pathway,1/120,0.0059999251180858,0.0105540458563941,0,0,19880.0,101706.2448082016,PIK3CD
14967,KEGG_2019_Human,Platelet activation,1/124,0.0061999236097501,0.0105540458563941,0,0,19876.0,101034.04709010696,PIK3CD
14968,KEGG_2019_Human,Osteoclast differentiation,1/127,0.0063499224962247,0.0105540458563941,0,0,19873.0,100543.72072014232,PIK3CD
14969,KEGG_2019_Human,Autophagy,1/128,0.0063999221281459,0.0105540458563941,0,0,19872.0,100382.8010329652,PIK3CD
14970,KEGG_2019_Human,Relaxin signaling pathway,1/130,0.0064999213952527,0.0105540458563941,0,0,19870.0,100064.62842845908,PIK3CD
14971,KEGG_2019_Human,Natural killer cell mediated cytotoxicity,1/131,0.0065499210316603,0.0105540458563941,0,0,19869.0,99907.33811343512,PIK3CD
14972,KEGG_2019_Human,FoxO signaling pathway,1/132,0.0065999206698993,0.0105540458563941,0,0,19868.0,99751.22090491928,PIK3CD
14973,KEGG_2019_Human,Insulin signaling pathway,1/137,0.0068499188797651,0.0105540458563941,0,0,19863.0,98987.62735269018,PIK3CD
14974,KEGG_2019_Human,Estrogen signaling pathway,1/137,0.0068499188797651,0.0105540458563941,0,0,19863.0,98987.62735269018,PIK3CD
14975,KEGG_2019_Human,Measles,1/138,0.0068999185254481,0.0105540458563941,0,0,19862.0,98838.19160389496,PIK3CD
14976,KEGG_2019_Human,Fluid shear stress and atherosclerosis,1/139,0.006949918172816,0.0105540458563941,0,0,19861.0,98689.81333375497,PIK3CD
14977,KEGG_2019_Human,Signaling pathways regulating pluripotency of stem cells,1/139,0.006949918172816,0.0105540458563941,0,0,19861.0,98689.81333375497,PIK3CD
14978,KEGG_2019_Human,Apoptosis,1/143,0.0071499167770442,0.0105540458563941,0,0,19857.0,98106.57763600958,PIK3CD
14979,KEGG_2019_Human,Breast cancer,1/147,0.0073499154017982,0.0105540458563941,0,0,19853.0,97539.10874372096,PIK3CD
14980,KEGG_2019_Human,Phospholipase D signaling pathway,1/148,0.007399915061391,0.0105540458563941,0,0,19852.0,97399.60470052566,PIK3CD
14981,KEGG_2019_Human,Non-alcoholic fatty liver disease (NAFLD),1/149,0.0074499147221605,0.0105540458563941,0,0,19851.0,97261.02051561224,PIK3CD
14982,KEGG_2019_Human,Gastric cancer,1/149,0.0074499147221605,0.0105540458563941,0,0,19851.0,97261.02051561224,PIK3CD
14983,KEGG_2019_Human,mTOR signaling pathway,1/152,0.0075999137114971,0.0105900436963484,0,0,19848.0,96850.665715497,PIK3CD
14984,KEGG_2019_Human,Hepatitis C,1/155,0.0077499127120574,0.0106248803310465,0,0,19845.0,96448.16254952336,PIK3CD
14985,KEGG_2019_Human,Cellular senescence,1/160,0.0079999110688441,0.0106575747433643,0,0,19840.0,95793.96509856998,PIK3CD
14986,KEGG_2019_Human,JAK-STAT signaling pathway,1/162,0.0080999104202618,0.0106575747433643,0,0,19838.0,95537.86936302872,PIK3CD
14987,KEGG_2019_Human,Hepatitis B,1/163,0.0081499100978668,0.0106575747433643,0,0,19837.0,95410.9786681514,PIK3CD
14988,KEGG_2019_Human,Hepatocellular carcinoma,1/168,0.0083999085011095,0.0108180639787016,0,0,19832.0,94787.72752807094,PIK3CD
14989,KEGG_2019_Human,Influenza A,1/171,0.0085499075557634,0.0108468976453715,0,0,19829.0,94422.42241345016,PIK3CD
14990,KEGG_2019_Human,Axon guidance,1/181,0.0090499044707863,0.0113123805884829,0,0,19819.0,93248.41634586031,PIK3CD
14991,KEGG_2019_Human,Kaposi sarcoma-associated herpesvirus infection,1/186,0.0092999029651357,0.0114564022034281,0,0,19814.0,92684.96451050608,PIK3CD
14992,KEGG_2019_Human,Chemokine signaling pathway,1/190,0.0094999017791995,0.0115355950175994,0,0,19810.0,92244.74636351672,PIK3CD
14993,KEGG_2019_Human,Focal adhesion,1/199,0.0099498991610159,0.0115438024319312,0,0,19801.0,91286.4288690606,PIK3CD
14994,KEGG_2019_Human,Viral carcinogenesis,1/201,0.0100498985877989,0.0115438024319312,0,0,19799.0,91079.21596609056,PIK3CD
14995,KEGG_2019_Human,Epstein-Barr virus infection,1/201,0.0100498985877989,0.0115438024319312,0,0,19799.0,91079.21596609056,PIK3CD
14996,KEGG_2019_Human,Proteoglycans in cancer,1/201,0.0100498985877989,0.0115438024319312,0,0,19799.0,91079.21596609056,PIK3CD
14997,KEGG_2019_Human,Rap1 signaling pathway,1/206,0.010299897173561,0.0116601419342253,0,0,19794.0,90569.849337325,PIK3CD
14998,KEGG_2019_Human,Human immunodeficiency virus 1 infection,1/212,0.0105998955026255,0.0116601419342253,0,0,19788.0,89974.27756224656,PIK3CD
14999,KEGG_2019_Human,cAMP signaling pathway,1/212,0.0105998955026255,0.0116601419342253,0,0,19788.0,89974.27756224656,PIK3CD
15000,KEGG_2019_Human,Regulation of actin cytoskeleton,1/214,0.0106998949514067,0.0116601419342253,0,0,19786.0,89779.39753374986,PIK3CD
15001,KEGG_2019_Human,Human T-cell leukemia virus 1 infection,1/219,0.0109498935894162,0.01178153107722,0,0,19781.0,89299.85161916987,PIK3CD
15002,KEGG_2019_Human,Human cytomegalovirus infection,1/225,0.0112498919790339,0.0119530102277235,0,0,19775.0,88738.27077557483,PIK3CD
15003,KEGG_2019_Human,Ras signaling pathway,1/232,0.0115998901349604,0.0121727242156991,0,0,19768.0,88101.22480150245,PIK3CD
15004,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0171035211464876,0,0,19670.0,80733.60565076157,PIK3CD
15005,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0181263653556166,0,0,19646.0,79255.8617626126,PIK3CD
15006,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0248926942055726,0,0,19508.0,72277.44006442746,PIK3CD
15007,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,PIK3CD
15008,KEGG_2019_Human,Fatty acid elongation,1/27,0.0013499718942362,0.0026999437884725,0,0,19973.0,131975.02298599784,PPT2
15009,KEGG_2019_Human,Lysosome,1/123,0.0061499239842961,0.0061499239842961,0,0,19877.0,101200.07933676826,PPT2
15010,KEGG_2019_Human,RIG-I-like receptor signaling pathway,1/70,0.0034999466296654,0.0100498985877989,0,0,19930.0,112704.30065625212,DDX3X
15011,KEGG_2019_Human,Hepatitis B,1/163,0.0081499100978668,0.0100498985877989,0,0,19837.0,95410.9786681514,DDX3X
15012,KEGG_2019_Human,Viral carcinogenesis,1/201,0.0100498985877989,0.0100498985877989,0,0,19799.0,91079.21596609056,DDX3X
15013,KEGG_2019_Human,Glycerophospholipid metabolism,1/97,0.0048499343304706,0.0049499334884068,0,0,19903.0,106058.9096435903,CDS2
15014,KEGG_2019_Human,Phosphatidylinositol signaling system,1/99,0.0049499334884068,0.0049499334884068,0,0,19901.0,105642.09305076736,CDS2
15015,KEGG_2019_Human,Bladder cancer,1/41,0.0020499625466866,0.0113998767410179,0,0,19959.0,123544.88783416104,RAF1
15016,KEGG_2019_Human,Endometrial cancer,1/58,0.0028999527887707,0.0113998767410179,0,0,19942.0,116522.31890946148,RAF1
15017,KEGG_2019_Human,VEGF signaling pathway,1/59,0.0029499522555206,0.0113998767410179,0,0,19941.0,116175.59385530632,RAF1
15018,KEGG_2019_Human,Long-term depression,1/60,0.002999951725986,0.0113998767410179,0,0,19940.0,115834.63209072244,RAF1
15019,KEGG_2019_Human,Central carbon metabolism in cancer,1/65,0.003249949134407,0.0113998767410179,0,0,19935.0,114209.92613860144,RAF1
15020,KEGG_2019_Human,Acute myeloid leukemia,1/66,0.003299948626608,0.0113998767410179,0,0,19934.0,113899.85357353876,RAF1
15021,KEGG_2019_Human,Non-small cell lung cancer,1/66,0.003299948626608,0.0113998767410179,0,0,19934.0,113899.85357353876,RAF1
15022,KEGG_2019_Human,Long-term potentiation,1/67,0.0033499481224912,0.0113998767410179,0,0,19933.0,113594.38808369274,RAF1
15023,KEGG_2019_Human,Fc epsilon RI signaling pathway,1/68,0.0033999476216189,0.0113998767410179,0,0,19932.0,113293.39338050144,RAF1
15024,KEGG_2019_Human,Renal cell carcinoma,1/69,0.003449947123837,0.0113998767410179,0,0,19931.0,112996.7391397682,RAF1
15025,KEGG_2019_Human,Prolactin signaling pathway,1/70,0.0034999466296654,0.0113998767410179,0,0,19930.0,112704.30065625212,RAF1
15026,KEGG_2019_Human,B cell receptor signaling pathway,1/71,0.0035499461386618,0.0113998767410179,0,0,19929.0,112415.9585341616,RAF1
15027,KEGG_2019_Human,Melanoma,1/72,0.0035999456502131,0.0113998767410179,0,0,19928.0,112131.59838572376,RAF1
15028,KEGG_2019_Human,Pancreatic cancer,1/75,0.0037499442041125,0.0113998767410179,0,0,19925.0,111301.33528642564,RAF1
15029,KEGG_2019_Human,Glioma,1/75,0.0037499442041125,0.0113998767410179,0,0,19925.0,111301.33528642564,RAF1
15030,KEGG_2019_Human,Chronic myeloid leukemia,1/76,0.0037999437281752,0.0113998767410179,0,0,19924.0,111031.8499691117,RAF1
15031,KEGG_2019_Human,ErbB signaling pathway,1/85,0.004249939567045,0.0113998767410179,0,0,19915.0,108752.83801948265,RAF1
15032,KEGG_2019_Human,Colorectal cancer,1/86,0.0042999391173866,0.0113998767410179,0,0,19914.0,108514.46102290176,RAF1
15033,KEGG_2019_Human,Gap junction,1/88,0.0043999382262822,0.0113998767410179,0,0,19912.0,108045.79305232369,RAF1
15034,KEGG_2019_Human,Fc gamma R-mediated phagocytosis,1/91,0.0045499369072032,0.0113998767410179,0,0,19909.0,107362.10783923086,RAF1
15035,KEGG_2019_Human,GnRH signaling pathway,1/93,0.0046499360391879,0.0113998767410179,0,0,19907.0,106918.54242106884,RAF1
15036,KEGG_2019_Human,Prostate cancer,1/97,0.0048499343304706,0.0113998767410179,0,0,19903.0,106058.9096435903,RAF1
15037,KEGG_2019_Human,Choline metabolism in cancer,1/99,0.0049499334884068,0.0113998767410179,0,0,19901.0,105642.09305076736,RAF1
15038,KEGG_2019_Human,Progesterone-mediated oocyte maturation,1/99,0.0049499334884068,0.0113998767410179,0,0,19901.0,105642.09305076736,RAF1
15039,KEGG_2019_Human,T cell receptor signaling pathway,1/101,0.0050499326546803,0.0113998767410179,0,0,19899.0,105233.48101229242,RAF1
15040,KEGG_2019_Human,Melanogenesis,1/101,0.0050499326546803,0.0113998767410179,0,0,19899.0,105233.48101229242,RAF1
15041,KEGG_2019_Human,C-type lectin receptor signaling pathway,1/104,0.0051999314202997,0.0113998767410179,0,0,19896.0,104635.24941415618,RAF1
15042,KEGG_2019_Human,"Parathyroid hormone synthesis, secretion and action",1/106,0.0052999306076525,0.0113998767410179,0,0,19894.0,104245.78450366124,RAF1
15043,KEGG_2019_Human,Serotonergic synapse,1/113,0.0056499278191151,0.0113998767410179,0,0,19887.0,102937.34947211576,RAF1
15044,KEGG_2019_Human,Thyroid hormone signaling pathway,1/116,0.0057999266512085,0.0113998767410179,0,0,19884.0,102400.8105961506,RAF1
15045,KEGG_2019_Human,Sphingolipid signaling pathway,1/119,0.0059499254985137,0.0113998767410179,0,0,19881.0,101877.73080211312,RAF1
15046,KEGG_2019_Human,Neurotrophin signaling pathway,1/119,0.0059499254985137,0.0113998767410179,0,0,19881.0,101877.73080211312,RAF1
15047,KEGG_2019_Human,Autophagy,1/128,0.0063999221281459,0.0113998767410179,0,0,19872.0,100382.8010329652,RAF1
15048,KEGG_2019_Human,Relaxin signaling pathway,1/130,0.0064999213952527,0.0113998767410179,0,0,19870.0,100064.62842845908,RAF1
15049,KEGG_2019_Human,Natural killer cell mediated cytotoxicity,1/131,0.0065499210316603,0.0113998767410179,0,0,19869.0,99907.33811343512,RAF1
15050,KEGG_2019_Human,Vascular smooth muscle contraction,1/132,0.0065999206698993,0.0113998767410179,0,0,19868.0,99751.22090491928,RAF1
15051,KEGG_2019_Human,FoxO signaling pathway,1/132,0.0065999206698993,0.0113998767410179,0,0,19868.0,99751.22090491928,RAF1
15052,KEGG_2019_Human,Insulin signaling pathway,1/137,0.0068499188797651,0.0113998767410179,0,0,19863.0,98987.62735269018,RAF1
15053,KEGG_2019_Human,Apelin signaling pathway,1/137,0.0068499188797651,0.0113998767410179,0,0,19863.0,98987.62735269018,RAF1
15054,KEGG_2019_Human,Estrogen signaling pathway,1/137,0.0068499188797651,0.0113998767410179,0,0,19863.0,98987.62735269018,RAF1
15055,KEGG_2019_Human,Signaling pathways regulating pluripotency of stem cells,1/139,0.006949918172816,0.0113998767410179,0,0,19861.0,98689.81333375497,RAF1
15056,KEGG_2019_Human,Apoptosis,1/143,0.0071499167770442,0.0113998767410179,0,0,19857.0,98106.57763600958,RAF1
15057,KEGG_2019_Human,Breast cancer,1/147,0.0073499154017982,0.0113998767410179,0,0,19853.0,97539.10874372096,RAF1
15058,KEGG_2019_Human,Phospholipase D signaling pathway,1/148,0.007399915061391,0.0113998767410179,0,0,19852.0,97399.60470052566,RAF1
15059,KEGG_2019_Human,Gastric cancer,1/149,0.0074499147221605,0.0113998767410179,0,0,19851.0,97261.02051561224,RAF1
15060,KEGG_2019_Human,mTOR signaling pathway,1/152,0.0075999137114971,0.0113998767410179,0,0,19848.0,96850.665715497,RAF1
15061,KEGG_2019_Human,Oxytocin signaling pathway,1/153,0.0076499133771537,0.0113998767410179,0,0,19847.0,96715.6407630817,RAF1
15062,KEGG_2019_Human,Hepatitis C,1/155,0.0077499127120574,0.0113998767410179,0,0,19845.0,96448.16254952336,RAF1
15063,KEGG_2019_Human,Cellular senescence,1/160,0.0079999110688441,0.0113998767410179,0,0,19840.0,95793.96509856998,RAF1
15064,KEGG_2019_Human,JAK-STAT signaling pathway,1/162,0.0080999104202618,0.0113998767410179,0,0,19838.0,95537.86936302872,RAF1
15065,KEGG_2019_Human,Hepatitis B,1/163,0.0081499100978668,0.0113998767410179,0,0,19837.0,95410.9786681514,RAF1
15066,KEGG_2019_Human,cGMP-PKG signaling pathway,1/166,0.0082999091363732,0.0113998767410179,0,0,19834.0,95034.82345515196,RAF1
15067,KEGG_2019_Human,Hepatocellular carcinoma,1/168,0.0083999085011095,0.0113998767410179,0,0,19832.0,94787.72752807094,RAF1
15068,KEGG_2019_Human,Influenza A,1/171,0.0085499075557634,0.0113998767410179,0,0,19829.0,94422.42241345016,RAF1
15069,KEGG_2019_Human,Tuberculosis,1/179,0.0089499050800561,0.011431458278888,0,0,19821.0,93478.0629355712,RAF1
15070,KEGG_2019_Human,Alcoholism,1/180,0.0089999047745351,0.011431458278888,0,0,19820.0,93362.92821536642,RAF1
15071,KEGG_2019_Human,Axon guidance,1/181,0.0090499044707863,0.011431458278888,0,0,19819.0,93248.41634586031,RAF1
15072,KEGG_2019_Human,Kaposi sarcoma-associated herpesvirus infection,1/186,0.0092999029651357,0.011544707129134,0,0,19814.0,92684.96451050608,RAF1
15073,KEGG_2019_Human,Chemokine signaling pathway,1/190,0.0094999017791995,0.0115931004763113,0,0,19810.0,92244.74636351672,RAF1
15074,KEGG_2019_Human,Focal adhesion,1/199,0.0099498991610159,0.011852191330789,0,0,19801.0,91286.4288690606,RAF1
15075,KEGG_2019_Human,Proteoglycans in cancer,1/201,0.0100498985877989,0.011852191330789,0,0,19799.0,91079.21596609056,RAF1
15076,KEGG_2019_Human,Rap1 signaling pathway,1/206,0.010299897173561,0.011852191330789,0,0,19794.0,90569.849337325,RAF1
15077,KEGG_2019_Human,Human immunodeficiency virus 1 infection,1/212,0.0105998955026255,0.011852191330789,0,0,19788.0,89974.27756224656,RAF1
15078,KEGG_2019_Human,cAMP signaling pathway,1/212,0.0105998955026255,0.011852191330789,0,0,19788.0,89974.27756224656,RAF1
15079,KEGG_2019_Human,Regulation of actin cytoskeleton,1/214,0.0106998949514067,0.011852191330789,0,0,19786.0,89779.39753374986,RAF1
15080,KEGG_2019_Human,Human cytomegalovirus infection,1/225,0.0112498919790339,0.0122726094316733,0,0,19775.0,88738.27077557483,RAF1
15081,KEGG_2019_Human,Ras signaling pathway,1/232,0.0115998901349604,0.0124655535778679,0,0,19768.0,88101.22480150245,RAF1
15082,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0155998685917058,0,0,19705.0,83086.53988020132,RAF1
15083,KEGG_2019_Human,MicroRNAs in cancer,1/299,0.0149498740670514,0.0155998685917058,0,0,19701.0,82804.33538735632,RAF1
15084,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0169712922435063,0,0,19670.0,80733.60565076157,RAF1
15085,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0179491564813861,0,0,19646.0,79255.8617626126,RAF1
15086,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,RAF1
15087,KEGG_2019_Human,Cell cycle,1/124,0.0061999236097501,0.0061999236097501,0,0,19876.0,101034.04709010696,ORC1
15088,KEGG_2019_Human,Ribosome,1/153,0.0076499133771537,0.0076499133771537,0,0,19847.0,96715.6407630817,RPL11
15089,KEGG_2019_Human,Purine metabolism,1/129,0.006449921761047,0.006449921761047,0,0,19871.0,100223.109907462,GUK1
15090,KEGG_2019_Human,Aminoacyl-tRNA biosynthesis,1/66,0.003299948626608,0.003299948626608,0,0,19934.0,113899.85357353876,LARS2
15091,KEGG_2019_Human,Insulin signaling pathway,1/137,0.0068499188797651,0.0068499188797651,0,0,19863.0,98987.62735269018,EXOC7
15092,KEGG_2019_Human,Vibrio cholerae infection,1/50,0.0024999572069037,0.0049999144138074,0,0,19950.0,119530.05920663515,ERO1A
15093,KEGG_2019_Human,Protein processing in endoplasmic reticulum,1/165,0.0082499094553477,0.0082499094553477,0,0,19835.0,95159.46482222488,ERO1A
15094,KEGG_2019_Human,Viral myocarditis,1/59,0.0029499522555206,0.0058999045110413,0,0,19941.0,116175.59385530632,EIF4G1
15095,KEGG_2019_Human,RNA transport,1/165,0.0082499094553477,0.0082499094553477,0,0,19835.0,95159.46482222488,EIF4G1
15096,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF26
15097,KEGG_2019_Human,Chronic myeloid leukemia,1/76,0.0037999437281752,0.0126816753470031,0,0,19924.0,111031.8499691117,CDKN1B
15098,KEGG_2019_Human,ErbB signaling pathway,1/85,0.004249939567045,0.0126816753470031,0,0,19915.0,108752.83801948265,CDKN1B
15099,KEGG_2019_Human,Small cell lung cancer,1/93,0.0046499360391879,0.0126816753470031,0,0,19907.0,106918.54242106884,CDKN1B
15100,KEGG_2019_Human,Prostate cancer,1/97,0.0048499343304706,0.0126816753470031,0,0,19903.0,106058.9096435903,CDKN1B
15101,KEGG_2019_Human,AGE-RAGE signaling pathway in diabetic complications,1/100,0.0049999330710556,0.0126816753470031,0,0,19900.0,105436.78197328727,CDKN1B
15102,KEGG_2019_Human,HIF-1 signaling pathway,1/100,0.0049999330710556,0.0126816753470031,0,0,19900.0,105436.78197328727,CDKN1B
15103,KEGG_2019_Human,Cell cycle,1/124,0.0061999236097501,0.0126816753470031,0,0,19876.0,101034.04709010696,CDKN1B
15104,KEGG_2019_Human,FoxO signaling pathway,1/132,0.0065999206698993,0.0126816753470031,0,0,19868.0,99751.22090491928,CDKN1B
15105,KEGG_2019_Human,Measles,1/138,0.0068999185254481,0.0126816753470031,0,0,19862.0,98838.19160389496,CDKN1B
15106,KEGG_2019_Human,Gastric cancer,1/149,0.0074499147221605,0.0126816753470031,0,0,19851.0,97261.02051561224,CDKN1B
15107,KEGG_2019_Human,Cushing syndrome,1/155,0.0077499127120574,0.0126816753470031,0,0,19845.0,96448.16254952336,CDKN1B
15108,KEGG_2019_Human,Transcriptional misregulation in cancer,1/186,0.0092999029651357,0.0129212981843129,0,0,19814.0,92684.96451050608,CDKN1B
15109,KEGG_2019_Human,Viral carcinogenesis,1/201,0.0100498985877989,0.0129212981843129,0,0,19799.0,91079.21596609056,CDKN1B
15110,KEGG_2019_Human,Epstein-Barr virus infection,1/201,0.0100498985877989,0.0129212981843129,0,0,19799.0,91079.21596609056,CDKN1B
15111,KEGG_2019_Human,MicroRNAs in cancer,1/299,0.0149498740670514,0.0179398488804617,0,0,19701.0,82804.33538735632,CDKN1B
15112,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.018562350891335,0,0,19670.0,80733.60565076157,CDKN1B
15113,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0187410310320355,0,0,19646.0,79255.8617626126,CDKN1B
15114,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,CDKN1B
15115,KEGG_2019_Human,Sphingolipid metabolism,1/47,0.0023499589392381,0.0046999178784763,0,0,19953.0,120782.64067395544,ASAH2
15116,KEGG_2019_Human,Sphingolipid signaling pathway,1/119,0.0059499254985137,0.0059499254985137,0,0,19881.0,101877.73080211312,ASAH2
15117,KEGG_2019_Human,RIG-I-like receptor signaling pathway,1/70,0.0034999466296654,0.0087998942265325,0,0,19930.0,112704.30065625212,ATG12
15118,KEGG_2019_Human,Autophagy,1/128,0.0063999221281459,0.0087998942265325,0,0,19872.0,100382.8010329652,ATG12
15119,KEGG_2019_Human,FoxO signaling pathway,1/132,0.0065999206698993,0.0087998942265325,0,0,19868.0,99751.22090491928,ATG12
15120,KEGG_2019_Human,NOD-like receptor signaling pathway,1/178,0.0088999053857096,0.0088999053857096,0,0,19822.0,93593.82745769851,ATG12
15121,KEGG_2019_Human,Cell cycle,1/124,0.0061999236097501,0.0119998666032662,0,0,19876.0,101034.04709010696,YWHAG
15122,KEGG_2019_Human,Oocyte meiosis,1/125,0.0062499232373748,0.0119998666032662,0,0,19875.0,100869.32368441945,YWHAG
15123,KEGG_2019_Human,Hepatitis C,1/155,0.0077499127120574,0.0119998666032662,0,0,19845.0,96448.16254952336,YWHAG
15124,KEGG_2019_Human,Hippo signaling pathway,1/160,0.0079999110688441,0.0119998666032662,0,0,19840.0,95793.96509856998,YWHAG
15125,KEGG_2019_Human,Viral carcinogenesis,1/201,0.0100498985877989,0.0120598783053587,0,0,19799.0,91079.21596609056,YWHAG
15126,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0176998626413668,0,0,19646.0,79255.8617626126,YWHAG
15127,KEGG_2019_Human,Endometrial cancer,1/58,0.0028999527887707,0.0073998893660899,0,0,19942.0,116522.31890946148,CTNNA1
15128,KEGG_2019_Human,Adherens junction,1/72,0.0035999456502131,0.0073998893660899,0,0,19928.0,112131.59838572376,CTNNA1
15129,KEGG_2019_Human,Arrhythmogenic right ventricular cardiomyopathy (ARVC),1/72,0.0035999456502131,0.0073998893660899,0,0,19928.0,112131.59838572376,CTNNA1
15130,KEGG_2019_Human,Bacterial invasion of epithelial cells,1/74,0.0036999446830449,0.0073998893660899,0,0,19926.0,111574.38983110404,CTNNA1
15131,KEGG_2019_Human,Leukocyte transendothelial migration,1/112,0.0055999282120529,0.0089598851392847,0,0,19888.0,103119.30984392198,CTNNA1
15132,KEGG_2019_Human,Gastric cancer,1/149,0.0074499147221605,0.0091427555072504,0,0,19851.0,97261.02051561224,CTNNA1
15133,KEGG_2019_Human,Hippo signaling pathway,1/160,0.0079999110688441,0.0091427555072504,0,0,19840.0,95793.96509856998,CTNNA1
15134,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,CTNNA1
15135,KEGG_2019_Human,Insulin secretion,1/86,0.0042999391173866,0.0097998678162159,0,0,19914.0,108514.46102290176,CCKAR
15136,KEGG_2019_Human,Pancreatic secretion,1/98,0.0048999339081079,0.0097998678162159,0,0,19902.0,105849.45495286948,CCKAR
15137,KEGG_2019_Human,Calcium signaling pathway,1/188,0.009399902370135,0.01253320316018,0,0,19812.0,92463.712994847,CCKAR
15138,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,CCKAR
15139,KEGG_2019_Human,Peroxisome,1/83,0.0041499404726918,0.0041499404726918,0,0,19917.0,109237.99888847338,PXMP4
15140,KEGG_2019_Human,Tyrosine metabolism,1/36,0.0017999657178272,0.0035999314356544,0,0,19964.0,126172.23364250171,DCT
15141,KEGG_2019_Human,Melanogenesis,1/101,0.0050499326546803,0.0050499326546803,0,0,19899.0,105233.48101229242,DCT
15142,KEGG_2019_Human,Arrhythmogenic right ventricular cardiomyopathy (ARVC),1/72,0.0035999456502131,0.0135109577093282,0,0,19928.0,112131.59838572376,ITGAV
15143,KEGG_2019_Human,ECM-receptor interaction,1/82,0.004099940929819,0.0135109577093282,0,0,19918.0,109484.9180722932,ITGAV
15144,KEGG_2019_Human,Hypertrophic cardiomyopathy (HCM),1/85,0.004249939567045,0.0135109577093282,0,0,19915.0,108752.83801948265,ITGAV
15145,KEGG_2019_Human,Dilated cardiomyopathy (DCM),1/91,0.0045499369072032,0.0135109577093282,0,0,19909.0,107362.10783923086,ITGAV
15146,KEGG_2019_Human,Small cell lung cancer,1/93,0.0046499360391879,0.0135109577093282,0,0,19907.0,106918.54242106884,ITGAV
15147,KEGG_2019_Human,Thyroid hormone signaling pathway,1/116,0.0057999266512085,0.0135109577093282,0,0,19884.0,102400.8105961506,ITGAV
15148,KEGG_2019_Human,Fluid shear stress and atherosclerosis,1/139,0.006949918172816,0.0135109577093282,0,0,19861.0,98689.81333375497,ITGAV
15149,KEGG_2019_Human,Cell adhesion molecules (CAMs),1/145,0.0072499160871101,0.0135109577093282,0,0,19855.0,97820.92670675044,ITGAV
15150,KEGG_2019_Human,Phagosome,1/152,0.0075999137114971,0.0135109577093282,0,0,19848.0,96850.665715497,ITGAV
15151,KEGG_2019_Human,Focal adhesion,1/199,0.0099498991610159,0.0138460208972725,0,0,19801.0,91286.4288690606,ITGAV
15152,KEGG_2019_Human,Proteoglycans in cancer,1/201,0.0100498985877989,0.0138460208972725,0,0,19799.0,91079.21596609056,ITGAV
15153,KEGG_2019_Human,Regulation of actin cytoskeleton,1/214,0.0106998949514067,0.0138460208972725,0,0,19786.0,89779.39753374986,ITGAV
15154,KEGG_2019_Human,Human cytomegalovirus infection,1/225,0.0112498919790339,0.0138460208972725,0,0,19775.0,88738.27077557483,ITGAV
15155,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0188569913816737,0,0,19670.0,80733.60565076157,ITGAV
15156,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0188798534841246,0,0,19646.0,79255.8617626126,ITGAV
15157,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,ITGAV
15158,KEGG_2019_Human,Platelet activation,1/124,0.0061999236097501,0.0061999236097501,0,0,19876.0,101034.04709010696,P2RY12
15159,KEGG_2019_Human,"Parathyroid hormone synthesis, secretion and action",1/106,0.0052999306076525,0.0082999091363732,0,0,19894.0,104245.78450366124,MEF2D
15160,KEGG_2019_Human,Apelin signaling pathway,1/137,0.0068499188797651,0.0082999091363732,0,0,19863.0,98987.62735269018,MEF2D
15161,KEGG_2019_Human,cGMP-PKG signaling pathway,1/166,0.0082999091363732,0.0082999091363732,0,0,19834.0,95034.82345515196,MEF2D
15162,KEGG_2019_Human,Notch signaling pathway,1/48,0.0023999583567988,0.0102898815625175,0,0,19952.0,120356.5272753826,JAG1
15163,KEGG_2019_Human,Th1 and Th2 cell differentiation,1/92,0.0045999364719865,0.0102898815625175,0,0,19908.0,107139.13814408927,JAG1
15164,KEGG_2019_Human,TNF signaling pathway,1/110,0.0054999290027479,0.0102898815625175,0,0,19890.0,103488.06969787036,JAG1
15165,KEGG_2019_Human,Apelin signaling pathway,1/137,0.0068499188797651,0.0102898815625175,0,0,19863.0,98987.62735269018,JAG1
15166,KEGG_2019_Human,Breast cancer,1/147,0.0073499154017982,0.0102898815625175,0,0,19853.0,97539.10874372096,JAG1
15167,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0192498453687919,0,0,19670.0,80733.60565076157,JAG1
15168,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,JAG1
15169,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,PTGDR
15170,KEGG_2019_Human,Cortisol synthesis and secretion,1/65,0.003249949134407,0.0122498347702699,0,0,19935.0,114209.92613860144,MC2R
15171,KEGG_2019_Human,Aldosterone synthesis and secretion,1/98,0.0048999339081079,0.0122498347702699,0,0,19902.0,105849.45495286948,MC2R
15172,KEGG_2019_Human,Cushing syndrome,1/155,0.0077499127120574,0.0129165211867624,0,0,19845.0,96448.16254952336,MC2R
15173,KEGG_2019_Human,cAMP signaling pathway,1/212,0.0105998955026255,0.0132498693782819,0,0,19788.0,89974.27756224656,MC2R
15174,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,MC2R
15175,KEGG_2019_Human,Ferroptosis,1/40,0.0019999631680592,0.0059998895041777,0,0,19960.0,124043.94523066044,SLC3A2
15176,KEGG_2019_Human,Protein digestion and absorption,1/90,0.0044999373439762,0.0067499060159643,0,0,19910.0,107587.50385474482,SLC3A2
15177,KEGG_2019_Human,mTOR signaling pathway,1/152,0.0075999137114971,0.0075999137114971,0,0,19848.0,96850.665715497,SLC3A2
15178,KEGG_2019_Human,Cholesterol metabolism,1/50,0.0024999572069037,0.0049999144138074,0,0,19950.0,119530.05920663515,NPC1
15179,KEGG_2019_Human,Lysosome,1/123,0.0061499239842961,0.0061499239842961,0,0,19877.0,101200.07933676826,NPC1
15180,KEGG_2019_Human,Pyruvate metabolism,1/39,0.0019499637955508,0.0019499637955508,0,0,19961.0,124555.53162481484,LDHD
15181,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR2G3
15182,KEGG_2019_Human,Wnt signaling pathway,1/158,0.0078999117225733,0.0078999117225733,0,0,19842.0,96053.2110949472,CACYBP
15183,KEGG_2019_Human,Pantothenate and CoA biosynthesis,1/19,0.00094997806231055,0.00094997806231055,0,0,19981.0,139049.2109571672,VNN3
15184,KEGG_2019_Human,Vitamin digestion and absorption,1/24,0.0011999741185782,0.0011999741185782,0,0,19976.0,134347.69487847842,BTD
15185,KEGG_2019_Human,Cellular senescence,1/160,0.0079999110688441,0.0079999110688441,0,0,19840.0,95793.96509856998,HIPK1
15186,KEGG_2019_Human,alpha-Linolenic acid metabolism,1/25,0.0012499733663791,0.0085498911417585,0,0,19975.0,133525.54486996148,PLA2G4C
15187,KEGG_2019_Human,Linoleic acid metabolism,1/29,0.001449970461791,0.0085498911417585,0,0,19971.0,130534.69172799008,PLA2G4C
15188,KEGG_2019_Human,Ether lipid metabolism,1/47,0.0023499589392381,0.0085498911417585,0,0,19953.0,120782.64067395544,PLA2G4C
15189,KEGG_2019_Human,Ovarian steroidogenesis,1/49,0.0024499577795033,0.0085498911417585,0,0,19951.0,119939.1172087114,PLA2G4C
15190,KEGG_2019_Human,VEGF signaling pathway,1/59,0.0029499522555206,0.0085498911417585,0,0,19941.0,116175.59385530632,PLA2G4C
15191,KEGG_2019_Human,Long-term depression,1/60,0.002999951725986,0.0085498911417585,0,0,19940.0,115834.63209072244,PLA2G4C
15192,KEGG_2019_Human,Arachidonic acid metabolism,1/63,0.0031499501598827,0.0085498911417585,0,0,19937.0,114844.46974572667,PLA2G4C
15193,KEGG_2019_Human,Fc epsilon RI signaling pathway,1/68,0.0033999476216189,0.0085498911417585,0,0,19932.0,113293.39338050144,PLA2G4C
15194,KEGG_2019_Human,GnRH signaling pathway,1/93,0.0046499360391879,0.0085498911417585,0,0,19907.0,106918.54242106884,PLA2G4C
15195,KEGG_2019_Human,Glycerophospholipid metabolism,1/97,0.0048499343304706,0.0085498911417585,0,0,19903.0,106058.9096435903,PLA2G4C
15196,KEGG_2019_Human,Choline metabolism in cancer,1/99,0.0049499334884068,0.0085498911417585,0,0,19901.0,105642.09305076736,PLA2G4C
15197,KEGG_2019_Human,Inflammatory mediator regulation of TRP channels,1/100,0.0049999330710556,0.0085498911417585,0,0,19900.0,105436.78197328727,PLA2G4C
15198,KEGG_2019_Human,Serotonergic synapse,1/113,0.0056499278191151,0.0085498911417585,0,0,19887.0,102937.34947211576,PLA2G4C
15199,KEGG_2019_Human,Glutamatergic synapse,1/114,0.005699927427839,0.0085498911417585,0,0,19886.0,102756.96431429044,PLA2G4C
15200,KEGG_2019_Human,Platelet activation,1/124,0.0061999236097501,0.0086623958792429,0,0,19876.0,101034.04709010696,PLA2G4C
15201,KEGG_2019_Human,Vascular smooth muscle contraction,1/132,0.0065999206698993,0.0086623958792429,0,0,19868.0,99751.22090491928,PLA2G4C
15202,KEGG_2019_Human,Phospholipase D signaling pathway,1/148,0.007399915061391,0.0089248989400127,0,0,19852.0,97399.60470052566,PLA2G4C
15203,KEGG_2019_Human,Oxytocin signaling pathway,1/153,0.0076499133771537,0.0089248989400127,0,0,19847.0,96715.6407630817,PLA2G4C
15204,KEGG_2019_Human,Necroptosis,1/162,0.0080999104202618,0.008952532569763,0,0,19838.0,95537.86936302872,PLA2G4C
15205,KEGG_2019_Human,Ras signaling pathway,1/232,0.0115998901349604,0.0121798846417084,0,0,19768.0,88101.22480150245,PLA2G4C
15206,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0147498749536506,0,0,19705.0,83086.53988020132,PLA2G4C
15207,KEGG_2019_Human,Proximal tubule bicarbonate reclamation,1/23,0.0011499748819949,0.0023499589392381,0,0,19977.0,135204.63922267244,MDH1
15208,KEGG_2019_Human,Glyoxylate and dicarboxylate metabolism,1/30,0.0014999697593334,0.0023499589392381,0,0,19970.0,129851.13732048514,MDH1
15209,KEGG_2019_Human,Citrate cycle (TCA cycle),1/30,0.0014999697593334,0.0023499589392381,0,0,19970.0,129851.13732048514,MDH1
15210,KEGG_2019_Human,Pyruvate metabolism,1/39,0.0019499637955508,0.0023499589392381,0,0,19961.0,124555.53162481484,MDH1
15211,KEGG_2019_Human,Cysteine and methionine metabolism,1/47,0.0023499589392381,0.0023499589392381,0,0,19953.0,120782.64067395544,MDH1
15212,KEGG_2019_Human,Insulin resistance,1/108,0.0053999298011749,0.0074499147221605,0,0,19892.0,103863.47861844616,MLXIPL
15213,KEGG_2019_Human,Non-alcoholic fatty liver disease (NAFLD),1/149,0.0074499147221605,0.0074499147221605,0,0,19851.0,97261.02051561224,MLXIPL
15214,KEGG_2019_Human,Progesterone-mediated oocyte maturation,1/99,0.0049499334884068,0.0062499232373748,0,0,19901.0,105642.09305076736,AURKA
15215,KEGG_2019_Human,Oocyte meiosis,1/125,0.0062499232373748,0.0062499232373748,0,0,19875.0,100869.32368441945,AURKA
15216,KEGG_2019_Human,Mismatch repair,1/23,0.0011499748819949,0.0034499246459849,0,0,19977.0,135204.63922267244,MSH6
15217,KEGG_2019_Human,Colorectal cancer,1/86,0.0042999391173866,0.0064499086760799,0,0,19914.0,108514.46102290176,MSH6
15218,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,MSH6
15219,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0147498749536506,0,0,19705.0,83086.53988020132,MAPK8IP1
15220,KEGG_2019_Human,Alcoholism,1/180,0.0089999047745351,0.0100498985877989,0,0,19820.0,93362.92821536642,HDAC9
15221,KEGG_2019_Human,Viral carcinogenesis,1/201,0.0100498985877989,0.0100498985877989,0,0,19799.0,91079.21596609056,HDAC9
15222,KEGG_2019_Human,Cytosolic DNA-sensing pathway,1/63,0.0031499501598827,0.0117248816857654,0,0,19937.0,114844.46974572667,IKBKE
15223,KEGG_2019_Human,RIG-I-like receptor signaling pathway,1/70,0.0034999466296654,0.0117248816857654,0,0,19930.0,112704.30065625212,IKBKE
15224,KEGG_2019_Human,IL-17 signaling pathway,1/93,0.0046499360391879,0.0117248816857654,0,0,19907.0,106918.54242106884,IKBKE
15225,KEGG_2019_Human,C-type lectin receptor signaling pathway,1/104,0.0051999314202997,0.0117248816857654,0,0,19896.0,104635.24941415618,IKBKE
15226,KEGG_2019_Human,Toll-like receptor signaling pathway,1/104,0.0051999314202997,0.0117248816857654,0,0,19896.0,104635.24941415618,IKBKE
15227,KEGG_2019_Human,Measles,1/138,0.0068999185254481,0.0117248816857654,0,0,19862.0,98838.19160389496,IKBKE
15228,KEGG_2019_Human,Hepatitis C,1/155,0.0077499127120574,0.0117248816857654,0,0,19845.0,96448.16254952336,IKBKE
15229,KEGG_2019_Human,Hepatitis B,1/163,0.0081499100978668,0.0117248816857654,0,0,19837.0,95410.9786681514,IKBKE
15230,KEGG_2019_Human,Influenza A,1/171,0.0085499075557634,0.0117248816857654,0,0,19829.0,94422.42241345016,IKBKE
15231,KEGG_2019_Human,NOD-like receptor signaling pathway,1/178,0.0088999053857096,0.0117248816857654,0,0,19822.0,93593.82745769851,IKBKE
15232,KEGG_2019_Human,Kaposi sarcoma-associated herpesvirus infection,1/186,0.0092999029651357,0.0117248816857654,0,0,19814.0,92684.96451050608,IKBKE
15233,KEGG_2019_Human,Epstein-Barr virus infection,1/201,0.0100498985877989,0.0117248816857654,0,0,19799.0,91079.21596609056,IKBKE
15234,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.017769088032731,0,0,19670.0,80733.60565076157,IKBKE
15235,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,IKBKE
15236,KEGG_2019_Human,African trypanosomiasis,1/37,0.0018499650702878,0.0024499577795033,0,0,19963.0,125618.9446446357,HBA2
15237,KEGG_2019_Human,Malaria,1/49,0.0024499577795033,0.0024499577795033,0,0,19951.0,119939.1172087114,HBA2
15238,KEGG_2019_Human,NOD-like receptor signaling pathway,1/178,0.0088999053857096,0.0088999053857096,0,0,19822.0,93593.82745769851,IFI16
15239,KEGG_2019_Human,Ribosome biogenesis in eukaryotes,1/101,0.0050499326546803,0.0082499094553477,0,0,19899.0,105233.48101229242,RPP38
15240,KEGG_2019_Human,RNA transport,1/165,0.0082499094553477,0.0082499094553477,0,0,19835.0,95159.46482222488,RPP38
15241,KEGG_2019_Human,Mucin type O-glycan biosynthesis,1/31,0.0015499690656704,0.0015499690656704,0,0,19969.0,129189.85098816035,C1GALT1
15242,KEGG_2019_Human,Insulin secretion,1/86,0.0042999391173866,0.0042999391173866,0,0,19914.0,108514.46102290176,KCNN3
15243,KEGG_2019_Human,Ubiquitin mediated proteolysis,1/137,0.0068499188797651,0.0068499188797651,0,0,19863.0,98987.62735269018,FBXO4
15244,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR2A2
15245,KEGG_2019_Human,Protein digestion and absorption,1/90,0.0044999373439762,0.0044999373439762,0,0,19910.0,107587.50385474482,MEP1B
15246,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZIM3
15247,KEGG_2019_Human,TNF signaling pathway,1/110,0.0054999290027479,0.0146998751759735,0,0,19890.0,103488.06969787036,CX3CL1
15248,KEGG_2019_Human,Chemokine signaling pathway,1/190,0.0094999017791995,0.0146998751759735,0,0,19810.0,92244.74636351672,CX3CL1
15249,KEGG_2019_Human,Human cytomegalovirus infection,1/225,0.0112498919790339,0.0146998751759735,0,0,19775.0,88738.27077557483,CX3CL1
15250,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0146998751759735,0,0,19706.0,83157.67014793828,CX3CL1
15251,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR10K2
15252,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR52B4
15253,KEGG_2019_Human,Homologous recombination,1/41,0.0020499625466866,0.0026999549628563,0,0,19959.0,123544.88783416104,EME1
15254,KEGG_2019_Human,Fanconi anemia pathway,1/54,0.0026999549628563,0.0026999549628563,0,0,19946.0,117971.01964061816,EME1
15255,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF223
15256,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF470
15257,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,TAC1
15258,KEGG_2019_Human,Renin-angiotensin system,1/23,0.0011499748819949,0.0018499650702878,0,0,19977.0,135204.63922267244,THOP1
15259,KEGG_2019_Human,African trypanosomiasis,1/37,0.0018499650702878,0.0018499650702878,0,0,19963.0,125618.9446446357,THOP1
15260,KEGG_2019_Human,Nicotine addiction,1/40,0.0019999631680592,0.0079798983989746,0,0,19960.0,124043.94523066044,CACNA1A
15261,KEGG_2019_Human,Type II diabetes mellitus,1/46,0.0022999595269283,0.0079798983989746,0,0,19954.0,121217.8313311442,CACNA1A
15262,KEGG_2019_Human,Long-term depression,1/60,0.002999951725986,0.0079798983989746,0,0,19940.0,115834.63209072244,CACNA1A
15263,KEGG_2019_Human,Synaptic vesicle cycle,1/78,0.0038999427840466,0.0079798983989746,0,0,19922.0,110503.2180492851,CACNA1A
15264,KEGG_2019_Human,Taste transduction,1/83,0.0041499404726918,0.0079798983989746,0,0,19917.0,109237.99888847338,CACNA1A
15265,KEGG_2019_Human,GABAergic synapse,1/89,0.0044499377838098,0.0079798983989746,0,0,19911.0,107815.380281759,CACNA1A
15266,KEGG_2019_Human,Morphine addiction,1/91,0.0045499369072032,0.0079798983989746,0,0,19909.0,107362.10783923086,CACNA1A
15267,KEGG_2019_Human,Cholinergic synapse,1/112,0.0055999282120529,0.0079798983989746,0,0,19888.0,103119.30984392198,CACNA1A
15268,KEGG_2019_Human,Serotonergic synapse,1/113,0.0056499278191151,0.0079798983989746,0,0,19887.0,102937.34947211576,CACNA1A
15269,KEGG_2019_Human,Glutamatergic synapse,1/114,0.005699927427839,0.0079798983989746,0,0,19886.0,102756.96431429044,CACNA1A
15270,KEGG_2019_Human,Dopaminergic synapse,1/131,0.0065499210316603,0.008336263131204,0,0,19869.0,99907.33811343512,CACNA1A
15271,KEGG_2019_Human,Retrograde endocannabinoid signaling,1/148,0.007399915061391,0.0086332342382895,0,0,19852.0,97399.60470052566,CACNA1A
15272,KEGG_2019_Human,Calcium signaling pathway,1/188,0.009399902370135,0.0101229717832223,0,0,19812.0,92463.712994847,CACNA1A
15273,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0147498749536506,0,0,19705.0,83086.53988020132,CACNA1A
15274,KEGG_2019_Human,Spliceosome,1/134,0.0066999199497742,0.0066999199497742,0,0,19866.0,99442.43560916925,PPIH
15275,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF567
15276,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR52L1
15277,KEGG_2019_Human,Renin-angiotensin system,1/23,0.0011499748819949,0.0034499246459849,0,0,19977.0,135204.63922267244,AGTR2
15278,KEGG_2019_Human,Adrenergic signaling in cardiomyocytes,1/145,0.0072499160871101,0.0108748741306652,0,0,19855.0,97820.92670675044,AGTR2
15279,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,AGTR2
15280,KEGG_2019_Human,Long-term depression,1/60,0.002999951725986,0.002999951725986,0,0,19940.0,115834.63209072244,GNAZ
15281,KEGG_2019_Human,JAK-STAT signaling pathway,1/162,0.0080999104202618,0.0146998751759735,0,0,19838.0,95537.86936302872,CNTFR
15282,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0146998751759735,0,0,19706.0,83157.67014793828,CNTFR
15283,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,CHRNE
15284,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0176998626413668,0,0,19646.0,79255.8617626126,TCL1A
15285,KEGG_2019_Human,RNA degradation,1/79,0.0039499423167337,0.0050499326546803,0,0,19921.0,110243.89578070649,XRN2
15286,KEGG_2019_Human,Ribosome biogenesis in eukaryotes,1/101,0.0050499326546803,0.0050499326546803,0,0,19899.0,105233.48101229242,XRN2
15287,KEGG_2019_Human,Renal cell carcinoma,1/69,0.003449947123837,0.0074998996065834,0,0,19931.0,112996.7391397682,EGLN3
15288,KEGG_2019_Human,HIF-1 signaling pathway,1/100,0.0049999330710556,0.0074998996065834,0,0,19900.0,105436.78197328727,EGLN3
15289,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,EGLN3
15290,KEGG_2019_Human,Galactose metabolism,1/31,0.0015499690656704,0.0075349107677416,0,0,19969.0,129189.85098816035,G6PC
15291,KEGG_2019_Human,Starch and sucrose metabolism,1/36,0.0017999657178272,0.0075349107677416,0,0,19964.0,126172.23364250171,G6PC
15292,KEGG_2019_Human,Carbohydrate digestion and absorption,1/44,0.0021999607179423,0.0075349107677416,0,0,19956.0,122117.06559109331,G6PC
15293,KEGG_2019_Human,Glycolysis / Gluconeogenesis,1/68,0.0033999476216189,0.0075349107677416,0,0,19932.0,113293.39338050144,G6PC
15294,KEGG_2019_Human,Adipocytokine signaling pathway,1/69,0.003449947123837,0.0075349107677416,0,0,19931.0,112996.7391397682,G6PC
15295,KEGG_2019_Human,Glucagon signaling pathway,1/103,0.0051499318302617,0.0075349107677416,0,0,19897.0,104832.7525292024,G6PC
15296,KEGG_2019_Human,Insulin resistance,1/108,0.0053999298011749,0.0075349107677416,0,0,19892.0,103863.47861844616,G6PC
15297,KEGG_2019_Human,AMPK signaling pathway,1/120,0.0059999251180858,0.0075349107677416,0,0,19880.0,101706.2448082016,G6PC
15298,KEGG_2019_Human,FoxO signaling pathway,1/132,0.0065999206698993,0.0075349107677416,0,0,19868.0,99751.22090491928,G6PC
15299,KEGG_2019_Human,Insulin signaling pathway,1/137,0.0068499188797651,0.0075349107677416,0,0,19863.0,98987.62735269018,G6PC
15300,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0176998626413668,0,0,19646.0,79255.8617626126,G6PC
15301,KEGG_2019_Human,Hedgehog signaling pathway,1/47,0.0023499589392381,0.0100798902013314,0,0,19953.0,120782.64067395544,CSNK1A1L
15302,KEGG_2019_Human,Breast cancer,1/147,0.0073499154017982,0.0100798902013314,0,0,19853.0,97539.10874372096,CSNK1A1L
15303,KEGG_2019_Human,Gastric cancer,1/149,0.0074499147221605,0.0100798902013314,0,0,19851.0,97261.02051561224,CSNK1A1L
15304,KEGG_2019_Human,Wnt signaling pathway,1/158,0.0078999117225733,0.0100798902013314,0,0,19842.0,96053.2110949472,CSNK1A1L
15305,KEGG_2019_Human,Hepatocellular carcinoma,1/168,0.0083999085011095,0.0100798902013314,0,0,19832.0,94787.72752807094,CSNK1A1L
15306,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0164998674589645,0,0,19670.0,80733.60565076157,CSNK1A1L
15307,KEGG_2019_Human,Spliceosome,1/134,0.0066999199497742,0.0066999199497742,0,0,19866.0,99442.43560916925,CTNNBL1
15308,KEGG_2019_Human,Platelet activation,1/124,0.0061999236097501,0.010299897173561,0,0,19876.0,101034.04709010696,APBB1IP
15309,KEGG_2019_Human,Rap1 signaling pathway,1/206,0.010299897173561,0.010299897173561,0,0,19794.0,90569.849337325,APBB1IP
15310,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZFP92
15311,KEGG_2019_Human,Glutathione metabolism,1/56,0.0027999538675741,0.0036999446830449,0,0,19944.0,117233.87022514464,GPX5
15312,KEGG_2019_Human,Arachidonic acid metabolism,1/63,0.0031499501598827,0.0036999446830449,0,0,19937.0,114844.46974572667,GPX5
15313,KEGG_2019_Human,Thyroid hormone synthesis,1/74,0.0036999446830449,0.0036999446830449,0,0,19926.0,111574.38983110404,GPX5
15314,KEGG_2019_Human,Inflammatory bowel disease (IBD),1/65,0.003249949134407,0.0118419915568778,0,0,19935.0,114209.92613860144,NFATC1
15315,KEGG_2019_Human,B cell receptor signaling pathway,1/71,0.0035499461386618,0.0118419915568778,0,0,19929.0,112415.9585341616,NFATC1
15316,KEGG_2019_Human,Th1 and Th2 cell differentiation,1/92,0.0045999364719865,0.0118419915568778,0,0,19908.0,107139.13814408927,NFATC1
15317,KEGG_2019_Human,AGE-RAGE signaling pathway in diabetic complications,1/100,0.0049999330710556,0.0118419915568778,0,0,19900.0,105436.78197328727,NFATC1
15318,KEGG_2019_Human,T cell receptor signaling pathway,1/101,0.0050499326546803,0.0118419915568778,0,0,19899.0,105233.48101229242,NFATC1
15319,KEGG_2019_Human,C-type lectin receptor signaling pathway,1/104,0.0051999314202997,0.0118419915568778,0,0,19896.0,104635.24941415618,NFATC1
15320,KEGG_2019_Human,Th17 cell differentiation,1/107,0.0053499302026925,0.0118419915568778,0,0,19893.0,104053.753408911,NFATC1
15321,KEGG_2019_Human,Osteoclast differentiation,1/127,0.0063499224962247,0.0118419915568778,0,0,19873.0,100543.72072014232,NFATC1
15322,KEGG_2019_Human,Natural killer cell mediated cytotoxicity,1/131,0.0065499210316603,0.0118419915568778,0,0,19869.0,99907.33811343512,NFATC1
15323,KEGG_2019_Human,Oxytocin signaling pathway,1/153,0.0076499133771537,0.0118419915568778,0,0,19847.0,96715.6407630817,NFATC1
15324,KEGG_2019_Human,Wnt signaling pathway,1/158,0.0078999117225733,0.0118419915568778,0,0,19842.0,96053.2110949472,NFATC1
15325,KEGG_2019_Human,Cellular senescence,1/160,0.0079999110688441,0.0118419915568778,0,0,19840.0,95793.96509856998,NFATC1
15326,KEGG_2019_Human,Hepatitis B,1/163,0.0081499100978668,0.0118419915568778,0,0,19837.0,95410.9786681514,NFATC1
15327,KEGG_2019_Human,cGMP-PKG signaling pathway,1/166,0.0082999091363732,0.0118419915568778,0,0,19834.0,95034.82345515196,NFATC1
15328,KEGG_2019_Human,Kaposi sarcoma-associated herpesvirus infection,1/186,0.0092999029651357,0.0118419915568778,0,0,19814.0,92684.96451050608,NFATC1
15329,KEGG_2019_Human,Human immunodeficiency virus 1 infection,1/212,0.0105998955026255,0.0118419915568778,0,0,19788.0,89974.27756224656,NFATC1
15330,KEGG_2019_Human,cAMP signaling pathway,1/212,0.0105998955026255,0.0118419915568778,0,0,19788.0,89974.27756224656,NFATC1
15331,KEGG_2019_Human,Human T-cell leukemia virus 1 infection,1/219,0.0109498935894162,0.0118419915568778,0,0,19781.0,89299.85161916987,NFATC1
15332,KEGG_2019_Human,Human cytomegalovirus infection,1/225,0.0112498919790339,0.0118419915568778,0,0,19775.0,88738.27077557483,NFATC1
15333,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0147498749536506,0,0,19705.0,83086.53988020132,NFATC1
15334,KEGG_2019_Human,Hematopoietic cell lineage,1/97,0.0048499343304706,0.0072499160871101,0,0,19903.0,106058.9096435903,CD34
15335,KEGG_2019_Human,Cell adhesion molecules (CAMs),1/145,0.0072499160871101,0.0072499160871101,0,0,19855.0,97820.92670675044,CD34
15336,KEGG_2019_Human,Long-term depression,1/60,0.002999951725986,0.0082499008373742,0,0,19940.0,115834.63209072244,GUCY1B1
15337,KEGG_2019_Human,Renin secretion,1/69,0.003449947123837,0.0082499008373742,0,0,19931.0,112996.7391397682,GUCY1B1
15338,KEGG_2019_Human,Gap junction,1/88,0.0043999382262822,0.0082499008373742,0,0,19912.0,108045.79305232369,GUCY1B1
15339,KEGG_2019_Human,Salivary secretion,1/90,0.0044999373439762,0.0082499008373742,0,0,19910.0,107587.50385474482,GUCY1B1
15340,KEGG_2019_Human,Circadian entrainment,1/97,0.0048499343304706,0.0082499008373742,0,0,19903.0,106058.9096435903,GUCY1B1
15341,KEGG_2019_Human,Platelet activation,1/124,0.0061999236097501,0.0082499008373742,0,0,19876.0,101034.04709010696,GUCY1B1
15342,KEGG_2019_Human,Purine metabolism,1/129,0.006449921761047,0.0082499008373742,0,0,19871.0,100223.109907462,GUCY1B1
15343,KEGG_2019_Human,Vascular smooth muscle contraction,1/132,0.0065999206698993,0.0082499008373742,0,0,19868.0,99751.22090491928,GUCY1B1
15344,KEGG_2019_Human,Oxytocin signaling pathway,1/153,0.0076499133771537,0.0082999091363732,0,0,19847.0,96715.6407630817,GUCY1B1
15345,KEGG_2019_Human,cGMP-PKG signaling pathway,1/166,0.0082999091363732,0.0082999091363732,0,0,19834.0,95034.82345515196,GUCY1B1
15346,KEGG_2019_Human,Inflammatory bowel disease (IBD),1/65,0.003249949134407,0.0066874127533657,0,0,19935.0,114209.92613860144,IL17A
15347,KEGG_2019_Human,Rheumatoid arthritis,1/91,0.0045499369072032,0.0066874127533657,0,0,19909.0,107362.10783923086,IL17A
15348,KEGG_2019_Human,IL-17 signaling pathway,1/93,0.0046499360391879,0.0066874127533657,0,0,19907.0,106918.54242106884,IL17A
15349,KEGG_2019_Human,Th17 cell differentiation,1/107,0.0053499302026925,0.0066874127533657,0,0,19893.0,104053.753408911,IL17A
15350,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0146998751759735,0,0,19706.0,83157.67014793828,IL17A
15351,KEGG_2019_Human,Amino sugar and nucleotide sugar metabolism,1/48,0.0023999583567988,0.0023999583567988,0,0,19952.0,120356.5272753826,UAP1
15352,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR10W1
15353,KEGG_2019_Human,One carbon pool by folate,1/20,0.0009999772468562472,0.0019999631680592,0,0,19980.0,138017.40508704726,SHMT1
15354,KEGG_2019_Human,Glyoxylate and dicarboxylate metabolism,1/30,0.0014999697593334,0.0019999631680592,0,0,19970.0,129851.13732048514,SHMT1
15355,KEGG_2019_Human,"Glycine, serine and threonine metabolism",1/40,0.0019999631680592,0.0019999631680592,0,0,19960.0,124043.94523066044,SHMT1
15356,KEGG_2019_Human,Proteasome,1/45,0.0022499601197094,0.0044999202394188,0,0,19955.0,121662.49782449217,PSMD8
15357,KEGG_2019_Human,Epstein-Barr virus infection,1/201,0.0100498985877989,0.0100498985877989,0,0,19799.0,91079.21596609056,PSMD8
15358,KEGG_2019_Human,RNA degradation,1/79,0.0039499423167337,0.0039499423167337,0,0,19921.0,110243.89578070649,EXOSC3
15359,KEGG_2019_Human,Renal cell carcinoma,1/69,0.003449947123837,0.006899894247674,0,0,19931.0,112996.7391397682,EPAS1
15360,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,EPAS1
15361,KEGG_2019_Human,Tight junction,1/170,0.0084999078692823,0.0084999078692823,0,0,19830.0,94543.49009679438,SYNPO
15362,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,GLRA1
15363,KEGG_2019_Human,Prion diseases,1/35,0.0017499663721595,0.0105031711755516,0,0,19965.0,126740.98858805298,MAPK1
15364,KEGG_2019_Human,Aldosterone-regulated sodium reabsorption,1/37,0.0018499650702878,0.0105031711755516,0,0,19963.0,125618.9446446357,MAPK1
15365,KEGG_2019_Human,Thyroid cancer,1/37,0.0018499650702878,0.0105031711755516,0,0,19963.0,125618.9446446357,MAPK1
15366,KEGG_2019_Human,Bladder cancer,1/41,0.0020499625466866,0.0105031711755516,0,0,19959.0,123544.88783416104,MAPK1
15367,KEGG_2019_Human,Type II diabetes mellitus,1/46,0.0022999595269283,0.0105031711755516,0,0,19954.0,121217.8313311442,MAPK1
15368,KEGG_2019_Human,Endometrial cancer,1/58,0.0028999527887707,0.0105031711755516,0,0,19942.0,116522.31890946148,MAPK1
15369,KEGG_2019_Human,VEGF signaling pathway,1/59,0.0029499522555206,0.0105031711755516,0,0,19941.0,116175.59385530632,MAPK1
15370,KEGG_2019_Human,Long-term depression,1/60,0.002999951725986,0.0105031711755516,0,0,19940.0,115834.63209072244,MAPK1
15371,KEGG_2019_Human,Central carbon metabolism in cancer,1/65,0.003249949134407,0.0105031711755516,0,0,19935.0,114209.92613860144,MAPK1
15372,KEGG_2019_Human,Shigellosis,1/65,0.003249949134407,0.0105031711755516,0,0,19935.0,114209.92613860144,MAPK1
15373,KEGG_2019_Human,Acute myeloid leukemia,1/66,0.003299948626608,0.0105031711755516,0,0,19934.0,113899.85357353876,MAPK1
15374,KEGG_2019_Human,Non-small cell lung cancer,1/66,0.003299948626608,0.0105031711755516,0,0,19934.0,113899.85357353876,MAPK1
15375,KEGG_2019_Human,Long-term potentiation,1/67,0.0033499481224912,0.0105031711755516,0,0,19933.0,113594.38808369274,MAPK1
15376,KEGG_2019_Human,Fc epsilon RI signaling pathway,1/68,0.0033999476216189,0.0105031711755516,0,0,19932.0,113293.39338050144,MAPK1
15377,KEGG_2019_Human,Renal cell carcinoma,1/69,0.003449947123837,0.0105031711755516,0,0,19931.0,112996.7391397682,MAPK1
15378,KEGG_2019_Human,Prolactin signaling pathway,1/70,0.0034999466296654,0.0105031711755516,0,0,19930.0,112704.30065625212,MAPK1
15379,KEGG_2019_Human,B cell receptor signaling pathway,1/71,0.0035499461386618,0.0105031711755516,0,0,19929.0,112415.9585341616,MAPK1
15380,KEGG_2019_Human,Adherens junction,1/72,0.0035999456502131,0.0105031711755516,0,0,19928.0,112131.59838572376,MAPK1
15381,KEGG_2019_Human,Melanoma,1/72,0.0035999456502131,0.0105031711755516,0,0,19928.0,112131.59838572376,MAPK1
15382,KEGG_2019_Human,Leishmaniasis,1/74,0.0036999446830449,0.0105031711755516,0,0,19926.0,111574.38983110404,MAPK1
15383,KEGG_2019_Human,Glioma,1/75,0.0037499442041125,0.0105031711755516,0,0,19925.0,111301.33528642564,MAPK1
15384,KEGG_2019_Human,Pancreatic cancer,1/75,0.0037499442041125,0.0105031711755516,0,0,19925.0,111301.33528642564,MAPK1
15385,KEGG_2019_Human,Chronic myeloid leukemia,1/76,0.0037999437281752,0.0105031711755516,0,0,19924.0,111031.8499691117,MAPK1
15386,KEGG_2019_Human,Pertussis,1/76,0.0037999437281752,0.0105031711755516,0,0,19924.0,111031.8499691117,MAPK1
15387,KEGG_2019_Human,ErbB signaling pathway,1/85,0.004249939567045,0.0105031711755516,0,0,19915.0,108752.83801948265,MAPK1
15388,KEGG_2019_Human,Colorectal cancer,1/86,0.0042999391173866,0.0105031711755516,0,0,19914.0,108514.46102290176,MAPK1
15389,KEGG_2019_Human,Salmonella infection,1/86,0.0042999391173866,0.0105031711755516,0,0,19914.0,108514.46102290176,MAPK1
15390,KEGG_2019_Human,Gap junction,1/88,0.0043999382262822,0.0105031711755516,0,0,19912.0,108045.79305232369,MAPK1
15391,KEGG_2019_Human,TGF-beta signaling pathway,1/90,0.0044999373439762,0.0105031711755516,0,0,19910.0,107587.50385474482,MAPK1
15392,KEGG_2019_Human,Fc gamma R-mediated phagocytosis,1/91,0.0045499369072032,0.0105031711755516,0,0,19909.0,107362.10783923086,MAPK1
15393,KEGG_2019_Human,Th1 and Th2 cell differentiation,1/92,0.0045999364719865,0.0105031711755516,0,0,19908.0,107139.13814408927,MAPK1
15394,KEGG_2019_Human,GnRH signaling pathway,1/93,0.0046499360391879,0.0105031711755516,0,0,19907.0,106918.54242106884,MAPK1
15395,KEGG_2019_Human,IL-17 signaling pathway,1/93,0.0046499360391879,0.0105031711755516,0,0,19907.0,106918.54242106884,MAPK1
15396,KEGG_2019_Human,Circadian entrainment,1/97,0.0048499343304706,0.0105031711755516,0,0,19903.0,106058.9096435903,MAPK1
15397,KEGG_2019_Human,Prostate cancer,1/97,0.0048499343304706,0.0105031711755516,0,0,19903.0,106058.9096435903,MAPK1
15398,KEGG_2019_Human,Choline metabolism in cancer,1/99,0.0049499334884068,0.0105031711755516,0,0,19901.0,105642.09305076736,MAPK1
15399,KEGG_2019_Human,Progesterone-mediated oocyte maturation,1/99,0.0049499334884068,0.0105031711755516,0,0,19901.0,105642.09305076736,MAPK1
15400,KEGG_2019_Human,AGE-RAGE signaling pathway in diabetic complications,1/100,0.0049999330710556,0.0105031711755516,0,0,19900.0,105436.78197328727,MAPK1
15401,KEGG_2019_Human,HIF-1 signaling pathway,1/100,0.0049999330710556,0.0105031711755516,0,0,19900.0,105436.78197328727,MAPK1
15402,KEGG_2019_Human,T cell receptor signaling pathway,1/101,0.0050499326546803,0.0105031711755516,0,0,19899.0,105233.48101229242,MAPK1
15403,KEGG_2019_Human,Melanogenesis,1/101,0.0050499326546803,0.0105031711755516,0,0,19899.0,105233.48101229242,MAPK1
15404,KEGG_2019_Human,Chagas disease (American trypanosomiasis),1/103,0.0051499318302617,0.0105031711755516,0,0,19897.0,104832.7525292024,MAPK1
15405,KEGG_2019_Human,Toll-like receptor signaling pathway,1/104,0.0051999314202997,0.0105031711755516,0,0,19896.0,104635.24941415618,MAPK1
15406,KEGG_2019_Human,C-type lectin receptor signaling pathway,1/104,0.0051999314202997,0.0105031711755516,0,0,19896.0,104635.24941415618,MAPK1
15407,KEGG_2019_Human,"Parathyroid hormone synthesis, secretion and action",1/106,0.0052999306076525,0.0105031711755516,0,0,19894.0,104245.78450366124,MAPK1
15408,KEGG_2019_Human,Th17 cell differentiation,1/107,0.0053499302026925,0.0105031711755516,0,0,19893.0,104053.753408911,MAPK1
15409,KEGG_2019_Human,TNF signaling pathway,1/110,0.0054999290027479,0.0105031711755516,0,0,19890.0,103488.06969787036,MAPK1
15410,KEGG_2019_Human,Cholinergic synapse,1/112,0.0055999282120529,0.0105031711755516,0,0,19888.0,103119.30984392198,MAPK1
15411,KEGG_2019_Human,Toxoplasmosis,1/113,0.0056499278191151,0.0105031711755516,0,0,19887.0,102937.34947211576,MAPK1
15412,KEGG_2019_Human,Serotonergic synapse,1/113,0.0056499278191151,0.0105031711755516,0,0,19887.0,102937.34947211576,MAPK1
15413,KEGG_2019_Human,Glutamatergic synapse,1/114,0.005699927427839,0.0105031711755516,0,0,19886.0,102756.96431429044,MAPK1
15414,KEGG_2019_Human,Thyroid hormone signaling pathway,1/116,0.0057999266512085,0.0105031711755516,0,0,19884.0,102400.8105961506,MAPK1
15415,KEGG_2019_Human,Sphingolipid signaling pathway,1/119,0.0059499254985137,0.0105031711755516,0,0,19881.0,101877.73080211312,MAPK1
15416,KEGG_2019_Human,Neurotrophin signaling pathway,1/119,0.0059499254985137,0.0105031711755516,0,0,19881.0,101877.73080211312,MAPK1
15417,KEGG_2019_Human,Platelet activation,1/124,0.0061999236097501,0.0105031711755516,0,0,19876.0,101034.04709010696,MAPK1
15418,KEGG_2019_Human,Oocyte meiosis,1/125,0.0062499232373748,0.0105031711755516,0,0,19875.0,100869.32368441945,MAPK1
15419,KEGG_2019_Human,Osteoclast differentiation,1/127,0.0063499224962247,0.0105031711755516,0,0,19873.0,100543.72072014232,MAPK1
15420,KEGG_2019_Human,Autophagy,1/128,0.0063999221281459,0.0105031711755516,0,0,19872.0,100382.8010329652,MAPK1
15421,KEGG_2019_Human,Relaxin signaling pathway,1/130,0.0064999213952527,0.0105031711755516,0,0,19870.0,100064.62842845908,MAPK1
15422,KEGG_2019_Human,Natural killer cell mediated cytotoxicity,1/131,0.0065499210316603,0.0105031711755516,0,0,19869.0,99907.33811343512,MAPK1
15423,KEGG_2019_Human,Vascular smooth muscle contraction,1/132,0.0065999206698993,0.0105031711755516,0,0,19868.0,99751.22090491928,MAPK1
15424,KEGG_2019_Human,FoxO signaling pathway,1/132,0.0065999206698993,0.0105031711755516,0,0,19868.0,99751.22090491928,MAPK1
15425,KEGG_2019_Human,Apelin signaling pathway,1/137,0.0068499188797651,0.0105031711755516,0,0,19863.0,98987.62735269018,MAPK1
15426,KEGG_2019_Human,Estrogen signaling pathway,1/137,0.0068499188797651,0.0105031711755516,0,0,19863.0,98987.62735269018,MAPK1
15427,KEGG_2019_Human,Insulin signaling pathway,1/137,0.0068499188797651,0.0105031711755516,0,0,19863.0,98987.62735269018,MAPK1
15428,KEGG_2019_Human,Signaling pathways regulating pluripotency of stem cells,1/139,0.006949918172816,0.0105031711755516,0,0,19861.0,98689.81333375497,MAPK1
15429,KEGG_2019_Human,Apoptosis,1/143,0.0071499167770442,0.0105031711755516,0,0,19857.0,98106.57763600958,MAPK1
15430,KEGG_2019_Human,Adrenergic signaling in cardiomyocytes,1/145,0.0072499160871101,0.0105031711755516,0,0,19855.0,97820.92670675044,MAPK1
15431,KEGG_2019_Human,Breast cancer,1/147,0.0073499154017982,0.0105031711755516,0,0,19853.0,97539.10874372096,MAPK1
15432,KEGG_2019_Human,Phospholipase D signaling pathway,1/148,0.007399915061391,0.0105031711755516,0,0,19852.0,97399.60470052566,MAPK1
15433,KEGG_2019_Human,Retrograde endocannabinoid signaling,1/148,0.007399915061391,0.0105031711755516,0,0,19852.0,97399.60470052566,MAPK1
15434,KEGG_2019_Human,Gastric cancer,1/149,0.0074499147221605,0.0105031711755516,0,0,19851.0,97261.02051561224,MAPK1
15435,KEGG_2019_Human,mTOR signaling pathway,1/152,0.0075999137114971,0.0105031711755516,0,0,19848.0,96850.665715497,MAPK1
15436,KEGG_2019_Human,Oxytocin signaling pathway,1/153,0.0076499133771537,0.0105031711755516,0,0,19847.0,96715.6407630817,MAPK1
15437,KEGG_2019_Human,Cushing syndrome,1/155,0.0077499127120574,0.0105031711755516,0,0,19845.0,96448.16254952336,MAPK1
15438,KEGG_2019_Human,Hepatitis C,1/155,0.0077499127120574,0.0105031711755516,0,0,19845.0,96448.16254952336,MAPK1
15439,KEGG_2019_Human,Cellular senescence,1/160,0.0079999110688441,0.0107011797414408,0,0,19840.0,95793.96509856998,MAPK1
15440,KEGG_2019_Human,Hepatitis B,1/163,0.0081499100978668,0.0107395180273613,0,0,19837.0,95410.9786681514,MAPK1
15441,KEGG_2019_Human,cGMP-PKG signaling pathway,1/166,0.0082999091363732,0.0107395180273613,0,0,19834.0,95034.82345515196,MAPK1
15442,KEGG_2019_Human,Hepatocellular carcinoma,1/168,0.0083999085011095,0.0107395180273613,0,0,19832.0,94787.72752807094,MAPK1
15443,KEGG_2019_Human,Alzheimer disease,1/171,0.0085499075557634,0.0107395180273613,0,0,19829.0,94422.42241345016,MAPK1
15444,KEGG_2019_Human,Influenza A,1/171,0.0085499075557634,0.0107395180273613,0,0,19829.0,94422.42241345016,MAPK1
15445,KEGG_2019_Human,NOD-like receptor signaling pathway,1/178,0.0088999053857096,0.0108388390754766,0,0,19822.0,93593.82745769851,MAPK1
15446,KEGG_2019_Human,Tuberculosis,1/179,0.0089499050800561,0.0108388390754766,0,0,19821.0,93478.0629355712,MAPK1
15447,KEGG_2019_Human,Alcoholism,1/180,0.0089999047745351,0.0108388390754766,0,0,19820.0,93362.92821536642,MAPK1
15448,KEGG_2019_Human,Axon guidance,1/181,0.0090499044707863,0.0108388390754766,0,0,19819.0,93248.41634586031,MAPK1
15449,KEGG_2019_Human,Kaposi sarcoma-associated herpesvirus infection,1/186,0.0092999029651357,0.0110102299472297,0,0,19814.0,92684.96451050608,MAPK1
15450,KEGG_2019_Human,Chemokine signaling pathway,1/190,0.0094999017791995,0.0111192032188358,0,0,19810.0,92244.74636351672,MAPK1
15451,KEGG_2019_Human,Focal adhesion,1/199,0.0099498991610159,0.0113751599400362,0,0,19801.0,91286.4288690606,MAPK1
15452,KEGG_2019_Human,Viral carcinogenesis,1/201,0.0100498985877989,0.0113751599400362,0,0,19799.0,91079.21596609056,MAPK1
15453,KEGG_2019_Human,Proteoglycans in cancer,1/201,0.0100498985877989,0.0113751599400362,0,0,19799.0,91079.21596609056,MAPK1
15454,KEGG_2019_Human,Rap1 signaling pathway,1/206,0.010299897173561,0.0115314066182259,0,0,19794.0,90569.849337325,MAPK1
15455,KEGG_2019_Human,cAMP signaling pathway,1/212,0.0105998955026255,0.0116009387367884,0,0,19788.0,89974.27756224656,MAPK1
15456,KEGG_2019_Human,Human immunodeficiency virus 1 infection,1/212,0.0105998955026255,0.0116009387367884,0,0,19788.0,89974.27756224656,MAPK1
15457,KEGG_2019_Human,Regulation of actin cytoskeleton,1/214,0.0106998949514067,0.0116009387367884,0,0,19786.0,89779.39753374986,MAPK1
15458,KEGG_2019_Human,Human T-cell leukemia virus 1 infection,1/219,0.0109498935894162,0.0117483233303112,0,0,19781.0,89299.85161916987,MAPK1
15459,KEGG_2019_Human,Human cytomegalovirus infection,1/225,0.0112498919790339,0.0119457615859844,0,0,19775.0,88738.27077557483,MAPK1
15460,KEGG_2019_Human,Ras signaling pathway,1/232,0.0115998901349604,0.0121917212642951,0,0,19768.0,88101.22480150245,MAPK1
15461,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0153458294972325,0,0,19705.0,83086.53988020132,MAPK1
15462,KEGG_2019_Human,MicroRNAs in cancer,1/299,0.0149498740670514,0.0153983702890629,0,0,19701.0,82804.33538735632,MAPK1
15463,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0168265975076568,0,0,19670.0,80733.60565076157,MAPK1
15464,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0178733907064783,0,0,19646.0,79255.8617626126,MAPK1
15465,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,MAPK1
15466,KEGG_2019_Human,Axon guidance,1/181,0.0090499044707863,0.0090499044707863,0,0,19819.0,93248.41634586031,NTN1
15467,KEGG_2019_Human,Glycosaminoglycan biosynthesis,1/53,0.0026499555173137,0.0026499555173137,0,0,19947.0,118349.78824235698,DSE
15468,KEGG_2019_Human,Spliceosome,1/134,0.0066999199497742,0.0066999199497742,0,0,19866.0,99442.43560916925,PRPF4
15469,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR5T3
15470,KEGG_2019_Human,mTOR signaling pathway,1/152,0.0075999137114971,0.0075999137114971,0,0,19848.0,96850.665715497,CLIP1
15471,KEGG_2019_Human,Proteasome,1/45,0.0022499601197094,0.0044999202394188,0,0,19955.0,121662.49782449217,PSMD14
15472,KEGG_2019_Human,Epstein-Barr virus infection,1/201,0.0100498985877989,0.0100498985877989,0,0,19799.0,91079.21596609056,PSMD14
15473,KEGG_2019_Human,RNA degradation,1/79,0.0039499423167337,0.0039499423167337,0,0,19921.0,110243.89578070649,PNLDC1
15474,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR4M1
15475,KEGG_2019_Human,Renin secretion,1/69,0.003449947123837,0.0092665575637547,0,0,19931.0,112996.7391397682,EDN1
15476,KEGG_2019_Human,Hypertrophic cardiomyopathy (HCM),1/85,0.004249939567045,0.0092665575637547,0,0,19915.0,108752.83801948265,EDN1
15477,KEGG_2019_Human,AGE-RAGE signaling pathway in diabetic complications,1/100,0.0049999330710556,0.0092665575637547,0,0,19900.0,105436.78197328727,EDN1
15478,KEGG_2019_Human,HIF-1 signaling pathway,1/100,0.0049999330710556,0.0092665575637547,0,0,19900.0,105436.78197328727,EDN1
15479,KEGG_2019_Human,Melanogenesis,1/101,0.0050499326546803,0.0092665575637547,0,0,19899.0,105233.48101229242,EDN1
15480,KEGG_2019_Human,TNF signaling pathway,1/110,0.0054999290027479,0.0092665575637547,0,0,19890.0,103488.06969787036,EDN1
15481,KEGG_2019_Human,Relaxin signaling pathway,1/130,0.0064999213952527,0.0092665575637547,0,0,19870.0,100064.62842845908,EDN1
15482,KEGG_2019_Human,Vascular smooth muscle contraction,1/132,0.0065999206698993,0.0092665575637547,0,0,19868.0,99751.22090491928,EDN1
15483,KEGG_2019_Human,Fluid shear stress and atherosclerosis,1/139,0.006949918172816,0.0092665575637547,0,0,19861.0,98689.81333375497,EDN1
15484,KEGG_2019_Human,cAMP signaling pathway,1/212,0.0105998955026255,0.0127198746031507,0,0,19788.0,89974.27756224656,EDN1
15485,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0184362172653377,0,0,19662.0,80229.79996326564,EDN1
15486,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,EDN1
15487,KEGG_2019_Human,Renal cell carcinoma,1/69,0.003449947123837,0.0107998823585693,0,0,19931.0,112996.7391397682,GAB1
15488,KEGG_2019_Human,Bacterial invasion of epithelial cells,1/74,0.0036999446830449,0.0107998823585693,0,0,19926.0,111574.38983110404,GAB1
15489,KEGG_2019_Human,ErbB signaling pathway,1/85,0.004249939567045,0.0107998823585693,0,0,19915.0,108752.83801948265,GAB1
15490,KEGG_2019_Human,Neurotrophin signaling pathway,1/119,0.0059499254985137,0.0107998823585693,0,0,19881.0,101877.73080211312,GAB1
15491,KEGG_2019_Human,Phospholipase D signaling pathway,1/148,0.007399915061391,0.0107998823585693,0,0,19852.0,97399.60470052566,GAB1
15492,KEGG_2019_Human,Gastric cancer,1/149,0.0074499147221605,0.0107998823585693,0,0,19851.0,97261.02051561224,GAB1
15493,KEGG_2019_Human,Hepatocellular carcinoma,1/168,0.0083999085011095,0.0107998823585693,0,0,19832.0,94787.72752807094,GAB1
15494,KEGG_2019_Human,Proteoglycans in cancer,1/201,0.0100498985877989,0.0113061359112738,0,0,19799.0,91079.21596609056,GAB1
15495,KEGG_2019_Human,Ras signaling pathway,1/232,0.0115998901349604,0.0115998901349604,0,0,19768.0,88101.22480150245,GAB1
15496,KEGG_2019_Human,TGF-beta signaling pathway,1/90,0.0044999373439762,0.0126698662591008,0,0,19910.0,107587.50385474482,BMPR2
15497,KEGG_2019_Human,Fluid shear stress and atherosclerosis,1/139,0.006949918172816,0.0126698662591008,0,0,19861.0,98689.81333375497,BMPR2
15498,KEGG_2019_Human,Signaling pathways regulating pluripotency of stem cells,1/139,0.006949918172816,0.0126698662591008,0,0,19861.0,98689.81333375497,BMPR2
15499,KEGG_2019_Human,Hippo signaling pathway,1/160,0.0079999110688441,0.0126698662591008,0,0,19840.0,95793.96509856998,BMPR2
15500,KEGG_2019_Human,Axon guidance,1/181,0.0090499044707863,0.0126698662591008,0,0,19819.0,93248.41634586031,BMPR2
15501,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0149498740670514,0,0,19706.0,83157.67014793828,BMPR2
15502,KEGG_2019_Human,MicroRNAs in cancer,1/299,0.0149498740670514,0.0149498740670514,0,0,19701.0,82804.33538735632,BMPR2
15503,KEGG_2019_Human,Arrhythmogenic right ventricular cardiomyopathy (ARVC),1/72,0.0035999456502131,0.0087298817948472,0,0,19928.0,112131.59838572376,ITGA1
15504,KEGG_2019_Human,ECM-receptor interaction,1/82,0.004099940929819,0.0087298817948472,0,0,19918.0,109484.9180722932,ITGA1
15505,KEGG_2019_Human,Hypertrophic cardiomyopathy (HCM),1/85,0.004249939567045,0.0087298817948472,0,0,19915.0,108752.83801948265,ITGA1
15506,KEGG_2019_Human,Dilated cardiomyopathy (DCM),1/91,0.0045499369072032,0.0087298817948472,0,0,19909.0,107362.10783923086,ITGA1
15507,KEGG_2019_Human,Hematopoietic cell lineage,1/97,0.0048499343304706,0.0087298817948472,0,0,19903.0,106058.9096435903,ITGA1
15508,KEGG_2019_Human,Focal adhesion,1/199,0.0099498991610159,0.0137570077946658,0,0,19801.0,91286.4288690606,ITGA1
15509,KEGG_2019_Human,Regulation of actin cytoskeleton,1/214,0.0106998949514067,0.0137570077946658,0,0,19786.0,89779.39753374986,ITGA1
15510,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0176998626413668,0,0,19670.0,80733.60565076157,ITGA1
15511,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0176998626413668,0,0,19646.0,79255.8617626126,ITGA1
15512,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR10T2
15513,KEGG_2019_Human,mRNA surveillance pathway,1/91,0.0045499369072032,0.0045499369072032,0,0,19909.0,107362.10783923086,CPSF1
15514,KEGG_2019_Human,African trypanosomiasis,1/37,0.0018499650702878,0.0087998839420457,0,0,19963.0,125618.9446446357,IL12B
15515,KEGG_2019_Human,Allograft rejection,1/38,0.001899964429635,0.0087998839420457,0,0,19962.0,125080.29732025368,IL12B
15516,KEGG_2019_Human,Type I diabetes mellitus,1/43,0.0021499613216957,0.0087998839420457,0,0,19957.0,122581.98940490963,IL12B
15517,KEGG_2019_Human,Legionellosis,1/55,0.0027499544131125,0.0087998839420457,0,0,19945.0,117599.1294878737,IL12B
15518,KEGG_2019_Human,Inflammatory bowel disease (IBD),1/65,0.003249949134407,0.0087998839420457,0,0,19935.0,114209.92613860144,IL12B
15519,KEGG_2019_Human,RIG-I-like receptor signaling pathway,1/70,0.0034999466296654,0.0087998839420457,0,0,19930.0,112704.30065625212,IL12B
15520,KEGG_2019_Human,Leishmaniasis,1/74,0.0036999446830449,0.0087998839420457,0,0,19926.0,111574.38983110404,IL12B
15521,KEGG_2019_Human,Pertussis,1/76,0.0037999437281752,0.0087998839420457,0,0,19924.0,111031.8499691117,IL12B
15522,KEGG_2019_Human,Th1 and Th2 cell differentiation,1/92,0.0045999364719865,0.0087998839420457,0,0,19908.0,107139.13814408927,IL12B
15523,KEGG_2019_Human,Amoebiasis,1/96,0.0047999347538706,0.0087998839420457,0,0,19904.0,106270.50039849174,IL12B
15524,KEGG_2019_Human,Chagas disease (American trypanosomiasis),1/103,0.0051499318302617,0.0087998839420457,0,0,19897.0,104832.7525292024,IL12B
15525,KEGG_2019_Human,C-type lectin receptor signaling pathway,1/104,0.0051999314202997,0.0087998839420457,0,0,19896.0,104635.24941415618,IL12B
15526,KEGG_2019_Human,Toll-like receptor signaling pathway,1/104,0.0051999314202997,0.0087998839420457,0,0,19896.0,104635.24941415618,IL12B
15527,KEGG_2019_Human,Toxoplasmosis,1/113,0.0056499278191151,0.0088784580014667,0,0,19887.0,102937.34947211576,IL12B
15528,KEGG_2019_Human,Measles,1/138,0.0068999185254481,0.0101198805039906,0,0,19862.0,98838.19160389496,IL12B
15529,KEGG_2019_Human,JAK-STAT signaling pathway,1/162,0.0080999104202618,0.0109387728756241,0,0,19838.0,95537.86936302872,IL12B
15530,KEGG_2019_Human,Influenza A,1/171,0.0085499075557634,0.0109387728756241,0,0,19829.0,94422.42241345016,IL12B
15531,KEGG_2019_Human,Tuberculosis,1/179,0.0089499050800561,0.0109387728756241,0,0,19821.0,93478.0629355712,IL12B
15532,KEGG_2019_Human,Proteoglycans in cancer,1/201,0.0100498985877989,0.0116367246806093,0,0,19799.0,91079.21596609056,IL12B
15533,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0161698626935708,0,0,19706.0,83157.67014793828,IL12B
15534,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0257712598834163,0,0,19508.0,72277.44006442746,IL12B
15535,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,IL12B
15536,KEGG_2019_Human,Basal transcription factors,1/45,0.0022499601197094,0.0022499601197094,0,0,19955.0,121662.49782449217,TAF12
15537,KEGG_2019_Human,Acute myeloid leukemia,1/66,0.003299948626608,0.0136873669867703,0,0,19934.0,113899.85357353876,SPI1
15538,KEGG_2019_Human,Osteoclast differentiation,1/127,0.0063499224962247,0.0136873669867703,0,0,19873.0,100543.72072014232,SPI1
15539,KEGG_2019_Human,Transcriptional misregulation in cancer,1/186,0.0092999029651357,0.0136873669867703,0,0,19814.0,92684.96451050608,SPI1
15540,KEGG_2019_Human,Human T-cell leukemia virus 1 infection,1/219,0.0109498935894162,0.0136873669867703,0,0,19781.0,89299.85161916987,SPI1
15541,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,SPI1
15542,KEGG_2019_Human,Phosphatidylinositol signaling system,1/99,0.0049499334884068,0.0049499334884068,0,0,19901.0,105642.09305076736,PPIP5K1
15543,KEGG_2019_Human,ECM-receptor interaction,1/82,0.004099940929819,0.0136998377595303,0,0,19918.0,109484.9180722932,SPP1
15544,KEGG_2019_Human,Toll-like receptor signaling pathway,1/104,0.0051999314202997,0.0136998377595303,0,0,19896.0,104635.24941415618,SPP1
15545,KEGG_2019_Human,Apelin signaling pathway,1/137,0.0068499188797651,0.0136998377595303,0,0,19863.0,98987.62735269018,SPP1
15546,KEGG_2019_Human,Focal adhesion,1/199,0.0099498991610159,0.0149248487415239,0,0,19801.0,91286.4288690606,SPP1
15547,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0176998626413668,0,0,19670.0,80733.60565076157,SPP1
15548,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0176998626413668,0,0,19646.0,79255.8617626126,SPP1
15549,KEGG_2019_Human,Endocrine and other factor-regulated calcium reabsorption,1/48,0.0023999583567988,0.0077998918409197,0,0,19952.0,120356.5272753826,SLC8A1
15550,KEGG_2019_Human,Mineral absorption,1/51,0.0025499566390179,0.0077998918409197,0,0,19949.0,119129.0228601236,SLC8A1
15551,KEGG_2019_Human,Arrhythmogenic right ventricular cardiomyopathy (ARVC),1/72,0.0035999456502131,0.0077998918409197,0,0,19928.0,112131.59838572376,SLC8A1
15552,KEGG_2019_Human,Cardiac muscle contraction,1/78,0.0038999427840466,0.0077998918409197,0,0,19922.0,110503.2180492851,SLC8A1
15553,KEGG_2019_Human,Hypertrophic cardiomyopathy (HCM),1/85,0.004249939567045,0.0077998918409197,0,0,19915.0,108752.83801948265,SLC8A1
15554,KEGG_2019_Human,Protein digestion and absorption,1/90,0.0044999373439762,0.0077998918409197,0,0,19910.0,107587.50385474482,SLC8A1
15555,KEGG_2019_Human,Dilated cardiomyopathy (DCM),1/91,0.0045499369072032,0.0077998918409197,0,0,19909.0,107362.10783923086,SLC8A1
15556,KEGG_2019_Human,Apelin signaling pathway,1/137,0.0068499188797651,0.0096665547828135,0,0,19863.0,98987.62735269018,SLC8A1
15557,KEGG_2019_Human,Adrenergic signaling in cardiomyocytes,1/145,0.0072499160871101,0.0096665547828135,0,0,19855.0,97820.92670675044,SLC8A1
15558,KEGG_2019_Human,cGMP-PKG signaling pathway,1/166,0.0082999091363732,0.0099598909636479,0,0,19834.0,95034.82345515196,SLC8A1
15559,KEGG_2019_Human,Calcium signaling pathway,1/188,0.009399902370135,0.0102544389492382,0,0,19812.0,92463.712994847,SLC8A1
15560,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,SLC8A1
15561,KEGG_2019_Human,Ribosome biogenesis in eukaryotes,1/101,0.0050499326546803,0.0082499094553477,0,0,19899.0,105233.48101229242,POP1
15562,KEGG_2019_Human,RNA transport,1/165,0.0082499094553477,0.0082499094553477,0,0,19835.0,95159.46482222488,POP1
15563,KEGG_2019_Human,TGF-beta signaling pathway,1/90,0.0044999373439762,0.0044999373439762,0,0,19910.0,107587.50385474482,HJV
15564,KEGG_2019_Human,mRNA surveillance pathway,1/91,0.0045499369072032,0.0106873844447042,0,0,19909.0,107362.10783923086,NXF1
15565,KEGG_2019_Human,Ribosome biogenesis in eukaryotes,1/101,0.0050499326546803,0.0106873844447042,0,0,19899.0,105233.48101229242,NXF1
15566,KEGG_2019_Human,RNA transport,1/165,0.0082499094553477,0.0106873844447042,0,0,19835.0,95159.46482222488,NXF1
15567,KEGG_2019_Human,Influenza A,1/171,0.0085499075557634,0.0106873844447042,0,0,19829.0,94422.42241345016,NXF1
15568,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,NXF1
15569,KEGG_2019_Human,Endocytosis,1/244,0.0121998870519305,0.0121998870519305,0,0,19756.0,87051.4275316661,VPS26B
15570,KEGG_2019_Human,Cell cycle,1/124,0.0061999236097501,0.0062499232373748,0,0,19876.0,101034.04709010696,SMC1B
15571,KEGG_2019_Human,Oocyte meiosis,1/125,0.0062499232373748,0.0062499232373748,0,0,19875.0,100869.32368441945,SMC1B
15572,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR6V1
15573,KEGG_2019_Human,Lysosome,1/123,0.0061499239842961,0.0061499239842961,0,0,19877.0,101200.07933676826,GGA2
15574,KEGG_2019_Human,Vitamin B6 metabolism,1/6,0.0002999905873105514,0.0002999905873105514,0,0,19994.0,162186.51863187927,PDXK
15575,KEGG_2019_Human,Basal transcription factors,1/45,0.0022499601197094,0.0044999202394188,0,0,19955.0,121662.49782449217,GTF2E1
15576,KEGG_2019_Human,Viral carcinogenesis,1/201,0.0100498985877989,0.0100498985877989,0,0,19799.0,91079.21596609056,GTF2E1
15577,KEGG_2019_Human,Protein processing in endoplasmic reticulum,1/165,0.0082499094553477,0.0082499094553477,0,0,19835.0,95159.46482222488,SEC24B
15578,KEGG_2019_Human,Basal cell carcinoma,1/63,0.0031499501598827,0.0109198810514423,0,0,19937.0,114844.46974572667,WNT9A
15579,KEGG_2019_Human,Melanogenesis,1/101,0.0050499326546803,0.0109198810514423,0,0,19899.0,105233.48101229242,WNT9A
15580,KEGG_2019_Human,Signaling pathways regulating pluripotency of stem cells,1/139,0.006949918172816,0.0109198810514423,0,0,19861.0,98689.81333375497,WNT9A
15581,KEGG_2019_Human,Breast cancer,1/147,0.0073499154017982,0.0109198810514423,0,0,19853.0,97539.10874372096,WNT9A
15582,KEGG_2019_Human,Gastric cancer,1/149,0.0074499147221605,0.0109198810514423,0,0,19851.0,97261.02051561224,WNT9A
15583,KEGG_2019_Human,mTOR signaling pathway,1/152,0.0075999137114971,0.0109198810514423,0,0,19848.0,96850.665715497,WNT9A
15584,KEGG_2019_Human,Cushing syndrome,1/155,0.0077499127120574,0.0109198810514423,0,0,19845.0,96448.16254952336,WNT9A
15585,KEGG_2019_Human,Wnt signaling pathway,1/158,0.0078999117225733,0.0109198810514423,0,0,19842.0,96053.2110949472,WNT9A
15586,KEGG_2019_Human,Hippo signaling pathway,1/160,0.0079999110688441,0.0109198810514423,0,0,19840.0,95793.96509856998,WNT9A
15587,KEGG_2019_Human,Hepatocellular carcinoma,1/168,0.0083999085011095,0.0109198810514423,0,0,19832.0,94787.72752807094,WNT9A
15588,KEGG_2019_Human,Proteoglycans in cancer,1/201,0.0100498985877989,0.0118771528764897,0,0,19799.0,91079.21596609056,WNT9A
15589,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0178748564138782,0,0,19670.0,80733.60565076157,WNT9A
15590,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,WNT9A
15591,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR52N2
15592,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR4C12
15593,KEGG_2019_Human,Neurotrophin signaling pathway,1/119,0.0059499254985137,0.0059499254985137,0,0,19881.0,101877.73080211312,ZNF274
15594,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF718
15595,KEGG_2019_Human,Protein export,1/23,0.0011499748819949,0.0011499748819949,0,0,19977.0,135204.63922267244,SEC11A
15596,KEGG_2019_Human,Prostate cancer,1/97,0.0048499343304706,0.0098943272707719,0,0,19903.0,106058.9096435903,FOXO1
15597,KEGG_2019_Human,AGE-RAGE signaling pathway in diabetic complications,1/100,0.0049999330710556,0.0098943272707719,0,0,19900.0,105436.78197328727,FOXO1
15598,KEGG_2019_Human,Longevity regulating pathway,1/102,0.0050999322416682,0.0098943272707719,0,0,19898.0,105032.15064717118,FOXO1
15599,KEGG_2019_Human,Glucagon signaling pathway,1/103,0.0051499318302617,0.0098943272707719,0,0,19897.0,104832.7525292024,FOXO1
15600,KEGG_2019_Human,Insulin resistance,1/108,0.0053999298011749,0.0098943272707719,0,0,19892.0,103863.47861844616,FOXO1
15601,KEGG_2019_Human,Thyroid hormone signaling pathway,1/116,0.0057999266512085,0.0098943272707719,0,0,19884.0,102400.8105961506,FOXO1
15602,KEGG_2019_Human,AMPK signaling pathway,1/120,0.0059999251180858,0.0098943272707719,0,0,19880.0,101706.2448082016,FOXO1
15603,KEGG_2019_Human,FoxO signaling pathway,1/132,0.0065999206698993,0.0098943272707719,0,0,19868.0,99751.22090491928,FOXO1
15604,KEGG_2019_Human,Insulin signaling pathway,1/137,0.0068499188797651,0.0098943272707719,0,0,19863.0,98987.62735269018,FOXO1
15605,KEGG_2019_Human,Cellular senescence,1/160,0.0079999110688441,0.0103998843894974,0,0,19840.0,95793.96509856998,FOXO1
15606,KEGG_2019_Human,Transcriptional misregulation in cancer,1/186,0.0092999029651357,0.0109907944133422,0,0,19814.0,92684.96451050608,FOXO1
15607,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0178748564138782,0,0,19670.0,80733.60565076157,FOXO1
15608,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,FOXO1
15609,KEGG_2019_Human,Amyotrophic lateral sclerosis (ALS),1/51,0.0025499566390179,0.01301986415119,0,0,19949.0,119129.0228601236,BCL2L1
15610,KEGG_2019_Human,Mitophagy,1/65,0.003249949134407,0.01301986415119,0,0,19935.0,114209.92613860144,BCL2L1
15611,KEGG_2019_Human,p53 signaling pathway,1/72,0.0035999456502131,0.01301986415119,0,0,19928.0,112131.59838572376,BCL2L1
15612,KEGG_2019_Human,Pancreatic cancer,1/75,0.0037499442041125,0.01301986415119,0,0,19925.0,111301.33528642564,BCL2L1
15613,KEGG_2019_Human,Chronic myeloid leukemia,1/76,0.0037999437281752,0.01301986415119,0,0,19924.0,111031.8499691117,BCL2L1
15614,KEGG_2019_Human,Small cell lung cancer,1/93,0.0046499360391879,0.01301986415119,0,0,19907.0,106918.54242106884,BCL2L1
15615,KEGG_2019_Human,NF-kappa B signaling pathway,1/95,0.0047499351803394,0.01301986415119,0,0,19905.0,106484.27183626965,BCL2L1
15616,KEGG_2019_Human,Toxoplasmosis,1/113,0.0056499278191151,0.01301986415119,0,0,19887.0,102937.34947211576,BCL2L1
15617,KEGG_2019_Human,Autophagy,1/128,0.0063999221281459,0.01301986415119,0,0,19872.0,100382.8010329652,BCL2L1
15618,KEGG_2019_Human,Measles,1/138,0.0068999185254481,0.01301986415119,0,0,19862.0,98838.19160389496,BCL2L1
15619,KEGG_2019_Human,Apoptosis,1/143,0.0071499167770442,0.01301986415119,0,0,19857.0,98106.57763600958,BCL2L1
15620,KEGG_2019_Human,JAK-STAT signaling pathway,1/162,0.0080999104202618,0.01301986415119,0,0,19838.0,95537.86936302872,BCL2L1
15621,KEGG_2019_Human,Hepatocellular carcinoma,1/168,0.0083999085011095,0.01301986415119,0,0,19832.0,94787.72752807094,BCL2L1
15622,KEGG_2019_Human,NOD-like receptor signaling pathway,1/178,0.0088999053857096,0.01301986415119,0,0,19822.0,93593.82745769851,BCL2L1
15623,KEGG_2019_Human,Transcriptional misregulation in cancer,1/186,0.0092999029651357,0.01301986415119,0,0,19814.0,92684.96451050608,BCL2L1
15624,KEGG_2019_Human,Human immunodeficiency virus 1 infection,1/212,0.0105998955026255,0.0135263391398671,0,0,19788.0,89974.27756224656,BCL2L1
15625,KEGG_2019_Human,Human T-cell leukemia virus 1 infection,1/219,0.0109498935894162,0.0135263391398671,0,0,19781.0,89299.85161916987,BCL2L1
15626,KEGG_2019_Human,Ras signaling pathway,1/232,0.0115998901349604,0.0135332051574538,0,0,19768.0,88101.22480150245,BCL2L1
15627,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0195630060773002,0,0,19646.0,79255.8617626126,BCL2L1
15628,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0258298309286059,0,0,19508.0,72277.44006442746,BCL2L1
15629,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,BCL2L1
15630,KEGG_2019_Human,Glycosaminoglycan degradation,1/19,0.00094997806231055,0.0018999561246211,0,0,19981.0,139049.2109571672,GALNS
15631,KEGG_2019_Human,Lysosome,1/123,0.0061499239842961,0.0061499239842961,0,0,19877.0,101200.07933676826,GALNS
15632,KEGG_2019_Human,DNA replication,1/36,0.0017999657178272,0.0035999314356544,0,0,19964.0,126172.23364250171,MCM5
15633,KEGG_2019_Human,Cell cycle,1/124,0.0061999236097501,0.0061999236097501,0,0,19876.0,101034.04709010696,MCM5
15634,KEGG_2019_Human,Glycosaminoglycan biosynthesis,1/53,0.0026499555173137,0.0026499555173137,0,0,19947.0,118349.78824235698,EXT2
15635,KEGG_2019_Human,Spliceosome,1/134,0.0066999199497742,0.0066999199497742,0,0,19866.0,99442.43560916925,HNRNPA1L2
15636,KEGG_2019_Human,Regulation of actin cytoskeleton,1/214,0.0106998949514067,0.0106998949514067,0,0,19786.0,89779.39753374986,ABI2
15637,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF585A
15638,KEGG_2019_Human,DNA replication,1/36,0.0017999657178272,0.0017999657178272,0,0,19964.0,126172.23364250171,RNASEH2B
15639,KEGG_2019_Human,Histidine metabolism,1/23,0.0011499748819949,0.0032666103726711,0,0,19977.0,135204.63922267244,ALDH7A1
15640,KEGG_2019_Human,Ascorbate and aldarate metabolism,1/27,0.0013499718942362,0.0032666103726711,0,0,19973.0,131975.02298599784,ALDH7A1
15641,KEGG_2019_Human,beta-Alanine metabolism,1/31,0.0015499690656704,0.0032666103726711,0,0,19969.0,129189.85098816035,ALDH7A1
15642,KEGG_2019_Human,Pyruvate metabolism,1/39,0.0019499637955508,0.0032666103726711,0,0,19961.0,124555.53162481484,ALDH7A1
15643,KEGG_2019_Human,"Glycine, serine and threonine metabolism",1/40,0.0019999631680592,0.0032666103726711,0,0,19960.0,124043.94523066044,ALDH7A1
15644,KEGG_2019_Human,Tryptophan metabolism,1/42,0.0020999619311272,0.0032666103726711,0,0,19958.0,123057.75613441122,ALDH7A1
15645,KEGG_2019_Human,Fatty acid degradation,1/44,0.0021999607179423,0.0032666103726711,0,0,19956.0,122117.06559109331,ALDH7A1
15646,KEGG_2019_Human,"Valine, leucine and isoleucine degradation",1/48,0.0023999583567988,0.0032666103726711,0,0,19952.0,120356.5272753826,ALDH7A1
15647,KEGG_2019_Human,Arginine and proline metabolism,1/49,0.0024499577795033,0.0032666103726711,0,0,19951.0,119939.1172087114,ALDH7A1
15648,KEGG_2019_Human,Lysine degradation,1/59,0.0029499522555206,0.0033272194910895,0,0,19941.0,116175.59385530632,ALDH7A1
15649,KEGG_2019_Human,Glycerolipid metabolism,1/61,0.0030499512001654,0.0033272194910895,0,0,19939.0,115499.24335773686,ALDH7A1
15650,KEGG_2019_Human,Glycolysis / Gluconeogenesis,1/68,0.0033999476216189,0.0033999476216189,0,0,19932.0,113293.39338050144,ALDH7A1
15651,KEGG_2019_Human,Endocytosis,1/244,0.0121998870519305,0.0121998870519305,0,0,19756.0,87051.4275316661,ARFGEF2
15652,KEGG_2019_Human,Thyroid hormone synthesis,1/74,0.0036999446830449,0.0036999446830449,0,0,19926.0,111574.38983110404,TTF2
15653,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR4P4
15654,KEGG_2019_Human,Vitamin digestion and absorption,1/24,0.0011999741185782,0.0011999741185782,0,0,19976.0,134347.69487847842,TCN2
15655,KEGG_2019_Human,Signaling pathways regulating pluripotency of stem cells,1/139,0.006949918172816,0.0139498544477036,0,0,19861.0,98689.81333375497,BMI1
15656,KEGG_2019_Human,Transcriptional misregulation in cancer,1/186,0.0092999029651357,0.0139498544477036,0,0,19814.0,92684.96451050608,BMI1
15657,KEGG_2019_Human,MicroRNAs in cancer,1/299,0.0149498740670514,0.0149498740670514,0,0,19701.0,82804.33538735632,BMI1
15658,KEGG_2019_Human,Ubiquitin mediated proteolysis,1/137,0.0068499188797651,0.0068499188797651,0,0,19863.0,98987.62735269018,UBE3C
15659,KEGG_2019_Human,Mannose type O-glycan biosynthesis,1/23,0.0011499748819949,0.0011499748819949,0,0,19977.0,135204.63922267244,FKTN
15660,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR1A1
15661,KEGG_2019_Human,JAK-STAT signaling pathway,1/162,0.0080999104202618,0.0080999104202618,0,0,19838.0,95537.86936302872,PTPN2
15662,KEGG_2019_Human,Viral carcinogenesis,1/201,0.0100498985877989,0.0100498985877989,0,0,19799.0,91079.21596609056,HPN
15663,KEGG_2019_Human,Linoleic acid metabolism,1/29,0.001449970461791,0.0047832644181221,0,0,19971.0,130534.69172799008,CYP3A4
15664,KEGG_2019_Human,Steroid hormone biosynthesis,1/60,0.002999951725986,0.0047832644181221,0,0,19940.0,115834.63209072244,CYP3A4
15665,KEGG_2019_Human,Retinol metabolism,1/67,0.0033499481224912,0.0047832644181221,0,0,19933.0,113594.38808369274,CYP3A4
15666,KEGG_2019_Human,Bile secretion,1/72,0.0035999456502131,0.0047832644181221,0,0,19928.0,112131.59838572376,CYP3A4
15667,KEGG_2019_Human,Metabolism of xenobiotics by cytochrome P450,1/74,0.0036999446830449,0.0047832644181221,0,0,19926.0,111574.38983110404,CYP3A4
15668,KEGG_2019_Human,Chemical carcinogenesis,1/82,0.004099940929819,0.0047832644181221,0,0,19918.0,109484.9180722932,CYP3A4
15669,KEGG_2019_Human,Drug metabolism,1/108,0.0053999298011749,0.0053999298011749,0,0,19892.0,103863.47861844616,CYP3A4
15670,KEGG_2019_Human,TGF-beta signaling pathway,1/90,0.0044999373439762,0.0089998746879525,0,0,19910.0,107587.50385474482,ZFYVE16
15671,KEGG_2019_Human,Endocytosis,1/244,0.0121998870519305,0.0121998870519305,0,0,19756.0,87051.4275316661,ZFYVE16
15672,KEGG_2019_Human,Ubiquitin mediated proteolysis,1/137,0.0068499188797651,0.0068499188797651,0,0,19863.0,98987.62735269018,TRIM37
15673,KEGG_2019_Human,Pathogenic Escherichia coli infection,1/55,0.0027499544131125,0.0027499544131125,0,0,19945.0,117599.1294878737,NCL
15674,KEGG_2019_Human,Primary immunodeficiency,1/37,0.0018499650702878,0.0091998589968987,0,0,19963.0,125618.9446446357,ORAI1
15675,KEGG_2019_Human,Cortisol synthesis and secretion,1/65,0.003249949134407,0.0091998589968987,0,0,19935.0,114209.92613860144,ORAI1
15676,KEGG_2019_Human,Renin secretion,1/69,0.003449947123837,0.0091998589968987,0,0,19931.0,112996.7391397682,ORAI1
15677,KEGG_2019_Human,Aldosterone synthesis and secretion,1/98,0.0048999339081079,0.0097998678162159,0,0,19902.0,105849.45495286948,ORAI1
15678,KEGG_2019_Human,Platelet activation,1/124,0.0061999236097501,0.0099198777756001,0,0,19876.0,101034.04709010696,ORAI1
15679,KEGG_2019_Human,Cushing syndrome,1/155,0.0077499127120574,0.0103332169494099,0,0,19845.0,96448.16254952336,ORAI1
15680,KEGG_2019_Human,Calcium signaling pathway,1/188,0.009399902370135,0.0105998955026255,0,0,19812.0,92463.712994847,ORAI1
15681,KEGG_2019_Human,cAMP signaling pathway,1/212,0.0105998955026255,0.0105998955026255,0,0,19788.0,89974.27756224656,ORAI1
15682,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF221
15683,KEGG_2019_Human,Type II diabetes mellitus,1/46,0.0022999595269283,0.0068499188797651,0,0,19954.0,121217.8313311442,SLC2A4
15684,KEGG_2019_Human,Adipocytokine signaling pathway,1/69,0.003449947123837,0.0068499188797651,0,0,19931.0,112996.7391397682,SLC2A4
15685,KEGG_2019_Human,Insulin resistance,1/108,0.0053999298011749,0.0068499188797651,0,0,19892.0,103863.47861844616,SLC2A4
15686,KEGG_2019_Human,AMPK signaling pathway,1/120,0.0059999251180858,0.0068499188797651,0,0,19880.0,101706.2448082016,SLC2A4
15687,KEGG_2019_Human,FoxO signaling pathway,1/132,0.0065999206698993,0.0068499188797651,0,0,19868.0,99751.22090491928,SLC2A4
15688,KEGG_2019_Human,Insulin signaling pathway,1/137,0.0068499188797651,0.0068499188797651,0,0,19863.0,98987.62735269018,SLC2A4
15689,KEGG_2019_Human,RNA transport,1/165,0.0082499094553477,0.0082499094553477,0,0,19835.0,95159.46482222488,NUP93
15690,KEGG_2019_Human,Prion diseases,1/35,0.0017499663721595,0.0088999053857096,0,0,19965.0,126740.98858805298,CASP12
15691,KEGG_2019_Human,Amyotrophic lateral sclerosis (ALS),1/51,0.0025499566390179,0.0088999053857096,0,0,19949.0,119129.0228601236,CASP12
15692,KEGG_2019_Human,Apoptosis,1/143,0.0071499167770442,0.0088999053857096,0,0,19857.0,98106.57763600958,CASP12
15693,KEGG_2019_Human,Hepatitis B,1/163,0.0081499100978668,0.0088999053857096,0,0,19837.0,95410.9786681514,CASP12
15694,KEGG_2019_Human,Protein processing in endoplasmic reticulum,1/165,0.0082499094553477,0.0088999053857096,0,0,19835.0,95159.46482222488,CASP12
15695,KEGG_2019_Human,Alzheimer disease,1/171,0.0085499075557634,0.0088999053857096,0,0,19829.0,94422.42241345016,CASP12
15696,KEGG_2019_Human,NOD-like receptor signaling pathway,1/178,0.0088999053857096,0.0088999053857096,0,0,19822.0,93593.82745769851,CASP12
15697,KEGG_2019_Human,Small cell lung cancer,1/93,0.0046499360391879,0.0114855983860559,0,0,19907.0,106918.54242106884,SKP2
15698,KEGG_2019_Human,Cell cycle,1/124,0.0061999236097501,0.0114855983860559,0,0,19876.0,101034.04709010696,SKP2
15699,KEGG_2019_Human,FoxO signaling pathway,1/132,0.0065999206698993,0.0114855983860559,0,0,19868.0,99751.22090491928,SKP2
15700,KEGG_2019_Human,Ubiquitin mediated proteolysis,1/137,0.0068499188797651,0.0114855983860559,0,0,19863.0,98987.62735269018,SKP2
15701,KEGG_2019_Human,mTOR signaling pathway,1/152,0.0075999137114971,0.0114855983860559,0,0,19848.0,96850.665715497,SKP2
15702,KEGG_2019_Human,Epstein-Barr virus infection,1/201,0.0100498985877989,0.0114855983860559,0,0,19799.0,91079.21596609056,SKP2
15703,KEGG_2019_Human,Viral carcinogenesis,1/201,0.0100498985877989,0.0114855983860559,0,0,19799.0,91079.21596609056,SKP2
15704,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,SKP2
15705,KEGG_2019_Human,Osteoclast differentiation,1/127,0.0063499224962247,0.0063499224962247,0,0,19873.0,100543.72072014232,SIRPA
15706,KEGG_2019_Human,Natural killer cell mediated cytotoxicity,1/131,0.0065499210316603,0.0065499210316603,0,0,19869.0,99907.33811343512,SH2D1B
15707,KEGG_2019_Human,Long-term potentiation,1/67,0.0033499481224912,0.0106771546448906,0,0,19933.0,113594.38808369274,CAMK2B
15708,KEGG_2019_Human,Amphetamine addiction,1/68,0.0033999476216189,0.0106771546448906,0,0,19932.0,113293.39338050144,CAMK2B
15709,KEGG_2019_Human,Gastric acid secretion,1/75,0.0037499442041125,0.0106771546448906,0,0,19925.0,111301.33528642564,CAMK2B
15710,KEGG_2019_Human,Glioma,1/75,0.0037499442041125,0.0106771546448906,0,0,19925.0,111301.33528642564,CAMK2B
15711,KEGG_2019_Human,ErbB signaling pathway,1/85,0.004249939567045,0.0106771546448906,0,0,19915.0,108752.83801948265,CAMK2B
15712,KEGG_2019_Human,Insulin secretion,1/86,0.0042999391173866,0.0106771546448906,0,0,19914.0,108514.46102290176,CAMK2B
15713,KEGG_2019_Human,GnRH signaling pathway,1/93,0.0046499360391879,0.0106771546448906,0,0,19907.0,106918.54242106884,CAMK2B
15714,KEGG_2019_Human,Circadian entrainment,1/97,0.0048499343304706,0.0106771546448906,0,0,19903.0,106058.9096435903,CAMK2B
15715,KEGG_2019_Human,Aldosterone synthesis and secretion,1/98,0.0048999339081079,0.0106771546448906,0,0,19902.0,105849.45495286948,CAMK2B
15716,KEGG_2019_Human,Inflammatory mediator regulation of TRP channels,1/100,0.0049999330710556,0.0106771546448906,0,0,19900.0,105436.78197328727,CAMK2B
15717,KEGG_2019_Human,HIF-1 signaling pathway,1/100,0.0049999330710556,0.0106771546448906,0,0,19900.0,105436.78197328727,CAMK2B
15718,KEGG_2019_Human,Melanogenesis,1/101,0.0050499326546803,0.0106771546448906,0,0,19899.0,105233.48101229242,CAMK2B
15719,KEGG_2019_Human,Glucagon signaling pathway,1/103,0.0051499318302617,0.0106771546448906,0,0,19897.0,104832.7525292024,CAMK2B
15720,KEGG_2019_Human,Cholinergic synapse,1/112,0.0055999282120529,0.0106771546448906,0,0,19888.0,103119.30984392198,CAMK2B
15721,KEGG_2019_Human,Neurotrophin signaling pathway,1/119,0.0059499254985137,0.0106771546448906,0,0,19881.0,101877.73080211312,CAMK2B
15722,KEGG_2019_Human,Oocyte meiosis,1/125,0.0062499232373748,0.0106771546448906,0,0,19875.0,100869.32368441945,CAMK2B
15723,KEGG_2019_Human,Dopaminergic synapse,1/131,0.0065499210316603,0.0106771546448906,0,0,19869.0,99907.33811343512,CAMK2B
15724,KEGG_2019_Human,Adrenergic signaling in cardiomyocytes,1/145,0.0072499160871101,0.0106771546448906,0,0,19855.0,97820.92670675044,CAMK2B
15725,KEGG_2019_Human,Oxytocin signaling pathway,1/153,0.0076499133771537,0.0106771546448906,0,0,19847.0,96715.6407630817,CAMK2B
15726,KEGG_2019_Human,Cushing syndrome,1/155,0.0077499127120574,0.0106771546448906,0,0,19845.0,96448.16254952336,CAMK2B
15727,KEGG_2019_Human,Wnt signaling pathway,1/158,0.0078999117225733,0.0106771546448906,0,0,19842.0,96053.2110949472,CAMK2B
15728,KEGG_2019_Human,Necroptosis,1/162,0.0080999104202618,0.0106771546448906,0,0,19838.0,95537.86936302872,CAMK2B
15729,KEGG_2019_Human,Tuberculosis,1/179,0.0089499050800561,0.0109038867493566,0,0,19821.0,93478.0629355712,CAMK2B
15730,KEGG_2019_Human,Axon guidance,1/181,0.0090499044707863,0.0109038867493566,0,0,19819.0,93248.41634586031,CAMK2B
15731,KEGG_2019_Human,Calcium signaling pathway,1/188,0.009399902370135,0.0109038867493566,0,0,19812.0,92463.712994847,CAMK2B
15732,KEGG_2019_Human,Proteoglycans in cancer,1/201,0.0100498985877989,0.0112095022710065,0,0,19799.0,91079.21596609056,CAMK2B
15733,KEGG_2019_Human,cAMP signaling pathway,1/212,0.0105998955026255,0.0113850729472645,0,0,19788.0,89974.27756224656,CAMK2B
15734,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0229926981863763,0,0,19556.0,74462.79263140135,CAMK2B
15735,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,CAMK2B
15736,KEGG_2019_Human,Aminoacyl-tRNA biosynthesis,1/66,0.003299948626608,0.003299948626608,0,0,19934.0,113899.85357353876,FARS2
15737,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR3A1
15738,KEGG_2019_Human,Proteasome,1/45,0.0022499601197094,0.0044999202394188,0,0,19955.0,121662.49782449217,PSMD1
15739,KEGG_2019_Human,Epstein-Barr virus infection,1/201,0.0100498985877989,0.0100498985877989,0,0,19799.0,91079.21596609056,PSMD1
15740,KEGG_2019_Human,Progesterone-mediated oocyte maturation,1/99,0.0049499334884068,0.010416538728958,0,0,19901.0,105642.09305076736,CDC25C
15741,KEGG_2019_Human,Cell cycle,1/124,0.0061999236097501,0.010416538728958,0,0,19876.0,101034.04709010696,CDC25C
15742,KEGG_2019_Human,Oocyte meiosis,1/125,0.0062499232373748,0.010416538728958,0,0,19875.0,100869.32368441945,CDC25C
15743,KEGG_2019_Human,Human immunodeficiency virus 1 infection,1/212,0.0105998955026255,0.0132498693782819,0,0,19788.0,89974.27756224656,CDC25C
15744,KEGG_2019_Human,MicroRNAs in cancer,1/299,0.0149498740670514,0.0149498740670514,0,0,19701.0,82804.33538735632,CDC25C
15745,KEGG_2019_Human,Progesterone-mediated oocyte maturation,1/99,0.0049499334884068,0.0068499188797651,0,0,19901.0,105642.09305076736,FZR1
15746,KEGG_2019_Human,Cell cycle,1/124,0.0061999236097501,0.0068499188797651,0,0,19876.0,101034.04709010696,FZR1
15747,KEGG_2019_Human,Ubiquitin mediated proteolysis,1/137,0.0068499188797651,0.0068499188797651,0,0,19863.0,98987.62735269018,FZR1
15748,KEGG_2019_Human,Ovarian steroidogenesis,1/49,0.0024499577795033,0.0059199114928719,0,0,19951.0,119939.1172087114,CGA
15749,KEGG_2019_Human,Autoimmune thyroid disease,1/53,0.0026499555173137,0.0059199114928719,0,0,19947.0,118349.78824235698,CGA
15750,KEGG_2019_Human,Regulation of lipolysis in adipocytes,1/55,0.0027499544131125,0.0059199114928719,0,0,19945.0,117599.1294878737,CGA
15751,KEGG_2019_Human,Prolactin signaling pathway,1/70,0.0034999466296654,0.0059199114928719,0,0,19930.0,112704.30065625212,CGA
15752,KEGG_2019_Human,Thyroid hormone synthesis,1/74,0.0036999446830449,0.0059199114928719,0,0,19926.0,111574.38983110404,CGA
15753,KEGG_2019_Human,GnRH signaling pathway,1/93,0.0046499360391879,0.0061999147189172,0,0,19907.0,106918.54242106884,CGA
15754,KEGG_2019_Human,cAMP signaling pathway,1/212,0.0105998955026255,0.0121141662887149,0,0,19788.0,89974.27756224656,CGA
15755,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,CGA
15756,KEGG_2019_Human,Estrogen signaling pathway,1/137,0.0068499188797651,0.0068499188797651,0,0,19863.0,98987.62735269018,KRT31
15757,KEGG_2019_Human,Glycosaminoglycan biosynthesis,1/53,0.0026499555173137,0.0026499555173137,0,0,19947.0,118349.78824235698,HS3ST1
15758,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,GZMA
15759,KEGG_2019_Human,Glycerolipid metabolism,1/61,0.0030499512001654,0.0048499343304706,0,0,19939.0,115499.24335773686,GPAT4
15760,KEGG_2019_Human,Glycerophospholipid metabolism,1/97,0.0048499343304706,0.0048499343304706,0,0,19903.0,106058.9096435903,GPAT4
15761,KEGG_2019_Human,Protein export,1/23,0.0011499748819949,0.0022999497639899,0,0,19977.0,135204.63922267244,SEC63
15762,KEGG_2019_Human,Protein processing in endoplasmic reticulum,1/165,0.0082499094553477,0.0082499094553477,0,0,19835.0,95159.46482222488,SEC63
15763,KEGG_2019_Human,Ribosome,1/153,0.0076499133771537,0.0076499133771537,0,0,19847.0,96715.6407630817,MRPS9
15764,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR2W1
15765,KEGG_2019_Human,MicroRNAs in cancer,1/299,0.0149498740670514,0.0149498740670514,0,0,19701.0,82804.33538735632,SLC7A1
15766,KEGG_2019_Human,Complement and coagulation cascades,1/79,0.0039499423167337,0.0048999339081079,0,0,19921.0,110243.89578070649,CPB2
15767,KEGG_2019_Human,Protein digestion and absorption,1/90,0.0044999373439762,0.0048999339081079,0,0,19910.0,107587.50385474482,CPB2
15768,KEGG_2019_Human,Pancreatic secretion,1/98,0.0048999339081079,0.0048999339081079,0,0,19902.0,105849.45495286948,CPB2
15769,KEGG_2019_Human,Primary bile acid biosynthesis,1/17,0.0008499797390404818,0.0025499392171214,0,0,19983.0,141285.76583697114,CYP27A1
15770,KEGG_2019_Human,Cholesterol metabolism,1/50,0.0024999572069037,0.0036999446830449,0,0,19950.0,119530.05920663515,CYP27A1
15771,KEGG_2019_Human,PPAR signaling pathway,1/74,0.0036999446830449,0.0036999446830449,0,0,19926.0,111574.38983110404,CYP27A1
15772,KEGG_2019_Human,Homologous recombination,1/41,0.0020499625466866,0.0020499625466866,0,0,19959.0,123544.88783416104,RBBP8
15773,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF343
15774,KEGG_2019_Human,Bacterial invasion of epithelial cells,1/74,0.0036999446830449,0.0036999446830449,0,0,19926.0,111574.38983110404,CD2AP
15775,KEGG_2019_Human,Lysosome,1/123,0.0061499239842961,0.0105998955026255,0,0,19877.0,101200.07933676826,AP1M2
15776,KEGG_2019_Human,Human immunodeficiency virus 1 infection,1/212,0.0105998955026255,0.0105998955026255,0,0,19788.0,89974.27756224656,AP1M2
15777,KEGG_2019_Human,Spliceosome,1/134,0.0066999199497742,0.0133998398995484,0,0,19866.0,99442.43560916925,SRSF5
15778,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,SRSF5
15779,KEGG_2019_Human,Lysine degradation,1/59,0.0029499522555206,0.0029499522555206,0,0,19941.0,116175.59385530632,CAMKMT
15780,KEGG_2019_Human,alpha-Linolenic acid metabolism,1/25,0.0012499733663791,0.0052874076132858,0,0,19975.0,133525.54486996148,PLA2G12A
15781,KEGG_2019_Human,Linoleic acid metabolism,1/29,0.001449970461791,0.0052874076132858,0,0,19971.0,130534.69172799008,PLA2G12A
15782,KEGG_2019_Human,Fat digestion and absorption,1/41,0.0020499625466866,0.0052874076132858,0,0,19959.0,123544.88783416104,PLA2G12A
15783,KEGG_2019_Human,Ether lipid metabolism,1/47,0.0023499589392381,0.0052874076132858,0,0,19953.0,120782.64067395544,PLA2G12A
15784,KEGG_2019_Human,Arachidonic acid metabolism,1/63,0.0031499501598827,0.005669910287789,0,0,19937.0,114844.46974572667,PLA2G12A
15785,KEGG_2019_Human,Glycerophospholipid metabolism,1/97,0.0048499343304706,0.0062999150247102,0,0,19903.0,106058.9096435903,PLA2G12A
15786,KEGG_2019_Human,Pancreatic secretion,1/98,0.0048999339081079,0.0062999150247102,0,0,19902.0,105849.45495286948,PLA2G12A
15787,KEGG_2019_Human,Vascular smooth muscle contraction,1/132,0.0065999206698993,0.0074249107536368,0,0,19868.0,99751.22090491928,PLA2G12A
15788,KEGG_2019_Human,Ras signaling pathway,1/232,0.0115998901349604,0.0115998901349604,0,0,19768.0,88101.22480150245,PLA2G12A
15789,KEGG_2019_Human,Leukocyte transendothelial migration,1/112,0.0055999282120529,0.0072499160871101,0,0,19888.0,103119.30984392198,ESAM
15790,KEGG_2019_Human,Cell adhesion molecules (CAMs),1/145,0.0072499160871101,0.0072499160871101,0,0,19855.0,97820.92670675044,ESAM
15791,KEGG_2019_Human,Protein processing in endoplasmic reticulum,1/165,0.0082499094553477,0.0082499094553477,0,0,19835.0,95159.46482222488,ERO1B
15792,KEGG_2019_Human,Spliceosome,1/134,0.0066999199497742,0.0066999199497742,0,0,19866.0,99442.43560916925,HNRNPM
15793,KEGG_2019_Human,Renal cell carcinoma,1/69,0.003449947123837,0.0074998996065834,0,0,19931.0,112996.7391397682,EGLN2
15794,KEGG_2019_Human,HIF-1 signaling pathway,1/100,0.0049999330710556,0.0074998996065834,0,0,19900.0,105436.78197328727,EGLN2
15795,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,EGLN2
15796,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR10D3
15797,KEGG_2019_Human,Estrogen signaling pathway,1/137,0.0068499188797651,0.0068499188797651,0,0,19863.0,98987.62735269018,KRT17
15798,KEGG_2019_Human,Basal transcription factors,1/45,0.0022499601197094,0.0044999202394188,0,0,19955.0,121662.49782449217,GTF2IRD1
15799,KEGG_2019_Human,cGMP-PKG signaling pathway,1/166,0.0082999091363732,0.0082999091363732,0,0,19834.0,95034.82345515196,GTF2IRD1
15800,KEGG_2019_Human,Bladder cancer,1/41,0.0020499625466866,0.0069749040587818,0,0,19959.0,123544.88783416104,MMP1
15801,KEGG_2019_Human,PPAR signaling pathway,1/74,0.0036999446830449,0.0069749040587818,0,0,19926.0,111574.38983110404,MMP1
15802,KEGG_2019_Human,Rheumatoid arthritis,1/91,0.0045499369072032,0.0069749040587818,0,0,19909.0,107362.10783923086,MMP1
15803,KEGG_2019_Human,IL-17 signaling pathway,1/93,0.0046499360391879,0.0069749040587818,0,0,19907.0,106918.54242106884,MMP1
15804,KEGG_2019_Human,Relaxin signaling pathway,1/130,0.0064999213952527,0.0077999056743033,0,0,19870.0,100064.62842845908,MMP1
15805,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,MMP1
15806,KEGG_2019_Human,Wnt signaling pathway,1/158,0.0078999117225733,0.0078999117225733,0,0,19842.0,96053.2110949472,CCN4
15807,KEGG_2019_Human,Gastric cancer,1/149,0.0074499147221605,0.0074499147221605,0,0,19851.0,97261.02051561224,REG4
15808,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR10A2
15809,KEGG_2019_Human,Focal adhesion,1/199,0.0099498991610159,0.0099498991610159,0,0,19801.0,91286.4288690606,PARVG
15810,KEGG_2019_Human,Transcriptional misregulation in cancer,1/186,0.0092999029651357,0.0092999029651357,0,0,19814.0,92684.96451050608,HOXA9
15811,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0146998751759735,0,0,19706.0,83157.67014793828,MSTN
15812,KEGG_2019_Human,Histidine metabolism,1/23,0.0011499748819949,0.0011499748819949,0,0,19977.0,135204.63922267244,HAL
15813,KEGG_2019_Human,AGE-RAGE signaling pathway in diabetic complications,1/100,0.0049999330710556,0.006949918172816,0,0,19900.0,105436.78197328727,NOX1
15814,KEGG_2019_Human,Osteoclast differentiation,1/127,0.0063499224962247,0.006949918172816,0,0,19873.0,100543.72072014232,NOX1
15815,KEGG_2019_Human,Fluid shear stress and atherosclerosis,1/139,0.006949918172816,0.006949918172816,0,0,19861.0,98689.81333375497,NOX1
15816,KEGG_2019_Human,Steroid hormone biosynthesis,1/60,0.002999951725986,0.002999951725986,0,0,19940.0,115834.63209072244,SULT2B1
15817,KEGG_2019_Human,Purine metabolism,1/129,0.006449921761047,0.006449921761047,0,0,19871.0,100223.109907462,GMPR
15818,KEGG_2019_Human,Pathogenic Escherichia coli infection,1/55,0.0027499544131125,0.0082498632393376,0,0,19945.0,117599.1294878737,ARHGEF2
15819,KEGG_2019_Human,Fluid shear stress and atherosclerosis,1/139,0.006949918172816,0.0084999078692823,0,0,19861.0,98689.81333375497,ARHGEF2
15820,KEGG_2019_Human,Tight junction,1/170,0.0084999078692823,0.0084999078692823,0,0,19830.0,94543.49009679438,ARHGEF2
15821,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF615
15822,KEGG_2019_Human,Pathogenic Escherichia coli infection,1/55,0.0027499544131125,0.0108665467971557,0,0,19945.0,117599.1294878737,YWHAZ
15823,KEGG_2019_Human,Cell cycle,1/124,0.0061999236097501,0.0108665467971557,0,0,19876.0,101034.04709010696,YWHAZ
15824,KEGG_2019_Human,Oocyte meiosis,1/125,0.0062499232373748,0.0108665467971557,0,0,19875.0,100869.32368441945,YWHAZ
15825,KEGG_2019_Human,Hepatitis C,1/155,0.0077499127120574,0.0108665467971557,0,0,19845.0,96448.16254952336,YWHAZ
15826,KEGG_2019_Human,Hippo signaling pathway,1/160,0.0079999110688441,0.0108665467971557,0,0,19840.0,95793.96509856998,YWHAZ
15827,KEGG_2019_Human,Hepatitis B,1/163,0.0081499100978668,0.0108665467971557,0,0,19837.0,95410.9786681514,YWHAZ
15828,KEGG_2019_Human,Viral carcinogenesis,1/201,0.0100498985877989,0.0114855983860559,0,0,19799.0,91079.21596609056,YWHAZ
15829,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0176998626413668,0,0,19646.0,79255.8617626126,YWHAZ
15830,KEGG_2019_Human,Oocyte meiosis,1/125,0.0062499232373748,0.0062499232373748,0,0,19875.0,100869.32368441945,REC8
15831,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0147498749536506,0,0,19705.0,83086.53988020132,PPP5C
15832,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR14I1
15833,KEGG_2019_Human,Proteasome,1/45,0.0022499601197094,0.0089998404788377,0,0,19955.0,121662.49782449217,PSMC1
15834,KEGG_2019_Human,Epstein-Barr virus infection,1/201,0.0100498985877989,0.0133998647837319,0,0,19799.0,91079.21596609056,PSMC1
15835,KEGG_2019_Human,Viral carcinogenesis,1/201,0.0100498985877989,0.0133998647837319,0,0,19799.0,91079.21596609056,PSMC1
15836,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0164998674589645,0,0,19670.0,80733.60565076157,PSMC1
15837,KEGG_2019_Human,Peroxisome,1/83,0.0041499404726918,0.0041499404726918,0,0,19917.0,109237.99888847338,PEX11G
15838,KEGG_2019_Human,Endocytosis,1/244,0.0121998870519305,0.0121998870519305,0,0,19756.0,87051.4275316661,RUFY1
15839,KEGG_2019_Human,Fructose and mannose metabolism,1/33,0.0016499677032113,0.0016499677032113,0,0,19967.0,127928.56031580272,ENOSF1
15840,KEGG_2019_Human,N-Glycan biosynthesis,1/50,0.0024999572069037,0.0024999572069037,0,0,19950.0,119530.05920663515,MGAT4A
15841,KEGG_2019_Human,Hepatitis C,1/155,0.0077499127120574,0.0077499127120574,0,0,19845.0,96448.16254952336,IFIT1B
15842,KEGG_2019_Human,Protein processing in endoplasmic reticulum,1/165,0.0082499094553477,0.0082499094553477,0,0,19835.0,95159.46482222488,DNAJA1
15843,KEGG_2019_Human,GnRH signaling pathway,1/93,0.0046499360391879,0.0054999290027479,0,0,19907.0,106918.54242106884,MMP14
15844,KEGG_2019_Human,"Parathyroid hormone synthesis, secretion and action",1/106,0.0052999306076525,0.0054999290027479,0,0,19894.0,104245.78450366124,MMP14
15845,KEGG_2019_Human,TNF signaling pathway,1/110,0.0054999290027479,0.0054999290027479,0,0,19890.0,103488.06969787036,MMP14
15846,KEGG_2019_Human,Amyotrophic lateral sclerosis (ALS),1/51,0.0025499566390179,0.0109038867493566,0,0,19949.0,119129.0228601236,PPP3CC
15847,KEGG_2019_Human,VEGF signaling pathway,1/59,0.0029499522555206,0.0109038867493566,0,0,19941.0,116175.59385530632,PPP3CC
15848,KEGG_2019_Human,Long-term potentiation,1/67,0.0033499481224912,0.0109038867493566,0,0,19933.0,113594.38808369274,PPP3CC
15849,KEGG_2019_Human,Amphetamine addiction,1/68,0.0033999476216189,0.0109038867493566,0,0,19932.0,113293.39338050144,PPP3CC
15850,KEGG_2019_Human,Renin secretion,1/69,0.003449947123837,0.0109038867493566,0,0,19931.0,112996.7391397682,PPP3CC
15851,KEGG_2019_Human,B cell receptor signaling pathway,1/71,0.0035499461386618,0.0109038867493566,0,0,19929.0,112415.9585341616,PPP3CC
15852,KEGG_2019_Human,Th1 and Th2 cell differentiation,1/92,0.0045999364719865,0.0109038867493566,0,0,19908.0,107139.13814408927,PPP3CC
15853,KEGG_2019_Human,T cell receptor signaling pathway,1/101,0.0050499326546803,0.0109038867493566,0,0,19899.0,105233.48101229242,PPP3CC
15854,KEGG_2019_Human,Glucagon signaling pathway,1/103,0.0051499318302617,0.0109038867493566,0,0,19897.0,104832.7525292024,PPP3CC
15855,KEGG_2019_Human,C-type lectin receptor signaling pathway,1/104,0.0051999314202997,0.0109038867493566,0,0,19896.0,104635.24941415618,PPP3CC
15856,KEGG_2019_Human,Th17 cell differentiation,1/107,0.0053499302026925,0.0109038867493566,0,0,19893.0,104053.753408911,PPP3CC
15857,KEGG_2019_Human,Glutamatergic synapse,1/114,0.005699927427839,0.0109038867493566,0,0,19886.0,102756.96431429044,PPP3CC
15858,KEGG_2019_Human,Oocyte meiosis,1/125,0.0062499232373748,0.0109038867493566,0,0,19875.0,100869.32368441945,PPP3CC
15859,KEGG_2019_Human,Osteoclast differentiation,1/127,0.0063499224962247,0.0109038867493566,0,0,19873.0,100543.72072014232,PPP3CC
15860,KEGG_2019_Human,Dopaminergic synapse,1/131,0.0065499210316603,0.0109038867493566,0,0,19869.0,99907.33811343512,PPP3CC
15861,KEGG_2019_Human,Natural killer cell mediated cytotoxicity,1/131,0.0065499210316603,0.0109038867493566,0,0,19869.0,99907.33811343512,PPP3CC
15862,KEGG_2019_Human,Oxytocin signaling pathway,1/153,0.0076499133771537,0.0109038867493566,0,0,19847.0,96715.6407630817,PPP3CC
15863,KEGG_2019_Human,Wnt signaling pathway,1/158,0.0078999117225733,0.0109038867493566,0,0,19842.0,96053.2110949472,PPP3CC
15864,KEGG_2019_Human,Cellular senescence,1/160,0.0079999110688441,0.0109038867493566,0,0,19840.0,95793.96509856998,PPP3CC
15865,KEGG_2019_Human,cGMP-PKG signaling pathway,1/166,0.0082999091363732,0.0109038867493566,0,0,19834.0,95034.82345515196,PPP3CC
15866,KEGG_2019_Human,Alzheimer disease,1/171,0.0085499075557634,0.0109038867493566,0,0,19829.0,94422.42241345016,PPP3CC
15867,KEGG_2019_Human,Tuberculosis,1/179,0.0089499050800561,0.0109038867493566,0,0,19821.0,93478.0629355712,PPP3CC
15868,KEGG_2019_Human,Axon guidance,1/181,0.0090499044707863,0.0109038867493566,0,0,19819.0,93248.41634586031,PPP3CC
15869,KEGG_2019_Human,Kaposi sarcoma-associated herpesvirus infection,1/186,0.0092999029651357,0.0109038867493566,0,0,19814.0,92684.96451050608,PPP3CC
15870,KEGG_2019_Human,Calcium signaling pathway,1/188,0.009399902370135,0.0109038867493566,0,0,19812.0,92463.712994847,PPP3CC
15871,KEGG_2019_Human,Human immunodeficiency virus 1 infection,1/212,0.0105998955026255,0.0116516738354279,0,0,19788.0,89974.27756224656,PPP3CC
15872,KEGG_2019_Human,Human T-cell leukemia virus 1 infection,1/219,0.0109498935894162,0.0116516738354279,0,0,19781.0,89299.85161916987,PPP3CC
15873,KEGG_2019_Human,Human cytomegalovirus infection,1/225,0.0112498919790339,0.0116516738354279,0,0,19775.0,88738.27077557483,PPP3CC
15874,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0147498749536506,0,0,19705.0,83086.53988020132,PPP3CC
15875,KEGG_2019_Human,mTOR signaling pathway,1/152,0.0075999137114971,0.0075999137114971,0,0,19848.0,96850.665715497,LAMTOR1
15876,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR6C65
15877,KEGG_2019_Human,Aldosterone-regulated sodium reabsorption,1/37,0.0018499650702878,0.0073998602811514,0,0,19963.0,125618.9446446357,SGK1
15878,KEGG_2019_Human,FoxO signaling pathway,1/132,0.0065999206698993,0.0101332182819961,0,0,19868.0,99751.22090491928,SGK1
15879,KEGG_2019_Human,mTOR signaling pathway,1/152,0.0075999137114971,0.0101332182819961,0,0,19848.0,96850.665715497,SGK1
15880,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0176998626413668,0,0,19646.0,79255.8617626126,SGK1
15881,KEGG_2019_Human,Salmonella infection,1/86,0.0042999391173866,0.0085998782347732,0,0,19914.0,108514.46102290176,PKN1
15882,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0176998626413668,0,0,19646.0,79255.8617626126,PKN1
15883,KEGG_2019_Human,Salmonella infection,1/86,0.0042999391173866,0.0042999391173866,0,0,19914.0,108514.46102290176,PLEKHM2
15884,KEGG_2019_Human,Spliceosome,1/134,0.0066999199497742,0.0133998398995484,0,0,19866.0,99442.43560916925,SRSF6
15885,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,SRSF6
15886,KEGG_2019_Human,Homologous recombination,1/41,0.0020499625466866,0.0049999256054833,0,0,19959.0,123544.88783416104,RAD51
15887,KEGG_2019_Human,Fanconi anemia pathway,1/54,0.0026999549628563,0.0049999256054833,0,0,19946.0,117971.01964061816,RAD51
15888,KEGG_2019_Human,Pancreatic cancer,1/75,0.0037499442041125,0.0049999256054833,0,0,19925.0,111301.33528642564,RAD51
15889,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,RAD51
15890,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF222
15891,KEGG_2019_Human,Basal cell carcinoma,1/63,0.0031499501598827,0.0109198810514423,0,0,19937.0,114844.46974572667,WNT10A
15892,KEGG_2019_Human,Melanogenesis,1/101,0.0050499326546803,0.0109198810514423,0,0,19899.0,105233.48101229242,WNT10A
15893,KEGG_2019_Human,Signaling pathways regulating pluripotency of stem cells,1/139,0.006949918172816,0.0109198810514423,0,0,19861.0,98689.81333375497,WNT10A
15894,KEGG_2019_Human,Breast cancer,1/147,0.0073499154017982,0.0109198810514423,0,0,19853.0,97539.10874372096,WNT10A
15895,KEGG_2019_Human,Gastric cancer,1/149,0.0074499147221605,0.0109198810514423,0,0,19851.0,97261.02051561224,WNT10A
15896,KEGG_2019_Human,mTOR signaling pathway,1/152,0.0075999137114971,0.0109198810514423,0,0,19848.0,96850.665715497,WNT10A
15897,KEGG_2019_Human,Cushing syndrome,1/155,0.0077499127120574,0.0109198810514423,0,0,19845.0,96448.16254952336,WNT10A
15898,KEGG_2019_Human,Wnt signaling pathway,1/158,0.0078999117225733,0.0109198810514423,0,0,19842.0,96053.2110949472,WNT10A
15899,KEGG_2019_Human,Hippo signaling pathway,1/160,0.0079999110688441,0.0109198810514423,0,0,19840.0,95793.96509856998,WNT10A
15900,KEGG_2019_Human,Hepatocellular carcinoma,1/168,0.0083999085011095,0.0109198810514423,0,0,19832.0,94787.72752807094,WNT10A
15901,KEGG_2019_Human,Proteoglycans in cancer,1/201,0.0100498985877989,0.0118771528764897,0,0,19799.0,91079.21596609056,WNT10A
15902,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0178748564138782,0,0,19670.0,80733.60565076157,WNT10A
15903,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,WNT10A
15904,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF557
15905,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR8D4
15906,KEGG_2019_Human,Thyroid cancer,1/37,0.0018499650702878,0.0071776714865532,0,0,19963.0,125618.9446446357,POLK
15907,KEGG_2019_Human,Fanconi anemia pathway,1/54,0.0026999549628563,0.0071776714865532,0,0,19946.0,117971.01964061816,POLK
15908,KEGG_2019_Human,Endometrial cancer,1/58,0.0028999527887707,0.0071776714865532,0,0,19942.0,116522.31890946148,POLK
15909,KEGG_2019_Human,Basal cell carcinoma,1/63,0.0031499501598827,0.0071776714865532,0,0,19937.0,114844.46974572667,POLK
15910,KEGG_2019_Human,Non-small cell lung cancer,1/66,0.003299948626608,0.0071776714865532,0,0,19934.0,113899.85357353876,POLK
15911,KEGG_2019_Human,Melanoma,1/72,0.0035999456502131,0.0071776714865532,0,0,19928.0,112131.59838572376,POLK
15912,KEGG_2019_Human,Pancreatic cancer,1/75,0.0037499442041125,0.0071776714865532,0,0,19925.0,111301.33528642564,POLK
15913,KEGG_2019_Human,Glioma,1/75,0.0037499442041125,0.0071776714865532,0,0,19925.0,111301.33528642564,POLK
15914,KEGG_2019_Human,Chronic myeloid leukemia,1/76,0.0037999437281752,0.0071776714865532,0,0,19924.0,111031.8499691117,POLK
15915,KEGG_2019_Human,Colorectal cancer,1/86,0.0042999391173866,0.0071862647878358,0,0,19914.0,108514.46102290176,POLK
15916,KEGG_2019_Human,Small cell lung cancer,1/93,0.0046499360391879,0.0071862647878358,0,0,19907.0,106918.54242106884,POLK
15917,KEGG_2019_Human,Breast cancer,1/147,0.0073499154017982,0.009742196175133,0,0,19853.0,97539.10874372096,POLK
15918,KEGG_2019_Human,Gastric cancer,1/149,0.0074499147221605,0.009742196175133,0,0,19851.0,97261.02051561224,POLK
15919,KEGG_2019_Human,Hepatocellular carcinoma,1/168,0.0083999085011095,0.0101998888942044,0,0,19832.0,94787.72752807094,POLK
15920,KEGG_2019_Human,Transcriptional misregulation in cancer,1/186,0.0092999029651357,0.0105398900271538,0,0,19814.0,92684.96451050608,POLK
15921,KEGG_2019_Human,Epstein-Barr virus infection,1/201,0.0100498985877989,0.0106780172495364,0,0,19799.0,91079.21596609056,POLK
15922,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,POLK
15923,KEGG_2019_Human,TNF signaling pathway,1/110,0.0054999290027479,0.0099332196295474,0,0,19890.0,103488.06969787036,ITCH
15924,KEGG_2019_Human,Ubiquitin mediated proteolysis,1/137,0.0068499188797651,0.0099332196295474,0,0,19863.0,98987.62735269018,ITCH
15925,KEGG_2019_Human,Non-alcoholic fatty liver disease (NAFLD),1/149,0.0074499147221605,0.0099332196295474,0,0,19851.0,97261.02051561224,ITCH
15926,KEGG_2019_Human,Endocytosis,1/244,0.0121998870519305,0.0121998870519305,0,0,19756.0,87051.4275316661,ITCH
15927,KEGG_2019_Human,Amoebiasis,1/96,0.0047999347538706,0.0047999347538706,0,0,19904.0,106270.50039849174,SERPINB3
15928,KEGG_2019_Human,African trypanosomiasis,1/37,0.0018499650702878,0.0072499160871101,0,0,19963.0,125618.9446446357,VCAM1
15929,KEGG_2019_Human,Malaria,1/49,0.0024499577795033,0.0072499160871101,0,0,19951.0,119939.1172087114,VCAM1
15930,KEGG_2019_Human,NF-kappa B signaling pathway,1/95,0.0047499351803394,0.0072499160871101,0,0,19905.0,106484.27183626965,VCAM1
15931,KEGG_2019_Human,AGE-RAGE signaling pathway in diabetic complications,1/100,0.0049999330710556,0.0072499160871101,0,0,19900.0,105436.78197328727,VCAM1
15932,KEGG_2019_Human,TNF signaling pathway,1/110,0.0054999290027479,0.0072499160871101,0,0,19890.0,103488.06969787036,VCAM1
15933,KEGG_2019_Human,Leukocyte transendothelial migration,1/112,0.0055999282120529,0.0072499160871101,0,0,19888.0,103119.30984392198,VCAM1
15934,KEGG_2019_Human,Fluid shear stress and atherosclerosis,1/139,0.006949918172816,0.0072499160871101,0,0,19861.0,98689.81333375497,VCAM1
15935,KEGG_2019_Human,Cell adhesion molecules (CAMs),1/145,0.0072499160871101,0.0072499160871101,0,0,19855.0,97820.92670675044,VCAM1
15936,KEGG_2019_Human,Prostate cancer,1/97,0.0048499343304706,0.0139498544477036,0,0,19903.0,106058.9096435903,ZEB1
15937,KEGG_2019_Human,Transcriptional misregulation in cancer,1/186,0.0092999029651357,0.0139498544477036,0,0,19814.0,92684.96451050608,ZEB1
15938,KEGG_2019_Human,MicroRNAs in cancer,1/299,0.0149498740670514,0.0149498740670514,0,0,19701.0,82804.33538735632,ZEB1
15939,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR10V1
15940,KEGG_2019_Human,cAMP signaling pathway,1/212,0.0105998955026255,0.0105998955026255,0,0,19788.0,89974.27756224656,FFAR2
15941,KEGG_2019_Human,Cell adhesion molecules (CAMs),1/145,0.0072499160871101,0.0072499160871101,0,0,19855.0,97820.92670675044,SPN
15942,KEGG_2019_Human,Mucin type O-glycan biosynthesis,1/31,0.0015499690656704,0.0015499690656704,0,0,19969.0,129189.85098816035,GALNT12
15943,KEGG_2019_Human,Pyrimidine metabolism,1/57,0.002849953326298,0.006449921761047,0,0,19943.0,116875.00742975442,ENTPD4
15944,KEGG_2019_Human,Lysosome,1/123,0.0061499239842961,0.006449921761047,0,0,19877.0,101200.07933676826,ENTPD4
15945,KEGG_2019_Human,Purine metabolism,1/129,0.006449921761047,0.006449921761047,0,0,19871.0,100223.109907462,ENTPD4
15946,KEGG_2019_Human,Protein digestion and absorption,1/90,0.0044999373439762,0.0044999373439762,0,0,19910.0,107587.50385474482,KCNE3
15947,KEGG_2019_Human,C-type lectin receptor signaling pathway,1/104,0.0051999314202997,0.0051999314202997,0,0,19896.0,104635.24941415618,CLEC6A
15948,KEGG_2019_Human,ECM-receptor interaction,1/82,0.004099940929819,0.004099940929819,0,0,19918.0,109484.9180722932,SV2C
15949,KEGG_2019_Human,Inositol phosphate metabolism,1/74,0.0036999446830449,0.0036999446830449,0,0,19926.0,111574.38983110404,FIG4
15950,KEGG_2019_Human,Glycosaminoglycan biosynthesis,1/53,0.0026499555173137,0.0026499555173137,0,0,19947.0,118349.78824235698,EXT1
15951,KEGG_2019_Human,Proximal tubule bicarbonate reclamation,1/23,0.0011499748819949,0.0062999150247102,0,0,19977.0,135204.63922267244,ATP1B4
15952,KEGG_2019_Human,Aldosterone-regulated sodium reabsorption,1/37,0.0018499650702878,0.0062999150247102,0,0,19963.0,125618.9446446357,ATP1B4
15953,KEGG_2019_Human,Carbohydrate digestion and absorption,1/44,0.0021999607179423,0.0062999150247102,0,0,19956.0,122117.06559109331,ATP1B4
15954,KEGG_2019_Human,Endocrine and other factor-regulated calcium reabsorption,1/48,0.0023999583567988,0.0062999150247102,0,0,19952.0,120356.5272753826,ATP1B4
15955,KEGG_2019_Human,Mineral absorption,1/51,0.0025499566390179,0.0062999150247102,0,0,19949.0,119129.0228601236,ATP1B4
15956,KEGG_2019_Human,Bile secretion,1/72,0.0035999456502131,0.0062999150247102,0,0,19928.0,112131.59838572376,ATP1B4
15957,KEGG_2019_Human,Thyroid hormone synthesis,1/74,0.0036999446830449,0.0062999150247102,0,0,19926.0,111574.38983110404,ATP1B4
15958,KEGG_2019_Human,Gastric acid secretion,1/75,0.0037499442041125,0.0062999150247102,0,0,19925.0,111301.33528642564,ATP1B4
15959,KEGG_2019_Human,Cardiac muscle contraction,1/78,0.0038999427840466,0.0062999150247102,0,0,19922.0,110503.2180492851,ATP1B4
15960,KEGG_2019_Human,Insulin secretion,1/86,0.0042999391173866,0.0062999150247102,0,0,19914.0,108514.46102290176,ATP1B4
15961,KEGG_2019_Human,Salivary secretion,1/90,0.0044999373439762,0.0062999150247102,0,0,19910.0,107587.50385474482,ATP1B4
15962,KEGG_2019_Human,Protein digestion and absorption,1/90,0.0044999373439762,0.0062999150247102,0,0,19910.0,107587.50385474482,ATP1B4
15963,KEGG_2019_Human,Pancreatic secretion,1/98,0.0048999339081079,0.0062999150247102,0,0,19902.0,105849.45495286948,ATP1B4
15964,KEGG_2019_Human,Aldosterone synthesis and secretion,1/98,0.0048999339081079,0.0062999150247102,0,0,19902.0,105849.45495286948,ATP1B4
15965,KEGG_2019_Human,Thyroid hormone signaling pathway,1/116,0.0057999266512085,0.0069599119814502,0,0,19884.0,102400.8105961506,ATP1B4
15966,KEGG_2019_Human,Adrenergic signaling in cardiomyocytes,1/145,0.0072499160871101,0.0081561555979989,0,0,19855.0,97820.92670675044,ATP1B4
15967,KEGG_2019_Human,cGMP-PKG signaling pathway,1/166,0.0082999091363732,0.0087881390855717,0,0,19834.0,95034.82345515196,ATP1B4
15968,KEGG_2019_Human,cAMP signaling pathway,1/212,0.0105998955026255,0.0105998955026255,0,0,19788.0,89974.27756224656,ATP1B4
15969,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF3
15970,KEGG_2019_Human,Small cell lung cancer,1/93,0.0046499360391879,0.0119398789932191,0,0,19907.0,106918.54242106884,BIRC3
15971,KEGG_2019_Human,NF-kappa B signaling pathway,1/95,0.0047499351803394,0.0119398789932191,0,0,19905.0,106484.27183626965,BIRC3
15972,KEGG_2019_Human,TNF signaling pathway,1/110,0.0054999290027479,0.0119398789932191,0,0,19890.0,103488.06969787036,BIRC3
15973,KEGG_2019_Human,Toxoplasmosis,1/113,0.0056499278191151,0.0119398789932191,0,0,19887.0,102937.34947211576,BIRC3
15974,KEGG_2019_Human,Ubiquitin mediated proteolysis,1/137,0.0068499188797651,0.0119398789932191,0,0,19863.0,98987.62735269018,BIRC3
15975,KEGG_2019_Human,Apoptosis,1/143,0.0071499167770442,0.0119398789932191,0,0,19857.0,98106.57763600958,BIRC3
15976,KEGG_2019_Human,Necroptosis,1/162,0.0080999104202618,0.0119398789932191,0,0,19838.0,95537.86936302872,BIRC3
15977,KEGG_2019_Human,NOD-like receptor signaling pathway,1/178,0.0088999053857096,0.0119398789932191,0,0,19822.0,93593.82745769851,BIRC3
15978,KEGG_2019_Human,Transcriptional misregulation in cancer,1/186,0.0092999029651357,0.0119398789932191,0,0,19814.0,92684.96451050608,BIRC3
15979,KEGG_2019_Human,Focal adhesion,1/199,0.0099498991610159,0.0119398789932191,0,0,19801.0,91286.4288690606,BIRC3
15980,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0264998334376226,0,0,19508.0,72277.44006442746,BIRC3
15981,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,BIRC3
15982,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF730
15983,KEGG_2019_Human,Glycerolipid metabolism,1/61,0.0030499512001654,0.0048499343304706,0,0,19939.0,115499.24335773686,GPAT2
15984,KEGG_2019_Human,Glycerophospholipid metabolism,1/97,0.0048499343304706,0.0048499343304706,0,0,19903.0,106058.9096435903,GPAT2
15985,KEGG_2019_Human,Other glycan degradation,1/18,0.0008999788927950273,0.00179995778559,0,0,19982.0,140136.54844084635,NEU2
15986,KEGG_2019_Human,Sphingolipid metabolism,1/47,0.0023499589392381,0.0023499589392381,0,0,19953.0,120782.64067395544,NEU2
15987,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF850
15988,KEGG_2019_Human,Vitamin B6 metabolism,1/6,0.0002999905873105514,0.0002999905873105514,0,0,19994.0,162186.51863187927,PHOSPHO2
15989,KEGG_2019_Human,mRNA surveillance pathway,1/91,0.0045499369072032,0.0101498825219542,0,0,19909.0,107362.10783923086,PPP2R3B
15990,KEGG_2019_Human,Sphingolipid signaling pathway,1/119,0.0059499254985137,0.0101498825219542,0,0,19881.0,101877.73080211312,PPP2R3B
15991,KEGG_2019_Human,AMPK signaling pathway,1/120,0.0059999251180858,0.0101498825219542,0,0,19880.0,101706.2448082016,PPP2R3B
15992,KEGG_2019_Human,Dopaminergic synapse,1/131,0.0065499210316603,0.0101498825219542,0,0,19869.0,99907.33811343512,PPP2R3B
15993,KEGG_2019_Human,Adrenergic signaling in cardiomyocytes,1/145,0.0072499160871101,0.0101498825219542,0,0,19855.0,97820.92670675044,PPP2R3B
15994,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0176998626413668,0,0,19670.0,80733.60565076157,PPP2R3B
15995,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0176998626413668,0,0,19646.0,79255.8617626126,PPP2R3B
15996,KEGG_2019_Human,Calcium signaling pathway,1/188,0.009399902370135,0.0224997839580678,0,0,19812.0,92463.712994847,PTGER1
15997,KEGG_2019_Human,Human cytomegalovirus infection,1/225,0.0112498919790339,0.0224997839580678,0,0,19775.0,88738.27077557483,PTGER1
15998,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0225331544354128,0,0,19662.0,80229.79996326564,PTGER1
15999,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,PTGER1
16000,KEGG_2019_Human,Peroxisome,1/83,0.0041499404726918,0.0041499404726918,0,0,19917.0,109237.99888847338,ECH1
16001,KEGG_2019_Human,Endocrine and other factor-regulated calcium reabsorption,1/48,0.0023999583567988,0.0077998855680932,0,0,19952.0,120356.5272753826,AP2M1
16002,KEGG_2019_Human,Synaptic vesicle cycle,1/78,0.0038999427840466,0.0077998855680932,0,0,19922.0,110503.2180492851,AP2M1
16003,KEGG_2019_Human,Huntington disease,1/193,0.0096499008972596,0.0121998870519305,0,0,19807.0,91920.47679471428,AP2M1
16004,KEGG_2019_Human,Endocytosis,1/244,0.0121998870519305,0.0121998870519305,0,0,19756.0,87051.4275316661,AP2M1
16005,KEGG_2019_Human,TGF-beta signaling pathway,1/90,0.0044999373439762,0.010424877259224,0,0,19910.0,107587.50385474482,INHBC
16006,KEGG_2019_Human,Signaling pathways regulating pluripotency of stem cells,1/139,0.006949918172816,0.010424877259224,0,0,19861.0,98689.81333375497,INHBC
16007,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0146998751759735,0,0,19706.0,83157.67014793828,INHBC
16008,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF584
16009,KEGG_2019_Human,Citrate cycle (TCA cycle),1/30,0.0014999697593334,0.0048749094888771,0,0,19970.0,129851.13732048514,FH
16010,KEGG_2019_Human,Pyruvate metabolism,1/39,0.0019499637955508,0.0048749094888771,0,0,19961.0,124555.53162481484,FH
16011,KEGG_2019_Human,Renal cell carcinoma,1/69,0.003449947123837,0.0057499118730617,0,0,19931.0,112996.7391397682,FH
16012,KEGG_2019_Human,Cushing syndrome,1/155,0.0077499127120574,0.0096873908900718,0,0,19845.0,96448.16254952336,FH
16013,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,FH
16014,KEGG_2019_Human,D-Glutamine and D-glutamate metabolism,1/5,0.0002499917995416556,0.0002499917995416556,0,0,19995.0,165840.17843725558,DGLUCY
16015,KEGG_2019_Human,Bile secretion,1/72,0.0035999456502131,0.0049499334884068,0,0,19928.0,112131.59838572376,SLC22A1
16016,KEGG_2019_Human,Choline metabolism in cancer,1/99,0.0049499334884068,0.0049499334884068,0,0,19901.0,105642.09305076736,SLC22A1
16017,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR51G2
16018,KEGG_2019_Human,Synaptic vesicle cycle,1/78,0.0038999427840466,0.0038999427840466,0,0,19922.0,110503.2180492851,CPLX2
16019,KEGG_2019_Human,Ribosome,1/153,0.0076499133771537,0.0076499133771537,0,0,19847.0,96715.6407630817,MRPL34
16020,KEGG_2019_Human,Huntington disease,1/193,0.0096499008972596,0.0096499008972596,0,0,19807.0,91920.47679471428,DNAH6
16021,KEGG_2019_Human,Fatty acid biosynthesis,1/13,0.0006499833083207112,0.0045498831582449,0,0,19987.0,146675.87616784443,ACSL4
16022,KEGG_2019_Human,Ferroptosis,1/40,0.0019999631680592,0.0048415972181405,0,0,19960.0,124043.94523066044,ACSL4
16023,KEGG_2019_Human,Fatty acid degradation,1/44,0.0021999607179423,0.0048415972181405,0,0,19956.0,122117.06559109331,ACSL4
16024,KEGG_2019_Human,Adipocytokine signaling pathway,1/69,0.003449947123837,0.0048415972181405,0,0,19931.0,112996.7391397682,ACSL4
16025,KEGG_2019_Human,PPAR signaling pathway,1/74,0.0036999446830449,0.0048415972181405,0,0,19926.0,111574.38983110404,ACSL4
16026,KEGG_2019_Human,Peroxisome,1/83,0.0041499404726918,0.0048415972181405,0,0,19917.0,109237.99888847338,ACSL4
16027,KEGG_2019_Human,Thermogenesis,1/231,0.0115498903940656,0.0115498903940656,0,0,19769.0,88191.07730937863,ACSL4
16028,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR2T4
16029,KEGG_2019_Human,ABC transporters,1/45,0.0022499601197094,0.0041499404726918,0,0,19955.0,121662.49782449217,ABCD2
16030,KEGG_2019_Human,Peroxisome,1/83,0.0041499404726918,0.0041499404726918,0,0,19917.0,109237.99888847338,ABCD2
16031,KEGG_2019_Human,Spliceosome,1/134,0.0066999199497742,0.0066999199497742,0,0,19866.0,99442.43560916925,PRPF6
16032,KEGG_2019_Human,Estrogen signaling pathway,1/137,0.0068499188797651,0.0068499188797651,0,0,19863.0,98987.62735269018,KRT12
16033,KEGG_2019_Human,Thyroid hormone synthesis,1/74,0.0036999446830449,0.0036999446830449,0,0,19926.0,111574.38983110404,ASGR1
16034,KEGG_2019_Human,Nitrogen metabolism,1/17,0.0008499797390404818,0.0008499797390404818,0,0,19983.0,141285.76583697114,CA5A
16035,KEGG_2019_Human,Leukocyte transendothelial migration,1/112,0.0055999282120529,0.0106998949514067,0,0,19888.0,103119.30984392198,ARHGAP35
16036,KEGG_2019_Human,Platelet activation,1/124,0.0061999236097501,0.0106998949514067,0,0,19876.0,101034.04709010696,ARHGAP35
16037,KEGG_2019_Human,Focal adhesion,1/199,0.0099498991610159,0.0106998949514067,0,0,19801.0,91286.4288690606,ARHGAP35
16038,KEGG_2019_Human,Regulation of actin cytoskeleton,1/214,0.0106998949514067,0.0106998949514067,0,0,19786.0,89779.39753374986,ARHGAP35
16039,KEGG_2019_Human,Galactose metabolism,1/31,0.0015499690656704,0.0034999466296654,0,0,19969.0,129189.85098816035,GALT
16040,KEGG_2019_Human,Amino sugar and nucleotide sugar metabolism,1/48,0.0023999583567988,0.0034999466296654,0,0,19952.0,120356.5272753826,GALT
16041,KEGG_2019_Human,Prolactin signaling pathway,1/70,0.0034999466296654,0.0034999466296654,0,0,19930.0,112704.30065625212,GALT
16042,KEGG_2019_Human,Other types of O-glycan biosynthesis,1/22,0.0010999756574123,0.0021999513148247,0,0,19978.0,136099.47030191717,ST6GAL2
16043,KEGG_2019_Human,N-Glycan biosynthesis,1/50,0.0024999572069037,0.0024999572069037,0,0,19950.0,119530.05920663515,ST6GAL2
16044,KEGG_2019_Human,Neurotrophin signaling pathway,1/119,0.0059499254985137,0.0059499254985137,0,0,19881.0,101877.73080211312,KIDINS220
16045,KEGG_2019_Human,Protein digestion and absorption,1/90,0.0044999373439762,0.0044999373439762,0,0,19910.0,107587.50385474482,SLC3A1
16046,KEGG_2019_Human,Histidine metabolism,1/23,0.0011499748819949,0.0023249535985056,0,0,19977.0,135204.63922267244,CNDP2
16047,KEGG_2019_Human,beta-Alanine metabolism,1/31,0.0015499690656704,0.0023249535985056,0,0,19969.0,129189.85098816035,CNDP2
16048,KEGG_2019_Human,Arginine and proline metabolism,1/49,0.0024499577795033,0.0024499577795033,0,0,19951.0,119939.1172087114,CNDP2
16049,KEGG_2019_Human,NF-kappa B signaling pathway,1/95,0.0047499351803394,0.0080999104202618,0,0,19905.0,106484.27183626965,PIAS4
16050,KEGG_2019_Human,Ubiquitin mediated proteolysis,1/137,0.0068499188797651,0.0080999104202618,0,0,19863.0,98987.62735269018,PIAS4
16051,KEGG_2019_Human,Fluid shear stress and atherosclerosis,1/139,0.006949918172816,0.0080999104202618,0,0,19861.0,98689.81333375497,PIAS4
16052,KEGG_2019_Human,JAK-STAT signaling pathway,1/162,0.0080999104202618,0.0080999104202618,0,0,19838.0,95537.86936302872,PIAS4
16053,KEGG_2019_Human,Pyrimidine metabolism,1/57,0.002849953326298,0.0053999298011749,0,0,19943.0,116875.00742975442,UPP1
16054,KEGG_2019_Human,Drug metabolism,1/108,0.0053999298011749,0.0053999298011749,0,0,19892.0,103863.47861844616,UPP1
16055,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR5K3
16056,KEGG_2019_Human,GnRH signaling pathway,1/93,0.0046499360391879,0.0092998720783758,0,0,19907.0,106918.54242106884,MAP3K4
16057,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0147498749536506,0,0,19705.0,83086.53988020132,MAP3K4
16058,KEGG_2019_Human,mRNA surveillance pathway,1/91,0.0045499369072032,0.0082499094553477,0,0,19909.0,107362.10783923086,UPF2
16059,KEGG_2019_Human,RNA transport,1/165,0.0082499094553477,0.0082499094553477,0,0,19835.0,95159.46482222488,UPF2
16060,KEGG_2019_Human,Cell adhesion molecules (CAMs),1/145,0.0072499160871101,0.0072499160871101,0,0,19855.0,97820.92670675044,MAG
16061,KEGG_2019_Human,Antigen processing and presentation,1/77,0.0038499432547502,0.0115498297642507,0,0,19923.0,110765.8407373636,CD74
16062,KEGG_2019_Human,Tuberculosis,1/179,0.0089499050800561,0.0134248576200842,0,0,19821.0,93478.0629355712,CD74
16063,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,CD74
16064,KEGG_2019_Human,Tight junction,1/170,0.0084999078692823,0.0084999078692823,0,0,19830.0,94543.49009679438,AMOTL1
16065,KEGG_2019_Human,Nicotinate and nicotinamide metabolism,1/30,0.0014999697593334,0.004274929989447,0,0,19970.0,129851.13732048514,NT5C2
16066,KEGG_2019_Human,Pyrimidine metabolism,1/57,0.002849953326298,0.004274929989447,0,0,19943.0,116875.00742975442,NT5C2
16067,KEGG_2019_Human,Purine metabolism,1/129,0.006449921761047,0.006449921761047,0,0,19871.0,100223.109907462,NT5C2
16068,KEGG_2019_Human,Purine metabolism,1/129,0.006449921761047,0.006449921761047,0,0,19871.0,100223.109907462,URAD
16069,KEGG_2019_Human,Primary immunodeficiency,1/37,0.0018499650702878,0.0074082429122622,0,0,19963.0,125618.9446446357,BTK
16070,KEGG_2019_Human,Fc epsilon RI signaling pathway,1/68,0.0033999476216189,0.0074082429122622,0,0,19932.0,113293.39338050144,BTK
16071,KEGG_2019_Human,B cell receptor signaling pathway,1/71,0.0035499461386618,0.0074082429122622,0,0,19929.0,112415.9585341616,BTK
16072,KEGG_2019_Human,NF-kappa B signaling pathway,1/95,0.0047499351803394,0.0074082429122622,0,0,19905.0,106484.27183626965,BTK
16073,KEGG_2019_Human,Platelet activation,1/124,0.0061999236097501,0.0074082429122622,0,0,19876.0,101034.04709010696,BTK
16074,KEGG_2019_Human,Osteoclast differentiation,1/127,0.0063499224962247,0.0074082429122622,0,0,19873.0,100543.72072014232,BTK
16075,KEGG_2019_Human,Epstein-Barr virus infection,1/201,0.0100498985877989,0.0100498985877989,0,0,19799.0,91079.21596609056,BTK
16076,KEGG_2019_Human,Cell adhesion molecules (CAMs),1/145,0.0072499160871101,0.0072499160871101,0,0,19855.0,97820.92670675044,CD6
16077,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF132
16078,KEGG_2019_Human,Cellular senescence,1/160,0.0079999110688441,0.0079999110688441,0,0,19840.0,95793.96509856998,FOXM1
16079,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF324
16080,KEGG_2019_Human,Folate biosynthesis,1/26,0.0012999726251831,0.0012999726251831,0,0,19974.0,132735.46073187632,GGH
16081,KEGG_2019_Human,B cell receptor signaling pathway,1/71,0.0035499461386618,0.0177497306933093,0,0,19929.0,112415.9585341616,RASGRP3
16082,KEGG_2019_Human,Rap1 signaling pathway,1/206,0.010299897173561,0.0184373436920633,0,0,19794.0,90569.849337325,RASGRP3
16083,KEGG_2019_Human,Ras signaling pathway,1/232,0.0115998901349604,0.0184373436920633,0,0,19768.0,88101.22480150245,RASGRP3
16084,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0184373436920633,0,0,19705.0,83086.53988020132,RASGRP3
16085,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,RASGRP3
16086,KEGG_2019_Human,Taste transduction,1/83,0.0041499404726918,0.0041499404726918,0,0,19917.0,109237.99888847338,CALHM1
16087,KEGG_2019_Human,Malaria,1/49,0.0024499577795033,0.0053249192079928,0,0,19951.0,119939.1172087114,CD81
16088,KEGG_2019_Human,B cell receptor signaling pathway,1/71,0.0035499461386618,0.0053249192079928,0,0,19929.0,112415.9585341616,CD81
16089,KEGG_2019_Human,Hepatitis C,1/155,0.0077499127120574,0.0077499127120574,0,0,19845.0,96448.16254952336,CD81
16090,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,HRH4
16091,KEGG_2019_Human,RNA transport,1/165,0.0082499094553477,0.0082499094553477,0,0,19835.0,95159.46482222488,EIF3B
16092,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,TRH
16093,KEGG_2019_Human,Endocytosis,1/244,0.0121998870519305,0.0121998870519305,0,0,19756.0,87051.4275316661,TSG101
16094,KEGG_2019_Human,Spliceosome,1/134,0.0066999199497742,0.0066999199497742,0,0,19866.0,99442.43560916925,RBMXL1
16095,KEGG_2019_Human,Insulin secretion,1/86,0.0042999391173866,0.0128998173521599,0,0,19914.0,108514.46102290176,GIP
16096,KEGG_2019_Human,cAMP signaling pathway,1/212,0.0105998955026255,0.0158998432539383,0,0,19788.0,89974.27756224656,GIP
16097,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,GIP
16098,KEGG_2019_Human,Bile secretion,1/72,0.0035999456502131,0.0035999456502131,0,0,19928.0,112131.59838572376,SLC22A7
16099,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0146998751759735,0,0,19706.0,83157.67014793828,TNFSF18
16100,KEGG_2019_Human,Ribosome biogenesis in eukaryotes,1/101,0.0050499326546803,0.0050499326546803,0,0,19899.0,105233.48101229242,UTP4
16101,KEGG_2019_Human,Osteoclast differentiation,1/127,0.0063499224962247,0.0126998449924495,0,0,19873.0,100543.72072014232,TNFRSF11B
16102,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0146998751759735,0,0,19706.0,83157.67014793828,TNFRSF11B
16103,KEGG_2019_Human,p53 signaling pathway,1/72,0.0035999456502131,0.0092398889378591,0,0,19928.0,112131.59838572376,CCNB1
16104,KEGG_2019_Human,Progesterone-mediated oocyte maturation,1/99,0.0049499334884068,0.0092398889378591,0,0,19901.0,105642.09305076736,CCNB1
16105,KEGG_2019_Human,Cell cycle,1/124,0.0061999236097501,0.0092398889378591,0,0,19876.0,101034.04709010696,CCNB1
16106,KEGG_2019_Human,Oocyte meiosis,1/125,0.0062499232373748,0.0092398889378591,0,0,19875.0,100869.32368441945,CCNB1
16107,KEGG_2019_Human,FoxO signaling pathway,1/132,0.0065999206698993,0.0092398889378591,0,0,19868.0,99751.22090491928,CCNB1
16108,KEGG_2019_Human,Cellular senescence,1/160,0.0079999110688441,0.0093332295803181,0,0,19840.0,95793.96509856998,CCNB1
16109,KEGG_2019_Human,Human immunodeficiency virus 1 infection,1/212,0.0105998955026255,0.0105998955026255,0,0,19788.0,89974.27756224656,CCNB1
16110,KEGG_2019_Human,Phospholipase D signaling pathway,1/148,0.007399915061391,0.0212398351696402,0,0,19852.0,97399.60470052566,LPAR4
16111,KEGG_2019_Human,Rap1 signaling pathway,1/206,0.010299897173561,0.0212398351696402,0,0,19794.0,90569.849337325,LPAR4
16112,KEGG_2019_Human,Regulation of actin cytoskeleton,1/214,0.0106998949514067,0.0212398351696402,0,0,19786.0,89779.39753374986,LPAR4
16113,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0212398351696402,0,0,19662.0,80229.79996326564,LPAR4
16114,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0212398351696402,0,0,19646.0,79255.8617626126,LPAR4
16115,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,LPAR4
16116,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF735
16117,KEGG_2019_Human,TGF-beta signaling pathway,1/90,0.0044999373439762,0.0092665575637547,0,0,19910.0,107587.50385474482,ACVR2B
16118,KEGG_2019_Human,Fluid shear stress and atherosclerosis,1/139,0.006949918172816,0.0092665575637547,0,0,19861.0,98689.81333375497,ACVR2B
16119,KEGG_2019_Human,Signaling pathways regulating pluripotency of stem cells,1/139,0.006949918172816,0.0092665575637547,0,0,19861.0,98689.81333375497,ACVR2B
16120,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0146998751759735,0,0,19706.0,83157.67014793828,ACVR2B
16121,KEGG_2019_Human,Other types of O-glycan biosynthesis,1/22,0.0010999756574123,0.0026499555173137,0,0,19978.0,136099.47030191717,B4GALT1
16122,KEGG_2019_Human,Mannose type O-glycan biosynthesis,1/23,0.0011499748819949,0.0026499555173137,0,0,19977.0,135204.63922267244,B4GALT1
16123,KEGG_2019_Human,Galactose metabolism,1/31,0.0015499690656704,0.0026499555173137,0,0,19969.0,129189.85098816035,B4GALT1
16124,KEGG_2019_Human,Glycosphingolipid biosynthesis,1/45,0.0022499601197094,0.0026499555173137,0,0,19955.0,121662.49782449217,B4GALT1
16125,KEGG_2019_Human,N-Glycan biosynthesis,1/50,0.0024999572069037,0.0026499555173137,0,0,19950.0,119530.05920663515,B4GALT1
16126,KEGG_2019_Human,Glycosaminoglycan biosynthesis,1/53,0.0026499555173137,0.0026499555173137,0,0,19947.0,118349.78824235698,B4GALT1
16127,KEGG_2019_Human,Long-term depression,1/60,0.002999951725986,0.0099165591808294,0,0,19940.0,115834.63209072244,PPP2R1A
16128,KEGG_2019_Human,TGF-beta signaling pathway,1/90,0.0044999373439762,0.0099165591808294,0,0,19910.0,107587.50385474482,PPP2R1A
16129,KEGG_2019_Human,mRNA surveillance pathway,1/91,0.0045499369072032,0.0099165591808294,0,0,19909.0,107362.10783923086,PPP2R1A
16130,KEGG_2019_Human,Chagas disease (American trypanosomiasis),1/103,0.0051499318302617,0.0099165591808294,0,0,19897.0,104832.7525292024,PPP2R1A
16131,KEGG_2019_Human,Sphingolipid signaling pathway,1/119,0.0059499254985137,0.0099165591808294,0,0,19881.0,101877.73080211312,PPP2R1A
16132,KEGG_2019_Human,AMPK signaling pathway,1/120,0.0059999251180858,0.0099165591808294,0,0,19880.0,101706.2448082016,PPP2R1A
16133,KEGG_2019_Human,Oocyte meiosis,1/125,0.0062499232373748,0.0099165591808294,0,0,19875.0,100869.32368441945,PPP2R1A
16134,KEGG_2019_Human,Dopaminergic synapse,1/131,0.0065499210316603,0.0099165591808294,0,0,19869.0,99907.33811343512,PPP2R1A
16135,KEGG_2019_Human,Adrenergic signaling in cardiomyocytes,1/145,0.0072499160871101,0.0099165591808294,0,0,19855.0,97820.92670675044,PPP2R1A
16136,KEGG_2019_Human,Hepatitis C,1/155,0.0077499127120574,0.0099165591808294,0,0,19845.0,96448.16254952336,PPP2R1A
16137,KEGG_2019_Human,Hippo signaling pathway,1/160,0.0079999110688441,0.0099165591808294,0,0,19840.0,95793.96509856998,PPP2R1A
16138,KEGG_2019_Human,Tight junction,1/170,0.0084999078692823,0.0099165591808294,0,0,19830.0,94543.49009679438,PPP2R1A
16139,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0176998626413668,0,0,19670.0,80733.60565076157,PPP2R1A
16140,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0176998626413668,0,0,19646.0,79255.8617626126,PPP2R1A
16141,KEGG_2019_Human,Mitophagy,1/65,0.003249949134407,0.003249949134407,0,0,19935.0,114209.92613860144,NBR1
16142,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR10J1
16143,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF662
16144,KEGG_2019_Human,Phenylalanine metabolism,1/17,0.0008499797390404818,0.0019999631680592,0,0,19983.0,141285.76583697114,AOC2
16145,KEGG_2019_Human,beta-Alanine metabolism,1/31,0.0015499690656704,0.0019999631680592,0,0,19969.0,129189.85098816035,AOC2
16146,KEGG_2019_Human,Tyrosine metabolism,1/36,0.0017999657178272,0.0019999631680592,0,0,19964.0,126172.23364250171,AOC2
16147,KEGG_2019_Human,"Glycine, serine and threonine metabolism",1/40,0.0019999631680592,0.0019999631680592,0,0,19960.0,124043.94523066044,AOC2
16148,KEGG_2019_Human,Endocrine and other factor-regulated calcium reabsorption,1/48,0.0023999583567988,0.0077998855680932,0,0,19952.0,120356.5272753826,AP2A1
16149,KEGG_2019_Human,Synaptic vesicle cycle,1/78,0.0038999427840466,0.0077998855680932,0,0,19922.0,110503.2180492851,AP2A1
16150,KEGG_2019_Human,Huntington disease,1/193,0.0096499008972596,0.0121998870519305,0,0,19807.0,91920.47679471428,AP2A1
16151,KEGG_2019_Human,Endocytosis,1/244,0.0121998870519305,0.0121998870519305,0,0,19756.0,87051.4275316661,AP2A1
16152,KEGG_2019_Human,mRNA surveillance pathway,1/91,0.0045499369072032,0.0045499369072032,0,0,19909.0,107362.10783923086,SMG6
16153,KEGG_2019_Human,Vibrio cholerae infection,1/50,0.0024999572069037,0.0049999144138074,0,0,19950.0,119530.05920663515,TJP2
16154,KEGG_2019_Human,Tight junction,1/170,0.0084999078692823,0.0084999078692823,0,0,19830.0,94543.49009679438,TJP2
16155,KEGG_2019_Human,Glycerolipid metabolism,1/61,0.0030499512001654,0.0030499512001654,0,0,19939.0,115499.24335773686,PNLIPRP3
16156,KEGG_2019_Human,Taste transduction,1/83,0.0041499404726918,0.0041499404726918,0,0,19917.0,109237.99888847338,TAS2R7
16157,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR8G5
16158,KEGG_2019_Human,Axon guidance,1/181,0.0090499044707863,0.0090499044707863,0,0,19819.0,93248.41634586031,NTN4
16159,KEGG_2019_Human,Complement and coagulation cascades,1/79,0.0039499423167337,0.0039499423167337,0,0,19921.0,110243.89578070649,SERPINA5
16160,KEGG_2019_Human,Legionellosis,1/55,0.0027499544131125,0.0104498870125997,0,0,19945.0,117599.1294878737,HSPA6
16161,KEGG_2019_Human,Antigen processing and presentation,1/77,0.0038499432547502,0.0104498870125997,0,0,19923.0,110765.8407373636,HSPA6
16162,KEGG_2019_Human,Longevity regulating pathway,1/102,0.0050999322416682,0.0104498870125997,0,0,19898.0,105032.15064717118,HSPA6
16163,KEGG_2019_Human,Toxoplasmosis,1/113,0.0056499278191151,0.0104498870125997,0,0,19887.0,102937.34947211576,HSPA6
16164,KEGG_2019_Human,Spliceosome,1/134,0.0066999199497742,0.0104498870125997,0,0,19866.0,99442.43560916925,HSPA6
16165,KEGG_2019_Human,Estrogen signaling pathway,1/137,0.0068499188797651,0.0104498870125997,0,0,19863.0,98987.62735269018,HSPA6
16166,KEGG_2019_Human,Measles,1/138,0.0068999185254481,0.0104498870125997,0,0,19862.0,98838.19160389496,HSPA6
16167,KEGG_2019_Human,Protein processing in endoplasmic reticulum,1/165,0.0082499094553477,0.0104498870125997,0,0,19835.0,95159.46482222488,HSPA6
16168,KEGG_2019_Human,Influenza A,1/171,0.0085499075557634,0.0104498870125997,0,0,19829.0,94422.42241345016,HSPA6
16169,KEGG_2019_Human,Endocytosis,1/244,0.0121998870519305,0.0134198757571236,0,0,19756.0,87051.4275316661,HSPA6
16170,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0147498749536506,0,0,19705.0,83086.53988020132,HSPA6
16171,KEGG_2019_Human,Inositol phosphate metabolism,1/74,0.0036999446830449,0.0078124040467185,0,0,19926.0,111574.38983110404,PLCZ1
16172,KEGG_2019_Human,Phosphatidylinositol signaling system,1/99,0.0049499334884068,0.0078124040467185,0,0,19901.0,105642.09305076736,PLCZ1
16173,KEGG_2019_Human,Thyroid hormone signaling pathway,1/116,0.0057999266512085,0.0078124040467185,0,0,19884.0,102400.8105961506,PLCZ1
16174,KEGG_2019_Human,Oocyte meiosis,1/125,0.0062499232373748,0.0078124040467185,0,0,19875.0,100869.32368441945,PLCZ1
16175,KEGG_2019_Human,Calcium signaling pathway,1/188,0.009399902370135,0.009399902370135,0,0,19812.0,92463.712994847,PLCZ1
16176,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR2A7
16177,KEGG_2019_Human,Wnt signaling pathway,1/158,0.0078999117225733,0.0078999117225733,0,0,19842.0,96053.2110949472,ZNRF3
16178,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF714
16179,KEGG_2019_Human,Inositol phosphate metabolism,1/74,0.0036999446830449,0.0049499334884068,0,0,19926.0,111574.38983110404,PI4K2B
16180,KEGG_2019_Human,Phosphatidylinositol signaling system,1/99,0.0049499334884068,0.0049499334884068,0,0,19901.0,105642.09305076736,PI4K2B
16181,KEGG_2019_Human,Pentose phosphate pathway,1/30,0.0014999697593334,0.0014999697593334,0,0,19970.0,129851.13732048514,H6PD
16182,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR6J1
16183,KEGG_2019_Human,Endometrial cancer,1/58,0.0028999527887707,0.0090748909211116,0,0,19942.0,116522.31890946148,FOXO3
16184,KEGG_2019_Human,Mitophagy,1/65,0.003249949134407,0.0090748909211116,0,0,19935.0,114209.92613860144,FOXO3
16185,KEGG_2019_Human,Non-small cell lung cancer,1/66,0.003299948626608,0.0090748909211116,0,0,19934.0,113899.85357353876,FOXO3
16186,KEGG_2019_Human,Prolactin signaling pathway,1/70,0.0034999466296654,0.0090748909211116,0,0,19930.0,112704.30065625212,FOXO3
16187,KEGG_2019_Human,Longevity regulating pathway,1/102,0.0050999322416682,0.0090748909211116,0,0,19898.0,105032.15064717118,FOXO3
16188,KEGG_2019_Human,Neurotrophin signaling pathway,1/119,0.0059499254985137,0.0090748909211116,0,0,19881.0,101877.73080211312,FOXO3
16189,KEGG_2019_Human,AMPK signaling pathway,1/120,0.0059999251180858,0.0090748909211116,0,0,19880.0,101706.2448082016,FOXO3
16190,KEGG_2019_Human,FoxO signaling pathway,1/132,0.0065999206698993,0.0090748909211116,0,0,19868.0,99751.22090491928,FOXO3
16191,KEGG_2019_Human,Cellular senescence,1/160,0.0079999110688441,0.0097776690841428,0,0,19840.0,95793.96509856998,FOXO3
16192,KEGG_2019_Human,Chemokine signaling pathway,1/190,0.0094999017791995,0.0104498919571195,0,0,19810.0,92244.74636351672,FOXO3
16193,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0176998626413668,0,0,19646.0,79255.8617626126,FOXO3
16194,KEGG_2019_Human,Inositol phosphate metabolism,1/74,0.0036999446830449,0.0049499334884068,0,0,19926.0,111574.38983110404,MTMR1
16195,KEGG_2019_Human,Phosphatidylinositol signaling system,1/99,0.0049499334884068,0.0049499334884068,0,0,19901.0,105642.09305076736,MTMR1
16196,KEGG_2019_Human,Leishmaniasis,1/74,0.0036999446830449,0.0088665659967466,0,0,19926.0,111574.38983110404,NCF1
16197,KEGG_2019_Human,Fc gamma R-mediated phagocytosis,1/91,0.0045499369072032,0.0088665659967466,0,0,19909.0,107362.10783923086,NCF1
16198,KEGG_2019_Human,Leukocyte transendothelial migration,1/112,0.0055999282120529,0.0088665659967466,0,0,19888.0,103119.30984392198,NCF1
16199,KEGG_2019_Human,Osteoclast differentiation,1/127,0.0063499224962247,0.0088665659967466,0,0,19873.0,100543.72072014232,NCF1
16200,KEGG_2019_Human,Fluid shear stress and atherosclerosis,1/139,0.006949918172816,0.0088665659967466,0,0,19861.0,98689.81333375497,NCF1
16201,KEGG_2019_Human,Phagosome,1/152,0.0075999137114971,0.0088665659967466,0,0,19848.0,96850.665715497,NCF1
16202,KEGG_2019_Human,Chemokine signaling pathway,1/190,0.0094999017791995,0.0094999017791995,0,0,19810.0,92244.74636351672,NCF1
16203,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR5K4
16204,KEGG_2019_Human,Glutathione metabolism,1/56,0.0027999538675741,0.0051249261622737,0,0,19944.0,117233.87022514464,HPGDS
16205,KEGG_2019_Human,Arachidonic acid metabolism,1/63,0.0031499501598827,0.0051249261622737,0,0,19937.0,114844.46974572667,HPGDS
16206,KEGG_2019_Human,Metabolism of xenobiotics by cytochrome P450,1/74,0.0036999446830449,0.0051249261622737,0,0,19926.0,111574.38983110404,HPGDS
16207,KEGG_2019_Human,Chemical carcinogenesis,1/82,0.004099940929819,0.0051249261622737,0,0,19918.0,109484.9180722932,HPGDS
16208,KEGG_2019_Human,Drug metabolism,1/108,0.0053999298011749,0.0053999298011749,0,0,19892.0,103863.47861844616,HPGDS
16209,KEGG_2019_Human,Protein export,1/23,0.0011499748819949,0.0011499748819949,0,0,19977.0,135204.63922267244,SRP68
16210,KEGG_2019_Human,TGF-beta signaling pathway,1/90,0.0044999373439762,0.0120665392943818,0,0,19910.0,107587.50385474482,GDF7
16211,KEGG_2019_Human,Hippo signaling pathway,1/160,0.0079999110688441,0.0120665392943818,0,0,19840.0,95793.96509856998,GDF7
16212,KEGG_2019_Human,Axon guidance,1/181,0.0090499044707863,0.0120665392943818,0,0,19819.0,93248.41634586031,GDF7
16213,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0146998751759735,0,0,19706.0,83157.67014793828,GDF7
16214,KEGG_2019_Human,Basal cell carcinoma,1/63,0.0031499501598827,0.0109198810514423,0,0,19937.0,114844.46974572667,WNT10B
16215,KEGG_2019_Human,Melanogenesis,1/101,0.0050499326546803,0.0109198810514423,0,0,19899.0,105233.48101229242,WNT10B
16216,KEGG_2019_Human,Signaling pathways regulating pluripotency of stem cells,1/139,0.006949918172816,0.0109198810514423,0,0,19861.0,98689.81333375497,WNT10B
16217,KEGG_2019_Human,Breast cancer,1/147,0.0073499154017982,0.0109198810514423,0,0,19853.0,97539.10874372096,WNT10B
16218,KEGG_2019_Human,Gastric cancer,1/149,0.0074499147221605,0.0109198810514423,0,0,19851.0,97261.02051561224,WNT10B
16219,KEGG_2019_Human,mTOR signaling pathway,1/152,0.0075999137114971,0.0109198810514423,0,0,19848.0,96850.665715497,WNT10B
16220,KEGG_2019_Human,Cushing syndrome,1/155,0.0077499127120574,0.0109198810514423,0,0,19845.0,96448.16254952336,WNT10B
16221,KEGG_2019_Human,Wnt signaling pathway,1/158,0.0078999117225733,0.0109198810514423,0,0,19842.0,96053.2110949472,WNT10B
16222,KEGG_2019_Human,Hippo signaling pathway,1/160,0.0079999110688441,0.0109198810514423,0,0,19840.0,95793.96509856998,WNT10B
16223,KEGG_2019_Human,Hepatocellular carcinoma,1/168,0.0083999085011095,0.0109198810514423,0,0,19832.0,94787.72752807094,WNT10B
16224,KEGG_2019_Human,Proteoglycans in cancer,1/201,0.0100498985877989,0.0118771528764897,0,0,19799.0,91079.21596609056,WNT10B
16225,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0178748564138782,0,0,19670.0,80733.60565076157,WNT10B
16226,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,WNT10B
16227,KEGG_2019_Human,SNARE interactions in vesicular transport,1/34,0.0016999670339032,0.0033999340678064,0,0,19966.0,127326.1054203148,STX17
16228,KEGG_2019_Human,Autophagy,1/128,0.0063999221281459,0.0063999221281459,0,0,19872.0,100382.8010329652,STX17
16229,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF333
16230,KEGG_2019_Human,Thermogenesis,1/231,0.0115498903940656,0.0115498903940656,0,0,19769.0,88191.07730937863,NDUFAF6
16231,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR13C5
16232,KEGG_2019_Human,Phototransduction,1/28,0.0013999711732997,0.0013999711732997,0,0,19972.0,131242.0761597353,SLC24A1
16233,KEGG_2019_Human,p53 signaling pathway,1/72,0.0035999456502131,0.0071499167770442,0,0,19928.0,112131.59838572376,TP53AIP1
16234,KEGG_2019_Human,Apoptosis,1/143,0.0071499167770442,0.0071499167770442,0,0,19857.0,98106.57763600958,TP53AIP1
16235,KEGG_2019_Human,Natural killer cell mediated cytotoxicity,1/131,0.0065499210316603,0.0065499210316603,0,0,19869.0,99907.33811343512,ULBP1
16236,KEGG_2019_Human,Terpenoid backbone biosynthesis,1/22,0.0010999756574123,0.0010999756574123,0,0,19978.0,136099.47030191717,PDSS1
16237,KEGG_2019_Human,Prion diseases,1/35,0.0017499663721595,0.009804221265768,0,0,19965.0,126740.98858805298,IL6
16238,KEGG_2019_Human,African trypanosomiasis,1/37,0.0018499650702878,0.009804221265768,0,0,19963.0,125618.9446446357,IL6
16239,KEGG_2019_Human,Graft-versus-host disease,1/41,0.0020499625466866,0.009804221265768,0,0,19959.0,123544.88783416104,IL6
16240,KEGG_2019_Human,Intestinal immune network for IgA production,1/48,0.0023999583567988,0.009804221265768,0,0,19952.0,120356.5272753826,IL6
16241,KEGG_2019_Human,Malaria,1/49,0.0024499577795033,0.009804221265768,0,0,19951.0,119939.1172087114,IL6
16242,KEGG_2019_Human,Legionellosis,1/55,0.0027499544131125,0.009804221265768,0,0,19945.0,117599.1294878737,IL6
16243,KEGG_2019_Human,Cytosolic DNA-sensing pathway,1/63,0.0031499501598827,0.009804221265768,0,0,19937.0,114844.46974572667,IL6
16244,KEGG_2019_Human,Inflammatory bowel disease (IBD),1/65,0.003249949134407,0.009804221265768,0,0,19935.0,114209.92613860144,IL6
16245,KEGG_2019_Human,Pertussis,1/76,0.0037999437281752,0.009804221265768,0,0,19924.0,111031.8499691117,IL6
16246,KEGG_2019_Human,Hypertrophic cardiomyopathy (HCM),1/85,0.004249939567045,0.009804221265768,0,0,19915.0,108752.83801948265,IL6
16247,KEGG_2019_Human,Salmonella infection,1/86,0.0042999391173866,0.009804221265768,0,0,19914.0,108514.46102290176,IL6
16248,KEGG_2019_Human,Rheumatoid arthritis,1/91,0.0045499369072032,0.009804221265768,0,0,19909.0,107362.10783923086,IL6
16249,KEGG_2019_Human,IL-17 signaling pathway,1/93,0.0046499360391879,0.009804221265768,0,0,19907.0,106918.54242106884,IL6
16250,KEGG_2019_Human,Amoebiasis,1/96,0.0047999347538706,0.009804221265768,0,0,19904.0,106270.50039849174,IL6
16251,KEGG_2019_Human,Hematopoietic cell lineage,1/97,0.0048499343304706,0.009804221265768,0,0,19903.0,106058.9096435903,IL6
16252,KEGG_2019_Human,AGE-RAGE signaling pathway in diabetic complications,1/100,0.0049999330710556,0.009804221265768,0,0,19900.0,105436.78197328727,IL6
16253,KEGG_2019_Human,HIF-1 signaling pathway,1/100,0.0049999330710556,0.009804221265768,0,0,19900.0,105436.78197328727,IL6
16254,KEGG_2019_Human,Chagas disease (American trypanosomiasis),1/103,0.0051499318302617,0.009804221265768,0,0,19897.0,104832.7525292024,IL6
16255,KEGG_2019_Human,Toll-like receptor signaling pathway,1/104,0.0051999314202997,0.009804221265768,0,0,19896.0,104635.24941415618,IL6
16256,KEGG_2019_Human,C-type lectin receptor signaling pathway,1/104,0.0051999314202997,0.009804221265768,0,0,19896.0,104635.24941415618,IL6
16257,KEGG_2019_Human,Th17 cell differentiation,1/107,0.0053499302026925,0.009804221265768,0,0,19893.0,104053.753408911,IL6
16258,KEGG_2019_Human,Insulin resistance,1/108,0.0053999298011749,0.009804221265768,0,0,19892.0,103863.47861844616,IL6
16259,KEGG_2019_Human,TNF signaling pathway,1/110,0.0054999290027479,0.009804221265768,0,0,19890.0,103488.06969787036,IL6
16260,KEGG_2019_Human,FoxO signaling pathway,1/132,0.0065999206698993,0.0112145888697225,0,0,19868.0,99751.22090491928,IL6
16261,KEGG_2019_Human,Measles,1/138,0.0068999185254481,0.0112145888697225,0,0,19862.0,98838.19160389496,IL6
16262,KEGG_2019_Human,Non-alcoholic fatty liver disease (NAFLD),1/149,0.0074499147221605,0.0112145888697225,0,0,19851.0,97261.02051561224,IL6
16263,KEGG_2019_Human,Cellular senescence,1/160,0.0079999110688441,0.0112145888697225,0,0,19840.0,95793.96509856998,IL6
16264,KEGG_2019_Human,JAK-STAT signaling pathway,1/162,0.0080999104202618,0.0112145888697225,0,0,19838.0,95537.86936302872,IL6
16265,KEGG_2019_Human,Hepatitis B,1/163,0.0081499100978668,0.0112145888697225,0,0,19837.0,95410.9786681514,IL6
16266,KEGG_2019_Human,Influenza A,1/171,0.0085499075557634,0.0112145888697225,0,0,19829.0,94422.42241345016,IL6
16267,KEGG_2019_Human,NOD-like receptor signaling pathway,1/178,0.0088999053857096,0.0112145888697225,0,0,19822.0,93593.82745769851,IL6
16268,KEGG_2019_Human,Tuberculosis,1/179,0.0089499050800561,0.0112145888697225,0,0,19821.0,93478.0629355712,IL6
16269,KEGG_2019_Human,Kaposi sarcoma-associated herpesvirus infection,1/186,0.0092999029651357,0.0112145888697225,0,0,19814.0,92684.96451050608,IL6
16270,KEGG_2019_Human,Transcriptional misregulation in cancer,1/186,0.0092999029651357,0.0112145888697225,0,0,19814.0,92684.96451050608,IL6
16271,KEGG_2019_Human,Epstein-Barr virus infection,1/201,0.0100498985877989,0.0117727383457073,0,0,19799.0,91079.21596609056,IL6
16272,KEGG_2019_Human,Human T-cell leukemia virus 1 infection,1/219,0.0109498935894162,0.0124660965173078,0,0,19781.0,89299.85161916987,IL6
16273,KEGG_2019_Human,Human cytomegalovirus infection,1/225,0.0112498919790339,0.0124660965173078,0,0,19775.0,88738.27077557483,IL6
16274,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0158603916372345,0,0,19706.0,83157.67014793828,IL6
16275,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0186075479050267,0,0,19646.0,79255.8617626126,IL6
16276,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0252148349541153,0,0,19508.0,72277.44006442746,IL6
16277,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,IL6
16278,KEGG_2019_Human,Purine metabolism,1/129,0.006449921761047,0.006449921761047,0,0,19871.0,100223.109907462,AMPD1
16279,KEGG_2019_Human,Hedgehog signaling pathway,1/47,0.0023499589392381,0.0062999003197655,0,0,19953.0,120782.64067395544,HHIP
16280,KEGG_2019_Human,Basal cell carcinoma,1/63,0.0031499501598827,0.0062999003197655,0,0,19937.0,114844.46974572667,HHIP
16281,KEGG_2019_Human,cAMP signaling pathway,1/212,0.0105998955026255,0.0141331940035007,0,0,19788.0,89974.27756224656,HHIP
16282,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,HHIP
16283,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR8B4
16284,KEGG_2019_Human,Bile secretion,1/72,0.0035999456502131,0.0056499278191151,0,0,19928.0,112131.59838572376,KCNN2
16285,KEGG_2019_Human,Insulin secretion,1/86,0.0042999391173866,0.0056499278191151,0,0,19914.0,108514.46102290176,KCNN2
16286,KEGG_2019_Human,Serotonergic synapse,1/113,0.0056499278191151,0.0056499278191151,0,0,19887.0,102937.34947211576,KCNN2
16287,KEGG_2019_Human,Endocytosis,1/244,0.0121998870519305,0.0121998870519305,0,0,19756.0,87051.4275316661,EPN2
16288,KEGG_2019_Human,Pancreatic cancer,1/75,0.0037499442041125,0.0128998173521599,0,0,19925.0,111301.33528642564,RALB
16289,KEGG_2019_Human,Colorectal cancer,1/86,0.0042999391173866,0.0128998173521599,0,0,19914.0,108514.46102290176,RALB
16290,KEGG_2019_Human,Phospholipase D signaling pathway,1/148,0.007399915061391,0.0139198681619524,0,0,19852.0,97399.60470052566,RALB
16291,KEGG_2019_Human,Rap1 signaling pathway,1/206,0.010299897173561,0.0139198681619524,0,0,19794.0,90569.849337325,RALB
16292,KEGG_2019_Human,Ras signaling pathway,1/232,0.0115998901349604,0.0139198681619524,0,0,19768.0,88101.22480150245,RALB
16293,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,RALB
16294,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR8G1
16295,KEGG_2019_Human,Protein processing in endoplasmic reticulum,1/165,0.0082499094553477,0.0082499094553477,0,0,19835.0,95159.46482222488,PLAA
16296,KEGG_2019_Human,Ovarian steroidogenesis,1/49,0.0024499577795033,0.0054165818906784,0,0,19951.0,119939.1172087114,CYP11A1
16297,KEGG_2019_Human,Steroid hormone biosynthesis,1/60,0.002999951725986,0.0054165818906784,0,0,19940.0,115834.63209072244,CYP11A1
16298,KEGG_2019_Human,Cortisol synthesis and secretion,1/65,0.003249949134407,0.0054165818906784,0,0,19935.0,114209.92613860144,CYP11A1
16299,KEGG_2019_Human,Aldosterone synthesis and secretion,1/98,0.0048999339081079,0.0061249173851349,0,0,19902.0,105849.45495286948,CYP11A1
16300,KEGG_2019_Human,Cushing syndrome,1/155,0.0077499127120574,0.0077499127120574,0,0,19845.0,96448.16254952336,CYP11A1
16301,KEGG_2019_Human,One carbon pool by folate,1/20,0.0009999772468562472,0.0009999772468562472,0,0,19980.0,138017.40508704726,MTHFD1
16302,KEGG_2019_Human,Ubiquitin mediated proteolysis,1/137,0.0068499188797651,0.0082499094553477,0,0,19863.0,98987.62735269018,UBE4B
16303,KEGG_2019_Human,Protein processing in endoplasmic reticulum,1/165,0.0082499094553477,0.0082499094553477,0,0,19835.0,95159.46482222488,UBE4B
16304,KEGG_2019_Human,Primary bile acid biosynthesis,1/17,0.0008499797390404818,0.0016999594780809,0,0,19983.0,141285.76583697114,AKR1C4
16305,KEGG_2019_Human,Steroid hormone biosynthesis,1/60,0.002999951725986,0.002999951725986,0,0,19940.0,115834.63209072244,AKR1C4
16306,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR1S2
16307,KEGG_2019_Human,"Glycine, serine and threonine metabolism",1/40,0.0019999631680592,0.0019999631680592,0,0,19960.0,124043.94523066044,PHGDH
16308,KEGG_2019_Human,AGE-RAGE signaling pathway in diabetic complications,1/100,0.0049999330710556,0.0049999330710556,0,0,19900.0,105436.78197328727,AGER
16309,KEGG_2019_Human,Wnt signaling pathway,1/158,0.0078999117225733,0.0078999117225733,0,0,19842.0,96053.2110949472,INVS
16310,KEGG_2019_Human,Sphingolipid signaling pathway,1/119,0.0059499254985137,0.0124498637045599,0,0,19881.0,101877.73080211312,OPRD1
16311,KEGG_2019_Human,cGMP-PKG signaling pathway,1/166,0.0082999091363732,0.0124498637045599,0,0,19834.0,95034.82345515196,OPRD1
16312,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,OPRD1
16313,KEGG_2019_Human,Insulin secretion,1/86,0.0042999391173866,0.0082999091363732,0,0,19914.0,108514.46102290176,KCNMB1
16314,KEGG_2019_Human,Vascular smooth muscle contraction,1/132,0.0065999206698993,0.0082999091363732,0,0,19868.0,99751.22090491928,KCNMB1
16315,KEGG_2019_Human,cGMP-PKG signaling pathway,1/166,0.0082999091363732,0.0082999091363732,0,0,19834.0,95034.82345515196,KCNMB1
16316,KEGG_2019_Human,Tryptophan metabolism,1/42,0.0020999619311272,0.0020999619311272,0,0,19958.0,123057.75613441122,KYNU
16317,KEGG_2019_Human,Mitophagy,1/65,0.003249949134407,0.003249949134407,0,0,19935.0,114209.92613860144,TBC1D15
16318,KEGG_2019_Human,Natural killer cell mediated cytotoxicity,1/131,0.0065499210316603,0.0092999029651357,0,0,19869.0,99907.33811343512,MICB
16319,KEGG_2019_Human,Kaposi sarcoma-associated herpesvirus infection,1/186,0.0092999029651357,0.0092999029651357,0,0,19814.0,92684.96451050608,MICB
16320,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR10G9
16321,KEGG_2019_Human,Rap1 signaling pathway,1/206,0.010299897173561,0.010299897173561,0,0,19794.0,90569.849337325,KRIT1
16322,KEGG_2019_Human,Aminoacyl-tRNA biosynthesis,1/66,0.003299948626608,0.003299948626608,0,0,19934.0,113899.85357353876,SARS2
16323,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR4X2
16324,KEGG_2019_Human,B cell receptor signaling pathway,1/71,0.0035499461386618,0.0035499461386618,0,0,19929.0,112415.9585341616,CD79B
16325,KEGG_2019_Human,One carbon pool by folate,1/20,0.0009999772468562472,0.0009999772468562472,0,0,19980.0,138017.40508704726,MTHFD1L
16326,KEGG_2019_Human,RNA transport,1/165,0.0082499094553477,0.0082499094553477,0,0,19835.0,95159.46482222488,NUP37
16327,KEGG_2019_Human,Glyoxylate and dicarboxylate metabolism,1/30,0.0014999697593334,0.0025999517274011,0,0,19970.0,129851.13732048514,ACSS2
16328,KEGG_2019_Human,Propanoate metabolism,1/32,0.0015999683804467,0.0025999517274011,0,0,19968.0,128549.41955786056,ACSS2
16329,KEGG_2019_Human,Pyruvate metabolism,1/39,0.0019499637955508,0.0025999517274011,0,0,19961.0,124555.53162481484,ACSS2
16330,KEGG_2019_Human,Glycolysis / Gluconeogenesis,1/68,0.0033999476216189,0.0033999476216189,0,0,19932.0,113293.39338050144,ACSS2
16331,KEGG_2019_Human,Maturity onset diabetes of the young,1/26,0.0012999726251831,0.0012999726251831,0,0,19974.0,132735.46073187632,FOXA3
16332,KEGG_2019_Human,Chemokine signaling pathway,1/190,0.0094999017791995,0.0146998751759735,0,0,19810.0,92244.74636351672,CCR2
16333,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0146998751759735,0,0,19706.0,83157.67014793828,CCR2
16334,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF468
16335,KEGG_2019_Human,Malaria,1/49,0.0024499577795033,0.0109564023927515,0,0,19951.0,119939.1172087114,TGFB2
16336,KEGG_2019_Human,Inflammatory bowel disease (IBD),1/65,0.003249949134407,0.0109564023927515,0,0,19935.0,114209.92613860144,TGFB2
16337,KEGG_2019_Human,Renal cell carcinoma,1/69,0.003449947123837,0.0109564023927515,0,0,19931.0,112996.7391397682,TGFB2
16338,KEGG_2019_Human,Leishmaniasis,1/74,0.0036999446830449,0.0109564023927515,0,0,19926.0,111574.38983110404,TGFB2
16339,KEGG_2019_Human,Pancreatic cancer,1/75,0.0037499442041125,0.0109564023927515,0,0,19925.0,111301.33528642564,TGFB2
16340,KEGG_2019_Human,Chronic myeloid leukemia,1/76,0.0037999437281752,0.0109564023927515,0,0,19924.0,111031.8499691117,TGFB2
16341,KEGG_2019_Human,Hypertrophic cardiomyopathy (HCM),1/85,0.004249939567045,0.0109564023927515,0,0,19915.0,108752.83801948265,TGFB2
16342,KEGG_2019_Human,Colorectal cancer,1/86,0.0042999391173866,0.0109564023927515,0,0,19914.0,108514.46102290176,TGFB2
16343,KEGG_2019_Human,TGF-beta signaling pathway,1/90,0.0044999373439762,0.0109564023927515,0,0,19910.0,107587.50385474482,TGFB2
16344,KEGG_2019_Human,Dilated cardiomyopathy (DCM),1/91,0.0045499369072032,0.0109564023927515,0,0,19909.0,107362.10783923086,TGFB2
16345,KEGG_2019_Human,Rheumatoid arthritis,1/91,0.0045499369072032,0.0109564023927515,0,0,19909.0,107362.10783923086,TGFB2
16346,KEGG_2019_Human,Amoebiasis,1/96,0.0047999347538706,0.0109564023927515,0,0,19904.0,106270.50039849174,TGFB2
16347,KEGG_2019_Human,AGE-RAGE signaling pathway in diabetic complications,1/100,0.0049999330710556,0.0109564023927515,0,0,19900.0,105436.78197328727,TGFB2
16348,KEGG_2019_Human,Chagas disease (American trypanosomiasis),1/103,0.0051499318302617,0.0109564023927515,0,0,19897.0,104832.7525292024,TGFB2
16349,KEGG_2019_Human,Toxoplasmosis,1/113,0.0056499278191151,0.0109564023927515,0,0,19887.0,102937.34947211576,TGFB2
16350,KEGG_2019_Human,Cell cycle,1/124,0.0061999236097501,0.0109564023927515,0,0,19876.0,101034.04709010696,TGFB2
16351,KEGG_2019_Human,Osteoclast differentiation,1/127,0.0063499224962247,0.0109564023927515,0,0,19873.0,100543.72072014232,TGFB2
16352,KEGG_2019_Human,FoxO signaling pathway,1/132,0.0065999206698993,0.0109564023927515,0,0,19868.0,99751.22090491928,TGFB2
16353,KEGG_2019_Human,Gastric cancer,1/149,0.0074499147221605,0.0109564023927515,0,0,19851.0,97261.02051561224,TGFB2
16354,KEGG_2019_Human,Cellular senescence,1/160,0.0079999110688441,0.0109564023927515,0,0,19840.0,95793.96509856998,TGFB2
16355,KEGG_2019_Human,Hippo signaling pathway,1/160,0.0079999110688441,0.0109564023927515,0,0,19840.0,95793.96509856998,TGFB2
16356,KEGG_2019_Human,Hepatitis B,1/163,0.0081499100978668,0.0109564023927515,0,0,19837.0,95410.9786681514,TGFB2
16357,KEGG_2019_Human,Hepatocellular carcinoma,1/168,0.0083999085011095,0.0109564023927515,0,0,19832.0,94787.72752807094,TGFB2
16358,KEGG_2019_Human,Tuberculosis,1/179,0.0089499050800561,0.0111873813500701,0,0,19821.0,93478.0629355712,TGFB2
16359,KEGG_2019_Human,Proteoglycans in cancer,1/201,0.0100498985877989,0.0120598783053587,0,0,19799.0,91079.21596609056,TGFB2
16360,KEGG_2019_Human,Human T-cell leukemia virus 1 infection,1/219,0.0109498935894162,0.0126344926031726,0,0,19781.0,89299.85161916987,TGFB2
16361,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0154653869659152,0,0,19706.0,83157.67014793828,TGFB2
16362,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0154653869659152,0,0,19705.0,83086.53988020132,TGFB2
16363,KEGG_2019_Human,MicroRNAs in cancer,1/299,0.0149498740670514,0.0154653869659152,0,0,19701.0,82804.33538735632,TGFB2
16364,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,TGFB2
16365,KEGG_2019_Human,Oxidative phosphorylation,1/133,0.0066499203093911,0.0115498903940656,0,0,19867.0,99596.2591544721,ATP5PB
16366,KEGG_2019_Human,Parkinson disease,1/142,0.0070999171242726,0.0115498903940656,0,0,19858.0,98250.87390500787,ATP5PB
16367,KEGG_2019_Human,Alzheimer disease,1/171,0.0085499075557634,0.0115498903940656,0,0,19829.0,94422.42241345016,ATP5PB
16368,KEGG_2019_Human,Huntington disease,1/193,0.0096499008972596,0.0115498903940656,0,0,19807.0,91920.47679471428,ATP5PB
16369,KEGG_2019_Human,Thermogenesis,1/231,0.0115498903940656,0.0115498903940656,0,0,19769.0,88191.07730937863,ATP5PB
16370,KEGG_2019_Human,Antigen processing and presentation,1/77,0.0038499432547502,0.0140623649737923,0,0,19923.0,110765.8407373636,TAPBP
16371,KEGG_2019_Human,Epstein-Barr virus infection,1/201,0.0100498985877989,0.0140623649737923,0,0,19799.0,91079.21596609056,TAPBP
16372,KEGG_2019_Human,Human immunodeficiency virus 1 infection,1/212,0.0105998955026255,0.0140623649737923,0,0,19788.0,89974.27756224656,TAPBP
16373,KEGG_2019_Human,Human cytomegalovirus infection,1/225,0.0112498919790339,0.0140623649737923,0,0,19775.0,88738.27077557483,TAPBP
16374,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,TAPBP
16375,KEGG_2019_Human,Butanoate metabolism,1/28,0.0013999711732997,0.0013999711732997,0,0,19972.0,131242.0761597353,ACSM4
16376,KEGG_2019_Human,Glycosylphosphatidylinositol (GPI)-anchor biosynthesis,1/25,0.0012499733663791,0.0012499733663791,0,0,19975.0,133525.54486996148,GPAA1
16377,KEGG_2019_Human,Cell adhesion molecules (CAMs),1/145,0.0072499160871101,0.0072499160871101,0,0,19855.0,97820.92670675044,NLGN2
16378,KEGG_2019_Human,Hematopoietic cell lineage,1/97,0.0048499343304706,0.0072499160871101,0,0,19903.0,106058.9096435903,CD2
16379,KEGG_2019_Human,Cell adhesion molecules (CAMs),1/145,0.0072499160871101,0.0072499160871101,0,0,19855.0,97820.92670675044,CD2
16380,KEGG_2019_Human,Sulfur relay system,1/8,0.0003999883241497325,0.0006749808857082532,0,0,19992.0,156418.91141655247,MPST
16381,KEGG_2019_Human,Sulfur metabolism,1/9,0.0004499872571388355,0.0006749808857082532,0,0,19991.0,154056.46923976458,MPST
16382,KEGG_2019_Human,Cysteine and methionine metabolism,1/47,0.0023499589392381,0.0023499589392381,0,0,19953.0,120782.64067395544,MPST
16383,KEGG_2019_Human,Glycerophospholipid metabolism,1/97,0.0048499343304706,0.0048499343304706,0,0,19903.0,106058.9096435903,ETNK2
16384,KEGG_2019_Human,N-Glycan biosynthesis,1/50,0.0024999572069037,0.002999951725986,0,0,19950.0,119530.05920663515,SRD5A3
16385,KEGG_2019_Human,Steroid hormone biosynthesis,1/60,0.002999951725986,0.002999951725986,0,0,19940.0,115834.63209072244,SRD5A3
16386,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF324B
16387,KEGG_2019_Human,Aminoacyl-tRNA biosynthesis,1/66,0.003299948626608,0.003299948626608,0,0,19934.0,113899.85357353876,GATC
16388,KEGG_2019_Human,Collecting duct acid secretion,1/27,0.0013499718942362,0.0081898864329657,0,0,19973.0,131975.02298599784,ATP6V1G2
16389,KEGG_2019_Human,Vibrio cholerae infection,1/50,0.0024999572069037,0.0081898864329657,0,0,19950.0,119530.05920663515,ATP6V1G2
16390,KEGG_2019_Human,Epithelial cell signaling in Helicobacter pylori infection,1/68,0.0033999476216189,0.0081898864329657,0,0,19932.0,113293.39338050144,ATP6V1G2
16391,KEGG_2019_Human,Synaptic vesicle cycle,1/78,0.0038999427840466,0.0081898864329657,0,0,19922.0,110503.2180492851,ATP6V1G2
16392,KEGG_2019_Human,Rheumatoid arthritis,1/91,0.0045499369072032,0.0081898864329657,0,0,19909.0,107362.10783923086,ATP6V1G2
16393,KEGG_2019_Human,Oxidative phosphorylation,1/133,0.0066499203093911,0.0085499029254342,0,0,19867.0,99596.2591544721,ATP6V1G2
16394,KEGG_2019_Human,mTOR signaling pathway,1/152,0.0075999137114971,0.0085499029254342,0,0,19848.0,96850.665715497,ATP6V1G2
16395,KEGG_2019_Human,Phagosome,1/152,0.0075999137114971,0.0085499029254342,0,0,19848.0,96850.665715497,ATP6V1G2
16396,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0164998674589645,0,0,19670.0,80733.60565076157,ATP6V1G2
16397,KEGG_2019_Human,Tyrosine metabolism,1/36,0.0017999657178272,0.0017999657178272,0,0,19964.0,126172.23364250171,FAH
16398,KEGG_2019_Human,Alzheimer disease,1/171,0.0085499075557634,0.0085499075557634,0,0,19829.0,94422.42241345016,IDE
16399,KEGG_2019_Human,mRNA surveillance pathway,1/91,0.0045499369072032,0.0096665547828135,0,0,19909.0,107362.10783923086,PPP2R5E
16400,KEGG_2019_Human,Sphingolipid signaling pathway,1/119,0.0059499254985137,0.0096665547828135,0,0,19881.0,101877.73080211312,PPP2R5E
16401,KEGG_2019_Human,AMPK signaling pathway,1/120,0.0059999251180858,0.0096665547828135,0,0,19880.0,101706.2448082016,PPP2R5E
16402,KEGG_2019_Human,Oocyte meiosis,1/125,0.0062499232373748,0.0096665547828135,0,0,19875.0,100869.32368441945,PPP2R5E
16403,KEGG_2019_Human,Dopaminergic synapse,1/131,0.0065499210316603,0.0096665547828135,0,0,19869.0,99907.33811343512,PPP2R5E
16404,KEGG_2019_Human,Adrenergic signaling in cardiomyocytes,1/145,0.0072499160871101,0.0096665547828135,0,0,19855.0,97820.92670675044,PPP2R5E
16405,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0176998626413668,0,0,19670.0,80733.60565076157,PPP2R5E
16406,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0176998626413668,0,0,19646.0,79255.8617626126,PPP2R5E
16407,KEGG_2019_Human,Neurotrophin signaling pathway,1/119,0.0059499254985137,0.0059499254985137,0,0,19881.0,101877.73080211312,BEX3
16408,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR10P1
16409,KEGG_2019_Human,RNA transport,1/165,0.0082499094553477,0.0082499094553477,0,0,19835.0,95159.46482222488,NUP85
16410,KEGG_2019_Human,Chronic myeloid leukemia,1/76,0.0037999437281752,0.0075998874563505,0,0,19924.0,111031.8499691117,BCR
16411,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,BCR
16412,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,NR3C1
16413,KEGG_2019_Human,Synaptic vesicle cycle,1/78,0.0038999427840466,0.0038999427840466,0,0,19922.0,110503.2180492851,STXBP1
16414,KEGG_2019_Human,Endocrine and other factor-regulated calcium reabsorption,1/48,0.0023999583567988,0.0064999046400777,0,0,19952.0,120356.5272753826,DNM1
16415,KEGG_2019_Human,Bacterial invasion of epithelial cells,1/74,0.0036999446830449,0.0064999046400777,0,0,19926.0,111574.38983110404,DNM1
16416,KEGG_2019_Human,Synaptic vesicle cycle,1/78,0.0038999427840466,0.0064999046400777,0,0,19922.0,110503.2180492851,DNM1
16417,KEGG_2019_Human,Phospholipase D signaling pathway,1/148,0.007399915061391,0.0092498938267387,0,0,19852.0,97399.60470052566,DNM1
16418,KEGG_2019_Human,Endocytosis,1/244,0.0121998870519305,0.0121998870519305,0,0,19756.0,87051.4275316661,DNM1
16419,KEGG_2019_Human,Cell cycle,1/124,0.0061999236097501,0.0105998955026255,0,0,19876.0,101034.04709010696,WEE2
16420,KEGG_2019_Human,Human immunodeficiency virus 1 infection,1/212,0.0105998955026255,0.0105998955026255,0,0,19788.0,89974.27756224656,WEE2
16421,KEGG_2019_Human,Maturity onset diabetes of the young,1/26,0.0012999726251831,0.0012999726251831,0,0,19974.0,132735.46073187632,NKX6-1
16422,KEGG_2019_Human,Purine metabolism,1/129,0.006449921761047,0.006449921761047,0,0,19871.0,100223.109907462,PDE9A
16423,KEGG_2019_Human,Cellular senescence,1/160,0.0079999110688441,0.0079999110688441,0,0,19840.0,95793.96509856998,HIPK4
16424,KEGG_2019_Human,cAMP signaling pathway,1/212,0.0105998955026255,0.0211997910052511,0,0,19788.0,89974.27756224656,CNGA2
16425,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,CNGA2
16426,KEGG_2019_Human,Glyoxylate and dicarboxylate metabolism,1/30,0.0014999697593334,0.0026666175574123,0,0,19970.0,129851.13732048514,GLYCTK
16427,KEGG_2019_Human,Pentose phosphate pathway,1/30,0.0014999697593334,0.0026666175574123,0,0,19970.0,129851.13732048514,GLYCTK
16428,KEGG_2019_Human,"Glycine, serine and threonine metabolism",1/40,0.0019999631680592,0.0026666175574123,0,0,19960.0,124043.94523066044,GLYCTK
16429,KEGG_2019_Human,Glycerolipid metabolism,1/61,0.0030499512001654,0.0030499512001654,0,0,19939.0,115499.24335773686,GLYCTK
16430,KEGG_2019_Human,IL-17 signaling pathway,1/93,0.0046499360391879,0.0092998720783758,0,0,19907.0,106918.54242106884,IL17RA
16431,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0146998751759735,0,0,19706.0,83157.67014793828,IL17RA
16432,KEGG_2019_Human,Taste transduction,1/83,0.0041499404726918,0.0041499404726918,0,0,19917.0,109237.99888847338,TAS2R3
16433,KEGG_2019_Human,FoxO signaling pathway,1/132,0.0065999206698993,0.0065999206698993,0,0,19868.0,99751.22090491928,FBXO32
16434,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF101
16435,KEGG_2019_Human,"Alanine, aspartate and glutamate metabolism",1/35,0.0017499663721595,0.0017499663721595,0,0,19965.0,126740.98858805298,NAT8L
16436,KEGG_2019_Human,N-Glycan biosynthesis,1/50,0.0024999572069037,0.0024999572069037,0,0,19950.0,119530.05920663515,MAN2A1
16437,KEGG_2019_Human,Aldosterone-regulated sodium reabsorption,1/37,0.0018499650702878,0.0018499650702878,0,0,19963.0,125618.9446446357,NR3C2
16438,KEGG_2019_Human,Purine metabolism,1/129,0.006449921761047,0.006449921761047,0,0,19871.0,100223.109907462,GDA
16439,KEGG_2019_Human,Ubiquitin mediated proteolysis,1/137,0.0068499188797651,0.0150748478816984,0,0,19863.0,98987.62735269018,UBE3A
16440,KEGG_2019_Human,Viral carcinogenesis,1/201,0.0100498985877989,0.0150748478816984,0,0,19799.0,91079.21596609056,UBE3A
16441,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0164998674589645,0,0,19670.0,80733.60565076157,UBE3A
16442,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF354A
16443,KEGG_2019_Human,Leukocyte transendothelial migration,1/112,0.0055999282120529,0.0055999282120529,0,0,19888.0,103119.30984392198,RHOH
16444,KEGG_2019_Human,Fat digestion and absorption,1/41,0.0020499625466866,0.0053999298011749,0,0,19959.0,123544.88783416104,SLC27A4
16445,KEGG_2019_Human,PPAR signaling pathway,1/74,0.0036999446830449,0.0053999298011749,0,0,19926.0,111574.38983110404,SLC27A4
16446,KEGG_2019_Human,Insulin resistance,1/108,0.0053999298011749,0.0053999298011749,0,0,19892.0,103863.47861844616,SLC27A4
16447,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0147498749536506,0,0,19705.0,83086.53988020132,PPM1B
16448,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0146998751759735,0,0,19706.0,83157.67014793828,IL37
16449,KEGG_2019_Human,Insulin secretion,1/86,0.0042999391173866,0.0105998955026255,0,0,19914.0,108514.46102290176,RAPGEF4
16450,KEGG_2019_Human,Leukocyte transendothelial migration,1/112,0.0055999282120529,0.0105998955026255,0,0,19888.0,103119.30984392198,RAPGEF4
16451,KEGG_2019_Human,Adrenergic signaling in cardiomyocytes,1/145,0.0072499160871101,0.0105998955026255,0,0,19855.0,97820.92670675044,RAPGEF4
16452,KEGG_2019_Human,Phospholipase D signaling pathway,1/148,0.007399915061391,0.0105998955026255,0,0,19852.0,97399.60470052566,RAPGEF4
16453,KEGG_2019_Human,Rap1 signaling pathway,1/206,0.010299897173561,0.0105998955026255,0,0,19794.0,90569.849337325,RAPGEF4
16454,KEGG_2019_Human,cAMP signaling pathway,1/212,0.0105998955026255,0.0105998955026255,0,0,19788.0,89974.27756224656,RAPGEF4
16455,KEGG_2019_Human,Type I diabetes mellitus,1/43,0.0021499613216957,0.0021499613216957,0,0,19957.0,122581.98940490963,CPE
16456,KEGG_2019_Human,Fructose and mannose metabolism,1/33,0.0016499677032113,0.0049499031096341,0,0,19967.0,127928.56031580272,PFKFB1
16457,KEGG_2019_Human,Glucagon signaling pathway,1/103,0.0051499318302617,0.0059999251180858,0,0,19897.0,104832.7525292024,PFKFB1
16458,KEGG_2019_Human,AMPK signaling pathway,1/120,0.0059999251180858,0.0059999251180858,0,0,19880.0,101706.2448082016,PFKFB1
16459,KEGG_2019_Human,Axon guidance,1/181,0.0090499044707863,0.0090499044707863,0,0,19819.0,93248.41634586031,TRPC5
16460,KEGG_2019_Human,Maturity onset diabetes of the young,1/26,0.0012999726251831,0.0012999726251831,0,0,19974.0,132735.46073187632,NEUROD1
16461,KEGG_2019_Human,Drug metabolism,1/108,0.0053999298011749,0.006449921761047,0,0,19892.0,103863.47861844616,GMPS
16462,KEGG_2019_Human,Purine metabolism,1/129,0.006449921761047,0.006449921761047,0,0,19871.0,100223.109907462,GMPS
16463,KEGG_2019_Human,Ubiquitin mediated proteolysis,1/137,0.0068499188797651,0.0068499188797651,0,0,19863.0,98987.62735269018,UBE2NL
16464,KEGG_2019_Human,Fructose and mannose metabolism,1/33,0.0016499677032113,0.0023999583567988,0,0,19967.0,127928.56031580272,PMM1
16465,KEGG_2019_Human,Amino sugar and nucleotide sugar metabolism,1/48,0.0023999583567988,0.0023999583567988,0,0,19952.0,120356.5272753826,PMM1
16466,KEGG_2019_Human,mRNA surveillance pathway,1/91,0.0045499369072032,0.0096665547828135,0,0,19909.0,107362.10783923086,PPP2R5D
16467,KEGG_2019_Human,Sphingolipid signaling pathway,1/119,0.0059499254985137,0.0096665547828135,0,0,19881.0,101877.73080211312,PPP2R5D
16468,KEGG_2019_Human,AMPK signaling pathway,1/120,0.0059999251180858,0.0096665547828135,0,0,19880.0,101706.2448082016,PPP2R5D
16469,KEGG_2019_Human,Oocyte meiosis,1/125,0.0062499232373748,0.0096665547828135,0,0,19875.0,100869.32368441945,PPP2R5D
16470,KEGG_2019_Human,Dopaminergic synapse,1/131,0.0065499210316603,0.0096665547828135,0,0,19869.0,99907.33811343512,PPP2R5D
16471,KEGG_2019_Human,Adrenergic signaling in cardiomyocytes,1/145,0.0072499160871101,0.0096665547828135,0,0,19855.0,97820.92670675044,PPP2R5D
16472,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0176998626413668,0,0,19670.0,80733.60565076157,PPP2R5D
16473,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0176998626413668,0,0,19646.0,79255.8617626126,PPP2R5D
16474,KEGG_2019_Human,Morphine addiction,1/91,0.0045499369072032,0.0121998870519305,0,0,19909.0,107362.10783923086,GRK5
16475,KEGG_2019_Human,Chemokine signaling pathway,1/190,0.0094999017791995,0.0121998870519305,0,0,19810.0,92244.74636351672,GRK5
16476,KEGG_2019_Human,Endocytosis,1/244,0.0121998870519305,0.0121998870519305,0,0,19756.0,87051.4275316661,GRK5
16477,KEGG_2019_Human,cAMP signaling pathway,1/212,0.0105998955026255,0.0105998955026255,0,0,19788.0,89974.27756224656,HCAR2
16478,KEGG_2019_Human,Staphylococcus aureus infection,1/68,0.0033999476216189,0.0067998952432378,0,0,19932.0,113293.39338050144,DEFA4
16479,KEGG_2019_Human,NOD-like receptor signaling pathway,1/178,0.0088999053857096,0.0088999053857096,0,0,19822.0,93593.82745769851,DEFA4
16480,KEGG_2019_Human,Notch signaling pathway,1/48,0.0023999583567988,0.0023999583567988,0,0,19952.0,120356.5272753826,DTX2
16481,KEGG_2019_Human,Regulation of actin cytoskeleton,1/214,0.0106998949514067,0.0106998949514067,0,0,19786.0,89779.39753374986,FGD1
16482,KEGG_2019_Human,Regulation of lipolysis in adipocytes,1/55,0.0027499544131125,0.0045749268002481,0,0,19945.0,117599.1294878737,PNPLA2
16483,KEGG_2019_Human,Glycerolipid metabolism,1/61,0.0030499512001654,0.0045749268002481,0,0,19939.0,115499.24335773686,PNPLA2
16484,KEGG_2019_Human,Thermogenesis,1/231,0.0115498903940656,0.0115498903940656,0,0,19769.0,88191.07730937863,PNPLA2
16485,KEGG_2019_Human,Human T-cell leukemia virus 1 infection,1/219,0.0109498935894162,0.0109498935894162,0,0,19781.0,89299.85161916987,MSX2
16486,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR4F4
16487,KEGG_2019_Human,cAMP signaling pathway,1/212,0.0105998955026255,0.0105998955026255,0,0,19788.0,89974.27756224656,HCAR3
16488,KEGG_2019_Human,Endocytosis,1/244,0.0121998870519305,0.0121998870519305,0,0,19756.0,87051.4275316661,PSD
16489,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF623
16490,KEGG_2019_Human,Wnt signaling pathway,1/158,0.0078999117225733,0.0078999117225733,0,0,19842.0,96053.2110949472,CER1
16491,KEGG_2019_Human,Nicotine addiction,1/40,0.0019999631680592,0.007583228178672,0,0,19960.0,124043.94523066044,GABRR1
16492,KEGG_2019_Human,GABAergic synapse,1/89,0.0044499377838098,0.007583228178672,0,0,19911.0,107815.380281759,GABRR1
16493,KEGG_2019_Human,Morphine addiction,1/91,0.0045499369072032,0.007583228178672,0,0,19909.0,107362.10783923086,GABRR1
16494,KEGG_2019_Human,Retrograde endocannabinoid signaling,1/148,0.007399915061391,0.0092498938267387,0,0,19852.0,97399.60470052566,GABRR1
16495,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,GABRR1
16496,KEGG_2019_Human,Acute myeloid leukemia,1/66,0.003299948626608,0.0098998458798241,0,0,19934.0,113899.85357353876,ZBTB16
16497,KEGG_2019_Human,Transcriptional misregulation in cancer,1/186,0.0092999029651357,0.0139498544477036,0,0,19814.0,92684.96451050608,ZBTB16
16498,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,ZBTB16
16499,KEGG_2019_Human,Ubiquitin mediated proteolysis,1/137,0.0068499188797651,0.0068499188797651,0,0,19863.0,98987.62735269018,MID1
16500,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0146998751759735,0,0,19706.0,83157.67014793828,TNFRSF19
16501,KEGG_2019_Human,Carbohydrate digestion and absorption,1/44,0.0021999607179423,0.0021999607179423,0,0,19956.0,122117.06559109331,SLC37A4
16502,KEGG_2019_Human,Inflammatory bowel disease (IBD),1/65,0.003249949134407,0.0133748255067314,0,0,19935.0,114209.92613860144,IL23R
16503,KEGG_2019_Human,Th17 cell differentiation,1/107,0.0053499302026925,0.0133748255067314,0,0,19893.0,104053.753408911,IL23R
16504,KEGG_2019_Human,JAK-STAT signaling pathway,1/162,0.0080999104202618,0.0134998507004364,0,0,19838.0,95537.86936302872,IL23R
16505,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0183748439699668,0,0,19706.0,83157.67014793828,IL23R
16506,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,IL23R
16507,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR5P2
16508,KEGG_2019_Human,Wnt signaling pathway,1/158,0.0078999117225733,0.0078999117225733,0,0,19842.0,96053.2110949472,CXXC4
16509,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF460
16510,KEGG_2019_Human,Endocrine and other factor-regulated calcium reabsorption,1/48,0.0023999583567988,0.0102898815625175,0,0,19952.0,120356.5272753826,ESR1
16511,KEGG_2019_Human,Prolactin signaling pathway,1/70,0.0034999466296654,0.0102898815625175,0,0,19930.0,112704.30065625212,ESR1
16512,KEGG_2019_Human,Thyroid hormone signaling pathway,1/116,0.0057999266512085,0.0102898815625175,0,0,19884.0,102400.8105961506,ESR1
16513,KEGG_2019_Human,Estrogen signaling pathway,1/137,0.0068499188797651,0.0102898815625175,0,0,19863.0,98987.62735269018,ESR1
16514,KEGG_2019_Human,Breast cancer,1/147,0.0073499154017982,0.0102898815625175,0,0,19853.0,97539.10874372096,ESR1
16515,KEGG_2019_Human,Proteoglycans in cancer,1/201,0.0100498985877989,0.0117248816857654,0,0,19799.0,91079.21596609056,ESR1
16516,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,ESR1
16517,KEGG_2019_Human,Peroxisome,1/83,0.0041499404726918,0.0041499404726918,0,0,19917.0,109237.99888847338,FAR1
16518,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR6X1
16519,KEGG_2019_Human,N-Glycan biosynthesis,1/50,0.0024999572069037,0.0049999144138074,0,0,19950.0,119530.05920663515,MAN1B1
16520,KEGG_2019_Human,Protein processing in endoplasmic reticulum,1/165,0.0082499094553477,0.0082499094553477,0,0,19835.0,95159.46482222488,MAN1B1
16521,KEGG_2019_Human,Cocaine addiction,1/49,0.0024499577795033,0.011374842268008,0,0,19951.0,119939.1172087114,DRD1
16522,KEGG_2019_Human,Amphetamine addiction,1/68,0.0033999476216189,0.011374842268008,0,0,19932.0,113293.39338050144,DRD1
16523,KEGG_2019_Human,Gap junction,1/88,0.0043999382262822,0.011374842268008,0,0,19912.0,108045.79305232369,DRD1
16524,KEGG_2019_Human,Morphine addiction,1/91,0.0045499369072032,0.011374842268008,0,0,19909.0,107362.10783923086,DRD1
16525,KEGG_2019_Human,Dopaminergic synapse,1/131,0.0065499210316603,0.0117498779626688,0,0,19869.0,99907.33811343512,DRD1
16526,KEGG_2019_Human,Parkinson disease,1/142,0.0070999171242726,0.0117498779626688,0,0,19858.0,98250.87390500787,DRD1
16527,KEGG_2019_Human,Alcoholism,1/180,0.0089999047745351,0.0117498779626688,0,0,19820.0,93362.92821536642,DRD1
16528,KEGG_2019_Human,Calcium signaling pathway,1/188,0.009399902370135,0.0117498779626688,0,0,19812.0,92463.712994847,DRD1
16529,KEGG_2019_Human,cAMP signaling pathway,1/212,0.0105998955026255,0.0117776616695839,0,0,19788.0,89974.27756224656,DRD1
16530,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,DRD1
16531,KEGG_2019_Human,Propanoate metabolism,1/32,0.0015999683804467,0.0015999683804467,0,0,19968.0,128549.41955786056,ACSS3
16532,KEGG_2019_Human,mRNA surveillance pathway,1/91,0.0045499369072032,0.0082499094553477,0,0,19909.0,107362.10783923086,UPF1
16533,KEGG_2019_Human,RNA transport,1/165,0.0082499094553477,0.0082499094553477,0,0,19835.0,95159.46482222488,UPF1
16534,KEGG_2019_Human,Citrate cycle (TCA cycle),1/30,0.0014999697593334,0.0014999697593334,0,0,19970.0,129851.13732048514,OGDH
16535,KEGG_2019_Human,Endocytosis,1/244,0.0121998870519305,0.0121998870519305,0,0,19756.0,87051.4275316661,EHD2
16536,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF680
16537,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF727
16538,KEGG_2019_Human,Spliceosome,1/134,0.0066999199497742,0.0066999199497742,0,0,19866.0,99442.43560916925,HNRNPA1
16539,KEGG_2019_Human,Cytosolic DNA-sensing pathway,1/63,0.0031499501598827,0.0109635257321443,0,0,19937.0,114844.46974572667,IRF7
16540,KEGG_2019_Human,RIG-I-like receptor signaling pathway,1/70,0.0034999466296654,0.0109635257321443,0,0,19930.0,112704.30065625212,IRF7
16541,KEGG_2019_Human,Toll-like receptor signaling pathway,1/104,0.0051999314202997,0.0109635257321443,0,0,19896.0,104635.24941415618,IRF7
16542,KEGG_2019_Human,Measles,1/138,0.0068999185254481,0.0109635257321443,0,0,19862.0,98838.19160389496,IRF7
16543,KEGG_2019_Human,Hepatitis C,1/155,0.0077499127120574,0.0109635257321443,0,0,19845.0,96448.16254952336,IRF7
16544,KEGG_2019_Human,Hepatitis B,1/163,0.0081499100978668,0.0109635257321443,0,0,19837.0,95410.9786681514,IRF7
16545,KEGG_2019_Human,Influenza A,1/171,0.0085499075557634,0.0109635257321443,0,0,19829.0,94422.42241345016,IRF7
16546,KEGG_2019_Human,NOD-like receptor signaling pathway,1/178,0.0088999053857096,0.0109635257321443,0,0,19822.0,93593.82745769851,IRF7
16547,KEGG_2019_Human,Kaposi sarcoma-associated herpesvirus infection,1/186,0.0092999029651357,0.0109635257321443,0,0,19814.0,92684.96451050608,IRF7
16548,KEGG_2019_Human,Epstein-Barr virus infection,1/201,0.0100498985877989,0.0109635257321443,0,0,19799.0,91079.21596609056,IRF7
16549,KEGG_2019_Human,Viral carcinogenesis,1/201,0.0100498985877989,0.0109635257321443,0,0,19799.0,91079.21596609056,IRF7
16550,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,IRF7
16551,KEGG_2019_Human,Morphine addiction,1/91,0.0045499369072032,0.008599895681396,0,0,19909.0,107362.10783923086,PDE4A
16552,KEGG_2019_Human,"Parathyroid hormone synthesis, secretion and action",1/106,0.0052999306076525,0.008599895681396,0,0,19894.0,104245.78450366124,PDE4A
16553,KEGG_2019_Human,Purine metabolism,1/129,0.006449921761047,0.008599895681396,0,0,19871.0,100223.109907462,PDE4A
16554,KEGG_2019_Human,cAMP signaling pathway,1/212,0.0105998955026255,0.0105998955026255,0,0,19788.0,89974.27756224656,PDE4A
16555,KEGG_2019_Human,Peroxisome,1/83,0.0041499404726918,0.0041499404726918,0,0,19917.0,109237.99888847338,DECR2
16556,KEGG_2019_Human,Salmonella infection,1/86,0.0042999391173866,0.0042999391173866,0,0,19914.0,108514.46102290176,KLC2
16557,KEGG_2019_Human,SNARE interactions in vesicular transport,1/34,0.0016999670339032,0.0033999340678064,0,0,19966.0,127326.1054203148,STX3
16558,KEGG_2019_Human,Synaptic vesicle cycle,1/78,0.0038999427840466,0.0038999427840466,0,0,19922.0,110503.2180492851,STX3
16559,KEGG_2019_Human,Platelet activation,1/124,0.0061999236097501,0.0140998535552025,0,0,19876.0,101034.04709010696,P2RX1
16560,KEGG_2019_Human,Calcium signaling pathway,1/188,0.009399902370135,0.0140998535552025,0,0,19812.0,92463.712994847,P2RX1
16561,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,P2RX1
16562,KEGG_2019_Human,Antigen processing and presentation,1/77,0.0038499432547502,0.0106798864628515,0,0,19923.0,110765.8407373636,HSP90AA1
16563,KEGG_2019_Human,IL-17 signaling pathway,1/93,0.0046499360391879,0.0106798864628515,0,0,19907.0,106918.54242106884,HSP90AA1
16564,KEGG_2019_Human,Prostate cancer,1/97,0.0048499343304706,0.0106798864628515,0,0,19903.0,106058.9096435903,HSP90AA1
16565,KEGG_2019_Human,Progesterone-mediated oocyte maturation,1/99,0.0049499334884068,0.0106798864628515,0,0,19901.0,105642.09305076736,HSP90AA1
16566,KEGG_2019_Human,Th17 cell differentiation,1/107,0.0053499302026925,0.0106798864628515,0,0,19893.0,104053.753408911,HSP90AA1
16567,KEGG_2019_Human,Estrogen signaling pathway,1/137,0.0068499188797651,0.0106798864628515,0,0,19863.0,98987.62735269018,HSP90AA1
16568,KEGG_2019_Human,Fluid shear stress and atherosclerosis,1/139,0.006949918172816,0.0106798864628515,0,0,19861.0,98689.81333375497,HSP90AA1
16569,KEGG_2019_Human,Necroptosis,1/162,0.0080999104202618,0.0106798864628515,0,0,19838.0,95537.86936302872,HSP90AA1
16570,KEGG_2019_Human,Protein processing in endoplasmic reticulum,1/165,0.0082499094553477,0.0106798864628515,0,0,19835.0,95159.46482222488,HSP90AA1
16571,KEGG_2019_Human,NOD-like receptor signaling pathway,1/178,0.0088999053857096,0.0106798864628515,0,0,19822.0,93593.82745769851,HSP90AA1
16572,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0193089410633093,0,0,19646.0,79255.8617626126,HSP90AA1
16573,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,HSP90AA1
16574,KEGG_2019_Human,Ovarian steroidogenesis,1/49,0.0024499577795033,0.0092998720783758,0,0,19951.0,119939.1172087114,FSHB
16575,KEGG_2019_Human,GnRH signaling pathway,1/93,0.0046499360391879,0.0092998720783758,0,0,19907.0,106918.54242106884,FSHB
16576,KEGG_2019_Human,cAMP signaling pathway,1/212,0.0105998955026255,0.0141331940035007,0,0,19788.0,89974.27756224656,FSHB
16577,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,FSHB
16578,KEGG_2019_Human,mTOR signaling pathway,1/152,0.0075999137114971,0.0075999137114971,0,0,19848.0,96850.665715497,MIOS
16579,KEGG_2019_Human,Inflammatory mediator regulation of TRP channels,1/100,0.0049999330710556,0.0106998604053851,0,0,19900.0,105436.78197328727,IL1RAP
16580,KEGG_2019_Human,Th17 cell differentiation,1/107,0.0053499302026925,0.0106998604053851,0,0,19893.0,104053.753408911,IL1RAP
16581,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0147498749536506,0,0,19706.0,83157.67014793828,IL1RAP
16582,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0147498749536506,0,0,19705.0,83086.53988020132,IL1RAP
16583,KEGG_2019_Human,RNA degradation,1/79,0.0039499423167337,0.0039499423167337,0,0,19921.0,110243.89578070649,CNOT4
16584,KEGG_2019_Human,Transcriptional misregulation in cancer,1/186,0.0092999029651357,0.0092999029651357,0,0,19814.0,92684.96451050608,EWSR1
16585,KEGG_2019_Human,Autophagy,1/128,0.0063999221281459,0.0063999221281459,0,0,19872.0,100382.8010329652,ATG4A
16586,KEGG_2019_Human,Porphyrin and chlorophyll metabolism,1/42,0.0020999619311272,0.0020999619311272,0,0,19958.0,123057.75613441122,BLVRA
16587,KEGG_2019_Human,NOD-like receptor signaling pathway,1/178,0.0088999053857096,0.0088999053857096,0,0,19822.0,93593.82745769851,ANTXR1
16588,KEGG_2019_Human,Ribosome biogenesis in eukaryotes,1/101,0.0050499326546803,0.0109498935894162,0,0,19899.0,105233.48101229242,XPO1
16589,KEGG_2019_Human,RNA transport,1/165,0.0082499094553477,0.0109498935894162,0,0,19835.0,95159.46482222488,XPO1
16590,KEGG_2019_Human,Influenza A,1/171,0.0085499075557634,0.0109498935894162,0,0,19829.0,94422.42241345016,XPO1
16591,KEGG_2019_Human,Human T-cell leukemia virus 1 infection,1/219,0.0109498935894162,0.0109498935894162,0,0,19781.0,89299.85161916987,XPO1
16592,KEGG_2019_Human,Endocrine and other factor-regulated calcium reabsorption,1/48,0.0023999583567988,0.0077998855680932,0,0,19952.0,120356.5272753826,CLTB
16593,KEGG_2019_Human,Bacterial invasion of epithelial cells,1/74,0.0036999446830449,0.0077998855680932,0,0,19926.0,111574.38983110404,CLTB
16594,KEGG_2019_Human,Synaptic vesicle cycle,1/78,0.0038999427840466,0.0077998855680932,0,0,19922.0,110503.2180492851,CLTB
16595,KEGG_2019_Human,Lysosome,1/123,0.0061499239842961,0.0092248859764442,0,0,19877.0,101200.07933676826,CLTB
16596,KEGG_2019_Human,Huntington disease,1/193,0.0096499008972596,0.0115798810767115,0,0,19807.0,91920.47679471428,CLTB
16597,KEGG_2019_Human,Endocytosis,1/244,0.0121998870519305,0.0121998870519305,0,0,19756.0,87051.4275316661,CLTB
16598,KEGG_2019_Human,Spliceosome,1/134,0.0066999199497742,0.0066999199497742,0,0,19866.0,99442.43560916925,TRA2A
16599,KEGG_2019_Human,Endocytosis,1/244,0.0121998870519305,0.0121998870519305,0,0,19756.0,87051.4275316661,WASHC4
16600,KEGG_2019_Human,Apoptosis,1/143,0.0071499167770442,0.0071499167770442,0,0,19857.0,98106.57763600958,CASP2
16601,KEGG_2019_Human,Peroxisome,1/83,0.0041499404726918,0.0041499404726918,0,0,19917.0,109237.99888847338,FAR2
16602,KEGG_2019_Human,Maturity onset diabetes of the young,1/26,0.0012999726251831,0.0025999452503662,0,0,19974.0,132735.46073187632,IAPP
16603,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,IAPP
16604,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF84
16605,KEGG_2019_Human,beta-Alanine metabolism,1/31,0.0015499690656704,0.0031999367608934,0,0,19969.0,129189.85098816035,MLYCD
16606,KEGG_2019_Human,Propanoate metabolism,1/32,0.0015999683804467,0.0031999367608934,0,0,19968.0,128549.41955786056,MLYCD
16607,KEGG_2019_Human,Peroxisome,1/83,0.0041499404726918,0.0055332539635891,0,0,19917.0,109237.99888847338,MLYCD
16608,KEGG_2019_Human,AMPK signaling pathway,1/120,0.0059999251180858,0.0059999251180858,0,0,19880.0,101706.2448082016,MLYCD
16609,KEGG_2019_Human,JAK-STAT signaling pathway,1/162,0.0080999104202618,0.0080999104202618,0,0,19838.0,95537.86936302872,IL22RA2
16610,KEGG_2019_Human,Wnt signaling pathway,1/158,0.0078999117225733,0.0078999117225733,0,0,19842.0,96053.2110949472,RSPO2
16611,KEGG_2019_Human,Long-term potentiation,1/67,0.0033499481224912,0.0098943272707719,0,0,19933.0,113594.38808369274,CAMK4
16612,KEGG_2019_Human,Amphetamine addiction,1/68,0.0033999476216189,0.0098943272707719,0,0,19932.0,113293.39338050144,CAMK4
16613,KEGG_2019_Human,Glioma,1/75,0.0037499442041125,0.0098943272707719,0,0,19925.0,111301.33528642564,CAMK4
16614,KEGG_2019_Human,Aldosterone synthesis and secretion,1/98,0.0048999339081079,0.0098943272707719,0,0,19902.0,105849.45495286948,CAMK4
16615,KEGG_2019_Human,Longevity regulating pathway,1/102,0.0050999322416682,0.0098943272707719,0,0,19898.0,105032.15064717118,CAMK4
16616,KEGG_2019_Human,Cholinergic synapse,1/112,0.0055999282120529,0.0098943272707719,0,0,19888.0,103119.30984392198,CAMK4
16617,KEGG_2019_Human,Neurotrophin signaling pathway,1/119,0.0059499254985137,0.0098943272707719,0,0,19881.0,101877.73080211312,CAMK4
16618,KEGG_2019_Human,Osteoclast differentiation,1/127,0.0063499224962247,0.0098943272707719,0,0,19873.0,100543.72072014232,CAMK4
16619,KEGG_2019_Human,Apelin signaling pathway,1/137,0.0068499188797651,0.0098943272707719,0,0,19863.0,98987.62735269018,CAMK4
16620,KEGG_2019_Human,Oxytocin signaling pathway,1/153,0.0076499133771537,0.0099448873902999,0,0,19847.0,96715.6407630817,CAMK4
16621,KEGG_2019_Human,Alcoholism,1/180,0.0089999047745351,0.0101832275676463,0,0,19820.0,93362.92821536642,CAMK4
16622,KEGG_2019_Human,Calcium signaling pathway,1/188,0.009399902370135,0.0101832275676463,0,0,19812.0,92463.712994847,CAMK4
16623,KEGG_2019_Human,cAMP signaling pathway,1/212,0.0105998955026255,0.0105998955026255,0,0,19788.0,89974.27756224656,CAMK4
16624,KEGG_2019_Human,TGF-beta signaling pathway,1/90,0.0044999373439762,0.0079999110688441,0,0,19910.0,107587.50385474482,E2F4
16625,KEGG_2019_Human,Cell cycle,1/124,0.0061999236097501,0.0079999110688441,0,0,19876.0,101034.04709010696,E2F4
16626,KEGG_2019_Human,Cellular senescence,1/160,0.0079999110688441,0.0079999110688441,0,0,19840.0,95793.96509856998,E2F4
16627,KEGG_2019_Human,Tryptophan metabolism,1/42,0.0020999619311272,0.0020999619311272,0,0,19958.0,123057.75613441122,ASMT
16628,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR2H2
16629,KEGG_2019_Human,RNA degradation,1/79,0.0039499423167337,0.0039499423167337,0,0,19921.0,110243.89578070649,BTG2
16630,KEGG_2019_Human,Intestinal immune network for IgA production,1/48,0.0023999583567988,0.0149109730634706,0,0,19952.0,120356.5272753826,CXCR4
16631,KEGG_2019_Human,Leukocyte transendothelial migration,1/112,0.0055999282120529,0.0149109730634706,0,0,19888.0,103119.30984392198,CXCR4
16632,KEGG_2019_Human,Axon guidance,1/181,0.0090499044707863,0.0149109730634706,0,0,19819.0,93248.41634586031,CXCR4
16633,KEGG_2019_Human,Calcium signaling pathway,1/188,0.009399902370135,0.0149109730634706,0,0,19812.0,92463.712994847,CXCR4
16634,KEGG_2019_Human,Chemokine signaling pathway,1/190,0.0094999017791995,0.0149109730634706,0,0,19810.0,92244.74636351672,CXCR4
16635,KEGG_2019_Human,Human immunodeficiency virus 1 infection,1/212,0.0105998955026255,0.0149109730634706,0,0,19788.0,89974.27756224656,CXCR4
16636,KEGG_2019_Human,Regulation of actin cytoskeleton,1/214,0.0106998949514067,0.0149109730634706,0,0,19786.0,89779.39753374986,CXCR4
16637,KEGG_2019_Human,Human cytomegalovirus infection,1/225,0.0112498919790339,0.0149109730634706,0,0,19775.0,88738.27077557483,CXCR4
16638,KEGG_2019_Human,Endocytosis,1/244,0.0121998870519305,0.0149109730634706,0,0,19756.0,87051.4275316661,CXCR4
16639,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0161698626935708,0,0,19706.0,83157.67014793828,CXCR4
16640,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,CXCR4
16641,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR51B4
16642,KEGG_2019_Human,IL-17 signaling pathway,1/93,0.0046499360391879,0.0079999110688441,0,0,19907.0,106918.54242106884,TRAF3IP2
16643,KEGG_2019_Human,Cellular senescence,1/160,0.0079999110688441,0.0079999110688441,0,0,19840.0,95793.96509856998,TRAF3IP2
16644,KEGG_2019_Human,N-Glycan biosynthesis,1/50,0.0024999572069037,0.0049999144138074,0,0,19950.0,119530.05920663515,STT3B
16645,KEGG_2019_Human,Protein processing in endoplasmic reticulum,1/165,0.0082499094553477,0.0082499094553477,0,0,19835.0,95159.46482222488,STT3B
16646,KEGG_2019_Human,Mannose type O-glycan biosynthesis,1/23,0.0011499748819949,0.0011499748819949,0,0,19977.0,135204.63922267244,POMK
16647,KEGG_2019_Human,Colorectal cancer,1/86,0.0042999391173866,0.0101873876223335,0,0,19914.0,108514.46102290176,BIRC5
16648,KEGG_2019_Human,Apoptosis,1/143,0.0071499167770442,0.0101873876223335,0,0,19857.0,98106.57763600958,BIRC5
16649,KEGG_2019_Human,Hippo signaling pathway,1/160,0.0079999110688441,0.0101873876223335,0,0,19840.0,95793.96509856998,BIRC5
16650,KEGG_2019_Human,Hepatitis B,1/163,0.0081499100978668,0.0101873876223335,0,0,19837.0,95410.9786681514,BIRC5
16651,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,BIRC5
16652,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF181
16653,KEGG_2019_Human,Taurine and hypotaurine metabolism,1/11,0.0005499852259717758,0.0021249493476012,0,0,19989.0,150029.8210287992,BAAT
16654,KEGG_2019_Human,Primary bile acid biosynthesis,1/17,0.0008499797390404818,0.0021249493476012,0,0,19983.0,141285.76583697114,BAAT
16655,KEGG_2019_Human,Biosynthesis of unsaturated fatty acids,1/27,0.0013499718942362,0.0022499531570604,0,0,19973.0,131975.02298599784,BAAT
16656,KEGG_2019_Human,Bile secretion,1/72,0.0035999456502131,0.0041499404726918,0,0,19928.0,112131.59838572376,BAAT
16657,KEGG_2019_Human,Peroxisome,1/83,0.0041499404726918,0.0041499404726918,0,0,19917.0,109237.99888847338,BAAT
16658,KEGG_2019_Human,Prolactin signaling pathway,1/70,0.0034999466296654,0.0034999466296654,0,0,19930.0,112704.30065625212,CSN2
16659,KEGG_2019_Human,Hepatitis C,1/155,0.0077499127120574,0.0085499075557634,0,0,19845.0,96448.16254952336,RSAD2
16660,KEGG_2019_Human,Influenza A,1/171,0.0085499075557634,0.0085499075557634,0,0,19829.0,94422.42241345016,RSAD2
16661,KEGG_2019_Human,NF-kappa B signaling pathway,1/95,0.0047499351803394,0.0047499351803394,0,0,19905.0,106484.27183626965,ERC1
16662,KEGG_2019_Human,Insulin resistance,1/108,0.0053999298011749,0.0068499188797651,0,0,19892.0,103863.47861844616,PPP1R3E
16663,KEGG_2019_Human,Insulin signaling pathway,1/137,0.0068499188797651,0.0068499188797651,0,0,19863.0,98987.62735269018,PPP1R3E
16664,KEGG_2019_Human,Amyotrophic lateral sclerosis (ALS),1/51,0.0025499566390179,0.0109038867493566,0,0,19949.0,119129.0228601236,PPP3CA
16665,KEGG_2019_Human,VEGF signaling pathway,1/59,0.0029499522555206,0.0109038867493566,0,0,19941.0,116175.59385530632,PPP3CA
16666,KEGG_2019_Human,Long-term potentiation,1/67,0.0033499481224912,0.0109038867493566,0,0,19933.0,113594.38808369274,PPP3CA
16667,KEGG_2019_Human,Amphetamine addiction,1/68,0.0033999476216189,0.0109038867493566,0,0,19932.0,113293.39338050144,PPP3CA
16668,KEGG_2019_Human,Renin secretion,1/69,0.003449947123837,0.0109038867493566,0,0,19931.0,112996.7391397682,PPP3CA
16669,KEGG_2019_Human,B cell receptor signaling pathway,1/71,0.0035499461386618,0.0109038867493566,0,0,19929.0,112415.9585341616,PPP3CA
16670,KEGG_2019_Human,Th1 and Th2 cell differentiation,1/92,0.0045999364719865,0.0109038867493566,0,0,19908.0,107139.13814408927,PPP3CA
16671,KEGG_2019_Human,T cell receptor signaling pathway,1/101,0.0050499326546803,0.0109038867493566,0,0,19899.0,105233.48101229242,PPP3CA
16672,KEGG_2019_Human,Glucagon signaling pathway,1/103,0.0051499318302617,0.0109038867493566,0,0,19897.0,104832.7525292024,PPP3CA
16673,KEGG_2019_Human,C-type lectin receptor signaling pathway,1/104,0.0051999314202997,0.0109038867493566,0,0,19896.0,104635.24941415618,PPP3CA
16674,KEGG_2019_Human,Th17 cell differentiation,1/107,0.0053499302026925,0.0109038867493566,0,0,19893.0,104053.753408911,PPP3CA
16675,KEGG_2019_Human,Glutamatergic synapse,1/114,0.005699927427839,0.0109038867493566,0,0,19886.0,102756.96431429044,PPP3CA
16676,KEGG_2019_Human,Oocyte meiosis,1/125,0.0062499232373748,0.0109038867493566,0,0,19875.0,100869.32368441945,PPP3CA
16677,KEGG_2019_Human,Osteoclast differentiation,1/127,0.0063499224962247,0.0109038867493566,0,0,19873.0,100543.72072014232,PPP3CA
16678,KEGG_2019_Human,Dopaminergic synapse,1/131,0.0065499210316603,0.0109038867493566,0,0,19869.0,99907.33811343512,PPP3CA
16679,KEGG_2019_Human,Natural killer cell mediated cytotoxicity,1/131,0.0065499210316603,0.0109038867493566,0,0,19869.0,99907.33811343512,PPP3CA
16680,KEGG_2019_Human,Oxytocin signaling pathway,1/153,0.0076499133771537,0.0109038867493566,0,0,19847.0,96715.6407630817,PPP3CA
16681,KEGG_2019_Human,Wnt signaling pathway,1/158,0.0078999117225733,0.0109038867493566,0,0,19842.0,96053.2110949472,PPP3CA
16682,KEGG_2019_Human,Cellular senescence,1/160,0.0079999110688441,0.0109038867493566,0,0,19840.0,95793.96509856998,PPP3CA
16683,KEGG_2019_Human,cGMP-PKG signaling pathway,1/166,0.0082999091363732,0.0109038867493566,0,0,19834.0,95034.82345515196,PPP3CA
16684,KEGG_2019_Human,Alzheimer disease,1/171,0.0085499075557634,0.0109038867493566,0,0,19829.0,94422.42241345016,PPP3CA
16685,KEGG_2019_Human,Tuberculosis,1/179,0.0089499050800561,0.0109038867493566,0,0,19821.0,93478.0629355712,PPP3CA
16686,KEGG_2019_Human,Axon guidance,1/181,0.0090499044707863,0.0109038867493566,0,0,19819.0,93248.41634586031,PPP3CA
16687,KEGG_2019_Human,Kaposi sarcoma-associated herpesvirus infection,1/186,0.0092999029651357,0.0109038867493566,0,0,19814.0,92684.96451050608,PPP3CA
16688,KEGG_2019_Human,Calcium signaling pathway,1/188,0.009399902370135,0.0109038867493566,0,0,19812.0,92463.712994847,PPP3CA
16689,KEGG_2019_Human,Human immunodeficiency virus 1 infection,1/212,0.0105998955026255,0.0116516738354279,0,0,19788.0,89974.27756224656,PPP3CA
16690,KEGG_2019_Human,Human T-cell leukemia virus 1 infection,1/219,0.0109498935894162,0.0116516738354279,0,0,19781.0,89299.85161916987,PPP3CA
16691,KEGG_2019_Human,Human cytomegalovirus infection,1/225,0.0112498919790339,0.0116516738354279,0,0,19775.0,88738.27077557483,PPP3CA
16692,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0147498749536506,0,0,19705.0,83086.53988020132,PPP3CA
16693,KEGG_2019_Human,Amino sugar and nucleotide sugar metabolism,1/48,0.0023999583567988,0.0023999583567988,0,0,19952.0,120356.5272753826,GNE
16694,KEGG_2019_Human,Glycosaminoglycan degradation,1/19,0.00094997806231055,0.0018999561246211,0,0,19981.0,139049.2109571672,GNS
16695,KEGG_2019_Human,Lysosome,1/123,0.0061499239842961,0.0061499239842961,0,0,19877.0,101200.07933676826,GNS
16696,KEGG_2019_Human,mRNA surveillance pathway,1/91,0.0045499369072032,0.0085499075557634,0,0,19909.0,107362.10783923086,DDX39B
16697,KEGG_2019_Human,Spliceosome,1/134,0.0066999199497742,0.0085499075557634,0,0,19866.0,99442.43560916925,DDX39B
16698,KEGG_2019_Human,RNA transport,1/165,0.0082499094553477,0.0085499075557634,0,0,19835.0,95159.46482222488,DDX39B
16699,KEGG_2019_Human,Influenza A,1/171,0.0085499075557634,0.0085499075557634,0,0,19829.0,94422.42241345016,DDX39B
16700,KEGG_2019_Human,p53 signaling pathway,1/72,0.0035999456502131,0.0035999456502131,0,0,19928.0,112131.59838572376,ZMAT3
16701,KEGG_2019_Human,Long-term depression,1/60,0.002999951725986,0.00951987796049,0,0,19940.0,115834.63209072244,GNA11
16702,KEGG_2019_Human,Cortisol synthesis and secretion,1/65,0.003249949134407,0.00951987796049,0,0,19935.0,114209.92613860144,GNA11
16703,KEGG_2019_Human,Insulin secretion,1/86,0.0042999391173866,0.00951987796049,0,0,19914.0,108514.46102290176,GNA11
16704,KEGG_2019_Human,Gap junction,1/88,0.0043999382262822,0.00951987796049,0,0,19912.0,108045.79305232369,GNA11
16705,KEGG_2019_Human,GnRH signaling pathway,1/93,0.0046499360391879,0.00951987796049,0,0,19907.0,106918.54242106884,GNA11
16706,KEGG_2019_Human,Amoebiasis,1/96,0.0047999347538706,0.00951987796049,0,0,19904.0,106270.50039849174,GNA11
16707,KEGG_2019_Human,Aldosterone synthesis and secretion,1/98,0.0048999339081079,0.00951987796049,0,0,19902.0,105849.45495286948,GNA11
16708,KEGG_2019_Human,Chagas disease (American trypanosomiasis),1/103,0.0051499318302617,0.00951987796049,0,0,19897.0,104832.7525292024,GNA11
16709,KEGG_2019_Human,"Parathyroid hormone synthesis, secretion and action",1/106,0.0052999306076525,0.00951987796049,0,0,19894.0,104245.78450366124,GNA11
16710,KEGG_2019_Human,Cholinergic synapse,1/112,0.0055999282120529,0.00951987796049,0,0,19888.0,103119.30984392198,GNA11
16711,KEGG_2019_Human,Vascular smooth muscle contraction,1/132,0.0065999206698993,0.0101998773989354,0,0,19868.0,99751.22090491928,GNA11
16712,KEGG_2019_Human,Cushing syndrome,1/155,0.0077499127120574,0.0108537273321804,0,0,19845.0,96448.16254952336,GNA11
16713,KEGG_2019_Human,cGMP-PKG signaling pathway,1/166,0.0082999091363732,0.0108537273321804,0,0,19834.0,95034.82345515196,GNA11
16714,KEGG_2019_Human,Calcium signaling pathway,1/188,0.009399902370135,0.0114141671637354,0,0,19812.0,92463.712994847,GNA11
16715,KEGG_2019_Human,Human immunodeficiency virus 1 infection,1/212,0.0105998955026255,0.0119530102277235,0,0,19788.0,89974.27756224656,GNA11
16716,KEGG_2019_Human,Human cytomegalovirus infection,1/225,0.0112498919790339,0.0119530102277235,0,0,19775.0,88738.27077557483,GNA11
16717,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,GNA11
16718,KEGG_2019_Human,Cell cycle,1/124,0.0061999236097501,0.0061999236097501,0,0,19876.0,101034.04709010696,DBF4
16719,KEGG_2019_Human,Glycerolipid metabolism,1/61,0.0030499512001654,0.0048499343304706,0,0,19939.0,115499.24335773686,MBOAT1
16720,KEGG_2019_Human,Glycerophospholipid metabolism,1/97,0.0048499343304706,0.0048499343304706,0,0,19903.0,106058.9096435903,MBOAT1
16721,KEGG_2019_Human,Sphingolipid metabolism,1/47,0.0023499589392381,0.0023499589392381,0,0,19953.0,120782.64067395544,SMPD4
16722,KEGG_2019_Human,Ascorbate and aldarate metabolism,1/27,0.0013499718942362,0.004685646776936,0,0,19973.0,131975.02298599784,UGT2B10
16723,KEGG_2019_Human,Pentose and glucuronate interconversions,1/34,0.0016999670339032,0.004685646776936,0,0,19966.0,127326.1054203148,UGT2B10
16724,KEGG_2019_Human,Porphyrin and chlorophyll metabolism,1/42,0.0020999619311272,0.004685646776936,0,0,19958.0,123057.75613441122,UGT2B10
16725,KEGG_2019_Human,Steroid hormone biosynthesis,1/60,0.002999951725986,0.004685646776936,0,0,19940.0,115834.63209072244,UGT2B10
16726,KEGG_2019_Human,Retinol metabolism,1/67,0.0033499481224912,0.004685646776936,0,0,19933.0,113594.38808369274,UGT2B10
16727,KEGG_2019_Human,Metabolism of xenobiotics by cytochrome P450,1/74,0.0036999446830449,0.004685646776936,0,0,19926.0,111574.38983110404,UGT2B10
16728,KEGG_2019_Human,Chemical carcinogenesis,1/82,0.004099940929819,0.004685646776936,0,0,19918.0,109484.9180722932,UGT2B10
16729,KEGG_2019_Human,Drug metabolism,1/108,0.0053999298011749,0.0053999298011749,0,0,19892.0,103863.47861844616,UGT2B10
16730,KEGG_2019_Human,Spliceosome,1/134,0.0066999199497742,0.0066999199497742,0,0,19866.0,99442.43560916925,SRSF10
16731,KEGG_2019_Human,Sulfur metabolism,1/9,0.0004499872571388355,0.0004499872571388355,0,0,19991.0,154056.46923976458,SQOR
16732,KEGG_2019_Human,Insulin resistance,1/108,0.0053999298011749,0.0053999298011749,0,0,19892.0,103863.47861844616,NR1H2
16733,KEGG_2019_Human,Pathogenic Escherichia coli infection,1/55,0.0027499544131125,0.0124998799767043,0,0,19945.0,117599.1294878737,ROCK1
16734,KEGG_2019_Human,Shigellosis,1/65,0.003249949134407,0.0124998799767043,0,0,19935.0,114209.92613860144,ROCK1
16735,KEGG_2019_Human,Salmonella infection,1/86,0.0042999391173866,0.0124998799767043,0,0,19914.0,108514.46102290176,ROCK1
16736,KEGG_2019_Human,TGF-beta signaling pathway,1/90,0.0044999373439762,0.0124998799767043,0,0,19910.0,107587.50385474482,ROCK1
16737,KEGG_2019_Human,Leukocyte transendothelial migration,1/112,0.0055999282120529,0.0124998799767043,0,0,19888.0,103119.30984392198,ROCK1
16738,KEGG_2019_Human,Sphingolipid signaling pathway,1/119,0.0059499254985137,0.0124998799767043,0,0,19881.0,101877.73080211312,ROCK1
16739,KEGG_2019_Human,Platelet activation,1/124,0.0061999236097501,0.0124998799767043,0,0,19876.0,101034.04709010696,ROCK1
16740,KEGG_2019_Human,Vascular smooth muscle contraction,1/132,0.0065999206698993,0.0124998799767043,0,0,19868.0,99751.22090491928,ROCK1
16741,KEGG_2019_Human,Oxytocin signaling pathway,1/153,0.0076499133771537,0.0124998799767043,0,0,19847.0,96715.6407630817,ROCK1
16742,KEGG_2019_Human,cGMP-PKG signaling pathway,1/166,0.0082999091363732,0.0124998799767043,0,0,19834.0,95034.82345515196,ROCK1
16743,KEGG_2019_Human,Tight junction,1/170,0.0084999078692823,0.0124998799767043,0,0,19830.0,94543.49009679438,ROCK1
16744,KEGG_2019_Human,Axon guidance,1/181,0.0090499044707863,0.0124998799767043,0,0,19819.0,93248.41634586031,ROCK1
16745,KEGG_2019_Human,Chemokine signaling pathway,1/190,0.0094999017791995,0.0124998799767043,0,0,19810.0,92244.74636351672,ROCK1
16746,KEGG_2019_Human,Focal adhesion,1/199,0.0099498991610159,0.0124998799767043,0,0,19801.0,91286.4288690606,ROCK1
16747,KEGG_2019_Human,Proteoglycans in cancer,1/201,0.0100498985877989,0.0124998799767043,0,0,19799.0,91079.21596609056,ROCK1
16748,KEGG_2019_Human,cAMP signaling pathway,1/212,0.0105998955026255,0.0124998799767043,0,0,19788.0,89974.27756224656,ROCK1
16749,KEGG_2019_Human,Regulation of actin cytoskeleton,1/214,0.0106998949514067,0.0124998799767043,0,0,19786.0,89779.39753374986,ROCK1
16750,KEGG_2019_Human,Human cytomegalovirus infection,1/225,0.0112498919790339,0.0124998799767043,0,0,19775.0,88738.27077557483,ROCK1
16751,KEGG_2019_Human,MicroRNAs in cancer,1/299,0.0149498740670514,0.0157367095442646,0,0,19701.0,82804.33538735632,ROCK1
16752,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,ROCK1
16753,KEGG_2019_Human,IL-17 signaling pathway,1/93,0.0046499360391879,0.0069749040587818,0,0,19907.0,106918.54242106884,TRAF4
16754,KEGG_2019_Human,Small cell lung cancer,1/93,0.0046499360391879,0.0069749040587818,0,0,19907.0,106918.54242106884,TRAF4
16755,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,TRAF4
16756,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF782
16757,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,GALR3
16758,KEGG_2019_Human,Hepatocellular carcinoma,1/168,0.0083999085011095,0.0115498903940656,0,0,19832.0,94787.72752807094,SMARCD2
16759,KEGG_2019_Human,Thermogenesis,1/231,0.0115498903940656,0.0115498903940656,0,0,19769.0,88191.07730937863,SMARCD2
16760,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF177
16761,KEGG_2019_Human,Thyroid cancer,1/37,0.0018499650702878,0.0095198963012574,0,0,19963.0,125618.9446446357,TCF7L2
16762,KEGG_2019_Human,Endometrial cancer,1/58,0.0028999527887707,0.0095198963012574,0,0,19942.0,116522.31890946148,TCF7L2
16763,KEGG_2019_Human,Basal cell carcinoma,1/63,0.0031499501598827,0.0095198963012574,0,0,19937.0,114844.46974572667,TCF7L2
16764,KEGG_2019_Human,Acute myeloid leukemia,1/66,0.003299948626608,0.0095198963012574,0,0,19934.0,113899.85357353876,TCF7L2
16765,KEGG_2019_Human,Adherens junction,1/72,0.0035999456502131,0.0095198963012574,0,0,19928.0,112131.59838572376,TCF7L2
16766,KEGG_2019_Human,Arrhythmogenic right ventricular cardiomyopathy (ARVC),1/72,0.0035999456502131,0.0095198963012574,0,0,19928.0,112131.59838572376,TCF7L2
16767,KEGG_2019_Human,Colorectal cancer,1/86,0.0042999391173866,0.0095198963012574,0,0,19914.0,108514.46102290176,TCF7L2
16768,KEGG_2019_Human,Prostate cancer,1/97,0.0048499343304706,0.0095198963012574,0,0,19903.0,106058.9096435903,TCF7L2
16769,KEGG_2019_Human,Melanogenesis,1/101,0.0050499326546803,0.0095198963012574,0,0,19899.0,105233.48101229242,TCF7L2
16770,KEGG_2019_Human,Breast cancer,1/147,0.0073499154017982,0.0095198963012574,0,0,19853.0,97539.10874372096,TCF7L2
16771,KEGG_2019_Human,Gastric cancer,1/149,0.0074499147221605,0.0095198963012574,0,0,19851.0,97261.02051561224,TCF7L2
16772,KEGG_2019_Human,Cushing syndrome,1/155,0.0077499127120574,0.0095198963012574,0,0,19845.0,96448.16254952336,TCF7L2
16773,KEGG_2019_Human,Wnt signaling pathway,1/158,0.0078999117225733,0.0095198963012574,0,0,19842.0,96053.2110949472,TCF7L2
16774,KEGG_2019_Human,Hippo signaling pathway,1/160,0.0079999110688441,0.0095198963012574,0,0,19840.0,95793.96509856998,TCF7L2
16775,KEGG_2019_Human,Hepatocellular carcinoma,1/168,0.0083999085011095,0.0095198963012574,0,0,19832.0,94787.72752807094,TCF7L2
16776,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0175311091751498,0,0,19670.0,80733.60565076157,TCF7L2
16777,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,TCF7L2
16778,KEGG_2019_Human,Pathogenic Escherichia coli infection,1/55,0.0027499544131125,0.0075110120515441,0,0,19945.0,117599.1294878737,CD14
16779,KEGG_2019_Human,Legionellosis,1/55,0.0027499544131125,0.0075110120515441,0,0,19945.0,117599.1294878737,CD14
16780,KEGG_2019_Human,Acute myeloid leukemia,1/66,0.003299948626608,0.0075110120515441,0,0,19934.0,113899.85357353876,CD14
16781,KEGG_2019_Human,Pertussis,1/76,0.0037999437281752,0.0075110120515441,0,0,19924.0,111031.8499691117,CD14
16782,KEGG_2019_Human,Salmonella infection,1/86,0.0042999391173866,0.0075110120515441,0,0,19914.0,108514.46102290176,CD14
16783,KEGG_2019_Human,NF-kappa B signaling pathway,1/95,0.0047499351803394,0.0075110120515441,0,0,19905.0,106484.27183626965,CD14
16784,KEGG_2019_Human,Amoebiasis,1/96,0.0047999347538706,0.0075110120515441,0,0,19904.0,106270.50039849174,CD14
16785,KEGG_2019_Human,Hematopoietic cell lineage,1/97,0.0048499343304706,0.0075110120515441,0,0,19903.0,106058.9096435903,CD14
16786,KEGG_2019_Human,Toll-like receptor signaling pathway,1/104,0.0051999314202997,0.0075110120515441,0,0,19896.0,104635.24941415618,CD14
16787,KEGG_2019_Human,Phagosome,1/152,0.0075999137114971,0.0098798878249462,0,0,19848.0,96850.665715497,CD14
16788,KEGG_2019_Human,Tuberculosis,1/179,0.0089499050800561,0.010074894878897,0,0,19821.0,93478.0629355712,CD14
16789,KEGG_2019_Human,Transcriptional misregulation in cancer,1/186,0.0092999029651357,0.010074894878897,0,0,19814.0,92684.96451050608,CD14
16790,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0147498749536506,0,0,19705.0,83086.53988020132,CD14
16791,KEGG_2019_Human,Autophagy,1/128,0.0063999221281459,0.0151998274229942,0,0,19872.0,100382.8010329652,MLST8
16792,KEGG_2019_Human,mTOR signaling pathway,1/152,0.0075999137114971,0.0151998274229942,0,0,19848.0,96850.665715497,MLST8
16793,KEGG_2019_Human,Thermogenesis,1/231,0.0115498903940656,0.0153998538587541,0,0,19769.0,88191.07730937863,MLST8
16794,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0176998626413668,0,0,19646.0,79255.8617626126,MLST8
16795,KEGG_2019_Human,Sulfur metabolism,1/9,0.0004499872571388355,0.0004499872571388355,0,0,19991.0,154056.46923976458,BPNT1
16796,KEGG_2019_Human,Folate biosynthesis,1/26,0.0012999726251831,0.0012999726251831,0,0,19974.0,132735.46073187632,PCBD2
16797,KEGG_2019_Human,Glycosylphosphatidylinositol (GPI)-anchor biosynthesis,1/25,0.0012499733663791,0.0012499733663791,0,0,19975.0,133525.54486996148,PIGP
16798,KEGG_2019_Human,Lysosome,1/123,0.0061499239842961,0.0061499239842961,0,0,19877.0,101200.07933676826,GM2A
16799,KEGG_2019_Human,Autophagy,1/128,0.0063999221281459,0.0063999221281459,0,0,19872.0,100382.8010329652,NRBF2
16800,KEGG_2019_Human,RNA transport,1/165,0.0082499094553477,0.0164998189106955,0,0,19835.0,95159.46482222488,EIF2B1
16801,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,EIF2B1
16802,KEGG_2019_Human,Spliceosome,1/134,0.0066999199497742,0.0066999199497742,0,0,19866.0,99442.43560916925,PRPF40B
16803,KEGG_2019_Human,RIG-I-like receptor signaling pathway,1/70,0.0034999466296654,0.0089499050800561,0,0,19930.0,112704.30065625212,CASP10
16804,KEGG_2019_Human,TNF signaling pathway,1/110,0.0054999290027479,0.0089499050800561,0,0,19890.0,103488.06969787036,CASP10
16805,KEGG_2019_Human,Apoptosis,1/143,0.0071499167770442,0.0089499050800561,0,0,19857.0,98106.57763600958,CASP10
16806,KEGG_2019_Human,Hepatitis B,1/163,0.0081499100978668,0.0089499050800561,0,0,19837.0,95410.9786681514,CASP10
16807,KEGG_2019_Human,Tuberculosis,1/179,0.0089499050800561,0.0089499050800561,0,0,19821.0,93478.0629355712,CASP10
16808,KEGG_2019_Human,RNA degradation,1/79,0.0039499423167337,0.0039499423167337,0,0,19921.0,110243.89578070649,CNOT7
16809,KEGG_2019_Human,Hepatocellular carcinoma,1/168,0.0083999085011095,0.0115498903940656,0,0,19832.0,94787.72752807094,SMARCC1
16810,KEGG_2019_Human,Thermogenesis,1/231,0.0115498903940656,0.0115498903940656,0,0,19769.0,88191.07730937863,SMARCC1
16811,KEGG_2019_Human,Lysosome,1/123,0.0061499239842961,0.0089499050800561,0,0,19877.0,101200.07933676826,LAMP2
16812,KEGG_2019_Human,Autophagy,1/128,0.0063999221281459,0.0089499050800561,0,0,19872.0,100382.8010329652,LAMP2
16813,KEGG_2019_Human,Phagosome,1/152,0.0075999137114971,0.0089499050800561,0,0,19848.0,96850.665715497,LAMP2
16814,KEGG_2019_Human,Tuberculosis,1/179,0.0089499050800561,0.0089499050800561,0,0,19821.0,93478.0629355712,LAMP2
16815,KEGG_2019_Human,Phototransduction,1/28,0.0013999711732997,0.0113938210547091,0,0,19972.0,131242.0761597353,CALM1
16816,KEGG_2019_Human,Long-term potentiation,1/67,0.0033499481224912,0.0113938210547091,0,0,19933.0,113594.38808369274,CALM1
16817,KEGG_2019_Human,Amphetamine addiction,1/68,0.0033999476216189,0.0113938210547091,0,0,19932.0,113293.39338050144,CALM1
16818,KEGG_2019_Human,Renin secretion,1/69,0.003449947123837,0.0113938210547091,0,0,19931.0,112996.7391397682,CALM1
16819,KEGG_2019_Human,Gastric acid secretion,1/75,0.0037499442041125,0.0113938210547091,0,0,19925.0,111301.33528642564,CALM1
16820,KEGG_2019_Human,Glioma,1/75,0.0037499442041125,0.0113938210547091,0,0,19925.0,111301.33528642564,CALM1
16821,KEGG_2019_Human,Pertussis,1/76,0.0037999437281752,0.0113938210547091,0,0,19924.0,111031.8499691117,CALM1
16822,KEGG_2019_Human,Salivary secretion,1/90,0.0044999373439762,0.0113938210547091,0,0,19910.0,107587.50385474482,CALM1
16823,KEGG_2019_Human,GnRH signaling pathway,1/93,0.0046499360391879,0.0113938210547091,0,0,19907.0,106918.54242106884,CALM1
16824,KEGG_2019_Human,Circadian entrainment,1/97,0.0048499343304706,0.0113938210547091,0,0,19903.0,106058.9096435903,CALM1
16825,KEGG_2019_Human,Aldosterone synthesis and secretion,1/98,0.0048999339081079,0.0113938210547091,0,0,19902.0,105849.45495286948,CALM1
16826,KEGG_2019_Human,Phosphatidylinositol signaling system,1/99,0.0049499334884068,0.0113938210547091,0,0,19901.0,105642.09305076736,CALM1
16827,KEGG_2019_Human,Inflammatory mediator regulation of TRP channels,1/100,0.0049999330710556,0.0113938210547091,0,0,19900.0,105436.78197328727,CALM1
16828,KEGG_2019_Human,Melanogenesis,1/101,0.0050499326546803,0.0113938210547091,0,0,19899.0,105233.48101229242,CALM1
16829,KEGG_2019_Human,Glucagon signaling pathway,1/103,0.0051499318302617,0.0113938210547091,0,0,19897.0,104832.7525292024,CALM1
16830,KEGG_2019_Human,C-type lectin receptor signaling pathway,1/104,0.0051999314202997,0.0113938210547091,0,0,19896.0,104635.24941415618,CALM1
16831,KEGG_2019_Human,Neurotrophin signaling pathway,1/119,0.0059499254985137,0.0113938210547091,0,0,19881.0,101877.73080211312,CALM1
16832,KEGG_2019_Human,Oocyte meiosis,1/125,0.0062499232373748,0.0113938210547091,0,0,19875.0,100869.32368441945,CALM1
16833,KEGG_2019_Human,Dopaminergic synapse,1/131,0.0065499210316603,0.0113938210547091,0,0,19869.0,99907.33811343512,CALM1
16834,KEGG_2019_Human,Vascular smooth muscle contraction,1/132,0.0065999206698993,0.0113938210547091,0,0,19868.0,99751.22090491928,CALM1
16835,KEGG_2019_Human,Insulin signaling pathway,1/137,0.0068499188797651,0.0113938210547091,0,0,19863.0,98987.62735269018,CALM1
16836,KEGG_2019_Human,Estrogen signaling pathway,1/137,0.0068499188797651,0.0113938210547091,0,0,19863.0,98987.62735269018,CALM1
16837,KEGG_2019_Human,Apelin signaling pathway,1/137,0.0068499188797651,0.0113938210547091,0,0,19863.0,98987.62735269018,CALM1
16838,KEGG_2019_Human,Fluid shear stress and atherosclerosis,1/139,0.006949918172816,0.0113938210547091,0,0,19861.0,98689.81333375497,CALM1
16839,KEGG_2019_Human,Adrenergic signaling in cardiomyocytes,1/145,0.0072499160871101,0.0113938210547091,0,0,19855.0,97820.92670675044,CALM1
16840,KEGG_2019_Human,Oxytocin signaling pathway,1/153,0.0076499133771537,0.0113938210547091,0,0,19847.0,96715.6407630817,CALM1
16841,KEGG_2019_Human,Cellular senescence,1/160,0.0079999110688441,0.0113938210547091,0,0,19840.0,95793.96509856998,CALM1
16842,KEGG_2019_Human,cGMP-PKG signaling pathway,1/166,0.0082999091363732,0.0113938210547091,0,0,19834.0,95034.82345515196,CALM1
16843,KEGG_2019_Human,Alzheimer disease,1/171,0.0085499075557634,0.0113938210547091,0,0,19829.0,94422.42241345016,CALM1
16844,KEGG_2019_Human,Tuberculosis,1/179,0.0089499050800561,0.0113938210547091,0,0,19821.0,93478.0629355712,CALM1
16845,KEGG_2019_Human,Alcoholism,1/180,0.0089999047745351,0.0113938210547091,0,0,19820.0,93362.92821536642,CALM1
16846,KEGG_2019_Human,Kaposi sarcoma-associated herpesvirus infection,1/186,0.0092999029651357,0.0113938210547091,0,0,19814.0,92684.96451050608,CALM1
16847,KEGG_2019_Human,Calcium signaling pathway,1/188,0.009399902370135,0.0113938210547091,0,0,19812.0,92463.712994847,CALM1
16848,KEGG_2019_Human,Rap1 signaling pathway,1/206,0.010299897173561,0.0117776616695839,0,0,19794.0,90569.849337325,CALM1
16849,KEGG_2019_Human,Human immunodeficiency virus 1 infection,1/212,0.0105998955026255,0.0117776616695839,0,0,19788.0,89974.27756224656,CALM1
16850,KEGG_2019_Human,cAMP signaling pathway,1/212,0.0105998955026255,0.0117776616695839,0,0,19788.0,89974.27756224656,CALM1
16851,KEGG_2019_Human,Human cytomegalovirus infection,1/225,0.0112498919790339,0.0121620453827393,0,0,19775.0,88738.27077557483,CALM1
16852,KEGG_2019_Human,Ras signaling pathway,1/232,0.0115998901349604,0.0122104106683793,0,0,19768.0,88101.22480150245,CALM1
16853,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0227690733587457,0,0,19556.0,74462.79263140135,CALM1
16854,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,CALM1
16855,KEGG_2019_Human,Ubiquitin mediated proteolysis,1/137,0.0068499188797651,0.0082499094553477,0,0,19863.0,98987.62735269018,FBXO2
16856,KEGG_2019_Human,Protein processing in endoplasmic reticulum,1/165,0.0082499094553477,0.0082499094553477,0,0,19835.0,95159.46482222488,FBXO2
16857,KEGG_2019_Human,Notch signaling pathway,1/48,0.0023999583567988,0.0114998411799664,0,0,19952.0,120356.5272753826,RBPJ
16858,KEGG_2019_Human,Th1 and Th2 cell differentiation,1/92,0.0045999364719865,0.0114998411799664,0,0,19908.0,107139.13814408927,RBPJ
16859,KEGG_2019_Human,Epstein-Barr virus infection,1/201,0.0100498985877989,0.0125623732347487,0,0,19799.0,91079.21596609056,RBPJ
16860,KEGG_2019_Human,Viral carcinogenesis,1/201,0.0100498985877989,0.0125623732347487,0,0,19799.0,91079.21596609056,RBPJ
16861,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0164998674589645,0,0,19670.0,80733.60565076157,RBPJ
16862,KEGG_2019_Human,Protein digestion and absorption,1/90,0.0044999373439762,0.0044999373439762,0,0,19910.0,107587.50385474482,PGA5
16863,KEGG_2019_Human,Leukocyte transendothelial migration,1/112,0.0055999282120529,0.0106998949514067,0,0,19888.0,103119.30984392198,MYL12A
16864,KEGG_2019_Human,Platelet activation,1/124,0.0061999236097501,0.0106998949514067,0,0,19876.0,101034.04709010696,MYL12A
16865,KEGG_2019_Human,Tight junction,1/170,0.0084999078692823,0.0106998949514067,0,0,19830.0,94543.49009679438,MYL12A
16866,KEGG_2019_Human,Axon guidance,1/181,0.0090499044707863,0.0106998949514067,0,0,19819.0,93248.41634586031,MYL12A
16867,KEGG_2019_Human,Focal adhesion,1/199,0.0099498991610159,0.0106998949514067,0,0,19801.0,91286.4288690606,MYL12A
16868,KEGG_2019_Human,Regulation of actin cytoskeleton,1/214,0.0106998949514067,0.0106998949514067,0,0,19786.0,89779.39753374986,MYL12A
16869,KEGG_2019_Human,Long-term depression,1/60,0.002999951725986,0.009807586003018,0,0,19940.0,115834.63209072244,PPP2CA
16870,KEGG_2019_Human,TGF-beta signaling pathway,1/90,0.0044999373439762,0.009807586003018,0,0,19910.0,107587.50385474482,PPP2CA
16871,KEGG_2019_Human,mRNA surveillance pathway,1/91,0.0045499369072032,0.009807586003018,0,0,19909.0,107362.10783923086,PPP2CA
16872,KEGG_2019_Human,Chagas disease (American trypanosomiasis),1/103,0.0051499318302617,0.009807586003018,0,0,19897.0,104832.7525292024,PPP2CA
16873,KEGG_2019_Human,Sphingolipid signaling pathway,1/119,0.0059499254985137,0.009807586003018,0,0,19881.0,101877.73080211312,PPP2CA
16874,KEGG_2019_Human,AMPK signaling pathway,1/120,0.0059999251180858,0.009807586003018,0,0,19880.0,101706.2448082016,PPP2CA
16875,KEGG_2019_Human,Oocyte meiosis,1/125,0.0062499232373748,0.009807586003018,0,0,19875.0,100869.32368441945,PPP2CA
16876,KEGG_2019_Human,Autophagy,1/128,0.0063999221281459,0.009807586003018,0,0,19872.0,100382.8010329652,PPP2CA
16877,KEGG_2019_Human,Dopaminergic synapse,1/131,0.0065499210316603,0.009807586003018,0,0,19869.0,99907.33811343512,PPP2CA
16878,KEGG_2019_Human,Adrenergic signaling in cardiomyocytes,1/145,0.0072499160871101,0.009807586003018,0,0,19855.0,97820.92670675044,PPP2CA
16879,KEGG_2019_Human,Hepatitis C,1/155,0.0077499127120574,0.009807586003018,0,0,19845.0,96448.16254952336,PPP2CA
16880,KEGG_2019_Human,Hippo signaling pathway,1/160,0.0079999110688441,0.009807586003018,0,0,19840.0,95793.96509856998,PPP2CA
16881,KEGG_2019_Human,Tight junction,1/170,0.0084999078692823,0.009807586003018,0,0,19830.0,94543.49009679438,PPP2CA
16882,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0176784294203191,0,0,19670.0,80733.60565076157,PPP2CA
16883,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0176998626413668,0,0,19646.0,79255.8617626126,PPP2CA
16884,KEGG_2019_Human,Fatty acid elongation,1/27,0.0013499718942362,0.0026999437884725,0,0,19973.0,131975.02298599784,THEM4
16885,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0176998626413668,0,0,19646.0,79255.8617626126,THEM4
16886,KEGG_2019_Human,Glucagon signaling pathway,1/103,0.0051499318302617,0.0051499318302617,0,0,19897.0,104832.7525292024,PPP4R3B
16887,KEGG_2019_Human,Graft-versus-host disease,1/41,0.0020499625466866,0.0057749148821253,0,0,19959.0,123544.88783416104,KIR3DL2
16888,KEGG_2019_Human,Antigen processing and presentation,1/77,0.0038499432547502,0.0057749148821253,0,0,19923.0,110765.8407373636,KIR3DL2
16889,KEGG_2019_Human,Natural killer cell mediated cytotoxicity,1/131,0.0065499210316603,0.0065499210316603,0,0,19869.0,99907.33811343512,KIR3DL2
16890,KEGG_2019_Human,Drug metabolism,1/108,0.0053999298011749,0.0053999298011749,0,0,19892.0,103863.47861844616,TPMT
16891,KEGG_2019_Human,Relaxin signaling pathway,1/130,0.0064999213952527,0.0129998427905055,0,0,19870.0,100064.62842845908,RXFP1
16892,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,RXFP1
16893,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0146998751759735,0,0,19706.0,83157.67014793828,CD27
16894,KEGG_2019_Human,Hedgehog signaling pathway,1/47,0.0023499589392381,0.0089998746879525,0,0,19953.0,120782.64067395544,SMURF1
16895,KEGG_2019_Human,TGF-beta signaling pathway,1/90,0.0044999373439762,0.0089998746879525,0,0,19910.0,107587.50385474482,SMURF1
16896,KEGG_2019_Human,Ubiquitin mediated proteolysis,1/137,0.0068499188797651,0.0091332251730202,0,0,19863.0,98987.62735269018,SMURF1
16897,KEGG_2019_Human,Endocytosis,1/244,0.0121998870519305,0.0121998870519305,0,0,19756.0,87051.4275316661,SMURF1
16898,KEGG_2019_Human,Long-term potentiation,1/67,0.0033499481224912,0.0099998771797997,0,0,19933.0,113594.38808369274,RPS6KA3
16899,KEGG_2019_Human,Progesterone-mediated oocyte maturation,1/99,0.0049499334884068,0.0099998771797997,0,0,19901.0,105642.09305076736,RPS6KA3
16900,KEGG_2019_Human,Insulin resistance,1/108,0.0053999298011749,0.0099998771797997,0,0,19892.0,103863.47861844616,RPS6KA3
16901,KEGG_2019_Human,Neurotrophin signaling pathway,1/119,0.0059499254985137,0.0099998771797997,0,0,19881.0,101877.73080211312,RPS6KA3
16902,KEGG_2019_Human,Oocyte meiosis,1/125,0.0062499232373748,0.0099998771797997,0,0,19875.0,100869.32368441945,RPS6KA3
16903,KEGG_2019_Human,mTOR signaling pathway,1/152,0.0075999137114971,0.0101332182819961,0,0,19848.0,96850.665715497,RPS6KA3
16904,KEGG_2019_Human,Thermogenesis,1/231,0.0115498903940656,0.0131998747360749,0,0,19769.0,88191.07730937863,RPS6KA3
16905,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0147498749536506,0,0,19705.0,83086.53988020132,RPS6KA3
16906,KEGG_2019_Human,mRNA surveillance pathway,1/91,0.0045499369072032,0.0045499369072032,0,0,19909.0,107362.10783923086,PCF11
16907,KEGG_2019_Human,Glycosaminoglycan biosynthesis,1/53,0.0026499555173137,0.0026499555173137,0,0,19947.0,118349.78824235698,UST
16908,KEGG_2019_Human,Ascorbate and aldarate metabolism,1/27,0.0013499718942362,0.004685646776936,0,0,19973.0,131975.02298599784,UGT2A2
16909,KEGG_2019_Human,Pentose and glucuronate interconversions,1/34,0.0016999670339032,0.004685646776936,0,0,19966.0,127326.1054203148,UGT2A2
16910,KEGG_2019_Human,Porphyrin and chlorophyll metabolism,1/42,0.0020999619311272,0.004685646776936,0,0,19958.0,123057.75613441122,UGT2A2
16911,KEGG_2019_Human,Steroid hormone biosynthesis,1/60,0.002999951725986,0.004685646776936,0,0,19940.0,115834.63209072244,UGT2A2
16912,KEGG_2019_Human,Retinol metabolism,1/67,0.0033499481224912,0.004685646776936,0,0,19933.0,113594.38808369274,UGT2A2
16913,KEGG_2019_Human,Metabolism of xenobiotics by cytochrome P450,1/74,0.0036999446830449,0.004685646776936,0,0,19926.0,111574.38983110404,UGT2A2
16914,KEGG_2019_Human,Chemical carcinogenesis,1/82,0.004099940929819,0.004685646776936,0,0,19918.0,109484.9180722932,UGT2A2
16915,KEGG_2019_Human,Drug metabolism,1/108,0.0053999298011749,0.0053999298011749,0,0,19892.0,103863.47861844616,UGT2A2
16916,KEGG_2019_Human,Taste transduction,1/83,0.0041499404726918,0.0041499404726918,0,0,19917.0,109237.99888847338,TAS2R8
16917,KEGG_2019_Human,Cardiac muscle contraction,1/78,0.0038999427840466,0.0112582177134695,0,0,19922.0,110503.2180492851,COX8C
16918,KEGG_2019_Human,Oxidative phosphorylation,1/133,0.0066499203093911,0.0112582177134695,0,0,19867.0,99596.2591544721,COX8C
16919,KEGG_2019_Human,Parkinson disease,1/142,0.0070999171242726,0.0112582177134695,0,0,19858.0,98250.87390500787,COX8C
16920,KEGG_2019_Human,Non-alcoholic fatty liver disease (NAFLD),1/149,0.0074499147221605,0.0112582177134695,0,0,19851.0,97261.02051561224,COX8C
16921,KEGG_2019_Human,Alzheimer disease,1/171,0.0085499075557634,0.0112582177134695,0,0,19829.0,94422.42241345016,COX8C
16922,KEGG_2019_Human,Huntington disease,1/193,0.0096499008972596,0.0112582177134695,0,0,19807.0,91920.47679471428,COX8C
16923,KEGG_2019_Human,Thermogenesis,1/231,0.0115498903940656,0.0115498903940656,0,0,19769.0,88191.07730937863,COX8C
16924,KEGG_2019_Human,Notch signaling pathway,1/48,0.0023999583567988,0.0050999214324284,0,0,19952.0,120356.5272753826,ADAM17
16925,KEGG_2019_Human,Epithelial cell signaling in Helicobacter pylori infection,1/68,0.0033999476216189,0.0050999214324284,0,0,19932.0,113293.39338050144,ADAM17
16926,KEGG_2019_Human,Alzheimer disease,1/171,0.0085499075557634,0.0085499075557634,0,0,19829.0,94422.42241345016,ADAM17
16927,KEGG_2019_Human,Inflammatory mediator regulation of TRP channels,1/100,0.0049999330710556,0.0049999330710556,0,0,19900.0,105436.78197328727,ASIC3
16928,KEGG_2019_Human,Retinol metabolism,1/67,0.0033499481224912,0.0033499481224912,0,0,19933.0,113594.38808369274,DHRS4L2
16929,KEGG_2019_Human,Fc epsilon RI signaling pathway,1/68,0.0033999476216189,0.0078599052379924,0,0,19932.0,113293.39338050144,LCP2
16930,KEGG_2019_Human,T cell receptor signaling pathway,1/101,0.0050499326546803,0.0078599052379924,0,0,19899.0,105233.48101229242,LCP2
16931,KEGG_2019_Human,Platelet activation,1/124,0.0061999236097501,0.0078599052379924,0,0,19876.0,101034.04709010696,LCP2
16932,KEGG_2019_Human,Osteoclast differentiation,1/127,0.0063499224962247,0.0078599052379924,0,0,19873.0,100543.72072014232,LCP2
16933,KEGG_2019_Human,Natural killer cell mediated cytotoxicity,1/131,0.0065499210316603,0.0078599052379924,0,0,19869.0,99907.33811343512,LCP2
16934,KEGG_2019_Human,Rap1 signaling pathway,1/206,0.010299897173561,0.010299897173561,0,0,19794.0,90569.849337325,LCP2
16935,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF555
16936,KEGG_2019_Human,Glycosylphosphatidylinositol (GPI)-anchor biosynthesis,1/25,0.0012499733663791,0.0012499733663791,0,0,19975.0,133525.54486996148,PIGK
16937,KEGG_2019_Human,Ferroptosis,1/40,0.0019999631680592,0.0019999631680592,0,0,19960.0,124043.94523066044,SLC7A11
16938,KEGG_2019_Human,Fanconi anemia pathway,1/54,0.0026999549628563,0.0026999549628563,0,0,19946.0,117971.01964061816,FAAP24
16939,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF543
16940,KEGG_2019_Human,mRNA surveillance pathway,1/91,0.0045499369072032,0.0085499075557634,0,0,19909.0,107362.10783923086,PABPN1L
16941,KEGG_2019_Human,Influenza A,1/171,0.0085499075557634,0.0085499075557634,0,0,19829.0,94422.42241345016,PABPN1L
16942,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR8K1
16943,KEGG_2019_Human,Leukocyte transendothelial migration,1/112,0.0055999282120529,0.0055999282120529,0,0,19888.0,103119.30984392198,TXK
16944,KEGG_2019_Human,N-Glycan biosynthesis,1/50,0.0024999572069037,0.0024999572069037,0,0,19950.0,119530.05920663515,ALG9
16945,KEGG_2019_Human,Ribosome,1/153,0.0076499133771537,0.0076499133771537,0,0,19847.0,96715.6407630817,RPL13A
16946,KEGG_2019_Human,Porphyrin and chlorophyll metabolism,1/42,0.0020999619311272,0.0020999619311272,0,0,19958.0,123057.75613441122,FXN
16947,KEGG_2019_Human,Small cell lung cancer,1/93,0.0046499360391879,0.0185997441567516,0,0,19907.0,106918.54242106884,MAX
16948,KEGG_2019_Human,Transcriptional misregulation in cancer,1/186,0.0092999029651357,0.0185998059302715,0,0,19814.0,92684.96451050608,MAX
16949,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0196664999382009,0,0,19705.0,83086.53988020132,MAX
16950,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,MAX
16951,KEGG_2019_Human,Starch and sucrose metabolism,1/36,0.0017999657178272,0.0032999410769135,0,0,19964.0,126172.23364250171,AMY2B
16952,KEGG_2019_Human,Carbohydrate digestion and absorption,1/44,0.0021999607179423,0.0032999410769135,0,0,19956.0,122117.06559109331,AMY2B
16953,KEGG_2019_Human,Pancreatic secretion,1/98,0.0048999339081079,0.0048999339081079,0,0,19902.0,105849.45495286948,AMY2B
16954,KEGG_2019_Human,Human immunodeficiency virus 1 infection,1/212,0.0105998955026255,0.0105998955026255,0,0,19788.0,89974.27756224656,APOBEC3A
16955,KEGG_2019_Human,Prion diseases,1/35,0.0017499663721595,0.0107945212775086,0,0,19965.0,126740.98858805298,MAP2K1
16956,KEGG_2019_Human,Thyroid cancer,1/37,0.0018499650702878,0.0107945212775086,0,0,19963.0,125618.9446446357,MAP2K1
16957,KEGG_2019_Human,Bladder cancer,1/41,0.0020499625466866,0.0107945212775086,0,0,19959.0,123544.88783416104,MAP2K1
16958,KEGG_2019_Human,Endometrial cancer,1/58,0.0028999527887707,0.0107945212775086,0,0,19942.0,116522.31890946148,MAP2K1
16959,KEGG_2019_Human,VEGF signaling pathway,1/59,0.0029499522555206,0.0107945212775086,0,0,19941.0,116175.59385530632,MAP2K1
16960,KEGG_2019_Human,Long-term depression,1/60,0.002999951725986,0.0107945212775086,0,0,19940.0,115834.63209072244,MAP2K1
16961,KEGG_2019_Human,Central carbon metabolism in cancer,1/65,0.003249949134407,0.0107945212775086,0,0,19935.0,114209.92613860144,MAP2K1
16962,KEGG_2019_Human,Acute myeloid leukemia,1/66,0.003299948626608,0.0107945212775086,0,0,19934.0,113899.85357353876,MAP2K1
16963,KEGG_2019_Human,Non-small cell lung cancer,1/66,0.003299948626608,0.0107945212775086,0,0,19934.0,113899.85357353876,MAP2K1
16964,KEGG_2019_Human,Long-term potentiation,1/67,0.0033499481224912,0.0107945212775086,0,0,19933.0,113594.38808369274,MAP2K1
16965,KEGG_2019_Human,Fc epsilon RI signaling pathway,1/68,0.0033999476216189,0.0107945212775086,0,0,19932.0,113293.39338050144,MAP2K1
16966,KEGG_2019_Human,Renal cell carcinoma,1/69,0.003449947123837,0.0107945212775086,0,0,19931.0,112996.7391397682,MAP2K1
16967,KEGG_2019_Human,Prolactin signaling pathway,1/70,0.0034999466296654,0.0107945212775086,0,0,19930.0,112704.30065625212,MAP2K1
16968,KEGG_2019_Human,B cell receptor signaling pathway,1/71,0.0035499461386618,0.0107945212775086,0,0,19929.0,112415.9585341616,MAP2K1
16969,KEGG_2019_Human,Melanoma,1/72,0.0035999456502131,0.0107945212775086,0,0,19928.0,112131.59838572376,MAP2K1
16970,KEGG_2019_Human,Pancreatic cancer,1/75,0.0037499442041125,0.0107945212775086,0,0,19925.0,111301.33528642564,MAP2K1
16971,KEGG_2019_Human,Glioma,1/75,0.0037499442041125,0.0107945212775086,0,0,19925.0,111301.33528642564,MAP2K1
16972,KEGG_2019_Human,Chronic myeloid leukemia,1/76,0.0037999437281752,0.0107945212775086,0,0,19924.0,111031.8499691117,MAP2K1
16973,KEGG_2019_Human,ErbB signaling pathway,1/85,0.004249939567045,0.0107945212775086,0,0,19915.0,108752.83801948265,MAP2K1
16974,KEGG_2019_Human,Colorectal cancer,1/86,0.0042999391173866,0.0107945212775086,0,0,19914.0,108514.46102290176,MAP2K1
16975,KEGG_2019_Human,Gap junction,1/88,0.0043999382262822,0.0107945212775086,0,0,19912.0,108045.79305232369,MAP2K1
16976,KEGG_2019_Human,Fc gamma R-mediated phagocytosis,1/91,0.0045499369072032,0.0107945212775086,0,0,19909.0,107362.10783923086,MAP2K1
16977,KEGG_2019_Human,GnRH signaling pathway,1/93,0.0046499360391879,0.0107945212775086,0,0,19907.0,106918.54242106884,MAP2K1
16978,KEGG_2019_Human,Prostate cancer,1/97,0.0048499343304706,0.0107945212775086,0,0,19903.0,106058.9096435903,MAP2K1
16979,KEGG_2019_Human,Choline metabolism in cancer,1/99,0.0049499334884068,0.0107945212775086,0,0,19901.0,105642.09305076736,MAP2K1
16980,KEGG_2019_Human,Progesterone-mediated oocyte maturation,1/99,0.0049499334884068,0.0107945212775086,0,0,19901.0,105642.09305076736,MAP2K1
16981,KEGG_2019_Human,HIF-1 signaling pathway,1/100,0.0049999330710556,0.0107945212775086,0,0,19900.0,105436.78197328727,MAP2K1
16982,KEGG_2019_Human,T cell receptor signaling pathway,1/101,0.0050499326546803,0.0107945212775086,0,0,19899.0,105233.48101229242,MAP2K1
16983,KEGG_2019_Human,Melanogenesis,1/101,0.0050499326546803,0.0107945212775086,0,0,19899.0,105233.48101229242,MAP2K1
16984,KEGG_2019_Human,Toll-like receptor signaling pathway,1/104,0.0051999314202997,0.0107945212775086,0,0,19896.0,104635.24941415618,MAP2K1
16985,KEGG_2019_Human,"Parathyroid hormone synthesis, secretion and action",1/106,0.0052999306076525,0.0107945212775086,0,0,19894.0,104245.78450366124,MAP2K1
16986,KEGG_2019_Human,TNF signaling pathway,1/110,0.0054999290027479,0.0107945212775086,0,0,19890.0,103488.06969787036,MAP2K1
16987,KEGG_2019_Human,Cholinergic synapse,1/112,0.0055999282120529,0.0107945212775086,0,0,19888.0,103119.30984392198,MAP2K1
16988,KEGG_2019_Human,Serotonergic synapse,1/113,0.0056499278191151,0.0107945212775086,0,0,19887.0,102937.34947211576,MAP2K1
16989,KEGG_2019_Human,Thyroid hormone signaling pathway,1/116,0.0057999266512085,0.0107945212775086,0,0,19884.0,102400.8105961506,MAP2K1
16990,KEGG_2019_Human,Sphingolipid signaling pathway,1/119,0.0059499254985137,0.0107945212775086,0,0,19881.0,101877.73080211312,MAP2K1
16991,KEGG_2019_Human,Neurotrophin signaling pathway,1/119,0.0059499254985137,0.0107945212775086,0,0,19881.0,101877.73080211312,MAP2K1
16992,KEGG_2019_Human,Oocyte meiosis,1/125,0.0062499232373748,0.0107945212775086,0,0,19875.0,100869.32368441945,MAP2K1
16993,KEGG_2019_Human,Osteoclast differentiation,1/127,0.0063499224962247,0.0107945212775086,0,0,19873.0,100543.72072014232,MAP2K1
16994,KEGG_2019_Human,Autophagy,1/128,0.0063999221281459,0.0107945212775086,0,0,19872.0,100382.8010329652,MAP2K1
16995,KEGG_2019_Human,Relaxin signaling pathway,1/130,0.0064999213952527,0.0107945212775086,0,0,19870.0,100064.62842845908,MAP2K1
16996,KEGG_2019_Human,Natural killer cell mediated cytotoxicity,1/131,0.0065499210316603,0.0107945212775086,0,0,19869.0,99907.33811343512,MAP2K1
16997,KEGG_2019_Human,Vascular smooth muscle contraction,1/132,0.0065999206698993,0.0107945212775086,0,0,19868.0,99751.22090491928,MAP2K1
16998,KEGG_2019_Human,FoxO signaling pathway,1/132,0.0065999206698993,0.0107945212775086,0,0,19868.0,99751.22090491928,MAP2K1
16999,KEGG_2019_Human,Insulin signaling pathway,1/137,0.0068499188797651,0.0107945212775086,0,0,19863.0,98987.62735269018,MAP2K1
17000,KEGG_2019_Human,Apelin signaling pathway,1/137,0.0068499188797651,0.0107945212775086,0,0,19863.0,98987.62735269018,MAP2K1
17001,KEGG_2019_Human,Estrogen signaling pathway,1/137,0.0068499188797651,0.0107945212775086,0,0,19863.0,98987.62735269018,MAP2K1
17002,KEGG_2019_Human,Signaling pathways regulating pluripotency of stem cells,1/139,0.006949918172816,0.0107945212775086,0,0,19861.0,98689.81333375497,MAP2K1
17003,KEGG_2019_Human,Apoptosis,1/143,0.0071499167770442,0.0107945212775086,0,0,19857.0,98106.57763600958,MAP2K1
17004,KEGG_2019_Human,Breast cancer,1/147,0.0073499154017982,0.0107945212775086,0,0,19853.0,97539.10874372096,MAP2K1
17005,KEGG_2019_Human,Phospholipase D signaling pathway,1/148,0.007399915061391,0.0107945212775086,0,0,19852.0,97399.60470052566,MAP2K1
17006,KEGG_2019_Human,Gastric cancer,1/149,0.0074499147221605,0.0107945212775086,0,0,19851.0,97261.02051561224,MAP2K1
17007,KEGG_2019_Human,mTOR signaling pathway,1/152,0.0075999137114971,0.0107945212775086,0,0,19848.0,96850.665715497,MAP2K1
17008,KEGG_2019_Human,Oxytocin signaling pathway,1/153,0.0076499133771537,0.0107945212775086,0,0,19847.0,96715.6407630817,MAP2K1
17009,KEGG_2019_Human,Cushing syndrome,1/155,0.0077499127120574,0.0107945212775086,0,0,19845.0,96448.16254952336,MAP2K1
17010,KEGG_2019_Human,Hepatitis C,1/155,0.0077499127120574,0.0107945212775086,0,0,19845.0,96448.16254952336,MAP2K1
17011,KEGG_2019_Human,Cellular senescence,1/160,0.0079999110688441,0.0109198810514423,0,0,19840.0,95793.96509856998,MAP2K1
17012,KEGG_2019_Human,Hepatitis B,1/163,0.0081499100978668,0.0109198810514423,0,0,19837.0,95410.9786681514,MAP2K1
17013,KEGG_2019_Human,cGMP-PKG signaling pathway,1/166,0.0082999091363732,0.0109198810514423,0,0,19834.0,95034.82345515196,MAP2K1
17014,KEGG_2019_Human,Hepatocellular carcinoma,1/168,0.0083999085011095,0.0109198810514423,0,0,19832.0,94787.72752807094,MAP2K1
17015,KEGG_2019_Human,Influenza A,1/171,0.0085499075557634,0.0109326686778614,0,0,19829.0,94422.42241345016,MAP2K1
17016,KEGG_2019_Human,Alcoholism,1/180,0.0089999047745351,0.0113224608453828,0,0,19820.0,93362.92821536642,MAP2K1
17017,KEGG_2019_Human,Kaposi sarcoma-associated herpesvirus infection,1/186,0.0092999029651357,0.0115141655758823,0,0,19814.0,92684.96451050608,MAP2K1
17018,KEGG_2019_Human,Chemokine signaling pathway,1/190,0.0094999017791995,0.0115780052933994,0,0,19810.0,92244.74636351672,MAP2K1
17019,KEGG_2019_Human,Focal adhesion,1/199,0.0099498991610159,0.0118771528764897,0,0,19801.0,91286.4288690606,MAP2K1
17020,KEGG_2019_Human,Proteoglycans in cancer,1/201,0.0100498985877989,0.0118771528764897,0,0,19799.0,91079.21596609056,MAP2K1
17021,KEGG_2019_Human,Rap1 signaling pathway,1/206,0.010299897173561,0.0119227400887104,0,0,19794.0,90569.849337325,MAP2K1
17022,KEGG_2019_Human,Human immunodeficiency virus 1 infection,1/212,0.0105998955026255,0.0119227400887104,0,0,19788.0,89974.27756224656,MAP2K1
17023,KEGG_2019_Human,cAMP signaling pathway,1/212,0.0105998955026255,0.0119227400887104,0,0,19788.0,89974.27756224656,MAP2K1
17024,KEGG_2019_Human,Regulation of actin cytoskeleton,1/214,0.0106998949514067,0.0119227400887104,0,0,19786.0,89779.39753374986,MAP2K1
17025,KEGG_2019_Human,Human T-cell leukemia virus 1 infection,1/219,0.0109498935894162,0.0120294605630206,0,0,19781.0,89299.85161916987,MAP2K1
17026,KEGG_2019_Human,Human cytomegalovirus infection,1/225,0.0112498919790339,0.0121873829772867,0,0,19775.0,88738.27077557483,MAP2K1
17027,KEGG_2019_Human,Ras signaling pathway,1/232,0.0115998901349604,0.0123944031579029,0,0,19768.0,88101.22480150245,MAP2K1
17028,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0155471654916858,0,0,19705.0,83086.53988020132,MAP2K1
17029,KEGG_2019_Human,MicroRNAs in cancer,1/299,0.0149498740670514,0.0155478690297335,0,0,19701.0,82804.33538735632,MAP2K1
17030,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0169340744973583,0,0,19670.0,80733.60565076157,MAP2K1
17031,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0179297309873586,0,0,19646.0,79255.8617626126,MAP2K1
17032,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,MAP2K1
17033,KEGG_2019_Human,Ribosome biogenesis in eukaryotes,1/101,0.0050499326546803,0.0050499326546803,0,0,19899.0,105233.48101229242,NVL
17034,KEGG_2019_Human,Human immunodeficiency virus 1 infection,1/212,0.0105998955026255,0.0105998955026255,0,0,19788.0,89974.27756224656,SAMHD1
17035,KEGG_2019_Human,Other glycan degradation,1/18,0.0008999788927950273,0.00179995778559,0,0,19982.0,140136.54844084635,FUCA1
17036,KEGG_2019_Human,Lysosome,1/123,0.0061499239842961,0.0061499239842961,0,0,19877.0,101200.07933676826,FUCA1
17037,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF195
17038,KEGG_2019_Human,Protein processing in endoplasmic reticulum,1/165,0.0082499094553477,0.0082499094553477,0,0,19835.0,95159.46482222488,DNAJA2
17039,KEGG_2019_Human,Endocytosis,1/244,0.0121998870519305,0.0121998870519305,0,0,19756.0,87051.4275316661,SMAP1
17040,KEGG_2019_Human,Kaposi sarcoma-associated herpesvirus infection,1/186,0.0092999029651357,0.0092999029651357,0,0,19814.0,92684.96451050608,CD200R1L
17041,KEGG_2019_Human,Vasopressin-regulated water reabsorption,1/44,0.0021999607179423,0.0064499086760799,0,0,19956.0,122117.06559109331,DYNC1LI1
17042,KEGG_2019_Human,Salmonella infection,1/86,0.0042999391173866,0.0064499086760799,0,0,19914.0,108514.46102290176,DYNC1LI1
17043,KEGG_2019_Human,Phagosome,1/152,0.0075999137114971,0.0075999137114971,0,0,19848.0,96850.665715497,DYNC1LI1
17044,KEGG_2019_Human,Fatty acid elongation,1/27,0.0013499718942362,0.0027428095506272,0,0,19973.0,131975.02298599784,HADHA
17045,KEGG_2019_Human,Butanoate metabolism,1/28,0.0013999711732997,0.0027428095506272,0,0,19972.0,131242.0761597353,HADHA
17046,KEGG_2019_Human,beta-Alanine metabolism,1/31,0.0015499690656704,0.0027428095506272,0,0,19969.0,129189.85098816035,HADHA
17047,KEGG_2019_Human,Propanoate metabolism,1/32,0.0015999683804467,0.0027428095506272,0,0,19968.0,128549.41955786056,HADHA
17048,KEGG_2019_Human,Tryptophan metabolism,1/42,0.0020999619311272,0.0027428095506272,0,0,19958.0,123057.75613441122,HADHA
17049,KEGG_2019_Human,Fatty acid degradation,1/44,0.0021999607179423,0.0027428095506272,0,0,19956.0,122117.06559109331,HADHA
17050,KEGG_2019_Human,"Valine, leucine and isoleucine degradation",1/48,0.0023999583567988,0.0027428095506272,0,0,19952.0,120356.5272753826,HADHA
17051,KEGG_2019_Human,Lysine degradation,1/59,0.0029499522555206,0.0029499522555206,0,0,19941.0,116175.59385530632,HADHA
17052,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF611
17053,KEGG_2019_Human,Glycosylphosphatidylinositol (GPI)-anchor biosynthesis,1/25,0.0012499733663791,0.0012499733663791,0,0,19975.0,133525.54486996148,GPLD1
17054,KEGG_2019_Human,Circadian rhythm,1/31,0.0015499690656704,0.0015499690656704,0,0,19969.0,129189.85098816035,FBXL3
17055,KEGG_2019_Human,Protein digestion and absorption,1/90,0.0044999373439762,0.0048999339081079,0,0,19910.0,107587.50385474482,CELA3A
17056,KEGG_2019_Human,Pancreatic secretion,1/98,0.0048999339081079,0.0048999339081079,0,0,19902.0,105849.45495286948,CELA3A
17057,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF658
17058,KEGG_2019_Human,Axon guidance,1/181,0.0090499044707863,0.0090499044707863,0,0,19819.0,93248.41634586031,SEMA6C
17059,KEGG_2019_Human,Chemokine signaling pathway,1/190,0.0094999017791995,0.0146998751759735,0,0,19810.0,92244.74636351672,CXCR5
17060,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0146998751759735,0,0,19706.0,83157.67014793828,CXCR5
17061,KEGG_2019_Human,Chemokine signaling pathway,1/190,0.0094999017791995,0.0146998751759735,0,0,19810.0,92244.74636351672,CXCL16
17062,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0146998751759735,0,0,19706.0,83157.67014793828,CXCL16
17063,KEGG_2019_Human,African trypanosomiasis,1/37,0.0018499650702878,0.0018499650702878,0,0,19963.0,125618.9446446357,HPR
17064,KEGG_2019_Human,Butanoate metabolism,1/28,0.0013999711732997,0.0013999711732997,0,0,19972.0,131242.0761597353,ACSM3
17065,KEGG_2019_Human,Ras signaling pathway,1/232,0.0115998901349604,0.022124812430476,0,0,19768.0,88101.22480150245,RASGRP4
17066,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.022124812430476,0,0,19705.0,83086.53988020132,RASGRP4
17067,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,RASGRP4
17068,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF432
17069,KEGG_2019_Human,Hedgehog signaling pathway,1/47,0.0023499589392381,0.0023499589392381,0,0,19953.0,120782.64067395544,CSNK1G1
17070,KEGG_2019_Human,Vibrio cholerae infection,1/50,0.0024999572069037,0.0067199138544635,0,0,19950.0,119530.05920663515,KCNQ1
17071,KEGG_2019_Human,Gastric acid secretion,1/75,0.0037499442041125,0.0067199138544635,0,0,19925.0,111301.33528642564,KCNQ1
17072,KEGG_2019_Human,Protein digestion and absorption,1/90,0.0044999373439762,0.0067199138544635,0,0,19910.0,107587.50385474482,KCNQ1
17073,KEGG_2019_Human,Pancreatic secretion,1/98,0.0048999339081079,0.0067199138544635,0,0,19902.0,105849.45495286948,KCNQ1
17074,KEGG_2019_Human,Cholinergic synapse,1/112,0.0055999282120529,0.0067199138544635,0,0,19888.0,103119.30984392198,KCNQ1
17075,KEGG_2019_Human,Adrenergic signaling in cardiomyocytes,1/145,0.0072499160871101,0.0072499160871101,0,0,19855.0,97820.92670675044,KCNQ1
17076,KEGG_2019_Human,Glycolysis / Gluconeogenesis,1/68,0.0033999476216189,0.0049999330710556,0,0,19932.0,113293.39338050144,ENO1
17077,KEGG_2019_Human,RNA degradation,1/79,0.0039499423167337,0.0049999330710556,0,0,19921.0,110243.89578070649,ENO1
17078,KEGG_2019_Human,HIF-1 signaling pathway,1/100,0.0049999330710556,0.0049999330710556,0,0,19900.0,105436.78197328727,ENO1
17079,KEGG_2019_Human,Aldosterone synthesis and secretion,1/98,0.0048999339081079,0.0097998678162159,0,0,19902.0,105849.45495286948,PRKD3
17080,KEGG_2019_Human,Rap1 signaling pathway,1/206,0.010299897173561,0.010299897173561,0,0,19794.0,90569.849337325,PRKD3
17081,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0146998751759735,0,0,19706.0,83157.67014793828,TNFRSF6B
17082,KEGG_2019_Human,Amino sugar and nucleotide sugar metabolism,1/48,0.0023999583567988,0.0023999583567988,0,0,19952.0,120356.5272753826,CYB5R3
17083,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR8B3
17084,KEGG_2019_Human,Amyotrophic lateral sclerosis (ALS),1/51,0.0025499566390179,0.0109038867493566,0,0,19949.0,119129.0228601236,PPP3CB
17085,KEGG_2019_Human,VEGF signaling pathway,1/59,0.0029499522555206,0.0109038867493566,0,0,19941.0,116175.59385530632,PPP3CB
17086,KEGG_2019_Human,Long-term potentiation,1/67,0.0033499481224912,0.0109038867493566,0,0,19933.0,113594.38808369274,PPP3CB
17087,KEGG_2019_Human,Amphetamine addiction,1/68,0.0033999476216189,0.0109038867493566,0,0,19932.0,113293.39338050144,PPP3CB
17088,KEGG_2019_Human,Renin secretion,1/69,0.003449947123837,0.0109038867493566,0,0,19931.0,112996.7391397682,PPP3CB
17089,KEGG_2019_Human,B cell receptor signaling pathway,1/71,0.0035499461386618,0.0109038867493566,0,0,19929.0,112415.9585341616,PPP3CB
17090,KEGG_2019_Human,Th1 and Th2 cell differentiation,1/92,0.0045999364719865,0.0109038867493566,0,0,19908.0,107139.13814408927,PPP3CB
17091,KEGG_2019_Human,T cell receptor signaling pathway,1/101,0.0050499326546803,0.0109038867493566,0,0,19899.0,105233.48101229242,PPP3CB
17092,KEGG_2019_Human,Glucagon signaling pathway,1/103,0.0051499318302617,0.0109038867493566,0,0,19897.0,104832.7525292024,PPP3CB
17093,KEGG_2019_Human,C-type lectin receptor signaling pathway,1/104,0.0051999314202997,0.0109038867493566,0,0,19896.0,104635.24941415618,PPP3CB
17094,KEGG_2019_Human,Th17 cell differentiation,1/107,0.0053499302026925,0.0109038867493566,0,0,19893.0,104053.753408911,PPP3CB
17095,KEGG_2019_Human,Glutamatergic synapse,1/114,0.005699927427839,0.0109038867493566,0,0,19886.0,102756.96431429044,PPP3CB
17096,KEGG_2019_Human,Oocyte meiosis,1/125,0.0062499232373748,0.0109038867493566,0,0,19875.0,100869.32368441945,PPP3CB
17097,KEGG_2019_Human,Osteoclast differentiation,1/127,0.0063499224962247,0.0109038867493566,0,0,19873.0,100543.72072014232,PPP3CB
17098,KEGG_2019_Human,Dopaminergic synapse,1/131,0.0065499210316603,0.0109038867493566,0,0,19869.0,99907.33811343512,PPP3CB
17099,KEGG_2019_Human,Natural killer cell mediated cytotoxicity,1/131,0.0065499210316603,0.0109038867493566,0,0,19869.0,99907.33811343512,PPP3CB
17100,KEGG_2019_Human,Oxytocin signaling pathway,1/153,0.0076499133771537,0.0109038867493566,0,0,19847.0,96715.6407630817,PPP3CB
17101,KEGG_2019_Human,Wnt signaling pathway,1/158,0.0078999117225733,0.0109038867493566,0,0,19842.0,96053.2110949472,PPP3CB
17102,KEGG_2019_Human,Cellular senescence,1/160,0.0079999110688441,0.0109038867493566,0,0,19840.0,95793.96509856998,PPP3CB
17103,KEGG_2019_Human,cGMP-PKG signaling pathway,1/166,0.0082999091363732,0.0109038867493566,0,0,19834.0,95034.82345515196,PPP3CB
17104,KEGG_2019_Human,Alzheimer disease,1/171,0.0085499075557634,0.0109038867493566,0,0,19829.0,94422.42241345016,PPP3CB
17105,KEGG_2019_Human,Tuberculosis,1/179,0.0089499050800561,0.0109038867493566,0,0,19821.0,93478.0629355712,PPP3CB
17106,KEGG_2019_Human,Axon guidance,1/181,0.0090499044707863,0.0109038867493566,0,0,19819.0,93248.41634586031,PPP3CB
17107,KEGG_2019_Human,Kaposi sarcoma-associated herpesvirus infection,1/186,0.0092999029651357,0.0109038867493566,0,0,19814.0,92684.96451050608,PPP3CB
17108,KEGG_2019_Human,Calcium signaling pathway,1/188,0.009399902370135,0.0109038867493566,0,0,19812.0,92463.712994847,PPP3CB
17109,KEGG_2019_Human,Human immunodeficiency virus 1 infection,1/212,0.0105998955026255,0.0116516738354279,0,0,19788.0,89974.27756224656,PPP3CB
17110,KEGG_2019_Human,Human T-cell leukemia virus 1 infection,1/219,0.0109498935894162,0.0116516738354279,0,0,19781.0,89299.85161916987,PPP3CB
17111,KEGG_2019_Human,Human cytomegalovirus infection,1/225,0.0112498919790339,0.0116516738354279,0,0,19775.0,88738.27077557483,PPP3CB
17112,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0147498749536506,0,0,19705.0,83086.53988020132,PPP3CB
17113,KEGG_2019_Human,Transcriptional misregulation in cancer,1/186,0.0092999029651357,0.0092999029651357,0,0,19814.0,92684.96451050608,UTY
17114,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0146998751759735,0,0,19706.0,83157.67014793828,TNFRSF10D
17115,KEGG_2019_Human,One carbon pool by folate,1/20,0.0009999772468562472,0.0009999772468562472,0,0,19980.0,138017.40508704726,MTHFD2
17116,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR5AR1
17117,KEGG_2019_Human,Arginine and proline metabolism,1/49,0.0024499577795033,0.0024499577795033,0,0,19951.0,119939.1172087114,PYCR3
17118,KEGG_2019_Human,Spliceosome,1/134,0.0066999199497742,0.0066999199497742,0,0,19866.0,99442.43560916925,RBM22
17119,KEGG_2019_Human,Pathogenic Escherichia coli infection,1/55,0.0027499544131125,0.0084999078692823,0,0,19945.0,117599.1294878737,TUBA8
17120,KEGG_2019_Human,Gap junction,1/88,0.0043999382262822,0.0084999078692823,0,0,19912.0,108045.79305232369,TUBA8
17121,KEGG_2019_Human,Apoptosis,1/143,0.0071499167770442,0.0084999078692823,0,0,19857.0,98106.57763600958,TUBA8
17122,KEGG_2019_Human,Phagosome,1/152,0.0075999137114971,0.0084999078692823,0,0,19848.0,96850.665715497,TUBA8
17123,KEGG_2019_Human,Tight junction,1/170,0.0084999078692823,0.0084999078692823,0,0,19830.0,94543.49009679438,TUBA8
17124,KEGG_2019_Human,RNA degradation,1/79,0.0039499423167337,0.0039499423167337,0,0,19921.0,110243.89578070649,BTG3
17125,KEGG_2019_Human,Circadian entrainment,1/97,0.0048499343304706,0.0096998686609413,0,0,19903.0,106058.9096435903,MTNR1A
17126,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,MTNR1A
17127,KEGG_2019_Human,SNARE interactions in vesicular transport,1/34,0.0016999670339032,0.0016999670339032,0,0,19966.0,127326.1054203148,GOSR2
17128,KEGG_2019_Human,Biosynthesis of unsaturated fatty acids,1/27,0.0013499718942362,0.0013499718942362,0,0,19973.0,131975.02298599784,ACOT7
17129,KEGG_2019_Human,Fatty acid elongation,1/27,0.0013499718942362,0.0013499718942362,0,0,19973.0,131975.02298599784,ACOT7
17130,KEGG_2019_Human,Terpenoid backbone biosynthesis,1/22,0.0010999756574123,0.0021999513148247,0,0,19978.0,136099.47030191717,MVK
17131,KEGG_2019_Human,Peroxisome,1/83,0.0041499404726918,0.0041499404726918,0,0,19917.0,109237.99888847338,MVK
17132,KEGG_2019_Human,Renin-angiotensin system,1/23,0.0011499748819949,0.0022999497639899,0,0,19977.0,135204.63922267244,PRCP
17133,KEGG_2019_Human,Protein digestion and absorption,1/90,0.0044999373439762,0.0044999373439762,0,0,19910.0,107587.50385474482,PRCP
17134,KEGG_2019_Human,Glycosphingolipid biosynthesis,1/45,0.0022499601197094,0.0022499601197094,0,0,19955.0,121662.49782449217,B3GALNT1
17135,KEGG_2019_Human,Terpenoid backbone biosynthesis,1/22,0.0010999756574123,0.0010999756574123,0,0,19978.0,136099.47030191717,IDI1
17136,KEGG_2019_Human,Tight junction,1/170,0.0084999078692823,0.010299897173561,0,0,19830.0,94543.49009679438,RAPGEF6
17137,KEGG_2019_Human,Rap1 signaling pathway,1/206,0.010299897173561,0.010299897173561,0,0,19794.0,90569.849337325,RAPGEF6
17138,KEGG_2019_Human,Cellular senescence,1/160,0.0079999110688441,0.009399902370135,0,0,19840.0,95793.96509856998,MCU
17139,KEGG_2019_Human,NOD-like receptor signaling pathway,1/178,0.0088999053857096,0.009399902370135,0,0,19822.0,93593.82745769851,MCU
17140,KEGG_2019_Human,Calcium signaling pathway,1/188,0.009399902370135,0.009399902370135,0,0,19812.0,92463.712994847,MCU
17141,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR4A47
17142,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF519
17143,KEGG_2019_Human,Renin secretion,1/69,0.003449947123837,0.0048999339081079,0,0,19931.0,112996.7391397682,CLCA2
17144,KEGG_2019_Human,Pancreatic secretion,1/98,0.0048999339081079,0.0048999339081079,0,0,19902.0,105849.45495286948,CLCA2
17145,KEGG_2019_Human,Regulation of lipolysis in adipocytes,1/55,0.0027499544131125,0.0036999446830449,0,0,19945.0,117599.1294878737,FABP4
17146,KEGG_2019_Human,PPAR signaling pathway,1/74,0.0036999446830449,0.0036999446830449,0,0,19926.0,111574.38983110404,FABP4
17147,KEGG_2019_Human,Endocytosis,1/244,0.0121998870519305,0.0121998870519305,0,0,19756.0,87051.4275316661,ARFGEF1
17148,KEGG_2019_Human,Basal transcription factors,1/45,0.0022499601197094,0.0022499601197094,0,0,19955.0,121662.49782449217,TAF7L
17149,KEGG_2019_Human,Prostate cancer,1/97,0.0048499343304706,0.0092999029651357,0,0,19903.0,106058.9096435903,TMPRSS2
17150,KEGG_2019_Human,Influenza A,1/171,0.0085499075557634,0.0092999029651357,0,0,19829.0,94422.42241345016,TMPRSS2
17151,KEGG_2019_Human,Transcriptional misregulation in cancer,1/186,0.0092999029651357,0.0092999029651357,0,0,19814.0,92684.96451050608,TMPRSS2
17152,KEGG_2019_Human,Mucin type O-glycan biosynthesis,1/31,0.0015499690656704,0.0015499690656704,0,0,19969.0,129189.85098816035,POC1B-GALNT4
17153,KEGG_2019_Human,Thyroid cancer,1/37,0.0018499650702878,0.0114298604932045,0,0,19963.0,125618.9446446357,PPARG
17154,KEGG_2019_Human,PPAR signaling pathway,1/74,0.0036999446830449,0.0114298604932045,0,0,19926.0,111574.38983110404,PPARG
17155,KEGG_2019_Human,Longevity regulating pathway,1/102,0.0050999322416682,0.0114298604932045,0,0,19898.0,105032.15064717118,PPARG
17156,KEGG_2019_Human,AMPK signaling pathway,1/120,0.0059999251180858,0.0114298604932045,0,0,19880.0,101706.2448082016,PPARG
17157,KEGG_2019_Human,Osteoclast differentiation,1/127,0.0063499224962247,0.0114298604932045,0,0,19873.0,100543.72072014232,PPARG
17158,KEGG_2019_Human,Transcriptional misregulation in cancer,1/186,0.0092999029651357,0.0124070154393338,0,0,19814.0,92684.96451050608,PPARG
17159,KEGG_2019_Human,Huntington disease,1/193,0.0096499008972596,0.0124070154393338,0,0,19807.0,91920.47679471428,PPARG
17160,KEGG_2019_Human,Thermogenesis,1/231,0.0115498903940656,0.0129936266933238,0,0,19769.0,88191.07730937863,PPARG
17161,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,PPARG
17162,KEGG_2019_Human,Cellular senescence,1/160,0.0079999110688441,0.0079999110688441,0,0,19840.0,95793.96509856998,ZFP36L2
17163,KEGG_2019_Human,Ascorbate and aldarate metabolism,1/27,0.0013499718942362,0.004685646776936,0,0,19973.0,131975.02298599784,UGT1A4
17164,KEGG_2019_Human,Pentose and glucuronate interconversions,1/34,0.0016999670339032,0.004685646776936,0,0,19966.0,127326.1054203148,UGT1A4
17165,KEGG_2019_Human,Porphyrin and chlorophyll metabolism,1/42,0.0020999619311272,0.004685646776936,0,0,19958.0,123057.75613441122,UGT1A4
17166,KEGG_2019_Human,Steroid hormone biosynthesis,1/60,0.002999951725986,0.004685646776936,0,0,19940.0,115834.63209072244,UGT1A4
17167,KEGG_2019_Human,Retinol metabolism,1/67,0.0033499481224912,0.004685646776936,0,0,19933.0,113594.38808369274,UGT1A4
17168,KEGG_2019_Human,Metabolism of xenobiotics by cytochrome P450,1/74,0.0036999446830449,0.004685646776936,0,0,19926.0,111574.38983110404,UGT1A4
17169,KEGG_2019_Human,Chemical carcinogenesis,1/82,0.004099940929819,0.004685646776936,0,0,19918.0,109484.9180722932,UGT1A4
17170,KEGG_2019_Human,Drug metabolism,1/108,0.0053999298011749,0.0053999298011749,0,0,19892.0,103863.47861844616,UGT1A4
17171,KEGG_2019_Human,Peroxisome,1/83,0.0041499404726918,0.0041499404726918,0,0,19917.0,109237.99888847338,CROT
17172,KEGG_2019_Human,Proteasome,1/45,0.0022499601197094,0.0022499601197094,0,0,19955.0,121662.49782449217,PSMA1
17173,KEGG_2019_Human,Thyroid hormone synthesis,1/74,0.0036999446830449,0.010999879273797,0,0,19926.0,111574.38983110404,HSP90B1
17174,KEGG_2019_Human,IL-17 signaling pathway,1/93,0.0046499360391879,0.010999879273797,0,0,19907.0,106918.54242106884,HSP90B1
17175,KEGG_2019_Human,Prostate cancer,1/97,0.0048499343304706,0.010999879273797,0,0,19903.0,106058.9096435903,HSP90B1
17176,KEGG_2019_Human,Estrogen signaling pathway,1/137,0.0068499188797651,0.010999879273797,0,0,19863.0,98987.62735269018,HSP90B1
17177,KEGG_2019_Human,Fluid shear stress and atherosclerosis,1/139,0.006949918172816,0.010999879273797,0,0,19861.0,98689.81333375497,HSP90B1
17178,KEGG_2019_Human,Protein processing in endoplasmic reticulum,1/165,0.0082499094553477,0.010999879273797,0,0,19835.0,95159.46482222488,HSP90B1
17179,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0202284144472764,0,0,19646.0,79255.8617626126,HSP90B1
17180,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,HSP90B1
17181,KEGG_2019_Human,Ether lipid metabolism,1/47,0.0023499589392381,0.0023499589392381,0,0,19953.0,120782.64067395544,ENPP6
17182,KEGG_2019_Human,Renin-angiotensin system,1/23,0.0011499748819949,0.0090415648307337,0,0,19977.0,135204.63922267244,AGT
17183,KEGG_2019_Human,Cortisol synthesis and secretion,1/65,0.003249949134407,0.0090415648307337,0,0,19935.0,114209.92613860144,AGT
17184,KEGG_2019_Human,Renin secretion,1/69,0.003449947123837,0.0090415648307337,0,0,19931.0,112996.7391397682,AGT
17185,KEGG_2019_Human,Hypertrophic cardiomyopathy (HCM),1/85,0.004249939567045,0.0090415648307337,0,0,19915.0,108752.83801948265,AGT
17186,KEGG_2019_Human,Dilated cardiomyopathy (DCM),1/91,0.0045499369072032,0.0090415648307337,0,0,19909.0,107362.10783923086,AGT
17187,KEGG_2019_Human,Aldosterone synthesis and secretion,1/98,0.0048999339081079,0.0090415648307337,0,0,19902.0,105849.45495286948,AGT
17188,KEGG_2019_Human,AGE-RAGE signaling pathway in diabetic complications,1/100,0.0049999330710556,0.0090415648307337,0,0,19900.0,105436.78197328727,AGT
17189,KEGG_2019_Human,Insulin resistance,1/108,0.0053999298011749,0.0090415648307337,0,0,19892.0,103863.47861844616,AGT
17190,KEGG_2019_Human,Vascular smooth muscle contraction,1/132,0.0065999206698993,0.0090415648307337,0,0,19868.0,99751.22090491928,AGT
17191,KEGG_2019_Human,Adrenergic signaling in cardiomyocytes,1/145,0.0072499160871101,0.0090415648307337,0,0,19855.0,97820.92670675044,AGT
17192,KEGG_2019_Human,Phospholipase D signaling pathway,1/148,0.007399915061391,0.0090415648307337,0,0,19852.0,97399.60470052566,AGT
17193,KEGG_2019_Human,Cushing syndrome,1/155,0.0077499127120574,0.0090415648307337,0,0,19845.0,96448.16254952336,AGT
17194,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0181998555055257,0,0,19662.0,80229.79996326564,AGT
17195,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,AGT
17196,KEGG_2019_Human,Retinol metabolism,1/67,0.0033499481224912,0.0033499481224912,0,0,19933.0,113594.38808369274,CYP26B1
17197,KEGG_2019_Human,Human T-cell leukemia virus 1 infection,1/219,0.0109498935894162,0.0109498935894162,0,0,19781.0,89299.85161916987,GPS2
17198,KEGG_2019_Human,One carbon pool by folate,1/20,0.0009999772468562472,0.0009999772468562472,0,0,19980.0,138017.40508704726,ALDH1L2
17199,KEGG_2019_Human,One carbon pool by folate,1/20,0.0009999772468562472,0.0019999544937124,0,0,19980.0,138017.40508704726,GART
17200,KEGG_2019_Human,Purine metabolism,1/129,0.006449921761047,0.006449921761047,0,0,19871.0,100223.109907462,GART
17201,KEGG_2019_Human,Protein digestion and absorption,1/90,0.0044999373439762,0.0044999373439762,0,0,19910.0,107587.50385474482,COL10A1
17202,KEGG_2019_Human,Vibrio cholerae infection,1/50,0.0024999572069037,0.0094998921393714,0,0,19950.0,119530.05920663515,ATP6V1H
17203,KEGG_2019_Human,Epithelial cell signaling in Helicobacter pylori infection,1/68,0.0033999476216189,0.0094998921393714,0,0,19932.0,113293.39338050144,ATP6V1H
17204,KEGG_2019_Human,Synaptic vesicle cycle,1/78,0.0038999427840466,0.0094998921393714,0,0,19922.0,110503.2180492851,ATP6V1H
17205,KEGG_2019_Human,Rheumatoid arthritis,1/91,0.0045499369072032,0.0094998921393714,0,0,19909.0,107362.10783923086,ATP6V1H
17206,KEGG_2019_Human,Lysosome,1/123,0.0061499239842961,0.0094998921393714,0,0,19877.0,101200.07933676826,ATP6V1H
17207,KEGG_2019_Human,Oxidative phosphorylation,1/133,0.0066499203093911,0.0094998921393714,0,0,19867.0,99596.2591544721,ATP6V1H
17208,KEGG_2019_Human,mTOR signaling pathway,1/152,0.0075999137114971,0.0094998921393714,0,0,19848.0,96850.665715497,ATP6V1H
17209,KEGG_2019_Human,Phagosome,1/152,0.0075999137114971,0.0094998921393714,0,0,19848.0,96850.665715497,ATP6V1H
17210,KEGG_2019_Human,Tuberculosis,1/179,0.0089499050800561,0.0099443389778401,0,0,19821.0,93478.0629355712,ATP6V1H
17211,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0164998674589645,0,0,19670.0,80733.60565076157,ATP6V1H
17212,KEGG_2019_Human,Other types of O-glycan biosynthesis,1/22,0.0010999756574123,0.0011499748819949,0,0,19978.0,136099.47030191717,POMT2
17213,KEGG_2019_Human,Mannose type O-glycan biosynthesis,1/23,0.0011499748819949,0.0011499748819949,0,0,19977.0,135204.63922267244,POMT2
17214,KEGG_2019_Human,Chronic myeloid leukemia,1/76,0.0037999437281752,0.0113998311845257,0,0,19924.0,111031.8499691117,MECOM
17215,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.022124812430476,0,0,19705.0,83086.53988020132,MECOM
17216,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,MECOM
17217,KEGG_2019_Human,Arachidonic acid metabolism,1/63,0.0031499501598827,0.0031499501598827,0,0,19937.0,114844.46974572667,PTGDS
17218,KEGG_2019_Human,Progesterone-mediated oocyte maturation,1/99,0.0049499334884068,0.0068499188797651,0,0,19901.0,105642.09305076736,ANAPC13
17219,KEGG_2019_Human,Cell cycle,1/124,0.0061999236097501,0.0068499188797651,0,0,19876.0,101034.04709010696,ANAPC13
17220,KEGG_2019_Human,Oocyte meiosis,1/125,0.0062499232373748,0.0068499188797651,0,0,19875.0,100869.32368441945,ANAPC13
17221,KEGG_2019_Human,Ubiquitin mediated proteolysis,1/137,0.0068499188797651,0.0068499188797651,0,0,19863.0,98987.62735269018,ANAPC13
17222,KEGG_2019_Human,RNA degradation,1/79,0.0039499423167337,0.0039499423167337,0,0,19921.0,110243.89578070649,PATL1
17223,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,NPBWR1
17224,KEGG_2019_Human,Spliceosome,1/134,0.0066999199497742,0.0066999199497742,0,0,19866.0,99442.43560916925,WBP11
17225,KEGG_2019_Human,Peroxisome,1/83,0.0041499404726918,0.0041499404726918,0,0,19917.0,109237.99888847338,NUDT7
17226,KEGG_2019_Human,RNA transport,1/165,0.0082499094553477,0.0106998949514067,0,0,19835.0,95159.46482222488,CYFIP2
17227,KEGG_2019_Human,Regulation of actin cytoskeleton,1/214,0.0106998949514067,0.0106998949514067,0,0,19786.0,89779.39753374986,CYFIP2
17228,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR11H12
17229,KEGG_2019_Human,Lysine degradation,1/59,0.0029499522555206,0.0029499522555206,0,0,19941.0,116175.59385530632,PRDM2
17230,KEGG_2019_Human,Protein processing in endoplasmic reticulum,1/165,0.0082499094553477,0.0082499094553477,0,0,19835.0,95159.46482222488,NPLOC4
17231,KEGG_2019_Human,Glutathione metabolism,1/56,0.0027999538675741,0.0094498771520562,0,0,19944.0,117233.87022514464,GSTA1
17232,KEGG_2019_Human,Metabolism of xenobiotics by cytochrome P450,1/74,0.0036999446830449,0.0094498771520562,0,0,19926.0,111574.38983110404,GSTA1
17233,KEGG_2019_Human,Chemical carcinogenesis,1/82,0.004099940929819,0.0094498771520562,0,0,19918.0,109484.9180722932,GSTA1
17234,KEGG_2019_Human,Drug metabolism,1/108,0.0053999298011749,0.0094498771520562,0,0,19892.0,103863.47861844616,GSTA1
17235,KEGG_2019_Human,Fluid shear stress and atherosclerosis,1/139,0.006949918172816,0.0097298854419424,0,0,19861.0,98689.81333375497,GSTA1
17236,KEGG_2019_Human,Hepatocellular carcinoma,1/168,0.0083999085011095,0.0097998932512944,0,0,19832.0,94787.72752807094,GSTA1
17237,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,GSTA1
17238,KEGG_2019_Human,Spliceosome,1/134,0.0066999199497742,0.0066999199497742,0,0,19866.0,99442.43560916925,AQR
17239,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF100
17240,KEGG_2019_Human,Proteoglycans in cancer,1/201,0.0100498985877989,0.0100498985877989,0,0,19799.0,91079.21596609056,TWIST1
17241,KEGG_2019_Human,Acute myeloid leukemia,1/66,0.003299948626608,0.0092999029651357,0,0,19934.0,113899.85357353876,FCGR1A
17242,KEGG_2019_Human,Staphylococcus aureus infection,1/68,0.0033999476216189,0.0092999029651357,0,0,19932.0,113293.39338050144,FCGR1A
17243,KEGG_2019_Human,Leishmaniasis,1/74,0.0036999446830449,0.0092999029651357,0,0,19926.0,111574.38983110404,FCGR1A
17244,KEGG_2019_Human,Fc gamma R-mediated phagocytosis,1/91,0.0045499369072032,0.0092999029651357,0,0,19909.0,107362.10783923086,FCGR1A
17245,KEGG_2019_Human,Hematopoietic cell lineage,1/97,0.0048499343304706,0.0092999029651357,0,0,19903.0,106058.9096435903,FCGR1A
17246,KEGG_2019_Human,Osteoclast differentiation,1/127,0.0063499224962247,0.0092999029651357,0,0,19873.0,100543.72072014232,FCGR1A
17247,KEGG_2019_Human,Systemic lupus erythematosus,1/133,0.0066499203093911,0.0092999029651357,0,0,19867.0,99596.2591544721,FCGR1A
17248,KEGG_2019_Human,Phagosome,1/152,0.0075999137114971,0.0092999029651357,0,0,19848.0,96850.665715497,FCGR1A
17249,KEGG_2019_Human,Tuberculosis,1/179,0.0089499050800561,0.0092999029651357,0,0,19821.0,93478.0629355712,FCGR1A
17250,KEGG_2019_Human,Transcriptional misregulation in cancer,1/186,0.0092999029651357,0.0092999029651357,0,0,19814.0,92684.96451050608,FCGR1A
17251,KEGG_2019_Human,Fanconi anemia pathway,1/54,0.0026999549628563,0.0026999549628563,0,0,19946.0,117971.01964061816,FANCF
17252,KEGG_2019_Human,Transcriptional misregulation in cancer,1/186,0.0092999029651357,0.0092999029651357,0,0,19814.0,92684.96451050608,CCNT1
17253,KEGG_2019_Human,Fatty acid degradation,1/44,0.0021999607179423,0.007199910141703,0,0,19956.0,122117.06559109331,CPT1C
17254,KEGG_2019_Human,Adipocytokine signaling pathway,1/69,0.003449947123837,0.007199910141703,0,0,19931.0,112996.7391397682,CPT1C
17255,KEGG_2019_Human,PPAR signaling pathway,1/74,0.0036999446830449,0.007199910141703,0,0,19926.0,111574.38983110404,CPT1C
17256,KEGG_2019_Human,Glucagon signaling pathway,1/103,0.0051499318302617,0.007199910141703,0,0,19897.0,104832.7525292024,CPT1C
17257,KEGG_2019_Human,AMPK signaling pathway,1/120,0.0059999251180858,0.007199910141703,0,0,19880.0,101706.2448082016,CPT1C
17258,KEGG_2019_Human,Thermogenesis,1/231,0.0115498903940656,0.0115498903940656,0,0,19769.0,88191.07730937863,CPT1C
17259,KEGG_2019_Human,ABC transporters,1/45,0.0022499601197094,0.0022499601197094,0,0,19955.0,121662.49782449217,ABCB7
17260,KEGG_2019_Human,Amoebiasis,1/96,0.0047999347538706,0.0047999347538706,0,0,19904.0,106270.50039849174,SERPINB9
17261,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF577
17262,KEGG_2019_Human,Lysosome,1/123,0.0061499239842961,0.0071499167770442,0,0,19877.0,101200.07933676826,CTSV
17263,KEGG_2019_Human,Apoptosis,1/143,0.0071499167770442,0.0071499167770442,0,0,19857.0,98106.57763600958,CTSV
17264,KEGG_2019_Human,ErbB signaling pathway,1/85,0.004249939567045,0.0176998626413668,0,0,19915.0,108752.83801948265,ERBB3
17265,KEGG_2019_Human,Calcium signaling pathway,1/188,0.009399902370135,0.0176998626413668,0,0,19812.0,92463.712994847,ERBB3
17266,KEGG_2019_Human,Proteoglycans in cancer,1/201,0.0100498985877989,0.0176998626413668,0,0,19799.0,91079.21596609056,ERBB3
17267,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0176998626413668,0,0,19705.0,83086.53988020132,ERBB3
17268,KEGG_2019_Human,MicroRNAs in cancer,1/299,0.0149498740670514,0.0176998626413668,0,0,19701.0,82804.33538735632,ERBB3
17269,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0176998626413668,0,0,19646.0,79255.8617626126,ERBB3
17270,KEGG_2019_Human,Arginine biosynthesis,1/21,0.0010499764455398,0.0010499764455398,0,0,19979.0,137035.71221916509,OTC
17271,KEGG_2019_Human,Ubiquitin mediated proteolysis,1/137,0.0068499188797651,0.0068499188797651,0,0,19863.0,98987.62735269018,UBA3
17272,KEGG_2019_Human,Mineral absorption,1/51,0.0025499566390179,0.0025499566390179,0,0,19949.0,119129.0228601236,MT1G
17273,KEGG_2019_Human,Wnt signaling pathway,1/158,0.0078999117225733,0.0078999117225733,0,0,19842.0,96053.2110949472,RSPO3
17274,KEGG_2019_Human,Transcriptional misregulation in cancer,1/186,0.0092999029651357,0.0092999029651357,0,0,19814.0,92684.96451050608,TLX1
17275,KEGG_2019_Human,Mucin type O-glycan biosynthesis,1/31,0.0015499690656704,0.0015499690656704,0,0,19969.0,129189.85098816035,GALNTL5
17276,KEGG_2019_Human,Taste transduction,1/83,0.0041499404726918,0.0041499404726918,0,0,19917.0,109237.99888847338,TAS2R1
17277,KEGG_2019_Human,Antigen processing and presentation,1/77,0.0038499432547502,0.0065499210316603,0,0,19923.0,110765.8407373636,KLRC2
17278,KEGG_2019_Human,Natural killer cell mediated cytotoxicity,1/131,0.0065499210316603,0.0065499210316603,0,0,19869.0,99907.33811343512,KLRC2
17279,KEGG_2019_Human,Base excision repair,1/33,0.0016499677032113,0.0016499677032113,0,0,19967.0,127928.56031580272,MBD4
17280,KEGG_2019_Human,Citrate cycle (TCA cycle),1/30,0.0014999697593334,0.0104997883153344,0,0,19970.0,129851.13732048514,SDHC
17281,KEGG_2019_Human,Oxidative phosphorylation,1/133,0.0066499203093911,0.0112582177134695,0,0,19867.0,99596.2591544721,SDHC
17282,KEGG_2019_Human,Parkinson disease,1/142,0.0070999171242726,0.0112582177134695,0,0,19858.0,98250.87390500787,SDHC
17283,KEGG_2019_Human,Non-alcoholic fatty liver disease (NAFLD),1/149,0.0074499147221605,0.0112582177134695,0,0,19851.0,97261.02051561224,SDHC
17284,KEGG_2019_Human,Alzheimer disease,1/171,0.0085499075557634,0.0112582177134695,0,0,19829.0,94422.42241345016,SDHC
17285,KEGG_2019_Human,Huntington disease,1/193,0.0096499008972596,0.0112582177134695,0,0,19807.0,91920.47679471428,SDHC
17286,KEGG_2019_Human,Thermogenesis,1/231,0.0115498903940656,0.0115498903940656,0,0,19769.0,88191.07730937863,SDHC
17287,KEGG_2019_Human,Vasopressin-regulated water reabsorption,1/44,0.0021999607179423,0.0089248482365629,0,0,19956.0,122117.06559109331,RAB5A
17288,KEGG_2019_Human,Amyotrophic lateral sclerosis (ALS),1/51,0.0025499566390179,0.0089248482365629,0,0,19949.0,119129.0228601236,RAB5A
17289,KEGG_2019_Human,Amoebiasis,1/96,0.0047999347538706,0.0111998477590315,0,0,19904.0,106270.50039849174,RAB5A
17290,KEGG_2019_Human,Phagosome,1/152,0.0075999137114971,0.0121998870519305,0,0,19848.0,96850.665715497,RAB5A
17291,KEGG_2019_Human,Tuberculosis,1/179,0.0089499050800561,0.0121998870519305,0,0,19821.0,93478.0629355712,RAB5A
17292,KEGG_2019_Human,Ras signaling pathway,1/232,0.0115998901349604,0.0121998870519305,0,0,19768.0,88101.22480150245,RAB5A
17293,KEGG_2019_Human,Endocytosis,1/244,0.0121998870519305,0.0121998870519305,0,0,19756.0,87051.4275316661,RAB5A
17294,KEGG_2019_Human,NOD-like receptor signaling pathway,1/178,0.0088999053857096,0.0088999053857096,0,0,19822.0,93593.82745769851,GBP3
17295,KEGG_2019_Human,Breast cancer,1/147,0.0073499154017982,0.0104998856263869,0,0,19853.0,97539.10874372096,FRAT1
17296,KEGG_2019_Human,Gastric cancer,1/149,0.0074499147221605,0.0104998856263869,0,0,19851.0,97261.02051561224,FRAT1
17297,KEGG_2019_Human,Wnt signaling pathway,1/158,0.0078999117225733,0.0104998856263869,0,0,19842.0,96053.2110949472,FRAT1
17298,KEGG_2019_Human,Hepatocellular carcinoma,1/168,0.0083999085011095,0.0104998856263869,0,0,19832.0,94787.72752807094,FRAT1
17299,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,FRAT1
17300,KEGG_2019_Human,"Alanine, aspartate and glutamate metabolism",1/35,0.0017499663721595,0.0017499663721595,0,0,19965.0,126740.98858805298,ASNS
17301,KEGG_2019_Human,Ovarian steroidogenesis,1/49,0.0024499577795033,0.0054165818906784,0,0,19951.0,119939.1172087114,HSD3B1
17302,KEGG_2019_Human,Steroid hormone biosynthesis,1/60,0.002999951725986,0.0054165818906784,0,0,19940.0,115834.63209072244,HSD3B1
17303,KEGG_2019_Human,Cortisol synthesis and secretion,1/65,0.003249949134407,0.0054165818906784,0,0,19935.0,114209.92613860144,HSD3B1
17304,KEGG_2019_Human,Aldosterone synthesis and secretion,1/98,0.0048999339081079,0.0061249173851349,0,0,19902.0,105849.45495286948,HSD3B1
17305,KEGG_2019_Human,Cushing syndrome,1/155,0.0077499127120574,0.0077499127120574,0,0,19845.0,96448.16254952336,HSD3B1
17306,KEGG_2019_Human,Endocytosis,1/244,0.0121998870519305,0.0121998870519305,0,0,19756.0,87051.4275316661,STAMBP
17307,KEGG_2019_Human,Protein processing in endoplasmic reticulum,1/165,0.0082499094553477,0.0082499094553477,0,0,19835.0,95159.46482222488,SEL1L
17308,KEGG_2019_Human,Ubiquitin mediated proteolysis,1/137,0.0068499188797651,0.0068499188797651,0,0,19863.0,98987.62735269018,UBE2W
17309,KEGG_2019_Human,Adherens junction,1/72,0.0035999456502131,0.0094498970637482,0,0,19928.0,112131.59838572376,SMAD4
17310,KEGG_2019_Human,Pancreatic cancer,1/75,0.0037499442041125,0.0094498970637482,0,0,19925.0,111301.33528642564,SMAD4
17311,KEGG_2019_Human,Chronic myeloid leukemia,1/76,0.0037999437281752,0.0094498970637482,0,0,19924.0,111031.8499691117,SMAD4
17312,KEGG_2019_Human,Colorectal cancer,1/86,0.0042999391173866,0.0094498970637482,0,0,19914.0,108514.46102290176,SMAD4
17313,KEGG_2019_Human,TGF-beta signaling pathway,1/90,0.0044999373439762,0.0094498970637482,0,0,19910.0,107587.50385474482,SMAD4
17314,KEGG_2019_Human,AGE-RAGE signaling pathway in diabetic complications,1/100,0.0049999330710556,0.0094498970637482,0,0,19900.0,105436.78197328727,SMAD4
17315,KEGG_2019_Human,Th17 cell differentiation,1/107,0.0053499302026925,0.0094498970637482,0,0,19893.0,104053.753408911,SMAD4
17316,KEGG_2019_Human,Cell cycle,1/124,0.0061999236097501,0.0094498970637482,0,0,19876.0,101034.04709010696,SMAD4
17317,KEGG_2019_Human,FoxO signaling pathway,1/132,0.0065999206698993,0.0094498970637482,0,0,19868.0,99751.22090491928,SMAD4
17318,KEGG_2019_Human,Apelin signaling pathway,1/137,0.0068499188797651,0.0094498970637482,0,0,19863.0,98987.62735269018,SMAD4
17319,KEGG_2019_Human,Signaling pathways regulating pluripotency of stem cells,1/139,0.006949918172816,0.0094498970637482,0,0,19861.0,98689.81333375497,SMAD4
17320,KEGG_2019_Human,Gastric cancer,1/149,0.0074499147221605,0.0094498970637482,0,0,19851.0,97261.02051561224,SMAD4
17321,KEGG_2019_Human,Wnt signaling pathway,1/158,0.0078999117225733,0.0094498970637482,0,0,19842.0,96053.2110949472,SMAD4
17322,KEGG_2019_Human,Hippo signaling pathway,1/160,0.0079999110688441,0.0094498970637482,0,0,19840.0,95793.96509856998,SMAD4
17323,KEGG_2019_Human,Hepatitis B,1/163,0.0081499100978668,0.0094498970637482,0,0,19837.0,95410.9786681514,SMAD4
17324,KEGG_2019_Human,Hepatocellular carcinoma,1/168,0.0083999085011095,0.0094498970637482,0,0,19832.0,94787.72752807094,SMAD4
17325,KEGG_2019_Human,Human T-cell leukemia virus 1 infection,1/219,0.0109498935894162,0.0115940049770289,0,0,19781.0,89299.85161916987,SMAD4
17326,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,SMAD4
17327,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR5B3
17328,KEGG_2019_Human,Mineral absorption,1/51,0.0025499566390179,0.0025499566390179,0,0,19949.0,119129.0228601236,MT2A
17329,KEGG_2019_Human,Cholesterol metabolism,1/50,0.0024999572069037,0.0049999144138074,0,0,19950.0,119530.05920663515,NPC2
17330,KEGG_2019_Human,Lysosome,1/123,0.0061499239842961,0.0061499239842961,0,0,19877.0,101200.07933676826,NPC2
17331,KEGG_2019_Human,African trypanosomiasis,1/37,0.0018499650702878,0.0135673630935286,0,0,19963.0,125618.9446446357,FAS
17332,KEGG_2019_Human,Allograft rejection,1/38,0.001899964429635,0.0135673630935286,0,0,19962.0,125080.29732025368,FAS
17333,KEGG_2019_Human,Graft-versus-host disease,1/41,0.0020499625466866,0.0135673630935286,0,0,19959.0,123544.88783416104,FAS
17334,KEGG_2019_Human,Type I diabetes mellitus,1/43,0.0021499613216957,0.0135673630935286,0,0,19957.0,122581.98940490963,FAS
17335,KEGG_2019_Human,Autoimmune thyroid disease,1/53,0.0026499555173137,0.0135673630935286,0,0,19947.0,118349.78824235698,FAS
17336,KEGG_2019_Human,p53 signaling pathway,1/72,0.0035999456502131,0.0135673630935286,0,0,19928.0,112131.59838572376,FAS
17337,KEGG_2019_Human,Chagas disease (American trypanosomiasis),1/103,0.0051499318302617,0.0135673630935286,0,0,19897.0,104832.7525292024,FAS
17338,KEGG_2019_Human,TNF signaling pathway,1/110,0.0054999290027479,0.0135673630935286,0,0,19890.0,103488.06969787036,FAS
17339,KEGG_2019_Human,Natural killer cell mediated cytotoxicity,1/131,0.0065499210316603,0.0135673630935286,0,0,19869.0,99907.33811343512,FAS
17340,KEGG_2019_Human,Measles,1/138,0.0068999185254481,0.0135673630935286,0,0,19862.0,98838.19160389496,FAS
17341,KEGG_2019_Human,Apoptosis,1/143,0.0071499167770442,0.0135673630935286,0,0,19857.0,98106.57763600958,FAS
17342,KEGG_2019_Human,Non-alcoholic fatty liver disease (NAFLD),1/149,0.0074499147221605,0.0135673630935286,0,0,19851.0,97261.02051561224,FAS
17343,KEGG_2019_Human,Hepatitis C,1/155,0.0077499127120574,0.0135673630935286,0,0,19845.0,96448.16254952336,FAS
17344,KEGG_2019_Human,Necroptosis,1/162,0.0080999104202618,0.0135673630935286,0,0,19838.0,95537.86936302872,FAS
17345,KEGG_2019_Human,Hepatitis B,1/163,0.0081499100978668,0.0135673630935286,0,0,19837.0,95410.9786681514,FAS
17346,KEGG_2019_Human,Influenza A,1/171,0.0085499075557634,0.0135673630935286,0,0,19829.0,94422.42241345016,FAS
17347,KEGG_2019_Human,Alzheimer disease,1/171,0.0085499075557634,0.0135673630935286,0,0,19829.0,94422.42241345016,FAS
17348,KEGG_2019_Human,Kaposi sarcoma-associated herpesvirus infection,1/186,0.0092999029651357,0.0135673630935286,0,0,19814.0,92684.96451050608,FAS
17349,KEGG_2019_Human,Epstein-Barr virus infection,1/201,0.0100498985877989,0.0135673630935286,0,0,19799.0,91079.21596609056,FAS
17350,KEGG_2019_Human,Proteoglycans in cancer,1/201,0.0100498985877989,0.0135673630935286,0,0,19799.0,91079.21596609056,FAS
17351,KEGG_2019_Human,Human immunodeficiency virus 1 infection,1/212,0.0105998955026255,0.0136284370748043,0,0,19788.0,89974.27756224656,FAS
17352,KEGG_2019_Human,Human cytomegalovirus infection,1/225,0.0112498919790339,0.0138066856106325,0,0,19775.0,88738.27077557483,FAS
17353,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.016593609322857,0,0,19706.0,83157.67014793828,FAS
17354,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.016593609322857,0,0,19705.0,83086.53988020132,FAS
17355,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0178198568556816,0,0,19670.0,80733.60565076157,FAS
17356,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0255459866326871,0,0,19508.0,72277.44006442746,FAS
17357,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,FAS
17358,KEGG_2019_Human,Long-term depression,1/60,0.002999951725986,0.0114123750625132,0,0,19940.0,115834.63209072244,GNA13
17359,KEGG_2019_Human,"Parathyroid hormone synthesis, secretion and action",1/106,0.0052999306076525,0.0114123750625132,0,0,19894.0,104245.78450366124,GNA13
17360,KEGG_2019_Human,Sphingolipid signaling pathway,1/119,0.0059499254985137,0.0114123750625132,0,0,19881.0,101877.73080211312,GNA13
17361,KEGG_2019_Human,Platelet activation,1/124,0.0061999236097501,0.0114123750625132,0,0,19876.0,101034.04709010696,GNA13
17362,KEGG_2019_Human,Vascular smooth muscle contraction,1/132,0.0065999206698993,0.0114123750625132,0,0,19868.0,99751.22090491928,GNA13
17363,KEGG_2019_Human,Apelin signaling pathway,1/137,0.0068499188797651,0.0114123750625132,0,0,19863.0,98987.62735269018,GNA13
17364,KEGG_2019_Human,Phospholipase D signaling pathway,1/148,0.007399915061391,0.0114123750625132,0,0,19852.0,97399.60470052566,GNA13
17365,KEGG_2019_Human,cGMP-PKG signaling pathway,1/166,0.0082999091363732,0.0114123750625132,0,0,19834.0,95034.82345515196,GNA13
17366,KEGG_2019_Human,Regulation of actin cytoskeleton,1/214,0.0106998949514067,0.0123748811769373,0,0,19786.0,89779.39753374986,GNA13
17367,KEGG_2019_Human,Human cytomegalovirus infection,1/225,0.0112498919790339,0.0123748811769373,0,0,19775.0,88738.27077557483,GNA13
17368,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,GNA13
17369,KEGG_2019_Human,p53 signaling pathway,1/72,0.0035999456502131,0.0107498477934666,0,0,19928.0,112131.59838572376,PMAIP1
17370,KEGG_2019_Human,Colorectal cancer,1/86,0.0042999391173866,0.0107498477934666,0,0,19914.0,108514.46102290176,PMAIP1
17371,KEGG_2019_Human,Apoptosis,1/143,0.0071499167770442,0.0119165279617403,0,0,19857.0,98106.57763600958,PMAIP1
17372,KEGG_2019_Human,Viral carcinogenesis,1/201,0.0100498985877989,0.0125623732347487,0,0,19799.0,91079.21596609056,PMAIP1
17373,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,PMAIP1
17374,KEGG_2019_Human,TGF-beta signaling pathway,1/90,0.0044999373439762,0.006949918172816,0,0,19910.0,107587.50385474482,ID3
17375,KEGG_2019_Human,Signaling pathways regulating pluripotency of stem cells,1/139,0.006949918172816,0.006949918172816,0,0,19861.0,98689.81333375497,ID3
17376,KEGG_2019_Human,Thyroid cancer,1/37,0.0018499650702878,0.0036999301405757,0,0,19963.0,125618.9446446357,TFG
17377,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,TFG
17378,KEGG_2019_Human,Aldosterone-regulated sodium reabsorption,1/37,0.0018499650702878,0.0106066582484997,0,0,19963.0,125618.9446446357,PIK3R1
17379,KEGG_2019_Human,Carbohydrate digestion and absorption,1/44,0.0021999607179423,0.0106066582484997,0,0,19956.0,122117.06559109331,PIK3R1
17380,KEGG_2019_Human,Type II diabetes mellitus,1/46,0.0022999595269283,0.0106066582484997,0,0,19954.0,121217.8313311442,PIK3R1
17381,KEGG_2019_Human,Regulation of lipolysis in adipocytes,1/55,0.0027499544131125,0.0106066582484997,0,0,19945.0,117599.1294878737,PIK3R1
17382,KEGG_2019_Human,Endometrial cancer,1/58,0.0028999527887707,0.0106066582484997,0,0,19942.0,116522.31890946148,PIK3R1
17383,KEGG_2019_Human,VEGF signaling pathway,1/59,0.0029499522555206,0.0106066582484997,0,0,19941.0,116175.59385530632,PIK3R1
17384,KEGG_2019_Human,Central carbon metabolism in cancer,1/65,0.003249949134407,0.0106066582484997,0,0,19935.0,114209.92613860144,PIK3R1
17385,KEGG_2019_Human,Acute myeloid leukemia,1/66,0.003299948626608,0.0106066582484997,0,0,19934.0,113899.85357353876,PIK3R1
17386,KEGG_2019_Human,Non-small cell lung cancer,1/66,0.003299948626608,0.0106066582484997,0,0,19934.0,113899.85357353876,PIK3R1
17387,KEGG_2019_Human,Fc epsilon RI signaling pathway,1/68,0.0033999476216189,0.0106066582484997,0,0,19932.0,113293.39338050144,PIK3R1
17388,KEGG_2019_Human,Renal cell carcinoma,1/69,0.003449947123837,0.0106066582484997,0,0,19931.0,112996.7391397682,PIK3R1
17389,KEGG_2019_Human,Prolactin signaling pathway,1/70,0.0034999466296654,0.0106066582484997,0,0,19930.0,112704.30065625212,PIK3R1
17390,KEGG_2019_Human,B cell receptor signaling pathway,1/71,0.0035499461386618,0.0106066582484997,0,0,19929.0,112415.9585341616,PIK3R1
17391,KEGG_2019_Human,Melanoma,1/72,0.0035999456502131,0.0106066582484997,0,0,19928.0,112131.59838572376,PIK3R1
17392,KEGG_2019_Human,Bacterial invasion of epithelial cells,1/74,0.0036999446830449,0.0106066582484997,0,0,19926.0,111574.38983110404,PIK3R1
17393,KEGG_2019_Human,Pancreatic cancer,1/75,0.0037499442041125,0.0106066582484997,0,0,19925.0,111301.33528642564,PIK3R1
17394,KEGG_2019_Human,Glioma,1/75,0.0037499442041125,0.0106066582484997,0,0,19925.0,111301.33528642564,PIK3R1
17395,KEGG_2019_Human,Chronic myeloid leukemia,1/76,0.0037999437281752,0.0106066582484997,0,0,19924.0,111031.8499691117,PIK3R1
17396,KEGG_2019_Human,ErbB signaling pathway,1/85,0.004249939567045,0.0106066582484997,0,0,19915.0,108752.83801948265,PIK3R1
17397,KEGG_2019_Human,Colorectal cancer,1/86,0.0042999391173866,0.0106066582484997,0,0,19914.0,108514.46102290176,PIK3R1
17398,KEGG_2019_Human,Fc gamma R-mediated phagocytosis,1/91,0.0045499369072032,0.0106066582484997,0,0,19909.0,107362.10783923086,PIK3R1
17399,KEGG_2019_Human,Small cell lung cancer,1/93,0.0046499360391879,0.0106066582484997,0,0,19907.0,106918.54242106884,PIK3R1
17400,KEGG_2019_Human,Amoebiasis,1/96,0.0047999347538706,0.0106066582484997,0,0,19904.0,106270.50039849174,PIK3R1
17401,KEGG_2019_Human,Prostate cancer,1/97,0.0048499343304706,0.0106066582484997,0,0,19903.0,106058.9096435903,PIK3R1
17402,KEGG_2019_Human,Choline metabolism in cancer,1/99,0.0049499334884068,0.0106066582484997,0,0,19901.0,105642.09305076736,PIK3R1
17403,KEGG_2019_Human,Phosphatidylinositol signaling system,1/99,0.0049499334884068,0.0106066582484997,0,0,19901.0,105642.09305076736,PIK3R1
17404,KEGG_2019_Human,Progesterone-mediated oocyte maturation,1/99,0.0049499334884068,0.0106066582484997,0,0,19901.0,105642.09305076736,PIK3R1
17405,KEGG_2019_Human,AGE-RAGE signaling pathway in diabetic complications,1/100,0.0049999330710556,0.0106066582484997,0,0,19900.0,105436.78197328727,PIK3R1
17406,KEGG_2019_Human,Inflammatory mediator regulation of TRP channels,1/100,0.0049999330710556,0.0106066582484997,0,0,19900.0,105436.78197328727,PIK3R1
17407,KEGG_2019_Human,HIF-1 signaling pathway,1/100,0.0049999330710556,0.0106066582484997,0,0,19900.0,105436.78197328727,PIK3R1
17408,KEGG_2019_Human,T cell receptor signaling pathway,1/101,0.0050499326546803,0.0106066582484997,0,0,19899.0,105233.48101229242,PIK3R1
17409,KEGG_2019_Human,Longevity regulating pathway,1/102,0.0050999322416682,0.0106066582484997,0,0,19898.0,105032.15064717118,PIK3R1
17410,KEGG_2019_Human,Chagas disease (American trypanosomiasis),1/103,0.0051499318302617,0.0106066582484997,0,0,19897.0,104832.7525292024,PIK3R1
17411,KEGG_2019_Human,Toll-like receptor signaling pathway,1/104,0.0051999314202997,0.0106066582484997,0,0,19896.0,104635.24941415618,PIK3R1
17412,KEGG_2019_Human,C-type lectin receptor signaling pathway,1/104,0.0051999314202997,0.0106066582484997,0,0,19896.0,104635.24941415618,PIK3R1
17413,KEGG_2019_Human,Insulin resistance,1/108,0.0053999298011749,0.0106066582484997,0,0,19892.0,103863.47861844616,PIK3R1
17414,KEGG_2019_Human,TNF signaling pathway,1/110,0.0054999290027479,0.0106066582484997,0,0,19890.0,103488.06969787036,PIK3R1
17415,KEGG_2019_Human,Leukocyte transendothelial migration,1/112,0.0055999282120529,0.0106066582484997,0,0,19888.0,103119.30984392198,PIK3R1
17416,KEGG_2019_Human,Cholinergic synapse,1/112,0.0055999282120529,0.0106066582484997,0,0,19888.0,103119.30984392198,PIK3R1
17417,KEGG_2019_Human,Thyroid hormone signaling pathway,1/116,0.0057999266512085,0.0106066582484997,0,0,19884.0,102400.8105961506,PIK3R1
17418,KEGG_2019_Human,Sphingolipid signaling pathway,1/119,0.0059499254985137,0.0106066582484997,0,0,19881.0,101877.73080211312,PIK3R1
17419,KEGG_2019_Human,Neurotrophin signaling pathway,1/119,0.0059499254985137,0.0106066582484997,0,0,19881.0,101877.73080211312,PIK3R1
17420,KEGG_2019_Human,AMPK signaling pathway,1/120,0.0059999251180858,0.0106066582484997,0,0,19880.0,101706.2448082016,PIK3R1
17421,KEGG_2019_Human,Platelet activation,1/124,0.0061999236097501,0.0106066582484997,0,0,19876.0,101034.04709010696,PIK3R1
17422,KEGG_2019_Human,Osteoclast differentiation,1/127,0.0063499224962247,0.0106066582484997,0,0,19873.0,100543.72072014232,PIK3R1
17423,KEGG_2019_Human,Autophagy,1/128,0.0063999221281459,0.0106066582484997,0,0,19872.0,100382.8010329652,PIK3R1
17424,KEGG_2019_Human,Relaxin signaling pathway,1/130,0.0064999213952527,0.0106066582484997,0,0,19870.0,100064.62842845908,PIK3R1
17425,KEGG_2019_Human,Natural killer cell mediated cytotoxicity,1/131,0.0065499210316603,0.0106066582484997,0,0,19869.0,99907.33811343512,PIK3R1
17426,KEGG_2019_Human,FoxO signaling pathway,1/132,0.0065999206698993,0.0106066582484997,0,0,19868.0,99751.22090491928,PIK3R1
17427,KEGG_2019_Human,Insulin signaling pathway,1/137,0.0068499188797651,0.0106066582484997,0,0,19863.0,98987.62735269018,PIK3R1
17428,KEGG_2019_Human,Estrogen signaling pathway,1/137,0.0068499188797651,0.0106066582484997,0,0,19863.0,98987.62735269018,PIK3R1
17429,KEGG_2019_Human,Measles,1/138,0.0068999185254481,0.0106066582484997,0,0,19862.0,98838.19160389496,PIK3R1
17430,KEGG_2019_Human,Fluid shear stress and atherosclerosis,1/139,0.006949918172816,0.0106066582484997,0,0,19861.0,98689.81333375497,PIK3R1
17431,KEGG_2019_Human,Signaling pathways regulating pluripotency of stem cells,1/139,0.006949918172816,0.0106066582484997,0,0,19861.0,98689.81333375497,PIK3R1
17432,KEGG_2019_Human,Apoptosis,1/143,0.0071499167770442,0.0106066582484997,0,0,19857.0,98106.57763600958,PIK3R1
17433,KEGG_2019_Human,Breast cancer,1/147,0.0073499154017982,0.0106066582484997,0,0,19853.0,97539.10874372096,PIK3R1
17434,KEGG_2019_Human,Phospholipase D signaling pathway,1/148,0.007399915061391,0.0106066582484997,0,0,19852.0,97399.60470052566,PIK3R1
17435,KEGG_2019_Human,Non-alcoholic fatty liver disease (NAFLD),1/149,0.0074499147221605,0.0106066582484997,0,0,19851.0,97261.02051561224,PIK3R1
17436,KEGG_2019_Human,Gastric cancer,1/149,0.0074499147221605,0.0106066582484997,0,0,19851.0,97261.02051561224,PIK3R1
17437,KEGG_2019_Human,mTOR signaling pathway,1/152,0.0075999137114971,0.0106398791960959,0,0,19848.0,96850.665715497,PIK3R1
17438,KEGG_2019_Human,Hepatitis C,1/155,0.0077499127120574,0.0106720109477513,0,0,19845.0,96448.16254952336,PIK3R1
17439,KEGG_2019_Human,Cellular senescence,1/160,0.0079999110688441,0.0106967570034502,0,0,19840.0,95793.96509856998,PIK3R1
17440,KEGG_2019_Human,JAK-STAT signaling pathway,1/162,0.0080999104202618,0.0106967570034502,0,0,19838.0,95537.86936302872,PIK3R1
17441,KEGG_2019_Human,Hepatitis B,1/163,0.0081499100978668,0.0106967570034502,0,0,19837.0,95410.9786681514,PIK3R1
17442,KEGG_2019_Human,Hepatocellular carcinoma,1/168,0.0083999085011095,0.0108552663706646,0,0,19832.0,94787.72752807094,PIK3R1
17443,KEGG_2019_Human,Influenza A,1/171,0.0085499075557634,0.010881700525517,0,0,19829.0,94422.42241345016,PIK3R1
17444,KEGG_2019_Human,Axon guidance,1/181,0.0090499044707863,0.011346148888747,0,0,19819.0,93248.41634586031,PIK3R1
17445,KEGG_2019_Human,Kaposi sarcoma-associated herpesvirus infection,1/186,0.0092999029651357,0.0114881154275206,0,0,19814.0,92684.96451050608,PIK3R1
17446,KEGG_2019_Human,Chemokine signaling pathway,1/190,0.0094999017791995,0.0115642668681522,0,0,19810.0,92244.74636351672,PIK3R1
17447,KEGG_2019_Human,Focal adhesion,1/199,0.0099498991610159,0.0115642668681522,0,0,19801.0,91286.4288690606,PIK3R1
17448,KEGG_2019_Human,Viral carcinogenesis,1/201,0.0100498985877989,0.0115642668681522,0,0,19799.0,91079.21596609056,PIK3R1
17449,KEGG_2019_Human,Epstein-Barr virus infection,1/201,0.0100498985877989,0.0115642668681522,0,0,19799.0,91079.21596609056,PIK3R1
17450,KEGG_2019_Human,Proteoglycans in cancer,1/201,0.0100498985877989,0.0115642668681522,0,0,19799.0,91079.21596609056,PIK3R1
17451,KEGG_2019_Human,Rap1 signaling pathway,1/206,0.010299897173561,0.0116726126742619,0,0,19794.0,90569.849337325,PIK3R1
17452,KEGG_2019_Human,Human immunodeficiency virus 1 infection,1/212,0.0105998955026255,0.0116726126742619,0,0,19788.0,89974.27756224656,PIK3R1
17453,KEGG_2019_Human,cAMP signaling pathway,1/212,0.0105998955026255,0.0116726126742619,0,0,19788.0,89974.27756224656,PIK3R1
17454,KEGG_2019_Human,Regulation of actin cytoskeleton,1/214,0.0106998949514067,0.0116726126742619,0,0,19786.0,89779.39753374986,PIK3R1
17455,KEGG_2019_Human,Human T-cell leukemia virus 1 infection,1/219,0.0109498935894162,0.0117921930962944,0,0,19781.0,89299.85161916987,PIK3R1
17456,KEGG_2019_Human,Human cytomegalovirus infection,1/225,0.0112498919790339,0.0119619104587196,0,0,19775.0,88738.27077557483,PIK3R1
17457,KEGG_2019_Human,Ras signaling pathway,1/232,0.0115998901349604,0.0121798846417084,0,0,19768.0,88101.22480150245,PIK3R1
17458,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0171109736611483,0,0,19670.0,80733.60565076157,PIK3R1
17459,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0181315666082294,0,0,19646.0,79255.8617626126,PIK3R1
17460,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0248962225817888,0,0,19508.0,72277.44006442746,PIK3R1
17461,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,PIK3R1
17462,KEGG_2019_Human,Allograft rejection,1/38,0.001899964429635,0.0112098185709785,0,0,19962.0,125080.29732025368,HLA-B
17463,KEGG_2019_Human,Graft-versus-host disease,1/41,0.0020499625466866,0.0112098185709785,0,0,19959.0,123544.88783416104,HLA-B
17464,KEGG_2019_Human,Type I diabetes mellitus,1/43,0.0021499613216957,0.0112098185709785,0,0,19957.0,122581.98940490963,HLA-B
17465,KEGG_2019_Human,Autoimmune thyroid disease,1/53,0.0026499555173137,0.0112098185709785,0,0,19947.0,118349.78824235698,HLA-B
17466,KEGG_2019_Human,Viral myocarditis,1/59,0.0029499522555206,0.0112098185709785,0,0,19941.0,116175.59385530632,HLA-B
17467,KEGG_2019_Human,Antigen processing and presentation,1/77,0.0038499432547502,0.0121914869733757,0,0,19923.0,110765.8407373636,HLA-B
17468,KEGG_2019_Human,Natural killer cell mediated cytotoxicity,1/131,0.0065499210316603,0.0133592467251027,0,0,19869.0,99907.33811343512,HLA-B
17469,KEGG_2019_Human,Cell adhesion molecules (CAMs),1/145,0.0072499160871101,0.0133592467251027,0,0,19855.0,97820.92670675044,HLA-B
17470,KEGG_2019_Human,Phagosome,1/152,0.0075999137114971,0.0133592467251027,0,0,19848.0,96850.665715497,HLA-B
17471,KEGG_2019_Human,Cellular senescence,1/160,0.0079999110688441,0.0133592467251027,0,0,19840.0,95793.96509856998,HLA-B
17472,KEGG_2019_Human,Kaposi sarcoma-associated herpesvirus infection,1/186,0.0092999029651357,0.0133592467251027,0,0,19814.0,92684.96451050608,HLA-B
17473,KEGG_2019_Human,Viral carcinogenesis,1/201,0.0100498985877989,0.0133592467251027,0,0,19799.0,91079.21596609056,HLA-B
17474,KEGG_2019_Human,Epstein-Barr virus infection,1/201,0.0100498985877989,0.0133592467251027,0,0,19799.0,91079.21596609056,HLA-B
17475,KEGG_2019_Human,Human immunodeficiency virus 1 infection,1/212,0.0105998955026255,0.0133592467251027,0,0,19788.0,89974.27756224656,HLA-B
17476,KEGG_2019_Human,Human T-cell leukemia virus 1 infection,1/219,0.0109498935894162,0.0133592467251027,0,0,19781.0,89299.85161916987,HLA-B
17477,KEGG_2019_Human,Human cytomegalovirus infection,1/225,0.0112498919790339,0.0133592467251027,0,0,19775.0,88738.27077557483,HLA-B
17478,KEGG_2019_Human,Endocytosis,1/244,0.0121998870519305,0.0136351678815694,0,0,19756.0,87051.4275316661,HLA-B
17479,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0174165267622403,0,0,19670.0,80733.60565076157,HLA-B
17480,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,HLA-B
17481,KEGG_2019_Human,Adherens junction,1/72,0.0035999456502131,0.0071998913004262,0,0,19928.0,112131.59838572376,PTPRM
17482,KEGG_2019_Human,Cell adhesion molecules (CAMs),1/145,0.0072499160871101,0.0072499160871101,0,0,19855.0,97820.92670675044,PTPRM
17483,KEGG_2019_Human,Prolactin signaling pathway,1/70,0.0034999466296654,0.0068749112534348,0,0,19930.0,112704.30065625212,IRF1
17484,KEGG_2019_Human,Pertussis,1/76,0.0037999437281752,0.0068749112534348,0,0,19924.0,111031.8499691117,IRF1
17485,KEGG_2019_Human,C-type lectin receptor signaling pathway,1/104,0.0051999314202997,0.0068749112534348,0,0,19896.0,104635.24941415618,IRF1
17486,KEGG_2019_Human,TNF signaling pathway,1/110,0.0054999290027479,0.0068749112534348,0,0,19890.0,103488.06969787036,IRF1
17487,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0164998674589645,0,0,19670.0,80733.60565076157,IRF1
17488,KEGG_2019_Human,Collecting duct acid secretion,1/27,0.0013499718942362,0.0013499718942362,0,0,19973.0,131975.02298599784,CLCNKB
17489,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF814
17490,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,P2RY13
17491,KEGG_2019_Human,Pathogenic Escherichia coli infection,1/55,0.0027499544131125,0.0065999073394233,0,0,19945.0,117599.1294878737,TUBB2A
17492,KEGG_2019_Human,Gap junction,1/88,0.0043999382262822,0.0065999073394233,0,0,19912.0,108045.79305232369,TUBB2A
17493,KEGG_2019_Human,Phagosome,1/152,0.0075999137114971,0.0075999137114971,0,0,19848.0,96850.665715497,TUBB2A
17494,KEGG_2019_Human,Oxidative phosphorylation,1/133,0.0066499203093911,0.0066499203093911,0,0,19867.0,99596.2591544721,PPA2
17495,KEGG_2019_Human,Taste transduction,1/83,0.0041499404726918,0.0041499404726918,0,0,19917.0,109237.99888847338,TAS2R30
17496,KEGG_2019_Human,Regulation of actin cytoskeleton,1/214,0.0106998949514067,0.0106998949514067,0,0,19786.0,89779.39753374986,TMSB4X
17497,KEGG_2019_Human,Legionellosis,1/55,0.0027499544131125,0.0054999088262251,0,0,19945.0,117599.1294878737,EEF1A1
17498,KEGG_2019_Human,RNA transport,1/165,0.0082499094553477,0.0082499094553477,0,0,19835.0,95159.46482222488,EEF1A1
17499,KEGG_2019_Human,Spliceosome,1/134,0.0066999199497742,0.0066999199497742,0,0,19866.0,99442.43560916925,DHX16
17500,KEGG_2019_Human,"Phenylalanine, tyrosine and tryptophan biosynthesis",1/5,0.0002499917995416556,0.0012499589977082,0,0,19995.0,165840.17843725558,TAT
17501,KEGG_2019_Human,Ubiquinone and other terpenoid-quinone biosynthesis,1/11,0.0005499852259717758,0.0013749630649294,0,0,19989.0,150029.8210287992,TAT
17502,KEGG_2019_Human,Phenylalanine metabolism,1/17,0.0008499797390404818,0.0014166328984008,0,0,19983.0,141285.76583697114,TAT
17503,KEGG_2019_Human,Tyrosine metabolism,1/36,0.0017999657178272,0.002249957147284,0,0,19964.0,126172.23364250171,TAT
17504,KEGG_2019_Human,Cysteine and methionine metabolism,1/47,0.0023499589392381,0.0023499589392381,0,0,19953.0,120782.64067395544,TAT
17505,KEGG_2019_Human,Homologous recombination,1/41,0.0020499625466866,0.0020499625466866,0,0,19959.0,123544.88783416104,BABAM2
17506,KEGG_2019_Human,Spliceosome,1/134,0.0066999199497742,0.0066999199497742,0,0,19866.0,99442.43560916925,RBM25
17507,KEGG_2019_Human,RNA degradation,1/79,0.0039499423167337,0.0039499423167337,0,0,19921.0,110243.89578070649,EXOSC10
17508,KEGG_2019_Human,Cocaine addiction,1/49,0.0024499577795033,0.0100748865256747,0,0,19951.0,119939.1172087114,GNAI1
17509,KEGG_2019_Human,Regulation of lipolysis in adipocytes,1/55,0.0027499544131125,0.0100748865256747,0,0,19945.0,117599.1294878737,GNAI1
17510,KEGG_2019_Human,Long-term depression,1/60,0.002999951725986,0.0100748865256747,0,0,19940.0,115834.63209072244,GNAI1
17511,KEGG_2019_Human,Renin secretion,1/69,0.003449947123837,0.0100748865256747,0,0,19931.0,112996.7391397682,GNAI1
17512,KEGG_2019_Human,Gastric acid secretion,1/75,0.0037499442041125,0.0100748865256747,0,0,19925.0,111301.33528642564,GNAI1
17513,KEGG_2019_Human,Pertussis,1/76,0.0037999437281752,0.0100748865256747,0,0,19924.0,111031.8499691117,GNAI1
17514,KEGG_2019_Human,Gap junction,1/88,0.0043999382262822,0.0100748865256747,0,0,19912.0,108045.79305232369,GNAI1
17515,KEGG_2019_Human,GABAergic synapse,1/89,0.0044499377838098,0.0100748865256747,0,0,19911.0,107815.380281759,GNAI1
17516,KEGG_2019_Human,Morphine addiction,1/91,0.0045499369072032,0.0100748865256747,0,0,19909.0,107362.10783923086,GNAI1
17517,KEGG_2019_Human,Circadian entrainment,1/97,0.0048499343304706,0.0100748865256747,0,0,19903.0,106058.9096435903,GNAI1
17518,KEGG_2019_Human,Progesterone-mediated oocyte maturation,1/99,0.0049499334884068,0.0100748865256747,0,0,19901.0,105642.09305076736,GNAI1
17519,KEGG_2019_Human,Melanogenesis,1/101,0.0050499326546803,0.0100748865256747,0,0,19899.0,105233.48101229242,GNAI1
17520,KEGG_2019_Human,Chagas disease (American trypanosomiasis),1/103,0.0051499318302617,0.0100748865256747,0,0,19897.0,104832.7525292024,GNAI1
17521,KEGG_2019_Human,"Parathyroid hormone synthesis, secretion and action",1/106,0.0052999306076525,0.0100748865256747,0,0,19894.0,104245.78450366124,GNAI1
17522,KEGG_2019_Human,Leukocyte transendothelial migration,1/112,0.0055999282120529,0.0100748865256747,0,0,19888.0,103119.30984392198,GNAI1
17523,KEGG_2019_Human,Cholinergic synapse,1/112,0.0055999282120529,0.0100748865256747,0,0,19888.0,103119.30984392198,GNAI1
17524,KEGG_2019_Human,Toxoplasmosis,1/113,0.0056499278191151,0.0100748865256747,0,0,19887.0,102937.34947211576,GNAI1
17525,KEGG_2019_Human,Serotonergic synapse,1/113,0.0056499278191151,0.0100748865256747,0,0,19887.0,102937.34947211576,GNAI1
17526,KEGG_2019_Human,Glutamatergic synapse,1/114,0.005699927427839,0.0100748865256747,0,0,19886.0,102756.96431429044,GNAI1
17527,KEGG_2019_Human,Sphingolipid signaling pathway,1/119,0.0059499254985137,0.0100748865256747,0,0,19881.0,101877.73080211312,GNAI1
17528,KEGG_2019_Human,Platelet activation,1/124,0.0061999236097501,0.0100748865256747,0,0,19876.0,101034.04709010696,GNAI1
17529,KEGG_2019_Human,Relaxin signaling pathway,1/130,0.0064999213952527,0.0100748865256747,0,0,19870.0,100064.62842845908,GNAI1
17530,KEGG_2019_Human,Dopaminergic synapse,1/131,0.0065499210316603,0.0100748865256747,0,0,19869.0,99907.33811343512,GNAI1
17531,KEGG_2019_Human,Estrogen signaling pathway,1/137,0.0068499188797651,0.0100748865256747,0,0,19863.0,98987.62735269018,GNAI1
17532,KEGG_2019_Human,Apelin signaling pathway,1/137,0.0068499188797651,0.0100748865256747,0,0,19863.0,98987.62735269018,GNAI1
17533,KEGG_2019_Human,Parkinson disease,1/142,0.0070999171242726,0.0100748865256747,0,0,19858.0,98250.87390500787,GNAI1
17534,KEGG_2019_Human,Adrenergic signaling in cardiomyocytes,1/145,0.0072499160871101,0.0100748865256747,0,0,19855.0,97820.92670675044,GNAI1
17535,KEGG_2019_Human,Retrograde endocannabinoid signaling,1/148,0.007399915061391,0.0100748865256747,0,0,19852.0,97399.60470052566,GNAI1
17536,KEGG_2019_Human,Oxytocin signaling pathway,1/153,0.0076499133771537,0.0100748865256747,0,0,19847.0,96715.6407630817,GNAI1
17537,KEGG_2019_Human,Cushing syndrome,1/155,0.0077499127120574,0.0100748865256747,0,0,19845.0,96448.16254952336,GNAI1
17538,KEGG_2019_Human,cGMP-PKG signaling pathway,1/166,0.0082999091363732,0.0104418211715663,0,0,19834.0,95034.82345515196,GNAI1
17539,KEGG_2019_Human,Alcoholism,1/180,0.0089999047745351,0.0106953416472929,0,0,19820.0,93362.92821536642,GNAI1
17540,KEGG_2019_Human,Axon guidance,1/181,0.0090499044707863,0.0106953416472929,0,0,19819.0,93248.41634586031,GNAI1
17541,KEGG_2019_Human,Chemokine signaling pathway,1/190,0.0094999017791995,0.0108969461584936,0,0,19810.0,92244.74636351672,GNAI1
17542,KEGG_2019_Human,Rap1 signaling pathway,1/206,0.010299897173561,0.0111728628270918,0,0,19794.0,90569.849337325,GNAI1
17543,KEGG_2019_Human,Human immunodeficiency virus 1 infection,1/212,0.0105998955026255,0.0111728628270918,0,0,19788.0,89974.27756224656,GNAI1
17544,KEGG_2019_Human,cAMP signaling pathway,1/212,0.0105998955026255,0.0111728628270918,0,0,19788.0,89974.27756224656,GNAI1
17545,KEGG_2019_Human,Human cytomegalovirus infection,1/225,0.0112498919790339,0.0115459417679558,0,0,19775.0,88738.27077557483,GNAI1
17546,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,GNAI1
17547,KEGG_2019_Human,African trypanosomiasis,1/37,0.0018499650702878,0.0020999619311272,0,0,19963.0,125618.9446446357,IDO2
17548,KEGG_2019_Human,Tryptophan metabolism,1/42,0.0020999619311272,0.0020999619311272,0,0,19958.0,123057.75613441122,IDO2
17549,KEGG_2019_Human,Glycerophospholipid metabolism,1/97,0.0048499343304706,0.0048499343304706,0,0,19903.0,106058.9096435903,PNPLA6
17550,KEGG_2019_Human,Renin secretion,1/69,0.003449947123837,0.0103748864204666,0,0,19931.0,112996.7391397682,PDE3A
17551,KEGG_2019_Human,Morphine addiction,1/91,0.0045499369072032,0.0103748864204666,0,0,19909.0,107362.10783923086,PDE3A
17552,KEGG_2019_Human,Purine metabolism,1/129,0.006449921761047,0.0103748864204666,0,0,19871.0,100223.109907462,PDE3A
17553,KEGG_2019_Human,cGMP-PKG signaling pathway,1/166,0.0082999091363732,0.0103748864204666,0,0,19834.0,95034.82345515196,PDE3A
17554,KEGG_2019_Human,cAMP signaling pathway,1/212,0.0105998955026255,0.0105998955026255,0,0,19788.0,89974.27756224656,PDE3A
17555,KEGG_2019_Human,Notch signaling pathway,1/48,0.0023999583567988,0.0023999583567988,0,0,19952.0,120356.5272753826,DTX1
17556,KEGG_2019_Human,NOD-like receptor signaling pathway,1/178,0.0088999053857096,0.0088999053857096,0,0,19822.0,93593.82745769851,TP53BP1
17557,KEGG_2019_Human,Tight junction,1/170,0.0084999078692823,0.0084999078692823,0,0,19830.0,94543.49009679438,MARVELD3
17558,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR51E2
17559,KEGG_2019_Human,Pancreatic cancer,1/75,0.0037499442041125,0.007499888408225,0,0,19925.0,111301.33528642564,ARHGEF6
17560,KEGG_2019_Human,Regulation of actin cytoskeleton,1/214,0.0106998949514067,0.0106998949514067,0,0,19786.0,89779.39753374986,ARHGEF6
17561,KEGG_2019_Human,Endocytosis,1/244,0.0121998870519305,0.0121998870519305,0,0,19756.0,87051.4275316661,EHD4
17562,KEGG_2019_Human,PPAR signaling pathway,1/74,0.0036999446830449,0.0036999446830449,0,0,19926.0,111574.38983110404,PLIN4
17563,KEGG_2019_Human,Phosphatidylinositol signaling system,1/99,0.0049499334884068,0.0049499334884068,0,0,19901.0,105642.09305076736,PPIP5K2
17564,KEGG_2019_Human,Ubiquitin mediated proteolysis,1/137,0.0068499188797651,0.0068499188797651,0,0,19863.0,98987.62735269018,FBXW7
17565,KEGG_2019_Human,NOD-like receptor signaling pathway,1/178,0.0088999053857096,0.0088999053857096,0,0,19822.0,93593.82745769851,TRIP6
17566,KEGG_2019_Human,Riboflavin metabolism,1/8,0.0003999883241497325,0.000799976648299465,0,0,19992.0,156418.91141655247,ACP2
17567,KEGG_2019_Human,Lysosome,1/123,0.0061499239842961,0.0061499239842961,0,0,19877.0,101200.07933676826,ACP2
17568,KEGG_2019_Human,Homologous recombination,1/41,0.0020499625466866,0.0026999549628563,0,0,19959.0,123544.88783416104,RAD51C
17569,KEGG_2019_Human,Fanconi anemia pathway,1/54,0.0026999549628563,0.0026999549628563,0,0,19946.0,117971.01964061816,RAD51C
17570,KEGG_2019_Human,Glycolysis / Gluconeogenesis,1/68,0.0033999476216189,0.0049999330710556,0,0,19932.0,113293.39338050144,PGK1
17571,KEGG_2019_Human,HIF-1 signaling pathway,1/100,0.0049999330710556,0.0049999330710556,0,0,19900.0,105436.78197328727,PGK1
17572,KEGG_2019_Human,Spliceosome,1/134,0.0066999199497742,0.0066999199497742,0,0,19866.0,99442.43560916925,DHX8
17573,KEGG_2019_Human,Hedgehog signaling pathway,1/47,0.0023499589392381,0.0136391480834414,0,0,19953.0,120782.64067395544,CCND2
17574,KEGG_2019_Human,Prolactin signaling pathway,1/70,0.0034999466296654,0.0136391480834414,0,0,19930.0,112704.30065625212,CCND2
17575,KEGG_2019_Human,p53 signaling pathway,1/72,0.0035999456502131,0.0136391480834414,0,0,19928.0,112131.59838572376,CCND2
17576,KEGG_2019_Human,Cell cycle,1/124,0.0061999236097501,0.0136391480834414,0,0,19876.0,101034.04709010696,CCND2
17577,KEGG_2019_Human,FoxO signaling pathway,1/132,0.0065999206698993,0.0136391480834414,0,0,19868.0,99751.22090491928,CCND2
17578,KEGG_2019_Human,Measles,1/138,0.0068999185254481,0.0136391480834414,0,0,19862.0,98838.19160389496,CCND2
17579,KEGG_2019_Human,Wnt signaling pathway,1/158,0.0078999117225733,0.0136391480834414,0,0,19842.0,96053.2110949472,CCND2
17580,KEGG_2019_Human,Cellular senescence,1/160,0.0079999110688441,0.0136391480834414,0,0,19840.0,95793.96509856998,CCND2
17581,KEGG_2019_Human,Hippo signaling pathway,1/160,0.0079999110688441,0.0136391480834414,0,0,19840.0,95793.96509856998,CCND2
17582,KEGG_2019_Human,JAK-STAT signaling pathway,1/162,0.0080999104202618,0.0136391480834414,0,0,19838.0,95537.86936302872,CCND2
17583,KEGG_2019_Human,Transcriptional misregulation in cancer,1/186,0.0092999029651357,0.0136391480834414,0,0,19814.0,92684.96451050608,CCND2
17584,KEGG_2019_Human,Focal adhesion,1/199,0.0099498991610159,0.0136391480834414,0,0,19801.0,91286.4288690606,CCND2
17585,KEGG_2019_Human,Viral carcinogenesis,1/201,0.0100498985877989,0.0136391480834414,0,0,19799.0,91079.21596609056,CCND2
17586,KEGG_2019_Human,Epstein-Barr virus infection,1/201,0.0100498985877989,0.0136391480834414,0,0,19799.0,91079.21596609056,CCND2
17587,KEGG_2019_Human,Human T-cell leukemia virus 1 infection,1/219,0.0109498935894162,0.0138698652132606,0,0,19781.0,89299.85161916987,CCND2
17588,KEGG_2019_Human,MicroRNAs in cancer,1/299,0.0149498740670514,0.0177529754546235,0,0,19701.0,82804.33538735632,CCND2
17589,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0184410283364897,0,0,19670.0,80733.60565076157,CCND2
17590,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.018683188343665,0,0,19646.0,79255.8617626126,CCND2
17591,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,CCND2
17592,KEGG_2019_Human,Hippo signaling pathway,1/160,0.0079999110688441,0.0133998647837319,0,0,19840.0,95793.96509856998,SCRIB
17593,KEGG_2019_Human,Tight junction,1/170,0.0084999078692823,0.0133998647837319,0,0,19830.0,94543.49009679438,SCRIB
17594,KEGG_2019_Human,Viral carcinogenesis,1/201,0.0100498985877989,0.0133998647837319,0,0,19799.0,91079.21596609056,SCRIB
17595,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0164998674589645,0,0,19670.0,80733.60565076157,SCRIB
17596,KEGG_2019_Human,Glycosaminoglycan biosynthesis,1/53,0.0026499555173137,0.0026499555173137,0,0,19947.0,118349.78824235698,CHST7
17597,KEGG_2019_Human,RNA degradation,1/79,0.0039499423167337,0.0068249053608048,0,0,19921.0,110243.89578070649,PABPC3
17598,KEGG_2019_Human,mRNA surveillance pathway,1/91,0.0045499369072032,0.0068249053608048,0,0,19909.0,107362.10783923086,PABPC3
17599,KEGG_2019_Human,RNA transport,1/165,0.0082499094553477,0.0082499094553477,0,0,19835.0,95159.46482222488,PABPC3
17600,KEGG_2019_Human,Spliceosome,1/134,0.0066999199497742,0.0066999199497742,0,0,19866.0,99442.43560916925,SNRPD2
17601,KEGG_2019_Human,Glucagon signaling pathway,1/103,0.0051499318302617,0.0051499318302617,0,0,19897.0,104832.7525292024,SIK1
17602,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF304
17603,KEGG_2019_Human,TGF-beta signaling pathway,1/90,0.0044999373439762,0.006949918172816,0,0,19910.0,107587.50385474482,SMAD5
17604,KEGG_2019_Human,Signaling pathways regulating pluripotency of stem cells,1/139,0.006949918172816,0.006949918172816,0,0,19861.0,98689.81333375497,SMAD5
17605,KEGG_2019_Human,Fluid shear stress and atherosclerosis,1/139,0.006949918172816,0.0082499094553477,0,0,19861.0,98689.81333375497,SUMO3
17606,KEGG_2019_Human,RNA transport,1/165,0.0082499094553477,0.0082499094553477,0,0,19835.0,95159.46482222488,SUMO3
17607,KEGG_2019_Human,Axon guidance,1/181,0.0090499044707863,0.0090499044707863,0,0,19819.0,93248.41634586031,EPHB4
17608,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF559
17609,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0147498749536506,0,0,19705.0,83086.53988020132,DUSP10
17610,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF708
17611,KEGG_2019_Human,Axon guidance,1/181,0.0090499044707863,0.0106998949514067,0,0,19819.0,93248.41634586031,SSH2
17612,KEGG_2019_Human,Regulation of actin cytoskeleton,1/214,0.0106998949514067,0.0106998949514067,0,0,19786.0,89779.39753374986,SSH2
17613,KEGG_2019_Human,mTOR signaling pathway,1/152,0.0075999137114971,0.0075999137114971,0,0,19848.0,96850.665715497,TTI1
17614,KEGG_2019_Human,Lysine degradation,1/59,0.0029499522555206,0.0029499522555206,0,0,19941.0,116175.59385530632,SUV39H1
17615,KEGG_2019_Human,Glucagon signaling pathway,1/103,0.0051499318302617,0.009399902370135,0,0,19897.0,104832.7525292024,PHKA2
17616,KEGG_2019_Human,Insulin signaling pathway,1/137,0.0068499188797651,0.009399902370135,0,0,19863.0,98987.62735269018,PHKA2
17617,KEGG_2019_Human,Calcium signaling pathway,1/188,0.009399902370135,0.009399902370135,0,0,19812.0,92463.712994847,PHKA2
17618,KEGG_2019_Human,Transcriptional misregulation in cancer,1/186,0.0092999029651357,0.0092999029651357,0,0,19814.0,92684.96451050608,ETV1
17619,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF257
17620,KEGG_2019_Human,RIG-I-like receptor signaling pathway,1/70,0.0034999466296654,0.010424877259224,0,0,19930.0,112704.30065625212,MAP3K7
17621,KEGG_2019_Human,Adherens junction,1/72,0.0035999456502131,0.010424877259224,0,0,19928.0,112131.59838572376,MAP3K7
17622,KEGG_2019_Human,Leishmaniasis,1/74,0.0036999446830449,0.010424877259224,0,0,19926.0,111574.38983110404,MAP3K7
17623,KEGG_2019_Human,IL-17 signaling pathway,1/93,0.0046499360391879,0.010424877259224,0,0,19907.0,106918.54242106884,MAP3K7
17624,KEGG_2019_Human,NF-kappa B signaling pathway,1/95,0.0047499351803394,0.010424877259224,0,0,19905.0,106484.27183626965,MAP3K7
17625,KEGG_2019_Human,T cell receptor signaling pathway,1/101,0.0050499326546803,0.010424877259224,0,0,19899.0,105233.48101229242,MAP3K7
17626,KEGG_2019_Human,Toll-like receptor signaling pathway,1/104,0.0051999314202997,0.010424877259224,0,0,19896.0,104635.24941415618,MAP3K7
17627,KEGG_2019_Human,TNF signaling pathway,1/110,0.0054999290027479,0.010424877259224,0,0,19890.0,103488.06969787036,MAP3K7
17628,KEGG_2019_Human,Toxoplasmosis,1/113,0.0056499278191151,0.010424877259224,0,0,19887.0,102937.34947211576,MAP3K7
17629,KEGG_2019_Human,AMPK signaling pathway,1/120,0.0059999251180858,0.010424877259224,0,0,19880.0,101706.2448082016,MAP3K7
17630,KEGG_2019_Human,Osteoclast differentiation,1/127,0.0063499224962247,0.010424877259224,0,0,19873.0,100543.72072014232,MAP3K7
17631,KEGG_2019_Human,Autophagy,1/128,0.0063999221281459,0.010424877259224,0,0,19872.0,100382.8010329652,MAP3K7
17632,KEGG_2019_Human,Measles,1/138,0.0068999185254481,0.010424877259224,0,0,19862.0,98838.19160389496,MAP3K7
17633,KEGG_2019_Human,Fluid shear stress and atherosclerosis,1/139,0.006949918172816,0.010424877259224,0,0,19861.0,98689.81333375497,MAP3K7
17634,KEGG_2019_Human,Wnt signaling pathway,1/158,0.0078999117225733,0.0106967570034502,0,0,19842.0,96053.2110949472,MAP3K7
17635,KEGG_2019_Human,Hepatitis B,1/163,0.0081499100978668,0.0106967570034502,0,0,19837.0,95410.9786681514,MAP3K7
17636,KEGG_2019_Human,NOD-like receptor signaling pathway,1/178,0.0088999053857096,0.0109940007705825,0,0,19822.0,93593.82745769851,MAP3K7
17637,KEGG_2019_Human,Epstein-Barr virus infection,1/201,0.0100498985877989,0.0117156739765861,0,0,19799.0,91079.21596609056,MAP3K7
17638,KEGG_2019_Human,Human immunodeficiency virus 1 infection,1/212,0.0105998955026255,0.0117156739765861,0,0,19788.0,89974.27756224656,MAP3K7
17639,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0154873687013332,0,0,19705.0,83086.53988020132,MAP3K7
17640,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,MAP3K7
17641,KEGG_2019_Human,Salivary secretion,1/90,0.0044999373439762,0.0105998955026255,0,0,19910.0,107587.50385474482,ATP2B4
17642,KEGG_2019_Human,Pancreatic secretion,1/98,0.0048999339081079,0.0105998955026255,0,0,19902.0,105849.45495286948,ATP2B4
17643,KEGG_2019_Human,Aldosterone synthesis and secretion,1/98,0.0048999339081079,0.0105998955026255,0,0,19902.0,105849.45495286948,ATP2B4
17644,KEGG_2019_Human,Adrenergic signaling in cardiomyocytes,1/145,0.0072499160871101,0.0105998955026255,0,0,19855.0,97820.92670675044,ATP2B4
17645,KEGG_2019_Human,cGMP-PKG signaling pathway,1/166,0.0082999091363732,0.0105998955026255,0,0,19834.0,95034.82345515196,ATP2B4
17646,KEGG_2019_Human,Calcium signaling pathway,1/188,0.009399902370135,0.0105998955026255,0,0,19812.0,92463.712994847,ATP2B4
17647,KEGG_2019_Human,cAMP signaling pathway,1/212,0.0105998955026255,0.0105998955026255,0,0,19788.0,89974.27756224656,ATP2B4
17648,KEGG_2019_Human,Thermogenesis,1/231,0.0115498903940656,0.0115498903940656,0,0,19769.0,88191.07730937863,PRDM16
17649,KEGG_2019_Human,Cardiac muscle contraction,1/78,0.0038999427840466,0.0060665825429376,0,0,19922.0,110503.2180492851,TPM2
17650,KEGG_2019_Human,Hypertrophic cardiomyopathy (HCM),1/85,0.004249939567045,0.0060665825429376,0,0,19915.0,108752.83801948265,TPM2
17651,KEGG_2019_Human,Dilated cardiomyopathy (DCM),1/91,0.0045499369072032,0.0060665825429376,0,0,19909.0,107362.10783923086,TPM2
17652,KEGG_2019_Human,Adrenergic signaling in cardiomyocytes,1/145,0.0072499160871101,0.0072499160871101,0,0,19855.0,97820.92670675044,TPM2
17653,KEGG_2019_Human,Vibrio cholerae infection,1/50,0.0024999572069037,0.0093498829262358,0,0,19950.0,119530.05920663515,PLCG1
17654,KEGG_2019_Human,VEGF signaling pathway,1/59,0.0029499522555206,0.0093498829262358,0,0,19941.0,116175.59385530632,PLCG1
17655,KEGG_2019_Human,Non-small cell lung cancer,1/66,0.003299948626608,0.0093498829262358,0,0,19934.0,113899.85357353876,PLCG1
17656,KEGG_2019_Human,Epithelial cell signaling in Helicobacter pylori infection,1/68,0.0033999476216189,0.0093498829262358,0,0,19932.0,113293.39338050144,PLCG1
17657,KEGG_2019_Human,Fc epsilon RI signaling pathway,1/68,0.0033999476216189,0.0093498829262358,0,0,19932.0,113293.39338050144,PLCG1
17658,KEGG_2019_Human,Inositol phosphate metabolism,1/74,0.0036999446830449,0.0093498829262358,0,0,19926.0,111574.38983110404,PLCG1
17659,KEGG_2019_Human,Glioma,1/75,0.0037499442041125,0.0093498829262358,0,0,19925.0,111301.33528642564,PLCG1
17660,KEGG_2019_Human,ErbB signaling pathway,1/85,0.004249939567045,0.0093498829262358,0,0,19915.0,108752.83801948265,PLCG1
17661,KEGG_2019_Human,Fc gamma R-mediated phagocytosis,1/91,0.0045499369072032,0.0093498829262358,0,0,19909.0,107362.10783923086,PLCG1
17662,KEGG_2019_Human,Th1 and Th2 cell differentiation,1/92,0.0045999364719865,0.0093498829262358,0,0,19908.0,107139.13814408927,PLCG1
17663,KEGG_2019_Human,NF-kappa B signaling pathway,1/95,0.0047499351803394,0.0093498829262358,0,0,19905.0,106484.27183626965,PLCG1
17664,KEGG_2019_Human,Phosphatidylinositol signaling system,1/99,0.0049499334884068,0.0093498829262358,0,0,19901.0,105642.09305076736,PLCG1
17665,KEGG_2019_Human,Choline metabolism in cancer,1/99,0.0049499334884068,0.0093498829262358,0,0,19901.0,105642.09305076736,PLCG1
17666,KEGG_2019_Human,AGE-RAGE signaling pathway in diabetic complications,1/100,0.0049999330710556,0.0093498829262358,0,0,19900.0,105436.78197328727,PLCG1
17667,KEGG_2019_Human,Inflammatory mediator regulation of TRP channels,1/100,0.0049999330710556,0.0093498829262358,0,0,19900.0,105436.78197328727,PLCG1
17668,KEGG_2019_Human,HIF-1 signaling pathway,1/100,0.0049999330710556,0.0093498829262358,0,0,19900.0,105436.78197328727,PLCG1
17669,KEGG_2019_Human,T cell receptor signaling pathway,1/101,0.0050499326546803,0.0093498829262358,0,0,19899.0,105233.48101229242,PLCG1
17670,KEGG_2019_Human,Th17 cell differentiation,1/107,0.0053499302026925,0.0093498829262358,0,0,19893.0,104053.753408911,PLCG1
17671,KEGG_2019_Human,Leukocyte transendothelial migration,1/112,0.0055999282120529,0.0093498829262358,0,0,19888.0,103119.30984392198,PLCG1
17672,KEGG_2019_Human,Thyroid hormone signaling pathway,1/116,0.0057999266512085,0.0093498829262358,0,0,19884.0,102400.8105961506,PLCG1
17673,KEGG_2019_Human,Neurotrophin signaling pathway,1/119,0.0059499254985137,0.0093498829262358,0,0,19881.0,101877.73080211312,PLCG1
17674,KEGG_2019_Human,Natural killer cell mediated cytotoxicity,1/131,0.0065499210316603,0.0098248815474905,0,0,19869.0,99907.33811343512,PLCG1
17675,KEGG_2019_Human,Phospholipase D signaling pathway,1/148,0.007399915061391,0.0106172694359088,0,0,19852.0,97399.60470052566,PLCG1
17676,KEGG_2019_Human,Hepatocellular carcinoma,1/168,0.0083999085011095,0.0114887695634984,0,0,19832.0,94787.72752807094,PLCG1
17677,KEGG_2019_Human,Axon guidance,1/181,0.0090499044707863,0.0114887695634984,0,0,19819.0,93248.41634586031,PLCG1
17678,KEGG_2019_Human,Kaposi sarcoma-associated herpesvirus infection,1/186,0.0092999029651357,0.0114887695634984,0,0,19814.0,92684.96451050608,PLCG1
17679,KEGG_2019_Human,Calcium signaling pathway,1/188,0.009399902370135,0.0114887695634984,0,0,19812.0,92463.712994847,PLCG1
17680,KEGG_2019_Human,Proteoglycans in cancer,1/201,0.0100498985877989,0.0116598850528881,0,0,19799.0,91079.21596609056,PLCG1
17681,KEGG_2019_Human,Rap1 signaling pathway,1/206,0.010299897173561,0.0116598850528881,0,0,19794.0,90569.849337325,PLCG1
17682,KEGG_2019_Human,Human immunodeficiency virus 1 infection,1/212,0.0105998955026255,0.0116598850528881,0,0,19788.0,89974.27756224656,PLCG1
17683,KEGG_2019_Human,Ras signaling pathway,1/232,0.0115998901349604,0.0123482701436675,0,0,19768.0,88101.22480150245,PLCG1
17684,KEGG_2019_Human,MicroRNAs in cancer,1/299,0.0149498740670514,0.0154170576316468,0,0,19701.0,82804.33538735632,PLCG1
17685,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,PLCG1
17686,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF737
17687,KEGG_2019_Human,Amyotrophic lateral sclerosis (ALS),1/51,0.0025499566390179,0.0120716763554332,0,0,19949.0,119129.0228601236,RAC1
17688,KEGG_2019_Human,VEGF signaling pathway,1/59,0.0029499522555206,0.0120716763554332,0,0,19941.0,116175.59385530632,RAC1
17689,KEGG_2019_Human,Viral myocarditis,1/59,0.0029499522555206,0.0120716763554332,0,0,19941.0,116175.59385530632,RAC1
17690,KEGG_2019_Human,Shigellosis,1/65,0.003249949134407,0.0120716763554332,0,0,19935.0,114209.92613860144,RAC1
17691,KEGG_2019_Human,Epithelial cell signaling in Helicobacter pylori infection,1/68,0.0033999476216189,0.0120716763554332,0,0,19932.0,113293.39338050144,RAC1
17692,KEGG_2019_Human,Fc epsilon RI signaling pathway,1/68,0.0033999476216189,0.0120716763554332,0,0,19932.0,113293.39338050144,RAC1
17693,KEGG_2019_Human,Renal cell carcinoma,1/69,0.003449947123837,0.0120716763554332,0,0,19931.0,112996.7391397682,RAC1
17694,KEGG_2019_Human,B cell receptor signaling pathway,1/71,0.0035499461386618,0.0120716763554332,0,0,19929.0,112415.9585341616,RAC1
17695,KEGG_2019_Human,Adherens junction,1/72,0.0035999456502131,0.0120716763554332,0,0,19928.0,112131.59838572376,RAC1
17696,KEGG_2019_Human,Bacterial invasion of epithelial cells,1/74,0.0036999446830449,0.0120716763554332,0,0,19926.0,111574.38983110404,RAC1
17697,KEGG_2019_Human,Pancreatic cancer,1/75,0.0037499442041125,0.0120716763554332,0,0,19925.0,111301.33528642564,RAC1
17698,KEGG_2019_Human,Salmonella infection,1/86,0.0042999391173866,0.0120716763554332,0,0,19914.0,108514.46102290176,RAC1
17699,KEGG_2019_Human,Colorectal cancer,1/86,0.0042999391173866,0.0120716763554332,0,0,19914.0,108514.46102290176,RAC1
17700,KEGG_2019_Human,Fc gamma R-mediated phagocytosis,1/91,0.0045499369072032,0.0120716763554332,0,0,19909.0,107362.10783923086,RAC1
17701,KEGG_2019_Human,Pancreatic secretion,1/98,0.0048999339081079,0.0120716763554332,0,0,19902.0,105849.45495286948,RAC1
17702,KEGG_2019_Human,Choline metabolism in cancer,1/99,0.0049499334884068,0.0120716763554332,0,0,19901.0,105642.09305076736,RAC1
17703,KEGG_2019_Human,AGE-RAGE signaling pathway in diabetic complications,1/100,0.0049999330710556,0.0120716763554332,0,0,19900.0,105436.78197328727,RAC1
17704,KEGG_2019_Human,Toll-like receptor signaling pathway,1/104,0.0051999314202997,0.0120716763554332,0,0,19896.0,104635.24941415618,RAC1
17705,KEGG_2019_Human,Leukocyte transendothelial migration,1/112,0.0055999282120529,0.0120716763554332,0,0,19888.0,103119.30984392198,RAC1
17706,KEGG_2019_Human,Sphingolipid signaling pathway,1/119,0.0059499254985137,0.0120716763554332,0,0,19881.0,101877.73080211312,RAC1
17707,KEGG_2019_Human,Neurotrophin signaling pathway,1/119,0.0059499254985137,0.0120716763554332,0,0,19881.0,101877.73080211312,RAC1
17708,KEGG_2019_Human,Osteoclast differentiation,1/127,0.0063499224962247,0.0120716763554332,0,0,19873.0,100543.72072014232,RAC1
17709,KEGG_2019_Human,Natural killer cell mediated cytotoxicity,1/131,0.0065499210316603,0.0120716763554332,0,0,19869.0,99907.33811343512,RAC1
17710,KEGG_2019_Human,Fluid shear stress and atherosclerosis,1/139,0.006949918172816,0.0120716763554332,0,0,19861.0,98689.81333375497,RAC1
17711,KEGG_2019_Human,Non-alcoholic fatty liver disease (NAFLD),1/149,0.0074499147221605,0.0120716763554332,0,0,19851.0,97261.02051561224,RAC1
17712,KEGG_2019_Human,Phagosome,1/152,0.0075999137114971,0.0120716763554332,0,0,19848.0,96850.665715497,RAC1
17713,KEGG_2019_Human,Wnt signaling pathway,1/158,0.0078999117225733,0.0120716763554332,0,0,19842.0,96053.2110949472,RAC1
17714,KEGG_2019_Human,Tight junction,1/170,0.0084999078692823,0.0120716763554332,0,0,19830.0,94543.49009679438,RAC1
17715,KEGG_2019_Human,Axon guidance,1/181,0.0090499044707863,0.0120716763554332,0,0,19819.0,93248.41634586031,RAC1
17716,KEGG_2019_Human,Kaposi sarcoma-associated herpesvirus infection,1/186,0.0092999029651357,0.0120716763554332,0,0,19814.0,92684.96451050608,RAC1
17717,KEGG_2019_Human,Chemokine signaling pathway,1/190,0.0094999017791995,0.0120716763554332,0,0,19810.0,92244.74636351672,RAC1
17718,KEGG_2019_Human,Focal adhesion,1/199,0.0099498991610159,0.0120716763554332,0,0,19801.0,91286.4288690606,RAC1
17719,KEGG_2019_Human,Epstein-Barr virus infection,1/201,0.0100498985877989,0.0120716763554332,0,0,19799.0,91079.21596609056,RAC1
17720,KEGG_2019_Human,Proteoglycans in cancer,1/201,0.0100498985877989,0.0120716763554332,0,0,19799.0,91079.21596609056,RAC1
17721,KEGG_2019_Human,Viral carcinogenesis,1/201,0.0100498985877989,0.0120716763554332,0,0,19799.0,91079.21596609056,RAC1
17722,KEGG_2019_Human,Rap1 signaling pathway,1/206,0.010299897173561,0.0120716763554332,0,0,19794.0,90569.849337325,RAC1
17723,KEGG_2019_Human,Human immunodeficiency virus 1 infection,1/212,0.0105998955026255,0.0120716763554332,0,0,19788.0,89974.27756224656,RAC1
17724,KEGG_2019_Human,cAMP signaling pathway,1/212,0.0105998955026255,0.0120716763554332,0,0,19788.0,89974.27756224656,RAC1
17725,KEGG_2019_Human,Regulation of actin cytoskeleton,1/214,0.0106998949514067,0.0120716763554332,0,0,19786.0,89779.39753374986,RAC1
17726,KEGG_2019_Human,Human cytomegalovirus infection,1/225,0.0112498919790339,0.0123748811769373,0,0,19775.0,88738.27077557483,RAC1
17727,KEGG_2019_Human,Ras signaling pathway,1/232,0.0115998901349604,0.0124486625838599,0,0,19768.0,88101.22480150245,RAC1
17728,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0154522499514435,0,0,19705.0,83086.53988020132,RAC1
17729,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0181114873539568,0,0,19646.0,79255.8617626126,RAC1
17730,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,RAC1
17731,KEGG_2019_Human,Spliceosome,1/134,0.0066999199497742,0.0066999199497742,0,0,19866.0,99442.43560916925,ISY1-RAB43
17732,KEGG_2019_Human,Transcriptional misregulation in cancer,1/186,0.0092999029651357,0.0092999029651357,0,0,19814.0,92684.96451050608,PROM1
17733,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF544
17734,KEGG_2019_Human,Transcriptional misregulation in cancer,1/186,0.0092999029651357,0.0115998901349604,0,0,19814.0,92684.96451050608,REL
17735,KEGG_2019_Human,Viral carcinogenesis,1/201,0.0100498985877989,0.0115998901349604,0,0,19799.0,91079.21596609056,REL
17736,KEGG_2019_Human,Ras signaling pathway,1/232,0.0115998901349604,0.0115998901349604,0,0,19768.0,88101.22480150245,REL
17737,KEGG_2019_Human,Wnt signaling pathway,1/158,0.0078999117225733,0.0078999117225733,0,0,19842.0,96053.2110949472,RNF43
17738,KEGG_2019_Human,Ras signaling pathway,1/232,0.0115998901349604,0.0115998901349604,0,0,19768.0,88101.22480150245,SYNGAP1
17739,KEGG_2019_Human,Legionellosis,1/55,0.0027499544131125,0.0045499369072032,0,0,19945.0,117599.1294878737,HBS1L
17740,KEGG_2019_Human,mRNA surveillance pathway,1/91,0.0045499369072032,0.0045499369072032,0,0,19909.0,107362.10783923086,HBS1L
17741,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF286A
17742,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF302
17743,KEGG_2019_Human,Lysosome,1/123,0.0061499239842961,0.0071499167770442,0,0,19877.0,101200.07933676826,CTSH
17744,KEGG_2019_Human,Apoptosis,1/143,0.0071499167770442,0.0071499167770442,0,0,19857.0,98106.57763600958,CTSH
17745,KEGG_2019_Human,Intestinal immune network for IgA production,1/48,0.0023999583567988,0.0047999167135976,0,0,19952.0,120356.5272753826,MADCAM1
17746,KEGG_2019_Human,Cell adhesion molecules (CAMs),1/145,0.0072499160871101,0.0072499160871101,0,0,19855.0,97820.92670675044,MADCAM1
17747,KEGG_2019_Human,Human immunodeficiency virus 1 infection,1/212,0.0105998955026255,0.0105998955026255,0,0,19788.0,89974.27756224656,APOBEC3G
17748,KEGG_2019_Human,Citrate cycle (TCA cycle),1/30,0.0014999697593334,0.0050999214324284,0,0,19970.0,129851.13732048514,PDHA1
17749,KEGG_2019_Human,Pyruvate metabolism,1/39,0.0019499637955508,0.0050999214324284,0,0,19961.0,124555.53162481484,PDHA1
17750,KEGG_2019_Human,Central carbon metabolism in cancer,1/65,0.003249949134407,0.0050999214324284,0,0,19935.0,114209.92613860144,PDHA1
17751,KEGG_2019_Human,Glycolysis / Gluconeogenesis,1/68,0.0033999476216189,0.0050999214324284,0,0,19932.0,113293.39338050144,PDHA1
17752,KEGG_2019_Human,HIF-1 signaling pathway,1/100,0.0049999330710556,0.0051499318302617,0,0,19900.0,105436.78197328727,PDHA1
17753,KEGG_2019_Human,Glucagon signaling pathway,1/103,0.0051499318302617,0.0051499318302617,0,0,19897.0,104832.7525292024,PDHA1
17754,KEGG_2019_Human,RNA degradation,1/79,0.0039499423167337,0.0039499423167337,0,0,19921.0,110243.89578070649,CNOT8
17755,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0147498749536506,0,0,19705.0,83086.53988020132,MAP3K12
17756,KEGG_2019_Human,Cholesterol metabolism,1/50,0.0024999572069037,0.0024999572069037,0,0,19950.0,119530.05920663515,ANGPTL3
17757,KEGG_2019_Human,Malaria,1/49,0.0024499577795033,0.0109498935894162,0,0,19951.0,119939.1172087114,ITGAL
17758,KEGG_2019_Human,Viral myocarditis,1/59,0.0029499522555206,0.0109498935894162,0,0,19941.0,116175.59385530632,ITGAL
17759,KEGG_2019_Human,Staphylococcus aureus infection,1/68,0.0033999476216189,0.0109498935894162,0,0,19932.0,113293.39338050144,ITGAL
17760,KEGG_2019_Human,Rheumatoid arthritis,1/91,0.0045499369072032,0.0109498935894162,0,0,19909.0,107362.10783923086,ITGAL
17761,KEGG_2019_Human,Leukocyte transendothelial migration,1/112,0.0055999282120529,0.0109498935894162,0,0,19888.0,103119.30984392198,ITGAL
17762,KEGG_2019_Human,Natural killer cell mediated cytotoxicity,1/131,0.0065499210316603,0.0109498935894162,0,0,19869.0,99907.33811343512,ITGAL
17763,KEGG_2019_Human,Cell adhesion molecules (CAMs),1/145,0.0072499160871101,0.0109498935894162,0,0,19855.0,97820.92670675044,ITGAL
17764,KEGG_2019_Human,Epstein-Barr virus infection,1/201,0.0100498985877989,0.0109498935894162,0,0,19799.0,91079.21596609056,ITGAL
17765,KEGG_2019_Human,Rap1 signaling pathway,1/206,0.010299897173561,0.0109498935894162,0,0,19794.0,90569.849337325,ITGAL
17766,KEGG_2019_Human,Regulation of actin cytoskeleton,1/214,0.0106998949514067,0.0109498935894162,0,0,19786.0,89779.39753374986,ITGAL
17767,KEGG_2019_Human,Human T-cell leukemia virus 1 infection,1/219,0.0109498935894162,0.0109498935894162,0,0,19781.0,89299.85161916987,ITGAL
17768,KEGG_2019_Human,Sphingolipid signaling pathway,1/119,0.0059499254985137,0.0059499254985137,0,0,19881.0,101877.73080211312,NSMAF
17769,KEGG_2019_Human,Allograft rejection,1/38,0.001899964429635,0.0106198281198744,0,0,19962.0,125080.29732025368,HLA-F
17770,KEGG_2019_Human,Graft-versus-host disease,1/41,0.0020499625466866,0.0106198281198744,0,0,19959.0,123544.88783416104,HLA-F
17771,KEGG_2019_Human,Type I diabetes mellitus,1/43,0.0021499613216957,0.0106198281198744,0,0,19957.0,122581.98940490963,HLA-F
17772,KEGG_2019_Human,Autoimmune thyroid disease,1/53,0.0026499555173137,0.0106198281198744,0,0,19947.0,118349.78824235698,HLA-F
17773,KEGG_2019_Human,Viral myocarditis,1/59,0.0029499522555206,0.0106198281198744,0,0,19941.0,116175.59385530632,HLA-F
17774,KEGG_2019_Human,Antigen processing and presentation,1/77,0.0038499432547502,0.0115498297642507,0,0,19923.0,110765.8407373636,HLA-F
17775,KEGG_2019_Human,Cell adhesion molecules (CAMs),1/145,0.0072499160871101,0.0134998703748406,0,0,19855.0,97820.92670675044,HLA-F
17776,KEGG_2019_Human,Phagosome,1/152,0.0075999137114971,0.0134998703748406,0,0,19848.0,96850.665715497,HLA-F
17777,KEGG_2019_Human,Cellular senescence,1/160,0.0079999110688441,0.0134998703748406,0,0,19840.0,95793.96509856998,HLA-F
17778,KEGG_2019_Human,Kaposi sarcoma-associated herpesvirus infection,1/186,0.0092999029651357,0.0134998703748406,0,0,19814.0,92684.96451050608,HLA-F
17779,KEGG_2019_Human,Viral carcinogenesis,1/201,0.0100498985877989,0.0134998703748406,0,0,19799.0,91079.21596609056,HLA-F
17780,KEGG_2019_Human,Epstein-Barr virus infection,1/201,0.0100498985877989,0.0134998703748406,0,0,19799.0,91079.21596609056,HLA-F
17781,KEGG_2019_Human,Human immunodeficiency virus 1 infection,1/212,0.0105998955026255,0.0134998703748406,0,0,19788.0,89974.27756224656,HLA-F
17782,KEGG_2019_Human,Human T-cell leukemia virus 1 infection,1/219,0.0109498935894162,0.0134998703748406,0,0,19781.0,89299.85161916987,HLA-F
17783,KEGG_2019_Human,Human cytomegalovirus infection,1/225,0.0112498919790339,0.0134998703748406,0,0,19775.0,88738.27077557483,HLA-F
17784,KEGG_2019_Human,Endocytosis,1/244,0.0121998870519305,0.0137248729334218,0,0,19756.0,87051.4275316661,HLA-F
17785,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0174704478977271,0,0,19670.0,80733.60565076157,HLA-F
17786,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,HLA-F
17787,KEGG_2019_Human,Protein processing in endoplasmic reticulum,1/165,0.0082499094553477,0.0082499094553477,0,0,19835.0,95159.46482222488,SEC24C
17788,KEGG_2019_Human,Autophagy,1/128,0.0063999221281459,0.0063999221281459,0,0,19872.0,100382.8010329652,UVRAG
17789,KEGG_2019_Human,Mitophagy,1/65,0.003249949134407,0.0075748989820205,0,0,19935.0,114209.92613860144,CSNK2A1
17790,KEGG_2019_Human,Adherens junction,1/72,0.0035999456502131,0.0075748989820205,0,0,19928.0,112131.59838572376,CSNK2A1
17791,KEGG_2019_Human,NF-kappa B signaling pathway,1/95,0.0047499351803394,0.0075748989820205,0,0,19905.0,106484.27183626965,CSNK2A1
17792,KEGG_2019_Human,Ribosome biogenesis in eukaryotes,1/101,0.0050499326546803,0.0075748989820205,0,0,19899.0,105233.48101229242,CSNK2A1
17793,KEGG_2019_Human,Measles,1/138,0.0068999185254481,0.0078999117225733,0,0,19862.0,98838.19160389496,CSNK2A1
17794,KEGG_2019_Human,Wnt signaling pathway,1/158,0.0078999117225733,0.0078999117225733,0,0,19842.0,96053.2110949472,CSNK2A1
17795,KEGG_2019_Human,Progesterone-mediated oocyte maturation,1/99,0.0049499334884068,0.0085623985997064,0,0,19901.0,105642.09305076736,CDC16
17796,KEGG_2019_Human,Cell cycle,1/124,0.0061999236097501,0.0085623985997064,0,0,19876.0,101034.04709010696,CDC16
17797,KEGG_2019_Human,Oocyte meiosis,1/125,0.0062499232373748,0.0085623985997064,0,0,19875.0,100869.32368441945,CDC16
17798,KEGG_2019_Human,Ubiquitin mediated proteolysis,1/137,0.0068499188797651,0.0085623985997064,0,0,19863.0,98987.62735269018,CDC16
17799,KEGG_2019_Human,Human T-cell leukemia virus 1 infection,1/219,0.0109498935894162,0.0109498935894162,0,0,19781.0,89299.85161916987,CDC16
17800,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF649
17801,KEGG_2019_Human,Basal transcription factors,1/45,0.0022499601197094,0.0022499601197094,0,0,19955.0,121662.49782449217,TAF5L
17802,KEGG_2019_Human,Mucin type O-glycan biosynthesis,1/31,0.0015499690656704,0.0015499690656704,0,0,19969.0,129189.85098816035,GALNT14
17803,KEGG_2019_Human,Spliceosome,1/134,0.0066999199497742,0.0066999199497742,0,0,19866.0,99442.43560916925,PQBP1
17804,KEGG_2019_Human,Fc gamma R-mediated phagocytosis,1/91,0.0045499369072032,0.0106998949514067,0,0,19909.0,107362.10783923086,LIMK1
17805,KEGG_2019_Human,Axon guidance,1/181,0.0090499044707863,0.0106998949514067,0,0,19819.0,93248.41634586031,LIMK1
17806,KEGG_2019_Human,Human immunodeficiency virus 1 infection,1/212,0.0105998955026255,0.0106998949514067,0,0,19788.0,89974.27756224656,LIMK1
17807,KEGG_2019_Human,Regulation of actin cytoskeleton,1/214,0.0106998949514067,0.0106998949514067,0,0,19786.0,89779.39753374986,LIMK1
17808,KEGG_2019_Human,Leishmaniasis,1/74,0.0036999446830449,0.0118998509970274,0,0,19926.0,111574.38983110404,IRAK1
17809,KEGG_2019_Human,Pertussis,1/76,0.0037999437281752,0.0118998509970274,0,0,19924.0,111031.8499691117,IRAK1
17810,KEGG_2019_Human,NF-kappa B signaling pathway,1/95,0.0047499351803394,0.0118998509970274,0,0,19905.0,106484.27183626965,IRAK1
17811,KEGG_2019_Human,Chagas disease (American trypanosomiasis),1/103,0.0051499318302617,0.0118998509970274,0,0,19897.0,104832.7525292024,IRAK1
17812,KEGG_2019_Human,Toll-like receptor signaling pathway,1/104,0.0051999314202997,0.0118998509970274,0,0,19896.0,104635.24941415618,IRAK1
17813,KEGG_2019_Human,Toxoplasmosis,1/113,0.0056499278191151,0.0118998509970274,0,0,19887.0,102937.34947211576,IRAK1
17814,KEGG_2019_Human,Neurotrophin signaling pathway,1/119,0.0059499254985137,0.0118998509970274,0,0,19881.0,101877.73080211312,IRAK1
17815,KEGG_2019_Human,Measles,1/138,0.0068999185254481,0.0120748574195343,0,0,19862.0,98838.19160389496,IRAK1
17816,KEGG_2019_Human,Hepatitis B,1/163,0.0081499100978668,0.0123665447530631,0,0,19837.0,95410.9786681514,IRAK1
17817,KEGG_2019_Human,Tuberculosis,1/179,0.0089499050800561,0.0123665447530631,0,0,19821.0,93478.0629355712,IRAK1
17818,KEGG_2019_Human,Epstein-Barr virus infection,1/201,0.0100498985877989,0.0123665447530631,0,0,19799.0,91079.21596609056,IRAK1
17819,KEGG_2019_Human,Human immunodeficiency virus 1 infection,1/212,0.0105998955026255,0.0123665447530631,0,0,19788.0,89974.27756224656,IRAK1
17820,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0158844807193161,0,0,19705.0,83086.53988020132,IRAK1
17821,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,IRAK1
17822,KEGG_2019_Human,Tyrosine metabolism,1/36,0.0017999657178272,0.0017999657178272,0,0,19964.0,126172.23364250171,DBH
17823,KEGG_2019_Human,Toll-like receptor signaling pathway,1/104,0.0051999314202997,0.0051999314202997,0,0,19896.0,104635.24941415618,IRF5
17824,KEGG_2019_Human,Lysosome,1/123,0.0061499239842961,0.0061499239842961,0,0,19877.0,101200.07933676826,GNPTAB
17825,KEGG_2019_Human,Pyrimidine metabolism,1/57,0.002849953326298,0.005699906652596,0,0,19943.0,116875.00742975442,CANT1
17826,KEGG_2019_Human,Purine metabolism,1/129,0.006449921761047,0.006449921761047,0,0,19871.0,100223.109907462,CANT1
17827,KEGG_2019_Human,NOD-like receptor signaling pathway,1/178,0.0088999053857096,0.0088999053857096,0,0,19822.0,93593.82745769851,CARD6
17828,KEGG_2019_Human,Inflammatory bowel disease (IBD),1/65,0.003249949134407,0.0111598835581629,0,0,19935.0,114209.92613860144,IFNGR1
17829,KEGG_2019_Human,Leishmaniasis,1/74,0.0036999446830449,0.0111598835581629,0,0,19926.0,111574.38983110404,IFNGR1
17830,KEGG_2019_Human,Salmonella infection,1/86,0.0042999391173866,0.0111598835581629,0,0,19914.0,108514.46102290176,IFNGR1
17831,KEGG_2019_Human,Th1 and Th2 cell differentiation,1/92,0.0045999364719865,0.0111598835581629,0,0,19908.0,107139.13814408927,IFNGR1
17832,KEGG_2019_Human,HIF-1 signaling pathway,1/100,0.0049999330710556,0.0111598835581629,0,0,19900.0,105436.78197328727,IFNGR1
17833,KEGG_2019_Human,Chagas disease (American trypanosomiasis),1/103,0.0051499318302617,0.0111598835581629,0,0,19897.0,104832.7525292024,IFNGR1
17834,KEGG_2019_Human,Th17 cell differentiation,1/107,0.0053499302026925,0.0111598835581629,0,0,19893.0,104053.753408911,IFNGR1
17835,KEGG_2019_Human,Toxoplasmosis,1/113,0.0056499278191151,0.0111598835581629,0,0,19887.0,102937.34947211576,IFNGR1
17836,KEGG_2019_Human,Osteoclast differentiation,1/127,0.0063499224962247,0.0111598835581629,0,0,19873.0,100543.72072014232,IFNGR1
17837,KEGG_2019_Human,Natural killer cell mediated cytotoxicity,1/131,0.0065499210316603,0.0111598835581629,0,0,19869.0,99907.33811343512,IFNGR1
17838,KEGG_2019_Human,Necroptosis,1/162,0.0080999104202618,0.0111598835581629,0,0,19838.0,95537.86936302872,IFNGR1
17839,KEGG_2019_Human,JAK-STAT signaling pathway,1/162,0.0080999104202618,0.0111598835581629,0,0,19838.0,95537.86936302872,IFNGR1
17840,KEGG_2019_Human,Influenza A,1/171,0.0085499075557634,0.0111598835581629,0,0,19829.0,94422.42241345016,IFNGR1
17841,KEGG_2019_Human,Tuberculosis,1/179,0.0089499050800561,0.0111598835581629,0,0,19821.0,93478.0629355712,IFNGR1
17842,KEGG_2019_Human,Kaposi sarcoma-associated herpesvirus infection,1/186,0.0092999029651357,0.0111598835581629,0,0,19814.0,92684.96451050608,IFNGR1
17843,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0165373595729701,0,0,19706.0,83157.67014793828,IFNGR1
17844,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0260468883313673,0,0,19508.0,72277.44006442746,IFNGR1
17845,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,IFNGR1
17846,KEGG_2019_Human,Allograft rejection,1/38,0.001899964429635,0.0112098185709785,0,0,19962.0,125080.29732025368,HLA-A
17847,KEGG_2019_Human,Graft-versus-host disease,1/41,0.0020499625466866,0.0112098185709785,0,0,19959.0,123544.88783416104,HLA-A
17848,KEGG_2019_Human,Type I diabetes mellitus,1/43,0.0021499613216957,0.0112098185709785,0,0,19957.0,122581.98940490963,HLA-A
17849,KEGG_2019_Human,Autoimmune thyroid disease,1/53,0.0026499555173137,0.0112098185709785,0,0,19947.0,118349.78824235698,HLA-A
17850,KEGG_2019_Human,Viral myocarditis,1/59,0.0029499522555206,0.0112098185709785,0,0,19941.0,116175.59385530632,HLA-A
17851,KEGG_2019_Human,Antigen processing and presentation,1/77,0.0038499432547502,0.0121914869733757,0,0,19923.0,110765.8407373636,HLA-A
17852,KEGG_2019_Human,Natural killer cell mediated cytotoxicity,1/131,0.0065499210316603,0.0133592467251027,0,0,19869.0,99907.33811343512,HLA-A
17853,KEGG_2019_Human,Cell adhesion molecules (CAMs),1/145,0.0072499160871101,0.0133592467251027,0,0,19855.0,97820.92670675044,HLA-A
17854,KEGG_2019_Human,Phagosome,1/152,0.0075999137114971,0.0133592467251027,0,0,19848.0,96850.665715497,HLA-A
17855,KEGG_2019_Human,Cellular senescence,1/160,0.0079999110688441,0.0133592467251027,0,0,19840.0,95793.96509856998,HLA-A
17856,KEGG_2019_Human,Kaposi sarcoma-associated herpesvirus infection,1/186,0.0092999029651357,0.0133592467251027,0,0,19814.0,92684.96451050608,HLA-A
17857,KEGG_2019_Human,Viral carcinogenesis,1/201,0.0100498985877989,0.0133592467251027,0,0,19799.0,91079.21596609056,HLA-A
17858,KEGG_2019_Human,Epstein-Barr virus infection,1/201,0.0100498985877989,0.0133592467251027,0,0,19799.0,91079.21596609056,HLA-A
17859,KEGG_2019_Human,Human immunodeficiency virus 1 infection,1/212,0.0105998955026255,0.0133592467251027,0,0,19788.0,89974.27756224656,HLA-A
17860,KEGG_2019_Human,Human T-cell leukemia virus 1 infection,1/219,0.0109498935894162,0.0133592467251027,0,0,19781.0,89299.85161916987,HLA-A
17861,KEGG_2019_Human,Human cytomegalovirus infection,1/225,0.0112498919790339,0.0133592467251027,0,0,19775.0,88738.27077557483,HLA-A
17862,KEGG_2019_Human,Endocytosis,1/244,0.0121998870519305,0.0136351678815694,0,0,19756.0,87051.4275316661,HLA-A
17863,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0174165267622403,0,0,19670.0,80733.60565076157,HLA-A
17864,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,HLA-A
17865,KEGG_2019_Human,Taste transduction,1/83,0.0041499404726918,0.0090998738144064,0,0,19917.0,109237.99888847338,GABBR2
17866,KEGG_2019_Human,GABAergic synapse,1/89,0.0044499377838098,0.0090998738144064,0,0,19911.0,107815.380281759,GABBR2
17867,KEGG_2019_Human,Morphine addiction,1/91,0.0045499369072032,0.0090998738144064,0,0,19909.0,107362.10783923086,GABBR2
17868,KEGG_2019_Human,Estrogen signaling pathway,1/137,0.0068499188797651,0.0102748783196477,0,0,19863.0,98987.62735269018,GABBR2
17869,KEGG_2019_Human,cAMP signaling pathway,1/212,0.0105998955026255,0.0127198746031507,0,0,19788.0,89974.27756224656,GABBR2
17870,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,GABBR2
17871,KEGG_2019_Human,mTOR signaling pathway,1/152,0.0075999137114971,0.0075999137114971,0,0,19848.0,96850.665715497,WDR59
17872,KEGG_2019_Human,Pyrimidine metabolism,1/57,0.002849953326298,0.006449921761047,0,0,19943.0,116875.00742975442,NME7
17873,KEGG_2019_Human,Drug metabolism,1/108,0.0053999298011749,0.006449921761047,0,0,19892.0,103863.47861844616,NME7
17874,KEGG_2019_Human,Purine metabolism,1/129,0.006449921761047,0.006449921761047,0,0,19871.0,100223.109907462,NME7
17875,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,BRS3
17876,KEGG_2019_Human,Renal cell carcinoma,1/69,0.003449947123837,0.010299897173561,0,0,19931.0,112996.7391397682,RAPGEF1
17877,KEGG_2019_Human,Neurotrophin signaling pathway,1/119,0.0059499254985137,0.010299897173561,0,0,19881.0,101877.73080211312,RAPGEF1
17878,KEGG_2019_Human,Insulin signaling pathway,1/137,0.0068499188797651,0.010299897173561,0,0,19863.0,98987.62735269018,RAPGEF1
17879,KEGG_2019_Human,Focal adhesion,1/199,0.0099498991610159,0.010299897173561,0,0,19801.0,91286.4288690606,RAPGEF1
17880,KEGG_2019_Human,Rap1 signaling pathway,1/206,0.010299897173561,0.010299897173561,0,0,19794.0,90569.849337325,RAPGEF1
17881,KEGG_2019_Human,Ras signaling pathway,1/232,0.0115998901349604,0.0115998901349604,0,0,19768.0,88101.22480150245,RGL2
17882,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF551
17883,KEGG_2019_Human,Vasopressin-regulated water reabsorption,1/44,0.0021999607179423,0.0064499086760799,0,0,19956.0,122117.06559109331,DYNC1I2
17884,KEGG_2019_Human,Salmonella infection,1/86,0.0042999391173866,0.0064499086760799,0,0,19914.0,108514.46102290176,DYNC1I2
17885,KEGG_2019_Human,Phagosome,1/152,0.0075999137114971,0.0075999137114971,0,0,19848.0,96850.665715497,DYNC1I2
17886,KEGG_2019_Human,Spliceosome,1/134,0.0066999199497742,0.0066999199497742,0,0,19866.0,99442.43560916925,HNRNPU
17887,KEGG_2019_Human,ECM-receptor interaction,1/82,0.004099940929819,0.0176998626413668,0,0,19918.0,109484.9180722932,TNC
17888,KEGG_2019_Human,Focal adhesion,1/199,0.0099498991610159,0.0176998626413668,0,0,19801.0,91286.4288690606,TNC
17889,KEGG_2019_Human,MicroRNAs in cancer,1/299,0.0149498740670514,0.0176998626413668,0,0,19701.0,82804.33538735632,TNC
17890,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0176998626413668,0,0,19670.0,80733.60565076157,TNC
17891,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0176998626413668,0,0,19646.0,79255.8617626126,TNC
17892,KEGG_2019_Human,mRNA surveillance pathway,1/91,0.0045499369072032,0.0082499094553477,0,0,19909.0,107362.10783923086,PNN
17893,KEGG_2019_Human,RNA transport,1/165,0.0082499094553477,0.0082499094553477,0,0,19835.0,95159.46482222488,PNN
17894,KEGG_2019_Human,TGF-beta signaling pathway,1/90,0.0044999373439762,0.0061999236097501,0,0,19910.0,107587.50385474482,TFDP1
17895,KEGG_2019_Human,Cell cycle,1/124,0.0061999236097501,0.0061999236097501,0,0,19876.0,101034.04709010696,TFDP1
17896,KEGG_2019_Human,Salmonella infection,1/86,0.0042999391173866,0.0085998782347732,0,0,19914.0,108514.46102290176,PKN2
17897,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0176998626413668,0,0,19646.0,79255.8617626126,PKN2
17898,KEGG_2019_Human,Taste transduction,1/83,0.0041499404726918,0.0041499404726918,0,0,19917.0,109237.99888847338,TAS2R46
17899,KEGG_2019_Human,Cell adhesion molecules (CAMs),1/145,0.0072499160871101,0.0072499160871101,0,0,19855.0,97820.92670675044,SDC3
17900,KEGG_2019_Human,Basal transcription factors,1/45,0.0022499601197094,0.0023499589392381,0,0,19955.0,121662.49782449217,ERCC2
17901,KEGG_2019_Human,Nucleotide excision repair,1/47,0.0023499589392381,0.0023499589392381,0,0,19953.0,120782.64067395544,ERCC2
17902,KEGG_2019_Human,Gap junction,1/88,0.0043999382262822,0.0187248161649618,0,0,19912.0,108045.79305232369,LPAR1
17903,KEGG_2019_Human,Phospholipase D signaling pathway,1/148,0.007399915061391,0.0187248161649618,0,0,19852.0,97399.60470052566,LPAR1
17904,KEGG_2019_Human,Rap1 signaling pathway,1/206,0.010299897173561,0.0187248161649618,0,0,19794.0,90569.849337325,LPAR1
17905,KEGG_2019_Human,Regulation of actin cytoskeleton,1/214,0.0106998949514067,0.0187248161649618,0,0,19786.0,89779.39753374986,LPAR1
17906,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0206498397482613,0,0,19662.0,80229.79996326564,LPAR1
17907,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0206498397482613,0,0,19646.0,79255.8617626126,LPAR1
17908,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,LPAR1
17909,KEGG_2019_Human,Oxidative phosphorylation,1/133,0.0066499203093911,0.0112582177134695,0,0,19867.0,99596.2591544721,NDUFB11
17910,KEGG_2019_Human,Parkinson disease,1/142,0.0070999171242726,0.0112582177134695,0,0,19858.0,98250.87390500787,NDUFB11
17911,KEGG_2019_Human,Retrograde endocannabinoid signaling,1/148,0.007399915061391,0.0112582177134695,0,0,19852.0,97399.60470052566,NDUFB11
17912,KEGG_2019_Human,Non-alcoholic fatty liver disease (NAFLD),1/149,0.0074499147221605,0.0112582177134695,0,0,19851.0,97261.02051561224,NDUFB11
17913,KEGG_2019_Human,Alzheimer disease,1/171,0.0085499075557634,0.0112582177134695,0,0,19829.0,94422.42241345016,NDUFB11
17914,KEGG_2019_Human,Huntington disease,1/193,0.0096499008972596,0.0112582177134695,0,0,19807.0,91920.47679471428,NDUFB11
17915,KEGG_2019_Human,Thermogenesis,1/231,0.0115498903940656,0.0115498903940656,0,0,19769.0,88191.07730937863,NDUFB11
17916,KEGG_2019_Human,Fc gamma R-mediated phagocytosis,1/91,0.0045499369072032,0.0106998949514067,0,0,19909.0,107362.10783923086,GSN
17917,KEGG_2019_Human,Viral carcinogenesis,1/201,0.0100498985877989,0.0106998949514067,0,0,19799.0,91079.21596609056,GSN
17918,KEGG_2019_Human,Regulation of actin cytoskeleton,1/214,0.0106998949514067,0.0106998949514067,0,0,19786.0,89779.39753374986,GSN
17919,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF23
17920,KEGG_2019_Human,Maturity onset diabetes of the young,1/26,0.0012999726251831,0.0025999452503662,0,0,19974.0,132735.46073187632,FOXA2
17921,KEGG_2019_Human,Longevity regulating pathway,1/102,0.0050999322416682,0.0050999322416682,0,0,19898.0,105032.15064717118,FOXA2
17922,KEGG_2019_Human,GABAergic synapse,1/89,0.0044499377838098,0.0088998755676196,0,0,19911.0,107815.380281759,HAP1
17923,KEGG_2019_Human,Huntington disease,1/193,0.0096499008972596,0.0096499008972596,0,0,19807.0,91920.47679471428,HAP1
17924,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF175
17925,KEGG_2019_Human,Inflammatory bowel disease (IBD),1/65,0.003249949134407,0.0095082284475112,0,0,19935.0,114209.92613860144,STAT6
17926,KEGG_2019_Human,Th1 and Th2 cell differentiation,1/92,0.0045999364719865,0.0095082284475112,0,0,19908.0,107139.13814408927,STAT6
17927,KEGG_2019_Human,Th17 cell differentiation,1/107,0.0053499302026925,0.0095082284475112,0,0,19893.0,104053.753408911,STAT6
17928,KEGG_2019_Human,Necroptosis,1/162,0.0080999104202618,0.0095082284475112,0,0,19838.0,95537.86936302872,STAT6
17929,KEGG_2019_Human,JAK-STAT signaling pathway,1/162,0.0080999104202618,0.0095082284475112,0,0,19838.0,95537.86936302872,STAT6
17930,KEGG_2019_Human,Hepatitis B,1/163,0.0081499100978668,0.0095082284475112,0,0,19837.0,95410.9786681514,STAT6
17931,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,STAT6
17932,KEGG_2019_Human,mTOR signaling pathway,1/152,0.0075999137114971,0.0075999137114971,0,0,19848.0,96850.665715497,SLC38A9
17933,KEGG_2019_Human,Leukocyte transendothelial migration,1/112,0.0055999282120529,0.0106998949514067,0,0,19888.0,103119.30984392198,MSN
17934,KEGG_2019_Human,Measles,1/138,0.0068999185254481,0.0106998949514067,0,0,19862.0,98838.19160389496,MSN
17935,KEGG_2019_Human,Tight junction,1/170,0.0084999078692823,0.0106998949514067,0,0,19830.0,94543.49009679438,MSN
17936,KEGG_2019_Human,Proteoglycans in cancer,1/201,0.0100498985877989,0.0106998949514067,0,0,19799.0,91079.21596609056,MSN
17937,KEGG_2019_Human,Regulation of actin cytoskeleton,1/214,0.0106998949514067,0.0106998949514067,0,0,19786.0,89779.39753374986,MSN
17938,KEGG_2019_Human,Spliceosome,1/134,0.0066999199497742,0.0066999199497742,0,0,19866.0,99442.43560916925,CDC40
17939,KEGG_2019_Human,Pentose phosphate pathway,1/30,0.0014999697593334,0.0043999138752303,0,0,19970.0,129851.13732048514,PFKP
17940,KEGG_2019_Human,Galactose metabolism,1/31,0.0015499690656704,0.0043999138752303,0,0,19969.0,129189.85098816035,PFKP
17941,KEGG_2019_Human,Fructose and mannose metabolism,1/33,0.0016499677032113,0.0043999138752303,0,0,19967.0,127928.56031580272,PFKP
17942,KEGG_2019_Human,Central carbon metabolism in cancer,1/65,0.003249949134407,0.0052665897556449,0,0,19935.0,114209.92613860144,PFKP
17943,KEGG_2019_Human,Glycolysis / Gluconeogenesis,1/68,0.0033999476216189,0.0052665897556449,0,0,19932.0,113293.39338050144,PFKP
17944,KEGG_2019_Human,RNA degradation,1/79,0.0039499423167337,0.0052665897556449,0,0,19921.0,110243.89578070649,PFKP
17945,KEGG_2019_Human,Thyroid hormone signaling pathway,1/116,0.0057999266512085,0.0059999251180858,0,0,19884.0,102400.8105961506,PFKP
17946,KEGG_2019_Human,AMPK signaling pathway,1/120,0.0059999251180858,0.0059999251180858,0,0,19880.0,101706.2448082016,PFKP
17947,KEGG_2019_Human,Vibrio cholerae infection,1/50,0.0024999572069037,0.0048999339081079,0,0,19950.0,119530.05920663515,SLC12A2
17948,KEGG_2019_Human,Salivary secretion,1/90,0.0044999373439762,0.0048999339081079,0,0,19910.0,107587.50385474482,SLC12A2
17949,KEGG_2019_Human,Pancreatic secretion,1/98,0.0048999339081079,0.0048999339081079,0,0,19902.0,105849.45495286948,SLC12A2
17950,KEGG_2019_Human,mTOR signaling pathway,1/152,0.0075999137114971,0.0075999137114971,0,0,19848.0,96850.665715497,FNIP1
17951,KEGG_2019_Human,"Parathyroid hormone synthesis, secretion and action",1/106,0.0052999306076525,0.0052999306076525,0,0,19894.0,104245.78450366124,GCM2
17952,KEGG_2019_Human,Arrhythmogenic right ventricular cardiomyopathy (ARVC),1/72,0.0035999456502131,0.0142498631734429,0,0,19928.0,112131.59838572376,ITGB3
17953,KEGG_2019_Human,ECM-receptor interaction,1/82,0.004099940929819,0.0142498631734429,0,0,19918.0,109484.9180722932,ITGB3
17954,KEGG_2019_Human,Hypertrophic cardiomyopathy (HCM),1/85,0.004249939567045,0.0142498631734429,0,0,19915.0,108752.83801948265,ITGB3
17955,KEGG_2019_Human,Dilated cardiomyopathy (DCM),1/91,0.0045499369072032,0.0142498631734429,0,0,19909.0,107362.10783923086,ITGB3
17956,KEGG_2019_Human,Hematopoietic cell lineage,1/97,0.0048499343304706,0.0142498631734429,0,0,19903.0,106058.9096435903,ITGB3
17957,KEGG_2019_Human,Thyroid hormone signaling pathway,1/116,0.0057999266512085,0.0142498631734429,0,0,19884.0,102400.8105961506,ITGB3
17958,KEGG_2019_Human,Platelet activation,1/124,0.0061999236097501,0.0142498631734429,0,0,19876.0,101034.04709010696,ITGB3
17959,KEGG_2019_Human,Osteoclast differentiation,1/127,0.0063499224962247,0.0142498631734429,0,0,19873.0,100543.72072014232,ITGB3
17960,KEGG_2019_Human,Fluid shear stress and atherosclerosis,1/139,0.006949918172816,0.0142498631734429,0,0,19861.0,98689.81333375497,ITGB3
17961,KEGG_2019_Human,Phagosome,1/152,0.0075999137114971,0.0142498631734429,0,0,19848.0,96850.665715497,ITGB3
17962,KEGG_2019_Human,Focal adhesion,1/199,0.0099498991610159,0.0142498631734429,0,0,19801.0,91286.4288690606,ITGB3
17963,KEGG_2019_Human,Proteoglycans in cancer,1/201,0.0100498985877989,0.0142498631734429,0,0,19799.0,91079.21596609056,ITGB3
17964,KEGG_2019_Human,Rap1 signaling pathway,1/206,0.010299897173561,0.0142498631734429,0,0,19794.0,90569.849337325,ITGB3
17965,KEGG_2019_Human,Regulation of actin cytoskeleton,1/214,0.0106998949514067,0.0142498631734429,0,0,19786.0,89779.39753374986,ITGB3
17966,KEGG_2019_Human,Human cytomegalovirus infection,1/225,0.0112498919790339,0.0142498631734429,0,0,19775.0,88738.27077557483,ITGB3
17967,KEGG_2019_Human,MicroRNAs in cancer,1/299,0.0149498740670514,0.0177529754546235,0,0,19701.0,82804.33538735632,ITGB3
17968,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0184410283364897,0,0,19670.0,80733.60565076157,ITGB3
17969,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.018683188343665,0,0,19646.0,79255.8617626126,ITGB3
17970,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ITGB3
17971,KEGG_2019_Human,T cell receptor signaling pathway,1/101,0.0050499326546803,0.0131398723072995,0,0,19899.0,105233.48101229242,DLG1
17972,KEGG_2019_Human,Hippo signaling pathway,1/160,0.0079999110688441,0.0131398723072995,0,0,19840.0,95793.96509856998,DLG1
17973,KEGG_2019_Human,Tight junction,1/170,0.0084999078692823,0.0131398723072995,0,0,19830.0,94543.49009679438,DLG1
17974,KEGG_2019_Human,Viral carcinogenesis,1/201,0.0100498985877989,0.0131398723072995,0,0,19799.0,91079.21596609056,DLG1
17975,KEGG_2019_Human,Human T-cell leukemia virus 1 infection,1/219,0.0109498935894162,0.0131398723072995,0,0,19781.0,89299.85161916987,DLG1
17976,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0164998674589645,0,0,19670.0,80733.60565076157,DLG1
17977,KEGG_2019_Human,"Parathyroid hormone synthesis, secretion and action",1/106,0.0052999306076525,0.0092999029651357,0,0,19894.0,104245.78450366124,RUNX2
17978,KEGG_2019_Human,Transcriptional misregulation in cancer,1/186,0.0092999029651357,0.0092999029651357,0,0,19814.0,92684.96451050608,RUNX2
17979,KEGG_2019_Human,Pathogenic Escherichia coli infection,1/55,0.0027499544131125,0.0065999073394233,0,0,19945.0,117599.1294878737,TUBB8
17980,KEGG_2019_Human,Gap junction,1/88,0.0043999382262822,0.0065999073394233,0,0,19912.0,108045.79305232369,TUBB8
17981,KEGG_2019_Human,Phagosome,1/152,0.0075999137114971,0.0075999137114971,0,0,19848.0,96850.665715497,TUBB8
17982,KEGG_2019_Human,p53 signaling pathway,1/72,0.0035999456502131,0.0075999137114971,0,0,19928.0,112131.59838572376,SESN2
17983,KEGG_2019_Human,Longevity regulating pathway,1/102,0.0050999322416682,0.0075999137114971,0,0,19898.0,105032.15064717118,SESN2
17984,KEGG_2019_Human,mTOR signaling pathway,1/152,0.0075999137114971,0.0075999137114971,0,0,19848.0,96850.665715497,SESN2
17985,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR2T34
17986,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF440
17987,KEGG_2019_Human,Transcriptional misregulation in cancer,1/186,0.0092999029651357,0.0092999029651357,0,0,19814.0,92684.96451050608,PBX3
17988,KEGG_2019_Human,FoxO signaling pathway,1/132,0.0065999206698993,0.0131998413397987,0,0,19868.0,99751.22090491928,SGK3
17989,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0176998626413668,0,0,19646.0,79255.8617626126,SGK3
17990,KEGG_2019_Human,Human T-cell leukemia virus 1 infection,1/219,0.0109498935894162,0.0109498935894162,0,0,19781.0,89299.85161916987,CRTC3
17991,KEGG_2019_Human,RNA transport,1/165,0.0082499094553477,0.0082499094553477,0,0,19835.0,95159.46482222488,EIF4A2
17992,KEGG_2019_Human,Insulin resistance,1/108,0.0053999298011749,0.0074499147221605,0,0,19892.0,103863.47861844616,SREBF1
17993,KEGG_2019_Human,AMPK signaling pathway,1/120,0.0059999251180858,0.0074499147221605,0,0,19880.0,101706.2448082016,SREBF1
17994,KEGG_2019_Human,Insulin signaling pathway,1/137,0.0068499188797651,0.0074499147221605,0,0,19863.0,98987.62735269018,SREBF1
17995,KEGG_2019_Human,Non-alcoholic fatty liver disease (NAFLD),1/149,0.0074499147221605,0.0074499147221605,0,0,19851.0,97261.02051561224,SREBF1
17996,KEGG_2019_Human,Nucleotide excision repair,1/47,0.0023499589392381,0.0046999178784763,0,0,19953.0,120782.64067395544,ERCC8
17997,KEGG_2019_Human,Ubiquitin mediated proteolysis,1/137,0.0068499188797651,0.0068499188797651,0,0,19863.0,98987.62735269018,ERCC8
17998,KEGG_2019_Human,Pancreatic cancer,1/75,0.0037499442041125,0.0112498326123375,0,0,19925.0,111301.33528642564,RALBP1
17999,KEGG_2019_Human,Ras signaling pathway,1/232,0.0115998901349604,0.0173998352024406,0,0,19768.0,88101.22480150245,RALBP1
18000,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,RALBP1
18001,KEGG_2019_Human,Spliceosome,1/134,0.0066999199497742,0.0133998398995484,0,0,19866.0,99442.43560916925,SRSF7
18002,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,SRSF7
18003,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF799
18004,KEGG_2019_Human,Protein processing in endoplasmic reticulum,1/165,0.0082499094553477,0.0082499094553477,0,0,19835.0,95159.46482222488,UBQLN1
18005,KEGG_2019_Human,Protein processing in endoplasmic reticulum,1/165,0.0082499094553477,0.0082499094553477,0,0,19835.0,95159.46482222488,SEC23A
18006,KEGG_2019_Human,Sulfur metabolism,1/9,0.0004499872571388355,0.0004499872571388355,0,0,19991.0,154056.46923976458,ETHE1
18007,KEGG_2019_Human,Spliceosome,1/134,0.0066999199497742,0.0066999199497742,0,0,19866.0,99442.43560916925,SF3B3
18008,KEGG_2019_Human,Ether lipid metabolism,1/47,0.0023499589392381,0.0023499589392381,0,0,19953.0,120782.64067395544,PAFAH1B2
18009,KEGG_2019_Human,IL-17 signaling pathway,1/93,0.0046499360391879,0.0046499360391879,0,0,19907.0,106918.54242106884,MAPK6
18010,KEGG_2019_Human,Tight junction,1/170,0.0084999078692823,0.0147498749536506,0,0,19830.0,94543.49009679438,RAPGEF2
18011,KEGG_2019_Human,Rap1 signaling pathway,1/206,0.010299897173561,0.0147498749536506,0,0,19794.0,90569.849337325,RAPGEF2
18012,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0147498749536506,0,0,19705.0,83086.53988020132,RAPGEF2
18013,KEGG_2019_Human,Circadian rhythm,1/31,0.0015499690656704,0.0103123868191847,0,0,19969.0,129189.85098816035,CUL1
18014,KEGG_2019_Human,Hedgehog signaling pathway,1/47,0.0023499589392381,0.0103123868191847,0,0,19953.0,120782.64067395544,CUL1
18015,KEGG_2019_Human,TGF-beta signaling pathway,1/90,0.0044999373439762,0.0103123868191847,0,0,19910.0,107587.50385474482,CUL1
18016,KEGG_2019_Human,Cell cycle,1/124,0.0061999236097501,0.0103123868191847,0,0,19876.0,101034.04709010696,CUL1
18017,KEGG_2019_Human,Oocyte meiosis,1/125,0.0062499232373748,0.0103123868191847,0,0,19875.0,100869.32368441945,CUL1
18018,KEGG_2019_Human,Ubiquitin mediated proteolysis,1/137,0.0068499188797651,0.0103123868191847,0,0,19863.0,98987.62735269018,CUL1
18019,KEGG_2019_Human,Wnt signaling pathway,1/158,0.0078999117225733,0.0103123868191847,0,0,19842.0,96053.2110949472,CUL1
18020,KEGG_2019_Human,Protein processing in endoplasmic reticulum,1/165,0.0082499094553477,0.0103123868191847,0,0,19835.0,95159.46482222488,CUL1
18021,KEGG_2019_Human,Human immunodeficiency virus 1 infection,1/212,0.0105998955026255,0.0117776616695839,0,0,19788.0,89974.27756224656,CUL1
18022,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,CUL1
18023,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF707
18024,KEGG_2019_Human,Neurotrophin signaling pathway,1/119,0.0059499254985137,0.0111998754963818,0,0,19881.0,101877.73080211312,YWHAE
18025,KEGG_2019_Human,Cell cycle,1/124,0.0061999236097501,0.0111998754963818,0,0,19876.0,101034.04709010696,YWHAE
18026,KEGG_2019_Human,Oocyte meiosis,1/125,0.0062499232373748,0.0111998754963818,0,0,19875.0,100869.32368441945,YWHAE
18027,KEGG_2019_Human,Hepatitis C,1/155,0.0077499127120574,0.0111998754963818,0,0,19845.0,96448.16254952336,YWHAE
18028,KEGG_2019_Human,Hippo signaling pathway,1/160,0.0079999110688441,0.0111998754963818,0,0,19840.0,95793.96509856998,YWHAE
18029,KEGG_2019_Human,Viral carcinogenesis,1/201,0.0100498985877989,0.0117248816857654,0,0,19799.0,91079.21596609056,YWHAE
18030,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0176998626413668,0,0,19646.0,79255.8617626126,YWHAE
18031,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF425
18032,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,MLNR
18033,KEGG_2019_Human,Phospholipase D signaling pathway,1/148,0.007399915061391,0.0121998870519305,0,0,19852.0,97399.60470052566,CYTH3
18034,KEGG_2019_Human,Endocytosis,1/244,0.0121998870519305,0.0121998870519305,0,0,19756.0,87051.4275316661,CYTH3
18035,KEGG_2019_Human,Drug metabolism,1/108,0.0053999298011749,0.0053999298011749,0,0,19892.0,103863.47861844616,FMO5
18036,KEGG_2019_Human,MicroRNAs in cancer,1/299,0.0149498740670514,0.0149498740670514,0,0,19701.0,82804.33538735632,IGF2BP1
18037,KEGG_2019_Human,Rap1 signaling pathway,1/206,0.010299897173561,0.010299897173561,0,0,19794.0,90569.849337325,MAGI3
18038,KEGG_2019_Human,mRNA surveillance pathway,1/91,0.0045499369072032,0.0045499369072032,0,0,19909.0,107362.10783923086,CPSF2
18039,KEGG_2019_Human,Endocytosis,1/244,0.0121998870519305,0.0121998870519305,0,0,19756.0,87051.4275316661,ACAP3
18040,KEGG_2019_Human,Other glycan degradation,1/18,0.0008999788927950273,0.0008999788927950273,0,0,19982.0,140136.54844084635,HEXD
18041,KEGG_2019_Human,Protein processing in endoplasmic reticulum,1/165,0.0082499094553477,0.0082499094553477,0,0,19835.0,95159.46482222488,ATXN3L
18042,KEGG_2019_Human,Protein digestion and absorption,1/90,0.0044999373439762,0.0097998678162159,0,0,19910.0,107587.50385474482,PRSS3
18043,KEGG_2019_Human,Pancreatic secretion,1/98,0.0048999339081079,0.0097998678162159,0,0,19902.0,105849.45495286948,PRSS3
18044,KEGG_2019_Human,Influenza A,1/171,0.0085499075557634,0.0113998767410179,0,0,19829.0,94422.42241345016,PRSS3
18045,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,PRSS3
18046,KEGG_2019_Human,Influenza A,1/171,0.0085499075557634,0.0085499075557634,0,0,19829.0,94422.42241345016,KPNA2
18047,KEGG_2019_Human,Fat digestion and absorption,1/41,0.0020499625466866,0.0045749268002481,0,0,19959.0,123544.88783416104,PNLIPRP1
18048,KEGG_2019_Human,Glycerolipid metabolism,1/61,0.0030499512001654,0.0045749268002481,0,0,19939.0,115499.24335773686,PNLIPRP1
18049,KEGG_2019_Human,Pancreatic secretion,1/98,0.0048999339081079,0.0048999339081079,0,0,19902.0,105849.45495286948,PNLIPRP1
18050,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR10G2
18051,KEGG_2019_Human,Proteasome,1/45,0.0022499601197094,0.0044999202394188,0,0,19955.0,121662.49782449217,PSMD11
18052,KEGG_2019_Human,Epstein-Barr virus infection,1/201,0.0100498985877989,0.0100498985877989,0,0,19799.0,91079.21596609056,PSMD11
18053,KEGG_2019_Human,Ascorbate and aldarate metabolism,1/27,0.0013499718942362,0.004685646776936,0,0,19973.0,131975.02298599784,UGT2B11
18054,KEGG_2019_Human,Pentose and glucuronate interconversions,1/34,0.0016999670339032,0.004685646776936,0,0,19966.0,127326.1054203148,UGT2B11
18055,KEGG_2019_Human,Porphyrin and chlorophyll metabolism,1/42,0.0020999619311272,0.004685646776936,0,0,19958.0,123057.75613441122,UGT2B11
18056,KEGG_2019_Human,Steroid hormone biosynthesis,1/60,0.002999951725986,0.004685646776936,0,0,19940.0,115834.63209072244,UGT2B11
18057,KEGG_2019_Human,Retinol metabolism,1/67,0.0033499481224912,0.004685646776936,0,0,19933.0,113594.38808369274,UGT2B11
18058,KEGG_2019_Human,Metabolism of xenobiotics by cytochrome P450,1/74,0.0036999446830449,0.004685646776936,0,0,19926.0,111574.38983110404,UGT2B11
18059,KEGG_2019_Human,Chemical carcinogenesis,1/82,0.004099940929819,0.004685646776936,0,0,19918.0,109484.9180722932,UGT2B11
18060,KEGG_2019_Human,Drug metabolism,1/108,0.0053999298011749,0.0053999298011749,0,0,19892.0,103863.47861844616,UGT2B11
18061,KEGG_2019_Human,Non-homologous end-joining,1/13,0.0006499833083207112,0.0012999666166414,0,0,19987.0,146675.87616784443,DCLRE1C
18062,KEGG_2019_Human,Primary immunodeficiency,1/37,0.0018499650702878,0.0018499650702878,0,0,19963.0,125618.9446446357,DCLRE1C
18063,KEGG_2019_Human,Ribosome,1/153,0.0076499133771537,0.0076499133771537,0,0,19847.0,96715.6407630817,RPL22
18064,KEGG_2019_Human,mRNA surveillance pathway,1/91,0.0045499369072032,0.0045499369072032,0,0,19909.0,107362.10783923086,CSTF3
18065,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF14
18066,KEGG_2019_Human,Choline metabolism in cancer,1/99,0.0049499334884068,0.0129998554868717,0,0,19901.0,105642.09305076736,TSC1
18067,KEGG_2019_Human,Longevity regulating pathway,1/102,0.0050999322416682,0.0129998554868717,0,0,19898.0,105032.15064717118,TSC1
18068,KEGG_2019_Human,AMPK signaling pathway,1/120,0.0059999251180858,0.0129998554868717,0,0,19880.0,101706.2448082016,TSC1
18069,KEGG_2019_Human,Autophagy,1/128,0.0063999221281459,0.0129998554868717,0,0,19872.0,100382.8010329652,TSC1
18070,KEGG_2019_Human,Insulin signaling pathway,1/137,0.0068499188797651,0.0129998554868717,0,0,19863.0,98987.62735269018,TSC1
18071,KEGG_2019_Human,Phospholipase D signaling pathway,1/148,0.007399915061391,0.0129998554868717,0,0,19852.0,97399.60470052566,TSC1
18072,KEGG_2019_Human,mTOR signaling pathway,1/152,0.0075999137114971,0.0129998554868717,0,0,19848.0,96850.665715497,TSC1
18073,KEGG_2019_Human,Cellular senescence,1/160,0.0079999110688441,0.0129998554868717,0,0,19840.0,95793.96509856998,TSC1
18074,KEGG_2019_Human,Human cytomegalovirus infection,1/225,0.0112498919790339,0.0150148575122852,0,0,19775.0,88738.27077557483,TSC1
18075,KEGG_2019_Human,Thermogenesis,1/231,0.0115498903940656,0.0150148575122852,0,0,19769.0,88191.07730937863,TSC1
18076,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0191748511948141,0,0,19670.0,80733.60565076157,TSC1
18077,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0191748511948141,0,0,19646.0,79255.8617626126,TSC1
18078,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,TSC1
18079,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0146998751759735,0,0,19706.0,83157.67014793828,BMP10
18080,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR52A1
18081,KEGG_2019_Human,Transcriptional misregulation in cancer,1/186,0.0092999029651357,0.0092999029651357,0,0,19814.0,92684.96451050608,NFKBIZ
18082,KEGG_2019_Human,Hippo signaling pathway,1/160,0.0079999110688441,0.0079999110688441,0,0,19840.0,95793.96509856998,SAV1
18083,KEGG_2019_Human,Aldosterone-regulated sodium reabsorption,1/37,0.0018499650702878,0.0018499650702878,0,0,19963.0,125618.9446446357,SLC9A3R2
18084,KEGG_2019_Human,Taste transduction,1/83,0.0041499404726918,0.0124498214180756,0,0,19917.0,109237.99888847338,P2RX3
18085,KEGG_2019_Human,Calcium signaling pathway,1/188,0.009399902370135,0.0140998535552025,0,0,19812.0,92463.712994847,P2RX3
18086,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,P2RX3
18087,KEGG_2019_Human,Apoptosis,1/143,0.0071499167770442,0.0071499167770442,0,0,19857.0,98106.57763600958,BOK
18088,KEGG_2019_Human,Ribosome,1/153,0.0076499133771537,0.0076499133771537,0,0,19847.0,96715.6407630817,MRPL35
18089,KEGG_2019_Human,Transcriptional misregulation in cancer,1/186,0.0092999029651357,0.0092999029651357,0,0,19814.0,92684.96451050608,SIX1
18090,KEGG_2019_Human,Viral myocarditis,1/59,0.0029499522555206,0.0048499343304706,0,0,19941.0,116175.59385530632,CD55
18091,KEGG_2019_Human,Complement and coagulation cascades,1/79,0.0039499423167337,0.0048499343304706,0,0,19921.0,110243.89578070649,CD55
18092,KEGG_2019_Human,Hematopoietic cell lineage,1/97,0.0048499343304706,0.0048499343304706,0,0,19903.0,106058.9096435903,CD55
18093,KEGG_2019_Human,Aldosterone-regulated sodium reabsorption,1/37,0.0018499650702878,0.0105540458563941,0,0,19963.0,125618.9446446357,PIK3CB
18094,KEGG_2019_Human,Carbohydrate digestion and absorption,1/44,0.0021999607179423,0.0105540458563941,0,0,19956.0,122117.06559109331,PIK3CB
18095,KEGG_2019_Human,Type II diabetes mellitus,1/46,0.0022999595269283,0.0105540458563941,0,0,19954.0,121217.8313311442,PIK3CB
18096,KEGG_2019_Human,Regulation of lipolysis in adipocytes,1/55,0.0027499544131125,0.0105540458563941,0,0,19945.0,117599.1294878737,PIK3CB
18097,KEGG_2019_Human,Endometrial cancer,1/58,0.0028999527887707,0.0105540458563941,0,0,19942.0,116522.31890946148,PIK3CB
18098,KEGG_2019_Human,VEGF signaling pathway,1/59,0.0029499522555206,0.0105540458563941,0,0,19941.0,116175.59385530632,PIK3CB
18099,KEGG_2019_Human,Central carbon metabolism in cancer,1/65,0.003249949134407,0.0105540458563941,0,0,19935.0,114209.92613860144,PIK3CB
18100,KEGG_2019_Human,Acute myeloid leukemia,1/66,0.003299948626608,0.0105540458563941,0,0,19934.0,113899.85357353876,PIK3CB
18101,KEGG_2019_Human,Non-small cell lung cancer,1/66,0.003299948626608,0.0105540458563941,0,0,19934.0,113899.85357353876,PIK3CB
18102,KEGG_2019_Human,Fc epsilon RI signaling pathway,1/68,0.0033999476216189,0.0105540458563941,0,0,19932.0,113293.39338050144,PIK3CB
18103,KEGG_2019_Human,Renal cell carcinoma,1/69,0.003449947123837,0.0105540458563941,0,0,19931.0,112996.7391397682,PIK3CB
18104,KEGG_2019_Human,Prolactin signaling pathway,1/70,0.0034999466296654,0.0105540458563941,0,0,19930.0,112704.30065625212,PIK3CB
18105,KEGG_2019_Human,B cell receptor signaling pathway,1/71,0.0035499461386618,0.0105540458563941,0,0,19929.0,112415.9585341616,PIK3CB
18106,KEGG_2019_Human,Melanoma,1/72,0.0035999456502131,0.0105540458563941,0,0,19928.0,112131.59838572376,PIK3CB
18107,KEGG_2019_Human,Inositol phosphate metabolism,1/74,0.0036999446830449,0.0105540458563941,0,0,19926.0,111574.38983110404,PIK3CB
18108,KEGG_2019_Human,Bacterial invasion of epithelial cells,1/74,0.0036999446830449,0.0105540458563941,0,0,19926.0,111574.38983110404,PIK3CB
18109,KEGG_2019_Human,Pancreatic cancer,1/75,0.0037499442041125,0.0105540458563941,0,0,19925.0,111301.33528642564,PIK3CB
18110,KEGG_2019_Human,Glioma,1/75,0.0037499442041125,0.0105540458563941,0,0,19925.0,111301.33528642564,PIK3CB
18111,KEGG_2019_Human,Chronic myeloid leukemia,1/76,0.0037999437281752,0.0105540458563941,0,0,19924.0,111031.8499691117,PIK3CB
18112,KEGG_2019_Human,ErbB signaling pathway,1/85,0.004249939567045,0.0105540458563941,0,0,19915.0,108752.83801948265,PIK3CB
18113,KEGG_2019_Human,Colorectal cancer,1/86,0.0042999391173866,0.0105540458563941,0,0,19914.0,108514.46102290176,PIK3CB
18114,KEGG_2019_Human,Fc gamma R-mediated phagocytosis,1/91,0.0045499369072032,0.0105540458563941,0,0,19909.0,107362.10783923086,PIK3CB
18115,KEGG_2019_Human,Small cell lung cancer,1/93,0.0046499360391879,0.0105540458563941,0,0,19907.0,106918.54242106884,PIK3CB
18116,KEGG_2019_Human,Amoebiasis,1/96,0.0047999347538706,0.0105540458563941,0,0,19904.0,106270.50039849174,PIK3CB
18117,KEGG_2019_Human,Prostate cancer,1/97,0.0048499343304706,0.0105540458563941,0,0,19903.0,106058.9096435903,PIK3CB
18118,KEGG_2019_Human,Choline metabolism in cancer,1/99,0.0049499334884068,0.0105540458563941,0,0,19901.0,105642.09305076736,PIK3CB
18119,KEGG_2019_Human,Phosphatidylinositol signaling system,1/99,0.0049499334884068,0.0105540458563941,0,0,19901.0,105642.09305076736,PIK3CB
18120,KEGG_2019_Human,Progesterone-mediated oocyte maturation,1/99,0.0049499334884068,0.0105540458563941,0,0,19901.0,105642.09305076736,PIK3CB
18121,KEGG_2019_Human,AGE-RAGE signaling pathway in diabetic complications,1/100,0.0049999330710556,0.0105540458563941,0,0,19900.0,105436.78197328727,PIK3CB
18122,KEGG_2019_Human,Inflammatory mediator regulation of TRP channels,1/100,0.0049999330710556,0.0105540458563941,0,0,19900.0,105436.78197328727,PIK3CB
18123,KEGG_2019_Human,HIF-1 signaling pathway,1/100,0.0049999330710556,0.0105540458563941,0,0,19900.0,105436.78197328727,PIK3CB
18124,KEGG_2019_Human,T cell receptor signaling pathway,1/101,0.0050499326546803,0.0105540458563941,0,0,19899.0,105233.48101229242,PIK3CB
18125,KEGG_2019_Human,Longevity regulating pathway,1/102,0.0050999322416682,0.0105540458563941,0,0,19898.0,105032.15064717118,PIK3CB
18126,KEGG_2019_Human,Chagas disease (American trypanosomiasis),1/103,0.0051499318302617,0.0105540458563941,0,0,19897.0,104832.7525292024,PIK3CB
18127,KEGG_2019_Human,Toll-like receptor signaling pathway,1/104,0.0051999314202997,0.0105540458563941,0,0,19896.0,104635.24941415618,PIK3CB
18128,KEGG_2019_Human,C-type lectin receptor signaling pathway,1/104,0.0051999314202997,0.0105540458563941,0,0,19896.0,104635.24941415618,PIK3CB
18129,KEGG_2019_Human,Insulin resistance,1/108,0.0053999298011749,0.0105540458563941,0,0,19892.0,103863.47861844616,PIK3CB
18130,KEGG_2019_Human,TNF signaling pathway,1/110,0.0054999290027479,0.0105540458563941,0,0,19890.0,103488.06969787036,PIK3CB
18131,KEGG_2019_Human,Leukocyte transendothelial migration,1/112,0.0055999282120529,0.0105540458563941,0,0,19888.0,103119.30984392198,PIK3CB
18132,KEGG_2019_Human,Cholinergic synapse,1/112,0.0055999282120529,0.0105540458563941,0,0,19888.0,103119.30984392198,PIK3CB
18133,KEGG_2019_Human,Thyroid hormone signaling pathway,1/116,0.0057999266512085,0.0105540458563941,0,0,19884.0,102400.8105961506,PIK3CB
18134,KEGG_2019_Human,Sphingolipid signaling pathway,1/119,0.0059499254985137,0.0105540458563941,0,0,19881.0,101877.73080211312,PIK3CB
18135,KEGG_2019_Human,Neurotrophin signaling pathway,1/119,0.0059499254985137,0.0105540458563941,0,0,19881.0,101877.73080211312,PIK3CB
18136,KEGG_2019_Human,AMPK signaling pathway,1/120,0.0059999251180858,0.0105540458563941,0,0,19880.0,101706.2448082016,PIK3CB
18137,KEGG_2019_Human,Platelet activation,1/124,0.0061999236097501,0.0105540458563941,0,0,19876.0,101034.04709010696,PIK3CB
18138,KEGG_2019_Human,Osteoclast differentiation,1/127,0.0063499224962247,0.0105540458563941,0,0,19873.0,100543.72072014232,PIK3CB
18139,KEGG_2019_Human,Autophagy,1/128,0.0063999221281459,0.0105540458563941,0,0,19872.0,100382.8010329652,PIK3CB
18140,KEGG_2019_Human,Relaxin signaling pathway,1/130,0.0064999213952527,0.0105540458563941,0,0,19870.0,100064.62842845908,PIK3CB
18141,KEGG_2019_Human,Natural killer cell mediated cytotoxicity,1/131,0.0065499210316603,0.0105540458563941,0,0,19869.0,99907.33811343512,PIK3CB
18142,KEGG_2019_Human,FoxO signaling pathway,1/132,0.0065999206698993,0.0105540458563941,0,0,19868.0,99751.22090491928,PIK3CB
18143,KEGG_2019_Human,Insulin signaling pathway,1/137,0.0068499188797651,0.0105540458563941,0,0,19863.0,98987.62735269018,PIK3CB
18144,KEGG_2019_Human,Estrogen signaling pathway,1/137,0.0068499188797651,0.0105540458563941,0,0,19863.0,98987.62735269018,PIK3CB
18145,KEGG_2019_Human,Measles,1/138,0.0068999185254481,0.0105540458563941,0,0,19862.0,98838.19160389496,PIK3CB
18146,KEGG_2019_Human,Fluid shear stress and atherosclerosis,1/139,0.006949918172816,0.0105540458563941,0,0,19861.0,98689.81333375497,PIK3CB
18147,KEGG_2019_Human,Signaling pathways regulating pluripotency of stem cells,1/139,0.006949918172816,0.0105540458563941,0,0,19861.0,98689.81333375497,PIK3CB
18148,KEGG_2019_Human,Apoptosis,1/143,0.0071499167770442,0.0105540458563941,0,0,19857.0,98106.57763600958,PIK3CB
18149,KEGG_2019_Human,Breast cancer,1/147,0.0073499154017982,0.0105540458563941,0,0,19853.0,97539.10874372096,PIK3CB
18150,KEGG_2019_Human,Phospholipase D signaling pathway,1/148,0.007399915061391,0.0105540458563941,0,0,19852.0,97399.60470052566,PIK3CB
18151,KEGG_2019_Human,Non-alcoholic fatty liver disease (NAFLD),1/149,0.0074499147221605,0.0105540458563941,0,0,19851.0,97261.02051561224,PIK3CB
18152,KEGG_2019_Human,Gastric cancer,1/149,0.0074499147221605,0.0105540458563941,0,0,19851.0,97261.02051561224,PIK3CB
18153,KEGG_2019_Human,mTOR signaling pathway,1/152,0.0075999137114971,0.0105900436963484,0,0,19848.0,96850.665715497,PIK3CB
18154,KEGG_2019_Human,Hepatitis C,1/155,0.0077499127120574,0.0106248803310465,0,0,19845.0,96448.16254952336,PIK3CB
18155,KEGG_2019_Human,Cellular senescence,1/160,0.0079999110688441,0.0106575747433643,0,0,19840.0,95793.96509856998,PIK3CB
18156,KEGG_2019_Human,JAK-STAT signaling pathway,1/162,0.0080999104202618,0.0106575747433643,0,0,19838.0,95537.86936302872,PIK3CB
18157,KEGG_2019_Human,Hepatitis B,1/163,0.0081499100978668,0.0106575747433643,0,0,19837.0,95410.9786681514,PIK3CB
18158,KEGG_2019_Human,Hepatocellular carcinoma,1/168,0.0083999085011095,0.0108180639787016,0,0,19832.0,94787.72752807094,PIK3CB
18159,KEGG_2019_Human,Influenza A,1/171,0.0085499075557634,0.0108468976453715,0,0,19829.0,94422.42241345016,PIK3CB
18160,KEGG_2019_Human,Axon guidance,1/181,0.0090499044707863,0.0113123805884829,0,0,19819.0,93248.41634586031,PIK3CB
18161,KEGG_2019_Human,Kaposi sarcoma-associated herpesvirus infection,1/186,0.0092999029651357,0.0114564022034281,0,0,19814.0,92684.96451050608,PIK3CB
18162,KEGG_2019_Human,Chemokine signaling pathway,1/190,0.0094999017791995,0.0115355950175994,0,0,19810.0,92244.74636351672,PIK3CB
18163,KEGG_2019_Human,Focal adhesion,1/199,0.0099498991610159,0.0115438024319312,0,0,19801.0,91286.4288690606,PIK3CB
18164,KEGG_2019_Human,Viral carcinogenesis,1/201,0.0100498985877989,0.0115438024319312,0,0,19799.0,91079.21596609056,PIK3CB
18165,KEGG_2019_Human,Epstein-Barr virus infection,1/201,0.0100498985877989,0.0115438024319312,0,0,19799.0,91079.21596609056,PIK3CB
18166,KEGG_2019_Human,Proteoglycans in cancer,1/201,0.0100498985877989,0.0115438024319312,0,0,19799.0,91079.21596609056,PIK3CB
18167,KEGG_2019_Human,Rap1 signaling pathway,1/206,0.010299897173561,0.0116601419342253,0,0,19794.0,90569.849337325,PIK3CB
18168,KEGG_2019_Human,Human immunodeficiency virus 1 infection,1/212,0.0105998955026255,0.0116601419342253,0,0,19788.0,89974.27756224656,PIK3CB
18169,KEGG_2019_Human,cAMP signaling pathway,1/212,0.0105998955026255,0.0116601419342253,0,0,19788.0,89974.27756224656,PIK3CB
18170,KEGG_2019_Human,Regulation of actin cytoskeleton,1/214,0.0106998949514067,0.0116601419342253,0,0,19786.0,89779.39753374986,PIK3CB
18171,KEGG_2019_Human,Human T-cell leukemia virus 1 infection,1/219,0.0109498935894162,0.01178153107722,0,0,19781.0,89299.85161916987,PIK3CB
18172,KEGG_2019_Human,Human cytomegalovirus infection,1/225,0.0112498919790339,0.0119530102277235,0,0,19775.0,88738.27077557483,PIK3CB
18173,KEGG_2019_Human,Ras signaling pathway,1/232,0.0115998901349604,0.0121727242156991,0,0,19768.0,88101.22480150245,PIK3CB
18174,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0171035211464876,0,0,19670.0,80733.60565076157,PIK3CB
18175,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0181263653556166,0,0,19646.0,79255.8617626126,PIK3CB
18176,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0248926942055726,0,0,19508.0,72277.44006442746,PIK3CB
18177,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,PIK3CB
18178,KEGG_2019_Human,Other types of O-glycan biosynthesis,1/22,0.0010999756574123,0.0010999756574123,0,0,19978.0,136099.47030191717,POGLUT1
18179,KEGG_2019_Human,Prion diseases,1/35,0.0017499663721595,0.0086085845260402,0,0,19965.0,126740.98858805298,IL1B
18180,KEGG_2019_Human,African trypanosomiasis,1/37,0.0018499650702878,0.0086085845260402,0,0,19963.0,125618.9446446357,IL1B
18181,KEGG_2019_Human,Graft-versus-host disease,1/41,0.0020499625466866,0.0086085845260402,0,0,19959.0,123544.88783416104,IL1B
18182,KEGG_2019_Human,Type I diabetes mellitus,1/43,0.0021499613216957,0.0086085845260402,0,0,19957.0,122581.98940490963,IL1B
18183,KEGG_2019_Human,Malaria,1/49,0.0024499577795033,0.0086085845260402,0,0,19951.0,119939.1172087114,IL1B
18184,KEGG_2019_Human,Legionellosis,1/55,0.0027499544131125,0.0086085845260402,0,0,19945.0,117599.1294878737,IL1B
18185,KEGG_2019_Human,Cytosolic DNA-sensing pathway,1/63,0.0031499501598827,0.0086085845260402,0,0,19937.0,114844.46974572667,IL1B
18186,KEGG_2019_Human,Inflammatory bowel disease (IBD),1/65,0.003249949134407,0.0086085845260402,0,0,19935.0,114209.92613860144,IL1B
18187,KEGG_2019_Human,Leishmaniasis,1/74,0.0036999446830449,0.0086085845260402,0,0,19926.0,111574.38983110404,IL1B
18188,KEGG_2019_Human,Pertussis,1/76,0.0037999437281752,0.0086085845260402,0,0,19924.0,111031.8499691117,IL1B
18189,KEGG_2019_Human,Salmonella infection,1/86,0.0042999391173866,0.0086085845260402,0,0,19914.0,108514.46102290176,IL1B
18190,KEGG_2019_Human,Rheumatoid arthritis,1/91,0.0045499369072032,0.0086085845260402,0,0,19909.0,107362.10783923086,IL1B
18191,KEGG_2019_Human,IL-17 signaling pathway,1/93,0.0046499360391879,0.0086085845260402,0,0,19907.0,106918.54242106884,IL1B
18192,KEGG_2019_Human,NF-kappa B signaling pathway,1/95,0.0047499351803394,0.0086085845260402,0,0,19905.0,106484.27183626965,IL1B
18193,KEGG_2019_Human,Amoebiasis,1/96,0.0047999347538706,0.0086085845260402,0,0,19904.0,106270.50039849174,IL1B
18194,KEGG_2019_Human,Hematopoietic cell lineage,1/97,0.0048499343304706,0.0086085845260402,0,0,19903.0,106058.9096435903,IL1B
18195,KEGG_2019_Human,AGE-RAGE signaling pathway in diabetic complications,1/100,0.0049999330710556,0.0086085845260402,0,0,19900.0,105436.78197328727,IL1B
18196,KEGG_2019_Human,Inflammatory mediator regulation of TRP channels,1/100,0.0049999330710556,0.0086085845260402,0,0,19900.0,105436.78197328727,IL1B
18197,KEGG_2019_Human,Chagas disease (American trypanosomiasis),1/103,0.0051499318302617,0.0086085845260402,0,0,19897.0,104832.7525292024,IL1B
18198,KEGG_2019_Human,Toll-like receptor signaling pathway,1/104,0.0051999314202997,0.0086085845260402,0,0,19896.0,104635.24941415618,IL1B
18199,KEGG_2019_Human,C-type lectin receptor signaling pathway,1/104,0.0051999314202997,0.0086085845260402,0,0,19896.0,104635.24941415618,IL1B
18200,KEGG_2019_Human,Th17 cell differentiation,1/107,0.0053499302026925,0.0086085845260402,0,0,19893.0,104053.753408911,IL1B
18201,KEGG_2019_Human,TNF signaling pathway,1/110,0.0054999290027479,0.0086085845260402,0,0,19890.0,103488.06969787036,IL1B
18202,KEGG_2019_Human,Osteoclast differentiation,1/127,0.0063499224962247,0.0095248837443371,0,0,19873.0,100543.72072014232,IL1B
18203,KEGG_2019_Human,Measles,1/138,0.0068999185254481,0.0096229636238991,0,0,19862.0,98838.19160389496,IL1B
18204,KEGG_2019_Human,Fluid shear stress and atherosclerosis,1/139,0.006949918172816,0.0096229636238991,0,0,19861.0,98689.81333375497,IL1B
18205,KEGG_2019_Human,Non-alcoholic fatty liver disease (NAFLD),1/149,0.0074499147221605,0.0099332196295474,0,0,19851.0,97261.02051561224,IL1B
18206,KEGG_2019_Human,Necroptosis,1/162,0.0080999104202618,0.0100686432150631,0,0,19838.0,95537.86936302872,IL1B
18207,KEGG_2019_Human,Influenza A,1/171,0.0085499075557634,0.0100686432150631,0,0,19829.0,94422.42241345016,IL1B
18208,KEGG_2019_Human,Alzheimer disease,1/171,0.0085499075557634,0.0100686432150631,0,0,19829.0,94422.42241345016,IL1B
18209,KEGG_2019_Human,NOD-like receptor signaling pathway,1/178,0.0088999053857096,0.0100686432150631,0,0,19822.0,93593.82745769851,IL1B
18210,KEGG_2019_Human,Tuberculosis,1/179,0.0089499050800561,0.0100686432150631,0,0,19821.0,93478.0629355712,IL1B
18211,KEGG_2019_Human,Human cytomegalovirus infection,1/225,0.0112498919790339,0.0122726094316733,0,0,19775.0,88738.27077557483,IL1B
18212,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0151712999523264,0,0,19706.0,83157.67014793828,IL1B
18213,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0151712999523264,0,0,19705.0,83086.53988020132,IL1B
18214,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,IL1B
18215,KEGG_2019_Human,Progesterone-mediated oocyte maturation,1/99,0.0049499334884068,0.0093748848560622,0,0,19901.0,105642.09305076736,MOS
18216,KEGG_2019_Human,Oocyte meiosis,1/125,0.0062499232373748,0.0093748848560622,0,0,19875.0,100869.32368441945,MOS
18217,KEGG_2019_Human,Regulation of actin cytoskeleton,1/214,0.0106998949514067,0.0106998949514067,0,0,19786.0,89779.39753374986,MOS
18218,KEGG_2019_Human,Oxidative phosphorylation,1/133,0.0066499203093911,0.0115498903940656,0,0,19867.0,99596.2591544721,ATP5F1B
18219,KEGG_2019_Human,Parkinson disease,1/142,0.0070999171242726,0.0115498903940656,0,0,19858.0,98250.87390500787,ATP5F1B
18220,KEGG_2019_Human,Alzheimer disease,1/171,0.0085499075557634,0.0115498903940656,0,0,19829.0,94422.42241345016,ATP5F1B
18221,KEGG_2019_Human,Huntington disease,1/193,0.0096499008972596,0.0115498903940656,0,0,19807.0,91920.47679471428,ATP5F1B
18222,KEGG_2019_Human,Thermogenesis,1/231,0.0115498903940656,0.0115498903940656,0,0,19769.0,88191.07730937863,ATP5F1B
18223,KEGG_2019_Human,Glycerophospholipid metabolism,1/97,0.0048499343304706,0.0048499343304706,0,0,19903.0,106058.9096435903,PTDSS2
18224,KEGG_2019_Human,Ribosome,1/153,0.0076499133771537,0.0076499133771537,0,0,19847.0,96715.6407630817,RPL6
18225,KEGG_2019_Human,Ferroptosis,1/40,0.0019999631680592,0.0024499577795033,0,0,19960.0,124043.94523066044,SAT1
18226,KEGG_2019_Human,Arginine and proline metabolism,1/49,0.0024499577795033,0.0024499577795033,0,0,19951.0,119939.1172087114,SAT1
18227,KEGG_2019_Human,Non-alcoholic fatty liver disease (NAFLD),1/149,0.0074499147221605,0.0082499094553477,0,0,19851.0,97261.02051561224,XBP1
18228,KEGG_2019_Human,Protein processing in endoplasmic reticulum,1/165,0.0082499094553477,0.0082499094553477,0,0,19835.0,95159.46482222488,XBP1
18229,KEGG_2019_Human,Long-term potentiation,1/67,0.0033499481224912,0.0103598810859474,0,0,19933.0,113594.38808369274,RAPGEF3
18230,KEGG_2019_Human,Leukocyte transendothelial migration,1/112,0.0055999282120529,0.0103598810859474,0,0,19888.0,103119.30984392198,RAPGEF3
18231,KEGG_2019_Human,Serotonergic synapse,1/113,0.0056499278191151,0.0103598810859474,0,0,19887.0,102937.34947211576,RAPGEF3
18232,KEGG_2019_Human,Adrenergic signaling in cardiomyocytes,1/145,0.0072499160871101,0.0103598810859474,0,0,19855.0,97820.92670675044,RAPGEF3
18233,KEGG_2019_Human,Phospholipase D signaling pathway,1/148,0.007399915061391,0.0103598810859474,0,0,19852.0,97399.60470052566,RAPGEF3
18234,KEGG_2019_Human,Rap1 signaling pathway,1/206,0.010299897173561,0.0105998955026255,0,0,19794.0,90569.849337325,RAPGEF3
18235,KEGG_2019_Human,cAMP signaling pathway,1/212,0.0105998955026255,0.0105998955026255,0,0,19788.0,89974.27756224656,RAPGEF3
18236,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,GPR50
18237,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0147498749536506,0,0,19705.0,83086.53988020132,PTPN7
18238,KEGG_2019_Human,Thyroid cancer,1/37,0.0018499650702878,0.0068713258399407,0,0,19963.0,125618.9446446357,CDH1
18239,KEGG_2019_Human,Bladder cancer,1/41,0.0020499625466866,0.0068713258399407,0,0,19959.0,123544.88783416104,CDH1
18240,KEGG_2019_Human,Pathogenic Escherichia coli infection,1/55,0.0027499544131125,0.0068713258399407,0,0,19945.0,117599.1294878737,CDH1
18241,KEGG_2019_Human,Endometrial cancer,1/58,0.0028999527887707,0.0068713258399407,0,0,19942.0,116522.31890946148,CDH1
18242,KEGG_2019_Human,Adherens junction,1/72,0.0035999456502131,0.0068713258399407,0,0,19928.0,112131.59838572376,CDH1
18243,KEGG_2019_Human,Melanoma,1/72,0.0035999456502131,0.0068713258399407,0,0,19928.0,112131.59838572376,CDH1
18244,KEGG_2019_Human,Bacterial invasion of epithelial cells,1/74,0.0036999446830449,0.0068713258399407,0,0,19926.0,111574.38983110404,CDH1
18245,KEGG_2019_Human,Apelin signaling pathway,1/137,0.0068499188797651,0.0094544403540885,0,0,19863.0,98987.62735269018,CDH1
18246,KEGG_2019_Human,Cell adhesion molecules (CAMs),1/145,0.0072499160871101,0.0094544403540885,0,0,19855.0,97820.92670675044,CDH1
18247,KEGG_2019_Human,Gastric cancer,1/149,0.0074499147221605,0.0094544403540885,0,0,19851.0,97261.02051561224,CDH1
18248,KEGG_2019_Human,Hippo signaling pathway,1/160,0.0079999110688441,0.0094544403540885,0,0,19840.0,95793.96509856998,CDH1
18249,KEGG_2019_Human,Rap1 signaling pathway,1/206,0.010299897173561,0.0111582219380244,0,0,19794.0,90569.849337325,CDH1
18250,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,CDH1
18251,KEGG_2019_Human,Ribosome,1/153,0.0076499133771537,0.0076499133771537,0,0,19847.0,96715.6407630817,RPS21
18252,KEGG_2019_Human,Glycosaminoglycan biosynthesis,1/53,0.0026499555173137,0.0026499555173137,0,0,19947.0,118349.78824235698,HS6ST1
18253,KEGG_2019_Human,Legionellosis,1/55,0.0027499544131125,0.0099748921483906,0,0,19945.0,117599.1294878737,CASP7
18254,KEGG_2019_Human,Pertussis,1/76,0.0037999437281752,0.0099748921483906,0,0,19924.0,111031.8499691117,CASP7
18255,KEGG_2019_Human,TNF signaling pathway,1/110,0.0054999290027479,0.0099748921483906,0,0,19890.0,103488.06969787036,CASP7
18256,KEGG_2019_Human,Apoptosis,1/143,0.0071499167770442,0.0099748921483906,0,0,19857.0,98106.57763600958,CASP7
18257,KEGG_2019_Human,Non-alcoholic fatty liver disease (NAFLD),1/149,0.0074499147221605,0.0099748921483906,0,0,19851.0,97261.02051561224,CASP7
18258,KEGG_2019_Human,Alzheimer disease,1/171,0.0085499075557634,0.0099748921483906,0,0,19829.0,94422.42241345016,CASP7
18259,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,CASP7
18260,KEGG_2019_Human,Prion diseases,1/35,0.0017499663721595,0.0079498959114788,0,0,19965.0,126740.98858805298,EGR1
18261,KEGG_2019_Human,GnRH signaling pathway,1/93,0.0046499360391879,0.0079498959114788,0,0,19907.0,106918.54242106884,EGR1
18262,KEGG_2019_Human,AGE-RAGE signaling pathway in diabetic complications,1/100,0.0049999330710556,0.0079498959114788,0,0,19900.0,105436.78197328727,EGR1
18263,KEGG_2019_Human,"Parathyroid hormone synthesis, secretion and action",1/106,0.0052999306076525,0.0079498959114788,0,0,19894.0,104245.78450366124,EGR1
18264,KEGG_2019_Human,Apelin signaling pathway,1/137,0.0068499188797651,0.0082199026557181,0,0,19863.0,98987.62735269018,EGR1
18265,KEGG_2019_Human,Human T-cell leukemia virus 1 infection,1/219,0.0109498935894162,0.0109498935894162,0,0,19781.0,89299.85161916987,EGR1
18266,KEGG_2019_Human,Citrate cycle (TCA cycle),1/30,0.0014999697593334,0.0029249456933262,0,0,19970.0,129851.13732048514,DLAT
18267,KEGG_2019_Human,Pyruvate metabolism,1/39,0.0019499637955508,0.0029249456933262,0,0,19961.0,124555.53162481484,DLAT
18268,KEGG_2019_Human,Glycolysis / Gluconeogenesis,1/68,0.0033999476216189,0.0033999476216189,0,0,19932.0,113293.39338050144,DLAT
18269,KEGG_2019_Human,Peroxisome,1/83,0.0041499404726918,0.0041499404726918,0,0,19917.0,109237.99888847338,PEX5
18270,KEGG_2019_Human,Glyoxylate and dicarboxylate metabolism,1/30,0.0014999697593334,0.00239995257067,0,0,19970.0,129851.13732048514,MCEE
18271,KEGG_2019_Human,Propanoate metabolism,1/32,0.0015999683804467,0.00239995257067,0,0,19968.0,128549.41955786056,MCEE
18272,KEGG_2019_Human,"Valine, leucine and isoleucine degradation",1/48,0.0023999583567988,0.0023999583567988,0,0,19952.0,120356.5272753826,MCEE
18273,KEGG_2019_Human,Leukocyte transendothelial migration,1/112,0.0055999282120529,0.0084999078692823,0,0,19888.0,103119.30984392198,CLDN16
18274,KEGG_2019_Human,Cell adhesion molecules (CAMs),1/145,0.0072499160871101,0.0084999078692823,0,0,19855.0,97820.92670675044,CLDN16
18275,KEGG_2019_Human,Hepatitis C,1/155,0.0077499127120574,0.0084999078692823,0,0,19845.0,96448.16254952336,CLDN16
18276,KEGG_2019_Human,Tight junction,1/170,0.0084999078692823,0.0084999078692823,0,0,19830.0,94543.49009679438,CLDN16
18277,KEGG_2019_Human,Spliceosome,1/134,0.0066999199497742,0.0133998398995484,0,0,19866.0,99442.43560916925,SRSF4
18278,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,SRSF4
18279,KEGG_2019_Human,Chemokine signaling pathway,1/190,0.0094999017791995,0.0146998751759735,0,0,19810.0,92244.74636351672,CCL14
18280,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0146998751759735,0,0,19706.0,83157.67014793828,CCL14
18281,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF529
18282,KEGG_2019_Human,Base excision repair,1/33,0.0016499677032113,0.0016499677032113,0,0,19967.0,127928.56031580272,APEX1
18283,KEGG_2019_Human,Nicotinate and nicotinamide metabolism,1/30,0.0014999697593334,0.0044999092780004,0,0,19970.0,129851.13732048514,BST1
18284,KEGG_2019_Human,Salivary secretion,1/90,0.0044999373439762,0.0048999339081079,0,0,19910.0,107587.50385474482,BST1
18285,KEGG_2019_Human,Pancreatic secretion,1/98,0.0048999339081079,0.0048999339081079,0,0,19902.0,105849.45495286948,BST1
18286,KEGG_2019_Human,Ribosome,1/153,0.0076499133771537,0.0076499133771537,0,0,19847.0,96715.6407630817,MRPL28
18287,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR7A10
18288,KEGG_2019_Human,Thyroid hormone synthesis,1/74,0.0036999446830449,0.0036999446830449,0,0,19926.0,111574.38983110404,SLC26A4
18289,KEGG_2019_Human,Type I diabetes mellitus,1/43,0.0021499613216957,0.0021499613216957,0,0,19957.0,122581.98940490963,ICA1
18290,KEGG_2019_Human,Histidine metabolism,1/23,0.0011499748819949,0.0033549463201819,0,0,19977.0,135204.63922267244,ALDH9A1
18291,KEGG_2019_Human,Ascorbate and aldarate metabolism,1/27,0.0013499718942362,0.0033549463201819,0,0,19973.0,131975.02298599784,ALDH9A1
18292,KEGG_2019_Human,beta-Alanine metabolism,1/31,0.0015499690656704,0.0033549463201819,0,0,19969.0,129189.85098816035,ALDH9A1
18293,KEGG_2019_Human,Pyruvate metabolism,1/39,0.0019499637955508,0.0033549463201819,0,0,19961.0,124555.53162481484,ALDH9A1
18294,KEGG_2019_Human,Tryptophan metabolism,1/42,0.0020999619311272,0.0033549463201819,0,0,19958.0,123057.75613441122,ALDH9A1
18295,KEGG_2019_Human,Fatty acid degradation,1/44,0.0021999607179423,0.0033549463201819,0,0,19956.0,122117.06559109331,ALDH9A1
18296,KEGG_2019_Human,"Valine, leucine and isoleucine degradation",1/48,0.0023999583567988,0.0033549463201819,0,0,19952.0,120356.5272753826,ALDH9A1
18297,KEGG_2019_Human,Arginine and proline metabolism,1/49,0.0024499577795033,0.0033549463201819,0,0,19951.0,119939.1172087114,ALDH9A1
18298,KEGG_2019_Human,Lysine degradation,1/59,0.0029499522555206,0.0033549463201819,0,0,19941.0,116175.59385530632,ALDH9A1
18299,KEGG_2019_Human,Glycerolipid metabolism,1/61,0.0030499512001654,0.0033549463201819,0,0,19939.0,115499.24335773686,ALDH9A1
18300,KEGG_2019_Human,Glycolysis / Gluconeogenesis,1/68,0.0033999476216189,0.0033999476216189,0,0,19932.0,113293.39338050144,ALDH9A1
18301,KEGG_2019_Human,Cocaine addiction,1/49,0.0024499577795033,0.0154665201799472,0,0,19951.0,119939.1172087114,BDNF
18302,KEGG_2019_Human,Neurotrophin signaling pathway,1/119,0.0059499254985137,0.0154665201799472,0,0,19881.0,101877.73080211312,BDNF
18303,KEGG_2019_Human,Alcoholism,1/180,0.0089999047745351,0.0154665201799472,0,0,19820.0,93362.92821536642,BDNF
18304,KEGG_2019_Human,Huntington disease,1/193,0.0096499008972596,0.0154665201799472,0,0,19807.0,91920.47679471428,BDNF
18305,KEGG_2019_Human,cAMP signaling pathway,1/212,0.0105998955026255,0.0154665201799472,0,0,19788.0,89974.27756224656,BDNF
18306,KEGG_2019_Human,Ras signaling pathway,1/232,0.0115998901349604,0.0154665201799472,0,0,19768.0,88101.22480150245,BDNF
18307,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0168569999470293,0,0,19705.0,83086.53988020132,BDNF
18308,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0176998626413668,0,0,19646.0,79255.8617626126,BDNF
18309,KEGG_2019_Human,Arachidonic acid metabolism,1/63,0.0031499501598827,0.0031499501598827,0,0,19937.0,114844.46974572667,PTGES3
18310,KEGG_2019_Human,Pentose phosphate pathway,1/30,0.0014999697593334,0.0049499031096341,0,0,19970.0,129851.13732048514,PFKL
18311,KEGG_2019_Human,Galactose metabolism,1/31,0.0015499690656704,0.0049499031096341,0,0,19969.0,129189.85098816035,PFKL
18312,KEGG_2019_Human,Fructose and mannose metabolism,1/33,0.0016499677032113,0.0049499031096341,0,0,19967.0,127928.56031580272,PFKL
18313,KEGG_2019_Human,Central carbon metabolism in cancer,1/65,0.003249949134407,0.0057936733090444,0,0,19935.0,114209.92613860144,PFKL
18314,KEGG_2019_Human,Glycolysis / Gluconeogenesis,1/68,0.0033999476216189,0.0057936733090444,0,0,19932.0,113293.39338050144,PFKL
18315,KEGG_2019_Human,RNA degradation,1/79,0.0039499423167337,0.0057936733090444,0,0,19921.0,110243.89578070649,PFKL
18316,KEGG_2019_Human,HIF-1 signaling pathway,1/100,0.0049999330710556,0.0057936733090444,0,0,19900.0,105436.78197328727,PFKL
18317,KEGG_2019_Human,Glucagon signaling pathway,1/103,0.0051499318302617,0.0057936733090444,0,0,19897.0,104832.7525292024,PFKL
18318,KEGG_2019_Human,AMPK signaling pathway,1/120,0.0059999251180858,0.0059999251180858,0,0,19880.0,101706.2448082016,PFKL
18319,KEGG_2019_Human,Cell adhesion molecules (CAMs),1/145,0.0072499160871101,0.0100498985877989,0,0,19855.0,97820.92670675044,CD58
18320,KEGG_2019_Human,Epstein-Barr virus infection,1/201,0.0100498985877989,0.0100498985877989,0,0,19799.0,91079.21596609056,CD58
18321,KEGG_2019_Human,Thermogenesis,1/231,0.0115498903940656,0.0115498903940656,0,0,19769.0,88191.07730937863,NDUFAF1
18322,KEGG_2019_Human,Cushing syndrome,1/155,0.0077499127120574,0.0092999029651357,0,0,19845.0,96448.16254952336,MEN1
18323,KEGG_2019_Human,Transcriptional misregulation in cancer,1/186,0.0092999029651357,0.0092999029651357,0,0,19814.0,92684.96451050608,MEN1
18324,KEGG_2019_Human,Biosynthesis of unsaturated fatty acids,1/27,0.0013499718942362,0.0020249578413544,0,0,19973.0,131975.02298599784,ACOT2
18325,KEGG_2019_Human,Fatty acid elongation,1/27,0.0013499718942362,0.0020249578413544,0,0,19973.0,131975.02298599784,ACOT2
18326,KEGG_2019_Human,Ovarian steroidogenesis,1/49,0.0024499577795033,0.0024499577795033,0,0,19951.0,119939.1172087114,ACOT2
18327,KEGG_2019_Human,mRNA surveillance pathway,1/91,0.0045499369072032,0.0045499369072032,0,0,19909.0,107362.10783923086,DAZAP1
18328,KEGG_2019_Human,Amyotrophic lateral sclerosis (ALS),1/51,0.0025499566390179,0.0121656667115461,0,0,19949.0,119129.0228601236,CYCS
18329,KEGG_2019_Human,Legionellosis,1/55,0.0027499544131125,0.0121656667115461,0,0,19945.0,117599.1294878737,CYCS
18330,KEGG_2019_Human,Viral myocarditis,1/59,0.0029499522555206,0.0121656667115461,0,0,19941.0,116175.59385530632,CYCS
18331,KEGG_2019_Human,p53 signaling pathway,1/72,0.0035999456502131,0.0121656667115461,0,0,19928.0,112131.59838572376,CYCS
18332,KEGG_2019_Human,Colorectal cancer,1/86,0.0042999391173866,0.0121656667115461,0,0,19914.0,108514.46102290176,CYCS
18333,KEGG_2019_Human,Small cell lung cancer,1/93,0.0046499360391879,0.0121656667115461,0,0,19907.0,106918.54242106884,CYCS
18334,KEGG_2019_Human,Toxoplasmosis,1/113,0.0056499278191151,0.0121656667115461,0,0,19887.0,102937.34947211576,CYCS
18335,KEGG_2019_Human,Measles,1/138,0.0068999185254481,0.0121656667115461,0,0,19862.0,98838.19160389496,CYCS
18336,KEGG_2019_Human,Parkinson disease,1/142,0.0070999171242726,0.0121656667115461,0,0,19858.0,98250.87390500787,CYCS
18337,KEGG_2019_Human,Apoptosis,1/143,0.0071499167770442,0.0121656667115461,0,0,19857.0,98106.57763600958,CYCS
18338,KEGG_2019_Human,Non-alcoholic fatty liver disease (NAFLD),1/149,0.0074499147221605,0.0121656667115461,0,0,19851.0,97261.02051561224,CYCS
18339,KEGG_2019_Human,Hepatitis C,1/155,0.0077499127120574,0.0121656667115461,0,0,19845.0,96448.16254952336,CYCS
18340,KEGG_2019_Human,Hepatitis B,1/163,0.0081499100978668,0.0121656667115461,0,0,19837.0,95410.9786681514,CYCS
18341,KEGG_2019_Human,Influenza A,1/171,0.0085499075557634,0.0121656667115461,0,0,19829.0,94422.42241345016,CYCS
18342,KEGG_2019_Human,Alzheimer disease,1/171,0.0085499075557634,0.0121656667115461,0,0,19829.0,94422.42241345016,CYCS
18343,KEGG_2019_Human,Tuberculosis,1/179,0.0089499050800561,0.0121656667115461,0,0,19821.0,93478.0629355712,CYCS
18344,KEGG_2019_Human,Kaposi sarcoma-associated herpesvirus infection,1/186,0.0092999029651357,0.0121656667115461,0,0,19814.0,92684.96451050608,CYCS
18345,KEGG_2019_Human,Huntington disease,1/193,0.0096499008972596,0.0121656667115461,0,0,19807.0,91920.47679471428,CYCS
18346,KEGG_2019_Human,Epstein-Barr virus infection,1/201,0.0100498985877989,0.0121656667115461,0,0,19799.0,91079.21596609056,CYCS
18347,KEGG_2019_Human,Human immunodeficiency virus 1 infection,1/212,0.0105998955026255,0.0121898798280194,0,0,19788.0,89974.27756224656,CYCS
18348,KEGG_2019_Human,Human cytomegalovirus infection,1/225,0.0112498919790339,0.0123213102627514,0,0,19775.0,88738.27077557483,CYCS
18349,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0257180134786985,0,0,19508.0,72277.44006442746,CYCS
18350,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,CYCS
18351,KEGG_2019_Human,Apelin signaling pathway,1/137,0.0068499188797651,0.0079999110688441,0,0,19863.0,98987.62735269018,CCN2
18352,KEGG_2019_Human,Hippo signaling pathway,1/160,0.0079999110688441,0.0079999110688441,0,0,19840.0,95793.96509856998,CCN2
18353,KEGG_2019_Human,Histidine metabolism,1/23,0.0011499748819949,0.0017499663721595,0,0,19977.0,135204.63922267244,ASPA
18354,KEGG_2019_Human,"Alanine, aspartate and glutamate metabolism",1/35,0.0017499663721595,0.0017499663721595,0,0,19965.0,126740.98858805298,ASPA
18355,KEGG_2019_Human,Circadian rhythm,1/31,0.0015499690656704,0.0030999381313408,0,0,19969.0,129189.85098816035,CLOCK
18356,KEGG_2019_Human,Dopaminergic synapse,1/131,0.0065499210316603,0.0065499210316603,0,0,19869.0,99907.33811343512,CLOCK
18357,KEGG_2019_Human,Cellular senescence,1/160,0.0079999110688441,0.0079999110688441,0,0,19840.0,95793.96509856998,RAD9B
18358,KEGG_2019_Human,Endocytosis,1/244,0.0121998870519305,0.0121998870519305,0,0,19756.0,87051.4275316661,PDCD6IP
18359,KEGG_2019_Human,Aminoacyl-tRNA biosynthesis,1/66,0.003299948626608,0.003299948626608,0,0,19934.0,113899.85357353876,QRSL1
18360,KEGG_2019_Human,Endocytosis,1/244,0.0121998870519305,0.0121998870519305,0,0,19756.0,87051.4275316661,WASHC1
18361,KEGG_2019_Human,Glycosaminoglycan biosynthesis,1/53,0.0026499555173137,0.0026499555173137,0,0,19947.0,118349.78824235698,NDST1
18362,KEGG_2019_Human,Tyrosine metabolism,1/36,0.0017999657178272,0.0047832644181221,0,0,19964.0,126172.23364250171,ADH1C
18363,KEGG_2019_Human,Fatty acid degradation,1/44,0.0021999607179423,0.0047832644181221,0,0,19956.0,122117.06559109331,ADH1C
18364,KEGG_2019_Human,Retinol metabolism,1/67,0.0033499481224912,0.0047832644181221,0,0,19933.0,113594.38808369274,ADH1C
18365,KEGG_2019_Human,Glycolysis / Gluconeogenesis,1/68,0.0033999476216189,0.0047832644181221,0,0,19932.0,113293.39338050144,ADH1C
18366,KEGG_2019_Human,Metabolism of xenobiotics by cytochrome P450,1/74,0.0036999446830449,0.0047832644181221,0,0,19926.0,111574.38983110404,ADH1C
18367,KEGG_2019_Human,Chemical carcinogenesis,1/82,0.004099940929819,0.0047832644181221,0,0,19918.0,109484.9180722932,ADH1C
18368,KEGG_2019_Human,Drug metabolism,1/108,0.0053999298011749,0.0053999298011749,0,0,19892.0,103863.47861844616,ADH1C
18369,KEGG_2019_Human,Systemic lupus erythematosus,1/133,0.0066499203093911,0.0066499203093911,0,0,19867.0,99596.2591544721,SSB
18370,KEGG_2019_Human,Malaria,1/49,0.0024499577795033,0.0048499343304706,0,0,19951.0,119939.1172087114,GYPA
18371,KEGG_2019_Human,Hematopoietic cell lineage,1/97,0.0048499343304706,0.0048499343304706,0,0,19903.0,106058.9096435903,GYPA
18372,KEGG_2019_Human,Fluid shear stress and atherosclerosis,1/139,0.006949918172816,0.0082499094553477,0,0,19861.0,98689.81333375497,SUMO1
18373,KEGG_2019_Human,RNA transport,1/165,0.0082499094553477,0.0082499094553477,0,0,19835.0,95159.46482222488,SUMO1
18374,KEGG_2019_Human,NOD-like receptor signaling pathway,1/178,0.0088999053857096,0.0088999053857096,0,0,19822.0,93593.82745769851,GBP1
18375,KEGG_2019_Human,Ribosome,1/153,0.0076499133771537,0.0076499133771537,0,0,19847.0,96715.6407630817,RPL36A
18376,KEGG_2019_Human,Inflammatory bowel disease (IBD),1/65,0.003249949134407,0.0106998604053851,0,0,19935.0,114209.92613860144,IL21
18377,KEGG_2019_Human,Th17 cell differentiation,1/107,0.0053499302026925,0.0106998604053851,0,0,19893.0,104053.753408911,IL21
18378,KEGG_2019_Human,JAK-STAT signaling pathway,1/162,0.0080999104202618,0.0107998805603491,0,0,19838.0,95537.86936302872,IL21
18379,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0146998751759735,0,0,19706.0,83157.67014793828,IL21
18380,KEGG_2019_Human,Notch signaling pathway,1/48,0.0023999583567988,0.0047999167135976,0,0,19952.0,120356.5272753826,NCSTN
18381,KEGG_2019_Human,Alzheimer disease,1/171,0.0085499075557634,0.0085499075557634,0,0,19829.0,94422.42241345016,NCSTN
18382,KEGG_2019_Human,PPAR signaling pathway,1/74,0.0036999446830449,0.0036999446830449,0,0,19926.0,111574.38983110404,FABP7
18383,KEGG_2019_Human,Pathogenic Escherichia coli infection,1/55,0.0027499544131125,0.0067332435395738,0,0,19945.0,117599.1294878737,NCK1
18384,KEGG_2019_Human,ErbB signaling pathway,1/85,0.004249939567045,0.0067332435395738,0,0,19915.0,108752.83801948265,NCK1
18385,KEGG_2019_Human,T cell receptor signaling pathway,1/101,0.0050499326546803,0.0067332435395738,0,0,19899.0,105233.48101229242,NCK1
18386,KEGG_2019_Human,Axon guidance,1/181,0.0090499044707863,0.0090499044707863,0,0,19819.0,93248.41634586031,NCK1
18387,KEGG_2019_Human,Ribosome biogenesis in eukaryotes,1/101,0.0050499326546803,0.0050499326546803,0,0,19899.0,105233.48101229242,WDR3
18388,KEGG_2019_Human,Ribosome,1/153,0.0076499133771537,0.0076499133771537,0,0,19847.0,96715.6407630817,UBA52
18389,KEGG_2019_Human,Th17 cell differentiation,1/107,0.0053499302026925,0.0140698580229185,0,0,19893.0,104053.753408911,IL6ST
18390,KEGG_2019_Human,Signaling pathways regulating pluripotency of stem cells,1/139,0.006949918172816,0.0140698580229185,0,0,19861.0,98689.81333375497,IL6ST
18391,KEGG_2019_Human,JAK-STAT signaling pathway,1/162,0.0080999104202618,0.0140698580229185,0,0,19838.0,95537.86936302872,IL6ST
18392,KEGG_2019_Human,Kaposi sarcoma-associated herpesvirus infection,1/186,0.0092999029651357,0.0140698580229185,0,0,19814.0,92684.96451050608,IL6ST
18393,KEGG_2019_Human,Viral carcinogenesis,1/201,0.0100498985877989,0.0140698580229185,0,0,19799.0,91079.21596609056,IL6ST
18394,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.017149854371969,0,0,19706.0,83157.67014793828,IL6ST
18395,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,IL6ST
18396,KEGG_2019_Human,Ribosome,1/153,0.0076499133771537,0.0076499133771537,0,0,19847.0,96715.6407630817,RPL34
18397,KEGG_2019_Human,Ribosome,1/153,0.0076499133771537,0.0076499133771537,0,0,19847.0,96715.6407630817,MRPL20
18398,KEGG_2019_Human,RIG-I-like receptor signaling pathway,1/70,0.0034999466296654,0.0118284317579111,0,0,19930.0,112704.30065625212,TRAF6
18399,KEGG_2019_Human,Leishmaniasis,1/74,0.0036999446830449,0.0118284317579111,0,0,19926.0,111574.38983110404,TRAF6
18400,KEGG_2019_Human,Pertussis,1/76,0.0037999437281752,0.0118284317579111,0,0,19924.0,111031.8499691117,TRAF6
18401,KEGG_2019_Human,IL-17 signaling pathway,1/93,0.0046499360391879,0.0118284317579111,0,0,19907.0,106918.54242106884,TRAF6
18402,KEGG_2019_Human,Small cell lung cancer,1/93,0.0046499360391879,0.0118284317579111,0,0,19907.0,106918.54242106884,TRAF6
18403,KEGG_2019_Human,NF-kappa B signaling pathway,1/95,0.0047499351803394,0.0118284317579111,0,0,19905.0,106484.27183626965,TRAF6
18404,KEGG_2019_Human,Chagas disease (American trypanosomiasis),1/103,0.0051499318302617,0.0118284317579111,0,0,19897.0,104832.7525292024,TRAF6
18405,KEGG_2019_Human,Toll-like receptor signaling pathway,1/104,0.0051999314202997,0.0118284317579111,0,0,19896.0,104635.24941415618,TRAF6
18406,KEGG_2019_Human,Toxoplasmosis,1/113,0.0056499278191151,0.0118284317579111,0,0,19887.0,102937.34947211576,TRAF6
18407,KEGG_2019_Human,Neurotrophin signaling pathway,1/119,0.0059499254985137,0.0118284317579111,0,0,19881.0,101877.73080211312,TRAF6
18408,KEGG_2019_Human,Osteoclast differentiation,1/127,0.0063499224962247,0.0118284317579111,0,0,19873.0,100543.72072014232,TRAF6
18409,KEGG_2019_Human,Autophagy,1/128,0.0063999221281459,0.0118284317579111,0,0,19872.0,100382.8010329652,TRAF6
18410,KEGG_2019_Human,Ubiquitin mediated proteolysis,1/137,0.0068499188797651,0.0118284317579111,0,0,19863.0,98987.62735269018,TRAF6
18411,KEGG_2019_Human,Measles,1/138,0.0068999185254481,0.0118284317579111,0,0,19862.0,98838.19160389496,TRAF6
18412,KEGG_2019_Human,Hepatitis C,1/155,0.0077499127120574,0.0119332067734082,0,0,19845.0,96448.16254952336,TRAF6
18413,KEGG_2019_Human,Hepatitis B,1/163,0.0081499100978668,0.0119332067734082,0,0,19837.0,95410.9786681514,TRAF6
18414,KEGG_2019_Human,NOD-like receptor signaling pathway,1/178,0.0088999053857096,0.0119332067734082,0,0,19822.0,93593.82745769851,TRAF6
18415,KEGG_2019_Human,Tuberculosis,1/179,0.0089499050800561,0.0119332067734082,0,0,19821.0,93478.0629355712,TRAF6
18416,KEGG_2019_Human,Epstein-Barr virus infection,1/201,0.0100498985877989,0.0126946087424829,0,0,19799.0,91079.21596609056,TRAF6
18417,KEGG_2019_Human,Human immunodeficiency virus 1 infection,1/212,0.0105998955026255,0.0127198746031507,0,0,19788.0,89974.27756224656,TRAF6
18418,KEGG_2019_Human,Endocytosis,1/244,0.0121998870519305,0.0139427280593492,0,0,19756.0,87051.4275316661,TRAF6
18419,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0160907726767098,0,0,19705.0,83086.53988020132,TRAF6
18420,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0256693971961301,0,0,19508.0,72277.44006442746,TRAF6
18421,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,TRAF6
18422,KEGG_2019_Human,mRNA surveillance pathway,1/91,0.0045499369072032,0.0045499369072032,0,0,19909.0,107362.10783923086,CPSF6
18423,KEGG_2019_Human,Basal cell carcinoma,1/63,0.0031499501598827,0.0109198810514423,0,0,19937.0,114844.46974572667,WNT1
18424,KEGG_2019_Human,Melanogenesis,1/101,0.0050499326546803,0.0109198810514423,0,0,19899.0,105233.48101229242,WNT1
18425,KEGG_2019_Human,Signaling pathways regulating pluripotency of stem cells,1/139,0.006949918172816,0.0109198810514423,0,0,19861.0,98689.81333375497,WNT1
18426,KEGG_2019_Human,Breast cancer,1/147,0.0073499154017982,0.0109198810514423,0,0,19853.0,97539.10874372096,WNT1
18427,KEGG_2019_Human,Gastric cancer,1/149,0.0074499147221605,0.0109198810514423,0,0,19851.0,97261.02051561224,WNT1
18428,KEGG_2019_Human,mTOR signaling pathway,1/152,0.0075999137114971,0.0109198810514423,0,0,19848.0,96850.665715497,WNT1
18429,KEGG_2019_Human,Cushing syndrome,1/155,0.0077499127120574,0.0109198810514423,0,0,19845.0,96448.16254952336,WNT1
18430,KEGG_2019_Human,Wnt signaling pathway,1/158,0.0078999117225733,0.0109198810514423,0,0,19842.0,96053.2110949472,WNT1
18431,KEGG_2019_Human,Hippo signaling pathway,1/160,0.0079999110688441,0.0109198810514423,0,0,19840.0,95793.96509856998,WNT1
18432,KEGG_2019_Human,Hepatocellular carcinoma,1/168,0.0083999085011095,0.0109198810514423,0,0,19832.0,94787.72752807094,WNT1
18433,KEGG_2019_Human,Proteoglycans in cancer,1/201,0.0100498985877989,0.0118771528764897,0,0,19799.0,91079.21596609056,WNT1
18434,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0178748564138782,0,0,19670.0,80733.60565076157,WNT1
18435,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,WNT1
18436,KEGG_2019_Human,Toxoplasmosis,1/113,0.0056499278191151,0.0140623649737923,0,0,19887.0,102937.34947211576,IL10RB
18437,KEGG_2019_Human,JAK-STAT signaling pathway,1/162,0.0080999104202618,0.0140623649737923,0,0,19838.0,95537.86936302872,IL10RB
18438,KEGG_2019_Human,Tuberculosis,1/179,0.0089499050800561,0.0140623649737923,0,0,19821.0,93478.0629355712,IL10RB
18439,KEGG_2019_Human,Human cytomegalovirus infection,1/225,0.0112498919790339,0.0140623649737923,0,0,19775.0,88738.27077557483,IL10RB
18440,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0146998751759735,0,0,19706.0,83157.67014793828,IL10RB
18441,KEGG_2019_Human,Notch signaling pathway,1/48,0.0023999583567988,0.0023999583567988,0,0,19952.0,120356.5272753826,NUMB
18442,KEGG_2019_Human,Cocaine addiction,1/49,0.0024499577795033,0.0107098658973247,0,0,19951.0,119939.1172087114,NFKB1
18443,KEGG_2019_Human,Legionellosis,1/55,0.0027499544131125,0.0107098658973247,0,0,19945.0,117599.1294878737,NFKB1
18444,KEGG_2019_Human,Cytosolic DNA-sensing pathway,1/63,0.0031499501598827,0.0107098658973247,0,0,19937.0,114844.46974572667,NFKB1
18445,KEGG_2019_Human,Inflammatory bowel disease (IBD),1/65,0.003249949134407,0.0107098658973247,0,0,19935.0,114209.92613860144,NFKB1
18446,KEGG_2019_Human,Shigellosis,1/65,0.003249949134407,0.0107098658973247,0,0,19935.0,114209.92613860144,NFKB1
18447,KEGG_2019_Human,Acute myeloid leukemia,1/66,0.003299948626608,0.0107098658973247,0,0,19934.0,113899.85357353876,NFKB1
18448,KEGG_2019_Human,Epithelial cell signaling in Helicobacter pylori infection,1/68,0.0033999476216189,0.0107098658973247,0,0,19932.0,113293.39338050144,NFKB1
18449,KEGG_2019_Human,Adipocytokine signaling pathway,1/69,0.003449947123837,0.0107098658973247,0,0,19931.0,112996.7391397682,NFKB1
18450,KEGG_2019_Human,Prolactin signaling pathway,1/70,0.0034999466296654,0.0107098658973247,0,0,19930.0,112704.30065625212,NFKB1
18451,KEGG_2019_Human,RIG-I-like receptor signaling pathway,1/70,0.0034999466296654,0.0107098658973247,0,0,19930.0,112704.30065625212,NFKB1
18452,KEGG_2019_Human,B cell receptor signaling pathway,1/71,0.0035499461386618,0.0107098658973247,0,0,19929.0,112415.9585341616,NFKB1
18453,KEGG_2019_Human,Leishmaniasis,1/74,0.0036999446830449,0.0107098658973247,0,0,19926.0,111574.38983110404,NFKB1
18454,KEGG_2019_Human,Pancreatic cancer,1/75,0.0037499442041125,0.0107098658973247,0,0,19925.0,111301.33528642564,NFKB1
18455,KEGG_2019_Human,Chronic myeloid leukemia,1/76,0.0037999437281752,0.0107098658973247,0,0,19924.0,111031.8499691117,NFKB1
18456,KEGG_2019_Human,Pertussis,1/76,0.0037999437281752,0.0107098658973247,0,0,19924.0,111031.8499691117,NFKB1
18457,KEGG_2019_Human,Salmonella infection,1/86,0.0042999391173866,0.0107098658973247,0,0,19914.0,108514.46102290176,NFKB1
18458,KEGG_2019_Human,Th1 and Th2 cell differentiation,1/92,0.0045999364719865,0.0107098658973247,0,0,19908.0,107139.13814408927,NFKB1
18459,KEGG_2019_Human,IL-17 signaling pathway,1/93,0.0046499360391879,0.0107098658973247,0,0,19907.0,106918.54242106884,NFKB1
18460,KEGG_2019_Human,Small cell lung cancer,1/93,0.0046499360391879,0.0107098658973247,0,0,19907.0,106918.54242106884,NFKB1
18461,KEGG_2019_Human,NF-kappa B signaling pathway,1/95,0.0047499351803394,0.0107098658973247,0,0,19905.0,106484.27183626965,NFKB1
18462,KEGG_2019_Human,Amoebiasis,1/96,0.0047999347538706,0.0107098658973247,0,0,19904.0,106270.50039849174,NFKB1
18463,KEGG_2019_Human,Prostate cancer,1/97,0.0048499343304706,0.0107098658973247,0,0,19903.0,106058.9096435903,NFKB1
18464,KEGG_2019_Human,AGE-RAGE signaling pathway in diabetic complications,1/100,0.0049999330710556,0.0107098658973247,0,0,19900.0,105436.78197328727,NFKB1
18465,KEGG_2019_Human,HIF-1 signaling pathway,1/100,0.0049999330710556,0.0107098658973247,0,0,19900.0,105436.78197328727,NFKB1
18466,KEGG_2019_Human,T cell receptor signaling pathway,1/101,0.0050499326546803,0.0107098658973247,0,0,19899.0,105233.48101229242,NFKB1
18467,KEGG_2019_Human,Longevity regulating pathway,1/102,0.0050999322416682,0.0107098658973247,0,0,19898.0,105032.15064717118,NFKB1
18468,KEGG_2019_Human,Chagas disease (American trypanosomiasis),1/103,0.0051499318302617,0.0107098658973247,0,0,19897.0,104832.7525292024,NFKB1
18469,KEGG_2019_Human,Toll-like receptor signaling pathway,1/104,0.0051999314202997,0.0107098658973247,0,0,19896.0,104635.24941415618,NFKB1
18470,KEGG_2019_Human,C-type lectin receptor signaling pathway,1/104,0.0051999314202997,0.0107098658973247,0,0,19896.0,104635.24941415618,NFKB1
18471,KEGG_2019_Human,Th17 cell differentiation,1/107,0.0053499302026925,0.0107098658973247,0,0,19893.0,104053.753408911,NFKB1
18472,KEGG_2019_Human,Insulin resistance,1/108,0.0053999298011749,0.0107098658973247,0,0,19892.0,103863.47861844616,NFKB1
18473,KEGG_2019_Human,TNF signaling pathway,1/110,0.0054999290027479,0.0107098658973247,0,0,19890.0,103488.06969787036,NFKB1
18474,KEGG_2019_Human,Toxoplasmosis,1/113,0.0056499278191151,0.0107098658973247,0,0,19887.0,102937.34947211576,NFKB1
18475,KEGG_2019_Human,Sphingolipid signaling pathway,1/119,0.0059499254985137,0.0107098658973247,0,0,19881.0,101877.73080211312,NFKB1
18476,KEGG_2019_Human,Neurotrophin signaling pathway,1/119,0.0059499254985137,0.0107098658973247,0,0,19881.0,101877.73080211312,NFKB1
18477,KEGG_2019_Human,Osteoclast differentiation,1/127,0.0063499224962247,0.011067433727052,0,0,19873.0,100543.72072014232,NFKB1
18478,KEGG_2019_Human,Relaxin signaling pathway,1/130,0.0064999213952527,0.011067433727052,0,0,19870.0,100064.62842845908,NFKB1
18479,KEGG_2019_Human,Measles,1/138,0.0068999185254481,0.0112267908945489,0,0,19862.0,98838.19160389496,NFKB1
18480,KEGG_2019_Human,Fluid shear stress and atherosclerosis,1/139,0.006949918172816,0.0112267908945489,0,0,19861.0,98689.81333375497,NFKB1
18481,KEGG_2019_Human,Apoptosis,1/143,0.0071499167770442,0.0112611189238446,0,0,19857.0,98106.57763600958,NFKB1
18482,KEGG_2019_Human,Non-alcoholic fatty liver disease (NAFLD),1/149,0.0074499147221605,0.0114474299389296,0,0,19851.0,97261.02051561224,NFKB1
18483,KEGG_2019_Human,Hepatitis C,1/155,0.0077499127120574,0.0116248690680862,0,0,19845.0,96448.16254952336,NFKB1
18484,KEGG_2019_Human,Cellular senescence,1/160,0.0079999110688441,0.0116691894583093,0,0,19840.0,95793.96509856998,NFKB1
18485,KEGG_2019_Human,Hepatitis B,1/163,0.0081499100978668,0.0116691894583093,0,0,19837.0,95410.9786681514,NFKB1
18486,KEGG_2019_Human,Influenza A,1/171,0.0085499075557634,0.0119570180980317,0,0,19829.0,94422.42241345016,NFKB1
18487,KEGG_2019_Human,NOD-like receptor signaling pathway,1/178,0.0088999053857096,0.0119570180980317,0,0,19822.0,93593.82745769851,NFKB1
18488,KEGG_2019_Human,Tuberculosis,1/179,0.0089499050800561,0.0119570180980317,0,0,19821.0,93478.0629355712,NFKB1
18489,KEGG_2019_Human,Kaposi sarcoma-associated herpesvirus infection,1/186,0.0092999029651357,0.0119570180980317,0,0,19814.0,92684.96451050608,NFKB1
18490,KEGG_2019_Human,Transcriptional misregulation in cancer,1/186,0.0092999029651357,0.0119570180980317,0,0,19814.0,92684.96451050608,NFKB1
18491,KEGG_2019_Human,Chemokine signaling pathway,1/190,0.0094999017791995,0.0119698762417914,0,0,19810.0,92244.74636351672,NFKB1
18492,KEGG_2019_Human,Viral carcinogenesis,1/201,0.0100498985877989,0.0121758386736795,0,0,19799.0,91079.21596609056,NFKB1
18493,KEGG_2019_Human,Epstein-Barr virus infection,1/201,0.0100498985877989,0.0121758386736795,0,0,19799.0,91079.21596609056,NFKB1
18494,KEGG_2019_Human,Human immunodeficiency virus 1 infection,1/212,0.0105998955026255,0.0123665447530631,0,0,19788.0,89974.27756224656,NFKB1
18495,KEGG_2019_Human,cAMP signaling pathway,1/212,0.0105998955026255,0.0123665447530631,0,0,19788.0,89974.27756224656,NFKB1
18496,KEGG_2019_Human,Human T-cell leukemia virus 1 infection,1/219,0.0109498935894162,0.0125426053842404,0,0,19781.0,89299.85161916987,NFKB1
18497,KEGG_2019_Human,Human cytomegalovirus infection,1/225,0.0112498919790339,0.0126561284764131,0,0,19775.0,88738.27077557483,NFKB1
18498,KEGG_2019_Human,Ras signaling pathway,1/232,0.0115998901349604,0.0128209312017983,0,0,19768.0,88101.22480150245,NFKB1
18499,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0159634248512583,0,0,19705.0,83086.53988020132,NFKB1
18500,KEGG_2019_Human,MicroRNAs in cancer,1/299,0.0149498740670514,0.0159634248512583,0,0,19701.0,82804.33538735632,NFKB1
18501,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0173248608319127,0,0,19670.0,80733.60565076157,NFKB1
18502,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0182801860066576,0,0,19646.0,79255.8617626126,NFKB1
18503,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0249966105760702,0,0,19508.0,72277.44006442746,NFKB1
18504,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,NFKB1
18505,KEGG_2019_Human,Synthesis and degradation of ketone bodies,1/10,0.0004999862257578379,0.0023332852888329,0,0,19990.0,151942.5908680334,HMGCS2
18506,KEGG_2019_Human,Terpenoid backbone biosynthesis,1/22,0.0010999756574123,0.0023332852888329,0,0,19978.0,136099.47030191717,HMGCS2
18507,KEGG_2019_Human,Butanoate metabolism,1/28,0.0013999711732997,0.0023332852888329,0,0,19972.0,131242.0761597353,HMGCS2
18508,KEGG_2019_Human,"Valine, leucine and isoleucine degradation",1/48,0.0023999583567988,0.0029999479459985,0,0,19952.0,120356.5272753826,HMGCS2
18509,KEGG_2019_Human,PPAR signaling pathway,1/74,0.0036999446830449,0.0036999446830449,0,0,19926.0,111574.38983110404,HMGCS2
18510,KEGG_2019_Human,MicroRNAs in cancer,1/299,0.0149498740670514,0.0149498740670514,0,0,19701.0,82804.33538735632,MIR124-2
18511,KEGG_2019_Human,Vibrio cholerae infection,1/50,0.0024999572069037,0.0100686432150631,0,0,19950.0,119530.05920663515,ATP6AP1
18512,KEGG_2019_Human,Epithelial cell signaling in Helicobacter pylori infection,1/68,0.0033999476216189,0.0100686432150631,0,0,19932.0,113293.39338050144,ATP6AP1
18513,KEGG_2019_Human,Rheumatoid arthritis,1/91,0.0045499369072032,0.0100686432150631,0,0,19909.0,107362.10783923086,ATP6AP1
18514,KEGG_2019_Human,Lysosome,1/123,0.0061499239842961,0.0100686432150631,0,0,19877.0,101200.07933676826,ATP6AP1
18515,KEGG_2019_Human,Oxidative phosphorylation,1/133,0.0066499203093911,0.0100686432150631,0,0,19867.0,99596.2591544721,ATP6AP1
18516,KEGG_2019_Human,Phagosome,1/152,0.0075999137114971,0.0100686432150631,0,0,19848.0,96850.665715497,ATP6AP1
18517,KEGG_2019_Human,Hepatitis B,1/163,0.0081499100978668,0.0100686432150631,0,0,19837.0,95410.9786681514,ATP6AP1
18518,KEGG_2019_Human,Tuberculosis,1/179,0.0089499050800561,0.0100686432150631,0,0,19821.0,93478.0629355712,ATP6AP1
18519,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0164998674589645,0,0,19670.0,80733.60565076157,ATP6AP1
18520,KEGG_2019_Human,Sulfur metabolism,1/9,0.0004499872571388355,0.0004499872571388355,0,0,19991.0,154056.46923976458,SUOX
18521,KEGG_2019_Human,Amino sugar and nucleotide sugar metabolism,1/48,0.0023999583567988,0.0023999583567988,0,0,19952.0,120356.5272753826,UAP1L1
18522,KEGG_2019_Human,Protein processing in endoplasmic reticulum,1/165,0.0082499094553477,0.0082499094553477,0,0,19835.0,95159.46482222488,ATXN3
18523,KEGG_2019_Human,Glucagon signaling pathway,1/103,0.0051499318302617,0.009399902370135,0,0,19897.0,104832.7525292024,PHKG2
18524,KEGG_2019_Human,Insulin signaling pathway,1/137,0.0068499188797651,0.009399902370135,0,0,19863.0,98987.62735269018,PHKG2
18525,KEGG_2019_Human,Calcium signaling pathway,1/188,0.009399902370135,0.009399902370135,0,0,19812.0,92463.712994847,PHKG2
18526,KEGG_2019_Human,Cell cycle,1/124,0.0061999236097501,0.0061999236097501,0,0,19876.0,101034.04709010696,CDC45
18527,KEGG_2019_Human,Ribosome,1/153,0.0076499133771537,0.0076499133771537,0,0,19847.0,96715.6407630817,RPS7
18528,KEGG_2019_Human,Melanoma,1/72,0.0035999456502131,0.0173998352024406,0,0,19928.0,112131.59838572376,FGF20
18529,KEGG_2019_Human,Breast cancer,1/147,0.0073499154017982,0.0173998352024406,0,0,19853.0,97539.10874372096,FGF20
18530,KEGG_2019_Human,Gastric cancer,1/149,0.0074499147221605,0.0173998352024406,0,0,19851.0,97261.02051561224,FGF20
18531,KEGG_2019_Human,Rap1 signaling pathway,1/206,0.010299897173561,0.0173998352024406,0,0,19794.0,90569.849337325,FGF20
18532,KEGG_2019_Human,Regulation of actin cytoskeleton,1/214,0.0106998949514067,0.0173998352024406,0,0,19786.0,89779.39753374986,FGF20
18533,KEGG_2019_Human,Ras signaling pathway,1/232,0.0115998901349604,0.0173998352024406,0,0,19768.0,88101.22480150245,FGF20
18534,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.018964124940408,0,0,19705.0,83086.53988020132,FGF20
18535,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0199123454715377,0,0,19646.0,79255.8617626126,FGF20
18536,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,FGF20
18537,KEGG_2019_Human,Cocaine addiction,1/49,0.0024499577795033,0.0118419799664935,0,0,19951.0,119939.1172087114,ATF2
18538,KEGG_2019_Human,Cortisol synthesis and secretion,1/65,0.003249949134407,0.0118419799664935,0,0,19935.0,114209.92613860144,ATF2
18539,KEGG_2019_Human,Amphetamine addiction,1/68,0.0033999476216189,0.0118419799664935,0,0,19932.0,113293.39338050144,ATF2
18540,KEGG_2019_Human,Thyroid hormone synthesis,1/74,0.0036999446830449,0.0118419799664935,0,0,19926.0,111574.38983110404,ATF2
18541,KEGG_2019_Human,Insulin secretion,1/86,0.0042999391173866,0.0118419799664935,0,0,19914.0,108514.46102290176,ATF2
18542,KEGG_2019_Human,Aldosterone synthesis and secretion,1/98,0.0048999339081079,0.0118419799664935,0,0,19902.0,105849.45495286948,ATF2
18543,KEGG_2019_Human,Longevity regulating pathway,1/102,0.0050999322416682,0.0118419799664935,0,0,19898.0,105032.15064717118,ATF2
18544,KEGG_2019_Human,Glucagon signaling pathway,1/103,0.0051499318302617,0.0118419799664935,0,0,19897.0,104832.7525292024,ATF2
18545,KEGG_2019_Human,"Parathyroid hormone synthesis, secretion and action",1/106,0.0052999306076525,0.0118419799664935,0,0,19894.0,104245.78450366124,ATF2
18546,KEGG_2019_Human,TNF signaling pathway,1/110,0.0054999290027479,0.0118419799664935,0,0,19890.0,103488.06969787036,ATF2
18547,KEGG_2019_Human,Relaxin signaling pathway,1/130,0.0064999213952527,0.0118419799664935,0,0,19870.0,100064.62842845908,ATF2
18548,KEGG_2019_Human,Dopaminergic synapse,1/131,0.0065499210316603,0.0118419799664935,0,0,19869.0,99907.33811343512,ATF2
18549,KEGG_2019_Human,Estrogen signaling pathway,1/137,0.0068499188797651,0.0118419799664935,0,0,19863.0,98987.62735269018,ATF2
18550,KEGG_2019_Human,Adrenergic signaling in cardiomyocytes,1/145,0.0072499160871101,0.0118419799664935,0,0,19855.0,97820.92670675044,ATF2
18551,KEGG_2019_Human,Cushing syndrome,1/155,0.0077499127120574,0.0118419799664935,0,0,19845.0,96448.16254952336,ATF2
18552,KEGG_2019_Human,Hepatitis B,1/163,0.0081499100978668,0.0118419799664935,0,0,19837.0,95410.9786681514,ATF2
18553,KEGG_2019_Human,cGMP-PKG signaling pathway,1/166,0.0082999091363732,0.0118419799664935,0,0,19834.0,95034.82345515196,ATF2
18554,KEGG_2019_Human,Influenza A,1/171,0.0085499075557634,0.0118419799664935,0,0,19829.0,94422.42241345016,ATF2
18555,KEGG_2019_Human,Alcoholism,1/180,0.0089999047745351,0.0118419799664935,0,0,19820.0,93362.92821536642,ATF2
18556,KEGG_2019_Human,Viral carcinogenesis,1/201,0.0100498985877989,0.0125542286892017,0,0,19799.0,91079.21596609056,ATF2
18557,KEGG_2019_Human,Human T-cell leukemia virus 1 infection,1/219,0.0109498935894162,0.0125542286892017,0,0,19781.0,89299.85161916987,ATF2
18558,KEGG_2019_Human,Human cytomegalovirus infection,1/225,0.0112498919790339,0.0125542286892017,0,0,19775.0,88738.27077557483,ATF2
18559,KEGG_2019_Human,Thermogenesis,1/231,0.0115498903940656,0.0125542286892017,0,0,19769.0,88191.07730937863,ATF2
18560,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0153644530767194,0,0,19705.0,83086.53988020132,ATF2
18561,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0176998626413668,0,0,19646.0,79255.8617626126,ATF2
18562,KEGG_2019_Human,Long-term potentiation,1/67,0.0033499481224912,0.0125271492303756,0,0,19933.0,113594.38808369274,RAP1B
18563,KEGG_2019_Human,Renal cell carcinoma,1/69,0.003449947123837,0.0125271492303756,0,0,19931.0,112996.7391397682,RAP1B
18564,KEGG_2019_Human,Pancreatic secretion,1/98,0.0048999339081079,0.0125271492303756,0,0,19902.0,105849.45495286948,RAP1B
18565,KEGG_2019_Human,Leukocyte transendothelial migration,1/112,0.0055999282120529,0.0125271492303756,0,0,19888.0,103119.30984392198,RAP1B
18566,KEGG_2019_Human,Neurotrophin signaling pathway,1/119,0.0059499254985137,0.0125271492303756,0,0,19881.0,101877.73080211312,RAP1B
18567,KEGG_2019_Human,Platelet activation,1/124,0.0061999236097501,0.0125271492303756,0,0,19876.0,101034.04709010696,RAP1B
18568,KEGG_2019_Human,Cushing syndrome,1/155,0.0077499127120574,0.0125271492303756,0,0,19845.0,96448.16254952336,RAP1B
18569,KEGG_2019_Human,Chemokine signaling pathway,1/190,0.0094999017791995,0.0125271492303756,0,0,19810.0,92244.74636351672,RAP1B
18570,KEGG_2019_Human,Focal adhesion,1/199,0.0099498991610159,0.0125271492303756,0,0,19801.0,91286.4288690606,RAP1B
18571,KEGG_2019_Human,Rap1 signaling pathway,1/206,0.010299897173561,0.0125271492303756,0,0,19794.0,90569.849337325,RAP1B
18572,KEGG_2019_Human,cAMP signaling pathway,1/212,0.0105998955026255,0.0125271492303756,0,0,19788.0,89974.27756224656,RAP1B
18573,KEGG_2019_Human,Ras signaling pathway,1/232,0.0115998901349604,0.0125665476462071,0,0,19768.0,88101.22480150245,RAP1B
18574,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0147498749536506,0,0,19705.0,83086.53988020132,RAP1B
18575,KEGG_2019_Human,Vascular smooth muscle contraction,1/132,0.0065999206698993,0.0084999078692823,0,0,19868.0,99751.22090491928,MYL6
18576,KEGG_2019_Human,Oxytocin signaling pathway,1/153,0.0076499133771537,0.0084999078692823,0,0,19847.0,96715.6407630817,MYL6
18577,KEGG_2019_Human,Tight junction,1/170,0.0084999078692823,0.0084999078692823,0,0,19830.0,94543.49009679438,MYL6
18578,KEGG_2019_Human,Drug metabolism,1/108,0.0053999298011749,0.0053999298011749,0,0,19892.0,103863.47861844616,CES1
18579,KEGG_2019_Human,RNA transport,1/165,0.0082499094553477,0.0082499094553477,0,0,19835.0,95159.46482222488,TRNT1
18580,KEGG_2019_Human,Long-term depression,1/60,0.002999951725986,0.0119998069039443,0,0,19940.0,115834.63209072244,CRH
18581,KEGG_2019_Human,Cushing syndrome,1/155,0.0077499127120574,0.0119998730327134,0,0,19845.0,96448.16254952336,CRH
18582,KEGG_2019_Human,Alcoholism,1/180,0.0089999047745351,0.0119998730327134,0,0,19820.0,93362.92821536642,CRH
18583,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,CRH
18584,KEGG_2019_Human,Viral carcinogenesis,1/201,0.0100498985877989,0.0109498935894162,0,0,19799.0,91079.21596609056,VAC14
18585,KEGG_2019_Human,Human T-cell leukemia virus 1 infection,1/219,0.0109498935894162,0.0109498935894162,0,0,19781.0,89299.85161916987,VAC14
18586,KEGG_2019_Human,Ribosome,1/153,0.0076499133771537,0.0076499133771537,0,0,19847.0,96715.6407630817,MRPL10
18587,KEGG_2019_Human,AGE-RAGE signaling pathway in diabetic complications,1/100,0.0049999330710556,0.0185598242159366,0,0,19900.0,105436.78197328727,VEGFD
18588,KEGG_2019_Human,Relaxin signaling pathway,1/130,0.0064999213952527,0.0185598242159366,0,0,19870.0,100064.62842845908,VEGFD
18589,KEGG_2019_Human,Focal adhesion,1/199,0.0099498991610159,0.0185598242159366,0,0,19801.0,91286.4288690606,VEGFD
18590,KEGG_2019_Human,Rap1 signaling pathway,1/206,0.010299897173561,0.0185598242159366,0,0,19794.0,90569.849337325,VEGFD
18591,KEGG_2019_Human,Ras signaling pathway,1/232,0.0115998901349604,0.0185598242159366,0,0,19768.0,88101.22480150245,VEGFD
18592,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0196664999382009,0,0,19705.0,83086.53988020132,VEGFD
18593,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0202284144472764,0,0,19646.0,79255.8617626126,VEGFD
18594,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,VEGFD
18595,KEGG_2019_Human,"Parathyroid hormone synthesis, secretion and action",1/106,0.0052999306076525,0.0052999306076525,0,0,19894.0,104245.78450366124,MMP17
18596,KEGG_2019_Human,Lysine degradation,1/59,0.0029499522555206,0.0058999045110413,0,0,19941.0,116175.59385530632,SETDB1
18597,KEGG_2019_Human,Signaling pathways regulating pluripotency of stem cells,1/139,0.006949918172816,0.006949918172816,0,0,19861.0,98689.81333375497,SETDB1
18598,KEGG_2019_Human,Cell cycle,1/124,0.0061999236097501,0.0061999236097501,0,0,19876.0,101034.04709010696,ORC3
18599,KEGG_2019_Human,Endocytosis,1/244,0.0121998870519305,0.0121998870519305,0,0,19756.0,87051.4275316661,MVB12B
18600,KEGG_2019_Human,Ribosome biogenesis in eukaryotes,1/101,0.0050499326546803,0.0082499094553477,0,0,19899.0,105233.48101229242,SNORD3B-2
18601,KEGG_2019_Human,RNA transport,1/165,0.0082499094553477,0.0082499094553477,0,0,19835.0,95159.46482222488,SNORD3B-2
18602,KEGG_2019_Human,"Glycine, serine and threonine metabolism",1/40,0.0019999631680592,0.0023499589392381,0,0,19960.0,124043.94523066044,SDSL
18603,KEGG_2019_Human,Cysteine and methionine metabolism,1/47,0.0023499589392381,0.0023499589392381,0,0,19953.0,120782.64067395544,SDSL
18604,KEGG_2019_Human,Antigen processing and presentation,1/77,0.0038499432547502,0.0065499210316603,0,0,19923.0,110765.8407373636,KIR2DS4
18605,KEGG_2019_Human,Natural killer cell mediated cytotoxicity,1/131,0.0065499210316603,0.0065499210316603,0,0,19869.0,99907.33811343512,KIR2DS4
18606,KEGG_2019_Human,Complement and coagulation cascades,1/79,0.0039499423167337,0.0039499423167337,0,0,19921.0,110243.89578070649,SERPINB2
18607,KEGG_2019_Human,Pantothenate and CoA biosynthesis,1/19,0.00094997806231055,0.00094997806231055,0,0,19981.0,139049.2109571672,PANK4
18608,KEGG_2019_Human,Fatty acid biosynthesis,1/13,0.0006499833083207112,0.0025999332332828,0,0,19987.0,146675.87616784443,ACSBG2
18609,KEGG_2019_Human,Fatty acid degradation,1/44,0.0021999607179423,0.0036999446830449,0,0,19956.0,122117.06559109331,ACSBG2
18610,KEGG_2019_Human,Adipocytokine signaling pathway,1/69,0.003449947123837,0.0036999446830449,0,0,19931.0,112996.7391397682,ACSBG2
18611,KEGG_2019_Human,PPAR signaling pathway,1/74,0.0036999446830449,0.0036999446830449,0,0,19926.0,111574.38983110404,ACSBG2
18612,KEGG_2019_Human,Endocrine and other factor-regulated calcium reabsorption,1/48,0.0023999583567988,0.0088198810345943,0,0,19952.0,120356.5272753826,ATP2B1
18613,KEGG_2019_Human,Mineral absorption,1/51,0.0025499566390179,0.0088198810345943,0,0,19949.0,119129.0228601236,ATP2B1
18614,KEGG_2019_Human,Salivary secretion,1/90,0.0044999373439762,0.0088198810345943,0,0,19910.0,107587.50385474482,ATP2B1
18615,KEGG_2019_Human,Pancreatic secretion,1/98,0.0048999339081079,0.0088198810345943,0,0,19902.0,105849.45495286948,ATP2B1
18616,KEGG_2019_Human,Aldosterone synthesis and secretion,1/98,0.0048999339081079,0.0088198810345943,0,0,19902.0,105849.45495286948,ATP2B1
18617,KEGG_2019_Human,Adrenergic signaling in cardiomyocytes,1/145,0.0072499160871101,0.0105748901664019,0,0,19855.0,97820.92670675044,ATP2B1
18618,KEGG_2019_Human,cGMP-PKG signaling pathway,1/166,0.0082999091363732,0.0105748901664019,0,0,19834.0,95034.82345515196,ATP2B1
18619,KEGG_2019_Human,Calcium signaling pathway,1/188,0.009399902370135,0.0105748901664019,0,0,19812.0,92463.712994847,ATP2B1
18620,KEGG_2019_Human,cAMP signaling pathway,1/212,0.0105998955026255,0.0105998955026255,0,0,19788.0,89974.27756224656,ATP2B1
18621,KEGG_2019_Human,Staphylococcus aureus infection,1/68,0.0033999476216189,0.0089499050800561,0,0,19932.0,113293.39338050144,CAMP
18622,KEGG_2019_Human,Salivary secretion,1/90,0.0044999373439762,0.0089499050800561,0,0,19910.0,107587.50385474482,CAMP
18623,KEGG_2019_Human,NOD-like receptor signaling pathway,1/178,0.0088999053857096,0.0089499050800561,0,0,19822.0,93593.82745769851,CAMP
18624,KEGG_2019_Human,Tuberculosis,1/179,0.0089499050800561,0.0089499050800561,0,0,19821.0,93478.0629355712,CAMP
18625,KEGG_2019_Human,Oocyte meiosis,1/125,0.0062499232373748,0.0062499232373748,0,0,19875.0,100869.32368441945,FBXO43
18626,KEGG_2019_Human,Vasopressin-regulated water reabsorption,1/44,0.0021999607179423,0.0044499377838098,0,0,19956.0,122117.06559109331,NSF
18627,KEGG_2019_Human,Synaptic vesicle cycle,1/78,0.0038999427840466,0.0044499377838098,0,0,19922.0,110503.2180492851,NSF
18628,KEGG_2019_Human,GABAergic synapse,1/89,0.0044499377838098,0.0044499377838098,0,0,19911.0,107815.380281759,NSF
18629,KEGG_2019_Human,GABAergic synapse,1/89,0.0044499377838098,0.0130498764018304,0,0,19911.0,107815.380281759,GNB4
18630,KEGG_2019_Human,Morphine addiction,1/91,0.0045499369072032,0.0130498764018304,0,0,19909.0,107362.10783923086,GNB4
18631,KEGG_2019_Human,Circadian entrainment,1/97,0.0048499343304706,0.0130498764018304,0,0,19903.0,106058.9096435903,GNB4
18632,KEGG_2019_Human,Cholinergic synapse,1/112,0.0055999282120529,0.0130498764018304,0,0,19888.0,103119.30984392198,GNB4
18633,KEGG_2019_Human,Serotonergic synapse,1/113,0.0056499278191151,0.0130498764018304,0,0,19887.0,102937.34947211576,GNB4
18634,KEGG_2019_Human,Glutamatergic synapse,1/114,0.005699927427839,0.0130498764018304,0,0,19886.0,102756.96431429044,GNB4
18635,KEGG_2019_Human,Relaxin signaling pathway,1/130,0.0064999213952527,0.0130498764018304,0,0,19870.0,100064.62842845908,GNB4
18636,KEGG_2019_Human,Dopaminergic synapse,1/131,0.0065499210316603,0.0130498764018304,0,0,19869.0,99907.33811343512,GNB4
18637,KEGG_2019_Human,Apelin signaling pathway,1/137,0.0068499188797651,0.0130498764018304,0,0,19863.0,98987.62735269018,GNB4
18638,KEGG_2019_Human,Retrograde endocannabinoid signaling,1/148,0.007399915061391,0.0130498764018304,0,0,19852.0,97399.60470052566,GNB4
18639,KEGG_2019_Human,Alcoholism,1/180,0.0089999047745351,0.0130498764018304,0,0,19820.0,93362.92821536642,GNB4
18640,KEGG_2019_Human,Kaposi sarcoma-associated herpesvirus infection,1/186,0.0092999029651357,0.0130498764018304,0,0,19814.0,92684.96451050608,GNB4
18641,KEGG_2019_Human,Chemokine signaling pathway,1/190,0.0094999017791995,0.0130498764018304,0,0,19810.0,92244.74636351672,GNB4
18642,KEGG_2019_Human,Human immunodeficiency virus 1 infection,1/212,0.0105998955026255,0.0130498764018304,0,0,19788.0,89974.27756224656,GNB4
18643,KEGG_2019_Human,Human cytomegalovirus infection,1/225,0.0112498919790339,0.0130498764018304,0,0,19775.0,88738.27077557483,GNB4
18644,KEGG_2019_Human,Ras signaling pathway,1/232,0.0115998901349604,0.0130498764018304,0,0,19768.0,88101.22480150245,GNB4
18645,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0187410310320355,0,0,19646.0,79255.8617626126,GNB4
18646,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,GNB4
18647,KEGG_2019_Human,Other glycan degradation,1/18,0.0008999788927950273,0.00179995778559,0,0,19982.0,140136.54844084635,GBA2
18648,KEGG_2019_Human,Sphingolipid metabolism,1/47,0.0023499589392381,0.0023499589392381,0,0,19953.0,120782.64067395544,GBA2
18649,KEGG_2019_Human,Thyroid hormone synthesis,1/74,0.0036999446830449,0.0036999446830449,0,0,19926.0,111574.38983110404,IYD
18650,KEGG_2019_Human,Longevity regulating pathway,1/102,0.0050999322416682,0.0094998921393714,0,0,19898.0,105032.15064717118,AKT1S1
18651,KEGG_2019_Human,AMPK signaling pathway,1/120,0.0059999251180858,0.0094998921393714,0,0,19880.0,101706.2448082016,AKT1S1
18652,KEGG_2019_Human,Autophagy,1/128,0.0063999221281459,0.0094998921393714,0,0,19872.0,100382.8010329652,AKT1S1
18653,KEGG_2019_Human,mTOR signaling pathway,1/152,0.0075999137114971,0.0094998921393714,0,0,19848.0,96850.665715497,AKT1S1
18654,KEGG_2019_Human,Thermogenesis,1/231,0.0115498903940656,0.0115498903940656,0,0,19769.0,88191.07730937863,AKT1S1
18655,KEGG_2019_Human,C-type lectin receptor signaling pathway,1/104,0.0051999314202997,0.0051999314202997,0,0,19896.0,104635.24941415618,CLEC1B
18656,KEGG_2019_Human,Ubiquitin mediated proteolysis,1/137,0.0068499188797651,0.0070999171242726,0,0,19863.0,98987.62735269018,UBA7
18657,KEGG_2019_Human,Parkinson disease,1/142,0.0070999171242726,0.0070999171242726,0,0,19858.0,98250.87390500787,UBA7
18658,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR4A16
18659,KEGG_2019_Human,Mucin type O-glycan biosynthesis,1/31,0.0015499690656704,0.0015499690656704,0,0,19969.0,129189.85098816035,B4GALT5
18660,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0146998751759735,0,0,19706.0,83157.67014793828,IL1RN
18661,KEGG_2019_Human,Nicotinate and nicotinamide metabolism,1/30,0.0014999697593334,0.0014999697593334,0,0,19970.0,129851.13732048514,NMNAT3
18662,KEGG_2019_Human,Linoleic acid metabolism,1/29,0.001449970461791,0.0056499278191151,0,0,19971.0,130534.69172799008,CYP2C8
18663,KEGG_2019_Human,Arachidonic acid metabolism,1/63,0.0031499501598827,0.0056499278191151,0,0,19937.0,114844.46974572667,CYP2C8
18664,KEGG_2019_Human,Retinol metabolism,1/67,0.0033499481224912,0.0056499278191151,0,0,19933.0,113594.38808369274,CYP2C8
18665,KEGG_2019_Human,Chemical carcinogenesis,1/82,0.004099940929819,0.0056499278191151,0,0,19918.0,109484.9180722932,CYP2C8
18666,KEGG_2019_Human,Drug metabolism,1/108,0.0053999298011749,0.0056499278191151,0,0,19892.0,103863.47861844616,CYP2C8
18667,KEGG_2019_Human,Serotonergic synapse,1/113,0.0056499278191151,0.0056499278191151,0,0,19887.0,102937.34947211576,CYP2C8
18668,KEGG_2019_Human,Hematopoietic cell lineage,1/97,0.0048499343304706,0.0048499343304706,0,0,19903.0,106058.9096435903,MS4A1
18669,KEGG_2019_Human,Inflammatory mediator regulation of TRP channels,1/100,0.0049999330710556,0.0049999330710556,0,0,19900.0,105436.78197328727,ASIC5
18670,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR10A7
18671,KEGG_2019_Human,Wnt signaling pathway,1/158,0.0078999117225733,0.0078999117225733,0,0,19842.0,96053.2110949472,GPC4
18672,KEGG_2019_Human,Lysine degradation,1/59,0.0029499522555206,0.0029499522555206,0,0,19941.0,116175.59385530632,NSD3
18673,KEGG_2019_Human,Endocytosis,1/244,0.0121998870519305,0.0121998870519305,0,0,19756.0,87051.4275316661,RBSN
18674,KEGG_2019_Human,"Alanine, aspartate and glutamate metabolism",1/35,0.0017499663721595,0.0017499663721595,0,0,19965.0,126740.98858805298,RIMKLB
18675,KEGG_2019_Human,Ubiquitin mediated proteolysis,1/137,0.0068499188797651,0.0068499188797651,0,0,19863.0,98987.62735269018,UBE2E3
18676,KEGG_2019_Human,N-Glycan biosynthesis,1/50,0.0024999572069037,0.0024999572069037,0,0,19950.0,119530.05920663515,DPM1
18677,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR2T11
18678,KEGG_2019_Human,Collecting duct acid secretion,1/27,0.0013499718942362,0.0081898864329657,0,0,19973.0,131975.02298599784,ATP6V1C1
18679,KEGG_2019_Human,Vibrio cholerae infection,1/50,0.0024999572069037,0.0081898864329657,0,0,19950.0,119530.05920663515,ATP6V1C1
18680,KEGG_2019_Human,Epithelial cell signaling in Helicobacter pylori infection,1/68,0.0033999476216189,0.0081898864329657,0,0,19932.0,113293.39338050144,ATP6V1C1
18681,KEGG_2019_Human,Synaptic vesicle cycle,1/78,0.0038999427840466,0.0081898864329657,0,0,19922.0,110503.2180492851,ATP6V1C1
18682,KEGG_2019_Human,Rheumatoid arthritis,1/91,0.0045499369072032,0.0081898864329657,0,0,19909.0,107362.10783923086,ATP6V1C1
18683,KEGG_2019_Human,Oxidative phosphorylation,1/133,0.0066499203093911,0.0085499029254342,0,0,19867.0,99596.2591544721,ATP6V1C1
18684,KEGG_2019_Human,mTOR signaling pathway,1/152,0.0075999137114971,0.0085499029254342,0,0,19848.0,96850.665715497,ATP6V1C1
18685,KEGG_2019_Human,Phagosome,1/152,0.0075999137114971,0.0085499029254342,0,0,19848.0,96850.665715497,ATP6V1C1
18686,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0164998674589645,0,0,19670.0,80733.60565076157,ATP6V1C1
18687,KEGG_2019_Human,Ribosome,1/153,0.0076499133771537,0.0076499133771537,0,0,19847.0,96715.6407630817,MRPL17
18688,KEGG_2019_Human,Oxidative phosphorylation,1/133,0.0066499203093911,0.0112582177134695,0,0,19867.0,99596.2591544721,NDUFC1
18689,KEGG_2019_Human,Parkinson disease,1/142,0.0070999171242726,0.0112582177134695,0,0,19858.0,98250.87390500787,NDUFC1
18690,KEGG_2019_Human,Retrograde endocannabinoid signaling,1/148,0.007399915061391,0.0112582177134695,0,0,19852.0,97399.60470052566,NDUFC1
18691,KEGG_2019_Human,Non-alcoholic fatty liver disease (NAFLD),1/149,0.0074499147221605,0.0112582177134695,0,0,19851.0,97261.02051561224,NDUFC1
18692,KEGG_2019_Human,Alzheimer disease,1/171,0.0085499075557634,0.0112582177134695,0,0,19829.0,94422.42241345016,NDUFC1
18693,KEGG_2019_Human,Huntington disease,1/193,0.0096499008972596,0.0112582177134695,0,0,19807.0,91920.47679471428,NDUFC1
18694,KEGG_2019_Human,Thermogenesis,1/231,0.0115498903940656,0.0115498903940656,0,0,19769.0,88191.07730937863,NDUFC1
18695,KEGG_2019_Human,TGF-beta signaling pathway,1/90,0.0044999373439762,0.0125623732347487,0,0,19910.0,107587.50385474482,RBL1
18696,KEGG_2019_Human,Cell cycle,1/124,0.0061999236097501,0.0125623732347487,0,0,19876.0,101034.04709010696,RBL1
18697,KEGG_2019_Human,Cellular senescence,1/160,0.0079999110688441,0.0125623732347487,0,0,19840.0,95793.96509856998,RBL1
18698,KEGG_2019_Human,Viral carcinogenesis,1/201,0.0100498985877989,0.0125623732347487,0,0,19799.0,91079.21596609056,RBL1
18699,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0164998674589645,0,0,19670.0,80733.60565076157,RBL1
18700,KEGG_2019_Human,Fanconi anemia pathway,1/54,0.0026999549628563,0.0026999549628563,0,0,19946.0,117971.01964061816,POLH
18701,KEGG_2019_Human,Inositol phosphate metabolism,1/74,0.0036999446830449,0.0049499334884068,0,0,19926.0,111574.38983110404,PIK3C2A
18702,KEGG_2019_Human,Phosphatidylinositol signaling system,1/99,0.0049499334884068,0.0049499334884068,0,0,19901.0,105642.09305076736,PIK3C2A
18703,KEGG_2019_Human,Peroxisome,1/83,0.0041499404726918,0.0041499404726918,0,0,19917.0,109237.99888847338,PEX7
18704,KEGG_2019_Human,GABAergic synapse,1/89,0.0044499377838098,0.0130498764018304,0,0,19911.0,107815.380281759,GNB5
18705,KEGG_2019_Human,Morphine addiction,1/91,0.0045499369072032,0.0130498764018304,0,0,19909.0,107362.10783923086,GNB5
18706,KEGG_2019_Human,Circadian entrainment,1/97,0.0048499343304706,0.0130498764018304,0,0,19903.0,106058.9096435903,GNB5
18707,KEGG_2019_Human,Cholinergic synapse,1/112,0.0055999282120529,0.0130498764018304,0,0,19888.0,103119.30984392198,GNB5
18708,KEGG_2019_Human,Serotonergic synapse,1/113,0.0056499278191151,0.0130498764018304,0,0,19887.0,102937.34947211576,GNB5
18709,KEGG_2019_Human,Glutamatergic synapse,1/114,0.005699927427839,0.0130498764018304,0,0,19886.0,102756.96431429044,GNB5
18710,KEGG_2019_Human,Relaxin signaling pathway,1/130,0.0064999213952527,0.0130498764018304,0,0,19870.0,100064.62842845908,GNB5
18711,KEGG_2019_Human,Dopaminergic synapse,1/131,0.0065499210316603,0.0130498764018304,0,0,19869.0,99907.33811343512,GNB5
18712,KEGG_2019_Human,Apelin signaling pathway,1/137,0.0068499188797651,0.0130498764018304,0,0,19863.0,98987.62735269018,GNB5
18713,KEGG_2019_Human,Retrograde endocannabinoid signaling,1/148,0.007399915061391,0.0130498764018304,0,0,19852.0,97399.60470052566,GNB5
18714,KEGG_2019_Human,Alcoholism,1/180,0.0089999047745351,0.0130498764018304,0,0,19820.0,93362.92821536642,GNB5
18715,KEGG_2019_Human,Kaposi sarcoma-associated herpesvirus infection,1/186,0.0092999029651357,0.0130498764018304,0,0,19814.0,92684.96451050608,GNB5
18716,KEGG_2019_Human,Chemokine signaling pathway,1/190,0.0094999017791995,0.0130498764018304,0,0,19810.0,92244.74636351672,GNB5
18717,KEGG_2019_Human,Human immunodeficiency virus 1 infection,1/212,0.0105998955026255,0.0130498764018304,0,0,19788.0,89974.27756224656,GNB5
18718,KEGG_2019_Human,Human cytomegalovirus infection,1/225,0.0112498919790339,0.0130498764018304,0,0,19775.0,88738.27077557483,GNB5
18719,KEGG_2019_Human,Ras signaling pathway,1/232,0.0115998901349604,0.0130498764018304,0,0,19768.0,88101.22480150245,GNB5
18720,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0187410310320355,0,0,19646.0,79255.8617626126,GNB5
18721,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,GNB5
18722,KEGG_2019_Human,Parkinson disease,1/142,0.0070999171242726,0.0070999171242726,0,0,19858.0,98250.87390500787,PARK7
18723,KEGG_2019_Human,Choline metabolism in cancer,1/99,0.0049499334884068,0.0049499334884068,0,0,19901.0,105642.09305076736,SLC22A4
18724,KEGG_2019_Human,Collecting duct acid secretion,1/27,0.0013499718942362,0.010009861195847,0,0,19973.0,131975.02298599784,ATP6V0D2
18725,KEGG_2019_Human,Vibrio cholerae infection,1/50,0.0024999572069037,0.010009861195847,0,0,19950.0,119530.05920663515,ATP6V0D2
18726,KEGG_2019_Human,Epithelial cell signaling in Helicobacter pylori infection,1/68,0.0033999476216189,0.010009861195847,0,0,19932.0,113293.39338050144,ATP6V0D2
18727,KEGG_2019_Human,Synaptic vesicle cycle,1/78,0.0038999427840466,0.010009861195847,0,0,19922.0,110503.2180492851,ATP6V0D2
18728,KEGG_2019_Human,Rheumatoid arthritis,1/91,0.0045499369072032,0.010009861195847,0,0,19909.0,107362.10783923086,ATP6V0D2
18729,KEGG_2019_Human,Lysosome,1/123,0.0061499239842961,0.0104498747719003,0,0,19877.0,101200.07933676826,ATP6V0D2
18730,KEGG_2019_Human,Oxidative phosphorylation,1/133,0.0066499203093911,0.0104498747719003,0,0,19867.0,99596.2591544721,ATP6V0D2
18731,KEGG_2019_Human,Phagosome,1/152,0.0075999137114971,0.0104498813533085,0,0,19848.0,96850.665715497,ATP6V0D2
18732,KEGG_2019_Human,Tuberculosis,1/179,0.0089499050800561,0.0109387728756241,0,0,19821.0,93478.0629355712,ATP6V0D2
18733,KEGG_2019_Human,Viral carcinogenesis,1/201,0.0100498985877989,0.0110548884465788,0,0,19799.0,91079.21596609056,ATP6V0D2
18734,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0164998674589645,0,0,19670.0,80733.60565076157,ATP6V0D2
18735,KEGG_2019_Human,Spliceosome,1/134,0.0066999199497742,0.0066999199497742,0,0,19866.0,99442.43560916925,SNRPG
18736,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,UCN2
18737,KEGG_2019_Human,Aminoacyl-tRNA biosynthesis,1/66,0.003299948626608,0.003299948626608,0,0,19934.0,113899.85357353876,DARS2
18738,KEGG_2019_Human,Collecting duct acid secretion,1/27,0.0013499718942362,0.0081898864329657,0,0,19973.0,131975.02298599784,ATP6V1G1
18739,KEGG_2019_Human,Vibrio cholerae infection,1/50,0.0024999572069037,0.0081898864329657,0,0,19950.0,119530.05920663515,ATP6V1G1
18740,KEGG_2019_Human,Epithelial cell signaling in Helicobacter pylori infection,1/68,0.0033999476216189,0.0081898864329657,0,0,19932.0,113293.39338050144,ATP6V1G1
18741,KEGG_2019_Human,Synaptic vesicle cycle,1/78,0.0038999427840466,0.0081898864329657,0,0,19922.0,110503.2180492851,ATP6V1G1
18742,KEGG_2019_Human,Rheumatoid arthritis,1/91,0.0045499369072032,0.0081898864329657,0,0,19909.0,107362.10783923086,ATP6V1G1
18743,KEGG_2019_Human,Oxidative phosphorylation,1/133,0.0066499203093911,0.0085499029254342,0,0,19867.0,99596.2591544721,ATP6V1G1
18744,KEGG_2019_Human,mTOR signaling pathway,1/152,0.0075999137114971,0.0085499029254342,0,0,19848.0,96850.665715497,ATP6V1G1
18745,KEGG_2019_Human,Phagosome,1/152,0.0075999137114971,0.0085499029254342,0,0,19848.0,96850.665715497,ATP6V1G1
18746,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0164998674589645,0,0,19670.0,80733.60565076157,ATP6V1G1
18747,KEGG_2019_Human,Propanoate metabolism,1/32,0.0015999683804467,0.0039165982320635,0,0,19968.0,128549.41955786056,LDHAL6B
18748,KEGG_2019_Human,Pyruvate metabolism,1/39,0.0019499637955508,0.0039165982320635,0,0,19961.0,124555.53162481484,LDHAL6B
18749,KEGG_2019_Human,Cysteine and methionine metabolism,1/47,0.0023499589392381,0.0039165982320635,0,0,19953.0,120782.64067395544,LDHAL6B
18750,KEGG_2019_Human,Glycolysis / Gluconeogenesis,1/68,0.0033999476216189,0.0042499345270236,0,0,19932.0,113293.39338050144,LDHAL6B
18751,KEGG_2019_Human,Glucagon signaling pathway,1/103,0.0051499318302617,0.0051499318302617,0,0,19897.0,104832.7525292024,LDHAL6B
18752,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR5M3
18753,KEGG_2019_Human,Wnt signaling pathway,1/158,0.0078999117225733,0.0078999117225733,0,0,19842.0,96053.2110949472,SFRP1
18754,KEGG_2019_Human,Glutathione metabolism,1/56,0.0027999538675741,0.0059999094170218,0,0,19944.0,117233.87022514464,RRM2
18755,KEGG_2019_Human,Pyrimidine metabolism,1/57,0.002849953326298,0.0059999094170218,0,0,19943.0,116875.00742975442,RRM2
18756,KEGG_2019_Human,p53 signaling pathway,1/72,0.0035999456502131,0.0059999094170218,0,0,19928.0,112131.59838572376,RRM2
18757,KEGG_2019_Human,Drug metabolism,1/108,0.0053999298011749,0.006449921761047,0,0,19892.0,103863.47861844616,RRM2
18758,KEGG_2019_Human,Purine metabolism,1/129,0.006449921761047,0.006449921761047,0,0,19871.0,100223.109907462,RRM2
18759,KEGG_2019_Human,MicroRNAs in cancer,1/299,0.0149498740670514,0.0149498740670514,0,0,19701.0,82804.33538735632,MIR520G
18760,KEGG_2019_Human,Proteasome,1/45,0.0022499601197094,0.0044999202394188,0,0,19955.0,121662.49782449217,PSMC2
18761,KEGG_2019_Human,Epstein-Barr virus infection,1/201,0.0100498985877989,0.0100498985877989,0,0,19799.0,91079.21596609056,PSMC2
18762,KEGG_2019_Human,Oxidative phosphorylation,1/133,0.0066499203093911,0.0112582177134695,0,0,19867.0,99596.2591544721,NDUFB6
18763,KEGG_2019_Human,Parkinson disease,1/142,0.0070999171242726,0.0112582177134695,0,0,19858.0,98250.87390500787,NDUFB6
18764,KEGG_2019_Human,Retrograde endocannabinoid signaling,1/148,0.007399915061391,0.0112582177134695,0,0,19852.0,97399.60470052566,NDUFB6
18765,KEGG_2019_Human,Non-alcoholic fatty liver disease (NAFLD),1/149,0.0074499147221605,0.0112582177134695,0,0,19851.0,97261.02051561224,NDUFB6
18766,KEGG_2019_Human,Alzheimer disease,1/171,0.0085499075557634,0.0112582177134695,0,0,19829.0,94422.42241345016,NDUFB6
18767,KEGG_2019_Human,Huntington disease,1/193,0.0096499008972596,0.0112582177134695,0,0,19807.0,91920.47679471428,NDUFB6
18768,KEGG_2019_Human,Thermogenesis,1/231,0.0115498903940656,0.0115498903940656,0,0,19769.0,88191.07730937863,NDUFB6
18769,KEGG_2019_Human,RNA transport,1/165,0.0082499094553477,0.0082499094553477,0,0,19835.0,95159.46482222488,EIF2S3
18770,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0146998751759735,0,0,19706.0,83157.67014793828,IL34
18771,KEGG_2019_Human,Proximal tubule bicarbonate reclamation,1/23,0.0011499748819949,0.0073998893660899,0,0,19977.0,135204.63922267244,PCK2
18772,KEGG_2019_Human,Citrate cycle (TCA cycle),1/30,0.0014999697593334,0.0073998893660899,0,0,19970.0,129851.13732048514,PCK2
18773,KEGG_2019_Human,Pyruvate metabolism,1/39,0.0019499637955508,0.0073998893660899,0,0,19961.0,124555.53162481484,PCK2
18774,KEGG_2019_Human,Glycolysis / Gluconeogenesis,1/68,0.0033999476216189,0.0073998893660899,0,0,19932.0,113293.39338050144,PCK2
18775,KEGG_2019_Human,Adipocytokine signaling pathway,1/69,0.003449947123837,0.0073998893660899,0,0,19931.0,112996.7391397682,PCK2
18776,KEGG_2019_Human,PPAR signaling pathway,1/74,0.0036999446830449,0.0073998893660899,0,0,19926.0,111574.38983110404,PCK2
18777,KEGG_2019_Human,Glucagon signaling pathway,1/103,0.0051499318302617,0.0074726387779256,0,0,19897.0,104832.7525292024,PCK2
18778,KEGG_2019_Human,Insulin resistance,1/108,0.0053999298011749,0.0074726387779256,0,0,19892.0,103863.47861844616,PCK2
18779,KEGG_2019_Human,AMPK signaling pathway,1/120,0.0059999251180858,0.0074726387779256,0,0,19880.0,101706.2448082016,PCK2
18780,KEGG_2019_Human,FoxO signaling pathway,1/132,0.0065999206698993,0.0074726387779256,0,0,19868.0,99751.22090491928,PCK2
18781,KEGG_2019_Human,Insulin signaling pathway,1/137,0.0068499188797651,0.0074726387779256,0,0,19863.0,98987.62735269018,PCK2
18782,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0176998626413668,0,0,19646.0,79255.8617626126,PCK2
18783,KEGG_2019_Human,Mitophagy,1/65,0.003249949134407,0.0125665476462071,0,0,19935.0,114209.92613860144,RRAS
18784,KEGG_2019_Human,C-type lectin receptor signaling pathway,1/104,0.0051999314202997,0.0125665476462071,0,0,19896.0,104635.24941415618,RRAS
18785,KEGG_2019_Human,Autophagy,1/128,0.0063999221281459,0.0125665476462071,0,0,19872.0,100382.8010329652,RRAS
18786,KEGG_2019_Human,Apelin signaling pathway,1/137,0.0068499188797651,0.0125665476462071,0,0,19863.0,98987.62735269018,RRAS
18787,KEGG_2019_Human,Phospholipase D signaling pathway,1/148,0.007399915061391,0.0125665476462071,0,0,19852.0,97399.60470052566,RRAS
18788,KEGG_2019_Human,Cellular senescence,1/160,0.0079999110688441,0.0125665476462071,0,0,19840.0,95793.96509856998,RRAS
18789,KEGG_2019_Human,Axon guidance,1/181,0.0090499044707863,0.0125665476462071,0,0,19819.0,93248.41634586031,RRAS
18790,KEGG_2019_Human,Proteoglycans in cancer,1/201,0.0100498985877989,0.0125665476462071,0,0,19799.0,91079.21596609056,RRAS
18791,KEGG_2019_Human,Rap1 signaling pathway,1/206,0.010299897173561,0.0125665476462071,0,0,19794.0,90569.849337325,RRAS
18792,KEGG_2019_Human,cAMP signaling pathway,1/212,0.0105998955026255,0.0125665476462071,0,0,19788.0,89974.27756224656,RRAS
18793,KEGG_2019_Human,Regulation of actin cytoskeleton,1/214,0.0106998949514067,0.0125665476462071,0,0,19786.0,89779.39753374986,RRAS
18794,KEGG_2019_Human,Ras signaling pathway,1/232,0.0115998901349604,0.0125665476462071,0,0,19768.0,88101.22480150245,RRAS
18795,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0147498749536506,0,0,19705.0,83086.53988020132,RRAS
18796,KEGG_2019_Human,Axon guidance,1/181,0.0090499044707863,0.0090499044707863,0,0,19819.0,93248.41634586031,EPHA4
18797,KEGG_2019_Human,Glutathione metabolism,1/56,0.0027999538675741,0.0094498771520562,0,0,19944.0,117233.87022514464,GSTM4
18798,KEGG_2019_Human,Metabolism of xenobiotics by cytochrome P450,1/74,0.0036999446830449,0.0094498771520562,0,0,19926.0,111574.38983110404,GSTM4
18799,KEGG_2019_Human,Chemical carcinogenesis,1/82,0.004099940929819,0.0094498771520562,0,0,19918.0,109484.9180722932,GSTM4
18800,KEGG_2019_Human,Drug metabolism,1/108,0.0053999298011749,0.0094498771520562,0,0,19892.0,103863.47861844616,GSTM4
18801,KEGG_2019_Human,Fluid shear stress and atherosclerosis,1/139,0.006949918172816,0.0097298854419424,0,0,19861.0,98689.81333375497,GSTM4
18802,KEGG_2019_Human,Hepatocellular carcinoma,1/168,0.0083999085011095,0.0097998932512944,0,0,19832.0,94787.72752807094,GSTM4
18803,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,GSTM4
18804,KEGG_2019_Human,Mismatch repair,1/23,0.0011499748819949,0.0020499625466866,0,0,19977.0,135204.63922267244,SSBP1
18805,KEGG_2019_Human,DNA replication,1/36,0.0017999657178272,0.0020499625466866,0,0,19964.0,126172.23364250171,SSBP1
18806,KEGG_2019_Human,Homologous recombination,1/41,0.0020499625466866,0.0020499625466866,0,0,19959.0,123544.88783416104,SSBP1
18807,KEGG_2019_Human,SNARE interactions in vesicular transport,1/34,0.0016999670339032,0.0016999670339032,0,0,19966.0,127326.1054203148,GOSR1
18808,KEGG_2019_Human,"Glycine, serine and threonine metabolism",1/40,0.0019999631680592,0.0019999631680592,0,0,19960.0,124043.94523066044,SRR
18809,KEGG_2019_Human,Primary immunodeficiency,1/37,0.0018499650702878,0.0089165503378209,0,0,19963.0,125618.9446446357,CD3D
18810,KEGG_2019_Human,Th1 and Th2 cell differentiation,1/92,0.0045999364719865,0.0089165503378209,0,0,19908.0,107139.13814408927,CD3D
18811,KEGG_2019_Human,Hematopoietic cell lineage,1/97,0.0048499343304706,0.0089165503378209,0,0,19903.0,106058.9096435903,CD3D
18812,KEGG_2019_Human,T cell receptor signaling pathway,1/101,0.0050499326546803,0.0089165503378209,0,0,19899.0,105233.48101229242,CD3D
18813,KEGG_2019_Human,Chagas disease (American trypanosomiasis),1/103,0.0051499318302617,0.0089165503378209,0,0,19897.0,104832.7525292024,CD3D
18814,KEGG_2019_Human,Th17 cell differentiation,1/107,0.0053499302026925,0.0089165503378209,0,0,19893.0,104053.753408911,CD3D
18815,KEGG_2019_Human,Measles,1/138,0.0068999185254481,0.0098570264649259,0,0,19862.0,98838.19160389496,CD3D
18816,KEGG_2019_Human,Epstein-Barr virus infection,1/201,0.0100498985877989,0.0109498935894162,0,0,19799.0,91079.21596609056,CD3D
18817,KEGG_2019_Human,Human immunodeficiency virus 1 infection,1/212,0.0105998955026255,0.0109498935894162,0,0,19788.0,89974.27756224656,CD3D
18818,KEGG_2019_Human,Human T-cell leukemia virus 1 infection,1/219,0.0109498935894162,0.0109498935894162,0,0,19781.0,89299.85161916987,CD3D
18819,KEGG_2019_Human,Cell adhesion molecules (CAMs),1/145,0.0072499160871101,0.0072499160871101,0,0,19855.0,97820.92670675044,ALCAM
18820,KEGG_2019_Human,Drug metabolism,1/108,0.0053999298011749,0.006449921761047,0,0,19892.0,103863.47861844616,HPRT1
18821,KEGG_2019_Human,Purine metabolism,1/129,0.006449921761047,0.006449921761047,0,0,19871.0,100223.109907462,HPRT1
18822,KEGG_2019_Human,Alcoholism,1/180,0.0089999047745351,0.0100498985877989,0,0,19820.0,93362.92821536642,HDAC10
18823,KEGG_2019_Human,Viral carcinogenesis,1/201,0.0100498985877989,0.0100498985877989,0,0,19799.0,91079.21596609056,HDAC10
18824,KEGG_2019_Human,RNA transport,1/165,0.0082499094553477,0.0082499094553477,0,0,19835.0,95159.46482222488,AAAS
18825,KEGG_2019_Human,Lysosome,1/123,0.0061499239842961,0.0061499239842961,0,0,19877.0,101200.07933676826,SLC17A5
18826,KEGG_2019_Human,Apoptosis,1/143,0.0071499167770442,0.0099498991610159,0,0,19857.0,98106.57763600958,CAPN2
18827,KEGG_2019_Human,Cellular senescence,1/160,0.0079999110688441,0.0099498991610159,0,0,19840.0,95793.96509856998,CAPN2
18828,KEGG_2019_Human,Necroptosis,1/162,0.0080999104202618,0.0099498991610159,0,0,19838.0,95537.86936302872,CAPN2
18829,KEGG_2019_Human,Protein processing in endoplasmic reticulum,1/165,0.0082499094553477,0.0099498991610159,0,0,19835.0,95159.46482222488,CAPN2
18830,KEGG_2019_Human,Alzheimer disease,1/171,0.0085499075557634,0.0099498991610159,0,0,19829.0,94422.42241345016,CAPN2
18831,KEGG_2019_Human,Focal adhesion,1/199,0.0099498991610159,0.0099498991610159,0,0,19801.0,91286.4288690606,CAPN2
18832,KEGG_2019_Human,Acute myeloid leukemia,1/66,0.003299948626608,0.0115498732374868,0,0,19934.0,113899.85357353876,EIF4EBP1
18833,KEGG_2019_Human,ErbB signaling pathway,1/85,0.004249939567045,0.0115498732374868,0,0,19915.0,108752.83801948265,EIF4EBP1
18834,KEGG_2019_Human,Choline metabolism in cancer,1/99,0.0049499334884068,0.0115498732374868,0,0,19901.0,105642.09305076736,EIF4EBP1
18835,KEGG_2019_Human,HIF-1 signaling pathway,1/100,0.0049999330710556,0.0115498732374868,0,0,19900.0,105436.78197328727,EIF4EBP1
18836,KEGG_2019_Human,Longevity regulating pathway,1/102,0.0050999322416682,0.0115498732374868,0,0,19898.0,105032.15064717118,EIF4EBP1
18837,KEGG_2019_Human,AMPK signaling pathway,1/120,0.0059999251180858,0.0115498732374868,0,0,19880.0,101706.2448082016,EIF4EBP1
18838,KEGG_2019_Human,Insulin signaling pathway,1/137,0.0068499188797651,0.0115498732374868,0,0,19863.0,98987.62735269018,EIF4EBP1
18839,KEGG_2019_Human,mTOR signaling pathway,1/152,0.0075999137114971,0.0115498732374868,0,0,19848.0,96850.665715497,EIF4EBP1
18840,KEGG_2019_Human,Cellular senescence,1/160,0.0079999110688441,0.0115498732374868,0,0,19840.0,95793.96509856998,EIF4EBP1
18841,KEGG_2019_Human,RNA transport,1/165,0.0082499094553477,0.0115498732374868,0,0,19835.0,95159.46482222488,EIF4EBP1
18842,KEGG_2019_Human,Human cytomegalovirus infection,1/225,0.0112498919790339,0.0143180443369522,0,0,19775.0,88738.27077557483,EIF4EBP1
18843,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0190613905368566,0,0,19670.0,80733.60565076157,EIF4EBP1
18844,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0190613905368566,0,0,19646.0,79255.8617626126,EIF4EBP1
18845,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,EIF4EBP1
18846,KEGG_2019_Human,Vitamin digestion and absorption,1/24,0.0011999741185782,0.0011999741185782,0,0,19976.0,134347.69487847842,SLC5A6
18847,KEGG_2019_Human,Glycerophospholipid metabolism,1/97,0.0048499343304706,0.0048499343304706,0,0,19903.0,106058.9096435903,GPD1L
18848,KEGG_2019_Human,beta-Alanine metabolism,1/31,0.0015499690656704,0.0031999367608934,0,0,19969.0,129189.85098816035,ALDH6A1
18849,KEGG_2019_Human,Propanoate metabolism,1/32,0.0015999683804467,0.0031999367608934,0,0,19968.0,128549.41955786056,ALDH6A1
18850,KEGG_2019_Human,"Valine, leucine and isoleucine degradation",1/48,0.0023999583567988,0.0031999444757317,0,0,19952.0,120356.5272753826,ALDH6A1
18851,KEGG_2019_Human,Inositol phosphate metabolism,1/74,0.0036999446830449,0.0036999446830449,0,0,19926.0,111574.38983110404,ALDH6A1
18852,KEGG_2019_Human,Basal transcription factors,1/45,0.0022499601197094,0.0035249384088572,0,0,19955.0,121662.49782449217,GTF2H4
18853,KEGG_2019_Human,Nucleotide excision repair,1/47,0.0023499589392381,0.0035249384088572,0,0,19953.0,120782.64067395544,GTF2H4
18854,KEGG_2019_Human,Viral carcinogenesis,1/201,0.0100498985877989,0.0100498985877989,0,0,19799.0,91079.21596609056,GTF2H4
18855,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF836
18856,KEGG_2019_Human,Fanconi anemia pathway,1/54,0.0026999549628563,0.0026999549628563,0,0,19946.0,117971.01964061816,FANCI
18857,KEGG_2019_Human,SNARE interactions in vesicular transport,1/34,0.0016999670339032,0.0016999670339032,0,0,19966.0,127326.1054203148,BET1
18858,KEGG_2019_Human,Insulin resistance,1/108,0.0053999298011749,0.0053999298011749,0,0,19892.0,103863.47861844616,TRIB3
18859,KEGG_2019_Human,Protein digestion and absorption,1/90,0.0044999373439762,0.0048999339081079,0,0,19910.0,107587.50385474482,CPA1
18860,KEGG_2019_Human,Pancreatic secretion,1/98,0.0048999339081079,0.0048999339081079,0,0,19902.0,105849.45495286948,CPA1
18861,KEGG_2019_Human,Endocytosis,1/244,0.0121998870519305,0.0121998870519305,0,0,19756.0,87051.4275316661,EPS15L1
18862,KEGG_2019_Human,Sphingolipid metabolism,1/47,0.0023499589392381,0.0046999178784763,0,0,19953.0,120782.64067395544,SPTLC1
18863,KEGG_2019_Human,Sphingolipid signaling pathway,1/119,0.0059499254985137,0.0059499254985137,0,0,19881.0,101877.73080211312,SPTLC1
18864,KEGG_2019_Human,Nicotine addiction,1/40,0.0019999631680592,0.007583228178672,0,0,19960.0,124043.94523066044,GABRP
18865,KEGG_2019_Human,GABAergic synapse,1/89,0.0044499377838098,0.007583228178672,0,0,19911.0,107815.380281759,GABRP
18866,KEGG_2019_Human,Morphine addiction,1/91,0.0045499369072032,0.007583228178672,0,0,19909.0,107362.10783923086,GABRP
18867,KEGG_2019_Human,Retrograde endocannabinoid signaling,1/148,0.007399915061391,0.0092498938267387,0,0,19852.0,97399.60470052566,GABRP
18868,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,GABRP
18869,KEGG_2019_Human,Proteasome,1/45,0.0022499601197094,0.0044999202394188,0,0,19955.0,121662.49782449217,PSMD3
18870,KEGG_2019_Human,Epstein-Barr virus infection,1/201,0.0100498985877989,0.0100498985877989,0,0,19799.0,91079.21596609056,PSMD3
18871,KEGG_2019_Human,Biosynthesis of unsaturated fatty acids,1/27,0.0013499718942362,0.0013499718942362,0,0,19973.0,131975.02298599784,ELOVL7
18872,KEGG_2019_Human,Fatty acid elongation,1/27,0.0013499718942362,0.0013499718942362,0,0,19973.0,131975.02298599784,ELOVL7
18873,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF713
18874,KEGG_2019_Human,Basal transcription factors,1/45,0.0022499601197094,0.0035249384088572,0,0,19955.0,121662.49782449217,GTF2H3
18875,KEGG_2019_Human,Nucleotide excision repair,1/47,0.0023499589392381,0.0035249384088572,0,0,19953.0,120782.64067395544,GTF2H3
18876,KEGG_2019_Human,Viral carcinogenesis,1/201,0.0100498985877989,0.0100498985877989,0,0,19799.0,91079.21596609056,GTF2H3
18877,KEGG_2019_Human,Ribosome,1/153,0.0076499133771537,0.0076499133771537,0,0,19847.0,96715.6407630817,RPS27A
18878,KEGG_2019_Human,Taste transduction,1/83,0.0041499404726918,0.0041499404726918,0,0,19917.0,109237.99888847338,TAS2R31
18879,KEGG_2019_Human,Arginine and proline metabolism,1/49,0.0024499577795033,0.0024499577795033,0,0,19951.0,119939.1172087114,CKMT2
18880,KEGG_2019_Human,Mitophagy,1/65,0.003249949134407,0.0064998982688141,0,0,19935.0,114209.92613860144,MFN1
18881,KEGG_2019_Human,NOD-like receptor signaling pathway,1/178,0.0088999053857096,0.0088999053857096,0,0,19822.0,93593.82745769851,MFN1
18882,KEGG_2019_Human,Ribosome biogenesis in eukaryotes,1/101,0.0050499326546803,0.0050499326546803,0,0,19899.0,105233.48101229242,NOP58
18883,KEGG_2019_Human,Butanoate metabolism,1/28,0.0013999711732997,0.0017499663721595,0,0,19972.0,131242.0761597353,ALDH5A1
18884,KEGG_2019_Human,"Alanine, aspartate and glutamate metabolism",1/35,0.0017499663721595,0.0017499663721595,0,0,19965.0,126740.98858805298,ALDH5A1
18885,KEGG_2019_Human,mRNA surveillance pathway,1/91,0.0045499369072032,0.0082499094553477,0,0,19909.0,107362.10783923086,NCBP1
18886,KEGG_2019_Human,Spliceosome,1/134,0.0066999199497742,0.0082499094553477,0,0,19866.0,99442.43560916925,NCBP1
18887,KEGG_2019_Human,RNA transport,1/165,0.0082499094553477,0.0082499094553477,0,0,19835.0,95159.46482222488,NCBP1
18888,KEGG_2019_Human,Mitophagy,1/65,0.003249949134407,0.003249949134407,0,0,19935.0,114209.92613860144,OPTN
18889,KEGG_2019_Human,Protein export,1/23,0.0011499748819949,0.0011499748819949,0,0,19977.0,135204.63922267244,SRP54
18890,KEGG_2019_Human,Galactose metabolism,1/31,0.0015499690656704,0.0023999583567988,0,0,19969.0,129189.85098816035,GALK1
18891,KEGG_2019_Human,Amino sugar and nucleotide sugar metabolism,1/48,0.0023999583567988,0.0023999583567988,0,0,19952.0,120356.5272753826,GALK1
18892,KEGG_2019_Human,B cell receptor signaling pathway,1/71,0.0035499461386618,0.0064999142753747,0,0,19929.0,112415.9585341616,MALT1
18893,KEGG_2019_Human,NF-kappa B signaling pathway,1/95,0.0047499351803394,0.0064999142753747,0,0,19905.0,106484.27183626965,MALT1
18894,KEGG_2019_Human,T cell receptor signaling pathway,1/101,0.0050499326546803,0.0064999142753747,0,0,19899.0,105233.48101229242,MALT1
18895,KEGG_2019_Human,C-type lectin receptor signaling pathway,1/104,0.0051999314202997,0.0064999142753747,0,0,19896.0,104635.24941415618,MALT1
18896,KEGG_2019_Human,Tuberculosis,1/179,0.0089499050800561,0.0089499050800561,0,0,19821.0,93478.0629355712,MALT1
18897,KEGG_2019_Human,Peroxisome,1/83,0.0041499404726918,0.0041499404726918,0,0,19917.0,109237.99888847338,PEX11A
18898,KEGG_2019_Human,Acute myeloid leukemia,1/66,0.003299948626608,0.0098998458798241,0,0,19934.0,113899.85357353876,DUSP6
18899,KEGG_2019_Human,Transcriptional misregulation in cancer,1/186,0.0092999029651357,0.0139498544477036,0,0,19814.0,92684.96451050608,DUSP6
18900,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0147498749536506,0,0,19705.0,83086.53988020132,DUSP6
18901,KEGG_2019_Human,Mucin type O-glycan biosynthesis,1/31,0.0015499690656704,0.0015499690656704,0,0,19969.0,129189.85098816035,GALNT7
18902,KEGG_2019_Human,T cell receptor signaling pathway,1/101,0.0050499326546803,0.0072499160871101,0,0,19899.0,105233.48101229242,PDCD1
18903,KEGG_2019_Human,Cell adhesion molecules (CAMs),1/145,0.0072499160871101,0.0072499160871101,0,0,19855.0,97820.92670675044,PDCD1
18904,KEGG_2019_Human,Malaria,1/49,0.0024499577795033,0.0099320113869332,0,0,19951.0,119939.1172087114,TGFB3
18905,KEGG_2019_Human,Inflammatory bowel disease (IBD),1/65,0.003249949134407,0.0099320113869332,0,0,19935.0,114209.92613860144,TGFB3
18906,KEGG_2019_Human,Renal cell carcinoma,1/69,0.003449947123837,0.0099320113869332,0,0,19931.0,112996.7391397682,TGFB3
18907,KEGG_2019_Human,Leishmaniasis,1/74,0.0036999446830449,0.0099320113869332,0,0,19926.0,111574.38983110404,TGFB3
18908,KEGG_2019_Human,Pancreatic cancer,1/75,0.0037499442041125,0.0099320113869332,0,0,19925.0,111301.33528642564,TGFB3
18909,KEGG_2019_Human,Chronic myeloid leukemia,1/76,0.0037999437281752,0.0099320113869332,0,0,19924.0,111031.8499691117,TGFB3
18910,KEGG_2019_Human,Hypertrophic cardiomyopathy (HCM),1/85,0.004249939567045,0.0099320113869332,0,0,19915.0,108752.83801948265,TGFB3
18911,KEGG_2019_Human,Colorectal cancer,1/86,0.0042999391173866,0.0099320113869332,0,0,19914.0,108514.46102290176,TGFB3
18912,KEGG_2019_Human,TGF-beta signaling pathway,1/90,0.0044999373439762,0.0099320113869332,0,0,19910.0,107587.50385474482,TGFB3
18913,KEGG_2019_Human,Dilated cardiomyopathy (DCM),1/91,0.0045499369072032,0.0099320113869332,0,0,19909.0,107362.10783923086,TGFB3
18914,KEGG_2019_Human,Rheumatoid arthritis,1/91,0.0045499369072032,0.0099320113869332,0,0,19909.0,107362.10783923086,TGFB3
18915,KEGG_2019_Human,Amoebiasis,1/96,0.0047999347538706,0.0099320113869332,0,0,19904.0,106270.50039849174,TGFB3
18916,KEGG_2019_Human,AGE-RAGE signaling pathway in diabetic complications,1/100,0.0049999330710556,0.0099320113869332,0,0,19900.0,105436.78197328727,TGFB3
18917,KEGG_2019_Human,Chagas disease (American trypanosomiasis),1/103,0.0051499318302617,0.0099320113869332,0,0,19897.0,104832.7525292024,TGFB3
18918,KEGG_2019_Human,Toxoplasmosis,1/113,0.0056499278191151,0.0101698700744073,0,0,19887.0,102937.34947211576,TGFB3
18919,KEGG_2019_Human,Cell cycle,1/124,0.0061999236097501,0.010308978614998,0,0,19876.0,101034.04709010696,TGFB3
18920,KEGG_2019_Human,FoxO signaling pathway,1/132,0.0065999206698993,0.010308978614998,0,0,19868.0,99751.22090491928,TGFB3
18921,KEGG_2019_Human,Gastric cancer,1/149,0.0074499147221605,0.010308978614998,0,0,19851.0,97261.02051561224,TGFB3
18922,KEGG_2019_Human,Cellular senescence,1/160,0.0079999110688441,0.010308978614998,0,0,19840.0,95793.96509856998,TGFB3
18923,KEGG_2019_Human,Hippo signaling pathway,1/160,0.0079999110688441,0.010308978614998,0,0,19840.0,95793.96509856998,TGFB3
18924,KEGG_2019_Human,Hepatitis B,1/163,0.0081499100978668,0.010308978614998,0,0,19837.0,95410.9786681514,TGFB3
18925,KEGG_2019_Human,Hepatocellular carcinoma,1/168,0.0083999085011095,0.010308978614998,0,0,19832.0,94787.72752807094,TGFB3
18926,KEGG_2019_Human,Tuberculosis,1/179,0.0089499050800561,0.0105064103113702,0,0,19821.0,93478.0629355712,TGFB3
18927,KEGG_2019_Human,Human T-cell leukemia virus 1 infection,1/219,0.0109498935894162,0.0123186302880933,0,0,19781.0,89299.85161916987,TGFB3
18928,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0153171778364834,0,0,19706.0,83157.67014793828,TGFB3
18929,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0153171778364834,0,0,19705.0,83086.53988020132,TGFB3
18930,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,TGFB3
18931,KEGG_2019_Human,Complement and coagulation cascades,1/79,0.0039499423167337,0.0039499423167337,0,0,19921.0,110243.89578070649,KLKB1
18932,KEGG_2019_Human,RNA degradation,1/79,0.0039499423167337,0.0068249053608048,0,0,19921.0,110243.89578070649,PABPC1
18933,KEGG_2019_Human,mRNA surveillance pathway,1/91,0.0045499369072032,0.0068249053608048,0,0,19909.0,107362.10783923086,PABPC1
18934,KEGG_2019_Human,RNA transport,1/165,0.0082499094553477,0.0082499094553477,0,0,19835.0,95159.46482222488,PABPC1
18935,KEGG_2019_Human,Ubiquitin mediated proteolysis,1/137,0.0068499188797651,0.0068499188797651,0,0,19863.0,98987.62735269018,HERC4
18936,KEGG_2019_Human,Thyroid hormone synthesis,1/74,0.0036999446830449,0.0036999446830449,0,0,19926.0,111574.38983110404,TTF1
18937,KEGG_2019_Human,Vasopressin-regulated water reabsorption,1/44,0.0021999607179423,0.0064499086760799,0,0,19956.0,122117.06559109331,DYNC1I1
18938,KEGG_2019_Human,Salmonella infection,1/86,0.0042999391173866,0.0064499086760799,0,0,19914.0,108514.46102290176,DYNC1I1
18939,KEGG_2019_Human,Phagosome,1/152,0.0075999137114971,0.0075999137114971,0,0,19848.0,96850.665715497,DYNC1I1
18940,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF684
18941,KEGG_2019_Human,Amino sugar and nucleotide sugar metabolism,1/48,0.0023999583567988,0.0023999583567988,0,0,19952.0,120356.5272753826,RENBP
18942,KEGG_2019_Human,Starch and sucrose metabolism,1/36,0.0017999657178272,0.0032999410769135,0,0,19964.0,126172.23364250171,AMY1C
18943,KEGG_2019_Human,Carbohydrate digestion and absorption,1/44,0.0021999607179423,0.0032999410769135,0,0,19956.0,122117.06559109331,AMY1C
18944,KEGG_2019_Human,Salivary secretion,1/90,0.0044999373439762,0.0044999373439762,0,0,19910.0,107587.50385474482,AMY1C
18945,KEGG_2019_Human,Protein processing in endoplasmic reticulum,1/165,0.0082499094553477,0.0082499094553477,0,0,19835.0,95159.46482222488,ERP29
18946,KEGG_2019_Human,Endocytosis,1/244,0.0121998870519305,0.0121998870519305,0,0,19756.0,87051.4275316661,WIPF3
18947,KEGG_2019_Human,Thermogenesis,1/231,0.0115498903940656,0.0115498903940656,0,0,19769.0,88191.07730937863,SLC25A29
18948,KEGG_2019_Human,Cushing syndrome,1/155,0.0077499127120574,0.0077499127120574,0,0,19845.0,96448.16254952336,ASH2L
18949,KEGG_2019_Human,Axon guidance,1/181,0.0090499044707863,0.0090499044707863,0,0,19819.0,93248.41634586031,RND1
18950,KEGG_2019_Human,Butanoate metabolism,1/28,0.0013999711732997,0.0026249495582393,0,0,19972.0,131242.0761597353,ABAT
18951,KEGG_2019_Human,beta-Alanine metabolism,1/31,0.0015499690656704,0.0026249495582393,0,0,19969.0,129189.85098816035,ABAT
18952,KEGG_2019_Human,Propanoate metabolism,1/32,0.0015999683804467,0.0026249495582393,0,0,19968.0,128549.41955786056,ABAT
18953,KEGG_2019_Human,"Alanine, aspartate and glutamate metabolism",1/35,0.0017499663721595,0.0026249495582393,0,0,19965.0,126740.98858805298,ABAT
18954,KEGG_2019_Human,"Valine, leucine and isoleucine degradation",1/48,0.0023999583567988,0.0028799500281585,0,0,19952.0,120356.5272753826,ABAT
18955,KEGG_2019_Human,GABAergic synapse,1/89,0.0044499377838098,0.0044499377838098,0,0,19911.0,107815.380281759,ABAT
18956,KEGG_2019_Human,PPAR signaling pathway,1/74,0.0036999446830449,0.0036999446830449,0,0,19926.0,111574.38983110404,FABP3
18957,KEGG_2019_Human,Pentose phosphate pathway,1/30,0.0014999697593334,0.0014999697593334,0,0,19970.0,129851.13732048514,PGLS
18958,KEGG_2019_Human,Phosphatidylinositol signaling system,1/99,0.0049499334884068,0.0049499334884068,0,0,19901.0,105642.09305076736,IP6K2
18959,KEGG_2019_Human,Shigellosis,1/65,0.003249949134407,0.0096998686609413,0,0,19935.0,114209.92613860144,ITGA5
18960,KEGG_2019_Human,Arrhythmogenic right ventricular cardiomyopathy (ARVC),1/72,0.0035999456502131,0.0096998686609413,0,0,19928.0,112131.59838572376,ITGA5
18961,KEGG_2019_Human,Bacterial invasion of epithelial cells,1/74,0.0036999446830449,0.0096998686609413,0,0,19926.0,111574.38983110404,ITGA5
18962,KEGG_2019_Human,Pertussis,1/76,0.0037999437281752,0.0096998686609413,0,0,19924.0,111031.8499691117,ITGA5
18963,KEGG_2019_Human,ECM-receptor interaction,1/82,0.004099940929819,0.0096998686609413,0,0,19918.0,109484.9180722932,ITGA5
18964,KEGG_2019_Human,Hypertrophic cardiomyopathy (HCM),1/85,0.004249939567045,0.0096998686609413,0,0,19915.0,108752.83801948265,ITGA5
18965,KEGG_2019_Human,Dilated cardiomyopathy (DCM),1/91,0.0045499369072032,0.0096998686609413,0,0,19909.0,107362.10783923086,ITGA5
18966,KEGG_2019_Human,Hematopoietic cell lineage,1/97,0.0048499343304706,0.0096998686609413,0,0,19903.0,106058.9096435903,ITGA5
18967,KEGG_2019_Human,Phagosome,1/152,0.0075999137114971,0.0135109577093282,0,0,19848.0,96850.665715497,ITGA5
18968,KEGG_2019_Human,Focal adhesion,1/199,0.0099498991610159,0.0142665266018757,0,0,19801.0,91286.4288690606,ITGA5
18969,KEGG_2019_Human,Proteoglycans in cancer,1/201,0.0100498985877989,0.0142665266018757,0,0,19799.0,91079.21596609056,ITGA5
18970,KEGG_2019_Human,Regulation of actin cytoskeleton,1/214,0.0106998949514067,0.0142665266018757,0,0,19786.0,89779.39753374986,ITGA5
18971,KEGG_2019_Human,MicroRNAs in cancer,1/299,0.0149498740670514,0.0183998450056017,0,0,19701.0,82804.33538735632,ITGA5
18972,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0188569913816737,0,0,19670.0,80733.60565076157,ITGA5
18973,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0188798534841246,0,0,19646.0,79255.8617626126,ITGA5
18974,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ITGA5
18975,KEGG_2019_Human,Staphylococcus aureus infection,1/68,0.0033999476216189,0.0067998952432378,0,0,19932.0,113293.39338050144,FPR3
18976,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,FPR3
18977,KEGG_2019_Human,Complement and coagulation cascades,1/79,0.0039499423167337,0.0154998090243753,0,0,19921.0,110243.89578070649,F2RL3
18978,KEGG_2019_Human,Platelet activation,1/124,0.0061999236097501,0.0154998090243753,0,0,19876.0,101034.04709010696,F2RL3
18979,KEGG_2019_Human,Rap1 signaling pathway,1/206,0.010299897173561,0.0171664952892684,0,0,19794.0,90569.849337325,F2RL3
18980,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0211248322831995,0,0,19662.0,80229.79996326564,F2RL3
18981,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,F2RL3
18982,KEGG_2019_Human,Ubiquitin mediated proteolysis,1/137,0.0068499188797651,0.0068499188797651,0,0,19863.0,98987.62735269018,FBXW8
18983,KEGG_2019_Human,Transcriptional misregulation in cancer,1/186,0.0092999029651357,0.0092999029651357,0,0,19814.0,92684.96451050608,ETV7
18984,KEGG_2019_Human,mRNA surveillance pathway,1/91,0.0045499369072032,0.0045499369072032,0,0,19909.0,107362.10783923086,SMG5
18985,KEGG_2019_Human,PPAR signaling pathway,1/74,0.0036999446830449,0.0073998893660899,0,0,19926.0,111574.38983110404,OLR1
18986,KEGG_2019_Human,Phagosome,1/152,0.0075999137114971,0.0075999137114971,0,0,19848.0,96850.665715497,OLR1
18987,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF253
18988,KEGG_2019_Human,B cell receptor signaling pathway,1/71,0.0035499461386618,0.0035499461386618,0,0,19929.0,112415.9585341616,DAPP1
18989,KEGG_2019_Human,Th17 cell differentiation,1/107,0.0053499302026925,0.0053499302026925,0,0,19893.0,104053.753408911,IRF4
18990,KEGG_2019_Human,Wnt signaling pathway,1/158,0.0078999117225733,0.0078999117225733,0,0,19842.0,96053.2110949472,WIF1
18991,KEGG_2019_Human,Asthma,1/31,0.0015499690656704,0.007428473457571,0,0,19969.0,129189.85098816035,IL10
18992,KEGG_2019_Human,African trypanosomiasis,1/37,0.0018499650702878,0.007428473457571,0,0,19963.0,125618.9446446357,IL10
18993,KEGG_2019_Human,Allograft rejection,1/38,0.001899964429635,0.007428473457571,0,0,19962.0,125080.29732025368,IL10
18994,KEGG_2019_Human,Intestinal immune network for IgA production,1/48,0.0023999583567988,0.007428473457571,0,0,19952.0,120356.5272753826,IL10
18995,KEGG_2019_Human,Malaria,1/49,0.0024499577795033,0.007428473457571,0,0,19951.0,119939.1172087114,IL10
18996,KEGG_2019_Human,Autoimmune thyroid disease,1/53,0.0026499555173137,0.007428473457571,0,0,19947.0,118349.78824235698,IL10
18997,KEGG_2019_Human,Inflammatory bowel disease (IBD),1/65,0.003249949134407,0.007428473457571,0,0,19935.0,114209.92613860144,IL10
18998,KEGG_2019_Human,Staphylococcus aureus infection,1/68,0.0033999476216189,0.007428473457571,0,0,19932.0,113293.39338050144,IL10
18999,KEGG_2019_Human,Leishmaniasis,1/74,0.0036999446830449,0.007428473457571,0,0,19926.0,111574.38983110404,IL10
19000,KEGG_2019_Human,Pertussis,1/76,0.0037999437281752,0.007428473457571,0,0,19924.0,111031.8499691117,IL10
19001,KEGG_2019_Human,Amoebiasis,1/96,0.0047999347538706,0.007428473457571,0,0,19904.0,106270.50039849174,IL10
19002,KEGG_2019_Human,T cell receptor signaling pathway,1/101,0.0050499326546803,0.007428473457571,0,0,19899.0,105233.48101229242,IL10
19003,KEGG_2019_Human,Chagas disease (American trypanosomiasis),1/103,0.0051499318302617,0.007428473457571,0,0,19897.0,104832.7525292024,IL10
19004,KEGG_2019_Human,C-type lectin receptor signaling pathway,1/104,0.0051999314202997,0.007428473457571,0,0,19896.0,104635.24941415618,IL10
19005,KEGG_2019_Human,Toxoplasmosis,1/113,0.0056499278191151,0.0075332370921535,0,0,19887.0,102937.34947211576,IL10
19006,KEGG_2019_Human,FoxO signaling pathway,1/132,0.0065999206698993,0.0078234356581072,0,0,19868.0,99751.22090491928,IL10
19007,KEGG_2019_Human,Systemic lupus erythematosus,1/133,0.0066499203093911,0.0078234356581072,0,0,19867.0,99596.2591544721,IL10
19008,KEGG_2019_Human,JAK-STAT signaling pathway,1/162,0.0080999104202618,0.0089999004669576,0,0,19838.0,95537.86936302872,IL10
19009,KEGG_2019_Human,Tuberculosis,1/179,0.0089499050800561,0.0094209527158485,0,0,19821.0,93478.0629355712,IL10
19010,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0146998751759735,0,0,19706.0,83157.67014793828,IL10
19011,KEGG_2019_Human,Mitophagy,1/65,0.003249949134407,0.0121998870519305,0,0,19935.0,114209.92613860144,UBB
19012,KEGG_2019_Human,Parkinson disease,1/142,0.0070999171242726,0.0121998870519305,0,0,19858.0,98250.87390500787,UBB
19013,KEGG_2019_Human,Kaposi sarcoma-associated herpesvirus infection,1/186,0.0092999029651357,0.0121998870519305,0,0,19814.0,92684.96451050608,UBB
19014,KEGG_2019_Human,Endocytosis,1/244,0.0121998870519305,0.0121998870519305,0,0,19756.0,87051.4275316661,UBB
19015,KEGG_2019_Human,Fructose and mannose metabolism,1/33,0.0016499677032113,0.0049499031096341,0,0,19967.0,127928.56031580272,PFKFB2
19016,KEGG_2019_Human,Thyroid hormone signaling pathway,1/116,0.0057999266512085,0.0059999251180858,0,0,19884.0,102400.8105961506,PFKFB2
19017,KEGG_2019_Human,AMPK signaling pathway,1/120,0.0059999251180858,0.0059999251180858,0,0,19880.0,101706.2448082016,PFKFB2
19018,KEGG_2019_Human,Glycerophospholipid metabolism,1/97,0.0048499343304706,0.0055999282120529,0,0,19903.0,106058.9096435903,ACHE
19019,KEGG_2019_Human,Cholinergic synapse,1/112,0.0055999282120529,0.0055999282120529,0,0,19888.0,103119.30984392198,ACHE
19020,KEGG_2019_Human,Mineral absorption,1/51,0.0025499566390179,0.0025499566390179,0,0,19949.0,119129.0228601236,STEAP1
19021,KEGG_2019_Human,Arachidonic acid metabolism,1/63,0.0031499501598827,0.0056499278191151,0,0,19937.0,114844.46974572667,ALOX12B
19022,KEGG_2019_Human,Serotonergic synapse,1/113,0.0056499278191151,0.0056499278191151,0,0,19887.0,102937.34947211576,ALOX12B
19023,KEGG_2019_Human,Prolactin signaling pathway,1/70,0.0034999466296654,0.0097998872023976,0,0,19930.0,112704.30065625212,ESR2
19024,KEGG_2019_Human,Estrogen signaling pathway,1/137,0.0068499188797651,0.0097998872023976,0,0,19863.0,98987.62735269018,ESR2
19025,KEGG_2019_Human,Breast cancer,1/147,0.0073499154017982,0.0097998872023976,0,0,19853.0,97539.10874372096,ESR2
19026,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,ESR2
19027,KEGG_2019_Human,Progesterone-mediated oocyte maturation,1/99,0.0049499334884068,0.0049499334884068,0,0,19901.0,105642.09305076736,KIF22
19028,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,MCHR1
19029,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0146998751759735,0,0,19706.0,83157.67014793828,RELT
19030,KEGG_2019_Human,Steroid hormone biosynthesis,1/60,0.002999951725986,0.002999951725986,0,0,19940.0,115834.63209072244,STS
19031,KEGG_2019_Human,Protein processing in endoplasmic reticulum,1/165,0.0082499094553477,0.0082499094553477,0,0,19835.0,95159.46482222488,LMAN2
19032,KEGG_2019_Human,Adipocytokine signaling pathway,1/69,0.003449947123837,0.0065999206698993,0,0,19931.0,112996.7391397682,PRKCQ
19033,KEGG_2019_Human,Th1 and Th2 cell differentiation,1/92,0.0045999364719865,0.0065999206698993,0,0,19908.0,107139.13814408927,PRKCQ
19034,KEGG_2019_Human,NF-kappa B signaling pathway,1/95,0.0047499351803394,0.0065999206698993,0,0,19905.0,106484.27183626965,PRKCQ
19035,KEGG_2019_Human,Inflammatory mediator regulation of TRP channels,1/100,0.0049999330710556,0.0065999206698993,0,0,19900.0,105436.78197328727,PRKCQ
19036,KEGG_2019_Human,T cell receptor signaling pathway,1/101,0.0050499326546803,0.0065999206698993,0,0,19899.0,105233.48101229242,PRKCQ
19037,KEGG_2019_Human,Th17 cell differentiation,1/107,0.0053499302026925,0.0065999206698993,0,0,19893.0,104053.753408911,PRKCQ
19038,KEGG_2019_Human,Insulin resistance,1/108,0.0053999298011749,0.0065999206698993,0,0,19892.0,103863.47861844616,PRKCQ
19039,KEGG_2019_Human,Autophagy,1/128,0.0063999221281459,0.0065999206698993,0,0,19872.0,100382.8010329652,PRKCQ
19040,KEGG_2019_Human,Vascular smooth muscle contraction,1/132,0.0065999206698993,0.0065999206698993,0,0,19868.0,99751.22090491928,PRKCQ
19041,KEGG_2019_Human,Vasopressin-regulated water reabsorption,1/44,0.0021999607179423,0.0115367054817097,0,0,19956.0,122117.06559109331,CREB3L4
19042,KEGG_2019_Human,Cocaine addiction,1/49,0.0024499577795033,0.0115367054817097,0,0,19951.0,119939.1172087114,CREB3L4
19043,KEGG_2019_Human,Cortisol synthesis and secretion,1/65,0.003249949134407,0.0115367054817097,0,0,19935.0,114209.92613860144,CREB3L4
19044,KEGG_2019_Human,Amphetamine addiction,1/68,0.0033999476216189,0.0115367054817097,0,0,19932.0,113293.39338050144,CREB3L4
19045,KEGG_2019_Human,Thyroid hormone synthesis,1/74,0.0036999446830449,0.0115367054817097,0,0,19926.0,111574.38983110404,CREB3L4
19046,KEGG_2019_Human,Insulin secretion,1/86,0.0042999391173866,0.0115367054817097,0,0,19914.0,108514.46102290176,CREB3L4
19047,KEGG_2019_Human,Prostate cancer,1/97,0.0048499343304706,0.0115367054817097,0,0,19903.0,106058.9096435903,CREB3L4
19048,KEGG_2019_Human,Aldosterone synthesis and secretion,1/98,0.0048999339081079,0.0115367054817097,0,0,19902.0,105849.45495286948,CREB3L4
19049,KEGG_2019_Human,Melanogenesis,1/101,0.0050499326546803,0.0115367054817097,0,0,19899.0,105233.48101229242,CREB3L4
19050,KEGG_2019_Human,Longevity regulating pathway,1/102,0.0050999322416682,0.0115367054817097,0,0,19898.0,105032.15064717118,CREB3L4
19051,KEGG_2019_Human,Glucagon signaling pathway,1/103,0.0051499318302617,0.0115367054817097,0,0,19897.0,104832.7525292024,CREB3L4
19052,KEGG_2019_Human,"Parathyroid hormone synthesis, secretion and action",1/106,0.0052999306076525,0.0115367054817097,0,0,19894.0,104245.78450366124,CREB3L4
19053,KEGG_2019_Human,Insulin resistance,1/108,0.0053999298011749,0.0115367054817097,0,0,19892.0,103863.47861844616,CREB3L4
19054,KEGG_2019_Human,TNF signaling pathway,1/110,0.0054999290027479,0.0115367054817097,0,0,19890.0,103488.06969787036,CREB3L4
19055,KEGG_2019_Human,Cholinergic synapse,1/112,0.0055999282120529,0.0115367054817097,0,0,19888.0,103119.30984392198,CREB3L4
19056,KEGG_2019_Human,AMPK signaling pathway,1/120,0.0059999251180858,0.0115367054817097,0,0,19880.0,101706.2448082016,CREB3L4
19057,KEGG_2019_Human,Relaxin signaling pathway,1/130,0.0064999213952527,0.0115367054817097,0,0,19870.0,100064.62842845908,CREB3L4
19058,KEGG_2019_Human,Dopaminergic synapse,1/131,0.0065499210316603,0.0115367054817097,0,0,19869.0,99907.33811343512,CREB3L4
19059,KEGG_2019_Human,Estrogen signaling pathway,1/137,0.0068499188797651,0.0115367054817097,0,0,19863.0,98987.62735269018,CREB3L4
19060,KEGG_2019_Human,Adrenergic signaling in cardiomyocytes,1/145,0.0072499160871101,0.0115476996679976,0,0,19855.0,97820.92670675044,CREB3L4
19061,KEGG_2019_Human,Cushing syndrome,1/155,0.0077499127120574,0.0115476996679976,0,0,19845.0,96448.16254952336,CREB3L4
19062,KEGG_2019_Human,Hepatitis B,1/163,0.0081499100978668,0.0115476996679976,0,0,19837.0,95410.9786681514,CREB3L4
19063,KEGG_2019_Human,cGMP-PKG signaling pathway,1/166,0.0082999091363732,0.0115476996679976,0,0,19834.0,95034.82345515196,CREB3L4
19064,KEGG_2019_Human,Alcoholism,1/180,0.0089999047745351,0.0119998730327134,0,0,19820.0,93362.92821536642,CREB3L4
19065,KEGG_2019_Human,Huntington disease,1/193,0.0096499008972596,0.0123198830870033,0,0,19807.0,91920.47679471428,CREB3L4
19066,KEGG_2019_Human,Viral carcinogenesis,1/201,0.0100498985877989,0.0123198830870033,0,0,19799.0,91079.21596609056,CREB3L4
19067,KEGG_2019_Human,cAMP signaling pathway,1/212,0.0105998955026255,0.0123198830870033,0,0,19788.0,89974.27756224656,CREB3L4
19068,KEGG_2019_Human,Human T-cell leukemia virus 1 infection,1/219,0.0109498935894162,0.0123198830870033,0,0,19781.0,89299.85161916987,CREB3L4
19069,KEGG_2019_Human,Human cytomegalovirus infection,1/225,0.0112498919790339,0.0123198830870033,0,0,19775.0,88738.27077557483,CREB3L4
19070,KEGG_2019_Human,Thermogenesis,1/231,0.0115498903940656,0.0123198830870033,0,0,19769.0,88191.07730937863,CREB3L4
19071,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0170321212479633,0,0,19670.0,80733.60565076157,CREB3L4
19072,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0176998626413668,0,0,19646.0,79255.8617626126,CREB3L4
19073,KEGG_2019_Human,Choline metabolism in cancer,1/99,0.0049499334884068,0.0049499334884068,0,0,19901.0,105642.09305076736,SLC44A3
19074,KEGG_2019_Human,Glycerolipid metabolism,1/61,0.0030499512001654,0.0030499512001654,0,0,19939.0,115499.24335773686,MOGAT1
19075,KEGG_2019_Human,Prostate cancer,1/97,0.0048499343304706,0.0092999029651357,0,0,19903.0,106058.9096435903,SPINT1
19076,KEGG_2019_Human,Transcriptional misregulation in cancer,1/186,0.0092999029651357,0.0092999029651357,0,0,19814.0,92684.96451050608,SPINT1
19077,KEGG_2019_Human,Fat digestion and absorption,1/41,0.0020499625466866,0.0036999446830449,0,0,19959.0,123544.88783416104,FABP2
19078,KEGG_2019_Human,PPAR signaling pathway,1/74,0.0036999446830449,0.0036999446830449,0,0,19926.0,111574.38983110404,FABP2
19079,KEGG_2019_Human,"Valine, leucine and isoleucine degradation",1/48,0.0023999583567988,0.0023999583567988,0,0,19952.0,120356.5272753826,IVD
19080,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF74
19081,KEGG_2019_Human,RNA polymerase,1/31,0.0015499690656704,0.0030999381313408,0,0,19969.0,129189.85098816035,POLR2A
19082,KEGG_2019_Human,Huntington disease,1/193,0.0096499008972596,0.0096499008972596,0,0,19807.0,91920.47679471428,POLR2A
19083,KEGG_2019_Human,Thyroid cancer,1/37,0.0018499650702878,0.0116998725551168,0,0,19963.0,125618.9446446357,CDKN1A
19084,KEGG_2019_Human,Bladder cancer,1/41,0.0020499625466866,0.0116998725551168,0,0,19959.0,123544.88783416104,CDKN1A
19085,KEGG_2019_Human,Endometrial cancer,1/58,0.0028999527887707,0.0116998725551168,0,0,19942.0,116522.31890946148,CDKN1A
19086,KEGG_2019_Human,Basal cell carcinoma,1/63,0.0031499501598827,0.0116998725551168,0,0,19937.0,114844.46974572667,CDKN1A
19087,KEGG_2019_Human,Non-small cell lung cancer,1/66,0.003299948626608,0.0116998725551168,0,0,19934.0,113899.85357353876,CDKN1A
19088,KEGG_2019_Human,Renal cell carcinoma,1/69,0.003449947123837,0.0116998725551168,0,0,19931.0,112996.7391397682,CDKN1A
19089,KEGG_2019_Human,Melanoma,1/72,0.0035999456502131,0.0116998725551168,0,0,19928.0,112131.59838572376,CDKN1A
19090,KEGG_2019_Human,p53 signaling pathway,1/72,0.0035999456502131,0.0116998725551168,0,0,19928.0,112131.59838572376,CDKN1A
19091,KEGG_2019_Human,Pancreatic cancer,1/75,0.0037499442041125,0.0116998725551168,0,0,19925.0,111301.33528642564,CDKN1A
19092,KEGG_2019_Human,Glioma,1/75,0.0037499442041125,0.0116998725551168,0,0,19925.0,111301.33528642564,CDKN1A
19093,KEGG_2019_Human,Chronic myeloid leukemia,1/76,0.0037999437281752,0.0116998725551168,0,0,19924.0,111031.8499691117,CDKN1A
19094,KEGG_2019_Human,ErbB signaling pathway,1/85,0.004249939567045,0.0116998725551168,0,0,19915.0,108752.83801948265,CDKN1A
19095,KEGG_2019_Human,Colorectal cancer,1/86,0.0042999391173866,0.0116998725551168,0,0,19914.0,108514.46102290176,CDKN1A
19096,KEGG_2019_Human,Small cell lung cancer,1/93,0.0046499360391879,0.0116998725551168,0,0,19907.0,106918.54242106884,CDKN1A
19097,KEGG_2019_Human,Prostate cancer,1/97,0.0048499343304706,0.0116998725551168,0,0,19903.0,106058.9096435903,CDKN1A
19098,KEGG_2019_Human,HIF-1 signaling pathway,1/100,0.0049999330710556,0.0116998725551168,0,0,19900.0,105436.78197328727,CDKN1A
19099,KEGG_2019_Human,"Parathyroid hormone synthesis, secretion and action",1/106,0.0052999306076525,0.0116998725551168,0,0,19894.0,104245.78450366124,CDKN1A
19100,KEGG_2019_Human,Cell cycle,1/124,0.0061999236097501,0.0116998725551168,0,0,19876.0,101034.04709010696,CDKN1A
19101,KEGG_2019_Human,FoxO signaling pathway,1/132,0.0065999206698993,0.0116998725551168,0,0,19868.0,99751.22090491928,CDKN1A
19102,KEGG_2019_Human,Breast cancer,1/147,0.0073499154017982,0.0116998725551168,0,0,19853.0,97539.10874372096,CDKN1A
19103,KEGG_2019_Human,Gastric cancer,1/149,0.0074499147221605,0.0116998725551168,0,0,19851.0,97261.02051561224,CDKN1A
19104,KEGG_2019_Human,Oxytocin signaling pathway,1/153,0.0076499133771537,0.0116998725551168,0,0,19847.0,96715.6407630817,CDKN1A
19105,KEGG_2019_Human,Cushing syndrome,1/155,0.0077499127120574,0.0116998725551168,0,0,19845.0,96448.16254952336,CDKN1A
19106,KEGG_2019_Human,Hepatitis C,1/155,0.0077499127120574,0.0116998725551168,0,0,19845.0,96448.16254952336,CDKN1A
19107,KEGG_2019_Human,Cellular senescence,1/160,0.0079999110688441,0.0116998725551168,0,0,19840.0,95793.96509856998,CDKN1A
19108,KEGG_2019_Human,JAK-STAT signaling pathway,1/162,0.0080999104202618,0.0116998725551168,0,0,19838.0,95537.86936302872,CDKN1A
19109,KEGG_2019_Human,Hepatitis B,1/163,0.0081499100978668,0.0116998725551168,0,0,19837.0,95410.9786681514,CDKN1A
19110,KEGG_2019_Human,Hepatocellular carcinoma,1/168,0.0083999085011095,0.0116998725551168,0,0,19832.0,94787.72752807094,CDKN1A
19111,KEGG_2019_Human,Kaposi sarcoma-associated herpesvirus infection,1/186,0.0092999029651357,0.0118771528764897,0,0,19814.0,92684.96451050608,CDKN1A
19112,KEGG_2019_Human,Transcriptional misregulation in cancer,1/186,0.0092999029651357,0.0118771528764897,0,0,19814.0,92684.96451050608,CDKN1A
19113,KEGG_2019_Human,Epstein-Barr virus infection,1/201,0.0100498985877989,0.0118771528764897,0,0,19799.0,91079.21596609056,CDKN1A
19114,KEGG_2019_Human,Proteoglycans in cancer,1/201,0.0100498985877989,0.0118771528764897,0,0,19799.0,91079.21596609056,CDKN1A
19115,KEGG_2019_Human,Viral carcinogenesis,1/201,0.0100498985877989,0.0118771528764897,0,0,19799.0,91079.21596609056,CDKN1A
19116,KEGG_2019_Human,Human T-cell leukemia virus 1 infection,1/219,0.0109498935894162,0.0125355939194949,0,0,19781.0,89299.85161916987,CDKN1A
19117,KEGG_2019_Human,Human cytomegalovirus infection,1/225,0.0112498919790339,0.0125355939194949,0,0,19775.0,88738.27077557483,CDKN1A
19118,KEGG_2019_Human,MicroRNAs in cancer,1/299,0.0149498740670514,0.0161956969059724,0,0,19701.0,82804.33538735632,CDKN1A
19119,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0173917521864761,0,0,19670.0,80733.60565076157,CDKN1A
19120,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0181656485003502,0,0,19646.0,79255.8617626126,CDKN1A
19121,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,CDKN1A
19122,KEGG_2019_Human,Natural killer cell mediated cytotoxicity,1/131,0.0065499210316603,0.0065499210316603,0,0,19869.0,99907.33811343512,RAET1E
19123,KEGG_2019_Human,Primary immunodeficiency,1/37,0.0018499650702878,0.0036999301405757,0,0,19963.0,125618.9446446357,AIRE
19124,KEGG_2019_Human,Ubiquitin mediated proteolysis,1/137,0.0068499188797651,0.0068499188797651,0,0,19863.0,98987.62735269018,AIRE
19125,KEGG_2019_Human,Notch signaling pathway,1/48,0.0023999583567988,0.0023999583567988,0,0,19952.0,120356.5272753826,DTX4
19126,KEGG_2019_Human,Protein digestion and absorption,1/90,0.0044999373439762,0.0057999266512085,0,0,19910.0,107587.50385474482,SLC16A10
19127,KEGG_2019_Human,Thyroid hormone signaling pathway,1/116,0.0057999266512085,0.0057999266512085,0,0,19884.0,102400.8105961506,SLC16A10
19128,KEGG_2019_Human,Cell adhesion molecules (CAMs),1/145,0.0072499160871101,0.0072499160871101,0,0,19855.0,97820.92670675044,VTCN1
19129,KEGG_2019_Human,Asthma,1/31,0.0015499690656704,0.0074398976627006,0,0,19969.0,129189.85098816035,IL13
19130,KEGG_2019_Human,Inflammatory bowel disease (IBD),1/65,0.003249949134407,0.0074398976627006,0,0,19935.0,114209.92613860144,IL13
19131,KEGG_2019_Human,Fc epsilon RI signaling pathway,1/68,0.0033999476216189,0.0074398976627006,0,0,19932.0,113293.39338050144,IL13
19132,KEGG_2019_Human,Th1 and Th2 cell differentiation,1/92,0.0045999364719865,0.0074398976627006,0,0,19908.0,107139.13814408927,IL13
19133,KEGG_2019_Human,IL-17 signaling pathway,1/93,0.0046499360391879,0.0074398976627006,0,0,19907.0,106918.54242106884,IL13
19134,KEGG_2019_Human,JAK-STAT signaling pathway,1/162,0.0080999104202618,0.0107998805603491,0,0,19838.0,95537.86936302872,IL13
19135,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0167998573439697,0,0,19706.0,83157.67014793828,IL13
19136,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,IL13
19137,KEGG_2019_Human,Fc gamma R-mediated phagocytosis,1/91,0.0045499369072032,0.0090998738144064,0,0,19909.0,107362.10783923086,ASAP2
19138,KEGG_2019_Human,Endocytosis,1/244,0.0121998870519305,0.0121998870519305,0,0,19756.0,87051.4275316661,ASAP2
19139,KEGG_2019_Human,Neurotrophin signaling pathway,1/119,0.0059499254985137,0.0089499050800561,0,0,19881.0,101877.73080211312,IRAK2
19140,KEGG_2019_Human,Tuberculosis,1/179,0.0089499050800561,0.0089499050800561,0,0,19821.0,93478.0629355712,IRAK2
19141,KEGG_2019_Human,Staphylococcus aureus infection,1/68,0.0033999476216189,0.0067998952432378,0,0,19932.0,113293.39338050144,SELPLG
19142,KEGG_2019_Human,Cell adhesion molecules (CAMs),1/145,0.0072499160871101,0.0072499160871101,0,0,19855.0,97820.92670675044,SELPLG
19143,KEGG_2019_Human,alpha-Linolenic acid metabolism,1/25,0.0012499733663791,0.0035999375351982,0,0,19975.0,133525.54486996148,ACAA1
19144,KEGG_2019_Human,Biosynthesis of unsaturated fatty acids,1/27,0.0013499718942362,0.0035999375351982,0,0,19973.0,131975.02298599784,ACAA1
19145,KEGG_2019_Human,Fatty acid degradation,1/44,0.0021999607179423,0.0035999375351982,0,0,19956.0,122117.06559109331,ACAA1
19146,KEGG_2019_Human,"Valine, leucine and isoleucine degradation",1/48,0.0023999583567988,0.0035999375351982,0,0,19952.0,120356.5272753826,ACAA1
19147,KEGG_2019_Human,PPAR signaling pathway,1/74,0.0036999446830449,0.0041499404726918,0,0,19926.0,111574.38983110404,ACAA1
19148,KEGG_2019_Human,Peroxisome,1/83,0.0041499404726918,0.0041499404726918,0,0,19917.0,109237.99888847338,ACAA1
19149,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF214
19150,KEGG_2019_Human,Progesterone-mediated oocyte maturation,1/99,0.0049499334884068,0.0062499232373748,0,0,19901.0,105642.09305076736,CPEB4
19151,KEGG_2019_Human,Oocyte meiosis,1/125,0.0062499232373748,0.0062499232373748,0,0,19875.0,100869.32368441945,CPEB4
19152,KEGG_2019_Human,Relaxin signaling pathway,1/130,0.0064999213952527,0.0129998427905055,0,0,19870.0,100064.62842845908,INSL5
19153,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,INSL5
19154,KEGG_2019_Human,Fructose and mannose metabolism,1/33,0.0016499677032113,0.003249949134407,0,0,19967.0,127928.56031580272,TIGAR
19155,KEGG_2019_Human,Central carbon metabolism in cancer,1/65,0.003249949134407,0.003249949134407,0,0,19935.0,114209.92613860144,TIGAR
19156,KEGG_2019_Human,Drug metabolism,1/108,0.0053999298011749,0.0053999298011749,0,0,19892.0,103863.47861844616,FMO4
19157,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZFP69B
19158,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR56A3
19159,KEGG_2019_Human,Progesterone-mediated oocyte maturation,1/99,0.0049499334884068,0.0062499232373748,0,0,19901.0,105642.09305076736,CPEB2
19160,KEGG_2019_Human,Oocyte meiosis,1/125,0.0062499232373748,0.0062499232373748,0,0,19875.0,100869.32368441945,CPEB2
19161,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR10A3
19162,KEGG_2019_Human,Influenza A,1/171,0.0085499075557634,0.0085499075557634,0,0,19829.0,94422.42241345016,TMPRSS4
19163,KEGG_2019_Human,Kaposi sarcoma-associated herpesvirus infection,1/186,0.0092999029651357,0.0140623649737923,0,0,19814.0,92684.96451050608,CCR3
19164,KEGG_2019_Human,Chemokine signaling pathway,1/190,0.0094999017791995,0.0140623649737923,0,0,19810.0,92244.74636351672,CCR3
19165,KEGG_2019_Human,Viral carcinogenesis,1/201,0.0100498985877989,0.0140623649737923,0,0,19799.0,91079.21596609056,CCR3
19166,KEGG_2019_Human,Human cytomegalovirus infection,1/225,0.0112498919790339,0.0140623649737923,0,0,19775.0,88738.27077557483,CCR3
19167,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0146998751759735,0,0,19706.0,83157.67014793828,CCR3
19168,KEGG_2019_Human,Cholesterol metabolism,1/50,0.0024999572069037,0.0049999144138074,0,0,19950.0,119530.05920663515,LDLRAP1
19169,KEGG_2019_Human,Endocytosis,1/244,0.0121998870519305,0.0121998870519305,0,0,19756.0,87051.4275316661,LDLRAP1
19170,KEGG_2019_Human,Natural killer cell mediated cytotoxicity,1/131,0.0065499210316603,0.0065499210316603,0,0,19869.0,99907.33811343512,RAET1L
19171,KEGG_2019_Human,Insulin signaling pathway,1/137,0.0068499188797651,0.0068499188797651,0,0,19863.0,98987.62735269018,PPP1R3F
19172,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0147498749536506,0,0,19705.0,83086.53988020132,ECSIT
19173,KEGG_2019_Human,Ribosome biogenesis in eukaryotes,1/101,0.0050499326546803,0.0082499094553477,0,0,19899.0,105233.48101229242,RPP30
19174,KEGG_2019_Human,RNA transport,1/165,0.0082499094553477,0.0082499094553477,0,0,19835.0,95159.46482222488,RPP30
19175,KEGG_2019_Human,Oxidative phosphorylation,1/133,0.0066499203093911,0.0112582177134695,0,0,19867.0,99596.2591544721,NDUFV1
19176,KEGG_2019_Human,Parkinson disease,1/142,0.0070999171242726,0.0112582177134695,0,0,19858.0,98250.87390500787,NDUFV1
19177,KEGG_2019_Human,Retrograde endocannabinoid signaling,1/148,0.007399915061391,0.0112582177134695,0,0,19852.0,97399.60470052566,NDUFV1
19178,KEGG_2019_Human,Non-alcoholic fatty liver disease (NAFLD),1/149,0.0074499147221605,0.0112582177134695,0,0,19851.0,97261.02051561224,NDUFV1
19179,KEGG_2019_Human,Alzheimer disease,1/171,0.0085499075557634,0.0112582177134695,0,0,19829.0,94422.42241345016,NDUFV1
19180,KEGG_2019_Human,Huntington disease,1/193,0.0096499008972596,0.0112582177134695,0,0,19807.0,91920.47679471428,NDUFV1
19181,KEGG_2019_Human,Thermogenesis,1/231,0.0115498903940656,0.0115498903940656,0,0,19769.0,88191.07730937863,NDUFV1
19182,KEGG_2019_Human,Glycerolipid metabolism,1/61,0.0030499512001654,0.007274901495706,0,0,19939.0,115499.24335773686,AGPAT3
19183,KEGG_2019_Human,Glycerophospholipid metabolism,1/97,0.0048499343304706,0.007274901495706,0,0,19903.0,106058.9096435903,AGPAT3
19184,KEGG_2019_Human,Phospholipase D signaling pathway,1/148,0.007399915061391,0.007399915061391,0,0,19852.0,97399.60470052566,AGPAT3
19185,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR10H5
19186,KEGG_2019_Human,Fc gamma R-mediated phagocytosis,1/91,0.0045499369072032,0.010299897173561,0,0,19909.0,107362.10783923086,VASP
19187,KEGG_2019_Human,Leukocyte transendothelial migration,1/112,0.0055999282120529,0.010299897173561,0,0,19888.0,103119.30984392198,VASP
19188,KEGG_2019_Human,Platelet activation,1/124,0.0061999236097501,0.010299897173561,0,0,19876.0,101034.04709010696,VASP
19189,KEGG_2019_Human,cGMP-PKG signaling pathway,1/166,0.0082999091363732,0.010299897173561,0,0,19834.0,95034.82345515196,VASP
19190,KEGG_2019_Human,Tight junction,1/170,0.0084999078692823,0.010299897173561,0,0,19830.0,94543.49009679438,VASP
19191,KEGG_2019_Human,Focal adhesion,1/199,0.0099498991610159,0.010299897173561,0,0,19801.0,91286.4288690606,VASP
19192,KEGG_2019_Human,Rap1 signaling pathway,1/206,0.010299897173561,0.010299897173561,0,0,19794.0,90569.849337325,VASP
19193,KEGG_2019_Human,Starch and sucrose metabolism,1/36,0.0017999657178272,0.0017999657178272,0,0,19964.0,126172.23364250171,GYG1
19194,KEGG_2019_Human,Fructose and mannose metabolism,1/33,0.0016499677032113,0.0016499677032113,0,0,19967.0,127928.56031580272,KHK
19195,KEGG_2019_Human,Phototransduction,1/28,0.0013999711732997,0.0113938210547091,0,0,19972.0,131242.0761597353,CALML6
19196,KEGG_2019_Human,Long-term potentiation,1/67,0.0033499481224912,0.0113938210547091,0,0,19933.0,113594.38808369274,CALML6
19197,KEGG_2019_Human,Amphetamine addiction,1/68,0.0033999476216189,0.0113938210547091,0,0,19932.0,113293.39338050144,CALML6
19198,KEGG_2019_Human,Renin secretion,1/69,0.003449947123837,0.0113938210547091,0,0,19931.0,112996.7391397682,CALML6
19199,KEGG_2019_Human,Gastric acid secretion,1/75,0.0037499442041125,0.0113938210547091,0,0,19925.0,111301.33528642564,CALML6
19200,KEGG_2019_Human,Glioma,1/75,0.0037499442041125,0.0113938210547091,0,0,19925.0,111301.33528642564,CALML6
19201,KEGG_2019_Human,Pertussis,1/76,0.0037999437281752,0.0113938210547091,0,0,19924.0,111031.8499691117,CALML6
19202,KEGG_2019_Human,Salivary secretion,1/90,0.0044999373439762,0.0113938210547091,0,0,19910.0,107587.50385474482,CALML6
19203,KEGG_2019_Human,GnRH signaling pathway,1/93,0.0046499360391879,0.0113938210547091,0,0,19907.0,106918.54242106884,CALML6
19204,KEGG_2019_Human,Circadian entrainment,1/97,0.0048499343304706,0.0113938210547091,0,0,19903.0,106058.9096435903,CALML6
19205,KEGG_2019_Human,Aldosterone synthesis and secretion,1/98,0.0048999339081079,0.0113938210547091,0,0,19902.0,105849.45495286948,CALML6
19206,KEGG_2019_Human,Phosphatidylinositol signaling system,1/99,0.0049499334884068,0.0113938210547091,0,0,19901.0,105642.09305076736,CALML6
19207,KEGG_2019_Human,Inflammatory mediator regulation of TRP channels,1/100,0.0049999330710556,0.0113938210547091,0,0,19900.0,105436.78197328727,CALML6
19208,KEGG_2019_Human,Melanogenesis,1/101,0.0050499326546803,0.0113938210547091,0,0,19899.0,105233.48101229242,CALML6
19209,KEGG_2019_Human,Glucagon signaling pathway,1/103,0.0051499318302617,0.0113938210547091,0,0,19897.0,104832.7525292024,CALML6
19210,KEGG_2019_Human,C-type lectin receptor signaling pathway,1/104,0.0051999314202997,0.0113938210547091,0,0,19896.0,104635.24941415618,CALML6
19211,KEGG_2019_Human,Neurotrophin signaling pathway,1/119,0.0059499254985137,0.0113938210547091,0,0,19881.0,101877.73080211312,CALML6
19212,KEGG_2019_Human,Oocyte meiosis,1/125,0.0062499232373748,0.0113938210547091,0,0,19875.0,100869.32368441945,CALML6
19213,KEGG_2019_Human,Dopaminergic synapse,1/131,0.0065499210316603,0.0113938210547091,0,0,19869.0,99907.33811343512,CALML6
19214,KEGG_2019_Human,Vascular smooth muscle contraction,1/132,0.0065999206698993,0.0113938210547091,0,0,19868.0,99751.22090491928,CALML6
19215,KEGG_2019_Human,Insulin signaling pathway,1/137,0.0068499188797651,0.0113938210547091,0,0,19863.0,98987.62735269018,CALML6
19216,KEGG_2019_Human,Estrogen signaling pathway,1/137,0.0068499188797651,0.0113938210547091,0,0,19863.0,98987.62735269018,CALML6
19217,KEGG_2019_Human,Apelin signaling pathway,1/137,0.0068499188797651,0.0113938210547091,0,0,19863.0,98987.62735269018,CALML6
19218,KEGG_2019_Human,Fluid shear stress and atherosclerosis,1/139,0.006949918172816,0.0113938210547091,0,0,19861.0,98689.81333375497,CALML6
19219,KEGG_2019_Human,Adrenergic signaling in cardiomyocytes,1/145,0.0072499160871101,0.0113938210547091,0,0,19855.0,97820.92670675044,CALML6
19220,KEGG_2019_Human,Oxytocin signaling pathway,1/153,0.0076499133771537,0.0113938210547091,0,0,19847.0,96715.6407630817,CALML6
19221,KEGG_2019_Human,Cellular senescence,1/160,0.0079999110688441,0.0113938210547091,0,0,19840.0,95793.96509856998,CALML6
19222,KEGG_2019_Human,cGMP-PKG signaling pathway,1/166,0.0082999091363732,0.0113938210547091,0,0,19834.0,95034.82345515196,CALML6
19223,KEGG_2019_Human,Alzheimer disease,1/171,0.0085499075557634,0.0113938210547091,0,0,19829.0,94422.42241345016,CALML6
19224,KEGG_2019_Human,Tuberculosis,1/179,0.0089499050800561,0.0113938210547091,0,0,19821.0,93478.0629355712,CALML6
19225,KEGG_2019_Human,Alcoholism,1/180,0.0089999047745351,0.0113938210547091,0,0,19820.0,93362.92821536642,CALML6
19226,KEGG_2019_Human,Kaposi sarcoma-associated herpesvirus infection,1/186,0.0092999029651357,0.0113938210547091,0,0,19814.0,92684.96451050608,CALML6
19227,KEGG_2019_Human,Calcium signaling pathway,1/188,0.009399902370135,0.0113938210547091,0,0,19812.0,92463.712994847,CALML6
19228,KEGG_2019_Human,Rap1 signaling pathway,1/206,0.010299897173561,0.0117776616695839,0,0,19794.0,90569.849337325,CALML6
19229,KEGG_2019_Human,Human immunodeficiency virus 1 infection,1/212,0.0105998955026255,0.0117776616695839,0,0,19788.0,89974.27756224656,CALML6
19230,KEGG_2019_Human,cAMP signaling pathway,1/212,0.0105998955026255,0.0117776616695839,0,0,19788.0,89974.27756224656,CALML6
19231,KEGG_2019_Human,Human cytomegalovirus infection,1/225,0.0112498919790339,0.0121620453827393,0,0,19775.0,88738.27077557483,CALML6
19232,KEGG_2019_Human,Ras signaling pathway,1/232,0.0115998901349604,0.0122104106683793,0,0,19768.0,88101.22480150245,CALML6
19233,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0227690733587457,0,0,19556.0,74462.79263140135,CALML6
19234,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,CALML6
19235,KEGG_2019_Human,Glycerolipid metabolism,1/61,0.0030499512001654,0.0048499343304706,0,0,19939.0,115499.24335773686,LCLAT1
19236,KEGG_2019_Human,Glycerophospholipid metabolism,1/97,0.0048499343304706,0.0048499343304706,0,0,19903.0,106058.9096435903,LCLAT1
19237,KEGG_2019_Human,TGF-beta signaling pathway,1/90,0.0044999373439762,0.0089998746879525,0,0,19910.0,107587.50385474482,DCN
19238,KEGG_2019_Human,Proteoglycans in cancer,1/201,0.0100498985877989,0.0100498985877989,0,0,19799.0,91079.21596609056,DCN
19239,KEGG_2019_Human,RNA transport,1/165,0.0082499094553477,0.0082499094553477,0,0,19835.0,95159.46482222488,ELAC2
19240,KEGG_2019_Human,Pentose and glucuronate interconversions,1/34,0.0016999670339032,0.0016999670339032,0,0,19966.0,127326.1054203148,CRYL1
19241,KEGG_2019_Human,Glycerolipid metabolism,1/61,0.0030499512001654,0.0061874168605085,0,0,19939.0,115499.24335773686,DGKQ
19242,KEGG_2019_Human,Glycerophospholipid metabolism,1/97,0.0048499343304706,0.0061874168605085,0,0,19903.0,106058.9096435903,DGKQ
19243,KEGG_2019_Human,Phosphatidylinositol signaling system,1/99,0.0049499334884068,0.0061874168605085,0,0,19901.0,105642.09305076736,DGKQ
19244,KEGG_2019_Human,Choline metabolism in cancer,1/99,0.0049499334884068,0.0061874168605085,0,0,19901.0,105642.09305076736,DGKQ
19245,KEGG_2019_Human,Phospholipase D signaling pathway,1/148,0.007399915061391,0.007399915061391,0,0,19852.0,97399.60470052566,DGKQ
19246,KEGG_2019_Human,Bile secretion,1/72,0.0035999456502131,0.004099940929819,0,0,19928.0,112131.59838572376,SULT2A1
19247,KEGG_2019_Human,Metabolism of xenobiotics by cytochrome P450,1/74,0.0036999446830449,0.004099940929819,0,0,19926.0,111574.38983110404,SULT2A1
19248,KEGG_2019_Human,Chemical carcinogenesis,1/82,0.004099940929819,0.004099940929819,0,0,19918.0,109484.9180722932,SULT2A1
19249,KEGG_2019_Human,Hematopoietic cell lineage,1/97,0.0048499343304706,0.0149997992131669,0,0,19903.0,106058.9096435903,EPO
19250,KEGG_2019_Human,HIF-1 signaling pathway,1/100,0.0049999330710556,0.0149997992131669,0,0,19900.0,105436.78197328727,EPO
19251,KEGG_2019_Human,JAK-STAT signaling pathway,1/162,0.0080999104202618,0.0161998208405236,0,0,19838.0,95537.86936302872,EPO
19252,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0212398351696402,0,0,19706.0,83157.67014793828,EPO
19253,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0212398351696402,0,0,19646.0,79255.8617626126,EPO
19254,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,EPO
19255,KEGG_2019_Human,Transcriptional misregulation in cancer,1/186,0.0092999029651357,0.0092999029651357,0,0,19814.0,92684.96451050608,FUS
19256,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,GALR2
19257,KEGG_2019_Human,Protein digestion and absorption,1/90,0.0044999373439762,0.0048999339081079,0,0,19910.0,107587.50385474482,CPB1
19258,KEGG_2019_Human,Pancreatic secretion,1/98,0.0048999339081079,0.0048999339081079,0,0,19902.0,105849.45495286948,CPB1
19259,KEGG_2019_Human,Thermogenesis,1/231,0.0115498903940656,0.0115498903940656,0,0,19769.0,88191.07730937863,COX19
19260,KEGG_2019_Human,Protein processing in endoplasmic reticulum,1/165,0.0082499094553477,0.0082499094553477,0,0,19835.0,95159.46482222488,RNF185
19261,KEGG_2019_Human,RNA degradation,1/79,0.0039499423167337,0.0066999199497742,0,0,19921.0,110243.89578070649,LSM8
19262,KEGG_2019_Human,Spliceosome,1/134,0.0066999199497742,0.0066999199497742,0,0,19866.0,99442.43560916925,LSM8
19263,KEGG_2019_Human,Porphyrin and chlorophyll metabolism,1/42,0.0020999619311272,0.0020999619311272,0,0,19958.0,123057.75613441122,HMBS
19264,KEGG_2019_Human,Endometrial cancer,1/58,0.0028999527887707,0.0100798902013314,0,0,19942.0,116522.31890946148,AXIN1
19265,KEGG_2019_Human,Basal cell carcinoma,1/63,0.0031499501598827,0.0100798902013314,0,0,19937.0,114844.46974572667,AXIN1
19266,KEGG_2019_Human,Colorectal cancer,1/86,0.0042999391173866,0.0100798902013314,0,0,19914.0,108514.46102290176,AXIN1
19267,KEGG_2019_Human,Signaling pathways regulating pluripotency of stem cells,1/139,0.006949918172816,0.0100798902013314,0,0,19861.0,98689.81333375497,AXIN1
19268,KEGG_2019_Human,Breast cancer,1/147,0.0073499154017982,0.0100798902013314,0,0,19853.0,97539.10874372096,AXIN1
19269,KEGG_2019_Human,Gastric cancer,1/149,0.0074499147221605,0.0100798902013314,0,0,19851.0,97261.02051561224,AXIN1
19270,KEGG_2019_Human,Cushing syndrome,1/155,0.0077499127120574,0.0100798902013314,0,0,19845.0,96448.16254952336,AXIN1
19271,KEGG_2019_Human,Wnt signaling pathway,1/158,0.0078999117225733,0.0100798902013314,0,0,19842.0,96053.2110949472,AXIN1
19272,KEGG_2019_Human,Hippo signaling pathway,1/160,0.0079999110688441,0.0100798902013314,0,0,19840.0,95793.96509856998,AXIN1
19273,KEGG_2019_Human,Hepatocellular carcinoma,1/168,0.0083999085011095,0.0100798902013314,0,0,19832.0,94787.72752807094,AXIN1
19274,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0179998554097794,0,0,19670.0,80733.60565076157,AXIN1
19275,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,AXIN1
19276,KEGG_2019_Human,Phosphonate and phosphinate metabolism,1/6,0.0002999905873105514,0.0008999717619316542,0,0,19994.0,162186.51863187927,SELENOI
19277,KEGG_2019_Human,Ether lipid metabolism,1/47,0.0023499589392381,0.0035249384088572,0,0,19953.0,120782.64067395544,SELENOI
19278,KEGG_2019_Human,Glycerophospholipid metabolism,1/97,0.0048499343304706,0.0048499343304706,0,0,19903.0,106058.9096435903,SELENOI
19279,KEGG_2019_Human,Epithelial cell signaling in Helicobacter pylori infection,1/68,0.0033999476216189,0.0033999476216189,0,0,19932.0,113293.39338050144,CSK
19280,KEGG_2019_Human,Glycosaminoglycan biosynthesis,1/53,0.0026499555173137,0.0026499555173137,0,0,19947.0,118349.78824235698,CHST3
19281,KEGG_2019_Human,Endocrine and other factor-regulated calcium reabsorption,1/48,0.0023999583567988,0.0077998855680932,0,0,19952.0,120356.5272753826,AP2B1
19282,KEGG_2019_Human,Synaptic vesicle cycle,1/78,0.0038999427840466,0.0077998855680932,0,0,19922.0,110503.2180492851,AP2B1
19283,KEGG_2019_Human,Huntington disease,1/193,0.0096499008972596,0.0121998870519305,0,0,19807.0,91920.47679471428,AP2B1
19284,KEGG_2019_Human,Endocytosis,1/244,0.0121998870519305,0.0121998870519305,0,0,19756.0,87051.4275316661,AP2B1
19285,KEGG_2019_Human,Th1 and Th2 cell differentiation,1/92,0.0045999364719865,0.0091698894443244,0,0,19908.0,107139.13814408927,CD247
19286,KEGG_2019_Human,T cell receptor signaling pathway,1/101,0.0050499326546803,0.0091698894443244,0,0,19899.0,105233.48101229242,CD247
19287,KEGG_2019_Human,Chagas disease (American trypanosomiasis),1/103,0.0051499318302617,0.0091698894443244,0,0,19897.0,104832.7525292024,CD247
19288,KEGG_2019_Human,Th17 cell differentiation,1/107,0.0053499302026925,0.0091698894443244,0,0,19893.0,104053.753408911,CD247
19289,KEGG_2019_Human,Natural killer cell mediated cytotoxicity,1/131,0.0065499210316603,0.0091698894443244,0,0,19869.0,99907.33811343512,CD247
19290,KEGG_2019_Human,Epstein-Barr virus infection,1/201,0.0100498985877989,0.0105998955026255,0,0,19799.0,91079.21596609056,CD247
19291,KEGG_2019_Human,Human immunodeficiency virus 1 infection,1/212,0.0105998955026255,0.0105998955026255,0,0,19788.0,89974.27756224656,CD247
19292,KEGG_2019_Human,Oxidative phosphorylation,1/133,0.0066499203093911,0.0066499203093911,0,0,19867.0,99596.2591544721,ATP12A
19293,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,UTS2R
19294,KEGG_2019_Human,Maturity onset diabetes of the young,1/26,0.0012999726251831,0.0097713176290677,0,0,19974.0,132735.46073187632,INS
19295,KEGG_2019_Human,Aldosterone-regulated sodium reabsorption,1/37,0.0018499650702878,0.0097713176290677,0,0,19963.0,125618.9446446357,INS
19296,KEGG_2019_Human,Type I diabetes mellitus,1/43,0.0021499613216957,0.0097713176290677,0,0,19957.0,122581.98940490963,INS
19297,KEGG_2019_Human,Type II diabetes mellitus,1/46,0.0022999595269283,0.0097713176290677,0,0,19954.0,121217.8313311442,INS
19298,KEGG_2019_Human,Ovarian steroidogenesis,1/49,0.0024499577795033,0.0097713176290677,0,0,19951.0,119939.1172087114,INS
19299,KEGG_2019_Human,Regulation of lipolysis in adipocytes,1/55,0.0027499544131125,0.0097713176290677,0,0,19945.0,117599.1294878737,INS
19300,KEGG_2019_Human,Prolactin signaling pathway,1/70,0.0034999466296654,0.0097713176290677,0,0,19930.0,112704.30065625212,INS
19301,KEGG_2019_Human,Insulin secretion,1/86,0.0042999391173866,0.0097713176290677,0,0,19914.0,108514.46102290176,INS
19302,KEGG_2019_Human,Prostate cancer,1/97,0.0048499343304706,0.0097713176290677,0,0,19903.0,106058.9096435903,INS
19303,KEGG_2019_Human,Progesterone-mediated oocyte maturation,1/99,0.0049499334884068,0.0097713176290677,0,0,19901.0,105642.09305076736,INS
19304,KEGG_2019_Human,HIF-1 signaling pathway,1/100,0.0049999330710556,0.0097713176290677,0,0,19900.0,105436.78197328727,INS
19305,KEGG_2019_Human,Longevity regulating pathway,1/102,0.0050999322416682,0.0097713176290677,0,0,19898.0,105032.15064717118,INS
19306,KEGG_2019_Human,Insulin resistance,1/108,0.0053999298011749,0.0097713176290677,0,0,19892.0,103863.47861844616,INS
19307,KEGG_2019_Human,AMPK signaling pathway,1/120,0.0059999251180858,0.0097713176290677,0,0,19880.0,101706.2448082016,INS
19308,KEGG_2019_Human,Oocyte meiosis,1/125,0.0062499232373748,0.0097713176290677,0,0,19875.0,100869.32368441945,INS
19309,KEGG_2019_Human,Autophagy,1/128,0.0063999221281459,0.0097713176290677,0,0,19872.0,100382.8010329652,INS
19310,KEGG_2019_Human,FoxO signaling pathway,1/132,0.0065999206698993,0.0097713176290677,0,0,19868.0,99751.22090491928,INS
19311,KEGG_2019_Human,Insulin signaling pathway,1/137,0.0068499188797651,0.0097713176290677,0,0,19863.0,98987.62735269018,INS
19312,KEGG_2019_Human,Phospholipase D signaling pathway,1/148,0.007399915061391,0.0097713176290677,0,0,19852.0,97399.60470052566,INS
19313,KEGG_2019_Human,Non-alcoholic fatty liver disease (NAFLD),1/149,0.0074499147221605,0.0097713176290677,0,0,19851.0,97261.02051561224,INS
19314,KEGG_2019_Human,mTOR signaling pathway,1/152,0.0075999137114971,0.0097713176290677,0,0,19848.0,96850.665715497,INS
19315,KEGG_2019_Human,cGMP-PKG signaling pathway,1/166,0.0082999091363732,0.0101862521219126,0,0,19834.0,95034.82345515196,INS
19316,KEGG_2019_Human,Rap1 signaling pathway,1/206,0.010299897173561,0.0120373818203326,0,0,19794.0,90569.849337325,INS
19317,KEGG_2019_Human,Regulation of actin cytoskeleton,1/214,0.0106998949514067,0.0120373818203326,0,0,19786.0,89779.39753374986,INS
19318,KEGG_2019_Human,Ras signaling pathway,1/232,0.0115998901349604,0.0125278813457572,0,0,19768.0,88101.22480150245,INS
19319,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0153171778364834,0,0,19705.0,83086.53988020132,INS
19320,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0176998626413668,0,0,19646.0,79255.8617626126,INS
19321,KEGG_2019_Human,Other glycan degradation,1/18,0.0008999788927950273,0.0008999788927950273,0,0,19982.0,140136.54844084635,MAN2B2
19322,KEGG_2019_Human,Glycerolipid metabolism,1/61,0.0030499512001654,0.0048499343304706,0,0,19939.0,115499.24335773686,PLPP5
19323,KEGG_2019_Human,Glycerophospholipid metabolism,1/97,0.0048499343304706,0.0048499343304706,0,0,19903.0,106058.9096435903,PLPP5
19324,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0146998751759735,0,0,19706.0,83157.67014793828,TNFRSF25
19325,KEGG_2019_Human,Pentose and glucuronate interconversions,1/34,0.0016999670339032,0.0033999340678064,0,0,19966.0,127326.1054203148,DHDH
19326,KEGG_2019_Human,Metabolism of xenobiotics by cytochrome P450,1/74,0.0036999446830449,0.0036999446830449,0,0,19926.0,111574.38983110404,DHDH
19327,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR4C3
19328,KEGG_2019_Human,Adrenergic signaling in cardiomyocytes,1/145,0.0072499160871101,0.0072499160871101,0,0,19855.0,97820.92670675044,CREM
19329,KEGG_2019_Human,Primary immunodeficiency,1/37,0.0018499650702878,0.0080832238841178,0,0,19963.0,125618.9446446357,CD19
19330,KEGG_2019_Human,B cell receptor signaling pathway,1/71,0.0035499461386618,0.0080832238841178,0,0,19929.0,112415.9585341616,CD19
19331,KEGG_2019_Human,Hematopoietic cell lineage,1/97,0.0048499343304706,0.0080832238841178,0,0,19903.0,106058.9096435903,CD19
19332,KEGG_2019_Human,Epstein-Barr virus infection,1/201,0.0100498985877989,0.0125623732347487,0,0,19799.0,91079.21596609056,CD19
19333,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0176998626413668,0,0,19646.0,79255.8617626126,CD19
19334,KEGG_2019_Human,VEGF signaling pathway,1/59,0.0029499522555206,0.0117248816857654,0,0,19941.0,116175.59385530632,MAPKAPK2
19335,KEGG_2019_Human,C-type lectin receptor signaling pathway,1/104,0.0051999314202997,0.0117248816857654,0,0,19896.0,104635.24941415618,MAPKAPK2
19336,KEGG_2019_Human,Neurotrophin signaling pathway,1/119,0.0059499254985137,0.0117248816857654,0,0,19881.0,101877.73080211312,MAPKAPK2
19337,KEGG_2019_Human,Cellular senescence,1/160,0.0079999110688441,0.0117248816857654,0,0,19840.0,95793.96509856998,MAPKAPK2
19338,KEGG_2019_Human,Kaposi sarcoma-associated herpesvirus infection,1/186,0.0092999029651357,0.0117248816857654,0,0,19814.0,92684.96451050608,MAPKAPK2
19339,KEGG_2019_Human,Viral carcinogenesis,1/201,0.0100498985877989,0.0117248816857654,0,0,19799.0,91079.21596609056,MAPKAPK2
19340,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0147498749536506,0,0,19705.0,83086.53988020132,MAPKAPK2
19341,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,UTS2
19342,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF682
19343,KEGG_2019_Human,Adherens junction,1/72,0.0035999456502131,0.0035999456502131,0,0,19928.0,112131.59838572376,SSX2IP
19344,KEGG_2019_Human,RNA degradation,1/79,0.0039499423167337,0.0039499423167337,0,0,19921.0,110243.89578070649,ZCCHC7
19345,KEGG_2019_Human,Phosphonate and phosphinate metabolism,1/6,0.0002999905873105514,0.0005999811746211028,0,0,19994.0,162186.51863187927,PCYT2
19346,KEGG_2019_Human,Glycerophospholipid metabolism,1/97,0.0048499343304706,0.0048499343304706,0,0,19903.0,106058.9096435903,PCYT2
19347,KEGG_2019_Human,Basal cell carcinoma,1/63,0.0031499501598827,0.0109198810514423,0,0,19937.0,114844.46974572667,WNT6
19348,KEGG_2019_Human,Melanogenesis,1/101,0.0050499326546803,0.0109198810514423,0,0,19899.0,105233.48101229242,WNT6
19349,KEGG_2019_Human,Signaling pathways regulating pluripotency of stem cells,1/139,0.006949918172816,0.0109198810514423,0,0,19861.0,98689.81333375497,WNT6
19350,KEGG_2019_Human,Breast cancer,1/147,0.0073499154017982,0.0109198810514423,0,0,19853.0,97539.10874372096,WNT6
19351,KEGG_2019_Human,Gastric cancer,1/149,0.0074499147221605,0.0109198810514423,0,0,19851.0,97261.02051561224,WNT6
19352,KEGG_2019_Human,mTOR signaling pathway,1/152,0.0075999137114971,0.0109198810514423,0,0,19848.0,96850.665715497,WNT6
19353,KEGG_2019_Human,Cushing syndrome,1/155,0.0077499127120574,0.0109198810514423,0,0,19845.0,96448.16254952336,WNT6
19354,KEGG_2019_Human,Wnt signaling pathway,1/158,0.0078999117225733,0.0109198810514423,0,0,19842.0,96053.2110949472,WNT6
19355,KEGG_2019_Human,Hippo signaling pathway,1/160,0.0079999110688441,0.0109198810514423,0,0,19840.0,95793.96509856998,WNT6
19356,KEGG_2019_Human,Hepatocellular carcinoma,1/168,0.0083999085011095,0.0109198810514423,0,0,19832.0,94787.72752807094,WNT6
19357,KEGG_2019_Human,Proteoglycans in cancer,1/201,0.0100498985877989,0.0118771528764897,0,0,19799.0,91079.21596609056,WNT6
19358,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0178748564138782,0,0,19670.0,80733.60565076157,WNT6
19359,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,WNT6
19360,KEGG_2019_Human,Protein processing in endoplasmic reticulum,1/165,0.0082499094553477,0.0082499094553477,0,0,19835.0,95159.46482222488,PREB
19361,KEGG_2019_Human,Collecting duct acid secretion,1/27,0.0013499718942362,0.0081898864329657,0,0,19973.0,131975.02298599784,ATP6V1E2
19362,KEGG_2019_Human,Vibrio cholerae infection,1/50,0.0024999572069037,0.0081898864329657,0,0,19950.0,119530.05920663515,ATP6V1E2
19363,KEGG_2019_Human,Epithelial cell signaling in Helicobacter pylori infection,1/68,0.0033999476216189,0.0081898864329657,0,0,19932.0,113293.39338050144,ATP6V1E2
19364,KEGG_2019_Human,Synaptic vesicle cycle,1/78,0.0038999427840466,0.0081898864329657,0,0,19922.0,110503.2180492851,ATP6V1E2
19365,KEGG_2019_Human,Rheumatoid arthritis,1/91,0.0045499369072032,0.0081898864329657,0,0,19909.0,107362.10783923086,ATP6V1E2
19366,KEGG_2019_Human,Oxidative phosphorylation,1/133,0.0066499203093911,0.0085499029254342,0,0,19867.0,99596.2591544721,ATP6V1E2
19367,KEGG_2019_Human,mTOR signaling pathway,1/152,0.0075999137114971,0.0085499029254342,0,0,19848.0,96850.665715497,ATP6V1E2
19368,KEGG_2019_Human,Phagosome,1/152,0.0075999137114971,0.0085499029254342,0,0,19848.0,96850.665715497,ATP6V1E2
19369,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0164998674589645,0,0,19670.0,80733.60565076157,ATP6V1E2
19370,KEGG_2019_Human,Vasopressin-regulated water reabsorption,1/44,0.0021999607179423,0.0021999607179423,0,0,19956.0,122117.06559109331,DCTN6
19371,KEGG_2019_Human,ABC transporters,1/45,0.0022499601197094,0.0022499601197094,0,0,19955.0,121662.49782449217,ABCG1
19372,KEGG_2019_Human,alpha-Linolenic acid metabolism,1/25,0.0012499733663791,0.0083598935608305,0,0,19975.0,133525.54486996148,PLA2G4A
19373,KEGG_2019_Human,Linoleic acid metabolism,1/29,0.001449970461791,0.0083598935608305,0,0,19971.0,130534.69172799008,PLA2G4A
19374,KEGG_2019_Human,Ether lipid metabolism,1/47,0.0023499589392381,0.0083598935608305,0,0,19953.0,120782.64067395544,PLA2G4A
19375,KEGG_2019_Human,Ovarian steroidogenesis,1/49,0.0024499577795033,0.0083598935608305,0,0,19951.0,119939.1172087114,PLA2G4A
19376,KEGG_2019_Human,VEGF signaling pathway,1/59,0.0029499522555206,0.0083598935608305,0,0,19941.0,116175.59385530632,PLA2G4A
19377,KEGG_2019_Human,Long-term depression,1/60,0.002999951725986,0.0083598935608305,0,0,19940.0,115834.63209072244,PLA2G4A
19378,KEGG_2019_Human,Arachidonic acid metabolism,1/63,0.0031499501598827,0.0083598935608305,0,0,19937.0,114844.46974572667,PLA2G4A
19379,KEGG_2019_Human,Fc epsilon RI signaling pathway,1/68,0.0033999476216189,0.0083598935608305,0,0,19932.0,113293.39338050144,PLA2G4A
19380,KEGG_2019_Human,Fc gamma R-mediated phagocytosis,1/91,0.0045499369072032,0.0083598935608305,0,0,19909.0,107362.10783923086,PLA2G4A
19381,KEGG_2019_Human,GnRH signaling pathway,1/93,0.0046499360391879,0.0083598935608305,0,0,19907.0,106918.54242106884,PLA2G4A
19382,KEGG_2019_Human,Glycerophospholipid metabolism,1/97,0.0048499343304706,0.0083598935608305,0,0,19903.0,106058.9096435903,PLA2G4A
19383,KEGG_2019_Human,Choline metabolism in cancer,1/99,0.0049499334884068,0.0083598935608305,0,0,19901.0,105642.09305076736,PLA2G4A
19384,KEGG_2019_Human,Inflammatory mediator regulation of TRP channels,1/100,0.0049999330710556,0.0083598935608305,0,0,19900.0,105436.78197328727,PLA2G4A
19385,KEGG_2019_Human,Serotonergic synapse,1/113,0.0056499278191151,0.0083598935608305,0,0,19887.0,102937.34947211576,PLA2G4A
19386,KEGG_2019_Human,Glutamatergic synapse,1/114,0.005699927427839,0.0083598935608305,0,0,19886.0,102756.96431429044,PLA2G4A
19387,KEGG_2019_Human,Platelet activation,1/124,0.0061999236097501,0.0085248949634064,0,0,19876.0,101034.04709010696,PLA2G4A
19388,KEGG_2019_Human,Vascular smooth muscle contraction,1/132,0.0065999206698993,0.008541073808105,0,0,19868.0,99751.22090491928,PLA2G4A
19389,KEGG_2019_Human,Phospholipase D signaling pathway,1/148,0.007399915061391,0.0088577944367043,0,0,19852.0,97399.60470052566,PLA2G4A
19390,KEGG_2019_Human,Oxytocin signaling pathway,1/153,0.0076499133771537,0.0088577944367043,0,0,19847.0,96715.6407630817,PLA2G4A
19391,KEGG_2019_Human,Necroptosis,1/162,0.0080999104202618,0.008909901462288,0,0,19838.0,95537.86936302872,PLA2G4A
19392,KEGG_2019_Human,Ras signaling pathway,1/232,0.0115998901349604,0.0121522658556728,0,0,19768.0,88101.22480150245,PLA2G4A
19393,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0147498749536506,0,0,19705.0,83086.53988020132,PLA2G4A
19394,KEGG_2019_Human,Insulin signaling pathway,1/137,0.0068499188797651,0.0068499188797651,0,0,19863.0,98987.62735269018,PRKAR1A
19395,KEGG_2019_Human,Starch and sucrose metabolism,1/36,0.0017999657178272,0.0017999657178272,0,0,19964.0,126172.23364250171,GYG2
19396,KEGG_2019_Human,Protein digestion and absorption,1/90,0.0044999373439762,0.0048999339081079,0,0,19910.0,107587.50385474482,CELA2A
19397,KEGG_2019_Human,Pancreatic secretion,1/98,0.0048999339081079,0.0048999339081079,0,0,19902.0,105849.45495286948,CELA2A
19398,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0146998751759735,0,0,19706.0,83157.67014793828,GDF2
19399,KEGG_2019_Human,Ubiquinone and other terpenoid-quinone biosynthesis,1/11,0.0005499852259717758,0.0005499852259717758,0,0,19989.0,150029.8210287992,COQ2
19400,KEGG_2019_Human,Primary bile acid biosynthesis,1/17,0.0008499797390404818,0.0008499797390404818,0,0,19983.0,141285.76583697114,CYP39A1
19401,KEGG_2019_Human,Axon guidance,1/181,0.0090499044707863,0.0090499044707863,0,0,19819.0,93248.41634586031,FES
19402,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0146998751759735,0,0,19706.0,83157.67014793828,IL32
19403,KEGG_2019_Human,Osteoclast differentiation,1/127,0.0063499224962247,0.0063499224962247,0,0,19873.0,100543.72072014232,OSCAR
19404,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR2J2
19405,KEGG_2019_Human,Aldosterone synthesis and secretion,1/98,0.0048999339081079,0.0092999029651357,0,0,19902.0,105849.45495286948,ATF1
19406,KEGG_2019_Human,Transcriptional misregulation in cancer,1/186,0.0092999029651357,0.0092999029651357,0,0,19814.0,92684.96451050608,ATF1
19407,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR6C68
19408,KEGG_2019_Human,Glutathione metabolism,1/56,0.0027999538675741,0.0094498771520562,0,0,19944.0,117233.87022514464,MGST3
19409,KEGG_2019_Human,Metabolism of xenobiotics by cytochrome P450,1/74,0.0036999446830449,0.0094498771520562,0,0,19926.0,111574.38983110404,MGST3
19410,KEGG_2019_Human,Chemical carcinogenesis,1/82,0.004099940929819,0.0094498771520562,0,0,19918.0,109484.9180722932,MGST3
19411,KEGG_2019_Human,Drug metabolism,1/108,0.0053999298011749,0.0094498771520562,0,0,19892.0,103863.47861844616,MGST3
19412,KEGG_2019_Human,Fluid shear stress and atherosclerosis,1/139,0.006949918172816,0.0097298854419424,0,0,19861.0,98689.81333375497,MGST3
19413,KEGG_2019_Human,Hepatocellular carcinoma,1/168,0.0083999085011095,0.0097998932512944,0,0,19832.0,94787.72752807094,MGST3
19414,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,MGST3
19415,KEGG_2019_Human,Apelin signaling pathway,1/137,0.0068499188797651,0.0100498985877989,0,0,19863.0,98987.62735269018,HDAC5
19416,KEGG_2019_Human,Alcoholism,1/180,0.0089999047745351,0.0100498985877989,0,0,19820.0,93362.92821536642,HDAC5
19417,KEGG_2019_Human,Viral carcinogenesis,1/201,0.0100498985877989,0.0100498985877989,0,0,19799.0,91079.21596609056,HDAC5
19418,KEGG_2019_Human,Mitophagy,1/65,0.003249949134407,0.003249949134407,0,0,19935.0,114209.92613860144,RHOT2
19419,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0146998751759735,0,0,19706.0,83157.67014793828,IL31RA
19420,KEGG_2019_Human,Hematopoietic cell lineage,1/97,0.0048499343304706,0.0048499343304706,0,0,19903.0,106058.9096435903,CD5
19421,KEGG_2019_Human,Ribosome biogenesis in eukaryotes,1/101,0.0050499326546803,0.0050499326546803,0,0,19899.0,105233.48101229242,RRP7A
19422,KEGG_2019_Human,Proteasome,1/45,0.0022499601197094,0.0022499601197094,0,0,19955.0,121662.49782449217,PSMB10
19423,KEGG_2019_Human,Fc gamma R-mediated phagocytosis,1/91,0.0045499369072032,0.0106998949514067,0,0,19909.0,107362.10783923086,LIMK2
19424,KEGG_2019_Human,Axon guidance,1/181,0.0090499044707863,0.0106998949514067,0,0,19819.0,93248.41634586031,LIMK2
19425,KEGG_2019_Human,Human immunodeficiency virus 1 infection,1/212,0.0105998955026255,0.0106998949514067,0,0,19788.0,89974.27756224656,LIMK2
19426,KEGG_2019_Human,Regulation of actin cytoskeleton,1/214,0.0106998949514067,0.0106998949514067,0,0,19786.0,89779.39753374986,LIMK2
19427,KEGG_2019_Human,p53 signaling pathway,1/72,0.0035999456502131,0.0035999456502131,0,0,19928.0,112131.59838572376,GORAB
19428,KEGG_2019_Human,Arrhythmogenic right ventricular cardiomyopathy (ARVC),1/72,0.0035999456502131,0.0079623895876056,0,0,19928.0,112131.59838572376,CACNG4
19429,KEGG_2019_Human,Cardiac muscle contraction,1/78,0.0038999427840466,0.0079623895876056,0,0,19922.0,110503.2180492851,CACNG4
19430,KEGG_2019_Human,Hypertrophic cardiomyopathy (HCM),1/85,0.004249939567045,0.0079623895876056,0,0,19915.0,108752.83801948265,CACNG4
19431,KEGG_2019_Human,Dilated cardiomyopathy (DCM),1/91,0.0045499369072032,0.0079623895876056,0,0,19909.0,107362.10783923086,CACNG4
19432,KEGG_2019_Human,Adrenergic signaling in cardiomyocytes,1/145,0.0072499160871101,0.0089248989400127,0,0,19855.0,97820.92670675044,CACNG4
19433,KEGG_2019_Human,Oxytocin signaling pathway,1/153,0.0076499133771537,0.0089248989400127,0,0,19847.0,96715.6407630817,CACNG4
19434,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0147498749536506,0,0,19705.0,83086.53988020132,CACNG4
19435,KEGG_2019_Human,D-Glutamine and D-glutamate metabolism,1/5,0.0002499917995416556,0.0014999507972499,0,0,19995.0,165840.17843725558,GLUD1
19436,KEGG_2019_Human,Nitrogen metabolism,1/17,0.0008499797390404818,0.0017249623229924,0,0,19983.0,141285.76583697114,GLUD1
19437,KEGG_2019_Human,Arginine biosynthesis,1/21,0.0010499764455398,0.0017249623229924,0,0,19979.0,137035.71221916509,GLUD1
19438,KEGG_2019_Human,Proximal tubule bicarbonate reclamation,1/23,0.0011499748819949,0.0017249623229924,0,0,19977.0,135204.63922267244,GLUD1
19439,KEGG_2019_Human,"Alanine, aspartate and glutamate metabolism",1/35,0.0017499663721595,0.0020999596465915,0,0,19965.0,126740.98858805298,GLUD1
19440,KEGG_2019_Human,Necroptosis,1/162,0.0080999104202618,0.0080999104202618,0,0,19838.0,95537.86936302872,GLUD1
19441,KEGG_2019_Human,African trypanosomiasis,1/37,0.0018499650702878,0.0096665547828135,0,0,19963.0,125618.9446446357,ICAM1
19442,KEGG_2019_Human,Malaria,1/49,0.0024499577795033,0.0096665547828135,0,0,19951.0,119939.1172087114,ICAM1
19443,KEGG_2019_Human,Viral myocarditis,1/59,0.0029499522555206,0.0096665547828135,0,0,19941.0,116175.59385530632,ICAM1
19444,KEGG_2019_Human,Staphylococcus aureus infection,1/68,0.0033999476216189,0.0096665547828135,0,0,19932.0,113293.39338050144,ICAM1
19445,KEGG_2019_Human,Rheumatoid arthritis,1/91,0.0045499369072032,0.0096665547828135,0,0,19909.0,107362.10783923086,ICAM1
19446,KEGG_2019_Human,NF-kappa B signaling pathway,1/95,0.0047499351803394,0.0096665547828135,0,0,19905.0,106484.27183626965,ICAM1
19447,KEGG_2019_Human,AGE-RAGE signaling pathway in diabetic complications,1/100,0.0049999330710556,0.0096665547828135,0,0,19900.0,105436.78197328727,ICAM1
19448,KEGG_2019_Human,TNF signaling pathway,1/110,0.0054999290027479,0.0096665547828135,0,0,19890.0,103488.06969787036,ICAM1
19449,KEGG_2019_Human,Leukocyte transendothelial migration,1/112,0.0055999282120529,0.0096665547828135,0,0,19888.0,103119.30984392198,ICAM1
19450,KEGG_2019_Human,Natural killer cell mediated cytotoxicity,1/131,0.0065499210316603,0.0096665547828135,0,0,19869.0,99907.33811343512,ICAM1
19451,KEGG_2019_Human,Fluid shear stress and atherosclerosis,1/139,0.006949918172816,0.0096665547828135,0,0,19861.0,98689.81333375497,ICAM1
19452,KEGG_2019_Human,Cell adhesion molecules (CAMs),1/145,0.0072499160871101,0.0096665547828135,0,0,19855.0,97820.92670675044,ICAM1
19453,KEGG_2019_Human,Influenza A,1/171,0.0085499075557634,0.0105229631455549,0,0,19829.0,94422.42241345016,ICAM1
19454,KEGG_2019_Human,Kaposi sarcoma-associated herpesvirus infection,1/186,0.0092999029651357,0.0106284605315837,0,0,19814.0,92684.96451050608,ICAM1
19455,KEGG_2019_Human,Epstein-Barr virus infection,1/201,0.0100498985877989,0.0107198918269855,0,0,19799.0,91079.21596609056,ICAM1
19456,KEGG_2019_Human,Human T-cell leukemia virus 1 infection,1/219,0.0109498935894162,0.0109498935894162,0,0,19781.0,89299.85161916987,ICAM1
19457,KEGG_2019_Human,Mucin type O-glycan biosynthesis,1/31,0.0015499690656704,0.0015499690656704,0,0,19969.0,129189.85098816035,GCNT1
19458,KEGG_2019_Human,Chemokine signaling pathway,1/190,0.0094999017791995,0.0146998751759735,0,0,19810.0,92244.74636351672,CX3CR1
19459,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0146998751759735,0,0,19706.0,83157.67014793828,CX3CR1
19460,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR2Y1
19461,KEGG_2019_Human,Basal cell carcinoma,1/63,0.0031499501598827,0.0109198810514423,0,0,19937.0,114844.46974572667,WNT2
19462,KEGG_2019_Human,Melanogenesis,1/101,0.0050499326546803,0.0109198810514423,0,0,19899.0,105233.48101229242,WNT2
19463,KEGG_2019_Human,Signaling pathways regulating pluripotency of stem cells,1/139,0.006949918172816,0.0109198810514423,0,0,19861.0,98689.81333375497,WNT2
19464,KEGG_2019_Human,Breast cancer,1/147,0.0073499154017982,0.0109198810514423,0,0,19853.0,97539.10874372096,WNT2
19465,KEGG_2019_Human,Gastric cancer,1/149,0.0074499147221605,0.0109198810514423,0,0,19851.0,97261.02051561224,WNT2
19466,KEGG_2019_Human,mTOR signaling pathway,1/152,0.0075999137114971,0.0109198810514423,0,0,19848.0,96850.665715497,WNT2
19467,KEGG_2019_Human,Cushing syndrome,1/155,0.0077499127120574,0.0109198810514423,0,0,19845.0,96448.16254952336,WNT2
19468,KEGG_2019_Human,Wnt signaling pathway,1/158,0.0078999117225733,0.0109198810514423,0,0,19842.0,96053.2110949472,WNT2
19469,KEGG_2019_Human,Hippo signaling pathway,1/160,0.0079999110688441,0.0109198810514423,0,0,19840.0,95793.96509856998,WNT2
19470,KEGG_2019_Human,Hepatocellular carcinoma,1/168,0.0083999085011095,0.0109198810514423,0,0,19832.0,94787.72752807094,WNT2
19471,KEGG_2019_Human,Proteoglycans in cancer,1/201,0.0100498985877989,0.0118771528764897,0,0,19799.0,91079.21596609056,WNT2
19472,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0178748564138782,0,0,19670.0,80733.60565076157,WNT2
19473,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,WNT2
19474,KEGG_2019_Human,Platelet activation,1/124,0.0061999236097501,0.009399902370135,0,0,19876.0,101034.04709010696,STIM1
19475,KEGG_2019_Human,Calcium signaling pathway,1/188,0.009399902370135,0.009399902370135,0,0,19812.0,92463.712994847,STIM1
19476,KEGG_2019_Human,Pertussis,1/76,0.0037999437281752,0.0077498933986465,0,0,19924.0,111031.8499691117,CXCL6
19477,KEGG_2019_Human,Rheumatoid arthritis,1/91,0.0045499369072032,0.0077498933986465,0,0,19909.0,107362.10783923086,CXCL6
19478,KEGG_2019_Human,IL-17 signaling pathway,1/93,0.0046499360391879,0.0077498933986465,0,0,19907.0,106918.54242106884,CXCL6
19479,KEGG_2019_Human,Chemokine signaling pathway,1/190,0.0094999017791995,0.0118748772239994,0,0,19810.0,92244.74636351672,CXCL6
19480,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0146998751759735,0,0,19706.0,83157.67014793828,CXCL6
19481,KEGG_2019_Human,Aldosterone-regulated sodium reabsorption,1/37,0.0018499650702878,0.002999951725986,0,0,19963.0,125618.9446446357,HSD11B2
19482,KEGG_2019_Human,Steroid hormone biosynthesis,1/60,0.002999951725986,0.002999951725986,0,0,19940.0,115834.63209072244,HSD11B2
19483,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR51G1
19484,KEGG_2019_Human,Complement and coagulation cascades,1/79,0.0039499423167337,0.0039499423167337,0,0,19921.0,110243.89578070649,SERPINF2
19485,KEGG_2019_Human,Endocytosis,1/244,0.0121998870519305,0.0121998870519305,0,0,19756.0,87051.4275316661,SH3GLB2
19486,KEGG_2019_Human,Fc gamma R-mediated phagocytosis,1/91,0.0045499369072032,0.0090998738144064,0,0,19909.0,107362.10783923086,ASAP3
19487,KEGG_2019_Human,Endocytosis,1/244,0.0121998870519305,0.0121998870519305,0,0,19756.0,87051.4275316661,ASAP3
19488,KEGG_2019_Human,Steroid biosynthesis,1/19,0.00094997806231055,0.0028499341869316,0,0,19981.0,139049.2109571672,LIPA
19489,KEGG_2019_Human,Cholesterol metabolism,1/50,0.0024999572069037,0.0037499358103555,0,0,19950.0,119530.05920663515,LIPA
19490,KEGG_2019_Human,Lysosome,1/123,0.0061499239842961,0.0061499239842961,0,0,19877.0,101200.07933676826,LIPA
19491,KEGG_2019_Human,Taurine and hypotaurine metabolism,1/11,0.0005499852259717758,0.0005499852259717758,0,0,19989.0,150029.8210287992,CSAD
19492,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,CHRNA2
19493,KEGG_2019_Human,Primary immunodeficiency,1/37,0.0018499650702878,0.0055498952108636,0,0,19963.0,125618.9446446357,RFX5
19494,KEGG_2019_Human,Antigen processing and presentation,1/77,0.0038499432547502,0.0057749148821253,0,0,19923.0,110765.8407373636,RFX5
19495,KEGG_2019_Human,Tuberculosis,1/179,0.0089499050800561,0.0089499050800561,0,0,19821.0,93478.0629355712,RFX5
19496,KEGG_2019_Human,Adherens junction,1/72,0.0035999456502131,0.0071998913004262,0,0,19928.0,112131.59838572376,NECTIN2
19497,KEGG_2019_Human,Cell adhesion molecules (CAMs),1/145,0.0072499160871101,0.0072499160871101,0,0,19855.0,97820.92670675044,NECTIN2
19498,KEGG_2019_Human,Nucleotide excision repair,1/47,0.0023499589392381,0.0026999549628563,0,0,19953.0,120782.64067395544,ERCC1
19499,KEGG_2019_Human,Fanconi anemia pathway,1/54,0.0026999549628563,0.0026999549628563,0,0,19946.0,117971.01964061816,ERCC1
19500,KEGG_2019_Human,Necroptosis,1/162,0.0080999104202618,0.0080999104202618,0,0,19838.0,95537.86936302872,SPATA2L
19501,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF766
19502,KEGG_2019_Human,Melanoma,1/72,0.0035999456502131,0.0173998352024406,0,0,19928.0,112131.59838572376,FGF17
19503,KEGG_2019_Human,Breast cancer,1/147,0.0073499154017982,0.0173998352024406,0,0,19853.0,97539.10874372096,FGF17
19504,KEGG_2019_Human,Gastric cancer,1/149,0.0074499147221605,0.0173998352024406,0,0,19851.0,97261.02051561224,FGF17
19505,KEGG_2019_Human,Rap1 signaling pathway,1/206,0.010299897173561,0.0173998352024406,0,0,19794.0,90569.849337325,FGF17
19506,KEGG_2019_Human,Regulation of actin cytoskeleton,1/214,0.0106998949514067,0.0173998352024406,0,0,19786.0,89779.39753374986,FGF17
19507,KEGG_2019_Human,Ras signaling pathway,1/232,0.0115998901349604,0.0173998352024406,0,0,19768.0,88101.22480150245,FGF17
19508,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.018964124940408,0,0,19705.0,83086.53988020132,FGF17
19509,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0199123454715377,0,0,19646.0,79255.8617626126,FGF17
19510,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,FGF17
19511,KEGG_2019_Human,N-Glycan biosynthesis,1/50,0.0024999572069037,0.0049999144138074,0,0,19950.0,119530.05920663515,MOGS
19512,KEGG_2019_Human,Protein processing in endoplasmic reticulum,1/165,0.0082499094553477,0.0082499094553477,0,0,19835.0,95159.46482222488,MOGS
19513,KEGG_2019_Human,Other glycan degradation,1/18,0.0008999788927950273,0.0008999788927950273,0,0,19982.0,140136.54844084635,ENGASE
19514,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR7D4
19515,KEGG_2019_Human,Malaria,1/49,0.0024499577795033,0.012299822789457,0,0,19951.0,119939.1172087114,COMP
19516,KEGG_2019_Human,ECM-receptor interaction,1/82,0.004099940929819,0.012299822789457,0,0,19918.0,109484.9180722932,COMP
19517,KEGG_2019_Human,Phagosome,1/152,0.0075999137114971,0.0149248487415239,0,0,19848.0,96850.665715497,COMP
19518,KEGG_2019_Human,Focal adhesion,1/199,0.0099498991610159,0.0149248487415239,0,0,19801.0,91286.4288690606,COMP
19519,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0176998626413668,0,0,19670.0,80733.60565076157,COMP
19520,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0176998626413668,0,0,19646.0,79255.8617626126,COMP
19521,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0146998751759735,0,0,19706.0,83157.67014793828,TNFSF4
19522,KEGG_2019_Human,Adherens junction,1/72,0.0035999456502131,0.0071998913004262,0,0,19928.0,112131.59838572376,SNAI2
19523,KEGG_2019_Human,Hippo signaling pathway,1/160,0.0079999110688441,0.0079999110688441,0,0,19840.0,95793.96509856998,SNAI2
19524,KEGG_2019_Human,Ferroptosis,1/40,0.0019999631680592,0.0019999631680592,0,0,19960.0,124043.94523066044,FTMT
19525,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0147498749536506,0,0,19705.0,83086.53988020132,TAOK1
19526,KEGG_2019_Human,Retinol metabolism,1/67,0.0033499481224912,0.0041499404726918,0,0,19933.0,113594.38808369274,DHRS4
19527,KEGG_2019_Human,Peroxisome,1/83,0.0041499404726918,0.0041499404726918,0,0,19917.0,109237.99888847338,DHRS4
19528,KEGG_2019_Human,Ubiquinone and other terpenoid-quinone biosynthesis,1/11,0.0005499852259717758,0.0005499852259717758,0,0,19989.0,150029.8210287992,COQ7
19529,KEGG_2019_Human,Thyroid hormone signaling pathway,1/116,0.0057999266512085,0.0057999266512085,0,0,19884.0,102400.8105961506,DIO3
19530,KEGG_2019_Human,Prion diseases,1/35,0.0017499663721595,0.0098943272707719,0,0,19965.0,126740.98858805298,PRKACG
19531,KEGG_2019_Human,Vasopressin-regulated water reabsorption,1/44,0.0021999607179423,0.0098943272707719,0,0,19956.0,122117.06559109331,PRKACG
19532,KEGG_2019_Human,Hedgehog signaling pathway,1/47,0.0023499589392381,0.0098943272707719,0,0,19953.0,120782.64067395544,PRKACG
19533,KEGG_2019_Human,Endocrine and other factor-regulated calcium reabsorption,1/48,0.0023999583567988,0.0098943272707719,0,0,19952.0,120356.5272753826,PRKACG
19534,KEGG_2019_Human,Cocaine addiction,1/49,0.0024499577795033,0.0098943272707719,0,0,19951.0,119939.1172087114,PRKACG
19535,KEGG_2019_Human,Ovarian steroidogenesis,1/49,0.0024499577795033,0.0098943272707719,0,0,19951.0,119939.1172087114,PRKACG
19536,KEGG_2019_Human,Vibrio cholerae infection,1/50,0.0024999572069037,0.0098943272707719,0,0,19950.0,119530.05920663515,PRKACG
19537,KEGG_2019_Human,Regulation of lipolysis in adipocytes,1/55,0.0027499544131125,0.0098943272707719,0,0,19945.0,117599.1294878737,PRKACG
19538,KEGG_2019_Human,Cortisol synthesis and secretion,1/65,0.003249949134407,0.0098943272707719,0,0,19935.0,114209.92613860144,PRKACG
19539,KEGG_2019_Human,Long-term potentiation,1/67,0.0033499481224912,0.0098943272707719,0,0,19933.0,113594.38808369274,PRKACG
19540,KEGG_2019_Human,Amphetamine addiction,1/68,0.0033999476216189,0.0098943272707719,0,0,19932.0,113293.39338050144,PRKACG
19541,KEGG_2019_Human,Renin secretion,1/69,0.003449947123837,0.0098943272707719,0,0,19931.0,112996.7391397682,PRKACG
19542,KEGG_2019_Human,Bile secretion,1/72,0.0035999456502131,0.0098943272707719,0,0,19928.0,112131.59838572376,PRKACG
19543,KEGG_2019_Human,Thyroid hormone synthesis,1/74,0.0036999446830449,0.0098943272707719,0,0,19926.0,111574.38983110404,PRKACG
19544,KEGG_2019_Human,Gastric acid secretion,1/75,0.0037499442041125,0.0098943272707719,0,0,19925.0,111301.33528642564,PRKACG
19545,KEGG_2019_Human,Taste transduction,1/83,0.0041499404726918,0.0098943272707719,0,0,19917.0,109237.99888847338,PRKACG
19546,KEGG_2019_Human,Insulin secretion,1/86,0.0042999391173866,0.0098943272707719,0,0,19914.0,108514.46102290176,PRKACG
19547,KEGG_2019_Human,Gap junction,1/88,0.0043999382262822,0.0098943272707719,0,0,19912.0,108045.79305232369,PRKACG
19548,KEGG_2019_Human,GABAergic synapse,1/89,0.0044499377838098,0.0098943272707719,0,0,19911.0,107815.380281759,PRKACG
19549,KEGG_2019_Human,Salivary secretion,1/90,0.0044999373439762,0.0098943272707719,0,0,19910.0,107587.50385474482,PRKACG
19550,KEGG_2019_Human,Morphine addiction,1/91,0.0045499369072032,0.0098943272707719,0,0,19909.0,107362.10783923086,PRKACG
19551,KEGG_2019_Human,Dilated cardiomyopathy (DCM),1/91,0.0045499369072032,0.0098943272707719,0,0,19909.0,107362.10783923086,PRKACG
19552,KEGG_2019_Human,GnRH signaling pathway,1/93,0.0046499360391879,0.0098943272707719,0,0,19907.0,106918.54242106884,PRKACG
19553,KEGG_2019_Human,Amoebiasis,1/96,0.0047999347538706,0.0098943272707719,0,0,19904.0,106270.50039849174,PRKACG
19554,KEGG_2019_Human,Circadian entrainment,1/97,0.0048499343304706,0.0098943272707719,0,0,19903.0,106058.9096435903,PRKACG
19555,KEGG_2019_Human,Aldosterone synthesis and secretion,1/98,0.0048999339081079,0.0098943272707719,0,0,19902.0,105849.45495286948,PRKACG
19556,KEGG_2019_Human,Progesterone-mediated oocyte maturation,1/99,0.0049499334884068,0.0098943272707719,0,0,19901.0,105642.09305076736,PRKACG
19557,KEGG_2019_Human,Inflammatory mediator regulation of TRP channels,1/100,0.0049999330710556,0.0098943272707719,0,0,19900.0,105436.78197328727,PRKACG
19558,KEGG_2019_Human,Melanogenesis,1/101,0.0050499326546803,0.0098943272707719,0,0,19899.0,105233.48101229242,PRKACG
19559,KEGG_2019_Human,Longevity regulating pathway,1/102,0.0050999322416682,0.0098943272707719,0,0,19898.0,105032.15064717118,PRKACG
19560,KEGG_2019_Human,Glucagon signaling pathway,1/103,0.0051499318302617,0.0098943272707719,0,0,19897.0,104832.7525292024,PRKACG
19561,KEGG_2019_Human,"Parathyroid hormone synthesis, secretion and action",1/106,0.0052999306076525,0.0098943272707719,0,0,19894.0,104245.78450366124,PRKACG
19562,KEGG_2019_Human,Cholinergic synapse,1/112,0.0055999282120529,0.0098943272707719,0,0,19888.0,103119.30984392198,PRKACG
19563,KEGG_2019_Human,Serotonergic synapse,1/113,0.0056499278191151,0.0098943272707719,0,0,19887.0,102937.34947211576,PRKACG
19564,KEGG_2019_Human,Glutamatergic synapse,1/114,0.005699927427839,0.0098943272707719,0,0,19886.0,102756.96431429044,PRKACG
19565,KEGG_2019_Human,Thyroid hormone signaling pathway,1/116,0.0057999266512085,0.0098943272707719,0,0,19884.0,102400.8105961506,PRKACG
19566,KEGG_2019_Human,Platelet activation,1/124,0.0061999236097501,0.0098943272707719,0,0,19876.0,101034.04709010696,PRKACG
19567,KEGG_2019_Human,Oocyte meiosis,1/125,0.0062499232373748,0.0098943272707719,0,0,19875.0,100869.32368441945,PRKACG
19568,KEGG_2019_Human,Autophagy,1/128,0.0063999221281459,0.0098943272707719,0,0,19872.0,100382.8010329652,PRKACG
19569,KEGG_2019_Human,Relaxin signaling pathway,1/130,0.0064999213952527,0.0098943272707719,0,0,19870.0,100064.62842845908,PRKACG
19570,KEGG_2019_Human,Dopaminergic synapse,1/131,0.0065499210316603,0.0098943272707719,0,0,19869.0,99907.33811343512,PRKACG
19571,KEGG_2019_Human,Vascular smooth muscle contraction,1/132,0.0065999206698993,0.0098943272707719,0,0,19868.0,99751.22090491928,PRKACG
19572,KEGG_2019_Human,Insulin signaling pathway,1/137,0.0068499188797651,0.0098943272707719,0,0,19863.0,98987.62735269018,PRKACG
19573,KEGG_2019_Human,Apelin signaling pathway,1/137,0.0068499188797651,0.0098943272707719,0,0,19863.0,98987.62735269018,PRKACG
19574,KEGG_2019_Human,Estrogen signaling pathway,1/137,0.0068499188797651,0.0098943272707719,0,0,19863.0,98987.62735269018,PRKACG
19575,KEGG_2019_Human,Parkinson disease,1/142,0.0070999171242726,0.0100207183123003,0,0,19858.0,98250.87390500787,PRKACG
19576,KEGG_2019_Human,Adrenergic signaling in cardiomyocytes,1/145,0.0072499160871101,0.0100207183123003,0,0,19855.0,97820.92670675044,PRKACG
19577,KEGG_2019_Human,Retrograde endocannabinoid signaling,1/148,0.007399915061391,0.0100207183123003,0,0,19852.0,97399.60470052566,PRKACG
19578,KEGG_2019_Human,Oxytocin signaling pathway,1/153,0.0076499133771537,0.0100685149405346,0,0,19847.0,96715.6407630817,PRKACG
19579,KEGG_2019_Human,Cushing syndrome,1/155,0.0077499127120574,0.0100685149405346,0,0,19845.0,96448.16254952336,PRKACG
19580,KEGG_2019_Human,Wnt signaling pathway,1/158,0.0078999117225733,0.0100685149405346,0,0,19842.0,96053.2110949472,PRKACG
19581,KEGG_2019_Human,Tight junction,1/170,0.0084999078692823,0.0106248848366029,0,0,19830.0,94543.49009679438,PRKACG
19582,KEGG_2019_Human,Calcium signaling pathway,1/188,0.009399902370135,0.0114350669564439,0,0,19812.0,92463.712994847,PRKACG
19583,KEGG_2019_Human,Chemokine signaling pathway,1/190,0.0094999017791995,0.0114350669564439,0,0,19810.0,92244.74636351672,PRKACG
19584,KEGG_2019_Human,Viral carcinogenesis,1/201,0.0100498985877989,0.0116650608608381,0,0,19799.0,91079.21596609056,PRKACG
19585,KEGG_2019_Human,Proteoglycans in cancer,1/201,0.0100498985877989,0.0116650608608381,0,0,19799.0,91079.21596609056,PRKACG
19586,KEGG_2019_Human,cAMP signaling pathway,1/212,0.0105998955026255,0.012087600134573,0,0,19788.0,89974.27756224656,PRKACG
19587,KEGG_2019_Human,Human T-cell leukemia virus 1 infection,1/219,0.0109498935894162,0.0122714324708975,0,0,19781.0,89299.85161916987,PRKACG
19588,KEGG_2019_Human,Human cytomegalovirus infection,1/225,0.0112498919790339,0.0123605386684004,0,0,19775.0,88738.27077557483,PRKACG
19589,KEGG_2019_Human,Thermogenesis,1/231,0.0115498903940656,0.0123605386684004,0,0,19769.0,88191.07730937863,PRKACG
19590,KEGG_2019_Human,Ras signaling pathway,1/232,0.0115998901349604,0.0123605386684004,0,0,19768.0,88101.22480150245,PRKACG
19591,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0154635785804402,0,0,19705.0,83086.53988020132,PRKACG
19592,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0170236727751221,0,0,19670.0,80733.60565076157,PRKACG
19593,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0225467191267267,0,0,19556.0,74462.79263140135,PRKACG
19594,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,PRKACG
19595,KEGG_2019_Human,N-Glycan biosynthesis,1/50,0.0024999572069037,0.0024999572069037,0,0,19950.0,119530.05920663515,ALG14
19596,KEGG_2019_Human,N-Glycan biosynthesis,1/50,0.0024999572069037,0.0024999572069037,0,0,19950.0,119530.05920663515,ALG12
19597,KEGG_2019_Human,SNARE interactions in vesicular transport,1/34,0.0016999670339032,0.0016999670339032,0,0,19966.0,127326.1054203148,STX19
19598,KEGG_2019_Human,Pyrimidine metabolism,1/57,0.002849953326298,0.002849953326298,0,0,19943.0,116875.00742975442,CTPS1
19599,KEGG_2019_Human,Cell cycle,1/124,0.0061999236097501,0.0061999236097501,0,0,19876.0,101034.04709010696,ORC2
19600,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF792
19601,KEGG_2019_Human,Phenylalanine metabolism,1/17,0.0008499797390404818,0.0016999594780809,0,0,19983.0,141285.76583697114,MIF
19602,KEGG_2019_Human,Tyrosine metabolism,1/36,0.0017999657178272,0.0017999657178272,0,0,19964.0,126172.23364250171,MIF
19603,KEGG_2019_Human,Basal transcription factors,1/45,0.0022499601197094,0.0035249384088572,0,0,19955.0,121662.49782449217,GTF2H1
19604,KEGG_2019_Human,Nucleotide excision repair,1/47,0.0023499589392381,0.0035249384088572,0,0,19953.0,120782.64067395544,GTF2H1
19605,KEGG_2019_Human,Viral carcinogenesis,1/201,0.0100498985877989,0.0100498985877989,0,0,19799.0,91079.21596609056,GTF2H1
19606,KEGG_2019_Human,Mannose type O-glycan biosynthesis,1/23,0.0011499748819949,0.0011499748819949,0,0,19977.0,135204.63922267244,LARGE2
19607,KEGG_2019_Human,RNA transport,1/165,0.0082499094553477,0.0082499094553477,0,0,19835.0,95159.46482222488,FXR2
19608,KEGG_2019_Human,NOD-like receptor signaling pathway,1/178,0.0088999053857096,0.0088999053857096,0,0,19822.0,93593.82745769851,GBP7
19609,KEGG_2019_Human,Thyroid cancer,1/37,0.0018499650702878,0.0068249053608048,0,0,19963.0,125618.9446446357,TPM3
19610,KEGG_2019_Human,Cardiac muscle contraction,1/78,0.0038999427840466,0.0068249053608048,0,0,19922.0,110503.2180492851,TPM3
19611,KEGG_2019_Human,Hypertrophic cardiomyopathy (HCM),1/85,0.004249939567045,0.0068249053608048,0,0,19915.0,108752.83801948265,TPM3
19612,KEGG_2019_Human,Dilated cardiomyopathy (DCM),1/91,0.0045499369072032,0.0068249053608048,0,0,19909.0,107362.10783923086,TPM3
19613,KEGG_2019_Human,Adrenergic signaling in cardiomyocytes,1/145,0.0072499160871101,0.0086998993045322,0,0,19855.0,97820.92670675044,TPM3
19614,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,TPM3
19615,KEGG_2019_Human,Legionellosis,1/55,0.0027499544131125,0.0083198902724796,0,0,19945.0,117599.1294878737,PYCARD
19616,KEGG_2019_Human,Cytosolic DNA-sensing pathway,1/63,0.0031499501598827,0.0083198902724796,0,0,19937.0,114844.46974572667,PYCARD
19617,KEGG_2019_Human,Pertussis,1/76,0.0037999437281752,0.0083198902724796,0,0,19924.0,111031.8499691117,PYCARD
19618,KEGG_2019_Human,Salmonella infection,1/86,0.0042999391173866,0.0083198902724796,0,0,19914.0,108514.46102290176,PYCARD
19619,KEGG_2019_Human,C-type lectin receptor signaling pathway,1/104,0.0051999314202997,0.0083198902724796,0,0,19896.0,104635.24941415618,PYCARD
19620,KEGG_2019_Human,Necroptosis,1/162,0.0080999104202618,0.0088999053857096,0,0,19838.0,95537.86936302872,PYCARD
19621,KEGG_2019_Human,Influenza A,1/171,0.0085499075557634,0.0088999053857096,0,0,19829.0,94422.42241345016,PYCARD
19622,KEGG_2019_Human,NOD-like receptor signaling pathway,1/178,0.0088999053857096,0.0088999053857096,0,0,19822.0,93593.82745769851,PYCARD
19623,KEGG_2019_Human,RNA transport,1/165,0.0082499094553477,0.0082499094553477,0,0,19835.0,95159.46482222488,NUP35
19624,KEGG_2019_Human,Lysosome,1/123,0.0061499239842961,0.0061499239842961,0,0,19877.0,101200.07933676826,AP4M1
19625,KEGG_2019_Human,GABAergic synapse,1/89,0.0044499377838098,0.005699927427839,0,0,19911.0,107815.380281759,SLC38A1
19626,KEGG_2019_Human,Glutamatergic synapse,1/114,0.005699927427839,0.005699927427839,0,0,19886.0,102756.96431429044,SLC38A1
19627,KEGG_2019_Human,Hematopoietic cell lineage,1/97,0.0048499343304706,0.0185598242159366,0,0,19903.0,106058.9096435903,KITLG
19628,KEGG_2019_Human,Melanogenesis,1/101,0.0050499326546803,0.0185598242159366,0,0,19899.0,105233.48101229242,KITLG
19629,KEGG_2019_Human,Phospholipase D signaling pathway,1/148,0.007399915061391,0.0185598242159366,0,0,19852.0,97399.60470052566,KITLG
19630,KEGG_2019_Human,Rap1 signaling pathway,1/206,0.010299897173561,0.0185598242159366,0,0,19794.0,90569.849337325,KITLG
19631,KEGG_2019_Human,Ras signaling pathway,1/232,0.0115998901349604,0.0185598242159366,0,0,19768.0,88101.22480150245,KITLG
19632,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0196664999382009,0,0,19705.0,83086.53988020132,KITLG
19633,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0202284144472764,0,0,19646.0,79255.8617626126,KITLG
19634,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,KITLG
19635,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,HCRT
19636,KEGG_2019_Human,Cytosolic DNA-sensing pathway,1/63,0.0031499501598827,0.0112998556382303,0,0,19937.0,114844.46974572667,CHUK
19637,KEGG_2019_Human,Shigellosis,1/65,0.003249949134407,0.0112998556382303,0,0,19935.0,114209.92613860144,CHUK
19638,KEGG_2019_Human,Acute myeloid leukemia,1/66,0.003299948626608,0.0112998556382303,0,0,19934.0,113899.85357353876,CHUK
19639,KEGG_2019_Human,Epithelial cell signaling in Helicobacter pylori infection,1/68,0.0033999476216189,0.0112998556382303,0,0,19932.0,113293.39338050144,CHUK
19640,KEGG_2019_Human,Adipocytokine signaling pathway,1/69,0.003449947123837,0.0112998556382303,0,0,19931.0,112996.7391397682,CHUK
19641,KEGG_2019_Human,RIG-I-like receptor signaling pathway,1/70,0.0034999466296654,0.0112998556382303,0,0,19930.0,112704.30065625212,CHUK
19642,KEGG_2019_Human,B cell receptor signaling pathway,1/71,0.0035499461386618,0.0112998556382303,0,0,19929.0,112415.9585341616,CHUK
19643,KEGG_2019_Human,Pancreatic cancer,1/75,0.0037499442041125,0.0112998556382303,0,0,19925.0,111301.33528642564,CHUK
19644,KEGG_2019_Human,Chronic myeloid leukemia,1/76,0.0037999437281752,0.0112998556382303,0,0,19924.0,111031.8499691117,CHUK
19645,KEGG_2019_Human,Th1 and Th2 cell differentiation,1/92,0.0045999364719865,0.0112998556382303,0,0,19908.0,107139.13814408927,CHUK
19646,KEGG_2019_Human,IL-17 signaling pathway,1/93,0.0046499360391879,0.0112998556382303,0,0,19907.0,106918.54242106884,CHUK
19647,KEGG_2019_Human,Small cell lung cancer,1/93,0.0046499360391879,0.0112998556382303,0,0,19907.0,106918.54242106884,CHUK
19648,KEGG_2019_Human,NF-kappa B signaling pathway,1/95,0.0047499351803394,0.0112998556382303,0,0,19905.0,106484.27183626965,CHUK
19649,KEGG_2019_Human,Prostate cancer,1/97,0.0048499343304706,0.0112998556382303,0,0,19903.0,106058.9096435903,CHUK
19650,KEGG_2019_Human,T cell receptor signaling pathway,1/101,0.0050499326546803,0.0112998556382303,0,0,19899.0,105233.48101229242,CHUK
19651,KEGG_2019_Human,Chagas disease (American trypanosomiasis),1/103,0.0051499318302617,0.0112998556382303,0,0,19897.0,104832.7525292024,CHUK
19652,KEGG_2019_Human,Toll-like receptor signaling pathway,1/104,0.0051999314202997,0.0112998556382303,0,0,19896.0,104635.24941415618,CHUK
19653,KEGG_2019_Human,C-type lectin receptor signaling pathway,1/104,0.0051999314202997,0.0112998556382303,0,0,19896.0,104635.24941415618,CHUK
19654,KEGG_2019_Human,Th17 cell differentiation,1/107,0.0053499302026925,0.0112998556382303,0,0,19893.0,104053.753408911,CHUK
19655,KEGG_2019_Human,TNF signaling pathway,1/110,0.0054999290027479,0.0112998556382303,0,0,19890.0,103488.06969787036,CHUK
19656,KEGG_2019_Human,Toxoplasmosis,1/113,0.0056499278191151,0.0112998556382303,0,0,19887.0,102937.34947211576,CHUK
19657,KEGG_2019_Human,Osteoclast differentiation,1/127,0.0063499224962247,0.0115498655629176,0,0,19873.0,100543.72072014232,CHUK
19658,KEGG_2019_Human,FoxO signaling pathway,1/132,0.0065999206698993,0.0115498655629176,0,0,19868.0,99751.22090491928,CHUK
19659,KEGG_2019_Human,Measles,1/138,0.0068999185254481,0.0115498655629176,0,0,19862.0,98838.19160389496,CHUK
19660,KEGG_2019_Human,Fluid shear stress and atherosclerosis,1/139,0.006949918172816,0.0115498655629176,0,0,19861.0,98689.81333375497,CHUK
19661,KEGG_2019_Human,Apoptosis,1/143,0.0071499167770442,0.0115498655629176,0,0,19857.0,98106.57763600958,CHUK
19662,KEGG_2019_Human,mTOR signaling pathway,1/152,0.0075999137114971,0.0116248690680862,0,0,19848.0,96850.665715497,CHUK
19663,KEGG_2019_Human,Hepatitis C,1/155,0.0077499127120574,0.0116248690680862,0,0,19845.0,96448.16254952336,CHUK
19664,KEGG_2019_Human,Hepatitis B,1/163,0.0081499100978668,0.0118033180727726,0,0,19837.0,95410.9786681514,CHUK
19665,KEGG_2019_Human,NOD-like receptor signaling pathway,1/178,0.0088999053857096,0.0124598675399935,0,0,19822.0,93593.82745769851,CHUK
19666,KEGG_2019_Human,Kaposi sarcoma-associated herpesvirus infection,1/186,0.0092999029651357,0.0124686210851994,0,0,19814.0,92684.96451050608,CHUK
19667,KEGG_2019_Human,Chemokine signaling pathway,1/190,0.0094999017791995,0.0124686210851994,0,0,19810.0,92244.74636351672,CHUK
19668,KEGG_2019_Human,Epstein-Barr virus infection,1/201,0.0100498985877989,0.012790780020835,0,0,19799.0,91079.21596609056,CHUK
19669,KEGG_2019_Human,Human immunodeficiency virus 1 infection,1/212,0.0105998955026255,0.0130939885620669,0,0,19788.0,89974.27756224656,CHUK
19670,KEGG_2019_Human,Human T-cell leukemia virus 1 infection,1/219,0.0109498935894162,0.0131248739755395,0,0,19781.0,89299.85161916987,CHUK
19671,KEGG_2019_Human,Human cytomegalovirus infection,1/225,0.0112498919790339,0.0131248739755395,0,0,19775.0,88738.27077557483,CHUK
19672,KEGG_2019_Human,Ras signaling pathway,1/232,0.0115998901349604,0.013167442855901,0,0,19768.0,88101.22480150245,CHUK
19673,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0163024933698244,0,0,19705.0,83086.53988020132,CHUK
19674,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.017769088032731,0,0,19670.0,80733.60565076157,CHUK
19675,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0185848557734352,0,0,19646.0,79255.8617626126,CHUK
19676,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0251998350522984,0,0,19508.0,72277.44006442746,CHUK
19677,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,CHUK
19678,KEGG_2019_Human,Glycosaminoglycan biosynthesis,1/53,0.0026499555173137,0.0026499555173137,0,0,19947.0,118349.78824235698,EXTL1
19679,KEGG_2019_Human,Protein processing in endoplasmic reticulum,1/165,0.0082499094553477,0.0082499094553477,0,0,19835.0,95159.46482222488,EDEM3
19680,KEGG_2019_Human,Oxidative phosphorylation,1/133,0.0066499203093911,0.0115498903940656,0,0,19867.0,99596.2591544721,ATP5F1C
19681,KEGG_2019_Human,Parkinson disease,1/142,0.0070999171242726,0.0115498903940656,0,0,19858.0,98250.87390500787,ATP5F1C
19682,KEGG_2019_Human,Alzheimer disease,1/171,0.0085499075557634,0.0115498903940656,0,0,19829.0,94422.42241345016,ATP5F1C
19683,KEGG_2019_Human,Huntington disease,1/193,0.0096499008972596,0.0115498903940656,0,0,19807.0,91920.47679471428,ATP5F1C
19684,KEGG_2019_Human,Thermogenesis,1/231,0.0115498903940656,0.0115498903940656,0,0,19769.0,88191.07730937863,ATP5F1C
19685,KEGG_2019_Human,Sphingolipid signaling pathway,1/119,0.0059499254985137,0.009899881004849,0,0,19881.0,101877.73080211312,S1PR4
19686,KEGG_2019_Human,FoxO signaling pathway,1/132,0.0065999206698993,0.009899881004849,0,0,19868.0,99751.22090491928,S1PR4
19687,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,S1PR4
19688,KEGG_2019_Human,Endocytosis,1/244,0.0121998870519305,0.0121998870519305,0,0,19756.0,87051.4275316661,RABEP1
19689,KEGG_2019_Human,Nicotinate and nicotinamide metabolism,1/30,0.0014999697593334,0.004274929989447,0,0,19970.0,129851.13732048514,NT5E
19690,KEGG_2019_Human,Pyrimidine metabolism,1/57,0.002849953326298,0.004274929989447,0,0,19943.0,116875.00742975442,NT5E
19691,KEGG_2019_Human,Purine metabolism,1/129,0.006449921761047,0.006449921761047,0,0,19871.0,100223.109907462,NT5E
19692,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,MC3R
19693,KEGG_2019_Human,Renal cell carcinoma,1/69,0.003449947123837,0.0115998901349604,0,0,19931.0,112996.7391397682,PAK6
19694,KEGG_2019_Human,ErbB signaling pathway,1/85,0.004249939567045,0.0115998901349604,0,0,19915.0,108752.83801948265,PAK6
19695,KEGG_2019_Human,T cell receptor signaling pathway,1/101,0.0050499326546803,0.0115998901349604,0,0,19899.0,105233.48101229242,PAK6
19696,KEGG_2019_Human,Axon guidance,1/181,0.0090499044707863,0.0115998901349604,0,0,19819.0,93248.41634586031,PAK6
19697,KEGG_2019_Human,Focal adhesion,1/199,0.0099498991610159,0.0115998901349604,0,0,19801.0,91286.4288690606,PAK6
19698,KEGG_2019_Human,Human immunodeficiency virus 1 infection,1/212,0.0105998955026255,0.0115998901349604,0,0,19788.0,89974.27756224656,PAK6
19699,KEGG_2019_Human,Regulation of actin cytoskeleton,1/214,0.0106998949514067,0.0115998901349604,0,0,19786.0,89779.39753374986,PAK6
19700,KEGG_2019_Human,Ras signaling pathway,1/232,0.0115998901349604,0.0115998901349604,0,0,19768.0,88101.22480150245,PAK6
19701,KEGG_2019_Human,Parkinson disease,1/142,0.0070999171242726,0.0071499167770442,0,0,19858.0,98250.87390500787,HTRA2
19702,KEGG_2019_Human,Apoptosis,1/143,0.0071499167770442,0.0071499167770442,0,0,19857.0,98106.57763600958,HTRA2
19703,KEGG_2019_Human,Phototransduction,1/28,0.0013999711732997,0.0013999711732997,0,0,19972.0,131242.0761597353,SAG
19704,KEGG_2019_Human,Terpenoid backbone biosynthesis,1/22,0.0010999756574123,0.003299926972237,0,0,19978.0,136099.47030191717,FDPS
19705,KEGG_2019_Human,Influenza A,1/171,0.0085499075557634,0.0109498935894162,0,0,19829.0,94422.42241345016,FDPS
19706,KEGG_2019_Human,Human T-cell leukemia virus 1 infection,1/219,0.0109498935894162,0.0109498935894162,0,0,19781.0,89299.85161916987,FDPS
19707,KEGG_2019_Human,mRNA surveillance pathway,1/91,0.0045499369072032,0.0045499369072032,0,0,19909.0,107362.10783923086,CLP1
19708,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF596
19709,KEGG_2019_Human,Basal cell carcinoma,1/63,0.0031499501598827,0.0109198810514423,0,0,19937.0,114844.46974572667,WNT11
19710,KEGG_2019_Human,Melanogenesis,1/101,0.0050499326546803,0.0109198810514423,0,0,19899.0,105233.48101229242,WNT11
19711,KEGG_2019_Human,Signaling pathways regulating pluripotency of stem cells,1/139,0.006949918172816,0.0109198810514423,0,0,19861.0,98689.81333375497,WNT11
19712,KEGG_2019_Human,Breast cancer,1/147,0.0073499154017982,0.0109198810514423,0,0,19853.0,97539.10874372096,WNT11
19713,KEGG_2019_Human,Gastric cancer,1/149,0.0074499147221605,0.0109198810514423,0,0,19851.0,97261.02051561224,WNT11
19714,KEGG_2019_Human,mTOR signaling pathway,1/152,0.0075999137114971,0.0109198810514423,0,0,19848.0,96850.665715497,WNT11
19715,KEGG_2019_Human,Cushing syndrome,1/155,0.0077499127120574,0.0109198810514423,0,0,19845.0,96448.16254952336,WNT11
19716,KEGG_2019_Human,Wnt signaling pathway,1/158,0.0078999117225733,0.0109198810514423,0,0,19842.0,96053.2110949472,WNT11
19717,KEGG_2019_Human,Hippo signaling pathway,1/160,0.0079999110688441,0.0109198810514423,0,0,19840.0,95793.96509856998,WNT11
19718,KEGG_2019_Human,Hepatocellular carcinoma,1/168,0.0083999085011095,0.0109198810514423,0,0,19832.0,94787.72752807094,WNT11
19719,KEGG_2019_Human,Proteoglycans in cancer,1/201,0.0100498985877989,0.0118771528764897,0,0,19799.0,91079.21596609056,WNT11
19720,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0178748564138782,0,0,19670.0,80733.60565076157,WNT11
19721,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,WNT11
19722,KEGG_2019_Human,Retinol metabolism,1/67,0.0033499481224912,0.0041499404726918,0,0,19933.0,113594.38808369274,DHRS4L1
19723,KEGG_2019_Human,Peroxisome,1/83,0.0041499404726918,0.0041499404726918,0,0,19917.0,109237.99888847338,DHRS4L1
19724,KEGG_2019_Human,African trypanosomiasis,1/37,0.0018499650702878,0.0024499577795033,0,0,19963.0,125618.9446446357,HBA1
19725,KEGG_2019_Human,Malaria,1/49,0.0024499577795033,0.0024499577795033,0,0,19951.0,119939.1172087114,HBA1
19726,KEGG_2019_Human,Glutamatergic synapse,1/114,0.005699927427839,0.0065999206698993,0,0,19886.0,102756.96431429044,HOMER2
19727,KEGG_2019_Human,FoxO signaling pathway,1/132,0.0065999206698993,0.0065999206698993,0,0,19868.0,99751.22090491928,HOMER2
19728,KEGG_2019_Human,Glyoxylate and dicarboxylate metabolism,1/30,0.0014999697593334,0.0029999395186669,0,0,19970.0,129851.13732048514,HAO2
19729,KEGG_2019_Human,Peroxisome,1/83,0.0041499404726918,0.0041499404726918,0,0,19917.0,109237.99888847338,HAO2
19730,KEGG_2019_Human,Primary bile acid biosynthesis,1/17,0.0008499797390404818,0.0016999594780809,0,0,19983.0,141285.76583697114,AKR1D1
19731,KEGG_2019_Human,Steroid hormone biosynthesis,1/60,0.002999951725986,0.002999951725986,0,0,19940.0,115834.63209072244,AKR1D1
19732,KEGG_2019_Human,Lysosome,1/123,0.0061499239842961,0.0061499239842961,0,0,19877.0,101200.07933676826,DNASE2B
19733,KEGG_2019_Human,TGF-beta signaling pathway,1/90,0.0044999373439762,0.0099998888360552,0,0,19910.0,107587.50385474482,BMPR1A
19734,KEGG_2019_Human,Fluid shear stress and atherosclerosis,1/139,0.006949918172816,0.0099998888360552,0,0,19861.0,98689.81333375497,BMPR1A
19735,KEGG_2019_Human,Signaling pathways regulating pluripotency of stem cells,1/139,0.006949918172816,0.0099998888360552,0,0,19861.0,98689.81333375497,BMPR1A
19736,KEGG_2019_Human,Hippo signaling pathway,1/160,0.0079999110688441,0.0099998888360552,0,0,19840.0,95793.96509856998,BMPR1A
19737,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0146998751759735,0,0,19706.0,83157.67014793828,BMPR1A
19738,KEGG_2019_Human,Relaxin signaling pathway,1/130,0.0064999213952527,0.0068499188797651,0,0,19870.0,100064.62842845908,ACTA2
19739,KEGG_2019_Human,Vascular smooth muscle contraction,1/132,0.0065999206698993,0.0068499188797651,0,0,19868.0,99751.22090491928,ACTA2
19740,KEGG_2019_Human,Apelin signaling pathway,1/137,0.0068499188797651,0.0068499188797651,0,0,19863.0,98987.62735269018,ACTA2
19741,KEGG_2019_Human,Fat digestion and absorption,1/41,0.0020499625466866,0.0030499512001654,0,0,19959.0,123544.88783416104,LIPF
19742,KEGG_2019_Human,Glycerolipid metabolism,1/61,0.0030499512001654,0.0030499512001654,0,0,19939.0,115499.24335773686,LIPF
19743,KEGG_2019_Human,Cysteine and methionine metabolism,1/47,0.0023499589392381,0.0046999178784763,0,0,19953.0,120782.64067395544,DNMT3B
19744,KEGG_2019_Human,MicroRNAs in cancer,1/299,0.0149498740670514,0.0149498740670514,0,0,19701.0,82804.33538735632,DNMT3B
19745,KEGG_2019_Human,Fat digestion and absorption,1/41,0.0020499625466866,0.0030499512001654,0,0,19959.0,123544.88783416104,DGAT2
19746,KEGG_2019_Human,Glycerolipid metabolism,1/61,0.0030499512001654,0.0030499512001654,0,0,19939.0,115499.24335773686,DGAT2
19747,KEGG_2019_Human,Gap junction,1/88,0.0043999382262822,0.0094165463651919,0,0,19912.0,108045.79305232369,HTR2C
19748,KEGG_2019_Human,Inflammatory mediator regulation of TRP channels,1/100,0.0049999330710556,0.0094165463651919,0,0,19900.0,105436.78197328727,HTR2C
19749,KEGG_2019_Human,Serotonergic synapse,1/113,0.0056499278191151,0.0094165463651919,0,0,19887.0,102937.34947211576,HTR2C
19750,KEGG_2019_Human,Calcium signaling pathway,1/188,0.009399902370135,0.0117498779626688,0,0,19812.0,92463.712994847,HTR2C
19751,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,HTR2C
19752,KEGG_2019_Human,Cardiac muscle contraction,1/78,0.0038999427840466,0.0112582177134695,0,0,19922.0,110503.2180492851,UQCRQ
19753,KEGG_2019_Human,Oxidative phosphorylation,1/133,0.0066499203093911,0.0112582177134695,0,0,19867.0,99596.2591544721,UQCRQ
19754,KEGG_2019_Human,Parkinson disease,1/142,0.0070999171242726,0.0112582177134695,0,0,19858.0,98250.87390500787,UQCRQ
19755,KEGG_2019_Human,Non-alcoholic fatty liver disease (NAFLD),1/149,0.0074499147221605,0.0112582177134695,0,0,19851.0,97261.02051561224,UQCRQ
19756,KEGG_2019_Human,Alzheimer disease,1/171,0.0085499075557634,0.0112582177134695,0,0,19829.0,94422.42241345016,UQCRQ
19757,KEGG_2019_Human,Huntington disease,1/193,0.0096499008972596,0.0112582177134695,0,0,19807.0,91920.47679471428,UQCRQ
19758,KEGG_2019_Human,Thermogenesis,1/231,0.0115498903940656,0.0115498903940656,0,0,19769.0,88191.07730937863,UQCRQ
19759,KEGG_2019_Human,Renal cell carcinoma,1/69,0.003449947123837,0.006899894247674,0,0,19931.0,112996.7391397682,FLCN
19760,KEGG_2019_Human,mTOR signaling pathway,1/152,0.0075999137114971,0.0075999137114971,0,0,19848.0,96850.665715497,FLCN
19761,KEGG_2019_Human,Taste transduction,1/83,0.0041499404726918,0.0123998472195002,0,0,19917.0,109237.99888847338,P2RY1
19762,KEGG_2019_Human,Platelet activation,1/124,0.0061999236097501,0.0123998472195002,0,0,19876.0,101034.04709010696,P2RY1
19763,KEGG_2019_Human,Rap1 signaling pathway,1/206,0.010299897173561,0.0137331962314147,0,0,19794.0,90569.849337325,P2RY1
19764,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,P2RY1
19765,KEGG_2019_Human,Rap1 signaling pathway,1/206,0.010299897173561,0.010299897173561,0,0,19794.0,90569.849337325,RGS14
19766,KEGG_2019_Human,Inflammatory mediator regulation of TRP channels,1/100,0.0049999330710556,0.0065999206698993,0,0,19900.0,105436.78197328727,PRKCH
19767,KEGG_2019_Human,Vascular smooth muscle contraction,1/132,0.0065999206698993,0.0065999206698993,0,0,19868.0,99751.22090491928,PRKCH
19768,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR52I2
19769,KEGG_2019_Human,Amino sugar and nucleotide sugar metabolism,1/48,0.0023999583567988,0.0023999583567988,0,0,19952.0,120356.5272753826,CMAS
19770,KEGG_2019_Human,Prolactin signaling pathway,1/70,0.0034999466296654,0.0103152665383761,0,0,19930.0,112704.30065625212,SHC3
19771,KEGG_2019_Human,Bacterial invasion of epithelial cells,1/74,0.0036999446830449,0.0103152665383761,0,0,19926.0,111574.38983110404,SHC3
19772,KEGG_2019_Human,Glioma,1/75,0.0037499442041125,0.0103152665383761,0,0,19925.0,111301.33528642564,SHC3
19773,KEGG_2019_Human,Chronic myeloid leukemia,1/76,0.0037999437281752,0.0103152665383761,0,0,19924.0,111031.8499691117,SHC3
19774,KEGG_2019_Human,ErbB signaling pathway,1/85,0.004249939567045,0.0103152665383761,0,0,19915.0,108752.83801948265,SHC3
19775,KEGG_2019_Human,Neurotrophin signaling pathway,1/119,0.0059499254985137,0.0103152665383761,0,0,19881.0,101877.73080211312,SHC3
19776,KEGG_2019_Human,Relaxin signaling pathway,1/130,0.0064999213952527,0.0103152665383761,0,0,19870.0,100064.62842845908,SHC3
19777,KEGG_2019_Human,Natural killer cell mediated cytotoxicity,1/131,0.0065499210316603,0.0103152665383761,0,0,19869.0,99907.33811343512,SHC3
19778,KEGG_2019_Human,Insulin signaling pathway,1/137,0.0068499188797651,0.0103152665383761,0,0,19863.0,98987.62735269018,SHC3
19779,KEGG_2019_Human,Estrogen signaling pathway,1/137,0.0068499188797651,0.0103152665383761,0,0,19863.0,98987.62735269018,SHC3
19780,KEGG_2019_Human,Breast cancer,1/147,0.0073499154017982,0.0103152665383761,0,0,19853.0,97539.10874372096,SHC3
19781,KEGG_2019_Human,Phospholipase D signaling pathway,1/148,0.007399915061391,0.0103152665383761,0,0,19852.0,97399.60470052566,SHC3
19782,KEGG_2019_Human,Gastric cancer,1/149,0.0074499147221605,0.0103152665383761,0,0,19851.0,97261.02051561224,SHC3
19783,KEGG_2019_Human,Hepatocellular carcinoma,1/168,0.0083999085011095,0.010535187346958,0,0,19832.0,94787.72752807094,SHC3
19784,KEGG_2019_Human,Alcoholism,1/180,0.0089999047745351,0.010535187346958,0,0,19820.0,93362.92821536642,SHC3
19785,KEGG_2019_Human,Chemokine signaling pathway,1/190,0.0094999017791995,0.010535187346958,0,0,19810.0,92244.74636351672,SHC3
19786,KEGG_2019_Human,Focal adhesion,1/199,0.0099498991610159,0.010535187346958,0,0,19801.0,91286.4288690606,SHC3
19787,KEGG_2019_Human,Ras signaling pathway,1/232,0.0115998901349604,0.0115998901349604,0,0,19768.0,88101.22480150245,SHC3
19788,KEGG_2019_Human,Phenylalanine metabolism,1/17,0.0008499797390404818,0.0008499797390404818,0,0,19983.0,141285.76583697114,GLYAT
19789,KEGG_2019_Human,Leishmaniasis,1/74,0.0036999446830449,0.0119332067734082,0,0,19926.0,111574.38983110404,IRAK4
19790,KEGG_2019_Human,Pertussis,1/76,0.0037999437281752,0.0119332067734082,0,0,19924.0,111031.8499691117,IRAK4
19791,KEGG_2019_Human,NF-kappa B signaling pathway,1/95,0.0047499351803394,0.0119332067734082,0,0,19905.0,106484.27183626965,IRAK4
19792,KEGG_2019_Human,Chagas disease (American trypanosomiasis),1/103,0.0051499318302617,0.0119332067734082,0,0,19897.0,104832.7525292024,IRAK4
19793,KEGG_2019_Human,Toll-like receptor signaling pathway,1/104,0.0051999314202997,0.0119332067734082,0,0,19896.0,104635.24941415618,IRAK4
19794,KEGG_2019_Human,Toxoplasmosis,1/113,0.0056499278191151,0.0119332067734082,0,0,19887.0,102937.34947211576,IRAK4
19795,KEGG_2019_Human,Neurotrophin signaling pathway,1/119,0.0059499254985137,0.0119332067734082,0,0,19881.0,101877.73080211312,IRAK4
19796,KEGG_2019_Human,Measles,1/138,0.0068999185254481,0.0119332067734082,0,0,19862.0,98838.19160389496,IRAK4
19797,KEGG_2019_Human,Hepatitis B,1/163,0.0081499100978668,0.0119332067734082,0,0,19837.0,95410.9786681514,IRAK4
19798,KEGG_2019_Human,Influenza A,1/171,0.0085499075557634,0.0119332067734082,0,0,19829.0,94422.42241345016,IRAK4
19799,KEGG_2019_Human,NOD-like receptor signaling pathway,1/178,0.0088999053857096,0.0119332067734082,0,0,19822.0,93593.82745769851,IRAK4
19800,KEGG_2019_Human,Tuberculosis,1/179,0.0089499050800561,0.0119332067734082,0,0,19821.0,93478.0629355712,IRAK4
19801,KEGG_2019_Human,Epstein-Barr virus infection,1/201,0.0100498985877989,0.0121141662887149,0,0,19799.0,91079.21596609056,IRAK4
19802,KEGG_2019_Human,Human immunodeficiency virus 1 infection,1/212,0.0105998955026255,0.0121141662887149,0,0,19788.0,89974.27756224656,IRAK4
19803,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0157331999505607,0,0,19705.0,83086.53988020132,IRAK4
19804,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,IRAK4
19805,KEGG_2019_Human,IL-17 signaling pathway,1/93,0.0046499360391879,0.0092998720783758,0,0,19907.0,106918.54242106884,IL17C
19806,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0146998751759735,0,0,19706.0,83157.67014793828,IL17C
19807,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR2T5
19808,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR10J5
19809,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR51I2
19810,KEGG_2019_Human,Protein processing in endoplasmic reticulum,1/165,0.0082499094553477,0.0082499094553477,0,0,19835.0,95159.46482222488,YOD1
19811,KEGG_2019_Human,Fructose and mannose metabolism,1/33,0.0016499677032113,0.0023999583567988,0,0,19967.0,127928.56031580272,MPI
19812,KEGG_2019_Human,Amino sugar and nucleotide sugar metabolism,1/48,0.0023999583567988,0.0023999583567988,0,0,19952.0,120356.5272753826,MPI
19813,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR2B2
19814,KEGG_2019_Human,Proximal tubule bicarbonate reclamation,1/23,0.0011499748819949,0.0034499246459849,0,0,19977.0,135204.63922267244,AQP1
19815,KEGG_2019_Human,Renin secretion,1/69,0.003449947123837,0.0035999456502131,0,0,19931.0,112996.7391397682,AQP1
19816,KEGG_2019_Human,Bile secretion,1/72,0.0035999456502131,0.0035999456502131,0,0,19928.0,112131.59838572376,AQP1
19817,KEGG_2019_Human,Ubiquitin mediated proteolysis,1/137,0.0068499188797651,0.0068499188797651,0,0,19863.0,98987.62735269018,MGRN1
19818,KEGG_2019_Human,Ascorbate and aldarate metabolism,1/27,0.0013499718942362,0.004685646776936,0,0,19973.0,131975.02298599784,UGT1A7
19819,KEGG_2019_Human,Pentose and glucuronate interconversions,1/34,0.0016999670339032,0.004685646776936,0,0,19966.0,127326.1054203148,UGT1A7
19820,KEGG_2019_Human,Porphyrin and chlorophyll metabolism,1/42,0.0020999619311272,0.004685646776936,0,0,19958.0,123057.75613441122,UGT1A7
19821,KEGG_2019_Human,Steroid hormone biosynthesis,1/60,0.002999951725986,0.004685646776936,0,0,19940.0,115834.63209072244,UGT1A7
19822,KEGG_2019_Human,Retinol metabolism,1/67,0.0033499481224912,0.004685646776936,0,0,19933.0,113594.38808369274,UGT1A7
19823,KEGG_2019_Human,Metabolism of xenobiotics by cytochrome P450,1/74,0.0036999446830449,0.004685646776936,0,0,19926.0,111574.38983110404,UGT1A7
19824,KEGG_2019_Human,Chemical carcinogenesis,1/82,0.004099940929819,0.004685646776936,0,0,19918.0,109484.9180722932,UGT1A7
19825,KEGG_2019_Human,Drug metabolism,1/108,0.0053999298011749,0.0053999298011749,0,0,19892.0,103863.47861844616,UGT1A7
19826,KEGG_2019_Human,Cytosolic DNA-sensing pathway,1/63,0.0031499501598827,0.0090998799855245,0,0,19937.0,114844.46974572667,CCL4
19827,KEGG_2019_Human,Salmonella infection,1/86,0.0042999391173866,0.0090998799855245,0,0,19914.0,108514.46102290176,CCL4
19828,KEGG_2019_Human,NF-kappa B signaling pathway,1/95,0.0047499351803394,0.0090998799855245,0,0,19905.0,106484.27183626965,CCL4
19829,KEGG_2019_Human,Toll-like receptor signaling pathway,1/104,0.0051999314202997,0.0090998799855245,0,0,19896.0,104635.24941415618,CCL4
19830,KEGG_2019_Human,Chemokine signaling pathway,1/190,0.0094999017791995,0.0131248739755395,0,0,19810.0,92244.74636351672,CCL4
19831,KEGG_2019_Human,Human cytomegalovirus infection,1/225,0.0112498919790339,0.0131248739755395,0,0,19775.0,88738.27077557483,CCL4
19832,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0146998751759735,0,0,19706.0,83157.67014793828,CCL4
19833,KEGG_2019_Human,Ubiquitin mediated proteolysis,1/137,0.0068499188797651,0.0121998870519305,0,0,19863.0,98987.62735269018,CBLC
19834,KEGG_2019_Human,Endocytosis,1/244,0.0121998870519305,0.0121998870519305,0,0,19756.0,87051.4275316661,CBLC
19835,KEGG_2019_Human,Sphingolipid metabolism,1/47,0.0023499589392381,0.0023499589392381,0,0,19953.0,120782.64067395544,B4GALT6
19836,KEGG_2019_Human,Osteoclast differentiation,1/127,0.0063499224962247,0.0063499224962247,0,0,19873.0,100543.72072014232,SIRPG
19837,KEGG_2019_Human,Autophagy,1/128,0.0063999221281459,0.0102598890669161,0,0,19872.0,100382.8010329652,EIF2AK4
19838,KEGG_2019_Human,Measles,1/138,0.0068999185254481,0.0102598890669161,0,0,19862.0,98838.19160389496,EIF2AK4
19839,KEGG_2019_Human,Hepatitis C,1/155,0.0077499127120574,0.0102598890669161,0,0,19845.0,96448.16254952336,EIF2AK4
19840,KEGG_2019_Human,Protein processing in endoplasmic reticulum,1/165,0.0082499094553477,0.0102598890669161,0,0,19835.0,95159.46482222488,EIF2AK4
19841,KEGG_2019_Human,Influenza A,1/171,0.0085499075557634,0.0102598890669161,0,0,19829.0,94422.42241345016,EIF2AK4
19842,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,EIF2AK4
19843,KEGG_2019_Human,Purine metabolism,1/129,0.006449921761047,0.006449921761047,0,0,19871.0,100223.109907462,ADA2
19844,KEGG_2019_Human,Complement and coagulation cascades,1/79,0.0039499423167337,0.0039499423167337,0,0,19921.0,110243.89578070649,CLU
19845,KEGG_2019_Human,p53 signaling pathway,1/72,0.0035999456502131,0.0035999456502131,0,0,19928.0,112131.59838572376,GTSE1
19846,KEGG_2019_Human,Chemokine signaling pathway,1/190,0.0094999017791995,0.0146998751759735,0,0,19810.0,92244.74636351672,CXCL14
19847,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0146998751759735,0,0,19706.0,83157.67014793828,CXCL14
19848,KEGG_2019_Human,Retinol metabolism,1/67,0.0033499481224912,0.0033499481224912,0,0,19933.0,113594.38808369274,ALDH1A1
19849,KEGG_2019_Human,Hematopoietic cell lineage,1/97,0.0048499343304706,0.0048499343304706,0,0,19903.0,106058.9096435903,CD9
19850,KEGG_2019_Human,Ribosome,1/153,0.0076499133771537,0.0076499133771537,0,0,19847.0,96715.6407630817,RPS24
19851,KEGG_2019_Human,Mannose type O-glycan biosynthesis,1/23,0.0011499748819949,0.0011499748819949,0,0,19977.0,135204.63922267244,FKRP
19852,KEGG_2019_Human,Viral myocarditis,1/59,0.0029499522555206,0.0045499369072032,0,0,19941.0,116175.59385530632,SGCG
19853,KEGG_2019_Human,Arrhythmogenic right ventricular cardiomyopathy (ARVC),1/72,0.0035999456502131,0.0045499369072032,0,0,19928.0,112131.59838572376,SGCG
19854,KEGG_2019_Human,Hypertrophic cardiomyopathy (HCM),1/85,0.004249939567045,0.0045499369072032,0,0,19915.0,108752.83801948265,SGCG
19855,KEGG_2019_Human,Dilated cardiomyopathy (DCM),1/91,0.0045499369072032,0.0045499369072032,0,0,19909.0,107362.10783923086,SGCG
19856,KEGG_2019_Human,Mineral absorption,1/51,0.0025499566390179,0.0048999339081079,0,0,19949.0,119129.0228601236,SLC26A3
19857,KEGG_2019_Human,Pancreatic secretion,1/98,0.0048999339081079,0.0048999339081079,0,0,19902.0,105849.45495286948,SLC26A3
19858,KEGG_2019_Human,Porphyrin and chlorophyll metabolism,1/42,0.0020999619311272,0.0020999619311272,0,0,19958.0,123057.75613441122,PPOX
19859,KEGG_2019_Human,SNARE interactions in vesicular transport,1/34,0.0016999670339032,0.0042999391173866,0,0,19966.0,127326.1054203148,STX1A
19860,KEGG_2019_Human,Amphetamine addiction,1/68,0.0033999476216189,0.0042999391173866,0,0,19932.0,113293.39338050144,STX1A
19861,KEGG_2019_Human,Synaptic vesicle cycle,1/78,0.0038999427840466,0.0042999391173866,0,0,19922.0,110503.2180492851,STX1A
19862,KEGG_2019_Human,Insulin secretion,1/86,0.0042999391173866,0.0042999391173866,0,0,19914.0,108514.46102290176,STX1A
19863,KEGG_2019_Human,Thyroid hormone synthesis,1/74,0.0036999446830449,0.0036999446830449,0,0,19926.0,111574.38983110404,ALB
19864,KEGG_2019_Human,Caffeine metabolism,1/5,0.0002499917995416556,0.0019999343963332,0,0,19995.0,165840.17843725558,CYP1A2
19865,KEGG_2019_Human,Linoleic acid metabolism,1/29,0.001449970461791,0.004685646776936,0,0,19971.0,130534.69172799008,CYP1A2
19866,KEGG_2019_Human,Tryptophan metabolism,1/42,0.0020999619311272,0.004685646776936,0,0,19958.0,123057.75613441122,CYP1A2
19867,KEGG_2019_Human,Steroid hormone biosynthesis,1/60,0.002999951725986,0.004685646776936,0,0,19940.0,115834.63209072244,CYP1A2
19868,KEGG_2019_Human,Retinol metabolism,1/67,0.0033499481224912,0.004685646776936,0,0,19933.0,113594.38808369274,CYP1A2
19869,KEGG_2019_Human,Metabolism of xenobiotics by cytochrome P450,1/74,0.0036999446830449,0.004685646776936,0,0,19926.0,111574.38983110404,CYP1A2
19870,KEGG_2019_Human,Chemical carcinogenesis,1/82,0.004099940929819,0.004685646776936,0,0,19918.0,109484.9180722932,CYP1A2
19871,KEGG_2019_Human,Drug metabolism,1/108,0.0053999298011749,0.0053999298011749,0,0,19892.0,103863.47861844616,CYP1A2
19872,KEGG_2019_Human,Aldosterone synthesis and secretion,1/98,0.0048999339081079,0.0052999306076525,0,0,19902.0,105849.45495286948,NR4A2
19873,KEGG_2019_Human,"Parathyroid hormone synthesis, secretion and action",1/106,0.0052999306076525,0.0052999306076525,0,0,19894.0,104245.78450366124,NR4A2
19874,KEGG_2019_Human,Spliceosome,1/134,0.0066999199497742,0.0068499188797651,0,0,19866.0,99442.43560916925,PRPF19
19875,KEGG_2019_Human,Ubiquitin mediated proteolysis,1/137,0.0068499188797651,0.0068499188797651,0,0,19863.0,98987.62735269018,PRPF19
19876,KEGG_2019_Human,Notch signaling pathway,1/48,0.0023999583567988,0.0023999583567988,0,0,19952.0,120356.5272753826,DTX3L
19877,KEGG_2019_Human,Adherens junction,1/72,0.0035999456502131,0.0106998949514067,0,0,19928.0,112131.59838572376,ACTN4
19878,KEGG_2019_Human,Amoebiasis,1/96,0.0047999347538706,0.0106998949514067,0,0,19904.0,106270.50039849174,ACTN4
19879,KEGG_2019_Human,Leukocyte transendothelial migration,1/112,0.0055999282120529,0.0106998949514067,0,0,19888.0,103119.30984392198,ACTN4
19880,KEGG_2019_Human,Systemic lupus erythematosus,1/133,0.0066499203093911,0.0106998949514067,0,0,19867.0,99596.2591544721,ACTN4
19881,KEGG_2019_Human,Tight junction,1/170,0.0084999078692823,0.0106998949514067,0,0,19830.0,94543.49009679438,ACTN4
19882,KEGG_2019_Human,Focal adhesion,1/199,0.0099498991610159,0.0106998949514067,0,0,19801.0,91286.4288690606,ACTN4
19883,KEGG_2019_Human,Viral carcinogenesis,1/201,0.0100498985877989,0.0106998949514067,0,0,19799.0,91079.21596609056,ACTN4
19884,KEGG_2019_Human,Regulation of actin cytoskeleton,1/214,0.0106998949514067,0.0106998949514067,0,0,19786.0,89779.39753374986,ACTN4
19885,KEGG_2019_Human,Fanconi anemia pathway,1/54,0.0026999549628563,0.0026999549628563,0,0,19946.0,117971.01964061816,CENPS-CORT
19886,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF81
19887,KEGG_2019_Human,Vitamin digestion and absorption,1/24,0.0011999741185782,0.0059999094170218,0,0,19976.0,134347.69487847842,SCARB1
19888,KEGG_2019_Human,Fat digestion and absorption,1/41,0.0020499625466866,0.0059999094170218,0,0,19959.0,123544.88783416104,SCARB1
19889,KEGG_2019_Human,Ovarian steroidogenesis,1/49,0.0024499577795033,0.0059999094170218,0,0,19951.0,119939.1172087114,SCARB1
19890,KEGG_2019_Human,Cholesterol metabolism,1/50,0.0024999572069037,0.0059999094170218,0,0,19950.0,119530.05920663515,SCARB1
19891,KEGG_2019_Human,Cortisol synthesis and secretion,1/65,0.003249949134407,0.0059999094170218,0,0,19935.0,114209.92613860144,SCARB1
19892,KEGG_2019_Human,Bile secretion,1/72,0.0035999456502131,0.0059999094170218,0,0,19928.0,112131.59838572376,SCARB1
19893,KEGG_2019_Human,Aldosterone synthesis and secretion,1/98,0.0048999339081079,0.0069999055830113,0,0,19902.0,105849.45495286948,SCARB1
19894,KEGG_2019_Human,Phagosome,1/152,0.0075999137114971,0.0077499127120574,0,0,19848.0,96850.665715497,SCARB1
19895,KEGG_2019_Human,Cushing syndrome,1/155,0.0077499127120574,0.0077499127120574,0,0,19845.0,96448.16254952336,SCARB1
19896,KEGG_2019_Human,Hepatitis C,1/155,0.0077499127120574,0.0077499127120574,0,0,19845.0,96448.16254952336,SCARB1
19897,KEGG_2019_Human,Lysine degradation,1/59,0.0029499522555206,0.0058999045110413,0,0,19941.0,116175.59385530632,SETD7
19898,KEGG_2019_Human,FoxO signaling pathway,1/132,0.0065999206698993,0.0065999206698993,0,0,19868.0,99751.22090491928,SETD7
19899,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF211
19900,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR10H2
19901,KEGG_2019_Human,Primary immunodeficiency,1/37,0.0018499650702878,0.0035499461386618,0,0,19963.0,125618.9446446357,CD79A
19902,KEGG_2019_Human,B cell receptor signaling pathway,1/71,0.0035499461386618,0.0035499461386618,0,0,19929.0,112415.9585341616,CD79A
19903,KEGG_2019_Human,mRNA surveillance pathway,1/91,0.0045499369072032,0.0082499094553477,0,0,19909.0,107362.10783923086,RNPS1
19904,KEGG_2019_Human,RNA transport,1/165,0.0082499094553477,0.0082499094553477,0,0,19835.0,95159.46482222488,RNPS1
19905,KEGG_2019_Human,Butanoate metabolism,1/28,0.0013999711732997,0.0023999583567988,0,0,19972.0,131242.0761597353,AACS
19906,KEGG_2019_Human,"Valine, leucine and isoleucine degradation",1/48,0.0023999583567988,0.0023999583567988,0,0,19952.0,120356.5272753826,AACS
19907,KEGG_2019_Human,Biosynthesis of unsaturated fatty acids,1/27,0.0013499718942362,0.0013499718942362,0,0,19973.0,131975.02298599784,ELOVL2
19908,KEGG_2019_Human,Fatty acid elongation,1/27,0.0013499718942362,0.0013499718942362,0,0,19973.0,131975.02298599784,ELOVL2
19909,KEGG_2019_Human,Inositol phosphate metabolism,1/74,0.0036999446830449,0.0049499334884068,0,0,19926.0,111574.38983110404,SACM1L
19910,KEGG_2019_Human,Phosphatidylinositol signaling system,1/99,0.0049499334884068,0.0049499334884068,0,0,19901.0,105642.09305076736,SACM1L
19911,KEGG_2019_Human,Mitophagy,1/65,0.003249949134407,0.0080999104202618,0,0,19935.0,114209.92613860144,PGAM5
19912,KEGG_2019_Human,TNF signaling pathway,1/110,0.0054999290027479,0.0080999104202618,0,0,19890.0,103488.06969787036,PGAM5
19913,KEGG_2019_Human,Necroptosis,1/162,0.0080999104202618,0.0080999104202618,0,0,19838.0,95537.86936302872,PGAM5
19914,KEGG_2019_Human,GABAergic synapse,1/89,0.0044499377838098,0.0130498764018304,0,0,19911.0,107815.380281759,GNG3
19915,KEGG_2019_Human,Morphine addiction,1/91,0.0045499369072032,0.0130498764018304,0,0,19909.0,107362.10783923086,GNG3
19916,KEGG_2019_Human,Circadian entrainment,1/97,0.0048499343304706,0.0130498764018304,0,0,19903.0,106058.9096435903,GNG3
19917,KEGG_2019_Human,Cholinergic synapse,1/112,0.0055999282120529,0.0130498764018304,0,0,19888.0,103119.30984392198,GNG3
19918,KEGG_2019_Human,Serotonergic synapse,1/113,0.0056499278191151,0.0130498764018304,0,0,19887.0,102937.34947211576,GNG3
19919,KEGG_2019_Human,Glutamatergic synapse,1/114,0.005699927427839,0.0130498764018304,0,0,19886.0,102756.96431429044,GNG3
19920,KEGG_2019_Human,Relaxin signaling pathway,1/130,0.0064999213952527,0.0130498764018304,0,0,19870.0,100064.62842845908,GNG3
19921,KEGG_2019_Human,Dopaminergic synapse,1/131,0.0065499210316603,0.0130498764018304,0,0,19869.0,99907.33811343512,GNG3
19922,KEGG_2019_Human,Apelin signaling pathway,1/137,0.0068499188797651,0.0130498764018304,0,0,19863.0,98987.62735269018,GNG3
19923,KEGG_2019_Human,Retrograde endocannabinoid signaling,1/148,0.007399915061391,0.0130498764018304,0,0,19852.0,97399.60470052566,GNG3
19924,KEGG_2019_Human,Alcoholism,1/180,0.0089999047745351,0.0130498764018304,0,0,19820.0,93362.92821536642,GNG3
19925,KEGG_2019_Human,Kaposi sarcoma-associated herpesvirus infection,1/186,0.0092999029651357,0.0130498764018304,0,0,19814.0,92684.96451050608,GNG3
19926,KEGG_2019_Human,Chemokine signaling pathway,1/190,0.0094999017791995,0.0130498764018304,0,0,19810.0,92244.74636351672,GNG3
19927,KEGG_2019_Human,Human immunodeficiency virus 1 infection,1/212,0.0105998955026255,0.0130498764018304,0,0,19788.0,89974.27756224656,GNG3
19928,KEGG_2019_Human,Human cytomegalovirus infection,1/225,0.0112498919790339,0.0130498764018304,0,0,19775.0,88738.27077557483,GNG3
19929,KEGG_2019_Human,Ras signaling pathway,1/232,0.0115998901349604,0.0130498764018304,0,0,19768.0,88101.22480150245,GNG3
19930,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0187410310320355,0,0,19646.0,79255.8617626126,GNG3
19931,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,GNG3
19932,KEGG_2019_Human,Arachidonic acid metabolism,1/63,0.0031499501598827,0.0031499501598827,0,0,19937.0,114844.46974572667,CYP2U1
19933,KEGG_2019_Human,Antigen processing and presentation,1/77,0.0038499432547502,0.0061499239842961,0,0,19923.0,110765.8407373636,LGMN
19934,KEGG_2019_Human,Lysosome,1/123,0.0061499239842961,0.0061499239842961,0,0,19877.0,101200.07933676826,LGMN
19935,KEGG_2019_Human,Human T-cell leukemia virus 1 infection,1/219,0.0109498935894162,0.0115998901349604,0,0,19781.0,89299.85161916987,ETS2
19936,KEGG_2019_Human,Ras signaling pathway,1/232,0.0115998901349604,0.0115998901349604,0,0,19768.0,88101.22480150245,ETS2
19937,KEGG_2019_Human,Nicotine addiction,1/40,0.0019999631680592,0.0084748917286727,0,0,19960.0,124043.94523066044,GABRB1
19938,KEGG_2019_Human,GABAergic synapse,1/89,0.0044499377838098,0.0084748917286727,0,0,19911.0,107815.380281759,GABRB1
19939,KEGG_2019_Human,Morphine addiction,1/91,0.0045499369072032,0.0084748917286727,0,0,19909.0,107362.10783923086,GABRB1
19940,KEGG_2019_Human,Serotonergic synapse,1/113,0.0056499278191151,0.0084748917286727,0,0,19887.0,102937.34947211576,GABRB1
19941,KEGG_2019_Human,Retrograde endocannabinoid signaling,1/148,0.007399915061391,0.0088798980736692,0,0,19852.0,97399.60470052566,GABRB1
19942,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,GABRB1
19943,KEGG_2019_Human,Amoebiasis,1/96,0.0047999347538706,0.0047999347538706,0,0,19904.0,106270.50039849174,SERPINB4
19944,KEGG_2019_Human,Proteasome,1/45,0.0022499601197094,0.0022499601197094,0,0,19955.0,121662.49782449217,PSMF1
19945,KEGG_2019_Human,Basal transcription factors,1/45,0.0022499601197094,0.0112498005985471,0,0,19955.0,121662.49782449217,TBPL2
19946,KEGG_2019_Human,Huntington disease,1/193,0.0096499008972596,0.0136873669867703,0,0,19807.0,91920.47679471428,TBPL2
19947,KEGG_2019_Human,Viral carcinogenesis,1/201,0.0100498985877989,0.0136873669867703,0,0,19799.0,91079.21596609056,TBPL2
19948,KEGG_2019_Human,Human T-cell leukemia virus 1 infection,1/219,0.0109498935894162,0.0136873669867703,0,0,19781.0,89299.85161916987,TBPL2
19949,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0164998674589645,0,0,19670.0,80733.60565076157,TBPL2
19950,KEGG_2019_Human,Glycerolipid metabolism,1/61,0.0030499512001654,0.0048499343304706,0,0,19939.0,115499.24335773686,MBOAT2
19951,KEGG_2019_Human,Glycerophospholipid metabolism,1/97,0.0048499343304706,0.0048499343304706,0,0,19903.0,106058.9096435903,MBOAT2
19952,KEGG_2019_Human,Cholesterol metabolism,1/50,0.0024999572069037,0.0024999572069037,0,0,19950.0,119530.05920663515,MYLIP
19953,KEGG_2019_Human,Chemokine signaling pathway,1/190,0.0094999017791995,0.0146998751759735,0,0,19810.0,92244.74636351672,PPBP
19954,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0146998751759735,0,0,19706.0,83157.67014793828,PPBP
19955,KEGG_2019_Human,Complement and coagulation cascades,1/79,0.0039499423167337,0.00868739771602,0,0,19921.0,110243.89578070649,PLAT
19956,KEGG_2019_Human,Prostate cancer,1/97,0.0048499343304706,0.00868739771602,0,0,19903.0,106058.9096435903,PLAT
19957,KEGG_2019_Human,Apelin signaling pathway,1/137,0.0068499188797651,0.00868739771602,0,0,19863.0,98987.62735269018,PLAT
19958,KEGG_2019_Human,Fluid shear stress and atherosclerosis,1/139,0.006949918172816,0.00868739771602,0,0,19861.0,98689.81333375497,PLAT
19959,KEGG_2019_Human,Transcriptional misregulation in cancer,1/186,0.0092999029651357,0.0092999029651357,0,0,19814.0,92684.96451050608,PLAT
19960,KEGG_2019_Human,Fanconi anemia pathway,1/54,0.0026999549628563,0.0026999549628563,0,0,19946.0,117971.01964061816,FANCB
19961,KEGG_2019_Human,Mannose type O-glycan biosynthesis,1/23,0.0011499748819949,0.0022499601197094,0,0,19977.0,135204.63922267244,FUT9
19962,KEGG_2019_Human,Glycosphingolipid biosynthesis,1/45,0.0022499601197094,0.0022499601197094,0,0,19955.0,121662.49782449217,FUT9
19963,KEGG_2019_Human,Pentose and glucuronate interconversions,1/34,0.0016999670339032,0.0033999476216189,0,0,19966.0,127326.1054203148,AKR1A1
19964,KEGG_2019_Human,Glycerolipid metabolism,1/61,0.0030499512001654,0.0033999476216189,0,0,19939.0,115499.24335773686,AKR1A1
19965,KEGG_2019_Human,Glycolysis / Gluconeogenesis,1/68,0.0033999476216189,0.0033999476216189,0,0,19932.0,113293.39338050144,AKR1A1
19966,KEGG_2019_Human,Glycerophospholipid metabolism,1/97,0.0048499343304706,0.0049499334884068,0,0,19903.0,106058.9096435903,CDS1
19967,KEGG_2019_Human,Phosphatidylinositol signaling system,1/99,0.0049499334884068,0.0049499334884068,0,0,19901.0,105642.09305076736,CDS1
19968,KEGG_2019_Human,Ribosome,1/153,0.0076499133771537,0.0076499133771537,0,0,19847.0,96715.6407630817,RPS11
19969,KEGG_2019_Human,Necroptosis,1/162,0.0080999104202618,0.0121998870519305,0,0,19838.0,95537.86936302872,VPS4A
19970,KEGG_2019_Human,Endocytosis,1/244,0.0121998870519305,0.0121998870519305,0,0,19756.0,87051.4275316661,VPS4A
19971,KEGG_2019_Human,Inflammatory mediator regulation of TRP channels,1/100,0.0049999330710556,0.0049999330710556,0,0,19900.0,105436.78197328727,TRPV3
19972,KEGG_2019_Human,Phototransduction,1/28,0.0013999711732997,0.0013999711732997,0,0,19972.0,131242.0761597353,GNAT2
19973,KEGG_2019_Human,Chemical carcinogenesis,1/82,0.004099940929819,0.004099940929819,0,0,19918.0,109484.9180722932,SULT1A1
19974,KEGG_2019_Human,Nicotine addiction,1/40,0.0019999631680592,0.007583228178672,0,0,19960.0,124043.94523066044,GABRR3
19975,KEGG_2019_Human,GABAergic synapse,1/89,0.0044499377838098,0.007583228178672,0,0,19911.0,107815.380281759,GABRR3
19976,KEGG_2019_Human,Morphine addiction,1/91,0.0045499369072032,0.007583228178672,0,0,19909.0,107362.10783923086,GABRR3
19977,KEGG_2019_Human,Retrograde endocannabinoid signaling,1/148,0.007399915061391,0.0092498938267387,0,0,19852.0,97399.60470052566,GABRR3
19978,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,GABRR3
19979,KEGG_2019_Human,Morphine addiction,1/91,0.0045499369072032,0.0076499133771537,0,0,19909.0,107362.10783923086,KCNJ3
19980,KEGG_2019_Human,Circadian entrainment,1/97,0.0048499343304706,0.0076499133771537,0,0,19903.0,106058.9096435903,KCNJ3
19981,KEGG_2019_Human,Cholinergic synapse,1/112,0.0055999282120529,0.0076499133771537,0,0,19888.0,103119.30984392198,KCNJ3
19982,KEGG_2019_Human,Serotonergic synapse,1/113,0.0056499278191151,0.0076499133771537,0,0,19887.0,102937.34947211576,KCNJ3
19983,KEGG_2019_Human,Glutamatergic synapse,1/114,0.005699927427839,0.0076499133771537,0,0,19886.0,102756.96431429044,KCNJ3
19984,KEGG_2019_Human,Dopaminergic synapse,1/131,0.0065499210316603,0.0076499133771537,0,0,19869.0,99907.33811343512,KCNJ3
19985,KEGG_2019_Human,Estrogen signaling pathway,1/137,0.0068499188797651,0.0076499133771537,0,0,19863.0,98987.62735269018,KCNJ3
19986,KEGG_2019_Human,Retrograde endocannabinoid signaling,1/148,0.007399915061391,0.0076499133771537,0,0,19852.0,97399.60470052566,KCNJ3
19987,KEGG_2019_Human,Oxytocin signaling pathway,1/153,0.0076499133771537,0.0076499133771537,0,0,19847.0,96715.6407630817,KCNJ3
19988,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF436
19989,KEGG_2019_Human,Regulation of lipolysis in adipocytes,1/55,0.0027499544131125,0.0095898864316712,0,0,19945.0,117599.1294878737,LIPE
19990,KEGG_2019_Human,Aldosterone synthesis and secretion,1/98,0.0048999339081079,0.0095898864316712,0,0,19902.0,105849.45495286948,LIPE
19991,KEGG_2019_Human,AMPK signaling pathway,1/120,0.0059999251180858,0.0095898864316712,0,0,19880.0,101706.2448082016,LIPE
19992,KEGG_2019_Human,Apelin signaling pathway,1/137,0.0068499188797651,0.0095898864316712,0,0,19863.0,98987.62735269018,LIPE
19993,KEGG_2019_Human,Insulin signaling pathway,1/137,0.0068499188797651,0.0095898864316712,0,0,19863.0,98987.62735269018,LIPE
19994,KEGG_2019_Human,cAMP signaling pathway,1/212,0.0105998955026255,0.0115498903940656,0,0,19788.0,89974.27756224656,LIPE
19995,KEGG_2019_Human,Thermogenesis,1/231,0.0115498903940656,0.0115498903940656,0,0,19769.0,88191.07730937863,LIPE
19996,KEGG_2019_Human,Steroid biosynthesis,1/19,0.00094997806231055,0.00094997806231055,0,0,19981.0,139049.2109571672,DHCR24
19997,KEGG_2019_Human,Mitophagy,1/65,0.003249949134407,0.003249949134407,0,0,19935.0,114209.92613860144,TAX1BP1
19998,KEGG_2019_Human,Legionellosis,1/55,0.0027499544131125,0.0054999088262251,0,0,19945.0,117599.1294878737,VCP
19999,KEGG_2019_Human,Protein processing in endoplasmic reticulum,1/165,0.0082499094553477,0.0082499094553477,0,0,19835.0,95159.46482222488,VCP
20000,KEGG_2019_Human,Signaling pathways regulating pluripotency of stem cells,1/139,0.006949918172816,0.006949918172816,0,0,19861.0,98689.81333375497,PCGF6
20001,KEGG_2019_Human,Hematopoietic cell lineage,1/97,0.0048499343304706,0.0084999078692823,0,0,19903.0,106058.9096435903,CD1A
20002,KEGG_2019_Human,Tight junction,1/170,0.0084999078692823,0.0084999078692823,0,0,19830.0,94543.49009679438,CD1A
20003,KEGG_2019_Human,Metabolism of xenobiotics by cytochrome P450,1/74,0.0036999446830449,0.0036999446830449,0,0,19926.0,111574.38983110404,AKR7A3
20004,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR4D2
20005,KEGG_2019_Human,Bile secretion,1/72,0.0035999456502131,0.0035999456502131,0,0,19928.0,112131.59838572376,SLC51B
20006,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF30
20007,KEGG_2019_Human,Cholesterol metabolism,1/50,0.0024999572069037,0.0049332595773933,0,0,19950.0,119530.05920663515,LPL
20008,KEGG_2019_Human,Glycerolipid metabolism,1/61,0.0030499512001654,0.0049332595773933,0,0,19939.0,115499.24335773686,LPL
20009,KEGG_2019_Human,PPAR signaling pathway,1/74,0.0036999446830449,0.0049332595773933,0,0,19926.0,111574.38983110404,LPL
20010,KEGG_2019_Human,Alzheimer disease,1/171,0.0085499075557634,0.0085499075557634,0,0,19829.0,94422.42241345016,LPL
20011,KEGG_2019_Human,NF-kappa B signaling pathway,1/95,0.0047499351803394,0.0142498055410182,0,0,19905.0,106484.27183626965,CCL19
20012,KEGG_2019_Human,Chemokine signaling pathway,1/190,0.0094999017791995,0.0142498526687993,0,0,19810.0,92244.74636351672,CCL19
20013,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0146998751759735,0,0,19706.0,83157.67014793828,CCL19
20014,KEGG_2019_Human,GnRH signaling pathway,1/93,0.0046499360391879,0.0092998720783758,0,0,19907.0,106918.54242106884,GNRHR
20015,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,GNRHR
20016,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR1A2
20017,KEGG_2019_Human,DNA replication,1/36,0.0017999657178272,0.0017999657178272,0,0,19964.0,126172.23364250171,RNASEH2A
20018,KEGG_2019_Human,Mismatch repair,1/23,0.0011499748819949,0.0026999549628563,0,0,19977.0,135204.63922267244,RPA2
20019,KEGG_2019_Human,DNA replication,1/36,0.0017999657178272,0.0026999549628563,0,0,19964.0,126172.23364250171,RPA2
20020,KEGG_2019_Human,Homologous recombination,1/41,0.0020499625466866,0.0026999549628563,0,0,19959.0,123544.88783416104,RPA2
20021,KEGG_2019_Human,Nucleotide excision repair,1/47,0.0023499589392381,0.0026999549628563,0,0,19953.0,120782.64067395544,RPA2
20022,KEGG_2019_Human,Fanconi anemia pathway,1/54,0.0026999549628563,0.0026999549628563,0,0,19946.0,117971.01964061816,RPA2
20023,KEGG_2019_Human,"Parathyroid hormone synthesis, secretion and action",1/106,0.0052999306076525,0.0131248739755395,0,0,19894.0,104245.78450366124,ARHGEF1
20024,KEGG_2019_Human,Platelet activation,1/124,0.0061999236097501,0.0131248739755395,0,0,19876.0,101034.04709010696,ARHGEF1
20025,KEGG_2019_Human,Vascular smooth muscle contraction,1/132,0.0065999206698993,0.0131248739755395,0,0,19868.0,99751.22090491928,ARHGEF1
20026,KEGG_2019_Human,Proteoglycans in cancer,1/201,0.0100498985877989,0.0131248739755395,0,0,19799.0,91079.21596609056,ARHGEF1
20027,KEGG_2019_Human,Regulation of actin cytoskeleton,1/214,0.0106998949514067,0.0131248739755395,0,0,19786.0,89779.39753374986,ARHGEF1
20028,KEGG_2019_Human,Human cytomegalovirus infection,1/225,0.0112498919790339,0.0131248739755395,0,0,19775.0,88738.27077557483,ARHGEF1
20029,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,ARHGEF1
20030,KEGG_2019_Human,Mannose type O-glycan biosynthesis,1/23,0.0011499748819949,0.0011499748819949,0,0,19977.0,135204.63922267244,POMGNT1
20031,KEGG_2019_Human,Terpenoid backbone biosynthesis,1/22,0.0010999756574123,0.003299926972237,0,0,19978.0,136099.47030191717,HMGCR
20032,KEGG_2019_Human,Bile secretion,1/72,0.0035999456502131,0.0053999184753196,0,0,19928.0,112131.59838572376,HMGCR
20033,KEGG_2019_Human,AMPK signaling pathway,1/120,0.0059999251180858,0.0059999251180858,0,0,19880.0,101706.2448082016,HMGCR
20034,KEGG_2019_Human,Endometrial cancer,1/58,0.0028999527887707,0.0100798902013314,0,0,19942.0,116522.31890946148,AXIN2
20035,KEGG_2019_Human,Basal cell carcinoma,1/63,0.0031499501598827,0.0100798902013314,0,0,19937.0,114844.46974572667,AXIN2
20036,KEGG_2019_Human,Colorectal cancer,1/86,0.0042999391173866,0.0100798902013314,0,0,19914.0,108514.46102290176,AXIN2
20037,KEGG_2019_Human,Signaling pathways regulating pluripotency of stem cells,1/139,0.006949918172816,0.0100798902013314,0,0,19861.0,98689.81333375497,AXIN2
20038,KEGG_2019_Human,Breast cancer,1/147,0.0073499154017982,0.0100798902013314,0,0,19853.0,97539.10874372096,AXIN2
20039,KEGG_2019_Human,Gastric cancer,1/149,0.0074499147221605,0.0100798902013314,0,0,19851.0,97261.02051561224,AXIN2
20040,KEGG_2019_Human,Cushing syndrome,1/155,0.0077499127120574,0.0100798902013314,0,0,19845.0,96448.16254952336,AXIN2
20041,KEGG_2019_Human,Wnt signaling pathway,1/158,0.0078999117225733,0.0100798902013314,0,0,19842.0,96053.2110949472,AXIN2
20042,KEGG_2019_Human,Hippo signaling pathway,1/160,0.0079999110688441,0.0100798902013314,0,0,19840.0,95793.96509856998,AXIN2
20043,KEGG_2019_Human,Hepatocellular carcinoma,1/168,0.0083999085011095,0.0100798902013314,0,0,19832.0,94787.72752807094,AXIN2
20044,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0179998554097794,0,0,19670.0,80733.60565076157,AXIN2
20045,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,AXIN2
20046,KEGG_2019_Human,Autophagy,1/128,0.0063999221281459,0.0063999221281459,0,0,19872.0,100382.8010329652,ZFYVE1
20047,KEGG_2019_Human,Taste transduction,1/83,0.0041499404726918,0.0041499404726918,0,0,19917.0,109237.99888847338,PKD2L1
20048,KEGG_2019_Human,Cushing syndrome,1/155,0.0077499127120574,0.0077499127120574,0,0,19845.0,96448.16254952336,AIP
20049,KEGG_2019_Human,RIG-I-like receptor signaling pathway,1/70,0.0034999466296654,0.0034999466296654,0,0,19930.0,112704.30065625212,TBKBP1
20050,KEGG_2019_Human,Wnt signaling pathway,1/158,0.0078999117225733,0.0078999117225733,0,0,19842.0,96053.2110949472,RSPO1
20051,KEGG_2019_Human,Leukocyte transendothelial migration,1/112,0.0055999282120529,0.0084999078692823,0,0,19888.0,103119.30984392198,CLDN2
20052,KEGG_2019_Human,Cell adhesion molecules (CAMs),1/145,0.0072499160871101,0.0084999078692823,0,0,19855.0,97820.92670675044,CLDN2
20053,KEGG_2019_Human,Hepatitis C,1/155,0.0077499127120574,0.0084999078692823,0,0,19845.0,96448.16254952336,CLDN2
20054,KEGG_2019_Human,Tight junction,1/170,0.0084999078692823,0.0084999078692823,0,0,19830.0,94543.49009679438,CLDN2
20055,KEGG_2019_Human,Thermogenesis,1/231,0.0115498903940656,0.0115498903940656,0,0,19769.0,88191.07730937863,COX14
20056,KEGG_2019_Human,Autophagy,1/128,0.0063999221281459,0.0151998274229942,0,0,19872.0,100382.8010329652,DDIT4
20057,KEGG_2019_Human,mTOR signaling pathway,1/152,0.0075999137114971,0.0151998274229942,0,0,19848.0,96850.665715497,DDIT4
20058,KEGG_2019_Human,MicroRNAs in cancer,1/299,0.0149498740670514,0.0176998626413668,0,0,19701.0,82804.33538735632,DDIT4
20059,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0176998626413668,0,0,19646.0,79255.8617626126,DDIT4
20060,KEGG_2019_Human,Prolactin signaling pathway,1/70,0.0034999466296654,0.0069998932593308,0,0,19930.0,112704.30065625212,SOCS5
20061,KEGG_2019_Human,JAK-STAT signaling pathway,1/162,0.0080999104202618,0.0080999104202618,0,0,19838.0,95537.86936302872,SOCS5
20062,KEGG_2019_Human,"Glycine, serine and threonine metabolism",1/40,0.0019999631680592,0.0019999631680592,0,0,19960.0,124043.94523066044,PSPH
20063,KEGG_2019_Human,Thyroid cancer,1/37,0.0018499650702878,0.0115057554322825,0,0,19963.0,125618.9446446357,HRAS
20064,KEGG_2019_Human,Bladder cancer,1/41,0.0020499625466866,0.0115057554322825,0,0,19959.0,123544.88783416104,HRAS
20065,KEGG_2019_Human,Endometrial cancer,1/58,0.0028999527887707,0.0115057554322825,0,0,19942.0,116522.31890946148,HRAS
20066,KEGG_2019_Human,VEGF signaling pathway,1/59,0.0029499522555206,0.0115057554322825,0,0,19941.0,116175.59385530632,HRAS
20067,KEGG_2019_Human,Long-term depression,1/60,0.002999951725986,0.0115057554322825,0,0,19940.0,115834.63209072244,HRAS
20068,KEGG_2019_Human,Mitophagy,1/65,0.003249949134407,0.0115057554322825,0,0,19935.0,114209.92613860144,HRAS
20069,KEGG_2019_Human,Central carbon metabolism in cancer,1/65,0.003249949134407,0.0115057554322825,0,0,19935.0,114209.92613860144,HRAS
20070,KEGG_2019_Human,Acute myeloid leukemia,1/66,0.003299948626608,0.0115057554322825,0,0,19934.0,113899.85357353876,HRAS
20071,KEGG_2019_Human,Non-small cell lung cancer,1/66,0.003299948626608,0.0115057554322825,0,0,19934.0,113899.85357353876,HRAS
20072,KEGG_2019_Human,Long-term potentiation,1/67,0.0033499481224912,0.0115057554322825,0,0,19933.0,113594.38808369274,HRAS
20073,KEGG_2019_Human,Fc epsilon RI signaling pathway,1/68,0.0033999476216189,0.0115057554322825,0,0,19932.0,113293.39338050144,HRAS
20074,KEGG_2019_Human,Renal cell carcinoma,1/69,0.003449947123837,0.0115057554322825,0,0,19931.0,112996.7391397682,HRAS
20075,KEGG_2019_Human,Prolactin signaling pathway,1/70,0.0034999466296654,0.0115057554322825,0,0,19930.0,112704.30065625212,HRAS
20076,KEGG_2019_Human,B cell receptor signaling pathway,1/71,0.0035499461386618,0.0115057554322825,0,0,19929.0,112415.9585341616,HRAS
20077,KEGG_2019_Human,Melanoma,1/72,0.0035999456502131,0.0115057554322825,0,0,19928.0,112131.59838572376,HRAS
20078,KEGG_2019_Human,Glioma,1/75,0.0037499442041125,0.0115057554322825,0,0,19925.0,111301.33528642564,HRAS
20079,KEGG_2019_Human,Chronic myeloid leukemia,1/76,0.0037999437281752,0.0115057554322825,0,0,19924.0,111031.8499691117,HRAS
20080,KEGG_2019_Human,ErbB signaling pathway,1/85,0.004249939567045,0.0115057554322825,0,0,19915.0,108752.83801948265,HRAS
20081,KEGG_2019_Human,Colorectal cancer,1/86,0.0042999391173866,0.0115057554322825,0,0,19914.0,108514.46102290176,HRAS
20082,KEGG_2019_Human,Gap junction,1/88,0.0043999382262822,0.0115057554322825,0,0,19912.0,108045.79305232369,HRAS
20083,KEGG_2019_Human,GnRH signaling pathway,1/93,0.0046499360391879,0.0115057554322825,0,0,19907.0,106918.54242106884,HRAS
20084,KEGG_2019_Human,Prostate cancer,1/97,0.0048499343304706,0.0115057554322825,0,0,19903.0,106058.9096435903,HRAS
20085,KEGG_2019_Human,Choline metabolism in cancer,1/99,0.0049499334884068,0.0115057554322825,0,0,19901.0,105642.09305076736,HRAS
20086,KEGG_2019_Human,AGE-RAGE signaling pathway in diabetic complications,1/100,0.0049999330710556,0.0115057554322825,0,0,19900.0,105436.78197328727,HRAS
20087,KEGG_2019_Human,T cell receptor signaling pathway,1/101,0.0050499326546803,0.0115057554322825,0,0,19899.0,105233.48101229242,HRAS
20088,KEGG_2019_Human,Melanogenesis,1/101,0.0050499326546803,0.0115057554322825,0,0,19899.0,105233.48101229242,HRAS
20089,KEGG_2019_Human,Longevity regulating pathway,1/102,0.0050999322416682,0.0115057554322825,0,0,19898.0,105032.15064717118,HRAS
20090,KEGG_2019_Human,C-type lectin receptor signaling pathway,1/104,0.0051999314202997,0.0115057554322825,0,0,19896.0,104635.24941415618,HRAS
20091,KEGG_2019_Human,Cholinergic synapse,1/112,0.0055999282120529,0.0115057554322825,0,0,19888.0,103119.30984392198,HRAS
20092,KEGG_2019_Human,Serotonergic synapse,1/113,0.0056499278191151,0.0115057554322825,0,0,19887.0,102937.34947211576,HRAS
20093,KEGG_2019_Human,Thyroid hormone signaling pathway,1/116,0.0057999266512085,0.0115057554322825,0,0,19884.0,102400.8105961506,HRAS
20094,KEGG_2019_Human,Sphingolipid signaling pathway,1/119,0.0059499254985137,0.0115057554322825,0,0,19881.0,101877.73080211312,HRAS
20095,KEGG_2019_Human,Neurotrophin signaling pathway,1/119,0.0059499254985137,0.0115057554322825,0,0,19881.0,101877.73080211312,HRAS
20096,KEGG_2019_Human,Autophagy,1/128,0.0063999221281459,0.0115057554322825,0,0,19872.0,100382.8010329652,HRAS
20097,KEGG_2019_Human,Relaxin signaling pathway,1/130,0.0064999213952527,0.0115057554322825,0,0,19870.0,100064.62842845908,HRAS
20098,KEGG_2019_Human,Natural killer cell mediated cytotoxicity,1/131,0.0065499210316603,0.0115057554322825,0,0,19869.0,99907.33811343512,HRAS
20099,KEGG_2019_Human,FoxO signaling pathway,1/132,0.0065999206698993,0.0115057554322825,0,0,19868.0,99751.22090491928,HRAS
20100,KEGG_2019_Human,Insulin signaling pathway,1/137,0.0068499188797651,0.0115057554322825,0,0,19863.0,98987.62735269018,HRAS
20101,KEGG_2019_Human,Apelin signaling pathway,1/137,0.0068499188797651,0.0115057554322825,0,0,19863.0,98987.62735269018,HRAS
20102,KEGG_2019_Human,Estrogen signaling pathway,1/137,0.0068499188797651,0.0115057554322825,0,0,19863.0,98987.62735269018,HRAS
20103,KEGG_2019_Human,Signaling pathways regulating pluripotency of stem cells,1/139,0.006949918172816,0.0115057554322825,0,0,19861.0,98689.81333375497,HRAS
20104,KEGG_2019_Human,Apoptosis,1/143,0.0071499167770442,0.0115057554322825,0,0,19857.0,98106.57763600958,HRAS
20105,KEGG_2019_Human,Breast cancer,1/147,0.0073499154017982,0.0115057554322825,0,0,19853.0,97539.10874372096,HRAS
20106,KEGG_2019_Human,Phospholipase D signaling pathway,1/148,0.007399915061391,0.0115057554322825,0,0,19852.0,97399.60470052566,HRAS
20107,KEGG_2019_Human,Gastric cancer,1/149,0.0074499147221605,0.0115057554322825,0,0,19851.0,97261.02051561224,HRAS
20108,KEGG_2019_Human,mTOR signaling pathway,1/152,0.0075999137114971,0.0115057554322825,0,0,19848.0,96850.665715497,HRAS
20109,KEGG_2019_Human,Oxytocin signaling pathway,1/153,0.0076499133771537,0.0115057554322825,0,0,19847.0,96715.6407630817,HRAS
20110,KEGG_2019_Human,Hepatitis C,1/155,0.0077499127120574,0.0115057554322825,0,0,19845.0,96448.16254952336,HRAS
20111,KEGG_2019_Human,Cellular senescence,1/160,0.0079999110688441,0.0115057554322825,0,0,19840.0,95793.96509856998,HRAS
20112,KEGG_2019_Human,JAK-STAT signaling pathway,1/162,0.0080999104202618,0.0115057554322825,0,0,19838.0,95537.86936302872,HRAS
20113,KEGG_2019_Human,Hepatitis B,1/163,0.0081499100978668,0.0115057554322825,0,0,19837.0,95410.9786681514,HRAS
20114,KEGG_2019_Human,Hepatocellular carcinoma,1/168,0.0083999085011095,0.0116306425399978,0,0,19832.0,94787.72752807094,HRAS
20115,KEGG_2019_Human,Alcoholism,1/180,0.0089999047745351,0.0120665392943818,0,0,19820.0,93362.92821536642,HRAS
20116,KEGG_2019_Human,Axon guidance,1/181,0.0090499044707863,0.0120665392943818,0,0,19819.0,93248.41634586031,HRAS
20117,KEGG_2019_Human,Kaposi sarcoma-associated herpesvirus infection,1/186,0.0092999029651357,0.0121744184270868,0,0,19814.0,92684.96451050608,HRAS
20118,KEGG_2019_Human,Chemokine signaling pathway,1/190,0.0094999017791995,0.0122141594303994,0,0,19810.0,92244.74636351672,HRAS
20119,KEGG_2019_Human,Focal adhesion,1/199,0.0099498991610159,0.0122642830223987,0,0,19801.0,91286.4288690606,HRAS
20120,KEGG_2019_Human,Viral carcinogenesis,1/201,0.0100498985877989,0.0122642830223987,0,0,19799.0,91079.21596609056,HRAS
20121,KEGG_2019_Human,Proteoglycans in cancer,1/201,0.0100498985877989,0.0122642830223987,0,0,19799.0,91079.21596609056,HRAS
20122,KEGG_2019_Human,Rap1 signaling pathway,1/206,0.010299897173561,0.0123598766082732,0,0,19794.0,90569.849337325,HRAS
20123,KEGG_2019_Human,Human immunodeficiency virus 1 infection,1/212,0.0105998955026255,0.0124256844596981,0,0,19788.0,89974.27756224656,HRAS
20124,KEGG_2019_Human,Regulation of actin cytoskeleton,1/214,0.0106998949514067,0.0124256844596981,0,0,19786.0,89779.39753374986,HRAS
20125,KEGG_2019_Human,Human T-cell leukemia virus 1 infection,1/219,0.0109498935894162,0.01251416410219,0,0,19781.0,89299.85161916987,HRAS
20126,KEGG_2019_Human,Human cytomegalovirus infection,1/225,0.0112498919790339,0.0126544256017749,0,0,19775.0,88738.27077557483,HRAS
20127,KEGG_2019_Human,Thermogenesis,1/231,0.0115498903940656,0.0126544256017749,0,0,19769.0,88191.07730937863,HRAS
20128,KEGG_2019_Human,Ras signaling pathway,1/232,0.0115998901349604,0.0126544256017749,0,0,19768.0,88101.22480150245,HRAS
20129,KEGG_2019_Human,Endocytosis,1/244,0.0121998870519305,0.0131103263841641,0,0,19756.0,87051.4275316661,HRAS
20130,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0155998685917058,0,0,19705.0,83086.53988020132,HRAS
20131,KEGG_2019_Human,MicroRNAs in cancer,1/299,0.0149498740670514,0.0155998685917058,0,0,19701.0,82804.33538735632,HRAS
20132,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0169712922435063,0,0,19670.0,80733.60565076157,HRAS
20133,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0179491564813861,0,0,19646.0,79255.8617626126,HRAS
20134,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,HRAS
20135,KEGG_2019_Human,Graft-versus-host disease,1/41,0.0020499625466866,0.0057749148821253,0,0,19959.0,123544.88783416104,KIR3DL1
20136,KEGG_2019_Human,Antigen processing and presentation,1/77,0.0038499432547502,0.0057749148821253,0,0,19923.0,110765.8407373636,KIR3DL1
20137,KEGG_2019_Human,Natural killer cell mediated cytotoxicity,1/131,0.0065499210316603,0.0065499210316603,0,0,19869.0,99907.33811343512,KIR3DL1
20138,KEGG_2019_Human,Vitamin digestion and absorption,1/24,0.0011999741185782,0.0023999482371564,0,0,19976.0,134347.69487847842,LRAT
20139,KEGG_2019_Human,Retinol metabolism,1/67,0.0033499481224912,0.0033499481224912,0,0,19933.0,113594.38808369274,LRAT
20140,KEGG_2019_Human,Thyroid cancer,1/37,0.0018499650702878,0.0095198963012574,0,0,19963.0,125618.9446446357,TCF7L1
20141,KEGG_2019_Human,Endometrial cancer,1/58,0.0028999527887707,0.0095198963012574,0,0,19942.0,116522.31890946148,TCF7L1
20142,KEGG_2019_Human,Basal cell carcinoma,1/63,0.0031499501598827,0.0095198963012574,0,0,19937.0,114844.46974572667,TCF7L1
20143,KEGG_2019_Human,Acute myeloid leukemia,1/66,0.003299948626608,0.0095198963012574,0,0,19934.0,113899.85357353876,TCF7L1
20144,KEGG_2019_Human,Adherens junction,1/72,0.0035999456502131,0.0095198963012574,0,0,19928.0,112131.59838572376,TCF7L1
20145,KEGG_2019_Human,Arrhythmogenic right ventricular cardiomyopathy (ARVC),1/72,0.0035999456502131,0.0095198963012574,0,0,19928.0,112131.59838572376,TCF7L1
20146,KEGG_2019_Human,Colorectal cancer,1/86,0.0042999391173866,0.0095198963012574,0,0,19914.0,108514.46102290176,TCF7L1
20147,KEGG_2019_Human,Prostate cancer,1/97,0.0048499343304706,0.0095198963012574,0,0,19903.0,106058.9096435903,TCF7L1
20148,KEGG_2019_Human,Melanogenesis,1/101,0.0050499326546803,0.0095198963012574,0,0,19899.0,105233.48101229242,TCF7L1
20149,KEGG_2019_Human,Breast cancer,1/147,0.0073499154017982,0.0095198963012574,0,0,19853.0,97539.10874372096,TCF7L1
20150,KEGG_2019_Human,Gastric cancer,1/149,0.0074499147221605,0.0095198963012574,0,0,19851.0,97261.02051561224,TCF7L1
20151,KEGG_2019_Human,Cushing syndrome,1/155,0.0077499127120574,0.0095198963012574,0,0,19845.0,96448.16254952336,TCF7L1
20152,KEGG_2019_Human,Wnt signaling pathway,1/158,0.0078999117225733,0.0095198963012574,0,0,19842.0,96053.2110949472,TCF7L1
20153,KEGG_2019_Human,Hippo signaling pathway,1/160,0.0079999110688441,0.0095198963012574,0,0,19840.0,95793.96509856998,TCF7L1
20154,KEGG_2019_Human,Hepatocellular carcinoma,1/168,0.0083999085011095,0.0095198963012574,0,0,19832.0,94787.72752807094,TCF7L1
20155,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0175311091751498,0,0,19670.0,80733.60565076157,TCF7L1
20156,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,TCF7L1
20157,KEGG_2019_Human,Purine metabolism,1/129,0.006449921761047,0.006449921761047,0,0,19871.0,100223.109907462,ENPP4
20158,KEGG_2019_Human,Proteasome,1/45,0.0022499601197094,0.0022499601197094,0,0,19955.0,121662.49782449217,PSMB4
20159,KEGG_2019_Human,Ubiquitin mediated proteolysis,1/137,0.0068499188797651,0.0105998955026255,0,0,19863.0,98987.62735269018,RNF7
20160,KEGG_2019_Human,Human immunodeficiency virus 1 infection,1/212,0.0105998955026255,0.0105998955026255,0,0,19788.0,89974.27756224656,RNF7
20161,KEGG_2019_Human,Autophagy,1/128,0.0063999221281459,0.0096186460002338,0,0,19872.0,100382.8010329652,EIF2S1
20162,KEGG_2019_Human,Measles,1/138,0.0068999185254481,0.0096186460002338,0,0,19862.0,98838.19160389496,EIF2S1
20163,KEGG_2019_Human,Apoptosis,1/143,0.0071499167770442,0.0096186460002338,0,0,19857.0,98106.57763600958,EIF2S1
20164,KEGG_2019_Human,Non-alcoholic fatty liver disease (NAFLD),1/149,0.0074499147221605,0.0096186460002338,0,0,19851.0,97261.02051561224,EIF2S1
20165,KEGG_2019_Human,Hepatitis C,1/155,0.0077499127120574,0.0096186460002338,0,0,19845.0,96448.16254952336,EIF2S1
20166,KEGG_2019_Human,Protein processing in endoplasmic reticulum,1/165,0.0082499094553477,0.0096186460002338,0,0,19835.0,95159.46482222488,EIF2S1
20167,KEGG_2019_Human,RNA transport,1/165,0.0082499094553477,0.0096186460002338,0,0,19835.0,95159.46482222488,EIF2S1
20168,KEGG_2019_Human,Influenza A,1/171,0.0085499075557634,0.0096186460002338,0,0,19829.0,94422.42241345016,EIF2S1
20169,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,EIF2S1
20170,KEGG_2019_Human,Retinol metabolism,1/67,0.0033499481224912,0.0056499278191151,0,0,19933.0,113594.38808369274,CYP2C18
20171,KEGG_2019_Human,Chemical carcinogenesis,1/82,0.004099940929819,0.0056499278191151,0,0,19918.0,109484.9180722932,CYP2C18
20172,KEGG_2019_Human,Serotonergic synapse,1/113,0.0056499278191151,0.0056499278191151,0,0,19887.0,102937.34947211576,CYP2C18
20173,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR10G4
20174,KEGG_2019_Human,Glutathione metabolism,1/56,0.0027999538675741,0.0094498771520562,0,0,19944.0,117233.87022514464,GSTA5
20175,KEGG_2019_Human,Metabolism of xenobiotics by cytochrome P450,1/74,0.0036999446830449,0.0094498771520562,0,0,19926.0,111574.38983110404,GSTA5
20176,KEGG_2019_Human,Chemical carcinogenesis,1/82,0.004099940929819,0.0094498771520562,0,0,19918.0,109484.9180722932,GSTA5
20177,KEGG_2019_Human,Drug metabolism,1/108,0.0053999298011749,0.0094498771520562,0,0,19892.0,103863.47861844616,GSTA5
20178,KEGG_2019_Human,Fluid shear stress and atherosclerosis,1/139,0.006949918172816,0.0097298854419424,0,0,19861.0,98689.81333375497,GSTA5
20179,KEGG_2019_Human,Hepatocellular carcinoma,1/168,0.0083999085011095,0.0097998932512944,0,0,19832.0,94787.72752807094,GSTA5
20180,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,GSTA5
20181,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR52J3
20182,KEGG_2019_Human,Glycosaminoglycan biosynthesis,1/53,0.0026499555173137,0.0026499555173137,0,0,19947.0,118349.78824235698,CHSY1
20183,KEGG_2019_Human,Lysosome,1/123,0.0061499239842961,0.0061499239842961,0,0,19877.0,101200.07933676826,GGA1
20184,KEGG_2019_Human,Caffeine metabolism,1/5,0.0002499917995416556,0.0012499589977082,0,0,19995.0,165840.17843725558,CYP2A6
20185,KEGG_2019_Human,Retinol metabolism,1/67,0.0033499481224912,0.0051249261622737,0,0,19933.0,113594.38808369274,CYP2A6
20186,KEGG_2019_Human,Metabolism of xenobiotics by cytochrome P450,1/74,0.0036999446830449,0.0051249261622737,0,0,19926.0,111574.38983110404,CYP2A6
20187,KEGG_2019_Human,Chemical carcinogenesis,1/82,0.004099940929819,0.0051249261622737,0,0,19918.0,109484.9180722932,CYP2A6
20188,KEGG_2019_Human,Drug metabolism,1/108,0.0053999298011749,0.0053999298011749,0,0,19892.0,103863.47861844616,CYP2A6
20189,KEGG_2019_Human,Longevity regulating pathway,1/102,0.0050999322416682,0.0082499094553477,0,0,19898.0,105032.15064717118,CRYAB
20190,KEGG_2019_Human,Protein processing in endoplasmic reticulum,1/165,0.0082499094553477,0.0082499094553477,0,0,19835.0,95159.46482222488,CRYAB
20191,KEGG_2019_Human,Arginine and proline metabolism,1/49,0.0024499577795033,0.0024499577795033,0,0,19951.0,119939.1172087114,ALDH18A1
20192,KEGG_2019_Human,Necroptosis,1/162,0.0080999104202618,0.0080999104202618,0,0,19838.0,95537.86936302872,PPIA
20193,KEGG_2019_Human,Proteasome,1/45,0.0022499601197094,0.0022499601197094,0,0,19955.0,121662.49782449217,PSMB11
20194,KEGG_2019_Human,Influenza A,1/171,0.0085499075557634,0.0085499075557634,0,0,19829.0,94422.42241345016,AGFG1
20195,KEGG_2019_Human,Ubiquitin mediated proteolysis,1/137,0.0068499188797651,0.0082499094553477,0,0,19863.0,98987.62735269018,UBE2D4
20196,KEGG_2019_Human,Protein processing in endoplasmic reticulum,1/165,0.0082499094553477,0.0082499094553477,0,0,19835.0,95159.46482222488,UBE2D4
20197,KEGG_2019_Human,Mucin type O-glycan biosynthesis,1/31,0.0015499690656704,0.0015499690656704,0,0,19969.0,129189.85098816035,GCNT3
20198,KEGG_2019_Human,Chemokine signaling pathway,1/190,0.0094999017791995,0.0146998751759735,0,0,19810.0,92244.74636351672,CCR6
20199,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0146998751759735,0,0,19706.0,83157.67014793828,CCR6
20200,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0146998751759735,0,0,19706.0,83157.67014793828,IL36RN
20201,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR2J3
20202,KEGG_2019_Human,Complement and coagulation cascades,1/79,0.0039499423167337,0.0096998686609413,0,0,19921.0,110243.89578070649,PLAU
20203,KEGG_2019_Human,NF-kappa B signaling pathway,1/95,0.0047499351803394,0.0096998686609413,0,0,19905.0,106484.27183626965,PLAU
20204,KEGG_2019_Human,Prostate cancer,1/97,0.0048499343304706,0.0096998686609413,0,0,19903.0,106058.9096435903,PLAU
20205,KEGG_2019_Human,Transcriptional misregulation in cancer,1/186,0.0092999029651357,0.0120598783053587,0,0,19814.0,92684.96451050608,PLAU
20206,KEGG_2019_Human,Proteoglycans in cancer,1/201,0.0100498985877989,0.0120598783053587,0,0,19799.0,91079.21596609056,PLAU
20207,KEGG_2019_Human,MicroRNAs in cancer,1/299,0.0149498740670514,0.0149498740670514,0,0,19701.0,82804.33538735632,PLAU
20208,KEGG_2019_Human,Complement and coagulation cascades,1/79,0.0039499423167337,0.0039499423167337,0,0,19921.0,110243.89578070649,SERPINA1
20209,KEGG_2019_Human,T cell receptor signaling pathway,1/101,0.0050499326546803,0.0063499224962247,0,0,19899.0,105233.48101229242,TEC
20210,KEGG_2019_Human,Osteoclast differentiation,1/127,0.0063499224962247,0.0063499224962247,0,0,19873.0,100543.72072014232,TEC
20211,KEGG_2019_Human,Sulfur relay system,1/8,0.0003999883241497325,0.0003999883241497325,0,0,19992.0,156418.91141655247,MOCS3
20212,KEGG_2019_Human,MicroRNAs in cancer,1/299,0.0149498740670514,0.0149498740670514,0,0,19701.0,82804.33538735632,MIR125B1
20213,KEGG_2019_Human,Mineral absorption,1/51,0.0025499566390179,0.0025499566390179,0,0,19949.0,119129.0228601236,SLC26A9
20214,KEGG_2019_Human,Apoptosis,1/143,0.0071499167770442,0.0071499167770442,0,0,19857.0,98106.57763600958,LMNB2
20215,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR4C11
20216,KEGG_2019_Human,Renin secretion,1/69,0.003449947123837,0.0148398537036758,0,0,19931.0,112996.7391397682,EDNRA
20217,KEGG_2019_Human,Vascular smooth muscle contraction,1/132,0.0065999206698993,0.0148398537036758,0,0,19868.0,99751.22090491928,EDNRA
20218,KEGG_2019_Human,cGMP-PKG signaling pathway,1/166,0.0082999091363732,0.0148398537036758,0,0,19834.0,95034.82345515196,EDNRA
20219,KEGG_2019_Human,Calcium signaling pathway,1/188,0.009399902370135,0.0148398537036758,0,0,19812.0,92463.712994847,EDNRA
20220,KEGG_2019_Human,cAMP signaling pathway,1/212,0.0105998955026255,0.0148398537036758,0,0,19788.0,89974.27756224656,EDNRA
20221,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0197165101309862,0,0,19662.0,80229.79996326564,EDNRA
20222,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,EDNRA
20223,KEGG_2019_Human,FoxO signaling pathway,1/132,0.0065999206698993,0.006949918172816,0,0,19868.0,99751.22090491928,KLF2
20224,KEGG_2019_Human,Apelin signaling pathway,1/137,0.0068499188797651,0.006949918172816,0,0,19863.0,98987.62735269018,KLF2
20225,KEGG_2019_Human,Fluid shear stress and atherosclerosis,1/139,0.006949918172816,0.006949918172816,0,0,19861.0,98689.81333375497,KLF2
20226,KEGG_2019_Human,Endocytosis,1/244,0.0121998870519305,0.0121998870519305,0,0,19756.0,87051.4275316661,RAB11FIP3
20227,KEGG_2019_Human,Peroxisome,1/83,0.0041499404726918,0.0048499343304706,0,0,19917.0,109237.99888847338,GNPAT
20228,KEGG_2019_Human,Glycerophospholipid metabolism,1/97,0.0048499343304706,0.0048499343304706,0,0,19903.0,106058.9096435903,GNPAT
20229,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR10AD1
20230,KEGG_2019_Human,Folate biosynthesis,1/26,0.0012999726251831,0.002124958792379,0,0,19974.0,132735.46073187632,AKR1B1
20231,KEGG_2019_Human,Galactose metabolism,1/31,0.0015499690656704,0.002124958792379,0,0,19969.0,129189.85098816035,AKR1B1
20232,KEGG_2019_Human,Fructose and mannose metabolism,1/33,0.0016499677032113,0.002124958792379,0,0,19967.0,127928.56031580272,AKR1B1
20233,KEGG_2019_Human,Pentose and glucuronate interconversions,1/34,0.0016999670339032,0.002124958792379,0,0,19966.0,127326.1054203148,AKR1B1
20234,KEGG_2019_Human,Glycerolipid metabolism,1/61,0.0030499512001654,0.0030499512001654,0,0,19939.0,115499.24335773686,AKR1B1
20235,KEGG_2019_Human,Tryptophan metabolism,1/42,0.0020999619311272,0.0020999619311272,0,0,19958.0,123057.75613441122,TDO2
20236,KEGG_2019_Human,Salivary secretion,1/90,0.0044999373439762,0.0044999373439762,0,0,19910.0,107587.50385474482,MUC7
20237,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR1D4
20238,KEGG_2019_Human,Regulation of lipolysis in adipocytes,1/55,0.0027499544131125,0.0061999236097501,0,0,19945.0,117599.1294878737,PTGS1
20239,KEGG_2019_Human,Arachidonic acid metabolism,1/63,0.0031499501598827,0.0061999236097501,0,0,19937.0,114844.46974572667,PTGS1
20240,KEGG_2019_Human,Serotonergic synapse,1/113,0.0056499278191151,0.0061999236097501,0,0,19887.0,102937.34947211576,PTGS1
20241,KEGG_2019_Human,Platelet activation,1/124,0.0061999236097501,0.0061999236097501,0,0,19876.0,101034.04709010696,PTGS1
20242,KEGG_2019_Human,Autophagy,1/128,0.0063999221281459,0.0075999137114971,0,0,19872.0,100382.8010329652,DEPTOR
20243,KEGG_2019_Human,mTOR signaling pathway,1/152,0.0075999137114971,0.0075999137114971,0,0,19848.0,96850.665715497,DEPTOR
20244,KEGG_2019_Human,Base excision repair,1/33,0.0016499677032113,0.0023499589392381,0,0,19967.0,127928.56031580272,POLE4
20245,KEGG_2019_Human,DNA replication,1/36,0.0017999657178272,0.0023499589392381,0,0,19964.0,126172.23364250171,POLE4
20246,KEGG_2019_Human,Nucleotide excision repair,1/47,0.0023499589392381,0.0023499589392381,0,0,19953.0,120782.64067395544,POLE4
20247,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR6C70
20248,KEGG_2019_Human,Prolactin signaling pathway,1/70,0.0034999466296654,0.0085749013020979,0,0,19930.0,112704.30065625212,TNFSF11
20249,KEGG_2019_Human,Rheumatoid arthritis,1/91,0.0045499369072032,0.0085749013020979,0,0,19909.0,107362.10783923086,TNFSF11
20250,KEGG_2019_Human,NF-kappa B signaling pathway,1/95,0.0047499351803394,0.0085749013020979,0,0,19905.0,106484.27183626965,TNFSF11
20251,KEGG_2019_Human,"Parathyroid hormone synthesis, secretion and action",1/106,0.0052999306076525,0.0085749013020979,0,0,19894.0,104245.78450366124,TNFSF11
20252,KEGG_2019_Human,Osteoclast differentiation,1/127,0.0063499224962247,0.0085749013020979,0,0,19873.0,100543.72072014232,TNFSF11
20253,KEGG_2019_Human,Breast cancer,1/147,0.0073499154017982,0.0085749013020979,0,0,19853.0,97539.10874372096,TNFSF11
20254,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0146998751759735,0,0,19706.0,83157.67014793828,TNFSF11
20255,KEGG_2019_Human,Base excision repair,1/33,0.0016499677032113,0.0016499677032113,0,0,19967.0,127928.56031580272,NEIL2
20256,KEGG_2019_Human,Ribosome,1/153,0.0076499133771537,0.0076499133771537,0,0,19847.0,96715.6407630817,MRPS2
20257,KEGG_2019_Human,Endometrial cancer,1/58,0.0028999527887707,0.0118123713296852,0,0,19942.0,116522.31890946148,GRB2
20258,KEGG_2019_Human,Acute myeloid leukemia,1/66,0.003299948626608,0.0118123713296852,0,0,19934.0,113899.85357353876,GRB2
20259,KEGG_2019_Human,Non-small cell lung cancer,1/66,0.003299948626608,0.0118123713296852,0,0,19934.0,113899.85357353876,GRB2
20260,KEGG_2019_Human,Fc epsilon RI signaling pathway,1/68,0.0033999476216189,0.0118123713296852,0,0,19932.0,113293.39338050144,GRB2
20261,KEGG_2019_Human,Renal cell carcinoma,1/69,0.003449947123837,0.0118123713296852,0,0,19931.0,112996.7391397682,GRB2
20262,KEGG_2019_Human,Prolactin signaling pathway,1/70,0.0034999466296654,0.0118123713296852,0,0,19930.0,112704.30065625212,GRB2
20263,KEGG_2019_Human,B cell receptor signaling pathway,1/71,0.0035499461386618,0.0118123713296852,0,0,19929.0,112415.9585341616,GRB2
20264,KEGG_2019_Human,Glioma,1/75,0.0037499442041125,0.0118123713296852,0,0,19925.0,111301.33528642564,GRB2
20265,KEGG_2019_Human,Chronic myeloid leukemia,1/76,0.0037999437281752,0.0118123713296852,0,0,19924.0,111031.8499691117,GRB2
20266,KEGG_2019_Human,ErbB signaling pathway,1/85,0.004249939567045,0.0118123713296852,0,0,19915.0,108752.83801948265,GRB2
20267,KEGG_2019_Human,Colorectal cancer,1/86,0.0042999391173866,0.0118123713296852,0,0,19914.0,108514.46102290176,GRB2
20268,KEGG_2019_Human,Gap junction,1/88,0.0043999382262822,0.0118123713296852,0,0,19912.0,108045.79305232369,GRB2
20269,KEGG_2019_Human,GnRH signaling pathway,1/93,0.0046499360391879,0.0118123713296852,0,0,19907.0,106918.54242106884,GRB2
20270,KEGG_2019_Human,Prostate cancer,1/97,0.0048499343304706,0.0118123713296852,0,0,19903.0,106058.9096435903,GRB2
20271,KEGG_2019_Human,Choline metabolism in cancer,1/99,0.0049499334884068,0.0118123713296852,0,0,19901.0,105642.09305076736,GRB2
20272,KEGG_2019_Human,T cell receptor signaling pathway,1/101,0.0050499326546803,0.0118123713296852,0,0,19899.0,105233.48101229242,GRB2
20273,KEGG_2019_Human,Neurotrophin signaling pathway,1/119,0.0059499254985137,0.0118123713296852,0,0,19881.0,101877.73080211312,GRB2
20274,KEGG_2019_Human,Osteoclast differentiation,1/127,0.0063499224962247,0.0118123713296852,0,0,19873.0,100543.72072014232,GRB2
20275,KEGG_2019_Human,Relaxin signaling pathway,1/130,0.0064999213952527,0.0118123713296852,0,0,19870.0,100064.62842845908,GRB2
20276,KEGG_2019_Human,Natural killer cell mediated cytotoxicity,1/131,0.0065499210316603,0.0118123713296852,0,0,19869.0,99907.33811343512,GRB2
20277,KEGG_2019_Human,FoxO signaling pathway,1/132,0.0065999206698993,0.0118123713296852,0,0,19868.0,99751.22090491928,GRB2
20278,KEGG_2019_Human,Insulin signaling pathway,1/137,0.0068499188797651,0.0118123713296852,0,0,19863.0,98987.62735269018,GRB2
20279,KEGG_2019_Human,Estrogen signaling pathway,1/137,0.0068499188797651,0.0118123713296852,0,0,19863.0,98987.62735269018,GRB2
20280,KEGG_2019_Human,Signaling pathways regulating pluripotency of stem cells,1/139,0.006949918172816,0.0118123713296852,0,0,19861.0,98689.81333375497,GRB2
20281,KEGG_2019_Human,Breast cancer,1/147,0.0073499154017982,0.0118123713296852,0,0,19853.0,97539.10874372096,GRB2
20282,KEGG_2019_Human,Phospholipase D signaling pathway,1/148,0.007399915061391,0.0118123713296852,0,0,19852.0,97399.60470052566,GRB2
20283,KEGG_2019_Human,Gastric cancer,1/149,0.0074499147221605,0.0118123713296852,0,0,19851.0,97261.02051561224,GRB2
20284,KEGG_2019_Human,mTOR signaling pathway,1/152,0.0075999137114971,0.0118123713296852,0,0,19848.0,96850.665715497,GRB2
20285,KEGG_2019_Human,Hepatitis C,1/155,0.0077499127120574,0.0118123713296852,0,0,19845.0,96448.16254952336,GRB2
20286,KEGG_2019_Human,JAK-STAT signaling pathway,1/162,0.0080999104202618,0.0118123713296852,0,0,19838.0,95537.86936302872,GRB2
20287,KEGG_2019_Human,Hepatitis B,1/163,0.0081499100978668,0.0118123713296852,0,0,19837.0,95410.9786681514,GRB2
20288,KEGG_2019_Human,Hepatocellular carcinoma,1/168,0.0083999085011095,0.0118123713296852,0,0,19832.0,94787.72752807094,GRB2
20289,KEGG_2019_Human,Alcoholism,1/180,0.0089999047745351,0.0122228496338095,0,0,19820.0,93362.92821536642,GRB2
20290,KEGG_2019_Human,Chemokine signaling pathway,1/190,0.0094999017791995,0.0122228496338095,0,0,19810.0,92244.74636351672,GRB2
20291,KEGG_2019_Human,Focal adhesion,1/199,0.0099498991610159,0.0122228496338095,0,0,19801.0,91286.4288690606,GRB2
20292,KEGG_2019_Human,Proteoglycans in cancer,1/201,0.0100498985877989,0.0122228496338095,0,0,19799.0,91079.21596609056,GRB2
20293,KEGG_2019_Human,Viral carcinogenesis,1/201,0.0100498985877989,0.0122228496338095,0,0,19799.0,91079.21596609056,GRB2
20294,KEGG_2019_Human,Human cytomegalovirus infection,1/225,0.0112498919790339,0.0130498764018304,0,0,19775.0,88738.27077557483,GRB2
20295,KEGG_2019_Human,Thermogenesis,1/231,0.0115498903940656,0.0130498764018304,0,0,19769.0,88191.07730937863,GRB2
20296,KEGG_2019_Human,Ras signaling pathway,1/232,0.0115998901349604,0.0130498764018304,0,0,19768.0,88101.22480150245,GRB2
20297,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0160177222146979,0,0,19705.0,83086.53988020132,GRB2
20298,KEGG_2019_Human,MicroRNAs in cancer,1/299,0.0149498740670514,0.0160177222146979,0,0,19701.0,82804.33538735632,GRB2
20299,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0172673031547303,0,0,19670.0,80733.60565076157,GRB2
20300,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0181021322468524,0,0,19646.0,79255.8617626126,GRB2
20301,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,GRB2
20302,KEGG_2019_Human,Asthma,1/31,0.0015499690656704,0.0083141731379497,0,0,19969.0,129189.85098816035,HLA-DMB
20303,KEGG_2019_Human,Allograft rejection,1/38,0.001899964429635,0.0083141731379497,0,0,19962.0,125080.29732025368,HLA-DMB
20304,KEGG_2019_Human,Graft-versus-host disease,1/41,0.0020499625466866,0.0083141731379497,0,0,19959.0,123544.88783416104,HLA-DMB
20305,KEGG_2019_Human,Type I diabetes mellitus,1/43,0.0021499613216957,0.0083141731379497,0,0,19957.0,122581.98940490963,HLA-DMB
20306,KEGG_2019_Human,Intestinal immune network for IgA production,1/48,0.0023999583567988,0.0083141731379497,0,0,19952.0,120356.5272753826,HLA-DMB
20307,KEGG_2019_Human,Autoimmune thyroid disease,1/53,0.0026499555173137,0.0083141731379497,0,0,19947.0,118349.78824235698,HLA-DMB
20308,KEGG_2019_Human,Viral myocarditis,1/59,0.0029499522555206,0.0083141731379497,0,0,19941.0,116175.59385530632,HLA-DMB
20309,KEGG_2019_Human,Inflammatory bowel disease (IBD),1/65,0.003249949134407,0.0083141731379497,0,0,19935.0,114209.92613860144,HLA-DMB
20310,KEGG_2019_Human,Staphylococcus aureus infection,1/68,0.0033999476216189,0.0083141731379497,0,0,19932.0,113293.39338050144,HLA-DMB
20311,KEGG_2019_Human,Leishmaniasis,1/74,0.0036999446830449,0.0083141731379497,0,0,19926.0,111574.38983110404,HLA-DMB
20312,KEGG_2019_Human,Antigen processing and presentation,1/77,0.0038499432547502,0.0083141731379497,0,0,19923.0,110765.8407373636,HLA-DMB
20313,KEGG_2019_Human,Rheumatoid arthritis,1/91,0.0045499369072032,0.0083141731379497,0,0,19909.0,107362.10783923086,HLA-DMB
20314,KEGG_2019_Human,Th1 and Th2 cell differentiation,1/92,0.0045999364719865,0.0083141731379497,0,0,19908.0,107139.13814408927,HLA-DMB
20315,KEGG_2019_Human,Hematopoietic cell lineage,1/97,0.0048499343304706,0.0083141731379497,0,0,19903.0,106058.9096435903,HLA-DMB
20316,KEGG_2019_Human,Th17 cell differentiation,1/107,0.0053499302026925,0.0084748917286727,0,0,19893.0,104053.753408911,HLA-DMB
20317,KEGG_2019_Human,Toxoplasmosis,1/113,0.0056499278191151,0.0084748917286727,0,0,19887.0,102937.34947211576,HLA-DMB
20318,KEGG_2019_Human,Systemic lupus erythematosus,1/133,0.0066499203093911,0.0093881227897286,0,0,19867.0,99596.2591544721,HLA-DMB
20319,KEGG_2019_Human,Cell adhesion molecules (CAMs),1/145,0.0072499160871101,0.0095998910039963,0,0,19855.0,97820.92670675044,HLA-DMB
20320,KEGG_2019_Human,Phagosome,1/152,0.0075999137114971,0.0095998910039963,0,0,19848.0,96850.665715497,HLA-DMB
20321,KEGG_2019_Human,Influenza A,1/171,0.0085499075557634,0.0102284629486356,0,0,19829.0,94422.42241345016,HLA-DMB
20322,KEGG_2019_Human,Tuberculosis,1/179,0.0089499050800561,0.0102284629486356,0,0,19821.0,93478.0629355712,HLA-DMB
20323,KEGG_2019_Human,Epstein-Barr virus infection,1/201,0.0100498985877989,0.0109635257321443,0,0,19799.0,91079.21596609056,HLA-DMB
20324,KEGG_2019_Human,Human T-cell leukemia virus 1 infection,1/219,0.0109498935894162,0.0114259759193908,0,0,19781.0,89299.85161916987,HLA-DMB
20325,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,HLA-DMB
20326,KEGG_2019_Human,Arachidonic acid metabolism,1/63,0.0031499501598827,0.0031499501598827,0,0,19937.0,114844.46974572667,PTGES2
20327,KEGG_2019_Human,Circadian entrainment,1/97,0.0048499343304706,0.0096998686609413,0,0,19903.0,106058.9096435903,MTNR1B
20328,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,MTNR1B
20329,KEGG_2019_Human,Starch and sucrose metabolism,1/36,0.0017999657178272,0.0032999410769135,0,0,19964.0,126172.23364250171,AMY1B
20330,KEGG_2019_Human,Carbohydrate digestion and absorption,1/44,0.0021999607179423,0.0032999410769135,0,0,19956.0,122117.06559109331,AMY1B
20331,KEGG_2019_Human,Salivary secretion,1/90,0.0044999373439762,0.0044999373439762,0,0,19910.0,107587.50385474482,AMY1B
20332,KEGG_2019_Human,Primary immunodeficiency,1/37,0.0018499650702878,0.0089165503378209,0,0,19963.0,125618.9446446357,CD4
20333,KEGG_2019_Human,Antigen processing and presentation,1/77,0.0038499432547502,0.0089165503378209,0,0,19923.0,110765.8407373636,CD4
20334,KEGG_2019_Human,Th1 and Th2 cell differentiation,1/92,0.0045999364719865,0.0089165503378209,0,0,19908.0,107139.13814408927,CD4
20335,KEGG_2019_Human,Hematopoietic cell lineage,1/97,0.0048499343304706,0.0089165503378209,0,0,19903.0,106058.9096435903,CD4
20336,KEGG_2019_Human,T cell receptor signaling pathway,1/101,0.0050499326546803,0.0089165503378209,0,0,19899.0,105233.48101229242,CD4
20337,KEGG_2019_Human,Th17 cell differentiation,1/107,0.0053499302026925,0.0089165503378209,0,0,19893.0,104053.753408911,CD4
20338,KEGG_2019_Human,Cell adhesion molecules (CAMs),1/145,0.0072499160871101,0.0103570229815859,0,0,19855.0,97820.92670675044,CD4
20339,KEGG_2019_Human,Human immunodeficiency virus 1 infection,1/212,0.0105998955026255,0.0121665484326847,0,0,19788.0,89974.27756224656,CD4
20340,KEGG_2019_Human,Human T-cell leukemia virus 1 infection,1/219,0.0109498935894162,0.0121665484326847,0,0,19781.0,89299.85161916987,CD4
20341,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0146998751759735,0,0,19706.0,83157.67014793828,CD4
20342,KEGG_2019_Human,Arachidonic acid metabolism,1/63,0.0031499501598827,0.0056499278191151,0,0,19937.0,114844.46974572667,ALOX12
20343,KEGG_2019_Human,Inflammatory mediator regulation of TRP channels,1/100,0.0049999330710556,0.0056499278191151,0,0,19900.0,105436.78197328727,ALOX12
20344,KEGG_2019_Human,Serotonergic synapse,1/113,0.0056499278191151,0.0056499278191151,0,0,19887.0,102937.34947211576,ALOX12
20345,KEGG_2019_Human,Glycosphingolipid biosynthesis,1/45,0.0022499601197094,0.0022499601197094,0,0,19955.0,121662.49782449217,ST3GAL6
20346,KEGG_2019_Human,JAK-STAT signaling pathway,1/162,0.0080999104202618,0.0146998751759735,0,0,19838.0,95537.86936302872,IL24
20347,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0146998751759735,0,0,19706.0,83157.67014793828,IL24
20348,KEGG_2019_Human,Ascorbate and aldarate metabolism,1/27,0.0013499718942362,0.004685646776936,0,0,19973.0,131975.02298599784,UGT1A3
20349,KEGG_2019_Human,Pentose and glucuronate interconversions,1/34,0.0016999670339032,0.004685646776936,0,0,19966.0,127326.1054203148,UGT1A3
20350,KEGG_2019_Human,Porphyrin and chlorophyll metabolism,1/42,0.0020999619311272,0.004685646776936,0,0,19958.0,123057.75613441122,UGT1A3
20351,KEGG_2019_Human,Steroid hormone biosynthesis,1/60,0.002999951725986,0.004685646776936,0,0,19940.0,115834.63209072244,UGT1A3
20352,KEGG_2019_Human,Retinol metabolism,1/67,0.0033499481224912,0.004685646776936,0,0,19933.0,113594.38808369274,UGT1A3
20353,KEGG_2019_Human,Metabolism of xenobiotics by cytochrome P450,1/74,0.0036999446830449,0.004685646776936,0,0,19926.0,111574.38983110404,UGT1A3
20354,KEGG_2019_Human,Chemical carcinogenesis,1/82,0.004099940929819,0.004685646776936,0,0,19918.0,109484.9180722932,UGT1A3
20355,KEGG_2019_Human,Drug metabolism,1/108,0.0053999298011749,0.0053999298011749,0,0,19892.0,103863.47861844616,UGT1A3
20356,KEGG_2019_Human,Nucleotide excision repair,1/47,0.0023499589392381,0.0023499589392381,0,0,19953.0,120782.64067395544,XPA
20357,KEGG_2019_Human,Ribosome,1/153,0.0076499133771537,0.0076499133771537,0,0,19847.0,96715.6407630817,MRPS11
20358,KEGG_2019_Human,Spliceosome,1/134,0.0066999199497742,0.0066999199497742,0,0,19866.0,99442.43560916925,SNRPF
20359,KEGG_2019_Human,Ribosome biogenesis in eukaryotes,1/101,0.0050499326546803,0.0050499326546803,0,0,19899.0,105233.48101229242,SBDS
20360,KEGG_2019_Human,Lysosome,1/123,0.0061499239842961,0.0071499167770442,0,0,19877.0,101200.07933676826,CTSO
20361,KEGG_2019_Human,Apoptosis,1/143,0.0071499167770442,0.0071499167770442,0,0,19857.0,98106.57763600958,CTSO
20362,KEGG_2019_Human,Hippo signaling pathway,1/160,0.0079999110688441,0.0079999110688441,0,0,19840.0,95793.96509856998,YAP1
20363,KEGG_2019_Human,Lysosome,1/123,0.0061499239842961,0.0105998955026255,0,0,19877.0,101200.07933676826,AP1S1
20364,KEGG_2019_Human,Human immunodeficiency virus 1 infection,1/212,0.0105998955026255,0.0105998955026255,0,0,19788.0,89974.27756224656,AP1S1
20365,KEGG_2019_Human,Endocytosis,1/244,0.0121998870519305,0.0121998870519305,0,0,19756.0,87051.4275316661,VPS25
20366,KEGG_2019_Human,Glycosylphosphatidylinositol (GPI)-anchor biosynthesis,1/25,0.0012499733663791,0.0012499733663791,0,0,19975.0,133525.54486996148,PIGV
20367,KEGG_2019_Human,Nicotinate and nicotinamide metabolism,1/30,0.0014999697593334,0.0014999697593334,0,0,19970.0,129851.13732048514,NADSYN1
20368,KEGG_2019_Human,mRNA surveillance pathway,1/91,0.0045499369072032,0.0082499094553477,0,0,19909.0,107362.10783923086,RBM8A
20369,KEGG_2019_Human,Spliceosome,1/134,0.0066999199497742,0.0082499094553477,0,0,19866.0,99442.43560916925,RBM8A
20370,KEGG_2019_Human,RNA transport,1/165,0.0082499094553477,0.0082499094553477,0,0,19835.0,95159.46482222488,RBM8A
20371,KEGG_2019_Human,Cellular senescence,1/160,0.0079999110688441,0.0079999110688441,0,0,19840.0,95793.96509856998,RAD1
20372,KEGG_2019_Human,Galactose metabolism,1/31,0.0015499690656704,0.0023999542904363,0,0,19969.0,129189.85098816035,UGP2
20373,KEGG_2019_Human,Pentose and glucuronate interconversions,1/34,0.0016999670339032,0.0023999542904363,0,0,19966.0,127326.1054203148,UGP2
20374,KEGG_2019_Human,Starch and sucrose metabolism,1/36,0.0017999657178272,0.0023999542904363,0,0,19964.0,126172.23364250171,UGP2
20375,KEGG_2019_Human,Amino sugar and nucleotide sugar metabolism,1/48,0.0023999583567988,0.0023999583567988,0,0,19952.0,120356.5272753826,UGP2
20376,KEGG_2019_Human,Cell adhesion molecules (CAMs),1/145,0.0072499160871101,0.0072499160871101,0,0,19855.0,97820.92670675044,CD276
20377,KEGG_2019_Human,Protein export,1/23,0.0011499748819949,0.0045998995279799,0,0,19977.0,135204.63922267244,SEC61A1
20378,KEGG_2019_Human,Vibrio cholerae infection,1/50,0.0024999572069037,0.0049999144138074,0,0,19950.0,119530.05920663515,SEC61A1
20379,KEGG_2019_Human,Phagosome,1/152,0.0075999137114971,0.0082499094553477,0,0,19848.0,96850.665715497,SEC61A1
20380,KEGG_2019_Human,Protein processing in endoplasmic reticulum,1/165,0.0082499094553477,0.0082499094553477,0,0,19835.0,95159.46482222488,SEC61A1
20381,KEGG_2019_Human,cAMP signaling pathway,1/212,0.0105998955026255,0.0168998658265596,0,0,19788.0,89974.27756224656,GIPR
20382,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,GIPR
20383,KEGG_2019_Human,Ferroptosis,1/40,0.0019999631680592,0.0039999263361184,0,0,19960.0,124043.94523066044,LPCAT3
20384,KEGG_2019_Human,Glycerophospholipid metabolism,1/97,0.0048499343304706,0.0048499343304706,0,0,19903.0,106058.9096435903,LPCAT3
20385,KEGG_2019_Human,TGF-beta signaling pathway,1/90,0.0044999373439762,0.0044999373439762,0,0,19910.0,107587.50385474482,TGIF2
20386,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF34
20387,KEGG_2019_Human,N-Glycan biosynthesis,1/50,0.0024999572069037,0.0024999572069037,0,0,19950.0,119530.05920663515,ALG13
20388,KEGG_2019_Human,Glutathione metabolism,1/56,0.0027999538675741,0.0094498771520562,0,0,19944.0,117233.87022514464,GSTO2
20389,KEGG_2019_Human,Metabolism of xenobiotics by cytochrome P450,1/74,0.0036999446830449,0.0094498771520562,0,0,19926.0,111574.38983110404,GSTO2
20390,KEGG_2019_Human,Chemical carcinogenesis,1/82,0.004099940929819,0.0094498771520562,0,0,19918.0,109484.9180722932,GSTO2
20391,KEGG_2019_Human,Drug metabolism,1/108,0.0053999298011749,0.0094498771520562,0,0,19892.0,103863.47861844616,GSTO2
20392,KEGG_2019_Human,Fluid shear stress and atherosclerosis,1/139,0.006949918172816,0.0097298854419424,0,0,19861.0,98689.81333375497,GSTO2
20393,KEGG_2019_Human,Hepatocellular carcinoma,1/168,0.0083999085011095,0.0097998932512944,0,0,19832.0,94787.72752807094,GSTO2
20394,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,GSTO2
20395,KEGG_2019_Human,Phosphatidylinositol signaling system,1/99,0.0049499334884068,0.0049499334884068,0,0,19901.0,105642.09305076736,PIP4P1
20396,KEGG_2019_Human,Amyotrophic lateral sclerosis (ALS),1/51,0.0025499566390179,0.0101089718877324,0,0,19949.0,119129.0228601236,MAPK14
20397,KEGG_2019_Human,VEGF signaling pathway,1/59,0.0029499522555206,0.0101089718877324,0,0,19941.0,116175.59385530632,MAPK14
20398,KEGG_2019_Human,Shigellosis,1/65,0.003249949134407,0.0101089718877324,0,0,19935.0,114209.92613860144,MAPK14
20399,KEGG_2019_Human,Epithelial cell signaling in Helicobacter pylori infection,1/68,0.0033999476216189,0.0101089718877324,0,0,19932.0,113293.39338050144,MAPK14
20400,KEGG_2019_Human,Fc epsilon RI signaling pathway,1/68,0.0033999476216189,0.0101089718877324,0,0,19932.0,113293.39338050144,MAPK14
20401,KEGG_2019_Human,Prolactin signaling pathway,1/70,0.0034999466296654,0.0101089718877324,0,0,19930.0,112704.30065625212,MAPK14
20402,KEGG_2019_Human,RIG-I-like receptor signaling pathway,1/70,0.0034999466296654,0.0101089718877324,0,0,19930.0,112704.30065625212,MAPK14
20403,KEGG_2019_Human,Leishmaniasis,1/74,0.0036999446830449,0.0101089718877324,0,0,19926.0,111574.38983110404,MAPK14
20404,KEGG_2019_Human,Pertussis,1/76,0.0037999437281752,0.0101089718877324,0,0,19924.0,111031.8499691117,MAPK14
20405,KEGG_2019_Human,Salmonella infection,1/86,0.0042999391173866,0.0101089718877324,0,0,19914.0,108514.46102290176,MAPK14
20406,KEGG_2019_Human,Th1 and Th2 cell differentiation,1/92,0.0045999364719865,0.0101089718877324,0,0,19908.0,107139.13814408927,MAPK14
20407,KEGG_2019_Human,IL-17 signaling pathway,1/93,0.0046499360391879,0.0101089718877324,0,0,19907.0,106918.54242106884,MAPK14
20408,KEGG_2019_Human,GnRH signaling pathway,1/93,0.0046499360391879,0.0101089718877324,0,0,19907.0,106918.54242106884,MAPK14
20409,KEGG_2019_Human,Progesterone-mediated oocyte maturation,1/99,0.0049499334884068,0.0101089718877324,0,0,19901.0,105642.09305076736,MAPK14
20410,KEGG_2019_Human,AGE-RAGE signaling pathway in diabetic complications,1/100,0.0049999330710556,0.0101089718877324,0,0,19900.0,105436.78197328727,MAPK14
20411,KEGG_2019_Human,Inflammatory mediator regulation of TRP channels,1/100,0.0049999330710556,0.0101089718877324,0,0,19900.0,105436.78197328727,MAPK14
20412,KEGG_2019_Human,T cell receptor signaling pathway,1/101,0.0050499326546803,0.0101089718877324,0,0,19899.0,105233.48101229242,MAPK14
20413,KEGG_2019_Human,Chagas disease (American trypanosomiasis),1/103,0.0051499318302617,0.0101089718877324,0,0,19897.0,104832.7525292024,MAPK14
20414,KEGG_2019_Human,Toll-like receptor signaling pathway,1/104,0.0051999314202997,0.0101089718877324,0,0,19896.0,104635.24941415618,MAPK14
20415,KEGG_2019_Human,C-type lectin receptor signaling pathway,1/104,0.0051999314202997,0.0101089718877324,0,0,19896.0,104635.24941415618,MAPK14
20416,KEGG_2019_Human,Th17 cell differentiation,1/107,0.0053499302026925,0.0101089718877324,0,0,19893.0,104053.753408911,MAPK14
20417,KEGG_2019_Human,TNF signaling pathway,1/110,0.0054999290027479,0.0101089718877324,0,0,19890.0,103488.06969787036,MAPK14
20418,KEGG_2019_Human,Leukocyte transendothelial migration,1/112,0.0055999282120529,0.0101089718877324,0,0,19888.0,103119.30984392198,MAPK14
20419,KEGG_2019_Human,Toxoplasmosis,1/113,0.0056499278191151,0.0101089718877324,0,0,19887.0,102937.34947211576,MAPK14
20420,KEGG_2019_Human,Sphingolipid signaling pathway,1/119,0.0059499254985137,0.0101089718877324,0,0,19881.0,101877.73080211312,MAPK14
20421,KEGG_2019_Human,Neurotrophin signaling pathway,1/119,0.0059499254985137,0.0101089718877324,0,0,19881.0,101877.73080211312,MAPK14
20422,KEGG_2019_Human,Platelet activation,1/124,0.0061999236097501,0.0101089718877324,0,0,19876.0,101034.04709010696,MAPK14
20423,KEGG_2019_Human,Osteoclast differentiation,1/127,0.0063499224962247,0.0101089718877324,0,0,19873.0,100543.72072014232,MAPK14
20424,KEGG_2019_Human,Relaxin signaling pathway,1/130,0.0064999213952527,0.0101089718877324,0,0,19870.0,100064.62842845908,MAPK14
20425,KEGG_2019_Human,Dopaminergic synapse,1/131,0.0065499210316603,0.0101089718877324,0,0,19869.0,99907.33811343512,MAPK14
20426,KEGG_2019_Human,FoxO signaling pathway,1/132,0.0065999206698993,0.0101089718877324,0,0,19868.0,99751.22090491928,MAPK14
20427,KEGG_2019_Human,Fluid shear stress and atherosclerosis,1/139,0.006949918172816,0.0101089718877324,0,0,19861.0,98689.81333375497,MAPK14
20428,KEGG_2019_Human,Signaling pathways regulating pluripotency of stem cells,1/139,0.006949918172816,0.0101089718877324,0,0,19861.0,98689.81333375497,MAPK14
20429,KEGG_2019_Human,Adrenergic signaling in cardiomyocytes,1/145,0.0072499160871101,0.0101484549413362,0,0,19855.0,97820.92670675044,MAPK14
20430,KEGG_2019_Human,Retrograde endocannabinoid signaling,1/148,0.007399915061391,0.0101484549413362,0,0,19852.0,97399.60470052566,MAPK14
20431,KEGG_2019_Human,Cellular senescence,1/160,0.0079999110688441,0.0105728563431785,0,0,19840.0,95793.96509856998,MAPK14
20432,KEGG_2019_Human,Hepatitis B,1/163,0.0081499100978668,0.0105728563431785,0,0,19837.0,95410.9786681514,MAPK14
20433,KEGG_2019_Human,Influenza A,1/171,0.0085499075557634,0.0107398860960673,0,0,19829.0,94422.42241345016,MAPK14
20434,KEGG_2019_Human,NOD-like receptor signaling pathway,1/178,0.0088999053857096,0.0107398860960673,0,0,19822.0,93593.82745769851,MAPK14
20435,KEGG_2019_Human,Tuberculosis,1/179,0.0089499050800561,0.0107398860960673,0,0,19821.0,93478.0629355712,MAPK14
20436,KEGG_2019_Human,Kaposi sarcoma-associated herpesvirus infection,1/186,0.0092999029651357,0.0108876912762565,0,0,19814.0,92684.96451050608,MAPK14
20437,KEGG_2019_Human,Epstein-Barr virus infection,1/201,0.0100498985877989,0.0112184914468453,0,0,19799.0,91079.21596609056,MAPK14
20438,KEGG_2019_Human,Proteoglycans in cancer,1/201,0.0100498985877989,0.0112184914468453,0,0,19799.0,91079.21596609056,MAPK14
20439,KEGG_2019_Human,Rap1 signaling pathway,1/206,0.010299897173561,0.0112362514620665,0,0,19794.0,90569.849337325,MAPK14
20440,KEGG_2019_Human,Human immunodeficiency virus 1 infection,1/212,0.0105998955026255,0.0113065552028006,0,0,19788.0,89974.27756224656,MAPK14
20441,KEGG_2019_Human,Human cytomegalovirus infection,1/225,0.0112498919790339,0.0117390177172527,0,0,19775.0,88738.27077557483,MAPK14
20442,KEGG_2019_Human,Thermogenesis,1/231,0.0115498903940656,0.0117956327428755,0,0,19769.0,88191.07730937863,MAPK14
20443,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0147498749536506,0,0,19705.0,83086.53988020132,MAPK14
20444,KEGG_2019_Human,Notch signaling pathway,1/48,0.0023999583567988,0.0071998750703964,0,0,19952.0,120356.5272753826,PSEN2
20445,KEGG_2019_Human,Neurotrophin signaling pathway,1/119,0.0059499254985137,0.0085499075557634,0,0,19881.0,101877.73080211312,PSEN2
20446,KEGG_2019_Human,Alzheimer disease,1/171,0.0085499075557634,0.0085499075557634,0,0,19829.0,94422.42241345016,PSEN2
20447,KEGG_2019_Human,mRNA surveillance pathway,1/91,0.0045499369072032,0.0045499369072032,0,0,19909.0,107362.10783923086,MSI2
20448,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF471
20449,KEGG_2019_Human,Shigellosis,1/65,0.003249949134407,0.0085998782347732,0,0,19935.0,114209.92613860144,PFN1
20450,KEGG_2019_Human,Salmonella infection,1/86,0.0042999391173866,0.0085998782347732,0,0,19914.0,108514.46102290176,PFN1
20451,KEGG_2019_Human,Rap1 signaling pathway,1/206,0.010299897173561,0.0106998949514067,0,0,19794.0,90569.849337325,PFN1
20452,KEGG_2019_Human,Regulation of actin cytoskeleton,1/214,0.0106998949514067,0.0106998949514067,0,0,19786.0,89779.39753374986,PFN1
20453,KEGG_2019_Human,Cell adhesion molecules (CAMs),1/145,0.0072499160871101,0.0072499160871101,0,0,19855.0,97820.92670675044,MPZ
20454,KEGG_2019_Human,Cellular senescence,1/160,0.0079999110688441,0.0079999110688441,0,0,19840.0,95793.96509856998,LIN37
20455,KEGG_2019_Human,Autophagy,1/128,0.0063999221281459,0.0063999221281459,0,0,19872.0,100382.8010329652,TP53INP2
20456,KEGG_2019_Human,Nucleotide excision repair,1/47,0.0023499589392381,0.0046999178784763,0,0,19953.0,120782.64067395544,RAD23B
20457,KEGG_2019_Human,Protein processing in endoplasmic reticulum,1/165,0.0082499094553477,0.0082499094553477,0,0,19835.0,95159.46482222488,RAD23B
20458,KEGG_2019_Human,Insulin signaling pathway,1/137,0.0068499188797651,0.0068499188797651,0,0,19863.0,98987.62735269018,PRKAR2A
20459,KEGG_2019_Human,Amino sugar and nucleotide sugar metabolism,1/48,0.0023999583567988,0.0023999583567988,0,0,19952.0,120356.5272753826,PGM3
20460,KEGG_2019_Human,Cholesterol metabolism,1/50,0.0024999572069037,0.0024999572069037,0,0,19950.0,119530.05920663515,APOC1
20461,KEGG_2019_Human,Spliceosome,1/134,0.0066999199497742,0.0066999199497742,0,0,19866.0,99442.43560916925,SNRNP40
20462,KEGG_2019_Human,Sphingolipid metabolism,1/47,0.0023499589392381,0.0023499589392381,0,0,19953.0,120782.64067395544,CERK
20463,KEGG_2019_Human,RNA polymerase,1/31,0.0015499690656704,0.0015499690656704,0,0,19969.0,129189.85098816035,POLR1E
20464,KEGG_2019_Human,Central carbon metabolism in cancer,1/65,0.003249949134407,0.0064998982688141,0,0,19935.0,114209.92613860144,SIRT6
20465,KEGG_2019_Human,Thermogenesis,1/231,0.0115498903940656,0.0115498903940656,0,0,19769.0,88191.07730937863,SIRT6
20466,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR4D6
20467,KEGG_2019_Human,Viral myocarditis,1/59,0.0029499522555206,0.0029499522555206,0,0,19941.0,116175.59385530632,CXADR
20468,KEGG_2019_Human,Pantothenate and CoA biosynthesis,1/19,0.00094997806231055,0.0023999583567988,0,0,19981.0,139049.2109571672,BCAT2
20469,KEGG_2019_Human,Cysteine and methionine metabolism,1/47,0.0023499589392381,0.0023999583567988,0,0,19953.0,120782.64067395544,BCAT2
20470,KEGG_2019_Human,"Valine, leucine and isoleucine degradation",1/48,0.0023999583567988,0.0023999583567988,0,0,19952.0,120356.5272753826,BCAT2
20471,KEGG_2019_Human,Mannose type O-glycan biosynthesis,1/23,0.0011499748819949,0.0011499748819949,0,0,19977.0,135204.63922267244,CHST10
20472,KEGG_2019_Human,N-Glycan biosynthesis,1/50,0.0024999572069037,0.0024999572069037,0,0,19950.0,119530.05920663515,MGAT5
20473,KEGG_2019_Human,Ribosome,1/153,0.0076499133771537,0.0076499133771537,0,0,19847.0,96715.6407630817,RPL18
20474,KEGG_2019_Human,Cysteine and methionine metabolism,1/47,0.0023499589392381,0.0023499589392381,0,0,19953.0,120782.64067395544,AHCY
20475,KEGG_2019_Human,Selenocompound metabolism,1/17,0.0008499797390404818,0.0023499589392381,0,0,19983.0,141285.76583697114,CTH
20476,KEGG_2019_Human,"Glycine, serine and threonine metabolism",1/40,0.0019999631680592,0.0023499589392381,0,0,19960.0,124043.94523066044,CTH
20477,KEGG_2019_Human,Cysteine and methionine metabolism,1/47,0.0023499589392381,0.0023499589392381,0,0,19953.0,120782.64067395544,CTH
20478,KEGG_2019_Human,Base excision repair,1/33,0.0016499677032113,0.0049499031096341,0,0,19967.0,127928.56031580272,HMGB1
20479,KEGG_2019_Human,Autophagy,1/128,0.0063999221281459,0.0080999104202618,0,0,19872.0,100382.8010329652,HMGB1
20480,KEGG_2019_Human,Necroptosis,1/162,0.0080999104202618,0.0080999104202618,0,0,19838.0,95537.86936302872,HMGB1
20481,KEGG_2019_Human,Proteasome,1/45,0.0022499601197094,0.0022499601197094,0,0,19955.0,121662.49782449217,PSMB8
20482,KEGG_2019_Human,Ribosome,1/153,0.0076499133771537,0.0076499133771537,0,0,19847.0,96715.6407630817,MRPL11
20483,KEGG_2019_Human,RNA polymerase,1/31,0.0015499690656704,0.0046499071970112,0,0,19969.0,129189.85098816035,POLR2H
20484,KEGG_2019_Human,Cytosolic DNA-sensing pathway,1/63,0.0031499501598827,0.0047249252398241,0,0,19937.0,114844.46974572667,POLR2H
20485,KEGG_2019_Human,Huntington disease,1/193,0.0096499008972596,0.0096499008972596,0,0,19807.0,91920.47679471428,POLR2H
20486,KEGG_2019_Human,Arrhythmogenic right ventricular cardiomyopathy (ARVC),1/72,0.0035999456502131,0.0045499369072032,0,0,19928.0,112131.59838572376,EMD
20487,KEGG_2019_Human,Hypertrophic cardiomyopathy (HCM),1/85,0.004249939567045,0.0045499369072032,0,0,19915.0,108752.83801948265,EMD
20488,KEGG_2019_Human,Dilated cardiomyopathy (DCM),1/91,0.0045499369072032,0.0045499369072032,0,0,19909.0,107362.10783923086,EMD
20489,KEGG_2019_Human,Legionellosis,1/55,0.0027499544131125,0.0027499544131125,0,0,19945.0,117599.1294878737,EEF1G
20490,KEGG_2019_Human,Fatty acid elongation,1/27,0.0013499718942362,0.0023999583567988,0,0,19973.0,131975.02298599784,ACAA2
20491,KEGG_2019_Human,Fatty acid degradation,1/44,0.0021999607179423,0.0023999583567988,0,0,19956.0,122117.06559109331,ACAA2
20492,KEGG_2019_Human,"Valine, leucine and isoleucine degradation",1/48,0.0023999583567988,0.0023999583567988,0,0,19952.0,120356.5272753826,ACAA2
20493,KEGG_2019_Human,AMPK signaling pathway,1/120,0.0059999251180858,0.0119998502361717,0,0,19880.0,101706.2448082016,RAB10
20494,KEGG_2019_Human,Endocytosis,1/244,0.0121998870519305,0.0121998870519305,0,0,19756.0,87051.4275316661,RAB10
20495,KEGG_2019_Human,Nicotinate and nicotinamide metabolism,1/30,0.0014999697593334,0.0014999697593334,0,0,19970.0,129851.13732048514,NMRK2
20496,KEGG_2019_Human,Inflammatory bowel disease (IBD),1/65,0.003249949134407,0.0071332402702567,0,0,19935.0,114209.92613860144,IL17F
20497,KEGG_2019_Human,IL-17 signaling pathway,1/93,0.0046499360391879,0.0071332402702567,0,0,19907.0,106918.54242106884,IL17F
20498,KEGG_2019_Human,Th17 cell differentiation,1/107,0.0053499302026925,0.0071332402702567,0,0,19893.0,104053.753408911,IL17F
20499,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0146998751759735,0,0,19706.0,83157.67014793828,IL17F
20500,KEGG_2019_Human,Asthma,1/31,0.0015499690656704,0.0015499690656704,0,0,19969.0,129189.85098816035,PRG2
20501,KEGG_2019_Human,Fatty acid elongation,1/27,0.0013499718942362,0.0023999583567988,0,0,19973.0,131975.02298599784,HADHB
20502,KEGG_2019_Human,Fatty acid degradation,1/44,0.0021999607179423,0.0023999583567988,0,0,19956.0,122117.06559109331,HADHB
20503,KEGG_2019_Human,"Valine, leucine and isoleucine degradation",1/48,0.0023999583567988,0.0023999583567988,0,0,19952.0,120356.5272753826,HADHB
20504,KEGG_2019_Human,Central carbon metabolism in cancer,1/65,0.003249949134407,0.003249949134407,0,0,19935.0,114209.92613860144,SIRT3
20505,KEGG_2019_Human,TGF-beta signaling pathway,1/90,0.0044999373439762,0.0119998666032662,0,0,19910.0,107587.50385474482,GDF6
20506,KEGG_2019_Human,Hippo signaling pathway,1/160,0.0079999110688441,0.0119998666032662,0,0,19840.0,95793.96509856998,GDF6
20507,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0146998751759735,0,0,19706.0,83157.67014793828,GDF6
20508,KEGG_2019_Human,Glycosaminoglycan degradation,1/19,0.00094997806231055,0.0018999561246211,0,0,19981.0,139049.2109571672,HYAL1
20509,KEGG_2019_Human,Lysosome,1/123,0.0061499239842961,0.0061499239842961,0,0,19877.0,101200.07933676826,HYAL1
20510,KEGG_2019_Human,Synaptic vesicle cycle,1/78,0.0038999427840466,0.0038999427840466,0,0,19922.0,110503.2180492851,CPLX3
20511,KEGG_2019_Human,TNF signaling pathway,1/110,0.0054999290027479,0.0063499224962247,0,0,19890.0,103488.06969787036,JUNB
20512,KEGG_2019_Human,Osteoclast differentiation,1/127,0.0063499224962247,0.0063499224962247,0,0,19873.0,100543.72072014232,JUNB
20513,KEGG_2019_Human,Oxytocin signaling pathway,1/153,0.0076499133771537,0.0124498637045599,0,0,19847.0,96715.6407630817,RGS2
20514,KEGG_2019_Human,cGMP-PKG signaling pathway,1/166,0.0082999091363732,0.0124498637045599,0,0,19834.0,95034.82345515196,RGS2
20515,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,RGS2
20516,KEGG_2019_Human,Oxidative phosphorylation,1/133,0.0066499203093911,0.0112582177134695,0,0,19867.0,99596.2591544721,NDUFA8
20517,KEGG_2019_Human,Parkinson disease,1/142,0.0070999171242726,0.0112582177134695,0,0,19858.0,98250.87390500787,NDUFA8
20518,KEGG_2019_Human,Retrograde endocannabinoid signaling,1/148,0.007399915061391,0.0112582177134695,0,0,19852.0,97399.60470052566,NDUFA8
20519,KEGG_2019_Human,Non-alcoholic fatty liver disease (NAFLD),1/149,0.0074499147221605,0.0112582177134695,0,0,19851.0,97261.02051561224,NDUFA8
20520,KEGG_2019_Human,Alzheimer disease,1/171,0.0085499075557634,0.0112582177134695,0,0,19829.0,94422.42241345016,NDUFA8
20521,KEGG_2019_Human,Huntington disease,1/193,0.0096499008972596,0.0112582177134695,0,0,19807.0,91920.47679471428,NDUFA8
20522,KEGG_2019_Human,Thermogenesis,1/231,0.0115498903940656,0.0115498903940656,0,0,19769.0,88191.07730937863,NDUFA8
20523,KEGG_2019_Human,Acute myeloid leukemia,1/66,0.003299948626608,0.0092999029651357,0,0,19934.0,113899.85357353876,BCL2A1
20524,KEGG_2019_Human,NF-kappa B signaling pathway,1/95,0.0047499351803394,0.0092999029651357,0,0,19905.0,106484.27183626965,BCL2A1
20525,KEGG_2019_Human,Apoptosis,1/143,0.0071499167770442,0.0092999029651357,0,0,19857.0,98106.57763600958,BCL2A1
20526,KEGG_2019_Human,Transcriptional misregulation in cancer,1/186,0.0092999029651357,0.0092999029651357,0,0,19814.0,92684.96451050608,BCL2A1
20527,KEGG_2019_Human,mTOR signaling pathway,1/152,0.0075999137114971,0.0075999137114971,0,0,19848.0,96850.665715497,TBC1D7
20528,KEGG_2019_Human,Carbohydrate digestion and absorption,1/44,0.0021999607179423,0.0107174211792485,0,0,19956.0,122117.06559109331,AKT3
20529,KEGG_2019_Human,Regulation of lipolysis in adipocytes,1/55,0.0027499544131125,0.0107174211792485,0,0,19945.0,117599.1294878737,AKT3
20530,KEGG_2019_Human,Endometrial cancer,1/58,0.0028999527887707,0.0107174211792485,0,0,19942.0,116522.31890946148,AKT3
20531,KEGG_2019_Human,VEGF signaling pathway,1/59,0.0029499522555206,0.0107174211792485,0,0,19941.0,116175.59385530632,AKT3
20532,KEGG_2019_Human,Central carbon metabolism in cancer,1/65,0.003249949134407,0.0107174211792485,0,0,19935.0,114209.92613860144,AKT3
20533,KEGG_2019_Human,Acute myeloid leukemia,1/66,0.003299948626608,0.0107174211792485,0,0,19934.0,113899.85357353876,AKT3
20534,KEGG_2019_Human,Non-small cell lung cancer,1/66,0.003299948626608,0.0107174211792485,0,0,19934.0,113899.85357353876,AKT3
20535,KEGG_2019_Human,Fc epsilon RI signaling pathway,1/68,0.0033999476216189,0.0107174211792485,0,0,19932.0,113293.39338050144,AKT3
20536,KEGG_2019_Human,Adipocytokine signaling pathway,1/69,0.003449947123837,0.0107174211792485,0,0,19931.0,112996.7391397682,AKT3
20537,KEGG_2019_Human,Renal cell carcinoma,1/69,0.003449947123837,0.0107174211792485,0,0,19931.0,112996.7391397682,AKT3
20538,KEGG_2019_Human,Prolactin signaling pathway,1/70,0.0034999466296654,0.0107174211792485,0,0,19930.0,112704.30065625212,AKT3
20539,KEGG_2019_Human,B cell receptor signaling pathway,1/71,0.0035499461386618,0.0107174211792485,0,0,19929.0,112415.9585341616,AKT3
20540,KEGG_2019_Human,Melanoma,1/72,0.0035999456502131,0.0107174211792485,0,0,19928.0,112131.59838572376,AKT3
20541,KEGG_2019_Human,Pancreatic cancer,1/75,0.0037499442041125,0.0107174211792485,0,0,19925.0,111301.33528642564,AKT3
20542,KEGG_2019_Human,Glioma,1/75,0.0037499442041125,0.0107174211792485,0,0,19925.0,111301.33528642564,AKT3
20543,KEGG_2019_Human,Chronic myeloid leukemia,1/76,0.0037999437281752,0.0107174211792485,0,0,19924.0,111031.8499691117,AKT3
20544,KEGG_2019_Human,ErbB signaling pathway,1/85,0.004249939567045,0.0107174211792485,0,0,19915.0,108752.83801948265,AKT3
20545,KEGG_2019_Human,Colorectal cancer,1/86,0.0042999391173866,0.0107174211792485,0,0,19914.0,108514.46102290176,AKT3
20546,KEGG_2019_Human,Fc gamma R-mediated phagocytosis,1/91,0.0045499369072032,0.0107174211792485,0,0,19909.0,107362.10783923086,AKT3
20547,KEGG_2019_Human,Small cell lung cancer,1/93,0.0046499360391879,0.0107174211792485,0,0,19907.0,106918.54242106884,AKT3
20548,KEGG_2019_Human,Prostate cancer,1/97,0.0048499343304706,0.0107174211792485,0,0,19903.0,106058.9096435903,AKT3
20549,KEGG_2019_Human,Choline metabolism in cancer,1/99,0.0049499334884068,0.0107174211792485,0,0,19901.0,105642.09305076736,AKT3
20550,KEGG_2019_Human,Progesterone-mediated oocyte maturation,1/99,0.0049499334884068,0.0107174211792485,0,0,19901.0,105642.09305076736,AKT3
20551,KEGG_2019_Human,AGE-RAGE signaling pathway in diabetic complications,1/100,0.0049999330710556,0.0107174211792485,0,0,19900.0,105436.78197328727,AKT3
20552,KEGG_2019_Human,HIF-1 signaling pathway,1/100,0.0049999330710556,0.0107174211792485,0,0,19900.0,105436.78197328727,AKT3
20553,KEGG_2019_Human,T cell receptor signaling pathway,1/101,0.0050499326546803,0.0107174211792485,0,0,19899.0,105233.48101229242,AKT3
20554,KEGG_2019_Human,Longevity regulating pathway,1/102,0.0050999322416682,0.0107174211792485,0,0,19898.0,105032.15064717118,AKT3
20555,KEGG_2019_Human,Chagas disease (American trypanosomiasis),1/103,0.0051499318302617,0.0107174211792485,0,0,19897.0,104832.7525292024,AKT3
20556,KEGG_2019_Human,Glucagon signaling pathway,1/103,0.0051499318302617,0.0107174211792485,0,0,19897.0,104832.7525292024,AKT3
20557,KEGG_2019_Human,Toll-like receptor signaling pathway,1/104,0.0051999314202997,0.0107174211792485,0,0,19896.0,104635.24941415618,AKT3
20558,KEGG_2019_Human,C-type lectin receptor signaling pathway,1/104,0.0051999314202997,0.0107174211792485,0,0,19896.0,104635.24941415618,AKT3
20559,KEGG_2019_Human,Insulin resistance,1/108,0.0053999298011749,0.0107174211792485,0,0,19892.0,103863.47861844616,AKT3
20560,KEGG_2019_Human,TNF signaling pathway,1/110,0.0054999290027479,0.0107174211792485,0,0,19890.0,103488.06969787036,AKT3
20561,KEGG_2019_Human,Cholinergic synapse,1/112,0.0055999282120529,0.0107174211792485,0,0,19888.0,103119.30984392198,AKT3
20562,KEGG_2019_Human,Toxoplasmosis,1/113,0.0056499278191151,0.0107174211792485,0,0,19887.0,102937.34947211576,AKT3
20563,KEGG_2019_Human,Thyroid hormone signaling pathway,1/116,0.0057999266512085,0.0107174211792485,0,0,19884.0,102400.8105961506,AKT3
20564,KEGG_2019_Human,Sphingolipid signaling pathway,1/119,0.0059499254985137,0.0107174211792485,0,0,19881.0,101877.73080211312,AKT3
20565,KEGG_2019_Human,Neurotrophin signaling pathway,1/119,0.0059499254985137,0.0107174211792485,0,0,19881.0,101877.73080211312,AKT3
20566,KEGG_2019_Human,AMPK signaling pathway,1/120,0.0059999251180858,0.0107174211792485,0,0,19880.0,101706.2448082016,AKT3
20567,KEGG_2019_Human,Platelet activation,1/124,0.0061999236097501,0.0107174211792485,0,0,19876.0,101034.04709010696,AKT3
20568,KEGG_2019_Human,Osteoclast differentiation,1/127,0.0063499224962247,0.0107174211792485,0,0,19873.0,100543.72072014232,AKT3
20569,KEGG_2019_Human,Autophagy,1/128,0.0063999221281459,0.0107174211792485,0,0,19872.0,100382.8010329652,AKT3
20570,KEGG_2019_Human,Relaxin signaling pathway,1/130,0.0064999213952527,0.0107174211792485,0,0,19870.0,100064.62842845908,AKT3
20571,KEGG_2019_Human,Dopaminergic synapse,1/131,0.0065499210316603,0.0107174211792485,0,0,19869.0,99907.33811343512,AKT3
20572,KEGG_2019_Human,FoxO signaling pathway,1/132,0.0065999206698993,0.0107174211792485,0,0,19868.0,99751.22090491928,AKT3
20573,KEGG_2019_Human,Insulin signaling pathway,1/137,0.0068499188797651,0.0107174211792485,0,0,19863.0,98987.62735269018,AKT3
20574,KEGG_2019_Human,Apelin signaling pathway,1/137,0.0068499188797651,0.0107174211792485,0,0,19863.0,98987.62735269018,AKT3
20575,KEGG_2019_Human,Estrogen signaling pathway,1/137,0.0068499188797651,0.0107174211792485,0,0,19863.0,98987.62735269018,AKT3
20576,KEGG_2019_Human,Measles,1/138,0.0068999185254481,0.0107174211792485,0,0,19862.0,98838.19160389496,AKT3
20577,KEGG_2019_Human,Fluid shear stress and atherosclerosis,1/139,0.006949918172816,0.0107174211792485,0,0,19861.0,98689.81333375497,AKT3
20578,KEGG_2019_Human,Signaling pathways regulating pluripotency of stem cells,1/139,0.006949918172816,0.0107174211792485,0,0,19861.0,98689.81333375497,AKT3
20579,KEGG_2019_Human,Apoptosis,1/143,0.0071499167770442,0.0107174211792485,0,0,19857.0,98106.57763600958,AKT3
20580,KEGG_2019_Human,Adrenergic signaling in cardiomyocytes,1/145,0.0072499160871101,0.0107174211792485,0,0,19855.0,97820.92670675044,AKT3
20581,KEGG_2019_Human,Breast cancer,1/147,0.0073499154017982,0.0107174211792485,0,0,19853.0,97539.10874372096,AKT3
20582,KEGG_2019_Human,Phospholipase D signaling pathway,1/148,0.007399915061391,0.0107174211792485,0,0,19852.0,97399.60470052566,AKT3
20583,KEGG_2019_Human,Non-alcoholic fatty liver disease (NAFLD),1/149,0.0074499147221605,0.0107174211792485,0,0,19851.0,97261.02051561224,AKT3
20584,KEGG_2019_Human,Gastric cancer,1/149,0.0074499147221605,0.0107174211792485,0,0,19851.0,97261.02051561224,AKT3
20585,KEGG_2019_Human,mTOR signaling pathway,1/152,0.0075999137114971,0.0107447055921166,0,0,19848.0,96850.665715497,AKT3
20586,KEGG_2019_Human,Hepatitis C,1/155,0.0077499127120574,0.0107623827670465,0,0,19845.0,96448.16254952336,AKT3
20587,KEGG_2019_Human,Cellular senescence,1/160,0.0079999110688441,0.0107623827670465,0,0,19840.0,95793.96509856998,AKT3
20588,KEGG_2019_Human,JAK-STAT signaling pathway,1/162,0.0080999104202618,0.0107623827670465,0,0,19838.0,95537.86936302872,AKT3
20589,KEGG_2019_Human,Hepatitis B,1/163,0.0081499100978668,0.0107623827670465,0,0,19837.0,95410.9786681514,AKT3
20590,KEGG_2019_Human,cGMP-PKG signaling pathway,1/166,0.0082999091363732,0.0107623827670465,0,0,19834.0,95034.82345515196,AKT3
20591,KEGG_2019_Human,Hepatocellular carcinoma,1/168,0.0083999085011095,0.0107623827670465,0,0,19832.0,94787.72752807094,AKT3
20592,KEGG_2019_Human,Influenza A,1/171,0.0085499075557634,0.0107860372241938,0,0,19829.0,94422.42241345016,AKT3
20593,KEGG_2019_Human,Tuberculosis,1/179,0.0089499050800561,0.0111195790388576,0,0,19821.0,93478.0629355712,AKT3
20594,KEGG_2019_Human,Kaposi sarcoma-associated herpesvirus infection,1/186,0.0092999029651357,0.0113819707931512,0,0,19814.0,92684.96451050608,AKT3
20595,KEGG_2019_Human,Chemokine signaling pathway,1/190,0.0094999017791995,0.0114557639102112,0,0,19810.0,92244.74636351672,AKT3
20596,KEGG_2019_Human,Focal adhesion,1/199,0.0099498991610159,0.0116069251295706,0,0,19801.0,91286.4288690606,AKT3
20597,KEGG_2019_Human,Epstein-Barr virus infection,1/201,0.0100498985877989,0.0116069251295706,0,0,19799.0,91079.21596609056,AKT3
20598,KEGG_2019_Human,Proteoglycans in cancer,1/201,0.0100498985877989,0.0116069251295706,0,0,19799.0,91079.21596609056,AKT3
20599,KEGG_2019_Human,Rap1 signaling pathway,1/206,0.010299897173561,0.0117304384476667,0,0,19794.0,90569.849337325,AKT3
20600,KEGG_2019_Human,Human immunodeficiency virus 1 infection,1/212,0.0105998955026255,0.011745830151558,0,0,19788.0,89974.27756224656,AKT3
20601,KEGG_2019_Human,cAMP signaling pathway,1/212,0.0105998955026255,0.011745830151558,0,0,19788.0,89974.27756224656,AKT3
20602,KEGG_2019_Human,Human T-cell leukemia virus 1 infection,1/219,0.0109498935894162,0.0119718836577617,0,0,19781.0,89299.85161916987,AKT3
20603,KEGG_2019_Human,Human cytomegalovirus infection,1/225,0.0112498919790339,0.0121380413457997,0,0,19775.0,88738.27077557483,AKT3
20604,KEGG_2019_Human,Ras signaling pathway,1/232,0.0115998901349604,0.0123531297541136,0,0,19768.0,88101.22480150245,AKT3
20605,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0155062787974276,0,0,19705.0,83086.53988020132,AKT3
20606,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0171264447042416,0,0,19670.0,80733.60565076157,AKT3
20607,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.018142359207401,0,0,19646.0,79255.8617626126,AKT3
20608,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0249035406954225,0,0,19508.0,72277.44006442746,AKT3
20609,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,AKT3
20610,KEGG_2019_Human,Protein digestion and absorption,1/90,0.0044999373439762,0.0048999339081079,0,0,19910.0,107587.50385474482,CPA2
20611,KEGG_2019_Human,Pancreatic secretion,1/98,0.0048999339081079,0.0048999339081079,0,0,19902.0,105849.45495286948,CPA2
20612,KEGG_2019_Human,Mismatch repair,1/23,0.0011499748819949,0.0023499589392381,0,0,19977.0,135204.63922267244,RFC5
20613,KEGG_2019_Human,DNA replication,1/36,0.0017999657178272,0.0023499589392381,0,0,19964.0,126172.23364250171,RFC5
20614,KEGG_2019_Human,Nucleotide excision repair,1/47,0.0023499589392381,0.0023499589392381,0,0,19953.0,120782.64067395544,RFC5
20615,KEGG_2019_Human,Calcium signaling pathway,1/188,0.009399902370135,0.0168998658265596,0,0,19812.0,92463.712994847,P2RX4
20616,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,P2RX4
20617,KEGG_2019_Human,Wnt signaling pathway,1/158,0.0078999117225733,0.0078999117225733,0,0,19842.0,96053.2110949472,SFRP4
20618,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR4C5
20619,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR7D2
20620,KEGG_2019_Human,Wnt signaling pathway,1/158,0.0078999117225733,0.0078999117225733,0,0,19842.0,96053.2110949472,SERPINF1
20621,KEGG_2019_Human,Kaposi sarcoma-associated herpesvirus infection,1/186,0.0092999029651357,0.0109498935894162,0,0,19814.0,92684.96451050608,ZFP36
20622,KEGG_2019_Human,Human T-cell leukemia virus 1 infection,1/219,0.0109498935894162,0.0109498935894162,0,0,19781.0,89299.85161916987,ZFP36
20623,KEGG_2019_Human,Base excision repair,1/33,0.0016499677032113,0.0018499650702878,0,0,19967.0,127928.56031580272,UNG
20624,KEGG_2019_Human,Primary immunodeficiency,1/37,0.0018499650702878,0.0018499650702878,0,0,19963.0,125618.9446446357,UNG
20625,KEGG_2019_Human,SNARE interactions in vesicular transport,1/34,0.0016999670339032,0.0033999340678064,0,0,19966.0,127326.1054203148,STX18
20626,KEGG_2019_Human,Phagosome,1/152,0.0075999137114971,0.0075999137114971,0,0,19848.0,96850.665715497,STX18
20627,KEGG_2019_Human,Influenza A,1/171,0.0085499075557634,0.0085499075557634,0,0,19829.0,94422.42241345016,TMPRSS13
20628,KEGG_2019_Human,Aminoacyl-tRNA biosynthesis,1/66,0.003299948626608,0.003299948626608,0,0,19934.0,113899.85357353876,PARS2
20629,KEGG_2019_Human,Cardiac muscle contraction,1/78,0.0038999427840466,0.0112582177134695,0,0,19922.0,110503.2180492851,UQCRHL
20630,KEGG_2019_Human,Oxidative phosphorylation,1/133,0.0066499203093911,0.0112582177134695,0,0,19867.0,99596.2591544721,UQCRHL
20631,KEGG_2019_Human,Parkinson disease,1/142,0.0070999171242726,0.0112582177134695,0,0,19858.0,98250.87390500787,UQCRHL
20632,KEGG_2019_Human,Non-alcoholic fatty liver disease (NAFLD),1/149,0.0074499147221605,0.0112582177134695,0,0,19851.0,97261.02051561224,UQCRHL
20633,KEGG_2019_Human,Alzheimer disease,1/171,0.0085499075557634,0.0112582177134695,0,0,19829.0,94422.42241345016,UQCRHL
20634,KEGG_2019_Human,Huntington disease,1/193,0.0096499008972596,0.0112582177134695,0,0,19807.0,91920.47679471428,UQCRHL
20635,KEGG_2019_Human,Thermogenesis,1/231,0.0115498903940656,0.0115498903940656,0,0,19769.0,88191.07730937863,UQCRHL
20636,KEGG_2019_Human,SNARE interactions in vesicular transport,1/34,0.0016999670339032,0.0033999340678064,0,0,19966.0,127326.1054203148,VAMP3
20637,KEGG_2019_Human,Phagosome,1/152,0.0075999137114971,0.0075999137114971,0,0,19848.0,96850.665715497,VAMP3
20638,KEGG_2019_Human,Protein digestion and absorption,1/90,0.0044999373439762,0.0044999373439762,0,0,19910.0,107587.50385474482,SLC15A1
20639,KEGG_2019_Human,Protein processing in endoplasmic reticulum,1/165,0.0082499094553477,0.0082499094553477,0,0,19835.0,95159.46482222488,DNAJB12
20640,KEGG_2019_Human,Pyrimidine metabolism,1/57,0.002849953326298,0.006449921761047,0,0,19943.0,116875.00742975442,NME1-NME2
20641,KEGG_2019_Human,Drug metabolism,1/108,0.0053999298011749,0.006449921761047,0,0,19892.0,103863.47861844616,NME1-NME2
20642,KEGG_2019_Human,Purine metabolism,1/129,0.006449921761047,0.006449921761047,0,0,19871.0,100223.109907462,NME1-NME2
20643,KEGG_2019_Human,Proximal tubule bicarbonate reclamation,1/23,0.0011499748819949,0.0062999150247102,0,0,19977.0,135204.63922267244,ATP1B3
20644,KEGG_2019_Human,Aldosterone-regulated sodium reabsorption,1/37,0.0018499650702878,0.0062999150247102,0,0,19963.0,125618.9446446357,ATP1B3
20645,KEGG_2019_Human,Carbohydrate digestion and absorption,1/44,0.0021999607179423,0.0062999150247102,0,0,19956.0,122117.06559109331,ATP1B3
20646,KEGG_2019_Human,Endocrine and other factor-regulated calcium reabsorption,1/48,0.0023999583567988,0.0062999150247102,0,0,19952.0,120356.5272753826,ATP1B3
20647,KEGG_2019_Human,Mineral absorption,1/51,0.0025499566390179,0.0062999150247102,0,0,19949.0,119129.0228601236,ATP1B3
20648,KEGG_2019_Human,Bile secretion,1/72,0.0035999456502131,0.0062999150247102,0,0,19928.0,112131.59838572376,ATP1B3
20649,KEGG_2019_Human,Thyroid hormone synthesis,1/74,0.0036999446830449,0.0062999150247102,0,0,19926.0,111574.38983110404,ATP1B3
20650,KEGG_2019_Human,Gastric acid secretion,1/75,0.0037499442041125,0.0062999150247102,0,0,19925.0,111301.33528642564,ATP1B3
20651,KEGG_2019_Human,Cardiac muscle contraction,1/78,0.0038999427840466,0.0062999150247102,0,0,19922.0,110503.2180492851,ATP1B3
20652,KEGG_2019_Human,Insulin secretion,1/86,0.0042999391173866,0.0062999150247102,0,0,19914.0,108514.46102290176,ATP1B3
20653,KEGG_2019_Human,Salivary secretion,1/90,0.0044999373439762,0.0062999150247102,0,0,19910.0,107587.50385474482,ATP1B3
20654,KEGG_2019_Human,Protein digestion and absorption,1/90,0.0044999373439762,0.0062999150247102,0,0,19910.0,107587.50385474482,ATP1B3
20655,KEGG_2019_Human,Pancreatic secretion,1/98,0.0048999339081079,0.0062999150247102,0,0,19902.0,105849.45495286948,ATP1B3
20656,KEGG_2019_Human,Aldosterone synthesis and secretion,1/98,0.0048999339081079,0.0062999150247102,0,0,19902.0,105849.45495286948,ATP1B3
20657,KEGG_2019_Human,Thyroid hormone signaling pathway,1/116,0.0057999266512085,0.0069599119814502,0,0,19884.0,102400.8105961506,ATP1B3
20658,KEGG_2019_Human,Adrenergic signaling in cardiomyocytes,1/145,0.0072499160871101,0.0081561555979989,0,0,19855.0,97820.92670675044,ATP1B3
20659,KEGG_2019_Human,cGMP-PKG signaling pathway,1/166,0.0082999091363732,0.0087881390855717,0,0,19834.0,95034.82345515196,ATP1B3
20660,KEGG_2019_Human,cAMP signaling pathway,1/212,0.0105998955026255,0.0105998955026255,0,0,19788.0,89974.27756224656,ATP1B3
20661,KEGG_2019_Human,Biosynthesis of unsaturated fatty acids,1/27,0.0013499718942362,0.0013499718942362,0,0,19973.0,131975.02298599784,ELOVL1
20662,KEGG_2019_Human,Fatty acid elongation,1/27,0.0013499718942362,0.0013499718942362,0,0,19973.0,131975.02298599784,ELOVL1
20663,KEGG_2019_Human,Oxidative phosphorylation,1/133,0.0066499203093911,0.0112582177134695,0,0,19867.0,99596.2591544721,NDUFA12
20664,KEGG_2019_Human,Parkinson disease,1/142,0.0070999171242726,0.0112582177134695,0,0,19858.0,98250.87390500787,NDUFA12
20665,KEGG_2019_Human,Retrograde endocannabinoid signaling,1/148,0.007399915061391,0.0112582177134695,0,0,19852.0,97399.60470052566,NDUFA12
20666,KEGG_2019_Human,Non-alcoholic fatty liver disease (NAFLD),1/149,0.0074499147221605,0.0112582177134695,0,0,19851.0,97261.02051561224,NDUFA12
20667,KEGG_2019_Human,Alzheimer disease,1/171,0.0085499075557634,0.0112582177134695,0,0,19829.0,94422.42241345016,NDUFA12
20668,KEGG_2019_Human,Huntington disease,1/193,0.0096499008972596,0.0112582177134695,0,0,19807.0,91920.47679471428,NDUFA12
20669,KEGG_2019_Human,Thermogenesis,1/231,0.0115498903940656,0.0115498903940656,0,0,19769.0,88191.07730937863,NDUFA12
20670,KEGG_2019_Human,Protein processing in endoplasmic reticulum,1/165,0.0082499094553477,0.0082499094553477,0,0,19835.0,95159.46482222488,UBQLN2
20671,KEGG_2019_Human,Ferroptosis,1/40,0.0019999631680592,0.0038249349585269,0,0,19960.0,124043.94523066044,FTH1
20672,KEGG_2019_Human,Mineral absorption,1/51,0.0025499566390179,0.0038249349585269,0,0,19949.0,119129.0228601236,FTH1
20673,KEGG_2019_Human,Necroptosis,1/162,0.0080999104202618,0.0080999104202618,0,0,19838.0,95537.86936302872,FTH1
20674,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0146998751759735,0,0,19706.0,83157.67014793828,IL1RL2
20675,KEGG_2019_Human,Riboflavin metabolism,1/8,0.0003999883241497325,0.0003999883241497325,0,0,19992.0,156418.91141655247,FLAD1
20676,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR5H2
20677,KEGG_2019_Human,Pathogenic Escherichia coli infection,1/55,0.0027499544131125,0.0084999078692823,0,0,19945.0,117599.1294878737,TUBA3D
20678,KEGG_2019_Human,Gap junction,1/88,0.0043999382262822,0.0084999078692823,0,0,19912.0,108045.79305232369,TUBA3D
20679,KEGG_2019_Human,Apoptosis,1/143,0.0071499167770442,0.0084999078692823,0,0,19857.0,98106.57763600958,TUBA3D
20680,KEGG_2019_Human,Phagosome,1/152,0.0075999137114971,0.0084999078692823,0,0,19848.0,96850.665715497,TUBA3D
20681,KEGG_2019_Human,Tight junction,1/170,0.0084999078692823,0.0084999078692823,0,0,19830.0,94543.49009679438,TUBA3D
20682,KEGG_2019_Human,Lysosome,1/123,0.0061499239842961,0.0061499239842961,0,0,19877.0,101200.07933676826,AP3D1
20683,KEGG_2019_Human,Lysine degradation,1/59,0.0029499522555206,0.0029499522555206,0,0,19941.0,116175.59385530632,KMT5A
20684,KEGG_2019_Human,SNARE interactions in vesicular transport,1/34,0.0016999670339032,0.0016999670339032,0,0,19966.0,127326.1054203148,VAMP5
20685,KEGG_2019_Human,N-Glycan biosynthesis,1/50,0.0024999572069037,0.0024999572069037,0,0,19950.0,119530.05920663515,ALG10B
20686,KEGG_2019_Human,Glycosylphosphatidylinositol (GPI)-anchor biosynthesis,1/25,0.0012499733663791,0.0012499733663791,0,0,19975.0,133525.54486996148,PIGH
20687,KEGG_2019_Human,Necroptosis,1/162,0.0080999104202618,0.0121998870519305,0,0,19838.0,95537.86936302872,CHMP5
20688,KEGG_2019_Human,Endocytosis,1/244,0.0121998870519305,0.0121998870519305,0,0,19756.0,87051.4275316661,CHMP5
20689,KEGG_2019_Human,Protein processing in endoplasmic reticulum,1/165,0.0082499094553477,0.0082499094553477,0,0,19835.0,95159.46482222488,SIL1
20690,KEGG_2019_Human,Apoptosis,1/143,0.0071499167770442,0.0080999104202618,0,0,19857.0,98106.57763600958,AIFM1
20691,KEGG_2019_Human,Necroptosis,1/162,0.0080999104202618,0.0080999104202618,0,0,19838.0,95537.86936302872,AIFM1
20692,KEGG_2019_Human,Signaling pathways regulating pluripotency of stem cells,1/139,0.006949918172816,0.006949918172816,0,0,19861.0,98689.81333375497,ESX1
20693,KEGG_2019_Human,Cytosolic DNA-sensing pathway,1/63,0.0031499501598827,0.0113061359112738,0,0,19937.0,114844.46974572667,MAVS
20694,KEGG_2019_Human,RIG-I-like receptor signaling pathway,1/70,0.0034999466296654,0.0113061359112738,0,0,19930.0,112704.30065625212,MAVS
20695,KEGG_2019_Human,Measles,1/138,0.0068999185254481,0.0113061359112738,0,0,19862.0,98838.19160389496,MAVS
20696,KEGG_2019_Human,Hepatitis C,1/155,0.0077499127120574,0.0113061359112738,0,0,19845.0,96448.16254952336,MAVS
20697,KEGG_2019_Human,Hepatitis B,1/163,0.0081499100978668,0.0113061359112738,0,0,19837.0,95410.9786681514,MAVS
20698,KEGG_2019_Human,Influenza A,1/171,0.0085499075557634,0.0113061359112738,0,0,19829.0,94422.42241345016,MAVS
20699,KEGG_2019_Human,NOD-like receptor signaling pathway,1/178,0.0088999053857096,0.0113061359112738,0,0,19822.0,93593.82745769851,MAVS
20700,KEGG_2019_Human,Epstein-Barr virus infection,1/201,0.0100498985877989,0.0113061359112738,0,0,19799.0,91079.21596609056,MAVS
20701,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,MAVS
20702,KEGG_2019_Human,mRNA surveillance pathway,1/91,0.0045499369072032,0.0045499369072032,0,0,19909.0,107362.10783923086,PAPOLG
20703,KEGG_2019_Human,Glutathione metabolism,1/56,0.0027999538675741,0.0094498771520562,0,0,19944.0,117233.87022514464,GSTA3
20704,KEGG_2019_Human,Metabolism of xenobiotics by cytochrome P450,1/74,0.0036999446830449,0.0094498771520562,0,0,19926.0,111574.38983110404,GSTA3
20705,KEGG_2019_Human,Chemical carcinogenesis,1/82,0.004099940929819,0.0094498771520562,0,0,19918.0,109484.9180722932,GSTA3
20706,KEGG_2019_Human,Drug metabolism,1/108,0.0053999298011749,0.0094498771520562,0,0,19892.0,103863.47861844616,GSTA3
20707,KEGG_2019_Human,Fluid shear stress and atherosclerosis,1/139,0.006949918172816,0.0097298854419424,0,0,19861.0,98689.81333375497,GSTA3
20708,KEGG_2019_Human,Hepatocellular carcinoma,1/168,0.0083999085011095,0.0097998932512944,0,0,19832.0,94787.72752807094,GSTA3
20709,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,GSTA3
20710,KEGG_2019_Human,cAMP signaling pathway,1/212,0.0105998955026255,0.0105998955026255,0,0,19788.0,89974.27756224656,FXYD1
20711,KEGG_2019_Human,Apoptosis,1/143,0.0071499167770442,0.0071499167770442,0,0,19857.0,98106.57763600958,LMNB1
20712,KEGG_2019_Human,Wnt signaling pathway,1/158,0.0078999117225733,0.0078999117225733,0,0,19842.0,96053.2110949472,SFRP5
20713,KEGG_2019_Human,Protein processing in endoplasmic reticulum,1/165,0.0082499094553477,0.0082499094553477,0,0,19835.0,95159.46482222488,PPP1R15A
20714,KEGG_2019_Human,Retinol metabolism,1/67,0.0033499481224912,0.0033499481224912,0,0,19933.0,113594.38808369274,DHRS9
20715,KEGG_2019_Human,Sphingolipid metabolism,1/47,0.0023499589392381,0.0023499589392381,0,0,19953.0,120782.64067395544,ACER3
20716,KEGG_2019_Human,Axon guidance,1/181,0.0090499044707863,0.0176998626413668,0,0,19819.0,93248.41634586031,EFNA1
20717,KEGG_2019_Human,Rap1 signaling pathway,1/206,0.010299897173561,0.0176998626413668,0,0,19794.0,90569.849337325,EFNA1
20718,KEGG_2019_Human,Ras signaling pathway,1/232,0.0115998901349604,0.0176998626413668,0,0,19768.0,88101.22480150245,EFNA1
20719,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0176998626413668,0,0,19705.0,83086.53988020132,EFNA1
20720,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0176998626413668,0,0,19646.0,79255.8617626126,EFNA1
20721,KEGG_2019_Human,Staphylococcus aureus infection,1/68,0.0033999476216189,0.0052665897556449,0,0,19932.0,113293.39338050144,C1S
20722,KEGG_2019_Human,Pertussis,1/76,0.0037999437281752,0.0052665897556449,0,0,19924.0,111031.8499691117,C1S
20723,KEGG_2019_Human,Complement and coagulation cascades,1/79,0.0039499423167337,0.0052665897556449,0,0,19921.0,110243.89578070649,C1S
20724,KEGG_2019_Human,Systemic lupus erythematosus,1/133,0.0066499203093911,0.0066499203093911,0,0,19867.0,99596.2591544721,C1S
20725,KEGG_2019_Human,Nicotine addiction,1/40,0.0019999631680592,0.0059998895041777,0,0,19960.0,124043.94523066044,CHRNA6
20726,KEGG_2019_Human,Cholinergic synapse,1/112,0.0055999282120529,0.0083998923180794,0,0,19888.0,103119.30984392198,CHRNA6
20727,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,CHRNA6
20728,KEGG_2019_Human,Cell cycle,1/124,0.0061999236097501,0.0065999206698993,0,0,19876.0,101034.04709010696,CDKN2D
20729,KEGG_2019_Human,FoxO signaling pathway,1/132,0.0065999206698993,0.0065999206698993,0,0,19868.0,99751.22090491928,CDKN2D
20730,KEGG_2019_Human,Ribosome,1/153,0.0076499133771537,0.0076499133771537,0,0,19847.0,96715.6407630817,MRPL27
20731,KEGG_2019_Human,Cytosolic DNA-sensing pathway,1/63,0.0031499501598827,0.0131465421529551,0,0,19937.0,114844.46974572667,TBK1
20732,KEGG_2019_Human,Mitophagy,1/65,0.003249949134407,0.0131465421529551,0,0,19935.0,114209.92613860144,TBK1
20733,KEGG_2019_Human,RIG-I-like receptor signaling pathway,1/70,0.0034999466296654,0.0131465421529551,0,0,19930.0,112704.30065625212,TBK1
20734,KEGG_2019_Human,IL-17 signaling pathway,1/93,0.0046499360391879,0.0131465421529551,0,0,19907.0,106918.54242106884,TBK1
20735,KEGG_2019_Human,Toll-like receptor signaling pathway,1/104,0.0051999314202997,0.0131465421529551,0,0,19896.0,104635.24941415618,TBK1
20736,KEGG_2019_Human,Measles,1/138,0.0068999185254481,0.0131465421529551,0,0,19862.0,98838.19160389496,TBK1
20737,KEGG_2019_Human,Hepatitis C,1/155,0.0077499127120574,0.0131465421529551,0,0,19845.0,96448.16254952336,TBK1
20738,KEGG_2019_Human,Hepatitis B,1/163,0.0081499100978668,0.0131465421529551,0,0,19837.0,95410.9786681514,TBK1
20739,KEGG_2019_Human,Influenza A,1/171,0.0085499075557634,0.0131465421529551,0,0,19829.0,94422.42241345016,TBK1
20740,KEGG_2019_Human,NOD-like receptor signaling pathway,1/178,0.0088999053857096,0.0131465421529551,0,0,19822.0,93593.82745769851,TBK1
20741,KEGG_2019_Human,Kaposi sarcoma-associated herpesvirus infection,1/186,0.0092999029651357,0.0131465421529551,0,0,19814.0,92684.96451050608,TBK1
20742,KEGG_2019_Human,Epstein-Barr virus infection,1/201,0.0100498985877989,0.0131465421529551,0,0,19799.0,91079.21596609056,TBK1
20743,KEGG_2019_Human,Human immunodeficiency virus 1 infection,1/212,0.0105998955026255,0.0131465421529551,0,0,19788.0,89974.27756224656,TBK1
20744,KEGG_2019_Human,Human cytomegalovirus infection,1/225,0.0112498919790339,0.0131465421529551,0,0,19775.0,88738.27077557483,TBK1
20745,KEGG_2019_Human,Ras signaling pathway,1/232,0.0115998901349604,0.0131465421529551,0,0,19768.0,88101.22480150245,TBK1
20746,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0175311091751498,0,0,19670.0,80733.60565076157,TBK1
20747,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,TBK1
20748,KEGG_2019_Human,Biosynthesis of unsaturated fatty acids,1/27,0.0013499718942362,0.0013499718942362,0,0,19973.0,131975.02298599784,ELOVL6
20749,KEGG_2019_Human,Fatty acid elongation,1/27,0.0013499718942362,0.0013499718942362,0,0,19973.0,131975.02298599784,ELOVL6
20750,KEGG_2019_Human,RNA degradation,1/79,0.0039499423167337,0.0039499423167337,0,0,19921.0,110243.89578070649,EXOSC8
20751,KEGG_2019_Human,Hippo signaling pathway,1/160,0.0079999110688441,0.0079999110688441,0,0,19840.0,95793.96509856998,MOB1A
20752,KEGG_2019_Human,Ribosome,1/153,0.0076499133771537,0.0076499133771537,0,0,19847.0,96715.6407630817,RPSA
20753,KEGG_2019_Human,Taste transduction,1/83,0.0041499404726918,0.0090998738144064,0,0,19917.0,109237.99888847338,GABBR1
20754,KEGG_2019_Human,GABAergic synapse,1/89,0.0044499377838098,0.0090998738144064,0,0,19911.0,107815.380281759,GABBR1
20755,KEGG_2019_Human,Morphine addiction,1/91,0.0045499369072032,0.0090998738144064,0,0,19909.0,107362.10783923086,GABBR1
20756,KEGG_2019_Human,Estrogen signaling pathway,1/137,0.0068499188797651,0.0102748783196477,0,0,19863.0,98987.62735269018,GABBR1
20757,KEGG_2019_Human,cAMP signaling pathway,1/212,0.0105998955026255,0.0127198746031507,0,0,19788.0,89974.27756224656,GABBR1
20758,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,GABBR1
20759,KEGG_2019_Human,Thyroid cancer,1/37,0.0018499650702878,0.0092887513355395,0,0,19963.0,125618.9446446357,GADD45G
20760,KEGG_2019_Human,Endometrial cancer,1/58,0.0028999527887707,0.0092887513355395,0,0,19942.0,116522.31890946148,GADD45G
20761,KEGG_2019_Human,Basal cell carcinoma,1/63,0.0031499501598827,0.0092887513355395,0,0,19937.0,114844.46974572667,GADD45G
20762,KEGG_2019_Human,Non-small cell lung cancer,1/66,0.003299948626608,0.0092887513355395,0,0,19934.0,113899.85357353876,GADD45G
20763,KEGG_2019_Human,p53 signaling pathway,1/72,0.0035999456502131,0.0092887513355395,0,0,19928.0,112131.59838572376,GADD45G
20764,KEGG_2019_Human,Melanoma,1/72,0.0035999456502131,0.0092887513355395,0,0,19928.0,112131.59838572376,GADD45G
20765,KEGG_2019_Human,Pancreatic cancer,1/75,0.0037499442041125,0.0092887513355395,0,0,19925.0,111301.33528642564,GADD45G
20766,KEGG_2019_Human,Glioma,1/75,0.0037499442041125,0.0092887513355395,0,0,19925.0,111301.33528642564,GADD45G
20767,KEGG_2019_Human,Chronic myeloid leukemia,1/76,0.0037999437281752,0.0092887513355395,0,0,19924.0,111031.8499691117,GADD45G
20768,KEGG_2019_Human,Colorectal cancer,1/86,0.0042999391173866,0.0092998720783758,0,0,19914.0,108514.46102290176,GADD45G
20769,KEGG_2019_Human,Small cell lung cancer,1/93,0.0046499360391879,0.0092998720783758,0,0,19907.0,106918.54242106884,GADD45G
20770,KEGG_2019_Human,Cell cycle,1/124,0.0061999236097501,0.0102436327429707,0,0,19876.0,101034.04709010696,GADD45G
20771,KEGG_2019_Human,FoxO signaling pathway,1/132,0.0065999206698993,0.0102436327429707,0,0,19868.0,99751.22090491928,GADD45G
20772,KEGG_2019_Human,Apoptosis,1/143,0.0071499167770442,0.0102436327429707,0,0,19857.0,98106.57763600958,GADD45G
20773,KEGG_2019_Human,Breast cancer,1/147,0.0073499154017982,0.0102436327429707,0,0,19853.0,97539.10874372096,GADD45G
20774,KEGG_2019_Human,Gastric cancer,1/149,0.0074499147221605,0.0102436327429707,0,0,19851.0,97261.02051561224,GADD45G
20775,KEGG_2019_Human,Cellular senescence,1/160,0.0079999110688441,0.0102665548346894,0,0,19840.0,95793.96509856998,GADD45G
20776,KEGG_2019_Human,Hepatocellular carcinoma,1/168,0.0083999085011095,0.0102665548346894,0,0,19832.0,94787.72752807094,GADD45G
20777,KEGG_2019_Human,Transcriptional misregulation in cancer,1/186,0.0092999029651357,0.0107683086964729,0,0,19814.0,92684.96451050608,GADD45G
20778,KEGG_2019_Human,Epstein-Barr virus infection,1/201,0.0100498985877989,0.0110548884465788,0,0,19799.0,91079.21596609056,GADD45G
20779,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0154522499514435,0,0,19705.0,83086.53988020132,GADD45G
20780,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,GADD45G
20781,KEGG_2019_Human,Amino sugar and nucleotide sugar metabolism,1/48,0.0023999583567988,0.0023999583567988,0,0,19952.0,120356.5272753826,GNPDA2
20782,KEGG_2019_Human,Signaling pathways regulating pluripotency of stem cells,1/139,0.006949918172816,0.006949918172816,0,0,19861.0,98689.81333375497,ISL1
20783,KEGG_2019_Human,Adherens junction,1/72,0.0035999456502131,0.0105332156300977,0,0,19928.0,112131.59838572376,NLK
20784,KEGG_2019_Human,FoxO signaling pathway,1/132,0.0065999206698993,0.0105332156300977,0,0,19868.0,99751.22090491928,NLK
20785,KEGG_2019_Human,Wnt signaling pathway,1/158,0.0078999117225733,0.0105332156300977,0,0,19842.0,96053.2110949472,NLK
20786,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0147498749536506,0,0,19705.0,83086.53988020132,NLK
20787,KEGG_2019_Human,Biosynthesis of unsaturated fatty acids,1/27,0.0013499718942362,0.0013499718942362,0,0,19973.0,131975.02298599784,HACD3
20788,KEGG_2019_Human,Fatty acid elongation,1/27,0.0013499718942362,0.0013499718942362,0,0,19973.0,131975.02298599784,HACD3
20789,KEGG_2019_Human,Ribosome biogenesis in eukaryotes,1/101,0.0050499326546803,0.0050499326546803,0,0,19899.0,105233.48101229242,UTP14A
20790,KEGG_2019_Human,Ascorbate and aldarate metabolism,1/27,0.0013499718942362,0.0023999583567988,0,0,19973.0,131975.02298599784,UGDH
20791,KEGG_2019_Human,Pentose and glucuronate interconversions,1/34,0.0016999670339032,0.0023999583567988,0,0,19966.0,127326.1054203148,UGDH
20792,KEGG_2019_Human,Amino sugar and nucleotide sugar metabolism,1/48,0.0023999583567988,0.0023999583567988,0,0,19952.0,120356.5272753826,UGDH
20793,KEGG_2019_Human,Bile secretion,1/72,0.0035999456502131,0.0035999456502131,0,0,19928.0,112131.59838572376,SLC4A5
20794,KEGG_2019_Human,Melanoma,1/72,0.0035999456502131,0.0173998352024406,0,0,19928.0,112131.59838572376,FGF22
20795,KEGG_2019_Human,Breast cancer,1/147,0.0073499154017982,0.0173998352024406,0,0,19853.0,97539.10874372096,FGF22
20796,KEGG_2019_Human,Gastric cancer,1/149,0.0074499147221605,0.0173998352024406,0,0,19851.0,97261.02051561224,FGF22
20797,KEGG_2019_Human,Rap1 signaling pathway,1/206,0.010299897173561,0.0173998352024406,0,0,19794.0,90569.849337325,FGF22
20798,KEGG_2019_Human,Regulation of actin cytoskeleton,1/214,0.0106998949514067,0.0173998352024406,0,0,19786.0,89779.39753374986,FGF22
20799,KEGG_2019_Human,Ras signaling pathway,1/232,0.0115998901349604,0.0173998352024406,0,0,19768.0,88101.22480150245,FGF22
20800,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.018964124940408,0,0,19705.0,83086.53988020132,FGF22
20801,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0199123454715377,0,0,19646.0,79255.8617626126,FGF22
20802,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,FGF22
20803,KEGG_2019_Human,Arachidonic acid metabolism,1/63,0.0031499501598827,0.0031499501598827,0,0,19937.0,114844.46974572667,PRXL2B
20804,KEGG_2019_Human,Pyrimidine metabolism,1/57,0.002849953326298,0.005699906652596,0,0,19943.0,116875.00742975442,ENTPD5
20805,KEGG_2019_Human,Purine metabolism,1/129,0.006449921761047,0.006449921761047,0,0,19871.0,100223.109907462,ENTPD5
20806,KEGG_2019_Human,Terpenoid backbone biosynthesis,1/22,0.0010999756574123,0.0010999756574123,0,0,19978.0,136099.47030191717,RCE1
20807,KEGG_2019_Human,Salivary secretion,1/90,0.0044999373439762,0.0044999373439762,0,0,19910.0,107587.50385474482,CST3
20808,KEGG_2019_Human,VEGF signaling pathway,1/59,0.0029499522555206,0.0029499522555206,0,0,19941.0,116175.59385530632,SH2D2A
20809,KEGG_2019_Human,Shigellosis,1/65,0.003249949134407,0.0042999391173866,0,0,19935.0,114209.92613860144,RHOG
20810,KEGG_2019_Human,Bacterial invasion of epithelial cells,1/74,0.0036999446830449,0.0042999391173866,0,0,19926.0,111574.38983110404,RHOG
20811,KEGG_2019_Human,Salmonella infection,1/86,0.0042999391173866,0.0042999391173866,0,0,19914.0,108514.46102290176,RHOG
20812,KEGG_2019_Human,Nitrogen metabolism,1/17,0.0008499797390404818,0.0008499797390404818,0,0,19983.0,141285.76583697114,CA7
20813,KEGG_2019_Human,Asthma,1/31,0.0015499690656704,0.0067427480126186,0,0,19969.0,129189.85098816035,CD40
20814,KEGG_2019_Human,Primary immunodeficiency,1/37,0.0018499650702878,0.0067427480126186,0,0,19963.0,125618.9446446357,CD40
20815,KEGG_2019_Human,Allograft rejection,1/38,0.001899964429635,0.0067427480126186,0,0,19962.0,125080.29732025368,CD40
20816,KEGG_2019_Human,Intestinal immune network for IgA production,1/48,0.0023999583567988,0.0067427480126186,0,0,19952.0,120356.5272753826,CD40
20817,KEGG_2019_Human,Malaria,1/49,0.0024499577795033,0.0067427480126186,0,0,19951.0,119939.1172087114,CD40
20818,KEGG_2019_Human,Autoimmune thyroid disease,1/53,0.0026499555173137,0.0067427480126186,0,0,19947.0,118349.78824235698,CD40
20819,KEGG_2019_Human,Viral myocarditis,1/59,0.0029499522555206,0.0067427480126186,0,0,19941.0,116175.59385530632,CD40
20820,KEGG_2019_Human,NF-kappa B signaling pathway,1/95,0.0047499351803394,0.0090398845105842,0,0,19905.0,106484.27183626965,CD40
20821,KEGG_2019_Human,Toll-like receptor signaling pathway,1/104,0.0051999314202997,0.0090398845105842,0,0,19896.0,104635.24941415618,CD40
20822,KEGG_2019_Human,Toxoplasmosis,1/113,0.0056499278191151,0.0090398845105842,0,0,19887.0,102937.34947211576,CD40
20823,KEGG_2019_Human,Systemic lupus erythematosus,1/133,0.0066499203093911,0.0096665547828135,0,0,19867.0,99596.2591544721,CD40
20824,KEGG_2019_Human,Cell adhesion molecules (CAMs),1/145,0.0072499160871101,0.0096665547828135,0,0,19855.0,97820.92670675044,CD40
20825,KEGG_2019_Human,Transcriptional misregulation in cancer,1/186,0.0092999029651357,0.0114460344186286,0,0,19814.0,92684.96451050608,CD40
20826,KEGG_2019_Human,Epstein-Barr virus infection,1/201,0.0100498985877989,0.0114855983860559,0,0,19799.0,91079.21596609056,CD40
20827,KEGG_2019_Human,Human T-cell leukemia virus 1 infection,1/219,0.0109498935894162,0.0116798864953773,0,0,19781.0,89299.85161916987,CD40
20828,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0146998751759735,0,0,19706.0,83157.67014793828,CD40
20829,KEGG_2019_Human,Pathogenic Escherichia coli infection,1/55,0.0027499544131125,0.0084999078692823,0,0,19945.0,117599.1294878737,CLDN1
20830,KEGG_2019_Human,Leukocyte transendothelial migration,1/112,0.0055999282120529,0.0084999078692823,0,0,19888.0,103119.30984392198,CLDN1
20831,KEGG_2019_Human,Cell adhesion molecules (CAMs),1/145,0.0072499160871101,0.0084999078692823,0,0,19855.0,97820.92670675044,CLDN1
20832,KEGG_2019_Human,Hepatitis C,1/155,0.0077499127120574,0.0084999078692823,0,0,19845.0,96448.16254952336,CLDN1
20833,KEGG_2019_Human,Tight junction,1/170,0.0084999078692823,0.0084999078692823,0,0,19830.0,94543.49009679438,CLDN1
20834,KEGG_2019_Human,Vitamin digestion and absorption,1/24,0.0011999741185782,0.0011999741185782,0,0,19976.0,134347.69487847842,SLC19A2
20835,KEGG_2019_Human,Bladder cancer,1/41,0.0020499625466866,0.004274929989447,0,0,19959.0,123544.88783416104,TYMP
20836,KEGG_2019_Human,Pyrimidine metabolism,1/57,0.002849953326298,0.004274929989447,0,0,19943.0,116875.00742975442,TYMP
20837,KEGG_2019_Human,Drug metabolism,1/108,0.0053999298011749,0.0053999298011749,0,0,19892.0,103863.47861844616,TYMP
20838,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF33A
20839,KEGG_2019_Human,Glycosaminoglycan degradation,1/19,0.00094997806231055,0.0018999561246211,0,0,19981.0,139049.2109571672,IDS
20840,KEGG_2019_Human,Lysosome,1/123,0.0061499239842961,0.0061499239842961,0,0,19877.0,101200.07933676826,IDS
20841,KEGG_2019_Human,Vibrio cholerae infection,1/50,0.0024999572069037,0.0105855998309452,0,0,19950.0,119530.05920663515,ACTG1
20842,KEGG_2019_Human,Pathogenic Escherichia coli infection,1/55,0.0027499544131125,0.0105855998309452,0,0,19945.0,117599.1294878737,ACTG1
20843,KEGG_2019_Human,Viral myocarditis,1/59,0.0029499522555206,0.0105855998309452,0,0,19941.0,116175.59385530632,ACTG1
20844,KEGG_2019_Human,Shigellosis,1/65,0.003249949134407,0.0105855998309452,0,0,19935.0,114209.92613860144,ACTG1
20845,KEGG_2019_Human,Adherens junction,1/72,0.0035999456502131,0.0105855998309452,0,0,19928.0,112131.59838572376,ACTG1
20846,KEGG_2019_Human,Arrhythmogenic right ventricular cardiomyopathy (ARVC),1/72,0.0035999456502131,0.0105855998309452,0,0,19928.0,112131.59838572376,ACTG1
20847,KEGG_2019_Human,Bacterial invasion of epithelial cells,1/74,0.0036999446830449,0.0105855998309452,0,0,19926.0,111574.38983110404,ACTG1
20848,KEGG_2019_Human,Hypertrophic cardiomyopathy (HCM),1/85,0.004249939567045,0.0105855998309452,0,0,19915.0,108752.83801948265,ACTG1
20849,KEGG_2019_Human,Salmonella infection,1/86,0.0042999391173866,0.0105855998309452,0,0,19914.0,108514.46102290176,ACTG1
20850,KEGG_2019_Human,Dilated cardiomyopathy (DCM),1/91,0.0045499369072032,0.0105855998309452,0,0,19909.0,107362.10783923086,ACTG1
20851,KEGG_2019_Human,Leukocyte transendothelial migration,1/112,0.0055999282120529,0.0105855998309452,0,0,19888.0,103119.30984392198,ACTG1
20852,KEGG_2019_Human,Thyroid hormone signaling pathway,1/116,0.0057999266512085,0.0105855998309452,0,0,19884.0,102400.8105961506,ACTG1
20853,KEGG_2019_Human,Platelet activation,1/124,0.0061999236097501,0.0105855998309452,0,0,19876.0,101034.04709010696,ACTG1
20854,KEGG_2019_Human,Fluid shear stress and atherosclerosis,1/139,0.006949918172816,0.0105855998309452,0,0,19861.0,98689.81333375497,ACTG1
20855,KEGG_2019_Human,Apoptosis,1/143,0.0071499167770442,0.0105855998309452,0,0,19857.0,98106.57763600958,ACTG1
20856,KEGG_2019_Human,Phagosome,1/152,0.0075999137114971,0.0105855998309452,0,0,19848.0,96850.665715497,ACTG1
20857,KEGG_2019_Human,Oxytocin signaling pathway,1/153,0.0076499133771537,0.0105855998309452,0,0,19847.0,96715.6407630817,ACTG1
20858,KEGG_2019_Human,Hippo signaling pathway,1/160,0.0079999110688441,0.0105855998309452,0,0,19840.0,95793.96509856998,ACTG1
20859,KEGG_2019_Human,Hepatocellular carcinoma,1/168,0.0083999085011095,0.0105855998309452,0,0,19832.0,94787.72752807094,ACTG1
20860,KEGG_2019_Human,Tight junction,1/170,0.0084999078692823,0.0105855998309452,0,0,19830.0,94543.49009679438,ACTG1
20861,KEGG_2019_Human,Influenza A,1/171,0.0085499075557634,0.0105855998309452,0,0,19829.0,94422.42241345016,ACTG1
20862,KEGG_2019_Human,Focal adhesion,1/199,0.0099498991610159,0.011127890749463,0,0,19801.0,91286.4288690606,ACTG1
20863,KEGG_2019_Human,Proteoglycans in cancer,1/201,0.0100498985877989,0.011127890749463,0,0,19799.0,91079.21596609056,ACTG1
20864,KEGG_2019_Human,Rap1 signaling pathway,1/206,0.010299897173561,0.011127890749463,0,0,19794.0,90569.849337325,ACTG1
20865,KEGG_2019_Human,Regulation of actin cytoskeleton,1/214,0.0106998949514067,0.011127890749463,0,0,19786.0,89779.39753374986,ACTG1
20866,KEGG_2019_Human,Thermogenesis,1/231,0.0115498903940656,0.0115498903940656,0,0,19769.0,88191.07730937863,ACTG1
20867,KEGG_2019_Human,JAK-STAT signaling pathway,1/162,0.0080999104202618,0.0176998626413668,0,0,19838.0,95537.86936302872,CSH1
20868,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0176998626413668,0,0,19706.0,83157.67014793828,CSH1
20869,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0176998626413668,0,0,19662.0,80229.79996326564,CSH1
20870,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0176998626413668,0,0,19646.0,79255.8617626126,CSH1
20871,KEGG_2019_Human,Protein export,1/23,0.0011499748819949,0.0011499748819949,0,0,19977.0,135204.63922267244,IMMP1L
20872,KEGG_2019_Human,HIF-1 signaling pathway,1/100,0.0049999330710556,0.0102748783196477,0,0,19900.0,105436.78197328727,MKNK2
20873,KEGG_2019_Human,Insulin signaling pathway,1/137,0.0068499188797651,0.0102748783196477,0,0,19863.0,98987.62735269018,MKNK2
20874,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0147498749536506,0,0,19705.0,83086.53988020132,MKNK2
20875,KEGG_2019_Human,Lysine degradation,1/59,0.0029499522555206,0.0029499522555206,0,0,19941.0,116175.59385530632,SUV39H2
20876,KEGG_2019_Human,Taurine and hypotaurine metabolism,1/11,0.0005499852259717758,0.0014249670934658,0,0,19989.0,150029.8210287992,GADL1
20877,KEGG_2019_Human,Pantothenate and CoA biosynthesis,1/19,0.00094997806231055,0.0014249670934658,0,0,19981.0,139049.2109571672,GADL1
20878,KEGG_2019_Human,beta-Alanine metabolism,1/31,0.0015499690656704,0.0015499690656704,0,0,19969.0,129189.85098816035,GADL1
20879,KEGG_2019_Human,Acute myeloid leukemia,1/66,0.003299948626608,0.006599897253216,0,0,19934.0,113899.85357353876,PIM2
20880,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,PIM2
20881,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF510
20882,KEGG_2019_Human,Ribosome,1/153,0.0076499133771537,0.0076499133771537,0,0,19847.0,96715.6407630817,RSL24D1
20883,KEGG_2019_Human,Wnt signaling pathway,1/158,0.0078999117225733,0.0090499044707863,0,0,19842.0,96053.2110949472,RYK
20884,KEGG_2019_Human,Axon guidance,1/181,0.0090499044707863,0.0090499044707863,0,0,19819.0,93248.41634586031,RYK
20885,KEGG_2019_Human,Melanoma,1/72,0.0035999456502131,0.0173998352024406,0,0,19928.0,112131.59838572376,FGF5
20886,KEGG_2019_Human,Breast cancer,1/147,0.0073499154017982,0.0173998352024406,0,0,19853.0,97539.10874372096,FGF5
20887,KEGG_2019_Human,Gastric cancer,1/149,0.0074499147221605,0.0173998352024406,0,0,19851.0,97261.02051561224,FGF5
20888,KEGG_2019_Human,Rap1 signaling pathway,1/206,0.010299897173561,0.0173998352024406,0,0,19794.0,90569.849337325,FGF5
20889,KEGG_2019_Human,Regulation of actin cytoskeleton,1/214,0.0106998949514067,0.0173998352024406,0,0,19786.0,89779.39753374986,FGF5
20890,KEGG_2019_Human,Ras signaling pathway,1/232,0.0115998901349604,0.0173998352024406,0,0,19768.0,88101.22480150245,FGF5
20891,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.018964124940408,0,0,19705.0,83086.53988020132,FGF5
20892,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0199123454715377,0,0,19646.0,79255.8617626126,FGF5
20893,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,FGF5
20894,KEGG_2019_Human,RNA polymerase,1/31,0.0015499690656704,0.0030999381313408,0,0,19969.0,129189.85098816035,POLR2C
20895,KEGG_2019_Human,Huntington disease,1/193,0.0096499008972596,0.0096499008972596,0,0,19807.0,91920.47679471428,POLR2C
20896,KEGG_2019_Human,Peroxisome,1/83,0.0041499404726918,0.0041499404726918,0,0,19917.0,109237.99888847338,PEX13
20897,KEGG_2019_Human,Cardiac muscle contraction,1/78,0.0038999427840466,0.0112582177134695,0,0,19922.0,110503.2180492851,UQCR10
20898,KEGG_2019_Human,Oxidative phosphorylation,1/133,0.0066499203093911,0.0112582177134695,0,0,19867.0,99596.2591544721,UQCR10
20899,KEGG_2019_Human,Parkinson disease,1/142,0.0070999171242726,0.0112582177134695,0,0,19858.0,98250.87390500787,UQCR10
20900,KEGG_2019_Human,Non-alcoholic fatty liver disease (NAFLD),1/149,0.0074499147221605,0.0112582177134695,0,0,19851.0,97261.02051561224,UQCR10
20901,KEGG_2019_Human,Alzheimer disease,1/171,0.0085499075557634,0.0112582177134695,0,0,19829.0,94422.42241345016,UQCR10
20902,KEGG_2019_Human,Huntington disease,1/193,0.0096499008972596,0.0112582177134695,0,0,19807.0,91920.47679471428,UQCR10
20903,KEGG_2019_Human,Thermogenesis,1/231,0.0115498903940656,0.0115498903940656,0,0,19769.0,88191.07730937863,UQCR10
20904,KEGG_2019_Human,Morphine addiction,1/91,0.0045499369072032,0.006449921761047,0,0,19909.0,107362.10783923086,PDE7A
20905,KEGG_2019_Human,Purine metabolism,1/129,0.006449921761047,0.006449921761047,0,0,19871.0,100223.109907462,PDE7A
20906,KEGG_2019_Human,Alcoholism,1/180,0.0089999047745351,0.0089999047745351,0,0,19820.0,93362.92821536642,SLC29A1
20907,KEGG_2019_Human,Basal cell carcinoma,1/63,0.0031499501598827,0.0109198810514423,0,0,19937.0,114844.46974572667,FZD2
20908,KEGG_2019_Human,Melanogenesis,1/101,0.0050499326546803,0.0109198810514423,0,0,19899.0,105233.48101229242,FZD2
20909,KEGG_2019_Human,Signaling pathways regulating pluripotency of stem cells,1/139,0.006949918172816,0.0109198810514423,0,0,19861.0,98689.81333375497,FZD2
20910,KEGG_2019_Human,Breast cancer,1/147,0.0073499154017982,0.0109198810514423,0,0,19853.0,97539.10874372096,FZD2
20911,KEGG_2019_Human,Gastric cancer,1/149,0.0074499147221605,0.0109198810514423,0,0,19851.0,97261.02051561224,FZD2
20912,KEGG_2019_Human,mTOR signaling pathway,1/152,0.0075999137114971,0.0109198810514423,0,0,19848.0,96850.665715497,FZD2
20913,KEGG_2019_Human,Cushing syndrome,1/155,0.0077499127120574,0.0109198810514423,0,0,19845.0,96448.16254952336,FZD2
20914,KEGG_2019_Human,Wnt signaling pathway,1/158,0.0078999117225733,0.0109198810514423,0,0,19842.0,96053.2110949472,FZD2
20915,KEGG_2019_Human,Hippo signaling pathway,1/160,0.0079999110688441,0.0109198810514423,0,0,19840.0,95793.96509856998,FZD2
20916,KEGG_2019_Human,Hepatocellular carcinoma,1/168,0.0083999085011095,0.0109198810514423,0,0,19832.0,94787.72752807094,FZD2
20917,KEGG_2019_Human,Proteoglycans in cancer,1/201,0.0100498985877989,0.0118771528764897,0,0,19799.0,91079.21596609056,FZD2
20918,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0178748564138782,0,0,19670.0,80733.60565076157,FZD2
20919,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,FZD2
20920,KEGG_2019_Human,Prion diseases,1/35,0.0017499663721595,0.0063999130051608,0,0,19965.0,126740.98858805298,C8B
20921,KEGG_2019_Human,Complement and coagulation cascades,1/79,0.0039499423167337,0.0063999130051608,0,0,19921.0,110243.89578070649,C8B
20922,KEGG_2019_Human,Amoebiasis,1/96,0.0047999347538706,0.0063999130051608,0,0,19904.0,106270.50039849174,C8B
20923,KEGG_2019_Human,Systemic lupus erythematosus,1/133,0.0066499203093911,0.0066499203093911,0,0,19867.0,99596.2591544721,C8B
20924,KEGG_2019_Human,Protein digestion and absorption,1/90,0.0044999373439762,0.0048999339081079,0,0,19910.0,107587.50385474482,CTRL
20925,KEGG_2019_Human,Pancreatic secretion,1/98,0.0048999339081079,0.0048999339081079,0,0,19902.0,105849.45495286948,CTRL
20926,KEGG_2019_Human,Allograft rejection,1/38,0.001899964429635,0.0112098185709785,0,0,19962.0,125080.29732025368,HLA-C
20927,KEGG_2019_Human,Graft-versus-host disease,1/41,0.0020499625466866,0.0112098185709785,0,0,19959.0,123544.88783416104,HLA-C
20928,KEGG_2019_Human,Type I diabetes mellitus,1/43,0.0021499613216957,0.0112098185709785,0,0,19957.0,122581.98940490963,HLA-C
20929,KEGG_2019_Human,Autoimmune thyroid disease,1/53,0.0026499555173137,0.0112098185709785,0,0,19947.0,118349.78824235698,HLA-C
20930,KEGG_2019_Human,Viral myocarditis,1/59,0.0029499522555206,0.0112098185709785,0,0,19941.0,116175.59385530632,HLA-C
20931,KEGG_2019_Human,Antigen processing and presentation,1/77,0.0038499432547502,0.0121914869733757,0,0,19923.0,110765.8407373636,HLA-C
20932,KEGG_2019_Human,Natural killer cell mediated cytotoxicity,1/131,0.0065499210316603,0.0133592467251027,0,0,19869.0,99907.33811343512,HLA-C
20933,KEGG_2019_Human,Cell adhesion molecules (CAMs),1/145,0.0072499160871101,0.0133592467251027,0,0,19855.0,97820.92670675044,HLA-C
20934,KEGG_2019_Human,Phagosome,1/152,0.0075999137114971,0.0133592467251027,0,0,19848.0,96850.665715497,HLA-C
20935,KEGG_2019_Human,Cellular senescence,1/160,0.0079999110688441,0.0133592467251027,0,0,19840.0,95793.96509856998,HLA-C
20936,KEGG_2019_Human,Kaposi sarcoma-associated herpesvirus infection,1/186,0.0092999029651357,0.0133592467251027,0,0,19814.0,92684.96451050608,HLA-C
20937,KEGG_2019_Human,Viral carcinogenesis,1/201,0.0100498985877989,0.0133592467251027,0,0,19799.0,91079.21596609056,HLA-C
20938,KEGG_2019_Human,Epstein-Barr virus infection,1/201,0.0100498985877989,0.0133592467251027,0,0,19799.0,91079.21596609056,HLA-C
20939,KEGG_2019_Human,Human immunodeficiency virus 1 infection,1/212,0.0105998955026255,0.0133592467251027,0,0,19788.0,89974.27756224656,HLA-C
20940,KEGG_2019_Human,Human T-cell leukemia virus 1 infection,1/219,0.0109498935894162,0.0133592467251027,0,0,19781.0,89299.85161916987,HLA-C
20941,KEGG_2019_Human,Human cytomegalovirus infection,1/225,0.0112498919790339,0.0133592467251027,0,0,19775.0,88738.27077557483,HLA-C
20942,KEGG_2019_Human,Endocytosis,1/244,0.0121998870519305,0.0136351678815694,0,0,19756.0,87051.4275316661,HLA-C
20943,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0174165267622403,0,0,19670.0,80733.60565076157,HLA-C
20944,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,HLA-C
20945,KEGG_2019_Human,Fanconi anemia pathway,1/54,0.0026999549628563,0.0053999099257126,0,0,19946.0,117971.01964061816,TELO2
20946,KEGG_2019_Human,mTOR signaling pathway,1/152,0.0075999137114971,0.0075999137114971,0,0,19848.0,96850.665715497,TELO2
20947,KEGG_2019_Human,Toxoplasmosis,1/113,0.0056499278191151,0.0056499278191151,0,0,19887.0,102937.34947211576,IRGM
20948,KEGG_2019_Human,Cardiac muscle contraction,1/78,0.0038999427840466,0.007583228178672,0,0,19922.0,110503.2180492851,TPM1
20949,KEGG_2019_Human,Hypertrophic cardiomyopathy (HCM),1/85,0.004249939567045,0.007583228178672,0,0,19915.0,108752.83801948265,TPM1
20950,KEGG_2019_Human,Dilated cardiomyopathy (DCM),1/91,0.0045499369072032,0.007583228178672,0,0,19909.0,107362.10783923086,TPM1
20951,KEGG_2019_Human,Adrenergic signaling in cardiomyocytes,1/145,0.0072499160871101,0.0090623951088877,0,0,19855.0,97820.92670675044,TPM1
20952,KEGG_2019_Human,MicroRNAs in cancer,1/299,0.0149498740670514,0.0149498740670514,0,0,19701.0,82804.33538735632,TPM1
20953,KEGG_2019_Human,Chemokine signaling pathway,1/190,0.0094999017791995,0.0146998751759735,0,0,19810.0,92244.74636351672,CCR7
20954,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0146998751759735,0,0,19706.0,83157.67014793828,CCR7
20955,KEGG_2019_Human,Inositol phosphate metabolism,1/74,0.0036999446830449,0.0049499334884068,0,0,19926.0,111574.38983110404,MTMR6
20956,KEGG_2019_Human,Phosphatidylinositol signaling system,1/99,0.0049499334884068,0.0049499334884068,0,0,19901.0,105642.09305076736,MTMR6
20957,KEGG_2019_Human,D-Glutamine and D-glutamate metabolism,1/5,0.0002499917995416556,0.0019999343963332,0,0,19995.0,165840.17843725558,GLS2
20958,KEGG_2019_Human,Arginine biosynthesis,1/21,0.0010499764455398,0.0030665996853199,0,0,19979.0,137035.71221916509,GLS2
20959,KEGG_2019_Human,Proximal tubule bicarbonate reclamation,1/23,0.0011499748819949,0.0030665996853199,0,0,19977.0,135204.63922267244,GLS2
20960,KEGG_2019_Human,"Alanine, aspartate and glutamate metabolism",1/35,0.0017499663721595,0.0034999327443191,0,0,19965.0,126740.98858805298,GLS2
20961,KEGG_2019_Human,Central carbon metabolism in cancer,1/65,0.003249949134407,0.0051999186150512,0,0,19935.0,114209.92613860144,GLS2
20962,KEGG_2019_Human,GABAergic synapse,1/89,0.0044499377838098,0.0059332503784131,0,0,19911.0,107815.380281759,GLS2
20963,KEGG_2019_Human,Glutamatergic synapse,1/114,0.005699927427839,0.0065142027746731,0,0,19886.0,102756.96431429044,GLS2
20964,KEGG_2019_Human,MicroRNAs in cancer,1/299,0.0149498740670514,0.0149498740670514,0,0,19701.0,82804.33538735632,GLS2
20965,KEGG_2019_Human,Rap1 signaling pathway,1/206,0.010299897173561,0.010299897173561,0,0,19794.0,90569.849337325,SKAP1
20966,KEGG_2019_Human,Cholesterol metabolism,1/50,0.0024999572069037,0.0107221121080662,0,0,19950.0,119530.05920663515,VDAC1
20967,KEGG_2019_Human,Parkinson disease,1/142,0.0070999171242726,0.0107221121080662,0,0,19858.0,98250.87390500787,VDAC1
20968,KEGG_2019_Human,Cellular senescence,1/160,0.0079999110688441,0.0107221121080662,0,0,19840.0,95793.96509856998,VDAC1
20969,KEGG_2019_Human,Necroptosis,1/162,0.0080999104202618,0.0107221121080662,0,0,19838.0,95537.86936302872,VDAC1
20970,KEGG_2019_Human,cGMP-PKG signaling pathway,1/166,0.0082999091363732,0.0107221121080662,0,0,19834.0,95034.82345515196,VDAC1
20971,KEGG_2019_Human,Influenza A,1/171,0.0085499075557634,0.0107221121080662,0,0,19829.0,94422.42241345016,VDAC1
20972,KEGG_2019_Human,NOD-like receptor signaling pathway,1/178,0.0088999053857096,0.0107221121080662,0,0,19822.0,93593.82745769851,VDAC1
20973,KEGG_2019_Human,Calcium signaling pathway,1/188,0.009399902370135,0.0107221121080662,0,0,19812.0,92463.712994847,VDAC1
20974,KEGG_2019_Human,Huntington disease,1/193,0.0096499008972596,0.0107221121080662,0,0,19807.0,91920.47679471428,VDAC1
20975,KEGG_2019_Human,Human T-cell leukemia virus 1 infection,1/219,0.0109498935894162,0.0109498935894162,0,0,19781.0,89299.85161916987,VDAC1
20976,KEGG_2019_Human,Glutamatergic synapse,1/114,0.005699927427839,0.0065999206698993,0,0,19886.0,102756.96431429044,HOMER1
20977,KEGG_2019_Human,FoxO signaling pathway,1/132,0.0065999206698993,0.0065999206698993,0,0,19868.0,99751.22090491928,HOMER1
20978,KEGG_2019_Human,Natural killer cell mediated cytotoxicity,1/131,0.0065499210316603,0.0106873844447042,0,0,19869.0,99907.33811343512,TNFRSF10A
20979,KEGG_2019_Human,Apoptosis,1/143,0.0071499167770442,0.0106873844447042,0,0,19857.0,98106.57763600958,TNFRSF10A
20980,KEGG_2019_Human,Necroptosis,1/162,0.0080999104202618,0.0106873844447042,0,0,19838.0,95537.86936302872,TNFRSF10A
20981,KEGG_2019_Human,Influenza A,1/171,0.0085499075557634,0.0106873844447042,0,0,19829.0,94422.42241345016,TNFRSF10A
20982,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0146998751759735,0,0,19706.0,83157.67014793828,TNFRSF10A
20983,KEGG_2019_Human,Vascular smooth muscle contraction,1/132,0.0065999206698993,0.0084999078692823,0,0,19868.0,99751.22090491928,MYL6B
20984,KEGG_2019_Human,Oxytocin signaling pathway,1/153,0.0076499133771537,0.0084999078692823,0,0,19847.0,96715.6407630817,MYL6B
20985,KEGG_2019_Human,Tight junction,1/170,0.0084999078692823,0.0084999078692823,0,0,19830.0,94543.49009679438,MYL6B
20986,KEGG_2019_Human,Oxidative phosphorylation,1/133,0.0066499203093911,0.0112582177134695,0,0,19867.0,99596.2591544721,NDUFV3
20987,KEGG_2019_Human,Parkinson disease,1/142,0.0070999171242726,0.0112582177134695,0,0,19858.0,98250.87390500787,NDUFV3
20988,KEGG_2019_Human,Retrograde endocannabinoid signaling,1/148,0.007399915061391,0.0112582177134695,0,0,19852.0,97399.60470052566,NDUFV3
20989,KEGG_2019_Human,Non-alcoholic fatty liver disease (NAFLD),1/149,0.0074499147221605,0.0112582177134695,0,0,19851.0,97261.02051561224,NDUFV3
20990,KEGG_2019_Human,Alzheimer disease,1/171,0.0085499075557634,0.0112582177134695,0,0,19829.0,94422.42241345016,NDUFV3
20991,KEGG_2019_Human,Huntington disease,1/193,0.0096499008972596,0.0112582177134695,0,0,19807.0,91920.47679471428,NDUFV3
20992,KEGG_2019_Human,Thermogenesis,1/231,0.0115498903940656,0.0115498903940656,0,0,19769.0,88191.07730937863,NDUFV3
20993,KEGG_2019_Human,Notch signaling pathway,1/48,0.0023999583567988,0.012790780020835,0,0,19952.0,120356.5272753826,HDAC1
20994,KEGG_2019_Human,Amphetamine addiction,1/68,0.0033999476216189,0.012790780020835,0,0,19932.0,113293.39338050144,HDAC1
20995,KEGG_2019_Human,Chronic myeloid leukemia,1/76,0.0037999437281752,0.012790780020835,0,0,19924.0,111031.8499691117,HDAC1
20996,KEGG_2019_Human,Longevity regulating pathway,1/102,0.0050999322416682,0.012790780020835,0,0,19898.0,105032.15064717118,HDAC1
20997,KEGG_2019_Human,Thyroid hormone signaling pathway,1/116,0.0057999266512085,0.012790780020835,0,0,19884.0,102400.8105961506,HDAC1
20998,KEGG_2019_Human,Cell cycle,1/124,0.0061999236097501,0.012790780020835,0,0,19876.0,101034.04709010696,HDAC1
20999,KEGG_2019_Human,Alcoholism,1/180,0.0089999047745351,0.012790780020835,0,0,19820.0,93362.92821536642,HDAC1
21000,KEGG_2019_Human,Transcriptional misregulation in cancer,1/186,0.0092999029651357,0.012790780020835,0,0,19814.0,92684.96451050608,HDAC1
21001,KEGG_2019_Human,Huntington disease,1/193,0.0096499008972596,0.012790780020835,0,0,19807.0,91920.47679471428,HDAC1
21002,KEGG_2019_Human,Viral carcinogenesis,1/201,0.0100498985877989,0.012790780020835,0,0,19799.0,91079.21596609056,HDAC1
21003,KEGG_2019_Human,Epstein-Barr virus infection,1/201,0.0100498985877989,0.012790780020835,0,0,19799.0,91079.21596609056,HDAC1
21004,KEGG_2019_Human,MicroRNAs in cancer,1/299,0.0149498740670514,0.0174415197448933,0,0,19701.0,82804.33538735632,HDAC1
21005,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.017769088032731,0,0,19670.0,80733.60565076157,HDAC1
21006,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,HDAC1
21007,KEGG_2019_Human,Arginine and proline metabolism,1/49,0.0024499577795033,0.0024499577795033,0,0,19951.0,119939.1172087114,P4HA3
21008,KEGG_2019_Human,Acute myeloid leukemia,1/66,0.003299948626608,0.0100311191300485,0,0,19934.0,113899.85357353876,STAT5A
21009,KEGG_2019_Human,Non-small cell lung cancer,1/66,0.003299948626608,0.0100311191300485,0,0,19934.0,113899.85357353876,STAT5A
21010,KEGG_2019_Human,Prolactin signaling pathway,1/70,0.0034999466296654,0.0100311191300485,0,0,19930.0,112704.30065625212,STAT5A
21011,KEGG_2019_Human,Chronic myeloid leukemia,1/76,0.0037999437281752,0.0100311191300485,0,0,19924.0,111031.8499691117,STAT5A
21012,KEGG_2019_Human,ErbB signaling pathway,1/85,0.004249939567045,0.0100311191300485,0,0,19915.0,108752.83801948265,STAT5A
21013,KEGG_2019_Human,Th1 and Th2 cell differentiation,1/92,0.0045999364719865,0.0100311191300485,0,0,19908.0,107139.13814408927,STAT5A
21014,KEGG_2019_Human,AGE-RAGE signaling pathway in diabetic complications,1/100,0.0049999330710556,0.0100311191300485,0,0,19900.0,105436.78197328727,STAT5A
21015,KEGG_2019_Human,Th17 cell differentiation,1/107,0.0053499302026925,0.0100311191300485,0,0,19893.0,104053.753408911,STAT5A
21016,KEGG_2019_Human,Measles,1/138,0.0068999185254481,0.0101873876223335,0,0,19862.0,98838.19160389496,STAT5A
21017,KEGG_2019_Human,Necroptosis,1/162,0.0080999104202618,0.0101873876223335,0,0,19838.0,95537.86936302872,STAT5A
21018,KEGG_2019_Human,JAK-STAT signaling pathway,1/162,0.0080999104202618,0.0101873876223335,0,0,19838.0,95537.86936302872,STAT5A
21019,KEGG_2019_Human,Hepatitis B,1/163,0.0081499100978668,0.0101873876223335,0,0,19837.0,95410.9786681514,STAT5A
21020,KEGG_2019_Human,Viral carcinogenesis,1/201,0.0100498985877989,0.0115960368320757,0,0,19799.0,91079.21596609056,STAT5A
21021,KEGG_2019_Human,Human T-cell leukemia virus 1 infection,1/219,0.0109498935894162,0.0117320288458031,0,0,19781.0,89299.85161916987,STAT5A
21022,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,STAT5A
21023,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR51F2
21024,KEGG_2019_Human,Hedgehog signaling pathway,1/47,0.0023499589392381,0.0023499589392381,0,0,19953.0,120782.64067395544,CSNK1G3
21025,KEGG_2019_Human,Inositol phosphate metabolism,1/74,0.0036999446830449,0.0073998893660899,0,0,19926.0,111574.38983110404,PIP5KL1
21026,KEGG_2019_Human,Endocytosis,1/244,0.0121998870519305,0.0121998870519305,0,0,19756.0,87051.4275316661,PIP5KL1
21027,KEGG_2019_Human,Shigellosis,1/65,0.003249949134407,0.0082499094553477,0,0,19935.0,114209.92613860144,UBE2D2
21028,KEGG_2019_Human,Ubiquitin mediated proteolysis,1/137,0.0068499188797651,0.0082499094553477,0,0,19863.0,98987.62735269018,UBE2D2
21029,KEGG_2019_Human,Protein processing in endoplasmic reticulum,1/165,0.0082499094553477,0.0082499094553477,0,0,19835.0,95159.46482222488,UBE2D2
21030,KEGG_2019_Human,Salmonella infection,1/86,0.0042999391173866,0.0075999137114971,0,0,19914.0,108514.46102290176,RILP
21031,KEGG_2019_Human,Phagosome,1/152,0.0075999137114971,0.0075999137114971,0,0,19848.0,96850.665715497,RILP
21032,KEGG_2019_Human,Thiamine metabolism,1/15,0.0007499814841592997,0.0012999726251831,0,0,19985.0,143801.30885993244,ALPP
21033,KEGG_2019_Human,Folate biosynthesis,1/26,0.0012999726251831,0.0012999726251831,0,0,19974.0,132735.46073187632,ALPP
21034,KEGG_2019_Human,Lysosome,1/123,0.0061499239842961,0.0061499239842961,0,0,19877.0,101200.07933676826,CTNS
21035,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,OPRL1
21036,KEGG_2019_Human,Non-small cell lung cancer,1/66,0.003299948626608,0.0164997431330402,0,0,19934.0,113899.85357353876,STK4
21037,KEGG_2019_Human,FoxO signaling pathway,1/132,0.0065999206698993,0.0164998016747484,0,0,19868.0,99751.22090491928,STK4
21038,KEGG_2019_Human,Ras signaling pathway,1/232,0.0115998901349604,0.0184373436920633,0,0,19768.0,88101.22480150245,STK4
21039,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0184373436920633,0,0,19705.0,83086.53988020132,STK4
21040,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,STK4
21041,KEGG_2019_Human,TNF signaling pathway,1/110,0.0054999290027479,0.0054999290027479,0,0,19890.0,103488.06969787036,BAG4
21042,KEGG_2019_Human,RNA degradation,1/79,0.0039499423167337,0.0039499423167337,0,0,19921.0,110243.89578070649,CNOT9
21043,KEGG_2019_Human,Neurotrophin signaling pathway,1/119,0.0059499254985137,0.0059499254985137,0,0,19881.0,101877.73080211312,PRDM4
21044,KEGG_2019_Human,Citrate cycle (TCA cycle),1/30,0.0014999697593334,0.0014999697593334,0,0,19970.0,129851.13732048514,IDH3G
21045,KEGG_2019_Human,Insulin signaling pathway,1/137,0.0068499188797651,0.0068499188797651,0,0,19863.0,98987.62735269018,TRIP10
21046,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0146998751759735,0,0,19706.0,83157.67014793828,GDF1
21047,KEGG_2019_Human,Pyrimidine metabolism,1/57,0.002849953326298,0.006449921761047,0,0,19943.0,116875.00742975442,NME4
21048,KEGG_2019_Human,Drug metabolism,1/108,0.0053999298011749,0.006449921761047,0,0,19892.0,103863.47861844616,NME4
21049,KEGG_2019_Human,Purine metabolism,1/129,0.006449921761047,0.006449921761047,0,0,19871.0,100223.109907462,NME4
21050,KEGG_2019_Human,HIF-1 signaling pathway,1/100,0.0049999330710556,0.0102748783196477,0,0,19900.0,105436.78197328727,MKNK1
21051,KEGG_2019_Human,Insulin signaling pathway,1/137,0.0068499188797651,0.0102748783196477,0,0,19863.0,98987.62735269018,MKNK1
21052,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0147498749536506,0,0,19705.0,83086.53988020132,MKNK1
21053,KEGG_2019_Human,Gastric acid secretion,1/75,0.0037499442041125,0.0037499442041125,0,0,19925.0,111301.33528642564,KCNJ10
21054,KEGG_2019_Human,IL-17 signaling pathway,1/93,0.0046499360391879,0.0092998720783758,0,0,19907.0,106918.54242106884,IL17RC
21055,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0146998751759735,0,0,19706.0,83157.67014793828,IL17RC
21056,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0147498749536506,0,0,19705.0,83086.53988020132,DUSP5
21057,KEGG_2019_Human,Calcium signaling pathway,1/188,0.009399902370135,0.009399902370135,0,0,19812.0,92463.712994847,TNNC2
21058,KEGG_2019_Human,Signaling pathways regulating pluripotency of stem cells,1/139,0.006949918172816,0.013899836345632,0,0,19861.0,98689.81333375497,DUSP9
21059,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0147498749536506,0,0,19705.0,83086.53988020132,DUSP9
21060,KEGG_2019_Human,Circadian rhythm,1/31,0.0015499690656704,0.0015499690656704,0,0,19969.0,129189.85098816035,CRY2
21061,KEGG_2019_Human,RNA degradation,1/79,0.0039499423167337,0.0039499423167337,0,0,19921.0,110243.89578070649,DCP1A
21062,KEGG_2019_Human,JAK-STAT signaling pathway,1/162,0.0080999104202618,0.0176998626413668,0,0,19838.0,95537.86936302872,GH1
21063,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0176998626413668,0,0,19706.0,83157.67014793828,GH1
21064,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0176998626413668,0,0,19662.0,80229.79996326564,GH1
21065,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0176998626413668,0,0,19646.0,79255.8617626126,GH1
21066,KEGG_2019_Human,Spliceosome,1/134,0.0066999199497742,0.0066999199497742,0,0,19866.0,99442.43560916925,BUD31
21067,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR4C46
21068,KEGG_2019_Human,Cushing syndrome,1/155,0.0077499127120574,0.0077499127120574,0,0,19845.0,96448.16254952336,WDR5
21069,KEGG_2019_Human,N-Glycan biosynthesis,1/50,0.0024999572069037,0.0024999572069037,0,0,19950.0,119530.05920663515,DPM3
21070,KEGG_2019_Human,Pertussis,1/76,0.0037999437281752,0.0039499423167337,0,0,19924.0,111031.8499691117,SERPING1
21071,KEGG_2019_Human,Complement and coagulation cascades,1/79,0.0039499423167337,0.0039499423167337,0,0,19921.0,110243.89578070649,SERPING1
21072,KEGG_2019_Human,Vitamin digestion and absorption,1/24,0.0011999741185782,0.0023999482371564,0,0,19976.0,134347.69487847842,SLC46A1
21073,KEGG_2019_Human,Mineral absorption,1/51,0.0025499566390179,0.0025499566390179,0,0,19949.0,119129.0228601236,SLC46A1
21074,KEGG_2019_Human,Rap1 signaling pathway,1/206,0.010299897173561,0.010299897173561,0,0,19794.0,90569.849337325,RAP1GAP
21075,KEGG_2019_Human,Inositol phosphate metabolism,1/74,0.0036999446830449,0.0049499334884068,0,0,19926.0,111574.38983110404,INPP5A
21076,KEGG_2019_Human,Phosphatidylinositol signaling system,1/99,0.0049499334884068,0.0049499334884068,0,0,19901.0,105642.09305076736,INPP5A
21077,KEGG_2019_Human,Endocytosis,1/244,0.0121998870519305,0.0121998870519305,0,0,19756.0,87051.4275316661,CAPZA1
21078,KEGG_2019_Human,Ubiquitin mediated proteolysis,1/137,0.0068499188797651,0.0068499188797651,0,0,19863.0,98987.62735269018,UBE2QL1
21079,KEGG_2019_Human,Collecting duct acid secretion,1/27,0.0013499718942362,0.0081898864329657,0,0,19973.0,131975.02298599784,ATP6V1E1
21080,KEGG_2019_Human,Vibrio cholerae infection,1/50,0.0024999572069037,0.0081898864329657,0,0,19950.0,119530.05920663515,ATP6V1E1
21081,KEGG_2019_Human,Epithelial cell signaling in Helicobacter pylori infection,1/68,0.0033999476216189,0.0081898864329657,0,0,19932.0,113293.39338050144,ATP6V1E1
21082,KEGG_2019_Human,Synaptic vesicle cycle,1/78,0.0038999427840466,0.0081898864329657,0,0,19922.0,110503.2180492851,ATP6V1E1
21083,KEGG_2019_Human,Rheumatoid arthritis,1/91,0.0045499369072032,0.0081898864329657,0,0,19909.0,107362.10783923086,ATP6V1E1
21084,KEGG_2019_Human,Oxidative phosphorylation,1/133,0.0066499203093911,0.0085499029254342,0,0,19867.0,99596.2591544721,ATP6V1E1
21085,KEGG_2019_Human,mTOR signaling pathway,1/152,0.0075999137114971,0.0085499029254342,0,0,19848.0,96850.665715497,ATP6V1E1
21086,KEGG_2019_Human,Phagosome,1/152,0.0075999137114971,0.0085499029254342,0,0,19848.0,96850.665715497,ATP6V1E1
21087,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0164998674589645,0,0,19670.0,80733.60565076157,ATP6V1E1
21088,KEGG_2019_Human,Staphylococcus aureus infection,1/68,0.0033999476216189,0.0067998952432378,0,0,19932.0,113293.39338050144,FPR2
21089,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,FPR2
21090,KEGG_2019_Human,Peroxisome,1/83,0.0041499404726918,0.0041499404726918,0,0,19917.0,109237.99888847338,PEX2
21091,KEGG_2019_Human,Mannose type O-glycan biosynthesis,1/23,0.0011499748819949,0.0011499748819949,0,0,19977.0,135204.63922267244,B3GAT2
21092,KEGG_2019_Human,Oxidative phosphorylation,1/133,0.0066499203093911,0.0112582177134695,0,0,19867.0,99596.2591544721,NDUFS2
21093,KEGG_2019_Human,Parkinson disease,1/142,0.0070999171242726,0.0112582177134695,0,0,19858.0,98250.87390500787,NDUFS2
21094,KEGG_2019_Human,Retrograde endocannabinoid signaling,1/148,0.007399915061391,0.0112582177134695,0,0,19852.0,97399.60470052566,NDUFS2
21095,KEGG_2019_Human,Non-alcoholic fatty liver disease (NAFLD),1/149,0.0074499147221605,0.0112582177134695,0,0,19851.0,97261.02051561224,NDUFS2
21096,KEGG_2019_Human,Alzheimer disease,1/171,0.0085499075557634,0.0112582177134695,0,0,19829.0,94422.42241345016,NDUFS2
21097,KEGG_2019_Human,Huntington disease,1/193,0.0096499008972596,0.0112582177134695,0,0,19807.0,91920.47679471428,NDUFS2
21098,KEGG_2019_Human,Thermogenesis,1/231,0.0115498903940656,0.0115498903940656,0,0,19769.0,88191.07730937863,NDUFS2
21099,KEGG_2019_Human,Phototransduction,1/28,0.0013999711732997,0.0013999711732997,0,0,19972.0,131242.0761597353,GUCA1A
21100,KEGG_2019_Human,ABC transporters,1/45,0.0022499601197094,0.0022499601197094,0,0,19955.0,121662.49782449217,ABCB10
21101,KEGG_2019_Human,Primary immunodeficiency,1/37,0.0018499650702878,0.0035999375351982,0,0,19963.0,125618.9446446357,TNFRSF13B
21102,KEGG_2019_Human,Intestinal immune network for IgA production,1/48,0.0023999583567988,0.0035999375351982,0,0,19952.0,120356.5272753826,TNFRSF13B
21103,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0146998751759735,0,0,19706.0,83157.67014793828,TNFRSF13B
21104,KEGG_2019_Human,Aminoacyl-tRNA biosynthesis,1/66,0.003299948626608,0.003299948626608,0,0,19934.0,113899.85357353876,HARS2
21105,KEGG_2019_Human,Mitophagy,1/65,0.003249949134407,0.0080999104202618,0,0,19935.0,114209.92613860144,SQSTM1
21106,KEGG_2019_Human,Osteoclast differentiation,1/127,0.0063499224962247,0.0080999104202618,0,0,19873.0,100543.72072014232,SQSTM1
21107,KEGG_2019_Human,Fluid shear stress and atherosclerosis,1/139,0.006949918172816,0.0080999104202618,0,0,19861.0,98689.81333375497,SQSTM1
21108,KEGG_2019_Human,Cellular senescence,1/160,0.0079999110688441,0.0080999104202618,0,0,19840.0,95793.96509856998,SQSTM1
21109,KEGG_2019_Human,Necroptosis,1/162,0.0080999104202618,0.0080999104202618,0,0,19838.0,95537.86936302872,SQSTM1
21110,KEGG_2019_Human,Spliceosome,1/134,0.0066999199497742,0.0066999199497742,0,0,19866.0,99442.43560916925,CWC15
21111,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF205
21112,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF610
21113,KEGG_2019_Human,SNARE interactions in vesicular transport,1/34,0.0016999670339032,0.0016999670339032,0,0,19966.0,127326.1054203148,STX8
21114,KEGG_2019_Human,Purine metabolism,1/129,0.006449921761047,0.006449921761047,0,0,19871.0,100223.109907462,GMPR2
21115,KEGG_2019_Human,Pantothenate and CoA biosynthesis,1/19,0.00094997806231055,0.00094997806231055,0,0,19981.0,139049.2109571672,PANK2
21116,KEGG_2019_Human,Cholinergic synapse,1/112,0.0055999282120529,0.0111998564241059,0,0,19888.0,103119.30984392198,CHRNB4
21117,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,CHRNB4
21118,KEGG_2019_Human,Glycosaminoglycan biosynthesis,1/53,0.0026499555173137,0.0026499555173137,0,0,19947.0,118349.78824235698,CHPF2
21119,KEGG_2019_Human,Calcium signaling pathway,1/188,0.009399902370135,0.0168998658265596,0,0,19812.0,92463.712994847,TACR2
21120,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,TACR2
21121,KEGG_2019_Human,Homologous recombination,1/41,0.0020499625466866,0.0026999549628563,0,0,19959.0,123544.88783416104,TOP3A
21122,KEGG_2019_Human,Fanconi anemia pathway,1/54,0.0026999549628563,0.0026999549628563,0,0,19946.0,117971.01964061816,TOP3A
21123,KEGG_2019_Human,Glycosaminoglycan degradation,1/19,0.00094997806231055,0.0018999561246211,0,0,19981.0,139049.2109571672,ARSB
21124,KEGG_2019_Human,Lysosome,1/123,0.0061499239842961,0.0061499239842961,0,0,19877.0,101200.07933676826,ARSB
21125,KEGG_2019_Human,Central carbon metabolism in cancer,1/65,0.003249949134407,0.003249949134407,0,0,19935.0,114209.92613860144,SCO2
21126,KEGG_2019_Human,Endocytosis,1/244,0.0121998870519305,0.0121998870519305,0,0,19756.0,87051.4275316661,EHD3
21127,KEGG_2019_Human,Notch signaling pathway,1/48,0.0023999583567988,0.0047999167135976,0,0,19952.0,120356.5272753826,APH1A
21128,KEGG_2019_Human,Alzheimer disease,1/171,0.0085499075557634,0.0085499075557634,0,0,19829.0,94422.42241345016,APH1A
21129,KEGG_2019_Human,Cytosolic DNA-sensing pathway,1/63,0.0031499501598827,0.0128570194046101,0,0,19937.0,114844.46974572667,IRF3
21130,KEGG_2019_Human,RIG-I-like receptor signaling pathway,1/70,0.0034999466296654,0.0128570194046101,0,0,19930.0,112704.30065625212,IRF3
21131,KEGG_2019_Human,Pertussis,1/76,0.0037999437281752,0.0128570194046101,0,0,19924.0,111031.8499691117,IRF3
21132,KEGG_2019_Human,Toll-like receptor signaling pathway,1/104,0.0051999314202997,0.0128570194046101,0,0,19896.0,104635.24941415618,IRF3
21133,KEGG_2019_Human,Measles,1/138,0.0068999185254481,0.0128570194046101,0,0,19862.0,98838.19160389496,IRF3
21134,KEGG_2019_Human,Hepatitis C,1/155,0.0077499127120574,0.0128570194046101,0,0,19845.0,96448.16254952336,IRF3
21135,KEGG_2019_Human,Hepatitis B,1/163,0.0081499100978668,0.0128570194046101,0,0,19837.0,95410.9786681514,IRF3
21136,KEGG_2019_Human,Influenza A,1/171,0.0085499075557634,0.0128570194046101,0,0,19829.0,94422.42241345016,IRF3
21137,KEGG_2019_Human,NOD-like receptor signaling pathway,1/178,0.0088999053857096,0.0128570194046101,0,0,19822.0,93593.82745769851,IRF3
21138,KEGG_2019_Human,Kaposi sarcoma-associated herpesvirus infection,1/186,0.0092999029651357,0.0128570194046101,0,0,19814.0,92684.96451050608,IRF3
21139,KEGG_2019_Human,Viral carcinogenesis,1/201,0.0100498985877989,0.0128570194046101,0,0,19799.0,91079.21596609056,IRF3
21140,KEGG_2019_Human,Epstein-Barr virus infection,1/201,0.0100498985877989,0.0128570194046101,0,0,19799.0,91079.21596609056,IRF3
21141,KEGG_2019_Human,Human immunodeficiency virus 1 infection,1/212,0.0105998955026255,0.0128570194046101,0,0,19788.0,89974.27756224656,IRF3
21142,KEGG_2019_Human,Human cytomegalovirus infection,1/225,0.0112498919790339,0.0128570194046101,0,0,19775.0,88738.27077557483,IRF3
21143,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0175998586228954,0,0,19670.0,80733.60565076157,IRF3
21144,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,IRF3
21145,KEGG_2019_Human,Basal cell carcinoma,1/63,0.0031499501598827,0.0109198810514423,0,0,19937.0,114844.46974572667,WNT7A
21146,KEGG_2019_Human,Melanogenesis,1/101,0.0050499326546803,0.0109198810514423,0,0,19899.0,105233.48101229242,WNT7A
21147,KEGG_2019_Human,Signaling pathways regulating pluripotency of stem cells,1/139,0.006949918172816,0.0109198810514423,0,0,19861.0,98689.81333375497,WNT7A
21148,KEGG_2019_Human,Breast cancer,1/147,0.0073499154017982,0.0109198810514423,0,0,19853.0,97539.10874372096,WNT7A
21149,KEGG_2019_Human,Gastric cancer,1/149,0.0074499147221605,0.0109198810514423,0,0,19851.0,97261.02051561224,WNT7A
21150,KEGG_2019_Human,mTOR signaling pathway,1/152,0.0075999137114971,0.0109198810514423,0,0,19848.0,96850.665715497,WNT7A
21151,KEGG_2019_Human,Cushing syndrome,1/155,0.0077499127120574,0.0109198810514423,0,0,19845.0,96448.16254952336,WNT7A
21152,KEGG_2019_Human,Wnt signaling pathway,1/158,0.0078999117225733,0.0109198810514423,0,0,19842.0,96053.2110949472,WNT7A
21153,KEGG_2019_Human,Hippo signaling pathway,1/160,0.0079999110688441,0.0109198810514423,0,0,19840.0,95793.96509856998,WNT7A
21154,KEGG_2019_Human,Hepatocellular carcinoma,1/168,0.0083999085011095,0.0109198810514423,0,0,19832.0,94787.72752807094,WNT7A
21155,KEGG_2019_Human,Proteoglycans in cancer,1/201,0.0100498985877989,0.0118771528764897,0,0,19799.0,91079.21596609056,WNT7A
21156,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0178748564138782,0,0,19670.0,80733.60565076157,WNT7A
21157,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,WNT7A
21158,KEGG_2019_Human,Arrhythmogenic right ventricular cardiomyopathy (ARVC),1/72,0.0035999456502131,0.0060665825429376,0,0,19928.0,112131.59838572376,LMNA
21159,KEGG_2019_Human,Hypertrophic cardiomyopathy (HCM),1/85,0.004249939567045,0.0060665825429376,0,0,19915.0,108752.83801948265,LMNA
21160,KEGG_2019_Human,Dilated cardiomyopathy (DCM),1/91,0.0045499369072032,0.0060665825429376,0,0,19909.0,107362.10783923086,LMNA
21161,KEGG_2019_Human,Apoptosis,1/143,0.0071499167770442,0.0071499167770442,0,0,19857.0,98106.57763600958,LMNA
21162,KEGG_2019_Human,Glyoxylate and dicarboxylate metabolism,1/30,0.0014999697593334,0.0014999697593334,0,0,19970.0,129851.13732048514,ACO2
21163,KEGG_2019_Human,Citrate cycle (TCA cycle),1/30,0.0014999697593334,0.0014999697593334,0,0,19970.0,129851.13732048514,ACO2
21164,KEGG_2019_Human,Phosphatidylinositol signaling system,1/99,0.0049499334884068,0.0049499334884068,0,0,19901.0,105642.09305076736,IP6K1
21165,KEGG_2019_Human,Estrogen signaling pathway,1/137,0.0068499188797651,0.0068499188797651,0,0,19863.0,98987.62735269018,KRT23
21166,KEGG_2019_Human,RNA degradation,1/79,0.0039499423167337,0.0039499423167337,0,0,19921.0,110243.89578070649,CNOT3
21167,KEGG_2019_Human,Hippo signaling pathway,1/160,0.0079999110688441,0.0079999110688441,0,0,19840.0,95793.96509856998,TEAD2
21168,KEGG_2019_Human,Fructose and mannose metabolism,1/33,0.0016499677032113,0.0032999354064227,0,0,19967.0,127928.56031580272,PFKFB4
21169,KEGG_2019_Human,AMPK signaling pathway,1/120,0.0059999251180858,0.0059999251180858,0,0,19880.0,101706.2448082016,PFKFB4
21170,KEGG_2019_Human,Peroxisome,1/83,0.0041499404726918,0.0041499404726918,0,0,19917.0,109237.99888847338,PEX16
21171,KEGG_2019_Human,JAK-STAT signaling pathway,1/162,0.0080999104202618,0.0176998626413668,0,0,19838.0,95537.86936302872,CSH2
21172,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0176998626413668,0,0,19706.0,83157.67014793828,CSH2
21173,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0176998626413668,0,0,19662.0,80229.79996326564,CSH2
21174,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0176998626413668,0,0,19646.0,79255.8617626126,CSH2
21175,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF548
21176,KEGG_2019_Human,Progesterone-mediated oocyte maturation,1/99,0.0049499334884068,0.0085623985997064,0,0,19901.0,105642.09305076736,ANAPC7
21177,KEGG_2019_Human,Cell cycle,1/124,0.0061999236097501,0.0085623985997064,0,0,19876.0,101034.04709010696,ANAPC7
21178,KEGG_2019_Human,Oocyte meiosis,1/125,0.0062499232373748,0.0085623985997064,0,0,19875.0,100869.32368441945,ANAPC7
21179,KEGG_2019_Human,Ubiquitin mediated proteolysis,1/137,0.0068499188797651,0.0085623985997064,0,0,19863.0,98987.62735269018,ANAPC7
21180,KEGG_2019_Human,Human T-cell leukemia virus 1 infection,1/219,0.0109498935894162,0.0109498935894162,0,0,19781.0,89299.85161916987,ANAPC7
21181,KEGG_2019_Human,C-type lectin receptor signaling pathway,1/104,0.0051999314202997,0.0089499050800561,0,0,19896.0,104635.24941415618,CD209
21182,KEGG_2019_Human,Measles,1/138,0.0068999185254481,0.0089499050800561,0,0,19862.0,98838.19160389496,CD209
21183,KEGG_2019_Human,Phagosome,1/152,0.0075999137114971,0.0089499050800561,0,0,19848.0,96850.665715497,CD209
21184,KEGG_2019_Human,Tuberculosis,1/179,0.0089499050800561,0.0089499050800561,0,0,19821.0,93478.0629355712,CD209
21185,KEGG_2019_Human,RNA degradation,1/79,0.0039499423167337,0.0066999199497742,0,0,19921.0,110243.89578070649,LSM7
21186,KEGG_2019_Human,Spliceosome,1/134,0.0066999199497742,0.0066999199497742,0,0,19866.0,99442.43560916925,LSM7
21187,KEGG_2019_Human,Primary bile acid biosynthesis,1/17,0.0008499797390404818,0.0008499797390404818,0,0,19983.0,141285.76583697114,HSD3B7
21188,KEGG_2019_Human,Ubiquitin mediated proteolysis,1/137,0.0068499188797651,0.0068499188797651,0,0,19863.0,98987.62735269018,UBE2E2
21189,KEGG_2019_Human,Taurine and hypotaurine metabolism,1/11,0.0005499852259717758,0.0010999704519435,0,0,19989.0,150029.8210287992,GGT7
21190,KEGG_2019_Human,Glutathione metabolism,1/56,0.0027999538675741,0.0027999538675741,0,0,19944.0,117233.87022514464,GGT7
21191,KEGG_2019_Human,PPAR signaling pathway,1/74,0.0036999446830449,0.0036999446830449,0,0,19926.0,111574.38983110404,FABP6
21192,KEGG_2019_Human,Ubiquitin mediated proteolysis,1/137,0.0068499188797651,0.0068499188797651,0,0,19863.0,98987.62735269018,UBE2U
21193,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0146998751759735,0,0,19706.0,83157.67014793828,GDF15
21194,KEGG_2019_Human,Glycosaminoglycan degradation,1/19,0.00094997806231055,0.0034999365518787,0,0,19981.0,139049.2109571672,GUSB
21195,KEGG_2019_Human,Pentose and glucuronate interconversions,1/34,0.0016999670339032,0.0034999365518787,0,0,19966.0,127326.1054203148,GUSB
21196,KEGG_2019_Human,Porphyrin and chlorophyll metabolism,1/42,0.0020999619311272,0.0034999365518787,0,0,19958.0,123057.75613441122,GUSB
21197,KEGG_2019_Human,Drug metabolism,1/108,0.0053999298011749,0.0061499239842961,0,0,19892.0,103863.47861844616,GUSB
21198,KEGG_2019_Human,Lysosome,1/123,0.0061499239842961,0.0061499239842961,0,0,19877.0,101200.07933676826,GUSB
21199,KEGG_2019_Human,Other types of O-glycan biosynthesis,1/22,0.0010999756574123,0.0010999756574123,0,0,19978.0,136099.47030191717,POFUT2
21200,KEGG_2019_Human,JAK-STAT signaling pathway,1/162,0.0080999104202618,0.0146998751759735,0,0,19838.0,95537.86936302872,IL19
21201,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0146998751759735,0,0,19706.0,83157.67014793828,IL19
21202,KEGG_2019_Human,African trypanosomiasis,1/37,0.0018499650702878,0.0018499650702878,0,0,19963.0,125618.9446446357,APOL1
21203,KEGG_2019_Human,Amino sugar and nucleotide sugar metabolism,1/48,0.0023999583567988,0.0023999583567988,0,0,19952.0,120356.5272753826,CYB5R2
21204,KEGG_2019_Human,Fat digestion and absorption,1/41,0.0020499625466866,0.0036999446830449,0,0,19959.0,123544.88783416104,FABP1
21205,KEGG_2019_Human,PPAR signaling pathway,1/74,0.0036999446830449,0.0036999446830449,0,0,19926.0,111574.38983110404,FABP1
21206,KEGG_2019_Human,Oxidative phosphorylation,1/133,0.0066499203093911,0.0066499203093911,0,0,19867.0,99596.2591544721,PPA1
21207,KEGG_2019_Human,Fatty acid elongation,1/27,0.0013499718942362,0.0013499718942362,0,0,19973.0,131975.02298599784,THEM5
21208,KEGG_2019_Human,Notch signaling pathway,1/48,0.0023999583567988,0.0114998411799664,0,0,19952.0,120356.5272753826,RBPJL
21209,KEGG_2019_Human,Th1 and Th2 cell differentiation,1/92,0.0045999364719865,0.0114998411799664,0,0,19908.0,107139.13814408927,RBPJL
21210,KEGG_2019_Human,Epstein-Barr virus infection,1/201,0.0100498985877989,0.0125623732347487,0,0,19799.0,91079.21596609056,RBPJL
21211,KEGG_2019_Human,Viral carcinogenesis,1/201,0.0100498985877989,0.0125623732347487,0,0,19799.0,91079.21596609056,RBPJL
21212,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0164998674589645,0,0,19670.0,80733.60565076157,RBPJL
21213,KEGG_2019_Human,Endocytosis,1/244,0.0121998870519305,0.0121998870519305,0,0,19756.0,87051.4275316661,CAPZA3
21214,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR13J1
21215,KEGG_2019_Human,Ferroptosis,1/40,0.0019999631680592,0.0019999631680592,0,0,19960.0,124043.94523066044,SLC39A8
21216,KEGG_2019_Human,Mucin type O-glycan biosynthesis,1/31,0.0015499690656704,0.0026499555173137,0,0,19969.0,129189.85098816035,ST3GAL1
21217,KEGG_2019_Human,Glycosphingolipid biosynthesis,1/45,0.0022499601197094,0.0026499555173137,0,0,19955.0,121662.49782449217,ST3GAL1
21218,KEGG_2019_Human,Glycosaminoglycan biosynthesis,1/53,0.0026499555173137,0.0026499555173137,0,0,19947.0,118349.78824235698,ST3GAL1
21219,KEGG_2019_Human,Serotonergic synapse,1/113,0.0056499278191151,0.0141331940035007,0,0,19887.0,102937.34947211576,HTR6
21220,KEGG_2019_Human,Calcium signaling pathway,1/188,0.009399902370135,0.0141331940035007,0,0,19812.0,92463.712994847,HTR6
21221,KEGG_2019_Human,cAMP signaling pathway,1/212,0.0105998955026255,0.0141331940035007,0,0,19788.0,89974.27756224656,HTR6
21222,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,HTR6
21223,KEGG_2019_Human,Caffeine metabolism,1/5,0.0002499917995416556,0.0007499753986249669,0,0,19995.0,165840.17843725558,NAT2
21224,KEGG_2019_Human,Chemical carcinogenesis,1/82,0.004099940929819,0.0053999298011749,0,0,19918.0,109484.9180722932,NAT2
21225,KEGG_2019_Human,Drug metabolism,1/108,0.0053999298011749,0.0053999298011749,0,0,19892.0,103863.47861844616,NAT2
21226,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR6N2
21227,KEGG_2019_Human,ErbB signaling pathway,1/85,0.004249939567045,0.0107498477934666,0,0,19915.0,108752.83801948265,AREG
21228,KEGG_2019_Human,Colorectal cancer,1/86,0.0042999391173866,0.0107498477934666,0,0,19914.0,108514.46102290176,AREG
21229,KEGG_2019_Human,Hippo signaling pathway,1/160,0.0079999110688441,0.0133331851147402,0,0,19840.0,95793.96509856998,AREG
21230,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0176998626413668,0,0,19705.0,83086.53988020132,AREG
21231,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0176998626413668,0,0,19646.0,79255.8617626126,AREG
21232,KEGG_2019_Human,Glyoxylate and dicarboxylate metabolism,1/30,0.0014999697593334,0.0026666175574123,0,0,19970.0,129851.13732048514,AGXT
21233,KEGG_2019_Human,"Alanine, aspartate and glutamate metabolism",1/35,0.0017499663721595,0.0026666175574123,0,0,19965.0,126740.98858805298,AGXT
21234,KEGG_2019_Human,"Glycine, serine and threonine metabolism",1/40,0.0019999631680592,0.0026666175574123,0,0,19960.0,124043.94523066044,AGXT
21235,KEGG_2019_Human,Peroxisome,1/83,0.0041499404726918,0.0041499404726918,0,0,19917.0,109237.99888847338,AGXT
21236,KEGG_2019_Human,Leishmaniasis,1/74,0.0036999446830449,0.0075999137114971,0,0,19926.0,111574.38983110404,NCF4
21237,KEGG_2019_Human,Leukocyte transendothelial migration,1/112,0.0055999282120529,0.0075999137114971,0,0,19888.0,103119.30984392198,NCF4
21238,KEGG_2019_Human,Osteoclast differentiation,1/127,0.0063499224962247,0.0075999137114971,0,0,19873.0,100543.72072014232,NCF4
21239,KEGG_2019_Human,Phagosome,1/152,0.0075999137114971,0.0075999137114971,0,0,19848.0,96850.665715497,NCF4
21240,KEGG_2019_Human,Cardiac muscle contraction,1/78,0.0038999427840466,0.0060665825429376,0,0,19922.0,110503.2180492851,TNNT2
21241,KEGG_2019_Human,Hypertrophic cardiomyopathy (HCM),1/85,0.004249939567045,0.0060665825429376,0,0,19915.0,108752.83801948265,TNNT2
21242,KEGG_2019_Human,Dilated cardiomyopathy (DCM),1/91,0.0045499369072032,0.0060665825429376,0,0,19909.0,107362.10783923086,TNNT2
21243,KEGG_2019_Human,Adrenergic signaling in cardiomyocytes,1/145,0.0072499160871101,0.0072499160871101,0,0,19855.0,97820.92670675044,TNNT2
21244,KEGG_2019_Human,JAK-STAT signaling pathway,1/162,0.0080999104202618,0.0220498127639602,0,0,19838.0,95537.86936302872,IL13RA1
21245,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0220498127639602,0,0,19706.0,83157.67014793828,IL13RA1
21246,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,IL13RA1
21247,KEGG_2019_Human,Taste transduction,1/83,0.0041499404726918,0.0112998556382303,0,0,19917.0,109237.99888847338,HTR1D
21248,KEGG_2019_Human,Serotonergic synapse,1/113,0.0056499278191151,0.0112998556382303,0,0,19887.0,102937.34947211576,HTR1D
21249,KEGG_2019_Human,cAMP signaling pathway,1/212,0.0105998955026255,0.0141331940035007,0,0,19788.0,89974.27756224656,HTR1D
21250,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,HTR1D
21251,KEGG_2019_Human,Vasopressin-regulated water reabsorption,1/44,0.0021999607179423,0.0021999607179423,0,0,19956.0,122117.06559109331,AQP3
21252,KEGG_2019_Human,Ferroptosis,1/40,0.0019999631680592,0.0027999538675741,0,0,19960.0,124043.94523066044,GCLC
21253,KEGG_2019_Human,Cysteine and methionine metabolism,1/47,0.0023499589392381,0.0027999538675741,0,0,19953.0,120782.64067395544,GCLC
21254,KEGG_2019_Human,Glutathione metabolism,1/56,0.0027999538675741,0.0027999538675741,0,0,19944.0,117233.87022514464,GCLC
21255,KEGG_2019_Human,Protein processing in endoplasmic reticulum,1/165,0.0082499094553477,0.0082499094553477,0,0,19835.0,95159.46482222488,UBQLN4
21256,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR5B21
21257,KEGG_2019_Human,Tyrosine metabolism,1/36,0.0017999657178272,0.0044999275889791,0,0,19964.0,126172.23364250171,LRTOMT
21258,KEGG_2019_Human,Steroid hormone biosynthesis,1/60,0.002999951725986,0.0044999275889791,0,0,19940.0,115834.63209072244,LRTOMT
21259,KEGG_2019_Human,Dopaminergic synapse,1/131,0.0065499210316603,0.0065499210316603,0,0,19869.0,99907.33811343512,LRTOMT
21260,KEGG_2019_Human,Fatty acid elongation,1/27,0.0013499718942362,0.0026999437884725,0,0,19973.0,131975.02298599784,PPT1
21261,KEGG_2019_Human,Lysosome,1/123,0.0061499239842961,0.0061499239842961,0,0,19877.0,101200.07933676826,PPT1
21262,KEGG_2019_Human,Human immunodeficiency virus 1 infection,1/212,0.0105998955026255,0.0105998955026255,0,0,19788.0,89974.27756224656,APOBEC3D
21263,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF404
21264,KEGG_2019_Human,Fc epsilon RI signaling pathway,1/68,0.0033999476216189,0.0115960368320757,0,0,19932.0,113293.39338050144,SYK
21265,KEGG_2019_Human,B cell receptor signaling pathway,1/71,0.0035499461386618,0.0115960368320757,0,0,19929.0,112415.9585341616,SYK
21266,KEGG_2019_Human,Fc gamma R-mediated phagocytosis,1/91,0.0045499369072032,0.0115960368320757,0,0,19909.0,107362.10783923086,SYK
21267,KEGG_2019_Human,NF-kappa B signaling pathway,1/95,0.0047499351803394,0.0115960368320757,0,0,19905.0,106484.27183626965,SYK
21268,KEGG_2019_Human,C-type lectin receptor signaling pathway,1/104,0.0051999314202997,0.0115960368320757,0,0,19896.0,104635.24941415618,SYK
21269,KEGG_2019_Human,Platelet activation,1/124,0.0061999236097501,0.0115960368320757,0,0,19876.0,101034.04709010696,SYK
21270,KEGG_2019_Human,Osteoclast differentiation,1/127,0.0063499224962247,0.0115960368320757,0,0,19873.0,100543.72072014232,SYK
21271,KEGG_2019_Human,Natural killer cell mediated cytotoxicity,1/131,0.0065499210316603,0.0115960368320757,0,0,19869.0,99907.33811343512,SYK
21272,KEGG_2019_Human,Phospholipase D signaling pathway,1/148,0.007399915061391,0.0115960368320757,0,0,19852.0,97399.60470052566,SYK
21273,KEGG_2019_Human,Tuberculosis,1/179,0.0089499050800561,0.0115960368320757,0,0,19821.0,93478.0629355712,SYK
21274,KEGG_2019_Human,Kaposi sarcoma-associated herpesvirus infection,1/186,0.0092999029651357,0.0115960368320757,0,0,19814.0,92684.96451050608,SYK
21275,KEGG_2019_Human,Viral carcinogenesis,1/201,0.0100498985877989,0.0115960368320757,0,0,19799.0,91079.21596609056,SYK
21276,KEGG_2019_Human,Epstein-Barr virus infection,1/201,0.0100498985877989,0.0115960368320757,0,0,19799.0,91079.21596609056,SYK
21277,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0189641385443216,0,0,19646.0,79255.8617626126,SYK
21278,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,SYK
21279,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF583
21280,KEGG_2019_Human,Cysteine and methionine metabolism,1/47,0.0023499589392381,0.0023499589392381,0,0,19953.0,120782.64067395544,BHMT2
21281,KEGG_2019_Human,Alzheimer disease,1/171,0.0085499075557634,0.0085499075557634,0,0,19829.0,94422.42241345016,NAE1
21282,KEGG_2019_Human,Leukocyte transendothelial migration,1/112,0.0055999282120529,0.0084999078692823,0,0,19888.0,103119.30984392198,CLDN15
21283,KEGG_2019_Human,Cell adhesion molecules (CAMs),1/145,0.0072499160871101,0.0084999078692823,0,0,19855.0,97820.92670675044,CLDN15
21284,KEGG_2019_Human,Hepatitis C,1/155,0.0077499127120574,0.0084999078692823,0,0,19845.0,96448.16254952336,CLDN15
21285,KEGG_2019_Human,Tight junction,1/170,0.0084999078692823,0.0084999078692823,0,0,19830.0,94543.49009679438,CLDN15
21286,KEGG_2019_Human,Rheumatoid arthritis,1/91,0.0045499369072032,0.0071499167770442,0,0,19909.0,107362.10783923086,CTSK
21287,KEGG_2019_Human,Toll-like receptor signaling pathway,1/104,0.0051999314202997,0.0071499167770442,0,0,19896.0,104635.24941415618,CTSK
21288,KEGG_2019_Human,Lysosome,1/123,0.0061499239842961,0.0071499167770442,0,0,19877.0,101200.07933676826,CTSK
21289,KEGG_2019_Human,Osteoclast differentiation,1/127,0.0063499224962247,0.0071499167770442,0,0,19873.0,100543.72072014232,CTSK
21290,KEGG_2019_Human,Apoptosis,1/143,0.0071499167770442,0.0071499167770442,0,0,19857.0,98106.57763600958,CTSK
21291,KEGG_2019_Human,Proteoglycans in cancer,1/201,0.0100498985877989,0.0100498985877989,0,0,19799.0,91079.21596609056,NUDT16L1
21292,KEGG_2019_Human,alpha-Linolenic acid metabolism,1/25,0.0012499733663791,0.0052874076132858,0,0,19975.0,133525.54486996148,PLA2G2C
21293,KEGG_2019_Human,Linoleic acid metabolism,1/29,0.001449970461791,0.0052874076132858,0,0,19971.0,130534.69172799008,PLA2G2C
21294,KEGG_2019_Human,Fat digestion and absorption,1/41,0.0020499625466866,0.0052874076132858,0,0,19959.0,123544.88783416104,PLA2G2C
21295,KEGG_2019_Human,Ether lipid metabolism,1/47,0.0023499589392381,0.0052874076132858,0,0,19953.0,120782.64067395544,PLA2G2C
21296,KEGG_2019_Human,Arachidonic acid metabolism,1/63,0.0031499501598827,0.005669910287789,0,0,19937.0,114844.46974572667,PLA2G2C
21297,KEGG_2019_Human,Glycerophospholipid metabolism,1/97,0.0048499343304706,0.0062999150247102,0,0,19903.0,106058.9096435903,PLA2G2C
21298,KEGG_2019_Human,Pancreatic secretion,1/98,0.0048999339081079,0.0062999150247102,0,0,19902.0,105849.45495286948,PLA2G2C
21299,KEGG_2019_Human,Vascular smooth muscle contraction,1/132,0.0065999206698993,0.0074249107536368,0,0,19868.0,99751.22090491928,PLA2G2C
21300,KEGG_2019_Human,Ras signaling pathway,1/232,0.0115998901349604,0.0115998901349604,0,0,19768.0,88101.22480150245,PLA2G2C
21301,KEGG_2019_Human,Glycosaminoglycan biosynthesis,1/53,0.0026499555173137,0.0026499555173137,0,0,19947.0,118349.78824235698,B3GAT3
21302,KEGG_2019_Human,Long-term depression,1/60,0.002999951725986,0.0138331818939554,0,0,19940.0,115834.63209072244,GNA12
21303,KEGG_2019_Human,"Parathyroid hormone synthesis, secretion and action",1/106,0.0052999306076525,0.0138331818939554,0,0,19894.0,104245.78450366124,GNA12
21304,KEGG_2019_Human,Sphingolipid signaling pathway,1/119,0.0059499254985137,0.0138331818939554,0,0,19881.0,101877.73080211312,GNA12
21305,KEGG_2019_Human,Vascular smooth muscle contraction,1/132,0.0065999206698993,0.0138331818939554,0,0,19868.0,99751.22090491928,GNA12
21306,KEGG_2019_Human,Phospholipase D signaling pathway,1/148,0.007399915061391,0.0138331818939554,0,0,19852.0,97399.60470052566,GNA12
21307,KEGG_2019_Human,cGMP-PKG signaling pathway,1/166,0.0082999091363732,0.0138331818939554,0,0,19834.0,95034.82345515196,GNA12
21308,KEGG_2019_Human,Regulation of actin cytoskeleton,1/214,0.0106998949514067,0.0140623649737923,0,0,19786.0,89779.39753374986,GNA12
21309,KEGG_2019_Human,Human cytomegalovirus infection,1/225,0.0112498919790339,0.0140623649737923,0,0,19775.0,88738.27077557483,GNA12
21310,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0163887499485007,0,0,19705.0,83086.53988020132,GNA12
21311,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,GNA12
21312,KEGG_2019_Human,Tyrosine metabolism,1/36,0.0017999657178272,0.0044999275889791,0,0,19964.0,126172.23364250171,COMT
21313,KEGG_2019_Human,Steroid hormone biosynthesis,1/60,0.002999951725986,0.0044999275889791,0,0,19940.0,115834.63209072244,COMT
21314,KEGG_2019_Human,Dopaminergic synapse,1/131,0.0065499210316603,0.0065499210316603,0,0,19869.0,99907.33811343512,COMT
21315,KEGG_2019_Human,Arginine and proline metabolism,1/49,0.0024499577795033,0.0024499577795033,0,0,19951.0,119939.1172087114,L3HYPDH
21316,KEGG_2019_Human,Salivary secretion,1/90,0.0044999373439762,0.0044999373439762,0,0,19910.0,107587.50385474482,CST4
21317,KEGG_2019_Human,Ribosome,1/153,0.0076499133771537,0.0076499133771537,0,0,19847.0,96715.6407630817,RPL23A
21318,KEGG_2019_Human,Hedgehog signaling pathway,1/47,0.0023499589392381,0.0117898578569886,0,0,19953.0,120782.64067395544,ARRB2
21319,KEGG_2019_Human,Morphine addiction,1/91,0.0045499369072032,0.0117898578569886,0,0,19909.0,107362.10783923086,ARRB2
21320,KEGG_2019_Human,"Parathyroid hormone synthesis, secretion and action",1/106,0.0052999306076525,0.0117898578569886,0,0,19894.0,104245.78450366124,ARRB2
21321,KEGG_2019_Human,Relaxin signaling pathway,1/130,0.0064999213952527,0.0117898578569886,0,0,19870.0,100064.62842845908,ARRB2
21322,KEGG_2019_Human,Dopaminergic synapse,1/131,0.0065499210316603,0.0117898578569886,0,0,19869.0,99907.33811343512,ARRB2
21323,KEGG_2019_Human,Chemokine signaling pathway,1/190,0.0094999017791995,0.0142498526687993,0,0,19810.0,92244.74636351672,ARRB2
21324,KEGG_2019_Human,Endocytosis,1/244,0.0121998870519305,0.0156855690667678,0,0,19756.0,87051.4275316661,ARRB2
21325,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.016593609322857,0,0,19705.0,83086.53988020132,ARRB2
21326,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,ARRB2
21327,KEGG_2019_Human,Cell cycle,1/124,0.0061999236097501,0.0061999236097501,0,0,19876.0,101034.04709010696,CDC7
21328,KEGG_2019_Human,Glycosaminoglycan degradation,1/19,0.00094997806231055,0.0018999561246211,0,0,19981.0,139049.2109571672,SGSH
21329,KEGG_2019_Human,Lysosome,1/123,0.0061499239842961,0.0061499239842961,0,0,19877.0,101200.07933676826,SGSH
21330,KEGG_2019_Human,Alcoholism,1/180,0.0089999047745351,0.0089999047745351,0,0,19820.0,93362.92821536642,CAMKK1
21331,KEGG_2019_Human,Lysosome,1/123,0.0061499239842961,0.0071499167770442,0,0,19877.0,101200.07933676826,CTSW
21332,KEGG_2019_Human,Apoptosis,1/143,0.0071499167770442,0.0071499167770442,0,0,19857.0,98106.57763600958,CTSW
21333,KEGG_2019_Human,TGF-beta signaling pathway,1/90,0.0044999373439762,0.010424877259224,0,0,19910.0,107587.50385474482,INHBB
21334,KEGG_2019_Human,Signaling pathways regulating pluripotency of stem cells,1/139,0.006949918172816,0.010424877259224,0,0,19861.0,98689.81333375497,INHBB
21335,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0146998751759735,0,0,19706.0,83157.67014793828,INHBB
21336,KEGG_2019_Human,Axon guidance,1/181,0.0090499044707863,0.0090499044707863,0,0,19819.0,93248.41634586031,SEMA3B
21337,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF230
21338,KEGG_2019_Human,Taste transduction,1/83,0.0041499404726918,0.0044999373439762,0,0,19917.0,109237.99888847338,KCNK5
21339,KEGG_2019_Human,Protein digestion and absorption,1/90,0.0044999373439762,0.0044999373439762,0,0,19910.0,107587.50385474482,KCNK5
21340,KEGG_2019_Human,Gastric acid secretion,1/75,0.0037499442041125,0.0106998949514067,0,0,19925.0,111301.33528642564,MYLK4
21341,KEGG_2019_Human,Platelet activation,1/124,0.0061999236097501,0.0106998949514067,0,0,19876.0,101034.04709010696,MYLK4
21342,KEGG_2019_Human,Vascular smooth muscle contraction,1/132,0.0065999206698993,0.0106998949514067,0,0,19868.0,99751.22090491928,MYLK4
21343,KEGG_2019_Human,Apelin signaling pathway,1/137,0.0068499188797651,0.0106998949514067,0,0,19863.0,98987.62735269018,MYLK4
21344,KEGG_2019_Human,Oxytocin signaling pathway,1/153,0.0076499133771537,0.0106998949514067,0,0,19847.0,96715.6407630817,MYLK4
21345,KEGG_2019_Human,cGMP-PKG signaling pathway,1/166,0.0082999091363732,0.0106998949514067,0,0,19834.0,95034.82345515196,MYLK4
21346,KEGG_2019_Human,Calcium signaling pathway,1/188,0.009399902370135,0.0106998949514067,0,0,19812.0,92463.712994847,MYLK4
21347,KEGG_2019_Human,Focal adhesion,1/199,0.0099498991610159,0.0106998949514067,0,0,19801.0,91286.4288690606,MYLK4
21348,KEGG_2019_Human,Regulation of actin cytoskeleton,1/214,0.0106998949514067,0.0106998949514067,0,0,19786.0,89779.39753374986,MYLK4
21349,KEGG_2019_Human,Sphingolipid metabolism,1/47,0.0023499589392381,0.0046999178784763,0,0,19953.0,120782.64067395544,CERS2
21350,KEGG_2019_Human,Sphingolipid signaling pathway,1/119,0.0059499254985137,0.0059499254985137,0,0,19881.0,101877.73080211312,CERS2
21351,KEGG_2019_Human,Primary immunodeficiency,1/37,0.0018499650702878,0.0055498952108636,0,0,19963.0,125618.9446446357,RFXAP
21352,KEGG_2019_Human,Antigen processing and presentation,1/77,0.0038499432547502,0.0057749148821253,0,0,19923.0,110765.8407373636,RFXAP
21353,KEGG_2019_Human,Tuberculosis,1/179,0.0089499050800561,0.0089499050800561,0,0,19821.0,93478.0629355712,RFXAP
21354,KEGG_2019_Human,Ubiquitin mediated proteolysis,1/137,0.0068499188797651,0.0068499188797651,0,0,19863.0,98987.62735269018,CDC34
21355,KEGG_2019_Human,mRNA surveillance pathway,1/91,0.0045499369072032,0.0045499369072032,0,0,19909.0,107362.10783923086,CSTF1
21356,KEGG_2019_Human,Adherens junction,1/72,0.0035999456502131,0.0035999456502131,0,0,19928.0,112131.59838572376,YES1
21357,KEGG_2019_Human,Ribosome biogenesis in eukaryotes,1/101,0.0050499326546803,0.0076499133771537,0,0,19899.0,105233.48101229242,RNA5S17
21358,KEGG_2019_Human,Ribosome,1/153,0.0076499133771537,0.0076499133771537,0,0,19847.0,96715.6407630817,RNA5S17
21359,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,KISS1R
21360,KEGG_2019_Human,Measles,1/138,0.0068999185254481,0.0068999185254481,0,0,19862.0,98838.19160389496,RAB9B
21361,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0147498749536506,0,0,19705.0,83086.53988020132,PPM1A
21362,KEGG_2019_Human,Necroptosis,1/162,0.0080999104202618,0.0121998870519305,0,0,19838.0,95537.86936302872,CHMP2B
21363,KEGG_2019_Human,Endocytosis,1/244,0.0121998870519305,0.0121998870519305,0,0,19756.0,87051.4275316661,CHMP2B
21364,KEGG_2019_Human,Axon guidance,1/181,0.0090499044707863,0.0090499044707863,0,0,19819.0,93248.41634586031,SEMA3G
21365,KEGG_2019_Human,beta-Alanine metabolism,1/31,0.0015499690656704,0.00239995257067,0,0,19969.0,129189.85098816035,HIBCH
21366,KEGG_2019_Human,Propanoate metabolism,1/32,0.0015999683804467,0.00239995257067,0,0,19968.0,128549.41955786056,HIBCH
21367,KEGG_2019_Human,"Valine, leucine and isoleucine degradation",1/48,0.0023999583567988,0.0023999583567988,0,0,19952.0,120356.5272753826,HIBCH
21368,KEGG_2019_Human,DNA replication,1/36,0.0017999657178272,0.0017999657178272,0,0,19964.0,126172.23364250171,PRIM2
21369,KEGG_2019_Human,Spliceosome,1/134,0.0066999199497742,0.0066999199497742,0,0,19866.0,99442.43560916925,PRPF18
21370,KEGG_2019_Human,JAK-STAT signaling pathway,1/162,0.0080999104202618,0.0146998751759735,0,0,19838.0,95537.86936302872,CRLF2
21371,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0146998751759735,0,0,19706.0,83157.67014793828,CRLF2
21372,KEGG_2019_Human,Lysosome,1/123,0.0061499239842961,0.0071499167770442,0,0,19877.0,101200.07933676826,CTSZ
21373,KEGG_2019_Human,Apoptosis,1/143,0.0071499167770442,0.0071499167770442,0,0,19857.0,98106.57763600958,CTSZ
21374,KEGG_2019_Human,Asthma,1/31,0.0015499690656704,0.0098873736834515,0,0,19969.0,129189.85098816035,TNF
21375,KEGG_2019_Human,African trypanosomiasis,1/37,0.0018499650702878,0.0098873736834515,0,0,19963.0,125618.9446446357,TNF
21376,KEGG_2019_Human,Allograft rejection,1/38,0.001899964429635,0.0098873736834515,0,0,19962.0,125080.29732025368,TNF
21377,KEGG_2019_Human,Graft-versus-host disease,1/41,0.0020499625466866,0.0098873736834515,0,0,19959.0,123544.88783416104,TNF
21378,KEGG_2019_Human,Type I diabetes mellitus,1/43,0.0021499613216957,0.0098873736834515,0,0,19957.0,122581.98940490963,TNF
21379,KEGG_2019_Human,Type II diabetes mellitus,1/46,0.0022999595269283,0.0098873736834515,0,0,19954.0,121217.8313311442,TNF
21380,KEGG_2019_Human,Malaria,1/49,0.0024499577795033,0.0098873736834515,0,0,19951.0,119939.1172087114,TNF
21381,KEGG_2019_Human,Amyotrophic lateral sclerosis (ALS),1/51,0.0025499566390179,0.0098873736834515,0,0,19949.0,119129.0228601236,TNF
21382,KEGG_2019_Human,Legionellosis,1/55,0.0027499544131125,0.0098873736834515,0,0,19945.0,117599.1294878737,TNF
21383,KEGG_2019_Human,Inflammatory bowel disease (IBD),1/65,0.003249949134407,0.0098873736834515,0,0,19935.0,114209.92613860144,TNF
21384,KEGG_2019_Human,Fc epsilon RI signaling pathway,1/68,0.0033999476216189,0.0098873736834515,0,0,19932.0,113293.39338050144,TNF
21385,KEGG_2019_Human,Adipocytokine signaling pathway,1/69,0.003449947123837,0.0098873736834515,0,0,19931.0,112996.7391397682,TNF
21386,KEGG_2019_Human,RIG-I-like receptor signaling pathway,1/70,0.0034999466296654,0.0098873736834515,0,0,19930.0,112704.30065625212,TNF
21387,KEGG_2019_Human,Leishmaniasis,1/74,0.0036999446830449,0.0098873736834515,0,0,19926.0,111574.38983110404,TNF
21388,KEGG_2019_Human,Pertussis,1/76,0.0037999437281752,0.0098873736834515,0,0,19924.0,111031.8499691117,TNF
21389,KEGG_2019_Human,Antigen processing and presentation,1/77,0.0038499432547502,0.0098873736834515,0,0,19923.0,110765.8407373636,TNF
21390,KEGG_2019_Human,Hypertrophic cardiomyopathy (HCM),1/85,0.004249939567045,0.0098873736834515,0,0,19915.0,108752.83801948265,TNF
21391,KEGG_2019_Human,TGF-beta signaling pathway,1/90,0.0044999373439762,0.0098873736834515,0,0,19910.0,107587.50385474482,TNF
21392,KEGG_2019_Human,Dilated cardiomyopathy (DCM),1/91,0.0045499369072032,0.0098873736834515,0,0,19909.0,107362.10783923086,TNF
21393,KEGG_2019_Human,Rheumatoid arthritis,1/91,0.0045499369072032,0.0098873736834515,0,0,19909.0,107362.10783923086,TNF
21394,KEGG_2019_Human,IL-17 signaling pathway,1/93,0.0046499360391879,0.0098873736834515,0,0,19907.0,106918.54242106884,TNF
21395,KEGG_2019_Human,NF-kappa B signaling pathway,1/95,0.0047499351803394,0.0098873736834515,0,0,19905.0,106484.27183626965,TNF
21396,KEGG_2019_Human,Amoebiasis,1/96,0.0047999347538706,0.0098873736834515,0,0,19904.0,106270.50039849174,TNF
21397,KEGG_2019_Human,Hematopoietic cell lineage,1/97,0.0048499343304706,0.0098873736834515,0,0,19903.0,106058.9096435903,TNF
21398,KEGG_2019_Human,AGE-RAGE signaling pathway in diabetic complications,1/100,0.0049999330710556,0.0098873736834515,0,0,19900.0,105436.78197328727,TNF
21399,KEGG_2019_Human,T cell receptor signaling pathway,1/101,0.0050499326546803,0.0098873736834515,0,0,19899.0,105233.48101229242,TNF
21400,KEGG_2019_Human,Chagas disease (American trypanosomiasis),1/103,0.0051499318302617,0.0098873736834515,0,0,19897.0,104832.7525292024,TNF
21401,KEGG_2019_Human,Toll-like receptor signaling pathway,1/104,0.0051999314202997,0.0098873736834515,0,0,19896.0,104635.24941415618,TNF
21402,KEGG_2019_Human,C-type lectin receptor signaling pathway,1/104,0.0051999314202997,0.0098873736834515,0,0,19896.0,104635.24941415618,TNF
21403,KEGG_2019_Human,Insulin resistance,1/108,0.0053999298011749,0.0098873736834515,0,0,19892.0,103863.47861844616,TNF
21404,KEGG_2019_Human,TNF signaling pathway,1/110,0.0054999290027479,0.0098873736834515,0,0,19890.0,103488.06969787036,TNF
21405,KEGG_2019_Human,Toxoplasmosis,1/113,0.0056499278191151,0.0098873736834515,0,0,19887.0,102937.34947211576,TNF
21406,KEGG_2019_Human,Sphingolipid signaling pathway,1/119,0.0059499254985137,0.0100968432702051,0,0,19881.0,101877.73080211312,TNF
21407,KEGG_2019_Human,Osteoclast differentiation,1/127,0.0063499224962247,0.0103443204812751,0,0,19873.0,100543.72072014232,TNF
21408,KEGG_2019_Human,Natural killer cell mediated cytotoxicity,1/131,0.0065499210316603,0.0103443204812751,0,0,19869.0,99907.33811343512,TNF
21409,KEGG_2019_Human,Systemic lupus erythematosus,1/133,0.0066499203093911,0.0103443204812751,0,0,19867.0,99596.2591544721,TNF
21410,KEGG_2019_Human,Fluid shear stress and atherosclerosis,1/139,0.006949918172816,0.0105187950723702,0,0,19861.0,98689.81333375497,TNF
21411,KEGG_2019_Human,Apoptosis,1/143,0.0071499167770442,0.0105367194609072,0,0,19857.0,98106.57763600958,TNF
21412,KEGG_2019_Human,Non-alcoholic fatty liver disease (NAFLD),1/149,0.0074499147221605,0.0105852466311029,0,0,19851.0,97261.02051561224,TNF
21413,KEGG_2019_Human,mTOR signaling pathway,1/152,0.0075999137114971,0.0105852466311029,0,0,19848.0,96850.665715497,TNF
21414,KEGG_2019_Human,Hepatitis C,1/155,0.0077499127120574,0.0105852466311029,0,0,19845.0,96448.16254952336,TNF
21415,KEGG_2019_Human,Necroptosis,1/162,0.0080999104202618,0.0106138364065242,0,0,19838.0,95537.86936302872,TNF
21416,KEGG_2019_Human,Hepatitis B,1/163,0.0081499100978668,0.0106138364065242,0,0,19837.0,95410.9786681514,TNF
21417,KEGG_2019_Human,Influenza A,1/171,0.0085499075557634,0.0106398849582833,0,0,19829.0,94422.42241345016,TNF
21418,KEGG_2019_Human,Alzheimer disease,1/171,0.0085499075557634,0.0106398849582833,0,0,19829.0,94422.42241345016,TNF
21419,KEGG_2019_Human,NOD-like receptor signaling pathway,1/178,0.0088999053857096,0.0106637166911307,0,0,19822.0,93593.82745769851,TNF
21420,KEGG_2019_Human,Tuberculosis,1/179,0.0089499050800561,0.0106637166911307,0,0,19821.0,93478.0629355712,TNF
21421,KEGG_2019_Human,Epstein-Barr virus infection,1/201,0.0100498985877989,0.0114855983860559,0,0,19799.0,91079.21596609056,TNF
21422,KEGG_2019_Human,Proteoglycans in cancer,1/201,0.0100498985877989,0.0114855983860559,0,0,19799.0,91079.21596609056,TNF
21423,KEGG_2019_Human,Human immunodeficiency virus 1 infection,1/212,0.0105998955026255,0.0118718829629406,0,0,19788.0,89974.27756224656,TNF
21424,KEGG_2019_Human,Human T-cell leukemia virus 1 infection,1/219,0.0109498935894162,0.0120234125687708,0,0,19781.0,89299.85161916987,TNF
21425,KEGG_2019_Human,Human cytomegalovirus infection,1/225,0.0112498919790339,0.0121152682851134,0,0,19775.0,88738.27077557483,TNF
21426,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0152961666186007,0,0,19706.0,83157.67014793828,TNF
21427,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0152961666186007,0,0,19705.0,83086.53988020132,TNF
21428,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0167998650491275,0,0,19670.0,80733.60565076157,TNF
21429,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,TNF
21430,KEGG_2019_Human,Homologous recombination,1/41,0.0020499625466866,0.0020499625466866,0,0,19959.0,123544.88783416104,BABAM1
21431,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR5AK2
21432,KEGG_2019_Human,Influenza A,1/171,0.0085499075557634,0.0085499075557634,0,0,19829.0,94422.42241345016,KPNA1
21433,KEGG_2019_Human,Inositol phosphate metabolism,1/74,0.0036999446830449,0.0072499083140107,0,0,19926.0,111574.38983110404,PLCD3
21434,KEGG_2019_Human,Phosphatidylinositol signaling system,1/99,0.0049499334884068,0.0072499083140107,0,0,19901.0,105642.09305076736,PLCD3
21435,KEGG_2019_Human,AGE-RAGE signaling pathway in diabetic complications,1/100,0.0049999330710556,0.0072499083140107,0,0,19900.0,105436.78197328727,PLCD3
21436,KEGG_2019_Human,Thyroid hormone signaling pathway,1/116,0.0057999266512085,0.0072499083140107,0,0,19884.0,102400.8105961506,PLCD3
21437,KEGG_2019_Human,Calcium signaling pathway,1/188,0.009399902370135,0.009399902370135,0,0,19812.0,92463.712994847,PLCD3
21438,KEGG_2019_Human,Malaria,1/49,0.0024499577795033,0.0024499577795033,0,0,19951.0,119939.1172087114,KLRB1
21439,KEGG_2019_Human,Vibrio cholerae infection,1/50,0.0024999572069037,0.0055499170245674,0,0,19950.0,119530.05920663515,PDIA4
21440,KEGG_2019_Human,Thyroid hormone synthesis,1/74,0.0036999446830449,0.0055499170245674,0,0,19926.0,111574.38983110404,PDIA4
21441,KEGG_2019_Human,Protein processing in endoplasmic reticulum,1/165,0.0082499094553477,0.0082499094553477,0,0,19835.0,95159.46482222488,PDIA4
21442,KEGG_2019_Human,Peroxisome,1/83,0.0041499404726918,0.0041499404726918,0,0,19917.0,109237.99888847338,NUDT19
21443,KEGG_2019_Human,Spliceosome,1/134,0.0066999199497742,0.0066999199497742,0,0,19866.0,99442.43560916925,PRPF38A
21444,KEGG_2019_Human,Glycosylphosphatidylinositol (GPI)-anchor biosynthesis,1/25,0.0012499733663791,0.0012499733663791,0,0,19975.0,133525.54486996148,PIGF
21445,KEGG_2019_Human,Fructose and mannose metabolism,1/33,0.0016499677032113,0.0023999583567988,0,0,19967.0,127928.56031580272,FPGT
21446,KEGG_2019_Human,Amino sugar and nucleotide sugar metabolism,1/48,0.0023999583567988,0.0023999583567988,0,0,19952.0,120356.5272753826,FPGT
21447,KEGG_2019_Human,Cellular senescence,1/160,0.0079999110688441,0.0080999104202618,0,0,19840.0,95793.96509856998,PPID
21448,KEGG_2019_Human,Necroptosis,1/162,0.0080999104202618,0.0080999104202618,0,0,19838.0,95537.86936302872,PPID
21449,KEGG_2019_Human,ErbB signaling pathway,1/85,0.004249939567045,0.004249939567045,0,0,19915.0,108752.83801948265,NRG2
21450,KEGG_2019_Human,Progesterone-mediated oocyte maturation,1/99,0.0049499334884068,0.0062499232373748,0,0,19901.0,105642.09305076736,SPDYE4
21451,KEGG_2019_Human,Oocyte meiosis,1/125,0.0062499232373748,0.0062499232373748,0,0,19875.0,100869.32368441945,SPDYE4
21452,KEGG_2019_Human,Ubiquinone and other terpenoid-quinone biosynthesis,1/11,0.0005499852259717758,0.0005499852259717758,0,0,19989.0,150029.8210287992,VKORC1
21453,KEGG_2019_Human,Transcriptional misregulation in cancer,1/186,0.0092999029651357,0.0147498749536506,0,0,19814.0,92684.96451050608,ELK4
21454,KEGG_2019_Human,Human T-cell leukemia virus 1 infection,1/219,0.0109498935894162,0.0147498749536506,0,0,19781.0,89299.85161916987,ELK4
21455,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0147498749536506,0,0,19705.0,83086.53988020132,ELK4
21456,KEGG_2019_Human,Natural killer cell mediated cytotoxicity,1/131,0.0065499210316603,0.0065499210316603,0,0,19869.0,99907.33811343512,HCST
21457,KEGG_2019_Human,Aldosterone synthesis and secretion,1/98,0.0048999339081079,0.0097998678162159,0,0,19902.0,105849.45495286948,PRKD2
21458,KEGG_2019_Human,Rap1 signaling pathway,1/206,0.010299897173561,0.010299897173561,0,0,19794.0,90569.849337325,PRKD2
21459,KEGG_2019_Human,Vascular smooth muscle contraction,1/132,0.0065999206698993,0.0065999206698993,0,0,19868.0,99751.22090491928,CALD1
21460,KEGG_2019_Human,Sphingolipid metabolism,1/47,0.0023499589392381,0.009399902370135,0,0,19953.0,120782.64067395544,SPHK1
21461,KEGG_2019_Human,VEGF signaling pathway,1/59,0.0029499522555206,0.009399902370135,0,0,19941.0,116175.59385530632,SPHK1
21462,KEGG_2019_Human,Fc gamma R-mediated phagocytosis,1/91,0.0045499369072032,0.009399902370135,0,0,19909.0,107362.10783923086,SPHK1
21463,KEGG_2019_Human,Sphingolipid signaling pathway,1/119,0.0059499254985137,0.009399902370135,0,0,19881.0,101877.73080211312,SPHK1
21464,KEGG_2019_Human,Apelin signaling pathway,1/137,0.0068499188797651,0.009399902370135,0,0,19863.0,98987.62735269018,SPHK1
21465,KEGG_2019_Human,Phospholipase D signaling pathway,1/148,0.007399915061391,0.009399902370135,0,0,19852.0,97399.60470052566,SPHK1
21466,KEGG_2019_Human,Tuberculosis,1/179,0.0089499050800561,0.009399902370135,0,0,19821.0,93478.0629355712,SPHK1
21467,KEGG_2019_Human,Calcium signaling pathway,1/188,0.009399902370135,0.009399902370135,0,0,19812.0,92463.712994847,SPHK1
21468,KEGG_2019_Human,Citrate cycle (TCA cycle),1/30,0.0014999697593334,0.0014999697593334,0,0,19970.0,129851.13732048514,IDH3A
21469,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF154
21470,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF700
21471,KEGG_2019_Human,Morphine addiction,1/91,0.0045499369072032,0.0121998870519305,0,0,19909.0,107362.10783923086,GRK6
21472,KEGG_2019_Human,Chemokine signaling pathway,1/190,0.0094999017791995,0.0121998870519305,0,0,19810.0,92244.74636351672,GRK6
21473,KEGG_2019_Human,Endocytosis,1/244,0.0121998870519305,0.0121998870519305,0,0,19756.0,87051.4275316661,GRK6
21474,KEGG_2019_Human,Ribosome biogenesis in eukaryotes,1/101,0.0050499326546803,0.0050499326546803,0,0,19899.0,105233.48101229242,GTPBP4
21475,KEGG_2019_Human,Endocytosis,1/244,0.0121998870519305,0.0121998870519305,0,0,19756.0,87051.4275316661,CAPZB
21476,KEGG_2019_Human,Allograft rejection,1/38,0.001899964429635,0.0041299331577289,0,0,19962.0,125080.29732025368,PRF1
21477,KEGG_2019_Human,Graft-versus-host disease,1/41,0.0020499625466866,0.0041299331577289,0,0,19959.0,123544.88783416104,PRF1
21478,KEGG_2019_Human,Type I diabetes mellitus,1/43,0.0021499613216957,0.0041299331577289,0,0,19957.0,122581.98940490963,PRF1
21479,KEGG_2019_Human,Autoimmune thyroid disease,1/53,0.0026499555173137,0.0041299331577289,0,0,19947.0,118349.78824235698,PRF1
21480,KEGG_2019_Human,Viral myocarditis,1/59,0.0029499522555206,0.0041299331577289,0,0,19941.0,116175.59385530632,PRF1
21481,KEGG_2019_Human,Natural killer cell mediated cytotoxicity,1/131,0.0065499210316603,0.0071499167770442,0,0,19869.0,99907.33811343512,PRF1
21482,KEGG_2019_Human,Apoptosis,1/143,0.0071499167770442,0.0071499167770442,0,0,19857.0,98106.57763600958,PRF1
21483,KEGG_2019_Human,Basal transcription factors,1/45,0.0022499601197094,0.0044999202394188,0,0,19955.0,121662.49782449217,GTF2B
21484,KEGG_2019_Human,Viral carcinogenesis,1/201,0.0100498985877989,0.0100498985877989,0,0,19799.0,91079.21596609056,GTF2B
21485,KEGG_2019_Human,Ribosome,1/153,0.0076499133771537,0.0076499133771537,0,0,19847.0,96715.6407630817,RPS10-NUDT3
21486,KEGG_2019_Human,Mitophagy,1/65,0.003249949134407,0.0127598791484564,0,0,19935.0,114209.92613860144,MRAS
21487,KEGG_2019_Human,C-type lectin receptor signaling pathway,1/104,0.0051999314202997,0.0127598791484564,0,0,19896.0,104635.24941415618,MRAS
21488,KEGG_2019_Human,Autophagy,1/128,0.0063999221281459,0.0127598791484564,0,0,19872.0,100382.8010329652,MRAS
21489,KEGG_2019_Human,Apelin signaling pathway,1/137,0.0068499188797651,0.0127598791484564,0,0,19863.0,98987.62735269018,MRAS
21490,KEGG_2019_Human,Phospholipase D signaling pathway,1/148,0.007399915061391,0.0127598791484564,0,0,19852.0,97399.60470052566,MRAS
21491,KEGG_2019_Human,Cellular senescence,1/160,0.0079999110688441,0.0127598791484564,0,0,19840.0,95793.96509856998,MRAS
21492,KEGG_2019_Human,Proteoglycans in cancer,1/201,0.0100498985877989,0.0127598791484564,0,0,19799.0,91079.21596609056,MRAS
21493,KEGG_2019_Human,Rap1 signaling pathway,1/206,0.010299897173561,0.0127598791484564,0,0,19794.0,90569.849337325,MRAS
21494,KEGG_2019_Human,Regulation of actin cytoskeleton,1/214,0.0106998949514067,0.0127598791484564,0,0,19786.0,89779.39753374986,MRAS
21495,KEGG_2019_Human,Ras signaling pathway,1/232,0.0115998901349604,0.0127598791484564,0,0,19768.0,88101.22480150245,MRAS
21496,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0147498749536506,0,0,19705.0,83086.53988020132,MRAS
21497,KEGG_2019_Human,IL-17 signaling pathway,1/93,0.0046499360391879,0.0092998720783758,0,0,19907.0,106918.54242106884,IL25
21498,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0146998751759735,0,0,19706.0,83157.67014793828,IL25
21499,KEGG_2019_Human,Fatty acid degradation,1/44,0.0021999607179423,0.0055499170245674,0,0,19956.0,122117.06559109331,CPT2
21500,KEGG_2019_Human,PPAR signaling pathway,1/74,0.0036999446830449,0.0055499170245674,0,0,19926.0,111574.38983110404,CPT2
21501,KEGG_2019_Human,Thermogenesis,1/231,0.0115498903940656,0.0115498903940656,0,0,19769.0,88191.07730937863,CPT2
21502,KEGG_2019_Human,"Phenylalanine, tyrosine and tryptophan biosynthesis",1/5,0.0002499917995416556,0.0017499425967915,0,0,19995.0,165840.17843725558,IL4I1
21503,KEGG_2019_Human,Phenylalanine metabolism,1/17,0.0008499797390404818,0.0023999583567988,0,0,19983.0,141285.76583697114,IL4I1
21504,KEGG_2019_Human,"Alanine, aspartate and glutamate metabolism",1/35,0.0017499663721595,0.0023999583567988,0,0,19965.0,126740.98858805298,IL4I1
21505,KEGG_2019_Human,Tyrosine metabolism,1/36,0.0017999657178272,0.0023999583567988,0,0,19964.0,126172.23364250171,IL4I1
21506,KEGG_2019_Human,Tryptophan metabolism,1/42,0.0020999619311272,0.0023999583567988,0,0,19958.0,123057.75613441122,IL4I1
21507,KEGG_2019_Human,Cysteine and methionine metabolism,1/47,0.0023499589392381,0.0023999583567988,0,0,19953.0,120782.64067395544,IL4I1
21508,KEGG_2019_Human,"Valine, leucine and isoleucine degradation",1/48,0.0023999583567988,0.0023999583567988,0,0,19952.0,120356.5272753826,IL4I1
21509,KEGG_2019_Human,Selenocompound metabolism,1/17,0.0008499797390404818,0.0016999594780809,0,0,19983.0,141285.76583697114,SEPSECS
21510,KEGG_2019_Human,Aminoacyl-tRNA biosynthesis,1/66,0.003299948626608,0.003299948626608,0,0,19934.0,113899.85357353876,SEPSECS
21511,KEGG_2019_Human,Pentose phosphate pathway,1/30,0.0014999697593334,0.0049499031096341,0,0,19970.0,129851.13732048514,FBP1
21512,KEGG_2019_Human,Fructose and mannose metabolism,1/33,0.0016499677032113,0.0049499031096341,0,0,19967.0,127928.56031580272,FBP1
21513,KEGG_2019_Human,Glycolysis / Gluconeogenesis,1/68,0.0033999476216189,0.0067998952432378,0,0,19932.0,113293.39338050144,FBP1
21514,KEGG_2019_Human,Glucagon signaling pathway,1/103,0.0051499318302617,0.0068499188797651,0,0,19897.0,104832.7525292024,FBP1
21515,KEGG_2019_Human,AMPK signaling pathway,1/120,0.0059999251180858,0.0068499188797651,0,0,19880.0,101706.2448082016,FBP1
21516,KEGG_2019_Human,Insulin signaling pathway,1/137,0.0068499188797651,0.0068499188797651,0,0,19863.0,98987.62735269018,FBP1
21517,KEGG_2019_Human,Bladder cancer,1/41,0.0020499625466866,0.0115998657393762,0,0,19959.0,123544.88783416104,RPS6KA5
21518,KEGG_2019_Human,Circadian entrainment,1/97,0.0048499343304706,0.0115998657393762,0,0,19903.0,106058.9096435903,RPS6KA5
21519,KEGG_2019_Human,TNF signaling pathway,1/110,0.0054999290027479,0.0115998657393762,0,0,19890.0,103488.06969787036,RPS6KA5
21520,KEGG_2019_Human,Neurotrophin signaling pathway,1/119,0.0059499254985137,0.0115998657393762,0,0,19881.0,101877.73080211312,RPS6KA5
21521,KEGG_2019_Human,Adrenergic signaling in cardiomyocytes,1/145,0.0072499160871101,0.0115998657393762,0,0,19855.0,97820.92670675044,RPS6KA5
21522,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0170855703623445,0,0,19705.0,83086.53988020132,RPS6KA5
21523,KEGG_2019_Human,MicroRNAs in cancer,1/299,0.0149498740670514,0.0170855703623445,0,0,19701.0,82804.33538735632,RPS6KA5
21524,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,RPS6KA5
21525,KEGG_2019_Human,Arachidonic acid metabolism,1/63,0.0031499501598827,0.0036999446830449,0,0,19937.0,114844.46974572667,CBR3
21526,KEGG_2019_Human,Metabolism of xenobiotics by cytochrome P450,1/74,0.0036999446830449,0.0036999446830449,0,0,19926.0,111574.38983110404,CBR3
21527,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR1E1
21528,KEGG_2019_Human,Vasopressin-regulated water reabsorption,1/44,0.0021999607179423,0.0098444837153162,0,0,19956.0,122117.06559109331,ADCY3
21529,KEGG_2019_Human,Ovarian steroidogenesis,1/49,0.0024499577795033,0.0098444837153162,0,0,19951.0,119939.1172087114,ADCY3
21530,KEGG_2019_Human,Vibrio cholerae infection,1/50,0.0024999572069037,0.0098444837153162,0,0,19950.0,119530.05920663515,ADCY3
21531,KEGG_2019_Human,Regulation of lipolysis in adipocytes,1/55,0.0027499544131125,0.0098444837153162,0,0,19945.0,117599.1294878737,ADCY3
21532,KEGG_2019_Human,Cortisol synthesis and secretion,1/65,0.003249949134407,0.0098444837153162,0,0,19935.0,114209.92613860144,ADCY3
21533,KEGG_2019_Human,Bile secretion,1/72,0.0035999456502131,0.0098444837153162,0,0,19928.0,112131.59838572376,ADCY3
21534,KEGG_2019_Human,Thyroid hormone synthesis,1/74,0.0036999446830449,0.0098444837153162,0,0,19926.0,111574.38983110404,ADCY3
21535,KEGG_2019_Human,Gastric acid secretion,1/75,0.0037499442041125,0.0098444837153162,0,0,19925.0,111301.33528642564,ADCY3
21536,KEGG_2019_Human,Insulin secretion,1/86,0.0042999391173866,0.0098444837153162,0,0,19914.0,108514.46102290176,ADCY3
21537,KEGG_2019_Human,Gap junction,1/88,0.0043999382262822,0.0098444837153162,0,0,19912.0,108045.79305232369,ADCY3
21538,KEGG_2019_Human,GABAergic synapse,1/89,0.0044499377838098,0.0098444837153162,0,0,19911.0,107815.380281759,ADCY3
21539,KEGG_2019_Human,Salivary secretion,1/90,0.0044999373439762,0.0098444837153162,0,0,19910.0,107587.50385474482,ADCY3
21540,KEGG_2019_Human,Dilated cardiomyopathy (DCM),1/91,0.0045499369072032,0.0098444837153162,0,0,19909.0,107362.10783923086,ADCY3
21541,KEGG_2019_Human,Morphine addiction,1/91,0.0045499369072032,0.0098444837153162,0,0,19909.0,107362.10783923086,ADCY3
21542,KEGG_2019_Human,GnRH signaling pathway,1/93,0.0046499360391879,0.0098444837153162,0,0,19907.0,106918.54242106884,ADCY3
21543,KEGG_2019_Human,Circadian entrainment,1/97,0.0048499343304706,0.0098444837153162,0,0,19903.0,106058.9096435903,ADCY3
21544,KEGG_2019_Human,Pancreatic secretion,1/98,0.0048999339081079,0.0098444837153162,0,0,19902.0,105849.45495286948,ADCY3
21545,KEGG_2019_Human,Aldosterone synthesis and secretion,1/98,0.0048999339081079,0.0098444837153162,0,0,19902.0,105849.45495286948,ADCY3
21546,KEGG_2019_Human,Progesterone-mediated oocyte maturation,1/99,0.0049499334884068,0.0098444837153162,0,0,19901.0,105642.09305076736,ADCY3
21547,KEGG_2019_Human,Inflammatory mediator regulation of TRP channels,1/100,0.0049999330710556,0.0098444837153162,0,0,19900.0,105436.78197328727,ADCY3
21548,KEGG_2019_Human,Melanogenesis,1/101,0.0050499326546803,0.0098444837153162,0,0,19899.0,105233.48101229242,ADCY3
21549,KEGG_2019_Human,Longevity regulating pathway,1/102,0.0050999322416682,0.0098444837153162,0,0,19898.0,105032.15064717118,ADCY3
21550,KEGG_2019_Human,"Parathyroid hormone synthesis, secretion and action",1/106,0.0052999306076525,0.0098444837153162,0,0,19894.0,104245.78450366124,ADCY3
21551,KEGG_2019_Human,Cholinergic synapse,1/112,0.0055999282120529,0.0098444837153162,0,0,19888.0,103119.30984392198,ADCY3
21552,KEGG_2019_Human,Glutamatergic synapse,1/114,0.005699927427839,0.0098444837153162,0,0,19886.0,102756.96431429044,ADCY3
21553,KEGG_2019_Human,Platelet activation,1/124,0.0061999236097501,0.0098444837153162,0,0,19876.0,101034.04709010696,ADCY3
21554,KEGG_2019_Human,Oocyte meiosis,1/125,0.0062499232373748,0.0098444837153162,0,0,19875.0,100869.32368441945,ADCY3
21555,KEGG_2019_Human,Purine metabolism,1/129,0.006449921761047,0.0098444837153162,0,0,19871.0,100223.109907462,ADCY3
21556,KEGG_2019_Human,Relaxin signaling pathway,1/130,0.0064999213952527,0.0098444837153162,0,0,19870.0,100064.62842845908,ADCY3
21557,KEGG_2019_Human,Vascular smooth muscle contraction,1/132,0.0065999206698993,0.0098444837153162,0,0,19868.0,99751.22090491928,ADCY3
21558,KEGG_2019_Human,Estrogen signaling pathway,1/137,0.0068499188797651,0.0098444837153162,0,0,19863.0,98987.62735269018,ADCY3
21559,KEGG_2019_Human,Apelin signaling pathway,1/137,0.0068499188797651,0.0098444837153162,0,0,19863.0,98987.62735269018,ADCY3
21560,KEGG_2019_Human,Adrenergic signaling in cardiomyocytes,1/145,0.0072499160871101,0.0098444837153162,0,0,19855.0,97820.92670675044,ADCY3
21561,KEGG_2019_Human,Phospholipase D signaling pathway,1/148,0.007399915061391,0.0098444837153162,0,0,19852.0,97399.60470052566,ADCY3
21562,KEGG_2019_Human,Retrograde endocannabinoid signaling,1/148,0.007399915061391,0.0098444837153162,0,0,19852.0,97399.60470052566,ADCY3
21563,KEGG_2019_Human,Oxytocin signaling pathway,1/153,0.0076499133771537,0.0098444837153162,0,0,19847.0,96715.6407630817,ADCY3
21564,KEGG_2019_Human,Cushing syndrome,1/155,0.0077499127120574,0.0098444837153162,0,0,19845.0,96448.16254952336,ADCY3
21565,KEGG_2019_Human,cGMP-PKG signaling pathway,1/166,0.0082999091363732,0.0102656770897248,0,0,19834.0,95034.82345515196,ADCY3
21566,KEGG_2019_Human,Calcium signaling pathway,1/188,0.009399902370135,0.0111623845905595,0,0,19812.0,92463.712994847,ADCY3
21567,KEGG_2019_Human,Chemokine signaling pathway,1/190,0.0094999017791995,0.0111623845905595,0,0,19810.0,92244.74636351672,ADCY3
21568,KEGG_2019_Human,Rap1 signaling pathway,1/206,0.010299897173561,0.0118071991989602,0,0,19794.0,90569.849337325,ADCY3
21569,KEGG_2019_Human,cAMP signaling pathway,1/212,0.0105998955026255,0.0118617878243667,0,0,19788.0,89974.27756224656,ADCY3
21570,KEGG_2019_Human,Human T-cell leukemia virus 1 infection,1/219,0.0109498935894162,0.0119684883419201,0,0,19781.0,89299.85161916987,ADCY3
21571,KEGG_2019_Human,Human cytomegalovirus infection,1/225,0.0112498919790339,0.0120169300685134,0,0,19775.0,88738.27077557483,ADCY3
21572,KEGG_2019_Human,Thermogenesis,1/231,0.0115498903940656,0.012063218856024,0,0,19769.0,88191.07730937863,ADCY3
21573,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0226824518840114,0,0,19556.0,74462.79263140135,ADCY3
21574,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,ADCY3
21575,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF701
21576,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF705A
21577,KEGG_2019_Human,Ferroptosis,1/40,0.0019999631680592,0.0027999538675741,0,0,19960.0,124043.94523066044,GCLM
21578,KEGG_2019_Human,Cysteine and methionine metabolism,1/47,0.0023499589392381,0.0027999538675741,0,0,19953.0,120782.64067395544,GCLM
21579,KEGG_2019_Human,Glutathione metabolism,1/56,0.0027999538675741,0.0027999538675741,0,0,19944.0,117233.87022514464,GCLM
21580,KEGG_2019_Human,Cell cycle,1/124,0.0061999236097501,0.0109498935894162,0,0,19876.0,101034.04709010696,BUB1B
21581,KEGG_2019_Human,Human T-cell leukemia virus 1 infection,1/219,0.0109498935894162,0.0109498935894162,0,0,19781.0,89299.85161916987,BUB1B
21582,KEGG_2019_Human,Lysosome,1/123,0.0061499239842961,0.0061499239842961,0,0,19877.0,101200.07933676826,ARSG
21583,KEGG_2019_Human,Natural killer cell mediated cytotoxicity,1/131,0.0065499210316603,0.0065499210316603,0,0,19869.0,99907.33811343512,ULBP2
21584,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR51L1
21585,KEGG_2019_Human,Protein processing in endoplasmic reticulum,1/165,0.0082499094553477,0.0082499094553477,0,0,19835.0,95159.46482222488,UFD1
21586,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR2S2
21587,KEGG_2019_Human,p53 signaling pathway,1/72,0.0035999456502131,0.0111998754963818,0,0,19928.0,112131.59838572376,BBC3
21588,KEGG_2019_Human,Colorectal cancer,1/86,0.0042999391173866,0.0111998754963818,0,0,19914.0,108514.46102290176,BBC3
21589,KEGG_2019_Human,Measles,1/138,0.0068999185254481,0.0111998754963818,0,0,19862.0,98838.19160389496,BBC3
21590,KEGG_2019_Human,Apoptosis,1/143,0.0071499167770442,0.0111998754963818,0,0,19857.0,98106.57763600958,BBC3
21591,KEGG_2019_Human,Hippo signaling pathway,1/160,0.0079999110688441,0.0111998754963818,0,0,19840.0,95793.96509856998,BBC3
21592,KEGG_2019_Human,Huntington disease,1/193,0.0096499008972596,0.0112582177134695,0,0,19807.0,91920.47679471428,BBC3
21593,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,BBC3
21594,KEGG_2019_Human,Ubiquinone and other terpenoid-quinone biosynthesis,1/11,0.0005499852259717758,0.0005499852259717758,0,0,19989.0,150029.8210287992,COQ6
21595,KEGG_2019_Human,Arrhythmogenic right ventricular cardiomyopathy (ARVC),1/72,0.0035999456502131,0.0079623895876056,0,0,19928.0,112131.59838572376,CACNG5
21596,KEGG_2019_Human,Cardiac muscle contraction,1/78,0.0038999427840466,0.0079623895876056,0,0,19922.0,110503.2180492851,CACNG5
21597,KEGG_2019_Human,Hypertrophic cardiomyopathy (HCM),1/85,0.004249939567045,0.0079623895876056,0,0,19915.0,108752.83801948265,CACNG5
21598,KEGG_2019_Human,Dilated cardiomyopathy (DCM),1/91,0.0045499369072032,0.0079623895876056,0,0,19909.0,107362.10783923086,CACNG5
21599,KEGG_2019_Human,Adrenergic signaling in cardiomyocytes,1/145,0.0072499160871101,0.0089248989400127,0,0,19855.0,97820.92670675044,CACNG5
21600,KEGG_2019_Human,Oxytocin signaling pathway,1/153,0.0076499133771537,0.0089248989400127,0,0,19847.0,96715.6407630817,CACNG5
21601,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0147498749536506,0,0,19705.0,83086.53988020132,CACNG5
21602,KEGG_2019_Human,Pentose phosphate pathway,1/30,0.0014999697593334,0.0041249192580284,0,0,19970.0,129851.13732048514,FBP2
21603,KEGG_2019_Human,Fructose and mannose metabolism,1/33,0.0016499677032113,0.0041249192580284,0,0,19967.0,127928.56031580272,FBP2
21604,KEGG_2019_Human,Glycolysis / Gluconeogenesis,1/68,0.0033999476216189,0.0056665793693648,0,0,19932.0,113293.39338050144,FBP2
21605,KEGG_2019_Human,AMPK signaling pathway,1/120,0.0059999251180858,0.0068499188797651,0,0,19880.0,101706.2448082016,FBP2
21606,KEGG_2019_Human,Insulin signaling pathway,1/137,0.0068499188797651,0.0068499188797651,0,0,19863.0,98987.62735269018,FBP2
21607,KEGG_2019_Human,Other types of O-glycan biosynthesis,1/22,0.0010999756574123,0.0026499555173137,0,0,19978.0,136099.47030191717,B4GALT2
21608,KEGG_2019_Human,Mannose type O-glycan biosynthesis,1/23,0.0011499748819949,0.0026499555173137,0,0,19977.0,135204.63922267244,B4GALT2
21609,KEGG_2019_Human,Galactose metabolism,1/31,0.0015499690656704,0.0026499555173137,0,0,19969.0,129189.85098816035,B4GALT2
21610,KEGG_2019_Human,Glycosphingolipid biosynthesis,1/45,0.0022499601197094,0.0026499555173137,0,0,19955.0,121662.49782449217,B4GALT2
21611,KEGG_2019_Human,N-Glycan biosynthesis,1/50,0.0024999572069037,0.0026499555173137,0,0,19950.0,119530.05920663515,B4GALT2
21612,KEGG_2019_Human,Glycosaminoglycan biosynthesis,1/53,0.0026499555173137,0.0026499555173137,0,0,19947.0,118349.78824235698,B4GALT2
21613,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZFP14
21614,KEGG_2019_Human,Synaptic vesicle cycle,1/78,0.0038999427840466,0.0044499377838098,0,0,19922.0,110503.2180492851,SLC6A12
21615,KEGG_2019_Human,GABAergic synapse,1/89,0.0044499377838098,0.0044499377838098,0,0,19911.0,107815.380281759,SLC6A12
21616,KEGG_2019_Human,GABAergic synapse,1/89,0.0044499377838098,0.0130498764018304,0,0,19911.0,107815.380281759,GNGT2
21617,KEGG_2019_Human,Morphine addiction,1/91,0.0045499369072032,0.0130498764018304,0,0,19909.0,107362.10783923086,GNGT2
21618,KEGG_2019_Human,Circadian entrainment,1/97,0.0048499343304706,0.0130498764018304,0,0,19903.0,106058.9096435903,GNGT2
21619,KEGG_2019_Human,Cholinergic synapse,1/112,0.0055999282120529,0.0130498764018304,0,0,19888.0,103119.30984392198,GNGT2
21620,KEGG_2019_Human,Serotonergic synapse,1/113,0.0056499278191151,0.0130498764018304,0,0,19887.0,102937.34947211576,GNGT2
21621,KEGG_2019_Human,Glutamatergic synapse,1/114,0.005699927427839,0.0130498764018304,0,0,19886.0,102756.96431429044,GNGT2
21622,KEGG_2019_Human,Relaxin signaling pathway,1/130,0.0064999213952527,0.0130498764018304,0,0,19870.0,100064.62842845908,GNGT2
21623,KEGG_2019_Human,Dopaminergic synapse,1/131,0.0065499210316603,0.0130498764018304,0,0,19869.0,99907.33811343512,GNGT2
21624,KEGG_2019_Human,Apelin signaling pathway,1/137,0.0068499188797651,0.0130498764018304,0,0,19863.0,98987.62735269018,GNGT2
21625,KEGG_2019_Human,Retrograde endocannabinoid signaling,1/148,0.007399915061391,0.0130498764018304,0,0,19852.0,97399.60470052566,GNGT2
21626,KEGG_2019_Human,Alcoholism,1/180,0.0089999047745351,0.0130498764018304,0,0,19820.0,93362.92821536642,GNGT2
21627,KEGG_2019_Human,Kaposi sarcoma-associated herpesvirus infection,1/186,0.0092999029651357,0.0130498764018304,0,0,19814.0,92684.96451050608,GNGT2
21628,KEGG_2019_Human,Chemokine signaling pathway,1/190,0.0094999017791995,0.0130498764018304,0,0,19810.0,92244.74636351672,GNGT2
21629,KEGG_2019_Human,Human immunodeficiency virus 1 infection,1/212,0.0105998955026255,0.0130498764018304,0,0,19788.0,89974.27756224656,GNGT2
21630,KEGG_2019_Human,Human cytomegalovirus infection,1/225,0.0112498919790339,0.0130498764018304,0,0,19775.0,88738.27077557483,GNGT2
21631,KEGG_2019_Human,Ras signaling pathway,1/232,0.0115998901349604,0.0130498764018304,0,0,19768.0,88101.22480150245,GNGT2
21632,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0187410310320355,0,0,19646.0,79255.8617626126,GNGT2
21633,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,GNGT2
21634,KEGG_2019_Human,Steroid hormone biosynthesis,1/60,0.002999951725986,0.0048499343304706,0,0,19940.0,115834.63209072244,SRD5A2
21635,KEGG_2019_Human,Prostate cancer,1/97,0.0048499343304706,0.0048499343304706,0,0,19903.0,106058.9096435903,SRD5A2
21636,KEGG_2019_Human,Shigellosis,1/65,0.003249949134407,0.0057749224031413,0,0,19935.0,114209.92613860144,WASF1
21637,KEGG_2019_Human,Adherens junction,1/72,0.0035999456502131,0.0057749224031413,0,0,19928.0,112131.59838572376,WASF1
21638,KEGG_2019_Human,Bacterial invasion of epithelial cells,1/74,0.0036999446830449,0.0057749224031413,0,0,19926.0,111574.38983110404,WASF1
21639,KEGG_2019_Human,Salmonella infection,1/86,0.0042999391173866,0.0057749224031413,0,0,19914.0,108514.46102290176,WASF1
21640,KEGG_2019_Human,Fc gamma R-mediated phagocytosis,1/91,0.0045499369072032,0.0057749224031413,0,0,19909.0,107362.10783923086,WASF1
21641,KEGG_2019_Human,Choline metabolism in cancer,1/99,0.0049499334884068,0.0057749224031413,0,0,19901.0,105642.09305076736,WASF1
21642,KEGG_2019_Human,Regulation of actin cytoskeleton,1/214,0.0106998949514067,0.0106998949514067,0,0,19786.0,89779.39753374986,WASF1
21643,KEGG_2019_Human,Complement and coagulation cascades,1/79,0.0039499423167337,0.0078998846334674,0,0,19921.0,110243.89578070649,PLAUR
21644,KEGG_2019_Human,Proteoglycans in cancer,1/201,0.0100498985877989,0.0100498985877989,0,0,19799.0,91079.21596609056,PLAUR
21645,KEGG_2019_Human,Endocytosis,1/244,0.0121998870519305,0.0121998870519305,0,0,19756.0,87051.4275316661,RAB35
21646,KEGG_2019_Human,Ether lipid metabolism,1/47,0.0023499589392381,0.0046999178784763,0,0,19953.0,120782.64067395544,LPCAT2
21647,KEGG_2019_Human,Glycerophospholipid metabolism,1/97,0.0048499343304706,0.0048499343304706,0,0,19903.0,106058.9096435903,LPCAT2
21648,KEGG_2019_Human,Proximal tubule bicarbonate reclamation,1/23,0.0011499748819949,0.0065332452108106,0,0,19977.0,135204.63922267244,FXYD2
21649,KEGG_2019_Human,Aldosterone-regulated sodium reabsorption,1/37,0.0018499650702878,0.0065332452108106,0,0,19963.0,125618.9446446357,FXYD2
21650,KEGG_2019_Human,Carbohydrate digestion and absorption,1/44,0.0021999607179423,0.0065332452108106,0,0,19956.0,122117.06559109331,FXYD2
21651,KEGG_2019_Human,Endocrine and other factor-regulated calcium reabsorption,1/48,0.0023999583567988,0.0065332452108106,0,0,19952.0,120356.5272753826,FXYD2
21652,KEGG_2019_Human,Mineral absorption,1/51,0.0025499566390179,0.0065332452108106,0,0,19949.0,119129.0228601236,FXYD2
21653,KEGG_2019_Human,Bile secretion,1/72,0.0035999456502131,0.0065332452108106,0,0,19928.0,112131.59838572376,FXYD2
21654,KEGG_2019_Human,Thyroid hormone synthesis,1/74,0.0036999446830449,0.0065332452108106,0,0,19926.0,111574.38983110404,FXYD2
21655,KEGG_2019_Human,Cardiac muscle contraction,1/78,0.0038999427840466,0.0065332452108106,0,0,19922.0,110503.2180492851,FXYD2
21656,KEGG_2019_Human,Insulin secretion,1/86,0.0042999391173866,0.0065332452108106,0,0,19914.0,108514.46102290176,FXYD2
21657,KEGG_2019_Human,Salivary secretion,1/90,0.0044999373439762,0.0065332452108106,0,0,19910.0,107587.50385474482,FXYD2
21658,KEGG_2019_Human,Protein digestion and absorption,1/90,0.0044999373439762,0.0065332452108106,0,0,19910.0,107587.50385474482,FXYD2
21659,KEGG_2019_Human,Pancreatic secretion,1/98,0.0048999339081079,0.0065332452108106,0,0,19902.0,105849.45495286948,FXYD2
21660,KEGG_2019_Human,Thyroid hormone signaling pathway,1/116,0.0057999266512085,0.0071383712630259,0,0,19884.0,102400.8105961506,FXYD2
21661,KEGG_2019_Human,Adrenergic signaling in cardiomyocytes,1/145,0.0072499160871101,0.0082856183852687,0,0,19855.0,97820.92670675044,FXYD2
21662,KEGG_2019_Human,cGMP-PKG signaling pathway,1/166,0.0082999091363732,0.0088532364121315,0,0,19834.0,95034.82345515196,FXYD2
21663,KEGG_2019_Human,cAMP signaling pathway,1/212,0.0105998955026255,0.0105998955026255,0,0,19788.0,89974.27756224656,FXYD2
21664,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,MC4R
21665,KEGG_2019_Human,Ribosome biogenesis in eukaryotes,1/101,0.0050499326546803,0.0050499326546803,0,0,19899.0,105233.48101229242,EIF6
21666,KEGG_2019_Human,Fat digestion and absorption,1/41,0.0020499625466866,0.0020499625466866,0,0,19959.0,123544.88783416104,CLPS
21667,KEGG_2019_Human,Nucleotide excision repair,1/47,0.0023499589392381,0.0023499589392381,0,0,19953.0,120782.64067395544,XPC
21668,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF227
21669,KEGG_2019_Human,"Glycine, serine and threonine metabolism",1/40,0.0019999631680592,0.0024499577795033,0,0,19960.0,124043.94523066044,GATM
21670,KEGG_2019_Human,Arginine and proline metabolism,1/49,0.0024499577795033,0.0024499577795033,0,0,19951.0,119939.1172087114,GATM
21671,KEGG_2019_Human,Spliceosome,1/134,0.0066999199497742,0.0066999199497742,0,0,19866.0,99442.43560916925,RBMX
21672,KEGG_2019_Human,Phototransduction,1/28,0.0013999711732997,0.0013999711732997,0,0,19972.0,131242.0761597353,GUCA1C
21673,KEGG_2019_Human,Chemokine signaling pathway,1/190,0.0094999017791995,0.0146998751759735,0,0,19810.0,92244.74636351672,XCL2
21674,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0146998751759735,0,0,19706.0,83157.67014793828,XCL2
21675,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR7A5
21676,KEGG_2019_Human,Linoleic acid metabolism,1/29,0.001449970461791,0.0057399173017466,0,0,19971.0,130534.69172799008,CYP2E1
21677,KEGG_2019_Human,Steroid hormone biosynthesis,1/60,0.002999951725986,0.0057399173017466,0,0,19940.0,115834.63209072244,CYP2E1
21678,KEGG_2019_Human,Arachidonic acid metabolism,1/63,0.0031499501598827,0.0057399173017466,0,0,19937.0,114844.46974572667,CYP2E1
21679,KEGG_2019_Human,Metabolism of xenobiotics by cytochrome P450,1/74,0.0036999446830449,0.0057399173017466,0,0,19926.0,111574.38983110404,CYP2E1
21680,KEGG_2019_Human,Chemical carcinogenesis,1/82,0.004099940929819,0.0057399173017466,0,0,19918.0,109484.9180722932,CYP2E1
21681,KEGG_2019_Human,Drug metabolism,1/108,0.0053999298011749,0.0062999181013708,0,0,19892.0,103863.47861844616,CYP2E1
21682,KEGG_2019_Human,Non-alcoholic fatty liver disease (NAFLD),1/149,0.0074499147221605,0.0074499147221605,0,0,19851.0,97261.02051561224,CYP2E1
21683,KEGG_2019_Human,Endocytosis,1/244,0.0121998870519305,0.0121998870519305,0,0,19756.0,87051.4275316661,SH3GL2
21684,KEGG_2019_Human,Phototransduction,1/28,0.0013999711732997,0.0113938210547091,0,0,19972.0,131242.0761597353,CALM2
21685,KEGG_2019_Human,Long-term potentiation,1/67,0.0033499481224912,0.0113938210547091,0,0,19933.0,113594.38808369274,CALM2
21686,KEGG_2019_Human,Amphetamine addiction,1/68,0.0033999476216189,0.0113938210547091,0,0,19932.0,113293.39338050144,CALM2
21687,KEGG_2019_Human,Renin secretion,1/69,0.003449947123837,0.0113938210547091,0,0,19931.0,112996.7391397682,CALM2
21688,KEGG_2019_Human,Gastric acid secretion,1/75,0.0037499442041125,0.0113938210547091,0,0,19925.0,111301.33528642564,CALM2
21689,KEGG_2019_Human,Glioma,1/75,0.0037499442041125,0.0113938210547091,0,0,19925.0,111301.33528642564,CALM2
21690,KEGG_2019_Human,Pertussis,1/76,0.0037999437281752,0.0113938210547091,0,0,19924.0,111031.8499691117,CALM2
21691,KEGG_2019_Human,Salivary secretion,1/90,0.0044999373439762,0.0113938210547091,0,0,19910.0,107587.50385474482,CALM2
21692,KEGG_2019_Human,GnRH signaling pathway,1/93,0.0046499360391879,0.0113938210547091,0,0,19907.0,106918.54242106884,CALM2
21693,KEGG_2019_Human,Circadian entrainment,1/97,0.0048499343304706,0.0113938210547091,0,0,19903.0,106058.9096435903,CALM2
21694,KEGG_2019_Human,Aldosterone synthesis and secretion,1/98,0.0048999339081079,0.0113938210547091,0,0,19902.0,105849.45495286948,CALM2
21695,KEGG_2019_Human,Phosphatidylinositol signaling system,1/99,0.0049499334884068,0.0113938210547091,0,0,19901.0,105642.09305076736,CALM2
21696,KEGG_2019_Human,Inflammatory mediator regulation of TRP channels,1/100,0.0049999330710556,0.0113938210547091,0,0,19900.0,105436.78197328727,CALM2
21697,KEGG_2019_Human,Melanogenesis,1/101,0.0050499326546803,0.0113938210547091,0,0,19899.0,105233.48101229242,CALM2
21698,KEGG_2019_Human,Glucagon signaling pathway,1/103,0.0051499318302617,0.0113938210547091,0,0,19897.0,104832.7525292024,CALM2
21699,KEGG_2019_Human,C-type lectin receptor signaling pathway,1/104,0.0051999314202997,0.0113938210547091,0,0,19896.0,104635.24941415618,CALM2
21700,KEGG_2019_Human,Neurotrophin signaling pathway,1/119,0.0059499254985137,0.0113938210547091,0,0,19881.0,101877.73080211312,CALM2
21701,KEGG_2019_Human,Oocyte meiosis,1/125,0.0062499232373748,0.0113938210547091,0,0,19875.0,100869.32368441945,CALM2
21702,KEGG_2019_Human,Dopaminergic synapse,1/131,0.0065499210316603,0.0113938210547091,0,0,19869.0,99907.33811343512,CALM2
21703,KEGG_2019_Human,Vascular smooth muscle contraction,1/132,0.0065999206698993,0.0113938210547091,0,0,19868.0,99751.22090491928,CALM2
21704,KEGG_2019_Human,Insulin signaling pathway,1/137,0.0068499188797651,0.0113938210547091,0,0,19863.0,98987.62735269018,CALM2
21705,KEGG_2019_Human,Estrogen signaling pathway,1/137,0.0068499188797651,0.0113938210547091,0,0,19863.0,98987.62735269018,CALM2
21706,KEGG_2019_Human,Apelin signaling pathway,1/137,0.0068499188797651,0.0113938210547091,0,0,19863.0,98987.62735269018,CALM2
21707,KEGG_2019_Human,Fluid shear stress and atherosclerosis,1/139,0.006949918172816,0.0113938210547091,0,0,19861.0,98689.81333375497,CALM2
21708,KEGG_2019_Human,Adrenergic signaling in cardiomyocytes,1/145,0.0072499160871101,0.0113938210547091,0,0,19855.0,97820.92670675044,CALM2
21709,KEGG_2019_Human,Oxytocin signaling pathway,1/153,0.0076499133771537,0.0113938210547091,0,0,19847.0,96715.6407630817,CALM2
21710,KEGG_2019_Human,Cellular senescence,1/160,0.0079999110688441,0.0113938210547091,0,0,19840.0,95793.96509856998,CALM2
21711,KEGG_2019_Human,cGMP-PKG signaling pathway,1/166,0.0082999091363732,0.0113938210547091,0,0,19834.0,95034.82345515196,CALM2
21712,KEGG_2019_Human,Alzheimer disease,1/171,0.0085499075557634,0.0113938210547091,0,0,19829.0,94422.42241345016,CALM2
21713,KEGG_2019_Human,Tuberculosis,1/179,0.0089499050800561,0.0113938210547091,0,0,19821.0,93478.0629355712,CALM2
21714,KEGG_2019_Human,Alcoholism,1/180,0.0089999047745351,0.0113938210547091,0,0,19820.0,93362.92821536642,CALM2
21715,KEGG_2019_Human,Kaposi sarcoma-associated herpesvirus infection,1/186,0.0092999029651357,0.0113938210547091,0,0,19814.0,92684.96451050608,CALM2
21716,KEGG_2019_Human,Calcium signaling pathway,1/188,0.009399902370135,0.0113938210547091,0,0,19812.0,92463.712994847,CALM2
21717,KEGG_2019_Human,Rap1 signaling pathway,1/206,0.010299897173561,0.0117776616695839,0,0,19794.0,90569.849337325,CALM2
21718,KEGG_2019_Human,Human immunodeficiency virus 1 infection,1/212,0.0105998955026255,0.0117776616695839,0,0,19788.0,89974.27756224656,CALM2
21719,KEGG_2019_Human,cAMP signaling pathway,1/212,0.0105998955026255,0.0117776616695839,0,0,19788.0,89974.27756224656,CALM2
21720,KEGG_2019_Human,Human cytomegalovirus infection,1/225,0.0112498919790339,0.0121620453827393,0,0,19775.0,88738.27077557483,CALM2
21721,KEGG_2019_Human,Ras signaling pathway,1/232,0.0115998901349604,0.0122104106683793,0,0,19768.0,88101.22480150245,CALM2
21722,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0227690733587457,0,0,19556.0,74462.79263140135,CALM2
21723,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,CALM2
21724,KEGG_2019_Human,Other glycan degradation,1/18,0.0008999788927950273,0.0028199507270857,0,0,19982.0,140136.54844084635,GLB1
21725,KEGG_2019_Human,Glycosaminoglycan degradation,1/19,0.00094997806231055,0.0028199507270857,0,0,19981.0,139049.2109571672,GLB1
21726,KEGG_2019_Human,Galactose metabolism,1/31,0.0015499690656704,0.0028199507270857,0,0,19969.0,129189.85098816035,GLB1
21727,KEGG_2019_Human,Glycosphingolipid biosynthesis,1/45,0.0022499601197094,0.0028199507270857,0,0,19955.0,121662.49782449217,GLB1
21728,KEGG_2019_Human,Sphingolipid metabolism,1/47,0.0023499589392381,0.0028199507270857,0,0,19953.0,120782.64067395544,GLB1
21729,KEGG_2019_Human,Lysosome,1/123,0.0061499239842961,0.0061499239842961,0,0,19877.0,101200.07933676826,GLB1
21730,KEGG_2019_Human,Pyruvate metabolism,1/39,0.0019499637955508,0.0019499637955508,0,0,19961.0,124555.53162481484,ME3
21731,KEGG_2019_Human,"Alanine, aspartate and glutamate metabolism",1/35,0.0017499663721595,0.0034999327443191,0,0,19965.0,126740.98858805298,DDO
21732,KEGG_2019_Human,Peroxisome,1/83,0.0041499404726918,0.0041499404726918,0,0,19917.0,109237.99888847338,DDO
21733,KEGG_2019_Human,alpha-Linolenic acid metabolism,1/25,0.0012499733663791,0.0040499156827088,0,0,19975.0,133525.54486996148,ACOX3
21734,KEGG_2019_Human,Biosynthesis of unsaturated fatty acids,1/27,0.0013499718942362,0.0040499156827088,0,0,19973.0,131975.02298599784,ACOX3
21735,KEGG_2019_Human,Fatty acid degradation,1/44,0.0021999607179423,0.0043999214358846,0,0,19956.0,122117.06559109331,ACOX3
21736,KEGG_2019_Human,PPAR signaling pathway,1/74,0.0036999446830449,0.0049799285672302,0,0,19926.0,111574.38983110404,ACOX3
21737,KEGG_2019_Human,Peroxisome,1/83,0.0041499404726918,0.0049799285672302,0,0,19917.0,109237.99888847338,ACOX3
21738,KEGG_2019_Human,cAMP signaling pathway,1/212,0.0105998955026255,0.0105998955026255,0,0,19788.0,89974.27756224656,ACOX3
21739,KEGG_2019_Human,Insulin secretion,1/86,0.0042999391173866,0.0044999373439762,0,0,19914.0,108514.46102290176,KCNN4
21740,KEGG_2019_Human,Salivary secretion,1/90,0.0044999373439762,0.0044999373439762,0,0,19910.0,107587.50385474482,KCNN4
21741,KEGG_2019_Human,Protein digestion and absorption,1/90,0.0044999373439762,0.0044999373439762,0,0,19910.0,107587.50385474482,KCNN4
21742,KEGG_2019_Human,DNA replication,1/36,0.0017999657178272,0.0017999657178272,0,0,19964.0,126172.23364250171,POLA2
21743,KEGG_2019_Human,Endocrine and other factor-regulated calcium reabsorption,1/48,0.0023999583567988,0.0050999132780359,0,0,19952.0,120356.5272753826,VDR
21744,KEGG_2019_Human,Mineral absorption,1/51,0.0025499566390179,0.0050999132780359,0,0,19949.0,119129.0228601236,VDR
21745,KEGG_2019_Human,"Parathyroid hormone synthesis, secretion and action",1/106,0.0052999306076525,0.0070665741435367,0,0,19894.0,104245.78450366124,VDR
21746,KEGG_2019_Human,Tuberculosis,1/179,0.0089499050800561,0.0089499050800561,0,0,19821.0,93478.0629355712,VDR
21747,KEGG_2019_Human,Ascorbate and aldarate metabolism,1/27,0.0013499718942362,0.004685646776936,0,0,19973.0,131975.02298599784,UGT1A5
21748,KEGG_2019_Human,Pentose and glucuronate interconversions,1/34,0.0016999670339032,0.004685646776936,0,0,19966.0,127326.1054203148,UGT1A5
21749,KEGG_2019_Human,Porphyrin and chlorophyll metabolism,1/42,0.0020999619311272,0.004685646776936,0,0,19958.0,123057.75613441122,UGT1A5
21750,KEGG_2019_Human,Steroid hormone biosynthesis,1/60,0.002999951725986,0.004685646776936,0,0,19940.0,115834.63209072244,UGT1A5
21751,KEGG_2019_Human,Retinol metabolism,1/67,0.0033499481224912,0.004685646776936,0,0,19933.0,113594.38808369274,UGT1A5
21752,KEGG_2019_Human,Metabolism of xenobiotics by cytochrome P450,1/74,0.0036999446830449,0.004685646776936,0,0,19926.0,111574.38983110404,UGT1A5
21753,KEGG_2019_Human,Chemical carcinogenesis,1/82,0.004099940929819,0.004685646776936,0,0,19918.0,109484.9180722932,UGT1A5
21754,KEGG_2019_Human,Drug metabolism,1/108,0.0053999298011749,0.0053999298011749,0,0,19892.0,103863.47861844616,UGT1A5
21755,KEGG_2019_Human,Pertussis,1/76,0.0037999437281752,0.0075998874563505,0,0,19924.0,111031.8499691117,SFTPA1
21756,KEGG_2019_Human,Phagosome,1/152,0.0075999137114971,0.0075999137114971,0,0,19848.0,96850.665715497,SFTPA1
21757,KEGG_2019_Human,Ferroptosis,1/40,0.0019999631680592,0.0083332217850927,0,0,19960.0,124043.94523066044,TFRC
21758,KEGG_2019_Human,Hematopoietic cell lineage,1/97,0.0048499343304706,0.0083332217850927,0,0,19903.0,106058.9096435903,TFRC
21759,KEGG_2019_Human,HIF-1 signaling pathway,1/100,0.0049999330710556,0.0083332217850927,0,0,19900.0,105436.78197328727,TFRC
21760,KEGG_2019_Human,Phagosome,1/152,0.0075999137114971,0.0094998921393714,0,0,19848.0,96850.665715497,TFRC
21761,KEGG_2019_Human,Endocytosis,1/244,0.0121998870519305,0.0121998870519305,0,0,19756.0,87051.4275316661,TFRC
21762,KEGG_2019_Human,Thermogenesis,1/231,0.0115498903940656,0.0115498903940656,0,0,19769.0,88191.07730937863,KLB
21763,KEGG_2019_Human,Cell adhesion molecules (CAMs),1/145,0.0072499160871101,0.0090499044707863,0,0,19855.0,97820.92670675044,LRRC4C
21764,KEGG_2019_Human,Axon guidance,1/181,0.0090499044707863,0.0090499044707863,0,0,19819.0,93248.41634586031,LRRC4C
21765,KEGG_2019_Human,Adherens junction,1/72,0.0035999456502131,0.0071998913004262,0,0,19928.0,112131.59838572376,NECTIN3
21766,KEGG_2019_Human,Cell adhesion molecules (CAMs),1/145,0.0072499160871101,0.0072499160871101,0,0,19855.0,97820.92670675044,NECTIN3
21767,KEGG_2019_Human,Vibrio cholerae infection,1/50,0.0024999572069037,0.0024999572069037,0,0,19950.0,119530.05920663515,KDELR2
21768,KEGG_2019_Human,Fatty acid elongation,1/27,0.0013499718942362,0.0013499718942362,0,0,19973.0,131975.02298599784,MECR
21769,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR52N4
21770,KEGG_2019_Human,Lysosome,1/123,0.0061499239842961,0.0061499239842961,0,0,19877.0,101200.07933676826,LAPTM5
21771,KEGG_2019_Human,Pathogenic Escherichia coli infection,1/55,0.0027499544131125,0.0084999078692823,0,0,19945.0,117599.1294878737,TUBA1A
21772,KEGG_2019_Human,Gap junction,1/88,0.0043999382262822,0.0084999078692823,0,0,19912.0,108045.79305232369,TUBA1A
21773,KEGG_2019_Human,Apoptosis,1/143,0.0071499167770442,0.0084999078692823,0,0,19857.0,98106.57763600958,TUBA1A
21774,KEGG_2019_Human,Phagosome,1/152,0.0075999137114971,0.0084999078692823,0,0,19848.0,96850.665715497,TUBA1A
21775,KEGG_2019_Human,Tight junction,1/170,0.0084999078692823,0.0084999078692823,0,0,19830.0,94543.49009679438,TUBA1A
21776,KEGG_2019_Human,Ovarian steroidogenesis,1/49,0.0024499577795033,0.0096873908900718,0,0,19951.0,119939.1172087114,ADCY4
21777,KEGG_2019_Human,Regulation of lipolysis in adipocytes,1/55,0.0027499544131125,0.0096873908900718,0,0,19945.0,117599.1294878737,ADCY4
21778,KEGG_2019_Human,Cortisol synthesis and secretion,1/65,0.003249949134407,0.0096873908900718,0,0,19935.0,114209.92613860144,ADCY4
21779,KEGG_2019_Human,Bile secretion,1/72,0.0035999456502131,0.0096873908900718,0,0,19928.0,112131.59838572376,ADCY4
21780,KEGG_2019_Human,Thyroid hormone synthesis,1/74,0.0036999446830449,0.0096873908900718,0,0,19926.0,111574.38983110404,ADCY4
21781,KEGG_2019_Human,Gastric acid secretion,1/75,0.0037499442041125,0.0096873908900718,0,0,19925.0,111301.33528642564,ADCY4
21782,KEGG_2019_Human,Taste transduction,1/83,0.0041499404726918,0.0096873908900718,0,0,19917.0,109237.99888847338,ADCY4
21783,KEGG_2019_Human,Insulin secretion,1/86,0.0042999391173866,0.0096873908900718,0,0,19914.0,108514.46102290176,ADCY4
21784,KEGG_2019_Human,Gap junction,1/88,0.0043999382262822,0.0096873908900718,0,0,19912.0,108045.79305232369,ADCY4
21785,KEGG_2019_Human,GABAergic synapse,1/89,0.0044499377838098,0.0096873908900718,0,0,19911.0,107815.380281759,ADCY4
21786,KEGG_2019_Human,Salivary secretion,1/90,0.0044999373439762,0.0096873908900718,0,0,19910.0,107587.50385474482,ADCY4
21787,KEGG_2019_Human,Dilated cardiomyopathy (DCM),1/91,0.0045499369072032,0.0096873908900718,0,0,19909.0,107362.10783923086,ADCY4
21788,KEGG_2019_Human,Morphine addiction,1/91,0.0045499369072032,0.0096873908900718,0,0,19909.0,107362.10783923086,ADCY4
21789,KEGG_2019_Human,GnRH signaling pathway,1/93,0.0046499360391879,0.0096873908900718,0,0,19907.0,106918.54242106884,ADCY4
21790,KEGG_2019_Human,Circadian entrainment,1/97,0.0048499343304706,0.0096873908900718,0,0,19903.0,106058.9096435903,ADCY4
21791,KEGG_2019_Human,Pancreatic secretion,1/98,0.0048999339081079,0.0096873908900718,0,0,19902.0,105849.45495286948,ADCY4
21792,KEGG_2019_Human,Aldosterone synthesis and secretion,1/98,0.0048999339081079,0.0096873908900718,0,0,19902.0,105849.45495286948,ADCY4
21793,KEGG_2019_Human,Progesterone-mediated oocyte maturation,1/99,0.0049499334884068,0.0096873908900718,0,0,19901.0,105642.09305076736,ADCY4
21794,KEGG_2019_Human,Inflammatory mediator regulation of TRP channels,1/100,0.0049999330710556,0.0096873908900718,0,0,19900.0,105436.78197328727,ADCY4
21795,KEGG_2019_Human,Melanogenesis,1/101,0.0050499326546803,0.0096873908900718,0,0,19899.0,105233.48101229242,ADCY4
21796,KEGG_2019_Human,Longevity regulating pathway,1/102,0.0050999322416682,0.0096873908900718,0,0,19898.0,105032.15064717118,ADCY4
21797,KEGG_2019_Human,"Parathyroid hormone synthesis, secretion and action",1/106,0.0052999306076525,0.0096873908900718,0,0,19894.0,104245.78450366124,ADCY4
21798,KEGG_2019_Human,Cholinergic synapse,1/112,0.0055999282120529,0.0096873908900718,0,0,19888.0,103119.30984392198,ADCY4
21799,KEGG_2019_Human,Glutamatergic synapse,1/114,0.005699927427839,0.0096873908900718,0,0,19886.0,102756.96431429044,ADCY4
21800,KEGG_2019_Human,Platelet activation,1/124,0.0061999236097501,0.0096873908900718,0,0,19876.0,101034.04709010696,ADCY4
21801,KEGG_2019_Human,Oocyte meiosis,1/125,0.0062499232373748,0.0096873908900718,0,0,19875.0,100869.32368441945,ADCY4
21802,KEGG_2019_Human,Purine metabolism,1/129,0.006449921761047,0.0096873908900718,0,0,19871.0,100223.109907462,ADCY4
21803,KEGG_2019_Human,Relaxin signaling pathway,1/130,0.0064999213952527,0.0096873908900718,0,0,19870.0,100064.62842845908,ADCY4
21804,KEGG_2019_Human,Vascular smooth muscle contraction,1/132,0.0065999206698993,0.0096873908900718,0,0,19868.0,99751.22090491928,ADCY4
21805,KEGG_2019_Human,Estrogen signaling pathway,1/137,0.0068499188797651,0.0096873908900718,0,0,19863.0,98987.62735269018,ADCY4
21806,KEGG_2019_Human,Apelin signaling pathway,1/137,0.0068499188797651,0.0096873908900718,0,0,19863.0,98987.62735269018,ADCY4
21807,KEGG_2019_Human,Adrenergic signaling in cardiomyocytes,1/145,0.0072499160871101,0.0096873908900718,0,0,19855.0,97820.92670675044,ADCY4
21808,KEGG_2019_Human,Phospholipase D signaling pathway,1/148,0.007399915061391,0.0096873908900718,0,0,19852.0,97399.60470052566,ADCY4
21809,KEGG_2019_Human,Retrograde endocannabinoid signaling,1/148,0.007399915061391,0.0096873908900718,0,0,19852.0,97399.60470052566,ADCY4
21810,KEGG_2019_Human,Oxytocin signaling pathway,1/153,0.0076499133771537,0.0096873908900718,0,0,19847.0,96715.6407630817,ADCY4
21811,KEGG_2019_Human,Cushing syndrome,1/155,0.0077499127120574,0.0096873908900718,0,0,19845.0,96448.16254952336,ADCY4
21812,KEGG_2019_Human,cGMP-PKG signaling pathway,1/166,0.0082999091363732,0.0100944840847783,0,0,19834.0,95034.82345515196,ADCY4
21813,KEGG_2019_Human,Calcium signaling pathway,1/188,0.009399902370135,0.0109614251298456,0,0,19812.0,92463.712994847,ADCY4
21814,KEGG_2019_Human,Chemokine signaling pathway,1/190,0.0094999017791995,0.0109614251298456,0,0,19810.0,92244.74636351672,ADCY4
21815,KEGG_2019_Human,Rap1 signaling pathway,1/206,0.010299897173561,0.0115873843202561,0,0,19794.0,90569.849337325,ADCY4
21816,KEGG_2019_Human,cAMP signaling pathway,1/212,0.0105998955026255,0.0116340316492232,0,0,19788.0,89974.27756224656,ADCY4
21817,KEGG_2019_Human,Human T-cell leukemia virus 1 infection,1/219,0.0109498935894162,0.0117320288458031,0,0,19781.0,89299.85161916987,ADCY4
21818,KEGG_2019_Human,Human cytomegalovirus infection,1/225,0.0112498919790339,0.0117731427687564,0,0,19775.0,88738.27077557483,ADCY4
21819,KEGG_2019_Human,Thermogenesis,1/231,0.0115498903940656,0.0118123879030216,0,0,19769.0,88191.07730937863,ADCY4
21820,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,ADCY4
21821,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF641
21822,KEGG_2019_Human,Cell cycle,1/124,0.0061999236097501,0.0061999236097501,0,0,19876.0,101034.04709010696,TFDP2
21823,KEGG_2019_Human,Vascular smooth muscle contraction,1/132,0.0065999206698993,0.0128748714669513,0,0,19868.0,99751.22090491928,ADORA2B
21824,KEGG_2019_Human,Alcoholism,1/180,0.0089999047745351,0.0128748714669513,0,0,19820.0,93362.92821536642,ADORA2B
21825,KEGG_2019_Human,Calcium signaling pathway,1/188,0.009399902370135,0.0128748714669513,0,0,19812.0,92463.712994847,ADORA2B
21826,KEGG_2019_Human,Rap1 signaling pathway,1/206,0.010299897173561,0.0128748714669513,0,0,19794.0,90569.849337325,ADORA2B
21827,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,ADORA2B
21828,KEGG_2019_Human,Chemokine signaling pathway,1/190,0.0094999017791995,0.0146998751759735,0,0,19810.0,92244.74636351672,CCL1
21829,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0146998751759735,0,0,19706.0,83157.67014793828,CCL1
21830,KEGG_2019_Human,Huntington disease,1/193,0.0096499008972596,0.0096499008972596,0,0,19807.0,91920.47679471428,IFT57
21831,KEGG_2019_Human,RNA transport,1/165,0.0082499094553477,0.0164998189106955,0,0,19835.0,95159.46482222488,EIF2B3
21832,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,EIF2B3
21833,KEGG_2019_Human,Vasopressin-regulated water reabsorption,1/44,0.0021999607179423,0.0043999214358846,0,0,19956.0,122117.06559109331,ARHGDIG
21834,KEGG_2019_Human,Neurotrophin signaling pathway,1/119,0.0059499254985137,0.0059499254985137,0,0,19881.0,101877.73080211312,ARHGDIG
21835,KEGG_2019_Human,RNA transport,1/165,0.0082499094553477,0.0164998189106955,0,0,19835.0,95159.46482222488,EIF2B2
21836,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,EIF2B2
21837,KEGG_2019_Human,Pathogenic Escherichia coli infection,1/55,0.0027499544131125,0.0084999078692823,0,0,19945.0,117599.1294878737,TUBA1B
21838,KEGG_2019_Human,Gap junction,1/88,0.0043999382262822,0.0084999078692823,0,0,19912.0,108045.79305232369,TUBA1B
21839,KEGG_2019_Human,Apoptosis,1/143,0.0071499167770442,0.0084999078692823,0,0,19857.0,98106.57763600958,TUBA1B
21840,KEGG_2019_Human,Phagosome,1/152,0.0075999137114971,0.0084999078692823,0,0,19848.0,96850.665715497,TUBA1B
21841,KEGG_2019_Human,Tight junction,1/170,0.0084999078692823,0.0084999078692823,0,0,19830.0,94543.49009679438,TUBA1B
21842,KEGG_2019_Human,Fatty acid biosynthesis,1/13,0.0006499833083207112,0.0006499833083207112,0,0,19987.0,146675.87616784443,MCAT
21843,KEGG_2019_Human,Chemokine signaling pathway,1/190,0.0094999017791995,0.0094999017791995,0,0,19810.0,92244.74636351672,FGR
21844,KEGG_2019_Human,p53 signaling pathway,1/72,0.0035999456502131,0.0035999456502131,0,0,19928.0,112131.59838572376,AIFM2
21845,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR1D5
21846,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,GLRA2
21847,KEGG_2019_Human,Mucin type O-glycan biosynthesis,1/31,0.0015499690656704,0.0015499690656704,0,0,19969.0,129189.85098816035,GALNT3
21848,KEGG_2019_Human,Basal cell carcinoma,1/63,0.0031499501598827,0.0123407788237995,0,0,19937.0,114844.46974572667,FZD3
21849,KEGG_2019_Human,Melanogenesis,1/101,0.0050499326546803,0.0123407788237995,0,0,19899.0,105233.48101229242,FZD3
21850,KEGG_2019_Human,Signaling pathways regulating pluripotency of stem cells,1/139,0.006949918172816,0.0123407788237995,0,0,19861.0,98689.81333375497,FZD3
21851,KEGG_2019_Human,Breast cancer,1/147,0.0073499154017982,0.0123407788237995,0,0,19853.0,97539.10874372096,FZD3
21852,KEGG_2019_Human,Gastric cancer,1/149,0.0074499147221605,0.0123407788237995,0,0,19851.0,97261.02051561224,FZD3
21853,KEGG_2019_Human,mTOR signaling pathway,1/152,0.0075999137114971,0.0123407788237995,0,0,19848.0,96850.665715497,FZD3
21854,KEGG_2019_Human,Cushing syndrome,1/155,0.0077499127120574,0.0123407788237995,0,0,19845.0,96448.16254952336,FZD3
21855,KEGG_2019_Human,Wnt signaling pathway,1/158,0.0078999117225733,0.0123407788237995,0,0,19842.0,96053.2110949472,FZD3
21856,KEGG_2019_Human,Hippo signaling pathway,1/160,0.0079999110688441,0.0123407788237995,0,0,19840.0,95793.96509856998,FZD3
21857,KEGG_2019_Human,Hepatocellular carcinoma,1/168,0.0083999085011095,0.0123407788237995,0,0,19832.0,94787.72752807094,FZD3
21858,KEGG_2019_Human,Axon guidance,1/181,0.0090499044707863,0.0123407788237995,0,0,19819.0,93248.41634586031,FZD3
21859,KEGG_2019_Human,Proteoglycans in cancer,1/201,0.0100498985877989,0.0125623732347487,0,0,19799.0,91079.21596609056,FZD3
21860,KEGG_2019_Human,MicroRNAs in cancer,1/299,0.0149498740670514,0.0172498546927516,0,0,19701.0,82804.33538735632,FZD3
21861,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0176784294203191,0,0,19670.0,80733.60565076157,FZD3
21862,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,FZD3
21863,KEGG_2019_Human,ECM-receptor interaction,1/82,0.004099940929819,0.004099940929819,0,0,19918.0,109484.9180722932,SV2B
21864,KEGG_2019_Human,Human immunodeficiency virus 1 infection,1/212,0.0105998955026255,0.0105998955026255,0,0,19788.0,89974.27756224656,APOBEC3B
21865,KEGG_2019_Human,Pertussis,1/76,0.0037999437281752,0.0039499423167337,0,0,19924.0,111031.8499691117,C4BPA
21866,KEGG_2019_Human,Complement and coagulation cascades,1/79,0.0039499423167337,0.0039499423167337,0,0,19921.0,110243.89578070649,C4BPA
21867,KEGG_2019_Human,Melanoma,1/72,0.0035999456502131,0.0173998352024406,0,0,19928.0,112131.59838572376,FGF7
21868,KEGG_2019_Human,Breast cancer,1/147,0.0073499154017982,0.0173998352024406,0,0,19853.0,97539.10874372096,FGF7
21869,KEGG_2019_Human,Gastric cancer,1/149,0.0074499147221605,0.0173998352024406,0,0,19851.0,97261.02051561224,FGF7
21870,KEGG_2019_Human,Rap1 signaling pathway,1/206,0.010299897173561,0.0173998352024406,0,0,19794.0,90569.849337325,FGF7
21871,KEGG_2019_Human,Regulation of actin cytoskeleton,1/214,0.0106998949514067,0.0173998352024406,0,0,19786.0,89779.39753374986,FGF7
21872,KEGG_2019_Human,Ras signaling pathway,1/232,0.0115998901349604,0.0173998352024406,0,0,19768.0,88101.22480150245,FGF7
21873,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.018964124940408,0,0,19705.0,83086.53988020132,FGF7
21874,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0199123454715377,0,0,19646.0,79255.8617626126,FGF7
21875,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,FGF7
21876,KEGG_2019_Human,Proximal tubule bicarbonate reclamation,1/23,0.0011499748819949,0.0062999150247102,0,0,19977.0,135204.63922267244,ATP1B2
21877,KEGG_2019_Human,Aldosterone-regulated sodium reabsorption,1/37,0.0018499650702878,0.0062999150247102,0,0,19963.0,125618.9446446357,ATP1B2
21878,KEGG_2019_Human,Carbohydrate digestion and absorption,1/44,0.0021999607179423,0.0062999150247102,0,0,19956.0,122117.06559109331,ATP1B2
21879,KEGG_2019_Human,Endocrine and other factor-regulated calcium reabsorption,1/48,0.0023999583567988,0.0062999150247102,0,0,19952.0,120356.5272753826,ATP1B2
21880,KEGG_2019_Human,Mineral absorption,1/51,0.0025499566390179,0.0062999150247102,0,0,19949.0,119129.0228601236,ATP1B2
21881,KEGG_2019_Human,Bile secretion,1/72,0.0035999456502131,0.0062999150247102,0,0,19928.0,112131.59838572376,ATP1B2
21882,KEGG_2019_Human,Thyroid hormone synthesis,1/74,0.0036999446830449,0.0062999150247102,0,0,19926.0,111574.38983110404,ATP1B2
21883,KEGG_2019_Human,Gastric acid secretion,1/75,0.0037499442041125,0.0062999150247102,0,0,19925.0,111301.33528642564,ATP1B2
21884,KEGG_2019_Human,Cardiac muscle contraction,1/78,0.0038999427840466,0.0062999150247102,0,0,19922.0,110503.2180492851,ATP1B2
21885,KEGG_2019_Human,Insulin secretion,1/86,0.0042999391173866,0.0062999150247102,0,0,19914.0,108514.46102290176,ATP1B2
21886,KEGG_2019_Human,Salivary secretion,1/90,0.0044999373439762,0.0062999150247102,0,0,19910.0,107587.50385474482,ATP1B2
21887,KEGG_2019_Human,Protein digestion and absorption,1/90,0.0044999373439762,0.0062999150247102,0,0,19910.0,107587.50385474482,ATP1B2
21888,KEGG_2019_Human,Pancreatic secretion,1/98,0.0048999339081079,0.0062999150247102,0,0,19902.0,105849.45495286948,ATP1B2
21889,KEGG_2019_Human,Aldosterone synthesis and secretion,1/98,0.0048999339081079,0.0062999150247102,0,0,19902.0,105849.45495286948,ATP1B2
21890,KEGG_2019_Human,Thyroid hormone signaling pathway,1/116,0.0057999266512085,0.0069599119814502,0,0,19884.0,102400.8105961506,ATP1B2
21891,KEGG_2019_Human,Adrenergic signaling in cardiomyocytes,1/145,0.0072499160871101,0.0081561555979989,0,0,19855.0,97820.92670675044,ATP1B2
21892,KEGG_2019_Human,cGMP-PKG signaling pathway,1/166,0.0082999091363732,0.0087881390855717,0,0,19834.0,95034.82345515196,ATP1B2
21893,KEGG_2019_Human,cAMP signaling pathway,1/212,0.0105998955026255,0.0105998955026255,0,0,19788.0,89974.27756224656,ATP1B2
21894,KEGG_2019_Human,Protein digestion and absorption,1/90,0.0044999373439762,0.0044999373439762,0,0,19910.0,107587.50385474482,SLC7A8
21895,KEGG_2019_Human,Salivary secretion,1/90,0.0044999373439762,0.0044999373439762,0,0,19910.0,107587.50385474482,CST5
21896,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR52I1
21897,KEGG_2019_Human,Wnt signaling pathway,1/158,0.0078999117225733,0.0078999117225733,0,0,19842.0,96053.2110949472,PRICKLE4
21898,KEGG_2019_Human,Proteasome,1/45,0.0022499601197094,0.0022499601197094,0,0,19955.0,121662.49782449217,PSMB5
21899,KEGG_2019_Human,Glutathione metabolism,1/56,0.0027999538675741,0.0036999446830449,0,0,19944.0,117233.87022514464,GPX8
21900,KEGG_2019_Human,Arachidonic acid metabolism,1/63,0.0031499501598827,0.0036999446830449,0,0,19937.0,114844.46974572667,GPX8
21901,KEGG_2019_Human,Thyroid hormone synthesis,1/74,0.0036999446830449,0.0036999446830449,0,0,19926.0,111574.38983110404,GPX8
21902,KEGG_2019_Human,Glycosylphosphatidylinositol (GPI)-anchor biosynthesis,1/25,0.0012499733663791,0.0012499733663791,0,0,19975.0,133525.54486996148,PIGM
21903,KEGG_2019_Human,Natural killer cell mediated cytotoxicity,1/131,0.0065499210316603,0.0065499210316603,0,0,19869.0,99907.33811343512,RAET1G
21904,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0146998751759735,0,0,19706.0,83157.67014793828,IL36A
21905,KEGG_2019_Human,Sphingolipid signaling pathway,1/119,0.0059499254985137,0.0118998509970274,0,0,19881.0,101877.73080211312,S1PR2
21906,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,S1PR2
21907,KEGG_2019_Human,Toll-like receptor signaling pathway,1/104,0.0051999314202997,0.0146180343095258,0,0,19896.0,104635.24941415618,IFNAR2
21908,KEGG_2019_Human,Osteoclast differentiation,1/127,0.0063499224962247,0.0146180343095258,0,0,19873.0,100543.72072014232,IFNAR2
21909,KEGG_2019_Human,Natural killer cell mediated cytotoxicity,1/131,0.0065499210316603,0.0146180343095258,0,0,19869.0,99907.33811343512,IFNAR2
21910,KEGG_2019_Human,Measles,1/138,0.0068999185254481,0.0146180343095258,0,0,19862.0,98838.19160389496,IFNAR2
21911,KEGG_2019_Human,Hepatitis C,1/155,0.0077499127120574,0.0146180343095258,0,0,19845.0,96448.16254952336,IFNAR2
21912,KEGG_2019_Human,Necroptosis,1/162,0.0080999104202618,0.0146180343095258,0,0,19838.0,95537.86936302872,IFNAR2
21913,KEGG_2019_Human,JAK-STAT signaling pathway,1/162,0.0080999104202618,0.0146180343095258,0,0,19838.0,95537.86936302872,IFNAR2
21914,KEGG_2019_Human,Influenza A,1/171,0.0085499075557634,0.0146180343095258,0,0,19829.0,94422.42241345016,IFNAR2
21915,KEGG_2019_Human,NOD-like receptor signaling pathway,1/178,0.0088999053857096,0.0146180343095258,0,0,19822.0,93593.82745769851,IFNAR2
21916,KEGG_2019_Human,Kaposi sarcoma-associated herpesvirus infection,1/186,0.0092999029651357,0.0146180343095258,0,0,19814.0,92684.96451050608,IFNAR2
21917,KEGG_2019_Human,Epstein-Barr virus infection,1/201,0.0100498985877989,0.0146180343095258,0,0,19799.0,91079.21596609056,IFNAR2
21918,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0195998335679646,0,0,19706.0,83157.67014793828,IFNAR2
21919,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0202284144472764,0,0,19670.0,80733.60565076157,IFNAR2
21920,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0202284144472764,0,0,19646.0,79255.8617626126,IFNAR2
21921,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.026239828244933,0,0,19508.0,72277.44006442746,IFNAR2
21922,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,IFNAR2
21923,KEGG_2019_Human,Mucin type O-glycan biosynthesis,1/31,0.0015499690656704,0.0015499690656704,0,0,19969.0,129189.85098816035,C1GALT1C1
21924,KEGG_2019_Human,Glycerophospholipid metabolism,1/97,0.0048499343304706,0.0048499343304706,0,0,19903.0,106058.9096435903,PISD
21925,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0146998751759735,0,0,19706.0,83157.67014793828,EDA
21926,KEGG_2019_Human,RNA transport,1/165,0.0082499094553477,0.0082499094553477,0,0,19835.0,95159.46482222488,NUP43
21927,KEGG_2019_Human,Pertussis,1/76,0.0037999437281752,0.0081499100978668,0,0,19924.0,111031.8499691117,TICAM2
21928,KEGG_2019_Human,NF-kappa B signaling pathway,1/95,0.0047499351803394,0.0081499100978668,0,0,19905.0,106484.27183626965,TICAM2
21929,KEGG_2019_Human,Toll-like receptor signaling pathway,1/104,0.0051999314202997,0.0081499100978668,0,0,19896.0,104635.24941415618,TICAM2
21930,KEGG_2019_Human,Necroptosis,1/162,0.0080999104202618,0.0081499100978668,0,0,19838.0,95537.86936302872,TICAM2
21931,KEGG_2019_Human,Hepatitis B,1/163,0.0081499100978668,0.0081499100978668,0,0,19837.0,95410.9786681514,TICAM2
21932,KEGG_2019_Human,Pyrimidine metabolism,1/57,0.002849953326298,0.005699906652596,0,0,19943.0,116875.00742975442,ENTPD6
21933,KEGG_2019_Human,Purine metabolism,1/129,0.006449921761047,0.006449921761047,0,0,19871.0,100223.109907462,ENTPD6
21934,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR51B5
21935,KEGG_2019_Human,Collecting duct acid secretion,1/27,0.0013499718942362,0.0072798990515251,0,0,19973.0,131975.02298599784,ATP6V0E2
21936,KEGG_2019_Human,Vibrio cholerae infection,1/50,0.0024999572069037,0.0072798990515251,0,0,19950.0,119530.05920663515,ATP6V0E2
21937,KEGG_2019_Human,Epithelial cell signaling in Helicobacter pylori infection,1/68,0.0033999476216189,0.0072798990515251,0,0,19932.0,113293.39338050144,ATP6V0E2
21938,KEGG_2019_Human,Synaptic vesicle cycle,1/78,0.0038999427840466,0.0072798990515251,0,0,19922.0,110503.2180492851,ATP6V0E2
21939,KEGG_2019_Human,Rheumatoid arthritis,1/91,0.0045499369072032,0.0072798990515251,0,0,19909.0,107362.10783923086,ATP6V0E2
21940,KEGG_2019_Human,Oxidative phosphorylation,1/133,0.0066499203093911,0.0086856156702824,0,0,19867.0,99596.2591544721,ATP6V0E2
21941,KEGG_2019_Human,Phagosome,1/152,0.0075999137114971,0.0086856156702824,0,0,19848.0,96850.665715497,ATP6V0E2
21942,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0164998674589645,0,0,19670.0,80733.60565076157,ATP6V0E2
21943,KEGG_2019_Human,Inositol phosphate metabolism,1/74,0.0036999446830449,0.0074249002326102,0,0,19926.0,111574.38983110404,ITPKA
21944,KEGG_2019_Human,Phosphatidylinositol signaling system,1/99,0.0049499334884068,0.0074249002326102,0,0,19901.0,105642.09305076736,ITPKA
21945,KEGG_2019_Human,Calcium signaling pathway,1/188,0.009399902370135,0.009399902370135,0,0,19812.0,92463.712994847,ITPKA
21946,KEGG_2019_Human,Huntington disease,1/193,0.0096499008972596,0.0096499008972596,0,0,19807.0,91920.47679471428,DNALI1
21947,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR2V1
21948,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0146998751759735,0,0,19706.0,83157.67014793828,CD70
21949,KEGG_2019_Human,Glycosaminoglycan biosynthesis,1/53,0.0026499555173137,0.0026499555173137,0,0,19947.0,118349.78824235698,CHST12
21950,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF689
21951,KEGG_2019_Human,Retinol metabolism,1/67,0.0033499481224912,0.0033499481224912,0,0,19933.0,113594.38808369274,RDH12
21952,KEGG_2019_Human,Signaling pathways regulating pluripotency of stem cells,1/139,0.006949918172816,0.0109498935894162,0,0,19861.0,98689.81333375497,TCF3
21953,KEGG_2019_Human,Transcriptional misregulation in cancer,1/186,0.0092999029651357,0.0109498935894162,0,0,19814.0,92684.96451050608,TCF3
21954,KEGG_2019_Human,Human T-cell leukemia virus 1 infection,1/219,0.0109498935894162,0.0109498935894162,0,0,19781.0,89299.85161916987,TCF3
21955,KEGG_2019_Human,Aminoacyl-tRNA biosynthesis,1/66,0.003299948626608,0.003299948626608,0,0,19934.0,113899.85357353876,FARSB
21956,KEGG_2019_Human,Glutathione metabolism,1/56,0.0027999538675741,0.0051874255908648,0,0,19944.0,117233.87022514464,GSTK1
21957,KEGG_2019_Human,Metabolism of xenobiotics by cytochrome P450,1/74,0.0036999446830449,0.0051874255908648,0,0,19926.0,111574.38983110404,GSTK1
21958,KEGG_2019_Human,Chemical carcinogenesis,1/82,0.004099940929819,0.0051874255908648,0,0,19918.0,109484.9180722932,GSTK1
21959,KEGG_2019_Human,Peroxisome,1/83,0.0041499404726918,0.0051874255908648,0,0,19917.0,109237.99888847338,GSTK1
21960,KEGG_2019_Human,Drug metabolism,1/108,0.0053999298011749,0.0053999298011749,0,0,19892.0,103863.47861844616,GSTK1
21961,KEGG_2019_Human,RNA transport,1/165,0.0082499094553477,0.0082499094553477,0,0,19835.0,95159.46482222488,NUP160
21962,KEGG_2019_Human,Asthma,1/31,0.0015499690656704,0.0083141731379497,0,0,19969.0,129189.85098816035,HLA-DQA2
21963,KEGG_2019_Human,Allograft rejection,1/38,0.001899964429635,0.0083141731379497,0,0,19962.0,125080.29732025368,HLA-DQA2
21964,KEGG_2019_Human,Graft-versus-host disease,1/41,0.0020499625466866,0.0083141731379497,0,0,19959.0,123544.88783416104,HLA-DQA2
21965,KEGG_2019_Human,Type I diabetes mellitus,1/43,0.0021499613216957,0.0083141731379497,0,0,19957.0,122581.98940490963,HLA-DQA2
21966,KEGG_2019_Human,Intestinal immune network for IgA production,1/48,0.0023999583567988,0.0083141731379497,0,0,19952.0,120356.5272753826,HLA-DQA2
21967,KEGG_2019_Human,Autoimmune thyroid disease,1/53,0.0026499555173137,0.0083141731379497,0,0,19947.0,118349.78824235698,HLA-DQA2
21968,KEGG_2019_Human,Viral myocarditis,1/59,0.0029499522555206,0.0083141731379497,0,0,19941.0,116175.59385530632,HLA-DQA2
21969,KEGG_2019_Human,Inflammatory bowel disease (IBD),1/65,0.003249949134407,0.0083141731379497,0,0,19935.0,114209.92613860144,HLA-DQA2
21970,KEGG_2019_Human,Staphylococcus aureus infection,1/68,0.0033999476216189,0.0083141731379497,0,0,19932.0,113293.39338050144,HLA-DQA2
21971,KEGG_2019_Human,Leishmaniasis,1/74,0.0036999446830449,0.0083141731379497,0,0,19926.0,111574.38983110404,HLA-DQA2
21972,KEGG_2019_Human,Antigen processing and presentation,1/77,0.0038499432547502,0.0083141731379497,0,0,19923.0,110765.8407373636,HLA-DQA2
21973,KEGG_2019_Human,Rheumatoid arthritis,1/91,0.0045499369072032,0.0083141731379497,0,0,19909.0,107362.10783923086,HLA-DQA2
21974,KEGG_2019_Human,Th1 and Th2 cell differentiation,1/92,0.0045999364719865,0.0083141731379497,0,0,19908.0,107139.13814408927,HLA-DQA2
21975,KEGG_2019_Human,Hematopoietic cell lineage,1/97,0.0048499343304706,0.0083141731379497,0,0,19903.0,106058.9096435903,HLA-DQA2
21976,KEGG_2019_Human,Th17 cell differentiation,1/107,0.0053499302026925,0.0084748917286727,0,0,19893.0,104053.753408911,HLA-DQA2
21977,KEGG_2019_Human,Toxoplasmosis,1/113,0.0056499278191151,0.0084748917286727,0,0,19887.0,102937.34947211576,HLA-DQA2
21978,KEGG_2019_Human,Systemic lupus erythematosus,1/133,0.0066499203093911,0.0093881227897286,0,0,19867.0,99596.2591544721,HLA-DQA2
21979,KEGG_2019_Human,Cell adhesion molecules (CAMs),1/145,0.0072499160871101,0.0095998910039963,0,0,19855.0,97820.92670675044,HLA-DQA2
21980,KEGG_2019_Human,Phagosome,1/152,0.0075999137114971,0.0095998910039963,0,0,19848.0,96850.665715497,HLA-DQA2
21981,KEGG_2019_Human,Influenza A,1/171,0.0085499075557634,0.0102284629486356,0,0,19829.0,94422.42241345016,HLA-DQA2
21982,KEGG_2019_Human,Tuberculosis,1/179,0.0089499050800561,0.0102284629486356,0,0,19821.0,93478.0629355712,HLA-DQA2
21983,KEGG_2019_Human,Epstein-Barr virus infection,1/201,0.0100498985877989,0.0109635257321443,0,0,19799.0,91079.21596609056,HLA-DQA2
21984,KEGG_2019_Human,Human T-cell leukemia virus 1 infection,1/219,0.0109498935894162,0.0114259759193908,0,0,19781.0,89299.85161916987,HLA-DQA2
21985,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,HLA-DQA2
21986,KEGG_2019_Human,Drug metabolism,1/108,0.0053999298011749,0.006449921761047,0,0,19892.0,103863.47861844616,IMPDH1
21987,KEGG_2019_Human,Purine metabolism,1/129,0.006449921761047,0.006449921761047,0,0,19871.0,100223.109907462,IMPDH1
21988,KEGG_2019_Human,Ribosome,1/153,0.0076499133771537,0.0076499133771537,0,0,19847.0,96715.6407630817,RPLP0
21989,KEGG_2019_Human,Glycosaminoglycan biosynthesis,1/53,0.0026499555173137,0.0026499555173137,0,0,19947.0,118349.78824235698,GLCE
21990,KEGG_2019_Human,Basal transcription factors,1/45,0.0022499601197094,0.0022499601197094,0,0,19955.0,121662.49782449217,TAF10
21991,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR5AU1
21992,KEGG_2019_Human,Ribosome,1/153,0.0076499133771537,0.0076499133771537,0,0,19847.0,96715.6407630817,MRPS21
21993,KEGG_2019_Human,Drug metabolism,1/108,0.0053999298011749,0.006449921761047,0,0,19892.0,103863.47861844616,IMPDH2
21994,KEGG_2019_Human,Purine metabolism,1/129,0.006449921761047,0.006449921761047,0,0,19871.0,100223.109907462,IMPDH2
21995,KEGG_2019_Human,Spliceosome,1/134,0.0066999199497742,0.0066999199497742,0,0,19866.0,99442.43560916925,SNRNP27
21996,KEGG_2019_Human,Lysosome,1/123,0.0061499239842961,0.0061499239842961,0,0,19877.0,101200.07933676826,LAMP3
21997,KEGG_2019_Human,Biosynthesis of unsaturated fatty acids,1/27,0.0013499718942362,0.0013499718942362,0,0,19973.0,131975.02298599784,ACOT1
21998,KEGG_2019_Human,Fatty acid elongation,1/27,0.0013499718942362,0.0013499718942362,0,0,19973.0,131975.02298599784,ACOT1
21999,KEGG_2019_Human,Taste transduction,1/83,0.0041499404726918,0.006449921761047,0,0,19917.0,109237.99888847338,ENTPD2
22000,KEGG_2019_Human,Purine metabolism,1/129,0.006449921761047,0.006449921761047,0,0,19871.0,100223.109907462,ENTPD2
22001,KEGG_2019_Human,Shigellosis,1/65,0.003249949134407,0.0064998982688141,0,0,19935.0,114209.92613860144,U2AF1L4
22002,KEGG_2019_Human,Spliceosome,1/134,0.0066999199497742,0.0066999199497742,0,0,19866.0,99442.43560916925,U2AF1L4
22003,KEGG_2019_Human,Proteasome,1/45,0.0022499601197094,0.0044999202394188,0,0,19955.0,121662.49782449217,PSMC4
22004,KEGG_2019_Human,Epstein-Barr virus infection,1/201,0.0100498985877989,0.0100498985877989,0,0,19799.0,91079.21596609056,PSMC4
22005,KEGG_2019_Human,Proteasome,1/45,0.0022499601197094,0.0022499601197094,0,0,19955.0,121662.49782449217,PSMA6
22006,KEGG_2019_Human,Protein digestion and absorption,1/90,0.0044999373439762,0.0044999373439762,0,0,19910.0,107587.50385474482,MEP1A
22007,KEGG_2019_Human,Circadian rhythm,1/31,0.0015499690656704,0.0089248989400127,0,0,19969.0,129189.85098816035,PRKAB1
22008,KEGG_2019_Human,Adipocytokine signaling pathway,1/69,0.003449947123837,0.0089248989400127,0,0,19931.0,112996.7391397682,PRKAB1
22009,KEGG_2019_Human,Hypertrophic cardiomyopathy (HCM),1/85,0.004249939567045,0.0089248989400127,0,0,19915.0,108752.83801948265,PRKAB1
22010,KEGG_2019_Human,Longevity regulating pathway,1/102,0.0050999322416682,0.0089248989400127,0,0,19898.0,105032.15064717118,PRKAB1
22011,KEGG_2019_Human,Glucagon signaling pathway,1/103,0.0051499318302617,0.0089248989400127,0,0,19897.0,104832.7525292024,PRKAB1
22012,KEGG_2019_Human,Insulin resistance,1/108,0.0053999298011749,0.0089248989400127,0,0,19892.0,103863.47861844616,PRKAB1
22013,KEGG_2019_Human,AMPK signaling pathway,1/120,0.0059999251180858,0.0089248989400127,0,0,19880.0,101706.2448082016,PRKAB1
22014,KEGG_2019_Human,FoxO signaling pathway,1/132,0.0065999206698993,0.0089248989400127,0,0,19868.0,99751.22090491928,PRKAB1
22015,KEGG_2019_Human,Insulin signaling pathway,1/137,0.0068499188797651,0.0089248989400127,0,0,19863.0,98987.62735269018,PRKAB1
22016,KEGG_2019_Human,Apelin signaling pathway,1/137,0.0068499188797651,0.0089248989400127,0,0,19863.0,98987.62735269018,PRKAB1
22017,KEGG_2019_Human,Non-alcoholic fatty liver disease (NAFLD),1/149,0.0074499147221605,0.0089248989400127,0,0,19851.0,97261.02051561224,PRKAB1
22018,KEGG_2019_Human,Oxytocin signaling pathway,1/153,0.0076499133771537,0.0089248989400127,0,0,19847.0,96715.6407630817,PRKAB1
22019,KEGG_2019_Human,Tight junction,1/170,0.0084999078692823,0.0091537469361502,0,0,19830.0,94543.49009679438,PRKAB1
22020,KEGG_2019_Human,Thermogenesis,1/231,0.0115498903940656,0.0115498903940656,0,0,19769.0,88191.07730937863,PRKAB1
22021,KEGG_2019_Human,Salivary secretion,1/90,0.0044999373439762,0.0044999373439762,0,0,19910.0,107587.50385474482,PRB2
22022,KEGG_2019_Human,Cysteine and methionine metabolism,1/47,0.0023499589392381,0.0023499589392381,0,0,19953.0,120782.64067395544,AHCYL2
22023,KEGG_2019_Human,Nicotinate and nicotinamide metabolism,1/30,0.0014999697593334,0.0014999697593334,0,0,19970.0,129851.13732048514,NAPRT
22024,KEGG_2019_Human,Pyrimidine metabolism,1/57,0.002849953326298,0.0053999298011749,0,0,19943.0,116875.00742975442,TK2
22025,KEGG_2019_Human,Drug metabolism,1/108,0.0053999298011749,0.0053999298011749,0,0,19892.0,103863.47861844616,TK2
22026,KEGG_2019_Human,Glyoxylate and dicarboxylate metabolism,1/30,0.0014999697593334,0.0024499577795033,0,0,19970.0,129851.13732048514,HOGA1
22027,KEGG_2019_Human,Arginine and proline metabolism,1/49,0.0024499577795033,0.0024499577795033,0,0,19951.0,119939.1172087114,HOGA1
22028,KEGG_2019_Human,Taste transduction,1/83,0.0041499404726918,0.0041499404726918,0,0,19917.0,109237.99888847338,TAS2R50
22029,KEGG_2019_Human,Amoebiasis,1/96,0.0047999347538706,0.0077248977453925,0,0,19904.0,106270.50039849174,GNA14
22030,KEGG_2019_Human,Chagas disease (American trypanosomiasis),1/103,0.0051499318302617,0.0077248977453925,0,0,19897.0,104832.7525292024,GNA14
22031,KEGG_2019_Human,Calcium signaling pathway,1/188,0.009399902370135,0.009399902370135,0,0,19812.0,92463.712994847,GNA14
22032,KEGG_2019_Human,Basal transcription factors,1/45,0.0022499601197094,0.0035249384088572,0,0,19955.0,121662.49782449217,CDK7
22033,KEGG_2019_Human,Nucleotide excision repair,1/47,0.0023499589392381,0.0035249384088572,0,0,19953.0,120782.64067395544,CDK7
22034,KEGG_2019_Human,Cell cycle,1/124,0.0061999236097501,0.0061999236097501,0,0,19876.0,101034.04709010696,CDK7
22035,KEGG_2019_Human,N-Glycan biosynthesis,1/50,0.0024999572069037,0.0024999572069037,0,0,19950.0,119530.05920663515,DOLPP1
22036,KEGG_2019_Human,Ribosome,1/153,0.0076499133771537,0.0076499133771537,0,0,19847.0,96715.6407630817,RPL39
22037,KEGG_2019_Human,Glycosylphosphatidylinositol (GPI)-anchor biosynthesis,1/25,0.0012499733663791,0.0012499733663791,0,0,19975.0,133525.54486996148,PIGB
22038,KEGG_2019_Human,Measles,1/138,0.0068999185254481,0.0068999185254481,0,0,19862.0,98838.19160389496,SLAMF1
22039,KEGG_2019_Human,Autoimmune thyroid disease,1/53,0.0026499555173137,0.0145586837375733,0,0,19947.0,118349.78824235698,IFNA7
22040,KEGG_2019_Human,Cytosolic DNA-sensing pathway,1/63,0.0031499501598827,0.0145586837375733,0,0,19937.0,114844.46974572667,IFNA7
22041,KEGG_2019_Human,RIG-I-like receptor signaling pathway,1/70,0.0034999466296654,0.0145586837375733,0,0,19930.0,112704.30065625212,IFNA7
22042,KEGG_2019_Human,Toll-like receptor signaling pathway,1/104,0.0051999314202997,0.0145586837375733,0,0,19896.0,104635.24941415618,IFNA7
22043,KEGG_2019_Human,Natural killer cell mediated cytotoxicity,1/131,0.0065499210316603,0.0145586837375733,0,0,19869.0,99907.33811343512,IFNA7
22044,KEGG_2019_Human,Measles,1/138,0.0068999185254481,0.0145586837375733,0,0,19862.0,98838.19160389496,IFNA7
22045,KEGG_2019_Human,Hepatitis C,1/155,0.0077499127120574,0.0145586837375733,0,0,19845.0,96448.16254952336,IFNA7
22046,KEGG_2019_Human,Necroptosis,1/162,0.0080999104202618,0.0145586837375733,0,0,19838.0,95537.86936302872,IFNA7
22047,KEGG_2019_Human,JAK-STAT signaling pathway,1/162,0.0080999104202618,0.0145586837375733,0,0,19838.0,95537.86936302872,IFNA7
22048,KEGG_2019_Human,Hepatitis B,1/163,0.0081499100978668,0.0145586837375733,0,0,19837.0,95410.9786681514,IFNA7
22049,KEGG_2019_Human,Influenza A,1/171,0.0085499075557634,0.0145586837375733,0,0,19829.0,94422.42241345016,IFNA7
22050,KEGG_2019_Human,NOD-like receptor signaling pathway,1/178,0.0088999053857096,0.0145586837375733,0,0,19822.0,93593.82745769851,IFNA7
22051,KEGG_2019_Human,Tuberculosis,1/179,0.0089499050800561,0.0145586837375733,0,0,19821.0,93478.0629355712,IFNA7
22052,KEGG_2019_Human,Kaposi sarcoma-associated herpesvirus infection,1/186,0.0092999029651357,0.0145586837375733,0,0,19814.0,92684.96451050608,IFNA7
22053,KEGG_2019_Human,Epstein-Barr virus infection,1/201,0.0100498985877989,0.0145586837375733,0,0,19799.0,91079.21596609056,IFNA7
22054,KEGG_2019_Human,Human immunodeficiency virus 1 infection,1/212,0.0105998955026255,0.0145586837375733,0,0,19788.0,89974.27756224656,IFNA7
22055,KEGG_2019_Human,Human cytomegalovirus infection,1/225,0.0112498919790339,0.0145586837375733,0,0,19775.0,88738.27077557483,IFNA7
22056,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0179665141039676,0,0,19706.0,83157.67014793828,IFNA7
22057,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0191051096893273,0,0,19670.0,80733.60565076157,IFNA7
22058,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0194698489055035,0,0,19646.0,79255.8617626126,IFNA7
22059,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0257712598834163,0,0,19508.0,72277.44006442746,IFNA7
22060,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,IFNA7
22061,KEGG_2019_Human,p53 signaling pathway,1/72,0.0035999456502131,0.0035999456502131,0,0,19928.0,112131.59838572376,SHISA5
22062,KEGG_2019_Human,NF-kappa B signaling pathway,1/95,0.0047499351803394,0.010999879273797,0,0,19905.0,106484.27183626965,UBE2I
22063,KEGG_2019_Human,Ubiquitin mediated proteolysis,1/137,0.0068499188797651,0.010999879273797,0,0,19863.0,98987.62735269018,UBE2I
22064,KEGG_2019_Human,RNA transport,1/165,0.0082499094553477,0.010999879273797,0,0,19835.0,95159.46482222488,UBE2I
22065,KEGG_2019_Human,MicroRNAs in cancer,1/299,0.0149498740670514,0.0149498740670514,0,0,19701.0,82804.33538735632,UBE2I
22066,KEGG_2019_Human,Ribosome biogenesis in eukaryotes,1/101,0.0050499326546803,0.0050499326546803,0,0,19899.0,105233.48101229242,IMP4
22067,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF514
22068,KEGG_2019_Human,Biosynthesis of unsaturated fatty acids,1/27,0.0013499718942362,0.0013499718942362,0,0,19973.0,131975.02298599784,ACOT4
22069,KEGG_2019_Human,Fatty acid elongation,1/27,0.0013499718942362,0.0013499718942362,0,0,19973.0,131975.02298599784,ACOT4
22070,KEGG_2019_Human,C-type lectin receptor signaling pathway,1/104,0.0051999314202997,0.0118771528764897,0,0,19896.0,104635.24941415618,IRF9
22071,KEGG_2019_Human,Osteoclast differentiation,1/127,0.0063499224962247,0.0118771528764897,0,0,19873.0,100543.72072014232,IRF9
22072,KEGG_2019_Human,Measles,1/138,0.0068999185254481,0.0118771528764897,0,0,19862.0,98838.19160389496,IRF9
22073,KEGG_2019_Human,Hepatitis C,1/155,0.0077499127120574,0.0118771528764897,0,0,19845.0,96448.16254952336,IRF9
22074,KEGG_2019_Human,Necroptosis,1/162,0.0080999104202618,0.0118771528764897,0,0,19838.0,95537.86936302872,IRF9
22075,KEGG_2019_Human,JAK-STAT signaling pathway,1/162,0.0080999104202618,0.0118771528764897,0,0,19838.0,95537.86936302872,IRF9
22076,KEGG_2019_Human,Influenza A,1/171,0.0085499075557634,0.0118771528764897,0,0,19829.0,94422.42241345016,IRF9
22077,KEGG_2019_Human,NOD-like receptor signaling pathway,1/178,0.0088999053857096,0.0118771528764897,0,0,19822.0,93593.82745769851,IRF9
22078,KEGG_2019_Human,Kaposi sarcoma-associated herpesvirus infection,1/186,0.0092999029651357,0.0118771528764897,0,0,19814.0,92684.96451050608,IRF9
22079,KEGG_2019_Human,Viral carcinogenesis,1/201,0.0100498985877989,0.0118771528764897,0,0,19799.0,91079.21596609056,IRF9
22080,KEGG_2019_Human,Epstein-Barr virus infection,1/201,0.0100498985877989,0.0118771528764897,0,0,19799.0,91079.21596609056,IRF9
22081,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0178748564138782,0,0,19670.0,80733.60565076157,IRF9
22082,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,IRF9
22083,KEGG_2019_Human,Galactose metabolism,1/31,0.0015499690656704,0.0038124390002067,0,0,19969.0,129189.85098816035,GLA
22084,KEGG_2019_Human,Glycosphingolipid biosynthesis,1/45,0.0022499601197094,0.0038124390002067,0,0,19955.0,121662.49782449217,GLA
22085,KEGG_2019_Human,Sphingolipid metabolism,1/47,0.0023499589392381,0.0038124390002067,0,0,19953.0,120782.64067395544,GLA
22086,KEGG_2019_Human,Glycerolipid metabolism,1/61,0.0030499512001654,0.0038124390002067,0,0,19939.0,115499.24335773686,GLA
22087,KEGG_2019_Human,Lysosome,1/123,0.0061499239842961,0.0061499239842961,0,0,19877.0,101200.07933676826,GLA
22088,KEGG_2019_Human,Ribosome,1/153,0.0076499133771537,0.0076499133771537,0,0,19847.0,96715.6407630817,RPS9
22089,KEGG_2019_Human,Cardiac muscle contraction,1/78,0.0038999427840466,0.0038999427840466,0,0,19922.0,110503.2180492851,SLC9A6
22090,KEGG_2019_Human,Tyrosine metabolism,1/36,0.0017999657178272,0.0047832644181221,0,0,19964.0,126172.23364250171,ADH4
22091,KEGG_2019_Human,Fatty acid degradation,1/44,0.0021999607179423,0.0047832644181221,0,0,19956.0,122117.06559109331,ADH4
22092,KEGG_2019_Human,Retinol metabolism,1/67,0.0033499481224912,0.0047832644181221,0,0,19933.0,113594.38808369274,ADH4
22093,KEGG_2019_Human,Glycolysis / Gluconeogenesis,1/68,0.0033999476216189,0.0047832644181221,0,0,19932.0,113293.39338050144,ADH4
22094,KEGG_2019_Human,Metabolism of xenobiotics by cytochrome P450,1/74,0.0036999446830449,0.0047832644181221,0,0,19926.0,111574.38983110404,ADH4
22095,KEGG_2019_Human,Chemical carcinogenesis,1/82,0.004099940929819,0.0047832644181221,0,0,19918.0,109484.9180722932,ADH4
22096,KEGG_2019_Human,Drug metabolism,1/108,0.0053999298011749,0.0053999298011749,0,0,19892.0,103863.47861844616,ADH4
22097,KEGG_2019_Human,B cell receptor signaling pathway,1/71,0.0035499461386618,0.0064999142753747,0,0,19929.0,112415.9585341616,BCL10
22098,KEGG_2019_Human,NF-kappa B signaling pathway,1/95,0.0047499351803394,0.0064999142753747,0,0,19905.0,106484.27183626965,BCL10
22099,KEGG_2019_Human,T cell receptor signaling pathway,1/101,0.0050499326546803,0.0064999142753747,0,0,19899.0,105233.48101229242,BCL10
22100,KEGG_2019_Human,C-type lectin receptor signaling pathway,1/104,0.0051999314202997,0.0064999142753747,0,0,19896.0,104635.24941415618,BCL10
22101,KEGG_2019_Human,Tuberculosis,1/179,0.0089499050800561,0.0089499050800561,0,0,19821.0,93478.0629355712,BCL10
22102,KEGG_2019_Human,Relaxin signaling pathway,1/130,0.0064999213952527,0.0129998427905055,0,0,19870.0,100064.62842845908,INSL3
22103,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,INSL3
22104,KEGG_2019_Human,Mannose type O-glycan biosynthesis,1/23,0.0011499748819949,0.0011499748819949,0,0,19977.0,135204.63922267244,RXYLT1
22105,KEGG_2019_Human,Mitophagy,1/65,0.003249949134407,0.0127598791484564,0,0,19935.0,114209.92613860144,RRAS2
22106,KEGG_2019_Human,C-type lectin receptor signaling pathway,1/104,0.0051999314202997,0.0127598791484564,0,0,19896.0,104635.24941415618,RRAS2
22107,KEGG_2019_Human,Autophagy,1/128,0.0063999221281459,0.0127598791484564,0,0,19872.0,100382.8010329652,RRAS2
22108,KEGG_2019_Human,Apelin signaling pathway,1/137,0.0068499188797651,0.0127598791484564,0,0,19863.0,98987.62735269018,RRAS2
22109,KEGG_2019_Human,Phospholipase D signaling pathway,1/148,0.007399915061391,0.0127598791484564,0,0,19852.0,97399.60470052566,RRAS2
22110,KEGG_2019_Human,Cellular senescence,1/160,0.0079999110688441,0.0127598791484564,0,0,19840.0,95793.96509856998,RRAS2
22111,KEGG_2019_Human,Proteoglycans in cancer,1/201,0.0100498985877989,0.0127598791484564,0,0,19799.0,91079.21596609056,RRAS2
22112,KEGG_2019_Human,cAMP signaling pathway,1/212,0.0105998955026255,0.0127598791484564,0,0,19788.0,89974.27756224656,RRAS2
22113,KEGG_2019_Human,Regulation of actin cytoskeleton,1/214,0.0106998949514067,0.0127598791484564,0,0,19786.0,89779.39753374986,RRAS2
22114,KEGG_2019_Human,Ras signaling pathway,1/232,0.0115998901349604,0.0127598791484564,0,0,19768.0,88101.22480150245,RRAS2
22115,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0147498749536506,0,0,19705.0,83086.53988020132,RRAS2
22116,KEGG_2019_Human,Proximal tubule bicarbonate reclamation,1/23,0.0011499748819949,0.0011499748819949,0,0,19977.0,135204.63922267244,SLC25A10
22117,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF564
22118,KEGG_2019_Human,Oxidative phosphorylation,1/133,0.0066499203093911,0.0112582177134695,0,0,19867.0,99596.2591544721,NDUFC2
22119,KEGG_2019_Human,Parkinson disease,1/142,0.0070999171242726,0.0112582177134695,0,0,19858.0,98250.87390500787,NDUFC2
22120,KEGG_2019_Human,Retrograde endocannabinoid signaling,1/148,0.007399915061391,0.0112582177134695,0,0,19852.0,97399.60470052566,NDUFC2
22121,KEGG_2019_Human,Non-alcoholic fatty liver disease (NAFLD),1/149,0.0074499147221605,0.0112582177134695,0,0,19851.0,97261.02051561224,NDUFC2
22122,KEGG_2019_Human,Alzheimer disease,1/171,0.0085499075557634,0.0112582177134695,0,0,19829.0,94422.42241345016,NDUFC2
22123,KEGG_2019_Human,Huntington disease,1/193,0.0096499008972596,0.0112582177134695,0,0,19807.0,91920.47679471428,NDUFC2
22124,KEGG_2019_Human,Thermogenesis,1/231,0.0115498903940656,0.0115498903940656,0,0,19769.0,88191.07730937863,NDUFC2
22125,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF785
22126,KEGG_2019_Human,Antigen processing and presentation,1/77,0.0038499432547502,0.0086856156702824,0,0,19923.0,110765.8407373636,CTSL
22127,KEGG_2019_Human,Rheumatoid arthritis,1/91,0.0045499369072032,0.0086856156702824,0,0,19909.0,107362.10783923086,CTSL
22128,KEGG_2019_Human,Lysosome,1/123,0.0061499239842961,0.0086856156702824,0,0,19877.0,101200.07933676826,CTSL
22129,KEGG_2019_Human,Autophagy,1/128,0.0063999221281459,0.0086856156702824,0,0,19872.0,100382.8010329652,CTSL
22130,KEGG_2019_Human,Fluid shear stress and atherosclerosis,1/139,0.006949918172816,0.0086856156702824,0,0,19861.0,98689.81333375497,CTSL
22131,KEGG_2019_Human,Apoptosis,1/143,0.0071499167770442,0.0086856156702824,0,0,19857.0,98106.57763600958,CTSL
22132,KEGG_2019_Human,Phagosome,1/152,0.0075999137114971,0.0086856156702824,0,0,19848.0,96850.665715497,CTSL
22133,KEGG_2019_Human,Proteoglycans in cancer,1/201,0.0100498985877989,0.0100498985877989,0,0,19799.0,91079.21596609056,CTSL
22134,KEGG_2019_Human,ECM-receptor interaction,1/82,0.004099940929819,0.016399763719276,0,0,19918.0,109484.9180722932,CHAD
22135,KEGG_2019_Human,Focal adhesion,1/199,0.0099498991610159,0.0176998626413668,0,0,19801.0,91286.4288690606,CHAD
22136,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0176998626413668,0,0,19670.0,80733.60565076157,CHAD
22137,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0176998626413668,0,0,19646.0,79255.8617626126,CHAD
22138,KEGG_2019_Human,Wnt signaling pathway,1/158,0.0078999117225733,0.0078999117225733,0,0,19842.0,96053.2110949472,PRICKLE3
22139,KEGG_2019_Human,Ovarian steroidogenesis,1/49,0.0024499577795033,0.0054165818906784,0,0,19951.0,119939.1172087114,STAR
22140,KEGG_2019_Human,Cholesterol metabolism,1/50,0.0024999572069037,0.0054165818906784,0,0,19950.0,119530.05920663515,STAR
22141,KEGG_2019_Human,Cortisol synthesis and secretion,1/65,0.003249949134407,0.0054165818906784,0,0,19935.0,114209.92613860144,STAR
22142,KEGG_2019_Human,Aldosterone synthesis and secretion,1/98,0.0048999339081079,0.0061249173851349,0,0,19902.0,105849.45495286948,STAR
22143,KEGG_2019_Human,Cushing syndrome,1/155,0.0077499127120574,0.0077499127120574,0,0,19845.0,96448.16254952336,STAR
22144,KEGG_2019_Human,Estrogen signaling pathway,1/137,0.0068499188797651,0.0068499188797651,0,0,19863.0,98987.62735269018,KRT20
22145,KEGG_2019_Human,RNA polymerase,1/31,0.0015499690656704,0.0030999381313408,0,0,19969.0,129189.85098816035,POLR2J
22146,KEGG_2019_Human,Huntington disease,1/193,0.0096499008972596,0.0096499008972596,0,0,19807.0,91920.47679471428,POLR2J
22147,KEGG_2019_Human,Other glycan degradation,1/18,0.0008999788927950273,0.0023749451557763,0,0,19982.0,140136.54844084635,HEXA
22148,KEGG_2019_Human,Glycosaminoglycan degradation,1/19,0.00094997806231055,0.0023749451557763,0,0,19981.0,139049.2109571672,HEXA
22149,KEGG_2019_Human,Glycosphingolipid biosynthesis,1/45,0.0022499601197094,0.0029999479459985,0,0,19955.0,121662.49782449217,HEXA
22150,KEGG_2019_Human,Amino sugar and nucleotide sugar metabolism,1/48,0.0023999583567988,0.0029999479459985,0,0,19952.0,120356.5272753826,HEXA
22151,KEGG_2019_Human,Lysosome,1/123,0.0061499239842961,0.0061499239842961,0,0,19877.0,101200.07933676826,HEXA
22152,KEGG_2019_Human,Peroxisome,1/83,0.0041499404726918,0.0041499404726918,0,0,19917.0,109237.99888847338,PHYH
22153,KEGG_2019_Human,p53 signaling pathway,1/72,0.0035999456502131,0.0138548471663736,0,0,19928.0,112131.59838572376,CCNE2
22154,KEGG_2019_Human,Small cell lung cancer,1/93,0.0046499360391879,0.0138548471663736,0,0,19907.0,106918.54242106884,CCNE2
22155,KEGG_2019_Human,Prostate cancer,1/97,0.0048499343304706,0.0138548471663736,0,0,19903.0,106058.9096435903,CCNE2
22156,KEGG_2019_Human,Cell cycle,1/124,0.0061999236097501,0.0138548471663736,0,0,19876.0,101034.04709010696,CCNE2
22157,KEGG_2019_Human,Oocyte meiosis,1/125,0.0062499232373748,0.0138548471663736,0,0,19875.0,100869.32368441945,CCNE2
22158,KEGG_2019_Human,Measles,1/138,0.0068999185254481,0.0138548471663736,0,0,19862.0,98838.19160389496,CCNE2
22159,KEGG_2019_Human,Gastric cancer,1/149,0.0074499147221605,0.0138548471663736,0,0,19851.0,97261.02051561224,CCNE2
22160,KEGG_2019_Human,Cushing syndrome,1/155,0.0077499127120574,0.0138548471663736,0,0,19845.0,96448.16254952336,CCNE2
22161,KEGG_2019_Human,Cellular senescence,1/160,0.0079999110688441,0.0138548471663736,0,0,19840.0,95793.96509856998,CCNE2
22162,KEGG_2019_Human,Hepatitis B,1/163,0.0081499100978668,0.0138548471663736,0,0,19837.0,95410.9786681514,CCNE2
22163,KEGG_2019_Human,Viral carcinogenesis,1/201,0.0100498985877989,0.0142373563327152,0,0,19799.0,91079.21596609056,CCNE2
22164,KEGG_2019_Human,Epstein-Barr virus infection,1/201,0.0100498985877989,0.0142373563327152,0,0,19799.0,91079.21596609056,CCNE2
22165,KEGG_2019_Human,Human T-cell leukemia virus 1 infection,1/219,0.0109498935894162,0.0143190916169289,0,0,19781.0,89299.85161916987,CCNE2
22166,KEGG_2019_Human,MicroRNAs in cancer,1/299,0.0149498740670514,0.018153418509991,0,0,19701.0,82804.33538735632,CCNE2
22167,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0186998497868264,0,0,19670.0,80733.60565076157,CCNE2
22168,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0188061040564523,0,0,19646.0,79255.8617626126,CCNE2
22169,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,CCNE2
22170,KEGG_2019_Human,p53 signaling pathway,1/72,0.0035999456502131,0.0099998771797997,0,0,19928.0,112131.59838572376,CDK1
22171,KEGG_2019_Human,Gap junction,1/88,0.0043999382262822,0.0099998771797997,0,0,19912.0,108045.79305232369,CDK1
22172,KEGG_2019_Human,Progesterone-mediated oocyte maturation,1/99,0.0049499334884068,0.0099998771797997,0,0,19901.0,105642.09305076736,CDK1
22173,KEGG_2019_Human,Cell cycle,1/124,0.0061999236097501,0.0099998771797997,0,0,19876.0,101034.04709010696,CDK1
22174,KEGG_2019_Human,Oocyte meiosis,1/125,0.0062499232373748,0.0099998771797997,0,0,19875.0,100869.32368441945,CDK1
22175,KEGG_2019_Human,Cellular senescence,1/160,0.0079999110688441,0.0105998955026255,0,0,19840.0,95793.96509856998,CDK1
22176,KEGG_2019_Human,Viral carcinogenesis,1/201,0.0100498985877989,0.0105998955026255,0,0,19799.0,91079.21596609056,CDK1
22177,KEGG_2019_Human,Human immunodeficiency virus 1 infection,1/212,0.0105998955026255,0.0105998955026255,0,0,19788.0,89974.27756224656,CDK1
22178,KEGG_2019_Human,Spliceosome,1/134,0.0066999199497742,0.0066999199497742,0,0,19866.0,99442.43560916925,PRPF31
22179,KEGG_2019_Human,Fatty acid elongation,1/27,0.0013499718942362,0.0028799500281585,0,0,19973.0,131975.02298599784,HADH
22180,KEGG_2019_Human,Butanoate metabolism,1/28,0.0013999711732997,0.0028799500281585,0,0,19972.0,131242.0761597353,HADH
22181,KEGG_2019_Human,Tryptophan metabolism,1/42,0.0020999619311272,0.0028799500281585,0,0,19958.0,123057.75613441122,HADH
22182,KEGG_2019_Human,Fatty acid degradation,1/44,0.0021999607179423,0.0028799500281585,0,0,19956.0,122117.06559109331,HADH
22183,KEGG_2019_Human,"Valine, leucine and isoleucine degradation",1/48,0.0023999583567988,0.0028799500281585,0,0,19952.0,120356.5272753826,HADH
22184,KEGG_2019_Human,Lysine degradation,1/59,0.0029499522555206,0.0029499522555206,0,0,19941.0,116175.59385530632,HADH
22185,KEGG_2019_Human,Fanconi anemia pathway,1/54,0.0026999549628563,0.0026999549628563,0,0,19946.0,117971.01964061816,RMI2
22186,KEGG_2019_Human,Staphylococcus aureus infection,1/68,0.0033999476216189,0.0052665897556449,0,0,19932.0,113293.39338050144,C2
22187,KEGG_2019_Human,Pertussis,1/76,0.0037999437281752,0.0052665897556449,0,0,19924.0,111031.8499691117,C2
22188,KEGG_2019_Human,Complement and coagulation cascades,1/79,0.0039499423167337,0.0052665897556449,0,0,19921.0,110243.89578070649,C2
22189,KEGG_2019_Human,Systemic lupus erythematosus,1/133,0.0066499203093911,0.0066499203093911,0,0,19867.0,99596.2591544721,C2
22190,KEGG_2019_Human,Ribosome,1/153,0.0076499133771537,0.0076499133771537,0,0,19847.0,96715.6407630817,MRPS18A
22191,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0146998751759735,0,0,19706.0,83157.67014793828,IL31
22192,KEGG_2019_Human,Endocytosis,1/244,0.0121998870519305,0.0121998870519305,0,0,19756.0,87051.4275316661,SMAP2
22193,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF540
22194,KEGG_2019_Human,Fanconi anemia pathway,1/54,0.0026999549628563,0.0026999549628563,0,0,19946.0,117971.01964061816,CENPS
22195,KEGG_2019_Human,Protein processing in endoplasmic reticulum,1/165,0.0082499094553477,0.0082499094553477,0,0,19835.0,95159.46482222488,RNF5
22196,KEGG_2019_Human,RNA degradation,1/79,0.0039499423167337,0.0039499423167337,0,0,19921.0,110243.89578070649,EXOSC6
22197,KEGG_2019_Human,Complement and coagulation cascades,1/79,0.0039499423167337,0.0039499423167337,0,0,19921.0,110243.89578070649,SERPIND1
22198,KEGG_2019_Human,Nicotine addiction,1/40,0.0019999631680592,0.007583228178672,0,0,19960.0,124043.94523066044,GABRR2
22199,KEGG_2019_Human,GABAergic synapse,1/89,0.0044499377838098,0.007583228178672,0,0,19911.0,107815.380281759,GABRR2
22200,KEGG_2019_Human,Morphine addiction,1/91,0.0045499369072032,0.007583228178672,0,0,19909.0,107362.10783923086,GABRR2
22201,KEGG_2019_Human,Retrograde endocannabinoid signaling,1/148,0.007399915061391,0.0092498938267387,0,0,19852.0,97399.60470052566,GABRR2
22202,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,GABRR2
22203,KEGG_2019_Human,Biosynthesis of unsaturated fatty acids,1/27,0.0013499718942362,0.0040499156827088,0,0,19973.0,131975.02298599784,SCD
22204,KEGG_2019_Human,PPAR signaling pathway,1/74,0.0036999446830449,0.0055499170245674,0,0,19926.0,111574.38983110404,SCD
22205,KEGG_2019_Human,AMPK signaling pathway,1/120,0.0059999251180858,0.0059999251180858,0,0,19880.0,101706.2448082016,SCD
22206,KEGG_2019_Human,Other glycan degradation,1/18,0.0008999788927950273,0.00179995778559,0,0,19982.0,140136.54844084635,MAN2B1
22207,KEGG_2019_Human,Lysosome,1/123,0.0061499239842961,0.0061499239842961,0,0,19877.0,101200.07933676826,MAN2B1
22208,KEGG_2019_Human,RNA transport,1/165,0.0082499094553477,0.0085499075557634,0,0,19835.0,95159.46482222488,RAE1
22209,KEGG_2019_Human,Influenza A,1/171,0.0085499075557634,0.0085499075557634,0,0,19829.0,94422.42241345016,RAE1
22210,KEGG_2019_Human,Pentose phosphate pathway,1/30,0.0014999697593334,0.0016999670339032,0,0,19970.0,129851.13732048514,RPE
22211,KEGG_2019_Human,Pentose and glucuronate interconversions,1/34,0.0016999670339032,0.0016999670339032,0,0,19966.0,127326.1054203148,RPE
22212,KEGG_2019_Human,Cocaine addiction,1/49,0.0024499577795033,0.0048999155590066,0,0,19951.0,119939.1172087114,CDK5R1
22213,KEGG_2019_Human,Alzheimer disease,1/171,0.0085499075557634,0.0085499075557634,0,0,19829.0,94422.42241345016,CDK5R1
22214,KEGG_2019_Human,Riboflavin metabolism,1/8,0.0003999883241497325,0.000799976648299465,0,0,19992.0,156418.91141655247,BLVRB
22215,KEGG_2019_Human,Porphyrin and chlorophyll metabolism,1/42,0.0020999619311272,0.0020999619311272,0,0,19958.0,123057.75613441122,BLVRB
22216,KEGG_2019_Human,Primary bile acid biosynthesis,1/17,0.0008499797390404818,0.0016999594780809,0,0,19983.0,141285.76583697114,AMACR
22217,KEGG_2019_Human,Peroxisome,1/83,0.0041499404726918,0.0041499404726918,0,0,19917.0,109237.99888847338,AMACR
22218,KEGG_2019_Human,Ovarian steroidogenesis,1/49,0.0024499577795033,0.002999951725986,0,0,19951.0,119939.1172087114,HSD17B1
22219,KEGG_2019_Human,Steroid hormone biosynthesis,1/60,0.002999951725986,0.002999951725986,0,0,19940.0,115834.63209072244,HSD17B1
22220,KEGG_2019_Human,Intestinal immune network for IgA production,1/48,0.0023999583567988,0.0047999167135976,0,0,19952.0,120356.5272753826,TNFRSF17
22221,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0146998751759735,0,0,19706.0,83157.67014793828,TNFRSF17
22222,KEGG_2019_Human,Cell cycle,1/124,0.0061999236097501,0.0109498935894162,0,0,19876.0,101034.04709010696,CDKN2C
22223,KEGG_2019_Human,Cushing syndrome,1/155,0.0077499127120574,0.0109498935894162,0,0,19845.0,96448.16254952336,CDKN2C
22224,KEGG_2019_Human,Transcriptional misregulation in cancer,1/186,0.0092999029651357,0.0109498935894162,0,0,19814.0,92684.96451050608,CDKN2C
22225,KEGG_2019_Human,Human T-cell leukemia virus 1 infection,1/219,0.0109498935894162,0.0109498935894162,0,0,19781.0,89299.85161916987,CDKN2C
22226,KEGG_2019_Human,Renal cell carcinoma,1/69,0.003449947123837,0.0083332217850927,0,0,19931.0,112996.7391397682,ARNT
22227,KEGG_2019_Human,Chemical carcinogenesis,1/82,0.004099940929819,0.0083332217850927,0,0,19918.0,109484.9180722932,ARNT
22228,KEGG_2019_Human,HIF-1 signaling pathway,1/100,0.0049999330710556,0.0083332217850927,0,0,19900.0,105436.78197328727,ARNT
22229,KEGG_2019_Human,Cushing syndrome,1/155,0.0077499127120574,0.0096873908900718,0,0,19845.0,96448.16254952336,ARNT
22230,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,ARNT
22231,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF561
22232,KEGG_2019_Human,Pathogenic Escherichia coli infection,1/55,0.0027499544131125,0.0065999073394233,0,0,19945.0,117599.1294878737,TUBB6
22233,KEGG_2019_Human,Gap junction,1/88,0.0043999382262822,0.0065999073394233,0,0,19912.0,108045.79305232369,TUBB6
22234,KEGG_2019_Human,Phagosome,1/152,0.0075999137114971,0.0075999137114971,0,0,19848.0,96850.665715497,TUBB6
22235,KEGG_2019_Human,Proteasome,1/45,0.0022499601197094,0.0044999202394188,0,0,19955.0,121662.49782449217,PSMD6
22236,KEGG_2019_Human,Epstein-Barr virus infection,1/201,0.0100498985877989,0.0100498985877989,0,0,19799.0,91079.21596609056,PSMD6
22237,KEGG_2019_Human,Signaling pathways regulating pluripotency of stem cells,1/139,0.006949918172816,0.006949918172816,0,0,19861.0,98689.81333375497,KLF4
22238,KEGG_2019_Human,Endocytosis,1/244,0.0121998870519305,0.0121998870519305,0,0,19756.0,87051.4275316661,ARF3
22239,KEGG_2019_Human,Ribosome,1/153,0.0076499133771537,0.0076499133771537,0,0,19847.0,96715.6407630817,MRPL2
22240,KEGG_2019_Human,Ferroptosis,1/40,0.0019999631680592,0.0025499566390179,0,0,19960.0,124043.94523066044,SLC40A1
22241,KEGG_2019_Human,Mineral absorption,1/51,0.0025499566390179,0.0025499566390179,0,0,19949.0,119129.0228601236,SLC40A1
22242,KEGG_2019_Human,Autophagy,1/128,0.0063999221281459,0.0121998870519305,0,0,19872.0,100382.8010329652,SH3GLB1
22243,KEGG_2019_Human,Endocytosis,1/244,0.0121998870519305,0.0121998870519305,0,0,19756.0,87051.4275316661,SH3GLB1
22244,KEGG_2019_Human,Mannose type O-glycan biosynthesis,1/23,0.0011499748819949,0.0022499601197094,0,0,19977.0,135204.63922267244,FUT4
22245,KEGG_2019_Human,Glycosphingolipid biosynthesis,1/45,0.0022499601197094,0.0022499601197094,0,0,19955.0,121662.49782449217,FUT4
22246,KEGG_2019_Human,Long-term potentiation,1/67,0.0033499481224912,0.0112348896989771,0,0,19933.0,113594.38808369274,PPP1CC
22247,KEGG_2019_Human,Amphetamine addiction,1/68,0.0033999476216189,0.0112348896989771,0,0,19932.0,113293.39338050144,PPP1CC
22248,KEGG_2019_Human,mRNA surveillance pathway,1/91,0.0045499369072032,0.0112348896989771,0,0,19909.0,107362.10783923086,PPP1CC
22249,KEGG_2019_Human,Inflammatory mediator regulation of TRP channels,1/100,0.0049999330710556,0.0112348896989771,0,0,19900.0,105436.78197328727,PPP1CC
22250,KEGG_2019_Human,Insulin resistance,1/108,0.0053999298011749,0.0112348896989771,0,0,19892.0,103863.47861844616,PPP1CC
22251,KEGG_2019_Human,Platelet activation,1/124,0.0061999236097501,0.0112348896989771,0,0,19876.0,101034.04709010696,PPP1CC
22252,KEGG_2019_Human,Oocyte meiosis,1/125,0.0062499232373748,0.0112348896989771,0,0,19875.0,100869.32368441945,PPP1CC
22253,KEGG_2019_Human,Dopaminergic synapse,1/131,0.0065499210316603,0.0112348896989771,0,0,19869.0,99907.33811343512,PPP1CC
22254,KEGG_2019_Human,Vascular smooth muscle contraction,1/132,0.0065999206698993,0.0112348896989771,0,0,19868.0,99751.22090491928,PPP1CC
22255,KEGG_2019_Human,Insulin signaling pathway,1/137,0.0068499188797651,0.0112348896989771,0,0,19863.0,98987.62735269018,PPP1CC
22256,KEGG_2019_Human,Adrenergic signaling in cardiomyocytes,1/145,0.0072499160871101,0.0112348896989771,0,0,19855.0,97820.92670675044,PPP1CC
22257,KEGG_2019_Human,Oxytocin signaling pathway,1/153,0.0076499133771537,0.0112348896989771,0,0,19847.0,96715.6407630817,PPP1CC
22258,KEGG_2019_Human,Cellular senescence,1/160,0.0079999110688441,0.0112348896989771,0,0,19840.0,95793.96509856998,PPP1CC
22259,KEGG_2019_Human,Hippo signaling pathway,1/160,0.0079999110688441,0.0112348896989771,0,0,19840.0,95793.96509856998,PPP1CC
22260,KEGG_2019_Human,cGMP-PKG signaling pathway,1/166,0.0082999091363732,0.0112348896989771,0,0,19834.0,95034.82345515196,PPP1CC
22261,KEGG_2019_Human,Alcoholism,1/180,0.0089999047745351,0.0112348896989771,0,0,19820.0,93362.92821536642,PPP1CC
22262,KEGG_2019_Human,Focal adhesion,1/199,0.0099498991610159,0.0112348896989771,0,0,19801.0,91286.4288690606,PPP1CC
22263,KEGG_2019_Human,Proteoglycans in cancer,1/201,0.0100498985877989,0.0112348896989771,0,0,19799.0,91079.21596609056,PPP1CC
22264,KEGG_2019_Human,cAMP signaling pathway,1/212,0.0105998955026255,0.0112348896989771,0,0,19788.0,89974.27756224656,PPP1CC
22265,KEGG_2019_Human,Regulation of actin cytoskeleton,1/214,0.0106998949514067,0.0112348896989771,0,0,19786.0,89779.39753374986,PPP1CC
22266,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,PPP1CC
22267,KEGG_2019_Human,Peroxisome,1/83,0.0041499404726918,0.0041499404726918,0,0,19917.0,109237.99888847338,PRDX1
22268,KEGG_2019_Human,Transcriptional misregulation in cancer,1/186,0.0092999029651357,0.0092999029651357,0,0,19814.0,92684.96451050608,LYL1
22269,KEGG_2019_Human,Butanoate metabolism,1/28,0.0013999711732997,0.0023999583567988,0,0,19972.0,131242.0761597353,ACADS
22270,KEGG_2019_Human,Fatty acid degradation,1/44,0.0021999607179423,0.0023999583567988,0,0,19956.0,122117.06559109331,ACADS
22271,KEGG_2019_Human,"Valine, leucine and isoleucine degradation",1/48,0.0023999583567988,0.0023999583567988,0,0,19952.0,120356.5272753826,ACADS
22272,KEGG_2019_Human,Fructose and mannose metabolism,1/33,0.0016499677032113,0.0023999583567988,0,0,19967.0,127928.56031580272,GMPPB
22273,KEGG_2019_Human,Amino sugar and nucleotide sugar metabolism,1/48,0.0023999583567988,0.0023999583567988,0,0,19952.0,120356.5272753826,GMPPB
22274,KEGG_2019_Human,Aldosterone-regulated sodium reabsorption,1/37,0.0018499650702878,0.0106066582484997,0,0,19963.0,125618.9446446357,PIK3R3
22275,KEGG_2019_Human,Carbohydrate digestion and absorption,1/44,0.0021999607179423,0.0106066582484997,0,0,19956.0,122117.06559109331,PIK3R3
22276,KEGG_2019_Human,Type II diabetes mellitus,1/46,0.0022999595269283,0.0106066582484997,0,0,19954.0,121217.8313311442,PIK3R3
22277,KEGG_2019_Human,Regulation of lipolysis in adipocytes,1/55,0.0027499544131125,0.0106066582484997,0,0,19945.0,117599.1294878737,PIK3R3
22278,KEGG_2019_Human,Endometrial cancer,1/58,0.0028999527887707,0.0106066582484997,0,0,19942.0,116522.31890946148,PIK3R3
22279,KEGG_2019_Human,VEGF signaling pathway,1/59,0.0029499522555206,0.0106066582484997,0,0,19941.0,116175.59385530632,PIK3R3
22280,KEGG_2019_Human,Central carbon metabolism in cancer,1/65,0.003249949134407,0.0106066582484997,0,0,19935.0,114209.92613860144,PIK3R3
22281,KEGG_2019_Human,Acute myeloid leukemia,1/66,0.003299948626608,0.0106066582484997,0,0,19934.0,113899.85357353876,PIK3R3
22282,KEGG_2019_Human,Non-small cell lung cancer,1/66,0.003299948626608,0.0106066582484997,0,0,19934.0,113899.85357353876,PIK3R3
22283,KEGG_2019_Human,Fc epsilon RI signaling pathway,1/68,0.0033999476216189,0.0106066582484997,0,0,19932.0,113293.39338050144,PIK3R3
22284,KEGG_2019_Human,Renal cell carcinoma,1/69,0.003449947123837,0.0106066582484997,0,0,19931.0,112996.7391397682,PIK3R3
22285,KEGG_2019_Human,Prolactin signaling pathway,1/70,0.0034999466296654,0.0106066582484997,0,0,19930.0,112704.30065625212,PIK3R3
22286,KEGG_2019_Human,B cell receptor signaling pathway,1/71,0.0035499461386618,0.0106066582484997,0,0,19929.0,112415.9585341616,PIK3R3
22287,KEGG_2019_Human,Melanoma,1/72,0.0035999456502131,0.0106066582484997,0,0,19928.0,112131.59838572376,PIK3R3
22288,KEGG_2019_Human,Bacterial invasion of epithelial cells,1/74,0.0036999446830449,0.0106066582484997,0,0,19926.0,111574.38983110404,PIK3R3
22289,KEGG_2019_Human,Pancreatic cancer,1/75,0.0037499442041125,0.0106066582484997,0,0,19925.0,111301.33528642564,PIK3R3
22290,KEGG_2019_Human,Glioma,1/75,0.0037499442041125,0.0106066582484997,0,0,19925.0,111301.33528642564,PIK3R3
22291,KEGG_2019_Human,Chronic myeloid leukemia,1/76,0.0037999437281752,0.0106066582484997,0,0,19924.0,111031.8499691117,PIK3R3
22292,KEGG_2019_Human,ErbB signaling pathway,1/85,0.004249939567045,0.0106066582484997,0,0,19915.0,108752.83801948265,PIK3R3
22293,KEGG_2019_Human,Colorectal cancer,1/86,0.0042999391173866,0.0106066582484997,0,0,19914.0,108514.46102290176,PIK3R3
22294,KEGG_2019_Human,Fc gamma R-mediated phagocytosis,1/91,0.0045499369072032,0.0106066582484997,0,0,19909.0,107362.10783923086,PIK3R3
22295,KEGG_2019_Human,Small cell lung cancer,1/93,0.0046499360391879,0.0106066582484997,0,0,19907.0,106918.54242106884,PIK3R3
22296,KEGG_2019_Human,Amoebiasis,1/96,0.0047999347538706,0.0106066582484997,0,0,19904.0,106270.50039849174,PIK3R3
22297,KEGG_2019_Human,Prostate cancer,1/97,0.0048499343304706,0.0106066582484997,0,0,19903.0,106058.9096435903,PIK3R3
22298,KEGG_2019_Human,Choline metabolism in cancer,1/99,0.0049499334884068,0.0106066582484997,0,0,19901.0,105642.09305076736,PIK3R3
22299,KEGG_2019_Human,Phosphatidylinositol signaling system,1/99,0.0049499334884068,0.0106066582484997,0,0,19901.0,105642.09305076736,PIK3R3
22300,KEGG_2019_Human,Progesterone-mediated oocyte maturation,1/99,0.0049499334884068,0.0106066582484997,0,0,19901.0,105642.09305076736,PIK3R3
22301,KEGG_2019_Human,AGE-RAGE signaling pathway in diabetic complications,1/100,0.0049999330710556,0.0106066582484997,0,0,19900.0,105436.78197328727,PIK3R3
22302,KEGG_2019_Human,Inflammatory mediator regulation of TRP channels,1/100,0.0049999330710556,0.0106066582484997,0,0,19900.0,105436.78197328727,PIK3R3
22303,KEGG_2019_Human,HIF-1 signaling pathway,1/100,0.0049999330710556,0.0106066582484997,0,0,19900.0,105436.78197328727,PIK3R3
22304,KEGG_2019_Human,T cell receptor signaling pathway,1/101,0.0050499326546803,0.0106066582484997,0,0,19899.0,105233.48101229242,PIK3R3
22305,KEGG_2019_Human,Longevity regulating pathway,1/102,0.0050999322416682,0.0106066582484997,0,0,19898.0,105032.15064717118,PIK3R3
22306,KEGG_2019_Human,Chagas disease (American trypanosomiasis),1/103,0.0051499318302617,0.0106066582484997,0,0,19897.0,104832.7525292024,PIK3R3
22307,KEGG_2019_Human,Toll-like receptor signaling pathway,1/104,0.0051999314202997,0.0106066582484997,0,0,19896.0,104635.24941415618,PIK3R3
22308,KEGG_2019_Human,C-type lectin receptor signaling pathway,1/104,0.0051999314202997,0.0106066582484997,0,0,19896.0,104635.24941415618,PIK3R3
22309,KEGG_2019_Human,Insulin resistance,1/108,0.0053999298011749,0.0106066582484997,0,0,19892.0,103863.47861844616,PIK3R3
22310,KEGG_2019_Human,TNF signaling pathway,1/110,0.0054999290027479,0.0106066582484997,0,0,19890.0,103488.06969787036,PIK3R3
22311,KEGG_2019_Human,Leukocyte transendothelial migration,1/112,0.0055999282120529,0.0106066582484997,0,0,19888.0,103119.30984392198,PIK3R3
22312,KEGG_2019_Human,Cholinergic synapse,1/112,0.0055999282120529,0.0106066582484997,0,0,19888.0,103119.30984392198,PIK3R3
22313,KEGG_2019_Human,Thyroid hormone signaling pathway,1/116,0.0057999266512085,0.0106066582484997,0,0,19884.0,102400.8105961506,PIK3R3
22314,KEGG_2019_Human,Sphingolipid signaling pathway,1/119,0.0059499254985137,0.0106066582484997,0,0,19881.0,101877.73080211312,PIK3R3
22315,KEGG_2019_Human,Neurotrophin signaling pathway,1/119,0.0059499254985137,0.0106066582484997,0,0,19881.0,101877.73080211312,PIK3R3
22316,KEGG_2019_Human,AMPK signaling pathway,1/120,0.0059999251180858,0.0106066582484997,0,0,19880.0,101706.2448082016,PIK3R3
22317,KEGG_2019_Human,Platelet activation,1/124,0.0061999236097501,0.0106066582484997,0,0,19876.0,101034.04709010696,PIK3R3
22318,KEGG_2019_Human,Osteoclast differentiation,1/127,0.0063499224962247,0.0106066582484997,0,0,19873.0,100543.72072014232,PIK3R3
22319,KEGG_2019_Human,Autophagy,1/128,0.0063999221281459,0.0106066582484997,0,0,19872.0,100382.8010329652,PIK3R3
22320,KEGG_2019_Human,Relaxin signaling pathway,1/130,0.0064999213952527,0.0106066582484997,0,0,19870.0,100064.62842845908,PIK3R3
22321,KEGG_2019_Human,Natural killer cell mediated cytotoxicity,1/131,0.0065499210316603,0.0106066582484997,0,0,19869.0,99907.33811343512,PIK3R3
22322,KEGG_2019_Human,FoxO signaling pathway,1/132,0.0065999206698993,0.0106066582484997,0,0,19868.0,99751.22090491928,PIK3R3
22323,KEGG_2019_Human,Insulin signaling pathway,1/137,0.0068499188797651,0.0106066582484997,0,0,19863.0,98987.62735269018,PIK3R3
22324,KEGG_2019_Human,Estrogen signaling pathway,1/137,0.0068499188797651,0.0106066582484997,0,0,19863.0,98987.62735269018,PIK3R3
22325,KEGG_2019_Human,Measles,1/138,0.0068999185254481,0.0106066582484997,0,0,19862.0,98838.19160389496,PIK3R3
22326,KEGG_2019_Human,Fluid shear stress and atherosclerosis,1/139,0.006949918172816,0.0106066582484997,0,0,19861.0,98689.81333375497,PIK3R3
22327,KEGG_2019_Human,Signaling pathways regulating pluripotency of stem cells,1/139,0.006949918172816,0.0106066582484997,0,0,19861.0,98689.81333375497,PIK3R3
22328,KEGG_2019_Human,Apoptosis,1/143,0.0071499167770442,0.0106066582484997,0,0,19857.0,98106.57763600958,PIK3R3
22329,KEGG_2019_Human,Breast cancer,1/147,0.0073499154017982,0.0106066582484997,0,0,19853.0,97539.10874372096,PIK3R3
22330,KEGG_2019_Human,Phospholipase D signaling pathway,1/148,0.007399915061391,0.0106066582484997,0,0,19852.0,97399.60470052566,PIK3R3
22331,KEGG_2019_Human,Non-alcoholic fatty liver disease (NAFLD),1/149,0.0074499147221605,0.0106066582484997,0,0,19851.0,97261.02051561224,PIK3R3
22332,KEGG_2019_Human,Gastric cancer,1/149,0.0074499147221605,0.0106066582484997,0,0,19851.0,97261.02051561224,PIK3R3
22333,KEGG_2019_Human,mTOR signaling pathway,1/152,0.0075999137114971,0.0106398791960959,0,0,19848.0,96850.665715497,PIK3R3
22334,KEGG_2019_Human,Hepatitis C,1/155,0.0077499127120574,0.0106720109477513,0,0,19845.0,96448.16254952336,PIK3R3
22335,KEGG_2019_Human,Cellular senescence,1/160,0.0079999110688441,0.0106967570034502,0,0,19840.0,95793.96509856998,PIK3R3
22336,KEGG_2019_Human,JAK-STAT signaling pathway,1/162,0.0080999104202618,0.0106967570034502,0,0,19838.0,95537.86936302872,PIK3R3
22337,KEGG_2019_Human,Hepatitis B,1/163,0.0081499100978668,0.0106967570034502,0,0,19837.0,95410.9786681514,PIK3R3
22338,KEGG_2019_Human,Hepatocellular carcinoma,1/168,0.0083999085011095,0.0108552663706646,0,0,19832.0,94787.72752807094,PIK3R3
22339,KEGG_2019_Human,Influenza A,1/171,0.0085499075557634,0.010881700525517,0,0,19829.0,94422.42241345016,PIK3R3
22340,KEGG_2019_Human,Axon guidance,1/181,0.0090499044707863,0.011346148888747,0,0,19819.0,93248.41634586031,PIK3R3
22341,KEGG_2019_Human,Kaposi sarcoma-associated herpesvirus infection,1/186,0.0092999029651357,0.0114881154275206,0,0,19814.0,92684.96451050608,PIK3R3
22342,KEGG_2019_Human,Chemokine signaling pathway,1/190,0.0094999017791995,0.0115642668681522,0,0,19810.0,92244.74636351672,PIK3R3
22343,KEGG_2019_Human,Focal adhesion,1/199,0.0099498991610159,0.0115642668681522,0,0,19801.0,91286.4288690606,PIK3R3
22344,KEGG_2019_Human,Viral carcinogenesis,1/201,0.0100498985877989,0.0115642668681522,0,0,19799.0,91079.21596609056,PIK3R3
22345,KEGG_2019_Human,Epstein-Barr virus infection,1/201,0.0100498985877989,0.0115642668681522,0,0,19799.0,91079.21596609056,PIK3R3
22346,KEGG_2019_Human,Proteoglycans in cancer,1/201,0.0100498985877989,0.0115642668681522,0,0,19799.0,91079.21596609056,PIK3R3
22347,KEGG_2019_Human,Rap1 signaling pathway,1/206,0.010299897173561,0.0116726126742619,0,0,19794.0,90569.849337325,PIK3R3
22348,KEGG_2019_Human,Human immunodeficiency virus 1 infection,1/212,0.0105998955026255,0.0116726126742619,0,0,19788.0,89974.27756224656,PIK3R3
22349,KEGG_2019_Human,cAMP signaling pathway,1/212,0.0105998955026255,0.0116726126742619,0,0,19788.0,89974.27756224656,PIK3R3
22350,KEGG_2019_Human,Regulation of actin cytoskeleton,1/214,0.0106998949514067,0.0116726126742619,0,0,19786.0,89779.39753374986,PIK3R3
22351,KEGG_2019_Human,Human T-cell leukemia virus 1 infection,1/219,0.0109498935894162,0.0117921930962944,0,0,19781.0,89299.85161916987,PIK3R3
22352,KEGG_2019_Human,Human cytomegalovirus infection,1/225,0.0112498919790339,0.0119619104587196,0,0,19775.0,88738.27077557483,PIK3R3
22353,KEGG_2019_Human,Ras signaling pathway,1/232,0.0115998901349604,0.0121798846417084,0,0,19768.0,88101.22480150245,PIK3R3
22354,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0171109736611483,0,0,19670.0,80733.60565076157,PIK3R3
22355,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0181315666082294,0,0,19646.0,79255.8617626126,PIK3R3
22356,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0248962225817888,0,0,19508.0,72277.44006442746,PIK3R3
22357,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,PIK3R3
22358,KEGG_2019_Human,mRNA surveillance pathway,1/91,0.0045499369072032,0.0096665547828135,0,0,19909.0,107362.10783923086,PPP2R5A
22359,KEGG_2019_Human,Sphingolipid signaling pathway,1/119,0.0059499254985137,0.0096665547828135,0,0,19881.0,101877.73080211312,PPP2R5A
22360,KEGG_2019_Human,AMPK signaling pathway,1/120,0.0059999251180858,0.0096665547828135,0,0,19880.0,101706.2448082016,PPP2R5A
22361,KEGG_2019_Human,Oocyte meiosis,1/125,0.0062499232373748,0.0096665547828135,0,0,19875.0,100869.32368441945,PPP2R5A
22362,KEGG_2019_Human,Dopaminergic synapse,1/131,0.0065499210316603,0.0096665547828135,0,0,19869.0,99907.33811343512,PPP2R5A
22363,KEGG_2019_Human,Adrenergic signaling in cardiomyocytes,1/145,0.0072499160871101,0.0096665547828135,0,0,19855.0,97820.92670675044,PPP2R5A
22364,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0176998626413668,0,0,19670.0,80733.60565076157,PPP2R5A
22365,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0176998626413668,0,0,19646.0,79255.8617626126,PPP2R5A
22366,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF112
22367,KEGG_2019_Human,Other types of O-glycan biosynthesis,1/22,0.0010999756574123,0.0011499748819949,0,0,19978.0,136099.47030191717,POMT1
22368,KEGG_2019_Human,Mannose type O-glycan biosynthesis,1/23,0.0011499748819949,0.0011499748819949,0,0,19977.0,135204.63922267244,POMT1
22369,KEGG_2019_Human,Pathogenic Escherichia coli infection,1/55,0.0027499544131125,0.0065999073394233,0,0,19945.0,117599.1294878737,TUBB
22370,KEGG_2019_Human,Gap junction,1/88,0.0043999382262822,0.0065999073394233,0,0,19912.0,108045.79305232369,TUBB
22371,KEGG_2019_Human,Phagosome,1/152,0.0075999137114971,0.0075999137114971,0,0,19848.0,96850.665715497,TUBB
22372,KEGG_2019_Human,Cholesterol metabolism,1/50,0.0024999572069037,0.0048499343304706,0,0,19950.0,119530.05920663515,LCAT
22373,KEGG_2019_Human,Glycerophospholipid metabolism,1/97,0.0048499343304706,0.0048499343304706,0,0,19903.0,106058.9096435903,LCAT
22374,KEGG_2019_Human,Pancreatic secretion,1/98,0.0048999339081079,0.0048999339081079,0,0,19902.0,105849.45495286948,RAB3D
22375,KEGG_2019_Human,Th1 and Th2 cell differentiation,1/92,0.0045999364719865,0.0161998208405236,0,0,19908.0,107139.13814408927,IL2RA
22376,KEGG_2019_Human,Hematopoietic cell lineage,1/97,0.0048499343304706,0.0161998208405236,0,0,19903.0,106058.9096435903,IL2RA
22377,KEGG_2019_Human,Th17 cell differentiation,1/107,0.0053499302026925,0.0161998208405236,0,0,19893.0,104053.753408911,IL2RA
22378,KEGG_2019_Human,Measles,1/138,0.0068999185254481,0.0161998208405236,0,0,19862.0,98838.19160389496,IL2RA
22379,KEGG_2019_Human,JAK-STAT signaling pathway,1/162,0.0080999104202618,0.0161998208405236,0,0,19838.0,95537.86936302872,IL2RA
22380,KEGG_2019_Human,Human T-cell leukemia virus 1 infection,1/219,0.0109498935894162,0.0174284100741865,0,0,19781.0,89299.85161916987,IL2RA
22381,KEGG_2019_Human,Endocytosis,1/244,0.0121998870519305,0.0174284100741865,0,0,19756.0,87051.4275316661,IL2RA
22382,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0183748439699668,0,0,19706.0,83157.67014793828,IL2RA
22383,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0196665140459632,0,0,19646.0,79255.8617626126,IL2RA
22384,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,IL2RA
22385,KEGG_2019_Human,Maturity onset diabetes of the young,1/26,0.0012999726251831,0.0034499392903924,0,0,19974.0,132735.46073187632,PDX1
22386,KEGG_2019_Human,Type II diabetes mellitus,1/46,0.0022999595269283,0.0034499392903924,0,0,19954.0,121217.8313311442,PDX1
22387,KEGG_2019_Human,Insulin secretion,1/86,0.0042999391173866,0.0042999391173866,0,0,19914.0,108514.46102290176,PDX1
22388,KEGG_2019_Human,Cortisol synthesis and secretion,1/65,0.003249949134407,0.0122498347702699,0,0,19935.0,114209.92613860144,NR4A1
22389,KEGG_2019_Human,Aldosterone synthesis and secretion,1/98,0.0048999339081079,0.0122498347702699,0,0,19902.0,105849.45495286948,NR4A1
22390,KEGG_2019_Human,Cushing syndrome,1/155,0.0077499127120574,0.0129165211867624,0,0,19845.0,96448.16254952336,NR4A1
22391,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0176998626413668,0,0,19705.0,83086.53988020132,NR4A1
22392,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0176998626413668,0,0,19646.0,79255.8617626126,NR4A1
22393,KEGG_2019_Human,Notch signaling pathway,1/48,0.0023999583567988,0.0075998874563505,0,0,19952.0,120356.5272753826,CTBP2
22394,KEGG_2019_Human,Chronic myeloid leukemia,1/76,0.0037999437281752,0.0075998874563505,0,0,19924.0,111031.8499691117,CTBP2
22395,KEGG_2019_Human,Wnt signaling pathway,1/158,0.0078999117225733,0.0105332156300977,0,0,19842.0,96053.2110949472,CTBP2
22396,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,CTBP2
22397,KEGG_2019_Human,Ribosome,1/153,0.0076499133771537,0.0076499133771537,0,0,19847.0,96715.6407630817,RPL27A
22398,KEGG_2019_Human,Dopaminergic synapse,1/131,0.0065499210316603,0.0121998870519305,0,0,19869.0,99907.33811343512,KIF5B
22399,KEGG_2019_Human,Endocytosis,1/244,0.0121998870519305,0.0121998870519305,0,0,19756.0,87051.4275316661,KIF5B
22400,KEGG_2019_Human,Mineral absorption,1/51,0.0025499566390179,0.0025499566390179,0,0,19949.0,119129.0228601236,MT1X
22401,KEGG_2019_Human,Amino sugar and nucleotide sugar metabolism,1/48,0.0023999583567988,0.0023999583567988,0,0,19952.0,120356.5272753826,CYB5R1
22402,KEGG_2019_Human,Phototransduction,1/28,0.0013999711732997,0.0027999423465995,0,0,19972.0,131242.0761597353,PDE6G
22403,KEGG_2019_Human,Purine metabolism,1/129,0.006449921761047,0.006449921761047,0,0,19871.0,100223.109907462,PDE6G
22404,KEGG_2019_Human,Asthma,1/31,0.0015499690656704,0.0083141731379497,0,0,19969.0,129189.85098816035,HLA-DOA
22405,KEGG_2019_Human,Allograft rejection,1/38,0.001899964429635,0.0083141731379497,0,0,19962.0,125080.29732025368,HLA-DOA
22406,KEGG_2019_Human,Graft-versus-host disease,1/41,0.0020499625466866,0.0083141731379497,0,0,19959.0,123544.88783416104,HLA-DOA
22407,KEGG_2019_Human,Type I diabetes mellitus,1/43,0.0021499613216957,0.0083141731379497,0,0,19957.0,122581.98940490963,HLA-DOA
22408,KEGG_2019_Human,Intestinal immune network for IgA production,1/48,0.0023999583567988,0.0083141731379497,0,0,19952.0,120356.5272753826,HLA-DOA
22409,KEGG_2019_Human,Autoimmune thyroid disease,1/53,0.0026499555173137,0.0083141731379497,0,0,19947.0,118349.78824235698,HLA-DOA
22410,KEGG_2019_Human,Viral myocarditis,1/59,0.0029499522555206,0.0083141731379497,0,0,19941.0,116175.59385530632,HLA-DOA
22411,KEGG_2019_Human,Inflammatory bowel disease (IBD),1/65,0.003249949134407,0.0083141731379497,0,0,19935.0,114209.92613860144,HLA-DOA
22412,KEGG_2019_Human,Staphylococcus aureus infection,1/68,0.0033999476216189,0.0083141731379497,0,0,19932.0,113293.39338050144,HLA-DOA
22413,KEGG_2019_Human,Leishmaniasis,1/74,0.0036999446830449,0.0083141731379497,0,0,19926.0,111574.38983110404,HLA-DOA
22414,KEGG_2019_Human,Antigen processing and presentation,1/77,0.0038499432547502,0.0083141731379497,0,0,19923.0,110765.8407373636,HLA-DOA
22415,KEGG_2019_Human,Rheumatoid arthritis,1/91,0.0045499369072032,0.0083141731379497,0,0,19909.0,107362.10783923086,HLA-DOA
22416,KEGG_2019_Human,Th1 and Th2 cell differentiation,1/92,0.0045999364719865,0.0083141731379497,0,0,19908.0,107139.13814408927,HLA-DOA
22417,KEGG_2019_Human,Hematopoietic cell lineage,1/97,0.0048499343304706,0.0083141731379497,0,0,19903.0,106058.9096435903,HLA-DOA
22418,KEGG_2019_Human,Th17 cell differentiation,1/107,0.0053499302026925,0.0084748917286727,0,0,19893.0,104053.753408911,HLA-DOA
22419,KEGG_2019_Human,Toxoplasmosis,1/113,0.0056499278191151,0.0084748917286727,0,0,19887.0,102937.34947211576,HLA-DOA
22420,KEGG_2019_Human,Systemic lupus erythematosus,1/133,0.0066499203093911,0.0093881227897286,0,0,19867.0,99596.2591544721,HLA-DOA
22421,KEGG_2019_Human,Cell adhesion molecules (CAMs),1/145,0.0072499160871101,0.0095998910039963,0,0,19855.0,97820.92670675044,HLA-DOA
22422,KEGG_2019_Human,Phagosome,1/152,0.0075999137114971,0.0095998910039963,0,0,19848.0,96850.665715497,HLA-DOA
22423,KEGG_2019_Human,Influenza A,1/171,0.0085499075557634,0.0102284629486356,0,0,19829.0,94422.42241345016,HLA-DOA
22424,KEGG_2019_Human,Tuberculosis,1/179,0.0089499050800561,0.0102284629486356,0,0,19821.0,93478.0629355712,HLA-DOA
22425,KEGG_2019_Human,Epstein-Barr virus infection,1/201,0.0100498985877989,0.0109635257321443,0,0,19799.0,91079.21596609056,HLA-DOA
22426,KEGG_2019_Human,Human T-cell leukemia virus 1 infection,1/219,0.0109498935894162,0.0114259759193908,0,0,19781.0,89299.85161916987,HLA-DOA
22427,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,HLA-DOA
22428,KEGG_2019_Human,One carbon pool by folate,1/20,0.0009999772468562472,0.0009999772468562472,0,0,19980.0,138017.40508704726,MTHFD2L
22429,KEGG_2019_Human,Protein processing in endoplasmic reticulum,1/165,0.0082499094553477,0.0082499094553477,0,0,19835.0,95159.46482222488,DERL2
22430,KEGG_2019_Human,Ascorbate and aldarate metabolism,1/27,0.0013499718942362,0.004685646776936,0,0,19973.0,131975.02298599784,UGT2B28
22431,KEGG_2019_Human,Pentose and glucuronate interconversions,1/34,0.0016999670339032,0.004685646776936,0,0,19966.0,127326.1054203148,UGT2B28
22432,KEGG_2019_Human,Porphyrin and chlorophyll metabolism,1/42,0.0020999619311272,0.004685646776936,0,0,19958.0,123057.75613441122,UGT2B28
22433,KEGG_2019_Human,Steroid hormone biosynthesis,1/60,0.002999951725986,0.004685646776936,0,0,19940.0,115834.63209072244,UGT2B28
22434,KEGG_2019_Human,Retinol metabolism,1/67,0.0033499481224912,0.004685646776936,0,0,19933.0,113594.38808369274,UGT2B28
22435,KEGG_2019_Human,Metabolism of xenobiotics by cytochrome P450,1/74,0.0036999446830449,0.004685646776936,0,0,19926.0,111574.38983110404,UGT2B28
22436,KEGG_2019_Human,Chemical carcinogenesis,1/82,0.004099940929819,0.004685646776936,0,0,19918.0,109484.9180722932,UGT2B28
22437,KEGG_2019_Human,Drug metabolism,1/108,0.0053999298011749,0.0053999298011749,0,0,19892.0,103863.47861844616,UGT2B28
22438,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,PRLHR
22439,KEGG_2019_Human,RNA transport,1/165,0.0082499094553477,0.0082499094553477,0,0,19835.0,95159.46482222488,NUP62
22440,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR1B1
22441,KEGG_2019_Human,Lysosome,1/123,0.0061499239842961,0.0105998955026255,0,0,19877.0,101200.07933676826,AP1G1
22442,KEGG_2019_Human,Human immunodeficiency virus 1 infection,1/212,0.0105998955026255,0.0105998955026255,0,0,19788.0,89974.27756224656,AP1G1
22443,KEGG_2019_Human,Basal transcription factors,1/45,0.0022499601197094,0.0023499589392381,0,0,19955.0,121662.49782449217,ERCC3
22444,KEGG_2019_Human,Nucleotide excision repair,1/47,0.0023499589392381,0.0023499589392381,0,0,19953.0,120782.64067395544,ERCC3
22445,KEGG_2019_Human,alpha-Linolenic acid metabolism,1/25,0.0012499733663791,0.0085498911417585,0,0,19975.0,133525.54486996148,JMJD7-PLA2G4B
22446,KEGG_2019_Human,Linoleic acid metabolism,1/29,0.001449970461791,0.0085498911417585,0,0,19971.0,130534.69172799008,JMJD7-PLA2G4B
22447,KEGG_2019_Human,Ether lipid metabolism,1/47,0.0023499589392381,0.0085498911417585,0,0,19953.0,120782.64067395544,JMJD7-PLA2G4B
22448,KEGG_2019_Human,Ovarian steroidogenesis,1/49,0.0024499577795033,0.0085498911417585,0,0,19951.0,119939.1172087114,JMJD7-PLA2G4B
22449,KEGG_2019_Human,VEGF signaling pathway,1/59,0.0029499522555206,0.0085498911417585,0,0,19941.0,116175.59385530632,JMJD7-PLA2G4B
22450,KEGG_2019_Human,Long-term depression,1/60,0.002999951725986,0.0085498911417585,0,0,19940.0,115834.63209072244,JMJD7-PLA2G4B
22451,KEGG_2019_Human,Arachidonic acid metabolism,1/63,0.0031499501598827,0.0085498911417585,0,0,19937.0,114844.46974572667,JMJD7-PLA2G4B
22452,KEGG_2019_Human,Fc epsilon RI signaling pathway,1/68,0.0033999476216189,0.0085498911417585,0,0,19932.0,113293.39338050144,JMJD7-PLA2G4B
22453,KEGG_2019_Human,GnRH signaling pathway,1/93,0.0046499360391879,0.0085498911417585,0,0,19907.0,106918.54242106884,JMJD7-PLA2G4B
22454,KEGG_2019_Human,Glycerophospholipid metabolism,1/97,0.0048499343304706,0.0085498911417585,0,0,19903.0,106058.9096435903,JMJD7-PLA2G4B
22455,KEGG_2019_Human,Choline metabolism in cancer,1/99,0.0049499334884068,0.0085498911417585,0,0,19901.0,105642.09305076736,JMJD7-PLA2G4B
22456,KEGG_2019_Human,Inflammatory mediator regulation of TRP channels,1/100,0.0049999330710556,0.0085498911417585,0,0,19900.0,105436.78197328727,JMJD7-PLA2G4B
22457,KEGG_2019_Human,Serotonergic synapse,1/113,0.0056499278191151,0.0085498911417585,0,0,19887.0,102937.34947211576,JMJD7-PLA2G4B
22458,KEGG_2019_Human,Glutamatergic synapse,1/114,0.005699927427839,0.0085498911417585,0,0,19886.0,102756.96431429044,JMJD7-PLA2G4B
22459,KEGG_2019_Human,Platelet activation,1/124,0.0061999236097501,0.0086623958792429,0,0,19876.0,101034.04709010696,JMJD7-PLA2G4B
22460,KEGG_2019_Human,Vascular smooth muscle contraction,1/132,0.0065999206698993,0.0086623958792429,0,0,19868.0,99751.22090491928,JMJD7-PLA2G4B
22461,KEGG_2019_Human,Phospholipase D signaling pathway,1/148,0.007399915061391,0.0089248989400127,0,0,19852.0,97399.60470052566,JMJD7-PLA2G4B
22462,KEGG_2019_Human,Oxytocin signaling pathway,1/153,0.0076499133771537,0.0089248989400127,0,0,19847.0,96715.6407630817,JMJD7-PLA2G4B
22463,KEGG_2019_Human,Necroptosis,1/162,0.0080999104202618,0.008952532569763,0,0,19838.0,95537.86936302872,JMJD7-PLA2G4B
22464,KEGG_2019_Human,Ras signaling pathway,1/232,0.0115998901349604,0.0121798846417084,0,0,19768.0,88101.22480150245,JMJD7-PLA2G4B
22465,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0147498749536506,0,0,19705.0,83086.53988020132,JMJD7-PLA2G4B
22466,KEGG_2019_Human,mRNA surveillance pathway,1/91,0.0045499369072032,0.0045499369072032,0,0,19909.0,107362.10783923086,CPSF3
22467,KEGG_2019_Human,Insulin resistance,1/108,0.0053999298011749,0.0053999298011749,0,0,19892.0,103863.47861844616,PTPA
22468,KEGG_2019_Human,cGMP-PKG signaling pathway,1/166,0.0082999091363732,0.0145998581192216,0,0,19834.0,95034.82345515196,SRF
22469,KEGG_2019_Human,Viral carcinogenesis,1/201,0.0100498985877989,0.0145998581192216,0,0,19799.0,91079.21596609056,SRF
22470,KEGG_2019_Human,Human T-cell leukemia virus 1 infection,1/219,0.0109498935894162,0.0145998581192216,0,0,19781.0,89299.85161916987,SRF
22471,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0147498749536506,0,0,19705.0,83086.53988020132,SRF
22472,KEGG_2019_Human,Salmonella infection,1/86,0.0042999391173866,0.0085998782347732,0,0,19914.0,108514.46102290176,PKN3
22473,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0176998626413668,0,0,19646.0,79255.8617626126,PKN3
22474,KEGG_2019_Human,Cardiac muscle contraction,1/78,0.0038999427840466,0.0060665825429376,0,0,19922.0,110503.2180492851,TPM4
22475,KEGG_2019_Human,Hypertrophic cardiomyopathy (HCM),1/85,0.004249939567045,0.0060665825429376,0,0,19915.0,108752.83801948265,TPM4
22476,KEGG_2019_Human,Dilated cardiomyopathy (DCM),1/91,0.0045499369072032,0.0060665825429376,0,0,19909.0,107362.10783923086,TPM4
22477,KEGG_2019_Human,Adrenergic signaling in cardiomyocytes,1/145,0.0072499160871101,0.0072499160871101,0,0,19855.0,97820.92670675044,TPM4
22478,KEGG_2019_Human,Pentose phosphate pathway,1/30,0.0014999697593334,0.0029999395186669,0,0,19970.0,129851.13732048514,PRPS1
22479,KEGG_2019_Human,Purine metabolism,1/129,0.006449921761047,0.006449921761047,0,0,19871.0,100223.109907462,PRPS1
22480,KEGG_2019_Human,RNA degradation,1/79,0.0039499423167337,0.0039499423167337,0,0,19921.0,110243.89578070649,CNOT10
22481,KEGG_2019_Human,Pentose phosphate pathway,1/30,0.0014999697593334,0.0035999314356544,0,0,19970.0,129851.13732048514,PGM1
22482,KEGG_2019_Human,Galactose metabolism,1/31,0.0015499690656704,0.0035999314356544,0,0,19969.0,129189.85098816035,PGM1
22483,KEGG_2019_Human,Starch and sucrose metabolism,1/36,0.0017999657178272,0.0035999314356544,0,0,19964.0,126172.23364250171,PGM1
22484,KEGG_2019_Human,Amino sugar and nucleotide sugar metabolism,1/48,0.0023999583567988,0.0035999375351982,0,0,19952.0,120356.5272753826,PGM1
22485,KEGG_2019_Human,Glycolysis / Gluconeogenesis,1/68,0.0033999476216189,0.0040799371459427,0,0,19932.0,113293.39338050144,PGM1
22486,KEGG_2019_Human,Purine metabolism,1/129,0.006449921761047,0.006449921761047,0,0,19871.0,100223.109907462,PGM1
22487,KEGG_2019_Human,Glioma,1/75,0.0037499442041125,0.009399902370135,0,0,19925.0,111301.33528642564,CAMK1D
22488,KEGG_2019_Human,Aldosterone synthesis and secretion,1/98,0.0048999339081079,0.009399902370135,0,0,19902.0,105849.45495286948,CAMK1D
22489,KEGG_2019_Human,Oxytocin signaling pathway,1/153,0.0076499133771537,0.009399902370135,0,0,19847.0,96715.6407630817,CAMK1D
22490,KEGG_2019_Human,Calcium signaling pathway,1/188,0.009399902370135,0.009399902370135,0,0,19812.0,92463.712994847,CAMK1D
22491,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF320
22492,KEGG_2019_Human,Legionellosis,1/55,0.0027499544131125,0.0104498870125997,0,0,19945.0,117599.1294878737,HSPA8
22493,KEGG_2019_Human,Antigen processing and presentation,1/77,0.0038499432547502,0.0104498870125997,0,0,19923.0,110765.8407373636,HSPA8
22494,KEGG_2019_Human,Longevity regulating pathway,1/102,0.0050999322416682,0.0104498870125997,0,0,19898.0,105032.15064717118,HSPA8
22495,KEGG_2019_Human,Toxoplasmosis,1/113,0.0056499278191151,0.0104498870125997,0,0,19887.0,102937.34947211576,HSPA8
22496,KEGG_2019_Human,Spliceosome,1/134,0.0066999199497742,0.0104498870125997,0,0,19866.0,99442.43560916925,HSPA8
22497,KEGG_2019_Human,Estrogen signaling pathway,1/137,0.0068499188797651,0.0104498870125997,0,0,19863.0,98987.62735269018,HSPA8
22498,KEGG_2019_Human,Measles,1/138,0.0068999185254481,0.0104498870125997,0,0,19862.0,98838.19160389496,HSPA8
22499,KEGG_2019_Human,Protein processing in endoplasmic reticulum,1/165,0.0082499094553477,0.0104498870125997,0,0,19835.0,95159.46482222488,HSPA8
22500,KEGG_2019_Human,Influenza A,1/171,0.0085499075557634,0.0104498870125997,0,0,19829.0,94422.42241345016,HSPA8
22501,KEGG_2019_Human,Endocytosis,1/244,0.0121998870519305,0.0134198757571236,0,0,19756.0,87051.4275316661,HSPA8
22502,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0147498749536506,0,0,19705.0,83086.53988020132,HSPA8
22503,KEGG_2019_Human,Proteasome,1/45,0.0022499601197094,0.0022499601197094,0,0,19955.0,121662.49782449217,PSMB6
22504,KEGG_2019_Human,Cocaine addiction,1/49,0.0024499577795033,0.0077498933986465,0,0,19951.0,119939.1172087114,FOSB
22505,KEGG_2019_Human,Amphetamine addiction,1/68,0.0033999476216189,0.0077498933986465,0,0,19932.0,113293.39338050144,FOSB
22506,KEGG_2019_Human,IL-17 signaling pathway,1/93,0.0046499360391879,0.0077498933986465,0,0,19907.0,106918.54242106884,FOSB
22507,KEGG_2019_Human,Osteoclast differentiation,1/127,0.0063499224962247,0.0079374031202809,0,0,19873.0,100543.72072014232,FOSB
22508,KEGG_2019_Human,Alcoholism,1/180,0.0089999047745351,0.0089999047745351,0,0,19820.0,93362.92821536642,FOSB
22509,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF486
22510,KEGG_2019_Human,Proteasome,1/45,0.0022499601197094,0.0038499432547502,0,0,19955.0,121662.49782449217,PSME2
22511,KEGG_2019_Human,Antigen processing and presentation,1/77,0.0038499432547502,0.0038499432547502,0,0,19923.0,110765.8407373636,PSME2
22512,KEGG_2019_Human,Pyrimidine metabolism,1/57,0.002849953326298,0.002849953326298,0,0,19943.0,116875.00742975442,DCTPP1
22513,KEGG_2019_Human,Vasopressin-regulated water reabsorption,1/44,0.0021999607179423,0.0035999456502131,0,0,19956.0,122117.06559109331,AQP4
22514,KEGG_2019_Human,Bile secretion,1/72,0.0035999456502131,0.0035999456502131,0,0,19928.0,112131.59838572376,AQP4
22515,KEGG_2019_Human,Base excision repair,1/33,0.0016499677032113,0.0016499677032113,0,0,19967.0,127928.56031580272,XRCC1
22516,KEGG_2019_Human,Biosynthesis of unsaturated fatty acids,1/27,0.0013499718942362,0.0013499718942362,0,0,19973.0,131975.02298599784,ELOVL3
22517,KEGG_2019_Human,Fatty acid elongation,1/27,0.0013499718942362,0.0013499718942362,0,0,19973.0,131975.02298599784,ELOVL3
22518,KEGG_2019_Human,Cytosolic DNA-sensing pathway,1/63,0.0031499501598827,0.0109927382859815,0,0,19937.0,114844.46974572667,DDX58
22519,KEGG_2019_Human,RIG-I-like receptor signaling pathway,1/70,0.0034999466296654,0.0109927382859815,0,0,19930.0,112704.30065625212,DDX58
22520,KEGG_2019_Human,NF-kappa B signaling pathway,1/95,0.0047499351803394,0.0109927382859815,0,0,19905.0,106484.27183626965,DDX58
22521,KEGG_2019_Human,Measles,1/138,0.0068999185254481,0.0109927382859815,0,0,19862.0,98838.19160389496,DDX58
22522,KEGG_2019_Human,Hepatitis C,1/155,0.0077499127120574,0.0109927382859815,0,0,19845.0,96448.16254952336,DDX58
22523,KEGG_2019_Human,Hepatitis B,1/163,0.0081499100978668,0.0109927382859815,0,0,19837.0,95410.9786681514,DDX58
22524,KEGG_2019_Human,Influenza A,1/171,0.0085499075557634,0.0109927382859815,0,0,19829.0,94422.42241345016,DDX58
22525,KEGG_2019_Human,Epstein-Barr virus infection,1/201,0.0100498985877989,0.0113061359112738,0,0,19799.0,91079.21596609056,DDX58
22526,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,DDX58
22527,KEGG_2019_Human,"Parathyroid hormone synthesis, secretion and action",1/106,0.0052999306076525,0.0127498618039235,0,0,19894.0,104245.78450366124,SLC9A3R1
22528,KEGG_2019_Human,Tight junction,1/170,0.0084999078692823,0.0127498618039235,0,0,19830.0,94543.49009679438,SLC9A3R1
22529,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0164998674589645,0,0,19670.0,80733.60565076157,SLC9A3R1
22530,KEGG_2019_Human,Basal transcription factors,1/45,0.0022499601197094,0.0022499601197094,0,0,19955.0,121662.49782449217,TAF6
22531,KEGG_2019_Human,Primary immunodeficiency,1/37,0.0018499650702878,0.0089998404788377,0,0,19963.0,125618.9446446357,TAP1
22532,KEGG_2019_Human,ABC transporters,1/45,0.0022499601197094,0.0089998404788377,0,0,19955.0,121662.49782449217,TAP1
22533,KEGG_2019_Human,Antigen processing and presentation,1/77,0.0038499432547502,0.0102665153460006,0,0,19923.0,110765.8407373636,TAP1
22534,KEGG_2019_Human,Phagosome,1/152,0.0075999137114971,0.0128570194046101,0,0,19848.0,96850.665715497,TAP1
22535,KEGG_2019_Human,Epstein-Barr virus infection,1/201,0.0100498985877989,0.0128570194046101,0,0,19799.0,91079.21596609056,TAP1
22536,KEGG_2019_Human,Human immunodeficiency virus 1 infection,1/212,0.0105998955026255,0.0128570194046101,0,0,19788.0,89974.27756224656,TAP1
22537,KEGG_2019_Human,Human cytomegalovirus infection,1/225,0.0112498919790339,0.0128570194046101,0,0,19775.0,88738.27077557483,TAP1
22538,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,TAP1
22539,KEGG_2019_Human,"Glycine, serine and threonine metabolism",1/40,0.0019999631680592,0.0019999631680592,0,0,19960.0,124043.94523066044,GNMT
22540,KEGG_2019_Human,Fanconi anemia pathway,1/54,0.0026999549628563,0.0026999549628563,0,0,19946.0,117971.01964061816,FANCG
22541,KEGG_2019_Human,Leishmaniasis,1/74,0.0036999446830449,0.0088999053857096,0,0,19926.0,111574.38983110404,CYBA
22542,KEGG_2019_Human,Leukocyte transendothelial migration,1/112,0.0055999282120529,0.0088999053857096,0,0,19888.0,103119.30984392198,CYBA
22543,KEGG_2019_Human,Osteoclast differentiation,1/127,0.0063499224962247,0.0088999053857096,0,0,19873.0,100543.72072014232,CYBA
22544,KEGG_2019_Human,Fluid shear stress and atherosclerosis,1/139,0.006949918172816,0.0088999053857096,0,0,19861.0,98689.81333375497,CYBA
22545,KEGG_2019_Human,Phagosome,1/152,0.0075999137114971,0.0088999053857096,0,0,19848.0,96850.665715497,CYBA
22546,KEGG_2019_Human,NOD-like receptor signaling pathway,1/178,0.0088999053857096,0.0088999053857096,0,0,19822.0,93593.82745769851,CYBA
22547,KEGG_2019_Human,Glycosaminoglycan biosynthesis,1/53,0.0026499555173137,0.0026499555173137,0,0,19947.0,118349.78824235698,CHST6
22548,KEGG_2019_Human,Ras signaling pathway,1/232,0.0115998901349604,0.0115998901349604,0,0,19768.0,88101.22480150245,PLA1A
22549,KEGG_2019_Human,Hippo signaling pathway,1/160,0.0079999110688441,0.0079999110688441,0,0,19840.0,95793.96509856998,RASSF2
22550,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,NTS
22551,KEGG_2019_Human,Taste transduction,1/83,0.0041499404726918,0.0041499404726918,0,0,19917.0,109237.99888847338,TAS2R43
22552,KEGG_2019_Human,Pancreatic secretion,1/98,0.0048999339081079,0.0048999339081079,0,0,19902.0,105849.45495286948,RAB27B
22553,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF556
22554,KEGG_2019_Human,Inositol phosphate metabolism,1/74,0.0036999446830449,0.0049499334884068,0,0,19926.0,111574.38983110404,MTM1
22555,KEGG_2019_Human,Phosphatidylinositol signaling system,1/99,0.0049499334884068,0.0049499334884068,0,0,19901.0,105642.09305076736,MTM1
22556,KEGG_2019_Human,Fructose and mannose metabolism,1/33,0.0016499677032113,0.0023999583567988,0,0,19967.0,127928.56031580272,GMDS
22557,KEGG_2019_Human,Amino sugar and nucleotide sugar metabolism,1/48,0.0023999583567988,0.0023999583567988,0,0,19952.0,120356.5272753826,GMDS
22558,KEGG_2019_Human,Protein processing in endoplasmic reticulum,1/165,0.0082499094553477,0.0082499094553477,0,0,19835.0,95159.46482222488,SEC24D
22559,KEGG_2019_Human,Inositol phosphate metabolism,1/74,0.0036999446830449,0.0049499334884068,0,0,19926.0,111574.38983110404,INPP1
22560,KEGG_2019_Human,Phosphatidylinositol signaling system,1/99,0.0049499334884068,0.0049499334884068,0,0,19901.0,105642.09305076736,INPP1
22561,KEGG_2019_Human,Ether lipid metabolism,1/47,0.0023499589392381,0.0023499589392381,0,0,19953.0,120782.64067395544,PAFAH1B1
22562,KEGG_2019_Human,Primary bile acid biosynthesis,1/17,0.0008499797390404818,0.0025499392171214,0,0,19983.0,141285.76583697114,ACOX2
22563,KEGG_2019_Human,PPAR signaling pathway,1/74,0.0036999446830449,0.0041499404726918,0,0,19926.0,111574.38983110404,ACOX2
22564,KEGG_2019_Human,Peroxisome,1/83,0.0041499404726918,0.0041499404726918,0,0,19917.0,109237.99888847338,ACOX2
22565,KEGG_2019_Human,Tryptophan metabolism,1/42,0.0020999619311272,0.0020999619311272,0,0,19958.0,123057.75613441122,KMO
22566,KEGG_2019_Human,Phototransduction,1/28,0.0013999711732997,0.0127816714696753,0,0,19972.0,131242.0761597353,GNGT1
22567,KEGG_2019_Human,GABAergic synapse,1/89,0.0044499377838098,0.0127816714696753,0,0,19911.0,107815.380281759,GNGT1
22568,KEGG_2019_Human,Morphine addiction,1/91,0.0045499369072032,0.0127816714696753,0,0,19909.0,107362.10783923086,GNGT1
22569,KEGG_2019_Human,Circadian entrainment,1/97,0.0048499343304706,0.0127816714696753,0,0,19903.0,106058.9096435903,GNGT1
22570,KEGG_2019_Human,Cholinergic synapse,1/112,0.0055999282120529,0.0127816714696753,0,0,19888.0,103119.30984392198,GNGT1
22571,KEGG_2019_Human,Serotonergic synapse,1/113,0.0056499278191151,0.0127816714696753,0,0,19887.0,102937.34947211576,GNGT1
22572,KEGG_2019_Human,Glutamatergic synapse,1/114,0.005699927427839,0.0127816714696753,0,0,19886.0,102756.96431429044,GNGT1
22573,KEGG_2019_Human,Relaxin signaling pathway,1/130,0.0064999213952527,0.0127816714696753,0,0,19870.0,100064.62842845908,GNGT1
22574,KEGG_2019_Human,Dopaminergic synapse,1/131,0.0065499210316603,0.0127816714696753,0,0,19869.0,99907.33811343512,GNGT1
22575,KEGG_2019_Human,Apelin signaling pathway,1/137,0.0068499188797651,0.0127816714696753,0,0,19863.0,98987.62735269018,GNGT1
22576,KEGG_2019_Human,Retrograde endocannabinoid signaling,1/148,0.007399915061391,0.0127816714696753,0,0,19852.0,97399.60470052566,GNGT1
22577,KEGG_2019_Human,Alcoholism,1/180,0.0089999047745351,0.0128927238431994,0,0,19820.0,93362.92821536642,GNGT1
22578,KEGG_2019_Human,Kaposi sarcoma-associated herpesvirus infection,1/186,0.0092999029651357,0.0128927238431994,0,0,19814.0,92684.96451050608,GNGT1
22579,KEGG_2019_Human,Chemokine signaling pathway,1/190,0.0094999017791995,0.0128927238431994,0,0,19810.0,92244.74636351672,GNGT1
22580,KEGG_2019_Human,Human immunodeficiency virus 1 infection,1/212,0.0105998955026255,0.0129645830920145,0,0,19788.0,89974.27756224656,GNGT1
22581,KEGG_2019_Human,Human cytomegalovirus infection,1/225,0.0112498919790339,0.0129645830920145,0,0,19775.0,88738.27077557483,GNGT1
22582,KEGG_2019_Human,Ras signaling pathway,1/232,0.0115998901349604,0.0129645830920145,0,0,19768.0,88101.22480150245,GNGT1
22583,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.018683188343665,0,0,19646.0,79255.8617626126,GNGT1
22584,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,GNGT1
22585,KEGG_2019_Human,Proteasome,1/45,0.0022499601197094,0.0038499432547502,0,0,19955.0,121662.49782449217,PSME1
22586,KEGG_2019_Human,Antigen processing and presentation,1/77,0.0038499432547502,0.0038499432547502,0,0,19923.0,110765.8407373636,PSME1
22587,KEGG_2019_Human,Nucleotide excision repair,1/47,0.0023499589392381,0.0046999178784763,0,0,19953.0,120782.64067395544,RAD23A
22588,KEGG_2019_Human,Protein processing in endoplasmic reticulum,1/165,0.0082499094553477,0.0082499094553477,0,0,19835.0,95159.46482222488,RAD23A
22589,KEGG_2019_Human,Mannose type O-glycan biosynthesis,1/23,0.0011499748819949,0.0011499748819949,0,0,19977.0,135204.63922267244,B4GAT1
22590,KEGG_2019_Human,Primary bile acid biosynthesis,1/17,0.0008499797390404818,0.0008499797390404818,0,0,19983.0,141285.76583697114,CH25H
22591,KEGG_2019_Human,Ubiquitin mediated proteolysis,1/137,0.0068499188797651,0.0068499188797651,0,0,19863.0,98987.62735269018,UBE2C
22592,KEGG_2019_Human,Notch signaling pathway,1/48,0.0023999583567988,0.0095998334271952,0,0,19952.0,120356.5272753826,HES5
22593,KEGG_2019_Human,Breast cancer,1/147,0.0073499154017982,0.0146998308035964,0,0,19853.0,97539.10874372096,HES5
22594,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0219998232786193,0,0,19670.0,80733.60565076157,HES5
22595,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,HES5
22596,KEGG_2019_Human,MicroRNAs in cancer,1/299,0.0149498740670514,0.0149498740670514,0,0,19701.0,82804.33538735632,MIR29A
22597,KEGG_2019_Human,Protein processing in endoplasmic reticulum,1/165,0.0082499094553477,0.0082499094553477,0,0,19835.0,95159.46482222488,NSFL1C
22598,KEGG_2019_Human,Proximal tubule bicarbonate reclamation,1/23,0.0011499748819949,0.0034499246459849,0,0,19977.0,135204.63922267244,SLC38A3
22599,KEGG_2019_Human,GABAergic synapse,1/89,0.0044499377838098,0.005699927427839,0,0,19911.0,107815.380281759,SLC38A3
22600,KEGG_2019_Human,Glutamatergic synapse,1/114,0.005699927427839,0.005699927427839,0,0,19886.0,102756.96431429044,SLC38A3
22601,KEGG_2019_Human,Peroxisome,1/83,0.0041499404726918,0.0041499404726918,0,0,19917.0,109237.99888847338,MPV17L
22602,KEGG_2019_Human,Circadian rhythm,1/31,0.0015499690656704,0.0089248989400127,0,0,19969.0,129189.85098816035,PRKAB2
22603,KEGG_2019_Human,Adipocytokine signaling pathway,1/69,0.003449947123837,0.0089248989400127,0,0,19931.0,112996.7391397682,PRKAB2
22604,KEGG_2019_Human,Hypertrophic cardiomyopathy (HCM),1/85,0.004249939567045,0.0089248989400127,0,0,19915.0,108752.83801948265,PRKAB2
22605,KEGG_2019_Human,Longevity regulating pathway,1/102,0.0050999322416682,0.0089248989400127,0,0,19898.0,105032.15064717118,PRKAB2
22606,KEGG_2019_Human,Glucagon signaling pathway,1/103,0.0051499318302617,0.0089248989400127,0,0,19897.0,104832.7525292024,PRKAB2
22607,KEGG_2019_Human,Insulin resistance,1/108,0.0053999298011749,0.0089248989400127,0,0,19892.0,103863.47861844616,PRKAB2
22608,KEGG_2019_Human,AMPK signaling pathway,1/120,0.0059999251180858,0.0089248989400127,0,0,19880.0,101706.2448082016,PRKAB2
22609,KEGG_2019_Human,FoxO signaling pathway,1/132,0.0065999206698993,0.0089248989400127,0,0,19868.0,99751.22090491928,PRKAB2
22610,KEGG_2019_Human,Insulin signaling pathway,1/137,0.0068499188797651,0.0089248989400127,0,0,19863.0,98987.62735269018,PRKAB2
22611,KEGG_2019_Human,Apelin signaling pathway,1/137,0.0068499188797651,0.0089248989400127,0,0,19863.0,98987.62735269018,PRKAB2
22612,KEGG_2019_Human,Non-alcoholic fatty liver disease (NAFLD),1/149,0.0074499147221605,0.0089248989400127,0,0,19851.0,97261.02051561224,PRKAB2
22613,KEGG_2019_Human,Oxytocin signaling pathway,1/153,0.0076499133771537,0.0089248989400127,0,0,19847.0,96715.6407630817,PRKAB2
22614,KEGG_2019_Human,Tight junction,1/170,0.0084999078692823,0.0091537469361502,0,0,19830.0,94543.49009679438,PRKAB2
22615,KEGG_2019_Human,Thermogenesis,1/231,0.0115498903940656,0.0115498903940656,0,0,19769.0,88191.07730937863,PRKAB2
22616,KEGG_2019_Human,Purine metabolism,1/129,0.006449921761047,0.006449921761047,0,0,19871.0,100223.109907462,APRT
22617,KEGG_2019_Human,Toxoplasmosis,1/113,0.0056499278191151,0.0096499008972596,0,0,19887.0,102937.34947211576,PPIF
22618,KEGG_2019_Human,Parkinson disease,1/142,0.0070999171242726,0.0096499008972596,0,0,19858.0,98250.87390500787,PPIF
22619,KEGG_2019_Human,cGMP-PKG signaling pathway,1/166,0.0082999091363732,0.0096499008972596,0,0,19834.0,95034.82345515196,PPIF
22620,KEGG_2019_Human,Calcium signaling pathway,1/188,0.009399902370135,0.0096499008972596,0,0,19812.0,92463.712994847,PPIF
22621,KEGG_2019_Human,Huntington disease,1/193,0.0096499008972596,0.0096499008972596,0,0,19807.0,91920.47679471428,PPIF
22622,KEGG_2019_Human,Wnt signaling pathway,1/158,0.0078999117225733,0.0078999117225733,0,0,19842.0,96053.2110949472,PRICKLE2
22623,KEGG_2019_Human,Porphyrin and chlorophyll metabolism,1/42,0.0020999619311272,0.0025499566390179,0,0,19958.0,123057.75613441122,HMOX2
22624,KEGG_2019_Human,Mineral absorption,1/51,0.0025499566390179,0.0025499566390179,0,0,19949.0,119129.0228601236,HMOX2
22625,KEGG_2019_Human,Type II diabetes mellitus,1/46,0.0022999595269283,0.0080953586760861,0,0,19954.0,121217.8313311442,PRKCD
22626,KEGG_2019_Human,Fc gamma R-mediated phagocytosis,1/91,0.0045499369072032,0.0080953586760861,0,0,19909.0,107362.10783923086,PRKCD
22627,KEGG_2019_Human,GnRH signaling pathway,1/93,0.0046499360391879,0.0080953586760861,0,0,19907.0,106918.54242106884,PRKCD
22628,KEGG_2019_Human,AGE-RAGE signaling pathway in diabetic complications,1/100,0.0049999330710556,0.0080953586760861,0,0,19900.0,105436.78197328727,PRKCD
22629,KEGG_2019_Human,Inflammatory mediator regulation of TRP channels,1/100,0.0049999330710556,0.0080953586760861,0,0,19900.0,105436.78197328727,PRKCD
22630,KEGG_2019_Human,C-type lectin receptor signaling pathway,1/104,0.0051999314202997,0.0080953586760861,0,0,19896.0,104635.24941415618,PRKCD
22631,KEGG_2019_Human,Insulin resistance,1/108,0.0053999298011749,0.0080953586760861,0,0,19892.0,103863.47861844616,PRKCD
22632,KEGG_2019_Human,Neurotrophin signaling pathway,1/119,0.0059499254985137,0.0080953586760861,0,0,19881.0,101877.73080211312,PRKCD
22633,KEGG_2019_Human,Autophagy,1/128,0.0063999221281459,0.0080953586760861,0,0,19872.0,100382.8010329652,PRKCD
22634,KEGG_2019_Human,Vascular smooth muscle contraction,1/132,0.0065999206698993,0.0080953586760861,0,0,19868.0,99751.22090491928,PRKCD
22635,KEGG_2019_Human,Estrogen signaling pathway,1/137,0.0068499188797651,0.0080953586760861,0,0,19863.0,98987.62735269018,PRKCD
22636,KEGG_2019_Human,NOD-like receptor signaling pathway,1/178,0.0088999053857096,0.0094999017791995,0,0,19822.0,93593.82745769851,PRKCD
22637,KEGG_2019_Human,Chemokine signaling pathway,1/190,0.0094999017791995,0.0094999017791995,0,0,19810.0,92244.74636351672,PRKCD
22638,KEGG_2019_Human,Prion diseases,1/35,0.0017499663721595,0.0102141538622461,0,0,19965.0,126740.98858805298,CCL5
22639,KEGG_2019_Human,Cytosolic DNA-sensing pathway,1/63,0.0031499501598827,0.0102141538622461,0,0,19937.0,114844.46974572667,CCL5
22640,KEGG_2019_Human,Epithelial cell signaling in Helicobacter pylori infection,1/68,0.0033999476216189,0.0102141538622461,0,0,19932.0,113293.39338050144,CCL5
22641,KEGG_2019_Human,Rheumatoid arthritis,1/91,0.0045499369072032,0.0102141538622461,0,0,19909.0,107362.10783923086,CCL5
22642,KEGG_2019_Human,Chagas disease (American trypanosomiasis),1/103,0.0051499318302617,0.0102141538622461,0,0,19897.0,104832.7525292024,CCL5
22643,KEGG_2019_Human,Toll-like receptor signaling pathway,1/104,0.0051999314202997,0.0102141538622461,0,0,19896.0,104635.24941415618,CCL5
22644,KEGG_2019_Human,TNF signaling pathway,1/110,0.0054999290027479,0.0102141538622461,0,0,19890.0,103488.06969787036,CCL5
22645,KEGG_2019_Human,Influenza A,1/171,0.0085499075557634,0.0123498723129594,0,0,19829.0,94422.42241345016,CCL5
22646,KEGG_2019_Human,NOD-like receptor signaling pathway,1/178,0.0088999053857096,0.0123498723129594,0,0,19822.0,93593.82745769851,CCL5
22647,KEGG_2019_Human,Chemokine signaling pathway,1/190,0.0094999017791995,0.0123498723129594,0,0,19810.0,92244.74636351672,CCL5
22648,KEGG_2019_Human,Human cytomegalovirus infection,1/225,0.0112498919790339,0.0132953268843128,0,0,19775.0,88738.27077557483,CCL5
22649,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0159248647739712,0,0,19706.0,83157.67014793828,CCL5
22650,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,CCL5
22651,KEGG_2019_Human,MicroRNAs in cancer,1/299,0.0149498740670514,0.0149498740670514,0,0,19701.0,82804.33538735632,MIR7-3
22652,KEGG_2019_Human,alpha-Linolenic acid metabolism,1/25,0.0012499733663791,0.0040499156827088,0,0,19975.0,133525.54486996148,ACOX1
22653,KEGG_2019_Human,Biosynthesis of unsaturated fatty acids,1/27,0.0013499718942362,0.0040499156827088,0,0,19973.0,131975.02298599784,ACOX1
22654,KEGG_2019_Human,Fatty acid degradation,1/44,0.0021999607179423,0.0043999214358846,0,0,19956.0,122117.06559109331,ACOX1
22655,KEGG_2019_Human,PPAR signaling pathway,1/74,0.0036999446830449,0.0049799285672302,0,0,19926.0,111574.38983110404,ACOX1
22656,KEGG_2019_Human,Peroxisome,1/83,0.0041499404726918,0.0049799285672302,0,0,19917.0,109237.99888847338,ACOX1
22657,KEGG_2019_Human,cAMP signaling pathway,1/212,0.0105998955026255,0.0105998955026255,0,0,19788.0,89974.27756224656,ACOX1
22658,KEGG_2019_Human,Antigen processing and presentation,1/77,0.0038499432547502,0.0079999110688441,0,0,19923.0,110765.8407373636,KIR2DL4
22659,KEGG_2019_Human,Natural killer cell mediated cytotoxicity,1/131,0.0065499210316603,0.0079999110688441,0,0,19869.0,99907.33811343512,KIR2DL4
22660,KEGG_2019_Human,Cellular senescence,1/160,0.0079999110688441,0.0079999110688441,0,0,19840.0,95793.96509856998,KIR2DL4
22661,KEGG_2019_Human,Proteasome,1/45,0.0022499601197094,0.0022499601197094,0,0,19955.0,121662.49782449217,PSMB7
22662,KEGG_2019_Human,Steroid biosynthesis,1/19,0.00094997806231055,0.00094997806231055,0,0,19981.0,139049.2109571672,FDFT1
22663,KEGG_2019_Human,FoxO signaling pathway,1/132,0.0065999206698993,0.0065999206698993,0,0,19868.0,99751.22090491928,PLK2
22664,KEGG_2019_Human,Axon guidance,1/181,0.0090499044707863,0.0106998949514067,0,0,19819.0,93248.41634586031,SSH1
22665,KEGG_2019_Human,Regulation of actin cytoskeleton,1/214,0.0106998949514067,0.0106998949514067,0,0,19786.0,89779.39753374986,SSH1
22666,KEGG_2019_Human,Oxidative phosphorylation,1/133,0.0066499203093911,0.0115498903940656,0,0,19867.0,99596.2591544721,ATP5MF
22667,KEGG_2019_Human,Thermogenesis,1/231,0.0115498903940656,0.0115498903940656,0,0,19769.0,88191.07730937863,ATP5MF
22668,KEGG_2019_Human,Glycosaminoglycan biosynthesis,1/53,0.0026499555173137,0.0026499555173137,0,0,19947.0,118349.78824235698,NDST2
22669,KEGG_2019_Human,Inflammatory bowel disease (IBD),1/65,0.003249949134407,0.0113607549253379,0,0,19935.0,114209.92613860144,STAT3
22670,KEGG_2019_Human,Acute myeloid leukemia,1/66,0.003299948626608,0.0113607549253379,0,0,19934.0,113899.85357353876,STAT3
22671,KEGG_2019_Human,Non-small cell lung cancer,1/66,0.003299948626608,0.0113607549253379,0,0,19934.0,113899.85357353876,STAT3
22672,KEGG_2019_Human,Adipocytokine signaling pathway,1/69,0.003449947123837,0.0113607549253379,0,0,19931.0,112996.7391397682,STAT3
22673,KEGG_2019_Human,Prolactin signaling pathway,1/70,0.0034999466296654,0.0113607549253379,0,0,19930.0,112704.30065625212,STAT3
22674,KEGG_2019_Human,Pancreatic cancer,1/75,0.0037499442041125,0.0113607549253379,0,0,19925.0,111301.33528642564,STAT3
22675,KEGG_2019_Human,AGE-RAGE signaling pathway in diabetic complications,1/100,0.0049999330710556,0.0113607549253379,0,0,19900.0,105436.78197328727,STAT3
22676,KEGG_2019_Human,HIF-1 signaling pathway,1/100,0.0049999330710556,0.0113607549253379,0,0,19900.0,105436.78197328727,STAT3
22677,KEGG_2019_Human,Th17 cell differentiation,1/107,0.0053499302026925,0.0113607549253379,0,0,19893.0,104053.753408911,STAT3
22678,KEGG_2019_Human,Insulin resistance,1/108,0.0053999298011749,0.0113607549253379,0,0,19892.0,103863.47861844616,STAT3
22679,KEGG_2019_Human,Toxoplasmosis,1/113,0.0056499278191151,0.0113607549253379,0,0,19887.0,102937.34947211576,STAT3
22680,KEGG_2019_Human,FoxO signaling pathway,1/132,0.0065999206698993,0.0113607549253379,0,0,19868.0,99751.22090491928,STAT3
22681,KEGG_2019_Human,Measles,1/138,0.0068999185254481,0.0113607549253379,0,0,19862.0,98838.19160389496,STAT3
22682,KEGG_2019_Human,Signaling pathways regulating pluripotency of stem cells,1/139,0.006949918172816,0.0113607549253379,0,0,19861.0,98689.81333375497,STAT3
22683,KEGG_2019_Human,Hepatitis C,1/155,0.0077499127120574,0.0113607549253379,0,0,19845.0,96448.16254952336,STAT3
22684,KEGG_2019_Human,JAK-STAT signaling pathway,1/162,0.0080999104202618,0.0113607549253379,0,0,19838.0,95537.86936302872,STAT3
22685,KEGG_2019_Human,Necroptosis,1/162,0.0080999104202618,0.0113607549253379,0,0,19838.0,95537.86936302872,STAT3
22686,KEGG_2019_Human,Hepatitis B,1/163,0.0081499100978668,0.0113607549253379,0,0,19837.0,95410.9786681514,STAT3
22687,KEGG_2019_Human,Kaposi sarcoma-associated herpesvirus infection,1/186,0.0092999029651357,0.0113607549253379,0,0,19814.0,92684.96451050608,STAT3
22688,KEGG_2019_Human,Chemokine signaling pathway,1/190,0.0094999017791995,0.0113607549253379,0,0,19810.0,92244.74636351672,STAT3
22689,KEGG_2019_Human,Epstein-Barr virus infection,1/201,0.0100498985877989,0.0113607549253379,0,0,19799.0,91079.21596609056,STAT3
22690,KEGG_2019_Human,Proteoglycans in cancer,1/201,0.0100498985877989,0.0113607549253379,0,0,19799.0,91079.21596609056,STAT3
22691,KEGG_2019_Human,Viral carcinogenesis,1/201,0.0100498985877989,0.0113607549253379,0,0,19799.0,91079.21596609056,STAT3
22692,KEGG_2019_Human,Human cytomegalovirus infection,1/225,0.0112498919790339,0.0121873829772867,0,0,19775.0,88738.27077557483,STAT3
22693,KEGG_2019_Human,MicroRNAs in cancer,1/299,0.0149498740670514,0.0155478690297335,0,0,19701.0,82804.33538735632,STAT3
22694,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,STAT3
22695,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR10H3
22696,KEGG_2019_Human,JAK-STAT signaling pathway,1/162,0.0080999104202618,0.0146998751759735,0,0,19838.0,95537.86936302872,IFNL3
22697,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0146998751759735,0,0,19706.0,83157.67014793828,IFNL3
22698,KEGG_2019_Human,Non-small cell lung cancer,1/66,0.003299948626608,0.0092998720783758,0,0,19934.0,113899.85357353876,RARB
22699,KEGG_2019_Human,Small cell lung cancer,1/93,0.0046499360391879,0.0092998720783758,0,0,19907.0,106918.54242106884,RARB
22700,KEGG_2019_Human,Gastric cancer,1/149,0.0074499147221605,0.0099332196295474,0,0,19851.0,97261.02051561224,RARB
22701,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,RARB
22702,KEGG_2019_Human,Cellular senescence,1/160,0.0079999110688441,0.0079999110688441,0,0,19840.0,95793.96509856998,LIN54
22703,KEGG_2019_Human,Purine metabolism,1/129,0.006449921761047,0.006449921761047,0,0,19871.0,100223.109907462,PAICS
22704,KEGG_2019_Human,Lysosome,1/123,0.0061499239842961,0.0061499239842961,0,0,19877.0,101200.07933676826,SCARB2
22705,KEGG_2019_Human,SNARE interactions in vesicular transport,1/34,0.0016999670339032,0.0016999670339032,0,0,19966.0,127326.1054203148,STX16
22706,KEGG_2019_Human,C-type lectin receptor signaling pathway,1/104,0.0051999314202997,0.0089499050800561,0,0,19896.0,104635.24941415618,CLEC4E
22707,KEGG_2019_Human,Tuberculosis,1/179,0.0089499050800561,0.0089499050800561,0,0,19821.0,93478.0629355712,CLEC4E
22708,KEGG_2019_Human,Ascorbate and aldarate metabolism,1/27,0.0013499718942362,0.004685646776936,0,0,19973.0,131975.02298599784,UGT1A10
22709,KEGG_2019_Human,Pentose and glucuronate interconversions,1/34,0.0016999670339032,0.004685646776936,0,0,19966.0,127326.1054203148,UGT1A10
22710,KEGG_2019_Human,Porphyrin and chlorophyll metabolism,1/42,0.0020999619311272,0.004685646776936,0,0,19958.0,123057.75613441122,UGT1A10
22711,KEGG_2019_Human,Steroid hormone biosynthesis,1/60,0.002999951725986,0.004685646776936,0,0,19940.0,115834.63209072244,UGT1A10
22712,KEGG_2019_Human,Retinol metabolism,1/67,0.0033499481224912,0.004685646776936,0,0,19933.0,113594.38808369274,UGT1A10
22713,KEGG_2019_Human,Metabolism of xenobiotics by cytochrome P450,1/74,0.0036999446830449,0.004685646776936,0,0,19926.0,111574.38983110404,UGT1A10
22714,KEGG_2019_Human,Chemical carcinogenesis,1/82,0.004099940929819,0.004685646776936,0,0,19918.0,109484.9180722932,UGT1A10
22715,KEGG_2019_Human,Drug metabolism,1/108,0.0053999298011749,0.0053999298011749,0,0,19892.0,103863.47861844616,UGT1A10
22716,KEGG_2019_Human,Staphylococcus aureus infection,1/68,0.0033999476216189,0.0039499423167337,0,0,19932.0,113293.39338050144,CFD
22717,KEGG_2019_Human,Complement and coagulation cascades,1/79,0.0039499423167337,0.0039499423167337,0,0,19921.0,110243.89578070649,CFD
22718,KEGG_2019_Human,Rheumatoid arthritis,1/91,0.0045499369072032,0.0096998686609413,0,0,19909.0,107362.10783923086,IL11
22719,KEGG_2019_Human,Hematopoietic cell lineage,1/97,0.0048499343304706,0.0096998686609413,0,0,19903.0,106058.9096435903,IL11
22720,KEGG_2019_Human,JAK-STAT signaling pathway,1/162,0.0080999104202618,0.0107998805603491,0,0,19838.0,95537.86936302872,IL11
22721,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0146998751759735,0,0,19706.0,83157.67014793828,IL11
22722,KEGG_2019_Human,SNARE interactions in vesicular transport,1/34,0.0016999670339032,0.0016999670339032,0,0,19966.0,127326.1054203148,BNIP1
22723,KEGG_2019_Human,Shigellosis,1/65,0.003249949134407,0.0085998782347732,0,0,19935.0,114209.92613860144,PFN2
22724,KEGG_2019_Human,Salmonella infection,1/86,0.0042999391173866,0.0085998782347732,0,0,19914.0,108514.46102290176,PFN2
22725,KEGG_2019_Human,Rap1 signaling pathway,1/206,0.010299897173561,0.0106998949514067,0,0,19794.0,90569.849337325,PFN2
22726,KEGG_2019_Human,Regulation of actin cytoskeleton,1/214,0.0106998949514067,0.0106998949514067,0,0,19786.0,89779.39753374986,PFN2
22727,KEGG_2019_Human,AMPK signaling pathway,1/120,0.0059999251180858,0.0075999137114971,0,0,19880.0,101706.2448082016,STRADB
22728,KEGG_2019_Human,mTOR signaling pathway,1/152,0.0075999137114971,0.0075999137114971,0,0,19848.0,96850.665715497,STRADB
22729,KEGG_2019_Human,Long-term depression,1/60,0.002999951725986,0.0099165591808294,0,0,19940.0,115834.63209072244,PPP2R1B
22730,KEGG_2019_Human,TGF-beta signaling pathway,1/90,0.0044999373439762,0.0099165591808294,0,0,19910.0,107587.50385474482,PPP2R1B
22731,KEGG_2019_Human,mRNA surveillance pathway,1/91,0.0045499369072032,0.0099165591808294,0,0,19909.0,107362.10783923086,PPP2R1B
22732,KEGG_2019_Human,Chagas disease (American trypanosomiasis),1/103,0.0051499318302617,0.0099165591808294,0,0,19897.0,104832.7525292024,PPP2R1B
22733,KEGG_2019_Human,Sphingolipid signaling pathway,1/119,0.0059499254985137,0.0099165591808294,0,0,19881.0,101877.73080211312,PPP2R1B
22734,KEGG_2019_Human,AMPK signaling pathway,1/120,0.0059999251180858,0.0099165591808294,0,0,19880.0,101706.2448082016,PPP2R1B
22735,KEGG_2019_Human,Oocyte meiosis,1/125,0.0062499232373748,0.0099165591808294,0,0,19875.0,100869.32368441945,PPP2R1B
22736,KEGG_2019_Human,Dopaminergic synapse,1/131,0.0065499210316603,0.0099165591808294,0,0,19869.0,99907.33811343512,PPP2R1B
22737,KEGG_2019_Human,Adrenergic signaling in cardiomyocytes,1/145,0.0072499160871101,0.0099165591808294,0,0,19855.0,97820.92670675044,PPP2R1B
22738,KEGG_2019_Human,Hepatitis C,1/155,0.0077499127120574,0.0099165591808294,0,0,19845.0,96448.16254952336,PPP2R1B
22739,KEGG_2019_Human,Hippo signaling pathway,1/160,0.0079999110688441,0.0099165591808294,0,0,19840.0,95793.96509856998,PPP2R1B
22740,KEGG_2019_Human,Tight junction,1/170,0.0084999078692823,0.0099165591808294,0,0,19830.0,94543.49009679438,PPP2R1B
22741,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0176998626413668,0,0,19670.0,80733.60565076157,PPP2R1B
22742,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0176998626413668,0,0,19646.0,79255.8617626126,PPP2R1B
22743,KEGG_2019_Human,Proteoglycans in cancer,1/201,0.0100498985877989,0.0149498740670514,0,0,19799.0,91079.21596609056,PDCD4
22744,KEGG_2019_Human,MicroRNAs in cancer,1/299,0.0149498740670514,0.0149498740670514,0,0,19701.0,82804.33538735632,PDCD4
22745,KEGG_2019_Human,Arginine biosynthesis,1/21,0.0010499764455398,0.0017499663721595,0,0,19979.0,137035.71221916509,GPT2
22746,KEGG_2019_Human,"Alanine, aspartate and glutamate metabolism",1/35,0.0017499663721595,0.0017499663721595,0,0,19965.0,126740.98858805298,GPT2
22747,KEGG_2019_Human,Ribosome,1/153,0.0076499133771537,0.0076499133771537,0,0,19847.0,96715.6407630817,RPL38
22748,KEGG_2019_Human,JAK-STAT signaling pathway,1/162,0.0080999104202618,0.0146998751759735,0,0,19838.0,95537.86936302872,IL20
22749,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0146998751759735,0,0,19706.0,83157.67014793828,IL20
22750,KEGG_2019_Human,Epithelial cell signaling in Helicobacter pylori infection,1/68,0.0033999476216189,0.0146998751759735,0,0,19932.0,113293.39338050144,CXCR1
22751,KEGG_2019_Human,Phospholipase D signaling pathway,1/148,0.007399915061391,0.0146998751759735,0,0,19852.0,97399.60470052566,CXCR1
22752,KEGG_2019_Human,Chemokine signaling pathway,1/190,0.0094999017791995,0.0146998751759735,0,0,19810.0,92244.74636351672,CXCR1
22753,KEGG_2019_Human,Endocytosis,1/244,0.0121998870519305,0.0146998751759735,0,0,19756.0,87051.4275316661,CXCR1
22754,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0146998751759735,0,0,19706.0,83157.67014793828,CXCR1
22755,KEGG_2019_Human,Ribosome biogenesis in eukaryotes,1/101,0.0050499326546803,0.0050499326546803,0,0,19899.0,105233.48101229242,MPHOSPH10
22756,KEGG_2019_Human,Axon guidance,1/181,0.0090499044707863,0.0106998949514067,0,0,19819.0,93248.41634586031,SSH3
22757,KEGG_2019_Human,Regulation of actin cytoskeleton,1/214,0.0106998949514067,0.0106998949514067,0,0,19786.0,89779.39753374986,SSH3
22758,KEGG_2019_Human,Circadian rhythm,1/31,0.0015499690656704,0.0091798960525845,0,0,19969.0,129189.85098816035,PRKAA1
22759,KEGG_2019_Human,Adipocytokine signaling pathway,1/69,0.003449947123837,0.0091798960525845,0,0,19931.0,112996.7391397682,PRKAA1
22760,KEGG_2019_Human,Hypertrophic cardiomyopathy (HCM),1/85,0.004249939567045,0.0091798960525845,0,0,19915.0,108752.83801948265,PRKAA1
22761,KEGG_2019_Human,Longevity regulating pathway,1/102,0.0050999322416682,0.0091798960525845,0,0,19898.0,105032.15064717118,PRKAA1
22762,KEGG_2019_Human,Glucagon signaling pathway,1/103,0.0051499318302617,0.0091798960525845,0,0,19897.0,104832.7525292024,PRKAA1
22763,KEGG_2019_Human,Insulin resistance,1/108,0.0053999298011749,0.0091798960525845,0,0,19892.0,103863.47861844616,PRKAA1
22764,KEGG_2019_Human,AMPK signaling pathway,1/120,0.0059999251180858,0.0091798960525845,0,0,19880.0,101706.2448082016,PRKAA1
22765,KEGG_2019_Human,Autophagy,1/128,0.0063999221281459,0.0091798960525845,0,0,19872.0,100382.8010329652,PRKAA1
22766,KEGG_2019_Human,FoxO signaling pathway,1/132,0.0065999206698993,0.0091798960525845,0,0,19868.0,99751.22090491928,PRKAA1
22767,KEGG_2019_Human,Insulin signaling pathway,1/137,0.0068499188797651,0.0091798960525845,0,0,19863.0,98987.62735269018,PRKAA1
22768,KEGG_2019_Human,Apelin signaling pathway,1/137,0.0068499188797651,0.0091798960525845,0,0,19863.0,98987.62735269018,PRKAA1
22769,KEGG_2019_Human,Fluid shear stress and atherosclerosis,1/139,0.006949918172816,0.0091798960525845,0,0,19861.0,98689.81333375497,PRKAA1
22770,KEGG_2019_Human,Non-alcoholic fatty liver disease (NAFLD),1/149,0.0074499147221605,0.0091798960525845,0,0,19851.0,97261.02051561224,PRKAA1
22771,KEGG_2019_Human,mTOR signaling pathway,1/152,0.0075999137114971,0.0091798960525845,0,0,19848.0,96850.665715497,PRKAA1
22772,KEGG_2019_Human,Oxytocin signaling pathway,1/153,0.0076499133771537,0.0091798960525845,0,0,19847.0,96715.6407630817,PRKAA1
22773,KEGG_2019_Human,Tight junction,1/170,0.0084999078692823,0.0095623963529426,0,0,19830.0,94543.49009679438,PRKAA1
22774,KEGG_2019_Human,Thermogenesis,1/231,0.0115498903940656,0.0122292957113635,0,0,19769.0,88191.07730937863,PRKAA1
22775,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0176998626413668,0,0,19646.0,79255.8617626126,PRKAA1
22776,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR9A2
22777,KEGG_2019_Human,Lysosome,1/123,0.0061499239842961,0.0061499239842961,0,0,19877.0,101200.07933676826,PSAPL1
22778,KEGG_2019_Human,Biosynthesis of unsaturated fatty acids,1/27,0.0013499718942362,0.0020249578413544,0,0,19973.0,131975.02298599784,HSD17B12
22779,KEGG_2019_Human,Fatty acid elongation,1/27,0.0013499718942362,0.0020249578413544,0,0,19973.0,131975.02298599784,HSD17B12
22780,KEGG_2019_Human,Steroid hormone biosynthesis,1/60,0.002999951725986,0.002999951725986,0,0,19940.0,115834.63209072244,HSD17B12
22781,KEGG_2019_Human,Propanoate metabolism,1/32,0.0015999683804467,0.0023999583567988,0,0,19968.0,128549.41955786056,DBT
22782,KEGG_2019_Human,"Valine, leucine and isoleucine degradation",1/48,0.0023999583567988,0.0023999583567988,0,0,19952.0,120356.5272753826,DBT
22783,KEGG_2019_Human,Ribosome,1/153,0.0076499133771537,0.0076499133771537,0,0,19847.0,96715.6407630817,MRPL1
22784,KEGG_2019_Human,Spliceosome,1/134,0.0066999199497742,0.0066999199497742,0,0,19866.0,99442.43560916925,SF3A1
22785,KEGG_2019_Human,African trypanosomiasis,1/37,0.0018499650702878,0.0090104087624296,0,0,19963.0,125618.9446446357,IFNG
22786,KEGG_2019_Human,Allograft rejection,1/38,0.001899964429635,0.0090104087624296,0,0,19962.0,125080.29732025368,IFNG
22787,KEGG_2019_Human,Graft-versus-host disease,1/41,0.0020499625466866,0.0090104087624296,0,0,19959.0,123544.88783416104,IFNG
22788,KEGG_2019_Human,Type I diabetes mellitus,1/43,0.0021499613216957,0.0090104087624296,0,0,19957.0,122581.98940490963,IFNG
22789,KEGG_2019_Human,Proteasome,1/45,0.0022499601197094,0.0090104087624296,0,0,19955.0,121662.49782449217,IFNG
22790,KEGG_2019_Human,Malaria,1/49,0.0024499577795033,0.0090104087624296,0,0,19951.0,119939.1172087114,IFNG
22791,KEGG_2019_Human,Inflammatory bowel disease (IBD),1/65,0.003249949134407,0.0090104087624296,0,0,19935.0,114209.92613860144,IFNG
22792,KEGG_2019_Human,Leishmaniasis,1/74,0.0036999446830449,0.0090104087624296,0,0,19926.0,111574.38983110404,IFNG
22793,KEGG_2019_Human,Antigen processing and presentation,1/77,0.0038499432547502,0.0090104087624296,0,0,19923.0,110765.8407373636,IFNG
22794,KEGG_2019_Human,Salmonella infection,1/86,0.0042999391173866,0.0090104087624296,0,0,19914.0,108514.46102290176,IFNG
22795,KEGG_2019_Human,TGF-beta signaling pathway,1/90,0.0044999373439762,0.0090104087624296,0,0,19910.0,107587.50385474482,IFNG
22796,KEGG_2019_Human,Rheumatoid arthritis,1/91,0.0045499369072032,0.0090104087624296,0,0,19909.0,107362.10783923086,IFNG
22797,KEGG_2019_Human,Th1 and Th2 cell differentiation,1/92,0.0045999364719865,0.0090104087624296,0,0,19908.0,107139.13814408927,IFNG
22798,KEGG_2019_Human,IL-17 signaling pathway,1/93,0.0046499360391879,0.0090104087624296,0,0,19907.0,106918.54242106884,IFNG
22799,KEGG_2019_Human,Amoebiasis,1/96,0.0047999347538706,0.0090104087624296,0,0,19904.0,106270.50039849174,IFNG
22800,KEGG_2019_Human,HIF-1 signaling pathway,1/100,0.0049999330710556,0.0090104087624296,0,0,19900.0,105436.78197328727,IFNG
22801,KEGG_2019_Human,T cell receptor signaling pathway,1/101,0.0050499326546803,0.0090104087624296,0,0,19899.0,105233.48101229242,IFNG
22802,KEGG_2019_Human,Chagas disease (American trypanosomiasis),1/103,0.0051499318302617,0.0090104087624296,0,0,19897.0,104832.7525292024,IFNG
22803,KEGG_2019_Human,Th17 cell differentiation,1/107,0.0053499302026925,0.0090104087624296,0,0,19893.0,104053.753408911,IFNG
22804,KEGG_2019_Human,Toxoplasmosis,1/113,0.0056499278191151,0.0090398845105842,0,0,19887.0,102937.34947211576,IFNG
22805,KEGG_2019_Human,Osteoclast differentiation,1/127,0.0063499224962247,0.0092520630391528,0,0,19873.0,100543.72072014232,IFNG
22806,KEGG_2019_Human,Natural killer cell mediated cytotoxicity,1/131,0.0065499210316603,0.0092520630391528,0,0,19869.0,99907.33811343512,IFNG
22807,KEGG_2019_Human,Systemic lupus erythematosus,1/133,0.0066499203093911,0.0092520630391528,0,0,19867.0,99596.2591544721,IFNG
22808,KEGG_2019_Human,Fluid shear stress and atherosclerosis,1/139,0.006949918172816,0.0092665575637547,0,0,19861.0,98689.81333375497,IFNG
22809,KEGG_2019_Human,Hepatitis C,1/155,0.0077499127120574,0.0095998938314214,0,0,19845.0,96448.16254952336,IFNG
22810,KEGG_2019_Human,JAK-STAT signaling pathway,1/162,0.0080999104202618,0.0095998938314214,0,0,19838.0,95537.86936302872,IFNG
22811,KEGG_2019_Human,Necroptosis,1/162,0.0080999104202618,0.0095998938314214,0,0,19838.0,95537.86936302872,IFNG
22812,KEGG_2019_Human,Influenza A,1/171,0.0085499075557634,0.0097713229208724,0,0,19829.0,94422.42241345016,IFNG
22813,KEGG_2019_Human,Tuberculosis,1/179,0.0089499050800561,0.0098757573297171,0,0,19821.0,93478.0629355712,IFNG
22814,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0156798668543717,0,0,19706.0,83157.67014793828,IFNG
22815,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0253933821725158,0,0,19508.0,72277.44006442746,IFNG
22816,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,IFNG
22817,KEGG_2019_Human,Wnt signaling pathway,1/158,0.0078999117225733,0.0082499094553477,0,0,19842.0,96053.2110949472,SENP2
22818,KEGG_2019_Human,RNA transport,1/165,0.0082499094553477,0.0082499094553477,0,0,19835.0,95159.46482222488,SENP2
22819,KEGG_2019_Human,Protein digestion and absorption,1/90,0.0044999373439762,0.0048999339081079,0,0,19910.0,107587.50385474482,CELA2B
22820,KEGG_2019_Human,Pancreatic secretion,1/98,0.0048999339081079,0.0048999339081079,0,0,19902.0,105849.45495286948,CELA2B
22821,KEGG_2019_Human,Salmonella infection,1/86,0.0042999391173866,0.0090998799855245,0,0,19914.0,108514.46102290176,CCL3
22822,KEGG_2019_Human,Rheumatoid arthritis,1/91,0.0045499369072032,0.0090998799855245,0,0,19909.0,107362.10783923086,CCL3
22823,KEGG_2019_Human,Chagas disease (American trypanosomiasis),1/103,0.0051499318302617,0.0090998799855245,0,0,19897.0,104832.7525292024,CCL3
22824,KEGG_2019_Human,Toll-like receptor signaling pathway,1/104,0.0051999314202997,0.0090998799855245,0,0,19896.0,104635.24941415618,CCL3
22825,KEGG_2019_Human,Chemokine signaling pathway,1/190,0.0094999017791995,0.0131248739755395,0,0,19810.0,92244.74636351672,CCL3
22826,KEGG_2019_Human,Human cytomegalovirus infection,1/225,0.0112498919790339,0.0131248739755395,0,0,19775.0,88738.27077557483,CCL3
22827,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0146998751759735,0,0,19706.0,83157.67014793828,CCL3
22828,KEGG_2019_Human,Nicotinate and nicotinamide metabolism,1/30,0.0014999697593334,0.0014999697593334,0,0,19970.0,129851.13732048514,NMRK1
22829,KEGG_2019_Human,Insulin secretion,1/86,0.0042999391173866,0.0128748295756542,0,0,19914.0,108514.46102290176,GCG
22830,KEGG_2019_Human,Glucagon signaling pathway,1/103,0.0051499318302617,0.0128748295756542,0,0,19897.0,104832.7525292024,GCG
22831,KEGG_2019_Human,cAMP signaling pathway,1/212,0.0105998955026255,0.014437362992582,0,0,19788.0,89974.27756224656,GCG
22832,KEGG_2019_Human,Thermogenesis,1/231,0.0115498903940656,0.014437362992582,0,0,19769.0,88191.07730937863,GCG
22833,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,GCG
22834,KEGG_2019_Human,Propanoate metabolism,1/32,0.0015999683804467,0.0015999683804467,0,0,19968.0,128549.41955786056,ECHDC1
22835,KEGG_2019_Human,Glycolysis / Gluconeogenesis,1/68,0.0033999476216189,0.0036999446830449,0,0,19932.0,113293.39338050144,MINPP1
22836,KEGG_2019_Human,Inositol phosphate metabolism,1/74,0.0036999446830449,0.0036999446830449,0,0,19926.0,111574.38983110404,MINPP1
22837,KEGG_2019_Human,p53 signaling pathway,1/72,0.0035999456502131,0.0035999456502131,0,0,19928.0,112131.59838572376,EI24
22838,KEGG_2019_Human,Arginine and proline metabolism,1/49,0.0024499577795033,0.0024499577795033,0,0,19951.0,119939.1172087114,PYCR2
22839,KEGG_2019_Human,Retinol metabolism,1/67,0.0033499481224912,0.0033499481224912,0,0,19933.0,113594.38808369274,SDR16C5
22840,KEGG_2019_Human,p53 signaling pathway,1/72,0.0035999456502131,0.0109498935894162,0,0,19928.0,112131.59838572376,CHEK1
22841,KEGG_2019_Human,Cell cycle,1/124,0.0061999236097501,0.0109498935894162,0,0,19876.0,101034.04709010696,CHEK1
22842,KEGG_2019_Human,Cellular senescence,1/160,0.0079999110688441,0.0109498935894162,0,0,19840.0,95793.96509856998,CHEK1
22843,KEGG_2019_Human,Viral carcinogenesis,1/201,0.0100498985877989,0.0109498935894162,0,0,19799.0,91079.21596609056,CHEK1
22844,KEGG_2019_Human,Human immunodeficiency virus 1 infection,1/212,0.0105998955026255,0.0109498935894162,0,0,19788.0,89974.27756224656,CHEK1
22845,KEGG_2019_Human,Human T-cell leukemia virus 1 infection,1/219,0.0109498935894162,0.0109498935894162,0,0,19781.0,89299.85161916987,CHEK1
22846,KEGG_2019_Human,Cell adhesion molecules (CAMs),1/145,0.0072499160871101,0.0072499160871101,0,0,19855.0,97820.92670675044,PDCD1LG2
22847,KEGG_2019_Human,Protein export,1/23,0.0011499748819949,0.0045998995279799,0,0,19977.0,135204.63922267244,SEC61A2
22848,KEGG_2019_Human,Vibrio cholerae infection,1/50,0.0024999572069037,0.0049999144138074,0,0,19950.0,119530.05920663515,SEC61A2
22849,KEGG_2019_Human,Phagosome,1/152,0.0075999137114971,0.0082499094553477,0,0,19848.0,96850.665715497,SEC61A2
22850,KEGG_2019_Human,Protein processing in endoplasmic reticulum,1/165,0.0082499094553477,0.0082499094553477,0,0,19835.0,95159.46482222488,SEC61A2
22851,KEGG_2019_Human,N-Glycan biosynthesis,1/50,0.0024999572069037,0.0024999572069037,0,0,19950.0,119530.05920663515,ALG8
22852,KEGG_2019_Human,Phenylalanine metabolism,1/17,0.0008499797390404818,0.0041999276220057,0,0,19983.0,141285.76583697114,MAOB
22853,KEGG_2019_Human,Histidine metabolism,1/23,0.0011499748819949,0.0041999276220057,0,0,19977.0,135204.63922267244,MAOB
22854,KEGG_2019_Human,Tyrosine metabolism,1/36,0.0017999657178272,0.0041999276220057,0,0,19964.0,126172.23364250171,MAOB
22855,KEGG_2019_Human,"Glycine, serine and threonine metabolism",1/40,0.0019999631680592,0.0041999276220057,0,0,19960.0,124043.94523066044,MAOB
22856,KEGG_2019_Human,Tryptophan metabolism,1/42,0.0020999619311272,0.0041999276220057,0,0,19958.0,123057.75613441122,MAOB
22857,KEGG_2019_Human,Arginine and proline metabolism,1/49,0.0024499577795033,0.0041999276220057,0,0,19951.0,119939.1172087114,MAOB
22858,KEGG_2019_Human,Cocaine addiction,1/49,0.0024499577795033,0.0041999276220057,0,0,19951.0,119939.1172087114,MAOB
22859,KEGG_2019_Human,Amphetamine addiction,1/68,0.0033999476216189,0.0050999214324284,0,0,19932.0,113293.39338050144,MAOB
22860,KEGG_2019_Human,Drug metabolism,1/108,0.0053999298011749,0.0067799133829382,0,0,19892.0,103863.47861844616,MAOB
22861,KEGG_2019_Human,Serotonergic synapse,1/113,0.0056499278191151,0.0067799133829382,0,0,19887.0,102937.34947211576,MAOB
22862,KEGG_2019_Human,Dopaminergic synapse,1/131,0.0065499210316603,0.0071453683981749,0,0,19869.0,99907.33811343512,MAOB
22863,KEGG_2019_Human,Alcoholism,1/180,0.0089999047745351,0.0089999047745351,0,0,19820.0,93362.92821536642,MAOB
22864,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF443
22865,KEGG_2019_Human,Fatty acid biosynthesis,1/13,0.0006499833083207112,0.0045498831582449,0,0,19987.0,146675.87616784443,ACSL3
22866,KEGG_2019_Human,Ferroptosis,1/40,0.0019999631680592,0.0048415972181405,0,0,19960.0,124043.94523066044,ACSL3
22867,KEGG_2019_Human,Fatty acid degradation,1/44,0.0021999607179423,0.0048415972181405,0,0,19956.0,122117.06559109331,ACSL3
22868,KEGG_2019_Human,Adipocytokine signaling pathway,1/69,0.003449947123837,0.0048415972181405,0,0,19931.0,112996.7391397682,ACSL3
22869,KEGG_2019_Human,PPAR signaling pathway,1/74,0.0036999446830449,0.0048415972181405,0,0,19926.0,111574.38983110404,ACSL3
22870,KEGG_2019_Human,Peroxisome,1/83,0.0041499404726918,0.0048415972181405,0,0,19917.0,109237.99888847338,ACSL3
22871,KEGG_2019_Human,Thermogenesis,1/231,0.0115498903940656,0.0115498903940656,0,0,19769.0,88191.07730937863,ACSL3
22872,KEGG_2019_Human,Ribosome biogenesis in eukaryotes,1/101,0.0050499326546803,0.0050499326546803,0,0,19899.0,105233.48101229242,REXO5
22873,KEGG_2019_Human,GABAergic synapse,1/89,0.0044499377838098,0.0130498764018304,0,0,19911.0,107815.380281759,GNG5
22874,KEGG_2019_Human,Morphine addiction,1/91,0.0045499369072032,0.0130498764018304,0,0,19909.0,107362.10783923086,GNG5
22875,KEGG_2019_Human,Circadian entrainment,1/97,0.0048499343304706,0.0130498764018304,0,0,19903.0,106058.9096435903,GNG5
22876,KEGG_2019_Human,Cholinergic synapse,1/112,0.0055999282120529,0.0130498764018304,0,0,19888.0,103119.30984392198,GNG5
22877,KEGG_2019_Human,Serotonergic synapse,1/113,0.0056499278191151,0.0130498764018304,0,0,19887.0,102937.34947211576,GNG5
22878,KEGG_2019_Human,Glutamatergic synapse,1/114,0.005699927427839,0.0130498764018304,0,0,19886.0,102756.96431429044,GNG5
22879,KEGG_2019_Human,Relaxin signaling pathway,1/130,0.0064999213952527,0.0130498764018304,0,0,19870.0,100064.62842845908,GNG5
22880,KEGG_2019_Human,Dopaminergic synapse,1/131,0.0065499210316603,0.0130498764018304,0,0,19869.0,99907.33811343512,GNG5
22881,KEGG_2019_Human,Apelin signaling pathway,1/137,0.0068499188797651,0.0130498764018304,0,0,19863.0,98987.62735269018,GNG5
22882,KEGG_2019_Human,Retrograde endocannabinoid signaling,1/148,0.007399915061391,0.0130498764018304,0,0,19852.0,97399.60470052566,GNG5
22883,KEGG_2019_Human,Alcoholism,1/180,0.0089999047745351,0.0130498764018304,0,0,19820.0,93362.92821536642,GNG5
22884,KEGG_2019_Human,Kaposi sarcoma-associated herpesvirus infection,1/186,0.0092999029651357,0.0130498764018304,0,0,19814.0,92684.96451050608,GNG5
22885,KEGG_2019_Human,Chemokine signaling pathway,1/190,0.0094999017791995,0.0130498764018304,0,0,19810.0,92244.74636351672,GNG5
22886,KEGG_2019_Human,Human immunodeficiency virus 1 infection,1/212,0.0105998955026255,0.0130498764018304,0,0,19788.0,89974.27756224656,GNG5
22887,KEGG_2019_Human,Human cytomegalovirus infection,1/225,0.0112498919790339,0.0130498764018304,0,0,19775.0,88738.27077557483,GNG5
22888,KEGG_2019_Human,Ras signaling pathway,1/232,0.0115998901349604,0.0130498764018304,0,0,19768.0,88101.22480150245,GNG5
22889,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0187410310320355,0,0,19646.0,79255.8617626126,GNG5
22890,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,GNG5
22891,KEGG_2019_Human,Inositol phosphate metabolism,1/74,0.0036999446830449,0.0049499334884068,0,0,19926.0,111574.38983110404,PI4KB
22892,KEGG_2019_Human,Phosphatidylinositol signaling system,1/99,0.0049499334884068,0.0049499334884068,0,0,19901.0,105642.09305076736,PI4KB
22893,KEGG_2019_Human,RNA transport,1/165,0.0082499094553477,0.0082499094553477,0,0,19835.0,95159.46482222488,GEMIN6
22894,KEGG_2019_Human,Cellular senescence,1/160,0.0079999110688441,0.0079999110688441,0,0,19840.0,95793.96509856998,RBBP4
22895,KEGG_2019_Human,alpha-Linolenic acid metabolism,1/25,0.0012499733663791,0.0083598935608305,0,0,19975.0,133525.54486996148,PLA2G4F
22896,KEGG_2019_Human,Linoleic acid metabolism,1/29,0.001449970461791,0.0083598935608305,0,0,19971.0,130534.69172799008,PLA2G4F
22897,KEGG_2019_Human,Ether lipid metabolism,1/47,0.0023499589392381,0.0083598935608305,0,0,19953.0,120782.64067395544,PLA2G4F
22898,KEGG_2019_Human,Ovarian steroidogenesis,1/49,0.0024499577795033,0.0083598935608305,0,0,19951.0,119939.1172087114,PLA2G4F
22899,KEGG_2019_Human,VEGF signaling pathway,1/59,0.0029499522555206,0.0083598935608305,0,0,19941.0,116175.59385530632,PLA2G4F
22900,KEGG_2019_Human,Long-term depression,1/60,0.002999951725986,0.0083598935608305,0,0,19940.0,115834.63209072244,PLA2G4F
22901,KEGG_2019_Human,Arachidonic acid metabolism,1/63,0.0031499501598827,0.0083598935608305,0,0,19937.0,114844.46974572667,PLA2G4F
22902,KEGG_2019_Human,Fc epsilon RI signaling pathway,1/68,0.0033999476216189,0.0083598935608305,0,0,19932.0,113293.39338050144,PLA2G4F
22903,KEGG_2019_Human,Fc gamma R-mediated phagocytosis,1/91,0.0045499369072032,0.0083598935608305,0,0,19909.0,107362.10783923086,PLA2G4F
22904,KEGG_2019_Human,GnRH signaling pathway,1/93,0.0046499360391879,0.0083598935608305,0,0,19907.0,106918.54242106884,PLA2G4F
22905,KEGG_2019_Human,Glycerophospholipid metabolism,1/97,0.0048499343304706,0.0083598935608305,0,0,19903.0,106058.9096435903,PLA2G4F
22906,KEGG_2019_Human,Choline metabolism in cancer,1/99,0.0049499334884068,0.0083598935608305,0,0,19901.0,105642.09305076736,PLA2G4F
22907,KEGG_2019_Human,Inflammatory mediator regulation of TRP channels,1/100,0.0049999330710556,0.0083598935608305,0,0,19900.0,105436.78197328727,PLA2G4F
22908,KEGG_2019_Human,Serotonergic synapse,1/113,0.0056499278191151,0.0083598935608305,0,0,19887.0,102937.34947211576,PLA2G4F
22909,KEGG_2019_Human,Glutamatergic synapse,1/114,0.005699927427839,0.0083598935608305,0,0,19886.0,102756.96431429044,PLA2G4F
22910,KEGG_2019_Human,Platelet activation,1/124,0.0061999236097501,0.0085248949634064,0,0,19876.0,101034.04709010696,PLA2G4F
22911,KEGG_2019_Human,Vascular smooth muscle contraction,1/132,0.0065999206698993,0.008541073808105,0,0,19868.0,99751.22090491928,PLA2G4F
22912,KEGG_2019_Human,Phospholipase D signaling pathway,1/148,0.007399915061391,0.0088577944367043,0,0,19852.0,97399.60470052566,PLA2G4F
22913,KEGG_2019_Human,Oxytocin signaling pathway,1/153,0.0076499133771537,0.0088577944367043,0,0,19847.0,96715.6407630817,PLA2G4F
22914,KEGG_2019_Human,Necroptosis,1/162,0.0080999104202618,0.008909901462288,0,0,19838.0,95537.86936302872,PLA2G4F
22915,KEGG_2019_Human,Ras signaling pathway,1/232,0.0115998901349604,0.0121522658556728,0,0,19768.0,88101.22480150245,PLA2G4F
22916,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0147498749536506,0,0,19705.0,83086.53988020132,PLA2G4F
22917,KEGG_2019_Human,Ribosome biogenesis in eukaryotes,1/101,0.0050499326546803,0.0082499094553477,0,0,19899.0,105233.48101229242,SNORD3B-1
22918,KEGG_2019_Human,RNA transport,1/165,0.0082499094553477,0.0082499094553477,0,0,19835.0,95159.46482222488,SNORD3B-1
22919,KEGG_2019_Human,Phototransduction,1/28,0.0013999711732997,0.0113938210547091,0,0,19972.0,131242.0761597353,CALML4
22920,KEGG_2019_Human,Long-term potentiation,1/67,0.0033499481224912,0.0113938210547091,0,0,19933.0,113594.38808369274,CALML4
22921,KEGG_2019_Human,Amphetamine addiction,1/68,0.0033999476216189,0.0113938210547091,0,0,19932.0,113293.39338050144,CALML4
22922,KEGG_2019_Human,Renin secretion,1/69,0.003449947123837,0.0113938210547091,0,0,19931.0,112996.7391397682,CALML4
22923,KEGG_2019_Human,Gastric acid secretion,1/75,0.0037499442041125,0.0113938210547091,0,0,19925.0,111301.33528642564,CALML4
22924,KEGG_2019_Human,Glioma,1/75,0.0037499442041125,0.0113938210547091,0,0,19925.0,111301.33528642564,CALML4
22925,KEGG_2019_Human,Pertussis,1/76,0.0037999437281752,0.0113938210547091,0,0,19924.0,111031.8499691117,CALML4
22926,KEGG_2019_Human,Salivary secretion,1/90,0.0044999373439762,0.0113938210547091,0,0,19910.0,107587.50385474482,CALML4
22927,KEGG_2019_Human,GnRH signaling pathway,1/93,0.0046499360391879,0.0113938210547091,0,0,19907.0,106918.54242106884,CALML4
22928,KEGG_2019_Human,Circadian entrainment,1/97,0.0048499343304706,0.0113938210547091,0,0,19903.0,106058.9096435903,CALML4
22929,KEGG_2019_Human,Aldosterone synthesis and secretion,1/98,0.0048999339081079,0.0113938210547091,0,0,19902.0,105849.45495286948,CALML4
22930,KEGG_2019_Human,Phosphatidylinositol signaling system,1/99,0.0049499334884068,0.0113938210547091,0,0,19901.0,105642.09305076736,CALML4
22931,KEGG_2019_Human,Inflammatory mediator regulation of TRP channels,1/100,0.0049999330710556,0.0113938210547091,0,0,19900.0,105436.78197328727,CALML4
22932,KEGG_2019_Human,Melanogenesis,1/101,0.0050499326546803,0.0113938210547091,0,0,19899.0,105233.48101229242,CALML4
22933,KEGG_2019_Human,Glucagon signaling pathway,1/103,0.0051499318302617,0.0113938210547091,0,0,19897.0,104832.7525292024,CALML4
22934,KEGG_2019_Human,C-type lectin receptor signaling pathway,1/104,0.0051999314202997,0.0113938210547091,0,0,19896.0,104635.24941415618,CALML4
22935,KEGG_2019_Human,Neurotrophin signaling pathway,1/119,0.0059499254985137,0.0113938210547091,0,0,19881.0,101877.73080211312,CALML4
22936,KEGG_2019_Human,Oocyte meiosis,1/125,0.0062499232373748,0.0113938210547091,0,0,19875.0,100869.32368441945,CALML4
22937,KEGG_2019_Human,Dopaminergic synapse,1/131,0.0065499210316603,0.0113938210547091,0,0,19869.0,99907.33811343512,CALML4
22938,KEGG_2019_Human,Vascular smooth muscle contraction,1/132,0.0065999206698993,0.0113938210547091,0,0,19868.0,99751.22090491928,CALML4
22939,KEGG_2019_Human,Insulin signaling pathway,1/137,0.0068499188797651,0.0113938210547091,0,0,19863.0,98987.62735269018,CALML4
22940,KEGG_2019_Human,Estrogen signaling pathway,1/137,0.0068499188797651,0.0113938210547091,0,0,19863.0,98987.62735269018,CALML4
22941,KEGG_2019_Human,Apelin signaling pathway,1/137,0.0068499188797651,0.0113938210547091,0,0,19863.0,98987.62735269018,CALML4
22942,KEGG_2019_Human,Fluid shear stress and atherosclerosis,1/139,0.006949918172816,0.0113938210547091,0,0,19861.0,98689.81333375497,CALML4
22943,KEGG_2019_Human,Adrenergic signaling in cardiomyocytes,1/145,0.0072499160871101,0.0113938210547091,0,0,19855.0,97820.92670675044,CALML4
22944,KEGG_2019_Human,Oxytocin signaling pathway,1/153,0.0076499133771537,0.0113938210547091,0,0,19847.0,96715.6407630817,CALML4
22945,KEGG_2019_Human,Cellular senescence,1/160,0.0079999110688441,0.0113938210547091,0,0,19840.0,95793.96509856998,CALML4
22946,KEGG_2019_Human,cGMP-PKG signaling pathway,1/166,0.0082999091363732,0.0113938210547091,0,0,19834.0,95034.82345515196,CALML4
22947,KEGG_2019_Human,Alzheimer disease,1/171,0.0085499075557634,0.0113938210547091,0,0,19829.0,94422.42241345016,CALML4
22948,KEGG_2019_Human,Tuberculosis,1/179,0.0089499050800561,0.0113938210547091,0,0,19821.0,93478.0629355712,CALML4
22949,KEGG_2019_Human,Alcoholism,1/180,0.0089999047745351,0.0113938210547091,0,0,19820.0,93362.92821536642,CALML4
22950,KEGG_2019_Human,Kaposi sarcoma-associated herpesvirus infection,1/186,0.0092999029651357,0.0113938210547091,0,0,19814.0,92684.96451050608,CALML4
22951,KEGG_2019_Human,Calcium signaling pathway,1/188,0.009399902370135,0.0113938210547091,0,0,19812.0,92463.712994847,CALML4
22952,KEGG_2019_Human,Rap1 signaling pathway,1/206,0.010299897173561,0.0117776616695839,0,0,19794.0,90569.849337325,CALML4
22953,KEGG_2019_Human,Human immunodeficiency virus 1 infection,1/212,0.0105998955026255,0.0117776616695839,0,0,19788.0,89974.27756224656,CALML4
22954,KEGG_2019_Human,cAMP signaling pathway,1/212,0.0105998955026255,0.0117776616695839,0,0,19788.0,89974.27756224656,CALML4
22955,KEGG_2019_Human,Human cytomegalovirus infection,1/225,0.0112498919790339,0.0121620453827393,0,0,19775.0,88738.27077557483,CALML4
22956,KEGG_2019_Human,Ras signaling pathway,1/232,0.0115998901349604,0.0122104106683793,0,0,19768.0,88101.22480150245,CALML4
22957,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0227690733587457,0,0,19556.0,74462.79263140135,CALML4
22958,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,CALML4
22959,KEGG_2019_Human,Propanoate metabolism,1/32,0.0015999683804467,0.0039165982320635,0,0,19968.0,128549.41955786056,LDHB
22960,KEGG_2019_Human,Pyruvate metabolism,1/39,0.0019499637955508,0.0039165982320635,0,0,19961.0,124555.53162481484,LDHB
22961,KEGG_2019_Human,Cysteine and methionine metabolism,1/47,0.0023499589392381,0.0039165982320635,0,0,19953.0,120782.64067395544,LDHB
22962,KEGG_2019_Human,Glycolysis / Gluconeogenesis,1/68,0.0033999476216189,0.0042499345270236,0,0,19932.0,113293.39338050144,LDHB
22963,KEGG_2019_Human,Glucagon signaling pathway,1/103,0.0051499318302617,0.0051499318302617,0,0,19897.0,104832.7525292024,LDHB
22964,KEGG_2019_Human,RNA polymerase,1/31,0.0015499690656704,0.0030999381313408,0,0,19969.0,129189.85098816035,POLR1C
22965,KEGG_2019_Human,Cytosolic DNA-sensing pathway,1/63,0.0031499501598827,0.0031499501598827,0,0,19937.0,114844.46974572667,POLR1C
22966,KEGG_2019_Human,"Glycine, serine and threonine metabolism",1/40,0.0019999631680592,0.0020999619311272,0,0,19960.0,124043.94523066044,ALAS1
22967,KEGG_2019_Human,Porphyrin and chlorophyll metabolism,1/42,0.0020999619311272,0.0020999619311272,0,0,19958.0,123057.75613441122,ALAS1
22968,KEGG_2019_Human,Necroptosis,1/162,0.0080999104202618,0.0121998870519305,0,0,19838.0,95537.86936302872,CHMP2A
22969,KEGG_2019_Human,Endocytosis,1/244,0.0121998870519305,0.0121998870519305,0,0,19756.0,87051.4275316661,CHMP2A
22970,KEGG_2019_Human,Lysosome,1/123,0.0061499239842961,0.0105998955026255,0,0,19877.0,101200.07933676826,AP1S3
22971,KEGG_2019_Human,Human immunodeficiency virus 1 infection,1/212,0.0105998955026255,0.0105998955026255,0,0,19788.0,89974.27756224656,AP1S3
22972,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF791
22973,KEGG_2019_Human,Glutathione metabolism,1/56,0.0027999538675741,0.0094498771520562,0,0,19944.0,117233.87022514464,GSTO1
22974,KEGG_2019_Human,Metabolism of xenobiotics by cytochrome P450,1/74,0.0036999446830449,0.0094498771520562,0,0,19926.0,111574.38983110404,GSTO1
22975,KEGG_2019_Human,Chemical carcinogenesis,1/82,0.004099940929819,0.0094498771520562,0,0,19918.0,109484.9180722932,GSTO1
22976,KEGG_2019_Human,Drug metabolism,1/108,0.0053999298011749,0.0094498771520562,0,0,19892.0,103863.47861844616,GSTO1
22977,KEGG_2019_Human,Fluid shear stress and atherosclerosis,1/139,0.006949918172816,0.0097298854419424,0,0,19861.0,98689.81333375497,GSTO1
22978,KEGG_2019_Human,Hepatocellular carcinoma,1/168,0.0083999085011095,0.0097998932512944,0,0,19832.0,94787.72752807094,GSTO1
22979,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,GSTO1
22980,KEGG_2019_Human,N-Glycan biosynthesis,1/50,0.0024999572069037,0.0049999144138074,0,0,19950.0,119530.05920663515,RPN1
22981,KEGG_2019_Human,Protein processing in endoplasmic reticulum,1/165,0.0082499094553477,0.0082499094553477,0,0,19835.0,95159.46482222488,RPN1
22982,KEGG_2019_Human,Mucin type O-glycan biosynthesis,1/31,0.0015499690656704,0.0015499690656704,0,0,19969.0,129189.85098816035,GALNT1
22983,KEGG_2019_Human,Retinol metabolism,1/67,0.0033499481224912,0.0033499481224912,0,0,19933.0,113594.38808369274,CYP26A1
22984,KEGG_2019_Human,Endocytosis,1/244,0.0121998870519305,0.0121998870519305,0,0,19756.0,87051.4275316661,SH3GL1
22985,KEGG_2019_Human,Ribosome,1/153,0.0076499133771537,0.0076499133771537,0,0,19847.0,96715.6407630817,MRPS16
22986,KEGG_2019_Human,Chemical carcinogenesis,1/82,0.004099940929819,0.004099940929819,0,0,19918.0,109484.9180722932,SULT1A2
22987,KEGG_2019_Human,Protein export,1/23,0.0011499748819949,0.0011499748819949,0,0,19977.0,135204.63922267244,SRPRA
22988,KEGG_2019_Human,Ubiquitin mediated proteolysis,1/137,0.0068499188797651,0.0068499188797651,0,0,19863.0,98987.62735269018,UBE2M
22989,KEGG_2019_Human,"Parathyroid hormone synthesis, secretion and action",1/106,0.0052999306076525,0.0052999306076525,0,0,19894.0,104245.78450366124,MMP24
22990,KEGG_2019_Human,Mannose type O-glycan biosynthesis,1/23,0.0011499748819949,0.0011499748819949,0,0,19977.0,135204.63922267244,B3GALNT2
22991,KEGG_2019_Human,Basal transcription factors,1/45,0.0022499601197094,0.0022499601197094,0,0,19955.0,121662.49782449217,TAF11
22992,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF79
22993,KEGG_2019_Human,RNA transport,1/165,0.0082499094553477,0.0082499094553477,0,0,19835.0,95159.46482222488,EIF5
22994,KEGG_2019_Human,Peroxisome,1/83,0.0041499404726918,0.0041499404726918,0,0,19917.0,109237.99888847338,PEX12
22995,KEGG_2019_Human,NOD-like receptor signaling pathway,1/178,0.0088999053857096,0.0088999053857096,0,0,19822.0,93593.82745769851,TXNIP
22996,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR6C74
22997,KEGG_2019_Human,Glycosphingolipid biosynthesis,1/45,0.0022499601197094,0.0022499601197094,0,0,19955.0,121662.49782449217,FUT1
22998,KEGG_2019_Human,Endocytosis,1/244,0.0121998870519305,0.0121998870519305,0,0,19756.0,87051.4275316661,SNF8
22999,KEGG_2019_Human,African trypanosomiasis,1/37,0.0018499650702878,0.0081713208033282,0,0,19963.0,125618.9446446357,IL12A
23000,KEGG_2019_Human,Allograft rejection,1/38,0.001899964429635,0.0081713208033282,0,0,19962.0,125080.29732025368,IL12A
23001,KEGG_2019_Human,Type I diabetes mellitus,1/43,0.0021499613216957,0.0081713208033282,0,0,19957.0,122581.98940490963,IL12A
23002,KEGG_2019_Human,Malaria,1/49,0.0024499577795033,0.0081713208033282,0,0,19951.0,119939.1172087114,IL12A
23003,KEGG_2019_Human,Legionellosis,1/55,0.0027499544131125,0.0081713208033282,0,0,19945.0,117599.1294878737,IL12A
23004,KEGG_2019_Human,Inflammatory bowel disease (IBD),1/65,0.003249949134407,0.0081713208033282,0,0,19935.0,114209.92613860144,IL12A
23005,KEGG_2019_Human,RIG-I-like receptor signaling pathway,1/70,0.0034999466296654,0.0081713208033282,0,0,19930.0,112704.30065625212,IL12A
23006,KEGG_2019_Human,Leishmaniasis,1/74,0.0036999446830449,0.0081713208033282,0,0,19926.0,111574.38983110404,IL12A
23007,KEGG_2019_Human,Pertussis,1/76,0.0037999437281752,0.0081713208033282,0,0,19924.0,111031.8499691117,IL12A
23008,KEGG_2019_Human,Th1 and Th2 cell differentiation,1/92,0.0045999364719865,0.0081713208033282,0,0,19908.0,107139.13814408927,IL12A
23009,KEGG_2019_Human,Amoebiasis,1/96,0.0047999347538706,0.0081713208033282,0,0,19904.0,106270.50039849174,IL12A
23010,KEGG_2019_Human,Chagas disease (American trypanosomiasis),1/103,0.0051499318302617,0.0081713208033282,0,0,19897.0,104832.7525292024,IL12A
23011,KEGG_2019_Human,C-type lectin receptor signaling pathway,1/104,0.0051999314202997,0.0081713208033282,0,0,19896.0,104635.24941415618,IL12A
23012,KEGG_2019_Human,Toll-like receptor signaling pathway,1/104,0.0051999314202997,0.0081713208033282,0,0,19896.0,104635.24941415618,IL12A
23013,KEGG_2019_Human,Toxoplasmosis,1/113,0.0056499278191151,0.0082865608013689,0,0,19887.0,102937.34947211576,IL12A
23014,KEGG_2019_Human,Measles,1/138,0.0068999185254481,0.0094873879724912,0,0,19862.0,98838.19160389496,IL12A
23015,KEGG_2019_Human,JAK-STAT signaling pathway,1/162,0.0080999104202618,0.0103630479874334,0,0,19838.0,95537.86936302872,IL12A
23016,KEGG_2019_Human,Influenza A,1/171,0.0085499075557634,0.0103630479874334,0,0,19829.0,94422.42241345016,IL12A
23017,KEGG_2019_Human,Tuberculosis,1/179,0.0089499050800561,0.0103630479874334,0,0,19821.0,93478.0629355712,IL12A
23018,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0161698626935708,0,0,19706.0,83157.67014793828,IL12A
23019,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0257712598834163,0,0,19508.0,72277.44006442746,IL12A
23020,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,IL12A
23021,KEGG_2019_Human,Insulin signaling pathway,1/137,0.0068499188797651,0.0068499188797651,0,0,19863.0,98987.62735269018,RHOQ
23022,KEGG_2019_Human,Pyruvate metabolism,1/39,0.0019499637955508,0.0019499637955508,0,0,19961.0,124555.53162481484,GLO1
23023,KEGG_2019_Human,Tight junction,1/170,0.0084999078692823,0.0084999078692823,0,0,19830.0,94543.49009679438,RAB8B
23024,KEGG_2019_Human,Propanoate metabolism,1/32,0.0015999683804467,0.0039165982320635,0,0,19968.0,128549.41955786056,LDHAL6A
23025,KEGG_2019_Human,Pyruvate metabolism,1/39,0.0019499637955508,0.0039165982320635,0,0,19961.0,124555.53162481484,LDHAL6A
23026,KEGG_2019_Human,Cysteine and methionine metabolism,1/47,0.0023499589392381,0.0039165982320635,0,0,19953.0,120782.64067395544,LDHAL6A
23027,KEGG_2019_Human,Glycolysis / Gluconeogenesis,1/68,0.0033999476216189,0.0042499345270236,0,0,19932.0,113293.39338050144,LDHAL6A
23028,KEGG_2019_Human,Glucagon signaling pathway,1/103,0.0051499318302617,0.0051499318302617,0,0,19897.0,104832.7525292024,LDHAL6A
23029,KEGG_2019_Human,Nitrogen metabolism,1/17,0.0008499797390404818,0.0008499797390404818,0,0,19983.0,141285.76583697114,CA8
23030,KEGG_2019_Human,Dopaminergic synapse,1/131,0.0065499210316603,0.0094999017791995,0,0,19869.0,99907.33811343512,GSK3A
23031,KEGG_2019_Human,Non-alcoholic fatty liver disease (NAFLD),1/149,0.0074499147221605,0.0094999017791995,0,0,19851.0,97261.02051561224,GSK3A
23032,KEGG_2019_Human,Chemokine signaling pathway,1/190,0.0094999017791995,0.0094999017791995,0,0,19810.0,92244.74636351672,GSK3A
23033,KEGG_2019_Human,Antigen processing and presentation,1/77,0.0038499432547502,0.0038499432547502,0,0,19923.0,110765.8407373636,KLRC4
23034,KEGG_2019_Human,Transcriptional misregulation in cancer,1/186,0.0092999029651357,0.0092999029651357,0,0,19814.0,92684.96451050608,HPGD
23035,KEGG_2019_Human,Citrate cycle (TCA cycle),1/30,0.0014999697593334,0.0050999214324284,0,0,19970.0,129851.13732048514,PDHB
23036,KEGG_2019_Human,Pyruvate metabolism,1/39,0.0019499637955508,0.0050999214324284,0,0,19961.0,124555.53162481484,PDHB
23037,KEGG_2019_Human,Central carbon metabolism in cancer,1/65,0.003249949134407,0.0050999214324284,0,0,19935.0,114209.92613860144,PDHB
23038,KEGG_2019_Human,Glycolysis / Gluconeogenesis,1/68,0.0033999476216189,0.0050999214324284,0,0,19932.0,113293.39338050144,PDHB
23039,KEGG_2019_Human,HIF-1 signaling pathway,1/100,0.0049999330710556,0.0051499318302617,0,0,19900.0,105436.78197328727,PDHB
23040,KEGG_2019_Human,Glucagon signaling pathway,1/103,0.0051499318302617,0.0051499318302617,0,0,19897.0,104832.7525292024,PDHB
23041,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF133
23042,KEGG_2019_Human,SNARE interactions in vesicular transport,1/34,0.0016999670339032,0.0016999670339032,0,0,19966.0,127326.1054203148,STX10
23043,KEGG_2019_Human,Lysosome,1/123,0.0061499239842961,0.0100498985877989,0,0,19877.0,101200.07933676826,CD63
23044,KEGG_2019_Human,Proteoglycans in cancer,1/201,0.0100498985877989,0.0100498985877989,0,0,19799.0,91079.21596609056,CD63
23045,KEGG_2019_Human,Lysosome,1/123,0.0061499239842961,0.0061499239842961,0,0,19877.0,101200.07933676826,CD164
23046,KEGG_2019_Human,Legionellosis,1/55,0.0027499544131125,0.003249949134407,0,0,19945.0,117599.1294878737,BCL2L13
23047,KEGG_2019_Human,Mitophagy,1/65,0.003249949134407,0.003249949134407,0,0,19935.0,114209.92613860144,BCL2L13
23048,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0147498749536506,0,0,19705.0,83086.53988020132,DUSP2
23049,KEGG_2019_Human,FoxO signaling pathway,1/132,0.0065999206698993,0.0065999206698993,0,0,19868.0,99751.22090491928,FBXO25
23050,KEGG_2019_Human,Glyoxylate and dicarboxylate metabolism,1/30,0.0014999697593334,0.0014999697593334,0,0,19970.0,129851.13732048514,PGP
23051,KEGG_2019_Human,Glycolysis / Gluconeogenesis,1/68,0.0033999476216189,0.0049999330710556,0,0,19932.0,113293.39338050144,ENO3
23052,KEGG_2019_Human,RNA degradation,1/79,0.0039499423167337,0.0049999330710556,0,0,19921.0,110243.89578070649,ENO3
23053,KEGG_2019_Human,HIF-1 signaling pathway,1/100,0.0049999330710556,0.0049999330710556,0,0,19900.0,105436.78197328727,ENO3
23054,KEGG_2019_Human,Hippo signaling pathway,1/160,0.0079999110688441,0.0079999110688441,0,0,19840.0,95793.96509856998,RASSF4
23055,KEGG_2019_Human,Bladder cancer,1/41,0.0020499625466866,0.0118586943545075,0,0,19959.0,123544.88783416104,E2F1
23056,KEGG_2019_Human,Mitophagy,1/65,0.003249949134407,0.0118586943545075,0,0,19935.0,114209.92613860144,E2F1
23057,KEGG_2019_Human,Non-small cell lung cancer,1/66,0.003299948626608,0.0118586943545075,0,0,19934.0,113899.85357353876,E2F1
23058,KEGG_2019_Human,Melanoma,1/72,0.0035999456502131,0.0118586943545075,0,0,19928.0,112131.59838572376,E2F1
23059,KEGG_2019_Human,Pancreatic cancer,1/75,0.0037499442041125,0.0118586943545075,0,0,19925.0,111301.33528642564,E2F1
23060,KEGG_2019_Human,Glioma,1/75,0.0037499442041125,0.0118586943545075,0,0,19925.0,111301.33528642564,E2F1
23061,KEGG_2019_Human,Chronic myeloid leukemia,1/76,0.0037999437281752,0.0118586943545075,0,0,19924.0,111031.8499691117,E2F1
23062,KEGG_2019_Human,Small cell lung cancer,1/93,0.0046499360391879,0.0118586943545075,0,0,19907.0,106918.54242106884,E2F1
23063,KEGG_2019_Human,Prostate cancer,1/97,0.0048499343304706,0.0118586943545075,0,0,19903.0,106058.9096435903,E2F1
23064,KEGG_2019_Human,Cell cycle,1/124,0.0061999236097501,0.0118586943545075,0,0,19876.0,101034.04709010696,E2F1
23065,KEGG_2019_Human,Breast cancer,1/147,0.0073499154017982,0.0118586943545075,0,0,19853.0,97539.10874372096,E2F1
23066,KEGG_2019_Human,Gastric cancer,1/149,0.0074499147221605,0.0118586943545075,0,0,19851.0,97261.02051561224,E2F1
23067,KEGG_2019_Human,Cushing syndrome,1/155,0.0077499127120574,0.0118586943545075,0,0,19845.0,96448.16254952336,E2F1
23068,KEGG_2019_Human,Hepatitis C,1/155,0.0077499127120574,0.0118586943545075,0,0,19845.0,96448.16254952336,E2F1
23069,KEGG_2019_Human,Cellular senescence,1/160,0.0079999110688441,0.0118586943545075,0,0,19840.0,95793.96509856998,E2F1
23070,KEGG_2019_Human,Hepatitis B,1/163,0.0081499100978668,0.0118586943545075,0,0,19837.0,95410.9786681514,E2F1
23071,KEGG_2019_Human,Hepatocellular carcinoma,1/168,0.0083999085011095,0.0118586943545075,0,0,19832.0,94787.72752807094,E2F1
23072,KEGG_2019_Human,Kaposi sarcoma-associated herpesvirus infection,1/186,0.0092999029651357,0.012399870620181,0,0,19814.0,92684.96451050608,E2F1
23073,KEGG_2019_Human,Epstein-Barr virus infection,1/201,0.0100498985877989,0.0126946087424829,0,0,19799.0,91079.21596609056,E2F1
23074,KEGG_2019_Human,Human T-cell leukemia virus 1 infection,1/219,0.0109498935894162,0.0128570194046101,0,0,19781.0,89299.85161916987,E2F1
23075,KEGG_2019_Human,Human cytomegalovirus infection,1/225,0.0112498919790339,0.0128570194046101,0,0,19775.0,88738.27077557483,E2F1
23076,KEGG_2019_Human,MicroRNAs in cancer,1/299,0.0149498740670514,0.0163089535276924,0,0,19701.0,82804.33538735632,E2F1
23077,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0172172530006586,0,0,19670.0,80733.60565076157,E2F1
23078,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,E2F1
23079,KEGG_2019_Human,Antigen processing and presentation,1/77,0.0038499432547502,0.0089499050800561,0,0,19923.0,110765.8407373636,CTSS
23080,KEGG_2019_Human,Lysosome,1/123,0.0061499239842961,0.0089499050800561,0,0,19877.0,101200.07933676826,CTSS
23081,KEGG_2019_Human,Apoptosis,1/143,0.0071499167770442,0.0089499050800561,0,0,19857.0,98106.57763600958,CTSS
23082,KEGG_2019_Human,Phagosome,1/152,0.0075999137114971,0.0089499050800561,0,0,19848.0,96850.665715497,CTSS
23083,KEGG_2019_Human,Tuberculosis,1/179,0.0089499050800561,0.0089499050800561,0,0,19821.0,93478.0629355712,CTSS
23084,KEGG_2019_Human,Progesterone-mediated oocyte maturation,1/99,0.0049499334884068,0.0085623985997064,0,0,19901.0,105642.09305076736,CDC27
23085,KEGG_2019_Human,Cell cycle,1/124,0.0061999236097501,0.0085623985997064,0,0,19876.0,101034.04709010696,CDC27
23086,KEGG_2019_Human,Oocyte meiosis,1/125,0.0062499232373748,0.0085623985997064,0,0,19875.0,100869.32368441945,CDC27
23087,KEGG_2019_Human,Ubiquitin mediated proteolysis,1/137,0.0068499188797651,0.0085623985997064,0,0,19863.0,98987.62735269018,CDC27
23088,KEGG_2019_Human,Human T-cell leukemia virus 1 infection,1/219,0.0109498935894162,0.0109498935894162,0,0,19781.0,89299.85161916987,CDC27
23089,KEGG_2019_Human,Glioma,1/75,0.0037499442041125,0.009399902370135,0,0,19925.0,111301.33528642564,CAMK1
23090,KEGG_2019_Human,Aldosterone synthesis and secretion,1/98,0.0048999339081079,0.009399902370135,0,0,19902.0,105849.45495286948,CAMK1
23091,KEGG_2019_Human,Oxytocin signaling pathway,1/153,0.0076499133771537,0.009399902370135,0,0,19847.0,96715.6407630817,CAMK1
23092,KEGG_2019_Human,Calcium signaling pathway,1/188,0.009399902370135,0.009399902370135,0,0,19812.0,92463.712994847,CAMK1
23093,KEGG_2019_Human,Ubiquitin mediated proteolysis,1/137,0.0068499188797651,0.0068499188797651,0,0,19863.0,98987.62735269018,KLHL9
23094,KEGG_2019_Human,Complement and coagulation cascades,1/79,0.0039499423167337,0.012299822789457,0,0,19921.0,110243.89578070649,VTN
23095,KEGG_2019_Human,ECM-receptor interaction,1/82,0.004099940929819,0.012299822789457,0,0,19918.0,109484.9180722932,VTN
23096,KEGG_2019_Human,Focal adhesion,1/199,0.0099498991610159,0.0150748478816984,0,0,19801.0,91286.4288690606,VTN
23097,KEGG_2019_Human,Proteoglycans in cancer,1/201,0.0100498985877989,0.0150748478816984,0,0,19799.0,91079.21596609056,VTN
23098,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0176998626413668,0,0,19670.0,80733.60565076157,VTN
23099,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0176998626413668,0,0,19646.0,79255.8617626126,VTN
23100,KEGG_2019_Human,One carbon pool by folate,1/20,0.0009999772468562472,0.0009999772468562472,0,0,19980.0,138017.40508704726,MTHFR
23101,KEGG_2019_Human,alpha-Linolenic acid metabolism,1/25,0.0012499733663791,0.0052874076132858,0,0,19975.0,133525.54486996148,PLA2G2F
23102,KEGG_2019_Human,Linoleic acid metabolism,1/29,0.001449970461791,0.0052874076132858,0,0,19971.0,130534.69172799008,PLA2G2F
23103,KEGG_2019_Human,Fat digestion and absorption,1/41,0.0020499625466866,0.0052874076132858,0,0,19959.0,123544.88783416104,PLA2G2F
23104,KEGG_2019_Human,Ether lipid metabolism,1/47,0.0023499589392381,0.0052874076132858,0,0,19953.0,120782.64067395544,PLA2G2F
23105,KEGG_2019_Human,Arachidonic acid metabolism,1/63,0.0031499501598827,0.005669910287789,0,0,19937.0,114844.46974572667,PLA2G2F
23106,KEGG_2019_Human,Glycerophospholipid metabolism,1/97,0.0048499343304706,0.0062999150247102,0,0,19903.0,106058.9096435903,PLA2G2F
23107,KEGG_2019_Human,Pancreatic secretion,1/98,0.0048999339081079,0.0062999150247102,0,0,19902.0,105849.45495286948,PLA2G2F
23108,KEGG_2019_Human,Vascular smooth muscle contraction,1/132,0.0065999206698993,0.0074249107536368,0,0,19868.0,99751.22090491928,PLA2G2F
23109,KEGG_2019_Human,Ras signaling pathway,1/232,0.0115998901349604,0.0115998901349604,0,0,19768.0,88101.22480150245,PLA2G2F
23110,KEGG_2019_Human,Viral carcinogenesis,1/201,0.0100498985877989,0.0109498935894162,0,0,19799.0,91079.21596609056,RANBP1
23111,KEGG_2019_Human,Human T-cell leukemia virus 1 infection,1/219,0.0109498935894162,0.0109498935894162,0,0,19781.0,89299.85161916987,RANBP1
23112,KEGG_2019_Human,Pantothenate and CoA biosynthesis,1/19,0.00094997806231055,0.00094997806231055,0,0,19981.0,139049.2109571672,AASDHPPT
23113,KEGG_2019_Human,SNARE interactions in vesicular transport,1/34,0.0016999670339032,0.0016999670339032,0,0,19966.0,127326.1054203148,VAMP1
23114,KEGG_2019_Human,Cytosolic DNA-sensing pathway,1/63,0.0031499501598827,0.0088999053857096,0,0,19937.0,114844.46974572667,RIPK3
23115,KEGG_2019_Human,TNF signaling pathway,1/110,0.0054999290027479,0.0088999053857096,0,0,19890.0,103488.06969787036,RIPK3
23116,KEGG_2019_Human,Necroptosis,1/162,0.0080999104202618,0.0088999053857096,0,0,19838.0,95537.86936302872,RIPK3
23117,KEGG_2019_Human,NOD-like receptor signaling pathway,1/178,0.0088999053857096,0.0088999053857096,0,0,19822.0,93593.82745769851,RIPK3
23118,KEGG_2019_Human,Spliceosome,1/134,0.0066999199497742,0.0149498740670514,0,0,19866.0,99442.43560916925,HNRNPK
23119,KEGG_2019_Human,Viral carcinogenesis,1/201,0.0100498985877989,0.0149498740670514,0,0,19799.0,91079.21596609056,HNRNPK
23120,KEGG_2019_Human,MicroRNAs in cancer,1/299,0.0149498740670514,0.0149498740670514,0,0,19701.0,82804.33538735632,HNRNPK
23121,KEGG_2019_Human,SNARE interactions in vesicular transport,1/34,0.0016999670339032,0.0033999340678064,0,0,19966.0,127326.1054203148,SNAP23
23122,KEGG_2019_Human,Platelet activation,1/124,0.0061999236097501,0.0061999236097501,0,0,19876.0,101034.04709010696,SNAP23
23123,KEGG_2019_Human,TGF-beta signaling pathway,1/90,0.0044999373439762,0.0079999110688441,0,0,19910.0,107587.50385474482,SMAD7
23124,KEGG_2019_Human,Hippo signaling pathway,1/160,0.0079999110688441,0.0079999110688441,0,0,19840.0,95793.96509856998,SMAD7
23125,KEGG_2019_Human,Insulin signaling pathway,1/137,0.0068499188797651,0.0068499188797651,0,0,19863.0,98987.62735269018,FLOT1
23126,KEGG_2019_Human,Asthma,1/31,0.0015499690656704,0.0065649124510844,0,0,19969.0,129189.85098816035,IL5
23127,KEGG_2019_Human,Allograft rejection,1/38,0.001899964429635,0.0065649124510844,0,0,19962.0,125080.29732025368,IL5
23128,KEGG_2019_Human,Intestinal immune network for IgA production,1/48,0.0023999583567988,0.0065649124510844,0,0,19952.0,120356.5272753826,IL5
23129,KEGG_2019_Human,Autoimmune thyroid disease,1/53,0.0026499555173137,0.0065649124510844,0,0,19947.0,118349.78824235698,IL5
23130,KEGG_2019_Human,Inflammatory bowel disease (IBD),1/65,0.003249949134407,0.0065649124510844,0,0,19935.0,114209.92613860144,IL5
23131,KEGG_2019_Human,Fc epsilon RI signaling pathway,1/68,0.0033999476216189,0.0065649124510844,0,0,19932.0,113293.39338050144,IL5
23132,KEGG_2019_Human,Th1 and Th2 cell differentiation,1/92,0.0045999364719865,0.0065649124510844,0,0,19908.0,107139.13814408927,IL5
23133,KEGG_2019_Human,IL-17 signaling pathway,1/93,0.0046499360391879,0.0065649124510844,0,0,19907.0,106918.54242106884,IL5
23134,KEGG_2019_Human,Hematopoietic cell lineage,1/97,0.0048499343304706,0.0065649124510844,0,0,19903.0,106058.9096435903,IL5
23135,KEGG_2019_Human,T cell receptor signaling pathway,1/101,0.0050499326546803,0.0065649124510844,0,0,19899.0,105233.48101229242,IL5
23136,KEGG_2019_Human,JAK-STAT signaling pathway,1/162,0.0080999104202618,0.009572621405764,0,0,19838.0,95537.86936302872,IL5
23137,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0159248647739712,0,0,19706.0,83157.67014793828,IL5
23138,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,IL5
23139,KEGG_2019_Human,Non-homologous end-joining,1/13,0.0006499833083207112,0.0017999657178272,0,0,19987.0,146675.87616784443,FEN1
23140,KEGG_2019_Human,Base excision repair,1/33,0.0016499677032113,0.0017999657178272,0,0,19967.0,127928.56031580272,FEN1
23141,KEGG_2019_Human,DNA replication,1/36,0.0017999657178272,0.0017999657178272,0,0,19964.0,126172.23364250171,FEN1
23142,KEGG_2019_Human,Protein export,1/23,0.0011499748819949,0.0011499748819949,0,0,19977.0,135204.63922267244,SEC11C
23143,KEGG_2019_Human,Ribosome biogenesis in eukaryotes,1/101,0.0050499326546803,0.0109498935894162,0,0,19899.0,105233.48101229242,RAN
23144,KEGG_2019_Human,RNA transport,1/165,0.0082499094553477,0.0109498935894162,0,0,19835.0,95159.46482222488,RAN
23145,KEGG_2019_Human,Human T-cell leukemia virus 1 infection,1/219,0.0109498935894162,0.0109498935894162,0,0,19781.0,89299.85161916987,RAN
23146,KEGG_2019_Human,Citrate cycle (TCA cycle),1/30,0.0014999697593334,0.0015999683804467,0,0,19970.0,129851.13732048514,SUCLG1
23147,KEGG_2019_Human,Propanoate metabolism,1/32,0.0015999683804467,0.0015999683804467,0,0,19968.0,128549.41955786056,SUCLG1
23148,KEGG_2019_Human,Primary immunodeficiency,1/37,0.0018499650702878,0.0063124158183504,0,0,19963.0,125618.9446446357,CD8B
23149,KEGG_2019_Human,Antigen processing and presentation,1/77,0.0038499432547502,0.0063124158183504,0,0,19923.0,110765.8407373636,CD8B
23150,KEGG_2019_Human,Hematopoietic cell lineage,1/97,0.0048499343304706,0.0063124158183504,0,0,19903.0,106058.9096435903,CD8B
23151,KEGG_2019_Human,T cell receptor signaling pathway,1/101,0.0050499326546803,0.0063124158183504,0,0,19899.0,105233.48101229242,CD8B
23152,KEGG_2019_Human,Cell adhesion molecules (CAMs),1/145,0.0072499160871101,0.0072499160871101,0,0,19855.0,97820.92670675044,CD8B
23153,KEGG_2019_Human,Hematopoietic cell lineage,1/97,0.0048499343304706,0.0161998208405236,0,0,19903.0,106058.9096435903,IL3RA
23154,KEGG_2019_Human,Apoptosis,1/143,0.0071499167770442,0.0161998208405236,0,0,19857.0,98106.57763600958,IL3RA
23155,KEGG_2019_Human,JAK-STAT signaling pathway,1/162,0.0080999104202618,0.0161998208405236,0,0,19838.0,95537.86936302872,IL3RA
23156,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0212398351696402,0,0,19706.0,83157.67014793828,IL3RA
23157,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0212398351696402,0,0,19646.0,79255.8617626126,IL3RA
23158,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,IL3RA
23159,KEGG_2019_Human,p53 signaling pathway,1/72,0.0035999456502131,0.0050999322416682,0,0,19928.0,112131.59838572376,SESN3
23160,KEGG_2019_Human,Longevity regulating pathway,1/102,0.0050999322416682,0.0050999322416682,0,0,19898.0,105032.15064717118,SESN3
23161,KEGG_2019_Human,NOD-like receptor signaling pathway,1/178,0.0088999053857096,0.0088999053857096,0,0,19822.0,93593.82745769851,CARD16
23162,KEGG_2019_Human,Wnt signaling pathway,1/158,0.0078999117225733,0.0109498935894162,0,0,19842.0,96053.2110949472,MMP7
23163,KEGG_2019_Human,Human T-cell leukemia virus 1 infection,1/219,0.0109498935894162,0.0109498935894162,0,0,19781.0,89299.85161916987,MMP7
23164,KEGG_2019_Human,Lysosome,1/123,0.0061499239842961,0.0061499239842961,0,0,19877.0,101200.07933676826,CLN5
23165,KEGG_2019_Human,Base excision repair,1/33,0.0016499677032113,0.0016499677032113,0,0,19967.0,127928.56031580272,NTHL1
23166,KEGG_2019_Human,Cell adhesion molecules (CAMs),1/145,0.0072499160871101,0.0072499160871101,0,0,19855.0,97820.92670675044,ICAM3
23167,KEGG_2019_Human,Mineral absorption,1/51,0.0025499566390179,0.0025499566390179,0,0,19949.0,119129.0228601236,MT1B
23168,KEGG_2019_Human,TGF-beta signaling pathway,1/90,0.0044999373439762,0.010299897173561,0,0,19910.0,107587.50385474482,ID1
23169,KEGG_2019_Human,Signaling pathways regulating pluripotency of stem cells,1/139,0.006949918172816,0.010299897173561,0,0,19861.0,98689.81333375497,ID1
23170,KEGG_2019_Human,Hippo signaling pathway,1/160,0.0079999110688441,0.010299897173561,0,0,19840.0,95793.96509856998,ID1
23171,KEGG_2019_Human,Rap1 signaling pathway,1/206,0.010299897173561,0.010299897173561,0,0,19794.0,90569.849337325,ID1
23172,KEGG_2019_Human,Phosphonate and phosphinate metabolism,1/6,0.0002999905873105514,0.0011999623492422,0,0,19994.0,162186.51863187927,CHPT1
23173,KEGG_2019_Human,Ether lipid metabolism,1/47,0.0023499589392381,0.0046999178784763,0,0,19953.0,120782.64067395544,CHPT1
23174,KEGG_2019_Human,Glycerophospholipid metabolism,1/97,0.0048499343304706,0.0049499334884068,0,0,19903.0,106058.9096435903,CHPT1
23175,KEGG_2019_Human,Choline metabolism in cancer,1/99,0.0049499334884068,0.0049499334884068,0,0,19901.0,105642.09305076736,CHPT1
23176,KEGG_2019_Human,Ribosome,1/153,0.0076499133771537,0.0076499133771537,0,0,19847.0,96715.6407630817,RPL41
23177,KEGG_2019_Human,One carbon pool by folate,1/20,0.0009999772468562472,0.0019999631680592,0,0,19980.0,138017.40508704726,SHMT2
23178,KEGG_2019_Human,Glyoxylate and dicarboxylate metabolism,1/30,0.0014999697593334,0.0019999631680592,0,0,19970.0,129851.13732048514,SHMT2
23179,KEGG_2019_Human,"Glycine, serine and threonine metabolism",1/40,0.0019999631680592,0.0019999631680592,0,0,19960.0,124043.94523066044,SHMT2
23180,KEGG_2019_Human,Oxidative phosphorylation,1/133,0.0066499203093911,0.0112582177134695,0,0,19867.0,99596.2591544721,NDUFA4L2
23181,KEGG_2019_Human,Parkinson disease,1/142,0.0070999171242726,0.0112582177134695,0,0,19858.0,98250.87390500787,NDUFA4L2
23182,KEGG_2019_Human,Retrograde endocannabinoid signaling,1/148,0.007399915061391,0.0112582177134695,0,0,19852.0,97399.60470052566,NDUFA4L2
23183,KEGG_2019_Human,Non-alcoholic fatty liver disease (NAFLD),1/149,0.0074499147221605,0.0112582177134695,0,0,19851.0,97261.02051561224,NDUFA4L2
23184,KEGG_2019_Human,Alzheimer disease,1/171,0.0085499075557634,0.0112582177134695,0,0,19829.0,94422.42241345016,NDUFA4L2
23185,KEGG_2019_Human,Huntington disease,1/193,0.0096499008972596,0.0112582177134695,0,0,19807.0,91920.47679471428,NDUFA4L2
23186,KEGG_2019_Human,Thermogenesis,1/231,0.0115498903940656,0.0115498903940656,0,0,19769.0,88191.07730937863,NDUFA4L2
23187,KEGG_2019_Human,Fat digestion and absorption,1/41,0.0020499625466866,0.0060999024003308,0,0,19959.0,123544.88783416104,AGPAT2
23188,KEGG_2019_Human,Glycerolipid metabolism,1/61,0.0030499512001654,0.0060999024003308,0,0,19939.0,115499.24335773686,AGPAT2
23189,KEGG_2019_Human,Glycerophospholipid metabolism,1/97,0.0048499343304706,0.0064665791072942,0,0,19903.0,106058.9096435903,AGPAT2
23190,KEGG_2019_Human,Phospholipase D signaling pathway,1/148,0.007399915061391,0.007399915061391,0,0,19852.0,97399.60470052566,AGPAT2
23191,KEGG_2019_Human,RNA transport,1/165,0.0082499094553477,0.0082499094553477,0,0,19835.0,95159.46482222488,SMN1
23192,KEGG_2019_Human,Necroptosis,1/162,0.0080999104202618,0.0121998870519305,0,0,19838.0,95537.86936302872,CHMP3
23193,KEGG_2019_Human,Endocytosis,1/244,0.0121998870519305,0.0121998870519305,0,0,19756.0,87051.4275316661,CHMP3
23194,KEGG_2019_Human,Folate biosynthesis,1/26,0.0012999726251831,0.0012999726251831,0,0,19974.0,132735.46073187632,FPGS
23195,KEGG_2019_Human,Asthma,1/31,0.0015499690656704,0.0083141731379497,0,0,19969.0,129189.85098816035,HLA-DQA1
23196,KEGG_2019_Human,Allograft rejection,1/38,0.001899964429635,0.0083141731379497,0,0,19962.0,125080.29732025368,HLA-DQA1
23197,KEGG_2019_Human,Graft-versus-host disease,1/41,0.0020499625466866,0.0083141731379497,0,0,19959.0,123544.88783416104,HLA-DQA1
23198,KEGG_2019_Human,Type I diabetes mellitus,1/43,0.0021499613216957,0.0083141731379497,0,0,19957.0,122581.98940490963,HLA-DQA1
23199,KEGG_2019_Human,Intestinal immune network for IgA production,1/48,0.0023999583567988,0.0083141731379497,0,0,19952.0,120356.5272753826,HLA-DQA1
23200,KEGG_2019_Human,Autoimmune thyroid disease,1/53,0.0026499555173137,0.0083141731379497,0,0,19947.0,118349.78824235698,HLA-DQA1
23201,KEGG_2019_Human,Viral myocarditis,1/59,0.0029499522555206,0.0083141731379497,0,0,19941.0,116175.59385530632,HLA-DQA1
23202,KEGG_2019_Human,Inflammatory bowel disease (IBD),1/65,0.003249949134407,0.0083141731379497,0,0,19935.0,114209.92613860144,HLA-DQA1
23203,KEGG_2019_Human,Staphylococcus aureus infection,1/68,0.0033999476216189,0.0083141731379497,0,0,19932.0,113293.39338050144,HLA-DQA1
23204,KEGG_2019_Human,Leishmaniasis,1/74,0.0036999446830449,0.0083141731379497,0,0,19926.0,111574.38983110404,HLA-DQA1
23205,KEGG_2019_Human,Antigen processing and presentation,1/77,0.0038499432547502,0.0083141731379497,0,0,19923.0,110765.8407373636,HLA-DQA1
23206,KEGG_2019_Human,Rheumatoid arthritis,1/91,0.0045499369072032,0.0083141731379497,0,0,19909.0,107362.10783923086,HLA-DQA1
23207,KEGG_2019_Human,Th1 and Th2 cell differentiation,1/92,0.0045999364719865,0.0083141731379497,0,0,19908.0,107139.13814408927,HLA-DQA1
23208,KEGG_2019_Human,Hematopoietic cell lineage,1/97,0.0048499343304706,0.0083141731379497,0,0,19903.0,106058.9096435903,HLA-DQA1
23209,KEGG_2019_Human,Th17 cell differentiation,1/107,0.0053499302026925,0.0084748917286727,0,0,19893.0,104053.753408911,HLA-DQA1
23210,KEGG_2019_Human,Toxoplasmosis,1/113,0.0056499278191151,0.0084748917286727,0,0,19887.0,102937.34947211576,HLA-DQA1
23211,KEGG_2019_Human,Systemic lupus erythematosus,1/133,0.0066499203093911,0.0093881227897286,0,0,19867.0,99596.2591544721,HLA-DQA1
23212,KEGG_2019_Human,Cell adhesion molecules (CAMs),1/145,0.0072499160871101,0.0095998910039963,0,0,19855.0,97820.92670675044,HLA-DQA1
23213,KEGG_2019_Human,Phagosome,1/152,0.0075999137114971,0.0095998910039963,0,0,19848.0,96850.665715497,HLA-DQA1
23214,KEGG_2019_Human,Influenza A,1/171,0.0085499075557634,0.0102284629486356,0,0,19829.0,94422.42241345016,HLA-DQA1
23215,KEGG_2019_Human,Tuberculosis,1/179,0.0089499050800561,0.0102284629486356,0,0,19821.0,93478.0629355712,HLA-DQA1
23216,KEGG_2019_Human,Epstein-Barr virus infection,1/201,0.0100498985877989,0.0109635257321443,0,0,19799.0,91079.21596609056,HLA-DQA1
23217,KEGG_2019_Human,Human T-cell leukemia virus 1 infection,1/219,0.0109498935894162,0.0114259759193908,0,0,19781.0,89299.85161916987,HLA-DQA1
23218,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,HLA-DQA1
23219,KEGG_2019_Human,Natural killer cell mediated cytotoxicity,1/131,0.0065499210316603,0.0065499210316603,0,0,19869.0,99907.33811343512,ULBP3
23220,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR2K2
23221,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF549
23222,KEGG_2019_Human,RNA degradation,1/79,0.0039499423167337,0.0039499423167337,0,0,19921.0,110243.89578070649,MPHOSPH6
23223,KEGG_2019_Human,ErbB signaling pathway,1/85,0.004249939567045,0.004249939567045,0,0,19915.0,108752.83801948265,NRG4
23224,KEGG_2019_Human,Axon guidance,1/181,0.0090499044707863,0.0090499044707863,0,0,19819.0,93248.41634586031,EFNB2
23225,KEGG_2019_Human,Autophagy,1/128,0.0063999221281459,0.0092999029651357,0,0,19872.0,100382.8010329652,ATG3
23226,KEGG_2019_Human,Kaposi sarcoma-associated herpesvirus infection,1/186,0.0092999029651357,0.0092999029651357,0,0,19814.0,92684.96451050608,ATG3
23227,KEGG_2019_Human,Mitophagy,1/65,0.003249949134407,0.0075748989820205,0,0,19935.0,114209.92613860144,CSNK2A3
23228,KEGG_2019_Human,Adherens junction,1/72,0.0035999456502131,0.0075748989820205,0,0,19928.0,112131.59838572376,CSNK2A3
23229,KEGG_2019_Human,NF-kappa B signaling pathway,1/95,0.0047499351803394,0.0075748989820205,0,0,19905.0,106484.27183626965,CSNK2A3
23230,KEGG_2019_Human,Ribosome biogenesis in eukaryotes,1/101,0.0050499326546803,0.0075748989820205,0,0,19899.0,105233.48101229242,CSNK2A3
23231,KEGG_2019_Human,Measles,1/138,0.0068999185254481,0.0078999117225733,0,0,19862.0,98838.19160389496,CSNK2A3
23232,KEGG_2019_Human,Wnt signaling pathway,1/158,0.0078999117225733,0.0078999117225733,0,0,19842.0,96053.2110949472,CSNK2A3
23233,KEGG_2019_Human,HIF-1 signaling pathway,1/100,0.0049999330710556,0.0173998352024406,0,0,19900.0,105436.78197328727,ANGPT2
23234,KEGG_2019_Human,Kaposi sarcoma-associated herpesvirus infection,1/186,0.0092999029651357,0.0173998352024406,0,0,19814.0,92684.96451050608,ANGPT2
23235,KEGG_2019_Human,Rap1 signaling pathway,1/206,0.010299897173561,0.0173998352024406,0,0,19794.0,90569.849337325,ANGPT2
23236,KEGG_2019_Human,Ras signaling pathway,1/232,0.0115998901349604,0.0173998352024406,0,0,19768.0,88101.22480150245,ANGPT2
23237,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0176998499443808,0,0,19705.0,83086.53988020132,ANGPT2
23238,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0176998626413668,0,0,19646.0,79255.8617626126,ANGPT2
23239,KEGG_2019_Human,HIF-1 signaling pathway,1/100,0.0049999330710556,0.0049999330710556,0,0,19900.0,105436.78197328727,TIMP1
23240,KEGG_2019_Human,Linoleic acid metabolism,1/29,0.001449970461791,0.0052499169331379,0,0,19971.0,130534.69172799008,CYP2J2
23241,KEGG_2019_Human,Ovarian steroidogenesis,1/49,0.0024499577795033,0.0052499169331379,0,0,19951.0,119939.1172087114,CYP2J2
23242,KEGG_2019_Human,Arachidonic acid metabolism,1/63,0.0031499501598827,0.0052499169331379,0,0,19937.0,114844.46974572667,CYP2J2
23243,KEGG_2019_Human,Inflammatory mediator regulation of TRP channels,1/100,0.0049999330710556,0.0056499278191151,0,0,19900.0,105436.78197328727,CYP2J2
23244,KEGG_2019_Human,Serotonergic synapse,1/113,0.0056499278191151,0.0056499278191151,0,0,19887.0,102937.34947211576,CYP2J2
23245,KEGG_2019_Human,Fanconi anemia pathway,1/54,0.0026999549628563,0.0026999549628563,0,0,19946.0,117971.01964061816,USP1
23246,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF841
23247,KEGG_2019_Human,Fanconi anemia pathway,1/54,0.0026999549628563,0.0026999549628563,0,0,19946.0,117971.01964061816,FANCC
23248,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0147498749536506,0,0,19705.0,83086.53988020132,MAPKAPK5
23249,KEGG_2019_Human,Lysine degradation,1/59,0.0029499522555206,0.0029499522555206,0,0,19941.0,116175.59385530632,PRDM6
23250,KEGG_2019_Human,Pathogenic Escherichia coli infection,1/55,0.0027499544131125,0.0063699116700844,0,0,19945.0,117599.1294878737,ARPC2
23251,KEGG_2019_Human,Shigellosis,1/65,0.003249949134407,0.0063699116700844,0,0,19935.0,114209.92613860144,ARPC2
23252,KEGG_2019_Human,Bacterial invasion of epithelial cells,1/74,0.0036999446830449,0.0063699116700844,0,0,19926.0,111574.38983110404,ARPC2
23253,KEGG_2019_Human,Salmonella infection,1/86,0.0042999391173866,0.0063699116700844,0,0,19914.0,108514.46102290176,ARPC2
23254,KEGG_2019_Human,Fc gamma R-mediated phagocytosis,1/91,0.0045499369072032,0.0063699116700844,0,0,19909.0,107362.10783923086,ARPC2
23255,KEGG_2019_Human,Regulation of actin cytoskeleton,1/214,0.0106998949514067,0.0121998870519305,0,0,19786.0,89779.39753374986,ARPC2
23256,KEGG_2019_Human,Endocytosis,1/244,0.0121998870519305,0.0121998870519305,0,0,19756.0,87051.4275316661,ARPC2
23257,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF860
23258,KEGG_2019_Human,Tryptophan metabolism,1/42,0.0020999619311272,0.0020999619311272,0,0,19958.0,123057.75613441122,AANAT
23259,KEGG_2019_Human,IL-17 signaling pathway,1/93,0.0046499360391879,0.0134998703748406,0,0,19907.0,106918.54242106884,TRAF5
23260,KEGG_2019_Human,Small cell lung cancer,1/93,0.0046499360391879,0.0134998703748406,0,0,19907.0,106918.54242106884,TRAF5
23261,KEGG_2019_Human,NF-kappa B signaling pathway,1/95,0.0047499351803394,0.0134998703748406,0,0,19905.0,106484.27183626965,TRAF5
23262,KEGG_2019_Human,TNF signaling pathway,1/110,0.0054999290027479,0.0134998703748406,0,0,19890.0,103488.06969787036,TRAF5
23263,KEGG_2019_Human,Necroptosis,1/162,0.0080999104202618,0.0134998703748406,0,0,19838.0,95537.86936302872,TRAF5
23264,KEGG_2019_Human,NOD-like receptor signaling pathway,1/178,0.0088999053857096,0.0134998703748406,0,0,19822.0,93593.82745769851,TRAF5
23265,KEGG_2019_Human,Epstein-Barr virus infection,1/201,0.0100498985877989,0.0134998703748406,0,0,19799.0,91079.21596609056,TRAF5
23266,KEGG_2019_Human,Viral carcinogenesis,1/201,0.0100498985877989,0.0134998703748406,0,0,19799.0,91079.21596609056,TRAF5
23267,KEGG_2019_Human,Human immunodeficiency virus 1 infection,1/212,0.0105998955026255,0.0134998703748406,0,0,19788.0,89974.27756224656,TRAF5
23268,KEGG_2019_Human,Human cytomegalovirus infection,1/225,0.0112498919790339,0.0134998703748406,0,0,19775.0,88738.27077557483,TRAF5
23269,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0264998334376226,0,0,19508.0,72277.44006442746,TRAF5
23270,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,TRAF5
23271,KEGG_2019_Human,Porphyrin and chlorophyll metabolism,1/42,0.0020999619311272,0.0062998857933818,0,0,19958.0,123057.75613441122,COX10
23272,KEGG_2019_Human,Oxidative phosphorylation,1/133,0.0066499203093911,0.0099748804640867,0,0,19867.0,99596.2591544721,COX10
23273,KEGG_2019_Human,Thermogenesis,1/231,0.0115498903940656,0.0115498903940656,0,0,19769.0,88191.07730937863,COX10
23274,KEGG_2019_Human,Protein export,1/23,0.0011499748819949,0.0043749159303989,0,0,19977.0,135204.63922267244,HSPA5
23275,KEGG_2019_Human,Prion diseases,1/35,0.0017499663721595,0.0043749159303989,0,0,19965.0,126740.98858805298,HSPA5
23276,KEGG_2019_Human,Thyroid hormone synthesis,1/74,0.0036999446830449,0.0048124290684378,0,0,19926.0,111574.38983110404,HSPA5
23277,KEGG_2019_Human,Antigen processing and presentation,1/77,0.0038499432547502,0.0048124290684378,0,0,19923.0,110765.8407373636,HSPA5
23278,KEGG_2019_Human,Protein processing in endoplasmic reticulum,1/165,0.0082499094553477,0.0082499094553477,0,0,19835.0,95159.46482222488,HSPA5
23279,KEGG_2019_Human,Fructose and mannose metabolism,1/33,0.0016499677032113,0.0016999670339032,0,0,19967.0,127928.56031580272,SORD
23280,KEGG_2019_Human,Pentose and glucuronate interconversions,1/34,0.0016999670339032,0.0016999670339032,0,0,19966.0,127326.1054203148,SORD
23281,KEGG_2019_Human,Huntington disease,1/193,0.0096499008972596,0.0096499008972596,0,0,19807.0,91920.47679471428,RCOR1
23282,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF552
23283,KEGG_2019_Human,TGF-beta signaling pathway,1/90,0.0044999373439762,0.0079999110688441,0,0,19910.0,107587.50385474482,E2F5
23284,KEGG_2019_Human,Cell cycle,1/124,0.0061999236097501,0.0079999110688441,0,0,19876.0,101034.04709010696,E2F5
23285,KEGG_2019_Human,Cellular senescence,1/160,0.0079999110688441,0.0079999110688441,0,0,19840.0,95793.96509856998,E2F5
23286,KEGG_2019_Human,Tight junction,1/170,0.0084999078692823,0.0084999078692823,0,0,19830.0,94543.49009679438,YBX3
23287,KEGG_2019_Human,C-type lectin receptor signaling pathway,1/104,0.0051999314202997,0.0089499050800561,0,0,19896.0,104635.24941415618,CLEC7A
23288,KEGG_2019_Human,Phagosome,1/152,0.0075999137114971,0.0089499050800561,0,0,19848.0,96850.665715497,CLEC7A
23289,KEGG_2019_Human,Tuberculosis,1/179,0.0089499050800561,0.0089499050800561,0,0,19821.0,93478.0629355712,CLEC7A
23290,KEGG_2019_Human,Ubiquitin mediated proteolysis,1/137,0.0068499188797651,0.0082499094553477,0,0,19863.0,98987.62735269018,SYVN1
23291,KEGG_2019_Human,Protein processing in endoplasmic reticulum,1/165,0.0082499094553477,0.0082499094553477,0,0,19835.0,95159.46482222488,SYVN1
23292,KEGG_2019_Human,Pathogenic Escherichia coli infection,1/55,0.0027499544131125,0.0054999088262251,0,0,19945.0,117599.1294878737,KRT18
23293,KEGG_2019_Human,Estrogen signaling pathway,1/137,0.0068499188797651,0.0068499188797651,0,0,19863.0,98987.62735269018,KRT18
23294,KEGG_2019_Human,Glutathione metabolism,1/56,0.0027999538675741,0.0094498771520562,0,0,19944.0,117233.87022514464,MGST2
23295,KEGG_2019_Human,Metabolism of xenobiotics by cytochrome P450,1/74,0.0036999446830449,0.0094498771520562,0,0,19926.0,111574.38983110404,MGST2
23296,KEGG_2019_Human,Chemical carcinogenesis,1/82,0.004099940929819,0.0094498771520562,0,0,19918.0,109484.9180722932,MGST2
23297,KEGG_2019_Human,Drug metabolism,1/108,0.0053999298011749,0.0094498771520562,0,0,19892.0,103863.47861844616,MGST2
23298,KEGG_2019_Human,Fluid shear stress and atherosclerosis,1/139,0.006949918172816,0.0097298854419424,0,0,19861.0,98689.81333375497,MGST2
23299,KEGG_2019_Human,Hepatocellular carcinoma,1/168,0.0083999085011095,0.0097998932512944,0,0,19832.0,94787.72752807094,MGST2
23300,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,MGST2
23301,KEGG_2019_Human,TGF-beta signaling pathway,1/90,0.0044999373439762,0.0092999029651357,0,0,19910.0,107587.50385474482,ID2
23302,KEGG_2019_Human,Signaling pathways regulating pluripotency of stem cells,1/139,0.006949918172816,0.0092999029651357,0,0,19861.0,98689.81333375497,ID2
23303,KEGG_2019_Human,Hippo signaling pathway,1/160,0.0079999110688441,0.0092999029651357,0,0,19840.0,95793.96509856998,ID2
23304,KEGG_2019_Human,Transcriptional misregulation in cancer,1/186,0.0092999029651357,0.0092999029651357,0,0,19814.0,92684.96451050608,ID2
23305,KEGG_2019_Human,mRNA surveillance pathway,1/91,0.0045499369072032,0.0101498825219542,0,0,19909.0,107362.10783923086,PPP2R3C
23306,KEGG_2019_Human,Sphingolipid signaling pathway,1/119,0.0059499254985137,0.0101498825219542,0,0,19881.0,101877.73080211312,PPP2R3C
23307,KEGG_2019_Human,AMPK signaling pathway,1/120,0.0059999251180858,0.0101498825219542,0,0,19880.0,101706.2448082016,PPP2R3C
23308,KEGG_2019_Human,Dopaminergic synapse,1/131,0.0065499210316603,0.0101498825219542,0,0,19869.0,99907.33811343512,PPP2R3C
23309,KEGG_2019_Human,Adrenergic signaling in cardiomyocytes,1/145,0.0072499160871101,0.0101498825219542,0,0,19855.0,97820.92670675044,PPP2R3C
23310,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0176998626413668,0,0,19670.0,80733.60565076157,PPP2R3C
23311,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0176998626413668,0,0,19646.0,79255.8617626126,PPP2R3C
23312,KEGG_2019_Human,Signaling pathways regulating pluripotency of stem cells,1/139,0.006949918172816,0.0139498544477036,0,0,19861.0,98689.81333375497,COMMD3-BMI1
23313,KEGG_2019_Human,Transcriptional misregulation in cancer,1/186,0.0092999029651357,0.0139498544477036,0,0,19814.0,92684.96451050608,COMMD3-BMI1
23314,KEGG_2019_Human,MicroRNAs in cancer,1/299,0.0149498740670514,0.0149498740670514,0,0,19701.0,82804.33538735632,COMMD3-BMI1
23315,KEGG_2019_Human,Basal transcription factors,1/45,0.0022499601197094,0.0022499601197094,0,0,19955.0,121662.49782449217,TAF5
23316,KEGG_2019_Human,Ubiquitin mediated proteolysis,1/137,0.0068499188797651,0.0068499188797651,0,0,19863.0,98987.62735269018,UBA2
23317,KEGG_2019_Human,Transcriptional misregulation in cancer,1/186,0.0092999029651357,0.0092999029651357,0,0,19814.0,92684.96451050608,FEV
23318,KEGG_2019_Human,Glycolysis / Gluconeogenesis,1/68,0.0033999476216189,0.0074998996065834,0,0,19932.0,113293.39338050144,GAPDH
23319,KEGG_2019_Human,HIF-1 signaling pathway,1/100,0.0049999330710556,0.0074998996065834,0,0,19900.0,105436.78197328727,GAPDH
23320,KEGG_2019_Human,Alzheimer disease,1/171,0.0085499075557634,0.0085499075557634,0,0,19829.0,94422.42241345016,GAPDH
23321,KEGG_2019_Human,Wnt signaling pathway,1/158,0.0078999117225733,0.0078999117225733,0,0,19842.0,96053.2110949472,DKK4
23322,KEGG_2019_Human,Selenocompound metabolism,1/17,0.0008499797390404818,0.0031332785856508,0,0,19983.0,141285.76583697114,KYAT3
23323,KEGG_2019_Human,Tryptophan metabolism,1/42,0.0020999619311272,0.0031332785856508,0,0,19958.0,123057.75613441122,KYAT3
23324,KEGG_2019_Human,Cysteine and methionine metabolism,1/47,0.0023499589392381,0.0031332785856508,0,0,19953.0,120782.64067395544,KYAT3
23325,KEGG_2019_Human,Chemical carcinogenesis,1/82,0.004099940929819,0.004099940929819,0,0,19918.0,109484.9180722932,KYAT3
23326,KEGG_2019_Human,Endocytosis,1/244,0.0121998870519305,0.0121998870519305,0,0,19756.0,87051.4275316661,FOLR3
23327,KEGG_2019_Human,Pathogenic Escherichia coli infection,1/55,0.0027499544131125,0.0077784669103536,0,0,19945.0,117599.1294878737,WASL
23328,KEGG_2019_Human,Shigellosis,1/65,0.003249949134407,0.0077784669103536,0,0,19935.0,114209.92613860144,WASL
23329,KEGG_2019_Human,Adherens junction,1/72,0.0035999456502131,0.0077784669103536,0,0,19928.0,112131.59838572376,WASL
23330,KEGG_2019_Human,Bacterial invasion of epithelial cells,1/74,0.0036999446830449,0.0077784669103536,0,0,19926.0,111574.38983110404,WASL
23331,KEGG_2019_Human,Salmonella infection,1/86,0.0042999391173866,0.0077784669103536,0,0,19914.0,108514.46102290176,WASL
23332,KEGG_2019_Human,Fc gamma R-mediated phagocytosis,1/91,0.0045499369072032,0.0077784669103536,0,0,19909.0,107362.10783923086,WASL
23333,KEGG_2019_Human,Choline metabolism in cancer,1/99,0.0049499334884068,0.0077784669103536,0,0,19901.0,105642.09305076736,WASL
23334,KEGG_2019_Human,Tight junction,1/170,0.0084999078692823,0.0116109910634661,0,0,19830.0,94543.49009679438,WASL
23335,KEGG_2019_Human,Chemokine signaling pathway,1/190,0.0094999017791995,0.0116109910634661,0,0,19810.0,92244.74636351672,WASL
23336,KEGG_2019_Human,Regulation of actin cytoskeleton,1/214,0.0106998949514067,0.0117698844465474,0,0,19786.0,89779.39753374986,WASL
23337,KEGG_2019_Human,Endocytosis,1/244,0.0121998870519305,0.0121998870519305,0,0,19756.0,87051.4275316661,WASL
23338,KEGG_2019_Human,Signaling pathways regulating pluripotency of stem cells,1/139,0.006949918172816,0.0121498656303927,0,0,19861.0,98689.81333375497,LIFR
23339,KEGG_2019_Human,JAK-STAT signaling pathway,1/162,0.0080999104202618,0.0121498656303927,0,0,19838.0,95537.86936302872,LIFR
23340,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0146998751759735,0,0,19706.0,83157.67014793828,LIFR
23341,KEGG_2019_Human,Ribosome,1/153,0.0076499133771537,0.0076499133771537,0,0,19847.0,96715.6407630817,RPS2
23342,KEGG_2019_Human,Ubiquitin mediated proteolysis,1/137,0.0068499188797651,0.0082499094553477,0,0,19863.0,98987.62735269018,UBE2J2
23343,KEGG_2019_Human,Parkinson disease,1/142,0.0070999171242726,0.0082499094553477,0,0,19858.0,98250.87390500787,UBE2J2
23344,KEGG_2019_Human,Protein processing in endoplasmic reticulum,1/165,0.0082499094553477,0.0082499094553477,0,0,19835.0,95159.46482222488,UBE2J2
23345,KEGG_2019_Human,Toxoplasmosis,1/113,0.0056499278191151,0.0139427280593492,0,0,19887.0,102937.34947211576,CCR5
23346,KEGG_2019_Human,Kaposi sarcoma-associated herpesvirus infection,1/186,0.0092999029651357,0.0139427280593492,0,0,19814.0,92684.96451050608,CCR5
23347,KEGG_2019_Human,Chemokine signaling pathway,1/190,0.0094999017791995,0.0139427280593492,0,0,19810.0,92244.74636351672,CCR5
23348,KEGG_2019_Human,Viral carcinogenesis,1/201,0.0100498985877989,0.0139427280593492,0,0,19799.0,91079.21596609056,CCR5
23349,KEGG_2019_Human,Human immunodeficiency virus 1 infection,1/212,0.0105998955026255,0.0139427280593492,0,0,19788.0,89974.27756224656,CCR5
23350,KEGG_2019_Human,Human cytomegalovirus infection,1/225,0.0112498919790339,0.0139427280593492,0,0,19775.0,88738.27077557483,CCR5
23351,KEGG_2019_Human,Endocytosis,1/244,0.0121998870519305,0.0139427280593492,0,0,19756.0,87051.4275316661,CCR5
23352,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0146998751759735,0,0,19706.0,83157.67014793828,CCR5
23353,KEGG_2019_Human,Bladder cancer,1/41,0.0020499625466866,0.0115498741890255,0,0,19959.0,123544.88783416104,E2F3
23354,KEGG_2019_Human,Non-small cell lung cancer,1/66,0.003299948626608,0.0115498741890255,0,0,19934.0,113899.85357353876,E2F3
23355,KEGG_2019_Human,Melanoma,1/72,0.0035999456502131,0.0115498741890255,0,0,19928.0,112131.59838572376,E2F3
23356,KEGG_2019_Human,Pancreatic cancer,1/75,0.0037499442041125,0.0115498741890255,0,0,19925.0,111301.33528642564,E2F3
23357,KEGG_2019_Human,Glioma,1/75,0.0037499442041125,0.0115498741890255,0,0,19925.0,111301.33528642564,E2F3
23358,KEGG_2019_Human,Chronic myeloid leukemia,1/76,0.0037999437281752,0.0115498741890255,0,0,19924.0,111031.8499691117,E2F3
23359,KEGG_2019_Human,Small cell lung cancer,1/93,0.0046499360391879,0.0115498741890255,0,0,19907.0,106918.54242106884,E2F3
23360,KEGG_2019_Human,Prostate cancer,1/97,0.0048499343304706,0.0115498741890255,0,0,19903.0,106058.9096435903,E2F3
23361,KEGG_2019_Human,Cell cycle,1/124,0.0061999236097501,0.0115498741890255,0,0,19876.0,101034.04709010696,E2F3
23362,KEGG_2019_Human,Breast cancer,1/147,0.0073499154017982,0.0115498741890255,0,0,19853.0,97539.10874372096,E2F3
23363,KEGG_2019_Human,Gastric cancer,1/149,0.0074499147221605,0.0115498741890255,0,0,19851.0,97261.02051561224,E2F3
23364,KEGG_2019_Human,Cushing syndrome,1/155,0.0077499127120574,0.0115498741890255,0,0,19845.0,96448.16254952336,E2F3
23365,KEGG_2019_Human,Hepatitis C,1/155,0.0077499127120574,0.0115498741890255,0,0,19845.0,96448.16254952336,E2F3
23366,KEGG_2019_Human,Cellular senescence,1/160,0.0079999110688441,0.0115498741890255,0,0,19840.0,95793.96509856998,E2F3
23367,KEGG_2019_Human,Hepatitis B,1/163,0.0081499100978668,0.0115498741890255,0,0,19837.0,95410.9786681514,E2F3
23368,KEGG_2019_Human,Hepatocellular carcinoma,1/168,0.0083999085011095,0.0115498741890255,0,0,19832.0,94787.72752807094,E2F3
23369,KEGG_2019_Human,Kaposi sarcoma-associated herpesvirus infection,1/186,0.0092999029651357,0.0120351685431168,0,0,19814.0,92684.96451050608,E2F3
23370,KEGG_2019_Human,Epstein-Barr virus infection,1/201,0.0100498985877989,0.0122832093850876,0,0,19799.0,91079.21596609056,E2F3
23371,KEGG_2019_Human,Human T-cell leukemia virus 1 infection,1/219,0.0109498935894162,0.0123748811769373,0,0,19781.0,89299.85161916987,E2F3
23372,KEGG_2019_Human,Human cytomegalovirus infection,1/225,0.0112498919790339,0.0123748811769373,0,0,19775.0,88738.27077557483,E2F3
23373,KEGG_2019_Human,MicroRNAs in cancer,1/299,0.0149498740670514,0.0156617728321491,0,0,19701.0,82804.33538735632,E2F3
23374,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,E2F3
23375,KEGG_2019_Human,Oxidative phosphorylation,1/133,0.0066499203093911,0.0115498903940656,0,0,19867.0,99596.2591544721,ATP5PD
23376,KEGG_2019_Human,Parkinson disease,1/142,0.0070999171242726,0.0115498903940656,0,0,19858.0,98250.87390500787,ATP5PD
23377,KEGG_2019_Human,Alzheimer disease,1/171,0.0085499075557634,0.0115498903940656,0,0,19829.0,94422.42241345016,ATP5PD
23378,KEGG_2019_Human,Huntington disease,1/193,0.0096499008972596,0.0115498903940656,0,0,19807.0,91920.47679471428,ATP5PD
23379,KEGG_2019_Human,Thermogenesis,1/231,0.0115498903940656,0.0115498903940656,0,0,19769.0,88191.07730937863,ATP5PD
23380,KEGG_2019_Human,Other glycan degradation,1/18,0.0008999788927950273,0.00179995778559,0,0,19982.0,140136.54844084635,AGA
23381,KEGG_2019_Human,Lysosome,1/123,0.0061499239842961,0.0061499239842961,0,0,19877.0,101200.07933676826,AGA
23382,KEGG_2019_Human,GnRH signaling pathway,1/93,0.0046499360391879,0.0092998720783758,0,0,19907.0,106918.54242106884,GNRH1
23383,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,GNRH1
23384,KEGG_2019_Human,Thiamine metabolism,1/15,0.0007499814841592997,0.0014999629683185,0,0,19985.0,143801.30885993244,AK4
23385,KEGG_2019_Human,Purine metabolism,1/129,0.006449921761047,0.006449921761047,0,0,19871.0,100223.109907462,AK4
23386,KEGG_2019_Human,"Glycine, serine and threonine metabolism",1/40,0.0019999631680592,0.0023499589392381,0,0,19960.0,124043.94523066044,SDS
23387,KEGG_2019_Human,Cysteine and methionine metabolism,1/47,0.0023499589392381,0.0023499589392381,0,0,19953.0,120782.64067395544,SDS
23388,KEGG_2019_Human,Ferroptosis,1/40,0.0019999631680592,0.0038249349585269,0,0,19960.0,124043.94523066044,FTL
23389,KEGG_2019_Human,Mineral absorption,1/51,0.0025499566390179,0.0038249349585269,0,0,19949.0,119129.0228601236,FTL
23390,KEGG_2019_Human,Necroptosis,1/162,0.0080999104202618,0.0080999104202618,0,0,19838.0,95537.86936302872,FTL
23391,KEGG_2019_Human,Cell cycle,1/124,0.0061999236097501,0.0105998955026255,0,0,19876.0,101034.04709010696,WEE1
23392,KEGG_2019_Human,Human immunodeficiency virus 1 infection,1/212,0.0105998955026255,0.0105998955026255,0,0,19788.0,89974.27756224656,WEE1
23393,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF600
23394,KEGG_2019_Human,Proteasome,1/45,0.0022499601197094,0.0044999202394188,0,0,19955.0,121662.49782449217,PSMD4
23395,KEGG_2019_Human,Epstein-Barr virus infection,1/201,0.0100498985877989,0.0100498985877989,0,0,19799.0,91079.21596609056,PSMD4
23396,KEGG_2019_Human,Ubiquitin mediated proteolysis,1/137,0.0068499188797651,0.0068499188797651,0,0,19863.0,98987.62735269018,UBE2H
23397,KEGG_2019_Human,Pantothenate and CoA biosynthesis,1/19,0.00094997806231055,0.00094997806231055,0,0,19981.0,139049.2109571672,PPCS
23398,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF705D
23399,KEGG_2019_Human,Cell adhesion molecules (CAMs),1/145,0.0072499160871101,0.0072499160871101,0,0,19855.0,97820.92670675044,VSIR
23400,KEGG_2019_Human,Intestinal immune network for IgA production,1/48,0.0023999583567988,0.0128331676730784,0,0,19952.0,120356.5272753826,IL15
23401,KEGG_2019_Human,Rheumatoid arthritis,1/91,0.0045499369072032,0.0128331676730784,0,0,19909.0,107362.10783923086,IL15
23402,KEGG_2019_Human,TNF signaling pathway,1/110,0.0054999290027479,0.0128331676730784,0,0,19890.0,103488.06969787036,IL15
23403,KEGG_2019_Human,JAK-STAT signaling pathway,1/162,0.0080999104202618,0.0141748432354582,0,0,19838.0,95537.86936302872,IL15
23404,KEGG_2019_Human,Human T-cell leukemia virus 1 infection,1/219,0.0109498935894162,0.0153298510251827,0,0,19781.0,89299.85161916987,IL15
23405,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.017149854371969,0,0,19706.0,83157.67014793828,IL15
23406,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,IL15
23407,KEGG_2019_Human,Sphingolipid metabolism,1/47,0.0023499589392381,0.0046999178784763,0,0,19953.0,120782.64067395544,ARSA
23408,KEGG_2019_Human,Lysosome,1/123,0.0061499239842961,0.0061499239842961,0,0,19877.0,101200.07933676826,ARSA
23409,KEGG_2019_Human,Vasopressin-regulated water reabsorption,1/44,0.0021999607179423,0.0087998428717693,0,0,19956.0,122117.06559109331,AVP
23410,KEGG_2019_Human,Vascular smooth muscle contraction,1/132,0.0065999206698993,0.009866553415188,0,0,19868.0,99751.22090491928,AVP
23411,KEGG_2019_Human,Phospholipase D signaling pathway,1/148,0.007399915061391,0.009866553415188,0,0,19852.0,97399.60470052566,AVP
23412,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,AVP
23413,KEGG_2019_Human,"Valine, leucine and isoleucine degradation",1/48,0.0023999583567988,0.0023999583567988,0,0,19952.0,120356.5272753826,MCCC1
23414,KEGG_2019_Human,Cell cycle,1/124,0.0061999236097501,0.0061999236097501,0,0,19876.0,101034.04709010696,CDC6
23415,KEGG_2019_Human,Staphylococcus aureus infection,1/68,0.0033999476216189,0.0059249134751006,0,0,19932.0,113293.39338050144,C3AR1
23416,KEGG_2019_Human,Complement and coagulation cascades,1/79,0.0039499423167337,0.0059249134751006,0,0,19921.0,110243.89578070649,C3AR1
23417,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,C3AR1
23418,KEGG_2019_Human,Natural killer cell mediated cytotoxicity,1/131,0.0065499210316603,0.0065499210316603,0,0,19869.0,99907.33811343512,NCR2
23419,KEGG_2019_Human,Collecting duct acid secretion,1/27,0.0013499718942362,0.0072798990515251,0,0,19973.0,131975.02298599784,ATP6V0E1
23420,KEGG_2019_Human,Vibrio cholerae infection,1/50,0.0024999572069037,0.0072798990515251,0,0,19950.0,119530.05920663515,ATP6V0E1
23421,KEGG_2019_Human,Epithelial cell signaling in Helicobacter pylori infection,1/68,0.0033999476216189,0.0072798990515251,0,0,19932.0,113293.39338050144,ATP6V0E1
23422,KEGG_2019_Human,Synaptic vesicle cycle,1/78,0.0038999427840466,0.0072798990515251,0,0,19922.0,110503.2180492851,ATP6V0E1
23423,KEGG_2019_Human,Rheumatoid arthritis,1/91,0.0045499369072032,0.0072798990515251,0,0,19909.0,107362.10783923086,ATP6V0E1
23424,KEGG_2019_Human,Oxidative phosphorylation,1/133,0.0066499203093911,0.0086856156702824,0,0,19867.0,99596.2591544721,ATP6V0E1
23425,KEGG_2019_Human,Phagosome,1/152,0.0075999137114971,0.0086856156702824,0,0,19848.0,96850.665715497,ATP6V0E1
23426,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0164998674589645,0,0,19670.0,80733.60565076157,ATP6V0E1
23427,KEGG_2019_Human,Lysosome,1/123,0.0061499239842961,0.0061499239842961,0,0,19877.0,101200.07933676826,CD68
23428,KEGG_2019_Human,RNA transport,1/165,0.0082499094553477,0.0082499094553477,0,0,19835.0,95159.46482222488,EIF3C
23429,KEGG_2019_Human,Ribosome,1/153,0.0076499133771537,0.0076499133771537,0,0,19847.0,96715.6407630817,MRPL33
23430,KEGG_2019_Human,N-Glycan biosynthesis,1/50,0.0024999572069037,0.0024999572069037,0,0,19950.0,119530.05920663515,MGAT1
23431,KEGG_2019_Human,Influenza A,1/171,0.0085499075557634,0.0085499075557634,0,0,19829.0,94422.42241345016,FURIN
23432,KEGG_2019_Human,Ribosome,1/153,0.0076499133771537,0.0076499133771537,0,0,19847.0,96715.6407630817,RPS5
23433,KEGG_2019_Human,RNA transport,1/165,0.0082499094553477,0.0082499094553477,0,0,19835.0,95159.46482222488,PAIP1
23434,KEGG_2019_Human,Ferroptosis,1/40,0.0019999631680592,0.0039999263361184,0,0,19960.0,124043.94523066044,ATG7
23435,KEGG_2019_Human,Autophagy,1/128,0.0063999221281459,0.0063999221281459,0,0,19872.0,100382.8010329652,ATG7
23436,KEGG_2019_Human,IL-17 signaling pathway,1/93,0.0046499360391879,0.0100498799246613,0,0,19907.0,106918.54242106884,SRSF1
23437,KEGG_2019_Human,Spliceosome,1/134,0.0066999199497742,0.0100498799246613,0,0,19866.0,99442.43560916925,SRSF1
23438,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,SRSF1
23439,KEGG_2019_Human,Purine metabolism,1/129,0.006449921761047,0.006449921761047,0,0,19871.0,100223.109907462,DGUOK
23440,KEGG_2019_Human,Oxidative phosphorylation,1/133,0.0066499203093911,0.0112582177134695,0,0,19867.0,99596.2591544721,NDUFA4
23441,KEGG_2019_Human,Parkinson disease,1/142,0.0070999171242726,0.0112582177134695,0,0,19858.0,98250.87390500787,NDUFA4
23442,KEGG_2019_Human,Retrograde endocannabinoid signaling,1/148,0.007399915061391,0.0112582177134695,0,0,19852.0,97399.60470052566,NDUFA4
23443,KEGG_2019_Human,Non-alcoholic fatty liver disease (NAFLD),1/149,0.0074499147221605,0.0112582177134695,0,0,19851.0,97261.02051561224,NDUFA4
23444,KEGG_2019_Human,Alzheimer disease,1/171,0.0085499075557634,0.0112582177134695,0,0,19829.0,94422.42241345016,NDUFA4
23445,KEGG_2019_Human,Huntington disease,1/193,0.0096499008972596,0.0112582177134695,0,0,19807.0,91920.47679471428,NDUFA4
23446,KEGG_2019_Human,Thermogenesis,1/231,0.0115498903940656,0.0115498903940656,0,0,19769.0,88191.07730937863,NDUFA4
23447,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,P2RY6
23448,KEGG_2019_Human,MicroRNAs in cancer,1/299,0.0149498740670514,0.0149498740670514,0,0,19701.0,82804.33538735632,MIR30C2
23449,KEGG_2019_Human,Endocytosis,1/244,0.0121998870519305,0.0121998870519305,0,0,19756.0,87051.4275316661,WASHC3
23450,KEGG_2019_Human,Endocytosis,1/244,0.0121998870519305,0.0121998870519305,0,0,19756.0,87051.4275316661,SNX1
23451,KEGG_2019_Human,Autophagy,1/128,0.0063999221281459,0.0075999137114971,0,0,19872.0,100382.8010329652,RRAGA
23452,KEGG_2019_Human,mTOR signaling pathway,1/152,0.0075999137114971,0.0075999137114971,0,0,19848.0,96850.665715497,RRAGA
23453,KEGG_2019_Human,Transcriptional misregulation in cancer,1/186,0.0092999029651357,0.0092999029651357,0,0,19814.0,92684.96451050608,KLF3
23454,KEGG_2019_Human,Fc gamma R-mediated phagocytosis,1/91,0.0045499369072032,0.0106998949514067,0,0,19909.0,107362.10783923086,SCIN
23455,KEGG_2019_Human,Viral carcinogenesis,1/201,0.0100498985877989,0.0106998949514067,0,0,19799.0,91079.21596609056,SCIN
23456,KEGG_2019_Human,Regulation of actin cytoskeleton,1/214,0.0106998949514067,0.0106998949514067,0,0,19786.0,89779.39753374986,SCIN
23457,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZFP1
23458,KEGG_2019_Human,Cocaine addiction,1/49,0.0024499577795033,0.010412369622399,0,0,19951.0,119939.1172087114,RELA
23459,KEGG_2019_Human,Legionellosis,1/55,0.0027499544131125,0.010412369622399,0,0,19945.0,117599.1294878737,RELA
23460,KEGG_2019_Human,Cytosolic DNA-sensing pathway,1/63,0.0031499501598827,0.010412369622399,0,0,19937.0,114844.46974572667,RELA
23461,KEGG_2019_Human,Inflammatory bowel disease (IBD),1/65,0.003249949134407,0.010412369622399,0,0,19935.0,114209.92613860144,RELA
23462,KEGG_2019_Human,Mitophagy,1/65,0.003249949134407,0.010412369622399,0,0,19935.0,114209.92613860144,RELA
23463,KEGG_2019_Human,Shigellosis,1/65,0.003249949134407,0.010412369622399,0,0,19935.0,114209.92613860144,RELA
23464,KEGG_2019_Human,Acute myeloid leukemia,1/66,0.003299948626608,0.010412369622399,0,0,19934.0,113899.85357353876,RELA
23465,KEGG_2019_Human,Epithelial cell signaling in Helicobacter pylori infection,1/68,0.0033999476216189,0.010412369622399,0,0,19932.0,113293.39338050144,RELA
23466,KEGG_2019_Human,Adipocytokine signaling pathway,1/69,0.003449947123837,0.010412369622399,0,0,19931.0,112996.7391397682,RELA
23467,KEGG_2019_Human,Prolactin signaling pathway,1/70,0.0034999466296654,0.010412369622399,0,0,19930.0,112704.30065625212,RELA
23468,KEGG_2019_Human,RIG-I-like receptor signaling pathway,1/70,0.0034999466296654,0.010412369622399,0,0,19930.0,112704.30065625212,RELA
23469,KEGG_2019_Human,B cell receptor signaling pathway,1/71,0.0035499461386618,0.010412369622399,0,0,19929.0,112415.9585341616,RELA
23470,KEGG_2019_Human,Leishmaniasis,1/74,0.0036999446830449,0.010412369622399,0,0,19926.0,111574.38983110404,RELA
23471,KEGG_2019_Human,Pancreatic cancer,1/75,0.0037499442041125,0.010412369622399,0,0,19925.0,111301.33528642564,RELA
23472,KEGG_2019_Human,Chronic myeloid leukemia,1/76,0.0037999437281752,0.010412369622399,0,0,19924.0,111031.8499691117,RELA
23473,KEGG_2019_Human,Pertussis,1/76,0.0037999437281752,0.010412369622399,0,0,19924.0,111031.8499691117,RELA
23474,KEGG_2019_Human,Salmonella infection,1/86,0.0042999391173866,0.010412369622399,0,0,19914.0,108514.46102290176,RELA
23475,KEGG_2019_Human,Th1 and Th2 cell differentiation,1/92,0.0045999364719865,0.010412369622399,0,0,19908.0,107139.13814408927,RELA
23476,KEGG_2019_Human,IL-17 signaling pathway,1/93,0.0046499360391879,0.010412369622399,0,0,19907.0,106918.54242106884,RELA
23477,KEGG_2019_Human,Small cell lung cancer,1/93,0.0046499360391879,0.010412369622399,0,0,19907.0,106918.54242106884,RELA
23478,KEGG_2019_Human,NF-kappa B signaling pathway,1/95,0.0047499351803394,0.010412369622399,0,0,19905.0,106484.27183626965,RELA
23479,KEGG_2019_Human,Amoebiasis,1/96,0.0047999347538706,0.010412369622399,0,0,19904.0,106270.50039849174,RELA
23480,KEGG_2019_Human,Prostate cancer,1/97,0.0048499343304706,0.010412369622399,0,0,19903.0,106058.9096435903,RELA
23481,KEGG_2019_Human,AGE-RAGE signaling pathway in diabetic complications,1/100,0.0049999330710556,0.010412369622399,0,0,19900.0,105436.78197328727,RELA
23482,KEGG_2019_Human,HIF-1 signaling pathway,1/100,0.0049999330710556,0.010412369622399,0,0,19900.0,105436.78197328727,RELA
23483,KEGG_2019_Human,T cell receptor signaling pathway,1/101,0.0050499326546803,0.010412369622399,0,0,19899.0,105233.48101229242,RELA
23484,KEGG_2019_Human,Longevity regulating pathway,1/102,0.0050999322416682,0.010412369622399,0,0,19898.0,105032.15064717118,RELA
23485,KEGG_2019_Human,Chagas disease (American trypanosomiasis),1/103,0.0051499318302617,0.010412369622399,0,0,19897.0,104832.7525292024,RELA
23486,KEGG_2019_Human,Toll-like receptor signaling pathway,1/104,0.0051999314202997,0.010412369622399,0,0,19896.0,104635.24941415618,RELA
23487,KEGG_2019_Human,C-type lectin receptor signaling pathway,1/104,0.0051999314202997,0.010412369622399,0,0,19896.0,104635.24941415618,RELA
23488,KEGG_2019_Human,Th17 cell differentiation,1/107,0.0053499302026925,0.010412369622399,0,0,19893.0,104053.753408911,RELA
23489,KEGG_2019_Human,Insulin resistance,1/108,0.0053999298011749,0.010412369622399,0,0,19892.0,103863.47861844616,RELA
23490,KEGG_2019_Human,TNF signaling pathway,1/110,0.0054999290027479,0.010412369622399,0,0,19890.0,103488.06969787036,RELA
23491,KEGG_2019_Human,Toxoplasmosis,1/113,0.0056499278191151,0.010412369622399,0,0,19887.0,102937.34947211576,RELA
23492,KEGG_2019_Human,Sphingolipid signaling pathway,1/119,0.0059499254985137,0.010412369622399,0,0,19881.0,101877.73080211312,RELA
23493,KEGG_2019_Human,Neurotrophin signaling pathway,1/119,0.0059499254985137,0.010412369622399,0,0,19881.0,101877.73080211312,RELA
23494,KEGG_2019_Human,Osteoclast differentiation,1/127,0.0063499224962247,0.0107761854710769,0,0,19873.0,100543.72072014232,RELA
23495,KEGG_2019_Human,Relaxin signaling pathway,1/130,0.0064999213952527,0.0107761854710769,0,0,19870.0,100064.62842845908,RELA
23496,KEGG_2019_Human,Measles,1/138,0.0068999185254481,0.0109461211221852,0,0,19862.0,98838.19160389496,RELA
23497,KEGG_2019_Human,Fluid shear stress and atherosclerosis,1/139,0.006949918172816,0.0109461211221852,0,0,19861.0,98689.81333375497,RELA
23498,KEGG_2019_Human,Apoptosis,1/143,0.0071499167770442,0.0109864574866777,0,0,19857.0,98106.57763600958,RELA
23499,KEGG_2019_Human,Non-alcoholic fatty liver disease (NAFLD),1/149,0.0074499147221605,0.0111748720832408,0,0,19851.0,97261.02051561224,RELA
23500,KEGG_2019_Human,Hepatitis C,1/155,0.0077499127120574,0.0113545232758051,0,0,19845.0,96448.16254952336,RELA
23501,KEGG_2019_Human,Cellular senescence,1/160,0.0079999110688441,0.0114098741370135,0,0,19840.0,95793.96509856998,RELA
23502,KEGG_2019_Human,Hepatitis B,1/163,0.0081499100978668,0.0114098741370135,0,0,19837.0,95410.9786681514,RELA
23503,KEGG_2019_Human,Influenza A,1/171,0.0085499075557634,0.0117096560002847,0,0,19829.0,94422.42241345016,RELA
23504,KEGG_2019_Human,NOD-like receptor signaling pathway,1/178,0.0088999053857096,0.011717877736071,0,0,19822.0,93593.82745769851,RELA
23505,KEGG_2019_Human,Tuberculosis,1/179,0.0089499050800561,0.011717877736071,0,0,19821.0,93478.0629355712,RELA
23506,KEGG_2019_Human,Kaposi sarcoma-associated herpesvirus infection,1/186,0.0092999029651357,0.011717877736071,0,0,19814.0,92684.96451050608,RELA
23507,KEGG_2019_Human,Transcriptional misregulation in cancer,1/186,0.0092999029651357,0.011717877736071,0,0,19814.0,92684.96451050608,RELA
23508,KEGG_2019_Human,Chemokine signaling pathway,1/190,0.0094999017791995,0.01173517278607,0,0,19810.0,92244.74636351672,RELA
23509,KEGG_2019_Human,Viral carcinogenesis,1/201,0.0100498985877989,0.0119461058685157,0,0,19799.0,91079.21596609056,RELA
23510,KEGG_2019_Human,Epstein-Barr virus infection,1/201,0.0100498985877989,0.0119461058685157,0,0,19799.0,91079.21596609056,RELA
23511,KEGG_2019_Human,Human immunodeficiency virus 1 infection,1/212,0.0105998955026255,0.0121416984848256,0,0,19788.0,89974.27756224656,RELA
23512,KEGG_2019_Human,cAMP signaling pathway,1/212,0.0105998955026255,0.0121416984848256,0,0,19788.0,89974.27756224656,RELA
23513,KEGG_2019_Human,Human T-cell leukemia virus 1 infection,1/219,0.0109498935894162,0.0123186302880933,0,0,19781.0,89299.85161916987,RELA
23514,KEGG_2019_Human,Human cytomegalovirus infection,1/225,0.0112498919790339,0.0124340911347216,0,0,19775.0,88738.27077557483,RELA
23515,KEGG_2019_Human,Ras signaling pathway,1/232,0.0115998901349604,0.0125998806638363,0,0,19768.0,88101.22480150245,RELA
23516,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.015749866475932,0,0,19705.0,83086.53988020132,RELA
23517,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0173248608319127,0,0,19670.0,80733.60565076157,RELA
23518,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0182801860066576,0,0,19646.0,79255.8617626126,RELA
23519,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0249966105760702,0,0,19508.0,72277.44006442746,RELA
23520,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,RELA
23521,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR1L8
23522,KEGG_2019_Human,Thyroid hormone synthesis,1/74,0.0036999446830449,0.0036999446830449,0,0,19926.0,111574.38983110404,TTR
23523,KEGG_2019_Human,Chemokine signaling pathway,1/190,0.0094999017791995,0.0146998751759735,0,0,19810.0,92244.74636351672,CCL15
23524,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0146998751759735,0,0,19706.0,83157.67014793828,CCL15
23525,KEGG_2019_Human,Vasopressin-regulated water reabsorption,1/44,0.0021999607179423,0.0115367054817097,0,0,19956.0,122117.06559109331,CREB3
23526,KEGG_2019_Human,Cocaine addiction,1/49,0.0024499577795033,0.0115367054817097,0,0,19951.0,119939.1172087114,CREB3
23527,KEGG_2019_Human,Cortisol synthesis and secretion,1/65,0.003249949134407,0.0115367054817097,0,0,19935.0,114209.92613860144,CREB3
23528,KEGG_2019_Human,Amphetamine addiction,1/68,0.0033999476216189,0.0115367054817097,0,0,19932.0,113293.39338050144,CREB3
23529,KEGG_2019_Human,Thyroid hormone synthesis,1/74,0.0036999446830449,0.0115367054817097,0,0,19926.0,111574.38983110404,CREB3
23530,KEGG_2019_Human,Insulin secretion,1/86,0.0042999391173866,0.0115367054817097,0,0,19914.0,108514.46102290176,CREB3
23531,KEGG_2019_Human,Prostate cancer,1/97,0.0048499343304706,0.0115367054817097,0,0,19903.0,106058.9096435903,CREB3
23532,KEGG_2019_Human,Aldosterone synthesis and secretion,1/98,0.0048999339081079,0.0115367054817097,0,0,19902.0,105849.45495286948,CREB3
23533,KEGG_2019_Human,Melanogenesis,1/101,0.0050499326546803,0.0115367054817097,0,0,19899.0,105233.48101229242,CREB3
23534,KEGG_2019_Human,Longevity regulating pathway,1/102,0.0050999322416682,0.0115367054817097,0,0,19898.0,105032.15064717118,CREB3
23535,KEGG_2019_Human,Glucagon signaling pathway,1/103,0.0051499318302617,0.0115367054817097,0,0,19897.0,104832.7525292024,CREB3
23536,KEGG_2019_Human,"Parathyroid hormone synthesis, secretion and action",1/106,0.0052999306076525,0.0115367054817097,0,0,19894.0,104245.78450366124,CREB3
23537,KEGG_2019_Human,Insulin resistance,1/108,0.0053999298011749,0.0115367054817097,0,0,19892.0,103863.47861844616,CREB3
23538,KEGG_2019_Human,TNF signaling pathway,1/110,0.0054999290027479,0.0115367054817097,0,0,19890.0,103488.06969787036,CREB3
23539,KEGG_2019_Human,Cholinergic synapse,1/112,0.0055999282120529,0.0115367054817097,0,0,19888.0,103119.30984392198,CREB3
23540,KEGG_2019_Human,AMPK signaling pathway,1/120,0.0059999251180858,0.0115367054817097,0,0,19880.0,101706.2448082016,CREB3
23541,KEGG_2019_Human,Relaxin signaling pathway,1/130,0.0064999213952527,0.0115367054817097,0,0,19870.0,100064.62842845908,CREB3
23542,KEGG_2019_Human,Dopaminergic synapse,1/131,0.0065499210316603,0.0115367054817097,0,0,19869.0,99907.33811343512,CREB3
23543,KEGG_2019_Human,Estrogen signaling pathway,1/137,0.0068499188797651,0.0115367054817097,0,0,19863.0,98987.62735269018,CREB3
23544,KEGG_2019_Human,Adrenergic signaling in cardiomyocytes,1/145,0.0072499160871101,0.0115476996679976,0,0,19855.0,97820.92670675044,CREB3
23545,KEGG_2019_Human,Cushing syndrome,1/155,0.0077499127120574,0.0115476996679976,0,0,19845.0,96448.16254952336,CREB3
23546,KEGG_2019_Human,Hepatitis B,1/163,0.0081499100978668,0.0115476996679976,0,0,19837.0,95410.9786681514,CREB3
23547,KEGG_2019_Human,cGMP-PKG signaling pathway,1/166,0.0082999091363732,0.0115476996679976,0,0,19834.0,95034.82345515196,CREB3
23548,KEGG_2019_Human,Alcoholism,1/180,0.0089999047745351,0.0119998730327134,0,0,19820.0,93362.92821536642,CREB3
23549,KEGG_2019_Human,Huntington disease,1/193,0.0096499008972596,0.0123198830870033,0,0,19807.0,91920.47679471428,CREB3
23550,KEGG_2019_Human,Viral carcinogenesis,1/201,0.0100498985877989,0.0123198830870033,0,0,19799.0,91079.21596609056,CREB3
23551,KEGG_2019_Human,cAMP signaling pathway,1/212,0.0105998955026255,0.0123198830870033,0,0,19788.0,89974.27756224656,CREB3
23552,KEGG_2019_Human,Human T-cell leukemia virus 1 infection,1/219,0.0109498935894162,0.0123198830870033,0,0,19781.0,89299.85161916987,CREB3
23553,KEGG_2019_Human,Human cytomegalovirus infection,1/225,0.0112498919790339,0.0123198830870033,0,0,19775.0,88738.27077557483,CREB3
23554,KEGG_2019_Human,Thermogenesis,1/231,0.0115498903940656,0.0123198830870033,0,0,19769.0,88191.07730937863,CREB3
23555,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0170321212479633,0,0,19670.0,80733.60565076157,CREB3
23556,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0176998626413668,0,0,19646.0,79255.8617626126,CREB3
23557,KEGG_2019_Human,Mitophagy,1/65,0.003249949134407,0.0064998982688141,0,0,19935.0,114209.92613860144,PINK1
23558,KEGG_2019_Human,Parkinson disease,1/142,0.0070999171242726,0.0070999171242726,0,0,19858.0,98250.87390500787,PINK1
23559,KEGG_2019_Human,Thyroid cancer,1/37,0.0018499650702878,0.0112498780622854,0,0,19963.0,125618.9446446357,CCND1
23560,KEGG_2019_Human,Bladder cancer,1/41,0.0020499625466866,0.0112498780622854,0,0,19959.0,123544.88783416104,CCND1
23561,KEGG_2019_Human,Hedgehog signaling pathway,1/47,0.0023499589392381,0.0112498780622854,0,0,19953.0,120782.64067395544,CCND1
23562,KEGG_2019_Human,Endometrial cancer,1/58,0.0028999527887707,0.0112498780622854,0,0,19942.0,116522.31890946148,CCND1
23563,KEGG_2019_Human,Viral myocarditis,1/59,0.0029499522555206,0.0112498780622854,0,0,19941.0,116175.59385530632,CCND1
23564,KEGG_2019_Human,Acute myeloid leukemia,1/66,0.003299948626608,0.0112498780622854,0,0,19934.0,113899.85357353876,CCND1
23565,KEGG_2019_Human,Non-small cell lung cancer,1/66,0.003299948626608,0.0112498780622854,0,0,19934.0,113899.85357353876,CCND1
23566,KEGG_2019_Human,Prolactin signaling pathway,1/70,0.0034999466296654,0.0112498780622854,0,0,19930.0,112704.30065625212,CCND1
23567,KEGG_2019_Human,Melanoma,1/72,0.0035999456502131,0.0112498780622854,0,0,19928.0,112131.59838572376,CCND1
23568,KEGG_2019_Human,p53 signaling pathway,1/72,0.0035999456502131,0.0112498780622854,0,0,19928.0,112131.59838572376,CCND1
23569,KEGG_2019_Human,Pancreatic cancer,1/75,0.0037499442041125,0.0112498780622854,0,0,19925.0,111301.33528642564,CCND1
23570,KEGG_2019_Human,Glioma,1/75,0.0037499442041125,0.0112498780622854,0,0,19925.0,111301.33528642564,CCND1
23571,KEGG_2019_Human,Chronic myeloid leukemia,1/76,0.0037999437281752,0.0112498780622854,0,0,19924.0,111031.8499691117,CCND1
23572,KEGG_2019_Human,Colorectal cancer,1/86,0.0042999391173866,0.0112498780622854,0,0,19914.0,108514.46102290176,CCND1
23573,KEGG_2019_Human,Small cell lung cancer,1/93,0.0046499360391879,0.0112498780622854,0,0,19907.0,106918.54242106884,CCND1
23574,KEGG_2019_Human,Prostate cancer,1/97,0.0048499343304706,0.0112498780622854,0,0,19903.0,106058.9096435903,CCND1
23575,KEGG_2019_Human,AGE-RAGE signaling pathway in diabetic complications,1/100,0.0049999330710556,0.0112498780622854,0,0,19900.0,105436.78197328727,CCND1
23576,KEGG_2019_Human,Thyroid hormone signaling pathway,1/116,0.0057999266512085,0.0112498780622854,0,0,19884.0,102400.8105961506,CCND1
23577,KEGG_2019_Human,AMPK signaling pathway,1/120,0.0059999251180858,0.0112498780622854,0,0,19880.0,101706.2448082016,CCND1
23578,KEGG_2019_Human,Cell cycle,1/124,0.0061999236097501,0.0112498780622854,0,0,19876.0,101034.04709010696,CCND1
23579,KEGG_2019_Human,FoxO signaling pathway,1/132,0.0065999206698993,0.0112498780622854,0,0,19868.0,99751.22090491928,CCND1
23580,KEGG_2019_Human,Apelin signaling pathway,1/137,0.0068499188797651,0.0112498780622854,0,0,19863.0,98987.62735269018,CCND1
23581,KEGG_2019_Human,Measles,1/138,0.0068999185254481,0.0112498780622854,0,0,19862.0,98838.19160389496,CCND1
23582,KEGG_2019_Human,Breast cancer,1/147,0.0073499154017982,0.0112498780622854,0,0,19853.0,97539.10874372096,CCND1
23583,KEGG_2019_Human,Gastric cancer,1/149,0.0074499147221605,0.0112498780622854,0,0,19851.0,97261.02051561224,CCND1
23584,KEGG_2019_Human,Oxytocin signaling pathway,1/153,0.0076499133771537,0.0112498780622854,0,0,19847.0,96715.6407630817,CCND1
23585,KEGG_2019_Human,Cushing syndrome,1/155,0.0077499127120574,0.0112498780622854,0,0,19845.0,96448.16254952336,CCND1
23586,KEGG_2019_Human,Hepatitis C,1/155,0.0077499127120574,0.0112498780622854,0,0,19845.0,96448.16254952336,CCND1
23587,KEGG_2019_Human,Wnt signaling pathway,1/158,0.0078999117225733,0.0112498780622854,0,0,19842.0,96053.2110949472,CCND1
23588,KEGG_2019_Human,Cellular senescence,1/160,0.0079999110688441,0.0112498780622854,0,0,19840.0,95793.96509856998,CCND1
23589,KEGG_2019_Human,Hippo signaling pathway,1/160,0.0079999110688441,0.0112498780622854,0,0,19840.0,95793.96509856998,CCND1
23590,KEGG_2019_Human,JAK-STAT signaling pathway,1/162,0.0080999104202618,0.0112498780622854,0,0,19838.0,95537.86936302872,CCND1
23591,KEGG_2019_Human,Hepatocellular carcinoma,1/168,0.0083999085011095,0.0112498780622854,0,0,19832.0,94787.72752807094,CCND1
23592,KEGG_2019_Human,Tight junction,1/170,0.0084999078692823,0.0112498780622854,0,0,19830.0,94543.49009679438,CCND1
23593,KEGG_2019_Human,Kaposi sarcoma-associated herpesvirus infection,1/186,0.0092999029651357,0.0115960368320757,0,0,19814.0,92684.96451050608,CCND1
23594,KEGG_2019_Human,Focal adhesion,1/199,0.0099498991610159,0.0115960368320757,0,0,19801.0,91286.4288690606,CCND1
23595,KEGG_2019_Human,Epstein-Barr virus infection,1/201,0.0100498985877989,0.0115960368320757,0,0,19799.0,91079.21596609056,CCND1
23596,KEGG_2019_Human,Proteoglycans in cancer,1/201,0.0100498985877989,0.0115960368320757,0,0,19799.0,91079.21596609056,CCND1
23597,KEGG_2019_Human,Viral carcinogenesis,1/201,0.0100498985877989,0.0115960368320757,0,0,19799.0,91079.21596609056,CCND1
23598,KEGG_2019_Human,Human T-cell leukemia virus 1 infection,1/219,0.0109498935894162,0.0123186302880933,0,0,19781.0,89299.85161916987,CCND1
23599,KEGG_2019_Human,Human cytomegalovirus infection,1/225,0.0112498919790339,0.0123474424160128,0,0,19775.0,88738.27077557483,CCND1
23600,KEGG_2019_Human,MicroRNAs in cancer,1/299,0.0149498740670514,0.0160177222146979,0,0,19701.0,82804.33538735632,CCND1
23601,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0172673031547303,0,0,19670.0,80733.60565076157,CCND1
23602,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0181021322468524,0,0,19646.0,79255.8617626126,CCND1
23603,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,CCND1
23604,KEGG_2019_Human,Basal transcription factors,1/45,0.0022499601197094,0.0022499601197094,0,0,19955.0,121662.49782449217,GTF2F2
23605,KEGG_2019_Human,Estrogen signaling pathway,1/137,0.0068499188797651,0.0068499188797651,0,0,19863.0,98987.62735269018,FKBP4
23606,KEGG_2019_Human,Adherens junction,1/72,0.0035999456502131,0.0106998949514067,0,0,19928.0,112131.59838572376,ACTN1
23607,KEGG_2019_Human,Amoebiasis,1/96,0.0047999347538706,0.0106998949514067,0,0,19904.0,106270.50039849174,ACTN1
23608,KEGG_2019_Human,Leukocyte transendothelial migration,1/112,0.0055999282120529,0.0106998949514067,0,0,19888.0,103119.30984392198,ACTN1
23609,KEGG_2019_Human,Systemic lupus erythematosus,1/133,0.0066499203093911,0.0106998949514067,0,0,19867.0,99596.2591544721,ACTN1
23610,KEGG_2019_Human,Tight junction,1/170,0.0084999078692823,0.0106998949514067,0,0,19830.0,94543.49009679438,ACTN1
23611,KEGG_2019_Human,Focal adhesion,1/199,0.0099498991610159,0.0106998949514067,0,0,19801.0,91286.4288690606,ACTN1
23612,KEGG_2019_Human,Viral carcinogenesis,1/201,0.0100498985877989,0.0106998949514067,0,0,19799.0,91079.21596609056,ACTN1
23613,KEGG_2019_Human,Regulation of actin cytoskeleton,1/214,0.0106998949514067,0.0106998949514067,0,0,19786.0,89779.39753374986,ACTN1
23614,KEGG_2019_Human,Ubiquitin mediated proteolysis,1/137,0.0068499188797651,0.0068499188797651,0,0,19863.0,98987.62735269018,UBE2B
23615,KEGG_2019_Human,Cell adhesion molecules (CAMs),1/145,0.0072499160871101,0.0072499160871101,0,0,19855.0,97820.92670675044,MPZL1
23616,KEGG_2019_Human,Oxidative phosphorylation,1/133,0.0066499203093911,0.0112582177134695,0,0,19867.0,99596.2591544721,NDUFB1
23617,KEGG_2019_Human,Parkinson disease,1/142,0.0070999171242726,0.0112582177134695,0,0,19858.0,98250.87390500787,NDUFB1
23618,KEGG_2019_Human,Retrograde endocannabinoid signaling,1/148,0.007399915061391,0.0112582177134695,0,0,19852.0,97399.60470052566,NDUFB1
23619,KEGG_2019_Human,Non-alcoholic fatty liver disease (NAFLD),1/149,0.0074499147221605,0.0112582177134695,0,0,19851.0,97261.02051561224,NDUFB1
23620,KEGG_2019_Human,Alzheimer disease,1/171,0.0085499075557634,0.0112582177134695,0,0,19829.0,94422.42241345016,NDUFB1
23621,KEGG_2019_Human,Huntington disease,1/193,0.0096499008972596,0.0112582177134695,0,0,19807.0,91920.47679471428,NDUFB1
23622,KEGG_2019_Human,Thermogenesis,1/231,0.0115498903940656,0.0115498903940656,0,0,19769.0,88191.07730937863,NDUFB1
23623,KEGG_2019_Human,Tight junction,1/170,0.0084999078692823,0.0164998674589645,0,0,19830.0,94543.49009679438,CRB3
23624,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0164998674589645,0,0,19670.0,80733.60565076157,CRB3
23625,KEGG_2019_Human,mRNA surveillance pathway,1/91,0.0045499369072032,0.0082499094553477,0,0,19909.0,107362.10783923086,MAGOHB
23626,KEGG_2019_Human,Spliceosome,1/134,0.0066999199497742,0.0082499094553477,0,0,19866.0,99442.43560916925,MAGOHB
23627,KEGG_2019_Human,RNA transport,1/165,0.0082499094553477,0.0082499094553477,0,0,19835.0,95159.46482222488,MAGOHB
23628,KEGG_2019_Human,Pyrimidine metabolism,1/57,0.002849953326298,0.002849953326298,0,0,19943.0,116875.00742975442,DHODH
23629,KEGG_2019_Human,Thyroid cancer,1/37,0.0018499650702878,0.0075998874563505,0,0,19963.0,125618.9446446357,DDB2
23630,KEGG_2019_Human,Nucleotide excision repair,1/47,0.0023499589392381,0.0075998874563505,0,0,19953.0,120782.64067395544,DDB2
23631,KEGG_2019_Human,Endometrial cancer,1/58,0.0028999527887707,0.0075998874563505,0,0,19942.0,116522.31890946148,DDB2
23632,KEGG_2019_Human,Basal cell carcinoma,1/63,0.0031499501598827,0.0075998874563505,0,0,19937.0,114844.46974572667,DDB2
23633,KEGG_2019_Human,Non-small cell lung cancer,1/66,0.003299948626608,0.0075998874563505,0,0,19934.0,113899.85357353876,DDB2
23634,KEGG_2019_Human,p53 signaling pathway,1/72,0.0035999456502131,0.0075998874563505,0,0,19928.0,112131.59838572376,DDB2
23635,KEGG_2019_Human,Melanoma,1/72,0.0035999456502131,0.0075998874563505,0,0,19928.0,112131.59838572376,DDB2
23636,KEGG_2019_Human,Pancreatic cancer,1/75,0.0037499442041125,0.0075998874563505,0,0,19925.0,111301.33528642564,DDB2
23637,KEGG_2019_Human,Glioma,1/75,0.0037499442041125,0.0075998874563505,0,0,19925.0,111301.33528642564,DDB2
23638,KEGG_2019_Human,Chronic myeloid leukemia,1/76,0.0037999437281752,0.0075998874563505,0,0,19924.0,111031.8499691117,DDB2
23639,KEGG_2019_Human,Colorectal cancer,1/86,0.0042999391173866,0.0077498933986465,0,0,19914.0,108514.46102290176,DDB2
23640,KEGG_2019_Human,Small cell lung cancer,1/93,0.0046499360391879,0.0077498933986465,0,0,19907.0,106918.54242106884,DDB2
23641,KEGG_2019_Human,Ubiquitin mediated proteolysis,1/137,0.0068499188797651,0.0098822452954229,0,0,19863.0,98987.62735269018,DDB2
23642,KEGG_2019_Human,Breast cancer,1/147,0.0073499154017982,0.0098822452954229,0,0,19853.0,97539.10874372096,DDB2
23643,KEGG_2019_Human,Gastric cancer,1/149,0.0074499147221605,0.0098822452954229,0,0,19851.0,97261.02051561224,DDB2
23644,KEGG_2019_Human,Hepatitis B,1/163,0.0081499100978668,0.0098822452954229,0,0,19837.0,95410.9786681514,DDB2
23645,KEGG_2019_Human,Hepatocellular carcinoma,1/168,0.0083999085011095,0.0098822452954229,0,0,19832.0,94787.72752807094,DDB2
23646,KEGG_2019_Human,Transcriptional misregulation in cancer,1/186,0.0092999029651357,0.0103332255168175,0,0,19814.0,92684.96451050608,DDB2
23647,KEGG_2019_Human,Epstein-Barr virus infection,1/201,0.0100498985877989,0.0105788406187357,0,0,19799.0,91079.21596609056,DDB2
23648,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,DDB2
23649,KEGG_2019_Human,Asthma,1/31,0.0015499690656704,0.0083141731379497,0,0,19969.0,129189.85098816035,HLA-DMA
23650,KEGG_2019_Human,Allograft rejection,1/38,0.001899964429635,0.0083141731379497,0,0,19962.0,125080.29732025368,HLA-DMA
23651,KEGG_2019_Human,Graft-versus-host disease,1/41,0.0020499625466866,0.0083141731379497,0,0,19959.0,123544.88783416104,HLA-DMA
23652,KEGG_2019_Human,Type I diabetes mellitus,1/43,0.0021499613216957,0.0083141731379497,0,0,19957.0,122581.98940490963,HLA-DMA
23653,KEGG_2019_Human,Intestinal immune network for IgA production,1/48,0.0023999583567988,0.0083141731379497,0,0,19952.0,120356.5272753826,HLA-DMA
23654,KEGG_2019_Human,Autoimmune thyroid disease,1/53,0.0026499555173137,0.0083141731379497,0,0,19947.0,118349.78824235698,HLA-DMA
23655,KEGG_2019_Human,Viral myocarditis,1/59,0.0029499522555206,0.0083141731379497,0,0,19941.0,116175.59385530632,HLA-DMA
23656,KEGG_2019_Human,Inflammatory bowel disease (IBD),1/65,0.003249949134407,0.0083141731379497,0,0,19935.0,114209.92613860144,HLA-DMA
23657,KEGG_2019_Human,Staphylococcus aureus infection,1/68,0.0033999476216189,0.0083141731379497,0,0,19932.0,113293.39338050144,HLA-DMA
23658,KEGG_2019_Human,Leishmaniasis,1/74,0.0036999446830449,0.0083141731379497,0,0,19926.0,111574.38983110404,HLA-DMA
23659,KEGG_2019_Human,Antigen processing and presentation,1/77,0.0038499432547502,0.0083141731379497,0,0,19923.0,110765.8407373636,HLA-DMA
23660,KEGG_2019_Human,Rheumatoid arthritis,1/91,0.0045499369072032,0.0083141731379497,0,0,19909.0,107362.10783923086,HLA-DMA
23661,KEGG_2019_Human,Th1 and Th2 cell differentiation,1/92,0.0045999364719865,0.0083141731379497,0,0,19908.0,107139.13814408927,HLA-DMA
23662,KEGG_2019_Human,Hematopoietic cell lineage,1/97,0.0048499343304706,0.0083141731379497,0,0,19903.0,106058.9096435903,HLA-DMA
23663,KEGG_2019_Human,Th17 cell differentiation,1/107,0.0053499302026925,0.0084748917286727,0,0,19893.0,104053.753408911,HLA-DMA
23664,KEGG_2019_Human,Toxoplasmosis,1/113,0.0056499278191151,0.0084748917286727,0,0,19887.0,102937.34947211576,HLA-DMA
23665,KEGG_2019_Human,Systemic lupus erythematosus,1/133,0.0066499203093911,0.0093881227897286,0,0,19867.0,99596.2591544721,HLA-DMA
23666,KEGG_2019_Human,Cell adhesion molecules (CAMs),1/145,0.0072499160871101,0.0095998910039963,0,0,19855.0,97820.92670675044,HLA-DMA
23667,KEGG_2019_Human,Phagosome,1/152,0.0075999137114971,0.0095998910039963,0,0,19848.0,96850.665715497,HLA-DMA
23668,KEGG_2019_Human,Influenza A,1/171,0.0085499075557634,0.0102284629486356,0,0,19829.0,94422.42241345016,HLA-DMA
23669,KEGG_2019_Human,Tuberculosis,1/179,0.0089499050800561,0.0102284629486356,0,0,19821.0,93478.0629355712,HLA-DMA
23670,KEGG_2019_Human,Epstein-Barr virus infection,1/201,0.0100498985877989,0.0109635257321443,0,0,19799.0,91079.21596609056,HLA-DMA
23671,KEGG_2019_Human,Human T-cell leukemia virus 1 infection,1/219,0.0109498935894162,0.0114259759193908,0,0,19781.0,89299.85161916987,HLA-DMA
23672,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,HLA-DMA
23673,KEGG_2019_Human,Sphingolipid metabolism,1/47,0.0023499589392381,0.0046999178784763,0,0,19953.0,120782.64067395544,ACER2
23674,KEGG_2019_Human,Sphingolipid signaling pathway,1/119,0.0059499254985137,0.0059499254985137,0,0,19881.0,101877.73080211312,ACER2
23675,KEGG_2019_Human,Vasopressin-regulated water reabsorption,1/44,0.0021999607179423,0.0021999607179423,0,0,19956.0,122117.06559109331,DYNLL1
23676,KEGG_2019_Human,Synaptic vesicle cycle,1/78,0.0038999427840466,0.005699927427839,0,0,19922.0,110503.2180492851,SLC1A6
23677,KEGG_2019_Human,Glutamatergic synapse,1/114,0.005699927427839,0.005699927427839,0,0,19886.0,102756.96431429044,SLC1A6
23678,KEGG_2019_Human,RNA polymerase,1/31,0.0015499690656704,0.0030999381313408,0,0,19969.0,129189.85098816035,POLR3H
23679,KEGG_2019_Human,Cytosolic DNA-sensing pathway,1/63,0.0031499501598827,0.0031499501598827,0,0,19937.0,114844.46974572667,POLR3H
23680,KEGG_2019_Human,Cysteine and methionine metabolism,1/47,0.0023499589392381,0.0023499589392381,0,0,19953.0,120782.64067395544,MAT2A
23681,KEGG_2019_Human,Shigellosis,1/65,0.003249949134407,0.0036999446830449,0,0,19935.0,114209.92613860144,ELMO3
23682,KEGG_2019_Human,Bacterial invasion of epithelial cells,1/74,0.0036999446830449,0.0036999446830449,0,0,19926.0,111574.38983110404,ELMO3
23683,KEGG_2019_Human,Ribosome,1/153,0.0076499133771537,0.0076499133771537,0,0,19847.0,96715.6407630817,RPL37A
23684,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR52B6
23685,KEGG_2019_Human,Gastric cancer,1/149,0.0074499147221605,0.0074499147221605,0,0,19851.0,97261.02051561224,CDX2
23686,KEGG_2019_Human,RNA transport,1/165,0.0082499094553477,0.0082499094553477,0,0,19835.0,95159.46482222488,SNUPN
23687,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF547
23688,KEGG_2019_Human,Systemic lupus erythematosus,1/133,0.0066499203093911,0.0066999199497742,0,0,19867.0,99596.2591544721,SNRPD1
23689,KEGG_2019_Human,Spliceosome,1/134,0.0066999199497742,0.0066999199497742,0,0,19866.0,99442.43560916925,SNRPD1
23690,KEGG_2019_Human,Pyruvate metabolism,1/39,0.0019499637955508,0.0019499637955508,0,0,19961.0,124555.53162481484,ACOT12
23691,KEGG_2019_Human,Adherens junction,1/72,0.0035999456502131,0.0049499334884068,0,0,19928.0,112131.59838572376,WASF3
23692,KEGG_2019_Human,Fc gamma R-mediated phagocytosis,1/91,0.0045499369072032,0.0049499334884068,0,0,19909.0,107362.10783923086,WASF3
23693,KEGG_2019_Human,Choline metabolism in cancer,1/99,0.0049499334884068,0.0049499334884068,0,0,19901.0,105642.09305076736,WASF3
23694,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF777
23695,KEGG_2019_Human,Phosphonate and phosphinate metabolism,1/6,0.0002999905873105514,0.0008999717619316542,0,0,19994.0,162186.51863187927,CEPT1
23696,KEGG_2019_Human,Ether lipid metabolism,1/47,0.0023499589392381,0.0035249384088572,0,0,19953.0,120782.64067395544,CEPT1
23697,KEGG_2019_Human,Glycerophospholipid metabolism,1/97,0.0048499343304706,0.0048499343304706,0,0,19903.0,106058.9096435903,CEPT1
23698,KEGG_2019_Human,Apoptosis,1/143,0.0071499167770442,0.0161998208405236,0,0,19857.0,98106.57763600958,MCL1
23699,KEGG_2019_Human,JAK-STAT signaling pathway,1/162,0.0080999104202618,0.0161998208405236,0,0,19838.0,95537.86936302872,MCL1
23700,KEGG_2019_Human,MicroRNAs in cancer,1/299,0.0149498740670514,0.0176998626413668,0,0,19701.0,82804.33538735632,MCL1
23701,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0176998626413668,0,0,19646.0,79255.8617626126,MCL1
23702,KEGG_2019_Human,Calcium signaling pathway,1/188,0.009399902370135,0.0168998658265596,0,0,19812.0,92463.712994847,CYSLTR1
23703,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,CYSLTR1
23704,KEGG_2019_Human,Arginine biosynthesis,1/21,0.0010499764455398,0.0010499764455398,0,0,19979.0,137035.71221916509,NAGS
23705,KEGG_2019_Human,Maturity onset diabetes of the young,1/26,0.0012999726251831,0.0012999726251831,0,0,19974.0,132735.46073187632,HNF1B
23706,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR4D1
23707,KEGG_2019_Human,Sulfur relay system,1/8,0.0003999883241497325,0.000799976648299465,0,0,19992.0,156418.91141655247,MOCS2
23708,KEGG_2019_Human,Folate biosynthesis,1/26,0.0012999726251831,0.0012999726251831,0,0,19974.0,132735.46073187632,MOCS2
23709,KEGG_2019_Human,Prion diseases,1/35,0.0017499663721595,0.0118771528764897,0,0,19965.0,126740.98858805298,BAX
23710,KEGG_2019_Human,Thyroid cancer,1/37,0.0018499650702878,0.0118771528764897,0,0,19963.0,125618.9446446357,BAX
23711,KEGG_2019_Human,Amyotrophic lateral sclerosis (ALS),1/51,0.0025499566390179,0.0118771528764897,0,0,19949.0,119129.0228601236,BAX
23712,KEGG_2019_Human,Endometrial cancer,1/58,0.0028999527887707,0.0118771528764897,0,0,19942.0,116522.31890946148,BAX
23713,KEGG_2019_Human,Basal cell carcinoma,1/63,0.0031499501598827,0.0118771528764897,0,0,19937.0,114844.46974572667,BAX
23714,KEGG_2019_Human,Non-small cell lung cancer,1/66,0.003299948626608,0.0118771528764897,0,0,19934.0,113899.85357353876,BAX
23715,KEGG_2019_Human,Melanoma,1/72,0.0035999456502131,0.0118771528764897,0,0,19928.0,112131.59838572376,BAX
23716,KEGG_2019_Human,p53 signaling pathway,1/72,0.0035999456502131,0.0118771528764897,0,0,19928.0,112131.59838572376,BAX
23717,KEGG_2019_Human,Pancreatic cancer,1/75,0.0037499442041125,0.0118771528764897,0,0,19925.0,111301.33528642564,BAX
23718,KEGG_2019_Human,Glioma,1/75,0.0037499442041125,0.0118771528764897,0,0,19925.0,111301.33528642564,BAX
23719,KEGG_2019_Human,Chronic myeloid leukemia,1/76,0.0037999437281752,0.0118771528764897,0,0,19924.0,111031.8499691117,BAX
23720,KEGG_2019_Human,Colorectal cancer,1/86,0.0042999391173866,0.0118771528764897,0,0,19914.0,108514.46102290176,BAX
23721,KEGG_2019_Human,Small cell lung cancer,1/93,0.0046499360391879,0.0118771528764897,0,0,19907.0,106918.54242106884,BAX
23722,KEGG_2019_Human,AGE-RAGE signaling pathway in diabetic complications,1/100,0.0049999330710556,0.0118771528764897,0,0,19900.0,105436.78197328727,BAX
23723,KEGG_2019_Human,Longevity regulating pathway,1/102,0.0050999322416682,0.0118771528764897,0,0,19898.0,105032.15064717118,BAX
23724,KEGG_2019_Human,Sphingolipid signaling pathway,1/119,0.0059499254985137,0.0118771528764897,0,0,19881.0,101877.73080211312,BAX
23725,KEGG_2019_Human,Neurotrophin signaling pathway,1/119,0.0059499254985137,0.0118771528764897,0,0,19881.0,101877.73080211312,BAX
23726,KEGG_2019_Human,Measles,1/138,0.0068999185254481,0.0118771528764897,0,0,19862.0,98838.19160389496,BAX
23727,KEGG_2019_Human,Apoptosis,1/143,0.0071499167770442,0.0118771528764897,0,0,19857.0,98106.57763600958,BAX
23728,KEGG_2019_Human,Breast cancer,1/147,0.0073499154017982,0.0118771528764897,0,0,19853.0,97539.10874372096,BAX
23729,KEGG_2019_Human,Gastric cancer,1/149,0.0074499147221605,0.0118771528764897,0,0,19851.0,97261.02051561224,BAX
23730,KEGG_2019_Human,Non-alcoholic fatty liver disease (NAFLD),1/149,0.0074499147221605,0.0118771528764897,0,0,19851.0,97261.02051561224,BAX
23731,KEGG_2019_Human,Hepatitis C,1/155,0.0077499127120574,0.0118771528764897,0,0,19845.0,96448.16254952336,BAX
23732,KEGG_2019_Human,Necroptosis,1/162,0.0080999104202618,0.0118771528764897,0,0,19838.0,95537.86936302872,BAX
23733,KEGG_2019_Human,Hepatitis B,1/163,0.0081499100978668,0.0118771528764897,0,0,19837.0,95410.9786681514,BAX
23734,KEGG_2019_Human,Protein processing in endoplasmic reticulum,1/165,0.0082499094553477,0.0118771528764897,0,0,19835.0,95159.46482222488,BAX
23735,KEGG_2019_Human,Hepatocellular carcinoma,1/168,0.0083999085011095,0.0118771528764897,0,0,19832.0,94787.72752807094,BAX
23736,KEGG_2019_Human,Tuberculosis,1/179,0.0089499050800561,0.0118771528764897,0,0,19821.0,93478.0629355712,BAX
23737,KEGG_2019_Human,Kaposi sarcoma-associated herpesvirus infection,1/186,0.0092999029651357,0.0118771528764897,0,0,19814.0,92684.96451050608,BAX
23738,KEGG_2019_Human,Transcriptional misregulation in cancer,1/186,0.0092999029651357,0.0118771528764897,0,0,19814.0,92684.96451050608,BAX
23739,KEGG_2019_Human,Huntington disease,1/193,0.0096499008972596,0.0118771528764897,0,0,19807.0,91920.47679471428,BAX
23740,KEGG_2019_Human,Epstein-Barr virus infection,1/201,0.0100498985877989,0.0118771528764897,0,0,19799.0,91079.21596609056,BAX
23741,KEGG_2019_Human,Viral carcinogenesis,1/201,0.0100498985877989,0.0118771528764897,0,0,19799.0,91079.21596609056,BAX
23742,KEGG_2019_Human,Human immunodeficiency virus 1 infection,1/212,0.0105998955026255,0.0121587036647764,0,0,19788.0,89974.27756224656,BAX
23743,KEGG_2019_Human,Human T-cell leukemia virus 1 infection,1/219,0.0109498935894162,0.0121873829772867,0,0,19781.0,89299.85161916987,BAX
23744,KEGG_2019_Human,Human cytomegalovirus infection,1/225,0.0112498919790339,0.0121873829772867,0,0,19775.0,88738.27077557483,BAX
23745,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0173917521864761,0,0,19670.0,80733.60565076157,BAX
23746,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.025247203163299,0,0,19508.0,72277.44006442746,BAX
23747,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,BAX
23748,KEGG_2019_Human,Hepatocellular carcinoma,1/168,0.0083999085011095,0.0212398351696402,0,0,19832.0,94787.72752807094,IGF2
23749,KEGG_2019_Human,Proteoglycans in cancer,1/201,0.0100498985877989,0.0212398351696402,0,0,19799.0,91079.21596609056,IGF2
23750,KEGG_2019_Human,Ras signaling pathway,1/232,0.0115998901349604,0.0212398351696402,0,0,19768.0,88101.22480150245,IGF2
23751,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0212398351696402,0,0,19705.0,83086.53988020132,IGF2
23752,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0212398351696402,0,0,19646.0,79255.8617626126,IGF2
23753,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,IGF2
23754,KEGG_2019_Human,Endocytosis,1/244,0.0121998870519305,0.0121998870519305,0,0,19756.0,87051.4275316661,VPS29
23755,KEGG_2019_Human,Prolactin signaling pathway,1/70,0.0034999466296654,0.0108883369016192,0,0,19930.0,112704.30065625212,SHC1
23756,KEGG_2019_Human,Bacterial invasion of epithelial cells,1/74,0.0036999446830449,0.0108883369016192,0,0,19926.0,111574.38983110404,SHC1
23757,KEGG_2019_Human,Glioma,1/75,0.0037499442041125,0.0108883369016192,0,0,19925.0,111301.33528642564,SHC1
23758,KEGG_2019_Human,Chronic myeloid leukemia,1/76,0.0037999437281752,0.0108883369016192,0,0,19924.0,111031.8499691117,SHC1
23759,KEGG_2019_Human,ErbB signaling pathway,1/85,0.004249939567045,0.0108883369016192,0,0,19915.0,108752.83801948265,SHC1
23760,KEGG_2019_Human,Neurotrophin signaling pathway,1/119,0.0059499254985137,0.0108883369016192,0,0,19881.0,101877.73080211312,SHC1
23761,KEGG_2019_Human,Relaxin signaling pathway,1/130,0.0064999213952527,0.0108883369016192,0,0,19870.0,100064.62842845908,SHC1
23762,KEGG_2019_Human,Natural killer cell mediated cytotoxicity,1/131,0.0065499210316603,0.0108883369016192,0,0,19869.0,99907.33811343512,SHC1
23763,KEGG_2019_Human,Insulin signaling pathway,1/137,0.0068499188797651,0.0108883369016192,0,0,19863.0,98987.62735269018,SHC1
23764,KEGG_2019_Human,Estrogen signaling pathway,1/137,0.0068499188797651,0.0108883369016192,0,0,19863.0,98987.62735269018,SHC1
23765,KEGG_2019_Human,Breast cancer,1/147,0.0073499154017982,0.0108883369016192,0,0,19853.0,97539.10874372096,SHC1
23766,KEGG_2019_Human,Phospholipase D signaling pathway,1/148,0.007399915061391,0.0108883369016192,0,0,19852.0,97399.60470052566,SHC1
23767,KEGG_2019_Human,Gastric cancer,1/149,0.0074499147221605,0.0108883369016192,0,0,19851.0,97261.02051561224,SHC1
23768,KEGG_2019_Human,Hepatocellular carcinoma,1/168,0.0083999085011095,0.0111204755329001,0,0,19832.0,94787.72752807094,SHC1
23769,KEGG_2019_Human,Alcoholism,1/180,0.0089999047745351,0.0111204755329001,0,0,19820.0,93362.92821536642,SHC1
23770,KEGG_2019_Human,Chemokine signaling pathway,1/190,0.0094999017791995,0.0111204755329001,0,0,19810.0,92244.74636351672,SHC1
23771,KEGG_2019_Human,Focal adhesion,1/199,0.0099498991610159,0.0111204755329001,0,0,19801.0,91286.4288690606,SHC1
23772,KEGG_2019_Human,Ras signaling pathway,1/232,0.0115998901349604,0.0122443284757915,0,0,19768.0,88101.22480150245,SHC1
23773,KEGG_2019_Human,MicroRNAs in cancer,1/299,0.0149498740670514,0.0149498740670514,0,0,19701.0,82804.33538735632,SHC1
23774,KEGG_2019_Human,Collecting duct acid secretion,1/27,0.0013499718942362,0.0081898864329657,0,0,19973.0,131975.02298599784,ATP6V1D
23775,KEGG_2019_Human,Vibrio cholerae infection,1/50,0.0024999572069037,0.0081898864329657,0,0,19950.0,119530.05920663515,ATP6V1D
23776,KEGG_2019_Human,Epithelial cell signaling in Helicobacter pylori infection,1/68,0.0033999476216189,0.0081898864329657,0,0,19932.0,113293.39338050144,ATP6V1D
23777,KEGG_2019_Human,Synaptic vesicle cycle,1/78,0.0038999427840466,0.0081898864329657,0,0,19922.0,110503.2180492851,ATP6V1D
23778,KEGG_2019_Human,Rheumatoid arthritis,1/91,0.0045499369072032,0.0081898864329657,0,0,19909.0,107362.10783923086,ATP6V1D
23779,KEGG_2019_Human,Oxidative phosphorylation,1/133,0.0066499203093911,0.0085499029254342,0,0,19867.0,99596.2591544721,ATP6V1D
23780,KEGG_2019_Human,mTOR signaling pathway,1/152,0.0075999137114971,0.0085499029254342,0,0,19848.0,96850.665715497,ATP6V1D
23781,KEGG_2019_Human,Phagosome,1/152,0.0075999137114971,0.0085499029254342,0,0,19848.0,96850.665715497,ATP6V1D
23782,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0164998674589645,0,0,19670.0,80733.60565076157,ATP6V1D
23783,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF433
23784,KEGG_2019_Human,Adrenergic signaling in cardiomyocytes,1/145,0.0072499160871101,0.0072499160871101,0,0,19855.0,97820.92670675044,SCN1B
23785,KEGG_2019_Human,N-Glycan biosynthesis,1/50,0.0024999572069037,0.0024999572069037,0,0,19950.0,119530.05920663515,DPAGT1
23786,KEGG_2019_Human,Spliceosome,1/134,0.0066999199497742,0.0066999199497742,0,0,19866.0,99442.43560916925,SF3B4
23787,KEGG_2019_Human,Pathogenic Escherichia coli infection,1/55,0.0027499544131125,0.0063699116700844,0,0,19945.0,117599.1294878737,ARPC3
23788,KEGG_2019_Human,Shigellosis,1/65,0.003249949134407,0.0063699116700844,0,0,19935.0,114209.92613860144,ARPC3
23789,KEGG_2019_Human,Bacterial invasion of epithelial cells,1/74,0.0036999446830449,0.0063699116700844,0,0,19926.0,111574.38983110404,ARPC3
23790,KEGG_2019_Human,Salmonella infection,1/86,0.0042999391173866,0.0063699116700844,0,0,19914.0,108514.46102290176,ARPC3
23791,KEGG_2019_Human,Fc gamma R-mediated phagocytosis,1/91,0.0045499369072032,0.0063699116700844,0,0,19909.0,107362.10783923086,ARPC3
23792,KEGG_2019_Human,Regulation of actin cytoskeleton,1/214,0.0106998949514067,0.0121998870519305,0,0,19786.0,89779.39753374986,ARPC3
23793,KEGG_2019_Human,Endocytosis,1/244,0.0121998870519305,0.0121998870519305,0,0,19756.0,87051.4275316661,ARPC3
23794,KEGG_2019_Human,Proteoglycans in cancer,1/201,0.0100498985877989,0.0149498740670514,0,0,19799.0,91079.21596609056,TIMP3
23795,KEGG_2019_Human,MicroRNAs in cancer,1/299,0.0149498740670514,0.0149498740670514,0,0,19701.0,82804.33538735632,TIMP3
23796,KEGG_2019_Human,Ribosome biogenesis in eukaryotes,1/101,0.0050499326546803,0.0050499326546803,0,0,19899.0,105233.48101229242,EMG1
23797,KEGG_2019_Human,Ascorbate and aldarate metabolism,1/27,0.0013499718942362,0.004685646776936,0,0,19973.0,131975.02298599784,UGT1A8
23798,KEGG_2019_Human,Pentose and glucuronate interconversions,1/34,0.0016999670339032,0.004685646776936,0,0,19966.0,127326.1054203148,UGT1A8
23799,KEGG_2019_Human,Porphyrin and chlorophyll metabolism,1/42,0.0020999619311272,0.004685646776936,0,0,19958.0,123057.75613441122,UGT1A8
23800,KEGG_2019_Human,Steroid hormone biosynthesis,1/60,0.002999951725986,0.004685646776936,0,0,19940.0,115834.63209072244,UGT1A8
23801,KEGG_2019_Human,Retinol metabolism,1/67,0.0033499481224912,0.004685646776936,0,0,19933.0,113594.38808369274,UGT1A8
23802,KEGG_2019_Human,Metabolism of xenobiotics by cytochrome P450,1/74,0.0036999446830449,0.004685646776936,0,0,19926.0,111574.38983110404,UGT1A8
23803,KEGG_2019_Human,Chemical carcinogenesis,1/82,0.004099940929819,0.004685646776936,0,0,19918.0,109484.9180722932,UGT1A8
23804,KEGG_2019_Human,Drug metabolism,1/108,0.0053999298011749,0.0053999298011749,0,0,19892.0,103863.47861844616,UGT1A8
23805,KEGG_2019_Human,Pathogenic Escherichia coli infection,1/55,0.0027499544131125,0.0065999073394233,0,0,19945.0,117599.1294878737,TUBB4A
23806,KEGG_2019_Human,Gap junction,1/88,0.0043999382262822,0.0065999073394233,0,0,19912.0,108045.79305232369,TUBB4A
23807,KEGG_2019_Human,Phagosome,1/152,0.0075999137114971,0.0075999137114971,0,0,19848.0,96850.665715497,TUBB4A
23808,KEGG_2019_Human,Steroid biosynthesis,1/19,0.00094997806231055,0.00094997806231055,0,0,19981.0,139049.2109571672,CYP51A1
23809,KEGG_2019_Human,Cytosolic DNA-sensing pathway,1/63,0.0031499501598827,0.0125998006395311,0,0,19937.0,114844.46974572667,CGAS
23810,KEGG_2019_Human,Human immunodeficiency virus 1 infection,1/212,0.0105998955026255,0.0149998559720452,0,0,19788.0,89974.27756224656,CGAS
23811,KEGG_2019_Human,Human cytomegalovirus infection,1/225,0.0112498919790339,0.0149998559720452,0,0,19775.0,88738.27077557483,CGAS
23812,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,CGAS
23813,KEGG_2019_Human,Renin secretion,1/69,0.003449947123837,0.008579900132453,0,0,19931.0,112996.7391397682,CTSB
23814,KEGG_2019_Human,Antigen processing and presentation,1/77,0.0038499432547502,0.008579900132453,0,0,19923.0,110765.8407373636,CTSB
23815,KEGG_2019_Human,Lysosome,1/123,0.0061499239842961,0.008579900132453,0,0,19877.0,101200.07933676826,CTSB
23816,KEGG_2019_Human,Autophagy,1/128,0.0063999221281459,0.008579900132453,0,0,19872.0,100382.8010329652,CTSB
23817,KEGG_2019_Human,Apoptosis,1/143,0.0071499167770442,0.008579900132453,0,0,19857.0,98106.57763600958,CTSB
23818,KEGG_2019_Human,NOD-like receptor signaling pathway,1/178,0.0088999053857096,0.0088999053857096,0,0,19822.0,93593.82745769851,CTSB
23819,KEGG_2019_Human,MicroRNAs in cancer,1/299,0.0149498740670514,0.0149498740670514,0,0,19701.0,82804.33538735632,MIRLET7A3
23820,KEGG_2019_Human,Lysosome,1/123,0.0061499239842961,0.0061499239842961,0,0,19877.0,101200.07933676826,GGA3
23821,KEGG_2019_Human,Inflammatory bowel disease (IBD),1/65,0.003249949134407,0.0096598947762759,0,0,19935.0,114209.92613860144,SMAD3
23822,KEGG_2019_Human,Adherens junction,1/72,0.0035999456502131,0.0096598947762759,0,0,19928.0,112131.59838572376,SMAD3
23823,KEGG_2019_Human,Pancreatic cancer,1/75,0.0037499442041125,0.0096598947762759,0,0,19925.0,111301.33528642564,SMAD3
23824,KEGG_2019_Human,Chronic myeloid leukemia,1/76,0.0037999437281752,0.0096598947762759,0,0,19924.0,111031.8499691117,SMAD3
23825,KEGG_2019_Human,Colorectal cancer,1/86,0.0042999391173866,0.0096598947762759,0,0,19914.0,108514.46102290176,SMAD3
23826,KEGG_2019_Human,TGF-beta signaling pathway,1/90,0.0044999373439762,0.0096598947762759,0,0,19910.0,107587.50385474482,SMAD3
23827,KEGG_2019_Human,AGE-RAGE signaling pathway in diabetic complications,1/100,0.0049999330710556,0.0096598947762759,0,0,19900.0,105436.78197328727,SMAD3
23828,KEGG_2019_Human,Chagas disease (American trypanosomiasis),1/103,0.0051499318302617,0.0096598947762759,0,0,19897.0,104832.7525292024,SMAD3
23829,KEGG_2019_Human,Th17 cell differentiation,1/107,0.0053499302026925,0.0096598947762759,0,0,19893.0,104053.753408911,SMAD3
23830,KEGG_2019_Human,Cell cycle,1/124,0.0061999236097501,0.0096598947762759,0,0,19876.0,101034.04709010696,SMAD3
23831,KEGG_2019_Human,Relaxin signaling pathway,1/130,0.0064999213952527,0.0096598947762759,0,0,19870.0,100064.62842845908,SMAD3
23832,KEGG_2019_Human,FoxO signaling pathway,1/132,0.0065999206698993,0.0096598947762759,0,0,19868.0,99751.22090491928,SMAD3
23833,KEGG_2019_Human,Apelin signaling pathway,1/137,0.0068499188797651,0.0096598947762759,0,0,19863.0,98987.62735269018,SMAD3
23834,KEGG_2019_Human,Signaling pathways regulating pluripotency of stem cells,1/139,0.006949918172816,0.0096598947762759,0,0,19861.0,98689.81333375497,SMAD3
23835,KEGG_2019_Human,Gastric cancer,1/149,0.0074499147221605,0.0096598947762759,0,0,19851.0,97261.02051561224,SMAD3
23836,KEGG_2019_Human,Wnt signaling pathway,1/158,0.0078999117225733,0.0096598947762759,0,0,19842.0,96053.2110949472,SMAD3
23837,KEGG_2019_Human,Cellular senescence,1/160,0.0079999110688441,0.0096598947762759,0,0,19840.0,95793.96509856998,SMAD3
23838,KEGG_2019_Human,Hippo signaling pathway,1/160,0.0079999110688441,0.0096598947762759,0,0,19840.0,95793.96509856998,SMAD3
23839,KEGG_2019_Human,Hepatitis B,1/163,0.0081499100978668,0.0096598947762759,0,0,19837.0,95410.9786681514,SMAD3
23840,KEGG_2019_Human,Hepatocellular carcinoma,1/168,0.0083999085011095,0.0096598947762759,0,0,19832.0,94787.72752807094,SMAD3
23841,KEGG_2019_Human,Human T-cell leukemia virus 1 infection,1/219,0.0109498935894162,0.0119927405979321,0,0,19781.0,89299.85161916987,SMAD3
23842,KEGG_2019_Human,Endocytosis,1/244,0.0121998870519305,0.0127544273724728,0,0,19756.0,87051.4275316661,SMAD3
23843,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,SMAD3
23844,KEGG_2019_Human,"Phenylalanine, tyrosine and tryptophan biosynthesis",1/5,0.0002499917995416556,0.0019999343963332,0,0,19995.0,165840.17843725558,GOT2
23845,KEGG_2019_Human,Phenylalanine metabolism,1/17,0.0008499797390404818,0.0024499577795033,0,0,19983.0,141285.76583697114,GOT2
23846,KEGG_2019_Human,Arginine biosynthesis,1/21,0.0010499764455398,0.0024499577795033,0,0,19979.0,137035.71221916509,GOT2
23847,KEGG_2019_Human,"Alanine, aspartate and glutamate metabolism",1/35,0.0017499663721595,0.0024499577795033,0,0,19965.0,126740.98858805298,GOT2
23848,KEGG_2019_Human,Tyrosine metabolism,1/36,0.0017999657178272,0.0024499577795033,0,0,19964.0,126172.23364250171,GOT2
23849,KEGG_2019_Human,Fat digestion and absorption,1/41,0.0020499625466866,0.0024499577795033,0,0,19959.0,123544.88783416104,GOT2
23850,KEGG_2019_Human,Cysteine and methionine metabolism,1/47,0.0023499589392381,0.0024499577795033,0,0,19953.0,120782.64067395544,GOT2
23851,KEGG_2019_Human,Arginine and proline metabolism,1/49,0.0024499577795033,0.0024499577795033,0,0,19951.0,119939.1172087114,GOT2
23852,KEGG_2019_Human,Endocytosis,1/244,0.0121998870519305,0.0121998870519305,0,0,19756.0,87051.4275316661,RAB31
23853,KEGG_2019_Human,Synaptic vesicle cycle,1/78,0.0038999427840466,0.0038999427840466,0,0,19922.0,110503.2180492851,CPLX4
23854,KEGG_2019_Human,Other glycan degradation,1/18,0.0008999788927950273,0.0008999788927950273,0,0,19982.0,140136.54844084635,FUCA2
23855,KEGG_2019_Human,Proteasome,1/45,0.0022499601197094,0.0022499601197094,0,0,19955.0,121662.49782449217,PSMA4
23856,KEGG_2019_Human,Nitrogen metabolism,1/17,0.0008499797390404818,0.0008499797390404818,0,0,19983.0,141285.76583697114,CA5B
23857,KEGG_2019_Human,One carbon pool by folate,1/20,0.0009999772468562472,0.0019999544937124,0,0,19980.0,138017.40508704726,MTFMT
23858,KEGG_2019_Human,Aminoacyl-tRNA biosynthesis,1/66,0.003299948626608,0.003299948626608,0,0,19934.0,113899.85357353876,MTFMT
23859,KEGG_2019_Human,Endocytosis,1/244,0.0121998870519305,0.0121998870519305,0,0,19756.0,87051.4275316661,VPS37C
23860,KEGG_2019_Human,Sphingolipid metabolism,1/47,0.0023499589392381,0.0046999178784763,0,0,19953.0,120782.64067395544,CERS1
23861,KEGG_2019_Human,Sphingolipid signaling pathway,1/119,0.0059499254985137,0.0059499254985137,0,0,19881.0,101877.73080211312,CERS1
23862,KEGG_2019_Human,RNA polymerase,1/31,0.0015499690656704,0.0030999381313408,0,0,19969.0,129189.85098816035,POLR1D
23863,KEGG_2019_Human,Cytosolic DNA-sensing pathway,1/63,0.0031499501598827,0.0031499501598827,0,0,19937.0,114844.46974572667,POLR1D
23864,KEGG_2019_Human,mRNA surveillance pathway,1/91,0.0045499369072032,0.0082499094553477,0,0,19909.0,107362.10783923086,UPF3A
23865,KEGG_2019_Human,RNA transport,1/165,0.0082499094553477,0.0082499094553477,0,0,19835.0,95159.46482222488,UPF3A
23866,KEGG_2019_Human,Endocytosis,1/244,0.0121998870519305,0.0121998870519305,0,0,19756.0,87051.4275316661,VPS26A
23867,KEGG_2019_Human,Ubiquitin mediated proteolysis,1/137,0.0068499188797651,0.0082499094553477,0,0,19863.0,98987.62735269018,UBE2G2
23868,KEGG_2019_Human,Parkinson disease,1/142,0.0070999171242726,0.0082499094553477,0,0,19858.0,98250.87390500787,UBE2G2
23869,KEGG_2019_Human,Protein processing in endoplasmic reticulum,1/165,0.0082499094553477,0.0082499094553477,0,0,19835.0,95159.46482222488,UBE2G2
23870,KEGG_2019_Human,Thyroid hormone signaling pathway,1/116,0.0057999266512085,0.0057999266512085,0,0,19884.0,102400.8105961506,MED17
23871,KEGG_2019_Human,Vibrio cholerae infection,1/50,0.0024999572069037,0.0054999088262251,0,0,19950.0,119530.05920663515,ARF1
23872,KEGG_2019_Human,Legionellosis,1/55,0.0027499544131125,0.0054999088262251,0,0,19945.0,117599.1294878737,ARF1
23873,KEGG_2019_Human,Phospholipase D signaling pathway,1/148,0.007399915061391,0.009866553415188,0,0,19852.0,97399.60470052566,ARF1
23874,KEGG_2019_Human,Endocytosis,1/244,0.0121998870519305,0.0121998870519305,0,0,19756.0,87051.4275316661,ARF1
23875,KEGG_2019_Human,One carbon pool by folate,1/20,0.0009999772468562472,0.0012999726251831,0,0,19980.0,138017.40508704726,DHFR
23876,KEGG_2019_Human,Folate biosynthesis,1/26,0.0012999726251831,0.0012999726251831,0,0,19974.0,132735.46073187632,DHFR
23877,KEGG_2019_Human,Homologous recombination,1/41,0.0020499625466866,0.0026999549628563,0,0,19959.0,123544.88783416104,MUS81
23878,KEGG_2019_Human,Fanconi anemia pathway,1/54,0.0026999549628563,0.0026999549628563,0,0,19946.0,117971.01964061816,MUS81
23879,KEGG_2019_Human,RNA transport,1/165,0.0082499094553477,0.0082499094553477,0,0,19835.0,95159.46482222488,EIF5B
23880,KEGG_2019_Human,RNA degradation,1/79,0.0039499423167337,0.0039499423167337,0,0,19921.0,110243.89578070649,TOB2
23881,KEGG_2019_Human,Cocaine addiction,1/49,0.0024499577795033,0.0073498733385099,0,0,19951.0,119939.1172087114,CDK5
23882,KEGG_2019_Human,Alzheimer disease,1/171,0.0085499075557634,0.0090499044707863,0,0,19829.0,94422.42241345016,CDK5
23883,KEGG_2019_Human,Axon guidance,1/181,0.0090499044707863,0.0090499044707863,0,0,19819.0,93248.41634586031,CDK5
23884,KEGG_2019_Human,Cysteine and methionine metabolism,1/47,0.0023499589392381,0.0023499589392381,0,0,19953.0,120782.64067395544,MRI1
23885,KEGG_2019_Human,Glycosaminoglycan biosynthesis,1/53,0.0026499555173137,0.0026499555173137,0,0,19947.0,118349.78824235698,B4GALT7
23886,KEGG_2019_Human,Prion diseases,1/35,0.0017499663721595,0.0102598890669161,0,0,19965.0,126740.98858805298,HSPA1A
23887,KEGG_2019_Human,Legionellosis,1/55,0.0027499544131125,0.0102598890669161,0,0,19945.0,117599.1294878737,HSPA1A
23888,KEGG_2019_Human,Antigen processing and presentation,1/77,0.0038499432547502,0.0102598890669161,0,0,19923.0,110765.8407373636,HSPA1A
23889,KEGG_2019_Human,Longevity regulating pathway,1/102,0.0050999322416682,0.0102598890669161,0,0,19898.0,105032.15064717118,HSPA1A
23890,KEGG_2019_Human,Toxoplasmosis,1/113,0.0056499278191151,0.0102598890669161,0,0,19887.0,102937.34947211576,HSPA1A
23891,KEGG_2019_Human,Spliceosome,1/134,0.0066999199497742,0.0102598890669161,0,0,19866.0,99442.43560916925,HSPA1A
23892,KEGG_2019_Human,Estrogen signaling pathway,1/137,0.0068499188797651,0.0102598890669161,0,0,19863.0,98987.62735269018,HSPA1A
23893,KEGG_2019_Human,Measles,1/138,0.0068999185254481,0.0102598890669161,0,0,19862.0,98838.19160389496,HSPA1A
23894,KEGG_2019_Human,Protein processing in endoplasmic reticulum,1/165,0.0082499094553477,0.0102598890669161,0,0,19835.0,95159.46482222488,HSPA1A
23895,KEGG_2019_Human,Influenza A,1/171,0.0085499075557634,0.0102598890669161,0,0,19829.0,94422.42241345016,HSPA1A
23896,KEGG_2019_Human,Endocytosis,1/244,0.0121998870519305,0.0133089676930151,0,0,19756.0,87051.4275316661,HSPA1A
23897,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0147498749536506,0,0,19705.0,83086.53988020132,HSPA1A
23898,KEGG_2019_Human,Ribosome,1/153,0.0076499133771537,0.0076499133771537,0,0,19847.0,96715.6407630817,MRPL4
23899,KEGG_2019_Human,Regulation of lipolysis in adipocytes,1/55,0.0027499544131125,0.0060999024003308,0,0,19945.0,117599.1294878737,MGLL
23900,KEGG_2019_Human,Glycerolipid metabolism,1/61,0.0030499512001654,0.0060999024003308,0,0,19939.0,115499.24335773686,MGLL
23901,KEGG_2019_Human,Retrograde endocannabinoid signaling,1/148,0.007399915061391,0.009866553415188,0,0,19852.0,97399.60470052566,MGLL
23902,KEGG_2019_Human,Thermogenesis,1/231,0.0115498903940656,0.0115498903940656,0,0,19769.0,88191.07730937863,MGLL
23903,KEGG_2019_Human,RNA degradation,1/79,0.0039499423167337,0.0039499423167337,0,0,19921.0,110243.89578070649,LSM1
23904,KEGG_2019_Human,Cholesterol metabolism,1/50,0.0024999572069037,0.0024999572069037,0,0,19950.0,119530.05920663515,APOH
23905,KEGG_2019_Human,Parkinson disease,1/142,0.0070999171242726,0.0109498935894162,0,0,19858.0,98250.87390500787,SLC25A5
23906,KEGG_2019_Human,Cellular senescence,1/160,0.0079999110688441,0.0109498935894162,0,0,19840.0,95793.96509856998,SLC25A5
23907,KEGG_2019_Human,Necroptosis,1/162,0.0080999104202618,0.0109498935894162,0,0,19838.0,95537.86936302872,SLC25A5
23908,KEGG_2019_Human,cGMP-PKG signaling pathway,1/166,0.0082999091363732,0.0109498935894162,0,0,19834.0,95034.82345515196,SLC25A5
23909,KEGG_2019_Human,Calcium signaling pathway,1/188,0.009399902370135,0.0109498935894162,0,0,19812.0,92463.712994847,SLC25A5
23910,KEGG_2019_Human,Huntington disease,1/193,0.0096499008972596,0.0109498935894162,0,0,19807.0,91920.47679471428,SLC25A5
23911,KEGG_2019_Human,Human T-cell leukemia virus 1 infection,1/219,0.0109498935894162,0.0109498935894162,0,0,19781.0,89299.85161916987,SLC25A5
23912,KEGG_2019_Human,RNA transport,1/165,0.0082499094553477,0.0082499094553477,0,0,19835.0,95159.46482222488,RANGAP1
23913,KEGG_2019_Human,Cellular senescence,1/160,0.0079999110688441,0.0079999110688441,0,0,19840.0,95793.96509856998,LIN52
23914,KEGG_2019_Human,Homologous recombination,1/41,0.0020499625466866,0.0020499625466866,0,0,19959.0,123544.88783416104,RAD51B
23915,KEGG_2019_Human,"Alanine, aspartate and glutamate metabolism",1/35,0.0017499663721595,0.0017499663721595,0,0,19965.0,126740.98858805298,RIMKLA
23916,KEGG_2019_Human,RNA polymerase,1/31,0.0015499690656704,0.0030999381313408,0,0,19969.0,129189.85098816035,POLR3K
23917,KEGG_2019_Human,Cytosolic DNA-sensing pathway,1/63,0.0031499501598827,0.0031499501598827,0,0,19937.0,114844.46974572667,POLR3K
23918,KEGG_2019_Human,TGF-beta signaling pathway,1/90,0.0044999373439762,0.0141331940035007,0,0,19910.0,107587.50385474482,AMH
23919,KEGG_2019_Human,Hippo signaling pathway,1/160,0.0079999110688441,0.0141331940035007,0,0,19840.0,95793.96509856998,AMH
23920,KEGG_2019_Human,cAMP signaling pathway,1/212,0.0105998955026255,0.0141331940035007,0,0,19788.0,89974.27756224656,AMH
23921,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0146998751759735,0,0,19706.0,83157.67014793828,AMH
23922,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0146998751759735,0,0,19706.0,83157.67014793828,CLCF1
23923,KEGG_2019_Human,One carbon pool by folate,1/20,0.0009999772468562472,0.0019999631680592,0,0,19980.0,138017.40508704726,AMT
23924,KEGG_2019_Human,Glyoxylate and dicarboxylate metabolism,1/30,0.0014999697593334,0.0019999631680592,0,0,19970.0,129851.13732048514,AMT
23925,KEGG_2019_Human,"Glycine, serine and threonine metabolism",1/40,0.0019999631680592,0.0019999631680592,0,0,19960.0,124043.94523066044,AMT
23926,KEGG_2019_Human,Oxidative phosphorylation,1/133,0.0066499203093911,0.0112582177134695,0,0,19867.0,99596.2591544721,NDUFA6
23927,KEGG_2019_Human,Parkinson disease,1/142,0.0070999171242726,0.0112582177134695,0,0,19858.0,98250.87390500787,NDUFA6
23928,KEGG_2019_Human,Retrograde endocannabinoid signaling,1/148,0.007399915061391,0.0112582177134695,0,0,19852.0,97399.60470052566,NDUFA6
23929,KEGG_2019_Human,Non-alcoholic fatty liver disease (NAFLD),1/149,0.0074499147221605,0.0112582177134695,0,0,19851.0,97261.02051561224,NDUFA6
23930,KEGG_2019_Human,Alzheimer disease,1/171,0.0085499075557634,0.0112582177134695,0,0,19829.0,94422.42241345016,NDUFA6
23931,KEGG_2019_Human,Huntington disease,1/193,0.0096499008972596,0.0112582177134695,0,0,19807.0,91920.47679471428,NDUFA6
23932,KEGG_2019_Human,Thermogenesis,1/231,0.0115498903940656,0.0115498903940656,0,0,19769.0,88191.07730937863,NDUFA6
23933,KEGG_2019_Human,Type II diabetes mellitus,1/46,0.0022999595269283,0.0069998932593308,0,0,19954.0,121217.8313311442,SOCS2
23934,KEGG_2019_Human,Prolactin signaling pathway,1/70,0.0034999466296654,0.0069998932593308,0,0,19930.0,112704.30065625212,SOCS2
23935,KEGG_2019_Human,Insulin signaling pathway,1/137,0.0068499188797651,0.0080999104202618,0,0,19863.0,98987.62735269018,SOCS2
23936,KEGG_2019_Human,JAK-STAT signaling pathway,1/162,0.0080999104202618,0.0080999104202618,0,0,19838.0,95537.86936302872,SOCS2
23937,KEGG_2019_Human,alpha-Linolenic acid metabolism,1/25,0.0012499733663791,0.0083598935608305,0,0,19975.0,133525.54486996148,PLA2G4D
23938,KEGG_2019_Human,Linoleic acid metabolism,1/29,0.001449970461791,0.0083598935608305,0,0,19971.0,130534.69172799008,PLA2G4D
23939,KEGG_2019_Human,Ether lipid metabolism,1/47,0.0023499589392381,0.0083598935608305,0,0,19953.0,120782.64067395544,PLA2G4D
23940,KEGG_2019_Human,Ovarian steroidogenesis,1/49,0.0024499577795033,0.0083598935608305,0,0,19951.0,119939.1172087114,PLA2G4D
23941,KEGG_2019_Human,VEGF signaling pathway,1/59,0.0029499522555206,0.0083598935608305,0,0,19941.0,116175.59385530632,PLA2G4D
23942,KEGG_2019_Human,Long-term depression,1/60,0.002999951725986,0.0083598935608305,0,0,19940.0,115834.63209072244,PLA2G4D
23943,KEGG_2019_Human,Arachidonic acid metabolism,1/63,0.0031499501598827,0.0083598935608305,0,0,19937.0,114844.46974572667,PLA2G4D
23944,KEGG_2019_Human,Fc epsilon RI signaling pathway,1/68,0.0033999476216189,0.0083598935608305,0,0,19932.0,113293.39338050144,PLA2G4D
23945,KEGG_2019_Human,Fc gamma R-mediated phagocytosis,1/91,0.0045499369072032,0.0083598935608305,0,0,19909.0,107362.10783923086,PLA2G4D
23946,KEGG_2019_Human,GnRH signaling pathway,1/93,0.0046499360391879,0.0083598935608305,0,0,19907.0,106918.54242106884,PLA2G4D
23947,KEGG_2019_Human,Glycerophospholipid metabolism,1/97,0.0048499343304706,0.0083598935608305,0,0,19903.0,106058.9096435903,PLA2G4D
23948,KEGG_2019_Human,Choline metabolism in cancer,1/99,0.0049499334884068,0.0083598935608305,0,0,19901.0,105642.09305076736,PLA2G4D
23949,KEGG_2019_Human,Inflammatory mediator regulation of TRP channels,1/100,0.0049999330710556,0.0083598935608305,0,0,19900.0,105436.78197328727,PLA2G4D
23950,KEGG_2019_Human,Serotonergic synapse,1/113,0.0056499278191151,0.0083598935608305,0,0,19887.0,102937.34947211576,PLA2G4D
23951,KEGG_2019_Human,Glutamatergic synapse,1/114,0.005699927427839,0.0083598935608305,0,0,19886.0,102756.96431429044,PLA2G4D
23952,KEGG_2019_Human,Platelet activation,1/124,0.0061999236097501,0.0085248949634064,0,0,19876.0,101034.04709010696,PLA2G4D
23953,KEGG_2019_Human,Vascular smooth muscle contraction,1/132,0.0065999206698993,0.008541073808105,0,0,19868.0,99751.22090491928,PLA2G4D
23954,KEGG_2019_Human,Phospholipase D signaling pathway,1/148,0.007399915061391,0.0088577944367043,0,0,19852.0,97399.60470052566,PLA2G4D
23955,KEGG_2019_Human,Oxytocin signaling pathway,1/153,0.0076499133771537,0.0088577944367043,0,0,19847.0,96715.6407630817,PLA2G4D
23956,KEGG_2019_Human,Necroptosis,1/162,0.0080999104202618,0.008909901462288,0,0,19838.0,95537.86936302872,PLA2G4D
23957,KEGG_2019_Human,Ras signaling pathway,1/232,0.0115998901349604,0.0121522658556728,0,0,19768.0,88101.22480150245,PLA2G4D
23958,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0147498749536506,0,0,19705.0,83086.53988020132,PLA2G4D
23959,KEGG_2019_Human,Protein export,1/23,0.0011499748819949,0.0011499748819949,0,0,19977.0,135204.63922267244,OXA1L
23960,KEGG_2019_Human,Pyrimidine metabolism,1/57,0.002849953326298,0.0053999298011749,0,0,19943.0,116875.00742975442,CMPK1
23961,KEGG_2019_Human,Drug metabolism,1/108,0.0053999298011749,0.0053999298011749,0,0,19892.0,103863.47861844616,CMPK1
23962,KEGG_2019_Human,Taurine and hypotaurine metabolism,1/11,0.0005499852259717758,0.0025799535860348,0,0,19989.0,150029.8210287992,GAD1
23963,KEGG_2019_Human,Butanoate metabolism,1/28,0.0013999711732997,0.0025799535860348,0,0,19972.0,131242.0761597353,GAD1
23964,KEGG_2019_Human,beta-Alanine metabolism,1/31,0.0015499690656704,0.0025799535860348,0,0,19969.0,129189.85098816035,GAD1
23965,KEGG_2019_Human,"Alanine, aspartate and glutamate metabolism",1/35,0.0017499663721595,0.0025799535860348,0,0,19965.0,126740.98858805298,GAD1
23966,KEGG_2019_Human,Type I diabetes mellitus,1/43,0.0021499613216957,0.0025799535860348,0,0,19957.0,122581.98940490963,GAD1
23967,KEGG_2019_Human,GABAergic synapse,1/89,0.0044499377838098,0.0044499377838098,0,0,19911.0,107815.380281759,GAD1
23968,KEGG_2019_Human,Riboflavin metabolism,1/8,0.0003999883241497325,0.0003999883241497325,0,0,19992.0,156418.91141655247,RFK
23969,KEGG_2019_Human,Terpenoid backbone biosynthesis,1/22,0.0010999756574123,0.0010999756574123,0,0,19978.0,136099.47030191717,ZMPSTE24
23970,KEGG_2019_Human,Progesterone-mediated oocyte maturation,1/99,0.0049499334884068,0.0123998472195002,0,0,19901.0,105642.09305076736,CDC25B
23971,KEGG_2019_Human,Cell cycle,1/124,0.0061999236097501,0.0123998472195002,0,0,19876.0,101034.04709010696,CDC25B
23972,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0149498740670514,0,0,19705.0,83086.53988020132,CDC25B
23973,KEGG_2019_Human,MicroRNAs in cancer,1/299,0.0149498740670514,0.0149498740670514,0,0,19701.0,82804.33538735632,CDC25B
23974,KEGG_2019_Human,Ferroptosis,1/40,0.0019999631680592,0.0019999631680592,0,0,19960.0,124043.94523066044,MAP1LC3C
23975,KEGG_2019_Human,Ribosome,1/153,0.0076499133771537,0.0076499133771537,0,0,19847.0,96715.6407630817,RPL35
23976,KEGG_2019_Human,Gap junction,1/88,0.0043999382262822,0.0069749040587818,0,0,19912.0,108045.79305232369,MAP3K2
23977,KEGG_2019_Human,GnRH signaling pathway,1/93,0.0046499360391879,0.0069749040587818,0,0,19907.0,106918.54242106884,MAP3K2
23978,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0147498749536506,0,0,19705.0,83086.53988020132,MAP3K2
23979,KEGG_2019_Human,Carbohydrate digestion and absorption,1/44,0.0021999607179423,0.0035999456502131,0,0,19956.0,122117.06559109331,SLC5A1
23980,KEGG_2019_Human,Mineral absorption,1/51,0.0025499566390179,0.0035999456502131,0,0,19949.0,119129.0228601236,SLC5A1
23981,KEGG_2019_Human,Bile secretion,1/72,0.0035999456502131,0.0035999456502131,0,0,19928.0,112131.59838572376,SLC5A1
23982,KEGG_2019_Human,DNA replication,1/36,0.0017999657178272,0.0017999657178272,0,0,19964.0,126172.23364250171,DNA2
23983,KEGG_2019_Human,TGF-beta signaling pathway,1/90,0.0044999373439762,0.0092665575637547,0,0,19910.0,107587.50385474482,ACVR1
23984,KEGG_2019_Human,Fluid shear stress and atherosclerosis,1/139,0.006949918172816,0.0092665575637547,0,0,19861.0,98689.81333375497,ACVR1
23985,KEGG_2019_Human,Signaling pathways regulating pluripotency of stem cells,1/139,0.006949918172816,0.0092665575637547,0,0,19861.0,98689.81333375497,ACVR1
23986,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0146998751759735,0,0,19706.0,83157.67014793828,ACVR1
23987,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF566
23988,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF878
23989,KEGG_2019_Human,Bladder cancer,1/41,0.0020499625466866,0.0122776447000745,0,0,19959.0,123544.88783416104,CDK4
23990,KEGG_2019_Human,Non-small cell lung cancer,1/66,0.003299948626608,0.0122776447000745,0,0,19934.0,113899.85357353876,CDK4
23991,KEGG_2019_Human,Melanoma,1/72,0.0035999456502131,0.0122776447000745,0,0,19928.0,112131.59838572376,CDK4
23992,KEGG_2019_Human,p53 signaling pathway,1/72,0.0035999456502131,0.0122776447000745,0,0,19928.0,112131.59838572376,CDK4
23993,KEGG_2019_Human,Pancreatic cancer,1/75,0.0037499442041125,0.0122776447000745,0,0,19925.0,111301.33528642564,CDK4
23994,KEGG_2019_Human,Glioma,1/75,0.0037499442041125,0.0122776447000745,0,0,19925.0,111301.33528642564,CDK4
23995,KEGG_2019_Human,Chronic myeloid leukemia,1/76,0.0037999437281752,0.0122776447000745,0,0,19924.0,111031.8499691117,CDK4
23996,KEGG_2019_Human,Small cell lung cancer,1/93,0.0046499360391879,0.0122776447000745,0,0,19907.0,106918.54242106884,CDK4
23997,KEGG_2019_Human,AGE-RAGE signaling pathway in diabetic complications,1/100,0.0049999330710556,0.0122776447000745,0,0,19900.0,105436.78197328727,CDK4
23998,KEGG_2019_Human,T cell receptor signaling pathway,1/101,0.0050499326546803,0.0122776447000745,0,0,19899.0,105233.48101229242,CDK4
23999,KEGG_2019_Human,Cell cycle,1/124,0.0061999236097501,0.0122776447000745,0,0,19876.0,101034.04709010696,CDK4
24000,KEGG_2019_Human,Measles,1/138,0.0068999185254481,0.0122776447000745,0,0,19862.0,98838.19160389496,CDK4
24001,KEGG_2019_Human,Breast cancer,1/147,0.0073499154017982,0.0122776447000745,0,0,19853.0,97539.10874372096,CDK4
24002,KEGG_2019_Human,Cushing syndrome,1/155,0.0077499127120574,0.0122776447000745,0,0,19845.0,96448.16254952336,CDK4
24003,KEGG_2019_Human,Hepatitis C,1/155,0.0077499127120574,0.0122776447000745,0,0,19845.0,96448.16254952336,CDK4
24004,KEGG_2019_Human,Cellular senescence,1/160,0.0079999110688441,0.0122776447000745,0,0,19840.0,95793.96509856998,CDK4
24005,KEGG_2019_Human,Hepatocellular carcinoma,1/168,0.0083999085011095,0.0122776447000745,0,0,19832.0,94787.72752807094,CDK4
24006,KEGG_2019_Human,Tight junction,1/170,0.0084999078692823,0.0122776447000745,0,0,19830.0,94543.49009679438,CDK4
24007,KEGG_2019_Human,Kaposi sarcoma-associated herpesvirus infection,1/186,0.0092999029651357,0.0124427315848939,0,0,19814.0,92684.96451050608,CDK4
24008,KEGG_2019_Human,Epstein-Barr virus infection,1/201,0.0100498985877989,0.0124427315848939,0,0,19799.0,91079.21596609056,CDK4
24009,KEGG_2019_Human,Viral carcinogenesis,1/201,0.0100498985877989,0.0124427315848939,0,0,19799.0,91079.21596609056,CDK4
24010,KEGG_2019_Human,Human T-cell leukemia virus 1 infection,1/219,0.0109498935894162,0.0127172691936905,0,0,19781.0,89299.85161916987,CDK4
24011,KEGG_2019_Human,Human cytomegalovirus infection,1/225,0.0112498919790339,0.0127172691936905,0,0,19775.0,88738.27077557483,CDK4
24012,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0178748564138782,0,0,19670.0,80733.60565076157,CDK4
24013,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0184078571470215,0,0,19646.0,79255.8617626126,CDK4
24014,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,CDK4
24015,KEGG_2019_Human,RNA degradation,1/79,0.0039499423167337,0.0039499423167337,0,0,19921.0,110243.89578070649,C1D
24016,KEGG_2019_Human,Toll-like receptor signaling pathway,1/104,0.0051999314202997,0.0142498526687993,0,0,19896.0,104635.24941415618,CXCL9
24017,KEGG_2019_Human,Chemokine signaling pathway,1/190,0.0094999017791995,0.0142498526687993,0,0,19810.0,92244.74636351672,CXCL9
24018,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0146998751759735,0,0,19706.0,83157.67014793828,CXCL9
24019,KEGG_2019_Human,Axon guidance,1/181,0.0090499044707863,0.0176998626413668,0,0,19819.0,93248.41634586031,EFNA4
24020,KEGG_2019_Human,Rap1 signaling pathway,1/206,0.010299897173561,0.0176998626413668,0,0,19794.0,90569.849337325,EFNA4
24021,KEGG_2019_Human,Ras signaling pathway,1/232,0.0115998901349604,0.0176998626413668,0,0,19768.0,88101.22480150245,EFNA4
24022,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0176998626413668,0,0,19705.0,83086.53988020132,EFNA4
24023,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0176998626413668,0,0,19646.0,79255.8617626126,EFNA4
24024,KEGG_2019_Human,Vasopressin-regulated water reabsorption,1/44,0.0021999607179423,0.0121998870519305,0,0,19956.0,122117.06559109331,RAB5B
24025,KEGG_2019_Human,Amoebiasis,1/96,0.0047999347538706,0.0121998870519305,0,0,19904.0,106270.50039849174,RAB5B
24026,KEGG_2019_Human,Phagosome,1/152,0.0075999137114971,0.0121998870519305,0,0,19848.0,96850.665715497,RAB5B
24027,KEGG_2019_Human,Tuberculosis,1/179,0.0089499050800561,0.0121998870519305,0,0,19821.0,93478.0629355712,RAB5B
24028,KEGG_2019_Human,Ras signaling pathway,1/232,0.0115998901349604,0.0121998870519305,0,0,19768.0,88101.22480150245,RAB5B
24029,KEGG_2019_Human,Endocytosis,1/244,0.0121998870519305,0.0121998870519305,0,0,19756.0,87051.4275316661,RAB5B
24030,KEGG_2019_Human,"Valine, leucine and isoleucine degradation",1/48,0.0023999583567988,0.0023999583567988,0,0,19952.0,120356.5272753826,AUH
24031,KEGG_2019_Human,Glycosylphosphatidylinositol (GPI)-anchor biosynthesis,1/25,0.0012499733663791,0.0012499733663791,0,0,19975.0,133525.54486996148,PIGN
24032,KEGG_2019_Human,Ribosome,1/153,0.0076499133771537,0.0076499133771537,0,0,19847.0,96715.6407630817,MRPL3
24033,KEGG_2019_Human,RNA transport,1/165,0.0082499094553477,0.0082499094553477,0,0,19835.0,95159.46482222488,EIF3J
24034,KEGG_2019_Human,PPAR signaling pathway,1/74,0.0036999446830449,0.0077499127120574,0,0,19926.0,111574.38983110404,NR1H3
24035,KEGG_2019_Human,Insulin resistance,1/108,0.0053999298011749,0.0077499127120574,0,0,19892.0,103863.47861844616,NR1H3
24036,KEGG_2019_Human,Non-alcoholic fatty liver disease (NAFLD),1/149,0.0074499147221605,0.0077499127120574,0,0,19851.0,97261.02051561224,NR1H3
24037,KEGG_2019_Human,Hepatitis C,1/155,0.0077499127120574,0.0077499127120574,0,0,19845.0,96448.16254952336,NR1H3
24038,KEGG_2019_Human,Taste transduction,1/83,0.0041499404726918,0.0041499404726918,0,0,19917.0,109237.99888847338,TAS2R4
24039,KEGG_2019_Human,MicroRNAs in cancer,1/299,0.0149498740670514,0.0149498740670514,0,0,19701.0,82804.33538735632,MIR146A
24040,KEGG_2019_Human,Ribosome,1/153,0.0076499133771537,0.0076499133771537,0,0,19847.0,96715.6407630817,MRPL16
24041,KEGG_2019_Human,Huntington disease,1/193,0.0096499008972596,0.0096499008972596,0,0,19807.0,91920.47679471428,DNAL1
24042,KEGG_2019_Human,Nucleotide excision repair,1/47,0.0023499589392381,0.0070498768177144,0,0,19953.0,120782.64067395544,CUL4A
24043,KEGG_2019_Human,Ubiquitin mediated proteolysis,1/137,0.0068499188797651,0.0102748783196477,0,0,19863.0,98987.62735269018,CUL4A
24044,KEGG_2019_Human,Human immunodeficiency virus 1 infection,1/212,0.0105998955026255,0.0105998955026255,0,0,19788.0,89974.27756224656,CUL4A
24045,KEGG_2019_Human,Ribosome,1/153,0.0076499133771537,0.0076499133771537,0,0,19847.0,96715.6407630817,RPS3A
24046,KEGG_2019_Human,RNA transport,1/165,0.0082499094553477,0.0082499094553477,0,0,19835.0,95159.46482222488,PHAX
24047,KEGG_2019_Human,Hematopoietic cell lineage,1/97,0.0048499343304706,0.0221248283017086,0,0,19903.0,106058.9096435903,FLT3LG
24048,KEGG_2019_Human,Ras signaling pathway,1/232,0.0115998901349604,0.0221248283017086,0,0,19768.0,88101.22480150245,FLT3LG
24049,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0221248283017086,0,0,19705.0,83086.53988020132,FLT3LG
24050,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0221248283017086,0,0,19646.0,79255.8617626126,FLT3LG
24051,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,FLT3LG
24052,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF286B
24053,KEGG_2019_Human,Ascorbate and aldarate metabolism,1/27,0.0013499718942362,0.0026999437884725,0,0,19973.0,131975.02298599784,MIOX
24054,KEGG_2019_Human,Inositol phosphate metabolism,1/74,0.0036999446830449,0.0036999446830449,0,0,19926.0,111574.38983110404,MIOX
24055,KEGG_2019_Human,Legionellosis,1/55,0.0027499544131125,0.0108570306047995,0,0,19945.0,117599.1294878737,CXCL3
24056,KEGG_2019_Human,Salmonella infection,1/86,0.0042999391173866,0.0108570306047995,0,0,19914.0,108514.46102290176,CXCL3
24057,KEGG_2019_Human,IL-17 signaling pathway,1/93,0.0046499360391879,0.0108570306047995,0,0,19907.0,106918.54242106884,CXCL3
24058,KEGG_2019_Human,TNF signaling pathway,1/110,0.0054999290027479,0.0108570306047995,0,0,19890.0,103488.06969787036,CXCL3
24059,KEGG_2019_Human,NOD-like receptor signaling pathway,1/178,0.0088999053857096,0.0108570306047995,0,0,19822.0,93593.82745769851,CXCL3
24060,KEGG_2019_Human,Kaposi sarcoma-associated herpesvirus infection,1/186,0.0092999029651357,0.0108570306047995,0,0,19814.0,92684.96451050608,CXCL3
24061,KEGG_2019_Human,Chemokine signaling pathway,1/190,0.0094999017791995,0.0108570306047995,0,0,19810.0,92244.74636351672,CXCL3
24062,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0146998751759735,0,0,19706.0,83157.67014793828,CXCL3
24063,KEGG_2019_Human,Proteasome,1/45,0.0022499601197094,0.0044999202394188,0,0,19955.0,121662.49782449217,PSMD2
24064,KEGG_2019_Human,Epstein-Barr virus infection,1/201,0.0100498985877989,0.0100498985877989,0,0,19799.0,91079.21596609056,PSMD2
24065,KEGG_2019_Human,RNA degradation,1/79,0.0039499423167337,0.0039499423167337,0,0,19921.0,110243.89578070649,SKIV2L
24066,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,NMUR1
24067,KEGG_2019_Human,Lysosome,1/123,0.0061499239842961,0.0061499239842961,0,0,19877.0,101200.07933676826,AP3M1
24068,KEGG_2019_Human,Bladder cancer,1/41,0.0020499625466866,0.014285523060159,0,0,19959.0,123544.88783416104,VEGFA
24069,KEGG_2019_Human,VEGF signaling pathway,1/59,0.0029499522555206,0.014285523060159,0,0,19941.0,116175.59385530632,VEGFA
24070,KEGG_2019_Human,Renal cell carcinoma,1/69,0.003449947123837,0.014285523060159,0,0,19931.0,112996.7391397682,VEGFA
24071,KEGG_2019_Human,Pancreatic cancer,1/75,0.0037499442041125,0.014285523060159,0,0,19925.0,111301.33528642564,VEGFA
24072,KEGG_2019_Human,Rheumatoid arthritis,1/91,0.0045499369072032,0.014285523060159,0,0,19909.0,107362.10783923086,VEGFA
24073,KEGG_2019_Human,AGE-RAGE signaling pathway in diabetic complications,1/100,0.0049999330710556,0.014285523060159,0,0,19900.0,105436.78197328727,VEGFA
24074,KEGG_2019_Human,HIF-1 signaling pathway,1/100,0.0049999330710556,0.014285523060159,0,0,19900.0,105436.78197328727,VEGFA
24075,KEGG_2019_Human,Relaxin signaling pathway,1/130,0.0064999213952527,0.0154442626062578,0,0,19870.0,100064.62842845908,VEGFA
24076,KEGG_2019_Human,Fluid shear stress and atherosclerosis,1/139,0.006949918172816,0.0154442626062578,0,0,19861.0,98689.81333375497,VEGFA
24077,KEGG_2019_Human,Kaposi sarcoma-associated herpesvirus infection,1/186,0.0092999029651357,0.0154665201799472,0,0,19814.0,92684.96451050608,VEGFA
24078,KEGG_2019_Human,Focal adhesion,1/199,0.0099498991610159,0.0154665201799472,0,0,19801.0,91286.4288690606,VEGFA
24079,KEGG_2019_Human,Proteoglycans in cancer,1/201,0.0100498985877989,0.0154665201799472,0,0,19799.0,91079.21596609056,VEGFA
24080,KEGG_2019_Human,Rap1 signaling pathway,1/206,0.010299897173561,0.0154665201799472,0,0,19794.0,90569.849337325,VEGFA
24081,KEGG_2019_Human,Human cytomegalovirus infection,1/225,0.0112498919790339,0.0154665201799472,0,0,19775.0,88738.27077557483,VEGFA
24082,KEGG_2019_Human,Ras signaling pathway,1/232,0.0115998901349604,0.0154665201799472,0,0,19768.0,88101.22480150245,VEGFA
24083,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0175880871377075,0,0,19705.0,83086.53988020132,VEGFA
24084,KEGG_2019_Human,MicroRNAs in cancer,1/299,0.0149498740670514,0.0175880871377075,0,0,19701.0,82804.33538735632,VEGFA
24085,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0183331860655161,0,0,19670.0,80733.60565076157,VEGFA
24086,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0186314343593335,0,0,19646.0,79255.8617626126,VEGFA
24087,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,VEGFA
24088,KEGG_2019_Human,Asthma,1/31,0.0015499690656704,0.0061998762626816,0,0,19969.0,129189.85098816035,CCL11
24089,KEGG_2019_Human,IL-17 signaling pathway,1/93,0.0046499360391879,0.0092998720783758,0,0,19907.0,106918.54242106884,CCL11
24090,KEGG_2019_Human,Chemokine signaling pathway,1/190,0.0094999017791995,0.0126665357055994,0,0,19810.0,92244.74636351672,CCL11
24091,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0146998751759735,0,0,19706.0,83157.67014793828,CCL11
24092,KEGG_2019_Human,Oxidative phosphorylation,1/133,0.0066499203093911,0.0112582177134695,0,0,19867.0,99596.2591544721,NDUFV2
24093,KEGG_2019_Human,Parkinson disease,1/142,0.0070999171242726,0.0112582177134695,0,0,19858.0,98250.87390500787,NDUFV2
24094,KEGG_2019_Human,Retrograde endocannabinoid signaling,1/148,0.007399915061391,0.0112582177134695,0,0,19852.0,97399.60470052566,NDUFV2
24095,KEGG_2019_Human,Non-alcoholic fatty liver disease (NAFLD),1/149,0.0074499147221605,0.0112582177134695,0,0,19851.0,97261.02051561224,NDUFV2
24096,KEGG_2019_Human,Alzheimer disease,1/171,0.0085499075557634,0.0112582177134695,0,0,19829.0,94422.42241345016,NDUFV2
24097,KEGG_2019_Human,Huntington disease,1/193,0.0096499008972596,0.0112582177134695,0,0,19807.0,91920.47679471428,NDUFV2
24098,KEGG_2019_Human,Thermogenesis,1/231,0.0115498903940656,0.0115498903940656,0,0,19769.0,88191.07730937863,NDUFV2
24099,KEGG_2019_Human,Pantothenate and CoA biosynthesis,1/19,0.00094997806231055,0.00094997806231055,0,0,19981.0,139049.2109571672,PPCDC
24100,KEGG_2019_Human,"Alanine, aspartate and glutamate metabolism",1/35,0.0017499663721595,0.0034999327443191,0,0,19965.0,126740.98858805298,ADSL
24101,KEGG_2019_Human,Purine metabolism,1/129,0.006449921761047,0.006449921761047,0,0,19871.0,100223.109907462,ADSL
24102,KEGG_2019_Human,Relaxin signaling pathway,1/130,0.0064999213952527,0.0129998427905055,0,0,19870.0,100064.62842845908,RLN1
24103,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,RLN1
24104,KEGG_2019_Human,Glycerolipid metabolism,1/61,0.0030499512001654,0.0048499343304706,0,0,19939.0,115499.24335773686,GPAM
24105,KEGG_2019_Human,Glycerophospholipid metabolism,1/97,0.0048499343304706,0.0048499343304706,0,0,19903.0,106058.9096435903,GPAM
24106,KEGG_2019_Human,Fatty acid biosynthesis,1/13,0.0006499833083207112,0.0006499833083207112,0,0,19987.0,146675.87616784443,OLAH
24107,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0146998751759735,0,0,19706.0,83157.67014793828,TNFRSF18
24108,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR1J4
24109,KEGG_2019_Human,Glycosaminoglycan biosynthesis,1/53,0.0026499555173137,0.0026499555173137,0,0,19947.0,118349.78824235698,CSGALNACT2
24110,KEGG_2019_Human,N-Glycan biosynthesis,1/50,0.0024999572069037,0.0024999572069037,0,0,19950.0,119530.05920663515,DOLK
24111,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF688
24112,KEGG_2019_Human,Shigellosis,1/65,0.003249949134407,0.0099998661421113,0,0,19935.0,114209.92613860144,DIAPH1
24113,KEGG_2019_Human,AGE-RAGE signaling pathway in diabetic complications,1/100,0.0049999330710556,0.0099998661421113,0,0,19900.0,105436.78197328727,DIAPH1
24114,KEGG_2019_Human,Focal adhesion,1/199,0.0099498991610159,0.0106998949514067,0,0,19801.0,91286.4288690606,DIAPH1
24115,KEGG_2019_Human,Regulation of actin cytoskeleton,1/214,0.0106998949514067,0.0106998949514067,0,0,19786.0,89779.39753374986,DIAPH1
24116,KEGG_2019_Human,Protein export,1/23,0.0011499748819949,0.0011499748819949,0,0,19977.0,135204.63922267244,SPCS3
24117,KEGG_2019_Human,Ribosome biogenesis in eukaryotes,1/101,0.0050499326546803,0.0050499326546803,0,0,19899.0,105233.48101229242,FCF1
24118,KEGG_2019_Human,MicroRNAs in cancer,1/299,0.0149498740670514,0.0149498740670514,0,0,19701.0,82804.33538735632,MIR205
24119,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0146998751759735,0,0,19706.0,83157.67014793828,ACKR4
24120,KEGG_2019_Human,Acute myeloid leukemia,1/66,0.003299948626608,0.006599897253216,0,0,19934.0,113899.85357353876,CEBPE
24121,KEGG_2019_Human,Transcriptional misregulation in cancer,1/186,0.0092999029651357,0.0092999029651357,0,0,19814.0,92684.96451050608,CEBPE
24122,KEGG_2019_Human,Salivary secretion,1/90,0.0044999373439762,0.0044999373439762,0,0,19910.0,107587.50385474482,HTN1
24123,KEGG_2019_Human,Adipocytokine signaling pathway,1/69,0.003449947123837,0.003449947123837,0,0,19931.0,112996.7391397682,AGRP
24124,KEGG_2019_Human,Glycosaminoglycan biosynthesis,1/53,0.0026499555173137,0.0026499555173137,0,0,19947.0,118349.78824235698,CHST14
24125,KEGG_2019_Human,Vitamin digestion and absorption,1/24,0.0011999741185782,0.0011999741185782,0,0,19976.0,134347.69487847842,MMACHC
24126,KEGG_2019_Human,RNA transport,1/165,0.0082499094553477,0.0082499094553477,0,0,19835.0,95159.46482222488,TACC3
24127,KEGG_2019_Human,RNA transport,1/165,0.0082499094553477,0.0082499094553477,0,0,19835.0,95159.46482222488,RPP14
24128,KEGG_2019_Human,Nicotinate and nicotinamide metabolism,1/30,0.0014999697593334,0.004274929989447,0,0,19970.0,129851.13732048514,NT5C
24129,KEGG_2019_Human,Pyrimidine metabolism,1/57,0.002849953326298,0.004274929989447,0,0,19943.0,116875.00742975442,NT5C
24130,KEGG_2019_Human,Purine metabolism,1/129,0.006449921761047,0.006449921761047,0,0,19871.0,100223.109907462,NT5C
24131,KEGG_2019_Human,Maturity onset diabetes of the young,1/26,0.0012999726251831,0.0025999452503662,0,0,19974.0,132735.46073187632,HHEX
24132,KEGG_2019_Human,Transcriptional misregulation in cancer,1/186,0.0092999029651357,0.0092999029651357,0,0,19814.0,92684.96451050608,HHEX
24133,KEGG_2019_Human,Inositol phosphate metabolism,1/74,0.0036999446830449,0.0049499334884068,0,0,19926.0,111574.38983110404,MTMR2
24134,KEGG_2019_Human,Phosphatidylinositol signaling system,1/99,0.0049499334884068,0.0049499334884068,0,0,19901.0,105642.09305076736,MTMR2
24135,KEGG_2019_Human,N-Glycan biosynthesis,1/50,0.0024999572069037,0.0024999572069037,0,0,19950.0,119530.05920663515,MGAT4B
24136,KEGG_2019_Human,MicroRNAs in cancer,1/299,0.0149498740670514,0.0149498740670514,0,0,19701.0,82804.33538735632,SOX4
24137,KEGG_2019_Human,Nicotinate and nicotinamide metabolism,1/30,0.0014999697593334,0.004274929989447,0,0,19970.0,129851.13732048514,NT5C1B
24138,KEGG_2019_Human,Pyrimidine metabolism,1/57,0.002849953326298,0.004274929989447,0,0,19943.0,116875.00742975442,NT5C1B
24139,KEGG_2019_Human,Purine metabolism,1/129,0.006449921761047,0.006449921761047,0,0,19871.0,100223.109907462,NT5C1B
24140,KEGG_2019_Human,AGE-RAGE signaling pathway in diabetic complications,1/100,0.0049999330710556,0.0185598242159366,0,0,19900.0,105436.78197328727,VEGFB
24141,KEGG_2019_Human,Relaxin signaling pathway,1/130,0.0064999213952527,0.0185598242159366,0,0,19870.0,100064.62842845908,VEGFB
24142,KEGG_2019_Human,Focal adhesion,1/199,0.0099498991610159,0.0185598242159366,0,0,19801.0,91286.4288690606,VEGFB
24143,KEGG_2019_Human,Rap1 signaling pathway,1/206,0.010299897173561,0.0185598242159366,0,0,19794.0,90569.849337325,VEGFB
24144,KEGG_2019_Human,Ras signaling pathway,1/232,0.0115998901349604,0.0185598242159366,0,0,19768.0,88101.22480150245,VEGFB
24145,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0196664999382009,0,0,19705.0,83086.53988020132,VEGFB
24146,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0202284144472764,0,0,19646.0,79255.8617626126,VEGFB
24147,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,VEGFB
24148,KEGG_2019_Human,Hippo signaling pathway,1/160,0.0079999110688441,0.0146398644623166,0,0,19840.0,95793.96509856998,PARD6A
24149,KEGG_2019_Human,Tight junction,1/170,0.0084999078692823,0.0146398644623166,0,0,19830.0,94543.49009679438,PARD6A
24150,KEGG_2019_Human,Axon guidance,1/181,0.0090499044707863,0.0146398644623166,0,0,19819.0,93248.41634586031,PARD6A
24151,KEGG_2019_Human,Rap1 signaling pathway,1/206,0.010299897173561,0.0146398644623166,0,0,19794.0,90569.849337325,PARD6A
24152,KEGG_2019_Human,Endocytosis,1/244,0.0121998870519305,0.0146398644623166,0,0,19756.0,87051.4275316661,PARD6A
24153,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0164998674589645,0,0,19670.0,80733.60565076157,PARD6A
24154,KEGG_2019_Human,HIF-1 signaling pathway,1/100,0.0049999330710556,0.0098998913464173,0,0,19900.0,105436.78197328727,EIF4E
24155,KEGG_2019_Human,Longevity regulating pathway,1/102,0.0050999322416682,0.0098998913464173,0,0,19898.0,105032.15064717118,EIF4E
24156,KEGG_2019_Human,Insulin signaling pathway,1/137,0.0068499188797651,0.0098998913464173,0,0,19863.0,98987.62735269018,EIF4E
24157,KEGG_2019_Human,mTOR signaling pathway,1/152,0.0075999137114971,0.0098998913464173,0,0,19848.0,96850.665715497,EIF4E
24158,KEGG_2019_Human,RNA transport,1/165,0.0082499094553477,0.0098998913464173,0,0,19835.0,95159.46482222488,EIF4E
24159,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0176998626413668,0,0,19646.0,79255.8617626126,EIF4E
24160,KEGG_2019_Human,Collecting duct acid secretion,1/27,0.0013499718942362,0.0081898864329657,0,0,19973.0,131975.02298599784,ATP6V1F
24161,KEGG_2019_Human,Vibrio cholerae infection,1/50,0.0024999572069037,0.0081898864329657,0,0,19950.0,119530.05920663515,ATP6V1F
24162,KEGG_2019_Human,Epithelial cell signaling in Helicobacter pylori infection,1/68,0.0033999476216189,0.0081898864329657,0,0,19932.0,113293.39338050144,ATP6V1F
24163,KEGG_2019_Human,Synaptic vesicle cycle,1/78,0.0038999427840466,0.0081898864329657,0,0,19922.0,110503.2180492851,ATP6V1F
24164,KEGG_2019_Human,Rheumatoid arthritis,1/91,0.0045499369072032,0.0081898864329657,0,0,19909.0,107362.10783923086,ATP6V1F
24165,KEGG_2019_Human,Oxidative phosphorylation,1/133,0.0066499203093911,0.0085499029254342,0,0,19867.0,99596.2591544721,ATP6V1F
24166,KEGG_2019_Human,mTOR signaling pathway,1/152,0.0075999137114971,0.0085499029254342,0,0,19848.0,96850.665715497,ATP6V1F
24167,KEGG_2019_Human,Phagosome,1/152,0.0075999137114971,0.0085499029254342,0,0,19848.0,96850.665715497,ATP6V1F
24168,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0164998674589645,0,0,19670.0,80733.60565076157,ATP6V1F
24169,KEGG_2019_Human,TGF-beta signaling pathway,1/90,0.0044999373439762,0.006949918172816,0,0,19910.0,107587.50385474482,ID4
24170,KEGG_2019_Human,Signaling pathways regulating pluripotency of stem cells,1/139,0.006949918172816,0.006949918172816,0,0,19861.0,98689.81333375497,ID4
24171,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,NPFFR1
24172,KEGG_2019_Human,p53 signaling pathway,1/72,0.0035999456502131,0.0138548471663736,0,0,19928.0,112131.59838572376,CCNE1
24173,KEGG_2019_Human,Small cell lung cancer,1/93,0.0046499360391879,0.0138548471663736,0,0,19907.0,106918.54242106884,CCNE1
24174,KEGG_2019_Human,Prostate cancer,1/97,0.0048499343304706,0.0138548471663736,0,0,19903.0,106058.9096435903,CCNE1
24175,KEGG_2019_Human,Cell cycle,1/124,0.0061999236097501,0.0138548471663736,0,0,19876.0,101034.04709010696,CCNE1
24176,KEGG_2019_Human,Oocyte meiosis,1/125,0.0062499232373748,0.0138548471663736,0,0,19875.0,100869.32368441945,CCNE1
24177,KEGG_2019_Human,Measles,1/138,0.0068999185254481,0.0138548471663736,0,0,19862.0,98838.19160389496,CCNE1
24178,KEGG_2019_Human,Gastric cancer,1/149,0.0074499147221605,0.0138548471663736,0,0,19851.0,97261.02051561224,CCNE1
24179,KEGG_2019_Human,Cushing syndrome,1/155,0.0077499127120574,0.0138548471663736,0,0,19845.0,96448.16254952336,CCNE1
24180,KEGG_2019_Human,Cellular senescence,1/160,0.0079999110688441,0.0138548471663736,0,0,19840.0,95793.96509856998,CCNE1
24181,KEGG_2019_Human,Hepatitis B,1/163,0.0081499100978668,0.0138548471663736,0,0,19837.0,95410.9786681514,CCNE1
24182,KEGG_2019_Human,Viral carcinogenesis,1/201,0.0100498985877989,0.0142373563327152,0,0,19799.0,91079.21596609056,CCNE1
24183,KEGG_2019_Human,Epstein-Barr virus infection,1/201,0.0100498985877989,0.0142373563327152,0,0,19799.0,91079.21596609056,CCNE1
24184,KEGG_2019_Human,Human T-cell leukemia virus 1 infection,1/219,0.0109498935894162,0.0143190916169289,0,0,19781.0,89299.85161916987,CCNE1
24185,KEGG_2019_Human,MicroRNAs in cancer,1/299,0.0149498740670514,0.018153418509991,0,0,19701.0,82804.33538735632,CCNE1
24186,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0186998497868264,0,0,19670.0,80733.60565076157,CCNE1
24187,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0188061040564523,0,0,19646.0,79255.8617626126,CCNE1
24188,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,CCNE1
24189,KEGG_2019_Human,Nicotinate and nicotinamide metabolism,1/30,0.0014999697593334,0.0073499008621619,0,0,19970.0,129851.13732048514,CD38
24190,KEGG_2019_Human,Salivary secretion,1/90,0.0044999373439762,0.0073499008621619,0,0,19910.0,107587.50385474482,CD38
24191,KEGG_2019_Human,Hematopoietic cell lineage,1/97,0.0048499343304706,0.0073499008621619,0,0,19903.0,106058.9096435903,CD38
24192,KEGG_2019_Human,Pancreatic secretion,1/98,0.0048999339081079,0.0073499008621619,0,0,19902.0,105849.45495286948,CD38
24193,KEGG_2019_Human,Oxytocin signaling pathway,1/153,0.0076499133771537,0.0091798960525845,0,0,19847.0,96715.6407630817,CD38
24194,KEGG_2019_Human,Calcium signaling pathway,1/188,0.009399902370135,0.009399902370135,0,0,19812.0,92463.712994847,CD38
24195,KEGG_2019_Human,mRNA surveillance pathway,1/91,0.0045499369072032,0.0085499075557634,0,0,19909.0,107362.10783923086,PABPN1
24196,KEGG_2019_Human,Influenza A,1/171,0.0085499075557634,0.0085499075557634,0,0,19829.0,94422.42241345016,PABPN1
24197,KEGG_2019_Human,Biosynthesis of unsaturated fatty acids,1/27,0.0013499718942362,0.0013499718942362,0,0,19973.0,131975.02298599784,HACD2
24198,KEGG_2019_Human,Fatty acid elongation,1/27,0.0013499718942362,0.0013499718942362,0,0,19973.0,131975.02298599784,HACD2
24199,KEGG_2019_Human,Citrate cycle (TCA cycle),1/30,0.0014999697593334,0.0015999683804467,0,0,19970.0,129851.13732048514,SUCLA2
24200,KEGG_2019_Human,Propanoate metabolism,1/32,0.0015999683804467,0.0015999683804467,0,0,19968.0,128549.41955786056,SUCLA2
24201,KEGG_2019_Human,RIG-I-like receptor signaling pathway,1/70,0.0034999466296654,0.0104998398889962,0,0,19930.0,112704.30065625212,IFNE
24202,KEGG_2019_Human,JAK-STAT signaling pathway,1/162,0.0080999104202618,0.0121498656303927,0,0,19838.0,95537.86936302872,IFNE
24203,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0146998751759735,0,0,19706.0,83157.67014793828,IFNE
24204,KEGG_2019_Human,Glycerolipid metabolism,1/61,0.0030499512001654,0.0030499512001654,0,0,19939.0,115499.24335773686,AGK
24205,KEGG_2019_Human,Glutathione metabolism,1/56,0.0027999538675741,0.0036999446830449,0,0,19944.0,117233.87022514464,GPX3
24206,KEGG_2019_Human,Arachidonic acid metabolism,1/63,0.0031499501598827,0.0036999446830449,0,0,19937.0,114844.46974572667,GPX3
24207,KEGG_2019_Human,Thyroid hormone synthesis,1/74,0.0036999446830449,0.0036999446830449,0,0,19926.0,111574.38983110404,GPX3
24208,KEGG_2019_Human,Thermogenesis,1/231,0.0115498903940656,0.0115498903940656,0,0,19769.0,88191.07730937863,NDUFAF4
24209,KEGG_2019_Human,Basal transcription factors,1/45,0.0022499601197094,0.0022499601197094,0,0,19955.0,121662.49782449217,TAF7
24210,KEGG_2019_Human,"Glycine, serine and threonine metabolism",1/40,0.0019999631680592,0.0024499577795033,0,0,19960.0,124043.94523066044,GAMT
24211,KEGG_2019_Human,Arginine and proline metabolism,1/49,0.0024499577795033,0.0024499577795033,0,0,19951.0,119939.1172087114,GAMT
24212,KEGG_2019_Human,Ubiquitin mediated proteolysis,1/137,0.0068499188797651,0.0068499188797651,0,0,19863.0,98987.62735269018,UBE2N
24213,KEGG_2019_Human,RNA transport,1/165,0.0082499094553477,0.0082499094553477,0,0,19835.0,95159.46482222488,TGS1
24214,KEGG_2019_Human,Pathogenic Escherichia coli infection,1/55,0.0027499544131125,0.0056499278191151,0,0,19945.0,117599.1294878737,LY96
24215,KEGG_2019_Human,Pertussis,1/76,0.0037999437281752,0.0056499278191151,0,0,19924.0,111031.8499691117,LY96
24216,KEGG_2019_Human,NF-kappa B signaling pathway,1/95,0.0047499351803394,0.0056499278191151,0,0,19905.0,106484.27183626965,LY96
24217,KEGG_2019_Human,Toll-like receptor signaling pathway,1/104,0.0051999314202997,0.0056499278191151,0,0,19896.0,104635.24941415618,LY96
24218,KEGG_2019_Human,Toxoplasmosis,1/113,0.0056499278191151,0.0056499278191151,0,0,19887.0,102937.34947211576,LY96
24219,KEGG_2019_Human,Synaptic vesicle cycle,1/78,0.0038999427840466,0.0038999427840466,0,0,19922.0,110503.2180492851,CPLX1
24220,KEGG_2019_Human,Basal transcription factors,1/45,0.0022499601197094,0.0044999202394188,0,0,19955.0,121662.49782449217,GTF2A2
24221,KEGG_2019_Human,Viral carcinogenesis,1/201,0.0100498985877989,0.0100498985877989,0,0,19799.0,91079.21596609056,GTF2A2
24222,KEGG_2019_Human,FoxO signaling pathway,1/132,0.0065999206698993,0.0065999206698993,0,0,19868.0,99751.22090491928,PLK4
24223,KEGG_2019_Human,Phospholipase D signaling pathway,1/148,0.007399915061391,0.0235998168551558,0,0,19852.0,97399.60470052566,LPAR6
24224,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0235998168551558,0,0,19662.0,80229.79996326564,LPAR6
24225,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0235998168551558,0,0,19646.0,79255.8617626126,LPAR6
24226,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,LPAR6
24227,KEGG_2019_Human,Collecting duct acid secretion,1/27,0.0013499718942362,0.010009861195847,0,0,19973.0,131975.02298599784,ATP6V0D1
24228,KEGG_2019_Human,Vibrio cholerae infection,1/50,0.0024999572069037,0.010009861195847,0,0,19950.0,119530.05920663515,ATP6V0D1
24229,KEGG_2019_Human,Epithelial cell signaling in Helicobacter pylori infection,1/68,0.0033999476216189,0.010009861195847,0,0,19932.0,113293.39338050144,ATP6V0D1
24230,KEGG_2019_Human,Synaptic vesicle cycle,1/78,0.0038999427840466,0.010009861195847,0,0,19922.0,110503.2180492851,ATP6V0D1
24231,KEGG_2019_Human,Rheumatoid arthritis,1/91,0.0045499369072032,0.010009861195847,0,0,19909.0,107362.10783923086,ATP6V0D1
24232,KEGG_2019_Human,Lysosome,1/123,0.0061499239842961,0.0104498747719003,0,0,19877.0,101200.07933676826,ATP6V0D1
24233,KEGG_2019_Human,Oxidative phosphorylation,1/133,0.0066499203093911,0.0104498747719003,0,0,19867.0,99596.2591544721,ATP6V0D1
24234,KEGG_2019_Human,Phagosome,1/152,0.0075999137114971,0.0104498813533085,0,0,19848.0,96850.665715497,ATP6V0D1
24235,KEGG_2019_Human,Tuberculosis,1/179,0.0089499050800561,0.0109387728756241,0,0,19821.0,93478.0629355712,ATP6V0D1
24236,KEGG_2019_Human,Viral carcinogenesis,1/201,0.0100498985877989,0.0110548884465788,0,0,19799.0,91079.21596609056,ATP6V0D1
24237,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0164998674589645,0,0,19670.0,80733.60565076157,ATP6V0D1
24238,KEGG_2019_Human,Spliceosome,1/134,0.0066999199497742,0.0066999199497742,0,0,19866.0,99442.43560916925,CCDC12
24239,KEGG_2019_Human,Pyrimidine metabolism,1/57,0.002849953326298,0.002849953326298,0,0,19943.0,116875.00742975442,UPRT
24240,KEGG_2019_Human,Steroid biosynthesis,1/19,0.00094997806231055,0.00094997806231055,0,0,19981.0,139049.2109571672,TM7SF2
24241,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,VIPR1
24242,KEGG_2019_Human,RNA degradation,1/79,0.0039499423167337,0.0066999199497742,0,0,19921.0,110243.89578070649,LSM5
24243,KEGG_2019_Human,Spliceosome,1/134,0.0066999199497742,0.0066999199497742,0,0,19866.0,99442.43560916925,LSM5
24244,KEGG_2019_Human,DNA replication,1/36,0.0017999657178272,0.0035999314356544,0,0,19964.0,126172.23364250171,MCM3
24245,KEGG_2019_Human,Cell cycle,1/124,0.0061999236097501,0.0061999236097501,0,0,19876.0,101034.04709010696,MCM3
24246,KEGG_2019_Human,Tight junction,1/170,0.0084999078692823,0.0084999078692823,0,0,19830.0,94543.49009679438,ACTR2
24247,KEGG_2019_Human,Tryptophan metabolism,1/42,0.0020999619311272,0.0029499522555206,0,0,19958.0,123057.75613441122,GCDH
24248,KEGG_2019_Human,Fatty acid degradation,1/44,0.0021999607179423,0.0029499522555206,0,0,19956.0,122117.06559109331,GCDH
24249,KEGG_2019_Human,Lysine degradation,1/59,0.0029499522555206,0.0029499522555206,0,0,19941.0,116175.59385530632,GCDH
24250,KEGG_2019_Human,Amoebiasis,1/96,0.0047999347538706,0.0047999347538706,0,0,19904.0,106270.50039849174,SERPINB6
24251,KEGG_2019_Human,mRNA surveillance pathway,1/91,0.0045499369072032,0.0045499369072032,0,0,19909.0,107362.10783923086,PELO
24252,KEGG_2019_Human,Aminoacyl-tRNA biosynthesis,1/66,0.003299948626608,0.003299948626608,0,0,19934.0,113899.85357353876,GATB
24253,KEGG_2019_Human,Ribosome biogenesis in eukaryotes,1/101,0.0050499326546803,0.0050499326546803,0,0,19899.0,105233.48101229242,NOB1
24254,KEGG_2019_Human,Ribosome biogenesis in eukaryotes,1/101,0.0050499326546803,0.0050499326546803,0,0,19899.0,105233.48101229242,RCL1
24255,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF621
24256,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF283
24257,KEGG_2019_Human,Mitophagy,1/65,0.003249949134407,0.0097498474032211,0,0,19935.0,114209.92613860144,USP8
24258,KEGG_2019_Human,Cushing syndrome,1/155,0.0077499127120574,0.0116248690680862,0,0,19845.0,96448.16254952336,USP8
24259,KEGG_2019_Human,Endocytosis,1/244,0.0121998870519305,0.0121998870519305,0,0,19756.0,87051.4275316661,USP8
24260,KEGG_2019_Human,Ribosome,1/153,0.0076499133771537,0.0076499133771537,0,0,19847.0,96715.6407630817,RPL14
24261,KEGG_2019_Human,Adherens junction,1/72,0.0035999456502131,0.0108704698249652,0,0,19928.0,112131.59838572376,TGFBR1
24262,KEGG_2019_Human,Pancreatic cancer,1/75,0.0037499442041125,0.0108704698249652,0,0,19925.0,111301.33528642564,TGFBR1
24263,KEGG_2019_Human,Chronic myeloid leukemia,1/76,0.0037999437281752,0.0108704698249652,0,0,19924.0,111031.8499691117,TGFBR1
24264,KEGG_2019_Human,Colorectal cancer,1/86,0.0042999391173866,0.0108704698249652,0,0,19914.0,108514.46102290176,TGFBR1
24265,KEGG_2019_Human,TGF-beta signaling pathway,1/90,0.0044999373439762,0.0108704698249652,0,0,19910.0,107587.50385474482,TGFBR1
24266,KEGG_2019_Human,AGE-RAGE signaling pathway in diabetic complications,1/100,0.0049999330710556,0.0108704698249652,0,0,19900.0,105436.78197328727,TGFBR1
24267,KEGG_2019_Human,Chagas disease (American trypanosomiasis),1/103,0.0051499318302617,0.0108704698249652,0,0,19897.0,104832.7525292024,TGFBR1
24268,KEGG_2019_Human,Th17 cell differentiation,1/107,0.0053499302026925,0.0108704698249652,0,0,19893.0,104053.753408911,TGFBR1
24269,KEGG_2019_Human,Osteoclast differentiation,1/127,0.0063499224962247,0.0108704698249652,0,0,19873.0,100543.72072014232,TGFBR1
24270,KEGG_2019_Human,Relaxin signaling pathway,1/130,0.0064999213952527,0.0108704698249652,0,0,19870.0,100064.62842845908,TGFBR1
24271,KEGG_2019_Human,FoxO signaling pathway,1/132,0.0065999206698993,0.0108704698249652,0,0,19868.0,99751.22090491928,TGFBR1
24272,KEGG_2019_Human,Apelin signaling pathway,1/137,0.0068499188797651,0.0108704698249652,0,0,19863.0,98987.62735269018,TGFBR1
24273,KEGG_2019_Human,Gastric cancer,1/149,0.0074499147221605,0.0108704698249652,0,0,19851.0,97261.02051561224,TGFBR1
24274,KEGG_2019_Human,Cellular senescence,1/160,0.0079999110688441,0.0108704698249652,0,0,19840.0,95793.96509856998,TGFBR1
24275,KEGG_2019_Human,Hippo signaling pathway,1/160,0.0079999110688441,0.0108704698249652,0,0,19840.0,95793.96509856998,TGFBR1
24276,KEGG_2019_Human,Hepatitis B,1/163,0.0081499100978668,0.0108704698249652,0,0,19837.0,95410.9786681514,TGFBR1
24277,KEGG_2019_Human,Hepatocellular carcinoma,1/168,0.0083999085011095,0.0108704698249652,0,0,19832.0,94787.72752807094,TGFBR1
24278,KEGG_2019_Human,Human T-cell leukemia virus 1 infection,1/219,0.0109498935894162,0.0133832032759532,0,0,19781.0,89299.85161916987,TGFBR1
24279,KEGG_2019_Human,Endocytosis,1/244,0.0121998870519305,0.0141261850074985,0,0,19756.0,87051.4275316661,TGFBR1
24280,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0154522499514435,0,0,19706.0,83157.67014793828,TGFBR1
24281,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0154522499514435,0,0,19705.0,83086.53988020132,TGFBR1
24282,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,TGFBR1
24283,KEGG_2019_Human,Spliceosome,1/134,0.0066999199497742,0.0066999199497742,0,0,19866.0,99442.43560916925,SF3B6
24284,KEGG_2019_Human,Starch and sucrose metabolism,1/36,0.0017999657178272,0.0017999657178272,0,0,19964.0,126172.23364250171,TREH
24285,KEGG_2019_Human,Notch signaling pathway,1/48,0.0023999583567988,0.0047999167135976,0,0,19952.0,120356.5272753826,APH1B
24286,KEGG_2019_Human,Alzheimer disease,1/171,0.0085499075557634,0.0085499075557634,0,0,19829.0,94422.42241345016,APH1B
24287,KEGG_2019_Human,NOD-like receptor signaling pathway,1/178,0.0088999053857096,0.0088999053857096,0,0,19822.0,93593.82745769851,NEK7
24288,KEGG_2019_Human,TGF-beta signaling pathway,1/90,0.0044999373439762,0.0146998751759735,0,0,19910.0,107587.50385474482,BMP8B
24289,KEGG_2019_Human,Hippo signaling pathway,1/160,0.0079999110688441,0.0146998751759735,0,0,19840.0,95793.96509856998,BMP8B
24290,KEGG_2019_Human,Thermogenesis,1/231,0.0115498903940656,0.0146998751759735,0,0,19769.0,88191.07730937863,BMP8B
24291,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0146998751759735,0,0,19706.0,83157.67014793828,BMP8B
24292,KEGG_2019_Human,Endocytosis,1/244,0.0121998870519305,0.0121998870519305,0,0,19756.0,87051.4275316661,VPS36
24293,KEGG_2019_Human,Cocaine addiction,1/49,0.0024499577795033,0.0102152727832286,0,0,19951.0,119939.1172087114,ATF4
24294,KEGG_2019_Human,Cortisol synthesis and secretion,1/65,0.003249949134407,0.0102152727832286,0,0,19935.0,114209.92613860144,ATF4
24295,KEGG_2019_Human,Mitophagy,1/65,0.003249949134407,0.0102152727832286,0,0,19935.0,114209.92613860144,ATF4
24296,KEGG_2019_Human,Long-term potentiation,1/67,0.0033499481224912,0.0102152727832286,0,0,19933.0,113594.38808369274,ATF4
24297,KEGG_2019_Human,Amphetamine addiction,1/68,0.0033999476216189,0.0102152727832286,0,0,19932.0,113293.39338050144,ATF4
24298,KEGG_2019_Human,Thyroid hormone synthesis,1/74,0.0036999446830449,0.0102152727832286,0,0,19926.0,111574.38983110404,ATF4
24299,KEGG_2019_Human,Insulin secretion,1/86,0.0042999391173866,0.0102152727832286,0,0,19914.0,108514.46102290176,ATF4
24300,KEGG_2019_Human,GnRH signaling pathway,1/93,0.0046499360391879,0.0102152727832286,0,0,19907.0,106918.54242106884,ATF4
24301,KEGG_2019_Human,Prostate cancer,1/97,0.0048499343304706,0.0102152727832286,0,0,19903.0,106058.9096435903,ATF4
24302,KEGG_2019_Human,Aldosterone synthesis and secretion,1/98,0.0048999339081079,0.0102152727832286,0,0,19902.0,105849.45495286948,ATF4
24303,KEGG_2019_Human,Longevity regulating pathway,1/102,0.0050999322416682,0.0102152727832286,0,0,19898.0,105032.15064717118,ATF4
24304,KEGG_2019_Human,Glucagon signaling pathway,1/103,0.0051499318302617,0.0102152727832286,0,0,19897.0,104832.7525292024,ATF4
24305,KEGG_2019_Human,"Parathyroid hormone synthesis, secretion and action",1/106,0.0052999306076525,0.0102152727832286,0,0,19894.0,104245.78450366124,ATF4
24306,KEGG_2019_Human,TNF signaling pathway,1/110,0.0054999290027479,0.0102152727832286,0,0,19890.0,103488.06969787036,ATF4
24307,KEGG_2019_Human,Cholinergic synapse,1/112,0.0055999282120529,0.0102152727832286,0,0,19888.0,103119.30984392198,ATF4
24308,KEGG_2019_Human,Neurotrophin signaling pathway,1/119,0.0059499254985137,0.0102152727832286,0,0,19881.0,101877.73080211312,ATF4
24309,KEGG_2019_Human,Relaxin signaling pathway,1/130,0.0064999213952527,0.0102152727832286,0,0,19870.0,100064.62842845908,ATF4
24310,KEGG_2019_Human,Dopaminergic synapse,1/131,0.0065499210316603,0.0102152727832286,0,0,19869.0,99907.33811343512,ATF4
24311,KEGG_2019_Human,Estrogen signaling pathway,1/137,0.0068499188797651,0.0102152727832286,0,0,19863.0,98987.62735269018,ATF4
24312,KEGG_2019_Human,Apoptosis,1/143,0.0071499167770442,0.0102152727832286,0,0,19857.0,98106.57763600958,ATF4
24313,KEGG_2019_Human,Adrenergic signaling in cardiomyocytes,1/145,0.0072499160871101,0.0102152727832286,0,0,19855.0,97820.92670675044,ATF4
24314,KEGG_2019_Human,Non-alcoholic fatty liver disease (NAFLD),1/149,0.0074499147221605,0.0102152727832286,0,0,19851.0,97261.02051561224,ATF4
24315,KEGG_2019_Human,Cushing syndrome,1/155,0.0077499127120574,0.0102152727832286,0,0,19845.0,96448.16254952336,ATF4
24316,KEGG_2019_Human,Hepatitis B,1/163,0.0081499100978668,0.0102152727832286,0,0,19837.0,95410.9786681514,ATF4
24317,KEGG_2019_Human,Protein processing in endoplasmic reticulum,1/165,0.0082499094553477,0.0102152727832286,0,0,19835.0,95159.46482222488,ATF4
24318,KEGG_2019_Human,cGMP-PKG signaling pathway,1/166,0.0082999091363732,0.0102152727832286,0,0,19834.0,95034.82345515196,ATF4
24319,KEGG_2019_Human,Alcoholism,1/180,0.0089999047745351,0.0106665538068564,0,0,19820.0,93362.92821536642,ATF4
24320,KEGG_2019_Human,Viral carcinogenesis,1/201,0.0100498985877989,0.0114855983860559,0,0,19799.0,91079.21596609056,ATF4
24321,KEGG_2019_Human,Human T-cell leukemia virus 1 infection,1/219,0.0109498935894162,0.0119998847776361,0,0,19781.0,89299.85161916987,ATF4
24322,KEGG_2019_Human,Human cytomegalovirus infection,1/225,0.0112498919790339,0.0119998847776361,0,0,19775.0,88738.27077557483,ATF4
24323,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0152256773715103,0,0,19705.0,83086.53988020132,ATF4
24324,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0176998626413668,0,0,19646.0,79255.8617626126,ATF4
24325,KEGG_2019_Human,Starch and sucrose metabolism,1/36,0.0017999657178272,0.0032999410769135,0,0,19964.0,126172.23364250171,AMY1A
24326,KEGG_2019_Human,Carbohydrate digestion and absorption,1/44,0.0021999607179423,0.0032999410769135,0,0,19956.0,122117.06559109331,AMY1A
24327,KEGG_2019_Human,Salivary secretion,1/90,0.0044999373439762,0.0044999373439762,0,0,19910.0,107587.50385474482,AMY1A
24328,KEGG_2019_Human,Malaria,1/49,0.0024499577795033,0.0048999155590066,0,0,19951.0,119939.1172087114,KLRK1
24329,KEGG_2019_Human,Natural killer cell mediated cytotoxicity,1/131,0.0065499210316603,0.0065499210316603,0,0,19869.0,99907.33811343512,KLRK1
24330,KEGG_2019_Human,Glyoxylate and dicarboxylate metabolism,1/30,0.0014999697593334,0.0014999697593334,0,0,19970.0,129851.13732048514,HYI
24331,KEGG_2019_Human,C-type lectin receptor signaling pathway,1/104,0.0051999314202997,0.0089499050800561,0,0,19896.0,104635.24941415618,CLEC4M
24332,KEGG_2019_Human,Measles,1/138,0.0068999185254481,0.0089499050800561,0,0,19862.0,98838.19160389496,CLEC4M
24333,KEGG_2019_Human,Phagosome,1/152,0.0075999137114971,0.0089499050800561,0,0,19848.0,96850.665715497,CLEC4M
24334,KEGG_2019_Human,Tuberculosis,1/179,0.0089499050800561,0.0089499050800561,0,0,19821.0,93478.0629355712,CLEC4M
24335,KEGG_2019_Human,Basal transcription factors,1/45,0.0022499601197094,0.0044999202394188,0,0,19955.0,121662.49782449217,TAF15
24336,KEGG_2019_Human,Transcriptional misregulation in cancer,1/186,0.0092999029651357,0.0092999029651357,0,0,19814.0,92684.96451050608,TAF15
24337,KEGG_2019_Human,Ribosome,1/153,0.0076499133771537,0.0076499133771537,0,0,19847.0,96715.6407630817,RPL8
24338,KEGG_2019_Human,Sphingolipid signaling pathway,1/119,0.0059499254985137,0.0124498637045599,0,0,19881.0,101877.73080211312,ADORA3
24339,KEGG_2019_Human,cGMP-PKG signaling pathway,1/166,0.0082999091363732,0.0124498637045599,0,0,19834.0,95034.82345515196,ADORA3
24340,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,ADORA3
24341,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0164998674589645,0,0,19670.0,80733.60565076157,TUBG1
24342,KEGG_2019_Human,RNA transport,1/165,0.0082499094553477,0.0082499094553477,0,0,19835.0,95159.46482222488,THOC7
24343,KEGG_2019_Human,Rheumatoid arthritis,1/91,0.0045499369072032,0.0091665483379131,0,0,19909.0,107362.10783923086,CCL20
24344,KEGG_2019_Human,IL-17 signaling pathway,1/93,0.0046499360391879,0.0091665483379131,0,0,19907.0,106918.54242106884,CCL20
24345,KEGG_2019_Human,TNF signaling pathway,1/110,0.0054999290027479,0.0091665483379131,0,0,19890.0,103488.06969787036,CCL20
24346,KEGG_2019_Human,Chemokine signaling pathway,1/190,0.0094999017791995,0.0118748772239994,0,0,19810.0,92244.74636351672,CCL20
24347,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0146998751759735,0,0,19706.0,83157.67014793828,CCL20
24348,KEGG_2019_Human,Nicotinate and nicotinamide metabolism,1/30,0.0014999697593334,0.004274929989447,0,0,19970.0,129851.13732048514,NT5M
24349,KEGG_2019_Human,Pyrimidine metabolism,1/57,0.002849953326298,0.004274929989447,0,0,19943.0,116875.00742975442,NT5M
24350,KEGG_2019_Human,Purine metabolism,1/129,0.006449921761047,0.006449921761047,0,0,19871.0,100223.109907462,NT5M
24351,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF442
24352,KEGG_2019_Human,Taste transduction,1/83,0.0041499404726918,0.0041499404726918,0,0,19917.0,109237.99888847338,TAS2R40
24353,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR2A4
24354,KEGG_2019_Human,Drug metabolism,1/108,0.0053999298011749,0.006449921761047,0,0,19892.0,103863.47861844616,ITPA
24355,KEGG_2019_Human,Purine metabolism,1/129,0.006449921761047,0.006449921761047,0,0,19871.0,100223.109907462,ITPA
24356,KEGG_2019_Human,Mismatch repair,1/23,0.0011499748819949,0.0023499589392381,0,0,19977.0,135204.63922267244,RFC3
24357,KEGG_2019_Human,DNA replication,1/36,0.0017999657178272,0.0023499589392381,0,0,19964.0,126172.23364250171,RFC3
24358,KEGG_2019_Human,Nucleotide excision repair,1/47,0.0023499589392381,0.0023499589392381,0,0,19953.0,120782.64067395544,RFC3
24359,KEGG_2019_Human,Histidine metabolism,1/23,0.0011499748819949,0.0011499748819949,0,0,19977.0,135204.63922267244,AMDHD1
24360,KEGG_2019_Human,Ether lipid metabolism,1/47,0.0023499589392381,0.0023499589392381,0,0,19953.0,120782.64067395544,TMEM86B
24361,KEGG_2019_Human,mRNA surveillance pathway,1/91,0.0045499369072032,0.0045499369072032,0,0,19909.0,107362.10783923086,RNMT
24362,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR1L1
24363,KEGG_2019_Human,Breast cancer,1/147,0.0073499154017982,0.0220497462053947,0,0,19853.0,97539.10874372096,HEY2
24364,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0247498011884467,0,0,19670.0,80733.60565076157,HEY2
24365,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,HEY2
24366,KEGG_2019_Human,Notch signaling pathway,1/48,0.0023999583567988,0.0099271645922203,0,0,19952.0,120356.5272753826,DVL2
24367,KEGG_2019_Human,Basal cell carcinoma,1/63,0.0031499501598827,0.0099271645922203,0,0,19937.0,114844.46974572667,DVL2
24368,KEGG_2019_Human,Melanogenesis,1/101,0.0050499326546803,0.0099271645922203,0,0,19899.0,105233.48101229242,DVL2
24369,KEGG_2019_Human,Signaling pathways regulating pluripotency of stem cells,1/139,0.006949918172816,0.0099271645922203,0,0,19861.0,98689.81333375497,DVL2
24370,KEGG_2019_Human,Breast cancer,1/147,0.0073499154017982,0.0099271645922203,0,0,19853.0,97539.10874372096,DVL2
24371,KEGG_2019_Human,Gastric cancer,1/149,0.0074499147221605,0.0099271645922203,0,0,19851.0,97261.02051561224,DVL2
24372,KEGG_2019_Human,mTOR signaling pathway,1/152,0.0075999137114971,0.0099271645922203,0,0,19848.0,96850.665715497,DVL2
24373,KEGG_2019_Human,Cushing syndrome,1/155,0.0077499127120574,0.0099271645922203,0,0,19845.0,96448.16254952336,DVL2
24374,KEGG_2019_Human,Wnt signaling pathway,1/158,0.0078999117225733,0.0099271645922203,0,0,19842.0,96053.2110949472,DVL2
24375,KEGG_2019_Human,Hippo signaling pathway,1/160,0.0079999110688441,0.0099271645922203,0,0,19840.0,95793.96509856998,DVL2
24376,KEGG_2019_Human,Hepatocellular carcinoma,1/168,0.0083999085011095,0.0099271645922203,0,0,19832.0,94787.72752807094,DVL2
24377,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0178748564138782,0,0,19670.0,80733.60565076157,DVL2
24378,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,DVL2
24379,KEGG_2019_Human,Necroptosis,1/162,0.0080999104202618,0.0121998870519305,0,0,19838.0,95537.86936302872,CHMP7
24380,KEGG_2019_Human,Endocytosis,1/244,0.0121998870519305,0.0121998870519305,0,0,19756.0,87051.4275316661,CHMP7
24381,KEGG_2019_Human,Leukocyte transendothelial migration,1/112,0.0055999282120529,0.0084999078692823,0,0,19888.0,103119.30984392198,CLDN14
24382,KEGG_2019_Human,Cell adhesion molecules (CAMs),1/145,0.0072499160871101,0.0084999078692823,0,0,19855.0,97820.92670675044,CLDN14
24383,KEGG_2019_Human,Hepatitis C,1/155,0.0077499127120574,0.0084999078692823,0,0,19845.0,96448.16254952336,CLDN14
24384,KEGG_2019_Human,Tight junction,1/170,0.0084999078692823,0.0084999078692823,0,0,19830.0,94543.49009679438,CLDN14
24385,KEGG_2019_Human,Steroid hormone biosynthesis,1/60,0.002999951725986,0.004099940929819,0,0,19940.0,115834.63209072244,AKR1C2
24386,KEGG_2019_Human,Chemical carcinogenesis,1/82,0.004099940929819,0.004099940929819,0,0,19918.0,109484.9180722932,AKR1C2
24387,KEGG_2019_Human,Steroid biosynthesis,1/19,0.00094997806231055,0.00094997806231055,0,0,19981.0,139049.2109571672,MSMO1
24388,KEGG_2019_Human,RNA polymerase,1/31,0.0015499690656704,0.0015499690656704,0,0,19969.0,129189.85098816035,POLR1B
24389,KEGG_2019_Human,Protein export,1/23,0.0011499748819949,0.0011499748819949,0,0,19977.0,135204.63922267244,SPCS2
24390,KEGG_2019_Human,PPAR signaling pathway,1/74,0.0036999446830449,0.0036999446830449,0,0,19926.0,111574.38983110404,FABP5
24391,KEGG_2019_Human,Steroid biosynthesis,1/19,0.00094997806231055,0.0018999561246211,0,0,19981.0,139049.2109571672,SOAT1
24392,KEGG_2019_Human,Cholesterol metabolism,1/50,0.0024999572069037,0.0024999572069037,0,0,19950.0,119530.05920663515,SOAT1
24393,KEGG_2019_Human,C-type lectin receptor signaling pathway,1/104,0.0051999314202997,0.0051999314202997,0,0,19896.0,104635.24941415618,CLEC4D
24394,KEGG_2019_Human,Phenylalanine metabolism,1/17,0.0008499797390404818,0.0035999314356544,0,0,19983.0,141285.76583697114,ALDH3B1
24395,KEGG_2019_Human,Histidine metabolism,1/23,0.0011499748819949,0.0035999314356544,0,0,19977.0,135204.63922267244,ALDH3B1
24396,KEGG_2019_Human,beta-Alanine metabolism,1/31,0.0015499690656704,0.0035999314356544,0,0,19969.0,129189.85098816035,ALDH3B1
24397,KEGG_2019_Human,Tyrosine metabolism,1/36,0.0017999657178272,0.0035999314356544,0,0,19964.0,126172.23364250171,ALDH3B1
24398,KEGG_2019_Human,Glycolysis / Gluconeogenesis,1/68,0.0033999476216189,0.004685646776936,0,0,19932.0,113293.39338050144,ALDH3B1
24399,KEGG_2019_Human,Metabolism of xenobiotics by cytochrome P450,1/74,0.0036999446830449,0.004685646776936,0,0,19926.0,111574.38983110404,ALDH3B1
24400,KEGG_2019_Human,Chemical carcinogenesis,1/82,0.004099940929819,0.004685646776936,0,0,19918.0,109484.9180722932,ALDH3B1
24401,KEGG_2019_Human,Drug metabolism,1/108,0.0053999298011749,0.0053999298011749,0,0,19892.0,103863.47861844616,ALDH3B1
24402,KEGG_2019_Human,Amoebiasis,1/96,0.0047999347538706,0.008666561860337,0,0,19904.0,106270.50039849174,GNA15
24403,KEGG_2019_Human,Chagas disease (American trypanosomiasis),1/103,0.0051499318302617,0.008666561860337,0,0,19897.0,104832.7525292024,GNA15
24404,KEGG_2019_Human,Relaxin signaling pathway,1/130,0.0064999213952527,0.008666561860337,0,0,19870.0,100064.62842845908,GNA15
24405,KEGG_2019_Human,Calcium signaling pathway,1/188,0.009399902370135,0.009399902370135,0,0,19812.0,92463.712994847,GNA15
24406,KEGG_2019_Human,Peroxisome,1/83,0.0041499404726918,0.0041499404726918,0,0,19917.0,109237.99888847338,HACL1
24407,KEGG_2019_Human,Sphingolipid metabolism,1/47,0.0023499589392381,0.0046999178784763,0,0,19953.0,120782.64067395544,ACER1
24408,KEGG_2019_Human,Sphingolipid signaling pathway,1/119,0.0059499254985137,0.0059499254985137,0,0,19881.0,101877.73080211312,ACER1
24409,KEGG_2019_Human,N-Glycan biosynthesis,1/50,0.0024999572069037,0.0049999144138074,0,0,19950.0,119530.05920663515,STT3A
24410,KEGG_2019_Human,Protein processing in endoplasmic reticulum,1/165,0.0082499094553477,0.0082499094553477,0,0,19835.0,95159.46482222488,STT3A
24411,KEGG_2019_Human,RNA transport,1/165,0.0082499094553477,0.0082499094553477,0,0,19835.0,95159.46482222488,NUP50
24412,KEGG_2019_Human,Phagosome,1/152,0.0075999137114971,0.0075999137114971,0,0,19848.0,96850.665715497,STX12
24413,KEGG_2019_Human,Protein processing in endoplasmic reticulum,1/165,0.0082499094553477,0.0082499094553477,0,0,19835.0,95159.46482222488,DNAJC5G
24414,KEGG_2019_Human,Amyotrophic lateral sclerosis (ALS),1/51,0.0025499566390179,0.0046249308538062,0,0,19949.0,119129.0228601236,GPX1
24415,KEGG_2019_Human,Glutathione metabolism,1/56,0.0027999538675741,0.0046249308538062,0,0,19944.0,117233.87022514464,GPX1
24416,KEGG_2019_Human,Arachidonic acid metabolism,1/63,0.0031499501598827,0.0046249308538062,0,0,19937.0,114844.46974572667,GPX1
24417,KEGG_2019_Human,Thyroid hormone synthesis,1/74,0.0036999446830449,0.0046249308538062,0,0,19926.0,111574.38983110404,GPX1
24418,KEGG_2019_Human,Huntington disease,1/193,0.0096499008972596,0.0096499008972596,0,0,19807.0,91920.47679471428,GPX1
24419,KEGG_2019_Human,Carbohydrate digestion and absorption,1/44,0.0021999607179423,0.0041499404726918,0,0,19956.0,122117.06559109331,GNAT3
24420,KEGG_2019_Human,Taste transduction,1/83,0.0041499404726918,0.0041499404726918,0,0,19917.0,109237.99888847338,GNAT3
24421,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF616
24422,KEGG_2019_Human,Mismatch repair,1/23,0.0011499748819949,0.0026999549628563,0,0,19977.0,135204.63922267244,RPA3
24423,KEGG_2019_Human,DNA replication,1/36,0.0017999657178272,0.0026999549628563,0,0,19964.0,126172.23364250171,RPA3
24424,KEGG_2019_Human,Homologous recombination,1/41,0.0020499625466866,0.0026999549628563,0,0,19959.0,123544.88783416104,RPA3
24425,KEGG_2019_Human,Nucleotide excision repair,1/47,0.0023499589392381,0.0026999549628563,0,0,19953.0,120782.64067395544,RPA3
24426,KEGG_2019_Human,Fanconi anemia pathway,1/54,0.0026999549628563,0.0026999549628563,0,0,19946.0,117971.01964061816,RPA3
24427,KEGG_2019_Human,Prolactin signaling pathway,1/70,0.0034999466296654,0.0034999466296654,0,0,19930.0,112704.30065625212,ELF5
24428,KEGG_2019_Human,Glycosphingolipid biosynthesis,1/45,0.0022499601197094,0.0022499601197094,0,0,19955.0,121662.49782449217,B3GNT5
24429,KEGG_2019_Human,Ascorbate and aldarate metabolism,1/27,0.0013499718942362,0.004685646776936,0,0,19973.0,131975.02298599784,UGT1A1
24430,KEGG_2019_Human,Pentose and glucuronate interconversions,1/34,0.0016999670339032,0.004685646776936,0,0,19966.0,127326.1054203148,UGT1A1
24431,KEGG_2019_Human,Porphyrin and chlorophyll metabolism,1/42,0.0020999619311272,0.004685646776936,0,0,19958.0,123057.75613441122,UGT1A1
24432,KEGG_2019_Human,Steroid hormone biosynthesis,1/60,0.002999951725986,0.004685646776936,0,0,19940.0,115834.63209072244,UGT1A1
24433,KEGG_2019_Human,Retinol metabolism,1/67,0.0033499481224912,0.004685646776936,0,0,19933.0,113594.38808369274,UGT1A1
24434,KEGG_2019_Human,Metabolism of xenobiotics by cytochrome P450,1/74,0.0036999446830449,0.004685646776936,0,0,19926.0,111574.38983110404,UGT1A1
24435,KEGG_2019_Human,Chemical carcinogenesis,1/82,0.004099940929819,0.004685646776936,0,0,19918.0,109484.9180722932,UGT1A1
24436,KEGG_2019_Human,Drug metabolism,1/108,0.0053999298011749,0.0053999298011749,0,0,19892.0,103863.47861844616,UGT1A1
24437,KEGG_2019_Human,Basal cell carcinoma,1/63,0.0031499501598827,0.0109198810514423,0,0,19937.0,114844.46974572667,WNT2B
24438,KEGG_2019_Human,Melanogenesis,1/101,0.0050499326546803,0.0109198810514423,0,0,19899.0,105233.48101229242,WNT2B
24439,KEGG_2019_Human,Signaling pathways regulating pluripotency of stem cells,1/139,0.006949918172816,0.0109198810514423,0,0,19861.0,98689.81333375497,WNT2B
24440,KEGG_2019_Human,Breast cancer,1/147,0.0073499154017982,0.0109198810514423,0,0,19853.0,97539.10874372096,WNT2B
24441,KEGG_2019_Human,Gastric cancer,1/149,0.0074499147221605,0.0109198810514423,0,0,19851.0,97261.02051561224,WNT2B
24442,KEGG_2019_Human,mTOR signaling pathway,1/152,0.0075999137114971,0.0109198810514423,0,0,19848.0,96850.665715497,WNT2B
24443,KEGG_2019_Human,Cushing syndrome,1/155,0.0077499127120574,0.0109198810514423,0,0,19845.0,96448.16254952336,WNT2B
24444,KEGG_2019_Human,Wnt signaling pathway,1/158,0.0078999117225733,0.0109198810514423,0,0,19842.0,96053.2110949472,WNT2B
24445,KEGG_2019_Human,Hippo signaling pathway,1/160,0.0079999110688441,0.0109198810514423,0,0,19840.0,95793.96509856998,WNT2B
24446,KEGG_2019_Human,Hepatocellular carcinoma,1/168,0.0083999085011095,0.0109198810514423,0,0,19832.0,94787.72752807094,WNT2B
24447,KEGG_2019_Human,Proteoglycans in cancer,1/201,0.0100498985877989,0.0118771528764897,0,0,19799.0,91079.21596609056,WNT2B
24448,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0178748564138782,0,0,19670.0,80733.60565076157,WNT2B
24449,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,WNT2B
24450,KEGG_2019_Human,Neurotrophin signaling pathway,1/119,0.0059499254985137,0.0176998626413668,0,0,19881.0,101877.73080211312,NTF4
24451,KEGG_2019_Human,Ras signaling pathway,1/232,0.0115998901349604,0.0176998626413668,0,0,19768.0,88101.22480150245,NTF4
24452,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0176998626413668,0,0,19705.0,83086.53988020132,NTF4
24453,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0176998626413668,0,0,19646.0,79255.8617626126,NTF4
24454,KEGG_2019_Human,Terpenoid backbone biosynthesis,1/22,0.0010999756574123,0.0010999756574123,0,0,19978.0,136099.47030191717,NUS1
24455,KEGG_2019_Human,Phototransduction,1/28,0.0013999711732997,0.0013999711732997,0,0,19972.0,131242.0761597353,RHO
24456,KEGG_2019_Human,Synaptic vesicle cycle,1/78,0.0038999427840466,0.005699927427839,0,0,19922.0,110503.2180492851,SLC1A1
24457,KEGG_2019_Human,Protein digestion and absorption,1/90,0.0044999373439762,0.005699927427839,0,0,19910.0,107587.50385474482,SLC1A1
24458,KEGG_2019_Human,Glutamatergic synapse,1/114,0.005699927427839,0.005699927427839,0,0,19886.0,102756.96431429044,SLC1A1
24459,KEGG_2019_Human,Chemokine signaling pathway,1/190,0.0094999017791995,0.0146998751759735,0,0,19810.0,92244.74636351672,CCL18
24460,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0146998751759735,0,0,19706.0,83157.67014793828,CCL18
24461,KEGG_2019_Human,Lysosome,1/123,0.0061499239842961,0.0061499239842961,0,0,19877.0,101200.07933676826,AP3M2
24462,KEGG_2019_Human,One carbon pool by folate,1/20,0.0009999772468562472,0.0012999726251831,0,0,19980.0,138017.40508704726,DHFR2
24463,KEGG_2019_Human,Folate biosynthesis,1/26,0.0012999726251831,0.0012999726251831,0,0,19974.0,132735.46073187632,DHFR2
24464,KEGG_2019_Human,Glutathione metabolism,1/56,0.0027999538675741,0.0094498771520562,0,0,19944.0,117233.87022514464,GSTA2
24465,KEGG_2019_Human,Metabolism of xenobiotics by cytochrome P450,1/74,0.0036999446830449,0.0094498771520562,0,0,19926.0,111574.38983110404,GSTA2
24466,KEGG_2019_Human,Chemical carcinogenesis,1/82,0.004099940929819,0.0094498771520562,0,0,19918.0,109484.9180722932,GSTA2
24467,KEGG_2019_Human,Drug metabolism,1/108,0.0053999298011749,0.0094498771520562,0,0,19892.0,103863.47861844616,GSTA2
24468,KEGG_2019_Human,Fluid shear stress and atherosclerosis,1/139,0.006949918172816,0.0097298854419424,0,0,19861.0,98689.81333375497,GSTA2
24469,KEGG_2019_Human,Hepatocellular carcinoma,1/168,0.0083999085011095,0.0097998932512944,0,0,19832.0,94787.72752807094,GSTA2
24470,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,GSTA2
24471,KEGG_2019_Human,Hippo signaling pathway,1/160,0.0079999110688441,0.0127498618039235,0,0,19840.0,95793.96509856998,LLGL1
24472,KEGG_2019_Human,Tight junction,1/170,0.0084999078692823,0.0127498618039235,0,0,19830.0,94543.49009679438,LLGL1
24473,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0164998674589645,0,0,19670.0,80733.60565076157,LLGL1
24474,KEGG_2019_Human,Base excision repair,1/33,0.0016499677032113,0.0023499589392381,0,0,19967.0,127928.56031580272,POLE2
24475,KEGG_2019_Human,DNA replication,1/36,0.0017999657178272,0.0023499589392381,0,0,19964.0,126172.23364250171,POLE2
24476,KEGG_2019_Human,Nucleotide excision repair,1/47,0.0023499589392381,0.0023499589392381,0,0,19953.0,120782.64067395544,POLE2
24477,KEGG_2019_Human,Kaposi sarcoma-associated herpesvirus infection,1/186,0.0092999029651357,0.0146998751759735,0,0,19814.0,92684.96451050608,CCR1
24478,KEGG_2019_Human,Chemokine signaling pathway,1/190,0.0094999017791995,0.0146998751759735,0,0,19810.0,92244.74636351672,CCR1
24479,KEGG_2019_Human,Human cytomegalovirus infection,1/225,0.0112498919790339,0.0146998751759735,0,0,19775.0,88738.27077557483,CCR1
24480,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0146998751759735,0,0,19706.0,83157.67014793828,CCR1
24481,KEGG_2019_Human,Protein processing in endoplasmic reticulum,1/165,0.0082499094553477,0.0082499094553477,0,0,19835.0,95159.46482222488,DNAJC5B
24482,KEGG_2019_Human,Glycosylphosphatidylinositol (GPI)-anchor biosynthesis,1/25,0.0012499733663791,0.0012499733663791,0,0,19975.0,133525.54486996148,PIGA
24483,KEGG_2019_Human,Inflammatory bowel disease (IBD),1/65,0.003249949134407,0.0102665548346894,0,0,19935.0,114209.92613860144,SMAD2
24484,KEGG_2019_Human,Adherens junction,1/72,0.0035999456502131,0.0102665548346894,0,0,19928.0,112131.59838572376,SMAD2
24485,KEGG_2019_Human,Pancreatic cancer,1/75,0.0037499442041125,0.0102665548346894,0,0,19925.0,111301.33528642564,SMAD2
24486,KEGG_2019_Human,Colorectal cancer,1/86,0.0042999391173866,0.0102665548346894,0,0,19914.0,108514.46102290176,SMAD2
24487,KEGG_2019_Human,TGF-beta signaling pathway,1/90,0.0044999373439762,0.0102665548346894,0,0,19910.0,107587.50385474482,SMAD2
24488,KEGG_2019_Human,AGE-RAGE signaling pathway in diabetic complications,1/100,0.0049999330710556,0.0102665548346894,0,0,19900.0,105436.78197328727,SMAD2
24489,KEGG_2019_Human,Chagas disease (American trypanosomiasis),1/103,0.0051499318302617,0.0102665548346894,0,0,19897.0,104832.7525292024,SMAD2
24490,KEGG_2019_Human,Th17 cell differentiation,1/107,0.0053499302026925,0.0102665548346894,0,0,19893.0,104053.753408911,SMAD2
24491,KEGG_2019_Human,Cell cycle,1/124,0.0061999236097501,0.0102665548346894,0,0,19876.0,101034.04709010696,SMAD2
24492,KEGG_2019_Human,Relaxin signaling pathway,1/130,0.0064999213952527,0.0102665548346894,0,0,19870.0,100064.62842845908,SMAD2
24493,KEGG_2019_Human,FoxO signaling pathway,1/132,0.0065999206698993,0.0102665548346894,0,0,19868.0,99751.22090491928,SMAD2
24494,KEGG_2019_Human,Apelin signaling pathway,1/137,0.0068499188797651,0.0102665548346894,0,0,19863.0,98987.62735269018,SMAD2
24495,KEGG_2019_Human,Signaling pathways regulating pluripotency of stem cells,1/139,0.006949918172816,0.0102665548346894,0,0,19861.0,98689.81333375497,SMAD2
24496,KEGG_2019_Human,Gastric cancer,1/149,0.0074499147221605,0.0102665548346894,0,0,19851.0,97261.02051561224,SMAD2
24497,KEGG_2019_Human,Cellular senescence,1/160,0.0079999110688441,0.0102665548346894,0,0,19840.0,95793.96509856998,SMAD2
24498,KEGG_2019_Human,Hippo signaling pathway,1/160,0.0079999110688441,0.0102665548346894,0,0,19840.0,95793.96509856998,SMAD2
24499,KEGG_2019_Human,Hepatitis B,1/163,0.0081499100978668,0.0102665548346894,0,0,19837.0,95410.9786681514,SMAD2
24500,KEGG_2019_Human,Hepatocellular carcinoma,1/168,0.0083999085011095,0.0102665548346894,0,0,19832.0,94787.72752807094,SMAD2
24501,KEGG_2019_Human,Proteoglycans in cancer,1/201,0.0100498985877989,0.0116367246806093,0,0,19799.0,91079.21596609056,SMAD2
24502,KEGG_2019_Human,Human T-cell leukemia virus 1 infection,1/219,0.0109498935894162,0.0120448829483578,0,0,19781.0,89299.85161916987,SMAD2
24503,KEGG_2019_Human,Endocytosis,1/244,0.0121998870519305,0.0127808340544034,0,0,19756.0,87051.4275316661,SMAD2
24504,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,SMAD2
24505,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR52E6
24506,KEGG_2019_Human,Aminoacyl-tRNA biosynthesis,1/66,0.003299948626608,0.003299948626608,0,0,19934.0,113899.85357353876,WARS2
24507,KEGG_2019_Human,Viral myocarditis,1/59,0.0029499522555206,0.0045499369072032,0,0,19941.0,116175.59385530632,SGCB
24508,KEGG_2019_Human,Arrhythmogenic right ventricular cardiomyopathy (ARVC),1/72,0.0035999456502131,0.0045499369072032,0,0,19928.0,112131.59838572376,SGCB
24509,KEGG_2019_Human,Hypertrophic cardiomyopathy (HCM),1/85,0.004249939567045,0.0045499369072032,0,0,19915.0,108752.83801948265,SGCB
24510,KEGG_2019_Human,Dilated cardiomyopathy (DCM),1/91,0.0045499369072032,0.0045499369072032,0,0,19909.0,107362.10783923086,SGCB
24511,KEGG_2019_Human,Ribosome,1/153,0.0076499133771537,0.0076499133771537,0,0,19847.0,96715.6407630817,MRPL22
24512,KEGG_2019_Human,Sphingolipid metabolism,1/47,0.0023499589392381,0.0046999178784763,0,0,19953.0,120782.64067395544,SMPD2
24513,KEGG_2019_Human,Sphingolipid signaling pathway,1/119,0.0059499254985137,0.0059499254985137,0,0,19881.0,101877.73080211312,SMPD2
24514,KEGG_2019_Human,Ribosome,1/153,0.0076499133771537,0.0076499133771537,0,0,19847.0,96715.6407630817,RPL36A-HNRNPH2
24515,KEGG_2019_Human,Ubiquitin mediated proteolysis,1/137,0.0068499188797651,0.0068499188797651,0,0,19863.0,98987.62735269018,HERC3
24516,KEGG_2019_Human,Renin secretion,1/69,0.003449947123837,0.0131998413397987,0,0,19931.0,112996.7391397682,EDN2
24517,KEGG_2019_Human,Vascular smooth muscle contraction,1/132,0.0065999206698993,0.0131998413397987,0,0,19868.0,99751.22090491928,EDN2
24518,KEGG_2019_Human,cAMP signaling pathway,1/212,0.0105998955026255,0.0141331940035007,0,0,19788.0,89974.27756224656,EDN2
24519,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,EDN2
24520,KEGG_2019_Human,Retinol metabolism,1/67,0.0033499481224912,0.0033499481224912,0,0,19933.0,113594.38808369274,RDH5
24521,KEGG_2019_Human,Estrogen signaling pathway,1/137,0.0068499188797651,0.0068499188797651,0,0,19863.0,98987.62735269018,KRT36
24522,KEGG_2019_Human,RIG-I-like receptor signaling pathway,1/70,0.0034999466296654,0.0034999466296654,0,0,19930.0,112704.30065625212,OTUD5
24523,KEGG_2019_Human,Autoimmune thyroid disease,1/53,0.0026499555173137,0.0145586837375733,0,0,19947.0,118349.78824235698,IFNA4
24524,KEGG_2019_Human,Cytosolic DNA-sensing pathway,1/63,0.0031499501598827,0.0145586837375733,0,0,19937.0,114844.46974572667,IFNA4
24525,KEGG_2019_Human,RIG-I-like receptor signaling pathway,1/70,0.0034999466296654,0.0145586837375733,0,0,19930.0,112704.30065625212,IFNA4
24526,KEGG_2019_Human,Toll-like receptor signaling pathway,1/104,0.0051999314202997,0.0145586837375733,0,0,19896.0,104635.24941415618,IFNA4
24527,KEGG_2019_Human,Natural killer cell mediated cytotoxicity,1/131,0.0065499210316603,0.0145586837375733,0,0,19869.0,99907.33811343512,IFNA4
24528,KEGG_2019_Human,Measles,1/138,0.0068999185254481,0.0145586837375733,0,0,19862.0,98838.19160389496,IFNA4
24529,KEGG_2019_Human,Hepatitis C,1/155,0.0077499127120574,0.0145586837375733,0,0,19845.0,96448.16254952336,IFNA4
24530,KEGG_2019_Human,Necroptosis,1/162,0.0080999104202618,0.0145586837375733,0,0,19838.0,95537.86936302872,IFNA4
24531,KEGG_2019_Human,JAK-STAT signaling pathway,1/162,0.0080999104202618,0.0145586837375733,0,0,19838.0,95537.86936302872,IFNA4
24532,KEGG_2019_Human,Hepatitis B,1/163,0.0081499100978668,0.0145586837375733,0,0,19837.0,95410.9786681514,IFNA4
24533,KEGG_2019_Human,Influenza A,1/171,0.0085499075557634,0.0145586837375733,0,0,19829.0,94422.42241345016,IFNA4
24534,KEGG_2019_Human,NOD-like receptor signaling pathway,1/178,0.0088999053857096,0.0145586837375733,0,0,19822.0,93593.82745769851,IFNA4
24535,KEGG_2019_Human,Tuberculosis,1/179,0.0089499050800561,0.0145586837375733,0,0,19821.0,93478.0629355712,IFNA4
24536,KEGG_2019_Human,Kaposi sarcoma-associated herpesvirus infection,1/186,0.0092999029651357,0.0145586837375733,0,0,19814.0,92684.96451050608,IFNA4
24537,KEGG_2019_Human,Epstein-Barr virus infection,1/201,0.0100498985877989,0.0145586837375733,0,0,19799.0,91079.21596609056,IFNA4
24538,KEGG_2019_Human,Human immunodeficiency virus 1 infection,1/212,0.0105998955026255,0.0145586837375733,0,0,19788.0,89974.27756224656,IFNA4
24539,KEGG_2019_Human,Human cytomegalovirus infection,1/225,0.0112498919790339,0.0145586837375733,0,0,19775.0,88738.27077557483,IFNA4
24540,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0179665141039676,0,0,19706.0,83157.67014793828,IFNA4
24541,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0191051096893273,0,0,19670.0,80733.60565076157,IFNA4
24542,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0194698489055035,0,0,19646.0,79255.8617626126,IFNA4
24543,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0257712598834163,0,0,19508.0,72277.44006442746,IFNA4
24544,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,IFNA4
24545,KEGG_2019_Human,Thermogenesis,1/231,0.0115498903940656,0.0115498903940656,0,0,19769.0,88191.07730937863,NDUFAF2
24546,KEGG_2019_Human,Spliceosome,1/134,0.0066999199497742,0.0066999199497742,0,0,19866.0,99442.43560916925,DDX46
24547,KEGG_2019_Human,Legionellosis,1/55,0.0027499544131125,0.0086427455757467,0,0,19945.0,117599.1294878737,CXCL1
24548,KEGG_2019_Human,Epithelial cell signaling in Helicobacter pylori infection,1/68,0.0033999476216189,0.0086427455757467,0,0,19932.0,113293.39338050144,CXCL1
24549,KEGG_2019_Human,Salmonella infection,1/86,0.0042999391173866,0.0086427455757467,0,0,19914.0,108514.46102290176,CXCL1
24550,KEGG_2019_Human,Rheumatoid arthritis,1/91,0.0045499369072032,0.0086427455757467,0,0,19909.0,107362.10783923086,CXCL1
24551,KEGG_2019_Human,IL-17 signaling pathway,1/93,0.0046499360391879,0.0086427455757467,0,0,19907.0,106918.54242106884,CXCL1
24552,KEGG_2019_Human,Amoebiasis,1/96,0.0047999347538706,0.0086427455757467,0,0,19904.0,106270.50039849174,CXCL1
24553,KEGG_2019_Human,TNF signaling pathway,1/110,0.0054999290027479,0.0086427455757467,0,0,19890.0,103488.06969787036,CXCL1
24554,KEGG_2019_Human,NOD-like receptor signaling pathway,1/178,0.0088999053857096,0.0104498919571195,0,0,19822.0,93593.82745769851,CXCL1
24555,KEGG_2019_Human,Kaposi sarcoma-associated herpesvirus infection,1/186,0.0092999029651357,0.0104498919571195,0,0,19814.0,92684.96451050608,CXCL1
24556,KEGG_2019_Human,Chemokine signaling pathway,1/190,0.0094999017791995,0.0104498919571195,0,0,19810.0,92244.74636351672,CXCL1
24557,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0146998751759735,0,0,19706.0,83157.67014793828,CXCL1
24558,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF773
24559,KEGG_2019_Human,Ascorbate and aldarate metabolism,1/27,0.0013499718942362,0.0014999697593334,0,0,19973.0,131975.02298599784,RGN
24560,KEGG_2019_Human,Pentose phosphate pathway,1/30,0.0014999697593334,0.0014999697593334,0,0,19970.0,129851.13732048514,RGN
24561,KEGG_2019_Human,Hematopoietic cell lineage,1/97,0.0048499343304706,0.0048499343304706,0,0,19903.0,106058.9096435903,CD7
24562,KEGG_2019_Human,Cysteine and methionine metabolism,1/47,0.0023499589392381,0.0023499589392381,0,0,19953.0,120782.64067395544,MAT2B
24563,KEGG_2019_Human,Necroptosis,1/162,0.0080999104202618,0.0121998870519305,0,0,19838.0,95537.86936302872,CHMP4B
24564,KEGG_2019_Human,Endocytosis,1/244,0.0121998870519305,0.0121998870519305,0,0,19756.0,87051.4275316661,CHMP4B
24565,KEGG_2019_Human,Glycosylphosphatidylinositol (GPI)-anchor biosynthesis,1/25,0.0012499733663791,0.0024999467327583,0,0,19975.0,133525.54486996148,DPM2
24566,KEGG_2019_Human,N-Glycan biosynthesis,1/50,0.0024999572069037,0.0024999572069037,0,0,19950.0,119530.05920663515,DPM2
24567,KEGG_2019_Human,Systemic lupus erythematosus,1/133,0.0066499203093911,0.0066999199497742,0,0,19867.0,99596.2591544721,SNRPD3
24568,KEGG_2019_Human,Spliceosome,1/134,0.0066999199497742,0.0066999199497742,0,0,19866.0,99442.43560916925,SNRPD3
24569,KEGG_2019_Human,Phosphonate and phosphinate metabolism,1/6,0.0002999905873105514,0.0008999717619316542,0,0,19994.0,162186.51863187927,PCYT1B
24570,KEGG_2019_Human,Glycerophospholipid metabolism,1/97,0.0048499343304706,0.0049499334884068,0,0,19903.0,106058.9096435903,PCYT1B
24571,KEGG_2019_Human,Choline metabolism in cancer,1/99,0.0049499334884068,0.0049499334884068,0,0,19901.0,105642.09305076736,PCYT1B
24572,KEGG_2019_Human,Glycerophospholipid metabolism,1/97,0.0048499343304706,0.006449921761047,0,0,19903.0,106058.9096435903,ADPRM
24573,KEGG_2019_Human,Purine metabolism,1/129,0.006449921761047,0.006449921761047,0,0,19871.0,100223.109907462,ADPRM
24574,KEGG_2019_Human,Base excision repair,1/33,0.0016499677032113,0.0016499677032113,0,0,19967.0,127928.56031580272,NEIL3
24575,KEGG_2019_Human,Biosynthesis of unsaturated fatty acids,1/27,0.0013499718942362,0.0013499718942362,0,0,19973.0,131975.02298599784,ELOVL5
24576,KEGG_2019_Human,Fatty acid elongation,1/27,0.0013499718942362,0.0013499718942362,0,0,19973.0,131975.02298599784,ELOVL5
24577,KEGG_2019_Human,Aldosterone-regulated sodium reabsorption,1/37,0.0018499650702878,0.0036999301405757,0,0,19963.0,125618.9446446357,KCNJ1
24578,KEGG_2019_Human,Gastric acid secretion,1/75,0.0037499442041125,0.0037499442041125,0,0,19925.0,111301.33528642564,KCNJ1
24579,KEGG_2019_Human,Estrogen signaling pathway,1/137,0.0068499188797651,0.0068499188797651,0,0,19863.0,98987.62735269018,FKBP5
24580,KEGG_2019_Human,NOD-like receptor signaling pathway,1/178,0.0088999053857096,0.0088999053857096,0,0,19822.0,93593.82745769851,CARD18
24581,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0146998751759735,0,0,19706.0,83157.67014793828,TNFRSF10C
24582,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF20
24583,KEGG_2019_Human,MicroRNAs in cancer,1/299,0.0149498740670514,0.0149498740670514,0,0,19701.0,82804.33538735632,MIR137
24584,KEGG_2019_Human,Notch signaling pathway,1/48,0.0023999583567988,0.0047999167135976,0,0,19952.0,120356.5272753826,CIR1
24585,KEGG_2019_Human,Epstein-Barr virus infection,1/201,0.0100498985877989,0.0100498985877989,0,0,19799.0,91079.21596609056,CIR1
24586,KEGG_2019_Human,Ribosome,1/153,0.0076499133771537,0.0076499133771537,0,0,19847.0,96715.6407630817,RPS4X
24587,KEGG_2019_Human,Thiamine metabolism,1/15,0.0007499814841592997,0.0014999629683185,0,0,19985.0,143801.30885993244,NTPCR
24588,KEGG_2019_Human,Purine metabolism,1/129,0.006449921761047,0.006449921761047,0,0,19871.0,100223.109907462,NTPCR
24589,KEGG_2019_Human,Pyrimidine metabolism,1/57,0.002849953326298,0.005699906652596,0,0,19943.0,116875.00742975442,DCK
24590,KEGG_2019_Human,Purine metabolism,1/129,0.006449921761047,0.006449921761047,0,0,19871.0,100223.109907462,DCK
24591,KEGG_2019_Human,Protein export,1/23,0.0011499748819949,0.0011499748819949,0,0,19977.0,135204.63922267244,SPCS1
24592,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0164998674589645,0,0,19670.0,80733.60565076157,NFX1
24593,KEGG_2019_Human,Huntington disease,1/193,0.0096499008972596,0.0096499008972596,0,0,19807.0,91920.47679471428,DNAL4
24594,KEGG_2019_Human,Toll-like receptor signaling pathway,1/104,0.0051999314202997,0.0089499050800561,0,0,19896.0,104635.24941415618,TLR1
24595,KEGG_2019_Human,Tuberculosis,1/179,0.0089499050800561,0.0089499050800561,0,0,19821.0,93478.0629355712,TLR1
24596,KEGG_2019_Human,Steroid hormone biosynthesis,1/60,0.002999951725986,0.0033499481224912,0,0,19940.0,115834.63209072244,HSD17B6
24597,KEGG_2019_Human,Retinol metabolism,1/67,0.0033499481224912,0.0033499481224912,0,0,19933.0,113594.38808369274,HSD17B6
24598,KEGG_2019_Human,Thyroid hormone signaling pathway,1/116,0.0057999266512085,0.0057999266512085,0,0,19884.0,102400.8105961506,RCAN2
24599,KEGG_2019_Human,Other glycan degradation,1/18,0.0008999788927950273,0.002699936678385,0,0,19982.0,140136.54844084635,NEU1
24600,KEGG_2019_Human,Sphingolipid metabolism,1/47,0.0023499589392381,0.0035249384088572,0,0,19953.0,120782.64067395544,NEU1
24601,KEGG_2019_Human,Lysosome,1/123,0.0061499239842961,0.0061499239842961,0,0,19877.0,101200.07933676826,NEU1
24602,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR1L3
24603,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,UCN3
24604,KEGG_2019_Human,Leishmaniasis,1/74,0.0036999446830449,0.0126998449924495,0,0,19926.0,111574.38983110404,TAB1
24605,KEGG_2019_Human,NF-kappa B signaling pathway,1/95,0.0047499351803394,0.0126998449924495,0,0,19905.0,106484.27183626965,TAB1
24606,KEGG_2019_Human,Toll-like receptor signaling pathway,1/104,0.0051999314202997,0.0126998449924495,0,0,19896.0,104635.24941415618,TAB1
24607,KEGG_2019_Human,TNF signaling pathway,1/110,0.0054999290027479,0.0126998449924495,0,0,19890.0,103488.06969787036,TAB1
24608,KEGG_2019_Human,Toxoplasmosis,1/113,0.0056499278191151,0.0126998449924495,0,0,19887.0,102937.34947211576,TAB1
24609,KEGG_2019_Human,Osteoclast differentiation,1/127,0.0063499224962247,0.0126998449924495,0,0,19873.0,100543.72072014232,TAB1
24610,KEGG_2019_Human,Hepatitis B,1/163,0.0081499100978668,0.0127198746031507,0,0,19837.0,95410.9786681514,TAB1
24611,KEGG_2019_Human,NOD-like receptor signaling pathway,1/178,0.0088999053857096,0.0127198746031507,0,0,19822.0,93593.82745769851,TAB1
24612,KEGG_2019_Human,Epstein-Barr virus infection,1/201,0.0100498985877989,0.0127198746031507,0,0,19799.0,91079.21596609056,TAB1
24613,KEGG_2019_Human,Human immunodeficiency virus 1 infection,1/212,0.0105998955026255,0.0127198746031507,0,0,19788.0,89974.27756224656,TAB1
24614,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0160907726767098,0,0,19705.0,83086.53988020132,TAB1
24615,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,TAB1
24616,KEGG_2019_Human,Ribosome,1/153,0.0076499133771537,0.0076499133771537,0,0,19847.0,96715.6407630817,RPL24
24617,KEGG_2019_Human,Nicotinate and nicotinamide metabolism,1/30,0.0014999697593334,0.004274929989447,0,0,19970.0,129851.13732048514,NT5C3B
24618,KEGG_2019_Human,Pyrimidine metabolism,1/57,0.002849953326298,0.004274929989447,0,0,19943.0,116875.00742975442,NT5C3B
24619,KEGG_2019_Human,Purine metabolism,1/129,0.006449921761047,0.006449921761047,0,0,19871.0,100223.109907462,NT5C3B
24620,KEGG_2019_Human,Type I diabetes mellitus,1/43,0.0021499613216957,0.0052665897556449,0,0,19957.0,122581.98940490963,HSPD1
24621,KEGG_2019_Human,Legionellosis,1/55,0.0027499544131125,0.0052665897556449,0,0,19945.0,117599.1294878737,HSPD1
24622,KEGG_2019_Human,RNA degradation,1/79,0.0039499423167337,0.0052665897556449,0,0,19921.0,110243.89578070649,HSPD1
24623,KEGG_2019_Human,Tuberculosis,1/179,0.0089499050800561,0.0089499050800561,0,0,19821.0,93478.0629355712,HSPD1
24624,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF558
24625,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF431
24626,KEGG_2019_Human,Lysosome,1/123,0.0061499239842961,0.0061499239842961,0,0,19877.0,101200.07933676826,NAGPA
24627,KEGG_2019_Human,Ras signaling pathway,1/232,0.0115998901349604,0.0115998901349604,0,0,19768.0,88101.22480150245,RASA4
24628,KEGG_2019_Human,N-Glycan biosynthesis,1/50,0.0024999572069037,0.0024999572069037,0,0,19950.0,119530.05920663515,MGAT4D
24629,KEGG_2019_Human,NOD-like receptor signaling pathway,1/178,0.0088999053857096,0.0140998535552025,0,0,19822.0,93593.82745769851,P2RX7
24630,KEGG_2019_Human,Calcium signaling pathway,1/188,0.009399902370135,0.0140998535552025,0,0,19812.0,92463.712994847,P2RX7
24631,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,P2RX7
24632,KEGG_2019_Human,Estrogen signaling pathway,1/137,0.0068499188797651,0.0068499188797651,0,0,19863.0,98987.62735269018,KRT35
24633,KEGG_2019_Human,Vasopressin-regulated water reabsorption,1/44,0.0021999607179423,0.0047999167135976,0,0,19956.0,122117.06559109331,RAB11A
24634,KEGG_2019_Human,Endocrine and other factor-regulated calcium reabsorption,1/48,0.0023999583567988,0.0047999167135976,0,0,19952.0,120356.5272753826,RAB11A
24635,KEGG_2019_Human,Pancreatic secretion,1/98,0.0048999339081079,0.0065332452108106,0,0,19902.0,105849.45495286948,RAB11A
24636,KEGG_2019_Human,Endocytosis,1/244,0.0121998870519305,0.0121998870519305,0,0,19756.0,87051.4275316661,RAB11A
24637,KEGG_2019_Human,RNA degradation,1/79,0.0039499423167337,0.0039499423167337,0,0,19921.0,110243.89578070649,EXOSC2
24638,KEGG_2019_Human,mRNA surveillance pathway,1/91,0.0045499369072032,0.0085499075557634,0,0,19909.0,107362.10783923086,BCL2L2-PABPN1
24639,KEGG_2019_Human,Influenza A,1/171,0.0085499075557634,0.0085499075557634,0,0,19829.0,94422.42241345016,BCL2L2-PABPN1
24640,KEGG_2019_Human,Amino sugar and nucleotide sugar metabolism,1/48,0.0023999583567988,0.0023999583567988,0,0,19952.0,120356.5272753826,NANP
24641,KEGG_2019_Human,Oxidative phosphorylation,1/133,0.0066499203093911,0.0112582177134695,0,0,19867.0,99596.2591544721,NDUFB5
24642,KEGG_2019_Human,Parkinson disease,1/142,0.0070999171242726,0.0112582177134695,0,0,19858.0,98250.87390500787,NDUFB5
24643,KEGG_2019_Human,Retrograde endocannabinoid signaling,1/148,0.007399915061391,0.0112582177134695,0,0,19852.0,97399.60470052566,NDUFB5
24644,KEGG_2019_Human,Non-alcoholic fatty liver disease (NAFLD),1/149,0.0074499147221605,0.0112582177134695,0,0,19851.0,97261.02051561224,NDUFB5
24645,KEGG_2019_Human,Alzheimer disease,1/171,0.0085499075557634,0.0112582177134695,0,0,19829.0,94422.42241345016,NDUFB5
24646,KEGG_2019_Human,Huntington disease,1/193,0.0096499008972596,0.0112582177134695,0,0,19807.0,91920.47679471428,NDUFB5
24647,KEGG_2019_Human,Thermogenesis,1/231,0.0115498903940656,0.0115498903940656,0,0,19769.0,88191.07730937863,NDUFB5
24648,KEGG_2019_Human,MicroRNAs in cancer,1/299,0.0149498740670514,0.0149498740670514,0,0,19701.0,82804.33538735632,BMF
24649,KEGG_2019_Human,Protein processing in endoplasmic reticulum,1/165,0.0082499094553477,0.0082499094553477,0,0,19835.0,95159.46482222488,SEC23B
24650,KEGG_2019_Human,Vasopressin-regulated water reabsorption,1/44,0.0021999607179423,0.0021999607179423,0,0,19956.0,122117.06559109331,DYNLL2
24651,KEGG_2019_Human,Ribosome,1/153,0.0076499133771537,0.0076499133771537,0,0,19847.0,96715.6407630817,RPS8
24652,KEGG_2019_Human,Aldosterone-regulated sodium reabsorption,1/37,0.0018499650702878,0.0018499650702878,0,0,19963.0,125618.9446446357,FXYD4
24653,KEGG_2019_Human,Glyoxylate and dicarboxylate metabolism,1/30,0.0014999697593334,0.0020999619311272,0,0,19970.0,129851.13732048514,AFMID
24654,KEGG_2019_Human,Tryptophan metabolism,1/42,0.0020999619311272,0.0020999619311272,0,0,19958.0,123057.75613441122,AFMID
24655,KEGG_2019_Human,Ribosome biogenesis in eukaryotes,1/101,0.0050499326546803,0.0082499094553477,0,0,19899.0,105233.48101229242,POP7
24656,KEGG_2019_Human,RNA transport,1/165,0.0082499094553477,0.0082499094553477,0,0,19835.0,95159.46482222488,POP7
24657,KEGG_2019_Human,Lysosome,1/123,0.0061499239842961,0.0089499050800561,0,0,19877.0,101200.07933676826,LAMP1
24658,KEGG_2019_Human,Autophagy,1/128,0.0063999221281459,0.0089499050800561,0,0,19872.0,100382.8010329652,LAMP1
24659,KEGG_2019_Human,Phagosome,1/152,0.0075999137114971,0.0089499050800561,0,0,19848.0,96850.665715497,LAMP1
24660,KEGG_2019_Human,Tuberculosis,1/179,0.0089499050800561,0.0089499050800561,0,0,19821.0,93478.0629355712,LAMP1
24661,KEGG_2019_Human,Pyrimidine metabolism,1/57,0.002849953326298,0.0085498599788941,0,0,19943.0,116875.00742975442,ENTPD3
24662,KEGG_2019_Human,Purine metabolism,1/129,0.006449921761047,0.0096748826415705,0,0,19871.0,100223.109907462,ENTPD3
24663,KEGG_2019_Human,Epstein-Barr virus infection,1/201,0.0100498985877989,0.0100498985877989,0,0,19799.0,91079.21596609056,ENTPD3
24664,KEGG_2019_Human,mRNA surveillance pathway,1/91,0.0045499369072032,0.0082499094553477,0,0,19909.0,107362.10783923086,MAGOH
24665,KEGG_2019_Human,Spliceosome,1/134,0.0066999199497742,0.0082499094553477,0,0,19866.0,99442.43560916925,MAGOH
24666,KEGG_2019_Human,RNA transport,1/165,0.0082499094553477,0.0082499094553477,0,0,19835.0,95159.46482222488,MAGOH
24667,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,HCRTR1
24668,KEGG_2019_Human,Oxidative phosphorylation,1/133,0.0066499203093911,0.0112582177134695,0,0,19867.0,99596.2591544721,NDUFA3
24669,KEGG_2019_Human,Parkinson disease,1/142,0.0070999171242726,0.0112582177134695,0,0,19858.0,98250.87390500787,NDUFA3
24670,KEGG_2019_Human,Retrograde endocannabinoid signaling,1/148,0.007399915061391,0.0112582177134695,0,0,19852.0,97399.60470052566,NDUFA3
24671,KEGG_2019_Human,Non-alcoholic fatty liver disease (NAFLD),1/149,0.0074499147221605,0.0112582177134695,0,0,19851.0,97261.02051561224,NDUFA3
24672,KEGG_2019_Human,Alzheimer disease,1/171,0.0085499075557634,0.0112582177134695,0,0,19829.0,94422.42241345016,NDUFA3
24673,KEGG_2019_Human,Huntington disease,1/193,0.0096499008972596,0.0112582177134695,0,0,19807.0,91920.47679471428,NDUFA3
24674,KEGG_2019_Human,Thermogenesis,1/231,0.0115498903940656,0.0115498903940656,0,0,19769.0,88191.07730937863,NDUFA3
24675,KEGG_2019_Human,Ether lipid metabolism,1/47,0.0023499589392381,0.0046999178784763,0,0,19953.0,120782.64067395544,LPCAT4
24676,KEGG_2019_Human,Glycerophospholipid metabolism,1/97,0.0048499343304706,0.0048499343304706,0,0,19903.0,106058.9096435903,LPCAT4
24677,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR52E4
24678,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,TAAR6
24679,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR51A4
24680,KEGG_2019_Human,Spliceosome,1/134,0.0066999199497742,0.0066999199497742,0,0,19866.0,99442.43560916925,SNRPA
24681,KEGG_2019_Human,Cortisol synthesis and secretion,1/65,0.003249949134407,0.0073499008621619,0,0,19935.0,114209.92613860144,KCNK3
24682,KEGG_2019_Human,Aldosterone synthesis and secretion,1/98,0.0048999339081079,0.0073499008621619,0,0,19902.0,105849.45495286948,KCNK3
24683,KEGG_2019_Human,Cushing syndrome,1/155,0.0077499127120574,0.0077499127120574,0,0,19845.0,96448.16254952336,KCNK3
24684,KEGG_2019_Human,Melanoma,1/72,0.0035999456502131,0.0136123170931188,0,0,19928.0,112131.59838572376,PDGFC
24685,KEGG_2019_Human,Gap junction,1/88,0.0043999382262822,0.0136123170931188,0,0,19912.0,108045.79305232369,PDGFC
24686,KEGG_2019_Human,Prostate cancer,1/97,0.0048499343304706,0.0136123170931188,0,0,19903.0,106058.9096435903,PDGFC
24687,KEGG_2019_Human,Choline metabolism in cancer,1/99,0.0049499334884068,0.0136123170931188,0,0,19901.0,105642.09305076736,PDGFC
24688,KEGG_2019_Human,Phospholipase D signaling pathway,1/148,0.007399915061391,0.0141776434982849,0,0,19852.0,97399.60470052566,PDGFC
24689,KEGG_2019_Human,Focal adhesion,1/199,0.0099498991610159,0.0141776434982849,0,0,19801.0,91286.4288690606,PDGFC
24690,KEGG_2019_Human,Rap1 signaling pathway,1/206,0.010299897173561,0.0141776434982849,0,0,19794.0,90569.849337325,PDGFC
24691,KEGG_2019_Human,Regulation of actin cytoskeleton,1/214,0.0106998949514067,0.0141776434982849,0,0,19786.0,89779.39753374986,PDGFC
24692,KEGG_2019_Human,Ras signaling pathway,1/232,0.0115998901349604,0.0141776434982849,0,0,19768.0,88101.22480150245,PDGFC
24693,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0162248624490157,0,0,19705.0,83086.53988020132,PDGFC
24694,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0176998626413668,0,0,19646.0,79255.8617626126,PDGFC
24695,KEGG_2019_Human,Ribosome biogenesis in eukaryotes,1/101,0.0050499326546803,0.0050499326546803,0,0,19899.0,105233.48101229242,UTP18
24696,KEGG_2019_Human,Renin-angiotensin system,1/23,0.0011499748819949,0.0022999497639899,0,0,19977.0,135204.63922267244,ACE2
24697,KEGG_2019_Human,Protein digestion and absorption,1/90,0.0044999373439762,0.0044999373439762,0,0,19910.0,107587.50385474482,ACE2
24698,KEGG_2019_Human,Protein processing in endoplasmic reticulum,1/165,0.0082499094553477,0.0082499094553477,0,0,19835.0,95159.46482222488,DERL3
24699,KEGG_2019_Human,Ubiquitin mediated proteolysis,1/137,0.0068499188797651,0.0080999104202618,0,0,19863.0,98987.62735269018,PIAS1
24700,KEGG_2019_Human,Hepatitis C,1/155,0.0077499127120574,0.0080999104202618,0,0,19845.0,96448.16254952336,PIAS1
24701,KEGG_2019_Human,JAK-STAT signaling pathway,1/162,0.0080999104202618,0.0080999104202618,0,0,19838.0,95537.86936302872,PIAS1
24702,KEGG_2019_Human,Ribosome biogenesis in eukaryotes,1/101,0.0050499326546803,0.0050499326546803,0,0,19899.0,105233.48101229242,RIOK1
24703,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF430
24704,KEGG_2019_Human,Transcriptional misregulation in cancer,1/186,0.0092999029651357,0.0092999029651357,0,0,19814.0,92684.96451050608,SS18
24705,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,NMBR
24706,KEGG_2019_Human,Estrogen signaling pathway,1/137,0.0068499188797651,0.0068499188797651,0,0,19863.0,98987.62735269018,TFF1
24707,KEGG_2019_Human,mRNA surveillance pathway,1/91,0.0045499369072032,0.0085499075557634,0,0,19909.0,107362.10783923086,NXT2
24708,KEGG_2019_Human,Ribosome biogenesis in eukaryotes,1/101,0.0050499326546803,0.0085499075557634,0,0,19899.0,105233.48101229242,NXT2
24709,KEGG_2019_Human,RNA transport,1/165,0.0082499094553477,0.0085499075557634,0,0,19835.0,95159.46482222488,NXT2
24710,KEGG_2019_Human,Influenza A,1/171,0.0085499075557634,0.0085499075557634,0,0,19829.0,94422.42241345016,NXT2
24711,KEGG_2019_Human,Glycosphingolipid biosynthesis,1/45,0.0022499601197094,0.0026499555173137,0,0,19955.0,121662.49782449217,B4GALT4
24712,KEGG_2019_Human,Glycosaminoglycan biosynthesis,1/53,0.0026499555173137,0.0026499555173137,0,0,19947.0,118349.78824235698,B4GALT4
24713,KEGG_2019_Human,Cocaine addiction,1/49,0.0024499577795033,0.0107410588823654,0,0,19951.0,119939.1172087114,ATF6B
24714,KEGG_2019_Human,Cortisol synthesis and secretion,1/65,0.003249949134407,0.0107410588823654,0,0,19935.0,114209.92613860144,ATF6B
24715,KEGG_2019_Human,Amphetamine addiction,1/68,0.0033999476216189,0.0107410588823654,0,0,19932.0,113293.39338050144,ATF6B
24716,KEGG_2019_Human,Thyroid hormone synthesis,1/74,0.0036999446830449,0.0107410588823654,0,0,19926.0,111574.38983110404,ATF6B
24717,KEGG_2019_Human,Insulin secretion,1/86,0.0042999391173866,0.0107410588823654,0,0,19914.0,108514.46102290176,ATF6B
24718,KEGG_2019_Human,Aldosterone synthesis and secretion,1/98,0.0048999339081079,0.0107410588823654,0,0,19902.0,105849.45495286948,ATF6B
24719,KEGG_2019_Human,Longevity regulating pathway,1/102,0.0050999322416682,0.0107410588823654,0,0,19898.0,105032.15064717118,ATF6B
24720,KEGG_2019_Human,"Parathyroid hormone synthesis, secretion and action",1/106,0.0052999306076525,0.0107410588823654,0,0,19894.0,104245.78450366124,ATF6B
24721,KEGG_2019_Human,TNF signaling pathway,1/110,0.0054999290027479,0.0107410588823654,0,0,19890.0,103488.06969787036,ATF6B
24722,KEGG_2019_Human,Relaxin signaling pathway,1/130,0.0064999213952527,0.0107410588823654,0,0,19870.0,100064.62842845908,ATF6B
24723,KEGG_2019_Human,Dopaminergic synapse,1/131,0.0065499210316603,0.0107410588823654,0,0,19869.0,99907.33811343512,ATF6B
24724,KEGG_2019_Human,Estrogen signaling pathway,1/137,0.0068499188797651,0.0107410588823654,0,0,19863.0,98987.62735269018,ATF6B
24725,KEGG_2019_Human,Adrenergic signaling in cardiomyocytes,1/145,0.0072499160871101,0.0107410588823654,0,0,19855.0,97820.92670675044,ATF6B
24726,KEGG_2019_Human,Cushing syndrome,1/155,0.0077499127120574,0.0107410588823654,0,0,19845.0,96448.16254952336,ATF6B
24727,KEGG_2019_Human,Hepatitis B,1/163,0.0081499100978668,0.0107410588823654,0,0,19837.0,95410.9786681514,ATF6B
24728,KEGG_2019_Human,Protein processing in endoplasmic reticulum,1/165,0.0082499094553477,0.0107410588823654,0,0,19835.0,95159.46482222488,ATF6B
24729,KEGG_2019_Human,cGMP-PKG signaling pathway,1/166,0.0082999091363732,0.0107410588823654,0,0,19834.0,95034.82345515196,ATF6B
24730,KEGG_2019_Human,Alcoholism,1/180,0.0089999047745351,0.0109998836133206,0,0,19820.0,93362.92821536642,ATF6B
24731,KEGG_2019_Human,Viral carcinogenesis,1/201,0.0100498985877989,0.0116367246806093,0,0,19799.0,91079.21596609056,ATF6B
24732,KEGG_2019_Human,Human T-cell leukemia virus 1 infection,1/219,0.0109498935894162,0.0117856011208926,0,0,19781.0,89299.85161916987,ATF6B
24733,KEGG_2019_Human,Human cytomegalovirus infection,1/225,0.0112498919790339,0.0117856011208926,0,0,19775.0,88738.27077557483,ATF6B
24734,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0176998626413668,0,0,19646.0,79255.8617626126,ATF6B
24735,KEGG_2019_Human,Oxidative phosphorylation,1/133,0.0066499203093911,0.0115498903940656,0,0,19867.0,99596.2591544721,ATP5MC3
24736,KEGG_2019_Human,Parkinson disease,1/142,0.0070999171242726,0.0115498903940656,0,0,19858.0,98250.87390500787,ATP5MC3
24737,KEGG_2019_Human,Alzheimer disease,1/171,0.0085499075557634,0.0115498903940656,0,0,19829.0,94422.42241345016,ATP5MC3
24738,KEGG_2019_Human,Huntington disease,1/193,0.0096499008972596,0.0115498903940656,0,0,19807.0,91920.47679471428,ATP5MC3
24739,KEGG_2019_Human,Thermogenesis,1/231,0.0115498903940656,0.0115498903940656,0,0,19769.0,88191.07730937863,ATP5MC3
24740,KEGG_2019_Human,Protein processing in endoplasmic reticulum,1/165,0.0082499094553477,0.0082499094553477,0,0,19835.0,95159.46482222488,PDIA6
24741,KEGG_2019_Human,Glycerolipid metabolism,1/61,0.0030499512001654,0.0061874168605085,0,0,19939.0,115499.24335773686,DGKE
24742,KEGG_2019_Human,Glycerophospholipid metabolism,1/97,0.0048499343304706,0.0061874168605085,0,0,19903.0,106058.9096435903,DGKE
24743,KEGG_2019_Human,Phosphatidylinositol signaling system,1/99,0.0049499334884068,0.0061874168605085,0,0,19901.0,105642.09305076736,DGKE
24744,KEGG_2019_Human,Choline metabolism in cancer,1/99,0.0049499334884068,0.0061874168605085,0,0,19901.0,105642.09305076736,DGKE
24745,KEGG_2019_Human,Phospholipase D signaling pathway,1/148,0.007399915061391,0.007399915061391,0,0,19852.0,97399.60470052566,DGKE
24746,KEGG_2019_Human,Terpenoid backbone biosynthesis,1/22,0.0010999756574123,0.0010999756574123,0,0,19978.0,136099.47030191717,FNTB
24747,KEGG_2019_Human,Glutathione metabolism,1/56,0.0027999538675741,0.0094498771520562,0,0,19944.0,117233.87022514464,MGST1
24748,KEGG_2019_Human,Metabolism of xenobiotics by cytochrome P450,1/74,0.0036999446830449,0.0094498771520562,0,0,19926.0,111574.38983110404,MGST1
24749,KEGG_2019_Human,Chemical carcinogenesis,1/82,0.004099940929819,0.0094498771520562,0,0,19918.0,109484.9180722932,MGST1
24750,KEGG_2019_Human,Drug metabolism,1/108,0.0053999298011749,0.0094498771520562,0,0,19892.0,103863.47861844616,MGST1
24751,KEGG_2019_Human,Fluid shear stress and atherosclerosis,1/139,0.006949918172816,0.0097298854419424,0,0,19861.0,98689.81333375497,MGST1
24752,KEGG_2019_Human,Hepatocellular carcinoma,1/168,0.0083999085011095,0.0097998932512944,0,0,19832.0,94787.72752807094,MGST1
24753,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,MGST1
24754,KEGG_2019_Human,Arginine biosynthesis,1/21,0.0010499764455398,0.0031499293366194,0,0,19979.0,137035.71221916509,ARG1
24755,KEGG_2019_Human,Arginine and proline metabolism,1/49,0.0024499577795033,0.0036749366692549,0,0,19951.0,119939.1172087114,ARG1
24756,KEGG_2019_Human,Amoebiasis,1/96,0.0047999347538706,0.0047999347538706,0,0,19904.0,106270.50039849174,ARG1
24757,KEGG_2019_Human,Phototransduction,1/28,0.0013999711732997,0.0013999711732997,0,0,19972.0,131242.0761597353,GNAT1
24758,KEGG_2019_Human,Ferroptosis,1/40,0.0019999631680592,0.0109498935894162,0,0,19960.0,124043.94523066044,VDAC3
24759,KEGG_2019_Human,Cholesterol metabolism,1/50,0.0024999572069037,0.0109498935894162,0,0,19950.0,119530.05920663515,VDAC3
24760,KEGG_2019_Human,Parkinson disease,1/142,0.0070999171242726,0.0109498935894162,0,0,19858.0,98250.87390500787,VDAC3
24761,KEGG_2019_Human,Cellular senescence,1/160,0.0079999110688441,0.0109498935894162,0,0,19840.0,95793.96509856998,VDAC3
24762,KEGG_2019_Human,Necroptosis,1/162,0.0080999104202618,0.0109498935894162,0,0,19838.0,95537.86936302872,VDAC3
24763,KEGG_2019_Human,Hepatitis B,1/163,0.0081499100978668,0.0109498935894162,0,0,19837.0,95410.9786681514,VDAC3
24764,KEGG_2019_Human,cGMP-PKG signaling pathway,1/166,0.0082999091363732,0.0109498935894162,0,0,19834.0,95034.82345515196,VDAC3
24765,KEGG_2019_Human,NOD-like receptor signaling pathway,1/178,0.0088999053857096,0.0109498935894162,0,0,19822.0,93593.82745769851,VDAC3
24766,KEGG_2019_Human,Calcium signaling pathway,1/188,0.009399902370135,0.0109498935894162,0,0,19812.0,92463.712994847,VDAC3
24767,KEGG_2019_Human,Huntington disease,1/193,0.0096499008972596,0.0109498935894162,0,0,19807.0,91920.47679471428,VDAC3
24768,KEGG_2019_Human,Viral carcinogenesis,1/201,0.0100498985877989,0.0109498935894162,0,0,19799.0,91079.21596609056,VDAC3
24769,KEGG_2019_Human,Human T-cell leukemia virus 1 infection,1/219,0.0109498935894162,0.0109498935894162,0,0,19781.0,89299.85161916987,VDAC3
24770,KEGG_2019_Human,Signaling pathways regulating pluripotency of stem cells,1/139,0.006949918172816,0.006949918172816,0,0,19861.0,98689.81333375497,PCGF1
24771,KEGG_2019_Human,Oxidative phosphorylation,1/133,0.0066499203093911,0.0112582177134695,0,0,19867.0,99596.2591544721,NDUFA2
24772,KEGG_2019_Human,Parkinson disease,1/142,0.0070999171242726,0.0112582177134695,0,0,19858.0,98250.87390500787,NDUFA2
24773,KEGG_2019_Human,Retrograde endocannabinoid signaling,1/148,0.007399915061391,0.0112582177134695,0,0,19852.0,97399.60470052566,NDUFA2
24774,KEGG_2019_Human,Non-alcoholic fatty liver disease (NAFLD),1/149,0.0074499147221605,0.0112582177134695,0,0,19851.0,97261.02051561224,NDUFA2
24775,KEGG_2019_Human,Alzheimer disease,1/171,0.0085499075557634,0.0112582177134695,0,0,19829.0,94422.42241345016,NDUFA2
24776,KEGG_2019_Human,Huntington disease,1/193,0.0096499008972596,0.0112582177134695,0,0,19807.0,91920.47679471428,NDUFA2
24777,KEGG_2019_Human,Thermogenesis,1/231,0.0115498903940656,0.0115498903940656,0,0,19769.0,88191.07730937863,NDUFA2
24778,KEGG_2019_Human,Endocytosis,1/244,0.0121998870519305,0.0121998870519305,0,0,19756.0,87051.4275316661,CAPZA2
24779,KEGG_2019_Human,JAK-STAT signaling pathway,1/162,0.0080999104202618,0.0146998751759735,0,0,19838.0,95537.86936302872,IL20RB
24780,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0146998751759735,0,0,19706.0,83157.67014793828,IL20RB
24781,KEGG_2019_Human,Alcoholism,1/180,0.0089999047745351,0.0089999047745351,0,0,19820.0,93362.92821536642,HAT1
24782,KEGG_2019_Human,Cytosolic DNA-sensing pathway,1/63,0.0031499501598827,0.0133686105123826,0,0,19937.0,114844.46974572667,IFNB1
24783,KEGG_2019_Human,RIG-I-like receptor signaling pathway,1/70,0.0034999466296654,0.0133686105123826,0,0,19930.0,112704.30065625212,IFNB1
24784,KEGG_2019_Human,Chagas disease (American trypanosomiasis),1/103,0.0051499318302617,0.0133686105123826,0,0,19897.0,104832.7525292024,IFNB1
24785,KEGG_2019_Human,Toll-like receptor signaling pathway,1/104,0.0051999314202997,0.0133686105123826,0,0,19896.0,104635.24941415618,IFNB1
24786,KEGG_2019_Human,TNF signaling pathway,1/110,0.0054999290027479,0.0133686105123826,0,0,19890.0,103488.06969787036,IFNB1
24787,KEGG_2019_Human,Osteoclast differentiation,1/127,0.0063499224962247,0.0133686105123826,0,0,19873.0,100543.72072014232,IFNB1
24788,KEGG_2019_Human,Natural killer cell mediated cytotoxicity,1/131,0.0065499210316603,0.0133686105123826,0,0,19869.0,99907.33811343512,IFNB1
24789,KEGG_2019_Human,Measles,1/138,0.0068999185254481,0.0133686105123826,0,0,19862.0,98838.19160389496,IFNB1
24790,KEGG_2019_Human,Hepatitis C,1/155,0.0077499127120574,0.0133686105123826,0,0,19845.0,96448.16254952336,IFNB1
24791,KEGG_2019_Human,Necroptosis,1/162,0.0080999104202618,0.0133686105123826,0,0,19838.0,95537.86936302872,IFNB1
24792,KEGG_2019_Human,JAK-STAT signaling pathway,1/162,0.0080999104202618,0.0133686105123826,0,0,19838.0,95537.86936302872,IFNB1
24793,KEGG_2019_Human,Hepatitis B,1/163,0.0081499100978668,0.0133686105123826,0,0,19837.0,95410.9786681514,IFNB1
24794,KEGG_2019_Human,Influenza A,1/171,0.0085499075557634,0.0133686105123826,0,0,19829.0,94422.42241345016,IFNB1
24795,KEGG_2019_Human,NOD-like receptor signaling pathway,1/178,0.0088999053857096,0.0133686105123826,0,0,19822.0,93593.82745769851,IFNB1
24796,KEGG_2019_Human,Tuberculosis,1/179,0.0089499050800561,0.0133686105123826,0,0,19821.0,93478.0629355712,IFNB1
24797,KEGG_2019_Human,Kaposi sarcoma-associated herpesvirus infection,1/186,0.0092999029651357,0.0133686105123826,0,0,19814.0,92684.96451050608,IFNB1
24798,KEGG_2019_Human,Epstein-Barr virus infection,1/201,0.0100498985877989,0.0135443109200215,0,0,19799.0,91079.21596609056,IFNB1
24799,KEGG_2019_Human,Human immunodeficiency virus 1 infection,1/212,0.0105998955026255,0.0135443109200215,0,0,19788.0,89974.27756224656,IFNB1
24800,KEGG_2019_Human,Human cytomegalovirus infection,1/225,0.0112498919790339,0.0136182902904094,0,0,19775.0,88738.27077557483,IFNB1
24801,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0169048564523695,0,0,19706.0,83157.67014793828,IFNB1
24802,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0180712834074373,0,0,19670.0,80733.60565076157,IFNB1
24803,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0185044018523381,0,0,19646.0,79255.8617626126,IFNB1
24804,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,IFNB1
24805,KEGG_2019_Human,Homologous recombination,1/41,0.0020499625466866,0.0033749401795641,0,0,19959.0,123544.88783416104,SEM1
24806,KEGG_2019_Human,Proteasome,1/45,0.0022499601197094,0.0033749401795641,0,0,19955.0,121662.49782449217,SEM1
24807,KEGG_2019_Human,Epstein-Barr virus infection,1/201,0.0100498985877989,0.0100498985877989,0,0,19799.0,91079.21596609056,SEM1
24808,KEGG_2019_Human,Aminoacyl-tRNA biosynthesis,1/66,0.003299948626608,0.003299948626608,0,0,19934.0,113899.85357353876,YARS2
24809,KEGG_2019_Human,Proteasome,1/45,0.0022499601197094,0.0022499601197094,0,0,19955.0,121662.49782449217,PSMA8
24810,KEGG_2019_Human,Endocrine and other factor-regulated calcium reabsorption,1/48,0.0023999583567988,0.0070665741435367,0,0,19952.0,120356.5272753826,PTH
24811,KEGG_2019_Human,Rheumatoid arthritis,1/91,0.0045499369072032,0.0070665741435367,0,0,19909.0,107362.10783923086,PTH
24812,KEGG_2019_Human,"Parathyroid hormone synthesis, secretion and action",1/106,0.0052999306076525,0.0070665741435367,0,0,19894.0,104245.78450366124,PTH
24813,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,PTH
24814,KEGG_2019_Human,Histidine metabolism,1/23,0.0011499748819949,0.0011499748819949,0,0,19977.0,135204.63922267244,HNMT
24815,KEGG_2019_Human,p53 signaling pathway,1/72,0.0035999456502131,0.0071998913004262,0,0,19928.0,112131.59838572376,CCNG1
24816,KEGG_2019_Human,MicroRNAs in cancer,1/299,0.0149498740670514,0.0149498740670514,0,0,19701.0,82804.33538735632,CCNG1
24817,KEGG_2019_Human,Oxidative phosphorylation,1/133,0.0066499203093911,0.0112582177134695,0,0,19867.0,99596.2591544721,NDUFA1
24818,KEGG_2019_Human,Parkinson disease,1/142,0.0070999171242726,0.0112582177134695,0,0,19858.0,98250.87390500787,NDUFA1
24819,KEGG_2019_Human,Retrograde endocannabinoid signaling,1/148,0.007399915061391,0.0112582177134695,0,0,19852.0,97399.60470052566,NDUFA1
24820,KEGG_2019_Human,Non-alcoholic fatty liver disease (NAFLD),1/149,0.0074499147221605,0.0112582177134695,0,0,19851.0,97261.02051561224,NDUFA1
24821,KEGG_2019_Human,Alzheimer disease,1/171,0.0085499075557634,0.0112582177134695,0,0,19829.0,94422.42241345016,NDUFA1
24822,KEGG_2019_Human,Huntington disease,1/193,0.0096499008972596,0.0112582177134695,0,0,19807.0,91920.47679471428,NDUFA1
24823,KEGG_2019_Human,Thermogenesis,1/231,0.0115498903940656,0.0115498903940656,0,0,19769.0,88191.07730937863,NDUFA1
24824,KEGG_2019_Human,Other types of O-glycan biosynthesis,1/22,0.0010999756574123,0.0010999756574123,0,0,19978.0,136099.47030191717,EOGT
24825,KEGG_2019_Human,Base excision repair,1/33,0.0016499677032113,0.0016499677032113,0,0,19967.0,127928.56031580272,TDG
24826,KEGG_2019_Human,Chemokine signaling pathway,1/190,0.0094999017791995,0.0146998751759735,0,0,19810.0,92244.74636351672,CCL27
24827,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0146998751759735,0,0,19706.0,83157.67014793828,CCL27
24828,KEGG_2019_Human,Retinol metabolism,1/67,0.0033499481224912,0.0033499481224912,0,0,19933.0,113594.38808369274,RETSAT
24829,KEGG_2019_Human,Taste transduction,1/83,0.0041499404726918,0.0041499404726918,0,0,19917.0,109237.99888847338,TAS2R9
24830,KEGG_2019_Human,p53 signaling pathway,1/72,0.0035999456502131,0.010559873071839,0,0,19928.0,112131.59838572376,CCNB2
24831,KEGG_2019_Human,Progesterone-mediated oocyte maturation,1/99,0.0049499334884068,0.010559873071839,0,0,19901.0,105642.09305076736,CCNB2
24832,KEGG_2019_Human,Cell cycle,1/124,0.0061999236097501,0.010559873071839,0,0,19876.0,101034.04709010696,CCNB2
24833,KEGG_2019_Human,Oocyte meiosis,1/125,0.0062499232373748,0.010559873071839,0,0,19875.0,100869.32368441945,CCNB2
24834,KEGG_2019_Human,FoxO signaling pathway,1/132,0.0065999206698993,0.010559873071839,0,0,19868.0,99751.22090491928,CCNB2
24835,KEGG_2019_Human,Cellular senescence,1/160,0.0079999110688441,0.0106665480917922,0,0,19840.0,95793.96509856998,CCNB2
24836,KEGG_2019_Human,Human immunodeficiency virus 1 infection,1/212,0.0105998955026255,0.0109498935894162,0,0,19788.0,89974.27756224656,CCNB2
24837,KEGG_2019_Human,Human T-cell leukemia virus 1 infection,1/219,0.0109498935894162,0.0109498935894162,0,0,19781.0,89299.85161916987,CCNB2
24838,KEGG_2019_Human,Spliceosome,1/134,0.0066999199497742,0.0066999199497742,0,0,19866.0,99442.43560916925,PPIL1
24839,KEGG_2019_Human,NF-kappa B signaling pathway,1/95,0.0047499351803394,0.0142498055410182,0,0,19905.0,106484.27183626965,TNFSF14
24840,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0220498127639602,0,0,19706.0,83157.67014793828,TNFSF14
24841,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,TNFSF14
24842,KEGG_2019_Human,TGF-beta signaling pathway,1/90,0.0044999373439762,0.0044999373439762,0,0,19910.0,107587.50385474482,FST
24843,KEGG_2019_Human,Other types of O-glycan biosynthesis,1/22,0.0010999756574123,0.0026499555173137,0,0,19978.0,136099.47030191717,B4GALT3
24844,KEGG_2019_Human,Mannose type O-glycan biosynthesis,1/23,0.0011499748819949,0.0026499555173137,0,0,19977.0,135204.63922267244,B4GALT3
24845,KEGG_2019_Human,Glycosphingolipid biosynthesis,1/45,0.0022499601197094,0.0026499555173137,0,0,19955.0,121662.49782449217,B4GALT3
24846,KEGG_2019_Human,N-Glycan biosynthesis,1/50,0.0024999572069037,0.0026499555173137,0,0,19950.0,119530.05920663515,B4GALT3
24847,KEGG_2019_Human,Glycosaminoglycan biosynthesis,1/53,0.0026499555173137,0.0026499555173137,0,0,19947.0,118349.78824235698,B4GALT3
24848,KEGG_2019_Human,SNARE interactions in vesicular transport,1/34,0.0016999670339032,0.0033999340678064,0,0,19966.0,127326.1054203148,STX2
24849,KEGG_2019_Human,Synaptic vesicle cycle,1/78,0.0038999427840466,0.0038999427840466,0,0,19922.0,110503.2180492851,STX2
24850,KEGG_2019_Human,RIG-I-like receptor signaling pathway,1/70,0.0034999466296654,0.0034999466296654,0,0,19930.0,112704.30065625212,RNF125
24851,KEGG_2019_Human,Ribosome,1/153,0.0076499133771537,0.0076499133771537,0,0,19847.0,96715.6407630817,MRPS18C
24852,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF554
24853,KEGG_2019_Human,JAK-STAT signaling pathway,1/162,0.0080999104202618,0.0146998751759735,0,0,19838.0,95537.86936302872,TSLP
24854,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0146998751759735,0,0,19706.0,83157.67014793828,TSLP
24855,KEGG_2019_Human,Ribosome biogenesis in eukaryotes,1/101,0.0050499326546803,0.0050499326546803,0,0,19899.0,105233.48101229242,RBM28
24856,KEGG_2019_Human,Proteasome,1/45,0.0022499601197094,0.0022499601197094,0,0,19955.0,121662.49782449217,PSMA7
24857,KEGG_2019_Human,Ribosome,1/153,0.0076499133771537,0.0076499133771537,0,0,19847.0,96715.6407630817,RPL32
24858,KEGG_2019_Human,Glycolysis / Gluconeogenesis,1/68,0.0033999476216189,0.0033999476216189,0,0,19932.0,113293.39338050144,GAPDHS
24859,KEGG_2019_Human,Vibrio cholerae infection,1/50,0.0024999572069037,0.0097713176290677,0,0,19950.0,119530.05920663515,ATP6V0B
24860,KEGG_2019_Human,Epithelial cell signaling in Helicobacter pylori infection,1/68,0.0033999476216189,0.0097713176290677,0,0,19932.0,113293.39338050144,ATP6V0B
24861,KEGG_2019_Human,Synaptic vesicle cycle,1/78,0.0038999427840466,0.0097713176290677,0,0,19922.0,110503.2180492851,ATP6V0B
24862,KEGG_2019_Human,Rheumatoid arthritis,1/91,0.0045499369072032,0.0097713176290677,0,0,19909.0,107362.10783923086,ATP6V0B
24863,KEGG_2019_Human,Lysosome,1/123,0.0061499239842961,0.0097713176290677,0,0,19877.0,101200.07933676826,ATP6V0B
24864,KEGG_2019_Human,Oxidative phosphorylation,1/133,0.0066499203093911,0.0097713176290677,0,0,19867.0,99596.2591544721,ATP6V0B
24865,KEGG_2019_Human,Phagosome,1/152,0.0075999137114971,0.0097713176290677,0,0,19848.0,96850.665715497,ATP6V0B
24866,KEGG_2019_Human,Tuberculosis,1/179,0.0089499050800561,0.0100686432150631,0,0,19821.0,93478.0629355712,ATP6V0B
24867,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0164998674589645,0,0,19670.0,80733.60565076157,ATP6V0B
24868,KEGG_2019_Human,Fat digestion and absorption,1/41,0.0020499625466866,0.0033332762758716,0,0,19959.0,123544.88783416104,ABCG5
24869,KEGG_2019_Human,ABC transporters,1/45,0.0022499601197094,0.0033332762758716,0,0,19955.0,121662.49782449217,ABCG5
24870,KEGG_2019_Human,Cholesterol metabolism,1/50,0.0024999572069037,0.0033332762758716,0,0,19950.0,119530.05920663515,ABCG5
24871,KEGG_2019_Human,Bile secretion,1/72,0.0035999456502131,0.0035999456502131,0,0,19928.0,112131.59838572376,ABCG5
24872,KEGG_2019_Human,Asthma,1/31,0.0015499690656704,0.0071332402702567,0,0,19969.0,129189.85098816035,IL4
24873,KEGG_2019_Human,Allograft rejection,1/38,0.001899964429635,0.0071332402702567,0,0,19962.0,125080.29732025368,IL4
24874,KEGG_2019_Human,Intestinal immune network for IgA production,1/48,0.0023999583567988,0.0071332402702567,0,0,19952.0,120356.5272753826,IL4
24875,KEGG_2019_Human,Autoimmune thyroid disease,1/53,0.0026499555173137,0.0071332402702567,0,0,19947.0,118349.78824235698,IL4
24876,KEGG_2019_Human,Inflammatory bowel disease (IBD),1/65,0.003249949134407,0.0071332402702567,0,0,19935.0,114209.92613860144,IL4
24877,KEGG_2019_Human,Fc epsilon RI signaling pathway,1/68,0.0033999476216189,0.0071332402702567,0,0,19932.0,113293.39338050144,IL4
24878,KEGG_2019_Human,Leishmaniasis,1/74,0.0036999446830449,0.0071332402702567,0,0,19926.0,111574.38983110404,IL4
24879,KEGG_2019_Human,Th1 and Th2 cell differentiation,1/92,0.0045999364719865,0.0071332402702567,0,0,19908.0,107139.13814408927,IL4
24880,KEGG_2019_Human,IL-17 signaling pathway,1/93,0.0046499360391879,0.0071332402702567,0,0,19907.0,106918.54242106884,IL4
24881,KEGG_2019_Human,Hematopoietic cell lineage,1/97,0.0048499343304706,0.0071332402702567,0,0,19903.0,106058.9096435903,IL4
24882,KEGG_2019_Human,T cell receptor signaling pathway,1/101,0.0050499326546803,0.0071332402702567,0,0,19899.0,105233.48101229242,IL4
24883,KEGG_2019_Human,Th17 cell differentiation,1/107,0.0053499302026925,0.0071332402702567,0,0,19893.0,104053.753408911,IL4
24884,KEGG_2019_Human,JAK-STAT signaling pathway,1/162,0.0080999104202618,0.0099691205172453,0,0,19838.0,95537.86936302872,IL4
24885,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0167998573439697,0,0,19706.0,83157.67014793828,IL4
24886,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0188798534841246,0,0,19646.0,79255.8617626126,IL4
24887,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,IL4
24888,KEGG_2019_Human,Gap junction,1/88,0.0043999382262822,0.0094165463651919,0,0,19912.0,108045.79305232369,HTR2B
24889,KEGG_2019_Human,Inflammatory mediator regulation of TRP channels,1/100,0.0049999330710556,0.0094165463651919,0,0,19900.0,105436.78197328727,HTR2B
24890,KEGG_2019_Human,Serotonergic synapse,1/113,0.0056499278191151,0.0094165463651919,0,0,19887.0,102937.34947211576,HTR2B
24891,KEGG_2019_Human,Calcium signaling pathway,1/188,0.009399902370135,0.0117498779626688,0,0,19812.0,92463.712994847,HTR2B
24892,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,HTR2B
24893,KEGG_2019_Human,Asthma,1/31,0.0015499690656704,0.0083141731379497,0,0,19969.0,129189.85098816035,HLA-DRB1
24894,KEGG_2019_Human,Allograft rejection,1/38,0.001899964429635,0.0083141731379497,0,0,19962.0,125080.29732025368,HLA-DRB1
24895,KEGG_2019_Human,Graft-versus-host disease,1/41,0.0020499625466866,0.0083141731379497,0,0,19959.0,123544.88783416104,HLA-DRB1
24896,KEGG_2019_Human,Type I diabetes mellitus,1/43,0.0021499613216957,0.0083141731379497,0,0,19957.0,122581.98940490963,HLA-DRB1
24897,KEGG_2019_Human,Intestinal immune network for IgA production,1/48,0.0023999583567988,0.0083141731379497,0,0,19952.0,120356.5272753826,HLA-DRB1
24898,KEGG_2019_Human,Autoimmune thyroid disease,1/53,0.0026499555173137,0.0083141731379497,0,0,19947.0,118349.78824235698,HLA-DRB1
24899,KEGG_2019_Human,Viral myocarditis,1/59,0.0029499522555206,0.0083141731379497,0,0,19941.0,116175.59385530632,HLA-DRB1
24900,KEGG_2019_Human,Inflammatory bowel disease (IBD),1/65,0.003249949134407,0.0083141731379497,0,0,19935.0,114209.92613860144,HLA-DRB1
24901,KEGG_2019_Human,Staphylococcus aureus infection,1/68,0.0033999476216189,0.0083141731379497,0,0,19932.0,113293.39338050144,HLA-DRB1
24902,KEGG_2019_Human,Leishmaniasis,1/74,0.0036999446830449,0.0083141731379497,0,0,19926.0,111574.38983110404,HLA-DRB1
24903,KEGG_2019_Human,Antigen processing and presentation,1/77,0.0038499432547502,0.0083141731379497,0,0,19923.0,110765.8407373636,HLA-DRB1
24904,KEGG_2019_Human,Rheumatoid arthritis,1/91,0.0045499369072032,0.0083141731379497,0,0,19909.0,107362.10783923086,HLA-DRB1
24905,KEGG_2019_Human,Th1 and Th2 cell differentiation,1/92,0.0045999364719865,0.0083141731379497,0,0,19908.0,107139.13814408927,HLA-DRB1
24906,KEGG_2019_Human,Hematopoietic cell lineage,1/97,0.0048499343304706,0.0083141731379497,0,0,19903.0,106058.9096435903,HLA-DRB1
24907,KEGG_2019_Human,Th17 cell differentiation,1/107,0.0053499302026925,0.0084748917286727,0,0,19893.0,104053.753408911,HLA-DRB1
24908,KEGG_2019_Human,Toxoplasmosis,1/113,0.0056499278191151,0.0084748917286727,0,0,19887.0,102937.34947211576,HLA-DRB1
24909,KEGG_2019_Human,Systemic lupus erythematosus,1/133,0.0066499203093911,0.0093881227897286,0,0,19867.0,99596.2591544721,HLA-DRB1
24910,KEGG_2019_Human,Cell adhesion molecules (CAMs),1/145,0.0072499160871101,0.0095998910039963,0,0,19855.0,97820.92670675044,HLA-DRB1
24911,KEGG_2019_Human,Phagosome,1/152,0.0075999137114971,0.0095998910039963,0,0,19848.0,96850.665715497,HLA-DRB1
24912,KEGG_2019_Human,Influenza A,1/171,0.0085499075557634,0.0102284629486356,0,0,19829.0,94422.42241345016,HLA-DRB1
24913,KEGG_2019_Human,Tuberculosis,1/179,0.0089499050800561,0.0102284629486356,0,0,19821.0,93478.0629355712,HLA-DRB1
24914,KEGG_2019_Human,Epstein-Barr virus infection,1/201,0.0100498985877989,0.0109635257321443,0,0,19799.0,91079.21596609056,HLA-DRB1
24915,KEGG_2019_Human,Human T-cell leukemia virus 1 infection,1/219,0.0109498935894162,0.0114259759193908,0,0,19781.0,89299.85161916987,HLA-DRB1
24916,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,HLA-DRB1
24917,KEGG_2019_Human,Long-term potentiation,1/67,0.0033499481224912,0.0106771546448906,0,0,19933.0,113594.38808369274,CAMK2D
24918,KEGG_2019_Human,Amphetamine addiction,1/68,0.0033999476216189,0.0106771546448906,0,0,19932.0,113293.39338050144,CAMK2D
24919,KEGG_2019_Human,Gastric acid secretion,1/75,0.0037499442041125,0.0106771546448906,0,0,19925.0,111301.33528642564,CAMK2D
24920,KEGG_2019_Human,Glioma,1/75,0.0037499442041125,0.0106771546448906,0,0,19925.0,111301.33528642564,CAMK2D
24921,KEGG_2019_Human,ErbB signaling pathway,1/85,0.004249939567045,0.0106771546448906,0,0,19915.0,108752.83801948265,CAMK2D
24922,KEGG_2019_Human,Insulin secretion,1/86,0.0042999391173866,0.0106771546448906,0,0,19914.0,108514.46102290176,CAMK2D
24923,KEGG_2019_Human,GnRH signaling pathway,1/93,0.0046499360391879,0.0106771546448906,0,0,19907.0,106918.54242106884,CAMK2D
24924,KEGG_2019_Human,Circadian entrainment,1/97,0.0048499343304706,0.0106771546448906,0,0,19903.0,106058.9096435903,CAMK2D
24925,KEGG_2019_Human,Aldosterone synthesis and secretion,1/98,0.0048999339081079,0.0106771546448906,0,0,19902.0,105849.45495286948,CAMK2D
24926,KEGG_2019_Human,Inflammatory mediator regulation of TRP channels,1/100,0.0049999330710556,0.0106771546448906,0,0,19900.0,105436.78197328727,CAMK2D
24927,KEGG_2019_Human,HIF-1 signaling pathway,1/100,0.0049999330710556,0.0106771546448906,0,0,19900.0,105436.78197328727,CAMK2D
24928,KEGG_2019_Human,Melanogenesis,1/101,0.0050499326546803,0.0106771546448906,0,0,19899.0,105233.48101229242,CAMK2D
24929,KEGG_2019_Human,Glucagon signaling pathway,1/103,0.0051499318302617,0.0106771546448906,0,0,19897.0,104832.7525292024,CAMK2D
24930,KEGG_2019_Human,Cholinergic synapse,1/112,0.0055999282120529,0.0106771546448906,0,0,19888.0,103119.30984392198,CAMK2D
24931,KEGG_2019_Human,Neurotrophin signaling pathway,1/119,0.0059499254985137,0.0106771546448906,0,0,19881.0,101877.73080211312,CAMK2D
24932,KEGG_2019_Human,Oocyte meiosis,1/125,0.0062499232373748,0.0106771546448906,0,0,19875.0,100869.32368441945,CAMK2D
24933,KEGG_2019_Human,Dopaminergic synapse,1/131,0.0065499210316603,0.0106771546448906,0,0,19869.0,99907.33811343512,CAMK2D
24934,KEGG_2019_Human,Adrenergic signaling in cardiomyocytes,1/145,0.0072499160871101,0.0106771546448906,0,0,19855.0,97820.92670675044,CAMK2D
24935,KEGG_2019_Human,Oxytocin signaling pathway,1/153,0.0076499133771537,0.0106771546448906,0,0,19847.0,96715.6407630817,CAMK2D
24936,KEGG_2019_Human,Cushing syndrome,1/155,0.0077499127120574,0.0106771546448906,0,0,19845.0,96448.16254952336,CAMK2D
24937,KEGG_2019_Human,Wnt signaling pathway,1/158,0.0078999117225733,0.0106771546448906,0,0,19842.0,96053.2110949472,CAMK2D
24938,KEGG_2019_Human,Necroptosis,1/162,0.0080999104202618,0.0106771546448906,0,0,19838.0,95537.86936302872,CAMK2D
24939,KEGG_2019_Human,Tuberculosis,1/179,0.0089499050800561,0.0109038867493566,0,0,19821.0,93478.0629355712,CAMK2D
24940,KEGG_2019_Human,Axon guidance,1/181,0.0090499044707863,0.0109038867493566,0,0,19819.0,93248.41634586031,CAMK2D
24941,KEGG_2019_Human,Calcium signaling pathway,1/188,0.009399902370135,0.0109038867493566,0,0,19812.0,92463.712994847,CAMK2D
24942,KEGG_2019_Human,Proteoglycans in cancer,1/201,0.0100498985877989,0.0112095022710065,0,0,19799.0,91079.21596609056,CAMK2D
24943,KEGG_2019_Human,cAMP signaling pathway,1/212,0.0105998955026255,0.0113850729472645,0,0,19788.0,89974.27756224656,CAMK2D
24944,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0229926981863763,0,0,19556.0,74462.79263140135,CAMK2D
24945,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,CAMK2D
24946,KEGG_2019_Human,cGMP-PKG signaling pathway,1/166,0.0082999091363732,0.0165998182727465,0,0,19834.0,95034.82345515196,ADRA2A
24947,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,ADRA2A
24948,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR51A2
24949,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR51A7
24950,KEGG_2019_Human,Lysine degradation,1/59,0.0029499522555206,0.0029499522555206,0,0,19941.0,116175.59385530632,HYKK
24951,KEGG_2019_Human,Ribosome biogenesis in eukaryotes,1/101,0.0050499326546803,0.0050499326546803,0,0,19899.0,105233.48101229242,UTP15
24952,KEGG_2019_Human,C-type lectin receptor signaling pathway,1/104,0.0051999314202997,0.0089499050800561,0,0,19896.0,104635.24941415618,PLK3
24953,KEGG_2019_Human,FoxO signaling pathway,1/132,0.0065999206698993,0.0089499050800561,0,0,19868.0,99751.22090491928,PLK3
24954,KEGG_2019_Human,Tuberculosis,1/179,0.0089499050800561,0.0089499050800561,0,0,19821.0,93478.0629355712,PLK3
24955,KEGG_2019_Human,Autoimmune thyroid disease,1/53,0.0026499555173137,0.0067332435395738,0,0,19947.0,118349.78824235698,CTLA4
24956,KEGG_2019_Human,Rheumatoid arthritis,1/91,0.0045499369072032,0.0067332435395738,0,0,19909.0,107362.10783923086,CTLA4
24957,KEGG_2019_Human,T cell receptor signaling pathway,1/101,0.0050499326546803,0.0067332435395738,0,0,19899.0,105233.48101229242,CTLA4
24958,KEGG_2019_Human,Cell adhesion molecules (CAMs),1/145,0.0072499160871101,0.0072499160871101,0,0,19855.0,97820.92670675044,CTLA4
24959,KEGG_2019_Human,Malaria,1/49,0.0024499577795033,0.0096665547828135,0,0,19951.0,119939.1172087114,SDC2
24960,KEGG_2019_Human,Fluid shear stress and atherosclerosis,1/139,0.006949918172816,0.0096665547828135,0,0,19861.0,98689.81333375497,SDC2
24961,KEGG_2019_Human,Cell adhesion molecules (CAMs),1/145,0.0072499160871101,0.0096665547828135,0,0,19855.0,97820.92670675044,SDC2
24962,KEGG_2019_Human,Proteoglycans in cancer,1/201,0.0100498985877989,0.0100498985877989,0,0,19799.0,91079.21596609056,SDC2
24963,KEGG_2019_Human,Ribosome biogenesis in eukaryotes,1/101,0.0050499326546803,0.0050499326546803,0,0,19899.0,105233.48101229242,NOP56
24964,KEGG_2019_Human,Ribosome,1/153,0.0076499133771537,0.0076499133771537,0,0,19847.0,96715.6407630817,MRPS14
24965,KEGG_2019_Human,mRNA surveillance pathway,1/91,0.0045499369072032,0.0103887762846784,0,0,19909.0,107362.10783923086,PPP2R2D
24966,KEGG_2019_Human,Chagas disease (American trypanosomiasis),1/103,0.0051499318302617,0.0103887762846784,0,0,19897.0,104832.7525292024,PPP2R2D
24967,KEGG_2019_Human,Sphingolipid signaling pathway,1/119,0.0059499254985137,0.0103887762846784,0,0,19881.0,101877.73080211312,PPP2R2D
24968,KEGG_2019_Human,AMPK signaling pathway,1/120,0.0059999251180858,0.0103887762846784,0,0,19880.0,101706.2448082016,PPP2R2D
24969,KEGG_2019_Human,Dopaminergic synapse,1/131,0.0065499210316603,0.0103887762846784,0,0,19869.0,99907.33811343512,PPP2R2D
24970,KEGG_2019_Human,Adrenergic signaling in cardiomyocytes,1/145,0.0072499160871101,0.0103887762846784,0,0,19855.0,97820.92670675044,PPP2R2D
24971,KEGG_2019_Human,Hepatitis C,1/155,0.0077499127120574,0.0103887762846784,0,0,19845.0,96448.16254952336,PPP2R2D
24972,KEGG_2019_Human,Hippo signaling pathway,1/160,0.0079999110688441,0.0103887762846784,0,0,19840.0,95793.96509856998,PPP2R2D
24973,KEGG_2019_Human,Tight junction,1/170,0.0084999078692823,0.0103887762846784,0,0,19830.0,94543.49009679438,PPP2R2D
24974,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0176998626413668,0,0,19670.0,80733.60565076157,PPP2R2D
24975,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0176998626413668,0,0,19646.0,79255.8617626126,PPP2R2D
24976,KEGG_2019_Human,Natural killer cell mediated cytotoxicity,1/131,0.0065499210316603,0.0102598890669161,0,0,19869.0,99907.33811343512,TNFSF10
24977,KEGG_2019_Human,FoxO signaling pathway,1/132,0.0065999206698993,0.0102598890669161,0,0,19868.0,99751.22090491928,TNFSF10
24978,KEGG_2019_Human,Apoptosis,1/143,0.0071499167770442,0.0102598890669161,0,0,19857.0,98106.57763600958,TNFSF10
24979,KEGG_2019_Human,Necroptosis,1/162,0.0080999104202618,0.0102598890669161,0,0,19838.0,95537.86936302872,TNFSF10
24980,KEGG_2019_Human,Influenza A,1/171,0.0085499075557634,0.0102598890669161,0,0,19829.0,94422.42241345016,TNFSF10
24981,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0146998751759735,0,0,19706.0,83157.67014793828,TNFSF10
24982,KEGG_2019_Human,Peroxisome,1/83,0.0041499404726918,0.0041499404726918,0,0,19917.0,109237.99888847338,PECR
24983,KEGG_2019_Human,RNA transport,1/165,0.0082499094553477,0.0082499094553477,0,0,19835.0,95159.46482222488,GEMIN7
24984,KEGG_2019_Human,Terpenoid backbone biosynthesis,1/22,0.0010999756574123,0.0010999756574123,0,0,19978.0,136099.47030191717,IDI2
24985,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR8D1
24986,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF426
24987,KEGG_2019_Human,Ribosome biogenesis in eukaryotes,1/101,0.0050499326546803,0.0050499326546803,0,0,19899.0,105233.48101229242,NOP10
24988,KEGG_2019_Human,Peroxisome,1/83,0.0041499404726918,0.0041499404726918,0,0,19917.0,109237.99888847338,PEX10
24989,KEGG_2019_Human,Cellular senescence,1/160,0.0079999110688441,0.0079999110688441,0,0,19840.0,95793.96509856998,RAD9A
24990,KEGG_2019_Human,Fatty acid degradation,1/44,0.0021999607179423,0.0023999583567988,0,0,19956.0,122117.06559109331,ACADSB
24991,KEGG_2019_Human,"Valine, leucine and isoleucine degradation",1/48,0.0023999583567988,0.0023999583567988,0,0,19952.0,120356.5272753826,ACADSB
24992,KEGG_2019_Human,Glutathione metabolism,1/56,0.0027999538675741,0.0094498771520562,0,0,19944.0,117233.87022514464,GSTM2
24993,KEGG_2019_Human,Metabolism of xenobiotics by cytochrome P450,1/74,0.0036999446830449,0.0094498771520562,0,0,19926.0,111574.38983110404,GSTM2
24994,KEGG_2019_Human,Chemical carcinogenesis,1/82,0.004099940929819,0.0094498771520562,0,0,19918.0,109484.9180722932,GSTM2
24995,KEGG_2019_Human,Drug metabolism,1/108,0.0053999298011749,0.0094498771520562,0,0,19892.0,103863.47861844616,GSTM2
24996,KEGG_2019_Human,Fluid shear stress and atherosclerosis,1/139,0.006949918172816,0.0097298854419424,0,0,19861.0,98689.81333375497,GSTM2
24997,KEGG_2019_Human,Hepatocellular carcinoma,1/168,0.0083999085011095,0.0097998932512944,0,0,19832.0,94787.72752807094,GSTM2
24998,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,GSTM2
24999,KEGG_2019_Human,Morphine addiction,1/91,0.0045499369072032,0.008599895681396,0,0,19909.0,107362.10783923086,PDE4C
25000,KEGG_2019_Human,"Parathyroid hormone synthesis, secretion and action",1/106,0.0052999306076525,0.008599895681396,0,0,19894.0,104245.78450366124,PDE4C
25001,KEGG_2019_Human,Purine metabolism,1/129,0.006449921761047,0.008599895681396,0,0,19871.0,100223.109907462,PDE4C
25002,KEGG_2019_Human,cAMP signaling pathway,1/212,0.0105998955026255,0.0105998955026255,0,0,19788.0,89974.27756224656,PDE4C
25003,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0147498749536506,0,0,19705.0,83086.53988020132,DUSP16
25004,KEGG_2019_Human,IL-17 signaling pathway,1/93,0.0046499360391879,0.0139498081175637,0,0,19907.0,106918.54242106884,CCL7
25005,KEGG_2019_Human,Chemokine signaling pathway,1/190,0.0094999017791995,0.0142498526687993,0,0,19810.0,92244.74636351672,CCL7
25006,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0146998751759735,0,0,19706.0,83157.67014793828,CCL7
25007,KEGG_2019_Human,Small cell lung cancer,1/93,0.0046499360391879,0.0092998720783758,0,0,19907.0,106918.54242106884,CKS2
25008,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,CKS2
25009,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR13G1
25010,KEGG_2019_Human,Vitamin digestion and absorption,1/24,0.0011999741185782,0.0023999482371564,0,0,19976.0,134347.69487847842,AWAT2
25011,KEGG_2019_Human,Retinol metabolism,1/67,0.0033499481224912,0.0033499481224912,0,0,19933.0,113594.38808369274,AWAT2
25012,KEGG_2019_Human,Ribosome,1/153,0.0076499133771537,0.0076499133771537,0,0,19847.0,96715.6407630817,MRPS5
25013,KEGG_2019_Human,Mannose type O-glycan biosynthesis,1/23,0.0011499748819949,0.0011499748819949,0,0,19977.0,135204.63922267244,POMGNT2
25014,KEGG_2019_Human,Progesterone-mediated oocyte maturation,1/99,0.0049499334884068,0.0083332309831664,0,0,19901.0,105642.09305076736,MAD2L1
25015,KEGG_2019_Human,Cell cycle,1/124,0.0061999236097501,0.0083332309831664,0,0,19876.0,101034.04709010696,MAD2L1
25016,KEGG_2019_Human,Oocyte meiosis,1/125,0.0062499232373748,0.0083332309831664,0,0,19875.0,100869.32368441945,MAD2L1
25017,KEGG_2019_Human,Human T-cell leukemia virus 1 infection,1/219,0.0109498935894162,0.0109498935894162,0,0,19781.0,89299.85161916987,MAD2L1
25018,KEGG_2019_Human,Adipocytokine signaling pathway,1/69,0.003449947123837,0.0090415648307337,0,0,19931.0,112996.7391397682,PPARA
25019,KEGG_2019_Human,PPAR signaling pathway,1/74,0.0036999446830449,0.0090415648307337,0,0,19926.0,111574.38983110404,PPARA
25020,KEGG_2019_Human,Glucagon signaling pathway,1/103,0.0051499318302617,0.0090415648307337,0,0,19897.0,104832.7525292024,PPARA
25021,KEGG_2019_Human,Insulin resistance,1/108,0.0053999298011749,0.0090415648307337,0,0,19892.0,103863.47861844616,PPARA
25022,KEGG_2019_Human,Non-alcoholic fatty liver disease (NAFLD),1/149,0.0074499147221605,0.0090415648307337,0,0,19851.0,97261.02051561224,PPARA
25023,KEGG_2019_Human,Hepatitis C,1/155,0.0077499127120574,0.0090415648307337,0,0,19845.0,96448.16254952336,PPARA
25024,KEGG_2019_Human,cAMP signaling pathway,1/212,0.0105998955026255,0.0105998955026255,0,0,19788.0,89974.27756224656,PPARA
25025,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR2T35
25026,KEGG_2019_Human,Ubiquitin mediated proteolysis,1/137,0.0068499188797651,0.0068499188797651,0,0,19863.0,98987.62735269018,SAE1
25027,KEGG_2019_Human,Progesterone-mediated oocyte maturation,1/99,0.0049499334884068,0.0106665480917922,0,0,19901.0,105642.09305076736,CDC25A
25028,KEGG_2019_Human,Cell cycle,1/124,0.0061999236097501,0.0106665480917922,0,0,19876.0,101034.04709010696,CDC25A
25029,KEGG_2019_Human,Cellular senescence,1/160,0.0079999110688441,0.0106665480917922,0,0,19840.0,95793.96509856998,CDC25A
25030,KEGG_2019_Human,MicroRNAs in cancer,1/299,0.0149498740670514,0.0149498740670514,0,0,19701.0,82804.33538735632,CDC25A
25031,KEGG_2019_Human,GABAergic synapse,1/89,0.0044499377838098,0.0130498764018304,0,0,19911.0,107815.380281759,GNG4
25032,KEGG_2019_Human,Morphine addiction,1/91,0.0045499369072032,0.0130498764018304,0,0,19909.0,107362.10783923086,GNG4
25033,KEGG_2019_Human,Circadian entrainment,1/97,0.0048499343304706,0.0130498764018304,0,0,19903.0,106058.9096435903,GNG4
25034,KEGG_2019_Human,Cholinergic synapse,1/112,0.0055999282120529,0.0130498764018304,0,0,19888.0,103119.30984392198,GNG4
25035,KEGG_2019_Human,Serotonergic synapse,1/113,0.0056499278191151,0.0130498764018304,0,0,19887.0,102937.34947211576,GNG4
25036,KEGG_2019_Human,Glutamatergic synapse,1/114,0.005699927427839,0.0130498764018304,0,0,19886.0,102756.96431429044,GNG4
25037,KEGG_2019_Human,Relaxin signaling pathway,1/130,0.0064999213952527,0.0130498764018304,0,0,19870.0,100064.62842845908,GNG4
25038,KEGG_2019_Human,Dopaminergic synapse,1/131,0.0065499210316603,0.0130498764018304,0,0,19869.0,99907.33811343512,GNG4
25039,KEGG_2019_Human,Apelin signaling pathway,1/137,0.0068499188797651,0.0130498764018304,0,0,19863.0,98987.62735269018,GNG4
25040,KEGG_2019_Human,Retrograde endocannabinoid signaling,1/148,0.007399915061391,0.0130498764018304,0,0,19852.0,97399.60470052566,GNG4
25041,KEGG_2019_Human,Alcoholism,1/180,0.0089999047745351,0.0130498764018304,0,0,19820.0,93362.92821536642,GNG4
25042,KEGG_2019_Human,Kaposi sarcoma-associated herpesvirus infection,1/186,0.0092999029651357,0.0130498764018304,0,0,19814.0,92684.96451050608,GNG4
25043,KEGG_2019_Human,Chemokine signaling pathway,1/190,0.0094999017791995,0.0130498764018304,0,0,19810.0,92244.74636351672,GNG4
25044,KEGG_2019_Human,Human immunodeficiency virus 1 infection,1/212,0.0105998955026255,0.0130498764018304,0,0,19788.0,89974.27756224656,GNG4
25045,KEGG_2019_Human,Human cytomegalovirus infection,1/225,0.0112498919790339,0.0130498764018304,0,0,19775.0,88738.27077557483,GNG4
25046,KEGG_2019_Human,Ras signaling pathway,1/232,0.0115998901349604,0.0130498764018304,0,0,19768.0,88101.22480150245,GNG4
25047,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0187410310320355,0,0,19646.0,79255.8617626126,GNG4
25048,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,GNG4
25049,KEGG_2019_Human,Toll-like receptor signaling pathway,1/104,0.0051999314202997,0.0142498526687993,0,0,19896.0,104635.24941415618,CXCL11
25050,KEGG_2019_Human,Chemokine signaling pathway,1/190,0.0094999017791995,0.0142498526687993,0,0,19810.0,92244.74636351672,CXCL11
25051,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0146998751759735,0,0,19706.0,83157.67014793828,CXCL11
25052,KEGG_2019_Human,RNA transport,1/165,0.0082499094553477,0.0082499094553477,0,0,19835.0,95159.46482222488,CLNS1A
25053,KEGG_2019_Human,Cysteine and methionine metabolism,1/47,0.0023499589392381,0.0023499589392381,0,0,19953.0,120782.64067395544,APIP
25054,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0146998751759735,0,0,19706.0,83157.67014793828,GDF3
25055,KEGG_2019_Human,Ubiquitin mediated proteolysis,1/137,0.0068499188797651,0.0082499094553477,0,0,19863.0,98987.62735269018,UBE2D3
25056,KEGG_2019_Human,Protein processing in endoplasmic reticulum,1/165,0.0082499094553477,0.0082499094553477,0,0,19835.0,95159.46482222488,UBE2D3
25057,KEGG_2019_Human,RNA polymerase,1/31,0.0015499690656704,0.0030999381313408,0,0,19969.0,129189.85098816035,POLR3F
25058,KEGG_2019_Human,Cytosolic DNA-sensing pathway,1/63,0.0031499501598827,0.0031499501598827,0,0,19937.0,114844.46974572667,POLR3F
25059,KEGG_2019_Human,Cysteine and methionine metabolism,1/47,0.0023499589392381,0.0023499589392381,0,0,19953.0,120782.64067395544,AHCYL1
25060,KEGG_2019_Human,ECM-receptor interaction,1/82,0.004099940929819,0.016399763719276,0,0,19918.0,109484.9180722932,IBSP
25061,KEGG_2019_Human,Focal adhesion,1/199,0.0099498991610159,0.0176998626413668,0,0,19801.0,91286.4288690606,IBSP
25062,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0176998626413668,0,0,19670.0,80733.60565076157,IBSP
25063,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0176998626413668,0,0,19646.0,79255.8617626126,IBSP
25064,KEGG_2019_Human,Human immunodeficiency virus 1 infection,1/212,0.0105998955026255,0.0105998955026255,0,0,19788.0,89974.27756224656,APOBEC3F
25065,KEGG_2019_Human,Cardiac muscle contraction,1/78,0.0038999427840466,0.0112582177134695,0,0,19922.0,110503.2180492851,COX7C
25066,KEGG_2019_Human,Oxidative phosphorylation,1/133,0.0066499203093911,0.0112582177134695,0,0,19867.0,99596.2591544721,COX7C
25067,KEGG_2019_Human,Parkinson disease,1/142,0.0070999171242726,0.0112582177134695,0,0,19858.0,98250.87390500787,COX7C
25068,KEGG_2019_Human,Non-alcoholic fatty liver disease (NAFLD),1/149,0.0074499147221605,0.0112582177134695,0,0,19851.0,97261.02051561224,COX7C
25069,KEGG_2019_Human,Alzheimer disease,1/171,0.0085499075557634,0.0112582177134695,0,0,19829.0,94422.42241345016,COX7C
25070,KEGG_2019_Human,Huntington disease,1/193,0.0096499008972596,0.0112582177134695,0,0,19807.0,91920.47679471428,COX7C
25071,KEGG_2019_Human,Thermogenesis,1/231,0.0115498903940656,0.0115498903940656,0,0,19769.0,88191.07730937863,COX7C
25072,KEGG_2019_Human,Folate biosynthesis,1/26,0.0012999726251831,0.0012999726251831,0,0,19974.0,132735.46073187632,QDPR
25073,KEGG_2019_Human,Malaria,1/49,0.0024499577795033,0.0119165128392871,0,0,19951.0,119939.1172087114,CCL2
25074,KEGG_2019_Human,Rheumatoid arthritis,1/91,0.0045499369072032,0.0119165128392871,0,0,19909.0,107362.10783923086,CCL2
25075,KEGG_2019_Human,IL-17 signaling pathway,1/93,0.0046499360391879,0.0119165128392871,0,0,19907.0,106918.54242106884,CCL2
25076,KEGG_2019_Human,AGE-RAGE signaling pathway in diabetic complications,1/100,0.0049999330710556,0.0119165128392871,0,0,19900.0,105436.78197328727,CCL2
25077,KEGG_2019_Human,Chagas disease (American trypanosomiasis),1/103,0.0051499318302617,0.0119165128392871,0,0,19897.0,104832.7525292024,CCL2
25078,KEGG_2019_Human,TNF signaling pathway,1/110,0.0054999290027479,0.0119165128392871,0,0,19890.0,103488.06969787036,CCL2
25079,KEGG_2019_Human,Fluid shear stress and atherosclerosis,1/139,0.006949918172816,0.0123498723129594,0,0,19861.0,98689.81333375497,CCL2
25080,KEGG_2019_Human,Influenza A,1/171,0.0085499075557634,0.0123498723129594,0,0,19829.0,94422.42241345016,CCL2
25081,KEGG_2019_Human,NOD-like receptor signaling pathway,1/178,0.0088999053857096,0.0123498723129594,0,0,19822.0,93593.82745769851,CCL2
25082,KEGG_2019_Human,Chemokine signaling pathway,1/190,0.0094999017791995,0.0123498723129594,0,0,19810.0,92244.74636351672,CCL2
25083,KEGG_2019_Human,Human cytomegalovirus infection,1/225,0.0112498919790339,0.0132953268843128,0,0,19775.0,88738.27077557483,CCL2
25084,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0159248647739712,0,0,19706.0,83157.67014793828,CCL2
25085,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,CCL2
25086,KEGG_2019_Human,Collecting duct acid secretion,1/27,0.0013499718942362,0.0081898864329657,0,0,19973.0,131975.02298599784,ATP6V1C2
25087,KEGG_2019_Human,Vibrio cholerae infection,1/50,0.0024999572069037,0.0081898864329657,0,0,19950.0,119530.05920663515,ATP6V1C2
25088,KEGG_2019_Human,Epithelial cell signaling in Helicobacter pylori infection,1/68,0.0033999476216189,0.0081898864329657,0,0,19932.0,113293.39338050144,ATP6V1C2
25089,KEGG_2019_Human,Synaptic vesicle cycle,1/78,0.0038999427840466,0.0081898864329657,0,0,19922.0,110503.2180492851,ATP6V1C2
25090,KEGG_2019_Human,Rheumatoid arthritis,1/91,0.0045499369072032,0.0081898864329657,0,0,19909.0,107362.10783923086,ATP6V1C2
25091,KEGG_2019_Human,Oxidative phosphorylation,1/133,0.0066499203093911,0.0085499029254342,0,0,19867.0,99596.2591544721,ATP6V1C2
25092,KEGG_2019_Human,mTOR signaling pathway,1/152,0.0075999137114971,0.0085499029254342,0,0,19848.0,96850.665715497,ATP6V1C2
25093,KEGG_2019_Human,Phagosome,1/152,0.0075999137114971,0.0085499029254342,0,0,19848.0,96850.665715497,ATP6V1C2
25094,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0164998674589645,0,0,19670.0,80733.60565076157,ATP6V1C2
25095,KEGG_2019_Human,SNARE interactions in vesicular transport,1/34,0.0016999670339032,0.0016999670339032,0,0,19966.0,127326.1054203148,VTI1B
25096,KEGG_2019_Human,Spliceosome,1/134,0.0066999199497742,0.0066999199497742,0,0,19866.0,99442.43560916925,SF3A3
25097,KEGG_2019_Human,RIG-I-like receptor signaling pathway,1/70,0.0034999466296654,0.0104998398889962,0,0,19930.0,112704.30065625212,IFNK
25098,KEGG_2019_Human,JAK-STAT signaling pathway,1/162,0.0080999104202618,0.0121498656303927,0,0,19838.0,95537.86936302872,IFNK
25099,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0146998751759735,0,0,19706.0,83157.67014793828,IFNK
25100,KEGG_2019_Human,"Glycine, serine and threonine metabolism",1/40,0.0019999631680592,0.0045332634954919,0,0,19960.0,124043.94523066044,PGAM1
25101,KEGG_2019_Human,Central carbon metabolism in cancer,1/65,0.003249949134407,0.0045332634954919,0,0,19935.0,114209.92613860144,PGAM1
25102,KEGG_2019_Human,Glycolysis / Gluconeogenesis,1/68,0.0033999476216189,0.0045332634954919,0,0,19932.0,113293.39338050144,PGAM1
25103,KEGG_2019_Human,Glucagon signaling pathway,1/103,0.0051499318302617,0.0051499318302617,0,0,19897.0,104832.7525292024,PGAM1
25104,KEGG_2019_Human,Neurotrophin signaling pathway,1/119,0.0059499254985137,0.0115498903940656,0,0,19881.0,101877.73080211312,FRS2
25105,KEGG_2019_Human,Proteoglycans in cancer,1/201,0.0100498985877989,0.0115498903940656,0,0,19799.0,91079.21596609056,FRS2
25106,KEGG_2019_Human,Thermogenesis,1/231,0.0115498903940656,0.0115498903940656,0,0,19769.0,88191.07730937863,FRS2
25107,KEGG_2019_Human,Spliceosome,1/134,0.0066999199497742,0.0066999199497742,0,0,19866.0,99442.43560916925,SYF2
25108,KEGG_2019_Human,Glutathione metabolism,1/56,0.0027999538675741,0.0094498771520562,0,0,19944.0,117233.87022514464,GSTM5
25109,KEGG_2019_Human,Metabolism of xenobiotics by cytochrome P450,1/74,0.0036999446830449,0.0094498771520562,0,0,19926.0,111574.38983110404,GSTM5
25110,KEGG_2019_Human,Chemical carcinogenesis,1/82,0.004099940929819,0.0094498771520562,0,0,19918.0,109484.9180722932,GSTM5
25111,KEGG_2019_Human,Drug metabolism,1/108,0.0053999298011749,0.0094498771520562,0,0,19892.0,103863.47861844616,GSTM5
25112,KEGG_2019_Human,Fluid shear stress and atherosclerosis,1/139,0.006949918172816,0.0097298854419424,0,0,19861.0,98689.81333375497,GSTM5
25113,KEGG_2019_Human,Hepatocellular carcinoma,1/168,0.0083999085011095,0.0097998932512944,0,0,19832.0,94787.72752807094,GSTM5
25114,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,GSTM5
25115,KEGG_2019_Human,"Glycine, serine and threonine metabolism",1/40,0.0019999631680592,0.0033999476216189,0,0,19960.0,124043.94523066044,BPGM
25116,KEGG_2019_Human,Glycolysis / Gluconeogenesis,1/68,0.0033999476216189,0.0033999476216189,0,0,19932.0,113293.39338050144,BPGM
25117,KEGG_2019_Human,Thyroid hormone signaling pathway,1/116,0.0057999266512085,0.0057999266512085,0,0,19884.0,102400.8105961506,MED27
25118,KEGG_2019_Human,Tryptophan metabolism,1/42,0.0020999619311272,0.0020999619311272,0,0,19958.0,123057.75613441122,HAAO
25119,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR2T29
25120,KEGG_2019_Human,Ubiquitin mediated proteolysis,1/137,0.0068499188797651,0.0068499188797651,0,0,19863.0,98987.62735269018,UBE2A
25121,KEGG_2019_Human,Melanoma,1/72,0.0035999456502131,0.0151581845144929,0,0,19928.0,112131.59838572376,PDGFA
25122,KEGG_2019_Human,Glioma,1/75,0.0037499442041125,0.0151581845144929,0,0,19925.0,111301.33528642564,PDGFA
25123,KEGG_2019_Human,Gap junction,1/88,0.0043999382262822,0.0151581845144929,0,0,19912.0,108045.79305232369,PDGFA
25124,KEGG_2019_Human,Prostate cancer,1/97,0.0048499343304706,0.0151581845144929,0,0,19903.0,106058.9096435903,PDGFA
25125,KEGG_2019_Human,Choline metabolism in cancer,1/99,0.0049499334884068,0.0151581845144929,0,0,19901.0,105642.09305076736,PDGFA
25126,KEGG_2019_Human,Fluid shear stress and atherosclerosis,1/139,0.006949918172816,0.0151581845144929,0,0,19861.0,98689.81333375497,PDGFA
25127,KEGG_2019_Human,Phospholipase D signaling pathway,1/148,0.007399915061391,0.0151581845144929,0,0,19852.0,97399.60470052566,PDGFA
25128,KEGG_2019_Human,JAK-STAT signaling pathway,1/162,0.0080999104202618,0.0151581845144929,0,0,19838.0,95537.86936302872,PDGFA
25129,KEGG_2019_Human,Transcriptional misregulation in cancer,1/186,0.0092999029651357,0.0151581845144929,0,0,19814.0,92684.96451050608,PDGFA
25130,KEGG_2019_Human,Focal adhesion,1/199,0.0099498991610159,0.0151581845144929,0,0,19801.0,91286.4288690606,PDGFA
25131,KEGG_2019_Human,Rap1 signaling pathway,1/206,0.010299897173561,0.0151581845144929,0,0,19794.0,90569.849337325,PDGFA
25132,KEGG_2019_Human,Regulation of actin cytoskeleton,1/214,0.0106998949514067,0.0151581845144929,0,0,19786.0,89779.39753374986,PDGFA
25133,KEGG_2019_Human,Ras signaling pathway,1/232,0.0115998901349604,0.0151690870995636,0,0,19768.0,88101.22480150245,PDGFA
25134,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0169431906093249,0,0,19705.0,83086.53988020132,PDGFA
25135,KEGG_2019_Human,MicroRNAs in cancer,1/299,0.0149498740670514,0.0169431906093249,0,0,19701.0,82804.33538735632,PDGFA
25136,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0188061040564523,0,0,19646.0,79255.8617626126,PDGFA
25137,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,PDGFA
25138,KEGG_2019_Human,Oxidative phosphorylation,1/133,0.0066499203093911,0.0115498903940656,0,0,19867.0,99596.2591544721,ATP5MC2
25139,KEGG_2019_Human,Parkinson disease,1/142,0.0070999171242726,0.0115498903940656,0,0,19858.0,98250.87390500787,ATP5MC2
25140,KEGG_2019_Human,Alzheimer disease,1/171,0.0085499075557634,0.0115498903940656,0,0,19829.0,94422.42241345016,ATP5MC2
25141,KEGG_2019_Human,Huntington disease,1/193,0.0096499008972596,0.0115498903940656,0,0,19807.0,91920.47679471428,ATP5MC2
25142,KEGG_2019_Human,Thermogenesis,1/231,0.0115498903940656,0.0115498903940656,0,0,19769.0,88191.07730937863,ATP5MC2
25143,KEGG_2019_Human,One carbon pool by folate,1/20,0.0009999772468562472,0.0009999772468562472,0,0,19980.0,138017.40508704726,MTHFS
25144,KEGG_2019_Human,Riboflavin metabolism,1/8,0.0003999883241497325,0.0015999532965989,0,0,19992.0,156418.91141655247,ACP5
25145,KEGG_2019_Human,Rheumatoid arthritis,1/91,0.0045499369072032,0.0063499224962247,0,0,19909.0,107362.10783923086,ACP5
25146,KEGG_2019_Human,Lysosome,1/123,0.0061499239842961,0.0063499224962247,0,0,19877.0,101200.07933676826,ACP5
25147,KEGG_2019_Human,Osteoclast differentiation,1/127,0.0063499224962247,0.0063499224962247,0,0,19873.0,100543.72072014232,ACP5
25148,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF225
25149,KEGG_2019_Human,Endocytosis,1/244,0.0121998870519305,0.0121998870519305,0,0,19756.0,87051.4275316661,ARF5
25150,KEGG_2019_Human,Cholesterol metabolism,1/50,0.0024999572069037,0.0074998716207111,0,0,19950.0,119530.05920663515,TSPO
25151,KEGG_2019_Human,Human T-cell leukemia virus 1 infection,1/219,0.0109498935894162,0.0164248403841244,0,0,19781.0,89299.85161916987,TSPO
25152,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,TSPO
25153,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF763
25154,KEGG_2019_Human,"Parathyroid hormone synthesis, secretion and action",1/106,0.0052999306076525,0.0052999306076525,0,0,19894.0,104245.78450366124,MMP25
25155,KEGG_2019_Human,RNA degradation,1/79,0.0039499423167337,0.006449921761047,0,0,19921.0,110243.89578070649,NUDT16
25156,KEGG_2019_Human,Purine metabolism,1/129,0.006449921761047,0.006449921761047,0,0,19871.0,100223.109907462,NUDT16
25157,KEGG_2019_Human,DNA replication,1/36,0.0017999657178272,0.0035999314356544,0,0,19964.0,126172.23364250171,MCM6
25158,KEGG_2019_Human,Cell cycle,1/124,0.0061999236097501,0.0061999236097501,0,0,19876.0,101034.04709010696,MCM6
25159,KEGG_2019_Human,Thermogenesis,1/231,0.0115498903940656,0.0115498903940656,0,0,19769.0,88191.07730937863,COA5
25160,KEGG_2019_Human,Shigellosis,1/65,0.003249949134407,0.0089499050800561,0,0,19935.0,114209.92613860144,RIPK2
25161,KEGG_2019_Human,Neurotrophin signaling pathway,1/119,0.0059499254985137,0.0089499050800561,0,0,19881.0,101877.73080211312,RIPK2
25162,KEGG_2019_Human,NOD-like receptor signaling pathway,1/178,0.0088999053857096,0.0089499050800561,0,0,19822.0,93593.82745769851,RIPK2
25163,KEGG_2019_Human,Tuberculosis,1/179,0.0089499050800561,0.0089499050800561,0,0,19821.0,93478.0629355712,RIPK2
25164,KEGG_2019_Human,Base excision repair,1/33,0.0016499677032113,0.0016499677032113,0,0,19967.0,127928.56031580272,MPG
25165,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR13H1
25166,KEGG_2019_Human,Melanoma,1/72,0.0035999456502131,0.0173998352024406,0,0,19928.0,112131.59838572376,FGF16
25167,KEGG_2019_Human,Breast cancer,1/147,0.0073499154017982,0.0173998352024406,0,0,19853.0,97539.10874372096,FGF16
25168,KEGG_2019_Human,Gastric cancer,1/149,0.0074499147221605,0.0173998352024406,0,0,19851.0,97261.02051561224,FGF16
25169,KEGG_2019_Human,Rap1 signaling pathway,1/206,0.010299897173561,0.0173998352024406,0,0,19794.0,90569.849337325,FGF16
25170,KEGG_2019_Human,Regulation of actin cytoskeleton,1/214,0.0106998949514067,0.0173998352024406,0,0,19786.0,89779.39753374986,FGF16
25171,KEGG_2019_Human,Ras signaling pathway,1/232,0.0115998901349604,0.0173998352024406,0,0,19768.0,88101.22480150245,FGF16
25172,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.018964124940408,0,0,19705.0,83086.53988020132,FGF16
25173,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0199123454715377,0,0,19646.0,79255.8617626126,FGF16
25174,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,FGF16
25175,KEGG_2019_Human,Ubiquinone and other terpenoid-quinone biosynthesis,1/11,0.0005499852259717758,0.0021999409038871,0,0,19989.0,150029.8210287992,NQO1
25176,KEGG_2019_Human,Fluid shear stress and atherosclerosis,1/139,0.006949918172816,0.0111998780014793,0,0,19861.0,98689.81333375497,NQO1
25177,KEGG_2019_Human,Hepatocellular carcinoma,1/168,0.0083999085011095,0.0111998780014793,0,0,19832.0,94787.72752807094,NQO1
25178,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,NQO1
25179,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR5K2
25180,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,TAAR1
25181,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR12D2
25182,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR2A14
25183,KEGG_2019_Human,Autoimmune thyroid disease,1/53,0.0026499555173137,0.0061665744717416,0,0,19947.0,118349.78824235698,TSHB
25184,KEGG_2019_Human,Regulation of lipolysis in adipocytes,1/55,0.0027499544131125,0.0061665744717416,0,0,19945.0,117599.1294878737,TSHB
25185,KEGG_2019_Human,Thyroid hormone synthesis,1/74,0.0036999446830449,0.0061665744717416,0,0,19926.0,111574.38983110404,TSHB
25186,KEGG_2019_Human,cAMP signaling pathway,1/212,0.0105998955026255,0.0132498693782819,0,0,19788.0,89974.27756224656,TSHB
25187,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,TSHB
25188,KEGG_2019_Human,Focal adhesion,1/199,0.0099498991610159,0.0099498991610159,0,0,19801.0,91286.4288690606,PARVB
25189,KEGG_2019_Human,MicroRNAs in cancer,1/299,0.0149498740670514,0.0149498740670514,0,0,19701.0,82804.33538735632,MIR9-1
25190,KEGG_2019_Human,Calcium signaling pathway,1/188,0.009399902370135,0.0168998658265596,0,0,19812.0,92463.712994847,TRHR
25191,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,TRHR
25192,KEGG_2019_Human,GABAergic synapse,1/89,0.0044499377838098,0.0130498764018304,0,0,19911.0,107815.380281759,GNG11
25193,KEGG_2019_Human,Morphine addiction,1/91,0.0045499369072032,0.0130498764018304,0,0,19909.0,107362.10783923086,GNG11
25194,KEGG_2019_Human,Circadian entrainment,1/97,0.0048499343304706,0.0130498764018304,0,0,19903.0,106058.9096435903,GNG11
25195,KEGG_2019_Human,Cholinergic synapse,1/112,0.0055999282120529,0.0130498764018304,0,0,19888.0,103119.30984392198,GNG11
25196,KEGG_2019_Human,Serotonergic synapse,1/113,0.0056499278191151,0.0130498764018304,0,0,19887.0,102937.34947211576,GNG11
25197,KEGG_2019_Human,Glutamatergic synapse,1/114,0.005699927427839,0.0130498764018304,0,0,19886.0,102756.96431429044,GNG11
25198,KEGG_2019_Human,Relaxin signaling pathway,1/130,0.0064999213952527,0.0130498764018304,0,0,19870.0,100064.62842845908,GNG11
25199,KEGG_2019_Human,Dopaminergic synapse,1/131,0.0065499210316603,0.0130498764018304,0,0,19869.0,99907.33811343512,GNG11
25200,KEGG_2019_Human,Apelin signaling pathway,1/137,0.0068499188797651,0.0130498764018304,0,0,19863.0,98987.62735269018,GNG11
25201,KEGG_2019_Human,Retrograde endocannabinoid signaling,1/148,0.007399915061391,0.0130498764018304,0,0,19852.0,97399.60470052566,GNG11
25202,KEGG_2019_Human,Alcoholism,1/180,0.0089999047745351,0.0130498764018304,0,0,19820.0,93362.92821536642,GNG11
25203,KEGG_2019_Human,Kaposi sarcoma-associated herpesvirus infection,1/186,0.0092999029651357,0.0130498764018304,0,0,19814.0,92684.96451050608,GNG11
25204,KEGG_2019_Human,Chemokine signaling pathway,1/190,0.0094999017791995,0.0130498764018304,0,0,19810.0,92244.74636351672,GNG11
25205,KEGG_2019_Human,Human immunodeficiency virus 1 infection,1/212,0.0105998955026255,0.0130498764018304,0,0,19788.0,89974.27756224656,GNG11
25206,KEGG_2019_Human,Human cytomegalovirus infection,1/225,0.0112498919790339,0.0130498764018304,0,0,19775.0,88738.27077557483,GNG11
25207,KEGG_2019_Human,Ras signaling pathway,1/232,0.0115998901349604,0.0130498764018304,0,0,19768.0,88101.22480150245,GNG11
25208,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0187410310320355,0,0,19646.0,79255.8617626126,GNG11
25209,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,GNG11
25210,KEGG_2019_Human,Terpenoid backbone biosynthesis,1/22,0.0010999756574123,0.0010999756574123,0,0,19978.0,136099.47030191717,DHDDS
25211,KEGG_2019_Human,Pertussis,1/76,0.0037999437281752,0.0082498935041218,0,0,19924.0,111031.8499691117,CXCL5
25212,KEGG_2019_Human,Rheumatoid arthritis,1/91,0.0045499369072032,0.0082498935041218,0,0,19909.0,107362.10783923086,CXCL5
25213,KEGG_2019_Human,IL-17 signaling pathway,1/93,0.0046499360391879,0.0082498935041218,0,0,19907.0,106918.54242106884,CXCL5
25214,KEGG_2019_Human,TNF signaling pathway,1/110,0.0054999290027479,0.0082498935041218,0,0,19890.0,103488.06969787036,CXCL5
25215,KEGG_2019_Human,Chemokine signaling pathway,1/190,0.0094999017791995,0.0113998821350394,0,0,19810.0,92244.74636351672,CXCL5
25216,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0146998751759735,0,0,19706.0,83157.67014793828,CXCL5
25217,KEGG_2019_Human,Basal cell carcinoma,1/63,0.0031499501598827,0.0115180602355462,0,0,19937.0,114844.46974572667,WNT5B
25218,KEGG_2019_Human,Melanogenesis,1/101,0.0050499326546803,0.0115180602355462,0,0,19899.0,105233.48101229242,WNT5B
25219,KEGG_2019_Human,Signaling pathways regulating pluripotency of stem cells,1/139,0.006949918172816,0.0115180602355462,0,0,19861.0,98689.81333375497,WNT5B
25220,KEGG_2019_Human,Breast cancer,1/147,0.0073499154017982,0.0115180602355462,0,0,19853.0,97539.10874372096,WNT5B
25221,KEGG_2019_Human,Gastric cancer,1/149,0.0074499147221605,0.0115180602355462,0,0,19851.0,97261.02051561224,WNT5B
25222,KEGG_2019_Human,mTOR signaling pathway,1/152,0.0075999137114971,0.0115180602355462,0,0,19848.0,96850.665715497,WNT5B
25223,KEGG_2019_Human,Cushing syndrome,1/155,0.0077499127120574,0.0115180602355462,0,0,19845.0,96448.16254952336,WNT5B
25224,KEGG_2019_Human,Wnt signaling pathway,1/158,0.0078999117225733,0.0115180602355462,0,0,19842.0,96053.2110949472,WNT5B
25225,KEGG_2019_Human,Hippo signaling pathway,1/160,0.0079999110688441,0.0115180602355462,0,0,19840.0,95793.96509856998,WNT5B
25226,KEGG_2019_Human,Hepatocellular carcinoma,1/168,0.0083999085011095,0.0115180602355462,0,0,19832.0,94787.72752807094,WNT5B
25227,KEGG_2019_Human,Axon guidance,1/181,0.0090499044707863,0.0115180602355462,0,0,19819.0,93248.41634586031,WNT5B
25228,KEGG_2019_Human,Proteoglycans in cancer,1/201,0.0100498985877989,0.0117248816857654,0,0,19799.0,91079.21596609056,WNT5B
25229,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.017769088032731,0,0,19670.0,80733.60565076157,WNT5B
25230,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,WNT5B
25231,KEGG_2019_Human,MicroRNAs in cancer,1/299,0.0149498740670514,0.0149498740670514,0,0,19701.0,82804.33538735632,MIR7-2
25232,KEGG_2019_Human,MicroRNAs in cancer,1/299,0.0149498740670514,0.0149498740670514,0,0,19701.0,82804.33538735632,MIR200B
25233,KEGG_2019_Human,Protein processing in endoplasmic reticulum,1/165,0.0082499094553477,0.0082499094553477,0,0,19835.0,95159.46482222488,FBXO6
25234,KEGG_2019_Human,Spliceosome,1/134,0.0066999199497742,0.0133998398995484,0,0,19866.0,99442.43560916925,SRSF3
25235,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,SRSF3
25236,KEGG_2019_Human,Ribosome,1/153,0.0076499133771537,0.0076499133771537,0,0,19847.0,96715.6407630817,RPL30
25237,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,NPB
25238,KEGG_2019_Human,Folate biosynthesis,1/26,0.0012999726251831,0.004099940929819,0,0,19974.0,132735.46073187632,CBR1
25239,KEGG_2019_Human,Arachidonic acid metabolism,1/63,0.0031499501598827,0.004099940929819,0,0,19937.0,114844.46974572667,CBR1
25240,KEGG_2019_Human,Metabolism of xenobiotics by cytochrome P450,1/74,0.0036999446830449,0.004099940929819,0,0,19926.0,111574.38983110404,CBR1
25241,KEGG_2019_Human,Chemical carcinogenesis,1/82,0.004099940929819,0.004099940929819,0,0,19918.0,109484.9180722932,CBR1
25242,KEGG_2019_Human,Vibrio cholerae infection,1/50,0.0024999572069037,0.0024999572069037,0,0,19950.0,119530.05920663515,KDELR3
25243,KEGG_2019_Human,Basal cell carcinoma,1/63,0.0031499501598827,0.0109198810514423,0,0,19937.0,114844.46974572667,WNT8B
25244,KEGG_2019_Human,Melanogenesis,1/101,0.0050499326546803,0.0109198810514423,0,0,19899.0,105233.48101229242,WNT8B
25245,KEGG_2019_Human,Signaling pathways regulating pluripotency of stem cells,1/139,0.006949918172816,0.0109198810514423,0,0,19861.0,98689.81333375497,WNT8B
25246,KEGG_2019_Human,Breast cancer,1/147,0.0073499154017982,0.0109198810514423,0,0,19853.0,97539.10874372096,WNT8B
25247,KEGG_2019_Human,Gastric cancer,1/149,0.0074499147221605,0.0109198810514423,0,0,19851.0,97261.02051561224,WNT8B
25248,KEGG_2019_Human,mTOR signaling pathway,1/152,0.0075999137114971,0.0109198810514423,0,0,19848.0,96850.665715497,WNT8B
25249,KEGG_2019_Human,Cushing syndrome,1/155,0.0077499127120574,0.0109198810514423,0,0,19845.0,96448.16254952336,WNT8B
25250,KEGG_2019_Human,Wnt signaling pathway,1/158,0.0078999117225733,0.0109198810514423,0,0,19842.0,96053.2110949472,WNT8B
25251,KEGG_2019_Human,Hippo signaling pathway,1/160,0.0079999110688441,0.0109198810514423,0,0,19840.0,95793.96509856998,WNT8B
25252,KEGG_2019_Human,Hepatocellular carcinoma,1/168,0.0083999085011095,0.0109198810514423,0,0,19832.0,94787.72752807094,WNT8B
25253,KEGG_2019_Human,Proteoglycans in cancer,1/201,0.0100498985877989,0.0118771528764897,0,0,19799.0,91079.21596609056,WNT8B
25254,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0178748564138782,0,0,19670.0,80733.60565076157,WNT8B
25255,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,WNT8B
25256,KEGG_2019_Human,Melanoma,1/72,0.0035999456502131,0.0173998352024406,0,0,19928.0,112131.59838572376,FGF4
25257,KEGG_2019_Human,Breast cancer,1/147,0.0073499154017982,0.0173998352024406,0,0,19853.0,97539.10874372096,FGF4
25258,KEGG_2019_Human,Gastric cancer,1/149,0.0074499147221605,0.0173998352024406,0,0,19851.0,97261.02051561224,FGF4
25259,KEGG_2019_Human,Rap1 signaling pathway,1/206,0.010299897173561,0.0173998352024406,0,0,19794.0,90569.849337325,FGF4
25260,KEGG_2019_Human,Regulation of actin cytoskeleton,1/214,0.0106998949514067,0.0173998352024406,0,0,19786.0,89779.39753374986,FGF4
25261,KEGG_2019_Human,Ras signaling pathway,1/232,0.0115998901349604,0.0173998352024406,0,0,19768.0,88101.22480150245,FGF4
25262,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.018964124940408,0,0,19705.0,83086.53988020132,FGF4
25263,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0199123454715377,0,0,19646.0,79255.8617626126,FGF4
25264,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,FGF4
25265,KEGG_2019_Human,Circadian rhythm,1/31,0.0015499690656704,0.0106070264425899,0,0,19969.0,129189.85098816035,SKP1
25266,KEGG_2019_Human,TGF-beta signaling pathway,1/90,0.0044999373439762,0.0106070264425899,0,0,19910.0,107587.50385474482,SKP1
25267,KEGG_2019_Human,Cell cycle,1/124,0.0061999236097501,0.0106070264425899,0,0,19876.0,101034.04709010696,SKP1
25268,KEGG_2019_Human,Oocyte meiosis,1/125,0.0062499232373748,0.0106070264425899,0,0,19875.0,100869.32368441945,SKP1
25269,KEGG_2019_Human,Ubiquitin mediated proteolysis,1/137,0.0068499188797651,0.0106070264425899,0,0,19863.0,98987.62735269018,SKP1
25270,KEGG_2019_Human,Wnt signaling pathway,1/158,0.0078999117225733,0.0106070264425899,0,0,19842.0,96053.2110949472,SKP1
25271,KEGG_2019_Human,Protein processing in endoplasmic reticulum,1/165,0.0082499094553477,0.0106070264425899,0,0,19835.0,95159.46482222488,SKP1
25272,KEGG_2019_Human,Human immunodeficiency virus 1 infection,1/212,0.0105998955026255,0.0119248824404537,0,0,19788.0,89974.27756224656,SKP1
25273,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,SKP1
25274,KEGG_2019_Human,Calcium signaling pathway,1/188,0.009399902370135,0.0168998658265596,0,0,19812.0,92463.712994847,TACR1
25275,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,TACR1
25276,KEGG_2019_Human,Nicotinate and nicotinamide metabolism,1/30,0.0014999697593334,0.0014999697593334,0,0,19970.0,129851.13732048514,NNMT
25277,KEGG_2019_Human,Ribosome biogenesis in eukaryotes,1/101,0.0050499326546803,0.0050499326546803,0,0,19899.0,105233.48101229242,GNL3
25278,KEGG_2019_Human,Hepatocellular carcinoma,1/168,0.0083999085011095,0.0115498903940656,0,0,19832.0,94787.72752807094,SMARCD3
25279,KEGG_2019_Human,Thermogenesis,1/231,0.0115498903940656,0.0115498903940656,0,0,19769.0,88191.07730937863,SMARCD3
25280,KEGG_2019_Human,Mineral absorption,1/51,0.0025499566390179,0.0025499566390179,0,0,19949.0,119129.0228601236,SLC31A1
25281,KEGG_2019_Human,Synthesis and degradation of ketone bodies,1/10,0.0004999862257578379,0.0009999724515156758,0,0,19990.0,151942.5908680334,BDH2
25282,KEGG_2019_Human,Butanoate metabolism,1/28,0.0013999711732997,0.0013999711732997,0,0,19972.0,131242.0761597353,BDH2
25283,KEGG_2019_Human,Pathogenic Escherichia coli infection,1/55,0.0027499544131125,0.0084999078692823,0,0,19945.0,117599.1294878737,TUBA1C
25284,KEGG_2019_Human,Gap junction,1/88,0.0043999382262822,0.0084999078692823,0,0,19912.0,108045.79305232369,TUBA1C
25285,KEGG_2019_Human,Apoptosis,1/143,0.0071499167770442,0.0084999078692823,0,0,19857.0,98106.57763600958,TUBA1C
25286,KEGG_2019_Human,Phagosome,1/152,0.0075999137114971,0.0084999078692823,0,0,19848.0,96850.665715497,TUBA1C
25287,KEGG_2019_Human,Tight junction,1/170,0.0084999078692823,0.0084999078692823,0,0,19830.0,94543.49009679438,TUBA1C
25288,KEGG_2019_Human,Selenocompound metabolism,1/17,0.0008499797390404818,0.0031332785856508,0,0,19983.0,141285.76583697114,KYAT1
25289,KEGG_2019_Human,Tryptophan metabolism,1/42,0.0020999619311272,0.0031332785856508,0,0,19958.0,123057.75613441122,KYAT1
25290,KEGG_2019_Human,Cysteine and methionine metabolism,1/47,0.0023499589392381,0.0031332785856508,0,0,19953.0,120782.64067395544,KYAT1
25291,KEGG_2019_Human,Chemical carcinogenesis,1/82,0.004099940929819,0.004099940929819,0,0,19918.0,109484.9180722932,KYAT1
25292,KEGG_2019_Human,Cholesterol metabolism,1/50,0.0024999572069037,0.0036999446830449,0,0,19950.0,119530.05920663515,APOC3
25293,KEGG_2019_Human,PPAR signaling pathway,1/74,0.0036999446830449,0.0036999446830449,0,0,19926.0,111574.38983110404,APOC3
25294,KEGG_2019_Human,Chemokine signaling pathway,1/190,0.0094999017791995,0.0146998751759735,0,0,19810.0,92244.74636351672,CCL26
25295,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0146998751759735,0,0,19706.0,83157.67014793828,CCL26
25296,KEGG_2019_Human,Intestinal immune network for IgA production,1/48,0.0023999583567988,0.0139998205301324,0,0,19952.0,120356.5272753826,CXCL12
25297,KEGG_2019_Human,Rheumatoid arthritis,1/91,0.0045499369072032,0.0139998205301324,0,0,19909.0,107362.10783923086,CXCL12
25298,KEGG_2019_Human,NF-kappa B signaling pathway,1/95,0.0047499351803394,0.0139998205301324,0,0,19905.0,106484.27183626965,CXCL12
25299,KEGG_2019_Human,Leukocyte transendothelial migration,1/112,0.0055999282120529,0.0139998205301324,0,0,19888.0,103119.30984392198,CXCL12
25300,KEGG_2019_Human,Axon guidance,1/181,0.0090499044707863,0.0140623649737923,0,0,19819.0,93248.41634586031,CXCL12
25301,KEGG_2019_Human,Chemokine signaling pathway,1/190,0.0094999017791995,0.0140623649737923,0,0,19810.0,92244.74636351672,CXCL12
25302,KEGG_2019_Human,Regulation of actin cytoskeleton,1/214,0.0106998949514067,0.0140623649737923,0,0,19786.0,89779.39753374986,CXCL12
25303,KEGG_2019_Human,Human cytomegalovirus infection,1/225,0.0112498919790339,0.0140623649737923,0,0,19775.0,88738.27077557483,CXCL12
25304,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0163331946399705,0,0,19706.0,83157.67014793828,CXCL12
25305,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,CXCL12
25306,KEGG_2019_Human,Cytosolic DNA-sensing pathway,1/63,0.0031499501598827,0.0109998580054958,0,0,19937.0,114844.46974572667,CXCL10
25307,KEGG_2019_Human,RIG-I-like receptor signaling pathway,1/70,0.0034999466296654,0.0109998580054958,0,0,19930.0,112704.30065625212,CXCL10
25308,KEGG_2019_Human,IL-17 signaling pathway,1/93,0.0046499360391879,0.0109998580054958,0,0,19907.0,106918.54242106884,CXCL10
25309,KEGG_2019_Human,Toll-like receptor signaling pathway,1/104,0.0051999314202997,0.0109998580054958,0,0,19896.0,104635.24941415618,CXCL10
25310,KEGG_2019_Human,TNF signaling pathway,1/110,0.0054999290027479,0.0109998580054958,0,0,19890.0,103488.06969787036,CXCL10
25311,KEGG_2019_Human,Hepatitis C,1/155,0.0077499127120574,0.0111665539864433,0,0,19845.0,96448.16254952336,CXCL10
25312,KEGG_2019_Human,Influenza A,1/171,0.0085499075557634,0.0111665539864433,0,0,19829.0,94422.42241345016,CXCL10
25313,KEGG_2019_Human,Chemokine signaling pathway,1/190,0.0094999017791995,0.0111665539864433,0,0,19810.0,92244.74636351672,CXCL10
25314,KEGG_2019_Human,Epstein-Barr virus infection,1/201,0.0100498985877989,0.0111665539864433,0,0,19799.0,91079.21596609056,CXCL10
25315,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0146998751759735,0,0,19706.0,83157.67014793828,CXCL10
25316,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF354B
25317,KEGG_2019_Human,Fanconi anemia pathway,1/54,0.0026999549628563,0.0026999549628563,0,0,19946.0,117971.01964061816,ATRIP
25318,KEGG_2019_Human,Lysosome,1/123,0.0061499239842961,0.0075999137114971,0,0,19877.0,101200.07933676826,M6PR
25319,KEGG_2019_Human,Phagosome,1/152,0.0075999137114971,0.0075999137114971,0,0,19848.0,96850.665715497,M6PR
25320,KEGG_2019_Human,p53 signaling pathway,1/72,0.0035999456502131,0.0078999117225733,0,0,19928.0,112131.59838572376,SIAH1
25321,KEGG_2019_Human,Ubiquitin mediated proteolysis,1/137,0.0068499188797651,0.0078999117225733,0,0,19863.0,98987.62735269018,SIAH1
25322,KEGG_2019_Human,Wnt signaling pathway,1/158,0.0078999117225733,0.0078999117225733,0,0,19842.0,96053.2110949472,SIAH1
25323,KEGG_2019_Human,Prolactin signaling pathway,1/70,0.0034999466296654,0.0069998932593308,0,0,19930.0,112704.30065625212,CISH
25324,KEGG_2019_Human,JAK-STAT signaling pathway,1/162,0.0080999104202618,0.0080999104202618,0,0,19838.0,95537.86936302872,CISH
25325,KEGG_2019_Human,mTOR signaling pathway,1/152,0.0075999137114971,0.0075999137114971,0,0,19848.0,96850.665715497,RNF152
25326,KEGG_2019_Human,Autophagy,1/128,0.0063999221281459,0.0075999137114971,0,0,19872.0,100382.8010329652,RRAGC
25327,KEGG_2019_Human,mTOR signaling pathway,1/152,0.0075999137114971,0.0075999137114971,0,0,19848.0,96850.665715497,RRAGC
25328,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0146998751759735,0,0,19706.0,83157.67014793828,GDF11
25329,KEGG_2019_Human,Vascular smooth muscle contraction,1/132,0.0065999206698993,0.0115498903940656,0,0,19868.0,99751.22090491928,NPPB
25330,KEGG_2019_Human,cGMP-PKG signaling pathway,1/166,0.0082999091363732,0.0115498903940656,0,0,19834.0,95034.82345515196,NPPB
25331,KEGG_2019_Human,Thermogenesis,1/231,0.0115498903940656,0.0115498903940656,0,0,19769.0,88191.07730937863,NPPB
25332,KEGG_2019_Human,JAK-STAT signaling pathway,1/162,0.0080999104202618,0.0146998751759735,0,0,19838.0,95537.86936302872,IFNL1
25333,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0146998751759735,0,0,19706.0,83157.67014793828,IFNL1
25334,KEGG_2019_Human,Cell cycle,1/124,0.0061999236097501,0.0119998666032662,0,0,19876.0,101034.04709010696,YWHAH
25335,KEGG_2019_Human,Oocyte meiosis,1/125,0.0062499232373748,0.0119998666032662,0,0,19875.0,100869.32368441945,YWHAH
25336,KEGG_2019_Human,Hepatitis C,1/155,0.0077499127120574,0.0119998666032662,0,0,19845.0,96448.16254952336,YWHAH
25337,KEGG_2019_Human,Hippo signaling pathway,1/160,0.0079999110688441,0.0119998666032662,0,0,19840.0,95793.96509856998,YWHAH
25338,KEGG_2019_Human,Viral carcinogenesis,1/201,0.0100498985877989,0.0120598783053587,0,0,19799.0,91079.21596609056,YWHAH
25339,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0176998626413668,0,0,19646.0,79255.8617626126,YWHAH
25340,KEGG_2019_Human,IL-17 signaling pathway,1/93,0.0046499360391879,0.0046499360391879,0,0,19907.0,106918.54242106884,S100A9
25341,KEGG_2019_Human,Steroid hormone biosynthesis,1/60,0.002999951725986,0.0036999446830449,0,0,19940.0,115834.63209072244,AKR1C1
25342,KEGG_2019_Human,Metabolism of xenobiotics by cytochrome P450,1/74,0.0036999446830449,0.0036999446830449,0,0,19926.0,111574.38983110404,AKR1C1
25343,KEGG_2019_Human,Sphingolipid signaling pathway,1/119,0.0059499254985137,0.0118998509970274,0,0,19881.0,101877.73080211312,S1PR5
25344,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,S1PR5
25345,KEGG_2019_Human,Amoebiasis,1/96,0.0047999347538706,0.010649875686409,0,0,19904.0,106270.50039849174,GNAL
25346,KEGG_2019_Human,Chagas disease (American trypanosomiasis),1/103,0.0051499318302617,0.010649875686409,0,0,19897.0,104832.7525292024,GNAL
25347,KEGG_2019_Human,Dopaminergic synapse,1/131,0.0065499210316603,0.010649875686409,0,0,19869.0,99907.33811343512,GNAL
25348,KEGG_2019_Human,Parkinson disease,1/142,0.0070999171242726,0.010649875686409,0,0,19858.0,98250.87390500787,GNAL
25349,KEGG_2019_Human,Calcium signaling pathway,1/188,0.009399902370135,0.011279882844162,0,0,19812.0,92463.712994847,GNAL
25350,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,GNAL
25351,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR13C8
25352,KEGG_2019_Human,RNA transport,1/165,0.0082499094553477,0.0082499094553477,0,0,19835.0,95159.46482222488,EIF1
25353,KEGG_2019_Human,Butanoate metabolism,1/28,0.0013999711732997,0.0013999711732997,0,0,19972.0,131242.0761597353,ACSM6
25354,KEGG_2019_Human,Amino sugar and nucleotide sugar metabolism,1/48,0.0023999583567988,0.0023999583567988,0,0,19952.0,120356.5272753826,GNPNAT1
25355,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF212
25356,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR1E2
25357,KEGG_2019_Human,Cholesterol metabolism,1/50,0.0024999572069037,0.0030499512001654,0,0,19950.0,119530.05920663515,LIPG
25358,KEGG_2019_Human,Glycerolipid metabolism,1/61,0.0030499512001654,0.0030499512001654,0,0,19939.0,115499.24335773686,LIPG
25359,KEGG_2019_Human,Progesterone-mediated oocyte maturation,1/99,0.0049499334884068,0.0062499232373748,0,0,19901.0,105642.09305076736,SPDYC
25360,KEGG_2019_Human,Oocyte meiosis,1/125,0.0062499232373748,0.0062499232373748,0,0,19875.0,100869.32368441945,SPDYC
25361,KEGG_2019_Human,Citrate cycle (TCA cycle),1/30,0.0014999697593334,0.0104997883153344,0,0,19970.0,129851.13732048514,SDHB
25362,KEGG_2019_Human,Oxidative phosphorylation,1/133,0.0066499203093911,0.0112582177134695,0,0,19867.0,99596.2591544721,SDHB
25363,KEGG_2019_Human,Parkinson disease,1/142,0.0070999171242726,0.0112582177134695,0,0,19858.0,98250.87390500787,SDHB
25364,KEGG_2019_Human,Non-alcoholic fatty liver disease (NAFLD),1/149,0.0074499147221605,0.0112582177134695,0,0,19851.0,97261.02051561224,SDHB
25365,KEGG_2019_Human,Alzheimer disease,1/171,0.0085499075557634,0.0112582177134695,0,0,19829.0,94422.42241345016,SDHB
25366,KEGG_2019_Human,Huntington disease,1/193,0.0096499008972596,0.0112582177134695,0,0,19807.0,91920.47679471428,SDHB
25367,KEGG_2019_Human,Thermogenesis,1/231,0.0115498903940656,0.0115498903940656,0,0,19769.0,88191.07730937863,SDHB
25368,KEGG_2019_Human,Complement and coagulation cascades,1/79,0.0039499423167337,0.0049999330710556,0,0,19921.0,110243.89578070649,F3
25369,KEGG_2019_Human,AGE-RAGE signaling pathway in diabetic complications,1/100,0.0049999330710556,0.0049999330710556,0,0,19900.0,105436.78197328727,F3
25370,KEGG_2019_Human,Notch signaling pathway,1/48,0.0023999583567988,0.0047999167135976,0,0,19952.0,120356.5272753826,PSENEN
25371,KEGG_2019_Human,Alzheimer disease,1/171,0.0085499075557634,0.0085499075557634,0,0,19829.0,94422.42241345016,PSENEN
25372,KEGG_2019_Human,Mitophagy,1/65,0.003249949134407,0.0092999029651357,0,0,19935.0,114209.92613860144,GABARAPL2
25373,KEGG_2019_Human,GABAergic synapse,1/89,0.0044499377838098,0.0092999029651357,0,0,19911.0,107815.380281759,GABARAPL2
25374,KEGG_2019_Human,Autophagy,1/128,0.0063999221281459,0.0092999029651357,0,0,19872.0,100382.8010329652,GABARAPL2
25375,KEGG_2019_Human,FoxO signaling pathway,1/132,0.0065999206698993,0.0092999029651357,0,0,19868.0,99751.22090491928,GABARAPL2
25376,KEGG_2019_Human,Apelin signaling pathway,1/137,0.0068499188797651,0.0092999029651357,0,0,19863.0,98987.62735269018,GABARAPL2
25377,KEGG_2019_Human,NOD-like receptor signaling pathway,1/178,0.0088999053857096,0.0092999029651357,0,0,19822.0,93593.82745769851,GABARAPL2
25378,KEGG_2019_Human,Kaposi sarcoma-associated herpesvirus infection,1/186,0.0092999029651357,0.0092999029651357,0,0,19814.0,92684.96451050608,GABARAPL2
25379,KEGG_2019_Human,Non-small cell lung cancer,1/66,0.003299948626608,0.0139198681619524,0,0,19934.0,113899.85357353876,RASSF5
25380,KEGG_2019_Human,Leukocyte transendothelial migration,1/112,0.0055999282120529,0.0139198681619524,0,0,19888.0,103119.30984392198,RASSF5
25381,KEGG_2019_Human,Cellular senescence,1/160,0.0079999110688441,0.0139198681619524,0,0,19840.0,95793.96509856998,RASSF5
25382,KEGG_2019_Human,Rap1 signaling pathway,1/206,0.010299897173561,0.0139198681619524,0,0,19794.0,90569.849337325,RASSF5
25383,KEGG_2019_Human,Ras signaling pathway,1/232,0.0115998901349604,0.0139198681619524,0,0,19768.0,88101.22480150245,RASSF5
25384,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,RASSF5
25385,KEGG_2019_Human,Ribosome,1/153,0.0076499133771537,0.0076499133771537,0,0,19847.0,96715.6407630817,RPS19
25386,KEGG_2019_Human,Fanconi anemia pathway,1/54,0.0026999549628563,0.0053999099257126,0,0,19946.0,117971.01964061816,FANCL
25387,KEGG_2019_Human,Ubiquitin mediated proteolysis,1/137,0.0068499188797651,0.0068499188797651,0,0,19863.0,98987.62735269018,FANCL
25388,KEGG_2019_Human,JAK-STAT signaling pathway,1/162,0.0080999104202618,0.0146998751759735,0,0,19838.0,95537.86936302872,IL22RA1
25389,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0146998751759735,0,0,19706.0,83157.67014793828,IL22RA1
25390,KEGG_2019_Human,Ferroptosis,1/40,0.0019999631680592,0.0027999538675741,0,0,19960.0,124043.94523066044,GSS
25391,KEGG_2019_Human,Cysteine and methionine metabolism,1/47,0.0023499589392381,0.0027999538675741,0,0,19953.0,120782.64067395544,GSS
25392,KEGG_2019_Human,Glutathione metabolism,1/56,0.0027999538675741,0.0027999538675741,0,0,19944.0,117233.87022514464,GSS
25393,KEGG_2019_Human,mRNA surveillance pathway,1/91,0.0045499369072032,0.0082499094553477,0,0,19909.0,107362.10783923086,EIF4A3
25394,KEGG_2019_Human,Spliceosome,1/134,0.0066999199497742,0.0082499094553477,0,0,19866.0,99442.43560916925,EIF4A3
25395,KEGG_2019_Human,RNA transport,1/165,0.0082499094553477,0.0082499094553477,0,0,19835.0,95159.46482222488,EIF4A3
25396,KEGG_2019_Human,Oxidative phosphorylation,1/133,0.0066499203093911,0.0115498903940656,0,0,19867.0,99596.2591544721,ATP5F1D
25397,KEGG_2019_Human,Parkinson disease,1/142,0.0070999171242726,0.0115498903940656,0,0,19858.0,98250.87390500787,ATP5F1D
25398,KEGG_2019_Human,Alzheimer disease,1/171,0.0085499075557634,0.0115498903940656,0,0,19829.0,94422.42241345016,ATP5F1D
25399,KEGG_2019_Human,Huntington disease,1/193,0.0096499008972596,0.0115498903940656,0,0,19807.0,91920.47679471428,ATP5F1D
25400,KEGG_2019_Human,Thermogenesis,1/231,0.0115498903940656,0.0115498903940656,0,0,19769.0,88191.07730937863,ATP5F1D
25401,KEGG_2019_Human,DNA replication,1/36,0.0017999657178272,0.0017999657178272,0,0,19964.0,126172.23364250171,PRIM1
25402,KEGG_2019_Human,Thyroid cancer,1/37,0.0018499650702878,0.0091040424289839,0,0,19963.0,125618.9446446357,GADD45B
25403,KEGG_2019_Human,Endometrial cancer,1/58,0.0028999527887707,0.0091040424289839,0,0,19942.0,116522.31890946148,GADD45B
25404,KEGG_2019_Human,Basal cell carcinoma,1/63,0.0031499501598827,0.0091040424289839,0,0,19937.0,114844.46974572667,GADD45B
25405,KEGG_2019_Human,Non-small cell lung cancer,1/66,0.003299948626608,0.0091040424289839,0,0,19934.0,113899.85357353876,GADD45B
25406,KEGG_2019_Human,p53 signaling pathway,1/72,0.0035999456502131,0.0091040424289839,0,0,19928.0,112131.59838572376,GADD45B
25407,KEGG_2019_Human,Melanoma,1/72,0.0035999456502131,0.0091040424289839,0,0,19928.0,112131.59838572376,GADD45B
25408,KEGG_2019_Human,Pancreatic cancer,1/75,0.0037499442041125,0.0091040424289839,0,0,19925.0,111301.33528642564,GADD45B
25409,KEGG_2019_Human,Glioma,1/75,0.0037499442041125,0.0091040424289839,0,0,19925.0,111301.33528642564,GADD45B
25410,KEGG_2019_Human,Chronic myeloid leukemia,1/76,0.0037999437281752,0.0091040424289839,0,0,19924.0,111031.8499691117,GADD45B
25411,KEGG_2019_Human,Colorectal cancer,1/86,0.0042999391173866,0.0091040424289839,0,0,19914.0,108514.46102290176,GADD45B
25412,KEGG_2019_Human,Small cell lung cancer,1/93,0.0046499360391879,0.0091040424289839,0,0,19907.0,106918.54242106884,GADD45B
25413,KEGG_2019_Human,NF-kappa B signaling pathway,1/95,0.0047499351803394,0.0091040424289839,0,0,19905.0,106484.27183626965,GADD45B
25414,KEGG_2019_Human,Cell cycle,1/124,0.0061999236097501,0.0100792963888054,0,0,19876.0,101034.04709010696,GADD45B
25415,KEGG_2019_Human,FoxO signaling pathway,1/132,0.0065999206698993,0.0100792963888054,0,0,19868.0,99751.22090491928,GADD45B
25416,KEGG_2019_Human,Apoptosis,1/143,0.0071499167770442,0.0100792963888054,0,0,19857.0,98106.57763600958,GADD45B
25417,KEGG_2019_Human,Breast cancer,1/147,0.0073499154017982,0.0100792963888054,0,0,19853.0,97539.10874372096,GADD45B
25418,KEGG_2019_Human,Gastric cancer,1/149,0.0074499147221605,0.0100792963888054,0,0,19851.0,97261.02051561224,GADD45B
25419,KEGG_2019_Human,Cellular senescence,1/160,0.0079999110688441,0.0101683102908167,0,0,19840.0,95793.96509856998,GADD45B
25420,KEGG_2019_Human,Hepatocellular carcinoma,1/168,0.0083999085011095,0.0101683102908167,0,0,19832.0,94787.72752807094,GADD45B
25421,KEGG_2019_Human,Transcriptional misregulation in cancer,1/186,0.0092999029651357,0.0106948884099061,0,0,19814.0,92684.96451050608,GADD45B
25422,KEGG_2019_Human,Epstein-Barr virus infection,1/201,0.0100498985877989,0.0110070317866369,0,0,19799.0,91079.21596609056,GADD45B
25423,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0154203238151802,0,0,19705.0,83086.53988020132,GADD45B
25424,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,GADD45B
25425,KEGG_2019_Human,mTOR signaling pathway,1/152,0.0075999137114971,0.0075999137114971,0,0,19848.0,96850.665715497,LAMTOR5
25426,KEGG_2019_Human,Protein processing in endoplasmic reticulum,1/165,0.0082499094553477,0.0082499094553477,0,0,19835.0,95159.46482222488,BAG2
25427,KEGG_2019_Human,VEGF signaling pathway,1/59,0.0029499522555206,0.007199902130806,0,0,19941.0,116175.59385530632,HSPB1
25428,KEGG_2019_Human,Amoebiasis,1/96,0.0047999347538706,0.007199902130806,0,0,19904.0,106270.50039849174,HSPB1
25429,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0147498749536506,0,0,19705.0,83086.53988020132,HSPB1
25430,KEGG_2019_Human,IL-17 signaling pathway,1/93,0.0046499360391879,0.0046499360391879,0,0,19907.0,106918.54242106884,LCN2
25431,KEGG_2019_Human,Spliceosome,1/134,0.0066999199497742,0.0066999199497742,0,0,19866.0,99442.43560916925,SMNDC1
25432,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,CHRNG
25433,KEGG_2019_Human,Mitophagy,1/65,0.003249949134407,0.0092999029651357,0,0,19935.0,114209.92613860144,GABARAPL1
25434,KEGG_2019_Human,GABAergic synapse,1/89,0.0044499377838098,0.0092999029651357,0,0,19911.0,107815.380281759,GABARAPL1
25435,KEGG_2019_Human,Autophagy,1/128,0.0063999221281459,0.0092999029651357,0,0,19872.0,100382.8010329652,GABARAPL1
25436,KEGG_2019_Human,FoxO signaling pathway,1/132,0.0065999206698993,0.0092999029651357,0,0,19868.0,99751.22090491928,GABARAPL1
25437,KEGG_2019_Human,Apelin signaling pathway,1/137,0.0068499188797651,0.0092999029651357,0,0,19863.0,98987.62735269018,GABARAPL1
25438,KEGG_2019_Human,NOD-like receptor signaling pathway,1/178,0.0088999053857096,0.0092999029651357,0,0,19822.0,93593.82745769851,GABARAPL1
25439,KEGG_2019_Human,Kaposi sarcoma-associated herpesvirus infection,1/186,0.0092999029651357,0.0092999029651357,0,0,19814.0,92684.96451050608,GABARAPL1
25440,KEGG_2019_Human,Collecting duct acid secretion,1/27,0.0013499718942362,0.0081898864329657,0,0,19973.0,131975.02298599784,ATP6V1A
25441,KEGG_2019_Human,Vibrio cholerae infection,1/50,0.0024999572069037,0.0081898864329657,0,0,19950.0,119530.05920663515,ATP6V1A
25442,KEGG_2019_Human,Epithelial cell signaling in Helicobacter pylori infection,1/68,0.0033999476216189,0.0081898864329657,0,0,19932.0,113293.39338050144,ATP6V1A
25443,KEGG_2019_Human,Synaptic vesicle cycle,1/78,0.0038999427840466,0.0081898864329657,0,0,19922.0,110503.2180492851,ATP6V1A
25444,KEGG_2019_Human,Rheumatoid arthritis,1/91,0.0045499369072032,0.0081898864329657,0,0,19909.0,107362.10783923086,ATP6V1A
25445,KEGG_2019_Human,Oxidative phosphorylation,1/133,0.0066499203093911,0.0085499029254342,0,0,19867.0,99596.2591544721,ATP6V1A
25446,KEGG_2019_Human,mTOR signaling pathway,1/152,0.0075999137114971,0.0085499029254342,0,0,19848.0,96850.665715497,ATP6V1A
25447,KEGG_2019_Human,Phagosome,1/152,0.0075999137114971,0.0085499029254342,0,0,19848.0,96850.665715497,ATP6V1A
25448,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0164998674589645,0,0,19670.0,80733.60565076157,ATP6V1A
25449,KEGG_2019_Human,Taste transduction,1/83,0.0041499404726918,0.0041499404726918,0,0,19917.0,109237.99888847338,TAS2R10
25450,KEGG_2019_Human,Glycosylphosphatidylinositol (GPI)-anchor biosynthesis,1/25,0.0012499733663791,0.0012499733663791,0,0,19975.0,133525.54486996148,PIGW
25451,KEGG_2019_Human,RNA degradation,1/79,0.0039499423167337,0.0039499423167337,0,0,19921.0,110243.89578070649,BTG1
25452,KEGG_2019_Human,Chemokine signaling pathway,1/190,0.0094999017791995,0.0146998751759735,0,0,19810.0,92244.74636351672,XCL1
25453,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0146998751759735,0,0,19706.0,83157.67014793828,XCL1
25454,KEGG_2019_Human,Ribosome,1/153,0.0076499133771537,0.0076499133771537,0,0,19847.0,96715.6407630817,RPS14
25455,KEGG_2019_Human,Glycosaminoglycan biosynthesis,1/53,0.0026499555173137,0.0026499555173137,0,0,19947.0,118349.78824235698,B3GNT7
25456,KEGG_2019_Human,Non-homologous end-joining,1/13,0.0006499833083207112,0.0006499833083207112,0,0,19987.0,146675.87616784443,XRCC4
25457,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR6C76
25458,KEGG_2019_Human,Amyotrophic lateral sclerosis (ALS),1/51,0.0025499566390179,0.0025499566390179,0,0,19949.0,119129.0228601236,TOMM40L
25459,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR13A1
25460,KEGG_2019_Human,Arginine and proline metabolism,1/49,0.0024499577795033,0.0024499577795033,0,0,19951.0,119939.1172087114,CKMT1B
25461,KEGG_2019_Human,Signaling pathways regulating pluripotency of stem cells,1/139,0.006949918172816,0.006949918172816,0,0,19861.0,98689.81333375497,PCGF5
25462,KEGG_2019_Human,Endocytosis,1/244,0.0121998870519305,0.0121998870519305,0,0,19756.0,87051.4275316661,SNX2
25463,KEGG_2019_Human,Legionellosis,1/55,0.0027499544131125,0.0027499544131125,0,0,19945.0,117599.1294878737,RAB1B
25464,KEGG_2019_Human,Taste transduction,1/83,0.0041499404726918,0.0041499404726918,0,0,19917.0,109237.99888847338,TAS2R13
25465,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF620
25466,KEGG_2019_Human,VEGF signaling pathway,1/59,0.0029499522555206,0.0127046415763852,0,0,19941.0,116175.59385530632,RAC3
25467,KEGG_2019_Human,Viral myocarditis,1/59,0.0029499522555206,0.0127046415763852,0,0,19941.0,116175.59385530632,RAC3
25468,KEGG_2019_Human,Fc epsilon RI signaling pathway,1/68,0.0033999476216189,0.0127046415763852,0,0,19932.0,113293.39338050144,RAC3
25469,KEGG_2019_Human,B cell receptor signaling pathway,1/71,0.0035499461386618,0.0127046415763852,0,0,19929.0,112415.9585341616,RAC3
25470,KEGG_2019_Human,Adherens junction,1/72,0.0035999456502131,0.0127046415763852,0,0,19928.0,112131.59838572376,RAC3
25471,KEGG_2019_Human,Pancreatic cancer,1/75,0.0037499442041125,0.0127046415763852,0,0,19925.0,111301.33528642564,RAC3
25472,KEGG_2019_Human,Colorectal cancer,1/86,0.0042999391173866,0.0127046415763852,0,0,19914.0,108514.46102290176,RAC3
25473,KEGG_2019_Human,Choline metabolism in cancer,1/99,0.0049499334884068,0.0127046415763852,0,0,19901.0,105642.09305076736,RAC3
25474,KEGG_2019_Human,Sphingolipid signaling pathway,1/119,0.0059499254985137,0.0127046415763852,0,0,19881.0,101877.73080211312,RAC3
25475,KEGG_2019_Human,Natural killer cell mediated cytotoxicity,1/131,0.0065499210316603,0.0127046415763852,0,0,19869.0,99907.33811343512,RAC3
25476,KEGG_2019_Human,Fluid shear stress and atherosclerosis,1/139,0.006949918172816,0.0127046415763852,0,0,19861.0,98689.81333375497,RAC3
25477,KEGG_2019_Human,Wnt signaling pathway,1/158,0.0078999117225733,0.0127046415763852,0,0,19842.0,96053.2110949472,RAC3
25478,KEGG_2019_Human,Axon guidance,1/181,0.0090499044707863,0.0127046415763852,0,0,19819.0,93248.41634586031,RAC3
25479,KEGG_2019_Human,Chemokine signaling pathway,1/190,0.0094999017791995,0.0127046415763852,0,0,19810.0,92244.74636351672,RAC3
25480,KEGG_2019_Human,Focal adhesion,1/199,0.0099498991610159,0.0127046415763852,0,0,19801.0,91286.4288690606,RAC3
25481,KEGG_2019_Human,Rap1 signaling pathway,1/206,0.010299897173561,0.0127046415763852,0,0,19794.0,90569.849337325,RAC3
25482,KEGG_2019_Human,Human immunodeficiency virus 1 infection,1/212,0.0105998955026255,0.0127046415763852,0,0,19788.0,89974.27756224656,RAC3
25483,KEGG_2019_Human,cAMP signaling pathway,1/212,0.0105998955026255,0.0127046415763852,0,0,19788.0,89974.27756224656,RAC3
25484,KEGG_2019_Human,Regulation of actin cytoskeleton,1/214,0.0106998949514067,0.0127046415763852,0,0,19786.0,89779.39753374986,RAC3
25485,KEGG_2019_Human,Human cytomegalovirus infection,1/225,0.0112498919790339,0.0127046415763852,0,0,19775.0,88738.27077557483,RAC3
25486,KEGG_2019_Human,Ras signaling pathway,1/232,0.0115998901349604,0.0127046415763852,0,0,19768.0,88101.22480150245,RAC3
25487,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0154203238151802,0,0,19705.0,83086.53988020132,RAC3
25488,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,RAC3
25489,KEGG_2019_Human,Oxidative phosphorylation,1/133,0.0066499203093911,0.0115498903940656,0,0,19867.0,99596.2591544721,ATP5MC1
25490,KEGG_2019_Human,Parkinson disease,1/142,0.0070999171242726,0.0115498903940656,0,0,19858.0,98250.87390500787,ATP5MC1
25491,KEGG_2019_Human,Alzheimer disease,1/171,0.0085499075557634,0.0115498903940656,0,0,19829.0,94422.42241345016,ATP5MC1
25492,KEGG_2019_Human,Huntington disease,1/193,0.0096499008972596,0.0115498903940656,0,0,19807.0,91920.47679471428,ATP5MC1
25493,KEGG_2019_Human,Thermogenesis,1/231,0.0115498903940656,0.0115498903940656,0,0,19769.0,88191.07730937863,ATP5MC1
25494,KEGG_2019_Human,Thermogenesis,1/231,0.0115498903940656,0.0115498903940656,0,0,19769.0,88191.07730937863,COA6
25495,KEGG_2019_Human,Ribosome,1/153,0.0076499133771537,0.0076499133771537,0,0,19847.0,96715.6407630817,MRPL32
25496,KEGG_2019_Human,Taste transduction,1/83,0.0041499404726918,0.0056499278191151,0,0,19917.0,109237.99888847338,HTR3B
25497,KEGG_2019_Human,Serotonergic synapse,1/113,0.0056499278191151,0.0056499278191151,0,0,19887.0,102937.34947211576,HTR3B
25498,KEGG_2019_Human,Sphingolipid metabolism,1/47,0.0023499589392381,0.0023499589392381,0,0,19953.0,120782.64067395544,GAL3ST1
25499,KEGG_2019_Human,Ether lipid metabolism,1/47,0.0023499589392381,0.0023499589392381,0,0,19953.0,120782.64067395544,GAL3ST1
25500,KEGG_2019_Human,Pentose and glucuronate interconversions,1/34,0.0016999670339032,0.0016999670339032,0,0,19966.0,127326.1054203148,DCXR
25501,KEGG_2019_Human,Protein processing in endoplasmic reticulum,1/165,0.0082499094553477,0.0082499094553477,0,0,19835.0,95159.46482222488,DNAJC5
25502,KEGG_2019_Human,Chemical carcinogenesis,1/82,0.004099940929819,0.004099940929819,0,0,19918.0,109484.9180722932,SULT1A3
25503,KEGG_2019_Human,Cardiac muscle contraction,1/78,0.0038999427840466,0.0112582177134695,0,0,19922.0,110503.2180492851,COX5B
25504,KEGG_2019_Human,Oxidative phosphorylation,1/133,0.0066499203093911,0.0112582177134695,0,0,19867.0,99596.2591544721,COX5B
25505,KEGG_2019_Human,Parkinson disease,1/142,0.0070999171242726,0.0112582177134695,0,0,19858.0,98250.87390500787,COX5B
25506,KEGG_2019_Human,Non-alcoholic fatty liver disease (NAFLD),1/149,0.0074499147221605,0.0112582177134695,0,0,19851.0,97261.02051561224,COX5B
25507,KEGG_2019_Human,Alzheimer disease,1/171,0.0085499075557634,0.0112582177134695,0,0,19829.0,94422.42241345016,COX5B
25508,KEGG_2019_Human,Huntington disease,1/193,0.0096499008972596,0.0112582177134695,0,0,19807.0,91920.47679471428,COX5B
25509,KEGG_2019_Human,Thermogenesis,1/231,0.0115498903940656,0.0115498903940656,0,0,19769.0,88191.07730937863,COX5B
25510,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR1N1
25511,KEGG_2019_Human,Ether lipid metabolism,1/47,0.0023499589392381,0.0023499589392381,0,0,19953.0,120782.64067395544,GDPD3
25512,KEGG_2019_Human,Protein processing in endoplasmic reticulum,1/165,0.0082499094553477,0.0082499094553477,0,0,19835.0,95159.46482222488,LMAN1L
25513,KEGG_2019_Human,Cardiac muscle contraction,1/78,0.0038999427840466,0.0112582177134695,0,0,19922.0,110503.2180492851,COX7B
25514,KEGG_2019_Human,Oxidative phosphorylation,1/133,0.0066499203093911,0.0112582177134695,0,0,19867.0,99596.2591544721,COX7B
25515,KEGG_2019_Human,Parkinson disease,1/142,0.0070999171242726,0.0112582177134695,0,0,19858.0,98250.87390500787,COX7B
25516,KEGG_2019_Human,Non-alcoholic fatty liver disease (NAFLD),1/149,0.0074499147221605,0.0112582177134695,0,0,19851.0,97261.02051561224,COX7B
25517,KEGG_2019_Human,Alzheimer disease,1/171,0.0085499075557634,0.0112582177134695,0,0,19829.0,94422.42241345016,COX7B
25518,KEGG_2019_Human,Huntington disease,1/193,0.0096499008972596,0.0112582177134695,0,0,19807.0,91920.47679471428,COX7B
25519,KEGG_2019_Human,Thermogenesis,1/231,0.0115498903940656,0.0115498903940656,0,0,19769.0,88191.07730937863,COX7B
25520,KEGG_2019_Human,Mitophagy,1/65,0.003249949134407,0.003249949134407,0,0,19935.0,114209.92613860144,FUNDC1
25521,KEGG_2019_Human,Salivary secretion,1/90,0.0044999373439762,0.0044999373439762,0,0,19910.0,107587.50385474482,LYZ
25522,KEGG_2019_Human,Prostate cancer,1/97,0.0048499343304706,0.0096998686609413,0,0,19903.0,106058.9096435903,NKX3-1
25523,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,NKX3-1
25524,KEGG_2019_Human,Progesterone-mediated oocyte maturation,1/99,0.0049499334884068,0.0085623985997064,0,0,19901.0,105642.09305076736,ANAPC11
25525,KEGG_2019_Human,Cell cycle,1/124,0.0061999236097501,0.0085623985997064,0,0,19876.0,101034.04709010696,ANAPC11
25526,KEGG_2019_Human,Oocyte meiosis,1/125,0.0062499232373748,0.0085623985997064,0,0,19875.0,100869.32368441945,ANAPC11
25527,KEGG_2019_Human,Ubiquitin mediated proteolysis,1/137,0.0068499188797651,0.0085623985997064,0,0,19863.0,98987.62735269018,ANAPC11
25528,KEGG_2019_Human,Human T-cell leukemia virus 1 infection,1/219,0.0109498935894162,0.0109498935894162,0,0,19781.0,89299.85161916987,ANAPC11
25529,KEGG_2019_Human,Leukocyte transendothelial migration,1/112,0.0055999282120529,0.0084999078692823,0,0,19888.0,103119.30984392198,CLDN24
25530,KEGG_2019_Human,Cell adhesion molecules (CAMs),1/145,0.0072499160871101,0.0084999078692823,0,0,19855.0,97820.92670675044,CLDN24
25531,KEGG_2019_Human,Hepatitis C,1/155,0.0077499127120574,0.0084999078692823,0,0,19845.0,96448.16254952336,CLDN24
25532,KEGG_2019_Human,Tight junction,1/170,0.0084999078692823,0.0084999078692823,0,0,19830.0,94543.49009679438,CLDN24
25533,KEGG_2019_Human,Spliceosome,1/134,0.0066999199497742,0.0066999199497742,0,0,19866.0,99442.43560916925,HNRNPC
25534,KEGG_2019_Human,Base excision repair,1/33,0.0016499677032113,0.0023499589392381,0,0,19967.0,127928.56031580272,POLE3
25535,KEGG_2019_Human,DNA replication,1/36,0.0017999657178272,0.0023499589392381,0,0,19964.0,126172.23364250171,POLE3
25536,KEGG_2019_Human,Nucleotide excision repair,1/47,0.0023499589392381,0.0023499589392381,0,0,19953.0,120782.64067395544,POLE3
25537,KEGG_2019_Human,Peroxisome,1/83,0.0041499404726918,0.0041499404726918,0,0,19917.0,109237.99888847338,MPV17L2
25538,KEGG_2019_Human,Lysosome,1/123,0.0061499239842961,0.0105998955026255,0,0,19877.0,101200.07933676826,AP1S2
25539,KEGG_2019_Human,Human immunodeficiency virus 1 infection,1/212,0.0105998955026255,0.0105998955026255,0,0,19788.0,89974.27756224656,AP1S2
25540,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR1L4
25541,KEGG_2019_Human,Vitamin B6 metabolism,1/6,0.0002999905873105514,0.0005999811746211028,0,0,19994.0,162186.51863187927,PSAT1
25542,KEGG_2019_Human,"Glycine, serine and threonine metabolism",1/40,0.0019999631680592,0.0019999631680592,0,0,19960.0,124043.94523066044,PSAT1
25543,KEGG_2019_Human,Hepatocellular carcinoma,1/168,0.0083999085011095,0.0115498903940656,0,0,19832.0,94787.72752807094,ACTL6A
25544,KEGG_2019_Human,Thermogenesis,1/231,0.0115498903940656,0.0115498903940656,0,0,19769.0,88191.07730937863,ACTL6A
25545,KEGG_2019_Human,Glycosphingolipid biosynthesis,1/45,0.0022499601197094,0.0022499601197094,0,0,19955.0,121662.49782449217,ST6GALNAC3
25546,KEGG_2019_Human,Asthma,1/31,0.0015499690656704,0.0046499071970112,0,0,19969.0,129189.85098816035,IL9
25547,KEGG_2019_Human,JAK-STAT signaling pathway,1/162,0.0080999104202618,0.0121498656303927,0,0,19838.0,95537.86936302872,IL9
25548,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0146998751759735,0,0,19706.0,83157.67014793828,IL9
25549,KEGG_2019_Human,Parkinson disease,1/142,0.0070999171242726,0.0109498935894162,0,0,19858.0,98250.87390500787,SLC25A6
25550,KEGG_2019_Human,Cellular senescence,1/160,0.0079999110688441,0.0109498935894162,0,0,19840.0,95793.96509856998,SLC25A6
25551,KEGG_2019_Human,Necroptosis,1/162,0.0080999104202618,0.0109498935894162,0,0,19838.0,95537.86936302872,SLC25A6
25552,KEGG_2019_Human,cGMP-PKG signaling pathway,1/166,0.0082999091363732,0.0109498935894162,0,0,19834.0,95034.82345515196,SLC25A6
25553,KEGG_2019_Human,Influenza A,1/171,0.0085499075557634,0.0109498935894162,0,0,19829.0,94422.42241345016,SLC25A6
25554,KEGG_2019_Human,Calcium signaling pathway,1/188,0.009399902370135,0.0109498935894162,0,0,19812.0,92463.712994847,SLC25A6
25555,KEGG_2019_Human,Huntington disease,1/193,0.0096499008972596,0.0109498935894162,0,0,19807.0,91920.47679471428,SLC25A6
25556,KEGG_2019_Human,Human T-cell leukemia virus 1 infection,1/219,0.0109498935894162,0.0109498935894162,0,0,19781.0,89299.85161916987,SLC25A6
25557,KEGG_2019_Human,Glutathione metabolism,1/56,0.0027999538675741,0.0027999538675741,0,0,19944.0,117233.87022514464,CHAC2
25558,KEGG_2019_Human,HIF-1 signaling pathway,1/100,0.0049999330710556,0.0098998913464173,0,0,19900.0,105436.78197328727,EIF4E2
25559,KEGG_2019_Human,Longevity regulating pathway,1/102,0.0050999322416682,0.0098998913464173,0,0,19898.0,105032.15064717118,EIF4E2
25560,KEGG_2019_Human,Insulin signaling pathway,1/137,0.0068499188797651,0.0098998913464173,0,0,19863.0,98987.62735269018,EIF4E2
25561,KEGG_2019_Human,mTOR signaling pathway,1/152,0.0075999137114971,0.0098998913464173,0,0,19848.0,96850.665715497,EIF4E2
25562,KEGG_2019_Human,RNA transport,1/165,0.0082499094553477,0.0098998913464173,0,0,19835.0,95159.46482222488,EIF4E2
25563,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0176998626413668,0,0,19646.0,79255.8617626126,EIF4E2
25564,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR56A1
25565,KEGG_2019_Human,IL-17 signaling pathway,1/93,0.0046499360391879,0.0046499360391879,0,0,19907.0,106918.54242106884,S100A7
25566,KEGG_2019_Human,NF-kappa B signaling pathway,1/95,0.0047499351803394,0.0080999104202618,0,0,19905.0,106484.27183626965,CFLAR
25567,KEGG_2019_Human,Chagas disease (American trypanosomiasis),1/103,0.0051499318302617,0.0080999104202618,0,0,19897.0,104832.7525292024,CFLAR
25568,KEGG_2019_Human,TNF signaling pathway,1/110,0.0054999290027479,0.0080999104202618,0,0,19890.0,103488.06969787036,CFLAR
25569,KEGG_2019_Human,Autophagy,1/128,0.0063999221281459,0.0080999104202618,0,0,19872.0,100382.8010329652,CFLAR
25570,KEGG_2019_Human,Apoptosis,1/143,0.0071499167770442,0.0080999104202618,0,0,19857.0,98106.57763600958,CFLAR
25571,KEGG_2019_Human,Hepatitis C,1/155,0.0077499127120574,0.0080999104202618,0,0,19845.0,96448.16254952336,CFLAR
25572,KEGG_2019_Human,Necroptosis,1/162,0.0080999104202618,0.0080999104202618,0,0,19838.0,95537.86936302872,CFLAR
25573,KEGG_2019_Human,Maturity onset diabetes of the young,1/26,0.0012999726251831,0.0012999726251831,0,0,19974.0,132735.46073187632,NEUROG3
25574,KEGG_2019_Human,Fructose and mannose metabolism,1/33,0.0016499677032113,0.0034999466296654,0,0,19967.0,127928.56031580272,TKFC
25575,KEGG_2019_Human,Glycerolipid metabolism,1/61,0.0030499512001654,0.0034999466296654,0,0,19939.0,115499.24335773686,TKFC
25576,KEGG_2019_Human,RIG-I-like receptor signaling pathway,1/70,0.0034999466296654,0.0034999466296654,0,0,19930.0,112704.30065625212,TKFC
25577,KEGG_2019_Human,Fat digestion and absorption,1/41,0.0020499625466866,0.0056570668438935,0,0,19959.0,123544.88783416104,PLPP2
25578,KEGG_2019_Human,Sphingolipid metabolism,1/47,0.0023499589392381,0.0056570668438935,0,0,19953.0,120782.64067395544,PLPP2
25579,KEGG_2019_Human,Ether lipid metabolism,1/47,0.0023499589392381,0.0056570668438935,0,0,19953.0,120782.64067395544,PLPP2
25580,KEGG_2019_Human,Glycerolipid metabolism,1/61,0.0030499512001654,0.0056570668438935,0,0,19939.0,115499.24335773686,PLPP2
25581,KEGG_2019_Human,Fc gamma R-mediated phagocytosis,1/91,0.0045499369072032,0.0056570668438935,0,0,19909.0,107362.10783923086,PLPP2
25582,KEGG_2019_Human,Glycerophospholipid metabolism,1/97,0.0048499343304706,0.0056570668438935,0,0,19903.0,106058.9096435903,PLPP2
25583,KEGG_2019_Human,Choline metabolism in cancer,1/99,0.0049499334884068,0.0056570668438935,0,0,19901.0,105642.09305076736,PLPP2
25584,KEGG_2019_Human,Phospholipase D signaling pathway,1/148,0.007399915061391,0.007399915061391,0,0,19852.0,97399.60470052566,PLPP2
25585,KEGG_2019_Human,Basal transcription factors,1/45,0.0022499601197094,0.0035249384088572,0,0,19955.0,121662.49782449217,GTF2H2
25586,KEGG_2019_Human,Nucleotide excision repair,1/47,0.0023499589392381,0.0035249384088572,0,0,19953.0,120782.64067395544,GTF2H2
25587,KEGG_2019_Human,Viral carcinogenesis,1/201,0.0100498985877989,0.0100498985877989,0,0,19799.0,91079.21596609056,GTF2H2
25588,KEGG_2019_Human,Leukocyte transendothelial migration,1/112,0.0055999282120529,0.0106998949514067,0,0,19888.0,103119.30984392198,MYL9
25589,KEGG_2019_Human,Vascular smooth muscle contraction,1/132,0.0065999206698993,0.0106998949514067,0,0,19868.0,99751.22090491928,MYL9
25590,KEGG_2019_Human,Oxytocin signaling pathway,1/153,0.0076499133771537,0.0106998949514067,0,0,19847.0,96715.6407630817,MYL9
25591,KEGG_2019_Human,cGMP-PKG signaling pathway,1/166,0.0082999091363732,0.0106998949514067,0,0,19834.0,95034.82345515196,MYL9
25592,KEGG_2019_Human,Tight junction,1/170,0.0084999078692823,0.0106998949514067,0,0,19830.0,94543.49009679438,MYL9
25593,KEGG_2019_Human,Axon guidance,1/181,0.0090499044707863,0.0106998949514067,0,0,19819.0,93248.41634586031,MYL9
25594,KEGG_2019_Human,Focal adhesion,1/199,0.0099498991610159,0.0106998949514067,0,0,19801.0,91286.4288690606,MYL9
25595,KEGG_2019_Human,cAMP signaling pathway,1/212,0.0105998955026255,0.0106998949514067,0,0,19788.0,89974.27756224656,MYL9
25596,KEGG_2019_Human,Regulation of actin cytoskeleton,1/214,0.0106998949514067,0.0106998949514067,0,0,19786.0,89779.39753374986,MYL9
25597,KEGG_2019_Human,RNA degradation,1/79,0.0039499423167337,0.0039499423167337,0,0,19921.0,110243.89578070649,EXOSC5
25598,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR52M1
25599,KEGG_2019_Human,Proteoglycans in cancer,1/201,0.0100498985877989,0.0100498985877989,0,0,19799.0,91079.21596609056,TWIST2
25600,KEGG_2019_Human,MicroRNAs in cancer,1/299,0.0149498740670514,0.0149498740670514,0,0,19701.0,82804.33538735632,MIR92A2
25601,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,PPY
25602,KEGG_2019_Human,Sphingolipid metabolism,1/47,0.0023499589392381,0.0046999178784763,0,0,19953.0,120782.64067395544,DEGS1
25603,KEGG_2019_Human,Sphingolipid signaling pathway,1/119,0.0059499254985137,0.0059499254985137,0,0,19881.0,101877.73080211312,DEGS1
25604,KEGG_2019_Human,MicroRNAs in cancer,1/299,0.0149498740670514,0.0149498740670514,0,0,19701.0,82804.33538735632,BCL2L2
25605,KEGG_2019_Human,Long-term potentiation,1/67,0.0033499481224912,0.0112348896989771,0,0,19933.0,113594.38808369274,PPP1CB
25606,KEGG_2019_Human,Amphetamine addiction,1/68,0.0033999476216189,0.0112348896989771,0,0,19932.0,113293.39338050144,PPP1CB
25607,KEGG_2019_Human,mRNA surveillance pathway,1/91,0.0045499369072032,0.0112348896989771,0,0,19909.0,107362.10783923086,PPP1CB
25608,KEGG_2019_Human,Inflammatory mediator regulation of TRP channels,1/100,0.0049999330710556,0.0112348896989771,0,0,19900.0,105436.78197328727,PPP1CB
25609,KEGG_2019_Human,Insulin resistance,1/108,0.0053999298011749,0.0112348896989771,0,0,19892.0,103863.47861844616,PPP1CB
25610,KEGG_2019_Human,Platelet activation,1/124,0.0061999236097501,0.0112348896989771,0,0,19876.0,101034.04709010696,PPP1CB
25611,KEGG_2019_Human,Oocyte meiosis,1/125,0.0062499232373748,0.0112348896989771,0,0,19875.0,100869.32368441945,PPP1CB
25612,KEGG_2019_Human,Dopaminergic synapse,1/131,0.0065499210316603,0.0112348896989771,0,0,19869.0,99907.33811343512,PPP1CB
25613,KEGG_2019_Human,Vascular smooth muscle contraction,1/132,0.0065999206698993,0.0112348896989771,0,0,19868.0,99751.22090491928,PPP1CB
25614,KEGG_2019_Human,Insulin signaling pathway,1/137,0.0068499188797651,0.0112348896989771,0,0,19863.0,98987.62735269018,PPP1CB
25615,KEGG_2019_Human,Adrenergic signaling in cardiomyocytes,1/145,0.0072499160871101,0.0112348896989771,0,0,19855.0,97820.92670675044,PPP1CB
25616,KEGG_2019_Human,Oxytocin signaling pathway,1/153,0.0076499133771537,0.0112348896989771,0,0,19847.0,96715.6407630817,PPP1CB
25617,KEGG_2019_Human,Cellular senescence,1/160,0.0079999110688441,0.0112348896989771,0,0,19840.0,95793.96509856998,PPP1CB
25618,KEGG_2019_Human,Hippo signaling pathway,1/160,0.0079999110688441,0.0112348896989771,0,0,19840.0,95793.96509856998,PPP1CB
25619,KEGG_2019_Human,cGMP-PKG signaling pathway,1/166,0.0082999091363732,0.0112348896989771,0,0,19834.0,95034.82345515196,PPP1CB
25620,KEGG_2019_Human,Alcoholism,1/180,0.0089999047745351,0.0112348896989771,0,0,19820.0,93362.92821536642,PPP1CB
25621,KEGG_2019_Human,Focal adhesion,1/199,0.0099498991610159,0.0112348896989771,0,0,19801.0,91286.4288690606,PPP1CB
25622,KEGG_2019_Human,Proteoglycans in cancer,1/201,0.0100498985877989,0.0112348896989771,0,0,19799.0,91079.21596609056,PPP1CB
25623,KEGG_2019_Human,cAMP signaling pathway,1/212,0.0105998955026255,0.0112348896989771,0,0,19788.0,89974.27756224656,PPP1CB
25624,KEGG_2019_Human,Regulation of actin cytoskeleton,1/214,0.0106998949514067,0.0112348896989771,0,0,19786.0,89779.39753374986,PPP1CB
25625,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,PPP1CB
25626,KEGG_2019_Human,Leukocyte transendothelial migration,1/112,0.0055999282120529,0.0106998949514067,0,0,19888.0,103119.30984392198,MYLPF
25627,KEGG_2019_Human,Focal adhesion,1/199,0.0099498991610159,0.0106998949514067,0,0,19801.0,91286.4288690606,MYLPF
25628,KEGG_2019_Human,Regulation of actin cytoskeleton,1/214,0.0106998949514067,0.0106998949514067,0,0,19786.0,89779.39753374986,MYLPF
25629,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR8G2P
25630,KEGG_2019_Human,Progesterone-mediated oocyte maturation,1/99,0.0049499334884068,0.0062499232373748,0,0,19901.0,105642.09305076736,PKMYT1
25631,KEGG_2019_Human,Cell cycle,1/124,0.0061999236097501,0.0062499232373748,0,0,19876.0,101034.04709010696,PKMYT1
25632,KEGG_2019_Human,Oocyte meiosis,1/125,0.0062499232373748,0.0062499232373748,0,0,19875.0,100869.32368441945,PKMYT1
25633,KEGG_2019_Human,PPAR signaling pathway,1/74,0.0036999446830449,0.0036999446830449,0,0,19926.0,111574.38983110404,DBI
25634,KEGG_2019_Human,Legionellosis,1/55,0.0027499544131125,0.0054999088262251,0,0,19945.0,117599.1294878737,SAR1A
25635,KEGG_2019_Human,Protein processing in endoplasmic reticulum,1/165,0.0082499094553477,0.0082499094553477,0,0,19835.0,95159.46482222488,SAR1A
25636,KEGG_2019_Human,Chemokine signaling pathway,1/190,0.0094999017791995,0.0146998751759735,0,0,19810.0,92244.74636351672,CCL23
25637,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0146998751759735,0,0,19706.0,83157.67014793828,CCL23
25638,KEGG_2019_Human,Cell adhesion molecules (CAMs),1/145,0.0072499160871101,0.0072499160871101,0,0,19855.0,97820.92670675044,TIGIT
25639,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR2J1
25640,KEGG_2019_Human,Bladder cancer,1/41,0.0020499625466866,0.0093598765565395,0,0,19959.0,123544.88783416104,CXCL8
25641,KEGG_2019_Human,Malaria,1/49,0.0024499577795033,0.0093598765565395,0,0,19951.0,119939.1172087114,CXCL8
25642,KEGG_2019_Human,Legionellosis,1/55,0.0027499544131125,0.0093598765565395,0,0,19945.0,117599.1294878737,CXCL8
25643,KEGG_2019_Human,Shigellosis,1/65,0.003249949134407,0.0093598765565395,0,0,19935.0,114209.92613860144,CXCL8
25644,KEGG_2019_Human,Epithelial cell signaling in Helicobacter pylori infection,1/68,0.0033999476216189,0.0093598765565395,0,0,19932.0,113293.39338050144,CXCL8
25645,KEGG_2019_Human,RIG-I-like receptor signaling pathway,1/70,0.0034999466296654,0.0093598765565395,0,0,19930.0,112704.30065625212,CXCL8
25646,KEGG_2019_Human,Pertussis,1/76,0.0037999437281752,0.0093598765565395,0,0,19924.0,111031.8499691117,CXCL8
25647,KEGG_2019_Human,Salmonella infection,1/86,0.0042999391173866,0.0093598765565395,0,0,19914.0,108514.46102290176,CXCL8
25648,KEGG_2019_Human,Rheumatoid arthritis,1/91,0.0045499369072032,0.0093598765565395,0,0,19909.0,107362.10783923086,CXCL8
25649,KEGG_2019_Human,IL-17 signaling pathway,1/93,0.0046499360391879,0.0093598765565395,0,0,19907.0,106918.54242106884,CXCL8
25650,KEGG_2019_Human,NF-kappa B signaling pathway,1/95,0.0047499351803394,0.0093598765565395,0,0,19905.0,106484.27183626965,CXCL8
25651,KEGG_2019_Human,Amoebiasis,1/96,0.0047999347538706,0.0093598765565395,0,0,19904.0,106270.50039849174,CXCL8
25652,KEGG_2019_Human,AGE-RAGE signaling pathway in diabetic complications,1/100,0.0049999330710556,0.0093598765565395,0,0,19900.0,105436.78197328727,CXCL8
25653,KEGG_2019_Human,Chagas disease (American trypanosomiasis),1/103,0.0051499318302617,0.0093598765565395,0,0,19897.0,104832.7525292024,CXCL8
25654,KEGG_2019_Human,Toll-like receptor signaling pathway,1/104,0.0051999314202997,0.0093598765565395,0,0,19896.0,104635.24941415618,CXCL8
25655,KEGG_2019_Human,Phospholipase D signaling pathway,1/148,0.007399915061391,0.0106873895015995,0,0,19852.0,97399.60470052566,CXCL8
25656,KEGG_2019_Human,Non-alcoholic fatty liver disease (NAFLD),1/149,0.0074499147221605,0.0106873895015995,0,0,19851.0,97261.02051561224,CXCL8
25657,KEGG_2019_Human,Cellular senescence,1/160,0.0079999110688441,0.0106873895015995,0,0,19840.0,95793.96509856998,CXCL8
25658,KEGG_2019_Human,Hepatitis B,1/163,0.0081499100978668,0.0106873895015995,0,0,19837.0,95410.9786681514,CXCL8
25659,KEGG_2019_Human,Influenza A,1/171,0.0085499075557634,0.0106873895015995,0,0,19829.0,94422.42241345016,CXCL8
25660,KEGG_2019_Human,NOD-like receptor signaling pathway,1/178,0.0088999053857096,0.0106873895015995,0,0,19822.0,93593.82745769851,CXCL8
25661,KEGG_2019_Human,Kaposi sarcoma-associated herpesvirus infection,1/186,0.0092999029651357,0.0106873895015995,0,0,19814.0,92684.96451050608,CXCL8
25662,KEGG_2019_Human,Transcriptional misregulation in cancer,1/186,0.0092999029651357,0.0106873895015995,0,0,19814.0,92684.96451050608,CXCL8
25663,KEGG_2019_Human,Chemokine signaling pathway,1/190,0.0094999017791995,0.0106873895015995,0,0,19810.0,92244.74636351672,CXCL8
25664,KEGG_2019_Human,Human cytomegalovirus infection,1/225,0.0112498919790339,0.0121498833373566,0,0,19775.0,88738.27077557483,CXCL8
25665,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.015265254990434,0,0,19706.0,83157.67014793828,CXCL8
25666,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,CXCL8
25667,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0176998626413668,0,0,19646.0,79255.8617626126,CDC37
25668,KEGG_2019_Human,Thermogenesis,1/231,0.0115498903940656,0.0115498903940656,0,0,19769.0,88191.07730937863,COA1
25669,KEGG_2019_Human,SNARE interactions in vesicular transport,1/34,0.0016999670339032,0.0016999670339032,0,0,19966.0,127326.1054203148,VAMP4
25670,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR5K1
25671,KEGG_2019_Human,TGF-beta signaling pathway,1/90,0.0044999373439762,0.0146998751759735,0,0,19910.0,107587.50385474482,BMP8A
25672,KEGG_2019_Human,Hippo signaling pathway,1/160,0.0079999110688441,0.0146998751759735,0,0,19840.0,95793.96509856998,BMP8A
25673,KEGG_2019_Human,Thermogenesis,1/231,0.0115498903940656,0.0146998751759735,0,0,19769.0,88191.07730937863,BMP8A
25674,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0146998751759735,0,0,19706.0,83157.67014793828,BMP8A
25675,KEGG_2019_Human,Progesterone-mediated oocyte maturation,1/99,0.0049499334884068,0.0062499232373748,0,0,19901.0,105642.09305076736,SPDYA
25676,KEGG_2019_Human,Oocyte meiosis,1/125,0.0062499232373748,0.0062499232373748,0,0,19875.0,100869.32368441945,SPDYA
25677,KEGG_2019_Human,MicroRNAs in cancer,1/299,0.0149498740670514,0.0149498740670514,0,0,19701.0,82804.33538735632,MIRLET7F1
25678,KEGG_2019_Human,Caffeine metabolism,1/5,0.0002499917995416556,0.0007499753986249669,0,0,19995.0,165840.17843725558,NAT1
25679,KEGG_2019_Human,Chemical carcinogenesis,1/82,0.004099940929819,0.0053999298011749,0,0,19918.0,109484.9180722932,NAT1
25680,KEGG_2019_Human,Drug metabolism,1/108,0.0053999298011749,0.0053999298011749,0,0,19892.0,103863.47861844616,NAT1
25681,KEGG_2019_Human,Glutathione metabolism,1/56,0.0027999538675741,0.0059999094170218,0,0,19944.0,117233.87022514464,RRM2B
25682,KEGG_2019_Human,Pyrimidine metabolism,1/57,0.002849953326298,0.0059999094170218,0,0,19943.0,116875.00742975442,RRM2B
25683,KEGG_2019_Human,p53 signaling pathway,1/72,0.0035999456502131,0.0059999094170218,0,0,19928.0,112131.59838572376,RRM2B
25684,KEGG_2019_Human,Drug metabolism,1/108,0.0053999298011749,0.006449921761047,0,0,19892.0,103863.47861844616,RRM2B
25685,KEGG_2019_Human,Purine metabolism,1/129,0.006449921761047,0.006449921761047,0,0,19871.0,100223.109907462,RRM2B
25686,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0146998751759735,0,0,19706.0,83157.67014793828,TNFSF12
25687,KEGG_2019_Human,cAMP signaling pathway,1/212,0.0105998955026255,0.0105998955026255,0,0,19788.0,89974.27756224656,SUCNR1
25688,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF780A
25689,KEGG_2019_Human,Endocytosis,1/244,0.0121998870519305,0.0121998870519305,0,0,19756.0,87051.4275316661,VPS37D
25690,KEGG_2019_Human,Glycerophospholipid metabolism,1/97,0.0048499343304706,0.0049499334884068,0,0,19903.0,106058.9096435903,LYPLA1
25691,KEGG_2019_Human,Choline metabolism in cancer,1/99,0.0049499334884068,0.0049499334884068,0,0,19901.0,105642.09305076736,LYPLA1
25692,KEGG_2019_Human,Glycosaminoglycan biosynthesis,1/53,0.0026499555173137,0.0026499555173137,0,0,19947.0,118349.78824235698,CHST11
25693,KEGG_2019_Human,Oxidative phosphorylation,1/133,0.0066499203093911,0.0112582177134695,0,0,19867.0,99596.2591544721,NDUFAB1
25694,KEGG_2019_Human,Parkinson disease,1/142,0.0070999171242726,0.0112582177134695,0,0,19858.0,98250.87390500787,NDUFAB1
25695,KEGG_2019_Human,Retrograde endocannabinoid signaling,1/148,0.007399915061391,0.0112582177134695,0,0,19852.0,97399.60470052566,NDUFAB1
25696,KEGG_2019_Human,Non-alcoholic fatty liver disease (NAFLD),1/149,0.0074499147221605,0.0112582177134695,0,0,19851.0,97261.02051561224,NDUFAB1
25697,KEGG_2019_Human,Alzheimer disease,1/171,0.0085499075557634,0.0112582177134695,0,0,19829.0,94422.42241345016,NDUFAB1
25698,KEGG_2019_Human,Huntington disease,1/193,0.0096499008972596,0.0112582177134695,0,0,19807.0,91920.47679471428,NDUFAB1
25699,KEGG_2019_Human,Thermogenesis,1/231,0.0115498903940656,0.0115498903940656,0,0,19769.0,88191.07730937863,NDUFAB1
25700,KEGG_2019_Human,Ubiquitin mediated proteolysis,1/137,0.0068499188797651,0.0068499188797651,0,0,19863.0,98987.62735269018,UBE2K
25701,KEGG_2019_Human,Epithelial cell signaling in Helicobacter pylori infection,1/68,0.0033999476216189,0.0084999078692823,0,0,19932.0,113293.39338050144,JAM3
25702,KEGG_2019_Human,Leukocyte transendothelial migration,1/112,0.0055999282120529,0.0084999078692823,0,0,19888.0,103119.30984392198,JAM3
25703,KEGG_2019_Human,Cell adhesion molecules (CAMs),1/145,0.0072499160871101,0.0084999078692823,0,0,19855.0,97820.92670675044,JAM3
25704,KEGG_2019_Human,Tight junction,1/170,0.0084999078692823,0.0084999078692823,0,0,19830.0,94543.49009679438,JAM3
25705,KEGG_2019_Human,Inositol phosphate metabolism,1/74,0.0036999446830449,0.0049499334884068,0,0,19926.0,111574.38983110404,INPP5E
25706,KEGG_2019_Human,Phosphatidylinositol signaling system,1/99,0.0049499334884068,0.0049499334884068,0,0,19901.0,105642.09305076736,INPP5E
25707,KEGG_2019_Human,Vasopressin-regulated water reabsorption,1/44,0.0021999607179423,0.006599882153827,0,0,19956.0,122117.06559109331,AVPR2
25708,KEGG_2019_Human,Phospholipase D signaling pathway,1/148,0.007399915061391,0.0110998725920865,0,0,19852.0,97399.60470052566,AVPR2
25709,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,AVPR2
25710,KEGG_2019_Human,Intestinal immune network for IgA production,1/48,0.0023999583567988,0.0071998750703964,0,0,19952.0,120356.5272753826,CCR10
25711,KEGG_2019_Human,Chemokine signaling pathway,1/190,0.0094999017791995,0.0142498526687993,0,0,19810.0,92244.74636351672,CCR10
25712,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0146998751759735,0,0,19706.0,83157.67014793828,CCR10
25713,KEGG_2019_Human,Axon guidance,1/181,0.0090499044707863,0.0176998626413668,0,0,19819.0,93248.41634586031,EFNA5
25714,KEGG_2019_Human,Rap1 signaling pathway,1/206,0.010299897173561,0.0176998626413668,0,0,19794.0,90569.849337325,EFNA5
25715,KEGG_2019_Human,Ras signaling pathway,1/232,0.0115998901349604,0.0176998626413668,0,0,19768.0,88101.22480150245,EFNA5
25716,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0176998626413668,0,0,19705.0,83086.53988020132,EFNA5
25717,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0176998626413668,0,0,19646.0,79255.8617626126,EFNA5
25718,KEGG_2019_Human,Ferroptosis,1/40,0.0019999631680592,0.0061249066019145,0,0,19960.0,124043.94523066044,ATG5
25719,KEGG_2019_Human,Mitophagy,1/65,0.003249949134407,0.0061249066019145,0,0,19935.0,114209.92613860144,ATG5
25720,KEGG_2019_Human,Shigellosis,1/65,0.003249949134407,0.0061249066019145,0,0,19935.0,114209.92613860144,ATG5
25721,KEGG_2019_Human,RIG-I-like receptor signaling pathway,1/70,0.0034999466296654,0.0061249066019145,0,0,19930.0,112704.30065625212,ATG5
25722,KEGG_2019_Human,Longevity regulating pathway,1/102,0.0050999322416682,0.0071399051383354,0,0,19898.0,105032.15064717118,ATG5
25723,KEGG_2019_Human,Autophagy,1/128,0.0063999221281459,0.0074665758161702,0,0,19872.0,100382.8010329652,ATG5
25724,KEGG_2019_Human,NOD-like receptor signaling pathway,1/178,0.0088999053857096,0.0088999053857096,0,0,19822.0,93593.82745769851,ATG5
25725,KEGG_2019_Human,Ribosome,1/153,0.0076499133771537,0.0076499133771537,0,0,19847.0,96715.6407630817,MRPL30
25726,KEGG_2019_Human,Ribosome,1/153,0.0076499133771537,0.0076499133771537,0,0,19847.0,96715.6407630817,MRPL13
25727,KEGG_2019_Human,Ribosome,1/153,0.0076499133771537,0.0076499133771537,0,0,19847.0,96715.6407630817,MRPS6
25728,KEGG_2019_Human,Pancreatic secretion,1/98,0.0048999339081079,0.0113332104923764,0,0,19902.0,105849.45495286948,RAB8A
25729,KEGG_2019_Human,AMPK signaling pathway,1/120,0.0059999251180858,0.0113332104923764,0,0,19880.0,101706.2448082016,RAB8A
25730,KEGG_2019_Human,Tight junction,1/170,0.0084999078692823,0.0113332104923764,0,0,19830.0,94543.49009679438,RAB8A
25731,KEGG_2019_Human,Endocytosis,1/244,0.0121998870519305,0.0121998870519305,0,0,19756.0,87051.4275316661,RAB8A
25732,KEGG_2019_Human,mRNA surveillance pathway,1/91,0.0045499369072032,0.0045499369072032,0,0,19909.0,107362.10783923086,ETF1
25733,KEGG_2019_Human,p53 signaling pathway,1/72,0.0035999456502131,0.0035999456502131,0,0,19928.0,112131.59838572376,TP53I3
25734,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF619
25735,KEGG_2019_Human,Ubiquitin mediated proteolysis,1/137,0.0068499188797651,0.0068499188797651,0,0,19863.0,98987.62735269018,UBE2E1
25736,KEGG_2019_Human,Ribosome,1/153,0.0076499133771537,0.0076499133771537,0,0,19847.0,96715.6407630817,MRPS7
25737,KEGG_2019_Human,PPAR signaling pathway,1/74,0.0036999446830449,0.0115498903940656,0,0,19926.0,111574.38983110404,UCP1
25738,KEGG_2019_Human,Apelin signaling pathway,1/137,0.0068499188797651,0.0115498903940656,0,0,19863.0,98987.62735269018,UCP1
25739,KEGG_2019_Human,Huntington disease,1/193,0.0096499008972596,0.0115498903940656,0,0,19807.0,91920.47679471428,UCP1
25740,KEGG_2019_Human,Thermogenesis,1/231,0.0115498903940656,0.0115498903940656,0,0,19769.0,88191.07730937863,UCP1
25741,KEGG_2019_Human,Natural killer cell mediated cytotoxicity,1/131,0.0065499210316603,0.0072499160871101,0,0,19869.0,99907.33811343512,ICAM2
25742,KEGG_2019_Human,Cell adhesion molecules (CAMs),1/145,0.0072499160871101,0.0072499160871101,0,0,19855.0,97820.92670675044,ICAM2
25743,KEGG_2019_Human,Salmonella infection,1/86,0.0042999391173866,0.0090998799855245,0,0,19914.0,108514.46102290176,CCL3L3
25744,KEGG_2019_Human,Rheumatoid arthritis,1/91,0.0045499369072032,0.0090998799855245,0,0,19909.0,107362.10783923086,CCL3L3
25745,KEGG_2019_Human,Chagas disease (American trypanosomiasis),1/103,0.0051499318302617,0.0090998799855245,0,0,19897.0,104832.7525292024,CCL3L3
25746,KEGG_2019_Human,Toll-like receptor signaling pathway,1/104,0.0051999314202997,0.0090998799855245,0,0,19896.0,104635.24941415618,CCL3L3
25747,KEGG_2019_Human,Chemokine signaling pathway,1/190,0.0094999017791995,0.0131248739755395,0,0,19810.0,92244.74636351672,CCL3L3
25748,KEGG_2019_Human,Human cytomegalovirus infection,1/225,0.0112498919790339,0.0131248739755395,0,0,19775.0,88738.27077557483,CCL3L3
25749,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0146998751759735,0,0,19706.0,83157.67014793828,CCL3L3
25750,KEGG_2019_Human,Cardiac muscle contraction,1/78,0.0038999427840466,0.0112582177134695,0,0,19922.0,110503.2180492851,COX4I2
25751,KEGG_2019_Human,Oxidative phosphorylation,1/133,0.0066499203093911,0.0112582177134695,0,0,19867.0,99596.2591544721,COX4I2
25752,KEGG_2019_Human,Parkinson disease,1/142,0.0070999171242726,0.0112582177134695,0,0,19858.0,98250.87390500787,COX4I2
25753,KEGG_2019_Human,Non-alcoholic fatty liver disease (NAFLD),1/149,0.0074499147221605,0.0112582177134695,0,0,19851.0,97261.02051561224,COX4I2
25754,KEGG_2019_Human,Alzheimer disease,1/171,0.0085499075557634,0.0112582177134695,0,0,19829.0,94422.42241345016,COX4I2
25755,KEGG_2019_Human,Huntington disease,1/193,0.0096499008972596,0.0112582177134695,0,0,19807.0,91920.47679471428,COX4I2
25756,KEGG_2019_Human,Thermogenesis,1/231,0.0115498903940656,0.0115498903940656,0,0,19769.0,88191.07730937863,COX4I2
25757,KEGG_2019_Human,Non-small cell lung cancer,1/66,0.003299948626608,0.0090070208994455,0,0,19934.0,113899.85357353876,TGFA
25758,KEGG_2019_Human,Renal cell carcinoma,1/69,0.003449947123837,0.0090070208994455,0,0,19931.0,112996.7391397682,TGFA
25759,KEGG_2019_Human,Pancreatic cancer,1/75,0.0037499442041125,0.0090070208994455,0,0,19925.0,111301.33528642564,TGFA
25760,KEGG_2019_Human,Glioma,1/75,0.0037499442041125,0.0090070208994455,0,0,19925.0,111301.33528642564,TGFA
25761,KEGG_2019_Human,ErbB signaling pathway,1/85,0.004249939567045,0.0090070208994455,0,0,19915.0,108752.83801948265,TGFA
25762,KEGG_2019_Human,Colorectal cancer,1/86,0.0042999391173866,0.0090070208994455,0,0,19914.0,108514.46102290176,TGFA
25763,KEGG_2019_Human,Prostate cancer,1/97,0.0048499343304706,0.0090070208994455,0,0,19903.0,106058.9096435903,TGFA
25764,KEGG_2019_Human,Estrogen signaling pathway,1/137,0.0068499188797651,0.0111311181796183,0,0,19863.0,98987.62735269018,TGFA
25765,KEGG_2019_Human,Hepatocellular carcinoma,1/168,0.0083999085011095,0.0121332011682693,0,0,19832.0,94787.72752807094,TGFA
25766,KEGG_2019_Human,Ras signaling pathway,1/232,0.0115998901349604,0.0150798571754485,0,0,19768.0,88101.22480150245,TGFA
25767,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.017431670399769,0,0,19705.0,83086.53988020132,TGFA
25768,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0191748511948141,0,0,19646.0,79255.8617626126,TGFA
25769,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,TGFA
25770,KEGG_2019_Human,Pathogenic Escherichia coli infection,1/55,0.0027499544131125,0.0063699116700844,0,0,19945.0,117599.1294878737,ARPC5L
25771,KEGG_2019_Human,Shigellosis,1/65,0.003249949134407,0.0063699116700844,0,0,19935.0,114209.92613860144,ARPC5L
25772,KEGG_2019_Human,Bacterial invasion of epithelial cells,1/74,0.0036999446830449,0.0063699116700844,0,0,19926.0,111574.38983110404,ARPC5L
25773,KEGG_2019_Human,Salmonella infection,1/86,0.0042999391173866,0.0063699116700844,0,0,19914.0,108514.46102290176,ARPC5L
25774,KEGG_2019_Human,Fc gamma R-mediated phagocytosis,1/91,0.0045499369072032,0.0063699116700844,0,0,19909.0,107362.10783923086,ARPC5L
25775,KEGG_2019_Human,Regulation of actin cytoskeleton,1/214,0.0106998949514067,0.0121998870519305,0,0,19786.0,89779.39753374986,ARPC5L
25776,KEGG_2019_Human,Endocytosis,1/244,0.0121998870519305,0.0121998870519305,0,0,19756.0,87051.4275316661,ARPC5L
25777,KEGG_2019_Human,Glycosphingolipid biosynthesis,1/45,0.0022499601197094,0.0022499601197094,0,0,19955.0,121662.49782449217,FUT3
25778,KEGG_2019_Human,Spliceosome,1/134,0.0066999199497742,0.0066999199497742,0,0,19866.0,99442.43560916925,SNRPE
25779,KEGG_2019_Human,Chemokine signaling pathway,1/190,0.0094999017791995,0.0146998751759735,0,0,19810.0,92244.74636351672,CCL24
25780,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0146998751759735,0,0,19706.0,83157.67014793828,CCL24
25781,KEGG_2019_Human,"Parathyroid hormone synthesis, secretion and action",1/106,0.0052999306076525,0.0052999306076525,0,0,19894.0,104245.78450366124,BGLAP
25782,KEGG_2019_Human,Lysosome,1/123,0.0061499239842961,0.0061499239842961,0,0,19877.0,101200.07933676826,NAPSA
25783,KEGG_2019_Human,Amphetamine addiction,1/68,0.0033999476216189,0.0033999476216189,0,0,19932.0,113293.39338050144,ARC
25784,KEGG_2019_Human,alpha-Linolenic acid metabolism,1/25,0.0012499733663791,0.0052874076132858,0,0,19975.0,133525.54486996148,PLA2G12B
25785,KEGG_2019_Human,Linoleic acid metabolism,1/29,0.001449970461791,0.0052874076132858,0,0,19971.0,130534.69172799008,PLA2G12B
25786,KEGG_2019_Human,Fat digestion and absorption,1/41,0.0020499625466866,0.0052874076132858,0,0,19959.0,123544.88783416104,PLA2G12B
25787,KEGG_2019_Human,Ether lipid metabolism,1/47,0.0023499589392381,0.0052874076132858,0,0,19953.0,120782.64067395544,PLA2G12B
25788,KEGG_2019_Human,Arachidonic acid metabolism,1/63,0.0031499501598827,0.005669910287789,0,0,19937.0,114844.46974572667,PLA2G12B
25789,KEGG_2019_Human,Glycerophospholipid metabolism,1/97,0.0048499343304706,0.0062999150247102,0,0,19903.0,106058.9096435903,PLA2G12B
25790,KEGG_2019_Human,Pancreatic secretion,1/98,0.0048999339081079,0.0062999150247102,0,0,19902.0,105849.45495286948,PLA2G12B
25791,KEGG_2019_Human,Vascular smooth muscle contraction,1/132,0.0065999206698993,0.0074249107536368,0,0,19868.0,99751.22090491928,PLA2G12B
25792,KEGG_2019_Human,Ras signaling pathway,1/232,0.0115998901349604,0.0115998901349604,0,0,19768.0,88101.22480150245,PLA2G12B
25793,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR1I1
25794,KEGG_2019_Human,Adipocytokine signaling pathway,1/69,0.003449947123837,0.0074499147221605,0,0,19931.0,112996.7391397682,ADIPOR2
25795,KEGG_2019_Human,Longevity regulating pathway,1/102,0.0050999322416682,0.0074499147221605,0,0,19898.0,105032.15064717118,ADIPOR2
25796,KEGG_2019_Human,AMPK signaling pathway,1/120,0.0059999251180858,0.0074499147221605,0,0,19880.0,101706.2448082016,ADIPOR2
25797,KEGG_2019_Human,Non-alcoholic fatty liver disease (NAFLD),1/149,0.0074499147221605,0.0074499147221605,0,0,19851.0,97261.02051561224,ADIPOR2
25798,KEGG_2019_Human,MicroRNAs in cancer,1/299,0.0149498740670514,0.0149498740670514,0,0,19701.0,82804.33538735632,MIRLET7B
25799,KEGG_2019_Human,Regulation of lipolysis in adipocytes,1/55,0.0027499544131125,0.01199983291727,0,0,19945.0,117599.1294878737,ADRB2
25800,KEGG_2019_Human,Renin secretion,1/69,0.003449947123837,0.01199983291727,0,0,19931.0,112996.7391397682,ADRB2
25801,KEGG_2019_Human,Salivary secretion,1/90,0.0044999373439762,0.01199983291727,0,0,19910.0,107587.50385474482,ADRB2
25802,KEGG_2019_Human,Adrenergic signaling in cardiomyocytes,1/145,0.0072499160871101,0.0121141662887149,0,0,19855.0,97820.92670675044,ADRB2
25803,KEGG_2019_Human,cGMP-PKG signaling pathway,1/166,0.0082999091363732,0.0121141662887149,0,0,19834.0,95034.82345515196,ADRB2
25804,KEGG_2019_Human,Calcium signaling pathway,1/188,0.009399902370135,0.0121141662887149,0,0,19812.0,92463.712994847,ADRB2
25805,KEGG_2019_Human,cAMP signaling pathway,1/212,0.0105998955026255,0.0121141662887149,0,0,19788.0,89974.27756224656,ADRB2
25806,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,ADRB2
25807,KEGG_2019_Human,RNA transport,1/165,0.0082499094553477,0.0082499094553477,0,0,19835.0,95159.46482222488,EIF3F
25808,KEGG_2019_Human,Fatty acid biosynthesis,1/13,0.0006499833083207112,0.0006499833083207112,0,0,19987.0,146675.87616784443,OXSM
25809,KEGG_2019_Human,Mineral absorption,1/51,0.0025499566390179,0.0025499566390179,0,0,19949.0,119129.0228601236,CYBRD1
25810,KEGG_2019_Human,Endocrine and other factor-regulated calcium reabsorption,1/48,0.0023999583567988,0.0077998855680932,0,0,19952.0,120356.5272753826,AP2S1
25811,KEGG_2019_Human,Synaptic vesicle cycle,1/78,0.0038999427840466,0.0077998855680932,0,0,19922.0,110503.2180492851,AP2S1
25812,KEGG_2019_Human,Huntington disease,1/193,0.0096499008972596,0.0121998870519305,0,0,19807.0,91920.47679471428,AP2S1
25813,KEGG_2019_Human,Endocytosis,1/244,0.0121998870519305,0.0121998870519305,0,0,19756.0,87051.4275316661,AP2S1
25814,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,CORT
25815,KEGG_2019_Human,Homologous recombination,1/41,0.0020499625466866,0.0020499625466866,0,0,19959.0,123544.88783416104,UIMC1
25816,KEGG_2019_Human,Bladder cancer,1/41,0.0020499625466866,0.0074199028507136,0,0,19959.0,123544.88783416104,HBEGF
25817,KEGG_2019_Human,Epithelial cell signaling in Helicobacter pylori infection,1/68,0.0033999476216189,0.0074199028507136,0,0,19932.0,113293.39338050144,HBEGF
25818,KEGG_2019_Human,ErbB signaling pathway,1/85,0.004249939567045,0.0074199028507136,0,0,19915.0,108752.83801948265,HBEGF
25819,KEGG_2019_Human,GnRH signaling pathway,1/93,0.0046499360391879,0.0074199028507136,0,0,19907.0,106918.54242106884,HBEGF
25820,KEGG_2019_Human,"Parathyroid hormone synthesis, secretion and action",1/106,0.0052999306076525,0.0074199028507136,0,0,19894.0,104245.78450366124,HBEGF
25821,KEGG_2019_Human,Estrogen signaling pathway,1/137,0.0068499188797651,0.0079915720263926,0,0,19863.0,98987.62735269018,HBEGF
25822,KEGG_2019_Human,Proteoglycans in cancer,1/201,0.0100498985877989,0.0100498985877989,0,0,19799.0,91079.21596609056,HBEGF
25823,KEGG_2019_Human,Asthma,1/31,0.0015499690656704,0.0083141731379497,0,0,19969.0,129189.85098816035,HLA-DPB1
25824,KEGG_2019_Human,Allograft rejection,1/38,0.001899964429635,0.0083141731379497,0,0,19962.0,125080.29732025368,HLA-DPB1
25825,KEGG_2019_Human,Graft-versus-host disease,1/41,0.0020499625466866,0.0083141731379497,0,0,19959.0,123544.88783416104,HLA-DPB1
25826,KEGG_2019_Human,Type I diabetes mellitus,1/43,0.0021499613216957,0.0083141731379497,0,0,19957.0,122581.98940490963,HLA-DPB1
25827,KEGG_2019_Human,Intestinal immune network for IgA production,1/48,0.0023999583567988,0.0083141731379497,0,0,19952.0,120356.5272753826,HLA-DPB1
25828,KEGG_2019_Human,Autoimmune thyroid disease,1/53,0.0026499555173137,0.0083141731379497,0,0,19947.0,118349.78824235698,HLA-DPB1
25829,KEGG_2019_Human,Viral myocarditis,1/59,0.0029499522555206,0.0083141731379497,0,0,19941.0,116175.59385530632,HLA-DPB1
25830,KEGG_2019_Human,Inflammatory bowel disease (IBD),1/65,0.003249949134407,0.0083141731379497,0,0,19935.0,114209.92613860144,HLA-DPB1
25831,KEGG_2019_Human,Staphylococcus aureus infection,1/68,0.0033999476216189,0.0083141731379497,0,0,19932.0,113293.39338050144,HLA-DPB1
25832,KEGG_2019_Human,Leishmaniasis,1/74,0.0036999446830449,0.0083141731379497,0,0,19926.0,111574.38983110404,HLA-DPB1
25833,KEGG_2019_Human,Antigen processing and presentation,1/77,0.0038499432547502,0.0083141731379497,0,0,19923.0,110765.8407373636,HLA-DPB1
25834,KEGG_2019_Human,Rheumatoid arthritis,1/91,0.0045499369072032,0.0083141731379497,0,0,19909.0,107362.10783923086,HLA-DPB1
25835,KEGG_2019_Human,Th1 and Th2 cell differentiation,1/92,0.0045999364719865,0.0083141731379497,0,0,19908.0,107139.13814408927,HLA-DPB1
25836,KEGG_2019_Human,Hematopoietic cell lineage,1/97,0.0048499343304706,0.0083141731379497,0,0,19903.0,106058.9096435903,HLA-DPB1
25837,KEGG_2019_Human,Th17 cell differentiation,1/107,0.0053499302026925,0.0084748917286727,0,0,19893.0,104053.753408911,HLA-DPB1
25838,KEGG_2019_Human,Toxoplasmosis,1/113,0.0056499278191151,0.0084748917286727,0,0,19887.0,102937.34947211576,HLA-DPB1
25839,KEGG_2019_Human,Systemic lupus erythematosus,1/133,0.0066499203093911,0.0093881227897286,0,0,19867.0,99596.2591544721,HLA-DPB1
25840,KEGG_2019_Human,Cell adhesion molecules (CAMs),1/145,0.0072499160871101,0.0095998910039963,0,0,19855.0,97820.92670675044,HLA-DPB1
25841,KEGG_2019_Human,Phagosome,1/152,0.0075999137114971,0.0095998910039963,0,0,19848.0,96850.665715497,HLA-DPB1
25842,KEGG_2019_Human,Influenza A,1/171,0.0085499075557634,0.0102284629486356,0,0,19829.0,94422.42241345016,HLA-DPB1
25843,KEGG_2019_Human,Tuberculosis,1/179,0.0089499050800561,0.0102284629486356,0,0,19821.0,93478.0629355712,HLA-DPB1
25844,KEGG_2019_Human,Epstein-Barr virus infection,1/201,0.0100498985877989,0.0109635257321443,0,0,19799.0,91079.21596609056,HLA-DPB1
25845,KEGG_2019_Human,Human T-cell leukemia virus 1 infection,1/219,0.0109498935894162,0.0114259759193908,0,0,19781.0,89299.85161916987,HLA-DPB1
25846,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,HLA-DPB1
25847,KEGG_2019_Human,Necroptosis,1/162,0.0080999104202618,0.0121998870519305,0,0,19838.0,95537.86936302872,CHMP6
25848,KEGG_2019_Human,Endocytosis,1/244,0.0121998870519305,0.0121998870519305,0,0,19756.0,87051.4275316661,CHMP6
25849,KEGG_2019_Human,mRNA surveillance pathway,1/91,0.0045499369072032,0.0085499075557634,0,0,19909.0,107362.10783923086,NXT1
25850,KEGG_2019_Human,Ribosome biogenesis in eukaryotes,1/101,0.0050499326546803,0.0085499075557634,0,0,19899.0,105233.48101229242,NXT1
25851,KEGG_2019_Human,RNA transport,1/165,0.0082499094553477,0.0085499075557634,0,0,19835.0,95159.46482222488,NXT1
25852,KEGG_2019_Human,Influenza A,1/171,0.0085499075557634,0.0085499075557634,0,0,19829.0,94422.42241345016,NXT1
25853,KEGG_2019_Human,Glycosphingolipid biosynthesis,1/45,0.0022499601197094,0.0022499601197094,0,0,19955.0,121662.49782449217,ST3GAL4
25854,KEGG_2019_Human,Ribosome,1/153,0.0076499133771537,0.0076499133771537,0,0,19847.0,96715.6407630817,MRPS17
25855,KEGG_2019_Human,MicroRNAs in cancer,1/299,0.0149498740670514,0.0149498740670514,0,0,19701.0,82804.33538735632,MIR206
25856,KEGG_2019_Human,Taste transduction,1/83,0.0041499404726918,0.0041499404726918,0,0,19917.0,109237.99888847338,TAS2R20
25857,KEGG_2019_Human,Oocyte meiosis,1/125,0.0062499232373748,0.0062499232373748,0,0,19875.0,100869.32368441945,FBXO5
25858,KEGG_2019_Human,Endocytosis,1/244,0.0121998870519305,0.0121998870519305,0,0,19756.0,87051.4275316661,FOLR1
25859,KEGG_2019_Human,Staphylococcus aureus infection,1/68,0.0033999476216189,0.0089499050800561,0,0,19932.0,113293.39338050144,FCGR2C
25860,KEGG_2019_Human,Leishmaniasis,1/74,0.0036999446830449,0.0089499050800561,0,0,19926.0,111574.38983110404,FCGR2C
25861,KEGG_2019_Human,Osteoclast differentiation,1/127,0.0063499224962247,0.0089499050800561,0,0,19873.0,100543.72072014232,FCGR2C
25862,KEGG_2019_Human,Phagosome,1/152,0.0075999137114971,0.0089499050800561,0,0,19848.0,96850.665715497,FCGR2C
25863,KEGG_2019_Human,Tuberculosis,1/179,0.0089499050800561,0.0089499050800561,0,0,19821.0,93478.0629355712,FCGR2C
25864,KEGG_2019_Human,Ribosome,1/153,0.0076499133771537,0.0076499133771537,0,0,19847.0,96715.6407630817,RPS10
25865,KEGG_2019_Human,Arginine and proline metabolism,1/49,0.0024499577795033,0.0024499577795033,0,0,19951.0,119939.1172087114,CKB
25866,KEGG_2019_Human,Primary immunodeficiency,1/37,0.0018499650702878,0.0047999167135976,0,0,19963.0,125618.9446446357,ICOS
25867,KEGG_2019_Human,Intestinal immune network for IgA production,1/48,0.0023999583567988,0.0047999167135976,0,0,19952.0,120356.5272753826,ICOS
25868,KEGG_2019_Human,T cell receptor signaling pathway,1/101,0.0050499326546803,0.0067332435395738,0,0,19899.0,105233.48101229242,ICOS
25869,KEGG_2019_Human,Cell adhesion molecules (CAMs),1/145,0.0072499160871101,0.0072499160871101,0,0,19855.0,97820.92670675044,ICOS
25870,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,MLN
25871,KEGG_2019_Human,Porphyrin and chlorophyll metabolism,1/42,0.0020999619311272,0.0020999619311272,0,0,19958.0,123057.75613441122,HCCS
25872,KEGG_2019_Human,Spliceosome,1/134,0.0066999199497742,0.0066999199497742,0,0,19866.0,99442.43560916925,SNRPA1
25873,KEGG_2019_Human,Glycosphingolipid biosynthesis,1/45,0.0022499601197094,0.0022499601197094,0,0,19955.0,121662.49782449217,B3GALT4
25874,KEGG_2019_Human,Type II diabetes mellitus,1/46,0.0022999595269283,0.0105944506669242,0,0,19954.0,121217.8313311442,MAPK8
25875,KEGG_2019_Human,Mitophagy,1/65,0.003249949134407,0.0105944506669242,0,0,19935.0,114209.92613860144,MAPK8
25876,KEGG_2019_Human,Shigellosis,1/65,0.003249949134407,0.0105944506669242,0,0,19935.0,114209.92613860144,MAPK8
25877,KEGG_2019_Human,Epithelial cell signaling in Helicobacter pylori infection,1/68,0.0033999476216189,0.0105944506669242,0,0,19932.0,113293.39338050144,MAPK8
25878,KEGG_2019_Human,Fc epsilon RI signaling pathway,1/68,0.0033999476216189,0.0105944506669242,0,0,19932.0,113293.39338050144,MAPK8
25879,KEGG_2019_Human,Adipocytokine signaling pathway,1/69,0.003449947123837,0.0105944506669242,0,0,19931.0,112996.7391397682,MAPK8
25880,KEGG_2019_Human,Prolactin signaling pathway,1/70,0.0034999466296654,0.0105944506669242,0,0,19930.0,112704.30065625212,MAPK8
25881,KEGG_2019_Human,RIG-I-like receptor signaling pathway,1/70,0.0034999466296654,0.0105944506669242,0,0,19930.0,112704.30065625212,MAPK8
25882,KEGG_2019_Human,Pancreatic cancer,1/75,0.0037499442041125,0.0105944506669242,0,0,19925.0,111301.33528642564,MAPK8
25883,KEGG_2019_Human,Pertussis,1/76,0.0037999437281752,0.0105944506669242,0,0,19924.0,111031.8499691117,MAPK8
25884,KEGG_2019_Human,ErbB signaling pathway,1/85,0.004249939567045,0.0105944506669242,0,0,19915.0,108752.83801948265,MAPK8
25885,KEGG_2019_Human,Colorectal cancer,1/86,0.0042999391173866,0.0105944506669242,0,0,19914.0,108514.46102290176,MAPK8
25886,KEGG_2019_Human,Salmonella infection,1/86,0.0042999391173866,0.0105944506669242,0,0,19914.0,108514.46102290176,MAPK8
25887,KEGG_2019_Human,Th1 and Th2 cell differentiation,1/92,0.0045999364719865,0.0105944506669242,0,0,19908.0,107139.13814408927,MAPK8
25888,KEGG_2019_Human,IL-17 signaling pathway,1/93,0.0046499360391879,0.0105944506669242,0,0,19907.0,106918.54242106884,MAPK8
25889,KEGG_2019_Human,GnRH signaling pathway,1/93,0.0046499360391879,0.0105944506669242,0,0,19907.0,106918.54242106884,MAPK8
25890,KEGG_2019_Human,Choline metabolism in cancer,1/99,0.0049499334884068,0.0105944506669242,0,0,19901.0,105642.09305076736,MAPK8
25891,KEGG_2019_Human,Progesterone-mediated oocyte maturation,1/99,0.0049499334884068,0.0105944506669242,0,0,19901.0,105642.09305076736,MAPK8
25892,KEGG_2019_Human,AGE-RAGE signaling pathway in diabetic complications,1/100,0.0049999330710556,0.0105944506669242,0,0,19900.0,105436.78197328727,MAPK8
25893,KEGG_2019_Human,Inflammatory mediator regulation of TRP channels,1/100,0.0049999330710556,0.0105944506669242,0,0,19900.0,105436.78197328727,MAPK8
25894,KEGG_2019_Human,Chagas disease (American trypanosomiasis),1/103,0.0051499318302617,0.0105944506669242,0,0,19897.0,104832.7525292024,MAPK8
25895,KEGG_2019_Human,Toll-like receptor signaling pathway,1/104,0.0051999314202997,0.0105944506669242,0,0,19896.0,104635.24941415618,MAPK8
25896,KEGG_2019_Human,C-type lectin receptor signaling pathway,1/104,0.0051999314202997,0.0105944506669242,0,0,19896.0,104635.24941415618,MAPK8
25897,KEGG_2019_Human,Th17 cell differentiation,1/107,0.0053499302026925,0.0105944506669242,0,0,19893.0,104053.753408911,MAPK8
25898,KEGG_2019_Human,Insulin resistance,1/108,0.0053999298011749,0.0105944506669242,0,0,19892.0,103863.47861844616,MAPK8
25899,KEGG_2019_Human,TNF signaling pathway,1/110,0.0054999290027479,0.0105944506669242,0,0,19890.0,103488.06969787036,MAPK8
25900,KEGG_2019_Human,Toxoplasmosis,1/113,0.0056499278191151,0.0105944506669242,0,0,19887.0,102937.34947211576,MAPK8
25901,KEGG_2019_Human,Sphingolipid signaling pathway,1/119,0.0059499254985137,0.0105944506669242,0,0,19881.0,101877.73080211312,MAPK8
25902,KEGG_2019_Human,Neurotrophin signaling pathway,1/119,0.0059499254985137,0.0105944506669242,0,0,19881.0,101877.73080211312,MAPK8
25903,KEGG_2019_Human,Osteoclast differentiation,1/127,0.0063499224962247,0.0105944506669242,0,0,19873.0,100543.72072014232,MAPK8
25904,KEGG_2019_Human,Autophagy,1/128,0.0063999221281459,0.0105944506669242,0,0,19872.0,100382.8010329652,MAPK8
25905,KEGG_2019_Human,Relaxin signaling pathway,1/130,0.0064999213952527,0.0105944506669242,0,0,19870.0,100064.62842845908,MAPK8
25906,KEGG_2019_Human,Dopaminergic synapse,1/131,0.0065499210316603,0.0105944506669242,0,0,19869.0,99907.33811343512,MAPK8
25907,KEGG_2019_Human,FoxO signaling pathway,1/132,0.0065999206698993,0.0105944506669242,0,0,19868.0,99751.22090491928,MAPK8
25908,KEGG_2019_Human,Insulin signaling pathway,1/137,0.0068499188797651,0.0105944506669242,0,0,19863.0,98987.62735269018,MAPK8
25909,KEGG_2019_Human,Measles,1/138,0.0068999185254481,0.0105944506669242,0,0,19862.0,98838.19160389496,MAPK8
25910,KEGG_2019_Human,Fluid shear stress and atherosclerosis,1/139,0.006949918172816,0.0105944506669242,0,0,19861.0,98689.81333375497,MAPK8
25911,KEGG_2019_Human,Apoptosis,1/143,0.0071499167770442,0.0105944506669242,0,0,19857.0,98106.57763600958,MAPK8
25912,KEGG_2019_Human,Retrograde endocannabinoid signaling,1/148,0.007399915061391,0.0105944506669242,0,0,19852.0,97399.60470052566,MAPK8
25913,KEGG_2019_Human,Non-alcoholic fatty liver disease (NAFLD),1/149,0.0074499147221605,0.0105944506669242,0,0,19851.0,97261.02051561224,MAPK8
25914,KEGG_2019_Human,Wnt signaling pathway,1/158,0.0078999117225733,0.0105944506669242,0,0,19842.0,96053.2110949472,MAPK8
25915,KEGG_2019_Human,Necroptosis,1/162,0.0080999104202618,0.0105944506669242,0,0,19838.0,95537.86936302872,MAPK8
25916,KEGG_2019_Human,Hepatitis B,1/163,0.0081499100978668,0.0105944506669242,0,0,19837.0,95410.9786681514,MAPK8
25917,KEGG_2019_Human,Protein processing in endoplasmic reticulum,1/165,0.0082499094553477,0.0105944506669242,0,0,19835.0,95159.46482222488,MAPK8
25918,KEGG_2019_Human,Tight junction,1/170,0.0084999078692823,0.0105944506669242,0,0,19830.0,94543.49009679438,MAPK8
25919,KEGG_2019_Human,Influenza A,1/171,0.0085499075557634,0.0105944506669242,0,0,19829.0,94422.42241345016,MAPK8
25920,KEGG_2019_Human,NOD-like receptor signaling pathway,1/178,0.0088999053857096,0.0106280122825666,0,0,19822.0,93593.82745769851,MAPK8
25921,KEGG_2019_Human,Tuberculosis,1/179,0.0089499050800561,0.0106280122825666,0,0,19821.0,93478.0629355712,MAPK8
25922,KEGG_2019_Human,Kaposi sarcoma-associated herpesvirus infection,1/186,0.0092999029651357,0.0108182544696477,0,0,19814.0,92684.96451050608,MAPK8
25923,KEGG_2019_Human,Focal adhesion,1/199,0.0099498991610159,0.0112322395981282,0,0,19801.0,91286.4288690606,MAPK8
25924,KEGG_2019_Human,Epstein-Barr virus infection,1/201,0.0100498985877989,0.0112322395981282,0,0,19799.0,91079.21596609056,MAPK8
25925,KEGG_2019_Human,Human immunodeficiency virus 1 infection,1/212,0.0105998955026255,0.0113998876160312,0,0,19788.0,89974.27756224656,MAPK8
25926,KEGG_2019_Human,cAMP signaling pathway,1/212,0.0105998955026255,0.0113998876160312,0,0,19788.0,89974.27756224656,MAPK8
25927,KEGG_2019_Human,Human T-cell leukemia virus 1 infection,1/219,0.0109498935894162,0.0115582210110505,0,0,19781.0,89299.85161916987,MAPK8
25928,KEGG_2019_Human,Ras signaling pathway,1/232,0.0115998901349604,0.0120217043216862,0,0,19768.0,88101.22480150245,MAPK8
25929,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.015013265577823,0,0,19705.0,83086.53988020132,MAPK8
25930,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,MAPK8
25931,KEGG_2019_Human,Tight junction,1/170,0.0084999078692823,0.0084999078692823,0,0,19830.0,94543.49009679438,EPB41L4B
25932,KEGG_2019_Human,Glutathione metabolism,1/56,0.0027999538675741,0.0094498771520562,0,0,19944.0,117233.87022514464,GSTM3
25933,KEGG_2019_Human,Metabolism of xenobiotics by cytochrome P450,1/74,0.0036999446830449,0.0094498771520562,0,0,19926.0,111574.38983110404,GSTM3
25934,KEGG_2019_Human,Chemical carcinogenesis,1/82,0.004099940929819,0.0094498771520562,0,0,19918.0,109484.9180722932,GSTM3
25935,KEGG_2019_Human,Drug metabolism,1/108,0.0053999298011749,0.0094498771520562,0,0,19892.0,103863.47861844616,GSTM3
25936,KEGG_2019_Human,Fluid shear stress and atherosclerosis,1/139,0.006949918172816,0.0097298854419424,0,0,19861.0,98689.81333375497,GSTM3
25937,KEGG_2019_Human,Hepatocellular carcinoma,1/168,0.0083999085011095,0.0097998932512944,0,0,19832.0,94787.72752807094,GSTM3
25938,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,GSTM3
25939,KEGG_2019_Human,Ubiquitin mediated proteolysis,1/137,0.0068499188797651,0.0068499188797651,0,0,19863.0,98987.62735269018,UBE2Z
25940,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF25
25941,KEGG_2019_Human,Cardiac muscle contraction,1/78,0.0038999427840466,0.0112582177134695,0,0,19922.0,110503.2180492851,COX8A
25942,KEGG_2019_Human,Oxidative phosphorylation,1/133,0.0066499203093911,0.0112582177134695,0,0,19867.0,99596.2591544721,COX8A
25943,KEGG_2019_Human,Parkinson disease,1/142,0.0070999171242726,0.0112582177134695,0,0,19858.0,98250.87390500787,COX8A
25944,KEGG_2019_Human,Non-alcoholic fatty liver disease (NAFLD),1/149,0.0074499147221605,0.0112582177134695,0,0,19851.0,97261.02051561224,COX8A
25945,KEGG_2019_Human,Alzheimer disease,1/171,0.0085499075557634,0.0112582177134695,0,0,19829.0,94422.42241345016,COX8A
25946,KEGG_2019_Human,Huntington disease,1/193,0.0096499008972596,0.0112582177134695,0,0,19807.0,91920.47679471428,COX8A
25947,KEGG_2019_Human,Thermogenesis,1/231,0.0115498903940656,0.0115498903940656,0,0,19769.0,88191.07730937863,COX8A
25948,KEGG_2019_Human,Endocytosis,1/244,0.0121998870519305,0.0121998870519305,0,0,19756.0,87051.4275316661,VTA1
25949,KEGG_2019_Human,Calcium signaling pathway,1/188,0.009399902370135,0.009399902370135,0,0,19812.0,92463.712994847,ORAI3
25950,KEGG_2019_Human,Staphylococcus aureus infection,1/68,0.0033999476216189,0.0039499423167337,0,0,19932.0,113293.39338050144,CFB
25951,KEGG_2019_Human,Complement and coagulation cascades,1/79,0.0039499423167337,0.0039499423167337,0,0,19921.0,110243.89578070649,CFB
25952,KEGG_2019_Human,Ubiquitin mediated proteolysis,1/137,0.0068499188797651,0.0082499094553477,0,0,19863.0,98987.62735269018,UBE2J1
25953,KEGG_2019_Human,Parkinson disease,1/142,0.0070999171242726,0.0082499094553477,0,0,19858.0,98250.87390500787,UBE2J1
25954,KEGG_2019_Human,Protein processing in endoplasmic reticulum,1/165,0.0082499094553477,0.0082499094553477,0,0,19835.0,95159.46482222488,UBE2J1
25955,KEGG_2019_Human,Renal cell carcinoma,1/69,0.003449947123837,0.0114165314662752,0,0,19931.0,112996.7391397682,ELOC
25956,KEGG_2019_Human,HIF-1 signaling pathway,1/100,0.0049999330710556,0.0114165314662752,0,0,19900.0,105436.78197328727,ELOC
25957,KEGG_2019_Human,Ubiquitin mediated proteolysis,1/137,0.0068499188797651,0.0114165314662752,0,0,19863.0,98987.62735269018,ELOC
25958,KEGG_2019_Human,Human immunodeficiency virus 1 infection,1/212,0.0105998955026255,0.0132498693782819,0,0,19788.0,89974.27756224656,ELOC
25959,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,ELOC
25960,KEGG_2019_Human,Cholinergic synapse,1/112,0.0055999282120529,0.0142665266018757,0,0,19888.0,103119.30984392198,CHRM5
25961,KEGG_2019_Human,Calcium signaling pathway,1/188,0.009399902370135,0.0142665266018757,0,0,19812.0,92463.712994847,CHRM5
25962,KEGG_2019_Human,Regulation of actin cytoskeleton,1/214,0.0106998949514067,0.0142665266018757,0,0,19786.0,89779.39753374986,CHRM5
25963,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,CHRM5
25964,KEGG_2019_Human,Ribosome,1/153,0.0076499133771537,0.0076499133771537,0,0,19847.0,96715.6407630817,RPL36
25965,KEGG_2019_Human,RIG-I-like receptor signaling pathway,1/70,0.0034999466296654,0.0132351670341575,0,0,19930.0,112704.30065625212,FADD
25966,KEGG_2019_Human,IL-17 signaling pathway,1/93,0.0046499360391879,0.0132351670341575,0,0,19907.0,106918.54242106884,FADD
25967,KEGG_2019_Human,Chagas disease (American trypanosomiasis),1/103,0.0051499318302617,0.0132351670341575,0,0,19897.0,104832.7525292024,FADD
25968,KEGG_2019_Human,Toll-like receptor signaling pathway,1/104,0.0051999314202997,0.0132351670341575,0,0,19896.0,104635.24941415618,FADD
25969,KEGG_2019_Human,TNF signaling pathway,1/110,0.0054999290027479,0.0132351670341575,0,0,19890.0,103488.06969787036,FADD
25970,KEGG_2019_Human,Measles,1/138,0.0068999185254481,0.0132351670341575,0,0,19862.0,98838.19160389496,FADD
25971,KEGG_2019_Human,Apoptosis,1/143,0.0071499167770442,0.0132351670341575,0,0,19857.0,98106.57763600958,FADD
25972,KEGG_2019_Human,Hepatitis C,1/155,0.0077499127120574,0.0132351670341575,0,0,19845.0,96448.16254952336,FADD
25973,KEGG_2019_Human,Necroptosis,1/162,0.0080999104202618,0.0132351670341575,0,0,19838.0,95537.86936302872,FADD
25974,KEGG_2019_Human,Hepatitis B,1/163,0.0081499100978668,0.0132351670341575,0,0,19837.0,95410.9786681514,FADD
25975,KEGG_2019_Human,Alzheimer disease,1/171,0.0085499075557634,0.0132351670341575,0,0,19829.0,94422.42241345016,FADD
25976,KEGG_2019_Human,NOD-like receptor signaling pathway,1/178,0.0088999053857096,0.0132351670341575,0,0,19822.0,93593.82745769851,FADD
25977,KEGG_2019_Human,Tuberculosis,1/179,0.0089499050800561,0.0132351670341575,0,0,19821.0,93478.0629355712,FADD
25978,KEGG_2019_Human,Kaposi sarcoma-associated herpesvirus infection,1/186,0.0092999029651357,0.0132351670341575,0,0,19814.0,92684.96451050608,FADD
25979,KEGG_2019_Human,Epstein-Barr virus infection,1/201,0.0100498985877989,0.0132351670341575,0,0,19799.0,91079.21596609056,FADD
25980,KEGG_2019_Human,Human immunodeficiency virus 1 infection,1/212,0.0105998955026255,0.0132351670341575,0,0,19788.0,89974.27756224656,FADD
25981,KEGG_2019_Human,Human cytomegalovirus infection,1/225,0.0112498919790339,0.0132351670341575,0,0,19775.0,88738.27077557483,FADD
25982,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0183331860655161,0,0,19670.0,80733.60565076157,FADD
25983,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0258945673469733,0,0,19508.0,72277.44006442746,FADD
25984,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,FADD
25985,KEGG_2019_Human,Lysosome,1/123,0.0061499239842961,0.0061499239842961,0,0,19877.0,101200.07933676826,LAPTM4A
25986,KEGG_2019_Human,Tyrosine metabolism,1/36,0.0017999657178272,0.0047832644181221,0,0,19964.0,126172.23364250171,ADH7
25987,KEGG_2019_Human,Fatty acid degradation,1/44,0.0021999607179423,0.0047832644181221,0,0,19956.0,122117.06559109331,ADH7
25988,KEGG_2019_Human,Retinol metabolism,1/67,0.0033499481224912,0.0047832644181221,0,0,19933.0,113594.38808369274,ADH7
25989,KEGG_2019_Human,Glycolysis / Gluconeogenesis,1/68,0.0033999476216189,0.0047832644181221,0,0,19932.0,113293.39338050144,ADH7
25990,KEGG_2019_Human,Metabolism of xenobiotics by cytochrome P450,1/74,0.0036999446830449,0.0047832644181221,0,0,19926.0,111574.38983110404,ADH7
25991,KEGG_2019_Human,Chemical carcinogenesis,1/82,0.004099940929819,0.0047832644181221,0,0,19918.0,109484.9180722932,ADH7
25992,KEGG_2019_Human,Drug metabolism,1/108,0.0053999298011749,0.0053999298011749,0,0,19892.0,103863.47861844616,ADH7
25993,KEGG_2019_Human,Pyrimidine metabolism,1/57,0.002849953326298,0.006449921761047,0,0,19943.0,116875.00742975442,NME6
25994,KEGG_2019_Human,Drug metabolism,1/108,0.0053999298011749,0.006449921761047,0,0,19892.0,103863.47861844616,NME6
25995,KEGG_2019_Human,Purine metabolism,1/129,0.006449921761047,0.006449921761047,0,0,19871.0,100223.109907462,NME6
25996,KEGG_2019_Human,Pyrimidine metabolism,1/57,0.002849953326298,0.006449921761047,0,0,19943.0,116875.00742975442,NME1
25997,KEGG_2019_Human,Drug metabolism,1/108,0.0053999298011749,0.006449921761047,0,0,19892.0,103863.47861844616,NME1
25998,KEGG_2019_Human,Purine metabolism,1/129,0.006449921761047,0.006449921761047,0,0,19871.0,100223.109907462,NME1
25999,KEGG_2019_Human,Terpenoid backbone biosynthesis,1/22,0.0010999756574123,0.0010999756574123,0,0,19978.0,136099.47030191717,ICMT
26000,KEGG_2019_Human,Leukocyte transendothelial migration,1/112,0.0055999282120529,0.0084999078692823,0,0,19888.0,103119.30984392198,CLDN19
26001,KEGG_2019_Human,Cell adhesion molecules (CAMs),1/145,0.0072499160871101,0.0084999078692823,0,0,19855.0,97820.92670675044,CLDN19
26002,KEGG_2019_Human,Hepatitis C,1/155,0.0077499127120574,0.0084999078692823,0,0,19845.0,96448.16254952336,CLDN19
26003,KEGG_2019_Human,Tight junction,1/170,0.0084999078692823,0.0084999078692823,0,0,19830.0,94543.49009679438,CLDN19
26004,KEGG_2019_Human,Purine metabolism,1/129,0.006449921761047,0.006449921761047,0,0,19871.0,100223.109907462,NUDT9
26005,KEGG_2019_Human,Oxidative phosphorylation,1/133,0.0066499203093911,0.0115498903940656,0,0,19867.0,99596.2591544721,COX11
26006,KEGG_2019_Human,Thermogenesis,1/231,0.0115498903940656,0.0115498903940656,0,0,19769.0,88191.07730937863,COX11
26007,KEGG_2019_Human,Nitrogen metabolism,1/17,0.0008499797390404818,0.0008499797390404818,0,0,19983.0,141285.76583697114,CA3
26008,KEGG_2019_Human,RNA transport,1/165,0.0082499094553477,0.0082499094553477,0,0,19835.0,95159.46482222488,GEMIN2
26009,KEGG_2019_Human,Taste transduction,1/83,0.0041499404726918,0.0127816714696753,0,0,19917.0,109237.99888847338,GNB3
26010,KEGG_2019_Human,GABAergic synapse,1/89,0.0044499377838098,0.0127816714696753,0,0,19911.0,107815.380281759,GNB3
26011,KEGG_2019_Human,Morphine addiction,1/91,0.0045499369072032,0.0127816714696753,0,0,19909.0,107362.10783923086,GNB3
26012,KEGG_2019_Human,Circadian entrainment,1/97,0.0048499343304706,0.0127816714696753,0,0,19903.0,106058.9096435903,GNB3
26013,KEGG_2019_Human,Cholinergic synapse,1/112,0.0055999282120529,0.0127816714696753,0,0,19888.0,103119.30984392198,GNB3
26014,KEGG_2019_Human,Serotonergic synapse,1/113,0.0056499278191151,0.0127816714696753,0,0,19887.0,102937.34947211576,GNB3
26015,KEGG_2019_Human,Glutamatergic synapse,1/114,0.005699927427839,0.0127816714696753,0,0,19886.0,102756.96431429044,GNB3
26016,KEGG_2019_Human,Relaxin signaling pathway,1/130,0.0064999213952527,0.0127816714696753,0,0,19870.0,100064.62842845908,GNB3
26017,KEGG_2019_Human,Dopaminergic synapse,1/131,0.0065499210316603,0.0127816714696753,0,0,19869.0,99907.33811343512,GNB3
26018,KEGG_2019_Human,Apelin signaling pathway,1/137,0.0068499188797651,0.0127816714696753,0,0,19863.0,98987.62735269018,GNB3
26019,KEGG_2019_Human,Retrograde endocannabinoid signaling,1/148,0.007399915061391,0.0127816714696753,0,0,19852.0,97399.60470052566,GNB3
26020,KEGG_2019_Human,Alcoholism,1/180,0.0089999047745351,0.0128927238431994,0,0,19820.0,93362.92821536642,GNB3
26021,KEGG_2019_Human,Kaposi sarcoma-associated herpesvirus infection,1/186,0.0092999029651357,0.0128927238431994,0,0,19814.0,92684.96451050608,GNB3
26022,KEGG_2019_Human,Chemokine signaling pathway,1/190,0.0094999017791995,0.0128927238431994,0,0,19810.0,92244.74636351672,GNB3
26023,KEGG_2019_Human,Human immunodeficiency virus 1 infection,1/212,0.0105998955026255,0.0129645830920145,0,0,19788.0,89974.27756224656,GNB3
26024,KEGG_2019_Human,Human cytomegalovirus infection,1/225,0.0112498919790339,0.0129645830920145,0,0,19775.0,88738.27077557483,GNB3
26025,KEGG_2019_Human,Ras signaling pathway,1/232,0.0115998901349604,0.0129645830920145,0,0,19768.0,88101.22480150245,GNB3
26026,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.018683188343665,0,0,19646.0,79255.8617626126,GNB3
26027,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,GNB3
26028,KEGG_2019_Human,Pathogenic Escherichia coli infection,1/55,0.0027499544131125,0.0065999073394233,0,0,19945.0,117599.1294878737,TUBB3
26029,KEGG_2019_Human,Gap junction,1/88,0.0043999382262822,0.0065999073394233,0,0,19912.0,108045.79305232369,TUBB3
26030,KEGG_2019_Human,Phagosome,1/152,0.0075999137114971,0.0075999137114971,0,0,19848.0,96850.665715497,TUBB3
26031,KEGG_2019_Human,Glycosylphosphatidylinositol (GPI)-anchor biosynthesis,1/25,0.0012499733663791,0.0012499733663791,0,0,19975.0,133525.54486996148,PIGX
26032,KEGG_2019_Human,Asthma,1/31,0.0015499690656704,0.0113331587387297,0,0,19969.0,129189.85098816035,IL3
26033,KEGG_2019_Human,Acute myeloid leukemia,1/66,0.003299948626608,0.0113331587387297,0,0,19934.0,113899.85357353876,IL3
26034,KEGG_2019_Human,Fc epsilon RI signaling pathway,1/68,0.0033999476216189,0.0113331587387297,0,0,19932.0,113293.39338050144,IL3
26035,KEGG_2019_Human,Hematopoietic cell lineage,1/97,0.0048499343304706,0.0121248358261767,0,0,19903.0,106058.9096435903,IL3
26036,KEGG_2019_Human,Apoptosis,1/143,0.0071499167770442,0.0132855756644796,0,0,19857.0,98106.57763600958,IL3
26037,KEGG_2019_Human,JAK-STAT signaling pathway,1/162,0.0080999104202618,0.0132855756644796,0,0,19838.0,95537.86936302872,IL3
26038,KEGG_2019_Human,Transcriptional misregulation in cancer,1/186,0.0092999029651357,0.0132855756644796,0,0,19814.0,92684.96451050608,IL3
26039,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0183748439699668,0,0,19706.0,83157.67014793828,IL3
26040,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0196665140459632,0,0,19646.0,79255.8617626126,IL3
26041,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,IL3
26042,KEGG_2019_Human,Steroid biosynthesis,1/19,0.00094997806231055,0.00094997806231055,0,0,19981.0,139049.2109571672,EBP
26043,KEGG_2019_Human,"Valine, leucine and isoleucine degradation",1/48,0.0023999583567988,0.0047999167135976,0,0,19952.0,120356.5272753826,HSD17B10
26044,KEGG_2019_Human,Alzheimer disease,1/171,0.0085499075557634,0.0085499075557634,0,0,19829.0,94422.42241345016,HSD17B10
26045,KEGG_2019_Human,RNA polymerase,1/31,0.0015499690656704,0.0030999381313408,0,0,19969.0,129189.85098816035,POLR3GL
26046,KEGG_2019_Human,Cytosolic DNA-sensing pathway,1/63,0.0031499501598827,0.0031499501598827,0,0,19937.0,114844.46974572667,POLR3GL
26047,KEGG_2019_Human,AMPK signaling pathway,1/120,0.0059999251180858,0.0075999137114971,0,0,19880.0,101706.2448082016,STRADA
26048,KEGG_2019_Human,mTOR signaling pathway,1/152,0.0075999137114971,0.0075999137114971,0,0,19848.0,96850.665715497,STRADA
26049,KEGG_2019_Human,Glycosaminoglycan biosynthesis,1/53,0.0026499555173137,0.0026499555173137,0,0,19947.0,118349.78824235698,HS3ST3B1
26050,KEGG_2019_Human,Steroid biosynthesis,1/19,0.00094997806231055,0.00094997806231055,0,0,19981.0,139049.2109571672,NSDHL
26051,KEGG_2019_Human,Proteasome,1/45,0.0022499601197094,0.0044999202394188,0,0,19955.0,121662.49782449217,PSMC5
26052,KEGG_2019_Human,Epstein-Barr virus infection,1/201,0.0100498985877989,0.0100498985877989,0,0,19799.0,91079.21596609056,PSMC5
26053,KEGG_2019_Human,Basal transcription factors,1/45,0.0022499601197094,0.0112498005985471,0,0,19955.0,121662.49782449217,TBPL1
26054,KEGG_2019_Human,Huntington disease,1/193,0.0096499008972596,0.0136873669867703,0,0,19807.0,91920.47679471428,TBPL1
26055,KEGG_2019_Human,Viral carcinogenesis,1/201,0.0100498985877989,0.0136873669867703,0,0,19799.0,91079.21596609056,TBPL1
26056,KEGG_2019_Human,Human T-cell leukemia virus 1 infection,1/219,0.0109498935894162,0.0136873669867703,0,0,19781.0,89299.85161916987,TBPL1
26057,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0164998674589645,0,0,19670.0,80733.60565076157,TBPL1
26058,KEGG_2019_Human,Cardiac muscle contraction,1/78,0.0038999427840466,0.0112582177134695,0,0,19922.0,110503.2180492851,UQCRH
26059,KEGG_2019_Human,Oxidative phosphorylation,1/133,0.0066499203093911,0.0112582177134695,0,0,19867.0,99596.2591544721,UQCRH
26060,KEGG_2019_Human,Parkinson disease,1/142,0.0070999171242726,0.0112582177134695,0,0,19858.0,98250.87390500787,UQCRH
26061,KEGG_2019_Human,Non-alcoholic fatty liver disease (NAFLD),1/149,0.0074499147221605,0.0112582177134695,0,0,19851.0,97261.02051561224,UQCRH
26062,KEGG_2019_Human,Alzheimer disease,1/171,0.0085499075557634,0.0112582177134695,0,0,19829.0,94422.42241345016,UQCRH
26063,KEGG_2019_Human,Huntington disease,1/193,0.0096499008972596,0.0112582177134695,0,0,19807.0,91920.47679471428,UQCRH
26064,KEGG_2019_Human,Thermogenesis,1/231,0.0115498903940656,0.0115498903940656,0,0,19769.0,88191.07730937863,UQCRH
26065,KEGG_2019_Human,Protein processing in endoplasmic reticulum,1/165,0.0082499094553477,0.0082499094553477,0,0,19835.0,95159.46482222488,CRYAA
26066,KEGG_2019_Human,Cholesterol metabolism,1/50,0.0024999572069037,0.0024999572069037,0,0,19950.0,119530.05920663515,VAPA
26067,KEGG_2019_Human,Sulfur relay system,1/8,0.0003999883241497325,0.0003999883241497325,0,0,19992.0,156418.91141655247,URM1
26068,KEGG_2019_Human,Endocytosis,1/244,0.0121998870519305,0.0121998870519305,0,0,19756.0,87051.4275316661,SNX12
26069,KEGG_2019_Human,Steroid biosynthesis,1/19,0.00094997806231055,0.00094997806231055,0,0,19981.0,139049.2109571672,SC5D
26070,KEGG_2019_Human,Antigen processing and presentation,1/77,0.0038499432547502,0.0076998865095004,0,0,19923.0,110765.8407373636,NFYA
26071,KEGG_2019_Human,Tuberculosis,1/179,0.0089499050800561,0.0089499050800561,0,0,19821.0,93478.0629355712,NFYA
26072,KEGG_2019_Human,Hematopoietic cell lineage,1/97,0.0048499343304706,0.0202497760506546,0,0,19903.0,106058.9096435903,IL7
26073,KEGG_2019_Human,JAK-STAT signaling pathway,1/162,0.0080999104202618,0.0202497760506546,0,0,19838.0,95537.86936302872,IL7
26074,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0221248283017086,0,0,19706.0,83157.67014793828,IL7
26075,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0221248283017086,0,0,19646.0,79255.8617626126,IL7
26076,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,IL7
26077,KEGG_2019_Human,Basal transcription factors,1/45,0.0022499601197094,0.0035249384088572,0,0,19955.0,121662.49782449217,GTF2H2C
26078,KEGG_2019_Human,Nucleotide excision repair,1/47,0.0023499589392381,0.0035249384088572,0,0,19953.0,120782.64067395544,GTF2H2C
26079,KEGG_2019_Human,Viral carcinogenesis,1/201,0.0100498985877989,0.0100498985877989,0,0,19799.0,91079.21596609056,GTF2H2C
26080,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,P2RY11
26081,KEGG_2019_Human,Measles,1/138,0.0068999185254481,0.0068999185254481,0,0,19862.0,98838.19160389496,RAB9A
26082,KEGG_2019_Human,Mineral absorption,1/51,0.0025499566390179,0.0025499566390179,0,0,19949.0,119129.0228601236,ATOX1
26083,KEGG_2019_Human,ECM-receptor interaction,1/82,0.004099940929819,0.0061999236097501,0,0,19918.0,109484.9180722932,GP9
26084,KEGG_2019_Human,Hematopoietic cell lineage,1/97,0.0048499343304706,0.0061999236097501,0,0,19903.0,106058.9096435903,GP9
26085,KEGG_2019_Human,Platelet activation,1/124,0.0061999236097501,0.0061999236097501,0,0,19876.0,101034.04709010696,GP9
26086,KEGG_2019_Human,Prion diseases,1/35,0.0017499663721595,0.008336263131204,0,0,19965.0,126740.98858805298,FYN
26087,KEGG_2019_Human,Pathogenic Escherichia coli infection,1/55,0.0027499544131125,0.008336263131204,0,0,19945.0,117599.1294878737,FYN
26088,KEGG_2019_Human,Viral myocarditis,1/59,0.0029499522555206,0.008336263131204,0,0,19941.0,116175.59385530632,FYN
26089,KEGG_2019_Human,Fc epsilon RI signaling pathway,1/68,0.0033999476216189,0.008336263131204,0,0,19932.0,113293.39338050144,FYN
26090,KEGG_2019_Human,Adherens junction,1/72,0.0035999456502131,0.008336263131204,0,0,19928.0,112131.59838572376,FYN
26091,KEGG_2019_Human,T cell receptor signaling pathway,1/101,0.0050499326546803,0.008336263131204,0,0,19899.0,105233.48101229242,FYN
26092,KEGG_2019_Human,Cholinergic synapse,1/112,0.0055999282120529,0.008336263131204,0,0,19888.0,103119.30984392198,FYN
26093,KEGG_2019_Human,Sphingolipid signaling pathway,1/119,0.0059499254985137,0.008336263131204,0,0,19881.0,101877.73080211312,FYN
26094,KEGG_2019_Human,Platelet activation,1/124,0.0061999236097501,0.008336263131204,0,0,19876.0,101034.04709010696,FYN
26095,KEGG_2019_Human,Osteoclast differentiation,1/127,0.0063499224962247,0.008336263131204,0,0,19873.0,100543.72072014232,FYN
26096,KEGG_2019_Human,Natural killer cell mediated cytotoxicity,1/131,0.0065499210316603,0.008336263131204,0,0,19869.0,99907.33811343512,FYN
26097,KEGG_2019_Human,Phospholipase D signaling pathway,1/148,0.007399915061391,0.0086332342382895,0,0,19852.0,97399.60470052566,FYN
26098,KEGG_2019_Human,Axon guidance,1/181,0.0090499044707863,0.0097460509685391,0,0,19819.0,93248.41634586031,FYN
26099,KEGG_2019_Human,Focal adhesion,1/199,0.0099498991610159,0.0099498991610159,0,0,19801.0,91286.4288690606,FYN
26100,KEGG_2019_Human,JAK-STAT signaling pathway,1/162,0.0080999104202618,0.0146998751759735,0,0,19838.0,95537.86936302872,CTF1
26101,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0146998751759735,0,0,19706.0,83157.67014793828,CTF1
26102,KEGG_2019_Human,IL-17 signaling pathway,1/93,0.0046499360391879,0.0092999029651357,0,0,19907.0,106918.54242106884,CEBPB
26103,KEGG_2019_Human,TNF signaling pathway,1/110,0.0054999290027479,0.0092999029651357,0,0,19890.0,103488.06969787036,CEBPB
26104,KEGG_2019_Human,Tuberculosis,1/179,0.0089499050800561,0.0092999029651357,0,0,19821.0,93478.0629355712,CEBPB
26105,KEGG_2019_Human,Transcriptional misregulation in cancer,1/186,0.0092999029651357,0.0092999029651357,0,0,19814.0,92684.96451050608,CEBPB
26106,KEGG_2019_Human,Pyrimidine metabolism,1/57,0.002849953326298,0.002849953326298,0,0,19943.0,116875.00742975442,DCTD
26107,KEGG_2019_Human,ECM-receptor interaction,1/82,0.004099940929819,0.0061999236097501,0,0,19918.0,109484.9180722932,GP1BA
26108,KEGG_2019_Human,Hematopoietic cell lineage,1/97,0.0048499343304706,0.0061999236097501,0,0,19903.0,106058.9096435903,GP1BA
26109,KEGG_2019_Human,Platelet activation,1/124,0.0061999236097501,0.0061999236097501,0,0,19876.0,101034.04709010696,GP1BA
26110,KEGG_2019_Human,Complement and coagulation cascades,1/79,0.0039499423167337,0.0039499423167337,0,0,19921.0,110243.89578070649,PROCR
26111,KEGG_2019_Human,Protein processing in endoplasmic reticulum,1/165,0.0082499094553477,0.0082499094553477,0,0,19835.0,95159.46482222488,SVIP
26112,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR9I1
26113,KEGG_2019_Human,Endocytosis,1/244,0.0121998870519305,0.0121998870519305,0,0,19756.0,87051.4275316661,RAB22A
26114,KEGG_2019_Human,Aldosterone-regulated sodium reabsorption,1/37,0.0018499650702878,0.0105921669634647,0,0,19963.0,125618.9446446357,IGF1
26115,KEGG_2019_Human,Ovarian steroidogenesis,1/49,0.0024499577795033,0.0105921669634647,0,0,19951.0,119939.1172087114,IGF1
26116,KEGG_2019_Human,Long-term depression,1/60,0.002999951725986,0.0105921669634647,0,0,19940.0,115834.63209072244,IGF1
26117,KEGG_2019_Human,Melanoma,1/72,0.0035999456502131,0.0105921669634647,0,0,19928.0,112131.59838572376,IGF1
26118,KEGG_2019_Human,p53 signaling pathway,1/72,0.0035999456502131,0.0105921669634647,0,0,19928.0,112131.59838572376,IGF1
26119,KEGG_2019_Human,Glioma,1/75,0.0037499442041125,0.0105921669634647,0,0,19925.0,111301.33528642564,IGF1
26120,KEGG_2019_Human,Hypertrophic cardiomyopathy (HCM),1/85,0.004249939567045,0.0105921669634647,0,0,19915.0,108752.83801948265,IGF1
26121,KEGG_2019_Human,Dilated cardiomyopathy (DCM),1/91,0.0045499369072032,0.0105921669634647,0,0,19909.0,107362.10783923086,IGF1
26122,KEGG_2019_Human,Prostate cancer,1/97,0.0048499343304706,0.0105921669634647,0,0,19903.0,106058.9096435903,IGF1
26123,KEGG_2019_Human,Progesterone-mediated oocyte maturation,1/99,0.0049499334884068,0.0105921669634647,0,0,19901.0,105642.09305076736,IGF1
26124,KEGG_2019_Human,Inflammatory mediator regulation of TRP channels,1/100,0.0049999330710556,0.0105921669634647,0,0,19900.0,105436.78197328727,IGF1
26125,KEGG_2019_Human,HIF-1 signaling pathway,1/100,0.0049999330710556,0.0105921669634647,0,0,19900.0,105436.78197328727,IGF1
26126,KEGG_2019_Human,Longevity regulating pathway,1/102,0.0050999322416682,0.0105921669634647,0,0,19898.0,105032.15064717118,IGF1
26127,KEGG_2019_Human,AMPK signaling pathway,1/120,0.0059999251180858,0.0107998773794959,0,0,19880.0,101706.2448082016,IGF1
26128,KEGG_2019_Human,Oocyte meiosis,1/125,0.0062499232373748,0.0107998773794959,0,0,19875.0,100869.32368441945,IGF1
26129,KEGG_2019_Human,FoxO signaling pathway,1/132,0.0065999206698993,0.0107998773794959,0,0,19868.0,99751.22090491928,IGF1
26130,KEGG_2019_Human,Signaling pathways regulating pluripotency of stem cells,1/139,0.006949918172816,0.0107998773794959,0,0,19861.0,98689.81333375497,IGF1
26131,KEGG_2019_Human,Breast cancer,1/147,0.0073499154017982,0.0107998773794959,0,0,19853.0,97539.10874372096,IGF1
26132,KEGG_2019_Human,mTOR signaling pathway,1/152,0.0075999137114971,0.0107998773794959,0,0,19848.0,96850.665715497,IGF1
26133,KEGG_2019_Human,Transcriptional misregulation in cancer,1/186,0.0092999029651357,0.0120911836385281,0,0,19814.0,92684.96451050608,IGF1
26134,KEGG_2019_Human,Focal adhesion,1/199,0.0099498991610159,0.0120911836385281,0,0,19801.0,91286.4288690606,IGF1
26135,KEGG_2019_Human,Proteoglycans in cancer,1/201,0.0100498985877989,0.0120911836385281,0,0,19799.0,91079.21596609056,IGF1
26136,KEGG_2019_Human,Rap1 signaling pathway,1/206,0.010299897173561,0.0120911836385281,0,0,19794.0,90569.849337325,IGF1
26137,KEGG_2019_Human,Ras signaling pathway,1/232,0.0115998901349604,0.0130498764018304,0,0,19768.0,88101.22480150245,IGF1
26138,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0159298649499427,0,0,19705.0,83086.53988020132,IGF1
26139,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0183806265891117,0,0,19646.0,79255.8617626126,IGF1
26140,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,IGF1
26141,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR11H4
26142,KEGG_2019_Human,TGF-beta signaling pathway,1/90,0.0044999373439762,0.0044999373439762,0,0,19910.0,107587.50385474482,LEFTY1
26143,KEGG_2019_Human,RIG-I-like receptor signaling pathway,1/70,0.0034999466296654,0.0104998398889962,0,0,19930.0,112704.30065625212,ISG15
26144,KEGG_2019_Human,Epstein-Barr virus infection,1/201,0.0100498985877989,0.0150748478816984,0,0,19799.0,91079.21596609056,ISG15
26145,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0164998674589645,0,0,19670.0,80733.60565076157,ISG15
26146,KEGG_2019_Human,Ferroptosis,1/40,0.0019999631680592,0.0024499577795033,0,0,19960.0,124043.94523066044,SAT2
26147,KEGG_2019_Human,Arginine and proline metabolism,1/49,0.0024499577795033,0.0024499577795033,0,0,19951.0,119939.1172087114,SAT2
26148,KEGG_2019_Human,Glycosphingolipid biosynthesis,1/45,0.0022499601197094,0.0022499601197094,0,0,19955.0,121662.49782449217,ST6GALNAC4
26149,KEGG_2019_Human,MicroRNAs in cancer,1/299,0.0149498740670514,0.0149498740670514,0,0,19701.0,82804.33538735632,MIR29B1
26150,KEGG_2019_Human,Human immunodeficiency virus 1 infection,1/212,0.0105998955026255,0.0211997910052511,0,0,19788.0,89974.27756224656,BST2
26151,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,BST2
26152,KEGG_2019_Human,Arginine and proline metabolism,1/49,0.0024499577795033,0.0024499577795033,0,0,19951.0,119939.1172087114,CKMT1A
26153,KEGG_2019_Human,Glycosylphosphatidylinositol (GPI)-anchor biosynthesis,1/25,0.0012499733663791,0.0012499733663791,0,0,19975.0,133525.54486996148,PIGL
26154,KEGG_2019_Human,Protein export,1/23,0.0011499748819949,0.0045998995279799,0,0,19977.0,135204.63922267244,SEC61B
26155,KEGG_2019_Human,Vibrio cholerae infection,1/50,0.0024999572069037,0.0049999144138074,0,0,19950.0,119530.05920663515,SEC61B
26156,KEGG_2019_Human,Phagosome,1/152,0.0075999137114971,0.0082499094553477,0,0,19848.0,96850.665715497,SEC61B
26157,KEGG_2019_Human,Protein processing in endoplasmic reticulum,1/165,0.0082499094553477,0.0082499094553477,0,0,19835.0,95159.46482222488,SEC61B
26158,KEGG_2019_Human,SNARE interactions in vesicular transport,1/34,0.0016999670339032,0.0033999340678064,0,0,19966.0,127326.1054203148,SNAP29
26159,KEGG_2019_Human,Autophagy,1/128,0.0063999221281459,0.0063999221281459,0,0,19872.0,100382.8010329652,SNAP29
26160,KEGG_2019_Human,Insulin signaling pathway,1/137,0.0068499188797651,0.0068499188797651,0,0,19863.0,98987.62735269018,FLOT2
26161,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR1J1
26162,KEGG_2019_Human,Ether lipid metabolism,1/47,0.0023499589392381,0.0023499589392381,0,0,19953.0,120782.64067395544,GDPD1
26163,KEGG_2019_Human,RNA degradation,1/79,0.0039499423167337,0.0066999199497742,0,0,19921.0,110243.89578070649,LSM4
26164,KEGG_2019_Human,Spliceosome,1/134,0.0066999199497742,0.0066999199497742,0,0,19866.0,99442.43560916925,LSM4
26165,KEGG_2019_Human,Aldosterone-regulated sodium reabsorption,1/37,0.0018499650702878,0.0053999184753196,0,0,19963.0,125618.9446446357,SFN
26166,KEGG_2019_Human,p53 signaling pathway,1/72,0.0035999456502131,0.0053999184753196,0,0,19928.0,112131.59838572376,SFN
26167,KEGG_2019_Human,Cell cycle,1/124,0.0061999236097501,0.0061999236097501,0,0,19876.0,101034.04709010696,SFN
26168,KEGG_2019_Human,Endocytosis,1/244,0.0121998870519305,0.0121998870519305,0,0,19756.0,87051.4275316661,VPS37B
26169,KEGG_2019_Human,Hepatocellular carcinoma,1/168,0.0083999085011095,0.0115498903940656,0,0,19832.0,94787.72752807094,SMARCE1
26170,KEGG_2019_Human,Thermogenesis,1/231,0.0115498903940656,0.0115498903940656,0,0,19769.0,88191.07730937863,SMARCE1
26171,KEGG_2019_Human,Spliceosome,1/134,0.0066999199497742,0.0066999199497742,0,0,19866.0,99442.43560916925,SNRPB2
26172,KEGG_2019_Human,Proteoglycans in cancer,1/201,0.0100498985877989,0.0100498985877989,0,0,19799.0,91079.21596609056,HSPB2
26173,KEGG_2019_Human,Cytosolic DNA-sensing pathway,1/63,0.0031499501598827,0.0031499501598827,0,0,19937.0,114844.46974572667,TREX1
26174,KEGG_2019_Human,Ribosome,1/153,0.0076499133771537,0.0076499133771537,0,0,19847.0,96715.6407630817,RPS20
26175,KEGG_2019_Human,MicroRNAs in cancer,1/299,0.0149498740670514,0.0149498740670514,0,0,19701.0,82804.33538735632,MIRLET7C
26176,KEGG_2019_Human,Vitamin digestion and absorption,1/24,0.0011999741185782,0.0011999741185782,0,0,19976.0,134347.69487847842,SLC52A3
26177,KEGG_2019_Human,RNA polymerase,1/31,0.0015499690656704,0.0030999381313408,0,0,19969.0,129189.85098816035,POLR2J3
26178,KEGG_2019_Human,Huntington disease,1/193,0.0096499008972596,0.0096499008972596,0,0,19807.0,91920.47679471428,POLR2J3
26179,KEGG_2019_Human,MicroRNAs in cancer,1/299,0.0149498740670514,0.0149498740670514,0,0,19701.0,82804.33538735632,MIR155
26180,KEGG_2019_Human,Starch and sucrose metabolism,1/36,0.0017999657178272,0.0017999657178272,0,0,19964.0,126172.23364250171,PGM2L1
26181,KEGG_2019_Human,RNA degradation,1/79,0.0039499423167337,0.0039499423167337,0,0,19921.0,110243.89578070649,EXOSC7
26182,KEGG_2019_Human,Epithelial cell signaling in Helicobacter pylori infection,1/68,0.0033999476216189,0.0146398644623166,0,0,19932.0,113293.39338050144,CXCR2
26183,KEGG_2019_Human,Phospholipase D signaling pathway,1/148,0.007399915061391,0.0146398644623166,0,0,19852.0,97399.60470052566,CXCR2
26184,KEGG_2019_Human,Chemokine signaling pathway,1/190,0.0094999017791995,0.0146398644623166,0,0,19810.0,92244.74636351672,CXCR2
26185,KEGG_2019_Human,Human cytomegalovirus infection,1/225,0.0112498919790339,0.0146398644623166,0,0,19775.0,88738.27077557483,CXCR2
26186,KEGG_2019_Human,Endocytosis,1/244,0.0121998870519305,0.0146398644623166,0,0,19756.0,87051.4275316661,CXCR2
26187,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0146998751759735,0,0,19706.0,83157.67014793828,CXCR2
26188,KEGG_2019_Human,Natural killer cell mediated cytotoxicity,1/131,0.0065499210316603,0.0065499210316603,0,0,19869.0,99907.33811343512,CD48
26189,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0146998751759735,0,0,19706.0,83157.67014793828,IL27
26190,KEGG_2019_Human,SNARE interactions in vesicular transport,1/34,0.0016999670339032,0.0033999340678064,0,0,19966.0,127326.1054203148,STX7
26191,KEGG_2019_Human,Phagosome,1/152,0.0075999137114971,0.0075999137114971,0,0,19848.0,96850.665715497,STX7
26192,KEGG_2019_Human,Ribosome,1/153,0.0076499133771537,0.0076499133771537,0,0,19847.0,96715.6407630817,MRPL19
26193,KEGG_2019_Human,Ubiquitin mediated proteolysis,1/137,0.0068499188797651,0.0068499188797651,0,0,19863.0,98987.62735269018,DET1
26194,KEGG_2019_Human,Endocytosis,1/244,0.0121998870519305,0.0121998870519305,0,0,19756.0,87051.4275316661,FOLR2
26195,KEGG_2019_Human,Lysosome,1/123,0.0061499239842961,0.0061499239842961,0,0,19877.0,101200.07933676826,LAPTM4B
26196,KEGG_2019_Human,Ribosome,1/153,0.0076499133771537,0.0076499133771537,0,0,19847.0,96715.6407630817,MRPL23
26197,KEGG_2019_Human,Sulfur relay system,1/8,0.0003999883241497325,0.0003999883241497325,0,0,19992.0,156418.91141655247,CTU2
26198,KEGG_2019_Human,"Glycine, serine and threonine metabolism",1/40,0.0019999631680592,0.0019999631680592,0,0,19960.0,124043.94523066044,CHDH
26199,KEGG_2019_Human,Tyrosine metabolism,1/36,0.0017999657178272,0.0017999657178272,0,0,19964.0,126172.23364250171,PNMT
26200,KEGG_2019_Human,Protein digestion and absorption,1/90,0.0044999373439762,0.0048999339081079,0,0,19910.0,107587.50385474482,CTRB1
26201,KEGG_2019_Human,Pancreatic secretion,1/98,0.0048999339081079,0.0048999339081079,0,0,19902.0,105849.45495286948,CTRB1
26202,KEGG_2019_Human,Cardiac muscle contraction,1/78,0.0038999427840466,0.0112582177134695,0,0,19922.0,110503.2180492851,COX6B1
26203,KEGG_2019_Human,Oxidative phosphorylation,1/133,0.0066499203093911,0.0112582177134695,0,0,19867.0,99596.2591544721,COX6B1
26204,KEGG_2019_Human,Parkinson disease,1/142,0.0070999171242726,0.0112582177134695,0,0,19858.0,98250.87390500787,COX6B1
26205,KEGG_2019_Human,Non-alcoholic fatty liver disease (NAFLD),1/149,0.0074499147221605,0.0112582177134695,0,0,19851.0,97261.02051561224,COX6B1
26206,KEGG_2019_Human,Alzheimer disease,1/171,0.0085499075557634,0.0112582177134695,0,0,19829.0,94422.42241345016,COX6B1
26207,KEGG_2019_Human,Huntington disease,1/193,0.0096499008972596,0.0112582177134695,0,0,19807.0,91920.47679471428,COX6B1
26208,KEGG_2019_Human,Thermogenesis,1/231,0.0115498903940656,0.0115498903940656,0,0,19769.0,88191.07730937863,COX6B1
26209,KEGG_2019_Human,Amino sugar and nucleotide sugar metabolism,1/48,0.0023999583567988,0.0023999583567988,0,0,19952.0,120356.5272753826,GNPDA1
26210,KEGG_2019_Human,RNA polymerase,1/31,0.0015499690656704,0.0046499071970112,0,0,19969.0,129189.85098816035,POLR2E
26211,KEGG_2019_Human,Cytosolic DNA-sensing pathway,1/63,0.0031499501598827,0.0047249252398241,0,0,19937.0,114844.46974572667,POLR2E
26212,KEGG_2019_Human,Huntington disease,1/193,0.0096499008972596,0.0096499008972596,0,0,19807.0,91920.47679471428,POLR2E
26213,KEGG_2019_Human,Sphingolipid metabolism,1/47,0.0023499589392381,0.0046999178784763,0,0,19953.0,120782.64067395544,DEGS2
26214,KEGG_2019_Human,Sphingolipid signaling pathway,1/119,0.0059499254985137,0.0059499254985137,0,0,19881.0,101877.73080211312,DEGS2
26215,KEGG_2019_Human,Hematopoietic cell lineage,1/97,0.0048499343304706,0.0121498656303927,0,0,19903.0,106058.9096435903,IL9R
26216,KEGG_2019_Human,JAK-STAT signaling pathway,1/162,0.0080999104202618,0.0121498656303927,0,0,19838.0,95537.86936302872,IL9R
26217,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0146998751759735,0,0,19706.0,83157.67014793828,IL9R
26218,KEGG_2019_Human,Homologous recombination,1/41,0.0020499625466866,0.0020499625466866,0,0,19959.0,123544.88783416104,SYCP3
26219,KEGG_2019_Human,JAK-STAT signaling pathway,1/162,0.0080999104202618,0.0146998751759735,0,0,19838.0,95537.86936302872,CNTF
26220,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0146998751759735,0,0,19706.0,83157.67014793828,CNTF
26221,KEGG_2019_Human,Mitophagy,1/65,0.003249949134407,0.003249949134407,0,0,19935.0,114209.92613860144,FIS1
26222,KEGG_2019_Human,Adrenergic signaling in cardiomyocytes,1/145,0.0072499160871101,0.0072499160871101,0,0,19855.0,97820.92670675044,KCNE1
26223,KEGG_2019_Human,Glycosphingolipid biosynthesis,1/45,0.0022499601197094,0.0022499601197094,0,0,19955.0,121662.49782449217,ABO
26224,KEGG_2019_Human,Salivary secretion,1/90,0.0044999373439762,0.0044999373439762,0,0,19910.0,107587.50385474482,PRH2
26225,KEGG_2019_Human,Ribosome,1/153,0.0076499133771537,0.0076499133771537,0,0,19847.0,96715.6407630817,RPL18A
26226,KEGG_2019_Human,Progesterone-mediated oocyte maturation,1/99,0.0049499334884068,0.0085623985997064,0,0,19901.0,105642.09305076736,CDC26
26227,KEGG_2019_Human,Cell cycle,1/124,0.0061999236097501,0.0085623985997064,0,0,19876.0,101034.04709010696,CDC26
26228,KEGG_2019_Human,Oocyte meiosis,1/125,0.0062499232373748,0.0085623985997064,0,0,19875.0,100869.32368441945,CDC26
26229,KEGG_2019_Human,Ubiquitin mediated proteolysis,1/137,0.0068499188797651,0.0085623985997064,0,0,19863.0,98987.62735269018,CDC26
26230,KEGG_2019_Human,Human T-cell leukemia virus 1 infection,1/219,0.0109498935894162,0.0109498935894162,0,0,19781.0,89299.85161916987,CDC26
26231,KEGG_2019_Human,Ubiquitin mediated proteolysis,1/137,0.0068499188797651,0.0068499188797651,0,0,19863.0,98987.62735269018,UBE2S
26232,KEGG_2019_Human,Hippo signaling pathway,1/160,0.0079999110688441,0.0079999110688441,0,0,19840.0,95793.96509856998,WWTR1
26233,KEGG_2019_Human,Thiamine metabolism,1/15,0.0007499814841592997,0.0014999629683185,0,0,19985.0,143801.30885993244,AK1
26234,KEGG_2019_Human,Purine metabolism,1/129,0.006449921761047,0.006449921761047,0,0,19871.0,100223.109907462,AK1
26235,KEGG_2019_Human,Bile secretion,1/72,0.0035999456502131,0.0073499008621619,0,0,19928.0,112131.59838572376,SCT
26236,KEGG_2019_Human,Pancreatic secretion,1/98,0.0048999339081079,0.0073499008621619,0,0,19902.0,105849.45495286948,SCT
26237,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,SCT
26238,KEGG_2019_Human,MicroRNAs in cancer,1/299,0.0149498740670514,0.0149498740670514,0,0,19701.0,82804.33538735632,MIR363
26239,KEGG_2019_Human,Fluid shear stress and atherosclerosis,1/139,0.006949918172816,0.0088999053857096,0,0,19861.0,98689.81333375497,TXN2
26240,KEGG_2019_Human,NOD-like receptor signaling pathway,1/178,0.0088999053857096,0.0088999053857096,0,0,19822.0,93593.82745769851,TXN2
26241,KEGG_2019_Human,beta-Alanine metabolism,1/31,0.0015499690656704,0.0027999538675741,0,0,19969.0,129189.85098816035,SRM
26242,KEGG_2019_Human,Cysteine and methionine metabolism,1/47,0.0023499589392381,0.0027999538675741,0,0,19953.0,120782.64067395544,SRM
26243,KEGG_2019_Human,Arginine and proline metabolism,1/49,0.0024499577795033,0.0027999538675741,0,0,19951.0,119939.1172087114,SRM
26244,KEGG_2019_Human,Glutathione metabolism,1/56,0.0027999538675741,0.0027999538675741,0,0,19944.0,117233.87022514464,SRM
26245,KEGG_2019_Human,Protein processing in endoplasmic reticulum,1/165,0.0082499094553477,0.0082499094553477,0,0,19835.0,95159.46482222488,SSR2
26246,KEGG_2019_Human,Cell cycle,1/124,0.0061999236097501,0.0109498935894162,0,0,19876.0,101034.04709010696,CDC20
26247,KEGG_2019_Human,Oocyte meiosis,1/125,0.0062499232373748,0.0109498935894162,0,0,19875.0,100869.32368441945,CDC20
26248,KEGG_2019_Human,Ubiquitin mediated proteolysis,1/137,0.0068499188797651,0.0109498935894162,0,0,19863.0,98987.62735269018,CDC20
26249,KEGG_2019_Human,Viral carcinogenesis,1/201,0.0100498985877989,0.0109498935894162,0,0,19799.0,91079.21596609056,CDC20
26250,KEGG_2019_Human,Human T-cell leukemia virus 1 infection,1/219,0.0109498935894162,0.0109498935894162,0,0,19781.0,89299.85161916987,CDC20
26251,KEGG_2019_Human,Fc epsilon RI signaling pathway,1/68,0.0033999476216189,0.0086332342382895,0,0,19932.0,113293.39338050144,GAB2
26252,KEGG_2019_Human,Chronic myeloid leukemia,1/76,0.0037999437281752,0.0086332342382895,0,0,19924.0,111031.8499691117,GAB2
26253,KEGG_2019_Human,Fc gamma R-mediated phagocytosis,1/91,0.0045499369072032,0.0086332342382895,0,0,19909.0,107362.10783923086,GAB2
26254,KEGG_2019_Human,Sphingolipid signaling pathway,1/119,0.0059499254985137,0.0086332342382895,0,0,19881.0,101877.73080211312,GAB2
26255,KEGG_2019_Human,Osteoclast differentiation,1/127,0.0063499224962247,0.0086332342382895,0,0,19873.0,100543.72072014232,GAB2
26256,KEGG_2019_Human,Phospholipase D signaling pathway,1/148,0.007399915061391,0.0086332342382895,0,0,19852.0,97399.60470052566,GAB2
26257,KEGG_2019_Human,Ras signaling pathway,1/232,0.0115998901349604,0.0115998901349604,0,0,19768.0,88101.22480150245,GAB2
26258,KEGG_2019_Human,DNA replication,1/36,0.0017999657178272,0.0017999657178272,0,0,19964.0,126172.23364250171,RNASEH1
26259,KEGG_2019_Human,Apelin signaling pathway,1/137,0.0068499188797651,0.0136998377595303,0,0,19863.0,98987.62735269018,APLN
26260,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,APLN
26261,KEGG_2019_Human,p53 signaling pathway,1/72,0.0035999456502131,0.011911407066113,0,0,19928.0,112131.59838572376,CDK2
26262,KEGG_2019_Human,Small cell lung cancer,1/93,0.0046499360391879,0.011911407066113,0,0,19907.0,106918.54242106884,CDK2
26263,KEGG_2019_Human,Prostate cancer,1/97,0.0048499343304706,0.011911407066113,0,0,19903.0,106058.9096435903,CDK2
26264,KEGG_2019_Human,Progesterone-mediated oocyte maturation,1/99,0.0049499334884068,0.011911407066113,0,0,19901.0,105642.09305076736,CDK2
26265,KEGG_2019_Human,Cell cycle,1/124,0.0061999236097501,0.011911407066113,0,0,19876.0,101034.04709010696,CDK2
26266,KEGG_2019_Human,Oocyte meiosis,1/125,0.0062499232373748,0.011911407066113,0,0,19875.0,100869.32368441945,CDK2
26267,KEGG_2019_Human,FoxO signaling pathway,1/132,0.0065999206698993,0.011911407066113,0,0,19868.0,99751.22090491928,CDK2
26268,KEGG_2019_Human,Measles,1/138,0.0068999185254481,0.011911407066113,0,0,19862.0,98838.19160389496,CDK2
26269,KEGG_2019_Human,Gastric cancer,1/149,0.0074499147221605,0.011911407066113,0,0,19851.0,97261.02051561224,CDK2
26270,KEGG_2019_Human,Cushing syndrome,1/155,0.0077499127120574,0.011911407066113,0,0,19845.0,96448.16254952336,CDK2
26271,KEGG_2019_Human,Hepatitis C,1/155,0.0077499127120574,0.011911407066113,0,0,19845.0,96448.16254952336,CDK2
26272,KEGG_2019_Human,Cellular senescence,1/160,0.0079999110688441,0.011911407066113,0,0,19840.0,95793.96509856998,CDK2
26273,KEGG_2019_Human,Hepatitis B,1/163,0.0081499100978668,0.011911407066113,0,0,19837.0,95410.9786681514,CDK2
26274,KEGG_2019_Human,Viral carcinogenesis,1/201,0.0100498985877989,0.0127298715445453,0,0,19799.0,91079.21596609056,CDK2
26275,KEGG_2019_Human,Epstein-Barr virus infection,1/201,0.0100498985877989,0.0127298715445453,0,0,19799.0,91079.21596609056,CDK2
26276,KEGG_2019_Human,Human T-cell leukemia virus 1 infection,1/219,0.0109498935894162,0.0130029986374318,0,0,19781.0,89299.85161916987,CDK2
26277,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0184410283364897,0,0,19670.0,80733.60565076157,CDK2
26278,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.018683188343665,0,0,19646.0,79255.8617626126,CDK2
26279,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,CDK2
26280,KEGG_2019_Human,TNF signaling pathway,1/110,0.0054999290027479,0.0107998805603491,0,0,19890.0,103488.06969787036,LIF
26281,KEGG_2019_Human,Signaling pathways regulating pluripotency of stem cells,1/139,0.006949918172816,0.0107998805603491,0,0,19861.0,98689.81333375497,LIF
26282,KEGG_2019_Human,JAK-STAT signaling pathway,1/162,0.0080999104202618,0.0107998805603491,0,0,19838.0,95537.86936302872,LIF
26283,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0146998751759735,0,0,19706.0,83157.67014793828,LIF
26284,KEGG_2019_Human,Amoebiasis,1/96,0.0047999347538706,0.0047999347538706,0,0,19904.0,106270.50039849174,SERPINB1
26285,KEGG_2019_Human,Non-homologous end-joining,1/13,0.0006499833083207112,0.0006499833083207112,0,0,19987.0,146675.87616784443,NHEJ1
26286,KEGG_2019_Human,Cardiac muscle contraction,1/78,0.0038999427840466,0.0112582177134695,0,0,19922.0,110503.2180492851,COX6C
26287,KEGG_2019_Human,Oxidative phosphorylation,1/133,0.0066499203093911,0.0112582177134695,0,0,19867.0,99596.2591544721,COX6C
26288,KEGG_2019_Human,Parkinson disease,1/142,0.0070999171242726,0.0112582177134695,0,0,19858.0,98250.87390500787,COX6C
26289,KEGG_2019_Human,Non-alcoholic fatty liver disease (NAFLD),1/149,0.0074499147221605,0.0112582177134695,0,0,19851.0,97261.02051561224,COX6C
26290,KEGG_2019_Human,Alzheimer disease,1/171,0.0085499075557634,0.0112582177134695,0,0,19829.0,94422.42241345016,COX6C
26291,KEGG_2019_Human,Huntington disease,1/193,0.0096499008972596,0.0112582177134695,0,0,19807.0,91920.47679471428,COX6C
26292,KEGG_2019_Human,Thermogenesis,1/231,0.0115498903940656,0.0115498903940656,0,0,19769.0,88191.07730937863,COX6C
26293,KEGG_2019_Human,Ribosome,1/153,0.0076499133771537,0.0076499133771537,0,0,19847.0,96715.6407630817,RPL17
26294,KEGG_2019_Human,Retrograde endocannabinoid signaling,1/148,0.007399915061391,0.007399915061391,0,0,19852.0,97399.60470052566,ABHD6
26295,KEGG_2019_Human,Autoimmune thyroid disease,1/53,0.0026499555173137,0.0145586837375733,0,0,19947.0,118349.78824235698,IFNA13
26296,KEGG_2019_Human,Cytosolic DNA-sensing pathway,1/63,0.0031499501598827,0.0145586837375733,0,0,19937.0,114844.46974572667,IFNA13
26297,KEGG_2019_Human,RIG-I-like receptor signaling pathway,1/70,0.0034999466296654,0.0145586837375733,0,0,19930.0,112704.30065625212,IFNA13
26298,KEGG_2019_Human,Toll-like receptor signaling pathway,1/104,0.0051999314202997,0.0145586837375733,0,0,19896.0,104635.24941415618,IFNA13
26299,KEGG_2019_Human,Natural killer cell mediated cytotoxicity,1/131,0.0065499210316603,0.0145586837375733,0,0,19869.0,99907.33811343512,IFNA13
26300,KEGG_2019_Human,Measles,1/138,0.0068999185254481,0.0145586837375733,0,0,19862.0,98838.19160389496,IFNA13
26301,KEGG_2019_Human,Hepatitis C,1/155,0.0077499127120574,0.0145586837375733,0,0,19845.0,96448.16254952336,IFNA13
26302,KEGG_2019_Human,Necroptosis,1/162,0.0080999104202618,0.0145586837375733,0,0,19838.0,95537.86936302872,IFNA13
26303,KEGG_2019_Human,JAK-STAT signaling pathway,1/162,0.0080999104202618,0.0145586837375733,0,0,19838.0,95537.86936302872,IFNA13
26304,KEGG_2019_Human,Hepatitis B,1/163,0.0081499100978668,0.0145586837375733,0,0,19837.0,95410.9786681514,IFNA13
26305,KEGG_2019_Human,Influenza A,1/171,0.0085499075557634,0.0145586837375733,0,0,19829.0,94422.42241345016,IFNA13
26306,KEGG_2019_Human,NOD-like receptor signaling pathway,1/178,0.0088999053857096,0.0145586837375733,0,0,19822.0,93593.82745769851,IFNA13
26307,KEGG_2019_Human,Tuberculosis,1/179,0.0089499050800561,0.0145586837375733,0,0,19821.0,93478.0629355712,IFNA13
26308,KEGG_2019_Human,Kaposi sarcoma-associated herpesvirus infection,1/186,0.0092999029651357,0.0145586837375733,0,0,19814.0,92684.96451050608,IFNA13
26309,KEGG_2019_Human,Epstein-Barr virus infection,1/201,0.0100498985877989,0.0145586837375733,0,0,19799.0,91079.21596609056,IFNA13
26310,KEGG_2019_Human,Human immunodeficiency virus 1 infection,1/212,0.0105998955026255,0.0145586837375733,0,0,19788.0,89974.27756224656,IFNA13
26311,KEGG_2019_Human,Human cytomegalovirus infection,1/225,0.0112498919790339,0.0145586837375733,0,0,19775.0,88738.27077557483,IFNA13
26312,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0179665141039676,0,0,19706.0,83157.67014793828,IFNA13
26313,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0191051096893273,0,0,19670.0,80733.60565076157,IFNA13
26314,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0194698489055035,0,0,19646.0,79255.8617626126,IFNA13
26315,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0257712598834163,0,0,19508.0,72277.44006442746,IFNA13
26316,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,IFNA13
26317,KEGG_2019_Human,RNA polymerase,1/31,0.0015499690656704,0.0030999381313408,0,0,19969.0,129189.85098816035,POLR2D
26318,KEGG_2019_Human,Huntington disease,1/193,0.0096499008972596,0.0096499008972596,0,0,19807.0,91920.47679471428,POLR2D
26319,KEGG_2019_Human,Spliceosome,1/134,0.0066999199497742,0.0082499094553477,0,0,19866.0,99442.43560916925,THOC3
26320,KEGG_2019_Human,RNA transport,1/165,0.0082499094553477,0.0082499094553477,0,0,19835.0,95159.46482222488,THOC3
26321,KEGG_2019_Human,Sphingolipid signaling pathway,1/119,0.0059499254985137,0.008579900132453,0,0,19881.0,101877.73080211312,CTSD
26322,KEGG_2019_Human,Lysosome,1/123,0.0061499239842961,0.008579900132453,0,0,19877.0,101200.07933676826,CTSD
26323,KEGG_2019_Human,Autophagy,1/128,0.0063999221281459,0.008579900132453,0,0,19872.0,100382.8010329652,CTSD
26324,KEGG_2019_Human,Estrogen signaling pathway,1/137,0.0068499188797651,0.008579900132453,0,0,19863.0,98987.62735269018,CTSD
26325,KEGG_2019_Human,Apoptosis,1/143,0.0071499167770442,0.008579900132453,0,0,19857.0,98106.57763600958,CTSD
26326,KEGG_2019_Human,Tuberculosis,1/179,0.0089499050800561,0.0089499050800561,0,0,19821.0,93478.0629355712,CTSD
26327,KEGG_2019_Human,Mineral absorption,1/51,0.0025499566390179,0.0025499566390179,0,0,19949.0,119129.0228601236,MT1M
26328,KEGG_2019_Human,Cardiac muscle contraction,1/78,0.0038999427840466,0.0112582177134695,0,0,19922.0,110503.2180492851,COX4I1
26329,KEGG_2019_Human,Oxidative phosphorylation,1/133,0.0066499203093911,0.0112582177134695,0,0,19867.0,99596.2591544721,COX4I1
26330,KEGG_2019_Human,Parkinson disease,1/142,0.0070999171242726,0.0112582177134695,0,0,19858.0,98250.87390500787,COX4I1
26331,KEGG_2019_Human,Non-alcoholic fatty liver disease (NAFLD),1/149,0.0074499147221605,0.0112582177134695,0,0,19851.0,97261.02051561224,COX4I1
26332,KEGG_2019_Human,Alzheimer disease,1/171,0.0085499075557634,0.0112582177134695,0,0,19829.0,94422.42241345016,COX4I1
26333,KEGG_2019_Human,Huntington disease,1/193,0.0096499008972596,0.0112582177134695,0,0,19807.0,91920.47679471428,COX4I1
26334,KEGG_2019_Human,Thermogenesis,1/231,0.0115498903940656,0.0115498903940656,0,0,19769.0,88191.07730937863,COX4I1
26335,KEGG_2019_Human,Other types of O-glycan biosynthesis,1/22,0.0010999756574123,0.003299926972237,0,0,19978.0,136099.47030191717,RFNG
26336,KEGG_2019_Human,Notch signaling pathway,1/48,0.0023999583567988,0.0035999375351982,0,0,19952.0,120356.5272753826,RFNG
26337,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0164998674589645,0,0,19670.0,80733.60565076157,RFNG
26338,KEGG_2019_Human,Glycolysis / Gluconeogenesis,1/68,0.0033999476216189,0.0049999330710556,0,0,19932.0,113293.39338050144,ENO2
26339,KEGG_2019_Human,RNA degradation,1/79,0.0039499423167337,0.0049999330710556,0,0,19921.0,110243.89578070649,ENO2
26340,KEGG_2019_Human,HIF-1 signaling pathway,1/100,0.0049999330710556,0.0049999330710556,0,0,19900.0,105436.78197328727,ENO2
26341,KEGG_2019_Human,Mineral absorption,1/51,0.0025499566390179,0.0025499566390179,0,0,19949.0,119129.0228601236,MT1H
26342,KEGG_2019_Human,MicroRNAs in cancer,1/299,0.0149498740670514,0.0149498740670514,0,0,19701.0,82804.33538735632,MIR129-2
26343,KEGG_2019_Human,Synaptic vesicle cycle,1/78,0.0038999427840466,0.0038999427840466,0,0,19922.0,110503.2180492851,NAPA
26344,KEGG_2019_Human,Primary bile acid biosynthesis,1/17,0.0008499797390404818,0.0016999594780809,0,0,19983.0,141285.76583697114,ACOT8
26345,KEGG_2019_Human,Peroxisome,1/83,0.0041499404726918,0.0041499404726918,0,0,19917.0,109237.99888847338,ACOT8
26346,KEGG_2019_Human,MicroRNAs in cancer,1/299,0.0149498740670514,0.0149498740670514,0,0,19701.0,82804.33538735632,MIR9-3
26347,KEGG_2019_Human,Ubiquitin mediated proteolysis,1/137,0.0068499188797651,0.0082499094553477,0,0,19863.0,98987.62735269018,UBE2D1
26348,KEGG_2019_Human,Protein processing in endoplasmic reticulum,1/165,0.0082499094553477,0.0082499094553477,0,0,19835.0,95159.46482222488,UBE2D1
26349,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR1F1
26350,KEGG_2019_Human,Tight junction,1/170,0.0084999078692823,0.0084999078692823,0,0,19830.0,94543.49009679438,RAB13
26351,KEGG_2019_Human,Ovarian steroidogenesis,1/49,0.0024499577795033,0.0061999147189172,0,0,19951.0,119939.1172087114,LHB
26352,KEGG_2019_Human,Prolactin signaling pathway,1/70,0.0034999466296654,0.0061999147189172,0,0,19930.0,112704.30065625212,LHB
26353,KEGG_2019_Human,GnRH signaling pathway,1/93,0.0046499360391879,0.0061999147189172,0,0,19907.0,106918.54242106884,LHB
26354,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,LHB
26355,KEGG_2019_Human,Protein processing in endoplasmic reticulum,1/165,0.0082499094553477,0.0082499094553477,0,0,19835.0,95159.46482222488,SSR4
26356,KEGG_2019_Human,Salivary secretion,1/90,0.0044999373439762,0.0044999373439762,0,0,19910.0,107587.50385474482,PRH1
26357,KEGG_2019_Human,Osteoclast differentiation,1/127,0.0063499224962247,0.0063499224962247,0,0,19873.0,100543.72072014232,LILRA5
26358,KEGG_2019_Human,IL-17 signaling pathway,1/93,0.0046499360391879,0.0092998720783758,0,0,19907.0,106918.54242106884,IL17B
26359,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0146998751759735,0,0,19706.0,83157.67014793828,IL17B
26360,KEGG_2019_Human,Ribosome,1/153,0.0076499133771537,0.0076499133771537,0,0,19847.0,96715.6407630817,MRPS15
26361,KEGG_2019_Human,MicroRNAs in cancer,1/299,0.0149498740670514,0.0149498740670514,0,0,19701.0,82804.33538735632,MIR200A
26362,KEGG_2019_Human,Mismatch repair,1/23,0.0011499748819949,0.0023499589392381,0,0,19977.0,135204.63922267244,POLD4
26363,KEGG_2019_Human,Base excision repair,1/33,0.0016499677032113,0.0023499589392381,0,0,19967.0,127928.56031580272,POLD4
26364,KEGG_2019_Human,DNA replication,1/36,0.0017999657178272,0.0023499589392381,0,0,19964.0,126172.23364250171,POLD4
26365,KEGG_2019_Human,Homologous recombination,1/41,0.0020499625466866,0.0023499589392381,0,0,19959.0,123544.88783416104,POLD4
26366,KEGG_2019_Human,Nucleotide excision repair,1/47,0.0023499589392381,0.0023499589392381,0,0,19953.0,120782.64067395544,POLD4
26367,KEGG_2019_Human,Necroptosis,1/162,0.0080999104202618,0.0080999104202618,0,0,19838.0,95537.86936302872,SPATA2
26368,KEGG_2019_Human,Leukocyte transendothelial migration,1/112,0.0055999282120529,0.0084999078692823,0,0,19888.0,103119.30984392198,CLDN23
26369,KEGG_2019_Human,Cell adhesion molecules (CAMs),1/145,0.0072499160871101,0.0084999078692823,0,0,19855.0,97820.92670675044,CLDN23
26370,KEGG_2019_Human,Hepatitis C,1/155,0.0077499127120574,0.0084999078692823,0,0,19845.0,96448.16254952336,CLDN23
26371,KEGG_2019_Human,Tight junction,1/170,0.0084999078692823,0.0084999078692823,0,0,19830.0,94543.49009679438,CLDN23
26372,KEGG_2019_Human,Long-term potentiation,1/67,0.0033499481224912,0.0123665447530631,0,0,19933.0,113594.38808369274,RAP1A
26373,KEGG_2019_Human,Renal cell carcinoma,1/69,0.003449947123837,0.0123665447530631,0,0,19931.0,112996.7391397682,RAP1A
26374,KEGG_2019_Human,Pancreatic secretion,1/98,0.0048999339081079,0.0123665447530631,0,0,19902.0,105849.45495286948,RAP1A
26375,KEGG_2019_Human,Leukocyte transendothelial migration,1/112,0.0055999282120529,0.0123665447530631,0,0,19888.0,103119.30984392198,RAP1A
26376,KEGG_2019_Human,Neurotrophin signaling pathway,1/119,0.0059499254985137,0.0123665447530631,0,0,19881.0,101877.73080211312,RAP1A
26377,KEGG_2019_Human,Platelet activation,1/124,0.0061999236097501,0.0123665447530631,0,0,19876.0,101034.04709010696,RAP1A
26378,KEGG_2019_Human,Cushing syndrome,1/155,0.0077499127120574,0.0123665447530631,0,0,19845.0,96448.16254952336,RAP1A
26379,KEGG_2019_Human,Tight junction,1/170,0.0084999078692823,0.0123665447530631,0,0,19830.0,94543.49009679438,RAP1A
26380,KEGG_2019_Human,Chemokine signaling pathway,1/190,0.0094999017791995,0.0123665447530631,0,0,19810.0,92244.74636351672,RAP1A
26381,KEGG_2019_Human,Focal adhesion,1/199,0.0099498991610159,0.0123665447530631,0,0,19801.0,91286.4288690606,RAP1A
26382,KEGG_2019_Human,Rap1 signaling pathway,1/206,0.010299897173561,0.0123665447530631,0,0,19794.0,90569.849337325,RAP1A
26383,KEGG_2019_Human,cAMP signaling pathway,1/212,0.0105998955026255,0.0123665447530631,0,0,19788.0,89974.27756224656,RAP1A
26384,KEGG_2019_Human,Ras signaling pathway,1/232,0.0115998901349604,0.0124921893761112,0,0,19768.0,88101.22480150245,RAP1A
26385,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0147498749536506,0,0,19705.0,83086.53988020132,RAP1A
26386,KEGG_2019_Human,Small cell lung cancer,1/93,0.0046499360391879,0.0117248816857654,0,0,19907.0,106918.54242106884,TRAF1
26387,KEGG_2019_Human,NF-kappa B signaling pathway,1/95,0.0047499351803394,0.0117248816857654,0,0,19905.0,106484.27183626965,TRAF1
26388,KEGG_2019_Human,TNF signaling pathway,1/110,0.0054999290027479,0.0117248816857654,0,0,19890.0,103488.06969787036,TRAF1
26389,KEGG_2019_Human,Apoptosis,1/143,0.0071499167770442,0.0117248816857654,0,0,19857.0,98106.57763600958,TRAF1
26390,KEGG_2019_Human,Transcriptional misregulation in cancer,1/186,0.0092999029651357,0.0117248816857654,0,0,19814.0,92684.96451050608,TRAF1
26391,KEGG_2019_Human,Viral carcinogenesis,1/201,0.0100498985877989,0.0117248816857654,0,0,19799.0,91079.21596609056,TRAF1
26392,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,TRAF1
26393,KEGG_2019_Human,Propanoate metabolism,1/32,0.0015999683804467,0.0023999583567988,0,0,19968.0,128549.41955786056,BCKDHA
26394,KEGG_2019_Human,"Valine, leucine and isoleucine degradation",1/48,0.0023999583567988,0.0023999583567988,0,0,19952.0,120356.5272753826,BCKDHA
26395,KEGG_2019_Human,Thiamine metabolism,1/15,0.0007499814841592997,0.0007499814841592997,0,0,19985.0,143801.30885993244,THTPA
26396,KEGG_2019_Human,Transcriptional misregulation in cancer,1/186,0.0092999029651357,0.0092999029651357,0,0,19814.0,92684.96451050608,SSX1
26397,KEGG_2019_Human,Apoptosis,1/143,0.0071499167770442,0.0071499167770442,0,0,19857.0,98106.57763600958,ENDOG
26398,KEGG_2019_Human,Phototransduction,1/28,0.0013999711732997,0.0113938210547091,0,0,19972.0,131242.0761597353,CALML3
26399,KEGG_2019_Human,Long-term potentiation,1/67,0.0033499481224912,0.0113938210547091,0,0,19933.0,113594.38808369274,CALML3
26400,KEGG_2019_Human,Amphetamine addiction,1/68,0.0033999476216189,0.0113938210547091,0,0,19932.0,113293.39338050144,CALML3
26401,KEGG_2019_Human,Renin secretion,1/69,0.003449947123837,0.0113938210547091,0,0,19931.0,112996.7391397682,CALML3
26402,KEGG_2019_Human,Gastric acid secretion,1/75,0.0037499442041125,0.0113938210547091,0,0,19925.0,111301.33528642564,CALML3
26403,KEGG_2019_Human,Glioma,1/75,0.0037499442041125,0.0113938210547091,0,0,19925.0,111301.33528642564,CALML3
26404,KEGG_2019_Human,Pertussis,1/76,0.0037999437281752,0.0113938210547091,0,0,19924.0,111031.8499691117,CALML3
26405,KEGG_2019_Human,Salivary secretion,1/90,0.0044999373439762,0.0113938210547091,0,0,19910.0,107587.50385474482,CALML3
26406,KEGG_2019_Human,GnRH signaling pathway,1/93,0.0046499360391879,0.0113938210547091,0,0,19907.0,106918.54242106884,CALML3
26407,KEGG_2019_Human,Circadian entrainment,1/97,0.0048499343304706,0.0113938210547091,0,0,19903.0,106058.9096435903,CALML3
26408,KEGG_2019_Human,Aldosterone synthesis and secretion,1/98,0.0048999339081079,0.0113938210547091,0,0,19902.0,105849.45495286948,CALML3
26409,KEGG_2019_Human,Phosphatidylinositol signaling system,1/99,0.0049499334884068,0.0113938210547091,0,0,19901.0,105642.09305076736,CALML3
26410,KEGG_2019_Human,Inflammatory mediator regulation of TRP channels,1/100,0.0049999330710556,0.0113938210547091,0,0,19900.0,105436.78197328727,CALML3
26411,KEGG_2019_Human,Melanogenesis,1/101,0.0050499326546803,0.0113938210547091,0,0,19899.0,105233.48101229242,CALML3
26412,KEGG_2019_Human,Glucagon signaling pathway,1/103,0.0051499318302617,0.0113938210547091,0,0,19897.0,104832.7525292024,CALML3
26413,KEGG_2019_Human,C-type lectin receptor signaling pathway,1/104,0.0051999314202997,0.0113938210547091,0,0,19896.0,104635.24941415618,CALML3
26414,KEGG_2019_Human,Neurotrophin signaling pathway,1/119,0.0059499254985137,0.0113938210547091,0,0,19881.0,101877.73080211312,CALML3
26415,KEGG_2019_Human,Oocyte meiosis,1/125,0.0062499232373748,0.0113938210547091,0,0,19875.0,100869.32368441945,CALML3
26416,KEGG_2019_Human,Dopaminergic synapse,1/131,0.0065499210316603,0.0113938210547091,0,0,19869.0,99907.33811343512,CALML3
26417,KEGG_2019_Human,Vascular smooth muscle contraction,1/132,0.0065999206698993,0.0113938210547091,0,0,19868.0,99751.22090491928,CALML3
26418,KEGG_2019_Human,Insulin signaling pathway,1/137,0.0068499188797651,0.0113938210547091,0,0,19863.0,98987.62735269018,CALML3
26419,KEGG_2019_Human,Estrogen signaling pathway,1/137,0.0068499188797651,0.0113938210547091,0,0,19863.0,98987.62735269018,CALML3
26420,KEGG_2019_Human,Apelin signaling pathway,1/137,0.0068499188797651,0.0113938210547091,0,0,19863.0,98987.62735269018,CALML3
26421,KEGG_2019_Human,Fluid shear stress and atherosclerosis,1/139,0.006949918172816,0.0113938210547091,0,0,19861.0,98689.81333375497,CALML3
26422,KEGG_2019_Human,Adrenergic signaling in cardiomyocytes,1/145,0.0072499160871101,0.0113938210547091,0,0,19855.0,97820.92670675044,CALML3
26423,KEGG_2019_Human,Oxytocin signaling pathway,1/153,0.0076499133771537,0.0113938210547091,0,0,19847.0,96715.6407630817,CALML3
26424,KEGG_2019_Human,Cellular senescence,1/160,0.0079999110688441,0.0113938210547091,0,0,19840.0,95793.96509856998,CALML3
26425,KEGG_2019_Human,cGMP-PKG signaling pathway,1/166,0.0082999091363732,0.0113938210547091,0,0,19834.0,95034.82345515196,CALML3
26426,KEGG_2019_Human,Alzheimer disease,1/171,0.0085499075557634,0.0113938210547091,0,0,19829.0,94422.42241345016,CALML3
26427,KEGG_2019_Human,Tuberculosis,1/179,0.0089499050800561,0.0113938210547091,0,0,19821.0,93478.0629355712,CALML3
26428,KEGG_2019_Human,Alcoholism,1/180,0.0089999047745351,0.0113938210547091,0,0,19820.0,93362.92821536642,CALML3
26429,KEGG_2019_Human,Kaposi sarcoma-associated herpesvirus infection,1/186,0.0092999029651357,0.0113938210547091,0,0,19814.0,92684.96451050608,CALML3
26430,KEGG_2019_Human,Calcium signaling pathway,1/188,0.009399902370135,0.0113938210547091,0,0,19812.0,92463.712994847,CALML3
26431,KEGG_2019_Human,Rap1 signaling pathway,1/206,0.010299897173561,0.0117776616695839,0,0,19794.0,90569.849337325,CALML3
26432,KEGG_2019_Human,Human immunodeficiency virus 1 infection,1/212,0.0105998955026255,0.0117776616695839,0,0,19788.0,89974.27756224656,CALML3
26433,KEGG_2019_Human,cAMP signaling pathway,1/212,0.0105998955026255,0.0117776616695839,0,0,19788.0,89974.27756224656,CALML3
26434,KEGG_2019_Human,Human cytomegalovirus infection,1/225,0.0112498919790339,0.0121620453827393,0,0,19775.0,88738.27077557483,CALML3
26435,KEGG_2019_Human,Ras signaling pathway,1/232,0.0115998901349604,0.0122104106683793,0,0,19768.0,88101.22480150245,CALML3
26436,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0227690733587457,0,0,19556.0,74462.79263140135,CALML3
26437,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,CALML3
26438,KEGG_2019_Human,Morphine addiction,1/91,0.0045499369072032,0.0076499133771537,0,0,19909.0,107362.10783923086,KCNJ9
26439,KEGG_2019_Human,Circadian entrainment,1/97,0.0048499343304706,0.0076499133771537,0,0,19903.0,106058.9096435903,KCNJ9
26440,KEGG_2019_Human,Serotonergic synapse,1/113,0.0056499278191151,0.0076499133771537,0,0,19887.0,102937.34947211576,KCNJ9
26441,KEGG_2019_Human,Dopaminergic synapse,1/131,0.0065499210316603,0.0076499133771537,0,0,19869.0,99907.33811343512,KCNJ9
26442,KEGG_2019_Human,Estrogen signaling pathway,1/137,0.0068499188797651,0.0076499133771537,0,0,19863.0,98987.62735269018,KCNJ9
26443,KEGG_2019_Human,Retrograde endocannabinoid signaling,1/148,0.007399915061391,0.0076499133771537,0,0,19852.0,97399.60470052566,KCNJ9
26444,KEGG_2019_Human,Oxytocin signaling pathway,1/153,0.0076499133771537,0.0076499133771537,0,0,19847.0,96715.6407630817,KCNJ9
26445,KEGG_2019_Human,Pentose phosphate pathway,1/30,0.0014999697593334,0.002474951554817,0,0,19970.0,129851.13732048514,ALDOC
26446,KEGG_2019_Human,Fructose and mannose metabolism,1/33,0.0016499677032113,0.002474951554817,0,0,19967.0,127928.56031580272,ALDOC
26447,KEGG_2019_Human,Glycolysis / Gluconeogenesis,1/68,0.0033999476216189,0.0033999476216189,0,0,19932.0,113293.39338050144,ALDOC
26448,KEGG_2019_Human,Apelin signaling pathway,1/137,0.0068499188797651,0.0082999091363732,0,0,19863.0,98987.62735269018,MEF2B
26449,KEGG_2019_Human,cGMP-PKG signaling pathway,1/166,0.0082999091363732,0.0082999091363732,0,0,19834.0,95034.82345515196,MEF2B
26450,KEGG_2019_Human,RNA polymerase,1/31,0.0015499690656704,0.0030999381313408,0,0,19969.0,129189.85098816035,POLR3G
26451,KEGG_2019_Human,Cytosolic DNA-sensing pathway,1/63,0.0031499501598827,0.0031499501598827,0,0,19937.0,114844.46974572667,POLR3G
26452,KEGG_2019_Human,N-Glycan biosynthesis,1/50,0.0024999572069037,0.0024999572069037,0,0,19950.0,119530.05920663515,ALG1
26453,KEGG_2019_Human,Ribosome,1/153,0.0076499133771537,0.0076499133771537,0,0,19847.0,96715.6407630817,RPL17-C18ORF32
26454,KEGG_2019_Human,Glycosphingolipid biosynthesis,1/45,0.0022499601197094,0.0026499555173137,0,0,19955.0,121662.49782449217,B3GNT2
26455,KEGG_2019_Human,Glycosaminoglycan biosynthesis,1/53,0.0026499555173137,0.0026499555173137,0,0,19947.0,118349.78824235698,B3GNT2
26456,KEGG_2019_Human,TGF-beta signaling pathway,1/90,0.0044999373439762,0.0044999373439762,0,0,19910.0,107587.50385474482,NBL1
26457,KEGG_2019_Human,Inflammatory bowel disease (IBD),1/65,0.003249949134407,0.0096298743648466,0,0,19935.0,114209.92613860144,IL23A
26458,KEGG_2019_Human,Pertussis,1/76,0.0037999437281752,0.0096298743648466,0,0,19924.0,111031.8499691117,IL23A
26459,KEGG_2019_Human,Rheumatoid arthritis,1/91,0.0045499369072032,0.0096298743648466,0,0,19909.0,107362.10783923086,IL23A
26460,KEGG_2019_Human,C-type lectin receptor signaling pathway,1/104,0.0051999314202997,0.0096298743648466,0,0,19896.0,104635.24941415618,IL23A
26461,KEGG_2019_Human,Th17 cell differentiation,1/107,0.0053499302026925,0.0096298743648466,0,0,19893.0,104053.753408911,IL23A
26462,KEGG_2019_Human,JAK-STAT signaling pathway,1/162,0.0080999104202618,0.011507020817215,0,0,19838.0,95537.86936302872,IL23A
26463,KEGG_2019_Human,Tuberculosis,1/179,0.0089499050800561,0.011507020817215,0,0,19821.0,93478.0629355712,IL23A
26464,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0165373595729701,0,0,19706.0,83157.67014793828,IL23A
26465,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,IL23A
26466,KEGG_2019_Human,Leukocyte transendothelial migration,1/112,0.0055999282120529,0.0084999078692823,0,0,19888.0,103119.30984392198,CLDN7
26467,KEGG_2019_Human,Cell adhesion molecules (CAMs),1/145,0.0072499160871101,0.0084999078692823,0,0,19855.0,97820.92670675044,CLDN7
26468,KEGG_2019_Human,Hepatitis C,1/155,0.0077499127120574,0.0084999078692823,0,0,19845.0,96448.16254952336,CLDN7
26469,KEGG_2019_Human,Tight junction,1/170,0.0084999078692823,0.0084999078692823,0,0,19830.0,94543.49009679438,CLDN7
26470,KEGG_2019_Human,Autophagy,1/128,0.0063999221281459,0.0063999221281459,0,0,19872.0,100382.8010329652,ATG4D
26471,KEGG_2019_Human,B cell receptor signaling pathway,1/71,0.0035499461386618,0.0035499461386618,0,0,19929.0,112415.9585341616,CD72
26472,KEGG_2019_Human,RNA transport,1/165,0.0082499094553477,0.0082499094553477,0,0,19835.0,95159.46482222488,PRMT5
26473,KEGG_2019_Human,Glycerophospholipid metabolism,1/97,0.0048499343304706,0.0048499343304706,0,0,19903.0,106058.9096435903,PEMT
26474,KEGG_2019_Human,Pyruvate metabolism,1/39,0.0019499637955508,0.0019499637955508,0,0,19961.0,124555.53162481484,ACYP1
26475,KEGG_2019_Human,PPAR signaling pathway,1/74,0.0036999446830449,0.0036999446830449,0,0,19926.0,111574.38983110404,PLIN2
26476,KEGG_2019_Human,Arrhythmogenic right ventricular cardiomyopathy (ARVC),1/72,0.0035999456502131,0.0079623895876056,0,0,19928.0,112131.59838572376,CACNG6
26477,KEGG_2019_Human,Cardiac muscle contraction,1/78,0.0038999427840466,0.0079623895876056,0,0,19922.0,110503.2180492851,CACNG6
26478,KEGG_2019_Human,Hypertrophic cardiomyopathy (HCM),1/85,0.004249939567045,0.0079623895876056,0,0,19915.0,108752.83801948265,CACNG6
26479,KEGG_2019_Human,Dilated cardiomyopathy (DCM),1/91,0.0045499369072032,0.0079623895876056,0,0,19909.0,107362.10783923086,CACNG6
26480,KEGG_2019_Human,Adrenergic signaling in cardiomyocytes,1/145,0.0072499160871101,0.0089248989400127,0,0,19855.0,97820.92670675044,CACNG6
26481,KEGG_2019_Human,Oxytocin signaling pathway,1/153,0.0076499133771537,0.0089248989400127,0,0,19847.0,96715.6407630817,CACNG6
26482,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0147498749536506,0,0,19705.0,83086.53988020132,CACNG6
26483,KEGG_2019_Human,Fat digestion and absorption,1/41,0.0020499625466866,0.0056570668438935,0,0,19959.0,123544.88783416104,PLPP1
26484,KEGG_2019_Human,Sphingolipid metabolism,1/47,0.0023499589392381,0.0056570668438935,0,0,19953.0,120782.64067395544,PLPP1
26485,KEGG_2019_Human,Ether lipid metabolism,1/47,0.0023499589392381,0.0056570668438935,0,0,19953.0,120782.64067395544,PLPP1
26486,KEGG_2019_Human,Glycerolipid metabolism,1/61,0.0030499512001654,0.0056570668438935,0,0,19939.0,115499.24335773686,PLPP1
26487,KEGG_2019_Human,Fc gamma R-mediated phagocytosis,1/91,0.0045499369072032,0.0056570668438935,0,0,19909.0,107362.10783923086,PLPP1
26488,KEGG_2019_Human,Glycerophospholipid metabolism,1/97,0.0048499343304706,0.0056570668438935,0,0,19903.0,106058.9096435903,PLPP1
26489,KEGG_2019_Human,Choline metabolism in cancer,1/99,0.0049499334884068,0.0056570668438935,0,0,19901.0,105642.09305076736,PLPP1
26490,KEGG_2019_Human,Phospholipase D signaling pathway,1/148,0.007399915061391,0.007399915061391,0,0,19852.0,97399.60470052566,PLPP1
26491,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0164998674589645,0,0,19670.0,80733.60565076157,HES2
26492,KEGG_2019_Human,Intestinal immune network for IgA production,1/48,0.0023999583567988,0.0071998750703964,0,0,19952.0,120356.5272753826,CCL25
26493,KEGG_2019_Human,Chemokine signaling pathway,1/190,0.0094999017791995,0.0142498526687993,0,0,19810.0,92244.74636351672,CCL25
26494,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0146998751759735,0,0,19706.0,83157.67014793828,CCL25
26495,KEGG_2019_Human,TGF-beta signaling pathway,1/90,0.0044999373439762,0.0044999373439762,0,0,19910.0,107587.50385474482,NOG
26496,KEGG_2019_Human,mTOR signaling pathway,1/152,0.0075999137114971,0.0075999137114971,0,0,19848.0,96850.665715497,CASTOR2
26497,KEGG_2019_Human,Oxidative phosphorylation,1/133,0.0066499203093911,0.0115498903940656,0,0,19867.0,99596.2591544721,ATP5PF
26498,KEGG_2019_Human,Parkinson disease,1/142,0.0070999171242726,0.0115498903940656,0,0,19858.0,98250.87390500787,ATP5PF
26499,KEGG_2019_Human,Alzheimer disease,1/171,0.0085499075557634,0.0115498903940656,0,0,19829.0,94422.42241345016,ATP5PF
26500,KEGG_2019_Human,Huntington disease,1/193,0.0096499008972596,0.0115498903940656,0,0,19807.0,91920.47679471428,ATP5PF
26501,KEGG_2019_Human,Thermogenesis,1/231,0.0115498903940656,0.0115498903940656,0,0,19769.0,88191.07730937863,ATP5PF
26502,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0146998751759735,0,0,19706.0,83157.67014793828,TNFSF15
26503,KEGG_2019_Human,MicroRNAs in cancer,1/299,0.0149498740670514,0.0149498740670514,0,0,19701.0,82804.33538735632,MIR145
26504,KEGG_2019_Human,Phagosome,1/152,0.0075999137114971,0.0075999137114971,0,0,19848.0,96850.665715497,SFTPD
26505,KEGG_2019_Human,cGMP-PKG signaling pathway,1/166,0.0082999091363732,0.0082999091363732,0,0,19834.0,95034.82345515196,KCNJ8
26506,KEGG_2019_Human,Oxidative phosphorylation,1/133,0.0066499203093911,0.0112582177134695,0,0,19867.0,99596.2591544721,NDUFS6
26507,KEGG_2019_Human,Parkinson disease,1/142,0.0070999171242726,0.0112582177134695,0,0,19858.0,98250.87390500787,NDUFS6
26508,KEGG_2019_Human,Retrograde endocannabinoid signaling,1/148,0.007399915061391,0.0112582177134695,0,0,19852.0,97399.60470052566,NDUFS6
26509,KEGG_2019_Human,Non-alcoholic fatty liver disease (NAFLD),1/149,0.0074499147221605,0.0112582177134695,0,0,19851.0,97261.02051561224,NDUFS6
26510,KEGG_2019_Human,Alzheimer disease,1/171,0.0085499075557634,0.0112582177134695,0,0,19829.0,94422.42241345016,NDUFS6
26511,KEGG_2019_Human,Huntington disease,1/193,0.0096499008972596,0.0112582177134695,0,0,19807.0,91920.47679471428,NDUFS6
26512,KEGG_2019_Human,Thermogenesis,1/231,0.0115498903940656,0.0115498903940656,0,0,19769.0,88191.07730937863,NDUFS6
26513,KEGG_2019_Human,Ribosome,1/153,0.0076499133771537,0.0076499133771537,0,0,19847.0,96715.6407630817,MRPL36
26514,KEGG_2019_Human,Cardiac muscle contraction,1/78,0.0038999427840466,0.0112582177134695,0,0,19922.0,110503.2180492851,COX7A1
26515,KEGG_2019_Human,Oxidative phosphorylation,1/133,0.0066499203093911,0.0112582177134695,0,0,19867.0,99596.2591544721,COX7A1
26516,KEGG_2019_Human,Parkinson disease,1/142,0.0070999171242726,0.0112582177134695,0,0,19858.0,98250.87390500787,COX7A1
26517,KEGG_2019_Human,Non-alcoholic fatty liver disease (NAFLD),1/149,0.0074499147221605,0.0112582177134695,0,0,19851.0,97261.02051561224,COX7A1
26518,KEGG_2019_Human,Alzheimer disease,1/171,0.0085499075557634,0.0112582177134695,0,0,19829.0,94422.42241345016,COX7A1
26519,KEGG_2019_Human,Huntington disease,1/193,0.0096499008972596,0.0112582177134695,0,0,19807.0,91920.47679471428,COX7A1
26520,KEGG_2019_Human,Thermogenesis,1/231,0.0115498903940656,0.0115498903940656,0,0,19769.0,88191.07730937863,COX7A1
26521,KEGG_2019_Human,Ribosome,1/153,0.0076499133771537,0.0076499133771537,0,0,19847.0,96715.6407630817,RPS28
26522,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,GAL
26523,KEGG_2019_Human,TGF-beta signaling pathway,1/90,0.0044999373439762,0.0044999373439762,0,0,19910.0,107587.50385474482,HAMP
26524,KEGG_2019_Human,Cardiac muscle contraction,1/78,0.0038999427840466,0.0072499160871101,0,0,19922.0,110503.2180492851,MYL4
26525,KEGG_2019_Human,Apelin signaling pathway,1/137,0.0068499188797651,0.0072499160871101,0,0,19863.0,98987.62735269018,MYL4
26526,KEGG_2019_Human,Adrenergic signaling in cardiomyocytes,1/145,0.0072499160871101,0.0072499160871101,0,0,19855.0,97820.92670675044,MYL4
26527,KEGG_2019_Human,Tight junction,1/170,0.0084999078692823,0.0084999078692823,0,0,19830.0,94543.49009679438,ACTR3C
26528,KEGG_2019_Human,Prion diseases,1/35,0.0017499663721595,0.0063748915975449,0,0,19965.0,126740.98858805298,SOD1
26529,KEGG_2019_Human,Amyotrophic lateral sclerosis (ALS),1/51,0.0025499566390179,0.0063748915975449,0,0,19949.0,119129.0228601236,SOD1
26530,KEGG_2019_Human,Peroxisome,1/83,0.0041499404726918,0.0063749153020852,0,0,19917.0,109237.99888847338,SOD1
26531,KEGG_2019_Human,Longevity regulating pathway,1/102,0.0050999322416682,0.0063749153020852,0,0,19898.0,105032.15064717118,SOD1
26532,KEGG_2019_Human,Huntington disease,1/193,0.0096499008972596,0.0096499008972596,0,0,19807.0,91920.47679471428,SOD1
26533,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0164998674589645,0,0,19670.0,80733.60565076157,HES3
26534,KEGG_2019_Human,Retinol metabolism,1/67,0.0033499481224912,0.0033499481224912,0,0,19933.0,113594.38808369274,RDH11
26535,KEGG_2019_Human,MicroRNAs in cancer,1/299,0.0149498740670514,0.0149498740670514,0,0,19701.0,82804.33538735632,MIR143
26536,KEGG_2019_Human,Ribosome,1/153,0.0076499133771537,0.0076499133771537,0,0,19847.0,96715.6407630817,RPL19
26537,KEGG_2019_Human,Axon guidance,1/181,0.0090499044707863,0.0176998626413668,0,0,19819.0,93248.41634586031,EFNA2
26538,KEGG_2019_Human,Rap1 signaling pathway,1/206,0.010299897173561,0.0176998626413668,0,0,19794.0,90569.849337325,EFNA2
26539,KEGG_2019_Human,Ras signaling pathway,1/232,0.0115998901349604,0.0176998626413668,0,0,19768.0,88101.22480150245,EFNA2
26540,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0176998626413668,0,0,19705.0,83086.53988020132,EFNA2
26541,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0176998626413668,0,0,19646.0,79255.8617626126,EFNA2
26542,KEGG_2019_Human,mRNA surveillance pathway,1/91,0.0045499369072032,0.0082499094553477,0,0,19909.0,107362.10783923086,NCBP2
26543,KEGG_2019_Human,Spliceosome,1/134,0.0066999199497742,0.0082499094553477,0,0,19866.0,99442.43560916925,NCBP2
26544,KEGG_2019_Human,RNA transport,1/165,0.0082499094553477,0.0082499094553477,0,0,19835.0,95159.46482222488,NCBP2
26545,KEGG_2019_Human,Nicotinate and nicotinamide metabolism,1/30,0.0014999697593334,0.0014999697593334,0,0,19970.0,129851.13732048514,ASPDH
26546,KEGG_2019_Human,Ribosome biogenesis in eukaryotes,1/101,0.0050499326546803,0.0082499094553477,0,0,19899.0,105233.48101229242,RPP25
26547,KEGG_2019_Human,RNA transport,1/165,0.0082499094553477,0.0082499094553477,0,0,19835.0,95159.46482222488,RPP25
26548,KEGG_2019_Human,Ribosome biogenesis in eukaryotes,1/101,0.0050499326546803,0.006449921761047,0,0,19899.0,105233.48101229242,AK6
26549,KEGG_2019_Human,Purine metabolism,1/129,0.006449921761047,0.006449921761047,0,0,19871.0,100223.109907462,AK6
26550,KEGG_2019_Human,Legionellosis,1/55,0.0027499544131125,0.0054999088262251,0,0,19945.0,117599.1294878737,SAR1B
26551,KEGG_2019_Human,Protein processing in endoplasmic reticulum,1/165,0.0082499094553477,0.0082499094553477,0,0,19835.0,95159.46482222488,SAR1B
26552,KEGG_2019_Human,Melanoma,1/72,0.0035999456502131,0.016571271621372,0,0,19928.0,112131.59838572376,FGF1
26553,KEGG_2019_Human,Breast cancer,1/147,0.0073499154017982,0.016571271621372,0,0,19853.0,97539.10874372096,FGF1
26554,KEGG_2019_Human,Gastric cancer,1/149,0.0074499147221605,0.016571271621372,0,0,19851.0,97261.02051561224,FGF1
26555,KEGG_2019_Human,Hippo signaling pathway,1/160,0.0079999110688441,0.016571271621372,0,0,19840.0,95793.96509856998,FGF1
26556,KEGG_2019_Human,Rap1 signaling pathway,1/206,0.010299897173561,0.016571271621372,0,0,19794.0,90569.849337325,FGF1
26557,KEGG_2019_Human,Regulation of actin cytoskeleton,1/214,0.0106998949514067,0.016571271621372,0,0,19786.0,89779.39753374986,FGF1
26558,KEGG_2019_Human,Ras signaling pathway,1/232,0.0115998901349604,0.016571271621372,0,0,19768.0,88101.22480150245,FGF1
26559,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0184373436920633,0,0,19705.0,83086.53988020132,FGF1
26560,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0196665140459632,0,0,19646.0,79255.8617626126,FGF1
26561,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,FGF1
26562,KEGG_2019_Human,Bladder cancer,1/41,0.0020499625466866,0.0115498741890255,0,0,19959.0,123544.88783416104,E2F2
26563,KEGG_2019_Human,Non-small cell lung cancer,1/66,0.003299948626608,0.0115498741890255,0,0,19934.0,113899.85357353876,E2F2
26564,KEGG_2019_Human,Melanoma,1/72,0.0035999456502131,0.0115498741890255,0,0,19928.0,112131.59838572376,E2F2
26565,KEGG_2019_Human,Pancreatic cancer,1/75,0.0037499442041125,0.0115498741890255,0,0,19925.0,111301.33528642564,E2F2
26566,KEGG_2019_Human,Glioma,1/75,0.0037499442041125,0.0115498741890255,0,0,19925.0,111301.33528642564,E2F2
26567,KEGG_2019_Human,Chronic myeloid leukemia,1/76,0.0037999437281752,0.0115498741890255,0,0,19924.0,111031.8499691117,E2F2
26568,KEGG_2019_Human,Small cell lung cancer,1/93,0.0046499360391879,0.0115498741890255,0,0,19907.0,106918.54242106884,E2F2
26569,KEGG_2019_Human,Prostate cancer,1/97,0.0048499343304706,0.0115498741890255,0,0,19903.0,106058.9096435903,E2F2
26570,KEGG_2019_Human,Cell cycle,1/124,0.0061999236097501,0.0115498741890255,0,0,19876.0,101034.04709010696,E2F2
26571,KEGG_2019_Human,Breast cancer,1/147,0.0073499154017982,0.0115498741890255,0,0,19853.0,97539.10874372096,E2F2
26572,KEGG_2019_Human,Gastric cancer,1/149,0.0074499147221605,0.0115498741890255,0,0,19851.0,97261.02051561224,E2F2
26573,KEGG_2019_Human,Cushing syndrome,1/155,0.0077499127120574,0.0115498741890255,0,0,19845.0,96448.16254952336,E2F2
26574,KEGG_2019_Human,Hepatitis C,1/155,0.0077499127120574,0.0115498741890255,0,0,19845.0,96448.16254952336,E2F2
26575,KEGG_2019_Human,Cellular senescence,1/160,0.0079999110688441,0.0115498741890255,0,0,19840.0,95793.96509856998,E2F2
26576,KEGG_2019_Human,Hepatitis B,1/163,0.0081499100978668,0.0115498741890255,0,0,19837.0,95410.9786681514,E2F2
26577,KEGG_2019_Human,Hepatocellular carcinoma,1/168,0.0083999085011095,0.0115498741890255,0,0,19832.0,94787.72752807094,E2F2
26578,KEGG_2019_Human,Kaposi sarcoma-associated herpesvirus infection,1/186,0.0092999029651357,0.0120351685431168,0,0,19814.0,92684.96451050608,E2F2
26579,KEGG_2019_Human,Epstein-Barr virus infection,1/201,0.0100498985877989,0.0122832093850876,0,0,19799.0,91079.21596609056,E2F2
26580,KEGG_2019_Human,Human T-cell leukemia virus 1 infection,1/219,0.0109498935894162,0.0123748811769373,0,0,19781.0,89299.85161916987,E2F2
26581,KEGG_2019_Human,Human cytomegalovirus infection,1/225,0.0112498919790339,0.0123748811769373,0,0,19775.0,88738.27077557483,E2F2
26582,KEGG_2019_Human,MicroRNAs in cancer,1/299,0.0149498740670514,0.0156617728321491,0,0,19701.0,82804.33538735632,E2F2
26583,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,E2F2
26584,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR8S1
26585,KEGG_2019_Human,Antigen processing and presentation,1/77,0.0038499432547502,0.0109498935894162,0,0,19923.0,110765.8407373636,NFYB
26586,KEGG_2019_Human,Tuberculosis,1/179,0.0089499050800561,0.0109498935894162,0,0,19821.0,93478.0629355712,NFYB
26587,KEGG_2019_Human,Human T-cell leukemia virus 1 infection,1/219,0.0109498935894162,0.0109498935894162,0,0,19781.0,89299.85161916987,NFYB
26588,KEGG_2019_Human,ECM-receptor interaction,1/82,0.004099940929819,0.0061999236097501,0,0,19918.0,109484.9180722932,GP1BB
26589,KEGG_2019_Human,Hematopoietic cell lineage,1/97,0.0048499343304706,0.0061999236097501,0,0,19903.0,106058.9096435903,GP1BB
26590,KEGG_2019_Human,Platelet activation,1/124,0.0061999236097501,0.0061999236097501,0,0,19876.0,101034.04709010696,GP1BB
26591,KEGG_2019_Human,Vascular smooth muscle contraction,1/132,0.0065999206698993,0.0131998413397987,0,0,19868.0,99751.22090491928,ADM
26592,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,ADM
26593,KEGG_2019_Human,Other types of O-glycan biosynthesis,1/22,0.0010999756574123,0.003299926972237,0,0,19978.0,136099.47030191717,MFNG
26594,KEGG_2019_Human,Notch signaling pathway,1/48,0.0023999583567988,0.0035999375351982,0,0,19952.0,120356.5272753826,MFNG
26595,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0164998674589645,0,0,19670.0,80733.60565076157,MFNG
26596,KEGG_2019_Human,Dilated cardiomyopathy (DCM),1/91,0.0045499369072032,0.0105998955026255,0,0,19909.0,107362.10783923086,PLN
26597,KEGG_2019_Human,Thyroid hormone signaling pathway,1/116,0.0057999266512085,0.0105998955026255,0,0,19884.0,102400.8105961506,PLN
26598,KEGG_2019_Human,Adrenergic signaling in cardiomyocytes,1/145,0.0072499160871101,0.0105998955026255,0,0,19855.0,97820.92670675044,PLN
26599,KEGG_2019_Human,cGMP-PKG signaling pathway,1/166,0.0082999091363732,0.0105998955026255,0,0,19834.0,95034.82345515196,PLN
26600,KEGG_2019_Human,Calcium signaling pathway,1/188,0.009399902370135,0.0105998955026255,0,0,19812.0,92463.712994847,PLN
26601,KEGG_2019_Human,cAMP signaling pathway,1/212,0.0105998955026255,0.0105998955026255,0,0,19788.0,89974.27756224656,PLN
26602,KEGG_2019_Human,Kaposi sarcoma-associated herpesvirus infection,1/186,0.0092999029651357,0.0092999029651357,0,0,19814.0,92684.96451050608,CLEC2B
26603,KEGG_2019_Human,Glycerophospholipid metabolism,1/97,0.0048499343304706,0.0048499343304706,0,0,19903.0,106058.9096435903,PHOSPHO1
26604,KEGG_2019_Human,Adipocytokine signaling pathway,1/69,0.003449947123837,0.0121498656303927,0,0,19931.0,112996.7391397682,LEP
26605,KEGG_2019_Human,AMPK signaling pathway,1/120,0.0059999251180858,0.0121498656303927,0,0,19880.0,101706.2448082016,LEP
26606,KEGG_2019_Human,Non-alcoholic fatty liver disease (NAFLD),1/149,0.0074499147221605,0.0121498656303927,0,0,19851.0,97261.02051561224,LEP
26607,KEGG_2019_Human,JAK-STAT signaling pathway,1/162,0.0080999104202618,0.0121498656303927,0,0,19838.0,95537.86936302872,LEP
26608,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0168998658265596,0,0,19706.0,83157.67014793828,LEP
26609,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,LEP
26610,KEGG_2019_Human,Steroid hormone biosynthesis,1/60,0.002999951725986,0.002999951725986,0,0,19940.0,115834.63209072244,DHRS11
26611,KEGG_2019_Human,MicroRNAs in cancer,1/299,0.0149498740670514,0.0149498740670514,0,0,19701.0,82804.33538735632,MIR29C
26612,KEGG_2019_Human,Glutathione metabolism,1/56,0.0027999538675741,0.0094498771520562,0,0,19944.0,117233.87022514464,GSTT2
26613,KEGG_2019_Human,Metabolism of xenobiotics by cytochrome P450,1/74,0.0036999446830449,0.0094498771520562,0,0,19926.0,111574.38983110404,GSTT2
26614,KEGG_2019_Human,Chemical carcinogenesis,1/82,0.004099940929819,0.0094498771520562,0,0,19918.0,109484.9180722932,GSTT2
26615,KEGG_2019_Human,Drug metabolism,1/108,0.0053999298011749,0.0094498771520562,0,0,19892.0,103863.47861844616,GSTT2
26616,KEGG_2019_Human,Fluid shear stress and atherosclerosis,1/139,0.006949918172816,0.0097298854419424,0,0,19861.0,98689.81333375497,GSTT2
26617,KEGG_2019_Human,Hepatocellular carcinoma,1/168,0.0083999085011095,0.0097998932512944,0,0,19832.0,94787.72752807094,GSTT2
26618,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,GSTT2
26619,KEGG_2019_Human,GnRH signaling pathway,1/93,0.0046499360391879,0.0092998720783758,0,0,19907.0,106918.54242106884,GNRH2
26620,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,GNRH2
26621,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR6C6
26622,KEGG_2019_Human,Pyrimidine metabolism,1/57,0.002849953326298,0.0053999298011749,0,0,19943.0,116875.00742975442,CDA
26623,KEGG_2019_Human,Drug metabolism,1/108,0.0053999298011749,0.0053999298011749,0,0,19892.0,103863.47861844616,CDA
26624,KEGG_2019_Human,Taurine and hypotaurine metabolism,1/11,0.0005499852259717758,0.0010999704519435,0,0,19989.0,150029.8210287992,GGT6
26625,KEGG_2019_Human,Glutathione metabolism,1/56,0.0027999538675741,0.0027999538675741,0,0,19944.0,117233.87022514464,GGT6
26626,KEGG_2019_Human,Homologous recombination,1/41,0.0020499625466866,0.0020499625466866,0,0,19959.0,123544.88783416104,RAD52
26627,KEGG_2019_Human,Intestinal immune network for IgA production,1/48,0.0023999583567988,0.0071998750703964,0,0,19952.0,120356.5272753826,CCL28
26628,KEGG_2019_Human,Chemokine signaling pathway,1/190,0.0094999017791995,0.0142498526687993,0,0,19810.0,92244.74636351672,CCL28
26629,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0146998751759735,0,0,19706.0,83157.67014793828,CCL28
26630,KEGG_2019_Human,Protein export,1/23,0.0011499748819949,0.0011499748819949,0,0,19977.0,135204.63922267244,SRPRB
26631,KEGG_2019_Human,Ribosome,1/153,0.0076499133771537,0.0076499133771537,0,0,19847.0,96715.6407630817,RPLP1
26632,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,NMB
26633,KEGG_2019_Human,Vascular smooth muscle contraction,1/132,0.0065999206698993,0.0065999206698993,0,0,19868.0,99751.22090491928,RAMP1
26634,KEGG_2019_Human,Parkinson disease,1/142,0.0070999171242726,0.0085499075557634,0,0,19858.0,98250.87390500787,SNCA
26635,KEGG_2019_Human,Alzheimer disease,1/171,0.0085499075557634,0.0085499075557634,0,0,19829.0,94422.42241345016,SNCA
26636,KEGG_2019_Human,Arachidonic acid metabolism,1/63,0.0031499501598827,0.0031499501598827,0,0,19937.0,114844.46974572667,PTGES
26637,KEGG_2019_Human,Shigellosis,1/65,0.003249949134407,0.0085998782347732,0,0,19935.0,114209.92613860144,PFN4
26638,KEGG_2019_Human,Salmonella infection,1/86,0.0042999391173866,0.0085998782347732,0,0,19914.0,108514.46102290176,PFN4
26639,KEGG_2019_Human,Rap1 signaling pathway,1/206,0.010299897173561,0.0106998949514067,0,0,19794.0,90569.849337325,PFN4
26640,KEGG_2019_Human,Regulation of actin cytoskeleton,1/214,0.0106998949514067,0.0106998949514067,0,0,19786.0,89779.39753374986,PFN4
26641,KEGG_2019_Human,Lysosome,1/123,0.0061499239842961,0.0061499239842961,0,0,19877.0,101200.07933676826,CTSE
26642,KEGG_2019_Human,Phototransduction,1/28,0.0013999711732997,0.0013999711732997,0,0,19972.0,131242.0761597353,GUCA1B
26643,KEGG_2019_Human,Glycosaminoglycan degradation,1/19,0.00094997806231055,0.00094997806231055,0,0,19981.0,139049.2109571672,HYAL2
26644,KEGG_2019_Human,Insulin secretion,1/86,0.0042999391173866,0.0073499008621619,0,0,19914.0,108514.46102290176,CCK
26645,KEGG_2019_Human,Pancreatic secretion,1/98,0.0048999339081079,0.0073499008621619,0,0,19902.0,105849.45495286948,CCK
26646,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,CCK
26647,KEGG_2019_Human,Oxidative phosphorylation,1/133,0.0066499203093911,0.0115498903940656,0,0,19867.0,99596.2591544721,ATP5ME
26648,KEGG_2019_Human,Thermogenesis,1/231,0.0115498903940656,0.0115498903940656,0,0,19769.0,88191.07730937863,ATP5ME
26649,KEGG_2019_Human,Insulin resistance,1/108,0.0053999298011749,0.0068499188797651,0,0,19892.0,103863.47861844616,PPP1R3D
26650,KEGG_2019_Human,Insulin signaling pathway,1/137,0.0068499188797651,0.0068499188797651,0,0,19863.0,98987.62735269018,PPP1R3D
26651,KEGG_2019_Human,Inositol phosphate metabolism,1/74,0.0036999446830449,0.0049499334884068,0,0,19926.0,111574.38983110404,IPMK
26652,KEGG_2019_Human,Phosphatidylinositol signaling system,1/99,0.0049499334884068,0.0049499334884068,0,0,19901.0,105642.09305076736,IPMK
26653,KEGG_2019_Human,p53 signaling pathway,1/72,0.0035999456502131,0.0035999456502131,0,0,19928.0,112131.59838572376,PERP
26654,KEGG_2019_Human,Acute myeloid leukemia,1/66,0.003299948626608,0.0073998893660899,0,0,19934.0,113899.85357353876,PPARD
26655,KEGG_2019_Human,PPAR signaling pathway,1/74,0.0036999446830449,0.0073998893660899,0,0,19926.0,111574.38983110404,PPARD
26656,KEGG_2019_Human,Wnt signaling pathway,1/158,0.0078999117225733,0.0105332156300977,0,0,19842.0,96053.2110949472,PPARD
26657,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,PPARD
26658,KEGG_2019_Human,Serotonergic synapse,1/113,0.0056499278191151,0.010424877259224,0,0,19887.0,102937.34947211576,DUSP1
26659,KEGG_2019_Human,Fluid shear stress and atherosclerosis,1/139,0.006949918172816,0.010424877259224,0,0,19861.0,98689.81333375497,DUSP1
26660,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0147498749536506,0,0,19705.0,83086.53988020132,DUSP1
26661,KEGG_2019_Human,Non-small cell lung cancer,1/66,0.003299948626608,0.006449921761047,0,0,19934.0,113899.85357353876,FHIT
26662,KEGG_2019_Human,Small cell lung cancer,1/93,0.0046499360391879,0.006449921761047,0,0,19907.0,106918.54242106884,FHIT
26663,KEGG_2019_Human,Purine metabolism,1/129,0.006449921761047,0.006449921761047,0,0,19871.0,100223.109907462,FHIT
26664,KEGG_2019_Human,Oxidative phosphorylation,1/133,0.0066499203093911,0.0115498903940656,0,0,19867.0,99596.2591544721,ATP5F1E
26665,KEGG_2019_Human,Parkinson disease,1/142,0.0070999171242726,0.0115498903940656,0,0,19858.0,98250.87390500787,ATP5F1E
26666,KEGG_2019_Human,Alzheimer disease,1/171,0.0085499075557634,0.0115498903940656,0,0,19829.0,94422.42241345016,ATP5F1E
26667,KEGG_2019_Human,Huntington disease,1/193,0.0096499008972596,0.0115498903940656,0,0,19807.0,91920.47679471428,ATP5F1E
26668,KEGG_2019_Human,Thermogenesis,1/231,0.0115498903940656,0.0115498903940656,0,0,19769.0,88191.07730937863,ATP5F1E
26669,KEGG_2019_Human,Steroid hormone biosynthesis,1/60,0.002999951725986,0.002999951725986,0,0,19940.0,115834.63209072244,HSD17B8
26670,KEGG_2019_Human,Cardiac muscle contraction,1/78,0.0038999427840466,0.0106998949514067,0,0,19922.0,110503.2180492851,MYL2
26671,KEGG_2019_Human,Hypertrophic cardiomyopathy (HCM),1/85,0.004249939567045,0.0106998949514067,0,0,19915.0,108752.83801948265,MYL2
26672,KEGG_2019_Human,Dilated cardiomyopathy (DCM),1/91,0.0045499369072032,0.0106998949514067,0,0,19909.0,107362.10783923086,MYL2
26673,KEGG_2019_Human,Leukocyte transendothelial migration,1/112,0.0055999282120529,0.0106998949514067,0,0,19888.0,103119.30984392198,MYL2
26674,KEGG_2019_Human,Apelin signaling pathway,1/137,0.0068499188797651,0.0106998949514067,0,0,19863.0,98987.62735269018,MYL2
26675,KEGG_2019_Human,Adrenergic signaling in cardiomyocytes,1/145,0.0072499160871101,0.0106998949514067,0,0,19855.0,97820.92670675044,MYL2
26676,KEGG_2019_Human,Tight junction,1/170,0.0084999078692823,0.0106998949514067,0,0,19830.0,94543.49009679438,MYL2
26677,KEGG_2019_Human,Focal adhesion,1/199,0.0099498991610159,0.0106998949514067,0,0,19801.0,91286.4288690606,MYL2
26678,KEGG_2019_Human,Regulation of actin cytoskeleton,1/214,0.0106998949514067,0.0106998949514067,0,0,19786.0,89779.39753374986,MYL2
26679,KEGG_2019_Human,Ribosome biogenesis in eukaryotes,1/101,0.0050499326546803,0.0082499094553477,0,0,19899.0,105233.48101229242,POP5
26680,KEGG_2019_Human,RNA transport,1/165,0.0082499094553477,0.0082499094553477,0,0,19835.0,95159.46482222488,POP5
26681,KEGG_2019_Human,TGF-beta signaling pathway,1/90,0.0044999373439762,0.0078999117225733,0,0,19910.0,107587.50385474482,BAMBI
26682,KEGG_2019_Human,Wnt signaling pathway,1/158,0.0078999117225733,0.0078999117225733,0,0,19842.0,96053.2110949472,BAMBI
26683,KEGG_2019_Human,Pathogenic Escherichia coli infection,1/55,0.0027499544131125,0.0063699116700844,0,0,19945.0,117599.1294878737,ARPC5
26684,KEGG_2019_Human,Shigellosis,1/65,0.003249949134407,0.0063699116700844,0,0,19935.0,114209.92613860144,ARPC5
26685,KEGG_2019_Human,Bacterial invasion of epithelial cells,1/74,0.0036999446830449,0.0063699116700844,0,0,19926.0,111574.38983110404,ARPC5
26686,KEGG_2019_Human,Salmonella infection,1/86,0.0042999391173866,0.0063699116700844,0,0,19914.0,108514.46102290176,ARPC5
26687,KEGG_2019_Human,Fc gamma R-mediated phagocytosis,1/91,0.0045499369072032,0.0063699116700844,0,0,19909.0,107362.10783923086,ARPC5
26688,KEGG_2019_Human,Regulation of actin cytoskeleton,1/214,0.0106998949514067,0.0121998870519305,0,0,19786.0,89779.39753374986,ARPC5
26689,KEGG_2019_Human,Endocytosis,1/244,0.0121998870519305,0.0121998870519305,0,0,19756.0,87051.4275316661,ARPC5
26690,KEGG_2019_Human,Glycerophospholipid metabolism,1/97,0.0048499343304706,0.0048499343304706,0,0,19903.0,106058.9096435903,LPGAT1
26691,KEGG_2019_Human,Arrhythmogenic right ventricular cardiomyopathy (ARVC),1/72,0.0035999456502131,0.0079623895876056,0,0,19928.0,112131.59838572376,CACNG2
26692,KEGG_2019_Human,Cardiac muscle contraction,1/78,0.0038999427840466,0.0079623895876056,0,0,19922.0,110503.2180492851,CACNG2
26693,KEGG_2019_Human,Hypertrophic cardiomyopathy (HCM),1/85,0.004249939567045,0.0079623895876056,0,0,19915.0,108752.83801948265,CACNG2
26694,KEGG_2019_Human,Dilated cardiomyopathy (DCM),1/91,0.0045499369072032,0.0079623895876056,0,0,19909.0,107362.10783923086,CACNG2
26695,KEGG_2019_Human,Adrenergic signaling in cardiomyocytes,1/145,0.0072499160871101,0.0089248989400127,0,0,19855.0,97820.92670675044,CACNG2
26696,KEGG_2019_Human,Oxytocin signaling pathway,1/153,0.0076499133771537,0.0089248989400127,0,0,19847.0,96715.6407630817,CACNG2
26697,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0147498749536506,0,0,19705.0,83086.53988020132,CACNG2
26698,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0176998626413668,0,0,19646.0,79255.8617626126,TCL1B
26699,KEGG_2019_Human,mRNA surveillance pathway,1/91,0.0045499369072032,0.0082499094553477,0,0,19909.0,107362.10783923086,SAP18
26700,KEGG_2019_Human,RNA transport,1/165,0.0082499094553477,0.0082499094553477,0,0,19835.0,95159.46482222488,SAP18
26701,KEGG_2019_Human,Ribosome,1/153,0.0076499133771537,0.0076499133771537,0,0,19847.0,96715.6407630817,RPS18
26702,KEGG_2019_Human,Fanconi anemia pathway,1/54,0.0026999549628563,0.0026999549628563,0,0,19946.0,117971.01964061816,CENPX
26703,KEGG_2019_Human,Salivary secretion,1/90,0.0044999373439762,0.0044999373439762,0,0,19910.0,107587.50385474482,HTN3
26704,KEGG_2019_Human,Ribosome,1/153,0.0076499133771537,0.0076499133771537,0,0,19847.0,96715.6407630817,RPS26
26705,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,GHRH
26706,KEGG_2019_Human,Mitophagy,1/65,0.003249949134407,0.003249949134407,0,0,19935.0,114209.92613860144,CITED2
26707,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR10G3
26708,KEGG_2019_Human,Shigellosis,1/65,0.003249949134407,0.0085998782347732,0,0,19935.0,114209.92613860144,PFN3
26709,KEGG_2019_Human,Salmonella infection,1/86,0.0042999391173866,0.0085998782347732,0,0,19914.0,108514.46102290176,PFN3
26710,KEGG_2019_Human,Rap1 signaling pathway,1/206,0.010299897173561,0.0106998949514067,0,0,19794.0,90569.849337325,PFN3
26711,KEGG_2019_Human,Regulation of actin cytoskeleton,1/214,0.0106998949514067,0.0106998949514067,0,0,19786.0,89779.39753374986,PFN3
26712,KEGG_2019_Human,Cardiac muscle contraction,1/78,0.0038999427840466,0.0112582177134695,0,0,19922.0,110503.2180492851,UQCR11
26713,KEGG_2019_Human,Oxidative phosphorylation,1/133,0.0066499203093911,0.0112582177134695,0,0,19867.0,99596.2591544721,UQCR11
26714,KEGG_2019_Human,Parkinson disease,1/142,0.0070999171242726,0.0112582177134695,0,0,19858.0,98250.87390500787,UQCR11
26715,KEGG_2019_Human,Non-alcoholic fatty liver disease (NAFLD),1/149,0.0074499147221605,0.0112582177134695,0,0,19851.0,97261.02051561224,UQCR11
26716,KEGG_2019_Human,Alzheimer disease,1/171,0.0085499075557634,0.0112582177134695,0,0,19829.0,94422.42241345016,UQCR11
26717,KEGG_2019_Human,Huntington disease,1/193,0.0096499008972596,0.0112582177134695,0,0,19807.0,91920.47679471428,UQCR11
26718,KEGG_2019_Human,Thermogenesis,1/231,0.0115498903940656,0.0115498903940656,0,0,19769.0,88191.07730937863,UQCR11
26719,KEGG_2019_Human,Ubiquinone and other terpenoid-quinone biosynthesis,1/11,0.0005499852259717758,0.0005499852259717758,0,0,19989.0,150029.8210287992,VKORC1L1
26720,KEGG_2019_Human,MicroRNAs in cancer,1/299,0.0149498740670514,0.0149498740670514,0,0,19701.0,82804.33538735632,MIR30A
26721,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0146998751759735,0,0,19706.0,83157.67014793828,TNFSF8
26722,KEGG_2019_Human,RIG-I-like receptor signaling pathway,1/70,0.0034999466296654,0.0104998398889962,0,0,19930.0,112704.30065625212,IFNW1
26723,KEGG_2019_Human,JAK-STAT signaling pathway,1/162,0.0080999104202618,0.0121498656303927,0,0,19838.0,95537.86936302872,IFNW1
26724,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0146998751759735,0,0,19706.0,83157.67014793828,IFNW1
26725,KEGG_2019_Human,RNA degradation,1/79,0.0039499423167337,0.0066999199497742,0,0,19921.0,110243.89578070649,LSM2
26726,KEGG_2019_Human,Spliceosome,1/134,0.0066999199497742,0.0066999199497742,0,0,19866.0,99442.43560916925,LSM2
26727,KEGG_2019_Human,Circadian rhythm,1/31,0.0015499690656704,0.0098998913464173,0,0,19969.0,129189.85098816035,RBX1
26728,KEGG_2019_Human,Nucleotide excision repair,1/47,0.0023499589392381,0.0098998913464173,0,0,19953.0,120782.64067395544,RBX1
26729,KEGG_2019_Human,Renal cell carcinoma,1/69,0.003449947123837,0.0098998913464173,0,0,19931.0,112996.7391397682,RBX1
26730,KEGG_2019_Human,TGF-beta signaling pathway,1/90,0.0044999373439762,0.0098998913464173,0,0,19910.0,107587.50385474482,RBX1
26731,KEGG_2019_Human,HIF-1 signaling pathway,1/100,0.0049999330710556,0.0098998913464173,0,0,19900.0,105436.78197328727,RBX1
26732,KEGG_2019_Human,Cell cycle,1/124,0.0061999236097501,0.0098998913464173,0,0,19876.0,101034.04709010696,RBX1
26733,KEGG_2019_Human,Oocyte meiosis,1/125,0.0062499232373748,0.0098998913464173,0,0,19875.0,100869.32368441945,RBX1
26734,KEGG_2019_Human,Ubiquitin mediated proteolysis,1/137,0.0068499188797651,0.0098998913464173,0,0,19863.0,98987.62735269018,RBX1
26735,KEGG_2019_Human,Wnt signaling pathway,1/158,0.0078999117225733,0.0098998913464173,0,0,19842.0,96053.2110949472,RBX1
26736,KEGG_2019_Human,Protein processing in endoplasmic reticulum,1/165,0.0082499094553477,0.0098998913464173,0,0,19835.0,95159.46482222488,RBX1
26737,KEGG_2019_Human,Human immunodeficiency virus 1 infection,1/212,0.0105998955026255,0.0115635223665006,0,0,19788.0,89974.27756224656,RBX1
26738,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,RBX1
26739,KEGG_2019_Human,Necroptosis,1/162,0.0080999104202618,0.0121998870519305,0,0,19838.0,95537.86936302872,CHMP1B
26740,KEGG_2019_Human,Endocytosis,1/244,0.0121998870519305,0.0121998870519305,0,0,19756.0,87051.4275316661,CHMP1B
26741,KEGG_2019_Human,Oxytocin signaling pathway,1/153,0.0076499133771537,0.0158998432539383,0,0,19847.0,96715.6407630817,OXT
26742,KEGG_2019_Human,cAMP signaling pathway,1/212,0.0105998955026255,0.0158998432539383,0,0,19788.0,89974.27756224656,OXT
26743,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,OXT
26744,KEGG_2019_Human,N-Glycan biosynthesis,1/50,0.0024999572069037,0.0024999572069037,0,0,19950.0,119530.05920663515,ALG5
26745,KEGG_2019_Human,RIG-I-like receptor signaling pathway,1/70,0.0034999466296654,0.0034999466296654,0,0,19930.0,112704.30065625212,AZI2
26746,KEGG_2019_Human,NF-kappa B signaling pathway,1/95,0.0047499351803394,0.0142498055410182,0,0,19905.0,106484.27183626965,CCL21
26747,KEGG_2019_Human,Chemokine signaling pathway,1/190,0.0094999017791995,0.0142498526687993,0,0,19810.0,92244.74636351672,CCL21
26748,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0146998751759735,0,0,19706.0,83157.67014793828,CCL21
26749,KEGG_2019_Human,Transcriptional misregulation in cancer,1/186,0.0092999029651357,0.0092999029651357,0,0,19814.0,92684.96451050608,SSX2
26750,KEGG_2019_Human,Proteasome,1/45,0.0022499601197094,0.0022499601197094,0,0,19955.0,121662.49782449217,POMP
26751,KEGG_2019_Human,Ribosome,1/153,0.0076499133771537,0.0076499133771537,0,0,19847.0,96715.6407630817,RPS25
26752,KEGG_2019_Human,Fc gamma R-mediated phagocytosis,1/91,0.0045499369072032,0.0121998870519305,0,0,19909.0,107362.10783923086,ARF6
26753,KEGG_2019_Human,Phospholipase D signaling pathway,1/148,0.007399915061391,0.0121998870519305,0,0,19852.0,97399.60470052566,ARF6
26754,KEGG_2019_Human,Ras signaling pathway,1/232,0.0115998901349604,0.0121998870519305,0,0,19768.0,88101.22480150245,ARF6
26755,KEGG_2019_Human,Endocytosis,1/244,0.0121998870519305,0.0121998870519305,0,0,19756.0,87051.4275316661,ARF6
26756,KEGG_2019_Human,Hepatitis C,1/155,0.0077499127120574,0.0077499127120574,0,0,19845.0,96448.16254952336,IFIT1
26757,KEGG_2019_Human,African trypanosomiasis,1/37,0.0018499650702878,0.0071498880956955,0,0,19963.0,125618.9446446357,IL18
26758,KEGG_2019_Human,Malaria,1/49,0.0024499577795033,0.0071498880956955,0,0,19951.0,119939.1172087114,IL18
26759,KEGG_2019_Human,Legionellosis,1/55,0.0027499544131125,0.0071498880956955,0,0,19945.0,117599.1294878737,IL18
26760,KEGG_2019_Human,Cytosolic DNA-sensing pathway,1/63,0.0031499501598827,0.0071498880956955,0,0,19937.0,114844.46974572667,IL18
26761,KEGG_2019_Human,Inflammatory bowel disease (IBD),1/65,0.003249949134407,0.0071498880956955,0,0,19935.0,114209.92613860144,IL18
26762,KEGG_2019_Human,Salmonella infection,1/86,0.0042999391173866,0.0071499008541764,0,0,19914.0,108514.46102290176,IL18
26763,KEGG_2019_Human,Rheumatoid arthritis,1/91,0.0045499369072032,0.0071499008541764,0,0,19909.0,107362.10783923086,IL18
26764,KEGG_2019_Human,Influenza A,1/171,0.0085499075557634,0.0098448955880617,0,0,19829.0,94422.42241345016,IL18
26765,KEGG_2019_Human,NOD-like receptor signaling pathway,1/178,0.0088999053857096,0.0098448955880617,0,0,19822.0,93593.82745769851,IL18
26766,KEGG_2019_Human,Tuberculosis,1/179,0.0089499050800561,0.0098448955880617,0,0,19821.0,93478.0629355712,IL18
26767,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0146998751759735,0,0,19706.0,83157.67014793828,IL18
26768,KEGG_2019_Human,JAK-STAT signaling pathway,1/162,0.0080999104202618,0.0176998626413668,0,0,19838.0,95537.86936302872,OSM
26769,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0176998626413668,0,0,19706.0,83157.67014793828,OSM
26770,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0176998626413668,0,0,19646.0,79255.8617626126,OSM
26771,KEGG_2019_Human,Purine metabolism,1/129,0.006449921761047,0.006449921761047,0,0,19871.0,100223.109907462,NUDT5
26772,KEGG_2019_Human,Mineral absorption,1/51,0.0025499566390179,0.0025499566390179,0,0,19949.0,119129.0228601236,MT1HL1
26773,KEGG_2019_Human,ErbB signaling pathway,1/85,0.004249939567045,0.004249939567045,0,0,19915.0,108752.83801948265,BTC
26774,KEGG_2019_Human,Bladder cancer,1/41,0.0020499625466866,0.0098998458798241,0,0,19959.0,123544.88783416104,RASSF1
26775,KEGG_2019_Human,Non-small cell lung cancer,1/66,0.003299948626608,0.0098998458798241,0,0,19934.0,113899.85357353876,RASSF1
26776,KEGG_2019_Human,Hippo signaling pathway,1/160,0.0079999110688441,0.0159998221376883,0,0,19840.0,95793.96509856998,RASSF1
26777,KEGG_2019_Human,Ras signaling pathway,1/232,0.0115998901349604,0.0173998352024406,0,0,19768.0,88101.22480150245,RASSF1
26778,KEGG_2019_Human,MicroRNAs in cancer,1/299,0.0149498740670514,0.0179398488804617,0,0,19701.0,82804.33538735632,RASSF1
26779,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,RASSF1
26780,KEGG_2019_Human,RNA polymerase,1/31,0.0015499690656704,0.0046499071970112,0,0,19969.0,129189.85098816035,POLR2L
26781,KEGG_2019_Human,Cytosolic DNA-sensing pathway,1/63,0.0031499501598827,0.0047249252398241,0,0,19937.0,114844.46974572667,POLR2L
26782,KEGG_2019_Human,Huntington disease,1/193,0.0096499008972596,0.0096499008972596,0,0,19807.0,91920.47679471428,POLR2L
26783,KEGG_2019_Human,Ribosome biogenesis in eukaryotes,1/101,0.0050499326546803,0.0082499094553477,0,0,19899.0,105233.48101229242,RPP25L
26784,KEGG_2019_Human,RNA transport,1/165,0.0082499094553477,0.0082499094553477,0,0,19835.0,95159.46482222488,RPP25L
26785,KEGG_2019_Human,Longevity regulating pathway,1/102,0.0050999322416682,0.0082499094553477,0,0,19898.0,105032.15064717118,EIF4EBP2
26786,KEGG_2019_Human,RNA transport,1/165,0.0082499094553477,0.0082499094553477,0,0,19835.0,95159.46482222488,EIF4EBP2
26787,KEGG_2019_Human,Mitophagy,1/65,0.003249949134407,0.0075748989820205,0,0,19935.0,114209.92613860144,CSNK2B
26788,KEGG_2019_Human,Adherens junction,1/72,0.0035999456502131,0.0075748989820205,0,0,19928.0,112131.59838572376,CSNK2B
26789,KEGG_2019_Human,NF-kappa B signaling pathway,1/95,0.0047499351803394,0.0075748989820205,0,0,19905.0,106484.27183626965,CSNK2B
26790,KEGG_2019_Human,Ribosome biogenesis in eukaryotes,1/101,0.0050499326546803,0.0075748989820205,0,0,19899.0,105233.48101229242,CSNK2B
26791,KEGG_2019_Human,Measles,1/138,0.0068999185254481,0.0078999117225733,0,0,19862.0,98838.19160389496,CSNK2B
26792,KEGG_2019_Human,Wnt signaling pathway,1/158,0.0078999117225733,0.0078999117225733,0,0,19842.0,96053.2110949472,CSNK2B
26793,KEGG_2019_Human,NOD-like receptor signaling pathway,1/178,0.0088999053857096,0.0088999053857096,0,0,19822.0,93593.82745769851,PYDC2
26794,KEGG_2019_Human,Endocytosis,1/244,0.0121998870519305,0.0121998870519305,0,0,19756.0,87051.4275316661,MVB12A
26795,KEGG_2019_Human,Cholesterol metabolism,1/50,0.0024999572069037,0.0024999572069037,0,0,19950.0,119530.05920663515,APOC2
26796,KEGG_2019_Human,Staphylococcus aureus infection,1/68,0.0033999476216189,0.0039499423167337,0,0,19932.0,113293.39338050144,CFI
26797,KEGG_2019_Human,Complement and coagulation cascades,1/79,0.0039499423167337,0.0039499423167337,0,0,19921.0,110243.89578070649,CFI
26798,KEGG_2019_Human,IL-17 signaling pathway,1/93,0.0046499360391879,0.0092998720783758,0,0,19907.0,106918.54242106884,IL17RB
26799,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0146998751759735,0,0,19706.0,83157.67014793828,IL17RB
26800,KEGG_2019_Human,Focal adhesion,1/199,0.0099498991610159,0.0212398351696402,0,0,19801.0,91286.4288690606,PGF
26801,KEGG_2019_Human,Rap1 signaling pathway,1/206,0.010299897173561,0.0212398351696402,0,0,19794.0,90569.849337325,PGF
26802,KEGG_2019_Human,Ras signaling pathway,1/232,0.0115998901349604,0.0212398351696402,0,0,19768.0,88101.22480150245,PGF
26803,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0212398351696402,0,0,19705.0,83086.53988020132,PGF
26804,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0212398351696402,0,0,19646.0,79255.8617626126,PGF
26805,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,PGF
26806,KEGG_2019_Human,"Glycine, serine and threonine metabolism",1/40,0.0019999631680592,0.0041499404726918,0,0,19960.0,124043.94523066044,PIPOX
26807,KEGG_2019_Human,Lysine degradation,1/59,0.0029499522555206,0.0041499404726918,0,0,19941.0,116175.59385530632,PIPOX
26808,KEGG_2019_Human,Peroxisome,1/83,0.0041499404726918,0.0041499404726918,0,0,19917.0,109237.99888847338,PIPOX
26809,KEGG_2019_Human,Melanogenesis,1/101,0.0050499326546803,0.0050499326546803,0,0,19899.0,105233.48101229242,ASIP
26810,KEGG_2019_Human,IL-17 signaling pathway,1/93,0.0046499360391879,0.0105332156300977,0,0,19907.0,106918.54242106884,FOSL1
26811,KEGG_2019_Human,Osteoclast differentiation,1/127,0.0063499224962247,0.0105332156300977,0,0,19873.0,100543.72072014232,FOSL1
26812,KEGG_2019_Human,Wnt signaling pathway,1/158,0.0078999117225733,0.0105332156300977,0,0,19842.0,96053.2110949472,FOSL1
26813,KEGG_2019_Human,Human T-cell leukemia virus 1 infection,1/219,0.0109498935894162,0.0109498935894162,0,0,19781.0,89299.85161916987,FOSL1
26814,KEGG_2019_Human,Intestinal immune network for IgA production,1/48,0.0023999583567988,0.0068249053608048,0,0,19952.0,120356.5272753826,TNFSF13
26815,KEGG_2019_Human,Rheumatoid arthritis,1/91,0.0045499369072032,0.0068249053608048,0,0,19909.0,107362.10783923086,TNFSF13
26816,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0146998751759735,0,0,19706.0,83157.67014793828,TNFSF13
26817,KEGG_2019_Human,Signaling pathways regulating pluripotency of stem cells,1/139,0.006949918172816,0.006949918172816,0,0,19861.0,98689.81333375497,HAND1
26818,KEGG_2019_Human,Vasopressin-regulated water reabsorption,1/44,0.0021999607179423,0.0043999214358846,0,0,19956.0,122117.06559109331,ARHGDIB
26819,KEGG_2019_Human,Neurotrophin signaling pathway,1/119,0.0059499254985137,0.0059499254985137,0,0,19881.0,101877.73080211312,ARHGDIB
26820,KEGG_2019_Human,SNARE interactions in vesicular transport,1/34,0.0016999670339032,0.0016999670339032,0,0,19966.0,127326.1054203148,BET1L
26821,KEGG_2019_Human,Maturity onset diabetes of the young,1/26,0.0012999726251831,0.0012999726251831,0,0,19974.0,132735.46073187632,NKX2-2
26822,KEGG_2019_Human,Malaria,1/49,0.0024499577795033,0.0072499160871101,0,0,19951.0,119939.1172087114,PECAM1
26823,KEGG_2019_Human,Leukocyte transendothelial migration,1/112,0.0055999282120529,0.0072499160871101,0,0,19888.0,103119.30984392198,PECAM1
26824,KEGG_2019_Human,Fluid shear stress and atherosclerosis,1/139,0.006949918172816,0.0072499160871101,0,0,19861.0,98689.81333375497,PECAM1
26825,KEGG_2019_Human,Cell adhesion molecules (CAMs),1/145,0.0072499160871101,0.0072499160871101,0,0,19855.0,97820.92670675044,PECAM1
26826,KEGG_2019_Human,MicroRNAs in cancer,1/299,0.0149498740670514,0.0149498740670514,0,0,19701.0,82804.33538735632,MIR96
26827,KEGG_2019_Human,MicroRNAs in cancer,1/299,0.0149498740670514,0.0149498740670514,0,0,19701.0,82804.33538735632,MIR31
26828,KEGG_2019_Human,Basal transcription factors,1/45,0.0022499601197094,0.0022499601197094,0,0,19955.0,121662.49782449217,TAF13
26829,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR2AE1
26830,KEGG_2019_Human,Ubiquitin mediated proteolysis,1/137,0.0068499188797651,0.0068499188797651,0,0,19863.0,98987.62735269018,UBE2R2
26831,KEGG_2019_Human,Thermogenesis,1/231,0.0115498903940656,0.0115498903940656,0,0,19769.0,88191.07730937863,COX16
26832,KEGG_2019_Human,alpha-Linolenic acid metabolism,1/25,0.0012499733663791,0.0052874076132858,0,0,19975.0,133525.54486996148,PLA2G2A
26833,KEGG_2019_Human,Linoleic acid metabolism,1/29,0.001449970461791,0.0052874076132858,0,0,19971.0,130534.69172799008,PLA2G2A
26834,KEGG_2019_Human,Fat digestion and absorption,1/41,0.0020499625466866,0.0052874076132858,0,0,19959.0,123544.88783416104,PLA2G2A
26835,KEGG_2019_Human,Ether lipid metabolism,1/47,0.0023499589392381,0.0052874076132858,0,0,19953.0,120782.64067395544,PLA2G2A
26836,KEGG_2019_Human,Arachidonic acid metabolism,1/63,0.0031499501598827,0.005669910287789,0,0,19937.0,114844.46974572667,PLA2G2A
26837,KEGG_2019_Human,Glycerophospholipid metabolism,1/97,0.0048499343304706,0.0062999150247102,0,0,19903.0,106058.9096435903,PLA2G2A
26838,KEGG_2019_Human,Pancreatic secretion,1/98,0.0048999339081079,0.0062999150247102,0,0,19902.0,105849.45495286948,PLA2G2A
26839,KEGG_2019_Human,Vascular smooth muscle contraction,1/132,0.0065999206698993,0.0074249107536368,0,0,19868.0,99751.22090491928,PLA2G2A
26840,KEGG_2019_Human,Ras signaling pathway,1/232,0.0115998901349604,0.0115998901349604,0,0,19768.0,88101.22480150245,PLA2G2A
26841,KEGG_2019_Human,RNA degradation,1/79,0.0039499423167337,0.0068249053608048,0,0,19921.0,110243.89578070649,PABPC1L2A
26842,KEGG_2019_Human,mRNA surveillance pathway,1/91,0.0045499369072032,0.0068249053608048,0,0,19909.0,107362.10783923086,PABPC1L2A
26843,KEGG_2019_Human,RNA transport,1/165,0.0082499094553477,0.0082499094553477,0,0,19835.0,95159.46482222488,PABPC1L2A
26844,KEGG_2019_Human,Ribosome,1/153,0.0076499133771537,0.0076499133771537,0,0,19847.0,96715.6407630817,RPS23
26845,KEGG_2019_Human,mTOR signaling pathway,1/152,0.0075999137114971,0.0075999137114971,0,0,19848.0,96850.665715497,CASTOR1
26846,KEGG_2019_Human,Signaling pathways regulating pluripotency of stem cells,1/139,0.006949918172816,0.006949918172816,0,0,19861.0,98689.81333375497,PCGF2
26847,KEGG_2019_Human,Chemokine signaling pathway,1/190,0.0094999017791995,0.0146998751759735,0,0,19810.0,92244.74636351672,PF4
26848,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0146998751759735,0,0,19706.0,83157.67014793828,PF4
26849,KEGG_2019_Human,Ribosome,1/153,0.0076499133771537,0.0076499133771537,0,0,19847.0,96715.6407630817,RPL36AL
26850,KEGG_2019_Human,Chemokine signaling pathway,1/190,0.0094999017791995,0.0146998751759735,0,0,19810.0,92244.74636351672,CXCL13
26851,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0146998751759735,0,0,19706.0,83157.67014793828,CXCL13
26852,KEGG_2019_Human,Vitamin digestion and absorption,1/24,0.0011999741185782,0.0011999741185782,0,0,19976.0,134347.69487847842,RBP2
26853,KEGG_2019_Human,RNA polymerase,1/31,0.0015499690656704,0.0030999381313408,0,0,19969.0,129189.85098816035,POLR2G
26854,KEGG_2019_Human,Huntington disease,1/193,0.0096499008972596,0.0096499008972596,0,0,19807.0,91920.47679471428,POLR2G
26855,KEGG_2019_Human,alpha-Linolenic acid metabolism,1/25,0.0012499733663791,0.0052874076132858,0,0,19975.0,133525.54486996148,PLA2G1B
26856,KEGG_2019_Human,Linoleic acid metabolism,1/29,0.001449970461791,0.0052874076132858,0,0,19971.0,130534.69172799008,PLA2G1B
26857,KEGG_2019_Human,Fat digestion and absorption,1/41,0.0020499625466866,0.0052874076132858,0,0,19959.0,123544.88783416104,PLA2G1B
26858,KEGG_2019_Human,Ether lipid metabolism,1/47,0.0023499589392381,0.0052874076132858,0,0,19953.0,120782.64067395544,PLA2G1B
26859,KEGG_2019_Human,Arachidonic acid metabolism,1/63,0.0031499501598827,0.005669910287789,0,0,19937.0,114844.46974572667,PLA2G1B
26860,KEGG_2019_Human,Glycerophospholipid metabolism,1/97,0.0048499343304706,0.0062999150247102,0,0,19903.0,106058.9096435903,PLA2G1B
26861,KEGG_2019_Human,Pancreatic secretion,1/98,0.0048999339081079,0.0062999150247102,0,0,19902.0,105849.45495286948,PLA2G1B
26862,KEGG_2019_Human,Vascular smooth muscle contraction,1/132,0.0065999206698993,0.0074249107536368,0,0,19868.0,99751.22090491928,PLA2G1B
26863,KEGG_2019_Human,Ras signaling pathway,1/232,0.0115998901349604,0.0115998901349604,0,0,19768.0,88101.22480150245,PLA2G1B
26864,KEGG_2019_Human,Type II diabetes mellitus,1/46,0.0022999595269283,0.009262399852077,0,0,19954.0,121217.8313311442,SOCS3
26865,KEGG_2019_Human,Adipocytokine signaling pathway,1/69,0.003449947123837,0.009262399852077,0,0,19931.0,112996.7391397682,SOCS3
26866,KEGG_2019_Human,Prolactin signaling pathway,1/70,0.0034999466296654,0.009262399852077,0,0,19930.0,112704.30065625212,SOCS3
26867,KEGG_2019_Human,Insulin resistance,1/108,0.0053999298011749,0.009262399852077,0,0,19892.0,103863.47861844616,SOCS3
26868,KEGG_2019_Human,TNF signaling pathway,1/110,0.0054999290027479,0.009262399852077,0,0,19890.0,103488.06969787036,SOCS3
26869,KEGG_2019_Human,Osteoclast differentiation,1/127,0.0063499224962247,0.009262399852077,0,0,19873.0,100543.72072014232,SOCS3
26870,KEGG_2019_Human,Ubiquitin mediated proteolysis,1/137,0.0068499188797651,0.009262399852077,0,0,19863.0,98987.62735269018,SOCS3
26871,KEGG_2019_Human,Insulin signaling pathway,1/137,0.0068499188797651,0.009262399852077,0,0,19863.0,98987.62735269018,SOCS3
26872,KEGG_2019_Human,Non-alcoholic fatty liver disease (NAFLD),1/149,0.0074499147221605,0.009262399852077,0,0,19851.0,97261.02051561224,SOCS3
26873,KEGG_2019_Human,Hepatitis C,1/155,0.0077499127120574,0.009262399852077,0,0,19845.0,96448.16254952336,SOCS3
26874,KEGG_2019_Human,JAK-STAT signaling pathway,1/162,0.0080999104202618,0.009262399852077,0,0,19838.0,95537.86936302872,SOCS3
26875,KEGG_2019_Human,Influenza A,1/171,0.0085499075557634,0.009262399852077,0,0,19829.0,94422.42241345016,SOCS3
26876,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,SOCS3
26877,KEGG_2019_Human,Biosynthesis of unsaturated fatty acids,1/27,0.0013499718942362,0.0013499718942362,0,0,19973.0,131975.02298599784,HACD4
26878,KEGG_2019_Human,Fatty acid elongation,1/27,0.0013499718942362,0.0013499718942362,0,0,19973.0,131975.02298599784,HACD4
26879,KEGG_2019_Human,Thermogenesis,1/231,0.0115498903940656,0.0115498903940656,0,0,19769.0,88191.07730937863,COA3
26880,KEGG_2019_Human,Progesterone-mediated oocyte maturation,1/99,0.0049499334884068,0.0085623985997064,0,0,19901.0,105642.09305076736,ANAPC4
26881,KEGG_2019_Human,Cell cycle,1/124,0.0061999236097501,0.0085623985997064,0,0,19876.0,101034.04709010696,ANAPC4
26882,KEGG_2019_Human,Oocyte meiosis,1/125,0.0062499232373748,0.0085623985997064,0,0,19875.0,100869.32368441945,ANAPC4
26883,KEGG_2019_Human,Ubiquitin mediated proteolysis,1/137,0.0068499188797651,0.0085623985997064,0,0,19863.0,98987.62735269018,ANAPC4
26884,KEGG_2019_Human,Human T-cell leukemia virus 1 infection,1/219,0.0109498935894162,0.0109498935894162,0,0,19781.0,89299.85161916987,ANAPC4
26885,KEGG_2019_Human,Vasopressin-regulated water reabsorption,1/44,0.0021999607179423,0.0043999214358846,0,0,19956.0,122117.06559109331,DCTN2
26886,KEGG_2019_Human,Huntington disease,1/193,0.0096499008972596,0.0096499008972596,0,0,19807.0,91920.47679471428,DCTN2
26887,KEGG_2019_Human,Breast cancer,1/147,0.0073499154017982,0.0104998856263869,0,0,19853.0,97539.10874372096,FRAT2
26888,KEGG_2019_Human,Gastric cancer,1/149,0.0074499147221605,0.0104998856263869,0,0,19851.0,97261.02051561224,FRAT2
26889,KEGG_2019_Human,Wnt signaling pathway,1/158,0.0078999117225733,0.0104998856263869,0,0,19842.0,96053.2110949472,FRAT2
26890,KEGG_2019_Human,Hepatocellular carcinoma,1/168,0.0083999085011095,0.0104998856263869,0,0,19832.0,94787.72752807094,FRAT2
26891,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,FRAT2
26892,KEGG_2019_Human,Oxidative phosphorylation,1/133,0.0066499203093911,0.0112582177134695,0,0,19867.0,99596.2591544721,NDUFC2-KCTD14
26893,KEGG_2019_Human,Parkinson disease,1/142,0.0070999171242726,0.0112582177134695,0,0,19858.0,98250.87390500787,NDUFC2-KCTD14
26894,KEGG_2019_Human,Retrograde endocannabinoid signaling,1/148,0.007399915061391,0.0112582177134695,0,0,19852.0,97399.60470052566,NDUFC2-KCTD14
26895,KEGG_2019_Human,Non-alcoholic fatty liver disease (NAFLD),1/149,0.0074499147221605,0.0112582177134695,0,0,19851.0,97261.02051561224,NDUFC2-KCTD14
26896,KEGG_2019_Human,Alzheimer disease,1/171,0.0085499075557634,0.0112582177134695,0,0,19829.0,94422.42241345016,NDUFC2-KCTD14
26897,KEGG_2019_Human,Huntington disease,1/193,0.0096499008972596,0.0112582177134695,0,0,19807.0,91920.47679471428,NDUFC2-KCTD14
26898,KEGG_2019_Human,Thermogenesis,1/231,0.0115498903940656,0.0115498903940656,0,0,19769.0,88191.07730937863,NDUFC2-KCTD14
26899,KEGG_2019_Human,GABAergic synapse,1/89,0.0044499377838098,0.0130498764018304,0,0,19911.0,107815.380281759,GNG8
26900,KEGG_2019_Human,Morphine addiction,1/91,0.0045499369072032,0.0130498764018304,0,0,19909.0,107362.10783923086,GNG8
26901,KEGG_2019_Human,Circadian entrainment,1/97,0.0048499343304706,0.0130498764018304,0,0,19903.0,106058.9096435903,GNG8
26902,KEGG_2019_Human,Cholinergic synapse,1/112,0.0055999282120529,0.0130498764018304,0,0,19888.0,103119.30984392198,GNG8
26903,KEGG_2019_Human,Serotonergic synapse,1/113,0.0056499278191151,0.0130498764018304,0,0,19887.0,102937.34947211576,GNG8
26904,KEGG_2019_Human,Glutamatergic synapse,1/114,0.005699927427839,0.0130498764018304,0,0,19886.0,102756.96431429044,GNG8
26905,KEGG_2019_Human,Relaxin signaling pathway,1/130,0.0064999213952527,0.0130498764018304,0,0,19870.0,100064.62842845908,GNG8
26906,KEGG_2019_Human,Dopaminergic synapse,1/131,0.0065499210316603,0.0130498764018304,0,0,19869.0,99907.33811343512,GNG8
26907,KEGG_2019_Human,Apelin signaling pathway,1/137,0.0068499188797651,0.0130498764018304,0,0,19863.0,98987.62735269018,GNG8
26908,KEGG_2019_Human,Retrograde endocannabinoid signaling,1/148,0.007399915061391,0.0130498764018304,0,0,19852.0,97399.60470052566,GNG8
26909,KEGG_2019_Human,Alcoholism,1/180,0.0089999047745351,0.0130498764018304,0,0,19820.0,93362.92821536642,GNG8
26910,KEGG_2019_Human,Kaposi sarcoma-associated herpesvirus infection,1/186,0.0092999029651357,0.0130498764018304,0,0,19814.0,92684.96451050608,GNG8
26911,KEGG_2019_Human,Chemokine signaling pathway,1/190,0.0094999017791995,0.0130498764018304,0,0,19810.0,92244.74636351672,GNG8
26912,KEGG_2019_Human,Human immunodeficiency virus 1 infection,1/212,0.0105998955026255,0.0130498764018304,0,0,19788.0,89974.27756224656,GNG8
26913,KEGG_2019_Human,Human cytomegalovirus infection,1/225,0.0112498919790339,0.0130498764018304,0,0,19775.0,88738.27077557483,GNG8
26914,KEGG_2019_Human,Ras signaling pathway,1/232,0.0115998901349604,0.0130498764018304,0,0,19768.0,88101.22480150245,GNG8
26915,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0187410310320355,0,0,19646.0,79255.8617626126,GNG8
26916,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,GNG8
26917,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0176998626413668,0,0,19646.0,79255.8617626126,MTCP1
26918,KEGG_2019_Human,Base excision repair,1/33,0.0016499677032113,0.0016499677032113,0,0,19967.0,127928.56031580272,SMUG1
26919,KEGG_2019_Human,Hedgehog signaling pathway,1/47,0.0023499589392381,0.0112198768592729,0,0,19953.0,120782.64067395544,BCL2
26920,KEGG_2019_Human,Amyotrophic lateral sclerosis (ALS),1/51,0.0025499566390179,0.0112198768592729,0,0,19949.0,119129.0228601236,BCL2
26921,KEGG_2019_Human,p53 signaling pathway,1/72,0.0035999456502131,0.0112198768592729,0,0,19928.0,112131.59838572376,BCL2
26922,KEGG_2019_Human,Colorectal cancer,1/86,0.0042999391173866,0.0112198768592729,0,0,19914.0,108514.46102290176,BCL2
26923,KEGG_2019_Human,Small cell lung cancer,1/93,0.0046499360391879,0.0112198768592729,0,0,19907.0,106918.54242106884,BCL2
26924,KEGG_2019_Human,NF-kappa B signaling pathway,1/95,0.0047499351803394,0.0112198768592729,0,0,19905.0,106484.27183626965,BCL2
26925,KEGG_2019_Human,Prostate cancer,1/97,0.0048499343304706,0.0112198768592729,0,0,19903.0,106058.9096435903,BCL2
26926,KEGG_2019_Human,AGE-RAGE signaling pathway in diabetic complications,1/100,0.0049999330710556,0.0112198768592729,0,0,19900.0,105436.78197328727,BCL2
26927,KEGG_2019_Human,HIF-1 signaling pathway,1/100,0.0049999330710556,0.0112198768592729,0,0,19900.0,105436.78197328727,BCL2
26928,KEGG_2019_Human,"Parathyroid hormone synthesis, secretion and action",1/106,0.0052999306076525,0.0112198768592729,0,0,19894.0,104245.78450366124,BCL2
26929,KEGG_2019_Human,Cholinergic synapse,1/112,0.0055999282120529,0.0112198768592729,0,0,19888.0,103119.30984392198,BCL2
26930,KEGG_2019_Human,Toxoplasmosis,1/113,0.0056499278191151,0.0112198768592729,0,0,19887.0,102937.34947211576,BCL2
26931,KEGG_2019_Human,Sphingolipid signaling pathway,1/119,0.0059499254985137,0.0112198768592729,0,0,19881.0,101877.73080211312,BCL2
26932,KEGG_2019_Human,Neurotrophin signaling pathway,1/119,0.0059499254985137,0.0112198768592729,0,0,19881.0,101877.73080211312,BCL2
26933,KEGG_2019_Human,Autophagy,1/128,0.0063999221281459,0.0112198768592729,0,0,19872.0,100382.8010329652,BCL2
26934,KEGG_2019_Human,Estrogen signaling pathway,1/137,0.0068499188797651,0.0112198768592729,0,0,19863.0,98987.62735269018,BCL2
26935,KEGG_2019_Human,Measles,1/138,0.0068999185254481,0.0112198768592729,0,0,19862.0,98838.19160389496,BCL2
26936,KEGG_2019_Human,Fluid shear stress and atherosclerosis,1/139,0.006949918172816,0.0112198768592729,0,0,19861.0,98689.81333375497,BCL2
26937,KEGG_2019_Human,Apoptosis,1/143,0.0071499167770442,0.0112198768592729,0,0,19857.0,98106.57763600958,BCL2
26938,KEGG_2019_Human,Adrenergic signaling in cardiomyocytes,1/145,0.0072499160871101,0.0112198768592729,0,0,19855.0,97820.92670675044,BCL2
26939,KEGG_2019_Human,Gastric cancer,1/149,0.0074499147221605,0.0112198768592729,0,0,19851.0,97261.02051561224,BCL2
26940,KEGG_2019_Human,JAK-STAT signaling pathway,1/162,0.0080999104202618,0.0112198768592729,0,0,19838.0,95537.86936302872,BCL2
26941,KEGG_2019_Human,Necroptosis,1/162,0.0080999104202618,0.0112198768592729,0,0,19838.0,95537.86936302872,BCL2
26942,KEGG_2019_Human,Hepatitis B,1/163,0.0081499100978668,0.0112198768592729,0,0,19837.0,95410.9786681514,BCL2
26943,KEGG_2019_Human,Protein processing in endoplasmic reticulum,1/165,0.0082499094553477,0.0112198768592729,0,0,19835.0,95159.46482222488,BCL2
26944,KEGG_2019_Human,NOD-like receptor signaling pathway,1/178,0.0088999053857096,0.0112702508415521,0,0,19822.0,93593.82745769851,BCL2
26945,KEGG_2019_Human,Tuberculosis,1/179,0.0089499050800561,0.0112702508415521,0,0,19821.0,93478.0629355712,BCL2
26946,KEGG_2019_Human,Focal adhesion,1/199,0.0099498991610159,0.0117826397236264,0,0,19801.0,91286.4288690606,BCL2
26947,KEGG_2019_Human,Epstein-Barr virus infection,1/201,0.0100498985877989,0.0117826397236264,0,0,19799.0,91079.21596609056,BCL2
26948,KEGG_2019_Human,Human immunodeficiency virus 1 infection,1/212,0.0105998955026255,0.0120132149029756,0,0,19788.0,89974.27756224656,BCL2
26949,KEGG_2019_Human,MicroRNAs in cancer,1/299,0.0149498740670514,0.0163966360735402,0,0,19701.0,82804.33538735632,BCL2
26950,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0188061040564523,0,0,19646.0,79255.8617626126,BCL2
26951,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0253452886456739,0,0,19508.0,72277.44006442746,BCL2
26952,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,BCL2
26953,KEGG_2019_Human,Progesterone-mediated oocyte maturation,1/99,0.0049499334884068,0.0062499232373748,0,0,19901.0,105642.09305076736,SPDYE2
26954,KEGG_2019_Human,Oocyte meiosis,1/125,0.0062499232373748,0.0062499232373748,0,0,19875.0,100869.32368441945,SPDYE2
26955,KEGG_2019_Human,Long-term potentiation,1/67,0.0033499481224912,0.0066998962449824,0,0,19933.0,113594.38808369274,PPP1R1A
26956,KEGG_2019_Human,Adrenergic signaling in cardiomyocytes,1/145,0.0072499160871101,0.0072499160871101,0,0,19855.0,97820.92670675044,PPP1R1A
26957,KEGG_2019_Human,Thermogenesis,1/231,0.0115498903940656,0.0115498903940656,0,0,19769.0,88191.07730937863,COA7
26958,KEGG_2019_Human,Purine metabolism,1/129,0.006449921761047,0.006449921761047,0,0,19871.0,100223.109907462,AK3
26959,KEGG_2019_Human,Spliceosome,1/134,0.0066999199497742,0.0133998398995484,0,0,19866.0,99442.43560916925,SRSF8
26960,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,SRSF8
26961,KEGG_2019_Human,AMPK signaling pathway,1/120,0.0059999251180858,0.0059999251180858,0,0,19880.0,101706.2448082016,RAB14
26962,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR4M2
26963,KEGG_2019_Human,Vasopressin-regulated water reabsorption,1/44,0.0021999607179423,0.0021999607179423,0,0,19956.0,122117.06559109331,DCTN5
26964,KEGG_2019_Human,Amyotrophic lateral sclerosis (ALS),1/51,0.0025499566390179,0.0025499566390179,0,0,19949.0,119129.0228601236,CCS
26965,KEGG_2019_Human,Ferroptosis,1/40,0.0019999631680592,0.0019999631680592,0,0,19960.0,124043.94523066044,MAP1LC3B
26966,KEGG_2019_Human,Arginine and proline metabolism,1/49,0.0024499577795033,0.0024499577795033,0,0,19951.0,119939.1172087114,PRODH
26967,KEGG_2019_Human,Ribosome,1/153,0.0076499133771537,0.0076499133771537,0,0,19847.0,96715.6407630817,RPL13
26968,KEGG_2019_Human,Basal transcription factors,1/45,0.0022499601197094,0.0023499589392381,0,0,19955.0,121662.49782449217,GTF2H5
26969,KEGG_2019_Human,Nucleotide excision repair,1/47,0.0023499589392381,0.0023499589392381,0,0,19953.0,120782.64067395544,GTF2H5
26970,KEGG_2019_Human,RNA degradation,1/79,0.0039499423167337,0.0039499423167337,0,0,19921.0,110243.89578070649,DCPS
26971,KEGG_2019_Human,Melanoma,1/72,0.0035999456502131,0.0173998352024406,0,0,19928.0,112131.59838572376,FGF19
26972,KEGG_2019_Human,Breast cancer,1/147,0.0073499154017982,0.0173998352024406,0,0,19853.0,97539.10874372096,FGF19
26973,KEGG_2019_Human,Gastric cancer,1/149,0.0074499147221605,0.0173998352024406,0,0,19851.0,97261.02051561224,FGF19
26974,KEGG_2019_Human,Rap1 signaling pathway,1/206,0.010299897173561,0.0173998352024406,0,0,19794.0,90569.849337325,FGF19
26975,KEGG_2019_Human,Regulation of actin cytoskeleton,1/214,0.0106998949514067,0.0173998352024406,0,0,19786.0,89779.39753374986,FGF19
26976,KEGG_2019_Human,Ras signaling pathway,1/232,0.0115998901349604,0.0173998352024406,0,0,19768.0,88101.22480150245,FGF19
26977,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.018964124940408,0,0,19705.0,83086.53988020132,FGF19
26978,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0199123454715377,0,0,19646.0,79255.8617626126,FGF19
26979,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,FGF19
26980,KEGG_2019_Human,AMPK signaling pathway,1/120,0.0059999251180858,0.0075999137114971,0,0,19880.0,101706.2448082016,CAB39
26981,KEGG_2019_Human,mTOR signaling pathway,1/152,0.0075999137114971,0.0075999137114971,0,0,19848.0,96850.665715497,CAB39
26982,KEGG_2019_Human,Taste transduction,1/83,0.0041499404726918,0.0134543910207109,0,0,19917.0,109237.99888847338,GNG13
26983,KEGG_2019_Human,GABAergic synapse,1/89,0.0044499377838098,0.0134543910207109,0,0,19911.0,107815.380281759,GNG13
26984,KEGG_2019_Human,Morphine addiction,1/91,0.0045499369072032,0.0134543910207109,0,0,19909.0,107362.10783923086,GNG13
26985,KEGG_2019_Human,Circadian entrainment,1/97,0.0048499343304706,0.0134543910207109,0,0,19903.0,106058.9096435903,GNG13
26986,KEGG_2019_Human,Cholinergic synapse,1/112,0.0055999282120529,0.0134543910207109,0,0,19888.0,103119.30984392198,GNG13
26987,KEGG_2019_Human,Serotonergic synapse,1/113,0.0056499278191151,0.0134543910207109,0,0,19887.0,102937.34947211576,GNG13
26988,KEGG_2019_Human,Glutamatergic synapse,1/114,0.005699927427839,0.0134543910207109,0,0,19886.0,102756.96431429044,GNG13
26989,KEGG_2019_Human,Relaxin signaling pathway,1/130,0.0064999213952527,0.0134543910207109,0,0,19870.0,100064.62842845908,GNG13
26990,KEGG_2019_Human,Dopaminergic synapse,1/131,0.0065499210316603,0.0134543910207109,0,0,19869.0,99907.33811343512,GNG13
26991,KEGG_2019_Human,Apelin signaling pathway,1/137,0.0068499188797651,0.0134543910207109,0,0,19863.0,98987.62735269018,GNG13
26992,KEGG_2019_Human,Retrograde endocannabinoid signaling,1/148,0.007399915061391,0.0134543910207109,0,0,19852.0,97399.60470052566,GNG13
26993,KEGG_2019_Human,Alcoholism,1/180,0.0089999047745351,0.0135712882559994,0,0,19820.0,93362.92821536642,GNG13
26994,KEGG_2019_Human,Kaposi sarcoma-associated herpesvirus infection,1/186,0.0092999029651357,0.0135712882559994,0,0,19814.0,92684.96451050608,GNG13
26995,KEGG_2019_Human,Chemokine signaling pathway,1/190,0.0094999017791995,0.0135712882559994,0,0,19810.0,92244.74636351672,GNG13
26996,KEGG_2019_Human,Human immunodeficiency virus 1 infection,1/212,0.0105998955026255,0.0136469295705416,0,0,19788.0,89974.27756224656,GNG13
26997,KEGG_2019_Human,Human cytomegalovirus infection,1/225,0.0112498919790339,0.0136469295705416,0,0,19775.0,88738.27077557483,GNG13
26998,KEGG_2019_Human,Ras signaling pathway,1/232,0.0115998901349604,0.0136469295705416,0,0,19768.0,88101.22480150245,GNG13
26999,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0196665140459632,0,0,19646.0,79255.8617626126,GNG13
27000,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0233682594997654,0,0,19556.0,74462.79263140135,GNG13
27001,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,GNG13
27002,KEGG_2019_Human,Ribosome,1/153,0.0076499133771537,0.0076499133771537,0,0,19847.0,96715.6407630817,MRPL18
27003,KEGG_2019_Human,Cysteine and methionine metabolism,1/47,0.0023499589392381,0.0023499589392381,0,0,19953.0,120782.64067395544,ENOPH1
27004,KEGG_2019_Human,Wnt signaling pathway,1/158,0.0078999117225733,0.0078999117225733,0,0,19842.0,96053.2110949472,CTNNBIP1
27005,KEGG_2019_Human,Ribosome,1/153,0.0076499133771537,0.0076499133771537,0,0,19847.0,96715.6407630817,RPL31
27006,KEGG_2019_Human,IL-17 signaling pathway,1/93,0.0046499360391879,0.0046499360391879,0,0,19907.0,106918.54242106884,S100A8
27007,KEGG_2019_Human,Autoimmune thyroid disease,1/53,0.0026499555173137,0.0145586837375733,0,0,19947.0,118349.78824235698,IFNA1
27008,KEGG_2019_Human,Cytosolic DNA-sensing pathway,1/63,0.0031499501598827,0.0145586837375733,0,0,19937.0,114844.46974572667,IFNA1
27009,KEGG_2019_Human,RIG-I-like receptor signaling pathway,1/70,0.0034999466296654,0.0145586837375733,0,0,19930.0,112704.30065625212,IFNA1
27010,KEGG_2019_Human,Toll-like receptor signaling pathway,1/104,0.0051999314202997,0.0145586837375733,0,0,19896.0,104635.24941415618,IFNA1
27011,KEGG_2019_Human,Natural killer cell mediated cytotoxicity,1/131,0.0065499210316603,0.0145586837375733,0,0,19869.0,99907.33811343512,IFNA1
27012,KEGG_2019_Human,Measles,1/138,0.0068999185254481,0.0145586837375733,0,0,19862.0,98838.19160389496,IFNA1
27013,KEGG_2019_Human,Hepatitis C,1/155,0.0077499127120574,0.0145586837375733,0,0,19845.0,96448.16254952336,IFNA1
27014,KEGG_2019_Human,Necroptosis,1/162,0.0080999104202618,0.0145586837375733,0,0,19838.0,95537.86936302872,IFNA1
27015,KEGG_2019_Human,JAK-STAT signaling pathway,1/162,0.0080999104202618,0.0145586837375733,0,0,19838.0,95537.86936302872,IFNA1
27016,KEGG_2019_Human,Hepatitis B,1/163,0.0081499100978668,0.0145586837375733,0,0,19837.0,95410.9786681514,IFNA1
27017,KEGG_2019_Human,Influenza A,1/171,0.0085499075557634,0.0145586837375733,0,0,19829.0,94422.42241345016,IFNA1
27018,KEGG_2019_Human,NOD-like receptor signaling pathway,1/178,0.0088999053857096,0.0145586837375733,0,0,19822.0,93593.82745769851,IFNA1
27019,KEGG_2019_Human,Tuberculosis,1/179,0.0089499050800561,0.0145586837375733,0,0,19821.0,93478.0629355712,IFNA1
27020,KEGG_2019_Human,Kaposi sarcoma-associated herpesvirus infection,1/186,0.0092999029651357,0.0145586837375733,0,0,19814.0,92684.96451050608,IFNA1
27021,KEGG_2019_Human,Epstein-Barr virus infection,1/201,0.0100498985877989,0.0145586837375733,0,0,19799.0,91079.21596609056,IFNA1
27022,KEGG_2019_Human,Human immunodeficiency virus 1 infection,1/212,0.0105998955026255,0.0145586837375733,0,0,19788.0,89974.27756224656,IFNA1
27023,KEGG_2019_Human,Human cytomegalovirus infection,1/225,0.0112498919790339,0.0145586837375733,0,0,19775.0,88738.27077557483,IFNA1
27024,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0179665141039676,0,0,19706.0,83157.67014793828,IFNA1
27025,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0191051096893273,0,0,19670.0,80733.60565076157,IFNA1
27026,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0194698489055035,0,0,19646.0,79255.8617626126,IFNA1
27027,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0257712598834163,0,0,19508.0,72277.44006442746,IFNA1
27028,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,IFNA1
27029,KEGG_2019_Human,Glutathione metabolism,1/56,0.0027999538675741,0.0027999538675741,0,0,19944.0,117233.87022514464,GGCT
27030,KEGG_2019_Human,Leukocyte transendothelial migration,1/112,0.0055999282120529,0.0084999078692823,0,0,19888.0,103119.30984392198,CLDN9
27031,KEGG_2019_Human,Cell adhesion molecules (CAMs),1/145,0.0072499160871101,0.0084999078692823,0,0,19855.0,97820.92670675044,CLDN9
27032,KEGG_2019_Human,Hepatitis C,1/155,0.0077499127120574,0.0084999078692823,0,0,19845.0,96448.16254952336,CLDN9
27033,KEGG_2019_Human,Tight junction,1/170,0.0084999078692823,0.0084999078692823,0,0,19830.0,94543.49009679438,CLDN9
27034,KEGG_2019_Human,Basal transcription factors,1/45,0.0022499601197094,0.0044999202394188,0,0,19955.0,121662.49782449217,GTF2E2
27035,KEGG_2019_Human,Viral carcinogenesis,1/201,0.0100498985877989,0.0100498985877989,0,0,19799.0,91079.21596609056,GTF2E2
27036,KEGG_2019_Human,Prion diseases,1/35,0.0017499663721595,0.0063999130051608,0,0,19965.0,126740.98858805298,C8G
27037,KEGG_2019_Human,Complement and coagulation cascades,1/79,0.0039499423167337,0.0063999130051608,0,0,19921.0,110243.89578070649,C8G
27038,KEGG_2019_Human,Amoebiasis,1/96,0.0047999347538706,0.0063999130051608,0,0,19904.0,106270.50039849174,C8G
27039,KEGG_2019_Human,Systemic lupus erythematosus,1/133,0.0066499203093911,0.0066499203093911,0,0,19867.0,99596.2591544721,C8G
27040,KEGG_2019_Human,Asthma,1/31,0.0015499690656704,0.0083141731379497,0,0,19969.0,129189.85098816035,HLA-DOB
27041,KEGG_2019_Human,Allograft rejection,1/38,0.001899964429635,0.0083141731379497,0,0,19962.0,125080.29732025368,HLA-DOB
27042,KEGG_2019_Human,Graft-versus-host disease,1/41,0.0020499625466866,0.0083141731379497,0,0,19959.0,123544.88783416104,HLA-DOB
27043,KEGG_2019_Human,Type I diabetes mellitus,1/43,0.0021499613216957,0.0083141731379497,0,0,19957.0,122581.98940490963,HLA-DOB
27044,KEGG_2019_Human,Intestinal immune network for IgA production,1/48,0.0023999583567988,0.0083141731379497,0,0,19952.0,120356.5272753826,HLA-DOB
27045,KEGG_2019_Human,Autoimmune thyroid disease,1/53,0.0026499555173137,0.0083141731379497,0,0,19947.0,118349.78824235698,HLA-DOB
27046,KEGG_2019_Human,Viral myocarditis,1/59,0.0029499522555206,0.0083141731379497,0,0,19941.0,116175.59385530632,HLA-DOB
27047,KEGG_2019_Human,Inflammatory bowel disease (IBD),1/65,0.003249949134407,0.0083141731379497,0,0,19935.0,114209.92613860144,HLA-DOB
27048,KEGG_2019_Human,Staphylococcus aureus infection,1/68,0.0033999476216189,0.0083141731379497,0,0,19932.0,113293.39338050144,HLA-DOB
27049,KEGG_2019_Human,Leishmaniasis,1/74,0.0036999446830449,0.0083141731379497,0,0,19926.0,111574.38983110404,HLA-DOB
27050,KEGG_2019_Human,Antigen processing and presentation,1/77,0.0038499432547502,0.0083141731379497,0,0,19923.0,110765.8407373636,HLA-DOB
27051,KEGG_2019_Human,Rheumatoid arthritis,1/91,0.0045499369072032,0.0083141731379497,0,0,19909.0,107362.10783923086,HLA-DOB
27052,KEGG_2019_Human,Th1 and Th2 cell differentiation,1/92,0.0045999364719865,0.0083141731379497,0,0,19908.0,107139.13814408927,HLA-DOB
27053,KEGG_2019_Human,Hematopoietic cell lineage,1/97,0.0048499343304706,0.0083141731379497,0,0,19903.0,106058.9096435903,HLA-DOB
27054,KEGG_2019_Human,Th17 cell differentiation,1/107,0.0053499302026925,0.0084748917286727,0,0,19893.0,104053.753408911,HLA-DOB
27055,KEGG_2019_Human,Toxoplasmosis,1/113,0.0056499278191151,0.0084748917286727,0,0,19887.0,102937.34947211576,HLA-DOB
27056,KEGG_2019_Human,Systemic lupus erythematosus,1/133,0.0066499203093911,0.0093881227897286,0,0,19867.0,99596.2591544721,HLA-DOB
27057,KEGG_2019_Human,Cell adhesion molecules (CAMs),1/145,0.0072499160871101,0.0095998910039963,0,0,19855.0,97820.92670675044,HLA-DOB
27058,KEGG_2019_Human,Phagosome,1/152,0.0075999137114971,0.0095998910039963,0,0,19848.0,96850.665715497,HLA-DOB
27059,KEGG_2019_Human,Influenza A,1/171,0.0085499075557634,0.0102284629486356,0,0,19829.0,94422.42241345016,HLA-DOB
27060,KEGG_2019_Human,Tuberculosis,1/179,0.0089499050800561,0.0102284629486356,0,0,19821.0,93478.0629355712,HLA-DOB
27061,KEGG_2019_Human,Epstein-Barr virus infection,1/201,0.0100498985877989,0.0109635257321443,0,0,19799.0,91079.21596609056,HLA-DOB
27062,KEGG_2019_Human,Human T-cell leukemia virus 1 infection,1/219,0.0109498935894162,0.0114259759193908,0,0,19781.0,89299.85161916987,HLA-DOB
27063,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,HLA-DOB
27064,KEGG_2019_Human,Glutathione metabolism,1/56,0.0027999538675741,0.0027999538675741,0,0,19944.0,117233.87022514464,CHAC1
27065,KEGG_2019_Human,Ubiquitin mediated proteolysis,1/137,0.0068499188797651,0.0070999171242726,0,0,19863.0,98987.62735269018,UBE2L6
27066,KEGG_2019_Human,Parkinson disease,1/142,0.0070999171242726,0.0070999171242726,0,0,19858.0,98250.87390500787,UBE2L6
27067,KEGG_2019_Human,MicroRNAs in cancer,1/299,0.0149498740670514,0.0149498740670514,0,0,19701.0,82804.33538735632,MIR124-3
27068,KEGG_2019_Human,Pyrimidine metabolism,1/57,0.002849953326298,0.005699906652596,0,0,19943.0,116875.00742975442,NUDT2
27069,KEGG_2019_Human,Purine metabolism,1/129,0.006449921761047,0.006449921761047,0,0,19871.0,100223.109907462,NUDT2
27070,KEGG_2019_Human,Renal cell carcinoma,1/69,0.003449947123837,0.0114165314662752,0,0,19931.0,112996.7391397682,ELOB
27071,KEGG_2019_Human,HIF-1 signaling pathway,1/100,0.0049999330710556,0.0114165314662752,0,0,19900.0,105436.78197328727,ELOB
27072,KEGG_2019_Human,Ubiquitin mediated proteolysis,1/137,0.0068499188797651,0.0114165314662752,0,0,19863.0,98987.62735269018,ELOB
27073,KEGG_2019_Human,Human immunodeficiency virus 1 infection,1/212,0.0105998955026255,0.0132498693782819,0,0,19788.0,89974.27756224656,ELOB
27074,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,ELOB
27075,KEGG_2019_Human,MicroRNAs in cancer,1/299,0.0149498740670514,0.0149498740670514,0,0,19701.0,82804.33538735632,MIR373
27076,KEGG_2019_Human,Glutathione metabolism,1/56,0.0027999538675741,0.0027999538675741,0,0,19944.0,117233.87022514464,TXNDC12
27077,KEGG_2019_Human,"Glycine, serine and threonine metabolism",1/40,0.0019999631680592,0.0023499589392381,0,0,19960.0,124043.94523066044,CBS
27078,KEGG_2019_Human,Cysteine and methionine metabolism,1/47,0.0023499589392381,0.0023499589392381,0,0,19953.0,120782.64067395544,CBS
27079,KEGG_2019_Human,Phototransduction,1/28,0.0013999711732997,0.0113938210547091,0,0,19972.0,131242.0761597353,CALML5
27080,KEGG_2019_Human,Long-term potentiation,1/67,0.0033499481224912,0.0113938210547091,0,0,19933.0,113594.38808369274,CALML5
27081,KEGG_2019_Human,Amphetamine addiction,1/68,0.0033999476216189,0.0113938210547091,0,0,19932.0,113293.39338050144,CALML5
27082,KEGG_2019_Human,Renin secretion,1/69,0.003449947123837,0.0113938210547091,0,0,19931.0,112996.7391397682,CALML5
27083,KEGG_2019_Human,Gastric acid secretion,1/75,0.0037499442041125,0.0113938210547091,0,0,19925.0,111301.33528642564,CALML5
27084,KEGG_2019_Human,Glioma,1/75,0.0037499442041125,0.0113938210547091,0,0,19925.0,111301.33528642564,CALML5
27085,KEGG_2019_Human,Pertussis,1/76,0.0037999437281752,0.0113938210547091,0,0,19924.0,111031.8499691117,CALML5
27086,KEGG_2019_Human,Salivary secretion,1/90,0.0044999373439762,0.0113938210547091,0,0,19910.0,107587.50385474482,CALML5
27087,KEGG_2019_Human,GnRH signaling pathway,1/93,0.0046499360391879,0.0113938210547091,0,0,19907.0,106918.54242106884,CALML5
27088,KEGG_2019_Human,Circadian entrainment,1/97,0.0048499343304706,0.0113938210547091,0,0,19903.0,106058.9096435903,CALML5
27089,KEGG_2019_Human,Aldosterone synthesis and secretion,1/98,0.0048999339081079,0.0113938210547091,0,0,19902.0,105849.45495286948,CALML5
27090,KEGG_2019_Human,Phosphatidylinositol signaling system,1/99,0.0049499334884068,0.0113938210547091,0,0,19901.0,105642.09305076736,CALML5
27091,KEGG_2019_Human,Inflammatory mediator regulation of TRP channels,1/100,0.0049999330710556,0.0113938210547091,0,0,19900.0,105436.78197328727,CALML5
27092,KEGG_2019_Human,Melanogenesis,1/101,0.0050499326546803,0.0113938210547091,0,0,19899.0,105233.48101229242,CALML5
27093,KEGG_2019_Human,Glucagon signaling pathway,1/103,0.0051499318302617,0.0113938210547091,0,0,19897.0,104832.7525292024,CALML5
27094,KEGG_2019_Human,C-type lectin receptor signaling pathway,1/104,0.0051999314202997,0.0113938210547091,0,0,19896.0,104635.24941415618,CALML5
27095,KEGG_2019_Human,Neurotrophin signaling pathway,1/119,0.0059499254985137,0.0113938210547091,0,0,19881.0,101877.73080211312,CALML5
27096,KEGG_2019_Human,Oocyte meiosis,1/125,0.0062499232373748,0.0113938210547091,0,0,19875.0,100869.32368441945,CALML5
27097,KEGG_2019_Human,Dopaminergic synapse,1/131,0.0065499210316603,0.0113938210547091,0,0,19869.0,99907.33811343512,CALML5
27098,KEGG_2019_Human,Vascular smooth muscle contraction,1/132,0.0065999206698993,0.0113938210547091,0,0,19868.0,99751.22090491928,CALML5
27099,KEGG_2019_Human,Insulin signaling pathway,1/137,0.0068499188797651,0.0113938210547091,0,0,19863.0,98987.62735269018,CALML5
27100,KEGG_2019_Human,Estrogen signaling pathway,1/137,0.0068499188797651,0.0113938210547091,0,0,19863.0,98987.62735269018,CALML5
27101,KEGG_2019_Human,Apelin signaling pathway,1/137,0.0068499188797651,0.0113938210547091,0,0,19863.0,98987.62735269018,CALML5
27102,KEGG_2019_Human,Fluid shear stress and atherosclerosis,1/139,0.006949918172816,0.0113938210547091,0,0,19861.0,98689.81333375497,CALML5
27103,KEGG_2019_Human,Adrenergic signaling in cardiomyocytes,1/145,0.0072499160871101,0.0113938210547091,0,0,19855.0,97820.92670675044,CALML5
27104,KEGG_2019_Human,Oxytocin signaling pathway,1/153,0.0076499133771537,0.0113938210547091,0,0,19847.0,96715.6407630817,CALML5
27105,KEGG_2019_Human,Cellular senescence,1/160,0.0079999110688441,0.0113938210547091,0,0,19840.0,95793.96509856998,CALML5
27106,KEGG_2019_Human,cGMP-PKG signaling pathway,1/166,0.0082999091363732,0.0113938210547091,0,0,19834.0,95034.82345515196,CALML5
27107,KEGG_2019_Human,Alzheimer disease,1/171,0.0085499075557634,0.0113938210547091,0,0,19829.0,94422.42241345016,CALML5
27108,KEGG_2019_Human,Tuberculosis,1/179,0.0089499050800561,0.0113938210547091,0,0,19821.0,93478.0629355712,CALML5
27109,KEGG_2019_Human,Alcoholism,1/180,0.0089999047745351,0.0113938210547091,0,0,19820.0,93362.92821536642,CALML5
27110,KEGG_2019_Human,Kaposi sarcoma-associated herpesvirus infection,1/186,0.0092999029651357,0.0113938210547091,0,0,19814.0,92684.96451050608,CALML5
27111,KEGG_2019_Human,Calcium signaling pathway,1/188,0.009399902370135,0.0113938210547091,0,0,19812.0,92463.712994847,CALML5
27112,KEGG_2019_Human,Rap1 signaling pathway,1/206,0.010299897173561,0.0117776616695839,0,0,19794.0,90569.849337325,CALML5
27113,KEGG_2019_Human,Human immunodeficiency virus 1 infection,1/212,0.0105998955026255,0.0117776616695839,0,0,19788.0,89974.27756224656,CALML5
27114,KEGG_2019_Human,cAMP signaling pathway,1/212,0.0105998955026255,0.0117776616695839,0,0,19788.0,89974.27756224656,CALML5
27115,KEGG_2019_Human,Human cytomegalovirus infection,1/225,0.0112498919790339,0.0121620453827393,0,0,19775.0,88738.27077557483,CALML5
27116,KEGG_2019_Human,Ras signaling pathway,1/232,0.0115998901349604,0.0122104106683793,0,0,19768.0,88101.22480150245,CALML5
27117,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0227690733587457,0,0,19556.0,74462.79263140135,CALML5
27118,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,CALML5
27119,KEGG_2019_Human,Ribosome,1/153,0.0076499133771537,0.0076499133771537,0,0,19847.0,96715.6407630817,RPL27
27120,KEGG_2019_Human,Thermogenesis,1/231,0.0115498903940656,0.0115498903940656,0,0,19769.0,88191.07730937863,COA4
27121,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0164998674589645,0,0,19670.0,80733.60565076157,TUBG2
27122,KEGG_2019_Human,Taste transduction,1/83,0.0041499404726918,0.0041499404726918,0,0,19917.0,109237.99888847338,TAS2R19
27123,KEGG_2019_Human,Ribosome,1/153,0.0076499133771537,0.0076499133771537,0,0,19847.0,96715.6407630817,RPL29
27124,KEGG_2019_Human,Ubiquitin mediated proteolysis,1/137,0.0068499188797651,0.0082499094553477,0,0,19863.0,98987.62735269018,UBE2G1
27125,KEGG_2019_Human,Parkinson disease,1/142,0.0070999171242726,0.0082499094553477,0,0,19858.0,98250.87390500787,UBE2G1
27126,KEGG_2019_Human,Protein processing in endoplasmic reticulum,1/165,0.0082499094553477,0.0082499094553477,0,0,19835.0,95159.46482222488,UBE2G1
27127,KEGG_2019_Human,Oxidative phosphorylation,1/133,0.0066499203093911,0.0112582177134695,0,0,19867.0,99596.2591544721,NDUFB2
27128,KEGG_2019_Human,Parkinson disease,1/142,0.0070999171242726,0.0112582177134695,0,0,19858.0,98250.87390500787,NDUFB2
27129,KEGG_2019_Human,Retrograde endocannabinoid signaling,1/148,0.007399915061391,0.0112582177134695,0,0,19852.0,97399.60470052566,NDUFB2
27130,KEGG_2019_Human,Non-alcoholic fatty liver disease (NAFLD),1/149,0.0074499147221605,0.0112582177134695,0,0,19851.0,97261.02051561224,NDUFB2
27131,KEGG_2019_Human,Alzheimer disease,1/171,0.0085499075557634,0.0112582177134695,0,0,19829.0,94422.42241345016,NDUFB2
27132,KEGG_2019_Human,Huntington disease,1/193,0.0096499008972596,0.0112582177134695,0,0,19807.0,91920.47679471428,NDUFB2
27133,KEGG_2019_Human,Thermogenesis,1/231,0.0115498903940656,0.0115498903940656,0,0,19769.0,88191.07730937863,NDUFB2
27134,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR52Z1
27135,KEGG_2019_Human,Cardiac muscle contraction,1/78,0.0038999427840466,0.0112582177134695,0,0,19922.0,110503.2180492851,COX6B2
27136,KEGG_2019_Human,Oxidative phosphorylation,1/133,0.0066499203093911,0.0112582177134695,0,0,19867.0,99596.2591544721,COX6B2
27137,KEGG_2019_Human,Parkinson disease,1/142,0.0070999171242726,0.0112582177134695,0,0,19858.0,98250.87390500787,COX6B2
27138,KEGG_2019_Human,Non-alcoholic fatty liver disease (NAFLD),1/149,0.0074499147221605,0.0112582177134695,0,0,19851.0,97261.02051561224,COX6B2
27139,KEGG_2019_Human,Alzheimer disease,1/171,0.0085499075557634,0.0112582177134695,0,0,19829.0,94422.42241345016,COX6B2
27140,KEGG_2019_Human,Huntington disease,1/193,0.0096499008972596,0.0112582177134695,0,0,19807.0,91920.47679471428,COX6B2
27141,KEGG_2019_Human,Thermogenesis,1/231,0.0115498903940656,0.0115498903940656,0,0,19769.0,88191.07730937863,COX6B2
27142,KEGG_2019_Human,Endocytosis,1/244,0.0121998870519305,0.0121998870519305,0,0,19756.0,87051.4275316661,SNX3
27143,KEGG_2019_Human,Fluid shear stress and atherosclerosis,1/139,0.006949918172816,0.0088999053857096,0,0,19861.0,98689.81333375497,TXN
27144,KEGG_2019_Human,NOD-like receptor signaling pathway,1/178,0.0088999053857096,0.0088999053857096,0,0,19822.0,93593.82745769851,TXN
27145,KEGG_2019_Human,Mineral absorption,1/51,0.0025499566390179,0.0025499566390179,0,0,19949.0,119129.0228601236,S100G
27146,KEGG_2019_Human,Parkinson disease,1/142,0.0070999171242726,0.0109498935894162,0,0,19858.0,98250.87390500787,SLC25A4
27147,KEGG_2019_Human,Cellular senescence,1/160,0.0079999110688441,0.0109498935894162,0,0,19840.0,95793.96509856998,SLC25A4
27148,KEGG_2019_Human,Necroptosis,1/162,0.0080999104202618,0.0109498935894162,0,0,19838.0,95537.86936302872,SLC25A4
27149,KEGG_2019_Human,cGMP-PKG signaling pathway,1/166,0.0082999091363732,0.0109498935894162,0,0,19834.0,95034.82345515196,SLC25A4
27150,KEGG_2019_Human,Calcium signaling pathway,1/188,0.009399902370135,0.0109498935894162,0,0,19812.0,92463.712994847,SLC25A4
27151,KEGG_2019_Human,Huntington disease,1/193,0.0096499008972596,0.0109498935894162,0,0,19807.0,91920.47679471428,SLC25A4
27152,KEGG_2019_Human,Human T-cell leukemia virus 1 infection,1/219,0.0109498935894162,0.0109498935894162,0,0,19781.0,89299.85161916987,SLC25A4
27153,KEGG_2019_Human,Apelin signaling pathway,1/137,0.0068499188797651,0.0096499008972596,0,0,19863.0,98987.62735269018,NRF1
27154,KEGG_2019_Human,Huntington disease,1/193,0.0096499008972596,0.0096499008972596,0,0,19807.0,91920.47679471428,NRF1
27155,KEGG_2019_Human,Oxidative phosphorylation,1/133,0.0066499203093911,0.0112582177134695,0,0,19867.0,99596.2591544721,NDUFS5
27156,KEGG_2019_Human,Parkinson disease,1/142,0.0070999171242726,0.0112582177134695,0,0,19858.0,98250.87390500787,NDUFS5
27157,KEGG_2019_Human,Retrograde endocannabinoid signaling,1/148,0.007399915061391,0.0112582177134695,0,0,19852.0,97399.60470052566,NDUFS5
27158,KEGG_2019_Human,Non-alcoholic fatty liver disease (NAFLD),1/149,0.0074499147221605,0.0112582177134695,0,0,19851.0,97261.02051561224,NDUFS5
27159,KEGG_2019_Human,Alzheimer disease,1/171,0.0085499075557634,0.0112582177134695,0,0,19829.0,94422.42241345016,NDUFS5
27160,KEGG_2019_Human,Huntington disease,1/193,0.0096499008972596,0.0112582177134695,0,0,19807.0,91920.47679471428,NDUFS5
27161,KEGG_2019_Human,Thermogenesis,1/231,0.0115498903940656,0.0115498903940656,0,0,19769.0,88191.07730937863,NDUFS5
27162,KEGG_2019_Human,Acute myeloid leukemia,1/66,0.003299948626608,0.0091665483379131,0,0,19934.0,113899.85357353876,CSF2
27163,KEGG_2019_Human,Fc epsilon RI signaling pathway,1/68,0.0033999476216189,0.0091665483379131,0,0,19932.0,113293.39338050144,CSF2
27164,KEGG_2019_Human,Salmonella infection,1/86,0.0042999391173866,0.0091665483379131,0,0,19914.0,108514.46102290176,CSF2
27165,KEGG_2019_Human,Rheumatoid arthritis,1/91,0.0045499369072032,0.0091665483379131,0,0,19909.0,107362.10783923086,CSF2
27166,KEGG_2019_Human,IL-17 signaling pathway,1/93,0.0046499360391879,0.0091665483379131,0,0,19907.0,106918.54242106884,CSF2
27167,KEGG_2019_Human,Amoebiasis,1/96,0.0047999347538706,0.0091665483379131,0,0,19904.0,106270.50039849174,CSF2
27168,KEGG_2019_Human,Hematopoietic cell lineage,1/97,0.0048499343304706,0.0091665483379131,0,0,19903.0,106058.9096435903,CSF2
27169,KEGG_2019_Human,T cell receptor signaling pathway,1/101,0.0050499326546803,0.0091665483379131,0,0,19899.0,105233.48101229242,CSF2
27170,KEGG_2019_Human,TNF signaling pathway,1/110,0.0054999290027479,0.0091665483379131,0,0,19890.0,103488.06969787036,CSF2
27171,KEGG_2019_Human,Natural killer cell mediated cytotoxicity,1/131,0.0065499210316603,0.0098248815474905,0,0,19869.0,99907.33811343512,CSF2
27172,KEGG_2019_Human,JAK-STAT signaling pathway,1/162,0.0080999104202618,0.0107306572674643,0,0,19838.0,95537.86936302872,CSF2
27173,KEGG_2019_Human,Kaposi sarcoma-associated herpesvirus infection,1/186,0.0092999029651357,0.0107306572674643,0,0,19814.0,92684.96451050608,CSF2
27174,KEGG_2019_Human,Transcriptional misregulation in cancer,1/186,0.0092999029651357,0.0107306572674643,0,0,19814.0,92684.96451050608,CSF2
27175,KEGG_2019_Human,Human T-cell leukemia virus 1 infection,1/219,0.0109498935894162,0.0117320288458031,0,0,19781.0,89299.85161916987,CSF2
27176,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0146998751759735,0,0,19706.0,83157.67014793828,CSF2
27177,KEGG_2019_Human,Proteasome,1/45,0.0022499601197094,0.0022499601197094,0,0,19955.0,121662.49782449217,PSMB1
27178,KEGG_2019_Human,Ribosome,1/153,0.0076499133771537,0.0076499133771537,0,0,19847.0,96715.6407630817,RPS17
27179,KEGG_2019_Human,Endocrine and other factor-regulated calcium reabsorption,1/48,0.0023999583567988,0.0077998855680932,0,0,19952.0,120356.5272753826,CLTA
27180,KEGG_2019_Human,Bacterial invasion of epithelial cells,1/74,0.0036999446830449,0.0077998855680932,0,0,19926.0,111574.38983110404,CLTA
27181,KEGG_2019_Human,Synaptic vesicle cycle,1/78,0.0038999427840466,0.0077998855680932,0,0,19922.0,110503.2180492851,CLTA
27182,KEGG_2019_Human,Lysosome,1/123,0.0061499239842961,0.0092248859764442,0,0,19877.0,101200.07933676826,CLTA
27183,KEGG_2019_Human,Huntington disease,1/193,0.0096499008972596,0.0115798810767115,0,0,19807.0,91920.47679471428,CLTA
27184,KEGG_2019_Human,Endocytosis,1/244,0.0121998870519305,0.0121998870519305,0,0,19756.0,87051.4275316661,CLTA
27185,KEGG_2019_Human,Bile secretion,1/72,0.0035999456502131,0.0035999456502131,0,0,19928.0,112131.59838572376,NR0B2
27186,KEGG_2019_Human,RNA degradation,1/79,0.0039499423167337,0.0066999199497742,0,0,19921.0,110243.89578070649,LSM3
27187,KEGG_2019_Human,Spliceosome,1/134,0.0066999199497742,0.0066999199497742,0,0,19866.0,99442.43560916925,LSM3
27188,KEGG_2019_Human,Glutathione metabolism,1/56,0.0027999538675741,0.0036999446830449,0,0,19944.0,117233.87022514464,GPX2
27189,KEGG_2019_Human,Arachidonic acid metabolism,1/63,0.0031499501598827,0.0036999446830449,0,0,19937.0,114844.46974572667,GPX2
27190,KEGG_2019_Human,Thyroid hormone synthesis,1/74,0.0036999446830449,0.0036999446830449,0,0,19926.0,111574.38983110404,GPX2
27191,KEGG_2019_Human,Cardiac muscle contraction,1/78,0.0038999427840466,0.0112582177134695,0,0,19922.0,110503.2180492851,COX6A1
27192,KEGG_2019_Human,Oxidative phosphorylation,1/133,0.0066499203093911,0.0112582177134695,0,0,19867.0,99596.2591544721,COX6A1
27193,KEGG_2019_Human,Parkinson disease,1/142,0.0070999171242726,0.0112582177134695,0,0,19858.0,98250.87390500787,COX6A1
27194,KEGG_2019_Human,Non-alcoholic fatty liver disease (NAFLD),1/149,0.0074499147221605,0.0112582177134695,0,0,19851.0,97261.02051561224,COX6A1
27195,KEGG_2019_Human,Alzheimer disease,1/171,0.0085499075557634,0.0112582177134695,0,0,19829.0,94422.42241345016,COX6A1
27196,KEGG_2019_Human,Huntington disease,1/193,0.0096499008972596,0.0112582177134695,0,0,19807.0,91920.47679471428,COX6A1
27197,KEGG_2019_Human,Thermogenesis,1/231,0.0115498903940656,0.0115498903940656,0,0,19769.0,88191.07730937863,COX6A1
27198,KEGG_2019_Human,C-type lectin receptor signaling pathway,1/104,0.0051999314202997,0.0142498526687993,0,0,19896.0,104635.24941415618,CCL22
27199,KEGG_2019_Human,Chemokine signaling pathway,1/190,0.0094999017791995,0.0142498526687993,0,0,19810.0,92244.74636351672,CCL22
27200,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0146998751759735,0,0,19706.0,83157.67014793828,CCL22
27201,KEGG_2019_Human,Arachidonic acid metabolism,1/63,0.0031499501598827,0.0031499501598827,0,0,19937.0,114844.46974572667,LTC4S
27202,KEGG_2019_Human,Oxidative phosphorylation,1/133,0.0066499203093911,0.0115498903940656,0,0,19867.0,99596.2591544721,COX17
27203,KEGG_2019_Human,Thermogenesis,1/231,0.0115498903940656,0.0115498903940656,0,0,19769.0,88191.07730937863,COX17
27204,KEGG_2019_Human,Chemokine signaling pathway,1/190,0.0094999017791995,0.0146998751759735,0,0,19810.0,92244.74636351672,CCL8
27205,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0146998751759735,0,0,19706.0,83157.67014793828,CCL8
27206,KEGG_2019_Human,Spliceosome,1/134,0.0066999199497742,0.0066999199497742,0,0,19866.0,99442.43560916925,PHF5A
27207,KEGG_2019_Human,Nucleotide excision repair,1/47,0.0023499589392381,0.0023499589392381,0,0,19953.0,120782.64067395544,ERCC5
27208,KEGG_2019_Human,Steroid hormone biosynthesis,1/60,0.002999951725986,0.004099940929819,0,0,19940.0,115834.63209072244,CYP3A7-CYP3A51P
27209,KEGG_2019_Human,Retinol metabolism,1/67,0.0033499481224912,0.004099940929819,0,0,19933.0,113594.38808369274,CYP3A7-CYP3A51P
27210,KEGG_2019_Human,Chemical carcinogenesis,1/82,0.004099940929819,0.004099940929819,0,0,19918.0,109484.9180722932,CYP3A7-CYP3A51P
27211,KEGG_2019_Human,Pathogenic Escherichia coli infection,1/55,0.0027499544131125,0.0112652343835177,0,0,19945.0,117599.1294878737,CDC42
27212,KEGG_2019_Human,VEGF signaling pathway,1/59,0.0029499522555206,0.0112652343835177,0,0,19941.0,116175.59385530632,CDC42
27213,KEGG_2019_Human,Shigellosis,1/65,0.003249949134407,0.0112652343835177,0,0,19935.0,114209.92613860144,CDC42
27214,KEGG_2019_Human,Epithelial cell signaling in Helicobacter pylori infection,1/68,0.0033999476216189,0.0112652343835177,0,0,19932.0,113293.39338050144,CDC42
27215,KEGG_2019_Human,Renal cell carcinoma,1/69,0.003449947123837,0.0112652343835177,0,0,19931.0,112996.7391397682,CDC42
27216,KEGG_2019_Human,Adherens junction,1/72,0.0035999456502131,0.0112652343835177,0,0,19928.0,112131.59838572376,CDC42
27217,KEGG_2019_Human,Bacterial invasion of epithelial cells,1/74,0.0036999446830449,0.0112652343835177,0,0,19926.0,111574.38983110404,CDC42
27218,KEGG_2019_Human,Pancreatic cancer,1/75,0.0037499442041125,0.0112652343835177,0,0,19925.0,111301.33528642564,CDC42
27219,KEGG_2019_Human,Salmonella infection,1/86,0.0042999391173866,0.0112652343835177,0,0,19914.0,108514.46102290176,CDC42
27220,KEGG_2019_Human,Fc gamma R-mediated phagocytosis,1/91,0.0045499369072032,0.0112652343835177,0,0,19909.0,107362.10783923086,CDC42
27221,KEGG_2019_Human,GnRH signaling pathway,1/93,0.0046499360391879,0.0112652343835177,0,0,19907.0,106918.54242106884,CDC42
27222,KEGG_2019_Human,AGE-RAGE signaling pathway in diabetic complications,1/100,0.0049999330710556,0.0112652343835177,0,0,19900.0,105436.78197328727,CDC42
27223,KEGG_2019_Human,T cell receptor signaling pathway,1/101,0.0050499326546803,0.0112652343835177,0,0,19899.0,105233.48101229242,CDC42
27224,KEGG_2019_Human,Leukocyte transendothelial migration,1/112,0.0055999282120529,0.0115031892971265,0,0,19888.0,103119.30984392198,CDC42
27225,KEGG_2019_Human,Neurotrophin signaling pathway,1/119,0.0059499254985137,0.0115031892971265,0,0,19881.0,101877.73080211312,CDC42
27226,KEGG_2019_Human,Non-alcoholic fatty liver disease (NAFLD),1/149,0.0074499147221605,0.0129290397329498,0,0,19851.0,97261.02051561224,CDC42
27227,KEGG_2019_Human,Tight junction,1/170,0.0084999078692823,0.0129290397329498,0,0,19830.0,94543.49009679438,CDC42
27228,KEGG_2019_Human,Axon guidance,1/181,0.0090499044707863,0.0129290397329498,0,0,19819.0,93248.41634586031,CDC42
27229,KEGG_2019_Human,Chemokine signaling pathway,1/190,0.0094999017791995,0.0129290397329498,0,0,19810.0,92244.74636351672,CDC42
27230,KEGG_2019_Human,Focal adhesion,1/199,0.0099498991610159,0.0129290397329498,0,0,19801.0,91286.4288690606,CDC42
27231,KEGG_2019_Human,Proteoglycans in cancer,1/201,0.0100498985877989,0.0129290397329498,0,0,19799.0,91079.21596609056,CDC42
27232,KEGG_2019_Human,Viral carcinogenesis,1/201,0.0100498985877989,0.0129290397329498,0,0,19799.0,91079.21596609056,CDC42
27233,KEGG_2019_Human,Rap1 signaling pathway,1/206,0.010299897173561,0.0129290397329498,0,0,19794.0,90569.849337325,CDC42
27234,KEGG_2019_Human,Regulation of actin cytoskeleton,1/214,0.0106998949514067,0.0129290397329498,0,0,19786.0,89779.39753374986,CDC42
27235,KEGG_2019_Human,Ras signaling pathway,1/232,0.0115998901349604,0.013455872556554,0,0,19768.0,88101.22480150245,CDC42
27236,KEGG_2019_Human,Endocytosis,1/244,0.0121998870519305,0.0136075663271533,0,0,19756.0,87051.4275316661,CDC42
27237,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0158424582835507,0,0,19705.0,83086.53988020132,CDC42
27238,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0170891484396418,0,0,19670.0,80733.60565076157,CDC42
27239,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,CDC42
27240,KEGG_2019_Human,Ribosome,1/153,0.0076499133771537,0.0076499133771537,0,0,19847.0,96715.6407630817,RPS4Y1
27241,KEGG_2019_Human,Fanconi anemia pathway,1/54,0.0026999549628563,0.0026999549628563,0,0,19946.0,117971.01964061816,UBE2T
27242,KEGG_2019_Human,Autoimmune thyroid disease,1/53,0.0026499555173137,0.0145586837375733,0,0,19947.0,118349.78824235698,IFNA14
27243,KEGG_2019_Human,Cytosolic DNA-sensing pathway,1/63,0.0031499501598827,0.0145586837375733,0,0,19937.0,114844.46974572667,IFNA14
27244,KEGG_2019_Human,RIG-I-like receptor signaling pathway,1/70,0.0034999466296654,0.0145586837375733,0,0,19930.0,112704.30065625212,IFNA14
27245,KEGG_2019_Human,Toll-like receptor signaling pathway,1/104,0.0051999314202997,0.0145586837375733,0,0,19896.0,104635.24941415618,IFNA14
27246,KEGG_2019_Human,Natural killer cell mediated cytotoxicity,1/131,0.0065499210316603,0.0145586837375733,0,0,19869.0,99907.33811343512,IFNA14
27247,KEGG_2019_Human,Measles,1/138,0.0068999185254481,0.0145586837375733,0,0,19862.0,98838.19160389496,IFNA14
27248,KEGG_2019_Human,Hepatitis C,1/155,0.0077499127120574,0.0145586837375733,0,0,19845.0,96448.16254952336,IFNA14
27249,KEGG_2019_Human,Necroptosis,1/162,0.0080999104202618,0.0145586837375733,0,0,19838.0,95537.86936302872,IFNA14
27250,KEGG_2019_Human,JAK-STAT signaling pathway,1/162,0.0080999104202618,0.0145586837375733,0,0,19838.0,95537.86936302872,IFNA14
27251,KEGG_2019_Human,Hepatitis B,1/163,0.0081499100978668,0.0145586837375733,0,0,19837.0,95410.9786681514,IFNA14
27252,KEGG_2019_Human,Influenza A,1/171,0.0085499075557634,0.0145586837375733,0,0,19829.0,94422.42241345016,IFNA14
27253,KEGG_2019_Human,NOD-like receptor signaling pathway,1/178,0.0088999053857096,0.0145586837375733,0,0,19822.0,93593.82745769851,IFNA14
27254,KEGG_2019_Human,Tuberculosis,1/179,0.0089499050800561,0.0145586837375733,0,0,19821.0,93478.0629355712,IFNA14
27255,KEGG_2019_Human,Kaposi sarcoma-associated herpesvirus infection,1/186,0.0092999029651357,0.0145586837375733,0,0,19814.0,92684.96451050608,IFNA14
27256,KEGG_2019_Human,Epstein-Barr virus infection,1/201,0.0100498985877989,0.0145586837375733,0,0,19799.0,91079.21596609056,IFNA14
27257,KEGG_2019_Human,Human immunodeficiency virus 1 infection,1/212,0.0105998955026255,0.0145586837375733,0,0,19788.0,89974.27756224656,IFNA14
27258,KEGG_2019_Human,Human cytomegalovirus infection,1/225,0.0112498919790339,0.0145586837375733,0,0,19775.0,88738.27077557483,IFNA14
27259,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0179665141039676,0,0,19706.0,83157.67014793828,IFNA14
27260,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0191051096893273,0,0,19670.0,80733.60565076157,IFNA14
27261,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0194698489055035,0,0,19646.0,79255.8617626126,IFNA14
27262,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0257712598834163,0,0,19508.0,72277.44006442746,IFNA14
27263,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,IFNA14
27264,KEGG_2019_Human,Mineral absorption,1/51,0.0025499566390179,0.0025499566390179,0,0,19949.0,119129.0228601236,MT1F
27265,KEGG_2019_Human,MicroRNAs in cancer,1/299,0.0149498740670514,0.0149498740670514,0,0,19701.0,82804.33538735632,MIR125B2
27266,KEGG_2019_Human,IL-17 signaling pathway,1/93,0.0046499360391879,0.0089165503378209,0,0,19907.0,106918.54242106884,IL17D
27267,KEGG_2019_Human,C-type lectin receptor signaling pathway,1/104,0.0051999314202997,0.0089165503378209,0,0,19896.0,104635.24941415618,IL17D
27268,KEGG_2019_Human,Th17 cell differentiation,1/107,0.0053499302026925,0.0089165503378209,0,0,19893.0,104053.753408911,IL17D
27269,KEGG_2019_Human,JAK-STAT signaling pathway,1/162,0.0080999104202618,0.0101248880253273,0,0,19838.0,95537.86936302872,IL17D
27270,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0146998751759735,0,0,19706.0,83157.67014793828,IL17D
27271,KEGG_2019_Human,Thyroid hormone signaling pathway,1/116,0.0057999266512085,0.0057999266512085,0,0,19884.0,102400.8105961506,MED4
27272,KEGG_2019_Human,RNA transport,1/165,0.0082499094553477,0.0082499094553477,0,0,19835.0,95159.46482222488,EIF4EBP3
27273,KEGG_2019_Human,Proteasome,1/45,0.0022499601197094,0.0044999202394188,0,0,19955.0,121662.49782449217,PSMD13
27274,KEGG_2019_Human,Epstein-Barr virus infection,1/201,0.0100498985877989,0.0100498985877989,0,0,19799.0,91079.21596609056,PSMD13
27275,KEGG_2019_Human,MicroRNAs in cancer,1/299,0.0149498740670514,0.0149498740670514,0,0,19701.0,82804.33538735632,MIR222
27276,KEGG_2019_Human,African trypanosomiasis,1/37,0.0018499650702878,0.0099998661421113,0,0,19963.0,125618.9446446357,NPPA
27277,KEGG_2019_Human,Regulation of lipolysis in adipocytes,1/55,0.0027499544131125,0.0099998661421113,0,0,19945.0,117599.1294878737,NPPA
27278,KEGG_2019_Human,Renin secretion,1/69,0.003449947123837,0.0099998661421113,0,0,19931.0,112996.7391397682,NPPA
27279,KEGG_2019_Human,Aldosterone synthesis and secretion,1/98,0.0048999339081079,0.0099998661421113,0,0,19902.0,105849.45495286948,NPPA
27280,KEGG_2019_Human,HIF-1 signaling pathway,1/100,0.0049999330710556,0.0099998661421113,0,0,19900.0,105436.78197328727,NPPA
27281,KEGG_2019_Human,Vascular smooth muscle contraction,1/132,0.0065999206698993,0.0103748864204666,0,0,19868.0,99751.22090491928,NPPA
27282,KEGG_2019_Human,Oxytocin signaling pathway,1/153,0.0076499133771537,0.0103748864204666,0,0,19847.0,96715.6407630817,NPPA
27283,KEGG_2019_Human,cGMP-PKG signaling pathway,1/166,0.0082999091363732,0.0103748864204666,0,0,19834.0,95034.82345515196,NPPA
27284,KEGG_2019_Human,cAMP signaling pathway,1/212,0.0105998955026255,0.0115498903940656,0,0,19788.0,89974.27756224656,NPPA
27285,KEGG_2019_Human,Thermogenesis,1/231,0.0115498903940656,0.0115498903940656,0,0,19769.0,88191.07730937863,NPPA
27286,KEGG_2019_Human,Purine metabolism,1/129,0.006449921761047,0.006449921761047,0,0,19871.0,100223.109907462,PDE6D
27287,KEGG_2019_Human,Cardiac muscle contraction,1/78,0.0038999427840466,0.0112582177134695,0,0,19922.0,110503.2180492851,COX7A2
27288,KEGG_2019_Human,Oxidative phosphorylation,1/133,0.0066499203093911,0.0112582177134695,0,0,19867.0,99596.2591544721,COX7A2
27289,KEGG_2019_Human,Parkinson disease,1/142,0.0070999171242726,0.0112582177134695,0,0,19858.0,98250.87390500787,COX7A2
27290,KEGG_2019_Human,Non-alcoholic fatty liver disease (NAFLD),1/149,0.0074499147221605,0.0112582177134695,0,0,19851.0,97261.02051561224,COX7A2
27291,KEGG_2019_Human,Alzheimer disease,1/171,0.0085499075557634,0.0112582177134695,0,0,19829.0,94422.42241345016,COX7A2
27292,KEGG_2019_Human,Huntington disease,1/193,0.0096499008972596,0.0112582177134695,0,0,19807.0,91920.47679471428,COX7A2
27293,KEGG_2019_Human,Thermogenesis,1/231,0.0115498903940656,0.0115498903940656,0,0,19769.0,88191.07730937863,COX7A2
27294,KEGG_2019_Human,Ether lipid metabolism,1/47,0.0023499589392381,0.0023499589392381,0,0,19953.0,120782.64067395544,PAFAH1B3
27295,KEGG_2019_Human,IL-17 signaling pathway,1/93,0.0046499360391879,0.0103998628405995,0,0,19907.0,106918.54242106884,CCL17
27296,KEGG_2019_Human,C-type lectin receptor signaling pathway,1/104,0.0051999314202997,0.0103998628405995,0,0,19896.0,104635.24941415618,CCL17
27297,KEGG_2019_Human,Chemokine signaling pathway,1/190,0.0094999017791995,0.0126665357055994,0,0,19810.0,92244.74636351672,CCL17
27298,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0146998751759735,0,0,19706.0,83157.67014793828,CCL17
27299,KEGG_2019_Human,MicroRNAs in cancer,1/299,0.0149498740670514,0.0149498740670514,0,0,19701.0,82804.33538735632,MIR19B2
27300,KEGG_2019_Human,Spliceosome,1/134,0.0066999199497742,0.0066999199497742,0,0,19866.0,99442.43560916925,BCAS2
27301,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR2A42
27302,KEGG_2019_Human,NOD-like receptor signaling pathway,1/178,0.0088999053857096,0.0088999053857096,0,0,19822.0,93593.82745769851,PYDC1
27303,KEGG_2019_Human,Asthma,1/31,0.0015499690656704,0.0083141731379497,0,0,19969.0,129189.85098816035,HLA-DQB1
27304,KEGG_2019_Human,Allograft rejection,1/38,0.001899964429635,0.0083141731379497,0,0,19962.0,125080.29732025368,HLA-DQB1
27305,KEGG_2019_Human,Graft-versus-host disease,1/41,0.0020499625466866,0.0083141731379497,0,0,19959.0,123544.88783416104,HLA-DQB1
27306,KEGG_2019_Human,Type I diabetes mellitus,1/43,0.0021499613216957,0.0083141731379497,0,0,19957.0,122581.98940490963,HLA-DQB1
27307,KEGG_2019_Human,Intestinal immune network for IgA production,1/48,0.0023999583567988,0.0083141731379497,0,0,19952.0,120356.5272753826,HLA-DQB1
27308,KEGG_2019_Human,Autoimmune thyroid disease,1/53,0.0026499555173137,0.0083141731379497,0,0,19947.0,118349.78824235698,HLA-DQB1
27309,KEGG_2019_Human,Viral myocarditis,1/59,0.0029499522555206,0.0083141731379497,0,0,19941.0,116175.59385530632,HLA-DQB1
27310,KEGG_2019_Human,Inflammatory bowel disease (IBD),1/65,0.003249949134407,0.0083141731379497,0,0,19935.0,114209.92613860144,HLA-DQB1
27311,KEGG_2019_Human,Staphylococcus aureus infection,1/68,0.0033999476216189,0.0083141731379497,0,0,19932.0,113293.39338050144,HLA-DQB1
27312,KEGG_2019_Human,Leishmaniasis,1/74,0.0036999446830449,0.0083141731379497,0,0,19926.0,111574.38983110404,HLA-DQB1
27313,KEGG_2019_Human,Antigen processing and presentation,1/77,0.0038499432547502,0.0083141731379497,0,0,19923.0,110765.8407373636,HLA-DQB1
27314,KEGG_2019_Human,Rheumatoid arthritis,1/91,0.0045499369072032,0.0083141731379497,0,0,19909.0,107362.10783923086,HLA-DQB1
27315,KEGG_2019_Human,Th1 and Th2 cell differentiation,1/92,0.0045999364719865,0.0083141731379497,0,0,19908.0,107139.13814408927,HLA-DQB1
27316,KEGG_2019_Human,Hematopoietic cell lineage,1/97,0.0048499343304706,0.0083141731379497,0,0,19903.0,106058.9096435903,HLA-DQB1
27317,KEGG_2019_Human,Th17 cell differentiation,1/107,0.0053499302026925,0.0084748917286727,0,0,19893.0,104053.753408911,HLA-DQB1
27318,KEGG_2019_Human,Toxoplasmosis,1/113,0.0056499278191151,0.0084748917286727,0,0,19887.0,102937.34947211576,HLA-DQB1
27319,KEGG_2019_Human,Systemic lupus erythematosus,1/133,0.0066499203093911,0.0093881227897286,0,0,19867.0,99596.2591544721,HLA-DQB1
27320,KEGG_2019_Human,Cell adhesion molecules (CAMs),1/145,0.0072499160871101,0.0095998910039963,0,0,19855.0,97820.92670675044,HLA-DQB1
27321,KEGG_2019_Human,Phagosome,1/152,0.0075999137114971,0.0095998910039963,0,0,19848.0,96850.665715497,HLA-DQB1
27322,KEGG_2019_Human,Influenza A,1/171,0.0085499075557634,0.0102284629486356,0,0,19829.0,94422.42241345016,HLA-DQB1
27323,KEGG_2019_Human,Tuberculosis,1/179,0.0089499050800561,0.0102284629486356,0,0,19821.0,93478.0629355712,HLA-DQB1
27324,KEGG_2019_Human,Epstein-Barr virus infection,1/201,0.0100498985877989,0.0109635257321443,0,0,19799.0,91079.21596609056,HLA-DQB1
27325,KEGG_2019_Human,Human T-cell leukemia virus 1 infection,1/219,0.0109498935894162,0.0114259759193908,0,0,19781.0,89299.85161916987,HLA-DQB1
27326,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,HLA-DQB1
27327,KEGG_2019_Human,Small cell lung cancer,1/93,0.0046499360391879,0.0092998720783758,0,0,19907.0,106918.54242106884,CKS1B
27328,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,CKS1B
27329,KEGG_2019_Human,Ribosome biogenesis in eukaryotes,1/101,0.0050499326546803,0.0050499326546803,0,0,19899.0,105233.48101229242,PWP2
27330,KEGG_2019_Human,Intestinal immune network for IgA production,1/48,0.0023999583567988,0.0047999167135976,0,0,19952.0,120356.5272753826,ICOSLG
27331,KEGG_2019_Human,Cell adhesion molecules (CAMs),1/145,0.0072499160871101,0.0072499160871101,0,0,19855.0,97820.92670675044,ICOSLG
27332,KEGG_2019_Human,Spliceosome,1/134,0.0066999199497742,0.0066999199497742,0,0,19866.0,99442.43560916925,ISY1
27333,KEGG_2019_Human,RNA transport,1/165,0.0082499094553477,0.0082499094553477,0,0,19835.0,95159.46482222488,RPP21
27334,KEGG_2019_Human,GABAergic synapse,1/89,0.0044499377838098,0.0130498764018304,0,0,19911.0,107815.380281759,GNG10
27335,KEGG_2019_Human,Morphine addiction,1/91,0.0045499369072032,0.0130498764018304,0,0,19909.0,107362.10783923086,GNG10
27336,KEGG_2019_Human,Circadian entrainment,1/97,0.0048499343304706,0.0130498764018304,0,0,19903.0,106058.9096435903,GNG10
27337,KEGG_2019_Human,Cholinergic synapse,1/112,0.0055999282120529,0.0130498764018304,0,0,19888.0,103119.30984392198,GNG10
27338,KEGG_2019_Human,Serotonergic synapse,1/113,0.0056499278191151,0.0130498764018304,0,0,19887.0,102937.34947211576,GNG10
27339,KEGG_2019_Human,Glutamatergic synapse,1/114,0.005699927427839,0.0130498764018304,0,0,19886.0,102756.96431429044,GNG10
27340,KEGG_2019_Human,Relaxin signaling pathway,1/130,0.0064999213952527,0.0130498764018304,0,0,19870.0,100064.62842845908,GNG10
27341,KEGG_2019_Human,Dopaminergic synapse,1/131,0.0065499210316603,0.0130498764018304,0,0,19869.0,99907.33811343512,GNG10
27342,KEGG_2019_Human,Apelin signaling pathway,1/137,0.0068499188797651,0.0130498764018304,0,0,19863.0,98987.62735269018,GNG10
27343,KEGG_2019_Human,Retrograde endocannabinoid signaling,1/148,0.007399915061391,0.0130498764018304,0,0,19852.0,97399.60470052566,GNG10
27344,KEGG_2019_Human,Alcoholism,1/180,0.0089999047745351,0.0130498764018304,0,0,19820.0,93362.92821536642,GNG10
27345,KEGG_2019_Human,Kaposi sarcoma-associated herpesvirus infection,1/186,0.0092999029651357,0.0130498764018304,0,0,19814.0,92684.96451050608,GNG10
27346,KEGG_2019_Human,Chemokine signaling pathway,1/190,0.0094999017791995,0.0130498764018304,0,0,19810.0,92244.74636351672,GNG10
27347,KEGG_2019_Human,Human immunodeficiency virus 1 infection,1/212,0.0105998955026255,0.0130498764018304,0,0,19788.0,89974.27756224656,GNG10
27348,KEGG_2019_Human,Human cytomegalovirus infection,1/225,0.0112498919790339,0.0130498764018304,0,0,19775.0,88738.27077557483,GNG10
27349,KEGG_2019_Human,Ras signaling pathway,1/232,0.0115998901349604,0.0130498764018304,0,0,19768.0,88101.22480150245,GNG10
27350,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0187410310320355,0,0,19646.0,79255.8617626126,GNG10
27351,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,GNG10
27352,KEGG_2019_Human,Pathogenic Escherichia coli infection,1/55,0.0027499544131125,0.0063699116700844,0,0,19945.0,117599.1294878737,ARPC1B
27353,KEGG_2019_Human,Shigellosis,1/65,0.003249949134407,0.0063699116700844,0,0,19935.0,114209.92613860144,ARPC1B
27354,KEGG_2019_Human,Bacterial invasion of epithelial cells,1/74,0.0036999446830449,0.0063699116700844,0,0,19926.0,111574.38983110404,ARPC1B
27355,KEGG_2019_Human,Salmonella infection,1/86,0.0042999391173866,0.0063699116700844,0,0,19914.0,108514.46102290176,ARPC1B
27356,KEGG_2019_Human,Fc gamma R-mediated phagocytosis,1/91,0.0045499369072032,0.0063699116700844,0,0,19909.0,107362.10783923086,ARPC1B
27357,KEGG_2019_Human,Regulation of actin cytoskeleton,1/214,0.0106998949514067,0.0121998870519305,0,0,19786.0,89779.39753374986,ARPC1B
27358,KEGG_2019_Human,Endocytosis,1/244,0.0121998870519305,0.0121998870519305,0,0,19756.0,87051.4275316661,ARPC1B
27359,KEGG_2019_Human,Pyrimidine metabolism,1/57,0.002849953326298,0.006449921761047,0,0,19943.0,116875.00742975442,NME3
27360,KEGG_2019_Human,Drug metabolism,1/108,0.0053999298011749,0.006449921761047,0,0,19892.0,103863.47861844616,NME3
27361,KEGG_2019_Human,Purine metabolism,1/129,0.006449921761047,0.006449921761047,0,0,19871.0,100223.109907462,NME3
27362,KEGG_2019_Human,Spliceosome,1/134,0.0066999199497742,0.0066999199497742,0,0,19866.0,99442.43560916925,ZMAT2
27363,KEGG_2019_Human,Leukocyte transendothelial migration,1/112,0.0055999282120529,0.0106998949514067,0,0,19888.0,103119.30984392198,MYL12B
27364,KEGG_2019_Human,Platelet activation,1/124,0.0061999236097501,0.0106998949514067,0,0,19876.0,101034.04709010696,MYL12B
27365,KEGG_2019_Human,Tight junction,1/170,0.0084999078692823,0.0106998949514067,0,0,19830.0,94543.49009679438,MYL12B
27366,KEGG_2019_Human,Axon guidance,1/181,0.0090499044707863,0.0106998949514067,0,0,19819.0,93248.41634586031,MYL12B
27367,KEGG_2019_Human,Focal adhesion,1/199,0.0099498991610159,0.0106998949514067,0,0,19801.0,91286.4288690606,MYL12B
27368,KEGG_2019_Human,Regulation of actin cytoskeleton,1/214,0.0106998949514067,0.0106998949514067,0,0,19786.0,89779.39753374986,MYL12B
27369,KEGG_2019_Human,MicroRNAs in cancer,1/299,0.0149498740670514,0.0149498740670514,0,0,19701.0,82804.33538735632,MIR18A
27370,KEGG_2019_Human,MicroRNAs in cancer,1/299,0.0149498740670514,0.0149498740670514,0,0,19701.0,82804.33538735632,MIR181A1
27371,KEGG_2019_Human,Glycosylphosphatidylinositol (GPI)-anchor biosynthesis,1/25,0.0012499733663791,0.0012499733663791,0,0,19975.0,133525.54486996148,PIGY
27372,KEGG_2019_Human,Salivary secretion,1/90,0.0044999373439762,0.0044999373439762,0,0,19910.0,107587.50385474482,STATH
27373,KEGG_2019_Human,ErbB signaling pathway,1/85,0.004249939567045,0.0085998782347732,0,0,19915.0,108752.83801948265,EREG
27374,KEGG_2019_Human,Colorectal cancer,1/86,0.0042999391173866,0.0085998782347732,0,0,19914.0,108514.46102290176,EREG
27375,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0176998626413668,0,0,19705.0,83086.53988020132,EREG
27376,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0176998626413668,0,0,19646.0,79255.8617626126,EREG
27377,KEGG_2019_Human,Ribosome,1/153,0.0076499133771537,0.0076499133771537,0,0,19847.0,96715.6407630817,MRPL15
27378,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,NPFF
27379,KEGG_2019_Human,Ribosome,1/153,0.0076499133771537,0.0076499133771537,0,0,19847.0,96715.6407630817,RPL21
27380,KEGG_2019_Human,Glycosaminoglycan biosynthesis,1/53,0.0026499555173137,0.0026499555173137,0,0,19947.0,118349.78824235698,HS2ST1
27381,KEGG_2019_Human,MicroRNAs in cancer,1/299,0.0149498740670514,0.0149498740670514,0,0,19701.0,82804.33538735632,MIR34A
27382,KEGG_2019_Human,mTOR signaling pathway,1/152,0.0075999137114971,0.0147498749536506,0,0,19848.0,96850.665715497,LAMTOR3
27383,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0147498749536506,0,0,19705.0,83086.53988020132,LAMTOR3
27384,KEGG_2019_Human,RNA polymerase,1/31,0.0015499690656704,0.0046499071970112,0,0,19969.0,129189.85098816035,POLR2K
27385,KEGG_2019_Human,Cytosolic DNA-sensing pathway,1/63,0.0031499501598827,0.0047249252398241,0,0,19937.0,114844.46974572667,POLR2K
27386,KEGG_2019_Human,Huntington disease,1/193,0.0096499008972596,0.0096499008972596,0,0,19807.0,91920.47679471428,POLR2K
27387,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR4F21
27388,KEGG_2019_Human,MicroRNAs in cancer,1/299,0.0149498740670514,0.0149498740670514,0,0,19701.0,82804.33538735632,MIR29B2
27389,KEGG_2019_Human,Asthma,1/31,0.0015499690656704,0.0083141731379497,0,0,19969.0,129189.85098816035,HLA-DRB5
27390,KEGG_2019_Human,Allograft rejection,1/38,0.001899964429635,0.0083141731379497,0,0,19962.0,125080.29732025368,HLA-DRB5
27391,KEGG_2019_Human,Graft-versus-host disease,1/41,0.0020499625466866,0.0083141731379497,0,0,19959.0,123544.88783416104,HLA-DRB5
27392,KEGG_2019_Human,Type I diabetes mellitus,1/43,0.0021499613216957,0.0083141731379497,0,0,19957.0,122581.98940490963,HLA-DRB5
27393,KEGG_2019_Human,Intestinal immune network for IgA production,1/48,0.0023999583567988,0.0083141731379497,0,0,19952.0,120356.5272753826,HLA-DRB5
27394,KEGG_2019_Human,Autoimmune thyroid disease,1/53,0.0026499555173137,0.0083141731379497,0,0,19947.0,118349.78824235698,HLA-DRB5
27395,KEGG_2019_Human,Viral myocarditis,1/59,0.0029499522555206,0.0083141731379497,0,0,19941.0,116175.59385530632,HLA-DRB5
27396,KEGG_2019_Human,Inflammatory bowel disease (IBD),1/65,0.003249949134407,0.0083141731379497,0,0,19935.0,114209.92613860144,HLA-DRB5
27397,KEGG_2019_Human,Staphylococcus aureus infection,1/68,0.0033999476216189,0.0083141731379497,0,0,19932.0,113293.39338050144,HLA-DRB5
27398,KEGG_2019_Human,Leishmaniasis,1/74,0.0036999446830449,0.0083141731379497,0,0,19926.0,111574.38983110404,HLA-DRB5
27399,KEGG_2019_Human,Antigen processing and presentation,1/77,0.0038499432547502,0.0083141731379497,0,0,19923.0,110765.8407373636,HLA-DRB5
27400,KEGG_2019_Human,Rheumatoid arthritis,1/91,0.0045499369072032,0.0083141731379497,0,0,19909.0,107362.10783923086,HLA-DRB5
27401,KEGG_2019_Human,Th1 and Th2 cell differentiation,1/92,0.0045999364719865,0.0083141731379497,0,0,19908.0,107139.13814408927,HLA-DRB5
27402,KEGG_2019_Human,Hematopoietic cell lineage,1/97,0.0048499343304706,0.0083141731379497,0,0,19903.0,106058.9096435903,HLA-DRB5
27403,KEGG_2019_Human,Th17 cell differentiation,1/107,0.0053499302026925,0.0084748917286727,0,0,19893.0,104053.753408911,HLA-DRB5
27404,KEGG_2019_Human,Toxoplasmosis,1/113,0.0056499278191151,0.0084748917286727,0,0,19887.0,102937.34947211576,HLA-DRB5
27405,KEGG_2019_Human,Systemic lupus erythematosus,1/133,0.0066499203093911,0.0093881227897286,0,0,19867.0,99596.2591544721,HLA-DRB5
27406,KEGG_2019_Human,Cell adhesion molecules (CAMs),1/145,0.0072499160871101,0.0095998910039963,0,0,19855.0,97820.92670675044,HLA-DRB5
27407,KEGG_2019_Human,Phagosome,1/152,0.0075999137114971,0.0095998910039963,0,0,19848.0,96850.665715497,HLA-DRB5
27408,KEGG_2019_Human,Influenza A,1/171,0.0085499075557634,0.0102284629486356,0,0,19829.0,94422.42241345016,HLA-DRB5
27409,KEGG_2019_Human,Tuberculosis,1/179,0.0089499050800561,0.0102284629486356,0,0,19821.0,93478.0629355712,HLA-DRB5
27410,KEGG_2019_Human,Epstein-Barr virus infection,1/201,0.0100498985877989,0.0109635257321443,0,0,19799.0,91079.21596609056,HLA-DRB5
27411,KEGG_2019_Human,Human T-cell leukemia virus 1 infection,1/219,0.0109498935894162,0.0114259759193908,0,0,19781.0,89299.85161916987,HLA-DRB5
27412,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,HLA-DRB5
27413,KEGG_2019_Human,MicroRNAs in cancer,1/299,0.0149498740670514,0.0149498740670514,0,0,19701.0,82804.33538735632,MIR99A
27414,KEGG_2019_Human,Spliceosome,1/134,0.0066999199497742,0.0066999199497742,0,0,19866.0,99442.43560916925,TXNL4A
27415,KEGG_2019_Human,MicroRNAs in cancer,1/299,0.0149498740670514,0.0149498740670514,0,0,19701.0,82804.33538735632,MIR20A
27416,KEGG_2019_Human,mRNA surveillance pathway,1/91,0.0045499369072032,0.0045499369072032,0,0,19909.0,107362.10783923086,WDR82
27417,KEGG_2019_Human,RIG-I-like receptor signaling pathway,1/70,0.0034999466296654,0.0034999466296654,0,0,19930.0,112704.30065625212,SIKE1
27418,KEGG_2019_Human,Nicotinate and nicotinamide metabolism,1/30,0.0014999697593334,0.004274929989447,0,0,19970.0,129851.13732048514,NT5C1B-RDH14
27419,KEGG_2019_Human,Pyrimidine metabolism,1/57,0.002849953326298,0.004274929989447,0,0,19943.0,116875.00742975442,NT5C1B-RDH14
27420,KEGG_2019_Human,Purine metabolism,1/129,0.006449921761047,0.006449921761047,0,0,19871.0,100223.109907462,NT5C1B-RDH14
27421,KEGG_2019_Human,Apelin signaling pathway,1/137,0.0068499188797651,0.0082999091363732,0,0,19863.0,98987.62735269018,BORCS8-MEF2B
27422,KEGG_2019_Human,cGMP-PKG signaling pathway,1/166,0.0082999091363732,0.0082999091363732,0,0,19834.0,95034.82345515196,BORCS8-MEF2B
27423,KEGG_2019_Human,Ribosome,1/153,0.0076499133771537,0.0076499133771537,0,0,19847.0,96715.6407630817,RPL37
27424,KEGG_2019_Human,Staphylococcus aureus infection,1/68,0.0033999476216189,0.0069749040587818,0,0,19932.0,113293.39338050144,DEFB4B
27425,KEGG_2019_Human,IL-17 signaling pathway,1/93,0.0046499360391879,0.0069749040587818,0,0,19907.0,106918.54242106884,DEFB4B
27426,KEGG_2019_Human,NOD-like receptor signaling pathway,1/178,0.0088999053857096,0.0088999053857096,0,0,19822.0,93593.82745769851,DEFB4B
27427,KEGG_2019_Human,Vascular smooth muscle contraction,1/132,0.0065999206698993,0.0082999091363732,0,0,19868.0,99751.22090491928,NPPC
27428,KEGG_2019_Human,Fluid shear stress and atherosclerosis,1/139,0.006949918172816,0.0082999091363732,0,0,19861.0,98689.81333375497,NPPC
27429,KEGG_2019_Human,cGMP-PKG signaling pathway,1/166,0.0082999091363732,0.0082999091363732,0,0,19834.0,95034.82345515196,NPPC
27430,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,NPW
27431,KEGG_2019_Human,Regulation of actin cytoskeleton,1/214,0.0106998949514067,0.0106998949514067,0,0,19786.0,89779.39753374986,TMSB4Y
27432,KEGG_2019_Human,Autophagy,1/128,0.0063999221281459,0.0063999221281459,0,0,19872.0,100382.8010329652,PRAP1
27433,KEGG_2019_Human,Oxidative phosphorylation,1/133,0.0066499203093911,0.0112582177134695,0,0,19867.0,99596.2591544721,NDUFB3
27434,KEGG_2019_Human,Parkinson disease,1/142,0.0070999171242726,0.0112582177134695,0,0,19858.0,98250.87390500787,NDUFB3
27435,KEGG_2019_Human,Retrograde endocannabinoid signaling,1/148,0.007399915061391,0.0112582177134695,0,0,19852.0,97399.60470052566,NDUFB3
27436,KEGG_2019_Human,Non-alcoholic fatty liver disease (NAFLD),1/149,0.0074499147221605,0.0112582177134695,0,0,19851.0,97261.02051561224,NDUFB3
27437,KEGG_2019_Human,Alzheimer disease,1/171,0.0085499075557634,0.0112582177134695,0,0,19829.0,94422.42241345016,NDUFB3
27438,KEGG_2019_Human,Huntington disease,1/193,0.0096499008972596,0.0112582177134695,0,0,19807.0,91920.47679471428,NDUFB3
27439,KEGG_2019_Human,Thermogenesis,1/231,0.0115498903940656,0.0115498903940656,0,0,19769.0,88191.07730937863,NDUFB3
27440,KEGG_2019_Human,RNA polymerase,1/31,0.0015499690656704,0.0030999381313408,0,0,19969.0,129189.85098816035,POLR2J2
27441,KEGG_2019_Human,Huntington disease,1/193,0.0096499008972596,0.0096499008972596,0,0,19807.0,91920.47679471428,POLR2J2
27442,KEGG_2019_Human,MicroRNAs in cancer,1/299,0.0149498740670514,0.0149498740670514,0,0,19701.0,82804.33538735632,MIR19B1
27443,KEGG_2019_Human,RNA degradation,1/79,0.0039499423167337,0.0068249053608048,0,0,19921.0,110243.89578070649,PABPC1L2B
27444,KEGG_2019_Human,mRNA surveillance pathway,1/91,0.0045499369072032,0.0068249053608048,0,0,19909.0,107362.10783923086,PABPC1L2B
27445,KEGG_2019_Human,RNA transport,1/165,0.0082499094553477,0.0082499094553477,0,0,19835.0,95159.46482222488,PABPC1L2B
27446,KEGG_2019_Human,Glutathione metabolism,1/56,0.0027999538675741,0.0036999446830449,0,0,19944.0,117233.87022514464,GPX7
27447,KEGG_2019_Human,Arachidonic acid metabolism,1/63,0.0031499501598827,0.0036999446830449,0,0,19937.0,114844.46974572667,GPX7
27448,KEGG_2019_Human,Thyroid hormone synthesis,1/74,0.0036999446830449,0.0036999446830449,0,0,19926.0,111574.38983110404,GPX7
27449,KEGG_2019_Human,MicroRNAs in cancer,1/299,0.0149498740670514,0.0149498740670514,0,0,19701.0,82804.33538735632,MIR183
27450,KEGG_2019_Human,MicroRNAs in cancer,1/299,0.0149498740670514,0.0149498740670514,0,0,19701.0,82804.33538735632,MIR1-1
27451,KEGG_2019_Human,Necroptosis,1/162,0.0080999104202618,0.0121998870519305,0,0,19838.0,95537.86936302872,CHMP4A
27452,KEGG_2019_Human,Endocytosis,1/244,0.0121998870519305,0.0121998870519305,0,0,19756.0,87051.4275316661,CHMP4A
27453,KEGG_2019_Human,Legionellosis,1/55,0.0027499544131125,0.0027499544131125,0,0,19945.0,117599.1294878737,RAB1A
27454,KEGG_2019_Human,RNA transport,1/165,0.0082499094553477,0.0082499094553477,0,0,19835.0,95159.46482222488,EIF3CL
27455,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,PMCH
27456,KEGG_2019_Human,MicroRNAs in cancer,1/299,0.0149498740670514,0.0149498740670514,0,0,19701.0,82804.33538735632,MIR135A2
27457,KEGG_2019_Human,RNA transport,1/165,0.0082499094553477,0.0082499094553477,0,0,19835.0,95159.46482222488,SMN2
27458,KEGG_2019_Human,MicroRNAs in cancer,1/299,0.0149498740670514,0.0149498740670514,0,0,19701.0,82804.33538735632,MIR494
27459,KEGG_2019_Human,MicroRNAs in cancer,1/299,0.0149498740670514,0.0149498740670514,0,0,19701.0,82804.33538735632,MIR16-1
27460,KEGG_2019_Human,Cardiac muscle contraction,1/78,0.0038999427840466,0.0112582177134695,0,0,19922.0,110503.2180492851,COX7A2L
27461,KEGG_2019_Human,Oxidative phosphorylation,1/133,0.0066499203093911,0.0112582177134695,0,0,19867.0,99596.2591544721,COX7A2L
27462,KEGG_2019_Human,Parkinson disease,1/142,0.0070999171242726,0.0112582177134695,0,0,19858.0,98250.87390500787,COX7A2L
27463,KEGG_2019_Human,Non-alcoholic fatty liver disease (NAFLD),1/149,0.0074499147221605,0.0112582177134695,0,0,19851.0,97261.02051561224,COX7A2L
27464,KEGG_2019_Human,Alzheimer disease,1/171,0.0085499075557634,0.0112582177134695,0,0,19829.0,94422.42241345016,COX7A2L
27465,KEGG_2019_Human,Huntington disease,1/193,0.0096499008972596,0.0112582177134695,0,0,19807.0,91920.47679471428,COX7A2L
27466,KEGG_2019_Human,Thermogenesis,1/231,0.0115498903940656,0.0115498903940656,0,0,19769.0,88191.07730937863,COX7A2L
27467,KEGG_2019_Human,Transcriptional misregulation in cancer,1/186,0.0092999029651357,0.0092999029651357,0,0,19814.0,92684.96451050608,NUPR1
27468,KEGG_2019_Human,alpha-Linolenic acid metabolism,1/25,0.0012499733663791,0.0052874076132858,0,0,19975.0,133525.54486996148,PLA2G2D
27469,KEGG_2019_Human,Linoleic acid metabolism,1/29,0.001449970461791,0.0052874076132858,0,0,19971.0,130534.69172799008,PLA2G2D
27470,KEGG_2019_Human,Fat digestion and absorption,1/41,0.0020499625466866,0.0052874076132858,0,0,19959.0,123544.88783416104,PLA2G2D
27471,KEGG_2019_Human,Ether lipid metabolism,1/47,0.0023499589392381,0.0052874076132858,0,0,19953.0,120782.64067395544,PLA2G2D
27472,KEGG_2019_Human,Arachidonic acid metabolism,1/63,0.0031499501598827,0.005669910287789,0,0,19937.0,114844.46974572667,PLA2G2D
27473,KEGG_2019_Human,Glycerophospholipid metabolism,1/97,0.0048499343304706,0.0062999150247102,0,0,19903.0,106058.9096435903,PLA2G2D
27474,KEGG_2019_Human,Pancreatic secretion,1/98,0.0048999339081079,0.0062999150247102,0,0,19902.0,105849.45495286948,PLA2G2D
27475,KEGG_2019_Human,Vascular smooth muscle contraction,1/132,0.0065999206698993,0.0074249107536368,0,0,19868.0,99751.22090491928,PLA2G2D
27476,KEGG_2019_Human,Ras signaling pathway,1/232,0.0115998901349604,0.0115998901349604,0,0,19768.0,88101.22480150245,PLA2G2D
27477,KEGG_2019_Human,Vitamin B6 metabolism,1/6,0.0002999905873105514,0.0002999905873105514,0,0,19994.0,162186.51863187927,PDXP
27478,KEGG_2019_Human,Peroxisome,1/83,0.0041499404726918,0.0041499404726918,0,0,19917.0,109237.99888847338,PRDX5
27479,KEGG_2019_Human,MicroRNAs in cancer,1/299,0.0149498740670514,0.0149498740670514,0,0,19701.0,82804.33538735632,MIR133B
27480,KEGG_2019_Human,Staphylococcus aureus infection,1/68,0.0033999476216189,0.0069749040587818,0,0,19932.0,113293.39338050144,DEFB4A
27481,KEGG_2019_Human,IL-17 signaling pathway,1/93,0.0046499360391879,0.0069749040587818,0,0,19907.0,106918.54242106884,DEFB4A
27482,KEGG_2019_Human,NOD-like receptor signaling pathway,1/178,0.0088999053857096,0.0088999053857096,0,0,19822.0,93593.82745769851,DEFB4A
27483,KEGG_2019_Human,MicroRNAs in cancer,1/299,0.0149498740670514,0.0149498740670514,0,0,19701.0,82804.33538735632,MIR520H
27484,KEGG_2019_Human,Cardiac muscle contraction,1/78,0.0038999427840466,0.0112582177134695,0,0,19922.0,110503.2180492851,COX5A
27485,KEGG_2019_Human,Oxidative phosphorylation,1/133,0.0066499203093911,0.0112582177134695,0,0,19867.0,99596.2591544721,COX5A
27486,KEGG_2019_Human,Parkinson disease,1/142,0.0070999171242726,0.0112582177134695,0,0,19858.0,98250.87390500787,COX5A
27487,KEGG_2019_Human,Non-alcoholic fatty liver disease (NAFLD),1/149,0.0074499147221605,0.0112582177134695,0,0,19851.0,97261.02051561224,COX5A
27488,KEGG_2019_Human,Alzheimer disease,1/171,0.0085499075557634,0.0112582177134695,0,0,19829.0,94422.42241345016,COX5A
27489,KEGG_2019_Human,Huntington disease,1/193,0.0096499008972596,0.0112582177134695,0,0,19807.0,91920.47679471428,COX5A
27490,KEGG_2019_Human,Thermogenesis,1/231,0.0115498903940656,0.0115498903940656,0,0,19769.0,88191.07730937863,COX5A
27491,KEGG_2019_Human,Pathogenic Escherichia coli infection,1/55,0.0027499544131125,0.0063699116700844,0,0,19945.0,117599.1294878737,ARPC1A
27492,KEGG_2019_Human,Shigellosis,1/65,0.003249949134407,0.0063699116700844,0,0,19935.0,114209.92613860144,ARPC1A
27493,KEGG_2019_Human,Bacterial invasion of epithelial cells,1/74,0.0036999446830449,0.0063699116700844,0,0,19926.0,111574.38983110404,ARPC1A
27494,KEGG_2019_Human,Salmonella infection,1/86,0.0042999391173866,0.0063699116700844,0,0,19914.0,108514.46102290176,ARPC1A
27495,KEGG_2019_Human,Fc gamma R-mediated phagocytosis,1/91,0.0045499369072032,0.0063699116700844,0,0,19909.0,107362.10783923086,ARPC1A
27496,KEGG_2019_Human,Regulation of actin cytoskeleton,1/214,0.0106998949514067,0.0121998870519305,0,0,19786.0,89779.39753374986,ARPC1A
27497,KEGG_2019_Human,Endocytosis,1/244,0.0121998870519305,0.0121998870519305,0,0,19756.0,87051.4275316661,ARPC1A
27498,KEGG_2019_Human,Ribosome,1/153,0.0076499133771537,0.0076499133771537,0,0,19847.0,96715.6407630817,RPL35A
27499,KEGG_2019_Human,Mitophagy,1/65,0.003249949134407,0.0089373959713052,0,0,19935.0,114209.92613860144,BECN2
27500,KEGG_2019_Human,Autophagy,1/128,0.0063999221281459,0.0089373959713052,0,0,19872.0,100382.8010329652,BECN2
27501,KEGG_2019_Human,Apelin signaling pathway,1/137,0.0068499188797651,0.0089373959713052,0,0,19863.0,98987.62735269018,BECN2
27502,KEGG_2019_Human,Apoptosis,1/143,0.0071499167770442,0.0089373959713052,0,0,19857.0,98106.57763600958,BECN2
27503,KEGG_2019_Human,Kaposi sarcoma-associated herpesvirus infection,1/186,0.0092999029651357,0.0092999029651357,0,0,19814.0,92684.96451050608,BECN2
27504,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR10J4
27505,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR4K3
27506,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF316
27507,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR52E1
27508,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR10AC1
27509,KEGG_2019_Human,Oxidative phosphorylation,1/133,0.0066499203093911,0.0112582177134695,0,0,19867.0,99596.2591544721,NDUFB7
27510,KEGG_2019_Human,Parkinson disease,1/142,0.0070999171242726,0.0112582177134695,0,0,19858.0,98250.87390500787,NDUFB7
27511,KEGG_2019_Human,Retrograde endocannabinoid signaling,1/148,0.007399915061391,0.0112582177134695,0,0,19852.0,97399.60470052566,NDUFB7
27512,KEGG_2019_Human,Non-alcoholic fatty liver disease (NAFLD),1/149,0.0074499147221605,0.0112582177134695,0,0,19851.0,97261.02051561224,NDUFB7
27513,KEGG_2019_Human,Alzheimer disease,1/171,0.0085499075557634,0.0112582177134695,0,0,19829.0,94422.42241345016,NDUFB7
27514,KEGG_2019_Human,Huntington disease,1/193,0.0096499008972596,0.0112582177134695,0,0,19807.0,91920.47679471428,NDUFB7
27515,KEGG_2019_Human,Thermogenesis,1/231,0.0115498903940656,0.0115498903940656,0,0,19769.0,88191.07730937863,NDUFB7
27516,KEGG_2019_Human,Progesterone-mediated oocyte maturation,1/99,0.0049499334884068,0.0062499232373748,0,0,19901.0,105642.09305076736,SPDYE16
27517,KEGG_2019_Human,Oocyte meiosis,1/125,0.0062499232373748,0.0062499232373748,0,0,19875.0,100869.32368441945,SPDYE16
27518,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR4E1
27519,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR10G6
27520,KEGG_2019_Human,Apoptosis,1/143,0.0071499167770442,0.0116248787064197,0,0,19857.0,98106.57763600958,DDIT3
27521,KEGG_2019_Human,Non-alcoholic fatty liver disease (NAFLD),1/149,0.0074499147221605,0.0116248787064197,0,0,19851.0,97261.02051561224,DDIT3
27522,KEGG_2019_Human,Protein processing in endoplasmic reticulum,1/165,0.0082499094553477,0.0116248787064197,0,0,19835.0,95159.46482222488,DDIT3
27523,KEGG_2019_Human,Transcriptional misregulation in cancer,1/186,0.0092999029651357,0.0116248787064197,0,0,19814.0,92684.96451050608,DDIT3
27524,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0147498749536506,0,0,19705.0,83086.53988020132,DDIT3
27525,KEGG_2019_Human,MicroRNAs in cancer,1/299,0.0149498740670514,0.0149498740670514,0,0,19701.0,82804.33538735632,MIR181B1
27526,KEGG_2019_Human,MicroRNAs in cancer,1/299,0.0149498740670514,0.0149498740670514,0,0,19701.0,82804.33538735632,MIR520B
27527,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF705E
27528,KEGG_2019_Human,Gastric acid secretion,1/75,0.0037499442041125,0.0037499442041125,0,0,19925.0,111301.33528642564,GAST
27529,KEGG_2019_Human,Fanconi anemia pathway,1/54,0.0026999549628563,0.0026999549628563,0,0,19946.0,117971.01964061816,SLX1A
27530,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR52E5
27531,KEGG_2019_Human,N-Glycan biosynthesis,1/50,0.0024999572069037,0.0049999144138074,0,0,19950.0,119530.05920663515,DAD1
27532,KEGG_2019_Human,Protein processing in endoplasmic reticulum,1/165,0.0082499094553477,0.0082499094553477,0,0,19835.0,95159.46482222488,DAD1
27533,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR12D1
27534,KEGG_2019_Human,Glucagon signaling pathway,1/103,0.0051499318302617,0.0051499318302617,0,0,19897.0,104832.7525292024,SIK1B
27535,KEGG_2019_Human,MicroRNAs in cancer,1/299,0.0149498740670514,0.0149498740670514,0,0,19701.0,82804.33538735632,MIR124-1
27536,KEGG_2019_Human,Bacterial invasion of epithelial cells,1/74,0.0036999446830449,0.0121998870519305,0,0,19926.0,111574.38983110404,CAV2
27537,KEGG_2019_Human,Fluid shear stress and atherosclerosis,1/139,0.006949918172816,0.0121998870519305,0,0,19861.0,98689.81333375497,CAV2
27538,KEGG_2019_Human,Focal adhesion,1/199,0.0099498991610159,0.0121998870519305,0,0,19801.0,91286.4288690606,CAV2
27539,KEGG_2019_Human,Proteoglycans in cancer,1/201,0.0100498985877989,0.0121998870519305,0,0,19799.0,91079.21596609056,CAV2
27540,KEGG_2019_Human,Endocytosis,1/244,0.0121998870519305,0.0121998870519305,0,0,19756.0,87051.4275316661,CAV2
27541,KEGG_2019_Human,RNA transport,1/165,0.0082499094553477,0.0082499094553477,0,0,19835.0,95159.46482222488,EIF1AY
27542,KEGG_2019_Human,Ribosome,1/153,0.0076499133771537,0.0076499133771537,0,0,19847.0,96715.6407630817,RPS27L
27543,KEGG_2019_Human,Protein digestion and absorption,1/90,0.0044999373439762,0.0097998678162159,0,0,19910.0,107587.50385474482,PRSS2
27544,KEGG_2019_Human,Pancreatic secretion,1/98,0.0048999339081079,0.0097998678162159,0,0,19902.0,105849.45495286948,PRSS2
27545,KEGG_2019_Human,Influenza A,1/171,0.0085499075557634,0.0113998767410179,0,0,19829.0,94422.42241345016,PRSS2
27546,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,PRSS2
27547,KEGG_2019_Human,SNARE interactions in vesicular transport,1/34,0.0016999670339032,0.0041249316196688,0,0,19966.0,127326.1054203148,SEC22B
27548,KEGG_2019_Human,Legionellosis,1/55,0.0027499544131125,0.0041249316196688,0,0,19945.0,117599.1294878737,SEC22B
27549,KEGG_2019_Human,Phagosome,1/152,0.0075999137114971,0.0075999137114971,0,0,19848.0,96850.665715497,SEC22B
27550,KEGG_2019_Human,Oxidative phosphorylation,1/133,0.0066499203093911,0.0115498903940656,0,0,19867.0,99596.2591544721,ATP5MG
27551,KEGG_2019_Human,Thermogenesis,1/231,0.0115498903940656,0.0115498903940656,0,0,19769.0,88191.07730937863,ATP5MG
27552,KEGG_2019_Human,Mucin type O-glycan biosynthesis,1/31,0.0015499690656704,0.0015499690656704,0,0,19969.0,129189.85098816035,GALNT4
27553,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,NPY4R2
27554,KEGG_2019_Human,ABC transporters,1/45,0.0022499601197094,0.0033999476216189,0,0,19955.0,121662.49782449217,DEFB1
27555,KEGG_2019_Human,Staphylococcus aureus infection,1/68,0.0033999476216189,0.0033999476216189,0,0,19932.0,113293.39338050144,DEFB1
27556,KEGG_2019_Human,Hematopoietic cell lineage,1/97,0.0048499343304706,0.0048499343304706,0,0,19903.0,106058.9096435903,CD24
27557,KEGG_2019_Human,mTOR signaling pathway,1/152,0.0075999137114971,0.0075999137114971,0,0,19848.0,96850.665715497,LAMTOR2
27558,KEGG_2019_Human,Chemical carcinogenesis,1/82,0.004099940929819,0.004099940929819,0,0,19918.0,109484.9180722932,SULT1A4
27559,KEGG_2019_Human,Progesterone-mediated oocyte maturation,1/99,0.0049499334884068,0.0085623985997064,0,0,19901.0,105642.09305076736,ANAPC10
27560,KEGG_2019_Human,Cell cycle,1/124,0.0061999236097501,0.0085623985997064,0,0,19876.0,101034.04709010696,ANAPC10
27561,KEGG_2019_Human,Oocyte meiosis,1/125,0.0062499232373748,0.0085623985997064,0,0,19875.0,100869.32368441945,ANAPC10
27562,KEGG_2019_Human,Ubiquitin mediated proteolysis,1/137,0.0068499188797651,0.0085623985997064,0,0,19863.0,98987.62735269018,ANAPC10
27563,KEGG_2019_Human,Human T-cell leukemia virus 1 infection,1/219,0.0109498935894162,0.0109498935894162,0,0,19781.0,89299.85161916987,ANAPC10
27564,KEGG_2019_Human,alpha-Linolenic acid metabolism,1/25,0.0012499733663791,0.0083598935608305,0,0,19975.0,133525.54486996148,PLA2G4B
27565,KEGG_2019_Human,Linoleic acid metabolism,1/29,0.001449970461791,0.0083598935608305,0,0,19971.0,130534.69172799008,PLA2G4B
27566,KEGG_2019_Human,Ether lipid metabolism,1/47,0.0023499589392381,0.0083598935608305,0,0,19953.0,120782.64067395544,PLA2G4B
27567,KEGG_2019_Human,Ovarian steroidogenesis,1/49,0.0024499577795033,0.0083598935608305,0,0,19951.0,119939.1172087114,PLA2G4B
27568,KEGG_2019_Human,VEGF signaling pathway,1/59,0.0029499522555206,0.0083598935608305,0,0,19941.0,116175.59385530632,PLA2G4B
27569,KEGG_2019_Human,Long-term depression,1/60,0.002999951725986,0.0083598935608305,0,0,19940.0,115834.63209072244,PLA2G4B
27570,KEGG_2019_Human,Arachidonic acid metabolism,1/63,0.0031499501598827,0.0083598935608305,0,0,19937.0,114844.46974572667,PLA2G4B
27571,KEGG_2019_Human,Fc epsilon RI signaling pathway,1/68,0.0033999476216189,0.0083598935608305,0,0,19932.0,113293.39338050144,PLA2G4B
27572,KEGG_2019_Human,Fc gamma R-mediated phagocytosis,1/91,0.0045499369072032,0.0083598935608305,0,0,19909.0,107362.10783923086,PLA2G4B
27573,KEGG_2019_Human,GnRH signaling pathway,1/93,0.0046499360391879,0.0083598935608305,0,0,19907.0,106918.54242106884,PLA2G4B
27574,KEGG_2019_Human,Glycerophospholipid metabolism,1/97,0.0048499343304706,0.0083598935608305,0,0,19903.0,106058.9096435903,PLA2G4B
27575,KEGG_2019_Human,Choline metabolism in cancer,1/99,0.0049499334884068,0.0083598935608305,0,0,19901.0,105642.09305076736,PLA2G4B
27576,KEGG_2019_Human,Inflammatory mediator regulation of TRP channels,1/100,0.0049999330710556,0.0083598935608305,0,0,19900.0,105436.78197328727,PLA2G4B
27577,KEGG_2019_Human,Serotonergic synapse,1/113,0.0056499278191151,0.0083598935608305,0,0,19887.0,102937.34947211576,PLA2G4B
27578,KEGG_2019_Human,Glutamatergic synapse,1/114,0.005699927427839,0.0083598935608305,0,0,19886.0,102756.96431429044,PLA2G4B
27579,KEGG_2019_Human,Platelet activation,1/124,0.0061999236097501,0.0085248949634064,0,0,19876.0,101034.04709010696,PLA2G4B
27580,KEGG_2019_Human,Vascular smooth muscle contraction,1/132,0.0065999206698993,0.008541073808105,0,0,19868.0,99751.22090491928,PLA2G4B
27581,KEGG_2019_Human,Phospholipase D signaling pathway,1/148,0.007399915061391,0.0088577944367043,0,0,19852.0,97399.60470052566,PLA2G4B
27582,KEGG_2019_Human,Oxytocin signaling pathway,1/153,0.0076499133771537,0.0088577944367043,0,0,19847.0,96715.6407630817,PLA2G4B
27583,KEGG_2019_Human,Necroptosis,1/162,0.0080999104202618,0.008909901462288,0,0,19838.0,95537.86936302872,PLA2G4B
27584,KEGG_2019_Human,Ras signaling pathway,1/232,0.0115998901349604,0.0121522658556728,0,0,19768.0,88101.22480150245,PLA2G4B
27585,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0147498749536506,0,0,19705.0,83086.53988020132,PLA2G4B
27586,KEGG_2019_Human,Ribosome,1/153,0.0076499133771537,0.0076499133771537,0,0,19847.0,96715.6407630817,MRPL12
27587,KEGG_2019_Human,MicroRNAs in cancer,1/299,0.0149498740670514,0.0149498740670514,0,0,19701.0,82804.33538735632,MIR122
27588,KEGG_2019_Human,MicroRNAs in cancer,1/299,0.0149498740670514,0.0149498740670514,0,0,19701.0,82804.33538735632,MIR19A
27589,KEGG_2019_Human,MicroRNAs in cancer,1/299,0.0149498740670514,0.0149498740670514,0,0,19701.0,82804.33538735632,MIR30D
27590,KEGG_2019_Human,MicroRNAs in cancer,1/299,0.0149498740670514,0.0149498740670514,0,0,19701.0,82804.33538735632,MIR30B
27591,KEGG_2019_Human,MicroRNAs in cancer,1/299,0.0149498740670514,0.0149498740670514,0,0,19701.0,82804.33538735632,MIR221
27592,KEGG_2019_Human,RNA degradation,1/79,0.0039499423167337,0.0066999199497742,0,0,19921.0,110243.89578070649,LSM6
27593,KEGG_2019_Human,Spliceosome,1/134,0.0066999199497742,0.0066999199497742,0,0,19866.0,99442.43560916925,LSM6
27594,KEGG_2019_Human,MicroRNAs in cancer,1/299,0.0149498740670514,0.0149498740670514,0,0,19701.0,82804.33538735632,MIR92A1
27595,KEGG_2019_Human,MicroRNAs in cancer,1/299,0.0149498740670514,0.0149498740670514,0,0,19701.0,82804.33538735632,MIR17
27596,KEGG_2019_Human,MicroRNAs in cancer,1/299,0.0149498740670514,0.0149498740670514,0,0,19701.0,82804.33538735632,MIR129-1
27597,KEGG_2019_Human,Ribosome biogenesis in eukaryotes,1/101,0.0050499326546803,0.0082499094553477,0,0,19899.0,105233.48101229242,SNORD3C
27598,KEGG_2019_Human,RNA transport,1/165,0.0082499094553477,0.0082499094553477,0,0,19835.0,95159.46482222488,SNORD3C
27599,KEGG_2019_Human,MicroRNAs in cancer,1/299,0.0149498740670514,0.0149498740670514,0,0,19701.0,82804.33538735632,MIR331
27600,KEGG_2019_Human,MicroRNAs in cancer,1/299,0.0149498740670514,0.0149498740670514,0,0,19701.0,82804.33538735632,MIR193B
27601,KEGG_2019_Human,MicroRNAs in cancer,1/299,0.0149498740670514,0.0149498740670514,0,0,19701.0,82804.33538735632,MIR15A
27602,KEGG_2019_Human,MicroRNAs in cancer,1/299,0.0149498740670514,0.0149498740670514,0,0,19701.0,82804.33538735632,MIR100
27603,KEGG_2019_Human,MicroRNAs in cancer,1/299,0.0149498740670514,0.0149498740670514,0,0,19701.0,82804.33538735632,MIRLET7D
27604,KEGG_2019_Human,MicroRNAs in cancer,1/299,0.0149498740670514,0.0149498740670514,0,0,19701.0,82804.33538735632,MIRLET7A1
27605,KEGG_2019_Human,Ribosome biogenesis in eukaryotes,1/101,0.0050499326546803,0.0082499094553477,0,0,19899.0,105233.48101229242,SNORD3A
27606,KEGG_2019_Human,RNA transport,1/165,0.0082499094553477,0.0082499094553477,0,0,19835.0,95159.46482222488,SNORD3A
27607,KEGG_2019_Human,Protein digestion and absorption,1/90,0.0044999373439762,0.0044999373439762,0,0,19910.0,107587.50385474482,PGA4
